FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU van Dijk, AE
   Olthof, MR
   Meeuse, JC
   Seebus, E
   Heine, RJ
   van Dam, RM
AF van Dijk, Aimee E.
   Olthof, Margreet R.
   Meeuse, Joke C.
   Seebus, Elin
   Heine, Rob J.
   van Dam, Rob M.
TI Acute Effects of Decaffeinated Coffee and the Major Coffee Components
   Chlorogenic Acid and Trigonelline on Glucose Tolerance
SO DIABETES CARE
LA English
DT Article
ID CAFFEINE; RATS; INHIBITORS; GLYCEMIA; PLASMA; RISK
AB OBJECTIVE - Coffee consumption has been associated with lower risk of type 2 diabetes. We evaluated the acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance.
   RESEARCH DESIGN AND METHODS - We conducted a randomized crossover trial of the effects of 12 g decaffeinated coffee, 1 g chlorogenic acid, 500 mg trigonelline, and placebo (1 g mannitol) on glucose and insulin concentrations during a 2-h oral glucose tolerance test (OGTT) in 15 overweight men.
   RESULTS - Chlorogenic acid and trigonelline ingestion significantly reduced glucose (-0.7 mmol/l, P = 0.007, and -0.5 mmol/l, P = 0.024, respectively) and insulin (-73 pmol/l, P = 0.038, and -117 pmol/l, P = 0.007) concentrations 15 min following an OGTT compared with placebo. None of the treatments affected insulin or glucose area under the curve values during the OGTT compared with placebo.
   CONCLUSIONS - Chlorogenic acid and trigonelline reduced early glucose and insulin responses during an OGTT. Diabetes Care 32:1.023-1025, 2009
C1 [van Dijk, Aimee E.; Olthof, Margreet R.; Meeuse, Joke C.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.
   [van Dijk, Aimee E.; Olthof, Margreet R.; Meeuse, Joke C.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Seebus, Elin; Heine, Rob J.] Vrije Univ Amsterdam, Dept Endocrinol, Amsterdam, Netherlands.
   [van Dam, Rob M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [van Dam, Rob M.] Harvard Univ, Brigham & Womens Hosp, Channing Lab, Sch Med, Boston, MA 02115 USA.
C3 Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije
   Universiteit Amsterdam; Harvard University; Harvard T.H. Chan School of
   Public Health; Harvard University; Harvard Medical School; Harvard
   University Medical Affiliates; Brigham & Women's Hospital
RP Olthof, MR (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.
EM margreet.olthof@falw.vu.nl
RI van Dam, Rob/F-9674-2010; van Nieuw Amerongen, Joke/HPD-2151-2023; van
   Dam, Rob/A-6693-2009
OI , Margreet/0000-0002-1982-9244; van Dam, Rob/0000-0002-7354-8734; van
   Nieuw Amerongen - Meeuse, Johanna Catharina/0000-0001-7584-3211
FU Dutch Diabetes Research Foundation [2006.11.020]
FX Acknowledgments-The research for this study was financially supported by
   the Dutch Diabetes Research Foundation (Stichting Diabetes Fonds
   Nederland Grant 2006.11.020).
CR Andrade-Cetto A, 2001, J ETHNOPHARMACOL, V78, P145, DOI 10.1016/S0378-8741(01)00335-X
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Ishikawa A, 2007, J NUTR SCI VITAMINOL, V53, P166, DOI 10.3177/jnsv.53.166
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Louie JCY, 2008, ASIA PAC J CLIN NUTR, V17, P657
   Minamisawa M, 2004, ANAL SCI, V20, P325, DOI 10.2116/analsci.20.325
   MISHKINSKY J, 1967, LANCET, V2, P1311
   Slow S, 2004, INT J BIOCHEM CELL B, V36, P870, DOI 10.1016/j.biocel.2003.10.001
   TRUGO LC, 1984, ANALYST, V109, P263, DOI 10.1039/an9840900263
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
NR 15
TC 211
Z9 226
U1 1
U2 45
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JUN
PY 2009
VL 32
IS 6
BP 1023
EP 1025
DI 10.2337/dc09-0207
PG 3
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 452EG
UT WOS:000266522200010
PM 19324944
OA hybrid, Green Published, Green Accepted
DA 2025-04-28
ER

PT J
AU Coelho, M
   Patarrao, RS
   Sousa-Lima, I
   Ribeiro, RT
   Meneses, MJ
   Andrade, R
   Mendes, VM
   Manadas, B
   Raposo, JF
   Macedo, MP
   Jones, JG
AF Coelho, Margarida
   Patarrao, Rita S.
   Sousa-Lima, Ines
   Ribeiro, Rogerio T.
   Meneses, Maria Joao
   Andrade, Rita
   Mendes, Vera M.
   Manadas, Bruno
   Raposo, Joao Filipe
   Macedo, M. Paula
   Jones, John G.
TI Increased Intake of Both Caffeine and Non-Caffeine Coffee Components Is
   Associated with Reduced NAFLD Severity in Subjects with Type 2 Diabetes
SO NUTRIENTS
LA English
DT Article
DE non-alcoholic fatty liver disease; fatty liver index; type 2 diabetes;
   caffeine; fibrosis
ID NONALCOHOLIC FATTY LIVER; DECAFFEINATED COFFEE; CIRCULATING ZONULIN;
   CHLOROGENIC ACID; CONSUMPTION; PLASMA; RISK; STEATOHEPATITIS; FIBROSIS;
   ALCOHOL
AB Coffee may protect against non-alcoholic fatty liver disease (NAFLD), but the roles of the caffeine and non-caffeine components are unclear. Coffee intake by 156 overweight subjects (87% with Type-2-Diabetes, T2D) was assessed via a questionnaire, with 98 subjects (all T2D) also providing a 24 h urine sample for quantification of coffee metabolites by LC-MS/MS. NAFLD was characterized by the fatty liver index (FLI) and by Fibroscan((R)) assessment of fibrosis. No associations were found between self-reported coffee intake and NAFLD parameters; however, total urine caffeine metabolites, defined as Sigma(caffeine) (caffeine + paraxanthine + theophylline), and adjusted for fat-free body mass, were significantly higher for subjects with no liver fibrosis than for those with fibrosis. Total non-caffeine metabolites, defined as Sigma(ncm) (trigonelline + caffeic acid + p-coumaric acid), showed a significant negative association with the FLI. Multiple regression analyses for overweight/obese T2D subjects (n = 89) showed that both Sigma(caffeine) and Sigma(ncm) were negatively associated with the FLI, after adjusting for age, sex, Hb(A1c), ethanol intake and glomerular filtration rate. The theophylline fraction of Sigma(caffeine) was significantly increased with both fibrosis and the FLI, possibly reflecting elevated CYP2E1 activity-a hallmark of NAFLD worsening. Thus, for overweight/obese T2D patients, higher intake of both caffeine and non-caffeine coffee components is associated with less severe NAFLD. Caffeine metabolites represent novel markers of NAFLD progression.
C1 [Coelho, Margarida; Mendes, Vera M.; Manadas, Bruno; Jones, John G.] Univ Coimbra, Ctr Neurosci & Cell Biol, CNC, P-3004504 Coimbra, Portugal.
   [Coelho, Margarida; Mendes, Vera M.; Manadas, Bruno; Jones, John G.] Univ Coimbra, CIBB Ctr Innovat Biomed & Biotechnol, P-3004531 Coimbra, Portugal.
   [Coelho, Margarida; Mendes, Vera M.; Manadas, Bruno; Jones, John G.] Univ Coimbra IIIUC, Inst Interdisciplinary Res 3, P-3030789 Coimbra, Portugal.
   [Patarrao, Rita S.; Sousa-Lima, Ines; Meneses, Maria Joao; Macedo, M. Paula] Univ Nova Lisboa, Fac Ciencias Med, NOVA Med Sch, NMS FCM,iNOVA4Health, P-1169056 Lisbon, Portugal.
   [Ribeiro, Rogerio T.; Andrade, Rita; Raposo, Joao Filipe; Macedo, M. Paula] APDP Diabet Portugal Educ & Res Ctr, P-1250189 Lisbon, Portugal.
C3 Universidade de Coimbra; Universidade de Coimbra; Universidade de
   Coimbra; Universidade Nova de Lisboa
RP Jones, JG (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, CNC, P-3004504 Coimbra, Portugal.; Jones, JG (corresponding author), Univ Coimbra, CIBB Ctr Innovat Biomed & Biotechnol, P-3004531 Coimbra, Portugal.; Jones, JG (corresponding author), Univ Coimbra IIIUC, Inst Interdisciplinary Res 3, P-3030789 Coimbra, Portugal.
EM john.griffith.jones@gmail.com
RI Jones, John/A-8684-2010; Manadas, Bruno/A-7667-2012; Meneses, Maria
   João/N-2584-2019; Sousa-Lima, Inês/AAH-8943-2021; Mendes,
   Vera/L-1995-2013; Raposo, João/B-9630-2011; Macedo, Maria/Q-7827-2018;
   Patarrao, Rita/Q-7832-2018; Coelho, Margarida/E-1815-2015; Ribeiro,
   Rogerio/N-3656-2016
OI Patarrao, Rita/0000-0001-8701-2917; Coelho,
   Margarida/0000-0002-0392-1118; Ribeiro, Rogerio/0000-0001-8840-7208;
   Sousa-Lima, Ines/0000-0003-1859-0486; Macedo, Maria
   Paula/0000-0002-2549-0275; Meneses, Maria Joao/0000-0002-8236-5411;
   RAPOSO, JOAO/0000-0003-2589-7208; Jones, John/0000-0002-3745-3885;
   Manadas, Bruno/0000-0002-2087-4042
FU Institute for Scientific Information on Coffee (ISIC); European Regional
   Development Fund (ERDF); COMPETE 2020-Operational Programme for
   Competitiveness and Internationalization; Portuguese national funds via
   Fundacao para a Ciencia e Tecnologia (FCT) [UIDB/04539/2020,
   UIDP/04539/2020, LA/P/0058/2020, PD/BD/135178/2017]; iNOVA4Health
   [UIDB/Multi/04462/2020]; National Mass Spectrometry Network (RNEM)
   [POCI-01-0145-FEDER-402-022125, ROTEIRO/0028/2013]; European Social Fund
   (ESF); POCH-Programa Operacional do Capital Humano; National funds via
   FCT; Centro 2020 Regional Operational Programme
FX This research was financed by a grant from the Institute for Scientific
   Information on Coffee (ISIC), by the European Regional Development Fund
   (ERDF), through the Centro 2020 Regional Operational Programme, the
   COMPETE 2020-Operational Programme for Competitiveness and
   Internationalization, and by Portuguese national funds via Fundacao para
   a Ciencia e Tecnologia (FCT): UIDB/04539/2020, UIDP/04539/2020,
   LA/P/0058/2020 and iNOVA4Health (UIDB/Multi/04462/2020). The National
   Mass Spectrometry Network (RNEM) provided funding under the contract
   POCI-01-0145-FEDER-402-022125 (ref.: ROTEIRO/0028/2013). M.C. was
   supported by PhD fellowship PD/BD/135178/2017, co-financed by the
   European Social Fund (ESF), through the POCH-Programa Operacional do
   Capital Humano, and national funds via FCT.
CR Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019
   Antonioli L, 2015, NAT REV ENDOCRINOL, V11, P228, DOI 10.1038/nrendo.2015.10
   Anty R, 2012, J HEPATOL, V57, P1090, DOI 10.1016/j.jhep.2012.07.014
   Bambha K, 2014, LIVER INT, V34, P1250, DOI 10.1111/liv.12379
   Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
   Bell LN, 1996, FOOD RES INT, V29, P785, DOI 10.1016/S0963-9969(97)00002-1
   Brandt A, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.101092
   Brunmair J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26245-4
   Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812
   Chen YP, 2019, CLIN NUTR, V38, P2552, DOI 10.1016/j.clnu.2018.11.030
   Csóka B, 2017, FASEB J, V31, P4985, DOI 10.1096/fj.201700398R
   Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126
   Ebadi M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13093042
   Hayat U, 2021, ANN HEPATOL, V20, DOI 10.1016/j.aohep.2020.08.071
   Hendy OM, 2017, APMIS, V125, P607, DOI 10.1111/apm.12696
   Hodge A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010056
   Hsu SJ, 2015, HEPATOLOGY, V61, P1672, DOI 10.1002/hep.27679
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Khalaf N, 2015, CLIN GASTROENTEROL H, V13, P1521, DOI 10.1016/j.cgh.2015.01.030
   Kim AS, 2018, DIABET METAB SYND OB, V11, P149, DOI 10.2147/DMSO.S163062
   Kim JH, 2018, CLIN CHIM ACTA, V481, P218, DOI 10.1016/j.cca.2018.03.005
   Klatsky AL, 2006, ARCH INTERN MED, V166, P1190, DOI 10.1001/archinte.166.11.1190
   Kositamongkol C, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.786596
   Lang R, 2008, J AGR FOOD CHEM, V56, P11114, DOI 10.1021/jf802838s
   Leung TM, 2013, J HEPATOL, V58, P395, DOI 10.1016/j.jhep.2012.08.018
   Lieber CS, 2004, AM J CLIN NUTR, V79, P502
   Luukkonen PK, 2022, J HEPATOL, V76, P526, DOI 10.1016/j.jhep.2021.10.013
   Ma HL, 2021, J GASTROEN HEPATOL, V36, P2925, DOI 10.1111/jgh.15554
   Martínez-López S, 2014, FOOD RES INT, V64, P125, DOI 10.1016/j.foodres.2014.05.043
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Massart J, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11020288
   Mazzone G, 2016, FUNCT FOODS HEALTH D, V6, P602
   Mendes VM, 2019, MOLECULES, V24, DOI 10.3390/molecules24162863
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Mouzaki M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151829
   Nebert DW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0431
   Olechno E, 2021, FOODS, V10, DOI 10.3390/foods10061208
   Pacifico L, 2014, WORLD J GASTROENTERO, V20, P17107, DOI 10.3748/wjg.v20.i45.17107
   Petrovic D, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0144-4
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Rothwell JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093474
   Rybak ME, 2014, ANAL BIOANAL CHEM, V406, P771, DOI 10.1007/s00216-013-7506-9
   Saponaro C, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0607-4
   Sharma L, 2018, FOOD CHEM TOXICOL, V121, P283, DOI 10.1016/j.fct.2018.09.011
   Shen Huafeng, 2016, Therap Adv Gastroenterol, V9, P113, DOI 10.1177/1756283X15593700
   Shi AM, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.693048
   Travassos M, 2015, J ALZHEIMERS DIS, V47, P1069, DOI 10.3233/JAD-150374
   Tricò D, 2018, HEPATOLOGY, V68, P1376, DOI 10.1002/hep.30035
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vanderlee L, 2018, J ACAD NUTR DIET, V118, P2245, DOI 10.1016/j.jand.2018.07.016
   Veronese N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010089
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092482
   Wang Q, 2015, INT IMMUNOPHARMACOL, V25, P340, DOI 10.1016/j.intimp.2015.02.012
   Wijarnpreecha K, 2017, EUR J GASTROEN HEPAT, V29, pE8, DOI 10.1097/MEG.0000000000000776
   Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X
   Xiao Q, 2014, HEPATOLOGY, V60, P2091, DOI 10.1002/hep.27367
   Yang Q, 2018, NAT REV MOL CELL BIO, V19, P654, DOI 10.1038/s41580-018-0044-8
   Zhang D, 2014, DIABETES RES CLIN PR, V106, P312, DOI 10.1016/j.diabres.2014.08.017
   Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093
NR 62
TC 12
Z9 12
U1 8
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JAN
PY 2023
VL 15
IS 1
AR 4
DI 10.3390/nu15010004
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 7R6DF
UT WOS:000910160900001
PM 36615664
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Thom, E
AF Thom, E.
TI The effect of chlorogenic acid enriched coffee on glucose absorption in
   healthy volunteers and its effect on body mass when used long-term in
   overweight and obese people
SO JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
LA English
DT Article
DE chlorogenic acid; coffee; glucose; diet
ID CAFFEIC ACID; CONSUMPTION; TOLERANCE; INHIBITORS; TEA
AB The results from a clinical study performed in 12 healthy volunteers with different coffee products containing glucose show that instant coffee enriched with chlorogenic acid induced a reduction in the absorption of glucose of 6.9% compared with the control. No such effects were seen with normal or decaffeinated instant coffee. In a second, comparative, randomized, double-blind, 12-week study we investigated the effect on the body mass of 30 overweight people, compared with normal instant coffee. The average losses in mass in the chlorogenic acid enriched and normal instant coffee groups were 5.4 and 1.7 kg, respectively. We conclude that chlorogenic acid enriched instant coffee appears to have a significant effect on the absorption and utilization of glucose from the diet. This effect, if the coffee is used for an extended time, may result in reduced body mass and body fat when compared with the use of normal instant coffee.
C1 ETC Res & Dev, N-0774 Oslo, Norway.
RP Thom, E (corresponding author), ETC Res & Dev, Stasjonsveien 5A, N-0774 Oslo, Norway.
EM erlingthom@etc.as
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Bidel S, 2006, HORM METAB RES, V38, P38, DOI 10.1055/s-2006-924982
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Andersen LF, 2006, AM J CLIN NUTR, V83, P1039, DOI 10.1093/ajcn/83.5.1039
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Herling AW, 1998, AM J PHYSIOL-GASTR L, V274, pG1087, DOI 10.1152/ajpgi.1998.274.6.G1087
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hiltunen LA, 2006, EUR J CLIN NUTR, V60, P1222, DOI 10.1038/sj.ejcn.1602441
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lafay S, 2005, INT J VITAM NUTR RES, V75, P119, DOI 10.1024/0300-9831.75.2.119
   Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   MELETIS CD, 2006, ALTERN COMPLEMEN FEB, P7
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Simon C, 2000, ARCH BIOCHEM BIOPHYS, V373, P418, DOI 10.1006/abbi.1999.1560
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
NR 24
TC 203
Z9 226
U1 1
U2 42
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0300-0605
EI 1473-2300
J9 J INT MED RES
JI J. Int. Med. Res.
PD NOV-DEC
PY 2007
VL 35
IS 6
BP 900
EP 908
DI 10.1177/147323000703500620
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 237NV
UT WOS:000251382700020
PM 18035001
DA 2025-04-28
ER

PT J
AU Gavrieli, A
   Karfopoulou, E
   Kardatou, E
   Spyreli, E
   Fragopoulou, E
   Mantzoros, CS
   Yannakoulia, M
AF Gavrieli, A.
   Karfopoulou, E.
   Kardatou, E.
   Spyreli, E.
   Fragopoulou, E.
   Mantzoros, C. S.
   Yannakoulia, M.
TI Effect of Different Amounts of Coffee on Dietary Intake and Appetite of
   Normal-Weight and Overweight/Obese Individuals
SO OBESITY
LA English
DT Article
ID CAFFEINE CONSUMPTION; CHLOROGENIC ACID; ENERGY-INTAKE; LONG-TERM;
   INSULIN; MEN; MANNOOLIGOSACCHARIDES; SECRETION; OBESITY; TEA
AB Objective: To investigate the effects of different coffee amounts on dietary intake and appetite feelings in normal-weight and overweight/obese individuals.
   Design and Methods: Thirty-three volunteers (16 normal-weight, 17 overweight/obese) participated in three trials: they consumed a standard breakfast along with 200 ml of either coffee with 3 or 6 mg caffeine/kg body weight (Coffee 3 and Coffee 6, respectively), or water. At fasting and at standard time points for the 3 h following breakfast/drink consumption participants recorded their appetite feelings on visual analogue scales. At 180 min, participants consumed an ad libitum meal and the next day they recalled their food intake during the experimental day.
   Results: A significant intervention effect was found for the energy intake of the ad libitum meal (P = 0.05) and of the whole day (P = 0.02) only in overweight/obese individuals. Specifically, Coffee 6 resulted in a reduced energy intake during the ad libitum meal compared to Coffee 3 (P = 0.03) and in the total day compared to both water (P = 0.04) and Coffee 3 (P = 0.008). No effect was observed for the appetite feelings.
   Conclusions: A moderate coffee amount can effectively reduce energy intake in the following meal and in the total day compared to lower or no coffee intake in overweight/obese participants.
C1 [Gavrieli, A.; Karfopoulou, E.; Kardatou, E.; Spyreli, E.; Fragopoulou, E.; Yannakoulia, M.] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece.
   [Mantzoros, C. S.] VA Boston Healthcare Syst, Endocrinol Sect, Dept Vet Affairs, Boston, MA USA.
   [Mantzoros, C. S.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.
C3 Harokopio University Athens; Harvard University; Harvard University
   Medical Affiliates; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Boston Healthcare System; Harvard University;
   Harvard University Medical Affiliates; Beth Israel Deaconess Medical
   Center
RP Yannakoulia, M (corresponding author), Harokopio Univ, Dept Nutr & Dietet, Athens, Greece.
EM myiannak@hua.gr
RI Fragopoulou, Elizabeth/AAN-2050-2021; Mantzoros, Christos/Y-2902-2019
OI Yannakoulia, Mary/0000-0003-2171-7337; Spyreli,
   Eleni/0000-0002-2289-8101
FU Department of Nutrition and Dietetics, Harokopio University
FX The study was supported through funding from the Graduate Program of the
   Department of Nutrition and Dietetics, Harokopio University. Additional
   Supporting Information may be found in the online version of this
   article.
CR [Anonymous], 2010, USDA National Nutrient Database for Standard Reference
   [Anonymous], 2006, DEV VAL REL HAR PHYS
   Brennan IM, 2009, AM J PHYSIOL-GASTR L, V297, pG602, DOI 10.1152/ajpgi.00051.2009
   DOUGLAS BR, 1990, AM J CLIN NUTR, V52, P553, DOI 10.1093/ajcn/52.3.553
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Jessen A, 2005, DIABETES OBES METAB, V7, P327, DOI 10.1111/j.1463-1326.2004.00389.x
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Neary MT, 2009, PHARMACOL THERAPEUT, V124, P44, DOI 10.1016/j.pharmthera.2009.06.005
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207
   Salinardi TC, 2010, J NUTR, V140, P1943, DOI 10.3945/jn.110.128207
   St-Onge MP, 2012, OBESITY, V20, P343, DOI 10.1038/oby.2011.289
   Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   TREMBLAY A, 1988, NUTR RES, V8, P553, DOI 10.1016/S0271-5317(88)80077-0
   VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866
   Yannakoulia M, 2010, J AM GERIATR SOC, V58, P1208, DOI 10.1111/j.1532-5415.2010.02893.x
   Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224
NR 27
TC 45
Z9 53
U1 1
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD JUN
PY 2013
VL 21
IS 6
BP 1127
EP 1132
DI 10.1002/oby.20190
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 192LV
UT WOS:000322487000010
PM 23671022
DA 2025-04-28
ER

PT J
AU Kusumah, J
   de Mejia, EG
AF Kusumah, Jennifer
   de Mejia, Elvira Gonzalez
TI Coffee constituents with antiadipogenic and antidiabetic potentials: A
   narrative review
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Review
DE Adipogenesis; Coffee; Diabetes; T2DM; Insulin resistance; Phenolic
   compounds
ID TYPE-2 DIABETES-MELLITUS; METABOLIC SYNDROME; BIOACTIVE SUBSTANCE;
   LIPID-ACCUMULATION; CHLOROGENIC ACID; CAFFEINE INTAKE; ROASTED COFFEE;
   GLUCOSE-UPTAKE; CONSUMPTION; EXTRACTION
AB Coffee consumption has been associated with the reduction of several chronic diseases, including type 2 diabetes mellitus (T2DM) and obesity. The aim of this review was to summarize the research conducted in the last five years (or older, when appropriate) on the relationship between the consumption of coffee bioactive compounds, obesity, and T2DM. A bibliographic search was performed using the Web of Sciences, Scopus, and Google Scholar. Keywords used were "caffeine," "coffee," "coffee consumption," "coffee extraction," "coffee bioactive components," "chlorogenic acid," "obesity," "antidiabetic," and "antiadipogenic." Epidemiological, clinical, animal, and cell culture studies were reviewed. Caffeine, chlorogenic acid, and diterpenes have been identified as potential bioactive compounds in coffee that exhibit antiadipogenic and antidiabetic effects. The concentration of these compounds in coffee depends on the coffee preparation method. The relationship between coffee consumption and obesity risk is inconsistent, as not all results report a positive association. The addition of sugar and cream may be responsible for these mixed results. The consumption of coffee and its constituents is consistently associated with a lower T2DM risk. Caffeine, chlorogenic acids, and diterpenes have antidiabetic properties and are associated with these effects. The available data do not allow us to draw a conclusion on the effect of coffee or its constituents on adipogenesis. Therefore, more tightly controlled human intervention studies are required for a deeper understanding about this relationship.
C1 [Kusumah, Jennifer; de Mejia, Elvira Gonzalez] Univ Illinois, Dept Food Sci & Human Nutr, 1201 West Gregory Dr, Urbana, IL 61801 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign
RP de Mejia, EG (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, 1201 West Gregory Dr, Urbana, IL 61801 USA.
EM edemejia@illinois.edu
RI GONZALEZ DE mEJIA, ELVIRA/IYI-9309-2023
CR Aldakinah AAA, 2017, J PHARM PHARMACOL, V69, P856, DOI 10.1111/jphp.12713
   Salamanca CA, 2017, FOOD CHEM, V214, P622, DOI 10.1016/j.foodchem.2016.07.120
   Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Angeloni G, 2019, FOOD RES INT, V116, P1327, DOI 10.1016/j.foodres.2018.10.022
   Angeloni G, 2019, J SCI FOOD AGR, V99, P391, DOI 10.1002/jsfa.9200
   [Anonymous], 2016, Jordan J Pharm Sci, DOI DOI 10.12816/0033383
   Arai K, 2015, ANAL SCI, V31, P831, DOI 10.2116/analsci.31.831
   Baek JH, 2017, BMB REP, V50, P566, DOI 10.5483/BMBRep.2017.50.11.031
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/c7fo00388a, 10.1039/C7FO00388A]
   Bhaktha G, 2015, J CLIN DIAGN RES, V9, pBC1, DOI 10.7860/JCDR/2015/10587.5371
   Budryn G, 2017, EUR FOOD RES TECHNOL, V243, P1323, DOI 10.1007/s00217-017-2843-0
   Butt J., 2021, PAK J PHYSL, V17, P15
   Cao C, 2020, J NUTR, V150, P1909, DOI 10.1093/jn/nxaa121
   Cao H, 2019, CRIT REV FOOD SCI, V59, P3371, DOI 10.1080/10408398.2018.1492900
   Caprioli G, 2015, INT J FOOD SCI NUTR, V66, P505, DOI 10.3109/09637486.2015.1064871
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Chen LW, 2019, AM J CLIN NUTR, V109, P1648, DOI 10.1093/ajcn/nqz019
   Cheng B, 2016, TRENDS FOOD SCI TECH, V57, P20, DOI 10.1016/j.tifs.2016.09.003
   Cherniack EP, 2018, J AM COLL NUTR, V37, P161, DOI 10.1080/07315724.2017.1372822
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Choi M, 2021, PHYTOTHER RES, V35, P1113, DOI 10.1002/ptr.6892
   Chrysant SG, 2015, AM J CARDIOL, V116, P818, DOI 10.1016/j.amjcard.2015.05.057
   Cordoba N, 2020, TRENDS FOOD SCI TECH, V96, P45, DOI 10.1016/j.tifs.2019.12.004
   Derossi A, 2018, J SCI FOOD AGR, V98, P3198, DOI 10.1002/jsfa.8826
   Farah A., 2012, Coffee Emerg. Health Effects Dis. Prevent., VVolume 1, P22
   Farah A., 2015, Coffee Heal. Dis. Prev., P789, DOI 10.1016/B978-0-12-409517-5.00087-5
   Farah a., 2015, Coffee in health and disease prevention, P5, DOI [DOI 10.1016/B978-0-12-409517-5.00001-2, 10.1016/b978-0-12-409517-5.00001-2]
   Farias-Pereira R, 2020, J AGR FOOD CHEM, V68, P9683, DOI 10.1021/acs.jafc.0c03030
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Febrina L, 2021, FOOD CHEM, V355, DOI 10.1016/j.foodchem.2021.129496
   Fernandez-Gomez B, 2016, J FUNCT FOODS, V25, P197, DOI 10.1016/j.jff.2016.06.001
   Fuller M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18247-4
   Gao F, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0321-8
   Gökcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grzelczyk J, 2020, J THERM ANAL CALORIM, V142, P877, DOI 10.1007/s10973-020-09801-w
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Hosseinabadi S, 2020, J HERB MED, V22, DOI 10.1016/j.hermed.2020.100340
   Iriondo-DeHond A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010088
   Jeszka-Skowron M, 2016, EUR FOOD RES TECHNOL, V242, P1403, DOI 10.1007/s00217-016-2643-y
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jin F, 2021, INT J OBESITY, V45, P279, DOI 10.1038/s41366-020-0617-4
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   Kim Y, 2018, BRIT J NUTR, V120, P1279, DOI [10.1017/S0007114518002635, 10.1017/s0007114518002635]
   Koyama T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103090
   Kwok MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep36500
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee JK, 2015, EUR J ENDOCRINOL, V172, P595, DOI 10.1530/EJE-14-0805
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Lee JH, 2016, KOREAN J FAM MED, V37, P7, DOI 10.4082/kjfm.2016.37.1.7
   Maki C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173264
   Martina Sake Juli, 2019, Open Access Maced J Med Sci, V7, P3363, DOI 10.3889/oamjms.2019.423
   Mellbye FB, 2017, J NAT PROD, V80, P2353, DOI 10.1021/acs.jnatprod.7b00395
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Mirmiran R, 2018, NUTR METAB CARDIOVAS, V28, P1261, DOI 10.1016/j.numecd.2018.09.001
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   Moeenfard M, 2015, INT J FOOD PROP, V18, P2284, DOI 10.1080/10942912.2014.933351
   Muhammad HFL, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/9606054
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Olas B, 2019, FOOD CHEM TOXICOL, V127, P31, DOI 10.1016/j.fct.2019.02.039
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Rakvaag E, 2016, EUR J NUTR, V55, P2221, DOI 10.1007/s00394-015-1032-9
   Rasouli B, 2018, DIABETES METAB, V44, P354, DOI 10.1016/j.diabet.2018.05.002
   Rebollo-Hernanz M, 2019, FOOD CHEM TOXICOL, V132, DOI 10.1016/j.fct.2019.110672
   Reis CEG, 2019, J TRADIT COMPL MED, V9, P184, DOI 10.1016/j.jtcme.2018.01.001
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Ruddarraju RR, 2019, BIOORG CHEM, V92, DOI 10.1016/j.bioorg.2019.103120
   Samoggia A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030653
   Samoggia A, 2018, APPETITE, V129, P70, DOI 10.1016/j.appet.2018.07.002
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Severini C., 2018, INT J CLIN NUTR DIET, V4, P127, DOI [10.15344/2456-8171/2018/127, DOI 10.15344/2456-8171/2018/127]
   Shahmohammadi HA, 2017, HEPAT MON, V17, DOI 10.5812/hepatmon.45609
   Shi L, 2020, J INTERN MED, V287, P405, DOI 10.1111/joim.13009
   Shokouh P, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101547
   Tverdal A, 2020, EUR J PREV CARDIOL, V27, P1986, DOI 10.1177/2047487320914443
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   Vilas-Boas AA, 2020, FOOD RES INT, V134, DOI 10.1016/j.foodres.2020.109223
   Wang XJ, 2016, FOOD RES INT, V89, P797, DOI 10.1016/j.foodres.2016.09.031
   Wang Y, 2020, PAK J PHARM SCI, V33, P1063, DOI 10.36721/PJPS.2020.33.3.REG.1063-1072.1
   Yonekura Y, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051370
   Yoshinari O., 2015, COFFEE HLTH DIS PREV, P765
   Zapata FJ, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103646
   Zhang C, 2012, FOOD RES INT, V49, P27, DOI 10.1016/j.foodres.2012.06.032
NR 88
TC 26
Z9 26
U1 2
U2 37
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD MAR
PY 2022
VL 161
DI 10.1016/j.fct.2022.112821
EA JAN 2022
PG 11
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA YS7DI
UT WOS:000750832500007
PM 35032569
DA 2025-04-28
ER

PT J
AU Robertson, TM
   Clifford, MN
   Penson, S
   Chope, G
   Robertson, MD
AF Robertson, Tracey M.
   Clifford, Michael N.
   Penson, Simon
   Chope, Gemma
   Robertson, M. Denise
TI A single serving of caffeinated coffee impairs postprandial glucose
   metabolism in overweight men
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Human; Coffee; Caffeine; Glucose; Insulin; Metabolism; Postprandial
   metabolism
ID DECAFFEINATED COFFEE; CHLOROGENIC ACID; INSULIN SENSITIVITY;
   BLOOD-GLUCOSE; ENERGY-EXPENDITURE; BODY-MASS; RISK; CONSUMPTION;
   TOLERANCE; INGESTION
AB Previous studies regarding the acute effects of coffee on glycaemic control have used a single large dose of coffee, typically containing the caffeine equivalent of 2-4 servings of coffee. This study investigates whether the acute effects of coffee are dose-dependent, starting with a single serving. A total of ten healthy overweight males participated in a two-part randomised double-blind cross-over study. In the first part, they ingested 2, 4 or 8 g instant decaffeinated coffee (DC) dissolved in 400 ml water with caffeine added in proportion to the DC (total 100, 200 or 400 mg caffeine) or control (400 ml water) all with 50 g glucose. In the second part, they ingested the same amounts of DC (2, 4, 8 g) or control, but with a standard 100 mg caffeine added to each. Capillary blood samples were taken every 15 min for 2 h after each drink and glucose and insulin levels were measured. Repeated measures ANOVA on glucose results found an effect when caffeine was varied in line with DC (P = 0.008). Post hoc analysis revealed that both 2 and 4 g DC with varied caffeine content increased the glycaemic response v. control. There was no effect of escalating doses of DC when caffeine remained constant at 100 mg. These results demonstrate that one standard serving of coffee (2 g) is sufficient to affect glucose metabolism. Furthermore, the amount of caffeine found in one serving (100 mg) is sufficient to mask any potential beneficial effects of increasing other components. No dose-dependent effect was found.
C1 [Robertson, Tracey M.; Clifford, Michael N.; Robertson, M. Denise] Univ Surrey, Dept Nutr Sci, Guildford GU2 7WG, Surrey, England.
   [Penson, Simon; Chope, Gemma] Campden BRI, Dept Primary Prod & Proc, Chipping Campden GL55 6LD, Glos, England.
C3 University of Surrey
RP Robertson, MD (corresponding author), Univ Surrey, Dept Nutr Sci, Guildford GU2 7WG, Surrey, England.
EM m.robertson@surrey.ac.uk
RI Robertson, Tracey/GWM-5192-2022; Clifford, Mike/ABD-5126-2021
OI Robertson, Tracey/0000-0002-8519-7572; Clifford,
   Mike/0000-0002-4204-5720
FU Biotechnology and Biological Sciences Research Council (BBSRC); Campden
   BRI, a BBSRC CASE Studentship
FX This work was supported by the Biotechnology and Biological Sciences
   Research Council (BBSRC) and Campden BRI as part of a BBSRC CASE
   Studentship.
CR [Anonymous], 1998, FAO Food Nutr Pap, V66, P1
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Beaudoin MS, 2013, APPL PHYSIOL NUTR ME, V38, P140, DOI 10.1139/apnm-2012-0201
   Beaudoin MS, 2011, J NUTR, V141, P574, DOI 10.3945/jn.110.132761
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Brouns F, 2005, NUTR RES REV, V18, P145, DOI 10.1079/NRR2005100
   Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Gavrieli A, 2013, METABOLISM, V62, P1099, DOI 10.1016/j.metabol.2013.02.003
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   GILBERT RM, 1976, CAN MED ASSOC J, V114, P205
   Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   LARSSONCOHN U, 1976, SCAND J CLIN LAB INV, V36, P805, DOI 10.3109/00365517609081941
   Ludwig IA, 2012, FOOD RES INT, V48, P57, DOI 10.1016/j.foodres.2012.02.023
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   Moisey LL, 2008, AM J CLIN NUTR, V87, P1254, DOI 10.1093/ajcn/87.5.1254
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Ohnaka K, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/207426
   Robertson MD, 2001, AM J CLIN NUTR, V73, P111
   Robinson LE, 2004, J NUTR, V134, P2528, DOI 10.1093/jn/134.10.2528
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529
   Strazzullo P, 2008, METABOLISM, V57, P355, DOI 10.1016/j.metabol.2007.10.010
   The British Coffee Association, 2015, COFF FACTS
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1
NR 42
TC 23
Z9 26
U1 0
U2 35
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD OCT 28
PY 2015
VL 114
IS 8
BP 1218
EP 1225
DI 10.1017/S0007114515002640
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CT7DT
UT WOS:000362974700014
PM 26316273
OA Bronze
DA 2025-04-28
ER

PT J
AU Karagöz, MF
   Koçyigit, E
   Koçak, T
   Sirin, AÖ
   Icer, MA
   Agagündüz, D
   Coreta-Gomes, F
AF Karagoz, Mustafa Fevzi
   Kocyigit, Emine
   Kocak, Tevfik
   Sirin, Aycil Ozturan
   Icer, Mehmet Arif
   Agagunduz, Duygu
   Coreta-Gomes, Filipe
TI Decoding coffee cardiometabolic potential: Chemical composition,
   nutritional, and health relationships
SO COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY
LA English
DT Review
DE cardiometabolic health; coffee bean; coffee beverage; structure-function
   relationship
ID HIGH-FAT-DIET; MODULATES GUT MICROBIOTA; CHLOROGENIC ACID; METABOLIC
   SYNDROME; GREEN COFFEE; BLOOD-PRESSURE; INSULIN SENSITIVITY;
   RISK-FACTORS; CARDIOVASCULAR-DISEASE; CAFFEINE CONSUMPTION
AB Coffee is one of the most consumed beverages worldwide, recognized for its unique taste and aroma and for its social and health impacts. Coffee contains a plethora of nutritional and bioactive components, whose content can vary depending on their origin, processing, and extraction methods. Gathered evidence in literature shows that the regular coffee consumption containing functional compounds (e.g., polysaccharides, phenolic compounds, and melanoidins) can have potential beneficial effects on cardiometabolic risk factors such as abdominal adiposity, hyperglycemia, and lipogenesis. On the other hand, coffee compounds, such as caffeine, diterpenes, and advanced glycation end products, may be considered a risk for cardiometabolic health. The present comprehensive review provides up-to-date knowledge on the structure-function relationships between different chemical compounds present in coffee, one of the most prevalent beverages present in human diet, and cardiometabolic health.
C1 [Karagoz, Mustafa Fevzi; Agagunduz, Duygu] Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkiye.
   [Karagoz, Mustafa Fevzi] Hitit Univ, Fac Hlth Sci, Dept Nutr & Dietet, Corum, Turkiye.
   [Kocyigit, Emine] Ordu Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ordu, Turkiye.
   [Kocak, Tevfik] Gumushane Univ, Fac Hlth Sci, Dept Nutr & Dietet, Gumushane, Turkiye.
   [Sirin, Aycil Ozturan] Adnan Menderes Univ, Fac Hlth Sci, Dept Nutr & Dietet, Aydin, Turkiye.
   [Icer, Mehmet Arif] Amasya Univ, Dept Nutr & Dietet, Fac Hlth Sci, Amasya, Turkiye.
   [Coreta-Gomes, Filipe] Univ Aveiro, Chem Dept, LAQV REQUIMTE, Aveiro, Portugal.
   [Coreta-Gomes, Filipe] Univ Coimbra, Inst Mol Sci CQC IMS, Coimbra Chem Ctr, Dept Chem, Coimbra, Portugal.
C3 Gazi University; Hitit University; Ordu University; Gumushane
   University; Adnan Menderes University; Amasya University; Universidade
   de Aveiro; Universidade de Coimbra
RP Coreta-Gomes, F (corresponding author), Univ Aveiro, Chem Dept, LAQV REQUIMTE, Aveiro, Portugal.
EM filipecoreta@ua.pt
RI Icer, Mehmet/AAA-8190-2021; Ağagündüz, Duygu/AAS-9583-2020;
   Coreta-Gomes, Filipe/AAE-2294-2020; Kocyigit, Emine/HEG-2522-2022;
   KARAGÖZ, Mustafa Fevzi/AHB-2604-2022; özturan şirin,
   ayçıl/KXQ-8184-2024; KOCAK, TEVFIK/GNP-0559-2022
OI AGAGUNDUZ, DUYGU/0000-0003-0010-0012; KOCAK, TEVFIK/0000-0002-4096-6796;
   Coreta-Gomes, Filipe/0000-0001-9498-2460
FU Fundacao para a Ciencia e a Tecnologia; LAQV-REQUIMTE; Filipe
   Coreta-Gomes
FX Fundacao para a Ciencia e a Tecnologia; LAQV-REQUIMTE, Grant/Award
   Numbers: 10.54499/LA/P/0008/2020, 10.54499/UIDP/50006/2020,
   10.54499/UIDB/50006/2020; Filipe Coreta-Gomes
CR Agudelo-Ochoa GM, 2016, J NUTR, V146, P524, DOI 10.3945/jn.115.224774
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   AL-Megrin WA, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/6762709
   Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Angeloni G, 2019, FOOD RES INT, V116, P1327, DOI 10.1016/j.foodres.2018.10.022
   [Anonymous], 2022, Health effects of overweight and obesity
   [Anonymous], 2021, Obesity and Overweight
   Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.010]
   Baek JH, 2017, BMB REP, V50, P566, DOI 10.5483/BMBRep.2017.50.11.031
   Bakhtiyari M, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05536-w
   Bansal S, 2023, WORLD J DIABETES, V14, P1146, DOI 10.4239/wjd.v14.i8.1146
   Barrea L, 2023, CRIT REV FOOD SCI, V63, P1238, DOI 10.1080/10408398.2021.1963207
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Bhandarkar NS, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10111369
   Bhandarkar NS, 2020, FASEB J, V34, P4783, DOI 10.1096/fj.201902416RR
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Bo S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041161
   Braojos C, 2023, FOODS, V12, DOI 10.3390/foods12142708
   Buscemi S., 2016, NFS Journal, V3, P1, DOI 10.1016/j.nfs.2016.02.001
   Calderón-Pérez L, 2021, FOOD CHEM, V344, DOI 10.1016/j.foodchem.2020.128567
   Caporaso N, 2014, FOOD RES INT, V61, P152, DOI 10.1016/j.foodres.2014.01.020
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Caro-Gómez E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030497
   Cavalcanti MH, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262270
   Choi S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030363
   Chong CW, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13535
   Chrysant SG, 2017, EXPERT REV CARDIOVAS, V15, P151, DOI 10.1080/14779072.2017.1287563
   Chuang YH, 2017, EUR J HUM GENET, V25, P608, DOI 10.1038/ejhg.2016.175
   Chung HK, 2020, NUTR METAB CARDIOVAS, V30, P1653, DOI 10.1016/j.numecd.2020.05.026
   Cockburn DW, 2016, J MOL BIOL, V428, P3230, DOI 10.1016/j.jmb.2016.06.021
   Cordoba N, 2020, TRENDS FOOD SCI TECH, V96, P45, DOI 10.1016/j.tifs.2019.12.004
   Coreta-Gomes FM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020437
   Cornelis MC, 2018, J INTERN MED, V283, P544, DOI 10.1111/joim.12737
   Cornelis MC, 2020, J NUTR, V150, P2772, DOI 10.1093/jn/nxaa212
   Costabile A, 2018, J FUNCT FOODS, V45, P409, DOI 10.1016/j.jff.2018.04.011
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   D'Amelio N, 2013, TALANTA, V110, P118, DOI 10.1016/j.talanta.2013.02.024
   Dai A, 2023, NUTRIENTS, V15, DOI 10.3390/nu15071747
   Daneschvar HL, 2021, AM J MED, V134, P626, DOI [10.1016/j,amjmed.2020.09.036, 10.1016/j.amjmed.2020.09.036]
   Pereira GVD, 2020, ADV FOOD NUTR RES, V91, P65, DOI 10.1016/bs.afnr.2019.10.002
   de Souza FB, 2021, LIFE SCI, V276, DOI 10.1016/j.lfs.2021.119450
   DePaula J, 2019, BEVERAGES, V5, DOI 10.3390/beverages5020037
   Derossi A, 2018, J SCI FOOD AGR, V98, P3198, DOI 10.1002/jsfa.8826
   Di Maso M, 2021, ADV NUTR, V12, P1160, DOI 10.1093/advances/nmaa177
   Ding Q, 2023, MOLECULES, V28, DOI 10.3390/molecules28041770
   Dippong T, 2022, FOODS, V11, DOI 10.3390/foods11193146
   Dong WJ, 2015, MOLECULES, V20, P16687, DOI 10.3390/molecules200916687
   Dziki D, 2015, LWT-FOOD SCI TECHNOL, V63, P691, DOI 10.1016/j.lwt.2015.03.076
   El-Kersh DM, 2023, FOOD CHEM TOXICOL, V179, DOI 10.1016/j.fct.2023.113971
   Emami MR, 2019, COMPLEMENT THER MED, V44, P282, DOI 10.1016/j.ctim.2019.05.003
   Enani S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082441
   Farag MA, 2021, TRENDS FOOD SCI TECH, V118, P920, DOI 10.1016/j.tifs.2021.11.004
   Farah A., 2019, Coffee Production, Quality and Chemistry, V1st ed., DOI [10.1039/9781782622437-FP001, DOI 10.1039/9781782622437-FP001]
   Faraji H, 2019, PROG NUTR, V21, P744, DOI 10.23751/pn.v21i4.6557
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Febrianto NA, 2023, FOOD CHEM, V412, DOI 10.1016/j.foodchem.2023.135489
   Costa-Machado LF, 2023, NAT COMMUN, V14, DOI 10.1038/s41467-023-38410-y
   Fogliano V, 2011, FOOD FUNCT, V2, P117, DOI 10.1039/c0fo00156b
   Fuller M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18247-4
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Gebeyehu GM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04886
   Ghavami HS, 2021, BMC CARDIOVASC DISOR, V21, DOI 10.1186/s12872-021-02058-7
   Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75
   Gkouskou KG, 2022, INT J OBESITY, V46, P162, DOI 10.1038/s41366-021-00972-6
   Gloess AN, 2013, EUR FOOD RES TECHNOL, V236, P607, DOI 10.1007/s00217-013-1917-x
   Gökcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   González S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051287
   Górecki M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040308
   Grosso G, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080890
   Guo CC, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.1007679
   Han B, 2019, PHYTOTHER RES, V33, P2918, DOI 10.1002/ptr.6481
   Harakeh S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230895
   Hedayatnia M, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01204-y
   Hegde S, 2022, NUTRIENTS, V14, DOI 10.3390/nu14224877
   Henn M, 2023, CLIN NUTR, V42, P477, DOI 10.1016/j.clnu.2023.02.004
   Hong SJ, 2024, FOOD CHEM X, V21, DOI 10.1016/j.fochx.2024.101119
   Hussain SK, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051395
   Ilmiawati C, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05052-y
   Janakiraman B, 2020, DIABET METAB SYND OB, V13, P343, DOI 10.2147/DMSO.S235981
   Jeon JS, 2019, J ADV RES, V17, P85, DOI 10.1016/j.jare.2019.01.002
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jin T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082228
   Karabegovic I, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22752-6
   Katafuchi T, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23116046
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   Kim J, 2014, FOOD SCI BIOTECHNOL, V23, P2029, DOI 10.1007/s10068-014-0276-0
   Kim Y, 2018, BRIT J NUTR, V120, P1279, DOI [10.1017/S0007114518002635, 10.1017/s0007114518002635]
   Kolb H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041144
   Kolb H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061842
   Komorita Y, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001252
   Kong L, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13795
   Koyama T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103090
   Kusumah J, 2022, FOOD CHEM TOXICOL, V161, DOI 10.1016/j.fct.2022.112821
   Lara-Guzmán OJ, 2021, FREE RADICAL BIO MED, V176, P345, DOI 10.1016/j.freeradbiomed.2021.10.012
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee DY, 2023, FRONT PUBLIC HEALTH, V11, DOI 10.3389/fpubh.2023.990029
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Lee S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061783
   Li HB, 2021, LIFE SCI, V269, DOI 10.1016/j.lfs.2021.119024
   Liao YC, 2022, LWT-FOOD SCI TECHNOL, V168, DOI 10.1016/j.lwt.2022.113965
   Lim L. T., 2019, Comprehensive biotechnology, DOI [DOI 10.1016/B978-0-444-64046-8.00462-6, 10.1016/B978-0-444-64046-8.00462-6]
   Liu CW, 2018, AM J PHYSIOL-ENDOC M, V314, pE433, DOI 10.1152/ajpendo.00094.2017
   Lopes GR, 2021, FOOD CHEM, V344, DOI 10.1016/j.foodchem.2020.128613
   Lopes GR, 2020, FOOD RES INT, V129, DOI 10.1016/j.foodres.2019.108864
   Lopes GR, 2016, FOOD RES INT, V89, P989, DOI 10.1016/j.foodres.2016.01.018
   Lu HJ, 2020, COMPR REV FOOD SCI F, V19, P3130, DOI 10.1111/1541-4337.12620
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI [10.1039/C4FO00290C, 10.1039/c4fo00290c]
   Lukitasari M, 2020, J ADV PHARM TECHNOL, V11, P81, DOI 10.4103/japtr.JAPTR_116_19
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Machado F, 2023, CRIT REV FOOD SCI, DOI 10.1080/10408398.2023.2221734
   Maki C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173264
   Manivel P., 2021, Handbook of dietary phytochemicals, P1033
   Mansour A, 2021, NUTR J, V20, DOI 10.1186/s12937-021-00694-5
   Mansour A, 2020, EXCLI J, V19, P241, DOI 10.17179/excli2019-2021
   Marino M, 2022, EUR J NUTR, V61, P1003, DOI 10.1007/s00394-021-02714-w
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Martins BC, 2023, J NUTR BIOCHEM, V117, DOI 10.1016/j.jnutbio.2023.109336
   Mateos R, 2022, FOOD FUNCT, V13, P574, DOI [10.1039/d1fo02272e, 10.1039/D1FO02272E]
   Mellbye FB, 2017, J NAT PROD, V80, P2353, DOI 10.1021/acs.jnatprod.7b00395
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Miranda AM, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007155
   Mirzaei S, 2021, PHARMACOL RES, V171, DOI 10.1016/j.phrs.2021.105759
   Moon JK, 2010, J AGR FOOD CHEM, V58, P5465, DOI 10.1021/jf1005148
   Moran-Lev H, 2023, CHILD OBES, V19, P121, DOI 10.1089/chi.2022.0032
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Moreira ASP, 2011, J AGR FOOD CHEM, V59, P10078, DOI 10.1021/jf2021072
   Moslehi A, 2023, IRAN J BASIC MED SCI, V26, P478, DOI 10.22038/IJBMS.2023.66827.14659
   Muhammad HFL, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/9606054
   Islam MT, 2018, CURR DRUG METAB, V19, P544, DOI 10.2174/1389200219666180302154551
   Muley A, 2012, CURR DIABETES REV, V8, P162, DOI 10.2174/157339912800564016
   Murai T, 2023, MOLECULES, V28, DOI 10.3390/molecules28052381
   Mussatto SI, 2011, FOOD BIOPROCESS TECH, V4, P661, DOI 10.1007/s11947-011-0565-z
   Namvarjah F, 2022, CELL BIOCHEM BIOPHYS, V80, P537, DOI 10.1007/s12013-022-01077-1
   Narita Y, 2011, FOOD CHEM, V127, P1532, DOI 10.1016/j.foodchem.2011.02.013
   Nerurkar PV, 2023, METABOLITES, V13, DOI 10.3390/metabo13030412
   Nishitsuji K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34571-9
   Oboh G, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13384
   Oboh Ganiyu, 2015, Journal of Basic and Clinical Physiology and Pharmacology, V26, P165, DOI 10.1515/jbcpp-2013-0141
   OestreichJanzen S., 2013, Chemistry of Coffee on Comprehensive Natural Products II: Chemistry and Biology, P1085
   Oikonomou EK, 2019, NAT REV CARDIOL, V16, P83, DOI 10.1038/s41569-018-0097-6
   Okati-Aliabad H, 2022, J OBES, V2022, DOI 10.1155/2022/8074837
   Olechno E, 2021, FOODS, V10, DOI 10.3390/foods10061208
   Ontawong A, 2019, PHYTOMEDICINE, V52, P187, DOI 10.1016/j.phymed.2018.06.021
   Park SY, 2018, CANCER EPIDEM BIOMAR, V27, P928, DOI 10.1158/1055-9965.EPI-18-0093
   Park Y, 2023, AM J CARDIOL, V186, P17, DOI 10.1016/j.amjcard.2022.10.010
   Parlati L, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100346
   Patil SB, 2023, 3 BIOTECH, V13, DOI 10.1007/s13205-023-03661-5
   Patil S, 2023, 3 BIOTECH, V13, DOI 10.1007/s13205-023-03698-6
   Pérez-Burillo S, 2020, FOOD CHEM, V316, DOI 10.1016/j.foodchem.2020.126309
   Pimentel GD, 2019, NUTR PREVENTION TREA, P329, DOI [10.1016/B978-0-12-816093-0,00024-0, DOI 10.1016/B978-0-12-816093-0,00024-0]
   Pimpley VA, 2023, NUTRITION, V115, DOI 10.1016/j.nut.2023.112141
   Pires CL, 2022, FOODS, V11, DOI 10.3390/foods11192935
   Pourmasoumi M, 2021, ADV EXP MED BIOL, V1328, P323, DOI 10.1007/978-3-030-73234-9_21
   Rakvaag E, 2016, EUR J NUTR, V55, P2221, DOI 10.1007/s00394-015-1032-9
   Ramli NNS, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57090957
   Ramos LV, 2022, J NUTR BIOCHEM, V100, DOI 10.1016/j.jnutbio.2021.108881
   Rebollo-Hernanz M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080279
   Reis CEG, 2019, J TRADIT COMPL MED, V9, P184, DOI 10.1016/j.jtcme.2018.01.001
   Ren YQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174238
   Ribeiro M, 2024, CRIT REV FOOD SCI, V64, P562, DOI 10.1080/10408398.2022.2106938
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Ruiz-Moreno C, 2021, EUR J NUTR, V60, P2077, DOI 10.1007/s00394-020-02393-z
   Safe S, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24032706
   Samoggia A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030653
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Saud S, 2021, MOLECULES, V26, DOI 10.3390/molecules26247634
   Scheijen JLJM, 2016, FOOD CHEM, V190, P1145, DOI 10.1016/j.foodchem.2015.06.049
   Seal RL, 2023, NUCLEIC ACIDS RES, V51, pD1003, DOI 10.1093/nar/gkac888
   Senftinger J, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-31857-5
   Shaheen S, 2022, CRIT REV FOOD SCI, V62, P8954, DOI 10.1080/10408398.2021.1937509
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Sharma L, 2018, FOOD CHEM TOXICOL, V121, P283, DOI 10.1016/j.fct.2018.09.011
   Sharma N, 2022, MOL NEUROBIOL, V59, P6834, DOI 10.1007/s12035-022-03005-z
   Shi XQ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0220-7
   Silva IMV, 2021, MOLECULES, V26, DOI 10.3390/molecules26154559
   Singh AK, 2023, CURR MED CHEM, V30, P3905, DOI 10.2174/0929867329666220816154634
   Snelson M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020215
   Song Z, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232314837
   Stoikidou T., 2023, Functional foods and their implications for health promotion, P29, DOI 10.1016/B978-0-12-823811-0.00006-7
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1258-y
   Surma S, 2021, CURR HYPERTENS REP, V23, DOI 10.1007/s11906-021-01156-3
   Svatun ÅL, 2022, OPEN HEART, V9, DOI 10.1136/openhrt-2021-001946
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Teng CL, 2016, AUST FAM PHYSICIAN, V45, P65
   TerentesPrintzios D., 2022, Coffee and cardiovascular health: Looking through the steaming cup
   Thelle Dag S., 1995, Current Opinion in Lipidology, V6, P25, DOI 10.1097/00041433-199502000-00006
   Le TKC, 2015, BIOMED RES-TOKYO, V36, P63, DOI 10.2220/biomedres.36.63
   Townsend N, 2022, NAT REV CARDIOL, V19, P133, DOI 10.1038/s41569-021-00607-3
   Toydemir G, 2021, FOOD CHEM, V341, DOI 10.1016/j.foodchem.2020.128261
   Tverdal A, 2020, EUR J PREV CARDIOL, V27, P1986, DOI 10.1177/2047487320914443
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   Vitaglione P, 2019, J NUTR SCI, V8, DOI 10.1017/jns.2019.10
   von Blittersdorff M, 2017, CRAFT AND SCIENCE OF COFFEE, P311, DOI 10.1016/B978-0-12-803520-7.00013-X
   Voskoboinik A, 2019, TRENDS CARDIOVAS MED, V29, P345, DOI 10.1016/j.tcm.2018.09.019
   Walker JM, 2020, J FUNCT FOODS, V72, DOI 10.1016/j.jff.2020.104063
   Wan F, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.784211
   Wang L, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.943911
   Wang S, 2022, FOOD CHEM, V372, DOI 10.1016/j.foodchem.2021.131334
   Wang SL, 2023, NUTRIENTS, V15, DOI 10.3390/nu15010107
   Wang TG, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0862-0
   Wang XP, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.818831
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Watanabe S, 2017, METAB SYNDR RELAT D, V15, P170, DOI 10.1089/met.2016.0114
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   Wei F., 2015, Coffee in health and disease prevention, P83, DOI [10.1016/B978-0-12-409517-5.00010-3, DOI 10.1016/B978-0-12-409517-5.00010-3]
   Wei FF, 2012, J AGR FOOD CHEM, V60, P1005, DOI 10.1021/jf205315r
   WHO, 2011, WORLD REPORT ON DISABILITY, P1
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Williamson G, 2020, FOOD FUNCT, V11, P4826, DOI [10.1039/d0fo01168a, 10.1039/D0FO01168A]
   Xu ZC, 2021, J FUNCT FOODS, V81, DOI 10.1016/j.jff.2021.104482
   Yao WQ, 2021, J FUNCT FOODS, V85, DOI 10.1016/j.jff.2021.104615
   Ye XL, 2022, BIOMED RES INT, V2022, DOI 10.1155/2022/4919153
   Ye XL, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.762691
   Yildirim S, 2023, J FOOD SCI TECH MYS, V60, P1933, DOI 10.1007/s13197-022-05460-x
   Yu SW, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6509083
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
   Yun Z, 2022, J FOOD BIOCHEM, V46, DOI 10.1111/jfbc.14505
   Zerga AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241432
   Zhang ZZ, 2011, AM J CLIN NUTR, V93, P1212, DOI 10.3945/ajcn.110.004044
   Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369
   Zhong YC, 2020, CURR PHARM BIOTECHNO, V21, P1099, DOI 10.2174/1389201021666200318124922
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 227
TC 2
Z9 2
U1 16
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1541-4337
J9 COMPR REV FOOD SCI F
JI Compr. Rev. Food. Sci. Food Saf.
PD SEP
PY 2024
VL 23
IS 5
AR e13414
DI 10.1111/1541-4337.13414
PG 29
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA C5C6H
UT WOS:001289546100001
PM 39137004
DA 2025-04-28
ER

PT J
AU Beam, JR
   Gibson, AL
   Kerksick, CM
   Conn, CA
   White, AC
   Mermier, CM
AF Beam, Jason R.
   Gibson, Ann L.
   Kerksick, Chad M.
   Conn, Carole A.
   White, Ailish C.
   Mermier, Christine M.
TI Effect of post-exercise caffeine and green coffee bean extract
   consumption on blood glucose and insulin concentrations
SO NUTRITION
LA English
DT Article
DE Chlorogenic acid; Oral glucose tolerance test; Cycling, glycogen;
   Carbohydrate; Insulin sensitivity index
ID CHLOROGENIC ACID; CARBOHYDRATE; MUSCLE; INGESTION; EXERCISE;
   RESYNTHESIS; METABOLISM; OVERWEIGHT
AB Objective: The aim of this study was to investigate the effects of ingesting caffeine and green coffee bean extract on blood glucose and insulin concentrations during a post-exercise oral glucose tolerance test.
   Methods: Ten male cyclists (age: 26 +/- 5 y; height: 179.9 +/- 5.4 cm; weight: 77.6 +/- 13.3 kg; body mass index: 24 +/- 4.3 kg/m(2); VO2 peak: 55.9 +/- 8.4 mL.kg.min(-1)) participated in this study. In a randomized order, each participant completed three 30-min bouts of cycling at 60% of peak power output. Immediately after exercise, each participant consumed 75 g of dextrose with either 5 mg/kg body weight of caffeine, 10 mg/kg of green coffee bean extract (5 mg/kg chlorogenic acid), or placebo. Venous blood samples were collected immediately before and after exercise during completion of the oral glucose tolerance test.
   Results: No significant time x treatment effects for blood glucose and insulin were found. Two-h glucose and insulin area under the curve values, respectively, for the caffeine (658 +/- 74 mmol/L and 30,005 +/- 13,304 pmol/L), green coffee bean extract (637 +/- 100 mmol/L and 31,965 +/- 23,586 pmol/L), and placebo (661 +/- 77 mmol/L and 27,020 +/- 12,339 pmol/L) trials were not significantly different (P > 0.05).
   Conclusion: Caffeine and green coffee bean extract did not significantly alter postexercise blood glucose and insulin concentrations when compared with a placebo. More human research is needed to determine the impact of these combined nutritional treatments and exercise on changes in blood glucose and insulin. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Beam, Jason R.; Gibson, Ann L.; White, Ailish C.; Mermier, Christine M.] Univ New Mexico, Dept Hlth Exercise & Sports Sci, Albuquerque, NM 87131 USA.
   [Kerksick, Chad M.] Lindenwood Univ, Sch Sport Recreat & Exercise Sci, Dept Exercise Sci, St Charles, MO USA.
   [Conn, Carole A.] Univ New Mexico, Dept Individual Family & Commun Educ, Albuquerque, NM 87131 USA.
C3 University of New Mexico; University of New Mexico
RP Beam, JR (corresponding author), Univ New Mexico, Dept Hlth Exercise & Sports Sci, Albuquerque, NM 87131 USA.
EM Jason.beam@sfcc.edu
RI Kerksick, Chad/G-9059-2013
FU university Academic Provost, College of Education, Graduate and
   Professional Student Association; university Graduate School, and
   Department of Health, Exercise & Sports Sciences
FX Partial funding and other support for this study was provided by the
   university's Academic Provost, College of Education, Graduate and
   Professional Student Association, Graduate School, and Department of
   Health, Exercise & Sports Sciences. JRB and CMM were responsible for the
   conception and design of the study; the generation, collection,
   assembly, analysis and/or interpretation of data; and drafting or
   revision of the manuscript. ALG and CMK, and CAC were responsible for
   the conception and design of the study and drafting or revision of the
   manuscript. ACW was responsible for generation, collection, assembly,
   analysis, and/or interpretation of data and drafting or revision of the
   manuscript. All authors approved the final version of the manuscript.
CR Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Battram DS, 2004, J APPL PHYSIOL, V96, P943, DOI 10.1152/japplphysiol.00745.2003
   Beelen M, 2012, MED SCI SPORT EXER, V44, P692, DOI 10.1249/MSS.0b013e31823a40ef
   BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
   Burke LM, 2008, APPL PHYSIOL NUTR ME, V33, P1319, DOI 10.1139/H08-130
   Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000
   Gagnon RC, 1998, J PHARMACOKINET BIOP, V26, P87, DOI 10.1023/A:1023228925137
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Graham TE, 2008, APPL PHYSIOL NUTR ME, V33, P1311, DOI 10.1139/H08-129
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Pedersen DJ, 2008, J APPL PHYSIOL, V105, P7, DOI 10.1152/japplphysiol.01121.2007
   Tarnopolsky MA, 2008, APPL PHYSIOL NUTR ME, V33, P1284, DOI 10.1139/H08-121
   Taylor C, 2011, INT J SPORT NUTR EXE, V21, P410, DOI 10.1123/ijsnem.21.5.410
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
NR 22
TC 16
Z9 19
U1 0
U2 39
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD FEB
PY 2015
VL 31
IS 2
BP 292
EP 297
DI 10.1016/j.nut.2014.07.012
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CA0WD
UT WOS:000348633400004
PM 25592006
DA 2025-04-28
ER

PT J
AU Greenberg, JA
   Geliebter, A
AF Greenberg, James A.
   Geliebter, Allan
TI Coffee, Hunger, and Peptide YY
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE coffee; decaffeinated coffee; caffeine; appetite; hunger; peptide YY;
   obesity; satiety hormones
ID FOOD-INTAKE; HORMONE-SECRETION; CHLOROGENIC ACID; LONG-TERM; OBESITY;
   WEIGHT; OVERWEIGHT; CAFFEINE; VOLUNTEERS; PYY3-36
AB Objective: There is evidence from several empirical studies suggesting that coffee may help people control body weight. Our objective was to assess the effects of caffeine, caffeinated coffee, and decaffeinated coffee, both alone and in combination with 75 g of glucose, on perceived hunger and satiety and related peptides.
   Methods: We conducted a placebo-controlled single-blinded randomized 4-way crossover trial. Eleven healthy male volunteers (mean age, 23.5 +/- 5.7 years; mean BMI, 23.6 +/- 4.2 kg/m(2)) ingested 1 of 3 test beverages (caffeine in water, caffeinated coffee, or decaffeinated coffee) or placebo (water), and 60 minutes later they ingested the glucose. Eight times during each laboratory visit, hunger and satiety were assessed by visual analog scales, and blood samples were drawn to measure 3 endogenous peptides associated with hunger and satiety: ghrelin, peptide YY (PYY), and leptin.
   Results: Compared to placebo, decaffeinated coffee yielded significantly lower hunger during the whole 180-minute study period and higher plasma PYY for the first 90 minutes (p < 0.05). Caffeine in water had no effects on hunger or PYY. Caffeinated coffee showed a pattern between that of decaffeinated coffee and caffeine in water. These findings suggest that one or more noncaffeine ingredients in coffee may have the potential to decrease body weight. Glucose ingestion did not change the effects of the beverages.
   Conclusions: Our randomized human trial showed that decaffeinated coffee can acutely decrease hunger and increase the satiety hormone PYY.
C1 [Greenberg, James A.] CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, Brooklyn, NY 11210 USA.
   [Geliebter, Allan] Columbia Univ, Dept Psychol, New York, NY 10027 USA.
   [Geliebter, Allan] St Lukes Roosevelt Hosp, New York Obes Nutr Res Ctr, New York, NY USA.
C3 City University of New York (CUNY) System; Brooklyn College (CUNY);
   Columbia University; Mount Sinai West; Mount Sinai St. Luke's
RP Greenberg, JA (corresponding author), CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, 2900 Bedford Ave, Brooklyn, NY 11210 USA.
EM jamesg@brooklyn.cuny.edu
FU Professional Staff Congress - City University of New York (PSC-CUNY)
   Research Award Program [68431-00 37]
FX This project was conducted with funds from the Professional Staff
   Congress - City University of New York (PSC-CUNY) Research Award
   Program, Award # 68431-00 37.
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887
   Bloom SR, 2008, MOL INTERV, V8, P82, DOI 10.1124/mi.8.2.6
   Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2
   Bult MJF, 2008, EUR J ENDOCRINOL, V158, P135, DOI 10.1530/EJE-07-0145
   Chaudhri OB, 2008, ANNU REV PHYSIOL, V70, P239, DOI 10.1146/annurev.physiol.70.113006.100506
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   DOUGLAS BR, 1990, AM J CLIN NUTR, V52, P553, DOI 10.1093/ajcn/52.3.553
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266
   Koegler FH, 2005, DIABETES, V54, P3198, DOI 10.2337/diabetes.54.11.3198
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lundsberg L.S., 1998, Caffeine, P199
   Moran TH, 2009, INT J OBESITY, V33, pS7, DOI 10.1038/ijo.2009.9
   (NHLBI) National Heart Lung and Blood Institute, 1998, NIH PUBL
   Onakpoya I, 2001, GASTROENT RES PRACT, V2011, P1
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Sileno AP, 2006, INT J OBESITY, V30, P68, DOI 10.1038/sj.ijo.0803067
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Ueno H, 2008, REGUL PEPTIDES, V145, P12, DOI 10.1016/j.regpep.2007.09.011
   Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325
NR 27
TC 23
Z9 30
U1 0
U2 34
PU AMER COLLEGE NUTRITION
PI CLEARWATER
PA 300 SOUTH DUNCAN AVENUE, STE 225, CLEARWATER, FL 33755 USA
SN 0731-5724
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD JUN
PY 2012
VL 31
IS 3
BP 160
EP 166
DI 10.1080/07315724.2012.10720023
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 069XN
UT WOS:000313470500004
PM 23204152
DA 2025-04-28
ER

PT J
AU Buelna-Chontal, M
AF Buelna-Chontal, Mabel
TI Coffee: Fuel for Your Day or Foe for Your Arteries
SO ANTIOXIDANTS
LA English
DT Review
DE cardiovascular disease; atherosclerosis; obesity; coffee consumption;
   cholesterol
ID ENDOTHELIAL DYSFUNCTION; ANTIOXIDANT CAPACITY; CHLOROGENIC ACID; GUT
   MICROBIOTA; LIPID PROFILE; IN-VITRO; CONSUMPTION; INFLAMMATION;
   CAFFEINE; PLASMA
AB Atherosclerosis, a major cause of cardiovascular diseases, is influenced by modifiable factors such as adiposity and blood cholesterol. Diet is crucial in these areas, particularly regarding antioxidant, inflammatory, and obesity effects. Coffee, a globally popular stimulant beverage, has garnered significant attention for its potential impact on cardiovascular diseases. Recent insights reinforce the need to re-examine the relationship between coffee consumption and atherosclerosis progression. Coffee's complex composition includes polyphenols, renowned for their antioxidant and anti-inflammatory properties as well as potential weight-reducing effects. In addition, studies have demonstrated that certain coffee compounds such as chlorogenic acid, caffeic, p-coumaric, and ferulic acid can prevent atherogenesis by preventing the oxidation of low-density lipoproteins. Conversely, diterpenes, found in some coffee brews, can elevate cholesterol levels, posing a risk to coronary health. Notably, coffee intake has been shown to influence gut microbiota diversity, potentially contributing to anti-obesity effects. This review explores the insights from preclinical and clinical studies investigating the potential mechanisms through which coffee consumption may reduce the risk of atherosclerosis-highlighting the potential benefits of moderate filtered coffee consumption and the potential risks associated with excessive coffee consumption. Understanding this relationship is crucial for informing public health recommendations and guiding future research.
C1 [Buelna-Chontal, Mabel] Natl Inst Cardiol, Dept Cardiovasc Biomed, Mexico City 14080, Mexico.
C3 National Institute of Cardiology - Mexico
RP Buelna-Chontal, M (corresponding author), Natl Inst Cardiol, Dept Cardiovasc Biomed, Mexico City 14080, Mexico.
EM mabel.buelna@cardiologia.org.mx
RI Buelna-Chontal, Mabel/AAZ-9298-2021
OI Buelna-Chontal, Mabel/0000-0002-9554-9412
FU Instituto Nacional de Cardiologia Ignacio Chavez
FX Open access funding for this article was supported by the Instituto
   Nacional de Cardiologia Ignacio Chavez.
CR Al-Fawaeir S, 2023, J AGR FOOD RES, V14, DOI 10.1016/j.jafr.2023.100904
   Alnsour L, 2022, MOLECULES, V27, DOI 10.3390/molecules27051591
   Amer SA, 2023, EUR REV MED PHARMACO, V27, P3230, DOI 10.26355/eurrev_202304_32093
   Bojic LA, 2016, ANAL BIOANAL CHEM, V408, P97, DOI 10.1007/s00216-015-9105-4
   Bulló M, 2007, PUBLIC HEALTH NUTR, V10, P1164, DOI 10.1017/S1368980007000663
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Caro-Gómez E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030497
   Cavalcanti MH, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262270
   Chang HC, 2020, J MULTIDISCIP HEALTH, V13, P1427, DOI 10.2147/JMDH.S276395
   Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955
   Cordoba N, 2020, TRENDS FOOD SCI TECH, V96, P45, DOI 10.1016/j.tifs.2019.12.004
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   da Costa MS, 2023, CLIN NUTR, V42, P1889, DOI 10.1016/j.clnu.2023.08.004
   Pereira GVD, 2020, ADV FOOD NUTR RES, V91, P65, DOI 10.1016/bs.afnr.2019.10.002
   Duangjai Acharaporn, 2018, Kobe J Med Sci, V64, pE84
   El-Huneidi W, 2021, MOLECULES, V26, DOI 10.3390/molecules26175167
   Engin A, 2017, ADV EXP MED BIOL, V960, P345, DOI 10.1007/978-3-319-48382-5_15
   Farag MA, 2022, FOODS, V11, DOI 10.3390/foods11060864
   Corrêa TAF, 2012, PLANT FOOD HUM NUTR, V67, P277, DOI 10.1007/s11130-012-0297-x
   Gómez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985
   Guercia E, 2024, INT J MOL SCI, V25, DOI 10.3390/ijms25116096
   Habash M, 2022, WOMENS HEALTH, V18, DOI 10.1177/17455057221112268
   Hang D, 2019, AM J CLIN NUTR, V109, P635, DOI 10.1093/ajcn/nqy295
   Henn M, 2023, CLIN NUTR, V42, P477, DOI 10.1016/j.clnu.2023.02.004
   Higgins LG, 2008, TOXICOL APPL PHARM, V226, P328, DOI 10.1016/j.taap.2007.09.018
   Hwang JH, 2016, CHEM-BIOL INTERACT, V248, P1, DOI 10.1016/j.cbi.2016.01.020
   ICO, 2023, Coffee Report and Outlook
   Iris M, 2018, CLIN IMMUNOL, V192, P68, DOI 10.1016/j.clim.2018.04.008
   Janda K, 2020, FOODS, V9, DOI 10.3390/foods9020121
   Lara-Guzmán OJ, 2016, FOOD RES INT, V89, P219, DOI 10.1016/j.foodres.2016.07.020
   Jia HJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0389-3
   Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183
   Kanchanasurakit S, 2023, SYST REV-LONDON, V12, DOI 10.1186/s13643-023-02311-4
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Khalili-Moghadam S, 2023, FRONT NUTR, V10, DOI 10.3389/fnut.2023.1241844
   Kuang A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121851
   Lara-Guzmán OJ, 2024, FOOD FUNCT, V15, P10399, DOI [10.1039/d4fo02114b, 10.1039/D4FO02114B]
   Lara-Guzmán OJ, 2020, FREE RADICAL BIO MED, V160, P604, DOI 10.1016/j.freeradbiomed.2020.07.020
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Martins BC, 2023, J NUTR BIOCHEM, V117, DOI 10.1016/j.jnutbio.2023.109336
   Miranda AM, 2022, EUR J NUTR, V61, P4205, DOI 10.1007/s00394-022-02946-4
   Miranda AM, 2017, CLIN NUTR, V36, P1635, DOI 10.1016/j.clnu.2016.10.012
   Muqaku B, 2016, MOL NUTR FOOD RES, V60, P2529, DOI 10.1002/mnfr.201600328
   Naidoo N, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-48
   Natella F, 2007, AM J CLIN NUTR, V86, P604, DOI 10.1093/ajcn/86.3.604
   Nieman DC, 2018, INT J SPORT NUTR EXE, V28, P55, DOI 10.1123/ijsnem.2017-0198
   Ontawong A, 2023, HELIYON, V9, DOI 10.1016/j.heliyon.2023.e13917
   Paapstel K, 2018, NUTR METAB CARDIOVAS, V28, P44, DOI 10.1016/j.numecd.2017.07.011
   Post SM, 1997, ARTERIOSCL THROM VAS, V17, P3064, DOI 10.1161/01.ATV.17.11.3064
   Purushothaman A, 2022, FREE RADICAL RES, V56, P617, DOI 10.1080/10715762.2022.2161379
   Quarta S, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11101545
   Rahimi MR, 2023, NUTRIENTS, V15, DOI 10.3390/nu15071634
   Raise-Abdullahi Payman, 2024, Prog Brain Res, V288, P133, DOI 10.1016/bs.pbr.2024.06.016
   Reis JP, 2010, ARTERIOSCL THROM VAS, V30, P2059, DOI 10.1161/ATVBAHA.110.208280
   Rodas L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082325
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Shanmugam G, 2024, NAT PROD RES, DOI 10.1080/14786419.2024.2386402
   Shechter M, 2011, AM J CARDIOL, V107, P1255, DOI 10.1016/j.amjcard.2010.12.035
   Stegemann C, 2014, CIRCULATION, V129, P1821, DOI 10.1161/CIRCULATIONAHA.113.002500
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Surma S, 2023, CARDIOL J, V30, P654, DOI 10.5603/CJ.a2022.0068
   Svatun ÅL, 2022, OPEN HEART, V9, DOI 10.1136/openhrt-2021-001946
   Tung WC, 2020, ARCH BIOCHEM BIOPHYS, V694, DOI 10.1016/j.abb.2020.108589
   Uner B, 2023, INT J OBESITY, V47, P1108, DOI 10.1038/s41366-023-01365-7
   Volz N, 2012, J AGR FOOD CHEM, V60, P9631, DOI 10.1021/jf302258u
   Voskoboinik A, 2019, TRENDS CARDIOVAS MED, V29, P345, DOI 10.1016/j.tcm.2018.09.019
   Wagner N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9112367
   Wang Q, 2023, FOOD FUNCT, V14, P5138, DOI [10.1039/d3fo01130e, 10.1039/D3FO01130E]
   Wu KC, 2014, PLANTA MED, V80, P97, DOI 10.1055/s-0033-1351097
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Ye XL, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.762691
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zmyslowski A, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0579-2
NR 75
TC 2
Z9 2
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD DEC
PY 2024
VL 13
IS 12
AR 1455
DI 10.3390/antiox13121455
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA Q4B2G
UT WOS:001384149200001
PM 39765784
OA gold
DA 2025-04-28
ER

PT J
AU Acar-Tek, N
   Agagündüz, D
   Ayhan, B
AF Acar-Tek, Nilufer
   Agagunduz, Duygu
   Ayhan, Busra
TI Effect of Green Coffee Consumption on Resting Energy Expenditure, Blood
   Pressure, and Body Temperature in Healthy Women: A Pilot Study
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE Green coffee; caffeine; chlorogenic acids; resting energy expenditure;
   blood pressure; body temperature
ID INDUCED INSULIN-RESISTANCE; CHLOROGENIC ACID; CAFFEINE; OBESITY;
   PHARMACOKINETICS; THERMOGENESIS; METABOLISM; BALANCE; HUMANS; PLASMA
AB Objective: This study was conducted to determine the effects of green coffee consumption on resting energy expenditures (REEs), blood pressure, and body temperature of individuals. Method: The study was conducted with 24 women. The REE values of the individuals were measured with the COSMED Fitmate PRO. After the first REE measurements, individuals were given 1 cup of green coffee that was prepared to contain 6 mg caffeine per kg of lean body mass. After coffee consumption, REE measurements were made at 30, 60, 120, and 180 minutes. Blood pressure (mm Hg) and body temperature values (degrees C) were measured simultaneously with REE measurement. Results: There was a positive correlation between the caffeine amounts given with green coffee and 30-minute (p < 0.05), 60-minute (p = 0.06), and 120-minute (p < 0.05) REE (kcal/d) values. There was also a positive correlation between the total chlorogenic acid taken with green coffee and 30-minute (p < 0.05), 60-minute (p = 0.06), and 120-minute (p < 0.05) REE (kcal/d) values. The intracellular and extracellular fluid amounts liter(l) before and after consumption of green coffee by individuals were 18.7 +/- 1.57 versus 18.6 +/- 1.44 (p < 0.05) and 11.4 +/- 1.01 versus 11.2 +/- 0.97 (p < 0.05), respectively. The body temperature (degrees C) changes observed in the individuals whose usual dietary caffeine intake was less than or equal to the 50th percentile after green coffee consumption were statistically significant (p < 0.05). Similarly, the diastolic blood pressure changes observed in the individuals whose usual dietary caffeine intake was less than or equal to the 50th percentile after green coffee consumption was almost statistically significant (p = 0.06). Conclusions: The results of this study showed that 6 mg caffeine/kg (lean body mass) intake among women changed body temperature and blood pressure values and liquid balance depending on the usual dietary coffee intake. In addition, chlorogenic acid is also correlated with REE values besides green coffee caffeine.
C1 [Acar-Tek, Nilufer; Agagunduz, Duygu; Ayhan, Busra] Gazi Univ, Dept Nutr & Dietet, Fac Hlth Sci, Ankara, Turkey.
C3 Gazi University
RP Ayhan, B (corresponding author), Gazi Univ, Dept Nutr & Dietet, Fac Hlth Sci, Ankara, Turkey.
EM busraayhan989@gmail.com
RI Ağagündüz, Duygu/AAS-9583-2020; Tek, Nilüfer/AAN-9250-2021
OI AGAGUNDUZ, DUYGU/0000-0003-0010-0012
CR Abdali D, 2015, MED PRIN PRACT, V24, P201, DOI 10.1159/000375305
   Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   [Anonymous], EFSA J
   [Anonymous], BMI CLASSIFICATION
   Armstrong LE, 2002, INT J SPORT NUTR EXE, V12, P189, DOI 10.1123/ijsnem.12.2.189
   Ballard TLP, 2006, CLIN EXP PHARMACOL P, V33, P310, DOI 10.1111/j.1440-1681.2006.04367.x
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bruckbauer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089166
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   COLLINS LC, 1994, INT J OBESITY, V18, P551
   Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4552
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Geleijnse JM, 2008, VASC HEALTH RISK MAN, V4, P963
   George SE, 2008, CRIT REV FOOD SCI, V48, P464, DOI 10.1080/10408390701522445
   Ghadieh HE, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0014-5
   Guessous I, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0468-2
   Harland BF, 2000, NUTRITION, V16, P522, DOI 10.1016/S0899-9007(00)00369-5
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jellin J, 2012, PHARM LETT PRESCRIBE
   Killer SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084154
   KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Martínez-López S, 2014, FOOD RES INT, V64, P125, DOI 10.1016/j.foodres.2014.05.043
   Maughan RJ, 2003, J HUM NUTR DIET, V16, P411, DOI 10.1046/j.1365-277X.2003.00477.x
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Rakcolu N., 2014, Yemek ve Besin Fotoraf Katalou, VVolume 132
   Revuelta-Iniesta R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/482704
   Riksen NP, 2009, PHARMACOL THERAPEUT, V121, P185, DOI 10.1016/j.pharmthera.2008.10.006
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Silva AM, 2013, APPL PHYSIOL NUTR ME, V38, P626, DOI 10.1139/apnm-2012-0253
   TARNOPOLSKY MA, 1994, SPORTS MED, V18, P109, DOI 10.2165/00007256-199418020-00004
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
NR 41
TC 5
Z9 5
U1 1
U2 9
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD NOV 17
PY 2018
VL 37
IS 8
BP 691
EP 700
DI 10.1080/07315724.2018.1461147
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HE1XU
UT WOS:000453068000006
PM 29723112
DA 2025-04-28
ER

PT J
AU Sarriá, B
   Sierra-Cinos, JL
   García-Diz, L
   Martínez-López, S
   Mateos, R
   Bravo-Clemente, L
AF Sarria, Beatriz
   Sierra-Cinos, Jose Luis
   Garcia-Diz, Luis
   Martinez-Lopez, Sara
   Mateos, Raquel
   Bravo-Clemente, Laura
TI Green/Roasted Coffee May Reduce Cardiovascular Risk in
   Hypercholesterolemic Subjects by Decreasing Body Weight, Abdominal
   Adiposity and Blood Pressure
SO FOODS
LA English
DT Article
DE green coffee; hypercholesterolemia; cardiovascular risk; weight; waist;
   overweight; obesity
ID INSULIN-RESISTANCE; LIPID PROFILE; OBESITY; GLUCOSE; CONSUMPTION;
   PLASMA; SUPPLEMENTATION; LIPOPROTEIN; MECHANISMS; DENSITY
AB In previous studies, after regularly consuming a green/roasted coffee blend, body weight, body fat%, glucose, plasminogen activator inhibitor-1 (PAI-1), resistin, leptin, ghrelin, diastolic (DBP) and systolic blood pressure (SBP) significantly changed in healthy and hypercholesterolemic subjects. However, glucagon, total-cholesterol (T-C), triglycerides (TG), LDL-cholesterol (LDL-C) and Homeostasis Model Assessment index to estimate insulin resistance (HOMA-IR) only changed in the hypercholesterolemics. This work looks into the antiobesity effects of coffee blend and into the relationship of antiobesity with the aforementioned cardiometabolic modifications in hypercholesterolemics. (1) Methods: Tricipital and subscapular skinfolds, hip, thigh, arm and waist circumference (WC) were measured in normocholesterolemic and hypercholesterolemics. To understand the relationship between cardiometabolic and antiobesity results in hypercholesterolemics, factor analysis was carried out using baseline values of the variables that changed. (2) Results: WC, WC/hip and WC/height showed significant coffeexgroup interaction, and in hypercholesterolemics tended to decrease. After factor analysis, three factors emerged, accounting for 29.46, 13.13 and 11.79% of variance. Only factor 1 (main loadings: WC, DBP and SBP, body weight, WC/hip and WC/height ratios, TG and ghrelin, inversely) decreased after coffee intake. (3) Conclusion: Regularly consuming green/roasted coffee may help to control body weight, and in hypercholesterolemics, may reduce cardiovascular risk by reducing abdominal adiposity and blood pressure.
C1 [Sarria, Beatriz; Martinez-Lopez, Sara; Mateos, Raquel; Bravo-Clemente, Laura] CSIC, Inst Food Sci Technol & Nutr ICTAN CSIC, Dept Metab & Nutr, Jose Antonio Novais 10, Madrid 28040, Spain.
   [Sierra-Cinos, Jose Luis; Garcia-Diz, Luis] Complutense Univ Madrid UCM, Sch Pharm, Dept Nutr & Food Sci 1, Ciudad Univ S-N, Madrid 28040, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Complutense
   University of Madrid
RP Sarriá, B (corresponding author), CSIC, Inst Food Sci Technol & Nutr ICTAN CSIC, Dept Metab & Nutr, Jose Antonio Novais 10, Madrid 28040, Spain.
EM beasarria@ictan.csic.es; jlscinos@farm.ucm.es; diz@farm.ucm.es;
   sara.martinez@universidadeuropea.es; raquel.mateos@ictan.csic.es;
   lbravo@ictan.csic.es
RI BRIZ, Raquel/H-9125-2012; Sarria, Beatriz/K-7929-2014; Bravo,
   Laura/F-4992-2012
OI Sarria, Beatriz/0000-0003-0614-4606; Martinez Lopez,
   Sara/0000-0002-4587-7100; Bravo, Laura/0000-0002-7312-8641
FU Ministerio de Economia y Competitividad [AGL2010-18269,
   AGL2015-69986-R]; Spanish National Research Council; European Social
   Fund
FX This research was funded by projects AGL2010-18269 and AGL2015-69986-R
   from the Ministerio de Economia y Competitividad. Sara Martinez-Lopez
   thanks the Spanish National Research Council for her pre-doctoral
   fellowship under the JAE-Pre program co-funded by the Spanish National
   Research Council and the European Social Fund.
CR Agudelo-Ochoa GM, 2016, J NUTR, V146, P524, DOI 10.3945/jn.115.224774
   Al-Massadi O, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163905
   ALBRINK MJ, 1980, LIPIDS, V15, P668, DOI 10.1007/BF02534017
   [Anonymous], 2004, FAO WHO UNO EXP CONS
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   BERCHTOLD P, 1981, INT J OBESITY, V5, P1
   Bravo L, 2019, COFFEE: CONSUMPTION AND HEALTH IMPLICATIONS, P105
   Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Denroche HC, 2012, J DIABETES INVEST, V3, P115, DOI 10.1111/j.2040-1124.2012.00203.x
   DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
   FAO/WHO/UNO, 1985, TECHNICAL REPORT SER, V724
   Garaulet M, 2001, INT J OBESITY, V25, P243, DOI 10.1038/sj.ijo.0801476
   Gavrieli A, 2013, METABOLISM, V62, P1099, DOI 10.1016/j.metabol.2013.02.003
   Gökcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   Gómez-Juaristi M, 2018, FOOD FUNCT, V9, P331, DOI [10.1039/c7fo01553d, 10.1039/C7FO01553D]
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hu GL, 2019, FOOD FUNCT, V10, P3113, DOI [10.1039/c9fo00288j, 10.1039/C9FO00288J]
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Martini D, 2021, EUR J NUTR, V60, P1453, DOI 10.1007/s00394-020-02347-5
   Martini D, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081805
   Momin M, 2020, OBESITY FACTS, V13, P245, DOI 10.1159/000506689
   Otto B, 2001, EUR J ENDOCRINOL, V145, pR5
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Ríos-Hoyo A, 2016, CURR OBES REP, V5, P262, DOI 10.1007/s13679-016-0214-y
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Sarriá B, 2016, FOOD RES INT, V89, P1023, DOI 10.1016/j.foodres.2015.12.032
   Shaposhnikov S, 2018, EUR J NUTR, V57, P533, DOI 10.1007/s00394-016-1336-4
   Siri WE., 1961, Techniques for measuring body composition, P223
   Song Young-Hwan, 2014, Korean J Pediatr, V57, P79, DOI 10.3345/kjp.2014.57.2.79
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   TERRY RB, 1989, J CLIN ENDOCR METAB, V68, P191, DOI 10.1210/jcem-68-1-191
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   Yarmolinsky J, 2016, SCI REP-UK, V6, DOI 10.1038/srep17714
NR 41
TC 6
Z9 6
U1 3
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2304-8158
J9 FOODS
JI Foods
PD SEP
PY 2020
VL 9
IS 9
AR 1191
DI 10.3390/foods9091191
PG 15
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA OF6FA
UT WOS:000581299800001
PM 32872136
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Gökcen, BB
   Sanlier, N
AF Gokcen, Busra Basar
   Sanlier, Nevin
TI Coffee consumption and disease correlations
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Coffee; caffeine; chlorogenic acid; kahweol; cafestol; diseases
ID BREAST-CANCER RISK; CHRONIC LIVER-DISEASE; COLORECTAL-CANCER;
   PANCREATIC-CANCER; PROSTATE-CANCER; CAFFEINE CONSUMPTION; DECAFFEINATED
   COFFEE; PARKINSONS-DISEASE; PROSPECTIVE COHORT; CHLOROGENIC ACID
AB Coffee is one of the most widely consumed beverages in the world. It has primarily consumed due to its stimulant effect and unique taste since the ancient times. Afterwards, its consumption has been historically associated with a lower risk of some diseases such as type 2 diabetes mellitus, obesity, cardiovascular disease and some type of cancer and thus it has also consumed due to health benefits. It contains many bioactive compounds such as caffeine, chlorogenic acids and diterpenoid alcohols which have so far been associated with many potential health benefits. For example, caffeine reduces risk of developing neurodegenerative disease and chlorogenic acids (CGA) and diterpene alcohols have many health benefits such as antioxidant and chemo-preventive. Coffee also have harmful effects. For example, diterpenoid alcohols increases serum homocysteine and cholesterol levels and thus it has adverse effects on cardiovascular system. Overall, the study that supports the health benefits of coffee is increasing. But, it is thought-provoking that the association with health benefits of coffee consumption and frequency at different levels in each study. For this reason, we aimed to examine the health effect of the coffee and how much consumption is to investigate whether it meets the claimed health benefits.
C1 [Gokcen, Busra Basar] Gazi Univ, Fac Hlth Sci, Nutr & Dietet Dept, Ankara, Turkey.
   [Sanlier, Nevin] Biruni Univ, Fac Hlth Sci, Nutr & Dietet Dept, 10 Yil Caddesi Protokol Yolu 10, TR-34010 Istanbul, Turkey.
C3 Gazi University; Biruni University
RP Sanlier, N (corresponding author), Biruni Univ, Fac Hlth Sci, Nutr & Dietet Dept, 10 Yil Caddesi Protokol Yolu 10, TR-34010 Istanbul, Turkey.
EM nevintekgul@gmail.com
RI GÖKCEN, Büşra/AAA-3726-2021
OI Basar Gokcen, Busra/0000-0002-5628-3658
CR Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Aleksandrova K, 2015, AM J CLIN NUTR, V102, P1498, DOI 10.3945/ajcn.115.116095
   Alperet DJ, 2016, CONT CLIN TRIAL COMM, V4, P105, DOI 10.1016/j.conctc.2016.06.013
   [Anonymous], FOOD NUTR PHYS ACT P
   [Anonymous], 2013, CIRCULATION
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   [Anonymous], 2011, **NON-TRADITIONAL**, DOI DOI 10.2903/J.EFSA.2011.2054
   [Anonymous], 2015, SCI REP UK
   [Anonymous], EFSA JOURNAL
   [Anonymous], BRIT J CANC
   [Anonymous], 2016, CRIT REV FOOD SCI
   [Anonymous], BIOMED RESEARCH INTE
   [Anonymous], SICHUAN ELECT POWER
   [Anonymous], 2009, JPN PHARN ACOL THER
   [Anonymous], TURKIYE KLIN J NEURO
   [Anonymous], GASTROENTEROLOGY RES
   [Anonymous], FOOD NUTR PHYS ACT P
   [Anonymous], 2010, QJM INT J MED
   [Anonymous], EVIDENCE BASED COMPL
   [Anonymous], IARC MON EV DRINK CO
   [Anonymous], DIET NUTR PHYS ACT L
   Ascherio A, 2004, AM J EPIDEMIOL, V160, P977, DOI 10.1093/aje/kwh312
   Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052
   Bharath Nagaraj, 2015, Contemp Clin Dent, V6, P166, DOI 10.4103/0976-237X.156036
   Bhoo-Pathy N, 2013, CLIN GASTROENTEROL H, V11, P1486, DOI 10.1016/j.cgh.2013.05.029
   Bidel S., 2012, Coffee: emerging health effects and disease prevention, P181
   Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a
   Bohn SK, 2014, MOL NUTR FOOD RES, V58, P915, DOI 10.1002/mnfr.201300526
   Budhathoki S, 2015, INT J CANCER, V137, P463, DOI 10.1002/ijc.29390
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cao SY, 2014, CARCINOGENESIS, V35, P256, DOI 10.1093/carcin/bgt482
   Capek P, 2014, CARBOHYD POLYM, V103, P418, DOI 10.1016/j.carbpol.2013.12.068
   Capek P, 2010, CARBOHYD POLYM, V80, P180, DOI 10.1016/j.carbpol.2009.11.016
   Cappelletti S, 2015, CURR NEUROPHARMACOL, V13, P71, DOI 10.2174/1570159X13666141210215655
   Cárdenas C, 2014, BIOCHEM BIOPH RES CO, V447, P452, DOI 10.1016/j.bbrc.2014.04.026
   Chae JI, 2014, PHYTOTHER RES, V28, P1879, DOI 10.1002/ptr.5217
   Chen SH, 2014, J GASTROEN HEPATOL, V29, P435, DOI 10.1111/jgh.12422
   Chinwe A. A. O., 2013, Journal of Current Research in Science, V1, P104
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Cornelis MC, 2007, CURR OPIN LIPIDOL, V18, P13, DOI 10.1097/MOL.0b013e3280127b04
   Costa J, 2010, J ALZHEIMERS DIS, V20, pS221, DOI 10.3233/JAD-2010-091525
   Darvesh AS, 2012, CURR PHARM BIOTECHNO, V13, P218
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Derkinderen P, 2014, MOVEMENT DISORD, V29, P976, DOI 10.1002/mds.25882
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dong J, 2011, WORLD J GASTROENTERO, V17, P1204, DOI 10.3748/wjg.v17.i9.1204
   El-Abhar HS, 2014, WORLD J DIABETES, V5, P176, DOI 10.4239/wjd.v5.i2.176
   Dias RCE, 2014, EUR FOOD RES TECHNOL, V239, P961, DOI 10.1007/s00217-014-2293-x
   Fagherazzi G, 2011, PUBLIC HEALTH NUTR, V14, P1315, DOI 10.1017/S1368980011000371
   Farag NH, 2010, J WOMENS HEALTH, V19, P1171, DOI 10.1089/jwh.2009.1664
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Fernandez-Gomez B, 2016, J FUNCT FOODS, V25, P197, DOI 10.1016/j.jff.2016.06.001
   Fukushima Y, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.19
   Ganguly P, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-6
   Ganmaa D, 2008, INT J CANCER, V122, P2071, DOI 10.1002/ijc.23336
   Gaspar S., 2016, Encyclopedia of Food and Health, P573
   Gasscht F, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0501-3
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Geleijnse JM, 2008, VASC HEALTH RISK MAN, V4, P963
   Genkinger JM, 2012, CANCER EPIDEM BIOMAR, V21, P305, DOI 10.1158/1055-9965.EPI-11-0945-T
   George SE, 2008, CRIT REV FOOD SCI, V48, P464, DOI 10.1080/10408390701522445
   Geybels MS, 2013, CANCER CAUSE CONTROL, V24, P1947, DOI 10.1007/s10552-013-0270-5
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Gostner JM, 2015, J AM COLL NUTR, V34, P212, DOI 10.1080/07315724.2014.907756
   Goto M, 2009, BIOSCI BIOTECH BIOCH, V73, P2439, DOI 10.1271/bbb.90393
   Groessl EJ, 2016, J CANCER EPIDEMIOL, V2016, DOI 10.1155/2016/6918431
   Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458
   Hashibe M, 2015, BRIT J CANCER, V113, P809, DOI 10.1038/bjc.2015.276
   Hernán MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hu G, 2007, MOVEMENT DISORD, V22, P2242, DOI 10.1002/mds.21706
   Inoue M, 2009, CANCER EPIDEM BIOMAR, V18, P1746, DOI 10.1158/1055-9965.EPI-08-0923
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   Jernström H, 2003, CARCINOGENESIS, V24, P991, DOI 10.1093/carcin/bgg047
   Jiang WJ, 2013, GYNECOL ONCOL, V129, P620, DOI 10.1016/j.ygyno.2013.03.014
   Johnson S, 2011, CANCER CAUSE CONTROL, V22, P503, DOI 10.1007/s10552-010-9725-0
   Kamiyama M, 2015, J AGR FOOD CHEM, V63, P1996, DOI 10.1021/jf5060563
   Kang NJ, 2011, CARCINOGENESIS, V32, P921, DOI 10.1093/carcin/bgr022
   Karabudak E, 2015, EXP THER MED, V9, P1841, DOI 10.3892/etm.2015.2342
   Klatsky AL, 2006, ARCH INTERN MED, V166, P1190, DOI 10.1001/archinte.166.11.1190
   Kotsopoulos J, 2007, CANCER EPIDEM BIOMAR, V16, P912, DOI 10.1158/1055-9965.EPI-06-1074
   Kurzrock T, 2001, FOOD REV INT, V17, P433, DOI 10.1081/FRI-100108532
   Lai GY, 2013, BRIT J CANCER, V109, P1344, DOI 10.1038/bjc.2013.405
   Larsson SC, 2006, AM J EPIDEMIOL, V163, P638, DOI 10.1093/aje/kwj067
   Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044
   Lee KA, 2012, J BIOMED SCI, V19, DOI [10.1186/1423-0127-19-60, 10.6117/kmeps.2012.19.3.001]
   Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206
   Li GW, 2013, PUBLIC HEALTH NUTR, V16, P346, DOI 10.1017/S1368980012002601
   Li Q, 2013, BRIT J CANCER, V108, P2381, DOI 10.1038/bjc.2013.238
   Li XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052681
   Liu H, 2015, NUTR CANCER, V67, P392, DOI 10.1080/01635581.2015.1004727
   Loftfield E, 2015, CANCER EPIDEM BIOMAR, V24, P1052, DOI 10.1158/1055-9965.EPI-15-0038-T
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Lu Y, 2014, CANCER CAUSE CONTROL, V25, P591, DOI 10.1007/s10552-014-0364-8
   Luo JH, 2007, EUR J CANCER PREV, V16, P542, DOI 10.1097/CEJ.0b013e32809b4d30
   Manne Vignan, 2015, Clin Liver Dis (Hoboken), V6, P139, DOI 10.1002/cld.517
   Martyn C, 2003, BRIT MED J, V326, P561, DOI 10.1136/bmj.326.7389.561
   Masterton GS, 2010, EUR J GASTROEN HEPAT, V22, P1277, DOI 10.1097/MEG.0b013e32833cca96
   Messina G., 2015, Biology and Medicine, V7, P1
   Michels KB, 2005, J NATL CANCER I, V97, P282, DOI 10.1093/jnci/dji039
   Muley A, 2012, CURR DIABETES REV, V8, P162, DOI 10.2174/157339912800564016
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Naganuma T, 2008, AM J EPIDEMIOL, V168, P1425, DOI 10.1093/aje/kwn282
   Naganuma T, 2007, INT J CANCER, V120, P1542, DOI 10.1002/ijc.22505
   Nie KC, 2016, MINERVA MED, V107, P270
   Nkondjock A, 2006, INT J CANCER, V118, P103, DOI 10.1002/ijc.21296
   Nkondjock A, 2009, CANCER LETT, V277, P121, DOI 10.1016/j.canlet.2008.08.022
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Nosál'ová G, 2011, INT J BIOL MACROMOL, V49, P493, DOI 10.1016/j.ijbiomac.2011.06.004
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Oh JK, 2015, INT J CANCER, V137, P1979, DOI 10.1002/ijc.29569
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Park GH, 2016, FOOD CHEM TOXICOL, V95, P142, DOI 10.1016/j.fct.2016.07.008
   Pathy NB, 2010, BREAST CANCER RES TR, V121, P461, DOI 10.1007/s10549-009-0583-y
   Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311
   Petrick JL, 2015, CANCER EPIDEM BIOMAR, V24, P1398, DOI 10.1158/1055-9965.EPI-15-0137
   Pimentel GD, 2014, NUTRITION IN THE PREVENTION AND TREATMENT OF ABDOMINAL OBESITY, P245, DOI 10.1016/B978-0-12-407869-7.00024-6
   Pimentel GD, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-6
   Prakash KM, 2011, BASAL GANGLIA, V1, P127, DOI 10.1016/j.baga.2011.07.001
   Ramalakshmi K, 1999, CRIT REV FOOD SCI, V39, P441, DOI 10.1080/10408699991279231
   Ran HQ, 2016, PAK J MED SCI, V32, P253, DOI 10.12669/pjms.321.8761
   Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674
   Sääksjärvi K, 2008, EUR J CLIN NUTR, V62, P908, DOI 10.1038/sj.ejcn.1602788
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Sang L., 2013, BMC Gastroenterology, V13, P1
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Schmit SL, 2016, CANCER EPIDEM BIOMAR, V25, P634, DOI 10.1158/1055-9965.EPI-15-0924
   Semen S, 2017, FOOD CHEM, V215, P92, DOI 10.1016/j.foodchem.2016.07.176
   Setiawan VW, 2015, GASTROENTEROLOGY, V148, P118, DOI 10.1053/j.gastro.2014.10.005
   Shateri Z., 2016, J CLIN NUTR DIETETIC, V02, P1
   Shimazu T, 2005, INT J CANCER, V116, P150, DOI 10.1002/ijc.20989
   Silva JA, 2012, FOOD ANAL METHOD, V5, P1404, DOI 10.1007/s12161-012-9387-5
   Sinha R, 2012, AM J CLIN NUTR, V96, P374, DOI 10.3945/ajcn.111.031328
   Song F., 2016, NFS Journal, V4, P9
   Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278
   Tang NP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.019
   Tofalo R, 2016, The Encyclopedia of Food and Health, P2
   Turati F, 2012, ANN ONCOL, V23, P311, DOI 10.1093/annonc/mdr331
   Tverdal A, 2015, BRIT J CANCER, V112, P576, DOI 10.1038/bjc.2014.645
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Volk BM, 2013, NUTRITION AND ENHANCED SPORTS PERFORMANCE: MUSCLE BUILDING, ENDURANCE, AND STRENGTH, P487, DOI 10.1016/B978-0-12-396454-0.00051-5
   Volz N, 2012, J AGR FOOD CHEM, V60, P9631, DOI 10.1021/jf302258u
   WCRF/AICR. World Cancer Research Fund/American Institute for Cancer Research, 2011, FOOD NUTR PHYS ACT P
   Wierzejska Regina, 2015, Rocz Panstw Zakl Hig, V66, P293
   Wilson KM, 2011, JNCI-J NATL CANCER I, V103, P876, DOI 10.1093/jnci/djr151
   Yamada H, 2014, J EPIDEMIOL, V24, P370, DOI 10.2188/jea.JE20130168
   Yamada-Fowler Naomi, 2015, Journal of Caffeine Research, V5, P3, DOI 10.1089/jcr.2014.0028
   Yarmolinsky J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126469
   You DC, 2011, TOX RESEARCH, V27, P7, DOI 10.5487/TR.2011.27.1.007
   Yu XH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-97
   Zhang C, 2012, FOOD RES INT, V49, P27, DOI 10.1016/j.foodres.2012.06.032
NR 156
TC 115
Z9 119
U1 1
U2 126
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD JAN 19
PY 2019
VL 59
IS 2
BP 336
EP 348
DI 10.1080/10408398.2017.1369391
PG 13
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA HR1HL
UT WOS:000462881700010
PM 28853910
DA 2025-04-28
ER

PT J
AU Socala, K
   Szopa, A
   Serefko, A
   Poleszak, E
   Wlaz, P
AF Socala, Katarzyna
   Szopa, Aleksandra
   Serefko, Anna
   Poleszak, Ewa
   Wlaz, Piotr
TI Neuroprotective Effects of Coffee Bioactive Compounds: A Review
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE coffee consumption; caffeine; chlorogenic acid; caffeic acid;
   trigonelline; neuroprotection; Alzheimer's disease; Parkinson's disease;
   stroke
ID ACID PHENETHYL-ESTER; ADENOSINE A(2A) RECEPTOR; ACUTE ISCHEMIC-STROKE;
   NEURONAL CELL-DEATH; CYTOCHROME-P450 1A2 ACTIVITY; NIGRAL
   DOPAMINERGIC-NEURONS; ACUTE MYOCARDIAL-INFARCTION; DOSE-RESPONSE
   METAANALYSIS; FOCAL CORTICAL INFARCTION; TANDEM MASS-SPECTROMETRY
AB Coffee is one of the most widely consumed beverages worldwide. It is usually identified as a stimulant because of a high content of caffeine. However, caffeine is not the only coffee bioactive component. The coffee beverage is in fact a mixture of a number of bioactive compounds such as polyphenols, especially chlorogenic acids (in green beans) and caffeic acid (in roasted coffee beans), alkaloids (caffeine and trigonelline), and the diterpenes (cafestol and kahweol). Extensive research shows that coffee consumption appears to have beneficial effects on human health. Regular coffee intake may protect from many chronic disorders, including cardiovascular disease, type 2 diabetes, obesity, and some types of cancer. Importantly, coffee consumption seems to be also correlated with a decreased risk of developing some neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, and dementia. Regular coffee intake may also reduce the risk of stroke. The mechanism underlying these effects is, however, still poorly understood. This review summarizes the current knowledge on the neuroprotective potential of the main bioactive coffee components, i.e., caffeine, chlorogenic acid, caffeic acid, trigonelline, kahweol, and cafestol. Data from both in vitro and in vivo preclinical experiments, including their potential therapeutic applications, are reviewed and discussed. Epidemiological studies and clinical reports on this matter are also described. Moreover, potential molecular mechanism(s) by which coffee bioactive components may provide neuroprotection are reviewed.
C1 [Socala, Katarzyna; Wlaz, Piotr] Marie Curie Sklodowska Univ, Inst Biol Sci, Dept Anim Physiol & Pharmacol, Akad 19, PL-20033 Lublin, Poland.
   [Szopa, Aleksandra; Serefko, Anna; Poleszak, Ewa] Med Univ Lublin, Chair & Dept Appl & Social Pharm, Lab Preclin Testing, Chodzki 1, PL-20093 Lublin, Poland.
C3 Maria Curie-Sklodowska University; Medical University of Lublin
RP Socala, K (corresponding author), Marie Curie Sklodowska Univ, Inst Biol Sci, Dept Anim Physiol & Pharmacol, Akad 19, PL-20033 Lublin, Poland.
EM k.socala@poczta.umcs.lublin.pl; aleksandra.szopa@umlub.pl;
   anna.serefko@umlub.pl; ewa.poleszak@umlub.pl;
   piotr.wlaz@poczta.umcs.lublin.pl
RI Wlaź, Piotr/ABH-1659-2021; Szopa, Aleksandra/ABC-2532-2020
OI Socala, Katarzyna/0000-0001-7706-2080; Serefko,
   Anna/0000-0002-5732-8950; Szopa, Aleksandra/0000-0002-7756-2904; Wlaz,
   Piotr/0000-0002-5389-0241
CR Ahn Eun Hee, 2011, Exp Neurobiol, V20, P169, DOI 10.5607/en.2011.20.4.169
   Aho L, 2006, STROKE, V37, P2940, DOI 10.1161/01.STR.0000248777.44128.93
   Akomolafe SF, 2017, NEUROTOXICOLOGY, V62, P6, DOI 10.1016/j.neuro.2017.04.008
   Alarcón-Herrera N, 2017, FOOD CHEM TOXICOL, V109, P1018, DOI 10.1016/j.fct.2017.04.048
   Alexander M, 2013, BRAIN SCI, V3, P177, DOI 10.3390/brainsci3010177
   Alexandrov Peter N, 2012, Int J Biochem Mol Biol, V3, P365
   Altman RD, 2011, MOVEMENT DISORD, V26, P2427, DOI 10.1002/mds.23873
   Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25
   Anjomshoa M, 2020, CURR PHARM DESIGN, V26, P5067, DOI 10.2174/1381612826666200610181259
   [Anonymous], WORLD ALZHEIMER REPO
   [Anonymous], 2015, J DRUG ALCOHOL RES, DOI DOI 10.4303/jdar/235959
   Anwar J, 2012, PHARMACOL BIOCHEM BE, V103, P386, DOI 10.1016/j.pbb.2012.09.006
   Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021
   Arendash GW, 2010, J ALZHEIMERS DIS, V20, pS117, DOI 10.3233/JAD-2010-091249
   Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087
   Arnaud MJ., 1993, CAFFEINE COFFEE HLTH, P43
   Aronowski J, 2003, STROKE, V34, P1246, DOI 10.1161/01.STR.0000068170.80517.B3
   Aseervatham GSB, 2016, BIOMED PHARMACOTHER, V82, P54, DOI 10.1016/j.biopha.2016.04.066
   Backman JT, 2006, BRIT J CLIN PHARMACO, V62, P345, DOI 10.1111/j.1365-2125.2006.02653.x
   Bae JH, 2014, INTEGR MED RES, V3, P189, DOI 10.1016/j.imr.2014.08.002
   Bae Jong Myon, 2020, Dement Neurocogn Disord, V19, P108, DOI 10.12779/dnd.2020.19.3.108
   Bagga P, 2016, NEUROCHEM INT, V92, P25, DOI 10.1016/j.neuint.2015.11.006
   Bagheri H, 1999, CLIN NEUROPHARMACOL, V22, P213
   Quintana JLB, 2007, NEUROL RES, V29, P91, DOI 10.1179/174313206X152546
   Silva RB, 2013, NEUROSCIENCE, V233, P86, DOI 10.1016/j.neuroscience.2012.12.041
   Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59
   Beghi E, 2019, LANCET NEUROL, V18, P357, DOI [10.1016/S1474-4422(19)30034-1, 10.1016/S1474-4422(18)30454-X, 10.1016/S1474-4422(18)30443-5]
   Beghi E, 2020, NEUROEPIDEMIOLOGY, V54, P185, DOI 10.1159/000503831
   Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278
   Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643
   Bizzo M.L.G., 2015, Coffee in Health and Disease Prevention, P11, DOI DOI 10.1016/B978-0-12-409517-5.00002-4
   BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933
   BLANCHARD J, 1983, J CLIN PHARMACOL, V23, P134, DOI 10.1002/j.1552-4604.1983.tb02716.x
   BLANCHARD J, 1983, J PHARMACOKINET BIOP, V11, P109, DOI 10.1007/BF01061844
   Blümcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   BONATI M, 1982, CLIN PHARMACOL THER, V32, P98, DOI 10.1038/clpt.1982.132
   Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012
   BRACHTEL D, 1988, Z GASTROENTEROL, V26, P245
   Bresciani L, 2020, MOL NUTR FOOD RES, DOI 10.1002/mnfr.202000489
   Briellmann RS, 2002, ANN NEUROL, V51, P641, DOI 10.1002/ana.10171
   Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381
   Brown RG, 2011, J NEUROL NEUROSUR PS, V82, P803, DOI 10.1136/jnnp.2010.213652
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   CALLAHAN MM, 1982, DRUG METAB DISPOS, V10, P417
   Camfield DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082897
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Carta AR, 2009, J NEUROCHEM, V111, P1478, DOI 10.1111/j.1471-4159.2009.06425.x
   Cereda C, 2012, FRONT NEUROL NEUROSC, V30, P128, DOI 10.1159/000333610
   Cervellati C, 2016, J INVEST MED, V64, P21, DOI 10.1136/jim-2015-000017
   Cheek Martin, 2002, Kew Bulletin, V57, P675, DOI 10.2307/4110998
   Chen JF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-10-j0001.2001
   Chen XS, 2008, J NEUROCHEM, V107, P1147, DOI 10.1111/j.1471-4159.2008.05697.x
   Chen Y, 2010, ANN PHARMACOTHER, V44, P1038, DOI 10.1345/aph.1M533
   Chen Y, 2009, CLIN EXP PHARMACOL P, V36, P828, DOI 10.1111/j.1440-1681.2009.05158.x
   Chen ZC, 2014, NEUROSCI BULL, V30, P271, DOI 10.1007/s12264-013-1423-y
   Cho ES, 2009, MUTAT RES-FUND MOL M, V661, P18, DOI 10.1016/j.mrfmmm.2008.10.021
   CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6
   Chowdhury AA, 2018, METAB BRAIN DIS, V33, P681, DOI 10.1007/s11011-017-0147-5
   Chowdhury AA, 2018, PHARMACOL REP, V70, P372, DOI 10.1016/j.pharep.2017.09.006
   Christensen A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00130
   Chu YF, 2009, J AGR FOOD CHEM, V57, P9801, DOI 10.1021/jf902095z
   Ciaramelli C, 2019, FOOD CHEM, V278, P47, DOI 10.1016/j.foodchem.2018.11.063
   Clifford MN, 2020, COMPR REV FOOD SCI F, V19, P1299, DOI 10.1111/1541-4337.12518
   Clifford MN, 2017, NAT PROD REP, V34, P1391, DOI 10.1039/c7np00030h
   CLIFFORD MN, 1991, PHYTOCHEMISTRY, V30, P4039, DOI 10.1016/0031-9422(91)83461-S
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Coelho VR, 2016, N-S ARCH PHARMACOL, V389, P1195, DOI 10.1007/s00210-016-1281-z
   Coelho VR, 2015, LIFE SCI, V122, P65, DOI 10.1016/j.lfs.2014.11.009
   Colombo R, 2020, CRIT REV FOOD SCI, V60, P760, DOI 10.1080/10408398.2018.1550384
   Colonnello A, 2020, NEUROTOX RES, V37, P326, DOI 10.1007/s12640-019-00133-8
   Contestabile A, 2011, BEHAV BRAIN RES, V221, P334, DOI 10.1016/j.bbr.2009.12.044
   Cornelis MC, 2007, CURR OPIN LIPIDOL, V18, P13, DOI 10.1097/MOL.0b013e3280127b04
   Costa J, 2010, J ALZHEIMERS DIS, V20, pS221, DOI 10.3233/JAD-2010-091525
   Costa MS, 2008, NEUROSCIENCE, V153, P1071, DOI 10.1016/j.neuroscience.2008.03.038
   Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160
   Crichton GE, 2013, PLANT FOOD HUM NUTR, V68, P279, DOI 10.1007/s11130-013-0370-0
   Cropley V, 2012, PSYCHOPHARMACOLOGY, V219, P737, DOI 10.1007/s00213-011-2395-0
   Dall'Igna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008
   Dall'lgna OP, 2003, BRIT J PHARMACOL, V138, P1207, DOI 10.1038/sj.bjp.0705185
   Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x
   Davis AP, 2004, BOT J LINN SOC, V146, P237, DOI 10.1111/j.1095-8339.2004.00328.x
   Davis AP, 2003, BOT J LINN SOC, V142, P111, DOI 10.1046/j.1095-8339.2003.00154.x
   de Lanerolle NC, 2005, EPILEPSY BEHAV, V7, P190, DOI 10.1016/j.yebeh.2005.06.003
   de Mendonça A, 2010, J ALZHEIMERS DIS, V20, pS1, DOI [10.3233/JAD-2010-1420, 10.3233/JAD-2010-01420]
   de Oliveira DM, 2011, QUIM NOVA, V34, P1051, DOI 10.1590/S0100-40422011000600023
   de Oliveira MR, 2020, NEUROTOX RES, V37, P100, DOI 10.1007/s12640-019-00107-w
   De Roos B, 1998, J INTERN MED, V244, P451, DOI 10.1111/j.1365-2796.1998.00386.x
   Delgado-Escueta A.V., 2010, HISTOPATHOLOGY HUMAN, V4th
   Dening Tom, 2015, Nurs Stand, V29, P37, DOI 10.7748/ns.29.37.37.e9405
   Deshmukh R, 2016, BIOMED PHARMACOTHER, V81, P56, DOI 10.1016/j.biopha.2016.03.017
   Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5
   Di Marco LY, 2015, NEUROBIOL DIS, V82, P593, DOI 10.1016/j.nbd.2015.08.014
   Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Divis Pavel, 2019, Potravinarstvo: Slovak Journal of Food Sciences, V13, P344, DOI 10.5219/1062
   Dórea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3
   Nunes RGD, 2019, PESTIC BIOCHEM PHYS, V157, P161, DOI 10.1016/j.pestbp.2019.03.017
   Sales IMD, 2011, NEUROL SCI, V32, P375, DOI 10.1007/s10072-010-0420-4
   Erk T, 2012, MOL NUTR FOOD RES, V56, P1488, DOI 10.1002/mnfr.201200222
   Eskelinen MH, 2010, J ALZHEIMERS DIS, V20, pS167, DOI 10.3233/JAD-2010-1404
   Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920
   Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506
   Evans SM, 1999, W INDIAN MED J, V48, P23
   Faber MS, 2004, CLIN PHARMACOL THER, V76, P178, DOI 10.1016/j.clpt.2004.04.003
   Fahanik-Babaei J, 2019, METAB BRAIN DIS, V34, P191, DOI 10.1007/s11011-018-0338-8
   Farah A., 2015, COFFEE HLTH DIS PREV, P789, DOI DOI 10.1016/B978-0-12-409517-5.00087-5
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farah A, 2018, BURL DODDS AGR SCI, V39, P259, DOI 10.19103/AS.2017.0036.14
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Farrell TL, 2011, DRUG METAB DISPOS, V39, P2338, DOI 10.1124/dmd.111.040147
   Folch J, 2015, LIFE SCI, V140, P19, DOI 10.1016/j.lfs.2015.05.002
   Fondell E, 2015, AMYOTROPH LAT SCL FR, V16, P366, DOI 10.3109/21678421.2015.1020813
   Fontanilla CV, 2011, NEUROSCIENCE, V188, P135, DOI 10.1016/j.neuroscience.2011.04.009
   Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Fu W, 2017, BEHAV BRAIN RES, V328, P81, DOI 10.1016/j.bbr.2017.04.012
   FUHR U, 1995, INT J CLIN PHARM TH, V33, P311
   FUHR U, 1993, BRIT J CLIN PHARMACO, V35, P431, DOI 10.1111/j.1365-2125.1993.tb04162.x
   FUHR U, 1992, ANTIMICROB AGENTS CH, V36, P942, DOI 10.1128/AAC.36.5.942
   Furstenau CR, 2019, TOXICOL IN VITRO, V61, DOI 10.1016/j.tiv.2019.104601
   Gans JMD, 2010, ARTERIOSCL THROM VAS, V30, P1665, DOI 10.1161/ATVBAHA.109.201939
   Gao LJ, 2020, DRUG DES DEV THER, V14, P1705, DOI 10.2147/DDDT.S235969
   Gaur V, 2013, PHARM BIOL, V51, P550, DOI 10.3109/13880209.2012.747547
   GEORGIEV V, 1993, BRAIN RES, V612, P271, DOI 10.1016/0006-8993(93)91672-F
   Gevaerd MS, 2001, BRAIN RES BULL, V55, P101, DOI 10.1016/S0361-9230(01)00501-9
   Giunta S, 2014, INT J BIOCHEM CELL B, V54, P122, DOI 10.1016/j.biocel.2014.07.009
   Gökcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   GRANT DM, 1983, CLIN PHARMACOL THER, V33, P355, DOI 10.1038/clpt.1983.45
   Greenberg JA, 2008, AM J CARDIOL, V102, P1502, DOI 10.1016/j.amjcard.2008.07.046
   Grosso LM, 2008, ANN EPIDEMIOL, V18, P172, DOI 10.1016/j.annepidem.2007.11.005
   Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003
   dos Santos NAG, 2014, NEUROTOXICOLOGY, V45, P131, DOI 10.1016/j.neuro.2014.09.007
   Gul Z, 2016, NEUROCHEM RES, V41, P2075, DOI 10.1007/s11064-016-1919-8
   Guo ZK, 2017, TRANSL NEUROSCI, V8, P176, DOI 10.1515/tnsci-2017-0024
   Ha HR, 1996, EUR J CLIN PHARMACOL, V49, P309, DOI 10.1007/BF00226333
   Habtemariam S, 2017, MINI-REV MED CHEM, V17, P667, DOI 10.2174/1389557516666161130100947
   Han K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158845
   Han ME, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-110
   Hao ML, 2015, EXP THER MED, V9, P1887, DOI 10.3892/etm.2015.2367
   Hao RL, 2020, FOOD CHEM TOXICOL, V144, DOI 10.1016/j.fct.2020.111636
   Hardoff R, 2001, MOVEMENT DISORD, V16, P1041, DOI 10.1002/mds.1203
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Hartley TR, 2004, AM J CARDIOL, V93, P1022, DOI 10.1016/j.amjcard.2003.12.057
   Hayes MT, 2019, AM J MED, V132, P802, DOI 10.1016/j.amjmed.2019.03.001
   Heitman E, 2017, NUTR NEUROSCI, V20, P32, DOI 10.1179/1476830514Y.0000000146
   Henshall DC, 2007, BIOCHEM SOC T, V35, P421, DOI 10.1042/BST0350421
   Hermansen Kjeld, 2012, Ugeskr Laeger, V174, P2293
   Hermawati E, 2020, EUR J NEUROSCI, V51, P651, DOI 10.1111/ejn.14556
   Hernán MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   Hervé D, 2005, J NEUROL NEUROSUR PS, V76, P200, DOI 10.1136/jnnp.2004.041012
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Homan DJ, 2006, NUTR REV, V64, P43, DOI 10.1301/nr.2006.jan.43-46
   Hornykiewicz O, 1987, Adv Neurol, V45, P19
   Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002
   Hu G, 2007, MOVEMENT DISORD, V22, P2242, DOI 10.1002/mds.21706
   Huang YJ, 2013, NEUROSCI LETT, V535, P146, DOI 10.1016/j.neulet.2012.12.051
   Hwang JY, 2013, NEUROPSYCHOPHARMACOL, V38, P167, DOI 10.1038/npp.2012.134
   Hwang SA, 2018, KOREAN J PHYSIOL PHA, V22, P101, DOI 10.4196/kjpp.2018.22.1.101
   Hwang YP, 2008, FEBS LETT, V582, P2655, DOI 10.1016/j.febslet.2008.06.045
   Ikeda K, 2002, J NEUROCHEM, V80, P262, DOI 10.1046/j.0022-3042.2001.00694.x
   Im SE, 2010, J MED FOOD, V13, P779, DOI 10.1089/jmf.2009.1204
   Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37
   International Coffee Organization, 2020, COFF TRAD STAT TABL
   Ishida K, 2020, NEUROSCI RES, V154, P35, DOI 10.1016/j.neures.2019.05.001
   Izuta H, 2008, J AGR FOOD CHEM, V56, P8944, DOI 10.1021/jf8014206
   JACKSON GD, 1990, NEUROLOGY, V40, P1869, DOI 10.1212/WNL.40.12.1869
   Jayaraj RL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1516-2
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   Jensen MB, 2005, ARCH NEUROL-CHICAGO, V62, P537, DOI 10.1001/archneur.62.4.537
   Jeong CH, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-25
   Jimenez-Del-Rio M, 2010, NEUROCHEM RES, V35, P227, DOI 10.1007/s11064-009-0046-1
   Jodynis-Liebert J, 2004, J CLIN PHARMACOL, V44, P338, DOI 10.1177/0091270004263468
   Joghataie MT, 2004, PARKINSONISM RELAT D, V10, P465, DOI 10.1016/j.parkreldis.2004.06.004
   Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283
   Kachroo A, 2010, EXP NEUROL, V223, P657, DOI 10.1016/j.expneurol.2010.02.007
   Kalia LV, 2016, NAT REV NEUROL, V12, P65, DOI 10.1038/nrneurol.2015.249
   Kalonia H, 2009, NEUROSCI BULL, V25, P343, DOI 10.1007/s12264-009-0513-3
   Kato M, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8608497
   Kawachi I, 1996, ARCH INTERN MED, V156, P521, DOI 10.1001/archinte.156.5.521
   Khalili M, 2018, INT IMMUNOPHARMACOL, V61, P355, DOI 10.1016/j.intimp.2018.06.019
   Khan KA, 2013, J PHARM PHARMACOL, V65, P1745, DOI 10.1111/jphp.12126
   Khan M, 2007, J NEUROCHEM, V102, P365, DOI 10.1111/j.1471-4159.2007.04526.x
   Kilicdag H, 2014, J MATERN-FETAL NEO M, V27, P1470, DOI 10.3109/14767058.2013.878694
   Kim B, 2012, KOREAN J FAM MED, V33, P356, DOI 10.4082/kjfm.2012.33.6.356
   Kim IH, 2013, PLANTA MED, V79, P313, DOI 10.1055/s-0032-1328211
   Kim J, 2012, NEUROCHEM INT, V60, P466, DOI 10.1016/j.neuint.2012.02.004
   Kim SR, 2000, PHYTOCHEMISTRY, V54, P503, DOI 10.1016/S0031-9422(00)00110-2
   Kim YS, 2015, NEUROEPIDEMIOLOGY, V44, P51, DOI 10.1159/000371710
   Klucken J, 2003, NEUROCHEM RES, V28, P1683, DOI 10.1023/A:1026061021946
   Kolahdouzan M, 2017, CNS NEUROSCI THER, V23, P272, DOI 10.1111/cns.12684
   Kolb H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061842
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Koo KA, 2006, LIFE SCI, V79, P709, DOI 10.1016/j.lfs.2006.02.019
   Kovacs GG, 2019, J CLIN PATHOL, V72, P725, DOI 10.1136/jclinpath-2019-205952
   Kumar G, 2019, N-S ARCH PHARMACOL, V392, P1293, DOI 10.1007/s00210-019-01670-x
   Kumar M, 2017, PHARMACOGN MAG, V13, pS10, DOI 10.4103/0973-1296.203974
   Kumral E, 2002, EUR J NEUROL, V9, P615, DOI 10.1046/j.1468-1331.2002.00452.x
   Kurauchi Y, 2012, BRIT J PHARMACOL, V166, P1151, DOI 10.1111/j.1476-5381.2012.01833.x
   Kwon SH, 2014, J ETHNOPHARMACOL, V152, P173, DOI 10.1016/j.jep.2013.12.048
   Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001
   Lampe JW, 2000, CARCINOGENESIS, V21, P1157, DOI 10.1093/carcin/21.6.1157
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Lang R, 2010, ANAL CHEM, V82, P1486, DOI 10.1021/ac902616k
   Larsson SC, 2008, STROKE, V39, P1681, DOI 10.1161/STROKEAHA.107.504183
   Larsson SC, 2014, STROKE, V45, P309, DOI 10.1161/STROKEAHA.113.003131
   Larsson SC, 2011, AM J EPIDEMIOL, V174, P993, DOI 10.1093/aje/kwr226
   Lashley T, 2015, NEUROPATH APPL NEURO, V41, P858, DOI 10.1111/nan.12250
   Laurent C, 2014, NEUROBIOL AGING, V35, P2079, DOI 10.1016/j.neurobiolaging.2014.03.027
   Lee DR, 2014, BONE, V63, P20, DOI 10.1016/j.bone.2014.02.007
   Lee HF, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102301
   Lee JK, 2015, EUR J ENDOCRINOL, V172, P595, DOI 10.1530/EJE-14-0805
   Lee KJ, 2007, TOXICOL LETT, V173, P80, DOI 10.1016/j.toxlet.2007.06.008
   Lee K, 2012, EUR J PHARMACOL, V689, P89, DOI 10.1016/j.ejphar.2012.05.028
   Lee M, 2016, NEUROBIOL AGING, V46, P113, DOI 10.1016/j.neurobiolaging.2016.06.015
   Lee TK, 2020, MOLECULES, V25, DOI 10.3390/molecules25163578
   Leite MR, 2011, EXP GERONTOL, V46, P309, DOI 10.1016/j.exger.2010.11.034
   Levine DA, 2015, JAMA-J AM MED ASSOC, V314, P41, DOI 10.1001/jama.2015.6968
   Levy M, 1984, ANN REV CHRONOPHARMA, V1, P97
   Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469
   Li C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-49
   Li YJ, 2008, ENVIRON TOXICOL PHAR, V26, P13, DOI 10.1016/j.etap.2007.12.008
   Li ZY, 2008, NEUROSCI LETT, V445, P1, DOI 10.1016/j.neulet.2008.08.053
   Liang GJ, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0064-x
   Lin CM, 2020, J FOOD DRUG ANAL, V28, P147, DOI 10.1016/j.jfda.2019.10.004
   Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074
   LIPPA CF, 1992, NEUROBIOL AGING, V13, P405, DOI 10.1016/0197-4580(92)90115-E
   Liu DQ, 2020, DRUG DES DEV THER, V14, P51, DOI 10.2147/DDDT.S228751
   Liu G, 2017, AM FAM PHYSICIAN, V96, P87
   Liu QF, 2018, BIOL PHARM BULL, V41, P470, DOI 10.1248/bpb.b17-00750
   Liu R, 2012, AM J EPIDEMIOL, V175, P1200, DOI 10.1093/aje/kwr451
   Lopez-Garcia E, 2009, CIRCULATION, V119, P1116, DOI 10.1161/CIRCULATIONAHA.108.826164
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Lugo-Huitrón R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/104024
   Machado JA, 2014, BEHAV BRAIN RES, V264, P116, DOI 10.1016/j.bbr.2014.01.051
   Maia L, 2002, EUR J NEUROL, V9, P377, DOI 10.1046/j.1468-1331.2002.00421.x
   Makowska J, 2014, J CHROMATOGR B, V968, P101, DOI 10.1016/j.jchromb.2013.12.001
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mancini RS, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00735
   Martin-Schild S, 2009, J STROKE CEREBROVASC, V18, P86, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.015
   Masuda M, 2009, FEBS LETT, V583, P787, DOI 10.1016/j.febslet.2009.01.037
   Matsui Y, 2007, J CHROMATOGR B, V858, P96, DOI 10.1016/j.jchromb.2007.08.013
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   McGeer PL, 2008, EXP NEUROL, V212, P235, DOI 10.1016/j.expneurol.2008.04.008
   Miao MS, 2017, SAUDI PHARM J, V25, P556, DOI 10.1016/j.jsps.2017.04.023
   Midttun O, 2018, AM J CLIN NUTR, V107, P941, DOI 10.1093/ajcn/nqy059
   Mikami Y, 2015, LIFE SCI, V139, P69, DOI 10.1016/j.lfs.2015.08.005
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Mira A, 2015, MOLECULES, V20, P4813, DOI 10.3390/molecules20034813
   Mirzaie M, 2016, NEUROPHYSIOLOGY+, V48, P176, DOI 10.1007/s11062-016-9586-6
   Mitkari B, 2015, J CEREBR BLOOD F MET, V35, P363, DOI 10.1038/jcbfm.2014.235
   Miyazaki I, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030221
   Mohamadi Neda, 2018, Journal of Dietary Supplements, V15, P207, DOI 10.1080/19390211.2017.1329244
   MOLINENGO L, 1994, LIFE SCI, V54, P1247, DOI 10.1016/0024-3205(94)00851-5
   Espíndola KMM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00541
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Morelli Micaela, 2009, Handb Exp Pharmacol, P589, DOI 10.1007/978-3-540-89615-9_18
   Morroni F, 2018, AGING DIS, V9, P605, DOI 10.14336/AD.2017.0903
   Mostofsky E, 2010, NEUROLOGY, V75, P1583, DOI 10.1212/WNL.0b013e3181fb443d
   Mukamal KJ, 2009, AM HEART J, V157, P495, DOI 10.1016/j.ahj.2008.11.009
   Mullin S, 2015, NEUROL CLIN, V33, P1, DOI 10.1016/j.ncl.2014.09.010
   Nabavi SF, 2017, CURR NEUROPHARMACOL, V15, P471, DOI 10.2174/1570159X14666160325120625
   NAGEL RA, 1990, J HEPATOL, V10, P149, DOI 10.1016/0168-8278(90)90044-R
   Nakajima Y, 2007, LIFE SCI, V80, P370, DOI 10.1016/j.lfs.2006.09.017
   Nakane M, 2002, NEURORADIOLOGY, V44, P915, DOI 10.1007/s00234-002-0846-3
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Nazir N, 2020, BMC COMPLEMENT MED, V20, DOI 10.1186/s12906-020-02942-3
   NEWTON R, 1981, EUR J CLIN PHARMACOL, V21, P45, DOI 10.1007/BF00609587
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   Noelker C, 2005, NEUROSCI LETT, V383, P39, DOI 10.1016/j.neulet.2005.04.023
   Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442
   Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687
   Nunes FM, 2010, PHYTOCHEM REV, V9, P171, DOI 10.1007/s11101-009-9151-7
   Oboh G, 2013, NEUROCHEM RES, V38, P413, DOI 10.1007/s11064-012-0935-6
   Ochiai R, 2019, J ALZHEIMERS DIS, V72, P1209, DOI 10.3233/JAD-190757
   Oleaga C, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/390385
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Omar SH, 2018, FITOTERAPIA, V128, P118, DOI 10.1016/j.fitote.2018.05.011
   Omar SH, 2017, MOLECULES, V22, DOI 10.3390/molecules22111858
   Ong LK, 2017, J CEREBR BLOOD F MET, V37, P1338, DOI 10.1177/0271678X16654920
   Palacios N, 2012, MOVEMENT DISORD, V27, P1276, DOI 10.1002/mds.25076
   Palaz MN, 2020, WORLD NEUROSURG, V138, pE736, DOI 10.1016/j.wneu.2020.03.058
   Park GJH, 2003, HEPATOLOGY, V38, P1227, DOI 10.1053/jhep.2003.50475
   Park JH, 2015, J MOV DISORD, V8, P109, DOI 10.14802/jmd.15018
   Patil Harshal, 2011, Mo Med, V108, P431
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Pavlica S, 2005, FREE RADICAL RES, V39, P1377, DOI 10.1080/09670260500197660
   Peltola J, 2000, EPILEPSY RES, V41, P205, DOI 10.1016/S0920-1211(00)00140-6
   Pereira P, 2006, BASIC CLIN PHARMACOL, V99, P374, DOI 10.1111/j.1742-7843.2006.pto_533.x
   Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006
   Pierri M, 2005, NEUROPHARMACOLOGY, V48, P517, DOI 10.1016/j.neuropharm.2004.11.009
   Fernandes FDP, 2014, BEHAV PHARMACOL, V25, P637, DOI 10.1097/FBP.0000000000000076
   Piriyawat P, 2003, STROKE, V34, P1242, DOI 10.1161/01.STR.0000067706.23777.04
   Poewe W, 2008, EUR J NEUROL, V15, P14, DOI 10.1111/j.1468-1331.2008.02056.x
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Popoli P, 1995, EUR J PHARMACOL, V287, P215, DOI 10.1016/0014-2999(95)00679-6
   Postuma RB, 2017, NEUROLOGY, V89, P310, DOI 10.1212/WNL.0000000000004163
   Postuma RB, 2012, NEUROLOGY, V79, P651, DOI 10.1212/WNL.0b013e318263570d
   Potter M, 2018, INT J DEV NEUROSCI, V70, P46, DOI 10.1016/j.ijdevneu.2018.02.001
   Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158
   Prasanthi JRP, 2010, FREE RADICAL BIO MED, V49, P1212, DOI 10.1016/j.freeradbiomed.2010.07.007
   Pravalika K, 2019, LIFE SCI, V216, P49, DOI 10.1016/j.lfs.2018.11.014
   Prediger RDS, 2010, J ALZHEIMERS DIS, V20, pS205, DOI 10.3233/JAD-2010-091459
   PRINEAS RJ, 1980, J CHRON DIS, V33, P67, DOI 10.1016/0021-9681(80)90029-6
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Qiu ZG, 2020, CHEM-BIOL INTERACT, V317, DOI 10.1016/j.cbi.2020.108946
   Rasmussen BB, 2002, PHARMACOGENETICS, V12, P473, DOI 10.1097/00008571-200208000-00008
   Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012
   Rebai O, 2018, NEUROTOX RES, V34, P559, DOI 10.1007/s12640-018-9911-5
   Rebai O, 2017, NEUROCHEM RES, V42, P3559, DOI 10.1007/s11064-017-2403-9
   Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022
   Reich SG, 2019, MED CLIN N AM, V103, P337, DOI 10.1016/j.mcna.2018.10.014
   Ren YQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174238
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Ritchie K, 2007, NEUROLOGY, V69, P536, DOI 10.1212/01.wnl.0000266670.35219.0c
   Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674
   RUDOLPHI KA, 1989, NEUROSCI LETT, V103, P275, DOI 10.1016/0304-3940(89)90112-2
   Sääksjärvi K, 2008, EUR J CLIN NUTR, V62, P908, DOI 10.1038/sj.ejcn.1602788
   Sachse KT, 2008, J CEREBR BLOOD F MET, V28, P395, DOI 10.1038/sj.jcbfm.9600539
   Saitou K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101337
   Sandercock PAG, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000029.pub3
   Santos C, 2010, J ALZHEIMERS DIS, V20, pS187, DOI 10.3233/JAD-2010-091387
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sarajärvi T, 2012, J CELL MOL MED, V16, P2754, DOI 10.1111/j.1582-4934.2012.01599.x
   Sasaki S, 2017, PEDIATR RES, V82, P19, DOI 10.1038/pr.2017.70
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5
   Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732
   SCOTT NR, 1984, ANN CLIN BIOCHEM, V21, P120, DOI 10.1177/000456328402100208
   Semerl JS, 2004, CROAT MED J, V45, P775
   Senard JM, 1997, J NEUROL NEUROSUR PS, V63, P584, DOI 10.1136/jnnp.63.5.584
   Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189
   Shan SH, 2019, MED SCI MONITOR, V25, P453, DOI 10.12659/MSM.911166
   Shen WJ, 2012, BRAIN RES BULL, V88, P487, DOI 10.1016/j.brainresbull.2012.04.010
   Siesjo BK, 1996, ACT NEUR S, V66, P8
   Silletta MG, 2007, CIRCULATION, V116, P2944, DOI 10.1161/CIRCULATIONAHA.107.712976
   Silva T, 2014, EXPERT OPIN THER PAT, V24, P1257, DOI 10.1517/13543776.2014.959492
   Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006
   Singh SS, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6571484
   Singh S, 2009, BRAIN RES, V1283, P115, DOI 10.1016/j.brainres.2009.06.002
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   SMITS P, 1985, AM J CARDIOL, V56, P958, DOI 10.1016/0002-9149(85)90412-6
   Song Y, 2006, BRAIN RES, V1085, P57, DOI 10.1016/j.brainres.2006.02.042
   Song Y, 2018, BRAIN RES, V1690, P96, DOI 10.1016/j.brainres.2018.03.006
   Sonké B, 2006, BOT J LINN SOC, V151, P425, DOI 10.1111/j.1095-8339.2006.00508.x
   Sonsalla PK, 2012, EXP NEUROL, V234, P482, DOI 10.1016/j.expneurol.2012.01.022
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Strong R, 2000, NEUROPHARMACOLOGY, V39, P515, DOI 10.1016/S0028-3908(99)00156-2
   Sul D, 2009, LIFE SCI, V84, P257, DOI 10.1016/j.lfs.2008.12.001
   SUTHERLAND GR, 1991, NEUROSCIENCE, V42, P171, DOI 10.1016/0306-4522(91)90157-J
   Szwajgier D, 2015, ANN AGR ENV MED, V22, P690, DOI 10.5604/12321966.1185777
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tan EK, 2007, PHARMACOGENET GENOM, V17, P1001, DOI 10.1097/FPC.0b013e3282f09265
   TANGLIU DD, 1983, J PHARMACOL EXP THER, V224, P180
   Taram F, 2016, BRAIN RES, V1648, P69, DOI 10.1016/j.brainres.2016.07.028
   Tavani A, 2001, EUR J EPIDEMIOL, V17, P1131, DOI 10.1023/A:1021276932160
   Teipel SJ, 2005, BRAIN, V128, P2626, DOI 10.1093/brain/awh589
   Teraoka M, 2012, J CLIN BIOCHEM NUTR, V51, P122, DOI 10.3164/jcbn.D-11-00030
   TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209
   Thom M, 2014, NEUROPATH APPL NEURO, V40, P520, DOI 10.1111/nan.12150
   Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384
   TOMBAUGH GC, 1993, J NEUROCHEM, V61, P793, DOI 10.1111/j.1471-4159.1993.tb03589.x
   TRANG JM, 1985, BIOPHARM DRUG DISPOS, V6, P51, DOI 10.1002/bdd.2510060107
   Trevitt J, 2009, PHARMACOL BIOCHEM BE, V94, P24, DOI 10.1016/j.pbb.2009.07.001
   Trinh K, 2010, J NEUROSCI, V30, P5525, DOI 10.1523/JNEUROSCI.4777-09.2010
   Tsai SJ, 2011, EUR J PHARMACOL, V670, P441, DOI 10.1016/j.ejphar.2011.09.171
   Tsai SK, 2006, LIFE SCI, V78, P2758, DOI 10.1016/j.lfs.2005.10.017
   Tu QY, 2008, NEURAL REGEN RES, V3, P1218
   Turan D, 2020, EUR J PHARMACOL, V883, DOI 10.1016/j.ejphar.2020.173342
   Uchiyama T, 2011, J NEUROL NEUROSUR PS, V82, P1382, DOI 10.1136/jnnp.2011.241075
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   van Gelder BM, 2007, EUR J CLIN NUTR, V61, P226, DOI 10.1038/sj.ejcn.1602495
   van Troostwijk LJAED, 2003, EUR J PHARM SCI, V20, P451, DOI 10.1016/j.ejps.2003.09.010
   van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318
   Vardi N, 2012, J CHEM NEUROANAT, V43, P43, DOI 10.1016/j.jchemneu.2011.09.003
   Aguiar LMV, 2006, PHARMACOL BIOCHEM BE, V84, P415, DOI 10.1016/j.pbb.2006.05.027
   Vauzour D, 2010, ARCH BIOCHEM BIOPHYS, V501, P106, DOI 10.1016/j.abb.2010.03.016
   VISTISEN K, 1991, ADV EXP MED BIOL, V283, P407
   Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033
   Wang XM, 2017, FOOD FUNCT, V8, P2924, DOI [10.1039/c7fo00659d, 10.1039/C7FO00659D]
   Wang YL, 2016, INT J MOL MED, V38, P869, DOI 10.3892/ijmm.2016.2683
   Wardlaw JM, 2005, J NEUROL NEUROSUR PS, V76, P617, DOI 10.1136/jnnp.2004.039982
   Washio T, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13288
   Wasim S, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9578
   Wei ML, 2016, NEUROSCI LETT, V617, P143, DOI 10.1016/j.neulet.2016.02.019
   Wei X, 2008, NEUROSCIENCE, V155, P1098, DOI 10.1016/j.neuroscience.2008.06.056
   White H, 2005, CIRCULATION, V111, P1327, DOI 10.1161/01.CIR.0000157736.19739.D0
   Wong CC, 2010, J NUTR BIOCHEM, V21, P1060, DOI 10.1016/j.jnutbio.2009.09.001
   Wostyn Peter, 2011, Int J Alzheimers Dis, V2011, P617420, DOI 10.4061/2011/617420
   Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026
   Xu K, 2005, PHARMACOL THERAPEUT, V105, P267, DOI 10.1016/j.pharmthera.2004.10.007
   Xu K, 2006, J NEUROSCI, V26, P535, DOI 10.1523/JNEUROSCI.3008-05.2006
   Xu K, 2010, NEUROSCIENCE, V167, P475, DOI 10.1016/j.neuroscience.2010.02.020
   Yang JQ, 2008, CNS NEUROSCI THER, V14, P10, DOI 10.1111/j.1527-3458.2007.00031.x
   Yao J, 2019, BIOFACTORS, V45, P616, DOI 10.1002/biof.1507
   Yiannopoulou KG, 2013, THER ADV NEUROL DISO, V6, P19, DOI 10.1177/1756285612461679
   Yu LQ, 2008, ANN NEUROL, V63, P338, DOI 10.1002/ana.21313
   Yuyama S, 1996, ADV EXP MED BIOL, V398, P599
   YUYAMA S, 1991, ADV EXP MED BIOL, V294, P475
   Zhang J, 2012, STROKE, V43, P1700, DOI 10.1161/STROKEAHA.111.632448
   Zhang J, 2012, J NEUROCHEM, V120, P564, DOI 10.1111/j.1471-4159.2011.07496.x
   Zhang L, 2007, LIFE SCI, V80, P530, DOI 10.1016/j.lfs.2006.09.039
   Zhang W, 2009, DIABETES CARE, V32, P1043, DOI 10.2337/dc08-2251
   Zhang Y, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104538
   Zhang YS, 2011, J CEREBR BLOOD F MET, V31, P572, DOI 10.1038/jcbfm.2010.127
   Zhao XR, 2010, STROKE, V41, P363, DOI 10.1161/STROKEAHA.109.562900
   Zhao ZH, 2010, PHYTOCHEM REV, V9, P133, DOI 10.1007/s11101-009-9145-5
   Zhou Y, 2006, ACTA PHARMACOL SIN, V27, P1103, DOI 10.1111/j.1745-7254.2006.00406.x
NR 412
TC 133
Z9 136
U1 5
U2 135
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2021
VL 22
IS 1
AR 107
DI 10.3390/ijms22010107
PG 64
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA PQ0FW
UT WOS:000606228100001
PM 33374338
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Bhandarkar, NS
   Brown, L
   Panchal, SK
AF Bhandarkar, Nikhil S.
   Brown, Lindsay
   Panchal, Sunil K.
TI Chlorogenic acid attenuates high-carbohydrate, high-fat diet-induced
   cardiovascular, liver, and metabolic changes in rats
SO NUTRITION RESEARCH
LA English
DT Article
DE Chlorogenic acid; Obesity; Metabolic syndrome; Cardiovascular disease;
   Coffee; High-carbohydrate, high-fat diet; Gut microbiota
ID INSULIN-RESISTANCE; COFFEE; OBESITY; SUPPLEMENTATION; ACCUMULATION;
   POLYPHENOLS; EXPRESSION; MICROBIOTA; CAFFEINE; PPAR
AB Chlorogenic acid as a constituent of coffee is consumed regularly in the human diet. Chlorogenic acid intake has been associated with decreased risk of cardiovascular disease and type 2 diabetes. We hypothesized that chlorogenic acid would improve cardiovascular, liver, and metabolic responses in a rat model of metabolic syndrome induced by a high-carbohydrate, high-fat diet. Male Wistar rats (8-9 weeks old, 335 +/- 2 g, n = 48) were divided into 4 groups and fed with corn starch diet (16 weeks); corn starch diet with chlorogenic acid in food for the last 8 weeks; high-carbohydrate, high-fat diet (16 weeks); or high-carbohydrate, high-fat diet with chlorogenic acid (similar to 100 mg/kg/d) in food for the last 8 weeks. In high-carbohydrate, high-fat diet-fed rats, chlorogenic acid reduced energy intake and food efficiency to reduce visceral fat, especially retroperitoneal fat, and abdominal circumference; reversed the elevated systolic blood pressure; and attenuated left ventricular diastolic stiffness with reduced collagen deposition and infiltration of inflammatory cells in the left ventricle. Chlorogenic acid decreased inflammation and fat deposition in the liver along with reduced plasma liver enzyme activities of obese rats but did not change the plasma lipid profile. Chlorogenic acid increased diversity of gut microbiota, which may improve overall metabolism in the body. Thus, chronic dietary chlorogenic acid attenuated diet-induced inflammation as well as cardiovascular, liver, and metabolic changes, suggesting that chlorogenic acid has potential for further clinical evaluation. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Bhandarkar, Nikhil S.; Brown, Lindsay; Panchal, Sunil K.] Univ Southern Queensland, Funct Foods Res Grp, Toowoomba, Qld 4350, Australia.
   [Brown, Lindsay] Univ Southern Queensland, Sch Hlth & Wellbeing, Fac Hlth Engn & Sci, Toowoomba, Qld 4350, Australia.
   [Bhandarkar, Nikhil S.] Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel.
C3 University of Southern Queensland; University of Southern Queensland;
   Ben-Gurion University of the Negev
RP Panchal, SK (corresponding author), Univ Southern Queensland, Funct Foods Res Grp, Toowoomba, Qld 4350, Australia.
EM Sunil.Panchal@usq.edu.au
RI ; Bhandarkar, Nikhil/AAV-4263-2020
OI Panchal, Sunil K/0000-0001-5464-3376; Bhandarkar,
   Nikhil/0000-0001-8790-8940
FU University of Southern Queensland Research and Innovation Division
FX We thank Brian Bynon for his assistance with plasma analyses. This work
   was supported by funding received from the University of Southern
   Queensland Research and Innovation Division. The authors declare no
   conflicts of interest.
CR Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/c7fo00388a, 10.1039/C7FO00388A]
   Del Rio D, 2010, NUTRIENTS, V2, P820, DOI 10.3390/nu2080820
   Farah A., 2015, COFFEE HLTH DIS PREV, P789, DOI DOI 10.1016/B978-0-12-409517-5.00087-5
   Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979
   Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Jeyakumar SM, 2006, OBESITY, V14, P52, DOI 10.1038/oby.2006.7
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Loader TB, 2017, NUTR REV, V75, P114, DOI 10.1093/nutrit/nuw057
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Ludwig IA, 2013, BIOFACTORS, V39, P623, DOI 10.1002/biof.1124
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI [10.1039/C4FO00290C, 10.1039/c4fo00290c]
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Narita Y, 2013, J AGR FOOD CHEM, V61, P966, DOI 10.1021/jf304105w
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]
   Park I, 2017, BRIT J NUTR, V117, P979, DOI 10.1017/S0007114517000587
   Parkar SG, 2013, ANAEROBE, V23, P12, DOI 10.1016/j.anaerobe.2013.07.009
   Peng BJ, 2015, BIOMED ENVIRON SCI, V28, P894, DOI 10.3967/bes2015.123
   Poudyal H, 2012, J NUTR BIOCHEM, V23, P153, DOI 10.1016/j.jnutbio.2010.11.011
   Rainone V, 2016, INT J OBESITY, V40, P1026, DOI 10.1038/ijo.2016.26
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Sanal MG, 2015, WORLD J GASTROENTERO, V21, P3223, DOI 10.3748/wjg.v21.i11.3223
   Sanmiguel C, 2015, CURR OBES REP, V4, P250, DOI 10.1007/s13679-015-0152-0
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Steinberg GR, 2007, MINI-REV MED CHEM, V7, P519
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tomas-Barberan F, 2014, MOL NUTR FOOD RES, V58, P1122, DOI 10.1002/mnfr.201300441
   Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007
   Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wanyonyi S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111261
   Wu LF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15904
   Wu Y, 2018, INT J FOOD SCI NUTR, V69, P566, DOI 10.1080/09637486.2017.1394449
   Zhang Z, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070677
NR 47
TC 118
Z9 127
U1 8
U2 60
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
J9 NUTR RES
JI Nutr. Res.
PD FEB
PY 2019
VL 62
BP 78
EP 88
DI 10.1016/j.nutres.2018.11.002
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HO3UQ
UT WOS:000460848800008
PM 30803509
DA 2025-04-28
ER

PT J
AU Gavrieli, A
   Fragopoulou, E
   Mantzoros, CS
   Yannakoulia, M
AF Gavrieli, Anna
   Fragopoulou, Elizabeth
   Mantzoros, Christos S.
   Yannakoulia, Mary
TI Gender and body mass index modify the effect of increasing amounts of
   caffeinated coffee on postprandial glucose and insulin concentrations; a
   randomized, controlled, clinical trial
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
DE Caffeine; Obesity; Women
ID TYPE-2 DIABETES-MELLITUS; HORMONE-BINDING GLOBULIN; DECAFFEINATED
   COFFEE; PROSPECTIVE COHORT; CHLOROGENIC ACID; MENSTRUAL-CYCLE; TOLERANCE
   TEST; BLOOD-GLUCOSE; DOUBLE-BLIND; CONSUMPTION
AB Objective. To examine the effects of different coffee amounts on blood glucose and insulin concentrations of healthy volunteers, and to assess potential effect modification by sex and body mass index category.
   Materials/Methods. Thirty-three volunteers [16 female/17 male, 16 normal-weight and 17 overweight/obese, 27.3 +/- 7.2 (19-44) y] took part in this randomized, crossover study. In the morning of each experimental day volunteers received a standardized meal along with 200 mL of water or instant coffee containing either 3 or 6 mg of caffeine/kg body weight. Blood samples were obtained and analyzed for glucose and insulin concentrations in the fasting state, immediately after meal/drink consumption and at standard time points for the next 3 h thereafter.
   Results. Coffee delayed the rise of insulin in response to the standardized meal and the fall of glucose concentrations from its maximum levels in the entire study sample. Glucose incremental area under the curve (IAUC) was significantly different between interventions (P = .009) with both coffee amounts inducing a greater area compared to water. Secondary, subgroup analysis at the nominal level showed that this might be more evident among females (P-IAUC = .05) and overweight/obese participants (P-IAUC = .03). Furthermore, coffee, mainly the 6 mg dose, could be lowering insulin concentrations the first 30 min after its consumption compared to water in men and overweight/obese participants.
   Conclusions. Coffee exerts an acute effect on postprandial glucose and insulin concentrations. This effect may be modified by sex and overweight/obese status. Future research is necessary to elucidate underlying mechanisms. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Gavrieli, Anna; Fragopoulou, Elizabeth; Yannakoulia, Mary] Harokopio Univ, Dept Nutr & Dietet, Athens 17671, Greece.
   [Mantzoros, Christos S.] VA Boston Healthcare Syst, Endocrinol Sect, Boston, MA USA.
   [Mantzoros, Christos S.] Beth Israel Deaconess Med Ctr Boston, Div Endocrinol Diabet & Metab, Boston, MA USA.
C3 Harokopio University Athens; Harvard University; Harvard University
   Medical Affiliates; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Boston Healthcare System; Harvard University;
   Harvard University Medical Affiliates; Beth Israel Deaconess Medical
   Center
RP Yannakoulia, M (corresponding author), Harokopio Univ, Dept Nutr & Dietet, Athens 17671, Greece.
EM myiannak@hua.gr
RI Mantzoros, Christos/Y-2902-2019; Fragopoulou, Elizabeth/AAN-2050-2021
OI Yannakoulia, Mary/0000-0003-2171-7337
FU Department of Nutrition and Dietetics, Harokopio University.
FX The study was supported through a research funding from the Graduate
   Program of the Department of Nutrition and Dietetics, Harokopio
   University.
CR [Anonymous], 2012, USDA NAT NUTR DAT ST
   [Anonymous], 2012, Global database on body mass index
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Brennan IM, 2009, AM J PHYSIOL-GASTR L, V297, pG602, DOI 10.1152/ajpgi.00051.2009
   Chao CY, 2011, METABOLISM, V60, P799, DOI 10.1016/j.metabol.2010.07.031
   Friberg E, 2009, INT J CANCER, V125, P2413, DOI 10.1002/ijc.24543
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Goralczyk T, 2012, METABOLISM, V61, P1171, DOI 10.1016/j.metabol.2011.12.013
   Goto A, 2011, DIABETES, V60, P269, DOI 10.2337/db10-1193
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Krebs JD, 2012, METABOLISM
   Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014
   Lane JD, 2004, DIABETES CARE, V27, P2047, DOI 10.2337/diacare.27.8.2047
   LEFLOCH JP, 1990, DIABETES CARE, V13, P172, DOI 10.2337/diacare.13.2.172
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Lovallo WR, 1996, PHARMACOL BIOCHEM BE, V55, P365, DOI 10.1016/S0091-3057(96)00105-0
   MacKenzie T, 2007, METABOLISM, V56, P1694, DOI 10.1016/j.metabol.2007.07.013
   MISHKINSKY J, 1967, LANCET, V2, P1311
   Moisey LL, 2010, BRIT J NUTR, V103, P833, DOI 10.1017/S0007114509992406
   Mooren FC, 2011, DIABETES OBES METAB, V13, P281, DOI 10.1111/j.1463-1326.2010.01332.x
   Natella F, 2007, AM J CLIN NUTR, V86, P604, DOI 10.1093/ajcn/86.3.604
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Pulido JME, 1999, ARCH MED RES, V30, P19, DOI 10.1016/S0188-0128(98)00008-6
   Rasmussen BB, 2002, PHARMACOGENETICS, V12, P473, DOI 10.1097/00008571-200208000-00008
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI [10.1139/H11-072, 10.1139/h11-072]
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   VERGAUWEN L, 1994, J CLIN INVEST, V93, P974, DOI 10.1172/JCI117104
   WACHMAN A, 1970, METABOLIS, V19, P539, DOI 10.1016/0026-0495(70)90009-0
   Wedick NM, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-86
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Wu JN, 2009, INT J CARDIOL, V137, P216, DOI 10.1016/j.ijcard.2008.06.051
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
NR 40
TC 26
Z9 30
U1 0
U2 31
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
J9 METABOLISM
JI Metab.-Clin. Exp.
PD AUG
PY 2013
VL 62
IS 8
BP 1099
EP 1106
DI 10.1016/j.metabol.2013.02.003
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 195ED
UT WOS:000322684200011
PM 23498899
DA 2025-04-28
ER

PT J
AU Larsen, SC
   Mikkelsen, MLK
   Frederiksen, P
   Heitmann, BL
AF Larsen, S. C.
   Mikkelsen, M-L K.
   Frederiksen, P.
   Heitmann, B. L.
TI Habitual coffee consumption and changes in measures of adiposity: a
   comprehensive study of longitudinal associations
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
ID CHLOROGENIC ACID; METABOLIC-RATE; OBESE WOMEN; WEIGHT-LOSS; LONG-TERM;
   CAFFEINE; RISK; METAANALYSIS; VOLUNTEERS; MORTALITY
AB BACKGROUND: A relationship between change in coffee consumption and reduced long-term weight gain has been suggested, but current evidence is inconsistent.
   OBJECTIVE: To examine longitudinal associations between coffee consumption and changes in body mass index (BMI), fat mass index (FMI), fat-free mass index (FFMI), body fat percentage (BF %) and waist circumference (WC).
   DESIGN: The study consisted of 2128 participants from the Danish part of the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) cohort with repeated information on coffee consumption, adiposity measures and covariates during an 11 year period. Linear regression analyses were conducted to assess the associations between baseline coffee consumption and subsequent change in adiposity measures. The same analyses were conducted analyzing associations between change in coffee consumption and concurrent as well as subsequent changes in adiposity measures,
   RESULTS: We found no consistent evidence of associations between baseline coffee consumption and subsequent 6-year changes in adiposity measures. A statistically significant association between increased coffee consumption over a 6-year period and decreased concurrent gain in BMI, FMI, BF % and WC (-0.05 kg m(-2) (95% confidence interval (Cl): -0.07, -0.02), -0.04 kg m(-2) (95% CI: -0.06, -0.02), -0.08% (95% CI: -0.13, -0.04) and -0.23 cm (95% CI: -0.34, -0.12), respectively, per 1 cup day 1 increase in coffee consumption) was found. No association was seen between change in coffee consumption and concurrent change in FFMI. Moreover, an initial change in coffee consumption during the first 5-year period was not associated with change in adiposity during the subsequent 6-year period.
   CONCLUSIONS: Increased coffee consumption was associated with a decreased concurrent gain in body weight, fat mass and waist circumference, but the associations were weak. Moreover, a causal relationship could not be established, as we found no evidence of associations between an initial change in coffee consumption and subsequent change in adiposity.
C1 [Larsen, S. C.; Mikkelsen, M-L K.; Frederiksen, P.; Heitmann, B. L.] Bispebjerg & Frederiksberg Hosp, Parker Inst, Res Unit Dietary Studies, Nordre Fasanvej 57,Entrance 5,Ground Floor, DK-2000 Frederiksberg, The Capital Reg, Denmark.
   [Heitmann, B. L.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.
   [Heitmann, B. L.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW, Australia.
   [Heitmann, B. L.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.
C3 University of Copenhagen; Bispebjerg Hospital; University of Southern
   Denmark; University of Sydney; University of Copenhagen
RP Larsen, SC (corresponding author), Bispebjerg & Frederiksberg Hosp, Parker Inst, Res Unit Dietary Studies, Nordre Fasanvej 57,Entrance 5,Ground Floor, DK-2000 Frederiksberg, The Capital Reg, Denmark.
EM sofus.larsen@regionh.dk
RI Heitmann, Berit/JBJ-6043-2023; Larsen, Sofus C./AAO-5894-2020
OI Mikkelsen, Marie-Louise Kirkegaard/0000-0003-4921-6593; Larsen, Sofus
   C./0000-0002-0838-9378; Heitmann, Berit Lilienthal/0000-0002-6809-4504
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Allison DB, 2001, CRIT REV FOOD SCI, V41, P1, DOI 10.1080/20014091091661
   Berkey CS, 2008, J PEDIATR, V153, P635, DOI 10.1016/j.jpeds.2008.04.072
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Carter BE, 2012, APPETITE, V59, P755, DOI 10.1016/j.appet.2012.08.015
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Greenberg JA, 2012, J AM COLL NUTR, V31, P160, DOI 10.1080/07315724.2012.10720023
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Gunter MJ, 2017, ANN INTERN MED, V167, P236, DOI 10.7326/M16-2945
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Jessen A, 2005, DIABETES OBES METAB, V7, P327, DOI 10.1111/j.1463-1326.2004.00389.x
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Larsen SC, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-43
   Larsen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069689
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Nuhu Abdulmumin A, 2014, ISRN Nutr, V2014, P384230, DOI 10.1155/2014/384230
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Shimoda Hiroshi, 2006, BMC Complement Altern Med, V6, P9, DOI 10.1186/1472-6882-6-9
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Wang AQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33711
   Wang TG, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0862-0
   YOSHIDA T, 1994, INT J OBESITY, V18, P345
NR 29
TC 29
Z9 29
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD APR
PY 2018
VL 42
IS 4
BP 880
EP 886
DI 10.1038/ijo.2017.310
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA GG4QL
UT WOS:000432681200037
PM 29381147
DA 2025-04-28
ER

PT J
AU Pimpley, V
   Patil, S
   Srinivasan, K
   Desai, N
   Murthy, PS
AF Pimpley, Vaibhavi
   Patil, Siddhi
   Srinivasan, Kartikeya
   Desai, Nivas
   Murthy, Pushpa S.
TI The chemistry of chlorogenic acid from green coffee and its role in
   attenuation of obesity and diabetes
SO PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY
LA English
DT Review
DE Chlorogenic acid; diabetes; green coffee; obesity; roasting
ID PRESSURIZED LIQUID EXTRACTION; PHENOLIC-COMPOUNDS; ASSISTED EXTRACTION;
   INHIBITORY-ACTIVITY; BEANS; FRACTION; MASS; CAFFEINE; RATS; PPAR
AB An overview of green coffee, the unroasted bean enriched with antioxidants, is presented in the following article. Green coffee beans are known to have a higher content of chlorogenic acid (CGA) with potential health benefits like activity against hypertension, diabetes, obesity, etc. There are three major classes of chlorogenic acids present in green coffee beans, namely: caffeoylquinic acid (CQA), di-caffeoylquinic acid (diCQA) and feruloylquinic acid (FQA). Another pivotal component of the green beans is caffeic acid. A compilation of the different research studies and reviews pertaining to the diverse biomolecules present in the green coffee, their structure and the different sources of CGA is presented. The traditional and modern methods of the extraction of CGA are also studied. Green coffee upon roasting develops its aromatic characteristics but the flavor development comes with a reciprocation of reduced chlorogenic acid content. Thus, the effect of processing is also addressed. There are numerous studies conducted to show the health benefits associated with the consumption of green coffee out of which, anti-diabetic and anti-obesity effects are particularly concentrated in this article.
C1 [Pimpley, Vaibhavi; Patil, Siddhi; Srinivasan, Kartikeya; Desai, Nivas; Murthy, Pushpa S.] CSIR Cent Food Technol Res Inst, Spice & Flavor Sci Dept, Mysuru, Karnataka, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Central Food Technological Research Institute (CFTRI)
RP Murthy, PS (corresponding author), CSIR Cent Food Technol Res Inst, Spice & Flavor Sci Dept, Mysuru, Karnataka, India.
EM pushpa@cftri.res.in
RI DESAI, NIVAS/AEE-8584-2022
OI Desai, Nivas/0000-0003-1288-9807
FU CSIR-CFTRI (Central Food Technological research Institute)
FX This paper was supported by CSIR-CFTRI (Central Food Technological
   research Institute).
CR Almoosawi S, 2010, NUTR BULL, V35, P207, DOI 10.1111/j.1467-3010.2010.01841.x
   Alonso-Salces RM, 2001, J CHROMATOGR A, V933, P37, DOI 10.1016/S0021-9673(01)01212-2
   Arya M, 2007, CRIT REV FOOD SCI, V47, P51, DOI 10.1080/10408390600550315
   Asfaw G., 2020, Journal of Applied Sciences & Environmental Management, V24, P187, DOI 10.4314/jasem.v24i1.27
   Bagdonaite K, 2008, J AGR FOOD CHEM, V56, P6081, DOI 10.1021/jf073051p
   Belay A., 2009, African Journal of Pure and Applied Chemistry, V3, P34, DOI DOI 10.5897/AJPAC
   Belitz H.-D., 2009, Food chemistry, P938, DOI [10.1007/978-3-540-69934-7_22, DOI 10.1007/978-3-540-69934-7_22, 10.1007/978-3-540-69934-76]
   Bravo J, 2013, FOOD RES INT, V50, P610, DOI 10.1016/j.foodres.2011.04.026
   Buffo RA, 2004, FLAVOUR FRAG J, V19, P99, DOI 10.1002/ffj.1325
   Carabias-Martínez R, 2005, J CHROMATOGR A, V1089, P1, DOI 10.1016/j.chroma.2005.06.072
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   CLIFFORD M N, 1985, P305
   Clifford M. N., 1987, 12 INT SCI C COFF SW
   Clifford MN, 2005, J AGR FOOD CHEM, V53, P3821, DOI 10.1021/jf050046h
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1063::AID-JSFA605>3.0.CO;2-Q]
   Daglia M, 2008, J AGR FOOD CHEM, V56, P11653, DOI 10.1021/jf802018c
   Dawidowicz AL, 2017, EUR FOOD RES TECHNOL, V243, P379, DOI 10.1007/s00217-016-2751-8
   de Azevedo ABA, 2008, BRAZ J CHEM ENG, V25, P543, DOI 10.1590/S0104-66322008000300012
   Dent M, 2015, CHEM BIOCHEM ENG Q, V29, P475, DOI 10.15255/CABEQ.2015.2168
   Deshpande S, 2014, J AGR FOOD CHEM, V62, P9160, DOI 10.1021/jf5017384
   Esquivel P, 2012, FOOD RES INT, V46, P488, DOI 10.1016/j.foodres.2011.05.028
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farah Adriana, 2006, Braz. J. Plant Physiol., V18, P23, DOI 10.1590/S1677-04202006000100003
   Ferrari M, 2010, COLLOID SURFACE A, V365, P79, DOI 10.1016/j.colsurfa.2010.02.002
   Franca AS, 2009, DESALINATION, V249, P267, DOI 10.1016/j.desal.2008.11.017
   Gil M., 2017, Ann. Univ. Mariae Curie-Sklodowska, Sect. AA-Chem., V72, DOI [10.17951/aa.2017.72.1.61, DOI 10.17951/AA.2017.72.1.61]
   Ginz M., 2001, INT SCI C COFF IT MA
   Gonzalez-Rios O, 2007, J FOOD COMPOS ANAL, V20, P289, DOI 10.1016/j.jfca.2006.07.009
   Grujic N, 2012, MOLECULES, V17, P2518, DOI 10.3390/molecules17032518
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Ibanez E., 2012, Marine Bioactive Compounds: Sources, Characterization and Applications 2012, DOI [DOI 10.1007/978-1-4614-1247-22, DOI 10.1007/978-1-4614-1247-2_2]
   Jaiswal R, 2012, FOOD FUNCT, V3, P976, DOI 10.1039/c2fo10260a
   Król K, 2020, EUR FOOD RES TECHNOL, V246, P33, DOI 10.1007/s00217-019-03388-9
   KRYGIER K, 1982, J AGR FOOD CHEM, V30, P330, DOI 10.1021/jf00110a028
   Suárez-Quiroz ML, 2014, J FOOD COMPOS ANAL, V33, P55, DOI 10.1016/j.jfca.2013.10.005
   Li H, 2005, ULTRASON SONOCHEM, V12, P295, DOI 10.1016/j.ultsonch.2004.01.033
   Lou XW, 1997, ANAL CHEM, V69, P1598, DOI 10.1021/ac960766a
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI [10.1039/C4FO00290C, 10.1039/c4fo00290c]
   Luthria DL, 2008, FOOD CHEM, V107, P745, DOI 10.1016/j.foodchem.2007.08.074
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Machmudah S, 2008, J SUPERCRIT FLUID, V44, P301, DOI 10.1016/j.supflu.2007.09.024
   Montavon P, 2003, J AGR FOOD CHEM, V51, P2328, DOI 10.1021/jf020831j
   Moon JK, 2009, J AGR FOOD CHEM, V57, P5365, DOI 10.1021/jf900012b
   Murthy PS, 2012, FOOD BIOPROCESS TECH, V5, P657, DOI 10.1007/s11947-010-0331-7
   Mussatto SI, 2011, FOOD BIOPROCESS TECH, V4, P661, DOI 10.1007/s11947-011-0565-z
   Naidu MM, 2008, FOOD CHEM, V107, P377, DOI 10.1016/j.foodchem.2007.08.056
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Natella F, 1999, J AGR FOOD CHEM, V47, P1453, DOI 10.1021/jf980737w
   Raseetha S., 2017, Malaysian Applied Biology, V46, P175
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   SHAHIDI F, 1992, CRIT REV FOOD SCI, V32, P67, DOI 10.1080/10408399209527581
   Smrke S, 2015, FOOD CHEM, V174, P637, DOI 10.1016/j.foodchem.2014.11.060
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Speer Karl, 2006, Braz. J. Plant Physiol., V18, P201, DOI 10.1590/S1677-04202006000100014
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   TRUGO LC, 1984, FOOD CHEM, V15, P219, DOI 10.1016/0308-8146(84)90006-2
   Upadhyay R, 2012, FOOD CHEM, V130, P184, DOI 10.1016/j.foodchem.2011.06.057
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Zhang Lan-tao, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P281, DOI 10.3881/j.issn.1000-503X.2011.03.015
NR 63
TC 94
Z9 96
U1 6
U2 106
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1082-6068
EI 1532-2297
J9 PREP BIOCHEM BIOTECH
JI Prep. Biochem. Biotechnol.
PD NOV 2
PY 2020
VL 50
IS 10
BP 969
EP 978
DI 10.1080/10826068.2020.1786699
EA JUL 2020
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA OO6PM
UT WOS:000546380700001
PM 32633686
DA 2025-04-28
ER

PT J
AU Greenberg, JA
   Owen, DR
   Geliebter, A
AF Greenberg, James A.
   Owen, David R.
   Geliebter, Allan
TI Decaffeinated Coffee and Glucose Metabolism in Young Men
SO DIABETES CARE
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; CHLOROGENIC ACID; BLOOD-GLUCOSE; CAFFEINE;
   CONSUMPTION; TOLERANCE; OBESE; RISK
AB OBJECTIVE - The epidemiological association between coffee drinking and decreased risk Of type 2 diabetes is strong. However, caffeinated coffee acutely impairs glucose metabolism. We assessed acute effects of decaffeinated coffee on glucose and insulin levels.
   RESEARCH DESIGN AND METHODS - This was a randomized, cross-over, placebo-controlled trial of the effects of decaffeinated coffee, caffeinated coffee, and caffeine on glucose, insulin, and glucose-de pendent insulinotropic poly-peptide (GIP) levels during a 2-h Oral glucose tolerance test (OGTT) in 11 young men.
   RESULTS - Within the first hour Of the CGTT, glucose and insulin were higher for decaffeinated coffee than for placebo (P < 0.05). During the whole OGTT, decaffeinated coffee yielded higher insulin than placebo and lower glucose and a higher insulin sensitivity index than caffeine. Changes in GIP could not explain any beverage effects on glucose and insulin.
   CONCLUSIONS - Some types of decaffeinated coffee may acutely impair glucose metabolism but less than caffeine.
C1 [Greenberg, James A.] NYU, Brooklyn Coll City, Dept Hlth & Nutr Sci, New York, NY 10003 USA.
   [Owen, David R.] NYU, Brooklyn Coll City, Dept Psychol, New York, NY USA.
   [Geliebter, Allan] St Lukes Roosevelt Hosp, New York Obes Res Ctr, New York, NY USA.
   [Geliebter, Allan] Columbia Univ, Dept Psychol, New York, NY 10027 USA.
C3 New York University; New York University; Mount Sinai West; Mount Sinai
   St. Luke's; Columbia University
RP Greenberg, JA (corresponding author), NYU, Brooklyn Coll City, Dept Hlth & Nutr Sci, New York, NY 10003 USA.
EM jamesg@brooklyn.cuny.edu
FU Professional Staff Congress; City University of New York Research Award
   Program
FX This work was supported by the Professional Staff Congress, City
   University of New York Research Award Program.
CR Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Belfiore F, 2001, METABOLISM, V50, P573, DOI 10.1053/meta.2001.22518
   Gautier JF, 2008, DIABETES METAB, V34, pS65, DOI 10.1016/S1262-3636(08)73397-4
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Lane JD, 2008, DIABETES CARE, V31, P221, DOI 10.2337/dc07-1112
   McCusker RR, 2006, J ANAL TOXICOL, V30, P611, DOI 10.1093/jat/30.8.611
   Moisey LL, 2008, AM J CLIN NUTR, V87, P1254, DOI 10.1093/ajcn/87.5.1254
   Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323
   Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
NR 12
TC 39
Z9 42
U1 0
U2 17
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD FEB
PY 2010
VL 33
IS 2
BP 278
EP 280
DI 10.2337/dc09-1539
PG 3
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 563PA
UT WOS:000275143700011
PM 19918017
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Santos, RMM
   Lima, DRA
AF Santos, Roseane Maria Maia
   Andrade Lima, Darcy Roberto
TI Coffee consumption, obesity and type 2 diabetes: a mini-review
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Review
DE Coffee; Obesity; Diabetes; Chlorogenic acid; Caffeine
ID ACTIVATED PROTEIN-KINASE; HORMONE-BINDING GLOBULIN; TO-HEIGHT RATIO;
   CHLOROGENIC ACID; INSULIN-RESISTANCE; DECAFFEINATED COFFEE; OXIDATIVE
   STRESS; CARDIOVASCULAR-DISEASE; ADIPONECTIN RECEPTORS; WAIST
   CIRCUMFERENCE
AB Purpose The effects of regular coffee intake on weight gain and development of diabetes are reviewed. The pathophysiology of obesity and type 2 diabetes as well as the necessity of preventive options based on the increasing prevalence of these two disorders worldwide is briefly discussed. The relationship between weight gain and development of diabetes is also presented. The two major constituents in the brewed coffee, chlorogenic acids and caffeine, are responsible for many of the beneficial effects suggested by numerous epidemiological studies of coffee consumption and the development of diabetes.
   Methods A wide search of various databases, such as PubMed and Google Scholar, preceded the writing of this manuscript, focusing on key words that are part of the title. It was selected mainly review papers from in vivo, ex vivo, in vitro experimental studies in animals and human tissues as well as wide population-based epidemiological studies in the last 10 years.
   Conclusion As of today, there are mounting evidences of the reduced risk of developing type 2 diabetes by regular coffee drinkers of 3-4 cups a day. The effects are likely due to the presence of chlorogenic acids and caffeine, the two constituents of coffee in higher concentration after the roasting process.
C1 [Santos, Roseane Maria Maia] South Univ, Sch Pharm, Dept Pharmaceut Sci, 709 Mall Blvd, Savannah, GA 31419 USA.
   [Andrade Lima, Darcy Roberto] Univ Fed Rio de Janeiro, Inst Neurol Deolindo Couto, Botafogo, RJ, Brazil.
C3 Universidade Federal do Rio de Janeiro
RP Santos, RMM (corresponding author), South Univ, Sch Pharm, Dept Pharmaceut Sci, 709 Mall Blvd, Savannah, GA 31419 USA.
EM rsantos@southuniversity.edu
RI Santos, Roseane/AAF-6636-2020
CR Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   ANDERSON DC, 1974, CLIN ENDOCRINOL, V3, P69, DOI 10.1111/j.1365-2265.1974.tb03298.x
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   [Anonymous], 2012, DIAB REP CARD 2012
   [Anonymous], 2015, Coffee in Health and Disease Prevention
   Arciero PJ, 2000, METABOLISM, V49, P101, DOI 10.1016/S0026-0495(00)90888-6
   Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   ASTRUP A, 1993, INT J OBESITY, V17, pS41
   Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x
   Bäckhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Bailey CJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1996
   Barbagallo Mario, 2003, Molecular Aspects of Medicine, V24, P39, DOI 10.1016/S0098-2997(02)00090-0
   Bekedam EK, 2008, J AGR FOOD CHEM, V56, P4597, DOI 10.1021/jf8004004
   Belin RJ, 2007, MAGNESIUM RES, V20, P107
   Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7
   Cavin C, 2001, FOOD CHEM TOXICOL, V39, P549, DOI 10.1016/S0278-6915(00)00168-X
   Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k
   Cruz R, 2015, FOOD RES INT, V73, P190, DOI 10.1016/j.foodres.2014.11.018
   Davidson MH, 2006, AM J CARDIOL, V98, p27I, DOI 10.1016/j.amjcard.2005.12.024
   de Valk HW, 1999, NETH J MED, V54, P139, DOI 10.1016/S0300-2977(99)00005-4
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Elkaim Y, 2011, NEWS STUDIES CONFIRM
   Esquivel P, 2012, FOOD RES INT, V46, P488, DOI 10.1016/j.foodres.2011.05.028
   Farah A., 2015, Coffee in Health and Disease Prevention
   Fisman EZ, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-103
   Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Fumeaux R, 2010, ORG BIOMOL CHEM, V8, P5199, DOI 10.1039/c0ob00137f
   Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008
   Goldstein E, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-18
   Goto A, 2014, CLIN CHEM, V60, P174, DOI 10.1373/clinchem.2013.207217
   Goto A, 2011, DIABETES, V60, P269, DOI 10.2337/db10-1193
   Graham TE, 2001, CAN J APPL PHYSIOL, V26, pS103, DOI 10.1139/h2001-046
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Gross-Steinmeyer K, 2012, TOXICOLOGY, V299, P69, DOI 10.1016/j.tox.2012.05.016
   Hamer M, 2008, BRIT J NUTR, V100, P1046, DOI 10.1017/S0007114508944135
   HAN TS, 1995, BRIT MED J, V311, P1401, DOI 10.1136/bmj.311.7017.1401
   Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116
   Hiltunen LA, 2006, EUR J CLIN NUTR, V60, P1222, DOI 10.1038/sj.ejcn.1602441
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   International Diabetes F, 2013, 66 WORLD HLTH ASS
   International Diabetes F, 2013, IDF ATL
   Jia HJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0389-3
   Jiménez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x
   Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892
   Kodiha M, 2011, TARGETING AMPK THERA, V1
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007
   LARSSON B, 1984, BMJ-BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401
   Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343
   Leong KS, 1999, BEST PRACT RES CL EN, V13, P221, DOI 10.1053/beem.1999.0017
   Lopaschuk GD, 2008, INT J OBESITY, V32, pS29, DOI 10.1038/ijo.2008.120
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245
   Malloy MJ, 2015, BASIC CLIN PHARM
   Matsui T, 2001, J AGR FOOD CHEM, V49, P1948, DOI 10.1021/jf001251u
   McTiernan A, 2006, OBESITY, V14, P1662, DOI 10.1038/oby.2006.191
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   MISHKINSKY J, 1967, LANCET, V2, P1311
   Monente C, 2015, J AGR FOOD CHEM, V63, P4327, DOI 10.1021/acs.jafc.5b01619
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Morisco F, 2014, J CLIN GASTROENTEROL, V48, pS87, DOI 10.1097/MCG.0000000000000240
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   NAISMITH DJ, 1970, NUTR METAB, V12, P144
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   NEHLIG A, 1994, INT J SPORTS MED, V15, P215, DOI 10.1055/s-2007-1021049
   Nuhu Abdulmumin A, 2014, ISRN Nutr, V2014, P384230, DOI 10.1155/2014/384230
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Paluska Scott A, 2003, Curr Sports Med Rep, V2, P213, DOI 10.1249/00149619-200308000-00008
   PAOLISSO G, 1990, DIABETOLOGIA, V33, P511, DOI 10.1007/BF00404136
   Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323
   Pincock S, 2006, LANCET, V368, P1643, DOI 10.1016/S0140-6736(06)69682-7
   Redeuil K, 2011, J CHROMATOGR A, V1218, P4678, DOI 10.1016/j.chroma.2011.05.050
   Rivera J, 2014, UNLOCKING COFFEES 1
   Robinson K, 2011, CRIT CARE, V15, DOI 10.1186/cc10021
   Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x
   Rustenbeck I, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.19
   Santos R. M., 2009, UNASHAMED DEFENSE CO
   Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220
   Serafini M, 2009, CLIN DERMATOL, V27, P225, DOI 10.1016/j.clindermatol.2008.04.007
   Slow S, 2004, EUR J CLIN NUTR, V58, P1253, DOI 10.1038/sj.ejcn.1601957
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   SPRIET LL, 1995, INT J SPORT NUTR, V5, pS84, DOI 10.1123/ijsn.5.s1.s84
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI [10.1152/physrev.00011.2008, 10.15252/embj.201488104]
   Svilaas A, 2004, J NUTR, V134, P562, DOI 10.1093/jn/134.3.562
   Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091134
   Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05
   Troup GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122834
   van Dam R M, 2006, Ned Tijdschr Geneeskd, V150, P1821
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dam RM, 2006, ANN INTERN MED, V145, P634, DOI 10.7326/0003-4819-145-8-200610170-00018
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460
   Wang HY, 2011, FOOD CHEM, V128, P573, DOI 10.1016/j.foodchem.2011.03.075
   Wu X, 1997, MUTAT RES-GEN TOX EN, V391, P171, DOI 10.1016/S1383-5718(97)00065-X
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Yamauchi T, 2014, BEST PRACT RES CL EN, V28, P15, DOI 10.1016/j.beem.2013.09.003
   Yoshinari O, 2010, CURR MED CHEM, V17, P2196, DOI 10.2174/092986710791299902
   Yoshinari O, 2009, BIOSCI BIOTECH BIOCH, V73, P1033, DOI 10.1271/bbb.80805
   Zanotti I, 2015, FOOD FUNCT, V6, P13, DOI [10.1039/c4fo00670d, 10.1039/C4FO00670D]
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 125
TC 118
Z9 127
U1 2
U2 80
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN
PY 2016
VL 55
IS 4
BP 1345
EP 1358
DI 10.1007/s00394-016-1206-0
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DM6UN
UT WOS:000376488200003
PM 27026242
DA 2025-04-28
ER

PT J
AU Matsuda, Y
   Kobayashi, M
   Yamauchi, R
   Ojika, M
   Hiramitsu, M
   Inoue, T
   Katagiri, T
   Murai, A
   Horio, F
AF Matsuda, Yuji
   Kobayashi, Misato
   Yamauchi, Rie
   Ojika, Makoto
   Hiramitsu, Masanori
   Inoue, Takashi
   Katagiri, Takao
   Murai, Atsushi
   Horio, Fumihiko
TI Coffee and Caffeine Improve Insulin Sensitivity and Glucose Tolerance in
   C57BL/6J Mice Fed a High-Fat Diet
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE coffee; caffeine; diet-induced impaired glucose tolerance; antidiabetic
   effect; insulin resistance
ID TYPE-2 DIABETES-MELLITUS; TUMOR-NECROSIS-FACTOR; CYTOKINE SIGNALING-3;
   CHLOROGENIC ACID; LIVER-DISEASE; RESISTANCE; CONSUMPTION; OBESITY; RISK;
   EXPRESSION
AB We have previously demonstrated that coffee and caffeine ameliorated hyperglycemia in spontaneously diabetic KK-A(y) mice. This present study evaluates the antidiabetic effects of coffee and caffeine on high-fat-diet-induced impaired glucose tolerance in C57BL/6J mice. C57BL/6J mice fed a high-fat diet were given regular drinking water (control group), or a 2.5-fold-diluted coffee or caffeine solution (200 mg/L) for 17 weeks. The ingestion of Coffee or caffeine improved glucose tolerance, insulin sensitivity, and hyperinsulinemia when compared with mice in the control group. The adipose tissue mRNA levels of inflammatory adipocytokines (MCP-1 and IL-6) and the liver mRNA levels of genes related to fatty acid synthesis were lower in the coffee and caffeine groups than those in the control group. These results suggest that coffee and caffeine exerted an ameliorative effect on high-fat-diet-induced impaired glucose tolerance by improving insulin sensitivity. This effect might be attributable in part to the reduction of inflammatory adipocytokine expression.
C1 [Matsuda, Yuji; Kobayashi, Misato; Yamauchi, Rie; Ojika, Makoto; Murai, Atsushi; Horio, Fumihiko] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan.
C3 Nagoya University
RP Horio, F (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan.
EM horiof@agr.nagoya-u.ac.jp
OI KOBAYASHI, Misato/0000-0002-2752-6358
FU All Japan Coffee Association; Grants-in-Aid for Scientific Research
   [21380079] Funding Source: KAKEN
FX We thank the All Japan Coffee Association for financial support for this
   study.
CR Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x
   Dray C, 2007, J PHYSIOL BIOCHEM, V63, P329, DOI 10.1007/BF03165764
   Egawa T, 2009, METABOLISM, V58, P1609, DOI 10.1016/j.metabol.2009.05.013
   Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/0264-6021:3490013
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Goto A, 2011, DIABETES, V60, P269, DOI 10.2337/db10-1193
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111
   Jung EH, 2007, J AGR FOOD CHEM, V55, P9800, DOI 10.1021/jf0714463
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Kagami K, 2008, J PHARM PHARMACOL, V60, P1161, DOI 10.1211/jpp.60.9.0007
   Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745
   Lorenzo M, 2008, J Anim Sci, V86, pE94
   Malecki MT, 2005, DIABETES RES CLIN PR, V68, pS10, DOI 10.1016/j.diabres.2005.03.003
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   MISHKINSKY J, 1967, LANCET, V2, P1311
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Parillo M, 2004, BRIT J NUTR, V92, P7, DOI 10.1079/BJN20041117
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   REBUFFESCRIVE M, 1993, METABOLISM, V42, P1405, DOI 10.1016/0026-0495(93)90190-Y
   Sacks DB, 1996, AM J CLIN PATHOL, V105, P149
   Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400
   Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200
   Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100
   Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200
   Shearer J, 2007, CAN J PHYSIOL PHARM, V85, P823, DOI 10.1139/Y07-070
   Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200
   Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832
   SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Yoshinari O, 2010, CURR MED CHEM, V17, P2196, DOI 10.2174/092986710791299902
NR 38
TC 44
Z9 48
U1 1
U2 39
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD DEC
PY 2011
VL 75
IS 12
BP 2309
EP 2315
DI 10.1271/bbb.110452
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA 871YX
UT WOS:000298774700008
PM 22146708
OA Bronze
DA 2025-04-28
ER

PT J
AU Flanagan, J
   Bily, A
   Rolland, Y
   Roller, M
AF Flanagan, John
   Bily, Antoine
   Rolland, Yohan
   Roller, Marc
TI Lipolytic Activity of Svetol®, a Decaffeinated Green Coffee Bean Extract
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE chlorogenic acid; adipocyte; weight loss; diabetes
ID CHLOROGENIC ACIDS; IN-VITRO; INHIBITION; VOLUNTEERS; OVERWEIGHT; MASS
AB The beneficial health effects of chlorogenic acids (CGAs), major components of coffee beans, are well known and have been attributed to multiple mechanisms of action. However, the lipolytic activity of CGAs does not appear to have been reported. We studied the effects of varying concentrations of Svetol (R), a decaffeinated green coffee bean extract enriched in CGAs, on the liberation of free fatty acids from human adipocytes following short-term (2h) and long-term (192h) exposure. The results showed that although lipolytic activity observed following short-term incubation could be tentatively linked to residual caffeine traces in the sample, longer-term exposure clearly showed the effects of Svetol (R) on release of free fatty acids, and this effect was not due to caffeine. The results of this study provide a further mechanism by which to explain the long-term health benefits of CGAs and Svetol (R). Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Flanagan, John; Bily, Antoine; Rolland, Yohan; Roller, Marc] Naturex SA, F-84911 Avignon 9, France.
RP Bily, A (corresponding author), Naturex SA, Site Agroparc BP 1218, F-84911 Avignon 9, France.
EM a.bily@naturex.com
FU Naturex
FX This work was funded by Naturex.
CR Blum J, 2007, NUTRAFOODS, V6, P13
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Dallas C, 2008, PHYTOMEDICINE, V15, P783, DOI 10.1016/j.phymed.2008.05.006
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Kamitani Y, 2009, J JPN SOC FOOD SCI, V56, P336, DOI 10.3136/nskkk.56.336
   RODBELL M, 1964, J BIOL CHEM, V239, P375
   Tanaka K, 2009, FOOD SCI TECHNOL RES, V15, P147, DOI 10.3136/fstr.15.147
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
NR 11
TC 31
Z9 33
U1 1
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD JUN
PY 2014
VL 28
IS 6
BP 946
EP 948
DI 10.1002/ptr.5085
PG 3
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA AJ3OE
UT WOS:000337575400021
PM 24338784
DA 2025-04-28
ER

PT J
AU Zheng, GD
   Qiu, YY
   Zhang, QF
   Li, DM
AF Zheng, Guodong
   Qiu, Yangyang
   Zhang, Qing-Feng
   Li, Dongming
TI Chlorogenic acid and caffeine in combination inhibit fat accumulation by
   regulating hepatic lipid metabolism-related enzymes in mice
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Chlorogenic acid; Caffeine; Fat accumulation; Lipid metabolism-related
   enzymes
ID GREEN TEA; COFFEE; DIFFERENTIATION; PROLIFERATION; THERMOGENESIS;
   CATECHINS; ALPHA; CELLS; LIVER
AB Obesity has become a public health concern due to its positive association with the incidence of many diseases, and coffee components including chlorogenic acid (CGA) and caffeine have been demonstrated to play roles in the suppression of fat accumulation. To investigate the mechanism by which CGA and caffeine regulate lipid metabolism, in the present study, forty mice were randomly assigned to four groups and fed diets containing no CGA or caffeine, CGA, caffeine, or CGA + caffeine for 24 weeks. Body weight, intraperitoneal adipose tissue (IPAT) weight, and serum biochemical parameters were measured, and the activities and mRNA and protein expression of lipid metabolism-related enzymes were analysed. There was a decrease in the body weight and IPAT weight of mice fed the CGA + caffeine diet. There was a significant decrease in the serum and hepatic concentrations of total cholesterol, TAG and leptin of mice fed the CGA + caffeine diet. The activities of carnitine acyltransferase (CAT) and acyl-CoA oxidase (ACO) were increased in mice fed the caffeine and CGA + caffeine diets, while the activity of fatty acid synthase (FAS) was suppressed in those fed the CGA + caffeine diet. The mRNA expression levels of AMP-activated protein kinase (AMPK), CAT and ACO were considerably up-regulated in mice fed the CGA + caffeine diet, while those of PPAR gamma 2 were down-regulated. The protein expression levels of AMPK were increased and those of FAS were decreased in mice fed the CGA + caffeine diet. These results indicate that CGA + caffeine suppresses fat accumulation and body weight gain by regulating the activities and mRNA and protein expression levels of hepatic lipid metabolism-related enzymes and that these effects are stronger than those exerted by CGA and caffeine individually.
C1 [Zheng, Guodong; Qiu, Yangyang; Zhang, Qing-Feng; Li, Dongming] Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Peoples R China.
C3 Jiangxi Agricultural University
RP Zheng, GD (corresponding author), Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Peoples R China.
EM zrs150716@aliyun.com
RI Li, Dongming/JAX-5328-2023; Zhang, Qing-FENG/F-6875-2015
FU National Natural Science Foundation of China [31160320]; Scientific
   Research Foundation for the Returned Overseas Chinese Scholar, State
   Education Ministry
FX The present study was supported by the National Natural Science
   Foundation of China (no. 31160320) and sponsored by the Scientific
   Research Foundation for the Returned Overseas Chinese Scholar, State
   Education Ministry (2009). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR BARTLETT GR, 1959, J BIOL CHEM, V234, P469
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200
   Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965
   Hirata T, 2011, BIOORG MED CHEM LETT, V21, P1786, DOI 10.1016/j.bmcl.2011.01.060
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Janecková R, 2001, PHYSIOL RES, V50, P443
   KELLEY DS, 1986, BIOCHEM J, V235, P87, DOI 10.1042/bj2350087
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Lee CE, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/759143
   Li BH, 2006, IUBMB LIFE, V58, P39, DOI 10.1080/15216540500507408
   Li M, 1999, BIOCHEM MOL BIOL INT, V47, P63
   Lord CC, 2012, ADIPOCYTE, V1, P123, DOI 10.4161/adip.20035
   MARKWELL MA, 1973, J BIOL CHEM, V248, P3426
   Miura D, 2007, BIOSCI BIOTECH BIOCH, V71, P2743, DOI 10.1271/bbb.70359
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Moriyama T, 2004, BIOSCI BIOTECH BIOCH, V68, P352, DOI 10.1271/bbb.68.352
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Narita Y, 2013, J AGR FOOD CHEM, V61, P966, DOI 10.1021/jf304105w
   Niseteo T, 2012, FOOD CHEM, V134, P1870, DOI 10.1016/j.foodchem.2012.03.095
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006
   OSUMI T, 1978, BIOCHEM BIOPH RES CO, V83, P479, DOI 10.1016/0006-291X(78)91015-X
   Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189
   Peng CH, 2011, J AGR FOOD CHEM, V59, P2663, DOI 10.1021/jf1043508
   Riedel A, 2012, FOOD FUNCT, V3, P955, DOI 10.1039/c2fo30053b
   Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520
   Su SJ, 2013, INT J FOOD SCI NUTR, V64, P429, DOI 10.3109/09637486.2012.759184
   Tanaka K, 2010, BIOSCI BIOTECH BIOCH, V74, P1606, DOI 10.1271/bbb.100197
   Tauler P, 2013, MED SCI SPORT EXER, V45, P1269, DOI 10.1249/MSS.0b013e3182857c8a
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   YOSHIOKA K, 1990, J NUTR SCI VITAMINOL, V36, P173, DOI 10.3177/jnsv.36.173
   Zhang A, 2013, OBES REV, V14, P344, DOI 10.1111/obr.12011
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zheng GD, 2004, IN VIVO, V18, P55
NR 38
TC 55
Z9 58
U1 0
U2 43
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD SEP 28
PY 2014
VL 112
IS 6
BP 1034
EP 1040
DI 10.1017/S0007114514001652
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AP3JD
UT WOS:000341970800019
PM 25201308
OA Bronze
DA 2025-04-28
ER

PT J
AU Ribeiro, M
   Alvarenga, L
   Cardozo, LFMF
   Kemp, JA
   Lima, LS
   de Almeida, JS
   Leal, VD
   Stenvinkel, P
   Shiels, PG
   Mafra, D
AF Ribeiro, Marcia
   Alvarenga, Livia
   Cardozo, Ludmila F. M. F.
   Kemp, Julie A.
   Lima, Ligia S.
   de Almeida, Jonatas S.
   Leal, Viviane de O.
   Stenvinkel, Peter
   Shiels, Paul G.
   Mafra, Denise
TI The magical smell and taste: Can coffee be good to patients with
   cardiometabolic disease?
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE burden of lifestyle diseases; coffee; coffee phytochemicals structure;
   gut microbiota; inflammation; oxidative stress
ID TYPE-2 DIABETES-MELLITUS; NF-KAPPA-B; CHLOROGENIC ACID; BLOOD-PRESSURE;
   ENDOTHELIAL FUNCTION; IN-VITRO; OXIDATIVE STRESS; GUT MICROBIOTA; GREEN
   COFFEE; DECAFFEINATED COFFEE
AB Coffee is a beverage consumed globally. Although few studies have indicated adverse effects, it is typically a beneficial health-promoting agent in a range of diseases, including depression, diabetes, cardiovascular disease, and obesity. Coffee is rich in caffeine, antioxidants, and phenolic compounds, which can modulate the composition of the gut microbiota and mitigate both inflammation and oxidative stress, common features of the burden of lifestyle diseases. This review will discuss the possible benefits of coffee on complications present in patients with diabetes, cardiovascular disease and chronic kidney disease, outwith the social and emotional benefits attributed to caffeine consumption.
C1 [Ribeiro, Marcia; Lima, Ligia S.; Mafra, Denise] Fed Univ Rio de Janeiro UFRJ, Grad Program Biol Sci Physiol, Rio De Janeiro, RJ, Brazil.
   [Ribeiro, Marcia; Alvarenga, Livia; Cardozo, Ludmila F. M. F.; Kemp, Julie A.; Lima, Ligia S.; de Almeida, Jonatas S.; Mafra, Denise] Univ Hosp Antonio Pedro, Unidade Pesquisa Clin UPC, Niteroi, RJ, Brazil.
   [Alvarenga, Livia; Mafra, Denise] Fluminense Fed Univ UFF, Grad Program Med Sci, Niteroi, RJ, Brazil.
   [Cardozo, Ludmila F. M. F.; Kemp, Julie A.] Fluminense Fed Univ UFF, Grad Program Cardiovasc Sci, Niteroi, RJ, Brazil.
   [Leal, Viviane de O.] Univ State Rio de Janeiro UERJ, Nutr Div, Pedro Ernesto Univ Hosp, Rio De Janeiro, RJ, Brazil.
   [Stenvinkel, Peter] Karolinska Inst, Div Renal Med & Baxter Novum, Dept Clin Sci Technol & Intervent, Stockholm, Sweden.
   [Shiels, Paul G.] Univ Glasgow, Wolfson Wohl Translat Res Ctr, Glasgow, Lanark, Scotland.
C3 Universidade Federal Fluminense; Universidade Federal Fluminense;
   Universidade do Estado do Rio de Janeiro; Karolinska Institutet;
   University of Glasgow
RP Mafra, D (corresponding author), Fed Univ Rio de Janeiro UFRJ, Grad Program Biol Sci Physiol, Rio De Janeiro, RJ, Brazil.; Mafra, D (corresponding author), Univ Hosp Antonio Pedro, Unidade Pesquisa Clin UPC, Niteroi, RJ, Brazil.; Mafra, D (corresponding author), Fluminense Fed Univ UFF, Grad Program Med Sci, Niteroi, RJ, Brazil.
EM dmafra30@gmail.com
RI Kemp, Julie/ABA-8603-2020; Cardozo, Ludmila/U-4502-2019; Mafra,
   Denise/D-4923-2015
OI Cardozo, Ludmila/0000-0001-8507-2369; Ferreira Ribeiro, Marcia
   Maria/0000-0002-4957-3630; Almeida, Jonatas/0000-0002-1560-9869;
   Stenvinkel, Peter/0000-0002-8785-4820; Shiels, Paul/0000-0002-7577-9843;
   Mafra, Denise/0000-0001-6752-6056; Kemp, Julie Ann/0000-0001-6739-8832;
   ALVARENGA, LIVIA/0000-0002-9347-8139
FU Conselho Nacional de Pesquisa (CNPq); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)
FX Conselho Nacional de Pesquisa (CNPq), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ) support Denise Mafra research.
CR Agudelo-Ochoa GM, 2016, J NUTR, V146, P524, DOI 10.3945/jn.115.224774
   Ahola AJ, 2019, DIABETES RES CLIN PR, V155, DOI 10.1016/j.diabres.2019.06.016
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   AL-Megrin WA, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/6762709
   Aljahdali N, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010241
   Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Alvarenga L, 2020, CLIN NUTR, V39, P3594, DOI 10.1016/j.clnu.2020.03.007
   Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101
   Angeloni G, 2019, J SCI FOOD AGR, V99, P391, DOI 10.1002/jsfa.9200
   [Anonymous], 2011, OJ L, V178, P1
   Aoun MH, 2021, J RENAL NUTR, V31, P648, DOI 10.1053/j.jrn.2021.01.025
   Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Arfian N, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5423703
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Asano I, 2004, FOOD SCI TECHNOL RES, V10, P273, DOI 10.3136/fstr.10.273
   Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029
   Badmos S, 2019, FOOD RES INT, V126, DOI 10.1016/j.foodres.2019.108544
   Baeza G, 2017, FOOD FUNCT, V8, P1333, DOI [10.1039/c6fo01404f, 10.1039/C6FO01404F]
   Bao LP, 2018, INT IMMUNOPHARMACOL, V54, P245, DOI 10.1016/j.intimp.2017.11.021
   Beaudoin MS, 2011, J NUTR, V141, P574, DOI 10.3945/jn.110.132761
   Bhandarkar NS, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10111369
   Bhandarkar NS, 2020, FASEB J, V34, P4783, DOI 10.1096/fj.201902416RR
   Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Bicho NC, 2013, INT J FOOD PROP, V16, P895, DOI 10.1080/10942912.2011.573114
   Binello A, 2021, FOOD CHEM, V344, DOI 10.1016/j.foodchem.2020.128631
   BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933
   Boekema PJ, 1999, SCAND J GASTROENTERO, V34, P35, DOI 10.1080/003655299750025525
   Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Boon EAJ, 2017, FOOD FUNCT, V8, P3366, DOI 10.1039/c7fo00926g
   Bravo L, 2019, COFFEE: CONSUMPTION AND HEALTH IMPLICATIONS, P105
   Busbee PB, 2013, NUTR REV, V71, P353, DOI 10.1111/nure.12024
   Caetano C, 2019, EUR J CLIN NUTR, V73, P924, DOI 10.1038/s41430-018-0328-2
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Calderón-Pérez L, 2021, FOOD CHEM, V344, DOI 10.1016/j.foodchem.2020.128567
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Caro-Gómez E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030497
   Cavalcanti MH, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262270
   Chan L, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02411-5
   Chen H, 2020, COMPLEMENT THER MED, V52, DOI 10.1016/j.ctim.2020.102498
   Chen WP, 2014, INT J CLIN EXP PATHO, V7, P8797
   Chen XM, 2018, FOOD CHEM, V249, P143, DOI 10.1016/j.foodchem.2017.12.073
   Chen XM, 2019, CRIT REV FOOD SCI, V59, P1008, DOI 10.1080/10408398.2018.1546667
   Cheng D, 2019, FOOD FUNCT, V10, P681, DOI [10.1039/c8fo01755g, 10.1039/C8FO01755G]
   Chieng D, 2022, TRENDS CARDIOVAS MED, V32, P399, DOI 10.1016/j.tcm.2021.08.004
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cho HJ, 2022, INT J FOOD SCI NUTR, V73, P513, DOI 10.1080/09637486.2021.2002829
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Chong CW, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13535
   Clark I, 2017, SLEEP MED REV, V31, P70, DOI 10.1016/j.smrv.2016.01.006
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Coffee P., 2016, AGENCY INSIDERS CONF
   Coreta-Gomes FM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020437
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-03153-7
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Cornelis MC, 2012, PROG MOL BIOL TRANSL, V108, P293, DOI 10.1016/B978-0-12-398397-8.00012-5
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   Davinelli S, 2022, BIOFACTORS, V48, P274, DOI 10.1002/biof.1785
   Pereira GVD, 2020, ADV FOOD NUTR RES, V91, P65, DOI 10.1016/bs.afnr.2019.10.002
   Del Giorno R, 2022, INT J FOOD SCI NUTR, V73, P106, DOI 10.1080/09637486.2021.1926935
   Denden S, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027487
   Di Maso M, 2021, ADV NUTR, V12, P1160, DOI 10.1093/advances/nmaa177
   Du YB, 2020, NUTR METAB CARDIOVAS, V30, P2159, DOI 10.1016/j.numecd.2020.08.017
   Duran CAA, 2017, REV VIRTUAL QUIM, V9, P107, DOI 10.21577/1984-6835.20170010
   Jovel CAE, 2017, NEUROLOGIA, V32, P394, DOI 10.1016/j.nrl.2014.12.016
   eufic, CAFF INF EUFIC
   Eulalia C, 2022, PHYSIOL BEHAV, V244, DOI 10.1016/j.physbeh.2021.113655
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Ferraro PM, 2022, AM J KIDNEY DIS, V79, P3, DOI 10.1053/j.ajkd.2021.07.002
   Folwarczna J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111196
   Folwarczna J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030133
   Fujii Y, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2014.71
   Gao F, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0321-8
   García-Cordero J, 2022, FOODS, V11, DOI 10.3390/foods11050679
   Gkouskou KG, 2022, INT J OBESITY, V46, P162, DOI 10.1038/s41366-021-00972-6
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   González S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051287
   Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539
   Grioni S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126550
   Guessous I, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0468-2
   Ha HR, 1996, EUR J CLIN PHARMACOL, V49, P309, DOI 10.1007/BF00226333
   He WJ, 2021, CLIN J AM SOC NEPHRO, V16, P1620, DOI 10.2215/CJN.05520421
   Herber-Gast GCM, 2016, AM J CLIN NUTR, V103, P1370, DOI 10.3945/ajcn.115.112755
   Higashi Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092104
   Ilavenil S, 2015, ASIAN PAC J TROP MED, V8, P263, DOI 10.1016/S1995-7645(14)60328-X
   Ilmiawati C, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05052-y
   Iriondo-DeHond A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10091219
   Jiang RJ, 2016, J NUTR BIOCHEM, V27, P53, DOI 10.1016/j.jnutbio.2015.08.017
   Jin T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082228
   Jokura H, 2015, NUTR RES, V35, P873, DOI 10.1016/j.nutres.2015.07.005
   Kaczmarczyk-Sedlak I, 2019, ARCH MED SCI, V15, P1073, DOI 10.5114/aoms.2019.85461
   Kajikawa M, 2019, EUR J NUTR, V58, P989, DOI 10.1007/s00394-018-1611-7
   Kalaska B, 2014, J AGR FOOD CHEM, V62, P2853, DOI 10.1021/jf5008538
   Kanbay M, 2021, J RENAL NUTR, V31, P5, DOI 10.1053/j.jrn.2020.08.004
   Gil-Madrigal AK, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102100
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   Kennedy OJ, 2020, AM J KIDNEY DIS, V75, P753, DOI 10.1053/j.ajkd.2019.08.025
   Kim AN, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155379
   Kolb H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041144
   Kolb H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061842
   Komorita Y, 2022, J DIABETES INVEST, V13, P1030, DOI 10.1111/jdi.13769
   Kusumah J, 2022, FOOD CHEM TOXICOL, V161, DOI 10.1016/j.fct.2022.112821
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lara-Guzmán OJ, 2021, FREE RADICAL BIO MED, V176, P345, DOI 10.1016/j.freeradbiomed.2021.10.012
   Lee JH, 2016, KOREAN J FAM MED, V37, P7, DOI 10.4082/kjfm.2016.37.1.7
   Lew QLJ, 2018, J NUTR, V148, P1315, DOI 10.1093/jn/nxy075
   Li WZ, 2016, INT J CARDIOL, V223, P870, DOI 10.1016/j.ijcard.2016.08.302
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Lim Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102377
   Liu YT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051301
   Lohsiriwat S, 2006, DIS ESOPHAGUS, V19, P183, DOI 10.1111/j.1442-2050.2006.00562.x
   Lonati E, 2022, MOLECULES, V27, DOI 10.3390/molecules27031049
   Lopez-Garcia E, 2016, CLIN NUTR, V35, P1457, DOI 10.1016/j.clnu.2016.03.021
   Lou ZX, 2011, J FOOD SCI, V76, pM398, DOI 10.1111/j.1750-3841.2011.02213.x
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Ludwig IA, 2013, BIOFACTORS, V39, P623, DOI 10.1002/biof.1124
   Mansour A, 2020, EXCLI J, V19, P241, DOI 10.17179/excli2019-2021
   Mao Y, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01370-z
   Martina Sake Juli, 2019, Open Access Maced J Med Sci, V7, P3363, DOI 10.3889/oamjms.2019.423
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Martini D, 2021, EUR J NUTR, V60, P1453, DOI 10.1007/s00394-020-02347-5
   Martini D, 2016, MOLECULES, V21, DOI 10.3390/molecules21080979
   Martins A.L., 2012, HIST COFFEE
   Maurin O, 2007, ANN BOT-LONDON, V100, P1565, DOI 10.1093/aob/mcm257
   Mihai S, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2180373
   Mikolajczyk-Stecyna J, 2017, APPETITE, V116, P57, DOI 10.1016/j.appet.2017.04.029
   Miranda AM, 2021, CLIN NUTR, V40, P542, DOI 10.1016/j.clnu.2020.05.052
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   Muchtaridi F.N., 2014, TINJAUAN KIMIA DAN A
   Naylor LH, 2021, AM J CLIN NUTR, V113, P370, DOI 10.1093/ajcn/nqaa312
   NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Neves JS, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00547
   Nikic PM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/707460
   Nikpayam O, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0489-8
   Nishitsuji K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34571-9
   Noguchi K, 2015, J PHARMACOL SCI, V127, P217, DOI 10.1016/j.jphs.2015.01.003
   Notara V, 2015, INT J FOOD SCI NUTR, V66, P722, DOI 10.3109/09637486.2015.1077795
   Ochiai R, 2014, NUTR RES, V34, P155, DOI 10.1016/j.nutres.2013.11.001
   Osama H, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13983
   Palatini P, 2015, EUR J EPIDEMIOL, V30, P209, DOI 10.1007/s10654-015-9990-z
   Palatini P, 2009, J HYPERTENS, V27, P1594, DOI 10.1097/HJH.0b013e32832ba850
   Park JB, 2022, CURR DEV NUTR, V6, DOI 10.1093/cdn/nzab145
   Pedruzzi LM, 2012, BIOCHIMIE, V94, P2461, DOI 10.1016/j.biochi.2012.07.015
   Peerapen P, 2022, BIOMED PHARMACOTHER, V149, DOI 10.1016/j.biopha.2022.112876
   Pérez-Burillo S, 2020, FOOD CHEM, V316, DOI 10.1016/j.foodchem.2020.126309
   Pérez-Burillo S, 2019, J AGR FOOD CHEM, V67, P2500, DOI 10.1021/acs.jafc.8b06604
   Pimentel GD, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-6
   Pirastu N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092065
   Priftis A, 2018, MUTAT RES-GEN TOX EN, V829, P33, DOI 10.1016/j.mrgentox.2018.03.003
   Ramalakshmi K, 2009, FOOD CHEM, V115, P79, DOI 10.1016/j.foodchem.2008.11.063
   Ramos LV, 2022, J NUTR BIOCHEM, V100, DOI 10.1016/j.jnutbio.2021.108881
   Reis CEG, 2018, BRIT J NUTR, V119, P1029, DOI 10.1017/S000711451800034X
   Robertson TM, 2018, BRIT J NUTR, V119, P792, DOI [10.1017/S0007114518000260, 10.1017/s0007114518000260]
   Rocha C.T., 2009, THESIS FEDERAL U LAV
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Rubach M, 2012, MOL NUTR FOOD RES, V56, P325, DOI 10.1002/mnfr.201100453
   Ruggiero E, 2021, J NUTR, V151, P395, DOI 10.1093/jn/nxaa365
   Sakamaki T, 2021, PUBLIC HEALTH, V191, P23, DOI 10.1016/j.puhe.2020.10.021
   Samsonowicz M, 2019, FOOD CHEM, V278, P101, DOI 10.1016/j.foodchem.2018.11.057
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sarriá B, 2020, FOODS, V9, DOI 10.3390/foods9091191
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Saud S, 2021, MOLECULES, V26, DOI 10.3390/molecules26247634
   Sauer T, 2013, AMINO ACIDS, V44, P1427, DOI 10.1007/s00726-012-1222-1
   Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6
   Schüttler D, 2022, EUR J NUTR, V61, P2847, DOI 10.1007/s00394-022-02853-8
   Shabir A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101528
   Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011
   Shao C, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2020.105452
   Shen T, 2010, BIOL PHARM BULL, V33, P1159, DOI 10.1248/bpb.33.1159
   Shokouh P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092074
   Shokouh P, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101547
   Signori C, 2021, J AGR FOOD CHEM, V69, P11236, DOI 10.1021/acs.jafc.1c03741
   Simon J, 2022, EUR J PREV CARDIOL, V29, P982, DOI 10.1093/eurjpc/zwac008
   Siswanto FM, 2022, J GERONTOL A-BIOL, V77, P1503, DOI 10.1093/gerona/glac062
   Somoza V., 2010, European Patent Office, Patent No. 2269468
   Song J, 2019, FOOD FUNCT, V10, P2947, DOI [10.1039/c8fo02599a, 10.1039/C8FO02599A]
   Srithongkul T, 2020, EUR J INTERN MED, V77, P111, DOI [10.1016/j.ejim.2020.04.018, 10.1016/j.ejm.2020.04.018]
   Srivastava B, 2022, SPECTROCHIM ACTA A, V264, DOI 10.1016/j.saa.2021.120322
   Stalmach A, 2014, FOOD FUNCT, V5, P1727, DOI [10.1039/c4fo00316k, 10.1039/C4FO00316K]
   Stefanello N, 2019, FOOD CHEM TOXICOL, V123, P298, DOI 10.1016/j.fct.2018.10.005
   Steffen M, 2012, J HYPERTENS, V30, P2245, DOI 10.1097/HJH.0b013e3283588d73
   Stevens LM, 2021, CIRC-HEART FAIL, V14, DOI 10.1161/CIRCHEARTFAILURE.119.006799
   Surma S, 2021, CURR HYPERTENS REP, V23, DOI 10.1007/s11906-021-01156-3
   Suzuki A, 2019, INT J FOOD SCI NUTR, V70, P901, DOI 10.1080/09637486.2019.1585763
   Suzuki M, 2017, J APPL PHYSIOL, V122, P1321, DOI 10.1152/japplphysiol.00278.2016
   Tagliazucchi D, 2012, J AGR FOOD CHEM, V60, P11056, DOI 10.1021/jf302694a
   Tfouni SAV, 2013, LWT-FOOD SCI TECHNOL, V50, P526, DOI 10.1016/j.lwt.2012.08.015
   Tom ENL, 2016, PHYTOMEDICINE, V23, P1037, DOI 10.1016/j.phymed.2016.06.012
   Toydemir G, 2021, FOOD CHEM, V341, DOI 10.1016/j.foodchem.2020.128261
   Tsirimiagkou C, 2021, CLIN NUTR ESPEN, V45, P363, DOI 10.1016/j.clnesp.2021.07.018
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Van Rymenant E, 2017, J NUTR BIOCHEM, V44, P44, DOI 10.1016/j.jnutbio.2017.02.018
   van Westing AC, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-1020-1
   Vieira MB, 2019, NEPHROL DIAL TRANSPL, V34, P974, DOI 10.1093/ndt/gfy234
   Vossoughinia H, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.15832
   Wan F, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.784211
   Wang L, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0043-0
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Ward NC, 2016, FOOD FUNCT, V7, P2197, DOI [10.1039/C6FO00248J, 10.1039/c6fo00248j]
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   Wei TY, 2019, TZU CHI MED J, V31, P169, DOI 10.4103/tcmj.tcmj_48_18
   WENDL B, 1994, ALIMENT PHARM THER, V8, P283
   Wijarnpreecha K, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12919
   Williamson G, 2020, FOOD FUNCT, V11, P4826, DOI [10.1039/d0fo01168a, 10.1039/D0FO01168A]
   Wolska J, 2017, BIOL TRACE ELEM RES, V179, P327, DOI 10.1007/s12011-017-0963-9
   Wu Y, 2018, INT J FOOD SCI NUTR, V69, P566, DOI 10.1080/09637486.2017.1394449
   Yan YW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01125
   Yao J, 2019, BIOFACTORS, V45, P616, DOI 10.1002/biof.1507
   Ye HY, 2016, ARCH PHARM RES, V39, P989, DOI 10.1007/s12272-016-0771-3
   Ye XL, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.762691
   Yeretzian C, 2012, FOOD CHEM, V131, P811, DOI 10.1016/j.foodchem.2011.09.048
   Yuan S, 2022, AM J KIDNEY DIS, V79, P9, DOI 10.1053/j.ajkd.2021.04.018
   Yunus J, 2020, Med J Malaysia, V75, P5
   Zhang Y, 2018, FOOD FUNCT, V9, P4968, DOI [10.1039/C8FO01126E, 10.1039/c8fo01126e]
   Zhong VW, 2019, HUM MOL GENET, V28, P2449, DOI 10.1093/hmg/ddz061
   Zimmermann-Viehoff F, 2016, NUTR NEUROSCI, V19, P169, DOI 10.1179/1476830515Y.0000000018
   Zuchinali P, 2016, JAMA INTERN MED, V176, P1752, DOI 10.1001/jamainternmed.2016.6374
   Zuchinali P, 2016, EUROPACE, V18, P257, DOI 10.1093/europace/euv261
NR 225
TC 7
Z9 7
U1 3
U2 30
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD JAN 13
PY 2024
VL 64
IS 2
BP 562
EP 583
DI 10.1080/10408398.2022.2106938
EA JUL 2022
PG 22
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA HA9T3
UT WOS:000836565700001
PM 35930394
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Fasihi, M
   Barzegar, A
   Sani, MA
AF Fasihi, Mehdi
   Barzegar, Ali
   Sani, Mahmood Alizadeh
TI The role of green coffee extract on weight loss, glucose an lipid
   metabolism
SO PROGRESS IN NUTRITION
LA English
DT Review
DE green coffee extract; chlorogenic acid; weight management; obesity
ID INDUCED INSULIN-RESISTANCE; CHLOROGENIC ACID; BEAN EXTRACT; WAIST
   CIRCUMFERENCE; CONSENSUS STATEMENT; BLOOD-PRESSURE; CAFFEIC ACID;
   BODY-MASS; IN-VITRO; OBESITY
AB The purpose of this paper was to perform a review about the role of green coffee extract on weight loss, glucose and lipid metabolism. It has been shown that overweight and obesity are important problems for health and the financial and psychological aspects have been imposed many damages to governments and health care providers. The management of overweight and obesity is related to lifestyle, physical activity, and diet. In the past decade, the studies have been published about the effects of green coffee extract on hypoglycemic, weight losing and hypotensive have been increasing. there are limited number of human studies in this area. However, the majority of interventional and epidemiological studies have been shown the beneficial effects of green coffee extract on weight and blood glucose management and metabolism of lipids. Green coffee extract reduces the fat reserves in adipocytes and regulate blood glucose by several mechanisms. Accordingly, green coffee extract supplementation may be effective in weight management, glucose and lipid metabolism.
C1 [Fasihi, Mehdi] Tabriz Univ Med Sci, Student Res Ctr, Nutr, Tabriz, Iran.
   [Barzegar, Ali] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Commun Nutr, Tabriz, Iran.
   [Sani, Mahmood Alizadeh] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Food Sci & Technol, Tabriz, Iran.
C3 Tabriz University of Medical Science; Tabriz University of Medical
   Science; Tabriz University of Medical Science
RP Barzegar, A (corresponding author), Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Commun Nutr, Tabriz, Iran.
EM ali-barzegar@hotmail.com
RI Sani, Mahmood/AAA-3349-2021
CR Almeida AAP, 2006, J AGR FOOD CHEM, V54, P8738, DOI 10.1021/jf0617317
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Beam JR, 2015, NUTRITION, V31, P292, DOI 10.1016/j.nut.2014.07.012
   BHUROSY T., 2014, The Scientific World Journal, V7
   Blum J, 2007, NUTRAFOODS, V6, P13
   Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002
   Clore JN, 2000, DIABETES, V49, P969, DOI 10.2337/diabetes.49.6.969
   dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   Dworzanski W, 2009, SIDE EFFECTS CAFFEIN
   Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775
   Farah A, 2007, 21 INT COFF SCI
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Frank J, 2003, J AGR FOOD CHEM, V51, P2526, DOI 10.1021/jf026127k
   Gault VA, 2003, NEUROPEPTIDES, V37, P253, DOI 10.1016/j.npep.2003.09.002
   Gómez-Ruiz JA, 2008, EUR FOOD RES TECHNOL, V227, P1017, DOI 10.1007/s00217-007-0815-5
   Haidari F, 2014, SAUDI MED J, V35, P967
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Holscher W., 1995, Developments in Food Science, V37, P785, DOI [DOI 10.1016/S0167-4501, 10.1016/S0167-4501(06)80196-2, DOI 10.1016/S0167-4501(06)80196-2]
   Horng T, 2011, NAT MED, V17, P164, DOI 10.1038/nm0211-164
   Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kim A, 2010, MOL NUTR FOOD RES, V54, P1361, DOI 10.1002/mnfr.200900317
   Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667
   Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009
   Lehnen AM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-67
   Lind L, 2016, ENVIRON HEALTH PERSP, V124, pA81, DOI 10.1289/ehp.1511115
   Ma CM, 2008, J MED CHEM, V51, P6188, DOI 10.1021/jm800621x
   MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155
   Manavski N, 2012, INT ARCH ALLERGY IMM, V159, P235, DOI 10.1159/000337461
   Matsui T, 2006, MINI-REV MED CHEM, V6, P349, DOI 10.2174/138955706776073484
   MCGUIRE MA, 1995, J DAIRY SCI, V78, P816, DOI 10.3168/jds.S0022-0302(95)76693-0
   McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8
   Mohammadshahi M, 2014, J NUTR METAB, V2014, P10
   Moon JK, 2009, J AGR FOOD CHEM, V57, P5365, DOI 10.1021/jf900012b
   Mooradian AD, 1999, DRUGS, V57, P19, DOI 10.2165/00003495-199957010-00003
   Murgia M, 2009, J PHYSIOL-LONDON, V587, P4319, DOI 10.1113/jphysiol.2009.174888
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Onakpoya I, 2010, GASTROENTEROL RES PR, V2011
   Onakpoya I, 2010, GASTROENTEROL RES PR, V6
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Prabhakar PK, 2009, PHYTOMEDICINE, V16, P1119, DOI 10.1016/j.phymed.2009.05.021
   Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rechner AR, 2001, FREE RADICAL BIO MED, V30, P1213, DOI 10.1016/S0891-5849(01)00506-8
   Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200
   Ruano M, 2005, OBES SURG, V15, P670, DOI 10.1381/0960892053923734
   Ryu S, 2001, J NUTR SCI VITAMINOL, V47, P139, DOI 10.3177/jnsv.47.139
   Saar I, 2011, NEUROCHEM INT, V58, P714, DOI 10.1016/j.neuint.2011.02.012
   Seta Y, 2006, ARCH HISTOL CYTOL, V69, P273, DOI 10.1679/aohc.69.273
   Simon C, 2000, ARCH BIOCHEM BIOPHYS, V373, P418, DOI 10.1006/abbi.1999.1560
   Song SJ, 2014, EVID BASED COMPLEMEN, V14
   Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971
   Suzuki A, 2006, FEBS LETT, V580, P2317, DOI 10.1016/j.febslet.2006.03.047
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62
   ZUSKIN E, 1985, BRIT J IND MED, V42, P415
NR 70
TC 2
Z9 2
U1 7
U2 102
PU MATTIOLI 1885
PI FIDENZA
PA VIA DELLA LODESANA 649-SX, FIDENZA, 43046 PR, ITALY
SN 1129-8723
J9 PROG NUTR
JI Prog. Nutr.
PD DEC
PY 2019
VL 21
SU 2
BP 14
EP 21
DI 10.23751/pn.v21i2-S.6260
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KG1ND
UT WOS:000509707300002
DA 2025-04-28
ER

PT J
AU McCarty, MF
AF McCarty, MF
TI A chlorogenic acid-induced increase in GLP-1 production may mediate the
   impact of heavy coffee consumption on diabetes risk
SO MEDICAL HYPOTHESES
LA English
DT Article
ID ALPHA-GLUCOSIDASE INHIBITORS; CAFFEINE-INDUCED IMPAIRMENT; MODERATE
   ALCOHOL INTAKE; INSULIN-PRODUCING CELLS; DIETARY GLYCEMIC INDEX;
   PANCREATIC BETA-CELLS; CANCER RISK; TRANSCRIPTION FACTOR; TOLERANCE;
   HUMANS
AB Recent prospective epidemiology links heavy coffee consumption to a substantial reduction in risk for type 2 diabetes. Yet there is no evidence that coffee improves insulin sensitivity and, at least in acute studies, caffeine has a negative impact in this regard. Thus, it is reasonable to suspect that coffee influences the risk for beta cell "failure" that precipitates diabetes in subjects who are already insulin resistant. Indeed, there is recent evidence that coffee increases production of the incretin hormone glucagon-like peptide-1 (GLP-1), possibly owing to an inhibitory effect of chlorogenic acid (CGA - the chief polyphenol in coffee) on glucose absorption. GLP-1 acts on beta cells, via cAMP-dependent mechanisms, to promote the synthesis and activity of the transcription factor IDX-1, crucial for maintaining the responsiveness of beta cells to an increase in plasma glucose. Conversely, the "glucolipotoxicity" thought to initiate and sustain beta cell dysfunction in diabetics can suppress expression of this transcription factor. The increased production of GLP-1 associated with frequent coffee consumption could thus be expected to counteract the adverse impact of chronic free fatty acid overexposure on beta cell function in overweight insulin resistant subjects. CGA's putative impact on glucose absorption may reflect the ability of this compound to inhibit glucose-6-phosphate translocase 1, now known to play a role in intestinal glucose transport. Delayed glucose absorption may itself protect beta cells by limiting postprandial hyperglycemia - though, owing to countervailing effects of caffeine on plasma glucose, and a paucity of relevant research studies, it is still unclear whether coffee ingestion blunts the postprandial rise in plasma glucose. More generally, diets high in "lente carbohydrate", or administration of nutraceuticals/ pharmaceuticals which stow the absorption of dietary carbohydrate, should help preserve efficient beta cell function by boosting GLP-1 production, as well as by blunting the glucotoxic impact of postprandial. hyperglycemia on beta cell function. (c) 2004 Elsevier Ltd. All rights reserved.
C1 NutriGuard Res, Encinitas, CA 92024 USA.
RP McCarty, MF (corresponding author), 4622 Santa Fe St, San Diego, CA 92109 USA.
EM mccarty@pantox.com
CR Abraham EJ, 2002, ENDOCRINOLOGY, V143, P3152, DOI 10.1210/en.143.8.3152
   Ahren Bo, 2003, Curr Diab Rep, V3, P365, DOI 10.1007/s11892-003-0079-9
   AMMON HPT, 1991, ARCH PHARM, V324, P261, DOI 10.1002/ardp.19913240502
   Augustin LSA, 2003, CANCER CAUSE CONTROL, V14, P657, DOI 10.1023/A:1025676907942
   Augustin LSA, 2003, ANN ONCOL, V14, P78, DOI 10.1093/annonc/dkg022
   Augustin LSA, 2001, ANN ONCOL, V12, P1533, DOI 10.1023/A:1013176129380
   Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5
   Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486
   Chu NV, 2002, DIABETES CARE, V25, P542, DOI 10.2337/diacare.25.3.542
   Cleophas TJ, 1999, BIOMED PHARMACOTHER, V53, P417, DOI 10.1016/S0753-3322(99)80121-8
   Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559
   Drucker DJ, 2003, DIABETES CARE, V26, P2929, DOI 10.2337/diacare.26.10.2929
   El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410
   Enç FY, 2001, AM J PHYSIOL-GASTR L, V281, pG752, DOI 10.1152/ajpgi.2001.281.3.G752
   FACCHINI F, 1994, DIABETES CARE, V17, P115, DOI 10.2337/diacare.17.2.115
   FEINBERG LJ, 1968, METABOLISM, V17, P916, DOI 10.1016/0026-0495(68)90158-3
   Folsom AR, 2003, NUTR CANCER, V46, P119, DOI 10.1207/S15327914NC4602_03
   Franceschi S, 2001, ANN ONCOL, V12, P173, DOI 10.1023/A:1008304128577
   Gault VA, 2003, BIOCHEM BIOPH RES CO, V308, P207, DOI 10.1016/S0006-291X(03)01361-5
   GOKE B, 1994, EUR J CLIN INVEST, V24, P25
   GOLDMAN JA, 1969, OBSTET GYNECOL, V33, P214
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261
   Habener JF, 2002, DRUG NEWS PERSPECT, V15, P491, DOI 10.1358/dnp.2002.15.8.740224
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Isogawa A, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12586-X
   JANKELSON OM, 1967, LANCET, V1, P527
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   KAWACHI I, 1994, BRIT HEART J, V72, P269
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Lapidot TM, 2002, J AGR FOOD CHEM, V50, P7220, DOI 10.1021/jf020615a
   Lebovitz HE, 1997, ENDOCRIN METAB CLIN, V26, P539, DOI 10.1016/S0889-8529(05)70266-8
   Lee SC, 2002, J AGR FOOD CHEM, V50, P6618, DOI 10.1021/jf020189t
   LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878
   MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434
   Michaud DS, 2002, J NATL CANCER I, V94, P1293, DOI 10.1093/jnci/94.17.1293
   Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547
   OLSON LK, 1995, P NATL ACAD SCI USA, V92, P9127, DOI 10.1073/pnas.92.20.9127
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Pizziol A, 1998, EUR J CLIN NUTR, V52, P846, DOI 10.1038/sj.ejcn.1600657
   Ranganath L, 1998, DIABETIC MED, V15, P120, DOI 10.1002/(SICI)1096-9136(199802)15:2<120::AID-DIA529>3.0.CO;2-I
   Roduit R, 2000, J BIOL CHEM, V275, P35799, DOI 10.1074/jbc.M006001200
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545
   Santer R, 2003, GASTROENTEROLOGY, V124, P34, DOI 10.1053/gast.2003.50009
   Scheen AJ, 2003, DRUGS, V63, P933, DOI 10.2165/00003495-200363100-00002
   Seifarth C, 1998, DIABETIC MED, V15, P485, DOI 10.1002/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y
   Seufert J, 1998, J CLIN INVEST, V101, P2528, DOI 10.1172/JCI2401
   Sierksma A, 2004, DIABETES CARE, V27, P184, DOI 10.2337/diacare.27.1.184
   Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741
   Stümpel F, 2001, P NATL ACAD SCI USA, V98, P11330, DOI 10.1073/pnas.211357698
   Thong FSL, 2002, J APPL PHYSIOL, V92, P2347, DOI 10.1152/japplphysiol.01229.2001
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   THORENS B, 1993, DIABETES, V42, P1219, DOI 10.2337/diabetes.42.9.1219
   TRUSWELL AS, 1992, EUR J CLIN NUTR S2, V46, P91
   UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van de Wiel A, 1998, NETH J MED, V52, P91, DOI 10.1016/S0300-2977(97)00087-9
   Vuksan V, 2000, DIABETES CARE, V23, P9, DOI 10.2337/diacare.23.1.9
   Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327
   Wang XL, 1999, ENDOCRINOLOGY, V140, P4904, DOI 10.1210/en.140.10.4904
   Wang XL, 2001, ENDOCRINOLOGY, V142, P1820, DOI 10.1210/en.142.5.1820
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Yoshida S, 2002, DIABETES, V51, P2505, DOI 10.2337/diabetes.51.8.2505
   Zangen DH, 1997, DIABETES, V46, P258, DOI 10.2337/diabetes.46.2.258
   Zhou J, 2002, J CELL PHYSIOL, V192, P304, DOI 10.1002/jcp.10143
NR 68
TC 136
Z9 151
U1 1
U2 35
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
J9 MED HYPOTHESES
JI Med. Hypotheses
PY 2005
VL 64
IS 4
BP 848
EP 853
DI 10.1016/j.mehy.2004.03.037
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 906SP
UT WOS:000227663500027
PM 15694706
DA 2025-04-28
ER

PT J
AU Xu, M
   Yang, LC
   Zhu, YP
   Liao, MF
   Chu, LL
   Li, X
   Lin, LZ
   Zheng, GD
AF Xu, Meng
   Yang, Licong
   Zhu, Yanping
   Liao, Mingfu
   Chu, Lulu
   Li, Xin
   Lin, Lezhen
   Zheng, Guodong
TI Collaborative effects of chlorogenic acid and caffeine on lipid
   metabolism via the AMPKα-LXRα/SREBP-1c pathway in high-fat
   diet-induced obese mice
SO FOOD & FUNCTION
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; EXPRESSION; AMPK; THERMOGENESIS; CHOLESTEROL;
   LIPOLYSIS; COFFEE
AB To investigate the mechanism of the combined effects of chlorogenic acid (CGA) and caffeine on lipid metabolism in high-fat diet-induced obese mice, eighty female ICR mice were randomly divided into eight groups and fed with a high-fat diet with/without CGA and/or caffeine for 14 weeks. The combination of CGA and caffeine effectively decreased body weight gain, intraperitoneal adipose tissue weight, serum LDL-c, FFA, TC, TG, leptin, IL-6 concentrations, and hepatic TG and TC levels and increased the serum adiponectin level. The CGA and caffeine combination also promoted the phosphorylation of AMPK alpha, inhibited the expressions of transcriptional regulators (SREBP-1c and LXR alpha), and decreased the expressions of FAS and HMGR. Besides, the expressions of ACO, ATGL and HSL were increased by the CGA and caffeine combinations. The results indicated that the combination of CGA and caffeine had anti-obesity effects and regulated lipid metabolism in high-fat diet-induced obese mice via the AMPK alpha-LXR alpha/SREBP-1c signaling pathway. Thus, chronic CGA and caffeine intakes may be potent for preventing obesity.
C1 [Xu, Meng; Yang, Licong; Zhu, Yanping; Chu, Lulu; Li, Xin; Lin, Lezhen; Zheng, Guodong] Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Sch Food Sci & Engn, Nanchang 330045, Jiangxi, Peoples R China.
   [Liao, Mingfu] Jiangxi Agr Univ, Sch Foreign Languages, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University; Jiangxi Agricultural University
RP Zheng, GD (corresponding author), Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Sch Food Sci & Engn, Nanchang 330045, Jiangxi, Peoples R China.
EM zrs150716@aliyun.com
OI Zheng, Guodong/0000-0002-9601-0056
FU National Natural Science Foundation of China [81760157]
FX This work was supported by the National Natural Science Foundation of
   China (81760157).
CR An S, 2010, J MED FOOD, V13, P406, DOI 10.1089/jmf.2009.1295
   [Anonymous], 2008, CAFFEINE HLTH CLARIF
   Bai QM, 2011, ATHEROSCLEROSIS, V214, P350, DOI 10.1016/j.atherosclerosis.2010.11.021
   Bjerregaard LG, 2018, NEW ENGL J MED, V378, P1302, DOI [10.1056/NEJMoa1713231, 10.1056/nejmoa1713231]
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901
   Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Doll S, 2002, INT J OBESITY, V26, P48, DOI 10.1038/sj.ijo.0801854
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Getz GS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113479
   Hall S, 2015, FOOD RES INT, V76, P626, DOI 10.1016/j.foodres.2015.07.027
   He F, 2018, CELL PHYSIOL BIOCHEM, V46, P2165, DOI 10.1159/000489546
   Huang WC, 2013, MOL NUTR FOOD RES, V57, P1803, DOI 10.1002/mnfr.201300001
   Ji LL, 2013, J NUTR BIOCHEM, V24, P1911, DOI 10.1016/j.jnutbio.2013.05.007
   Jiao Y, 2018, DIABETES, V67, P2227, DOI 10.2337/db18-0184
   Jin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120842
   Karbowska J, 2012, STEROIDS, V77, P1359, DOI 10.1016/j.steroids.2012.08.002
   Kim HY, 2015, MOLECULES, V20, P3107, DOI 10.3390/molecules20023107
   Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003
   Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798
   Latino-Martel P, 2016, CRIT REV ONCOL HEMAT, V99, P308, DOI 10.1016/j.critrevonc.2016.01.002
   Lee J, 2015, MOL CELL ENDOCRINOL, V414, P148, DOI 10.1016/j.mce.2015.07.031
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Liou CJ, 2018, CELL PHYSIOL BIOCHEM, V49, P1870, DOI 10.1159/000493650
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI [10.1039/C4FO00290C, 10.1039/c4fo00290c]
   Ma YJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1369, DOI 10.1152/ajpendo.90555.2008
   Niseteo T, 2012, FOOD CHEM, V134, P1870, DOI 10.1016/j.foodchem.2012.03.095
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   Saint-Laurent C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195876
   Seo YJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111802
   Stark R, 2013, MOL CELL ENDOCRINOL, V366, P215, DOI 10.1016/j.mce.2012.06.012
   Tanigaki K, 2018, J CLIN INVEST, V128, P309, DOI 10.1172/JCI89333
   Tsai KL, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700928
   Wu LY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00122
   Xiong D., 2015, BIOCH BIOPHYS ACTA M, V1851, P1521
   Yan Y, 2017, J NUTR BIOCHEM, V46, P68, DOI 10.1016/j.jnutbio.2017.04.007
   Yap F, 2011, INT J BIOL SCI, V7, P645, DOI 10.7150/ijbs.7.645
   ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543
   Zhao Y, 2017, EUR J NUTR, V56, P2309, DOI 10.1007/s00394-016-1271-4
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
NR 42
TC 40
Z9 42
U1 2
U2 70
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD NOV 1
PY 2019
VL 10
IS 11
BP 7489
EP 7497
DI 10.1039/c9fo00502a
PG 9
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA JO7NY
UT WOS:000497763600045
PM 31670366
DA 2025-04-28
ER

PT J
AU Tanaka, K
   Nishizono, S
   Tamaru, S
   Kondo, M
   Shimoda, H
   Tanaka, J
   Okada, T
AF Tanaka, Kazunari
   Nishizono, Shoko
   Tamaru, Shizuka
   Kondo, Mihoko
   Shimoda, Hiroshi
   Tanaka, Junji
   Okada, Tadashi
TI Anti-Obesity and Hypotriglyceridemic Properties of Coffee Bean Extract
   in SD Rats
SO FOOD SCIENCE AND TECHNOLOGY RESEARCH
LA English
DT Article
DE coffee bean extract; anti-obesity; hypotriglyceridemic activity;
   lipogenesis; lipolysis
ID FATTY-ACID SYNTHESIS; CHLOROGENIC ACID; GREEN TEA; LONG-TERM; CAFFEINE;
   TRIACYLGLYCEROL; CHOLESTEROL; ENZYMES; MICE; DIET
AB Coffee bean extract (CBE) was prepared from raw green coffee beans and contained 10.0% caffeine and 27.0% chlorogenic acid. Male Sprague-Dawley rats were fed a diet containing 1% CBE for 4 weeks. Although there was no difference in food intake between rats fed the control diet without CBE and those fed the CBE-containing diet, body weight gain and white adipose tissue weight were significantly decreased in CBE-fed rats than in control rats. The CBE-fed group exerted a significant and extreme reduction in serum and liver triglyceride concentrations compared to the control group. Also, in the CBE-fed group, activities of fatty acid synthetic enzymes in the hepatic cytosol were significantly decreased, while that of fatty acid oxidative enzymes in the hepatic mitochondria was significantly, increased. Our results suggest that CBE has potent anti-obesity and hypotriglyceridemic properties, and there is a possibility that these effects are exerted at least in part by the suppression of lipogenesis and the acceleration of lipolysis.
C1 [Tanaka, Kazunari; Nishizono, Shoko; Tamaru, Shizuka; Kondo, Mihoko] Nagasaki Univ, Grad Sch Human Hlth Sci, Nagoya, Nagasaki 8512195, Japan.
   [Nishizono, Shoko] Miyazaki Univ, Cooperat Res Ctr, Miyazaki 8892191, Japan.
   [Shimoda, Hiroshi; Tanaka, Junji; Okada, Tadashi] Oryza Oil & Fat Chem Co Ltd, Ctr Res & Dev, Ichinomiya, Aichi 4938001, Japan.
C3 Nagasaki University; University of Miyazaki
RP Tanaka, K (corresponding author), Nagasaki Univ, Grad Sch Human Hlth Sci, 1-1-1 Manabino, Nagoya, Nagasaki 8512195, Japan.
EM katanaka@sun.ac.jp
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500
   CARSON CA, 1994, INT J EPIDEMIOL, V24, P243
   CHEN MD, 1994, CHIN MED J, V53, P257
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   Han LK, 2001, INT J OBESITY, V25, P1459, DOI 10.1038/sj.ijo.0801747
   Hasegawa N, 2000, J HEALTH SCI, V46, P153
   Ikeda I, 2005, BIOSCI BIOTECH BIOCH, V69, P1049, DOI 10.1271/bbb.69.1049
   KELLEY DS, 1986, BIOCHEM J, V235, P87, DOI 10.1042/bj2350087
   KELLEY DS, 1984, BIOCHEM J, V217, P543, DOI 10.1042/bj2170543
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Li BH, 2006, IUBMB LIFE, V58, P39, DOI 10.1080/15216540500507408
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maki KC, 2002, AM J CLIN NUTR, V76, P1230, DOI 10.1093/ajcn/76.6.1230
   MARKWELL MA, 1973, J BIOL CHEM, V248, P3426
   Michna L, 2003, LIFE SCI, V73, P1383, DOI 10.1016/S0024-3205(03)00468-5
   Nosaka Naohisa, 2003, J Atheroscler Thromb, V10, P290
   OCHOA S, 1955, METHOD ENZYMOL, V1, P739, DOI 10.1016/0076-6879(55)01129-4
   Post SM, 2000, ARTERIOSCL THROM VAS, V20, P1551, DOI 10.1161/01.ATV.20.6.1551
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129
   SPERRY WM, 1950, J BIOL CHEM, V187, P97
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Urgert R, 1997, ANNU REV NUTR, V17, P305, DOI 10.1146/annurev.nutr.17.1.305
   WALTON PA, 1985, ANAL BIOCHEM, V151, P479, DOI 10.1016/0003-2697(85)90208-8
   Zheng GD, 2004, IN VIVO, V18, P55
NR 31
TC 28
Z9 29
U1 0
U2 18
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1344-6606
J9 FOOD SCI TECHNOL RES
JI Food Sci. Technol. Res.
PD MAR
PY 2009
VL 15
IS 2
BP 147
EP 152
DI 10.3136/fstr.15.147
PG 6
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 435MK
UT WOS:000265347800007
OA Bronze
DA 2025-04-28
ER

PT J
AU Yamagata, K
AF Yamagata, Kazuo
TI Do Coffee Polyphenols Have a Preventive Action on Metabolic Syndrome
   Associated Endothelial Dysfunctions? An Assessment of the Current
   Evidence
SO ANTIOXIDANTS
LA English
DT Review
DE antioxidative effects; chlorogenic acid; endothelial dysfunction;
   metabolic syndrome
ID NONALCOHOLIC FATTY LIVER; DOSE-RESPONSE METAANALYSIS; OXIDATIVE STRESS;
   CHLOROGENIC ACID; TEA CONSUMPTION; CARDIOVASCULAR-DISEASE; RISK-FACTORS;
   DECAFFEINATED COFFEE; INSULIN-RESISTANCE; VASCULAR-DISEASE
AB Epidemiologic studies from several countries have found that mortality rates associated with the metabolic syndrome are inversely associated with coffee consumption. Metabolic syndrome can lead to arteriosclerosis by endothelial dysfunction, and increases the risk for myocardial and cerebral infarction. Accordingly, it is important to understand the possible protective effects of coffee against components of the metabolic syndrome, including vascular endothelial function impairment, obesity and diabetes. Coffee contains many components, including caffeine, chlorogenic acid, diterpenes and trigonelline. Studies have found that coffee polyphenols, such as chlorogenic acids, have many health-promoting properties, such as antioxidant, anti-inflammatory, anti-cancer, anti-diabetes, and antihypertensive properties. Chlorogenic acids may exert protective effects against metabolic syndrome risk through their antioxidant properties, in particular toward vascular endothelial cells, in which nitric oxide production may be enhanced, by promoting endothelial nitric oxide synthase expression. These effects indicate that coffee components may support the maintenance of normal endothelial function and play an important role in the prevention of metabolic syndrome. However, results related to coffee consumption and the metabolic syndrome are heterogeneous among studies, and the mechanisms of its functions and corresponding molecular targets remain largely elusive. This review describes the results of studies exploring the putative effects of coffee components, especially in protecting vascular endothelial function and preventing metabolic syndrome.
C1 [Yamagata, Kazuo] Nihon Univ, Coll Bioresource Sci NUBS, Dept Food Biosci & Biotechnol, Lab Mol Hlth Sci Food, 1866 Kameino, Fujisawa, Kanagawa 2528510, Japan.
C3 Nihon University
RP Yamagata, K (corresponding author), Nihon Univ, Coll Bioresource Sci NUBS, Dept Food Biosci & Biotechnol, Lab Mol Hlth Sci Food, 1866 Kameino, Fujisawa, Kanagawa 2528510, Japan.
EM kyamagat@brs.nihon-u.ac.jp
FU Grants-in-Aid for Scientific Research [15K08321] Funding Source: KAKEN
CR Akerele OA, 2015, MED HYPOTHESES, V85, P754, DOI 10.1016/j.mehy.2015.10.013
   Andreasen MF, 2001, J AGR FOOD CHEM, V49, P4090, DOI 10.1021/jf0101758
   Andriantsitohaina R, 2012, BRIT J NUTR, V108, P1532, DOI 10.1017/S0007114512003406
   Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/c7fo00388a, 10.1039/C7FO00388A]
   Bekedam EK, 2008, J AGR FOOD CHEM, V56, P7138, DOI 10.1021/jf800999a
   Bloomer RJ, 2013, NUTR METAB INSIGHTS, V6, P35, DOI 10.4137/NMI.S12215
   Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006
   Brezová V, 2009, FOOD CHEM, V114, P859, DOI 10.1016/j.foodchem.2008.10.025
   Caprioli G, 2015, INT J FOOD SCI NUTR, V66, P505, DOI 10.3109/09637486.2015.1064871
   Chang CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038874
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013
   Davinelli S, 2016, HIGH BLOOD PRESS CAR, V23, P197, DOI 10.1007/s40292-016-0149-0
   Di Lorenzo A, 2017, CURR PHARM DESIGN, V23, P2474, DOI 10.2174/1381612823666170215145855
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dos Santos Poliana Rodrigues, 2015, Clin Nutr Res, V4, P41, DOI 10.7762/cnr.2015.4.1.41
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Edeas M, 2010, PATHOL BIOL, V58, P220, DOI 10.1016/j.patbio.2009.09.011
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j
   Fuster JJ, 2016, CIRC RES, V118, P1786, DOI 10.1161/CIRCRESAHA.115.306885
   García-Vilas JA, 2017, FOOD CHEM, V221, P1741, DOI 10.1016/j.foodchem.2016.10.111
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Goh GBB, 2014, HEPATOLOGY, V60, P661, DOI 10.1002/hep.27054
   Grassi D, 2011, CURR PHARM BIOTECHNO, V12, P1343, DOI 10.2174/138920111798281018
   Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494
   Grosso G, 2016, EUR J CLIN NUTR, V70, P109, DOI 10.1038/ejcn.2015.119
   Grosso G, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080890
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hodge A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010056
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hu G, 2007, AM J CLIN NUTR, V86, P457, DOI 10.1093/ajcn/86.2.457
   Huang WY, 2017, J FOOD SCI, V82, P1239, DOI 10.1111/1750-3841.13706
   InterAct Consortium, 2016, DIABETOLOGIA, V59, P2613, DOI 10.1007/s00125-016-4090-5
   Jiang RJ, 2016, J NUTR BIOCHEM, V27, P53, DOI 10.1016/j.jnutbio.2015.08.017
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jung HJ, 2017, BMB REP, V50, P323, DOI 10.5483/BMBRep.2017.50.6.182
   Kajikawa M, 2019, EUR J NUTR, V58, P989, DOI 10.1007/s00394-018-1611-7
   Katz DL, 2011, ANTIOXID REDOX SIGN, V15, P2779, DOI 10.1089/ars.2010.3697
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167007
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Kougias P, 2005, J SURG RES, V126, P121, DOI 10.1016/j.jss.2004.12.023
   Kumar SS, 2001, INT J RADIAT BIOL, V77, P617, DOI 10.1080/09553000110034649
   Kwok MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep36500
   Landberg R, 2012, CURR OPIN LIPIDOL, V23, P147, DOI 10.1097/MOL.0b013e328351123a
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   Lee C, 2000, CLIN CHIM ACTA, V295, P141, DOI 10.1016/S0009-8981(00)00201-1
   Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x
   Low WY, 2015, INT J OCCUP MED ENV, V28, P20, DOI 10.2478/s13382-014-0326-0
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Martini D, 2016, MOLECULES, V21, DOI 10.3390/molecules21080979
   Maruyama K, 2009, J STROKE CEREBROVASC, V18, P173, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.008
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P358, DOI 10.1080/09637486.2017.1362690
   Miller PE, 2017, AM J MED, V130, P188, DOI 10.1016/j.amjmed.2016.08.038
   Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Oboh Ganiyu, 2015, Journal of Basic and Clinical Physiology and Pharmacology, V26, P165, DOI 10.1515/jbcpp-2013-0141
   Ochiai R, 2015, INT J FOOD SCI NUTR, V66, P350, DOI 10.3109/09637486.2015.1007453
   Ono M, 2010, CLIN J GASTROENTEROL, V3, P263, DOI 10.1007/s12328-010-0182-9
   Opitz SEW, 2014, FOODS, V3, P586, DOI 10.3390/foods3040586
   Palatini P, 2009, J HYPERTENS, V27, P1594, DOI 10.1097/HJH.0b013e32832ba850
   Paoletti R, 2006, VASC HEALTH RISK MAN, V2, P145, DOI 10.2147/vhrm.2006.2.2.145
   Patel YR, 2017, CLIN NUTR ESPEN, V17, P18, DOI 10.1016/j.clnesp.2016.12.003
   León-Carmona JR, 2011, J PHYS CHEM B, V115, P4538, DOI 10.1021/jp201383y
   Reis JP, 2010, ARTERIOSCL THROM VAS, V30, P2059, DOI 10.1161/ATVBAHA.110.208280
   Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Serafini M, 2009, CLIN DERMATOL, V27, P225, DOI 10.1016/j.clindermatol.2008.04.007
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Sjöholm Å, 2005, LANCET, V365, P610, DOI 10.1016/S0140-6736(05)70804-7
   Stalmach Angélique, 2006, Braz. J. Plant Physiol., V18, P253, DOI 10.1590/S1677-04202006000100018
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Suliga E, 2017, INT J FOOD SCI NUTR, V68, P507, DOI 10.1080/09637486.2016.1256381
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Uemura H, 2013, EUR J CLIN NUTR, V67, P1109, DOI 10.1038/ejcn.2013.132
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x
   Vykoukal D, 2012, VASCULAR, V20, P156, DOI 10.1258/vasc.2011.201201
   Walton HB, 2013, SCOT MED J, V58, P217, DOI 10.1177/0036933013507869
   Wang TG, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0862-0
   Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006
   Yen AMF, 2006, AM J CLIN NUTR, V83, P1153, DOI 10.1093/ajcn/83.5.1153
   Yen GC, 1999, J AGR FOOD CHEM, V47, P1326, DOI 10.1021/jf9810618
   Yesil A, 2013, ALIMENT PHARM THER, V38, P1038, DOI 10.1111/apt.12489
   Yki-Järvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4
   Zelber-Sagi S, 2015, TRANSL RES, V165, P428, DOI 10.1016/j.trsl.2014.10.008
   Zhao YG, 2011, ADV DIFFER EQU-NY, DOI 10.1186/1687-1847-2011-10
NR 100
TC 51
Z9 53
U1 1
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD FEB
PY 2018
VL 7
IS 2
AR 26
DI 10.3390/antiox7020026
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA FZ3QR
UT WOS:000427505500005
PM 29401716
OA Green Submitted, Green Published, gold
DA 2025-04-28
ER

PT J
AU Verma, N
   Mittal, M
   Mahdi, AA
   Awasthi, V
   Kumar, P
   Goel, A
   Banik, SP
   Chakraborty, S
   Rungta, M
   Bagchi, M
   Bagchi, D
AF Verma, Narsingh
   Mittal, Madhukar
   Mahdi, Abbas Ali
   Awasthi, Vandana
   Kumar, Pawan
   Goel, Apurva
   Banik, Samudra P.
   Chakraborty, Sanjoy
   Rungta, Mehul
   Bagchi, Manashi
   Bagchi, Debasis
TI Clinical Evaluation of a Novel, Patented Green Coffee Bean Extract
   (GCB70®), Enriched in 70% Chlorogenic Acid, in Overweight Individuals
SO JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION
LA English
DT Article
DE Green coffee bean extract (GCB70); t-chlorogenic acid; 3-caffeoylquinic
   acid (CQA); body weight; BMI; plasma leptin; fasting glucose; HbA1c;
   total blood chemistry; adverse events
ID METABOLIC SYNDROME; PROTEIN-KINASE; CONSUMPTION; OBESITY
AB Objective: Obesity and overweight are challenging health problems of the millennium that lead to diabetes, hypertension, dyslipidemia, nonalcoholic fatty liver disease (NAFLD), and atherosclerosis. Green coffee bean exhibited significant promise in healthy weight management, potentiating glucose-insulin sensitization and supporting liver health. The safety and efficacy of a novel, patented water-soluble green coffee bean extract (GCB70 (R) enriched in 70% total chlorogenic acid and <1% caffeine) was investigated in 105 participants for 12 consecutive weeks. An institutional review board and Drugs Controller General (India) (DCGI) approvals were obtained, and the study was registered at ClinicalTrials.gov.Method: Body weight, body mass index (BMI), waist circumference, lipid profile, plasma leptin, glycosylated hemoglobin (HbA1c), and total blood chemistry were assessed over a period of 12 weeks of treatment. Safety was affirmed.ResultsGCB70 (500 mg BID) supplementation significantly reduced body weight (approximately 6%; p = 0.000**) in approximately 97% of the study population. About a 5.65% statistically significant reduction (p = 0.000**) in BMI was observed in 96% of the study volunteers. Waist circumference was significantly reduced by 6.77% and 6.62% in 98% of the male and female participants, respectively. Plasma leptin levels decreased by 13.6% in 99% of the study population as compared to the baseline value. Upon completion of 12 weeks' treatment, fasting glucose levels decreased by 13.05% (p = 0.000**) in 79% of the study population. There was a statistically significant decrease in HbA1c levels in both male and female participants (p = 0.000**), while 86.7% of the study participants showed a statistically significant decrease in thyroid-stimulating hormone (TSH) levels (p = 0.000**). The mean decrease in TSH levels on completion of the treatment was 14.07% in the study population as compared to baseline levels. Total blood chemistry analysis exhibited broad-spectrum safety.Conclusions: This investigation demonstrated that GCB70 is safe and efficacious in healthy weight management.
C1 [Verma, Narsingh; Awasthi, Vandana] King Georges Med Univ KGMU, Dept Physiol, Lucknow, India.
   [Verma, Narsingh; Awasthi, Vandana] King Georges Med Univ KGMU, Dept Transfus Med, Lucknow, India.
   [Mittal, Madhukar; Mahdi, Abbas Ali] King Georges Med Univ KGMU, Dept Endocrinol, Lucknow, India.
   King Georges Med Univ, Dept Biochem, Lucknow, India.
   [Kumar, Pawan; Rungta, Mehul] Chem Resources CHERESO, R&D Dept, Panchkula, Haryana, India.
   [Goel, Apurva] Chem Resources CHERESO, Regulatory Dept, Panchkula, Haryana, India.
   [Banik, Samudra P.] Maulana Azad Coll, Dept Microbiol, Kolkata, India.
   [Chakraborty, Sanjoy] CUNY Brooklyn, New York City Coll Technol, Dept Biol Sci, Brooklyn, NY USA.
   [Bagchi, Manashi] Dr Herbs LLC, Dept R&D, Concord, CA USA.
   [Bagchi, Debasis] Adelphi Univ, Coll Arts & Sci, Dept Biol, Garden City, NY 11530 USA.
   [Bagchi, Debasis] Adelphi Univ, Gordon F Derner Sch Psychol, Dept Psychol, Garden City, NY USA.
   [Bagchi, Debasis] Texas Southern Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Houston, TX USA.
C3 King George's Medical University; King George's Medical University; King
   George's Medical University; King George's Medical University; City
   University of New York (CUNY) System; Brooklyn College (CUNY); Adelphi
   University; Adelphi University; Texas Southern University
RP Bagchi, D (corresponding author), Adelphi Univ, Coll Arts & Sci, Dept Biol, Garden City, NY 11530 USA.
EM dbagchi@adelphi.edu
RI Banik, Samudra Prosad/JQJ-4870-2023; verma, nipun/GLN-5512-2022; Mahdi,
   Abbas/AAB-2293-2021; Mittal, Madhukar/P-8946-2017
OI verma, Narsingh/0000-0003-0348-7419; Mittal,
   Madhukar/0000-0002-6919-5614
FU Chemical Resources, Panchkula, Haryana, India
FX Partially funded by Chemical Resources, Panchkula, Haryana, India.
CR Abdel-Mohsen DM, 2023, J FOOD BIOCHEM, V2023, DOI 10.1155/2023/1500032
   AL-Megrin WA, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/6762709
   Artusa V, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.806010
   Awwad S, 2021, MOLECULES, V26, DOI 10.3390/molecules26247502
   Boccellino M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165642
   Boccellino M, 2019, EUR J MED CHEM, V180, P637, DOI 10.1016/j.ejmech.2019.07.033
   Cabral JP, 2022, CUREUS J MED SCIENCE, V14, DOI 10.7759/cureus.21045
   Chang YC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060817
   Chen H, 2020, COMPLEMENT THER MED, V52, DOI 10.1016/j.ctim.2020.102498
   Chen Y, 2020, PHYTOTHER RES, V34, P2159, DOI 10.1002/ptr.6667
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Cory H, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00087
   Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484
   Dubey P, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061864
   Dziki D, 2015, LWT-FOOD SCI TECHNOL, V63, P691, DOI 10.1016/j.lwt.2015.03.076
   Feldman F, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020672
   Flier JS, 2000, J CLIN INVEST, V105, P859, DOI 10.1172/JCI9725
   Gawlik-Dziki U, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8070228
   Han X, 2019, J FOOD SCI, V84, P3815, DOI 10.1111/1750-3841.14838
   Ilias I, 2022, MEDICINA-LITHUANIA, V58, DOI 10.3390/medicina58030430
   Ilmiawati C, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05052-y
   Kim KH, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12051048
   Konstantinidis N, 2023, MOLECULES, V28, DOI 10.3390/molecules28083460
   Kukuminato S, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/spectrum.01142-21
   Lee IC, 2019, IRAN J PUBLIC HEALTH, V48, P2025
   Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200
   Li Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23123164
   Liang YD, 2023, BIOCHIMIE, V206, P93, DOI 10.1016/j.biochi.2022.10.009
   Lobstein T, 2023, World Obesity Atlas 2023
   Masek A, 2020, FORESTS, V11, DOI 10.3390/f11050557
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Mehaya FM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05508
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Miranda AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165791
   Müller TD, 2022, NAT REV DRUG DISCOV, V21, P201, DOI 10.1038/s41573-021-00337-8
   Murray A., 2023, StatPearls
   Nikpayam O, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0489-8
   Persad LAB, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00116
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Sák M, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10030490
   Seliem EM, 2022, LIFE-BASEL, V12, DOI 10.3390/life12050693
   Sharma L, 2018, FOOD CHEM TOXICOL, V121, P283, DOI 10.1016/j.fct.2018.09.011
   SONG SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/718379
   Sudeep HV, 2021, SAGE OPEN MED, V9, DOI 10.1177/20503121211002590
   Szaefer H, 2007, TOXICOLOGY, V230, P1, DOI 10.1016/j.tox.2006.10.001
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tak YJ, 2021, WORLD J MENS HEALTH, V39, P208, DOI 10.5534/wjmh.200010
   Torequl Islam Muhammad, 2022, Evid Based Complement Alternat Med, V2022, P4787643, DOI 10.1155/2022/4787643
   Velluzzi F, 2022, J CLIN MED, V11, DOI 10.3390/jcm11175125
   Wang L, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.943911
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Williamson G, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103135
   Willson C, 2018, TOXICOL REP, V5, P1140, DOI 10.1016/j.toxrep.2018.11.002
   Xu HY, 2019, NEUROPSYCH DIS TREAT, V15, P2087, DOI 10.2147/NDT.S208061
   Yahfoufi N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111618
   Yesil A, 2013, ALIMENT PHARM THER, V38, P1038, DOI 10.1111/apt.12489
   Zhong YC, 2020, CURR PHARM BIOTECHNO, V21, P1099, DOI 10.2174/1389201021666200318124922
NR 57
TC 6
Z9 6
U1 0
U2 5
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2769-7061
EI 2769-707X
J9 J AM NUTR ASSOC
JI J. Am. Nutr. Assoc.
PD MAY 18
PY 2024
VL 43
IS 4
BP 315
EP 325
DI 10.1080/27697061.2023.2284994
EA DEC 2023
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA OK6O4
UT WOS:001143959200001
PM 38227783
DA 2025-04-28
ER

PT J
AU Watanabe, S
   Takahashi, T
   Ogawa, H
   Uehara, H
   Tsunematsu, T
   Baba, H
   Morimoto, Y
   Tsuneyama, K
AF Watanabe, Syunsuke
   Takahashi, Tetsuyuki
   Ogawa, Hirohisa
   Uehara, Hisanori
   Tsunematsu, Takaaki
   Baba, Hayato
   Morimoto, Yuki
   Tsuneyama, Koichi
TI Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and
   Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic
   Syndrome, Tsumura-Suzuki Obese Diabetic Mice
SO METABOLIC SYNDROME AND RELATED DISORDERS
LA English
DT Article
DE coffee intake; nonalcoholic steatohepatitis; beta cell failure; animal
   model; hepatocellular carcinoma
ID FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; CAFFEINE CONSUMPTION;
   CHLOROGENIC ACID; RAT MODEL; FIBROSIS; RISK; INFLAMMATION; DRINKING;
   FEATURES
AB Background: Metabolic syndrome is one of the most important health issues worldwide. Obesity causes insulin resistance, hyperlipidemia, diabetes, and various diseases throughout the body. The liver phenotype, which is called nonalcoholic steatohepatitis (NASH), frequently progresses to hepatocellular carcinoma. We recently established a new animal model, Tsumura-Suzuki obese diabetic (TSOD) mice, which spontaneously exhibit obesity, diabetes, hyperlipidemia, and NASH with liver nodules.
   Methods: We examined the effects of coffee intake on various conditions of the metabolic syndrome using TSOD mice. The daily volume of coffee administered was limited so that it reflected the appropriate quantities consumed in humans. To clarify the effects of the specific components, animals were divided into two coffee-intake groups that included with and without caffeine.
   Results: Coffee intake did not significantly affect obesity and hyperlipidemia in TSOD mice. In contrast, coffee intake caused various degrees of improvement in the pancreatic beta cell damage and steatohepatitis with liver carcinogenesis. Most of the effects were believed to be caused by a synergistic effect of caffeine with other components such as polyphenols. However, the antifibrotic effects of coffee appeared to be due to the polyphenols rather than the caffeine.
   Conclusions: A daily habit of drinking coffee could possibly play a role in the prevention of metabolic syndrome.
C1 [Watanabe, Syunsuke; Ogawa, Hirohisa; Uehara, Hisanori; Tsunematsu, Takaaki; Baba, Hayato; Morimoto, Yuki; Tsuneyama, Koichi] Univ Tokushima, Grad Sch, Dept Pathol & Lab Med, Inst Biomed Sci, 3-18-15 Kuramoto, Tokushima, Tokushima 7708503, Japan.
   [Takahashi, Tetsuyuki] Musashino Univ, Dept Anat & Cell Biol, Fac Pharm, Pharmaceut Sci Res Inst, Nishitokyo, Japan.
C3 Tokushima University
RP Tsuneyama, K (corresponding author), Univ Tokushima, Grad Sch, Dept Pathol & Lab Med, Inst Biomed Sci, 3-18-15 Kuramoto, Tokushima, Tokushima 7708503, Japan.
EM tsuneyama.koichi@tokushima-u.ac.jp
OI Tsuneyama, Koichi/0000-0002-0670-9868; Tsunematsu,
   Takaaki/0000-0003-1043-2790
FU JSPS KAKENHI [24390181, 25340121, 15K15098]; All Japan Coffee
   Association; Grants-in-Aid for Scientific Research [15K15098, 24390181]
   Funding Source: KAKEN
FX Part of this article was presented at the 24th conference of the APASL,
   2015, Turkey. This work was supported by JSPS KAKENHI Grant-in-Aid for
   Scientific Research (B) number 24390181, (C) number 25340121, and
   Grant-in-Aid for challenging Exploratory Research number 15K15098 and a
   2012 research grant from the All Japan Coffee Association.
CR Abrahao SA, 2013, PLANT FOOD HUM NUTR, V68, P184, DOI 10.1007/s11130-013-0355-z
   Akase T, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep052
   Anty R, 2012, J HEPATOL, V57, P1090, DOI 10.1016/j.jhep.2012.07.014
   Arauz J, 2014, EUR J GASTROEN HEPAT, V26, P164, DOI 10.1097/MEG.0b013e3283644e26
   Arauz J, 2013, J APPL TOXICOL, V33, P970, DOI 10.1002/jat.2788
   Attar BM, 2013, SCI WORLD J, DOI 10.1155/2013/481893
   Bioulac-Sage P, 2011, SEMIN LIVER DIS, V31, P91, DOI 10.1055/s-0031-1272837
   Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006
   Bravi F, 2007, HEPATOLOGY, V46, P430, DOI 10.1002/hep.21708
   Bravi F, 2013, CLIN GASTROENTEROL H, V11, P1413, DOI 10.1016/j.cgh.2013.04.039
   Canale MP, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/865965
   Dal Bello B, 2010, CLIN CANCER RES, V16, P2157, DOI 10.1158/1078-0432.CCR-09-1978
   Freedman ND, 2011, GASTROENTEROLOGY, V140, P1961, DOI 10.1053/j.gastro.2011.02.061
   Fujimoto M, 2008, EXP BIOL MED, V233, P328, DOI 10.3181/0707-RM-207
   Fujimoto M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/892697
   Fujimoto M, 2012, DIGEST LIVER DIS, V44, P767, DOI 10.1016/j.dld.2012.02.002
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Furtado KS, 2014, FOOD CHEM TOXICOL, V64, P20, DOI 10.1016/j.fct.2013.11.011
   Furtado KS, 2012, BASIC CLIN PHARMACOL, V111, P339, DOI 10.1111/j.1742-7843.2012.00903.x
   Gelatti U, 2005, J HEPATOL, V42, P528, DOI 10.1016/j.jhep.2004.11.039
   Hirayama I, 1999, DIABETES, V48, P1183, DOI 10.2337/diabetes.48.5.1183
   Ichimura M, 2013, NUTR RES, V33, P397, DOI 10.1016/j.nutres.2013.03.006
   Iizuka S, 2005, EXP ANIM TOKYO, V54, P71, DOI 10.1538/expanim.54.71
   Jang ES, 2013, LIVER INT, V33, P1092, DOI 10.1111/liv.12186
   Johnson S, 2011, CANCER CAUSE CONTROL, V22, P503, DOI 10.1007/s10552-010-9725-0
   Kato S, 2008, HEPATOL RES, V38, P743, DOI 10.1111/j.1872-034X.2008.00342.x
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kurozawa Y, 2005, BRIT J CANCER, V93, P607, DOI 10.1038/sj.bjc.6602737
   Machado SR, 2014, BRAZ J INFECT DIS, V18, P170, DOI 10.1016/j.bjid.2013.09.001
   Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Nakanishi Y, 2008, J AUTOIMMUN, V30, P42, DOI 10.1016/j.jaut.2007.11.016
   Nishida T, 2013, LAB INVEST, V93, P230, DOI 10.1038/labinvest.2012.155
   Ohfuji S, 2006, HEPATOL RES, V36, P201, DOI 10.1016/j.hepres.2006.07.010
   Omagari K, 2010, PATHOLOGY, V42, P66, DOI 10.3109/00313020903434389
   Ong A, 2011, LIVER INT, V31, P1047, DOI 10.1111/j.1478-3231.2011.02555.x
   Pappachan JM, 2014, ENDOCRINE, V45, P344, DOI 10.1007/s12020-013-0087-8
   Rahimi RS, 2013, NUTR CLIN PRACT, V28, P40, DOI 10.1177/0884533612470464
   Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Shi HY, 2009, EUR J PHARMACOL, V623, P119, DOI 10.1016/j.ejphar.2009.09.026
   Shim SG, 2013, J GASTROEN HEPATOL, V28, P1877, DOI 10.1111/jgh.12317
   Suzuki W, 1999, EXP ANIM TOKYO, V48, P181, DOI 10.1538/expanim.48.181
   Takayanagi K, 2011, J AGR FOOD CHEM, V59, P12342, DOI 10.1021/jf202821u
   Targher G, 2013, SEMIN THROMB HEMOST, V39, P214, DOI 10.1055/s-0033-1334866
   Tsuneyama K, 2013, CLIN REV ALLERG IMMU, V45, P143, DOI 10.1007/s12016-013-8383-x
   Tsuneyama K, 2011, THESCIENTIFICWORLDJO, V11, P2124, DOI 10.1100/2011/380236
   Vonghia L, 2013, INT J MOL SCI, V14, P19867, DOI 10.3390/ijms141019867
   Wong TCL, 2013, DIGEST DIS, V31, P130, DOI 10.1159/000347208
   Yesil A, 2013, ALIMENT PHARM THER, V38, P1038, DOI 10.1111/apt.12489
   Younossi ZM, 2014, ALIMENT PHARM THER, V39, P3, DOI 10.1111/apt.12543
   Yu J, 2013, SEMIN CANCER BIOL, V23, P483, DOI 10.1016/j.semcancer.2013.07.003
NR 52
TC 22
Z9 22
U1 0
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1540-4196
EI 1557-8518
J9 METAB SYNDR RELAT D
JI Metab. Syndr. Relat. Disord.
PD MAY
PY 2017
VL 15
IS 4
BP 170
EP 177
DI 10.1089/met.2016.0114
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA ET2MG
UT WOS:000400106700002
PM 28358620
DA 2025-04-28
ER

PT J
AU Fernández-Cardero, A
   Sierra-Cinos, JL
   Bravo, L
   Sarriá, B
AF Fernandez-Cardero, Alvaro
   Sierra-Cinos, Jose Luis
   Bravo, Laura
   Sarria, Beatriz
TI Consumption of a Coffee Rich in Phenolic Compounds May Improve the Body
   Composition of People with Overweight or Obesity: Preliminary Insights
   from a Randomized, Controlled and Blind Crossover Study
SO NUTRIENTS
LA English
DT Article
DE coffee; polyphenols; chlorogenic acid; caffeine; obesity; overweight;
   metabolic syndrome; body composition
ID RESPONSE METAANALYSIS; METABOLIC SYNDROME; DEFINITION; RISK
AB This study analyzes the effects on body composition and variables related to metabolic syndrome of two coffees with different degree of roasting and phenolic content. Sixty participants with body mass index between 25 and 35 kg/m(2) and a median age of 51.0 years (Interquartile range 46.3-56) were recruited. The study was a controlled, randomized, single-blind crossover trial consisting in drinking three cups/day of roasted coffee (RC) or lightly roasted coffee (LRC) during 12 weeks with 2-week wash-out stages before each coffee intervention. LRC contained approximate to 400 mg of hydroxycinnamic acids and approximate to 130 mg of caffeine per 200 mL/cup while RC contained approximate to 150 mg of hydroxycinnamic acids and approximate to 70 mg of caffeine per 200 mL/cup. Along the study, in each of the six visits, blood pressure, body composition by bioimpedance, anthropometric measurements, and blood biochemistry were analyzed. The mean differences and p values were calculated using a linear mixed model (JASP.v.0.18.0.3). A total of 38 participants completed the study. After the consumption of both coffees, fat mass and body fat percentage (LRC: -1.4%, p < 0.001; RC: -1.0%, p = 0.005) were reduced, whereas muscle mass and muscle mass percentage slightly increased (LRC: 0.8%, p < 0.001; RC: 0.7%, p = 0.002). The decrease in fat percentage was greater with LRC compared to RC (-0.8%; p = 0.029). There were no significant changes in metabolic syndrome variables or in body weight. In conclusion, LRC was slightly superior at inducing changes in body composition.
C1 [Fernandez-Cardero, Alvaro; Bravo, Laura; Sarria, Beatriz] CSIC, Inst Food Sci Technol & Nutr ICTAN, Dept Metab & Nutr, C Jose Antonio Novais 6, Madrid 28040, Spain.
   [Sierra-Cinos, Jose Luis] Univ Int Isabel I Burgos Ui1, Sch Hlth Sci, Dept Hlth Sci, C de Fernan Gonzalez 76, Burgos 09003, Spain.
   [Sierra-Cinos, Jose Luis; Sarria, Beatriz] Univ Complutense Madrid, Sch Pharm, Dept Nutr & Food Sci 1, Ciudad Univ S-N, Madrid 28040, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Complutense
   University of Madrid
RP Sarriá, B (corresponding author), CSIC, Inst Food Sci Technol & Nutr ICTAN, Dept Metab & Nutr, C Jose Antonio Novais 6, Madrid 28040, Spain.; Sarriá, B (corresponding author), Univ Complutense Madrid, Sch Pharm, Dept Nutr & Food Sci 1, Ciudad Univ S-N, Madrid 28040, Spain.
EM alvafe22@ucm.es; joseluis.sierra@ui1.es; lbravo@ictan.csic.es;
   beasarria@ictan.csic.es
RI Fernández Cardero, Álvaro/KIG-8234-2024; Sarria, Beatriz/K-7929-2014;
   Bravo, Laura/F-4992-2012
OI Sarria, Beatriz/0000-0003-0614-4606; Fernandez Cardero,
   Alvaro/0009-0003-4437-8013; Bravo, Laura/0000-0002-7312-8641
FU MICIU/AEI/ [PID2020-114102RB-I00]; ERDF/EU; CSIC JAE Intro fellowship
   [JAEINT_23_00055]
FX This article is part of project PID2020-114102RB-I00 funded by
   MICIU/AEI/10.13039/501100011033 and by ERDF/EU. & Aacute;.F.-C. was
   granted with a CSIC JAE Intro fellowship (Ref.: JAEINT_23_00055).
CR Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Aranceta J, 2010, REV ESP NUTR COMUNIT, V16, P173
   Borghi C, 2022, BLOOD PRESSURE, V31, P284, DOI 10.1080/08037051.2022.2136621
   Chen SJ, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.1023345
   Cho AR, 2014, J FOOD BIOCHEM, V38, P271, DOI 10.1111/jfbc.12045
   Dent R, 2020, METABOLISM, V113, DOI 10.1016/j.metabol.2020.154388
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Dirks-Naylor AJ, 2015, LIFE SCI, V143, P182, DOI 10.1016/j.lfs.2015.11.005
   Dwan K, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4378
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Fernández-Bergés D, 2012, REV ESP CARDIOL, V65, P241, DOI [10.1016/j.recesp.2011.10.015, 10.1016/j.rec.2011.10.017]
   García-Cordero J, 2022, FOODS, V11, DOI 10.3390/foods11050679
   Gómez-Hernández A, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/1216783
   Guo YT, 2014, EXP GERONTOL, V50, P1, DOI 10.1016/j.exger.2013.11.005
   Haghighatdoost F, 2023, NUTRIENTS, V15, DOI 10.3390/nu15133060
   Jang YJ, 2018, FOOD FUNCT, V9, P1102, DOI [10.1039/c7fo01683b, 10.1039/C7FO01683B]
   Kawakami R, 2023, BRIT J NUTR, V130, P127, DOI 10.1017/S0007114522003099
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   Król K, 2020, EUR FOOD RES TECHNOL, V246, P33, DOI 10.1007/s00217-019-03388-9
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Nguyen V, 2024, NUTRIENTS, V16, DOI 10.3390/nu16070924
   Raiman L, 2023, CLIN MED, V23, P311, DOI 10.7861/clinmed.2023-0152
   Ren YQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174238
   Revuelta-Iniesta R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/482704
   Saeed M, 2019, CRIT REV FOOD SCI, V59, P3293, DOI 10.1080/10408398.2018.1489368
   Sanchez JM, 2017, FOODS, V6, DOI 10.3390/foods6120109
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Sarriá B, 2020, FOODS, V9, DOI 10.3390/foods9091191
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Saud S, 2021, MOLECULES, V26, DOI 10.3390/molecules26247634
   Stohs SJ, 2016, PHYTOTHER RES, V30, P732, DOI 10.1002/ptr.5583
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Wang K, 2024, FOOD SCI NUTR, V12, P4185, DOI 10.1002/fsn3.4079
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339
   World Health Organization WHO, 2022, Regional Office for Europe WHO European Regional Obesity: Report 2022
   Zamora-Ros R, 2016, EUR J NUTR, V55, P1359, DOI 10.1007/s00394-015-0950-x
   Zhang Y, 2023, FOOD CHEM, V404, DOI 10.1016/j.foodchem.2022.134668
NR 41
TC 3
Z9 3
U1 5
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD SEP
PY 2024
VL 16
IS 17
AR 2848
DI 10.3390/nu16172848
PG 17
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA F9G8I
UT WOS:001312824300001
PM 39275165
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Chen, LW
   Murrin, CM
   Mehegan, J
   Kelleher, CC
   Phillips, CM
AF Chen, Ling-Wei
   Murrin, Celine M.
   Mehegan, John
   Kelleher, Cecily C.
   Phillips, Catherine M.
CA Lifeways Cross-Generation Cohort
TI Maternal, but not paternal or grandparental, caffeine intake is
   associated with childhood obesity and adiposity: The Lifeways
   Cross-Generation Cohort Study
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE caffeine; coffee; tea; pregnancy; child; obesity; adiposity
ID BODY-MASS INDEX; DIETARY ASSESSMENT METHODS; COFFEE CONSUMPTION;
   PREGNANCY; RISK; METAANALYSIS; OUTCOMES; EXPOSURE; GROWTH; FETAL
AB Background: Maternal caffeine intake is associated with adverse birth outcomes, but its long-term influence on offspring adiposity outcomes is not well studied. Furthermore, few studies have investigated paternal and grandparental caffeine intake in relation to offspring outcomes.
   Objective: To study the associations between maternal, paternal, and grandparental caffeine intake and offspring childhood adiposity.
   Design: The core study sample consists of 558 mother-child pairs from the Lifeways Study. Caffeine intake was derived from relevant food items in a self-administered validated food frequency questionnaire in early pregnancy. Children's body mass index (BMI) and waist circumference (WC) were measured at 5- and 9-y follow-up. Childhood overall and central obesity were defined as age-and sex-specific BMI z-score > International Obesity Task Force cut-off and WC z-score > 90th percentile, respectively. Multiple linear and logistic regressions were used to assess associations.
   Results: Study mothers had a mean age of 30.8 y and a mean prepregnancy BMI (kg/m(2)) of 23.7. In adjusted models, maternal caffeine intake was associated with a higher offspring BMI z-score [beta (95% CI): 0.13 (0.06, 0.21) for year 5 and 0.17 (0.04, 0.29) for year 9; per 100 mg/d increment in maternal caffeine intake], WC z-score [beta (95% CI): 0.09 (0.01, 0.17) for year 5 and 0.19 (0.05, 0.32) for year 9], and a higher risk of offspring overall obesity [OR (95% CI): 1.32 (1.11, 1.57) for year 5 and 1.44 (1.10, 1.88) for year 9] and central obesity [1.28 (1.02, 1.60) for year 5 and 1.62 (1.12, 2.34) for year 9]. The influence was stronger for coffee caffeine than tea caffeine. No consistent associations were observed for paternal and grandparental caffeine intake.
   Conclusions: Maternal antenatal, but not paternal or grandparental, caffeine intake is associated with higher offspring adiposity and obesity risk at age 5 and 9 y, with stronger associations observed for coffee caffeine. This prospective observational study was registered at the ISRCTN Registry as ISRCTN16537904.
C1 [Chen, Ling-Wei; Murrin, Celine M.; Mehegan, John; Kelleher, Cecily C.; Phillips, Catherine M.; Lifeways Cross-Generation Cohort] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Hlth Res Board, Ctr Diet & Hlth Res, Dublin, Ireland.
C3 Health Research Board - Ireland; University College Dublin
RP Phillips, CM (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Hlth Res Board, Ctr Diet & Hlth Res, Dublin, Ireland.
EM catherine.phillips@ucd.ie
RI Murrin, Celine/ABA-3881-2021; Phillips, Catherine/E-4412-2013; Chen,
   Ling-Wei/D-5559-2016
OI Phillips, Catherine/0000-0003-4916-4463; Chen,
   Ling-Wei/0000-0002-2661-8752; Mehegan, John/0000-0002-4229-3599;
   Kelleher, Cecily/0000-0001-9548-4914; Murrin, Celine/0000-0002-9728-9781
FU Irish Health Research Board [HRC/2007/13]; ERA-Net on Biomarkers for
   Nutrition and Health (ERA HDHL), Horizon 2020 grant [696295]; Science
   Foundation Ireland, Ireland [SFI/16/ERA-HDHL/3360]; European Union
FX The Lifeways Cross-Generation Cohort Study is funded by the Irish Health
   Research Board and is overseen by an inter-disciplinary steering group.
   This work was supported by a research grant from the Irish Health
   Research Board(reference HRC/2007/13). Further support was received
   through an award by the ERA-Net on Biomarkers for Nutrition and Health
   (ERA HDHL), Horizon 2020 grant agreement number 696295. Funding was
   provided by Science Foundation Ireland, Ireland, (Grant Number
   SFI/16/ERA-HDHL/3360) and the European Union.
CR ALDRIDGE A, 1979, CLIN PHARMACOL THER, V25, P447
   [Anonymous], 1997, DISSERTATION
   Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137
   Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332
   Bracken MB, 2002, EPIDEMIOLOGY, V13, P165, DOI 10.1097/00001648-200203000-00011
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Chen LW, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010002
   Chen LW, 2016, PUBLIC HEALTH NUTR, V19, P1233, DOI 10.1017/S1368980015002463
   Chen LW, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0174-6
   Chia AR, 2016, AM J CLIN NUTR, V104, P1416, DOI 10.3945/ajcn.116.133892
   Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x
   COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25
   Englund-Ögge L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1446
   Fallon U B, 2007, Ir Med J, V100, P23
   Farah A., 2012, Coffee: emerging health effects and disease prevention, P21
   Greenberg JA, 2012, J AM COLL NUTR, V31, P160, DOI 10.1080/07315724.2012.10720023
   Greenwood DC, 2014, EUR J EPIDEMIOL, V29, P725, DOI 10.1007/s10654-014-9944-x
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso LM, 2008, ANN EPIDEMIOL, V18, P172, DOI 10.1016/j.annepidem.2007.11.005
   Hanson M, 2011, AM J CLIN NUTR, V94, p1754S, DOI 10.3945/ajcn.110.001206
   JAMES JE, 1989, BRIT J CLIN PHARMACO, V27, P507, DOI 10.1111/j.1365-2125.1989.tb05400.x
   Kelleher CC, 2014, P NUTR SOC, V73, P118, DOI 10.1017/S002966511300373X
   Klebanoff MA, 2015, EPIDEMIOLOGY, V26, P185, DOI 10.1097/EDE.0000000000000220
   Li DK, 2015, INT J OBESITY, V39, P658, DOI 10.1038/ijo.2014.196
   Li J, 2015, INT J GYNECOL OBSTET, V130, P116, DOI 10.1016/j.ijgo.2015.03.033
   Malerba S, 2013, EUR J EPIDEMIOL, V28, P527, DOI 10.1007/s10654-013-9834-7
   Mameli C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090838
   Ministry of Agriculture, 1997, SURV CAFF OTH METH E, V1997, P18
   Murrin C, 2013, EUR J CLIN NUTR, V67, P670, DOI 10.1038/ejcn.2013.76
   Murrin CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-81
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nishtar S, 2016, LANCET, V387, P825, DOI 10.1016/S0140-6736(16)00140-9
   O'Mahony D, 2007, Ir Med J, V100, P3
   Papadopoulou E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018895
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Public Health England, 2021, McCance and Widdowson's composition of foods integrated dataset
   Riboli E, 1997, INT J EPIDEMIOL, V26, pS161, DOI 10.1093/ije/26.suppl_1.S161
   Safefood, 2016, EN DRINKS IR REV
   Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42
   Song MY, 2018, EUR J EPIDEMIOL, V33, P137, DOI 10.1007/s10654-018-0371-2
   StataCorp, 2013, STAT MULT IMP REF MA
   The Food Safety Authority of Ireland, 2018, CAFF PREGN
   Verster JC, 2018, CRIT REV FOOD SCI, V58, P1250, DOI 10.1080/10408398.2016.1247252
   Voerman E, 2016, OBESITY, V24, P1170, DOI 10.1002/oby.21466
   Wu MY, 2018, ISSCC DIG TECH PAP I, P130, DOI 10.1109/ISSCC.2018.8310218
   Wu YM, 2015, TOXICOL APPL PHARM, V289, P109, DOI 10.1016/j.taap.2015.09.007
   Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016
   Xu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044497
NR 48
TC 17
Z9 17
U1 1
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD JUN
PY 2019
VL 109
IS 6
BP 1648
EP 1655
DI 10.1093/ajcn/nqz019
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA IM5XI
UT WOS:000478066900018
PM 31136661
OA Bronze, Green Published
DA 2025-04-28
ER

PT J
AU Olthof, MR
   van Dijk, AE
   Deacon, CF
   Heine, RJ
   van Dam, RM
AF Olthof, Margreet R.
   van Dijk, Aimee E.
   Deacon, Carolyn F.
   Heine, Robert J.
   van Dam, Rob M.
TI Acute effects of decaffeinated coffee and the major coffee components
   chlorogenic acid and trigonelline on incretin hormones
SO NUTRITION & METABOLISM
LA English
DT Article
ID GLUCOSE-TOLERANCE; CONSUMPTION; SECRETION; PLASMA; RISK
AB Coffee consumption is associated with a lower risk of type 2 diabetes. We tested the hypothesis that this is mediated by incretin hormones by measuring the acute effects of decaffeinated coffee and coffee components on GLP-1 and GIP concentrations. A randomized cross-over trial of the effects of 12 g decaffeinated coffee, 1 g chlorogenic acid, 500 mg trigonelline, and placebo on total and intact GLP-1 and GIP concentrations during an oral glucose tolerance test took place in fifteen overweight men. No treatment significantly affected the overall GLP-1 or GIP secretion pattern following an OGTT relative to placebo. Decaffeinated coffee slightly increased total GLP-1 concentration 30 minutes after ingestion (before the OGTT) relative to placebo (2.7 pmol/L, p = 0.03), but this change did not correspond with changes in glucose or insulin secretion. These findings do not support the hypothesis that coffee acutely improves glucose tolerance through effects on the secretion of incretin hormones. Chronic effects of coffee and its major components still need to be investigated.
C1 [Olthof, Margreet R.; van Dijk, Aimee E.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.
   [Olthof, Margreet R.; van Dijk, Aimee E.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Deacon, Carolyn F.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-1168 Copenhagen, Denmark.
   [Heine, Robert J.] Vrije Univ Amsterdam, Med Ctr, Dept Endocrinol, Ctr Diabet, Amsterdam, Netherlands.
   [van Dam, Rob M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore.
   [van Dam, Rob M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore.
C3 Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University
   of Copenhagen; Vrije Universiteit Amsterdam; National University of
   Singapore; National University of Singapore
RP Olthof, MR (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.
EM margreet.olthof@falw.vu.nl
RI van Dam, Rob/F-9674-2010; van Dam, Rob/A-6693-2009
OI , Margreet/0000-0002-1982-9244; Deacon, Carolyn/0000-0003-2611-5642; van
   Dam, Rob/0000-0002-7354-8734
FU Dutch Diabetes Research Foundation [2006.11.020]
FX The research was financially supported by the Dutch Diabetes Research
   Foundation (Stichting Diabetes Fonds Nederland, grant no. 2006.11.020).
   This study is registered at the Dutch Trial Register
   http://www.trialregister.nl under identifier NTR 1051.
CR Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Minamisawa M, 2004, ANAL SCI, V20, P325, DOI 10.2116/analsci.20.325
   MISHKINSKY J, 1967, LANCET, V2, P1311
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vilsboll T, 2003, J CLIN ENDOCR METAB, V88, P2706, DOI 10.1210/jc.2002-021873
   Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124
NR 13
TC 57
Z9 60
U1 0
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-7075
J9 NUTR METAB
JI Nutr. Metab.
PD FEB 7
PY 2011
VL 8
AR 10
DI 10.1186/1743-7075-8-10
PG 4
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 724WE
UT WOS:000287606200001
PM 21299855
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Takahashi, S
   Saito, K
   Li, XG
   Jia, HJ
   Kato, H
AF Takahashi, Shoko
   Saito, Kenji
   Li, Xuguang
   Jia, Huijuan
   Kato, Hisanori
TI iTRAQ-Based Quantitative Proteomics Reveals the Energy Metabolism
   Alterations Induced by Chlorogenic Acid in HepG2 Cells
SO NUTRIENTS
LA English
DT Article
DE coffee; chlorogenic acid; energy metabolism; lipid metabolism; HepG2
   cells; proteomics
ID COFFEE CONSUMPTION; RISK; EXPRESSION; RECEPTOR; LIVER; TEA
AB Epidemiological studies have suggested that coffee consumption is associated with a decrease in the risk of developing obesity and diabetes; however, the detailed mechanisms underlying these effects of coffee consumption remain poorly understood. In this study, we examined the effects of chlorogenic acid on energy metabolism in vitro. Hepatocellular carcinoma G2 (HepG2) cells were cultured in a medium containing chlorogenic acid. Chlorogenic acid increased the activity of mitochondrial enzymes, including citrate synthase, isocitrate dehydrogenase, and malate dehydrogenase (MDH), which are involved in the tricarboxylic acid (TCA) cycle. Proteome analysis using the isobaric tags for the relative and absolute quantitation (iTRAQ) method revealed the upregulation of proteins involved in the glycolytic system, electron transport system, and ATP synthesis in mitochondria. Therefore, we propose a notable mechanism whereby chlorogenic acid enhances energy metabolism, including the TCA cycle, glycolytic system, electron transport, and ATP synthesis. This mechanism provides important insights into understanding the beneficial effects of coffee consumption.
C1 [Takahashi, Shoko; Saito, Kenji; Li, Xuguang; Jia, Huijuan; Kato, Hisanori] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Hlth Nutr,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.
C3 University of Tokyo
RP Jia, HJ (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Hlth Nutr,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.
EM takahashi@genequest.jp; skkj774@gmail.com; lixuguang1225@gmail.com;
   akakeiken@g.ecc.u-tokyo.ac.jp; akatoq@g.ecc.u-tokyo.ac.jp
RI Li, Xuguang/H-2827-2016
OI Jia, Huijuan/0000-0002-9920-8340; Li, Xuguang/0009-0002-6309-6663
FU All Japan Coffee Association
FX This research was partly funded by a grant from the All Japan Coffee
   Association.
CR [Anonymous], 1969, Methods Enzymol, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]
   Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jia HJ, 2021, NUTRIENTS, V13, DOI 10.3390/nu13114041
   Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048
   Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044
   Li DM, 2020, FOOD FUNCT, V11, P6487, DOI [10.1039/D0FO01350A, 10.1039/d0fo01350a]
   Liu YX, 2011, J AGR FOOD CHEM, V59, P12254, DOI 10.1021/jf203136j
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Riedel A, 2014, FOOD FUNCT, V5, P454, DOI 10.1039/c3fo60320b
   Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200
   Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091134
   Takahashi S, 2014, J FUNCT FOODS, V6, P157, DOI 10.1016/j.jff.2013.10.002
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Vaynshteyn David, 2012, Drug Metab Lett, V6, P116
   Vijayakumar K, 2019, INDIAN J CLIN BIOCHE, V34, P324, DOI 10.1007/s12291-018-0752-z
   Williamson G, 2011, MOL NUTR FOOD RES, V55, P864, DOI 10.1002/mnfr.201000631
NR 17
TC 4
Z9 4
U1 2
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR
PY 2022
VL 14
IS 8
AR 1676
DI 10.3390/nu14081676
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 0S6EM
UT WOS:000786364500001
PM 35458238
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Alfawaz, HA
   Khan, N
   Yakout, SM
   Khattak, MNK
   Alsaikhan, AA
   Almousa, AA
   Alsuwailem, TA
   Almjlad, TM
   Alamri, NA
   Alshammari, SG
   Al-Daghri, NM
AF Alfawaz, Hanan A.
   Khan, Nasiruddin
   Yakout, Sobhy M.
   Khattak, Malak N. K.
   Alsaikhan, Amani A.
   Almousa, Areej A.
   Alsuwailem, Taghreed A.
   Almjlad, Taghreed M.
   Alamri, Nada A.
   Alshammari, Sahar G.
   Al-Daghri, Nasser M.
TI Prevalence, Predictors, and Awareness of Coffee Consumption and Its
   Trend among Saudi Female Students
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE coffee; BMI; health awareness; academic performance; female students;
   Saudi Arabia
ID DOSE-RESPONSE METAANALYSIS; CAFFEINE INTAKE; YOUNG-ADULTS; PATTERNS;
   HEALTH; RISK; ASSOCIATION; UNIVERSITY; CHILDREN; DISEASE
AB This study aimed to investigate the prevalence, trends, and predictors of coffee consumption among Saudi female students and its association with anthropometric and demographic variables. A survey-based study using a face-to-face interview was designed, and 930 (aged 21.5 +/- 2.1 years) apparently healthy female students from different departments of King Saud University participated. The prevalence of coffee consumption was significantly higher (88.2%, p < 0.03) in the central Riyadh region. Coffee consumers had significantly higher prevalence of being overweight than non-consumers (p = 0.02). The frequency of coffee consumption was significantly higher (p < 0.02) in students who were single and belonged to families with a moderate income level. Coffee consumption was significantly higher among first-year students with a high-scale grade point average (GPA) (p < 0.001 and p = 0.03, respectively). Increased coffee consumption during exam and stress conditions was associated with unhealthy dietary habits such as using more sugar and spices. The prevalence of coffee consumption was high among Saudi females. High body mass index (BMI) and increased family income level were strong determinants for coffee consumption. Continued nutritional education and awareness about the potential positive and negative health effects of coffee consumption and the importance of food label use should be provided to younger generations in order to correct the wrong perceptions.
C1 [Alfawaz, Hanan A.; Alsaikhan, Amani A.; Almousa, Areej A.; Alsuwailem, Taghreed A.; Almjlad, Taghreed M.; Alamri, Nada A.; Alshammari, Sahar G.] King Saud Univ, Coll Food Sci & Agr, Dept Food Sci & Nutr, Riyadh 11451, Saudi Arabia.
   [Alfawaz, Hanan A.; Yakout, Sobhy M.; Khattak, Malak N. K.; Al-Daghri, Nasser M.] King Saud Univ, Coll Sci, Dept Biochem, Chair Biomarkers Chron Dis, Riyadh 11451, Saudi Arabia.
   [Khan, Nasiruddin] A Sharqiyah Univ, Coll Appl & Hlth Sci, Dept Food Sci & Human Nutr, Ibra 400, Oman.
C3 King Saud University; King Saud University
RP Alfawaz, HA (corresponding author), King Saud Univ, Coll Food Sci & Agr, Dept Food Sci & Nutr, Riyadh 11451, Saudi Arabia.; Alfawaz, HA (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Chair Biomarkers Chron Dis, Riyadh 11451, Saudi Arabia.
EM amanias1919@gmail.com; knasiruddin@asu.edu.om; syakout@KSU.EDU.SA;
   malaknawaz@yahoo.com; amanias1919@gmail.com; areejalmousa55@gmail.com;
   t.suwailem@gmail.com; totaalmjlad@gmail.com; nada.alamri1992@gmail.com;
   sahar_gharbi@hotmail.com; aldaghri2011@gmail.com
RI YAKOUT, SOBHY/F-1106-2019; Al-Daghri, Nasser/A-8360-2011; ALFAWAZ,
   HANAN/E-6913-2018; Khan, Nasiruddin/AAP-3955-2020; Khattak, Malak Nawaz
   Khan/D-2626-2019
OI ALFAWAZ, HANAN/0000-0002-4794-1778; Khan,
   Nasiruddin/0000-0002-1192-5565; Al-Daghri, Nasser/0000-0001-5472-1725;
   Khattak, Malak Nawaz Khan/0000-0002-1493-7297
FU Chair for Biomarkers of Chronic Diseases (CBCD), KSU, Riyadh, Saudi
   Arabia
FX This work was supported by the Deanship of Scientific Research, Chair
   for Biomarkers of Chronic Diseases (CBCD), KSU, Riyadh, Saudi Arabia.
CR Ahluwalia N, 2014, AM J CLIN NUTR, V100, P1124, DOI 10.3945/ajcn.113.082172
   Ahmed F., 2014, J NUTR HLTH SCI, V1, P14
   Al-Mssallem MQ, 2013, SAUDI MED J, V34, P923
   Al-Othman A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-56
   Al-Shoshan A. A., 2007, Pakistan Journal of Nutrition, V6, P597
   ALI ME, 1993, J ROY SOC HEALTH, V113, P288, DOI 10.1177/146642409311300602
   Alkazemi Dalal, 2019, Nutrition and Health (Bicester), V25, P75, DOI 10.1177/0260106018817410
   Almalki AA., 2015, Int Dent J Stud Res, V3, P170
   [Anonymous], 2017, BREW BOOMERS GOURMET
   [Anonymous], 2016, ROUNDT REP GOOD THIN
   Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052
   Badkook M., 2013, INT J NUTR FOOD SCI, V2, P280, DOI DOI 10.11648/J.IJNFS.20130206.13
   Baltas G., 2001, European Journal of Marketing, V35, P708, DOI 10.1108/03090560110388178
   Bawazeer N.A., 2013, Int J Med Stud, V1, P104, DOI [https://doi.org/10.5195/ijms.2013.215, DOI 10.5195/IJMS.2013.215]
   Branum AM, 2014, PEDIATRICS, V133, P386, DOI 10.1542/peds.2013-2877
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Chen LW, 2016, PUBLIC HEALTH NUTR, V19, P1233, DOI 10.1017/S1368980015002463
   Conklin AI, 2014, SOC SCI MED, V100, P167, DOI 10.1016/j.socscimed.2013.08.018
   Derry CJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009281.pub3
   Deshmukh-Taskar P, 2007, J AM DIET ASSOC, V107, P223, DOI 10.1016/j.jada.2006.11.004
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Drewnowski A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030154
   Faris M. A. E., 2014, Food and Nutrition Sciences, V5, P158, DOI 10.4236/fns.2014.52021
   Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P331, DOI 10.1055/s-0031-1286347
   Fulgoni VL, 2015, AM J CLIN NUTR, V101, P1081, DOI 10.3945/ajcn.113.080077
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Heo M, 2011, OBESITY FACTS, V4, P449, DOI 10.1159/000335279
   International Coffee Organization (ICO), 2019, COFF MARK REP
   Jahrami H, 2020, FOODS, V9, DOI 10.3390/foods9040473
   Jalloun RA., 2020, J. Saud. Soc. Food Nutr.(JSSFN), V13, P59
   Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Maki C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173264
   Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35
   Martyn D, 2018, FOOD CHEM TOXICOL, V111, P71, DOI 10.1016/j.fct.2017.10.059
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   McLellan TM, 2016, NEUROSCI BIOBEHAV R, V71, P294, DOI 10.1016/j.neubiorev.2016.09.001
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B
   Panza F, 2015, J NUTR HEALTH AGING, V19, P313, DOI 10.1007/s12603-014-0563-8
   Peeling P, 2007, ADV PHYSIOL EDUC, V31, P332, DOI 10.1152/advan.00003.2007
   Penafort A. G., 2016, Food and Nutrition Sciences, V7, P30, DOI 10.4236/fns.2016.71004
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Rasberry CN, 2007, AM J HEALTH EDUC, V38, P76, DOI 10.1080/19325037.2007.10598947
   Revel FG, 2009, NEUROSCI BIOBEHAV R, V33, P874, DOI 10.1016/j.neubiorev.2009.03.002
   Rezk N. L., 2018, African Journal of Pharmacy and Pharmacology, V12, P19, DOI 10.5897/ajpp2017.4880
   Ríos JL, 2013, P R HEALTH SCI J, V32, P95
   Robby D., 2017, J SCI RES REP, V15, P1, DOI [10.1007/s13755-018-0056-y, DOI 10.9734/JSRR/2017/34978]
   Rola M. A. G., 2017, AJNE, V1, DOI [10.18502/ajne.v1i3.1230, DOI 10.18502/AJNE.V1I3.1230, https://doi.org/10.18502/ajne.v1i3.1230]
   Serdarevic Nafija, 2019, Med Arch, V73, P104, DOI 10.5455/medarh.2019.73.104-108
   Spiller M.A., 1998, Caffeine, P97
   Subaiea GM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7731-z
   Szeitz-Szabó M, 2011, ACTA ALIMENT HUNG, V40, P142, DOI 10.1556/AAlim.40.2011.1.16
   Temple JL, 2010, EXP CLIN PSYCHOPHARM, V18, P510, DOI 10.1037/a0021651
   Tran NL, 2016, FOOD CHEM TOXICOL, V94, P227, DOI 10.1016/j.fct.2016.06.007
NR 57
TC 30
Z9 32
U1 3
U2 20
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD OCT
PY 2020
VL 17
IS 19
AR 7020
DI 10.3390/ijerph17197020
PG 17
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA ON5VM
UT WOS:000586768300001
PM 32992846
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Di Lorenzo, A
   Curti, V
   Tenore, GC
   Nabavi, SM
   Daglia, M
AF Di Lorenzo, Arianna
   Curti, Valeria
   Tenore, Gian C.
   Nabavi, Seyed M.
   Daglia, Maria
TI Effects of Tea and Coffee Consumption on Cardiovascular Diseases and
   Relative Risk Factors: An Update
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE Cardiovascular diseases; risk factors; tea; coffee; dietary bioactive
   components; physiological and pharmacological effects
ID RANDOMIZED CONTROLLED-TRIAL; DOSE-RESPONSE METAANALYSIS; CHINESE GREEN
   TEA; BODY-MASS INDEX; BLACK TEA; BLOOD-PRESSURE; CHLOROGENIC ACID;
   POSTPRANDIAL GLUCOSE; CLINICAL-TRIAL; ANTIBACTERIAL ACTIVITY
AB Background: Tea and coffee are the second and third most consumed beverages after water, respectively. The high consumption of these beverages is due to the sensorial properties and effects on psychological and physiological functions, induced by caffeine and many other bioactive components responsible for the protective effects on human health generally ascribed to these beverages.
   Methods: The goal of this review article is to collect the scientific data obtained from clinical trials published in the last five years on the role of tea and coffee consumption against cardiovascular diseases (CVDs) and CVD risk factors such as hypertension, hyperglicemia, and hyperlipidaemia.
   Results: In normal weight subjects, clinical trials showed that the consumption of tea is inversely associated to CVD risk factors or no association was found. Differently, in overweight subjects, the clinical trials and the metaanalyses showed an inverse correlation between tea consumption and CVDs. As regards coffee, it has long been suspected to be associated to high risk of CVDs. Nevertheless, some recent investigations reported that moderate coffee consumption have no effect or even protective effects against CVDs risk factors. The results of the metaanalyses confirm this trend suggesting that moderate coffee drinkers could be associated to a lower risk of CVDs than non-or occasional coffee drinkers or no association can be demonstrated between coffee consumption and CVDs.
   Conclusion: Literature data on tea consumption and CVD risk factors support that tea consumption reduces some risk factors especially in overweight people and obese subjects. Therefore, these results seem to suggest that tea could exert a protective effects against CVD development. As regards coffee, the results are controversial and did not allow to draw conclusions. Therefore, further research is needed before definitive recommendations for coffee consumption against CVD development can be made.
C1 [Di Lorenzo, Arianna; Curti, Valeria; Daglia, Maria] Univ Pavia, Dept Drug Sci, Med Chem & Pharmaceut Technol Sect, Via Taramelli 12, I-27100 Pavia, Italy.
   [Tenore, Gian C.] Univ Naples Federico II, Dept Pharm, Via D Montesano 49, I-80131 Naples, Italy.
   [Nabavi, Seyed M.] Baqiyatallah Univ Med Sci, Appl Biotechnol Res Ctr, POB 19395-5487, Tehran, Iran.
C3 University of Pavia; University of Naples Federico II; Baqiyatallah
   University of Medical Sciences (BMSU)
RP Daglia, M (corresponding author), Pavia Univ, Dept Drug Sci, I-27100 Pavia, Italy.
EM maria.daglia@unipv.it
RI Daglia, Maria/AAC-9498-2019; Nabavi, Seyed Mohammad/G-5335-2010
OI Daglia, Maria/0000-0002-4870-7713
CR Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001
   Almeida AAP, 2006, J AGR FOOD CHEM, V54, P8738, DOI 10.1021/jf0617317
   Arazi H, 2014, HIGH BLOOD PRESS CAR, V21, P213, DOI 10.1007/s40292-014-0048-1
   Arnaud M J, 1987, Prog Drug Res, V31, P273
   Bahorun T, 2012, PREV MED, V54, pS98, DOI 10.1016/j.ypmed.2011.12.009
   Belitz H.-D., 2009, Food Chemistry, V4th, P374
   Bertoia ML, 2013, AM J CLIN NUTR, V97, P1356, DOI 10.3945/ajcn.112.044248
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Bicho NC, 2011, EUR FOOD RES TECHNOL, V233, P303, DOI 10.1007/s00217-011-1518-5
   Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Bohn SK, 2014, FOOD FUNCT, V5, P1613, DOI 10.1039/c4fo00209a
   Boros K, 2016, PHARMACOGN MAG, V12, P75, DOI 10.4103/0973-1296.176061
   Brown AL, 2011, BRIT J NUTR, V106, P1880, DOI 10.1017/S0007114511002376
   Cardoso GA, 2013, J MED FOOD, V16, P120, DOI 10.1089/jmf.2012.0062
   Catterall F, 2003, XENOBIOTICA, V33, P743, DOI 10.1080/0049825031000108315
   Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7
   Chen HD, 2012, J AGR FOOD CHEM, V60, P10850, DOI 10.1021/jf303749z
   Cheng TO, 2006, INT J CARDIOL, V108, P301, DOI 10.1016/j.ijcard.2005.05.038
   Chiu FL, 2005, J AGR FOOD CHEM, V53, P7035, DOI 10.1021/jf0507442
   Cho ES, 2009, MUTAT RES-FUND MOL M, V661, P18, DOI 10.1016/j.mrfmmm.2008.10.021
   Chu SL, 2011, CHIN J INTEGR MED, V17, P492, DOI 10.1007/s11655-011-0781-4
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T
   Corrêa TAF, 2013, NUTRITION, V29, P977, DOI 10.1016/j.nut.2013.01.003
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   Daglia M, 2007, J AGR FOOD CHEM, V55, P10208, DOI 10.1021/jf0722607
   dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236
   de Oliveira MR, 2016, PHARMACOL RES, V104, P70, DOI 10.1016/j.phrs.2015.12.027
   dePaulis T, 2003, COFFEE TEA CHOCOLATE
   deRoos B, 1997, J AGR FOOD CHEM, V45, P3065, DOI 10.1021/jf9700900
   Desai MJ, 2005, CHIRALITY, V17, P154, DOI 10.1002/chir.20144
   Di Lorenzo A, 2016, MOL NUTR FOOD RES, V60, P566, DOI 10.1002/mnfr.201500567
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Duarte G, 2009, P 22 INT C COFF SCI, P224
   Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646
   Dias RCE, 2014, EUR FOOD RES TECHNOL, V239, P961, DOI 10.1007/s00217-014-2293-x
   Farah A, 2006, FOOD CHEM, V98, P373, DOI 10.1016/j.foodchem.2005.07.032
   Farah A, 2005, J AGR FOOD CHEM, V53, P1505, DOI 10.1021/jf048701t
   Farah Adriana, 2006, Braz. J. Plant Physiol., V18, P23, DOI 10.1590/S1677-04202006000100003
   Fox J. E., 2003, ENCY FOOD SCI NUTR, P5538
   Fronza M, 2012, PHYTOCHEMISTRY, V78, P107, DOI 10.1016/j.phytochem.2012.02.015
   Gavrieli A, 2013, METABOLISM, V62, P1099, DOI 10.1016/j.metabol.2013.02.003
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Grassi D, 2015, NUTRIENTS, V7, P1037, DOI 10.3390/nu7021037
   Gross G, 1997, FOOD CHEM TOXICOL, V35, P547, DOI 10.1016/S0278-6915(96)00123-8
   Grujic-Letic N, 2015, VOJNOSANIT PREGL, V72, P1018, DOI 10.2298/VSP130915096G
   Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Henning SM, 2004, AM J CLIN NUTR, V80, P1558
   Hirakawa N, 2005, BIOSCI BIOTECH BIOCH, V69, P653, DOI 10.1271/bbb.69.653
   Hodgson JM, 2013, AM J CLIN NUTR, V97, P943, DOI 10.3945/ajcn.112.051375
   Hodgson JM, 2013, FOOD FUNCT, V4, P111, DOI 10.1039/c2fo30186e
   Hodgson JM, 2012, ARCH INTERN MED, V172, P186, DOI 10.1001/archinte.172.2.186
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Je Y, 2014, BRIT J NUTR, V111, P1162, DOI 10.1017/S0007114513003814
   Kamimori GH, 2002, INT J PHARM, V234, P159, DOI 10.1016/S0378-5173(01)00958-9
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Koutelidakis AE, 2014, EUR J NUTR, V53, P479, DOI 10.1007/s00394-013-0548-0
   Kubot K, 2011, NUTR RES, V31, P421, DOI 10.1016/j.nutres.2011.05.004
   Larsson SC, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0447-8
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Lee C, 2000, CLIN CHIM ACTA, V295, P141, DOI 10.1016/S0009-8981(00)00201-1
   Lee KJ, 2007, FOOD CHEM TOXICOL, V45, P2118, DOI 10.1016/j.fct.2007.05.010
   Li GW, 2015, J HYPERTENS, V33, P243, DOI 10.1097/HJH.0000000000000426
   Lin LZ, 2008, J AGR FOOD CHEM, V56, P8130, DOI 10.1021/jf800986s
   Lisowska A, 2015, EUR REV MED PHARMACO, V19, P209
   Liu C, 2014, INTERNATIONAL CONFERENCE ON ELECTRONIC AND ELECTRICAL ENGINEERING (CEEE 2014), P1
   Liu G, 2014, BRIT J NUTR, V112, P1043, DOI 10.1017/S0007114514001731
   Loftfield E, 2015, AM J EPIDEMIOL, V182, P1010, DOI 10.1093/aje/kwv146
   Lopez-Garcia E, 2011, AM J CLIN NUTR, V94, P218, DOI 10.3945/ajcn.110.010249
   Malerba S, 2013, EUR J EPIDEMIOL, V28, P527, DOI 10.1007/s10654-013-9834-7
   Marchese A, 2014, FOOD RES INT, V63, P182, DOI 10.1016/j.foodres.2014.01.036
   Miyauchi S, 2014, J BIOSCI BIOENG, V118, P710, DOI 10.1016/j.jbiosc.2014.05.008
   Miyazaki R, 2013, GERIATR GERONTOL INT, V13, P622, DOI 10.1111/j.1447-0594.2012.00952.x
   Mori H, 1996, ENV MUTAGEN RES, V18, P73
   Mostofsky E, 2012, CIRC-HEART FAIL, V5, P401, DOI 10.1161/CIRCHEARTFAILURE.112.967299
   Mozaffari-Khosravi Hassan, 2013, Journal of Dietary Supplements, V10, P105, DOI 10.3109/19390211.2013.790333
   Narotzki B, 2013, J AM COLL NUTR, V32, P31, DOI 10.1080/07315724.2013.767661
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   Nowotny B, 2015, DIABETOLOGIA, V58, P255, DOI 10.1007/s00125-014-3457-8
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Ochiai R, 2014, NUTR RES, V34, P155, DOI 10.1016/j.nutres.2013.11.001
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Onakpoya I, 2014, NUTR METAB CARDIOVAS, V24, P823, DOI 10.1016/j.numecd.2014.01.016
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Pang J, 2016, INT J CARDIOL, V202, P967, DOI 10.1016/j.ijcard.2014.12.176
   Perera V, 2010, BIOMED CHROMATOGR, V24, P1136, DOI 10.1002/bmc.1419
   Perrone D, 2008, FOOD CHEM, V110, P1030, DOI 10.1016/j.foodchem.2008.03.012
   Poquet L, 2008, DRUG METAB DISPOS, V36, P190, DOI 10.1124/dmd.107.017558
   Quinlan P, 1997, PSYCHOPHARMACOLOGY, V134, P164, DOI 10.1007/s002130050438
   Renaud J, 2015, REJUV RES, V18, P257, DOI 10.1089/rej.2014.1639
   Renouf M, 2014, MOL NUTR FOOD RES, V58, P301, DOI 10.1002/mnfr.201300349
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Ribeiro-Alves MA, 2003, J NUTR, V133, P393, DOI 10.1093/jn/133.2.393
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Ruan JY, 2012, J SCI FOOD AGR, V92, P1375, DOI 10.1002/jsfa.4709
   SCHOLZ BM, 1990, Z LEBENSM UNTERS FOR, V190, P132, DOI 10.1007/BF01193483
   Shearer J, 2007, CAN J PHYSIOL PHARM, V85, P823, DOI 10.1139/Y07-070
   Shen L, 2012, J ZHEJIANG UNIV-SC B, V13, P652, DOI 10.1631/jzus.B1201001
   Speer Karl, 2006, Braz. J. Plant Physiol., V18, P201, DOI 10.1590/S1677-04202006000100014
   Spencer JPE, 2003, J NUTR, V133, p3255S, DOI 10.1093/jn/133.10.3255S
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Stauder M, 2010, J AGR FOOD CHEM, V58, P11662, DOI 10.1021/jf1031839
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Sun LY, 2013, CAN J PHYSIOL PHARM, V91, P562, DOI 10.1139/cjpp-2012-0309
   Takahashi M, 2014, BRIT J NUTR, V112, P1542, DOI 10.1017/S0007114514002530
   Tang J, 2015, BRIT J NUTR, V114, P673, DOI 10.1017/S0007114515002329
   Teekachunhatean S., 2013, ISRN PHARM, V2013, P7
   Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384
   Toolsee NA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/412379
   Troup R, 2015, J ACAD NUTR DIET, V115, P264, DOI 10.1016/j.jand.2014.07.021
   Unno T, 1999, J AGR FOOD CHEM, V47, P1593, DOI 10.1021/jf981113t
   van Cruchten STJ, 2010, DRUG METAB DISPOS, V38, P635, DOI 10.1124/dmd.109.030213
   Wedick NM, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-86
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   White JR, 2016, CLIN TOXICOL, V54, P308, DOI 10.3109/15563650.2016.1146740
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   Xu WP, 2012, J AGR FOOD CHEM, V60, P7064, DOI 10.1021/jf301340z
   Yang HY, 2012, BRIT J NUTR, V107, P749, DOI 10.1017/S0007114511005095
   Yang TY, 2014, PHYTOTHER RES, V28, P1096, DOI 10.1002/ptr.5111
   Yarmolinsky J, 2015, NUTR REV, V73, P236, DOI 10.1093/nutrit/nuv001
   Zhang C, 2015, EUR J EPIDEMIOL, V30, P103, DOI 10.1007/s10654-014-9960-x
   Zhao YM, 2015, PUBLIC HEALTH NUTR, V18, P1282, DOI 10.1017/S1368980014001438
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
   Ziegler D, 2015, DIABETES CARE, V38, P1750, DOI 10.2337/dc15-0466
NR 126
TC 29
Z9 31
U1 2
U2 56
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2017
VL 23
IS 17
BP 2474
EP 2487
DI 10.2174/1381612823666170215145855
PG 14
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA FA6CI
UT WOS:000405530500008
PM 28215148
DA 2025-04-28
ER

PT J
AU González, S
   Salazar, N
   Ruiz-Saavedra, S
   Gómez-Martín, M
   de los Reyes-Gavilán, CG
   Gueimonde, M
AF Gonzalez, Sonia
   Salazar, Nuria
   Ruiz-Saavedra, Sergio
   Gomez-Martin, Maria
   de los Reyes-Gavilan, Clara G.
   Gueimonde, Miguel
TI Long-Term Coffee Consumption is Associated with Fecal Microbial
   Composition in Humans
SO NUTRIENTS
LA English
DT Article
DE coffee; (poly)phenol; gut microbiota; Bacteroides
ID GUT-MICROBIOTA; CHLOROGENIC ACID; BLOOD-PRESSURE; DIETARY FIBER;
   FATTY-ACIDS; METABOLISM; CAFFEINE; OBESITY; HEALTH; IMPACT
AB Coffee consumption has been related to a preventive effect against several non-transmissible pathologies. Due to the content of this beverage in phytochemicals and minerals, it has been proposed that its impact on health may partly depend on gut microbiota modulation. Our aim was to explore the interaction among gut microbiota, fecal short chain fatty acids, and health-related parameters in 147 healthy subjects classified according to coffee consumption, to deepen the association of the role of the (poly)phenol and alkaloid content of this beverage. Food daily intake was assessed by an annual food frequency questionnaire (FFQ). Coffee consumption was categorized into three groups: non-coffee-consumers (0-3 mL/day), moderate consumers (3-45 mL/day) and high-coffee consumers (45-500 mL/day). Some relevant groups of the gut microbiota were determined by qPCR, and concentration of fecal short chain fatty acids by gas chromatography. Serum health related biomarkers were determined by standardized methods. Interestingly, a higher level of Bacteroides-Prevotella-Porphyromonas was observed in the high consumers of coffee, who also had lower levels of lipoperoxidation. Two groups of coffee-derived (poly)phenol, methoxyphenols and alkylphenols, and caffeine, among alkaloids, were directly associated with Bacteroides group levels. Thus, regular consumption of coffee appears to be associated with changes in some intestinal microbiota groups in which dietary (poly)phenol and caffeine may play a role.
C1 [Gonzalez, Sonia; Gomez-Martin, Maria] Univ Oviedo, Dept Funct Biol, Oviedo 33006, Spain.
   [Gonzalez, Sonia; Salazar, Nuria; Ruiz-Saavedra, Sergio; Gomez-Martin, Maria; de los Reyes-Gavilan, Clara G.; Gueimonde, Miguel] Inst Invest Sanitaria Principado Asturias ISPA, Diet Microbiota & Hlth Grp, Oviedo 33011, Spain.
   [Salazar, Nuria; Ruiz-Saavedra, Sergio; de los Reyes-Gavilan, Clara G.; Gueimonde, Miguel] Inst Prod Lacteos Asturias IPLA CSIC, Dept Microbiol & Biochem Dairy Prod, Villaviciosa 33300, Asturias, Spain.
C3 University of Oviedo; Instituto de Investigacion Sanitaria del
   Principado de Asturias (ISPA); Consejo Superior de Investigaciones
   Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias
   (IPLA)
RP Gueimonde, M (corresponding author), Inst Invest Sanitaria Principado Asturias ISPA, Diet Microbiota & Hlth Grp, Oviedo 33011, Spain.; Gueimonde, M (corresponding author), Inst Prod Lacteos Asturias IPLA CSIC, Dept Microbiol & Biochem Dairy Prod, Villaviciosa 33300, Asturias, Spain.
EM soniagsolares@uniovi.es; nuriasg@ipla.csic.es; sergioruizsa3@gmail.com;
   mariagomart@gmail.com; greyes_gavilan@ipla.csic.es;
   mgueimonde@ipla.csic.es
RI Gueimonde, Miguel/A-2106-2008; G. de los Reyes-Gavilan,
   Clara/E-5443-2011; Gonzalez-Solares, Sonia/P-6720-2015; Salazar,
   Nuria/D-2189-2015
OI Gueimonde, Miguel/0000-0002-0192-901X; G. de los Reyes-Gavilan,
   Clara/0000-0001-9396-6311; Gonzalez-Solares, Sonia/0000-0003-2602-7036;
   Ruiz Saavedra, Sergio/0000-0002-6834-9060; Gomez Martin,
   Maria/0000-0001-7300-7471; Salazar, Nuria/0000-0003-1435-7628
FU Plan Estatal de I +D +I [AGL2017-83653-R, RTI2018-098288-B-I00];
   Biopolis SL (Valencia, Spain); CAUCE Foundation (Oviedo, Spain);
   Alimerka Foundation (Llanera, Spain); Fundacion para la Investigacion
   Biosanitaria de Asturias (FINBA); FPU [FPU18/03393]; Spanish Ministry of
   Science, Innovation and Universities
FX This research was funded by Plan Estatal de I +D +I through projects
   AGL2017-83653-R (AEI/FEDER, UE) and RTI2018-098288-B-I00
   (MCIU/AEI/FEDER, UE), and by contracts with Biopolis SL (Valencia,
   Spain), CAUCE Foundation (Oviedo, Spain) and Alimerka Foundation
   (Llanera, Spain). N.S. was granted a postdoctoral contract awarded by
   the Fundacion para la Investigacion Biosanitaria de Asturias (FINBA);
   M.G-M. was supported by a FPU (FPU18/03393) predoctoral grant from the
   Spanish Ministry of Science, Innovation and Universities; and S.R.-S. is
   the recipient of a Research Training contract awarded under project
   RTI2018-098288-B-I00.
CR [Anonymous], TABL COMP AL MED CAS
   Aura AM, 2005, EUR J NUTR, V44, P133, DOI 10.1007/s00394-004-0502-2
   Aura Anna-Marja, 2008, Phytochemistry Reviews, V7, P407, DOI 10.1007/s11101-008-9095-3
   Baek JH, 2017, BMB REP, V50, P566, DOI 10.5483/BMBRep.2017.50.11.031
   Bhandarkar NS, 2020, FASEB J, V34, P4783, DOI 10.1096/fj.201902416RR
   BROWN SR, 1990, GUT, V31, P450, DOI 10.1136/gut.31.4.450
   Chrysant SG, 2017, EXPERT REV CARDIOVAS, V15, P151, DOI 10.1080/14779072.2017.1287563
   Couteau D, 2001, J APPL MICROBIOL, V90, P873, DOI 10.1046/j.1365-2672.2001.01316.x
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   Cuervo A, 2015, J AM COLL NUTR, V34, P135, DOI 10.1080/07315724.2014.904763
   Cuervo A, 2014, J AGR FOOD CHEM, V62, P5330, DOI 10.1021/jf501546a
   Dórea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Farias-Pereira R, 2018, J FUNCT FOODS, V48, P586, DOI 10.1016/j.jff.2018.07.049
   Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606
   Fernández-Navarro T, 2019, FOOD RES INT, V121, P533, DOI 10.1016/j.foodres.2018.12.009
   Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032
   Gérard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790
   Gniechwitz D, 2007, J AGR FOOD CHEM, V55, P6989, DOI 10.1021/jf070646b
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Grosso G, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080890
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Khokhlova EV, 2012, MICROBIOL IMMUNOL, V56, P27, DOI 10.1111/j.1348-0421.2011.00398.x
   Lally JSV, 2012, ACTA PHYSIOL, V205, P71, DOI 10.1111/j.1748-1716.2012.02396.x
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Marlett JA, 1997, J AM DIET ASSOC, V97, P1139, DOI 10.1016/S0002-8223(97)00275-7
   Martini D, 2016, MOLECULES, V21, DOI 10.3390/molecules21080979
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Mulak A, 2015, WORLD J GASTROENTERO, V21, P10609, DOI 10.3748/wjg.v21.i37.10609
   Nakayama T, 2013, FEMS MICROBIOL LETT, V343, P161, DOI 10.1111/1574-6968.12142
   Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024
   Nogacka AM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030906
   O'Keefe JH, 2018, PROG CARDIOVASC DIS, V61, P38, DOI 10.1016/j.pcad.2018.02.002
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Rothwell JA, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900659
   Salazar N, 2008, APPL ENVIRON MICROB, V74, P4737, DOI 10.1128/AEM.00325-08
   Salvucci E, 2019, INT J FOOD SCI NUTR, V70, P781, DOI 10.1080/09637486.2019.1580682
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Silveira AK, 2018, PHYTOTHER RES, V32, P2466, DOI 10.1002/ptr.6185
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031
   USDA, FoodData Central
   Valdés L, 2017, EUR FOOD RES TECHNOL, V243, P157, DOI 10.1007/s00217-016-2732-y
   Williamson G, 2010, BRIT J NUTR, V104, pS48, DOI 10.1017/S0007114510003946
   Yamamoto T, 2014, BIOSCI BIOTECH BIOCH, V78, P2059, DOI 10.1080/09168451.2014.942252
NR 50
TC 68
Z9 69
U1 1
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD MAY
PY 2020
VL 12
IS 5
AR 1287
DI 10.3390/nu12051287
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA MB0AV
UT WOS:000542272700139
PM 32369976
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Revuelta-Iniesta, R
   Al-Dujaili, EAS
AF Revuelta-Iniesta, R.
   Al-Dujaili, E. A. S.
TI Consumption of Green Coffee Reduces Blood Pressure and Body Composition
   by Influencing 11β-HSD1 Enzyme Activity in Healthy Individuals: A Pilot
   Crossover Study Using Green and Black Coffee
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID CHLOROGENIC ACID; BEAN EXTRACT; HABITUAL COFFEE; CAFFEINE;
   DEHYDROGENASE; TEA; RISK
AB Dietary polyphenols may have a protective role against the development of CVD. Thus, we aimed to investigate the effects of green coffee (GC), rich in chlorogenic acid, and black coffee (BC) on cardiovascular markers. A randomised pilot crossover study was performed on healthy subjects who consumed both coffees for 2 weeks. We measured anthropometry, blood pressure, and arterial elasticity after each intervention and collected urine samples to monitor antioxidant capacity. Free cortisol and cortisone levels were obtained from urine and analysed by specific ELISA methods. Systolic blood pressure (P = 0.018) and arterial elasticity (P = 0.001) were significantly reduced after GC. BMI (P = 0.04 for BC; P = 0.01 for GC) and abdominal fat (P = 0.01 for BC; P = 0.009 for GC) were also significantly reduced with no changes in energy intake. Urinary free cortisol was significantly reduced from 125.6 +/- 85.9 nmol/day to 76.0 +/- 54.9 nmol/day following GC and increased to 132.1 +/- 89.1 nmol/day after BC. Urinary free cortisone increased by 18% following BC and 9% following GC (nonsignificant). Cortisol/cortisone ratio (indicating 11 beta-HSD1 activity) was reduced after GC (from 3.5 +/- 1.9 to 1.7 +/- 1.04, P = 0.002). This suggests that GC can play a role in reducing cardiovascular risk factors. Further research including hypertensive and overweight individuals will now be justified to clarify whether GC could have a therapeutic role in CVD.
C1 [Revuelta-Iniesta, R.; Al-Dujaili, E. A. S.] Queen Margaret Univ, Dept Dietet Nutr & Biol Sci, Edinburgh EH21 6UU, Midlothian, Scotland.
C3 Queen Margaret University
RP Al-Dujaili, EAS (corresponding author), Queen Margaret Univ, Dept Dietet Nutr & Biol Sci, Queen Margaret Univ Dr, Edinburgh EH21 6UU, Midlothian, Scotland.
EM ealdujaili@qmu.ac.uk
RI Iniesta, Raquel/AAL-4373-2021; Stefanadis, Christodoulos/ABH-2232-2020
OI Stefanadis, Christodoulos/0000-0001-5974-6454
FU Society for Endocrinology, UK
FX The authors are indebted to the Society for Endocrinology, UK, for their
   financial support of the research project.
CR Al Moosawi S., 2010, THESIS QUEEN MARGARE
   Al-Dujaili EAS, 2012, STEROIDS, V77, P703, DOI 10.1016/j.steroids.2012.03.001
   Almoosawi S., 2009, END ABSTR, V19, P122
   Arao T, 2011, J HEALTH SCI, V57, P436, DOI 10.1248/jhs.57.436
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bland M., 2004, DIRECTORY RANDOMISAT
   Corti R, 2002, CIRCULATION, V106, P2935, DOI 10.1161/01.CIR.0000046228.97025.3A
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Folkow B, 1997, ACTA PHYSIOL SCAND, V161, P34
   Geleijnse JM, 2008, VASC HEALTH RISK MAN, V4, P963
   George SE, 2008, CRIT REV FOOD SCI, V48, P464, DOI 10.1080/10408390701522445
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Griffin J.E., 2004, TXB ENDOCRINE PHYSL
   Gropper S.A., 2009, Advanced Nutrition and Human Metabolism
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   HOFER I, 1994, PHARMACOL BIOCHEM BE, V48, P899, DOI 10.1016/0091-3057(94)90198-8
   Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Kaliora AC, 2006, ATHEROSCLEROSIS, V187, P1, DOI 10.1016/j.atherosclerosis.2005.11.001
   Kirilov G, 2003, EUR J ENDOCRINOL, V149, P549, DOI 10.1530/eje.0.1490549
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P2738, DOI 10.1210/jc.2002-030017
   Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664
   Mitchell Brett M, 2002, Biol Res Nurs, V4, P16, DOI 10.1177/1099800402004001003
   National Institute for Clinical Excellence (NICE), 2006, HYP CLIN MAN PRIM HY, V34
   Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   ROSMARIN PC, 1990, J GEN INTERN MED, V5, P211, DOI 10.1007/BF02600536
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Singleton VL, 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Uiterwaal CSPM, 2007, AM J CLIN NUTR, V85, P718, DOI 10.1093/ajcn/85.3.718
   Veilleux A, 2009, J CLIN ENDOCR METAB, V94, P3550, DOI 10.1210/jc.2008-2011
   Vlachopoulos C, 2006, ARTERY RES, V1, pS15, DOI 10.1016/S1872-9312(07)70003-0
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
   World Health Organisation (WHO 2008), 2011, WAIST CIRC WAIST HIP
   Yamaguchi T, 2008, NUTR METAB CARDIOVAS, V18, P408, DOI 10.1016/j.numecd.2007.03.004
NR 42
TC 43
Z9 44
U1 1
U2 34
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
VL 2014
AR 482704
DI 10.1155/2014/482704
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AM4AA
UT WOS:000339792900001
PM 25133164
OA Green Published, Green Submitted, hybrid
DA 2025-04-28
ER

PT J
AU Li, ZQ
   Niu, L
   Chen, YF
   Qiu, XY
   Du, TT
   Zhu, MH
   Wang, ML
   Mo, HY
   Xiao, SE
AF Li, Ziqiang
   Niu, Li
   Chen, Yangfeng
   Qiu, Xiaoyan
   Du, Tiantian
   Zhu, Miaohua
   Wang, Minglei
   Mo, Huiying
   Xiao, Shengen
TI Recent advance in the biological activity of chlorogenic acid and its
   application in food industry
SO INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY
LA English
DT Review
DE Application; biological activity; chlorogenic acid; food nutrition; food
   packaging; food safety
ID COFFEE BEAN EXTRACT; ANTIOXIDANT ACTIVITY; BLOOD-PRESSURE; ENDOTHELIAL
   FUNCTION; FUNCTIONAL-PROPERTIES; ASSISTED EXTRACTION;
   HEALTHY-VOLUNTEERS; CHITOSAN; BIOSYNTHESIS; GLUCOSE
AB In recent years, people have been paying more attention to food safety and dietary health. An increasing number of natural active ingredients are used in the field of food and nutrition. Chlorogenic acid (CGA), as a phenolic acid compound extensive present in the diet, has been reported to have a variety of beneficial biological activities in alleviating and preventing various diet-related chronic diseases. Moreover, it has various applications in food safety and food nutrition as a new type of food additive. In this context, this paper reviews the role of CGA as an antioxidant, antibacterial, hypotensive, hypoglycaemic, antiobesity and gastrointestinal health agent starting from its distribution, source, in vivo metabolism and isolation. Furthermore, the practical application of chlorogenic acid in active food packaging, food quality control and nutritional dietary supplements is discussed. Finally, the future development and challenges of CGA in the field of food is described, providing new ideas for the application of CGA in food safety and dietary supplements and future research.
   Biological activity and application of chlorogenic acid in food.image
C1 [Li, Ziqiang; Niu, Li; Chen, Yangfeng; Qiu, Xiaoyan; Du, Tiantian; Zhu, Miaohua; Wang, Minglei; Mo, Huiying; Xiao, Shengen] Hunan Agr Univ, Coll Hort, Changsha, Hunan, Peoples R China.
   [Niu, Li] Minist Educ, Key Lab Tea Sci, Changsha, Hunan, Peoples R China.
   [Niu, Li] Natl Res Ctr Engn & Technol Utilizat Bot Funct Ing, Changsha, Hunan, Peoples R China.
   [Niu, Li] Coinnovat Ctr Educ Minist Utilizat Bot Funct Ingre, Changsha, Hunan, Peoples R China.
C3 Hunan Agricultural University
RP Niu, L; Xiao, SE (corresponding author), Hunan Agr Univ, Coll Hort, Changsha, Hunan, Peoples R China.; Niu, L (corresponding author), Minist Educ, Key Lab Tea Sci, Changsha, Hunan, Peoples R China.; Niu, L (corresponding author), Natl Res Ctr Engn & Technol Utilizat Bot Funct Ing, Changsha, Hunan, Peoples R China.; Niu, L (corresponding author), Coinnovat Ctr Educ Minist Utilizat Bot Funct Ingre, Changsha, Hunan, Peoples R China.
EM niuli@hunau.edu.cn; xiaosg@hunau.net
RI ziqiang, li/P-7648-2017
FU This work was financially supported by the Hunan Provincial Natural
   Science Foundation of the Provincial and Municipal Joint Fund Project
   (2022JJ50044); Hunan Province Innovative Provincial Construction Special
   Key Ramp;D Project (2021SK2012) (Xiang Cai J [2022JJ50044]; Hunan
   Provincial Natural Science Foundation of the Provincial and Municipal
   Joint Fund Project [2021SK2012, 47]; Hunan Province Innovative
   Provincial Construction Special Key Ramp;D Project [2021JJ30346];
   General Project of Hunan Provincial Innovative Natural Science
   Foundation
FX This work was financially supported by the Hunan Provincial Natural
   Science Foundation of the Provincial and Municipal Joint Fund Project
   (2022JJ50044); Hunan Province Innovative Provincial Construction Special
   Key R & D Project (2021SK2012) (Xiang Cai Jiao Zhi 2021 No. 47); General
   Project of Hunan Provincial Innovative Natural Science Foundation
   (2021JJ30346) (Xianjin Fund Committee 2021 No. 1).
CR Amano Y, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12030110
   Bai XY, 2022, SCI HORTIC-AMSTERDAM, V291, DOI 10.1016/j.scienta.2021.110563
   BARNES HM, 1950, J AM CHEM SOC, V72, P4178, DOI 10.1021/ja01165a095
   Caprioli G, 2017, NAT PROD RES, V31, P515, DOI 10.1080/14786419.2016.1195383
   Cejas JP, 2021, BBA-BIOMEMBRANES, V1863, DOI 10.1016/j.bbamem.2020.183484
   Cha MN, 2014, J MICROBIOL BIOTECHN, V24, P1109, DOI 10.4014/jmb.1403.03033
   Chen JL, 2019, APPL MICROBIOL BIOT, V103, P8157, DOI 10.1007/s00253-019-10025-8
   Chen JL, 2018, J NUTR BIOCHEM, V59, P84, DOI 10.1016/j.jnutbio.2018.06.005
   Chen L, 2017, EUR J PHARM SCI, V100, P102, DOI 10.1016/j.ejps.2017.01.011
   Chen XD, 2020, J AGR FOOD CHEM, V68, P12485, DOI 10.1021/acs.jafc.0c05020
   Chen YS, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13361
   Cheng D, 2019, FOOD FUNCT, V10, P681, DOI [10.1039/c8fo01755g, 10.1039/C8FO01755G]
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023
   Claude SJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126333
   Clifford MN, 2020, COMPR REV FOOD SCI F, V19, P1299, DOI 10.1111/1541-4337.12518
   Clifford MN, 2017, NAT PROD REP, V34, P1391, DOI 10.1039/c7np00030h
   da Encarnaçao JA, 2015, MOL NUTR FOOD RES, V59, P231, DOI 10.1002/mnfr.201400498
   da Silva LC, 2020, FOOD CHEM, V318, DOI 10.1016/j.foodchem.2020.126450
   Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326
   Ding XQ, 2022, FOOD CHEM, V368, DOI 10.1016/j.foodchem.2021.130865
   Dominguez R, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11010060
   Farah A., 2019, The Royal Society of Chemistry, P364
   Feng YS, 2016, INT J PHARMACEUT, V501, P342, DOI 10.1016/j.ijpharm.2016.01.081
   da Silveira TFF, 2017, PLANT FOOD HUM NUTR, V72, P219, DOI 10.1007/s11130-017-0613-6
   Frosi I, 2021, MOLECULES, V26, DOI 10.3390/molecules26154515
   Fu SL, 2017, FOOD CHEM, V221, P657, DOI 10.1016/j.foodchem.2016.11.123
   Gohel MG, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-56
   Gómez-Juaristi M, 2018, FOOD CHEM, V240, P1028, DOI 10.1016/j.foodchem.2017.08.003
   Goodarzi MO, 2018, LANCET DIABETES ENDO, V6, P223, DOI 10.1016/S2213-8587(17)30200-0
   Guo KY, 2022, J FOOD MEAS CHARACT, V16, P202, DOI 10.1007/s11694-021-01148-6
   Hajji S, 2017, PROCESS SAF ENVIRON, V111, P112, DOI 10.1016/j.psep.2017.06.018
   He XY, 2021, J SCI FOOD AGR, V101, P631, DOI 10.1002/jsfa.10675
   Hirohama D, 2019, HYPERTENS RES, V42, P1848, DOI 10.1038/s41440-019-0332-5
   Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Hu F, 2020, INT J BIOL MACROMOL, V159, P333, DOI 10.1016/j.ijbiomac.2020.05.089
   Hu W, 2015, CHIN J NAT MEDICINES, V13, P445, DOI 10.1016/S1875-5364(15)30038-8
   Huang S.W., 2015, CHIN J ANIM SCI, V51, P79
   Huang X, 2019, FOOD SCI BIOTECHNOL, V28, P1275, DOI 10.1007/s10068-019-00631-7
   Jiang H, 2021, NAT PROD COMMUN, V16, DOI 10.1177/1934578X211046105
   Jiao WX, 2019, POSTHARVEST BIOL TEC, V154, P129, DOI 10.1016/j.postharvbio.2019.05.003
   Jiao WX, 2018, FOOD CHEM, V260, P274, DOI 10.1016/j.foodchem.2018.04.010
   Jin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120842
   Kai K, 2021, WORLD J MICROB BIOT, V37, DOI 10.1007/s11274-021-03062-x
   Kaul K, 2013, ADV EXP MED BIOL, V771, P1
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kim BG, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-15
   Kim JK, 2019, EXCLI J, V18, P310, DOI 10.17179/excli2019-1404
   Kim SO, 2021, J FOOD SAFETY, V41, DOI 10.1111/jfs.12870
   Kopjar M, 2012, J FOOD PROCESS PRES, V36, P545, DOI 10.1111/j.1745-4549.2011.00631.x
   Kremr D, 2016, QUIM NOVA, V39, P530
   Kundu A, 2019, PLANT BIOLOGY, V21, P185, DOI 10.1111/plb.12947
   Le YJ, 2022, FEMS MICROBIOL LETT, V369, DOI 10.1093/femsle/fnac061
   Li GH, 2014, EUR FOOD RES TECHNOL, V238, P589, DOI 10.1007/s00217-013-2140-5
   Li SZ, 2021, J AGR FOOD CHEM, V69, P2816, DOI 10.1021/acs.jafc.0c07588
   Li Y, 2022, BIOACT MATER, V15, P392, DOI 10.1016/j.bioactmat.2022.02.025
   Liang NJ, 2016, FOOD CHEM, V213, P251, DOI 10.1016/j.foodchem.2016.06.041
   Liu C, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10061094
   Loader TB, 2017, NUTR REV, V75, P114, DOI 10.1093/nutrit/nuw057
   Lou ZX, 2011, J FOOD SCI, V76, pM398, DOI 10.1111/j.1750-3841.2011.02213.x
   Lu HJ, 2020, COMPR REV FOOD SCI F, V19, P3130, DOI 10.1111/1541-4337.12620
   Lu YR, 2000, FOOD CHEM, V68, P81, DOI 10.1016/S0308-8146(99)00167-3
   Ludwig IA, 2013, BIOFACTORS, V39, P623, DOI 10.1002/biof.1124
   Ma CM, 2007, BIOORGAN MED CHEM, V15, P6830, DOI 10.1016/j.bmc.2007.07.038
   Ma CM, 2010, BIOORGAN MED CHEM, V18, P863, DOI 10.1016/j.bmc.2009.11.043
   Mansour A, 2021, NUTR J, V20, DOI 10.1186/s12937-021-00694-5
   Mateos R, 2006, J AGR FOOD CHEM, V54, P8724, DOI 10.1021/jf061664g
   McClements DJ, 2012, CURR OPIN COLLOID IN, V17, P235, DOI 10.1016/j.cocis.2012.06.002
   Menin B, 2010, PLANT SCI, V179, P338, DOI 10.1016/j.plantsci.2010.06.010
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Naylor LH, 2021, AM J CLIN NUTR, V113, P370, DOI 10.1093/ajcn/nqaa312
   Ommati MM, 2020, BIOLOGIA, V75, P1221, DOI 10.2478/s11756-020-00429-7
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Perumal P., 2018, Asian J. Pharm. Clin. Res, V11, P194, DOI DOI 10.22159/AJPCR.2018.V11I3.22393
   Qu SQ, 2020, PHYTOTHER RES, V34, P3189, DOI 10.1002/ptr.6765
   Qu ZH, 2021, CRIT REV FOOD SCI, V61, P211, DOI 10.1080/10408398.2020.1723057
   Ren G, 2019, INT J BIOL MACROMOL, V141, P936, DOI 10.1016/j.ijbiomac.2019.08.265
   Rohloff JC, 1998, J ORG CHEM, V63, P4545, DOI 10.1021/jo980330q
   Rosa-Martínez E, 2021, FOOD RES INT, V147, DOI 10.1016/j.foodres.2021.110531
   Ruan Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097815
   Rui LY, 2017, CARBOHYD POLYM, V170, P206, DOI 10.1016/j.carbpol.2017.04.076
   Sanlier N, 2019, CRIT REV FOOD SCI, V59, P2573, DOI 10.1080/10408398.2018.1461061
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Sefkow M, 2001, EUR J ORG CHEM, V2001, P1137, DOI 10.1002/1099-0690(200103)2001:6<1137::AID-EJOC1137>3.0.CO;2-2
   Shao P, 2014, FOOD HYDROCOLLOID, V41, P132, DOI 10.1016/j.foodhyd.2014.04.003
   Shi AM, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.693048
   Shirazi-Tehrani E, 2022, RNA BIOL, V19, P575, DOI 10.1080/15476286.2022.2066335
   Shuang F.F., 2022, LWT, V172, P218
   Simsek A, 2023, EUR FOOD RES TECHNOL, V249, P2077, DOI 10.1007/s00217-023-04277-y
   Smarrito CM, 2008, ORG BIOMOL CHEM, V6, P986, DOI 10.1039/b719132d
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   Song J, 2019, FOOD FUNCT, V10, P2947, DOI [10.1039/c8fo02599a, 10.1039/C8FO02599A]
   Sonnante G, 2010, PLANT PHYSIOL, V153, P1224, DOI 10.1104/pp.109.150144
   Su MM, 2019, FOODBORNE PATHOG DIS, V16, P823, DOI 10.1089/fpd.2019.2678
   Sun J., 2020, Food Hydrocolloids, V108
   Sun ZL, 2020, WORLD J MICROB BIOT, V36, DOI 10.1007/s11274-020-2799-2
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   Suzuki A, 2006, FEBS LETT, V580, P2317, DOI 10.1016/j.febslet.2006.03.047
   Suzuki A, 2002, HYPERTENS RES, V25, P99, DOI 10.1291/hypres.25.99
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tang ZX, 2012, J CHROMATOGR SCI, V50, P76, DOI 10.1093/chromsci/bmr003
   Tom ENL, 2016, PHYTOMEDICINE, V23, P1037, DOI 10.1016/j.phymed.2016.06.012
   Tomas-Barberan F, 2014, MOL NUTR FOOD RES, V58, P1122, DOI 10.1002/mnfr.201300441
   Tosovic J, 2017, FOOD CHEM, V237, P390, DOI 10.1016/j.foodchem.2017.05.080
   Tsai CF, 2021, PROCESSES, V9, DOI 10.3390/pr9112040
   Tsou SH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092235
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI [10.1139/H11-072, 10.1139/h11-072]
   Venditti A, 2014, CHEM BIODIVERS, V11, P245, DOI 10.1002/cbdv.201300253
   von Schwartzenberg RJ, 2021, NATURE, V595, P272, DOI 10.1038/s41586-021-03663-4
   Vu DC, 2021, MOLECULES, V26, DOI 10.3390/molecules26216496
   Wang L, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.943911
   Wang LN, 2016, MOLECULES, V21, DOI 10.3390/molecules21060737
   Wang S, 2021, FOOD CHEM, V357, DOI 10.1016/j.foodchem.2021.129904
   Wang WW, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01681
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Ward NC, 2016, FOOD FUNCT, V7, P2197, DOI [10.1039/C6FO00248J, 10.1039/c6fo00248j]
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Wei ZH, 2016, INT J BIOL MACROMOL, V86, P376, DOI 10.1016/j.ijbiomac.2016.01.084
   Wen H, 2022, FOOD SCI HUM WELL, V11, P854, DOI 10.1016/j.fshw.2022.03.007
   Willem M, 2022, SCIENCE, V375, P147, DOI 10.1126/science.abn5428
   Wu Y, 2018, INT J FOOD SCI NUTR, V69, P566, DOI 10.1080/09637486.2017.1394449
   Xi Y, 2022, FOOD FUNCT, V13, P1535, DOI [10.1039/D1FO03334D, 10.1039/d1fo03334d]
   Xiao F, 2022, ACS SYNTH BIOL, V11, P800, DOI 10.1021/acssynbio.1c00487
   Xie MG, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/3456542
   Xu HX, 2019, FOOD CHEM, V298, DOI 10.1016/j.foodchem.2019.125024
   Xu JG, 2012, J AGR FOOD CHEM, V60, P11625, DOI 10.1021/jf303771s
   Xu XX, 2020, ECOTOX ENVIRON SAFE, V205, DOI 10.1016/j.ecoenv.2020.111376
   Yang LC, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-018-2720-1
   Yao J, 2019, BIOFACTORS, V45, P616, DOI 10.1002/biof.1507
   Yao XH, 2018, J CHROMATOGR B, V1092, P82, DOI 10.1016/j.jchromb.2018.05.045
   Ye XL, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.762691
   Yildirim S, 2018, COMPR REV FOOD SCI F, V17, P165, DOI 10.1111/1541-4337.12322
   Yu Y, 2021, CROP J, V9, P204, DOI 10.1016/j.cj.2020.06.003
   Zeng L, 2022, BIOMED PHARMACOTHER, V149, DOI 10.1016/j.biopha.2022.112831
   Zhang JR, 2017, PLANT PHYSIOL BIOCH, V121, P74, DOI 10.1016/j.plaphy.2017.10.017
   Zhang XH, 2020, POULTRY SCI, V99, P6606, DOI 10.1016/j.psj.2020.09.082
   Zhang Y, 2018, FOOD FUNCT, V9, P4968, DOI [10.1039/C8FO01126E, 10.1039/c8fo01126e]
   Zhao MM, 2010, FOOD CHEM, V120, P1138, DOI 10.1016/j.foodchem.2009.11.044
   Zhao YY, 2018, TALANTA, V181, P271, DOI 10.1016/j.talanta.2018.01.037
   Zhou BL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00575
   Zhu S., 2020, Royal Society Open Science, V7
   Zou YC, 2020, CARBOHYD POLYM, V247, DOI 10.1016/j.carbpol.2020.116711
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 145
TC 10
Z9 10
U1 18
U2 53
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-5423
EI 1365-2621
J9 INT J FOOD SCI TECH
JI Int. J. Food Sci. Technol.
PD OCT
PY 2023
VL 58
IS 10
BP 4931
EP 4947
DI 10.1111/ijfs.16617
PG 17
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA CJ6P3
UT WOS:001124927400026
DA 2025-04-28
ER

PT J
AU Panchal, SK
   Poudyal, H
   Waanders, J
   Brown, L
AF Panchal, Sunil K.
   Poudyal, Hemant
   Waanders, Jennifer
   Brown, Lindsay
TI Coffee Extract Attenuates Changes in Cardiovascular and Hepatic
   Structure and Function without Decreasing Obesity in High-Carbohydrate,
   High-Fat Diet-Fed Male Rats
SO JOURNAL OF NUTRITION
LA English
DT Article
ID METABOLIC SYNDROME; ENDOTHELIAL FUNCTION; ABDOMINAL OBESITY; CHLOROGENIC
   ACID; BLOOD-PRESSURE; RISK; CONSUMPTION; CAFFEINE; DISEASE; HEALTHY
AB Coffee, a rich source of natural products, including caffeine, chlorogenic acid, and diterpenoid alcohols, has been part of the human diet since the 15th century. In this study, we characterized the effects of Colombian coffee extract (CE), which contains high concentrations of caffeine and diterpenoids, on a rat model of human metabolic syndrome. The 8-9 wk old male Wistar rats were divided into four groups. Two groups of rats were fed a corn starch-rich diet whereas the other two groups were given a high-carbohydrate, high-fat diet with 25% fructose in drinking water for 16 wk. One group fed each diet was supplemented with 5% aqueous CE for the final 8 wk of this protocol. The corn starch diet contained similar to 68% carbohydrates mainly as polysaccharides, whereas the high-carbohydrate, high-fat diet contained similar to 68% carbohydrates mainly as fructose and sucrose together with 24% fat, mainly as saturated and monounsaturated fat from beef tallow. The high-carbohydrate, high-fat diet-fed rats showed the symptoms of metabolic syndrome leading to cardiovascular remodeling and nonalcoholic fatty liver disease. CE supplementation attenuated impairment in glucose tolerance, hypertension, cardiovascular remodeling, and nonalcoholic fatty liver disease without changing abdominal obesity and dyslipidemia. This study suggests that CE can attenuate diet-induced changes in the structure and function of the heart and the liver without changing the abdominal fat deposition. J. Nutr. 142: 690-697, 2012.
C1 [Panchal, Sunil K.; Brown, Lindsay] Univ So Queensland, Dept Biol & Phys Sci, Toowoomba, Qld 4350, Australia.
   [Panchal, Sunil K.; Poudyal, Hemant; Brown, Lindsay] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.
   [Waanders, Jennifer] Univ Queensland, Sch Land Crop & Food Sci, Brisbane, Qld, Australia.
C3 University of Southern Queensland; University of Queensland; University
   of Queensland
RP Brown, L (corresponding author), Univ So Queensland, Dept Biol & Phys Sci, Toowoomba, Qld 4350, Australia.
EM Lindsay.Brown@usq.edu.au
RI Poudyal, Hemant/HOH-9324-2023
OI Panchal, Sunil K/0000-0001-5464-3376
FU Dr. Red Nutraceuticals, Brisbane, Australia; Prince Charles Hospital
   Foundation, Brisbane, Australia
FX Supported by Dr. Red Nutraceuticals, Brisbane, Australia and The Prince
   Charles Hospital Foundation, Brisbane, Australia.
CR ARO A, 1987, METABOLISM, V36, P1027, DOI 10.1016/0026-0495(87)90021-7
   Bachmann K, 1996, ENVIRON HEALTH PERSP, V104, P400, DOI 10.2307/3432684
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   Bhattacharya J, 2011, J ECON PERSPECT, V25, P139, DOI 10.1257/jep.25.1.139
   Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006
   Buscemi S, 2010, EUR J CLIN NUTR, V64, P483, DOI 10.1038/ejcn.2010.9
   Casanueva FF, 2010, CLIN ENDOCRINOL, V73, P35, DOI 10.1111/j.1365-2265.2009.03727.x
   Catalano D, 2010, DIGEST DIS SCI, V55, P3200, DOI 10.1007/s10620-010-1143-3
   de Roos B, 1999, CURR OPIN LIPIDOL, V10, P41, DOI 10.1097/00041433-199902000-00008
   de Roos B, 2001, AM J CLIN NUTR, V73, P45
   DESIMONE G, 1988, JPN HEART J, V29, P151
   Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5
   Duvnjak M, 2007, WORLD J GASTROENTERO, V13, P4539, DOI 10.3748/wjg.v13.i34.4539
   Geleijnse JM, 2008, VASC HEALTH RISK MAN, V4, P963
   Giovannucci E, 1998, AM J EPIDEMIOL, V147, P1043, DOI 10.1093/oxfordjournals.aje.a009398
   Hamer M, 2006, J HUM HYPERTENS, V20, P909, DOI 10.1038/sj.jhh.1002076
   Hu G, 2008, HEPATOLOGY, V48, P129, DOI 10.1002/hep.22320
   Inoue M, 1998, CANCER CAUSE CONTROL, V9, P209, DOI 10.1023/A:1008890529261
   Jakobsen MU, 2007, EPIDEMIOL REV, V29, P77, DOI 10.1093/epirev/mxm002
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kiyohara C, 1999, BRIT J NUTR, V82, P125, DOI 10.1017/S0007114599001270
   Klag MJ, 2002, ARCH INTERN MED, V162, P657, DOI 10.1001/archinte.162.6.657
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188
   Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x
   Nishi M, 1996, JPN J CLIN ONCOL, V26, P42, DOI 10.1093/oxfordjournals.jjco.a023177
   Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899
   Panchal SK, 2011, J NUTR, V141, P1062, DOI 10.3945/jn.111.137877
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]
   Papamichael CM, 2005, CLIN SCI, V109, P55, DOI 10.1042/CS20040358
   Poudyal H, 2012, J NUTR BIOCHEM, V23, P153, DOI 10.1016/j.jnutbio.2010.11.011
   Poudyal H, 2010, BRIT J NUTR, V104, P1322, DOI 10.1017/S0007114510002308
   Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18
   SCHWARZ B, 1994, PREV MED, V23, P377, DOI 10.1006/pmed.1994.1052
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4
   Tofovic SP, 2002, KIDNEY INT, V61, P1433, DOI 10.1046/j.1523-1755.2002.00278.x
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120
   WILSON JR, 1980, AM J MED, V68, P664, DOI 10.1016/0002-9343(80)90252-1
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
NR 47
TC 79
Z9 81
U1 0
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD APR
PY 2012
VL 142
IS 4
BP 690
EP 697
DI 10.3945/jn.111.153577
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 914RT
UT WOS:000301970200008
PM 22378327
OA Bronze
DA 2025-04-28
ER

PT J
AU Budryn, G
   Zaklos-Szyda, M
   Zaczynska, D
   Zyzelewicz, D
   Grzelczyk, J
   Zdunczyk, Z
   Juskiewicz, J
AF Budryn, Grazyna
   Zaklos-Szyda, Malgorzata
   Zaczynska, Donata
   Zyzelewicz, Dorota
   Grzelczyk, Joanna
   Zdunczyk, Zenon
   Juskiewicz, Jerzy
TI Green and roasted coffee extracts as antioxidants in βTC3 cells with
   induced oxidative stress and lipid accumulation inhibitors in 3T3L1
   cells, and their bioactivity in rats fed high fat diet
SO EUROPEAN FOOD RESEARCH AND TECHNOLOGY
LA English
DT Article
DE Green and roasted coffee; Chlorogenic acids; Dichlorogenic acids; 3T3L1;
   beta TC3; Rat model; Antidiabetic activity
ID CHLOROGENIC ACID; IN-VITRO; EGG-WHITE; MELANOIDINS; BEANS; CYCLODEXTRIN;
   PEROXIDATION; INCLUSION; DIGESTION; PRODUCTS
AB Chlorogenic acids from coffee show high antioxidant activity that contributes to inhibition of oxidative stress, which results in anticancer, antidiabetic and antiobesity coffee activities. Coffee roasting causes their partial decomposition and partial incorporation into Maillard reaction products also of high antioxidant activity, and it is still not clear whether more favorable impact on health is associated with the consumption of green or roasted coffee. The aim of the study was to evaluate the impact of coffee roasting process and also of the degree of chlorogenic acid esterification on bioactivity of coffee extracts. Extracts of green and roasted coffee and their fractions containing mono- and dichlorogenic acids (six extracts) were obtained by purification and optional fractionation of crude extracts using preparative centrifugal partition chromatography technique. The extracts were evaluated in vitro in terms of scavenging capacity, influence on lipids accumulation in 3T3L1 adipocytes, cytoprotective potential decreasing oxidative stress induced by cellular pro-oxidants in beta TC3 cells, and in vivo by selected physiological indices in rats fed diets supplemented with the extracts. Roasted coffee extracts, in particular hydrophilic fraction containing monochlorogenic acids and Maillard reaction products, showed the highest scavenging capacity and contributed to the highest level of antioxidants in the hydrophilic fraction of rats serum and may be potentially used as anticancer nutraceutical with oxidative stress inhibitor activity. Non-fractionated green coffee extract exhibited antidiabetic activities including inhibition of adipogenesis, while in vivo it significantly lowered the levels of triglycerides, glucose and oxidized glutathione.
C1 [Budryn, Grazyna; Zaczynska, Donata; Zyzelewicz, Dorota; Grzelczyk, Joanna] Lodz Univ Technol, Inst Food Technol & Anal, Fac Biotechnol & Food Sci, PL-90924 Lodz, Poland.
   [Zaklos-Szyda, Malgorzata] Lodz Univ Technol, Inst Tech Biochem, Fac Biotechnol & Food Sci, PL-90924 Lodz, Poland.
   [Zdunczyk, Zenon; Juskiewicz, Jerzy] Polish Acad Sci, Inst Anim Reprod & Food Res, PL-10748 Olsztyn, Poland.
C3 Lodz University of Technology; Lodz University of Technology; Polish
   Academy of Sciences; Institute of Animal Reproduction & Food Research of
   the Polish Academy of Sciences
RP Budryn, G (corresponding author), Lodz Univ Technol, Inst Food Technol & Anal, Fac Biotechnol & Food Sci, PL-90924 Lodz, Poland.
EM grazyna.budryn@p.lodz.pl
RI Budryn, Grazyna/M-4168-2018; Zduńczyk, Zenon/H-7272-2017; Zaklos-Szyda,
   Malgorzata/M-5229-2019; Grzelczyk, Joanna/G-5698-2019; Zyzelewicz,
   Dorota/M-3397-2018; JUSKIEWICZ, Jerzy/H-7193-2017
OI Zaklos-Szyda, Malgorzata/0000-0001-8341-1654; Grzelczyk,
   Joanna/0000-0002-0802-7115; Zyzelewicz, Dorota/0000-0003-0989-0671;
   JUSKIEWICZ, Jerzy/0000-0003-0068-5970
FU NCBiR [POIG.02.01.00-10-171/09]
FX The financial support of this study was provided by the NCBiR (Project
   No. POIG.02.01.00-10-171/09).
CR Ahmed G. M., 2013, Advance Journal of Food Science & Technology, V5, P619
   Andueza S, 2009, FOOD RES INT, V42, P51, DOI 10.1016/j.foodres.2008.08.006
   Ayyagari VN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-61
   Azza E. M., 2011, INT J PHARM TOXICOLO, V1, P24
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Bohn SK, 2014, MOL NUTR FOOD RES, V58, P915, DOI 10.1002/mnfr.201300526
   BOTSOGLOU NA, 1994, J AGR FOOD CHEM, V42, P1931, DOI 10.1021/jf00045a019
   Budryn G., 2013, International Food Research Journal, V20, P2133
   Budryn G, 2015, FOOD CHEM, V168, P276, DOI 10.1016/j.foodchem.2014.07.056
   Budryn G, 2014, FOOD RES INT, V61, P202, DOI 10.1016/j.foodres.2013.10.013
   Budryn G, 2014, INT J FOOD PROP, V17, P1529, DOI 10.1080/10942912.2012.723235
   Budryn G, 2009, EUR FOOD RES TECHNOL, V228, P913, DOI 10.1007/s00217-008-1004-x
   Cheng JC, 2007, FOOD CHEM, V104, P132, DOI 10.1016/j.foodchem.2006.11.012
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Chu YF, 2011, FOOD CHEM, V124, P914, DOI 10.1016/j.foodchem.2010.07.019
   Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297
   Daglia M, 2008, J AGR FOOD CHEM, V56, P11653, DOI 10.1021/jf802018c
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   Iwai K, 2012, FOOD SCI TECHNOL RES, V18, P849, DOI 10.3136/fstr.18.849
   Kim J, 2014, FOOD SCI BIOTECHNOL, V23, P2029, DOI 10.1007/s10068-014-0276-0
   Kim SM, 2010, PHYTOCHEM ANALYSIS, V21, P457, DOI 10.1002/pca.1218
   Kowalska K, 2014, FOOD CHEM, V148, P246, DOI 10.1016/j.foodchem.2013.10.032
   Lee KW, 2006, BIOFACTORS, V26, P105, DOI 10.1002/biof.5520260202
   Liang NJ, 2016, FOOD CHEM, V213, P251, DOI 10.1016/j.foodchem.2016.06.041
   Liu YZ, 2011, FOOD RES INT, V44, P2418, DOI 10.1016/j.foodres.2010.12.037
   Lou ZX, 2011, J FOOD SCI, V76, pM398, DOI 10.1111/j.1750-3841.2011.02213.x
   Nam YH, 2015, J AGR FOOD CHEM, V63, P5612, DOI 10.1021/acs.jafc.5b00027
   Oboh G, 2013, NEUROCHEM RES, V38, P413, DOI 10.1007/s11064-012-0935-6
   Perrone D, 2012, J AGR FOOD CHEM, V60, P4265, DOI 10.1021/jf205388x
   Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378
   Reeves PG, 1997, J NUTR, V127, pS838
   Rufián-Henares JA, 2007, J AGR FOOD CHEM, V55, P10016, DOI 10.1021/jf0718291
   Satake T, 2007, BIOL PHARM BULL, V30, P935, DOI 10.1248/bpb.30.935
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Scherer R, 2009, FOOD CHEM, V112, P654, DOI 10.1016/j.foodchem.2008.06.026
   Shi HT, 2013, INFLAMM RES, V62, P581, DOI 10.1007/s00011-013-0610-7
   Sudha G., 2011, Int J Curr Pharm Res, V3, P137, DOI DOI 10.1111/J.1750-3841.2012.02944
   Sulaiman Shaida Fariza, 2011, Journal of Dietary Supplements, V8, P293, DOI 10.3109/19390211.2011.593618
   Sung WS, 2010, PURE APPL CHEM, V82, P219, DOI 10.1351/PAC-CON-09-01-08
   Tagliazucchi D, 2010, J AGR FOOD CHEM, V58, P2513, DOI 10.1021/jf903701h
   Vicente SJV, 2014, J AGR FOOD CHEM, V62, P116, DOI 10.1021/jf401777m
   Widowati W, 2014, IRAN J BASIC MED SCI, V17, P702
   Zaklos-Szyda M, 2015, CURR TOP MED CHEM, V15, P2431, DOI 10.2174/1568026615666150619143051
   Zyzelewicz D, 2016, FOOD RES INT, V89, P946, DOI 10.1016/j.foodres.2016.01.009
NR 44
TC 22
Z9 23
U1 3
U2 33
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1438-2377
EI 1438-2385
J9 EUR FOOD RES TECHNOL
JI Eur. Food Res. Technol.
PD AUG
PY 2017
VL 243
IS 8
BP 1323
EP 1334
DI 10.1007/s00217-017-2843-0
PG 12
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA FA2ZX
UT WOS:000405311800003
OA hybrid
DA 2025-04-28
ER

PT J
AU Lin, P
   Liang, ZA
   Wang, MY
AF Lin, Ping
   Liang, Zongan
   Wang, Maoyun
TI Caffeine consumption and mortality in populations with different weight
   statuses: An analysis of NHANES 1999-2014
SO NUTRITION
LA English
DT Article
DE Caffeine; Weightstatuses; NHANES; Mortality; Coffee
ID OXIDATIVE STRESS; ALL-CAUSE; ASSOCIATION; HEALTH; OVERWEIGHT; OBESITY;
   COFFEE
AB Objectives: The association between caffeine consumption and mortality in different weight statuses is unclear. This study aimed to explore the effects of caffeine consumption on mortality in different weight statuses. Methods: Data from the National Health and Nutrition Examination Survey (1999-2014) was used in this study. We used multivariable Cox proportional hazards models with appropriate sampling weight to assess the association of caffeine intake with mortality in different weight statuses. Results: A total of 37 211 participants were included in our study. Multivariate-adjusted analyses showed that moderate caffeine consumption was associated with decreased all-cause mortality in total participants (haz-ard ratio: 0.61; 95% confidence interval [CI], 0.42-0.89). In subsequent analyses, a significant association was found between moderate caffeine consumption and all-cause mortality in overweight persons, but this asso-ciation was not found among other weight groups. In comparison with nonconsumers, the pooled multivari-ate hazard ratios for all-cause mortality in overweight persons were 0.75 (95% CI, 0.39-1.43) for those who had low caffeine consumption (<100 mg/d), 0.44 (95% CI, 0.22-0.89) for moderate caffeine consumption (100-<200 mg/d), and 0.53 (95% CI, 0.27-1.03) for high caffeine consumption (>= 200 mg/d). No associations were found between caffeine intake and cardiovascular and cancer mortality. Conclusions: The present study suggests that moderate caffeine intake is associated with a lower risk of all-cause mortality in a large study of U.S. adults, especially among those who are overweight. Overweight individuals were more likely to benefit from moderate caffeine intake. (c) 2022 Elsevier Inc. All rights reserved.
C1 [Liang, Zongan; Wang, Maoyun] Sichuan Univ, West China Sch Med, Dept Resp & Crit Care Med, Chengdu, Peoples R China.
   Sichuan Univ, West China Hosp, Chengdu, Peoples R China.
C3 Sichuan University; Sichuan University
RP Liang, ZA; Wang, MY (corresponding author), Sichuan Univ, West China Sch Med, Dept Resp & Crit Care Med, Chengdu, Peoples R China.
EM liangza@scu.edu.cn; wmmyun@hotmail.com
CR Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   [Anonymous], NCHS RES ETH REV BOA
   Çakir ÖK, 2017, PHYSIOL BEHAV, V168, P1, DOI 10.1016/j.physbeh.2016.10.010
   Feng J, 2021, NURS REP, V11, P901, DOI 10.3390/nursrep11040083
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j
   Fulgoni VL, 2015, AM J CLIN NUTR, V101, P1081, DOI 10.3945/ajcn.113.080077
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Irwin C, 2020, NEUROSCI BIOBEHAV R, V108, P877, DOI 10.1016/j.neubiorev.2019.12.008
   Lopez-Garcia E, 2008, ANN INTERN MED, V148, P904, DOI 10.7326/0003-4819-148-12-200806170-00003
   Mazidi M, 2022, ARCH MED SCI, V18, P900, DOI 10.5114/aoms/144905
   McLellan TM, 2016, NEUROSCI BIOBEHAV R, V71, P294, DOI 10.1016/j.neubiorev.2016.09.001
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   Mukamal KJ, 2009, AM HEART J, V157, P495, DOI 10.1016/j.ahj.2008.11.009
   National Center for Health Statistics, NAT HLTH NUTR EX SUR
   National Center for Health Statistics. Office of Analysis and Epidemiology, PUBL US LINK MORT LI
   Neves JS, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00547
   Paganini-Hill A, 2007, PREV MED, V44, P305, DOI 10.1016/j.ypmed.2006.12.011
   Penson P, 2018, CRIT REV FOOD SCI, V58, P1706, DOI 10.1080/10408398.2016.1272045
   Tamakoshi A, 2011, EUR J EPIDEMIOL, V26, P285, DOI 10.1007/s10654-011-9548-7
   The National Center for Health Statistics, MEAS GUID DIET REC I
   Tsujimoto T, 2017, MAYO CLIN PROC, V92, P1190, DOI 10.1016/j.mayocp.2017.03.010
   Vieira MB, 2019, NEPHROL DIAL TRANSPL, V34, P974, DOI 10.1093/ndt/gfy234
   Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x
   WHO-World Health Organization, 2020, Overweight and Obesity
   Wickham KA, 2018, SPORTS MED, V48, pS79, DOI 10.1007/s40279-017-0848-2
   Wonisch W, 2012, AGING MALE, V15, P159, DOI 10.3109/13685538.2012.669436
   World Health Organization, Obesity and overweight
NR 27
TC 11
Z9 11
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD OCT
PY 2022
VL 102
AR 111731
DI 10.1016/j.nut.2022.111731
EA JUL 2022
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 6I8EE
UT WOS:000886363600014
PM 35810576
DA 2025-04-28
ER

PT J
AU Stohs, SJ
   Badmaev, V
AF Stohs, Sidney J.
   Badmaev, Vladimir
TI A Review of Natural Stimulant and Non-stimulant Thermogenic Agents
SO PHYTOTHERAPY RESEARCH
LA English
DT Review
DE thermogenesis; stimulant; non-stimulant; caffeine; ephedra; chlorogenic
   acid; p-synephrine; forskolin; green tea; capsaicin; flavonoids;
   carotenoids
ID AURANTIUM BITTER ORANGE; BROWN ADIPOSE-TISSUE; P-SYNEPHRINE; GREEN TEA;
   SALACIA-RETICULATA; INSULIN-RESISTANCE; METABOLIC SYNDROME; CITRUS
   FLAVONOIDS; POTENTIAL TARGET; DOWN-REGULATION
AB Obesity and overweight are major health issues. Exercise and calorie intake control are recognized as the primary mechanisms for addressing excess body weight. Naturally occurring thermogenic plant constituents offer adjunct means for assisting in weight management. The controlling mechanisms for thermogenesis offer many intervention points. Thermogenic agents can act through stimulation of the central nervous system with associated adverse cardiovascular effects and through metabolic mechanisms that are non-stimulatory or a combination thereof. Examples of stimulatory thermogenic agents that will be discussed include ephedrine and caffeine. Examples of non-stimulatory thermogenic agents include p-synephrine (bitter orange extract), capsaicin, forskolin (Coleus root extract), and chlorogenic acid (green coffee bean extract). Green tea is an example of a thermogenic with the potential to produce mild but clinically insignificant undesirable stimulatory effects. The use of the aforementioned thermogenic agents in combination with other extracts such as those derived from Salacia reticulata, Sesamum indicum, Lagerstroemia speciosa, Cissus quadrangularis, and Moringa olifera, as well as the use of the carotenoids as lutein and fucoxanthin, and flavonoids as naringin and hesperidin can further facilitate energy metabolism and weight management as well as sports performance without adverse side effects. (c) 2016 The Authors Phytotherapy Research published by John Wiley & Sons Ltd.
C1 [Stohs, Sidney J.] Creighton Univ, Sch Pharm & Hlth Profess, Omaha, NE 68178 USA.
   [Badmaev, Vladimir] Amer Med Holdings Inc, Staten Isl, NY 10314 USA.
C3 Creighton University
RP Stohs, SJ (corresponding author), 7068 Maumee Valley Court, Frisco, TX 75034 USA.
EM sid.stohs9@gmail.com
CR Abidov M, 2010, DIABETES OBES METAB, V12, P72, DOI 10.1111/j.1463-1326.2009.01132.x
   Alam MA, 2014, ADV NUTR, V5, P404, DOI 10.3945/an.113.005603
   Andraws R, 2005, PROG CARDIOVASC DIS, V47, P217, DOI 10.1016/j.pcad.2004.07.006
   [Anonymous], HERBALGRAM
   [Anonymous], OBESITY EPIDEMIOLOGY
   Arao K, 2004, BIOSCI BIOTECH BIOCH, V68, P2643, DOI 10.1271/bbb.68.2643
   Arao Keisuke, 2004, Lipids Health Dis, V3, P24, DOI 10.1186/1476-511X-3-24
   Asgary S, 2013, SCI WORLD J, DOI [10.1155/2013.365892eCollection, DOI 10.1155/2013.365892]
   Astrup A, 2000, ENDOCRINE, V13, P207, DOI 10.1385/ENDO:13:2:207
   Badmaev V, 2002, NUTRACOS, V1, P1
   Badmaev V, 2015, J FUNCT FOODS, V15, P44, DOI 10.1016/j.jff.2015.03.007
   Bahmani M, 2015, J EVID COMPL ALTERN
   BENOWITZ NL, 1990, ANNU REV MED, V41, P277, DOI 10.1146/annurev.me.41.020190.001425
   Biswas A, 2010, J FOOD SCI, V75, pH274, DOI 10.1111/j.1750-3841.2010.01821.x
   Bruckbauer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089166
   Carey AL, 2015, DIABETOLOGIA, V58, P1045, DOI 10.1007/s00125-015-3543-6
   Carpéné C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357
   Carpene' MA, 2014, TRENDS ENDOCRIN MET, V26, P238
   Celi FS, 2015, TRENDS ENDOCRIN MET, V26, P238, DOI 10.1016/j.tem.2015.03.003
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clapham JC, 2012, NEUROPHARMACOLOGY, V63, P111, DOI 10.1016/j.neuropharm.2011.10.014
   Copeland S, 2013, INT J OCCUP ENV MED, V4, P211
   Crespillo A, 2011, BRIT J PHARMACOL, V164, P1899, DOI 10.1111/j.1476-5381.2011.01477.x
   De Matteis R, 2002, INT J OBESITY, V26, P1442, DOI 10.1038/sj.ijo.0802148
   de Oliveira AL, 2014, MOL CELL BIOCHEM, V388, P135, DOI 10.1007/s11010-013-1905-2
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Donovan J L, 2001, Psychopharmacol Bull, V35, P30
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   European Food Safety Authority, 2015, EFSA J, V13, P120, DOI [10.2903/j.efsa.2015.4120, DOI 10.2903/J.EFSA.2015.4120]
   Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010
   Franke AA, 2014, ARCH BIOCHEM BIOPHYS, V559, P24, DOI 10.1016/j.abb.2014.06.007
   Godard MP, 2005, OBES RES, V13, P1335, DOI 10.1038/oby.2005.162
   Goldwasser J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012399, 10.1371/journal.pone.0013842]
   Hackman RM, 2006, INT J OBESITY, V30, P1545, DOI 10.1038/sj.ijo.0803283
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Hong NY, 2012, BIOCHEM BIOPH RES CO, V418, P720, DOI 10.1016/j.bbrc.2012.01.085
   Inchiosa MA, 2011, J OBES, V2011, DOI 10.1155/2011/764584
   INSEL PA, 1982, J BIOL CHEM, V257, P7485
   Janssens PLHR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067786
   Jitomir J, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-23
   Kaats GR, 2013, FOOD CHEM TOXICOL, V55, P358, DOI 10.1016/j.fct.2013.01.013
   Kamiya Tomoyasu, 2012, Glob J Health Sci, V4, P147, DOI 10.5539/gjhs.v4n5p147
   Kassis O, 2013, ISRAELI MED ASS, V15, P487
   Lai CS, 2012, J AGR FOOD CHEM, V60, P1094, DOI 10.1021/jf204862d
   Landsberg L, 1996, Blood Press Suppl, V1, P25
   Li PB, 2013, FOOD CHEM TOXICOL, V60, P1, DOI 10.1016/j.fct.2013.07.019
   LIU YL, 1995, INT J OBESITY, V19, P678
   Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Maeda H, 2015, J OLEO SCI, V64, P125, DOI 10.5650/jos.ess14226
   Matsumura Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112180
   Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7
   McCarty MF, 2015, OPEN HEART, V2, DOI [10.1136/openhrt-2015-000162eCollection., DOI 10.1136/OPENHRT-2015-000162]
   McNulty H, 2008, AM J CARDIOL, V101, p20D, DOI 10.1016/j.amjcard.2008.02.004
   Mercader J, 2011, J PHYSIOL BIOCHEM, V67, P443, DOI 10.1007/s13105-011-0078-2
   Montoya GA, 2014, BRIT J NUTR, V112, P1427, DOI 10.1017/S0007114514002232
   Mulvihill EE, 2009, DIABETES, V58, P2198, DOI 10.2337/db09-0634
   Mund RA, 2013, CARDIOL REV, V21, P265, DOI 10.1097/CRD.0b013e31829cabff
   Muriach M, 2008, J PHYSIOL BIOCHEM, V64, P149, DOI 10.1007/BF03168243
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Nunes AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00406
   Oelkrug R, 2015, J COMP PHYSIOL B, V185, P587, DOI 10.1007/s00360-015-0907-7
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Osakabe N, 2014, LIFE SCI, V114, P51, DOI 10.1016/j.lfs.2014.07.041
   Parhiz H, 2015, PHYTOTHER RES, V29, P323, DOI 10.1002/ptr.5256
   Peixoto JS, 2012, MOLECULES, V17, P5854, DOI 10.3390/molecules17055854
   Pichiah PBT, 2012, NUTR RES, V32, P856, DOI 10.1016/j.nutres.2012.09.015
   Poekes L, 2015, CLIN SCI, V129, P933, DOI 10.1042/CS20150339
   Ratamess NA, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0096-5
   Ray S, 2005, ARCH TOXICOL, V79, P330, DOI 10.1007/s00204-005-0672-6
   Reinbach HC, 2010, FOOD QUAL PREFER, V21, P655, DOI 10.1016/j.foodqual.2010.04.003
   Rosenbaum M, 2010, AM J CLIN NUTR, V88, P906
   Sayin MR, 2012, WIEN KLIN WOCHENSCHR, V124, P285, DOI 10.1007/s00508-012-0163-8
   Serra F, 1999, INT J OBESITY, V23, P650, DOI 10.1038/sj.ijo.0800897
   Srinivasan K., 2015, CRIT REV FOOD SCI NU, DOI [10.1080/10408398.772090, DOI 10.1080/10408398.772090]
   Stohs SJ, 2015, PHYTOTHER RES, V29, P986, DOI 10.1002/ptr.5382
   Stohs SJ, 2015, PHYTOTHER RES, V29, P796, DOI 10.1002/ptr.5325
   Stohs SJ, 2013, PHYTOTHER RES, V27, P1107, DOI 10.1002/ptr.4846
   Stohs SJ, 2012, INT J MED SCI, V9, P527, DOI 10.7150/ijms.4446
   Stohs SJ, 2012, PHYTOTHER RES, V26, P317, DOI 10.1002/ptr.3664
   Stohs SJ, 2011, PHYTOTHER RES, V25, P1421, DOI 10.1002/ptr.3490
   Stohs SJ, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/482973
   Stohs SJ, 2011, INT J MED SCI, V8, P295, DOI 10.7150/ijms.8.295
   Türközü D, 2017, CRIT REV FOOD SCI, V57, P254, DOI 10.1080/10408398.2014.986672
   Vukovich MD, 2005, CLIN EXP PHARMACOL P, V32, P47, DOI 10.1111/j.1440-1681.2005.04152.x
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Westfall TC, 2014, GOODMAN AND GILMANS
   Yoneshiro T, 2013, CURR OPIN CLIN NUTR, V16, P625, DOI 10.1097/MCO.0b013e3283653ee1
   Zhao J, 1997, J BIOL CHEM, V272, P32847, DOI 10.1074/jbc.272.52.32847
   Zheng Weijiang, 2013, Weishengwu Xuebao, V53, P1251
NR 91
TC 86
Z9 90
U1 1
U2 71
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD MAY
PY 2016
VL 30
IS 5
BP 732
EP 740
DI 10.1002/ptr.5583
PG 9
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA DL6YY
UT WOS:000375787200003
PM 26856274
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Yohannis, E
   Teka, TA
   Adebo, JA
   Urugo, MM
   Hossain, A
   Astatkie, T
AF Yohannis, Eyasu
   Teka, Tilahun A.
   Adebo, Janet Adeyinka
   Urugo, Markos Makiso
   Hossain, Abul
   Astatkie, Tessema
TI Phytochemical constituents, ethnomedicinal uses, and applications of
   coffee (Coffea arabica) leaves in functional beverages
SO JOURNAL OF FOOD COMPOSITION AND ANALYSIS
LA English
DT Article
DE Antioxidant activity; Bioavailability; Mangiferin; Modes of action;
   Rutin
ID NF-KAPPA-B; CHLOROGENIC ACID; IN-VITRO; ANTIOXIDANT PROPERTIES;
   PHENOLIC-COMPOUNDS; NICOTINIC-ACID; INDUCED DAMAGE; CAFFEINE;
   MANGIFERIN; INHIBITION
AB Traditionally, coffee-growing communities have used coffee leaves to make tea-like beverages valued for their rich phytonutrient content and ethnomedicinal properties. Among these phytonutrients, phenolic compounds, mainly mangiferin, found in Coffea arabica leaves, stands out for its potential therapeutic benefits, which may surpass those of coffee beans. Moreover, bioactive molecules in coffee leaves, such as mangiferin, trigonelline, caffeine, chlorogenic acids (CGAs), and rutin, contribute to their antioxidant, anti-inflammatory, anti-hypertensive, anti-obesity, antibacterial, antifungal, anticancer, and neuroprotective effects. However, the precise mechanisms underlying these activities remain unclear. This review offers a comprehensive overview of the phytochemical constituents, ethnomedicinal uses, and potential applications of C. arabica and C. robusta leaves in functional beverages. Additionally, it examines the mechanisms through which coffee leaves exert their therapeutic effects. It emphasizes the need for further studies to fully understand the pharmacological benefits, structure-activity relationships, and the impact of processing on bioactive compounds and bio-functional characteristics. Optimizing processing methods to preserve and enhance these bioactive compounds is crucial. Thus, this review promotes a deeper understanding of coffee leaves' potential in the functional beverage market, encouraging further exploration into their bioactive properties.
C1 [Yohannis, Eyasu; Teka, Tilahun A.; Urugo, Markos Makiso] Jimma Univ, Coll Agr & Vet Med, Dept Postharvest Management, POB 307, Jimma, Ethiopia.
   [Yohannis, Eyasu; Urugo, Markos Makiso] Wachemo Univ, Coll Agr Sci, Dept Food Sci & Postharvest Technol, Hossana, Ethiopia.
   [Adebo, Janet Adeyinka] Univ Johannesburg, Coll Business & Econ, Sch Tourism & Hospitality, Food Evolut Res Lab, Johannesburg, South Africa.
   [Hossain, Abul] Mem Univ Newfoundland, Dept Biochem, St John, NF A1C 5S7, Canada.
   [Astatkie, Tessema] Dalhousie Univ, Fac Agr, Truro, NS, Canada.
C3 Jimma University; University of Johannesburg; Memorial University
   Newfoundland; Dalhousie University
RP Teka, TA (corresponding author), Jimma Univ, Coll Agr & Vet Med, Dept Postharvest Management, POB 307, Jimma, Ethiopia.
EM tilaeta@gmail.com
RI Adebo, Janet/AAA-3571-2022; Urugo, Markos/GQQ-4360-2022; Hossain,
   Abul/AAE-4714-2020; Astatkie, Tess/J-7231-2012
OI Astatkie, Tess/0000-0002-9779-8789; Makiso, Urugo,
   Markos/0000-0002-6241-1417; Adebo, Janet Adeyinka/0000-0003-0044-9126
FX The authors declare that they have no known competing interests or
   personal relationships that could have appeared to the work reported in
   this paper.
CR Ali HM, 2019, MED CHEM RES, V28, P2262, DOI 10.1007/s00044-019-02452-z
   Almeida AAP, 2012, FOOD RES INT, V49, P459, DOI 10.1016/j.foodres.2012.07.026
   Andrs M, 2016, RSC ADV, V6, P32534, DOI 10.1039/c5ra22889a
   Antonio AG, 2011, ARCH ORAL BIOL, V56, P556, DOI 10.1016/j.archoralbio.2010.12.001
   Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493
   Ashihara H., 2015, Coffee in Health and Disease Prevention, V1, P19, DOI 10.1016/B978-0-12-409517-5.00003-6
   Ashihara H, 2015, PHYTOCHEM REV, V14, P765, DOI 10.1007/s11101-014-9375-z
   Belayneh A, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-18
   Bendary E., 2013, Annals of Agricultural Science (Cairo), V58, P173, DOI 10.1016/j.aoas.2013.07.002
   Bessada S M., 2018, Cosmetics, V5, P5, DOI [DOI 10.3390/COSMETICS5010005, 10.3390/cosmetics5010005]
   Bhattacharyya S, 2014, J SCI FOOD AGR, V94, P1380, DOI 10.1002/jsfa.6422
   Bohn T, 2014, NUTR REV, V72, P429, DOI 10.1111/nure.12114
   Boros B, 2010, J CHROMATOGR A, V1217, P7972, DOI 10.1016/j.chroma.2010.07.042
   Bucic-Kojic A, 2020, FOOD FUNCT, V11, P680, DOI [10.1039/c9fo02296a, 10.1039/C9FO02296A]
   Campa C, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01126
   Campa C, 2012, ANN BOT-LONDON, V110, P595, DOI 10.1093/aob/mcs119
   Cangeloni L, 2022, FOODS, V11, DOI 10.3390/foods11162495
   Chen XM, 2018, FOOD CHEM, V249, P143, DOI 10.1016/j.foodchem.2017.12.073
   Chen XM, 2019, CRIT REV FOOD SCI, V59, P1008, DOI 10.1080/10408398.2018.1546667
   Chu YF, 2011, FOOD CHEM, V124, P914, DOI 10.1016/j.foodchem.2010.07.019
   Cintineo HP, 2022, J INT SOC SPORT NUTR, V19, P543, DOI 10.1080/15502783.2022.2113339
   Corbo MR, 2014, COMPR REV FOOD SCI F, V13, P1192, DOI 10.1111/1541-4337.12109
   Côté J, 2010, CRIT REV FOOD SCI, V50, P666, DOI 10.1080/10408390903044107
   Davis AP, 2011, BOT J LINN SOC, V167, P357, DOI 10.1111/j.1095-8339.2011.01177.x
   de Almeida RF, 2019, FOOD RES INT, V115, P493, DOI 10.1016/j.foodres.2018.10.006
   DePaula J, 2019, BEVERAGES, V5, DOI 10.3390/beverages5020037
   Dini I, 2019, SCI BEVERAGES, V11, P1, DOI 10.1016/B978-0-12-816397-9.00001-7
   Scholz MBD, 2016, EUPHYTICA, V209, P429, DOI 10.1007/s10681-016-1653-y
   Du SY, 2018, MOL MED REP, V18, P4775, DOI 10.3892/mmr.2018.9529
   Durak A, 2014, FOOD CHEM, V162, P81, DOI 10.1016/j.foodchem.2014.03.132
   Dutta T, 2023, N-S ARCH PHARMACOL, V396, P851, DOI 10.1007/s00210-022-02373-6
   Ehlers A, 2019, FOOD CHEM TOXICOL, V130, P109, DOI 10.1016/j.fct.2019.05.028
   Ernest U, 2018, MOLECULES, V23, DOI 10.3390/molecules23112787
   Fernandez-Gomez B, 2016, FOOD RES INT, V89, P1015, DOI 10.1016/j.foodres.2016.03.006
   Ghiasi M, 2011, CARBOHYD RES, V346, P739, DOI 10.1016/j.carres.2011.01.021
   Ghorbani A, 2017, BIOMED PHARMACOTHER, V96, P305, DOI 10.1016/j.biopha.2017.10.001
   Giday M, 2010, J ETHNOPHARMACOL, V132, P75, DOI 10.1016/j.jep.2010.07.046
   Kitzberger CSG, 2016, AIMS AGRIC FOOD, V1, P254, DOI 10.3934/agrfood.2016.3.254
   Kitzberger CSG, 2013, J FOOD COMPOS ANAL, V30, P52, DOI 10.1016/j.jfca.2013.01.007
   Greenhough A, 2007, INT J CANCER, V121, P2172, DOI 10.1002/ijc.22917
   Grgic J, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100923
   Grzegorzewski J, 2022, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.752826
   Hasanah M., 2016, Sci. J. PPI-UKM Sci. Eng., V3, P2356, DOI [10.21752/sjppi-ukm/se/a14092016, DOI 10.21752/SJPPI-UKM/SE/A14092016]
   He Hui, 2017, Journal of Caffeine Research, V7, P95, DOI 10.1089/jcr.2017.0006
   Hu GL, 2019, FOOD FUNCT, V10, P3113, DOI [10.1039/c9fo00288j, 10.1039/C9FO00288J]
   Hwang JH, 2016, CHEM-BIOL INTERACT, V248, P1, DOI 10.1016/j.cbi.2016.01.020
   Imran M, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0449-y
   Izu GO, 2024, ANTIOXIDANTS-BASEL, V13, DOI 10.3390/antiox13040456
   Jyotshna, 2016, BIOFACTORS, V42, P504, DOI 10.1002/biof.1308
   Khurana RK, 2016, PHARM PAT ANAL, V5, P169, DOI 10.4155/ppa-2016-0003
   Kobayashi M, 2017, J NUTR SCI VITAMINOL, V63, P200, DOI 10.3177/jnsv.63.200
   Kot M, 2008, PHARMACOL REP, V60, P789
   Kurang R. Y., 2021, AIP Conference Proceedings, V2349, DOI [10.1063/5.0051835, DOI 10.1063/5.0051835]
   Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714
   Lamorde M, 2010, J ETHNOPHARMACOL, V130, P43, DOI 10.1016/j.jep.2010.04.004
   Lei JX, 2012, J CELL BIOCHEM, V113, P2633, DOI 10.1002/jcb.24138
   Lephart ED, 2016, AGEING RES REV, V31, P36, DOI 10.1016/j.arr.2016.08.001
   Li XC, 2018, CHEMISTRYOPEN, V7, P730, DOI 10.1002/open.201800108
   Liao WZ, 2016, EUR J MED CHEM, V114, P24, DOI 10.1016/j.ejmech.2016.02.045
   Lippolis T, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24043813
   Liu HH, 2012, DRUG METAB DISPOS, V40, P2109, DOI 10.1124/dmd.112.045849
   Liu J, 2019, RSC ADV, V9, P35825, DOI 10.1039/c9ra07808h
   Liu Y, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00867
   Luczkiewicz P, 2014, MED HYPOTHESES, V83, P570, DOI 10.1016/j.mehy.2014.08.021
   Madeira MH, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4761081
   Manea A, 2010, CELL TISSUE RES, V342, P325, DOI 10.1007/s00441-010-1060-y
   Martins SCV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094862
   Maxiselly Yudithia, 2022, International Journal of Plant Biology, V13, P106, DOI 10.3390/ijpb13020011
   Mittal Saurabh, 2020, J Complement Integr Med, V18, P9, DOI 10.1515/jcim-2019-0250
   Monteiro A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9010006
   Munyendo LM, 2021, J FOOD COMPOS ANAL, V102, DOI 10.1016/j.jfca.2021.103995
   Nascimento GO, 2023, J BIOMOL STRUCT DYN, V41, P14871, DOI 10.1080/07391102.2023.2188421
   Ngamsuk S, 2019, FOODS, V8, DOI 10.3390/foods8090389
   Nguyen V, 2024, INT J MOL SCI, V25, DOI 10.3390/ijms25063385
   Niture NT, 2014, INDIAN J EXP BIOL, V52, P720
   Pan Y, 2023, NAT PROD J, V13, DOI 10.2174/2210315513666230307115348
   Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41
   Patay ÉB, 2016, ASIAN PAC J TROP MED, V9, P1127, DOI 10.1016/j.apjtm.2016.11.008
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Quirós-Sauceda AE, 2014, FOOD FUNCT, V5, P1063, DOI 10.1039/c4fo00073k
   Rai S, 2018, INT J BIOL MACROMOL, V110, P425, DOI 10.1016/j.ijbiomac.2017.11.049
   Ramalakshmi K, 2009, FOOD CHEM, V115, P79, DOI 10.1016/j.foodchem.2008.11.063
   Ratanamarno S, 2017, MAEJO INT J SCI TECH, V11, P211
   Raveesha K. A., 2011, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V2, P856
   Refolo MG, 2015, J CELL PHYSIOL, V230, P2973, DOI 10.1002/jcp.25026
   Ren XP, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.602697
   Rodrigues F, 2017, HANDBOOK OF COFFEE PROCESSING BY-PRODUCTS: SUSTAINABLE APPLICATIONS, P195, DOI 10.1016/B978-0-12-811290-8.00007-4
   Rufián-Henares JA, 2007, J AGR FOOD CHEM, V55, P1480, DOI 10.1021/jf062604d
   Santana-Gálvez J, 2020, CYTA-J FOOD, V18, P245, DOI 10.1080/19476337.2020.1743762
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Segheto L, 2018, IND CROP PROD, V126, P48, DOI 10.1016/j.indcrop.2018.09.027
   Seruga M, 2014, INT J ELECTROCHEM SC, V9, P6134
   Shahidi F, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12010203
   Shan L, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.1030173
   Shen XJ, 2023, FOOD SCI NUTR, V11, P917, DOI 10.1002/fsn3.3126
   Shen YB, 2019, FOOD SCI NUTR, V7, P3062, DOI 10.1002/fsn3.1165
   Shi HT, 2016, CLIN NUTR, V35, P1366, DOI 10.1016/j.clnu.2016.03.002
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Simonsson M, 2013, CANCER CAUSE CONTROL, V24, P929, DOI 10.1007/s10552-013-0169-1
   Socala K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010107
   Souard F, 2018, FOOD CHEM, V245, P603, DOI 10.1016/j.foodchem.2017.10.022
   Stalmach A., 2012, Coffee: emerging health effects and disease prevention, P59
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stefanello N, 2014, MOL CELL BIOCHEM, V388, P277, DOI 10.1007/s11010-013-1919-9
   Steger MC, 2022, FOODS, V11, DOI 10.3390/foods11172553
   Suzuki A, 2006, FEBS LETT, V580, P2317, DOI 10.1016/j.febslet.2006.03.047
   Tabuti JRS, 2010, J ETHNOPHARMACOL, V127, P130, DOI 10.1016/j.jep.2009.09.035
   Trevitt J, 2009, PHARMACOL BIOCHEM BE, V94, P24, DOI 10.1016/j.pbb.2009.07.001
   Tungmunnithum Duangjai, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5030093
   Upadhyay R, 2013, CRIT REV FOOD SCI, V53, P968, DOI 10.1080/10408398.2011.576319
   Valko M, 2016, ARCH TOXICOL, V90, P1, DOI 10.1007/s00204-015-1579-5
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   Wang YB, 2015, EXP THER MED, V9, P451, DOI 10.3892/etm.2014.2090
   Wintgens J.N., 2004, Coffee: Growing, Processing, Sustainable Production, P87
   Woldeab B, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/4630371
   Xu HH, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110441
   Yang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033509
   Yang JX, 2008, LWT-FOOD SCI TECHNOL, V41, P1060, DOI 10.1016/j.lwt.2007.06.010
   Yosboonruang A, 2022, J MICROBIOL BIOTECHN, V32, P1003, DOI 10.4014/jmb.2204.04003
   Yoshinari O, 2009, BIOSCI BIOTECH BIOCH, V73, P1033, DOI 10.1271/bbb.80805
   Zhang TT, 2015, J FUNCT FOODS, V18, P423, DOI 10.1016/j.jff.2015.08.005
   Zhou JY, 2013, FUND CLIN PHARMACOL, V27, P279, DOI 10.1111/j.1472-8206.2011.01022.x
   Zhou L, 2016, J PHARMACOL EXP THER, V356, P74, DOI 10.1124/jpet.115.229005
NR 123
TC 0
Z9 0
U1 5
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1575
EI 1096-0481
J9 J FOOD COMPOS ANAL
JI J. Food Compos. Anal.
PD NOV
PY 2024
VL 135
AR 106570
DI 10.1016/j.jfca.2024.106570
EA AUG 2024
PG 15
WC Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology
GA D4L4N
UT WOS:001295912300001
DA 2025-04-28
ER

PT J
AU Uner, B
   Celebi, MSM
AF Uner, Burcu
   Celebi, Melahat Sedanur Macit
TI Anti-obesity effects of chlorogenic acid and caffeine- lipid
   nanoparticles through PPAR-γ/C/EBP-alpha pathways
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
ID COFFEE EXTRACTS; STABILITY; GREEN; SLN; DIFFERENTIATION; NANOEMULSIONS;
   ACCUMULATION; OPTIMIZATION; ANTIOXIDANTS; METABOLISM
AB Obesity is considered one of the most crucial health problems of the century. Therefore, reducing obesity is critically important. Caffeine (CF) and chlorogenic acid (CLA), which are substantial components in green bean coffee which maximize thermogenesis in brown adipose tissue. In our study, we have prepared CF, CLA, and CF + CLA loaded-solid lipid nanoparticles (SLN) since the SLNs are cost-effective, tissue-localized, and highly stable. The central composite design model was preferred to select the optimized formulation. UHPLC was used for quantification related to the CF and CLA amounts. The high-pressure homogenization (HPH) method was used while SLN formulations were prepared in the presence of poloxamer (R) 407 (surfactant) and Compritol (R) 888 ATO (solid lipid). The nanoparticles were characterized, followed by the utilization of 3T3-F442A cell lines for the evaluation of the adipogenesis activity of the formulations. Then, rt-PCR and ELISA studies of adipogenic markers were conducted. After optimal formulations were selected with an average of 110.2 & PLUSMN; 0.1 nm, CF (1 mM) + CLA (0.5 mM)-loaded SLN formulation has been proven significantly effective by using PPAR-?/C/EBP-a pathways. In a nutshell, our study has shown that CF + CLA loaded-SLN has been affected 45.8% times more than regular extracted coffee (p < 0.05) on the adipocyte cells.
C1 [Uner, Burcu] Univ Hlth Sci & Pharm St Louis, Dept Pharmaceut & Adm Sci, St Louis, MO 63110 USA.
   [Celebi, Melahat Sedanur Macit] Ondokuz Mayis Univ, Dept Nutr & Dietet, Samsun, Turkiye.
C3 University of Health Sciences & Pharmacy in St. Louis; Ondokuz Mayis
   University
RP Uner, B (corresponding author), Univ Hlth Sci & Pharm St Louis, Dept Pharmaceut & Adm Sci, St Louis, MO 63110 USA.
EM burcu.uner@uhsp.edu
RI Uner, Burcu/GPG-1519-2022
CR Ahmed WH, 2021, MOLECULES, V26, DOI 10.3390/molecules26133831
   Alvarez-Parrilla E, 2005, J INCL PHENOM MACRO, V53, P121, DOI 10.1007/s10847-005-1620-z
   [Anonymous], 2018, About us
   Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415
   Banerjee P, 2014, J FORENSIC SCI, V59, P865, DOI 10.1111/1556-4029.12387
   BLANCHARD J, 1983, J PHARMACOKINET BIOP, V11, P109, DOI 10.1007/BF01061844
   Budryn G, 2017, EUR FOOD RES TECHNOL, V243, P1323, DOI 10.1007/s00217-017-2843-0
   Cañueto J, 2012, BRIT J DERMATOL, V166, P830, DOI 10.1111/j.1365-2133.2011.10756.x
   Chantaburanan T, 2017, J COLLOID INTERF SCI, V504, P247, DOI 10.1016/j.jcis.2017.05.038
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113
   Cirera Susanna, 2013, BMC Res Notes, V6, P472, DOI 10.1186/1756-0500-6-472
   Daurio Dominick, 2011, Pharmaceutics, V3, P582, DOI 10.3390/pharmaceutics3030582
   de Carvalho SM, 2013, IND CROP PROD, V49, P278, DOI 10.1016/j.indcrop.2013.04.054
   del Campo G, 2010, TALANTA, V81, P367, DOI 10.1016/j.talanta.2009.12.010
   Duarte GS, 2010, FOOD CHEM, V118, P851, DOI 10.1016/j.foodchem.2009.05.042
   Faudone G, 2021, J MED CHEM, V64, P7156, DOI 10.1021/acs.jmedchem.1c00261
   Freitas C, 1999, J MICROENCAPSUL, V16, P59, DOI 10.1080/026520499289310
   García CB, 2015, J APPL STAT, V42, P648, DOI 10.1080/02664763.2014.980789
   Grzelczyk J, 2020, J THERM ANAL CALORIM, V142, P877, DOI 10.1007/s10973-020-09801-w
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Hamdani J, 2003, INT J PHARM, V260, P47, DOI 10.1016/S0378-5173(03)00229-1
   Harmonization E., 2005, GUID VAL AN PROC TEX
   He XY, 2021, J SCI FOOD AGR, V101, P631, DOI 10.1002/jsfa.10675
   Hosseinabadi S, 2020, J HERB MED, V22, DOI 10.1016/j.hermed.2020.100340
   Jeszka-Skowron M, 2016, EUR FOOD RES TECHNOL, V242, P1403, DOI 10.1007/s00217-016-2643-y
   Jiao Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020102
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kong L, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13795
   Kurylowicz A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176241
   Kusumah J, 2022, FOOD CHEM TOXICOL, V161, DOI 10.1016/j.fct.2022.112821
   Liu MT, 2021, INT J ENDOCRINOL, V2021, DOI 10.1155/2021/2215274
   Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333
   Maki C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173264
   Makino K, 2010, LANGMUIR, V26, P18016, DOI 10.1021/la1035745
   Malvern Instruments Ltd, 2014, ACH HIGH SENS DIFF S
   Marion-Letellier R, 2016, EUR J PHARMACOL, V785, P44, DOI 10.1016/j.ejphar.2015.11.004
   Martins IJ, 2017, ANN OBES DISORD, V2, P1018
   Mehaya FM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05508
   Mendonsa NS, 2018, INT J PHARMACEUT, V537, P122, DOI 10.1016/j.ijpharm.2017.12.008
   Michalchuk AAL, 2018, J MATER SCI, V53, P13380, DOI 10.1007/s10853-018-2324-2
   Mohamed IN, 2018, ACTA HISTOCHEM, V120, P242, DOI 10.1016/j.acthis.2018.02.006
   Monteiro MC, 2012, FOOD CHEM, V134, P611, DOI 10.1016/j.foodchem.2012.02.118
   Muller Rainer H, 2011, Curr Drug Discov Technol, V8, P207
   Müller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4
   Olofsson LE, 2008, J CLIN ENDOCR METAB, V93, P4880, DOI 10.1210/jc.2008-0574
   Sahagún DO, 2012, PPAR RES, V2012, DOI 10.1155/2012/318613
   Pan Q, 2015, J CONTROL RELEASE, V201, P32, DOI 10.1016/j.jconrel.2015.01.009
   Pardeike J, 2009, INT J PHARMACEUT, V366, P170, DOI 10.1016/j.ijpharm.2008.10.003
   Pinto SS, 2006, J CHEM THERMODYN, V38, P1515, DOI 10.1016/j.jct.2006.04.008
   Pirim D, 2014, J LIPID RES, V55, P85, DOI 10.1194/jlr.M043265
   Puglia C, 2016, DRUG DELIV, V23, P36, DOI 10.3109/10717544.2014.903011
   Pydi SP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11003-4
   Singh AK, 2023, CURR MED CHEM, V30, P3905, DOI 10.2174/0929867329666220816154634
   Sugiura C, 2020, J FOOD SCI, V85, P192, DOI 10.1111/1750-3841.14811
   Sun NN, 2016, MOLECULES, V21, DOI 10.3390/molecules21101351
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Trauer S, 2009, BRIT J CLIN PHARMACO, V68, P181, DOI 10.1111/j.1365-2125.2009.03463.x
   Uner B, 2023, AAPS PHARMSCITECH, V24, DOI 10.1208/s12249-023-02551-6
   Üner B, 2022, J MICROENCAPSUL, V39, P327, DOI 10.1080/02652048.2022.2079744
   Van Schaik L, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.621356
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   WHO, 2021, About us
   Wilfinger WW, 1997, BIOTECHNIQUES, V22, P474, DOI 10.2144/97223st01
   World Health Organization (WHO), 2022, About us
   Wu BG, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1500107
   Wu DP, 2013, HEPATO-GASTROENTEROL, V60, P99, DOI 10.5754/hge12415
   Wu SJ, 2018, RSC ADV, V8, P8544, DOI 10.1039/c8ra00539g
   Wulff-Pérez M, 2009, FOOD HYDROCOLLOID, V23, P1096, DOI 10.1016/j.foodhyd.2008.09.017
   Yang W, 2018, HERZ, V43, P719, DOI 10.1007/s00059-017-4618-6
   Yuan Y, 2008, FOOD RES INT, V41, P61, DOI 10.1016/j.foodres.2007.09.006
   Zhang CH, 2021, IRAN POLYM J, V30, P81, DOI 10.1007/s13726-020-00875-9
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zheng XJ, 2018, J FOOD BIOCHEM, V42, DOI 10.1111/jfbc.12501
NR 76
TC 9
Z9 9
U1 1
U2 15
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD NOV
PY 2023
VL 47
IS 11
BP 1108
EP 1119
DI 10.1038/s41366-023-01365-7
EA AUG 2023
PG 12
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA W0VH1
UT WOS:001051210400001
PM 37596386
DA 2025-04-28
ER

PT J
AU Farias-Pereira, R
   Park, CS
   Park, Y
AF Farias-Pereira, Renalison
   Park, Cheon-Seok
   Park, Yeonhwa
TI Mechanisms of action of coffee bioactive components on lipid metabolism
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Article
DE Alkaloid; Phenolic acid; Cholesterol; Obesity; Fat
ID ACTIVATED RECEPTOR-ALPHA; CHOLESTEROL-RAISING FACTOR; INDUCED HEPATIC
   STEATOSIS; PULP AQUEOUS EXTRACT; CHLOROGENIC ACID; PROTEIN-KINASE;
   ANTIOXIDANT ACTIVITY; INSULIN-RESISTANCE; FAT ACCUMULATION;
   NICOTINIC-ACID
AB Coffee consumption is associated with reduced risk of metabolic syndrome, obesity and diabetes, which may be related to the effects of coffee and its bioactive components on lipid metabolism. Coffee contains caffeine, a known neuromodulator that acts as an adenosine receptor antagonist, as well as other components, such as chlorogenic acids, trigonelline, cafestol and kahweol. Thus, this review discusses the up-to-date knowledge of mechanisms of action of coffee and its bioactive compounds on lipid metabolism. Although there is evidence that coffee and/or its bioactive compounds regulate transcription factors (e.g. peroxisome proliferator-activated receptors and sterol regulatory element binding proteins) and enzymes (e.g. AMP-activated protein kinase) involved in lipogenesis, lipid uptake, transport, fatty acid beta-oxidation and/or lipolysis, needs for the understanding of coffee and its effects on lipid metabolism in humans remain to be answered.
C1 [Farias-Pereira, Renalison; Park, Yeonhwa] Univ Massachusetts, Dept Food Sci, Amherst, MA 01003 USA.
   [Park, Cheon-Seok; Park, Yeonhwa] Kyung Hee Univ, Dept Food Sci & Biotechnol, Yongin 17104, South Korea.
C3 University of Massachusetts System; University of Massachusetts Amherst;
   Kyung Hee University
RP Park, Y (corresponding author), Univ Massachusetts, Dept Food Sci, Amherst, MA 01003 USA.; Park, Y (corresponding author), Kyung Hee Univ, Dept Food Sci & Biotechnol, Yongin 17104, South Korea.
EM ypark@foodsci.umass.edu
RI Park, Cheon-Seok/AAK-7189-2020; Park, Yeonhwa/B-9064-2008;
   Farias-Pereira, Renalison/F-8771-2012
OI Farias-Pereira, Renalison/0000-0002-8608-2347
FU Brazilian National Counsel of Technological and Scientific Development
   [CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico]
FX This work was financially supported by the Brazilian National Counsel of
   Technological and Scientific Development [CNPq, Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico]. The authors thank Mr. Joshua
   Barsczewski for his assistance editing this manuscript.
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Baek JH, 2017, BMB REP, V50, P566, DOI 10.5483/BMBRep.2017.50.11.031
   Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11
   Calvo D, 1998, J LIPID RES, V39, P777
   Caria CREP, 2014, FOOD RES INT, V61, P120, DOI 10.1016/j.foodres.2014.02.025
   Caron A, 2015, ANNU REV NUTR, V35, P321, DOI 10.1146/annurev-nutr-071714-034355
   Carrageta DF, 2018, J FUNCT FOODS, V43, P84, DOI 10.1016/j.jff.2018.02.001
   Cha KH, 2012, J AGR FOOD CHEM, V60, P7152, DOI 10.1021/jf301047f
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Chung S, 2016, PPAR RES, V2016, DOI 10.1155/2016/4794576
   Clifford MN, 2017, NAT PROD REP, V34, P1391, DOI 10.1039/c7np00030h
   da Cruz RG, 2018, FOOD SCI TECH-BRAZIL, V38, P447, DOI [10.1590/1678-457x.08017, 10.1590/1678-457X.08017]
   de Azevedo ABA, 2008, BRAZ J CHEM ENG, V25, P543, DOI 10.1590/S0104-66322008000300012
   Egawa T, 2011, ACTA PHYSIOL, V201, P227, DOI 10.1111/j.1748-1716.2010.02169.x
   Farah A., 2012, Coffee: emerging health effects and disease prevention, P21
   Farias-Pereira R, 2018, J FUNCT FOODS, V48, P586, DOI 10.1016/j.jff.2018.07.049
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Hamden Khaled, 2013, Sci Pharm, V81, P233, DOI 10.3797/scipharm.1211-14
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Jeon TI, 2013, CELL METAB, V18, P51, DOI 10.1016/j.cmet.2013.06.010
   Jeszka-Skowron M, 2016, EUR FOOD RES TECHNOL, V242, P1403, DOI 10.1007/s00217-016-2643-y
   Jia HJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0389-3
   Kamiyama M, 2015, J AGR FOOD CHEM, V63, P1996, DOI 10.1021/jf5060563
   Kim J, 2014, FOOD SCI BIOTECHNOL, V23, P2029, DOI 10.1007/s10068-014-0276-0
   Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x
   Lally JSV, 2012, ACTA PHYSIOL, V205, P71, DOI 10.1111/j.1748-1716.2012.02396.x
   Lee KJ, 2007, TOXICOL LETT, V173, P80, DOI 10.1016/j.toxlet.2007.06.008
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Limaa CS, 2017, BIOMED PHARMACOTHER, V92, P1045, DOI 10.1016/j.biopha.2017.05.109
   Liu CW, 2018, AM J PHYSIOL-ENDOC M, V314, pE433, DOI 10.1152/ajpendo.00094.2017
   Liu Jinning, 2018, Prev Nutr Food Sci, V23, P214, DOI [10.3746/pnf.2018.23.2.214, 10.3746/pnf.2018.23.3.214]
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Maréchal L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051529
   Martinez-Saez N, 2014, FOOD CHEM, V150, P227, DOI 10.1016/j.foodchem.2013.10.100
   Massafra V, 2018, BBA-MOL BASIS DIS, V1864, P45, DOI 10.1016/j.bbadis.2017.10.003
   Mathew TS, 2014, BIOCHEM BIOPH RES CO, V453, P411, DOI 10.1016/j.bbrc.2014.09.094
   Mellbye FB, 2017, J NAT PROD, V80, P2353, DOI 10.1021/acs.jnatprod.7b00395
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Mohamadi Neda, 2018, Journal of Dietary Supplements, V15, P207, DOI 10.1080/19390211.2017.1329244
   Mougios V, 2003, J APPL PHYSIOL, V94, P476, DOI 10.1152/japplphysiol.00624.2002
   Ameca GM, 2018, CIENC AGROTEC, V42, P307, DOI 10.1590/1413-70542018423000818
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Nakayama T, 2017, ONCOL LETT, V14, P1109, DOI 10.3892/ol.2017.6227
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Oh SH, 2018, FOOD CHEM TOXICOL, V121, P326, DOI 10.1016/j.fct.2018.09.008
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Ontawong A, 2019, J FUNCT FOODS, V54, P568, DOI 10.1016/j.jff.2019.02.011
   Ontawong A, 2019, PHYTOMEDICINE, V52, P187, DOI 10.1016/j.phymed.2018.06.021
   Palatini P, 2015, EUR J EPIDEMIOL, V30, P209, DOI 10.1007/s10654-015-9990-z
   Park I, 2017, BRIT J NUTR, V117, P979, DOI 10.1017/S0007114517000587
   Peng SG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8594767
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Post SM, 1997, ARTERIOSCL THROM VAS, V17, P3064, DOI 10.1161/01.ATV.17.11.3064
   Proença ARG, 2014, BRAZ J MED BIOL RES, V47, P192, DOI 10.1590/1414-431X20132911
   Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153
   Ramasamy I, 2014, CLIN CHEM LAB MED, V52, P1695, DOI 10.1515/cclm-2013-0358
   Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193
   Reis CEG, 2019, J TRADIT COMPL MED, V9, P184, DOI 10.1016/j.jtcme.2018.01.001
   Reis CEG, 2018, BRIT J NUTR, V119, P1029, DOI 10.1017/S000711451800034X
   Rendón MY, 2018, FOOD RES INT, V108, P280, DOI 10.1016/j.foodres.2018.03.041
   Ricketts ML, 2007, MOL ENDOCRINOL, V21, P1603, DOI 10.1210/me.2007-0133
   Riedel A, 2014, J NUTR BIOCHEM, V25, P750, DOI 10.1016/j.jnutbio.2014.03.002
   Robertson TM, 2018, BRIT J NUTR, V119, P792, DOI [10.1017/S0007114518000260, 10.1017/s0007114518000260]
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Saeed M, 2019, REV FOOD SCI NUTR, DOI [10.1080/10408398.2018.1489368, DOI 10.1080/10408398.2018.1489368]
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Schnuck JK, 2018, J PHYSIOL BIOCHEM, V74, P35, DOI 10.1007/s13105-017-0601-1
   Sharma L, 2018, FOOD CHEM TOXICOL, V121, P283, DOI 10.1016/j.fct.2018.09.011
   Shokouh P, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010006
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1258-y
   Takahashi K, 2017, NUTRITION, V38, P1, DOI 10.1016/j.nut.2016.12.021
   Urgert R, 1997, AM J CLIN NUTR, V65, P519, DOI 10.1093/ajcn/65.2.519
   van Cruchten S.T.J, 2010, THESIS
   Vandenberghe C, 2017, CAN J PHYSIOL PHARM, V95, P455, DOI 10.1139/cjpp-2016-0338
   Vignoli JA, 2014, FOOD RES INT, V61, P279, DOI 10.1016/j.foodres.2013.06.006
   Wang S, 2006, J NUTR, V136, P2791, DOI 10.1093/jn/136.11.2791
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Wu LF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15904
   Yang JS, 2019, FOOD CHEM TOXICOL, V125, P595, DOI 10.1016/j.fct.2019.02.005
   Yoshinari O, 2009, BIOSCI BIOTECH BIOCH, V73, P1033, DOI 10.1271/bbb.80805
   Yue YR, 2019, J SCI FOOD AGR, V99, P1190, DOI 10.1002/jsfa.9288
   Zhang SJ, 2015, FOOD FUNCT, V6, P2578, DOI [10.1039/c5fo00247h, 10.1039/C5FO00247H]
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zheng XC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0206-3
NR 92
TC 55
Z9 57
U1 8
U2 77
PU KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST
PI SEOUL
PA #605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL,
   135-703, SOUTH KOREA
SN 1226-7708
EI 2092-6456
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD OCT
PY 2019
VL 28
IS 5
BP 1287
EP 1296
DI 10.1007/s10068-019-00662-0
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA JG4HW
UT WOS:000492036200002
PM 31695927
OA Green Published
DA 2025-04-28
ER

PT J
AU Myslobodsky, M
   Eldan, A
AF Myslobodsky, M.
   Eldan, A.
TI Winning a Won Game: Caffeine Panacea for Obesity Syndemic
SO CURRENT NEUROPHARMACOLOGY
LA English
DT Article
DE Caffeine targets; obesity; reactive oxygen species; networks;
   polypharmacy
ID OBSTRUCTIVE SLEEP-APNEA; ENDOTHELIAL GROWTH-FACTOR; BLOOD-PRESSURE
   RHYTHM; TNF-ALPHA PRODUCTION; BODY-MASS INDEX; ADIPOSE-TISSUE;
   SUBSTANCE-P; ADENOSINE RECEPTORS; COFFEE CONSUMPTION; CIRCADIAN PATTERNS
AB Over the past decades, chronic sleep reduction and a concurrent development of obesity have been recognized as a common problem in the industrialized world. Among its numerous untoward effects, there is a possibility that insomnia is also a major contributor to obesity. This attribution poses a problem for caffeine, an inexpensive, "natural" agent that is purported to improve a number of conditions and is often indicated in a long-term pharmacotherapy in the context of weight management. The present study used the "common target" approach by exploring the tentative shared molecular networks of insomnia and adiposity. It discusses caffeine targets beyond those associated with adenosine signaling machinery, phosphodiesterases, and calcium release channels. Here, we provide a view suggesting that caffeine could exert some of its effects by acting on several signaling complexes composed of HIF-1 alpha/VEGF/IL-8 along with NO, TNF-alpha, IL1, and GHRH, among others. Although the relevance of these targets to the reported therapeutic effects of caffeine has remained difficult to assess, the utilization of caffeine efficacies and potencies recommend its repurposing for development of novel therapeutic approaches. Among indications mentioned, are neuroprotective, nootropic, antioxidant, proliferative, anti-fibrotic, and anti-angiogenic that appear under a variety of dissimilar diagnostic labels comorbid with obesity. In the absence of safe and efficacious antiobesity agents, caffeine remains an attractive adjuvant.
C1 [Myslobodsky, M.] NIMH, Clin Brain Disorders Branch, NIH, Bethesda, MD 20892 USA.
   [Myslobodsky, M.] Howard Univ, Grad Sch, Washington, DC 20059 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Mental Health (NIMH); Howard University
RP Myslobodsky, M (corresponding author), NIMH, Clin Brain Disorders Branch, NIH, Bethesda, MD 20892 USA.
EM myslobom@mail.nih.gov
CR Albensi BC, 2000, SYNAPSE, V35, P151
   Alonso-Vale MIC, 2005, AM J PHYSIOL-ENDOC M, V288, pE805, DOI 10.1152/ajpendo.00478.2004
   Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447
   Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   Astrup A, 2000, ENDOCRINE, V13, P207, DOI 10.1385/ENDO:13:2:207
   Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022
   Baethge C, 2009, BIPOLAR DISORD, V11, P494, DOI 10.1111/j.1399-5618.2009.00727.x
   Bass J, 2005, ARCH INTERN MED, V165, P15, DOI 10.1001/archinte.165.1.15
   Blanck HM, 2007, J AM DIET ASSOC, V107, P441, DOI 10.1016/j.jada.2006.12.009
   Blundell JE, 2006, OBESITY, V14, p160S, DOI 10.1038/oby.2006.298
   Bogdan A, 2001, LIFE SCI, V68, P1607, DOI 10.1016/S0024-3205(01)00966-3
   Bogdan A, 2005, BRIT J NUTR, V93, P515, DOI 10.1079/BJN20041380
   Bray GA, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801269
   Calabrese EJ, 2008, AGEING RES REV, V7, P8, DOI 10.1016/j.arr.2007.07.001
   Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985
   Carley DW, 2005, IDRUGS, V8, P310
   Casadó V, 2009, PHARMACOL THERAPEUT, V124, P248, DOI 10.1016/j.pharmthera.2009.07.005
   Chaput JP, 2006, EUR J CLIN PHARMACOL, V62, P793, DOI 10.1007/s00228-006-0186-z
   Chavez-Valdez R, 2009, PEDIATR RES, V65, P203, DOI 10.1203/PDR.0b013e31818d66b1
   Cohen MV, 2008, BASIC RES CARDIOL, V103, P203, DOI 10.1007/s00395-007-0687-7
   COLAS C, 2009, INT J ANDROL
   COLLINS C, 1979, J PHARM PHARMACOL, V31, P611, DOI 10.1111/j.2042-7158.1979.tb13602.x
   CONNOR S, 2003, INDEPENDENT, V8, P1
   Cornelis MC, 2004, J MED GENET, V41, P758, DOI 10.1136/jmg.2004.022012
   Crawford C, 2000, ANN NY ACAD SCI, V907, P21
   Daly JW, 2007, CELL MOL LIFE SCI, V64, P2153, DOI 10.1007/s00018-007-7051-9
   Daly JW, 2000, J AUTONOM NERV SYST, V81, P44, DOI 10.1016/S0165-1838(00)00110-7
   Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111
   Dray C, 2007, J PHYSIOL BIOCHEM, V63, P329, DOI 10.1007/BF03165764
   Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x
   Edwards JM, 2008, CORONARY ARTERY DIS, V19, P27, DOI 10.1097/MCA.0b013e3282f262b4
   Eichling PS, 2005, J CLIN SLEEP MED, V1, P291
   FEIHL F, 2008, CARDIOVASC RES, V22
   Feihl F, 2006, HYPERTENSION, V48, P1012, DOI 10.1161/01.HYP.0000249510.20326.72
   Ferre S, 2008, FRONT BIOSCI-LANDMRK, V13, P2391, DOI 10.2741/2852
   Flier JS, 2004, ANN INTERN MED, V141, P885, DOI 10.7326/0003-4819-141-11-200412070-00014
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Garvey JF, 2009, EUR RESPIR J, V33, P1195, DOI 10.1183/09031936.00111208
   Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901
   Goel N, 2009, J BIOL RHYTHM, V24, P85, DOI 10.1177/0748730408328914
   GOMEZAMBROSI J, 2009, J NUTR BIOCH
   Greenway Frank L, 2008, Endocr Pract, V14, P697
   Gross K, 2009, AM J PHYSIOL-GASTR L, V296, pG1012, DOI 10.1152/ajpgi.90351.2008
   Gunga HC, 2003, EUR J APPL PHYSIOL, V88, P497, DOI 10.1007/s00421-002-0734-x
   Gurevich F, 2009, AM J MED, V122, P322, DOI 10.1016/j.amjmed.2008.11.025
   Hackman RM, 2006, INT J OBESITY, V30, P1545, DOI 10.1038/sj.ijo.0803283
   Haguenauer D, 2000, OSTEOPOROSIS INT, V11, P727, DOI 10.1007/s001980070051
   Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011
   Härtter S, 2003, BRIT J CLIN PHARMACO, V56, P679, DOI 10.1046/j.1365-2125.2003.01933.x
   Haslam D, 2006, BMJ-BRIT MED J, V333, P640, DOI 10.1136/bmj.333.7569.640
   Hasler G, 2004, SLEEP, V27, P661, DOI 10.1093/sleep/27.4.661
   Hayashi K, 2009, J ORTHOP SCI, V14, P253, DOI 10.1007/s00776-009-1336-9
   Hemmrich K, 2006, MOL PSYCHIATR, V11, P980, DOI 10.1038/sj.mp.4001892
   Hong BN, 2008, NEUROSCI LETT, V441, P302, DOI 10.1016/j.neulet.2008.06.049
   Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013
   Horrigan LA, 2004, INT IMMUNOPHARMACOL, V4, P1409, DOI 10.1016/j.intimp.2004.06.005
   Hu G, 2007, AM J CLIN NUTR, V86, P457, DOI 10.1093/ajcn/86.2.457
   Huang C, 2009, PREV CHRONIC DIS, V6
   Huang QL, 2006, J ENDOCRINOL, V191, P179, DOI 10.1677/joe.1.06906
   Jacobson Kenneth A, 2009, Handb Exp Pharmacol, P1, DOI 10.1007/978-3-540-89615-9_1
   Janson C, 2001, SLEEP, V24, P425, DOI 10.1093/sleep/24.4.425
   Jessen A, 2005, DIABETES OBES METAB, V7, P327, DOI 10.1111/j.1463-1326.2004.00389.x
   Kamat JP, 2000, INT J RADIAT BIOL, V76, P1281
   Karagiannides I, 2008, GASTROENTEROLOGY, V134, P747, DOI 10.1053/j.gastro.2007.12.032
   Kawahara M, 2008, ANTICANCER RES, V28, P1681
   Kidd PM, 2008, ALTERN MED REV, V13, P85
   Kiefer FN, 2003, CURR PHARM DESIGN, V9, P1733, DOI 10.2174/1381612033454540
   KNOBLOVITS P, 2009, J ANDROL
   KOSTOPOULOS G, 1987, EPILEPSIA, V28, P415, DOI 10.1111/j.1528-1157.1987.tb03667.x
   Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521
   Lacobellis G, 2008, HORM METAB RES, V40, P442, DOI 10.1055/s-2008-1062724
   LANDAW SA, 1990, CLIN LAB MED, V10, P857
   Landolt HP, 2008, BIOCHEM PHARMACOL, V75, P2070, DOI 10.1016/j.bcp.2008.02.024
   Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpregu.00304.2005
   Lauderdale DS, 2009, AM J EPIDEMIOL, V170, P805, DOI 10.1093/aje/kwp230
   Lavie L, 2009, PROG CARDIOVASC DIS, V51, P303, DOI 10.1016/j.pcad.2008.08.003
   Lavie P, 2009, J SLEEP RES, V18, P397, DOI 10.1111/j.1365-2869.2009.00754.x
   Ledoux S, 2008, DIABETES, V57, P3247, DOI 10.2337/db07-1812
   Lee SH, 2008, INT J GERONTOL, V2, P1, DOI 10.1016/S1873-9598(08)70001-2
   Liao J, 2004, NUTR CANCER, V48, P44, DOI 10.1207/s15327914nc4801_7
   Liu ZW, 2007, J NEUROPHYSIOL, V97, P837, DOI 10.1152/jn.00873.2006
   Martin-Schild S, 2009, J STROKE CEREBROVASC, V18, P86, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.015
   Meier M, 2009, CURR PROBL DERMATOL, V38, P1, DOI 10.1159/000232301
   Merighi S, 2007, MOL PHARMACOL, V72, P395, DOI 10.1124/mol.106.032920
   Motivala SJ, 2009, PSYCHONEUROENDOCRINO, V34, P540, DOI 10.1016/j.psyneuen.2008.10.016
   Mourad JJ, 2008, ANN ONCOL, V19, P927, DOI 10.1093/annonc/mdm550
   Mutphy P, 2002, LEUKEMIA RES, V26, P1007, DOI 10.1016/S0145-2126(02)00053-X
   Myslobodsky M, 2010, REV NEUROSCIENCE, V21, P67
   Myslobodsky M, 2009, OBESITY FACTS, V2, P384, DOI 10.1159/000261422
   Myslobodsky M, 2009, CURR DRUG TARGETS, V10, P1009, DOI 10.2174/138945009789577927
   NABE B, 1995, J SLEEP RES, V4, P97, DOI 10.1111/j.1365-2869.1995.tb00196.x
   Naguib M, 2007, J PINEAL RES, V42, P12, DOI 10.1111/j.1600-079X.2006.00384.x
   Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925
   Nielsch U, 2007, DRUG DISCOV TODAY, V12, P1025, DOI 10.1016/j.drudis.2007.10.004
   Nilsson PM, 2004, DIABETES CARE, V27, P2464, DOI 10.2337/diacare.27.10.2464
   Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749
   Norman D, 2008, SLEEP BREATH, V12, P199, DOI 10.1007/s11325-007-0153-7
   Obal F, 2003, FRONT BIOSCI-LANDMRK, V8, pD520, DOI 10.2741/1033
   Ohta M, 1999, ANN NUTR METAB, V43, P52, DOI 10.1159/000012767
   Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098
   Pastorino F, 2009, CURR DRUG TARGETS, V10, P1021, DOI 10.2174/138945009789577954
   Patel SR, 2008, INT J OBESITY, V32, P1825, DOI 10.1038/ijo.2008.198
   Penev Plamen D, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P374, DOI 10.1097/MED.0b013e3282be9093
   Pietersen AN, 2009, NEUROPHARMACOLOGY, V56, P481, DOI 10.1016/j.neuropharm.2008.10.001
   Prunet-Marcassus B, 2003, ENDOCRINOLOGY, V144, P5347, DOI 10.1210/en.2003-0693
   Qin LQ, 2003, LIFE SCI, V73, P2467, DOI 10.1016/S0024-3205(03)00628-3
   Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019
   Riksen NP, 2009, PHARMACOL THERAPEUT, V121, P185, DOI 10.1016/j.pharmthera.2008.10.006
   Ryzhov S, 2007, J PHARMACOL EXP THER, V320, P565, DOI 10.1124/jpet.106.114850
   Sabisz M, 2008, CURR PHARM BIOTECHNO, V9, P325, DOI 10.2174/138920108785161497
   SAWYNOK J, 1995, DRUGS, V49, P37, DOI 10.2165/00003495-199549010-00004
   Sawynok J, 1998, EUR J PHARMACOL, V347, P1, DOI 10.1016/S0014-2999(97)01605-1
   She MH, 2009, PHARMACOL RES, V59, P248, DOI 10.1016/j.phrs.2009.01.005
   Shi D, 2003, CELL MOL NEUROBIOL, V23, P331, DOI 10.1023/A:1023688604792
   SILVERMAN K, 1992, NEW ENGL J MED, V327, P1109, DOI 10.1056/NEJM199210153271601
   Simon C, 1998, J CLIN ENDOCR METAB, V83, P1893, DOI 10.1210/jc.83.6.1893
   Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423
   Sinton CM, 1999, J SLEEP RES, V8, P197, DOI 10.1046/j.1365-2869.1999.00158.x
   Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055
   SNYDER SH, 1984, J PSYCHIAT RES, V18, P91, DOI 10.1016/0022-3956(84)90001-3
   Son TG, 2008, NEUROMOL MED, V10, P236, DOI 10.1007/s12017-008-8037-y
   Song YM, 2009, ACTA BIOL HUNG, V60, P399, DOI 10.1556/ABiol.60.2009.4.6
   Spinetta MJ, 2008, PSYCHOPHARMACOLOGY, V201, P361, DOI 10.1007/s00213-008-1294-5
   Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107
   Stone Trevor W, 2009, Handb Exp Pharmacol, P535, DOI 10.1007/978-3-540-89615-9_17
   Strandberg L, 2008, OBESITY, V16, P710, DOI 10.1038/oby.2007.95
   Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006
   Sullivan SS, 2009, EXPERT OPIN EMERG DR, V14, P411, DOI 10.1517/14728210903171948
   Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942
   Szentirmai E, 2007, AM J PHYSIOL-REG I, V293, pR922, DOI 10.1152/ajpregu.00237.2007
   Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x
   Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249
   Tchekalarova J, 2009, SEIZURE-EUR J EPILEP, V18, P463, DOI 10.1016/j.seizure.2009.04.002
   Terzano MG, 2003, DRUG SAFETY, V26, P261, DOI 10.2165/00002018-200326040-00004
   Tjepkema Michael, 2005, Health Rep, V17, P9
   Tobinick EL, 2009, DRUG NEWS PERSPECT, V22, P119, DOI 10.1358/dnp.2009.22.2.1303818
   Tsioufis C, 2008, J HUM HYPERTENS, V22, P501, DOI 10.1038/jhh.2008.20
   Ursing C, 2003, J ENDOCRINOL INVEST, V26, P403, DOI 10.1007/BF03345194
   Vali A, 2005, J DERMATOL TREAT, V16, P234, DOI 10.1080/09546630510011801
   Vondracek SF, 2009, PHARMACOTHERAPY, V29, P305, DOI 10.1592/phco.29.3.305
   Vorona RD, 2005, ARCH INTERN MED, V165, P25, DOI 10.1001/archinte.165.1.25
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Widberg CH, 2009, AM J PHYSIOL-ENDOC M, V296, pE121, DOI 10.1152/ajpendo.90602.2008
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Wolden-Hanson T, 2000, ENDOCRINOLOGY, V141, P487, DOI 10.1210/en.141.2.487
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang HY, 2004, CLIN EXP METASTAS, V21, P719, DOI 10.1007/s10585-004-8251-4
   Yang R, 2008, J ANDROL, V29, P586, DOI 10.2164/jandrol.107.004721
   Yeomans MR, 2007, PHYSIOL BEHAV, V92, P831, DOI 10.1016/j.physbeh.2007.06.006
   Yoshimura Hiroshi, 2005, Current Neuropharmacology, V3, P309, DOI 10.2174/157015905774322543
   Yu LQ, 2006, NEUROSCI LETT, V393, P31, DOI 10.1016/j.neulet.2005.09.036
   Zhang GL, 2004, BRAIN RES, V1028, P225, DOI 10.1016/j.brainres.2004.09.017
   Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983
   Zhao J, 2003, BRIT J PHARMACOL, V140, P1399, DOI 10.1038/sj.bjp.0705573
NR 157
TC 1
Z9 2
U1 0
U2 4
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-159X
EI 1875-6190
J9 CURR NEUROPHARMACOL
JI Curr. Neuropharmacol.
PD JUN
PY 2010
VL 8
IS 2
BP 149
EP 160
DI 10.2174/157015910791233213
PG 12
WC Neurosciences; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 599KE
UT WOS:000277910000010
PM 21119886
OA Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Kong, L
   Xu, M
   Qiu, YY
   Liao, MF
   Zhang, QF
   Yang, LC
   Zheng, GD
AF Kong, Li
   Xu, Meng
   Qiu, Yangyang
   Liao, Mingfu
   Zhang, Qingfeng
   Yang, Licong
   Zheng, Guodong
TI Chlorogenic acid and caffeine combination attenuates adipogenesis by
   regulating fat metabolism and inhibiting adipocyte differentiation in
   3T3-L1 cells
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article
DE L1 cells; caffeine; chlorogenic acid; differentiation; fat metabolism
ID ACTIVATED PROTEIN-KINASE; AMPK-DEPENDENT PATHWAY; LIPID-METABOLISM;
   PPAR-GAMMA; C/EBP-ALPHA; OBESITY; EXPRESSION; MANAGEMENT; ENZYMES;
   TARGET
AB Obesity is a complex disease spreading in the world. In our previous studies, chlorogenic acid (CGA) and caffeine had ever been reported to reduce the body weight gain and fat accumulation in mice. This study investigated the anti-obesity effect of CGA and caffeine on 3T3-L1 cells. According to triglyceride (TG) assay and Oil-Red O staining, 40 mu g/ml CGA and 160 mu g/ml caffeine reduced TG content. Moreover, CGA + caffeine inhibited the mRNA expression of major adipogenic markers, PPAR-gamma 2, and C/EBP alpha in the metaphase and anaphase stages of differentiation induction (Day 2 and 4). CGA + caffeine improved P-AMPK/AMPK accompanied by decreasing the expression of GPDH and FAS to depress the lipid synthesis, increasing the mRNA expression of ACO and CAT to promote fatty acid oxidation and up-regulated the expression of hydrolysis-related enzyme adipose TG lipase (ATGL) and P-HSL/HSL. Furthermore, CGA + caffeine improved the expression of Glut4 which promoted the glucose transport. Taken together, these data demonstrated CGA + caffeine inhibited 3T3-L1 cells differentiation in the middle and late stages and reduced the fat accumulation through AMPK pathway by regulating the fat metabolism-related enzyme in 3T3-L1 cells to attenuates adipogenesis.
   Practical applications The aim of this study was to elucidate the potential role of chlorogenic acid and caffeine in the treatment of obesity.
C1 [Kong, Li; Xu, Meng; Qiu, Yangyang; Liao, Mingfu; Zhang, Qingfeng; Yang, Licong; Zheng, Guodong] Jiangxi Agr Univ, Sch Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University
RP Yang, LC; Zheng, GD (corresponding author), Jiangxi Agr Univ, Sch Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Jiangxi, Peoples R China.
EM wanttobea@163.com; zrs150716@aliyun.com
RI Zhang, Qing-FENG/F-6875-2015
OI Zheng, Guodong/0000-0002-9601-0056
FU National Natural Science Foundation of China [81760157, 82060165]
FX National Natural Science Foundation of China, Grant/Award Number:
   81760157 and 82060165
CR Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Catalioto RM, 2013, BIOCHEM PHARMACOL, V86, P508, DOI 10.1016/j.bcp.2013.06.005
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Feng L, 2010, ACTA PHARMACOL SIN, V31, P329, DOI 10.1038/aps.2010.11
   Forbes-Hernández TY, 2020, FOOD FUNCT, V11, P297, DOI [10.1039/c9fo02285f, 10.1039/C9FO02285F]
   Gowans GJ, 2014, BIOCHEM SOC T, V42, P71, DOI 10.1042/BST20130244
   Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965
   Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116
   Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x
   Hu GL, 2019, FOOD FUNCT, V10, P3113, DOI [10.1039/c9fo00288j, 10.1039/C9FO00288J]
   Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015
   Ruiz-Ojeda FJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071040
   Jeong YU, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020460
   Karri S, 2019, BIOMED PHARMACOTHER, V110, P224, DOI 10.1016/j.biopha.2018.11.076
   KELLEY DS, 1986, BIOCHEM J, V235, P87, DOI 10.1042/bj2350087
   Kralova E, 2021, J PHARM PHARMACOL, V73, P778, DOI 10.1093/jpp/rgab005
   Lee JW, 2012, J LIPID RES, V53, P1277, DOI 10.1194/jlr.M022897
   Liu JL, 2018, FOOD SCI TECHNOL RES, V24, P903, DOI 10.3136/fstr.24.903
   Luiken JJFP, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165775
   Maki C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173264
   Morais S, 2007, PHYSIOL GENOMICS, V28, P239, DOI 10.1152/physiolgenomics.00136.2006
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mouton AJ, 2020, CIRC RES, V126, P789, DOI 10.1161/CIRCRESAHA.119.312321
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Park HJ, 2012, FOOD CHEM, V134, P227, DOI 10.1016/j.foodchem.2012.02.101
   Rao MY, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/5101423
   Reddy MRG, 2016, BBA-MOL CELL BIOL L, V1861, P156, DOI 10.1016/j.bbalip.2015.11.005
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882
   Sun NN, 2016, MOLECULES, V21, DOI 10.3390/molecules21101351
   Vazirian M, 2018, FOOD CHEM TOXICOL, V122, P69, DOI 10.1016/j.fct.2018.09.079
   Wang J, 2019, J AGR FOOD CHEM, V67, P14056, DOI 10.1021/acs.jafc.9b05072
   Wang L, 2015, CELL PHYSIOL BIOCHEM, V35, P2285, DOI 10.1159/000374032
   Wang QQ, 2017, CURR PHARM DESIGN, V23, P3677, DOI 10.2174/1381612823666170704125104
   Wang QA, 2014, ADIPOCYTE, V3, P146, DOI 10.4161/adip.27656
   Wang ZY, 2019, J AGR FOOD CHEM, V67, P1092, DOI 10.1021/acs.jafc.8b05281
   World Health Organization, 2020, WHO GLOB INF
   Xu M, 2019, FOOD FUNCT, V10, P7489, DOI 10.1039/c9fo00502a
   Xu Y, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00219
   Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070663
   Zhao Y, 2017, EUR J NUTR, V56, P2309, DOI 10.1007/s00394-016-1271-4
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zou TD, 2020, J SCI FOOD AGR, V100, P2389, DOI 10.1002/jsfa.10248
NR 45
TC 29
Z9 30
U1 3
U2 46
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD JUL
PY 2021
VL 45
IS 7
AR e13795
DI 10.1111/jfbc.13795
EA MAY 2021
PG 11
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA TC4HC
UT WOS:000654042600001
PM 34036605
OA gold
DA 2025-04-28
ER

PT J
AU Reis, CEG
   Paiva, CLRD
   Amato, AA
   Lofrano-Porto, A
   Wassell, S
   Bluck, LJC
   Dórea, JG
   da Costa, THM
AF Reis, Caio E. G.
   Paiva, Cicilia L. R. dos S.
   Amato, Angelica A.
   Lofrano-Porto, Adriana
   Wassell, Sara
   Bluck, Leslie J. C.
   Dorea, Jose G.
   da Costa, Teresa H. M.
TI Decaffeinated coffee improves insulin sensitivity in healthy men
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Glucose; Stable isotopes; Insulin sensitivity assessment; Intestinal
   cytokines
ID CAFFEINATED COFFEE; GLUCOSE-TOLERANCE; GLYCEMIC INDEX; POSTPRANDIAL
   GLUCOSE; CHLOROGENIC ACID; BODY-MASS; CONSUMPTION; OVERWEIGHT;
   HOMEOSTASIS; METABOLISM
AB Epidemiological studies have found coffee consumption is associated with a lower risk for type 2 diabetes mellitus, but the underlying mechanisms remain unclear. Thus, the aim of this randomised, cross-over single-blind study was to investigate the effects of regular coffee, regular coffee with sugar and decaffeinated coffee consumption on glucose metabolism and incretin hormones. Seventeen healthy men participated in five trials each, during which they consumed coffee (decaffeinated, regular (containing caffeine) or regular with sugar) or water (with or without sugar). After 1 h of each intervention, they received an oral glucose tolerance test with one intravenous dose of [1-C-13] glucose. The Oral Dose Intravenous Label Experiment was applied and glucose and insulin levels were interpreted using a stable isotope two-compartment minimal model. A mixed-model procedure (PROC MIXED), with subject as random effect and time as repeated measure, was used to compare the effects of the beverages on glucose metabolism and incretin parameters (glucose-dependent insulinotropic peptide (GIP)) and glucagon-like peptide-1 (GLP-1)). Insulin sensitivity was higher with decaffeinated coffee than with water (P<0.05). Regular coffee with sugar did not significantly affect glucose, insulin, C-peptide and incretin hormones, compared with water with sugar. Glucose, insulin, C-peptide, GLP-1 and GIP levels were not statistically different after regular and decaffeinated coffee compared with water. Our findings demonstrated that the consumption of decaffeinated coffee improves insulin sensitivity without changing incretin hormones levels. There was no short-term adverse effect on glucose homoeostasis, after an oral glucose challenge, attributable to the consumption of regular coffee with sugar.
C1 [Reis, Caio E. G.; Dorea, Jose G.; da Costa, Teresa H. M.] Univ Brasilia, Dept Nutr, BR-70910900 Brasilia, DF, Brazil.
   [Paiva, Cicilia L. R. dos S.] Univ Brasilia, Fac Hlth Sci, BR-70910900 Brasilia, DF, Brazil.
   [Amato, Angelica A.; Lofrano-Porto, Adriana] Univ Brasilia, Dept Pharmaceut Sci, BR-70910900 Brasilia, DF, Brazil.
   [Wassell, Sara; Bluck, Leslie J. C.] MRC, Elsie Widdowson Lab, Cambridge CB1 9NL, England.
C3 Universidade de Brasilia; Universidade de Brasilia; Universidade de
   Brasilia; UK Research & Innovation (UKRI); Medical Research Council UK
   (MRC); MRC Human Nutrition Research
RP da Costa, THM (corresponding author), Univ Brasilia, Dept Nutr, BR-70910900 Brasilia, DF, Brazil.
EM thmdacosta@gmail.com
RI da Costa, Teresa/H-8434-2013; Reis, Caio/O-1889-2013; Porto,
   Adriana/J-8310-2014
OI Reis, Caio/0000-0001-7260-9497
FU National Council for Scientific and Technological Development (CNPq,
   Brazil) [473074-2010-9]; MRC-Elsie Widdowson Laboratory
   [MC_UP_A090_1005, MC_U105960384]; MRC [MC_U105960384] Funding Source:
   UKRI
FX The study was funded by National Council for Scientific and
   Technological Development (CNPq, Brazil, grant no. 473074-2010-9) and
   MRC-Elsie Widdowson Laboratory (UK, Physiological Modelling of Metabolic
   Risk - MC_UP_A090_1005 and Nutrition Surveys and Studies -
   MC_U105960384).
CR Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Aldughpassi A, 2009, BRIT J NUTR, V101, P1282, DOI 10.1017/S0007114508079610
   [Anonymous], 2000, WHO TECHN REP SER
   [Anonymous], 2013, ISRN pharmacology
   [Anonymous], EUROPEAN J NUTR
   Aston L, 2007, INT J OBESITY, V31, pS28
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Beaudoin MS, 2011, J NUTR, V141, P574, DOI 10.3945/jn.110.132761
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Bluck L, 2013, ISRN ENDOCRINOL
   Bluck LJC, 2006, RAPID COMMUN MASS SP, V20, P493, DOI 10.1002/rcm.2326
   Bluck LJC, 2004, MEAS SCI TECHNOL, V15, pN21, DOI 10.1088/0957-0233/15/2/N02
   Buscemi S, 2010, EUR J CLIN NUTR, V64, P483, DOI 10.1038/ejcn.2010.9
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Casal S, 2017, CURR MED CHEM, V24, P376, DOI 10.2174/0929867323666161003123717
   Clapperton A. T., 2001, Proceedings of the Nutrition Society, V60, p217A
   Clapperton AT, 2002, RAPID COMMUN MASS SP, V16, P2009, DOI 10.1002/rcm.815
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dórea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974
   Dube S, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0605-6
   Gavrieli A, 2013, METABOLISM, V62, P1099, DOI 10.1016/j.metabol.2013.02.003
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539
   Gutch Manish, 2015, Indian J Endocrinol Metab, V19, P160, DOI 10.4103/2230-8210.146874
   Hätönen KA, 2012, EUR J NUTR, V51, P801, DOI 10.1007/s00394-011-0258-4
   Jackson SJ, 2007, RAPID COMMUN MASS SP, V21, P3123, DOI 10.1002/rcm.3195
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kim SD, 2015, J MICROBIOL BIOTECHN, V25, P174, DOI 10.4014/jmb.1411.11057
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Liang NJ, 2014, MOLECULES, V19, P19180, DOI 10.3390/molecules191119180
   Littell RC, 1998, J ANIM SCI, V76, P1216
   Louie JCY, 2008, ASIA PAC J CLIN NUTR, V17, P657
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   LUKASKI HC, 1986, J APPL PHYSIOL, V60, P1327, DOI 10.1152/jappl.1986.60.4.1327
   [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI [10.5935/abc.20160153, 10.5935/abc.20160152]
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Moisey LL, 2008, AM J CLIN NUTR, V87, P1254, DOI 10.1093/ajcn/87.5.1254
   Moisey LL, 2010, BRIT J NUTR, V103, P833, DOI 10.1017/S0007114509992406
   Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Nuhu Abdulmumin A, 2014, ISRN Nutr, V2014, P384230, DOI 10.1155/2014/384230
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Sousa AG, 2015, BRIT J NUTR, V113, P1615, DOI 10.1017/S0007114515000835
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Wang Bin, 2009, Journal of Aeronautical Materials, V29, P1
NR 50
TC 23
Z9 23
U1 0
U2 12
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD MAY 14
PY 2018
VL 119
IS 9
BP 1029
EP 1038
DI 10.1017/S000711451800034X
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GN6IV
UT WOS:000439185100008
PM 29514721
OA Bronze
DA 2025-04-28
ER

PT J
AU Barrea, L
   Pugliese, G
   Frias-Toral, E
   El Ghoche, M
   Castellucci, B
   Chapela, SP
   Carignano, MD
   Laudisio, D
   Savastano, S
   Colao, A
   Muscogiuri, G
AF Barrea, Luigi
   Pugliese, Gabriella
   Frias-Toral, Evelyn
   El Ghoche, Marwan
   Castellucci, Bianca
   Pablo Chapela, Sebastian
   de los Angeles Carignano, Maria
   Laudisio, Daniela
   Savastano, Silvia
   Colao, Annamaria
   Muscogiuri, Giovanna
TI Coffee consumption, health benefits and side effects: a narrative review
   and update for dietitians and nutritionists
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Coffee; caffeine; obesity; metabolic syndrome; nutritionist
ID POLYCYCLIC AROMATIC-HYDROCARBONS; DOSE-RESPONSE METAANALYSIS; HEPATIC
   LIPID-METABOLISM; INDUCED OXIDATIVE STRESS; CHLOROGENIC ACID; TEA
   CONSUMPTION; GREEN COFFEE; GEOGRAPHICAL ORIGIN; DIABETES-MELLITUS;
   GLUCOSE-TOLERANCE
AB Coffee is one of the most popular beverages worldwide; however, its impact on health outcomes and adverse effects is not fully understood. The current review aims to establish an update about the benefits of coffee consumption on health outcomes highlighting its side effects, and finally coming up with an attempt to provide some recommendations on its doses. A literature review using the PubMed/Medline database was carried out and the data were summarized by applying a narrative approach using the available evidence based on the literature. The main findings were the following: first, coffee may contribute to the prevention of inflammatory and oxidative stress-related diseases, such as obesity, metabolic syndrome and type 2 diabetes; second, coffee consumption seems to be associated with a lower incidence of several types of cancer and with a reduction in the risk of all-cause mortality; finally, the consumption of up to 400 mg/day (1-4 cups per day) of caffeine is safe. However, the time gap between coffee consumption and some drugs should be taken into account in order to avoid interaction. However, most of the data were based on cross-sectional or/and observational studies highlighting an association of coffee intake and health outcomes; thus, randomized controlled studies are needed in order to identify a causality link.
C1 [Barrea, Luigi] Univ Telemat Pegaso, Dipartimento Sci Umanist, Via Porzio,Isola F2, I-80143 Naples, Italy.
   [Barrea, Luigi; Pugliese, Gabriella; Castellucci, Bianca; Laudisio, Daniela; Savastano, Silvia; Colao, Annamaria; Muscogiuri, Giovanna] Univ Med Sch Naples, Ctr Italiano Cura & Benessere Paziente Obesita CI, Dept Clin Med & Surg, Endocrinol Unit, Via Sergio Pansini 5, I-80131 Naples, Italy.
   [Pugliese, Gabriella; Laudisio, Daniela; Savastano, Silvia; Colao, Annamaria; Muscogiuri, Giovanna] Univ Naples Federico II, Unit Endocrinol, Dipartimento Med Clin & Chirurg, Med Sch Naples, Via Sergio Pansini 5, I-80131 Naples, Italy.
   [Frias-Toral, Evelyn] Univ Catolica Santiago Guayaquil, Sch Med, Guayaquil, Ecuador.
   [El Ghoche, Marwan] Beirut Arab Univ, Fac Hlth Sci, Dept Nutr & Dietet, POB 11-5020 Riad El Solh, Beirut 11072809, Lebanon.
   [Pablo Chapela, Sebastian] Univ Buenos Aires, Fac Med, Dept Bioquim Humana, Buenos Aires, DF, Argentina.
   [Pablo Chapela, Sebastian] Hosp Britan Buenos Aires, Dept Terapia Intens, Buenos Aires, DF, Argentina.
   [de los Angeles Carignano, Maria] Sanatorio Franchin, Intens Care Unit, Bartolome Mitre 3565, Buenos Aires, DF, Argentina.
   [Colao, Annamaria; Muscogiuri, Giovanna] Univ Federico II, Cattedra Unesco Educ Salute & Allo Sviluppo Soste, Naples, Italy.
C3 Pegaso Online University; University of Naples Federico II; Beirut Arab
   University; University of Buenos Aires; Hospital Britanico de Buenos
   Aires; University of Naples Federico II
RP Barrea, L (corresponding author), Univ Telemat Pegaso, Dipartimento Sci Umanist, Via Porzio,Isola F2, I-80143 Naples, Italy.; Barrea, L (corresponding author), Univ Med Sch Naples, Ctr Italiano Cura & Benessere Paziente Obesita CI, Dept Clin Med & Surg, Endocrinol Unit, Via Sergio Pansini 5, I-80131 Naples, Italy.
EM luigi.barrea@unipegaso.it
RI Colao, Annamaria/A-7671-2011; Savastano, Silvia/K-6546-2016; Barrea,
   Luigi/K-6551-2016; Frias-Toral, Evelyn/AAZ-7346-2020
OI Savastano, Silvia/0000-0002-3211-4307; , Gabriella/0000-0002-8127-1755;
   El Ghoch, Marwan/0000-0003-4277-4752; Barrea, Luigi/0000-0001-9054-456X;
   Frias-Toral, Evelyn/0000-0002-2228-0141; Castellucci,
   Bianca/0000-0001-7297-7492; Chapela, Sebastian Pablo/0000-0002-8083-1714
CR Abreu RV, 2011, PHARMACOL BIOCHEM BE, V99, P659, DOI 10.1016/j.pbb.2011.06.010
   Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Alharbi WDM, 2018, METAB BRAIN DIS, V33, P1203, DOI 10.1007/s11011-018-0230-6
   Alonso-Salces RM, 2009, J AGR FOOD CHEM, V57, P4224, DOI 10.1021/jf8037117
   Angeloni G, 2019, FOOD RES INT, V116, P1327, DOI 10.1016/j.foodres.2018.10.022
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Asbaghi O, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00587-z
   Asbaghi O, 2020, COMPLEMENT THER MED, V51, DOI 10.1016/j.ctim.2020.102424
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bae JH, 2014, INTEGR MED RES, V3, P189, DOI 10.1016/j.imr.2014.08.002
   Bae Jong Myon, 2020, Dement Neurocogn Disord, V19, P108, DOI 10.12779/dnd.2020.19.3.108
   BAK AAA, 1989, NEW ENGL J MED, V321, P1432, DOI 10.1056/NEJM198911233212103
   Quintana JLB, 2007, NEUROL RES, V29, P91, DOI 10.1179/174313206X152546
   Barrea L, 2021, CRIT REV FOOD SCI, V61, P25, DOI 10.1080/10408398.2020.1714542
   Barrea L, 2021, PANMINERVA MED, V63, P349, DOI 10.23736/S0031-0808.21.04213-0
   Barrea L, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02465-y
   Beghi E, 2011, AM J EPIDEMIOL, V174, P1002, DOI 10.1093/aje/kwr229
   Belayneh A, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7909703
   Binello A, 2021, FOOD CHEM, V344, DOI 10.1016/j.foodchem.2020.128631
   Bitter NQ, 2020, FOOD CHEM, V320, DOI 10.1016/j.foodchem.2020.126602
   Boekema PJ, 1999, SCAND J GASTROENTERO, V34, P35, DOI 10.1080/003655299750025525
   Borota D, 2014, NAT NEUROSCI, V17, P201, DOI 10.1038/nn.3623
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Bravi F, 2017, EUR J CANCER PREV, V26, P368, DOI [10.1097/cej.0000000000000252, 10.1097/CEJ.0000000000000252]
   Broderick Pamela J, 2005, J Okla State Med Assoc, V98, P380
   Buratti S, 2015, J SCI FOOD AGR, V95, P2192, DOI 10.1002/jsfa.6933
   Cappelletti S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050611
   Cappelletti S, 2015, CURR NEUROPHARMACOL, V13, P71, DOI 10.2174/1570159X13666141210215655
   Caprioli G, 2015, INT J FOOD SCI NUTR, V66, P505, DOI 10.3109/09637486.2015.1064871
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Chai T, 2020, MINERVA ENDOCRINOL, V45, P12, DOI 10.23736/S0391-1977.18.02832-8
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Ciaramelli C, 2019, FOOD CHEM, V278, P47, DOI 10.1016/j.foodchem.2018.11.063
   Coffeeandhealth, COFF HLTH I SCIENT I
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   D'Elia L, 2019, EUR J NUTR, V58, P271, DOI 10.1007/s00394-017-1591-z
   Dankowska A, 2017, TALANTA, V172, P215, DOI 10.1016/j.talanta.2017.05.036
   Davidson MH, 2006, AM J CARDIOL, V98, p27I, DOI 10.1016/j.amjcard.2005.12.024
   Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Pereira GVD, 2020, ADV FOOD NUTR RES, V91, P65, DOI 10.1016/bs.afnr.2019.10.002
   Pereira GVD, 2019, FOOD CHEM, V272, P441, DOI 10.1016/j.foodchem.2018.08.061
   Déchamp E, 2015, METHODS MOL BIOL, V1224, P275, DOI 10.1007/978-1-4939-1658-0_22
   Derkinderen P, 2014, MOVEMENT DISORD, V29, P976, DOI 10.1002/mds.25882
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Federico S, 2012, EXPERT OPIN THER PAT, V22, P369, DOI 10.1517/13543776.2012.669375
   dos Santos MKF, 2018, N-S ARCH PHARMACOL, V391, P1301, DOI 10.1007/s00210-018-1570-9
   Ferguson KK, 2017, ENVIRON SCI TECHNOL, V51, P4652, DOI 10.1021/acs.est.7b01252
   Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3
   Flambeau KJ, 2017, FOOD SCI BIOTECHNOL, V26, P1245, DOI 10.1007/s10068-017-0168-1
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Gao S, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/7649080
   Gapstur SM, 2017, CANCER EPIDEM BIOMAR, V26, P1477, DOI [10.1158/1055-9965.epi-17-0353, 10.1158/1055-9965.EPI-17-0353]
   Gebremedhin D, 2010, J CEREBR BLOOD F MET, V30, P1777, DOI 10.1038/jcbfm.2010.70
   Ghavami HS, 2021, BMC CARDIOVASC DISOR, V21, DOI 10.1186/s12872-021-02058-7
   Giesbrecht T, 2010, NUTR NEUROSCI, V13, P283, DOI 10.1179/147683010X12611460764840
   Gökcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   González S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051287
   Gorji Z, 2019, PHYTOMEDICINE, V63, DOI 10.1016/j.phymed.2019.153018
   Grgic J, 2020, BRIT J SPORT MED, V54, P681, DOI 10.1136/bjsports-2018-100278
   Grosso G, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080890
   American Heart Association, 2005, Cardiol Rev, V13, P322
   Gunter MJ, 2017, ANN INTERN MED, V167, P236, DOI 10.7326/M16-2945
   Gurwara S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030613
   Han TJ, 2016, IRAN J PUBLIC HEALTH, V45, P1126
   HAN X, 1988, LYMPHOKINE RES, V7, P227
   Hang D, 2019, AM J CLIN NUTR, V109, P635, DOI 10.1093/ajcn/nqy295
   Hearn JK, 2020, J AM ACAD PSYCHIATRY, V48, P376, DOI 10.29158/JAAPL.003923-20
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Henkler Frank, 2012, Exp Suppl, V101, P107, DOI 10.1007/978-3-7643-8340-4_5
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hiramatsu T, 2013, CLIN CHEM LAB MED, V51, P1233, DOI 10.1515/cclm-2012-0700
   Hosseinabadi S, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2019.102290
   Hu G, 2007, MOVEMENT DISORD, V22, P2242, DOI 10.1002/mds.21706
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ikram M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090902
   Iriondo-DeHond A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010088
   Iriondo-DeHond A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10091219
   Iwai K, 2012, FOOD SCI TECHNOL RES, V18, P849, DOI 10.3136/fstr.18.849
   James JE, 2004, PSYCHOSOM MED, V66, P63, DOI 10.1097/10.PSY.0000107884.78247.F9
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   Jiang WJ, 2013, GYNECOL ONCOL, V129, P620, DOI 10.1016/j.ygyno.2013.03.014
   Jiménez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Jin T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082228
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   Kahathuduwa CN, 2017, NUTR NEUROSCI, V20, P369, DOI [10.1080/1028415X.2016.1144845, 10.1080/1028415x.2016.1144845]
   Kalra S., 2020, MINERVA ENDOCRINOL, DOI [10.23736/S0391-1977.20.03353-2, DOI 10.23736/S0391-1977.20.03353-2]
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kerimi A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76558-5
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kim JY, 2006, BIOFACTORS, V26, P17, DOI 10.1002/biof.5520260103
   Kim JY, 2004, FEBS LETT, V569, P321, DOI 10.1016/j.febslet.2004.05.070
   Kim SA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122992
   Kim Y, 2019, EUR J EPIDEMIOL, V34, P731, DOI 10.1007/s10654-019-00524-3
   Klingel T, 2020, FOODS, V9, DOI 10.3390/foods9050665
   Kumar VHS, 2019, CHILDREN-BASEL, V6, DOI 10.3390/children6110118
   Lara DR, 2010, J ALZHEIMERS DIS, V20, pS239, DOI 10.3233/JAD-2010-1378
   Laudisio D, 2018, EUR J OBSTET GYN R B, V230, P217, DOI 10.1016/j.ejogrb.2018.03.050
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee KJ, 2007, TOXICOL LETT, V173, P80, DOI 10.1016/j.toxlet.2007.06.008
   Leviton A, 2002, FOOD CHEM TOXICOL, V40, P1271, DOI 10.1016/S0278-6915(02)00092-3
   Liu CW, 2018, AM J PHYSIOL-ENDOC M, V314, pE433, DOI 10.1152/ajpendo.00094.2017
   Liu JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147056
   Liu YJ, 2019, CNS NEUROSCI THER, V25, P899, DOI 10.1111/cns.13190
   Loftfield E, 2015, AM J EPIDEMIOL, V182, P1010, DOI 10.1093/aje/kwv146
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Lv XW, 2010, INFLAMM RES, V59, P635, DOI 10.1007/s00011-010-0176-6
   Martini D, 2016, MOLECULES, V21, DOI 10.3390/molecules21080979
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Marx B, 2016, M S-MED SCI, V32, P485, DOI 10.1051/medsci/20163205015
   Matsui T, 2001, J AGR FOOD CHEM, V49, P1948, DOI 10.1021/jf001251u
   McEvoy CT, 2014, J ACAD NUTR DIET, V114, P1759, DOI 10.1016/j.jand.2014.05.001
   McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248
   Mena P, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2271-2
   Metro D, 2017, J CLIN TRANSL ENDOCR, V10, P22, DOI 10.1016/j.jcte.2017.10.001
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P417, DOI 10.1080/09637486.2017.1373752
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Miranda AM, 2021, CLIN NUTR, V40, P542, DOI 10.1016/j.clnu.2020.05.052
   Mormile R, 2019, MINERVA ENDOCRINOL, V44, P331, DOI 10.23736/S0391-1977.18.02816-X
   Morvaridi M, 2020, J DIABETES METAB DIS, V19, P645, DOI 10.1007/s40200-020-00536-x
   Mostofsky E, 2012, CIRC-HEART FAIL, V5, P401, DOI 10.1161/CIRCHEARTFAILURE.112.967299
   Moura-Nunes N, 2009, INT J FOOD SCI NUTR, V60, P173, DOI 10.1080/09637480903158893
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Muscogiuri G, 2022, CRIT REV FOOD SCI, V62, P6947, DOI 10.1080/10408398.2021.1908223
   Muscogiuri G, 2019, CRIT REV FOOD SCI, V59, P2158, DOI 10.1080/10408398.2018.1506979
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Nehlig Astrid, 2010, Dialogues Clin Neurosci, V12, P255
   Nie KC, 2016, MINERVA MED, V107, P270
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Oh JK, 2015, INT J CANCER, V137, P1979, DOI 10.1002/ijc.29569
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ongo EA, 2020, FOOD RES INT, V134, DOI 10.1016/j.foodres.2020.109227
   Paiva CLRS, 2019, CRIT REV FOOD SCI, V59, P652, DOI 10.1080/10408398.2017.1386159
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Papakonstantinou E, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0146-0
   Park SY, 2018, CANCER EPIDEM BIOMAR, V27, P928, DOI 10.1158/1055-9965.EPI-18-0093
   Park SY, 2017, ANN INTERN MED, V167, P228, DOI 10.7326/M16-2472
   Paschou SA, 2019, MINERVA ENDOCRINOL, V44, P333, DOI 10.23736/S0391-1977.19.03040-2
   Peerapen P, 2018, ADV NUTR, V9, P419, DOI 10.1093/advances/nmy016
   Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Ren XP, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.602697
   Ricketts ML, 2007, MOL ENDOCRINOL, V21, P1603, DOI 10.1210/me.2007-0133
   Riise T, 2003, NEUROLOGY, V61, P1122, DOI 10.1212/01.WNL.0000081305.66687.D2
   Ríos-Hoyo A, 2016, CURR OBES REP, V5, P262, DOI 10.1007/s13679-016-0214-y
   Rogers PJ, 2010, NEUROPSYCHOPHARMACOL, V35, P1973, DOI 10.1038/npp.2010.71
   Ruggeri RM, 2021, THYROID, V31, P96, DOI 10.1089/thy.2020.0299
   Saeed M, 2019, CRIT REV FOOD SCI, V59, P3293, DOI 10.1080/10408398.2018.1489368
   Salari-Moghaddam A, 2019, J CLIN ENDOCR METAB, V104, P5346, DOI 10.1210/jc.2019-00637
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sartorelli DS, 2010, AM J CLIN NUTR, V91, P1002, DOI 10.3945/ajcn.2009.28741
   Savanelli MC, 2016, ENDOCRINE, V52, P111, DOI 10.1007/s12020-015-0779-3
   Schmit SL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72993-6
   Schouten MA, 2020, CRIT REV FOOD SCI, V60, P3807, DOI 10.1080/10408398.2019.1708264
   Schwarzschild Michael A., 2003, Neurology, V61, pS55
   Serra F, 2005, RAPID COMMUN MASS SP, V19, P2111, DOI 10.1002/rcm.2034
   Setiawan VW, 2015, GASTROENTEROLOGY, V148, P118, DOI 10.1053/j.gastro.2014.10.005
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Shimamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065996
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644
   SONG SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/718379
   Stefan N, 2020, LANCET DIABETES ENDO, V8, P616, DOI 10.1016/S2213-8587(20)30110-8
   Steffen M, 2012, J HYPERTENS, V30, P2245, DOI 10.1097/HJH.0b013e3283588d73
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1258-y
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Temple JL, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00080
   Thorn CF, 2012, PHARMACOGENET GENOM, V22, P389, DOI 10.1097/FPC.0b013e3283505d5e
   Tian T, 2017, J AGR FOOD CHEM, V65, P2784, DOI 10.1021/acs.jafc.6b04716
   Turnbull D, 2017, REGUL TOXICOL PHARM, V89, P165, DOI 10.1016/j.yrtph.2017.07.025
   Um CY, 2020, CANCER EPIDEMIOL, V67, DOI 10.1016/j.canep.2020.101730
   Valdez RC, 2011, J PEDIATR-US, V158, P38, DOI 10.1016/j.jpeds.2010.06.051
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   Vignoli JA, 2014, FOOD RES INT, V61, P279, DOI 10.1016/j.foodres.2013.06.006
   Voskoboinik A, 2019, TRENDS CARDIOVAS MED, V29, P345, DOI 10.1016/j.tcm.2018.09.019
   Wang LF, 2016, AUST NZ J PSYCHIAT, V50, P228, DOI 10.1177/0004867415603131
   Watanabe S, 2017, METAB SYNDR RELAT D, V15, P170, DOI 10.1089/met.2016.0114
   Williamson G, 2020, FOOD FUNCT, V11, P4826, DOI [10.1039/d0fo01168a, 10.1039/D0FO01168A]
   Willson C, 2018, TOXICOL REP, V5, P1140, DOI 10.1016/j.toxrep.2018.11.002
   Winiarska-Mieczan A, 2021, BIOL TRACE ELEM RES, V199, P2420, DOI 10.1007/s12011-020-02332-3
   Wondmkun YT, 2020, DIABET METAB SYND OB, V13, P3611, DOI 10.2147/DMSO.S275898
   Worku M, 2019, FOOD CHEM, V290, P295, DOI 10.1016/j.foodchem.2019.03.135
   Xie Y, 2016, EUR J CLIN NUTR, V70, P199, DOI 10.1038/ejcn.2015.96
   Yan R, 2018, P NATL ACAD SCI USA, V115, pE12053, DOI 10.1073/pnas.1813365115
   Yang LL, 2017, ENVIRON POLLUT, V223, P305, DOI 10.1016/j.envpol.2017.01.027
   Yenisetti SC, 2016, AIMS PUBLIC HEALTH, V3, P407, DOI 10.3934/publichealth.2016.2.407
   Zhang Y, 2011, NUTR METAB CARDIOVAS, V21, P418, DOI 10.1016/j.numecd.2009.10.020
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zhou Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep13410
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 208
TC 57
Z9 57
U1 6
U2 66
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD APR 3
PY 2023
VL 63
IS 9
BP 1238
EP 1261
DI 10.1080/10408398.2021.1963207
EA AUG 2021
PG 24
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA D4AH4
UT WOS:000690826100001
PM 34455881
DA 2025-04-28
ER

PT J
AU Gunes, FE
   Bekiroglu, N
   Imeryuz, N
   Agirbasli, M
AF Gunes, Fatma Esra
   Bekiroglu, Nural
   Imeryuz, Nese
   Agirbasli, Mehmet
TI Relation between Eating Habits and a High Body Mass Index among Freshman
   Students: A Cross-Sectional Study
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE eating habits; body mass index; freshman students; obesity; overweight
ID FAST-FOOD CONSUMPTION; UNIVERSITY-STUDENTS; COLLEGE-STUDENTS;
   ENERGY-INTAKE; LIFE-STYLE; SNACKING PATTERNS; MEDICAL-STUDENTS; DIETARY
   HABITS; WEIGHT STATUS; OBESITY RISK
AB Objectives: This study aimed to examine the relation between eating habits and a high body mass index (BMI) in first-year freshman university students and included 2525 freshman university students 18 to 22 years old from a Turkish population.
   Methods: in this study, 48% of the students were men. They were asked to complete a questionnaire on their dietary habits including the frequency of their consumption of individual food items, demographic data, and smoking habit.
   Results: The effects of eating habits on increased BMI (>= 25) were analyzed. Of 2259 subjects included in the analyses, 322 were overweight or obese and 1937 had normal and thin BMI (<25). Multivariate analyses identified male gender, recent weight change, and high number of meals as independent predictors of obesity/overweight. Frequent consumptions of beer, alcoholic drinks other than beer and wine (e.g., spirits including whisky, gin, raid, vodka), coffee, tea, coke, red meat, variety meat, and eggs were associated with a significantly higher risk of obesity/overweight, whereas frequent consumption of snacks was associated with a low risk.
   Conclusions: Findings of further studies, possibly taking into consideration the absolute quantities of consumption along with cultural and local issues, would guide the adoption of healthier feeding behaviors in this particular age group.
C1 [Gunes, Fatma Esra] Marmara Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-34000 Istanbul, Turkey.
   [Bekiroglu, Nural] Marmara Univ, Sch Med, Dept Biostat, TR-34000 Istanbul, Turkey.
   [Imeryuz, Nese] Marmara Univ, Sch Med, Dept Gastroenterol, TR-34000 Istanbul, Turkey.
   [Agirbasli, Mehmet] Marmara Univ, Sch Med, Dept Cardiol, TR-34000 Istanbul, Turkey.
C3 Marmara University; Marmara University; Marmara University; Marmara
   University
RP Gunes, FE (corresponding author), Marmara Univ, Fac Hlth Sci, Dept Nutr & Dietet, E-5 Uzeri Yanyol, TR-34000 Istanbul, Turkey.
EM fegunes@marmara.edu.tr
RI Gunes, Fatma/E-5188-2015; Agirbasli, Mehmet/AFP-1794-2022; Imeryuz,
   Nese/MVT-9319-2025
CR Adlaf EM, 2001, J AM COLL HEALTH, V50, P67, DOI 10.1080/07448480109596009
   Al-Rethaiaa AS, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-39
   Ayranci U, 2010, NUTRITION, V26, P772, DOI 10.1016/j.nut.2009.07.007
   Bagriacik N., 2009, Int J DiabetesMetabolism, V17, P5
   Baric IC, 2003, INT J FOOD SCI NUTR, V54, P473, DOI 10.1080/09637480310001622332
   Bellisle F, 1997, BRIT J NUTR, V77, pS57, DOI 10.1079/BJN19970104
   Bertéus-Forslund H, 2005, INT J OBESITY, V29, P711, DOI 10.1038/sj.ijo.0802950
   Boo NY, 2010, SINGAP MED J, V51, P126
   Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Brunt AR, 2008, APPETITE, V51, P615, DOI 10.1016/j.appet.2008.04.019
   Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   Chourdakis M, 2010, APPETITE, V55, P722, DOI 10.1016/j.appet.2010.08.013
   de Graaf C, 2006, APPETITE, V47, P18, DOI 10.1016/j.appet.2006.02.007
   Dinger MK, 1997, AM J HEALTH PROMOT, V11, P360, DOI 10.4278/0890-1171-11.5.360
   Duffrin C, 2010, INTERNET J NUTR WELL, V10
   Farshchi HR, 2004, INT J OBESITY, V28, P653, DOI 10.1038/sj.ijo.0802616
   GLORE SR, 1993, J AM COLL NUTR, V12, P517, DOI 10.1080/07315724.1993.10718345
   Gow RW, 2010, EAT BEHAV, V11, P33, DOI 10.1016/j.eatbeh.2009.08.005
   Gyntelberg F, 2009, INT J FOOD SCI NUTR, V60, P56, DOI 10.1080/09637480802668471
   Hajhosseini L, 2006, J AM COLL NUTR, V25, P123, DOI 10.1080/07315724.2006.10719522
   Hampl JS, 2003, J HUM NUTR DIET, V16, P3, DOI 10.1046/j.1365-277X.2003.00417.x
   Hoffman DJ, 2006, J AM COLL HEALTH, V55, P41, DOI 10.3200/JACH.55.1.41-46
   Hosmer W., 2000, Applied Logistic Regression, VSecond
   Kirk TR, 2000, P NUTR SOC, V59, P349, DOI 10.1017/S0029665100000409
   Larson N.I., 2007, PREV CHRONIC DIS, V4, pA51
   Lukasiewicz E, 2005, PUBLIC HEALTH NUTR, V8, P315, DOI 10.1079/PHN2004680
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malinauskas BM, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-11
   Marmonier C, 1999, AM J CLIN NUTR, V70, P854
   Mihas C, 2010, PUBLIC HEALTH NUTR, V13, P712, DOI 10.1017/S1368980009991625
   Papadaki A, 2007, APPETITE, V49, P169, DOI 10.1016/j.appet.2007.01.008
   Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x
   Sakamaki R, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-4
   Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.1551
   Singhal N, 2010, EUR J CLIN NUTR, V64, P364, DOI 10.1038/ejcn.2009.150
   Spanos D, 2010, J HUM NUTR DIET, V23, P102, DOI 10.1111/j.1365-277X.2009.01005.x
   Suleiman A. A., 2009, Journal of Biological Sciences, V9, P738
   Taveras EM, 2005, PEDIATRICS, V116, pE518, DOI 10.1542/peds.2004-2732
   Taylor CB, 1998, INT J EAT DISORDER, V24, P31, DOI 10.1002/(SICI)1098-108X(199807)24:1<31::AID-EAT3>3.0.CO;2-1
   Vik FN, 2010, SCAND J PUBLIC HEALT, V38, P13, DOI 10.1177/1403494810378920
   Wang Y, 2009, INT J OBESITY, V33, P621, DOI 10.1038/ijo.2009.45
   Yahia N, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-32
   Zemel MB, 2005, OBES RES, V13, P192, DOI 10.1038/oby.2005.26
NR 45
TC 26
Z9 28
U1 1
U2 44
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD JUN
PY 2012
VL 31
IS 3
BP 167
EP 174
DI 10.1080/07315724.2012.10720024
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA 069XN
UT WOS:000313470500005
PM 23204153
DA 2025-04-28
ER

PT J
AU Paz-Graniel, I
   Babio, N
   Becerra-Tomás, N
   Toledo, E
   Camacho-Barcia, L
   Corella, D
   Castañer-Niño, O
   Romaguera, D
   Vioque, J
   Alonso-Gómez, AM
   Wärnberg, J
   Martínez, JA
   Serra-Majem, L
   Estruch, R
   Tinahones, FJ
   Fernandez-Aranda, F
   Lapetra, J
   Pintó, X
   Tur, JA
   García-Rios, A
   Bueno-Cavanillas, A
   Gaforio, JJ
   Matía-Martín, P
   Daimiel, L
   Sanchez, VM
   Vidal, J
   Prieto-Sanchez, L
   Ros, E
   Razquin, C
   Mestres, C
   Sorli, JV
   Cuenca-Royo, AM
   Rios, A
   Torres-Collado, L
   Vaquero-Luna, J
   Pérez-Farinós, N
   Zulet, MA
   Sanchez-Villegas, A
   Casas, R
   Bernal-Lopez, MR
   Santos-Lozano, JM
   Corbella, X
   Mateos, D
   Buil-Cosiales, P
   Jimenez-Murcia, S
   Fernandez-Carrion, R
   Forcano-Gamazo, L
   López, M
   Sempere-Pascual, MA
   Moreno-Rodriguez, A
   Gea, A
   De la Torre-Fornell, R
   Salas-Salvadó, J
AF Paz-Graniel, Indira
   Babio, Nancy
   Becerra-Tomas, Nerea
   Toledo, Estefania
   Camacho-Barcia, Lucia
   Corella, Dolores
   Castaner-Nino, Olga
   Romaguera, Dora
   Vioque, Jesus
   Alonso-Gomez, Angel M.
   Warnberg, Julia
   Martinez, J. Alfredo
   Serra-Majem, Luis
   Estruch, Ramon
   Tinahones, Francisco J.
   Fernandez-Aranda, Fernando
   Lapetra, Jose
   Pinto, Xavier
   Tur, Josep A.
   Garcia-Rios, Antonio
   Bueno-Cavanillas, Aurora
   Gaforio, Jose J.
   Matia-Martin, Pilar
   Daimiel, Lidia
   Sanchez, Vicente Martin
   Vidal, Josep
   Prieto-Sanchez, Lucia
   Ros, Emilio
   Razquin, Cristina
   Mestres, Cristina
   Sorli, Jose V.
   Cuenca-Royo, Aida M.
   Rios, Angel
   Torres-Collado, Laura
   Vaquero-Luna, Jessica
   Perez-Farinos, Napoleon
   Zulet, M. Angeles
   Sanchez-Villegas, Almudena
   Casas, Rosa
   Bernal-Lopez, M. Rosa
   Santos-Lozano, Jose Manuel
   Corbella, Xavier
   Mateos, David
   Buil-Cosiales, Pilar
   Jimenez-Murcia, Susana
   Fernandez-Carrion, Rebeca
   Forcano-Gamazo, Laura
   Lopez, Meritxell
   Sempere-Pascual, Miguel Angel
   Moreno-Rodriguez, Anai
   Gea, Alfredo
   De la Torre-Fornell, Rafael
   Salas-Salvado, Jordi
CA PREDIMED-Plus Ivestigators
TI Association between coffee consumption and total dietary caffeine intake
   with cognitive functioning: cross-sectional assessment in an elderly
   Mediterranean population
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Cognitive impairment; Mini-Mental State Examination; Coffee; Caffeine;
   PREDIMED-plus
ID PHYSICAL-ACTIVITY QUESTIONNAIRE; MINI-MENTAL STATE; OLDER; IMPAIRMENT;
   BENEFITS; RISK; VALIDATION; COMPONENT; DEMENTIA; DISEASE
AB Purpose Coffee is rich in compounds such as polyphenols, caffeine, diterpenes, melanoidins and trigonelline, which can stimulate brain activity. Therefore, the possible association of coffee consumption with cognition is of considerable research interest. In this paper, we assess the association of coffee consumption and total dietary caffeine intake with the risk of poor cognitive functioning in a population of elderly overweight/obese adults with metabolic syndrome (MetS). Methods PREDIMED-plus study participants who completed the Mini-Mental State Examination test (MMSE) (n = 6427; mean age = 65 +/- 5 years) or a battery of neuropsychological tests were included in this cross-sectional analysis. Coffee consumption and total dietary caffeine intake were assessed at baseline using a food frequency questionnaire. Logistic regression models were fitted to evaluate the association between total, caffeinated and decaffeinated coffee consumption or total dietary caffeine intake and cognitive impairment. Results Total coffee consumers and caffeinated coffee consumers had better cognitive functioning than non-consumers when measured by the MMSE and after adjusting for potential confounders (OR 0.63; 95% CI 0.44-0.90 and OR 0.56; 95% CI 0.38-0.83, respectively). Results were similar when cognitive performance was measured using the Clock Drawing Test (CDT) and Trail Making Test B (TMT-B). These associations were not observed for decaffeinated coffee consumption. Participants in the highest tertile of total dietary caffeine intake had lower odds of poor cognitive functioning than those in the reference tertile when screened by the MMSE (OR 0.64; 95% CI 0.47-0.87) or other neurophysiological tests evaluating a variety of cognitive domains (i.e., CDT and TMT-A). Conclusions Coffee consumption and total dietary caffeine intake were associated with better cognitive functioning as measured by various neuropsychological tests in a Mediterranean cohort of elderly individuals with MetS.
C1 [Paz-Graniel, Indira; Babio, Nancy; Becerra-Tomas, Nerea; Camacho-Barcia, Lucia; Salas-Salvado, Jordi] Rovira & Virgili Univ, Dept Biochem & Biotechnol, Human Nutr Unit, Reus, Spain.
   [Paz-Graniel, Indira; Babio, Nancy; Becerra-Tomas, Nerea; Camacho-Barcia, Lucia; Salas-Salvado, Jordi] Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain.
   [Paz-Graniel, Indira; Babio, Nancy; Becerra-Tomas, Nerea; Toledo, Estefania; Camacho-Barcia, Lucia; Corella, Dolores; Castaner-Nino, Olga; Romaguera, Dora; Alonso-Gomez, Angel M.; Warnberg, Julia; Martinez, J. Alfredo; Serra-Majem, Luis; Estruch, Ramon; Tinahones, Francisco J.; Fernandez-Aranda, Fernando; Lapetra, Jose; Pinto, Xavier; Tur, Josep A.; Garcia-Rios, Antonio; Sanchez, Vicente Martin; Ros, Emilio; Razquin, Cristina; Sorli, Jose V.; Cuenca-Royo, Aida M.; Vaquero-Luna, Jessica; Perez-Farinos, Napoleon; Zulet, M. Angeles; Sanchez-Villegas, Almudena; Casas, Rosa; Bernal-Lopez, M. Rosa; Santos-Lozano, Jose Manuel; Mateos, David; Buil-Cosiales, Pilar; Jimenez-Murcia, Susana; Fernandez-Carrion, Rebeca; Forcano-Gamazo, Laura; Moreno-Rodriguez, Anai; Gea, Alfredo; De la Torre-Fornell, Rafael; Salas-Salvado, Jordi] Carlos III Hlth Inst, CIBER Physiol Obes & Nutr CIBEROBN, Madrid, Spain.
   [Becerra-Tomas, Nerea] Univ Valencia, Sch Med, Dept Prevent Med & Publ Hlth, Valencia 46010, Spain.
   [Toledo, Estefania; Razquin, Cristina; Buil-Cosiales, Pilar; Gea, Alfredo] Univ Navarra, Dept Prevent Med & Publ Hlth, IdiSNA, Pamplona, Spain.
   [Corella, Dolores; Sorli, Jose V.; Fernandez-Carrion, Rebeca] Univ Valencia, Dept Prevent Med, Valencia, Spain.
   [Castaner-Nino, Olga; Romaguera, Dora] Hosp del Mar Res Inst IMIM, Cardiovasc Risk & Nutr Res Grp CARIN, Barcelona, Spain.
   [Tur, Josep A.; Rios, Angel; Lopez, Meritxell] Univ Hosp Son Espases, Hlth Res Inst Balear Islands IdISBa, Palma De Mallorca, Spain.
   [Vioque, Jesus; Gaforio, Jose J.; Torres-Collado, Laura; Mateos, David] Carlos III Hlth Inst, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.
   [Vioque, Jesus; Torres-Collado, Laura] Miguel Hernandez Univ, ISABIAL UMH, Alicante, Spain.
   [Alonso-Gomez, Angel M.; Bueno-Cavanillas, Aurora; Vaquero-Luna, Jessica; Moreno-Rodriguez, Anai] Univ Basque Country UPV EHU, Araba Univ Hosp, Bioaraba Hlth Res Inst, Osakidetza Basque Hlth Serv, Vitoria, Spain.
   [Warnberg, Julia] Univ Malaga, Sch Hlth Sci, Dept Nursing, Inst Invest Biomed Malaga IBIMA, Malaga, Spain.
   [Martinez, J. Alfredo; Zulet, M. Angeles] Univ Navarra, Dept Nutr Food Sci & Physiol, IDISNA, Pamplona, Spain.
   [Martinez, J. Alfredo; Daimiel, Lidia] CSIC, Nutr Genom & Epigen Grp, IMDEA Food, CEI UAM, Madrid, Spain.
   [Serra-Majem, Luis; Sanchez-Villegas, Almudena] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci IUIBS, Ctr Hosp Univ Insular Materno Infantil CHUIMI, Prevent Med Serv,Canarian Hlth Serv, Las Palmas Gran Canaria, Spain.
   [Estruch, Ramon; Casas, Rosa] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin, Dept Internal Med, Barcelona, Spain.
   [Tinahones, Francisco J.] Univ Malaga, Virgen Victoria Hosp, Dept Endocrinol, Biomed Res Inst Malaga IBIMA, Malaga, Spain.
   [Fernandez-Aranda, Fernando; Jimenez-Murcia, Susana] Bellvitge Univ Hosp, IDIBELL, Dept Psychiat, Barcelona, Spain.
   [Lapetra, Jose; Santos-Lozano, Jose Manuel] Distrito Sanitario Atenc Primaria Sevilla, Dept Family Med, Res Unit, Seville, Spain.
   [Pinto, Xavier; Corbella, Xavier] Bellvitge Univ Hosp, Internal Med, Lipids & Vasc Risk Unit, Barcelona, Spain.
   [Tur, Josep A.; Mateos, David] Univ Balear Islands, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain.
   [Garcia-Rios, Antonio] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Dept Internal Med, Cordoba, Spain.
   [Bueno-Cavanillas, Aurora] Univ Granada, Dept Prevent Med, Granada, Spain.
   [Gaforio, Jose J.] Univ Jaen, Dept Ciencias Salud, Ctr Estudios Avanzados Olivar & Aceites Oliva, Jaen, Spain.
   [Matia-Martin, Pilar] San Carlos Clin Hosp IdISSC, Hlth Res Inst, Dept Endocrinol & Nutr, Madrid, Spain.
   [Sanchez, Vicente Martin] Univ Leon, Inst Biomed IBIOMED, Leon, Spain.
   [Vidal, Josep] Carlos III Hlth Inst ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain.
   [Vidal, Josep] Univ Barcelona, August Pi & Sunyer Biomed Res Inst IDIBAPS, Hosp Clin, Dept Endocrinol, Barcelona, Spain.
   [Prieto-Sanchez, Lucia] Fdn Jimenez Diaz, Dept Endocrinol, Madrid, Spain.
   [Ros, Emilio] August Pi & Sunyer Biomed Res Inst IDIBAPS, Hosp Clin, Dept Endocrinol & Nutr, Lipid Clin, Barcelona, Spain.
   [Mestres, Cristina] Joan XXIII Univ Hosp, Tarragona, Spain.
   [Mestres, Cristina] Horts Miro Hlth Ctr, Reus, Spain.
   [Cuenca-Royo, Aida M.; Forcano-Gamazo, Laura; De la Torre-Fornell, Rafael] Hosp del Mar Res Inst IMIM, Integrat Pharmacol & Syst Neurosci FINS, Barcelona, Spain.
   [Perez-Farinos, Napoleon] Univ Malaga, Sch Med, Dept Publ Hlth, Biomed Res Inst Malaga IBIMA, Malaga, Spain.
   [Zulet, M. Angeles] Univ Navarra, Fac Pharm & Nutr, Ctr Nutr Res, Pamplona, Spain.
   [Bernal-Lopez, M. Rosa] Reg Univ Hosp Malaga, Inst Invest Biomed Malaga IBIMA, Internal Med Dept, Malaga, Spain.
   [Corbella, Xavier] Univ Int Catalunya, Med & Hlth Sci Fac, Barcelona, Spain.
   [Sempere-Pascual, Miguel Angel] Santa Pola Hlth Ctr, Alicante, Spain.
   [Salas-Salvado, Jordi] Sant Joan Univ Hosp, Human Nutr Unit, Reus, Spain.
C3 Universitat Rovira i Virgili; Universitat Rovira i Virgili; Institut
   d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de
   Investigacion Biomedica en Red; CIBEROBN; University of Valencia;
   University of Navarra; University of Valencia; Hospital del Mar Research
   Institute; Hospital del Mar; Hospital Universitari Son Espases; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERESP; General University
   Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat
   d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante
   (ISABIAL); University of Basque Country; University Hospital of Araba;
   Bioaraba Health Research Institute; Universidad de Malaga; Instituto de
   Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA);
   University of Navarra; Consejo Superior de Investigaciones Cientificas
   (CSIC); IMDEA Food Institute; Universidad de Las Palmas de Gran Canaria;
   University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS;
   Universidad de Malaga; Instituto de Investigacion Biomedica de Malaga y
   Plataforma en Nanomedicina (IBIMA); Institut d'Investigacio Biomedica de
   Bellvitge (IDIBELL); Bellvitge University Hospital; University of
   Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL);
   Bellvitge University Hospital; University of Barcelona; Universidad de
   Cordoba; University of Granada; Universidad de Jaen; Universidad de
   Leon; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM;
   University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS;
   University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital
   del Mar Research Institute; Hospital del Mar; Instituto de Investigacion
   Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA); Universidad de
   Malaga; University of Navarra; Universidad de Malaga; Instituto de
   Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA);
   Universitat Internacional de Catalunya (UIC)
RP Babio, N; Salas-Salvadó, J (corresponding author), Rovira & Virgili Univ, Dept Biochem & Biotechnol, Human Nutr Unit, Reus, Spain.; Babio, N; Salas-Salvadó, J (corresponding author), Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain.; Babio, N; Salas-Salvadó, J (corresponding author), Carlos III Hlth Inst, CIBER Physiol Obes & Nutr CIBEROBN, Madrid, Spain.; Salas-Salvadó, J (corresponding author), Sant Joan Univ Hosp, Human Nutr Unit, Reus, Spain.
EM nancy.babio@urv.cat; jordi.salas@urv.cat
RI Toledo, Estefania/H-6211-2014; Vioque, Jesus/A-1066-2008; Sorlí,
   José/L-8758-2014; FORCANO, LAURA/AAP-1933-2020; Sanchez-Villegas,
   Almudena/T-6733-2019; Bueno-Cavanillas, Aurora/O-1513-2015; Romaguera,
   Dora/ABE-7004-2020; Abad-Gurumeta, Alfredo/M-2337-2019; Lapetra,
   Jose/F-2552-2015; Castaner, Olga/F-1533-2013; Casas, Rosa/ABD-1915-2020;
   Babio, Nancy/AAN-2715-2020; Martínez, J./K-8709-2014; Capó,
   Xavier/AAD-6322-2022; Fernandez-Carrion, Rebeca/AAA-5713-2019; Vidal,
   Josep/MIK-6936-2025; Zulet, M./H-1317-2017; Tur, Josep/AAE-5748-2020;
   ALONSO GOMEZ, ANGEL/HLG-2476-2023; Razquin, Cristina/H-2366-2017;
   Corella, Dolores/L-9888-2014; Paz-Graniel, Indira/ABH-2583-2020; Mateos,
   David/N-7366-2018; Pintó, Xavier/AGI-4297-2022; Estruch,
   Ramon/AAZ-3723-2020; Tinahones, Francisco/AAB-2882-2020; de la Torre,
   Rafael/D-3561-2018; Sureda, Antoni/N-9588-2019; Ortega-Calvo,
   Manuel/D-6960-2015; Botella, Cristina/F-9230-2010; Canudas,
   Silvia/K-4184-2014; Camafort-Babkowski, Miguel/H-6310-2014; Prieto,
   Rafel M./J-3995-2017; Sayon-Orea, Carmen/A-9828-2017; Hernandez-Alonso,
   Pablo/Q-1090-2018; BES-RASTROLLO, MAIRA/A-1329-2009; Salas-Salvado,
   Jordi/C-7229-2017; JIMENEZ-MURCIA, SUSANA/L-9786-2014; Forcano Gamazo,
   Laura/B-1154-2017; Becerra-Tomas, Nerea/H-3937-2018; Lozano Madrid,
   Maria/IQV-7373-2023; Torrego-Ellacuria, Macarena/AAD-9621-2020; Aguera,
   Zaida/K-9771-2014; Delgado Rodriguez, Miguel/H-4940-2017; Daimiel-Ruiz,
   Lidia Angeles/M-7779-2014; Camacho-Barcia, Lucia/AAB-2096-2021;
   Warnberg, Julia/G-1390-2011; Martin, Vicente/A-1597-2008; Ruiz-Canela,
   Miguel/I-7738-2016; FERNANDEZ-ARANDA, FERNANDO/L-9762-2014; Fito
   Colomer, Montse/C-1822-2012; Salas-Huetos, Albert/A-8509-2011
OI Casas, Rosa/0000-0002-0211-9166; Oncina Canovas,
   Alejandro/0000-0003-4652-0565; Granado-Font, Esther/0000-0002-4484-6054;
   Guillem Saiz, Patricia/0000-0003-4422-5538; Cuenca Royo,
   Aida/0000-0001-8551-5457; Sagarra Alamo, Ramon/0000-0002-5544-0172;
   Ortega-Calvo, Manuel/0000-0003-2391-0106; Aldea-Perona,
   Ana/0000-0002-3791-8814; Sorli, Jose V/0000-0002-0130-2006; Corbella,
   Emili/0000-0001-8818-1907; Botella, Cristina/0000-0001-8783-6959; Rubio,
   Miguel A./0000-0002-0495-6240; Compan Gabucio, Laura
   M/0000-0001-5324-1535; Canudas, Silvia/0000-0002-5630-1588; Gimenez
   Alba, Ignacio Manuel/0000-0002-6380-8467; Garcia de la Hera,
   Manuela/0000-0001-5742-2704; GARCIA LAYANA, ALFREDO/0000-0001-5732-2797;
   Camafort-Babkowski, Miguel/0000-0002-8669-6410; Lopez-Miranda,
   Jose/0000-0002-8844-0718; Sanchez Villegas,
   Almudena/0000-0001-7733-9238; , Antoni/0000-0001-8656-6838; Yanez
   Santana, Alejandro/0000-0002-1736-552X; Perez-Vega, Karla
   Alejandra/0000-0002-7524-2034; Zomeno, M. Dolores/0000-0003-1280-7680;
   Perez Suarez, Santiago Tomas/0000-0001-5702-4773; Tojal Sierra,
   Lucas/0000-0001-5338-9601; Prieto, Rafel M./0000-0001-8814-900X;
   Sayon-Orea, Carmen/0000-0002-4137-3263; Esteve-Luque,
   Virginia/0000-0002-7631-8301; Gonzalez Palacios,
   Sandra/0000-0003-3358-472X; Hernandez-Alonso, Pablo/0000-0002-9977-8976;
   BES-RASTROLLO, MAIRA/0000-0002-9139-4206; Salas-Salvado,
   Jordi/0000-0003-2700-7459; Ruiz Garcia, Veronica/0000-0002-7405-2319;
   Sanchez Navarro, Silvia/0009-0000-8492-6609; Bautista-Castano,
   Inmaculada/0000-0001-9257-8739; Tercero Macia,
   Cristina/0009-0000-6092-9231; BABIO SANCHEZ, NANCY/0000-0003-3527-5277;
   Mestres, Gaspar/0000-0002-8699-7037; Lopez Zamora,
   Meritxell/0000-0002-1805-1987; JIMENEZ-MURCIA,
   SUSANA/0000-0002-3596-8033; Quiles Guinau, Laura/0000-0002-4596-2313;
   Paz Graniel, Indira/0000-0002-3204-6877; Orozco-Beltran,
   Domingo/0000-0002-8231-2635; /0000-0002-2246-5867; Buil-Cosiales,
   Pilar/0000-0002-8586-577X; Forcano Gamazo, Laura/0000-0002-8478-1451;
   Becerra-Tomas, Nerea/0000-0002-4429-6507; Salaverria Lete,
   Itziar/0000-0002-9504-4668; Yanez, Aina M/0000-0001-8527-3937; Castaner
   Nino, Olga/0000-0003-3169-997X; Lozano Madrid,
   Maria/0000-0003-3833-317X; Torrego-Ellacuria,
   Macarena/0000-0001-8071-8976; Aguera, Zaida/0000-0003-4453-4939; Basora,
   Josep/0000-0003-0278-1149; Lopez Maldonado, Alicia/0000-0002-2042-8958;
   Cabre Vila, Juan Jose/0000-0003-1082-6861; MARTINEZ PEREZ, MARIA
   MAGDALENA/0009-0003-9227-8404; Domenech, Monica/0000-0001-5447-6686;
   Delgado Rodriguez, Miguel/0000-0002-3838-2548; Fernandez Soto, Gerardo
   Fernando/0000-0002-0246-0380; Ortega Martinez de Victoria,
   Emilio/0000-0002-2217-8905; Daimiel-Ruiz, Lidia
   Angeles/0000-0001-9898-6629; Capo Fiol, Xavier/0000-0002-3499-5494;
   Camacho-Barcia, Lucia/0000-0002-5989-936X; Diaz-Lopez,
   Andres/0000-0002-7500-5629; ELOSUA, ROBERTO/0000-0001-8235-0095;
   Warnberg, Julia/0000-0002-8408-316X; Freixer Ballesteros,
   Gala/0000-0001-8182-6784; iturralde iriso, jesus/0000-0002-7800-3928;
   Riquelme Gallego, Blanca/0000-0003-3422-7310; Pascual Fuster,
   Vicente/0009-0007-0714-2924; galmes, aina/0000-0001-6977-9874;
   Torres-Collado, Laura/0000-0003-2842-1344; Tinahones, Francisco
   J/0000-0001-6871-4403; Martin, Vicente/0000-0003-0552-2804; Ruiz-Canela,
   Miguel/0000-0002-7684-2787; FERNANDEZ-ARANDA,
   FERNANDO/0000-0002-2968-9898; Fito Colomer, Montse/0000-0002-1817-483X;
   Salas-Huetos, Albert/0000-0001-5914-6862; zorrilla,
   Inaki/0000-0001-6444-8208; Vioque, Jesus/0000-0002-2284-148X; Zamanillo
   Campos, Rocio/0000-0001-7162-0889
FU Spanish government's official funding agency for biomedical research,
   ISCIII, through the Fondo de Investigacion para la Salud (FIS); European
   Union ERDF/ESF, "A way to make Europe"/"Investing in your future"
   [PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233,
   PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636,
   PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374,
   PI14/00972, PI14/00728, PI14/01471]; Special Action Project entitled:
   Implementacion y evaluacion de una intervencion intensiva sobre la
   actividad fisica Cohorte PREDIMED-Plus grant; European Research Council
   [340918]; Recercaixa Grant [2013ACUP00194]; Consejeria de Salud de la
   Junta de Andalucia [PI0458/2013, PS0358/2016, PI0137/2018]; Generalitat
   Valenciana [PROMETEO/2017/017]; SEMERGEN grant; European Regional
   Development Fund [CB06/03]; EU-H2020 Grant (EAT2BENICE/H2020-SFS-2016-2)
   [728018]; Department of Health of the Generalitat de Catalunya
   [SLT006/17/00246]; ICREA under the ICREA Academia program; Spanish
   Ministry of Education, Culture and Sports [FPU 17/01925]; Generalitat de
   Catalunya's Department of Universities [FI-DGR 2017]; Juan de la
   Cierva-Formacion [FJC2018-036016-I]; "Miguel Servet Type I" program from
   the ISCIII-Madrid (Spain) [CP15/00028]; Fondo Europeo de Desarrollo
   Regional-FEDER;  [PI16/00473];  [PI16/00662];  [PI16/01873]; 
   [PI16/01094];  [PI16/00501];  [PI16/00533];  [PI16/00381]; 
   [PI16/00366];  [PI16/01522];  [PI16/01120];  [PI17/00764]; 
   [PI17/01183];  [PI17/00855];  [PI17/01347];  [PI17/00525]; 
   [PI17/01827];  [PI17/00532];  [PI17/00215];  [PI17/01441]; 
   [PI17/00508];  [PI17/01732];  [PI17/00926];  [PI19/00957]; 
   [PI19/00386];  [PI19/00309];  [PI19/01032];  [PI19/00576]; 
   [PI19/00017];  [PI19/01226];  [PI19/00781];  [PI19/01560];  [PI19/01332]
FX The PREDIMED-Plus trial was supported by the Spanish government's
   official funding agency for biomedical research, ISCIII, through the
   Fondo de Investigacion para la Salud (FIS) and co-funded by European
   Union ERDF/ESF, "A way to make Europe"/"Investing in your future" (five
   coordinated FIS projects led by JS-S and JVid, including the following
   project PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462,
   PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722,
   PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853,
   PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662,
   PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366,
   PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347,
   PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508,
   PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032,
   PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560 and
   PI19/01332), the Special Action Project entitled: Implementacion y
   evaluacion de una intervencion intensiva sobre la actividad fisica
   Cohorte PREDIMED-Plus grant to JS-S, the European Research Council
   (Advanced Research Grant 2013-2018, 340918) to MAM-G, the Recercaixa
   Grant to JS-S (2013ACUP00194), grants from the Consejeria de Salud de la
   Junta de Andalucia (PI0458/2013, PS0358/2016 and PI0137/2018), a grant
   from the Generalitat Valenciana (PROMETEO/2017/017), a SEMERGEN grant,
   and funds from the European Regional Development Fund (CB06/03). This
   research was also partially funded by EU-H2020 Grant
   (EAT2BENICE/H2020-SFS-2016-2; Ref 728018). Study resulting from the
   SLT006/17/00246 grant was funded by the Department of Health of the
   Generalitat de Catalunya by the call "Accio instrumental de programes de
   recerca orientats en l'ambit de la recerca i la innovacio en salut." We
   thank CERCA Programme/Generalitat de Catalunya for institutional
   support. This work is partially supported by ICREA under the ICREA
   Academia program. IP-G receives a grant from the Spanish Ministry of
   Education, Culture and Sports (FPU 17/01925). L.C.-B. is the recipient
   of a predoctoral fellowship from the Generalitat de Catalunya's
   Department of Universities (FI-DGR 2017). NB-T is supported by a
   postdoctoral fellowship (Juan de la Cierva-Formacion, FJC2018-036016-I)
   MRBL was supported by "Miguel Servet Type I" program (CP15/00028) from
   the ISCIII-Madrid (Spain), cofinanced by the Fondo Europeo de Desarrollo
   Regional-FEDER.
CR [Anonymous], 1999, WAIS 3 ESC INT WECHS
   Aprahamian Ivan, 2009, Dement. neuropsychol., V3, P74, DOI 10.1590/S1980-57642009DN30200002
   Araújo LF, 2015, NUTRIENTS, V7, P9590, DOI 10.3390/nu7115487
   Atti AR, 2019, AM J GERIAT PSYCHIAT, V27, P625, DOI 10.1016/j.jagp.2019.01.214
   Basurto-Islas G, 2014, NEUROBIOL AGING, V35, P2701, DOI 10.1016/j.neurobiolaging.2014.06.012
   Benton AL, 1994, Multilingual aphasia examination
   Berendsen AAM, 2017, J AM MED DIR ASSOC, V18, P427, DOI 10.1016/j.jamda.2016.11.026
   Blesa R, 2001, NEUROPSYCHOLOGIA, V39, P1150, DOI 10.1016/S0028-3932(01)00055-0
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Camfield DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082897
   Cao CH, 2011, J ALZHEIMERS DIS, V25, P323, DOI 10.3233/JAD-2011-110110
   Castelli V, 2018, CURR PHARM DESIGN, V24, P227, DOI 10.2174/1381612824666171213100449
   Chu YF, 2012, FOOD CHEM, V135, P2095, DOI 10.1016/j.foodchem.2012.04.148
   Colombo R, 2020, CRIT REV FOOD SCI, V60, P760, DOI 10.1080/10408398.2018.1550384
   Dong X, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030840
   Driscoll I, 2016, J GERONTOL A-BIOL, V71, P1596, DOI 10.1093/gerona/glw078
   ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966
   Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011
   Ferreira-Pêgo C, 2014, NUTR HOSP, V29, P1171, DOI 10.3305/nh.2014.29.5.7421
   Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Hajjar I, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-017-1026-z
   Haskell-Ramsay CF, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101386
   Jackson NHH., 2015, J GERONTOL GERIATR R, V4, DOI [10.4172/2167-7182.1000233, DOI 10.4172/2167-7182.1000233]
   JARVIS MJ, 1993, PSYCHOPHARMACOLOGY, V110, P45, DOI 10.1007/BF02246949
   Johnson-Kozlow M, 2002, AM J EPIDEMIOL, V156, P842, DOI 10.1093/aje/kwf119
   Konishi Y, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0202247, 10.1371/journa]
   Kromhout MA, 2019, EXP GERONTOL, V122, P85, DOI 10.1016/j.exger.2019.04.017
   Llinàs-Reglà J, 2017, ASSESSMENT, V24, P183, DOI 10.1177/1073191115602552
   Mancini RS, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00735
   Martínez-González MA, 2019, INT J EPIDEMIOL, V48, P387, DOI 10.1093/ije/dyy225
   Mataix Verdu J., 2003, TABLA COMPOSICION AL
   Moreiras O., 2005, Tablas de composicion de alimentos
   Navarro AM, 2018, AM J CLIN NUTR, V108, P1113, DOI 10.1093/ajcn/nqy198
   Nissensohn M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040232
   Paganini-Hill A, 2011, DEMENT GER COGN D EX, V1, P75, DOI 10.1159/000326781
   Paz-Graniel I, 2020, EUR J NUTR, V59, P1595, DOI 10.1007/s00394-019-02015-3
   Quijano TD, 2004, MED CLIN-BARCELONA, V122, P727, DOI 10.1157/13062190
   Ros E, 2013, CIRCULATION, V128, P553, DOI 10.1161/CIRCULATIONAHA.112.001119
   Salas-Salvadó J, 2019, DIABETES CARE, V42, P777, DOI 10.2337/dc18-0836
   Santos C, 2010, J ALZHEIMERS DIS, V20, pS187, DOI 10.3233/JAD-2010-091387
   Sanz J., 2003, Clinica y Salud, V14, P249
   Schröder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566
   SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305
   Singh B, 2014, J ALZHEIMERS DIS, V39, P271, DOI 10.3233/JAD-130830
   Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644
   Solas M, 2017, CURR OPIN PHARMACOL, V37, P87, DOI 10.1016/j.coph.2017.10.005
   WHO, 2019, Risk reduction of cognitive decline and dementia: WHO guidelines
   Wu L, 2017, CLIN NUTR, V36, P730, DOI 10.1016/j.clnu.2016.05.015
   Yates KF, 2012, ARTERIOSCL THROM VAS, V32, P2060, DOI 10.1161/ATVBAHA.112.252759
   Zucconi S., 2013, Supporting Publications EN-394, DOI [DOI 10.2903/SP.EFSA.2013.EN, 10.2903/sp.efsa.2013.EN-394, DOI 10.2903/SP.EFSA.2013.EN-394]
NR 52
TC 19
Z9 19
U1 1
U2 48
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD AUG
PY 2021
VL 60
IS 5
BP 2381
EP 2396
DI 10.1007/s00394-020-02415-w
EA OCT 2020
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA TI0VN
UT WOS:000583015100002
PM 33125576
DA 2025-04-28
ER

PT J
AU Aoyagi, R
   Funakoshi-Tago, M
   Fujiwara, Y
   Tamura, H
AF Aoyagi, Ryohei
   Funakoshi-Tago, Megumi
   Fujiwara, Yosuke
   Tamura, Hiroomi
TI Coffee Inhibits Adipocyte Differentiation via Inactivation of
   PPARγ
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE 3T3-L1; adipocyte; coffee; differentiation; obesity; peroxisome
   proliferator-activated receptor gamma (PPAR gamma)
ID NF-KAPPA-B; GENE-EXPRESSION; 3T3-L1 ADIPOCYTES; ANTIOXIDANT;
   CONSUMPTION; METABOLISM; OBESITY; CELLS; NRF2; MICE
AB Recent epidemiological studies showed that coffee consumption is associated with a lower risk of type 2 diabetes, presumably due to suppression of excess fat accumulation in adipocytes. However, the mechanism underlying the effect of coffee on adipocyte differentiation has not been well documented. To elucidate the mechanism, we investigated the effect of coffee on the differentiation of mouse preadipocyte 3T3-L1 cells. Coffee reduced the accumulation of lipids during adipocytic differentiation of 3T3-L1 cells. At 5% coffee, the accumulation of lipids decreased to half that of the control. Coffee also inhibited the expression of the peroxisome proliferator-activated receptor gamma (PPAR gamma), a transcription factor controlling the differentiation of adipocytes. Furthermore, coffee reduced the expression of other differentiation marker genes, aP2, adiponectin, CCAAT-enhancer-binding protein alpha (C/EBP alpha), glucose transporter 4 (GLUT4), and lipoprotein lipase (LPL), during adipocyte differentiation. Major bioactive constituents in coffee extracts, such as caffeine, trigonelline, chlorogenic acid, and caffeic acid, showed no effect on PPAR gamma gene expression. The inhibitory activity was produced by the roasting of the coffee beans.
C1 [Aoyagi, Ryohei; Funakoshi-Tago, Megumi; Fujiwara, Yosuke; Tamura, Hiroomi] Keio Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo 1058512, Japan.
C3 Keio University
RP Tamura, H (corresponding author), Keio Univ, Grad Sch Pharmaceut Sci, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.
EM tamura-hr@pha.keio.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT) of
   Japan; MEXT-Supported Program for the Strategic Research Foundation at
   Private Universities; Grants-in-Aid for Scientific Research [24500996]
   Funding Source: KAKEN
FX We are grateful to Dr. K. Oka for his encouragement. This work was
   supported in part by a Grant-in-Aid from the Ministry of Education,
   Culture, Sports, Science and Technology (MEXT) of Japan, and by a Grant
   from the MEXT-Supported Program for the Strategic Research Foundation at
   Private Universities.
CR Daglia M, 2000, J AGR FOOD CHEM, V48, P1449, DOI 10.1021/jf990510g
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Floyd ZE, 2012, BBA-MOL BASIS DIS, V1822, P1090, DOI 10.1016/j.bbadis.2012.03.014
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hemati N, 1997, J BIOL CHEM, V272, P25913, DOI 10.1074/jbc.272.41.25913
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Isshiki M, 2011, BIOL PHARM BULL, V34, P1624, DOI 10.1248/bpb.34.1624
   Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395
   Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI [10.3233/BIO-2009-1083, 10.1002/biof.5520340405]
   Nicoli MC, 1997, CANCER LETT, V114, P71, DOI 10.1016/S0304-3835(97)04628-4
   Paur I, 2010, CANCER PREV RES, V3, P653, DOI 10.1158/1940-6207.CAPR-09-0089
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8
   Takahashi S, 2014, J FUNCT FOODS, V6, P157, DOI 10.1016/j.jff.2013.10.002
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Wahli W, 2008, J INTERN MED, V263, P613, DOI 10.1111/j.1365-2796.2008.01951.x
   White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Zhan LJ, 2012, FREE RADICAL BIO MED, V53, P758, DOI 10.1016/j.freeradbiomed.2012.05.041
NR 24
TC 33
Z9 37
U1 0
U2 25
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD NOV
PY 2014
VL 37
IS 11
BP 1820
EP 1825
DI 10.1248/bpb.b14-00378
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA AS0JW
UT WOS:000343964500017
PM 25212747
OA gold
DA 2025-04-28
ER

PT J
AU Wu, TY
   Hankinson, SE
   Willett, WC
   Giovannucci, E
AF Wu, TY
   Hankinson, SE
   Willett, WC
   Giovannucci, E
TI Caffeinated coffee, decaffeinated coffee, and caffeine in relation to
   plasma C-peptide levels, a marker of insulin secretion, in US women
SO DIABETES CARE
LA English
DT Article
ID GLUCOSE DISPOSAL; CONSUMPTION; RISK; REPRODUCIBILITY; RESISTANCE;
   INGESTION; VALIDITY; BLOOD; MODEL; ACID
AB OBJECTIVE - Coffee consumption is associated with reduced risk of type 2 diabetes, but the mechanism is not clearly understood. Elevated C-peptide, as a marker of insulin secretion, has been linked to insulin-resistant type 2 diabetes. In this study, we examined consumption of caffeinated and decaffeinated coffee and total caffeine in relation to concentrations of plasma C-peptide.
   RESEARCH DESIGN AND METHODS - Plasma C-peptide concentrations were measured in a cross-sectional setting among 2,112 healthy women from the Nurses' Health Study I who provided blood samples in 1989-1990. Consumption of caffeinated and decaffeinated coffee and total caffeine was assessed using a semiquantitative food-frequency questionnaire in 1990.
   RESULTS - intakes of caffeinated and decaffeinated coffee and caffeine in 1990 were each inversely associated with C-peptide concentration in age-adjusted, BMI-adjusted, and multivariable-adjusted analyses. In multivariable analysis, concentrations of C-peptide were 16% less in women who drank > 4 cups/day of caffeinated or decaffeinated coffee compared with nondrinkers (P < 0.005 for each). Women in the highest quintile compared with the lowest quintile of caffeine intake had 10% lower C-pepticle levels (P = 0.02). We did not find any association between tea and C-peptide. The inverse association between caffeinated coffee and C-peptide was considerably stronger in obese (27% reduction) and overweight women (20% reduction) than in normal weight women (11% reduction) (P = 0.005).
   CONCLUSIONS - Our findings suggest a potential reduction of insulin secretion by coffee in women. This reduction may be related to other components in coffee rather than caffeine.
C1 Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Channing Lab, Dept Med, Boston, MA USA.
   Brigham & Womens Hosp, Boston, MA 02115 USA.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard Medical School; Harvard University; Harvard
   University Medical Affiliates; Brigham & Women's Hospital
RP Harvard Univ, Sch Publ Hlth, Dept Nutr, 655 Huntington Ave, Boston, MA 02115 USA.
EM tianying@hsph.harvard.edu
RI Giovannucci, Edward/ADE-8028-2022; Willett, Walter/E-2352-2013
OI Yang, Shuman/0000-0002-9638-0890
FU NCI NIH HHS [5P01 CA 87969, CA 49449] Funding Source: Medline; NIDDK NIH
   HHS [5R01 DK 58845] Funding Source: Medline
CR Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI [10.1001/jama.291.10.1199-b, 10.1001/jama.291.10.1199-a]
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   BROWN CR, 1989, PHARMACOL BIOCHEM BE, V34, P565, DOI 10.1016/0091-3057(89)90559-5
   Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338
   Chen CH, 1999, INT J CARDIOL, V68, P179, DOI 10.1016/S0167-5273(98)00366-0
   CHERASKIN E, 1968, LANCET, V2, P689
   Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Haban Peter, 2002, Med Sci Monit, V8, pCR175
   Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138
   HANKINSON SE, 1989, CLIN CHEM, V35, P2313
   JACOB S, 1995, ARZNEIMITTEL-FORSCH, V45-2, P872
   JENKINS DJA, 1988, AM J CLIN NUTR, V48, P248, DOI 10.1093/ajcn/48.2.248
   Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Meyer KA, 2003, J AM COLL NUTR, V22, P185, DOI 10.1080/07315724.2003.10719292
   *NCA, CONS US
   Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   SPRIET LL, 1992, AM J PHYSIOL, V262, pE891, DOI 10.1152/ajpendo.1992.262.6.E891
   Svilaas A, 2004, J NUTR, V134, P562, DOI 10.1093/jn/134.3.562
   Thirunavukkarasu V, 2004, DIABETES OBES METAB, V6, P200, DOI 10.1111/j.1462-8902.2004.00332.x
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Wahren J, 2000, AM J PHYSIOL-ENDOC M, V278, pE759, DOI 10.1152/ajpendo.2000.278.5.E759
   WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086
   Willett WC, 1998, NUTR EPIDEMIOLOGY
   WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991
   Wu TY, 2004, AM J CLIN NUTR, V80, P1043, DOI 10.1093/ajcn/80.4.1043
   ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248
NR 36
TC 120
Z9 128
U1 0
U2 5
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JUN
PY 2005
VL 28
IS 6
BP 1390
EP 1396
DI 10.2337/diacare.28.6.1390
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 931QM
UT WOS:000229500000019
PM 15920057
OA Bronze
DA 2025-04-28
ER

PT J
AU Peron, G
   Santarossa, D
   Voinovich, D
   Dall'Acqua, S
   Sut, S
AF Peron, Gregorio
   Santarossa, Davide
   Voinovich, Dario
   Dall'Acqua, Stefano
   Sut, Stefania
TI Urine metabolomics shows an induction of fatty acids metabolism in
   healthy adult volunteers after supplementation with green coffee
   (Coffea robusta L.) bean extract
SO PHYTOMEDICINE
LA English
DT Article
DE Green coffee; Metabolomics; Urine; Caffeoyl quinic acid
ID ACTIVATED RECEPTOR-ALPHA; CHLOROGENIC ACID; LC-MSN; 5-CAFFEOYLQUINIC
   ACID; NUTRACEUTICALS; OBESITY; MASS; TEA; IDENTIFICATION; CONSUMPTION
AB Background and objective: Green coffee bean extract is used as herbal medicine or supplement for weight reduction and obesity. The active constituents are considered caffeine and chlorogenic acid (CGA) derivatives. The mode of action of CGA is still unclear and can be related to peroxisome proliferator-activated receptor a (PPAR-alpha) and liver X receptor R alpha (LXR-alpha). Metabolomics may be an innovative tool for the description and discovery of the multiple target nature of such phytocomplex.
   Methods: 24 h urine samples were collected once a week from ten healthy adult volunteers consuming daily 400 mg of dry Green coffee bean extract (GCBE, 4.9% of chlorogenic acid) each day for 30 days (5 harvesting days, considering also the first day of supplementation). Urine samples were analyzed by LC-QTOF using both untargeted and targeted approaches. The latter was used to monitor two urinary markers of oxidative stress (allantoin, 8-OHdG).
   Results: Metabolomics analysis (PLS-DA) revealed changes in urine composition before and during the treatment with GCBE. Markers related to treatment were metabolites related to polyphenol administration as hippuric acid, benzoic acid derivatives, dihydroferulic and dihydrosinapic acid sulphate, but also carnitine derivatives and dicarboxylic acids. On the other hand, no changes in the levels of allantoin and 8-OHdG were observed.
   Conclusion: This preliminary study showed the possible usefulness of metabolomics approach in the evaluation of GCBE consumption in healthy subjects. The observed changes in urinary composition can be related to the catabolism of GCBE constituents and to induced fatty acid metabolism, mainly related to carnitine derivatives. This latter result could be considered, at least in part, as a further proof of the mode of action of green coffee extract.
C1 [Peron, Gregorio; Dall'Acqua, Stefano; Sut, Stefania] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Via Marzolo 5, I-35131 Padua, Italy.
   [Santarossa, Davide; Voinovich, Dario] Univ Trieste, Dept Chem & Pharmaceut Sci, Ple Europa 1, I-34127 Trieste, Italy.
C3 University of Padua; University of Trieste
RP Dall'Acqua, S (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Via Marzolo 5, I-35131 Padua, Italy.
EM stefano.dallacqua@unipd.it
RI Dall'Acqua, Stefano/C-1353-2013; PERON, GREGORIO/A-8440-2019
OI PERON, GREGORIO/0000-0002-6007-6184; Voinovich,
   Dario/0000-0003-3830-8038
CR [Anonymous], INTEGR MED ALERT
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Babova O, 2016, PHYTOCHEMISTRY, V123, P33, DOI 10.1016/j.phytochem.2016.01.016
   Bajko E, 2016, LWT-FOOD SCI TECHNOL, V65, P471, DOI 10.1016/j.lwt.2015.08.024
   Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025
   Brower V, 1998, NAT BIOTECHNOL, V16, P728, DOI 10.1038/nbt0898-728
   Buchanan R, 2013, J EVID-BASED INTEGR, V18, P309, DOI 10.1177/2156587213496818
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 2008, FOOD CHEM, V106, P379, DOI 10.1016/j.foodchem.2007.05.081
   Clifford MN, 2006, J AGR FOOD CHEM, V54, P4095, DOI 10.1021/jf060536p
   Clifford MN, 2005, J AGR FOOD CHEM, V53, P3821, DOI 10.1021/jf050046h
   Clifford MN, 2003, J AGR FOOD CHEM, V51, P2900, DOI 10.1021/jf026187q
   Cooke MS, 2002, FREE RADICAL BIO MED, V33, P1601, DOI 10.1016/S0891-5849(02)01146-2
   Deen D, 2004, AM FAM PHYSICIAN, V69, P2875
   Del Rio D, 2010, NUTRIENTS, V2, P820, DOI 10.3390/nu2080820
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farah Adriana, 2006, Braz. J. Plant Physiol., V18, P23, DOI 10.1590/S1677-04202006000100003
   Gao K, 2006, J NUTR, V136, P52, DOI 10.1093/jn/136.1.52
   Gaullier JM, 2005, J NUTR, V135, P778
   Gervois P, 2000, CLIN CHEM LAB MED, V38, P3, DOI 10.1515/CCLM.2000.002
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Huang C., 2016, BMC COMPLEMENT ALTER, V16
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Il'yasova D, 2012, CLIN CHIM ACTA, V413, P1446, DOI 10.1016/j.cca.2012.06.012
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P6418, DOI 10.1021/jf049560y
   Krupp D, 2012, J NUTR, V142, P1314, DOI 10.3945/jn.112.159319
   Kuzbicka Karolina, 2013, Pediatr Endocrinol Diabetes Metab, V19, P106
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Liu SL, 2015, FOOD FUNCT, V6, P2779, DOI 10.1039/c5fo00626k
   Maeda H, 2015, J OLEO SCI, V64, P125, DOI 10.5650/jos.ess14226
   Meng S., 2013, ALTERN MED, V2013
   Miyashita K, 2014, NUTRITION IN THE PREVENTION AND TREATMENT OF ABDOMINAL OBESITY, P329, DOI 10.1016/B978-0-12-407869-7.00030-1
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Nakajima Hideto, 2012, Open Neurol J, V6, P51, DOI 10.2174/1874205X01206010051
   Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Peron G, 2017, J PHARMACEUT BIOMED, V140, P62, DOI 10.1016/j.jpba.2017.03.015
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   Poddar K, 2011, NUTR CLIN PRACT, V26, P539, DOI 10.1177/0884533611419859
   Revuelta-Iniesta R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/482704
   Ríos-Hoyol A, 2014, INT J VITAM NUTR RES, V84, P113, DOI 10.1024/0300-9831/a000198
   Sharma S., 2009, DRUG DISCOVERY TODAY, V6
   Shimoda H., 2006, BMC COMPLEMENT ALTER, V6
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1258-y
   Sut S, 2016, CURR MED CHEM, V23, P3198, DOI 10.2174/0929867323666160615104837
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tolun AA, 2010, ANAL BIOCHEM, V402, P191, DOI 10.1016/j.ab.2010.03.033
   TSERNG KY, 1991, BIOCHEMISTRY-US, V30, P2508, DOI 10.1021/bi00223a030
   VERHAEGHE BJ, 1992, BIOL MASS SPECTROM, V21, P27, DOI 10.1002/bms.1200210107
   Vorkas PA, 2015, ANAL CHEM, V87, P4184, DOI 10.1021/ac503775m
   Wolfender JL, 2013, CURR MED CHEM, V20, P1056
   Yang Y., 2017, EVID BASED COMPLEMEN, V2017
NR 57
TC 9
Z9 9
U1 2
U2 24
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0944-7113
J9 PHYTOMEDICINE
JI Phytomedicine
PD JAN 1
PY 2018
VL 38
BP 74
EP 83
DI 10.1016/j.phymed.2017.11.002
PG 10
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA FW2YY
UT WOS:000425172900008
PM 29425657
DA 2025-04-28
ER

PT J
AU Bulczak, EM
   Chmurzynska, AU
AF Bulczak, Ewa M.
   Chmurzynska, Agata U.
TI Caffeine Consumption in Polish Adults: Development and Validation of a
   Polish Questionnaire for Assessing Caffeine Intake
SO JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION
LA English
DT Article
DE Caffeine intake; coffee; tea; food frequency questionnaire; validation
ID COFFEE; REPRODUCIBILITY; INCREASES; WOMEN; RISK
AB Objective: Caffeine is one of the oldest natural substances consumed by people. Its consumption in Poland has not been well described. The aim of this study was to design and validate an online food frequency questionnaire (FFQ) on caffeine intake and to use it to estimate caffeine consumption in Polish adults.Method: The FFQ was prepared and validated in a pilot study. The intake assessment was conducted in 2019-2020 on 372 respondents, aged 18 to 60 years. The FFQ included products such as coffee, tea, energy drinks, and carbonated drinks, as well as supplements and chocolate.Results: We showed good repeatability of the FFQ and it was considered a valid tool. The mean total caffeine intake among all participants was 426.7 mg +/- 283.4 mg/day of all sources; in women, it was 446.4 mg +/- 306.2 mg/day, while in men, it was 394.1 +/- 236.4 mg/day. Forty-three percent of the respondents consumed more than 400 mg of caffeine/day. Coffee was the main source of caffeine and contributed to 65% of total caffeine consumption. Women consumed 90% more green tea than men (p < 0.01). Overweight and obese people have 20% greater total caffeine intake (p = 0.01) and consumed 20% more coffee (p = 0.02) and 30% more black tea (p = 0.01) than people of normal weight.Conclusions: Average caffeine consumption among Polish adults slightly exceeds the safe consumption dose established by the European Food Safety Authority. Body weight status can differentiate caffeine intake.
C1 [Bulczak, Ewa M.; Chmurzynska, Agata U.] Poznan Univ Life Sci, Dept Human Nutr & Dietet, Poznan, Poland.
   [Chmurzynska, Agata U.] Poznan Univ Life Sci, Dept Human Nutr & Dietet, Wojska Polskiego 31, PL-60624 Poznan, Poland.
C3 Poznan University of Life Sciences; Poznan University of Life Sciences
RP Chmurzynska, AU (corresponding author), Poznan Univ Life Sci, Dept Human Nutr & Dietet, Wojska Polskiego 31, PL-60624 Poznan, Poland.
EM agata.chmurzynska@up.poznan.pl
OI Bulczak, Ewa/0000-0002-1243-6114; Chmurzynska, Agata/0000-0002-2045-0709
CR Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   Alfawaz HA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197020
   Blaszczyk-Bebenek E, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112373
   Boylan SM, 2008, BRIT J NUTR, V100, P875, DOI 10.1017/S0007114508939842
   Bühler E, 2014, ERNAHRUNGS UMSCHAU, V61, P58, DOI 10.4455/eu.2014.011
   Caprioli G, 2015, INT J FOOD SCI NUTR, V66, P505, DOI 10.3109/09637486.2015.1064871
   Chin JM, 2008, J ANAL TOXICOL, V32, P702, DOI 10.1093/jat/32.8.702
   Clark I, 2017, SLEEP MED REV, V31, P70, DOI 10.1016/j.smrv.2016.01.006
   Czarniecka-Skubina E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18083948
   Derossi A, 2018, J SCI FOOD AGR, V98, P3198, DOI 10.1002/jsfa.8826
   Ferraroni M, 2004, EUR J CLIN NUTR, V58, P674, DOI 10.1038/sj.ejcn.1601864
   Fitt E, 2013, FOOD CHEM, V140, P421, DOI 10.1016/j.foodchem.2012.07.092
   Frankowski Marcin, 2008, Bromatologia i Chemia Toksykologiczna, V41, P21
   Fulgoni VL, 2015, AM J CLIN NUTR, V101, P1081, DOI 10.3945/ajcn.113.080077
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Goluch-Koniuszy Z., 2017, BROMATOL CHEM TOKSYK, P201
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68
   Irons Jessica G., 2016, Journal of Caffeine Research, V6, P20, DOI 10.1089/jcr.2015.0012
   Keast RSJ, 2015, BRIT J NUTR, V113, P366, DOI 10.1017/S000711451400378X
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI [10.1039/C4FO00290C, 10.1039/c4fo00290c]
   Malczyk Ewa, 2021, Rocz Panstw Zakl Hig, V72, P273, DOI 10.32394/rpzh.2021.0171
   Martyn D, 2018, FOOD CHEM TOXICOL, V111, P71, DOI 10.1016/j.fct.2017.10.059
   Meinhart AD, 2010, J AGR FOOD CHEM, V58, P2188, DOI 10.1021/jf903781w
   Mikolajczyk-Stecyna J, 2021, FOOD QUAL PREFER, V90, DOI 10.1016/j.foodqual.2020.104115
   Niseteo T, 2012, FOOD CHEM, V134, P1870, DOI 10.1016/j.foodchem.2012.03.095
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Nowak D, 2015, INT J ENV RES PUB HE, V12, P7910, DOI 10.3390/ijerph120707910
   Penolazzi B, 2012, APPETITE, V58, P971, DOI 10.1016/j.appet.2012.02.001
   Poole Robin, 2019, BMJ Nutr Prev Health, V2, P11, DOI 10.1136/bmjnph-2018-000013
   PRZYBYSZ M.A., 2013, ZESZ PROBL POST P W, V572, P65
   Rapuri PB, 2001, AM J CLIN NUTR, V74, P694
   Rehm CD, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082463
   Reyes CM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111772
   Rochat C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010028
   Rudolph E, 2014, EUR J CLIN NUTR, V68, P793, DOI 10.1038/ejcn.2014.50
   Schliep KC, 2013, AM J EPIDEMIOL, V177, P690, DOI 10.1093/aje/kws283
   Shohet KL, 2001, PSYCHOL REP, V89, P521, DOI 10.2466/PR0.89.7.521-526
   Stachyshyn S, 2021, NUTRIENTS, V13, DOI 10.3390/nu13051493
   Verster JC, 2018, CRIT REV FOOD SCI, V58, P1250, DOI 10.1080/10408398.2016.1247252
   Wang TG, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0862-0
   Watson EJ, 2017, INT J FOOD SCI NUTR, V68, P617, DOI 10.1080/09637486.2016.1268102
   Wierzbicka E., 2010, PROBL HIG EPIDEMIOL, V91, P564
   Wojtowicz-Chomicz K, 2014, FAM MED PRIM CARE RE, V16, P302
   Zucconi S., 2013, Supporting Publications EN-394, DOI [DOI 10.2903/SP.EFSA.2013.EN, 10.2903/sp.efsa.2013.EN-394, DOI 10.2903/SP.EFSA.2013.EN-394]
NR 45
TC 3
Z9 3
U1 1
U2 7
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2769-7061
EI 2769-707X
J9 J AM NUTR ASSOC
JI J. Am. Nutr. Assoc.
PD NOV 17
PY 2023
VL 42
IS 8
BP 769
EP 775
DI 10.1080/27697061.2023.2172749
EA JAN 2023
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA X0MY4
UT WOS:000922477900001
PM 36725370
DA 2025-04-28
ER

PT J
AU Cao, C
   Liu, QR
   Abufaraj, M
   Han, YN
   Xu, TL
   Waldhoer, T
   Shariat, SF
   Li, SX
   Yang, L
   Smith, L
AF Cao, Chao
   Liu, Qinran
   Abufaraj, Mohammad
   Han, Yunan
   Xu, Tianlin
   Waldhoer, Thomas
   Shariat, Shahrokh F.
   Li, Shengxu
   Yang, Lin
   Smith, Lee
TI Regular Coffee Consumption Is Associated with Lower Regional Adiposity
   Measured by DXA among US Women
SO JOURNAL OF NUTRITION
LA English
DT Article
DE coffee consumption; NHANES; body fat; adiposity; gender; DXA
ID ENERGY-EXPENDITURE; METABOLIC SYNDROME; TEA CONSUMPTION; CAFFEINE;
   WEIGHT; METAANALYSIS; REDUCTION; OBESITY
AB Background: Coffee is among the most popular daily beverages in the United States. Importantly, coffee consumption has been associated with a lower risk of multiple health outcomes including a reduction in adiposity. DXA is a means to assess body fat and distribution.
   Objectives: The aim of this study was to examine the relation between coffee consumption and DXA-assessed adiposity and adiposity distribution.
   Methods: Cross-sectional data from the NHANES were used. Participants were adults aged 20-69 y from the 2003-2004 and 2005-2006 waves. Information on coffee consumption was assessed through the FFQ (categorized as no coffee, 0 to <0.25 cup/d, 0.25 to <1 cup/d, 1 cup/d, 2-3 cups/d, or >= 4 cups/d). Both caffeinated and decaffeinated coffee consumption were included. Trunk fat and total fat percentage were measured via whole-body DXA scans. The association between coffee consumption and body fat was investigated using age-adjusted and multivariable-adjusted linear regression models which accounted for sample weights.
   Results: Higher coffee consumption was associated with significantly lower total body fat percentage and trunk body fat percentage in a dose-response manner (all P values < 0.05) among women. Although this dose-response relation was nonsignificant among men, men aged 20-44 y who drank 2-3 cups/d had 1.3% (95% CI: -2.7%, 0.1%) less total fat and 1.8% (95% CI: -3.3%, -0.4%) less trunk fat than those who did not consume coffee. Furthermore, the association between coffee consumption and body fat percentage exhibited for both caffeinated and decaffeinated coffee among women (all P for trend < 0.001) but not among men (all P for trend > 0.05).
   Conclusions: The present study found a significant association between higher coffee consumption and lower DXA-measured adiposity. Moreover, a gender difference in this association in the general US adult population was also observed.
C1 [Cao, Chao] Washington Univ, Program Phys Therapy, Sch Med, St Louis, MO 63130 USA.
   [Cao, Chao] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63130 USA.
   [Liu, Qinran; Han, Yunan] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA.
   [Abufaraj, Mohammad] Univ Jordan, Jordan Univ Hosp, Dept Special Surg, Div Urol, Amman, Jordan.
   [Han, Yunan] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang, Peoples R China.
   [Xu, Tianlin] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA.
   [Waldhoer, Thomas] Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, Vienna, Austria.
   [Shariat, Shahrokh F.] Med Univ Vienna, Dept Urol, Vienna, Austria.
   [Shariat, Shahrokh F.] Karl Landsteiner Inst Urol & Androl, Vienna, Austria.
   [Shariat, Shahrokh F.] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA.
   [Shariat, Shahrokh F.] Weill Cornell Med Coll, New York Presbyterian Hosp, Dept Urol, New York, NY USA.
   [Li, Shengxu] Childrens Hosp & Clin Minnesota, Childrens Minnesota Res Inst, Minneapolis, MN USA.
   [Yang, Lin] Alberta Hlth Serv, Dept Canc Epidemiol & Prevent Res, Calgary, AB, Canada.
   [Yang, Lin] Univ Calgary, Dept Oncol, Calgary, AB, Canada.
   [Yang, Lin] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.
   [Smith, Lee] Anglia Ruskin Univ, Cambridge Ctr Sport & Exercise Sci, Cambridge, England.
C3 Washington University (WUSTL); Washington University (WUSTL); Washington
   University (WUSTL); University of Jordan; China Medical University;
   University of Texas System; University of Texas Health Science Center
   Houston; University of Texas School Public Health; Medical University of
   Vienna; Medical University of Vienna; University of Texas System;
   University of Texas Southwestern Medical Center Dallas;
   NewYork-Presbyterian Hospital; Cornell University; Weill Cornell
   Medicine; Children's Hospitals & Clinics of Minnesota; Alberta Health
   Services (AHS); University of Calgary; University of Calgary; University
   of Calgary; Anglia Ruskin University
RP Cao, C (corresponding author), Washington Univ, Program Phys Therapy, Sch Med, St Louis, MO 63130 USA.; Cao, C (corresponding author), Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63130 USA.
EM caochao@wustl.edu
RI Li, Shengxu/D-8915-2012; Cao, Chao/AAJ-8013-2020; Abufaraj,
   Mohammad/I-2336-2019; Yang, Lin/AAE-4979-2020; Smith, Lee/JPA-1418-2023;
   Waldhoer, Thomas/I-1215-2019; Xu, Tianlin/H-5660-2016; Yang,
   Lin/H-2156-2016
OI Smith, Lee/0000-0002-5340-9833; Liu, Qinran/0000-0001-7090-8485; Yang,
   Lin/0000-0002-1698-6666; Li, Shengxu/0000-0001-9210-7283; Xu,
   Tianlin/0000-0002-5699-5540; Han, Yunan/0000-0002-6378-7715
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cao C, 2020, AM J MED, V133, P961, DOI 10.1016/j.amjmed.2019.12.041
   Cao C, 2020, J AFFECT DISORDERS, V269, P51, DOI 10.1016/j.jad.2020.03.031
   *CDC, 2008, TECHN DOC 1999 2004
   Curtin Lester R, 2012, Vital Health Stat 2, P1
   Dai ZW, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0390-3
   Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002
   Grabovac I, 2019, AM J MED, V132, P489, DOI 10.1016/j.amjmed.2018.11.021
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Hales Craig M, 2020, NCHS Data Brief, P1
   Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882
   Hang D, 2019, AM J CLIN NUTR, V109, P635, DOI 10.1093/ajcn/nqy295
   Hashemian M, 2019, ANN EPIDEMIOL, V34, P33, DOI 10.1016/j.annepidem.2019.03.014
   Hong XW, 2018, NUTR CANCER, V70, P1217, DOI 10.1080/01635581.2018.1512636
   Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060
   Jeszka-Skowron M, 2015, EUR FOOD RES TECHNOL, V240, P19, DOI 10.1007/s00217-014-2356-z
   Kim Y, 2019, EUR J EPIDEMIOL, V34, P731, DOI 10.1007/s10654-019-00524-3
   KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101
   Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x
   Muhammad HFL, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/9606054
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   National Center for Health Statistics, 2018, NHANES 1999 2006 DXA
   National Health and Nutrition Examination Survey, 2010, 2005 2006 DAT DOC
   Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Roberts J, 2020, OBESITY, V28, P445, DOI 10.1002/oby.22705
   Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Temple Jennifer L, 2011, J Caffeine Res, V1, P41, DOI 10.1089/jcr.2011.0005
   Vidal-Puig A, 1999, OBES RES, V7, P133, DOI 10.1002/j.1550-8528.1999.tb00694.x
   Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522
   WILLIAMSSMITH DL, 1977, BIOCHIM BIOPHYS ACTA, V499, P432, DOI 10.1016/0304-4165(77)90074-5
   World Health Organization, 2021, Obesity and overweight, DOI DOI 10.1080/10810730903279694
   Yang L, 2019, JAMA-J AM MED ASSOC, V321, P1587, DOI 10.1001/jama.2019.3636
   Yuan YC, 2018, IEEE T IMAGE PROCESS, V27, P1311, DOI 10.1109/TIP.2017.2762422
NR 38
TC 6
Z9 8
U1 2
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD JUL
PY 2020
VL 150
IS 7
BP 1909
EP 1915
DI 10.1093/jn/nxaa121
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA NM9TR
UT WOS:000568433300029
PM 32361729
OA Bronze
DA 2025-04-28
ER

PT J
AU He, XY
   Zheng, SJ
   Sheng, Y
   Miao, T
   Xu, J
   Xu, WT
   Huang, KL
   Zhao, CH
AF He, Xiaoyun
   Zheng, Shujuan
   Sheng, Yao
   Miao, Tong
   Xu, Jia
   Xu, Wentao
   Huang, Kunlun
   Zhao, Changhui
TI Chlorogenic acid ameliorates obesity by preventing energy balance shift
   in high-fat diet induced obese mice
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE chlorogenic acid; energy expenditure; gut microbiota; intake; obesity
ID METABOLIC SYNDROME; GENE-EXPRESSION; ORAL GLUCOSE; CHOLESTEROL; RELEASE;
   CAFFEINE; EXTRACT; PLASMA
AB BACKGROUND Chlorogenic acid is a type of phenolic acid found in many plants. Chlorogenic acid has an anti-obesity effect with an unclear mechanism. The present study aimed to investigate the regulatory effect of chlorogenic acid on energy balance in high-fat diet (HFD) induced obese C57BL/6J mice administrated 100 mg kg(-1)chlorogenic acid for 13 weeks. RESULTS The consumption of chlorogenic acid ameliorated HFD induced obesity. Chlorogenic acid did not change the physical activity but significantly decreased food intake and increased body temperature, thermal dissipation and brown adipose tissue activity. Moreover, chlorogenic acid improved glucose tolerance but had a moderate impact on other blood indices. Additionally, chlorogenic acid failed to restore the microbiota change associated with HFD induced obesity, but modified the gut bacterial composition in a unique way. CONCLUSION Supplementation with chlorogenic acid can improve HFD induced obesity and associated glucose intolerance mainly via regulating food intake and energy expenditure.
C1 [He, Xiaoyun; Zheng, Shujuan; Sheng, Yao; Miao, Tong; Xu, Jia; Xu, Wentao; Huang, Kunlun] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.
   [He, Xiaoyun; Zheng, Shujuan; Sheng, Yao; Miao, Tong; Xu, Jia; Xu, Wentao; Huang, Kunlun] China Agr Univ, Coll Food Sci & Nutr Engn, Special Food Res Ctr, Beijing, Peoples R China.
   [Zhao, Changhui] Jilin Univ, Coll Food Sci & Engn, Dept Food Qual & Safety, Jilin, Jilin, Peoples R China.
C3 China Agricultural University; China Agricultural University; Jilin
   University
RP Huang, KL (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.; Zhao, CH (corresponding author), Jilin Univ, Coll Food Sci & Engn, Dept Food Qual & Safety, Jilin, Jilin, Peoples R China.
EM foodsafety66@cau.edu.cn; czhao@jlu.edu.cn
RI Zhao, Changhui/N-2378-2019; XU, Wentao/GVU-6771-2022
OI Shujuan, Zheng/0000-0001-6545-0748; he, xiaoyun/0000-0002-9503-8532;
   Zhao, Changhui/0000-0002-1882-7490; Kunlun, Huang/0000-0002-2350-5859
CR Anderson GH, 2012, J NUTR, V142, p1163S, DOI 10.3945/jn.111.149617
   Valiñas MA, 2017, FOOD CHEM, V229, P837, DOI 10.1016/j.foodchem.2017.02.150
   Awad MA, 2000, SCI HORTIC-AMSTERDAM, V83, P249, DOI 10.1016/S0304-4238(99)00124-7
   Barahuie F, 2016, SCI ADV MATER, V8, P501, DOI 10.1166/sam.2016.2662
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Budryn G, 2009, EUR FOOD RES TECHNOL, V228, P913, DOI 10.1007/s00217-008-1004-x
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Chi QB, 2017, INT J MED MUSHROOMS, V19, P1001, DOI [10.1615/IntJMedMushrooms.2017024486, 10.1615/intjmedmushrooms.2017024486]
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Deka SJ, 2017, CURR MOL MED, V17, P79, DOI 10.2174/1566524017666170209160619
   Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326
   Frank J, 2003, J AGR FOOD CHEM, V51, P2526, DOI 10.1021/jf026127k
   Han YY, 2018, J FUNCT FOODS, V45, P462, DOI 10.1016/j.jff.2018.04.027
   Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Khan A, 1998, EUR J PHARMACOL, V349, P325, DOI 10.1016/S0014-2999(98)00188-5
   Koyuncu I, 2018, CELL MOL BIOL, V64, P75, DOI 10.14715/cmb/2018.64.1.14
   Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x
   Marotz Clarisse A., 2016, Yale Journal of Biology and Medicine, V89, P383
   Mayer MA, 2009, CURR CLIN PHARMACOL, V4, P53, DOI 10.2174/157488409787236128
   Morris MJ, 2008, APPETITE, V51, P387
   Muthulakshmi S, 2015, J PHYSIOL BIOCHEM, V71, P29, DOI 10.1007/s13105-014-0376-6
   Pal S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020091
   Peng BJ, 2015, BIOMED ENVIRON SCI, V28, P894, DOI 10.3967/bes2015.123
   Plazas M, 2013, NOT BOT HORTI AGROBO, V41, P26
   Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z
   SALERA M, 1982, J CLIN ENDOCR METAB, V55, P329, DOI 10.1210/jcem-55-2-329
   Sánchez-Villavicencio ML, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-016-1519-9
   Sheng Y, 2019, FOOD SCI NUTR, V7, P1295, DOI 10.1002/fsn3.962
   Slimestad R, 2005, J AGR FOOD CHEM, V53, P7251, DOI 10.1021/jf050737d
   Voss JD, 2019, INT J OBESITY, V43, P437, DOI 10.1038/s41366-018-0060-y
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang XM, 2018, J FUNCT FOODS, V40, P365, DOI 10.1016/j.jff.2017.11.013
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
   Zhai BQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21421-x
   Zhang TH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081055
   Zhao SG, 2016, CELL REP, V14, P2872, DOI 10.1016/j.celrep.2016.02.076
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
NR 40
TC 61
Z9 61
U1 6
U2 113
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD JAN 30
PY 2021
VL 101
IS 2
BP 631
EP 637
DI 10.1002/jsfa.10675
EA AUG 2020
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA PA4FG
UT WOS:000557526200001
PM 32683698
DA 2025-04-28
ER

PT J
AU Cheong, JDLK
   Croft, KD
   Henry, PD
   Matthews, V
   Hodgson, JM
   Ward, NC
AF Cheong, J. D. Li Kwok
   Croft, K. D.
   Henry, P. D.
   Matthews, V.
   Hodgson, J. M.
   Ward, N. C.
TI Green coffee polyphenols do not attenuate features of the metabolic
   syndrome and improve endothelial function in mice fed a high fat diet
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Chlorogenic acid; Atherosclerosis; Metabolic syndrome; Endothelial
   dysfunction; Coffee
ID E-KNOCKOUT MICE; CHLOROGENIC ACID; OXIDATIVE STRESS; PHENOLIC-COMPOUNDS;
   TEA CONSUMPTION; DYSFUNCTION; OBESITY; PLASMA; ATHEROSCLEROSIS;
   CARBOHYDRATE
AB We have investigated the effects of the major polyphenol in coffee, chlorogenic acid (CGA), on obesity, glucose intolerance, insulin resistance, systemic oxidative stress and endothelial dysfunction in a mouse model of the metabolic syndrome. Thirty C57BL6 mice were randomly divided into (n = 10/group) (i) normal diet (ND), (ii) high fat diet (HFD), or (iii) high fat diet supplemented with 0.5% w/w green coffee bean extract (GCE) rich in chlorogenic acid (HFD + GCE). The high fat diet consisted of 28% fat and all animals were maintained on their diets for 12 weeks. The mice fed a HFD and HFD + GCE displayed symptoms of the metabolic syndrome compared to their normal fed counterparts, although no endothelial dysfunction was detected in the abdominal aortas after 12 weeks. GCE did not attenuate HFD-induced obesity, glucose intolerance, insulin resistance or systemic oxidative stress. Furthermore, GCE did not protect against ex vivo oxidant (hypochlorous acid)-induced endothelial dysfunction. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Cheong, J. D. Li Kwok; Croft, K. D.; Henry, P. D.; Hodgson, J. M.; Ward, N. C.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6847, Australia.
   [Matthews, V.] Harry Perkins Inst Med Res, UWA Ctr Med Res, Lab Metab Dysfunct, Perth, WA, Australia.
C3 University of Western Australia; Harry Perkins Institute of Medical
   Research
RP Ward, NC (corresponding author), Univ Western Australia, Sch Med & Pharmacol, GPO Box X2213, Perth, WA 6847, Australia.
EM natalie.ward@uwa.edu.au
RI Croft, Kevin/C-4675-2013
OI Croft, Kevin/0000-0003-1596-4913; Henry, Peter/0000-0002-8213-0508;
   Ward, Natalie/0000-0002-6042-437X
FU Raine Medical Research Foundation; MRF/UWA Postdoctoral Fellowship;
   NHMRC
FX This study was supported by a Raine Medical Research Foundation Priming
   Grant. The authors acknowledge the A. Mubarak, A. Indrawan and Y. Shen
   for their valuable laboratory assistance. N.C. Ward acknowledges the
   support of a MRF/UWA Postdoctoral Fellowship. J.M. Hodgson acknowledges
   the support of a NHMRC Senior Research Fellowship. V. Matthews
   acknowledges the support of a NHMRC Career Development Fellowship.
CR Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a
   Bondonno CP, 2012, FREE RADICAL BIO MED, V52, P95, DOI 10.1016/j.freeradbiomed.2011.09.028
   Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Deckert V, 1999, CIRCULATION, V100, P1230, DOI 10.1161/01.CIR.100.11.1230
   Deedwania Prakash C, 2003, Curr Diab Rep, V3, P289, DOI 10.1007/s11892-003-0019-8
   DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013
   Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848
   Esper RJ, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-4
   Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   Hollman PCH, 2011, J NUTR, V141, p989S, DOI 10.3945/jn.110.131490
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jaiswal R, 2012, FOOD FUNCT, V3, P976, DOI 10.1039/c2fo10260a
   Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11
   Kobayasi R, 2010, J HYPERTENS, V28, P2111, DOI 10.1097/HJH.0b013e32833ca68c
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Liu J., 2013, MAYO CLIN P, V88, P10
   Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Mori TA, 1999, ANAL BIOCHEM, V268, P117, DOI 10.1006/abio.1998.3037
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Perticone F, 2001, DIABETES, V50, P159, DOI 10.2337/diabetes.50.1.159
   Roberts CK, 2005, J APPL PHYSIOL, V98, P203, DOI 10.1152/japplphysiol.00463.2004
   Ruhl CE, 2005, GASTROENTEROLOGY, V129, P1928, DOI 10.1053/j.gastro.2005.08.056
   Shen Y, 2013, FREE RADICAL BIO MED, V65, P908, DOI 10.1016/j.freeradbiomed.2013.08.185
   Shen Y, 2012, BIOCHEM PHARMACOL, V84, P1036, DOI 10.1016/j.bcp.2012.07.016
   Stalmach Angélique, 2006, Braz. J. Plant Physiol., V18, P253, DOI 10.1590/S1677-04202006000100018
   Stocker R, 2004, ARTERIOSCL THROM VAS, V24, P2028, DOI 10.1161/01.ATV.0000143388.20994.fa
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
NR 39
TC 30
Z9 31
U1 0
U2 60
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 46
EP 52
DI 10.1016/j.abb.2014.02.005
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100008
PM 24583266
OA Green Submitted
DA 2025-04-28
ER

PT J
AU Cicero, AFG
   Rosticci, M
   Parini, A
   Morbini, M
   Urso, R
   Grandi, E
   Borghi, C
AF Cicero, Arrigo F. G.
   Rosticci, Martina
   Parini, Angelo
   Morbini, Martino
   Urso, Riccardo
   Grandi, Elisa
   Borghi, Claudio
TI Short-term effects of a combined nutraceutical of insulin-sensitivity,
   lipid level and indexes of liver steatosis: a double-blind, randomized,
   cross-over clinical trial
SO NUTRITION JOURNAL
LA English
DT Article
DE Berberine; Chlorogenic acid; Nutraceutical; Insulin-sensitivity;
   Lipoproteins; Liver steatosis
ID METABOLIC SYNDROME; CHLOROGENIC ACID; PRECLINICAL EVIDENCES;
   CARDIOVASCULAR RISK; COFFEE CONSUMPTION; DISEASE; OVERWEIGHT; BERBERINE;
   OBESITY; DIET
AB Background: Overweight subjects easily develop alterations of the glucose and lipid metabolism and are exposed to an increased cardiometabolic risk. This condition is potentially reversible through the improvement of dietary and behavioural habits. However, a well-assembled nutraceutical would be a useful tool to better improve the metabolic parameters associated to overweight and insulin resistance.
   Methods: To evaluate the effect of a combined nutraceutical containing berberine, chlorogenic acid and tocotrienols, we performed a double blind, cross-over designed trial versus placebo, in 40 overweight subjects with mixed hyperlipidaemia. After the first 8 weeks of treatment (or placebo), patients were asked to observe a 2-week washout period, and they were then assigned to the alternative treatment for a further period of 8 weeks. Clinical and laboratory data associated to hyperlipidaemia and insulin resistance have been obtained at the baseline, at the end of the first treatment period, after the washout, and again after the second treatment period.
   Results: Both groups experienced a significant improvement of anthropometric and biochemical parameters versus baseline. However, total cholesterol, LDL cholesterol, triglycerides, non-HDL cholesterol, fasting insulin, HOMA-IR, GOT and Lipid Accumulation Product decreased more significantly in the nutraceutical group versus placebo.
   Conclusions: This combination seems to improve a large number of metabolic and liver parameters on the short-term in overweight subjects. Further studies are needed to confirm these observations on the middle-and long-term.
C1 [Cicero, Arrigo F. G.; Rosticci, Martina; Parini, Angelo; Morbini, Martino; Urso, Riccardo; Grandi, Elisa; Borghi, Claudio] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy.
   [Cicero, Arrigo F. G.] Hypertens Res Ctr, I-40138 Bologna, Italy.
C3 University of Bologna
RP Cicero, AFG (corresponding author), Univ Bologna, Dept Med & Surg Sci, Bologna, Italy.
EM afgcicero@cardionet.it
RI Grandi, Elisa/HLQ-5882-2023; Cicero, Arrigo/H-8244-2019
OI Cicero, Arrigo Francesco Giuseppe/0000-0002-4367-3884; Grandi,
   Elisa/0000-0003-3867-6228
CR Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6
   BORNER K, 1977, J CLIN CHEM CLIN BIO, V15, P121
   Chen SH, 2014, J GASTROEN HEPATOL, V29, P435, DOI 10.1111/jgh.12422
   Cicero AFG, 2013, CURR TOP NUTRACEUT R, V11, P41
   Cicero AF, 2014, CURR VASC PHARMACOL, V12, P565, DOI 10.2174/15701611113119990120
   Cicero AF, 2009, CLIN LIPIDOL, V4, P553, DOI 10.2217/CLP.09.41
   Cicero AFG, 2013, INTERN EMERG MED, V8, P265, DOI 10.1007/s11739-012-0875-9
   Cicero AFG, 2010, J WOMENS HEALTH, V19, P133, DOI 10.1089/jwh.2008.1268
   Conroy KP, 2011, P NUTR SOC, V70, P426, DOI 10.1017/S0029665111001662
   Derosa G, 2012, EXPERT OPIN BIOL TH, V12, P1113, DOI 10.1517/14712598.2012.704014
   Ebbert JO, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0445-x
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gruben N, 2014, BBA-MOL BASIS DIS, V1842, P2329, DOI 10.1016/j.bbadis.2014.08.004
   HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182
   Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162
   Kones Richard, 2014, Hosp Pract (1995), V42, P92, DOI 10.3810/hp.2014.02.1096
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Magrone T, 2013, CAN J PHYSIOL PHARM, V91, P387, DOI 10.1139/cjpp-2012-0307
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nseir W, 2014, WORLD J GASTROENTERO, V20, P9338, DOI 10.3748/wjg.v20.i28.9338
   Oboh Ganiyu, 2015, Journal of Basic and Clinical Physiology and Pharmacology, V26, P165, DOI 10.1515/jbcpp-2013-0141
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Rueda-Clausen CF, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3526
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Wahlefeld AW, 1974, METHODS ENZYMATIC AN, V2nd, P18
   Yang Z, 2014, MED CARE, V52, P658, DOI 10.1097/MLR.0000000000000154
NR 28
TC 27
Z9 26
U1 0
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2891
J9 NUTR J
JI Nutr. J.
PD MAR 28
PY 2015
VL 14
AR 30
DI 10.1186/s12937-015-0019-y
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CG8CF
UT WOS:000353534100001
PM 25886384
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Haidari, F
   Samadi, M
   Mohammadshahi, M
   Jalali, MT
   Engali, KA
AF Haidari, Fatemeh
   Samadi, Mehnoosh
   Mohammadshahi, Majid
   Jalali, Mohammad Taha
   Engali, Kambiz Ahmadi
TI Energy restriction combined with green coffee bean extract affects serum
   adipocytokines and the body composition in obese women
SO ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE adipocytokine; body composition; chlorogenic acid; lipid profile;
   obesity
ID CHLOROGENIC ACID; WEIGHT-LOSS; GLUCOSE-METABOLISM; FAT ACCUMULATION;
   CAFFEINE INTAKE; MASS INDEX; POLYPHENOLS; CONSUMPTION; EXPRESSION;
   LEPTIN
AB Background and Objectives: Obesity has become a public health problem and is a cause of some preventable illnesses. Among several methods for treating obesity, the use of food supplements is highly common. A commonly used food supplement is green coffee bean extract. The objective of this study was to evaluate the efficacy of green coffee bean extract combined with an energy-restricted diet on the body composition and serum adipocytokines in obese women. Methods and Study Design: In this randomised clinical trial, 64 obese women aged 20-45 years were selected and divided into two groups: an intervention group (receiving 400 mg green coffee bean extract for 8 weeks) and control group (receiving placebo). All participants were on an energy-restricted diet. The body composition, leptin, adiponectin, lipid profile, free fatty acids (FFAs), and fasting blood sugar were compared between the two groups. Results: We observed significant reductions in the body weight, body mass and fat mass indices, and waist-to-hip circumference ratio in both groups; however, the decrease was higher in the intervention group. Moreover, serum total cholesterol, low-density lipoprotein, leptin, and plasma free fatty acids significantly decreased in the intervention group (p<0.05) after adjustment for energy and fibre intake. The serum adiponectin concentration significantly increased in the intervention group (p<0.05). Conclusions: Green coffee bean extract combined with an energy-restricted diet affects fat accumulation and lipid metabolism and is thus an inexpensive method for weight control in obese people.
C1 [Haidari, Fatemeh; Samadi, Mehnoosh; Mohammadshahi, Majid] Ahvaz Jundishapur Univ Med Sci, Nutr & Metab Dis Res Ctr, Ahvaz 6135715794, Iran.
   [Jalali, Mohammad Taha] Ahvaz Jundishapur Univ Med Sci, Hyperlipidemia Res Ctr, Ahvaz, Iran.
   [Engali, Kambiz Ahmadi] Ahvaz Jundishapur Univ Med Sci, Fac Publ Hlth, Ahvaz, Iran.
C3 Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz
   Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur
   University of Medical Sciences (AJUMS)
RP Samadi, M (corresponding author), Ahvaz Jundishapur Univ Med Sci, Nutr & Metab Dis Res Ctr, Ahvaz 6135715794, Iran.
EM mehnoosh_samadi@yahoo.com
RI Jafarabadi, Mohammmad/A-7478-2017; samady, mehnoosh/AAG-3682-2019;
   jalali, mohammadtaha/ABH-9257-2020; Haidari, Fatemeh/K-4157-2018
OI Haidari, Fatemeh/0000-0001-9104-4639; Jalali,
   Mohammad-Taha/0000-0002-5094-8049
FU Ahvaz Jundishapur University of Medical Sciences
FX We thank the participants for their assistance in the biochemical and
   nutritional evaluation and Ahvaz Jundishapur University of Medical
   Sciences for the grant support.
CR Andrade KS, 2012, TALANTA, V88, P544, DOI 10.1016/j.talanta.2011.11.031
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Camps SGJA, 2015, METABOLISM, V64, P1284, DOI 10.1016/j.metabol.2015.06.016
   Chen YQ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-52
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Chevance G, 2017, PSYCHOL HEALTH MED, V22, P319, DOI 10.1080/13548506.2016.1159705
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Goto T, 2015, EXP CLIN ENDOCR DIAB, V123, P492, DOI 10.1055/s-0035-1549965
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Icken D, 2016, EUR J CLIN NUTR, V70, P532, DOI 10.1038/ejcn.2015.183
   Inoue M, 2009, CANCER EPIDEM BIOMAR, V18, P1746, DOI 10.1158/1055-9965.EPI-08-0923
   Jung SH, 2008, J NUTR BIOCHEM, V19, P371, DOI 10.1016/j.jnutbio.2007.05.007
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Meyer MRU, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150406
   Miller LE, 2009, OBESITY, V17, P199, DOI 10.1038/oby.2008.498
   Mills CE, 2013, FOOD CHEM, V141, P3335, DOI 10.1016/j.foodchem.2013.06.014
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Ormsbee MJ, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-37
   Samadi M, 2015, J NUTR DISORDERS THE, V5, P180, DOI [10.4172/2161-0509.1000180, DOI 10.4172/2161-0509.1000180]
   Samadi M, 2013, J RES MED SCI, V18, P536
   Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037
   Slee SJ, 2013, JARO-J ASSOC RES OTO, V14, P1, DOI 10.1007/s10162-012-0364-x
   Sotillo D. V. R., 2002, J NUTR BIOCH, V13, P717
   Tverdal A, 2003, ANN EPIDEMIOL, V13, P419, DOI 10.1016/S1047-2797(02)00462-3
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Varady KA, 2009, METABOLISM, V58, P1096, DOI 10.1016/j.metabol.2009.04.010
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Wolin KY, 2008, J PHYS ACT HEALTH, V5, P746, DOI 10.1123/jpah.5.5.746
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
NR 39
TC 51
Z9 53
U1 0
U2 22
PU H E C PRESS, HEALTHY EATING CLUB PTY LTD
PI MCKINNON
PA PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA
SN 0964-7058
EI 1440-6047
J9 ASIA PAC J CLIN NUTR
JI Asia Pac. J. Clin. Nutr.
PY 2017
VL 26
IS 6
BP 1048
EP 1054
DI 10.6133/apjcn.022017.03
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FI4EJ
UT WOS:000411922300010
PM 28917230
DA 2025-04-28
ER

PT J
AU Yonekura, Y
   Terauchi, M
   Hirose, A
   Odai, T
   Kato, K
   Miyasaka, N
AF Yonekura, Yuka
   Terauchi, Masakazu
   Hirose, Asuka
   Odai, Tamami
   Kato, Kiyoko
   Miyasaka, Naoyuki
TI Daily Coffee and Green Tea Consumption Is Inversely Associated with Body
   Mass Index, Body Fat Percentage, and Cardio-Ankle Vascular Index in
   Middle-Aged Japanese Women: A Cross-Sectional Study
SO NUTRIENTS
LA English
DT Article
DE menopause; atheromatous arteriosclerosis; metabolic syndrome; obesity;
   caffeine; polyphenol
ID CARDIOVASCULAR RISK; ARTERIAL STIFFNESS; CHLOROGENIC ACID;
   BLOOD-PRESSURE; CATECHINS; METAANALYSIS; POLYPHENOLS; ANTIOXIDANT;
   HUMANS; IMPACT
AB This study aimed to investigate the links between coffee (CF)/green tea (GT) consumption and body composition/cardiovascular parameters in middle-aged Japanese women. We conducted a cross-sectional study of 232 Japanese women aged 40-65 years who had been referred to the menopause clinic of Tokyo Medical and Dental University Hospital between November 2007 and August 2017. Body composition, cardiovascular parameters, and CF/GT consumption frequency were evaluated on their initial visits, using a body composition analyzer, vascular screening system, and brief-type self-administered diet history questionnaire, respectively. We investigated the associations between variables using multivariate logistic regression. After adjustment for age, menopausal status, and other factors, daily CF consumption was inversely associated with high body mass index (BMI) (adjusted odds ratio, 0.14; 95% confidence interval, 0.14-0.96) and body fat percentage (BF%) (0.33; 0.14-0.82), and daily GT consumption with high BF% (0.36; 0.14-0.96). Daily CF + GT consumption was also inversely associated with high BMI (0.15; 0.05-0.50) and BF% (0.30; 0.12-0.74). In pre- and perimenopausal women, daily CF + GT consumption was inversely associated with high cardio-ankle vascular index (CAVI) (0.05; 0.003-0.743). In conclusion, daily CF/GT consumption was inversely associated with high BMI, BF%, and CAVI in middle-aged Japanese women.
C1 [Yonekura, Yuka; Hirose, Asuka; Miyasaka, Naoyuki] Tokyo Med & Dent Univ, Dept Obstet & Gynecol, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138510, Japan.
   [Terauchi, Masakazu; Odai, Tamami; Kato, Kiyoko] Tokyo Med & Dent Univ, Dept Womens Hlth, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138510, Japan.
C3 Institute of Science Tokyo; Tokyo Medical & Dental University (TMDU);
   Institute of Science Tokyo; Tokyo Medical & Dental University (TMDU)
RP Terauchi, M (corresponding author), Tokyo Med & Dent Univ, Dept Womens Hlth, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138510, Japan.
EM 160992ms@tmd.ac.jp; teragyne@tmd.ac.jp; a-kacrm@tmd.ac.jp;
   odycrm@tmd.ac.jp; kiyo.crm@tmd.ac.jp; n.miyasaka.gyne@tmd.ac.jp
RI Terauchi, Masakazu/D-9831-2013
OI Terauchi, Masakazu/0000-0001-5577-0094
FU Honjo International Scholarship Foundation [X2977]
FX This research was funded by the Honjo International Scholarship
   Foundation (X2977).
CR Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242
   Collins P, 2007, EUR HEART J, V28, P2028, DOI 10.1093/eurheartj/ehm296
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j
   Hibi M, 2018, NUTR RES, V55, P1, DOI 10.1016/j.nutres.2018.03.012
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Kajikawa M, 2019, EUR J NUTR, V58, P989, DOI 10.1007/s00394-018-1611-7
   Khalesi S, 2014, EUR J NUTR, V53, P1299, DOI 10.1007/s00394-014-0720-1
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   Li YF, 2017, CELL PHYSIOL BIOCHEM, V43, P926, DOI 10.1159/000481643
   Lizcano F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/757461
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Martini D, 2016, MOLECULES, V21, DOI 10.3390/molecules21080979
   Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Ota N, 2010, J HEALTH SCI, V56, P745, DOI 10.1248/jhs.56.745
   Parsanathan R, 2020, METAB SYNDR RELAT D, V18, P10, DOI 10.1089/met.2019.0073
   Parsanathan R, 2019, ARCH BIOCHEM BIOPHYS, V663, P11, DOI 10.1016/j.abb.2018.12.023
   Parsanathan R, 2018, AMINO ACIDS, V50, P909, DOI 10.1007/s00726-018-2559-x
   Rosano GM, 2006, CLIMACTERIC, V9, P19, DOI 10.1080/13697130600917732
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Saiki A, 2016, J ATHEROSCLER THROMB, V23, P155, DOI 10.5551/jat.32797
   Shirai K, 2015, PULSE, V3, P118, DOI 10.1159/000431235
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   Suzuki A, 2019, INT J FOOD SCI NUTR, V70, P901, DOI 10.1080/09637486.2019.1585763
   Taguchi C, 2020, EUR J NUTR, V59, P1263, DOI 10.1007/s00394-019-02136-9
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   Williamson G, 2011, MOL NUTR FOOD RES, V55, P864, DOI 10.1002/mnfr.201000631
   World Health Organization, Cardiovascular Disease (CVDs)
   Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018
NR 33
TC 24
Z9 25
U1 2
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD MAY
PY 2020
VL 12
IS 5
AR 1370
DI 10.3390/nu12051370
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA MB0AV
UT WOS:000542272700062
PM 32403338
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Kolb, H
   Martin, S
   Kempf, K
AF Kolb, Hubert
   Martin, Stephan
   Kempf, Kerstin
TI Coffee and Lower Risk of Type 2 Diabetes: Arguments for a Causal
   Relationship
SO NUTRIENTS
LA English
DT Review
DE coffee; diabetes; caffeine; chlorogenic; acids; hepatosteatosis; beta
   cells; hormesis; Nrf2
ID TRANSCRIPTION FACTOR NRF2; PATHWAY IN-VITRO; COMPONENTS CHLOROGENIC
   ACID; ARYL-HYDROCARBON RECEPTOR; BETA-CELL DYSFUNCTION; DECAFFEINATED
   COFFEE; INSULIN SENSITIVITY; CAFFEIC ACID; DITERPENES CAFESTOL;
   GLUCOSE-METABOLISM
AB Prospective epidemiological studies concur in an association between habitual coffee consumption and a lower risk of type 2 diabetes. Several aspects of these studies support a cause-effect relationship. There is a dependency on daily coffee dose. Study outcomes are similar in different regions of the world, show no differences between sexes, between obese versus lean, young versus old, smokers versus nonsmokers, regardless of the number of confounders adjusted for. Randomized controlled intervention trials did not find a consistent impact of drinking coffee on acute metabolic control, except for effects of caffeine. Therefore, lowering of diabetes risk by coffee consumption does not involve an acute effect on the post-meal course of blood glucose, insulin or insulin resistance. Several studies in animals and humans find that the ingestion of coffee phytochemicals induces an adaptive cellular response characterized by upregulation and de novo synthesis of enzymes involved in cell defense and repair. A key regulator is the nuclear factor erythroid 2-related factor 2 (Nrf2) in association with the aryl hydrocarbon receptor, AMP-activated kinase and sirtuins. One major site of coffee actions appears to be the liver, causing improved fat oxidation and lower risk of steatosis. Another major effect of coffee intake is preservation of functional beta cell mass via enhanced mitochondrial function, lower endoplasmic reticulum stress and prevention or clearance of aggregates of misfolded proinsulin or amylin. Long-term preservation of proper liver and beta cell function may account for the association of habitual coffee drinking with a lower risk of type 2 diabetes, rather than acute improvement of metabolic control.
C1 [Kolb, Hubert; Martin, Stephan] Univ Duesseldorf, Fac Med, Moorenstr 5, D-40225 Dusseldorf, Germany.
   [Kolb, Hubert; Martin, Stephan; Kempf, Kerstin] Duesseldorf Catholic Hosp Grp, West German Ctr Diabet & Hlth, Hohensandweg 37, D-40591 Dusseldorf, Germany.
RP Kempf, K (corresponding author), Duesseldorf Catholic Hosp Grp, West German Ctr Diabet & Hlth, Hohensandweg 37, D-40591 Dusseldorf, Germany.
EM hubert.kolb@hhu.de; stephan.martin@uni-duesseldorf.de;
   kerstin.kempf@wdgz.de
OI Kempf, Kerstin/0000-0003-4285-3127
FU Gesellschaft von Freunden und Forderern der Heinrich-HeineUniversitat
   Dusseldorf e.V.
FX The authors thank the Gesellschaft von Freunden und Forderern der
   Heinrich-HeineUniversitat Dusseldorf e.V. for financial support.
CR Accili D, 2016, DIABETES OBES METAB, V18, P117, DOI 10.1111/dom.12723
   Alferink LJM, 2018, SEMIN LIVER DIS, V38, P193, DOI 10.1055/s-0038-1666869
   Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Altieri F, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010186
   Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101
   Aranaz P, 2019, MOLECULES, V24, DOI 10.3390/molecules24061045
   Araujo AR, 2020, ADV EXP MED BIOL, V1250, P159, DOI 10.1007/978-981-15-3262-7_11
   Arunagiri A, 2019, ELIFE, V8, DOI 10.7554/eLife.44532
   Bakuradze T, 2016, MOL NUTR FOOD RES, V60, P682, DOI 10.1002/mnfr.201500668
   Balstad TR, 2011, MOL NUTR FOOD RES, V55, P185, DOI 10.1002/mnfr.201000204
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Baumel-Alterzon S, 2021, TRENDS ENDOCRIN MET, V32, P7, DOI 10.1016/j.tem.2020.11.002
   Berti F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051823
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Boncler M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180022
   Brandt A, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.101092
   Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Carrasco-Pozo C, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3839756
   Cavin C, 2008, FOOD CHEM TOXICOL, V46, P1239, DOI 10.1016/j.fct.2007.09.099
   Chaari A, 2020, INT J BIOL MACROMOL, V164, P1794, DOI 10.1016/j.ijbiomac.2020.08.080
   Chaari A, 2020, INT J BIOL MACROMOL, V162, P284, DOI 10.1016/j.ijbiomac.2020.06.170
   Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z
   Chen YP, 2019, CLIN NUTR, V38, P2552, DOI 10.1016/j.clnu.2018.11.030
   Ciaramelli C, 2018, FOOD CHEM, V252, P171, DOI 10.1016/j.foodchem.2018.01.075
   Ciolino HP, 1999, BIOCHEM J, V340, P715, DOI 10.1042/0264-6021:3400715
   Cornelis MC, 2018, J INTERN MED, V283, P544, DOI 10.1111/joim.12737
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101343
   Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033
   Costea T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051062
   Costes S, 2013, DIABETES, V62, P327, DOI 10.2337/db12-1326
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dubey R, 2019, BIOCHEM J, V476, P889, DOI 10.1042/BCJ20180820
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4552
   Esser N, 2020, DIABETOLOGIA, V63, P2007, DOI 10.1007/s00125-020-05245-x
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Favari C, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202000875
   Fouzder C, 2021, TOXICOL IN VITRO, V70, DOI 10.1016/j.tiv.2020.105038
   Franco R, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090373
   Fratantonio D, 2017, BIOFACTORS, V43, P54, DOI 10.1002/biof.1312
   Fu JQ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/639191
   Fukuyama K, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800238
   Ganesan Kumar, 2020, Eur J Pharmacol, V888, P173606, DOI 10.1016/j.ejphar.2020.173606
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Hang D, 2020, DIABETES CARE, V43, P2588, DOI 10.2337/dc20-0800
   Hardie DG, 2014, J INTERN MED, V276, P543, DOI 10.1111/joim.12268
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Hayat U, 2021, ANN HEPATOL, V20, DOI 10.1016/j.aohep.2020.08.071
   Higgins LG, 2008, TOXICOL APPL PHARM, V226, P328, DOI 10.1016/j.taap.2007.09.018
   Hjellvik V, 2011, EPIDEMIOLOGY, V22, P418, DOI 10.1097/EDE.0b013e31821083e3
   Hu WH, 2020, MOLECULES, V25, DOI 10.3390/molecules25173769
   Ishida K, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020494
   Ishikawa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102152
   Iside C, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01225
   Islam B, 2015, DRUG DES DEV THER, V9, P4943, DOI 10.2147/DDDT.S86705
   Jahic A, 2020, NEUROCHEM INT, V140, DOI 10.1016/j.neuint.2020.104806
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048
   Kalthoff S, 2010, J BIOL CHEM, V285, P5993, DOI 10.1074/jbc.M109.075770
   Kanner J, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090797
   Karadas O, 2019, APPL BIOCHEM BIOTECH, V188, P514, DOI 10.1007/s12010-018-02934-7
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   Kobayashi H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103561
   Köhle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009
   Kolb H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061842
   Kolb H, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1225-1
   Kolb H, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0901-x
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Kuang A, 2020, EUR J NUTR, V59, P1529, DOI 10.1007/s00394-019-02009-1
   Kuang A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121851
   Kumar A, 2018, DIABETES, V67, P1561, DOI 10.2337/db17-0943
   Labbadia J, 2017, CELL REP, V21, P1481, DOI 10.1016/j.celrep.2017.10.038
   Lane JD, 2008, DIABETES CARE, V31, P221, DOI 10.2337/dc07-1112
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Lei LM, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00662
   León-González AJ, 2015, BIOCHEM PHARMACOL, V98, P371, DOI 10.1016/j.bcp.2015.07.017
   Li CG, 2018, BIOMED PHARMACOTHER, V97, P1229, DOI 10.1016/j.biopha.2017.11.063
   Liang NJ, 2019, MOL CELL BIOCHEM, V457, P105, DOI 10.1007/s11010-019-03516-9
   Liu GJ, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101701
   Liu XN, 2018, INT J EPIDEMIOL, V47, P1887, DOI 10.1093/ije/dyy173
   Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   MacKenzie T, 2007, METABOLISM, V56, P1694, DOI 10.1016/j.metabol.2007.07.013
   Marselli L, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108466
   McCusker RR, 2006, J ANAL TOXICOL, V30, P611, DOI 10.1093/jat/30.8.611
   Meex RCR, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.201900942
   Moens C, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201901009
   Moisey LL, 2008, AM J CLIN NUTR, V87, P1254, DOI 10.1093/ajcn/87.5.1254
   Murakami A, 2014, ARCH BIOCHEM BIOPHYS, V557, P3, DOI 10.1016/j.abb.2014.04.018
   Murakami A, 2012, FOOD FUNCT, V3, P462, DOI 10.1039/c2fo10274a
   Naoi M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102451
   Nicolopoulos K, 2020, CLIN NUTR, V39, P3467, DOI 10.1016/j.clnu.2020.03.009
   Ohnaka Keizo, 2012, J Nutr Metab, V2012, P207426, DOI 10.1155/2012/207426
   Oketch-Rabah HA, 2020, TOXICOL REP, V7, P386, DOI 10.1016/j.toxrep.2020.02.008
   Olson KR, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101731
   Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Priftis A, 2018, MOL MED REP, V17, P8325, DOI 10.3892/mmr.2018.8924
   Rakvaag E, 2016, EUR J NUTR, V55, P2221, DOI 10.1007/s00394-015-1032-9
   Raleigh D, 2017, J MOL ENDOCRINOL, V59, pR121, DOI 10.1530/JME-17-0105
   Reis CEG, 2018, BRIT J NUTR, V119, P1029, DOI 10.1017/S000711451800034X
   Ren YQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174238
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Rothhammer V, 2019, NAT REV IMMUNOL, V19, P184, DOI 10.1038/s41577-019-0125-8
   Safe S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186654
   Said MA, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016808
   Salminen A, 2016, CELL SIGNAL, V28, P887, DOI 10.1016/j.cellsig.2016.03.009
   Salomone F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010085
   Salomone F, 2014, TRANSL RES, V163, P593, DOI 10.1016/j.trsl.2013.12.001
   Sauer T, 2013, AMINO ACIDS, V44, P1427, DOI 10.1007/s00726-012-1222-1
   Schultheis J, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7518510
   Seow WJ, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.202000527
   Shaito A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062084
   Shao B, 2020, FREE RADICAL BIO MED, V159, P107, DOI 10.1016/j.freeradbiomed.2020.06.033
   Shi AM, 2018, INT IMMUNOPHARMACOL, V54, P125, DOI 10.1016/j.intimp.2017.11.007
   Shi XQ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0220-7
   Sinisi V, 2015, FOOD CHEM, V168, P332, DOI 10.1016/j.foodchem.2014.07.080
   Sirota R, 2015, REDOX BIOL, V4, P48, DOI 10.1016/j.redox.2014.11.012
   Stefanello N, 2019, FOOD CHEM TOXICOL, V123, P298, DOI 10.1016/j.fct.2018.10.005
   Taguchi C, 2015, NUTRIENTS, V7, P10269, DOI 10.3390/nu7125530
   Taylor R, 2019, LANCET DIABETES ENDO, V7, P726, DOI 10.1016/S2213-8587(19)30076-2
   Tong RY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/2543504
   Tung WC, 2020, ARCH BIOCHEM BIOPHYS, V694, DOI 10.1016/j.abb.2020.108589
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   Tuomilehto J, 2009, DIABETES CARE, V32, pS189, DOI 10.2337/dc09-S308
   Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13
   Vachali PP, 2016, BIOSENSORS-BASEL, V6, DOI 10.3390/bios6010006
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vicente SJV, 2014, J AGR FOOD CHEM, V62, P116, DOI 10.1021/jf401777m
   Vitaglione P, 2019, J NUTR SCI, V8, DOI 10.1017/jns.2019.10
   Volz N, 2012, J AGR FOOD CHEM, V60, P9631, DOI 10.1021/jf302258u
   Wang DJ, 2015, MOL NUTR FOOD RES, V59, P1025, DOI 10.1002/mnfr.201400544
   Wang ZK, 2020, NANOTECHNOLOGY, V31, DOI 10.1088/1361-6528/ab70fb
   Watanabe S, 2017, METAB SYNDR RELAT D, V15, P170, DOI 10.1089/met.2016.0114
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Wei MJ, 2018, TOXICOL SCI, V162, P99, DOI 10.1093/toxsci/kfx230
   Weir GC, 2020, LANCET DIABETES ENDO, V8, P249, DOI 10.1016/S2213-8587(20)30022-X
   Wong THT, 2020, BRIT J NUTR, V124, P785, DOI 10.1017/S0007114520001750
   Wu CZ, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01180-w
   Yang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005632
   Younes M, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5239
   Yuan S, 2020, DIABETOLOGIA, V63, P2359, DOI 10.1007/s00125-020-05253-x
   Zamora-Ros R, 2016, EUR J NUTR, V55, P1359, DOI 10.1007/s00394-015-0950-x
   Zamora-Ros R, 2013, BRIT J NUTR, V110, P1500, DOI 10.1017/S0007114513000688
NR 157
TC 41
Z9 44
U1 2
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR
PY 2021
VL 13
IS 4
AR 1144
DI 10.3390/nu13041144
PG 17
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA RR8QP
UT WOS:000643356200001
PM 33807132
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Wang, M
   Guo, W
   Chen, JF
AF Wang, Meng
   Guo, Wei
   Chen, Jiang-Fan
TI Caffeine: a potential mechanism for anti-obesity
SO PURINERGIC SIGNALLING
LA English
DT Review; Early Access
DE Obesity; Caffeine; Energy consumption; Appetite; Lipid metabolism
ID BROWN ADIPOSE-TISSUE; ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET;
   CORTICOTROPIN-RELEASING-FACTOR; ADENOSINE RECEPTOR AGONISTS;
   FOOD-INTAKE; GREEN TEA; CHLOROGENIC ACID; BODY-WEIGHT; COFFEE
   CONSUMPTION
AB Obesity refers to the excessive accumulation of fat caused by a long-term imbalance between energy intake (EI) and energy expenditure (EE). Over recent years, obesity has become a major public health challenge. Caffeine is a natural product that has been demonstrated to exert anti-obesity effects; however, the mechanisms responsible for the effect of caffeine on weight loss have yet to be fully elucidated. Most obesity-related deaths are due to cardiovascular disease. Recent research has demonstrated that caffeine can reduce the risk of death from cardiovascular disease; thus, it can be hypothesized that caffeine may represent a new therapeutic agent for weight loss. In this review, we synthesize data arising from clinical and animal studies over the last decade and discuss the potential mechanisms by which caffeine may induce weight loss, focusing particularly on increasing energy consumption, suppressing appetite, altering lipid metabolism, and influencing the gut microbiota. Finally, we summarize the major challenges associated with caffeine and anti-obesity research and highlight possible directions for future research and development.
C1 [Wang, Meng] Chengdu Univ Tradit Chinese Med, Int Joint Res Ctr Purinerg Signaling, Sch Acupuncture & Tuina, Chengdu 610075, Peoples R China.
   [Guo, Wei; Chen, Jiang-Fan] Wenzhou Med Univ, Eye Hosp, Mol Neuropharmacol Lab, State Key Lab Ophthalmol Optometry & Visual Sci, Wenzhou 325027, Peoples R China.
   [Guo, Wei; Chen, Jiang-Fan] Wenzhou Med Univ, Eye Hosp, Eye Brain Res Ctr, State Key Lab Ophthalmol Optometry & Visual Sci, Wenzhou 325027, Peoples R China.
C3 Chengdu University of Traditional Chinese Medicine; Wenzhou Medical
   University; Wenzhou Medical University
RP Chen, JF (corresponding author), Wenzhou Med Univ, Eye Hosp, Mol Neuropharmacol Lab, State Key Lab Ophthalmol Optometry & Visual Sci, Wenzhou 325027, Peoples R China.; Chen, JF (corresponding author), Wenzhou Med Univ, Eye Hosp, Eye Brain Res Ctr, State Key Lab Ophthalmol Optometry & Visual Sci, Wenzhou 325027, Peoples R China.
EM wm19980116@163.com; guoweihaha@126.com; chenjf555@gmail.com
RI Guo, Wei/KJM-4941-2024
OI Guo, Wei/0000-0002-8560-6700
FU National Natural Science Foundation of China [82151308]; Research Fund
   for International Senior Scientists [82150710558]; Program Project from
   the State Key Laboratory of Ophthalmology, Optometry and Vision Science,
   Wenzhou Medical University [J01-20190101]; Key Research Project from
   Zhejiang Provincial Administration of Science Technology [2023C03079]
FX This study was funded by the National Natural Science Foundation of
   China (Grant No. 82151308 to J.-F.C.); the Research Fund for
   International Senior Scientists (Grant No. 82150710558 to J.-F.C);
   Program Project from the State Key Laboratory of Ophthalmology,
   Optometry and Vision Science, Wenzhou Medical University (Grant No.
   J01-20190101 to J.-F.C); and Key Research Project (Grant No. 2023C03079
   to J.-F.C) from Zhejiang Provincial Administration of Science &
   Technology.
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Adan A, 2008, PROG NEURO-PSYCHOPH, V32, P1698, DOI 10.1016/j.pnpbp.2008.07.005
   Allard B, 2023, CELL REP MED, V4, DOI 10.1016/j.xcrm.2023.101188
   Allom V, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5392-y
   Aminian A, 2022, JAMA-J AM MED ASSOC, V327, P2423, DOI 10.1001/jama.2022.9009
   Bartrina JA, 2013, NUTR HOSP, V28, P128, DOI 10.3305/nh.2013.28.sup5.6928
   Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021
   ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bakuradze T, 2014, FOOD RES INT, V63, P420, DOI 10.1016/j.foodres.2014.05.032
   Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182
   Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025
   Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495
   Bray GA, 2014, BEST PRACT RES CL GA, V28, P665, DOI 10.1016/j.bpg.2014.07.015
   Cai YL, 2022, OBES REV, V23, DOI 10.1111/obr.13490
   Canas PM, 2009, J NEUROSCI, V29, P14741, DOI 10.1523/JNEUROSCI.3728-09.2009
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004
   Carter BE, 2012, APPETITE, V59, P755, DOI 10.1016/j.appet.2012.08.015
   Cero C, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.139160
   Cerri M, 2005, NEUROSCIENCE, V135, P627, DOI 10.1016/j.neuroscience.2005.06.039
   Cha KH, 2012, J AGR FOOD CHEM, V60, P7152, DOI 10.1021/jf301047f
   Chen JF, 2020, PURINERG SIGNAL, V16, P167, DOI 10.1007/s11302-020-09694-2
   Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955
   Chen JF, 2010, J ALZHEIMERS DIS, V20, pS17, DOI 10.3233/JAD-2010-1403
   Chen L, 2023, DIABETOL METAB SYNDR, V15, DOI 10.1186/s13098-023-00993-3
   Chen Y, 2017, CELL, V171, P836, DOI 10.1016/j.cell.2017.09.015
   Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004
   Chieng D, 2022, TRENDS CARDIOVAS MED, V32, P399, DOI 10.1016/j.tcm.2021.08.004
   Collado-Mateo D, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123603
   Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102
   Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   Dall'Igna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008
   Dangol M, 2017, J CONTROL RELEASE, V265, P41, DOI 10.1016/j.jconrel.2017.03.400
   Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200
   Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
   de Vos WM, 2022, GUT, V71, P1020, DOI 10.1136/gutjnl-2021-326789
   Deen D, 2004, AM FAM PHYSICIAN, V69, P2875
   Deng X, 2015, BBA-MOL CELL BIOL L, V1851, P1521, DOI 10.1016/j.bbalip.2015.08.007
   DeOliveira CC, 2017, EUR J PHARMACOL, V799, P154, DOI 10.1016/j.ejphar.2017.02.017
   DESMEDT H, 1991, J BIOL CHEM, V266, P7092
   Di Bonaventura MVM, 2012, BEHAV PHARMACOL, V23, P567, DOI 10.1097/FBP.0b013e3283566a60
   Di Bonaventura MVM, 2019, J PSYCHOPHARMACOL, V33, P1550, DOI 10.1177/0269881119845798
   Ding L, 2016, SCI REP-UK, V6, DOI 10.1038/srep34374
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Domaszewski P, 2023, NUTRIENTS, V15, DOI 10.3390/nu15061318
   Draper-Joyce CJ, 2021, NATURE, V597, P571, DOI 10.1038/s41586-021-03897-2
   Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x
   DULLOO AG, 1991, INT J OBESITY, V15, P317
   Duval C, 2006, BIOCHEM BIOPH RES CO, V340, P1259, DOI 10.1016/j.bbrc.2005.12.137
   EHRLICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145, DOI 10.1016/0165-6147(94)90074-4
   El Yacoubi M, 2001, BRIT J PHARMACOL, V134, P68, DOI 10.1038/sj.bjp.0704240
   Elsaid MI, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2022.35003
   Engin A, 2017, ADV EXP MED BIOL, V960, P1, DOI 10.1007/978-3-319-48382-5_1
   Escalante G, 2019, J COSMET DERMATOL-US, V18, P1037, DOI 10.1111/jocd.12801
   Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010
   Feigin VL, 2021, LANCET NEUROL, V20, P795, DOI 10.1016/S1474-4422(21)00252-0
   Ferraro PM, 2013, CLIN J AM SOC NEPHRO, V8, P1389, DOI 10.2215/CJN.11661112
   Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905
   Fredholm BB, 2001, PHARMACOL REV, V53, P527
   Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731
   Fredholm BB, 2017, MOL ASPECTS MED, V55, P20, DOI 10.1016/j.mam.2016.11.011
   Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285
   Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856
   Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267
   Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816
   Gosselin C, 2013, BRIT J NUTR, V110, P282, DOI 10.1017/S0007114512005089
   Grant SS, 2018, INT J PSYCHOPHYSIOL, V133, P193, DOI 10.1016/j.ijpsycho.2018.07.001
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Greenberg JA, 2012, J AM COLL NUTR, V31, P160, DOI 10.1080/07315724.2012.10720023
   Grgic J, 2020, BRIT J SPORT MED, V54, P681, DOI 10.1136/bjsports-2018-100278
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Herman A, 2013, SKIN PHARMACOL PHYS, V26, P8, DOI 10.1159/000343174
   Herrmann-Frank A, 1999, J MUSCLE RES CELL M, V20, P223, DOI 10.1023/A:1005496708505
   Hongu N, 2000, J NUTR, V130, P152, DOI 10.1093/jn/130.2.152
   Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002
   HORTON R, 1988, GEN PHARMACOL-VASC S, V19, P403, DOI 10.1016/0306-3623(88)90037-7
   Hosoi T, 2014, NEUROSCI LETT, V569, P23, DOI 10.1016/j.neulet.2014.03.053
   Huang ZL, 2014, INT REV NEUROBIOL, V119, P349, DOI 10.1016/B978-0-12-801022-8.00014-3
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396
   Icken D, 2016, EUR J CLIN NUTR, V70, P532, DOI 10.1038/ejcn.2015.183
   Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429
   Ishibashi K, 2022, MOVEMENT DISORD, V37, P853, DOI 10.1002/mds.28897
   Janssens PLHR, 2016, PHYSIOL BEHAV, V162, P83, DOI 10.1016/j.physbeh.2016.01.044
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Jia WP, 2015, FRONT MED-PRC, V9, P129, DOI 10.1007/s11684-015-0387-x
   Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398
   Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007
   Kang YB, 2023, MOL NUTR FOOD RES, V67, DOI 10.1002/mnfr.202300141
   Kaster MP, 2015, P NATL ACAD SCI USA, V112, P7833, DOI 10.1073/pnas.1423088112
   Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035
   Kenny DJ, 2020, CELL HOST MICROBE, V28, P245, DOI 10.1016/j.chom.2020.05.013
   Kim EY, 2015, INT J MOL SCI, V16, P4581, DOI 10.3390/ijms16034581
   Kim HY, 2015, MOLECULES, V20, P3107, DOI 10.3390/molecules20023107
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kim MS, 2021, EUR HEART J, V42, P3388, DOI 10.1093/eurheartj/ehab454
   Kolahdouzan M, 2017, CNS NEUROSCI THER, V23, P272, DOI 10.1111/cns.12684
   Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a
   Kong L, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13795
   KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854
   Kratz M, 2002, J CLIN ENDOCR METAB, V87, P5008, DOI 10.1210/jc.2002-020496
   Kulkarni K, 2016, MATURITAS, V89, P22, DOI 10.1016/j.maturitas.2016.04.006
   Kwon YJ, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.824269
   Lagiou P, 1999, ANN NUTR METAB, V43, P23, DOI 10.1159/000012763
   Larsson SC, 2023, BMJ MED, V2, DOI 10.1136/bmjmed-2022-000335
   Lassen ML, 2022, J NUCL MED, V63, P431, DOI 10.2967/jnumed.121.261970
   Lebeau PF, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28240-9
   Lee LS, 2015, MOL NUTR FOOD RES, V59, P784, DOI 10.1002/mnfr.201400470
   LEVINE AS, 1983, PHARMACOL BIOCHEM BE, V19, P23, DOI 10.1016/0091-3057(83)90305-2
   Liu CW, 2018, AM J PHYSIOL-ENDOC M, V314, pE433, DOI 10.1152/ajpendo.00094.2017
   Lo Sasso G, 2010, CELL METAB, V12, P187, DOI 10.1016/j.cmet.2010.07.002
   Lopes JP, 2019, BIOCHEM PHARMACOL, V166, P313, DOI 10.1016/j.bcp.2019.06.008
   MacKenzie T, 2007, METABOLISM, V56, P1694, DOI 10.1016/j.metabol.2007.07.013
   Mannucci E, 2008, NUTR METAB CARDIOVAS, V18, P342, DOI 10.1016/j.numecd.2007.03.010
   MARTIN PT, 1992, P NATL ACAD SCI USA, V89, P10257, DOI 10.1073/pnas.89.21.10257
   Maus M, 2017, CELL METAB, V25, P698, DOI 10.1016/j.cmet.2016.12.021
   McConnell MN, 2023, ENV MICROBIOL REP, V15, P422, DOI 10.1111/1758-2229.13165
   McGuire S, 2014, ADV NUTR, V5, P585, DOI 10.3945/an.114.006692
   Mielgo-Ayuso J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102313
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Mizuno Y, 2013, MOVEMENT DISORD, V28, P1138, DOI 10.1002/mds.25418
   Montoya GA, 2014, BRIT J NUTR, V112, P1427, DOI 10.1017/S0007114514002232
   Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677
   Motta EVS, 2023, MICROBIOL SPECTR, V11, DOI 10.1128/spectrum.00520-23
   Mougios V, 2003, J APPL PHYSIOL, V94, P476, DOI 10.1152/japplphysiol.00624.2002
   Moustafa Farah, 2014, Dermatol Online J, V20, P22608
   Müller TD, 2022, NAT REV DRUG DISCOV, V21, P201, DOI 10.1038/s41573-021-00337-8
   Mund RA, 2013, CARDIOL REV, V21, P265, DOI 10.1097/CRD.0b013e31829cabff
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI [10.3233/BIO-2009-1083, 10.1002/biof.5520340405]
   Nauck MA, 2020, MOL METAB, V46, DOI 10.1016/j.molmet.2020.101102
   Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014
   Oberholzer HM, 2015, ENVIRON TOXICOL PHAR, V40, P71, DOI 10.1016/j.etap.2015.05.011
   Oelkrug R, 2015, J COMP PHYSIOL B, V185, P587, DOI 10.1007/s00360-015-0907-7
   Ohara T, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0123-7
   Oishi Y, 2008, P NATL ACAD SCI USA, V105, P19992, DOI 10.1073/pnas.0810926105
   Ontawong A, 2019, PHYTOMEDICINE, V52, P187, DOI 10.1016/j.phymed.2018.06.021
   Owolabi JO, 2017, ANN NEUROSCI, V24, P65, DOI 10.1159/000475895
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Postuma RB, 2012, NEUROLOGY, V79, P651, DOI 10.1212/WNL.0b013e318263570d
   Preti D, 2015, MED RES REV, V35, P790, DOI 10.1002/med.21344
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153
   RACOTTA IS, 1994, PHARMACOL BIOCHEM BE, V48, P887, DOI 10.1016/0091-3057(94)90196-1
   Ramírez-Maldonado M, 2021, J INT SOC SPORT NUTR, V18, DOI 10.1186/s12970-020-00400-6
   Ribeiro JA, 2010, J ALZHEIMERS DIS, V20, pS3, DOI 10.3233/JAD-2010-1379
   Riedel A, 2012, FOOD FUNCT, V3, P955, DOI 10.1039/c2fo30053b
   Sacramento JF, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00262
   Saimaiti A, 2023, CRIT REV FOOD SCI, V63, P9648, DOI 10.1080/10408398.2022.2074362
   Samoggia A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020344
   Schnuck JK, 2018, J PHYSIOL BIOCHEM, V74, P35, DOI 10.1007/s13105-017-0601-1
   Simon J, 2022, EUR J PREV CARDIOL, V29, P982, DOI 10.1093/eurjpc/zwac008
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Stohs SJ, 2016, PHYTOTHER RES, V30, P732, DOI 10.1002/ptr.5583
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Sweeney P, 2016, APPETITE, V101, P171, DOI 10.1016/j.appet.2016.03.013
   Tauler P, 2013, MED SCI SPORT EXER, V45, P1269, DOI 10.1249/MSS.0b013e3182857c8a
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Valadas JS, 2012, J NEUROCHEM, V123, P1030, DOI 10.1111/jnc.12050
   van Galen KA, 2021, OBES REV, V22, DOI 10.1111/obr.13210
   Van Schaik L, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.621356
   Vandenberghe C, 2017, CAN J PHYSIOL PHARM, V95, P455, DOI 10.1139/cjpp-2016-0338
   Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033
   Vaughan RA, 2012, NUTR METAB INSIGHTS, V5, DOI 10.4137/NMI.S10233
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Walker J, 2012, FOOD CHEM TOXICOL, V50, P390, DOI 10.1016/j.fct.2011.09.041
   Weerawatanakorn M, 2023, ACS OMEGA, V8, P33997, DOI 10.1021/acsomega.3c04874
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325
   Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Wu LF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15904
   Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046
   Xu M, 2019, FOOD FUNCT, V10, P7489, DOI 10.1039/c9fo00502a
   Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6
   Yang L, 2015, CELL REP, V11, P798, DOI 10.1016/j.celrep.2015.04.002
   Yang LC, 2021, J SCI FOOD AGR, V101, P573, DOI 10.1002/jsfa.10669
   Yoneshiro T, 2017, AM J CLIN NUTR, V105, P873, DOI 10.3945/ajcn.116.144972
   Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606
   Zeng Q, 2021, LANCET DIABETES ENDO, V9, P393, DOI 10.1016/S2213-8587(21)00047-4
   Zeng X, 2019, NATURE, V569, P229, DOI 10.1038/s41586-019-1156-9
   Zhang LJ, 2012, ANAL CHEM, V84, P2805, DOI 10.1021/ac203197d
   Zhang SJ, 2015, FOOD FUNCT, V6, P2578, DOI [10.1039/c5fo00247h, 10.1039/C5FO00247H]
   Zhang SM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123671
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zheng XC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0206-3
   Zhu MZ, 2021, FOOD FUNCT, V12, P4105, DOI [10.1039/d0fo01768j, 10.1039/D0FO01768J]
   Zhu XJ, 2017, EXP THER MED, V13, P688, DOI 10.3892/etm.2016.3975
   ,, 2017, New England Journal of Medicine, V377, P13
NR 199
TC 2
Z9 2
U1 13
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1573-9538
EI 1573-9546
J9 PURINERG SIGNAL
JI Purinergic Signal.
PD 2024 MAY 28
PY 2024
DI 10.1007/s11302-024-10022-1
EA MAY 2024
PG 17
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA SC2P2
UT WOS:001232197400001
PM 38802651
DA 2025-04-28
ER

PT J
AU Kanchanasurakit, S
   Saokaew, S
   Phisalprapa, P
   Duangjai, A
AF Kanchanasurakit, Sukrit
   Saokaew, Surasak
   Phisalprapa, Pochamana
   Duangjai, Acharaporn
TI Chlorogenic acid in green bean coffee on body weight: a systematic
   review and meta-analysis of randomized controlled trials
SO SYSTEMATIC REVIEWS
LA English
DT Review
DE Green bean coffee; Chlorogenic acid; Body weight; Obesity; Meta-analysis
ID EXTRACT; OBESITY
AB Background Supplemental green bean coffee extract (GBCE) with caffeine has been shown to prevent weight gain. There are different dosages of GBCE that contain chlorogenic acid (CGA), and the data for their effectiveness in preventing weight gain (500 mg/day) is currently out of date. To better understand the effects of GBCE containing CGA on body weight, the present study sets out to perform a systematic review and meta-analysis of these studies.
   Methods Using electronic databases, including Scopus, Embase, PubMed, and Cochrane Library databases, literature was searched up to October 13, 2022. For the meta-analysis examining the impact of GBCE containing CGA (500 mg/day) on body weight with a random-effects model, the randomized controlled trials (RCTs) were considered. We calculated weighted mean differences and 95% confidence intervals (CIs). To gauge study heterogeneity, the Cochran Q statistic and I-squared tests (I-2) were employed.
   Results The meta-analysis includes three RCTs with 103 individuals (case = 51, control = 52). The combined findings of GBCE with CGA at least 500 mg/day result in body weight reduction (WMD: - 1.30 and 95% CI: - 2.07 to - 0.52, p = 0.001) without study heterogeneity (I-2 = 0%, p = 0.904) and without publication bias estimated using Egger's and Begger's test (p = 0.752 and p = 0.602, respectively).
   Conclusions According to the meta-analysis, GBCE with CGA 500 mg/day lowers body weight. Nevertheless, despite its limited sample size and short-term study, this study was successful. Long-term research on the effectiveness and safety of GBCE and CGA on body weight require more clinical trials.
C1 [Kanchanasurakit, Sukrit] Univ Phayao, Sch Pharmaceut Sci, Dept Pharmaceut Care, Div Clin Pharm, Phayao 56000, Thailand.
   [Kanchanasurakit, Sukrit] Phrae Hosp, Dept Pharm, Div Pharmaceut Care, Phrae 54000, Thailand.
   [Kanchanasurakit, Sukrit; Saokaew, Surasak] Univ Phayao, Ctr Hlth Outcomes Res & Therapeut Safety Cohorts, Sch Pharmaceut Sci, Phayao 56000, Thailand.
   [Kanchanasurakit, Sukrit; Saokaew, Surasak] Univ Phayao, Sch Pharmaceut Sci, Unit Excellence Clin Outcomes Res & Integrat UNIC, Phayao 56000, Thailand.
   [Kanchanasurakit, Sukrit; Saokaew, Surasak] Univ Phayao, Sch Pharmaceut Sci, Unit Excellence Herbal Med, Phayao 56000, Thailand.
   [Saokaew, Surasak] Univ Phayao, Sch Pharmaceut Sci, Dept Pharmaceut Care, Div Social & Adm Pharm, Phayao 56000, Thailand.
   [Phisalprapa, Pochamana] Mahidol Univ, Siriraj Hosp, Dept Med, Div Ambulatory Med,Fac Med, Bangkok 10700, Thailand.
   [Duangjai, Acharaporn] Univ Phayao, Sch Med Sci, Div Physiol, Unit Excellence Res & Prod Dev Coffee, Phayao 56000, Thailand.
C3 University of Phayao; University of Phayao; University of Phayao;
   University of Phayao; University of Phayao; Mahidol University;
   University of Phayao
RP Phisalprapa, P (corresponding author), Mahidol Univ, Siriraj Hosp, Dept Med, Div Ambulatory Med,Fac Med, Bangkok 10700, Thailand.; Duangjai, A (corresponding author), Univ Phayao, Sch Med Sci, Div Physiol, Unit Excellence Res & Prod Dev Coffee, Phayao 56000, Thailand.
EM coco_a105@hotmail.com; achara.phso@gmail.com
RI Saokaew, Surasak/AAI-9804-2021
FU Unit of Excellence in Research and Product Development of Coffee,
   University of Phayao, Thailand [UoE63004, UoE64002]
FX This article was supported by the Unit of Excellence in Research and
   Product Development of Coffee [UoE63004], [UoE64002], University of
   Phayao, Thailand.
CR Amano Y, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12030110
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   [Anonymous], 2016, Jordan J Pharm Sci, DOI DOI 10.12816/0033383
   Bagchi D, 2017, FASEB J, V31
   Bahmani M, 2016, J EVID-BASED INTEGR, V21, P228, DOI 10.1177/2156587215599105
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Ding F, 2020, NUTR METAB CARDIOVAS, V30, P1, DOI 10.1016/j.numecd.2019.10.002
   Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140
   Erlandson M, 2016, AM FAM PHYSICIAN, V94, P361
   Gadde KM, 2018, J AM COLL CARDIOL, V71, P69, DOI 10.1016/j.jacc.2017.11.011
   Gorji Z, 2019, PHYTOMEDICINE, V63, DOI 10.1016/j.phymed.2019.153018
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Hausenblas H, 2014, Publish Nat Med J, V6
   Kumar R, 2020, CURR MOL PHARMACOL, V13, P7, DOI 10.2174/1874467212666190716145210
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Shahmohammadi HA, 2017, HEPAT MON, V17, DOI 10.5812/hepatmon.45609
   Palmieri MGS, 2018, BIOCATAL AGR BIOTECH, V16, P43, DOI 10.1016/j.bcab.2018.07.011
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Sudeep HV, 2021, SAGE OPEN MED, V9, DOI 10.1177/20503121211002590
   Tanaka K, 2009, FOOD SCI TECHNOL RES, V15, P147, DOI 10.3136/fstr.15.147
   Zhong YC, 2020, CURR PHARM BIOTECHNO, V21, P1099, DOI 10.2174/1389201021666200318124922
NR 26
TC 6
Z9 6
U1 2
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2046-4053
J9 SYST REV-LONDON
JI Syst. Rev.
PD SEP 14
PY 2023
VL 12
IS 1
AR 163
DI 10.1186/s13643-023-02311-4
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LS9R9
UT WOS:001188914600001
PM 37710316
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Cornelis, MC
AF Cornelis, Marilyn C.
TI Recent consumption of a caffeine-containing beverage and serum
   biomarkers of cardiometabolic function in the UK Biobank
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Caffeine; Coffee; Glucose; Cholesterol; Acute effects; Genetics;
   Biomarkers
ID CARDIOVASCULAR-DISEASE; COFFEE INGESTION; EPIDEMIOLOGY; METAANALYSIS;
   VARIANTS; GLUCOSE; CYP1A2; RISK; AGE
AB We investigated the impact of recent caffeine drinking on glucose and other biomarkers of cardiometabolic function under free-living conditions while also accounting for lifestyle and genetic factors that alter caffeine metabolism and drinking behaviour. Up to 447 794 UK Biobank participants aged 37-73 years in 2006-2010 provided a non-fasting blood sample, for genetic and biomarker measures, and completed questionnaires regarding sociodemographics, medical history and lifestyle. Caffeine drinking (yes/no) about 1 h before blood collection was also recorded. Multivariable regressions were used to examine the association between recent caffeine drinking and serum levels of glycated Hb, glucose, lipids, apo, lipoprotein(a) and C-reactive protein. Men and women reporting recent caffeine drinking had clinically and significantly higher glucose levels than those not recently drinking caffeine (P < 0 center dot 0001). Larger effect sizes were observed among those 55+ years of age and with higher adiposity and longer fasting times (P <= 0 center dot 02 for interactions). Significant CYP1A2 rs2472297xcaffeine and MLXIPL rs7800944 x caffeine interactions on glucose levels were observed among women (P = 0 center dot 004), with similar but non-significant interactions in men. Larger effect sizes were observed among women with rs2472297 CC or rs7800944 CC genotypes than among rs2472297 T or rs7800944 T carriers, respectively. In summary, men and women drinking caffeine within about 1 h of blood draw had higher glucose levels than those not drinking caffeine. Findings were modified by age, adiposity, fasting time and genetic factors related to caffeine metabolism and drinking behaviour. Implications for clinical and population studies of caffeine-containing beverages and cardiometabolic health are discussed.
C1 [Cornelis, Marilyn C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
C3 Northwestern University; Feinberg School of Medicine
RP Cornelis, MC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
EM marilyn.cornelis@northwestern.edu
FU Office of the Provost; Office for Research; National Institute on Aging
   (NIA) [K01AG053477]; Northwestern University Information Technology
FX This research has been conducted using the UK Biobank Resource
   (application no. 21394). Computations in this paper were run on the
   Quest cluster supported in part through the computational resources and
   staff contributions provided for the Quest high performance computing
   facility at Northwestern University, which is jointly supported by the
   Office of the Provost, the Office for Research and Northwestern
   University Information Technology. This work was supported by the
   National Institute on Aging (NIA, K01AG053477). M. C. C. designed and
   conducted the research, analysed the data, wrote the paper and had
   primary responsibility for final content.
CR Abdul-Wahed A, 2017, CELL METAB, V26, P324, DOI 10.1016/j.cmet.2017.07.004
   [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005
   [Anonymous], UK BIOB PROT LARG SC
   Arnaud Maurice J, 2011, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-642-13443-2_3
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   BLANE D, 1989, BRIT J SOCIOL, V40, P344, DOI 10.2307/590279
   Bradbury KE, 2018, J NUTR SCI, V7, DOI 10.1017/jns.2017.66
   Cheung RJ, 2005, ANN PHARMACOTHER, V39, P1209, DOI 10.1345/aph.1G005
   Chung WG, 2000, CLIN PHARMACOL THER, V67, P258, DOI 10.1067/mcp.2000.104617
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis M. C., 2014, Current Nutrition Reports, V3, P178
   Cornelis MC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101343
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Cornelis MC, 2015, CURR OPIN LIPIDOL, V26, P20, DOI 10.1097/MOL.0000000000000143
   Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033
   Cornelis MC., 2019, ADV FOOD NUTR RES
   Emami MR, 2019, COMPLEMENT THER MED, V44, P282, DOI 10.1016/j.ctim.2019.05.003
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246
   Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9
   Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935
   Koupenova Milka, 2013, J Cell Physiol, DOI 10.1002/jcp.24352
   Liu B, 2011, PUBLIC HEALTH NUTR, V14, P1998, DOI 10.1017/S1368980011000942
   Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3
   McKeown NM, 2018, DIABETOLOGIA, V61, P317, DOI 10.1007/s00125-017-4475-0
   Nybo M, 2005, CLIN CHEM, V51, P1563, DOI 10.1373/clinchem.2005.051789
   Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Reyes CM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111772
   Shechter M, 2011, AM J CARDIOL, V107, P1255, DOI 10.1016/j.amjcard.2010.12.035
   Simundic AM, 2014, CLIN CHIM ACTA, V432, P33, DOI 10.1016/j.cca.2013.11.008
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Thorn CF, 2012, PHARMACOGENET GENOM, V22, P73, DOI 10.1097/FPC.0b013e32834c6efd
   UK Biobank, 2015, GENOTYPE IMPUTATION
   UK Biobank, 2011, BIOSP MAN COLL BIOL
   UK Biobank, 2011, BLOOD SAMPL COLL PRO
   UK Biobank, 2019, UK BIOB BIOM PROJ CO
   Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363
   Yang WS, 2014, BRIT J NUTR, V111, P1329, DOI 10.1017/S0007114513003887
   Zargar A, 2013, J CLIN LIPIDOL, V7, P165, DOI 10.1016/j.jacl.2012.11.001
   Zhong VW, 2019, HUM MOL GENET, V28, P2449, DOI 10.1093/hmg/ddz061
NR 43
TC 3
Z9 3
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD AUG 28
PY 2021
VL 126
IS 4
BP 582
EP 590
AR PII S0007114520004377
DI 10.1017/S0007114520004377
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA TI0CQ
UT WOS:000672449600011
PM 33143770
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Voerman, E
   Jaddoe, VWV
   Gishti, O
   Hofman, A
   Franco, OH
   Gaillard, R
AF Voerman, Ellis
   Jaddoe, Vincent W. V.
   Gishti, Olta
   Hofman, Albert
   Franco, Oscar H.
   Gaillard, Romy
TI Maternal Caffeine Intake During Pregnancy, Early Growth, and Body Fat
   Distribution at School Age
SO OBESITY
LA English
DT Article
ID BIRTH-WEIGHT; COFFEE CONSUMPTION; RISK; ADIPOSITY; CHILDHOOD; EXPOSURE;
   OBESITY; UPDATE; LENGTH; INDEX
AB Objective: The associations of maternal caffeine intake during pregnancy with offspring growth patterns and body fat and insulin levels at school age were examined.
   Methods: In a population-based birth cohort among 7,857 mothers and their children, maternal caffeine intake during pregnancy was assessed by questionnaires. Growth characteristics were measured from birth onward. At 6 years, body fat and insulin levels were measured.
   Results: Compared to children whose mothers consumed <2 units of caffeine per day during pregnancy (1 unit of caffeine is equivalent to 1 cup of coffee (90 mg caffeine)), those whose mothers consumed >= 6 units of caffeine per day tended to have a lower weight at birth, higher weight gain from birth to 6 years, and higher body mass index from 6 months to 6 years. Both children whose mothers consumed 4-5.9 and >= 6 units of caffeine per day during pregnancy tended to have a higher childhood body mass index and total body fat mass. Only children whose mothers consumed >= 6 units of caffeine per day had a higher android/gynoid fat mass ratio.
   Conclusions: These results suggest that high levels of maternal caffeine intake during pregnancy are associated with adverse offspring growth patterns and childhood body fat distribution.
C1 [Voerman, Ellis; Jaddoe, Vincent W. V.; Gishti, Olta; Gaillard, Romy] Erasmus MC, Univ Med Ctr, Generat Study Grp R, Rotterdam, Netherlands.
   [Voerman, Ellis; Jaddoe, Vincent W. V.; Gishti, Olta; Hofman, Albert; Franco, Oscar H.; Gaillard, Romy] Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.
   [Voerman, Ellis; Jaddoe, Vincent W. V.; Gishti, Olta; Gaillard, Romy] Erasmus MC, Univ Med Ctr, Dept Pediat, Rotterdam, Netherlands.
C3 Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam;
   Erasmus MC; Erasmus University Rotterdam; Erasmus MC
RP Gaillard, R (corresponding author), Erasmus MC, Univ Med Ctr, Generat Study Grp R, Rotterdam, Netherlands.; Gaillard, R (corresponding author), Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.; Gaillard, R (corresponding author), Erasmus MC, Univ Med Ctr, Dept Pediat, Rotterdam, Netherlands.
EM r.gaillard@erasmusmc.nl
RI Franco, Óscar/ABE-2305-2020; Gaillard, Romy/H-9674-2019
OI Franco, Oscar/0000-0002-4606-4929
FU Erasmus Medical Center, Rotterdam; Erasmus University Rotterdam;
   Netherlands Organization for Health Research and Development;
   Netherlands Organization for Health Research and Development (NWO)
   [ZonMw-VIDI 016.136.361]; European Research Council
   [ERC-2014-CoG-648916]; Nestle Nutrition (Nestec Ltd.); Metagenics Inc.;
   AXA; European Union [289346]
FX The Generation R Study is financially supported by the Erasmus Medical
   Center, Rotterdam, the Erasmus University Rotterdam, and the Netherlands
   Organization for Health Research and Development. VWVJ received an
   additional grant from the Netherlands Organization for Health Research
   and Development (NWO, ZonMw-VIDI 016.136.361) and a European Research
   Council Consolidator Grant (ERC-2014-CoG-648916). OHF works in
   ErasmusAGE, a center for aging research across the life course funded by
   Nestle Nutrition (Nestec Ltd.), Metagenics Inc., and AXA. Nestle
   Nutrition (Nestec Ltd.), Metagenics Inc., and AXA had no role in design
   and conduct of the study; collection, management, analysis, and
   interpretation of the data; or preparation, review, or approval of the
   manuscript. The research leading to these results has received funding
   from the European Union's Seventh Framework Programme (FP7/2007-2013),
   project EarlyNutrition under grant no. 289346.
CR [Anonymous], 2013, VOEDINGSCENTRUM
   [Anonymous], 2006, NEVO TAB 20006 DUTCH
   Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332
   Brent RL, 2011, BIRTH DEFECTS RES B, V92, P152, DOI 10.1002/bdrb.20288
   Chen LW, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0174-6
   Clausson B, 2002, AM J EPIDEMIOL, V155, P429, DOI 10.1093/aje/155.5.429
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006
   Gishti O, 2015, PEDIATR RES, V77, P710, DOI 10.1038/pr.2015.29
   GOLDSTEIN A, 1962, BIOCHEM PHARMACOL, V11, P166, DOI 10.1016/0006-2952(62)90106-5
   Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7
   Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071
   Helba M, 2009, PEDIATR RADIOL, V39, P647, DOI 10.1007/s00247-009-1247-0
   Holzhauer S, 2009, EUR J EPIDEMIOL, V24, P521, DOI 10.1007/s10654-009-9368-1
   Ibáñez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778
   Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1
   KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8
   Klebanoff MA, 2015, EPIDEMIOLOGY, V26, P185, DOI 10.1097/EDE.0000000000000220
   Kruithof CJ, 2014, EUR J EPIDEMIOL, V29, P911, DOI 10.1007/s10654-014-9980-6
   Li DK, 2014, INT J OBES LOND, V39, P658
   Liu YS, 2012, TOXICOL APPL PHARM, V262, P205, DOI 10.1016/j.taap.2012.05.002
   Mook-Kanamori DO, 2009, ULTRASOUND MED BIOL, V35, P1938, DOI 10.1016/j.ultrasmedbio.2009.07.002
   NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x
   Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967
   Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891
   Reynolds RM, 2010, J STEROID BIOCHEM, V122, P3, DOI 10.1016/j.jsbmb.2010.01.009
   Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42
   Srinivasan SR, 2009, AM J CARDIOL, V104, P721, DOI 10.1016/j.amjcard.2009.04.037
   Staiano AE, 2012, INT J OBESITY, V36, P1261, DOI 10.1038/ijo.2012.95
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393
   SUZUKI R, 1993, AM J MED, V95, P309, DOI 10.1016/0002-9343(93)90284-V
   Tan Y, 2012, TOXICOL LETT, V214, P279, DOI 10.1016/j.toxlet.2012.09.007
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886
   Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016
   Xu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044497
NR 40
TC 30
Z9 33
U1 2
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD MAY
PY 2016
VL 24
IS 5
BP 1170
EP 1177
DI 10.1002/oby.21466
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA DO1DU
UT WOS:000377519500024
PM 27015969
OA Green Accepted, Bronze
DA 2025-04-28
ER

PT J
AU Ramerth, A
   Chapple, B
   Winter, J
   Moore, W
AF Ramerth, Alexis
   Chapple, Brooke
   Winter, Jeremiah
   Moore, William
TI The Other Side of the Perfect Cup: Coffee-Derived Non-Polyphenols and
   Their Roles in Mitigating Factors Affecting the Pathogenesis of Type 2
   Diabetes
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE type 2 diabetes; coffee; alkaloids; caffeine; inflammation; oxidative
   stress; theobromine; theophylline
ID BETA-CARBOLINE ALKALOIDS; INSULIN-SECRETION; OXIDATIVE STRESS; KAPPA-B;
   MATRIX METALLOPROTEINASES; INFLAMMASOME ACTIVATION; SIGNALING PATHWAYS;
   CHLOROGENIC ACID; CELL DEATH; GLUCOSE
AB The global prevalence of type 2 diabetes (T2D) is 10.5% among adults in the age range of 20-79 years. The primary marker of T2D is persistent fasting hyperglycemia, resulting from insulin resistance and beta-cell dysfunction. Multiple factors can promote the development of T2D, including obesity, inflammation, and oxidative stress. In contrast, dietary choices have been shown to prevent the onset of T2D. Oatmeal, lean proteins, fruits, and non-starchy vegetables have all been reported to decrease the likelihood of T2D onset. One of the most widely consumed beverages in the world, coffee, has also demonstrated an impressive ability to reduce T2D risk. Coffee contains a diverse array of bioactive molecules. The antidiabetic effects of coffee-derived polyphenols have been thoroughly described and recently reviewed; however, several non-polyphenolic molecules are less prominent but still elicit potent physiological actions. This review summarizes the effects of select coffee-derived non-polyphenols on various aspects of T2D pathogenesis.
C1 [Ramerth, Alexis; Chapple, Brooke; Winter, Jeremiah; Moore, William] Liberty Univ, Sch Hlth Sci, Dept Biol & Chem, Lynchburg, VA 24515 USA.
C3 Liberty University
RP Moore, W (corresponding author), Liberty Univ, Sch Hlth Sci, Dept Biol & Chem, Lynchburg, VA 24515 USA.
EM aramerth@liberty.edu; bechapple@liberty.edu; jwinter11@liberty.edu;
   wtmoore@liberty.edu
FU Liberty University Office of Sponsored Programs and Research
FX The APC was funded by the Liberty University Office of Sponsored
   Programs and Research.
CR Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Alves RC, 2007, J AGR FOOD CHEM, V55, P1832, DOI 10.1021/jf063128u
   [Anonymous], NATL DIABETES STAT R
   [Anonymous], 2013, CDC Newsroom
   Antonietti S, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.825584
   Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119
   Ashihara H, 2016, NAT PROD COMMUN, V11, P1047
   Azarova I, 2021, LIFE-BASEL, V11, DOI 10.3390/life11090886
   Bakala H, 2012, BBA-MOL BASIS DIS, V1822, P1527, DOI 10.1016/j.bbadis.2012.05.016
   Bakuradze T, 2014, FOOD RES INT, V63, P420, DOI 10.1016/j.foodres.2014.05.032
   Barak S, 2014, INT J BIOL MACROMOL, V66, P74, DOI 10.1016/j.ijbiomac.2014.02.017
   Barnes PJ, 2010, PHARMACEUTICALS, V3, P725, DOI 10.3390/ph3030725
   Behl T, 2022, MOLECULES, V27, DOI 10.3390/molecules27185851
   Bensalem S, 2014, J ETHNOPHARMACOL, V154, P361, DOI 10.1016/j.jep.2014.03.070
   Berlowitz I, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.886408
   Bhatti JS, 2022, FREE RADICAL BIO MED, V184, P114, DOI 10.1016/j.freeradbiomed.2022.03.019
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Brandl B, 2024, BEVERAGES, V10, DOI 10.3390/beverages10010012
   Bresciani L, 2020, MOL NUTR FOOD RES, DOI 10.1002/mnfr.202000489
   Burke SJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE715, DOI 10.1152/ajpendo.00153.2015
   Caporaso N, 2018, FOOD RES INT, V106, P193, DOI 10.1016/j.foodres.2017.12.031
   Carrey E.A., 2013, Encyclopedia of Human Nutrition, V3rd ed., P189
   Castañeda R, 2017, PHYTOMEDICINE, V36, P128, DOI 10.1016/j.phymed.2017.09.023
   cdc, Diabetes Quick Facts|Basics|Diabetes|CDC
   Chang YC, 2010, AM J TRANSL RES, V2, P316
   Chapple B, 2024, MOLECULES, V29, DOI 10.3390/molecules29040751
   Chiazza F., 2016, Molecular Nutrition and Diabetes: A Volume in the Molecular Nutrition Series, P105, DOI [10.1016/B978-0-12-801585-8.00009-9, DOI 10.1016/B978-0-12-801585-8.00009-9]
   Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97
   Colak E, 2019, HANDBOOK OF NUTRITION, DIET, AND THE EYE, 2ND EDITION, P85, DOI 10.1016/B978-0-12-815245-4.00006-5
   Cooper EJ, 2003, EUR J PHARMACOL, V482, P189, DOI 10.1016/j.ejphar.2003.09.039
   Corvera S, 2014, BBA-MOL BASIS DIS, V1842, P463, DOI 10.1016/j.bbadis.2013.06.003
   Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416
   Cruz-Pineda WD, 2022, J LEUKOCYTE BIOL, V111, P197, DOI 10.1002/JLB.2RU1220-847R
   Damani L.A., 1984, COMPREHENSIVE HETERO, P223
   De Marco LM, 2011, J AGR FOOD CHEM, V59, P11417, DOI 10.1021/jf202778w
   DePaula J, 2019, BEVERAGES, V5, DOI 10.3390/beverages5020037
   Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301
   diabetes, Diabetes Diagnosis & Tests
   diabetes, Lower Your Risk of Diabetes Complications|ADA
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dong RJ, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.620238
   Esnault S, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/7479107
   Farid MM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73514-1
   Farmaki P, 2020, CURR CARDIOL REV, V16, P249, DOI 10.2174/1573403X1604201229115531
   Feng JL, 2023, FOOD HYDROCOLLOID, V139, DOI 10.1016/j.foodhyd.2023.108522
   Freeman AM, 2024, StatPearls
   Fuggetta MP, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/1515621
   Galicia-Garcia U, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176275
   Ganeshpurkar Aditya, 2013, Ayu, V34, P109, DOI 10.4103/0974-8520.115446
   Gomes PC, 2020, FOOD CONTROL, V108, DOI 10.1016/j.foodcont.2019.106887
   Gong J, 2016, J ETHNOPHARMACOL, V194, P260, DOI 10.1016/j.jep.2016.08.003
   Gong MM, 2023, BIOMED PHARMACOTHER, V168, DOI 10.1016/j.biopha.2023.115747
   Gonzales-Yépez KA, 2023, INT J FOOD SCI, V2023, DOI 10.1155/2023/4323645
   Gu RH, 2020, INT IMMUNOPHARMACOL, V82, DOI 10.1016/j.intimp.2020.106226
   Guan YB, 2001, J TOXICOL ENV HEAL A, V64, P645, DOI 10.1080/152873901753246241
   Habtemariam S, 2019, MEDICINAL FOODS AS POTENTIAL THERAPIES FOR TYPE-2 DIABETES AND ASSOCIATED DISEASES: THE CHEMICAL AND PHARMACOLOGICAL BASIS OF THEIR ACTION, P579, DOI 10.1016/B978-0-08-102922-0.00017-1
   Hamden Khaled, 2013, Sci Pharm, V81, P233, DOI 10.3797/scipharm.1211-14
   Heck DE, 2010, ANN NY ACAD SCI, V1203, P120, DOI 10.1111/j.1749-6632.2010.05603.x
   Heinrich M, 2021, MOLECULES, V26, DOI 10.3390/molecules26071836
   Herraiz T, 2008, CHEM RES TOXICOL, V21, P2172, DOI 10.1021/tx8002565
   Herraiz T, 2023, MOLECULES, V28, DOI 10.3390/molecules28062723
   HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854
   Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988
   Huang JH, 2023, FRONT PHARMACOL, V14, DOI 10.3389/fphar.2023.1218015
   Hudish LI, 2019, J CLIN INVEST, V129, P4001, DOI 10.1172/JCI129188
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1991, COFFEE TEA MATE METH
   Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111
   Institute of Medicine, 2001, Caffeine for the Sustainment of Mental Task Performance: Formulations for Military Operations, DOI [10.17226/10219, DOI 10.17226/10219]
   Iriondo-DeHond A, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.730343
   Ito K, 2020, PLANT BIOTECHNOL-NAR, V37, P459, DOI 10.5511/plantbiotechnology.20.0721a
   Jeszka-Skowron M, 2020, LWT-FOOD SCI TECHNOL, V125, DOI 10.1016/j.lwt.2020.109344
   Jilani T. N., 2024, StatPearls
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Juhász AE, 2023, AM J CLIN NUTR, V117, P266, DOI 10.1016/j.ajcnut.2022.12.015
   Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200
   Kang CH, 2012, FOOD CHEM TOXICOL, V50, P4270, DOI 10.1016/j.fct.2012.08.041
   Karcz-Kubicha M, 2003, NEUROPSYCHOPHARMACOL, V28, P1281, DOI 10.1038/sj.npp.1300167
   Kawabe M, 1997, JPN J CANCER RES, V88, P350, DOI 10.1111/j.1349-7006.1997.tb00388.x
   Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009
   Kobashi C, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-25
   Kolb H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041144
   Konstantinidis N, 2023, MOLECULES, V28, DOI 10.3390/molecules28083460
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Koupenova Milka, 2013, J Cell Physiol, DOI 10.1002/jcp.24352
   Kukula-Koch WA, 2017, PHARMACOGNOSY: FUNDAMENTALS, APPLICATIONS AND STRATEGIES, P163, DOI 10.1016/B978-0-12-802104-0.00009-3
   Kumar M., 2023, Heterocyclic Drug Discovery, P117
   Kurek J., 2019, AlkaloidsTheir Importance in Nature and Human Life
   Lang R, 2010, ANAL CHEM, V82, P1486, DOI 10.1021/ac902616k
   Lee HS, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms231810546
   Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566
   Lee S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061783
   Li AN, 2014, NUTRIENTS, V6, P6020, DOI 10.3390/nu6126020
   Li XR, 2023, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1153915
   Li YW, 2020, RSC ADV, V10, P4397, DOI 10.1039/c9ra09383d
   Li Y, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.614429
   Li YY, 2019, EXP THER MED, V18, P1331, DOI 10.3892/etm.2019.7698
   Liang WZ, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.908749
   Liang YD, 2023, BIOCHIMIE, V206, P93, DOI 10.1016/j.biochi.2022.10.009
   LINDENBLAD GE, 1956, J BIOL CHEM, V219, P893
   Liu L, 2018, EUR J PHARMACOL, V836, P115, DOI 10.1016/j.ejphar.2018.08.025
   Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23
   Liu W, 2022, MOLECULES, V27, DOI 10.3390/molecules27020402
   Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586
   Lutchmansingh FK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198626
   Madi M, 2016, ETHIOP J HEALTH SCI, V26, P523, DOI 10.4314/ejhs.v26i6.4
   Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318
   Makiso MU, 2024, FOOD SCI NUTR, V12, P734, DOI 10.1002/fsn3.3848
   Marcus GM, 2023, NEW ENGL J MED, V388, P1092, DOI 10.1056/NEJMoa2204737
   Martínez-Pinilla E, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00030
   mayoclinic, How Much Caffeine Is in Your Cup?
   McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655
   Meniailo ME, 2018, INT IMMUNOPHARMACOL, V56, P217, DOI 10.1016/j.intimp.2018.01.036
   Mesías M, 2017, CURR OPIN FOOD SCI, V14, P37, DOI 10.1016/j.cofs.2017.01.007
   Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314
   Moon SM, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113976
   Moura DJ, 2007, MUTAGENESIS, V22, P293, DOI 10.1093/mutage/gem016
   Mourad NI, 2012, ENDOCRINOLOGY, V153, P4644, DOI 10.1210/en.2012-1450
   Mukherjee P. K., 2019, Quality Control and Evaluation of Herbal Drugs, P237, DOI [10.1016/B978-0-12-813374-3.00007-7, DOI 10.1016/B978-0-12-813374-3.00007-7]
   Nguyen V, 2024, INT J MOL SCI, V25, DOI 10.3390/ijms25063385
   Nibbelink MG, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091532
   Nuhu Abdulmumin A, 2014, ISRN Nutr, V2014, P384230, DOI 10.1155/2014/384230
   Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034
   Ohnaka Keizo, 2012, J Nutr Metab, V2012, P207426, DOI 10.1155/2012/207426
   Olechno E, 2021, FOODS, V10, DOI 10.3390/foods10061208
   Onyango AN, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8765972
   Ouedraogo R, 2003, DIABETES, V52, P111, DOI 10.2337/diabetes.52.1.111
   paho, Diabetes-PAHO/WHO|Pan American Health Organization
   Pari K, 2000, J BIOL CHEM, V275, P2455, DOI 10.1074/jbc.275.4.2455
   Pasquini S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147685
   Peerapen P, 2020, FOOD CHEM TOXICOL, V135, DOI 10.1016/j.fct.2019.110915
   Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311
   Pérez-Burillo S, 2020, FOOD CHEM, V316, DOI 10.1016/j.foodchem.2020.126309
   Piechowska P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040814
   Pimentel GD, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-6
   Pua LJW, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23031108
   Quarta S, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11101545
   RABINOVITCH A, 1990, DIABETOLOGIA, V33, P506, DOI 10.1007/BF00405114
   RADOSEVICH PM, 1989, AM J PHYSIOL, V256, pE322, DOI 10.1152/ajpendo.1989.256.2.E322
   Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264
   Rajput A, 2022, MATER TODAY-PROC, V48, P1407, DOI 10.1016/j.matpr.2021.09.189
   Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003
   Rehman K, 2017, CRIT REV EUKAR GENE, V27, P229, DOI 10.1615/CritRevEukaryotGeneExpr.2017019712
   Reis CEG, 2019, J TRADIT COMPL MED, V9, P184, DOI 10.1016/j.jtcme.2018.01.001
   Riedel A, 2014, FOOD FUNCT, V5, P454, DOI 10.1039/c3fo60320b
   Rohm TV, 2022, IMMUNITY, V55, P31, DOI 10.1016/j.immuni.2021.12.013
   Rufian-Henares J.A., 2015, Coffee in Health and Disease Prevention, P183, DOI [10.1016/B978-0-12-409517-5.00020-6, DOI 10.1016/B978-0-12-409517-5.00020-6]
   Sanni O, 2023, BMC ENDOCR DISORD, V23, DOI 10.1186/s12902-023-01354-x
   Schönbeck U, 1998, J IMMUNOL, V161, P3340
   Sharma JK, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.708194
   Shen SH, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11061147
   Shi XQ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0220-7
   Shimizu S., 2000, ULLMANNS ENCY IND CH
   Smolders L, 2018, CLIN NUTR, V37, P719, DOI 10.1016/j.clnu.2017.06.007
   Soliman ML, 2013, LIPIDS, V48, P651, DOI 10.1007/s11745-013-3799-x
   Su CM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92941-2
   Subramanian S.P., 2014, Biomed. Preven. Nutrit, V4, P475, DOI [10.1016/j.bionut.2014.07.001, DOI 10.1016/J.BIONUT.2014.07.001, 10.1016/J.BIONUT.2014.07.001]
   Sugiura H, 2012, AM J PHYSIOL-LUNG C, V302, pL764, DOI 10.1152/ajplung.00342.2011
   Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545
   Sykiotis GP, 2001, MOL ENDOCRINOL, V15, P1864, DOI 10.1210/me.15.11.1864
   Tagliazucchi D., 2015, Coffee in Health and Disease Prevention, P859, DOI 10.1016/B978- 0-12-409517-5.00095-4
   Tharaheswari M, 2014, MOL CELL BIOCHEM, V396, P161, DOI 10.1007/s11010-014-2152-x
   Thatikayala M, 2022, EUR J MED CHEM REP, V6, DOI 10.1016/j.ejmcr.2022.100096
   Trask Laura E, 2014, J Diabetes Sci Technol, V8, P1018, DOI 10.1177/1932296814538939
   Traverso N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/972913
   Triantaphylidès C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690
   Vargas-Pozada EE, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23179954
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   Walker JM, 2020, J FUNCT FOODS, V72, DOI 10.1016/j.jff.2020.104063
   Wondmkun YT, 2020, DIABET METAB SYND OB, V13, P3611, DOI 10.2147/DMSO.S275898
   Xu B, 1999, FREE RADICAL BIO MED, V27, P830, DOI 10.1016/S0891-5849(99)00130-6
   Xu P, 2023, PLOS ONE, V18, DOI 10.1371/journal.pone.0282343
   Yajima H, 1999, DIABETES, V48, P1006, DOI 10.2337/diabetes.48.5.1006
   Yang Y, 2022, J AGR FOOD RES, V10, DOI 10.1016/j.jafr.2022.100437
   Yeh S.-L., 2014, DIABETES OXIDATIVE S, P121
   Yolcu ES, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00342
   Yusni Y, 2022, PHARMACIA, V69, P903, DOI 10.3897/pharmacia.69.e85397
   Yuyama S, 1996, ADV EXP MED BIOL, V398, P599
   Zariffard MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116911
   Zhang R, 2009, ENDOCRINOLOGY, V150, P3076, DOI 10.1210/en.2009-0108
   Zhao WM, 2019, INT J BIOL SCI, V15, P1571, DOI 10.7150/ijbs.34211
   Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057
   Zhou C., 2017, HYPOXIA HUMAN DIS
NR 183
TC 0
Z9 0
U1 2
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2024
VL 25
IS 16
AR 8966
DI 10.3390/ijms25168966
PG 24
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA E7H8R
UT WOS:001304688600001
PM 39201652
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Giri, A
   Sturgeon, SR
   Luisi, N
   Bertone-Johnson, E
   Balasubramanian, R
   Reeves, KW
AF Giri, Ayush
   Sturgeon, Susan R.
   Luisi, Nicole
   Bertone-Johnson, Elizabeth
   Balasubramanian, Raji
   Reeves, Katherine W.
TI Caffeinated Coffee, Decaffeinated Coffee and Endometrial Cancer Risk: A
   Prospective Cohort Study among US Postmenopausal Women
SO NUTRIENTS
LA English
DT Article
DE coffee; endometrial cancer; estrogen; insulin; body mass index
ID HORMONE-BINDING GLOBULIN; CHLOROGENIC ACID; DIETARY FACTORS;
   CONSUMPTION; INSULIN; PREMENOPAUSAL; POLYMORPHISMS; EPIDEMIOLOGY;
   SECRETION; OBESITY
AB There is plausible biological evidence as well as epidemiologic evidence to suggest coffee consumption may lower endometrial cancer risk. We evaluated the associations between self-reported total coffee, caffeinated coffee and decaffeinated coffee, and endometrial cancer risk using the Women's Health Initiative Observational Study Research Materials obtained from the National Heart, Lung, and Blood Institute Biological Specimen and Data Repository Coordinating Center. Our primary analyses included 45,696 women and 427 incident endometrial cancer cases, diagnosed over a total of 342,927 person-years of follow-up. We used Cox-proportional hazard models to evaluate coffee consumption and endometrial cancer risk. Overall, we did not find an association between coffee consumption and endometrial cancer risk. Compared to non-daily drinkers (none or <1 cup/day), the multivariable adjusted hazard ratios for women who drank >= 4 cups/day were 0.86 (95% confidence interval (CI) 0.63, 1.18) for total coffee, 0.89 (95% CI 0.63, 1.27) for caffeinated coffee, and 0.51 (95% CI 0.25, 1.03) for decaf coffee. In subgroup analyses by body mass index (BMI) there were no associations among normal-weight and overweight women for total coffee and caffeinated coffee. However among obese women, compared to the referent group (none or <1 cup/day), the hazard ratios for women who drank >= 2 cups/day were: 0.72 (95% CI 0.50, 1.04) for total coffee and 0.66 (95% CI 0.45, 0.97) for caffeinated coffee. Hazard ratios for women who drank >= 2 cups/day for decaffeinated coffee drinkers were 0.67 (0.43-1.06), 0.93 (0.55-1.58) and 0.80 (0.49-1.30) for normal, overweight and obese women, respectively. Our study suggests that caffeinated coffee consumption may be associated with lower endometrial cancer risk among obese postmenopausal women, but the association with decaffeinated coffee remains unclear.
C1 [Giri, Ayush; Sturgeon, Susan R.; Luisi, Nicole; Bertone-Johnson, Elizabeth; Balasubramanian, Raji; Reeves, Katherine W.] Univ Massachusetts Amherst, Dept Publ Hlth, Sch Publ Hlth & Hlth Sci, Div Biostat & Epidemiol, Amherst, MA 01003 USA.
C3 Massachusetts Department of Public Health; University of Massachusetts
   System; University of Massachusetts Amherst
RP Reeves, KW (corresponding author), Univ Massachusetts Amherst, Dept Publ Hlth, Sch Publ Hlth & Hlth Sci, Div Biostat & Epidemiol, 715 N Pleasant St, Amherst, MA 01003 USA.
EM agiri@schoolph.umass.edu; ssturgeon@schoolph.umass.edu;
   nluisi@schoolph.umass.edu; ebertone@schoolph.umass.edu;
   rbalasub@schoolph.umass.edu; kwreeves@schoolph.umass.edu
OI Sturgeon, Susan R/0000-0001-9032-871X; Luisi, Nicole/0000-0003-4466-7141
CR Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI [10.1001/jama.291.10.1199-b, 10.1001/jama.291.10.1199-a]
   Bandera EV, 2009, CANCER CAUSE CONTROL, V20, P1117, DOI 10.1007/s10552-009-9336-9
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1063::AID-JSFA605>3.0.CO;2-Q]
   Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6
   ELWOOD JM, 1977, JNCI-J NATL CANCER I, V59, P1055, DOI 10.1093/jnci/59.4.1055
   Ferrini RL, 1996, AM J EPIDEMIOL, V144, P642, DOI 10.1093/oxfordjournals.aje.a008975
   Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5
   Friberg E, 2009, INT J CANCER, V125, P2413, DOI 10.1002/ijc.24543
   Goto A, 2011, DIABETES, V60, P269, DOI 10.2337/db10-1193
   GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O
   Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502
   Horn-Ross PL, 2003, J NATL CANCER I, V95, P1158, DOI 10.1093/jnci/djg015
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kalandidi A, 1996, ONCOLOGY, V53, P354
   KAZER RR, 1995, INT J CANCER, V62, P403, DOI 10.1002/ijc.2910620408
   Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328
   LEVI F, 1993, CANCER, V71, P3575, DOI 10.1002/1097-0142(19930601)71:11<3575::AID-CNCR2820711119>3.0.CO;2-0
   LONDON S, 1991, AM J CLIN NUTR, V53, P166, DOI 10.1093/ajcn/53.1.166
   Lukanova A, 2004, INT J CANCER, V108, P425, DOI 10.1002/ijc.11529
   McCann SE, 2009, INT J CANCER, V124, P1650, DOI 10.1002/ijc.24125
   Mikhailova ON, 2006, PHARMACOGENOMICS J, V6, P189, DOI 10.1038/sj.tpj.6500365
   Nagamani M, 1998, AM J OBSTET GYNECOL, V179, P6, DOI 10.1016/S0002-9378(98)70244-3
   Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635
   NESTLER JE, 1991, J CLIN ENDOCR METAB, V72, P83, DOI 10.1210/jcem-72-1-83
   PARAZZINI F, 1991, AM J OBSTET GYNECOL, V164, P522, DOI 10.1016/S0002-9378(11)80012-8
   Purdie DM, 2001, BEST PRACT RES CL OB, V15, P341, DOI 10.1053/beog.2000.0180
   Sachse C, 2003, BRIT J CLIN PHARMACO, V55, P68, DOI 10.1046/j.1365-2125.2003.01733.x
   Shimazu T, 2008, INT J CANCER, V123, P2406, DOI 10.1002/ijc.23760
   STENSVOLD I, 1994, CANCER CAUSE CONTROL, V5, P401, DOI 10.1007/BF01694753
   Svilaas A, 2004, J NUTR, V134, P562, DOI 10.1093/jn/134.3.562
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   World Cancer Research Fund, 2007, FOOD NUTR PHYS ACT P
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Yu XF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-96
   Zeleniuch-Jacquotte A, 2001, BRIT J CANCER, V84, P975, DOI 10.1054/bjoc.2001.1704
NR 39
TC 30
Z9 33
U1 0
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2011
VL 3
IS 11
BP 937
EP 950
DI 10.3390/nu3110937
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 864OH
UT WOS:000298249000003
PM 22254087
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Shokouh, P
   Jeppesen, PB
   Christiansen, CB
   Mellbye, FB
   Hermansen, K
   Gregersen, S
AF Shokouh, Pedram
   Jeppesen, Per B.
   Christiansen, Christine B.
   Mellbye, Fredrik B.
   Hermansen, Kjeld
   Gregersen, Soren
TI Efficacy of Arabica Versus Robusta Coffee in Improving Weight, Insulin
   Resistance, and Liver Steatosis in a Rat Model of Type-2 Diabetes
SO NUTRIENTS
LA English
DT Article
DE coffee; insulin resistance; type 2 diabetes mellitus; liver steatosis;
   gene expression
ID CHLOROGENIC ACID; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; RODENT MODELS;
   SERUM-LIPIDS; CONSUMPTION; CAFFEINE; PLASMA; OBESE; CHOLESTEROL
AB The effects of chronic coffee exposure in models of type 2 diabetes mellitus (T2D) is scarcely studied, and the efficacy of the main coffee species has never been compared. We tested the hypothesis that long-term consumption of arabica and robusta coffee may differentially delay and affect T2D development in Zucker diabetic fatty rats. Three study groups received either chow mixed with arabica or robusta instant coffee (1.8% w/w) or unsupplemented chow food for 10 weeks. Both coffee species reduced liver triglyceride content and area under the curve of fasting and postprandial insulin. At study end, plasma adiponectin, total cholesterol and high density lipoprotein levels were higher in the robust group compared with both arabica and control groups. The liver gene expression of Glucose-6-phosphatase, catalytic subunit (G6pc) and Mechanistic target of rapamycin (mTOR) in robusta and Cpt1a in both coffee groups was downregulated. In conclusion, long-term consumption of both coffee species reduced weight gain and liver steatosis and improved insulin sensitivity in a rat model of T2D. Robusta coffee was seemingly superior to arabica coffee with respect to effects on lipid profile, adiponectin level and hepatic gene expression.
C1 [Shokouh, Pedram; Mellbye, Fredrik B.; Hermansen, Kjeld; Gregersen, Soren] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark.
   [Shokouh, Pedram] Odense Univ Hosp, Danish Diabet Acad, Klovervaenget 10, DK-5000 Odense C, Denmark.
   [Jeppesen, Per B.; Christiansen, Christine B.; Hermansen, Kjeld] Aarhus Univ, Dept Clin Med, Palle Juul Jensens Blvd 165, DK-8200 Aarhus N, Denmark.
   [Gregersen, Soren] Steno Diabet Ctr, Palle Juul Jensens Blvd 165, DK-8200 Aarhus N, Denmark.
C3 Aarhus University; University of Southern Denmark; Odense University
   Hospital; Aarhus University; Steno Diabetes Center
RP Gregersen, S (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark.; Gregersen, S (corresponding author), Steno Diabet Ctr, Palle Juul Jensens Blvd 165, DK-8200 Aarhus N, Denmark.
EM soeren.gregersen@aarhus.rm.dk
RI Gregersen, Søren/HJZ-2527-2023; Shokouh, Pedram/AAX-4572-2021;
   hermansen, kjeld/AAY-4241-2021
OI Gregersen, Soren/0000-0002-1953-8631; Shokouh,
   Pedram/0000-0002-4514-0045; Jeppesen, Per Bendix/0000-0001-8042-7554;
   Mellbye, Fredrik Drews/0000-0002-1477-1178; Christiansen, Christine
   Bodelund/0000-0001-6381-5360
FU Aarhus University Research Foundation; Danish Diabetes Academy; Novo
   Nordisk Foundation - Innovation Fund Denmark [1308-00028B]; Riisfort
   Foundation
FX Aarhus University Research Foundation and the Danish Diabetes Academy
   supported by the Novo Nordisk Foundation provided funding in form of
   doctoral fellowships. The current research was also partly funded by a
   grant from Innovation Fund Denmark (grant No. 1308-00028B) and Riisfort
   Foundation.
CR Abrahao SA, 2013, PLANT FOOD HUM NUTR, V68, P184, DOI 10.1007/s11130-013-0355-z
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Beynen AC, 1996, BRIT J NUTR, V76, P755, DOI 10.1079/BJN19960081
   Bicho NC, 2013, INT J FOOD PROP, V16, P895, DOI 10.1080/10942912.2011.573114
   Brader Lea, 2013, Rev Diabet Stud, V10, P270, DOI 10.1900/RDS.2013.10.270
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Chen D, 2005, DIABETES OBES METAB, V7, P307, DOI 10.1111/j.1463-1326.2004.00392.x
   Chen Z., 2016, J. Mol. Genet. Med., V10, P238, DOI [DOI 10.4172/1747-0862.1000238, 10.4172/1747-0862.1000238]
   Clore JN, 2000, DIABETES, V49, P969, DOI 10.2337/diabetes.49.6.969
   Conti R, 2011, DIABETES, V60, P644, DOI 10.2337/db10-0346
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Farah A, 2006, FOOD CHEM, V98, P373, DOI 10.1016/j.foodchem.2005.07.032
   Ferrannini E, 1998, J HYPERTENS, V16, P895, DOI 10.1097/00004872-199816070-00001
   Gross G, 1997, FOOD CHEM TOXICOL, V35, P547, DOI 10.1016/S0278-6915(96)00123-8
   Hamden Khaled, 2013, Sci Pharm, V81, P233, DOI 10.3797/scipharm.1211-14
   HAYTER AJ, 1986, J AM STAT ASSOC, V81, P1000
   Janssen SWJ, 1999, HORM METAB RES, V31, P610, DOI 10.1055/s-2007-978806
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jouihan H., 2012, Bio-protocol, V2, pe223, DOI DOI 10.21769/BIOPROTOC.223
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Keung W, 2013, DIABETES, V62, P711, DOI 10.2337/db12-0259
   Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921
   Leonard BL, 2005, ACTA DIABETOL, V42, P162, DOI 10.1007/s00592-005-0197-8
   Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x
   Martin MJ, 1998, TALANTA, V46, P1259, DOI 10.1016/S0039-9140(97)00409-8
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   MENSINK RP, 1995, J INTERN MED, V237, P543, DOI 10.1111/j.1365-2796.1995.tb00883.x
   Mues C, 2009, HORM METAB RES, V41, P730, DOI 10.1055/s-0029-1225360
   Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Perrone D, 2008, FOOD CHEM, V106, P859, DOI 10.1016/j.foodchem.2007.06.053
   Poole Robin, 2019, BMJ Nutr Prev Health, V2, P11, DOI 10.1136/bmjnph-2018-000013
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200
   Rustenbeck I, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.19
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Tfouni SAV, 2012, INT J FOOD SCI TECH, V47, P406, DOI 10.1111/j.1365-2621.2011.02854.x
   TOKUYAMA Y, 1995, DIABETES, V44, P1447, DOI 10.2337/diabetes.44.12.1447
   VANROOIJ J, 1995, AM J CLIN NUTR, V61, P1277, DOI 10.1093/ajcn/61.6.1277
   Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012
   Wang YW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/401723
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Yoshinari O, 2010, CURR MED CHEM, V17, P2196, DOI 10.2174/092986710791299902
NR 51
TC 21
Z9 21
U1 2
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD SEP
PY 2019
VL 11
IS 9
AR 2074
DI 10.3390/nu11092074
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA JA6PP
UT WOS:000487964600197
PM 31484373
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Tajik, N
   Tajik, M
   Mack, I
   Enck, P
AF Tajik, Narges
   Tajik, Mahboubeh
   Mack, Isabelle
   Enck, Paul
TI The potential effects of chlorogenic acid, the main phenolic components
   in coffee, on health: a comprehensive review of the literature
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Review
DE Green coffee bean extracts; Chlorogenic acid; Antioxidant;
   Anti-inflammatory
ID HIGH-FAT DIET; HYDROXYHYDROQUINONE-FREE COFFEE; TYPE-2
   DIABETES-MELLITUS; ACUTE LIVER-INJURY; PATHWAY IN-VITRO; BEAN EXTRACT;
   CAFFEIC ACID; ENDOTHELIAL FUNCTION; INSULIN-RESISTANCE; DECAFFEINATED
   COFFEE
AB Chlorogenic acid (CGA), an important biologically active dietary polyphenol, is produced by certain plant species and is a major component of coffee. Reduction in the risk of a variety of diseases following CGA consumption has been mentioned in recent basic and clinical research studies. This systematic review discusses in vivo animal and human studies of the physiological and biochemical effects of chlorogenic acids (CGAs) on biomarkers of chronic disease. We searched PubMed, Embase, Amed and Scopus using the following search terms: ("chlorogenic acid" OR "green coffee bean extract") AND (human OR animal) (last performed on April 1st, 2015) for relevant literature on the in vivo effects of CGAs in animal and human models, including clinical trials on cardiovascular, metabolic, cancerogenic, neurological and other functions. After exclusion of editorials and letters, uncontrolled observations, duplicate and not relevant publications the remaining 94 studies have been reviewed. The biological properties of CGA in addition to its antioxidant and anti-inflammatory effects have recently been reported. It is postulated that CGA is able to exert pivotal roles on glucose and lipid metabolism regulation and on the related disorders, e.g. diabetes, cardiovascular disease (CVD), obesity, cancer, and hepatic steatosis. The wide range of potential health benefits of CGA, including its anti-diabetic, anti-carcinogenic, anti-inflammatory and anti-obesity impacts, may provide a non-pharmacological and non-invasive approach for treatment or prevention of some chronic diseases. In this study, the effects of CGAs on different aspects of health by reviewing the related literatures have been discussed.
C1 [Tajik, Narges; Mack, Isabelle; Enck, Paul] Univ Hosp Tuebingen, Dept Internal Med Psychosomat Med & Psychotherapy, Frondsbergstr 23, D-72076 Tubingen, Germany.
   [Tajik, Mahboubeh] Ferdowsi Univ Mashhad, Fac Phys Educ & Sport Sci, Int Branch, Mashhad, Iran.
C3 Eberhard Karls University of Tubingen; Eberhard Karls University
   Hospital; Ferdowsi University Mashhad
RP Enck, P (corresponding author), Univ Hosp Tuebingen, Dept Internal Med Psychosomat Med & Psychotherapy, Frondsbergstr 23, D-72076 Tubingen, Germany.
EM paul.enck@uni-tuebingen.de
FU Department of Internal Medicine VI: Psychosomatic Medicine and
   Psychotherapy, University Hospital Tuebingen, Tuebingen, Germany
FX Funding for this review was provided by the Department of Internal
   Medicine VI: Psychosomatic Medicine and Psychotherapy, University
   Hospital Tuebingen, Tuebingen, Germany.
CR Ahrens MJ, 2013, J MED FOOD, V16, P211, DOI 10.1089/jmf.2012.0069
   Akashi I, 2009, J PHARM PHARMACOL, V61, P473, DOI [10.1211/jpp/61.04.0009, 10.1211/jpp.61.04.0009]
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Bagdas D, 2014, BIOL PHARM BULL, V37, P361, DOI 10.1248/bpb.b13-00635
   Bagdas D, 2013, J NAT MED-TOKYO, V67, P698, DOI 10.1007/s11418-012-0726-z
   Bakuradze T, 2015, EUR J NUTR, V54, P149, DOI 10.1007/s00394-014-0696-x
   Bakuradze T, 2011, RISK ASSESS PHYTOCHE, P364
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Baset P, 1996, BIOL PHARM BULL, V19, P1479, DOI 10.1248/bpb.19.1479
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Battram DS, 2007, J PHYSIOL-LONDON, V583, P1069, DOI 10.1113/jphysiol.2007.130526
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Behl C, 2002, FREE RADICAL BIO MED, V33, P182, DOI 10.1016/S0891-5849(02)00883-3
   Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115
   Bouayed J, 2007, J NEUROL SCI, V262, P77, DOI 10.1016/j.jns.2007.06.028
   Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840
   Camfield DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082897
   Chauhan PS, 2012, PHYTOTHER RES, V26, P1156, DOI 10.1002/ptr.3684
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cho ES, 2009, MUTAT RES-FUND MOL M, V661, P18, DOI 10.1016/j.mrfmmm.2008.10.021
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   CLIFFORD MN, 1976, J SCI FOOD AGR, V27, P73, DOI 10.1002/jsfa.2740270112
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1063::AID-JSFA605>3.0.CO;2-Q]
   Cropley V, 2012, PSYCHOPHARMACOLOGY, V219, P737, DOI 10.1007/s00213-011-2395-0
   CZOK G, 1961, ARZNEIMITTEL-FORSCH, V11, P448
   dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236
   Moreira MED, 2013, J FUNCT FOODS, V5, P466, DOI 10.1016/j.jff.2012.12.002
   de Paulis T, 2002, EUR J PHARMACOL, V442, P215, DOI 10.1016/S0014-2999(02)01540-6
   De Sotillo DR, 1998, J FOOD SCI, V63, P907, DOI 10.1111/j.1365-2621.1998.tb17924.x
   de Sotillo DVR, 2006, J NUTR BIOCHEM, V17, P63, DOI 10.1016/j.jnutbio.2005.06.004
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   Dentali F, 2009, SEMIN THROMB HEMOST, V35, P451, DOI 10.1055/s-0029-1234140
   Di Paola R, 2010, FREE RADICAL RES, V44, P74, DOI 10.3109/10715760903300709
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Frank J, 2003, J AGR FOOD CHEM, V51, P2526, DOI 10.1021/jf026127k
   Gebhardt R, 1998, J PHARMACOL EXP THER, V286, P1122
   George SE, 2008, CRIT REV FOOD SCI, V48, P464, DOI 10.1080/10408390701522445
   GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333
   Gorzalczany S, 2011, J ETHNOPHARMACOL, V134, P733, DOI 10.1016/j.jep.2011.01.025
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   HACH B, 1971, ARZNEI-FORSCHUNG, V21, P23
   Han J, 2010, NEUROSCIENCE, V169, P1039, DOI 10.1016/j.neuroscience.2010.05.049
   Hara K, 2014, EUR J PHARMACOL, V723, P459, DOI 10.1016/j.ejphar.2013.10.046
   Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3
   Haskell CF, 2008, BIOL PSYCHOL, V77, P113, DOI 10.1016/j.biopsycho.2007.09.008
   Herling AW, 1999, EUR J PHARMACOL, V386, P75, DOI 10.1016/S0014-2999(99)00748-7
   Herling AW, 2002, BBA-GEN SUBJECTS, V1569, P105, DOI 10.1016/S0304-4165(01)00239-2
   Hoelzl C, 2010, MOL NUTR FOOD RES, V54, P1722, DOI 10.1002/mnfr.201000048
   Honjo S, 2001, J CLIN EPIDEMIOL, V54, P823, DOI 10.1016/S0895-4356(01)00344-4
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   HUANG MT, 1988, CANCER RES, V48, P5941
   Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jang YJ, 2013, BEHAV BRAIN RES, V245, P113, DOI 10.1016/j.bbr.2013.02.003
   Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Kamtchouing P, 2006, J ETHNOPHARMACOL, V104, P306, DOI 10.1016/j.jep.2005.08.075
   Kanegae MPP, 2007, BIOCHEM PHARMACOL, V74, P457, DOI 10.1016/j.bcp.2007.05.004
   Kanno Y, 2013, INT HEART J, V54, P176, DOI 10.1536/ihj.54.176
   KAPIL A, 1995, PHYTOTHER RES, V9, P189, DOI 10.1002/ptr.2650090307
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Karthikesan K, 2010, J FUNCT FOODS, V2, P134, DOI 10.1016/j.jff.2010.04.001
   Karthikesan K, 2010, GEN PHYSIOL BIOPHYS, V29, P23, DOI 10.4149/gpb_2010_01_23
   Kasai H, 2000, FOOD CHEM TOXICOL, V38, P467, DOI 10.1016/S0278-6915(00)00014-4
   Kim Cinoo, 2010, Korean J Ophthalmol, V24, P163, DOI 10.3341/kjo.2010.24.3.163
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Kono Y, 1998, BIOSCI BIOTECH BIOCH, V62, P22, DOI 10.1271/bbb.62.22
   Koriem KMM, 2014, J TOXICOL-US, V2014, DOI 10.1155/2014/583494
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Krakauer T, 2002, IMMUNOPHARM IMMUNOT, V24, P113, DOI 10.1081/IPH-120003407
   Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001
   La Vecchia C, 2005, J HEPATOL, V42, P444, DOI 10.1016/j.jhep.2005.01.004
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lapchak PA, 2007, EXP NEUROL, V205, P407, DOI 10.1016/j.expneurol.2007.02.017
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Lee K, 2012, EUR J PHARMACOL, V689, P89, DOI 10.1016/j.ejphar.2012.05.028
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Li YJ, 2008, ENVIRON TOXICOL PHAR, V26, P13, DOI 10.1016/j.etap.2007.12.008
   Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Ludwig IA, 2012, FOOD RES INT, V48, P57, DOI 10.1016/j.foodres.2012.02.023
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Marrassini C, 2010, PHYTOTHER RES, V24, P1807, DOI 10.1002/ptr.3188
   Matsunaga Kengo, 2002, Asian Pac J Cancer Prev, V3, P163
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   McDowell IFW, 2000, J NUTR, V130, p369S, DOI 10.1093/jn/130.2.369S
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Mori H, 1997, J CELL BIOCHEM, P35
   MORI H, 1986, CANCER LETT, V30, P49, DOI 10.1016/0304-3835(86)90131-X
   Morishita Y, 1997, JPN J CANCER RES, V88, P815, DOI 10.1111/j.1349-7006.1997.tb00456.x
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   NEWMARK HL, 1987, CAN J PHYSIOL PHARM, V65, P461, DOI 10.1139/y87-079
   Newmark HL, 1985, HYPOTHESIS DIETARY C
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052
   Ohnishi R, 2006, BIOSCI BIOTECH BIOCH, V70, P2560, DOI 10.1271/bbb.60243
   Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Pari L, 2010, MOL CELL BIOCHEM, V341, P109, DOI 10.1007/s11010-010-0442-5
   Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311
   Perrone D, 2008, FOOD CHEM, V106, P859, DOI 10.1016/j.foodchem.2007.06.053
   Perrone D, 2010, J AGR FOOD CHEM, V58, P12238, DOI 10.1021/jf102110u
   Qu ZW, 2014, NEUROSCI LETT, V567, P35, DOI 10.1016/j.neulet.2014.03.027
   Rees K, 1999, PSYCHOPHARMACOLOGY, V145, P181, DOI 10.1007/s002130051047
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Revuelta-Iniesta R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/482704
   Reyes-Izquierdo T, 2013, BRIT J NUTR, V110, P420, DOI 10.1017/S0007114512005338
   Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624
   Ruan Z, 2014, CHLOROGENIC ACID DEC
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Shen WJ, 2012, BRAIN RES BULL, V88, P487, DOI 10.1016/j.brainresbull.2012.04.010
   Shi HY, 2009, EUR J PHARMACOL, V623, P119, DOI 10.1016/j.ejphar.2009.09.026
   Shimizu Masahito, 1999, Journal of Toxicological Sciences, V24, P433
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Shin JY, 2013, J KOREAN MED SCI, V28, P608, DOI 10.3346/jkms.2013.28.4.608
   Simon C, 2000, ARCH BIOCHEM BIOPHYS, V373, P418, DOI 10.1006/abbi.1999.1560
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   STICH HF, 1984, ADV EXP MED BIOL, V177, P1
   Surh YJ, 2005, J NUTR, V135, p2993S, DOI 10.1093/jn/135.12.2993S
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   Suzuki A, 2006, FEBS LETT, V580, P2317, DOI 10.1016/j.febslet.2006.03.047
   Suzuki A, 2002, HYPERTENS RES, V25, P99, DOI 10.1291/hypres.25.99
   Suzuki A, 2008, AM J HYPERTENS, V21, P23, DOI 10.1038/ajh.2007.3
   Taguchi K, 2014, BIOL PHARM BULL, V37, P1056, DOI 10.1248/bpb.b14-00157
   Tanaka K, 2009, FOOD SCI TECHNOL RES, V15, P147, DOI 10.3136/fstr.15.147
   TANAKA T, 1990, BASIC LIFE SCI, V52, P429
   TANAKA T, 1993, CARCINOGENESIS, V14, P1321, DOI 10.1093/carcin/14.7.1321
   Tessarollo L, 1998, CYTOKINE GROWTH F R, V9, P125, DOI 10.1016/S1359-6101(98)00003-3
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Thomson A.W., 2003, CYTOKINE HDB
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   Tousch D, 2008, BIOCHEM BIOPH RES CO, V377, P131, DOI 10.1016/j.bbrc.2008.09.088
   Tsuchiya T, 1996, BIOSCI BIOTECH BIOCH, V60, P765, DOI 10.1271/bbb.60.765
   Tu Q, 2005, CHLOROGENIC ACID PRO
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI [10.1139/H11-072, 10.1139/h11-072]
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   van Dijk TH, 2001, J BIOL CHEM, V276, P25727, DOI 10.1074/jbc.M101223200
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   Volz N, 2012, J AGR FOOD CHEM, V60, P9631, DOI 10.1021/jf302258u
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Xu DM, 2014, ENVIRON TOXICOL PHAR, V37, P1212, DOI 10.1016/j.etap.2014.04.022
   Xu YX, 2010, INFLAMM RES, V59, P871, DOI 10.1007/s00011-010-0199-z
   Yamaguchi T, 2008, NUTR METAB CARDIOVAS, V18, P408, DOI 10.1016/j.numecd.2007.03.004
   Yamamoto M, 1996, NEUROCHEM RES, V21, P929, DOI 10.1007/BF02532343
   Yonathan M, 2006, J ETHNOPHARMACOL, V108, P462, DOI 10.1016/j.jep.2006.06.006
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
   Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018
   Zang LY, 2003, MOL CELL BIOCHEM, V247, P205, DOI 10.1023/A:1024103428348
   Zhang Lan-tao, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P281, DOI 10.3881/j.issn.1000-503X.2011.03.015
NR 170
TC 523
Z9 554
U1 25
U2 384
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT
PY 2017
VL 56
IS 7
BP 2215
EP 2244
DI 10.1007/s00394-017-1379-1
PG 30
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FG9TV
UT WOS:000410783500001
PM 28391515
DA 2025-04-28
ER

PT J
AU Paiva, CLRS
   Beserra, BTS
   Reis, CEG
   Dorea, JG
   Da Costa, THM
   Amato, AA
AF Paiva, C. L. R. S.
   Beserra, B. T. S.
   Reis, C. E. G.
   Dorea, J. G.
   Da Costa, T. H. M.
   Amato, A. A.
TI Consumption of coffee or caffeine and serum concentration of
   inflammatory markers: A systematic review
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Inflammatory markers; inflammatory response; coffee; caffeine
ID ALL-CAUSE MORTALITY; METABOLIC SYNDROME; RISK; ASSOCIATION; HEALTHY;
   BIOMARKERS; STRESS; TRIGONELLINE; DRINKING; OBESITY
AB Coffee consumption is associated with reduced risk of conditions that share low-grade inflammation as their physiopathological basis. We therefore summarized the effects of coffee or coffee components on serum levels of inflammatory markers. Clinical trials assessing the effect of coffee, caffeine or other coffee components on inflammatory markers were searched without restriction to publication date. Fifteen studies (8 involving coffee and 7 caffeine) were included. Increased adiponectin levels were found in four of seven trials comparing filtered coffee/caffeinated coffee with placebo or comparing its levels at baseline and after consumption of medium or dark roasted coffee, but no change was seen in caffeine trials. None of the five studies assessing the effects of coffee found changes in C-reactive protein (CPR), but one out of three trials found decreased CPR levels in response to caffeine. Interleukin (IL)-6 was increased by caffeinated coffee compared with placebo in one of four coffee trials, and by caffeine in three out of five studies. Caffeine increased IL-10 levels in two of three trials. These data suggest a predominant anti-inflammatory action of coffee but not of caffeine consumption. Moreover, the proinflammatory and anti-inflammatory responses to caffeine point to its complex effects on the inflammatory response.
C1 [Paiva, C. L. R. S.; Beserra, B. T. S.; Amato, A. A.] Univ Brasilia, Sch Hlth Sci, Dept Pharmaceut Sci, Lab Mol Pharmacol, Brasilia, DF, Brazil.
   [Reis, C. E. G.; Dorea, J. G.; Da Costa, T. H. M.] Univ Brasilia, Sch Hlth Sci, Dept Nutr, Lab Biochem Nutr, Brasilia, DF, Brazil.
C3 Universidade de Brasilia; Universidade de Brasilia
RP Paiva, CLRS; Beserra, BTS; Amato, AA (corresponding author), Univ Brasilia, Fac Ciencias Saude, Lab Farmacol Mol, Campus Univ Darcy Ribeiro, BR-71910900 Brasilia, DF, Brazil.; Reis, CEG; Dorea, JG; Da Costa, THM (corresponding author), Univ Brasilia, Nucleo Nutr, Lab Bioquim Nutr, BR-71910900 Brasilia, DF, Brazil.
EM ciciliarocha@yahoo.com.br; brunna_telless@hotmail.com;
   caioedureis@gmail.com; jg.dorea@gmail.com; thmdacosta@gmail.com;
   angelicamato@unb.br
RI da Costa, Teresa/H-8434-2013; Reis, Caio/O-1889-2013
OI Reis, Caio/0000-0001-7260-9497
CR ADA, 2017, DIABETES CARE, V40, pS11, DOI [10.2337/dc17-S005, DOI 10.2337/dc15-S005]
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Alexopoulos N, 2008, EUR J CARDIOV PREV R, V15, P300, DOI 10.1097/HJR.0b013e3282f4832f
   [Anonymous], CLIN NUTR
   [Anonymous], SCI TRANSL MED
   [Anonymous], 2015, About diabetes
   [Anonymous], COFFEE HLTH DIS PREV
   [Anonymous], NUTR J
   Antonisamy P, 2016, FOOD FUNCT, V7, P398, DOI [10.1039/C5FO00403A, 10.1039/c5fo00403a]
   Bidel S, 2010, EUR J CLIN NUTR, V64, P917, DOI 10.1038/ejcn.2010.103
   Bloomer RJ, 2013, HUM EXP TOXICOL, V32, P1126, DOI 10.1177/0960327113475680
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1063::AID-JSFA605>3.0.CO;2-Q]
   Corrêa TAF, 2013, NUTRITION, V29, P977, DOI 10.1016/j.nut.2013.01.003
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Del Rio D, 2010, NUTRIENTS, V2, P820, DOI 10.3390/nu2080820
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004
   Farah A., 2012, Coffee: emerging health effects and disease prevention, P21
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Giugliano D, 2006, J AM COLL CARDIOL, V48, P677, DOI 10.1016/j.jacc.2006.03.052
   Gómez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985
   Gouin JP, 2008, NEUROIMMUNOMODULAT, V15, P251, DOI 10.1159/000156468
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Jacobs S, 2014, AM J CLIN NUTR, V100, P891, DOI 10.3945/ajcn.113.080317
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393
   Köröglu ÖA, 2014, NEONATOLOGY, V106, P235, DOI 10.1159/000363217
   Koloverou E, 2015, EUR J CLIN NUTR, V69, P1220, DOI 10.1038/ejcn.2015.98
   Kotani K, 2008, CLIN CHEM LAB MED, V46, P1434, DOI 10.1515/CCLM.2008.286
   Lang R, 2013, J AGR FOOD CHEM, V61, P12123, DOI 10.1021/jf403846g
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Lopez-Garcia E, 2014, CLIN NUTR, V33, P143, DOI 10.1016/j.clnu.2013.04.004
   McArdle Maeve A, 2013, Front Endocrinol (Lausanne), V4, P52, DOI 10.3389/fendo.2013.00052
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2700]
   Muqaku B, 2016, MOL NUTR FOOD RES, V60, P2529, DOI 10.1002/mnfr.201600328
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Ohnaka K, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/207426
   Owoyele B V, 2015, Afr J Med Med Sci, V44, P229
   Palócz O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166642
   Ramakers BP, 2011, CRIT CARE, V15, DOI 10.1186/cc9400
   Riedel A, 2014, FOOD RES INT, V63, P409, DOI 10.1016/j.foodres.2014.04.002
   Saito M, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/146865
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sartorelli DS, 2010, AM J CLIN NUTR, V91, P1002, DOI 10.3945/ajcn.2009.28741
   Schauren BC, 2014, J DEV ORIG HLTH DIS, V5, P299, DOI 10.1017/S2040174414000269
   Schulze MB, 2005, AM J CLIN NUTR, V82, P675, DOI 10.1093/ajcn/82.3.675
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Shechter M, 2011, AM J CARDIOL, V107, P1255, DOI 10.1016/j.amjcard.2010.12.035
   Stofkova A, 2009, Endocr Regul, V43, P157
   Tauler P, 2016, INT J SPORT NUTR EXE, V26, P8, DOI 10.1123/ijsnem.2015-0052
   Tauler P, 2013, MED SCI SPORT EXER, V45, P1269, DOI 10.1249/MSS.0b013e3182857c8a
   Tharaheswari M, 2014, MOL CELL BIOCHEM, V396, P161, DOI 10.1007/s11010-014-2152-x
   Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x
   Tunc T, 2013, REGUL PEPTIDES, V182, P41, DOI 10.1016/j.regpep.2012.12.016
   Valdez RC, 2011, J PEDIATR-US, V158, P38, DOI 10.1016/j.jpeds.2010.06.051
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   Walker GJ, 2007, MED SCI SPORT EXER, V39, P1554, DOI 10.1249/mss.0b013e3180a74228
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6
   Ye HY, 2017, INFLAMMATION, V40, P523, DOI 10.1007/s10753-016-0498-9
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
   Zhang W, 2009, DIABETES CARE, V32, P1043, DOI 10.2337/dc08-2251
   Zhao YM, 2015, PUBLIC HEALTH NUTR, V18, P1282, DOI 10.1017/S1368980014001438
NR 71
TC 57
Z9 59
U1 2
U2 30
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD FEB 21
PY 2019
VL 59
IS 4
BP 652
EP 663
DI 10.1080/10408398.2017.1386159
PG 12
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA HT4ZG
UT WOS:000464571300009
PM 28967799
DA 2025-04-28
ER

PT J
AU Saeed, M
   Naveed, M
   BiBi, J
   Ali Kamboh, A
   Phil, L
   Chao, S
AF Saeed, Muhammad
   Naveed, Muhammad
   BiBi, Jannat
   Ali Kamboh, Asghar
   Phil, Lucas
   Chao, Sun
TI Potential nutraceutical and food additive properties and risks of
   coffee: a comprehensive overview
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Phenolic compounds; caffeine; diterpenes; metabolic syndrome; mental
   health; liver disease; antioxidant; antimicrobial; modulators; risk
   factors; pregnancy; cigarette smoking
ID GAMMA-GLUTAMYL-TRANSFERASE; CORONARY-HEART-DISEASE; LOW-BIRTH-WEIGHT;
   IMPAIRED GLUCOSE-TOLERANCE; CHOLESTEROL-RAISING FACTOR; PLASMA TOTAL
   HOMOCYSTEINE; ACTIVATED PROTEIN-KINASE; ALL-CAUSE MORTALITY; CHLOROGENIC
   ACID; CAFFEINE CONSUMPTION
AB Coffee is a composite mixture of more than a thousand diverse phytochemicals like alkaloids, phenolic compounds, vitamins, carbohydrates, lipids, minerals and nitrogenous compounds. Coffee has multifunctional properties as a food additive and nutraceutical. As a nutraceutical, coffee has anti-inflammatory, anti-oxidant, antidyslipidemic, anti-obesity, type-2 diabetes mellitus (DM), and cardiovascular diseases (CVD), which can serve for the treatment and prevention of metabolic syndrome and associated disorders. On the other hand, as a food additive, coffee has antimicrobial activity against a wide range of microorganisms, inhibits lipid peroxidation (LPO), and can function as a prebiotic. The outcomes of different studies also revealed that coffee intake may reduce the incidence of numerous chronic diseases, like liver disease, mental health, and it also overcomes the all-cause mortality, and suicidal risks. In some studies, high intake of coffee is linked to increase CVD risk factors, like cholesterol, plasma homocysteine and blood pressure (BP). There is also a little evidence that associated the coffee consumption with increased risk of lung tumors in smokers. Among adults who consume the moderate amount of coffee, there is slight indication of health hazards with strong indicators of health benefits. Moreover, existing literature suggests that it may be cautious for pregnant women to eliminate the chances of miscarriages and impaired fetal growth. The primary purpose of this narrative review is to provide an overview of the findings of the positive impacts and risks of coffee consumption on human health. In conclusion, to date, the best available evidence from research indicates that drinking coffee up to 3-4 cups/day provides health benefits for most people.
C1 [Saeed, Muhammad; Chao, Sun] Northwest A&F Univ, Coll Anim Sci & Technol, Dept Anim Nutr, Yangling 71200, Shaanxi, Peoples R China.
   [Naveed, Muhammad] Nanjing Med Univ, Sch Pharm, Dept Clin Pharmacol, Nanjing, Jiangsu, Peoples R China.
   [BiBi, Jannat] Shaanxi Normal Univ, Dept Phys Educ, Xian, Shaanxi, Peoples R China.
   [Ali Kamboh, Asghar] Sindh Agr Univ, Fac Anim Husb & Vet Sci, Dept Vet Microbiol, Tandojam, Sindh Province, Pakistan.
   [Phil, Lucas] China Pharmaceut Univ, Sch Pharm, Dept Pharmaceut Anal, Nanjing, Jiangsu, Peoples R China.
C3 Northwest A&F University - China; Nanjing Medical University; Shaanxi
   Normal University; Sindh Agricultural University; China Pharmaceutical
   University
RP Chao, S (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Dept Anim Nutr, Yangling 71200, Shaanxi, Peoples R China.
EM sunchao2775@163.com
RI Saeed, Muhammad/D-1844-2017; PHIL, LUCAS/IRZ-1617-2023; Naveed,
   Muhammad/Y-3856-2018; Kamboh, Asghar/AAA-2099-2020; Bibi,
   Jannat/AAB-3363-2020
OI Sun, Chao/0000-0001-7222-4028; Bibi, Jannat/0000-0002-6710-5216; Kamboh,
   Asghar/0000-0002-5176-6685; Saeed, Muhammad/0000-0001-5048-5753
FU National Nature Science Foundation of China [31572365, 2017KCT-24];
   Major National Scientific Research Projects [2015CB943102]
FX This work was supported by National Nature Science Foundation of China
   [31572365 & 2017KCT-24], and Major National Scientific Research Projects
   [#. 2015CB943102] P.R China. We are highly thankful to Mr. Muhammad
   Karim Ahmed from CRI for critically reviewing the text of this paper.
CR Abreu RV, 2011, PHARMACOL BIOCHEM BE, V99, P659, DOI 10.1016/j.pbb.2011.06.010
   ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   Akter S, 2016, JPN J CLIN ONCOL, V46, P781, DOI 10.1093/jjco/hyw059
   ALDERETE E, 1995, EPIDEMIOLOGY, V6, P403, DOI 10.1097/00001648-199507000-00013
   Andueza S, 2004, LEBENSM-WISS TECHNOL, V37, P893, DOI 10.1016/j.lwt.2004.04.004
   [Anonymous], 1977, MED LETT DRUGS THER, V19, P65
   [Anonymous], JAMA INTERNAL MED
   [Anonymous], 2014, J VASC SURG, DOI DOI 10.1016/J.JVS.2014.03.267
   [Anonymous], CULTURAL HIST PLANTS
   [Anonymous], BOT CLASSIFICATION C
   [Anonymous], ENH UND QUANT SOIL R
   [Anonymous], MOVEMENT DISORDERS
   [Anonymous], US DEP AGR FOR AGR S
   [Anonymous], FILTERED COFFEE LOWE
   [Anonymous], AM J CLIN NUTR
   [Anonymous], SCI NEWS
   [Anonymous], EUROPEAN J NUTR
   [Anonymous], COFFEE SELECTION BRE
   [Anonymous], FOOD CHEM TOXICOLOGY
   [Anonymous], PEDIATRICS
   [Anonymous], ANN U DUNAREA JOS GA
   [Anonymous], DIETARY ANTIOXIDANTS
   [Anonymous], DIET REF INT THIAM R
   [Anonymous], J LEPIDOPTERISTS SOC
   [Anonymous], J JAPAN SOC STUDY OB
   [Anonymous], INT J FOOD AGR ENV
   [Anonymous], J NEUROSCIENCE
   [Anonymous], BRIT J NUTR
   [Anonymous], YAKURI TO CHIRYO
   [Anonymous], DIABETOLOGIA
   [Anonymous], EUROPEAN J NUTR
   [Anonymous], NUTRIENTS
   [Anonymous], NUTR REV
   [Anonymous], UND DIFF AR VS ROB
   [Anonymous], CLIN CHEM LAB MED CC
   [Anonymous], CAFFEINE HLTH
   [Anonymous], SYNTHESIS AVAILABILI
   [Anonymous], CRITICAL REV FOOD SC
   Antonio AG, 2012, PLANTA MED, V78, P755, DOI 10.1055/s-0031-1298435
   Arciero PJ, 1998, EUR J CLIN NUTR, V52, P805, DOI 10.1038/sj.ejcn.1600651
   Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021
   Arendash GW, 2010, J ALZHEIMERS DIS, V20, pS117, DOI 10.3233/JAD-2010-091249
   ARMSTRONG BG, 1992, AM J PUBLIC HEALTH, V82, P85, DOI 10.2105/AJPH.82.1.85
   Arya M, 2007, CRIT REV FOOD SCI, V47, P51, DOI 10.1080/10408390600550315
   Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Aubin HJ, 2012, NEW ENGL J MED, V367, P576, DOI 10.1056/NEJMc1207172
   Ayseli MT, 2016, TRENDS FOOD SCI TECH, V48, P69, DOI 10.1016/j.tifs.2015.11.005
   Baeta-Corral R, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00079
   Bagdas D, 2014, N-S ARCH PHARMACOL, V387, P1101, DOI 10.1007/s00210-014-1034-9
   Bajko E, 2016, LWT-FOOD SCI TECHNOL, V65, P471, DOI 10.1016/j.lwt.2015.08.024
   Quintana JLB, 2007, NEUROL RES, V29, P91, DOI 10.1179/174313206X152546
   Becerra-Moreno A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00837
   Belkaid A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-7
   BERLIN CM, 1984, PEDIATRICS, V73, P59
   Bidel S, 2006, DIABETOLOGIA, V49, P2618, DOI 10.1007/s00125-006-0435-9
   BIRKETT NJ, 1988, J HYPERTENS, V6, pS620, DOI 10.1097/00004872-198812040-00194
   Boekema PJ, 1999, SCAND J GASTROENTERO, V34, P35, DOI 10.1080/003655299750025525
   Boekschoten MV, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-7
   Boekschoten MV, 2005, J NUTR, V135, P785, DOI 10.1093/jn/135.4.785
   Bonthuis M, 2010, EUR J CLIN NUTR, V64, P569, DOI 10.1038/ejcn.2010.45
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Bracken MB, 2002, EPIDEMIOLOGY, V13, P165, DOI 10.1097/00001648-200203000-00011
   Bravi F, 2007, HEPATOLOGY, V46, P430, DOI 10.1002/hep.21708
   Bravi F, 2017, EUR J CANCER PREV, V26, P368, DOI [10.1097/cej.0000000000000252, 10.1097/CEJ.0000000000000252]
   Brown OI, 2016, CORONARY ARTERY DIS, V27, P566, DOI 10.1097/MCA.0000000000000397
   BROWN SR, 1990, GUT, V31, P450, DOI 10.1136/gut.31.4.450
   BRUCE M, 1992, ARCH GEN PSYCHIAT, V49, P867
   BURKE V, 1992, J CLIN EPIDEMIOL, V45, P1061, DOI 10.1016/0895-4356(92)90146-E
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   CAAN BJ, 1989, AM J PUBLIC HEALTH, V79, P1299, DOI 10.2105/AJPH.79.9.1299
   Camfield DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082897
   Canas PM, 2009, J NEUROSCI, V29, P14741, DOI 10.1523/JNEUROSCI.3728-09.2009
   Cao CH, 2009, J ALZHEIMERS DIS, V17, P681, DOI 10.3233/JAD-2009-1071
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   CASIGLIA E, 1993, EUR J EPIDEMIOL, V9, P293, DOI 10.1007/BF00146266
   Castellanos FX, 2002, FOOD CHEM TOXICOL, V40, P1235, DOI 10.1016/S0278-6915(02)00097-2
   Cavin C, 2008, FOOD CHEM TOXICOL, V46, P1239, DOI 10.1016/j.fct.2007.09.099
   Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7
   CHELSKY LB, 1990, JAMA-J AM MED ASSOC, V264, P2236, DOI 10.1001/jama.264.17.2236
   CHENG WSC, 1990, CLIN PHARMACOL THER, V47, P516, DOI 10.1038/clpt.1990.66
   Chiang LC, 2002, ANTIVIR RES, V55, P53, DOI 10.1016/S0166-3542(02)00007-4
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Christensen B, 2001, AM J CLIN NUTR, V74, P302
   CHRISTIANSON RE, 1989, LANCET, V1, P378
   Chu YF, 2012, FOOD CHEM, V135, P2095, DOI 10.1016/j.foodchem.2012.04.148
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1063::AID-JSFA605>3.0.CO;2-Q]
   Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503
   Cook DG, 1996, BRIT MED J, V313, P1358, DOI 10.1136/bmj.313.7069.1358
   Cornelis MC, 2007, CURR OPIN CLIN NUTR, V10, P745, DOI 10.1097/MCO.0b013e3282f05d81
   Corrao G, 2001, ANN EPIDEMIOL, V11, P458, DOI 10.1016/S1047-2797(01)00223-X
   CORRAO G, 1994, EUR J EPIDEMIOL, V10, P657, DOI 10.1007/BF01719277
   Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200
   Crews HM, 2001, FOOD ADDIT CONTAM, V18, P1075, DOI 10.1080/02652030110056630
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   de Bree A, 2001, AM J EPIDEMIOL, V154, P150, DOI 10.1093/aje/154.2.150
   De Roos B, 1998, J INTERN MED, V244, P451, DOI 10.1111/j.1365-2796.1998.00386.x
   De Roos B, 2000, J INTERN MED, V248, P211, DOI 10.1046/j.1365-2796.2000.00728.x
   de Vreede-Swagemakers JJM, 1999, J CLIN EPIDEMIOL, V52, P601, DOI 10.1016/S0895-4356(99)00044-X
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   DORFMAN LJ, 1970, CLIN PHARMACOL THER, V11, P869
   Dukas L, 2000, AM J EPIDEMIOL, V151, P958, DOI 10.1093/oxfordjournals.aje.a010139
   Dukas L, 2000, CANCER CAUSE CONTROL, V11, P907, DOI 10.1023/A:1026559624330
   Egger G, 1999, MED J AUSTRALIA, V171, P604, DOI 10.5694/j.1326-5377.1999.tb123817.x
   Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920
   Esposito F, 2013, PATHOG DIS, V68, P116, DOI 10.1111/2049-632X.12051
   FARESJO T, 1994, SCAND J SOC MED, V22, P86, DOI 10.1177/140349489402200202
   Farzaei MH, 2015, WORLD J GASTROENTERO, V21, P6499, DOI 10.3748/wjg.v21.i21.6499
   Fernandes O, 1998, REPROD TOXICOL, V12, P435, DOI 10.1016/S0890-6238(98)00024-0
   Fernández MA, 1998, J PHARM PHARMACOL, V50, P1183, DOI 10.1111/j.2042-7158.1998.tb03332.x
   Fiamegos YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018127
   FLORACK EIM, 1994, PREV MED, V23, P175, DOI 10.1006/pmed.1994.1024
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   FRIED PA, 1987, NEUROTOXICOL TERATOL, V9, P79, DOI 10.1016/0892-0362(87)90082-1
   Frost L, 2005, AM J CLIN NUTR, V81, P578
   Fu L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4287461
   Fujimoto T, 2008, BIOORG MED CHEM LETT, V18, P2771, DOI 10.1016/j.bmcl.2008.04.011
   Galeone C, 2010, CANCER CAUSE CONTROL, V21, P1949, DOI 10.1007/s10552-010-9623-5
   Gallus S, 2002, ANN EPIDEMIOL, V12, P202, DOI 10.1016/S1047-2797(01)00304-0
   Gapstur SM, 2017, CANCER EPIDEM BIOMAR, V26, P1477, DOI [10.1158/1055-9965.epi-17-0353, 10.1158/1055-9965.EPI-17-0353]
   Garcia-Tsao G, 2012, Goldman's Cecil Medicine, V1, P999, DOI [10.1016/B978-1-4377-1604-7.00156-1, DOI 10.1016/B978-1-4377-1604-7.00156-1]
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   George SE, 2008, CRIT REV FOOD SCI, V48, P464, DOI 10.1080/10408390701522445
   Giannelli M, 2003, PAEDIATR PERINAT EP, V17, P316, DOI 10.1046/j.1365-3016.2003.00523.x
   Giesbrecht T, 2010, NUTR NEUROSCI, V13, P283, DOI 10.1179/147683010X12611460764840
   Godos J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090950
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   GROBBEE DE, 1990, NEW ENGL J MED, V323, P1026, DOI 10.1056/NEJM199010113231504
   Gross G, 1997, FOOD CHEM TOXICOL, V35, P547, DOI 10.1016/S0278-6915(96)00123-8
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso LM, 2001, EPIDEMIOLOGY, V12, P447, DOI 10.1097/00001648-200107000-00015
   Grubben MJ, 2000, AM J CLIN NUTR, V71, P480
   Grubben MJAL, 2000, ALIMENT PHARM THER, V14, P1181, DOI 10.1046/j.1365-2036.2000.00826.x
   Gunter MJ, 2017, ANN INTERN MED, V167, P236, DOI 10.7326/M16-2945
   Hakim RB, 1998, FERTIL STERIL, V70, P632, DOI 10.1016/S0015-0282(98)00257-X
   Hale S, 2010, REPROD SCI, V17, P871, DOI 10.1177/1933719110376545
   Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077
   Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710
   HARRIS SS, 1994, AM J CLIN NUTR, V60, P573, DOI 10.1093/ajcn/60.4.573
   HASTE FM, 1990, J EPIDEMIOL COMMUN H, V44, P205, DOI 10.1136/jech.44.3.205
   HEYDEN S, 1978, ARCH INTERN MED, V138, P1472, DOI 10.1001/archinte.138.10.1472
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Honjo S, 2001, J CLIN EPIDEMIOL, V54, P823, DOI 10.1016/S0895-4356(01)00344-4
   Honjo S, 1999, ANN EPIDEMIOL, V9, P325, DOI 10.1016/S1047-2797(99)00013-7
   Horton TJ, 1996, INT J OBESITY, V20, P91
   Hosaka S, 2001, FOOD CHEM TOXICOL, V39, P557, DOI 10.1016/S0278-6915(00)00175-7
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Huber WW, 1997, MUTAT RES-FUND MOL M, V376, P115, DOI 10.1016/S0027-5107(97)00033-X
   Huber WW, 2002, ARCH TOXICOL, V76, P209, DOI 10.1007/s00204-002-0322-1
   Huber WW, 2002, ARCH TOXICOL, V75, P685, DOI 10.1007/s00204-001-0295-5
   Husemoen LLN, 2004, EUR J CLIN NUTR, V58, P1142, DOI 10.1038/sj.ejcn.1601942
   Isokawa M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1239629
   Iwai K, 2012, FOOD SCI TECHNOL RES, V18, P849, DOI 10.3136/fstr.18.849
   IZZO JL, 1983, AM J CARDIOL, V52, P769, DOI 10.1016/0002-9149(83)90413-7
   Jacobo-Velázquez DA, 2011, J AGR FOOD CHEM, V59, P6583, DOI 10.1021/jf2006529
   James JE, 2004, PSYCHOSOM MED, V66, P63, DOI 10.1097/10.PSY.0000107884.78247.F9
   Jannasch F, 2017, J NUTR, V147, P1174, DOI 10.3945/jn.116.242552
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Je Y, 2014, BRIT J NUTR, V111, P1162, DOI 10.1017/S0007114513003814
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   Jensen TK, 1998, REPROD TOXICOL, V12, P289, DOI 10.1016/S0890-6238(98)00002-1
   Jiang Y, 2000, PHYTOMEDICINE, V7, P483, DOI 10.1016/S0944-7113(00)80034-3
   Jiménez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Jin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120842
   JOERES R, 1988, HEPATOLOGY, V8, P575, DOI 10.1002/hep.1840080323
   Johnson-Kozlow M, 2002, AM J EPIDEMIOL, V156, P842, DOI 10.1093/aje/kwf119
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Karunanidhi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/392058
   Kawachi I, 1996, ARCH INTERN MED, V156, P521, DOI 10.1001/archinte.156.5.521
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kerzendorfer C, 2009, J INVEST DERMATOL, V129, P1611, DOI 10.1038/jid.2009.99
   Khan MTH, 2005, ANTIVIR RES, V67, P107, DOI 10.1016/j.antiviral.2005.05.002
   KIEL DP, 1990, AM J EPIDEMIOL, V132, P675, DOI 10.1093/oxfordjournals.aje.a115709
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Klatsky A L, 1993, Ann Epidemiol, V3, P375, DOI 10.1016/1047-2797(93)90064-B
   KLATSKY AL, 1992, AM J EPIDEMIOL, V136, P1248, DOI 10.1093/oxfordjournals.aje.a116433
   Klebanoff MA, 1999, NEW ENGL J MED, V341, P1639, DOI 10.1056/NEJM199911253412202
   Kolahdouzan M, 2017, CNS NEUROSCI THER, V23, P272, DOI 10.1111/cns.12684
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Krul C, 1998, J CHROMATOGR B, V709, P27, DOI 10.1016/S0378-4347(98)00016-4
   La Vecchia C, 2005, J HEPATOL, V42, P444, DOI 10.1016/j.jhep.2005.01.004
   Laguerre M, 2011, J AGR FOOD CHEM, V59, P10361, DOI 10.1021/jf2026742
   Laguerre M, 2009, J AGR FOOD CHEM, V57, P11335, DOI 10.1021/jf9026266
   LANCASTER T, 1994, J ROY SOC MED, V87, P506
   LANG T, 1983, EUR HEART J, V4, P602, DOI 10.1093/oxfordjournals.eurheartj.a061531
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LARROQUE B, 1993, AM J EPIDEMIOL, V137, P941, DOI 10.1093/oxfordjournals.aje.a116764
   Larsson SC, 2017, EUR HEART J, V38, P2192, DOI 10.1093/eurheartj/ehx140
   Lee KJ, 2007, INT J CANCER, V121, P1312, DOI 10.1002/ijc.22778
   Leviton A, 2002, FOOD CHEM TOXICOL, V40, P1271, DOI 10.1016/S0278-6915(02)00092-3
   LEVITON A, 1990, CANCER LETT, V51, P91, DOI 10.1016/0304-3835(90)90043-W
   Li LQ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1758-z
   Li X, 2013, PLOS ONE, V8, DOI [10.1371/annotation/235dc29f-c950-4da9-8e86-ca4bff836873, 10.1371/journal.pone.0075549, 10.1371/journal.pone.0073293, 10.1371/journal.pone.0074306]
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Lin LS, 2014, J MATER CHEM B, V2, P1031, DOI 10.1039/c3tb21479f
   Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074
   Liu CC, 2017, MOL MED REP, V16, P1369, DOI 10.3892/mmr.2017.6698
   Liu SM, 2000, AM J CLIN NUTR, V71, P1455
   Lloyd T, 1998, J AM COLL NUTR, V17, P454, DOI 10.1080/07315724.1998.10718793
   Lloyd T, 2000, J AM COLL NUTR, V19, P256, DOI 10.1080/07315724.2000.10718924
   López-Galilea I, 2006, FOOD CHEM, V94, P75, DOI 10.1016/j.foodchem.2004.10.052
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Mahboob T, 2016, ASIAN PAC J TROP MED, V9, P844, DOI 10.1016/j.apjtm.2016.07.008
   Martín-Núñez GM, 2014, EPIGENETICS-US, V9, P1322, DOI 10.4161/15592294.2014.969617
   Torres-Contreras AM, 2014, J AGR FOOD CHEM, V62, P7671, DOI 10.1021/jf5026983
   MARTIN TR, 1987, AM J EPIDEMIOL, V126, P813, DOI 10.1093/oxfordjournals.aje.a114718
   Martini D, 2016, MOLECULES, V21, DOI 10.3390/molecules21080979
   Massey LK, 1998, DRUG AGING, V13, P43, DOI 10.2165/00002512-199813010-00005
   Massey LK, 2001, AM J CLIN NUTR, V74, P569
   Mattioli AV, 2007, FUTUR CARDIOL, V3, P203, DOI 10.2217/14796678.3.2.203
   Maurin O, 2007, ANN BOT-LONDON, V100, P1565, DOI 10.1093/aob/mcm257
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   McEvoy CT, 2014, J ACAD NUTR DIET, V114, P1759, DOI 10.1016/j.jand.2014.05.001
   Mercer JR, 2012, ARTERIOSCL THROM VAS, V32, P2461, DOI 10.1161/ATVBAHA.112.251322
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   MILLS JL, 1993, JAMA-J AM MED ASSOC, V269, P593, DOI 10.1001/jama.269.5.593
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Mostofsky E, 2010, NEUROLOGY, V75, P1583, DOI 10.1212/WNL.0b013e3181fb443d
   Mostofsky E, 2012, CIRC-HEART FAIL, V5, P401, DOI 10.1161/CIRCHEARTFAILURE.112.967299
   Mostofsky E, 2011, AM J EPIDEMIOL, V173, P330, DOI 10.1093/aje/kwq369
   Mukamal KJ, 2004, AM HEART J, V147, P999, DOI 10.1016/j.ahj.2003.12.038
   Murthy PS, 2009, EUR FOOD RES TECHNOL, V229, P645, DOI 10.1007/s00217-009-1098-9
   MYERS MG, 1988, CHEST, V94, P4, DOI 10.1378/chest.94.1.4
   Nakanishi N, 2000, EUR J EPIDEMIOL, V16, P419, DOI 10.1023/A:1007683626665
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Nehlig Astrid, 2016, Pract Neurol, V16, P89, DOI 10.1136/practneurol-2015-001162
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Nygard O, 1997, AM J CLIN NUTR, V65, P136, DOI 10.1093/ajcn/65.1.136
   OLSEN J, 1991, EPIDEMIOLOGY, V2, P370, DOI 10.1097/00001648-199109000-00011
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Paiva C. L. R. S., 2017, CRIT REV FOOD SCI, P1
   Palacios N, 2010, PARKINSONISM RELAT D, V16, P370, DOI 10.1016/j.parkreldis.2010.02.012
   Panza F, 2015, J NUTR HEALTH AGING, V19, P313, DOI 10.1007/s12603-014-0563-8
   Park SY, 2017, ANN INTERN MED, V167, P228, DOI 10.7326/M16-2472
   Partridge BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028416
   Pasquale LR, 2012, INVEST OPHTH VIS SCI, V53, P6427, DOI 10.1167/iovs.12-10085
   Patti AM, 2015, ANGIOLOGY, V66, P856, DOI 10.1177/0003319714568792
   PERITI M, 1990, EUR J EPIDEMIOL, V6, P76, DOI 10.1007/BF00155554
   Pintus F, 1996, EUR J EPIDEMIOL, V12, P71, DOI 10.1007/BF00144431
   Plesko S, 2015, ACTA CHIM SLOV, V62, P555
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Pourshahidi LK, 2016, COMPR REV FOOD SCI F, V15, P671, DOI 10.1111/1541-4337.12206
   PRABHA PS, 1990, PROSTAG LEUKOTR ESS, V41, P27, DOI 10.1016/0952-3278(90)90127-7
   Prasanthi JRP, 2010, FREE RADICAL BIO MED, V49, P1212, DOI 10.1016/j.freeradbiomed.2010.07.007
   Ramalakshmi K, 1999, CRIT REV FOOD SCI, V39, P441, DOI 10.1080/10408699991279231
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Rapuri PB, 2001, AM J CLIN NUTR, V74, P694
   Rasch V, 2003, ACTA OBSTET GYN SCAN, V82, P182, DOI 10.1034/j.1600-0412.2003.00078.x
   Redón J, 2003, HYPERTENSION, V41, P1096, DOI 10.1161/01.HYP.0000068370.21009.38
   Ricketts ML, 2007, MOL ENDOCRINOL, V21, P1603, DOI 10.1210/me.2007-0133
   Riise T, 2003, NEUROLOGY, V61, P1122, DOI 10.1212/01.WNL.0000081305.66687.D2
   Rondo PHC, 1996, EUR J CLIN NUTR, V50, P705
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Ruhl CE, 2005, GASTROENTEROLOGY, V128, P24, DOI 10.1053/j.gastro.2004.09.075
   RYU JE, 1985, DEV PHARMACOL THERAP, V8, P329, DOI 10.1159/000457057
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   SALVAGGIO A, 1990, J HYPERTENS, V8, P585, DOI 10.1097/00004872-199006000-00013
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Santos IS, 1998, AM J EPIDEMIOL, V147, P620, DOI 10.1093/oxfordjournals.aje.a009502
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sasaki K, 2010, FOOD CHEM, V118, P830, DOI 10.1016/j.foodchem.2009.05.070
   Schwarzschild MA, 2002, NEUROLOGY, V58, P1154, DOI 10.1212/WNL.58.8.1154
   Schwarzschild Michael A., 2003, Neurology, V61, pS55
   Shahidi F., 2016, Handbook of Functional Beverages and Human Health
   SHARP DS, 1995, AM J EPIDEMIOL, V141, P480, DOI 10.1093/oxfordjournals.aje.a117455
   Sharwood LN, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1140
   Shin HS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020165
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Shlonsky AK, 2003, ANN EPIDEMIOL, V13, P273, DOI 10.1016/S1047-2797(02)00414-3
   SHU XO, 1995, EPIDEMIOLOGY, V6, P115, DOI 10.1097/00001648-199503000-00005
   Signorello LB, 2004, EPIDEMIOLOGY, V15, P229, DOI 10.1097/01.ede.0000112221.24237.0c
   Song F., 2016, NFS Journal, V4, P9
   Soriguer F, 2004, ANN INTERN MED, V141, P321, DOI 10.7326/0003-4819-141-4-200408170-00017
   Sousa R, 2014, CLIN INFECT DIS, V59, P41, DOI 10.1093/cid/ciu235
   Spiller M A, 1984, Prog Clin Biol Res, V158, P91
   Splaver A, 2004, AM HEART J, V148, P34, DOI 10.1016/j.ahj.2004.02.004
   Stein MA, 1996, ARCH PEDIAT ADOL MED, V150, P284, DOI 10.1001/archpedi.1996.02170280054010
   STENSVOLD I, 1989, J CLIN EPIDEMIOL, V42, P877, DOI 10.1016/0895-4356(89)90101-7
   Stolzenberg-Solomon RZ, 1999, AM J CLIN NUTR, V69, P467
   Stookey JD, 1999, EUR J EPIDEMIOL, V15, P181, DOI 10.1023/A:1007559725607
   Strandhagen E, 2004, INT J MOL MED, V13, P811
   Strandhagen E, 2003, EUR J CLIN NUTR, V57, P1411, DOI 10.1038/sj.ejcn.1601703
   Sudano I, 2005, HYPERTENSION, V46, P521, DOI 10.1161/01.HYP.0000177448.56745.c7
   Sung WS, 2010, PURE APPL CHEM, V82, P219, DOI 10.1351/PAC-CON-09-01-08
   Suzuki A, 2002, AM J HYPERTENS, V15, P351, DOI 10.1016/S0895-7061(01)02337-8
   Tamura H, 2006, MOL NUTR FOOD RES, V50, P396, DOI 10.1002/mnfr.200500216
   Tanaka K, 1998, INT J EPIDEMIOL, V27, P438, DOI 10.1093/ije/27.3.438
   Tanaka K, 2007, CANCER SCI, V98, P214, DOI 10.1111/j.1349-7006.2006.00368.x
   Tang NP, 2010, LUNG CANCER, V67, P17, DOI 10.1016/j.lungcan.2009.03.012
   Tanskanen A, 2000, EUR J EPIDEMIOL, V16, P789, DOI 10.1023/A:1007614714579
   Tavani A, 2004, CANCER CAUSE CONTROL, V15, P743, DOI 10.1023/B:CACO.0000043415.28319.c1
   Tavani A, 2000, EUR J CANCER PREV, V9, P241, DOI 10.1097/00008469-200008000-00004
   THELLE DS, 1987, ATHEROSCLEROSIS, V67, P97, DOI 10.1016/0021-9150(87)90270-X
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Thomas GD, 2001, JAMA-J AM MED ASSOC, V285, P2055, DOI 10.1001/jama.285.16.2055
   Tian T, 2017, J AGR FOOD CHEM, V65, P2784, DOI 10.1021/acs.jafc.6b04716
   TODA S, 1991, PLANTA MED, V57, P8, DOI 10.1055/s-2006-960005
   Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384
   Tsabar M, 2015, NUCLEIC ACIDS RES, V43, P6902, DOI 10.1093/nar/gkv525
   Turati F, 2011, EUR J CANCER PREV, V20, P287, DOI 10.1097/CEJ.0b013e32834572e7
   URGERT R, 1995, J AGR FOOD CHEM, V43, P2167, DOI 10.1021/jf00056a039
   Urgert R, 1997, AM J CLIN NUTR, V65, P519, DOI 10.1093/ajcn/65.2.519
   Urgert R, 1997, ANNU REV NUTR, V17, P305, DOI 10.1146/annurev.nutr.17.1.305
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   van Dongen LH, 2017, AM J CLIN NUTR, V106, P1113, DOI 10.3945/ajcn.117.153338
   van Gelder BM, 2007, EUR J CLIN NUTR, V61, P226, DOI 10.1038/sj.ejcn.1602495
   Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244
   Vieira O, 1998, BIOCHEM PHARMACOL, V55, P333, DOI 10.1016/S0006-2952(97)00470-X
   Vik T, 2003, PAEDIATR PERINAT EP, V17, P324, DOI 10.1046/j.1365-3016.2003.00507.x
   Vlajinac HD, 1997, AM J EPIDEMIOL, V145, P335, DOI 10.1093/oxfordjournals.aje.a009110
   WAHLLANDER A, 1985, SCAND J GASTROENTERO, V20, P1133, DOI 10.3109/00365528509088884
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227
   Wilhelmsen L, 2001, J INTERN MED, V250, P382, DOI 10.1046/j.1365-2796.2001.00902.x
   Willett WC, 1996, JAMA-J AM MED ASSOC, V275, P458, DOI 10.1001/jama.275.6.458
   WILLIAMS MA, 1990, LANCET, V335, P1603, DOI 10.1016/0140-6736(90)91440-L
   Wilson PWF, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003089
   Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481
   Wu JN, 2009, INT J CARDIOL, V137, P216, DOI 10.1016/j.ijcard.2008.06.051
   Xie FY, 2014, NUTRIENTS, V6, P3734, DOI 10.3390/nu6093734
   Yagasaki K, 2000, CYTOTECHNOLOGY, V33, P229, DOI 10.1023/A:1008141918852
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
   Yoshioka K, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12585-8
   Yu XF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-96
   Yuan YL, 2017, INT IMMUNOPHARMACOL, V44, P97, DOI 10.1016/j.intimp.2017.01.017
   Zeegers MPA, 2004, WORLD J UROL, V21, P392, DOI 10.1007/s00345-003-0382-8
   Zeng SB, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001640
   Zhang W, 2009, DIABETES CARE, V32, P1043, DOI 10.2337/dc08-2251
   Zhang ZZ, 2011, AM J CLIN NUTR, V93, P1212, DOI 10.3945/ajcn.110.004044
   Zhao YM, 2015, PUBLIC HEALTH NUTR, V18, P1282, DOI 10.1017/S1368980014001438
   Zhao ZH, 2008, J AGR FOOD CHEM, V56, P3863, DOI 10.1021/jf073168d
   Zhou JY, 2013, FUND CLIN PHARMACOL, V27, P279, DOI 10.1111/j.1472-8206.2011.01022.x
NR 345
TC 32
Z9 34
U1 3
U2 79
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD NOV 13
PY 2019
VL 59
IS 20
BP 3293
EP 3319
DI 10.1080/10408398.2018.1489368
PG 27
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Food Science & Technology; Nutrition & Dietetics
GA JN0WC
UT WOS:000496624400004
PM 30614268
DA 2025-04-28
ER

PT J
AU Lee, A
   Lim, W
   Kim, S
   Khil, H
   Cheon, E
   An, S
   Hong, S
   Lee, DH
   Kang, SS
   Oh, H
   Keum, N
   Hsieh, CC
AF Lee, Ariel
   Lim, Woobin
   Kim, Seoyeon
   Khil, Hayeong
   Cheon, Eugene
   An, Soobin
   Hong, SungEun
   Lee, Dong Hoon
   Kang, Seok-Seong
   Oh, Hannah
   Keum, NaNa
   Hsieh, Chung-Cheng
TI Coffee Intake and Obesity: A Meta-Analysis
SO NUTRIENTS
LA English
DT Review
DE coffee intake; obesity; adiposity; body mass index; waist circumference;
   meta-analysis
ID METABOLIC SYNDROME; TEA CONSUMPTION; HEALTH; ASSOCIATION; CAFFEINE
AB Many studies have explored the relationship between coffee-one of the most commonly consumed beverages today-and obesity. Despite inconsistent results, the relationship has not been systematically summarized. Thus, we conducted a meta-analysis by compiling data from 12 epidemiologic studies identified from PubMed and Embase through February 2019. The included studies assessed obesity by body mass index (BMI, a measure of overall adiposity) or waist circumference (WC, a measure of central adiposity); analyzed the measure as a continuous outcome or binary outcome. Using random effects model, weighted mean difference (WMD) and 95% confidence interval (CI) were obtained for continuous outcomes; summary relative risk (RR) and 95% CI for the highest vs. lowest categories of coffee intake were estimated for binary outcome. For BMI, WMD was -0.08 (95% CI -0.14, -0.02); RR was 1.49 (95% CI 0.97, 2.29). For WC, WMD was -0.27 (95% CI -0.51, -0.02) and RR was 1.07 (95% CI 0.84, 1.36). In subgroup analysis by sex, evidence for an inverse association was more evident in men, specifically for continuous outcome, with WMD -0.05 (95% CI -0.09, -0.02) for BMI and -0.21 (95% CI -0.35, -0.08) for WC. Our meta-analysis suggests that higher coffee intake might be modestly associated with reduced adiposity, particularly in men.
C1 [Lee, Ariel] Dartmouth Coll, Hanover, NH 03755 USA.
   [Lim, Woobin; Kim, Seoyeon; Khil, Hayeong; Cheon, Eugene; An, Soobin; Hong, SungEun; Kang, Seok-Seong; Keum, NaNa] Dongguk Univ, Dept Food Sci & Biotechnol, Goyang 10325, South Korea.
   [Lee, Dong Hoon; Keum, NaNa] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02138 USA.
   [Oh, Hannah] Korea Univ, Coll Hlth Sci, Seoul 02841, South Korea.
   [Hsieh, Chung-Cheng] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02138 USA.
C3 Dartmouth College; Dongguk University; Harvard University; Harvard T.H.
   Chan School of Public Health; Korea University; Harvard University;
   Harvard T.H. Chan School of Public Health
RP Keum, N (corresponding author), Dongguk Univ, Dept Food Sci & Biotechnol, Goyang 10325, South Korea.; Keum, N (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02138 USA.; Oh, H (corresponding author), Korea Univ, Coll Hlth Sci, Seoul 02841, South Korea.
EM ariel.lee.21@dartmouth.edu; dladnqls1234@naver.com; sy98727@naver.com;
   kyk3079@naver.com; eugenecheon9@naver.com; asv0321@naver.com;
   olivialol@naver.com; dhlee@mail.harvard.edu; sskang@dongguk.edu;
   hannahoh@korea.ac.kr; nak212@mail.harvard.edu; CHESIEH@hsph.harvard.edu
RI Oh, Hannah/AAR-5568-2020
OI Oh, Hannah/0000-0002-8368-3032; Lee, Dong Hoon/0000-0003-1329-4637
FU National Research Foundation of Korea (NRF) - Korea government
   [2018R1C1B6008822, 2018R1A4A1022589, 2019R1G1A1004227]; Korea University
   [K1808781]; Dongguk University; National Research Foundation of Korea
   [2019R1G1A1004227] Funding Source: Korea Institute of Science &
   Technology Information (KISTI), National Science & Technology
   Information Service (NTIS)
FX This work was supported by the National Research Foundation of Korea
   (NRF) grants funded by the Korea government (2018R1C1B6008822 [N.K.];
   2018R1A4A1022589 [N.K.]; 2019R1G1A1004227 [H.O.]); a Korea University
   Grant (K1808781) (H.O.); the Dongguk University Research Grant of 2017
   (N.K.).
CR Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x
   Ilavenil S, 2014, PHYTOMEDICINE, V21, P758, DOI 10.1016/j.phymed.2013.11.007
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Leeners B, 2017, HUM REPROD UPDATE, V23, P300, DOI 10.1093/humupd/dmw045
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Maki C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173264
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Shin H, 2017, KOREAN J FAM MED, V38, P346, DOI 10.4082/kjfm.2017.38.6.346
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Wang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20691
   Wille N, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-421
NR 26
TC 58
Z9 60
U1 5
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUN
PY 2019
VL 11
IS 6
AR 1274
DI 10.3390/nu11061274
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA II1AJ
UT WOS:000474936700080
PM 31195610
OA Green Published, Green Submitted, gold
DA 2025-04-28
ER

PT J
AU Lin, SL
   Lin, ZJ
   Zhang, YF
   Zheng, BD
   Tan, BK
   Zhang, Y
   Hu, JM
AF Lin, Shaoling
   Lin, Zhongjing
   Zhang, Yifei
   Zheng, Baodong
   Tan, Bee K.
   Zhang, Yi
   Hu, Jiamiao
TI Analysis of transcriptomic, lipidomic and phospho-kinase profiles
   reveals the effects of chlorogenic acid on 3T3-L1 preadipocytes
   differentiation
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Chlorogenic acid; Transcriptomics; Lipidomics; Phospho-kinase
ID EXPRESSION; LIVER; ACCUMULATION; INHIBITION; COFFEE; BROWN
AB Chlorogenic acid has been widely reported to profoundly influence preadipocyte differentiation but without consensus being achieved. In the current study, 3 T3-L1 preadipocytes were differentiated using adipogenic cocktail with or without chlorogenic acid. The influences of chlorogenic acid on the mRNA, lipid and phosphokinase profiles were evaluated using transcriptomic analysis, lipidomic analysis and phospho-kinase array assay. The obtained results showed that chlorogenic acid treatment during 3T3-L1 cells differentiation altered a series of genes transcription, resulted in obvious changes in the contents of various lipids, and inhibited phosphorylation of several adipogenesis-related kinases. Overall, the observed changes in transcriptomic, lipidomic and phospho-kinase profiles in the current study favor the findings that chlorogenic acid may inhibit the differentiation of 3T3-L1 preadipocytes. In conclusion, the findings from this study highlighted the therapeutic potential of chlorogenic acid for the treatment of obesity.
C1 [Lin, Shaoling; Lin, Zhongjing; Zhang, Yifei; Zheng, Baodong; Zhang, Yi; Hu, Jiamiao] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Fujian, Peoples R China.
   [Zheng, Baodong; Zhang, Yi] Fujian Prov Key Lab Qual Sci & Proc Technol Specia, Fuzhou 350002, Fujian, Peoples R China.
   [Tan, Bee K.; Hu, Jiamiao] Univ Leicester, Coll Life Sci, Leicester LE1 7RH, England.
C3 Fujian Agriculture & Forestry University; University of Leicester
RP Hu, JM (corresponding author), Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Fujian, Peoples R China.
EM jh921@leicester.ac.uk
RI Hu, Jiamiao/W-5312-2019
OI Hu, Jiamiao/0000-0001-6489-9877
FU China Postdoctoral Science Foundation [2018M63072, 2019T120551]; Hundred
   Talents Program of Fujian Province [118360020]; Research Fund for
   Taiwan-Straits Postdoctoral Exchange Program [2022-ZD-014]; Science and
   Technology Major Project of Fuzhou [2022-82]; Special Funds for Science
   and Technology Innovation of Fujian Agriculture and Forestry University;
    [2018B003]
FX Authors acknowledge that this work was supported by the following funds:
   China Postdoctoral Science Foundation (2018M63072, 2019T120551) ,
   Hundred Talents Program of Fujian Province (118360020) , Research Fund
   for Taiwan-Straits Postdoctoral Exchange Program (2018B003) , Science
   and Technology Major Project of Fuzhou (2022-ZD-014) , and Special Funds
   for Science and Technology Innovation of Fujian Agriculture and Forestry
   University (2022-82) .
CR Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002
   Caraballo SCG, 2017, BBA-MOL BASIS DIS, V1863, P1789, DOI 10.1016/j.bbadis.2017.04.022
   Chen JC, 2015, J CELL PHYSIOL, V230, P2233, DOI 10.1002/jcp.24952
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Du Y, 2022, PHYTOMEDICINE, V98, DOI 10.1016/j.phymed.2022.153959
   Enerbäck S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008
   Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z
   Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200
   He XY, 2021, J SCI FOOD AGR, V101, P631, DOI 10.1002/jsfa.10675
   Honma T, 2012, BIOGERONTOLOGY, V13, P93, DOI 10.1007/s10522-011-9363-2
   Hu JM, 2020, TRENDS FOOD SCI TECH, V97, P221, DOI 10.1016/j.tifs.2020.01.013
   Hwang S, 2020, HEPATOLOGY, V72, P873, DOI 10.1002/hep.31390
   Jakab J, 2021, CURR ISSUES MOL BIOL, V43, P2082, DOI 10.3390/cimb43030144
   Ji S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01167
   Alonso-Castro AJ, 2008, J ETHNOPHARMACOL, V120, P458, DOI 10.1016/j.jep.2008.09.019
   Kaltenecker D, 2020, MOL METAB, V40, DOI 10.1016/j.molmet.2020.101026
   Kong L, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13795
   Liaw L, 2016, J CELL BIOCHEM, V117, P2182, DOI 10.1002/jcb.25522
   Lin SL, 2017, J FUNCT FOODS, V32, P285, DOI 10.1016/j.jff.2017.03.009
   Liu LB, 2023, FOOD BIOSCI, V51, DOI 10.1016/j.fbio.2022.102330
   Liu MT, 2021, INT J ENDOCRINOL, V2021, DOI 10.1155/2021/2215274
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Manigandan S, 2021, ARCH BIOCHEM BIOPHYS, V704, DOI 10.1016/j.abb.2021.108885
   McCafferty BJ, 2020, TECH VASC INTERV RAD, V23, DOI 10.1016/j.tvir.2020.100653
   Moon S, 2020, BIOTECHNOL BIOPROC E, V25, P22, DOI 10.1007/s12257-019-0352-7
   Pan ZY, 2022, J ANIM SCI TECHNOL, V64, P1199, DOI 10.5187/jast.2022.e60
   Pang G, 2014, Food Sci Hum Wellness, V3, P89, DOI [DOI 10.1016/J.FSHW.2015.01.001, 10.1016/j.fshw.2015.01.001]
   Peng BJ, 2015, BIOMED ENVIRON SCI, V28, P894, DOI 10.3967/bes2015.123
   Peng SG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8594767
   Rizzatti V, 2013, EUR J HISTOCHEM, V57, P159, DOI 10.4081/ejh.2013.e24
   Sudhakar M, 2020, J FUNCT FOODS, V74, DOI 10.1016/j.jff.2020.104161
   Sun WP, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.564339
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   White U, 2023, FRONT CELL DEV BIOL, V11, DOI 10.3389/fcell.2023.1188844
   Zhang F, 2004, DRUG NEWS PERSPECT, V17, P661, DOI 10.1358/dnp.2004.17.10.873918
   Zhang PP, 2022, SCI DATA, V9, DOI 10.1038/s41597-022-01149-0
   Zhao C, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12401
   Zhou Y, 2009, BIOL PHARM BULL, V32, P993, DOI 10.1248/bpb.32.993
   Zingg JM, 2017, BIOFACTORS, V43, P42, DOI 10.1002/biof.1307
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 43
TC 4
Z9 4
U1 7
U2 33
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD NOV
PY 2023
VL 110
AR 105828
DI 10.1016/j.jff.2023.105828
EA OCT 2023
PG 13
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA X6UJ1
UT WOS:001099775700001
OA gold
DA 2025-04-28
ER

PT J
AU Soares, MJ
   Figueira, MD
   Sampaio, GR
   Soares-Freitas, RAM
   Pinaffi-Langley, ACD
   Torres, EAFD
AF Soares, Maiara Jurema
   Figueira, Marcela de Souza
   Sampaio, Geni Rodrigues
   Soares-Freitas, Rosana Aparecida Manolio
   Pinaffi-Langley, Ana Clara da Costa
   Torres, Elizabeth Aparecida Ferraz da Silva
TI Coffee simulated inhibition of pancreatic lipase and antioxidant
   activities: Effect of milk and decaffeination
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article
DE Coffee; Decaffeinated; Milk; Caffeine; Phenolic acids; Antioxidant;
   Lipase
ID CHLOROGENIC ACIDS; PHENOLIC-ACIDS; TEA POLYPHENOLS; GREEN TEA;
   BIOAVAILABILITY; EXTRACT; DPPH; ABSORPTION; DIGESTION; CAPACITY
AB Noncommunicable diseases (NCDs) are the leading cause of mortality worldwide. Dietary intake of polyphenols may protect against the development of NCDs. Coffee is a rich source of phenolic acids in the Western diet that may prevent or treat hyperlipidemia, type 2 diabetes, chronic liver diseases, and obesity. These health effects are attributed, at least partially, to the antioxidant properties and inhibitory activity of phenolic acids on lipases. However, the effect of milk on these properties is not clear. Thus, we aimed to evaluate the antiradical properties and inhibitory activity on pancreatic lipase in vitro of phenolic acids from coffee. We obtained commercial traditional and decaffeinated espresso coffee capsules and prepared the beverages according to the manufac-turer's instructions using a domestic coffee maker. Espresso prepared with traditional and decaffeinated coffee capsules were evaluated with and without the addition of milk following in vitro digestion. The total phenolic content ranged from 168.21 to 397.38 mg equivalent to chlorogenic acid/mL. All coffee-based beverages showed antioxidant activity, with emphasis on decaffeinated and milk-added beverages, respectively. Caffeic acid was the most abundant phenolic compound followed by 5-caffeoylquinic acid before digestion. In contrast after in vitro digestion, only caffeic acid was bioaccessible. The addition of milk improved the bioaccessibility of caffeic acid and caffeine. Overall, the half-maximal inhibitory concentration of the samples for pancreatic lipase varied between 222 and 3035.8 mu g/mL. Decaffeinated coffee had a greater inhibitory effect than regular coffee regardless of milk addition. In conclusion, decaffeinated and milk-added coffee beverages have a greater effect on lipase inhibition. This may be related to the greater bioaccessibility of phenolic compounds in these samples. Further studies are needed to elucidate the mechanisms of enzymatic inhibition by phenolic acids.
C1 [Soares, Maiara Jurema; Figueira, Marcela de Souza; Sampaio, Geni Rodrigues; Soares-Freitas, Rosana Aparecida Manolio; Pinaffi-Langley, Ana Clara da Costa; Torres, Elizabeth Aparecida Ferraz da Silva] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Ave Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
   [Figueira, Marcela de Souza] Fed Univ Para, Inst Hlth Sci, Fac Nutr, Augusto Correa 01, BR-66075110 Belem, PA, Brazil.
   [Pinaffi-Langley, Ana Clara da Costa] Univ Oklahoma Hlth Sci Ctr, Coll Allied Hlth, Dept Nutr Sci, Oklahoma City, OK 73117 USA.
C3 Universidade de Sao Paulo; Universidade Federal do Para; University of
   Oklahoma System; University of Oklahoma Health Sciences Center
RP Torres, EAFD (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Ave Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
EM eatorres@usp.br
RI Soares-Freitas, Rosana/AFB-7230-2022; Soares, Maiara
   Jurema/KCY-3860-2024
OI da Costa Pinaffi Langley, Ana Clara/0000-0001-6354-6658; Manolio
   Soares-Freitas, Rosana Aparecida/0000-0001-7955-656X
FU Coordination Office for Academic Staff Improvement (CAPES); National
   Council for Scientific and Technological Development (CNPq)
FX We would like to address our thanks to Coordination Office for Academic
   Staff Improvement (CAPES) and to the National Council for Scientific and
   Technological Development (CNPq) for their support and for granting
   scholarships to the authors.
CR Abramovic H, 2017, ACTA CHIM SLOV, V64, P491, DOI 10.17344/acsi.2017.3408
   Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Bohn T, 2014, NUTR REV, V72, P429, DOI 10.1111/nure.12114
   BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25
   Brodkorb A, 2019, NAT PROTOC, V14, P991, DOI 10.1038/s41596-018-0119-1
   Budryn G, 2015, FOOD CHEM, V168, P276, DOI 10.1016/j.foodchem.2014.07.056
   Bustos AS, 2018, J FOOD SCI, V83, P2071, DOI 10.1111/1750-3841.14217
   Cha KH, 2012, J AGR FOOD CHEM, V60, P7152, DOI 10.1021/jf301047f
   Chen Z, 2013, FOOD CHEM, V138, P414, DOI 10.1016/j.foodchem.2012.11.001
   de Camargo AC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112644
   Das A, 2019, J FOOD SCI TECH MYS, V56, P5009, DOI 10.1007/s13197-019-03973-6
   de Camargo AC, 2021, MOLECULES, V26, DOI 10.3390/molecules26020463
   de Oliveira DM, 2017, EUR J NUTR, V56, P2541, DOI 10.1007/s00394-016-1290-1
   Doepker C, 2016, ANNU REV FOOD SCI T, V7, P117, DOI 10.1146/annurev-food-041715-033243
   DOWNEY WK, 1970, J DAIRY RES, V37, P47, DOI 10.1017/S0022029900013066
   Duangjai A, 2021, PREV NUTR FOOD SCI, V26, P338, DOI 10.3746/pnf.2021.26.3.338
   Duarte GS, 2011, J AGR FOOD CHEM, V59, P7925, DOI 10.1021/jf201906p
   Dupas CJ, 2006, J FOOD SCI, V71, pS253, DOI 10.1111/j.1365-2621.2006.tb15650.x
   Siqueira ADE, 2017, ARQ BRAS CARDIOL, V109, P39, DOI 10.5935/abc.20170068
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Gil-Rodríguez AM, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.06.015
   Gülcin I, 2008, J ENZYM INHIB MED CH, V23, P149, DOI [10.1080/14756360701306404, 10.1080/14756360701306404 ]
   Guideline I.H.T., 2005, INT C HARM GEN SWITZ, VQ2, DOI DOI 10.1590/S1984-82502011000100012
   Hasni I, 2011, FOOD CHEM, V126, P630, DOI 10.1016/j.foodchem.2010.11.087
   He ZY, 2015, FOOD CHEM, V175, P457, DOI 10.1016/j.foodchem.2014.12.007
   Hecimovic I, 2011, FOOD CHEM, V129, P991, DOI 10.1016/j.foodchem.2011.05.059
   Heleno SA, 2015, FOOD CHEM, V173, P501, DOI 10.1016/j.foodchem.2014.10.057
   Hu B, 2015, INT J BIOL MACROMOL, V80, P529, DOI 10.1016/j.ijbiomac.2015.07.031
   Hur SJ, 2011, FOOD CHEM, V125, P1, DOI 10.1016/j.foodchem.2010.08.036
   Jafar S, 2018, LWT-FOOD SCI TECHNOL, V98, P212, DOI 10.1016/j.lwt.2018.08.024
   Jakobek L, 2015, FOOD CHEM, V175, P556, DOI 10.1016/j.foodchem.2014.12.013
   Komes D, 2015, EUR FOOD RES TECHNOL, V241, P115, DOI 10.1007/s00217-015-2440-z
   Konishi Y, 2006, J AGR FOOD CHEM, V54, P7539, DOI 10.1021/jf061554+
   Kurihara H, 2003, BIOL PHARM BULL, V26, P383, DOI 10.1248/bpb.26.383
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lafay Sophie, 2008, Phytochemistry Reviews, V7, P301, DOI 10.1007/s11101-007-9077-x
   Lesser S, 2004, J NUTR, V134, P1508, DOI 10.1093/jn/134.6.1508
   Liu TT, 2020, BIOMED PHARMACOTHER, V128, DOI 10.1016/j.biopha.2020.110314
   Lunagariya NA, 2014, EXCLI J, V13, P897
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S
   McClements DJ, 2004, CURR OPIN COLLOID IN, V9, P305, DOI 10.1016/j.cocis.2004.09.003
   Murase T, 2012, BRIT J NUTR, V107, P1757, DOI 10.1017/S0007114511005083
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Niseteo T, 2012, FOOD CHEM, V134, P1870, DOI 10.1016/j.foodchem.2012.03.095
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ontawong A, 2019, PHYTOMEDICINE, V52, P187, DOI 10.1016/j.phymed.2018.06.021
   Otemuyiwa IO, 2017, NUTR FOOD SCI, V47, P458, DOI [10.1108/nfs-08-2016-0134, 10.1108/NFS-08-2016-0134]
   Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o
   Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774
   Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698
   Qie XJ, 2022, FOOD CHEM, V375, DOI 10.1016/j.foodchem.2021.131644
   Quan W, 2020, FOOD CHEM, V308, DOI 10.1016/j.foodchem.2019.125598
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Rein M. J., 2017, IMPROVEMENT BIOACCES, P401, DOI [10.1007/978-1-4939-6595-3_15, DOI 10.1007/978-1-4939-6595-3_15]
   Reis PM, 2008, FOOD BIOPHYS, V3, P370, DOI 10.1007/s11483-008-9091-6
   Ribas-Agustí A, 2018, CRIT REV FOOD SCI, V58, P2531, DOI 10.1080/10408398.2017.1331200
   Saad H. H., 2015, DIABETES, V10, P11, DOI [10.4172/2167-0412.1000203, DOI 10.4172/2167-0412.1000203]
   Sánchez-Moreno C, 2002, FOOD SCI TECHNOL INT, V8, P121, DOI 10.1106/108201302026770
   Sanz-Buenhombre M, 2016, J FUNCT FOODS, V21, P178, DOI 10.1016/j.jff.2015.11.044
   Serafini M, 1996, EUR J CLIN NUTR, V50, P28
   Shahidi F, 2015, J FUNCT FOODS, V18, P820, DOI 10.1016/j.jff.2015.06.018
   Sharma V, 2008, FOOD RES INT, V41, P124, DOI 10.1016/j.foodres.2007.10.009
   Sherer Y, 2006, NAT CLIN PRACT RHEUM, V2, P99, DOI 10.1038/ncprheum0092
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Slanc P, 2009, PHYTOTHER RES, V23, P874, DOI 10.1002/ptr.2718
   Soares MJ, 2021, LWT-FOOD SCI TECHNOL, V135, DOI 10.1016/j.lwt.2020.110255
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Tabart J, 2009, FOOD CHEM, V113, P1226, DOI 10.1016/j.foodchem.2008.08.013
   Thaipong K, 2006, J FOOD COMPOS ANAL, V19, P669, DOI 10.1016/j.jfca.2006.01.003
   Toci AT, 2014, FOOD CHEM, V153, P298, DOI 10.1016/j.foodchem.2013.12.040
   Trisat K., 2017, International Journal of Vegetable Science, V23, P260, DOI 10.1080/19315260.2016.1258604
   Vignoli J. A., 2012, Coffee Science, V7, P68
   Villaño D, 2007, TALANTA, V71, P230, DOI 10.1016/j.talanta.2006.03.050
   Williamson G, 2017, NUTR BULL, V42, P226, DOI 10.1111/nbu.12278
   Williamson G, 2013, MOL NUTR FOOD RES, V57, P48, DOI 10.1002/mnfr.201200511
   Ye AQ, 2010, INT DAIRY J, V20, P822, DOI 10.1016/j.idairyj.2010.06.007
   Zanotti I, 2015, FOOD FUNCT, V6, P13, DOI [10.1039/c4fo00670d, 10.1039/C4FO00670D]
NR 80
TC 3
Z9 3
U1 2
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0963-9969
EI 1873-7145
J9 FOOD RES INT
JI Food Res. Int.
PD OCT
PY 2022
VL 160
AR 111730
DI 10.1016/j.foodres.2022.111730
EA JUL 2022
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 3Z3RV
UT WOS:000844335900005
PM 36076418
DA 2025-04-28
ER

PT J
AU Kempf, K
   Kolb, H
   Gärtner, B
   Bytof, G
   Stiebitz, H
   Lantz, I
   Lang, R
   Hofmann, T
   Martin, S
AF Kempf, Kerstin
   Kolb, Hubert
   Gaertner, Babette
   Bytof, Gerhard
   Stiebitz, Herbert
   Lantz, Ingo
   Lang, Roman
   Hofmann, Thomas
   Martin, Stephan
TI Cardiometabolic effects of two coffee blends differing in content for
   major constituents in overweight adults: a randomized controlled trial
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Coffee; N-methylpyridinium; Coffee and health; Coffee and body weight
ID PATHWAY IN-VITRO; CHLOROGENIC ACID; BLOOD-PRESSURE; WEIGHT-LOSS;
   N-METHYLPYRIDINIUM; GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; RISK;
   CONSUMPTION; METAANALYSIS
AB Purpose The hypothesis was tested that coffee types differing in content of major constituents also differ with regard to cardiometabolic effects.
   Methods Overweight persons (n = 118) were randomized to consume a dark roast [rich in N-methylpyridinium (NMP)] or medium roast (rich in caffeoylquinic acids, trigonelline) coffee blend for 3 months, after a washout period of 4 weeks. Before and after the intervention period, body weight and 15 further general and biochemical parameters were determined.
   Results Participants consumed an average of 4-5 cups per day. Mean body weight, body mass index and waist circumference did not change during the coffee consumption phase in either of the study groups. Systolic blood pressure decreased in the dark roast coffee group only (p < 0.05). High-density lipoprotein cholesterol levels increased in the medium roast coffee group only, and triglyceride levels increased in the dark roast coffee group only. Glucoregulation and insulin levels were not affected, although there was a small increase of hemoglobin A1c values in both groups. An increase of adiponectin levels occurred in the medium roast coffee group only and was negatively associated with NMP concentrations. Differences did not remain statistically significant after correction for multiple testing.
   Conclusion Medium and dark roast coffee blends exert small but possibly relevant different cardiometabolic effects. Further studies of health outcomes in relation to coffee constituents seem warranted.
C1 [Kempf, Kerstin; Kolb, Hubert; Gaertner, Babette; Martin, Stephan] West German Ctr Diabet & Hlth, Dusseldorf Cathol Hosp Grp, D-40591 Dusseldorf, Germany.
   [Bytof, Gerhard; Stiebitz, Herbert; Lantz, Ingo] Tchibo GmbH, Hamburg, Germany.
   [Lang, Roman; Hofmann, Thomas] Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, D-85354 Freising Weihenstephan, Germany.
C3 Technical University of Munich
RP Kempf, K (corresponding author), West German Ctr Diabet & Hlth, Dusseldorf Cathol Hosp Grp, Hohensandweg 37, D-40591 Dusseldorf, Germany.
EM kerstin.kempf@wdgz.de
RI Bytof, Gerhard/GXV-5991-2022; Hofmann, Thomas/O-3346-2015
OI Hofmann, Thomas/0000-0003-4057-7165; Lang, Roman/0000-0003-0610-7186
FU Tchibo GmbH, Germany
FX The authors G. Bytof, H. Stiebitz and I. Lantz are employees of Tchibo
   GmbH, Germany, the company that sponsored part of this research. H. Kolb
   received consulting fees from Tchibo GmbH. S. Martin and K. Kempf
   received a research grant from Tchibo GmbH. B. Gartner, T. Hofmann and
   R. Lang declare that they have no conflict of interest.
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   [Anonymous], GASTROENTEROLOGY RES
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Boekschoten M V, 2006, Ned Tijdschr Geneeskd, V150, P2873
   Boettler U, 2012, MOL BIOL REP, V39, P7155, DOI 10.1007/s11033-012-1547-6
   Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Chikama A, 2008, J HEALTH SCI, V54, P162, DOI 10.1248/jhs.54.162
   Corrêa TAF, 2013, NUTRITION, V29, P977, DOI 10.1016/j.nut.2013.01.003
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Gómez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080
   Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kiefer FW, 2008, ENDOCRINOLOGY, V149, P1350, DOI 10.1210/en.2007-1312
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Lang R, 2012, ACS S SERIES
   Lang R, 2011, MOL NUTR FOOD RES, V55, P1613, DOI 10.1002/mnfr.201000656
   Lang R, 2010, ANAL CHEM, V82, P1486, DOI 10.1021/ac902616k
   Larsson SC, 2011, AM J EPIDEMIOL, V174, P993, DOI 10.1093/aje/kwr226
   Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976
   Liu J, 2013, MAYO CLIN P
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Moisey LL, 2010, BRIT J NUTR, V103, P833, DOI 10.1017/S0007114509992406
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Muley A, 2012, CURR DIABETES REV, V8, P162, DOI 10.2174/157339912800564016
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Ohnaka K, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/207426
   Perrone D, 2010, J AGR FOOD CHEM, V58, P12238, DOI 10.1021/jf102110u
   RATNAYAKE WMN, 1993, FOOD CHEM TOXICOL, V31, P263, DOI 10.1016/0278-6915(93)90076-B
   Rebello SA, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0403-1
   Smrke S, 2013, FOOD FUNCT, V4, P1082, DOI 10.1039/c3fo30377b
   Speer Karl, 2006, Braz. J. Plant Physiol., V18, P201, DOI 10.1590/S1677-04202006000100014
   Volz N, 2012, J AGR FOOD CHEM, V60, P9631, DOI 10.1021/jf302258u
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Weiss C, 2010, J AGR FOOD CHEM, V58, P1976, DOI 10.1021/jf903614d
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
NR 47
TC 37
Z9 39
U1 0
U2 15
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD AUG
PY 2015
VL 54
IS 5
BP 845
EP 854
DI 10.1007/s00394-014-0763-3
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CN1PG
UT WOS:000358191500017
PM 25204719
DA 2025-04-28
ER

PT J
AU Henn, M
   Babio, N
   Romaguera, D
   Vázquez-Ruiz, Z
   Konieczna, J
   Vioque, J
   Torres-Collado, L
   Razquin, C
   Buil-Cosiales, P
   Fitó, M
   Schröder, H
   Hu, FB
   Abete, I
   Zulet, MA
   Fernández-Villa, T
   Martín, V
   Estruch, R
   Vidal, J
   Paz-Graniel, I
   Martínez, JA
   Salas-Salvadó, J
   Martínez-González, MA
   Ruiz-Canela, M
AF Henn, Matthias
   Babio, Nancy
   Romaguera, Dora
   Vazquez-Ruiz, Zenaida
   Konieczna, Jadwiga
   Vioque, Jesus
   Torres-Collado, Laura
   Razquin, Cristina
   Buil-Cosiales, Pilar
   Fito, Montserrat
   Schroder, Helmut
   Hu, Frank B.
   Abete, Itziar
   Zulet, M. Angeles
   Fernandez-Villa, Tania
   Martin, Vicente
   Estruch, Ramon
   Vidal, Josep
   Paz-Graniel, Indira
   Martinez, J. Alfredo
   Salas-Salvado, Jordi
   Martinez-Gonzalez, Miguel A.
   Ruiz-Canela, Miguel
TI Increase from low to moderate, but not high, caffeinated coffee
   consumption is associated with favorable changes in body fat
SO CLINICAL NUTRITION
LA English
DT Article
DE Coffee consumption; Caffeine; Visceral fat; DXA; PREDIMED-Plus trial;
   Adiposity distribution
ID MEDITERRANEAN DIET ADHERENCE; X-RAY ABSORPTIOMETRY; ALL-CAUSE; METABOLIC
   SYNDROME; VISCERAL FAT; RISK-FACTORS; OBESITY; WEIGHT; QUESTIONNAIRE;
   MORTALITY
AB Background & aims: Higher consumption of coffee and caffeine has been linked to less weight gain and lower body mass index in prospective cohort studies. The aim of the study was to longitudinally assess the association of changes in coffee and caffeine intake with changes in fat tissue, in particular, visceral adipose tissue (VAT) using dual x-ray absorptiometry (DXA).Methods: In the setting of a large, randomized trial of Mediterranean diet and physical activity inter-vention, we evaluated 1483 participants with metabolic syndrome (MetS). Repeated measurements of coffee consumption from validated food frequency questionnaires (FFQ) and DXA measurements of adipose tissue were collected at baseline, 6 months, 12 months and 3 years of follow-up. DXA-derived measurements of total and regional adipose tissue expressed as % of total body weight were transformed into sex-specific z-scores. Linear multilevel mixed-effect models were used to investigate the relation-ship between changes in coffee consumption and corresponding concurrent changes in fat tissue during a 3-year follow-up.Results: After adjustment for intervention group, and other potential confounders, an increase in caffeinated coffee consumption from no or infrequent consumption (<= 3 cups/month) to moderate consumption (1-7 cups/week) was associated with reductions in total body fat (D z-score:-0.06; 95%
C1 [Henn, Matthias; Vazquez-Ruiz, Zenaida; Razquin, Cristina; Buil-Cosiales, Pilar; Martinez-Gonzalez, Miguel A.; Ruiz-Canela, Miguel] Univ Navarra, Dept Prevent Med & Publ Hlth, IdiSNA Inst Invest Sanitaria Navarra, Pamplona, Spain.
   [Henn, Matthias; Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   [Babio, Nancy; Romaguera, Dora; Vazquez-Ruiz, Zenaida; Konieczna, Jadwiga; Razquin, Cristina; Buil-Cosiales, Pilar; Fito, Montserrat; Abete, Itziar; Zulet, M. Angeles; Estruch, Ramon; Paz-Graniel, Indira; Martinez, J. Alfredo; Salas-Salvado, Jordi; Martinez-Gonzalez, Miguel A.; Ruiz-Canela, Miguel] Inst Salud Carlos III, CIBER Fisiopatol Obes & Nutr CIBERObn, Madrid, Spain.
   [Babio, Nancy; Paz-Graniel, Indira; Salas-Salvado, Jordi] Univ Rovira & Virgili, Inst Invest Sanitaria Pere & Virgili, Dept Bioquim & Biotecnol, Unitat Nutr Humana, Reus 43201, Spain.
   [Romaguera, Dora; Konieczna, Jadwiga] Univ Hosp Son Espases HUSE, Hlth Res Inst Balear Isl IdISBa, Res Grp Nutr Epidemiol & Cardiovasc Physiopathol, Palma De Mallorca, Spain.
   [Vioque, Jesus; Torres-Collado, Laura] ISABIAL UMH, Inst Invest Sanitaria & Biomed Alicante, Alicante, Spain.
   [Vioque, Jesus; Torres-Collado, Laura; Schroder, Helmut; Fernandez-Villa, Tania; Martin, Vicente] Inst Salud Carlos III ISCIII, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.
   [Buil-Cosiales, Pilar] Serv Atenc Primaria, Serv Navarro Salud, Pamplona, Spain.
   [Fito, Montserrat; Schroder, Helmut] Univ Barcelona, Hosp Del Mar Med Res Inst IMIM, Dept Med, Cardiovasc Risk & Nutr Res Grp, Barcelona, Spain.
   [Fernandez-Villa, Tania; Martin, Vicente] Univ Leon, Inst Biomed IBIOMED, Res Grp Gene Environm & Hlth Interact GIIGAS, Leon, Spain.
   [Estruch, Ramon] Univ Barcelona, Hosp Clin, Dept Internal Med, IDIBAPS, Barcelona, Spain.
   [Vidal, Josep] Inst Salud Carlos III ISCIII, CIBER Diabet & Enfermedades Metab CIBERDEM, Madrid 28029, Spain.
   [Vidal, Josep] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi Sunyer IDIBAPS, Dept Endocrinol, Barcelona, Spain.
   [Martinez, J. Alfredo] Univ Navarra, Navarra Inst Hlth Res IdiSNA, Ctr Nutr Res, Dept Nutr Food Sci & Physiol, Pamplona, Spain.
   [Martinez, J. Alfredo] CEI UAM CSIC, Precis Nutr & Cardiometab Hlth Program, IMDEA Food, Madrid, Spain.
C3 University of Navarra; Harvard University; Harvard T.H. Chan School of
   Public Health; CIBER - Centro de Investigacion Biomedica en Red;
   CIBEROBN; Instituto de Salud Carlos III; Universitat Rovira i Virgili;
   Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Hospital
   Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears
   (IdISBa); General University Hospital of Alicante; Universidad Miguel
   Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion
   Sanitaria y Biomedica de Alicante (ISABIAL); CIBER - Centro de
   Investigacion Biomedica en Red; CIBERESP; Servicio Navarro de Salud -
   Osasunbidea; University of Barcelona; Hospital del Mar Research
   Institute; Hospital del Mar; Universidad de Leon; University of
   Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERDEM; University of Barcelona;
   Hospital Clinic de Barcelona; IDIBAPS; University of Navarra; IMDEA Food
   Institute; Consejo Superior de Investigaciones Cientificas (CSIC)
RP Henn, M; Ruiz-Canela, M (corresponding author), Univ Navarra, Dept Prevent Med & Publ Hlth, IdiSNA Inst Invest Sanitaria Navarra, Pamplona, Spain.
EM mhenn@alumni.unav.es; mcanela@unav.es
RI Konieczna, Jadwiga/AAB-2817-2020; Estruch, Ramon/AAZ-3723-2020; Villa,
   Tania/GLU-1260-2022; Ruiz-Canela, Miguel/JYP-1794-2024; Babio,
   Nancy/AAN-2715-2020; Zulet, M./H-1317-2017; Paz-Graniel,
   Indira/ABH-2583-2020; Vidal, Josep/MIK-6936-2025; Vioque,
   Jesus/A-1066-2008; Romaguera, Dora/ABE-7004-2020; Hu, Frank/C-1919-2013;
   Razquin, Cristina/H-2366-2017; Martínez, J./K-8709-2014; Henn, Matthias
   Christoph/JSL-3098-2023; Fito Colomer, Montse/C-1822-2012; Vazquez-Ruiz,
   Zenaida/AAB-7202-2020; Salas-Salvado, Jordi/C-7229-2017; Schroder,
   Helmut/G-2586-2015; Martin, Vicente/A-1597-2008
OI Vioque, Jesus/0000-0002-2284-148X; Paz Graniel,
   Indira/0000-0002-3204-6877; Fito Colomer, Montse/0000-0002-1817-483X;
   Vazquez-Ruiz, Zenaida/0000-0002-6828-9627; Salas-Salvado,
   Jordi/0000-0003-2700-7459; Schroder, Helmut/0000-0003-2231-5081;
   Konieczna, Jadwiga/0000-0002-2947-1338; Torres-Collado,
   Laura/0000-0003-2842-1344; Henn, Matthias Christoph/0000-0001-9217-2069;
   Martin, Vicente/0000-0003-0552-2804; BABIO SANCHEZ,
   NANCY/0000-0003-3527-5277
FU official funding agency for biomedical research of the Spanish
   Government; official funding agency for biomedical research of the
   Spanish Government, Instituto de Salud Carlos III ( [Carlos III Health
   Institute] , Sevilla, Spain) , through the Fondo de Investigacion para
   la Salud (FIS); European Regional Development Fund [PI13/00673,
   PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184,
   PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/0147, PI14/00636,
   PI14/00972, PI14/00618, PI14/00696, PI14/01206, 2013-2018 340918];
   Recercaixa grant [2013ACUP00194]; Consejeria de Salud de la Junta de
   Andalucia [PI0458/2013, PS0358/2016, PI0137/2018]; Generalitat
   Valenciana; SEMERGEN grant, FEDER funds [1R01DK127601-01]; NIH
   [PROMETEO/2017/017]; ICREA; Spanish Ministry of Economy, Industry and
   Competitiveness; European Social Funds;  [CB06/03];  [IJC2019-042420-I]
FX The PREDIMED-Plus trial was supported by the official funding agency for
   biomedical research of the Spanish Government, Instituto de Salud Carlos
   III ( [Carlos III Health Institute] , Sevilla, Spain) , through the
   Fondo de Investigacion para la Salud (FIS) , which is co-funded by the
   European Regional Development Fund PI13/00673, PI13/00492, PI13/00272,
   PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090,
   PI13/01056, PI14/01722, PI14/0147, PI14/00636, PI14/00972, PI14/00618,
   PI14/00696, PI14/01206, PI14/Advanced Research Grant 2013-2018 340918,
   the Recercaixa grant 2013ACUP00194, grants from the Consejeria de Salud
   de la Junta de Andalucia PI0458/2013; PS0358/2016, PI0137/2018, the
   PROMETEO/2017/017 grant from the Generalitat Valenciana, the SEMERGEN
   grant, FEDER funds CB06/03 and the NIH grant 1R01DK127601-01. Dr.
   Salas-Salvado is partially supported by ICREA under the ICREA Academia
   Program. JK is supported by Juan de la Cierva-Incorporacion research
   grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry
   and Competitiveness and European Social Funds. None of the funding
   sources took part in the design, collection, analysis or interpretation
   of the data and in writing the manuscript, or in the decision to submit
   the manuscript for publication.
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   [Anonymous], 2009, Tablas de Composicion de Alimentos
   Bell R.M., 2002, Survey Methodology, V28, P169
   Bi X, 2015, EUR J CLIN NUTR, V69, P329, DOI 10.1038/ejcn.2014.227
   Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027
   Cao C, 2020, J NUTR, V150, P1909, DOI 10.1093/jn/nxaa121
   Collaborators G. B. D. O., 2017, N Engl J Med, V377, P13, DOI DOI 10.1056/NEJMOA1614362
   de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156
   de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Favari C, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202000875
   Fernández-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Goossens GH, 2017, OBESITY FACTS, V10, P207, DOI 10.1159/000471488
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393
   Konieczna J, 2019, CLIN NUTR, V38, P1883, DOI 10.1016/j.clnu.2018.07.005
   Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43
   Lara-Guzmán OJ, 2021, FREE RADICAL BIO MED, V176, P345, DOI 10.1016/j.freeradbiomed.2021.10.012
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Martínez-González MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745
   Martínez-González MA, 2019, INT J EPIDEMIOL, V48, P387, DOI 10.1093/ije/dyy225
   Massey LK, 1998, DRUG AGING, V13, P43, DOI 10.2165/00002512-199813010-00005
   McCarty MF, 2001, MED HYPOTHESES, V57, P192, DOI 10.1054/mehy.2001.1317
   Miazgowski T, 2014, ENDOCRINE, V47, P500, DOI 10.1007/s12020-014-0180-7
   Molina L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168148
   Moreiras O., 2013, Tablas de Composicion de Alimentos
   OSTMAN J, 1979, METABOLISM, V28, P1198, DOI 10.1016/0026-0495(79)90131-8
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Ponti F, 2019, CASE REV BODY COMPOS
   Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031
   Rosique-Esteban N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172253
   Sasai Hiroyuki, 2015, J Diabetes Sci Technol, V9, P917, DOI 10.1177/1932296815577424
   Sayón-Orea C, 2019, JAMA-J AM MED ASSOC, V322, P1486, DOI 10.1001/jama.2019.14630
   Schröder H, 2021, CLIN NUTR, V40, P4971, DOI 10.1016/j.clnu.2021.06.030
   Schröder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007
   Willett W.C., 2013, Nutritional Epidemiology
   Zhou SF, 2010, DRUG METAB REV, V42, P268, DOI 10.3109/03602530903286476
NR 45
TC 9
Z9 9
U1 2
U2 5
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0261-5614
EI 1532-1983
J9 CLIN NUTR
JI Clin. Nutr.
PD APR
PY 2023
VL 42
IS 4
BP 477
EP 485
DI 10.1016/j.clnu.2023.02.004
EA MAR 2023
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA H5KJ2
UT WOS:000996346200001
PM 36870243
OA hybrid, Green Published
DA 2025-04-28
ER

PT J
AU Winkler, S
   Dieminger, N
   Blust, V
   Riedel, A
   Bakuradze, T
   Montoya, G
   Hassmann, U
   Lang, R
   Hofmann, T
   Somoza, V
   Richling, E
   Bytof, G
   Stiebitz, H
   Lantz, I
   Schipp, D
   Raedle, J
   Marko, D
AF Winkler, Swantje
   Dieminger, Natalie
   Blust, Volker
   Riedel, Annett
   Bakuradze, Tamara
   Montoya, Gina
   Hassmann, Ute
   Lang, Roman
   Hofmann, Thomas
   Somoza, Veronika
   Richling, Elke
   Bytof, Gerhard
   Stiebitz, Herbert
   Lantz, Ingo
   Schipp, Dorothea
   Raedle, Jochen
   Marko, Doris
TI Modulation of inflammatory gene transcription after long-term coffee
   consumption
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT 2nd International Congress on Cocoa Coffee and Tea (CoCoTea)
CY OCT 09-11, 2013
CL Congress Ctr Univ Naples Federico II, Naples, ITALY
SP NESPRESSO
HO Congress Ctr Univ Naples Federico II
DE Nrf2; Inflammation; Obesity; Coffee; Chlorogenic acid; Polymorphism
ID TYPE-2 DIABETES-MELLITUS; PATHWAY IN-VITRO; HIGH-FAT DIET; CHLOROGENIC
   ACID; PRO12ALA POLYMORPHISM; DECAFFEINATED COFFEE; INSULIN-RESISTANCE;
   OXIDATIVE STRESS; LIPID-METABOLISM; ADIPOSE-TISSUE
AB Scope: Obesity has been found to be associated with low grade inflammation accompanied by chronic oxidative stress. The transcription factor Nrf2 is likely involved in lipid metabolism and inflammation processes, possibly mediated by an antioxidant response element (ARE)-similar region located in the promoter of lipogenic genes like peroxisome-proliferator activated receptor gamma (PPAR gamma) and pro-inflammatory interleukin 6 (IL6). The present study investigates the influence of coffee consumption on the transcription of obesity-associated genes in human peripheral blood lymphocytes (PBL). Two different coffee blends with comparable caffeine concentrations were provided, rich either in chlorogenic acids and trigonelline (market blend, MB) or in N-methylpyridinium (NMP, study blend, SB).
   Methods and results: In a cross-over randomized double blind intervention study 84 volunteers (male and female, 25.6 +/- 5.8 years, BMI 22.9 +/- 1.9 kg/m(2), healthy, nonsmokers, regular coffee drinker) daily consumed 750 mL of the respective coffee over a period of 4 weeks, respectively. Transcription of IL6 in PBL was found to be positively associated with body fat. In the first intervention period consumption of MB decreased significantly the transcription of Nrf2, PPAR gamma and IL6 while concomitantly an enhanced level of PPAR alpha mRNA was found. Due to carry-over effects for Nrf2 and PPAR alpha, data of both intervention periods could only be pooled for PPAR gamma and IL6. Pooled data from both intervention periods showed a significant decrease of IL6 transcripts for SB consumption only. The changes in gene transcription appear to correlate with the level of different CGA metabolites in the plasma of the volunteers. Initial results further indicate a potential contribution of genetic polymorphisms in the nrf2 promoter and the ppar gamma-gene to the influence of coffee consumption on PPAR gamma transcription.
   Conclusion: Regular coffee consumption affects the transcription of genes associated with obesity and/or inflammation. Metabolites of chlorogenic acids as well as genetic polymorphisms may be relevant influencing factors. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Winkler, Swantje; Blust, Volker; Hassmann, Ute; Marko, Doris] Univ Vienna, Dept Food Chem & Toxicol, A-1090 Vienna, Austria.
   [Dieminger, Natalie; Lang, Roman; Hofmann, Thomas] Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, D-85354 Freising Weihenstephan, Germany.
   [Riedel, Annett; Somoza, Veronika] Univ Vienna, Dept Physiol Chem & Nutr, A-1090 Vienna, Austria.
   [Bakuradze, Tamara; Montoya, Gina; Richling, Elke] Univ Kaiserslautern, Dept Chem, Div Food Chem & Toxicol, D-67663 Kaiserslautern, Germany.
   [Bytof, Gerhard; Stiebitz, Herbert; Lantz, Ingo] Tchibo GmbH, D-22297 Hamburg, Germany.
   [Raedle, Jochen] Westpfalzklinikum, Innere Med 3, Kaiserslautern, Germany.
C3 University of Vienna; Technical University of Munich; University of
   Vienna; University of Kaiserslautern
RP Marko, D (corresponding author), Univ Vienna, Dept Food Chem & Toxicol, Wahringerstr 38, A-1090 Vienna, Austria.
EM doris.marko@univie.ac.at
RI Bytof, Gerhard/GXV-5991-2022; Somoza, Veronika/D-4141-2013; Marko,
   Doris/B-9354-2014; Hofmann, Thomas/O-3346-2015
OI Somoza, Veronika/0000-0003-2456-9245; Marko, Doris/0000-0001-6568-2944;
   Lang, Roman/0000-0003-0610-7186; Hofmann, Thomas/0000-0003-4057-7165;
   Schroter, Annett/0000-0002-2542-0867; Montoya Parra, Gina
   Alejandra/0000-0003-2848-1339
FU German Federal Ministry of Education and Research (BMBF) [01EA1365];
   Tchibo GmbH
FX The project was funded by the German Federal Ministry of Education and
   Research (BMBF, grant no. 01EA1365) and supported by Tchibo GmbH. The
   authors G. Bytof, H. Stiebitz and I. Lantz are employees of Tchibo GmbH.
   All other authors have declared no conflict of interest. We gratefully
   acknowledge the most valuable contribution of G. Eisenbrand to the
   successful realization of the project.
CR Bakuradze T, 2014, FOOD RES INT, V63, P420, DOI 10.1016/j.foodres.2014.05.032
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285
   Berhouma R, 2013, BIOCHEM GENET, V51, P256, DOI 10.1007/s10528-012-9560-y
   Boettler U, 2012, MOL BIOL REP, V39, P7155, DOI 10.1007/s11033-012-1547-6
   Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Di Paola R, 2010, FREE RADICAL RES, V44, P74, DOI 10.3109/10715760903300709
   Ek J, 1999, DIABETOLOGIA, V42, P892, DOI 10.1007/s001250051243
   Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200
   Fujioka K, 2002, OBES RES, V10, p116S, DOI 10.1038/oby.2002.204
   Gouda HN, 2010, AM J EPIDEMIOL, V171, P645, DOI 10.1093/aje/kwp450
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Higdon JV, 2003, ARTERIOSCL THROM VAS, V23, P365, DOI 10.1161/01.ATV.0000063608.43095.E2
   Hou YY, 2012, FREE RADICAL BIO MED, V52, P462, DOI 10.1016/j.freeradbiomed.2011.10.453
   Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010
   ICO, 2011, MONTHL COFF MARK REP
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jones B., 1988, DESIGN ANAL CROSS OV
   Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13
   Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282
   Kempf K, 2010, MED KLIN, V105, P910, DOI 10.1007/s00063-010-1156-x
   Kesh SB, 2013, LIFE SCI, V92, P938, DOI 10.1016/j.lfs.2013.03.015
   Lang R., 2012, Recent Advances in the Analysis of Food and Flavors, VVolume 1098, P13
   Lang R, 2013, J AGR FOOD CHEM, V61, P12123, DOI 10.1021/jf403846g
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   López-Alarcón M, 2012, GENE, V511, P404, DOI 10.1016/j.gene.2012.09.057
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com
   Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201
   Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10
   Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955
   Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003
   Prabhakar PK, 2011, J AGR FOOD CHEM, V59, P9835, DOI 10.1021/jf2015717
   Riedel A, 2014, FOOD RES INT, V63, P409, DOI 10.1016/j.foodres.2014.04.002
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Shi HT, 2013, INFLAMM RES, V62, P581, DOI 10.1007/s00011-013-0610-7
   Somoza V, 2003, J AGR FOOD CHEM, V51, P6861, DOI 10.1021/jf034750e
   Son MJ, 2010, J CLIN BIOCHEM NUTR, V46, P150, DOI 10.3164/jcbn.09-98
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Stienstra R, 2007, PPAR RES, V2007, DOI 10.1155/2007/95974
   Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   Volz N, 2012, J AGR FOOD CHEM, V60, P9631, DOI 10.1021/jf302258u
   Wang SX, 2012, CHIN J INTEGR MED, V18, P437, DOI 10.1007/s11655-012-1114-y
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Weiss C, 2010, J AGR FOOD CHEM, V58, P1976, DOI 10.1021/jf903614d
   Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008
   Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716
NR 57
TC 6
Z9 6
U1 0
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0963-9969
EI 1873-7145
J9 FOOD RES INT
JI Food Res. Int.
PD SEP
PY 2014
VL 63
SI SI
BP 428
EP 438
DI 10.1016/j.foodres.2014.05.073
PN C
PG 11
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Food Science & Technology
GA AQ1PE
UT WOS:000342552500020
DA 2025-04-28
ER

PT J
AU Cornelis, MC
   Byrne, EM
   Esko, T
   Nalls, MA
   Ganna, A
   Paynter, N
   Monda, KL
   Amin, N
   Fischer, K
   Renstrom, F
   Ngwa, JS
   Huikari, V
   Cavadino, A
   Nolte, IM
   Teumer, A
   Yu, K
   Marques-Vidal, P
   Rawal, R
   Manichaikul, A
   Wojczynski, MK
   Vink, JM
   Zhao, JH
   Burlutsky, G
   Lahti, J
   Mikkilä, V
   Lemaitre, RN
   Eriksson, J
   Musani, SK
   Tanaka, T
   Geller, F
   Luan, J
   Hui, J
   Mägi, R
   Dimitriou, M
   Garcia, ME
   Ho, WK
   Wright, MJ
   Rose, LM
   Magnusson, PKE
   Pedersen, NL
   Couper, D
   Oostra, BA
   Hofman, A
   Ikram, MA
   Tiemeier, HW
   Uitterlinden, AG
   van Rooij, FJA
   Barroso, I
   Johansson, I
   Xue, L
   Kaakinen, M
   Milani, L
   Power, C
   Snieder, H
   Stolk, RP
   Baumeister, SE
   Biffar, R
   Gu, F
   Bastardot, F
   Kutalik, Z
   Jacobs, DR 
   Forouhi, NG
   Mihailov, E
   Lind, L
   Lindgren, C
   Michaëlsson, K
   Morris, A
   Jensen, M
   Khaw, KT
   Luben, RN
   Wang, JJ
   Männistö, S
   Perälä, MM
   Kähönen, M
   Lehtimäki, T
   Viikari, J
   Mozaffarian, D
   Mukamal, K
   Psaty, BM
   Döring, A
   Heath, AC
   Montgomery, GW
   Dahmen, N
   Carithers, T
   Tucker, KL
   Ferrucci, L
   Boyd, HA
   Melbye, M
   Treur, JL
   Mellström, D
   Hottenga, JJ
   Prokopenko, I
   Tönjes, A
   Deloukas, P
   Kanoni, S
   Lorentzon, M
   Houston, DK
   Liu, Y
   Danesh, J
   Rasheed, A
   Mason, MA
   Zonderman, AB
   Franke, L
   Kristal, BS
   Karjalainen, J
   Reed, DR
   Westra, HJ
   Evans, MK
   Saleheen, D
   Harris, TB
   Dedoussis, G
   Curhan, G
   Stumvoll, M
   Beilby, J
   Pasquale, LR
   Feenstra, B
   Bandinelli, S
   Ordovas, JM
   Chan, AT
   Peters, U
   Ohlsson, C
   Gieger, C
   Martin, NG
   Waldenberger, M
   Siscovick, DS
   Raitakari, O
   Eriksson, JG
   Mitchell, P
   Hunter, DJ
   Kraft, P
   Rimm, EB
   Boomsma, DI
   Borecki, IB
   Loos, RJF
   Wareham, NJ
   Vollenweider, P
   Caporaso, N
   Grabe, HJ
   Neuhouser, ML
   Wolffenbuttel, BHR
   Hu, FB
   Hyppönen, E
   Järvelin, MR
   Cupples, LA
   Franks, PW
   Ridker, PM
   van Duijn, CM
   Heiss, G
   Metspalu, A
   North, KE
   Ingelsson, E
   Nettleton, JA
   van Dam, RM
   Chasman, DI
AF Cornelis, M. C.
   Byrne, E. M.
   Esko, T.
   Nalls, M. A.
   Ganna, A.
   Paynter, N.
   Monda, K. L.
   Amin, N.
   Fischer, K.
   Renstrom, F.
   Ngwa, J. S.
   Huikari, V.
   Cavadino, A.
   Nolte, I. M.
   Teumer, A.
   Yu, K.
   Marques-Vidal, P.
   Rawal, R.
   Manichaikul, A.
   Wojczynski, M. K.
   Vink, J. M.
   Zhao, J. H.
   Burlutsky, G.
   Lahti, J.
   Mikkila, V.
   Lemaitre, R. N.
   Eriksson, J.
   Musani, S. K.
   Tanaka, T.
   Geller, F.
   Luan, J.
   Hui, J.
   Maegi, R.
   Dimitriou, M.
   Garcia, M. E.
   Ho, W-K
   Wright, M. J.
   Rose, L. M.
   Magnusson, P. K. E.
   Pedersen, N. L.
   Couper, D.
   Oostra, B. A.
   Hofman, A.
   Ikram, M. A.
   Tiemeier, H. W.
   Uitterlinden, A. G.
   van Rooij, F. J. A.
   Barroso, I.
   Johansson, I.
   Xue, L.
   Kaakinen, M.
   Milani, L.
   Power, C.
   Snieder, H.
   Stolk, R. P.
   Baumeister, S. E.
   Biffar, R.
   Gu, F.
   Bastardot, F.
   Kutalik, Z.
   Jacobs, D. R., Jr.
   Forouhi, N. G.
   Mihailov, E.
   Lind, L.
   Lindgren, C.
   Michaelsson, K.
   Morris, A.
   Jensen, M.
   Khaw, K-T
   Luben, R. N.
   Wang, J. J.
   Mannisto, S.
   Perala, M-M
   Kahonen, M.
   Lehtimaki, T.
   Viikari, J.
   Mozaffarian, D.
   Mukamal, K.
   Psaty, B. M.
   Doering, A.
   Heath, A. C.
   Montgomery, G. W.
   Dahmen, N.
   Carithers, T.
   Tucker, K. L.
   Ferrucci, L.
   Boyd, H. A.
   Melbye, M.
   Treur, J. L.
   Mellstrom, D.
   Hottenga, J. J.
   Prokopenko, I.
   Toenjes, A.
   Deloukas, P.
   Kanoni, S.
   Lorentzon, M.
   Houston, D. K.
   Liu, Y.
   Danesh, J.
   Rasheed, A.
   Mason, M. A.
   Zonderman, A. B.
   Franke, L.
   Kristal, B. S.
   Karjalainen, J.
   Reed, D. R.
   Westra, H-J
   Evans, M. K.
   Saleheen, D.
   Harris, T. B.
   Dedoussis, G.
   Curhan, G.
   Stumvoll, M.
   Beilby, J.
   Pasquale, L. R.
   Feenstra, B.
   Bandinelli, S.
   Ordovas, J. M.
   Chan, A. T.
   Peters, U.
   Ohlsson, C.
   Gieger, C.
   Martin, N. G.
   Waldenberger, M.
   Siscovick, D. S.
   Raitakari, O.
   Eriksson, J. G.
   Mitchell, P.
   Hunter, D. J.
   Kraft, P.
   Rimm, E. B.
   Boomsma, D. I.
   Borecki, I. B.
   Loos, R. J. F.
   Wareham, N. J.
   Vollenweider, P.
   Caporaso, N.
   Grabe, H. J.
   Neuhouser, M. L.
   Wolffenbuttel, B. H. R.
   Hu, F. B.
   Hyppoenen, E.
   Jarvelin, M-R
   Cupples, L. A.
   Franks, P. W.
   Ridker, P. M.
   van Duijn, C. M.
   Heiss, G.
   Metspalu, A.
   North, K. E.
   Ingelsson, E.
   Nettleton, J. A.
   van Dam, R. M.
   Chasman, D. I.
CA Coffee & Caffeine Genetics Consort
   Int Parkinson's Dis Genomics Conso
   North Amer Brain Expression Consor
   UK Brain Expression Consortium
TI Genome-wide meta-analysis identifies six novel loci associated with
   habitual coffee consumption
SO MOLECULAR PSYCHIATRY
LA English
DT Article
ID PROTEIN; CAFFEINE; GLUCOKINASE; INVOLVEMENT; VARIANTS; RECEPTOR;
   BINDING; BRAIN; BDNF
AB Coffee, a major dietary source of caffeine, is among the most widely consumed beverages in the world and has received considerable attention regarding health risks and benefits. We conducted a genome-wide (GW) meta-analysis of predominately regular-type coffee consumption (cups per day) among up to 91 462 coffee consumers of European ancestry with top single-nucleotide polymorphisms (SNPs) followed-up in similar to 30 062 and 7964 coffee consumers of European and African-American ancestry, respectively. Studies from both stages were combined in a trans-ethnic meta-analysis. Confirmed loci were examined for putative functional and biological relevance. Eight loci, including six novel loci, met GW significance (log(10)Bayes factor (BF) > 5.64) with per-allele effect sizes of 0.03-0.14 cups per day. Six are located in or near genes potentially involved in pharmacokinetics (ABCG2, AHR, POR and CYP1A2) and pharmacodynamics (BDNF and SLC6A4) of caffeine. Two map to GCKR and MLXIPL genes related to metabolic traits but lacking known roles in coffee consumption. Enhancer and promoter histone marks populate the regions of many confirmed loci and several potential regulatory SNPs are highly correlated with the lead SNP of each. SNP alleles near GCKR, MLXIPL, BDNF and CYP1A2 that were associated with higher coffee consumption have previously been associated with smoking initiation, higher adiposity and fasting insulin and glucose but lower blood pressure and favorable lipid, inflammatory and liver enzyme profiles (P < 5x10(-8)). Our genetic findings among European and African-American adults reinforce the role of caffeine in mediating habitual coffee consumption and may point to molecular mechanisms underlying inter-individual variability in pharmacological and health effects of coffee.
C1 [Cornelis, M. C.; Mozaffarian, D.; Curhan, G.; Pasquale, L. R.; Chan, A. T.; Hunter, D. J.; Rimm, E. B.; Hu, F. B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02215 USA.
   [Cornelis, M. C.; Jensen, M.; Mozaffarian, D.; Rimm, E. B.; Hu, F. B.; Franks, P. W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02215 USA.
   [Byrne, E. M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.
   [Esko, T.; Fischer, K.; Maegi, R.; Milani, L.; Mihailov, E.; Metspalu, A.] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia.
   [Esko, T.] Childrens Hosp Boston, Div Endocrinol, Boston, MA USA.
   [Esko, T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA.
   [Esko, T.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA.
   [Nalls, M. A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.
   [Ganna, A.; Magnusson, P. K. E.; Pedersen, N. L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Karolinska, Sweden.
   [Paynter, N.; Rose, L. M.; Ridker, P. M.; Chasman, D. I.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA.
   [Monda, K. L.; Heiss, G.; North, K. E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA.
   [Amin, N.; Hofman, A.; Ikram, M. A.; Tiemeier, H. W.; Uitterlinden, A. G.; van Rooij, F. J. A.; van Duijn, C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.
   [Renstrom, F.; Franks, P. W.] Lund Univ, Dept Clin Sci, Malmo, Sweden.
   [Ngwa, J. S.; Xue, L.; Cupples, L. A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA.
   [Huikari, V.; Kaakinen, M.; Jarvelin, M-R] Univ Oulu, Inst Hlth Sci, Oulu, Finland.
   [Cavadino, A.; Power, C.; Hyppoenen, E.] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, Ctr Epidemiol Child Hlth,MRC, London, England.
   [Nolte, I. M.; Snieder, H.; Stolk, R. P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.
   [Teumer, A.] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany.
   [Yu, K.; Gu, F.; Caporaso, N.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.
   [Marques-Vidal, P.] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland.
   [Rawal, R.; Gieger, C.] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Munich, Germany.
   [Manichaikul, A.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA.
   [Wojczynski, M. K.; Borecki, I. B.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA.
   [Vink, J. M.; Treur, J. L.; Hottenga, J. J.; Boomsma, D. I.] Vrije Univ Amsterdam, Dept Biol Psychol Netherlands Twin Register, Amsterdam, Netherlands.
   [Zhao, J. H.; Luan, J.; Forouhi, N. G.; Loos, R. J. F.; Wareham, N. J.] Univ Cambridge, Epidemiol Unit, MRC, Cambridge, England.
   [Burlutsky, G.; Wang, J. J.; Mitchell, P.] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia.
   [Burlutsky, G.; Wang, J. J.; Mitchell, P.] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia.
   [Lahti, J.] Univ Helsinki, Inst Behav Sci, Helsinki, Finland.
   [Lahti, J.; Eriksson, J. G.] Folkhalsan Res Ctr, Helsinki, Finland.
   [Mikkila, V.] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.
   [Mikkila, V.; Raitakari, O.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland.
   [Mikkila, V.; Raitakari, O.] Turku Univ Hosp, FIN-20520 Turku, Finland.
   [Lemaitre, R. N.; Psaty, B. M.; Siscovick, D. S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA.
   [Eriksson, J.; Mellstrom, D.; Lorentzon, M.; Ohlsson, C.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden.
   [Musani, S. K.] Univ Mississippi, Med Ctr, Jackson, MI USA.
   [Tanaka, T.; Ferrucci, L.] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
   [Geller, F.; Boyd, H. A.; Melbye, M.; Feenstra, B.] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.
   [Hui, J.; Beilby, J.] Busselton Populat Med Res Fdn Inc, Busselton, WA, Australia.
   [Hui, J.; Beilby, J.] PathWest Lab Med, Nedlands, WA, Australia.
   [Hui, J.; Beilby, J.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia.
   [Hui, J.] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia.
   [Dimitriou, M.; Dedoussis, G.] Harokopio Univ, Athens, Greece.
   [Garcia, M. E.; Harris, T. B.] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA.
   [Ho, W-K; Khaw, K-T; Luben, R. N.; Danesh, J.; Saleheen, D.] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England.
   [Wright, M. J.; Montgomery, G. W.; Martin, N. G.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [Couper, D.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA.
   [Oostra, B. A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.
   [Ikram, M. A.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands.
   [Ikram, M. A.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Tiemeier, H. W.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands.
   [Uitterlinden, A. G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.
   [Barroso, I.; Deloukas, P.] Wellcome Trust Sanger Inst, Cambridge, England.
   [Barroso, I.] Univ Cambridge, Metab Res Labs, Cambridge, England.
   [Barroso, I.] NIHR Cambridge Biomed Res Ctr, Cambridge, England.
   [Johansson, I.] Umea Univ, Dept Odontol, Umea, Sweden.
   [Kaakinen, M.; Jarvelin, M-R] Univ Oulu, Bioctr Oulu, Oulu, Finland.
   [Kaakinen, M.; Jarvelin, M-R] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC Hlth Protect Agcy HPE, Ctr Environm & Hlth,Sch Publ Hlth, London SW7 2AZ, England.
   [Baumeister, S. E.] Univ Med Greifswald, Inst Community Med, Greifswald, Germany.
   [Biffar, R.] Univ Med Greifswald, Ctr Oral Hlth, Dept Prosthodont Gerodontol & Biomat, Greifswald, Germany.
   [Bastardot, F.; Vollenweider, P.] CHU Vaudois, Dept Internal Med, Lausanne, Switzerland.
   [Bastardot, F.; Stumvoll, M.] Univ Lausanne, Lausanne, Switzerland.
   [Kutalik, Z.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.
   [Kutalik, Z.] CHU Vaudois, Inst Social & Prevent Med IUMSP, CH-1011 Lausanne, Switzerland.
   [Kutalik, Z.] Swiss Inst Bioinformat, Lausanne, Switzerland.
   [Jacobs, D. R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA.
   [Lind, L.; Ingelsson, E.] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden.
   [Lindgren, C.; Morris, A.; Prokopenko, I.; Ingelsson, E.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Michaelsson, K.] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.
   [Mannisto, S.; Perala, M-M] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.
   [Kahonen, M.] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland.
   [Kahonen, M.; Lehtimaki, T.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland.
   [Lehtimaki, T.] Univ Tampere, Fimlab Labs, Dept Clin Chem, FIN-33101 Tampere, Finland.
   [Viikari, J.] Univ Turku, Dept Med, Turku, Finland.
   [Viikari, J.] Turku Univ Hosp, FIN-20520 Turku, Finland.
   [Mozaffarian, D.; Rimm, E. B.; Hu, F. B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Mozaffarian, D.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.
   [Mukamal, K.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Psaty, B. M.; Siscovick, D. S.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA.
   [Psaty, B. M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA.
   [Psaty, B. M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA.
   [Doering, A.] Helmholtz Zentrum Munchen, Inst Epidemiol, Munich, Germany.
   [Heath, A. C.] Washington Univ, Dept Psychiat, St Louis, MO USA.
   [Dahmen, N.] Johannes Gutenberg Univ Mainz, Dept Psychiat, Mainz, Germany.
   [Carithers, T.] Univ Mississippi, Sch Appl Sci, Oxford, MS USA.
   [Tucker, K. L.] Univ MA Lowell, Clin Lab & Nutr Sci, Lowell, MA USA.
   [Prokopenko, I.] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London, England.
   [Toenjes, A.; Stumvoll, M.] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany.
   [Toenjes, A.; Stumvoll, M.] Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany.
   [Deloukas, P.; Kanoni, S.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.
   [Deloukas, P.] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia.
   [Houston, D. K.] Wake Forest Sch Med, Winston Salem, NC USA.
   [Houston, D. K.; Liu, Y.] Wake Forest Univ Hlth Sci, Winston Salem, NC USA.
   [Rasheed, A.; Saleheen, D.] Ctr Noncommunicable Dis, Karachi, Pakistan.
   [Mason, M. A.; Evans, M. K.] NIA, Hlth Dispar Res Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA.
   [Zonderman, A. B.] NIA, Lab Personal & Cognit, NIH, Baltimore, MD 21224 USA.
   [Franke, L.; Karjalainen, J.; Westra, H-J] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.
   [Kristal, B. S.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA.
   [Kristal, B. S.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.
   [Reed, D. R.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA.
   [Pasquale, L. R.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA.
   [Bandinelli, S.] Azienda Sanitaria Firenze, Geriatr Unit, Florence, Italy.
   [Ordovas, J. M.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA.
   [Chan, A. T.] MA Gen Hosp, Div Gastroenterol, Boston, MA USA.
   [Peters, U.; Neuhouser, M. L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA.
   [Waldenberger, M.] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Munich, Germany.
   [Raitakari, O.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland.
   [Eriksson, J. G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland.
   [Eriksson, J. G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland.
   [Hunter, D. J.; Kraft, P.] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA.
   [Loos, R. J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA.
   [Loos, R. J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA.
   [Grabe, H. J.] Univ Med Greifswald, HELIOS Hosp Stralsund, Dept Psychiat & Psychotherapy, Greifswald, Germany.
   [Wolffenbuttel, B. H. R.] Univ Groningen, Dept Endocrinol, Univ Med Ctr Groningen, Groningen, Netherlands.
   [Hyppoenen, E.] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5001, Australia.
   [Hyppoenen, E.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.
   [Jarvelin, M-R] Natl Inst Hlth & Welf, Dept Children & Young People & Families, Oulu, Finland.
   [Jarvelin, M-R] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland.
   [Cupples, L. A.] Framingham Heart Dis Epidemiol Study, Framingham, MA USA.
   [Franks, P. W.] Umea Univ, Med Sect, Dept Publ Hlth & Clin Med, Umea, Sweden.
   [van Duijn, C. M.] Netherlands Consortium Hlth Ageing, Leiden, Netherlands.
   [van Duijn, C. M.] Natl Genom Initiat, Leiden, Netherlands.
   [Nettleton, J. A.] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.
   [van Dam, R. M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.
   [van Dam, R. M.] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore.
   [van Dam, R. M.] Natl Univ Hlth Syst, Singapore, Singapore.
C3 Harvard University; Harvard Medical School; Harvard University Medical
   Affiliates; Brigham & Women's Hospital; Harvard University; Harvard T.H.
   Chan School of Public Health; University of Queensland; University of
   Tartu; Harvard University; Harvard University Medical Affiliates; Boston
   Children's Hospital; Harvard University; Harvard Medical School; Harvard
   University; Massachusetts Institute of Technology (MIT); Broad
   Institute; National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA); Karolinska Institutet; Harvard University;
   Harvard University Medical Affiliates; Brigham & Women's Hospital;
   Harvard Medical School; University of North Carolina; University of
   North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus MC;
   Lund University; Boston University; University of Oulu; University of
   London; University College London; University of Groningen; Universitat
   Greifswald; Greifswald Medical School; National Institutes of Health
   (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Cancer
   Institute- Division of Cancer Epidemiology & Genetics; University of
   Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Helmholtz
   Association; Helmholtz-Center Munich - German Research Center for
   Environmental Health; University of Virginia; Washington University
   (WUSTL); Vrije Universiteit Amsterdam; University of Cambridge;
   University of Sydney; University of Sydney; Westmead Institute for
   Medical Research; University of Helsinki; Folkhalsan Research Center;
   University of Helsinki; University of Turku; University of Turku;
   University of Washington; University of Washington Seattle; University
   of Gothenburg; University of Mississippi Medical Center; University of
   Mississippi; National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA); Statens Serum Institut; Pathwest Laboratory
   Medicine; University of Western Australia; University of Western
   Australia; University of Western Australia; Harokopio University Athens;
   National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); University of Cambridge; QIMR Berghofer Medical Research
   Institute; University of North Carolina; University of North Carolina
   Chapel Hill; Erasmus University Rotterdam; Erasmus MC; Erasmus
   University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus
   MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University
   Rotterdam; Erasmus MC; Wellcome Trust Sanger Institute; University of
   Cambridge; University of Cambridge; Umea University; University of Oulu;
   Imperial College London; Universitat Greifswald; Greifswald Medical
   School; Universitat Greifswald; Greifswald Medical School; University of
   Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of
   Lausanne; University of Lausanne; University of Lausanne; Centre
   Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of
   Bioinformatics; University of Minnesota System; University of Minnesota
   Twin Cities; Uppsala University; University of Oxford; Wellcome Centre
   for Human Genetics; Uppsala University; Finland National Institute for
   Health & Welfare; Tampere University; Tampere University Hospital;
   Tampere University; Tampere University; University of Turku; University
   of Turku; Harvard University; Harvard T.H. Chan School of Public Health;
   Tufts University; Harvard University; Harvard University Medical
   Affiliates; Beth Israel Deaconess Medical Center; University of
   Washington; University of Washington Seattle; University of Washington;
   University of Washington Seattle; Group Health Cooperative; Helmholtz
   Association; Helmholtz-Center Munich - German Research Center for
   Environmental Health; Washington University (WUSTL); Johannes Gutenberg
   University of Mainz; University of Mississippi; University of
   Massachusetts System; University of Massachusetts Lowell; Imperial
   College London; Leipzig University; Leipzig University; University of
   London; Queen Mary University London; King Abdulaziz University; Wake
   Forest University; Wake Forest University; Wake Forest University School
   of Medicine; National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH
   National Institute on Aging (NIA); University of Groningen; Harvard
   University; Harvard University Medical Affiliates; Brigham & Women's
   Hospital; Harvard University; Harvard Medical School; Monell Chemical
   Senses Center; Harvard University; Harvard University Medical
   Affiliates; Massachusetts Eye & Ear Infirmary; Azienda Sanitaria di
   Firenze; Tufts University; United States Department of Agriculture
   (USDA); Fred Hutchinson Cancer Center; Helmholtz Association;
   Helmholtz-Center Munich - German Research Center for Environmental
   Health; University of Turku; University of Helsinki; University of
   Helsinki; Helsinki University Central Hospital; Harvard University;
   Harvard T.H. Chan School of Public Health; Icahn School of Medicine at
   Mount Sinai; Icahn School of Medicine at Mount Sinai; Universitat
   Greifswald; Greifswald Medical School; University of Groningen;
   University of South Australia; South Australian Health & Medical
   Research Institute (SAHMRI); Finland National Institute for Health &
   Welfare; University of Oulu; Framingham Heart Study; Umea University;
   University of Texas System; University of Texas Health Science Center
   Houston; National University of Singapore; National University of
   Singapore; National University of Singapore
RP Cornelis, MC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 401 Pk Dr, Boston, MA 02215 USA.
EM mcorneli@hsph.harvard.edu; dchasman@research.bwh.harvard.edu
RI Forouhi, Nita/JAC-2361-2023; Luben, Robert/KIC-1257-2024; Jacobs,
   David/G-5405-2011; Bick, Alexander/A-9429-2012; ,
   Uitterlinden/AFV-9968-2022; Tucker, Katherine/A-4545-2010; Ellervik,
   Christina/H-2977-2019; Deloukas, Panos/B-2922-2013; Evans,
   Michele/AAE-4776-2019; Hunter, David/HRA-2096-2023; Kanoni,
   Stavroula/AAN-7161-2021; Mukamal, Kenneth/GVR-7978-2022; Wang,
   Jie/P-1499-2014; Ikram, M./AAM-5225-2021; Hu, Frank/C-1919-2013; Hui,
   Jennie/A-9543-2013; Baumeister, Sebastian-Edgar/P-7894-2019; Cavadino,
   Alana/CAG-8915-2022; van Rooij, Frank/AAI-3997-2020; Prokopenko,
   Inga/AAU-9895-2020; Vink, Jacqueline/A-7648-2012; Tiemeier,
   Henning/H-6534-2019; Pedersen, Nancy/ADM-3900-2022; Loos,
   Ruth/AFU-8669-2022; Milani, Lili/N-1097-2019; Lehtimäki,
   Terho/AAD-1094-2022; Dedoussis, George/AAN-7252-2021; Ferrucci,
   Luigi/AED-9724-2022; Fischer, Krista/AFK-0237-2022; Mägi,
   Reedik/AAJ-9679-2021; Michaelsson, Karl/AAM-9094-2021; Lahti,
   Jari/P-2283-2019; Martin, Nicholas/R-9235-2019; Timpson,
   Nicholas/O-7548-2015; Kutalik, Zoltan/HHZ-5697-2022; Stumvoll,
   Michael/ABE-1121-2021; Manichaikul, Ani/B-7726-2009; Stolk,
   Ronald/B-2341-2013; van Dam, Rob/F-9674-2010; Garcia-Closas,
   Montserrat/F-3871-2015; Lind, Lars/KAM-1968-2024; bandinelli,
   stefania/AAL-4570-2020; Chan, Andrew/ADM-9271-2022; Singleton,
   Andrew/C-3010-2009; Franks, Paul/AAA-3300-2020; Kraft,
   Peter/GQH-8448-2022; Karjalainen, Juha/P-8624-2016; Raitakari,
   Olli/AAQ-7389-2021; Khaw, Kay-Tee/AAZ-3209-2021; van Leeuwen,
   Elisabeth/G-3382-2017; Waldenberger, Melanie/B-5355-2014; Zonderman,
   Alan/A-5807-2013; Boomsma, Dorret/AAX-4470-2020; Gieger,
   Christian/A-3083-2013; Mitchell, Paul/P-1498-2014; Gibbs, J.
   Raphael/A-3984-2010; Lorentzon, Mattias/W-7878-2019; Ohlsson,
   Claes/AGP-3544-2022; Amin, Najaf/D-1859-2012; Morris, Huw/B-8527-2008;
   Hardy, John/C-2451-2009; Wood, Nicholas/C-2505-2009; Ohlsson,
   Claes/HIR-6959-2022; Weale, Michael/F-2587-2010; van Dam,
   Rob/A-6693-2009; Milani, Lili/C-8759-2011; Wright, Margaret/A-4560-2016;
   Prokopenko, Inga/H-3241-2014; Rivadeneira, Fernando/O-5385-2015;
   Marques-Vidal, Pedro/C-9449-2009; Montgomery, Grant/B-7148-2008; Byrne,
   Enda/J-6068-2014; Franke, Lude/P-7036-2016; Loos, Ruth/Q-2862-2016;
   Vollenweider, Peter/Q-4603-2016; Bastardot, Francois/J-4013-2017;
   Hypponen, Elina/B-2596-2014; Lahti, Jari/P-7987-2018; Magnusson,
   Patrik/C-4458-2017; corvol, jean-christophe/I-6387-2012; Schapira,
   Anthony/A-1245-2010; Teumer, Alexander/S-7438-2019
OI Gasser, Thomas/0000-0002-1069-1146; Hudson, Gavin/0000-0001-7210-2733;
   Carithers, Teresa/0000-0001-9876-8779; de Bie, Rob/0000-0001-5267-0784;
   Morris, Huw/0000-0002-5473-3774; Hardy, John/0000-0002-3122-0423;
   Michaelsson, Karl/0000-0003-2815-1217; Wood,
   Nicholas/0000-0002-9500-3348; Zonderman, Alan B/0000-0002-6523-4778;
   Lehtimaki, Terho/0000-0002-2555-4427; Ohlsson,
   Claes/0000-0002-9633-2805; Talbot, Kevin/0000-0001-5490-1697; Deloukas,
   Panos/0000-0001-9251-070X; Ganna, Andrea/0000-0002-8147-240X; Amin,
   Najaf/0000-0002-8944-1771; Martin, Nicholas/0000-0003-4069-8020;
   Ferrucci, Luigi/0000-0002-6273-1613; Morrison, Karen
   Elaine/0000-0003-0216-5717; Perala, Mia-Maria/0000-0002-6349-6301;
   Venkatasubramanian, Siddharth/0000-0002-5860-0768; Guerreiro,
   Rita/0000-0001-5879-3486; Lambert, Jean-Charles/0000-0003-0829-7817; Van
   Duijn, Cornelia/0000-0002-2374-9204; Hu, Michele/0000-0001-6382-5841;
   Kahonen, Mika/0000-0002-4510-7341; Weale, Michael/0000-0003-4593-1186;
   Forouhi, Nita/0000-0002-5041-248X; van Dam, Rob/0000-0002-7354-8734;
   Tucker, Katherine/0000-0001-7640-662X; Stolk,
   Ronald/0000-0002-0518-1205; Cupples, L. Adrienne/0000-0003-0273-7965;
   Milani, Lili/0000-0002-5323-3102; Lindgren, Cecilia/0000-0002-4903-9374;
   van Rooij, Frank/0000-0002-8600-9852; Kaakinen,
   Marika/0000-0002-9228-0462; Hui, Jennie/0000-0002-1653-2496; Lorentzon,
   Mattias/0000-0003-0749-1431; Wright, Margaret/0000-0001-7133-4970;
   Kutalik, Zoltan/0000-0001-8285-7523; Prokopenko,
   Inga/0000-0003-1624-7457; Geller, Frank/0000-0002-9238-3269; Kanoni,
   Stavroula/0000-0002-1691-9615; Wolffenbuttel, Bruce
   H.R./0000-0001-9262-6921; Rivadeneira, Fernando/0000-0001-9435-9441;
   Schulte, Claudia/0000-0003-4006-1265; Mannisto,
   Satu/0000-0002-8668-3046; Gardner, Michelle/0009-0008-4479-5366; Evans,
   Michele/0000-0002-8546-2831; Heutink, Peter/0000-0001-5218-1737;
   Uitterlinden, Andre G/0000-0002-7276-3387; Feenstra,
   Bjarke/0000-0003-1478-649X; Chinnery, Patrick/0000-0002-7065-6617;
   Jonsson, Palmi V/0009-0002-7174-2274; Marques-Vidal,
   Pedro/0000-0002-4548-8500; Montgomery, Grant/0000-0002-4140-8139;
   Gieger, Christian/0000-0001-6986-9554; Berendse,
   Henk/0000-0002-9189-3662; Byrne, Enda/0000-0002-9491-7797; Ikram,
   Mohammad Arfan/0000-0003-0372-8585; Stumvoll,
   Michael/0000-0001-6225-8240; HO, WEANG KEE/0000-0002-8269-7344;
   Bandinelli, Stefania/0000-0002-6491-0850; Jarvelin,
   Marjo-Riitta/0000-0002-2149-0630; Franke, Lude/0000-0002-5159-8802;
   Loos, Ruth/0000-0002-8532-5087; , Danish National
   Biobank/0009-0006-7615-7073; Couper, David/0000-0002-4313-9235;
   Vollenweider, Peter/0000-0002-0765-896X; Magi,
   Reedik/0000-0002-2964-6011; Jensen, Majken Karoline/0000-0003-4729-7545;
   Dong, Jing/0000-0001-9856-5963; Bastardot, Francois/0000-0003-4060-0353;
   Brice, Alexis/0000-0002-0941-3990; Deuschl, Gunther/0000-0002-4176-9196;
   Hypponen, Elina/0000-0003-3670-9399; Mellstrom, Dan/0000-0003-2761-3723;
   Eriksson, Johan/0000-0002-2516-2060; Edkins, Sarah/0000-0003-0717-1972;
   Lahti, Jari/0000-0002-4310-5297; Magnusson, Patrik/0000-0002-7315-7899;
   Esko, Tonu/0000-0003-1982-6569; Counsell, Carl/0000-0001-6622-7839;
   melbye, mads/0000-0001-8264-6785; Boyd, Heather/0000-0001-6849-9985;
   Ramasamy, Adaikalavan/0000-0002-7598-2892; corvol,
   jean-christophe/0000-0001-7325-0199; Tonjes, Anke/0009-0005-1944-1812;
   Jacobs, David/0000-0002-7232-0543; Luben, Robert/0000-0002-5088-6343;
   Gibbs, J. Raphael/0000-0002-6985-0658; , Mary K/0000-0002-2420-162X;
   Plagnol, Vincent/0000-0002-5597-9215; Tiemeier,
   Henning/0000-0002-4395-1397; Rawal, Rajesh/0000-0002-0151-9344;
   Cavadino, Alana/0000-0002-5709-367X; Schapira,
   Anthony/0000-0002-3018-3966; Burn, David/0000-0001-7658-1209; Houston,
   Denise/0000-0002-3355-4304; Franks, Paul/0000-0002-0520-7604;
   Williams-Gray, Caroline/0000-0002-2648-9743; Teumer,
   Alexander/0000-0002-8309-094X; Chen, Honglei/0000-0003-3446-7779; Treur,
   Jorien/0000-0003-4370-3390
FU MRC [MC_UU_12015/1, MC_UP_A100_1003, MC_UU_12015/5, MR/L003120/1]
   Funding Source: UKRI
CR Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x
   Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101
   Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357
   Byrne EM, 2012, SLEEP, V35, P967, DOI 10.5665/sleep.1962
   Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964
   Carter MJ, 2014, THER RECREAT J, V48, P275
   Cornelis M. C., 2014, Current Nutrition Reports, V3, P178
   Cornelis MC, 2012, PROG MOL BIOL TRANSL, V108, P293, DOI 10.1016/B978-0-12-398397-8.00012-5
   Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906
   Franceschini N, 2012, AM J HUM GENET, V91, P744, DOI 10.1016/j.ajhg.2012.08.021
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571
   Hindorff L.A., 2013, A Catalog of Published Genome-Wide Association Studies
   Hu L, 2012, PHARMACOGENET GENOM, V22, P812, DOI 10.1097/FPC.0b013e328358d92b
   Jorge-Nebert LF, 2010, HUM MUTAT, V31, P27, DOI 10.1002/humu.21132
   Kot M, 2008, BIOCHEM PHARMACOL, V76, P543, DOI 10.1016/j.bcp.2008.05.025
   Le Vee M, 2010, TOXICOL IN VITRO, V24, P1775, DOI 10.1016/j.tiv.2010.07.001
   Ledda M, 2014, HUM MOL GENET, V23, P259, DOI 10.1093/hmg/ddt404
   Lindskog M, 2002, NATURE, V418, P774, DOI 10.1038/nature00817
   Mägi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288
   Nosrat IV, 2012, J BIOL CHEM, V287, P16791, DOI 10.1074/jbc.M111.328476
   Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237
   Pandey AV, 2013, PHARMACOL THERAPEUT, V138, P229, DOI 10.1016/j.pharmthera.2013.01.010
   Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324
   Rome S, 2009, DIABETOLOGIA, V52, P1899, DOI 10.1007/s00125-009-1442-4
   Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108
   Segrè AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058
   Sellke T, 2001, AM STAT, V55, P62, DOI 10.1198/000313001300339950
   Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982
   Söderberg MM, 2013, PHARMACOGENET GENOM, V23, P279, DOI 10.1097/FPC.0b013e3283602876
   Spiller M.A., 1998, Caffeine, P97
   Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Swanson HI, 2002, CHEM-BIOL INTERACT, V141, P63, DOI 10.1016/S0009-2797(02)00066-2
   Vinkhuyzen AAE, 2013, ANNU REV GENET, V47, P75, DOI 10.1146/annurev-genet-111212-133258
   Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340
   Woodward OM, 2013, P NATL ACAD SCI USA, V110, P5223, DOI 10.1073/pnas.1214530110
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213
   Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011
NR 42
TC 202
Z9 210
U1 0
U2 88
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1359-4184
EI 1476-5578
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD MAY
PY 2015
VL 20
IS 5
BP 647
EP 656
DI 10.1038/mp.2014.107
PG 10
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA CH0JS
UT WOS:000353706400016
PM 25288136
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Bahmannia, M
   Azizzade, M
   Heydari, S
   Nasrollahzadeh, J
   Rabiei, S
   Naja, F
   Mobarakeh, ZS
   Hejazi, J
   Hejazi, E
AF Bahmannia, Mahsa
   Azizzade, Maryam
   Heydari, Sahar
   Nasrollahzadeh, Javad
   Rabiei, Samira
   Naja, Farah
   Mobarakeh, Zahra Sheikhi
   Hejazi, Jalal
   Hejazi, Ehsan
TI Effects of decaffeinated green coffee extract supplementation on
   anthropometric indices, blood glucose, leptin, adiponectin and
   neuropeptide Y (NPY) in breast cancer survivors: a randomized clinical
   trial
SO FOOD & FUNCTION
LA English
DT Article
ID CHLOROGENIC ACID; BEAN EXTRACT; WEIGHT-LOSS; INSULIN-RESISTANCE;
   GLYCEMIC CONTROL; CAFFEINE INTAKE; DOUBLE-BLIND; OVERWEIGHT; OBESITY;
   ACCUMULATION
AB Objective: This study aimed to evaluate the effects of decaffeinated green coffee extract (DGCE) supplementation on anthropometric indices, blood glucose, leptin, adiponectin, and neuropeptide Y (NPY) in breast cancer survivors with obesity. Method: A total of 44 breast cancer survivors with obesity aged between 18 and 70 years and with a mean body mass index (BMI) of 31.62 +/- 4.97 kg m(-2) participated in this double-blind randomized clinical trial. Eligible patients were randomized to the intervention (n = 22) and control (n = 22) groups. They received two 400 mg capsules of DGCE or two identical placebos daily for 12 weeks. Serum concentrations of leptin, adiponectin, NPY, fasting blood sugar, insulin, and homeostatic model assessment for insulin resistance (HOMA-IR) were measured at the baseline and after completion of the intervention. Also, weight, waist circumference, fat percentage, muscle percentage, and visceral fat were measured. Results: There were no significant differences in terms of changes of anthropometric indices and concentrations of leptin, adiponectin, NPY, and blood sugar between the two studied groups. Conclusion: Supplementation with DGCE in breast cancer survivors with obesity had no significant effect on anthropometric indices and blood glucose, leptin, adiponectin, and NPY levels.
C1 [Bahmannia, Mahsa; Azizzade, Maryam; Heydari, Sahar; Nasrollahzadeh, Javad; Rabiei, Samira; Hejazi, Ehsan] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Natl Nutr & Food Technol Res Inst, Dept Clin Nutr & Dietet, Tehran, Iran.
   [Azizzade, Maryam; Heydari, Sahar] Shahid Beheshti Univ Med Sci, Dept & Fac Nutr Sci & Food Technol, Student Res Comm, Tehran, Iran.
   [Naja, Farah] Amer Univ Beirut, Fac Agr & Food Sci, Dept Nutr & Food Sci, Beirut, Lebanon.
   [Mobarakeh, Zahra Sheikhi] ACECR, Motamed Canc Inst, Qual Life Dept, Breast Canc Res Ctr, Acecr, Iran.
   [Hejazi, Jalal] Zanjan Univ Med Sci, Fac Med, Dept Nutr, Zanjan, Iran.
C3 Shahid Beheshti University Medical Sciences; Shahid Beheshti University
   Medical Sciences; American University of Beirut; Academic Center for
   Education, Culture & Research (ACECR)
RP Hejazi, E (corresponding author), Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Natl Nutr & Food Technol Res Inst, Dept Clin Nutr & Dietet, Tehran, Iran.; Mobarakeh, ZS (corresponding author), ACECR, Motamed Canc Inst, Qual Life Dept, Breast Canc Res Ctr, Acecr, Iran.
EM dr.shaikhi88@gmail.com; ehsanhejazi@sbmu.ac.ir
RI Nasrollahzadeh, Javad/AIE-5000-2022; Rabiei, Samira/T-8057-2017;
   Sheikhi, Zahra/AAH-7423-2019; hejazi, ehsan/ABI-4715-2022; Hejazi,
   Jalal/G-9084-2012
OI Sheikhi, Zahra/0000-0002-5670-1012; Hejazi, Jalal/0000-0003-4021-6650
FU Shahid Beheshti University of Medical Sciences, Tehran, Iran [13367]
FX We acknowledge Shahid Beheshti University of Medical Sciences, Tehran,
   Iran for financial and technical support of this project (13367). Also
   we would like to thank all the study subjects who participated in this
   study.
CR Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887
   Bhaktha G, 2015, J CLIN DIAGN RES, V9, pBC1, DOI 10.7860/JCDR/2015/10587.5371
   Brothers SP, 2010, EMBO MOL MED, V2, P429, DOI 10.1002/emmm.201000100
   Chen Y, 2020, PHYTOTHER RES, V34, P2159, DOI 10.1002/ptr.6667
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   Emens LA, 2005, CANCER RES, V65, P8059, DOI 10.1158/0008-5472.CAN-05-1797
   Faraji H, 2019, PROG NUTR, V21, P744, DOI 10.23751/pn.v21i4.6557
   Fukagawa S, 2017, BIOSCI BIOTECH BIOCH, V81, P1814, DOI 10.1080/09168451.2017.1345614
   Greenberg JA, 2012, J AM COLL NUTR, V31, P160, DOI 10.1080/07315724.2012.10720023
   Grönberg M, 2012, ACTA ONCOL, V51, P386, DOI 10.3109/0284186X.2011.631576
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Hosseinabadi S, 2020, J HERB MED, V22, DOI 10.1016/j.hermed.2020.100340
   Hosseinabadi S, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2019.102290
   Icken D, 2016, EUR J CLIN NUTR, V70, P532, DOI 10.1038/ejcn.2015.183
   Izadi V, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_37_14
   Jiang WJ, 2013, GYNECOL ONCOL, V129, P620, DOI 10.1016/j.ygyno.2013.03.014
   Jin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120842
   Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042
   Madsen EL, 2008, EUR J ENDOCRINOL, V158, P179, DOI 10.1530/EJE-07-0721
   Mansour A, 2021, NUTR J, V20, DOI 10.1186/s12937-021-00694-5
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Mills CE, 2013, FOOD CHEM, V141, P3335, DOI 10.1016/j.foodchem.2013.06.014
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Nikpayam O, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0489-8
   Nugroho DA., 2017, Asian J Pharmaceutical Clin Res, V10, P279, DOI [10.2159/ajpcr.2017.v10i9.19329, DOI 10.2159/AJPCR.2017.V10I9.19329, 10.12688/f1000research.55470.1, DOI 10.22159/AJPCR.2017.V10I9.19329]
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Owumi S. E., 2021, Toxicology Research, V10, P345, DOI 10.1093/toxres/tfab002
   Owumi SE, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13615
   Parida S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102519
   Park JuYeon Park JuYeon, 2010, Korean Journal of Nutrition, V43, P374
   Porter GA, 2006, ANN SURG ONCOL, V13, P327, DOI 10.1245/ASO.2006.03.049
   Pribyl M I., 2011, International journal of exercise science, V4, P2
   Ricci R, 2012, VET J, V191, P292, DOI 10.1016/j.tvjl.2011.04.009
   Rock CL, 2015, J CLIN ONCOL, V33, P3169, DOI 10.1200/JCO.2015.61.1095
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Salamat S., 2018, J BIOCHEM TECHNOL, V2, P75
   Shahmohammadi HA, 2017, HEPAT MON, V17, DOI 10.5812/hepatmon.45609
   SONG SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/718379
   Sun LJ, 2020, CRIT REV FOOD SCI, V60, P541, DOI 10.1080/10408398.2018.1544883
   Suzuki A, 2008, AM J HYPERTENS, V21, P23, DOI 10.1038/ajh.2007.3
   Vance V, 2011, OBES REV, V12, P282, DOI 10.1111/j.1467-789X.2010.00805.x
   Vinson, 2014, PHYTOTHER RES, V28, P946
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Wong RHX, 2014, NUTRIENTS, V6, P4881, DOI 10.3390/nu6114881
   Yang JS, 2012, IN VIVO, V26, P971
   Zheng GD, 2004, IN VIVO, V18, P55
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 59
TC 7
Z9 7
U1 0
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD OCT 3
PY 2022
VL 13
IS 19
BP 10347
EP 10356
DI 10.1039/d2fo00983h
EA SEP 2022
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 5B1GZ
UT WOS:000856039300001
PM 36134465
DA 2025-04-28
ER

PT J
AU Sirotkin, AV
   Kolesarova, A
AF Sirotkin, Alexander, V
   Kolesarova, Adriana
TI The Anti-Obesity and Health-Promoting Effects of Tea and Coffee
SO PHYSIOLOGICAL RESEARCH
LA English
DT Review
DE Obesity; Adipocyte; Tea; Coffee; Metabolism; Food consumption
ID GREEN TEA; BODY-WEIGHT; RESPONSE METAANALYSIS; METABOLIC SYNDROME;
   ANTIOXIDANT; MECHANISMS; OBESITY; HOMEOSTASIS; CONSUMPTION; HUMANS
AB This paper reviews provenance, chemical composition and properties of tea (Camelia sinensis L.) and coffee (Coffee arabica, L. and Coffea caniphora, L.), their general health effects, as well as the currently available knowledge concerning their action on fat storage, physiological mechanisms of their effects, as well as their safety and recommended dosage for treatment of obesity. Both tea and coffee possess the ability to promote health and to prevent, to mitigate and to treat numerous disorders. This ability can be partially due to presence of caffeine in both plants. Further physiological and medicinal effects could be explained by other molecules (theaflavins, catechins, their metabolites and polyphenols in tea and polyphenol chlorogenic acid in coffee). These plants and plant molecules can be efficient for prevention and treatment of numerous metabolic disorders including metabolic syndrome, cardiovascular diseases, type 2 diabetes and obesity. Both plants and their constituents can reduce fat storage through suppression of adipocyte functions, and support of gut microbiota. In addition, tea can prevent obesity via reduction of appetite, food consumption and food absorption in gastrointestinal system and through the changes in fat metabolism.
C1 [Sirotkin, Alexander, V] Constantine Philosopher Univ Nitra, Fac Nat Sci, Nitra, Slovakia.
   [Kolesarova, Adriana] Slovak Univ Agr, Fac Biotechnol & Food Sci, Nitra, Slovakia.
C3 Constantine the Philosopher University in Nitra; Slovak University of
   Agriculture Nitra
RP Sirotkin, AV (corresponding author), Constantine Philosopher Univ Nitra, Dept Zool & Anthropol, Tr A Hlinku 1, Nitra 94974, Slovakia.
EM asirotkin@ukf.sk
RI Sirotkin, Alexander/U-3466-2017; Kolesarova, Adriana/I-7526-2019
FU Slovak Research and Development Agency (APVV) [APVV-15-0296,
   APVV-18-0312]; Slovak Grant Agency of the Ministry of Education, Science
   and Sport; Slovak Academy of Science (VEGA) [VEGA 1/0392/17, VEGA
   1/0266/20]
FX This work was supported by the Slovak Research and Development Agency
   (APVV) under the contract APVV-15-0296, APVV-18-0312 and by the Slovak
   Grant Agency of the Ministry of Education, Science and Sport and the
   Slovak Academy of Science (VEGA), project VEGA 1/0392/17, VEGA
   1/0266/20.
CR Bedrood Z, 2018, PHYTOTHER RES, V32, P1163, DOI 10.1002/ptr.6063
   Bhatti SK, 2013, CURR OPIN CLIN NUTR, V16, P688, DOI 10.1097/MCO.0b013e328365b9a0
   Cao JH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120762
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   de Roos B, 1999, P NUTR SOC, V58, P551, DOI 10.1017/S0029665199000725
   Dybkowska Ewa, 2017, Rocz Panstw Zakl Hig, V68, P347
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Hu J, 2018, REGUL TOXICOL PHARM, V95, P412, DOI 10.1016/j.yrtph.2018.03.019
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Janssens PLHR, 2016, PHYSIOL BEHAV, V162, P83, DOI 10.1016/j.physbeh.2016.01.044
   Karak T, 2017, CRIT REV FOOD SCI, V57, P2996, DOI 10.1080/10408398.2015.1083534
   Li YC, 2016, DIABETES-METAB RES, V32, P2, DOI 10.1002/dmrr.2641
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Mazzanti G, 2015, ARCH TOXICOL, V89, P1175, DOI 10.1007/s00204-015-1521-x
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Mohamed G. A., 2014, Bulletin of the Faculty of Pharmacy, Cairo University, V52, P269, DOI 10.1016/j.bfopcu.2014.05.001
   Islam MT, 2018, CURR DRUG METAB, V19, P544, DOI 10.2174/1389200219666180302154551
   Odzakovic B, 2016, ACTA SCI POLON-TECHN, V15, P409, DOI 10.17306/J.AFS.2016.4.39
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Oz HS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060561
   Pan HB, 2016, MOLECULES, V21, DOI 10.3390/molecules21121659
   Pan JX, 2018, FOOD SCI BIOTECHNOL, V27, P1311
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Ricci E, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0257-2
   Ríos-Hoyo A, 2016, CURR OBES REP, V5, P262, DOI 10.1007/s13679-016-0214-y
   Rothenberg DO, 2018, MOLECULES, V23, DOI 10.3390/molecules23051176
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Silvester AJ, 2019, J NUTR BIOCHEM, V64, P1, DOI 10.1016/j.jnutbio.2018.09.028
   Singh AK, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060731
   Skrypnik K, 2017, ACTA SCI POLON-TECHN, V16, P83, DOI 10.17306/J.AFS.2017.0442
   Sung J, 2018, FOOD FUNCT, V9, P6082, DOI 10.1039/c8fo01561a
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tamura H, 2020, YAKUGAKU ZASSHI, V140, P1351, DOI 10.1248/yakushi.20-00150
   Tang GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246196
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Türközü D, 2017, CRIT REV FOOD SCI, V57, P254, DOI 10.1080/10408398.2014.986672
   Unachukwu UJ, 2010, J FOOD SCI, V75, pC541, DOI 10.1111/j.1750-3841.2010.01705.x
   Unno K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101468
   Cisneros LCV, 2017, NUTR HOSP, V34, P731, DOI 10.20960/nh.753
   Willems MET, 2018, INT J SPORT NUTR EXE, V28, P536, DOI 10.1123/ijsnem.2017-0237
   Williamson G, 2011, MOL NUTR FOOD RES, V55, P864, DOI 10.1002/mnfr.201000631
   Xie C, 2018, J HUM HYPERTENS, V32, P83, DOI 10.1038/s41371-017-0007-0
   Xu H, 2018, NEUROPSYCH DIS TREAT, V14, P1795, DOI 10.2147/NDT.S165618
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2018, J FOOD DRUG ANAL, V26, P1, DOI 10.1016/j.jfda.2017.10.010
   Yashin A, 2013, ANTIOXIDANTS-BASEL, V2, P230, DOI 10.3390/antiox2040230
NR 48
TC 54
Z9 56
U1 3
U2 80
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PD APR
PY 2021
VL 70
IS 2
BP 161
EP 168
DI 10.33549/physiolres.934674
PG 8
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA TI2AG
UT WOS:000672587800004
PM 33992045
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Chapple, B
   Woodfin, S
   Moore, W
AF Chapple, Brooke
   Woodfin, Seth
   Moore, William
TI The Perfect Cup? Coffee-Derived Polyphenols and Their Roles in
   Mitigating Factors Affecting Type 2 Diabetes Pathogenesis
SO MOLECULES
LA English
DT Review
DE insulin resistance; beta-cell function; enterodiol; enterolactone;
   matairesinol; secoisolariciresinol; kaempferol; quercetin; chlorogenic
   acid
ID NF-KAPPA-B; INSULIN SENSITIVITY; LIPID-ACCUMULATION; SIGNALING PATHWAY;
   CHLOROGENIC ACID; BREAST-CANCER; HUMAN HEALTH; SECOISOLARICIRESINOL
   DIGLUCOSIDE; CARDIOVASCULAR-DISEASE; URINARY ENTEROLACTONE
AB Type 2 diabetes (T2D) is a growing health concern with an estimated 462 million people having been diagnosed worldwide. T2D is characterized by chronically elevated blood glucose and insulin resistance, which culminate in a diminished function of the beta-cell mass in its later stages. This can be perpetuated by and result in inflammation, excess reactive oxygen species production, obesity, and the dysregulation of multiple cellular pathways. Many naturally occurring small molecules have been investigated in terms of their roles in modulating glucose homeostasis and beta-cell function. Many of these compounds can be found in commonly used sources of food and drink. Interestingly, a correlation has been observed between coffee consumption and T2D incidence. However, the specific compounds responsible for this correlation and their mechanisms are still somewhat undetermined. This paper reviews recent research findings on the effects of several polyphenols that are either found in coffee or are metabolites of compounds found in coffee (enterodiol, enterolactone, matairesinol, secoisolariciresinol, kaempferol, quercetin, and chlorogenic acid) on glucose homeostasis and health complications associated with glucose dysregulation, with a special emphasis on their potential anti-diabetic effects. The factors that affect polyphenol content in coffee are also addressed.
C1 [Chapple, Brooke; Woodfin, Seth; Moore, William] Liberty Univ, Sch Hlth Sci, Dept Biol & Chem, Lynchburg, VA 24515 USA.
C3 Liberty University
RP Moore, W (corresponding author), Liberty Univ, Sch Hlth Sci, Dept Biol & Chem, Lynchburg, VA 24515 USA.
EM bechapple@liberty.edu; sfwoodfin@liberty.edu; wtmoore@liberty.edu
OI Moore, William/0000-0002-2979-3660
FU Liberty University Office of Sponsored Programs and Research; Liberty
   University Department of Biology and Chemistry; Office of Sponsored
   Programs Research
FX We thank the Liberty University Department of Biology and Chemistry and
   the Office of Sponsored Programs & Research for their support of ongoing
   work in our lab. We also thank Gregory Raner for his input and support
   during the development of this review.
CR Abdelwahab AH, 2023, FRONT PHARMACOL, V14, DOI 10.3389/fphar.2023.1199294
   Al-Numair KS, 2015, REDOX REP, V20, P198, DOI 10.1179/1351000214Y.0000000117
   Alemany M, 2021, WORLD J DIABETES, V12, P1622, DOI 10.4239/wjd.v12.i10.1622
   Ali A, 2022, MOLECULES, V27, DOI 10.3390/molecules27165126
   Alkhalidy H, 2018, MOLECULES, V23, DOI 10.3390/molecules23092338
   Alkhalidy H, 2018, J NUTR BIOCHEM, V58, P90, DOI 10.1016/j.jnutbio.2018.04.014
   Angeloni S, 2020, FOOD CHEM, V325, DOI 10.1016/j.foodchem.2020.126924
   Ariadi A., 2019, Open Access Macedonian Journal of Medical Sciences, V7, P2084
   ARO A, 1987, METABOLISM, V36, P1027, DOI 10.1016/0026-0495(87)90021-7
   Barker D, 2019, MOLECULES, V24, DOI 10.3390/molecules24071424
   Barros RPA, 2006, TRENDS MOL MED, V12, P425, DOI 10.1016/j.molmed.2006.07.004
   Bartolomé A, 2023, BIOMOLECULES, V13, DOI 10.3390/biom13030495
   Bartolomé A, 2021, J CLIN ENDOCR METAB, V106, pE1466, DOI 10.1210/clinem/dgaa906
   Bermont F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020538
   Biasiotto G, 2018, BRIT J NUTR, V120, P751, DOI 10.1017/S0007114518001824
   Bitar MS, 2010, LIFE SCI, V86, P844, DOI 10.1016/j.lfs.2010.03.019
   Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Centers for Disease Control and Prevention, National diabetes statistics report
   Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037
   Chen LH, 2009, J NUTR, V139, P653, DOI 10.3945/jn.108.101832
   Chen Y, 2016, NAT PROD RES, V30, P1988, DOI 10.1080/14786419.2015.1101105
   Chhillar H, 2021, CRIT REV FOOD SCI, V61, P2719, DOI 10.1080/10408398.2020.1784840
   Chi TC, 2007, LIFE SCI, V80, P1713, DOI 10.1016/j.lfs.2007.02.002
   Chung HS, 2013, FOOD SCI BIOTECHNOL, V22, P23
   Cipolletti M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092624
   Coelho M, 2013, ARCH MED SCI, V9, P191, DOI 10.5114/aoms.2013.33181
   Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8
   Corona G, 2007, BIOCHEM BIOPH RES CO, V362, P606, DOI 10.1016/j.bbrc.2007.08.049
   Corsini E, 2010, J AGR FOOD CHEM, V58, P6678, DOI 10.1021/jf100471n
   Crespo I, 2008, BRIT J NUTR, V100, P968, DOI 10.1017/S0007114508966083
   Danbara N, 2005, ANTICANCER RES, V25, P2269
   Dayem AA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090581
   de Godoy JMP, 2022, MED B SISLI ETFAL HO, V56, P509, DOI 10.14744/SEMB.2022.34979
   de Sousa E, 2004, J NAT PROD, V67, P829, DOI 10.1021/np030513u
   DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302
   Dhanya R, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00336
   Di Marzo V, 2009, EUR J ENDOCRINOL, V161, P715, DOI 10.1530/EJE-09-0643
   Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243
   dos Santos JM, 2018, MOL CELL BIOCHEM, V449, P251, DOI 10.1007/s11010-018-3361-5
   Elksnis A, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00107
   Emran T.B., 2023, Biointerface Res Appl Chem, V13, P588, DOI [10.33263/BRIAC136.588, DOI 10.33263/BRIAC136.588]
   Fatchiyah F, 2013, BIOINFORMATION, V9, P853, DOI 10.6026/97320630009853
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j
   Gloess AN, 2013, EUR FOOD RES TECHNOL, V236, P607, DOI 10.1007/s00217-013-1917-x
   Gordillo-Delgado F, 2012, J SCI FOOD AGR, V92, P2316, DOI 10.1002/jsfa.5628
   Gragnoli C, 2011, OPHTHALMIC GENET, V32, P228, DOI 10.3109/13816810.2011.592174
   Gu W, 2022, INT J CLIN PRACT, V2022, DOI 10.1155/2022/9734738
   Guo H, 2010, ACTA PHARMACOL SIN, V31, P963, DOI 10.1038/aps.2010.78
   Guo XH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050452
   Hajibabaie F, 2022, J FOOD BIOCHEM, V46, DOI 10.1111/jfbc.14480
   Halldin E, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801159
   Halvorsen BL, 2006, AM J CLIN NUTR, V84, P95, DOI 10.1093/ajcn/84.1.95
   Handy JA, 2010, J CELL BIOCHEM, V110, P1195, DOI 10.1002/jcb.22634
   Hasbullah Umar Hafidz Asy'ari, 2021, Journal of Physics: Conference Series, V1764, DOI 10.1088/1742-6596/1764/1/012033
   Hirano T, 2018, J ATHEROSCLER THROMB, V25, P771, DOI 10.5551/jat.RV17023
   Hossain R, 2022, BIOMOL THER, V30, P473, DOI 10.4062/biomolther.2022.088
   Hu JX, 2018, CANCER BIOMARK, V21, P883, DOI 10.3233/CBM-170942
   Huang XJ, 2018, INT J BIOL SCI, V14, P1483, DOI 10.7150/ijbs.27173
   Hyun U, 2022, EXP MOL MED, V54, P370, DOI 10.1038/s12276-021-00705-9
   Izawa K, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 4: CHEMICAL ECOLOGY, P631
   Jaballah A, 2021, BIOCHEM GENET, V59, P1558, DOI 10.1007/s10528-021-10066-7
   Jang WY, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232415482
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Marín-Peñalver JJ, 2016, WORLD J DIABETES, V7, P354, DOI 10.4239/wjd.v7.i17.354
   Juan CA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094642
   Kezimana P, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00641
   Khan MAB, 2020, J EPIDEMIOL GLOB HEA, V10, P107, DOI 10.2991/jegh.k.191028.001
   Kim D, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01566-0
   Klein S, 2022, CELL METAB, V34, P11, DOI 10.1016/j.cmet.2021.12.012
   Knudsen KEB, 2003, J NUTR, V133, P1368
   Kolb H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041144
   Koster JC, 2005, DIABETES, V54, P3065, DOI 10.2337/diabetes.54.11.3065
   Król K, 2020, EUR FOOD RES TECHNOL, V246, P33, DOI 10.1007/s00217-019-03388-9
   Kyro C, 2015, BREAST CANCER RES TR, V154, P389, DOI 10.1007/s10549-015-3595-9
   Lam CS, 2023, NUTRIENTS, V15, DOI 10.3390/nu15133006
   Landete JM, 2012, FOOD RES INT, V46, P410, DOI 10.1016/j.foodres.2011.12.023
   Lee B, 2015, J MED FOOD, V18, P1363, DOI 10.1089/jmf.2015.3457
   Lee JK, 2023, FRONT CELL DEV BIOL, V11, DOI 10.3389/fcell.2023.1124164
   Lee M, 2016, NEUROBIOL AGING, V46, P113, DOI 10.1016/j.neurobiolaging.2016.06.015
   Lee YJ, 2015, FOOD FUNCT, V6, P2824, DOI 10.1039/c5fo00481k
   Li F, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.912591
   Li H, 2015, J AGR FOOD CHEM, V63, P7198, DOI 10.1021/acs.jafc.5b01639
   Li JS, 2022, J ETHNOPHARMACOL, V283, DOI 10.1016/j.jep.2021.114713
   Li TT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21206-3
   Li YX, 2023, GENE, V853, DOI 10.1016/j.gene.2022.147080
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Lim AKH, 2009, DIABETOLOGIA, V52, P347, DOI 10.1007/s00125-008-1215-5
   Liu CQ, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0053-5
   Liu K, 2014, AM J CLIN NUTR, V99, P1510, DOI 10.3945/ajcn.113.082024
   Liu Z, 2021, J CANCER, V12, P2787, DOI 10.7150/jca.55477
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y
   Lu XL, 2011, CELL STRESS CHAPERON, V16, P539, DOI 10.1007/s12192-011-0265-7
   Lv LX, 2015, ENDOCRINE, V49, P669, DOI 10.1007/s12020-015-0543-8
   Ma N, 2022, MEDICINE, V101, DOI 10.1097/MD.0000000000030049
   Mahjabeen W, 2022, COMPLEMENT THER MED, V66, DOI 10.1016/j.ctim.2022.102819
   Mali AV, 2019, EUR J PHARMACOL, V852, P107, DOI 10.1016/j.ejphar.2019.02.022
   Mali AV, 2018, CANCER BIOL MED, V15, P137, DOI 10.20892/j.issn.2095-3941.2018.0012
   Markovic S, 2016, SPECTROCHIM ACTA A, V164, P67, DOI 10.1016/j.saa.2016.03.044
   Marroqui L, 2015, EBIOMEDICINE, V2, P378, DOI 10.1016/j.ebiom.2015.03.012
   Mazur WM, 1998, BRIT J NUTR, V79, P37, DOI 10.1079/BJN19980007
   Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9
   Meek Thomas H, 2012, Indian J Endocrinol Metab, V16, pS534, DOI 10.4103/2230-8210.105568
   Miehle K, 2012, CLIN ENDOCRINOL, V76, P2, DOI 10.1111/j.1365-2265.2011.04234.x
   Milek M, 2021, ACTA SCI POLON-TECHN, V20, P179, DOI [10.17306/J.AFS.2021.0890, 10.17306/J.AFS.0890]
   Miles FL, 2017, FOOD FUNCT, V8, P3209, DOI 10.1039/c7fo00684e
   Hoang MH, 2015, J NUTR BIOCHEM, V26, P868, DOI 10.1016/j.jnutbio.2015.03.005
   Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990
   Moore WT, 2023, FOOD SCI HUM WELL, V12, P2087, DOI 10.1016/j.fshw.2023.03.028
   Movahed A, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/851267
   Nakanishi S, 2004, DIABETES-METAB RES, V20, P399, DOI 10.1002/dmrr.469
   Naz R, 2023, MOLECULES, V28, DOI 10.3390/molecules28103996
   Nie T, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.798329
   Niseteo T, 2012, FOOD CHEM, V134, P1870, DOI 10.1016/j.foodchem.2012.03.095
   Nor-Hidayah Mustafa Nor-Hidayah Mustafa, 2018, Journal of Applied Pharmaceutical Science, V8, P152
   Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176
   Oguntibeju Oluwafemi Omoniyi, 2019, Int J Physiol Pathophysiol Pharmacol, V11, P45
   Olechno E, 2020, MOLECULES, V25, DOI 10.3390/molecules25225274
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Osama H, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13983
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   Peng X, 2016, FOOD CHEM, V190, P207, DOI 10.1016/j.foodchem.2015.05.088
   Penumathsa SV, 2008, J CELL MOL MED, V12, P2350, DOI 10.1111/j.1582-4934.2008.00251.x
   Pérez-Martínez M, 2010, J AGR FOOD CHEM, V58, P2958, DOI 10.1021/jf9037375
   Pietrofesa RA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030322
   Prasad CNV, 2010, FEBS LETT, V584, P531, DOI 10.1016/j.febslet.2009.11.092
   Prasad K, 2000, MOL CELL BIOCHEM, V206, P141, DOI 10.1023/A:1007018030524
   Prasad K., 2002, INT J ANGIOL, V11, P107, DOI [10.1007/BF01616377, DOI 10.1007/BF01616377]
   Prasad K., 2023, Scr. Medica (Engl. Ed.), V54, P87, DOI [10.5937/scriptamed54-41932, DOI 10.5937/SCRIPTAMED54-41932]
   Prigent SVE, 2003, J AGR FOOD CHEM, V51, P5088, DOI 10.1021/jf021229w
   Puukila S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122852
   Rai U, 2019, LIFE SCI, V236, DOI 10.1016/j.lfs.2019.116836
   Ramos S, 2008, MOL NUTR FOOD RES, V52, P507, DOI 10.1002/mnfr.200700326
   Rana A, 2022, J FOOD BIOCHEM, V46, DOI 10.1111/jfbc.14264
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Regué L, 2023, DIABETES, V72, P33, DOI 10.2337/db21-1087
   Restaino RM, 2017, EXP PHYSIOL, V102, P139, DOI 10.1113/EP085794
   Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010
   Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101
   Sahu A, 2003, FRONT NEUROENDOCRIN, V24, P225, DOI 10.1016/j.yfrne.2003.10.001
   Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106
   Schneeberger M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00185
   Schultze SM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002109
   Sekhon-Loodu S, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00053
   Sheahan KH, 2020, POSTGRAD MED J, V96, P156, DOI 10.1136/postgradmedj-2019-137186
   Shen BY, 2019, J CELL MOL MED, V23, P4063, DOI 10.1111/jcmm.14293
   Shin MK, 2019, J SCI FOOD AGR, V99, P2411, DOI 10.1002/jsfa.9448
   Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540
   Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053
   Speelman T, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11142163
   Su LJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5080843
   Su MM, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11061085
   Sun JJ, 2019, J CLIN ENDOCR METAB, V104, P83, DOI 10.1210/jc.2018-00968
   Sun J, 2016, J FUNCT FOODS, V24, P482, DOI 10.1016/j.jff.2016.04.032
   SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418
   Szczech LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110535
   Szkudelski T, 2015, BBA-MOL BASIS DIS, V1852, P1145, DOI 10.1016/j.bbadis.2014.10.013
   Tabrizi R, 2020, CRIT REV FOOD SCI, V60, P375, DOI 10.1080/10408398.2018.1529654
   Tan BL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112579
   Tang B, 2016, INT J NANOMED, V11, P6401, DOI 10.2147/IJN.S101285
   Tangney CC, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0324-x
   Tantiwong P, 2010, AM J PHYSIOL-ENDOC M, V299, pE794, DOI 10.1152/ajpendo.00776.2009
   Tay VSY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54554-8
   Torres-Villarreal D, 2019, J PHYSIOL BIOCHEM, V75, P83, DOI 10.1007/s13105-018-0659-4
   Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001
   Usher ET, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.102623
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397
   van Loo G, 2023, NAT REV IMMUNOL, V23, P289, DOI 10.1038/s41577-022-00792-3
   Várady M, 2022, LWT-FOOD SCI TECHNOL, V172, DOI 10.1016/j.lwt.2022.114245
   Varshney R, 2018, J NUTR BIOCHEM, V57, P212, DOI 10.1016/j.jnutbio.2018.02.017
   Varshney R, 2017, MOL CELL ENDOCRINOL, V448, P1, DOI 10.1016/j.mce.2017.02.033
   Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106
   Velikova TV, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/7297419
   Vishal K, 2023, BIOINFORM BIOL INSIG, V17, DOI 10.1177/11779322231167977
   Walstra P, 1999, Dairy technology: Principles of milk properties and processes
   Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8
   Wang LQ, 2002, J CHROMATOGR B, V777, P289, DOI 10.1016/S1570-0232(02)00281-7
   Wang TQ, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4532482
   Wang YW, 2015, J FUNCT FOODS, V18, P1, DOI 10.1016/j.jff.2015.06.053
   Webster JD, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00365
   White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001
   Wu CM, 2014, J NUTR BIOCHEM, V25, P412, DOI 10.1016/j.jnutbio.2013.12.002
   Wu HJ, 2022, FOOD BIOSCI, V46, DOI 10.1016/j.fbio.2021.101373
   Wu XD, 2022, EUR J MED CHEM, V232, DOI 10.1016/j.ejmech.2022.114171
   Xu C, 2015, BRIT J NUTR, V113, P683, DOI 10.1017/S0007114514004115
   Xu P, 2017, NEUROCHEM RES, V42, P2850, DOI 10.1007/s11064-017-2301-1
   Yan H, 2019, DIABETES, V68, P291, DOI 10.2337/db18-0638
   Yan YW, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/9680508
   Yeager SE, 2023, CRIT REV FOOD SCI, V63, P1010, DOI 10.1080/10408398.2021.1957767
   Young JE, 2005, MOL NUTR FOOD RES, V49, P1136, DOI 10.1002/mnfr.200500080
   Yuksel Z, 2010, FOOD CHEM, V121, P450, DOI 10.1016/j.foodchem.2009.12.064
   Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257
   Zhang HY, 2020, EXP HEMATOL ONCOL, V9, DOI 10.1186/s40164-020-00191-1
   Zhang XP, 2019, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00802
   Zhang YL, 2013, J NUTR BIOCHEM, V24, P638, DOI 10.1016/j.jnutbio.2012.03.008
   Zhang YL, 2011, EUR J PHARMACOL, V670, P325, DOI 10.1016/j.ejphar.2011.08.011
   Zhou F, 2017, CYTOTECHNOLOGY, V69, P493, DOI 10.1007/s10616-016-9965-2
NR 199
TC 3
Z9 3
U1 4
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD FEB
PY 2024
VL 29
IS 4
AR 751
DI 10.3390/molecules29040751
PG 24
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA JW3D9
UT WOS:001176151000001
PM 38398503
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Cornelis, MC
   Munafo, MR
AF Cornelis, Marilyn C.
   Munafo, Marcus R.
TI Mendelian Randomization Studies of Coffee and Caffeine Consumption
SO NUTRIENTS
LA English
DT Review
DE Mendelian Randomization; coffee; caffeine; behavior; causality; genetic
   epidemiology; epidemiological methods
ID GENETIC-VARIANTS; INSTRUMENTAL VARIABLES; CAUSAL ROLE; RISK;
   EPIDEMIOLOGY; CHOLESTEROL; CONTRIBUTE; CANNABIS; ALCOHOL; OBESITY
AB Habitual coffee and caffeine consumption has been reported to be associated with numerous health outcomes. This perspective focuses on Mendelian Randomization (MR) approaches for determining whether such associations are causal. Genetic instruments for coffee and caffeine consumption are described, along with key concepts of MR and particular challenges when applying this approach to studies of coffee and caffeine. To date, at least fifteen MR studies have investigated the causal role of coffee or caffeine use on risk of type 2 diabetes, cardiovascular disease, Alzheimer's disease, Parkinson's disease, gout, osteoarthritis, cancers, sleep disturbances and other substance use. Most studies provide no consistent support for a causal role of coffee or caffeine on these health outcomes. Common study limitations include low statistical power, potential pleiotropy, and risk of collider bias. As a result, in many cases a causal role cannot confidently be ruled out. Conceptual challenges also arise from the different aspects of coffee and caffeine use captured by current genetic instruments. Nevertheless, with continued genome-wide searches for coffee and caffeine related loci along with advanced statistical methods and MR designs, MR promises to be a valuable approach to understanding the causal impact that coffee and caffeine have in human health.
C1 [Cornelis, Marilyn C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
   [Munafo, Marcus R.] Univ Bristol, Sch Psychol Sci, UK Ctr Tobacco & Alcohol Studies, MRC Integrat Epidemiol Unit IEU, Bristol BS8 1TU, Avon, England.
C3 Northwestern University; Feinberg School of Medicine; University of
   Bristol
RP Cornelis, MC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
EM marilyn.cornelis@northwestern.edu; marcus.munafo@bristol.ac.uk
RI Munafo, Marcus/AAE-2306-2020
OI Munafo, Marcus/0000-0002-4049-993X
FU National Institute on Aging [K01AG053477]; Benjamin Meaker Visiting
   Professorship; MRC [MC_UU_00011/7] Funding Source: UKRI
FX This work was funded by the National Institute on Aging (K01AG053477 to
   M.C.C.) and a Benjamin Meaker Visiting Professorship (to M.C.C.).
CR Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101
   Andrzejewski D, 2004, J AGR FOOD CHEM, V52, P1996, DOI 10.1021/jf0349634
   [Anonymous], GENOME WIDE AS UNPUB
   [Anonymous], BIORXIV
   [Anonymous], CATALOGUE PUBLISHED
   [Anonymous], 2018, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.K601
   [Anonymous], TRAD STAT
   [Anonymous], BIORXIV
   Bjorngaard JH, 2017, INT J EPIDEMIOL, V46, P1958, DOI 10.1093/ije/dyx147
   Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965
   Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080
   Burgess S, 2017, EPIDEMIOLOGY, V28, P30, DOI 10.1097/EDE.0000000000000559
   Burgess S, 2016, STAT MED, V35, P1880, DOI 10.1002/sim.6835
   Burgess S, 2015, INT J EPIDEMIOL, V44, P484, DOI 10.1093/ije/dyu176
   Burgess S, 2015, AM J EPIDEMIOL, V181, P251, DOI 10.1093/aje/kwu283
   Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758
   Carter MJ, 2014, THER RECREAT J, V48, P275
   Cho Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep18422
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Cornelis MC, 2015, CURR OPIN LIPIDOL, V26, P20, DOI 10.1097/MOL.0000000000000143
   Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033
   Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Glymour MM, 2012, AM J EPIDEMIOL, V175, P332, DOI 10.1093/aje/kwr323
   Haycock PC, 2016, AM J CLIN NUTR, V103, P965, DOI 10.3945/ajcn.115.118216
   Hemani G, 2018, HUM MOL GENET, V27, pR195, DOI 10.1093/hmg/ddy163
   Holmes MV, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.78
   KATAN MB, 1986, LANCET, V1, P507
   Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P674, DOI 10.1001/archpsyc.65.6.674
   Kwok MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep36500
   Larsson SC, 2018, ANN RHEUM DIS, V77, P1544, DOI 10.1136/annrheumdis-2018-213055
   Larsson SC, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5375
   Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034
   Lee YH, 2018, CLIN RHEUMATOL, V37, P3133, DOI 10.1007/s10067-018-4252-6
   Leviton A, 1996, EPIDEMIOLOGY, V7, P110, DOI 10.1097/00001648-199601000-00022
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI [10.1039/C4FO00290C, 10.1039/c4fo00290c]
   Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274
   MARKS V, 1973, LANCET, V1, P827
   Milder IEJ, 2005, BRIT J NUTR, V93, P393, DOI 10.1079/BJN20051371
   Minamisawa M, 2004, ANAL SCI, V20, P325, DOI 10.2116/analsci.20.325
   Munafò MR, 2018, INT J EPIDEMIOL, V47, P226, DOI 10.1093/ije/dyx206
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Nordestgaard AT, 2016, INT J EPIDEMIOL, V45, P1938, DOI 10.1093/ije/dyw325
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Ong JS, 2018, INT J EPIDEMIOL, V47, P450, DOI 10.1093/ije/dyx236
   Paternoster L, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006944
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Relton CL, 2012, INT J EPIDEMIOL, V41, P161, DOI 10.1093/ije/dyr233
   Scalbert Augustin, 2000, Journal of Nutrition, V130, p2073S
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070
   Soroko S, 1996, J AM COLL NUTR, V15, P97
   Spiller M.A., 1998, Caffeine, P97
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Swanson SA, 2017, EPIDEMIOLOGY, V28, P653, DOI 10.1097/EDE.0000000000000699
   Taylor AE, 2018, ADDICTION, V113, P148, DOI 10.1111/add.13975
   Taylor AE, 2017, INT J CANCER, V140, P322, DOI 10.1002/ijc.30462
   Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270
   Treur JL, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12695
   Treur JL, 2017, ADDICT BIOL, V22, P1090, DOI 10.1111/adb.12391
   URGERT R, 1995, J AGR FOOD CHEM, V43, P2167, DOI 10.1021/jf00056a039
   van Dam RM, 2018, J INTERN MED, V283, P588, DOI 10.1111/joim.12754
   Vanyukov MM, 2012, DRUG ALCOHOL DEPEN, V123, pS3, DOI 10.1016/j.drugalcdep.2011.12.018
   Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7
   Verweij KJH, 2013, ADDICT BIOL, V18, P846, DOI 10.1111/j.1369-1600.2012.00478.x
   Wald A, 1940, ANN MATH STAT, V11, P284, DOI 10.1214/aoms/1177731868
   Ward ME, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100248, 10.1371/journal.pone.0103448]
   Ware JJ, 2017, ADDICTION, V112, P1842, DOI 10.1111/add.13888
   White JR, 2016, CLIN TOXICOL, V54, P308, DOI 10.3109/15563650.2016.1146740
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Yanagimoto K, 2004, J AGR FOOD CHEM, V52, P592, DOI 10.1021/jf030317t
   Zheng Jie, 2017, Curr Epidemiol Rep, V4, P330, DOI 10.1007/s40471-017-0128-6
   Zhou A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25919-2
   Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2
NR 75
TC 64
Z9 65
U1 1
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2018
VL 10
IS 10
AR 1343
DI 10.3390/nu10101343
PG 19
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GY7UM
UT WOS:000448821300009
PM 30241358
OA gold, Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Kumar, R
   Sharma, A
   Iqbal, MS
   Srivastava, JK
AF Kumar, Rajnish
   Sharma, Anju
   Iqbal, Mohammed Shariq
   Srivastava, Janmejai K.
TI Therapeutic Promises of chlorogenic Acid Emphasis on its Anti-Obesity
   Property
SO CURRENT MOLECULAR PHARMACOLOGY
LA English
DT Review
DE Chlorogenic acid; coffee; lipid; medicinal activity; obesity; CPT
ID LOW-DENSITY-LIPOPROTEIN; COFFEE BEAN EXTRACT; CAFFEIC ACID; ANTIOXIDANT
   ACTIVITY; IN-VITRO; PHENOLIC-ACIDS; BLOOD-PRESSURE; FERULIC ACID;
   CHOLESTEROL; CONSUMPTION
AB Background: Chlorogenic acid (CGA) is a quinic acid conjugate of caffeic acid. It is an ester formed between caffeic acid and the 3-hydroxyl of L-quinic acid. This polyphenol is naturally present in substantial amount in the green coffee beans. Minor quantities of CGA arc also reported in apples, eggplant, blueberries, tomatoes, strawberries and potatoes. CGA is reported to he beneficial in hypertension, hyperglycemia, antimicrobial, antitumor, memory enhancer, weight management etc. Further, it is also reported to have anticancer, antioxidant and anti-inflammatory activities. Since the last decade, CGA drew public attention for its widely recommended use as a medicine or natural food additive suppletnent for the management of obesity.
   Objective: The current review explores the medicinal promises of CGA and emphasizes on its anti obese property as reported by various scientific reports and publication.
   Conclusion: CGA shows promises as an antioxidant, glycemic control agent, anti-hypertensive, anti-inflammatory, antimicrobial, neuro-protective and anti-obesity agent. It primarily activates the AMP-activated protein kinase, inhibits 3-hydroxy 3-methylglutaryl coenzyme-A reductase and strengthens the activity of camitine palmitoyltransferase to control the obesity.
C1 [Kumar, Rajnish; Sharma, Anju; Srivastava, Janmejai K.] Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Lucknow 226028, Uttar Pradesh, India.
   [Sharma, Anju] Indian Inst Informat Technol, Dept Appl Sci, Allahabad, Uttar Pradesh, India.
   [Iqbal, Mohammed Shariq] Amity Univ Uttar Pradesh, Amity Res Cell, Lucknow 226028, Uttar Pradesh, India.
C3 Indian Institute of Information Technology Allahabad
RP Srivastava, JK (corresponding author), Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Lucknow 226028, Uttar Pradesh, India.
EM jksrivastava@lko.amity.edu
RI Iqbal, Mohammed/GYA-1556-2022; Sharma, Anju/Y-7046-2019; Kumar,
   Rajnish/GLT-8067-2022; Srivastava, Janmejai/AAU-2418-2021
OI Kumar, Rajnish/0000-0001-7614-245X; Shariq Iqbal,
   Mohammed/0000-0002-8382-7040; Srivastava, janmejai/0000-0002-1571-5557;
   Sharma, Anju/0000-0002-3727-5329
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q
   Bailly F, 2005, CURR MED CHEM, V12, P1811, DOI 10.2174/0929867054367239
   Ben-Ami H, 1999, ARCH INTERN MED, V159, P281, DOI 10.1001/archinte.159.3.281
   BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1063::AID-JSFA605>3.0.CO;2-Q]
   Cropley V, 2012, PSYCHOPHARMACOLOGY, V219, P737, DOI 10.1007/s00213-011-2395-0
   de Sotillo DVR, 2006, J NUTR BIOCHEM, V17, P63, DOI 10.1016/j.jnutbio.2005.06.004
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Deka SJ, 2017, CURR MOL MED, V17, P79, DOI 10.2174/1566524017666170209160619
   Falé PL, 2013, J ETHNOPHARMACOL, V150, P718, DOI 10.1016/j.jep.2013.09.029
   Frank J, 2003, J AGR FOOD CHEM, V51, P2526, DOI 10.1021/jf026127k
   Gebhardt R, 1998, J PHARMACOL EXP THER, V286, P1122
   GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333
   Gómez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985
   Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084
   Habtemariam S, 2017, MINI-REV MED CHEM, V17, P667, DOI 10.2174/1389557516666161130100947
   Hamden K, 2009, CHEM-BIOL INTERACT, V180, P421, DOI 10.1016/j.cbi.2009.04.002
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   HUANG MT, 1988, CANCER RES, V48, P5941
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Iqbal D, 2014, PHYTOTHER RES, V28, P899, DOI 10.1002/ptr.5077
   Jeszka-Skowron M, 2016, EUR FOOD RES TECHNOL, V242, P1403, DOI 10.1007/s00217-016-2643-y
   Jin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120842
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kabir F, 2014, J KOREAN SOC APPL BI, V57, P359, DOI 10.1007/s13765-014-4056-6
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kang TY, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/617243
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Karunanidhi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/392058
   Katada S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040525
   Kato M, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8608497
   Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Kremr D, 2016, QUIM NOVA, V39, P530
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Laguerre M, 2011, J AGR FOOD CHEM, V59, P10361, DOI 10.1021/jf2026742
   LARANJINHA JAN, 1994, BIOCHEM PHARMACOL, V48, P487, DOI 10.1016/0006-2952(94)90278-X
   [李文娜 Li Wenna], 2012, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V23, P30
   Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180
   Liu CC, 2017, MOL MED REP, V16, P1369, DOI 10.3892/mmr.2017.6698
   Liu Ying Liu Ying, 2009, Chinese Journal of Veterinary Science, V29, P1233
   Lou ZX, 2011, J FOOD SCI, V76, pM398, DOI 10.1111/j.1750-3841.2011.02213.x
   Mills CE, 2013, FOOD CHEM, V141, P3335, DOI 10.1016/j.foodchem.2013.06.014
   Nabavi SF, 2017, CURR NEUROPHARMACOL, V15, P471, DOI 10.2174/1570159X14666160325120625
   NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y
   Navarro-González I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083968
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Nicasio P, 2005, PHYTOTHER RES, V19, P661, DOI 10.1002/ptr.1722
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Prabhakar PK, 2011, THER ADV ENDOCRINOL, V2, P103, DOI 10.1177/2042018811411356
   Qu Q, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.132
   Radtke J, 1998, Z ERNAHRUNGSWISS, V37, P190, DOI 10.1007/s003940050016
   Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Sasaki K, 2010, FOOD CHEM, V118, P830, DOI 10.1016/j.foodchem.2009.05.070
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Seiler SE, 2014, J LIPID RES, V55, P635, DOI 10.1194/jlr.M043448
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Suzuki A, 2002, HYPERTENS RES, V25, P99, DOI 10.1291/hypres.25.99
   Suzuki A, 2008, AM J HYPERTENS, V21, P23, DOI 10.1038/ajh.2007.3
   Suzuki R., 1994, IUPAC COMMISSION NOM, P71
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vieira O, 1998, BIOCHEM PHARMACOL, V55, P333, DOI 10.1016/S0006-2952(97)00470-X
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   [王建辉 Wang Jianhui], 2012, [食品工业科技, Science & Technology of Food Industry], V33, P360
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Yadav M, 2017, J CLIN DIAGN RES, V11, DOI 10.7860/JCDR/2017/25743.9898
   Yang F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00929
   Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001
   Yuan YL, 2017, INT IMMUNOPHARMACOL, V44, P97, DOI 10.1016/j.intimp.2017.01.017
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
   Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018
   Zhang Lan-tao, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P281, DOI 10.3881/j.issn.1000-503X.2011.03.015
   Zhao ZH, 2008, J AGR FOOD CHEM, V56, P3863, DOI 10.1021/jf073168d
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 86
TC 54
Z9 57
U1 3
U2 62
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1874-4672
EI 1874-4702
J9 CURR MOL PHARMACOL
JI Curr. Molec. Pharmacol.
PY 2020
VL 13
IS 1
BP 7
EP 16
DI 10.2174/1874467212666190716145210
PG 10
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA KD1EV
UT WOS:000507615500003
PM 31333144
DA 2025-04-28
ER

PT J
AU Tuomilehto, J
   Hu, G
   Bidel, S
   Lindström, J
   Jousilahti, P
AF Tuomilehto, J
   Hu, G
   Bidel, S
   Lindström, J
   Jousilahti, P
TI Coffee consumption and risk of type 2 diabetes mellitus among
   middle-aged Finnish men and women
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Article
ID GASTRIC-INHIBITORY POLYPEPTIDE; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE;
   PHYSICAL-ACTIVITY; CHLOROGENIC ACID; CAFFEINE INTAKE; LEISURE-TIME;
   LIFE-STYLE; GREEN TEA; DISEASE
AB Context Only a few studies of coffee consumption and diabetes mellitus (DM) have been reported, even though coffee is the most consumed beverage in the world.
   Objective To determine the relationship between coffee consumption and the incidence of type 2 DM among Finnish individuals, who have the highest coffee consumption in the world.
   Design, Setting, and Participants A prospective study from combined surveys conducted in 1982, 1987, and 1992 of 6974 Finnish men and 7655 women aged 35 to 64 years without history of stroke, coronary heart disease, or DM at baseline, with 175682 person-years of follow-up. Coffee consumption and other study parameters were determined at baseline using standardized measurements.
   Main Outcome Measures Hazard ratios (HRs) for the incidence of type 2 DM were estimated for different levels of daily coffee consumption.
   Results During a mean follow-up of 12 years, there were 381 incident cases of type 2 DM. After adjustment for confounding factors (age, study year, body mass index, systolic blood pressure, education, occupational, commuting and leisure-time physical activity, alcohol and tea consumption, and smoking), the HRs of DM associated with the amount of coffee consumed daily (0-2, 3-4, 5-6, 7-9, greater than or equal to10 cups) were 1.00, 0.71 (95% confidence interval [CI], 0.48-1.05), 0.39 (95% CI, 0.25-0.60), 0.39 (95% CI, 0.20-0.74), and 0.21 (95% CI, 0.06-0.69) (P for trend <.001) in women, and 1.00, 0.73 (95% CI, 0.47-1.13), 0.70 (95% CI, 0.45-1.05), 0.67 (95% CI, 0.40-1.12), and 0.45 (95% CI, 0.25-0.81) (P for trend=.12) in men, respectively. In both sexes combined, the multivariate-adjusted inverse association was significant (P for trend <.001) and persisted when stratified by younger and older than 50 years; smokers and never smokers; healthy weight, overweight, and obese participants; alcohol drinker and nondrinker; and participants drinking filtered and nonfiltered coffee.
   Conclusion Coffee drinking has a graded inverse association with the risk of type 2 DM; however, the reasons for this risk reduction associated with coffee remain unclear.
C1 Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, FIN-00300 Helsinki, Finland.
   Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.
   Inst Biomed, Helsinki, Finland.
C3 Finland National Institute for Health & Welfare; University of Helsinki
RP Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, Mannerheimintie 166, FIN-00300 Helsinki, Finland.
EM jaakko.tuomilehto@ktl.fi
RI Hu, Gang/V-7947-2019; tuomilehto, jaakko/E-6504-2011; Hu,
   Gang/N-1971-2017
OI Lindstrom, Jaana/0000-0001-9255-020X; Hu, Gang/0000-0002-6172-8017
CR Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621
   Andrade-Cetto A, 2001, J ETHNOPHARMACOL, V78, P145, DOI 10.1016/S0378-8741(01)00335-X
   [Anonymous], WHO TECHN REP SER
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   ARO A, 1990, COFFEE CORONARY HEAR, P71
   Barbagallo Mario, 2003, Molecular Aspects of Medicine, V24, P39, DOI 10.1016/S0098-2997(02)00090-0
   Curhan GC, 1998, ANN INTERN MED, V128, P534, DOI 10.7326/0003-4819-128-7-199804010-00003
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   Ferrini RL, 1996, AM J EPIDEMIOL, V144, P642, DOI 10.1093/oxfordjournals.aje.a008975
   Goodman-Gruen D, 2001, J NUTR, V131, P1202, DOI 10.1093/jn/131.4.1202
   Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x
   Isogawa A, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12586-X
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Keys A., 1980, 7 COUNTRIES MULTIVAR
   Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/nejmoa012512
   Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832
   Leitzmann MF, 1999, JAMA-J AM MED ASSOC, V281, P2106, DOI 10.1001/jama.281.22.2106
   Meier JJ, 2001, DIABETES, V50, P2497, DOI 10.2337/diabetes.50.11.2497
   Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635
   NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186
   NEWGARD CB, 1984, DIABETES, V33, P192, DOI 10.2337/diabetes.33.2.192
   PAJAK A, 1988, World Health Statistics Quarterly, V41, P115
   Paolisso G, 1997, AM J HYPERTENS, V10, P346, DOI 10.1016/S0895-7061(96)00342-1
   PAOLISSO G, 1990, DIABETOLOGIA, V33, P511, DOI 10.1007/BF00404136
   PAOLISSO G, 1995, J CLIN ENDOCR METAB, V80, P1382, DOI 10.1210/jc.80.4.1382
   PIETINEN P, 1990, INT J EPIDEMIOL, V19, P586, DOI 10.1093/ije/19.3.586
   Pizziol A, 1998, EUR J CLIN NUTR, V52, P846, DOI 10.1038/sj.ejcn.1600657
   Reunanen A, 2003, LANCET, V361, P702, DOI 10.1016/S0140-6736(03)12583-4
   ROBERTSON D, 1984, AM J MED, V77, P54, DOI 10.1016/0002-9343(84)90435-2
   Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   TUNSTALL-PEDOE H, 1988, Journal of Clinical Epidemiology, V41, P105
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Tuomilehto J, 2003, DIABETES CARE, V26, P61
   Tuomilehto J, 2003, DIABETES CARE, V26, P1770
   TUOMILEHTO J, 1990, BRIT MED J, V300, P642, DOI 10.1136/bmj.300.6725.642
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49
   *WORLD RES I, EARTH TRENDS DAT TAB
   Yoshioka K, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12585-8
   YOUN JH, 1986, J BIOL CHEM, V261, P5960
   Zeegers MPA, 2001, INT J EPIDEMIOL, V30, P353, DOI 10.1093/ije/30.2.353
NR 44
TC 214
Z9 237
U1 0
U2 25
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAR 10
PY 2004
VL 291
IS 10
BP 1213
EP 1219
DI 10.1001/jama.291.10.1213
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 800XV
UT WOS:000220061900021
PM 15010442
DA 2025-04-28
ER

PT J
AU Cha, KH
   Song, DG
   Kim, SM
   Pan, CH
AF Cha, Kwang Hyun
   Song, Dae-Geun
   Kim, Sang Min
   Pan, Cheol-Ho
TI Inhibition of Gastrointestinal Lipolysis by Green Tea, Coffee, and
   Gomchui (Ligularia fischeri) Tea Polyphenols during Simulated
   Digestion
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE EGCG; DCQA; lipase inhibition; green tea; coffee; Ligularia fischeri;
   simulated digestion
ID LIPASE IN-VITRO; PANCREATIC LIPASE; CHLOROGENIC ACID; ANTIOXIDANT
   ACTIVITY; BLACK TEA; CATECHINS; BIOAVAILABILITY; INGESTION;
   IDENTIFICATION; INFLAMMATION
AB Green tea, coffee, and gomchui (Ligularia fischeri) tea, which are rich in polyphenols, may exhibit antiobesity effects by inhibiting pancreatic lipase. However, the bioavailability of some polyphenols is poor due to either degradation or absorption difficulties in the gastrointestinal tract, thus making their beneficial effects doubtful. This study was conducted,to evaluate the inhibitory effect of three beverages on lipolysis and the contribution of their major polyphenols during simulated digestion. During simulated digestion, gomchui tea was the most potent at inhibiting gastrointestinal lipolysis, whereas green tea was the least potent. The strongest lipase inhibitor among purified major polyphenols was a green tea polyphenol, (-)-epigallocatechin gallate (EGCG, IC50 = 1.8 +/- 0.57 mu M), followed by di-O-caffeoylquinic acid isomers (DCQA, IC50 from 12.7 +/- 4.5 to 404 +/- 23 mu M), which are gomchui tea polyphenols. However, the stability of DCQA was greater than that of EGCG when subjected to simulated digestion. Taken together, gomchui tea, which has DCQA as the major polyphenol, showed stronger lipolysis inhibitory activity during simulated digestion compared to both green tea and coffee.
C1 [Cha, Kwang Hyun; Song, Dae-Geun; Kim, Sang Min; Pan, Cheol-Ho] Korea Inst Sci & Technol, Funct Food Ctr, Kangnung 210340, South Korea.
C3 Korea Institute of Science & Technology (KIST)
RP Pan, CH (corresponding author), Korea Inst Sci & Technol, Funct Food Ctr, Kangnung 210340, South Korea.
EM cheolpan@gmail.com
RI Kim, Sangmin/I-3969-2012
OI Song, Dae-Geun/0000-0003-0471-8602
FU Korea Institute of Science and Technology Gangneung Institute [2Z03560]
FX This study was supported by the Korea Institute of Science and
   Technology Gangneung Institute intramural research grant 2Z03560.
CR Almoosawi S, 2010, NUTR BULL, V35, P207, DOI 10.1111/j.1467-3010.2010.01841.x
   Amaki K, 2011, BIOSCI BIOTECH BIOCH, V75, P829, DOI 10.1271/bbb.100444
   [Anonymous], 1976, BIOCHEM J
   Arts ICW, 2000, J AGR FOOD CHEM, V48, P1752, DOI 10.1021/jf000026+
   Bonfili L, 2011, BIOCHIMIE, V93, P931, DOI 10.1016/j.biochi.2011.02.003
   Chen W.W., 2012, DRUG METAB LETT, DOI [10.2174/ 1872212225945643128, DOI 10.2174/1872212225945643128]
   Garrett DA, 1999, J AGR FOOD CHEM, V47, P4301, DOI 10.1021/jf9903298
   Gondoin A, 2010, FOOD RES INT, V43, P1537, DOI 10.1016/j.foodres.2010.04.029
   Green RJ, 2007, MOL NUTR FOOD RES, V51, P1152, DOI 10.1002/mnfr.200700086
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Guo YQ, 2009, NUTR RES, V29, P656, DOI 10.1016/j.nutres.2009.09.005
   HADVARY P, 1988, BIOCHEM J, V256, P357, DOI 10.1042/bj2560357
   Han C, 1997, CANCER LETT, V114, P153, DOI 10.1016/S0304-3835(97)04647-8
   Han LK, 2001, INT J OBESITY, V25, P1459, DOI 10.1038/sj.ijo.0801747
   Hashimoto F, 1996, BIOORG MED CHEM LETT, V6, P695, DOI 10.1016/0960-894X(96)00095-9
   Henning SM, 2004, AM J CLIN NUTR, V80, P1558
   Highlander Peter, 2010, Ther Adv Cardiovasc Dis, V4, P43, DOI 10.1177/1753944709354305
   Jumtee K, 2009, J SEP SCI, V32, P2296, DOI 10.1002/jssc.200900096
   Karu N, 2007, J AGR FOOD CHEM, V55, P2824, DOI 10.1021/jf0628025
   Kim CY, 2008, FOOD SCI BIOTECHNOL, V17, P846
   Kotani A, 2003, J CHROMATOGR B, V788, P269, DOI 10.1016/S1570-0232(02)01036-X
   Krul C, 2001, MUTAT RES-FUND MOL M, V474, P71, DOI 10.1016/S0027-5107(00)00158-5
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   Lee JE, 2011, J AGR FOOD CHEM, V59, P10579, DOI 10.1021/jf202304z
   Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025
   Lee YS, 2010, CYTOTECHNOLOGY, V62, P367, DOI 10.1007/s10616-010-9288-7
   LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2
   McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948
   McClendon KS, 2009, EXPERT OPIN DRUG SAF, V8, P727, DOI 10.1517/14740330903321485
   McDougall GJ, 2008, BIOFACTORS, V34, P73, DOI 10.1002/biof.5520340108
   Mullen W, 2011, J AGR FOOD CHEM, V59, P3754, DOI 10.1021/jf200122m
   Murase T, 2012, BRIT J NUTR, V107, P1757, DOI 10.1017/S0007114511005083
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Neilson AP, 2007, J AGR FOOD CHEM, V55, P8941, DOI 10.1021/jf071645m
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Parada J, 2007, J FOOD SCI, V72, pR21, DOI 10.1111/j.1750-3841.2007.00274.x
   Pecorari M, 2010, MOL NUTR FOOD RES, V54, pS278, DOI 10.1002/mnfr.200900583
   Renouf M, 2011, EUR J NUTR, V50, P575, DOI 10.1007/s00394-010-0164-1
   Richelle M, 2001, J AGR FOOD CHEM, V49, P3438, DOI 10.1021/jf0101410
   Shang YF, 2010, J FOOD SCI, V75, pC530, DOI 10.1111/j.1750-3841.2010.01714.x
   Sugiyama H, 2007, J AGR FOOD CHEM, V55, P4604, DOI 10.1021/jf070569k
   Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Yoshikawa M, 2002, J NUTR, V132, P1819, DOI 10.1093/jn/132.7.1819
   Yoshino K, 1999, J NUTR BIOCHEM, V10, P223, DOI 10.1016/S0955-2863(98)00103-X
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
NR 47
TC 73
Z9 80
U1 5
U2 121
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUL 25
PY 2012
VL 60
IS 29
BP 7152
EP 7157
DI 10.1021/jf301047f
PG 6
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 978EV
UT WOS:000306724300009
PM 22730927
DA 2025-04-28
ER

PT J
AU Wong, RHX
   Garg, ML
   Wood, LG
   Howe, PRC
AF Wong, Rachel H. X.
   Garg, Manohar L.
   Wood, Lisa G.
   Howe, Peter R. C.
TI Antihypertensive Potential of Combined Extracts of Olive Leaf, Green
   Coffee Bean and Beetroot: A Randomized, Double-Blind, Placebo-Controlled
   Crossover Trial
SO NUTRIENTS
LA English
DT Article
DE ambulatory blood pressure; olive leaf extract; chlorogenic acid;
   hypertension; cholesterol; insulin sensitivity
ID BLOOD-PRESSURE; CHLOROGENIC ACID; METABOLISM; OLEUROPEIN; NITRATE
AB Extracts of olive leaf, green coffee bean and beetroot may deliver cardiovascular benefits. This study sought to evaluate the effects of regularly consuming a combination of these extracts on blood pressure (BP), arterial compliance, blood lipids, blood glucose and insulin sensitivity. A double-blind randomised placebo-controlled crossover trial was conducted in adults with untreated high normal or borderline elevated BP. They were randomised to take an active supplement, comprising 500 mg olive leaf extract, 100 mg green coffee bean extract and 150 mg beet powder, or a matching placebo twice daily for six weeks, followed by the alternate supplement for a further six weeks. Assessments of 24-h ambulatory BP (ABP), clinic BP arterial compliance (pulse-wave analysis), blood lipids, blood glucose and insulin were obtained at baseline and at the end of each treatment phase. Baseline clinic BP in 37 overweight middle-aged men and women who completed the trial averaged 145/84 mmHg. There was no significant effect of treatment on ABP or any other outcome measure. The failure to confirm prior evidence of the antihypertensive benefits of these extracts emphasises the importance of placebo control and the value of ABP monitoring. Further dose-response evaluation of olive leaf, green coffee bean or beetroot extracts is required to confirm or refute the purported benefits.
C1 [Howe, Peter R. C.] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Clin Nutr Res Ctr, Callaghan, NSW 2308, Australia.
   Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Nutraceut Res Grp, Callaghan, NSW 2308, Australia.
C3 University of Newcastle; University of Newcastle
RP Howe, PRC (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Clin Nutr Res Ctr, Callaghan, NSW 2308, Australia.
EM rachel.wong@newcastle.edu.au; manohar.garg@newcastle.edu.au;
   lisa.wood@newcastle.edu.au; peter.howe@newcastle.edu.au
RI Wong, Rachel/D-8332-2012; Garg, Manohar/A-5795-2009; Howe,
   Peter/A-5006-2008; Wood, Lisa/G-7068-2013
OI Howe, Peter/0000-0001-6546-7742; Garg, Manohar/0000-0003-0514-0865;
   Wood, Lisa/0000-0002-0941-9225; Wong, Rachel/0000-0002-6550-5646
FU HealthWorld Ltd.
FX HealthWorld Ltd. provided the financial support and investigational
   products; however, they were at arm's length from the study, including
   trial design, management, data analysis and interpretation. The authors
   declare no conflict of interest.
CR Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843
   [Anonymous], 2005, HEART LUNG CIRC, V14, P275
   [Anonymous], 2011, EUR YB 2011, P33
   Asmar R, 2001, AM J HYPERTENS, V14, P546, DOI 10.1016/S0895-7061(00)01286-3
   Cassileth BR, 2009, PHARM BIOL, V47, P761, DOI 10.1080/13880200902991581
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Colagiuri S., 2009, National evidence based guideline for blood glucose control in type 2 diabetes
   De Bock M., 2013, PLOS ONE, V8, P1
   de Bock M, 2013, MOL NUTR FOOD RES, V57, P2079, DOI 10.1002/mnfr.201200795
   El SN, 2009, NUTR REV, V67, P632, DOI 10.1111/j.1753-4887.2009.00248.x
   GOULD AL, 1995, CIRCULATION, V91, P2274, DOI 10.1161/01.CIR.91.8.2274
   Hobbs DA, 2012, BRIT J NUTR, V108, P2066, DOI 10.1017/S0007114512000190
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Pannala AS, 2003, FREE RADICAL BIO MED, V34, P576, DOI 10.1016/S0891-5849(02)01353-9
   Perrinjaquet-Moccetti T, 2008, PHYTOTHER RES, V22, P1239, DOI 10.1002/ptr.2455
   Susalit E, 2011, PHYTOMEDICINE, V18, P251, DOI 10.1016/j.phymed.2010.08.016
   Suzuki A, 2002, HYPERTENS RES, V25, P99, DOI 10.1291/hypres.25.99
   van Velzen AG, 2008, TOXICOL LETT, V181, P177, DOI 10.1016/j.toxlet.2008.07.019
   Verdecchia P, 2000, HYPERTENSION, V35, P844, DOI 10.1161/01.HYP.35.3.844
   Visioli F, 1998, LIFE SCI, V62, P541, DOI 10.1016/S0024-3205(97)01150-8
   Wainstein J, 2012, J MED FOOD, V15, P605, DOI 10.1089/jmf.2011.0243
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Webb A, 2008, FASEB J, V22
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
NR 26
TC 17
Z9 17
U1 0
U2 37
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2014
VL 6
IS 11
BP 4881
EP 4894
DI 10.3390/nu6114881
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AU3RM
UT WOS:000345531300017
PM 25379688
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU van Dam, RM
   Hu, FB
AF van Dam, RM
   Hu, FB
TI Coffee consumption and risk of type 2 diabetes - A systematic review
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Review
ID CAFFEINE-INDUCED IMPAIRMENT; GLUCOSE-TOLERANCE; CHLOROGENIC ACID;
   BLOOD-GLUCOSE; INSULIN ACTION; LIFE-STYLE; METAANALYSIS; INGESTION;
   PLASMA; MEN
AB Context Emerging epidemiological evidence suggests that higher coffee consumption may reduce the risk of type 2 diabetes.
   Objective To examine the association between habitual coffee consumption and risk of type 2 diabetes and related outcomes.
   Data Sources and Study Selection We searched MEDLINE through January 2005 and examined the reference lists of the retrieved articles. Because this review focuses on studies of habitual coffee consumption and risk of type 2 diabetes, we excluded studies of type 1 diabetes, animal studies, and studies of short-term exposure to coffee or caffeine, leaving 15 epidemiological studies (cohort or cross-sectional).
   Data Extraction Information on study design, participant characteristics, measurement of coffee consumption and outcomes, adjustment for potential confounders, and estimates of associations was abstracted independently by 2 investigators.
   Data Synthesis We identified 9 cohort studies of coffee consumption and risk of type 2 diabetes, including 193 473 participants and 8394 incident cases of type 2 diabetes, and calculated summary relative risks (RRs) using a random-effects model. The RR of type 2 diabetes was 0.65 (95% confidence interval [CI], 0. 54-0.78) for the highest (>= 6 or >= 7 cups per day) and 0.72 (95% Cl, 0.62-0.83) for the second highest (4-6 cups per day) category of coffee-consumption compared with the lowest consumption category (0 or <= 2 cups per day). These associations did not differ substantially by sex, obesity, or region (United States and Europe). In the cross-sectional studies conducted in northern Europe, southern Europe, and Japan, higher coffee consumption was consistently associated with a lower prevalence of newly detected hyperglycemia, particularly postprandial hyperglycemia.
   Conclusions This systematic review supports the hypothesis that habitual coffee consumption is associated with a substantially lower risk of type 2 diabetes. Longer-term intervention studies of coffee consumption and glucose metabolism are warranted to examine the mechanisms underlying the relationship between coffee consumption and type 2 diabetes.
C1 Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
   Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Nutr & Hlth, Amsterdam, Netherlands.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard University Medical Affiliates; Brigham & Women's
   Hospital; Harvard University; Harvard Medical School; Vrije Universiteit
   Amsterdam
RP Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave,Bldg 2, Boston, MA 02115 USA.
EM rvan-dam@hsph.harvard.edu
RI Hu, Frank/C-1919-2013; van Dam, Rob/F-9674-2010; van Dam,
   Rob/A-6693-2009
OI van Dam, Rob/0000-0002-7354-8734
FU NIDDK NIH HHS [DK58845] Funding Source: Medline
CR Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   Andrade-Cetto A, 2001, J ETHNOPHARMACOL, V78, P145, DOI 10.1016/S0378-8741(01)00335-X
   [Anonymous], MODERN EPIDEMIOLOGY, DOI DOI 10.1002/(SICI)1097-0258(20000215)19:3335::AID-SIM3363.0.CO;2-Z
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI [10.1001/jama.291.10.1199-b, 10.1001/jama.291.10.1199-a]
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   Bracken MB, 2002, EPIDEMIOLOGY, V13, P165, DOI 10.1097/00001648-200203000-00011
   BROWN CR, 1989, PHARMACOL BIOCHEM BE, V34, P565, DOI 10.1016/0091-3057(89)90559-5
   Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185
   Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1063::AID-JSFA605>3.0.CO;2-Q]
   de Paulis T, 2002, EUR J PHARMACOL, V442, P215, DOI 10.1016/S0014-2999(02)01540-6
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   de Valk HW, 1999, NETH J MED, V54, P139, DOI 10.1016/S0300-2977(99)00005-4
   deGroot JGAJ, 1996, EUR J CLIN NUTR, V50, pS101
   DENARO CP, 1991, EUR J CLIN PHARMACOL, V40, P273, DOI 10.1007/BF00315208
   Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E
   Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Isogawa A, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12586-X
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   KAWACHI I, 1994, BRIT HEART J, V72, P269
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/nejmoa012512
   Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719
   Lane JD, 2004, DIABETES CARE, V27, P2047, DOI 10.2337/diacare.27.8.2047
   *NAT COFF ASS, 2002, NAT COFF DRINK TREND
   NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306
   PIETINEN P, 1988, PREV MED, V17, P183, DOI 10.1016/0091-7435(88)90062-X
   Pizziol A, 1998, EUR J CLIN NUTR, V52, P846, DOI 10.1038/sj.ejcn.1600657
   Pulido R, 2003, EUR J CLIN NUTR, V57, P1275, DOI 10.1038/sj.ejcn.1601685
   Reunanen A, 2003, LANCET, V361, P702, DOI 10.1016/S0140-6736(03)12583-4
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Robinson LE, 2004, J NUTR, V134, P2528, DOI 10.1093/jn/134.10.2528
   Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1111/j.0014-3820.2005.tb01004.x
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858
   Saremi A, 2003, DIABETES CARE, V26, P2211, DOI 10.2337/diacare.26.7.2211
   Schaafsma G., 1989, Voeding, V50, P223
   Schaefer B, 2004, ANN INTERN MED, V141, P321, DOI 10.7326/0003-4819-141-4-200408170-00016
   Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529
   Soriguer F, 2004, ANN INTERN MED, V141, P321, DOI 10.7326/0003-4819-141-4-200408170-00017
   Sutton AJ, 2000, STAT METHODS MED RES, V9, P421, DOI 10.1191/096228000701555244
   Svilaas A, 2004, J NUTR, V134, P562, DOI 10.1093/jn/134.3.562
   Tavani A, 2000, EUR J CANCER PREV, V9, P241, DOI 10.1097/00008469-200008000-00004
   Thong FSL, 2002, J APPL PHYSIOL, V92, P2347, DOI 10.1152/japplphysiol.01229.2001
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   Urgert R, 1996, BRIT MED J, V313, P1362, DOI 10.1136/bmj.313.7069.1362
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   Van Dam RM, 2004, DIABETES CARE, V27, P2990, DOI 10.2337/diacare.27.12.2990
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dam RM, 2003, ANN NUTR METAB, V47, P627
   van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040
   WACHMAN A, 1970, METABOLIS, V19, P539, DOI 10.1016/0026-0495(70)90009-0
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
   Yoshioka K, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12585-8
NR 62
TC 497
Z9 534
U1 1
U2 92
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD JUL 6
PY 2005
VL 294
IS 1
BP 97
EP 104
DI 10.1001/jama.294.1.97
PG 8
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 941JD
UT WOS:000230210200030
PM 15998896
DA 2025-04-28
ER

PT J
AU Alshahrani, SH
   Atia, YA
   Badir, RA
   Almalki, SG
   Tayyib, NA
   Shahab, S
   Romero-Parra, RM
   Abid, MK
   Hussien, BM
   Ramaiah, P
AF Alshahrani, Shadia Hamoud
   Atia, Yasir A.
   Badir, Raheem Atiya
   Almalki, Sami G.
   Tayyib, Nahla A.
   Shahab, Sana
   Romero-Parra, Rosario Mireya
   Abid, Mohammed Kadhem
   Hussien, Beneen M.
   Ramaiah, Pushpamala
TI Dietary caffeine intake is associated with favorable metabolic profile
   among apparently healthy overweight and obese individuals
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Dietary caffeine intake; Obesity; Overweight; Metabolic parameters;
   Glycemic status
ID QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; WEIGHT-LOSS; DECAFFEINATED COFFEE;
   INSULIN SENSITIVITY; SERUM-CHOLESTEROL; TEA CONSUMPTION; RISK;
   HYPERTENSION; METAANALYSIS
AB Background: Recent studies have revealed some conflicting results about the health effects of caffeine. These studies are inconsistent in terms of design and population and source of consumed caffeine. In the current study, we aimed to evaluate the possible health effects of dietary caffeine intake among overweight and obese individuals.Methods: In this cross-sectional study, 488 apparently healthy individuals with overweight and obesity were participated. Dietary intake was assessed by a Food Frequency Questionnaire (FFQ) and the amount of dietary caffeine was calculated. Body composition was determined by bioelectrical impedance analysis (BIA). Enzymatic methods were used to evaluate serum lipid, glucose, and insulin concentrations.Results: Those at the highest tertile of dietary caffeine intake had lower percentage of fat mass, higher fat free mass and appetite score (P < 0.05). Also, lower total cholesterol (TC) and low density lipoprotein cholesterol (LDL-c) was observed in higher tertiles of dietary caffeine intake compared with lower tertiles. In multinomial adjusted models, those at the second tertile of dietary caffeine intake were more likely to have higher serum insulin (P = 0.04) and lower homeostatic model assessment of insulin resistance (HOMA-IR) values compared with first tertile (P = 0.03) in crude model. While, in the age, body mass index (BMI), sex, physical activity, socio-economic status (SES) and energy intake -adjusted model (Model III), those at the third tertile of dietary caffeine intake were more likely to have low serum LDL concentrations [odds ratio (OR) = 0.957; CI = 0.918-0.997; P = 0.04]. With further adjustment to dietary vegetable, fiber and grain intake, those at the third tertile of dietary caffeine intake were more likely to have low systolic blood pressure (SBP), LDL and high HDL levels compared with those at the first tertile (P < 0.05).Conclusion: High intakes of dietary caffeine was associated with lower LDL, SBP, insulin resistance and higher HDL concentrations among overweight and obese individuals. However, due to observational design of the study, causal inference is impossible and further studies are warranted to confirm our findings.
C1 [Alshahrani, Shadia Hamoud] King Khalid Univ, Med Surg Nursing Dept, Khamis Mushate, Saudi Arabia.
   [Atia, Yasir A.] Univ Baghdad, Al Kindy Coll Med, Dept Med Chem, Baghdad, Iraq.
   [Badir, Raheem Atiya] Al Bayan Univ, Coll Nursing, Baghdad, Iraq.
   [Almalki, Sami G.] Majmaah Univ, Coll Appl Med Sci, Dept Med Lab Sci, Majmaah 11952, Saudi Arabia.
   [Tayyib, Nahla A.] Umm Al Qura Univ, Fac Nursing, Postgrad Res & Sci Studies, Mecca, Saudi Arabia.
   [Shahab, Sana] Princess Nourah Bint Abdulrahman Univ, Coll Business Adm, Dept Business Adm, POB 84428, Riyadh 11671, Saudi Arabia.
   [Romero-Parra, Rosario Mireya] Univ Continental, Univ Continental Lima, Dept Gen Studies, Lima, Peru.
   [Abid, Mohammed Kadhem] Al Ayen Univ, Coll Hlth & Med Technol, Dept Anesthesia, Thi Qar, Iraq.
   [Hussien, Beneen M.] Islamic Univ, Coll Med Technol, Med Lab Technol Dept, Najaf, Iraq.
   [Ramaiah, Pushpamala] Umm Al Qura Univ, Fac Nursing, Mecca, Saudi Arabia.
C3 King Khalid University; University of Baghdad; Al-Bayan University;
   Majmaah University; Umm Al-Qura University; Princess Nourah bint
   Abdulrahman University; Universidad Continental; Al-Ayen University;
   Islamic University College; Umm Al-Qura University
RP Atia, YA (corresponding author), Univ Baghdad, Al Kindy Coll Med, Dept Med Chem, Baghdad, Iraq.; Romero-Parra, RM (corresponding author), Univ Continental, Univ Continental Lima, Dept Gen Studies, Lima, Peru.
EM yasirabas@kmc.uobaghdad.edu.iq
RI Romero-Parra, Rosario/ABD-2076-2020; alshahrani, shadia/HGU-3299-2022;
   Tayyib, Nahla/AAE-6025-2022; Atia, Yasir Abbas/KCL-5952-2024; Ramaiah,
   Pushpamala/AFF-0997-2022; Shahab, Siyamak/E-1399-2016
OI kadhem abid, mohammed/0000-0001-7499-9054; Ramaiah, Prof.
   Pushpamala/0000-0001-8324-7807; Alshahrani, Shadia/0000-0002-1428-787X
FU This research was supported by the Princess Nourah bint Abdulrahman
   University Researchers Supporting Project number (PNURSP2023R259),
   Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
   [PNURSP2023R259]; Princess Nourah bint Abdulrahman University
   Researchers Supporting Project; Princess Nourah bint Abdulrahman
   University, Riyadh, Saudi Arabia
FX This research was supported by the Princess Nourah bint Abdulrahman
   University Researchers Supporting Project number (PNURSP2023R259),
   Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Al-Obaidi ZMJ, 2022, EGYPT J CHEM, V65, P433, DOI 10.21608/EJCHEM.2021.106753.4898
   Ali AM, 2017, ASIAN J PSYCHIATR, V30, P56, DOI 10.1016/j.ajp.2017.07.018
   Alquhaidan M, 2018, TROP J PHARM RES, V17, P2335, DOI 10.4314/tjpr.v17i12.3
   Altaher Y, 2022, J NANOMATER, V2022, DOI 10.1155/2022/4013016
   ANDERSON JW, 1987, AM J CARDIOL, V60, pG17, DOI 10.1016/0002-9149(87)90587-X
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bozkir Ç, 2024, NUTR HEALTH-UK, V30, P139, DOI 10.1177/02601060221105030
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Cardoso FB., 2023, Nurture, V17, P455, DOI [10.55951/nurture.v17i3.369, DOI 10.55951/NURTURE.V17I3.369]
   Castellana F, 2021, FOODS, V10, DOI 10.3390/foods10102458
   Chei CL, 2018, EUR J NUTR, V57, P1333, DOI 10.1007/s00394-017-1412-4
   Chen S, 2022, Front Nutr, P9
   Chen S, 2021, REV PSICOL DEPORTE, V30, P1
   Chen X, 2019, FOOD POLICY, V87, DOI 10.1016/j.foodpol.2019.101746
   CURB JD, 1986, AM J EPIDEMIOL, V123, P648, DOI 10.1093/oxfordjournals.aje.a114284
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Farhangi MA, 2017, EAT WEIGHT DISORD-ST, V22, P451, DOI 10.1007/s40519-016-0288-2
   Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083
   Gaeini Z, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0355-6
   Gallegos-Gonzalez G, 2021, AM J HEALTH BEHAV, V45, P1091, DOI 10.5993/AJHB.45.6.12
   Gaspar S., 2016, Consumption and health effects, P573, DOI 10.1016/B978-0-12-384947-2.00099-4
   Gosadi IM, 2017, SAUDI MED J, V38, P636, DOI 10.15537/smj.2017.6.20055
   Grant SS, 2018, INT J PSYCHOPHYSIOL, V133, P193, DOI 10.1016/j.ijpsycho.2018.07.001
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Guerra ZC, 2022, AM J HEALTH BEHAV, V46, P324, DOI 10.5993/AJHB.46.3.11
   Hagen K, 2009, J HEADACHE PAIN, V10, P153, DOI 10.1007/s10194-009-0114-6
   Hakim IA, 2003, PREV MED, V36, P64, DOI 10.1006/pmed.2002.1130
   Hjazi A, 2023, PHYTOTHER RES, V37, P3859, DOI 10.1002/ptr.7922
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Hyder K M., 2021, Journal of Natural Science, Biology and Medicine, V12, P230, DOI DOI 10.4103/JNSBM.JNSBM_222_20
   Imatoh T, 2011, EUR J NUTR, V50, P279, DOI 10.1007/s00394-010-0136-5
   JENSEN J, 1990, MATURITAS, V12, P321, DOI 10.1016/0378-5122(90)90012-U
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Kamolthip R, 2021, AM J HEALTH BEHAV, V45, P828, DOI 10.5993/AJHB.45.5.3
   Kandeel M., 2021, Bioinformatics of thymidine metabolism in Trypanosoma evansi: exploring nucleoside deoxyribosyltransferase (NDRT) as a drug target
   Kawakami R, 2023, BRIT J NUTR, V130, P127, DOI 10.1017/S0007114522003099
   Kim K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167007
   Kumar V, 2018, Nutrition & Food Science
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Liu AG, 2015, OBESITY, V23, P1830, DOI 10.1002/oby.21163
   Liu AG, 2013, OBESITY, V21, P1991, DOI 10.1002/oby.20416
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Mazeaud S, 2022, METABOLITES, V12, DOI 10.3390/metabo12070654
   Mirmiran P, 2009, METABOLISM, V58, P460, DOI 10.1016/j.metabol.2008.11.002
   Pour-Abbasi MS, 2023, BMC ENDOCR DISORD, V23, DOI 10.1186/s12902-022-01243-9
   Rhee JJ, 2016, AM J CLIN NUTR, V103, P210, DOI 10.3945/ajcn.115.120147
   Rifai N., 2017, Tietz textbook of clinical chemistry and molecular diagnostics-e-book, V6th
   SALVAGGIO A, 1991, AM J EPIDEMIOL, V134, P149, DOI 10.1093/oxfordjournals.aje.a116067
   Shen HF, 2014, AM J GASTROENTEROL, V109, pS158, DOI 10.1177/1756283X15593700
   SHIRLOW MJ, 1984, INT J EPIDEMIOL, V13, P422, DOI 10.1093/ije/13.4.422
   Spence C, 2020, FOOD QUAL PREFER, V80, DOI 10.1016/j.foodqual.2019.103802
   Staessen JA., 1994, Hypertens Postmenopausal Women, P15
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3
   WALTON C, 1993, EUR J CLIN INVEST, V23, P466, DOI 10.1111/j.1365-2362.1993.tb00792.x
   Washburn RA, 2000, RES Q EXERCISE SPORT, V71, pS79, DOI 10.1080/02701367.2000.11082790
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6
   Zelenovic M, 2022, REV PSICOL DEPORTE, V31, P1
NR 62
TC 5
Z9 5
U1 3
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD OCT 20
PY 2023
VL 23
IS 1
AR 227
DI 10.1186/s12902-023-01477-1
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA X6KM4
UT WOS:001099518800003
PM 37864190
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Hua, YN
   Ren, SY
   Guo, R
   Rogers, O
   Nair, RP
   Bagchi, D
   Swaroop, A
   Nair, S
AF Hua, Yinan
   Ren, Sidney Y.
   Guo, Rui
   Rogers, Olivia
   Nair, Rama P.
   Bagchi, Debasis
   Swaroop, Anand
   Nair, Sreejayan
TI Furostanolic saponins from Trigonella foenum-graecum
   alleviate diet-induced glucose intolerance and hepatic fat accumulation
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Fenugreek; Glucose Intolerance; Green coffee bean; Obesity
ID INDUCED INSULIN-RESISTANCE; FENUGREEK SEED EXTRACT; CHLOROGENIC ACID;
   GLYCEMIC CONTROL; OBESITY; SUPPLEMENTATION; METAANALYSIS; METABOLISM;
   CAFFEINE
AB Scope: The objective of this study was to evaluate the effect of fenugreek furostanolic saponins (Fenfuro (TM)) either alone or in combination with chlorogenic acid (GCB-70 (TM)) on insulin resistance in mice.
   Methods and results: Male C57BL/6J mice were subjected to a normal or high-fat diet (HFD) and were randomly assigned to receive Fenfuro (TM), GCB-70 (TM), or their combination for 24 wk. Metabolic parameters, glucose tolerance, serum triglycerides, cardiac function, and hepatic insulin signaling were evaluated using indirect open-circuit calorimetry, intraperitoneal glucose tolerance test, oil red O staining, echocardiography, and Western blotting, respectively. Intraperitoneal glucose tolerance test revealed glucose intolerance in the mice receiving HFD, which was attenuated by Fenfuro (TM). Serum triglyceride that was elevated following an HFD was reconciled by both Fenfuro (TM) and the combination. HFD compromised myocardial contractile function, which was unaffected by the treatment. Insulin-stimulated phosphorylation of Protein kinase B (AKT) in the liver was attenuated in mice receiving HFD, which was partially rescued by GCB-70 (TM). Neither treatment altered metabolic parameters or energy expenditure.
   Conclusion: Collectively, our data suggest that fenugreek furostanolic saponins and green coffee bean extract may have potential benefits in treating insulin resistance and related conditions.
C1 [Hua, Yinan; Ren, Sidney Y.; Guo, Rui; Rogers, Olivia; Nair, Sreejayan] Univ Wyoming, Coll Hlth Sci, Sch Pharm, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.
   [Nair, Rama P.] Nutriwyo LLC, Div Res & Dev, Laramie, WY USA.
   [Bagchi, Debasis] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA.
   [Bagchi, Debasis; Swaroop, Anand] Cepham Inc, Div Res & Dev, Piscataway, NJ USA.
C3 University of Wyoming; University of Houston System; University of
   Houston
RP Nair, S (corresponding author), Univ Wyoming, Coll Hlth Sci, Sch Pharm, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.
EM sreejay@uwyo.edu
RI Hu, Nantao/AFS-0059-2022; Ye, Kai/B-3640-2012
FU Cepham Inc.
FX This study was funded by a research grant from Cepham Inc. that holds
   the patent for Fenfuro (TM) and GCB-70 (TM). A.S. is the CEO of Cepham,
   Concord, California, USA.
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   [Anonymous], 2014, BIOMED RES INT, DOI DOI 10.1155/2014/606021
   Beam JR, 2015, NUTRITION, V31, P292, DOI 10.1016/j.nut.2014.07.012
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Egede LE, 2002, DIABETES CARE, V25, P324, DOI 10.2337/diacare.25.2.324
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Haber S. L., 2013, AM J HEALTH-SYST PH, V70, P1202
   Haber S. L., 2013, AM J HEALTH-SYST PH, V70, P1200
   Haber SL, 2013, AM J HEALTH-SYST PH, V70, P1196, DOI 10.2146/ajhp120523
   Hamza N, 2012, J ETHNOPHARMACOL, V142, P516, DOI 10.1016/j.jep.2012.05.028
   Handa T, 2005, BIOSCI BIOTECH BIOCH, V69, P1186, DOI 10.1271/bbb.69.1186
   Haritha C, 2013, J Nat Sci Biol Med, V4, P207, DOI 10.4103/0976-9668.107292
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Hua YA, 2013, HYPERTENSION, V61, P1184, DOI 10.1161/HYPERTENSIONAHA.111.00947
   Hua YN, 2013, DIABETES, V62, P498, DOI 10.2337/db12-0350
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Kouzi Samir A, 2015, Front Biosci (Elite Ed), V7, P94
   KULKARNI GV, 1994, J CELL SCI, V107, P1169
   Mathern JR, 2009, PHYTOTHER RES, V23, P1543, DOI 10.1002/ptr.2795
   Maurya CK, 2014, MOL CELL ENDOCRINOL, V395, P51, DOI 10.1016/j.mce.2014.07.018
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Neelakantan N, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-7
   Panzhinskiy E, 2014, J PHARMACOL EXP THER, V349, P248, DOI 10.1124/jpet.113.208728
   Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016
   Rawat AK, 2014, FITOTERAPIA, V99, P307, DOI 10.1016/j.fitote.2014.10.006
   RIBES G, 1986, P SOC EXP BIOL MED, V182, P159
   SONG SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/718379
   Sreejayan N, 2008, OBESITY, V16, P1331, DOI 10.1038/oby.2008.217
   Suksomboon N, 2011, J ETHNOPHARMACOL, V137, P1328, DOI 10.1016/j.jep.2011.07.059
   Swaroop A, 2014, TOXICOL MECH METHOD, V24, P495, DOI 10.3109/15376516.2014.943443
   Vijayakumar MV, 2005, BRIT J PHARMACOL, V146, P41, DOI 10.1038/sj.bjp.0706312
   Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
NR 35
TC 15
Z9 15
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD OCT
PY 2015
VL 59
IS 10
BP 2094
EP 2100
DI 10.1002/mnfr.201500197
PG 7
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA CT1HZ
UT WOS:000362550700020
PM 26201993
DA 2025-04-28
ER

PT J
AU Jin, F
   Qiao, C
AF Jin, Feng
   Qiao, Chong
TI Association of maternal caffeine intake during pregnancy with low birth
   weight, childhood overweight, and obesity: a meta-analysis of cohort
   studies
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Review
ID COFFEE CONSUMPTION; PRETERM BIRTH; GROWTH; OUTCOMES; RISK
AB Background Epidemiological studies reported inconsistent results on the associations between maternal caffeine intake during pregnancy and risk of low birth weight (LBW) and childhood overweight and obesity in their offspring. Methods We conducted a meta-analysis of cohort studies to quantitatively assess these associations. Pertinent studies were identified by searching PubMed and Embase through June 2019. Study-specifics risk estimates were combined using fixed effects models, or random-effects models when significant heterogeneity was detected. Dose-response analysis was modeled by using restricted cubic splines. Results A total of 15 cohort studies, with 102,347 pregnancy women, was included in the meta-analysis. The pooled relative risk (RR) for LBW was 1.33 (95% CI: 1.12, 1.57) for mothers with the highest compared with the lowest level of caffeine intake during pregnancy, with significant heterogeneity across studies (I-2 = 49.3%,P = 0.032). The pooled RR was 1.07 (95% CI: 1.02, 1.11) for each 100 mg/day increase of caffeine intake. The pooled RR for childhood overweight and obesity was 1.39 (95% CI: 1.15, 1.69) for mothers with the highest compared with the lowest level of caffeine intake during pregnancy. No significant heterogeneity across studies was detected (I-2 = 38.9%,P = 0.179). The pooled RR was 1.31 (95% CI: 1.11, 1.55) for each 100 mg/day increase of caffeine intake. No evidence of publication bias was indicated. Conclusions Maternal caffeine intake during pregnancy is associated with higher risk of LBW and childhood overweight and obesity. Further studies may focus on investigating the potential mechanisms before the recommendation of complete avoidance of caffeine intake during pregnancy.
C1 [Jin, Feng; Qiao, Chong] China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China.
C3 China Medical University
RP Qiao, C (corresponding author), China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China.
EM qiaochong2002@hotmail.com
CR Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Bech BH, 2006, INT J EPIDEMIOL, V35, P948, DOI 10.1093/ije/dyl116
   Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332
   Bracken MB, 2003, AM J EPIDEMIOL, V157, P456, DOI 10.1093/aje/kwf220
   Chen LW, 2019, AM J CLIN NUTR, V109, P1648, DOI 10.1093/ajcn/nqz019
   Chen LW, 2018, AM J CLIN NUTR, V108, P1301, DOI 10.1093/ajcn/nqy219
   Cho Won Kyoung, 2016, Korean J Pediatr, V59, P1, DOI 10.3345/kjp.2016.59.1.1
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Desai M, 2011, SEMIN REPROD MED, V29, P237, DOI 10.1055/s-0031-1275517
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eskenazi B, 1999, EPIDEMIOLOGY, V10, P242, DOI 10.1097/00001648-199905000-00009
   FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763
   GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237
   Greenwood DC, 2014, EUR J EPIDEMIOL, V29, P725, DOI 10.1007/s10654-014-9944-x
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso LM, 2001, EPIDEMIOLOGY, V12, P447, DOI 10.1097/00001648-200107000-00015
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Jahanfar S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006965.pub4
   Li DK, 2015, INT J OBESITY, V39, P658, DOI 10.1038/ijo.2014.196
   LINN S, 1982, NEW ENGL J MED, V306, P141, DOI 10.1056/NEJM198201213060304
   MARTIN TR, 1987, AM J EPIDEMIOL, V126, P813, DOI 10.1093/oxfordjournals.aje.a114718
   MCDONALD AD, 1992, AM J PUBLIC HEALTH, V82, P87, DOI 10.2105/AJPH.82.1.87
   MILLS JL, 1993, JAMA-J AM MED ASSOC, V269, P593, DOI 10.1001/jama.269.5.593
   Modzelewska D, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2215-9
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2700]
   Okubo H, 2015, NUTR RES, V35, P309, DOI 10.1016/j.nutres.2015.02.009
   OLSEN J, 1991, EPIDEMIOLOGY, V2, P370, DOI 10.1097/00001648-199109000-00011
   Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265
   Papadopoulou E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018895
   Peacock A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030319
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Rhee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132334
   Roh E, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.4
   Sasaki S, 2017, PEDIATR RES, V82, P19, DOI 10.1038/pr.2017.70
   Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42
   Signorello LB, 2001, OBSTET GYNECOL, V98, P1059, DOI 10.1016/S0029-7844(01)01575-7
   van der Hoeven T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177619
   Vitti FP, 2018, REV BRAS GINECOL OBS, V40, P749, DOI 10.1055/s-0038-1675806
   Voerman E, 2016, OBESITY, V24, P1170, DOI 10.1002/oby.21466
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016
   Xu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044497
   ,, 2010, Obstetrics & Gynecology (New York), V116, P467
NR 43
TC 26
Z9 27
U1 8
U2 27
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD FEB
PY 2021
VL 45
IS 2
BP 279
EP 287
DI 10.1038/s41366-020-0617-4
EA JUN 2020
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA PY9SZ
UT WOS:000539167100001
PM 32518355
DA 2025-04-28
ER

PT J
AU Açikalin, B
   Sanlier, N
AF Acikalin, Busra
   Sanlier, Nevin
TI Coffee and its effects on the immune system
SO TRENDS IN FOOD SCIENCE & TECHNOLOGY
LA English
DT Article
DE Coffee; Caffeine; Chlorogenic acids; Cafestol; Kahweol; Immunity; Health
ID HUMAN LYMPHOCYTE-ACTIVATION; IN-VITRO; CYTOKINE RELEASE; GREEN COFFEE;
   CAFFEINE; ANTIOXIDANT; CONSUMPTION; MECHANISMS; TRIGONELLINE;
   AUTOIMMUNITY
AB Background: Coffee is one of the beverages consumed the most worldwide since ancient times. Previously, coffee used to be consumed due to its stimulating effect stemming from caffeine and its distinctive taste. In recent years, it has gone beyond being just a hot drink containing stimulating agents and has started to be consumed with the awareness about its positive effects on health. The compounds of coffee bearing antioxidant potential can be listed as caffeine, chlorogenic acids, caffeic acid, coumaric acid, nicotinic acid, ferulic acid, trigonelline, cafestol, and kahweol. Scope and approach: While it is reported that coffee impacts a range of chronic diseases including obesity, cancer, neurodegenerative and cardiovascular diseases due to the caffeine, chlorogenic acids, and diterpenoid alcohol it contains and that further research is needed in this respect, coffee is also related to a reduced risk of autoimmune diseases. This review aims to elaborate on the relationship between coffee consumption and the immune system. Key findings and conclusions: In addition, it has been highlighted in recent years that the above-mentioned compounds of coffee stimulate the immune system thanks to their antioxidant and anti-inflammatory effects. The positive effects of coffee on the immune system stem from caffeine, chlorogenic acids, kahweol, cafestol and similar compounds it contains. Particularly caffeine and polyphenols are considered as the main agents nourishing coffee with immunomodulatory characteristics depending on the daily dose of consumption.
C1 [Acikalin, Busra] Ankara Medipol Univ, Fac Fine Arts Design & Architecture, Dept Gastron & Culinary Arts, Ankara, Turkey.
   [Sanlier, Nevin] Ankara Medipol Univ, Sch Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey.
C3 Ankara Medipol University; Ankara Medipol University
RP Sanlier, N (corresponding author), Ankara Medipol Univ, Sch Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey.
EM nevin.sanlier@ankaramedipol.edu.tr
RI Sanlier, Nevin/W-7657-2018
OI Sanlier, Nevin/0000-0001-5937-0485
CR Abbasi A, 2018, LIFE SCI, V199, P41, DOI 10.1016/j.lfs.2018.03.009
   Agudelo-Ochoa GM, 2016, J NUTR, V146, P524, DOI 10.3945/jn.115.224774
   Al Reef T, 2018, IMMUNOBIOLOGY, V223, P818, DOI 10.1016/j.imbio.2018.08.011
   [Anonymous], 2016, CRIT REV FOOD SCI
   Arslan E., 2018, SPORMETRE, V16, P1
   Bharath Nagaraj, 2015, Contemp Clin Dent, V6, P166, DOI 10.4103/0976-237X.156036
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Bortoluzzi A, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1089-8
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Capek P, 2014, CARBOHYD POLYM, V103, P418, DOI 10.1016/j.carbpol.2013.12.068
   Cappelletti S, 2015, CURR NEUROPHARMACOL, V13, P71, DOI 10.2174/1570159X13666141210215655
   Cárdenas C, 2014, BIOCHEM BIOPH RES CO, V447, P452, DOI 10.1016/j.bbrc.2014.04.026
   Castro ACCM, 2018, FOOD CHEM, V246, P48, DOI 10.1016/j.foodchem.2017.10.153
   Chan JYM, 2017, BMC PUBLIC HEALTH, V17, DOI [10.1186/s12889-017-4362-0, 10.1186/s12906-017-1695-2, 10.1186/s12885-017-3378-2]
   Chavez-Valdez R, 2016, PEDIATR RES, V80, P101, DOI 10.1038/pr.2016.50
   Chowdhury P, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.590716
   Clark I, 2017, SLEEP MED REV, V31, P70, DOI 10.1016/j.smrv.2016.01.006
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Di Dalmazi G, 2016, AUTOIMMUN HIGHLIGHTS, V7, DOI 10.1007/s13317-016-0083-0
   Di Matteo G, 2020, FOODS, V9, DOI 10.3390/foods9081036
   Dulson DK, 2016, APPL PHYSIOL NUTR ME, V41, P224, DOI 10.1139/apnm-2015-0456
   El-Abhar HS, 2014, WORLD J DIABETES, V5, P176, DOI 10.4239/wjd.v5.i2.176
   Esquivel P, 2012, FOOD RES INT, V46, P488, DOI 10.1016/j.foodres.2011.05.028
   Farah A., 2012, Coffee Constituents. Coffee: Emerging Health Effects and Disease Prevention
   Farah Adriana, 2006, Braz. J. Plant Physiol., V18, P23, DOI 10.1590/S1677-04202006000100003
   Ferreira SS, 2018, FOOD CHEM, V242, P548, DOI 10.1016/j.foodchem.2017.09.059
   Fletcher DK, 2012, SCAND J MED SCI SPOR, V22, P249, DOI 10.1111/j.1600-0838.2010.01223.x
   Folwarczna J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030133
   Francis S, 2019, EARLY MOD EXCHANGE, P1, DOI 10.1080/14789450.2019.1697236
   Gebeyehu B T., 2015, American Journal of Applied Chemistry, V3, P69, DOI [10.11648/j.ajac.20150302.16, DOI 10.11648/J.AJAC.20150302.16]
   Gökcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   Gostner JM, 2015, J AM COLL NUTR, V34, P212, DOI 10.1080/07315724.2014.907756
   Green TD, 2012, J LEUKOCYTE BIOL, V92, P633, DOI 10.1189/jlb.1211604
   Hashemian F, 2020, EUR J PHARMACOL, V887, P1
   Hirakawa N, 2005, BIOSCI BIOTECH BIOCH, V69, P653, DOI 10.1271/bbb.69.653
   Ilhan M, 2014, EVID-BASED COMPL ALT, V2014, P1, DOI 10.1155/2014/578103
   Jäger A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x
   Jia HJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0389-3
   Jung S, 2017, J MED FOOD, V20, P626
   Kale L. B., 2017, International Journal of Community Medicine and Public Health, V4, P835
   Kelly, 2013, P INT CYT SOC ANN M
   Köröglu ÖA, 2014, NEONATOLOGY, V106, P235, DOI 10.1159/000363217
   Kurzrock T, 2001, FOOD REV INT, V17, P433, DOI 10.1081/FRI-100108532
   Lee KA, 2012, J BIOMED SCI, V19, DOI [10.1186/1423-0127-19-60, 10.6117/kmeps.2012.19.3.001]
   Liu CW, 2018, AM J PHYSIOL-ENDOC M, V314, pE433, DOI 10.1152/ajpendo.00094.2017
   Loftfield E, 2015, CANCER EPIDEM BIOMAR, V24, P1052, DOI 10.1158/1055-9965.EPI-15-0038-T
   López-Barrera DM, 2016, FOOD CHEM, V212, P282, DOI 10.1016/j.foodchem.2016.05.175
   Mesías M, 2014, FOOD RES INT, V62, P1120, DOI 10.1016/j.foodres.2014.05.058
   Molina N, 2015, INT IMMUNOPHARMACOL, V28, P985, DOI 10.1016/j.intimp.2015.08.011
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Niseteo T, 2012, FOOD CHEM, V134, P1870, DOI 10.1016/j.foodchem.2012.03.095
   Owoyele B V, 2015, Afr J Med Med Sci, V44, P229
   Pimentel GD, 2014, NUTRITION IN THE PREVENTION AND TREATMENT OF ABDOMINAL OBESITY, P245, DOI 10.1016/B978-0-12-407869-7.00024-6
   Pohanka M, 2015, J APPL BIOMED, V13, P1, DOI 10.1016/j.jab.2014.09.001
   Pourshahidi LK, 2016, COMPR REV FOOD SCI F, V15, P671, DOI 10.1111/1541-4337.12206
   Ramamoorthy V, 2017, J ASSOC NURSE AIDS C, V28, P897, DOI 10.1016/j.jana.2017.07.008
   Ramanaviciene A, 2004, J PHARM PHARMACOL, V56, P671, DOI 10.1211/0022357023268
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Reichardt N, 2009, MOL NUTR FOOD RES, V53, P287, DOI 10.1002/mnfr.200700509
   Revuelta-Iniesta R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/482704
   Reyes CM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111772
   Samieirad S, 2017, J CRANIO MAXILL SURG, V45, P1614, DOI 10.1016/j.jcms.2017.06.014
   Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005
   Semen S, 2017, FOOD CHEM, V215, P92, DOI 10.1016/j.foodchem.2016.07.176
   Sharif K, 2017, AUTOIMMUN REV, V16, P712, DOI 10.1016/j.autrev.2017.05.007
   Sharma D., 2020, AIJR PREPRINTS, V78, P1
   Steck RP, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.180
   Tek N., 2017, KAHVE TUKETIMI VE BA
   Toci AT, 2008, FOOD CHEM, V108, P1133, DOI 10.1016/j.foodchem.2007.11.064
   Tofalo R, 2016, The Encyclopedia of Food and Health, P2
   Tomas-Barberan F., 2011, TEAS COCOA COFFEE PL, P169
   Tunc T, 2013, REGUL PEPTIDES, V182, P41, DOI 10.1016/j.regpep.2012.12.016
   Valdez RC, 2011, J PEDIATR-US, V158, P38, DOI 10.1016/j.jpeds.2010.06.051
   Vázquez-Sánchez K, 2018, FOOD CHEM, V261, P253, DOI 10.1016/j.foodchem.2018.04.064
   Viani R., 2005, ESPRESSO COFFEE SCI, P148
   Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582
   Wachamo H L., 2017, Medicinal Aromatic Plants, V6, DOI [DOI 10.4172/2167-0412.1000301, 10.4172/2155-9821.1000301, DOI 10.4172/2155-9821.1000301]
   Xu JG, 2012, J AGR FOOD CHEM, V60, P11625, DOI 10.1021/jf303771s
   Yesilada E, 2015, BESIN DESTEKLERI VE
   You DC, 2011, TOX RESEARCH, V27, P7, DOI 10.5487/TR.2011.27.1.007
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
   Zhang C, 2012, FOOD RES INT, V49, P27, DOI 10.1016/j.foodres.2012.06.032
   Zhou J, 2012, CURR MED CHEM, V19, P3523, DOI 10.2174/092986712801323171
   Zhou JY, 2013, FUND CLIN PHARMACOL, V27, P279, DOI 10.1111/j.1472-8206.2011.01022.x
NR 84
TC 30
Z9 31
U1 5
U2 62
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0924-2244
EI 1879-3053
J9 TRENDS FOOD SCI TECH
JI Trends Food Sci. Technol.
PD AUG
PY 2021
VL 114
BP 625
EP 632
DI 10.1016/j.tifs.2021.06.023
EA JUN 2021
PG 8
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA TD3EQ
UT WOS:000669214600014
DA 2025-04-28
ER

PT J
AU Yin, HY
   Zhu, W
   Guo, LQ
   Li, WS
   Liang, M
AF Yin, Huangyi
   Zhu, Wei
   Guo, Liuqing
   Li, Weishan
   Liang, Min
TI Association between coffee intake and skeletal muscle mass among US
   adults: a population-based study
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE caffeine intake; caffeinated coffee; decaffeinated coffee; skeletal
   muscle mass; obesity
ID NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; CONSUMPTION; SARCOPENIA;
   AUTOPHAGY; OBESITY; ACTIVATION
AB Background: A limited number of studies have reported that the possible effects of coffee intake on skeletal muscle mass, but the results have been inconsistently conclusive and there are no large sample studies concerning the U.S. population. Therefore, the purpose of our study was to explore the connection between coffee consumption and skeletal muscle mass in U.S. adults. Methods: The population for this cross-sectional study was drawn from the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2018. Appendicular lean mass was accurately obtained from DXA, and skeletal muscle mass was assessed using appendicular skeletal muscle mass adjusted for body mass index (ASMBMI). Coffee and caffeine consumptions were obtained on a 24-h dietary recall questionnaire. Furthermore, the associations between coffee and caffeine intake and skeletal muscle mass were evaluated using three multiple linear regression models and smoothed curve fitting. Subgroup analyses based on age, gender, ethnicity and body mass index (BMI) were performed to assess the robustness of these relationships. Results: This cross-sectional survey included a total of 8,333 participants. After adjusting for all covariates, higher intake of coffee, caffeinated coffee, and caffeine was associated with elevated ASMBMI (coffee: beta = 0.01, 95% CI: 0.01, 0.02, P-value < 0.001; caffeinated coffee: beta = 0.01, 95% CI: 0.01, 0.02, P-value < 0.001; caffeine: beta = 0.02, 95% CI: 0.01, 0.04, P-value < 0.001). Meanwhile, smoothed curve fitting showed that coffee, caffeinated coffee, and caffeine intake were linearly and positively associated with ASMBMI. After further stratification by sex, age, and ethnicity, the positive relationships between coffee (especially caffeinated coffee) and caffeine intake and ASMBMI were not modified (P for interaction > 0.05). However, these relationships disappeared when the BMI over 30 kg/m(2). Conclusions: In general, consumption of coffee and caffeine is positively associated with skeletal muscle mass. Therefore, an appropriate increase in coffee and caffeine intake may be advocated in populations at high risk for low skeletal muscle mass.
C1 [Yin, Huangyi; Zhu, Wei; Guo, Liuqing; Li, Weishan] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China.
   [Liang, Min] Guangxi Med Univ, Affiliated Hosp 1, Geriatr Endocrinol, Nanning, Peoples R China.
C3 Guangxi Medical University; Guangxi Medical University
RP Liang, M (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Geriatr Endocrinol, Nanning, Peoples R China.
EM liangm@gxmu.edu.cn
RI 朱, 玮/HKN-1733-2023
FU Guangxi Natural Science Foundation [2023GXNSFAA026148]
FX The author(s) declare financial support was received for the research,
   authorship, and/or publication of this article. This work was supported
   by grants from the Guangxi Natural Science Foundation project
   (2023GXNSFAA026148).
CR Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Chen JQ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/1476-511X-14-2
   Choi S, 2023, BRIT J NUTR, V130, P2146, DOI 10.1017/S0007114523001241
   Chung H, 2017, KOREAN J FAM MED, V38, P141, DOI 10.4082/kjfm.2017.38.3.141
   Clark LJ, 2009, AM J ALZHEIMERS DIS, V24, P461, DOI 10.1177/1533317509345154
   Egawa T, 2009, METABOLISM, V58, P1609, DOI 10.1016/j.metabol.2009.05.013
   Farvid MS, 2021, BRIT J CANCER, V124, P1873, DOI 10.1038/s41416-021-01277-1
   Feng J, 2021, NURS REP, V11, P901, DOI 10.3390/nursrep11040083
   Guo YT, 2014, EXP GERONTOL, V50, P1, DOI 10.1016/j.exger.2013.11.005
   Hong YP, 2024, FRONT NUTR, V11, DOI 10.3389/fnut.2024.1393596
   Huang Q, 2024, J HAZARD MATER, V464, DOI 10.1016/j.jhazmat.2023.133005
   Hussain T, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7432797
   Iwasaka C, 2021, GERIATR GERONTOL INT, V21, P950, DOI 10.1111/ggi.14264
   Jang YJ, 2018, FOOD FUNCT, V9, P1102, DOI [10.1039/c7fo01683b, 10.1039/C7FO01683B]
   Kawakami R, 2023, BRIT J NUTR, V130, P127, DOI 10.1017/S0007114522003099
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   Kolb H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041144
   Lee DY, 2023, FRONT PUBLIC HEALTH, V11, DOI 10.3389/fpubh.2023.990029
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Li SY, 2023, FRONT NUTR, V10, DOI 10.3389/fnut.2023.1109824
   Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911
   Martini D, 2016, MOLECULES, V21, DOI 10.3390/molecules21080979
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   Mathew TS, 2014, BIOCHEM BIOPH RES CO, V453, P411, DOI 10.1016/j.bbrc.2014.09.094
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Murdock DJ, 2022, SKELET MUSCLE, V12, DOI 10.1186/s13395-022-00309-5
   Nicolopoulos K, 2020, CLIN NUTR, V39, P3467, DOI 10.1016/j.clnu.2020.03.009
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Pallauf K, 2013, AGEING RES REV, V12, P237, DOI 10.1016/j.arr.2012.03.008
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Pietrocola F, 2014, CELL CYCLE, V13, P1987, DOI 10.4161/cc.28929
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558
   Ribeiro M, 2024, CRIT REV FOOD SCI, V64, P562, DOI 10.1080/10408398.2022.2106938
   Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S
   Sanchez AMJ, 2014, AM J PHYSIOL-REG I, V307, pR956, DOI 10.1152/ajpregu.00187.2014
   Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006
   Tuttle CSL, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101185
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Zhao WM, 2019, INT J BIOL SCI, V15, P1571, DOI 10.7150/ijbs.34211
NR 42
TC 0
Z9 0
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD AUG 7
PY 2024
VL 11
AR 1390309
DI 10.3389/fnut.2024.1390309
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA D2V6G
UT WOS:001294818300001
PM 39171111
OA Green Published
DA 2025-04-28
ER

PT J
AU Nerurkar, PV
   Gandhi, K
   Chen, JJ
AF Nerurkar, Pratibha, V
   Gandhi, Krupa
   Chen, John J.
TI Correlations between Coffee Consumption and Metabolic Phenotypes, Plasma
   Folate, and Vitamin B12: NHANES 2003 to 2006
SO NUTRIENTS
LA English
DT Article
DE coffee; metabolic healthy obesity; metabolically healthy phenotype;
   metabolically unhealthy phenotypes
ID TOTAL HOMOCYSTEINE CONCENTRATIONS; RANDOMIZED CONTROLLED-TRIAL;
   ALL-CAUSE MORTALITY; BODY-MASS INDEX; HEALTHY OBESITY; FOLLOW-UP;
   SERUM-CHOLESTEROL; NORMAL-WEIGHT; RISK; CAFFEINE
AB Metabolic syndrome (MetS) is prevalent not only among the overweight and obese but also normal weight individuals, and the phenotype is referred to as a metabolically unhealthy phenotype (MUHP). Besides normal weight individuals, overweight/obese individuals are also protected from MetS, and the phenotype is known as a metabolically healthy phenotype (MHP). Epidemiological studies indicate that coffee and micronutrients such as plasma folate or vitamin B12 (vit. B12) are inversely associated with MetS. However, correlations among coffee consumption metabolic phenotypes, plasma folate, and vit. B12 remain unknown. Our objective was to investigate the correlation between coffee consumption, metabolic phenotypes, plasma folate, and vit. B12 as well as to understand associations between plasma folate, vit. B12, and metabolic phenotypes. Associations among coffee consumption metabolic phenotypes, plasma folate, and vit. B12 were assessed in a cross-sectional study of 2201 participants, 18 years or older, from 2003-2004 and 2005-2006 National Health and Nutrition Examination Surveys (NHANES). MUHP was classified as having > three metabolic abnormalities. Coffee consumption was not associated with metabolic phenotypes, but negatively correlated with several metabolic variables, including BMI (p < 0.001). Plasma folate was positively associated with MUHP (p < 0.004), while vit. B12 was inversely associated with MUHP (p < 0.035). Our results suggest the potential protective impact of coffee on individual components of MetS and indicate a positive correlation between coffee consumption and MUHP among overweight individuals. Identifying possible dietary factors may provide practical and low-cost dietary intervention targets, specifically for early intervention. Larger and randomized intervention studies and prospective longitudinal studies are required to further evaluate these associations.
C1 [Nerurkar, Pratibha, V] Univ Hawaii Manoa, Coll Trop Agr & Human Resources CTAHR, Dept Mol Biosci & Bioengn MBBE, Lab Metab Disorders & Alternat Med, Honolulu, HI 96822 USA.
   [Gandhi, Krupa] Thomas Jefferson Univ Hosp, Div Biostat, Philadelphia, PA 19107 USA.
   [Chen, John J.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Quantitat Hlth Sci, Honolulu, HI 96813 USA.
C3 University of Hawaii System; University of Hawaii Manoa; Thomas
   Jefferson University; University of Hawaii System; University of Hawaii
   Manoa
RP Nerurkar, PV (corresponding author), Univ Hawaii Manoa, Coll Trop Agr & Human Resources CTAHR, Dept Mol Biosci & Bioengn MBBE, Lab Metab Disorders & Alternat Med, Honolulu, HI 96822 USA.
EM pratibha@hawaii.edu; krupa.gandhi@jefferson.edu; jjchen@hawaii.edu
RI Chen, John/KQU-2986-2024; Gandhi, Krupa/K-6605-2019
FU Agriculture and Food Research Initiative, National Institute of Food and
   Agriculture, USDA [HAW05023-R, HAW00598-H, W3122, W4122, HAW00526-H,
   2004-34135-15182]; National Institute of Health (NIH) [U54MD007601]
FX This work was supported partly by grants to PVN from Agriculture and
   Food Research Initiative, National Institute of Food and Agriculture,
   USDA (HAW05023-R, HAW00598-H, W3122, W4122, HAW00526-H,
   2004-34135-15182). J.J.C. was partially supported by the U54MD007601
   (Ola HAWAII) grant from the National Institute of Health (NIH).
CR Al-khalidi B, 2019, CLIN NUTR, V38, P820, DOI 10.1016/j.clnu.2018.02.025
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/c7fo00388a, 10.1039/C7FO00388A]
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Bidel Siamak, 2013, Eur Endocrinol, V9, P99, DOI 10.17925/EE.2013.09.02.99
   Bird JK, 2015, J NUTR, V145, P79, DOI 10.3945/jn.114.199117
   Calcaterra V, 2019, MED PRIN PRACT, V28, P48, DOI 10.1159/000494138
   Choi MK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1166
   Corrêa TAF, 2013, NUTRITION, V29, P977, DOI 10.1016/j.nut.2013.01.003
   CURB JD, 1986, AM J EPIDEMIOL, V123, P648, DOI 10.1093/oxfordjournals.aje.a114284
   DAVIS BR, 1988, AM J EPIDEMIOL, V128, P124, DOI 10.1093/oxfordjournals.aje.a114935
   Davis J, 2013, ETHNIC DIS, V23, P65
   De Lorenzo A, 2017, OBES RES CLIN PRACT, V11, P315, DOI 10.1016/j.orcp.2016.08.009
   de Winter M, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/7496768
   DESAI HG, 1973, GASTROENTEROLOGY, V65, P694
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009
   Esposito F, 2003, ALIMENT PHARM THER, V17, P595, DOI 10.1046/j.1365-2036.2003.01429.x
   Esteghamati A, 2014, DIABETES METAB, V40, P347, DOI 10.1016/j.diabet.2014.02.007
   Flores-Guerrero JL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19274
   Gonçalves CG, 2016, NUTRITION, V32, P14, DOI 10.1016/j.nut.2015.07.010
   Grubben MJ, 2000, AM J CLIN NUTR, V71, P480
   Hall YN, 2011, ETHNIC DIS, V21, P40
   Han LY, 2017, AM J CLIN NUTR, V106, P1321, DOI 10.3945/ajcn.117.156232
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035
   Heinzle S, 2016, PEDIATR OBES, V11, P425, DOI 10.1111/ijpo.12083
   Hosseinpanah F, 2014, EUR J CLIN NUTR, V68, P295, DOI 10.1038/ejcn.2013.142
   Kanth V V Ravi, 2011, J Cardiovasc Dis Res, V2, P156, DOI 10.4103/0975-3583.85262
   Karelis AD, 2014, DIABETES METAB, V40, P319, DOI 10.1016/j.diabet.2014.03.001
   Karelis AD, 2004, DIABETES OBES METAB, V6, P456, DOI 10.1111/j.1462-8902.2004.00377.x
   Kawada T, 2019, INT J FOOD SCI NUTR, V70, P651, DOI 10.1080/09637486.2018.1563878
   Kim AN, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155379
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002335
   Kim K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167007
   Kim YH, 2018, J EXERC REHABIL, V14, P183, DOI 10.12965/jer.1836074.037
   Kim Y, 2018, BRIT J NUTR, V120, P1279, DOI [10.1017/S0007114518002635, 10.1017/s0007114518002635]
   Komorita Y, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001252
   Koyama T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103090
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Lee WY, 2005, DIABETES RES CLIN PR, V67, P70, DOI 10.1016/j.diabres.2004.05.006
   Lin HL, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008838
   Loftfield E, 2016, J NUTR, V146, P1762, DOI 10.3945/jn.116.233940
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Mendes MD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200701
   Messier V, 2010, OBESITY, V18, P911, DOI 10.1038/oby.2009.364
   Miranda AM, 2021, INT J FOOD SCI NUTR, V72, P794, DOI 10.1080/09637486.2020.1862069
   Miranda AM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030276
   Mirmiran P, 2020, INT J FOOD SCI NUTR, V71, P891, DOI 10.1080/09637486.2020.1746955
   Islam MT, 2018, CURR DRUG METAB, V19, P544, DOI 10.2174/1389200219666180302154551
   Muñoz-Garach A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060320
   Mursu J, 2005, FREE RADICAL BIO MED, V38, P527, DOI 10.1016/j.freeradbiomed.2004.11.025
   NHANES National Health and Nutrition Examination Survey NHANES, ANTHR PROC MAN
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   Nygard O, 1997, AM J CLIN NUTR, V65, P136, DOI 10.1093/ajcn/65.1.136
   O'Keefe JH, 2018, PROG CARDIOVASC DIS, V61, P38, DOI 10.1016/j.pcad.2018.02.002
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Panagiotakos DB, 2004, HEART VESSELS, V19, P280, DOI 10.1007/s00380-004-0779-3
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Paramsothy P, 2009, METABOLISM, V58, P212, DOI 10.1016/j.metabol.2008.09.016
   Rehm CD, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082463
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Ruggiero E, 2021, J NUTR, V151, P395, DOI 10.1093/jn/nxaa365
   Sakamaki T, 2021, PUBLIC HEALTH, V191, P23, DOI 10.1016/j.puhe.2020.10.021
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213
   Song F., 2016, NFS Journal, V4, P9
   Tan LJ, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030920
   Teramoto M, 2021, STROKE, V52, P957, DOI 10.1161/STROKEAHA.120.032273
   Martínez-Larrad MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106641
   Thomas DR, 2020, CURR DEV NUTR, V4, DOI 10.1093/cdn/nzz142
   Tian DD, 2019, CTS-CLIN TRANSL SCI, V12, P39, DOI 10.1111/cts.12598
   Tomiyama AJ, 2016, INT J OBESITY, V40, P883, DOI 10.1038/ijo.2016.17
   Ulvik A, 2008, CLIN CHEM, V54, P1489, DOI 10.1373/clinchem.2008.103465
   Urgert R, 2000, AM J CLIN NUTR, V72, P1107
   Urgert R, 1997, ANNU REV NUTR, V17, P305, DOI 10.1146/annurev.nutr.17.1.305
   Van Dam RM, 2004, DIABETES CARE, V27, P2990, DOI 10.2337/diacare.27.12.2990
   Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244
   Vollset SE, 2000, AM J CLIN NUTR, V71, P403
   Wang TG, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0862-0
   Waskiewicz A, 2010, KARDIOL POL, V68, P275
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617
   Yamagata K, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7020026
   Yoshihara T, 2019, J PHARMACOL SCI, V139, P209, DOI 10.1016/j.jphs.2019.01.006
   Zhou A, 2019, AM J CLIN NUTR, V109, P509, DOI 10.1093/ajcn/nqy297
NR 87
TC 12
Z9 12
U1 1
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR
PY 2021
VL 13
IS 4
AR 1348
DI 10.3390/nu13041348
PG 18
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA RR8LT
UT WOS:000643343600001
PM 33919513
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Wedick, NM
   Brennan, AM
   Sun, Q
   Hu, FB
   Mantzoros, CS
   van Dam, RM
AF Wedick, Nicole M.
   Brennan, Aoife M.
   Sun, Qi
   Hu, Frank B.
   Mantzoros, Christos S.
   van Dam, Rob M.
TI Effects of caffeinated and decaffeinated coffee on biological risk
   factors for type 2 diabetes: a randomized controlled trial
SO NUTRITION JOURNAL
LA English
DT Article
ID INSULIN-RESISTANCE; CHLOROGENIC ACID; GLUCOSE-TOLERANCE; FETUIN-A;
   CONSUMPTION; METAANALYSIS; SENSITIVITY; MELLITUS; HEALTHY; PLASMA
AB Background: Coffee consumption has been associated with a lower risk of type 2 diabetes in prospective cohort studies, but the underlying mechanisms remain unclear. The aim of this study was to evaluate the effects of regular and decaffeinated coffee on biological risk factors for type 2 diabetes.
   Methods: Randomized parallel-arm intervention conducted in 45 healthy overweight volunteers who were nonsmokers and regular coffee consumers. Participants were assigned to consumption of 5 cups (177 mL each) per day of instant caffeinated coffee, decaffeinated coffee, or no coffee (i.e., water) for 8 weeks.
   Results: Average age was 40 years and body mass index was 29.5 kg/m(2). Compared with consuming no coffee, consumption of caffeinated coffee increased adiponectin (difference in change from baseline 1.4 mu g/mL; 95% CI: 0.2, 2.7) and interleukin-6 (difference: 60%; 95% CI: 8, 138) concentrations and consumption of decaffeinated coffee decreased fetuin-A concentrations (difference: -20%; 95% CI: -35, -1). For measures of glucose tolerance, insulin sensitivity, and insulin secretion, no significant differences were found between treatment groups.
   Conclusions: Although no changes in glycemia and/or insulin sensitivity were observed after 8 weeks of coffee consumption, improvements in adipocyte and liver function as indicated by changes in adiponectin and fetuin-A concentrations may contribute to beneficial metabolic effects of long-term coffee consumption.
C1 [Wedick, Nicole M.; Sun, Qi; Hu, Frank B.; van Dam, Rob M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Brennan, Aoife M.; Mantzoros, Christos S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.
   [Hu, Frank B.; van Dam, Rob M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Sun, Qi; Hu, Frank B.; van Dam, Rob M.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA.
   [Mantzoros, Christos S.] Harvard Univ, Sch Med, Endocrinol Sect, Boston VA Healthcare Syst, Boston, MA 02115 USA.
   [Mantzoros, Christos S.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard University Medical Affiliates; Beth Israel Deaconess
   Medical Center; Harvard Medical School; Harvard University; Harvard T.H.
   Chan School of Public Health; Harvard University; Harvard University
   Medical Affiliates; Brigham & Women's Hospital; Harvard University;
   Harvard University Medical Affiliates; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); VA Boston Healthcare
   System; Harvard Medical School; Harvard University; Harvard T.H. Chan
   School of Public Health
RP Wedick, NM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
EM nwedick@hsph.harvard.edu
RI Mantzoros, Christos/Y-2902-2019; Sun, Qi/KVY-1113-2024; van Dam,
   Rob/F-9674-2010; Hu, Frank/C-1919-2013; Stefanadis,
   Christodoulos/ABH-2232-2020; van Dam, Rob/A-6693-2009
OI Stefanadis, Christodoulos/0000-0001-5974-6454; Sun,
   Qi/0000-0002-8480-1563; van Dam, Rob/0000-0002-7354-8734
FU Boston Obesity Nutrition Research Center [2005-P-000377/2]; National
   Center for Research Resources [UL1RR025758]
FX We gratefully thank the participants of the Coffee Trial for their
   participation and the General Clinical Research Center nurses and
   nutritionists at Beth Israel Deaconess Medical Center for their
   invaluable contribution to the conduct of the trial. We are grateful to
   David J. Greenblatt (Tufts University School of Medicine and Tufts
   Medical Center, Boston, MA) for measurement of caffeine concentrations,
   Peter C. Hollman and Dini Venema (RIKILT Institute of Food Safety,
   Wageningen, The Netherlands) for the measurement of chlorogenic acid,
   and Sandy Slow (Canterbury Health Laboratories, Christchurch, New
   Zealand) for the measurement of trigonelline. The research for this
   study was financially supported by a Boston Obesity Nutrition Research
   Center pilot and feasibility grant (grant#: 2005-P-000377/2) and by
   Clinical Translational Science Award UL1RR025758 to Harvard University
   and Beth Israel Deaconess Medical Center from the National Center for
   Research Resources. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   National Center for Research Resources or the National Institutes of
   Health. The clinical trial registration number is NCT00305097. The
   coffee was supplied by Nestle.
CR Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   BERGMAN RN, 1985, ENDOCR REV, V6, P45, DOI 10.1210/edrv-6-1-45
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Fève B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62
   Homan DJ, 2006, NUTR REV, V64, P43, DOI 10.1301/nr.2006.jan.43-46
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ix JH, 2008, JAMA-J AM MED ASSOC, V300, P182, DOI 10.1001/jama.300.2.182
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   KEMPF K, AM J CLIN NUTR, V91, P950
   Kotani K, 2008, CLIN CHEM LAB MED, V46, P1434, DOI 10.1515/CCLM.2008.286
   LEVER M, 1992, ANAL BIOCHEM, V205, P14, DOI 10.1016/0003-2697(92)90572-O
   Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Mathews ST, 2000, MOL CELL ENDOCRINOL, V164, P87, DOI 10.1016/S0303-7207(00)00237-9
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484
   Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d
   Shearer J, 2007, CAN J PHYSIOL PHARM, V85, P823, DOI 10.1139/Y07-070
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   TRUGO LC, 1984, ANALYST, V109, P263, DOI 10.1039/an9840900263
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Van Dam RM, 2004, DIABETES CARE, V27, P2990, DOI 10.2337/diacare.27.12.2990
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
NR 29
TC 133
Z9 143
U1 0
U2 49
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2891
J9 NUTR J
JI Nutr. J.
PD SEP 13
PY 2011
VL 10
AR 93
DI 10.1186/1475-2891-10-93
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 826TJ
UT WOS:000295377300002
PM 21914162
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Redondo-Puente, M
   Mateos, R
   Seguido, MA
   García-Cordero, J
   González, S
   Tarradas, RM
   Bravo-Clemente, L
   Sarriá, B
AF Redondo-Puente, Monica
   Mateos, Raquel
   Seguido, Miguel A.
   Garcia-Cordero, Joaquin
   Gonzalez, Susana
   Tarradas, Rosa M.
   Bravo-Clemente, Laura
   Sarria, Beatriz
TI Appetite and Satiety Effects of the Acute and Regular Consumption of
   Green Coffee Phenols and Green Coffee Phenol/Oat β-Glucan Nutraceuticals
   in Subjects with Overweight and Obesity
SO FOODS
LA English
DT Article
DE green coffee; beta-glucan; nutraceutical; polyphenols; satiety; ghrelin;
   leptin; overweight
ID CHLOROGENIC ACID; DIETARY FIBER; BODY-WEIGHT; METABOLIC SYNDROME;
   FOOD-INTAKE; TEA; SUPPLEMENTATION; INCREASES; VISCOSITY; RESPONSES
AB Green coffee has weight management properties, yet its effects on appetite and satiety remain unclear as few, mainly acute, studies perform objective measurements. Therefore, the influence on appetite/satiety of acute and regular consumption of two nutraceuticals, a decaffeinated green coffee phenolic extract (GC) alone or combined with oat beta-glucans (GC/BG), with known satiating properties, has been analysed subjectively using visual analog scales (VAS) and objectively measuring actual food intake and postprandial appetite and satiety hormones. A randomised, cross-over, blind trial was carried out in 29 overweight volunteers who consumed GC or GC/BG twice a day for 8 weeks. After acute (day = 0) and regular consumption (day = 56) of the nutraceuticals, satiety was measured at 30, 60, 90, 150, and 210 min, as well as food intake at breakfast (30 min) and lunch (300 min). Additionally, in a subgroup of participants (n = 9), cholecystokinin, peptide-YY, glucagon-like-peptide-1, ghrelin and leptin concentrations were analysed in blood samples taken at the same time-points. According to VAS results, GC/BG reduced hunger more efficiently than GC. However, there were no statistically significant differences in food intake. Comparing the effects of the acute consumption of GC/BG and GC, leptin concentration at 150 min was higher after GC/BG intake vs. GC. Moreover, when comparing the effects of regularly consuming the two nutraceuticals, maximum ghrelin level decreased with GC/BG vs. GC. In conclusion, acute and regular effects of the nutraceuticals on appetite/satiety differed, and subjective and objective results partially agreed; GC/BG may reduce hunger more efficiently than GC.
C1 [Redondo-Puente, Monica; Mateos, Raquel; Seguido, Miguel A.; Garcia-Cordero, Joaquin; Gonzalez, Susana; Tarradas, Rosa M.; Bravo-Clemente, Laura; Sarria, Beatriz] CSIC, Dept Metab & Nutr, Inst Food Sci Technol & Nutr ICTAN CSIC, Jose Antonio Novais 10, Madrid 28040, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN)
RP Sarriá, B (corresponding author), CSIC, Dept Metab & Nutr, Inst Food Sci Technol & Nutr ICTAN CSIC, Jose Antonio Novais 10, Madrid 28040, Spain.
EM m.redondo@ictan.csic.es; raquel.mateos@ictan.csic.es;
   m.seguido@ictan.csic.es; yoaquin1995@gmail.com;
   s.gonzalez@ictan.csic.es; rosa.tarradas.valero@gmail.com;
   lbravo@ictan.csic.es; beasarria@ictan.csic.es
RI Bravo, Laura/JMC-4928-2023; BRIZ, Raquel/H-9125-2012; Sarria,
   Beatriz/K-7929-2014; Bravo, Laura/F-4992-2012
OI Sarria, Beatriz/0000-0003-0614-4606; Bravo, Laura/0000-0002-7312-8641
FU panish Ministry of Economy and Competitivity [AGL2015-69986-R]; Ministry
   of Science, Innovation and Universities [PEJ2018-001982-A]; Comunidad de
   Madrid;  [PEJD-2017-PRE_BIO-4225]
FX This research was funded by project AGL2015-69986-R from the Spanish
   Ministry of Economy and Competitivity. J.G.-C. had a pre-doctoral grant
   funded by Comunidad de Madrid (PEJD-2017-PRE_BIO-4225). M.R.-P. had a
   pre-doctoral contract (PEJ2018-001982-A) funded by the Ministry of
   Science, Innovation and Universities. M.A.S. had a pre-doctoral contract
   funded by Comunidad de Madrid (PEJD-2018-PRE/SAL-9104).
CR Anini Y, 2003, DIABETES, V52, P252, DOI 10.2337/diabetes.52.2.252
   Asbaghi O, 2020, COMPLEMENT THER MED, V51, DOI 10.1016/j.ctim.2020.102424
   Barber TM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103209
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Beck EJ, 2009, NUTR RES, V29, P705, DOI 10.1016/j.nutres.2009.09.012
   Bergmann NC, 2019, DIABETOLOGIA, V62, P665, DOI 10.1007/s00125-018-4810-0
   Boix-Castejón M, 2018, FOOD FUNCT, V9, P3173, DOI [10.1039/C8FO00367J, 10.1039/c8fo00367j]
   Capomolla AS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061271
   Chaudhri OB, 2008, ANNU REV PHYSIOL, V70, P239, DOI 10.1146/annurev.physiol.70.113006.100506
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Crespo Mayte Alvarez, 2009, Endocrinol Nutr, V56, P317, DOI 10.1016/S1575-0922(09)71946-1
   Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908
   Dikeman CL, 2006, CRIT REV FOOD SCI, V46, P649, DOI 10.1080/10408390500511862
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Gómez-Juaristi M, 2018, FOOD CHEM, V240, P1028, DOI 10.1016/j.foodchem.2017.08.003
   Greenberg JA, 2012, J AM COLL NUTR, V31, P160, DOI 10.1080/07315724.2012.10720023
   Hassanzadeh-Rostami Z, 2021, EXP CLIN ENDOCR DIAB, V129, P322, DOI 10.1055/a-0998-3883
   Hussein GME, 2011, BIOL PHARM BULL, V34, P1849, DOI 10.1248/bpb.34.1849
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Juvonen KR, 2009, J NUTR, V139, P461, DOI 10.3945/jn.108.099945
   Kristensen M, 2011, APPETITE, V56, P65, DOI 10.1016/j.appet.2010.11.147
   Mateos R., FOOD FUNCT
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Méndez-del Villar M, 2014, METAB SYNDR RELAT D, V12, P497, DOI 10.1089/met.2014.0082
   Müller M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030275
   Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Panickar KS, 2013, MOL NUTR FOOD RES, V57, P34, DOI 10.1002/mnfr.201200431
   Rebello CJ, 2016, NUTR REV, V74, P131, DOI 10.1093/nutrit/nuv063
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Sarriá B, 2020, FOODS, V9, DOI 10.3390/foods9091191
   Stuby J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092238
   Timper K, 2017, DIS MODEL MECH, V10, P679, DOI 10.1242/dmm.026609
   Ueno H, 2008, REGUL PEPTIDES, V145, P12, DOI 10.1016/j.regpep.2007.09.011
   Vitaglione P, 2009, APPETITE, V53, P338, DOI 10.1016/j.appet.2009.07.013
   Wanders AJ, 2011, OBES REV, V12, P724, DOI 10.1111/j.1467-789X.2011.00895.x
   Weickert MO, 2006, BRIT J NUTR, V96, P795, DOI 10.1017/BJN20061902
   World Health Organization (WHO), ers on effectively addressing overweight and obesity in the
   Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992
   Yuliana ND, 2011, OBES REV, V12, P499, DOI 10.1111/j.1467-789X.2010.00790.x
   Zaremba SMM, 2018, APPETITE, V128, P197, DOI 10.1016/j.appet.2018.06.019
NR 41
TC 12
Z9 12
U1 0
U2 17
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
EI 2304-8158
J9 FOODS
JI Foods
PD NOV
PY 2021
VL 10
IS 11
AR 2511
DI 10.3390/foods10112511
PG 15
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA XL2TP
UT WOS:000728002000001
PM 34828792
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU la Vega, LMD
   Martinez-Lopez, E
   Sanchez-Murguia, T
   Madrigal-Juarez, A
   Rodriguez-Reyes, SC
   Aguilar-Vega, I
   Torres-Castillo, N
AF la Vega, Lisset Magana-de
   Martinez-Lopez, Erika
   Sanchez-Murguia, Tania
   Madrigal-Juarez, Andrea
   Rodriguez-Reyes, Sarai Citlalic
   Aguilar-Vega, Ivan
   Torres-Castillo, Nathaly
TI Effect of coffee intake on appetite parameters in woman with overweight
   or obesity: A pilot crossover randomized trial
SO ENDOCRINOLOGIA DIABETES Y NUTRICION
LA English
DT Article
DE Coffee; Sweet taste; Ghrelin; Cholecystokinin; Obesity; Women
ID REPRODUCIBILITY; MECHANISMS; TASTE
AB Introduction: Coffee consumption has demonstrated an effect on the regulation of appetite, causing less hunger and/or greater satiety; however, its effects are not well known in woman with overweight or obesity. Therefore, this study aimed to evaluate the effect of coffee consumption on hunger, satiety, sensory specific desire (SSD), and dietary intake in women with overweight or obesity. Methodology: A randomized crossover clinical trial was realized in 3 sessions: in the first session a clinical history, anthropometric measurements and body composition analysis were performed; in sessions 2 and 3 the participants randomly consumed 240 mL of coffee with 6 mg/caffeine/kg of weight or 240 mL of water along with a standardized breakfast. At fasting and every 30 min after breakfast for the next 3 h, appetite sensations and SSD were recorded using visual analog scales. Blood samples were taken at fasting, 30 and 180 min after breakfast. Dietary intake was recorded in the rest of the intervention days. Results: In the coffee intervention there was an increased desire for sweet foods, higher fructose intake during the rest of the day, and higher triglyceride levels than with the water intervention. No differences were detected in ghrelin or cholecystokinin. Conclusions: Coffee consumption may lead to higher triglycerides and higher intake of simple sugars, mainly fructose, through changes in the SSD. Clinical Trial Registration: https://clinicaltrials.gov/ NCT05774119. (c) 2024 SEEN y SED. Published by Elsevier Espana, a, S.L.U. All rights reserved.
C1 [la Vega, Lisset Magana-de; Martinez-Lopez, Erika; Sanchez-Murguia, Tania; Madrigal-Juarez, Andrea; Rodriguez-Reyes, Sarai Citlalic; Aguilar-Vega, Ivan; Torres-Castillo, Nathaly] Univ Guadalajara, Ctr Univ Ciencias Salud, Dept Biol Mol & Genom, Inst Nutrigenet & Nutrigen Traslac, Guadalajara, JA, Mexico.
   [la Vega, Lisset Magana-de; Martinez-Lopez, Erika; Madrigal-Juarez, Andrea; Rodriguez-Reyes, Sarai Citlalic; Aguilar-Vega, Ivan; Torres-Castillo, Nathaly] Univ Guadalajara, Ctr Univ Ciencias Salud, Dept Clin Reprod Humana Crecimiento & Desarrollo I, Ciencias Nutr Traslac, Guadalajara, JA, Mexico.
C3 Universidad de Guadalajara; Universidad de Guadalajara
RP Torres-Castillo, N (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Salud, Dept Biol Mol & Genom, Inst Nutrigenet & Nutrigen Traslac, Guadalajara, JA, Mexico.; Torres-Castillo, N (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Salud, Dept Clin Reprod Humana Crecimiento & Desarrollo I, Ciencias Nutr Traslac, Guadalajara, JA, Mexico.
EM nathaly.torrescas@academicos.udg.mx
RI Torres, Nathaly/KDO-9390-2024
OI Magana-de la Vega, Lisset/0000-0002-6830-1171
FU PRODEP (NPTC) [UDG-PTC-1600]; The "PRO-SNI" (Universidad de Guadalajara)
   [265180]; The "PIN III" (Universidad de Guadalajara) [271723]
FX This research was funded by "PRODEP" (NPTC 2020, UDG-PTC-1600) and
   "PRO-SNI" (Universidad de Guadalajara, number 265180, 2022) and "PIN
   III" (Universidad de Guadalajara, number 271723, 2023) .
CR [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373, DOI 10.1001/jama.2013.281053
   Blundell J, 2010, OBES REV, V11, P251, DOI 10.1111/j.1467-789X.2010.00714.x
   Boesveldt S, 2017, PERCEPTION, V46, P307, DOI 10.1177/0301006616685576
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Dalton M., 2013, Current Nutrition Reports, V2, P207
   DOUGLAS BR, 1990, AM J CLIN NUTR, V52, P553, DOI 10.1093/ajcn/52.3.553
   Du YB, 2020, NUTR METAB CARDIOVAS, V30, P2159, DOI 10.1016/j.numecd.2020.08.017
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083
   Forestell CA, 2017, ANN NUTR METAB, V70, P17, DOI 10.1159/000478759
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Graham CAM, 2021, Chem Senses, V46
   Greenberg JA, 2012, J AM COLL NUTR, V31, P160, DOI 10.1080/07315724.2012.10720023
   Hirschberg AL, 2012, MATURITAS, V71, P248, DOI 10.1016/j.maturitas.2011.12.016
   Horner KM, 2014, APPETITE, V81, P116, DOI 10.1016/j.appet.2014.06.025
   Koliaki C, 2020, CURR OBES REP, V9, P255, DOI 10.1007/s13679-020-00396-9
   Li BD, 2014, FOOD QUAL PREFER, V36, P27, DOI 10.1016/j.foodqual.2014.03.001
   López-Aguilar Xochitl, 2011, Rev. Mex. de trastor. aliment, V2, P24
   Low JYQ, 2019, BRIT J NUTR, V122, P829, DOI 10.1017/S0007114519001703
   Malik VS, 2022, NAT REV ENDOCRINOL, V18, P205, DOI 10.1038/s41574-021-00627-6
   Payant MA, 2021, NEUROSCI BIOBEHAV R, V128, P346, DOI 10.1016/j.neubiorev.2021.06.034
   Poole Rachel L., 2017, Journal of Caffeine Research, V7, P39, DOI 10.1089/jcr.2016.0030
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Posit team, 2023, Rstudio
   Ren YQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174238
   Suzuki K, 2012, EXP DIABETES RES, DOI 10.1155/2012/824305
   Temple Jennifer L, 2011, J Caffeine Res, V1, P41, DOI 10.1089/jcr.2011.0005
   Wallace CW, 2022, NUTR RES REV, V35, P236, DOI 10.1017/S0954422421000196
   Woodside J.V., 2015, NUTR RES METHODOLOGI, P28
NR 31
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2530-0180
J9 ENDOCRINOL DIAB NUTR
JI Endocrinol. Diabetes Nutr.
PD JUN-JUL
PY 2024
VL 71
IS 6
BP 236
EP 245
DI 10.1016/j.endien.2024.03.021
EA JUL 2024
PG 10
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA YG4O8
UT WOS:001267324400001
PM 38986627
DA 2025-04-28
ER

PT J
AU Lehtonen, A
   Uusitalo, L
   Auriola, S
   Backman, K
   Heinonen, S
   Keski-Nisula, L
   Pasanen, M
   Pekkanen, J
   Tuomainen, TP
   Voutilainen, R
   Hantunen, S
   Lehtonen, M
AF Lehtonen, Anni
   Uusitalo, Lauri
   Auriola, Seppo
   Backman, Katri
   Heinonen, Seppo
   Keski-Nisula, Leea
   Pasanen, Markku
   Pekkanen, Juha
   Tuomainen, Tomi-Pekka
   Voutilainen, Raimo
   Hantunen, Sari
   Lehtonen, Marko
TI Caffeine content in newborn hair correlates with maternal dietary intake
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Caffeine; Diet; Newborn; Pregnancy; Hair; Mass spectrometry; Food safety
ID CONSUMPTION; PREGNANCY; PARAXANTHINE; ASSOCIATION; COFFEE; BIRTH; RISK
AB Purpose High-maternal caffeine intake during pregnancy may be harmful for perinatal outcomes and future child health, but the level of fetal cumulative exposure has been difficult to measure thus far. Here, we present maternal dietary caffeine intake during the last trimester and its correlation to caffeine content in newborn hair after birth. Methods Maternal third trimester diets and dietary caffeine intake were prospectively collected in Kuopio Birth Cohort (KuBiCo) using a 160-item food frequency questionnaire (n = 2840). Newborn hair was collected within 48 h after birth and analyzed by high-resolution mass spectrometry (HRMS) for caffeine (n = 316). Correlation between dietary caffeine intake and neonatal hair caffeine content was evaluated from 203 mother-child pairs. Results Mean dietary caffeine intake was 167 mg/days (95% CI 162-172 mg/days), of which coffee comprised 81%. Caffeine in the maternal diet and caffeine content in newborn hair correlated significantly (r = 0.50; p < 0.001). Older, multiparous, overweight women, and smokers had the highest caffeine levels in the maternal diet, as well as in their newborn babies' hair. Conclusion Caffeine exposure, estimated from newborn hair samples, reflects maternal third trimester dietary caffeine intake and introduces a new method to assess fetal cumulative caffeine exposure. Further studies to evaluate the effects of caffeine exposure on both perinatal and postnatal outcomes are warranted, since over 40% of pregnant women consume caffeine more than the current suggested recommendations (European Food Safety Association, EFSA recommendations).
C1 [Lehtonen, Anni; Tuomainen, Tomi-Pekka; Hantunen, Sari] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.
   [Uusitalo, Lauri; Backman, Katri; Keski-Nisula, Leea; Voutilainen, Raimo] Univ Eastern Finland, Inst Clin Med, Sch Med, Kuopio, Finland.
   [Uusitalo, Lauri; Keski-Nisula, Leea] Kuopio Univ Hosp, Dept Obstet & Gynecol, Kuopio, Finland.
   [Auriola, Seppo; Lehtonen, Marko] LC MS Metab Ctr, Bioctr, Kuopio, Finland.
   [Backman, Katri; Voutilainen, Raimo] Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland.
   [Heinonen, Seppo] Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland.
   [Heinonen, Seppo] Univ Helsinki, Helsinki, Finland.
   [Pasanen, Markku] Univ Eastern Finland, Sch Pharm, Kuopio, Finland.
   [Pekkanen, Juha] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.
   [Pekkanen, Juha] Natl Inst Hlth & Welf, Environm Hlth Unit, Helsinki, Finland.
C3 University of Eastern Finland; University of Eastern Finland; Kuopio
   University Hospital; University of Eastern Finland; University of
   Eastern Finland Hospital; Kuopio University Hospital; University of
   Eastern Finland; University of Eastern Finland Hospital; University of
   Helsinki; Helsinki University Central Hospital; University of Helsinki;
   University of Eastern Finland; University of Helsinki; Finland National
   Institute for Health & Welfare
RP Uusitalo, L (corresponding author), Univ Eastern Finland, Inst Clin Med, Sch Med, Kuopio, Finland.; Uusitalo, L (corresponding author), Kuopio Univ Hosp, Dept Obstet & Gynecol, Kuopio, Finland.
EM lauriuus@uef.fi
RI Backman, Katri/AAF-7700-2021
OI Lehtonen, Marko/0000-0002-5611-0466; Kukkonen, Anni/0000-0002-9687-8365;
   Pekkanen, Juha/0000-0002-1083-8777; Voutilainen,
   Raimo/0000-0002-7858-665X
FU University of Eastern Finland (UEF) including Kuopio University Hospital
FX Open access funding provided by University of Eastern Finland (UEF)
   including Kuopio University Hospital.
CR Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332
   D'Anna-Hernandez KL, 2011, PHYSIOL BEHAV, V104, P348, DOI 10.1016/j.physbeh.2011.02.041
   De Kesel PMM, 2015, TALANTA, V144, P62, DOI 10.1016/j.talanta.2015.05.084
   Dussy F, 2014, DRUG TEST ANAL, V6, P5, DOI 10.1002/dta.1627
   Eichelberger KY, 2015, OBSTET GYNECOL, V126, P725, DOI 10.1097/AOG.0000000000001041
   ETL, 2018, FINN FOOD DRINK IND
   Forbes LE, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081032
   Gareri J, 2010, FORENSIC SCI INT, V196, P27, DOI 10.1016/j.forsciint.2009.12.024
   Greenwood DC, 2014, EUR J EPIDEMIOL, V29, P725, DOI 10.1007/s10654-014-9944-x
   Huuskonen P, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2013-9
   Kaufmann A, 2012, ANAL BIOANAL CHEM, V403, P1233, DOI 10.1007/s00216-011-5629-4
   Leviton A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091152
   Li J, 2015, INT J GYNECOL OBSTET, V130, P116, DOI 10.1016/j.ijgo.2015.03.033
   Lyngso J, 2017, CLIN EPIDEMIOL, V9, P699, DOI 10.2147/CLEP.S146496
   Mannisto S, 1996, J CLIN EPIDEMIOL, V49, P401, DOI 10.1016/0895-4356(95)00551-X
   Mazzafera P, 2004, FRONT BIOSCI-LANDMRK, V9, P1348, DOI 10.2741/1339
   Montesano C, 2014, J PHARMACEUT BIOMED, V88, P295, DOI 10.1016/j.jpba.2013.08.050
   Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42
   Stefanidou EM, 2011, EUR J OBSTET GYN R B, V158, P220, DOI 10.1016/j.ejogrb.2011.04.024
   Vitti FP, 2018, REV BRAS GINECOL OBS, V40, P749, DOI 10.1055/s-0038-1675806
NR 21
TC 11
Z9 11
U1 0
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD FEB
PY 2021
VL 60
IS 1
BP 193
EP 201
DI 10.1007/s00394-020-02231-2
EA APR 2020
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA QD5RS
UT WOS:000523112300001
PM 32246261
OA hybrid, Green Published
DA 2025-04-28
ER

PT J
AU Chakrabarti, M
   Ghosh, I
   Jana, A
   Ghosh, M
   Mukherjee, A
AF Chakrabarti, Manoswini
   Ghosh, Ilika
   Jana, Aditi
   Ghosh, Manosij
   Mukherjee, Anita
TI Genotoxicity of antiobesity drug orlistat and effect of caffeine
   intervention: an in vitro study
SO DRUG AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Caffeine; comet assay; DNA damage; lymphocyte; orlisat; sibutramine
ID WEIGHT-LOSS; CELLS; MICE; LYMPHOCYTES; INHIBITION; ANTIOXIDANT;
   SIBUTRAMINE; MANAGEMENT; TOXICITY; OBESITY
AB Context: Obesity is a major global health problem associated with various adverse effects. Pharmacological interventions are often necessary for the management of obesity. Orlistat is an FDA-approved antiobesity drug which is a potent inhibitor of intestinal lipases. Objective: In the current study, orlistat was evaluated for its genotoxic potential in human lymphocyte cells in vitro and was compared with that of another antiobesity drug sibutramine, presently withdrawn from market due its undesirable health effects. Caffeine intake may be an additional burden in people using anorectic drugs, therefore, further work is needed to be carried out to evaluate the possible effects of caffeine on orlistat-induced DNA damage. Materials and methods: Human lymphocytes were exposed to orlistat (250, 500 and 1000 mu g/ml), sibutramine (250, 500 and 1000 mu g/ml) and caffeine (25, 50, 75, 100, 125 and 150 mu g/ml) to assess their genotoxicity by comet assay in vitro. In addition, lymphocytes were co-incubated with caffeine (50, 75 and 100 mu g/ml) and a single concentration of orlistat (250 mu g/ml). Results: Orlistat and sibutramine were genotoxic at all concentrations tested, sibutramine being more genotoxic. Caffeine was found to be genotoxic at concentrations 125 mu g/ml and above. Co-treatment of orlistat with non-genotoxic concentrations (50, 75 and 100 mu g/ml) of caffeine lead to a decrease in DNA damage. Discussion and conclusion: Orlistat can induce DNA damage in human lymphocytes in vitro and caffeine was found to reduce orlistat-induced genotoxicity.
C1 [Chakrabarti, Manoswini; Ghosh, Ilika; Jana, Aditi; Ghosh, Manosij; Mukherjee, Anita] Univ Calcutta, Ctr Adv Study, Dept Bot, Cell Biol & Genet Toxicol Lab, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India.
C3 University of Calcutta
RP Mukherjee, A (corresponding author), Univ Calcutta, Ctr Adv Study, Dept Bot, Cell Biol & Genet Toxicol Lab, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India.
EM anitamukherjee28@gmail.com
RI Ghosh, Manosij/G-3374-2013
OI Ghosh, Manosij/0000-0001-5034-001X; JANA, ADITI/0000-0002-4209-0329;
   Ghosh, Ilika/0000-0001-5997-5986
FU University Grant Commission Basic Scientific Research fellowship
   [UGC/1260/RFSMS/BOT]
FX The authors report no declarations of interest. Manoswini Chakrabarti
   sincerely acknowledges the University Grant Commission Basic Scientific
   Research fellowship (UGC/1260/RFSMS/BOT dated: 24.11.2014) for the
   financial assistance.
CR Abraham SK, 2004, MUTAT RES-GEN TOX EN, V561, P23, DOI 10.1016/j.mrgentox.2004.03.010
   BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x
   Bravo J, 2013, FOOD CHEM TOXICOL, V60, P397, DOI 10.1016/j.fct.2013.08.002
   Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8
   da Silva CJ, 2010, HUM EXP TOXICOL, V29, P187, DOI 10.1177/0960327109358732
   Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5
   Drew BS, 2007, VASC HEALTH RISK MAN, V3, P817
   Faust F, 2004, MUTAT RES-REV MUTAT, V566, P209, DOI 10.1016/j.mrrev.2003.09.007
   Filippatos TD, 2008, DRUG SAFETY, V31, P53, DOI 10.2165/00002018-200831010-00005
   Fujiwara J, 2012, INT J ONCOL, V40, P1483, DOI 10.3892/ijo.2012.1353
   Geriyol P, 2015, DRUG CHEM TOXICOL, V38, P188, DOI 10.3109/01480545.2014.928720
   Guzman CD, 2011, P W PHARMACOL SOC, V54, P73
   Heck AM, 2000, PHARMACOTHERAPY, V20, P270, DOI 10.1592/phco.20.4.270.34882
   James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114
   Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13
   Kazmi Syed Asif J, 2009, J Ayub Med Coll Abbottabad, V21, P45
   Li MF, 2011, WORLD J DIABETES, V2, P19, DOI 10.4239/wjd.v2.i2.19
   Lin Kuan-Hung, 2013, BMC Res Notes, V6, P490, DOI 10.1186/1756-0500-6-490
   Manning S, 2014, THER ADV CHRONIC DIS, V5, P135, DOI 10.1177/2040622314522848
   Moller P, 2004, BASIC CLIN PHARMACOL, V96, P1
   OECD, 2010, OECD GUIDELINE TESTI
   Ohara T, 2015, PHYTOTHER RES, V29, P310, DOI 10.1002/ptr.5258
   Orsolin PC, 2012, FOOD CHEM TOXICOL, V50, P2598, DOI 10.1016/j.fct.2012.05.008
   Pendleton Morgan, 2013, Journal of Dietary Supplements, V10, P1, DOI 10.3109/19390211.2012.758215
   Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621
   Sabisz M, 2008, CURR PHARM BIOTECHNO, V9, P325, DOI 10.2174/138920108785161497
   SEN S, 1994, DRUG CHEM TOXICOL, V17, P113, DOI 10.3109/01480549409014305
   Sinha S, 2014, FOOD CHEM TOXICOL, V68, P71, DOI 10.1016/j.fct.2014.02.036
   TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   WHO, 2016, OB OV FACT SHEET 311
   Zheng GD, 2004, IN VIVO, V18, P55
NR 32
TC 10
Z9 11
U1 0
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0148-0545
EI 1525-6014
J9 DRUG CHEM TOXICOL
JI Drug Chem. Toxicol.
PD JUL
PY 2017
VL 40
IS 3
BP 339
EP 343
DI 10.1080/01480545.2016.1236128
PG 5
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Pharmacology & Pharmacy; Toxicology
GA ES7PQ
UT WOS:000399743000013
PM 27707005
DA 2025-04-28
ER

PT J
AU Takahashi, S
   Egashira, K
   Saito, K
   Jia, HJ
   Abe, K
   Kato, H
AF Takahashi, Shoko
   Egashira, Kenji
   Saito, Kenji
   Jia, Huijuan
   Abe, Keiko
   Kato, Hisanori
TI Coffee intake down-regulates the hepatic gene expression of peroxisome
   proliferator-activated receptor gamma in C57BL/6J mice fed a high-fat
   diet
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE DNA microarray; Anti-obesity; Adipogenic hepatic steatosis; Chlorogenic
   acid; Lipid metabolism
ID PPAR-GAMMA; TRANSCRIPTIONAL REGULATION; GLUCOSE-TOLERANCE; CHLOROGENIC
   ACID; MOUSE-LIVER; CONSUMPTION; HUMANS; RISK; STEATOSIS
AB Several lines of evidence, including those from epidemiological studies, have suggested that coffee intake reduces the risks of diabetes and obesity, although the detailed mechanisms of such effects are not clearly understood. The present study was conducted to examine the effects of three types of coffee (caffeinated, decaffeinated, and green unroasted coffee) on the livers of C57BL/6J mice fed a high-fat diet, and to elucidate the detailed physiological responses to coffee intake by analysing the data obtained from a transcriptomic analysis using DNA microarrays. The results showed that the three types of coffee suppressed the weight gain and fat accumulation induced by a high-fat diet. A remarkable finding was a down-regulation of PPAR gamma and related molecules. Furthermore, the protein levels of hepatic peroxisome proliferator-activated receptor gamma (PPAR gamma) were revealed by Western blot analysis to be lower in all of the coffee-fed groups compared to the high-fat group. Since overexpression of PPAR gamma in the liver has been implicated in adipogenic hepatic steatosis, we hypothesised that the alterations in PPAR gamma and its target molecules, which play pivotal roles in adipogenic hepatic steatosis, might be involved in the anti-obesity effect of coffee. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Takahashi, Shoko; Egashira, Kenji; Abe, Keiko] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.
   [Takahashi, Shoko; Egashira, Kenji; Saito, Kenji; Jia, Huijuan; Kato, Hisanori] Univ Tokyo, Org Interdisciplinary Res Projects, Bunkyo Ku, Tokyo 1138657, Japan.
C3 University of Tokyo; University of Tokyo
RP Kato, H (corresponding author), Univ Tokyo, Org Interdisciplinary Res Projects, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.
EM akatoq@mail.ecc.u-tokyo.ac.jp
FU All Japan Coffee Association
FX We are grateful to Dr. Yoichi Fukushima for the valuable discussion
   during this study. We thank Nestle Japan for providing dried coffee
   samples. This study was partly supported by a grant from the All Japan
   Coffee Association.
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155
   Bidel S, 2006, HORM METAB RES, V38, P38, DOI 10.1055/s-2006-924982
   Boelsterli UA, 2002, BIOCHEM PHARMACOL, V63, P1, DOI 10.1016/S0006-2952(01)00817-6
   Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Hoelzl C, 2010, MOL NUTR FOOD RES, V54, P1722, DOI 10.1002/mnfr.201000048
   Hong SH, 2001, J BIOL CHEM, V276, P28098, DOI 10.1074/jbc.M010912200
   Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Jia HJ, 2013, J FUNCT FOODS, V5, P1611, DOI 10.1016/j.jff.2013.07.003
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kadota K, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-8
   Kato H, 2005, CURR OPIN CLIN NUTR, V8, P516, DOI 10.1097/01.mco.0000179166.33323.c3
   Kreppenhofer S, 2011, FOOD CHEM, V126, P441, DOI 10.1016/j.foodchem.2010.11.008
   Lim HJ, 2006, PROSTAG OTH LIPID M, V80, P165, DOI 10.1016/j.prostaglandins.2006.06.006
   Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Pimentel GD, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-6
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Williamson G, 2011, MOL NUTR FOOD RES, V55, P864, DOI 10.1002/mnfr.201000631
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200
NR 32
TC 9
Z9 9
U1 1
U2 23
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN
PY 2014
VL 6
BP 157
EP 167
DI 10.1016/j.jff.2013.10.002
PG 11
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA AA9OO
UT WOS:000331423000015
DA 2025-04-28
ER

PT J
AU Pereira, MA
   Parker, ED
   Folsom, AR
AF Pereira, MA
   Parker, ED
   Folsom, AR
TI Coffee consumption and risk of type 2 diabetes mellitus - An 11-year
   prospective study of 28 812 postmenopausal women
SO ARCHIVES OF INTERNAL MEDICINE
LA English
DT Article
ID GASTRIC-INHIBITORY POLYPEPTIDE; FOOD FREQUENCY QUESTIONNAIRE;
   GLUCOSE-TOLERANCE; MAGNESIUM INTAKE; OLDER WOMEN; CAFFEINE; HUMANS;
   REPRODUCIBILITY; POLYPHENOLS; TEA
AB Background: Coffee intake may be associated with reduced risk of type 2 diabetes mellitus because of minerals, phytochemicals, and antioxidants in coffee, but the role of caffeine is unclear. Our objective was to examine the association between total, caffeinated, and decaffeinated coffee intake, as assessed by food frequency questionnaire at baseline, and risk of incident type 2 diabetes mellitus.
   Methods: This prospective analysis of the Iowa Women's Health Study (1986-1997) included 28 812 postmenopausal women free of diabetes and cardiovascular disease in the general community. The main outcome measure was incident type 2 diabetes mellitus as determined by mailed questionnaire.
   Results: Coffee intake was categorized as 0, less than 1, 1 to 3, 4 to 5, and 6 or more cups per day. During 11 years of follow-up, there were 1418 incident cases of diabetes. Relative risks (RRs) were adjusted for a variety of demographic, adiposity, and lifestyle measures. Compared with women who reported 0 cups of coffee per day, women who consumed 6 or more cups per day had a 22% lower risk (RR = 0.78; 95% confidence interval [CI], 0.61-1.01) of diabetes (P for linear trend across categories, .06). This association appeared to be largely explained by decaffeinated coffee (RR = 0.67; 95% CI, 0.42-1.08; P for trend, .006) rather than regular coffee (RR = 0.79; 95% CI, 0.59-1.05; P for trend, .90). Intake of magnesium and phytate did not explain these associations. Intakes of caffeine from all sources was not associated with risk of diabetes.
   Conclusion: Coffee intake, especially decaffeinated, was inversely associated with risk of type 2 diabetes mellitus in this cohort of postmenopausal women.
C1 Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Med, Minneapolis, MN 55454 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities
RP Pereira, MA (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Med, 1300 S 2nd St,Suite 300, Minneapolis, MN 55454 USA.
EM pereira@epi.umn.edu
OI Parker, Emily/0000-0002-6219-4360; Pereira, Mark/0000-0002-6704-5276
FU NCI NIH HHS [CA 3974, R01 CA039742] Funding Source: Medline
CR Andrade-Cetto A, 2001, J ETHNOPHARMACOL, V78, P145, DOI 10.1016/S0378-8741(01)00335-X
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Barbagallo Mario, 2003, Molecular Aspects of Medicine, V24, P39, DOI 10.1016/S0098-2997(02)00090-0
   Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185
   Folsom AR, 2000, AM J PUBLIC HEALTH, V90, P134, DOI 10.2105/AJPH.90.1.134
   FOLSOM AR, 1989, INT J EPIDEMIOL, V18, P361, DOI 10.1093/ije/18.2.361
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Isogawa A, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12586-X
   KAYE SA, 1991, J CLIN EPIDEMIOL, V44, P329, DOI 10.1016/0895-4356(91)90044-A
   Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832
   KUSHI LH, 1988, AM J EPIDEMIOL, V128, P740, DOI 10.1093/oxfordjournals.aje.a115027
   Lane JD, 2004, DIABETES CARE, V27, P2047, DOI 10.2337/diacare.27.8.2047
   Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Meier JJ, 2001, DIABETES, V50, P2497, DOI 10.2337/diabetes.50.11.2497
   MUNGER RG, 1992, AM J EPIDEMIOL, V136, P192, DOI 10.1093/oxfordjournals.aje.a116485
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186
   Reunanen A, 2003, LANCET, V361, P702, DOI 10.1016/S0140-6736(03)12583-4
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Saremi A, 2003, DIABETES CARE, V26, P2211, DOI 10.2337/diacare.26.7.2211
   Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59
   Svilaas A, 2004, J NUTR, V134, P562, DOI 10.1093/jn/134.3.562
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086
   Yokota K, 2004, J AM COLL NUTR, V23, p506S, DOI 10.1080/07315724.2004.10719390
NR 32
TC 129
Z9 140
U1 1
U2 34
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610-0946 USA
SN 0003-9926
J9 ARCH INTERN MED
JI Arch. Intern. Med.
PD JUN 26
PY 2006
VL 166
IS 12
BP 1311
EP 1316
DI 10.1001/archinte.166.12.1311
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 056YI
UT WOS:000238560600010
PM 16801515
DA 2025-04-28
ER

PT J
AU Seal, AD
   Bardis, CN
   Gavrieli, A
   Grigorakis, P
   Adams, JD
   Arnaoutis, G
   Yannakoulia, M
   Kavouras, SA
AF Seal, Adam D.
   Bardis, Costas N.
   Gavrieli, Anna
   Grigorakis, Petros
   Adams, J. D.
   Arnaoutis, Giannis
   Yannakoulia, Mary
   Kavouras, Stavros A.
TI Coffee with High but Not Low Caffeine Content Augments Fluid and
   Electrolyte Excretion at Rest
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE caffeine; fluid balance; electrolytes; hydration; coffee; dehydration;
   hypohydration
ID METABOLIC SYNDROME; INDUCED DIURESIS; EXERCISE; HYDRATION; SPORTS;
   PHARMACOKINETICS; CONSUMPTION; INGESTION; OBESITY; BALANCE
AB Background: Low levels of caffeine ingestion do not induce dehydration at rest, while it is not clear if larger doses do have an acute diuretic effect. The aim of the present investigation was to examine the acute effect of low and high levels of caffeine, via coffee, on fluid balance in habitual coffee drinkers (at least one per day) at rest.
   Methods: Ten healthy adults (eight males and two females; age: 27 +/- 5 years, weight: 89.5 +/- 14.8 kg, height: 1.75 +/- 0.08 m, and body mass index: 29.1 +/- 4.4 kg m(-2)) ingested 200 mL of water (W), coffee with low caffeine (3 mg kg(-1), LCAF), or coffee with high caffeine (6 mg kg(-1), HCAF) on three respective separate occasions. All sessions were performed at 09: 00 in the morning in a counterbalanced, crossover manner, at least 5 days apart. Subjects remained in the laboratory while urine samples were collected every 60 min for 3 h post ingestion.
   Results: Absolute caffeine consumption was 269 +/- 45 and 537 +/- 89 mg for the LCAF and HCAF, respectively. Coffee ingestion at the HCAF trial induced greater diuresis during the 3-h period (613 +/- 101 mL, P < 0.05), when compared to W (356 +/- 53 mL) and LCAF (316 +/- 38 mL). In addition, cumulative urinary osmotic excretion was significantly greater in the HCAF (425 +/- 92 mmol, P < 0.05), as compared to the W (249 +/- 36 mmol) and LCAF (177 +/- 16 mmol) trials.
   Conclusion: The data indicate that caffeine intake of 6 mg kg(-1) in the form of coffee can induce an acute diuretic effect, while 3 mg kg(-1) do not disturb fluid balance in healthy casual coffee drinking adults at rest.
C1 [Seal, Adam D.; Adams, J. D.; Kavouras, Stavros A.] Univ Arkansas, Hydrat Sci Lab, Fayetteville, AR 72701 USA.
   [Bardis, Costas N.; Gavrieli, Anna; Grigorakis, Petros; Arnaoutis, Giannis; Yannakoulia, Mary] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece.
   [Kavouras, Stavros A.] Univ Arkansas Med Sci, Div Endocrinol, Little Rock, AR 72205 USA.
C3 University of Arkansas System; University of Arkansas Fayetteville;
   Harokopio University Athens; University of Arkansas System; University
   of Arkansas Medical Sciences
RP Kavouras, SA (corresponding author), Univ Arkansas, Hydrat Sci Lab, Fayetteville, AR 72701 USA.; Kavouras, SA (corresponding author), Univ Arkansas Med Sci, Div Endocrinol, Little Rock, AR 72205 USA.
EM kavouras@uark.edu
RI ; Kavouras, Stavros/X-3170-2018
OI Adams, J.D./0000-0002-0738-5826; Arnaoutis, Giannis/0000-0001-9134-1641;
   Kavouras, Stavros/0000-0001-7485-8112; Yannakoulia,
   Mary/0000-0003-2171-7337
FU Department of Nutrition and Dietetics at Harokopio University
FX The study was funded by the Graduate Program of the Department of
   Nutrition and Dietetics at Harokopio University.
CR Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   [Anonymous], FDA INV ADD CAFF US
   [Anonymous], CAFFEINE CONTENT COF
   [Anonymous], NUTR ERGOGENIC AIDS
   Armstrong LE, 2007, EXERC SPORT SCI REV, V35, P135
   Armstrong LE, 2005, INT J SPORT NUTR EXE, V15, P252, DOI 10.1123/ijsnem.15.3.252
   Baselt R.C., 2002, Disposition of Toxic Drugs and Chemicals in Man, V6th
   Bird ET, 2005, NEUROUROL URODYNAM, V24, P611, DOI 10.1002/nau.20179
   BRATER DC, 1983, J PHARMACOL EXP THER, V227, P92
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   CLAUSEN JP, 1974, J APPL PHYSIOL, V37, P716, DOI 10.1152/jappl.1974.37.5.716
   Fenton RA, 2015, AM J PHYSIOL-RENAL, V308, pF1409, DOI 10.1152/ajprenal.00129.2015
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Killer SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084154
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245
   Matthaei J, 2016, CLIN PHARMACOL THER, V100, P606, DOI 10.1002/cpt.444
   Maughan RJ, 2003, J HUM NUTR DIET, V16, P411, DOI 10.1046/j.1365-277X.2003.00477.x
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   Millard-Stafford ML, 2007, INT J SPORT NUTR EXE, V17, P163, DOI 10.1123/ijsnem.17.2.163
   NeuhauserBerthold M, 1997, ANN NUTR METAB, V41, P29, DOI 10.1159/000177975
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   NUSSBERGER J, 1990, J CARDIOVASC PHARM, V15, P685, DOI 10.1097/00005344-199005000-00001
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Olson R., 2015, Dietary Guidelines for Americans 2015-2020 Eighth Edition
   Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x
   Rush EC, 2013, EUR J CLIN NUTR, V67, P492, DOI 10.1038/ejcn.2013.11
   Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9
   Wemple RD, 1997, INT J SPORTS MED, V18, P40, DOI 10.1055/s-2007-972593
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Yu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25746
   Zhang Y, 2015, J SCI MED SPORT, V18, P569, DOI 10.1016/j.jsams.2014.07.017
NR 34
TC 34
Z9 35
U1 1
U2 26
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD AUG 18
PY 2017
VL 4
AR 40
DI 10.3389/fnut.2017.00040
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FF5JO
UT WOS:000409024400001
PM 28868290
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Bhatti, SK
   O'Keefe, JH
   Lavie, CJ
AF Bhatti, Salman K.
   O'Keefe, James H.
   Lavie, Carl J.
TI Coffee and tea: perks for health and longevity?
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Review
DE beverages; caffeine; coffee; LDL; HDL; tea
ID GREEN TEA; DECAFFEINATED COFFEE; METABOLIC SYNDROME; BLOOD-PRESSURE;
   CANCER-RISK; BLACK TEA; CONSUMPTION; CAFFEINE; METAANALYSIS; CATECHINS
AB Purpose of reviewTea and coffee, after water, are the most commonly consumed beverages in the world and are the top sources of caffeine and antioxidant polyphenols in the American diet. The purpose of this review is to assess the health effects of chronic tea and/or coffee consumption.Recent findingsTea consumption, especially green tea, is associated with significantly reduced risks for stroke, diabetes and depression, and improved levels of glucose, cholesterol, abdominal obesity and blood pressure. Habitual coffee consumption in large epidemiological studies is associated with reduced mortality, both for all-cause and cardiovascular deaths. In addition, coffee intake is associated with risks of heart failure, stroke, diabetes mellitus and some cancers in an inverse dose-dependent fashion. Surprisingly, coffee is associated with neutral to reduced risks for both atrial and ventricular arrhythmias. However, caffeine at high doses can increase anxiety, insomnia, calcium loss and possibly the risk of fractures.SummaryCoffee and tea can generally be recommended as health-promoting additions to an adult diet. Adequate dietary calcium intake may be particularly important for tea and coffee drinkers.
C1 [Bhatti, Salman K.; O'Keefe, James H.] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA.
   [Bhatti, Salman K.; O'Keefe, James H.] Univ Missouri, Kansas City, MO 64110 USA.
   [Lavie, Carl J.] Univ Queensland, Sch Med, Ochsner Clin Sch, John Ochsner Heart & Vasc Inst, New Orleans, LA USA.
   [Lavie, Carl J.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Prevent Med, Baton Rouge, LA USA.
C3 Saint Luke's Mid America Heart Institute; University of Missouri System;
   University of Missouri Kansas City; University of Queensland; Ochsner
   Health System; Louisiana State University System; Louisiana State
   University; Pennington Biomedical Research Center
RP Bhatti, SK (corresponding author), St Lukes Mid Amer Heart Inst, 4330 Wornall Rd,Ste 2000, Kansas City, MO 64111 USA.
EM jokeefe@saint-lukes.org
RI Lavie, Carl/A-6014-2011
OI O'Keefe, James/0000-0002-3376-5822
CR [Anonymous], 2012, NAT COFF DRINK TREND
   Aurora RN, 2012, CHEST, V142, P631, DOI 10.1378/chest.11-2894
   Bahorun T, 2012, PREV MED, V54, pS98, DOI 10.1016/j.ypmed.2011.12.009
   Beresniak A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000648
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Bravi F, 2013, CLIN GASTROENTEROL H, DOI 10.1016/j.cgh.2013.04.039
   Brown AL, 2011, BRIT J NUTR, V106, P1880, DOI 10.1017/S0007114511002376
   Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808
   D'Elia GC, 2012, J HYPERTENS SA, V30, pe107
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Floegel A, 2012, AM J CLIN NUTR, V95, P901, DOI 10.3945/ajcn.111.023648
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Giri A, 2011, NUTRIENTS, V3, P937, DOI 10.3390/nu3110937
   Gutiérrez-Grobe Y, 2012, ANN HEPATOL, V11, P350, DOI 10.1016/S1665-2681(19)30931-7
   Hodgson JM, 2012, ARCH INTERN MED, V172, P186, DOI 10.1001/archinte.172.2.186
   Houtkooper L., 2011, CALCIUM SUPPLEMENT G
   Je Y, 2012, INT J CANCER, V131, P1700, DOI 10.1002/ijc.27408
   Josic J, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-63
   Kim A, 2011, J AM DIET ASSOC, V111, P1720, DOI 10.1016/j.jada.2011.08.009
   Kim B, 2012, KOREAN J FAM MED, V33, P356, DOI 10.4082/kjfm.2012.33.6.356
   Klatsky Arthur L, 2011, Perm J, V15, P19
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   Li GW, 2013, PUBLIC HEALTH NUTR, V16, P346, DOI 10.1017/S1368980012002601
   Li JM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2879
   Liu HF, 2012, ARCH MED SCI, V8, P776, DOI 10.5114/aoms.2012.31612
   Liu J, 2013, MAYO CLIN P
   Matheson EM, 2011, ANN FAM MED, V9, P299, DOI 10.1370/afm.1262
   Mayo Foundation for Medical Education and Research Staff MC, 2011, CAFF CONT COFF TEA S
   Mostofsky E, 2012, CIRC-HEART FAIL, V5, P401, DOI 10.1161/CIRCHEARTFAILURE.112.967299
   O'Keefe JH, 2013, J AM COLL CARDIOL
   Pham NM, 2013, PUBLIC HLTH NUTR, DOI 10.1017/S1368980013000360
   Pyshchyta G, 2012, CLIN NUTR, V31, P267, DOI 10.1016/j.clnu.2011.10.011
   Ras RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016974
   Reis JP, 2010, ARTERIOSCL THROM VAS, V30, P2059, DOI 10.1161/ATVBAHA.110.208280
   Renda G, 2012, AM J CLIN NUTR, V95, P241, DOI 10.3945/ajcn.111.018267
   Shafique K, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-42
   Shen L, 2012, J ZHEJIANG UNIV-SC B, V13, P652, DOI 10.1631/jzus.B1201001
   Siasos G, 2013, VASC MED, V18, P55, DOI 10.1177/1358863X13480258
   Sinha R, 2012, AM J CLIN NUTR, V96, P374, DOI 10.3945/ajcn.111.031328
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Thomas-Jean F, 2013, EUR SOC HYP ESH 2013
   Tsuneki Hiroshi, 2004, BMC Pharmacology, V4, P18, DOI 10.1186/1471-2210-4-18
   Valls-Pedret C, 2012, J ALZHEIMERS DIS, V29, P773, DOI 10.3233/JAD-2012-111799
   van Woudenbergh GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036910
   Vercambre MN, 2013, J ALZHEIMERS DIS, V35, P413, DOI 10.3233/JAD-122371
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   von Ruesten A, 2013, EUR J CLIN NUTR, V67, P412, DOI 10.1038/ejcn.2013.7
   Wang YP, 2012, LUNG CANCER, V78, P169, DOI 10.1016/j.lungcan.2012.08.009
   Wein S, 2013, J MED FOOD, V16, P312, DOI 10.1089/jmf.2012.0205
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
NR 52
TC 45
Z9 52
U1 3
U2 138
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD NOV
PY 2013
VL 16
IS 6
BP 688
EP 697
DI 10.1097/MCO.0b013e328365b9a0
PG 10
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 247BA
UT WOS:000326586800013
PM 24071782
DA 2025-04-28
ER

PT J
AU Starling-Soares, B
   Pereira, M
   Renke, G
AF Starling-Soares, Bernardo
   Pereira, Marcela
   Renke, Guilherme
TI Extrapolating the Coffee and Caffeine (1,3,7-Trimethylxanthine) Effects
   on Exercise and Metabolism-A Concise Review
SO NUTRIENTS
LA English
DT Review
DE caffeine; insulin resistance; obesity; exercise; thermogenic effect
ID CONSUMPTION; RISK; PERFORMANCE; INGESTION; OBESITY
AB The consumption of coffee and caffeine (1,3,7-trimethylxanthine) is part of many cultures worldwide. Their properties include serving as a neurostimulant aid, enhancing energy substrate levels, and improving general exercise performance. Both present therapeutic effects that can also be used to control chronic and metabolic diseases due to four mechanisms: adenosine receptor antagonism, increased catecholamine concentrations, a phosphodiesterase inhibitor, and a stimulator of calcium-release channels. Despite the individual genetic variabilities, distinct mechanisms have been demonstrated to improve physical performance, thermogenesis, lipolysis, insulin sensitivity, and hormonal modulation. Thus, coffee consumption and caffeine supplementation may enhance physical and mental performance and may improve metabolic variables, reducing oxidative stress, inflammation, and insulin resistance. Current data reveal vital aspects of coffee and caffeine consumption in specific populations, although further studies are needed to define clinical interventions with caffeine in obesity and chronic conditions.
C1 [Starling-Soares, Bernardo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31310250 Belo Horizonte, MG, Brazil.
   [Starling-Soares, Bernardo] Extreme Sports Nutr Inst INEE, BR-31310370 Belo Horizonte, MG, Brazil.
   [Pereira, Marcela; Renke, Guilherme] Nutrindo Ideais Performance & Nutr Res Ctr, BR-22640100 Rio De Janeiro, RJ, Brazil.
   [Renke, Guilherme] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, BR-21941913 Rio De Janeiro, RJ, Brazil.
C3 Universidade Federal de Minas Gerais; Universidade Federal do Rio de
   Janeiro
RP Starling-Soares, B (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31310250 Belo Horizonte, MG, Brazil.; Starling-Soares, B (corresponding author), Extreme Sports Nutr Inst INEE, BR-31310370 Belo Horizonte, MG, Brazil.; Renke, G (corresponding author), Nutrindo Ideais Performance & Nutr Res Ctr, BR-22640100 Rio De Janeiro, RJ, Brazil.; Renke, G (corresponding author), Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, BR-21941913 Rio De Janeiro, RJ, Brazil.
EM bernardostarling@gmail.com; renke@renke.com.br
RI Renke, Guilherme/JKJ-2777-2023; Pereira, Marcela/J-6563-2015
OI Starling-Soares, Bernardo/0000-0002-0730-7684; Renke,
   Guilherme/0000-0002-7940-3667; , Instituto Nutrindo
   Ideais/0009-0007-9143-4697
FU Nutrindo Ideais Performance and Nutrition Research Center
FX No Statement Available
CR Aguilar-Navarro M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020286
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Arnaud Maurice J, 2011, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-642-13443-2_3
   Barcelos RP, 2020, NUTR RES, V80, P1, DOI 10.1016/j.nutres.2020.05.005
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Bonetti Gabriele, 2022, J Prev Med Hyg, V63, pE169, DOI 10.15167/2421-4248/jpmh2022.63.2S3.2758
   Cappelletti S, 2015, CURR NEUROPHARMACOL, V13, P71, DOI 10.2174/1570159X13666141210215655
   Carek PJ, 1999, DRUGS, V57, P883, DOI 10.2165/00003495-199957060-00005
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   CASIGLIA E, 1991, J INTERN MED, V229, P501, DOI 10.1111/j.1365-2796.1991.tb00385.x
   Clark KS, 2019, CLIN EXP PHARMACOL P, V46, P475, DOI 10.1111/1440-1681.13065
   Clarke ND, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112575
   COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155
   Daly JW, 2004, NUTR BRAIN BEHAV, P1
   Davis JM, 2003, AM J PHYSIOL-REG I, V284, pR399, DOI 10.1152/ajpregu.00386.2002
   Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
   De Souza JG, 2022, EUR J NUTR, V61, P3823, DOI 10.1007/s00394-022-02874-3
   Denoeud F, 2014, SCIENCE, V345, P1181, DOI 10.1126/science.1255274
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Dludla PV, 2023, MOLECULES, V28, DOI 10.3390/molecules28186440
   Dludla PV, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010023
   Domínguez R, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020584
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200
   Foskett A, 2009, INT J SPORT NUTR EXE, V19, P410, DOI 10.1123/ijsnem.19.4.410
   Gardener SL, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.744872
   Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Guest N, 2018, MED SCI SPORT EXER, V50, P1570, DOI 10.1249/MSS.0000000000001596
   Guest NS, 2021, J INT SOC SPORT NUTR, V18, DOI 10.1186/s12970-020-00383-4
   Gutiérrez-Hellín J, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030715
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]
   Hoppe J., 1857, Deutsch. Klin, V9, P181
   Jodra P, 2020, J INT SOC SPORT NUTR, V17, DOI 10.1186/s12970-019-0332-5
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Kolb H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041144
   Kolb H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061842
   Larsson SC, 2023, BMJ MED, V2, DOI 10.1136/bmjmed-2022-000335
   Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566
   Lieberman HR, 2002, PSYCHOPHARMACOLOGY, V164, P250, DOI 10.1007/s00213-002-1217-9
   Liguori A, 1997, PHARMACOL BIOCHEM BE, V58, P721, DOI 10.1016/S0091-3057(97)00003-8
   Lipton RB, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0806-2
   Lonati E, 2022, MOLECULES, V27, DOI 10.3390/molecules27031049
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Loureiro LMR, 2021, NUTRIENTS, V13, DOI 10.3390/nu13103335
   Lucas M, 2014, WORLD J BIOL PSYCHIA, V15, P377, DOI 10.3109/15622975.2013.795243
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Nordestgaard AT, 2020, J INTERN MED, V287, P42, DOI 10.1111/joim.12970
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Pérez-Torres I, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041786
   Pickering RJ, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020171
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Reis CEG, 2019, J TRADIT COMPL MED, V9, P184, DOI 10.1016/j.jtcme.2018.01.001
   Richardson DL, 2016, J STRENGTH COND RES, V30, P2892, DOI 10.1519/JSC.0000000000001382
   Ruiz-Moreno C, 2021, EUR J NUTR, V60, P2077, DOI 10.1007/s00394-020-02393-z
   Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x
   San Juan AF, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092120
   Sanchez-Medina A, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24021440
   Smith E., 1859, Philos. Trans, V149, P681
   Southward K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101352
   Stuart GR, 2005, MED SCI SPORT EXER, V37, P1998, DOI 10.1249/01.mss.0000177216.21847.8a
   Trexler ET, 2016, EUR J SPORT SCI, V16, P702, DOI 10.1080/17461391.2015.1085097
   TSE SYH, 1992, J PHARM SCI, V81, P449, DOI 10.1002/jps.2600810512
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Varillas-Delgado D, 2023, BIOL SPORT, V40, P827, DOI 10.5114/biolsport.2023.121321
   WEBER A, 1968, J GEN PHYSIOL, V52, P750, DOI 10.1085/jgp.52.5.750
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8
NR 71
TC 2
Z9 3
U1 2
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD DEC
PY 2023
VL 15
IS 24
AR 5031
DI 10.3390/nu15245031
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DI3R0
UT WOS:001131367200001
PM 38140290
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Tian, D
   Liu, SL
   Lu, YL
   Zhang, TT
   Wang, X
   Zhang, CQ
   Hu, CY
   Chen, P
   Deng, H
   Meng, YH
AF Tian, Dan
   Liu, Shenlin
   Lu, Yalong
   Zhang, Tingting
   Wang, Xue
   Zhang, Chaoqun
   Hu, Ching Yuan
   Chen, Ping
   Deng, Hong
   Meng, Yonghong
TI Low-methoxy-pectin and chlorogenic acid synergistically promote
   lipolysis and β-oxidation by regulating AMPK signaling pathway in obese
   mice
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chlorogenic acid; Pectin; Conjugates; Obesity; Lipid metabolism
ID DIET-INDUCED OBESITY; GUT MICROBIOTA; INSULIN-RESISTANCE; ANTIOXIDANT
   ACTIVITY; DELIVERY-SYSTEM; FAT; INFLAMMATION; METABOLISM; MECHANISM;
   PPAR
AB Chlorogenic acid (CGA) displays various biological activities in preventing high-calorie diet-induced metabolic complications. The absorption efficiency of CGA in the stomach and small intestine is relatively low, with approximately 70 % of CGA being metabolized by colonic microorganisms before it enters the bloodstream. In this study, we successfully developed CGA-LMP (Low-methoxy-pectin) conjugates to improve the absorption rate of CGA. C57BL/6J mice were fed high-fat diets (HFD) supplemented with CGA, LMP, or CGA-LMP conjugates for a duration of eight weeks. The results demonstrated that the CGA, LMP, or CGA-LMP conjugates prevented HFDinduced hyperlipidemia, inflammation, liver steatosis, and adipocyte hypertrophy in obese mice. Notably, the CGA-LMP conjugates demonstrated superior efficacy in alleviating obesity compared to CGA or LMP alone. Further studies revealed that the primary mechanism of weight loss was the activation of the AMPK signaling pathway, which facilitates lipolysis and lipid beta-oxidation. These findings highlight that the enhanced the antiobesity effectiveness of CGA-LMP conjugates, expanding their potential applications in the field of functional nutrition and foods.
C1 [Tian, Dan; Liu, Shenlin; Lu, Yalong; Zhang, Tingting; Wang, Xue; Zhang, Chaoqun; Hu, Ching Yuan; Deng, Hong; Meng, Yonghong] Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Engn Res Ctr High Valued Utilizat Fruit Resources, Natl Res & Dev Ctr Apple Proc Technol,Minist Educ, 620 West Changan Ave, Xian 710119, Peoples R China.
   [Hu, Ching Yuan] Univ Hawaii Manoa, Coll Trop Agr & Human Resources, Dept Human Nutr Food & Anim Sci, 1955 East West Rd,AgSci 415J, Honolulu, HI 96822 USA.
   [Chen, Ping] Shaanxi Prov Ctr Dis Control & Prevent, Xian 710054, Peoples R China.
C3 Shaanxi Normal University; University of Hawaii System; University of
   Hawaii Manoa
RP Deng, H; Meng, YH (corresponding author), Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Engn Res Ctr High Valued Utilizat Fruit Resources, Natl Res & Dev Ctr Apple Proc Technol,Minist Educ, 620 West Changan Ave, Xian 710119, Peoples R China.
EM hongden@snnu.edu.cn; mengyonghong@snnu.edu.cn
RI Zhang, Chaoqun/AAF-2394-2020; Hu, Ching/KDM-7972-2024; Zhang,
   Tingting/JXX-5204-2024
FU China Agriculture Research System [CARS-27]; Shaanxi Province Key
   industrial innovation chain Program in Agriculture Field
   [2020ZDLNY05-06]; Key Research and Development Plan in Shaanxi Province
   [2023-YBNY-183]
FX This research was supported by the China Agriculture Research System
   (CARS-27) , the Shaanxi Province Key industrial innovation chain Program
   in Agriculture Field (2020ZDLNY05-06) , and the Key Research and
   Development Plan in Shaanxi Province (2023-YBNY-183) .
CR Bai QM, 2011, ATHEROSCLEROSIS, V214, P350, DOI 10.1016/j.atherosclerosis.2010.11.021
   Bray GA, 2016, LANCET, V387, P1947, DOI 10.1016/S0140-6736(16)00271-3
   Espín JC, 2017, BIOCHEM PHARMACOL, V139, P82, DOI 10.1016/j.bcp.2017.04.033
   Chen HD, 2014, J FUNCT FOODS, V7, P26, DOI 10.1016/j.jff.2014.01.013
   Chen KL, 2019, INT J BIOL MACROMOL, V136, P936, DOI 10.1016/j.ijbiomac.2019.06.138
   Collins B, 2016, J NUTR BIOCHEM, V31, P150, DOI 10.1016/j.jnutbio.2015.12.021
   Feng KL, 2020, J AGR FOOD CHEM, V68, P6142, DOI 10.1021/acs.jafc.0c01778
   Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026
   Frühbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X
   Ghibaudo F, 2018, COLLOID SURFACE B, V170, P538, DOI 10.1016/j.colsurfb.2018.06.052
   Ghibaudo F, 2017, J FUNCT FOODS, V39, P299, DOI 10.1016/j.jff.2017.10.028
   Green CJ, 2014, NUTRIENTS, V6, P5018, DOI 10.3390/nu6115018
   He J, 2021, J FUNCT FOODS, V81, DOI 10.1016/j.jff.2021.104476
   Ho CK, 2019, J CELL MOL MED, V23, P5108, DOI 10.1111/jcmm.14380
   Hsiao YH, 2021, J AGR FOOD CHEM, V69, P4745, DOI 10.1021/acs.jafc.1c01117
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Jiang TT, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030126
   Jin B, 2018, INT J BIOL MACROMOL, V116, P1, DOI 10.1016/j.ijbiomac.2018.04.164
   Kim NY, 2021, FOODS, V10, DOI 10.3390/foods10081914
   Li DQ, 2021, INT J BIOL MACROMOL, V185, P49, DOI 10.1016/j.ijbiomac.2021.06.088
   Li J, 2018, FOOD RES INT, V114, P251, DOI 10.1016/j.foodres.2018.08.073
   Li X, 2021, J FUNCT FOODS, V77, DOI 10.1016/j.jff.2020.104332
   Liu JH, 2020, J AGR FOOD CHEM, V68, P33, DOI 10.1021/acs.jafc.9b06817
   Liu J, 2017, J AGR FOOD CHEM, V65, P9237, DOI 10.1021/acs.jafc.7b03382
   Lu YL, 2019, FOOD FUNCT, V10, P4153, DOI 10.1039/c8fo02379d
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   Ma CH, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4849
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Ma YJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1369, DOI 10.1152/ajpendo.90555.2008
   Molino S, 2023, J AGR FOOD CHEM, V71, P13988, DOI 10.1021/acs.jafc.3c02949
   Mortelé O, 2021, FOOD FUNCT, V12, P417, DOI [10.1039/D0FO02629H, 10.1039/d0fo02629h]
   Nabavi SF, 2017, CURR NEUROPHARMACOL, V15, P471, DOI 10.2174/1570159X14666160325120625
   Nallamuthu I, 2015, ASIAN J PHARM SCI, V10, P203, DOI 10.1016/j.ajps.2014.09.005
   Oliveira GF, 2010, CARBOHYD POLYM, V82, P1004, DOI 10.1016/j.carbpol.2010.06.041
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Peron G, 2020, J AGR FOOD CHEM, V68, P1780, DOI 10.1021/acs.jafc.9b01687
   Ruby MA, 2017, CELL REP, V18, P636, DOI 10.1016/j.celrep.2016.12.070
   Salinas-Rubio D, 2018, CURR OPIN CLIN NUTR, V21, P49, DOI 10.1097/MCO.0000000000000429
   Schmitt LO, 2023, METABOLITES, V13, DOI 10.3390/metabo13010086
   Sheng Y, 2019, FOOD FUNCT, V10, P4771, DOI [10.1039/C9FO00883G, 10.1039/c9fo00883g]
   Singh P., 2019, Obesity Medicine, V16, P100140, DOI [10.1016/j.obmed.2019.100140, DOI 10.1016/J.OBMED.2019.100140]
   Singh SS, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00757
   Singh SS, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6571484
   Song SL, 2010, MOL CELL ENDOCRINOL, V325, P54, DOI 10.1016/j.mce.2010.05.019
   Sun XY, 2019, FOOD HYDROCOLLOID, V96, P402, DOI 10.1016/j.foodhyd.2019.05.040
   Ullah K, 2019, INT J PHARMACEUT, V569, DOI 10.1016/j.ijpharm.2019.118557
   Vukelic I, 2018, FOOD CHEM TOXICOL, V121, P140, DOI 10.1016/j.fct.2018.08.061
   Wang X, 2019, J FUNCT FOODS, V62, DOI 10.1016/j.jff.2019.103525
   Wang YP, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062061
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Wei Y, 2020, J COLLOID INTERF SCI, V563, P291, DOI 10.1016/j.jcis.2019.12.085
   Wu SJ, 2021, J NUTR BIOCHEM, V91, DOI 10.1016/j.jnutbio.2021.108602
   Wu ZH, 2019, J FUNCT FOODS, V61, DOI 10.1016/j.jff.2019.103498
   Xia JH, 2021, J AGR FOOD CHEM, V69, P9157, DOI 10.1021/acs.jafc.0c07342
   Xu M, 2019, FOOD FUNCT, V10, P7489, DOI 10.1039/c9fo00502a
   Xue YW, 2019, FOOD CHEM TOXICOL, V133, DOI 10.1016/j.fct.2019.110751
   Yap F, 2011, INT J BIOL SCI, V7, P645, DOI 10.7150/ijbs.7.645
   Yuan ED, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020187
   Zagury Y, 2019, J FUNCT FOODS, V59, P362, DOI 10.1016/j.jff.2019.05.053
   Zagury Y, 2019, J FUNCT FOODS, V52, P121, DOI 10.1016/j.jff.2018.10.025
   Zheng JQ, 2020, FOOD HYDROCOLLOID, V101, DOI 10.1016/j.foodhyd.2019.105536
   Zhu K, 2020, J AGR FOOD CHEM, V68, P8688, DOI 10.1021/acs.jafc.0c02654
   Zhu XP, 2019, FREE RADICAL BIO MED, V141, P192, DOI 10.1016/j.freeradbiomed.2019.06.019
   Zhu ZJ, 2022, INT J BIOL MACROMOL, V209, P1430, DOI 10.1016/j.ijbiomac.2022.04.107
NR 64
TC 0
Z9 0
U1 13
U2 20
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD NOV
PY 2024
VL 280
AR 135552
DI 10.1016/j.ijbiomac.2024.135552
EA SEP 2024
PN 1
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA G8U9F
UT WOS:001319331900001
PM 39288856
DA 2025-04-28
ER

PT J
AU Nordestgaard, AT
   Thomsen, M
   Nordestgaard, BG
AF Nordestgaard, Ask Tybjaerg
   Thomsen, Mette
   Nordestgaard, Borge Gronne
TI Coffee intake and risk of obesity, metabolic syndrome and type 2
   diabetes: a Mendelian randomization study
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE Coffee; metabolic syndrome; type 2 diabetes; BMI; blood pressure; plasma
   cholesterol; plasma glucose
ID DECAFFEINATED COFFEE; TEA CONSUMPTION; ASSOCIATION; METAANALYSIS;
   CAFFEINE; GENETICS; MELLITUS; HEART
AB Background: Coffee is one of the most widely consumed beverages. We tested the hypothesis that genetically high coffee intake is associated with low risk of obesity, metabolic syndrome and type 2 diabetes, and with related components thereof.
   Methods: We included 93 179 individuals from two large general population cohorts in a Mendelian randomization study. We tested first whether high coffee intake is associated with low risk of obesity, metabolic syndrome and type 2 diabetes, and with related components thereof, in observational analyses; second, whether five genetic variants near the CYP1A1, CYP1A2 and AHR genes are associated with coffee intake; and third, whether the genetic variants are associated with obesity, metabolic syndrome and type 2 diabetes, and with related components thereof. Finally, we tested the genetic association with type 2 diabetes in a meta-analysis including up to 78 021 additional individuals from the DIAGRAM consortium.
   Results: Observationally, high coffee intake was associated with low risk of obesity, metabolic syndrome and type 2 diabetes. Further, high coffee intake was associated with high body mass index, waist circumference, weight, height, systolic/diastolic blood pressure, triglycerides and total cholesterol and with low high-density lipoprotein cholesterol, but not with glucose levels. In genetic analyses, 9-10 vs 0-3 coffee-intake alleles were associated with 29% higher coffee intake. However, genetically derived high coffee intake was not associated convincingly with obesity, metabolic syndrome, type 2 diabetes, body mass index, waist circumference, weight, height, systolic/diastolic blood pressure, triglycerides, total cholesterol, high-density lipoprotein cholesterol or glucose levels. Perallele meta-analysed odds ratios for type 2 diabetes were 1.01 (0.98-1.04) for AHR rs4410790, 0.98 (0.95-1.01) for AHR rs6968865, 1.01 (0.99-1.03) for CYP1A1/2 rs2470893, 1.01 (0.98-1.03) for CYP1A1/2 rs2472297 and 0.98 (0.95-1.01) for CYP1A1 rs2472299.
   Conclusions: High coffee intake was associated observationally with low risk of obesity, metabolic syndrome and type 2 diabetes, and was associated observationally with related components thereof, but with no genetic evidence to support corresponding causal relationships.
C1 [Nordestgaard, Ask Tybjaerg; Thomsen, Mette; Nordestgaard, Borge Gronne] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark.
   [Nordestgaard, Ask Tybjaerg; Thomsen, Mette; Nordestgaard, Borge Gronne] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark.
   [Nordestgaard, Borge Gronne] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark.
   [Nordestgaard, Ask Tybjaerg; Thomsen, Mette; Nordestgaard, Borge Gronne] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.
C3 University of Copenhagen; Herlev & Gentofte Hospital; Copenhagen
   University Hospital; University of Copenhagen; Copenhagen University
   Hospital; Herlev & Gentofte Hospital; University of Copenhagen;
   Copenhagen University Hospital; University of Copenhagen
RP Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.
EM Boerge.Nordestgaard@regionh.dk
RI Nordestgaard, Ask/JBJ-0847-2023; Nordestgaard, Borge/ABF-1310-2020
OI Nordestgaard, Borge/0000-0002-1954-7220; Nordestgaard, Ask
   Tybjaerg/0000-0002-5500-686X
FU Herlev Hospital, Copenhagen University Hospital
FX This study was supported by Herlev Hospital, Copenhagen University
   Hospital. The funding organizations had no role in the design and
   conduct of the study, the collection, analysis and interpretation of the
   data or the writing of the paper.
CR [Anonymous], EUR J NUTR
   [Anonymous], DIABETES IN DENMARK
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x
   Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801
   Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512
   Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   McMahon G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103448
   Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031
   Rebello SA, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0403-1
   Rodenburg EM, 2012, AM J CLIN NUTR, V96, P182, DOI 10.3945/ajcn.111.027102
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402
   Zhou SF, 2010, DRUG METAB REV, V42, P268, DOI 10.3109/03602530903286476
NR 36
TC 139
Z9 145
U1 1
U2 70
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD APR
PY 2015
VL 44
IS 2
BP 551
EP 565
DI 10.1093/ije/dyv083
PG 15
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA CL6VO
UT WOS:000357106100018
PM 26002927
OA Bronze
DA 2025-04-28
ER

PT J
AU Kukkonen, A
   Hantunen, S
   Voutilainen, A
   Ruusunen, A
   Uusitalo, L
   Backman, K
   Voutilainen, R
   Pasanen, M
   Kirjavainen, P
   Keski-Nisula, L
AF Kukkonen, Anni
   Hantunen, Sari
   Voutilainen, Ari
   Ruusunen, Anu
   Uusitalo, Lauri
   Backman, Katri
   Voutilainen, Raimo
   Pasanen, Markku
   Kirjavainen, Pirkka, V
   Keski-Nisula, Leea
TI Maternal caffeine, coffee and cola drink intake and the risk of
   gestational diabetes - Kuopio Birth Cohort
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Coffee; Caffeine; Maternal diet; Gestational diabetes; Pregnancy
ID PERINATAL OUTCOMES; GLUCOSE-TOLERANCE; CONSUMPTION; PREGNANCY; MELLITUS;
   WOMEN; ASSOCIATION; METABOLISM; OBESITY; AGE
AB Aims: Coffee intake is associated with a decreased risk of type 2 diabetes among non -pregnant people. We aimed to investigate the association between caffeine, coffee and cola drink intake in early pregnancy and the risk of gestational diabetes (GDM). Methods: Kuopio Birth Cohort (KuBiCo) is a prospective cohort study including pregnant women who were followed at the prenatal clinics in outpatient healthcare centers and gave birth in Kuopio University Hospital, Finland (n =2214). Maternal diet during the first trimester of pregnancy was assessed using a 160 -item food frequency questionnaire. GDM was diagnosed by oral glucose tolerance test according to the Finnish national guidelines mainly between 24 and 28 gestational weeks. Results: Women with moderate coffee intake in the first trimester were less likely diagnosed with GDM than women without coffee intake in an age -adjusted model (OR 0.87; 95% CI 0.76 -0.99; p = 0.03), but the association was attenuated in multi -adjusted models (p = 0.11). No association was found between caffeine intake and GDM. One third (32.4%) of pregnant women consumed caffeine over the recommendation ( > 200 mg/d). Women who consumed cola drinks more than the median (33.3 mL/d) had an increased risk of GDM (OR 1.29; 95% CI 1.02 -1.63, p = 0.037) in multi -adjusted model compared to those who consumed less. Conclusions: Caffeine intake during the first trimester of pregnancy was not associated with the risk of GDM but a minor non -significant decrease was seen with moderate coffee intake. Although the average consumption of cola drinks was low in the KuBiCo cohort, higher consumption was associated with an increased risk of GDM. Further studies are needed to evaluate the safe amount of coffee during pregnancy, since the recommended caffeine intake was exceeded in almost half of the coffee drinkers.
C1 [Kukkonen, Anni; Hantunen, Sari; Voutilainen, Ari; Ruusunen, Anu; Kirjavainen, Pirkka, V] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.
   [Ruusunen, Anu] Kuopio Univ Hosp, Dept Psychiat, Kuopio, Finland.
   [Ruusunen, Anu] Deakin Univ, IMPACT Inst Mental & Phys Hlth & Clin Translat, Sch Med, Barwon Hlth, Geelong, Australia.
   [Uusitalo, Lauri; Backman, Katri; Voutilainen, Raimo; Keski-Nisula, Leea] Univ Eastern Finland, Inst Clin Med, Sch Med, Kuopio, Finland.
   [Kukkonen, Anni; Backman, Katri; Voutilainen, Raimo] Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland.
   [Pasanen, Markku] Univ Eastern Finland, Sch Pharm, Kuopio, Finland.
   Natl Inst Hlth & Welf, Environm Hlth Unit, Kuopio, Finland.
   [Keski-Nisula, Leea] Kuopio Univ Hosp, Dept Obstet & Gynecol, Kuopio 70211, Finland.
C3 University of Eastern Finland; Kuopio University Hospital; University of
   Eastern Finland; University of Eastern Finland Hospital; Deakin
   University; University of Eastern Finland; University of Eastern
   Finland; University of Eastern Finland Hospital; Kuopio University
   Hospital; University of Eastern Finland; Finland National Institute for
   Health & Welfare; University of Eastern Finland; University of Eastern
   Finland Hospital; Kuopio University Hospital
RP Kukkonen, A; Hantunen, S (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.
EM anni.kukkonen@uef.fi; sari.hantunen@uef.fi
RI Backman, Katri/AAF-7700-2021; Kirjavainen, Pirkka/AAX-8069-2020
OI Voutilainen, Raimo/0000-0002-7858-665X; Kukkonen,
   Anni/0000-0002-9687-8365
FU Research Committee of the Kuopio University Hospital Catchment Area for
   the State Research Funding; Pediatric Research Foundation; Juho Vainio
   Foundation; Paivikki and Sakari Sohlberg Foundation; YrjoJahnsson
   Foundation; Doctoral Programme in Health Sciences at the University of
   Eastern Finland for Anni Kukkonen
FX Research Committee of the Kuopio University Hospital Catchment Area for
   the State Research Funding and the Pediatric Research Foundation for
   KuBiCo study. Juho Vainio Foundation, Paivikki and Sakari Sohlberg
   Foundation, YrjoJahnsson Foundation, and Doctoral Programme in Health
   Sciences at the University of Eastern Finland for Anni Kukkonen.
CR Adeney KL, 2007, ACTA OBSTET GYN SCAN, V86, P161, DOI 10.1080/00016340600994992
   Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Chen LW, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0174-6
   Chen LW, 2009, DIABETES CARE, V32, P2236, DOI 10.2337/dc09-0866
   Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a
   Di Cianni G, 2003, DIABETES-METAB RES, V19, P259, DOI 10.1002/dmrr.390
   Dörsam AF, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040840
   Donazar-Ezcurra M, 2018, CLIN NUTR, V37, P638, DOI 10.1016/j.clnu.2017.02.005
   Finnish Fur Breeders Association, 2023, Peltotuet
   Finnish Institute for Health and Welfare, 2020, Perinatal statistics-parturients, delivers and newborns 2019
   Finnish Institute for Health and Welfare, 2018, Ravitsemus Suomessa-FinRavinto 2017 -tutkimus
   Flores-le Roux JA, 2012, DIABETES RES CLIN PR, V97, P217, DOI 10.1016/j.diabres.2012.03.011
   Gormaz JG, 2016, CURR MED CHEM, V23, P115, DOI 10.2174/0929867323666151127201732
   Grosso LM, 2005, ANN EPIDEMIOL, V15, P460, DOI 10.1016/j.annepidem.2004.12.011
   Hakkarainen H, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1958-z
   Hinkle SN, 2015, BJOG-INT J OBSTET GY, V122, P420, DOI 10.1111/1471-0528.12930
   Hinkle SN, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.33401
   Huuskonen P, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2013-9
   James JE, 2021, BMJ EVID-BASED MED, V26, P114, DOI 10.1136/bmjebm-2020-111432
   Järvelä IY, 2006, DIABETES CARE, V29, P607, DOI 10.2337/diacare.29.03.06.dc05-1118
   Jensen DM, 2003, DIABETIC MED, V20, P51, DOI 10.1046/j.1464-5491.2003.00857.x
   Kamana KC, 2015, ANN NUTR METAB, V66, P14, DOI 10.1159/000371628
   Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862
   KNUTTI R, 1981, EUR J CLIN PHARMACOL, V21, P121, DOI 10.1007/BF00637512
   Lao TT, 2006, DIABETES CARE, V29, P948, DOI 10.2337/diacare.29.04.06.dc05-2568
   Lawson CC, 2004, REPROD TOXICOL, V18, P625, DOI 10.1016/j.reprotox.2004.03.004
   Lehnen H, 2013, MOL HUM REPROD, V19, P415, DOI 10.1093/molehr/gat020
   Lehtonen A, 2021, EUR J NUTR, V60, P193, DOI 10.1007/s00394-020-02231-2
   Leviton A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091152
   Li LJ, 2018, METABOLISM, V83, P216, DOI 10.1016/j.metabol.2017.10.004
   Mannisto S, 1996, J CLIN EPIDEMIOL, V49, P401, DOI 10.1016/0895-4356(95)00551-X
   Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288
   McIntyre HD, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0098-8
   Ni JY, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.739359
   Nicolì F, 2021, DIABETES RES CLIN PR, V178, DOI 10.1016/j.diabres.2021.108943
   Robinson LE, 2009, J OBSTET GYNAECOL CA, V31, P304, DOI 10.1016/S1701-2163(16)34147-0
   Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42
   Shi XQ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0220-7
   Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tan PC, 2009, INT J GYNECOL OBSTET, V105, P50, DOI 10.1016/j.ijgo.2008.11.038
   Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x
   Tryggvadottir EA, 2016, EUR J CLIN NUTR, V70, P237, DOI 10.1038/ejcn.2015.145
   Vitti FP, 2018, REV BRAS GINECOL OBS, V40, P749, DOI 10.1055/s-0038-1675806
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   Working group set up by the Finnish Medical Society Duodecim the Finnish Diabetes Association and the Finnish Society of Obstetrics and Gynaecology, 2024, Gestational diabetes. Current Care Guidelines
   Zhang CL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025517
   Zhu YY, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0699-x
NR 50
TC 2
Z9 2
U1 1
U2 4
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD JUN
PY 2024
VL 18
IS 3
BP 362
EP 367
DI 10.1016/j.pcd.2024.02.005
EA MAY 2024
PG 6
WC Endocrinology & Metabolism; Primary Health Care
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; General & Internal Medicine
GA UA3O9
UT WOS:001245305500001
PM 38423827
OA hybrid
DA 2025-04-28
ER

PT J
AU de Campos, ML
   de Castro, MB
   Campos, AD
   Fernandes, MF
   Conegundes, JLM
   Rodrigues, MN
   Mügge, FLB
   da Silva, AM
   Sabarense, CM
   Castañon, MCMN
   Andreazzi, AE
   Scio, E
AF de Campos, Mara Lucia
   de Castro, Marina Bento
   Campos, Artur Domingos
   Fernandes, Maria Fernanda
   Mota Conegundes, Jessica Leiras
   Rodrigues, Matheus Nehrer
   Brandao Mugge, Fernanda Lins
   da Silva, Aristobolo Mendes
   Sabarense, Cephora Maria
   Marques Nogueira Castanon, Maria Christina
   Andreazzi, Ana Eliza
   Scio, Elita
TI Antiobesity, hepatoprotective and anti-hyperglycemic effects of a
   pharmaceutical formulation containing Cecropia pachystachya
   Trecul in mice fed with a hypercaloric diet
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Cecropia pachystachya; Type 2 diabetes; Obesity; Antioxidant
ID INSULIN-RESISTANCE; ADIPOSE-TISSUE; MACROPHAGE INFILTRATION; OXIDATIVE
   STRESS; CHLOROGENIC ACID; LIVER-DISEASE; WEIGHT-LOSS; LONG-TERM;
   OBESITY; ADIPOCYTE
AB Ethnopharmacological relevance: The leaves of Cecropia pachystachya Tre acute accent cul (Urticaceae), known as embauba, are used as hypoglycemic and for weight reduction in Brazilian traditional medicine.
   Aim of the study: This study investigated the effects of a pharmaceutical formulation (ECP20) containing C. pachystachya extract on some metabolic alterations caused by a hypercaloric diet in mice.
   Material and methods: Mice were randomly fed with a standard or hypercaloric diet and orally treated with ECP20 or vehicle for 13 weeks. Subsequently, adiposity, glucose intolerance, and the presence of nonalcoholic fatty liver disease were assessed. Adipose tissue and liver were collected after euthanasia and frozen at-80 degrees C for histological and antioxidant analyzes. The effect of ECP20 on the differentiation of 3T3-L1 pre-adipocytes was also investigated.
   Results: Animals treated with ECP20 showed less weight gain, reduced glycemia, glucose tolerance restored, and hepatoprotective effect. Also, ECP20 presented significant in vivo antioxidant activity. Treatment of 3T3-L1 preadipocytes with ECP20 did not inhibit cellular differencing.
   Conclusions: Therefore, ECP20 presented promising effects in the control of obesity and related disorders. Considering that glucose intolerance and hyperglycemia are strong evidence for the development of type 2 diabetes, the findings corroborated the traditional use of C. pachystachya to treat this disease. The chlorogenic acid and the flavonoids orientin and iso-orientin, present in the extract, might be involved in the activities found.
C1 [de Campos, Mara Lucia; de Castro, Marina Bento; Campos, Artur Domingos; Fernandes, Maria Fernanda; Mota Conegundes, Jessica Leiras; Scio, Elita] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Biochem, Lab Bioact Nat Prod, BR-36036900 Juiz De Fora, MG, Brazil.
   [Rodrigues, Matheus Nehrer; Marques Nogueira Castanon, Maria Christina] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Morphol, BR-36036900 Juiz De Fora, MG, Brazil.
   [Brandao Mugge, Fernanda Lins; da Silva, Aristobolo Mendes] Univ Fed Minas Gerais, Inst Biol Sci, Lab Inflammatory Genes, BR-31270901 Belo Horizonte, MG, Brazil.
   [Sabarense, Cephora Maria] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Nutr, BR-36036900 Juiz De Fora, MG, Brazil.
   [Andreazzi, Ana Eliza] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Physiol, BR-36036900 Juiz De Fora, MG, Brazil.
C3 Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de
   Fora; Universidade Federal de Minas Gerais; Universidade Federal de Juiz
   de Fora; Universidade Federal de Juiz de Fora
RP Scio, E (corresponding author), Univ Fed Juiz de Fora, Inst Biol Sci, Dept Biochem, Lab Bioact Nat Prod, BR-36036900 Juiz De Fora, MG, Brazil.
EM maralucampos@hotmail.com; marina.bcastro14@gmail.com;
   arturdcjf@hotmail.com; mf_mariafernanda@hotmail.com;
   jessicaleiras26@gmail.com; matheusnehrer@hotmail.com;
   fernandalbm@gmail.com; aristobolo@icb.ufmg.br;
   cephora.sabarense@ufjf.edu.br; christina.nogueira@terra.com.br;
   anaelizabio@yahoo.com.br; elitascio887@gmail.com
RI Scio, Elita/GLT-9411-2022; Silva, Aristobolo/CAF-4874-2022; Scio,
   Elita/G-4870-2012
OI Scio, Elita/0000-0002-5580-4845; Silva, Aristobolo/0000-0001-7473-7433;
   Mugge, Fernanda/0000-0003-2224-4551
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [FAPEMIG -
   APQ-00487-16, APQ 01087-18]
FX This work was supported by the grant from Fundacao de Amparo a Pesquisa
   do Estado de Minas Gerais (FAPEMIG - APQ-00487-16 and APQ 01087-18).
CR Afshin A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172277
   Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001
   Andrade-Cetto A, 2005, J ETHNOPHARMACOL, V99, P325, DOI 10.1016/j.jep.2005.04.019
   Andrade-Cetto A, 2010, J ETHNOPHARMACOL, V130, P93, DOI 10.1016/j.jep.2010.04.016
   [Anonymous], 1985, WHO TECH REP SER, P1
   Arag ~ao D.M.O., 2015, CECROPIA PACHYSTACHY
   Aragao DMO, 2010, J ETHNOPHARMACOL, V128, P629, DOI 10.1016/j.jep.2010.01.008
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Berg C.C., 1990, Flora Neotrop, V51, P1
   BERG C.C., 2005, Flora Neotropica Monograph, V94
   Beutler E., 1975, RED CELL METABOLISM, V2, P160
   Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551
   Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286
   Buege J A, 1978, Methods Enzymol, V52, P302
   Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x
   Caria CREP, 2017, EXP CELL RES, V359, P431, DOI 10.1016/j.yexcr.2017.08.026
   Castro AVB, 2014, ARQ BRAS ENDOCRINOL, V58, P600, DOI 10.1590/0004-2730000003223
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009
   Cheung BMY, 2013, THER ADV DRUG SAF, V4, P171, DOI 10.1177/2042098613489721
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Consolini AE, 2006, J ETHNOPHARMACOL, V106, P90, DOI 10.1016/j.jep.2005.12.006
   Corbalán MS, 2002, CLIN GENET, V61, P305
   da Silva MAB, 2010, REV BRAS FARMACOGN, V20, P549, DOI 10.1590/S0102-695X2010000400014
   Cadena-Zamudio JD, 2019, ACTA BOT MEX, V126, DOI 10.21829/abm126.2019.1361
   Aragao DMD, 2013, PHYTOTHER RES, V27, P926, DOI 10.1002/ptr.4811
   Di Carlo G, 1999, LIFE SCI, V65, P337, DOI 10.1016/S0024-3205(99)00120-4
   Duarte-Alonso A, 2020, J ETHNOPHARMACOL, V261, DOI 10.1016/j.jep.2020.113087
   Faulhaber-Walter R, 2011, DIABETES, V60, P2578, DOI 10.2337/db11-0058
   Filho Ribeiro Mariosa L.S.S., 2006, ARQ BRAS ENDOCRINOL, V50
   Fraloub J.C., 2010, J CLIN BIOCHEM NUTR, V46, P1
   Gaglioti A.L., 2014, URTICACEAE NO ESTADO
   Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019
   He XY, 2021, J SCI FOOD AGR, V101, P631, DOI 10.1002/jsfa.10675
   Hollman P C, 1998, Arch Toxicol Suppl, V20, P237
   Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5
   Jeyakumar SM, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-27
   Katan MB, 2009, NEW ENGL J MED, V360, P923, DOI 10.1056/NEJMe0810291
   Klump KL, 2013, INT J EAT DISORDER, V46, P729, DOI 10.1002/eat.22139
   Lê KA, 2011, DIABETES, V60, P2802, DOI 10.2337/db10-1263
   Lee M.J., 2010, Adipose Tissue in Health and Disease, P283, DOI DOI 10.1002/9783527629527.CH15
   Li YJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111865
   Lorenzi H., 2002, PLANTAS MEDICINAIS N, P118
   Ma XQ, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00001
   Mehra A, 2007, ANAL BIOCHEM, V362, P281, DOI 10.1016/j.ab.2006.12.016
   Nagai S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020130
   Ojo O, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081905
   Pacheco NR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/301294
   Pascual-Serrano A, 2017, INT J OBESITY, V41, P1246, DOI 10.1038/ijo.2017.90
   Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004
   Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540
   Revilla-Monsalve MC, 2007, J ETHNOPHARMACOL, V111, P636, DOI 10.1016/j.jep.2007.01.014
   Rivera-Mondragón A, 2017, PHARM BIOL, V55, P1500, DOI 10.1080/13880209.2017.1307421
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Rosen ED, 2018, DIABETES, V67, P1923, DOI 10.2337/db18-0537
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207
   Shawar Said M, 2012, Oman Med J, V27, P274, DOI 10.5001/omj.2012.69
   Sipe LM, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.13
   Soraru S.B., 1978, PLANTAS MED POPULAR, P76
   Sudhakar M, 2020, J FUNCT FOODS, V74, DOI 10.1016/j.jff.2020.104161
   Sundaram S, 2016, NUTR RES, V36, P603, DOI 10.1016/j.nutres.2016.02.005
   Tanofsky-Kraff M, 2017, J CONSULT CLIN PSYCH, V85, P218, DOI 10.1037/ccp0000153
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937
   Verboven K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22962-x
   Videla LA, 2006, TRENDS MOL MED, V12, P555, DOI 10.1016/j.molmed.2006.10.001
   Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177
   WADE GN, 1975, J COMP PHYSIOL PSYCH, V88, P183, DOI 10.1037/h0076186
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337
   Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x
   World Health Organization, 2016, WHO OBES OVERW FACT
   Yoo S, 2018, J OBES METAB SYNDR, V27, P203, DOI 10.7570/jomes.2018.27.4.203
   Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005
   Zheng YX, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103587
NR 76
TC 6
Z9 6
U1 0
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD NOV 15
PY 2021
VL 280
AR 114418
DI 10.1016/j.jep.2021.114418
EA JUL 2021
PG 11
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA WF6JX
UT WOS:000706410800004
PM 34271111
DA 2025-04-28
ER

PT J
AU Ghadieh, HE
   Smiley, ZN
   Kopfman, MW
   Najjar, MG
   Hake, MJ
   Najjar, SM
AF Ghadieh, Hilda E.
   Smiley, Zachary N.
   Kopfman, Melissa W.
   Najjar, Mona G.
   Hake, Michael J.
   Najjar, Sonia M.
TI Chlorogenic acid/chromium supplement rescues diet-induced insulin
   resistance and obesity in mice
SO NUTRITION & METABOLISM
LA English
DT Article
ID HIGH-FAT DIET; CHROMIUM DINICOCYSTEINATE SUPPLEMENTATION; CONTINUOUS
   MODERATE EXERCISE; NF-KAPPA-B; METABOLIC SYNDROME; ANTIOXIDANT
   PROPERTIES; ACID; COFFEE; FRUCTOSE; GLUCOSE
AB Abdominal obesity is a major risk factor for insulin resistance, type 2 diabetes and cardiovascular diseases. Dietary fat induces insulin resistance in humans and rodents. The current study investigates whether a Chlorogenic acid/Chromium III supplement rescues obesity and insulin resistance caused by high-fat feeding of male C57BL/6 J mice for 7 weeks. Administering an oral daily dose of this supplement in the last 3 weeks of feeding reversed diet-induced body weight gain and insulin resistance, assessed by hyperglycemia, glucose intolerance and insulin intolerance. Indirect calorimetry analysis revealed that this effect is mediated at least partly, by increasing energy expenditure and spontaneous locomoter activity. These findings underscore the important role that chlorogenic acid and chromium play in maintaining glucose metabolism and insulin response in mice fed a high-fat diet.
C1 [Ghadieh, Hilda E.; Smiley, Zachary N.; Kopfman, Melissa W.; Najjar, Mona G.; Hake, Michael J.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res CeDER, Toledo, OH 43614 USA.
   [Ghadieh, Hilda E.; Smiley, Zachary N.; Kopfman, Melissa W.; Najjar, Mona G.; Hake, Michael J.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Toledo, OH 43614 USA.
   [Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Toledo, OH 43614 USA.
C3 University System of Ohio; University of Toledo; University System of
   Ohio; University of Toledo; University System of Ohio; University of
   Toledo
RP Najjar, SM (corresponding author), Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res CeDER, Toledo, OH 43614 USA.
EM sonia.najjar@utoledo.edu
RI najjar, sonia/GXW-2217-2022
OI najjar, sonia/0000-0001-6209-8902
FU NIH [R01 DK054254, R01 DK083850, R01 HL112248]; Middle-East Diabetes
   Research Center (MEDRC)
FX This work was supported by grants from the NIH [R01 DK054254, R01
   DK083850 and R01 HL112248] to S.M. Najjar, and by a pre-doctoral
   fellowship from the Middle-East Diabetes Research Center (MEDRC) to H.E.
   Ghadieh.
CR Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Al-Share QY, 2015, DIABETES
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Bakker LEH, 2014, DIABETES, V63, P248, DOI 10.2337/db13-0696
   Bellisle F, 2007, EUR J CLIN NUTR, V61, P691, DOI 10.1038/sj.ejcn.1602649
   Bermúndez-Soto MJ, 2007, J NUTR BIOCHEM, V18, P259, DOI 10.1016/j.jnutbio.2006.05.003
   Bowman TA, 2010, ENDOCRINOLOGY, V151, P5157, DOI 10.1210/en.2010-0176
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035
   Dragan S, 2015, CURR MED CHEM, V22, P14
   Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Haram PM, 2009, CARDIOVASC RES, V81, P723, DOI 10.1093/cvr/cvn332
   Heinrich G, 2010, GASTROENTEROLOGY, V139, P644, DOI 10.1053/j.gastro.2010.03.056
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Iqbal N, 2009, METAB SYNDR RELAT D, V7, P143, DOI 10.1089/met.2008.0048
   Jain SK, 2012, MOL NUTR FOOD RES, V56, P1333, DOI 10.1002/mnfr.201100719
   Jain SK, 2010, MOL NUTR FOOD RES, V54, P1371, DOI 10.1002/mnfr.200900177
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Król E, 2014, BIOL TRACE ELEM RES, V157, P147, DOI 10.1007/s12011-013-9877-3
   LeRoith D, 2008, NAT CLIN PRACT ENDOC, V4, P164, DOI 10.1038/ncpendmet0729
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Mesarwi O, 2013, ENDOCRIN METAB CLIN, V42, P617, DOI 10.1016/j.ecl.2013.05.001
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Najjar SM, 2014, SEMIN IMMUNOPATHOL, V36, P55, DOI 10.1007/s00281-013-0407-3
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975
   Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530
   Patel PR, 2012, DIABETOLOGIA, V55, P763, DOI 10.1007/s00125-011-2388-x
   Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840
   Rippe JM, 2013, ADV NUTR, V4, P236, DOI 10.3945/an.112.002824
   Ruhl Constance E, 2004, Clin Liver Dis, V8, P501, DOI 10.1016/j.cld.2004.04.008
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Selcuk MY, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-30
   Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8
   Teff KL, 2004, J CLIN ENDOCR METAB, V89, P2963, DOI 10.1210/jc.2003-031855
   Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007
   Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c
   Wang ZQ, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00099
   Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001
NR 44
TC 27
Z9 29
U1 1
U2 36
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-7075
J9 NUTR METAB
JI Nutr. Metab.
PD MAY 22
PY 2015
VL 12
AR 19
DI 10.1186/s12986-015-0014-5
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CK0PY
UT WOS:000355908300001
PM 26045713
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Bhandarkar, NS
   Mouatt, P
   Brown, L
   Panchal, SK
AF Bhandarkar, Nikhil S.
   Mouatt, Peter
   Brown, Lindsay
   Panchal, Sunil K.
TI Green coffee ameliorates components of diet-induced metabolic syndrome
   in rats 
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Green coffee; Obesity; Metabolic syndrome; High-carbohydrate, high-fat
   diet; Cardiovascular disease; 
ID BIOACTIVE SUBSTANCE; CHLOROGENIC ACIDS; HIGH-CARBOHYDRATE; CAFFEINE;
   EXTRACTS; TRIGONELLINE; CAFESTOL; OBESITY
AB Metabolic syndrome, especially obesity, increases the risk of type 2 diabetes and cardiovascular disease. We hypothesised that green coffee will attenuate metabolic, cardiovascular and liver parameters in high-carbohydrate high-fat diet-fed rats. Male Wistar rats (8-9 weeks old) were divided into 6 groups and fed for 16 weeks with either corn starch diet (C), C with either 5% green or decaffeinated green coffee in food for the last 8 weeks, high-carbohydrate high-fat diet (H) or H with either 5% green or decaffeinated green coffee in food for the last 8 weeks. Green coffee contained chlorogenic acids, trigonelline, caffeine and diterpenoids; decaffeinated green coffee contained these compounds but no caffeine. Green coffee attenuated body weight, systolic blood pressure, inflammation in the heart and liver and diastolic stiffness without improving glucose sensitivity or plasma lipids. We suggest that chlorogenic acids, trigonelline and diterpenoids in green coffee attenuate diet-induced abnormalities in heart and liver. 
C1 [Bhandarkar, Nikhil S.; Brown, Lindsay] Univ Southern Queensland, Sch Hlth & Wellbeing, Toowoomba, Qld 4350, Australia.
   [Bhandarkar, Nikhil S.; Brown, Lindsay; Panchal, Sunil K.] Univ Southern Queensland, Funct Foods Res Grp, Toowoomba, Qld 4350, Australia.
   [Mouatt, Peter] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW 2480, Australia.
   [Bhandarkar, Nikhil S.] Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel.
C3 University of Southern Queensland; University of Southern Queensland;
   Southern Cross University; Ben-Gurion University of the Negev
RP Panchal, SK (corresponding author), Univ Southern Queensland, Funct Foods Res Grp, Toowoomba, Qld 4350, Australia.
EM Sunil.Panchal@usq.edu.au
RI Mouatt, Peter/JRW-8914-2023; Bhandarkar, Nikhil/AAV-4263-2020
OI Bhandarkar, Nikhil/0000-0001-8790-8940; , Peter/0000-0002-0631-7258
FU University of Southern Queensland Research and Innovation Division
FX We would like to thank Brain Bynon, School of Veterinary Sciences, The
   University of Queensland, Gatton, for plasma biochemical analyses. This
   study was supported by funding received from the University of Southern
   Queensland Research and Innovation Division.
CR Alristina AD., 2018, HLTH NOTIONS, V2, P446
   Baeza G, 2016, J AGR FOOD CHEM, V64, P9663, DOI 10.1021/acs.jafc.6b04022
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/c7fo00388a, 10.1039/C7FO00388A]
   Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002
   Brando C. H. J., 2008, COFFEE GROWING PRO 3, P604, DOI DOI 10.1002/
   Brown L, 2015, OBES REV, V16, P914, DOI 10.1111/obr.12313
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Moreira MED, 2013, J FUNCT FOODS, V5, P466, DOI 10.1016/j.jff.2012.12.002
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   ICO, 2018, INT COFF ORG TRAD ST
   Jeszka-Skowron M, 2017, J SCI FOOD AGR, V97, P4022, DOI 10.1002/jsfa.8269
   Jeszka-Skowron M, 2016, EUR FOOD RES TECHNOL, V242, P1403, DOI 10.1007/s00217-016-2643-y
   Kim J, 2014, FOOD SCI BIOTECHNOL, V23, P2029, DOI 10.1007/s10068-014-0276-0
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Malafaia AB, 2013, ABCD-ARQ BRAS CIR DI, V26, P17, DOI 10.1590/S0102-67202013000600005
   Mellbye FB, 2017, J NAT PROD, V80, P2353, DOI 10.1021/acs.jnatprod.7b00395
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Mohamadi Neda, 2018, Journal of Dietary Supplements, V15, P207, DOI 10.1080/19390211.2017.1329244
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   Nongmaithem BD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17551-3
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]
   Penson P, 2018, CRIT REV FOOD SCI, V58, P1706, DOI 10.1080/10408398.2016.1272045
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Poudyal H, 2012, J NUTR BIOCHEM, V23, P153, DOI 10.1016/j.jnutbio.2010.11.011
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Sanlier N, 2019, CRIT REV FOOD SCI, V59, P2573, DOI 10.1080/10408398.2018.1461061
   Shokouh P, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010006
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tang Z, 2012, IEEE SYM PARA DISTR, P2012, DOI 10.1109/IPDPSW.2012.250
   Tharaheswari M, 2014, MOL CELL BIOCHEM, V396, P161, DOI 10.1007/s11010-014-2152-x
   Zulli A, 2016, EUR J NUTR, V55, P1331, DOI 10.1007/s00394-016-1179-z
NR 37
TC 14
Z9 15
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JUN
PY 2019
VL 57
BP 141
EP 149
DI 10.1016/j.jff.2019.04.003
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA IB1VT
UT WOS:000470053800016
DA 2025-04-28
ER

PT J
AU Witkowska, A
   Mironczuk-Chodakowska, I
   Terlikowska, KM
   Kulesza, K
   Zujko, ME
AF Witkowska, Anna
   Mironczuk-Chodakowska, Iwona
   Terlikowska, Katarzyna M.
   Kulesza, Kamila
   Zujko, Malgorzata E.
TI Coffee and its Biologically Active Components: Is There a Connection to
   Breast, Endometrial, and Ovarian Cancer? - a Review
SO POLISH JOURNAL OF FOOD AND NUTRITION SCIENCES
LA English
DT Review
DE coffee; caffeine; breast cancer; ovarian cancer; endometrial cancer
ID DIETARY ACRYLAMIDE INTAKE; PROSPECTIVE COHORT; CAFFEINE INTAKE;
   DECAFFEINATED COFFEE; POSTMENOPAUSAL WOMEN; EUROPEAN COUNTRIES;
   INSULIN-RESISTANCE; SEX-HORMONES; TEA INTAKE; GREEN TEA
AB Coffee is an important dietary source of biologically active components, not to mention caffeine, phenolic acids, and diterpenes. It has been suggested that selected coffee secondary metabolites may beneficially modulate several mechanisms of anti-cancer protection. This literature review was intended to present current knowledge related to coffee and its components and hormone-dependent female cancers, such as breast. endometrial and ovarian cancer, and to identify gaps in research that may be exploited in the future. The search for studies was conducted through electronic databases. Publications on coffee composition. coffee preparation and brewing methods, in vitro and in vivo experiments with the use of substances naturally present in coffee, observational studies, and meta-analyses were collected. In population studies, the greatest attention has been paid to the anticancer effect of caffeinated coffee and/or caffeine. In general, most studies and meta-analyses indicated that there was no clear correlation between coffee and breast cancer or ovarian cancer. Some subgroups of women may benefit from coffee consumption. This is the case for post-menopausal women with regard to the risk of breast cancer and obese women with regard to the risk of endometrial cancer. This paper identifies a number of issues for future research, related to a better understanding of the anti-cancer mechanisms of coffee compounds and further research that would focus on specific target groups. taking into account both the different methods of coffee preparation and lifestyle factors that may influence the results.
C1 [Witkowska, Anna; Mironczuk-Chodakowska, Iwona; Terlikowska, Katarzyna M.; Kulesza, Kamila; Zujko, Malgorzata E.] Med Univ Bialystok, Fac Hlth Sci, Dept Food Biotechnol, Szpitalna 37, PL-15295 Bialystok, Poland.
C3 Medical University of Bialystok
RP Witkowska, A (corresponding author), Med Univ Bialystok, Fac Hlth Sci, Dept Food Biotechnol, Szpitalna 37, PL-15295 Bialystok, Poland.
EM anna.witkowska@umb.edu.pl
RI Mironczuk-Chodakowska, Iwona/R-6034-2018; Zujko, Malgorzata
   Elzbieta/R-5958-2018; Witkowska, Anna/R-6026-2018; Terlikowska,
   Katarzyna/R-9746-2018
OI Zujko, Malgorzata Elzbieta/0000-0002-0410-3539; Witkowska,
   Anna/0000-0002-0092-3409; Terlikowska, Katarzyna/0000-0001-7685-8976
CR Bray Freddie, 2018, CA Cancer J Clin, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
   [Anonymous], 2010, BREAST CANCER RES TR, DOI DOI 10.1007/S10549-009-0583-Y
   [Anonymous], 2014, BIOCHEM BIOPH RES CO, DOI DOI 10.1016/J.BBRC.2014.04.026
   [Anonymous], 2014, NUTR CANCER, DOI DOI 10.1080/01635581.2014.948214
   [Anonymous], 2019, JNCI CANCER SPECT, DOI DOI 10.1093/JNCICS/PKZ029
   [Anonymous], 2019, BEVERAGES, DOI DOI 10.3390/BEVERAGES5020037
   [Anonymous], 1998, NUTR CANCER
   [Anonymous], 2012, EUR J CLIN NUTR, DOI DOI 10.1038/EJCN.2012.36
   [Anonymous], 2005, LANCET
   [Anonymous], 2010, CANCER CAUSE CONTROL, DOI DOI 10.1007/S10552-010-9582-X
   [Anonymous], 2015, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965.EPI-14-0970
   [Anonymous], 2013, FOOD CHEM TOXICOLOGY, DOI DOI 10.1016/J.FCT.2012.09.017
   [Anonymous], 2011, AUTOPHAGY, DOI DOI 10.4161/AUTO.7.2.14074
   [Anonymous], 2003, J CELL PHYSL, DOI DOI 10.1002/JCP.10289
   [Anonymous], 2015, REDOX BIOL, DOI DOI 10.1016/J.REDOX.2014.11.012
   [Anonymous], 2014, BMC WOMENS HEALTH, DOI DOI 10.1186/1472-6874-14-48
   [Anonymous], 2008, J AGR FOOD CHEM, DOI DOI 10.1021/JF802838S
   [Anonymous], 2012, INT J CANCER, DOI DOI 10.1002/IJC.27408
   [Anonymous], 2015, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965.EPI-15-0038-T
   [Anonymous], 2015, INT J CANC, DOI DOI 10.1002/IJC.29569
   [Anonymous], 2009, J STEROID BIOCHEM, DOI DOI 10.1016/J.JSBMB.2008.11.011
   [Anonymous], 2018, CANCER SCI, DOI DOI 10.1111/CAS.13496
   [Anonymous], 2015, SCI REP UK, DOI DOI 10.1038/SREP13410
   [Anonymous], 2009, AM J EPIDEMIOL, DOI DOI 10.1093/AJE/KWN421
   [Anonymous], 2010, NUTR CANCER, DOI DOI 10.1080/01635581.2010.492083
   [Anonymous], 2014, FOOD CHEM, DOI DOI 10.1016/J.FOODCHEM.2013.08.016
   [Anonymous], 2016, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965.EPI-15-0822
   [Anonymous], 1998, AM J HUMAN GENETICS
   [Anonymous], 2012, FOOD RES INT, DOI DOI 10.1016/J.FOODRES.2012.06.032
   [Anonymous], 2008, J STEROID BIOCHEM, DOI DOI 10.1016/J.JSBMB.2007.09.020
   [Anonymous], 1995, J INTERN MED
   [Anonymous], 2009, INT J CANCER, DOI DOI 10.1002/IJC.24543
   [Anonymous], 2018, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965.EPI-18-0093
   [Anonymous], 2015, J MOL ENDOCRINOL, DOI DOI 10.1530/JME-14-0252
   [Anonymous], 2015, EUR J CANCER, DOI DOI 10.1016/J.EJCA.2015.08.031
   [Anonymous], 2019, NUTRIENTS, DOI DOI 10.3390/NU11030653
   [Anonymous], 2015, INT J CANCER, DOI DOI 10.1002/IJC.29339
   [Anonymous], 2011, PUBLIC HEALTH NUTR, DOI DOI 10.1017/S1368980011000371
   [Anonymous], 2014, GERIATR GERONTOL INT, DOI DOI 10.1111/GGI.12123
   [Anonymous], 2010, FOOD CHEM TOXICOL, DOI DOI 10.1016/J.FCT.2010.05.009
   [Anonymous], 2016, CANCER EPIDEMIOL, DOI DOI 10.1016/J.CANEP.2016.10.010
   [Anonymous], 2015, EUR J NUTR, DOI DOI 10.1007/S00394-014-0696-X
   [Anonymous], 2018, J MASS SPECTROM, DOI DOI 10.1002/JMS.4251
   [Anonymous], 2005, METHOD ENZYMOL, DOI DOI 10.1016/S0076-6879(05)01020-7
   [Anonymous], 2014, INT J GYNECOL CANCER, DOI DOI 10.1097/IGC.0000000000000075
   [Anonymous], 2010, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965.EPI-10-0391
   [Anonymous], 2015, STEROIDS A, DOI DOI 10.1016/J.STEROIDS.2015.02.015
   [Anonymous], 2015, INT J CANCER, DOI DOI 10.1002/IJC.29210
   [Anonymous], 2013, BREAST S2, DOI DOI 10.1016/J.BREAST.2013.07.007
   [Anonymous], 2009, CANCER AM CANCER SOC, DOI DOI 10.1002/CNCR.24328
   [Anonymous], 2016, POL J FOOD NUTR SCI, DOI DOI 10.1515/PJFNS-2015-0048
   [Anonymous], 2016, CANCER CAUSE CONTROL, DOI DOI 10.1007/S10552-016-0719-4
   [Anonymous], 2017, ANN INTERNAL MED, DOI DOI 10.7326/M16-2945
   [Anonymous], 2015, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965.EPI-15-0246
   [Anonymous], 2009, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965.EPI-08-0868
   [Anonymous], 2016, EUR J EPIDEMIOL, DOI DOI 10.1007/S10654-016-0202-2
   [Anonymous], 2016, ONCOL REP, DOI DOI 10.3892/OR.2015.4399
   [Anonymous], 2016, NUTRITION, DOI DOI 10.1016/J.NUT.2015.11.015
   [Anonymous], 2018, NUTRIENTS, DOI DOI 10.3390/NU10070865
   [Anonymous], 2012, AM J CLIN NUTR, DOI DOI 10.3945/AJCN.111.026393
   [Anonymous], 2019, INT J CANCER, DOI DOI 10.1002/IJC.31961
   [Anonymous], 2010, CANCER CAUSE CONTROL, DOI DOI 10.1007/S10552-010-9622-6
   [Anonymous], 2003, CANCER RES
   [Anonymous], 2006, INT J CANC, DOI DOI 10.1002/IJC.21296
   [Anonymous], 2007, CANC EPIDEMIOLOGY BI, DOI DOI 10.1158/1055-9965.EPI-06-1074
   [Anonymous], 2020, ANTIOXIDANTS BASEL, DOI DOI 10.3390/ANTIOX9020093
   [Anonymous], 2015, ACTA ONCOL, DOI DOI 10.3109/0284186X.2014.1001035
   [Anonymous], 2015, EFSA J, DOI DOI 10.2903/J.EFSA.2015.4104
   [Anonymous], 2013, LANCET ONCOL, DOI DOI 10.1016/S1470-2045(13)70301-2
   [Anonymous], 2015, NUTRIENTS, DOI DOI 10.3390/NU7115464
   [Anonymous], 2018, CANCER CAUSE CONTROL, DOI DOI 10.1007/S10552-018-1028-X
   [Anonymous], 1998, BRIT J NUTR
   [Anonymous], 2018, NUTRIENTS, DOI DOI 10.3390/NU10081047
   [Anonymous], 2015, BREAST CANCER RES, DOI DOI 10.1186/S13058-015-0521-3
   [Anonymous], 2009, BREAST J S1, DOI DOI 10.1111/J.1524-4741.2009.00806.X
   [Anonymous], 2019, J ADV RES, DOI DOI 10.1016/J.JARE.2019.01.002
   [Anonymous], 2015, J NUTRIGENET NUTRIGE, DOI DOI 10.1159/000439110
   [Anonymous], 2017, BRIT J PHARMACOL, DOI DOI 10.1111/bph.13622
   [Anonymous], 2013, FOOD NUTR RES, DOI DOI 10.3402/FNR.V57I0.19805
   [Anonymous], 2012, INT J CANCER, DOI DOI 10.1002/IJC.26372
   [Anonymous], 2003, MUTATION RES
   [Anonymous], 2016, EUR J EPIDEMIOL, DOI DOI 10.1007/S10654-016-0142-X
   [Anonymous], 2018, NUTR CANCER, DOI DOI 10.1080/01635581.2018.1460681
   [Anonymous], 2011, J NUTR BIOCHEM, DOI DOI 10.1016/J.JNUTBIO.2010.03.011
   [Anonymous], 2011, NUTRIENTS, DOI DOI 10.3390/NU3110937
   [Anonymous], 2017, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.J5024
   [Anonymous], 2013, BRIT J CANCER, DOI DOI 10.1038/BJC.2013.540
   [Anonymous], 2017, PUBLIC HEALTH NUTR, DOI DOI 10.1017/S1368980016001749
   [Anonymous], 2013, GYNECOL ONCOL, DOI DOI 10.1016/J.YGYNO.2013.03.014
   [Anonymous], 2009, J NUTR, DOI DOI 10.3945/JN.109.108001
   [Anonymous], 2017, ANNU REV NUTR, DOI DOI 10.1146/ANNUREV-NUTR-071816-064941
   [Anonymous], 2017, NUTRIENTS, DOI DOI 10.3390/NU9111223
   [Anonymous], 2015, J NAT PROD, DOI DOI 10.1021/ACS.JNATPROD.5B00481
   [Anonymous], 2011, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0023407
   [Anonymous], 2015, AM J CLIN NUTR, DOI DOI 10.3945/AJCN.113.081836
   [Anonymous], 2015, BRIT J CANCER, DOI DOI 10.1038/BJC.2015.276
   [Anonymous], 2014, FOOD CHEM, DOI DOI 10.1016/J.FOODCHEM.2013.10.131
   [Anonymous], 2011, BREAST CANCER RES, DOI DOI 10.1186/BCR2879
   [Anonymous], 2014, FOOD FUNCT, DOI DOI 10.1039/C4FO00290C
   [Anonymous], 2017, CANC GENOMICS PROTEO, DOI DOI 10.21873/CGP.20058
   [Anonymous], 2013, EUR J NUTR, DOI DOI 10.1007/S00394-012-0446-X
   [Anonymous], 2007, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965.EPI-07-0581
   [Anonymous], 2018, INT J EPIDEMIOLOGY, DOI DOI 10.1093/IJE/DYX236
   [Anonymous], 2011, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965.EPI-11-0766
   [Anonymous], 2015, CLIN CANCER RES, DOI DOI 10.1158/1078-0432.CCR-14-1748
   [Anonymous], 2019, INT J GYNECOL CANCER, DOI DOI 10.1136/IJGC-2018-000102
   [Anonymous], 2013, BIOMED RES INT, DOI DOI 10.1155/2013/251754
   [Anonymous], 2014, DIABETES CARE, DOI DOI 10.2337/DC13-1203
   [Anonymous], 2015, STEROIDS A, DOI DOI 10.1016/J.STEROIDS.2014.12.013
   [Anonymous], 2008, CLIMACTERIC, DOI DOI 10.1080/13697130802348728
   [Anonymous], 1997, FOOD CHEM TOXICOL
   [Anonymous], 2017, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965.EPI-17-0353
   [Anonymous], 2018, CANCER EPIDEMIOL, DOI DOI 10.1016/J.CANEP.2018.07.013
   [Anonymous], 2018, NUTRIENTS, DOI DOI 10.3390/NU10020112
   [Anonymous], 2018, J AGR FOOD CHEM, DOI DOI 10.1021/ACS.JAFC.7B04506
   Berhardt Leon V., 2015, ADV MED BIOL, P1
   Berretta M., 2018, ONCOTARGET, V9, P20807
   Centers for Disease Control and Prevention, 2013, ANT RES THREATS US
   EFSA, 2011, EFSA J, V9, P2133
   Lee P.M.Y, 2019, SCI REPORTS, V9
   Madeira M.H., 2017, MEDIATORS INFLAMMATI, V2017
   Mojska H., 2013, ROCZ PANSTW ZAKL HIG, V64, P173
   Speer K, 2011, 23 INT C COFF SCI BA, V1, P84
   WHO World Health Organization. International Agency for Research on Cancer, 2018, IARC MONOGRAPHS EVAL, P247
   Zhu Y., 2017, PLOS ONE, V12
NR 125
TC 2
Z9 2
U1 1
U2 15
PU INST ANIMAL REPRODUCTION & FOOD RESEARCH POLISH ACAD SCIENCES OLSZTYN
PI OLSZTYN
PA UL J TUWIMA 10, OLSZTYN, 10-747, POLAND
SN 1230-0322
EI 2083-6007
J9 POL J FOOD NUTR SCI
JI Pol. J. food Nutr. Sci.
PY 2020
VL 70
IS 3
BP 207
EP 222
DI 10.31883/pjfns/120017
PG 16
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA NE9ZJ
UT WOS:000562962100001
OA gold
DA 2025-04-28
ER

PT J
AU Pérez-Ara, MA
   Gili, M
   Visser, M
   Penninx, BWJH
   Brouwer, IA
   Watkins, E
   Owens, M
   García-Toro, M
   Hegerl, U
   Kohls, E
   Bot, M
   Roca, M
AF Perez-Ara, M. Angeles
   Gili, Margalida
   Visser, Marjolein
   Penninx, Brenda W. J. H.
   Brouwer, Ingeborg A.
   Watkins, Ed
   Owens, Matt
   Garcia-Toro, Mauro
   Hegerl, Ulrich
   Kohls, Elisabeth
   Bot, Mariska
   Roca, Miquel
TI Associations of Non-Alcoholic Beverages with Major Depressive Disorder
   History and Depressive Symptoms Clusters in a Sample of Overweight
   Adults
SO NUTRIENTS
LA English
DT Article
DE depression; depressive symptoms clusters; soft drinks; coffee; tea
ID SOFT DRINK CONSUMPTION; MENTAL-HEALTH; RISK; COFFEE; CAFFEINE;
   METAANALYSIS; TEA; QUESTIONNAIRE; NUTRITION; PATTERNS
AB Background: Meta-analysis of observational studies concluded that soft drinks may increase the risk of depression, while high consumption of coffee and tea may reduce the risk. Objectives were to explore the associations between the consumption of soft drinks, coffee or tea and: (1) a history of major depressive disorder (MDD) and (2) the severity of depressive symptoms clusters (mood, cognitive and somatic/vegetative symptoms). Methods: Cross-sectional and longitudinal analysis based on baseline and 12-month-follow-up data collected from four countries participating in the European MooDFOOD prevention trial. In total, 941 overweight adults with subsyndromal depressive symptoms aged 18 to 75 years were analyzed. History of MDD, depressive symptoms and beverages intake were assessed. Results: Sugar-sweetened soft drinks were positively related to MDD history rates whereas soft drinks with non-nutritive sweeteners were inversely related for the high vs. low categories of intake. Longitudinal analysis showed no significant associations between beverages and mood, cognitive and somatic/vegetative clusters. Conclusion: Our findings point toward a relationship between soft drinks and past MDD diagnoses depending on how they are sweetened while we found no association with coffee and tea. No significant effects were found between any studied beverages and the depressive symptoms clusters in a sample of overweight adults.
C1 [Perez-Ara, M. Angeles; Gili, Margalida; Garcia-Toro, Mauro; Roca, Miquel] Univ Balearic Isl, Inst Univ Invest Ciencies Salut, Idisba, Rediapp, Palma De Mallorca 07122, Spain.
   [Visser, Marjolein; Brouwer, Ingeborg A.] Vrije Univ Amsterdam, Fac Sci, Dept Hlth Sci, NL-1081 HV Amsterdam, Netherlands.
   [Visser, Marjolein; Brouwer, Ingeborg A.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, NL-1081 HV Amsterdam, Netherlands.
   [Penninx, Brenda W. J. H.; Bot, Mariska] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Dept Psychiat, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.
   [Watkins, Ed; Owens, Matt] Univ Exeter, Dept Psychol, Exeter EX4 4QG, Devon, England.
   [Hegerl, Ulrich] Goethe Univ Frankfurt, Dept Psychiat Psychosomat & Psychotherapy, D-60438 Frankfurt, Germany.
   [Kohls, Elisabeth] Univ Leipzig, Med Fac, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Germany.
C3 Universitat de les Illes Balears; Institut Investigacio Sanitaria Illes
   Balears (IdISBa); Vrije Universiteit Amsterdam; Vrije Universiteit
   Amsterdam; Vrije Universiteit Amsterdam; University of Exeter; Goethe
   University Frankfurt; Leipzig University
RP Roca, M (corresponding author), Univ Balearic Isl, Inst Univ Invest Ciencies Salut, Idisba, Rediapp, Palma De Mallorca 07122, Spain.
EM m.perez@uib.es; mgili@uib.es; m.visser@vu.nl; b.penninx@amsterdamumc.nl;
   ingeborg.brouwer@vu.nl; E.R.Watkins@exeter.ac.uk;
   M.Owens-Solari@exeter.ac.uk; mauro.garcia@uib.es;
   ulrich.hegerl@deutsche-depressionshilfe.de;
   Elisabeth.Kohls@medizin.uni-leipzig.de; m.bot@ggzingeest.nl;
   mroca@uib.es
RI Garcia-Toro, Mauro/AAL-1153-2020; Brouwer, Inge/K-8455-2013; Visser,
   Marjolein/AAP-3224-2020; Owens, Matthew/GPW-7887-2022; Gili,
   Margalida/H-7680-2013; Penninx, Brenda WJH/S-7627-2017
OI Visser, Marjolein/0000-0002-5136-298X; Gili,
   Margalida/0000-0002-0535-6773; Perez-Ara, M.
   Angeles/0000-0002-2073-6539; Mauro, Garcia-Toro/0000-0002-2251-1368;
   Brouwer, Ingeborg/0000-0002-8762-382X; Penninx, Brenda
   WJH/0000-0001-7779-9672; Owens, Matthew/0000-0001-7407-6540; Bot,
   Mariska/0000-0002-5488-1814
FU European Union FP7 MooDFOOD Project "Multi-country collaborative project
   on the role of diet, food-related behaviour, and obesity in the
   prevention of depression" [613598]; National Institute for Health
   Research (NIHR), through the Primary Care Research Network; NIHR Exeter
   Clinical Research Facility
FX Funding for this paper was provided by the European Union FP7 MooDFOOD
   Project "Multi-country collaborative project on the role of diet,
   food-related behaviour, and obesity in the prevention of depression"
   (grant agreement no. 613598). This work is supported in the UK by the
   National Institute for Health Research (NIHR), through the Primary Care
   Research Network, and the NIHR Exeter Clinical Research Facility.
   Funding sponsors did not participate in the study design; collection,
   management, analysis, and interpretation of data; or writing of the
   report. They did not participate in the decision to submit the report
   for publication.
CR American Psychiatric Association, 1994, STAT MAN MENT DIS
   Anderson G, 2014, CNS DRUGS, V28, P1, DOI 10.1007/s40263-013-0119-1
   Babor TF., 1992, AUDIT. The Alcohol Use Disorders Identification Test: Guidelines for use in primary health care
   Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]
   Bot M, 2019, JAMA-J AM MED ASSOC, V321, P858, DOI 10.1001/jama.2019.0556
   Brussaard JH, 2002, EUR J CLIN NUTR, V56, pS89, DOI 10.1038/sj.ejcn.1601432
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Corruble E, 1999, J AFFECT DISORDERS, V56, P95, DOI 10.1016/S0165-0327(99)00055-5
   Coughlin J.R., 2017, P 24 INT C COFF SCI, P25
   Dong XX, 2015, AUST NZ J PSYCHIAT, V49, P334, DOI 10.1177/0004867414567759
   Elstgeest LEM, 2019, BRIT J NUTR, V121, P439, DOI [10.1017/S0007114518003203, 10.1017/s0007114518003203]
   Farajzadeh Y., 2017, NURSING PRACTICE TOD, V4, P1
   Fava M, 2004, PSYCHOL MED, V34, P1299, DOI 10.1017/S0033291704002612
   Fowler SPG, 2016, PHYSIOL BEHAV, V164, P517, DOI 10.1016/j.physbeh.2016.04.047
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Garcia-Larsen V, 2011, EUR J CLIN NUTR, V65, P750, DOI 10.1038/ejcn.2011.15
   Grech A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070833
   Grosso G, 2016, MOL NUTR FOOD RES, V60, P223, DOI 10.1002/mnfr.201500620
   Guo XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094715
   Hall S, 2015, FOOD RES INT, V76, P626, DOI 10.1016/j.foodres.2015.07.027
   Hu DQ, 2019, J AFFECT DISORDERS, V245, P348, DOI 10.1016/j.jad.2018.11.015
   Jacka FN, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0791-y
   Kang D, 2018, EUR J CLIN NUTR, V72, P1506, DOI 10.1038/s41430-018-0121-2
   Kaster MP, 2015, P NATL ACAD SCI USA, V112, P7833, DOI 10.1073/pnas.1423088112
   Kawada T, 2019, BRIT J NUTR, V122, P480, DOI 10.1017/S0007114519001387
   Kim J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091201
   Kimura Y, 2020, J EPIDEMIOL, V30, P338, DOI 10.2188/jea.JE20190010
   Knüppel A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05649-7
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lassale C, 2020, MOL PSYCHIATR, V25, P3121, DOI 10.1038/s41380-019-0510-5
   Loftfield E, 2015, AM J EPIDEMIOL, V182, P1010, DOI 10.1093/aje/kwv146
   Murray CJL, 2013, LANCET, V381, P628
   Paans NPG, 2018, J PSYCHOSOM RES, V108, P85, DOI 10.1016/j.jpsychores.2018.03.003
   Pabayo R, 2016, PUBLIC HEALTH NUTR, V19, P3062, DOI 10.1017/S1368980016001828
   Park RJ, 2015, EUR J CLIN NUTR, V69, P501, DOI 10.1038/ejcn.2014.247
   Patil Harshal, 2011, Mo Med, V108, P431
   Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2
   Richards Gareth, 2016, Journal of Caffeine Research, V6, P49, DOI 10.1089/jcr.2015.0033
   Roca M, 2009, J AFFECT DISORDERS, V119, P52, DOI 10.1016/j.jad.2009.03.014
   Roca M, 2011, COMPR PSYCHIAT, V52, P26, DOI 10.1016/j.comppsych.2010.04.011
   Roca M, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0900-z
   Rothenberg DO, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061361
   Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558
   Ruusunen A, 2010, PUBLIC HEALTH NUTR, V13, P1215, DOI 10.1017/S1368980010000509
   Sanchez-Villegas A, 2018, BRIT J NUTR, V119, P211, DOI 10.1017/S0007114517003361
   Schotte CKW, 2006, DEPRESS ANXIETY, V23, P312, DOI 10.1002/da.20177
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi
   Shi ZM, 2010, PUBLIC HEALTH NUTR, V13, P1073, DOI 10.1017/S1368980009993132
   Tanskanen A, 2000, ADDICTION, V95, P1699, DOI 10.1046/j.1360-0443.2000.9511169910.x
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Wang LF, 2016, AUST NZ J PSYCHIAT, V50, P228, DOI 10.1177/0004867415603131
   Wang M, 2015, J DIABETES INVEST, V6, P360, DOI 10.1111/jdi.12309
   Wardenaar KJ, 2010, J AFFECT DISORDERS, V125, P146, DOI 10.1016/j.jad.2009.12.020
   Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8
   WHO, 2017, Depression and Other Common Mental Disorders: Global Health Estimates
   Yu B, 2015, J AFFECT DISORDERS, V172, P422, DOI 10.1016/j.jad.2014.10.026
   Yu ZJM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06529-w
NR 58
TC 12
Z9 12
U1 1
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2020
VL 12
IS 10
AR 3202
DI 10.3390/nu12103202
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA OL6RM
UT WOS:000585464500001
PM 33092067
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU da Costa, MS
   Pontes, KSD
   Guedes, MR
   Silva, MIB
   Klein, MRST
AF da Costa, Mariana Silva
   Pontes, Karine Scanci da Silva
   Guedes, Marcella Rodrigues
   Silva, Maria Ines Barreto
   Klein, Marcia Regina Simas Torres
TI Association of habitual coffee consumption with obesity, sarcopenia,
   bone mineral density and cardiovascular risk factors: A two-year
   follow-up study in kidney transplant recipients
SO CLINICAL NUTRITION
LA English
DT Article
DE Coffee; Obesity; Sarcopenia; Bone mineral density; Cardiovascular
   disease; Kidney transplantation
ID DOSE-RESPONSE METAANALYSIS; METABOLIC SYNDROME; BODY-COMPOSITION;
   DISEASE; MUSCLE; OSTEOPOROSIS; CAFFEINE; HEALTH; TEA; HYPERTENSION
AB Background & aims: Recent evidence suggests that moderate coffee intake is associated with multiple health benefits, including lower risk of obesity, sarcopenia and cardiovascular disease (CVD) in the general population. However, to date, no study has evaluated these associations in kidney transplant recipients (KTR). The aim of the present study was to evaluate the association of habitual coffee con-sumption with obesity, sarcopenia, bone mineral density and CVD risk factors in KTR.Methods: This prospective 2 years-follow-up study included 170 KTR (59% men) aged 49.5 (42.0-57.0) years. At baseline participants were submitted to the following evaluations: clinical, laboratorial, dietary intake (including coffee), muscle strength, anthropometric and body composition by bioelectrical impedance analysis (BIA) and dual-energy X-ray absorptiometry (DXA). After two years 163 KTR were re-evaluated by anthropometry, BIA and muscle strength. Sarcopenia was defined according to EWGSOP2. Risk factors for CVD were hypertension, diabetes mellitus, dyslipidemia, metabolic syndrome and hyperhomcysteinemia. Participants were stratified according to coffee intake: 0 or 1 time/day (Gr0-1) and 2 or 3 times/day (Gr2-3). Results: The median coffee consumption was 200 (150-250)mL/day and 112 (71-155)mL/100 0 kcal/day. At baseline, Gr2-3 vs. Gr0-1 exhibited significantly higher values of waist circumference, waist-to-height ratio (WHtR) and presented a higher odds ratio for central obesity according to WHtR (2.68; 95%CI:1.19-6.02; p = 0.02) after adjustment for confounders. Coffee consumption (mL/1000 kcal/day) showed, even after adjustment for confounders, (1) a positive association with all parameters of body adiposity (anthropometry, BIA and DXA) and (2) a negative association with muscle quality index. After two years, coffee intake (mL/1000 kcal/day) at baseline presented a positive correlation with changes in fat mass (kg) by BIA (r = 0.22, p = 0.01) after adjustment for confounders.Conclusion: This study suggests that in KTR, higher coffee consumption is associated with increased adiposity, specially, central adiposity and lower muscle quality, but is not related with the other evaluated parameters.& COPY; 2023 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
C1 [da Costa, Mariana Silva] Univ Estado Rio De Janeiro, Post Grad Program Med Sci, Rio De Janeiro, Brazil.
   [Pontes, Karine Scanci da Silva; Guedes, Marcella Rodrigues] State Univ Rio de Janeiro UERJ, Postgrad Program Clin & Expt Pathophysiol, Rio De Janeiro, Brazil.
   [Silva, Maria Ines Barreto; Klein, Marcia Regina Simas Torres] State Univ Rio de Janeiro UERJ, Nutr Inst, Dept Appl Nutr, Rio De Janeiro, Brazil.
   [Silva, Maria Ines Barreto] Fed Univ State Rio de Janeiro UNIRIO, Nutr Sch, Dept Appl Nutr, Rio De Janeiro, Brazil.
   [Silva, Maria Ines Barreto] Univ Alberta, Dept Agr Food & Nutr Sci, Div Human Nutr, Human Nutr Res Unit, Edmonton, AB, Canada.
   [Klein, Marcia Regina Simas Torres] Ave 28 Setembro 87,Rooms 363 & 361, BR-20551030 Vila Isabel, RJ, Brazil.
C3 Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio
   de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade
   Federal do Estado do Rio de Janeiro; University of Alberta
RP Klein, MRST (corresponding author), State Univ Rio de Janeiro UERJ, Nutr Inst, Dept Appl Nutr, Rio De Janeiro, Brazil.; Klein, MRST (corresponding author), Ave 28 Setembro 87,Rooms 363 & 361, BR-20551030 Vila Isabel, RJ, Brazil.
EM nutricao_mari@hotmail.com; karinescanci@gmail.com;
   marcella.rg@hotmail.com; inesbarreto26@gmail.com; marciarsimas@gmail.com
RI Klein, Marcia/AAA-1695-2022
OI Silva da Costa, Mariana/0000-0001-8895-7680; Scanci da Silva Pontes,
   Karine/0000-0003-1057-4705; Guedes, Marcella/0000-0002-7333-9019; Klein,
   Marcia/0000-0003-0298-3613
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil
   (CAPES) [001]; Fundacao Carlos Chagas Filho de Amparo a~Pesquisa do
   Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico , Brasil
FX This study was financed in part by the (1) Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) Finance
   Code 001; (2) Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro; (3) Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Brasil.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Aparicio-Ugarriza R, 2015, CLIN CHEM LAB MED, V53, P1149, DOI 10.1515/cclm-2014-0784
   Ayub N, 2021, J CLIN MED, V10, DOI 10.3390/jcm10133002
   Azad MB, 2017, CAN MED ASSOC J, V189, pE929, DOI 10.1503/cmaj.161390
   BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
   BELLET S, 1968, METABOLISM, V17, P702, DOI 10.1016/0026-0495(68)90054-1
   Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38
   Berman NK, 2022, OSTEOPOROSIS INT, V33, P1235, DOI 10.1007/s00198-021-05972-w
   Bobková A, 2020, J ENVIRON SCI HEAL B, V55, P495, DOI 10.1080/03601234.2020.1724660
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Cao C, 2020, J NUTR, V150, P1909, DOI 10.1093/jn/nxaa121
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Chan W, 2014, J RENAL NUTR, V24, P1, DOI 10.1053/j.jrn.2013.09.002
   Chang HC, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6168-0
   Chen YC, 2022, BMC MED, V20, DOI 10.1186/s12916-022-02636-2
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147762
   Chung H, 2017, KOREAN J FAM MED, V38, P141, DOI 10.4082/kjfm.2017.38.3.141
   Conway JM, 2003, AM J CLIN NUTR, V77, P1171, DOI 10.1093/ajcn/77.5.1171
   Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
   D'Elia L, 2019, EUR J NUTR, V58, P271, DOI 10.1007/s00394-017-1591-z
   Devine PA, 2019, J NEPHROL, V32, P389, DOI 10.1007/s40620-018-0549-4
   Di Maso M, 2021, ADV NUTR, V12, P1160, DOI 10.1093/advances/nmaa177
   Dienemann T, 2021, AM J KIDNEY DIS, V78, P816, DOI 10.1053/j.ajkd.2020.11.032
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Doepker C, 2022, FOOD CHEM TOXICOL, V170, DOI 10.1016/j.fct.2022.113472
   Drewnowski A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1068
   ElSayed NA, 2023, DIABETES CARE, V46, pS19, DOI 10.2337/dc23-S002
   Fahal IH, 2014, NEPHROL DIAL TRANSPL, V29, P1655, DOI 10.1093/ndt/gft070
   Faulkner KG, 2005, OSTEOPOROSIS INT, V16, P347, DOI 10.1007/s00198-004-1779-y
   Feng WL, 2023, CRIT REV FOOD SCI, V63, P3420, DOI 10.1080/10408398.2021.1989374
   Florindo Alex Antonio, 2003, Rev Bras Med Esporte, V9, P129
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Garriguet Didier, 2008, Health Rep, V19, P23
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Hallström H, 2013, AM J EPIDEMIOL, V178, P898, DOI 10.1093/aje/kwt062
   Harada H, 2012, TRANSPL P, V44, P672, DOI 10.1016/j.transproceed.2011.12.010
   Henn M, 2023, CLIN NUTR, V42, P477, DOI 10.1016/j.clnu.2023.02.004
   Hou C, 2022, AM J CLIN NUTR, V116, P730, DOI 10.1093/ajcn/nqac148
   Instituto Brasileiro de Geografia e Estatistica Coordenacaoe de Trabalho e Rendimento, 2020, Perfil das despesas no Brasil indicadores selecionados
   Instituto Brasileiro de Geografia e Estatistica. IBGE, 2020, POF 2017-2018: brasileiro ainda mantem dieta a base de arroz e feija~o, mas consumo de frutas e legumes e abaixo do esperado
   Instituto Brasileiro de Geografia e Estatistica-IBGE, 2011, Pesquisa de Orcamentos familiares 2008-2009: tabela de Composica~o nutricional dos alimentos consumidos no Brasil, V39
   Iwasaka C, 2021, GERIATR GERONTOL INT, V21, P950, DOI 10.1111/ggi.14264
   Jang YJ, 2018, FOOD FUNCT, V9, P1102, DOI [10.1039/c7fo01683b, 10.1039/C7FO01683B]
   Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1
   Jyväkorpi SK, 2021, AGING CLIN EXP RES, V33, P1371, DOI 10.1007/s40520-020-01645-6
   Kawakami R, 2023, BRIT J NUTR, V130, P127, DOI 10.1017/S0007114522003099
   Kenkre JS, 2018, ANN CLIN BIOCHEM, V55, P308, DOI 10.1177/0004563218759371
   Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT SUPPL, V3, P1, DOI DOI 10.1038/KISUP.2012.73
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   Kim Y, 2019, EUR J EPIDEMIOL, V34, P731, DOI 10.1007/s10654-019-00524-3
   Kim Y, 2018, BRIT J NUTR, V120, P1279, DOI [10.1017/S0007114518002635, 10.1017/s0007114518002635]
   Kusumah J, 2022, FOOD CHEM TOXICOL, V161, DOI 10.1016/j.fct.2022.112821
   Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee C, 2018, J AGING RES CLIN PRA, V7, P45, DOI [10.14283/jarcp.2018.11, DOI 10.14283/JARCP.2018.11]
   Lee DY, 2023, FRONT PUBLIC HEALTH, V11, DOI 10.3389/fpubh.2023.990029
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Lohman T.G., 1992, Advances in Body Composition Assessment
   Machado-Fragua MD, 2019, EUR J NUTR, V58, P1415, DOI 10.1007/s00394-018-1664-7
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mazeaud S, 2022, METABOLITES, V12, DOI 10.3390/metabo12070654
   Barreto APMM, 2019, BRIT J NUTR, V122, P1386, DOI 10.1017/S0007114519002459
   de Oliveira RAM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070741
   Miranda AM, 2021, CLIN NUTR, V40, P542, DOI 10.1016/j.clnu.2020.05.052
   Morgan PT, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.569904
   Netto MCAS, 2012, TRANSPL P, V44, P2366, DOI 10.1016/j.transproceed.2012.07.041
   Nicolopoulos K, 2020, CLIN NUTR, V39, P3467, DOI 10.1016/j.clnu.2020.03.009
   Nordestgaard AT, 2022, EUR J NUTR, V61, P573, DOI 10.1007/s00394-021-02650-9
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Park WY, 2017, TRANSPL P, V49, P1033, DOI 10.1016/j.transproceed.2017.03.038
   Pitanga FJG, 2006, REV ASSOC MED BRAS, V52, DOI [10.1590/S0104-42302006000300016, DOI 10.1590/S0104-42302006000300016]
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Powell-Wiley TM, 2021, CIRCULATION, V143, pE984, DOI 10.1161/CIR.0000000000000973
   Ragi MEE, 2022, BRIT J NUTR, V128, P352, DOI 10.1017/S0007114521003238
   Ribeiro M, 2024, CRIT REV FOOD SCI, V64, P562, DOI 10.1080/10408398.2022.2106938
   Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051
   Ruggiero E, 2021, J NUTR, V151, P395, DOI 10.1093/jn/nxaa365
   Barroso WKS, 2021, ARQ BRAS CARDIOL, V116, P516, DOI 10.36660/abc.20201238
   Shahinfar H, 2021, NUTR METAB CARDIOVAS, V31, P2526, DOI 10.1016/j.numecd.2021.05.014
   Siervo M, 2015, PUBLIC HEALTH NUTR, V18, P1245, DOI 10.1017/S1368980014001918
   Tanski W, 2021, EUR REV MED PHARMACO, V25, P3557, DOI 10.26355/eurrev_202105_25838
   Universidade Estadual de Campinas (Unicamp), 2011, Tabela brasileira de composicao de alimentos-TACO, V4
   Valenzuela PL, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-03228-y
   Vangala C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00211
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Voora S, 2019, AM J KIDNEY DIS, V73, P866, DOI 10.1053/j.ajkd.2019.01.031
   Wang AYM, 2018, SEMIN NEPHROL, V38, P383, DOI 10.1016/j.semnephrol.2018.05.008
   WHO, 2008, STEP wise approach to surveillance (STEPS)
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Wong THT, 2021, ADV NUTR, V12, P708, DOI 10.1093/advances/nmaa132
   Xie C, 2018, J HUM HYPERTENS, V32, P83, DOI 10.1038/s41371-017-0007-0
   Xu J, 2022, GERONTOLOGY, V68, P361, DOI 10.1159/000517099
   Yang JX, 2022, AM J CLIN NUTR, V116, P1693, DOI 10.1093/ajcn/nqac241
   Yuan S, 2019, CALCIFIED TISSUE INT, V105, P582, DOI 10.1007/s00223-019-00606-0
   Zhang XM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021252
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
NR 104
TC 5
Z9 5
U1 2
U2 8
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0261-5614
EI 1532-1983
J9 CLIN NUTR
JI Clin. Nutr.
PD OCT
PY 2023
VL 42
IS 10
BP 1889
EP 1900
DI 10.1016/j.clnu.2023.08.004
EA AUG 2023
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA R5YJ8
UT WOS:001065105000001
PM 37625318
DA 2025-04-28
ER

PT J
AU Ma, YJ
   Gao, MM
   Liu, DX
AF Ma, Yongjie
   Gao, Mingming
   Liu, Dexi
TI Chlorogenic Acid Improves High Fat Diet-Induced Hepatic Steatosis and
   Insulin Resistance in Mice
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE Chlorogenic acid (CGA); Hepatic steatosis; Inflammation; Insulin
   resistance; Obesity
ID PPAR-GAMMA; INDUCED OBESITY; COFFEE CONSUMPTION; OXIDATIVE STRESS;
   GENE-EXPRESSION; CAFFEIC ACID; LIVER; INFLAMMATION; RATS; OVEREXPRESSION
AB Purpose Chlorogenic acid (CGA), the most abundant component in coffee, has exhibited many biological activities. The objective of this study is to assess preventive and therapeutic effects of CGA on obesity and obesity-related liver steatosis and insulin resistance.
   Methods Two sets of experiments were conducted. In set I, 6-week old C57BL/6 mice were fed a regular chow or high-fat diet (HFD) for 15 weeks with twice intra-peritoneal (IP) injection of CGA (100 mg/kg) or DMSO (carrier solution) per week. In set 2, obese mice (average 50 g) were treated by CGA (100 mg/kg, IP, twice weekly) or DMSO for 6 weeks. Body weight, body composition and food intake were monitored. Blood glucose, insulin and lipid levels were measured at end of the study. Hepatic lipid accumulation and glucose homeostasis were evaluated. Additionally, genes involved in lipid metabolism and inflammation were analyzed by real time PCR.
   Results CGA significantly blocked the development of diet-induced obesity but did not affect body weight in obese mice. CGA treatment curbed HFD-induced hepatic steatosis and insulin resistance. Quantitative PCR analysis shows that CGA treatment suppressed hepatic expression of Ppar gamma, Cd36, Fabp4, and Mgot I gene. CGA treatment also attenuated inflammation in the liver and white adipose tissue accompanied by a decrease in mRNA levels of macrophage marker genes including F4/80, Cd68, Cd11b, Cd11c, and Tnf alpha, Mcp-1 and Ccr2 encoding inflammatory proteins.
   Conclusion Our study provides direct evidence in support of CGA as a potent compound in preventing diet-induced obesity and obesity-related metabolic syndrome. Our results suggest that drinking coffee is beneficial in maintaining metabolic homeostasis when on a high fat diet.
C1 [Ma, Yongjie; Gao, Mingming; Liu, Dexi] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.
C3 University System of Georgia; University of Georgia
RP Liu, DX (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Room 450 Pharm South,250 West Green St, Athens, GA 30602 USA.
EM dliu@uga.edu
RI MA, YONGJIE/O-3861-2015; Gao, Mingming/F-4317-2016
FU National Institute of Health [RO1EB007357, RO1HL098295]
FX This work was supported in part by the National Institute of Health
   (RO1EB007357 and RO1HL098295). We thank Ms. Ryan Fugett for
   proof-reading and English editing.
CR Ahrens MJ, 2013, J MED FOOD, V16, P211, DOI 10.1089/jmf.2012.0069
   Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q
   Bu L, 2013, AAPS J, V15, P1001, DOI 10.1208/s12248-013-9501-7
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cortés VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002
   Cui R, 2014, GENE THER, V21, P840, DOI 10.1038/gt.2014.64
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7
   Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844
   Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Gao MM, 2014, J CONTROL RELEASE, V185, P1, DOI 10.1016/j.jconrel.2014.03.047
   Gao MM, 2013, PHARM RES-DORDR, V30, P2940, DOI 10.1007/s11095-013-1125-1
   Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Karthikesan K, 2010, J FUNCT FOODS, V2, P134, DOI 10.1016/j.jff.2010.04.001
   Kim Y, 2010, BIOTECHNOL J, V5, P99, DOI 10.1002/biot.200900228
   Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907
   Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109
   Ma YJ, 2013, PHARM RES-DORDR, V30, P1447, DOI 10.1007/s11095-013-0986-7
   Ma YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038734
   Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645
   Morán-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Perlemuter G, 2007, NAT CLIN PRACT ENDOC, V3, P458, DOI 10.1038/ncpendmet0505
   Prabhakar PK, 2009, PHYTOMEDICINE, V16, P1119, DOI 10.1016/j.phymed.2009.05.021
   Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200
   Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037
NR 40
TC 163
Z9 172
U1 3
U2 57
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD APR
PY 2015
VL 32
IS 4
BP 1200
EP 1209
DI 10.1007/s11095-014-1526-9
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Pharmacology & Pharmacy
GA CD6AG
UT WOS:000351169800003
PM 25248334
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Glibowski, P
   Spodymek, A
   Gazda, P
   Silka, L
   Rzad, Z
AF Glibowski, Pawel
   Spodymek, Agnieszka
   Gazda, Patrycja
   Silka, Lukasz
   Rzad, Zuzanna
TI Food-derived caffeine in human nutrition
SO JOURNAL OF FOOD AND NUTRITION RESEARCH
LA English
DT Review
DE caffeine; coffee; tea; nutrition
ID COFFEE CONSUMPTION; RISK; METABOLISM; EXTRACTION; OUTCOMES
AB Caffeine, a substance discovered in plant raw materials over 200 years ago, has been extensively studied. However, many of the mechanisms of its influence on the human body have not yet been elucidated or have given contradictory results in experiments. The aim of this paper was to review and systematize current knowledge on caffeine and its impacts on the human body. A combined physiological and psychological effect of caffeine consumption has been shown to depend mainly on individual genotype and the frequency as well as degree of exposure to the substance. An example of this is the effect of caffeine on sports results, depending on the genotype as well as the effect on the cardiovascular system. People who regularly consume large amounts of coffee or tea do not have increased blood pressure, in contrast to occasional users. Caffeine has many positive properties, which include a slight increase in energy expenditure by increasing basal metabolic rate and promoting less fat gain, by potential reduction of the expression of genes associated with obesity, which can help maintain correct normal body weight and help its normalization.
C1 [Glibowski, Pawel; Spodymek, Agnieszka; Gazda, Patrycja; Silka, Lukasz; Rzad, Zuzanna] Univ Life Sci Lublin, Fac Food Sci & Biotechnol, Dept Biotechnol Microbiol & Human Nutr, Skromna 8, PL-20704 Lublin, Poland.
C3 University of Life Sciences in Lublin
RP Glibowski, P (corresponding author), Univ Life Sci Lublin, Fac Food Sci & Biotechnol, Dept Biotechnol Microbiol & Human Nutr, Skromna 8, PL-20704 Lublin, Poland.
EM pawel.glibowski@up.lublin.pl
CR Abalo R, 2021, NUTRIENTS, V13, DOI 10.3390/nu13092918
   Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   Amaresh N., 2011, Int J Nutr Pharmacol Neurol Dis, V1, P110, DOI [10.4103/2231-0738.84198, DOI 10.4103/2231-0738.84198]
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V280
   [Anonymous], 2018, IARC MONOGRAPHS EVAL, V116
   [Anonymous], 2001, Caffeine for the sustainment of mental task performance: Formulations for military operations, DOI [10.17226/10219, DOI 10.17226/10219]
   Bo S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041161
   Bodar V, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011346
   Brent RL, 2011, BIRTH DEFECTS RES B, V92, P152, DOI 10.1002/bdrb.20288
   Brugada J, 2020, EUR HEART J, V41, P655, DOI 10.1093/eurheartj/ehz467
   Clarke R.J., 2003, Encyclopedia of Food Sciences and Nutrition, VSecond, P1506, DOI DOI 10.1016/B0-12-227055-X/00272-8
   De Marco I, 2018, J SUPERCRIT FLUID, V133, P393, DOI 10.1016/j.supflu.2017.11.005
   DePaula J, 2019, BEVERAGES, V5, DOI 10.3390/beverages5020037
   Farah A, 2009, WOODHEAD PUBL FOOD S, P370, DOI 10.1201/9781420099881.ch15
   Ghasemzadeh-mohammadi V, 2017, FOOD SCI BIOTECHNOL, V26, P1281, DOI 10.1007/s10068-017-0182-3
   Gökcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso LM, 2005, ANN EPIDEMIOL, V15, P460, DOI 10.1016/j.annepidem.2004.12.011
   Guest N, 2018, MED SCI SPORT EXER, V50, P1570, DOI 10.1249/MSS.0000000000001596
   Guijarro C, 2021, CLIN INVEST ARTERIOS, V33, P25, DOI 10.1016/j.arteri.2020.12.004
   Hallström H, 2013, AM J EPIDEMIOL, V178, P898, DOI 10.1093/aje/kwt062
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   HATCH EE, 1993, AM J EPIDEMIOL, V138, P1082, DOI 10.1093/oxfordjournals.aje.a116826
   ICD-11 for Mortality and Morbidity Statistics, INT CLASSIFICATION D
   Institute of Medicine, 2014, CAFFEINE FOOD DIETAR, DOI DOI 10.17226/18607
   Janiszewska E., 2005, ZYWN-NAUK TECHNOL JA, V4, P5
   Jarosz M, 2009, Bromat Chem Toksykol, V3, P776
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kolb H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061842
   Krittanawong C, 2021, EUR J PREV CARDIOL, V28, pE13, DOI 10.1177/2047487320908385
   Lane J. D., 2011, Journal of Caffeine Research, V1, P23, DOI 10.1089/jcr.2010.0007
   Larsson SC, 2022, NUTRIENTS, V14, DOI 10.3390/nu14091697
   Lee DR, 2014, BONE, V63, P20, DOI 10.1016/j.bone.2014.02.007
   Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X
   Mazzafera P, 2012, FOOD ENERGY SECUR, V1, P70, DOI 10.1002/fes3.4
   McLellan TM, 2016, NEUROSCI BIOBEHAV R, V71, P294, DOI 10.1016/j.neubiorev.2016.09.001
   Meredith Steven E, 2013, J Caffeine Res, V3, P114, DOI 10.1089/jcr.2013.0016
   Modzelewska D, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2215-9
   Morgan K J, 1982, Regul Toxicol Pharmacol, V2, P296, DOI 10.1016/0273-2300(82)90003-4
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   O'Callaghan F, 2018, RISK MANAG HEALTHC P, V11, P263, DOI 10.2147/RMHP.S156404
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Onaolapo O.J., 2019, Caffeinated and Cocoa Based Beverages, V8, P163
   Peerapen P, 2018, ADV NUTR, V9, P419, DOI 10.1093/advances/nmy016
   Peerapen P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38536
   Pesta DH, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-71
   Pietsch A, 2017, CRAFT AND SCIENCE OF COFFEE, P225, DOI 10.1016/B978-0-12-803520-7.00010-4
   Pujer K., 2016, DIETETYKA ZYWIENIE Z
   Qian J., BIOL REPROD, V99, P2018
   Ramalakshmi K, 1999, CRIT REV FOOD SCI, V39, P441, DOI 10.1080/10408699991279231
   Rivers WHR, 1907, J PHYSIOL-LONDON, V36, P33
   Rosenfeld LS, 2014, NUTR REV, V72, P23, DOI 10.1111/nure.12136
   Selvamuthukumaran M., 2019, P ETH COFF SCI SOC E
   Soos R, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182312389
   Spigset O, 2001, Tidsskr Nor Laegeforen, V121, P3080
   Stadnicka G, 2015, J ED HLTH SPORT, V5, P505, DOI [DOI 10.5281/ZENODO.18817, 10.5281/zenodo.31300]
   Surma S, 2022, GINEKOL POL, V93, P591, DOI 10.5603/GP.a2022.0061
   Temple JL, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00080
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   Vitale K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061289
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339
   Williamson G, 2020, FOOD FUNCT, V11, P4826, DOI [10.1039/d0fo01168a, 10.1039/D0FO01168A]
   Willson C, 2018, TOXICOL REP, V5, P1140, DOI 10.1016/j.toxrep.2018.11.002
   Zajac MA, 2003, SYNTHETIC COMMUN, V33, P3291, DOI 10.1081/SCC-120023986
NR 66
TC 0
Z9 0
U1 2
U2 8
PU VUP FOOD RESEARCH INST, BRATISLAVA
PI BRATISLAVA 26
PA PRIEMYSELNA 4, PO BOX 25, BRATISLAVA 26, SK-824 75, SLOVAKIA
SN 1336-8672
EI 1338-4260
J9 J FOOD NUTR RES-SLOV
JI J. Food Nutr. Res.
PY 2023
VL 62
IS 1
BP 1
EP 13
PG 13
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA D0JX2
UT WOS:000965686600001
DA 2025-04-28
ER

PT J
AU Mubarak, A
   Hodgson, JM
   Considine, MJ
   Croft, KD
   Matthews, VB
AF Mubarak, Aidilla
   Hodgson, Jonathan M.
   Considine, Michael J.
   Croft, Kevin D.
   Matthews, Vance B.
TI Supplementation of a High-Fat Diet with Chlorogenic Acid Is Associated
   with Insulin Resistance and Hepatic Lipid Accumulation in Mice
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Chlorogenic acid; glucose tolerance; insulin sensitivity; fatty acid
   oxidation; mouse; metabolic syndrome
ID NITRIC-OXIDE STATUS; ENDOTHELIAL FUNCTION; METABOLIC SYNDROME;
   BLOOD-PRESSURE; CAFFEIC ACID; COFFEE; OBESITY; POLYPHENOLS; MORTALITY;
   OXIDATION
AB The increasing prevalence of the metabolic syndrome requires a greater need for therapeutic and prevention strategies. Higher coffee consumption is consistently associated with a lower risk of type 2 diabetes in population studies. Dietary polyphenols have been linked to benefits on several features of the metabolic syndrome. Chlorogenic acid (CGA), a major component of coffee, is one of the most consumed polyphenols in the diet. In our study, we conducted a controlled dietary intervention over 12 weeks in male mice. There were three dietary groups: (i) normal diet, (ii) high-fat diet, and (iii) high-fat diet + CGA. We assessed the effect of CGA at a physiologically obtainable dose (1 g/kg of diet) on high-fat-diet-induced obesity, glucose intolerance, insulin resistance, and also fatty acid oxidation and insulin signaling in C57BL/6 male mice. Supplementation of CGA in the high-fat diet did not reduce body weight compared to mice fed the high-fat diet alone (p = 0.32). CGA resulted in increased insulin resistance compared to mice fed a high-fat diet only (p < 0.05). CGA resulted in decreased phosphorylation of AMP-activated protein kinase (AMPK) (p < 0.001) and acetyl carboxylase beta (ACC beta), a downstream target of AMPK (p < 0.05), in liver. The liver of mice fed a high-fat diet supplemented with CGA had a higher lipid content (p < 0.05) and more steatosis relative to mice fed a high-fat diet only, indicating impaired fatty acid oxidation. This study suggests that CGA supplementation in a high-fat diet does not protect against features of the metabolic syndrome in diet-induced obese mice.
C1 [Mubarak, Aidilla; Considine, Michael J.] Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia.
   [Mubarak, Aidilla; Considine, Michael J.] Univ Western Australia, Inst Agr, Crawley, WA 6009, Australia.
   [Mubarak, Aidilla; Hodgson, Jonathan M.; Croft, Kevin D.] Univ Western Australia, Med Res Fdn, Sch Med & Pharmacol, Perth, WA 6000, Australia.
   [Mubarak, Aidilla] Univ Malaysia Terengganu, Fac Agrotechnol & Food Sci, Kuala Terengganu 21030, Malaysia.
   [Considine, Michael J.] Dept Agr & Food Western Australia, S Perth, WA 6151, Australia.
   [Matthews, Vance B.] Med Res Fdn, Western Australian Inst Med Res, UWA Ctr Med Res, Lab Metab Dysfunct, Perth, WA 6000, Australia.
C3 University of Western Australia; University of Western Australia;
   University of Western Australia; Universiti Malaysia Terengganu;
   Government of Western Australia; Department of Agriculture & Food -
   Western Australia; University of Western Australia
RP Matthews, VB (corresponding author), Med Res Fdn, Western Australian Inst Med Res, UWA Ctr Med Res, Lab Metab Dysfunct, Level 6,Rear 50 Murray St, Perth, WA 6000, Australia.
EM vance.matthews@waimr.uwa.edu.au
RI Croft, Kevin/C-4675-2013; Hodgson, Jonathan/C-3900-2008; Mubarak,
   Aidilla/A-7157-2019; Considine, Michael/A-9978-2011
OI Mubarak, Aidilla/0000-0002-1381-3532; Considine,
   Michael/0000-0002-4468-6820; Croft, Kevin/0000-0003-1596-4913
FU Australian Research Council [LP0882884]; Australian Research Council
   [LP0882884] Funding Source: Australian Research Council
FX This study is supported by Australian Research Council Linkage Grant
   LP0882884.
CR Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Bondonno CP, 2012, FREE RADICAL BIO MED, V52, P95, DOI 10.1016/j.freeradbiomed.2011.09.028
   Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078
   Cascio G, 2012, CURR DIABETES REV, V8, P2, DOI 10.2174/157339912798829241
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769
   HA J, 1994, J BIOL CHEM, V269, P22162
   Harwood HJ, 2005, EXPERT OPIN THER TAR, V9, P267, DOI 10.1517/14728222.9.2.267
   Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46
   INGS RMJ, 1990, XENOBIOTICA, V20, P1201, DOI 10.3109/00498259009046839
   Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y
   Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P10256, DOI 10.1021/jf302903k
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Murase T, 2012, BRIT J NUTR, V107, P1757, DOI 10.1017/S0007114511005083
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Muthusamy VS, 2010, BRIT J NUTR, V104, P813, DOI 10.1017/S0007114510001480
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Pérez-Jiménez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096
   Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006
   Renaud SC, 2004, AM J CLIN NUTR, V80, P621
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X
   Tavani A, 2000, EUR J CANCER PREV, V9, P241, DOI 10.1097/00008469-200008000-00004
   Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383
   Wing RR, 2001, DIABETES CARE, V24, P117, DOI 10.2337/diacare.24.1.117
   Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215
NR 35
TC 70
Z9 76
U1 1
U2 83
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAY 8
PY 2013
VL 61
IS 18
BP 4371
EP 4378
DI 10.1021/jf400920x
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 143AT
UT WOS:000318839400021
PM 23586419
DA 2025-04-28
ER

PT J
AU Kasabri, V
   Al-Hallaq, EK
   Bustanji, YK
   Abdul-Razzak, KK
   Abaza, IF
   Afifi, FU
AF Kasabri, Violet
   Al-Hallaq, Entisar K.
   Bustanji, Yasser K.
   Abdul-Razzak, Khalid K.
   Abaza, Ismail F.
   Afifi, Fatma U.
TI Antiobesity and antihyperglycaemic effects of Adiantum
   capillus-veneris extracts: in vitro and in vivo
   evaluations
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE Adiantaceae; pancreatic lipase and amylase; high cholesterol diet;
   phenolics
ID MEDITERRANEAN DIETARY PLANTS; LIPASE INHIBITORY-ACTIVITIES; METABOLIC
   SYNDROME; ALPHA-AMYLASE; MEDICINAL-PLANTS; CHLOROGENIC ACID; OBESITY;
   RATS; ENZYMES; JORDAN
AB Context: Adiantum capillus-veneris L. (Adiantaceae) hypocholesterolemic activity is therapeutically praised.
   Objectives: Pharmacological modulation of pancreatic triacylglycerol lipase (PL) and alpha-amylase/alpha-glucosidase by A. capillus-veneris are evaluated.
   Materials and methods: Using positive controls (acarbose, orlistat, guar gum, atorvastatin, glipizide and metformin) as appropriate, crude aqueous extracts (AEs) of A. capillus-veneris aerial parts were tested via a combination of in vitro enzymatic (0.24-100 mg/mL), acute in vivo carbohydrate tolerance tests (125, 250 or 500 mg/kg body weight [b.wt]) and chronic in vivo studies (500 mg/kg b.wt) in high cholesterol diet (HCD) fed Wistar rats.
   Results: Like acarbose, A. capillus-veneris as well as chlorogenic acid, with respective IC50 values (mg/mL) of 0.8 +/- 0.0 and 0.2 +/- 0.0, were identified as in vitro potent dual inhibitors of alpha-amylase/alpha-glucosidase. Unlike guar gum, A. capillus-veneris had no glucose diffusion hindrance capacity. Equivalent to orlistat, A. capillus-veneris and its phytoconstituents inhibited PL in vitro with an ascending order of PL-IC50 values (mu g/mL): ferulic acid; 0.48 +/- 0.06< ellagic acid; 13.53 +/- 1.83< chlorogenic acid; 38.4 +/- 2.8< A. capillus-veneris; 1600 +/- 100. Incomparable to acarbose or metformin and glipizide, A. capillus-veneris (125, 250 and 500 mg/kg b.wt) lacked antihyperglycaemic efficacies in acute starch- or glucose-evoked postprandial hyperglycaemia increments in normoglycaemic overnight fasting rats. Superior to atorvastatin; A. capillus-veneris exerted significant antiobesity (p< 0.001) with marked triacylglycerol-reducing capacities (p< 0.001) in comparison to rats fed with HCD for 10 weeks.
   Discussion and conclusion: A. capillus-veneris, modulating pancreatic digestive enzymes, may be advocated as a combinatorial diabesity prevention/phytotherapy agent.
C1 [Kasabri, Violet; Bustanji, Yasser K.; Abaza, Ismail F.; Afifi, Fatma U.] Univ Jordan, Sch Pharm, Queen Rania St, Amman 11942, Jordan.
   [Al-Hallaq, Entisar K.] MSD Anim Hlth, Amman, Jordan.
   [Abdul-Razzak, Khalid K.] Jordan Univ Sci & Technol, Sch Pharm, Irbid, Jordan.
C3 University of Jordan; Merck & Company; Intervet International B.V.;
   Jordan University of Science & Technology
RP Afifi, FU (corresponding author), Univ Jordan, Sch Pharm, Queen Rania St, Amman 11942, Jordan.
EM fatueafi@ju.edu.jo
RI Kasabri, Violet/AAI-4099-2020; Kasabri, Violet/C-3596-2015; Bustanji,
   Yasser/C-2626-2015
OI Kasabri, Violet/0000-0003-1927-0193; Bustanji,
   Yasser/0000-0003-1315-0609
FU Scientific Research Fund, Ministry of Higher Education [MPH/1/05/2014];
   Deanship of Academic Research, The University of Jordan [1347, 1348]
FX We are grateful for the Scientific Research Fund, Ministry of Higher
   Education [grant No. MPH/1/05/2014] and the Deanship of Academic
   Research, The University of Jordan [grant No. 1347, 1348] for funding
   this work.
CR Abuharfeil N, 2012, J BIOL LIFE SCI, V3, P37
   Adisakwattana S, 2011, EUR REV MED PHARMACO, V15, P803
   Afifi Fatma U, 2013, Sci Pharm, V81, P889, DOI 10.3797/scipharm.1212-20
   Al-Hallaq E. K., 2013, Food and Nutrition Sciences, V4, P972, DOI 10.4236/fns.2013.49126
   Al-Hallaq EK, 2015, REV ROUM CHIM, V60, P357
   Al-Hallaq EK, 2012, NAT PROD COMMUN, V7, P35
   Al-Jamal A. R., 2011, Jordan Journal of Biological Sciences (JJBS), V4, P199
   Al-Kloub MI, 2009, SAUDI MED J, V30, P737
   Al-Nsour M., 2012, PREV CHRONIC DIS, V9, pE25, DOI DOI 10.5888/PCD9.110077
   Aljamal A., 2012, African Journal of Plant Science, V6, P222
   Bansal P, 2011, BIOMED PREV NUTR, V1, P268, DOI DOI 10.1016/J.BIONUT.2011.09.002
   Bustanji Y, 2011, J ENZYM INHIB MED CH, V26, P453, DOI 10.3109/14756366.2010.525509
   Butt MS, 2007, INT J FOOD PROP, V10, P345, DOI 10.1080/10942910601052707
   Dan W, 2013, J FUNCT FOODS, V5, P633
   Etoundi C. B., 2010, Journal of Natural Products (India), V3, P165
   Gallagher AM, 2003, NUTR RES, V23, P413, DOI 10.1016/S0271-5317(02)00533-X
   Grussu D, 2011, J AGR FOOD CHEM, V59, P2324, DOI 10.1021/jf1045359
   Gürbüz I, 2003, J ETHNOPHARMACOL, V88, P93, DOI 10.1016/S0378-8741(03)00174-0
   Habtemariam S, 2012, PHARM BIOL, V50, P1519, DOI 10.3109/13880209.2012.688838
   Hadrich F, 2014, J OLEO SCI, V63, P515, DOI 10.5650/jos.ess13163
   Hasani-Ranjbar S, 2008, ARCH MED SCI, V4, P285
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Issa A, 2011, J MED PLANTS RES, V5, P3876
   Jeong SM, 2012, NUTR RES PRACT, V6, P201
   Kamal M, 2009, PHARMACOGN MAG, V5, P301
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Kasabri V., 2015, British Journal of Medicine and Medical Research, V7, P180
   Kasabri V, 2014, REV ROUM CHIM, V59, P693
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Li Y, 2009, J FOOD SCI, V74, pC199, DOI 10.1111/j.1750-3841.2009.01080.x
   Li YQ, 2011, EUR FOOD RES TECHNOL, V233, P63, DOI 10.1007/s00217-011-1491-z
   Malloy J, 2012, DIABETES METAB SYNDR, V5, P419, DOI 10.2147/DMSO.S34241
   Marrelli M, 2014, J SCI FOOD AGR, V94, P2217, DOI 10.1002/jsfa.6544
   Marrelli M, 2013, PLANT FOOD HUM NUTR, V68, P340, DOI 10.1007/s11130-013-0390-9
   Mnafgui K, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/620384
   Panchal SK, 2013, EUR J NUTR, V52, P559, DOI 10.1007/s00394-012-0358-9
   Qinna NA, 2012, ISRN PHARM, V2012
   Raju S. N., 2010, Der Pharmacia Lettre, V2, P237
   Rani N, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/715912
   Sakulnarmrat K, 2012, FOOD CHEM, V134, P1011, DOI 10.1016/j.foodchem.2012.02.217
   Sun Xiaoli, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1319
   Tschöp MH, 2012, DIABETES, V61, P1309, DOI 10.2337/db12-0272
   Wierzbicki AS, 2012, INT J CLIN PRACT, V66, P270, DOI 10.1111/j.1742-1241.2011.02867.x
   Xanthakis V, 2015, DIABETES CARE, V38, P1082, DOI 10.2337/dc14-2460
   Zohary M., 1966, FLORA PALAESTINA ISR, P7
NR 45
TC 29
Z9 32
U1 2
U2 26
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PY 2017
VL 55
IS 1
BP 164
EP 172
DI 10.1080/13880209.2016.1233567
PG 9
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA EG2BE
UT WOS:000390846600010
PM 27663206
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Hsu, CL
   Huang, SL
   Yen, GC
AF Hsu, Chin-Lin
   Huang, Shih-Li
   Yen, Gow-Chin
TI Inhibitory effect of phenolic acids on the proliferation of 3T3-L1
   preadipocytes in relation to their antioxidant activity
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE phenolic acid; preadipocytes; proliferation; antiobesity; antioxidant
   activity
ID CONJUGATED LINOLEIC-ACID; INDUCED APOPTOSIS; HEART-DISEASE; TEA
   CATECHINS; GALLIC ACID; CELL-LINES; OBESITY; ADIPOGENESIS; FLAVONOIDS;
   CANCER
AB Obesity is an important topic in the world of public health and preventive medicine. Inhibition of preadipocyte proliferation plays an important role in the mechanisms of proposed antiobesity. In this in vitro study, the inhibitory effect of phenolic acids on 3T3-L1 preadipocytes was evaluated, and a relationship analysis was then conducted. The results showed that the addition of phenolic acids to the growth medium decreased the cell population growth of 3T3-L1 preadipocytes. The IC50 values of chlorogenic acid, gallic acid, o- coumaric acid and m-coumaric acid on 3T3-L1 preadipocytes were 72.3, 43.3, 48.2, and 49.2 mu M, respectively. A relationship analysis indicated that there is a significant linear correlation between the influence of phenolic acids on cell population growth and their antioxidant activity (r=0.77, p < 0.01). The cell cycle assay indicated that the treatment of 3T3-L1 preadipocytes with chlorogenic acid, o- coumaric acid, and m-coumaric acid caused cell cycle arrest in the G(1) phase. Gallic acid did not affect the cell cycle profile; however, it increased the number of apoptotic cells (sub-G(1) phase) in a time- and dose- dependent manner. Annexin V- fluorescein isothiocyanate (FITC) propidium iodide (PI) apoptosis flow cytometric assay showed that gallic acid increased the number of early apoptotic (annexin-FITC+/ PI-) and late apoptotic cells (annexin V-FITC+/ PI+) but not necrotic cells (annexin V- FITC-/PI+). The treatment of cells with gallic acid caused the loss of mitochondrial membrane potential (Delta Psi(m)). These results indicate that the inhibition of preadipocyte population growth by some phenolic acids might have further implication in in vivo antiobesity effects.
C1 Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan.
   Kaohsiung Hospital Coll, Dept Baking Technol & Management, Kaohsiung 81271, Taiwan.
C3 National Chung Hsing University; Kaohsiung Medical University
RP Yen, GC (corresponding author), Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, 250 Kuokuang Rd, Taichung 40227, Taiwan.
EM gcyen@nchu.edu.tw
RI Yen, Gow-Chin/B-7886-2009
OI Yen, Gow-Chin/0000-0001-9538-4219
CR Aejmelaeus RT, 1997, FREE RADICAL BIO MED, V23, P69, DOI 10.1016/S0891-5849(96)00591-6
   ARAI Y, 2001, J NUTR, V130, P2378
   Artico M, 1998, J MED CHEM, V41, P3948, DOI 10.1021/jm9707232
   Benavente-García O, 1997, J AGR FOOD CHEM, V45, P4505, DOI 10.1021/jf970373s
   CAO G, 1995, CLIN CHEM, V41, P1738
   Cao GH, 1996, J AGR FOOD CHEM, V44, P3426, DOI 10.1021/jf9602535
   Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6
   Carrière A, 2003, FEBS LETT, V550, P163, DOI 10.1016/S0014-5793(03)00862-7
   Evans M, 2000, LIPIDS, V35, P899, DOI 10.1007/S11745-000-0599-6
   FERGUSON LR, 1994, MUTAT RES, V307, P395, DOI 10.1016/0027-5107(94)90313-1
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3
   Halliwell B, 2005, AM J CLIN NUTR, V81, p268S, DOI 10.1093/ajcn/81.1.268S
   Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5
   HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381
   Hua KJ, 2004, CYTOKINE, V25, P61, DOI 10.1016/j.cyto.2003.09.008
   Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, pC1094, DOI 10.1152/ajpcell.00569.2004
   Jensen B, 2004, EXP CELL RES, V301, P280, DOI 10.1016/j.yexcr.2004.08.030
   Kao Y, 2000, AM J CLIN NUTR, V72, P1232
   Kohen R, 1999, METHOD ENZYMOL, V300, P285
   Konishi Y, 2005, J AGR FOOD CHEM, V53, P9928, DOI 10.1021/jf051962y
   KOPELMAN PG, 1994, MED INT, V22, P385
   Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1
   Lin YT, 2005, BIOCHEM PHARMACOL, V70, P1469, DOI 10.1016/j.bcp.2005.07.035
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Middleton E, 2000, PHARMACOL REV, V52, P673
   Montpied P, 2003, MOL BRAIN RES, V115, P111, DOI 10.1016/S0169-328X(03)00178-5
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MURAMATSU K, 1986, J NUTR SCI VITAMINOL, V32, P613, DOI 10.3177/jnsv.32.613
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Niesler CU, 2000, J ENDOCRINOL, V167, P165, DOI 10.1677/joe.0.1670165
   Nyska A, 2003, TOXICOL PATHOL, V31, P39, DOI 10.1080/01926230390173833
   Ohno Y, 1999, ANTI-CANCER DRUG, V10, P845, DOI 10.1097/00001813-199910000-00008
   ROSS SE, 2000, SCIENCE, V289, P950, DOI DOI 10.1126/SCIENCE.289.5481.950
   SALAH N, 1995, ARCH BIOCHEM BIOPHYS, V322, P339, DOI 10.1006/abbi.1995.1473
   Salucci M, 2002, BRIT J CANCER, V86, P1645, DOI 10.1038/sj.bjc.6600295
   Serrano A, 1998, ARCH BIOCHEM BIOPHYS, V350, P49, DOI 10.1006/abbi.1997.0474
   Son S, 2002, J AGR FOOD CHEM, V50, P468, DOI 10.1021/jf010830b
   SPIEGELMAN BM, 1993, J BIOL CHEM, V268, P6823
   STAVRIC B, 1994, CLIN BIOCHEM, V27, P319, DOI 10.1016/0009-9120(94)00039-5
   Takada E, 2001, J IMMUNOL, V166, P1641, DOI 10.4049/jimmunol.166.3.1641
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Wang YW, 2004, INT J OBESITY, V28, P941, DOI 10.1038/sj.ijo.0802641
NR 44
TC 139
Z9 149
U1 1
U2 41
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUN 14
PY 2006
VL 54
IS 12
BP 4191
EP 4197
DI 10.1021/jf0609882
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 050PR
UT WOS:000238100900019
PM 16756346
DA 2025-04-28
ER

PT J
AU Chandika, RM
   Elfaki, FA
   Alsayegh, AA
   Khalafalla, HE
   Alsayed, EA
   Hadi, HM
   Alhazmy, NM
   Aqili, FA
   Al-Hadi, AH
AF Chandika, Rama M.
   Elfaki, Fatima A.
   Alsayegh, Abdulrahman A.
   Khalafalla, Husameldin E.
   Alsayed, Emadaldeen A.
   Hadi, Hussin M.
   Alhazmy, Nasser M.
   Aqili, Fahed A.
   Al-Hadi, Ahmed H.
TI Awareness of insomnia caused by coffee consumption among adults in
   Jazan, Saudi Arabia
SO MEDICINE
LA English
DT Article
DE Arabic coffee; chi-square test; coffee consumption; insomnia; Saudi
   Arabia
ID CAFFEINE; HEALTH
AB The Kingdom of Saudi Arabia is the second largest country in the Arabian Peninsula and ranks 61st out of 150 countries in terms of coffee consumption. Excessive coffee consumption is associated with the risk of adverse health outcomes. This study aimed to assess awareness of the effects of coffee consumption and its relationship with insomnia among the adult population in Jazan, Saudi Arabia. A cross-sectional study was conducted with 431 adults in the Jazan region. A self-administered questionnaire was distributed to the participants using an online survey. Data were analyzed using Statistical Program for the Social Sciences, Version 24.0. Of 431 participants, 377 (87.5%) consumed coffee. Females and married women consumed more coffee than their counterparts (91.3%, P < .01; 92.8%, P < .05; respectively), while students consumed coffee (85.2%) less than both the employed and unemployed (P < .05). The proportion of consumption increased from underweight (79.7%) to normal weight (88.5%), and as high as 91.3% among overweight/obese (P < .05). More than one-third of the participants (35.5%) preferred drinking coffee at coffee shops. The most preferred coffee was Arabic coffee (40%), and the major reason for drinking coffee was to change their mood (29.7%). More than half of the participants (54.5%) reported that coffee caused insomnia (P < .01). Awareness-raising initiatives for the negative effects of excessive coffee consumption are important. Longitudinal studies are required in the next stage of research to identify trends such as the motivations and profiles of Saudi coffee drinkers.
C1 [Chandika, Rama M.; Elfaki, Fatima A.; Alsayegh, Abdulrahman A.; Alsayed, Emadaldeen A.; Hadi, Hussin M.; Alhazmy, Nasser M.; Aqili, Fahed A.; Al-Hadi, Ahmed H.] Jazan Univ, Coll Nursing & Hlth Sci, Dept Clin Nutr, Jazan 45142, Saudi Arabia.
   [Khalafalla, Husameldin E.] Maastricht Univ, Res Inst Nutr & Translat Res Metab, Maastricht, Netherlands.
   [Khalafalla, Husameldin E.] Maastricht Univ, Dept Hlth Educ & Promot, Maastricht, Netherlands.
C3 Jazan University; Maastricht University; Maastricht University
RP Chandika, RM (corresponding author), Jazan Univ, Coll Nursing & Hlth Sci, Dept Clin Nutr, Jazan 45142, Saudi Arabia.
EM rchandika@jazanu.edu.sa; famohamed@jazanu.edu.sa;
   aalsayegh@jazanu.edu.sa; husawi@gmail.com; emadaldeen.alsayed@gmail.com;
   hus.mhadi@gmail.com; nasirmali2000@gmail.com;
   ramamohan.chandika@gmail.com; wendod31@gmail.com
RI CHANDIKA, RAMA/GQP-2060-2022; Khalafalla, Husam/G-2961-2012; Elfaki,
   Fatima/KIK-5269-2024
OI CHANDIKA, RAMA/0000-0001-7095-1248; alsayed, emad
   aldeen/0009-0005-7587-0806
FU Deputyship for Research & Innovation, Ministry of Education in Saudi
   Arabia [ISP-2024]
FX This research received funding support from the Deputyship for Research
   & Innovation, Ministry of Education in Saudi Arabia, through project
   number ISP-2024.
CR Alawadh RA, 2022, CUREUS J MED SCIENCE, V14, DOI 10.7759/cureus.30848
   Albar SA, 2021, NUTRIENTS, V13, DOI 10.3390/nu13061960
   Alfawaz HA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197020
   Arab Newspaper, 2019, INT J BIOL PHARM ALL, V8, P1517, DOI DOI 10.31032/IJBPAS/2019/8.8.4779
   Batista P, 2022, BEHAV SCI-BASEL, V12, DOI 10.3390/bs12100386
   Bin Abdulrahman KA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18157869
   Choueiry N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149643
   Colten HR., 2006, Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Irish LA, 2015, SLEEP MED REV, V22, P23, DOI 10.1016/j.smrv.2014.10.001
   Itani O, 2017, SLEEP MED, V32, P246, DOI 10.1016/j.sleep.2016.08.006
   Kharaba Z, 2022, J NUTR METAB, V2022, DOI 10.1155/2022/5762299
   Knapik JJ, 2022, NUTR J, V21, DOI 10.1186/s12937-022-00774-0
   LeBlanc M, 2009, SLEEP, V32, P1027, DOI 10.1093/sleep/32.8.1027
   Lone A, 2023, PSYCHOL RES BEHAV MA, V16, P3925, DOI 10.2147/PRBM.S427867
   Mahoney CR, 2019, CLIN NUTR, V38, P668, DOI 10.1016/j.clnu.2018.04.004
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   Meredith Steven E, 2013, J Caffeine Res, V3, P114, DOI 10.1089/jcr.2013.0016
   Nehlig A, 1999, NEUROSCI BIOBEHAV R, V23, P563, DOI 10.1016/S0149-7634(98)00050-5
   NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B
   O'Keefe JH, 2018, PROG CARDIOVASC DIS, V61, P38, DOI 10.1016/j.pcad.2018.02.002
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Rezk N. L., 2018, African Journal of Pharmacy and Pharmacology, V12, P19, DOI 10.5897/ajpp2017.4880
   Rola M. A. G., 2017, AJNE, V1, DOI [10.18502/ajne.v1i3.1230, DOI 10.18502/AJNE.V1I3.1230, https://doi.org/10.18502/ajne.v1i3.1230]
NR 24
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD SEP 20
PY 2024
VL 103
IS 38
AR e39784
DI 10.1097/MD.0000000000039784
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA H3G5K
UT WOS:001322353600084
PM 39312364
OA gold
DA 2025-04-28
ER

PT J
AU Mattioli, AV
   Pennella, S
   Manenti, A
   Puviani, MB
   Farinetti, A
AF Mattioli, Anna Vittoria
   Pennella, Sonia
   Manenti, Antonio
   Puviani, Matteo Ballerini
   Farinetti, Alberto
TI Influence of energy drinks on obesity: a preliminary experimental study
SO PROGRESS IN NUTRITION
LA English
DT Article
DE obesity; energy drinks; caffeine
ID BODY-WEIGHT; CONSUMPTION; COFFEE; ADOLESCENTS; CAFFEINE; ALCOHOL;
   DISEASE; RISK; DIET
AB We performed an experimental research in Sprague-Dawley rats in order to evaluate the effects of different caffeinated beverages on obesity. Animals were divided in 4 groups and received beverages containing different concentration of caffeine: a commercial Energy Drink, a commercial Cola Soda, regular coffee and water. After 15 days we found that Energy Drink and Cola Soda induced body weight gain, on contrary sweetened coffee and water did not influence weight. Besides, an increased reactivity and motility was observed in the Energy Drink supplemented animals. Laboratory tests excluded obesity-correlated dysmetabolism. We supposed a central nervous action of some components of Energy Drink other than caffeine, even if their finest mechanisms are unknown. At long term, degeneration from a condition of body weight gain to obesity cannot be excluded.
C1 [Mattioli, Anna Vittoria; Manenti, Antonio; Farinetti, Alberto] Univ Modena & Reggio Emilia, Surg Med & Dent Dept Morphol Sci Transplant Oncol, Modena, Italy.
   [Pennella, Sonia; Puviani, Matteo Ballerini] UO Univ Modena & Reggio, Ist Nazl Ric Cardiovasc, Modena, Italy.
C3 Universita di Modena e Reggio Emilia
RP Mattioli, AV (corresponding author), Univ Modena & Reggio Emilia, Surg Med & Dent Dept Morphol Sci Transplant Oncol, Modena, Italy.
EM annavittoria.mattioli@unimore.it
RI Farinetti, Alberto/A-3591-2016; Mattioli, Anna Vittoria/G-6001-2012
OI Mattioli, Anna Vittoria/0000-0003-1487-9530
FU "Fondazione Vignola" (Italy)
FX This research was supported by a grant from "Fondazione Vignola" (Italy)
CR Ali F, 2015, POSTGRAD MED, V127, P308, DOI 10.1080/00325481.2015.1001712
   Alsunni AA, 2015, INT J HEALTH SCI-IJH, V9, P468, DOI 10.12816/0031237
   Avci S, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2013.06.031
   Babwah TJ, 2014, PUBLIC HEALTH NUTR, V17, P2156, DOI 10.1017/S1368980013003339
   Dungan CM, 2016, LIPIDS
   Emond JA, 2014, J PEDIATR-US, V165, P1194, DOI 10.1016/j.jpeds.2014.08.050
   Flotta D, 2014, ALCOHOL CLIN EXP RES, V38, P1654, DOI 10.1111/acer.12394
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Harris JL, 2015, NUTR REV, V73, P247, DOI 10.1093/nutrit/nuu061
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101
   Kälin S, 2015, NAT REV ENDOCRINOL, V11, P339, DOI 10.1038/nrendo.2015.48
   Karadavut B, 2017, PROG NUTR, V19, P41, DOI 10.23751/pn.v19i1.5133
   Kristiansen MNB, 2016, WORLD J HEPATOL, V8, P673, DOI 10.4254/wjh.v8.i16.673
   Kumar G, 2015, AM J HEALTH PROMOT, V29, P238, DOI 10.4278/ajhp.130820-QUAN-435
   Kumar GS, 2014, PATIENT EDUC COUNS, V94, P250, DOI 10.1016/j.pec.2013.09.026
   Mattioli AV, 2013, NUTR METAB CARDIOVAS, V23, P115, DOI 10.1016/j.numecd.2011.03.005
   Mattioli AV, 2012, PROG NUTR, V14, P87
   Mattioli AV, 2011, NUTR METAB CARDIOVAS, V21, P412, DOI 10.1016/j.numecd.2009.11.003
   Mattioli AV, 2016, J CARDIOVASC MED, V17, P902, DOI 10.2459/JCM.0000000000000416
   Mattioli AV, 2007, FUTUR CARDIOL, V3, P203, DOI 10.2217/14796678.3.2.203
   McClelland J, 2013, EUR EAT DISORD REV, V21, P436, DOI 10.1002/erv.2256
   McLellan TM, 2012, NUTR REV, V70, P730, DOI 10.1111/j.1753-4887.2012.00525.x
   Pennella S, CLIN NUTR IN PRESS, DOI [10.1016/j.clnu.2017.05.00, DOI 10.1016/J.CLNU.2017.05.00]
   Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
NR 25
TC 3
Z9 3
U1 0
U2 13
PU MATTIOLI 1885
PI FIDENZA
PA VIA DELLA LODESANA 649-SX, FIDENZA, 43046 PR, ITALY
SN 1129-8723
J9 PROG NUTR
JI Prog. Nutr.
PD DEC
PY 2017
VL 19
IS 4
BP 369
EP 372
DI 10.23751/pn.v19i4.6438
PG 4
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FV6OU
UT WOS:000424701700003
DA 2025-04-28
ER

PT J
AU Goya, L
   Sánchez-Medina, A
   Redondo-Puente, M
   Dupak, R
   Bravo, L
   Sarriá, B
AF Goya, Luis
   Sanchez-Medina, Andrea
   Redondo-Puente, Monica
   Dupak, Rudolf
   Bravo, Laura
   Sarria, Beatriz
TI Main Colonic Metabolites from Coffee Chlorogenic Acid May Counteract
   Tumor Necrosis Factor-α-Induced Inflammation and Oxidative Stress in
   3T3-L1 Cells
SO MOLECULES
LA English
DT Article
DE inflammation; oxidative stress; coffee metabolites; dihydrocaffeic acid;
   dihydroferulic acid; hydroxyhippuric acid; obesity; adipocytes; IL-6;
   IL-1 beta; MCP-1
ID IDENTIFICATION; PREADIPOCYTES; RESVERATROL; ADIPONECTIN; EXPRESSION;
   PLASMA
AB Obesity is coupled with an altered redox state and low-level inflammation. Oxidative stress may increase pre-adipocyte proliferation, adipocyte differentiation and mature adipocyte size. Regarding inflammation, the dysregulation of cytokine production by adipose tissue takes place in obesity, which is promoted by oxidative stress. Polyphenols may exert a positive effect on obesity, not only by modulating the redox state, but also due to their anti-inflammatory activity. Coffee, which is one of the most consumed beverages, is very rich in phenolic compounds. Bioavailability studies on coffee phenols have shown that the most abundant group of metabolites in plasma and urine are dihydrocaffeic (DHCA), dihydroferulic (DHFA), and hydroxyhippuric (HHA) acids, the three acids of colonic origin. To better understand the antioxidant and anti-inflammatory properties of DHCA, DHFA, and HHA, an inflammation/oxidation model was set up in the pre-adipocyte 3T3-L1 cell line using tumor necrosis factor-alpha (TNF-alpha). After the exposure of 3T3-L1 cells to 0.5, 1, 5, and 10 mu M of TNF-alpha at different times, the cell viability, interleukin (IL)-6 secretion, and the production of reactive oxygen species (ROS) and glutathione (GSH) were determined. Using the TNF-alpha prooxidant and proinflammatory conditions established (10 mu M, 24 h), it was observed that the physiological concentrations (0.5, 1, 5, and 10 mu M) of DHCA, DHFA, and HHA induced dose-dependent antioxidant effects according to the ROS, GSH, and antioxidant enzyme (glutathione peroxidase) results. In addition, reductions in the IL-1 beta, IL-6, and monocyte chemoattractant protein-1 (MCP-1) concentrations were observed to different extents depending on the metabolite (DHFA, HHA, or DHCA) and the concentration used. In conclusion, the main colonic metabolites from coffee chlorogenic acids may counteract TNF-alpha-induced inflammation and oxidative stress in the 3T3-L1 cell line, and thus, they present antiobesity potential.
C1 [Goya, Luis; Sanchez-Medina, Andrea; Redondo-Puente, Monica; Bravo, Laura; Sarria, Beatriz] CSIC, Inst Food Sci Technol & Nutr ICTAN CSIC, Dept Metab & Nutr, Jose Antonio Novais 10, Madrid 28040, Spain.
   [Sanchez-Medina, Andrea; Sarria, Beatriz] Univ Complutense Madrid UCM, Fac Pharm, Dept Nutr & Food Sci, Plaza Ramon Y Cajal S-N, Madrid 28040, Spain.
   [Dupak, Rudolf] Slovak Univ Agr, Inst Appl Biol, Fac Biotechnol & Food Sci, Trieda Andreja Hlinku 2, Nitra 94976, Slovakia.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Complutense
   University of Madrid; Slovak University of Agriculture Nitra
RP Sarriá, B (corresponding author), CSIC, Inst Food Sci Technol & Nutr ICTAN CSIC, Dept Metab & Nutr, Jose Antonio Novais 10, Madrid 28040, Spain.; Sarriá, B (corresponding author), Univ Complutense Madrid UCM, Fac Pharm, Dept Nutr & Food Sci, Plaza Ramon Y Cajal S-N, Madrid 28040, Spain.
EM luisgoya@ictan.csic.es; andsan25@ucm.es; monicaredondopuente@gmail.com;
   xdupak@uniag.sk; lbravo@ictan.csic.es; beasarria@ictan.csic.es
RI Sarria, Beatriz/K-7929-2014; Martín, Maria Angeles/JAO-0626-2023; Bravo,
   Laura/F-4992-2012
OI Bravo, Laura/0000-0002-7312-8641
FU Intramural Project of the Spanish National Research Council (CSIC)
   [202170I026]; Spanish Ministry of Science and Innovation
   [PID2020-114102RB-I00]; Ministry of Science and Innovation
   [PEJ2018-001982-A]
FX This research was funded by the Intramural Project of the Spanish
   National Research Council (CSIC: Ref. 202170I026) and the Spanish
   Ministry of Science and Innovation (Ref. PID2020-114102RB-I00). MR had a
   contract (PEJ2018-001982-A) funded by the Ministry of Science and
   Innovation. RD had an EIT Food RIS Fellowship Action Line 2021. The
   funders had no role in the design of the study; in the collection,
   analyses, or interpretation of data; in the writing of the manuscript;
   or in the decision to publish the results.
CR Adwas A., 2019, J. Appl. Biotechnol. Bioeng., V6, P43, DOI [DOI 10.15406/JABB.2019.06.00173, 10.15406/jabb.2019.06.00173]
   Ahmadinejad F, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6030051
   Ahn J, 2007, BIOCHEM BIOPH RES CO, V364, P972, DOI 10.1016/j.bbrc.2007.10.109
   Alvarez-Cilleros D, 2020, FOOD CHEM TOXICOL, V146, DOI 10.1016/j.fct.2020.111824
   Seguido MA, 2022, NUTRIENTS, V14, DOI 10.3390/nu14122445
   Araki S, 2006, LIFE SCI, V79, P2405, DOI 10.1016/j.lfs.2006.08.004
   Baeza G, 2016, FOOD RES INT, V87, P25, DOI 10.1016/j.foodres.2016.06.011
   Campos EM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061592
   Castro-Barquero S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101523
   Cave E, 2019, METHODS MOL BIOL, V1916, P263, DOI 10.1007/978-1-4939-8994-2_25
   Chaiprasongsuk A, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.823881
   Chang E, 2014, MOL MED REP, V10, P905, DOI 10.3892/mmr.2014.2278
   Chang WC, 2010, EUR J NUTR, V49, P267, DOI 10.1007/s00394-009-0083-1
   Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596
   Coimbra S, 2013, OBES REV, V14, P771, DOI 10.1111/obr.12057
   Coman V, 2020, J SCI FOOD AGR, V100, P483, DOI 10.1002/jsfa.10010
   Gómez-Juaristi M, 2018, FOOD FUNCT, V9, P331, DOI [10.1039/c7fo01553d, 10.1039/C7FO01553D]
   Goya L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040212
   Hussain M, 2019, 2019 2ND INTERNATIONAL CONFERENCE ON COMPUTER APPLICATIONS & INFORMATION SECURITY (ICCAIS)
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Jiao WY, 2022, FOOD CHEM, V374, DOI 10.1016/j.foodchem.2021.131755
   Kawabata K, 2019, MOLECULES, V24, DOI 10.3390/molecules24020370
   Landolt L, 2022, NEPHROL DIAL TRANSPL, V37, P1024, DOI 10.1093/ndt/gfaa301
   Lee YW, 2008, J NUTR BIOCHEM, V19, P819, DOI 10.1016/j.jnutbio.2007.10.006
   Liu JF, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01756-y
   Lugrin J, 2014, BIOL CHEM, V395, P203, DOI 10.1515/hsz-2013-0241
   Marhuenda-Muñoz M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112725
   Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66
   Monagas M, 2009, BRIT J NUTR, V102, P201, DOI 10.1017/S0007114508162110
   Myhrstad MCW, 2002, FREE RADICAL BIO MED, V32, P386, DOI 10.1016/S0891-5849(01)00812-7
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Sanchez-Medina A, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24021440
   Savini I, 2013, INT J MOL SCI, V14, P10497, DOI 10.3390/ijms140510497
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Sies H, 2022, NAT REV MOL CELL BIO, V23, P499, DOI 10.1038/s41580-022-00456-z
   Sies H, 2020, OXIDATIVE STRESS: EUSTRESS AND DISTRESS, P3, DOI 10.1016/B978-0-12-818606-0.00001-8
   Silva SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189535
   Stagos D, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9010019
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Surma S, 2023, PHARMACOL RES, V187, DOI 10.1016/j.phrs.2022.106596
   Wang SL, 2019, INT J FOOD SCI NUTR, V70, P267, DOI 10.1080/09637486.2018.1505834
   Yang HL, 2014, J ETHNOPHARMACOL, V151, P394, DOI 10.1016/j.jep.2013.10.052
   Yen GC, 2011, J AGR FOOD CHEM, V59, P546, DOI 10.1021/jf1036992
   Zhou Y, 2008, INFLAMMATION, V31, P355, DOI 10.1007/s10753-008-9086-y
   Zhu J, 2008, BIOCHEM BIOPH RES CO, V369, P471, DOI 10.1016/j.bbrc.2008.02.034
NR 45
TC 6
Z9 6
U1 8
U2 21
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JAN
PY 2024
VL 29
IS 1
AR 88
DI 10.3390/molecules29010088
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA EU5L2
UT WOS:001141459300001
PM 38202671
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Narayan, VP
   Yoon, SY
AF Narayan, V. P.
   Yoon, S. Y.
TI Associations of Blood Caffeine and Genetically Predicted Coffee
   Consumption with Anthropometric Measures of Obesity: A Two Sample
   Mendelian Randomization Study
SO JOURNAL OF NUTRITION HEALTH & AGING
LA English
DT Article
DE Caffeine; coffee; mendelian randomization; obesity; body mass index
ID METABOLIC SYNDROME; RISK
AB Objectives In observational studies, caffeine has been associated with a lower risk of obesity. However, whether the associations are causal and apply to coffee, which is a mixture of chemical compounds is unclear. Design Two sample Mendelian randomization study. Setting and Participants Genetic instruments predicting caffeine were extracted from an existing GWAS of serum metabolites in 1960 individuals of European descent. For coffee consumption up to 91,462 individuals of European ancestry with top SNPs followed-up in similar to 30,062 coffee consumers and up to 375,833 individuals of European ancestry were taken from two separate studies. Genetic associations with obesity classes (n= 263,407), waist-to-hip ratio (WHR) (n=210,086), waist circumference (WC) (n= 231,355), and hip circumference (HC) (n=211,117) were obtained from summary statistics of individuals of European ancestry from the Genetic Investigation of Anthropocentric Traits (GIANT). Methods The inverse-variance weighted method (IVW) was used as the main analysis. We also employed the weighted median approach (WM) and MR-Egger regression as sensitivity analyses. To gauge evidence of directional pleiotropy, we used Cochrane's Q test, and MR-PRESSO global test, as measures of heterogeneity between ratio estimates of variants. Results There was little evidence to support an association between blood caffeine and any anthropometric measure of obesity in the primary and sensitivity analyses. However, genetically predicted coffee consumption was positively associated with higher class I obesity and WHR. Furthermore, this association was maintained after correction for multiple testing (P < 0.05/6 = 0.008). Results from the GWAS of coffee consumption were in tandem with results from the GWMA, but associations with class I obesity and waist to hip ratio (WHR) were not maintained after correction for multiple testing. Conclusion We found little evidence that caffeine or coffee consumption protects against obesity, adding to growing literature suggesting that previous observational studies may have been confounded. This study demonstrates the dangers of ignoring genetic testing for targeted interventions and basing dietary policy recommendations solely on observational studies restricted to specific populations.
C1 [Narayan, V. P.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia.
   [Narayan, V. P.] Univ Exeter, Coll Life & Environm Sci, Penryn, England.
   [Yoon, S. Y.] Ewha Womans Univ, Syst Hlth & Engn Major Grad Sch, BK21 Plus Program, Seoul 03760, South Korea.
   [Yoon, S. Y.] Ewha Womans Univ, Dept Nutr Sci & Food Management, Seoul 03760, South Korea.
C3 University of Queensland; University of Exeter; Ewha Womans University;
   Ewha Womans University
RP Narayan, VP (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia.
EM v.narayan@uqconnect.edu.au
CR Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243
   Anty R, 2012, J HEPATOL, V57, P1090, DOI 10.1016/j.jhep.2012.07.014
   Bowden J, 2019, INT J EPIDEMIOL, V48, P728, DOI 10.1093/ije/dyy258
   Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965
   Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x
   Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758
   Burgess S, 2011, STAT MED, V30, P1312, DOI 10.1002/sim.4197
   Censin JC, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008405
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Freedman DS, 2002, JAMA-J AM MED ASSOC, V288, P1758, DOI 10.1001/jama.288.14.1758
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kitahara CM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001673
   Kwok MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep36500
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Long T, 2017, NAT GENET, V49, P568, DOI 10.1038/ng.3809
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Muhammad HFL, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/9606054
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Pirastu N, 2016, SCI REP-UK, V6, DOI 10.1038/srep31590
   Thomas DR, 2020, CURR DEV NUTR, V4, DOI 10.1093/cdn/nzz142
   Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7
   Ward ME, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100248, 10.1371/journal.pone.0103448]
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   Zhong VW, 2019, HUM MOL GENET, V28, P2449, DOI 10.1093/hmg/ddz061
   Zhou A, 2021, CLIN NUTR, V40, P4404, DOI 10.1016/j.clnu.2020.12.042
NR 29
TC 3
Z9 3
U1 1
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1279-7707
EI 1760-4788
J9 J NUTR HEALTH AGING
JI J. Nutr. Health Aging
PD FEB
PY 2022
VL 26
IS 2
BP 190
EP 196
DI 10.1007/s12603-022-1736-5
EA FEB 2022
PG 7
WC Geriatrics & Gerontology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Nutrition & Dietetics
GA YY9QX
UT WOS:000753711400001
PM 35166314
OA hybrid
DA 2025-04-28
ER

PT J
AU Roshan, H
   Nikpayam, O
   Sedaghat, M
   Sohrab, G
AF Roshan, Hanieh
   Nikpayam, Omid
   Sedaghat, Meghdad
   Sohrab, Golbon
TI Effects of green coffee extract supplementation on anthropometric
   indices, glycaemic control, blood pressure, lipid profile, insulin
   resistance and appetite in patients with the metabolic syndrome: a
   randomised clinical trial
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Green coffee bean extract; Chlorogenic acid; Blood pressure; Weight;
   Fasting blood glucose; Lipid profile; Insulin resistance
ID HIGH-FAT DIET; CHLOROGENIC ACID; ENDOTHELIAL FUNCTION;
   HEALTHY-VOLUNTEERS; BEAN EXTRACT; WEIGHT-LOSS; MICE; METAANALYSIS;
   CONSUMPTION; OVERWEIGHT
AB This study was conducted to elucidate the effects of decaffeinated green coffee bean extract (GCE) on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome (Mets). Subjects were randomly allocated to consume 400 mg GCE or placebo capsules twice per d for 8 weeks. Both groups were advised to follow an energy balanced diet. After GCE supplementation, systolic blood pressure (SBP) significantly reduced compared with the placebo group (-13.76 (SD 8.48) v. -6.56 (SD 9.58) mmHg, P = 0.01). Also, GCE treatment significantly reduced fasting blood glucose (FBS) (-5.15 (SD 60.22) v. 29.42 (SD 40.01) mg/dl (-0.28 (SD 3.34) v. 1.63 (SD 2.22) mmol/l); P = 0.03) and homoeostatic model of assessment of insulin resistance in comparison to placebo (-1.41 (SD 3.33) v. 1.23 (SD 3.84), P = 0.02). In addition, waist circumference (-2.40 (SD 2.54) v. -0.66 (SD 1.17) cm, P = 0.009) and appetite score (-1.44 (SD 1.72) v. -0.2 (SD 1.32), P = 0.01) of the individuals supplemented with GCE indicated a significant decline. Besides, weight and BMI reduction in the intervention group was almost twice as much as the placebo group; however, this discrepancy was marginally significant (weight: -2.08 (SD 2.11) v. -0.92 (SD 1.30) kg, P = 0.05). No difference was observed in terms of glycated Hb (HbA1c) percentage and lipid profile parameters between the two groups. To sum up, GCE administration had an ameliorating effect on some of the Mets components such as high SBP, high FBS and Mets main aetiological factors including insulin resistance and abdominal obesity. Furthermore, GCE supplementation could reduce appetite level.
C1 [Roshan, Hanieh; Nikpayam, Omid] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Clin Nutr & Dietet Dept, Tehran 1981619573, Iran.
   [Sedaghat, Meghdad] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Tehran 1981619573, Iran.
   [Sohrab, Golbon] Shahid Beheshti Univ Med Sci, Internal Med Dept, Tehran 1985717443, Iran.
C3 Shahid Beheshti University Medical Sciences; Shahid Beheshti University
   Medical Sciences; Shahid Beheshti University Medical Sciences
RP Sohrab, G (corresponding author), Shahid Beheshti Univ Med Sci, Internal Med Dept, Tehran 1985717443, Iran.
EM golbonsohrab@yahoo.com
RI Nikpayam, Omid/AGG-5000-2022; Sohrab, Golbon/AHE-4922-2022; Roshan,
   Hanieh/G-1175-2017; sedaghat, meghdad/K-3289-2017
OI Roshan, Hanieh/0000-0003-1460-5265; sedaghat,
   meghdad/0000-0002-3966-0597; nikpayam, omid/0000-0002-6301-1597
FU National Nutrition and Food Technology Research Institute of Shahid
   Beheshti University [655]
FX This study was financially supported by a grant from the National
   Nutrition and Food Technology Research Institute of Shahid Beheshti
   University (G. S., grant no. 655). The GCE and placebo capsules were
   provided by Arjuna Natural Extracts Ltd as a donation. The funders had
   no role in the design, analysis or writing of this article.
CR Ahmed G. M., 2013, Advance Journal of Food Science & Technology, V5, P619
   Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   [Anonymous], 2006, The IDF Consensus Worldwide Definition of the Metabolic Syndrome
   Blum J, 2007, NUTRAFOODS, V6, P13
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   Ebrahimi M, 2009, ACTA CARDIOL, V64, P321, DOI 10.2143/AC.64.3.2038016
   Ghaffarpour M., 1999, TEHRAN NASHRE OLUME, V7, P42
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Jin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120842
   Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI [10.1039/C4FO00290C, 10.1039/c4fo00290c]
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Razavi BM, 2017, J SCI FOOD AGR, V97, P1679, DOI 10.1002/jsfa.8134
   Revuelta-Iniesta R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/482704
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Sarria B, 2016, EUR J NUTR
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Shimoda Hiroshi, 2006, BMC Complement Altern Med, V6, P9, DOI 10.1186/1472-6882-6-9
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Upadhyay R, 2013, CRIT REV FOOD SCI, V53, P968, DOI 10.1080/10408398.2011.576319
   Varghese M, 2014, TRANSL NEUROSCI, V5, P111, DOI 10.2478/s13380-014-0213-y
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074
NR 36
TC 114
Z9 115
U1 1
U2 39
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD FEB 14
PY 2018
VL 119
IS 3
BP 250
EP 258
DI 10.1017/S0007114517003439
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FX2XG
UT WOS:000425928600002
PM 29307310
OA Bronze
DA 2025-04-28
ER

PT J
AU Iso, H
   Date, C
   Wakai, K
   Fukui, M
   Tamakoshi, A
AF Iso, H
   Date, C
   Wakai, K
   Fukui, M
   Tamakoshi, A
CA JACC Study Grp
TI The relationship between green tea and total caffeine intake and risk
   for self-reported type 2 diabetes among Japanese adults
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Article
ID COFFEE CONSUMPTION; EPIGALLOCATECHIN GALLATE; MELLITUS; PREVALENCE;
   TOLERANCE
AB Background: in western populations, coffee consumption is associated with a reduced risk for type 2 diabetes; however, the effect of green, black, and oolong teas is unclear.
   Objective: To examine the relationship between consumption of these beverages and risk for diabetes.
   Design: Retrospective cohort study.
   Setting: 25 communities across Japan.
   Participants: A total of 17 413 persons (6727 men and 10 686 women; 49% of the original study population) who were 40 to 65 years of age; had no history of type 2 diabetes, cardiovascular disease, or cancer at the baseline lifestyle survey; and completed the 5-year follow-up questionnaire. There was no difference in body mass index levels at baseline between respondents and non-respondents.
   Measurements: Questionnaire on consumption of coffee; black, green, and oolong teas; and physician-diagnosed diabetes. Results: During the 5-year follow-up, there were 444 self-reported new cases of diabetes in 231 men and 213 women (5-year event rates, 3.4% and 2.0%, respectively). Consumption of green tea and coffee was inversely associated with risk for diabetes after adjustment for age, sex, body mass index, and other risk factors. Multivariable odds ratios for diabetes among participants who frequently drank green tea and coffee ( :6 cups of green tea per day and 3 cups of coffee per day) were 0.67 (95% Cl, 0.47 to 0.94) and 0.58 (Cl, 0.37 to 0.90), respectively, compared with those who drank less than I cup per week. No association was found between consumption of black or oolong teas and the risk for diabetes. Total caffeine intake from these beverages was associated with a 33% reduced risk for diabetes. These inverse associations were more pronounced in women and in overweight men.
   Limitations: Diabetes was self-reported, no data were available on consumption of soda, and the follow-up rate was low.
   Conclusions: Consumption of green tea, coffee, and total caffeine was associated with a reduced risk for type 2 diabetes.
C1 Osaka Univ, Grad Sch Med, Dept Social & Environm Hlth, Suita, Osaka 5650871, Japan.
   Osaka City Univ, Osaka 558, Japan.
   Nara Womens Univ, Nara 630, Japan.
   Aichi Canc Ctr, Nagoya, Aichi 464, Japan.
   Nagoya Univ, Nagoya, Aichi, Japan.
C3 The University of Osaka; Osaka Metropolitan University; Nara Womens
   University; Aichi Cancer Center; Nagoya University
RP Osaka Univ, Grad Sch Med, Dept Social & Environm Hlth, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM iso@pbhei.med.osaka-u-ac.jp
RI Tamakoshi, Akiko/D-5105-2012; Wakai, Kenji/I-7248-2014
OI TOKUDOME, SHINKAN/0000-0001-7311-2458; Iso,
   Hiroyasu/0000-0002-9241-7289; Kawamura, Takeshi/0000-0003-1613-6968
CR [Anonymous], STAND TABL FOOD COMP
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185
   Date C, 2005, J EPIDEMIOL, V15, pS9, DOI 10.2188/jea.15.S9
   Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   OHMURA T, 1993, DIABETOLOGIA, V36, P1198, DOI 10.1007/BF00401066
   Ohno Y, 2001, J Epidemiol, V11, P144
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472
   Sasazuki S, 2004, CANCER CAUSE CONTROL, V15, P483, DOI 10.1023/B:CACO.0000036449.68454.42
   Song EK, 2003, ARCH PHARM RES, V26, P559, DOI 10.1007/BF02976881
   SPRIET LL, 1992, AM J PHYSIOL, V262, pE891, DOI 10.1152/ajpendo.1992.262.6.E891
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200
NR 22
TC 361
Z9 409
U1 5
U2 59
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD APR 18
PY 2006
VL 144
IS 8
BP 554
EP 562
DI 10.7326/0003-4819-144-8-200604180-00005
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 035QZ
UT WOS:000237017900002
PM 16618952
DA 2025-04-28
ER

PT J
AU Arçari, DP
   Bartchewsky, W
   dos Santos, TW
   Oliveira, KA
   Funck, A
   Pedrazzoli, J
   de Souza, MFF
   Saad, MJ
   Bastos, DHM
   Gambero, A
   Carvalho, PD
   Ribeiro, ML
AF Arcari, Demetrius P.
   Bartchewsky, Waldemar
   dos Santos, Tanila W.
   Oliveira, Karim A.
   Funck, Alexandre
   Pedrazzoli, Jose
   de Souza, Marina F. F.
   Saad, Mario J.
   Bastos, Deborah H. M.
   Gambero, Alessandra
   Carvalho, Patricia de O.
   Ribeiro, Marcelo L.
TI Antiobesity Effects of yerba mate Extract (Ilex
   paraguariensis) in High-fat Diet-induced Obese Mice
SO OBESITY
LA English
DT Article
ID NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; UNCOUPLING PROTEINS;
   INSULIN-RESISTANCE; CHLOROGENIC ACID; POTENTIAL ROLE; TNF-ALPHA; LEPTIN;
   PLASMA; INFLAMMATION
AB Because the potential of yerba mate (Ilex paraguariensis) has been suggested in the management of obesity, the aim of the present study was to evaluate the effects of yerba mate extract on weight loss, obesity-related biochemical parameters, and the regulation of adipose tissue gene expression in high-fat diet-induced obesity in mice. Thirty animals were randomly assigned to three groups. The mice were introduced to standard or high-fat diets. After 12 weeks on a high-fat diet, mice were randomly assigned according to the treatment (water or yerba mate extract 1.0 g/-kg). After treatment intervention, plasma concentrations of total cholesterol, high-density lipoprotein cholesterol, triglyceride, low-density lipoprotein (LDL) cholesterol, and glucose were evaluated. Adipose tissue was examined to determine the mRNA levels of several genes such as tumor necrosis factor-alpha (TNF-alpha), leptin, interleukin-6 (IL-6), C-C motif chemokine ligand-2 (CCL2), CCL receptor-2 (CCR2), angiotensinogen, plasminogen activator inhibitor-1 (PAI-1), adiponectin, resistin, peroxisome proliferator-activated receptor-gamma(2) (PPAR-gamma(2)), uncoupling protein-1 (UCP1), and PPAR-gamma coactivator-1 alpha (PGC-1 alpha). The F4/80 levels were determined by immunoblotting. We found that obese mice treated with yerba mate exhibited marked attenuation of weight gain, adiposity, a decrease in epididymal fat-pad weight, and restoration of the serum levels of cholesterol, triglycerides, LDL cholesterol, and glucose. The gene and protein expression levels were directly regulated by the high-fat diet. After treatment with yerba mate extract, we observed a recovery of the expression levels. In conclusion, our data show that yerba mate extract has potent antiobesity activity in vivo. Additionally, we observed that the treatment had a modulatory effect on the expression of several genes related to obesity.
C1 [Arcari, Demetrius P.; Bartchewsky, Waldemar; dos Santos, Tanila W.; Oliveira, Karim A.; Funck, Alexandre; Pedrazzoli, Jose; Gambero, Alessandra; Ribeiro, Marcelo L.] Univ Sao Francisco, Unidade Integrada Farmacol & Gastroenterol, BR-12900000 Braganca Paulista, SP, Brazil.
   [Arcari, Demetrius P.; de Souza, Marina F. F.; Bastos, Deborah H. M.] Univ Sao Paulo, Fac Saude Publ, Dept Nutr, Sao Paulo, Brazil.
   [Carvalho, Patricia de O.] Univ Sao Francisco, Lab Multidisciplinar Pesquisa, BR-12900000 Braganca Paulista, SP, Brazil.
   [Saad, Mario J.] Univ Estadual Campinas, Dept Med Interna, Campinas, SP, Brazil.
C3 Universidade Sao Francisco; Universidade de Sao Paulo; Universidade Sao
   Francisco; Universidade Estadual de Campinas
RP Ribeiro, ML (corresponding author), Univ Sao Francisco, Unidade Integrada Farmacol & Gastroenterol, BR-12900000 Braganca Paulista, SP, Brazil.
EM marcelo.ribeiro@saofrancisco.edu.br
RI Ribeiro, Marcelo/H-8856-2013; Gambero, Alessandra/G-5792-2013; Bastos,
   Deborah/G-3596-2012; dos Santos, Tanila/AHA-7922-2022; de Oliveira
   Carvalho, Patricia/B-8579-2012; Saad, Mario/ABD-8262-2020
OI Gambero, Alessandra/0000-0002-4862-4328; WOOD DOS SANTOS,
   TANILA/0000-0002-1699-6477; /0000-0003-4529-7832; Carvalho, Patricia
   de/0000-0002-2681-7022
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/61797-0];
   Financiadora de Estudos e Projetos (FINEP); Leao Junior S/A
FX We thank Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (06/61797-0), Financiadora de Estudos e Projetos (FINEP), and Leao
   Junior S/A for financial support.
CR Arabbi PR, 2004, J AGR FOOD CHEM, V52, P1124, DOI 10.1021/jf0499525
   Argilés JM, 2002, BIOCHEM BIOPH RES CO, V293, P1145, DOI 10.1016/S0006-291X(02)00355-8
   Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001
   Bastos DHM., 2007, Med Aromat Plant Sci Biotechnol, V1, P37
   Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34
   Bulló M, 2002, INT J OBESITY, V26, P652, DOI 10.1038/sj.ijo.0801977
   Bulló M, 2007, PUBLIC HEALTH NUTR, V10, P1164, DOI 10.1017/S1368980007000663
   Corica F, 1999, INT J OBESITY, V23, P355, DOI 10.1038/sj.ijo.0800826
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Han UK, 2002, J NUTR, V132, P2241, DOI 10.1093/jn/132.8.2241
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697
   Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745
   KRUITHOF EKO, 1988, ENZYME, V40, P113, DOI 10.1159/000469153
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527
   Massiéra F, 2001, FASEB J, V15, P2727, DOI 10.1096/fj.01-0457fje
   Massiera F, 2001, ENDOCRINOLOGY, V142, P5220, DOI 10.1210/en.142.12.5220
   Miranda DDC, 2008, MUTAGENESIS, V23, P261, DOI 10.1093/mutage/gen011
   Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106
   NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pomilio AB, 2002, PHYTOCHEM ANALYSIS, V13, P235, DOI 10.1002/pca.647
   PRIMROSE JN, 1992, THROMB HAEMOSTASIS, V68, P396
   Rodríguez E, 2004, OBES RES, V12, P1455, DOI 10.1038/oby.2004.182
   Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145
   SAWDEY MS, 1991, J CLIN INVEST, V88, P1346, DOI 10.1172/JCI115440
   Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448
   Skurk T, 2004, INT J OBESITY, V28, P1357, DOI 10.1038/sj.ijo.0802778
   Stein FLP, 2005, BIOL RES NURS, V7, P146, DOI 10.1177/1099800405280521
   Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Xenachis C, 2001, J ENDOCRINOL INVEST, V24, P865, DOI 10.1007/BF03343943
   Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815
   Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972
NR 39
TC 130
Z9 139
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD DEC
PY 2009
VL 17
IS 12
BP 2127
EP 2133
DI 10.1038/oby.2009.158
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 523RD
UT WOS:000272091200002
PM 19444227
OA Bronze
DA 2025-04-28
ER

PT J
AU Takebayashi, J
   Kubo, K
   Saeki, A
   Saito, M
AF Takebayashi, Jun
   Kubo, Kazuhiro
   Saeki, Akiko
   Saito, Morio
TI Effect of Citrus aurantium combined with caffeine and/or tea
   catechins on body fat accumulation and its safety in rats
SO JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
LA English
DT Article
DE Citrus aurantium; caffeine; tea catechins; body fat accumulation; safety
ID EPHEDRA-FREE; GREEN TEA; SYNEPHRINE STEREOISOMERS; GARCINIA-CAMBOGIA;
   OVERWEIGHT; OCTOPAMINE; DIET; POLYPHENOLS; SUPPLEMENT; OXIDATION
AB We investigated the weight loss efficacy and safety of Citrus aurantium (CA, 1,000 mg/kg diet) along with usual levels of adrenergic stimulants in foods, i.e. caffeine (100 mg/kg diet) and/or tea catechins (500 mg/kg diet), in rats for 44 or 45 days. Even in combination with caffeine and tea catechins, the suppressive effect of CA against body fat accumulation was negligible, whereas no deleterious influences concerning cardiotoxicity were observed. Thus, although the efficacy of CA for weight loss seems to be questionable, no safety problems may occur even in people who habitually consume coffee and tea. However, it is noteworthy that the intake of CA markedly elevated the urinary excretion of adrenaline, and this was not affected by intake of caffeine and/or tea catechins at the usual levels. Therefore, the safety of CA intake with high levels of caffeine and tea catechins, especially in people at risk of heart disease, remains to be elucidated further.
C1 Natl Inst Hlth & Nutrit, Div Food Sci, Incorporated Adm Agcy, Shinjuku Ku, Tokyo 1628636, Japan.
C3 National Institute of Health & Nutrition - Japan
RP Kubo, K (corresponding author), Natl Inst Hlth & Nutrit, Div Food Sci, Incorporated Adm Agcy, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.
EM msaito@nih.go.jp
CR Armstrong W.J., 2001, Journal of Exercise Physiology Online, V4, P28
   Behonick GS, 2001, J APPL TOXICOL, V21, pS15, DOI 10.1002/jat.793
   Bouchard NC, 2005, MAYO CLIN PROC, V80, P541, DOI 10.4065/80.4.541
   BROWN CM, 1988, BRIT J PHARMACOL, V93, P417, DOI 10.1111/j.1476-5381.1988.tb11449.x
   Calapai G, 1999, FITOTERAPIA, V70, P586, DOI 10.1016/S0367-326X(99)00093-3
   Carpéné C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Fugh-Berman A, 2004, EXP BIOL MED, V229, P698, DOI 10.1177/153537020422900802
   GARCIACARMONA F, 1987, BIOCHEM INT, V14, P1003
   Goto T, 1996, J CHROMATOGR A, V749, P295, DOI 10.1016/0021-9673(96)00456-6
   Gougeon R, 2005, OBES RES, V13, P1187, DOI 10.1038/oby.2005.141
   Haaz S, 2006, OBES REV, V7, P79, DOI 10.1111/j.1467-789X.2006.00195.x
   Haller CA, 2005, AM J MED, V118, P998, DOI 10.1016/j.amjmed.2005.02.034
   JORDAN R, 1987, J PHARM PHARMACOL, V39, P752, DOI 10.1111/j.2042-7158.1987.tb06986.x
   Jordan Scott, 2004, CMAJ, V171, P993
   Kalman DS, 2000, CURR THER RES CLIN E, V61, P199, DOI 10.1016/S0011-393X(00)89034-7
   Kiyose C, 2006, J CLIN BIOCHEM NUTR, V38, P180, DOI 10.3164/jcbn.38.180
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Kubo K, 2005, J CLIN BIOCHEM NUTR, V36, P11, DOI 10.3164/jcbn.36.11
   Marcus DM, 2003, SCIENCE, V301, P1669
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nasir JM, 2004, MAYO CLIN PROC, V79, P1059, DOI 10.4065/79.8.1059
   Nykamp DL, 2004, ANN PHARMACOTHER, V38, P812, DOI 10.1345/aph.1D473
   Pellati F, 2002, J PHARMACEUT BIOMED, V29, P1113, DOI 10.1016/S0731-7085(02)00153-X
   Preuss Harry G., 2002, Journal of Medicine (Westbury), V33, P247
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Saito M, 2005, FOOD CHEM TOXICOL, V43, P411, DOI 10.1016/j.fct.2004.11.008
   2004, HLTH CAN HLTH CANADA
NR 30
TC 0
Z9 0
U1 0
U2 5
PU JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
PI KYOTO
PA KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR
   GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN
SN 0912-0009
EI 1880-5086
J9 J CLIN BIOCHEM NUTR
JI J. Clin. Biochem. Nutr.
PD NOV
PY 2006
VL 39
IS 3
BP 172
EP 179
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 107XX
UT WOS:000242205400009
DA 2025-04-28
ER

PT J
AU Reza-Zaldivar, EE
   Jacobo-Velázquez, DA
AF Reza-Zaldivar, Edwin Estefan
   Jacobo-Velazquez, Daniel A.
TI Evaluating bioactivity retention in metabolism: a comparative study of
   chlorogenic acid and its metabolite dihydrocaffeic acid on antioxidant,
   anti-inflammatory, and anti-obesogenic activities in vitro
SO CYTA-JOURNAL OF FOOD
LA English
DT Article
DE Chlorogenic acid; dihydrocaffeic acid; metabolic transformation;
   metabolites; obesity; metabolic syndrome; oxidative stress-related
   disorders
ID WHITE ADIPOCYTES; PPAR-ALPHA; ACTIVATION; STRATEGIES; OBESITY; STRESS
AB This study investigates the bioactivity retention of chlorogenic acid (CGA) and its metabolite dihydrocaffeic acid (DHCA) by comparing their antioxidant, anti-inflammatory, and anti-obesogenic properties in vitro. CGA, found in coffee, fruits, and vegetables, is metabolized into DHCA, potentially enhancing bioactivity. Antioxidant capacity was assessed in Caco-2 cells, with DHCA showing superior activity at lower concentrations than CGA. Anti-inflammatory effects were evaluated in LPS-stimulated RAW 264.7 cells, where DHCA exhibited significant dose-dependent inhibition of nitrite production, surpassing CGA. Anti-obesogenic potential was analyzed in 3T3-L1 cells, with DHCA demonstrating stronger inhibition of adipogenesis and notable downregulation of adipogenic genes like PPAR gamma and C/EBP alpha. These results suggest that DHCA's enhanced therapeutic potential due to its simplified structure and increased bioavailability. This study highlights the importance of metabolic transformations in dietary polyphenols for chronic disease prevention and management.
C1 [Reza-Zaldivar, Edwin Estefan; Jacobo-Velazquez, Daniel A.] Tecnol Monterrey, Escuela Ingn & Ciencias, Campus Guadalajara,Ave Gen Ramon Corona 2514, Zapopan 45201, Jalisco, Mexico.
C3 Tecnologico de Monterrey
RP Jacobo-Velázquez, DA (corresponding author), Tecnol Monterrey, Escuela Ingn & Ciencias, Campus Guadalajara,Ave Gen Ramon Corona 2514, Zapopan 45201, Jalisco, Mexico.
RI Jacobo-Velázquez, Daniel/AAG-5973-2020; Jacobo-Velazquez, Daniel
   Alberto/E-4225-2013
OI Jacobo-Velazquez, Daniel Alberto/0000-0002-9478-2570
FU Tecnologico de Monterrey-The Institute for Obesity Research
FX Financial support for this study was provided by Tecnologico de
   Monterrey-The Institute for Obesity Research.
CR Alam MA, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0080-3
   Anantharaju PG, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0217-2
   Baeza G, 2017, FOOD FUNCT, V8, P1333, DOI [10.1039/c6fo01404f, 10.1039/C6FO01404F]
   Baeza G, 2016, FOOD RES INT, V87, P25, DOI 10.1016/j.foodres.2016.06.011
   Cheenpracha S, 2010, MAR DRUGS, V8, P429, DOI 10.3390/md8030429
   de Llano DG, 2023, METABOLITES, V13, DOI 10.3390/metabo13010108
   Duangjai Acharaporn, 2018, Kobe J Med Sci, V64, pE84
   Ekbatan SS, 2016, FOOD CHEM, V204, P453, DOI 10.1016/j.foodchem.2016.02.140
   Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320
   Heleno SA, 2015, FOOD CHEM, V173, P501, DOI 10.1016/j.foodchem.2014.10.057
   Huang JJ, 2004, J NUTR BIOCHEM, V15, P722, DOI 10.1016/j.jnutbio.2004.07.002
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Jiang N, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.870250
   Kong L, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13795
   Kumar Priti, 2018, Cold Spring Harb Protoc, V2018, DOI 10.1101/pdb.prot095505
   Kumar R, 2020, CURR MOL PHARMACOL, V13, P7, DOI 10.2174/1874467212666190716145210
   Kuppusamy P, 2021, MOLECULES, V26, DOI 10.3390/molecules26071984
   Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009
   Langin D, 2010, BBA-MOL CELL BIOL L, V1801, P372, DOI 10.1016/j.bbalip.2009.09.008
   Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011
   Li HB, 2019, PHARMACOL RES, V147, DOI 10.1016/j.phrs.2019.104393
   Li ZL, 2020, FASEB J, V34, P4527, DOI 10.1096/fj.201902222R
   Liu CC, 2017, MOL MED REP, V16, P1369, DOI 10.3892/mmr.2017.6698
   Liu MT, 2021, INT J ENDOCRINOL, V2021, DOI 10.1155/2021/2215274
   Lu HJ, 2020, COMPR REV FOOD SCI F, V19, P3130, DOI 10.1111/1541-4337.12620
   Ludwig IA, 2013, BIOFACTORS, V39, P623, DOI 10.1002/biof.1124
   Monagas M, 2009, BRIT J NUTR, V102, P201, DOI 10.1017/S0007114508162110
   Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Peng SG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8594767
   Pimpley V, 2020, PREP BIOCHEM BIOTECH, V50, P969, DOI 10.1080/10826068.2020.1786699
   Reza-Zaldívar EE, 2024, J AGR FOOD RES, V16, DOI 10.1016/j.jafr.2024.101155
   Russell WR, 2008, NUTR CANCER, V60, P636, DOI 10.1080/01635580801987498
   Santana-Gálvez J, 2020, CYTA-J FOOD, V18, P245, DOI 10.1080/19476337.2020.1743762
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Sudhakar M, 2020, J FUNCT FOODS, V74, DOI 10.1016/j.jff.2020.104161
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   Wang L, 2013, DIABETES, V62, P4122, DOI 10.2337/db13-0518
   Wang L, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.943911
   Wang SL, 2019, INT J FOOD SCI NUTR, V70, P267, DOI 10.1080/09637486.2018.1505834
   Wilson A.P., 2000, Animal cell culture: a practical approach, V3, P175, DOI DOI 10.1093/OSO/9780199637973.003.0007
   Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166
   Xu M, 2019, FOOD FUNCT, V10, P7489, DOI 10.1039/c9fo00502a
   Yan YW, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.1042044
   Zhao XY, 2019, ANAL BIOCHEM, V568, P57, DOI 10.1016/j.ab.2018.12.020
NR 46
TC 1
Z9 1
U1 7
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1947-6337
EI 1947-6345
J9 CYTA-J FOOD
JI CyTA-J. Food
PD DEC 31
PY 2024
VL 22
IS 1
AR 2390997
DI 10.1080/19476337.2024.2390997
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA D1P2K
UT WOS:001293969100001
OA gold
DA 2025-04-28
ER

PT J
AU Gkouskou, KG
   Georgiopoulos, G
   Vlastos, I
   Lazou, E
   Chaniotis, D
   Papaioannou, TG
   Mantzoros, CS
   Sanoudou, D
   Eliopoulos, AG
AF Gkouskou, Kalliopi G.
   Georgiopoulos, Georgios
   Vlastos, Ioannis
   Lazou, Evgenia
   Chaniotis, Dimitrios
   Papaioannou, Theodore G.
   Mantzoros, Christos S.
   Sanoudou, Despina
   Eliopoulos, Aristides G.
TI CYP1A2 polymorphisms modify the association of habitual coffee
   consumption with appetite, macronutrient intake, and body mass index:
   results from an observational cohort and a cross-over randomized study
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
ID GENETIC RISK; CAFFEINE; OBESITY; WEIGHT; DEFICIENCY; ASPROSIN; DIETARY;
   PROTEIN; BIRTH
AB Background/Objectives Evidence regarding the influence of coffee on appetite and weight control is equivocal and the influence of covariates, such as genetic variation in caffeine metabolism, remains unknown. Herein, we addressed the novel hypothesis that genetic variation in CYP1A2, a gene responsible for more than 95% of caffeine metabolism, differentially impacts the association of coffee consumption with appetite and BMI among individuals with different genetic predispositions to obesity. Subjects/Methods A cross-over randomized intervention study involving 18 volunteers assessed the effects of coffee consumption on dietary intake, appetite, and levels of the appetite-controlling hormones asprosin and leptin. Data on habitual coffee intake, BMI, and perceived appetite were obtained from an observational cohort of 284 volunteers using validated questionnaires. Participants were stratified according to a validated genetic risk score (GRS) for obesity and to the -163C > A (rs762551) polymorphism of CYP1A2 as rapid (AA), intermediate (AC), or slow (CC) caffeine metabolizers. Results Coffee consumption led to lower energy and dietary fat intake and circulating asprosin levels (P for interaction of rs762551 genotype*coffee consumption=0.056, 0.039, and 0.043, respectively) as compared to slow/intermediate metabolizers. High coffee consumption was more prevalent in rapid compared to slow metabolizers (P = 0.008 after adjustment for age, sex, and BMI) and was associated with lower appetite perception and lower BMI only in rapid metabolizers (P for interaction of rs762551 genotype*coffee consumption = 0.002 and 0.048, respectively). This differential association of rs762551 genotype and coffee consumption with BMI was more evident in individuals at higher genetic risk of obesity (mean adjusted difference in BMI = -5.82 kg/m(2) for rapid versus slow/intermediate metabolizers who consumed more than 14 cups of coffee per week). Conclusions CYP1A2 rs762551 polymorphism modifies the association of habitual coffee consumption with BMI, in part by influencing appetite, energy intake and circulating levels of the orexigenic hormone asprosin. This association is more evident in subjects with high genetic predisposition to obesity. ClinicalTrials.gov: registered Clinical Trial NCT04514588.
C1 [Gkouskou, Kalliopi G.; Vlastos, Ioannis; Lazou, Evgenia; Eliopoulos, Aristides G.] Natl & Kapodistrian Univ Athens, Sch Med, Dept Biol, Athens, Greece.
   [Gkouskou, Kalliopi G.] Embiodiagnost Biol Res Co, Iraklion, Greece.
   [Georgiopoulos, Georgios] Kings Coll London, Sch Biomed Engn & Imaging Sci, St Thomas Hosp, London, England.
   [Chaniotis, Dimitrios] Univ West Attica, Dept Biomed Sci, Athens, Greece.
   [Papaioannou, Theodore G.] Natl & Kapodistrian Univ Athens, Hippokrat Hosp, Sch Med, Dept Cardiol 1,Biomed Engn Unit, Athens, Greece.
   [Mantzoros, Christos S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
   [Sanoudou, Despina] Natl & Kapodistrian Univ Athens, Sch Med, Dept Internal Med 4, Clin Genom & Pharmacogen Unit, Athens, Greece.
   [Sanoudou, Despina; Eliopoulos, Aristides G.] Natl & Kapodistrian Univ Athens, Ctr New Biotechnol & Precis Med, Sch Med, Athens, Greece.
   [Sanoudou, Despina; Eliopoulos, Aristides G.] Acad Athens, Ctr Basic Res, Biomed Res Fdn, Athens, Greece.
C3 Athens Medical School; National & Kapodistrian University of Athens;
   Guy's & St Thomas' NHS Foundation Trust; University of London; King's
   College London; University of West Attica; National & Kapodistrian
   University of Athens; Hippokration General Hospital; Athens Medical
   School; Harvard University; Harvard University Medical Affiliates; Beth
   Israel Deaconess Medical Center; Harvard Medical School; Athens Medical
   School; National & Kapodistrian University of Athens; National &
   Kapodistrian University of Athens; Athens Medical School; Academy of
   Athens
RP Gkouskou, KG; Eliopoulos, AG (corresponding author), Natl & Kapodistrian Univ Athens, Sch Med, Dept Biol, Athens, Greece.; Gkouskou, KG (corresponding author), Embiodiagnost Biol Res Co, Iraklion, Greece.; Eliopoulos, AG (corresponding author), Natl & Kapodistrian Univ Athens, Ctr New Biotechnol & Precis Med, Sch Med, Athens, Greece.; Eliopoulos, AG (corresponding author), Acad Athens, Ctr Basic Res, Biomed Res Fdn, Athens, Greece.
EM gkouskoukal@med.uoa.gr; eliopag@med.uoa.gr
RI GEORGIOPOULOS, GEORGIOS/AAH-7442-2020; ELIOPOULOS,
   ARISTIDES/R-9449-2018; Sanoudou, Despina/AAD-8139-2019; Mantzoros,
   Christos/Y-2902-2019
OI Lazou, Evgenia/0000-0002-4160-9854; GEORGIOPOULOS,
   GEORGIOS/0000-0001-7661-5253; vlastos, ioannis/0000-0002-2741-5877
CR Bray GA, 2019, CURR OBES REP, V8, P262, DOI 10.1007/s13679-019-00353-1
   Charakida M, 2019, EUR HEART J, V40, P345, DOI 10.1093/eurheartj/ehy524
   Chrysafi P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18885-9
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Ding M, 2018, AM J CLIN NUTR, V108, P1291, DOI 10.1093/ajcn/nqy203
   Dobrinas M, 2011, CLIN PHARMACOL THER, V90, P117, DOI 10.1038/clpt.2011.70
   Du C, 2021, SUPPORT CARE CANCER, V29, P1369, DOI 10.1007/s00520-020-05621-8
   Duerrschmid C, 2017, NAT MED, V23, P1444, DOI 10.1038/nm.4432
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Gkouskou K, 2020, ADV NUTR, V11, P1405, DOI 10.1093/advances/nmaa089
   Go AS, 2013, CIRCULATION, V127, P143, DOI [10.1161/CIR.0b013e318282ab8f, 10.1161/CIR.0000000000000366]
   Huntley ED, 2012, PSYCHOL ASSESSMENT, V24, P592, DOI 10.1037/a0026417
   Irons Jessica G., 2016, Journal of Caffeine Research, V6, P20, DOI 10.1089/jcr.2015.0012
   Khera AV, 2019, CELL, V177, P587, DOI 10.1016/j.cell.2019.03.028
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Liu HY, 2019, INT J OBESITY, V43, P23, DOI 10.1038/s41366-018-0056-7
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Masi S, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1059-x
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Riveros-McKay F, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007603
   Romere C, 2016, CELL, V165, P566, DOI 10.1016/j.cell.2016.02.063
   S S, 1996, STAT ANAL EPIDEMIOLO
   Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748
   Schubert MM, 2017, INT J FOOD SCI NUTR, V68, P901, DOI 10.1080/09637486.2017.1320537
   Schubert MM, 2014, APPETITE, V83, P317, DOI 10.1016/j.appet.2014.09.006
   Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686
   Stamatelopoulos K, 2019, CIRC RES, V125, P744, DOI 10.1161/CIRCRESAHA.119.314862
   Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153
   Tews D, 2013, ENDOCRINOLOGY, V154, P3141, DOI 10.1210/en.2012-1873
   Thorn CF, 2012, PHARMACOGENET GENOM, V22, P389, DOI 10.1097/FPC.0b013e3283505d5e
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Walter S, 2016, JAMA-J AM MED ASSOC, V316, P63, DOI 10.1001/jama.2016.8729
   Wang CY, 2019, INT J OBESITY, V43, P1019, DOI 10.1038/s41366-018-0248-1
   Wang TG, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0862-0
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   Yen JY, 2018, APPETITE, V125, P18, DOI 10.1016/j.appet.2018.01.029
NR 38
TC 15
Z9 15
U1 3
U2 7
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD JAN
PY 2022
VL 46
IS 1
BP 162
EP 168
DI 10.1038/s41366-021-00972-6
EA SEP 2021
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA YE3GJ
UT WOS:000700557900002
PM 34564706
DA 2025-04-28
ER

PT J
AU James, JE
AF James, Jack E.
TI Maternal caffeine consumption and pregnancy outcomes: a narrative review
   with implications for advice to mothers and mothers-to-be
SO BMJ EVIDENCE-BASED MEDICINE
LA English
DT Review
DE behavioral medicine; child health; policy; substance-related disorders;
   women&apos; s health
ID FOR-GESTATIONAL-AGE; BIRTH-WEIGHT; DOSE-RESPONSE; CHILDHOOD LEUKEMIA;
   PRETERM BIRTH; WITHDRAWAL SYMPTOMS; COFFEE CONSUMPTION; PARENTAL
   SMOKING; BEVERAGE INTAKE; HEALTHY-ADULTS
AB Objectives
   Caffeine is a habit-forming substance consumed daily by the majority of pregnant women. Accordingly, it is important that women receive sound evidence-based advice about potential caffeine-related harm. This narrative review examines evidence of association between maternal caffeine consumption and negative pregnancy outcomes, and assesses whether current health advice concerning maternal caffeine consumption is soundly based.
   Methods
   Database searches using terms linking caffeine and caffeinated beverages to pregnancy outcomes identified 1261 English language peer-reviewed articles. Screening yielded a total of 48 original observational studies and meta-analyses of maternal caffeine consumption published in the past two decades. The articles reported results for one or more of six major categories of negative pregnancy outcomes: miscarriage, stillbirth, low birth weight and/or small for gestational age, preterm birth, childhood acute leukaemia, and childhood overweight and obesity.
   Results
   Of 42 separate sets of findings reported in 37 observational studies, 32 indicated significantly increased caffeine-related risk and 10 suggested no or inconclusive associations. Caffeine-related increased risk was reported with moderate to high levels of consistency for all pregnancy outcomes except preterm birth. Of 11 studies reporting 17 meta-analyses, there was unanimity among 14 analyses in finding maternal caffeine consumption to be associated with increased risk for the four outcome categories of miscarriage, stillbirth, low birth weight and/or small for gestational age, and childhood acute leukaemia. The three remaining meta-analyses were also unanimous in reporting absence of a reliable association between maternal caffeine consumption and preterm birth. No meta-analyses were identified for childhood overweight and obesity, although four of five original observational studies reported significant associations linking maternal caffeine consumption to that outcome category.
   Conclusions
   The substantial majority finding from observational studies and meta-analyses is that maternal caffeine consumption is reliably associated with major negative pregnancy outcomes. Reported findings were robust to threats from potential confounding and misclassification. Among both observational studies and meta-analyses, there were frequent reports of significant dose-response associations suggestive of causation, and frequent reports of no threshold of consumption below which associations were absent. Consequently, current evidence does not support health advice that assumes 'moderate' caffeine consumption during pregnancy is safe. On the contrary, the cumulative scientific evidence supports pregnant women and women contemplating pregnancy being advised to avoid caffeine.
C1 [James, Jack E.] Reykjavik Univ, Psychol, IS-101 Reykjavik, Iceland.
C3 Reykjavik University
RP James, JE (corresponding author), Reykjavik Univ, Psychol, IS-101 Reykjavik, Iceland.
EM jack@ru.is
OI James, Jack/0000-0003-3918-062X
CR ALDRIDGE A, 1981, SEMIN PERINATOL, V5, P310
   American College of Obstetricians and Gynecologists, 2016, COMM OP MOD CAFF CON
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   [Anonymous], National Accuracy Clearinghouse (NAC) Evaluation: Final Report
   Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Bech BH, 2007, BMJ-BRIT MED J, V334, P409, DOI 10.1136/bmj.39062.520648.BE
   Bech BH, 2006, INT J EPIDEMIOL, V35, P948, DOI 10.1093/ije/dyl116
   Bech Bodil Hammer, 2015, Journal of Caffeine Research, V5, P65, DOI 10.1089/jcr.2015.0001
   Bonaventure A, 2013, CANCER CAUSE CONTROL, V24, P783, DOI 10.1007/s10552-013-0161-9
   Boylan SM, 2013, MATERN CHILD HLTH J, V17, P601, DOI 10.1007/s10995-012-1034-7
   Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332
   Bracken MB, 2003, AM J EPIDEMIOL, V157, P456, DOI 10.1093/aje/kwf220
   BRAZIER JL, 1981, SEMIN PERINATOL, V5, P315
   Buscariollo DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087547
   CARTER AJ, 1995, J PHARMACOL EXP THER, V273, P637
   Chen LW, 2019, AM J CLIN NUTR, V109, P1648, DOI 10.1093/ajcn/nqz019
   Chen LW, 2018, AM J CLIN NUTR, V108, P1301, DOI 10.1093/ajcn/nqy219
   Chen LW, 2016, PUBLIC HEALTH NUTR, V19, P1233, DOI 10.1017/S1368980015002463
   Chen LW, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0174-6
   Cheng J, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.026
   Chiaffarino F, 2006, EUR J CLIN NUTR, V60, P610, DOI 10.1038/sj.ejcn.1602358
   Clausson B, 2002, AM J EPIDEMIOL, V155, P429, DOI 10.1093/aje/155.5.429
   Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503
   Curtin SallyC., 2013, Pregnancy Rates for U.S. Women Continue to Drop
   Darakjian LI, 2019, MOL PHARMACEUT, V16, P1340, DOI 10.1021/acs.molpharmaceut.8b01276
   Demortain D., 2018, PERV POW CORP AUTH P
   DK L, 2015, INT J OBESITY, V39, P658
   Doepker C, 2016, ANNU REV FOOD SCI T, V7, P117, DOI 10.1146/annurev-food-041715-033243
   Doepker C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101536
   DUMAS M, 1982, DEV PHARMACOL THERAP, V4, P182, DOI 10.1159/000457375
   DUNLOP M, 1981, BIOL NEONATE, V39, P178
   Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31
   EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4552
   Ewing AC, 2017, MATERN CHILD HLTH J, V21, P786, DOI 10.1007/s10995-016-2165-z
   dos Santos MKF, 2018, N-S ARCH PHARMACOL, V391, P1301, DOI 10.1007/s00210-018-1570-9
   Fernandes O, 1998, REPROD TOXICOL, V12, P435, DOI 10.1016/S0890-6238(98)00024-0
   Ferré S, 2016, PSYCHOPHARMACOLOGY, V233, P1963, DOI 10.1007/s00213-016-4212-2
   FRANCHETTI P, 1994, J MED CHEM, V37, P2970, DOI 10.1021/jm00044a018
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   FUJII T, 1972, TOXICOL APPL PHARM, V22, P449, DOI 10.1016/0041-008X(72)90252-9
   Fulgoni VL, 2015, AM J CLIN NUTR, V101, P1081, DOI 10.3945/ajcn.113.080077
   Galéra C, 2016, BIOL PSYCHIAT, V80, P720, DOI 10.1016/j.biopsych.2015.08.034
   GARRETT BE, 1994, PHARMACOL BIOCHEM BE, V47, P89, DOI 10.1016/0091-3057(94)90115-5
   Gaskins AJ, 2018, EUR J NUTR, V57, P107, DOI 10.1007/s00394-016-1301-2
   Giannelli M, 2003, PAEDIATR PERINAT EP, V17, P316, DOI 10.1046/j.1365-3016.2003.00523.x
   GILBERT EF, 1973, J REPROD FERTIL, V34, P495, DOI 10.1530/jrf.0.0340495
   Goyan J., 1980, FOOD DRUG ADM NEWS R, pP80
   Greenhalgh S, 2019, PERSPECT BIOL MED, V62, P131, DOI 10.1353/pbm.2019.0007
   Greenhalgh S, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5050
   Greenwood DC, 2014, EUR J EPIDEMIOL, V29, P725, DOI 10.1007/s10654-014-9944-x
   Greenwood DC, 2010, EUR J EPIDEMIOL, V25, P275, DOI 10.1007/s10654-010-9443-7
   Grimm H.-U., 2016, INT FOOD LAW POLICY, P3
   HADEED A, 1993, CLIN PEDIATR, V32, P45, DOI 10.1177/000992289303200108
   HORNING MG, 1975, LIFE SCI, V16, P651, DOI 10.1016/0024-3205(75)90343-4
   Hoyert Donna L, 2016, Natl Vital Stat Rep, V65, P1
   Hoyt AT, 2014, MATERN CHILD HLTH J, V18, P1540, DOI 10.1007/s10995-013-1397-4
   Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972
   Jahanfar S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006965.pub4
   James J., 1997, UNDERSTANDING CAFFEI
   James J E, 1985, Rev Environ Health, V5, P151
   James J.E., 1991, CAFFEINE HLTH
   James JE, 1998, NEUROPSYCHOBIOLOGY, V38, P32, DOI 10.1159/000026514
   JAMES JE, 1994, ADDICTION, V89, P1595, DOI 10.1111/j.1360-0443.1994.tb03760.x
   James JE, 2002, ADDICTION, V97, P1251, DOI 10.1046/j.1360-0443.2002.00146.x
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   Karalexi MA, 2019, CANCER EPIDEMIOL, V62, DOI 10.1016/j.canep.2019.101581
   Khoury J C, 2004, J Matern Fetal Neonatal Med, V15, P44, DOI 10.1080/14767050310001650716
   KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8
   Klebanoff MA, 2002, AM J EPIDEMIOL, V155, P32, DOI 10.1093/aje/155.1.32
   Klebanoff MA, 2015, EPIDEMIOLOGY, V26, P185, DOI 10.1097/EDE.0000000000000220
   KNUTTI R, 1981, EUR J CLIN PHARMACOL, V21, P121, DOI 10.1007/BF00637512
   Kobayashi S, 2019, PAEDIATR PERINAT EP, V33, P185, DOI 10.1111/ppe.12551
   Lane JD, 2002, PSYCHOSOM MED, V64, P595, DOI 10.1097/01.PSY.0000021946.90613.DB
   LEBLANC J, 1994, CAN J PHYSIOL PHARM, V72, P113, DOI 10.1139/y94-018
   Lehtonen A, 2021, EUR J NUTR, V60, P193, DOI 10.1007/s00394-020-02231-2
   Leviton A, 2002, FOOD CHEM TOXICOL, V40, P1271, DOI 10.1016/S0278-6915(02)00092-3
   LEVITON A, 1988, J REPROD MED, V33, P175
   LEVITON A, 1984, CAFFEINE PERSPECTIVE, P188
   Leviton A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091152
   Li J, 2015, INT J GYNECOL OBSTET, V130, P116, DOI 10.1016/j.ijgo.2015.03.033
   Li J, 2015, TOXICOL APPL PHARM, V284, P345, DOI 10.1016/j.taap.2015.03.002
   LIEBERMAN HR, 1987, PSYCHOPHARMACOLOGY, V92, P308, DOI 10.1007/BF00210835
   MacDonald R, 2001, BRIT MED J, V322, P576, DOI 10.1136/bmj.322.7286.576
   Martin J.A., 2017, BIRTHS FINAL DATA 20, V66
   Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1
   Maslova E, 2010, AM J CLIN NUTR, V92, P1120, DOI 10.3945/ajcn.2010.29789
   Matijasevich A, 2006, PAEDIATR PERINAT EP, V20, P100, DOI 10.1111/j.1365-3016.2006.00706.x
   McCoy GM., 2019, MED HLTH SCI COMMONS
   MCGOWAN JD, 1988, SOUTH MED J, V81, P1092, DOI 10.1097/00007611-198809000-00006
   Menegaux F, 2007, PAEDIATR PERINAT EP, V21, P293, DOI 10.1111/j.1365-3016.2007.00824.x
   MEYER LC, 1994, PAEDIATR PERINAT EP, V8, P145, DOI 10.1111/j.1365-3016.1994.tb00445.x
   Milne E, 2018, CANCER CAUSE CONTROL, V29, P539, DOI 10.1007/s10552-018-1024-1
   Milne E, 2011, CANCER CAUSE CONTROL, V22, P207, DOI 10.1007/s10552-010-9688-1
   Modzelewska D, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2215-9
   National Health Service, 2018, SHOULD I LIM CAFF PR
   Okubo H, 2015, NUTR RES, V35, P309, DOI 10.1016/j.nutres.2015.02.009
   Orsi L, 2015, CANCER CAUSE CONTROL, V26, P1003, DOI 10.1007/s10552-015-0593-5
   Papadopoulou E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018895
   PARSONS WD, 1981, J PEDIATR-US, V98, P640, DOI 10.1016/S0022-3476(81)80784-6
   PEARLMAN SA, 1989, DEV PHARMACOL THERAP, V12, P65, DOI 10.1159/000480966
   Peck JD, 2010, FOOD CHEM TOXICOL, V48, P2549, DOI 10.1016/j.fct.2010.06.019
   Pendergrast Mark., 1999, UNCOMMON GROUNDS HIS
   PhillipsBute BG, 1997, PHYSIOL BEHAV, V63, P35, DOI 10.1016/S0031-9384(97)00384-3
   Purdue-Smithe AC, 2019, FERTIL STERIL, V112, pE27, DOI 10.1016/j.fertnstert.2019.07.203
   RALL T W, 1990, P618
   RESCH BA, 1983, AM J OBSTET GYNECOL, V146, P231, DOI 10.1016/0002-9378(83)91070-0
   Rhee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132334
   Rivkees SA, 2011, PEDIATR RES, V69, P271, DOI 10.1203/PDR.0b013e31820efbcf
   Santos I S, 1998, Cad Saude Publica, V14, P523, DOI 10.1590/S0102-311X1998000300009
   Sapra Katherine J, 2017, Reprod Sci, V24, P502, DOI 10.1177/1933719116654994
   Sasaki S, 2017, PEDIATR RES, V82, P19, DOI 10.1038/pr.2017.70
   Savitz DA, 2008, EPIDEMIOLOGY, V19, P55, DOI 10.1097/EDE.0b013e31815c09b9
   Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42
   Shrestha B, 2017, PEDIATR NEONATOL, V58, P391, DOI 10.1016/j.pedneo.2016.10.003
   Smit HJ, 2000, PSYCHOPHARMACOLOGY, V152, P167, DOI 10.1007/s002130000506
   SOMANI SM, 1988, INT J CLIN PHARM TH, V26, P521
   Stefanidou EM, 2011, EUR J OBSTET GYN R B, V158, P220, DOI 10.1016/j.ejogrb.2011.04.024
   Stein Z, 1991, Epidemiology, V2, P163
   Strassheim H., 2019, Behavioural policies for health promotion and disease prevention, P73
   THAYER PS, 1973, TOXICOL APPL PHARM, V25, P169, DOI 10.1016/S0041-008X(73)80003-1
   Thomopoulos TP, 2015, CANCER EPIDEMIOL, V39, P1047, DOI 10.1016/j.canep.2015.08.009
   US Food and Drug Administration (FDA), 2024, Spilling the beans: How much caffeine is too much?
   VANTHOFF W, 1982, LANCET, V1, P1020
   Voerman E, 2016, OBESITY, V24, P1170, DOI 10.1002/oby.21466
   Wen WQ, 2001, EPIDEMIOLOGY, V12, P38, DOI 10.1097/00001648-200101000-00008
   Weng XP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.803
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Wisborg K, 2003, BRIT MED J, V326, P420, DOI 10.1136/bmj.326.7386.420
   Wu YM, 2015, TOXICOL APPL PHARM, V289, P109, DOI 10.1016/j.taap.2015.09.007
   Xu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044497
   Yu T, 2016, J CLIN PHARMACOL, V56, P590, DOI 10.1002/jcph.632
   Zeltner Thomas., 2000, Tobacco Company Strategies to Undermine Tobacco Contorl Activities at the World Health Organization: A Report of the Committee of Experts on Tobacco Industry Documents
NR 132
TC 44
Z9 45
U1 1
U2 17
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2515-446X
EI 2515-4478
J9 BMJ EVID-BASED MED
JI BMJ Evid.-Based Med.
PD JUN
PY 2021
VL 26
IS 3
BP 114
EP +
DI 10.1136/bmjebm-2020-111432
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA SK8QI
UT WOS:000656481900015
PM 32843532
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Greenberg, JA
   Axen, KV
   Schnoll, R
   Boozer, CN
AF Greenberg, JA
   Axen, KV
   Schnoll, R
   Boozer, CN
TI Coffee, tea and diabetes: the role of weight loss and caffeine
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE coffee; tea; beverages; caffeine; diabetes risk; weight loss
ID GLUCOSE-TOLERANCE; CONSUMPTION; RISK; MEN; MELLITUS; OBESE
AB OBJECTIVE: To assess the effect of weight change on the relationship between coffee and tea consumption and diabetes risk. DESIGN: Prospective cohort study, using data from the First National Health and Nutrition Examination Survey Epidemiologic Follow Up Study. Survival analyses were conducted using 301 selfreported cases of diabetes and eight documented diabetes deaths during an 8.4-y follow-up.
   SUBJECTS: A total of 7006 subjects aged 32-88 y with no reported history of diabetes were included in the study.
   RESULTS: For all subjects combined, increases in consumption of ground-caffeinated coffee and caffeine at baseline were followed by decreases in diabetes risk during follow-up. There were significant statistical interactions between age and consumption of caffeine (P = 0.02) and ground-caffeinated coffee (P = 0.03). Age-stratified analysis showed that the decrease in diabetes risk only applied to <= 60-y-old subjects, for whom the decrease in diabetes risk also obtained for ground-decaffeinated coffee and regular tea. The multivariate hazard ratio (HR) and 95% confidence interval for a 2 cups/day increment in the intake of ground-caffeinated coffee, ground-decaffeinated coffee and regular tea was 0.86 (0.75-0.99), 0.58 (0.34-0.99) and 0.77 (0.59-1.00), respectively. The diabetes risk was negatively related to the consumption in a dose-response manner. There were strong statistical interactions between prior weight change and beverage consumption for <= 60-y-old subjects. Further analysis revealed that the decrease in diabetes risk only applied to those who had lost weight, and that there was a positive dose response relationship between diabetes risk and weight change. For example, the multivariate HR and 95% confidence interval for 40 vs 0 cups/day of ground-decaffeinated coffee was 0.17 (0.04-0.74), 0.52 (0.19-1.42), 0.77 (0.30-1.96) and 0.91 (0.39-2.14)for subgroups with weight change of <= 0, 0-10, 10-20 and > 20 lbs, respectively. There was no significant association between diabetes risk and consumption of instant-caffeinated coffee, instant-decaffeinated coffee or herbal tea. Caffeine intake appeared to explain some, but not all, of the diabetes-risk reduction and weight change.
   CONCLUSION: The negative relationship between diabetes risk and consumption of ground coffee and regular tea, observed for all NHEFS subjects, actually only applied to nonelderly adults who had previously lost weight.
C1 CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, Brooklyn, NY 11210 USA.
   St Lukes Roosevelt Hosp, New York Obes Res Ctr, Energy Metab Core Lab, Bronx, NY USA.
   Columbia Univ, Ctr Med, Inst Human Nutr, Dept Med, New York, NY USA.
C3 City University of New York (CUNY) System; Brooklyn College (CUNY);
   Mount Sinai West; Mount Sinai St. Luke's; Columbia University
RP CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, 2900 Bedford Ave, Brooklyn, NY 11210 USA.
EM jamesg@brooklyn.cuny.edu
CR Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   Arciero PJ, 2000, METABOLISM, V49, P101, DOI 10.1016/S0026-0495(00)90888-6
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI [10.1001/jama.291.10.1199-b, 10.1001/jama.291.10.1199-a]
   ASTRUP A, 1993, INT J OBESITY, V17, pS41
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   *BUNK MCW, 1979, 8 USDA
   COX DR, 1972, J R STAT SOC B, V34, P187
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Greenberg JA, 2001, INT J OBESITY, V25, P1071, DOI 10.1038/sj.ijo.0801648
   HARRIS MI, 1998, DIABETES CARE, V21, P475
   HILLAR P, 1973, VITAL HLTH STAT SER, V1
   Isogawa A, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12586-X
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   KATZEL LI, 1995, JAMA-J AM MED ASSOC, V274, P1915, DOI 10.1001/jama.274.24.1915
   *NAT COFF ASS, 2000, COFF DRINK TRENDS SU
   *NAT CTR HLTH STAT, 1987, VITAL HLTH STAT SER, V1
   Reunanen A, 2003, LANCET, V361, P702, DOI 10.1016/S0140-6736(03)12583-4
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Saremi A, 2003, DIABETES CARE, V26, P2211, DOI 10.2337/diacare.26.7.2211
   *SPSS INC, 1997, ADV STAT 7 5, P285
   Tabachnick B.G., 1996, Using mutivariate statistics
   *TEA ASS US INC, 2004, TEA FACT SHEET
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   *USDA, 1967, AGR HDB REV COMP FOO
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008
NR 27
TC 132
Z9 145
U1 1
U2 60
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD SEP
PY 2005
VL 29
IS 9
BP 1121
EP 1129
DI 10.1038/sj.ijo.0802999
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 954CC
UT WOS:000231130700014
PM 15925959
DA 2025-04-28
ER

PT J
AU Kim, Y
   Je, Y
AF Kim, Youngyo
   Je, Youjin
TI Moderate coffee consumption is inversely associated with the metabolic
   syndrome in the Korean adult population
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Coffee; Metabolic syndrome; Korean adults; Obesity
ID NUTRITION EXAMINATION SURVEY; NONALCOHOLIC FATTY LIVER; NATIONAL-HEALTH;
   CARDIOVASCULAR-DISEASE; CHLOROGENIC ACID; RISK; METAANALYSIS;
   PREVALENCE; MORTALITY; PATTERNS
AB Results from studies investigating the association between coffee consumption and the metabolic syndrome in Koreans have been inconsistent and remain controversial. We examined coffee intake in relation to the metabolic syndrome using data from the. Korea National Health and Nutrition Examination Survey 2012-2015, with 8387 adults aged 19-64 years. Furthermore, we conducted a stratified analysis by obesity status (BMI <25 v. >= 25 kg/m(2)) to examine whether the association varied by obesity status. A 112-item FFQ was used to assess diet. Multivariable logistic regression models were used to determine the association of coffee consumption (<1, 1-2, 3-4 and >= 5 times/d) and the metabolic syndrome. Compared to people who consumed <1 time/d of coffee, the OR for the metabolic syndrome in those who consumed 3-4 times/d of coffee was 0.75 (95% CI 0.58, 0.97). However, >= 5 times/d of coffee consumption was not significantly associated with the metabolic syndrome. By obesity status, in non-obese people, those consuming more coffee had lower odds of the metabolic syndrome, showing a significant linear trend (P-trend =0.0248). In obese people, the OR for the metabolic syndrome in people with 3-4 times/d of coffee consumption v. <1 time/d was 0.68 (95% CI 0.50, 0.93), but >= 5 times/d of coffee consumption showed a non-significant positive association. Our findings suggest that moderate coffee consumption of 3-4 times/d is inversely associated with the metabolic syndrome in Korean adults. The association between heavy coffee consumption of >= 5 times/d and the metabolic syndrome varied by obesity status.
C1 [Kim, Youngyo; Je, Youjin] Kyung Hee Univ, Dept Food & Nutr, 26 Kyunghee Daero, Seoul 02447, South Korea.
C3 Kyung Hee University
RP Je, Y (corresponding author), Kyung Hee Univ, Dept Food & Nutr, 26 Kyunghee Daero, Seoul 02447, South Korea.
EM youjinje@khu.ac.kr
RI Je, Youjin/N-2822-2018
OI Je, Youjin/0000-0002-2099-4204
FU National Research Foundation of Korea - Ministry of Science, ICT and
   Future Planning [NRF-2015R1A1A1A05001362]; Ministry of Education
   [NRF-2017R1A6A3A01075728]
FX This work was supported by the Basic Science Research Program through
   the National Research Foundation of Korea, funded by the Ministry of
   Science, ICT and Future Planning (NRF-2015R1A1A1A05001362) and by the
   Ministry of Education (NRF-2017R1A6A3A01075728). Funders had no role in
   the study design, data collection and analysis, decision to publish or
   preparation of the manuscript.
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   [Anonymous], 2017, KOR HLTH STAT 2016 K
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Baik I, 2013, NUTR RES PRACT, V7, P233, DOI 10.4162/nrp.2013.7.3.233
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336
   Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11
   Je Y, 2014, BRIT J NUTR, V111, P1162, DOI 10.1017/S0007114513003814
   Kim DW, 2015, PUBLIC HEALTH NUTR, V18, P1369, DOI 10.1017/S1368980014001712
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim KY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168413
   Kim Y, 2016, DIABETIC MED, V33, P428, DOI 10.1111/dme.12970
   Kim Y, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040390
   Kolovou GD, 2007, AM J MED SCI, V333, P362, DOI 10.1097/MAJ.0b013e318065c3a1
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Lee HH, 2013, EUR J CLIN NUTR, V67, P83, DOI 10.1038/ejcn.2012.181
   Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109
   Lin TK, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0344-y
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Mancini A, 2015, MOLECULES, V20, P17339, DOI 10.3390/molecules200917339
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Narain A, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12927
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Shin H, 2017, KOREAN J FAM MED, V38, P346, DOI 10.4082/kjfm.2017.38.6.346
   Shin HJ, 2014, J NUTR, V144, P1247, DOI 10.3945/jn.113.188441
   Siervo M, 2014, PUBLIC HEALTH NUTR, V17, P587, DOI 10.1017/S1368980013000141
   Suzuki A, 2007, AM J HYPERTENS, V20, P508, DOI 10.1016/j.amjhyper.2006.11.008
   USDA Foreign Agricultural Service, 2015, COFF MARK BRIEF UPD
   Wang JW, 2013, PEDIATR OBES, V8, P284, DOI 10.1111/j.2047-6310.2012.00108.x
   Wang JW, 2014, J NUTR, V144, P81, DOI 10.3945/jn.113.182519
   Welsh JA, 2011, CIRCULATION, V123, P249, DOI 10.1161/CIRCULATIONAHA.110.972166
   Yesil A, 2013, ALIMENT PHARM THER, V38, P1038, DOI 10.1111/apt.12489
NR 40
TC 23
Z9 23
U1 0
U2 12
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD DEC 14
PY 2018
VL 120
IS 11
BP 1279
EP 1287
DI 10.1017/S0007114518002635
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HC3JY
UT WOS:000451699500008
PM 30311595
OA Bronze
DA 2025-04-28
ER

PT J
AU Qu, YM
   Xu, W
   Guo, SJ
   Wu, H
AF Qu, Yangming
   Xu, Wei
   Guo, Shijie
   Wu, Hui
TI Association of sociodemographic and lifestyle factors and dietary intake
   with overweight and obesity among US children: findings from NHANES
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Child; Overweight; Obesity; Dietary intake
ID CHILDHOOD OBESITY; VITAMIN-A; MOLECULAR-MECHANISMS; MEXICAN-AMERICAN;
   ADOLESCENTS; PREVALENCE; SUPPLEMENTATION; ADIPOSITY; QUALITY; IMPACT
AB Childhood overweight/obesity is a serious problem that has not been adequately addressed. As a key factor affecting weight gain, the association between dietary intake with childhood overweight and obesity is still unclear. The objective of this study was to analyze the association between sociodemographic, lifestyle factors and dietary intake with overweight or obesity. We used data from a large cross-sectional National Health and Nutrition Examination Survey (NHANES). The U.S. children aged 6-15 years with both weight data and dietary data were included. For univariate analysis of sociodemographic data, t tests was performed for continuous variables and chi-square tests was performed for discrete variables. Dietary intakes were described by median and quartile, and differences in dietary intake between children with normal weight and children with overweight or obesity were compared by rank sum tests. A modern statistical shrinkage technique, LASSO regression was used to examine the association between dietary intake and childhood obesity. Our study confirms that Hispanic ethnicity, increasing age, passive exposure to smoking, higher protein intake, and higher caffeine intake were positively associated with child overweight or obesity. Additionally, non-Hispanic White race, higher physical activity levels, higher household income, and higher vitamin A intake were negatively associated with child overweight or obesity.
C1 [Qu, Yangming; Xu, Wei; Guo, Shijie; Wu, Hui] First Hosp Jilin Univ, Dept Neonatol, 1 Xinmin St, Changchun 130021, Jilin, Peoples R China.
   [Qu, Yangming] Jilin Univ, Sch Publ Hlth, Changchun, Peoples R China.
C3 Jilin University; Jilin University
RP Wu, H (corresponding author), First Hosp Jilin Univ, Dept Neonatol, 1 Xinmin St, Changchun 130021, Jilin, Peoples R China.
EM wuhui@jlu.edu.cn
RI Wu, Hui/IUQ-0848-2023
CR Aeberli I, 2009, INT J OBESITY, V33, P1111, DOI 10.1038/ijo.2009.146
   Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   [Anonymous], 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19430
   Astrup A, 2015, INT J OBESITY, V39, P721, DOI 10.1038/ijo.2014.216
   Barrea L, 2023, CRIT REV FOOD SCI, V63, P1238, DOI 10.1080/10408398.2021.1963207
   Bradley Morgan, 2023, Obes Pillars, V8, P100087, DOI 10.1016/j.obpill.2023.100087
   Chen LW, 2019, AM J CLIN NUTR, V109, P1648, DOI 10.1093/ajcn/nqz019
   Dabas A, 2018, INDIAN J PEDIATR, V85, P546, DOI 10.1007/s12098-018-2636-x
   Davidson LM, 2015, HUM FERTIL, V18, P184, DOI 10.3109/14647273.2015.1070438
   Duan RA, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.747088
   Eagle TF, 2012, AM HEART J, V163, P836, DOI 10.1016/j.ahj.2012.02.025
   FLEGAL KM, 1993, CRIT REV FOOD SCI, V33, P307, DOI 10.1080/10408399309527625
   García OP, 2009, NUTR REV, V67, P559, DOI 10.1111/j.1753-4887.2009.00228.x
   Grow HMG, 2010, SOC SCI MED, V71, P584, DOI 10.1016/j.socscimed.2010.04.018
   Gunanti IR, 2014, J NUTR, V144, P489, DOI 10.3945/jn.113.183137
   Hay WW, 2014, WORLD REV NUTR DIET, V110, P64, DOI 10.1159/000358459
   Hernández-Valero MA, 2012, J IMMIGR MINOR HEALT, V14, P517, DOI 10.1007/s10903-011-9535-9
   Huang D, 2023, J NUTR SCI VITAMINOL, V69, P157, DOI 10.3177/jnsv.69.157
   Huang JY, 2015, WORLD J PEDIATR, V11, P101, DOI 10.1007/s12519-015-0018-2
   Kim H, 2016, J AM MED DIR ASSOC, V17, P1011, DOI 10.1016/j.jamda.2016.06.016
   Lee EY, 2018, FRONT MED-PRC, V12, P658, DOI 10.1007/s11684-018-0640-1
   Lepe M, 2011, NUTR HOSP, V26, P1256, DOI [10.1590/S0212-16112011000600010, 10.3305/nh.2011.26.6.5353]
   Lin Q, 2019, J AM STAT ASSOC, V114, P1726, DOI 10.1080/01621459.2018.1520115
   Malandrino N, 2023, ENDOCRIN METAB CLIN, V52, P317, DOI 10.1016/j.ecl.2022.10.001
   Moore BF, 2016, ENVIRON HEALTH PERSP, V124, P1316, DOI 10.1289/ehp.1510138
   Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Ogden CL, 2018, JAMA-J AM MED ASSOC, V319, P2410, DOI 10.1001/jama.2018.5158
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI [10.1001/jama.2012.39, 10.1001/jama.2012.40]
   Owens J, 2014, PEDIATRICS, V134, pE921, DOI 10.1542/peds.2014-1696
   Roberge JB, 2019, J PEDIATR-US, V204, P46, DOI 10.1016/j.jpeds.2018.08.063
   Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813
   Smith JD, 2015, AM J CLIN NUTR, V101, P1216, DOI 10.3945/ajcn.114.100867
   Tang WF, 2022, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.816975
   Tian T, 2022, NUTRIENTS, V14
   Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840
   Tziomalos K, 2004, CLIN ENDOCRINOL, V61, P664, DOI 10.1111/j.1365-2265.2004.02161.x
   Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005
   Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355
   Vrijheid Martine, 2020, Environ Health Perspect, V128, P67009, DOI 10.1289/EHP5975
   Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007
   Wei XP, 2016, ASIA PAC J CLIN NUTR, V25, P563, DOI 10.6133/apjcn.092015.03
   Wright SM, 2012, ABDOM IMAGING, V37, P730, DOI 10.1007/s00261-012-9862-x
   Xu SM, 2016, EXP THER MED, V11, P1545, DOI 10.3892/etm.2016.3137
   Youn JY, 2014, DIABETES, V63, P2344, DOI 10.2337/db13-0719
   Yu LL, 2022, ENVIRON SCI POLLUT R, V29, P57618, DOI 10.1007/s11356-022-19836-1
   Zhang JG, 2015, BRIT J NUTR, V113, P1978, DOI 10.1017/S0007114515001154
NR 47
TC 0
Z9 0
U1 6
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD AUG 12
PY 2024
VL 24
IS 1
AR 2176
DI 10.1186/s12889-024-19637-w
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA C5W7R
UT WOS:001290076900005
PM 39135163
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Buscemi, S
   Verga, S
   Batsis, JA
   Donatelli, M
   Tranchina, MR
   Belmonte, S
   Mattina, A
   Re, A
   Cerasola, G
AF Buscemi, S.
   Verga, S.
   Batsis, J. A.
   Donatelli, M.
   Tranchina, M. R.
   Belmonte, S.
   Mattina, A.
   Re, A.
   Cerasola, G.
TI Acute effects of coffee on endothelial function in healthy subjects
SO EUROPEAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE coffee; endothelial function; FMD; insulin
ID CORONARY-ARTERY-DISEASE; FLOW-MEDIATED VASODILATION; CARDIOVASCULAR
   EVENTS; TEA CONSUMPTION; MYOCARDIAL-INFARCTION; MEDITERRANEAN DIET;
   INSULIN-RESISTANCE; CARBOHYDRATE DIET; CHLOROGENIC ACID; BLOOD-PRESSURE
AB Background/Objectives: Coffee is the most widely consumed beverage in the world, but its effect on the cardiovascular system has not been fully understood. Coffee contains caffeine and antioxidants, which may influence endothelial function, both of which have not yet been investigated. The objective of this study was to investigate the acute effects of coffee on endothelial function measured by brachial artery flow-mediated dilation (FMD).
   Subjects/Methods: A total of 20 (10 males and 10 females) healthy non-obese subjects underwent a double-blind, crossover study. Subjects ingested one cup of caffeinated (CC) and one cup of decaffeinated (DC) Italian espresso coffee in random order at 5- to 7-day intervals.
   Results: Following CC ingestion, FMD decreased progressively and significantly (mean +/- s.e.m.: 0 min, 7.7 +/- 0.6; 30 min, 6.3 +/- 0.7; 60 min, 6.0 +/- 0.8%; ANOVA (analysis of variance), P<0.05), but it did not significantly increase after DC ingestion (0 min, 6.9 +/- 0.6; 30 min, 8.1 +/- 0.9; 60 min, 8.5 +/- 0.9%; P = 0.115). Similarly, CC significantly increased both systolic and diastolic blood pressure; this effect was not observed after DC ingestion. Blood glucose concentrations remained unchanged after ingestion of both CC and DC, but insulin (0 min, 15.8 +/- 0.9; 60 min, 15.0 +/- 0.8 mu U/ml; P<0.05) and C-peptide (0 min, 1.25 +/- 0.09; 60 min, 1.18 +/- 0.09 ng/ml; P<0.01) blood concentrations decreased significantly only after CC ingestion.
   Conclusions: CC acutely induced unfavorable cardiovascular effects, especially on endothelial function. In the fasting state, insulin secretion is also likely reduced after CC ingestion. Future studies will determine whether CC has detrimental clinically relevant effects, especially in unhealthy subjects. European Journal of Clinical Nutrition (2010) 64, 483-489; doi:10.1038/ejcn.2010.9; published online 3 February 2010
C1 [Buscemi, S.] Univ Palermo, Dipartimento Med Interna Malattie Cardiovasc & Ne, Fac Med, Policlin P Giaccone, I-90127 Palermo, Italy.
   [Batsis, J. A.] Dartmouth Hitchcock Med Ctr, Gen Internal Med Sect, Lebanon, NH 03766 USA.
   [Donatelli, M.] Univ Palermo, Fac Med, Dipartimento Biomed Med Interna & Specialist, I-90127 Palermo, Italy.
C3 University of Palermo; Dartmouth College; University of Palermo
RP Buscemi, S (corresponding author), Univ Palermo, Dipartimento Med Interna Malattie Cardiovasc & Ne, Fac Med, Policlin P Giaccone, Via Vespro 129, I-90127 Palermo, Italy.
EM silbus@tin.it
RI Belmonte, Silvia Alejandra/AAW-5131-2021; Batsis, John/AAC-7185-2019;
   Mattina, Alessandro/F-6020-2019; buscemi, silvio/K-9662-2016
OI VERGA, Salvatore/0000-0002-7743-7847; DONATELLI,
   MARIA/0000-0002-9928-8248; Mattina, Alessandro/0000-0003-3458-0894;
   buscemi, silvio/0000-0003-0730-7649
FU Italian Ministry of Education; Associazione Onlus Nutrizione e Salute,
   Italy
FX This study was supported in part by the Italian Ministry of Education
   (ex 60% funds, 2007) and by the Associazione Onlus Nutrizione e Salute,
   Italy. The authors are gratefully indebted to the voluntary subjects who
   participated in the study and to Giovanna Seddio and Giovanni De Canzio
   for their invaluable technical support in the laboratory work.
CR Alexopoulos N, 2008, EUR J CARDIOV PREV R, V15, P300, DOI 10.1097/HJR.0b013e3282f4832f
   Barac A, 2007, HYPERTENSION, V49, P748, DOI 10.1161/01.HYP.0000259601.38807.a6
   Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006
   Buscemi S, 2009, EUR J CLIN NUTR, V63, P1200, DOI 10.1038/ejcn.2009.51
   Buscemi S, 2009, EUR J CLIN INVEST, V39, P339, DOI 10.1111/j.1365-2362.2009.02091.x
   Buus NH, 2007, BLOOD PRESSURE, V16, P106, DOI 10.1080/08037050701343688
   CASIGLIA E, 1991, J INTERN MED, V229, P501, DOI 10.1111/j.1365-2796.1991.tb00385.x
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6
   Corti R, 2002, CIRCULATION, V106, P2935, DOI 10.1161/01.CIR.0000046228.97025.3A
   Daglia M, 2000, J AGR FOOD CHEM, V48, P1449, DOI 10.1021/jf990510g
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   Duffy SJ, 2001, CIRCULATION, V104, P151, DOI 10.1161/01.CIR.104.2.151
   Esposito K, 2003, AM J CLIN NUTR, V77, P139, DOI 10.1093/ajcn/77.1.139
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Fujioka K, 2008, FOOD CHEM, V106, P217, DOI 10.1016/j.foodchem.2007.05.091
   FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0
   Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47
   Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hamdy O, 2003, DIABETES CARE, V26, P2119, DOI 10.2337/diacare.26.7.2119
   Keogh JB, 2005, ARTERIOSCL THROM VAS, V25, P1274, DOI 10.1161/01.ATV.0000163185.28245.a1
   Kitta Y, 2009, J AM COLL CARDIOL, V53, P323, DOI 10.1016/j.jacc.2008.08.074
   Klatsky AL, 2008, AM J CARDIOL, V101, P825, DOI 10.1016/j.amjcard.2007.11.022
   Lane JD, 2008, DIABETES CARE, V31, P221, DOI 10.2337/dc07-1112
   Larsson SC, 2008, STROKE, V39, P1681, DOI 10.1161/STROKEAHA.107.504183
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Mäki-Petäjä KM, 2007, J AM COLL CARDIOL, V50, P852, DOI 10.1016/j.jacc.2007.04.076
   Mahmud A, 2001, HYPERTENSION, V38, P227, DOI 10.1161/01.HYP.38.2.227
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Moens AL, 2005, CHEST, V127, P2254, DOI 10.1378/chest.127.6.2254
   Moisey LL, 2008, AM J CLIN NUTR, V87, P1254, DOI 10.1093/ajcn/87.5.1254
   Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Papamichael CM, 2005, CLIN SCI, V109, P55, DOI 10.1042/CS20040358
   Riksen NP, 2009, PHARMACOL THERAPEUT, V121, P185, DOI 10.1016/j.pharmthera.2008.10.006
   Rossi R, 2008, J AM COLL CARDIOL, V51, P997, DOI 10.1016/j.jacc.2007.11.044
   Shimabukuro M, 2007, AM J CLIN NUTR, V86, P923, DOI 10.1093/ajcn/86.4.923
   Silletta MG, 2007, CIRCULATION, V116, P2944, DOI 10.1161/CIRCULATIONAHA.107.712976
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   van Woudenbergh GJ, 2008, ARTERIOSCL THROM VAS, V28, P1018, DOI 10.1161/ATVBAHA.107.160457
   VANDAM RM, 2008, JAMA-J AM MED ASSOC, V294, P97
   VERGA S, 1994, ACTA DIABETOL, V31, P47, DOI 10.1007/BF00580761
   Vogel RA, 2000, J AM COLL CARDIOL, V36, P1455, DOI 10.1016/S0735-1097(00)00896-2
   WHITSETT TL, 1984, AM J CARDIOL, V53, P918, DOI 10.1016/0002-9149(84)90525-3
   Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X
   Wu GY, 2002, ANNU REV NUTR, V22, P61, DOI 10.1146/annurev.nutr.22.110901.145329
   Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
NR 51
TC 82
Z9 87
U1 0
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0954-3007
EI 1476-5640
J9 EUR J CLIN NUTR
JI Eur. J. Clin. Nutr.
PD MAY
PY 2010
VL 64
IS 5
BP 483
EP 489
DI 10.1038/ejcn.2010.9
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 591VJ
UT WOS:000277332800007
PM 20125186
DA 2025-04-28
ER

PT J
AU Braojos, C
   Gila-Díaz, A
   Rodíguez-Rodríguez, P
   Monedero-Cobeta, I
   Morales, MD
   Ruvira, S
   Ramiro-Cortijo, D
   Benítez, V
   Martín-Cabrejas, MA
   Arribas, SM
AF Braojos, Cheyenne
   Gila-Diaz, Andrea
   Rodriguez-Rodriguez, Pilar
   Monedero-Cobeta, Ignacio
   Morales, Maria Dolores
   Ruvira, Santiago
   Ramiro-Cortijo, David
   Benitez, Vanesa
   Martin-Cabrejas, Maria A.
   Arribas, Silvia M.
TI Effect of Supplementation with Coffee and Cocoa By-Products to
   Ameliorate Metabolic Syndrome Alterations Induced by High-Fat Diet in
   Female Mice
SO FOODS
LA English
DT Article
DE coffee pulp; cocoa shell; polyphenols; caffeine; glycemia; adipocytes
ID CARDIOVASCULAR RISK; INDUCED OBESITY; ACID; CONSUMPTION; EXTRACT;
   C57BL/6; LIVER; MODEL; PULP
AB Coffee and cocoa manufacturing produces large amounts of waste. Generated by-products contain bioactive compounds with antioxidant and anti-inflammatory properties, suitable for treating metabolic syndrome (MetS). We aimed to compare the efficacy of aqueous extracts and flours from coffee pulp (CfPulp-E, CfPulp-F) and cocoa shell (CcShell-E, CcShell-F) to ameliorate MetS alterations induced by a high-fat diet (HFD). Bioactive component content was assessed by HPLC/MS. C57BL/6 female mice were fed for 6 weeks with HFD followed by 6 weeks with HFD plus supplementation with one of the ingredients (500 mg/kg/day, 5 days/week), and compared to non-supplemented HFD and Control group fed with regular chow. Body weight, adipocyte size and browning (Mitotracker, confocal microscopy), plasma glycemia (basal, glucose tolerance test-area under the curve, GTT-AUC), lipid profile, and leptin were compared between groups. Cocoa shell ingredients had mainly caffeine, theobromine, protocatechuic acid, and flavan-3-ols. Coffee pulp showed a high content in caffeine, protocatechuic, and chlorogenic acids. Compared to Control mice, HFD group showed alterations in all parameters. Compared to HFD, CcShell-F significantly reduced adipocyte size, increased browning and high-density lipoprotein cholesterol (HDL), and normalized basal glycemia, while CcShell-E only increased HDL. Both coffee pulp ingredients normalized adipocyte size, basal glycemia, and GTT-AUC. Additionally, CfPulp-E improved hyperleptinemia, reduced triglycerides, and slowed weight gain, and CfPulp-F increased HDL. In conclusion, coffee pulp ingredients showed a better efficacy against MetS, likely due to the synergic effect of caffeine, protocatechuic, and chlorogenic acids. Since coffee pulp is already approved as a food ingredient, this by-product could be used in humans to treat obesity-related MetS alterations.
C1 [Braojos, Cheyenne; Benitez, Vanesa; Martin-Cabrejas, Maria A.] Univ Autonoma Madrid UAM CSIC, Inst Food Sci Res CIAL, C-Nicolas Cabrera 9, Madrid 28049, Spain.
   [Braojos, Cheyenne; Benitez, Vanesa; Martin-Cabrejas, Maria A.] Univ Autonoma Madrid UAM CSIC, Fac Sci, Dept Agr Chem & Food Sci, Ciudad Univ Cantoblanco, Madrid 28049, Spain.
   [Braojos, Cheyenne; Gila-Diaz, Andrea; Rodriguez-Rodriguez, Pilar; Monedero-Cobeta, Ignacio; Ruvira, Santiago; Ramiro-Cortijo, David; Benitez, Vanesa; Martin-Cabrejas, Maria A.; Arribas, Silvia M.] Univ Autonoma Madrid UAM CSIC, Food Oxidat Stress & Cardiovasc Hlth FOSCH Res Grp, Ciudad Univ Cantoblanco, Madrid 28049, Spain.
   [Gila-Diaz, Andrea; Rodriguez-Rodriguez, Pilar; Monedero-Cobeta, Ignacio; Ruvira, Santiago; Ramiro-Cortijo, David; Arribas, Silvia M.] Univ Autonoma Madrid UAM CSIC, Fac Med, Dept Physiol, C-Arbobispo Morcillo 2, Madrid 28029, Spain.
   [Morales, Maria Dolores] Univ Autonoma Madrid UAM CSIC, Fac Med, Interdept Res Serv SiDI, Confocal Microscopy Unit, C-Arzobispo Morcillo 2, Madrid 28029, Spain.
   [Ruvira, Santiago] Univ Autonoma Madrid UAM CSIC, Doctoral Sch, PhD Program Pharmacol & Physiol, C-Francisco Tomas & Valiente 2, Madrid 28049, Spain.
C3 Autonomous University of Madrid; Consejo Superior de Investigaciones
   Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de
   la Alimentacion (CIAL); Autonomous University of Madrid; Autonomous
   University of Madrid; Autonomous University of Madrid; Autonomous
   University of Madrid; Autonomous University of Madrid
RP Arribas, SM (corresponding author), Univ Autonoma Madrid UAM CSIC, Food Oxidat Stress & Cardiovasc Hlth FOSCH Res Grp, Ciudad Univ Cantoblanco, Madrid 28049, Spain.; Arribas, SM (corresponding author), Univ Autonoma Madrid UAM CSIC, Fac Med, Dept Physiol, C-Arbobispo Morcillo 2, Madrid 28029, Spain.
EM silvia.arribas@uam.es
RI Ramiro Cortijo, David/V-1217-2019; Arribas, Sara/AAD-3221-2021;
   Gila-Diaz, Andrea/AAK-3735-2020; Monedero Cobeta, Ignacio/G-4858-2015;
   Benitez, Vanesa/B-5858-2012; martin-cabrejas, maria/L-6433-2014
OI Ruvira Hernando, Santiago/0000-0003-2216-5335; Ramiro Cortijo,
   David/0000-0001-7442-1586; Gila-Diaz, Andrea/0000-0001-7744-9330;
   Monedero Cobeta, Ignacio/0000-0001-6370-0467; Benitez,
   Vanesa/0000-0001-7517-9752; martin-cabrejas, maria/0000-0001-9834-639X;
   Braojos Molero de Avila, Cheyenne/0000-0001-5736-4524
FU Knowledge Transfer Project from Universidad Autonoma de Madrid (UAM,
   Madrid, Spain); AORA Health S.L. (Madrid, Spain) [PFTC-19]; Community of
   Madrid (Spain)-UAM [TED2021-129262A-I00]; Ministry of Science and
   Innovation; Spain [TED2021-129262A-I00]
FX This research was funded by the Knowledge Transfer Project from
   Universidad Autonoma de Madrid (UAM, Madrid, Spain) and AORA Health S.L.
   (Madrid, Spain), grant number PFTC-19; The Excellence Line (2019-2023)
   for University Teaching Staff within the Multiannual Agreement between
   the Community of Madrid (Spain)-UAM; and the Spanish Plan for
   Scientific, Technical and Innovation Research (2021-2023; PEICTI) within
   the Spanish Recovery, Transformation and Resilience thought the Projects
   Oriented to the Ecological Transition and to the Digital Transition
   (Ministry of Science and Innovation; Spain), grant number
   TED2021-129262A-I00.
CR Andrade N, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.966734
   [Anonymous], ImageJ. Fiji
   Antony A, 2022, APPL SCI-BASEL, V12, DOI 10.3390/app12042107
   Arancibia-Radich J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36555-1
   Bobková A, 2020, J ENVIRON SCI HEAL B, V55, P495, DOI 10.1080/03601234.2020.1724660
   Bonetti Gabriele, 2022, J Prev Med Hyg, V63, pE160, DOI 10.15167/2421-4248/jpmh2022.63.2S3.2757
   Boonphang O, 2021, MOLECULES, V26, DOI 10.3390/molecules26071907
   Braojos C., 2020, Proceedings, V61, DOI [10.3390/IECN2020-06997, DOI 10.3390/IECN2020-06997]
   Brodkorb A, 2019, NAT PROTOC, V14, P991, DOI 10.1038/s41596-018-0119-1
   Caas S., 2020, Proceedings, V70, DOI [10.3390/foods2020-07623, DOI 10.3390/FOODS2020-07623]
   Canas Silvia, 2022, Food Res Int, V162, P112117, DOI 10.1016/j.foodres.2022.112117
   Cañas S, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11091818
   del Castillo M.D., 2016, COFFEE SILVERSKIN EX, V1st ed.
   Durán-Aranguren DD, 2021, MOLECULES, V26, DOI 10.3390/molecules26247605
   Fahed G, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020786
   Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83
   Gao YX, 2022, CRIT REV FOOD SCI, V62, P9053, DOI 10.1080/10408398.2021.1939265
   Gil-Lespinard M, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11122425
   Gil-Ortega M, 2016, VASC PHARMACOL, V77, P38, DOI 10.1016/j.vph.2015.05.012
   Gil-Ortega M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095312
   González-Blázquez R, 2021, CLIN SCI, V135, P2763, DOI 10.1042/CS20210971
   Greenberg JA, 2012, J AM COLL NUTR, V31, P160, DOI 10.1080/07315724.2012.10720023
   Grzelak-Blaszczyk K, 2020, FOOD FUNCT, V11, P3585, DOI [10.1039/C9FO02633A, 10.1039/c9fo02633a]
   Hadaegh F, 2023, FRONT ENDOCRINOL, V14, DOI 10.3389/fendo.2023.1164771
   Hu S, 2023, CURR RES FOOD SCI, V6, DOI 10.1016/j.crfs.2023.100475
   ICO International Coffee Organization, About us
   Ikeda K, 2018, TRENDS ENDOCRIN MET, V29, P191, DOI 10.1016/j.tem.2018.01.001
   Kohansal K, 2022, CARDIOVASC DIABETOL, V21, DOI 10.1186/s12933-022-01709-z
   Li JL, 2020, EXP ANIM TOKYO, V69, P326, DOI 10.1538/expanim.19-0148
   LIczbinski P, 2022, IND CROP PROD, V175, DOI 10.1016/j.indcrop.2021.114265
   Lu MY, 2022, NUTRIENTS, V14, DOI 10.3390/nu14091867
   Moran-Lev H, 2023, CHILD OBES, V19, P121, DOI 10.1089/chi.2022.0032
   de Araújo MFM, 2022, J FOOD BIOCHEM, V46, DOI 10.1111/jfbc.14081
   Murthy PS, 2012, RESOUR CONSERV RECY, V66, P45, DOI 10.1016/j.resconrec.2012.06.005
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Nour OA, 2021, EUR J PHARMACOL, V907, DOI 10.1016/j.ejphar.2021.174257
   Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966
   Okiyama DCG, 2017, TRENDS FOOD SCI TECH, V63, P103, DOI 10.1016/j.tifs.2017.03.007
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Ontawong A, 2019, PHYTOMEDICINE, V52, P187, DOI 10.1016/j.phymed.2018.06.021
   Pagliari S, 2022, LWT-FOOD SCI TECHNOL, V170, DOI 10.1016/j.lwt.2022.114115
   Prabhakar PK, 2013, PHYTOMEDICINE, V20, P488, DOI 10.1016/j.phymed.2012.12.004
   Pucci G, 2017, PHARMACOL RES, V120, P34, DOI 10.1016/j.phrs.2017.03.008
   Ramón V, 2023, AGRONOMY-BASEL, V13, DOI 10.3390/agronomy13010015
   Rebollo-Hernanz M, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.866233
   Rebollo-Hernanz M, 2021, SEP PURIF TECHNOL, V270, DOI 10.1016/j.seppur.2021.118779
   Rebollo-Hernanz M, 2021, FOODS, V10, DOI 10.3390/foods10030653
   Rebollo-Hernanz M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080279
   Rebollo-Hernanz M, 2019, FOOD CHEM TOXICOL, V132, DOI 10.1016/j.fct.2019.110672
   Rodríguez-Rodríguez P, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10102504
   Rodriguez-Rodriguez P, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11020429
   Ruvira S, 2023, ANIMALS-BASEL, V13, DOI 10.3390/ani13111827
   Santilli F, 2017, CURR MED CHEM, V24, P2602, DOI 10.2174/0929867324666170710121145
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Soares TF, 2022, MOLECULES, V27, DOI 10.3390/molecules27051625
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Tibaes JRB, 2022, J NUTR, V152, P1347, DOI 10.1093/jn/nxac024
   Seraglio SKT, 2017, FOOD RES INT, V99, P670, DOI 10.1016/j.foodres.2017.06.024
   Turck D, 2022, EFSA J, V20, DOI 10.2903/j.efsa.2022.7596
   Unger CA, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-21228-x
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang SH, 2022, FOOD FUNCT, V13, P9734, DOI [10.1039/d2fo01552h, 10.1039/D2FO01552H]
   Wilson RA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030346
   Xiang YY, 2023, MOL NUTR FOOD RES, V67, DOI 10.1002/mnfr.202200244
   Yonekura Y, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051370
   Zhang SY, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22116110
   Zhao YM, 2021, FOOD FUNCT, V12, P11557, DOI [10.1039/d1fo02906a, 10.1039/D1FO02906A]
   Zhong YC, 2020, CURR PHARM BIOTECHNO, V21, P1099, DOI 10.2174/1389201021666200318124922
   Zhu F, 2018, CRIT REV FOOD SCI, V58, P1808, DOI 10.1080/10408398.2017.1287659
NR 70
TC 6
Z9 6
U1 4
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2304-8158
J9 FOODS
JI Foods
PD JUL
PY 2023
VL 12
IS 14
AR 2708
DI 10.3390/foods12142708
PG 20
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA N7CH2
UT WOS:001038542700001
PM 37509800
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Ngueta, G
AF Ngueta, Gerard
TI Caffeine and caffeine metabolites in relation to hypertension in US
   adults
SO EUROPEAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID COFFEE CONSUMPTION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; SYSTEMATIC
   ANALYSIS; INSULIN-RESISTANCE; RISK; MEN; METAANALYSIS; LIPIDS; WOMEN
AB Background/Objectives Most studies assessing the association between coffee consumption and hypertension ascertained caffeine intake in terms of number of cups per days, and yield mixed results. Although the inter-individuals variability in the caffeine metabolism is known, the relation of caffeine metabolites with hypertension remains unsettled. We examined the association of caffeine and 13 direct and indirect caffeine metabolites with hypertension in U.S. adults. Methods Using data from 2009-2010 National Health and Nutrition Examination Survey, we included 2278 individuals aged 18 to 80 years. Urinary methyluric acids (MU) and methylxanthines (MX) products of caffeine metabolism were measured using high performance liquid chromatography-electrospray ionization-tandem quadrupole mass spectrometry. We used multivariate logistic regression to model hypertension (systolic blood pressure >= 130 mmHg or diastolic blood pressure >= 80 mmHg) as functions of urinary coffee metabolites. Results The odds of hypertension decreased across quartiles of 3-MU, 7-MU, 3-MX and 7-MX, with 7-MU being the more powerful metabolite. Compared with adults in the bottom quartile of 7-MU, the odds of hypertension decreased by 81% (95% CI: -90 to -22%) in those in the upper quartile. In contrast, the odds ratio for being hypertensive from the bottom to the upper quartile were 4.47 (95% CI: 1.21-16.50) for 1,3-dimethyluric acid, 4.45 (95% CI: 1.48-13.39) for 1,3-dimethylxanthine, and 5.08 (95% CI: 1.11-23.36) for 1,7-dimethylxanthine. Neither insulin resistance nor abdominal obesity were moderators in these associations. Conclusions Final metabolites of caffeine (namely 3-MU, 7-MU, 3-MX and 7-MX), but not caffeine, significantly reduce the odds for hypertension in this population.
C1 [Ngueta, Gerard] Univ Laval, Fac Pharm, Quebec City, PQ, Canada.
   [Ngueta, Gerard] Inst Natl Sante Publ Quebec, Bur Informat & Etud Sante Populat, Quebec City, PQ, Canada.
   [Ngueta, Gerard] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.
C3 Laval University; Institut national de sante publique du Quebec (INSPQ);
   Laval University; Laval University Hospital
RP Ngueta, G (corresponding author), Univ Laval, Fac Pharm, Quebec City, PQ, Canada.; Ngueta, G (corresponding author), Inst Natl Sante Publ Quebec, Bur Informat & Etud Sante Populat, Quebec City, PQ, Canada.; Ngueta, G (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.
EM Ngueta@hotmail.com
RI Ngueta, Gerard/T-9569-2019
FU Canadian Institute of Health Research (CIHR) [146885]
FX This research was supported by a grant from the Canadian Institute of
   Health Research (CIHR) (#146885) to GN.
CR Alsabri Sami G., 2018, Journal of Caffeine and Adenosine Research, V8, P3, DOI 10.1089/caff.2017.0011
   [Anonymous], COFF WORLD MARK TRAD
   Chei CL, 2018, EUR J NUTR, V57, P1333, DOI 10.1007/s00394-017-1412-4
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   D'Elia L, 2019, EUR J NUTR, V58, P271, DOI 10.1007/s00394-017-1591-z
   Ford ES, 2011, CIRCULATION, V123, P1737, DOI 10.1161/CIRCULATIONAHA.110.005645
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2
   Grosso G, 2016, EUR J CLIN NUTR, V70, P109, DOI 10.1038/ejcn.2015.119
   Guessous I, 2015, HYPERTENSION, V65, P691, DOI 10.1161/HYPERTENSIONAHA.114.04512
   Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625
   Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177
   Hartley TR, 2000, HYPERTENSION, V36, P137, DOI 10.1161/01.HYP.36.1.137
   Hu G, 2007, AM J CLIN NUTR, V86, P457, DOI 10.1093/ajcn/86.2.457
   Kaminsky LA, 1998, J SPORT MED PHYS FIT, V38, P53
   Klag MJ, 2002, ARCH INTERN MED, V162, P657, DOI 10.1001/archinte.162.6.657
   LANCASTER T, 1994, J ROY SOC MED, V87, P506
   LELO A, 1989, J PHARMACOL EXP THER, V248, P315
   Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
   Liu HH, 2018, HYPERTENSION, V71, P1039, DOI 10.1161/HYPERTENSIONAHA.118.11063
   Loftfield E, 2016, J NUTR, V146, P1762, DOI 10.3945/jn.116.233940
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664
   Martínez-López S, 2014, FOOD RES INT, V64, P125, DOI 10.1016/j.foodres.2014.05.043
   Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912
   Navarro AM, 2019, CLIN NUTR, V38, P389, DOI 10.1016/j.clnu.2017.12.009
   Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899
   OHNISHI A, 1986, J CLIN INVEST, V78, P1045, DOI 10.1172/JCI112659
   Palatini P, 2007, ANN MED, V39, P545, DOI 10.1080/07853890701491018
   Rhee JJ, 2016, AM J CLIN NUTR, V103, P210, DOI 10.3945/ajcn.115.120147
   Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052
   Smith R, 2000, SAFETY ASPECTS DIETA
   STENSVOLD I, 1989, J CLIN EPIDEMIOL, V42, P877, DOI 10.1016/0895-4356(89)90101-7
   Textor J, ADJUSTMENT CRITERIA
   Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be
   Uiterwaal CSPM, 2007, AM J CLIN NUTR, V85, P718, DOI 10.1093/ajcn/85.3.718
   US-CDC, 2013, NAT HLTH NUTR EX SUR
   Whelton PK, 2018, CIRCULATION, V138, pE426, DOI 10.1161/CIR.0000000000000597
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
   Xie C, 2018, J HUM HYPERTENS, V32, P83, DOI 10.1038/s41371-017-0007-0
   Zhang ZZ, 2011, AM J CLIN NUTR, V93, P1212, DOI 10.3945/ajcn.110.004044
   Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483
NR 41
TC 25
Z9 27
U1 2
U2 27
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0954-3007
EI 1476-5640
J9 EUR J CLIN NUTR
JI Eur. J. Clin. Nutr.
PD JAN
PY 2020
VL 74
IS 1
BP 77
EP 86
DI 10.1038/s41430-019-0430-0
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KD4OW
UT WOS:000507846800008
PM 31019247
DA 2025-04-28
ER

PT J
AU Arsenault, BJ
   Earnest, CP
   Després, JP
   Blair, SN
   Church, TS
AF Arsenault, B. J.
   Earnest, C. P.
   Despres, J-P
   Blair, S. N.
   Church, T. S.
TI Obesity, coffee consumption and CRP levels in postmenopausal
   overweight/obese women: importance of hormone replacement therapy use
SO EUROPEAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE obesity; coffee; CRP; postmenopausal women; hormone replacement therapy
ID C-REACTIVE PROTEIN; TYPE-2 DIABETES-MELLITUS; RISK; MARKERS; SERUM;
   INFLAMMATION; POPULATION; HEALTHY; DISEASE
AB Background/Objectives: Obesity is associated with an inflammatory state that is often characterized by elevated plasma C-reactive protein (CRP) levels. Although coffee is broadly consumed in Western societies, few studies have examined the relationship between obesity, coffee consumption and CRP levels. The objective of this study was to assess the relationship between obesity, coffee consumption and variation in CRP in postmenopausal, overweight/obese women with or without hormone replacement therapy (HRT) use.
   Subjects/Methods: Cross-sectional analyses of 344 healthy sedentary, overweight/obese postmenopausal women (mean age = 57.1 +/- 6.4 years and mean body mass index (BMI) = 36.1 +/- 3.9 kg/m(2)). Plasma CRP levels were measured by a highly sensitive immunoassay that used monoclonal antibodies coated with polystyrene particles. Diet was assessed using the Food Intake and Analysis System semiquantitative food frequency questionnaire.
   Results: Plasma CRP was positively associated with BMI (P < 0.001) and negatively associated with coffee consumption (P <= 0.05). In women using HRT, plasma CRP was positively associated with BMI in women consuming less than one cup of coffee per month (r(2) = 0.15 (P < 0.001)), one cup per day (0.14 (P = 0.02)) and more than one cup per day (0.12 (P = 0.03)). In women who did not use HRT, CRP was associated with BMI only in women consuming less than one cup of coffee per day (r(2) = 0.16 (P < 0.001)) but not in women consuming one cup per day (0.06 (P = 0.10)) or more than one daily cup of coffee (0.03 (P = 0.27)).
   Conclusions: Among overweight/obese postmenopausal women, coffee consumption is negatively associated with CRP. Coffee consumption appears to attenuate the association between BMI and CRP, but only in women not using HRT. European Journal of Clinical Nutrition (2009) 63, 1419-1424; doi:10.1038/ejcn.2009.112; published online 16 September 2009
C1 [Earnest, C. P.; Church, T. S.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
   [Arsenault, B. J.; Despres, J-P] Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Dept Cardiol, Quebec City, PQ, Canada.
   [Arsenault, B. J.] Univ Laval, Fac Med, Dept Anat & Physiol, Quebec City, PQ G1K 7P4, Canada.
   [Despres, J-P] Univ Laval, Div Kinesiol, Dept Social & Prevent Med, Quebec City, PQ G1K 7P4, Canada.
   [Blair, S. N.] Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.
   [Blair, S. N.] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; Laval University; Laval
   University; University of South Carolina System; University of South
   Carolina Columbia; University of South Carolina System; University of
   South Carolina Columbia
RP Church, TS (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM tim.church@pbrc.edu
RI Blair, Steven/AFU-2008-2022; Earnest, Conrad/M-6849-2017; Stefanadis,
   Christodoulos/ABH-2232-2020
OI Earnest, Conrad/0000-0002-6546-1268; Stefanadis,
   Christodoulos/0000-0001-5974-6454
FU National Institutes of Health [HL66262, HL071900]
FX The authors thank the participants and the staff and the Scientific
   Advisory Board of the Cooper Clinic Institute. Dr Despres is Scientific
   Director of the International Chair on Cardiometabolic Risk, which is
   supported by an unrestricted grant from Sanofi Aventis awarded to
   Universite Laval. This study was supported by Grant nos. HL66262 and
   HL071900 from the National Institutes of Health.
CR Brett K.M., 2001, HORMONE REPLACEMENT
   Buchbinder S, 2008, SCAND J CLIN LAB INV, V68, P140, DOI 10.1080/00365510701487727
   Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com
   Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081
   COOPER BC, 2007, AM J OBSTET GYNECOL, V196, P123
   Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804
   Dehghan A, 2007, DIABETES CARE, V30, P2695, DOI 10.2337/dc07-0348
   Andersen LF, 2006, AM J CLIN NUTR, V83, P1039, DOI 10.1093/ajcn/83.5.1039
   Ganmaa D, 2008, INT J CANCER, V122, P2071, DOI 10.1002/ijc.23336
   Kotani K, 2008, CLIN CHEM LAB MED, V46, P1434, DOI 10.1515/CCLM.2008.286
   Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607
   Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Morss GM, 2004, MED SCI SPORT EXER, V36, P336, DOI 10.1249/01.MSS.0000113738.06267.E5
   Nakamura H, 2008, DIABETES RES CLIN PR, V79, P330, DOI 10.1016/j.diabres.2007.09.004
   Nanri A, 2007, ASIAN PAC J CANCER P, V8, P167
   Ridker PM, 1999, CIRCULATION, V100, P713, DOI 10.1161/01.CIR.100.7.713
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Silvestri A, 2003, CIRCULATION, V107, P3165, DOI 10.1161/01.CIR.0000074208.02226.5E
   Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009
   *U TX H, 1996, FOOD INT AN SYST COM
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
NR 24
TC 27
Z9 29
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0954-3007
EI 1476-5640
J9 EUR J CLIN NUTR
JI Eur. J. Clin. Nutr.
PD DEC
PY 2009
VL 63
IS 12
BP 1419
EP 1424
DI 10.1038/ejcn.2009.112
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 525WN
UT WOS:000272248200006
PM 19756031
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Narita, Y
   Inouye, K
AF Narita, Yusaku
   Inouye, Kuniyo
TI Degradation Kinetics of Chlorogenic Acid at Various pH Values and
   Effects of Ascorbic Acid and Epigallocatechin Gallate on Its Stability
   under Alkaline Conditions
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE chlorogenic acid; caffeic acid; (-)-epigallocatechin gallate;
   degradation kinetics; Weibull equation
ID GREEN COFFEE BEANS; NONLINEAR LEAST-SQUARES; CAFFEIC ACID;
   THERMAL-STABILITY; DERIVATIVES; L.; IDENTIFICATION; POLYPHENOLICS;
   OXIDATION; EXTRACT
AB 5-Caffeoylquinic acid (5-CQA) is generally referred to as chlorogenic acid and exhibits various biological activities such as antioxidant activity and porcine pancreas a-amylase inhibitory activities. 5-CQA may be useful as an antioxidant for food and to prevent diabetes and obesity. The degradation of 5-CQA and caffeic acid (CA) in an aqueous solution at 37 degrees C and pH 5.0-9.0 was studied. The degradation of 5-CQA and CA, demonstrating time and pH dependence (i.e., the rate constant, k, was higher at higher pH), was satisfactorily described by the Weibull equation. The stability of 5-CQA at pH 7.4 and 9.0 was improved by adding (-)-epigallocatechin gallate (EGCG) and ascorbic acid (AA). Moreover, the degradation of 5-CQA in the presence of EGCG or AA could be described by the Weibull equation. The k value in the presence of EGCG or AA was dependent on their concentration.
C1 [Narita, Yusaku; Inouye, Kuniyo] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.
   [Narita, Yusaku] UCC Ueshima Coffee Co Ltd, R&D Ctr, Takatsuki, Osaka 5690036, Japan.
C3 Kyoto University
RP Inouye, K (corresponding author), Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.
EM inouye@kais.kyoto-u.ac.jp
CR [Anonymous], 1976, Biochem J, V153, P23
   Arakawa R, 2004, J AM SOC MASS SPECTR, V15, P1228, DOI 10.1016/j.jasms.2004.05.007
   Chen ZY, 1998, J AGR FOOD CHEM, V46, P2512, DOI 10.1021/jf971022g
   Clifford MN, 2006, J AGR FOOD CHEM, V54, P1957, DOI 10.1021/jf0601665
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Cruz R, 2012, J AGR FOOD CHEM, V60, P7777, DOI 10.1021/jf3018854
   Cunha LM, 1998, J FOOD ENG, V37, P175, DOI 10.1016/S0260-8774(98)00085-5
   Dawidowicz AL, 2011, EUR FOOD RES TECHNOL, V233, P223, DOI 10.1007/s00217-011-1513-x
   Dawidowicz AL, 2010, J AGR FOOD CHEM, V58, P12578, DOI 10.1021/jf103373t
   de Levie R, 1999, J CHEM EDUC, V76, P1594, DOI 10.1021/ed076p1594
   Friedman M, 2000, J AGR FOOD CHEM, V48, P2101, DOI 10.1021/jf990489j
   Fujioka K, 2008, FOOD CHEM, V106, P217, DOI 10.1016/j.foodchem.2007.05.091
   Harris DC, 1998, J CHEM EDUC, V75, P119, DOI 10.1021/ed075p119
   Hotta H, 2002, ANAL BIOCHEM, V303, P66, DOI 10.1006/abio.2002.5577
   Ishikawa A, 2007, J NUTR SCI VITAMINOL, V53, P166, DOI 10.3177/jnsv.53.166
   Islam MS, 2002, J AGR FOOD CHEM, V50, P3718, DOI 10.1021/jf020120l
   Iwai K, 2004, J AGR FOOD CHEM, V52, P4893, DOI 10.1021/jf040048m
   Iwai K, 2012, FOOD SCI TECHNOL RES, V18, P849, DOI 10.3136/fstr.18.849
   Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028
   Khajavi SH, 2005, J FOOD ENG, V68, P309, DOI 10.1016/j.jfoodeng.2004.06.004
   Kono Y, 1997, BBA-GEN SUBJECTS, V1335, P335, DOI 10.1016/S0304-4165(96)00151-1
   Kurata R, 2007, J AGR FOOD CHEM, V55, P185, DOI 10.1021/jf0620259
   Ky CL, 2001, FOOD CHEM, V75, P223, DOI 10.1016/S0308-8146(01)00204-7
   Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206
   Manso MC, 2001, INT J FOOD SCI TECH, V36, P303, DOI 10.1046/j.1365-2621.2001.t01-1-00460.x
   Matsui Y, 2007, J CHROMATOGR B, V858, P96, DOI 10.1016/j.jchromb.2007.08.013
   MURATA M, 1995, BIOSCI BIOTECH BIOCH, V59, P1887, DOI 10.1271/bbb.59.1887
   Nakatani N, 2000, J AGR FOOD CHEM, V48, P5512, DOI 10.1021/jf000422s
   Narita Y, 2011, FOOD CHEM, V127, P1532, DOI 10.1016/j.foodchem.2011.02.013
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   Oomori T, 2004, BIOCHEM ENG J, V18, P143, DOI 10.1016/j.bej.2003.08.002
   Shima M, 2007, J BIOSCI BIOENG, V103, P278, DOI 10.1263/jbb.103.278
   Takenaka M, 2003, J AGR FOOD CHEM, V51, P793, DOI 10.1021/jf020735i
   TRUGO LC, 1984, ANALYST, V109, P263, DOI 10.1039/an9840900263
   Watanabe Y., 2009, Japan Journal of Food Engineering, DOI [10.11301/jsfe.10.117, DOI 10.11301/JSFE.10.117]
   Xie C, 2011, J AGR FOOD CHEM, V59, P11078, DOI 10.1021/jf203104k
   Yoshimoto M, 2002, BIOSCI BIOTECH BIOCH, V66, P2336, DOI 10.1271/bbb.66.2336
   Zhang HY, 1997, ANAL LETT, V30, P1293, DOI 10.1080/00032719708007217
   Zhao YK, 2000, CHROMATOGRAPHIA, V51, P483, DOI 10.1007/BF02490489
NR 39
TC 82
Z9 96
U1 1
U2 104
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JAN 30
PY 2013
VL 61
IS 4
BP 966
EP 972
DI 10.1021/jf304105w
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 083VF
UT WOS:000314492600024
PM 23298331
DA 2025-04-28
ER

PT J
AU Murase, T
   Yokoi, Y
   Misawa, K
   Ominami, H
   Suzuki, Y
   Shibuya, Y
   Hase, T
AF Murase, Takatoshi
   Yokoi, Yuka
   Misawa, Koichi
   Ominami, Hideo
   Suzuki, Yasuto
   Shibuya, Yusuke
   Hase, Tadashi
TI Coffee polyphenols modulate whole-body substrate oxidation and suppress
   postprandial hyperglycaemia, hyperinsulinaemia and hyperlipidaemia
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Chlorogenic acid; Energy metabolism; Glucosidase; Hyperglycaemia;
   Polyphenols
ID GASTRIC-INHIBITORY POLYPEPTIDE; TYPE-2 DIABETES-MELLITUS; CHLOROGENIC
   ACID; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; GLYCEMIC
   INDEX; MALONYL-COA; HUMANS; RISK
AB Postprandial energy metabolism, including postprandial hyperglycaemia, hyperinsulinaemia and hyperlipidaemia, is related to the risk for developing obesity and CVD. In the present study, we examined the effects of polyphenols purified from coffee (coffee polyphenols (CPP)) on postprandial carbohydrate and lipid metabolism, and whole-body substrate oxidation in C57BL/6J mice. In mice that co-ingested CPP with a lipid-carbohydrate (sucrose or starch)-mixed emulsion, the respiratory quotient determined by indirect calorimetry was significantly lower than that in control mice, whereas there was no difference in V-O2 (energy expenditure), indicating that CPP modulates postprandial energy partitioning. CPP also suppressed postprandial increases in plasma glucose, insulin, glucose-dependent insulinotropic polypeptide and TAG levels. Inhibition experiments on digestive enzymes revealed that CPP inhibits maltase and sucrase, and, to a lesser extent, pancreatic lipase in a concentration-dependent manner. Among the nine kinds of polyphenols (caffeoyl quinic acids (CQA), di-CQA, feruloyl quinic acids (FQA)) contained in CPP, di-CQA showed more potent inhibitory activity than CQA or FQA on these digestive enzymes, suggesting a predominant role of di-CQA in the regulation of postprandial energy metabolism. These results suggest that CPP modulates whole-body substrate oxidation by suppressing postprandial hyperglycaemia and hyperinsulinaemia, and these effects are mediated by inhibiting digestive enzymes.
C1 [Murase, Takatoshi; Yokoi, Yuka; Misawa, Koichi; Ominami, Hideo; Suzuki, Yasuto; Shibuya, Yusuke; Hase, Tadashi] Kao Corp, Biol Sci Labs, Ichikai, Tochigi 3213497, Japan.
C3 KAO Corporation
RP Murase, T (corresponding author), Kao Corp, Biol Sci Labs, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.
EM murase.takatoshi@kao.co.jp
OI HASE, TADASHI/0009-0003-3657-5332; Misawa, Koichi/0000-0002-0317-0609
CR Aston LM, 2006, P NUTR SOC, V65, P125, DOI 10.1079/PNS2005485
   Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   BECK B, 1983, REGUL PEPTIDES, V7, P3, DOI 10.1016/0167-0115(83)90276-8
   Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223
   Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162
   Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5
   Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   COLLIER G, 1983, AM J CLIN NUTR, V37, P941, DOI 10.1093/ajcn/37.6.941
   de Paulis T, 2002, EUR J PHARMACOL, V442, P215, DOI 10.1016/S0014-2999(02)01540-6
   Després JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228
   Díaz EO, 2006, OBES REV, V7, P219, DOI 10.1111/j.1467-789X.2006.00225.x
   Dórea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   ECKEL RH, 1979, DIABETES, V28, P1141, DOI 10.2337/diabetes.28.12.1141
   FLATT JP, 1995, AM J CLIN NUTR, V61, p952S, DOI 10.1093/ajcn/61.4.952S
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Guerciolini R, 1997, INT J OBESITY, V21, pS12
   Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120
   IDA Y, 1994, PHYTOCHEMISTRY, V35, P209, DOI 10.1016/S0031-9422(00)90536-3
   Ishikawa A, 2007, J NUTR SCI VITAMINOL, V53, P166, DOI 10.3177/jnsv.53.166
   Iwai K, 2004, J AGR FOOD CHEM, V52, P4893, DOI 10.1021/jf040048m
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kanter JE, 2007, CIRC RES, V100, P769, DOI 10.1161/01.RES.0000259589.34348.74
   Kiso T, 2003, BIOSCI BIOTECH BIOCH, V67, P1719, DOI 10.1271/bbb.67.1719
   Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107
   OBEN J, 1991, J ENDOCRINOL, V130, P267, DOI 10.1677/joe.0.1300267
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344
   Scheen AJ, 2003, DRUGS, V63, P933, DOI 10.2165/00003495-200363100-00002
   Shimotoyodome A, 2009, ENDOCRINOLOGY, V150, P2118, DOI 10.1210/en.2008-1162
NR 37
TC 54
Z9 55
U1 0
U2 46
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JUN 28
PY 2012
VL 107
IS 12
BP 1757
EP 1765
DI 10.1017/S0007114511005083
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 969XJ
UT WOS:000306092400004
PM 22017960
OA Bronze
DA 2025-04-28
ER

PT J
AU Mah, E
   Chen, O
   Liska, DJ
   Blumberg, JB
AF Mah, Eunice
   Chen, Oliver
   Liska, DeAnn J.
   Blumberg, Jeffrey B.
TI Dietary Supplements for Weight Management: A Narrative Review of Safety
   and Metabolic Health Benefits
SO NUTRIENTS
LA English
DT Review
DE cardiometabolic; diabetes; energy; body weight; BMI; liver; blood
   pressure
ID NONALCOHOLIC FATTY LIVER; TYPE-2 DIABETES-MELLITUS; GREEN COFFEE
   EXTRACT; DENSITY-LIPOPROTEIN CHOLESTEROL; DOSE-RESPONSE METAANALYSIS;
   BLOOD-PRESSURE; GLYCEMIC CONTROL; INSULIN SENSITIVITY; LIPID PROFILE;
   BODY-WEIGHT
AB Dietary supplements for weight management include myriad ingredients with thermogenic, lipotropic, satiety, and other metabolic effects. Recently, the safety of this product category has been questioned. In this review, we summarize the safety evidence as well as relevant clinical findings on weight management and metabolic effects of six representative dietary supplement ingredients: caffeine, green tea extract (GTE), green coffee bean extract (GCBE), choline, glucomannan, and capsaicinoids and capsinoids. Of these, caffeine, GTE (specifically epigallocatechin gallate [EGCG]), and choline have recommended intake limits, which appear not to be exceeded when used according to manufacturers' instructions. Serious adverse events from supplements with these ingredients are rare and typically involve unusually high intakes. As with any dietary component, the potential for gastrointestinal intolerance, as well as possible interactions with concomitant medications/supplements exist, and the health status of the consumer should be considered when consuming these components. Most of the ingredients reviewed also improved markers of metabolic health, such as glucose, lipids, and blood pressure, although the data are limited for some. In summary, weight management supplements containing caffeine, GTE, GCBE, choline, glucomannan, and capsaicinoids and capsinoids are generally safe when taken as directed and demonstrate metabolic health benefits for overweight and obese people.
C1 [Mah, Eunice] Biofortis Res, Addison, IL 60101 USA.
   [Chen, Oliver; Blumberg, Jeffrey B.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.
C3 Tufts University
RP Mah, E (corresponding author), Biofortis Res, Addison, IL 60101 USA.
EM eunice.mah@mxns.com; nutrategic@gmail.com; deannliska@gmail.com;
   jeffrey.blumberg@tufts.edu
RI Blumberg, Jeffrey/ABH-7888-2020
OI Blumberg, Jeffrey B./0000-0003-3871-8635; Chen,
   Oliver/0000-0002-6273-9017
FU Council of Responsible Nutrition [C222]
FX This research was funded by the Council of Responsible Nutrition, grant
   number C222.
CR Agostini CV, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2812
   Agostoni C, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2210
   Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1798
   Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   Amini MR, 2021, CLIN NUTR, V40, P1767, DOI 10.1016/j.clnu.2020.10.018
   [Anonymous], 21CFR201319 FDA
   [Anonymous], 739 FDA NDI
   Arias N, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082340
   Asbaghi O, 2021, DIABETES METAB SYND, V15, P23, DOI 10.1016/j.dsx.2020.11.004
   Asbaghi O, 2021, COMPLEMENT MED RES, V28, P244, DOI 10.1159/000511665
   Asbaghi O, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00587-z
   Asbaghi O, 2020, COMPLEMENT THER MED, V51, DOI 10.1016/j.ctim.2020.102424
   Asbaghi O, 2020, DIAB MET SYND CLIN R, V14, P293, DOI 10.1016/j.dsx.2020.03.018
   Basith S, 2016, MOLECULES, V21, DOI 10.3390/molecules21080966
   Beaudoin MS, 2013, APPL PHYSIOL NUTR ME, V38, P140, DOI 10.1139/apnm-2012-0201
   Behera SS, 2016, INT J BIOL MACROMOL, V92, P942, DOI 10.1016/j.ijbiomac.2016.07.098
   Benson SM, 2019, FOOD CHEM TOXICOL, V125, P271, DOI 10.1016/j.fct.2018.12.053
   Bessell E, 2021, INT J OBESITY, V45, P1631, DOI 10.1038/s41366-021-00839-w
   Blum J, 2007, NUTRAFOODS, V6, P13
   Blumberg J, 2010, NUTR REV, V68, P478, DOI 10.1111/j.1753-4887.2010.00307.x
   Bosso H, 2023, CRIT REV FOOD SCI, V63, P394, DOI 10.1080/10408398.2021.1948817
   Buchman AL, 2001, JPEN-PARENTER ENTER, V25, P260, DOI 10.1177/0148607101025005260
   Calatayud M, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.700571
   Cappelletti S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050611
   Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Chen Y, 2020, PHYTOTHER RES, V34, P2159, DOI 10.1002/ptr.6667
   Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b
   Daniells S, CRN SURVEY 80 AM NOW
   Dekant W, 2017, TOXICOL LETT, V277, P104, DOI 10.1016/j.toxlet.2017.06.008
   Deshpande J, 2016, J TOXICOL-US, V2016, DOI 10.1155/2016/6584649
   Devaraj RD, 2019, INT J BIOL MACROMOL, V126, P273, DOI 10.1016/j.ijbiomac.2018.12.203
   Du YB, 2021, NUTR CANCER, V73, P45, DOI 10.1080/01635581.2020.1733625
   Dwyer JT, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010041
   Dwyer JT, 2016, ADV NUTR, V7, P747, DOI 10.3945/an.115.010926
   EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4448
   Elsawy G, 2014, J HUM KINET, V40, P77, DOI 10.2478/hukin-2014-0009
   Farah A, 2019, BEVERAGES, V5, DOI 10.3390/beverages5010011
   FDA, GUID IND HIGHL CONC
   FDA, GUID IND EV BAS REV
   FDA, FDA GRANTS CIT PET G
   Fulgoni VL, 2015, AM J CLIN NUTR, V101, P1081, DOI 10.3945/ajcn.113.080077
   Fuse S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092676
   Gao X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155403
   Geller AI, 2015, NEW ENGL J MED, V373, P1531, DOI 10.1056/NEJMsa1504267
   Grgic J, 2020, BRIT J SPORT MED, V54, P681, DOI 10.1136/bjsports-2018-100278
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Guerrerio AL, 2012, AM J CLIN NUTR, V95, P892, DOI 10.3945/ajcn.111.020156
   Haghighatdoost F, 2018, NUTRITION, V45, P17, DOI 10.1016/j.nut.2017.06.022
   Haghighatdoost F, 2017, J AM COLL NUTR, V36, P541, DOI 10.1080/07315724.2017.1333470
   Han B, 2019, PHYTOTHER RES, V33, P2918, DOI 10.1002/ptr.6481
   Health Canada, SUMM SAF REVIEWGREEN
   HENRY DA, 1986, BRIT MED J, V292, P591, DOI 10.1136/bmj.292.6520.591-a
   Heymsfield S., 2018, Clinical perspectives on obesity treatment: Challenges, gaps, and promising opportunities
   Ho HVT, 2017, AM J CLIN NUTR, V105, P1239, DOI 10.3945/ajcn.116.142158
   Hornick B., 2013, Nutrition Today, V48, P168, DOI 10.1097/NT.0b013e31829da149
   Hu J, 2018, REGUL TOXICOL PHARM, V95, P412, DOI 10.1016/j.yrtph.2018.03.019
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Huang XF, 2013, CURR MED CHEM, V20, P2661, DOI 10.2174/0929867311320210004
   Institute of Medicine, 1998, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and Its Panel on Folate, Other B Vitamins, and Choline. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline, DOI [10.17226/6015, DOI 10.17226/6015]
   Integrated Laboratory Systems, CHLOR AC CAFF AC REV
   Irwin C, 2020, NEUROSCI BIOBEHAV R, V108, P877, DOI 10.1016/j.neubiorev.2019.12.008
   Jafari A, 2021, BMC PEDIATR, V21, DOI 10.1186/s12887-021-02677-1
   Jang HH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77983-2
   Kaats Gilbert R, 2015, J Am Coll Nutr, P1
   Khalesi S, 2014, EUR J NUTR, V53, P1299, DOI 10.1007/s00394-014-0720-1
   Killgore WDS, 2010, INT J EAT DISORDER, V43, P6, DOI 10.1002/eat.20658
   Kim A, 2011, J AM DIET ASSOC, V111, P1720, DOI 10.1016/j.jada.2011.08.009
   Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E
   Kumar RB, 2021, EXPERT REV ENDOCRINO, V16, P321, DOI 10.1080/17446651.2021.1991310
   Kwon Y, 2021, NUTRIENTS, V13, DOI 10.3390/nu13072461
   Larsson SC, 2021, BMC MED, V19, DOI 10.1186/s12916-021-02188-x
   Leermakers ETM, 2015, NUTR REV, V73, P500, DOI 10.1093/nutrit/nuv010
   Lejeune MPGM, 2003, BRIT J NUTR, V90, P651, DOI 10.1079/BJN2003938
   Lemaitre RN, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.22844
   Li DX, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051115
   Li GW, 2015, J HYPERTENS, V33, P243, DOI 10.1097/HJH.0000000000000426
   Li Y, 2022, FRONT CELL INFECT MI, V12, DOI 10.3389/fcimb.2022.771748
   Liang WX, 2023, CRIT REV FOOD SCI, V63, P3634, DOI 10.1080/10408398.2021.1991883
   Lin Y, 2020, PHYTOTHER RES, V34, P2459, DOI 10.1002/ptr.6697
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   López-Carrillo L, 2003, INT J CANCER, V106, P277, DOI 10.1002/ijc.11195
   Lu HJ, 2020, COMPR REV FOOD SCI F, V19, P3130, DOI 10.1111/1541-4337.12620
   Ludwig DS, 2021, AM J CLIN NUTR, V114, P1873, DOI 10.1093/ajcn/nqab270
   Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100
   Luo L, 2021, ASIA PAC J CLIN NUTR, V30, P130, DOI 10.6133/apjcn.202103_30(1).0016
   Mansour A, 2021, NUTR J, V20, DOI 10.1186/s12937-021-00694-5
   Mansour-Ghanaei F, 2018, PHYTOTHER RES, V32, P1876, DOI 10.1002/ptr.6130
   Marcason W, 2013, J ACAD NUTR DIET, V113, P364, DOI 10.1016/j.jand.2012.12.004
   Martino F, 2005, NUTR METAB CARDIOVAS, V15, P174, DOI 10.1016/j.numecd.2004.04.004
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   Mortensen A, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4864
   Morvaridi M, 2020, J DIABETES METAB DIS, V19, P645, DOI 10.1007/s40200-020-00536-x
   Naghipour S, 2021, NUTR RES REV, V34, P125, DOI 10.1017/S0954422420000177
   NAKAMURA T, 1967, TOHOKU J EXP MED, V93, P219, DOI 10.1620/tjem.93.219
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Neves JS, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00547
   NIH Office of Dietary Supplements, 2021, FACT SHEET HLTH PROF
   Nikpayam O, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0489-8
   Nirengi S, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.091305
   Oketch-Rabah HA, 2020, TOXICOL REP, V7, P386, DOI 10.1016/j.toxrep.2020.02.008
   Olthof MR, 2005, PLOS MED, V2, P446, DOI 10.1371/journal.pmed.0020135
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Onakpoya I, 2014, NUTR METAB CARDIOVAS, V24, P823, DOI 10.1016/j.numecd.2014.01.016
   Onakpoya I, 2014, J AM COLL NUTR, V33, P70, DOI 10.1080/07315724.2014.870013
   Pabalan Noel, 2014, J Gastrointest Cancer, V45, P334, DOI 10.1007/s12029-014-9610-2
   Page MJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n160
   Pastore RL, 2006, EXPLORE-NY, V2, P531, DOI 10.1016/j.explore.2006.08.008
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Qin Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091037
   Rasaei N, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10111731
   Rashvand S, 2020, BIOL TRACE ELEM RES, V194, P328, DOI 10.1007/s12011-019-01802-7
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Shearer J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123850
   Sherriff JL, 2016, ADV NUTR, V7, P5, DOI 10.3945/an.114.007955
   Shi XQ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0220-7
   Shi Z, 2017, INT J OBESITY, V41, P1074, DOI 10.1038/ijo.2017.88
   Shin KO, 2008, J SPORT SCI MED, V7, P365
   Shin KO, 2007, J NUTR SCI VITAMINOL, V53, P124, DOI 10.3177/jnsv.53.124
   Shirani F, 2021, PHYTOTHER RES, V35, P6080, DOI 10.1002/ptr.7217
   Soni & Associates Inc, EV GEN REC SAF GRAS
   Sood N, 2008, AM J CLIN NUTR, V88, P1167, DOI 10.1093/ajcn/88.4.1167
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Tester RF, 2016, J SCI FOOD AGR, V96, P3283, DOI 10.1002/jsfa.7571
   Tobias DK, 2021, CELL METAB, V33, P2314, DOI 10.1016/j.cmet.2021.10.005
   Torres-Ugalde YC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072489
   Turck D, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5718
   U.S. Department of Agriculture U.S. Department of Health and Human Services, 2020, DIET GUID AM 2020 20, V9th
   Ueno H, 2023, J AM NUTR ASSOC, V42, P123, DOI 10.1080/07315724.2021.2002739
   Urbina SL, 2017, APPETITE, V113, P264, DOI 10.1016/j.appet.2017.02.025
   van Avesaat M, 2016, AM J CLIN NUTR, V103, P305, DOI 10.3945/ajcn.115.123414
   Van Schaik L, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.621356
   Verster JC, 2018, CRIT REV FOOD SCI, V58, P1250, DOI 10.1080/10408398.2016.1247252
   Vido Loredana, 1993, Paediatrie und Paedologie, V28, P133
   Vieux F, 2020, J NUTR, V150, P2147, DOI 10.1093/jn/nxaa145
   Wallace JMW, 2012, BRIT J NUTR, V108, P1264, DOI 10.1017/S000711451100674X
   Wang X, 2014, J HUM NUTR DIET, V27, P501, DOI 10.1111/jhn.12181
   Whiting S, 2014, APPETITE, V73, P183, DOI 10.1016/j.appet.2013.11.005
   Whiting S, 2012, APPETITE, V59, P341, DOI 10.1016/j.appet.2012.05.015
   Wiedeman AM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101513
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Williamson DA, 2015, OBESITY, V23, P2319, DOI 10.1002/oby.21358
   Xu RF, 2020, NUTR METAB, V17, DOI [10.1186/s12986-020-00469-5, 10.1186/s12986-020-00472-w]
   Xu RF, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00557-5
   Xu RF, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019047
   Xu XY, 2023, CRIT REV FOOD SCI, V63, P3716, DOI 10.1080/10408398.2021.1992748
   Yates AA, 2017, REGUL TOXICOL PHARM, V84, P94, DOI 10.1016/j.yrtph.2017.01.002
   Yoshida A, 2020, ANN NUTR METAB, V76, P259, DOI 10.1159/000508674
   Younes M, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5239
   Yu DX, 2014, J NUTR, V144, P2034, DOI 10.3945/jn.114.197533
   Yu JY, 2017, DIABETES METAB J, V41, P251
   Yuan F, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201601122
   Zalewski BM, 2015, NUTRITION, V31, P437, DOI 10.1016/j.nut.2014.09.004
   Zalewski BM, 2019, J PEDIATR-US, V211, P85, DOI 10.1016/j.jpeds.2019.03.044
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
   Zsiborás C, 2018, CRIT REV FOOD SCI, V58, P1419, DOI 10.1080/10408398.2016.1262324
NR 158
TC 13
Z9 13
U1 0
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD MAY
PY 2022
VL 14
IS 9
AR 1787
DI 10.3390/nu14091787
PG 23
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 1E5MZ
UT WOS:000794533700001
PM 35565754
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Al-Obaidi, H
   Afzal, M
AF Al-Obaidi, Hetham
   Afzal, Mohammad
TI Methylxanthine content in hot drinks consumed in the State of Kuwait
SO JOURNAL OF FOOD AGRICULTURE & ENVIRONMENT
LA English
DT Article
DE Tea; coffee; methylxanthine; caffeine; theophylline; theobromine; HPLC
ID GREEN TEA; KIDNEY-STONES; BEVERAGE USE; BLACK TEA; CAFFEINE;
   THEOBROMINE; OBESITY; RISK; THEOPHYLLINE; ADENOSINE
AB Apart from four major catechins present in Camellia sinensis (tea), four major methylxanthines are also present in tea aqueous extract. Caffeine with its structural similarity to uric acid is the predominant methylxanthine in tea and it is known to contribute to hypertension and obesity leading to diabetes. Caffeine intake from tea, soft drinks and candies may be contributing to high level of obesity and diabetes prevalent in Kuwait. There are a variety of hot drinks that are traditional to the culture of Kuwait and their caffeine content has not been established. In this study we have undertaken to establish caffeine content in traditional hot drinks used in Kuwait and have found that Arabic Gahwa, a very popular hot drink in Kuwait, has one of the lowest caffeine content among coffee drinks but its high frequency of consumption may have an additive effect on caffeine intake. Caffeine content of commercial brands and herbal teas used in Kuwait has also been established and found that Rabea black tea had the highest caffeine and theobromine content, while Red label black tea has the lowest caffeine. Reverse phase high performance liquid chromatography (HPLC) was used to establish methylxanthine content in different tea aqueous extracts. A comparison of caffeine content in various hot drinks is presented.
C1 [Afzal, Mohammad] Kuwait Univ, Fac Sci, Dept Biol Sci, Safat 13060, Kuwait.
   [Al-Obaidi, Hetham] Publ Author Appl Educ &Training, Coll Technol Studies, Dept Lab Technol Appl Sci, Kuwait, Kuwait.
C3 Kuwait University; Public Authority for Applied Education & Training
   (PAAET) - Kuwait
RP Afzal, M (corresponding author), Kuwait Univ, Fac Sci, Dept Biol Sci, POB 5969, Safat 13060, Kuwait.
EM afzalq8@gmail.com
RI Afzal, Mohammad/LDE-8761-2024
CR ABERNETHY DR, 1985, BRIT J CLIN PHARMACO, V20, P61, DOI 10.1111/j.1365-2125.1985.tb02799.x
   Ahmad N, 1999, NUTR REV, V57, P78, DOI 10.1111/j.1753-4887.1999.tb06927.x
   Al-Kandari YY, 2006, OBES REV, V7, P147, DOI 10.1111/j.1467-789X.2006.00231.x
   ALAWADI F, 1989, J ROY SOC HEALTH, V109, P175, DOI 10.1177/146642408910900508
   Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c
   Bispo MS, 2002, J CHROMATOGR SCI, V40, P45, DOI 10.1093/chromsci/40.1.45
   BRENNER M, 1988, CLIN ALLERGY, V18, P143, DOI 10.1111/j.1365-2222.1988.tb02853.x
   BUTCHER RW, 1962, J BIOL CHEM, V237, P1244
   Cao J, 1996, FUND APPL TOXICOL, V29, P244, DOI 10.1006/faat.1996.0028
   Curhan GC, 1996, AM J EPIDEMIOL, V143, P240, DOI 10.1093/oxfordjournals.aje.a008734
   Curhan GC, 1998, ANN INTERN MED, V128, P534, DOI 10.7326/0003-4819-128-7-199804010-00003
   Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731
   GENNARO MC, 1992, FRESEN J ANAL CHEM, V343, P523, DOI 10.1007/BF00322162
   GRYGIEL JJ, 1981, CLIN PHARMACOL THER, V30, P491, DOI 10.1038/clpt.1981.193
   Itoh Y, 2005, J UROLOGY, V173, P271, DOI 10.1097/01.ju.0000141311.51003.87
   JOAN L, 2006, J FOOD SCI, V48, P745
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Khanchi AR, 2007, FOOD CHEM, V103, P1062, DOI 10.1016/j.foodchem.2006.07.035
   KIM RO, 2008, J NUTR, V38, P2111
   Miyagawa C, 1997, BIOSCI BIOTECH BIOCH, V61, P1901, DOI 10.1271/bbb.61.1901
   Pharn-Huy LAN, 2008, J FOOD AGRIC ENVIRON, V6, P6
   RAUCH G, 1986, METHOD FIND EXP CLIN, V8, P147
   Sai K, 1998, FOOD CHEM TOXICOL, V36, P1043, DOI 10.1016/S0278-6915(98)00073-8
   SCOTT LND, 1999, ALTERN MED REV, V4, P178
   SLATTERY ML, 1993, CANCER CAUSE CONTROL, V4, P559, DOI 10.1007/BF00052432
   SNYDER SH, 1981, P NATL ACAD SCI-BIOL, V78, P3260, DOI 10.1073/pnas.78.5.3260
   STUHLINGER W, 1980, SCHWEIZ MED WOCHENSC, V110, P380
   SUZUKI T, 1975, BIOCHEM J, V146, P87, DOI 10.1042/bj1460087
   TAHA TH, 1983, DIABETOLOGIA, V25, P306, DOI 10.1007/BF00253190
   Tiwari RP, 2005, INDIAN J MED RES, V122, P80
   van het Hof KH, 1998, EUR J CLIN NUTR, V52, P356, DOI 10.1038/sj.ejcn.1600568
   VASIL AV, 2004, PHARM CHEM J, V23, P776
   Vinson JA, 1998, FEBS LETT, V433, P44, DOI 10.1016/S0014-5793(98)00880-1
   Vinson JA, 2005, J AGR FOOD CHEM, V53, P3710, DOI 10.1021/jf048052l
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
NR 35
TC 1
Z9 1
U1 0
U2 4
PU WFL PUBL
PI HELSINKI
PA MERI-RASTILANTIE 3 C, HELSINKI, FI-00980, FINLAND
SN 1459-0255
EI 1459-0263
J9 J FOOD AGRIC ENVIRON
JI J. Food Agric. Environ.
PD JAN
PY 2010
VL 8
IS 1
BP 41
EP 43
PG 3
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 545JC
UT WOS:000273727300009
DA 2025-04-28
ER

PT J
AU Ohishi, T
   Fukutomi, R
   Shoji, Y
   Goto, S
   Isemura, M
AF Ohishi, Tomokazu
   Fukutomi, Ryuuta
   Shoji, Yutaka
   Goto, Shingo
   Isemura, Mamoru
TI The Beneficial Effects of Principal Polyphenols from Green Tea, Coffee,
   Wine, and Curry on Obesity
SO MOLECULES
LA English
DT Review
DE polyphenols; epigallocatechin-3-O-gallate; chlorogenic acid;
   resveratrol; curcumin; obesity; reactive oxygen species; 5&#8242;
   -AMP-activated protein kinase; nuclear factor-&#954; B; randomized
   controlled trial
AB Several epidemiological studies and clinical trials have reported the beneficial effects of green tea, coffee, wine, and curry on human health, with its anti-obesity, anti-cancer, anti-diabetic, and neuroprotective properties. These effects, which have been supported using cell-based and animal studies, are mainly attributed to epigallocatechin gallate found in green tea, chlorogenic acid in coffee, resveratrol in wine, and curcumin in curry. Polyphenols are proposed to function via various mechanisms, the most important of which is related to reactive oxygen species (ROS). These polyphenols exert conflicting dual actions as anti- and pro-oxidants. Their anti-oxidative actions help scavenge ROS and downregulate nuclear factor-kappa B to produce favorable anti-inflammatory effects. Meanwhile, pro-oxidant actions appear to promote ROS generation leading to the activation of 5 '-AMP-activated protein kinase, which modulates different enzymes and factors with health beneficial roles. Currently, it remains unclear how these polyphenols exert either pro- or anti-oxidant effects. Similarly, several human studies showed no beneficial effects of these foods, and, by extension polyphenols, on obesity. These inconsistencies may be attributed to different confounding study factors. Thus, this review provides a state-of-the-art update on these foods and their principal polyphenol components, with an assumption that it prevents obesity.
C1 [Ohishi, Tomokazu] Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Shizuoka 4100301, Japan.
   [Fukutomi, Ryuuta] Higuchi Inc, Qual Management Div, Minato Ku, Tokyo 1080075, Japan.
   [Shoji, Yutaka; Isemura, Mamoru] Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Shizuoka 4228526, Japan.
   [Goto, Shingo] Natl Agr & Food Res Org NARO, Div Citrus Res, Inst Fruit Tree & Tea Sci, Shimizu, Shizuoka 4240292, Japan.
C3 University of Shizuoka; National Agriculture & Food Research
   Organization - Japan
RP Ohishi, T (corresponding author), Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Shizuoka 4100301, Japan.
EM ohishit@bikaken.or.jp; fukutomi_ryuuta@mac.com; fukutomi_ryuuta@mac.com;
   gotos@affrc.go.jp; isemura@u-shizuoka-ken.ac.jp
RI Goto, Shingo/AAU-4777-2021
OI Fukutomi, Ryuuta/0000-0002-3918-5159; Shoji, Yutaka/0000-0001-7837-3411;
   Isemura, Mamoru/0000-0002-2965-1742; Ohishi,
   Tomokazu/0000-0002-9039-4474
CR Abdel-Magid AF, 2013, ACS MED CHEM LETT, V4, P16, DOI 10.1021/ml3004044
   Ahn J, 2010, AM J PHYSIOL-CELL PH, V298, pC1510, DOI 10.1152/ajpcell.00369.2009
   André DM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17558-w
   Bae UJ, 2018, AM J CHINESE MED, V46, P617, DOI [10.1142/s0192415x18500325, 10.1142/S0192415X18500325]
   Bao LP, 2018, INT IMMUNOPHARMACOL, V54, P245, DOI 10.1016/j.intimp.2017.11.021
   Barrio-Lopez MT, 2013, CLIN NUTR, V32, P797, DOI 10.1016/j.clnu.2012.12.002
   Baselga-Escudero L, 2014, NUCLEIC ACIDS RES, V42, P882, DOI 10.1093/nar/gkt1011
   Basil JS, 2016, J PEDIATR-US, V173, P143, DOI 10.1016/j.jpeds.2016.02.046
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Baum L, 2007, PHARMACOL RES, V56, P509, DOI 10.1016/j.phrs.2007.09.013
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Calvo D, 1998, J LIPID RES, V39, P777
   Catalano D, 2010, DIGEST DIS SCI, V55, P3200, DOI 10.1007/s10620-010-1143-3
   Chabowski A, 2005, FEBS LETT, V579, P2428, DOI 10.1016/j.febslet.2004.11.118
   Chen CY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092729
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Chen JL, 2016, FOOD CHEM TOXICOL, V96, P70, DOI 10.1016/j.fct.2016.07.030
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544
   Cioccoloni G, 2020, J CHEMOTHERAPY, V32, P30, DOI 10.1080/1120009X.2019.1694761
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Cordain L, 2000, METABOLISM, V49, P1473, DOI 10.1053/meta.2000.17672
   Cotter DG, 2014, AM J PHYSIOL-ENDOC M, V307, pE176, DOI 10.1152/ajpendo.00087.2014
   Di Pierro F, 2015, EUR REV MED PHARMACO, V19, P4195
   Dostal AM, 2016, J NUTR, V146, P38, DOI 10.3945/jn.115.222414
   Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966
   Eseberri I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184875
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Flechtner-Mors M, 2004, INT J OBESITY, V28, P1420, DOI 10.1038/sj.ijo.0802786
   FRIEDMAN TC, 1986, ENDOCRINOLOGY, V118, P562, DOI 10.1210/endo-118-2-562
   Fu XH, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/8042097
   Ganjali S, 2014, SCI WORLD J, DOI 10.1155/2014/898361
   Giordo R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113838
   Gong WF, 2019, CELL CYCLE, V18, P1549, DOI 10.1080/15384101.2019.1612697
   Gualdoni GA, 2014, BBA-GEN SUBJECTS, V1840, P95, DOI 10.1016/j.bbagen.2013.09.009
   Guo J, 2020, J VASC RES, V57, P325, DOI 10.1159/000509217
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Han DD, 2019, FREE RADICAL BIO MED, V137, P1, DOI 10.1016/j.freeradbiomed.2019.04.014
   Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06
   Hayakawa S., 2018, Bioactive Molecules in Food, P1, DOI DOI 10.3390/MOLECULES25194553
   Hayakawa S, 2020, MOLECULES, V25, DOI 10.3390/molecules25194553
   Hayakawa Sumio, 2016, Asian Pac J Cancer Prev, V17, P1649
   Herranz-López M, 2020, FOOD CHEM TOXICOL, V144, DOI 10.1016/j.fct.2020.111606
   Honnappa CG, 2016, INT J IMMUNOPATH PH, V29, P562, DOI 10.1177/0394632016673369
   Hosseinabadi S, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2019.102290
   Hou N, 2017, ANTI-CANCER DRUG, V28, P59, DOI 10.1097/CAD.0000000000000430
   Hsieh CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201920
   Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Huang LH, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2355-x
   Huang S, 2019, THERANOSTICS, V9, P6745, DOI 10.7150/thno.34674
   Iacomino G, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0577-z
   Igarashi Y, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1334484
   Inan-Eroglu E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145178
   Jang MH, 2017, BIOL PHARM BULL, V40, P797, DOI 10.1248/bpb.b16-00884
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Khan MS, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7860650
   Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kong DQ, 2019, FREE RADICAL RES, V53, P680, DOI 10.1080/10715762.2019.1621308
   Koyama T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103090
   Kunnumakkara AB, 2017, BRIT J PHARMACOL, V174, P1325, DOI 10.1111/bph.13621
   La XQ, 2019, J AGR FOOD CHEM, V67, P2510, DOI 10.1021/acs.jafc.8b06665
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Lee MS, 2009, PHYTOTHER RES, V23, P1088, DOI 10.1002/ptr.2737
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473
   Lewandowska U, 2013, J AGR FOOD CHEM, V61, P12183, DOI 10.1021/jf404439b
   Li C, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2648-8
   Li F, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01366
   Li QP, 2019, FOOD FUNCT, V10, P7983, DOI 10.1039/c9fo02159k
   Liang HH, 2018, LIFE SCI, V209, P43, DOI 10.1016/j.lfs.2018.07.047
   Lin XY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216711
   Lin Y, 2020, PHYTOTHER RES, V34, P2459, DOI 10.1002/ptr.6697
   Liu CW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44689
   Liu G, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5716241
   Liu J, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0768-7
   Liu SW, 2018, J FUNCT FOODS, V40, P648, DOI 10.1016/j.jff.2017.11.048
   Lu J, 2018, LIFE SCI, V209, P324, DOI 10.1016/j.lfs.2018.08.007
   Lu XH, 2019, PHARM BIOL, V57, P250, DOI 10.1080/13880209.2019.1594311
   Lukasiewicz E, 2005, PUBLIC HEALTH NUTR, V8, P315, DOI 10.1079/PHN2004680
   Ma FY, 2017, PHARM BIOL, V55, P1263, DOI 10.1080/13880209.2017.1297838
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Maréchal L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051529
   Mirzaaghaei S, 2019, ACS OMEGA, V4, P8421, DOI 10.1021/acsomega.9b00224
   Mousavi SM, 2020, CRIT REV FOOD SCI, V60, P171, DOI 10.1080/10408398.2018.1517724
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakamae I, 2019, MOLECULES, V24, DOI 10.3390/molecules24224067
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Nozari E, 2020, LIFE SCI, V259, DOI 10.1016/j.lfs.2020.118293
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Osella Alberto R, 2014, Rev Fac Cien Med Univ Nac Cordoba, V71, P113
   Pan J, 2017, ONCOTARGET, V8, P65743, DOI 10.18632/oncotarget.19445
   Pastor RF, 2019, CRIT REV FOOD SCI, V59, P1237, DOI 10.1080/10408398.2017.1400517
   Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265
   Peng SG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8594767
   Posadino AM, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9060209
   Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Qin S, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0293-y
   Qin SN, 2019, DRUG DES DEV THER, V13, P2759, DOI 10.2147/DDDT.S215358
   Rakshit S, 2010, BIOCHEM PHARMACOL, V80, P1662, DOI 10.1016/j.bcp.2010.08.013
   Ramdani LH, 2020, ACTA VIROL, V64, P276, DOI 10.4149/av_2020_309
   Ran ZL, 2019, MOL MED REP, V19, P1024, DOI 10.3892/mmr.2018.9749
   Reddy AT, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118136
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Sadeghi A, 2018, INFLAMMOPHARMACOLOGY, V26, P1265, DOI 10.1007/s10787-018-0466-0
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Saeki K, 2018, MOLECULES, V23, DOI 10.3390/molecules23061295
   Sahebkar A, 2016, PHARMACOL RES, V107, P234, DOI 10.1016/j.phrs.2016.03.026
   Sakamoto Naoya, 2017, Noncoding RNA Res, V2, P83, DOI 10.1016/j.ncrna.2017.05.002
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Saraf-Bank S, 2019, PHYTOTHER RES, V33, P2015, DOI 10.1002/ptr.6370
   Shao WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028784
   Silva J, 2021, ALCOHOL, V91, P1, DOI 10.1016/j.alcohol.2020.10.002
   Singh AP, 2019, MED RES REV, V39, P1851, DOI 10.1002/med.21565
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   Soltani A, 2019, J CELL PHYSIOL, V234, P2241, DOI 10.1002/jcp.27192
   Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005
   Subedi L, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8092713
   Suzuki T, 2016, MOLECULES, V21, DOI 10.3390/molecules21101305
   Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975
   Tan Y, 2017, WORLD J GASTROENTERO, V23, P3805, DOI 10.3748/wjg.v23.i21.3805
   Tanabe H., 2017, OBES CONTROL THER, V4, P1, DOI [10.15226/2374-8354/4/3/00142, DOI 10.15226/2374-8354/4/3/00142]
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Thomson CA, 2012, INT J OBESITY, V36, P1158, DOI 10.1038/ijo.2012.84
   Tian L, 2019, J CELL MOL MED, V23, P4666, DOI 10.1111/jcmm.14351
   Tian LL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.455
   Tian WX, 2006, CURR MED CHEM, V13, P967, DOI 10.2174/092986706776361012
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   Tsai CY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010016
   Tsai KL, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700928
   Ueda-Wakagi M, 2018, FOOD FUNCT, V9, P4223, DOI [10.1039/c8fo00807h, 10.1039/C8FO00807H]
   UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644
   Vidot DC, 2016, METAB SYNDR RELAT D, V14, P354, DOI 10.1089/met.2015.0171
   Vlavcheski F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040914
   Wada Y, 2019, SURG TODAY, V49, P536, DOI 10.1007/s00595-019-1761-0
   Wahab A, 2017, MOLECULES, V22, DOI 10.3390/molecules22081329
   Wang F, 2020, ORAL DIS, V26, P815, DOI 10.1111/odi.13290
   Wang H, 2015, SHOCK, V44, P173, DOI 10.1097/SHK.0000000000000390
   Wang L, 2020, DRUG DES DEV THER, V14, P4451, DOI 10.2147/DDDT.S266502
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   Weisberg SP, 2008, ENDOCRINOLOGY, V149, P3549, DOI 10.1210/en.2008-0262
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Xian YX, 2020, N-S ARCH PHARMACOL, V393, P2009, DOI 10.1007/s00210-019-01777-1
   Xicota L, 2020, CLIN NUTR, V39, P1292, DOI 10.1016/j.clnu.2019.05.028
   Xu M, 2019, FOOD FUNCT, V10, P7489, DOI 10.1039/c9fo00502a
   Yan B, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1346958
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641
   Yang F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00929
   Yang JS, 2012, IN VIVO, V26, P971
   Yi JJ, 2020, FOOD CHEM TOXICOL, V135, DOI 10.1016/j.fct.2019.111051
   Yonekura Y, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051370
   Yu H, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819870781
   Yu TZ, 2019, J CELL PHYSIOL, V234, P6371, DOI 10.1002/jcp.27370
   Yuan H, 2020, AGING CELL, V19, DOI 10.1111/acel.13199
   Zeng JH, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.202000452
   Zhang LZ, 2020, COPD, V17, P333, DOI 10.1080/15412555.2020.1780576
   Zhang R, 2006, BIOTECHNOL APPL BIOC, V43, P1, DOI 10.1042/BA20050064
   Zhang S, 2017, ANTICANCER RES, V37, P464, DOI 10.21873/anticanres.11338
   Zhang WT, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100473
   Zhong X, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801230
   Zhong Y, 2020, EXP THER MED, V20, P1856, DOI 10.3892/etm.2020.8915
   Zhou TW, 2020, PHYTOTHER RES, V34, P2074, DOI 10.1002/ptr.6674
   Zhou Y, 2016, BIOCHEM BIOPH RES CO, V469, P1083, DOI 10.1016/j.bbrc.2015.12.094
NR 174
TC 72
Z9 72
U1 2
U2 54
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JAN
PY 2021
VL 26
IS 2
AR 453
DI 10.3390/molecules26020453
PG 22
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA PY5BT
UT WOS:000612060200001
PM 33467101
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Dostal, AM
   Arikawa, A
   Espejo, L
   Kurzers, MS
AF Dostal, Allison M.
   Arikawa, Andrea
   Espejo, Luis
   Kurzers, Mindy S.
TI Long-Term Supplementation of Green Tea Extract Does Not Modify Adiposity
   or Bone Mineral Density in a Randomized Trial of Overweight and Obese
   Postmenopausal Women
SO JOURNAL OF NUTRITION
LA English
DT Article
DE green tea; obesity; body composition; bone health; postmenopausal women
ID CATECHOL-O-METHYLTRANSFERASE; BREAST-CANCER RISK; BODY-MASS INDEX;
   WEIGHT-LOSS; FAT MASS; OSTEOPOROSIS; HEALTH; ADIPONECTIN; CAFFEINE; COMT
AB Background: Green tea extract (GTE) consumption has been linked to favorable changes in adiposity and bone mineral density (BMD), although it is unknown if these effects are due to green tea catechins or caffeine. The catechol-O-methyltransferase (COM7) genotype may also modify these associations.
   Objective: We examined the impact of decaffeinated GTE on body composition (using dual-energy X-ray absorptiometry) and obesity-associated hormones.
   Methods: The Minnesota Green Tea Trial was a 12-mo randomized, double-blind, placebo-controlled clinical trial in 937 postmenopausal women (aged 50-70 y) assigned to receive either GTE containing 843 mg (-)-epigallocatechin-3-gallate or placebo. This substudy was conducted in 121 overweight/obese participants [body mass index (BMI) (kg/m(2))
   Results: There were no differences in changes in BMI (-0.13 +/- 0.11 compared with -0.05 +/- 0.11; P= 0.61), total fat mass (-0.30 +/- 0.16 compared with -0.12 +/- 0.15 kg; P = 0.40), percentage of body fat (-0.15% +/- 0.17% compared with -0.15% +/- 0.16%; P = 0.99), or BMD (-0.006 +/- 0.002 compared with -0.003 +/- 0.002 g/cm(2); P = 0.49) over 12 mo between women taking GTE (n = 61) and those taking a placebo (n = 60). Interactions were observed between treatment and time for gynoid percentage of fat (%fat) and tissue %fat. Gynoid %fat increased from baseline to month 12 in the placebo group as baseline BMI increased and decreased over time as baseline BMI increased in the GTE group (P-interaction = 0.02). Tissue %fat increased from baseline to month 12 in the placebo group as baseline BMI increased. In the GTE group, tissue %fat decreased during the intervention as baseline BMI increased (P-interaction = 0.04). No changes were seen in circulating leptin, ghrelin, adiponectin, or insulin concentrations. COMT genotype did not modify the effect of GTE on any variable.
   Conclusions: Decaffeinated GTE was not associated with overall reductions in adiposity or improvements in BMD in overweight/obese postmenopausal women. However, GTE may be beneficial for reduction in tissue and gynoid %fat in individuals with higher BMI. This clinical trial was registered at www.clinicaltrials.gov as NCT00917735.
C1 [Dostal, Allison M.; Espejo, Luis; Kurzers, Mindy S.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA.
   [Arikawa, Andrea] Univ N Florida, Dept Nutr & Dietet, Jacksonville, FL USA.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   State University System of Florida; University of North Florida
RP Kurzers, MS (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA.
EM mkurzer@umn.edu
RI Arikawa, Andrea/ABA-8106-2021
OI Dostal Webster, Allison/0000-0002-6467-8430
FU NIH/National Cancer Institute [R01 CA127236]; National Cancer Institute
   [T32CA132670]; University of Minnesota Agricultural Experiment Station
   project [MIN-18-103]; National Center for Advancing Translational
   Sciences of the NIH [UL1TR000114]
FX Supported by NIH/National Cancer Institute grant R01 CA127236, award
   T32CA132670 from the National Cancer Institute, the University of
   Minnesota Agricultural Experiment Station project MIN-18-103, and the
   National Center for Advancing Translational Sciences of the NIH award
   UL1TR000114.
CR Alissa EM, 2014, J AM COLL NUTR, V33, P206, DOI 10.1080/07315724.2013.866528
   Alvehus M, 2010, OBESITY, V18, P879, DOI 10.1038/oby.2010.22
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bhagwat S, 2014, 3 USDA
   Chen D, 2005, BIOCHEM PHARMACOL, V69, P1523, DOI 10.1016/j.bcp.2005.01.024
   Dawling S, 2001, CANCER RES, V61, P6716
   Dostal AM, 2015, FOOD CHEM TOXICOL, V83, P26, DOI 10.1016/j.fct.2015.05.019
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117
   Fu X, 2011, OSTEOPOROSIS INT, V22, P113, DOI 10.1007/s00198-010-1210-9
   Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hodgson AB, 2013, ADV NUTR, V4, P129, DOI 10.3945/an.112.003269
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Jurgens TM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008650.pub2
   KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   Kriska AM., 2002, MED SCI SPORTS MED, V29, pS73
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   Lorenz M, 2014, EUR J PHARMACOL, V740, P645, DOI 10.1016/j.ejphar.2014.06.014
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Metz JA, 2000, ARCH INTERN MED, V160, P2150, DOI 10.1001/archinte.160.14.2150
   MIKSICEK RJ, 1993, MOL PHARMACOL, V44, P37
   Mohiti-Ardekani J, 2014, J BONE MINER METAB, V32, P400, DOI 10.1007/s00774-013-0511-4
   Muraki S, 2007, J ORTHOP SCI, V12, P317, DOI 10.1007/s00776-007-1143-0
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakagawa H, 2002, BIOCHEM BIOPH RES CO, V292, P94, DOI 10.1006/bbrc.2002.6622
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Ong T, 2014, BONE, V59, P207, DOI 10.1016/j.bone.2013.11.024
   Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Samavat H, 2015, CANCER CAUSE CONTROL, V26, P1405, DOI 10.1007/s10552-015-0632-2
   Shen CL, 2012, OSTEOPOROSIS INT, V23, P1541, DOI 10.1007/s00198-011-1731-x
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   SUZUKI N, 1995, MATURITAS, V22, P9, DOI 10.1016/0378-5122(95)00902-W
   Suzuki T, 1997, BONE, V21, P461, DOI 10.1016/S8756-3282(97)00179-8
   Syvanen AC, 1997, PHARMACOGENETICS, V7, P65
   Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630
   U.S. Department of Agriculture (USDA 2000) Human Nutrition Research Center, 2000, CONT SURV FOOD INT I
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Watts NB, 2014, NAT REV ENDOCRINOL, V10, P412, DOI 10.1038/nrendo.2014.55
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Williams GA, 2009, ENDOCRINOLOGY, V150, P3603, DOI 10.1210/en.2008-1639
   Wongdee K, 2015, WORLD J DIABETES, V6, P673, DOI 10.4239/wjd.v6.i5.673
   Wu AH, 2012, CANCER PREV RES, V5, P393, DOI 10.1158/1940-6207.CAPR-11-0407
   Yuan JM, 2013, AM J CLIN NUTR, V98, p1676S, DOI 10.3945/ajcn.113.058271
   Zhao LJ, 2008, J BONE MINER RES, V23, P17, DOI [10.1359/jbmr.070813, 10.1359/JBMR.070813]
   Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572
NR 53
TC 63
Z9 63
U1 0
U2 32
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD FEB
PY 2016
VL 146
IS 2
BP 256
EP 264
DI 10.3945/jn.115.219238
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DC9RD
UT WOS:000369557800011
PM 26701796
OA Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Suliga, E
   Koziel, D
   Ciesla, E
   Rebak, D
   Gluszek, S
AF Suliga, Edyta
   Koziel, Dorota
   Ciesla, Elzbieta
   Rebak, Dorota
   Gluszek, Stanislaw
TI Coffee consumption and the occurrence and intensity of metabolic
   syndrome: a cross-sectional study
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE Coffee consumption; BMI; metabolic syndrome
ID TEA CONSUMPTION; AMSTERDAM GROWTH; DIETARY-INTAKE; RISK; METAANALYSIS;
   ASSOCIATION; PREVALENCE; OBESITY; DISEASE; WEIGHT
AB The objective of the study was to investigate associations between coffee consumption and the occurrence of metabolic syndrome (MetS) and its components in individuals with a normal BMI, as well in those who are overweight and obese. The analysis was based on the data of 10,367 participants. The studies included a questionnaire interview, anthropometric measurements, blood pressure measurements and analyses of collected fasting-blood samples. In the overweight and obese participants, lower coffee consumption, compared with higher consumption was correlated with a significantly higher risk of abdominal obesity, hypertension, an abnormal glucose concentration, HDL cholesterol, triglycerides and MetS (p<.05). In the participants with a normal BMI, lower coffee consumption was related to the abdominal obesity, HDL cholesterol and MetS (p<.05). Individuals with a normal BMI may react slightly differently to nutritional factors modifying metabolism such as coffee, compared with those with excessive body mass.
C1 [Suliga, Edyta] Jan Kochanowski Univ, Inst Nursing & Midwifery, Dept Prevent Alimentary Tract Dis, Fac Med & Hlth Sci, Kielce, Poland.
   [Koziel, Dorota; Rebak, Dorota; Gluszek, Stanislaw] Jan Kochanowski Univ, Inst Med Sci, Dept Surg & Surg Nursing, Fac Med & Hlth Sci,Sci Res Lab, Kielce, Poland.
   [Ciesla, Elzbieta] Jan Kochanowski Univ, Inst Publ Hlth, Dept Dev Age Res, Fac Med & Hlth Sci, Kielce, Poland.
C3 Jan Kochanowski University; Jan Kochanowski University; Jan Kochanowski
   University
RP Suliga, E (corresponding author), Jan Kochanowski Univ, Fac Med & Hlth Sci, Al 9 Wiekow Kielc 19, PL-25317 Kielce, Poland.
EM edyta.suliga@ujk.edu.pl
RI Stanisław, Gluszek/S-3303-2019
OI Gluszek, Stanislaw/0000-0001-7752-0459; Rebak,
   Dorota/0000-0001-6922-9231; Suliga, Edyta/0000-0003-3063-0380; Koziel,
   Dorota/0000-0001-8114-1814
FU Maria Sklodowska-Curie Institute of Oncology in Warsaw; Polish-Norwegian
   Foundation Research Fund; Ministry of Science and Higher Education; Jan
   Kochanowski University [615501.00]
FX The study was conducted with the support of the Maria Sklodowska-Curie
   Institute of Oncology in Warsaw and the Polish-Norwegian Foundation
   Research Fund (study design). The research data were collected within
   the scope of PONS research: " Establishing infrastructure for studies
   concerning health state of the population of Poland" (PNRF-228-AI-1/07)
   (data collection). The PONS team, who collected the data that we used in
   our analysis, received the funds mentioned above. The study was also
   supported by The Ministry of Science and Higher Education from the funds
   received within financing statutory activity for Faculty of Medicine and
   Health Sciences, Jan Kochanowski University, research project no.
   615501.00 (analysis and preparation of the manuscript).
CR Allam-Ndoul B, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060324
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Pimentel VRD, 2014, CIENC SAUDE COLETIVA, V19, P49, DOI 10.1590/1413-81232014191.1901
   Dehghan M, 2012, J HUM NUTR DIET, V25, P225, DOI 10.1111/j.1365-277X.2012.01240.x
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Hedström AK, 2016, J NEUROL NEUROSUR PS, V87, P454, DOI 10.1136/jnnp-2015-312176
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Lee AH, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.19
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Neary MT, 2009, PHARMACOL THERAPEUT, V124, P44, DOI 10.1016/j.pharmthera.2009.06.005
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Ran HQ, 2016, PAK J MED SCI, V32, P253, DOI 10.12669/pjms.321.8761
   Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207
   Saleh D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-666
   Schmit SL, 2016, CANCER EPIDEM BIOMAR, V25, P634, DOI 10.1158/1055-9965.EPI-15-0924
   Setiawan VW, 2015, GASTROENTEROLOGY, V148, P118, DOI 10.1053/j.gastro.2014.10.005
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644
   Suliga E, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0045-9
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Wilson PWF, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003089
   Zak-Golab A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/674106
   Zamora-Ros R, 2014, J NUTR, V144, P335, DOI 10.3945/jn.113.184945
   Zatonski WA, 2011, ANN AGR ENV MED, V18, P203
NR 38
TC 21
Z9 21
U1 0
U2 26
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD JUN
PY 2017
VL 68
IS 4
BP 507
EP 513
DI 10.1080/09637486.2016.1256381
PG 7
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA ES5RS
UT WOS:000399601500014
PM 27842207
DA 2025-04-28
ER

PT J
AU Papadopoulou, E
   Botton, J
   Brantsæter, AL
   Haugen, M
   Alexander, J
   Meltzer, HM
   Bacelis, J
   Elfvin, A
   Jacobsson, B
   Engpiel, V
AF Papadopoulou, Eleni
   Botton, Jeremie
   Brantsaeter, Anne-Lise
   Haugen, Margaretha
   Alexander, Jan
   Meltzer, Helle Margrete
   Bacelis, Jonas
   Elfvin, Anders
   Jacobsson, Bo
   Engpiel, Verena
TI Maternal caffeine intake during pregnancy and childhood growth and
   overweight: results from a large Norwegian prospective observational
   cohort study
SO BMJ OPEN
LA English
DT Article
ID GESTATIONAL WEIGHT-GAIN; BODY-MASS INDEX; BIRTH-WEIGHT; RAPID GROWTH;
   DEVELOPMENTAL ORIGINS; POOLED ANALYSIS; METABOLIC RISK; DISEASE;
   INFANCY; ASSOCIATION
AB Objectives To study the association between maternal caffeine intake during pregnancy and the child's weight gain and overweight risk up to 8 years.
   Design Prospective nationwide pregnancy cohort.
   Setting The Norwegian Mother and Child Cohort Study.
   Participants A total of 50943 mothers recruited from 2002 to 2008 and their children, after singleton pregnancies, with information about average caffeine intake assessed at mid-pregnancy.
   Outcome measure Child's body size information at 11 age points from 6 weeks to 8 years. We defined excess growth in infancy as a WHO weight gain z-score of >0.67 from birth to age 1 year, and overweight according to the International Obesity Task Force. We used a growth model to assess individual growth trajectories.
   Results Compared with pregnant women with low caffeine intake (<50 mg/day, 46%), women with average (50-199 mg/day, 44 %), high (>= 200-299 mg/day, 7 %) and very high (>= 300 mg/day, 3%) caffeine intakes had an increased risk of their child experiencing excess growth in infancy, after adjustment for confounders (OR=1.15, 95% CI 1.09 to 1.22, OR=1.30, 95% CI 1.16 to 1.45, OR=1.66, 95%CI 1.42 to 1.93, respectively). In utero exposure to any caffeine was associated with higher risk of overweight at age 3 years and 5 years, while the association persisted at 8 years, only for very high exposures. Any caffeine intake was associated with increased body mass index from infancy to childhood. Children prenatally exposed to caffeine intake >200 mg/day had consistently higher weight. Very High caffeine exposures were associated with higher weight gain velocity from infancy to age 8 years.
   Conclusion Any caffeine consumption during pregnancy is associated with a higher risk of excess infant growth and of childhood overweight, mainly at preschool ages. Maternal caffeine intake may modify the overall weight growth trajectory of the child from birth to 8 years. This study adds supporting evidence for the current advice to reduce caffeine intake during pregnancy.
C1 [Papadopoulou, Eleni; Brantsaeter, Anne-Lise; Haugen, Margaretha] Norwegian Inst Publ Hlth, Dept Environm Exposure & Epidemiol, Div Infect Control & Environm Hlth, Oslo, Norway.
   [Botton, Jeremie] Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, INSERM, Early Determinants Childs Hlth & Dev Team ORCHAD, UMR1 153, Paris, France.
   [Botton, Jeremie] Univ Paris Saclay, Univ Paris Sud, Fac Pharm, Chatenay Malabry, France.
   [Alexander, Jan; Meltzer, Helle Margrete] Norwegian Inst Publ Hlth, Div Infect Control & Environm Hlth, Oslo, Norway.
   [Bacelis, Jonas; Jacobsson, Bo] Univ Gothenburg, Sahlgrenska Acad, Dept Obstet & Gynecol, Gothenburg, Sweden.
   [Elfvin, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
   [Jacobsson, Bo] Norwegian Inst Publ Hlth, Dept Genet & Bioinforrnat, Div Hlth Data & Digitalizat, Oslo, Norway.
   [Engpiel, Verena] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden.
C3 Norwegian Institute of Public Health (NIPH); Universite Paris Cite;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris Saclay; Norwegian Institute of Public Health (NIPH);
   University of Gothenburg; University of Gothenburg; Norwegian Institute
   of Public Health (NIPH); Sahlgrenska University Hospital
RP Papadopoulou, E (corresponding author), Norwegian Inst Publ Hlth, Dept Environm Exposure & Epidemiol, Div Infect Control & Environm Hlth, Oslo, Norway.
EM eleni.papadopoulou@fhi.no
RI Brantsaeter, Anne Lise/H-7014-2016; Jacobsson, Bo/O-8007-2014; Botton,
   Jérémie/I-1584-2019; PAPADOPOULOU, ELENI/U-9483-2017
OI Brantsaeter, Anne Lise/0000-0001-6315-7134; Meltzer, Helle
   Margrete/0000-0002-3591-7017; PAPADOPOULOU, ELENI/0000-0001-7034-5897;
   Bacelis, Jonas/0000-0002-2450-732X; Botton, Jeremie/0000-0002-4814-6370
FU Norwegian Ministry of Health and Care Services; Ministry of Education
   and Research; NIH/NIEHS [N01-ES-75558]; NIH/NINDS [1 U01 NS 047537-01, 2
   U01 NS 047537-06A1]; Stiftelsen Sigurd och Elsa Goljes Minnesfond
   [LA2013-0241]; Stiftelsen Fru Mary von Sydows, fodd Wijk, donationsfond;
   Wilhelm och Martina Lundgrens Vetenskapsfond [1 vet1-119/2014]
FX The Norwegian Mother and Child Cohort Study is supported by the
   Norwegian Ministry of Health and Care Services and Ministry of Education
   and Research, NIH/NIEHS (contract no N01-ES-75558), NIH/NINDS (grant no.
   1 U01 NS 047537-01 and grant no. 2 U01 NS 047537-06A1). VS has received
   grants from Stiftelsen Sigurd och Elsa Goljes Minnesfond (LA2013-0241
   "Koffeinintag, fodelsevikt och barnutfall"), Stiftelsen Fru Mary von
   Sydows, fodd Wijk, donationsfond (2014 "Koffeinintag, fodelsevikt och
   barnutfall") and Wilhelm och Martina Lundgrens Vetenskapsfond (1
   vet1-119/2014: "Koffeinintag, fodelsevikt och barnutfall").
CR Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   [Anonymous], 2006, WHO Child Growth Standards: Length/height-for-age, Weight-for-age, Weight-for-length, Weight-for-height and Body Mass Index-for-age: Methods and Development
   [Anonymous], 2001, Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis
   [Anonymous], NORW MOTH CHILD STUD
   [Anonymous], 2015, RISK ASS OTH SUBST C
   Baidal JAW, 2016, AM J PREV MED, V50, P761, DOI 10.1016/j.amepre.2015.11.012
   Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0
   Barker DJP, 2005, J AM SOC NEPHROL, V16, P2537, DOI 10.1681/ASN.2005020160
   BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171
   Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019
   BERKEY CS, 1982, BIOMETRICS, V38, P221, DOI 10.2307/2530305
   Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760
   Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332
   Brantsæter AL, 2008, MATERN CHILD NUTR, V4, P28, DOI 10.1111/j.1740-8709.2007.00103.x
   Brantsæter AL, 2007, PUBLIC HEALTH NUTR, V10, P838, DOI 10.1017/S1368980007339037
   Brew BK, 2017, SCAND J PUBLIC HEALT, V45, P36, DOI 10.1177/1403494817702324
   Buscariollo DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087547
   Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x
   Comets E., 2014, saemix: Stochastic Approximation Expectation Maximization (SAEM) algorithm
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   de Medeiros TS, 2017, MATERN CHILD HLTH J, V21, P1297, DOI 10.1007/s10995-016-2230-7
   Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/s0140-6736(16)30054-x
   Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071
   Gluckman PD, 2005, EARLY HUM DEV, V81, P51, DOI 10.1016/j.earlhumdev.2004.10.003
   Hanson M, 2011, AM J CLIN NUTR, V94, p1754S, DOI 10.3945/ajcn.110.001206
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hindmarsh PC, 2008, PEDIATR RES, V63, P99, DOI 10.1203/PDR.0b013e31815b8e8f
   JENSS RACHEL M., 1937, HUMAN BIOL, V9, P556
   Jones-Smith JC, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2012.32
   Karaolis-Danckert N, 2006, AM J CLIN NUTR, V84, P1449, DOI 10.1093/ajcn/84.6.1449
   Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356
   Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761
   Li DK, 2015, INT J OBESITY, V39, P658, DOI 10.1038/ijo.2014.196
   Li J, 2015, TOXICOL APPL PHARM, V284, P345, DOI 10.1016/j.taap.2015.03.002
   Liu JX, 2018, INT J OBESITY, V42, P8, DOI 10.1038/ijo.2017.183
   Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029
   Mihrshahi S, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-99
   Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x
   Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x
   Morgen CS, 2018, INT J OBESITY, V42, P594, DOI 10.1038/ijo.2017.217
   Mort JR, 2008, ANN PHARMACOTHER, V42, P105, DOI 10.1345/aph.1K337
   Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754
   Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967
   Perng W, 2016, J PEDIATR-US, V173, P122, DOI 10.1016/j.jpeds.2016.02.053
   R Core team, 2016, R: A Language and Environmental Statistical Computing, DOI DOI 10.1007/978-3-540-74686-7
   Rhee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132334
   Richmond RC, 2014, EARLY HUM DEV, V90, P769, DOI 10.1016/j.earlhumdev.2014.08.023
   Rivkees SA, 2011, PEDIATR RES, V69, P271, DOI 10.1203/PDR.0b013e31820efbcf
   Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42
   Skjærven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x
   Stratakis N, 2016, JAMA PEDIATR, V170, P381, DOI 10.1001/jamapediatrics.2015.4430
   Subhan FB, 2017, MATERN CHILD HLTH J, V21, P1396, DOI 10.1007/s10995-016-2246-z
   Tomimatsu T, 2007, REPROD SCI, V14, P588, DOI 10.1177/1933719107307717
   Voerman E, 2016, OBESITY, V24, P1170, DOI 10.1002/oby.21466
   Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Wu YM, 2015, TOXICOL APPL PHARM, V289, P109, DOI 10.1016/j.taap.2015.09.007
   Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016
   Xu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044497
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Yang S, 2016, ANN EPIDEMIOL, V26, P77, DOI 10.1016/j.annepidem.2015.10.002
NR 61
TC 43
Z9 45
U1 1
U2 18
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD MAR
PY 2018
VL 8
IS 3
AR e018895
DI 10.1136/bmjopen-2017-018895
PG 11
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA GH7YZ
UT WOS:000433881200074
PM 29685923
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Elkahoui, S
   Bartley, GE
   Yokoyama, WH
   Friedman, M
AF Elkahoui, Salem
   Bartley, Glenn E.
   Yokoyama, Wallace H.
   Friedman, Mendel
TI Dietary Supplementation of Potato Peel Powders Prepared from
   Conventional and Organic Russet and Non-organic Gold and Red Potatoes
   Reduces Weight Gain in Mice on a High-Fat Diet
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE potato; potato peel powder; mice; high-fat diet; antiobesity
ID GENE-EXPRESSION; PLASMA-CHOLESTEROL; HEPATIC STEATOSIS; FLAVONOID
   CONTENT; CHLOROGENIC ACID; INDUCED OBESITY; GUT MICROBIOTA;
   GLYCOALKALOIDS; EXTRACT; TOMATO
AB The present study investigated the potential of potato peel powders, high in bioactive phenolic compounds and glycoalkaloids, to reduce weight gain in mice consuming a high-fat diet. Potato peel powders were prepared from the following fresh commercial potato varieties by hand-peeling and then freeze-drying and grinding the peels into powder: non-organic (conventionally grown) gold, red, and Russet and organically grown Russet. Mice diets (25% fat by weight) were supplemented with either 10 or 20% potato peel powders for 3 weeks. In comparison to the control diet, the isocaloric and isonitrogenous peel containing diets induced a reduction in weight gain that ranged from 17-45% (10% peel diets) to 46-73% (20% peel diets), suggesting that differences in weight gain are associated with the potato peel source and peel concentration of the diet. Weight reductions were accompanied by reduced epididymal white adipose tissue ranging from 22 to 80% as well as changes in the microbiota analyzed using next-generation sequencing and in obesity-associated genetic biomarkers determined by the quantitative real-time polymerase chain reaction. Safety aspects and possible mechanisms of the antiobesity effects are discussed in terms of the composition of the bioactive potato peel compounds, which were determined using high-performance liquid chromatography. The results suggest that potato peels, a major peeling byproduct of potato processing used to prepare fries, chips, and potato flour, that showed exceptionally high antiobesity properties in fat mice, have the potential to serve as an antiobesity functional food.
C1 [Elkahoui, Salem] Ctr Biotechnol Borj Cedria, Lab Bioact Subst, BP 901, Hammam Lif 2050, Tunisia.
   [Bartley, Glenn E.; Yokoyama, Wallace H.; Friedman, Mendel] ARS, Hlth Proc Foods Res, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.
C3 Centre de Biotechnologie de Borj Cedria; United States Department of
   Agriculture (USDA)
RP Friedman, M (corresponding author), ARS, Hlth Proc Foods Res, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.
EM mendel.friedman@ars.usda.gov
RI ELKAHOUI, Salem/AAR-6542-2021
OI Friedman, Mendel/0000-0003-2582-7517; ELKAHOUI,
   SALEM/0000-0001-5577-1011
CR Abdel-Hafeez HM, 2018, J ANIM PHYSIOL AN N, V102, P56, DOI 10.1111/jpn.12656
   Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389
   Bagarolli RA, 2017, J NUTR BIOCHEM, V50, P16, DOI 10.1016/j.jnutbio.2017.08.006
   Bartley GE, 2010, J NUTR, V140, P1255, DOI 10.3945/jn.109.118349
   Ben Jeddou K, 2017, FOOD CHEM, V217, P668, DOI 10.1016/j.foodchem.2016.08.081
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi KM, 2013, J NUTR BIOCHEM, V24, P335, DOI 10.1016/j.jnutbio.2012.06.018
   Choi SH, 2016, J FOOD COMPOS ANAL, V50, P77, DOI 10.1016/j.jfca.2016.05.011
   Dahiya DK, 2018, FUTURE MICROBIOL, V13, P1007, DOI 10.2217/fmb-2017-0280
   DAO L, 1994, J AGR FOOD CHEM, V42, P633, DOI 10.1021/jf00039a006
   Derrien M, 2017, MICROB PATHOGENESIS, V106, P171, DOI 10.1016/j.micpath.2016.02.005
   Eberlé D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   Ferré P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x
   Friedman M, 2000, FOOD CHEM TOXICOL, V38, P549, DOI 10.1016/S0278-6915(00)00050-8
   Friedman M, 1996, J NUTR, V126, P989, DOI 10.1093/jn/126.4.989
   Friedman M, 2005, J AGR FOOD CHEM, V53, P6162, DOI 10.1021/jf050620p
   Friedman M, 2003, J AGR FOOD CHEM, V51, P2964, DOI 10.1021/jf021146f
   FRIEDMAN M, 1992, ACS SYM SER, V484, P429
   Friedman M, 2000, J FOOD SCI, V65, P897, DOI 10.1111/j.1365-2621.2000.tb13608.x
   Friedman M, 2006, J AGR FOOD CHEM, V54, P8655, DOI 10.1021/jf061471t
   Friedman M, 2017, J FOOD COMPOS ANAL, V62, P69, DOI 10.1016/j.jfca.2017.04.019
   Friedman M, 2016, FOODS, V5, DOI 10.3390/foods5040080
   Friedman M, 2015, J AGR FOOD CHEM, V63, P3323, DOI 10.1021/acs.jafc.5b00818
   HEFTMANN E, 1973, PHYTOCHEMISTRY, V12, P2661, DOI 10.1016/0031-9422(73)85075-7
   Juneja VK, 2018, J FOOD PROCESS PRES, V42, DOI 10.1111/jfpp.13558
   Kang MC, 2016, FOOD CHEM TOXICOL, V90, P36, DOI 10.1016/j.fct.2016.01.023
   Kim H, 2015, J AGR FOOD CHEM, V63, P1460, DOI 10.1021/jf5026373
   Kim H, 2014, J AGR FOOD CHEM, V62, P1919, DOI 10.1021/jf404832s
   Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411
   Kim SP, 2015, FOOD FUNCT, V6, P2939, DOI 10.1039/c5fo00469a
   Kowalska K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188583
   Kozukue N, 2008, J AGR FOOD CHEM, V56, P11920, DOI 10.1021/jf802631t
   Kubow S, 2014, MOL NUTR FOOD RES, V58, P2235, DOI 10.1002/mnfr.201400013
   Langkilde S, 2009, FOOD CHEM TOXICOL, V47, P1099, DOI 10.1016/j.fct.2009.01.045
   Lazarov K, 1996, MED SCI RES, V24, P581
   Li W, 2015, FOOD CHEM, V170, P336, DOI 10.1016/j.foodchem.2014.08.078
   Li Z, 2016, BIOCHEM BIOPH RES CO, V480, P222, DOI 10.1016/j.bbrc.2016.10.031
   Lim J, 2017, J AGR FOOD CHEM, V65, P10011, DOI 10.1021/acs.jafc.7b03764
   Lim WC, 2016, J MED FOOD, V19, P410, DOI 10.1089/jmf.2015.3590
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mathur R, 2015, EXPERT REV GASTROENT, V9, P1087, DOI 10.1586/17474124.2015.1051029
   Nihei N, 2018, BIOFACTORS, V44, P336, DOI 10.1002/biof.1429
   Parkar SG, 2013, ANAEROBE, V23, P12, DOI 10.1016/j.anaerobe.2013.07.009
   RODDICK JG, 1979, PHYTOCHEMISTRY, V18, P1467, DOI 10.1016/S0031-9422(00)98476-0
   Saito T, 2016, NUTR RES, V36, P1090, DOI 10.1016/j.nutres.2016.09.004
   Seo DB, 2015, J MED FOOD, V18, P549, DOI 10.1089/jmf.2014.3265
   Seo KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167680
   Sepelev I, 2015, RES RURAL DEV, P130
   Singh N, 2005, CLIN CHIM ACTA, V353, P165, DOI 10.1016/j.cccn.2004.10.016
   SWINYARD CA, 1973, TERATOLOGY, V8, P349, DOI 10.1002/tera.1420080318
   Tice R, 1998, ALPHA CHACONINE ALPH
   Tomas-Barberan F, 2014, MOL NUTR FOOD RES, V58, P1122, DOI 10.1002/mnfr.201300441
   Tusnio A, 2013, J ANIM FEED SCI, V22, P130
   Wadhwa M., 2015, CAB Reviews, V10, P1, DOI 10.1079/PAVSNNR201510043
   Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008
   Wang L, 2017, J AGR FOOD CHEM, V65, P8374, DOI 10.1021/acs.jafc.7b03230
NR 56
TC 29
Z9 30
U1 0
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUN 20
PY 2018
VL 66
IS 24
BP 6064
EP 6072
DI 10.1021/acs.jafc.8b01987
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA GK5JS
UT WOS:000436212000013
PM 29877090
DA 2025-04-28
ER

PT J
AU Gholami, F
   Samadi, M
   Soveid, N
   Mirzaei, K
AF Gholami, Fatemeh
   Samadi, Mahsa
   Soveid, Neda
   Mirzaei, Khadijeh
TI Healthy beverages may reduce the genetic risk of abdominal obesity and
   related metabolic comorbidities: a gene-diet interaction study in
   Iranian women
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Healthy beverage index; Genetic risk score; Obesity; Metabolic markers
ID BODY-MASS INDEX; DECAFFEINATED COFFEE; INSULIN SENSITIVITY; CHLOROGENIC
   ACID; CALCIUM INTAKE; CONSUMPTION; ASSOCIATION; SCORE; PREVALENCE;
   OVERWEIGHT
AB Background & aims The nutrition transition in developing countries like Iran causes the increasing rise of obesity and abdominal obesity rates. However, it is not yet well proven that environmental modifications like improving the quality of beverage intake can be effective in people who have a genetic predisposition to obesity. So, in the present study, we examine the interaction between genetic predisposition and healthy beverage index (HBI) with abdominal obesity and obesity-related metabolic risk factors in overweight and obese women. Method Based on inclusion and exclusion criteria, 202 overweight or obese females were chosen for this cross-sectional study. Body composition, anthropometric measures, physical activity, and beverage intake data were collected and analyzed using recognized and trustworthy methodologies. Biochemical tests were performed on serum samples. A genetic risk score (GRS) was calculated based on the results of genetic tests. The predetermined HBI was calculated based on previous studies. A generalized linear model was used to estimate the interactions between GRS and HBI (GLM). Results We found significant interactions between GRS and HBI on WHR (beta = - 0.39, CI: -0.07 to 0.001, P = 0.05) and WC (beta = - 6.18, CI: - 13.41 to 1.05, P = 0.09). Also, there were significant gene-diet interactions for HBI and GRS on HDL (beta = 7.09, CI: - 0.73 to 14.92, P = 0.07) and FBS (beta = - 9.07, CI: - 18.63 to 0.47, P = 0.06). Conclusions These findings emphasize the HBI considering genetics appears to protect against the risks of abdominal obesity and metabolic associated obesity markers.
C1 [Gholami, Fatemeh; Samadi, Mahsa; Soveid, Neda; Mirzaei, Khadijeh] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, POB 6446, Tehran 14155, Iran.
C3 Tehran University of Medical Sciences
RP Mirzaei, K (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, POB 6446, Tehran 14155, Iran.
EM mirzaei_kh@sina.tums.ac.ir
RI Mirzaei, Khadijeh/D-5408-2018
FU Tehran University of Medical Sciences (TUMS), Tehran, Iran
   [970316141144]
FX This study was supported by Tehran University of Medical Sciences
   (TUMS), Tehran, Iran (code 970316141144).
CR Aadahl M, 2003, MED SCI SPORT EXER, V35, P1196, DOI 10.1249/01.MSS.0000074446.02192.14
   Abaj F, 2021, BMC ENDOCR DISORD, V21, DOI 10.1186/s12902-021-00800-y
   Alexander DD, 2016, BRIT J NUTR, V115, P737, DOI 10.1017/S0007114515005000
   AlTamimi JZ, 2022, INT J GEN MED, V15, P3333, DOI 10.2147/IJGM.S359639
   Belsky DW, 2013, BIODEMOGR SOC BIOL, V59, P85, DOI 10.1080/19485565.2013.774628
   Brunkwall L, 2016, AM J CLIN NUTR, V104, P809, DOI 10.3945/ajcn.115.126052
   Casas-Agustench P, 2014, J ACAD NUTR DIET, V114, P1954, DOI 10.1016/j.jand.2014.03.014
   Christakoudi S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71302-5
   Cornelis MC, 2020, J NUTR, V150, P2772, DOI 10.1093/jn/nxaa212
   Dashti HS, 2022, BMC MED, V20, DOI 10.1186/s12916-021-02198-9
   Dashti HS, 2022, AM J CLIN NUTR, V115, P180, DOI 10.1093/ajcn/nqab303
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   Duffey KJ, 2006, J NUTR, V136, P2901, DOI 10.1093/jn/136.11.2901
   Duffey KJ, 2015, J ACAD NUTR DIET, V115, P1682, DOI 10.1016/j.jand.2015.05.005
   Garver WS, 2013, GENES NUTR, V8, P271, DOI 10.1007/s12263-013-0339-5
   Ghaffarpour M., 1999, TEHRAN NASHRE OLUME, V7, P42
   Haslam DE, 2018, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00368
   Hedrick V. E., 2015, Current Nutrition Reports, V4, P72
   Hedrick VE, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010083
   Hedrick VE, 2015, NUTRIENTS, V7, P10168, DOI 10.3390/nu7125525
   Hu EA, 2020, CURR DEV NUTR, V4, DOI 10.1093/cdn/nzaa088
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Jacobsen R, 2005, INT J OBESITY, V29, P292, DOI 10.1038/sj.ijo.0802785
   Jafari-Adli S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0121-2
   Jalilpiran Y, 2021, EAT WEIGHT DISORD-ST, V26, P1437, DOI 10.1007/s40519-020-00954-z
   Jibril AT, 2022, EAT WEIGHT DISORD-ST, V27, P2541, DOI 10.1007/s40519-022-01391-w
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jones AC, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0488-5
   Kmietowicz Z, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7994
   Lee KW, 2018, J MED FOOD, V21, P935, DOI 10.1089/jmf.2017.0119
   Li SY, 2020, PUBLIC HEALTH NUTR, V23, P2770, DOI 10.1017/S1368980019003653
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Lorenzen JK, 2011, BRIT J NUTR, V105, P1823, DOI 10.1017/S0007114510005581
   Lorenzen JK, 2007, AM J CLIN NUTR, V85, P678, DOI 10.1093/ajcn/85.3.678
   Lukács A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7839-1
   Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Miranda AM, 2019, CLIN NUTR, V38, P1721, DOI 10.1016/j.clnu.2018.07.033
   Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698
   Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901
   Nam GE, 2020, J OBES METAB SYNDR, V29, P124, DOI 10.7570/jomes20058
   Olsen NJ, 2016, AM J CLIN NUTR, V104, P816, DOI 10.3945/ajcn.115.122820
   Pérez-Rodrigo C, 2022, REV ESP CARDIOL, V75, P232, DOI 10.1016/j.rec.2020.12.020
   Popkin BM, 2022, OBES REV, V23, DOI 10.1111/obr.13366
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Ragino YI, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030374
   Rahmani Asghar, 2015, Acta Med Iran, V53, P596
   Rodríguez-Morán M, 2003, DIABETES CARE, V26, P1147, DOI 10.2337/diacare.26.4.1147
   Sánchez-Villegas A, 2009, PUBLIC HEALTH NUTR, V12, P351, DOI 10.1017/S1368980008002127
   Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348
   Tabrizi JS, 2018, IRAN J PUBLIC HEALTH, V47, P1583
   Tangestani Hadith, 2021, Clin Nutr Res, V10, P48, DOI 10.7762/cnr.2021.10.1.48
   Tyrrell J, 2017, INT J EPIDEMIOL, V46, P559, DOI 10.1093/ije/dyw337
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vera B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18268-z
   Wang TG, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0862-0
   Yadegari M, 2022, ANN HUM GENET, V86, P14, DOI 10.1111/ahg.12443
   Yarizadeh HMA., 2020, CLIN NUTR, V40, P495
   Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271
   Yu KP, 2020, GENE, V733, DOI 10.1016/j.gene.2020.144372
   Zhao XY, 2014, GENE, V535, P299, DOI 10.1016/j.gene.2013.11.006
NR 62
TC 2
Z9 2
U1 1
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD SEP 27
PY 2022
VL 14
IS 1
AR 143
DI 10.1186/s13098-022-00911-z
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 4X0XG
UT WOS:000860574500002
PM 36167582
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Aljamal, A
   Al-Shawabkeh, M
   Abu-Zaiton, A
   Khaleel, SM
   Almuhur, RA
   Altalafha, H
AF Aljamal, Abdulrahim
   Al-Shawabkeh, Mahmoud
   Abu-Zaiton, Ahmed
   Khaleel, Sabah Mohammad
   Almuhur, Rana Ahmad
   Altalafha, Hazem
TI Effect of Green Coffee and Orlistat on Obese Individuals
SO INTERNATIONAL JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Green coffee; orlistat drug; blood glucose; lipid profiles; minerals
ID CHLOROGENIC ACID; BEAN EXTRACT; BLOOD-PRESSURE; MANAGEMENT; ABSORPTION;
   TERM
AB Background and Objective: Obesity is a condition in which excess body fat has accumulated to such an extent that it may hurt health correlated with various diseases and conditions, particularly cardiovascular diseases and type 2 diabetes. The present study represents the evaluation result of green coffee beans compared to anti obese orlistat drug in some physiological vital parameters levels among obese male humans. Materials and Methods: Sixty males of age 30 years or older were recruited for the study and divided into four groups each of 15 persons done among Jordanian people at Al-Mafraq city in Jordan for one month. Group 1 received 120 mg orlistat once daily, Group 2 have taken 350 mg green coffee beans 3 times daily, Group 3 have taken the combination of orlistat and green coffee as the previous daily table and group 4 was a control group that didn't receive either orlistat or green coffee. Results: The present data showed that green coffee beans exerted a reduction of about 15-21% in fast blood glucose and lipid parameters (cholesterol, triglyceride, and LDH) in addition to a 32% increase in HDL. On the other hand, orlistat showed less effect on these parameters about 8-13%. No noticeable effect of either green coffee or orlistat on blood pressure. Among physiological minerals, Mg increased significantly (30%) due to green coffee uptake compared to a similar effect of orlistat, whereas, other minerals (Zn, Ca, Mg) and vitamin B12 were not affected in the presence of either green coffee or orlistat. The combination of green coffee and orlistat didn't exert an additive effect on all parameters. Conclusion: Green coffee may be recommended to improve some physiological parameters such as the reduction in cholesterol, triglyceride, LDH and an increase in HDL levels. Moreover, an increase in Mg levels in obese people.
C1 [Aljamal, Abdulrahim; Abu-Zaiton, Ahmed; Khaleel, Sabah Mohammad; Almuhur, Rana Ahmad; Altalafha, Hazem] Al Al Bayt Univ, Dept Biol Sci, POB 130040, Mafraq 25113, Jordan.
   [Al-Shawabkeh, Mahmoud] Appl Sci Private Univ, Fac Pharm, Amman 19328, Jordan.
C3 Al al-Bayt University
RP Aljamal, A (corresponding author), Al Al Bayt Univ, Dept Biol Sci, POB 130040, Mafraq 25113, Jordan.
RI Abu-zaiton, Ahmed/AAE-5616-2019; Almuhur, Rana/HQY-6056-2023; Khaleel,
   Sabah/GNW-6890-2022; aljamal, abdulrahim/AGC-6310-2022; Al-Talafha,
   Hazem/GLU-7550-2022
OI Almuhur, Rana/0000-0002-8628-8660; Khaleel, Sabah/0000-0002-9581-3498;
   Al-Talafha, Hazem/0000-0003-1732-8603
CR Al Jamal A., 2017, J CHEM PHARM RES, V9, P9
   Barnes Patricia M, 2004, Adv Data, P1
   Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2
   Czerwienska Beata, 2004, Pol Arch Med Wewn, V112, P1415
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Drew BS, 2007, VASC HEALTH RISK MAN, V3, P817
   Hasani-Ranjbar S, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-28
   Hauptman J, 2000, ENDOCRINE, V13, P201, DOI 10.1385/ENDO:13:2:201
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Morvaridi M, 2020, J DIABETES METAB DIS, V19, P645, DOI 10.1007/s40200-020-00536-x
   Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Padwal R, 2004, Cochrane Database Syst Rev, pCD004094, DOI 10.1002/14651858.CD004094.pub2
   Patra S., 2015, Translational Biomedicine, V6, DOI DOI 10.21767/2172-0479.100021
   Perrone D, 2010, J AGR FOOD CHEM, V58, P12238, DOI 10.1021/jf102110u
   Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096
   Semen S, 2017, FOOD CHEM, V215, P92, DOI 10.1016/j.foodchem.2016.07.176
   Stelmach E, 2015, FOOD CHEM, V182, P302, DOI 10.1016/j.foodchem.2015.02.105
   Suzuki A, 2002, AM J HYPERTENS, V15, P351, DOI 10.1016/S0895-7061(01)02337-8
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tsai CY, 2017, ANIM FEED SCI TECH, V229, P32, DOI 10.1016/j.anifeedsci.2017.05.004
   Tziomalos K, 2009, VASC HEALTH RISK MAN, V5, P441
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Wu JQ, 2014, MOLECULES, V19, P1685, DOI 10.3390/molecules19021685
NR 27
TC 1
Z9 1
U1 0
U2 10
PU ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET
PI FAISALABAD
PA 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN
SN 1811-7775
EI 1812-5700
J9 INT J PHARMACOL
JI Int. J. Pharmacol.
PY 2022
VL 18
IS 5
BP 864
EP 868
DI 10.3923/ijp.2022.864.868
PG 5
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 4W1HW
UT WOS:000859917600003
DA 2025-04-28
ER

PT J
AU Cherniack, EP
   Buslach, N
   Lee, HF
AF Cherniack, E. Paul
   Buslach, Natalie
   Lee, Heather F.
TI The Potential Effects of Caffeinated Beverages on Insulin Sensitivity
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Review
DE Insulin sensitivity; coffee; tea; caffeine
ID HIGH-FAT DIET; CARDIOVASCULAR RISK-FACTORS; GREEN TEA EXTRACT; IMPAIRED
   GLUCOSE-TOLERANCE; DOSE-RESPONSE METAANALYSIS; TYPE-2 DIABETES-MELLITUS;
   RICH DARK CHOCOLATE; DECAFFEINATED COFFEE; BLOOD-PRESSURE; OBESE ADULTS
AB Caffeinated beverages, most commonly tea and coffee, may have important effects on insulin regulation that may give their consumption an important role among nutritional factors in the development of diseases of glucose and insulin metabolism, such as diabetes and atherosclerotic vascular diseases. These beverages include compounds that may have contradictory effects on insulin and glucose: Caffeine impairs insulin sensitivity, but polyphenolic molecules within tea, coffee, and cocoa augment the effects of insulin. In addition, epidemiologic associations exist between greater consumption of such beverages and lower risk of diabetes. The beneficial effects of such beverages might be enhanced by changing the process of their preparation and substitution of other substances commonly added to caffeinated beverages that impair the effect of insulin, such as sugar or milk.
C1 [Cherniack, E. Paul] Univ Miami, Miller Sch Med, Div Geriatr & Palliat Med, Miami, FL 33136 USA.
   [Cherniack, E. Paul] Miami VA Med Ctr, Miami, FL USA.
   [Buslach, Natalie] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Chicago, IL USA.
   [Lee, Heather F.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
C3 University of Miami; Chicago Medical School; Rosalind Franklin
   University of Medicine & Science; University of Miami
RP Cherniack, EP (corresponding author), Bruce Carter Miami VA Med Ctr, 1201 NW 16St,Room NH 445, Miami, FL 33162 USA.
EM evan.cherniack@va.gov
RI LEE, HEATHER/JKI-8132-2023
CR Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   Alkerwi A, 2016, BRIT J NUTR, V115, P1661, DOI 10.1017/S0007114516000702
   Almoosawi S, 2012, FOOD FUNCT, V3, P1035, DOI 10.1039/c2fo30060e
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI [10.1001/jama.291.10.1199-b, 10.1001/jama.291.10.1199-a]
   Ashida H, 2004, BIOFACTORS, V22, P135, DOI 10.1002/biof.5520220126
   Basu A, 2015, J NUTR, V145, P2325, DOI 10.3945/jn.115.215772
   Beam JR, 2015, NUTRITION, V31, P292, DOI 10.1016/j.nut.2014.07.012
   Bruder-Nascimento T, 2013, ARQ BRAS ENDOCRINOL, V57, P642, DOI 10.1590/S0004-27302013000800010
   Cao ZH, 2011, PHYTOTHER RES, V25, P234, DOI 10.1002/ptr.3247
   Catalano D, 2008, CLIMACTERIC, V11, P373, DOI 10.1080/13697130802348728
   Cordero-Herrera I, 2014, FOOD CHEM TOXICOL, V64, P10, DOI 10.1016/j.fct.2013.11.014
   Dawling S, 2001, CANCER RES, V61, P6716
   Deng JN, 2015, EVID-BASED COMPL ALT, V2015
   Di Girolamo FG, 2016, NUTRITION, V32, P928, DOI 10.1016/j.nut.2016.02.001
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dorenkott MR, 2014, J AGR FOOD CHEM, V62, P2216, DOI 10.1021/jf500333y
   Dostal AM, 2017, J HUM NUTR DIET, V30, P166, DOI 10.1111/jhn.12408
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Ferreira MA, 2016, OBES REV, V17, P1316, DOI 10.1111/obr.12452
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671
   Grassi D, 2012, HYPERTENSION, V60, P827, DOI 10.1161/HYPERTENSIONAHA.112.193995
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ihm SH, 2012, ATHEROSCLEROSIS, V224, P377, DOI 10.1016/j.atherosclerosis.2012.07.006
   Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kerr D, 2005, DIABETOLOGIA, V48, P1418, DOI 10.1007/s00125-005-1790-7
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Kubot K, 2011, NUTR RES, V31, P421, DOI 10.1016/j.nutres.2011.05.004
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Mastroiacovo D, 2015, AM J CLIN NUTR, V101, P538, DOI 10.3945/ajcn.114.092189
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Morakinyo A O, 2013, Niger J Physiol Sci, V28, P179
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Muley A, 2012, CURR DIABETES REV, V8, P162, DOI 10.2174/157339912800564016
   Muniyappa R, 2008, AM J CLIN NUTR, V88, P1685, DOI 10.3945/ajcn.2008.26457
   Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rakvaag E, 2016, EUR J NUTR, V55, P2221, DOI 10.1007/s00394-015-1032-9
   Richard D, 2009, PHARMACOL RES, V59, P351, DOI 10.1016/j.phrs.2009.01.015
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Santana A, 2015, J NUTR BIOCHEM, V26, P893, DOI 10.1016/j.jnutbio.2015.03.001
   Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260
   Shrime MG, 2011, J NUTR, V141, P1982, DOI 10.3945/jn.111.145482
   SONG SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/718379
   Stote KS, 2012, EUR J CLIN NUTR, V66, P1153, DOI 10.1038/ejcn.2012.101
   Wu LY, 2004, EUR J NUTR, V43, P116, DOI 10.1007/s00394-004-0450-x
   Yamashita Y, 2012, ARCH BIOCHEM BIOPHYS, V527, P95, DOI 10.1016/j.abb.2012.03.018
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Yang WS, 2014, BRIT J NUTR, V111, P1329, DOI 10.1017/S0007114513003887
   Yarmolinsky J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126469
NR 55
TC 3
Z9 3
U1 1
U2 18
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PY 2018
VL 37
IS 2
BP 161
EP 167
DI 10.1080/07315724.2017.1372822
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GA8LV
UT WOS:000428592600011
PM 29313749
DA 2025-04-28
ER

PT J
AU Kim, Y
   Je, Y
   Giovannucci, E
AF Kim, Youngyo
   Je, Youjin
   Giovannucci, Edward
TI Coffee consumption and all-cause and cause-specific mortality: a
   meta-analysis by potential modifiers
SO EUROPEAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE Coffee; Mortality; Meta-analysis; Age; BMI; Alcohol consumption
ID CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; FOLLOW-UP; NONALCOHOLIC
   BEVERAGE; INSULIN-RESISTANCE; EUROPEAN COUNTRIES; CANCER-MORTALITY;
   TREND ESTIMATION; TEA CONSUMPTION; BLOOD-PRESSURE
AB Coffee consumption has been associated with decreased mortality in previous studies. As aging, obesity, and lifestyle factors affect the risk of mortality, the association between coffee and mortality needs to be examined in various subpopulations by characteristics of subjects. To quantitatively assess this association, we conducted an updated meta-analysis including stratified analyses by potential modifiers. We searched in the PubMed and Web of Science databases through March 8, 2019, and conducted meta-analysis including linear and non-linear dose-response analyses. We identified 40 studies including 3,852,651 subjects and 450,256 all-cause and cause-specific deaths. Non-linear inverse associations between coffee consumption and mortality from all-causes, cardiovascular disease (CVD), and cancers were found. The lowest relative risk (RR) was at intakes of 3.5cups/day for all-cause mortality (RR=0.85, 95% CI 0.82-0.89), 2.5cups/day for CVD mortality (RR=0.83, 95% CI 0.80-0.87), and 2cups/day for cancer mortality (RR=0.96, 95% CI 0.94-0.99), while additional intakes were not associated with further lower mortality. An inverse association between coffee consumption and all-cause mortality was maintained irrespective of age, overweight status, alcohol drinking, smoking status, and caffeine content of coffee. By region, Europe and Asia showed stronger inverse associations than US. A non-linear inverse association was found for mortality from respiratory disease and diabetes, while linear inverse association was found for mortality from non-CVD, non-cancer causes. Moderate coffee consumption (e.g. 2-4cups/day) was associated with reduced all-cause and cause-specific mortality, compared to no coffee consumption. The inverse association between coffee and all-cause mortality was consistent by potential modifiers except region.
C1 [Kim, Youngyo; Je, Youjin] Kyung Hee Univ, Dept Food & Nutr, 26 Kyunghee Daero, Seoul 02447, South Korea.
   [Giovannucci, Edward] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   [Giovannucci, Edward] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
C3 Kyung Hee University; Harvard University; Harvard T.H. Chan School of
   Public Health; Harvard University; Harvard T.H. Chan School of Public
   Health
RP Je, Y (corresponding author), Kyung Hee Univ, Dept Food & Nutr, 26 Kyunghee Daero, Seoul 02447, South Korea.
EM youjinje@khu.ac.kr
RI Giovannucci, Edward/ADE-8028-2022; Je, Youjin/N-2822-2018
OI Je, Youjin/0000-0002-2099-4204
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education [NRF-2017R1A6A3A01075728]; Ministry of
   Science, ICT and Future Planning [NRF-2018R1D1A1B07045353]
FX This work was supported by the Basic Science Research Program through
   the National Research Foundation of Korea, funded by the Ministry of
   Education (NRF-2017R1A6A3A01075728) and by the Ministry of Science, ICT
   and Future Planning (NRF-2018R1D1A1B07045353). Funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Alfaro TM, 2018, CLIN RESPIR J, V12, P1283, DOI 10.1111/crj.12662
   [Anonymous], NEWCASTLE OTTAWA SCA
   Arciero PJ, 2009, APPL PHYSIOL NUTR ME, V34, P754, DOI 10.1139/H09-068
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Elsamadony A, 2017, OBESITY, V25, P1974, DOI 10.1002/oby.22003
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Andersen LF, 2006, AM J CLIN NUTR, V83, P1039, DOI 10.1093/ajcn/83.5.1039
   Gapstur SM, 2017, CANCER EPIDEM BIOMAR, V26, P1477, DOI [10.1158/1055-9965.epi-17-0353, 10.1158/1055-9965.EPI-17-0353]
   Gardener H, 2013, J NUTR, V143, P1299, DOI 10.3945/jn.112.173807
   GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2017, PUBLIC HEALTH NUTR, V20, P82, DOI [10.1017/S1368980016001749, 10.1017/s1368980016001749]
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Gunter MJ, 2017, ANN INTERN MED, V167, P236, DOI 10.7326/M16-2945
   Hang D, 2019, AM J CLIN NUTR, V109, P635, DOI 10.1093/ajcn/nqy295
   Happonen P, 2008, BRIT J NUTR, V99, P1354, DOI 10.1017/S0007114507871650
   Hart C, 1997, J EPIDEMIOL COMMUN H, V51, P461, DOI 10.1136/jech.51.4.461
   Hoelzl C, 2010, MOL NUTR FOOD RES, V54, P1722, DOI 10.1002/mnfr.201000048
   Hong X, 2018, NUTR CANC, V1, P1
   Hori A, 2014, NUTR CANCER, V66, P964, DOI 10.1080/01635581.2014.932398
   Iwai Nobuo, 2002, J Epidemiol, V12, P191
   JACOBSEN BK, 1986, JNCI-J NATL CANCER I, V76, P823
   Jazbec A, 2003, J HEALTH POPUL NUTR, V21, P332
   Je Y, 2014, BRIT J NUTR, V111, P1162, DOI 10.1017/S0007114513003814
   Jeszka-Skowron M, 2015, EUR FOOD RES TECHNOL, V240, P19, DOI 10.1007/s00217-014-2356-z
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   KAHN HA, 1984, AM J EPIDEMIOL, V119, P775, DOI 10.1093/oxfordjournals.aje.a113798
   Kang D, 2018, EUR J CLIN NUTR, V72, P1506, DOI 10.1038/s41430-018-0121-2
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Klatsky A L, 1993, Ann Epidemiol, V3, P375, DOI 10.1016/1047-2797(93)90064-B
   Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393
   KOHLMEIER L, 1991, EUR HEART J, V12, P869, DOI 10.1093/eurheartj/12.8.869
   LEGRADY D, 1987, AM J EPIDEMIOL, V126, P803, DOI 10.1093/oxfordjournals.aje.a114717
   Li Q, 2019, J HUM NUTR DIET
   Liang NJ, 2014, MOLECULES, V19, P19180, DOI 10.3390/molecules191119180
   Lim WH, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011720
   LINDSTED KD, 1992, J CLIN EPIDEMIOL, V45, P733, DOI 10.1016/0895-4356(92)90051-N
   Liu JX, 2013, MAYO CLIN PROC, V88, P1066, DOI 10.1016/j.mayocp.2013.06.020
   Löf M, 2015, EUR J EPIDEMIOL, V30, P1027, DOI 10.1007/s10654-015-0052-3
   Loftfield E, 2018, JAMA INTERN MED, V178, P1086, DOI 10.1001/jamainternmed.2018.2425
   Loftfield E, 2015, AM J EPIDEMIOL, V182, P1010, DOI 10.1093/aje/kwv146
   Loomba RS, 2016, AM J THER, V23, pE232, DOI 10.1097/MJT.0000000000000099
   Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X
   Lucas M, 2014, WORLD J BIOL PSYCHIA, V15, P377, DOI 10.3109/15622975.2013.795243
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Misik M, 2010, MUTAT RES-FUND MOL M, V692, P42, DOI 10.1016/j.mrfmmm.2010.08.003
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   Navarro AM, 2018, AM J CLIN NUTR, V108, P1113, DOI 10.1093/ajcn/nqy198
   Nightingale CM, 2013, DIABETES CARE, V36, P1712, DOI 10.2337/dc12-1726
   Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d
   Nordestgaard AT, 2016, INT J EPIDEMIOL, V45, P1938, DOI 10.1093/ije/dyw325
   Odegaard AO, 2015, J NUTR, V145, P595, DOI 10.3945/jn.114.200253
   Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103
   Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265
   Paganini-Hill A, 2007, PREV MED, V44, P305, DOI 10.1016/j.ypmed.2006.12.011
   Park SY, 2017, ANN INTERN MED, V167, P228, DOI 10.7326/M16-2472
   ROSENGREN A, 1991, J INTERN MED, V230, P67, DOI 10.1111/j.1365-2796.1991.tb00407.x
   Sado J, 2019, CIRC J
   Sado J, 2017, CANCER SCI, V108, P2079, DOI 10.1111/cas.13328
   Saito E, 2015, AM J CLIN NUTR, V101, P1029, DOI 10.3945/ajcn.114.104273
   Schöttker B, 2015, J GERONTOL A-BIOL, V70, P518, DOI 10.1093/gerona/glu111
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Sugiyama K, 2010, J NUTR, V140, P1007, DOI 10.3945/jn.109.109314
   Tamakoshi A, 2011, EUR J EPIDEMIOL, V26, P285, DOI 10.1007/s10654-011-9548-7
   Torres-Collado L, 2018, EUR J NUTR
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van den Brandt PA, 2018, EUR J EPIDEMIOL
   VANDENBROUCKE JP, 1986, AM J EPIDEMIOL, V123, P359, DOI 10.1093/oxfordjournals.aje.a114245
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481
   Wu WX, 2015, SCI REP-UK, V5, DOI 10.1038/srep09051
   Zhang Y, 2018, INT J FOOD SCI NUTR
NR 83
TC 107
Z9 107
U1 9
U2 47
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0393-2990
EI 1573-7284
J9 EUR J EPIDEMIOL
JI Eur. J. Epidemiol.
PD AUG
PY 2019
VL 34
IS 8
BP 731
EP 752
DI 10.1007/s10654-019-00524-3
PG 22
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA IH3VL
UT WOS:000474420600005
PM 31055709
DA 2025-04-28
ER

PT J
AU Al-Othman, A
   Al-Musharaf, S
   Al-Daghri, NM
   Yakout, S
   Alkharfy, KM
   Al-Saleh, Y
   Al-Attas, OS
   Alokail, MS
   Moharram, O
   Sabico, S
   Kumar, S
   Chrousos, GP
AF Al-Othman, Abdulaziz
   Al-Musharaf, Sara
   Al-Daghri, Nasser M.
   Yakout, Sobhy
   Alkharfy, Khalid M.
   Al-Saleh, Yousef
   Al-Attas, Omar S.
   Alokail, Majed S.
   Moharram, Osama
   Sabico, Shaun
   Kumar, Sudhesh
   Chrousos, George P.
TI Tea and coffee consumption in relation to vitamin D and calcium levels
   in Saudi adolescents
SO NUTRITION JOURNAL
LA English
DT Article
DE Coffee intake; Tea intake; Vitamin D levels; Saudi adolescents
ID WEIGHT-LOSS; POSTMENOPAUSAL WOMEN; CAFFEINE CONSUMPTION; RISK-FACTORS;
   BODY-MASS; BONE LOSS; METABOLISM; OVERWEIGHT; POLYMORPHISMS;
   THERMOGENESIS
AB Background: Coffee and tea consumption was hypothesized to interact with variants of vitamin D-receptor polymorphisms, but limited evidence exists. Here we determine for the first time whether increased coffee and tea consumption affects circulating levels of 25-hydroxyvitamin D in a cohort of Saudi adolescents.
   Methods: A total of 330 randomly selected Saudi adolescents were included. Anthropometrics were recorded and fasting blood samples were analyzed for routine analysis of fasting glucose, lipid levels, calcium, albumin and phosphorous. Frequency of coffee and tea intake was noted. 25-hydroxyvitamin D levels were measured using enzyme-linked immunosorbent assays.
   Results: Improved lipid profiles were observed in both boys and girls, as demonstrated by increased levels of HDL-cholesterol, even after controlling for age and BMI, among those consuming 9-12 cups of coffee/week. Vitamin D levels were significantly highest among those consuming 9-12 cups of tea/week in all subjects (p-value 0.009) independent of age, gender, BMI, physical activity and sun exposure.
   Conclusion: This study suggests a link between tea consumption and vitamin D levels in a cohort of Saudi adolescents, independent of age, BMI, gender, physical activity and sun exposure. These findings should be confirmed prospectively.
C1 [Al-Othman, Abdulaziz; Al-Daghri, Nasser M.; Alkharfy, Khalid M.; Al-Saleh, Yousef; Al-Attas, Omar S.; Alokail, Majed S.] King Saud Univ, Prince Mutaib Chair Biomarkers Osteoporosis, Riyadh, Saudi Arabia.
   [Al-Othman, Abdulaziz] King Saud Univ, Coll Appl Med Sci, Riyadh, Saudi Arabia.
   [Al-Musharaf, Sara] King Saud Univ, Coll Sci, Womens Sect, Riyadh 11451, Saudi Arabia.
   [Al-Daghri, Nasser M.; Yakout, Sobhy; Al-Attas, Omar S.; Alokail, Majed S.; Sabico, Shaun; Chrousos, George P.] King Saud Univ, Coll Sci, Dept Biochem, Biomarkers Res Program, Riyadh 11451, Saudi Arabia.
   [Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.] King Saud Univ, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia.
   [Alkharfy, Khalid M.] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia.
   [Al-Saleh, Yousef] King Saud Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia.
   [Moharram, Osama] King Saud Univ, King Abdulaziz Univ Hosp, Riyadh, Saudi Arabia.
   [Kumar, Sudhesh] Univ Warwick, Diabet & Metab Unit, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England.
   [Chrousos, George P.] Univ Athens, Sch Med, Dept Pediat 1, GR-11527 Athens, Greece.
   [Al-Daghri, Nasser M.] King Saud Univ, Coll Sci, Dept Biochem, Prince Mutaib Bin Abdullah Chair Osteoporosis, Riyadh 11451, Saudi Arabia.
C3 King Saud University; King Saud University; King Saud University; King
   Saud University; King Saud University; King Saud University; King Saud
   Bin Abdulaziz University for Health Sciences; King Abdulaziz University;
   King Saud University; King Abdulaziz University Hospital - Riyadh;
   University of Warwick; National & Kapodistrian University of Athens;
   Athens Medical School; King Saud University
RP Al-Daghri, NM (corresponding author), King Saud Univ, Prince Mutaib Chair Biomarkers Osteoporosis, Riyadh, Saudi Arabia.
EM aldaghri2011@gmail.com
RI Al-Daghri, Nasser/A-8360-2011; Chrousos, George/G-8702-2011; Alkharfy,
   Khalid/GZG-5048-2022; YAKOUT, SOBHY/F-1106-2019; Al-okail,
   Majed/E-5565-2016; Al-Musharaf, Sara/AAN-9650-2021; kumar,
   sudhesh/D-6945-2013; Sabico, Shaun/C-9086-2011
OI kumar, sudhesh/0000-0003-4326-5941; Al-Daghri,
   Nasser/0000-0001-5472-1725; Sabico, Shaun/0000-0002-5248-2350
CR Astrup A, 2000, ENDOCRINE, V13, P207, DOI 10.1385/ENDO:13:2:207
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Castellanos FX, 2002, FOOD CHEM TOXICOL, V40, P1235, DOI 10.1016/S0278-6915(02)00097-2
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   FAO, 2024, Food Balance Sheets 20102022. Global
   Gates S, 1999, BRIT J CLIN PHARMACO, V47, P299, DOI 10.1046/j.1365-2125.1999.00890.x
   Gong G, 1999, OSTEOPOROSIS INT, V9, P55, DOI 10.1007/s001980050116
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710
   HASLING C, 1992, J NUTR, V122, P1119, DOI 10.1093/jn/122.5.1119
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   HealthCanada, 2003, FACT SHEET CAFF YOUR
   HEANEY RP, 1982, J LAB CLIN MED, V99, P46
   Heaney RP, 1996, NUTR REV, V54, pS3
   Heaney RP, 2002, FOOD CHEM TOXICOL, V40, P1263, DOI 10.1016/S0278-6915(02)00094-7
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Huopio J, 2000, OSTEOPOROSIS INT, V11, P219, DOI 10.1007/s001980050284
   Izuora K, 2011, J CLIN ENDOCR METAB, V96, P2318, DOI 10.1210/jc.2010-2891
   Jorde R, 2001, EUR J EPIDEMIOL, V17, P1117, DOI 10.1023/A:1021272831251
   Kamycheva E, 2003, J NUTR, V133, P102, DOI 10.1093/jn/133.1.102
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   KREIGER N, 1992, INT J EPIDEMIOL, V21, P953, DOI 10.1093/ije/21.5.953
   MASSEY LK, 1993, J NUTR, V123, P1611, DOI 10.1093/jn/123.9.1611
   Rapuri PB, 2001, AM J CLIN NUTR, V74, P694
   Rapuri PB, 2007, J STEROID BIOCHEM, V103, P368, DOI 10.1016/j.jsbmb.2006.12.037
   Riedt CS, 2005, J BONE MINER RES, V20, P455, DOI 10.1359/JBMR.041132
   Ryu S, 2001, J NUTR SCI VITAMINOL, V47, P139, DOI 10.3177/jnsv.47.139
   Schneider C, 2009, AM FAM PHYSICIAN, V79, P591
   Spiller M.A., 1998, Caffeine, P97
   TAFT JL, 1984, BIOCHEM BIOPH RES CO, V121, P355, DOI 10.1016/0006-291X(84)90730-7
   TAGLIABUE A, 1994, INT J OBESITY, V18, P537
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tzotzas T, 2010, J CLIN ENDOCR METAB, V95, P4251, DOI 10.1210/jc.2010-0757
   ULLRICH D, 1992, EUR J CLIN PHARMACOL, V43, P167, DOI 10.1007/BF01740665
   Wood RJ, 1998, ANNU REV NUTR, V18, P233, DOI 10.1146/annurev.nutr.18.1.233
   Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004
NR 38
TC 32
Z9 33
U1 0
U2 19
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2891
J9 NUTR J
JI Nutr. J.
PD AUG 20
PY 2012
VL 11
AR 56
DI 10.1186/1475-2891-11-56
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 025TZ
UT WOS:000310218900001
PM 22905922
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Shokouh, P
   Jeppesen, PB
   Hermansen, K
   Laustsen, C
   Stodkilde-Jorgensen, H
   Hamilton-Dutoit, SJ
   Schmedes, M
   Qi, HY
   Norlinger, T
   Gregersen, S
AF Shokouh, Pedram
   Jeppesen, Per Bendix
   Hermansen, Kjeld
   Laustsen, Christoffer
   Stodkilde-Jorgensen, Hans
   Hamilton-Dutoit, Stephen Jacques
   Schmedes, Mette Sondergaard
   Qi, Haiyun
   Norlinger, Thomas Stokholm
   Gregersen, Soren
TI Effects of Unfiltered Coffee and Bioactive Coffee Compounds on the
   Development of Metabolic Syndrome Components in a
   High-Fat-/High-Fructose-Fed Rat Model
SO NUTRIENTS
LA English
DT Article
DE coffee; chlorogenic acid; caffeic acid; trigonelline; insulin
   resistance; metabolic syndrome x; non-alcoholic fatty liver disease;
   carbon-13 magnetic resonance spectroscopy; phytotherapy
ID DECAFFEINATED COFFEE; GLUCOSE-HOMEOSTASIS; MAGNETIC-RESONANCE;
   INSULIN-RESISTANCE; HEPATIC STEATOSIS; CONSUMPTION; RISK; OBESITY;
   GREEN; TEA
AB The literature is inconsistent as to how coffee affects metabolic syndrome (MetS), and which bioactive compounds are responsible for its metabolic effects. This study aimed to evaluate the effects of unfiltered coffee on diet-induced MetS and investigate whether or not phenolic acids and trigonelline are the main bioactive compounds in coffee. Twenty-four male SpragueDawley rats were fed a high-fat (35% W/W) diet plus 20% W/W fructose in drinking water for 14 weeks, and were randomized into three groups: control, coffee, or nutraceuticals (5-O-caffeoylquinic acid, caffeic acid, and trigonelline). Coffee or nutraceuticals were provided in drinking water at a dosage equal to 4 cups/day in a human. Compared to the controls, total food intake (p = 0.023) and mean body weight at endpoint (p = 0.016) and estimated average plasma glucose (p = 0.041) were lower only in the coffee group. Surrogate measures of insulin resistance including the overall fasting insulin (p = 0.010), endpoint HOMA-IR (p = 0.022), and oral glucose tolerance (p = 0.029) were improved in the coffee group. Circulating triglyceride levels were lower (p = 0.010), and histopathological and quantitative (p = 0.010) measurements indicated lower grades of liver steatosis compared to controls after long-term coffee consumption. In conclusion, a combination of phenolic acids and trigonelline was not as effective as coffee per se in improving the components of the MetS. This points to the role of other coffee chemicals and a potential synergism between compounds.
C1 [Shokouh, Pedram; Jeppesen, Per Bendix; Hermansen, Kjeld; Gregersen, Soren] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Palle Juul Jensens Blvd 165, DK-8200 Aarhus N, Denmark.
   [Shokouh, Pedram] Odense Univ Hosp, Danish Diabet Acad, Klovervaenget 10, DK-5000 Odense, Denmark.
   [Laustsen, Christoffer; Stodkilde-Jorgensen, Hans; Qi, Haiyun; Norlinger, Thomas Stokholm] Aarhus Univ, Hosp Skejby, MR Res Ctr, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark.
   [Hamilton-Dutoit, Stephen Jacques] Aarhus Univ, Hosp Skejby, Inst Pathol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark.
   [Schmedes, Mette Sondergaard] Aarhus Univ, Dept Food Sci, DK-5792 Arslev, Denmark.
C3 Aarhus University; University of Southern Denmark; Odense University
   Hospital; Aarhus University; Aarhus University; Aarhus University
RP Shokouh, P (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Palle Juul Jensens Blvd 165, DK-8200 Aarhus N, Denmark.; Shokouh, P (corresponding author), Odense Univ Hosp, Danish Diabet Acad, Klovervaenget 10, DK-5000 Odense, Denmark.
EM Shokouh.P@Gmail.com; per.bendix.jeppesen@clin.au.dk;
   kjeld.hermansen@aarhus.rm.dk; cl@clin.au.dk; hsj@clin.au.dk;
   stephami@rm.dk; mette.schmedes@food.au.dk; qi@clin.au.dk;
   thomasnorlinger@gmail.com; soeren.gregersen@aarhus.rm.dk
RI hermansen, kjeld/AAY-4241-2021; Shokouh, Pedram/AAX-4572-2021;
   Gregersen, Søren/HJZ-2527-2023; Laustsen, Christoffer/AFL-9477-2022;
   Dutoit, Stephen/E-1815-2013
OI Jeppesen, Per Bendix/0000-0001-8042-7554; Hamilton-Dutoit,
   Stephen/0000-0003-2158-3885; Laustsen, Christoffer/0000-0002-0317-2911;
   Stodkilde-Jorgensen, Hans/0000-0002-8649-4173; Gregersen,
   Soren/0000-0002-1953-8631; Shokouh, Pedram/0000-0002-4514-0045
FU Aarhus University; Danish Diabetes Academy; Novo Nordisk Foundation;
   Innovation Fund Denmark [1308-00028B]; Riisfort Foundation
FX Aarhus University and the Danish Diabetes Academy, supported by the Novo
   Nordisk Foundation, provided funding for this project in the form of a
   doctoral fellowships to Pedram Shokouh. Further financial support was
   provided by a grant from the Innovation Fund Denmark (no: 1308-00028B)
   and the Riisfort Foundation. None of the fund providers had any
   involvement in study planning, execution, data analysis, or manuscript
   preparation.
CR Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   [Anonymous], THESIS
   Beynen AC, 1996, BRIT J NUTR, V76, P755, DOI 10.1079/BJN19960081
   Buckley AJ, 2018, DIABETES RES CLIN PR, V144, P144, DOI 10.1016/j.diabres.2018.08.011
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Chen SH, 2014, J GASTROEN HEPATOL, V29, P435, DOI 10.1111/jgh.12422
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Comment A, 2014, BIOCHEMISTRY-US, V53, P7333, DOI 10.1021/bi501225t
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   Crescenzo R, 2014, EXP PHYSIOL, V99, P1203, DOI 10.1113/expphysiol.2014.079632
   Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
   de Pascual-Teresa S, 2000, J AGR FOOD CHEM, V48, P5331, DOI 10.1021/jf000549h
   Després JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Farah A, 2005, J AGR FOOD CHEM, V53, P1505, DOI 10.1021/jf048701t
   HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5
   HAYTER AJ, 1986, J AM STAT ASSOC, V81, P1000
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jaiswal R, 2010, J AGR FOOD CHEM, V58, P8722, DOI 10.1021/jf1014457
   Jia HJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0389-3
   Jouihan H., 2012, Bio-protocol, V2, pe223, DOI DOI 10.21769/BIOPROTOC.223
   Laustsen C, 2017, AM J PHYSIOL-RENAL, V312, pF192, DOI 10.1152/ajprenal.00148.2016
   Lewis AJM, 2016, DIABETES, V65, P3544, DOI 10.2337/db16-0804
   Li XD, 2011, PROTEIN CELL, V2, P189, DOI 10.1007/s13238-011-1016-3
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Maki C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173264
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Mazur WM, 1998, BRIT J NUTR, V79, P37, DOI 10.1079/BJN19980007
   Mellbye FB, 2017, J NAT PROD, V80, P2353, DOI 10.1021/acs.jnatprod.7b00395
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Moon CM, 2017, BIOCHEM BIOPH RES CO, V482, P112, DOI 10.1016/j.bbrc.2016.08.118
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]
   Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982
   Park S, 2007, METABOLISM, V56, P599, DOI 10.1016/j.metabol.2006.12.004
   Peng BJ, 2015, BIOMED ENVIRON SCI, V28, P894, DOI 10.3967/bes2015.123
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rustenbeck I, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.19
   Salomone F, 2014, TRANSL RES, V163, P593, DOI 10.1016/j.trsl.2013.12.001
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Shi XQ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0220-7
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   STENNERT A, 1994, Z LEBENSM UNTERS FOR, V199, P198, DOI 10.1007/BF01193443
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   Wang JJ, 2007, EUR HEART J, V28, P857, DOI 10.1093/eurheartj/ehl524
   Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923
   Xu ZH, 2014, J ETHNOPHARMACOL, V151, P548, DOI 10.1016/j.jep.2013.11.021
NR 60
TC 11
Z9 11
U1 1
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2018
VL 10
IS 10
AR 1547
DI 10.3390/nu10101547
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GY7UM
UT WOS:000448821300213
PM 30347674
OA Green Submitted, gold, Green Published
DA 2025-04-28
ER

PT J
AU Ohara, T
   Muroyama, K
   Yamamoto, Y
   Murosaki, S
AF Ohara, Tatsuya
   Muroyama, Koutarou
   Yamamoto, Yoshihiro
   Murosaki, Shinji
TI Oral intake of a combination of glucosyl hesperidin and caffeine elicits
   an anti-obesity effect in healthy, moderately obese subjects: a
   randomized double-blind placebo-controlled trial
SO NUTRITION JOURNAL
LA English
DT Article
DE Glucosyl hesperidin; Caffeine; Obesity; Body fat; Body mass index
ID SUBCUTANEOUS ADIPOSE-TISSUE; SERUM TRIGLYCERIDE LEVEL; METABOLIC
   SYNDROME; BODY-FAT; CARDIOVASCULAR-DISEASE; CITRIC-ACID; HEPG2 CELLS; KK
   MICE; OSTEOARTHRITIS; LIPOPROTEIN
AB Background: We have previously shown that a combination of glucosyl hesperidin (G-hesperidin) plus caffeine reduces accumulation of body fat, whereas G-hesperidin or caffeine alone shows little effect on high-fat diet-induced obesity in mice. The aim of this study is to evaluate the anti-obesity effect of G-hesperidin plus caffeine on body fat and serum TG in healthy subjects with moderately high body mass index (BMI) and serum TG. Since we considered that there are individual differences in caffeine sensitivity, we conducted dose-finding study of caffeine combined with G-hesperidin.
   Methods: Seventy-five healthy subjects with moderately high BMI (24-30 kg/m(2)) and serum TG (100-250 mg/dl) were divided and assigned to 12-week intervention with daily intakes of 500 mg of G-hesperidin with or without 25, 50, or 75 mg of caffeine, or placebo in a randomized double-blind placebo-controlled design.
   Results: After intervention, decreases in abdominal fat area (AFA), especially subcutaneous fat area (SFA), were significantly greater in the G-hesperidin with 50-mg caffeine group (AFA:-8.4 +/- 21.9 v. s. 16.3 +/- 34.1 cm(2); p < 0.05, SFA: -9.3 +/- 17.1 v.s. 11.2 +/- 18.3 cm(2); p < 0.01) and in the G-hesperidin with 75-mg caffeine group (AFA:-17.0 +/- 31.4 v.s. 16.3 +/- 34.1 cm(2); p < 0.01, SFA: -12.4 +/- 18.7 v. s. 11.2 +/- 18.3 cm(2); p < 0.01) than in the placebo group. Fat-decreasing effects of G-hesperidin were enhanced dose-dependently by caffeine addition. BMI decreases were significantly greater in the G-hesperidin with 75-mg caffeine group than in the placebo group (-0.56 +/- 0.74 v. s. -0.02 +/- 0.58 kg/m(2); p < 0.05). G-hesperidin with/without caffeine had no effect on serum TG (p > 0.05 v. s. placebo).
   Conclusions: These data suggested that a combination of 500-mg G-hesperidin with 50- or 75-mg caffeine may be useful for the prevention or treatment of obesity.
C1 [Ohara, Tatsuya; Muroyama, Koutarou; Yamamoto, Yoshihiro; Murosaki, Shinji] House Wellness Foods Corp, Inst Res & Dev, Itami, Hyogo 6640011, Japan.
RP Ohara, T (corresponding author), House Wellness Foods Corp, Inst Res & Dev, 3-20 Imoji, Itami, Hyogo 6640011, Japan.
EM Ohara_Tatsuya@house-wf.co.jp
FU House Wellness Foods Corporation
FX This study was supported by House Wellness Foods Corporation. All
   authors belong to House Wellness Foods Corporation. All authors are
   named as inventors of a patent (JP5564330B2) or patent pending
   (PCT/JP2011/050495) held by the House Wellness Foods Corporation on the
   composition for the prevention, amelioration or treatment of the
   metabolic syndrome.
CR Akiyama S, 2009, BIOSCI BIOTECH BIOCH, V73, P2779, DOI 10.1271/bbb.90576
   ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939
   ASTRUP A, 1992, METABOLISM, V41, P686, DOI 10.1016/0026-0495(92)90304-S
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bissonnette S, 2013, J LIPID RES, V54, P1466, DOI 10.1194/jlr.P023176
   Chiba H, 2003, J NUTR, V133, P1892, DOI 10.1093/jn/133.6.1892
   CORREA H, 1978, AM J CLIN NUTR, V31, P1431, DOI 10.1093/ajcn/31.8.1431
   COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155
   DAVIS MA, 1988, AM J EPIDEMIOL, V127, P1019, DOI 10.1093/oxfordjournals.aje.a114878
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Gormsen LC, 2009, AM J PHYSIOL-ENDOC M, V296, pE165, DOI 10.1152/ajpendo.90675.2008
   Hanawa M, 2008, J NUTR FOOD, V11, P1
   HART DJ, 1993, J RHEUMATOL, V20, P331
   Hijiya H, 1991, European Patent, Patent No. 0402049A2
   Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9
   HY-YA M., 2011, JPN PHARMACOL THER, V39, P727
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   LEIJTEN PAA, 1984, J PHYSIOL-LONDON, V357, P327, DOI 10.1113/jphysiol.1984.sp015502
   LEWIS GF, 1993, DIABETES, V42, P833, DOI 10.2337/diabetes.42.6.833
   LIEBERMAN HR, 1987, PSYCHOPHARMACOLOGY, V92, P308, DOI 10.1007/BF00210835
   Manek NJ, 2003, ARTHRITIS RHEUM-US, V48, P1024, DOI 10.1002/art.10884
   MITCHELL GW, 1953, NEW ENGL J MED, V249, P835, DOI 10.1056/NEJM195311192492102
   Miwa Y, 2005, J NUTR SCI VITAMINOL, V51, P460, DOI 10.3177/jnsv.51.460
   Miwa Y, 2004, J NUTR SCI VITAMINOL, V50, P211, DOI 10.3177/jnsv.50.211
   Miwa Y, 2006, J NUTR SCI VITAMINOL, V52, P223, DOI 10.3177/jnsv.52.223
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Muroyama K, 2003, J NUTR SCI VITAMINOL, V49, P56, DOI 10.3177/jnsv.49.56
   Muroyama K, 2003, BIOSCI BIOTECH BIOCH, V67, P2325, DOI 10.1271/bbb.67.2325
   Ninomiya T, 2007, STROKE, V38, P2063, DOI 10.1161/STROKEAHA.106.479642
   Ohara T, 2015, PHYTOTHER RES, V29, P310, DOI 10.1002/ptr.5258
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rowland AS, 2002, EPIDEMIOLOGY, V13, P668, DOI 10.1097/00001648-200211000-00011
   Smit HJ, 2000, PSYCHOPHARMACOLOGY, V152, P167, DOI 10.1007/s002130000506
   Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693
   TOKUNAGA K, 1983, INT J OBESITY, V7, P437
   YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704
NR 37
TC 39
Z9 39
U1 0
U2 20
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2891
J9 NUTR J
JI Nutr. J.
PD JAN 19
PY 2016
VL 15
AR 6
DI 10.1186/s12937-016-0123-7
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DB1IX
UT WOS:000368263000001
PM 26786000
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Reddy, JG
   Ebbert, JO
   Klesges, LM
   Enders, FTB
   Klesges, RC
   Lanctot, JQ
   McClanahan, BS
AF Reddy, Jagadeshwar G.
   Ebbert, Jon O.
   Klesges, Lisa M.
   Enders, Felicity T. B.
   Klesges, Robert C.
   Lanctot, Jennifer Q.
   McClanahan, Barbara S.
TI THE RELATIONSHIP BETWEEN CAFFEINE AND BLOOD PRESSURE IN PREADOLESCENT
   AFRICAN AMERICAN GIRLS
SO ETHNICITY & DISEASE
LA English
DT Article
DE Caffeine; Child; Blood Pressure; African Americans; Risk Factors
ID CARDIOVASCULAR RISK-FACTORS; DIETARY ASSESSMENT; COFFEE-DRINKING;
   HEART-RATE; CHILDREN; HYPERTENSION; ADOLESCENTS; OVERWEIGHT;
   ASSOCIATION; TOLERANCE
AB Background: While high caffeine consumption has been shown to be associated with increased blood pressure in controlled experiments, the relationship between caffeine consumption and blood pressure in preadolescent (ages 6-11 years) and adolescent (ages 12-19 years) children has not been well studied. The primary objective of this study was to assess the cross-sectional relationship between caffeine intake and blood pressure in 8- to 10-year-old African American girls who eat an unrestricted diet.
   Methods: Demographic, 24-hour dietary recall, and blood pressure data collected at baseline from 303 African American girls aged 8-10 years in the Girls health Enrichment Multisite Studies (GEMS) cohort were analyzed by using linear and multiple regression models.
   Results: Dietary caffeine intake was not associated with either systolic or diastolic blood pressure (P= .33 and P = .36, respectively). However, consistent with the literature, height and body mass index were each positively and independently associated with systolic blood pressure (both P<.0001). Height and amount of sodium intake were positively associated with diastolic blood pressure (P = .01 and P = .02, respectively).
   Conclusions: Dietary caffeine intake in low amounts is not associated with elevated blood pressure in 8- to 10-year-old African American girls who eat an unrestricted diet. (Ethn Dis. 2008; 18:283-288)
C1 [Reddy, Jagadeshwar G.; Ebbert, Jon O.; Klesges, Lisa M.; Enders, Felicity T. B.; Klesges, Robert C.] Mayo Clin, Coll Med, Rochester, MN 55905 USA.
   [Lanctot, Jennifer Q.; McClanahan, Barbara S.] Univ Memphis, Memphis, TN 38152 USA.
C3 Mayo Clinic; University of Memphis
RP Reddy, JG (corresponding author), Mayo Clin, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.
EM reddy.jagadeshwar@mayo.edu
OI Enders, Felicity/0000-0002-3261-5400; Klesges, Lisa/0000-0001-6237-4743
FU National Heart, Lung, and Blood Institute [HL62662]
FX This study was supported by the National Heart, Lung, and Blood
   Institute grant HL62662.
CR AMMON HPT, 1983, BRIT J CLIN PHARMACO, V15, P701, DOI 10.1111/j.1365-2125.1983.tb01553.x
   Burke V, 2005, INT J OBESITY, V29, P15, DOI 10.1038/sj.ijo.0802750
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Cullen KW, 2004, PREV MED, V38, pS34, DOI 10.1016/j.ypmed.2003.05.002
   Cullen KW, 2004, PREV MED, V38, pS24, DOI 10.1016/j.ypmed.2003.05.001
   Daniels JW, 1998, J APPL PHYSIOL, V85, P154, DOI 10.1152/jappl.1998.85.1.154
   Daniels SR, 1998, HYPERTENSION, V31, P97, DOI 10.1161/01.HYP.31.1.97
   Daniels SR, 1998, CIRCULATION, V97, P1907, DOI 10.1161/01.CIR.97.19.1907
   Dekkers JC, 2002, J PEDIATR-US, V141, P770, DOI 10.1067/mpd.2002.128113
   ECK LH, 1989, J AM DIET ASSOC, V89, P784
   Eldridge AL, 1998, J AM DIET ASSOC, V98, P777, DOI 10.1016/S0002-8223(98)00175-8
   FAUST HS, 1982, AM J CLIN NUTR, V35, P1459, DOI 10.1093/ajcn/35.6.1459
   Ford ES, 2004, PEDIATRICS, V114, P1534, DOI 10.1542/peds.2004-0674
   Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175
   Genovesi S, 2005, J HYPERTENS, V23, P493, DOI 10.1097/01.hjh.0000160203.35910.9f
   Green PJ, 1996, J BEHAV MED, V19, P111, DOI 10.1007/BF01857602
   James JE, 2004, PSYCHOPHYSIOLOGY, V41, P914, DOI 10.1111/j.1469-8986.2004.00248.x
   Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647
   Lane JD, 1998, PSYCHOSOM MED, V60, P327, DOI 10.1097/00006842-199805000-00019
   Lovallo WR, 2004, HYPERTENSION, V43, P760, DOI 10.1161/01.HYP.0000120965.63962.93
   LYTLE LA, 1993, J AM DIET ASSOC, V93, P1431, DOI 10.1016/0002-8223(93)92247-U
   Morrison JA, 1999, J PEDIATR-US, V135, P451, DOI 10.1016/S0022-3476(99)70167-8
   Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555
   NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302
   Obarzanek Eva, 2003, Ethnicity & Disease, V13, pS1
   Paradis G, 2004, CIRCULATION, V110, P1832, DOI 10.1161/01.CIR.0000143100.31752.B7
   PINCOMB GA, 1985, AM J CARDIOL, V56, P119, DOI 10.1016/0002-9149(85)90578-8
   *PREV CFDCA, SAS PROGR CDC GROWTH
   Rochon James, 2003, Ethn Dis, V13, pS6
   Savoca MR, 2005, AM J HYPERTENS, V18, P116, DOI 10.1016/j.amjhyper.2004.08.011
   Savoca MR, 2004, ARCH PEDIAT ADOL MED, V158, P473, DOI 10.1001/archpedi.158.5.473
   SCHAKEL SF, 1988, J AM DIET ASSOC, V88, P1268
   SIEVERT YA, 1989, CONTROL CLIN TRIALS, V10, P416, DOI 10.1016/0197-2456(89)90006-8
   SimonsMorton DG, 1997, PEDIATR NEPHROL, V11, P244, DOI 10.1007/s004670050271
   SINAIKO AR, 1993, HYPERTENSION, V21, P989, DOI 10.1161/01.HYP.21.6.989
   Sorof JM, 2004, PEDIATRICS, V113, P475, DOI 10.1542/peds.113.3.475
   Sorof JM, 2002, J PEDIATR-US, V140, P660, DOI 10.1067/mpd.2002.125228
   Sung BH, 1995, AM J HYPERTENS, V8, P1184, DOI 10.1016/0895-7061(95)00331-2
   VANHORN LV, 1990, J AM DIET ASSOC, V90, P412
   VANHORN LV, 1993, J AM DIET ASSOC, V93, P1396, DOI 10.1016/0002-8223(93)92241-O
   Verma M, 1994, Indian Pediatr, V31, P1065
   Waring WS, 2003, AM J HYPERTENS, V16, P919, DOI 10.1016/S0895-7061(03)01014-8
   Watson J, 2002, BRIT J CLIN PHARMACO, V54, P400, DOI 10.1046/j.1365-2125.2002.01681.x
   Wilson Dawn K., 1999, Ethnicity and Disease, V9, P350
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
NR 45
TC 5
Z9 6
U1 0
U2 9
PU ETHNICITY & DISEASE, INC
PI OWINGS MILL
PA 9812 SHERWOOD FARM RD, OWINGS MILL, MD, UNITED KINGDOM
SN 1049-510X
EI 1945-0826
J9 ETHNIC DIS
JI Ethn. Dis.
PD SUM
PY 2008
VL 18
IS 3
BP 283
EP 288
PG 6
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA 489MC
UT WOS:000269423200003
PM 18785440
DA 2025-04-28
ER

PT J
AU Zapata, FJ
   Rebollo-Hernanz, M
   Novakofski, JE
   Nakamura, MT
   de Mejia, EG
AF Zapata, Fatima J.
   Rebollo-Hernanz, Miguel
   Novakofski, Jan E.
   Nakamura, Manabu T.
   de Mejia, Elvira Gonzalez
TI Caffeine, but not other phytochemicals, in mate tea (Ilex
   paraguariensis St. Hilaire) attenuates
   high-fat-high-sucrose-diet-driven lipogenesis and body fat accumulation
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Caffeine; Fat accumulation; Ilex paraguariensis; Lipogenesis; Obesity;
   Yerba mate
ID TRIGLYCERIDE TRANSFER PROTEIN; HUMAN ADIPOSE-TISSUE; YERBA-MATE; ACID
   SYNTHASE; CAFFEOYLQUINIC ACIDS; LIPID-ACCUMULATION; INSULIN-RESISTANCE;
   CHLOROGENIC ACID; PYRUVATE-KINASE; AQUEOUS EXTRACT
AB The objective was to examine the effectiveness of mate tea (MT, Ilex paraguariensis St. Hilaire) and caffeine from mate tea (MC) on in vitro lipid accumulation and in vivo diet-driven-obesity. MC and decaffeinated mate (DM) were obtained using supercritical CO2 extraction and mainly composed of caffeine and caffeoylquinic acids, respectively. MC reduced lipid accumulation (41%) via downregulation of fatty acid synthase (Fasn) (39%) in 3T3-L1 adipocytes. Rats fed a high-fat-high-sucrose-diet and 0.1% of caffeine from MC, MT, or DM. MC attenuated weight gain (16%) and body fat accumulation (22%). MC reduced Fasn expression in both adipose tissue (66%) and liver (37%). MC diminished pyruvate kinase (PK, 59%) and microsomal triglyceride transfer protein (MTP, 50%) hepatic expression. In silica, neochlorogenic acid interacted with PK and MTP allosteric sites. FAS beta-ketoacyl reductase domain showed the highest affinity to 3,5-dicaffeoylquinic acid. Caffeine suppressed lipid accumulation and body weight gain, through the modulation of lipogenic gene expression.
C1 [Zapata, Fatima J.; Novakofski, Jan E.; Nakamura, Manabu T.; de Mejia, Elvira Gonzalez] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.
   [Rebollo-Hernanz, Miguel] UAM CSIC, Inst Food Sci Res, CIAL, Madrid 28049, Spain.
   [Rebollo-Hernanz, Miguel] Univ Autonoma Madrid, Dept Agr Chem & Food Sci, E-28049 Madrid, Spain.
   [Rebollo-Hernanz, Miguel; Nakamura, Manabu T.; de Mejia, Elvira Gonzalez] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.
   [Novakofski, Jan E.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM -
   Instituto de Investigacion en Ciencias de la Alimentacion (CIAL);
   Autonomous University of Madrid; University of Illinois System;
   University of Illinois Urbana-Champaign; University of Illinois System;
   University of Illinois Urbana-Champaign
RP de Mejia, EG (corresponding author), 228 ERML,1201 West Gregory Dr, Urbana, IL 61801 USA.
EM miguel.rebollo@uam.es; edemejia@illinois.edu
RI GONZALEZ DE mEJIA, ELVIRA/IYI-9309-2023; Rebollo-Hernanz,
   Miguel/S-6539-2019
OI DE MEJIA, ELVIRA/0000-0001-7426-9035; Nakamura,
   Manabu/0000-0002-2292-2650; Rebollo-Hernanz, Miguel/0000-0003-1034-1290
FU Division of Nutritional Sciences, University of Illinois through the
   20/20 initiative; Ministry of Science, Innovation, and Universities
   [FPU15/04238]; University of Illinois, Urbana-Champaign [EST18/0064]
FX The Division of Nutritional Sciences, University of Illinois fully
   funded this research through the 20/20 initiative. M. Rebollo-Hernanz
   received funding from the program of the Ministry of Science,
   Innovation, and Universities for his predoctoral fellowship
   (FPU15/04238) and the support for the international research at the
   University of Illinois, Urbana-Champaign (EST18/0064).
CR Angeles TS, 2016, EXPERT OPIN DRUG DIS, V11, P1187, DOI 10.1080/17460441.2016.1245286
   Arçari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Arçari DP, 2013, FOOD CHEM, V141, P809, DOI 10.1016/j.foodchem.2013.04.062
   Arzola-Paniagua MA, 2016, OBESITY, V24, P1454, DOI 10.1002/oby.21523
   Belay A, 2008, FOOD CHEM, V108, P310, DOI 10.1016/j.foodchem.2007.10.024
   Berndt J, 2007, DIABETOLOGIA, V50, P1472, DOI 10.1007/s00125-007-0689-x
   Bradbury P, 1999, J BIOL CHEM, V274, P3159, DOI 10.1074/jbc.274.5.3159
   Bravo L, 2007, FOOD RES INT, V40, P393, DOI 10.1016/j.foodres.2006.10.016
   Boaventura BCB, 2015, LWT-FOOD SCI TECHNOL, V62, P948, DOI 10.1016/j.lwt.2015.02.028
   Carrageta DF, 2018, J FUNCT FOODS, V43, P84, DOI 10.1016/j.jff.2018.02.001
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Cassel E, 2010, J FOOD ENG, V100, P656, DOI 10.1016/j.jfoodeng.2010.05.015
   Chandra S, 2004, J AGR FOOD CHEM, V52, P3583, DOI 10.1021/jf0352632
   Che BQ, 2012, NEUROTOXICOLOGY, V33, P1248, DOI 10.1016/j.neuro.2012.07.004
   Choi MS, 2017, J MED FOOD, V20, P1168, DOI 10.1089/jmf.2017.3995
   da Silva LA., 2017, J APPL PHARM SCI, V7, P215, DOI [10.7324/JAPS, DOI 10.7324/JAPS]
   De Mejia EG, 2005, J AGR FOOD CHEM, V53, P1966, DOI 10.1021/jf048158g
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   de Morais EC, 2009, J AGR FOOD CHEM, V57, P8316, DOI 10.1021/jf901660g
   de Oliveira DM, 2017, EUR J NUTR, V56, P2541, DOI 10.1007/s00394-016-1290-1
   de Paulis T, 2002, EUR J PHARMACOL, V442, P215, DOI 10.1016/S0014-2999(02)01540-6
   de Resende PE, 2015, J FUNCT FOODS, V15, P440, DOI 10.1016/j.jff.2015.03.040
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Fernandes CEF, 2017, J FOOD SCI TECH MYS, V54, P98, DOI 10.1007/s13197-016-2440-4
   Gao HL, 2013, PHYTOTHER RES, V27, P1225, DOI 10.1002/ptr.4856
   Gao HL, 2013, EXP GERONTOL, V48, P572, DOI 10.1016/j.exger.2013.03.008
   Gao HL, 2013, FITOTERAPIA, V84, P264, DOI 10.1016/j.fitote.2012.12.024
   Gómez-Juaristi M, 2018, FOOD CHEM, V240, P1028, DOI 10.1016/j.foodchem.2017.08.003
   González-Muniesa P, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.34
   Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883
   Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Heck CI, 2008, J AGR FOOD CHEM, V56, P8394, DOI 10.1021/jf801748s
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Hodges RE, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/760689
   Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]
   Hu B, 2015, INT J BIOL MACROMOL, V80, P529, DOI 10.1016/j.ijbiomac.2015.07.031
   Iizuka K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020181
   Jacques RA, 2006, J SEP SCI, V29, P2780, DOI 10.1002/jssc.200600024
   Jiang LD, 2016, MOL SIMULAT, V42, P1223, DOI 10.1080/08927022.2016.1149701
   Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5
   Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779
   Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kim YM, 2010, J BIOL CHEM, V285, P29069, DOI 10.1074/jbc.M110.120386
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Liu LT, 2018, J FUNCT FOODS, V47, P156, DOI 10.1016/j.jff.2018.05.030
   Lodhi IJ, 2012, CELL METAB, V16, P189, DOI 10.1016/j.cmet.2012.06.013
   Martel J, 2017, NAT REV ENDOCRINOL, V13, P149, DOI 10.1038/nrendo.2016.142
   Matsumoto RLT, 2009, NUTRIENTS, V1, P18, DOI 10.3390/nu1010018
   McCommis KS, 2015, BIOCHEM J, V466, P443, DOI 10.1042/BJ20141171
   Menendez JA, 2009, CLIN CHEM, V55, P425, DOI 10.1373/clinchem.2008.115352
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Pang C, 2015, J ZHEJIANG UNIV-SC B, V16, P602, DOI 10.1631/jzus.B1400346
   Perez LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03730-9
   Pimentel GD, 2013, J NUTR BIOCHEM, V24, P809, DOI 10.1016/j.jnutbio.2012.04.016
   Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153
   Rebollo-Hernanz M, 2019, FOODS, V8, DOI 10.3390/foods8100438
   Rebollo-Hernanz M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080279
   Rebollo-Hernanz M, 2019, FOOD CHEM TOXICOL, V132, DOI 10.1016/j.fct.2019.110672
   Rebollo-Hernanz M, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801413
   Riachi LG, 2017, J FUNCT FOODS, V38, P308, DOI 10.1016/j.jff.2017.09.020
   Schütz K, 2004, J AGR FOOD CHEM, V52, P4090, DOI 10.1021/jf049625x
   Sikkeland J, 2014, METHOD ENZYMOL, V542, P407, DOI 10.1016/B978-0-12-416618-9.00021-2
   Soleymani T, 2016, OBES REV, V17, P81, DOI 10.1111/obr.12322
   Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   VANATTA RE, 1979, J CHEM EDUC, V56, P666, DOI 10.1021/ed056p666
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Viegas MF, 2018, J PHYS CHEM B, V122, P77, DOI 10.1021/acs.jpcb.7b09645
   Walsh MT, 2017, CRIT REV CL LAB SCI, V54, P26, DOI 10.1080/10408363.2016.1221883
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   World Health Organization, 2018, Obesity andoverweight fact sheet 2018.
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Yun JW, 2008, EXP ANIM TOKYO, V57, P461, DOI 10.1538/expanim.57.461
   Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005
   Zechner R, 2000, INT J OBESITY, V24, pS53, DOI 10.1038/sj.ijo.0801506
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
NR 81
TC 27
Z9 29
U1 1
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN
PY 2020
VL 64
AR 103646
DI 10.1016/j.jff.2019.103646
PG 13
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA KE3WY
UT WOS:000508491000044
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Gamboa-Gómez, CI
   Barragán-Zúñiga, LJ
   Guerrero-Romero, F
   Martínez-Aguilar, G
   Gónzalez, JL
   Valenzuela-Ramírez, AA
   Rojas-Contreras, JA
   Anese, M
   Flores, MC
   Alongi, M
AF Gamboa-Gomez, Claudia I.
   Barragan-Zuniga, Laura J.
   Guerrero-Romero, Fernando
   Martinez-Aguilar, Gerardo
   Gonzalez, Jose Luis
   Valenzuela-Ramirez, Almendra A.
   Rojas-Contreras, Juan A.
   Anese, Monica
   Flores, Maribel Cervantes
   Alongi, Marilisa
TI Effects of coffee with different roasting degrees on obesity and related
   metabolic disorders
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Coffee roasting; Obesity; Metabolic disorders; Body weight; Insulin
   resistance; Liver steatosis
ID HEPATIC LIPID-METABOLISM; INSULIN-RESISTANCE; BODY-WEIGHT; FATTY-ACIDS;
   IN-VITRO; CAFFEINE; RATS; SENSITIVITY; INHIBITION; STEATOSIS
AB This study aimed to assess the effect of unroasted, dark and very dark roasted coffee on obesity and metabolic disorders in obese rats. All coffee samples significantly reduced weight gain (-17%) compared to obese control. Coffee reduced glucose levels (-17%) upon a glucose tolerance test in all cases compared to the control, while fasting glucose only decreased (-26%) with very dark coffee. Insulin levels and insulin resistance significantly decreased (-77% and 65% respectively) with all coffee samples compared to the control. Unroasted and dark roasted coffee decreased triglycerides (-21% and -11%, respectively), and unroasted coffee also reduced free fatty acids (-43%) and adipocyte size. Coffee decreased liver steatosis (-55%) and Caspase-3 levels (-27%), regardless of the roasting degree. Overall, coffee plays a positive role in restraining obesity and related metabolic disorders but, depending on the metabolic pathway and relevant marker, an effect of roasting could be either found or not.
C1 [Gamboa-Gomez, Claudia I.; Barragan-Zuniga, Laura J.; Guerrero-Romero, Fernando] Inst Mexicano Seguro Social, Unidad Invest Biomed, Canoas 100, Durango 34067, Mexico.
   [Martinez-Aguilar, Gerardo] Univ Juarez Estado Durango, Fac Med & Nutr, Ave Univ & Fanny Anitua S-N, Durango 34000, Mexico.
   [Gonzalez, Jose Luis] Hosp Gen Zona No 1, Dept Patol, Inst Mexicano Seguro Social, Canoas S-N, Durango 34067, Mexico.
   [Valenzuela-Ramirez, Almendra A.; Rojas-Contreras, Juan A.] TecNM Inst Tecnol Durango, Felipe Pescador 1830 Ote, Durango 34080, Dgo, Mexico.
   [Anese, Monica; Alongi, Marilisa] Univ Juarez Estado Durango, Fac Chem Sci, Ave Vet S-N Col Valle Sur, Durango 34120, Mexico.
   [Flores, Maribel Cervantes] Univ Udine, Dept Agr Food Environm & Anim Sci, Via Sondrio 2-A, I-33100 Udine, Italy.
C3 Instituto Mexicano del Seguro Social; Universidad Juarez del Estado de
   Durango; Instituto Mexicano del Seguro Social; Universidad Juarez del
   Estado de Durango; University of Udine
RP Alongi, M (corresponding author), Univ Juarez Estado Durango, Fac Chem Sci, Ave Vet S-N Col Valle Sur, Durango 34120, Mexico.; Flores, MC (corresponding author), Univ Udine, Dept Agr Food Environm & Anim Sci, Via Sondrio 2-A, I-33100 Udine, Italy.
EM maribel.cervantes@ujed.mx; marilisa.alongi@uniud.it
RI contreras, juan/AAH-8617-2020; Hidalgo González, José
   Luis/AAG-4123-2020; ALONGI, MARILISA/P-9770-2019; Martinez,
   Gerardo/B-8029-2018
OI Gamboa-Gomez, Claudia I/0000-0002-2815-9406; Martinez,
   Gerardo/0000-0002-7878-2503; ALONGI, MARILISA/0000-0003-4708-6297;
   BARRAGAN ZUNIGA, LAURA JAZEL/0000-0002-9925-6668; Guerrero-Romero,
   Fernando/0000-0001-9636-9870
FU Mexican National System of Researchers (SNI) [CVU 1042204,
   COCYTED/DG-202/2020]; Mexican Council of Science and Technology
   (CONACYT) [209339]
FX This project was supported by COCYTED/DG-202/2020 and with the
   scholarship of the Mexican National System of Researchers (SNI, No.
   209339). Author AAVR. thanks the Mexican Council of Science and
   Technology (CONACYT) for the graduate scholarship (CVU 1042204). The
   authors appreciate the technical support of Victor Ivan Sayago-Monreal
   and Julio C. Ramirez-Espana.
CR Abdelaal S, 2019, Egyptian Journal of Histology, V42, P133, DOI [10.21608/ejh.2018.5079.1022, DOI 10.21608/EJH.2018.5079.1022]
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Alongi M., 2020, Food Chemistry, V342
   Alongi M, 2018, FOOD RES INT, V111, P480, DOI 10.1016/j.foodres.2018.05.061
   An H, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-21-621
   Anese M, 2023, FOOD RES INT, V165, DOI 10.1016/j.foodres.2023.112530
   BANGSBO J, 1992, J APPL PHYSIOL, V72, P1297, DOI 10.1063/1.351736
   Barf RP, 2012, PHYSIOL BEHAV, V107, P322, DOI 10.1016/j.physbeh.2012.09.005
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/c7fo00388a, 10.1039/C7FO00388A]
   Granado-Serrano AB, 2006, J NUTR, V136, P2715, DOI 10.1093/jn/136.11.2715
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Budryn G, 2017, EUR FOOD RES TECHNOL, V243, P1323, DOI 10.1007/s00217-017-2843-0
   Cai FF, 2019, BIOMED PHARMACOTHER, V114, DOI 10.1016/j.biopha.2019.108863
   Campbell BI, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0123-1
   Campfield LA, 1998, SCIENCE, V280, P1383, DOI 10.1126/science.280.5368.1383
   Choi S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030363
   Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8
   Civera M, 2010, DIABETES-METAB RES, V26, P187, DOI 10.1002/dmrr.1070
   Clarke R. J., 1987, Coffee-Technology, P73
   Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6
   Duangjai A, 2021, PREV NUTR FOOD SCI, V26, P338, DOI 10.3746/pnf.2021.26.3.338
   FALHOLT K, 1973, CLIN CHIM ACTA, V46, P105, DOI 10.1016/0009-8981(73)90016-8
   Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004
   Feyisa TO, 2019, LAB ANIM RES, V35, DOI 10.1186/s42826-019-0024-y
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Furtado KS, 2012, BASIC CLIN PHARMACOL, V111, P339, DOI 10.1111/j.1742-7843.2012.00903.x
   Galisteo M, 2004, MOL CELL BIOCHEM, V259, P91, DOI 10.1023/B:MCBI.0000021360.89867.64
   Gamboa-Gómez C, 2014, FOOD FUNCT, V5, P927, DOI 10.1039/c3fo60604j
   Gamboa-Gómez CI, 2017, FOOD RES INT, V102, P690, DOI 10.1016/j.foodres.2017.09.040
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   Grzelczyk J, 2022, FOOD CHEM, V392, DOI 10.1016/j.foodchem.2022.133328
   Harb AA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50352-4
   Hernández JA, 2007, J FOOD ENG, V78, P1141, DOI 10.1016/j.jfoodeng.2005.12.041
   Ilmiawati C, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05052-y
   Jayo M., 1999, NOM-062-ZOO-1999
   Jiménez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kawasaki T, 2005, BRIT J NUTR, V93, P613, DOI 10.1079/BJN20051407
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161
   Konstantinidi Melina, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6030094
   Kovacs P, 2005, BEST PRACT RES CL EN, V19, P625, DOI 10.1016/j.beem.2005.07.003
   Kramer M, 2017, BIOL REV, V92, P431, DOI 10.1111/brv.12237
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee Y, 2020, DIABETES METAB J, V44, P658, DOI 10.4093/dmj.2019.0220
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Meex RCR, 2019, OBES REV, V20, P1205, DOI 10.1111/obr.12862
   National Institutes of Health, 2002, Office of laboratory animal welfare, United States. Public health service. Public Health Service Policy on Humane Care and Use of Laboratory Animals
   Nikpayam O, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0489-8
   Nistiar F, 2012, J ENVIRON SCI HEAL A, V47, P1224, DOI 10.1080/10934529.2012.672071
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Nugroho DA., 2017, Asian J Pharmaceutical Clin Res, V10, P279, DOI [10.2159/ajpcr.2017.v10i9.19329, DOI 10.2159/AJPCR.2017.V10I9.19329, 10.12688/f1000research.55470.1, DOI 10.22159/AJPCR.2017.V10I9.19329]
   Nzekoue FK, 2021, BEVERAGES, V7, DOI 10.3390/beverages7030061
   Olechno E, 2021, FOODS, V10, DOI 10.3390/foods10061208
   Olini N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072539
   Perrone D, 2012, J AGR FOOD CHEM, V60, P4265, DOI 10.1021/jf205388x
   Pimentel GD, 2014, NUTRITION IN THE PREVENTION AND TREATMENT OF ABDOMINAL OBESITY, P245, DOI 10.1016/B978-0-12-407869-7.00024-6
   Pimpley V, 2020, PREP BIOCHEM BIOTECH, V50, P969, DOI 10.1080/10826068.2020.1786699
   Ramos LV, 2022, J NUTR BIOCHEM, V100, DOI 10.1016/j.jnutbio.2021.108881
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Ruban A, 2019, CLIN MED, V19, P205, DOI 10.7861/clinmedicine.19-3-205
   Sarma S, 2021, DIABETES OBES METAB, V23, P3, DOI 10.1111/dom.14290
   Shokouh P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092074
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099
   Sualeh A, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05812
   Udia P.M., 2013, Research J Pharmacogn Phytochem., V5, P300
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   Walker JM, 2020, J FUNCT FOODS, V72, DOI 10.1016/j.jff.2020.104063
   Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Zhang SJ, 2015, FOOD FUNCT, V6, P2578, DOI [10.1039/c5fo00247h, 10.1039/C5FO00247H]
NR 75
TC 2
Z9 2
U1 2
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD DEC
PY 2023
VL 111
AR 105889
DI 10.1016/j.jff.2023.105889
EA NOV 2023
PG 11
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA Z2ZS6
UT WOS:001110814500001
OA gold
DA 2025-04-28
ER

PT J
AU Anese, M
   Alongi, M
   Cervantes-Flores, M
   Simental-Mendía, LE
   Martínez-Aguilar, G
   Valenzuela-Ramírez, AA
   Rojas-Contreras, JA
   Guerrero-Romero, F
   Gamboa-Gómez, CI
AF Anese, Monica
   Alongi, Marilisa
   Cervantes-Flores, Maribel
   Simental-Mendia, Luis E.
   Martinez-Aguilar, Gerardo
   Valenzuela-Ramirez, Almendra A.
   Rojas-Contreras, Juan A.
   Guerrero-Romero, Fernando
   Gamboa-Gomez, Claudia I.
TI Influence of coffee roasting degree on inflammatory and oxidative stress
   markers in high-fructose and saturated fat-fed rats
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article
DE Coffee roasting degree; Oxidative stress markers; Inflammatory markers;
   High-fructose and saturated fat
ID NF-KAPPA-B; CHLOROGENIC ACID; ANTIOXIDANT ACTIVITY; OBESITY; MODULATION;
   MECHANISMS; NITRITE; ASSAY
AB The objective of this study was to evaluate the effect of roasting coffee degree on inflammatory (NF-k beta F-6 and TNF-alpha) and stress oxidative markers (malondialdehyde (MDA), nitric oxide (NO) end product concentrations, catalase (CAT), and superoxide dismutase (SOD) in high-fructose and saturated fat (HFSFD)-fed rats. Roasting was performed using hot air circulation (200 degrees C) for 45 and 60 min, obtaining dark and very dark coffee, respectively. Male Wistar rats were randomly assigned to receive a) unroasted coffee, b) dark coffee, c) very dark coffee, or distilled water for the control group (n = 8). Coffee brews (7.4 mL/per day equivalent to 75 mL/day in humans) were given by gavage for sixteen weeks. All treated groups significantly decreased NF-k beta F-6 (similar to 30 % for unroasted, similar to 50 % for dark, and similar to 75 % for very dark group) and TNF-alpha in the liver compared with the control group. Additionally, TNF-alpha showed a significant reduction in all treatment groups (similar to 26 % for unroasted and dark groups, and similar to 39 % for very dark group) in adipose tissue (AT) compared with the negative control. Regarding oxidative stress makers, all coffee brews exerted antioxidant effects in serum, AT, liver, kidney, and heart.
   Our results revealed that the anti-inflammatory and antioxidant effects of coffee vary according to the roasting degree in HFSFD-fed rats.
C1 [Anese, Monica; Alongi, Marilisa] Univ Udine, Dept Agr Food Environm & Anim Sci, Via Sondrio 2-A, I-33100 Udine, Italy.
   [Cervantes-Flores, Maribel] Univ Juarez Estado Durango, Fac Chem Sci, Ave Vet S-N, Durango 34120, Mexico.
   [Simental-Mendia, Luis E.; Martinez-Aguilar, Gerardo; Guerrero-Romero, Fernando; Gamboa-Gomez, Claudia I.] Mexican Social Secur Inst Durango, Biomed Res Unit, Canoas 100, Durango 34067, Mexico.
   [Valenzuela-Ramirez, Almendra A.; Rojas-Contreras, Juan A.] TecNM Inst Tecnol Durango, Felipe Pescador 1830 Ote, Durango 34080, Dgo, Mexico.
C3 University of Udine; Universidad Juarez del Estado de Durango
RP Guerrero-Romero, F; Gamboa-Gómez, CI (corresponding author), Mexican Social Secur Inst Durango, Biomed Res Unit, Canoas 100, Durango 34067, Mexico.
EM guerrero.romero@gmail.com; clau140382@hotmail.com
RI ALONGI, MARILISA/P-9770-2019; contreras, juan/AAH-8617-2020; Martinez,
   Gerardo/B-8029-2018
OI Rojas Contreras, Juan Antonio/0000-0002-9632-7555; Simental-Mendia, Luis
   E./0000-0002-3617-4921; Martinez, Gerardo/0000-0002-7878-2503
FU  [COCYTED/DG-202/2020]
FX Acknowledgement This project was supported by COCYTED/DG-202/2020. The
   authorsappreciate the technical support of Victor Iv?an Sayago-Monreal
   and Julio C. Ramirez-Espan?a.
CR Akash MSH, 2018, J CELL BIOCHEM, V119, P105, DOI 10.1002/jcb.26174
   Al-Brakati A, 2020, METAB BRAIN DIS, V35, P1175, DOI 10.1007/s11011-020-00583-6
   Aliko V, 2018, FISH SHELLFISH IMMUN, V76, P101, DOI 10.1016/j.fsi.2018.02.042
   Alongi M, 2021, FOOD CHEM, V342, DOI 10.1016/j.foodchem.2020.128289
   Alongi M, 2019, J FUNCT FOODS, V58, P130, DOI 10.1016/j.jff.2019.04.057
   Alongi M, 2018, FOOD RES INT, V111, P480, DOI 10.1016/j.foodres.2018.05.061
   [Anonymous], 2002, PUBL HLTH SERV POL H
   AOAC International, 1996, Official methods of analysis of AOAC International, V16th
   Augusto O, 2019, FREE RADICAL BIO MED, V135, P210, DOI 10.1016/j.freeradbiomed.2019.02.026
   Bao LP, 2018, INT IMMUNOPHARMACOL, V54, P245, DOI 10.1016/j.intimp.2017.11.021
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Budryn G., 2017, EUR FOOD RES TECHNOL
   Carlström M, 2021, NAT REV NEPHROL, V17, P575, DOI 10.1038/s41581-021-00429-z
   Choi S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030363
   Clarke R. J., 1987, Coffee-Technology, P73
   Cruz-Teno C, 2012, MOL NUTR FOOD RES, V56, P854, DOI 10.1002/mnfr.201200096
   de Miranda JA, 2015, J HUM HYPERTENS, V29, P109, DOI 10.1038/jhh.2014.48
   Dludla PV, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010023
   Fujioka K, 2008, FOOD CHEM, V106, P217, DOI 10.1016/j.foodchem.2007.05.091
   Giridharan S, 2018, J INFLAMM RES, V11, P407, DOI 10.2147/JIR.S140188
   Hou NN, 2015, CLIN ENDOCRINOL, V83, P339, DOI 10.1111/cen.12658
   Ji MY, 2020, MOLECULES, V25, DOI 10.3390/molecules25040917
   Jiménez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Jones D, 2017, WOOD PUBL SER CIVIL, P1
   Jung S, 2017, J MED FOOD, V20, P626
   Karnina R, 2021, ANN MED SURG, V69, DOI 10.1016/j.amsu.2021.102660
   Kicel A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3482521
   Kim JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.115
   Klaikeaw N, 2020, WORLD J HEPATOL, V12, P363, DOI 10.4254/wjh.v12.i7.363
   Koloverou E, 2015, EUR J CLIN NUTR, V69, P1220, DOI 10.1038/ejcn.2015.98
   Liang NJ, 2014, MOLECULES, V19, P19180, DOI 10.3390/molecules191119180
   Lima AR, 2013, REV BRAS FARMACOGN, V23, P506, DOI 10.1590/S0102-695X2013005000036
   Linden DR, 2014, ANTIOXID REDOX SIGN, V20, P818, DOI 10.1089/ars.2013.5312
   Liu XH, 2021, CURR DRUG METAB, V22, P415, DOI 10.2174/1389200222666210406110450
   McMurray F, 2016, OBESITY, V24, P2301, DOI 10.1002/oby.21654
   Mills CE, 2013, FOOD CHEM, V141, P3335, DOI 10.1016/j.foodchem.2013.06.014
   Nicoli MC, 1997, FOOD SCI TECHNOL-LEB, V30, P292, DOI 10.1006/fstl.1996.0181
   Noeman SA, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-17
   Norma Oficial Mexicana, 1999, NOM-062-ZOO
   Nzekoue FK, 2021, BEVERAGES, V7, DOI 10.3390/beverages7030061
   Olechno E, 2021, FOODS, V10, DOI 10.3390/foods10061208
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Perrone D, 2012, J AGR FOOD CHEM, V60, P4265, DOI 10.1021/jf205388x
   de Torre MP, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8050142
   Pimpley V, 2020, PREP BIOCHEM BIOTECH, V50, P969, DOI 10.1080/10826068.2020.1786699
   Pinheiro-Castro N, 2019, ADV EXP MED BIOL, V1134, P149, DOI 10.1007/978-3-030-12668-1_8
   Rabago-Velasco M., 2000, J HIGH ENERGY PHYS
   Ramos LV, 2022, J NUTR BIOCHEM, V100, DOI 10.1016/j.jnutbio.2021.108881
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rezapour H, 2022, REV FR ALLERGOL, V62, P470, DOI 10.1016/j.reval.2021.08.007
   Rocha-Guzman N. E., 2018, MED CHEM RES
   Sastry KVH, 2002, ANAL BIOCHEM, V306, P79, DOI 10.1006/abio.2002.5676
   Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002
   SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7
   Somoza V, 2005, MOL NUTR FOOD RES, V49, P663, DOI 10.1002/mnfr.200500034
   Taso O.V., 2019, Annals of Research Hospitals, V3, P2, DOI DOI 10.21037/ARH.2018.12.02
   Teodoro AJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3765986
   Tsikas D, 2017, ANAL BIOCHEM, V524, P13, DOI 10.1016/j.ab.2016.10.021
   Ukeda H, 1999, BIOSCI BIOTECH BIOCH, V63, P485, DOI 10.1271/bbb.63.485
NR 59
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0963-9969
EI 1873-7145
J9 FOOD RES INT
JI Food Res. Int.
PD MAR
PY 2023
VL 165
AR 112530
DI 10.1016/j.foodres.2023.112530
EA FEB 2023
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 8V5TP
UT WOS:000930693000001
PM 36869534
DA 2025-04-28
ER

PT J
AU Wang, TY
   Xu, H
   Sun, Y
   Hou, JM
   Yin, LY
AF Wang, Tianyu
   Xu, He
   Sun, Yue
   Hou, Jumin
   Yin, Liying
TI Synergistic Effects of Chlorogenic Acid and Ganoderma Lucidum
   Polysaccharide on Hepatic Fat Accumulation
SO CURRENT TOPICS IN NUTRACEUTICAL RESEARCH
LA English
DT Article
DE Chlorogenic acid; Combined treatment; Ganoderma lucidum polysaccharide;
   Obesity; Lipid metabolism
ID GUT MICROBIOTA; MECHANISMS; POLYPHENOLS; METABOLISM; EXPRESSION;
   ANTITUMOR; KINASE
AB This study aimed to investigate the impact of different doses of chlorogenic acid and Ganoderma lucidum polysaccharide on lipid accumulation using an obese rat model. We utilized blood glucose assays, oil red O staining, and triglyceride content analysis to examine the effects of chlorogenic acid combined with G. lucidum polysaccharide on fat metabolism in rats. We found substantial potential in using chlorogenic acid combined with G. lucidum polysaccharide for weight control and metabolic regulation in obese rats. After a long-term dietary intervention, chlorogenic acid and G. lucidum polysaccharide markedly inhibited the expression of proteins related to fatty acid synthesis, including AMP -activated protein kinase, fatty acid synthase, and SREBP-1c, leading to reduced body weight and decreased hepatic fat deposition. Additionally, the combined treatment substantially affected enzymes and proteins involved in glucose metabolism, reducing glycogen synthase expression and indicating a potential mechanism for weight reduction through glycogen synthesis inhibition. Furthermore, elevated glucose kinase levels indicated that chlorogenic acid and G. lucidum polysaccharide may enhance hepatic glycogen degradation, thereby reducing hepatic fat accumulation. These findings reveal that chlorogenic acid combined with G. lucidum polysaccharide has a synergistic impact, providing a theoretical basis for their potential as a combined therapeutic approach for obesity.
C1 [Wang, Tianyu; Xu, He; Sun, Yue; Hou, Jumin; Yin, Liying] Changchun Univ, Sch Food Sci & Engn, Changchun 130022, Peoples R China.
C3 Changchun University
RP Yin, LY (corresponding author), Changchun Univ, Sch Food Sci & Engn, Changchun 130022, Peoples R China.
EM yinliying_0321@163.com
RI Wang, Tianyu/KHD-6479-2024
FU Science and Technology Projects of the Jilin Provincial Department of
   Education [JJKH20210617KJ]; Science and Technology Development Project
   Foundation of Jilin Province [20210203179SF]
FX This work was funded by the Science and Technology Projects of the Jilin
   Provincial Department of Education (JJKH20210617KJ) and the Science and
   Technology Development Project Foundation of Jilin Province
   (20210203179SF) .
CR Baldwin J, 2016, J NUTR BIOCHEM, V27, P123, DOI 10.1016/j.jnutbio.2015.08.027
   Cao Y, 2012, FUNGAL DIVERS, V56, P49, DOI 10.1007/s13225-012-0178-5
   CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2
   Carrieri R., Structural data and immunomodulatory properties of a water-soluble heteroglycan extracted from the mycelium of an Italian isolate of Ganoderma lucidum, V31, P2119, DOI [10.1080/14786419.2017.1278593, DOI 10.1080/14786419.2017.1278593]
   Chadaideh KS, 2021, CELL METAB, V33, P857, DOI 10.1016/j.cmet.2021.04.011
   Chang CJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8489
   Cheng DM, 2016, MOL NUTR FOOD RES, V60, P2367, DOI 10.1002/mnfr.201600290
   Chooi YC, 2019, METABOLISM, V92, P6, DOI 10.1016/j.metabol.2018.09.005
   Feldman AT, 2014, METHODS MOL BIOL, V1180, P31, DOI 10.1007/978-1-4939-1050-2_3
   Gallagher Sean, 2008, J Vis Exp, DOI 10.3791/759
   Gao YH, 2005, IMMUNOL INVEST, V34, P171, DOI 10.1081/IMM-200055813
   Gao YL, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.1092582
   Li MT, 2022, CURR ONCOL, V29, P5247, DOI 10.3390/curroncol29080417
   Lin ZB, 2004, ACTA PHARMACOL SIN, V25, P1387
   Liu ZG, 2016, INT J BIOL MACROMOL, V82, P973, DOI 10.1016/j.ijbiomac.2015.10.088
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu JH, 2020, INT J BIOL MACROMOL, V150, P765, DOI 10.1016/j.ijbiomac.2020.02.035
   Meng Y, 2020, BIOMACROMOLECULES, V21, P1653, DOI 10.1021/acs.biomac.9b01644
   Moutzouri E, 2023, INT J STROKE, V18, P1219, DOI 10.1177/17474930231181010
   Renard CMGC, 2001, INT J BIOL MACROMOL, V29, P115, DOI 10.1016/S0141-8130(01)00155-6
   Rtibi K, 2018, J ETHNOPHARMACOL, V224, P242, DOI 10.1016/j.jep.2018.06.001
   Samodien E, 2019, MOL METAB, V27, P1, DOI 10.1016/j.molmet.2019.06.022
   Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247
   Simonsen HT, 2009, J AGR FOOD CHEM, V57, P2056, DOI 10.1021/jf802057v
   Sohretoglu D, 2018, ANTI-CANCER AGENT ME, V18, P667, DOI 10.2174/1871520617666171113121246
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Trefts E, 2021, MOL CELL, V81, P3677, DOI 10.1016/j.molcel.2021.08.015
   Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007
   Wang H, 2019, APPL MICROBIOL BIOT, V103, P903, DOI 10.1007/s00253-018-9482-7
   Wang YN, 2011, DIAGN CYTOPATHOL, V39, P272, DOI 10.1002/dc.21390
   Wu Z, 2011, J AGR FOOD CHEM, V59, P10737, DOI 10.1021/jf202722w
   Yu LM, 2021, J FUNCT FOODS, V85, DOI 10.1016/j.jff.2021.104640
   Zawawi NAF, 2022, APPL SCI-BASEL, V12, DOI 10.3390/app12041864
   Zhang L, 2018, FOOD FUNCT, V9, P6156, DOI [10.1039/C8FO01281D, 10.1039/c8fo01281d]
   Zhang Z, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070677
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
NR 36
TC 0
Z9 0
U1 11
U2 16
PU NEW CENTURY HEALTH PUBLISHERS, LLC
PI COPPELL
PA PO BOX 175, COPPELL, TX 75019 USA
SN 1540-7535
EI 2641-452X
J9 CURR TOP NUTRACEUT R
JI Curr. Top. Nutraceutical Res.
PD MAY
PY 2024
VL 22
IS 2
BP 792
EP 802
PG 11
WC Nutrition & Dietetics; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Pharmacology & Pharmacy
GA SM0R4
UT WOS:001234757000007
DA 2025-04-28
ER

PT J
AU Kim, J
   Yun, S
   Oh, K
AF Kim, Jihee
   Yun, Sungha
   Oh, Kyungwon
TI Beverage consumption among Korean adolescents: data from 2016 Korea
   Youth Risk Behavior Survey
SO NUTRITION RESEARCH AND PRACTICE
LA English
DT Article
DE Adolescent; carbonated beverage; sugar-sweetened beverage; energy drink;
   Korea
ID SUGAR-SWEETENED BEVERAGES; CAFFEINE INTAKE; CHILDREN; CARBOHYDRATE;
   OVERWEIGHT; ADULTS; ENERGY
AB BACKGROUND/OBJECTIVES: Association between the consumption of sugar-sweetened beverages (SSBs) and obesity is universally a controversial issue. This study was undertaken to examine the beverage consumption pattern of Korean adolescents.
   SUBJECTS/METHODS: Data was collected from the 2016 Korea Youth Risk Behavior Survey involving 65,528 adolescent respondents. A list of the most frequently consumed beverages was analyzed, and the consumption frequency of carbonated beverages, SSBs, and energy drinks during the past seven-days was assessed. The main reasons for the adolescents to consume the beverages were also determined.
   RESULTS: The beverage preference of adolescents were carbonated beverages (31.0%), 'fruit and vegetable beverages (17.7%)', 'milk (13.6%)', and 'coffee (12.7%)'. Carbonated beverages and SSBs were consumed more than three times a week by 27.1% and 41.1% of the respondents, respectively. About 86.2% of adolescents did not take of any energy drinks during the last seven-days. Taste was the most common reason that adolescents considered when choosing a drink. Carbonated beverages consumed more frequently by boys than girls, and high school students drank coffee more frequently than middle school students.
   CONCLUSIONS: Boys had a higher preference for unhealthy beverages than girls, whereas consumption of high-caffeine drinks was greater amongst high-school students than middle school students.
C1 [Kim, Jihee; Yun, Sungha; Oh, Kyungwon] Korea Ctr Dis Control & Prevent, Osong Hlth Technol Adm Complex, Div Hlth & Nutr Survey, 187 Osongsaengmyeong 2 Ro, Cheongju 28159, Chungbuk, South Korea.
C3 Korea Disease Control & Prevention Agency (KDCA)
RP Oh, K (corresponding author), Korea Ctr Dis Control & Prevent, Osong Hlth Technol Adm Complex, Div Hlth & Nutr Survey, 187 Osongsaengmyeong 2 Ro, Cheongju 28159, Chungbuk, South Korea.
EM kwoh27@korea.kr
CR Bae YunJung Bae YunJung, 2013, Korean Journal of Nutrition, V46, P34, DOI 10.4163/kjn.2013.46.1.34
   Brener Nancy D., 2011, Morbidity and Mortality Weekly Report, V60, P778
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   Duffey KJ, 2012, EUR J CLIN NUTR, V66, P244, DOI 10.1038/ejcn.2011.166
   Garriguet Didier, 2008, Health Rep, V19, P17
   Guelinckx I, 2015, EUR J NUTR, V54, P69, DOI 10.1007/s00394-015-0955-5
   Gui ZH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121302
   Ha K, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010031
   Her EunSil Her EunSil, 2008, Korean Journal of Community Nutrition, V13, P189
   Jiménez-Aguilar A, 2009, SALUD PUBLICA MEXICO, V51, pS604, DOI 10.1590/S0036-36342009001000015
   Jin MJ, 2016, KOREAN J FAM MED, V37, P111, DOI 10.4082/kjfm.2016.37.2.111
   Kang BokSun Kang BokSun, 2006, Korean Journal of Community Nutrition, V11, P469
   김은주, 2014, [Korean Journal of Food and Cookery Science, 한국식품조리과학회지], V30, P650
   도영숙, 2014, [Journal of Food Hygiene and Safety, 한국식품위생안전성학회지], V29, P105
   Kim Y, 2016, INT J EPIDEMIOL, V45, DOI 10.1093/ije/dyw070
   Lee Haeng-Shin, 2013, Clin Nutr Res, V2, P135, DOI 10.7762/cnr.2013.2.2.135
   Lee HaengShin Lee HaengShin, 2014, Journal of Nutrition and Health, V47, P268, DOI 10.4163/jnh.2014.47.4.268
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2017, 13 KOR YOUTH RISK BE
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2016, 12 KOR YOUTH RISK BE
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2017, KOR HLTH STAT 2016 K
   Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465
   Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014
   Park JY, 2010, J E ASIAN SOC DIET L, V20, P201
   Patrick K, 2004, ARCH PEDIAT ADOL MED, V158, P385, DOI 10.1001/archpedi.158.4.385
   Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010
   Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009
   Sui ZX, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110678
   Veugelers PJ, 2005, CAN MED ASSOC J, V173, P607, DOI 10.1503/cmaj.050445
NR 30
TC 8
Z9 9
U1 1
U2 11
PU KOREAN NUTRITION SOC
PI SEOUL
PA 804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-1457
EI 2005-6168
J9 NUTR RES PRACT
JI Nutr. Res. Pract.
PD FEB
PY 2019
VL 13
IS 1
BP 70
EP 75
DI 10.4162/nrp.2019.13.1.70
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HM1UH
UT WOS:000459238100010
PM 30788059
OA hybrid, Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Cho, AS
   Jeon, SM
   Kim, MJ
   Yeo, J
   Seo, KI
   Choi, MS
   Lee, MK
AF Cho, Ae-Sim
   Jeon, Seon-Min
   Kim, Myung-Joo
   Yeo, Jiyoung
   Seo, Kwon-Il
   Choi, Myung-Sook
   Lee, Mi-Kyung
TI Chlorogenic acid exhibits anti-obesity property and improves lipid
   metabolism in high-fat diet-induced-obese mice
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Chlorogenic acid; Caffeic acid; High-fat diet; Lipid metabolism; Obesity
ID CAFFEIC ACID; INSULIN SENSITIVITY; ADIPOSE-TISSUE; RAT-LIVER;
   ADIPONECTIN; CHOLESTEROL; PROTEIN; HYPOADIPONECTINEMIA; CARCINOGENESIS;
   ASSOCIATION
AB This study investigated the efficacy of chlorogenic acid on altering body fat in high-fat diet (37% calories from fat) induced-obese mice compared to caffeic acid. Caffeic acid or chlorogenic acid was supplemented with high-fat diet at 0.02% (wt/wt) dose. Both caffeic acid and chlorogenic acid significantly lowered body weight, visceral fat mass and plasma leptin and insulin levels compared to the high-fat control group. They also lowered triglyceride (in plasma, liver and heart) and cholesterol (in plasma, adipose tissue and heart) concentrations. Triglyceride content in adipose tissue was significantly lowered, whereas the plasma adiponectin level was elevated by chlorogenic acid supplementation compared to the high-fat control group. Body weight was significantly correlated with plasma leptin (r = 0.894. p < 0.01) and insulin (r = 0.496, p < 0.01) levels, respectively. Caffeic acid and chlorogenic acid significantly inhibited fatty acid synthase, 3-hydroxy-3-methylglutaryl CoA reductase and acyl-CoA: cholesterol acyltransferase activities, while they increased fatty acid beta-oxidation activity and peroxisome proliferator-activated receptors alpha expression in the liver compared to the high-fat group. These results suggest that caffeic acid and chlorogenic acid improve body weight, lipid metabolism and obesity-related hormones levels in high-fat fed mice. Chlorogenic acid seemed to be more potent for body weight reduction and regulation of lipid metabolism than caffeic acid. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Jeon, Seon-Min; Choi, Myung-Sook] Kyungpook Natl Univ, Dept Food Sci & Nutr, Taegu 702701, South Korea.
   [Cho, Ae-Sim] Sunchon Natl Univ, Grad Sch Educ, Dept Nutr Educ, Sunchon 540742, South Korea.
   [Kim, Myung-Joo] Daegu Polytech Coll, Dept Food Sci & Nutr, Taegu 706022, South Korea.
   [Yeo, Jiyoung] Pusan Natl Univ, Sch Oriental Med, Pusan 626810, South Korea.
   [Seo, Kwon-Il; Lee, Mi-Kyung] Sunchon Natl Univ, Dept Food & Nutr, Sunchon 540742, South Korea.
C3 Kyungpook National University (KNU); Sunchon National University; Pusan
   National University; Sunchon National University
RP Choi, MS (corresponding author), Kyungpook Natl Univ, Dept Food Sci & Nutr, 1370 Sankyuk Dong, Taegu 702701, South Korea.
EM mschoi@knu.ac.kr; leemk@sunchon.ac.kr
FU Korea Science and Engineering Foundation (KOSEF) [2009-0063409]
FX This work was supported by the Science Research Center (SRC) program of
   Korea Science and Engineering Foundation (KOSEF, No. 2009-0063409).
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   [Anonymous], J NUTR
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q
   Bergeron R, 2006, ENDOCRINOLOGY, V147, P4252, DOI 10.1210/en.2005-1535
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chen XL, 2008, METABOLISM, V57, P1516, DOI 10.1016/j.metabol.2008.06.005
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   ERICKSON SK, 1980, J LIPID RES, V21, P930
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GILLIES PJ, 1986, EXP MOL PATHOL, V44, P329, DOI 10.1016/0014-4800(86)90046-8
   Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084
   Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   HULCHER FH, 1973, J LIPID RES, V14, P625
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005
   Kim H, 2003, DIABETES, V52, P1770, DOI 10.2337/diabetes.52.7.1770
   Kim HK, 2003, CLIN CHIM ACTA, V327, P129, DOI 10.1016/S0009-8981(02)00344-3
   Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50
   Lafontan M, 2008, DIABETES METAB, V34, P317, DOI 10.1016/j.diabet.2008.04.001
   Lazarow P B, 1981, Methods Enzymol, V72, P315
   Lee MK, 2003, J BIOCHEM MOL TOXIC, V17, P255, DOI 10.1002/jbt.10087
   Mathieu P, 2008, INT J BIOCHEM CELL B, V40, P821, DOI 10.1016/j.biocel.2007.12.001
   MORI H, 1986, CANCER LETT, V30, P49, DOI 10.1016/0304-3835(86)90131-X
   NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y
   Nepokroeff C M, 1975, Methods Enzymol, V35, P37, DOI 10.1016/0076-6879(75)35136-7
   Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8
   Radtke J, 1998, Z ERNAHRUNGSWISS, V37, P190, DOI 10.1007/s003940050016
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   SHAPIRO DJ, 1974, BIOCHIM BIOPHYS ACTA, V370, P369, DOI 10.1016/0005-2744(74)90098-9
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   TANAKA T, 1993, CARCINOGENESIS, V14, P1321, DOI 10.1093/carcin/14.7.1321
   Torre-Villalvazo I, 2008, J NUTR, V138, P462, DOI 10.1093/jn/138.3.462
   Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x
   Tsuchiya T, 1996, BIOSCI BIOTECH BIOCH, V60, P765, DOI 10.1271/bbb.60.765
   Willson TM, 1997, CURR OPIN CHEM BIOL, V1, P235, DOI 10.1016/S1367-5931(97)80015-4
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Bieri J. G., 1977, Journal of Nutrition, V107, P1394
NR 42
TC 615
Z9 679
U1 9
U2 192
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD MAR
PY 2010
VL 48
IS 3
BP 937
EP 943
DI 10.1016/j.fct.2010.01.003
PG 7
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA 573VO
UT WOS:000275943600026
PM 20064576
DA 2025-04-28
ER

PT J
AU Vinson, JA
   Chen, X
   Garver, DD
AF Vinson, Joe A.
   Chen, Xi
   Garver, Deanne Dulik
TI Determination of Total Chlorogenic Acids in Commercial Green Coffee
   Extracts
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE caffeine; chlorogenic acids; green coffee extract; HPLC; L; MS
ID PROFILE
AB Obesity and type II diabetes are serious health problems and are among the leading causes of death. There are a few prescription weight loss drugs, but they have a high cost and their adverse effects have limited their widespread use. For the consumer, the use of dietary supplements represents a natural and presumably safer means of losing weight. A high-pressure liquid chromatography (HPLC) method was developed to provide a simple, inexpensive method for analysis of 54 commercially available extracts of green coffee beans. Both chlorogenic acids (CGAs), which are the purported bioactives, and caffeine were measured using 5-chloroquinic acid as the standard and published extinction coefficients for the other monomeric and dimeric CGAs present. The average labeled dose of CGA was 233 mg, whereas the average calculated by HPLC analysis was only 157 mg. Thus, the consumer is likely to obtain product containing a little more than half of the reported label amount of CGA. Caffeine levels ranged from 0% to 17%. The marketing literature touts 50% CGA content as being the gold standard of green coffee bean extract products. Based on this value, only 28% of the commercial products we studied met this goal.
C1 [Vinson, Joe A.; Chen, Xi] Univ Scranton, Loyola Sci Ctr, Dept Chem, 925 Ridge Row, Scranton, PA 18510 USA.
   [Garver, Deanne Dulik] Marywood Univ, Dept Sci Math & Comp Sci, Scranton, PA USA.
C3 University of Scranton
RP Vinson, JA (corresponding author), Univ Scranton, Loyola Sci Ctr, Dept Chem, 925 Ridge Row, Scranton, PA 18510 USA.
EM joe.vinson@scranton.edu
CR Abrankó L, 2017, J AGR FOOD CHEM, V65, P3602, DOI 10.1021/acs.jafc.7b00729
   Chong PW, 2014, PHYTOTHER RES, V28, P1520, DOI 10.1002/ptr.5158
   Craig AP, 2016, TALANTA, V154, P481, DOI 10.1016/j.talanta.2016.03.101
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farah Adriana, 2006, Braz. J. Plant Physiol., V18, P23, DOI 10.1590/S1677-04202006000100003
   Moon JK, 2009, J AGR FOOD CHEM, V57, P5823, DOI 10.1021/jf901136e
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nuhu AA, 2014, ISRN NUTR, V2014, P1, DOI DOI 10.1155/2014/384230
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Pepper L, 2013, GREEN COFFEE BEAN QU
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   TRUGO LC, 1984, ANALYST, V109, P263, DOI 10.1039/an9840900263
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 13
TC 23
Z9 24
U1 2
U2 39
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD MAR 1
PY 2019
VL 22
IS 3
BP 314
EP 320
DI 10.1089/jmf.2018.0039
PG 7
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition &
   Dietetics
GA HP4TN
UT WOS:000461669100012
PM 30888913
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Bouchard, DR
   Ross, R
   Janssen, I
AF Bouchard, Danielle R.
   Ross, Robert
   Janssen, Ian
TI Coffee, Tea and Their Additives: Association with BMI and Waist
   Circumference
SO OBESITY FACTS
LA English
DT Article
DE Obesity; Caffeine; Whitener; Sweetener
ID WEIGHT-LOSS; METABOLIC SYNDROME; LIFE-STYLE; LONG-TERM; BODY-FAT;
   CONSUMPTION; HEALTH; CAFFEINE; RISK; CONSEQUENCES
AB Objective: The purposes of this study were to perform a detailed analysis how: i) the frequency of coffee/tea consumption and ii) the use of additives in coffee/tea is associated with measures of total and abdominal obesity. Method: 3,823 participants of the 2003-2004 National Health and Nutrition Examination Survey were examined. Obesity was assessed by BMI and waist circumference (WC). Coffee and tea consumption and use of additives were assessed by questionnaire. Results: Coffee consumption was not related to BMI or WC in either gender. However, men who drank >= 2 cups of tea per day had lower BMI (25.9 vs. 28.0 kg/m(2)) and WC (95.2 vs. 101.32 cm) values than men who never drank drink tea (p <= 0.05). The associations between tea consumption and BMI or WC were no longer significant after adjustment for additive use. Coffee/tea drinkers who used artificial sweeteners had larger (p <= 0.05) BMIs than coffee/tea drinkers who did not use sweeteners (28.2 vs. 27.1 kg/m(2) in men, 28.4 vs. 27.1 kg/m(2) in women). Conclusion: Frequency of coffee/tea consumption was not associated with measures of obesity because additive use explained the association between tea consumption and obesity in men. Artificial sweetener use within coffee/tea was associated with higher BMI.
C1 [Bouchard, Danielle R.; Ross, Robert; Janssen, Ian] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.
   [Janssen, Ian] Queens Univ, Dept Community Hlth Epidemiol, Kingston, ON, Canada.
C3 Queens University - Canada; Queens University - Canada
RP Bouchard, DR (corresponding author), Ctr Rech Etienne Lebel CHUS, 3001,12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.
EM Danielle.Bouchard@usherbrooke.ca
RI Janssen, Ian/B-7700-2009
OI Janssen, Ian/0000-0003-2159-3012
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   [Anonymous], USDA DIET GUID AM
   [Anonymous], 2008, USDA NAT NUTR DAT ST
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   BEERBORST S, 1995, Z ERNAHRUNGSWISS, V34, P183, DOI 10.1007/BF01623156
   Bellisle F, 2007, EUR J CLIN NUTR, V61, P691, DOI 10.1038/sj.ejcn.1602649
   Bellisle F, 2001, J HUM NUTR DIET, V14, P191, DOI 10.1046/j.1365-277X.2001.00289.x
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Cameron AJ, 2009, MED J AUSTRALIA, V191, P202, DOI 10.5694/j.1326-5377.2009.tb02753.x
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   Egger G, 1999, MED J AUSTRALIA, V171, P604, DOI 10.5694/j.1326-5377.1999.tb123817.x
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   GREGERSEN NT, 2009, BR J NUTR, P1
   GYNTELBERG F, 2009, INT J FOOD SCI NUTR, P1
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Ito Y, 2008, BIOMED RES-TOKYO, V29, P27, DOI 10.2220/biomedres.29.27
   Lee BL, 2000, J CHROMATOGR A, V881, P439, DOI 10.1016/S0021-9673(00)00215-6
   MONTERROSA AE, 1995, DIABETES CARE, V18, P448, DOI 10.2337/diacare.18.4.448
   *NAT COFF ASS US, NAT COFF DRINK TREND
   National Center for Health Statistics, 2001 2002 NAT HLTH N
   National Center for Health Statistics, 1999 2000 NAT HLTH N
   National Coffee Association, NAT COFF DRINK TREND
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   ROSS CE, 1994, J HEALTH SOC BEHAV, V35, P161, DOI 10.2307/2137363
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Schneider C, 2009, AM FAM PHYSICIAN, V79, P591
   Serafini M, 2003, NATURE, V424, P1013, DOI 10.1038/4241013a
   Shields DH, 2004, J AM DIET ASSOC, V104, P650, DOI 10.1016/j.jada.2004.01.015
   Soriguer F, 2004, ANN INTERN MED, V141, P321, DOI 10.7326/0003-4819-141-4-200408170-00017
   Swithers SE, 2010, PHYSIOL BEHAV, V100, P55, DOI 10.1016/j.physbeh.2009.12.021
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534
NR 42
TC 53
Z9 56
U1 0
U2 42
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1662-4025
EI 1662-4033
J9 OBESITY FACTS
JI Obes. Facts
PY 2010
VL 3
IS 6
BP 345
EP 352
DI 10.1159/000322915
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 698HS
UT WOS:000285585500004
PM 21196787
OA Green Published
DA 2025-04-28
ER

PT J
AU Hamada, T
   Kotani, K
   Higashi, A
   Ikeda, J
   Tagaki, E
   Igarashi, A
   Matsubara, C
   Yoshida, T
   Sakane, N
AF Hamada, Taku
   Kotani, Kazuhiko
   Higashi, Akane
   Ikeda, Junko
   Tagaki, Emi
   Igarashi, Aiko
   Matsubara, Chikanobu
   Yoshida, Toshihide
   Sakane, Naoki
TI Lack of association of the Trp64Arg polymorphism of
   β3-adrenergic receptor gene with energy expenditure in
   response to caffeine among young healthy women
SO TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE beta(3)-adrenergic receptor; polymorphism; caffeine; energy expenditure;
   genotype
ID BASAL METABOLIC-RATE; INSULIN-RESISTANCE SYNDROME; OBESE FINNS;
   WEIGHT-LOSS; MUTATION; FAT; JAPANESE
AB A close relationship between coffee intake and certain metabolic disorders is known. Caffeine, one of coffee components, can increase energy expenditure (EE), but there are considerable individual differences in the caffeine effects on EE, and the causes have not been fully established in humans. The Arg allele in the beta(3)-adrenergic receptor gene (beta(3)-AR), a marker for obesity-related traits, may be a contributor to individual variations in EE. This study investigated the effect of the Arg allele of beta(3)-AR on caffeine-induced increases in EE. In 44 healthy young women (21 +/- 1 years), physical characteristics, blood pressure, biochemical profiles and dietary nutritional intake were measured. A caffeine-loading test was conducted at a dosage of 4 mg per body weight (kg). EE was measured using an indirect open-circuit calorimeter for a 10-min period before, and at 30 min and 60 min after the caffeine-loading test. The beta(3)-AR Trp64Arg polymorphism was detected with a PCR-restriction fragment length polymorphism method. The frequency of the Arg allele was 24%. The distribution of the Trp/Trp, Trp/Arg, and Arg/Arg genotypes was 58%, 36%, and 6%, respectively. At the baseline, subjects with the Arg/Arg genotype had a significantly lower EE level than those with the Trp/Trp or Trp/Arg genotype. After the caffeine-loading test, there were caffeine-induced increases in EE in all genotypes, but there were no differences in the levels of increase among the genotypes. These findings suggest that the genotypes of beta(3)-AR Trp64Arg polymorphism might be not associated with caffeine-induced increases in EE levels.
C1 [Hamada, Taku; Kotani, Kazuhiko; Sakane, Naoki] Natl Hosp Org Kyoto Med Ctr, Clin Res Inst Endocrine & Metab Dis, Div Med & Diabet Educ, Fushimi Ku, Kyoto 6128555, Japan.
   [Kotani, Kazuhiko] Tottori Univ, Fac Med, Div Hlth Adm & Promot, Yonago, Tottori 683, Japan.
   [Higashi, Akane; Tagaki, Emi; Igarashi, Aiko; Matsubara, Chikanobu] Kyoto Prefectural Univ, Fac Human Environm, Kyoto 606, Japan.
   [Ikeda, Junko] Kyoto Bunkyo Jr Coll, Dept Home Econ, Tokyo, Japan.
   [Yoshida, Toshihide] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Diabet Endocrinol & Metab, Kyoto, Japan.
C3 Tottori University; Kyoto Prefectural University; Kyoto Prefectural
   University of Medicine
RP Sakane, N (corresponding author), Natl Hosp Org Kyoto Med Ctr, Clin Res Inst Endocrine & Metab Dis, Div Med & Diabet Educ, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.
EM nsakane@kyotolan.hosp.go.jp
RI Higashi, Akane/AAC-1977-2019
CR BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500
   CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605
   Date C, 1996, J Epidemiol, V6, pS131
   KADOWAKI H, 1995, BIOCHEM BIOPH RES CO, V215, P555, DOI 10.1006/bbrc.1995.2500
   Kurokawa N, 2001, OBES RES, V9, P741, DOI 10.1038/oby.2001.102
   Lusk G, 1924, J BIOL CHEM, V59, P41
   PietriRouxel F, 1997, EUR J BIOCHEM, V247, P1174, DOI 10.1111/j.1432-1033.1997.01174.x
   Sakane N, 1997, DIABETES, V46, P1633, DOI 10.2337/diabetes.46.10.1633
   Sakane N, 1997, DIABETES CARE, V20, P1887, DOI 10.2337/diacare.20.12.1887
   Sakane N, 1997, DIABETOLOGIA, V40, P200, DOI 10.1007/s001250050663
   Sipilainen R, 1997, DIABETES, V46, P77, DOI 10.2337/diabetes.46.1.77
   Tchernof A, 1999, DIABETES, V48, P1425, DOI 10.2337/diabetes.48.7.1425
   Umekawa T, 1999, DIABETES, V48, P117, DOI 10.2337/diabetes.48.1.117
   Valve R, 1998, DIABETOLOGIA, V41, P357, DOI 10.1007/s001250050915
   WALSTON J, 1995, NEW ENGL J MED, V333, P343, DOI 10.1056/NEJM199508103330603
   WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604
   YOSHIDA T, 1994, INT J OBESITY, V18, P345
   YOSHIDA T, 1995, LANCET, V346, P1433, DOI 10.1016/S0140-6736(95)92452-3
   YOSHIOKA K, 1990, J NUTR SCI VITAMINOL, V36, P173, DOI 10.3177/jnsv.36.173
NR 19
TC 4
Z9 5
U1 0
U2 1
PU TOHOKU UNIV MEDICAL PRESS
PI SENDAI
PA 2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN
SN 0040-8727
EI 1349-3329
J9 TOHOKU J EXP MED
JI Tohoku J. Exp. Med.
PD APR
PY 2008
VL 214
IS 4
BP 365
EP 370
DI 10.1620/tjem.214.365
PG 6
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA 296ZN
UT WOS:000255584600011
PM 18441513
OA Bronze
DA 2025-04-28
ER

PT J
AU Watanabe, T
   Arisawa, K
   Nguyen, TV
   Ishizu, M
   Katsuura-Kamano, S
   Hishida, A
   Tamura, T
   Kato, Y
   Okada, R
   Ibusuki, R
   Koriyama, C
   Suzuki, S
   Otani, T
   Koyama, T
   Tomida, S
   Kuriki, K
   Takashima, N
   Miyagawa, N
   Wakai, K
   Matsuo, K
AF Watanabe, Takeshi
   Arisawa, Kokichi
   Nguyen, Tien Van
   Ishizu, Masashi
   Katsuura-Kamano, Sakurako
   Hishida, Asahi
   Tamura, Takashi
   Kato, Yasufumi
   Okada, Rieko
   Ibusuki, Rie
   Koriyama, Chihaya
   Suzuki, Sadao
   Otani, Takahiro
   Koyama, Teruhide
   Tomida, Satomi
   Kuriki, Kiyonori
   Takashima, Naoyuki
   Miyagawa, Naoko
   Wakai, Kenji
   Matsuo, Keitaro
CA Japan MultiInst Collaborat Cohort
TI Coffee and metabolic phenotypes: A cross-sectional analysis of the Japan
   multi-institutional collaborative cohort (J-MICC) study
SO NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
LA English
DT Article
DE Coffee consumption; Obesity; Metabolic phenotypes
ID FOOD FREQUENCY QUESTIONNAIRE; UNHEALTHY NORMAL-WEIGHT; DIETARY PATTERNS;
   CHLOROGENIC ACID; TEA CONSUMPTION; METAANALYSIS; PREVALENCE; SECRETION;
   HEALTHY; OBESITY
AB Background and aims: To date, the relationship between coffee consumption and metabolic phenotypes has hardly been investigated and remains controversial. Therefore, the aim of this cross-sectional study is to examine the associations between coffee consumption and metabolic phenotypes in a Japanese population. Methods and results: We analyzed the data of 26,363 subjects (aged 35-69 years) in the baseline survey of the Japan Multi-Institutional Collaborative Cohort Study. Coffee consumption was assessed using a questionnaire. Metabolic Syndrome (MetS) was defined according to the Joint Interim Statement Criteria of 2009, using body mass index (BMI) instead of waist circumference. Subjects stratified by the presence or absence of obesity (normal weight: BMI <25 kg/m2; obesity: BMI >= 25 kg/m2) were classified by the number of MetS components (metabolically healthy: no components; metabolically unhealthy: one or more components) other than BMI. In multiple logistic regression analyses adjusted for sex, age, and other potential confounders, high coffee consumption (>= 3 cups/day) was associated with a lower prevalence of MetS and metabolically unhealthy phenotypes both in normal weight (OR 0.83, 95% CI 0.76-0.90) and obese subjects (OR 0.83, 95% CI 0.69-0.99). Filtered/instant coffee consumption was inversely associated with the prevalence of MetS and metabolically unhealthy phenotypes, whereas canned/bottled/packed coffee consumption was not. Conclusion: The present results suggest that high coffee consumption, particularly filtered/ instant coffee, is inversely associated with the prevalence of metabolically unhealthy phenotypes in both normal weight and obese Japanese adults. 2022 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Ital-ian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
C1 [Watanabe, Takeshi; Arisawa, Kokichi; Nguyen, Tien Van; Ishizu, Masashi; Katsuura-Kamano, Sakurako] Tokushima Univ, Dept Prevent Med, Grad Sch Biomed Sci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.
   [Hishida, Asahi; Tamura, Takashi; Kato, Yasufumi; Okada, Rieko; Wakai, Kenji] Nagoya Univ, Dept Prevent Med, Grad Sch Med, Nagoya, Aichi, Japan.
   [Ibusuki, Rie] Kagoshima Univ, Dept Int Isl & Community Med, Grad Sch Med & Dent Sci, Kagoshima, Japan.
   [Koriyama, Chihaya] Kagoshima Univ, Dept Epidemiol & Prevent Med, Grad Sch Med & Dent Sci, Kagoshima, Japan.
   [Suzuki, Sadao; Otani, Takahiro] Nagoya City Univ, Dept Publ Hlth, Grad Sch Med Sci, Nagoya, Aichi, Japan.
   [Koyama, Teruhide; Tomida, Satomi] Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kyoto, Japan.
   [Tomida, Satomi] Kyoto Prefectural Univ Med, Dept Endocrine & Breast Surg, Kyoto, Japan.
   [Kuriki, Kiyonori] Univ Shizuoka, Sch Food & Nutr Sci, Div Nutr Sci, Lab Publ Hlth, Shizuoka, Japan.
   [Takashima, Naoyuki] Kindai Univ, Fac Med, Dept Publ Hlth, Osaka, Japan.
   [Takashima, Naoyuki; Miyagawa, Naoko] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga, Japan.
   [Miyagawa, Naoko] Keio Univ, Dept Prevent Med & Publ Hlth, Sch Med, Tokyo, Japan.
   [Matsuo, Keitaro] Aichi Canc Ctr, Div Canc Epidemiol & Prevent, Res Inst, Nagoya, Aichi, Japan.
   [Matsuo, Keitaro] Nagoya Univ, Dept Canc Epidemiol, Grad Sch Med, Nagoya, Aichi, Japan.
C3 Tokushima University; Nagoya University; Kagoshima University; Kagoshima
   University; Nagoya City University; Kyoto Prefectural University of
   Medicine; Kyoto Prefectural University of Medicine; University of
   Shizuoka; Kindai University (Kinki University); Shiga University of
   Medical Science; Keio University; Aichi Cancer Center; Nagoya University
RP Watanabe, T (corresponding author), Tokushima Univ, Dept Prevent Med, Grad Sch Biomed Sci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.
EM watanabe.takeshi.2@tokushima-u.ac.jp
RI Hishida, Asahi/C-4888-2016; Tamura, Takashi/ADO-2791-2022; Matsuo,
   Keitaro/H-6758-2019; 晃英, 小山/AAI-9805-2020; Wakai, Kenji/I-7248-2014;
   Okada, Rieko/M-4989-2014; Ishizu, Masashi/JTT-8561-2023; Nguyen,
   Phuong/KFS-2753-2024; Watanabe, Takeshi/AHA-0210-2022
OI Watanabe, Takeshi/0000-0002-4532-0556; Van Nguyen,
   Tien/0000-0001-9022-1170
FU Japanese Ministry of Education, Culture, Sports, Science and Technology
   [17015018, 221S0001]; JSPS KAKENHI [JP16H06277, 22H04923]; Japanese
   Society for the Promotion of Science [20K18659];  [18K10086];
   Grants-in-Aid for Scientific Research [21K11791, 22H04923, 20K18659]
   Funding Source: KAKEN
FX This study was supported by Grants-in-Aid for Scientific Research on
   Priority Areas of Cancer (No. 17015018) , on Innovative Areas (No.
   221S0001) , and the Platform of Supporting Cohort Study and Biospecimen
   Analysis (CoBiA, JSPS KAKENHI Grant No. JP16H06277 & 22H04923) from the
   Japanese Ministry of Education, Culture, Sports, Science and Technology
   and by Grants-in-Aid for Early-Career Scientists (JSPS KAKENHI Grant No.
   20K18659) and for Scientific Research (C) (JSPS KAKENHI Grant No.
   18K10086) from the Japanese Society for the Promotion of Science.
CR Abiri B, 2023, CRIT REV FOOD SCI, V63, P5856, DOI 10.1080/10408398.2021.2025036
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   [Anonymous], 2021, SURVEY DATA ALL JAPA
   Barrea L, 2023, CRIT REV FOOD SCI, V63, P1238, DOI 10.1080/10408398.2021.1963207
   Cao Z, 2020, BRIT J CANCER, V123, P1336, DOI 10.1038/s41416-020-1012-6
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Dibaba DT, 2017, AM J CLIN NUTR, V106, P921, DOI 10.3945/ajcn.117.155291
   Eckel N, 2016, EUR J PREV CARDIOL, V23, P956, DOI 10.1177/2047487315623884
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317
   Hang D, 2020, DIABETES CARE, V43, P2588, DOI 10.2337/dc20-0800
   Heo J, 2020, FOODS, V9, DOI 10.3390/foods9121746
   Imaeda N, 2007, J EPIDEMIOL, V17, P100, DOI 10.2188/jea.17.100
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kanbay M, 2023, EUR J CLIN INVEST, V53, DOI 10.1111/eci.13878
   Kass L, 2012, EUR J CLIN NUTR, V66, P411, DOI 10.1038/ejcn.2012.4
   Katsuura-Kamano S, 2021, PREV MED REP, V24, DOI 10.1016/j.pmedr.2021.101613
   Koyanagi YN, 2022, CANCER SCI, V113, P1441, DOI 10.1111/cas.15286
   Lauria MW, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-74
   Lu MY, 2022, NUTRIENTS, V14, DOI 10.3390/nu14091867
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Matoba N, 2020, NAT HUM BEHAV, V4, P308, DOI 10.1038/s41562-019-0805-1
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Mirmiran P, 2020, INT J FOOD SCI NUTR, V71, P891, DOI 10.1080/09637486.2020.1746955
   Mirzababaei A, 2019, DIABETES METAB SYND, V13, P322, DOI 10.1016/j.dsx.2018.09.012
   Myers J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071652
   Nakagawa-Senda H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19914-w
   Nerurkar PV, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041348
   Nguyen TV, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0269550
   Nikniaz L, 2019, BMC ENDOCR DISORD, V19, DOI 10.1186/s12902-019-0455-3
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Ortega FB, 2018, PROG CARDIOVASC DIS, V61, P190, DOI 10.1016/j.pcad.2018.07.008
   Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379
   Rodríguez-Monforte M, 2017, EUR J NUTR, V56, P925, DOI 10.1007/s00394-016-1305-y
   Rosique-Esteban N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020168
   Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b
   Saito M, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/146865
   Scott RA, 2014, DIABETES, V63, P4378, DOI 10.2337/db14-0319
   Shab-Bidar S, 2018, PUBLIC HEALTH NUTR, V21, P1681, DOI [10.1017/s1368980018000216, 10.1017/S1368980018000216]
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Shiwaku K, 2005, DIABETES RES CLIN PR, V69, P52, DOI 10.1016/j.diabres.2004.11.001
   Smith GI, 2019, J CLIN INVEST, V129, P3978, DOI 10.1172/JCI129186
   Stefan N, 2020, ENDOCRINOL METAB, V35, P487, DOI 10.3803/EnM.2020.301
   Stefan N, 2017, CELL METAB, V26, P292, DOI 10.1016/j.cmet.2017.07.008
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Takeuchi K, 2021, J EPIDEMIOL, V31, P660, DOI 10.2188/jea.JE20200147
   Tokudome Shinkan, 2004, Asian Pac J Cancer Prev, V5, P40
   Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135
   VanderWeele TJ, 2010, AM J EPIDEMIOL, V172, P1339, DOI 10.1093/aje/kwq332
   Wakai K, 2011, J EPIDEMIOL, V21, P223, DOI 10.2188/jea.JE20100139
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4
   Zembic A, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.8505
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Zhou ZY, 2021, DIABETOLOGIA, V64, P1963, DOI 10.1007/s00125-021-05484-6
   Ziki MDA, 2016, CURR OPIN LIPIDOL, V27, P162, DOI 10.1097/MOL.0000000000000276
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 57
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 0939-4753
EI 1590-3729
J9 NUTR METAB CARDIOVAS
JI Nutr. Metab. Carbiovasc. Dis.
PD MAR
PY 2023
VL 33
IS 3
BP 620
EP 630
DI 10.1016/j.numecd.2022.12.019
EA FEB 2023
PG 11
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition
   & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism;
   Nutrition & Dietetics
GA G6IN7
UT WOS:000990172100001
PM 36710119
OA Bronze
DA 2025-04-28
ER

PT J
AU Naveed, M
   Hejazi, V
   Abbas, M
   Kamboh, AA
   Khan, GJ
   Shumzaid, M
   Ahmad, F
   Babazadeh, D
   Xia, FF
   Modarresi-Ghazani, F
   Li, WH
   Zhou, XH
AF Naveed, Muhammad
   Hejazi, Veghar
   Abbas, Muhammad
   Kamboh, Asghar Ali
   Khan, Ghulam Jilany
   Shumzaid, Muhammad
   Ahmad, Fawwad
   Babazadeh, Daryoush
   Xia FangFang
   Modarresi-Ghazani, Faezeh
   Li WenHua
   Zhou XiaoHui
TI Chlorogenic acid (CGA): A pharmacological review and call for further
   research
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Review
DE Clinical pharmacology; Medicinal values; Anti-hypertension; Antioxidant;
   Food additive; Green coffee extract
ID COFFEE BEAN EXTRACT; GLANDULAR TRICHOMES; BIOLOGICAL-ACTIVITY;
   ANTIINFLAMMATORY ACTIVITY; 5-CAFFEOYLQUINIC ACID; SECONDARY METABOLITES;
   OXIDATIVE STRESS; IN-SILICO; ANTIOXIDANT; DERIVATIVES
AB Phenolic acids have recently gained substantial attention due to their various practical, biological and pharmacological effects. Chlorogenic Acid (CGA, 3-CQA) is a most abundant isomer among caffeoylquinic acid isomers (3-, 4-, and 5-CQA), that currently known as 5-CQA as per guidelines of IUPAC. It is one of the most available acids among phenolic acid compounds which can be naturally found in green coffee extracts and tea. CGA is an important and biologically active dietary polyphenol, playing several important and therapeutic roles such as antioxidant activity, antibacterial, hepatoprotective, cardioprotective, anti-inflammatory, antipyretic, neuroprotective, anti-obesity, antiviral, anti-microbial, anti-hypertension, free radicals scavenger and a central nervous system (CNS) stimulator. In addition, it has been found that CGA could modulate lipid metabolism and glucose in both genetically and healthy metabolic related disorders. It is speculated that CGA can perform crucial roles in lipid and glucose metabolism regulation and thus help to treat many disorders such as hepatic steatosis, cardiovascular disease, diabetes, and obesity as well. Furthermore, this phenolic acid (CGA) causes hepatoprotective effects by protecting animals from chemical or lipopolysaccharide-induced injuries. The hypocholesterolemic influence of CGA can result from the altered metabolism of nutrients, including amino acids, glucose and fatty acids (FA). The purpose of this review was to broaden the scope of knowledge of researchers to conduct more studies on this subject to both unveil and optimize its biological and pharmacological effects. As a result, CGA may be practically used as a natural safeguard food additive to replace the synthetic antibiotics and thereby reduce the medicinal cost.
C1 [Naveed, Muhammad; Abbas, Muhammad; Zhou XiaoHui] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Clin Pharm, Sch Pharm, Nanjing 211198, Jiangsu, Peoples R China.
   [Naveed, Muhammad; Li WenHua] Aviat Gen Hosp, Dept Urol Surg, Beijing 100012, Peoples R China.
   [Hejazi, Veghar] Tabriz Univ Med Sci, Tabriz, Iran.
   [Kamboh, Asghar Ali] Sindh Agr Univ, Fac Anim Husb & Vet Sci, Dept Vet Microbiol, Tandojam 70060, Pakistan.
   [Khan, Ghulam Jilany] China Pharmaceut Univ, Jiangsu Ctr Pharmacodynam Res & Evaluat, Dept Pharmacol, Sch Pharm, Nanjing 210009, Jiangsu, Peoples R China.
   [Shumzaid, Muhammad] Riphah Int Univ, Riphah Inst Pharmaceut Sci, Lahore 54770, Pakistan.
   [Ahmad, Fawwad] Univ Agr Faisalabad, Inst Anim & Dairy Sci, Dept Poultry Sci, Faisalabad 38040, Pakistan.
   [Babazadeh, Daryoush] Shiraz Univ, Avian Dis Res Ctr, Fac Vet Med, Shiraz, Iran.
   [Xia FangFang] Nanjing Xiaozhuang Univ, Coll Environm Sci, Dept Chem, Nanjing 211171, Jiangsu, Peoples R China.
   [Modarresi-Ghazani, Faezeh] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.
   [Zhou XiaoHui] Nanjing Shuiximen Hosp, Dept Heart Surg, Nanjing 210017, Jiangsu, Peoples R China.
   [Zhou XiaoHui] Southeast Univ, Zhongda Hosp, Dept Cardiothorac Surg, Nanjing 210017, Jiangsu, Peoples R China.
C3 China Pharmaceutical University; Tabriz University of Medical Science;
   Sindh Agricultural University; China Pharmaceutical University;
   University of Agriculture Faisalabad; Shiraz University; Nanjing
   Xiaozhuang University; Tabriz University of Medical Science; Southeast
   University - China
RP Zhou, XH (corresponding author), China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Clin Pharm, Sch Pharm, Nanjing 211198, Jiangsu, Peoples R China.; Li, WH (corresponding author), Aviat Gen Hosp, Dept Urol Surg, Beijing 100012, Peoples R China.; Modarresi-Ghazani, F (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.
EM faezeh.modarres@gmail.com; liwenhua361@sina.com; zhxh@cpu.edu.cn
RI Zhou, Xiaohui/MIQ-5125-2025; Yang, Xueli/AAW-4792-2021; Abbas,
   Muhammad/AAY-1430-2020; Kamboh, Asghar/AAA-2099-2020; Khan, Ghulam
   Jilany/C-2135-2017; Babazadeh, Daryoush/H-8472-2019; Naveed,
   Muhammad/Y-3856-2018
OI Khan, Ghulam Jilany/0000-0002-2748-5314; Hejazi,
   Veghar/0000-0001-8871-3694; Kamboh, Asghar/0000-0002-5176-6685;
   Babazadeh, Daryoush/0000-0003-1118-2295; Xiaohui,
   Zhou/0000-0002-6375-4497; Naveed, Muhammad/0000-0002-2193-9266;
   Modarresi-Ghazani, Faezeh/0000-0002-9857-8040
FU Chinese Scholarship Council (CSC) P.R China
FX The author M. Naveed (Langrial) is highly thankful to Dr. Muhammad Saeed
   (NW A & F University, Yangling, Shaanxi, P. R China) for his assistance
   and proper guidelines on the CGA review, in addition, He is thankful to
   the Chinese Scholarship Council (CSC) P.R China for their generous
   financial support for his studies.
CR [Anonymous], J BIOCH
   [Anonymous], EUROPEAN J NUTR
   [Anonymous], 2009, ELECT J DIFFERENTIAL, DOI DOI 10.1371/J0URNAL.P0NE.0106787
   Attele AS, 2002, DIABETES, V51, P1851, DOI 10.2337/diabetes.51.6.1851
   Ayseli MT, 2016, TRENDS FOOD SCI TECH, V48, P69, DOI 10.1016/j.tifs.2015.11.005
   Bagdas D, 2014, N-S ARCH PHARMACOL, V387, P1101, DOI 10.1007/s00210-014-1034-9
   Bajko E, 2016, LWT-FOOD SCI TECHNOL, V65, P471, DOI 10.1016/j.lwt.2015.08.024
   Caprioli G, 2017, NAT PROD RES, V31, P515, DOI 10.1080/14786419.2016.1195383
   Chiang LC, 2002, ANTIVIR RES, V55, P53, DOI 10.1016/S0166-3542(02)00007-4
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T
   Esposito F, 2013, PATHOG DIS, V68, P116, DOI 10.1111/2049-632X.12051
   Farzaei MH, 2015, WORLD J GASTROENTERO, V21, P6499, DOI 10.3748/wjg.v21.i21.6499
   Fernández MA, 1998, J PHARM PHARMACOL, V50, P1183, DOI 10.1111/j.2042-7158.1998.tb03332.x
   Fiamegos YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018127
   Francisco V, 2013, J ETHNOPHARMACOL, V148, P126, DOI 10.1016/j.jep.2013.03.077
   Fu L., 2016, BIOMED RES INT, V2016
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Hakkou Z, 2017, BIOMED PHARMACOTHER, V93, P62, DOI 10.1016/j.biopha.2017.06.015
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Jin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120842
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jung HA, 1999, ARCH PHARM RES, V22, P213, DOI 10.1007/BF02976549
   Karunanidhi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/392058
   Khan MTH, 2005, ANTIVIR RES, V67, P107, DOI 10.1016/j.antiviral.2005.05.002
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Kremr D, 2016, QUIM NOVA, V39, P530
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Les F, 2017, IND CROP PROD, V108, P295, DOI 10.1016/j.indcrop.2017.06.043
   Liu CC, 2017, MOL MED REP, V16, P1369, DOI 10.3892/mmr.2017.6698
   Mandrone M, 2015, IND CROP PROD, V76, P402, DOI 10.1016/j.indcrop.2015.07.012
   Meng S., 2013, EVIDENCE BASED COMPL, V2013
   Mills CE, 2013, FOOD CHEM, V141, P3335, DOI 10.1016/j.foodchem.2013.06.014
   Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645
   Naso LG, 2014, J INORG BIOCHEM, V135, P86, DOI 10.1016/j.jinorgbio.2014.02.013
   Natella F, 1999, J AGR FOOD CHEM, V47, P1453, DOI 10.1021/jf980737w
   Nicasio P, 2005, PHYTOTHER RES, V19, P661, DOI 10.1002/ptr.1722
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Ornano L, 2016, NAT PROD RES, V30, P920, DOI 10.1080/14786419.2015.1079189
   Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41
   Panico R., 1994, IUPAC COMMISSION NOM, P71
   Park HJ, 2010, ARCH PHARM RES, V33, P1703, DOI 10.1007/s12272-010-1101-9
   Plesko S, 2015, ACTA CHIM SLOV, V62, P555
   Puupponen-Pimiä R, 2001, J APPL MICROBIOL, V90, P494, DOI 10.1046/j.1365-2672.2001.01271.x
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Sasaki K, 2010, FOOD CHEM, V118, P830, DOI 10.1016/j.foodchem.2009.05.070
   Senol FS, 2011, PHYTOCHEM LETT, V4, P462, DOI 10.1016/j.phytol.2011.08.016
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Shin HS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020165
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Sousa R, 2014, CLIN INFECT DIS, V59, P41, DOI 10.1093/cid/ciu235
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Stauder M, 2010, J AGR FOOD CHEM, V58, P11662, DOI 10.1021/jf1031839
   Sung WS, 2010, PURE APPL CHEM, V82, P219, DOI 10.1351/PAC-CON-09-01-08
   Suzuki A, 2002, HYPERTENS RES, V25, P99, DOI 10.1291/hypres.25.99
   Tamura H, 2006, MOL NUTR FOOD RES, V50, P396, DOI 10.1002/mnfr.200500216
   Tom ENL, 2016, PHYTOMEDICINE, V23, P1037, DOI 10.1016/j.phymed.2016.06.012
   Venditti A., 2017, CHEM BIODIVERS, V14
   Venditti A, 2016, CHEM BIODIVERS, V13, P1380, DOI 10.1002/cbdv.201600082
   Venditti A, 2015, IND CROP PROD, V77, P353, DOI 10.1016/j.indcrop.2015.09.002
   Venditti A, 2015, PHARM BIOL, V53, P1505, DOI 10.3109/13880209.2014.991833
   Venditti A, 2014, CHEM BIODIVERS, V11, P245, DOI 10.1002/cbdv.201300253
   Vieira O, 1998, BIOCHEM PHARMACOL, V55, P333, DOI 10.1016/S0006-2952(97)00470-X
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Yuan YL, 2017, INT IMMUNOPHARMACOL, V44, P97, DOI 10.1016/j.intimp.2017.01.017
   Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018
   Zhang LB, 2011, MAR ENVIRON RES, V72, P33, DOI 10.1016/j.marenvres.2011.04.002
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Zhao ZH, 2008, J AGR FOOD CHEM, V56, P3863, DOI 10.1021/jf073168d
NR 74
TC 1065
Z9 1140
U1 48
U2 538
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JAN
PY 2018
VL 97
BP 67
EP 74
DI 10.1016/j.biopha.2017.10.064
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA FR4NC
UT WOS:000419041300009
PM 29080460
DA 2025-04-28
ER

PT J
AU Wedick, NM
   Mantzoros, CS
   Ding, EL
   Brennan, AM
   Rosner, B
   Rimm, EB
   Hu, FB
   van Dam, RM
AF Wedick, Nicole M.
   Mantzoros, Christos S.
   Ding, Eric L.
   Brennan, Aoife M.
   Rosner, Bernard
   Rimm, Eric B.
   Hu, Frank B.
   van Dam, Rob M.
TI The effects of caffeinated and decaffeinated coffee on sex
   hormone-binding globulin and endogenous sex hormone levels: a randomized
   controlled trial
SO NUTRITION JOURNAL
LA English
DT Article
DE Coffee; Sex hormones; Randomized trial
ID POSTMENOPAUSAL WOMEN; RISK; PREMENOPAUSAL; CONSUMPTION; ESTRADIOL;
   ALCOHOL; MEN
AB Background: Findings from observational studies suggest that sex hormone-binding globulin (SHBG) and endogenous sex hormones may be mediators of the putative relation between coffee consumption and lower risk of type 2 diabetes. The objective of this study was to evaluate the effects of caffeinated and decaffeinated coffee on SHBG and sex hormone levels.
   Findings: After a two-week run-in phase with caffeine abstention, we conducted an 8-week parallel-arm randomized controlled trial. Healthy adults (n = 42) were recruited from the Boston community who were regular coffee consumers, nonsmokers, and overweight. Participants were randomized to five 6-ounce cups of caffeinated or decaffeinated instant coffee or water (control group) per day consumed with each meal, mid-morning, and mid-afternoon. The main outcome measures were SHBG and sex hormones [i.e., testosterone, estradiol, dehydroepiandrosterone sulfate]. No significant differences were found between treatment groups for any of the studied outcomes at week 8. At 4 weeks, decaffeinated coffee was associated with a borderline significant increase in SHBG in women, but not in men. At week 4, we also observed several differences in hormone concentrations between the treatment groups. Among men, consumption of caffeinated coffee increased total testosterone and decreased total and free estradiol. Among women, decaffeinated coffee decreased total and free testosterone and caffeinated coffee decreased total testosterone.
   Conclusions: Our data do not indicate a consistent effect of caffeinated coffee consumption on SHBG in men or women, however results should be interpreted with caution given the small sample size. This is the first randomized trial investigating the effects of caffeinated and decaffeinated coffee on SHBG and sex hormones and our findings necessitate further examination in a larger intervention trial.
C1 [Wedick, Nicole M.; Ding, Eric L.; Rimm, Eric B.; Hu, Frank B.; van Dam, Rob M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Mantzoros, Christos S.] Harvard Univ, Sch Med, Boston VA Healthcare Syst, Endocrinol Sect, Boston, MA 02115 USA.
   [Mantzoros, Christos S.; Brennan, Aoife M.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA.
   [Ding, Eric L.; Rosner, Bernard; Rimm, Eric B.; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA.
   [Rosner, Bernard] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   [Rimm, Eric B.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [van Dam, Rob M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore.
   [van Dam, Rob M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard Medical School; Harvard University Medical
   Affiliates; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Boston Healthcare System; Harvard University;
   Harvard Medical School; Harvard University Medical Affiliates; Beth
   Israel Deaconess Medical Center; Harvard University; Harvard University
   Medical Affiliates; Brigham & Women's Hospital; Harvard University;
   Harvard T.H. Chan School of Public Health; Harvard University; Harvard
   T.H. Chan School of Public Health; National University of Singapore;
   National University of Singapore
RP Wedick, NM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.
EM nwedick@hsph.harvard.edu
RI van Dam, Rob/F-9674-2010; Ding, Eric/K-1118-2019; Mantzoros,
   Christos/Y-2902-2019; Hu, Frank/C-1919-2013; van Dam, Rob/A-6693-2009
OI Ding, Eric/0000-0002-5881-8097; van Dam, Rob/0000-0002-7354-8734
FU Harvard Catalyst Human Research Center Laboratory Support Award; Boston
   Obesity Nutrition Research Center pilot and feasibility grant
   [2005-P-000377/2]; National Institutes of Health - National Center for
   Research Resources [M01-RR-01032]; National Institute of Diabetes and
   Digestive and Kidney Diseases [58785, 79929, 81913, AG032030];  [UL1
   RR025758]
FX We gratefully thank the participants of the Coffee Trial for their
   participation. We also thank the General Clinical Research Center (GCRC)
   nurses at Beth Israel Deaconess Medical Center for assistance with
   collection of the samples for this research, and the GCRC nutritionists
   for conducting the dietary assessments, body composition measurements,
   and dispensing of treatment. We thank the Harvard Catalyst Human
   Research Center Laboratory for the timely and careful measurement of the
   sex hormones used for this analysis. The research for this study was
   financially supported by a Harvard Catalyst Human Research Center
   Laboratory Support Award, a Boston Obesity Nutrition Research Center
   pilot and feasibility grant (grant#: 2005-P-000377/2), and a National
   Institutes of Health - National Center for Research Resources grant
   M01-RR-01032 (Harvard Clinical and Translational Science Center) and
   grant number UL1 RR025758. The Mantzoros Lab is also supported by the
   National Institute of Diabetes and Digestive and Kidney Diseases grants
   58785, 79929 and 81913, and AG032030.
CR COOPER C, 1992, J BONE MINER RES, V7, P465
   Ding EL, 2007, DIABETOLOGIA, V50, P2076, DOI 10.1007/s00125-007-0785-y
   Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288
   Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381
   Ferrini RL, 1996, AM J EPIDEMIOL, V144, P642, DOI 10.1093/oxfordjournals.aje.a008975
   Goto A, 2011, DIABETES, V60, P269, DOI 10.2337/db10-1193
   Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328
   LONDON S, 1991, AM J CLIN NUTR, V53, P166, DOI 10.1093/ajcn/53.1.166
   Lucero J, 2001, FERTIL STERIL, V76, P723, DOI 10.1016/S0015-0282(01)02005-2
   Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635
   PHILLIPS GB, 1992, STEROIDS, V57, P135, DOI 10.1016/0039-128X(92)90071-G
   SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
NR 13
TC 39
Z9 41
U1 1
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2891
J9 NUTR J
JI Nutr. J.
PD OCT 19
PY 2012
VL 11
AR 86
DI 10.1186/1475-2891-11-86
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 041VF
UT WOS:000311428600001
PM 23078574
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Caro-Gómez, E
   Sierra, JA
   Escobar, JS
   Alvarez-Quintero, R
   Naranjo, M
   Medina, S
   Velásquez-Mejía, EP
   Tabares-Guevara, JH
   Jaramillo, JC
   León-Varela, YM
   Muñoz-Durango, K
   Ramírez-Pineda, JR
AF Caro-Gomez, Erika
   Sierra, Jelver A.
   Escobar, Juan S.
   Alvarez-Quintero, Rafael
   Naranjo, Mauricio
   Medina, Sonia
   Velasquez-Mejia, Eliana P.
   Tabares-Guevara, Jorge H.
   Jaramillo, Julio C.
   Leon-Varela, Yudy M.
   Munoz-Durango, Katalina
   Ramirez-Pineda, Jose R.
TI Green Coffee Extract Improves Cardiometabolic Parameters and Modulates
   Gut Microbiota in High-Fat-Diet-Fed ApoE<SUP>-/-</SUP> Mice
SO NUTRIENTS
LA English
DT Article
DE green coffee; atherosclerosis; cardiometabolic syndrome; NAFLD; high fat
   diet; immune system; gut dysbiosis
ID INDUCED HEPATIC STEATOSIS; INSULIN-RESISTANCE; LIVER-DISEASE;
   NONALCOHOLIC STEATOHEPATITIS; CARDIOVASCULAR-DISEASE; LIPID-METABOLISM;
   MAJOR FOOD; INFLAMMATION; CAFFEINE; ATHEROSCLEROSIS
AB Chlorogenic acids (CGA) are the most abundant phenolic compounds in green coffee beans and in the human diet and have been suggested to mitigate several cardiometabolic risk factors. Here, we aimed to evaluate the effect of a water-based standardized green coffee extract (GCE) on cardiometabolic parameters in ApoE(-/-) mice and to explore the potential underlying mechanisms. Mice were fed an atherogenic diet without (vehicle) or with GCE by gavage (equivalent to 220 mg/kg of CGA) for 14 weeks. We assessed several metabolic, pathological, and inflammatory parameters and inferred gut microbiota composition, diversity, and functional potential. Although GCE did not reduce atherosclerotic lesion progression or plasma lipid levels, it induced important favorable changes. Specifically, improved metabolic parameters, including fasting glucose, insulin resistance, serum leptin, urinary catecholamines, and liver triglycerides, were observed. These changes were accompanied by reduced weight gain, decreased adiposity, lower inflammatory infiltrate in adipose tissue, and protection against liver damage. Interestingly, GCE also modulated hepatic IL-6 and total serum IgM and induced shifts in gut microbiota. Altogether, our results reveal the cooccurrence of these beneficial cardiometabolic effects in response to GCE in the same experimental model and suggest potential mediators and pathways involved.
C1 [Caro-Gomez, Erika; Tabares-Guevara, Jorge H.; Jaramillo, Julio C.; Leon-Varela, Yudy M.; Ramirez-Pineda, Jose R.] Univ Antioquia, Grp Inmunomodulac GIM, Calle 70 52-21, Medellin 050010, Colombia.
   [Sierra, Jelver A.; Escobar, Juan S.; Velasquez-Mejia, Eliana P.; Munoz-Durango, Katalina] Grp Empresarial Nutresa, Vidarium Nutr Hlth & Wellness Res Ctr, Calle 8 Sur 50-67, Medellin 050023, Colombia.
   [Alvarez-Quintero, Rafael] Univ Antioquia, Fac Ciencias Farmaceut & Alimentarias, Grp Invest Sustancias Bioact, Calle 70 52-21, Medellin 050010, Colombia.
   [Naranjo, Mauricio] Ind Colombiana Cafe SAS, Colcafe Res Coffee Grp, Calle 8 Sur 50-19, Medellin 050023, Colombia.
   [Medina, Sonia] Corp Univ Lasallista, Fac Ingn, Carrera 51 118 Sur 57, Caldas 055440, Colombia.
C3 Universidad de Antioquia; Universidad de Antioquia
RP Ramírez-Pineda, JR (corresponding author), Univ Antioquia, Grp Inmunomodulac GIM, Calle 70 52-21, Medellin 050010, Colombia.; Muñoz-Durango, K (corresponding author), Grp Empresarial Nutresa, Vidarium Nutr Hlth & Wellness Res Ctr, Calle 8 Sur 50-67, Medellin 050023, Colombia.
EM erikabril@gmail.com; jasierra@serviciosnutresa.com;
   jsescobar@serviciosnutresa.com; ralvarezq@ces.edu.co;
   mnaranjo@colcafe.com.co; soniamedes@gmail.com;
   epvelasquez@serviciosnutresa.com; jorgetabare@gmail.com;
   jcjara05@gmail.com; yudyleon@gmail.com; kmunoz@serviciosnutresa.com;
   jrobinson.ramirez@udea.edu.co
RI ; Sierra Restrepo, Jelver Alexander/F-4970-2013; Escobar, Juan
   S/F-7234-2013; Medina, Sonia/M-2479-2014
OI Tabares Guevara, Jorge Humberto/0000-0003-4207-7543; Caro,
   Erika/0000-0002-5960-1295; Sierra Restrepo, Jelver
   Alexander/0000-0001-8541-1535; Alvarez Quintero,
   Rafael/0000-0002-0937-8259; Escobar, Juan S/0000-0001-7304-917X;
   Munoz-Durango, Katalina/0000-0002-7905-1243; Ramirez-Pineda, Jose
   Robinson/0000-0002-4340-4860; Medina, Sonia/0000-0002-7231-6480
FU Colcafe S.A.S; Vidarium-Nutrition, Health and Wellness Research Center;
   Universidad de Antioquia
FX This study was funded by Colcafe S.A.S; Vidarium-Nutrition, Health and
   Wellness Research Center; and Universidad de Antioquia.
CR Al Khodor S, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00138
   Alsabri Sami G., 2018, Journal of Caffeine and Adenosine Research, V8, P3, DOI 10.1089/caff.2017.0011
   Alvaro D, 2000, HEPATOLOGY, V32, P174, DOI 10.1053/jhep.2000.9078
   Ampuero J, 2015, REV ESP ENFERM DIG, V107, P10
   [Anonymous], METABOLIC SYNDROME
   [Anonymous], WATERS APPL NOTES
   [Anonymous], 10767 DIN
   [Anonymous], 2008, ISO 20481:2008
   Bäck M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5
   Banerjee S, 2017, DRUGS, V77, P521, DOI 10.1007/s40265-017-0701-9
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Buscemi S., 2016, NFS Journal, V3, P1, DOI 10.1016/j.nfs.2016.02.001
   Cai XB, 2016, J GASTROENTEROL, V51, P819, DOI 10.1007/s00535-015-1154-0
   Espín JC, 2017, BIOCHEM PHARMACOL, V139, P82, DOI 10.1016/j.bcp.2017.04.033
   Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010
   Chiappini F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46658
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155
   de la Cuesta-Zuluaga J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010051
   Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734
   Farias-Pereira R, 2018, J FUNCT FOODS, V48, P586, DOI 10.1016/j.jff.2018.07.049
   Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026
   Gaggini M, 2013, NUTRIENTS, V5, P1544, DOI 10.3390/nu5051544
   Gao B, 2016, GASTROENTEROLOGY, V150, P1704, DOI 10.1053/j.gastro.2016.01.025
   Gniechwitz D, 2007, J AGR FOOD CHEM, V55, P6989, DOI 10.1021/jf070646b
   Harmon DB, 2016, ARTERIOSCL THROM VAS, V36, P682, DOI 10.1161/ATVBAHA.116.307166
   HARTMANN M, 1980, Z ERNAHRUNGSWISS, V19, P215, DOI 10.1007/BF02018787
   Hendrikx T, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0652-0
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180
   Insull W, 2009, AM J MED, V122, pS3, DOI 10.1016/j.amjmed.2008.10.013
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Jebel FS, 2016, CARBOHYD POLYM, V149, P8, DOI 10.1016/j.carbpol.2016.04.089
   Jeszka-Skowron M, 2017, J SCI FOOD AGR, V97, P4022, DOI 10.1002/jsfa.8269
   Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184
   Karschin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117865
   Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467
   King VL, 2010, OBESITY, V18, P35, DOI 10.1038/oby.2009.176
   Kocabay G, 2011, BRATISL MED J, V112, P626
   Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Linden DR, 2014, ANTIOXID REDOX SIGN, V20, P818, DOI 10.1089/ars.2013.5312
   Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687
   Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
   Ma YJ, 2015, BBA-MOL BASIS DIS, V1852, P1001, DOI 10.1016/j.bbadis.2015.01.017
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Marra F, 2013, CURR PHARM DESIGN, V19, P5250, DOI 10.2174/13816128113199990344
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mazidi M, 2016, DIAB MET SYND CLIN R, V10, pS150, DOI 10.1016/j.dsx.2016.01.024
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024
   Mowers J, 2013, ELIFE, V2, DOI 10.7554/eLife.01119
   Murphy EA, 2015, CURR OPIN CLIN NUTR, V18, P515, DOI 10.1097/MCO.0000000000000209
   Nicholls SG, 2013, SOC SCI MED, V87, P9, DOI 10.1016/j.socscimed.2013.03.009
   Nugroho DA., 2017, Asian J Pharmaceutical Clin Res, V10, P279, DOI [10.2159/ajpcr.2017.v10i9.19329, DOI 10.2159/AJPCR.2017.V10I9.19329, 10.12688/f1000research.55470.1, DOI 10.22159/AJPCR.2017.V10I9.19329]
   Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2
   Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627
   PAIGEN B, 1987, ATHEROSCLEROSIS, V64, P215, DOI 10.1016/0021-9150(87)90249-8
   Pham TD, 2017, MUCOSAL IMMUNOL, V10, P1468, DOI 10.1038/mi.2017.25
   Picardi A, 2008, AM J GASTROENTEROL, V103, P3036, DOI 10.1111/j.1572-0241.2008.02196.x
   Pimentel GD, 2013, DRUG DEVELOP RES, V74, P393, DOI 10.1002/ddr.21092
   Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004
   Puerta G., 2011, CENICAFE technical advances, V414, P1
   Rabasa-Lhoret R, 2003, J CLIN ENDOCR METAB, V88, P4917, DOI 10.1210/jc.2002-030316
   Rahmouni K, 2010, CURR HYPERTENS REV, V6, P104, DOI 10.2174/157340210791170994
   Ravandi A, 2011, J LIPID RES, V52, P1829, DOI 10.1194/jlr.M015776
   Reis CEG, 2019, J TRADIT COMPL MED, V9, P184, DOI 10.1016/j.jtcme.2018.01.001
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403
   Rosenfeld SM, 2015, CIRC RES, V117, pE28, DOI 10.1161/CIRCRESAHA.117.306044
   Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001
   Schierwagen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12931
   Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004
   Schubert AM, 2014, MBIO, V5, DOI 10.1128/mBio.01021-14
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Sepúlveda J, 2014, SCIENCE, V345, P1275, DOI 10.1126/science.1257099
   Shen L, 2015, DIABETES, V64, P593, DOI 10.2337/db14-0554
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   St-Onge MP, 2012, OBESITY, V20, P343, DOI 10.1038/oby.2011.289
   Stål P, 2015, WORLD J GASTROENTERO, V21, P11077, DOI 10.3748/wjg.v21.i39.11077
   Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545
   Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16
   Taguchi C, 2015, NUTRIENTS, V7, P10269, DOI 10.3390/nu7125530
   Tangney CC, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0324-x
   Tresserra-Rimbau A, 2013, NUTR METAB CARDIOVAS, V23, P953, DOI 10.1016/j.numecd.2012.10.008
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Viegas C, 2017, J TOXICOL ENV HEAL A, V80, P719, DOI 10.1080/15287394.2017.1286927
   Vinjé S, 2014, EUR HEART J, V35, P883, DOI 10.1093/eurheartj/eht467
   Wadhawan M, 2016, J CLIN EXP HEPATOL, V6, P40, DOI 10.1016/j.jceh.2016.02.003
   Wan JH, 2014, AM J PATHOL, V184, P1763, DOI 10.1016/j.ajpath.2014.02.014
   Wemheuer, 2018, TAX4FUN2 R BASED TOO, V7
   Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38
   Wills ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090981
   Wu CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095452
   Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353
   Yamagata K, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7020026
   Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75
   Yan H, 2018, J BIOSCIENCES, V43, P287, DOI 10.1007/s12038-018-9746-5
   Zamora-Ros R, 2016, EUR J NUTR, V55, P1359, DOI 10.1007/s00394-015-0950-x
   Zhang SJ, 2015, FOOD FUNCT, V6, P2578, DOI [10.1039/c5fo00247h, 10.1039/C5FO00247H]
   Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011
NR 105
TC 36
Z9 36
U1 0
U2 24
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD FEB 27
PY 2019
VL 11
IS 3
AR 497
DI 10.3390/nu11030497
PG 22
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HT2CN
UT WOS:000464370900015
PM 30818779
OA gold, Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Fukutomi, R
   Ohishi, T
   Koyama, Y
   Pervin, M
   Nakamura, Y
   Isemura, M
AF Fukutomi, Ryuuta
   Ohishi, Tomokazu
   Koyama, Yu
   Pervin, Monira
   Nakamura, Yoriyuki
   Isemura, Mamoru
TI Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic
   Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases
SO MOLECULES
LA English
DT Review
DE polyphenols; EGCG; chlorogenic acid; resveratrol; curcumin; NDD; ROS;
   AMPK; NF-&#954; B
AB Many observational and clinical studies have shown that consumption of diets rich in plant polyphenols have beneficial effects on various diseases such as cancer, obesity, diabetes, cardiovascular diseases, and neurodegenerative diseases (NDDs). Animal and cellular studies have indicated that these polyphenolic compounds contribute to such effects. The representative polyphenols are epigallocatechin-3-O-gallate in tea, chlorogenic acids in coffee, resveratrol in wine, and curcumin in curry. The results of human studies have suggested the beneficial effects of consumption of these foods on NDDs including Alzheimer's and Parkinson's diseases, and cellular animal experiments have provided molecular basis to indicate contribution of these representative polyphenols to these effects. This article provides updated information on the effects of these foods and their polyphenols on NDDs with discussions on mechanistic aspects of their actions mainly based on the findings derived from basic experiments.
C1 [Fukutomi, Ryuuta] Higuchi Inc, Qual Management Div, Minato Ku, Tokyo 1080075, Japan.
   [Ohishi, Tomokazu] Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Shizuoka 4100301, Japan.
   [Koyama, Yu] Shizuoka Eiwa Gakuin Univ, Jr Coll, Suruga Ku, Shizuoka 4228545, Japan.
   [Pervin, Monira; Nakamura, Yoriyuki; Isemura, Mamoru] Univ Shizuoka, Tea Sci Res Ctr, Suruga Ku, Shizuoka 4228526, Japan.
C3 University of Shizuoka
RP Fukutomi, R (corresponding author), Higuchi Inc, Qual Management Div, Minato Ku, Tokyo 1080075, Japan.; Isemura, M (corresponding author), Univ Shizuoka, Tea Sci Res Ctr, Suruga Ku, Shizuoka 4228526, Japan.
EM fukutomi_ryuuta@mac.com; ohishit@bikaken.or.jp;
   y.koyama@shizuoka-eiwa.ac.jp; monira689@yahoo.com;
   yori.naka@u-shizuoka-ken.ac.jp; isemura@u-shizuoka-ken.ac.jp
OI Fukutomi, Ryuuta/0000-0002-3918-5159; Ohishi,
   Tomokazu/0000-0002-9039-4474
CR Al-Edresi S, 2020, NEUROBIOL AGING, V94, P24, DOI 10.1016/j.neurobiolaging.2020.04.012
   Arntzen KA, 2010, ACTA NEUROL SCAND, V122, P23, DOI 10.1111/j.1600-0404.2010.01371.x
   Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052
   Baghbaderani S, 2020, PSYCHOPHARMACOLOGY, DOI 10.1007/s00213-020-05633-6
   Quintana JLB, 2007, NEUROL RES, V29, P91, DOI 10.1179/174313206X152546
   Quintana JLB, 2009, J AM COLL NUTR, V28, P1
   Basli A, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/805762
   Bastianetto S, 2015, BBA-MOL BASIS DIS, V1852, P1195, DOI 10.1016/j.bbadis.2014.09.011
   Baum L, 2008, J CLIN PSYCHOPHARM, V28, P110, DOI 10.1097/jcp.0b013e318160862c
   Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455
   Benedetti MD, 2000, NEUROLOGY, V55, P1350, DOI 10.1212/WNL.55.9.1350
   Bhat A, 2019, BIOFACTORS, V45, P666, DOI 10.1002/biof.1533
   Birch AM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-25
   Biswas SK, 2005, ANTIOXID REDOX SIGN, V7, P32, DOI 10.1089/ars.2005.7.32
   Boulos C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081896
   Cai ZY, 2013, NEUROMOL MED, V15, P25, DOI 10.1007/s12017-012-8207-9
   Camfield DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082897
   Chandra V, 2001, NEUROLOGY, V57, P985, DOI 10.1212/WNL.57.6.985
   Checkoway H, 2002, AM J EPIDEMIOL, V155, P732, DOI 10.1093/aje/155.8.732
   Chen HL, 2015, PARKINSONISM RELAT D, V21, P1200, DOI 10.1016/j.parkreldis.2015.08.020
   Chen Y, 2019, MOL MED REP, V19, P3783, DOI 10.3892/mmr.2019.10010
   Cho ES, 2009, MUTAT RES-FUND MOL M, V661, P18, DOI 10.1016/j.mrfmmm.2008.10.021
   Chuang YH, 2016, NEUROEPIDEMIOLOGY, V47, P192, DOI 10.1159/000450855
   Ciaramelli C, 2018, FOOD CHEM, V252, P171, DOI 10.1016/j.foodchem.2018.01.075
   Cicero AFG, 2019, ARCH MED SCI, V15, P936, DOI 10.5114/aoms.2019.85463
   Cole GM, 2007, ADV EXP MED BIOL, V595, P197
   Cox KHM, 2015, J PSYCHOPHARMACOL, V29, P642, DOI 10.1177/0269881114552744
   Cropley V, 2012, PSYCHOPHARMACOLOGY, V219, P737, DOI 10.1007/s00213-011-2395-0
   de la Torre R, 2020, CLIN NUTR, V39, P378, DOI 10.1016/j.clnu.2019.02.028
   de la Torre R, 2016, LANCET NEUROL, V15, P801, DOI 10.1016/S1474-4422(16)30034-5
   Di Fabio E, 2020, MOLECULES, V25, DOI 10.3390/molecules25204603
   Dietz C, 2017, FOOD RES INT, V99, P72, DOI 10.1016/j.foodres.2017.05.002
   DiSilvestro RA, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-79
   Dong SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031211
   Dong X, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030840
   Du K, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700890
   Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920
   Evans HM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010027
   Fan Y, 2005, NEUROSCI LETT, V374, P222, DOI 10.1016/j.neulet.2004.10.063
   Feng L, 2015, J Prev Alzheimers Dis, V2, P136, DOI 10.14283/jpad.2015.57
   Feng L, 2010, J NUTR HEALTH AGING, V14, P433
   Fischer K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070852
   Freyssin A, 2020, NEURAL REGEN RES, V15, P843, DOI 10.4103/1673-5374.268970
   Fukuyama K, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800238
   Gagliardi S, 2020, MOLECULES, V25, DOI 10.3390/molecules25225389
   Ganguli M, 2000, ARCH NEUROL-CHICAGO, V57, P824, DOI 10.1001/archneur.57.6.824
   Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x
   Gelber RP, 2011, J ALZHEIMERS DIS, V23, P607, DOI 10.3233/JAD-2010-101428
   Gigante AF, 2018, NEUROL SCI, V39, P551, DOI 10.1007/s10072-018-3253-1
   Gocmez SS, 2016, NEUROBIOL LEARN MEM, V131, P131, DOI 10.1016/j.nlm.2016.03.022
   Goozee KG, 2016, BRIT J NUTR, V115, P449, DOI 10.1017/S0007114515004687
   Granzotto A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00095
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Gu YJ, 2018, AGING MENT HEALTH, V22, P1232, DOI 10.1080/13607863.2017.1339779
   Guo YJ, 2016, MOL NUTR FOOD RES, V60, P2161, DOI 10.1002/mnfr.201600111
   Guo YF, 2017, NEUROREPORT, V28, P590, DOI [10.1097/wnr.0000000000000803, 10.1097/WNR.0000000000000803]
   Han J, 2010, NEUROSCIENCE, V169, P1039, DOI 10.1016/j.neuroscience.2010.05.049
   Hayakawa S, 2020, MOLECULES, V25, DOI 10.3390/molecules25194553
   Hayakawa Sumio, 2016, Asian Pac J Cancer Prev, V17, P1649
   He Miao, 2012, Zhong Yao Cai, V35, P1641
   Hernán MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   Hishikawa Nozomi, 2012, Ayu, V33, P499, DOI 10.4103/0974-8520.110524
   Hoelzl C, 2010, MOL NUTR FOOD RES, V54, P1722, DOI 10.1002/mnfr.201000048
   Hu G, 2007, MOVEMENT DISORD, V22, P2242, DOI 10.1002/mds.21706
   Huang HC, 2012, J ALZHEIMERS DIS, V32, P981, DOI 10.3233/JAD-2012-120688
   Ide K, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0168-7
   Ishida K, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020494
   Ishida K, 2020, NEUROSCI RES, V154, P35, DOI 10.1016/j.neures.2019.05.001
   Jayaraj RL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/236182
   Jayasena T, 2013, AGEING RES REV, V12, P867, DOI 10.1016/j.arr.2013.06.003
   Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005
   Jomova K, 2012, TRANSIT METAL CHEM, V37, P127, DOI 10.1007/s11243-012-9583-6
   Kandinov B, 2009, PARKINSONISM RELAT D, V15, P41, DOI 10.1016/j.parkreldis.2008.02.011
   Kawabata K, 2019, MOLECULES, V24, DOI 10.3390/molecules24020370
   Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792
   Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641
   Khatri DK, 2016, PHARMACOL BIOCHEM BE, V150, P39, DOI 10.1016/j.pbb.2016.09.002
   Khatri DK, 2016, PHARMACOGN MAG, V12, pS116, DOI 10.4103/0973-1296.182168
   Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022
   Kim JW, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0604-5
   Kim JS, 2010, J CLIN NEUROSCI, V17, P1165, DOI 10.1016/j.jocn.2010.01.042
   Kim J, 2012, NEUROCHEM INT, V60, P466, DOI 10.1016/j.neuint.2012.02.004
   Kim TY, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9070583
   Kim YS, 2015, NEUROEPIDEMIOLOGY, V44, P51, DOI 10.1159/000371710
   Kitamura K, 2016, DEMENT GER COGN D EX, V6, P341, DOI 10.1159/000447963
   Koukoulitsa C, 2016, J ENZYM INHIB MED CH, V31, P67, DOI 10.3109/14756366.2014.1003928
   Kucukgoncu S, 2019, J CLIN PSYCHOPHARM, V39, P182, DOI 10.1097/JCP.0000000000001012
   Kuriyama S, 2006, AM J CLIN NUTR, V83, P355
   Kwok MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep36500
   Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001
   Larsson SC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101501
   Lee JW, 2009, J NUTR, V139, P1987, DOI 10.3945/jn.109.109785
   Lee K, 2012, EUR J PHARMACOL, V689, P89, DOI 10.1016/j.ejphar.2012.05.028
   Levites Y, 2003, FASEB J, V17, P952, DOI 10.1096/fj.02-0881fje
   Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x
   Li D, 2017, BRAIN RES, V1654, P1, DOI 10.1016/j.brainres.2016.10.013
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001
   Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074
   Liu JB, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4962351
   Liu QP, 2016, NUTRITION, V32, P628, DOI 10.1016/j.nut.2015.11.015
   Louis ED, 2003, NEUROLOGY, V61, P24, DOI 10.1212/01.WNL.0000072330.07328.D6
   Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028
   Ma QL, 2013, J BIOL CHEM, V288, P4056, DOI 10.1074/jbc.M112.393751
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Maiti P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/495091
   Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x
   Marx W, 2018, NUTR REV, V76, P432, DOI 10.1093/nutrit/nuy010
   Mehlig K, 2008, AM J EPIDEMIOL, V167, P684, DOI 10.1093/aje/kwm366
   Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220
   Miyazaki I, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030221
   Miyoshi N, 2020, MOLECULES, V25, DOI 10.3390/molecules25112588
   Mohorko N, 2010, J NEUROPATH EXP NEUR, V69, P405, DOI 10.1097/NEN.0b013e3181d709eb
   MORANO A, 1994, ACTA NEUROL SCAND, V89, P164
   Moussa C, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0779-0
   Mythri RB, 2012, CURR PHARM DESIGN, V18, P91, DOI 10.2174/138161212798918995
   Nakajima Y, 2007, LIFE SCI, V80, P370, DOI 10.1016/j.lfs.2006.09.017
   Nam SM, 2014, J MED FOOD, V17, P641, DOI 10.1089/jmf.2013.2965
   Ng CH, 2012, J NEUROSCI, V32, P14311, DOI 10.1523/JNEUROSCI.0499-12.2012
   Ng TP, 2008, AM J CLIN NUTR, V88, P224, DOI 10.1093/ajcn/88.1.224
   Ng TP, 2006, AM J EPIDEMIOL, V164, P898, DOI 10.1093/aje/kwj267
   Noguchi-Shinohara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096013
   Noyce AJ, 2019, MOVEMENT DISORD, V34, P1864, DOI 10.1002/mds.27873
   Oboh G, 2013, NEUROCHEM RES, V38, P413, DOI 10.1007/s11064-012-0935-6
   Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025
   Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185
   Orhan I, 2004, J ETHNOPHARMACOL, V91, P57, DOI 10.1016/j.jep.2003.11.016
   Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160
   Pan J, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-16
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   Perez Carlos A, 2008, Curr Bioact Compd, V4, P150, DOI 10.2174/157340708786305952
   Pervin M, 2018, MOLECULES, V23, DOI 10.3390/molecules23061297
   Pervin Monira, 2017, Biochem Biophys Rep, V9, P180, DOI 10.1016/j.bbrep.2016.12.012
   Polito CA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050655
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Porquet D, 2013, AGE, V35, P1851, DOI 10.1007/s11357-012-9489-4
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Qiao PF, 2020, CURR ALZHEIMER RES, V17, P735, DOI 10.2174/1567205017666201111120919
   Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200
   Rainey-Smith SR, 2016, BRIT J NUTR, V115, P2106, DOI 10.1017/S0007114516001203
   Ramis MR, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020326
   Rane JS, 2017, J ALZHEIMERS DIS, V60, P999, DOI 10.3233/JAD-170351
   Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002
   Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1
   Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005
   Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107
   Ringman JM, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt146
   Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674
   Rossetti F, 2020, MOLECULES, V25, DOI 10.3390/molecules25184276
   Sääksjärvi K, 2008, EUR J CLIN NUTR, V62, P908, DOI 10.1038/sj.ejcn.1602788
   Saitou K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101337
   Scholey A, 2012, APPETITE, V58, P767, DOI 10.1016/j.appet.2011.11.016
   Selkoe D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011460
   Sharma N, 2018, INFLAMMOPHARMACOLOGY, V26, P349, DOI 10.1007/s10787-017-0402-8
   Shen W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140739
   Shen WJ, 2012, BRAIN RES BULL, V88, P487, DOI 10.1016/j.brainresbull.2012.04.010
   Shi M, 2020, INT J NEUROSCI, V130, P700, DOI 10.1080/00207454.2019.1702547
   Shirai Y, 2020, PUBLIC HEALTH NUTR, V23, P1049, DOI 10.1017/S1368980019002659
   Singh AP, 2019, MED RES REV, V39, P1851, DOI 10.1002/med.21565
   Singh NA, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0179-4
   Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203
   Singh SS, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00757
   Singh SS, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6571484
   Small GW, 2018, AM J GERIAT PSYCHIAT, V26, P266, DOI 10.1016/j.jagp.2017.10.010
   Solfrizzi V, 2015, J ALZHEIMERS DIS, V47, P889, DOI 10.3233/JAD-150333
   Soo SK, 2020, MECH AGEING DEV, V190, DOI 10.1016/j.mad.2020.111297
   Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005
   Sun CY, 2013, PHARMACOL BIOCHEM BE, V105, P76, DOI 10.1016/j.pbb.2013.02.002
   Sun XY, 2019, CURR ALZHEIMER RES, V16, P710, DOI 10.2174/1567205016666190801153751
   Suzuki T, 2016, MOLECULES, V21, DOI 10.3390/molecules21101305
   Tabatabaei NH, 2013, FUNCT NEUROL, V28, P107, DOI 10.11138/FNeur/2013.28.2.107
   Tan EK, 2003, J NEUROL SCI, V216, P163, DOI 10.1016/j.jns.2003.07.006
   Tan LC, 2008, AM J EPIDEMIOL, V167, P553, DOI 10.1093/aje/kwm338
   Tanabe H., 2017, OBES CONTROL THER, V4, P1, DOI [10.15226/2374-8354/4/3/00142, DOI 10.15226/2374-8354/4/3/00142]
   Tanaka K, 2011, PARKINSONISM RELAT D, V17, P446, DOI 10.1016/j.parkreldis.2011.02.016
   Teraoka M, 2012, J CLIN BIOCHEM NUTR, V51, P122, DOI 10.3164/jcbn.D-11-00030
   Turner RS, 2015, NEUROLOGY, V85, P1383, DOI 10.1212/WNL.0000000000002035
   Uchiumi Fumiaki, 2011, Curr Aging Sci, V4, P1
   van Gelder BM, 2007, EUR J CLIN NUTR, V61, P226, DOI 10.1038/sj.ejcn.1602495
   Van Leeuw R, 2014, J FOOD COMPOS ANAL, V36, P40, DOI 10.1016/j.jfca.2014.07.001
   Venigalla M, 2015, NEURAL REGEN RES, V10, P1181, DOI 10.4103/1673-5374.162686
   Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061
   Voulgaropoulou SD, 2019, BRAIN RES, V1725, DOI 10.1016/j.brainres.2019.146476
   Walker JM, 2015, J ALZHEIMERS DIS, V44, P561, DOI 10.3233/JAD-140981
   Wang XX, 2020, DIABET METAB SYND OB, V13, P1061, DOI 10.2147/DMSO.S243560
   Wasim S, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9578
   Wei BB, 2019, ACTA PHARMACOL SIN, V40, P1490, DOI 10.1038/s41401-019-0243-7
   Wightman EL, 2012, HUM PSYCHOPHARM CLIN, V27, P177, DOI 10.1002/hup.1263
   Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014
   Wojtowicz S, 2020, NEUROCHEM RES, V45, P972, DOI 10.1007/s11064-020-02993-5
   Wu L, 2017, CLIN NUTR, V36, P730, DOI 10.1016/j.clnu.2016.05.015
   Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516
   Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548
   Yadav E, 2019, NEUROCHEM RES, V44, P1665, DOI 10.1007/s11064-019-02792-7
   Yanagisawa D, 2011, J ALZHEIMERS DIS, V24, P33, DOI 10.3233/JAD-2011-102100
   Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641
   Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200
   Yang LL, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801432
   Yang L, 2016, AGE AGEING, V45, P707, DOI 10.1093/ageing/afw088
   Zaw JJT, 2021, CLIN NUTR, V40, P820, DOI 10.1016/j.clnu.2020.08.025
   Zhang H, 2012, J NEUROSCI, V32, P15565, DOI 10.1523/JNEUROSCI.3668-12.2012
   Zhang S, 2020, PHYTOMEDICINE, V79, DOI 10.1016/j.phymed.2020.153316
   Zhang YQ, 2019, MOL MED REP, V20, P4587, DOI 10.3892/mmr.2019.10723
   Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3
   Zhang YQ, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0387-7
   Zhao ZM, 2020, NUTR NEUROSCI, V23, P971, DOI 10.1080/1028415X.2019.1581460
   Zheng KM, 2017, MOL NEUROBIOL, V54, P1967, DOI 10.1007/s12035-016-9802-9
   Zhou TT, 2018, MOL MED REP, V17, P4883, DOI 10.3892/mmr.2018.8470
NR 208
TC 49
Z9 49
U1 2
U2 29
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JAN
PY 2021
VL 26
IS 2
AR 415
DI 10.3390/molecules26020415
PG 28
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA PX6KY
UT WOS:000611464300001
PM 33466849
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Pavlíková, N
AF Pavlikova, Nela
TI Caffeic Acid and Diseases-Mechanisms of Action
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE caffeic acid; cancer; diabetes; obesity; atherosclerosis; Alzheimer's
   disease
ID HEPATOCELLULAR-CARCINOMA; ANTICANCER ACTIVITY; ENDOTHELIAL-CELLS;
   CHLOROGENIC ACID; IN-VIVO; STAPHYLOCOCCUS-AUREUS; INDUCED NEUROTOXICITY;
   OXIDATIVE STRESS; PHENETHYL ESTER; BREAST-CANCER
AB Caffeic acid belongs to the polyphenol compounds we consume daily, often in the form of coffee. Even though it is less explored than caffeic acid phenethyl ester, it still has many positive effects on human health. Caffeic acid can affect cancer, diabetes, atherosclerosis, Alzheimer's disease, or bacterial and viral infections. This review focuses on the molecular mechanisms of how caffeic acid achieves its effects.
C1 [Pavlikova, Nela] Charles Univ Prague, Fac Med 3, Div Cell & Mol Biol, Prague 10000, Czech Republic.
   [Pavlikova, Nela] Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague 10000, Czech Republic.
C3 Charles University Prague; Charles University Prague
RP Pavlíková, N (corresponding author), Charles Univ Prague, Fac Med 3, Div Cell & Mol Biol, Prague 10000, Czech Republic.; Pavlíková, N (corresponding author), Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague 10000, Czech Republic.
EM nela.paylikova@lf3.cuni.cz
RI Pavlikova, Nela/W-7000-2018
OI Pavlikova, Nela/0000-0001-7468-1505
FU National Institute for Research of Metabolic and Cardiovascular Diseases
   [LX22NPO5104]; European Union-Next Generation EU; Charles University
   Cooperatio METD
FX This work was supported by the project National Institute for Research
   of Metabolic and Cardiovascular Diseases (Programme EXCELES, ID Project
   No. LX22NPO5104)-Funded by the European Union-Next Generation EU and by
   Charles University Cooperatio METD.
CR Adeyeye SAO, 2020, POLYCYCL AROMAT COMP, V40, P1557, DOI 10.1080/10406638.2018.1559208
   Andrade S, 2021, INT J BIOL MACROMOL, V190, P853, DOI 10.1016/j.ijbiomac.2021.08.198
   Bray Freddie, 2018, CA Cancer J Clin, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
   Baba S, 2004, LIFE SCI, V75, P165, DOI 10.1016/j.lfs.2003.11.028
   Bai X, 2022, J AGR FOOD CHEM, V70, P8326, DOI 10.1021/acs.jafc.2c03009
   Balupillai A, 2018, TOXICOL APPL PHARM, V352, P87, DOI 10.1016/j.taap.2018.05.030
   Balupillai A, 2015, PHOTOCHEM PHOTOBIOL, V91, P1458, DOI 10.1111/php.12522
   Bhat SH, 2007, TOXICOL APPL PHARM, V218, P249, DOI 10.1016/j.taap.2006.11.022
   Bradley MA, 2010, FREE RADICAL BIO MED, V48, P1570, DOI 10.1016/j.freeradbiomed.2010.02.016
   Brautigan DL, 2018, BIOCHEM BIOPH RES CO, V505, P612, DOI 10.1016/j.bbrc.2018.09.155
   BRIMIJOIN S, 1983, PROG NEUROBIOL, V21, P291, DOI 10.1016/0301-0082(83)90015-1
   Bunz Fred., 2016, Principles of Cancer Genetics
   Cai H, 2016, EUR J MED CHEM, V108, P89, DOI 10.1016/j.ejmech.2015.11.013
   Cao XY, 2019, CHEM BIODIVERS, V16, DOI 10.1002/cbdv.201900174
   Celinska-Janowicz K, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00336
   Celli N, 2007, J AGR FOOD CHEM, V55, P3398, DOI 10.1021/jf063477o
   Chang WC, 2015, FOOD RES INT, V77, P24, DOI 10.1016/j.foodres.2015.04.010
   Chang WC, 2019, J AGR FOOD CHEM, V67, P7684, DOI 10.1021/acs.jafc.9b02078
   Cheng KW, 2009, MOL NUTR FOOD RES, V53, P716, DOI 10.1002/mnfr.200800206
   Chomanicova N, 2021, PHYSIOL RES, V70, P501, DOI 10.33549/physiolres.934618
   Choudhary S, 2016, INFLAMMOPHARMACOLOGY, V24, P347, DOI 10.1007/s10787-016-0287-y
   Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com
   Crottes D, 2019, CELL CALCIUM, V82, DOI 10.1016/j.ceca.2019.06.004
   Damasceno SS, 2017, CURR PHARM DESIGN, V23, P3015, DOI 10.2174/1381612822666161208145508
   Dantas M. B., 2018, African Journal of Pharmacy and Pharmacology, V12, P263, DOI 10.5897/ajpp2018.4937
   Deshmukh R, 2016, BIOMED PHARMACOTHER, V81, P56, DOI 10.1016/j.biopha.2016.03.017
   dos Santos JFS, 2018, COMP IMMUNOL MICROB, V57, P22, DOI 10.1016/j.cimid.2018.03.001
   Dziedzic A, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/6793456
   Dziedzic A, 2014, INT J MOL SCI, V15, P18725, DOI 10.3390/ijms151018725
   Dzitoyeva S, 2008, J NEURAL TRANSM, V115, P823, DOI 10.1007/s00702-008-0034-7
   El-Seedi HR, 2012, J AGR FOOD CHEM, V60, P10877, DOI 10.1021/jf301807g
   Felton JS, 2007, MUTAT RES-FUND MOL M, V616, P90, DOI 10.1016/j.mrfmmm.2006.11.010
   Fratantonio D, 2017, BIOFACTORS, V43, P54, DOI 10.1002/biof.1312
   Gu WT, 2016, RSC ADV, V6, P82774, DOI 10.1039/c6ra07703j
   Gupta B, 2016, ONCOLOGY-BASEL, V91, P13, DOI 10.1159/000446117
   Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025
   Hong YJ, 2015, BIOL PHARM BULL, V38, P201, DOI 10.1248/bpb.b14-00495
   Huang D, 2019, GENES DIS, V6, P167, DOI 10.1016/j.gendis.2018.05.005
   Huang YJ, 2013, NEUROSCI LETT, V535, P146, DOI 10.1016/j.neulet.2012.12.051
   Ikeda K, 2011, INT J MOL MED, V28, P595, DOI 10.3892/ijmm.2011.739
   Jiang F, 2014, TOXICOL LETT, V231, P55, DOI 10.1016/j.toxlet.2014.08.024
   Kabala-Dzik A, 2018, INTEGR CANCER THER, V17, P1247, DOI 10.1177/1534735418801521
   Kabala-Dzik A, 2017, MOLECULES, V22, DOI 10.3390/molecules22091554
   Khan FA, 2016, J FOOD DRUG ANAL, V24, P695, DOI 10.1016/j.jfda.2016.05.003
   Khan F, 2021, J AGR FOOD CHEM, V69, P2979, DOI 10.1021/acs.jafc.0c07579
   Khan KA, 2013, J PHARM PHARMACOL, V65, P1745, DOI 10.1111/jphp.12126
   Kim HM, 2018, NUTRITION, V55-56, P63, DOI 10.1016/j.nut.2018.03.010
   Kim JH, 2015, NUTR RES PRACT, V9, P480
   Knez D, 2018, EUR J MED CHEM, V156, P598, DOI 10.1016/j.ejmech.2018.07.033
   Koraneekit A, 2018, ONCOL LETT, V15, P7397, DOI 10.3892/ol.2018.8256
   Kwon YI, 2007, FOOD BIOTECHNOL, V21, P71, DOI 10.1080/08905430701191205
   Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714
   Langland J, 2018, ANTIVIR RES, V160, P143, DOI 10.1016/j.antiviral.2018.10.021
   Lee ES, 2012, J AGR FOOD CHEM, V60, P2730, DOI 10.1021/jf203774y
   Lee JE, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-29
   Liang GJ, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0064-x
   Lin CL, 2012, INT J MOL SCI, V13, P6236, DOI 10.3390/ijms13056236
   Lin CC, 2020, BIOMED J, V43, P134, DOI 10.1016/j.bj.2020.01.001
   Liu Y, 2021, PAK J ZOOL, V53, P1045, DOI 10.17582/journal.pjz/20200106060120
   Luís A, 2014, BIOFOULING, V30, P69, DOI 10.1080/08927014.2013.845878
   Lutfi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178833
   MAROTEAUX L, 1988, J NEUROSCI, V8, P2804
   McGlynn KA, 2021, HEPATOLOGY, V73, P4, DOI 10.1002/hep.31288
   Min J, 2018, CELL PHYSIOL BIOCHEM, V48, P1433, DOI 10.1159/000492253
   Ming M, 2012, CANCER LETT, V319, P125, DOI 10.1016/j.canlet.2012.01.003
   Mirzaei S, 2021, PHARMACOL RES, V171, DOI 10.1016/j.phrs.2021.105759
   Espíndola KMM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00541
   Moon MK, 2009, BIOL PHARM BULL, V32, P1371, DOI 10.1248/bpb.32.1371
   Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068
   Natarelli L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142421
   Oboh G, 2013, NEUROCHEM RES, V38, P413, DOI 10.1007/s11064-012-0935-6
   Ogawa M, 2021, J INFECT CHEMOTHER, V27, P397, DOI 10.1016/j.jiac.2020.10.015
   Ogawa M, 2018, J INFECT CHEMOTHER, V24, P597, DOI 10.1016/j.jiac.2018.03.005
   Orsolic N, 2021, MOLECULES, V26, DOI 10.3390/molecules26113262
   Ozansoy M, 2013, MOL NEUROBIOL, V47, P460, DOI 10.1007/s12035-012-8369-3
   Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767
   Pan YQ, 2010, NEURAL REGEN RES, V5, P1634, DOI 10.3969/j.issn.1673-5374.2010.21.006
   Papa S, 2019, ONCOGENE, V38, P2223, DOI 10.1038/s41388-018-0582-8
   Pelinson LP, 2019, MOL BIOL REP, V46, P2085, DOI 10.1007/s11033-019-04658-1
   Phang JM, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00060
   Pinho E, 2014, BIOMED RES INT-UK, V2014, DOI 10.1155/2014/814590
   Pohanka M, 2014, INT J MOL SCI, V15, P9809, DOI 10.3390/ijms15069809
   Rezaei-Seresht H, 2019, AVICENNA J PHYTOMEDI, V9, P574, DOI [10.22038/ajp.2019.13475, 10.22038/AJP.2019.13475]
   Rosendahl AH, 2015, CLIN CANCER RES, V21, P1877, DOI 10.1158/1078-0432.CCR-14-1748
   Saavedra MJ, 2010, MED CHEM, V6, P174, DOI 10.2174/1573406411006030174
   Salau VF, 2020, BIOL TRACE ELEM RES, V196, P517, DOI 10.1007/s12011-019-01937-7
   Servet C, 2012, FRONT BIOSCI-LANDMRK, V17, P607, DOI 10.2741/3947
   Shen J, 2018, ANTIVIR RES, V154, P166, DOI 10.1016/j.antiviral.2018.04.008
   Simonetti P, 2001, J AGR FOOD CHEM, V49, P5964, DOI 10.1021/jf010546k
   Sivakumar S, 2020, J KING SAUD UNIV SCI, V32, P904, DOI 10.1016/j.jksus.2019.05.003
   Song Y, 2004, NEUROREPORT, V15, P2181, DOI 10.1097/00001756-200410050-00007
   Sul D, 2009, LIFE SCI, V84, P257, DOI 10.1016/j.lfs.2008.12.001
   Toma L, 2017, BIOFACTORS, V43, P685, DOI 10.1002/biof.1373
   Trandafir I, 2013, ARCH LATINOAM NUTR, V63, P87
   Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001
   Tyszka-Czochara M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010266
   Tyszka-Czochara M, 2017, FOOD CHEM TOXICOL, V106, P260, DOI 10.1016/j.fct.2017.05.065
   Tyszka-Czochara M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020462
   Utsunomiya H, 2014, INT J MOL MED, V34, P1020, DOI 10.3892/ijmm.2014.1859
   Vacaresse N, 2001, BRIT J PHARMACOL, V132, P1777, DOI 10.1038/sj.bjp.0703981
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   Castro MFV, 2021, LIFE SCI, V277, DOI 10.1016/j.lfs.2021.119421
   Vici P, 2015, CANCER TREAT REV, V41, P69, DOI 10.1016/j.ctrv.2014.12.005
   Virtanen KA, 2011, CURR OPIN LIPIDOL, V22, P49, DOI 10.1097/MOL.0b013e3283425243
   Vu M, 2018, CURR PROB CANCER, V42, P457, DOI 10.1016/j.currproblcancer.2018.06.003
   Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002
   Wang LL, 2015, RSC ADV, V5, P52952, DOI 10.1039/c5ra05878c
   Wang Y, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/8913926
   Wang YL, 2016, INT J MOL MED, V38, P869, DOI 10.3892/ijmm.2016.2683
   web1, CANC TRENDS LUNG CAN
   web2, CANC TRENDS BREAST C
   web3, CANC TRENDS LIVER CA
   Wilkins LR, 2017, CARDIOVASC INTER RAD, V40, P430, DOI 10.1007/s00270-016-1515-y
   Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530
   Xu WG, 2020, TROP J PHARM RES, V19, P1227, DOI 10.4314/tjpr.v19i6.17
   Yang G, 2014, CANCER PREV RES, V7, P1056, DOI 10.1158/1940-6207.CAPR-14-0141
   Yang JQ, 2008, CNS NEUROSCI THER, V14, P10, DOI 10.1111/j.1527-3458.2007.00031.x
   Yang Y, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.687871
   Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058915
   Zannella VE, 2011, RADIOTHER ONCOL, V99, P293, DOI 10.1016/j.radonc.2011.05.049
   Zhang N, 2020, FOOD CHEM, V317, DOI 10.1016/j.foodchem.2020.126447
   Zhang Y, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104538
   Zhang Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04888-y
   Zheng HC, 2006, ANTICANCER RES, V26, P3579
   Zheng LF, 2008, FOOD CHEM TOXICOL, V46, P149, DOI 10.1016/j.fct.2007.07.010
NR 125
TC 87
Z9 89
U1 62
U2 202
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2023
VL 24
IS 1
AR 588
DI 10.3390/ijms24010588
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 7Q7XI
UT WOS:000909599300001
PM 36614030
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Narita, Y
   Inouye, K
AF Narita, Yusaku
   Inouye, Kuniyo
TI Kinetic Analysis and Mechanism on the Inhibition of Chlorogenic Acid and
   Its Components against Porcine Pancreas α-Amylase Isozymes I and II
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE alpha-Amylase inhibitor; caffeic acid; chlorogenic acid; enzyme
   kinetics; mixed-type inhibition
ID HUMAN MATRIX-METALLOPROTEINASE-7 MATRILYSIN; GREEN COFFEE BEANS;
   MALTOPENTAOSE HYDROLYSIS; HUMAN SALIVARY; CAFFEIC ACID; THERMOLYSIN;
   DERIVATIVES; ACTIVATION; SUBSTRATE; CHLORIDE
AB Chlorogenic acid (5-caffeoylquinic acid, 5-CQA) is a kind of polyphenol and is richly included in green coffee beans. The inhibitory effects of 5-CQA and its components, caffeic acid (CA) and quinic acid (QA), on the two porcine pancreas (alpha-amylase (PPA) isozymes, PPA-I and PPA-II, were investigated using p-nitrophenyl-alpha-D-maltoside as substrate at pH 6.9 and 30 degrees C. The inhibition potencies of the respective inhibitors against both PPA isozymes were almost the same and in the order of 5-CQA > CA >> QA. Their IC50 values were 0.07-0.08 mM, 0.37-0.40 mM, and 25.3-26.5 mM, respectively. The inhibition mechanisms of 5-CQA and CA were investigated by kinetic analyses, and the inhibitor constants K-i and K-i' (for the free enzyme and enzyme-substrate complex, respectively) were determined. It was indicated that 5-CQA and CA showed mixed-type inhibition with Ki > Ki' against both PPA-I and PPA-II. The binding of PPA-I or PPA-II with 5-CQA or CA was all exothermic and enthalpy-driven. CIA is a poor inhibitor, and its inhibitory mode was unique and hardly analyzed by a simple Michaelis-Menten-type interaction between the enzyme and inhibitor. However, it was shown that the inhibitory activity of CA was enhanced 5 times by ester-bond formation with QA in the form of 5-CQA. These results provide us with significant hints for the development of alpha-amylase inhibitors useful for the prevention of diabetes and obesity.
C1 [Narita, Yusaku; Inouye, Kuniyo] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan.
   [Narita, Yusaku] UCC Ueshima Coffee Co Ltd, R&D Ctr, Takatsuki, Osaka 5690036, Japan.
C3 Kyoto University
RP Inouye, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan.
EM inouye@kais.kyoto-u.ac.jp
FU Japan Society for the Promotion of Science [17380065, 20380061];
   Grants-in-Aid for Scientific Research [17380065] Funding Source: KAKEN
FX Received May 23, 2009. Revised manuscript received August 13, 2009.
   Accepted August 26, 2009. This study was supported in part by the
   Grants-in-Aid for Scientific Research (nos. 17380065 and 20380061) from
   the Japan Society for the Promotion of Science.
CR Al Kazaz M, 1998, EUR J BIOCHEM, V252, P100, DOI 10.1046/j.1432-1327.1998.2520100.x
   Alkazaz M, 1996, EUR J BIOCHEM, V241, P787, DOI 10.1111/j.1432-1033.1996.00787.x
   [Anonymous], 1976, BIOCHEM J
   Clifford MN, 2006, J AGR FOOD CHEM, V54, P1957, DOI 10.1021/jf0601665
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   CLIFFORD MN, 1987, FOOD CHEM, V26, P59, DOI 10.1016/0308-8146(87)90167-1
   Cornish-Bowden A, 2002, J BIOSCIENCES, V27, P121, DOI 10.1007/BF02703768
   Cornish-Bowden A., 1976, Principles of Enzyme Kinetics, P52
   CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143
   Desseaux V, 2002, BIOLOGIA, V57, P163
   Inouye K, 1996, BIOCHEM J, V315, P133, DOI 10.1042/bj3150133
   INOUYE K, 1994, J BIOCHEM-TOKYO, V116, P530, DOI 10.1093/oxfordjournals.jbchem.a124557
   Islam MS, 2002, J AGR FOOD CHEM, V50, P3718, DOI 10.1021/jf020120l
   Iwai K, 2004, J AGR FOOD CHEM, V52, P4893, DOI 10.1021/jf040048m
   Jencks W. P., 1969, CATALYSIS CHEM ENZYM, P282
   Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028
   KLUH I, 1981, FEBS LETT, V136, P231, DOI 10.1016/0014-5793(81)80624-2
   KOMIYAMA T, 1975, ARCH BIOCHEM BIOPHYS, V171, P727, DOI 10.1016/0003-9861(75)90085-5
   Kono Y, 1997, BBA-GEN SUBJECTS, V1335, P335, DOI 10.1016/S0304-4165(96)00151-1
   Ky CL, 2001, FOOD CHEM, V75, P223, DOI 10.1016/S0308-8146(01)00204-7
   LEVITZKI A, 1974, EUR J BIOCHEM, V41, P171, DOI 10.1111/j.1432-1033.1974.tb03257.x
   MARCHISMOUREN G, 1967, BIOCHIM BIOPHYS ACTA, V140, P366, DOI 10.1016/0005-2795(67)90478-3
   MARUTA Y, 1995, J AGR FOOD CHEM, V43, P2592, DOI 10.1021/jf00058a007
   MELOUN B, 1980, COLLECT CZECH CHEM C, V45, P2572, DOI 10.1135/cccc19802572
   Muta Y, 2002, J BIOCHEM, V132, P945, DOI 10.1093/oxfordjournals.jbchem.a003308
   NAKAMURA Y, 1984, GENE, V28, P263, DOI 10.1016/0378-1119(84)90265-8
   NISHIDE T, 1986, GENE, V41, P299
   Oneda H, 2004, J BIOCHEM, V135, P421, DOI 10.1093/jb/mvh050
   Oneda H, 2003, J BIOCHEM, V133, P571, DOI 10.1093/jb/mvg073
   Oneda H, 2001, J BIOCHEM, V129, P429, DOI 10.1093/oxfordjournals.jbchem.a002874
   PASERO L, 1986, BIOCHIM BIOPHYS ACTA, V869, P147, DOI 10.1016/0167-4838(86)90289-X
   ROBYT JF, 1970, J BIOL CHEM, V245, P3917
   Rohn S, 2002, J AGR FOOD CHEM, V50, P3566, DOI 10.1021/jf011714b
   SAKANO Y, 1983, DEMPUN KAGAKU, V30, P30
   Segel IH, 1975, ENZYME KINETICS BEHA, P161
   Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801
   Takenaka M, 2003, J AGR FOOD CHEM, V51, P793, DOI 10.1021/jf020735i
   Tormo MA, 2006, BRIT J NUTR, V96, P539, DOI 10.1079/BJN20061836
   TRONRUD DE, 1986, EUR J BIOCHEM, V157, P261, DOI 10.1111/j.1432-1033.1986.tb09664.x
   Tsujita T, 2008, J NUTR SCI VITAMINOL, V54, P82, DOI 10.3177/jnsv.54.82
   YAMASHITA H, 1991, J BIOCHEM-TOKYO, V110, P605, DOI 10.1093/oxfordjournals.jbchem.a123627
NR 41
TC 104
Z9 110
U1 2
U2 55
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD OCT 14
PY 2009
VL 57
IS 19
BP 9218
EP 9225
DI 10.1021/jf9017383
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 502LM
UT WOS:000270461500068
PM 19807164
DA 2025-04-28
ER

PT J
AU Kubow, S
   Hobson, L
   Iskandar, MM
   Sabally, K
   Donnelly, DJ
   Agellon, LB
AF Kubow, Stan
   Hobson, Luc
   Iskandar, Michele M.
   Sabally, Kebba
   Donnelly, Danielle J.
   Agellon, Luis B.
TI Extract of Irish potatoes (Solanum tuberosum L.) decreases body
   weight gain and adiposity and improves glucose control in the mouse
   model of diet-induced obesity
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Glucose tolerance; Polyphenols; Potato; Sex differences
ID HIGH-FAT DIET; LIPID-METABOLISM; FERULIC ACID; CHLOROGENIC ACID;
   RESISTANCE; PATHWAYS; MICE
AB Both sexes of mice were fed a high fat diet (HFD) for 10 weeks without and with polyphenolic-rich potato extracts (PRPE) of cultivars Onaway and Russet Burbank. PRPE attenuated weight gain in male and female mice by as much as 63.2%, which was associated mostly with a reduction in adiposity. Mice receiving PRPE showed enhanced capacity for blood glucose clearance. Sex differences regarding the impact of HFD and PRPE on plasma levels of insulin, ghrelin, leptin, gastric inhibitory peptide, and resistin were noted. PRPE may serve as part of a preventative dietary strategy against the development of obesity and type 2 diabetes.
C1 [Kubow, Stan; Hobson, Luc; Iskandar, Michele M.; Sabally, Kebba; Agellon, Luis B.] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
   [Donnelly, Danielle J.] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
C3 McGill University; McGill University
RP Kubow, S (corresponding author), McGill Univ, Sch Dietet & Human Nutr, 21,111 Lakeshore, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
EM stan.kubow@mcgill.ca
RI Kubow, Stan/AAJ-6913-2021; Iskandar, Michele/U-6627-2019
OI Kubow, Stan/0000-0001-5831-9880
FU Natural Sciences and Engineering Council of Canada; Canadian Institutes
   of Health Research; Canada Foundation for Innovation
FX This research was funded by Strategic and Discovery grants from the
   Natural Sciences and Engineering Council of Canada to S.K., D.D., and
   L.B.A., Canadian Institutes of Health Research to S.K. and D.D., and
   Canada Foundation for Innovation to L.B.A.
CR Andallu B, 2003, CLIN CHIM ACTA, V338, P3, DOI 10.1016/S0009-8981(03)00322-X
   Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Bolkent S, 2000, J ETHNOPHARMACOL, V73, P251, DOI 10.1016/S0378-8741(00)00328-7
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cox LM, 2013, CELL METAB, V17, P883, DOI 10.1016/j.cmet.2013.05.004
   Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235
   FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311
   Gomez G, 2012, REGUL PEPTIDES, V173, P60, DOI 10.1016/j.regpep.2011.09.006
   Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878
   Kamalakkannan N, 2003, J ETHNOPHARMACOL, V87, P207, DOI 10.1016/S0378-8741(03)00148-X
   Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240
   Liu QO, 2010, BBA-GENE REGUL MECH, V1799, P854, DOI 10.1016/j.bbagrm.2010.06.004
   Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Ohnishi M, 2004, BIOFACTORS, V21, P315, DOI 10.1002/biof.552210161
   Park HJ, 2013, MOL NUTR FOOD RES, V57, P360, DOI 10.1002/mnfr.201200447
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Romo-Vaquero M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094687
   Rondini L, 2004, J AGR FOOD CHEM, V52, P4338, DOI 10.1021/jf0348323
   Seeram NP, 2004, J AGR FOOD CHEM, V52, P2512, DOI 10.1021/jf0352778
   Shehzad A, 2011, EUR J NUTR, V50, P151, DOI 10.1007/s00394-011-0188-1
   Singh N, 2005, PLANT FOOD HUM NUTR, V60, P49, DOI 10.1007/s11130-005-5099-y
   Son MJ, 2010, J CLIN BIOCHEM NUTR, V46, P150, DOI 10.3164/jcbn.09-98
   Sugiyama MG, 2012, BIOCHEM CELL BIOL, V90, P124, DOI [10.1139/O11-067, 10.1139/o11-067]
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI [10.1139/H11-072, 10.1139/h11-072]
   Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27
   Yang ZH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-32
   Yoon SS, 2008, J ETHNOPHARMACOL, V118, P396, DOI 10.1016/j.jep.2008.05.014
NR 29
TC 24
Z9 29
U1 1
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD NOV
PY 2014
VL 58
IS 11
BP 2235
EP 2238
DI 10.1002/mnfr.201400013
PG 4
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA AT8XK
UT WOS:000345212200014
PM 25066548
DA 2025-04-28
ER

PT J
AU Daily, JW
   Liu, M
   Park, S
AF Daily, J. W.
   Liu, M.
   Park, S.
TI High genetic risk scores of SLIT3, PLEKHA5 and
   PPP2R2C variants increased insulin resistance and interacted with
   coffee and caffeine consumption in middle-aged adults
SO NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
LA English
DT Article
DE Insulin resistance; Insulin secretion; Coffee intake; GMDR; Metabolic
   syndrome
ID TYPE-2 DIABETES-MELLITUS; METABOLIC SYNDROME; ALCOHOL-CONSUMPTION;
   ENVIRONMENT INTERACTIONS; ASSOCIATION; POLYMORPHISM; METAANALYSIS;
   OBESITY; LOCUS
AB Backgrounds and Aims: Insulin resistance is a common feature of metabolic syndrome that may be influenced by genetic risk factors. We hypothesized that genetic risk scores (GRS) of SNPs that influence insulin resistance and signaling interact with lifestyles to modulate insulin resistance in Korean adults.
   Methods and results: Genome-wide association studies (GWAS) of subjects aged 40-65 years who participated in the Ansung/Ansan cohorts (8842 adults) in Korea revealed 52 genetic variants that influence insulin resistance. The best gene-gene interaction model was explored using the generalized multifactor dimensionality reduction (GMDR) method. GRS from the best model were calculated and the GRS were divided into low, medium and high groups. The best model for representing insulin resistance included SLIT3_rs2974430, PLEKHA5_rs1077044, and PPP2R2C_rs16838853. The odds ratios for insulin resistance were increased by 150% in the High-GRS group compared to the Low-GRS group. However, ORs for insulin secretion capacity, measured by HOMA-B, were not associated with GRS. Coffee and caffeine intake and GRS had an interaction with insulin resistance: In subjects with high coffee (>= 10 cups/week) or caffeine intake (>= 220 mg caffeine/day), insulin resistance was significantly elevated in the High-GRS group, but not in the Low-GRS. However, alcohol intake, smoking and physical activity did not have an interaction with GRS. Insulin secretion capacity was not significantly influenced by GRS when evaluating the adjusted odds ratios.
   Conclusions: Subjects with High-GRS may be susceptible to increased insulin resistance by 50% and its risk may be exacerbated by consuming more than 10 cups coffee/week or 220 mg caffeine/day. (C) 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
C1 [Daily, J. W.] Daily Mfg Inc, Dept R&D, Rockwell, NC USA.
   [Liu, M.; Park, S.] Hoseo Univ, Dept Food & Nutr, Obes Diabet Res Ctr, Asan, South Korea.
C3 Hoseo University
RP Park, S (corresponding author), Hoseo Univ, Food & Nutr, 165 Sechul Ri, Asan 336795, Chungnam Do, South Korea.
EM smpark@hoseo.edu
OI Park, Sunmin/0000-0002-6092-8340
FU Traditional Culture Convergence Research Program through the National
   Research Foundation of Korea (NRF) - Ministry of Science and Information
   and Communication Technology [NRF-2016M3C1B5907049]
FX This study was funded by a grant from Traditional Culture Convergence
   Research Program through the National Research Foundation of Korea (NRF)
   funded by the Ministry of Science and Information and Communication
   Technology (NRF-2016M3C1B5907049).
CR Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   Bae JC, 2015, J DIABETES, V7, P791, DOI 10.1111/1753-0407.12248
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/c7fo00388a, 10.1039/C7FO00388A]
   Carlborg Ö, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407
   Corella D, 2011, INT J OBESITY, V35, P666, DOI 10.1038/ijo.2010.187
   Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Fan YL, 2013, FEBS LETT, V587, P3892, DOI 10.1016/j.febslet.2013.09.029
   Fraser HI, 2010, J IMMUNOL, V184, P5075, DOI 10.4049/jimmunol.0903734
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   He W, 2015, OBESITY, V23, P684, DOI 10.1002/oby.20995
   Hong KW, 2018, NUTR RES, V51, P82, DOI 10.1016/j.nutres.2017.12.012
   Hwang JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33043
   Jilaveanu LB, 2015, CLIN CANCER RES, V21, P2138, DOI 10.1158/1078-0432.CCR-14-0861
   Jung D, 2018, HORM METAB RES, V50, P308, DOI 10.1055/a-0583-0201
   Jung S, 2017, J MED FOOD, V20, P626
   Jyothi KU, 2015, META GENE, V5, P9, DOI 10.1016/j.mgene.2015.05.001
   Kim DS, 2018, DIABETES-METAB RES, P34
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim JD, 2016, ENDOCRINOL METAB, V31, P354, DOI 10.3803/EnM.2016.31.3.354
   Koska J, 2016, METABOLISM, V65, P1621, DOI 10.1016/j.metabol.2016.07.015
   Kouli GM, 2018, EUR J NUTR, V57, P1677, DOI 10.1007/s00394-017-1455-6
   Mehdi AM, 2018, JCI INSIGHT, P3
   Meyer SU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139520
   Park SY, 2014, HYPERTENS RES, V37, P811, DOI 10.1038/hr.2014.84
   Park S, 2016, CLIN NUTR, V35, P1159, DOI 10.1016/j.clnu.2015.09.010
   Park S, 2016, J NUTRIGENET NUTRIGE, V9, P47, DOI 10.1159/000446499
   Parker R, 2018, NAT REV GASTRO HEPAT, V15, P50, DOI 10.1038/nrgastro.2017.116
   Platt DE, 2016, ANN NUTR METAB, V68, P1, DOI 10.1159/000441481
   Reis CEG, 2018, BRIT J NUTR, V119, P1029, DOI 10.1017/S000711451800034X
   Ryu J, 2012, HUM MUTAT, V33, P655, DOI 10.1002/humu.22040
   Schrieks IC, 2015, DIABETES CARE, V38, P723, DOI 10.2337/dc14-1556
   Scott RA, 2014, DIABETES, V63, P4378, DOI 10.2337/db14-0319
   Soberg S, 2017, CELL METAB, V25, P1045, DOI 10.1016/j.cmet.2017.04.009
   Stephens FB, 2018, BIOCHEM SOC T, V46, P111, DOI 10.1042/BST20170198
   Suarez EC, 2017, INT J BEHAV MED, V24, P927, DOI 10.1007/s12529-017-9652-5
   Tam CS, 2012, DIABETES CARE, V35, P1605, DOI 10.2337/dc11-2339
   Tatsumi Y, 2018, DIABETES RES CLIN PR, V135, P11, DOI 10.1016/j.diabres.2017.10.021
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Xiao S, 2016, MED SCI MONITOR, V22, P474
   Xu HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086723
   Yang YHC, 2013, P NATL ACAD SCI USA, V110, P16480, DOI 10.1073/pnas.1214312110
NR 42
TC 15
Z9 15
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0939-4753
EI 1590-3729
J9 NUTR METAB CARDIOVAS
JI Nutr. Metab. Carbiovasc. Dis.
PD JAN
PY 2019
VL 29
IS 1
BP 79
EP 89
DI 10.1016/j.numecd.2018.09.009
PG 11
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition
   & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism;
   Nutrition & Dietetics
GA HG2NL
UT WOS:000454800000012
PM 30454882
DA 2025-04-28
ER

PT J
AU Stohs, SJ
   Kaats, GR
   Preuss, HG
AF Stohs, Sidney J.
   Kaats, Gilbert R.
   Preuss, Harry G.
TI Safety and Efficacy of Banaba-Moringa oleifera-Green Coffee Bean
   Extracts and Vitamin D3 in a Sustained Release Weight Management
   Supplement
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE Moringa oleifera; green coffee bean extract; Lagerstroemia speciosa
   (banaba); vitamin D
ID CHLOROGENIC ACID; BODY-WEIGHT; OVERWEIGHT; SVETOL(R); HEALTHY
AB This 60-day, 30-subject pilot study examined a novel combination of ingredients in a unique sustained release (Carbopol matrix) tablet consumed twice daily. The product was composed of extracts of banaba leaf, green coffee bean, and Moringa oleifera leaf and vitamin D3. Safety was assessed using a 45-measurement blood chemistry panel, an 86-item self-reported Quality of Life Inventory, bone mineral density, and cardiovascular changes. Efficacy was assessed by calculating a body composition improvement index (BCI) based on changes in dual energy X-ray absorptiometry measured fat mass (FM) and fat-free mass (FFM) as well as between the study group (SG) and a historical placebo group. No changes occurred in any blood chemistry measurements. Positive changes were found in the Quality of Life (QOL) inventory composite scores. No adverse effects were observed. Decreases occurred in FM (p=0.004) and increases in FFM (p=0.009). Relative to the historical placebo group, the SG lost more FM (p<0.0001), gained more FFM (p=<0.0001), and had a negative BCI of -2.7lb. compared with a positive BCI in the SG of 3.4lb., a 6.1 discordance (p=0.0009). The data support the safety and efficacy of this unique product and demonstrate importance of using changes in body composition versus scale weight and BMI. (c) 2016 The Authors Phytotherapy Research Published by John Wiley & Sons Ltd
C1 [Stohs, Sidney J.] Creighton Univ, 7068 Maumee Valley Court, Frisco, TX 75034 USA.
   [Kaats, Gilbert R.] Integrat Hlth Technol Inc, 5170 Broadway, San Antonio, TX USA.
   [Preuss, Harry G.] Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20007 USA.
C3 Creighton University; Georgetown University
RP Stohs, SJ (corresponding author), Creighton Univ, 7068 Maumee Valley Court, Frisco, TX 75034 USA.
EM sid.stohs9@gmail.com
FU AdvoCare International
FX This study was supported by a grant from AdvoCare International.
CR Arbeeny CM, 2004, OBES RES, V12, P1191, DOI 10.1038/oby.2004.150
   Cipriani C, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/841248
   Duffy KJ, 2011, PLOS MED, V8, DOI [10.1371/Jounral.pmed.1001050, DOI 10.1371/JOUNRAL.PMED.1001050]
   Esteghamati A, 2015, INT J ENDOCRINOL MET, V13, DOI 10.5812/ijem.19678
   Ferraro ZM, 2015, CLIN MED INSIGHTS-EN, V8, P7, DOI 10.4137/CMED.S23060
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Grosso G, 2014, NUTRITION, V30, P1398, DOI 10.1016/j.nut.2014.04.012
   Kaats GR, 2006, J AM COLL NUTR, V25, P389, DOI 10.1080/07315724.2006.10719550
   Kaats GR, 2013, OBESITY EPIDEMIOLOGY, P833
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI [10.1039/C4FO00290C, 10.1039/c4fo00290c]
   Mbikay M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00024
   Nardon K, 2007, AGRO FOOD IND HI TEC, V18, P37
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Opala T, 2006, EUR J MED RES, V11, P343
   Patel C, 2008, FOOD CHEM TOXICOL, V46, P2728, DOI 10.1016/j.fct.2008.04.035
   Pathak K, 2014, OBES REV, V15, P528, DOI 10.1111/obr.12162
   Pérez-Vásquez A, 2014, J NAT PROD, V77, P516, DOI 10.1021/np400785z
   Shanmugalingam T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-712
   Shim KS, 2009, PHYTOTHER RES, V23, P1754, DOI 10.1002/ptr.2843
   Stohs SJ, 2015, PHYTOTHER RES, V29, P796, DOI 10.1002/ptr.5325
   Stohs SJ, 2012, PHYTOTHER RES, V26, P317, DOI 10.1002/ptr.3664
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Vaughan RA, 2014, ISRN NUTR, DOI [10.1155/2014/650264, DOI 10.1155/2014/650264]
NR 23
TC 2
Z9 2
U1 0
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD APR
PY 2016
VL 30
IS 4
BP 681
EP 688
DI 10.1002/ptr.5577
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA DJ1VQ
UT WOS:000373993500018
PM 26871553
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Zhou, Y
   Ruan, Z
   Wen, YM
   Yang, YH
   Mi, SM
   Zhou, LL
   Wu, X
   Ding, S
   Deng, ZY
   Wu, GY
   Yin, YL
AF Zhou, Yan
   Ruan, Zheng
   Wen, Yanmei
   Yang, Yuhui
   Mi, Shumei
   Zhou, Lili
   Wu, Xin
   Ding, Sheng
   Deng, Zeyuan
   Wu, Guoyao
   Yin, Yulong
TI Chlorogenic acid from honeysuckle improves hepatic lipid dysregulation
   and modulates hepatic fatty acid composition in rats with chronic
   endotoxin infusion
SO JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
LA English
DT Article
DE chlorogenic acid; lipid metabolism; fatty acids; AMP-activated protein
   kinase
ID DIET-INDUCED OBESITY; INSULIN-RESISTANCE; SKELETAL-MUSCLE;
   LONICERA-JAPONICA; ADIPOSE-TISSUE; PROTEIN-KINASE; LIVER; MICE;
   INCREASES; ACCUMULATION
AB Chlorogenic acid as a natural hydroxycinnamic acid has protective effect for liver. Endotoxin induced metabolic disorder, such as lipid dysregulation and hyperlipidemia. In this study, we investigated the effect of chlorogenic acid in rats with chronic endotoxin infusion. The Sprague-Dawley rats with lipid metabolic disorder (LD group) were intraperitoneally injected endotoxin. And the rats of chlorogenic acid-LD group were daily received chlorogenic acid by intragastric administration. In chlorogenic acid-LD group, the area of visceral adipocyte was decreased and liver injury was ameliorated, as compared to LD group. In chlorogenic acid-LD group, serum triglycerides, free fatty acids, hepatic triglycerides and cholesterol were decreased, the proportion of C20:1, C24:1 and C18:3n-6, Delta 9-18 and Delta 6-desaturase activity index in the liver Were decreased, and the proportion of C18:3n-3 acid was increased, compared to the LD group. Moreover, levels of phosphorylated AMP-activated protein kinase, carnitine palmitoyltransferase-I, and fatty acid beta-oxidation were increased in chlorogenic acid-LD group compared to LD rats, whereas levels of fatty acid synthase and acetyl-CoA carboxylase were decreased. These findings demonstrate that chlorogenic acid effectively improves hepatic lipid dysregulation in rats by regulating fatty acid metabolism enzymes, stimulating AMP-activated protein kinase activation, and modulating levels of hepatic fatty acids.
C1 [Zhou, Yan; Ruan, Zheng; Wen, Yanmei; Yang, Yuhui; Mi, Shumei; Zhou, Lili; Wu, Xin; Deng, Zeyuan; Yin, Yulong] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang 330047, Peoples R China.
   [Zhou, Yan; Ruan, Zheng; Wen, Yanmei; Yang, Yuhui; Mi, Shumei; Zhou, Lili; Wu, Xin; Deng, Zeyuan; Yin, Yulong] Nanchang Univ, Coll Food Sci, Nanchang 330047, Peoples R China.
   [Wu, Xin; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Changsha 410125, Hunan, Peoples R China.
   [Ding, Sheng] Ctr Dis Control & Prevent Jiangxi Prov, Inst Nutr & Food Safety, Nanchang 330029, Peoples R China.
   [Wu, Guoyao] Texas A&M Univ, Fac Nutr, Dept Anim Sci, College Stn, TX 77843 USA.
C3 Nanchang University; Nanchang University; Chinese Academy of Sciences;
   Institute of Subtropical Agriculture, CAS; Texas A&M University System;
   Texas A&M University College Station
RP Ruan, Z (corresponding author), Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang 330047, Peoples R China.; Ruan, Z (corresponding author), Nanchang Univ, Coll Food Sci, Nanchang 330047, Peoples R China.
EM ruanzheng@ncu.edu.cn
RI li, yuying/JDW-4642-2023; Ruan, Zheng/IUM-7758-2023; Zhou,
   Lili/J-5687-2016; ding, sheng/LMP-1860-2024; Wu, Xin/ITU-1370-2023;
   yuhui, yang/AAZ-8126-2021; deng, zeyuan/P-1933-2014
OI deng, zeyuan/0000-0001-5650-1507; Yang, Yuhui/0000-0002-4949-3745
FU National Natural Science Foundation of China [31360552]; Natural Science
   Foundation of Jiangxi Province [20151BAB204036]; Open Project Program of
   State Key Laboratory of Food Science and Technology, Nanchang University
   [SKLF-KF-201414]
FX This research was financially supported by the National Natural Science
   Foundation of China (No. 31360552), the Natural Science Foundation of
   Jiangxi Province (20151BAB204036) and the Open Project Program of State
   Key Laboratory of Food Science and Technology, Nanchang University (No.
   SKLF-KF-201414).
CR Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3
   Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035
   BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9
   BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462
   Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006
   Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727
   Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155
   Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286
   FEINGOLD KR, 1992, J LIPID RES, V33, P1765
   FRIEDMAN MI, 1986, BRAIN RES BULL, V17, P855, DOI 10.1016/0361-9230(86)90099-7
   Ginsberg HN, 2006, OBESITY, V14, p41S, DOI 10.1038/oby.2006.281
   GOODRIDGE AG, 1972, J BIOL CHEM, V247, P6946
   Gotoh N, 2009, J AGR FOOD CHEM, V57, P11047, DOI 10.1021/jf9026553
   Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Khan M, 2000, J ENDOTOXIN RES, V6, P41, DOI 10.1177/09680519000060010601
   Khatchadourian A, 2012, BBA-MOL CELL BIOL L, V1821, P607, DOI 10.1016/j.bbalip.2012.01.007
   Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197
   Lazarow P B, 1981, Methods Enzymol, V72, P315
   Leung HWC, 2008, FOOD CHEM TOXICOL, V46, P3389, DOI 10.1016/j.fct.2008.08.022
   Mai K, 2012, METABOLISM, V61, P108, DOI 10.1016/j.metabol.2011.05.018
   Mason KE, 2008, ARCH BIOCHEM BIOPHYS, V469, P151, DOI 10.1016/j.abb.2007.10.018
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Murase T, 2005, BBA-MOL CELL BIOL L, V1733, P224, DOI 10.1016/j.bbalip.2004.12.015
   NOLAN JP, 1989, HEPATOLOGY, V10, P887, DOI 10.1002/hep.1840100523
   Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Orellana-Gavaldà JM, 2011, HEPATOLOGY, V53, P821, DOI 10.1002/hep.24140
   Park JW, 2013, BRIT J NUTR, V109, P283, DOI 10.1017/S0007114512001122
   Porta F, 2009, INFLAMMATION, V32, P315, DOI 10.1007/s10753-009-9138-y
   Suh SJ, 2006, J CELL BIOCHEM, V99, P1298, DOI 10.1002/jcb.20912
   Torre-Villalvazo I, 2008, J NUTR, V138, P462, DOI 10.1093/jn/138.3.462
   Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001
   Uchiumi D, 2004, J PERIODONTAL RES, V39, P120, DOI 10.1111/j.1600-0765.2004.00716.x
   Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590
   van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049
   Wall R, 2009, AM J CLIN NUTR, V89, P1393, DOI 10.3945/ajcn.2008.27023
   Warensjö E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Wu CH, 2010, J AGR FOOD CHEM, V58, P7075, DOI 10.1021/jf101415v
   Xu YX, 2010, INFLAMM RES, V59, P871, DOI 10.1007/s00011-010-0199-z
   Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557
   Zhao GX, 2004, J NUTR, V134, P2991, DOI 10.1093/jn/134.11.2991
   Zhou YL, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/979414
NR 53
TC 21
Z9 26
U1 2
U2 44
PU JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
PI KYOTO
PA KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR
   GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN
SN 0912-0009
EI 1880-5086
J9 J CLIN BIOCHEM NUTR
JI J. Clin. Biochem. Nutr.
PD MAR 1
PY 2016
VL 58
IS 2
BP 146
EP 155
DI 10.3164/jcbn.14-138
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DI8LJ
UT WOS:000373752200009
PM 27013782
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Ontawong, A
   Boonphang, O
   Pasachan, T
   Duangjai, A
   Pongchaidecha, A
   Phatsara, M
   Jinakote, M
   Amornlerdpison, D
   Srimaroeng, C
AF Ontawong, Atcharaporn
   Boonphang, Oranit
   Pasachan, Tipthida
   Duangjai, Acharaporn
   Pongchaidecha, Anchalee
   Phatsara, Manussaborn
   Jinakote, Metee
   Amornlerdpison, Doungporn
   Srimaroeng, Chutima
TI Hepatoprotective effect of coffee pulp aqueous extract combined with
   simvastatin against hepatic steatosis in high-fat diet-induced obese
   rats
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Coffee pulp aqueous extract; Lipogenesis; Lipolysis; Obese insulin
   resistance; Simvastatin
ID ACTIVATED PROTEIN-KINASE; CHLOROGENIC ACID; LIVER-DISEASE;
   LIPID-ACCUMULATION; GENE-EXPRESSION; PPAR-GAMMA; INSULIN-SENSITIVITY;
   OXIDATIVE STRESS; CD36 EXPRESSION; CHOLESTEROL
AB This study investigated the effect of coffee pulp aqueous extract (CPE) on obesity- induced hepatic steatosis in rats and the mechanism involved. Male Wistar rats were fed high-fat diet for 12 weeks and supplemented with 1000 mg/kg BW CPE or 40 mg/kg BW simvastatin or CPE combined with 20 mg/kg BW simvastatin for another 12 weeks. The lipid profiles, presence of insulin resistance, development of hepatic steatosis and related mechanisms were investigated. Results show that CPE, simvastatin and combined treatment improved lipid profiles, insulin resistance, oxidative stress and hepatic steatosis. Correspondingly, CPE induced the lipolytic gene PPAR alpha, while combination treatment additively suppressed the lipogenic genes PPAR gamma and SREBP1-c. Such effects downregulated the fatty acid transporter FAT/CD36, and activated AMPK, which concomitantly improved obese induced-hepatic steatosis. Collectively, hepato-protective effects of CPE, particularly combined with simvastatin, could broaden the therapeutic options for hyperlipidaemia and NAFLD patients who receive lipid-lowering drugs.
C1 [Ontawong, Atcharaporn; Boonphang, Oranit; Pasachan, Tipthida; Pongchaidecha, Anchalee; Srimaroeng, Chutima] Chiang Mai Univ, Fac Med, Dept Physiol, 110 Intavaroros Rd, Chiang Mai 50200, Thailand.
   [Ontawong, Atcharaporn; Duangjai, Acharaporn] Univ Phayao, Sch Med Sci, Div Physiol, Phayao, Thailand.
   [Phatsara, Manussaborn] Chiang Mai Univ, Fac Med, Dept Anat, Chiang Mai, Thailand.
   [Jinakote, Metee] Chiangrai Coll, Fac Oriental Med, Chiang Rai, Thailand.
   [Amornlerdpison, Doungporn] Maejo Univ, Fac Fisheries Technol & Aquat Resources, Chiang Mai, Thailand.
C3 Chiang Mai University; University of Phayao; Chiang Mai University;
   Maejo University
RP Srimaroeng, C (corresponding author), Chiang Mai Univ, Fac Med, Dept Physiol, 110 Intavaroros Rd, Chiang Mai 50200, Thailand.
EM chutima.srimaroeng@cmu.ac.th
RI Jinakote, Metee/AAY-5480-2021; Jinakote, Metee/B-8590-2019
OI Duangjai, Acharaporn/0000-0002-5153-8738; Srimaroeng,
   Chutima/0000-0002-5537-1023; Jinakote, Metee/0000-0002-5661-8585
FU Faculty of Medicine Endowment Fund, Chiang Mai University, Chiang Mai,
   Thailand [66/2560, 116/2559]; Research and Researcher for Industry
   (RRi), Thailand Research Fund (TRF), Thailand [PHD58I0010]; NSTDA Chair
   Professor grant (the Fourth Grant) of the Crown Property Bureau
   Foundation, Thailand; National Science and Technology Development
   Agency, Thailand
FX The authors would like to thank Ms. Rattanaporn Janthip for her
   assistance with coffee pulp aqueous extract preparation. Ms. Sineenart
   Santidherakul, Medical Science Research Equipment Center, Faculty of
   Medicine, Chiang Mai University for technical assistance. Ms. Lamaiporn
   Peerapapong, Department of Anatomy, Faculty of Medicine, Chiang Mai
   University for technical assistance. This research was supported by the
   Faculty of Medicine Endowment Fund, Chiang Mai University, Chiang Mai,
   Thailand (no 66/2560 to CS and AO and no 116/2559 to CS and OB), the
   Research and Researcher for Industry (RRi), Thailand Research Fund
   (TRF), Thailand (no PHD58I0010 to CS and AO) and the NSTDA Chair
   Professor grant (the Fourth Grant) of the Crown Property Bureau
   Foundation, Thailand and the National Science and Technology Development
   Agency, Thailand to Professor Dr. Vatcharin Rukachaisirikul.
CR Attele AS, 2002, DIABETES, V51, P1851, DOI 10.2337/diabetes.51.6.1851
   Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519
   Boelsterli UA, 2002, BIOCHEM PHARMACOL, V63, P1, DOI 10.1016/S0006-2952(01)00817-6
   Bonen A, 2006, INT J OBESITY, V30, P877, DOI 10.1038/sj.ijo.0803212
   Campolongo G, 2016, IJC METAB ENDOCR, V11, P3, DOI 10.1016/j.ijcme.2016.03.001
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Chen CW, 2006, J NUTR, V136, P1472, DOI 10.1093/jn/136.6.1472
   Cheng H, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700303
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Duangjai A, 2016, INTEGR MED RES, V5, P324, DOI 10.1016/j.imr.2016.09.001
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006
   Filippatos TD, 2008, DRUG SAFETY, V31, P53, DOI 10.2165/00002018-200831010-00005
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Ghanbari-Niaki A, 2014, ANN APPL SPORT SCI, V2, P37
   Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004
   Hao S, 2016, PHARM BIOL, V54, P251, DOI 10.3109/13880209.2015.1029054
   Hatzis Georgios, 2013, Curr Top Med Chem, V13, P139
   Heidker RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154305
   Houssier M, 2008, PLOS MED, V5, P323, DOI 10.1371/journal.pmed.0050039
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Kim E, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/290104
   Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200
   Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907
   Kotla S, 2017, REDOX BIOL, V11, P350, DOI 10.1016/j.redox.2016.12.005
   Lasker SS, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5348
   Li L, 2015, J PHARMACOL SCI, V127, P244, DOI 10.1016/j.jphs.2014.12.001
   Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009
   Limaye PV, 2003, MOL CELL BIOCHEM, V243, P147, DOI 10.1023/A:1021620414979
   Luchsinger Jose A, 2006, Sci Aging Knowledge Environ, V2006, ppe19, DOI 10.1126/sageke.2006.10.pe19
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538
   Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021
   Ontawong A, 2019, PHYTOMEDICINE, V52, P187, DOI 10.1016/j.phymed.2018.06.021
   Prodanovic R, 2016, RES VET SCI, V107, P16, DOI 10.1016/j.rvsc.2016.04.007
   Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153
   Quine SD, 2005, PHARMACOL REP, V57, P610
   Ramirez-Coronel MAN, 2004, J AGR FOOD CHEM, V52, P1344, DOI 10.1021/jf035208t
   Samovski D, 2015, DIABETES, V64, P353, DOI 10.2337/db14-0582
   Sayiner M, 2016, CLIN LIVER DIS, V20, P205, DOI 10.1016/j.cld.2015.10.001
   Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3
   Spangenburg EE, 2009, MOL CELL BIOCHEM, V332, P225, DOI 10.1007/s11010-009-0195-1
   Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882
   Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194
   Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200
   Tsuchiya T, 1996, BIOSCI BIOTECH BIOCH, V60, P765, DOI 10.1271/bbb.60.765
   Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x
   Wallace A, 2003, BRIT MED J, V327, P788, DOI 10.1136/bmj.327.7418.788
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001
   WHO, 2017, OB OV FACTSH
   Yang XY, 2016, CAN J PHYSIOL PHARM, V94, P1336, DOI 10.1139/cjpp-2016-0295
   Yin MH, 2017, J VASC RES, V54, P123, DOI 10.1159/000464288
   Yu HW, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-4
   Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037
NR 55
TC 21
Z9 22
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD MAR
PY 2019
VL 54
BP 568
EP 577
DI 10.1016/j.jff.2019.02.011
PG 10
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA HQ8RN
UT WOS:000462693100060
DA 2025-04-28
ER

PT J
AU Zhang, Y
   Liu, ZP
   Choudhury, T
   Cornelis, MC
   Liu, WQ
AF Zhang, Yang
   Liu, Zhipeng
   Choudhury, Tasnim
   Cornelis, Marilyn C.
   Liu, Wanqing
TI Habitual coffee intake and risk for nonalcoholic fatty liver disease: a
   two-sample Mendelian randomization study
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Coffee; Nonalcoholic fatty liver disease (NAFLD); Causal effect;
   Mendelian randomization; Genome-wide association study (GWAS)
ID CONSUMPTION; CAFFEINE; OBESITY; BIAS
AB Purpose Epidemiological studies support a protective role of habitual coffee and caffeine consumption against the risk of non-alcoholic fatty liver disease (NAFLD). We aimed to investigate the causal relationship between coffee intake and the risk of NAFLD. Methods We performed a two-sample Mendelian randomization (MR) analysis using SNPs associated with habitual coffee intake in a published genome-wide association study (GWAS) as genetic instruments and summary-level data from a published GWAS of NAFLD (1122 cases and 399,900 healthy controls) in the UK Biobank. The causal relationship was estimated with the inverse weighted method using a 4-SNP and 6-SNP instrument based on the single largest non-UK Biobank GWAS (n = 91,462) and meta-analysis (n = 121,524) of GWAS data on habitual coffee intake, respectively. To maximize power, we also used up to 77 SNPs associated with coffee intake at a liberal significance level (p <= 1e-4) as instruments. Results We observed a non-significant trend towards a causal protective effect of coffee intake on NAFLD based upon either the 4-SNP (OR: 0.76; 95% CI 0.51, 1.14,p = 0.19) or 6-SNP genetic instruments (OR: 0.77; 95% CI 0.48, 1.25,p = 0.29). The result also remains non-significant when using the more liberal 77-SNP instrument. Conclusion Our findings do not support a causal relationship between coffee intake and NAFLD risk. However, despite the largest-to-date sample size, the power of this study may be limited by the non-specificity and moderate effect size of the genetic alleles on coffee intake.
C1 [Zhang, Yang; Choudhury, Tasnim; Liu, Wanqing] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Detroit, MI 48202 USA.
   [Liu, Zhipeng] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.
   [Cornelis, Marilyn C.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Liu, Wanqing] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48202 USA.
   [Liu, Wanqing] Wayne State Univ, Integrat Biosci Ctr, Room 2401,6135 Woodward Ave, Detroit, MI 48202 USA.
C3 Wayne State University; Purdue University System; Purdue University;
   Northwestern University; Feinberg School of Medicine; Wayne State
   University; Wayne State University
RP Liu, WQ (corresponding author), Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Detroit, MI 48202 USA.; Liu, WQ (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48202 USA.; Liu, WQ (corresponding author), Wayne State Univ, Integrat Biosci Ctr, Room 2401,6135 Woodward Ave, Detroit, MI 48202 USA.
EM wliu@wayne.edu
RI LIU, ZHIPENG/GWQ-5972-2022; Liu, Zhipeng/AIB-6246-2022
OI Liu, Zhipeng/0000-0001-7159-5038; Zhang, Yang/0000-0001-7462-2935
FU NIH/NIDDK Grant [R01DK106540]; Office of Vice President for Research of
   Wayne State University
FX This study is supported in part by the NIH/NIDDK Grant (R01DK106540)
   (W.L.), and the start-up fund of the Office of Vice President for
   Research of Wayne State University (W.L.).
CR Arauz J, 2017, NUTR RES, V40, P65, DOI 10.1016/j.nutres.2017.03.008
   Bajaj JS, 2018, HEPATOLOGY, V68, P234, DOI 10.1002/hep.29791
   Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965
   Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080
   Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998
   Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Caro-Gómez E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030497
   Chen YP, 2019, CLIN NUTR, V38, P2552, DOI 10.1016/j.clnu.2018.11.030
   Choi B, 2017, FOOD SCI BIOTECHNOL, V26, P921, DOI 10.1007/s10068-017-0144-9
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101343
   Georgiou Andrea N, 2021, Inflamm Bowel Dis, V27, P162, DOI 10.1093/ibd/izaa152
   Hosseinabadi S, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2019.102290
   Jang YJ, 2018, FOOD FUNCT, V9, P1102, DOI [10.1039/c7fo01683b, 10.1039/C7FO01683B]
   Jeznach-Steinhagen A, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55050166
   Jung S, 2017, J MED FOOD, V20, P626
   Liu ZP, 2020, J HEPATOL, V73, P263, DOI 10.1016/j.jhep.2020.03.006
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Lu H, 2020, MULT SCLER RELAT DIS, V44, DOI 10.1016/j.msard.2020.102300
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Metro D, 2017, J CLIN TRANSL ENDOCR, V10, P22, DOI 10.1016/j.jcte.2017.10.001
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Espíndola KMM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00541
   Nicolopoulos K, 2020, CLIN NUTR, V39, P3467, DOI 10.1016/j.clnu.2020.03.009
   Nishitsuji K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34571-9
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Paternoster L, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006944
   Perdomo CM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030677
   Qian Y, 2020, ANN NEUROL, V87, P525, DOI 10.1002/ana.25693
   Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Seo HY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070863
   Shokouh P, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101547
   Shokouh P, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010006
   Sidoryk K, 2018, MOLECULES, V23, DOI 10.3390/molecules23092199
   Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753
   Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009
   Suárez M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101052
   Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Vitaglione P, 2019, J NUTR SCI, V8, DOI 10.1017/jns.2019.10
   Wang TG, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0862-0
   Wijarnpreecha K, 2017, EUR J GASTROEN HEPAT, V29, pE8, DOI 10.1097/MEG.0000000000000776
   Yavorska OO, 2017, INT J EPIDEMIOL, V46, P1734, DOI 10.1093/ije/dyx034
   Zheng Jie, 2017, Curr Epidemiol Rep, V4, P330, DOI 10.1007/s40471-017-0128-6
   Zhong VW, 2019, HUM MOL GENET, V28, P2449, DOI 10.1093/hmg/ddz061
   Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y
NR 48
TC 43
Z9 44
U1 3
U2 23
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN
PY 2021
VL 60
IS 4
BP 1761
EP 1767
DI 10.1007/s00394-020-02369-z
EA AUG 2020
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA SF0TU
UT WOS:000563227600001
PM 32856188
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Lopez, DS
   Advani, S
   Qiu, XT
   Tsilidis, KK
   Khera, M
   Kim, J
   Canfield, S
AF Lopez, David S.
   Advani, Shailesh
   Qiu, Xueting
   Tsilidis, Konstantinos K.
   Khera, Mohit
   Kim, Jeri
   Canfield, Steven
TI Caffeine intake is not associated with serum testosterone levels in
   adult men: cross-sectional findings from the NHANES 1999-2004 and
   2011-2012
SO AGING MALE
LA English
DT Article
DE Caffeine intake; testosterone; race/ethnicity; obesity
ID PROSTATE-CANCER; RACIAL/ETHNIC DIFFERENCES; HORMONE CONCENTRATIONS;
   CONSUMPTION; RESPONSES; OBESITY; RISK
AB Objective: The association of caffeine intake with testosterone remains unclear. We evaluated the association of caffeine intake with serum testosterone among American men and determined whether this association varied by race/ethnicity and measurements of adiposity. Methods: Data were analyzed for 2581 men (>= 20 years old) who participated in the cycles of the NHANES 1999-2004 and 2011-2012, a cross-sectional study. Testosterone (ng/mL) was measured by immunoassay among men who participated in the morning examination session. We analyzed 24-h dietary recall data to estimate caffeine intake (mg/day). Multivariable weighted linear regression models were conducted. Results: We identified no linear relationship between caffeine intake and testosterone levels in the total population, but there was a non-linear association (p(nonlinearity) < .01). Similarly, stratified analysis showed nonlinear associations among Mexican-American and Non-Hispanic White men (p(nonlinearity) <= .03 both) and only among men with waist circumference <102 cm and body mass index <25 kg/m(2) (p(nonlinearity) < .01, both). Conclusion: No linear association was identified between levels of caffeine intake and testosterone in US men, but we observed a non-linear association, including among racial/ethnic groups and measurements of adiposity in this cross-sectional study. These associations are warranted to be investigated in larger prospective studies.
C1 [Lopez, David S.; Advani, Shailesh; Qiu, Xueting] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA.
   [Lopez, David S.; Canfield, Steven] UTHlth McGovern Med Sch, Div Urol, Houston, TX USA.
   [Advani, Shailesh] Georgetown Univ, Div Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA.
   [Tsilidis, Konstantinos K.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina, Greece.
   [Tsilidis, Konstantinos K.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.
   [Khera, Mohit] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA.
   [Kim, Jeri] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.
C3 University of Texas System; University of Texas Health Science Center
   Houston; University of Texas School Public Health; Georgetown
   University; University of Ioannina; Imperial College London; Baylor
   College of Medicine; University of Texas System; UTMD Anderson Cancer
   Center
RP Lopez, DS (corresponding author), Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, 1200 Herman Pressler,Suite E-629, Houston, TX 77030 USA.
EM david.s.lopez@uth.tmc.edu
RI Advani, Shailesh/AAA-2812-2020
OI Tsilidis, Konstantinos/0000-0002-8452-8472; Lopez, David
   S./0000-0002-2321-0372
CR Ahuja J, 2012, USDA food and nutrient database for dietary studies, 5.0
   Allott EH, 2013, EUR UROL, V63, P800, DOI 10.1016/j.eururo.2012.11.013
   [Anonymous], 1994, Vital Health Stat 1, P1
   [Anonymous], LAB DIAGNOSIS TESTOS
   Beaven CM, 2008, INT J SPORT NUTR EXE, V18, P131, DOI 10.1123/ijsnem.18.2.131
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   Donald C.M.C., 2017, International Journal of Exercise Science, V10, P108
   Drewnowski A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030154
   Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050
   GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005
   Hsieh CC, 1998, J CLIN EPIDEMIOL, V51, P837, DOI 10.1016/S0895-4356(98)00069-9
   Khera M, 2016, J SEX MED, V13, P1787, DOI 10.1016/j.jsxm.2016.10.009
   Lopez DS, 2018, ENERG BALANCE CANCER, V14, P21, DOI 10.1007/978-3-319-64940-5_2
   Lopez DS, 2018, AM J EPIDEMIOL, V187, P951, DOI 10.1093/aje/kwx304
   Lopez DS, 2017, INT J ENDOCRINOL MET, V15, DOI 10.5812/ijem.44926
   Lopez DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123547
   Lopez DS, 2013, CANCER CAUSE CONTROL, V24, P817, DOI 10.1007/s10552-013-0154-8
   National Center for Health Statistics, NAT HLTH NUTR EX SUR
   Nyante SJ, 2012, INT J ANDROL, V35, P456, DOI 10.1111/j.1365-2605.2011.01230.x
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Park M, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/368475
   León-Carmona JR, 2011, J PHYS CHEM B, V115, P4538, DOI 10.1021/jp201383y
   Rohrmann S, 2007, J CLIN ENDOCR METAB, V92, P2519, DOI 10.1210/jc.2007-0028
   Rohrmann S, 2011, CANCER CAUSE CONTROL, V22, P1141, DOI 10.1007/s10552-011-9790-z
   Strom SS, 2008, PROSTATE, V68, P563, DOI 10.1002/pros.20713
   Svartberg J, 2003, EUR J ENDOCRINOL, V149, P145, DOI 10.1530/eje.0.1490145
   Vesper HW, 2015, CLIN CHEM, V61, P1495, DOI 10.1373/clinchem.2015.245969
   Wedick NM, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-86
   Wendell CR, 2016, NEUROPSYCHOLOGY, V30, P980, DOI 10.1037/neu0000298
   Wilson KM, 2011, JNCI-J NATL CANCER I, V103, P876, DOI 10.1093/jnci/djr151
   Wu BH, 2015, J SPORT MED PHYS FIT, V55, P1242
NR 33
TC 4
Z9 4
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1368-5538
EI 1473-0790
J9 AGING MALE
JI Aging Male
PD JAN 2
PY 2019
VL 22
IS 1
BP 45
EP 54
DI 10.1080/13685538.2018.1465912
PG 10
WC Endocrinology & Metabolism; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Urology & Nephrology
GA HH8RL
UT WOS:000455999800007
PM 29692226
OA Green Submitted
DA 2025-04-28
ER

PT J
AU de Araújo, MFM
   Gaspar, MWG
   Veras, VS
   de Freitas, RWF
   Paula, MD
   Serra, MAAD
   Neto, JCGL
   Damasceno, MMC
   Moreira, AVB
   de Mello, VD
AF Moura de Araujo, Marcio Flavio
   Gueiros Gaspar, Maria Wendiane
   Veras, Vivian Saraiva
   Freire de Freitas, Roberto Wagner Junior
   Paula, Maria do Livramento
   Alves de Oliveira Serra, Maria Aparecida
   Garcia Lira Neto, Jose Claudio
   Coelho Damasceno, Marta Maria
   Bandeira Moreira, Ana Vladia
   de Mello, Vanessa Derenji
TI Consumption of caffeinated and decaffeinated coffee enriched with cocoa
   and fructo-oligosaccharides among non-diabetic persons: Double blind
   randomized clinical trial
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article
DE body composition; cacao; caffeine; coffee; glycemic control
ID MINI-MENTAL-STATE; METABOLIC RISK; OBESITY; ENERGY
AB Food industry has been investing in bringing to the market coffee-based drinks enriched in compounds that promise weight loss, which consequently influences diabetes risk. However, there are no clinical trials showing the effects of brewed coffee (with or without caffeine) enriched with bioactive compounds on body fat and glycemic control in healthy individuals. Therefore, we have evaluated the effect of consuming two coffee formulas enriched with cocoa and fructo-oligosaccharides (FOS) on glycemic and anthropometric biomarkers and blood pressure in non-diabetic adults for 10 weeks. In general, we observed that the values of fasting plasma glucose (FPG) (p = .006) and fasting capillary blood glucose (FCBG) (p < .001) had lower values with a tendency to decrease in FCG (p = .003) and FBG (p < .005) in both formulas. We observed statistically significant reductions in waist circumference (WC) (p = .012), arm circumference (AC) (p = .015), and percentage of fat (<0.0001) for all participants. However, we noticed a greater reduction in the caffeinated formula group (-2.92%, p = .005) compared to the decaffeinated formula (-1.62%, p = .008). Consumers of both cocoa and FOS-enriched coffee formulas benefited from reduced FBG, FCG, WC, and body fat percentage. The consumption of caffeinated formula was more effective in reducing the percentage of fat, while the decaffeinated formula was more effective in reducing diastolic blood pressure. Practical applications This study provides robust evidence that effects of fortified coffee on non-diabetic people is positive for reduction in blood glucose, body fat and diastolic blood pressure. This study proposes a practical and safe coffee formulation for the consumption of caffeinated and decaffeinated coffee for non-diabetic people.
C1 [Moura de Araujo, Marcio Flavio; Freire de Freitas, Roberto Wagner Junior] Fundacao Oswaldo Cruz, Hlth Family, Eusebio, Brazil.
   [Gueiros Gaspar, Maria Wendiane; Veras, Vivian Saraiva] Univ Int Integrat Lusophony Afro Brazilian, Nursing Dept, Redencao, Brazil.
   [Paula, Maria do Livramento] Univ Maranhao, Pharm Dept, Sao Luis, Maranhao, Brazil.
   [Alves de Oliveira Serra, Maria Aparecida] Univ Fed Maranhao, Nursing Dept, Imperatriz, Brazil.
   [Garcia Lira Neto, Jose Claudio] Univ Ribeirao Preto, Med Dept, Ribeirao Preto, Brazil.
   [Coelho Damasceno, Marta Maria] Univ Fed Ceara, Nursing Dentist & Pharm Fac, Nursing Dept, Fortaleza, Ceara, Brazil.
   [Bandeira Moreira, Ana Vladia] Univ Fed Juiz de Fora, Nutr Dept, Juiz De Fora, Brazil.
   [de Mello, Vanessa Derenji] Eastern Univ Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.
C3 Fundacao Oswaldo Cruz; Universidade Federal do Maranhao; Universidade de
   Ribeirao Preto; Universidade Federal do Ceara; Universidade Federal de
   Juiz de Fora
RP de Araújo, MFM (corresponding author), Fundacao Oswaldo Cruz, Rua Sao Jose S-N, BR-61760000 Eusebio, Brazil.
EM marcio.moura@fiocruz.br
RI Araújo, Márcio/GPC-7993-2022; Garcia Lira Neto, José
   Claudio/AFA-3224-2022; Coelho, Marta/HNP-0966-2023; Freitas,
   Roberto/AAQ-7055-2020; Moura de Araujo, Marcio Flavio/A-4244-2013;
   Oliveira Serra, Maria Aparecida Alves de/AAC-5295-2019
OI Garcia Lira Neto, Jose Claudio/0000-0003-2777-1406; Moura de Araujo,
   Marcio Flavio/0000-0001-8832-8323; de Mello,
   Vanessa/0000-0003-3414-6983; Oliveira Serra, Maria Aparecida Alves
   de/0000-0003-0952-9560; Freitas, Roberto/0000-0001-9295-1177; GUEIROS
   GASPAR, MARIA WENDIANE/0000-0003-1452-7180; Saraiva Veras,
   Vivian/0000-0003-3267-3712
FU Brazilian National Council for Scientific and Technological Development
   (CNPq) [421316/2018-7]
FX Brazilian National Council for Scientific and Technological Development
   (CNPq), Grant/Award Number: 421316/2018-7
CR [Anonymous], 2018, Statistics about diabetes
   Barengolts E, 2016, ENDOCR PRACT, V22, P1224, DOI 10.4158/EP151157.RA
   Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014
   Canela M. D., 2009, Nutrire - Revista da Sociedade Brasileira de Alimentacao e Nutricao, V34, P143
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Cavalcante J W, 2000, Arq Bras Cardiol, V75, P97
   Cerdó T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030635
   Chrysant SG, 2017, EXPERT REV CARDIOVAS, V15, P151, DOI 10.1080/14779072.2017.1287563
   Cozzolino F., 2012, Recent Pat Eng, V6, P2
   Cropley V, 2012, PSYCHOPHARMACOLOGY, V219, P737, DOI 10.1007/s00213-011-2395-0
   Desch S, 2010, AM J HYPERTENS, V23, P97, DOI 10.1038/ajh.2009.213
   Dewar L, 2017, DIAB MET SYND CLIN R, V11, pS631, DOI 10.1016/j.dsx.2017.04.017
   Encarnacao R O., 2003, Cafe saude humana
   Figueiredo D.M., 2018, J NURSING HLTH SCI, V4, P1
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Hauschild SD, 2018, RBONE-REV BRAS OBES, V12, P851
   Higashi Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092104
   Hoffman Jay R, 2006, J Int Soc Sports Nutr, V3, P35, DOI 10.1186/1550-2783-3-1-35
   Latham LS, 2014, J CLIN HYPERTENS, V16, P101, DOI 10.1111/jch.12223
   Latif R, 2013, CURR OPIN CLIN NUTR, V16, P669, DOI 10.1097/MCO.0b013e328365a235
   Lima R.C.A., 2018, SANARE, V17, P56
   Loureiro L.M.R., 2020, THESIS U BRASILIA
   Matsudo S, 2001, Rev bras ativ fis saude, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18
   Neeland IJ, 2013, OBESITY, V21, pE439, DOI [10.1038/oby.20135, 10.1002/oby.20135]
   Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132
   Paiva C.L.R.S., 2018, THESIS U BRASILIA
   Passos Luciana Maria Liboni, 2003, Cienc. Rural, V33, P385, DOI 10.1590/S0103-84782003000200034
   Pérez-Pevida B, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1787-5
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Preis SR, 2010, J CLIN ENDOCR METAB, V95, P3701, DOI 10.1210/jc.2009-1779
   Ribeiro Aída Calvão, 2006, Rev. Nutr., V19, P553, DOI 10.1590/S1415-52732006000500003
   Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39
   Saad S.M.I., 2011, PROBIOTICS PREBIOTIC
   Saeed M, 2019, CRIT REV FOOD SCI, V59, P3293, DOI 10.1080/10408398.2018.1489368
   Saldanha L.A., 2012, EFEITOS INGESTAO CAF
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Shearer J, 2014, NUTR REV, V72, P121, DOI 10.1111/nure.12124
   Shi XQ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0220-7
   Silva D., 2007, Nutrire Rev. Soc. Bras. Aliment, V32, P41
   Smith C, 2009, CARDIOVASC J AFR, V20, P178
   Sociedade Brasileira de Cardiologia, 2016, 7 BRAZ GUID ART HYP
   Sociedade Brasileira de Diabetes, 2018, DIR SOC BRAS DIAB
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Trabal J, 2015, NUTR REV, V73, P624, DOI 10.1093/nutrit/nuv023
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Zaharieva DP, 2013, APPL PHYSIOL NUTR ME, V38, P813, DOI 10.1139/apnm-2012-0471
NR 49
TC 2
Z9 2
U1 3
U2 11
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD MAY
PY 2022
VL 46
IS 5
AR e14081
DI 10.1111/jfbc.14081
EA JAN 2022
PG 12
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 1H9CX
UT WOS:000745346100001
PM 35064574
OA gold
DA 2025-04-28
ER

PT J
AU Mullin, GE
AF Mullin, Gerard E.
TI Supplements for Weight Loss: Hype or Help for Obesity? Part II. The
   Inside Scoop on Green Coffee Bean Extract
SO NUTRITION IN CLINICAL PRACTICE
LA English
DT Article
ID LONG-TERM; OVERWEIGHT; MEN
C1 Johns Hopkins Univ Hosp, Baltimore, MD 21205 USA.
C3 Johns Hopkins University; Johns Hopkins Medicine
RP Mullin, GE (corresponding author), Johns Hopkins Univ Hosp, 600 N Wolfe St,Carnegie 464, Baltimore, MD 21205 USA.
EM gmullin1@jhmi.edu
RI Mullin, Gerry/H-5294-2019
OI Mullin, Gerard/0000-0001-5317-6788
CR Anese M, 2014, FOOD CHEM, V145, P168, DOI 10.1016/j.foodchem.2013.08.047
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Hausenblas H, 2014, NAT MED J, V6
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Mullin GE, 2014, NUTR CLIN PRACT, V29, P842, DOI 10.1177/0884533614552852
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Phillip A., 2014, The Washington Post
   Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   St-Onge MP, 2012, OBESITY, V20, P343, DOI 10.1038/oby.2011.289
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
NR 15
TC 1
Z9 1
U1 0
U2 62
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-5336
EI 1941-2452
J9 NUTR CLIN PRACT
JI Nutr. Clin. Pract.
PD APR
PY 2015
VL 30
IS 2
BP 311
EP 312
DI 10.1177/0884533615572655
PG 2
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CF3ZM
UT WOS:000352487800019
PM 25757951
DA 2025-04-28
ER

PT J
AU Sonestedt, E
   Lukic, M
AF Sonestedt, Emily
   Lukic, Marko
TI Beverages - a scoping review for Nordic Nutrition Recommendations 2023
SO FOOD & NUTRITION RESEARCH
LA English
DT Review
DE beverages; coffee; tea; sugar-sweetened beverages; sweeteners; dietary
   guidelines
ID DOSE-RESPONSE METAANALYSIS; HABITUAL COFFEE CONSUMPTION; CALORIE
   SWEETENED BEVERAGES; TYPE-2 DIABETES-MELLITUS; TEA CONSUMPTION;
   CARDIOVASCULAR-DISEASE; CAFFEINE CONSUMPTION; PARKINSONS-DISEASE;
   CHLOROGENIC ACIDS; PREGNANCY LOSS
AB Background : Coffee, tea, sugar -sweetened beverages (SSBs), and low- and no -calorie sweetened beverages (LNCSBs) are generally frequently consumed in the Nordic and Baltic countries. These beverages have also been related to potential health effects. This scoping review describes the evidence for the role of coffee, tea, SSBs, and LNCSBs for health -related outcomes as a basis for setting and updating food -based dietary guidelines. We used evidence from several qualified systematic reviews (i.e. World Cancer Research Fund, US Dietary Guidelines Advisory Committee, European Food Safety Authority, and World Health Organization) and performed a search for additional systematic reviews. The evidence suggests that moderate coffee and tea consumption do not have long-term adverse health effects. The long-term favorable effects of coffee consumption are related to reduced risk of endometrial and liver cancer, type 2 diabetes, and cardiovascular deaths. However, results from randomized controlled trials (RCTs) suggest that coffee brews that are rich in diterpenes, such as boiled coffee, increase serum cholesterol concentrations. High caffeine intake in pregnancy is associated with higher risk of pregnancy loss, preterm birth, and low birth weight. High consumption of SSBs has been associated with increased risk of obesity, type 2 diabetes, hypertension, and cardiovascular disease, based on data from RCTs and prospective cohort studies. The consumption of LNCSBs may result in a small reduction in body weight in adults, likely mediated through the effect of reduced energy intake, but has neutral effects on other cardiometabolic risk markers using evidence from RCTs. However, evidence from observational studies indicates increased risk of cardiometabolic diseases among high LNCSB consumers. In conclusion, current evidence suggests that moderate coffee and tea consumption have no long-term adverse health effects. The evidence of beneficial effects of coffee consumption on liver and endometrial cancer risk, and some cardiovascular outcomes, comes from observational studies. High consumption of boiled coffee should be avoided due to negative effect on lipid profile. Pregnant women should not exceed the recommended daily dose of caffeine intake of 200 mg set by the European Food Safety Authority as a safe level for the fetus. High consumption of SSBs has consistently been associated with adverse health effects, which is mainly due to excess energy intake, and should be limited. The conflicting results from RCTs and observational studies regarding LNCSBs may be due to revere causation and should be explored further.
C1 [Sonestedt, Emily] Lund Univ, Dept Clin Sci Malmo, Jan Waldenstroms gata 35, S-21428 Malmo, Sweden.
   [Lukic, Marko] UiT The Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway.
C3 Lund University; UiT The Arctic University of Tromso
RP Sonestedt, E (corresponding author), Lund Univ, Dept Clin Sci Malmo, Jan Waldenstroms gata 35, S-21428 Malmo, Sweden.
EM emily.sonestedt@med.lu.se
RI Sonestedt, Emily/I-3814-2016
CR Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   Aguilar F, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3496
   [Anonymous], 2017, Diet, nutrition, physical activity and colorectal cancer
   [Anonymous], 2020, Scientific Report of the 2020 Dietary Guidelines Advisory Committee: Advisory Report to the Secretary of Agriculture and Secretary of Health and Human Services, DOI DOI 10.52570/DGAC2020
   Asbaghi O, 2021, DIABETES METAB SYND, V15, P23, DOI 10.1016/j.dsx.2020.11.004
   Azam Sonish, 2003, Med Sci Monit, V9, pBR325
   Bhardwaj P, 2013, CHIN J NAT MEDICINES, V11, P345, DOI 10.1016/S1875-5364(13)60051-5
   Blomhoff R., 2023, Nordic Nutrition Recommendations 2023: Integrating Environmental Aspects
   Borrelli RC, 2002, J AGR FOOD CHEM, V50, P6527, DOI 10.1021/jf025686o
   Brown OI, 2016, CORONARY ARTERY DIS, V27, P566, DOI 10.1097/MCA.0000000000000397
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7
   Chen LW, 2016, PUBLIC HEALTH NUTR, V19, P1233, DOI 10.1017/S1368980015002463
   Cheungpasitporn W, 2015, CLIN EXP HYPERTENS, V37, P587, DOI 10.3109/10641963.2015.1026044
   Chin JM, 2008, J ANAL TOXICOL, V32, P702, DOI 10.1093/jat/32.8.702
   Christensen JJ, 2020, FOOD NUTR RES, V64, DOI 10.29219/fnr.v64.4402
   Chung M, 2020, ADV NUTR, V11, P790, DOI 10.1093/advances/nmaa010
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T
   Costa J, 2010, J ALZHEIMERS DIS, V20, pS221, DOI 10.3233/JAD-2010-091525
   D'Elia L, 2019, EUR J NUTR, V58, P271, DOI 10.1007/s00394-017-1591-z
   Deng YY, 2022, HEPATOL COMMUN, V6, P2147, DOI 10.1002/hep4.1960
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Du YB, 2020, NUTR METAB CARDIOVAS, V30, P2159, DOI 10.1016/j.numecd.2020.08.017
   EFSA Panel on Nutrition Novel Foods and Food Allergens, 2022, EFSA J, V20, P337
   EFSA Panel on Nutrition Novel Foods and Food Allergens (NDA), 2022, EFSA J, V20, pAnn, DOI DOI 10.2903/J.EFSA.2022.7074
   Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Grosso G, 2016, MOL NUTR FOOD RES, V60, P223, DOI 10.1002/mnfr.201500620
   Han MJ, 2022, J KOREAN MED SCI, V37, DOI 10.3346/jkms.2022.37.e332
   Herforth A, 2019, ADV NUTR, V10, P590, DOI 10.1093/advances/nmy130
   Hernán MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   Hong CT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061860
   Hoyer A, 2021, FOOD NUTR RES, V65, DOI 10.29219/fnr.v65.7828
   Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576
   Institute of Medicine (U.S.). Committee on Military Nutrition Research, 2001, Caffeine for the sustainment of mental task performance: formulations for military operations, pxiv
   IOM Institute of Medicine (IOM), 2014, CAFF FOOD DIET SUPPL
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jin F, 2021, INT J OBESITY, V45, P279, DOI 10.1038/s41366-020-0617-4
   Kennedy OJ, 2016, ALIMENT PHARM THER, V43, P562, DOI 10.1111/apt.13523
   Kim EJ, 2021, JAMA INTERN MED, V181, P1185, DOI 10.1001/jamainternmed.2021.3616
   Kim Y, 2016, ARCH CARDIOVASC DIS, V109, P242, DOI 10.1016/j.acvd.2015.10.005
   Kolb H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041144
   Kositamongkol C, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.786596
   Kwok MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep36500
   Lange KW, 2022, FOOD SCI HUM WELL, V11, P445, DOI 10.1016/j.fshw.2021.12.034
   Larsson SC, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0447-8
   Laurence G, 2012, J SPORT SCI, V30, P1235, DOI 10.1080/02640414.2012.693620
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee JJ, 2022, DIABETES CARE, V45, P1917, DOI 10.2337/dc21-2130
   Lemming EW, 2022, FOOD NUTR RES, V66, DOI 10.29219/fnr.v66.8572
   Li HY, 2022, J PUBLIC HEALTH-UK, V44, P516, DOI 10.1093/pubmed/fdab069
   Li J, 2015, INT J GYNECOL OBSTET, V130, P116, DOI 10.1016/j.ijgo.2015.03.033
   Lin Y, 2020, PHYTOTHER RES, V34, P2459, DOI 10.1002/ptr.6697
   Lippi G, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.06.14
   Liu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142457
   Liu QP, 2016, NUTRITION, V32, P628, DOI 10.1016/j.nut.2015.11.015
   Liu XY, 2017, ONCOTARGET, V8, P43306, DOI 10.18632/oncotarget.17429
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Mahdavi-Roshan M, 2020, COMPLEMENT THER MED, V51, DOI 10.1016/j.ctim.2020.102430
   Malerba S, 2013, EUR J EPIDEMIOL, V28, P527, DOI 10.1007/s10654-013-9834-7
   Maslova E, 2010, AM J CLIN NUTR, V92, P1120, DOI 10.3945/ajcn.2010.29789
   Meng YT, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082636
   Moeenfard M, 2015, INT J FOOD PROP, V18, P2284, DOI 10.1080/10942912.2014.933351
   Mostofsky E, 2012, CIRC-HEART FAIL, V5, P401, DOI 10.1161/CIRCHEARTFAILURE.112.967299
   Nordestgaard AT, 2022, ATHEROSCLEROSIS, V348, P36, DOI 10.1016/j.atherosclerosis.2022.03.022
   NordicCouncil of Ministers, 2014, NordicNutrition Recommendations 2012-intergrating nutrition and physical activity, V5
   Norwegian Director of Health, 2014, Norwegian Guidelines on diet, nutrition and physical activity
   Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687
   Nunes CB, 2023, INT J EPIDEMIOL, V52, P165, DOI 10.1093/ije/dyac121
   van Oort S, 2020, AM HEART J, V227, P64, DOI 10.1016/j.ahj.2020.06.007
   Osama H, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13983
   Pan A, 2011, CURR OPIN CLIN NUTR, V14, P385, DOI 10.1097/MCO.0b013e328346df36
   Pan B, 2022, CRIT REV FOOD SCI, V62, P8908, DOI 10.1080/10408398.2021.1937040
   Parras P, 2007, FOOD CHEM, V102, P582, DOI 10.1016/j.foodchem.2006.05.037
   Peng XL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06251
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Qian Y, 2020, ANN NEUROL, V87, P525, DOI 10.1002/ana.25693
   Qin P, 2020, EUR J EPIDEMIOL, V35, P655, DOI 10.1007/s10654-020-00655-y
   Rhee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132334
   Rios-Leyvraz M., 2022, HLTH EFFECTS USE NON
   Rogers PJ, 2013, PSYCHOPHARMACOLOGY, V226, P229, DOI 10.1007/s00213-012-2889-4
   Rustan AC, 1997, ARTERIOSCL THROM VAS, V17, P2140, DOI 10.1161/01.ATV.17.10.2140
   Said MA, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016808
   Shahinfar H, 2021, NUTR METAB CARDIOVAS, V31, P2526, DOI 10.1016/j.numecd.2021.05.014
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Swedish National Food Agency, Sweden's dietary guidelines: 'Find yourway to eat greener, not too much and to be active!'
   Sylvetsky AC, 2016, PHYSIOL BEHAV, V164, P446, DOI 10.1016/j.physbeh.2016.03.030
   Tang J, 2015, BRIT J NUTR, V114, P673, DOI 10.1017/S0007114515002329
   Tfouni SAV, 2014, INT J FOOD SCI TECH, V49, P747, DOI 10.1111/ijfs.12361
   Unesda-soft drinks Europe, Sales and consumption
   Urgert R, 1997, ANNU REV NUTR, V17, P305, DOI 10.1146/annurev.nutr.17.1.305
   van Oort S, 2020, HYPERTENSION, V76, P1971, DOI 10.1161/HYPERTENSIONAHA.120.15761
   Wang LF, 2016, AUST NZ J PSYCHIAT, V50, P228, DOI 10.1177/0004867415603131
   Wijarnpreecha K, 2017, EUR J GASTROEN HEPAT, V29, pE8, DOI 10.1097/MEG.0000000000000776
   Xie C, 2018, J HUM HYPERTENS, V32, P83, DOI 10.1038/s41371-017-0007-0
   Xu ZC, 2021, J FUNCT FOODS, V81, DOI 10.1016/j.jff.2021.104482
   Yang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005632
   Yin JW, 2021, ADV NUTR, V12, P89, DOI 10.1093/advances/nmaa084
   Yuan S, 2022, EUR J EPIDEMIOL, V37, P723, DOI 10.1007/s10654-022-00868-3
   Yuan S, 2021, FERTIL STERIL, V116, P1061, DOI 10.1016/j.fertnstert.2021.05.103
   Yuan S, 2021, NUTRIENTS, V13, DOI 10.3390/nu13072218
   Yuan S, 2019, NUTR METAB CARDIOVAS, V29, P1185, DOI 10.1016/j.numecd.2019.07.015
   Zhang YB, 2021, ADV NUTR, V12, P374, DOI 10.1093/advances/nmaa110
   Zhang Y, 2021, EUR J NUTR, V60, P1761, DOI 10.1007/s00394-020-02369-z
   Zhang ZZ, 2021, J ALZHEIMERS DIS, V83, P1815, DOI 10.3233/JAD-210678
   Zhen C, 2019, NEUROL ASIA, V24, P31
   Zheng MB, 2015, J ACAD NUTR DIET, V115, P767, DOI 10.1016/j.jand.2015.01.006
   Zhong VW, 2019, HUM MOL GENET, V28, P2449, DOI 10.1093/hmg/ddz061
   Zhou A, 2021, CLIN NUTR, V40, P4404, DOI 10.1016/j.clnu.2020.12.042
NR 112
TC 4
Z9 4
U1 1
U2 6
PU SWEDISH NUTRITION FOUNDATION-SNF
PI LUND
PA IDEON SCIENCE PARK, BESOK SCHEELEV 17 BETA 5, 3V, LUND, 223 70, SWEDEN
SN 1654-6628
EI 1654-661X
J9 FOOD NUTR RES
JI Food Nutr. Res.
PD APR 2
PY 2024
VL 68
AR 10458
DI 10.29219/fnr.v68.10458
PG 13
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA QT1J7
UT WOS:001223026800001
PM 38571923
OA gold
DA 2025-04-28
ER

PT J
AU Kotyczka, C
   Boettler, U
   Lang, R
   Stiebitz, H
   Bytof, G
   Lantz, I
   Hofmann, T
   Marko, D
   Somoza, V
AF Kotyczka, Christine
   Boettler, Ute
   Lang, Roman
   Stiebitz, Herbert
   Bytof, Gerhard
   Lantz, Ingo
   Hofmann, Thomas
   Marko, Doris
   Somoza, Veronika
TI Dark roast coffee is more effective than light roast coffee in reducing
   body weight, and in restoring red blood cell vitamin E and glutathione
   concentrations in healthy volunteers
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Antioxidant activity; Body weight loss; Coffee; Superoxide dismutase;
   Vitamin E
ID ANTIOXIDANT PROPERTIES; OXIDATIVE STRESS; CHLOROGENIC ACID; IN-VITRO;
   CONSUMPTION; CANCER; RISK
AB Recent results from prospective cohort studies have shown that moderate coffee consumption is associated with a reduced risk for diabetes mellitus type II or Alzheimer's disease. Since reactive oxygen species (ROS) are believed to be involved in the pathogenesis of these diseases, antioxidants in coffee might contribute to this risk reduction. We aimed at elucidating whether a dark roast coffee beverage (CB) rich in N-methylpyridinium ions (NMP: 785 mu mol/L) and low in chlorogenic acids (CGA: 523 mu mol/L) has stronger antioxidant effects on human erythrocytes than a CB prepared from a light roast with opposite proportions (CGA: 4538 mu mol/L; NMP: 56 mu mol/L). Following a 2-wk wash out period, 500 mL of the respective CB was administered to 30 subjects daily for 4-wk. Blood and spot urine samples were collected at the beginning and at the end of each intervention. Intake of the dark roast CB most effectively improved the antioxidant status of erythrocytes: superoxide dismutase and glutathione peroxidase activity decreased by 5.8 and 15%, respectively, whereas tocopherol and total glutathione concentrations increased by 41 and 14%, respectively. Furthermore, administration of the NMP-rich CB led to a significant body weight reduction in pre-obese subjects, whereas the CGA-rich CB did not.
C1 [Somoza, Veronika] Univ Vienna, Dept Nutr & Physiol Chem, A-1090 Vienna, Austria.
   [Kotyczka, Christine] Deutsch Forsch Anstalt Lebensmittelchem, Freising Weihenstephan, Germany.
   [Boettler, Ute; Hofmann, Thomas] Univ Vienna, Dept Food Chem & Toxicol, A-1090 Vienna, Austria.
   [Lang, Roman; Marko, Doris] Tech Univ, Lehrstuhl Lebensmittelchem & Mol Sensorik, Freising Weihenstephan, Germany.
   [Stiebitz, Herbert; Bytof, Gerhard; Lantz, Ingo] Tchibo GmbH, Hamburg, Germany.
C3 University of Vienna; Leibniz Association; Leibniz-Institute for Food
   Systems Biology at the Technical University of Munich; University of
   Vienna
RP Somoza, V (corresponding author), Univ Vienna, Dept Nutr & Physiol Chem, Althanstr 14, A-1090 Vienna, Austria.
EM veronika.somoza@univie.ac.at
RI Bytof, Gerhard/GXV-5991-2022; Hofmann, Thomas/O-3346-2015; Somoza,
   Veronika/D-4141-2013; Marko, Doris/B-9354-2014
OI Hofmann, Thomas/0000-0003-4057-7165; Somoza,
   Veronika/0000-0003-2456-9245; Lang, Roman/0000-0003-0610-7186; Marko,
   Doris/0000-0001-6568-2944
FU Federal Ministry of Education and Research (BMBF) [0313843]; Tchibo
   GmbH, Germany
FX Kristin Kahlenberg provided excellent technical assistance for blood
   sample preparation and biochemical analyses. The study was financially
   supported by the Federal Ministry of Education and Research (BMBF),
   grant no. 0313843.The authors H. Stiebitz, G. Bytof, I. Lantz are
   employees of Tchibo GmbH, Germany, the company that sponsored part of
   this research.
CR Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Daglia M, 2004, J AGR FOOD CHEM, V52, P1700, DOI 10.1021/jf030298n
   Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753
   ESPOSITO F, 2003, BIOORGAN MED CHEM, V11, P4797
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Grubben MJAL, 2000, ALIMENT PHARM THER, V14, P1181, DOI 10.1046/j.1365-2036.2000.00826.x
   Hassan HA, 2009, FOOD CHEM TOXICOL, V47, P2332, DOI 10.1016/j.fct.2009.06.023
   Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483
   Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017
   Moreira DP, 2005, J AGR FOOD CHEM, V53, P1399, DOI 10.1021/jf0485436
   Mursu J, 2005, FREE RADICAL BIO MED, V38, P527, DOI 10.1016/j.freeradbiomed.2004.11.025
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   Nicoli MC, 1997, FOOD SCI TECHNOL-LEB, V30, P292, DOI 10.1006/fstl.1996.0181
   OHNISHI M, 1994, PHYTOCHEMISTRY, V36, P579, DOI 10.1016/S0031-9422(00)89778-2
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Somoza V, 2003, J AGR FOOD CHEM, V51, P6861, DOI 10.1021/jf034750e
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Tavani A, 2000, EUR J CANCER PREV, V9, P241, DOI 10.1097/00008469-200008000-00004
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
NR 20
TC 52
Z9 53
U1 0
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD OCT
PY 2011
VL 55
IS 10
BP 1582
EP 1586
DI 10.1002/mnfr.201100248
PG 5
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 841XE
UT WOS:000296547700016
PM 21809439
DA 2025-04-28
ER

PT J
AU Castro, A
   Gili, M
   Visser, M
   Penninx, BWJH
   Brouwer, IA
   Montaño, JJ
   Pérez-Ara, MA
   García-Toro, M
   Watkins, E
   Owens, M
   Hegerl, U
   Kohls, E
   Bot, M
   Roca, M
AF Castro, Adoracion
   Gili, Margalida
   Visser, Marjolein
   Penninx, Brenda W. J. H.
   Brouwer, Ingeborg A.
   Montano, Juan Jose
   Perez-Ara, Maria Angeles
   Garcia-Toro, Mauro
   Watkins, Ed
   Owens, Matt
   Hegerl, Ulrich
   Kohls, Elisabeth
   Bot, Mariska
   Roca, Miquel
TI Soft Drinks and Symptoms of Depression and Anxiety in Overweight
   Subjects: A Longitudinal Analysis of an European Cohort
SO NUTRIENTS
LA English
DT Article
DE depression; anxiety; soft drinks; coffee; tea
ID MENTAL-HEALTH; L-THEANINE; CONSUMPTION; ADULTS; DISORDER; CAFFEINE
AB Background: Studies about the association of carbonated/soft drinks, coffee, and tea with depression and anxiety are scarce and inconclusive and little is known about this association in European adults. Our aim was to examine the association between the consumption of these beverages and depressive and anxiety symptom severity. Methods: A total of 941 European overweight adults (mean age, 46.8 years) with subsyndromal depression that participated in the MooDFOOD depression prevention randomized controlled trial (Clinical Trials.gov identifier: NCT2529423; date of the study: from 2014 to 2018) were analyzed. Depressive and anxiety symptom severity and beverage consumption were assessed using multilevel mixed-effects ordinal logistic regression models for each beverage consumption (carbonated/soft drink with sugar, carbonated/soft drink with non-nutritive sweeteners, coffee, and tea) with the three repeated measures of follow-up (baseline and 6 and 12 months). A case report form for participants' sociodemographic and clinical characteristics, the Food Frequency Questionnaire, the Patient Health Questionnaire-9, the Generalized Anxiety Disorder 7-Item Scale, the MINI International Neuropsychiatric Interview 5.0, the Short Questionnaire to Assess Health-Enhancing Psychical Activity, and the Alcohol Use Disorders Identification Test were the research tools used. Results: Daily consumption of carbonated/soft drinks with sugar was associated with a higher level of anxiety. Trends towards significance were found for associations between both daily consumption of carbonated/soft drinks with sugar and non-nutritive sweeteners and a higher level of depression. No relationship was found between coffee and tea consumption and the level of depression and anxiety. Conclusions: The high and regular consumption of carbonated/soft drink with sugar (amount of consumption: & GE;1 unit (200 mL)/day) tended to be associated with higher level of anxiety in a multicountry sample of overweight subjects with subsyndromal depressive symptoms. It is important to point out that further research in this area is essential to provide valuable information about the intake patterns of non-alcoholic beverages and their relationship with affective disorders in the European adult population.
C1 [Castro, Adoracion; Gili, Margalida; Perez-Ara, Maria Angeles; Garcia-Toro, Mauro; Roca, Miquel] Univ Balear Isl UIB, Res Inst Hlth Sci IUNICS, Palma De Mallorca 07122, Spain.
   [Castro, Adoracion; Gili, Margalida; Montano, Juan Jose; Garcia-Toro, Mauro; Roca, Miquel] Hosp Univ Son Espases, Hlth Res Inst Balear Isl IdiSBa, Edificio S, Palma De Mallorca 07120, Spain.
   [Castro, Adoracion; Gili, Margalida; Montano, Juan Jose] Univ Balear Isl UIB, Dept Psychol, Palma De Mallorca 07122, Spain.
   [Visser, Marjolein; Brouwer, Ingeborg A.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Fac Sci, Dept Hlth Sci, NL-1081 HV Amsterdam, Netherlands.
   [Penninx, Brenda W. J. H.; Bot, Mariska] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Psychiat, Amsterdam UMC, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.
   [Garcia-Toro, Mauro; Roca, Miquel] Univ Balear Isl UIB, Dept Med, Palma De Mallorca 07122, Spain.
   [Watkins, Ed; Owens, Matt] Univ Exeter, Dept Psychol, Exeter EX4 4PY, England.
   [Hegerl, Ulrich] Goethe Univ Frankfurt Main, Dept Psychiat Psychosomat & Psychotherapy, D-60528 Frankfurt, Germany.
   [Kohls, Elisabeth] Univ Leipzig, Med Fac, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Germany.
C3 Universitat de les Illes Balears; IUNICS; Institut Investigacio
   Sanitaria Illes Balears (IdISBa); Hospital Universitari Son Espases;
   Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University
   of Exeter; Goethe University Frankfurt; Leipzig University
RP Castro, A (corresponding author), Univ Balear Isl UIB, Res Inst Hlth Sci IUNICS, Palma De Mallorca 07122, Spain.; Castro, A (corresponding author), Hosp Univ Son Espases, Hlth Res Inst Balear Isl IdiSBa, Edificio S, Palma De Mallorca 07120, Spain.; Castro, A (corresponding author), Univ Balear Isl UIB, Dept Psychol, Palma De Mallorca 07122, Spain.
EM a.castro@uib.es; mgili@uib.es; m.visser@vu.nl;
   b.penninx@amsterdamumc.nl; ingeborg.brouwer@vu.nl;
   e.r.watkins@exeter.ac.uk; m.owens-solari@exeter.ac.uk;
   ulrich.hegerl@deutsche-depressionshilfe.de;
   elisabeth.kohls@medizin.uni-leipzig.de; m.bot1@amsterdamumc.nl;
   mroca@uib.es
RI Castro, Adoración/ADU-2901-2022; Brouwer, Inge/K-8455-2013; Garcia-Toro,
   Mauro/AAL-1153-2020; Montaño, Juan José/Z-3559-2019; Visser,
   Marjolein/AAP-3224-2020; Penninx, Brenda/S-7627-2017; Gili,
   Margalida/H-7680-2013
OI Watkins, Edward/0000-0002-2432-5577; Brouwer,
   Ingeborg/0000-0002-8762-382X; Montano, Juan Jose/0000-0002-1116-1964;
   Gili, Margalida/0000-0002-0535-6773; Bot, Mariska/0000-0002-5488-1814;
   Visser, Marjolein/0000-0002-5136-298X; Mauro,
   Garcia-Toro/0000-0002-2251-1368; Castro, Adoracion/0000-0002-8025-4945
FU European Union [613598]; UK by the National Institute for Health
   Research (NIHR); NIHR Exeter Clinical Research Facility
FX This study was funded by the European Union FP7 MooDFOOD Project
   "Multi-country collaborative project on the role of diet, food-related
   behaviour, and obesity in the prevention of depression" (grant agreement
   no. 613598). Also, this work was supported in the UK by the National
   Institute for Health Research (NIHR), through the Primary Care Research
   Network, and the NIHR Exeter Clinical Research Facility.The sources of
   funding had no role in the study design; collection,& nbsp; <EM><STRONG>
   </STRONG></EM>management, analysis, and interpretation of data; writing
   of the report; or participate in the decision to submit the report for
   publication.
CR Alasmari F, 2020, SAUDI PHARM J, V28, P445, DOI 10.1016/j.jsps.2020.02.005
   Babor TF., 1992, AUDIT. The Alcohol Use Disorders Identification Test: Guidelines for use in primary health care
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   Boaz M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124193
   Bot M, 2019, JAMA-J AM MED ASSOC, V321, P858, DOI 10.1001/jama.2019.0556
   Caroppo E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18168433
   Chen YX, 2022, NUTR RES, V103, P59, DOI 10.1016/j.nutres.2022.03.010
   Choda N, 2020, NUTR J, V19, DOI 10.1186/s12937-019-0515-6
   Diagnostic A., 1994, Statistical Manual of Mental Disorders, P394
   Food & Drug Administration (FDA), Spilling the Beans: How Much Caffeine Is Too Much?
   Garcia-Larsen V, 2011, EUR J CLIN NUTR, V65, P750, DOI 10.1038/ejcn.2011.15
   Iranpour S, 2019, PSYCHIAT RES, V271, P732, DOI 10.1016/j.psychres.2018.11.004
   Kashino I, 2021, NUTRITION, V81, DOI 10.1016/j.nut.2020.110860
   Kimura Y, 2020, J EPIDEMIOL, V30, P338, DOI 10.2188/jea.JE20190010
   Klevebrant L, 2022, GEN HOSP PSYCHIAT, V74, P22, DOI 10.1016/j.genhosppsych.2021.11.005
   Kokubo Y, 2019, ENVIRON HEALTH PREV, V24, DOI 10.1186/s12199-019-0767-y
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lara DR, 2010, J ALZHEIMERS DIS, V20, pS239, DOI 10.3233/JAD-2010-1378
   Mancini E, 2017, PHYTOMEDICINE, V34, P26, DOI 10.1016/j.phymed.2017.07.008
   Nanri A, 2022, NUTRIENTS, V14, DOI 10.3390/nu14010167
   Ng TP, 2021, J NUTR HEALTH AGING, V25, P295, DOI 10.1007/s12603-020-1526-x
   Nouri-Majd S, 2022, PUBLIC HEALTH NUTR, V25, P3509, DOI 10.1017/S1368980022000271
   Oliván-Blázquez B, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082724
   Pérez-Ara MA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103202
   Pomeranz JL, 2012, J PUBLIC HEALTH POL, V33, P75, DOI 10.1057/jphp.2011.46
   Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2
   Roca M, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0900-z
   Sarris J, 2019, J PSYCHIATR RES, V110, P31, DOI 10.1016/j.jpsychires.2018.12.014
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi
   Shi ZM, 2010, PUBLIC HEALTH NUTR, V13, P1073, DOI 10.1017/S1368980009993132
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   StataCorp, 2019, STATA STAT SOFTWARE
   Torabynasab K, 2023, FRONT NUTR, V10, DOI 10.3389/fnut.2023.1051444
   Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2
   Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8
   Werneck AO, 2021, BRAZ J PSYCHIAT, V43, P574, DOI 10.1590/1516-4446-2020-1073
   Williams JL, 2020, PLANT FOOD HUM NUTR, V75, P12, DOI 10.1007/s11130-019-00771-5
   World Health Organization, 2016, WHO urges global action to curtail consumption and health impacts of sugary drinks
   World Health Organization, 2017, IEEE T POWER SYSTEMS, P1, DOI [DOI 10.13155/46607, DOI 10.1109/IEEESTD.2017.7920364]
   Xu H, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00458
   Yu B, 2015, J AFFECT DISORDERS, V172, P422, DOI 10.1016/j.jad.2014.10.026
   Zhang XY, 2019, PUBLIC HEALTH NUTR, V22, P2553, DOI 10.1017/S1368980019001009
NR 42
TC 4
Z9 4
U1 7
U2 19
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD SEP
PY 2023
VL 15
IS 18
AR 3865
DI 10.3390/nu15183865
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA S9PN3
UT WOS:001074413100001
PM 37764652
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Saimaiti, A
   Zhou, DD
   Li, JH
   Xiong, RG
   Gan, RY
   Huang, SY
   Shang, A
   Zhao, CN
   Li, HY
   Li, HB
AF Saimaiti, Adila
   Zhou, Dan-Dan
   Li, Jiahui
   Xiong, Ruo-Gu
   Gan, Ren-You
   Huang, Si-Yu
   Shang, Ao
   Zhao, Cai-Ning
   Li, Hang-Yu
   Li, Hua-Bin
TI Dietary sources, health benefits, and risks of caffeine
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Caffeine; cancer; cardiovascular disease; diabetes mellitus; liver
   disease; neurodegenerative disease; obesity; side effect
ID ORAL RECOMBINANT METHIONINASE; HEPATIC STELLATE CELLS;
   INTRAOCULAR-PRESSURE; OXIDATIVE STRESS; PARKINSONS-DISEASE; COFFEE
   CONSUMPTION; CYP1A2 GENOTYPE; GUT MICROBIOTA; GREEN TEA; MECHANISMS
AB Dietary intake of caffeine has significantly increased in recent years, and beneficial and harmful effects of caffeine have been extensively studied. This paper reviews antioxidant and anti-inflammatory activities of caffeine as well as its protective effects on cardiovascular diseases, obesity, diabetes mellitus, cancers, and neurodegenerative and liver diseases. In addition, we summarize the side effects of long-term or excessive caffeine consumption on sleep, migraine, intraocular pressure, pregnant women, children, and adolescents. The health benefits of caffeine depend on the amount of caffeine intake and the physical condition of consumers. Moderate intake of caffeine helps to prevent and modulate several diseases. However, the long-term or over-consumption of caffeine can lead to addiction, insomnia, migraine, and other side effects. In addition, children, adolescents, pregnant women, and people who are sensitive to caffeine should be recommended to restrict/reduce their intake to avoid potential adverse effects.
C1 [Saimaiti, Adila; Zhou, Dan-Dan; Xiong, Ruo-Gu; Huang, Si-Yu; Li, Hang-Yu; Li, Hua-Bin] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Peoples R China.
   [Li, Jiahui] Hong Kong Univ Sci & Technol, Sch Sci, Hong Kong, Peoples R China.
   [Gan, Ren-You] Chinese Acad Agr Sci, Natl Agr Sci & Technol Ctr, Inst Urban Agr, Res Ctr Plants & Human Hlth, Chengdu, Peoples R China.
   [Gan, Ren-You] Chengdu Univ, Key Lab Coarse Cereal Proc, Minist Agr & Rural Affairs, Sch Food & Biol Engn,Sichuan Engn & Technol Res C, Chengdu, Peoples R China.
   [Shang, Ao] Univ Hong Kong, Li Ka Shing Fac Med, Sch Chinese Med, Hong Kong, Peoples R China.
   [Zhao, Cai-Ning] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Peoples R China.
C3 Sun Yat Sen University; Hong Kong University of Science & Technology;
   Chinese Academy of Agricultural Sciences; Institute of Urban
   Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Chengdu
   University; University of Hong Kong; University of Hong Kong
RP Li, HB (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Peoples R China.; Gan, RY (corresponding author), Chinese Acad Agr Sci, Natl Agr Sci & Technol Ctr, Inst Urban Agr, Res Ctr Plants & Human Hlth, Chengdu, Peoples R China.; Gan, RY (corresponding author), Chengdu Univ, Key Lab Coarse Cereal Proc, Minist Agr & Rural Affairs, Sch Food & Biol Engn,Sichuan Engn & Technol Res C, Chengdu, Peoples R China.
EM ganrenyou@caas.cn; lihuabin@mail.sysu.edu.cn
RI Huang, Si Yu/GQP-7166-2022; Li, Hua-Bin/AEX-9846-2022; Zhou,
   Dandan/GNH-3721-2022; Li, Hang-Yu/MSY-5665-2025; Gan, Renyou/C-9868-2009
OI Gan, Ren-You/0000-0002-4162-1511; Saimaiti, Adila/0000-0003-2377-0908
FU National Key R&D Program of China [2018YFC1604405]; Local Financial
   Funds of National Agricultural Science and Technology Center, Chengdu
   [NASC2021KR01]; Key Project of Guangdong Provincial Science and
   Technology Program [2014B020205002]
FX This study was supported by the National Key R&D Program of China (No.
   2018YFC1604405), Local Financial Funds of National Agricultural Science
   and Technology Center, Chengdu (No. NASC2021KR01), and the Key Project
   of Guangdong Provincial Science and Technology Program (No.
   2014B020205002).
CR Abbasi A, 2018, LIFE SCI, V199, P41, DOI 10.1016/j.lfs.2018.03.009
   Akomolafe SF, 2019, J PHARM PHARMACOL, V71, P1565, DOI 10.1111/jphp.13142
   Alhowail A, 2020, EUR REV MED PHARMACO, V24, P11909, DOI 10.26355/eurrev_202011_23849
   Allard B, 2013, CLIN CANCER RES, V19, P5626, DOI 10.1158/1078-0432.CCR-13-0545
   Alstadhaug KB, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.01002
   Alzoubi KH, 2018, J MOL NEUROSCI, V66, P222, DOI 10.1007/s12031-018-1158-3
   Amer MG, 2017, INT J IMMUNOPATH PH, V30, P13, DOI 10.1177/0394632017694898
   Andrews KW, 2007, ANAL BIOANAL CHEM, V389, P231, DOI 10.1007/s00216-007-1437-2
   Arroyo-Johnson C, 2016, GASTROENTEROL CLIN N, V45, P571, DOI 10.1016/j.gtc.2016.07.012
   Atti AR, 2019, AM J GERIAT PSYCHIAT, V27, P625, DOI 10.1016/j.jagp.2019.01.214
   Avisar R, 2002, ANN PHARMACOTHER, V36, P992, DOI 10.1345/aph.1A279
   Bakshi R, 2020, J PARKINSON DIS, V10, P505, DOI 10.3233/JPD-191882
   Baldissera MD, 2019, FISH PHYSIOL BIOCHEM, V45, P1041, DOI 10.1007/s10695-019-00616-7
   Begum M.M., 2018, J PHARM RES INT, V22, P1, DOI [10.9734/JPRI/2018/40988, DOI 10.9734/JPRI/2018/40988]
   Blomstrand E, 2001, AMINO ACIDS, V20, P25, DOI 10.1007/s007260170063
   Busada JT, 2017, CURR TOP DEV BIOL, V125, P147, DOI 10.1016/bs.ctdb.2016.12.004
   Cadoná FC, 2022, CRIT REV FOOD SCI, V62, P7222, DOI 10.1080/10408398.2021.1913091
   Cao SY, 2020, FOODS, V9, DOI 10.3390/foods9030262
   Cao SY, 2019, TRENDS FOOD SCI TECH, V92, P194, DOI 10.1016/j.tifs.2019.08.004
   Cao SY, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8060166
   Chandrasekaran S, 2005, J GLAUCOMA, V14, P504, DOI 10.1097/01.ijg.0000184832.08783.be
   Chen F, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3900
   Chen JQA, 2020, J ALZHEIMERS DIS, V78, P1519, DOI 10.3233/JAD-201069
   Chen JF, 2020, PARKINSONISM RELAT D, V80, pS45, DOI 10.1016/j.parkreldis.2020.10.024
   Collado-Mateo D, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123603
   Costa J, 2010, J ALZHEIMERS DIS, V20, pS221, DOI 10.3233/JAD-2010-091525
   da Silva LA, 2019, CURR NUTR FOOD SCI, V15, P621, DOI 10.2174/1573401314666180515143951
   da Silva LA, 2020, CURR NUTR FOOD SCI, V16, P364, DOI 10.2174/1573401315666181211144036
   Derry CJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009281.pub2
   Duarte JMN, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01015
   Egesoy H, 2020, PROG NUTR, V22, P168, DOI 10.23751/pn.v22i1-S.9813
   El-Sohemy A, 2007, GENES NUTR, V2, P155, DOI 10.1007/s12263-007-0043-4
   Eraky SM, 2018, BIOMED PHARMACOTHER, V101, P49, DOI 10.1016/j.biopha.2018.02.064
   Erukainure OL, 2017, BIOMED PHARMACOTHER, V96, P1065, DOI 10.1016/j.biopha.2017.11.120
   Esmaili Z, 2021, BRAIN RES BULL, V170, P137, DOI 10.1016/j.brainresbull.2021.02.007
   Fabiani C, 2022, MOL PHARMACOL, V101, P154, DOI 10.1124/molpharm.121.000415
   Fabiani C, 2018, NEUROPHARMACOLOGY, V135, P464, DOI 10.1016/j.neuropharm.2018.03.041
   França AP, 2020, MOL NEUROBIOL, V57, P3902, DOI 10.1007/s12035-020-02002-4
   Gaeini Z, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0355-6
   Gessi S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10092344
   Ghaffary EM, 2020, LIFE SCI, V246, DOI 10.1016/j.lfs.2020.117420
   Gonçalves DF, 2020, TOXICOL RES-UK, V9, P726, DOI 10.1093/toxres/tfaa075
   Harland BF, 2000, NUTRITION, V16, P522, DOI 10.1016/S0899-9007(00)00369-5
   He B, 2019, J ENDOCRINOL, V242, P211, DOI 10.1530/JOE-19-0066
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Higuchi T, 2019, ANTICANCER RES, V39, P4653, DOI 10.21873/anticanres.13646
   Higuchi T, 2018, ANTICANCER RES, V38, P5639, DOI 10.21873/anticanres.12899
   Hinton DJ, 2019, BEHAV BRAIN RES, V370, DOI 10.1016/j.bbr.2019.111943
   Hosny EN, 2019, NUTR NEUROSCI, V22, P789, DOI 10.1080/1028415X.2018.1446812
   Hrycek E, 2013, RHEUMATOL INT, V33, P2423, DOI 10.1007/s00296-012-2393-5
   Hu SW, 2019, TOXICOLOGY, V417, P23, DOI 10.1016/j.tox.2019.02.008
   Igarashi K, 2017, ANTICANCER RES, V37, P1005, DOI 10.21873/anticanres.11410
   Ikram M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090902
   Iris M, 2018, CLIN IMMUNOL, V192, P68, DOI 10.1016/j.clim.2018.04.008
   Irwin C, 2020, NEUROSCI BIOBEHAV R, V108, P877, DOI 10.1016/j.neubiorev.2019.12.008
   James JE, 2018, J PSYCHOSOM RES, V110, P16, DOI 10.1016/j.jpsychores.2018.04.010
   Ramos-Campo DJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092040
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   Karuppagounder SS, 2021, NEUROCHEM INT, V148, DOI 10.1016/j.neuint.2021.105066
   Kim IY, 2017, J PARKINSON DIS, V7, P677, DOI 10.3233/JPD-171175
   Kim J, 2021, OPHTHALMOLOGY, V128, P866, DOI 10.1016/j.ophtha.2020.12.009
   Kim J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091201
   Ko J, 2020, ENDOCR J, V67, P439, DOI 10.1507/endocrj.EJ19-0521
   Kwak Y, 2017, TOXICOL RES-GER, V33, P157, DOI 10.5487/TR.2017.33.2.157
   Kwak Y, 2017, REPROD TOXICOL, V69, P43, DOI 10.1016/j.reprotox.2017.01.007
   Lee JB, 2019, CHINESE J PHYSIOL, V62, P279, DOI 10.4103/CJP.CJP_59_19
   Li BY, 2019, FOODS, V8, DOI 10.3390/foods8100440
   Li BY, 2021, FOODS, V10, DOI 10.3390/foods10061232
   Li N, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5364973
   Li YF, 2018, THERANOSTICS, V8, P5713, DOI 10.7150/thno.28778
   Li YJ, 2017, INT J MOL MED, V40, P1405, DOI 10.3892/ijmm.2017.3145
   Li YM, 2018, PHYSIOL RES, V67, P975, DOI 10.33549/physiolres.933906
   Lin FJ, 2021, TRENDS FOOD SCI TECH, V109, P126, DOI 10.1016/j.tifs.2021.01.030
   Liu HY, 2017, MOL MED REP, V16, P2445, DOI 10.3892/mmr.2017.6894
   Liu LT, 2018, J FUNCT FOODS, V47, P156, DOI 10.1016/j.jff.2018.05.030
   Liu LT, 2017, BIOSCI BIOTECH BIOCH, V81, P1948, DOI 10.1080/09168451.2017.1364618
   Liu QS, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600910
   Lv XW, 2010, INFLAMM RES, V59, P635, DOI 10.1007/s00011-010-0176-6
   Machado DG, 2020, PROG NEURO-PSYCHOPH, V98, DOI 10.1016/j.pnpbp.2019.109776
   Machado KL, 2021, NUTR CANCER, V73, P1378, DOI 10.1080/01635581.2020.1795693
   Machado ML, 2021, NUTR NEUROSCI, V24, P697, DOI 10.1080/1028415X.2019.1671694
   Madeira MH, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4761081
   Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201
   Meisaprow P, 2021, MOLECULES, V26, DOI 10.3390/molecules26247659
   Meng JM, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8060170
   Metro D, 2017, J CLIN TRANSL ENDOCR, V10, P22, DOI 10.1016/j.jcte.2017.10.001
   Min H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082517
   Min H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113348
   Min H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051334
   Mirmiran R, 2018, NUTR METAB CARDIOVAS, V28, P1261, DOI 10.1016/j.numecd.2018.09.001
   Muñoz A, 2020, INT J SPORT PHYSIOL, V15, P1406, DOI 10.1123/ijspp.2019-0847
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Ngueta G, 2020, EUR J CLIN NUTR, V74, P77, DOI 10.1038/s41430-019-0430-0
   Nowaczewska M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082259
   Oboh G, 2018, ORIENTAL PHARM EXP M, V18, P247, DOI 10.1007/s13596-018-0313-2
   Oda Y, 2017, BIOL PHARM BULL, V40, P2005, DOI 10.1248/bpb.b17-00457
   Palatini P, 2009, J HYPERTENS, V27, P1594, DOI 10.1097/HJH.0b013e32832ba850
   Panagiotou M, 2019, J PSYCHOPHARMACOL, V33, P122, DOI 10.1177/0269881118806300
   Parola M, 2008, MOL ASPECTS MED, V29, P58, DOI 10.1016/j.mam.2007.09.002
   Paz-Graniel I, 2022, NUTRIENTS, V14, DOI 10.3390/nu14061242
   Paz-Graniel I, 2021, EUR J NUTR, V60, P2381, DOI 10.1007/s00394-020-02415-w
   Pihan-Le Bars F, 2017, CLIN ENDOCRINOL, V87, P475, DOI 10.1111/cen.13411
   Popovic DJ, 2018, EUR REV MED PHARMACO, V22, P2461, DOI 10.26355/eurrev_201804_14840
   Qian JJ, 2020, TRENDS ENDOCRIN MET, V31, P218, DOI 10.1016/j.tem.2019.11.004
   Rasalkar DD, 2011, PEDIATR RADIOL, V41, P227, DOI 10.1007/s00247-010-1809-1
   Rashwan EH, 2018, INT J PHARM RES ALLI, V7, P49
   Redondo B, 2020, GRAEF ARCH CLIN EXP, V258, P613, DOI 10.1007/s00417-019-04556-z
   Rhee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132334
   Ruiz-Moreno C, 2021, EUR J NUTR, V60, P2077, DOI 10.1007/s00394-020-02393-z
   Russell VA, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-9
   Ryu KY, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050951
   Said MA, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016808
   Samadi M, 2021, DRUG CHEM TOXICOL, V44, P613, DOI 10.1080/01480545.2019.1643874
   Shang A, 2021, FREE RADICAL BIO MED, V172, P181, DOI 10.1016/j.freeradbiomed.2021.06.006
   Shang AO, 2021, CRIT REV FOOD SCI, V61, P2061, DOI 10.1080/10408398.2020.1769548
   Shim SG, 2013, J GASTROEN HEPATOL, V28, P1877, DOI 10.1111/jgh.12317
   Shushtari N, 2017, CELL J, V19, P415, DOI 10.22074/cellj.2017.4364
   Soerjomataram I, 2021, NAT REV CLIN ONCOL, V18, P663, DOI 10.1038/s41571-021-00514-z
   Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005
   Stanková P, 2010, TOXICOL IN VITRO, V24, P2097, DOI 10.1016/j.tiv.2010.06.011
   Stazi M, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-021-04062-8
   Syrova A, 2020, TURK J PHARM SCI, V17, P408, DOI 10.4274/tjps.galenos.2019.92063
   Szopa A, 2016, N-S ARCH PHARMACOL, V389, P211, DOI 10.1007/s00210-015-1189-z
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Tan Y, 2018, TOXICOL LETT, V295, P229, DOI 10.1016/j.toxlet.2018.06.1221
   Tang GY, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8060180
   Tao J, 2020, CRIT REV FOOD SCI, V60, P1025, DOI 10.1080/10408398.2018.1555789
   Tej GNVC, 2019, INT IMMUNOPHARMACOL, V77, DOI 10.1016/j.intimp.2019.106002
   Tej GNVC, 2019, EUR J PHARMACOL, V859, DOI 10.1016/j.ejphar.2019.172538
   Tellone E, 2019, CURR MED CHEM, V26, P5137, DOI 10.2174/0929867324666171009104040
   Temple JL, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00080
   Tonkaboni A, 2021, NUTR CANCER, V73, P1998, DOI 10.1080/01635581.2020.1819344
   Unno K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070777
   Vera J, 2019, PSYCHOPHARMACOLOGY, V236, P811, DOI 10.1007/s00213-018-5114-2
   Verster JC, 2018, CRIT REV FOOD SCI, V58, P1250, DOI 10.1080/10408398.2016.1247252
   Wadhwa M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00049
   Wang ZS, 2020, PATHOL ONCOL RES, V26, P209, DOI 10.1007/s12253-018-0415-7
   Wang ZL, 2019, MED ONCOL, V36, DOI 10.1007/s12032-019-1323-8
   Wei X, 2018, KIDNEY BLOOD PRESS R, V43, P439, DOI 10.1159/000488256
   Weiser T, 2018, EUR J PAIN, V22, P28, DOI 10.1002/ejp.1068
   Wrzesniok D, 2018, FOOD CHEM TOXICOL, V120, P566, DOI 10.1016/j.fct.2018.07.049
   Xu M, 2019, FOOD FUNCT, V10, P7489, DOI 10.1039/c9fo00502a
   Xu XY, 2020, CRIT REV FOOD SCI, V60, P1693, DOI 10.1080/10408398.2019.1588223
   Xu XY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101553
   Xue J, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9932
   Yamaguchi M, 2017, BIOL PHARM BULL, V40, P658, DOI 10.1248/bpb.b16-00947
   Yang Z, 2019, PHYTOTHER RES, V33, P1019, DOI 10.1002/ptr.6295
   Zhao CN, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8070215
   Zhou A, 2019, AM J CLIN NUTR, V109, P509, DOI 10.1093/ajcn/nqy297
   Zhou DD, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6627355
   Zhu MZ, 2021, FOOD FUNCT, V12, P4105, DOI [10.1039/d0fo01768j, 10.1039/D0FO01768J]
   Zhu XJ, 2017, EXP THER MED, V13, P688, DOI 10.3892/etm.2016.3975
   Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118
NR 154
TC 46
Z9 49
U1 18
U2 210
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD NOV 17
PY 2023
VL 63
IS 29
BP 9648
EP 9666
DI 10.1080/10408398.2022.2074362
EA MAY 2022
PG 19
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA HN6E5
UT WOS:000796396300001
PM 35574653
DA 2025-04-28
ER

PT J
AU Wang, Q
   Hu, GL
   Qiu, MH
   Cao, J
   Xiong, WY
AF Wang, Qian
   Hu, Gui-Lin
   Qiu, Ming-Hua
   Cao, Jun
   Xiong, Wen-Yong
TI Coffee, tea, and cocoa in obesity prevention: Mechanisms of action and
   future prospects
SO CURRENT RESEARCH IN FOOD SCIENCE
LA English
DT Review
DE Functional foods; Adipocyte; Adipogenesis; Lipid metabolism;
   Thermogenesis
ID HIGH-FAT-DIET; ACTIVATED PROTEIN-KINASE; INDUCED HEPATIC STEATOSIS;
   GREEN TEA; CHLOROGENIC ACID; LIPID-METABOLISM; BROWN FAT;
   MOLECULAR-MECHANISMS; ADIPOSE-TISSUE; CHOCOLATE CONSUMPTION
AB Obesity, a major public health problem, causes numerous complications that threaten human health and increase the socioeconomic burden. The pathophysiology of obesity is primarily attributed to lipid metabolism disorders. Conventional anti -obesity medications have a high abuse potential and frequently deliver insufficient efficacy and have negative side -effects. Hence, functional foods are regarded as effective alternatives to address obesity. Coffee, tea, and cocoa, three widely consumed beverages, have long been considered to have the potential to prevent obesity, and several studies have focused on their intrinsic molecular mechanisms in past few years. Therefore, in this review, we discuss the mechanisms by which the bioactive ingredients in these three beverages counteract obesity from the aspects of adipogenesis, lipolysis, and energy expenditure (thermogenesis). The future prospects and challenges for coffee, tea, and cocoa as functional products for the treatment of obesity are also discussed, which can be pursued for future drug development and prevention strategies against obesity.
C1 [Wang, Qian; Xiong, Wen-Yong] Yunnan Univ, Yunnan Prov Ctr Res & Dev Nat Prod, Sch Pharm, Key Lab Med Chem Nat Resource,Minist Educ, Kunming 650500, Peoples R China.
   [Hu, Gui-Lin; Qiu, Ming-Hua] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Chi, Kunming 650201, Yunnan, Peoples R China.
   [Cao, Jun] Yunnan Univ, Key Lab Transboundary Ecosecur Southwest China, Yunnan Key Lab Plant Reprod Adaptat & Evolutionary, Inst Biodivers,Sch Ecol & Environm Sci, Kunming 650504, Yunnan, Peoples R China.
C3 Yunnan University; Chinese Academy of Sciences; Kunming Institute of
   Botany, CAS; Yunnan University
RP Xiong, WY (corresponding author), Yunnan Univ, Yunnan Prov Ctr Res & Dev Nat Prod, Sch Pharm, Key Lab Med Chem Nat Resource,Minist Educ, Kunming 650500, Peoples R China.; Cao, J (corresponding author), Yunnan Univ, Key Lab Transboundary Ecosecur Southwest China, Yunnan Key Lab Plant Reprod Adaptat & Evolutionary, Inst Biodivers,Sch Ecol & Environm Sci, Kunming 650504, Yunnan, Peoples R China.
EM juncao@vip.163.com; xwy@ynu.edu.cn
RI Xiong, Wenyong/C-3835-2013
OI Xiong, Wenyong/0000-0001-9174-3667
FU National Natural Science Foundation of China [82360730]; Yunnan
   Fundamental Research Project [202301AT070382, 202401AT070451]; China
   Postdoctoral Science Foundation [2023M743591]; Postdoctoral Fellowship
   Program of CPSF [GZC20232766]; Scientific Research Foundation of
   Education Department of Yunnan Province [2023J0010]; Yunnan Province
   Science and Technology Department [202402AA310009]; National Key R&D
   Program of China [2019YFE0109200]; Coffee Industry Science and
   Technology Mission in Zhenkang County, Yunnan [202204BI090009]
FX This work was supported by the National Natural Science Foundation of
   China under Grant [82360730] ; Yunnan Fundamental Research Project under
   Grant [202301AT070382] and [202401AT070451] ; China Postdoctoral Science
   Foundation under Grant [2023M743591] ; Postdoctoral Fellowship Program
   of CPSF under Grant [GZC20232766] ; Scientific Research Foundation of
   Education Department of Yunnan Province under Grant [2023J0010] ; Yunnan
   Province Science and Technology Department [202402AA310009] ; National
   Key R&D Program of China under Grant [2019YFE0109200] ; Coffee Industry
   Science and Technology Mission in Zhenkang County, Yunnan [No.
   202204BI090009] .
CR Alexopoulos SJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16298-2
   Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001
   Ali F, 2014, MOL NUTR FOOD RES, V58, P33, DOI 10.1002/mnfr.201300277
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Aprotosoaie Ana Clara, 2016, Diseases, V4, DOI 10.3390/diseases4040039
   Aranaz P, 2019, FOOD FUNCT, V10, P4811, DOI [10.1039/C9FO00918C, 10.1039/c9fo00918c]
   Arias N, 2016, EUR J NUTR, V55, P341, DOI 10.1007/s00394-015-0854-9
   Ashihara H, 2015, PHYTOCHEM REV, V14, P765, DOI 10.1007/s11101-014-9375-z
   Audano M, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-022-04169-6
   Baba S, 2007, AM J CLIN NUTR, V85, P709, DOI 10.1093/ajcn/85.3.709
   Baek JH, 2017, BMB REP, V50, P566, DOI 10.5483/BMBRep.2017.50.11.031
   Cai XQ, 2021, FOOD FUNCT, V12, P9922, DOI [10.1039/d1fo01966j, 10.1039/D1FO01966J]
   Cao QW, 2024, FOOD CHEM, V444, DOI 10.1016/j.foodchem.2024.138514
   Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Chan CY, 2011, LIFE SCI, V89, P779, DOI 10.1016/j.lfs.2011.09.006
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Cheng H, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700303
   Cheng LZ, 2024, CRIT REV FOOD SCI, V64, P11321, DOI 10.1080/10408398.2023.2236701
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Choi M, 2021, PHYTOTHER RES, V35, P1113, DOI 10.1002/ptr.6892
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Chouchani ET, 2019, NAT METAB, V1, P189, DOI 10.1038/s42255-018-0021-8
   Chouchani ET, 2019, CELL METAB, V29, P27, DOI 10.1016/j.cmet.2018.11.002
   Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399
   D'Anna R, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/653561
   Dai ZJ, 2023, FOOD CHEM, V418, DOI 10.1016/j.foodchem.2023.135980
   Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484
   de Sá PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Deng XJ, 2021, FOOD SCI NUTR, V9, P1160, DOI 10.1002/fsn3.2096
   Desjardins EM, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1049-6
   Di Renzo L, 2013, EUR REV MED PHARMACO, V17, P2257
   Farias-Pereira R, 2020, J AGR FOOD CHEM, V68, P9683, DOI 10.1021/acs.jafc.0c03030
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Farias-Pereira R, 2020, FOOD CHEM, V307, DOI 10.1016/j.foodchem.2019.125537
   Farias-Pereira R, 2018, J FUNCT FOODS, V48, P586, DOI 10.1016/j.jff.2018.07.049
   Fernández-Elías VE, 2015, INT J SPORT NUTR EXE, V25, P46, DOI 10.1123/ijsnem.2014-0037
   Fuggetta MP, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/1515621
   Gao XX, 2024, FOOD SCI HUM WELL, V13, P90, DOI 10.26599/FSHW.2022.9250007
   Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z
   Gökcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   Golomb BA, 2012, ARCH INTERN MED, V172, P519, DOI 10.1001/archinternmed.2011.2100
   Gouveia HJCB, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23158344
   Gramza-Michalowska A, 2014, J NUTR HEALTH AGING, V18, P143, DOI 10.1007/s12603-013-0404-1
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Guo YY, 2019, J BIOL CHEM, V294, P15014, DOI 10.1074/jbc.RA119.009936
   Gutiérrez-Salmeán G, 2014, EUR J PHARMACOL, V728, P24, DOI 10.1016/j.ejphar.2014.01.053
   Hamden Khaled, 2013, Sci Pharm, V81, P233, DOI 10.3797/scipharm.1211-14
   He J, 2021, J FUNCT FOODS, V81, DOI 10.1016/j.jff.2021.104476
   He XY, 2021, J SCI FOOD AGR, V101, P631, DOI 10.1002/jsfa.10675
   Hildebrandt X, 2023, CELL DEATH DIFFER, V30, P279, DOI 10.1038/s41418-022-01062-4
   Hiraike Y, 2017, NAT CELL BIOL, V19, P1081, DOI 10.1038/ncb3590
   Hu GL, 2019, FOOD FUNCT, V10, P3113, DOI [10.1039/c9fo00288j, 10.1039/C9FO00288J]
   Huang FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12896-x
   Huang JB, 2020, FOOD FUNCT, V11, P9924, DOI [10.1039/d0fo02152k, 10.1039/D0FO02152K]
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Ilavenil S, 2014, PHYTOMEDICINE, V21, P758, DOI 10.1016/j.phymed.2013.11.007
   Ilmiawati C, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05052-y
   Imran A, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0688-6
   Jalil AMM, 2008, J AGR FOOD CHEM, V56, P7877, DOI 10.1021/jf8015915
   Jang MH, 2020, EUR J NUTR, V59, P3503, DOI 10.1007/s00394-020-02184-6
   Jang MH, 2018, BIOTECHNOL BIOPROC E, V23, P617, DOI 10.1007/s12257-018-0434-y
   Jang YJ, 2015, FOOD FUNCT, V6, P2365, DOI 10.1039/c5fo00397k
   Flores MEJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040751
   Ji L, 2023, FOOD CHEM, V421, DOI 10.1016/j.foodchem.2023.136181
   Jiang ZD, 2023, CURR OPIN FOOD SCI, V51, DOI 10.1016/j.cofs.2023.101014
   Jin DY, 2013, J FUNCT FOODS, V5, P1142, DOI 10.1016/j.jff.2013.03.011
   Jonfia-Essien WA, 2008, FOOD CHEM, V108, P1155, DOI 10.1016/j.foodchem.2007.12.001
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kim JS, 2018, NAT PROD RES, V32, P1216, DOI 10.1080/14786419.2017.1326039
   Kim J, 2014, CRIT REV FOOD SCI, V54, P1458, DOI 10.1080/10408398.2011.641041
   Kissig M, 2016, CELL, V166, P258, DOI 10.1016/j.cell.2016.06.038
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Ko HJ, 2015, J FUNCT FOODS, V17, P271, DOI 10.1016/j.jff.2015.05.033
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x
   Kong L, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13795
   Kuang JL, 2020, METABOLITES, V10, DOI 10.3390/metabo10110475
   Kumar R, 2020, CURR MOL PHARMACOL, V13, P7, DOI 10.2174/1874467212666190716145210
   Kurosawa T, 2005, J ATHEROSCLER THROMB, V12, P20, DOI 10.5551/jat.12.20
   Kusumah J, 2022, FOOD CHEM TOXICOL, V161, DOI 10.1016/j.fct.2022.112821
   Lee MS, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1325307
   Lemarcq V, 2020, FOOD CHEM, V332, DOI 10.1016/j.foodchem.2020.127467
   Li F, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01366
   Li HY, 2023, J ADV RES, V52, P59, DOI 10.1016/j.jare.2023.01.008
   Li HY, 2022, FOODS, V11, DOI 10.3390/foods11193000
   Li HY, 2016, MOL NUTR FOOD RES, V60, P2565, DOI 10.1002/mnfr.201600162
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Li XP, 2018, FOOD FUNCT, V9, P4651, DOI 10.1039/c8fo01293h
   Liang JJ, 2022, NUTR METAB, V19, DOI 10.1186/s12986-022-00664-6
   Liao YY, 2022, CRIT REV FOOD SCI, V62, P3751, DOI 10.1080/10408398.2020.1868970
   Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200
   Lin L, 2020, FOOD FUNCT, V11, P1798, DOI [10.1039/c9fo02451d, 10.1039/C9FO02451D]
   Liu CW, 2018, AM J PHYSIOL-ENDOC M, V314, pE433, DOI 10.1152/ajpendo.00094.2017
   Liu JH, 2023, J SCI FOOD AGR, V103, P2436, DOI 10.1002/jsfa.12476
   Liu LT, 2018, J FUNCT FOODS, V47, P156, DOI 10.1016/j.jff.2018.05.030
   Liu YunLong Liu YunLong, 2015, Chinese Journal of Animal Nutrition, V27, P2140
   Long PP, 2023, TRENDS FOOD SCI TECH, V133, P37, DOI 10.1016/j.tifs.2023.01.013
   Lu HJ, 2020, COMPR REV FOOD SCI F, V19, P3130, DOI 10.1111/1541-4337.12620
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Matsui N, 2005, NUTRITION, V21, P594, DOI 10.1016/j.nut.2004.10.008
   Mi YS, 2018, FOOD FUNCT, V9, P3374, DOI 10.1039/c8fo00167g
   Miao MS, 2020, ADV PHARMACOL, V87, P71, DOI 10.1016/bs.apha.2019.12.002
   Min SY, 2013, INT J OBESITY, V37, P584, DOI 10.1038/ijo.2012.85
   Mitani T, 2017, BBA-MOL CELL RES, V1864, P2438, DOI 10.1016/j.bbamcr.2017.09.017
   Miyata Y, 2011, FOOD SCI TECHNOL RES, V17, P585, DOI 10.3136/fstr.17.585
   Müller TD, 2018, PHARMACOL REV, V70, P712, DOI 10.1124/pr.117.014803
   Müller TD, 2022, NAT REV DRUG DISCOV, V21, P201, DOI 10.1038/s41573-021-00337-8
   Mursu J, 2004, FREE RADICAL BIO MED, V37, P1351, DOI 10.1016/j.freeradbiomed.2004.06.002
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Neyrinck AM, 2017, J NUTR BIOCHEM, V49, P15, DOI 10.1016/j.jnutbio.2017.07.008
   Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019
   Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Peng CX, 2013, J ANAL APPL PYROL, V104, P226, DOI 10.1016/j.jaap.2013.07.011
   Peng WQ, 2021, DIABETES, V70, P1458, DOI 10.2337/db20-1210
   Pfeifer A, 2015, ANNU REV PHARMACOL, V55, P207, DOI 10.1146/annurev-pharmtox-010814-124346
   Pirillo A, 2021, NAT REV CARDIOL, V18, P689, DOI 10.1038/s41569-021-00541-4
   Rabadan-Chávez G, 2016, J FUNCT FOODS, V20, P54, DOI 10.1016/j.jff.2015.10.016
   Ramadan G, 2009, BRIT J NUTR, V102, P1611, DOI 10.1017/S000711450999208X
   Ren YQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174238
   RIZACK MA, 1964, J BIOL CHEM, V239, P392
   Rodríguez-Pérez C, 2019, CRIT REV FOOD SCI, V59, P1212, DOI 10.1080/10408398.2017.1399859
   Ruiz-Moreno C, 2021, EUR J NUTR, V60, P2077, DOI 10.1007/s00394-020-02393-z
   Ruzaidi A, 2005, J ETHNOPHARMACOL, V98, P55, DOI 10.1016/j.jep.2004.12.018
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Schachter J, 2018, BRAIN BEHAV IMMUN, V69, P1, DOI 10.1016/j.bbi.2017.08.026
   Seo YS, 2015, INT J MOL MED, V35, P1779, DOI 10.3892/ijmm.2015.2185
   Seravalle G, 2017, PHARMACOL RES, V122, P1, DOI 10.1016/j.phrs.2017.05.013
   Sharma L, 2018, FOOD CHEM TOXICOL, V121, P283, DOI 10.1016/j.fct.2018.09.011
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   Sudhakar M, 2020, J FUNCT FOODS, V74, DOI 10.1016/j.jff.2020.104161
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Takemoto M, 2016, BIOL PHARM BULL, V39, P1347, DOI 10.1248/bpb.b16-00284
   Tanaka E, 2022, J NUTR BIOCHEM, V100, DOI 10.1016/j.jnutbio.2021.108898
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100
   Türközü D, 2017, CRIT REV FOOD SCI, V57, P1681, DOI 10.1080/10408398.2015.1016141
   Urgert R, 1997, EUR J CLIN NUTR, V51, P431, DOI 10.1038/sj.ejcn.1600414
   Ussher JR, 2023, NAT REV CARDIOL, V20, P463, DOI 10.1038/s41569-023-00849-3
   Varela CE, 2017, EUR J PHARMACOL, V811, P48, DOI 10.1016/j.ejphar.2017.05.051
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   Wang JY, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.875549
   Wang Q, 2023, FOOD FUNCT, V14, P5138, DOI [10.1039/d3fo01130e, 10.1039/D3FO01130E]
   Wang Y, 2021, J AGR FOOD CHEM, V69, P11900, DOI 10.1021/acs.jafc.1c04626
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Wen X, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01149-x
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wu LF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15904
   Xiao Y, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104285
   Xiao Y, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020204
   Xing YW, 2019, WORLD J GASTROENTERO, V25, P955, DOI 10.3748/wjg.v25.i8.955
   Xu JL, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.202000353
   Xu M, 2019, FOOD FUNCT, V10, P7489, DOI 10.1039/c9fo00502a
   Xu W, 2023, J SCI FOOD AGR, V103, P1283, DOI 10.1002/jsfa.12222
   Xu XY, 2023, CRIT REV FOOD SCI, V63, P3716, DOI 10.1080/10408398.2021.1992748
   Yan QX, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9747256
   Yang GZ, 2023, COMPR REV FOOD SCI F, V22, P1686, DOI 10.1111/1541-4337.13127
   Yang Z, 2019, PHYTOTHER RES, V33, P1019, DOI 10.1002/ptr.6295
   Yasuda A, 2008, BIOFACTORS, V33, P211, DOI 10.1002/biof.5520330307
   Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018
   Zhan W, 2016, RSC ADV, V6, P96918, DOI 10.1039/c6ra20750b
   Zhang JM, 2018, PHYSIOL RES, V67, P347, DOI 10.33549/physiolres.933650
   Zhang J, 2017, BIOMED PHARMACOTHER, V86, P292, DOI 10.1016/j.biopha.2016.12.019
   Zhang L, 2019, COMPR REV FOOD SCI F, V18, P1474, DOI 10.1111/1541-4337.12479
   Zhang SJ, 2015, FOOD FUNCT, V6, P2578, DOI [10.1039/c5fo00247h, 10.1039/C5FO00247H]
   Zhang WJ, 2020, J AGR FOOD CHEM, V68, P2673, DOI 10.1021/acs.jafc.0c00148
   Zhang XJ, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0370-7
   Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493
   Zhao L, 2017, EXP THER MED, V14, P5942, DOI 10.3892/etm.2017.5331
   Zhao L, 2017, FOOD FUNCT, V8, P4644, DOI [10.1039/C7FO01383C, 10.1039/c7fo01383c]
   Zhao ML, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107769
   Zheng GD, 2004, IN VIVO, V18, P55
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zheng XC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0206-3
   Zhong YC, 2020, CURR PHARM BIOTECHNO, V21, P1099, DOI 10.2174/1389201021666200318124922
   Zhou JF, 2021, FOOD BIOSCI, V43, DOI 10.1016/j.fbio.2021.101248
   Zhou JH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111681
   Zhou MM, 2012, J PROTEOME RES, V11, P4961, DOI 10.1021/pr3004826
   [周莎 ZHOU Sha], 2008, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V23, P190
   Zhu MZ, 2021, FOOD FUNCT, V12, P4105, DOI [10.1039/d0fo01768j, 10.1039/D0FO01768J]
   Zhu XJ, 2017, EXP THER MED, V13, P688, DOI 10.3892/etm.2016.3975
   Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747
NR 185
TC 3
Z9 3
U1 15
U2 27
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2665-9271
J9 CURR RES FOOD SCI
JI Curr. Res. Food Sci.
PY 2024
VL 8
AR 100741
DI 10.1016/j.crfs.2024.100741
PG 20
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA SS5C3
UT WOS:001236440700001
PM 38694556
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Nicotra, G
AF Nicotra, Giovanna
TI Obesity and natural dietary supplements
SO AGRO FOOD INDUSTRY HI-TECH
LA English
DT Review
DE Obesity; overweight; dietary supplements; BMI; energy expenditure;
   thermogenesis; Griffonia; Guarana; Common Bean; Green Tea
ID PHASEOLUS-VULGARIS; WEIGHT-LOSS; EFFICACY; CAFFEINE; EPHEDRINE; PLACEBO
C1 EPO Srl Ist Farmochim Fitoterap, I-20141 Milan, Italy.
RP Nicotra, G (corresponding author), EPO Srl Ist Farmochim Fitoterap, Via Stadera 19, I-20141 Milan, Italy.
CR [Anonymous], NAT STAND DAT
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   Barrett ML, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-24
   Berube-Parent S., BR J NUTR, V94, P432
   Boozer C.N., INT J OBES RELAT MET, V26, P593
   Capasso F., 2006, FITOTERAPIA, P455
   Carai MAM, 2009, DIABETES METAB SYNDR, V2, P145, DOI 10.2147/DMSO.S4236
   Celleno Leonardo, 2007, Int J Med Sci, V4, P45
   Chevalier A., 1996, ENCY MED PLANTS, P243
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Duke J.A., 1983, Handbook of Energy Crops
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Li MF, 2011, WORLD J DIABETES, V2, P19, DOI 10.4239/wjd.v2.i2.19
   Opala T, 2006, EUR J MED RES, V11, P343
   Rondanelli M, 2009, INT J OBESITY, V33, P1174, DOI 10.1038/ijo.2009.155
   Singh DK, 2009, J NUTR BIOCHEM, V20, P816, DOI 10.1016/j.jnutbio.2008.07.011
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   US National Library of Medicine National Institutes of Health, NAT MED COMPR DAT
   World Health Organization (WHO), 2011, FACT SHEET 311
NR 19
TC 0
Z9 0
U1 0
U2 15
PU TEKNOSCIENZE PUBL
PI MILANO
PA VIALE BRIANZA 22, 20127 MILANO, ITALY
SN 1722-6996
EI 2035-4606
J9 AGRO FOOD IND HI TEC
JI Agro Food Ind. Hi-Tech
PD NOV-DEC
PY 2011
VL 22
IS 6
BP 26
EP 29
PG 4
WC Biotechnology & Applied Microbiology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 872TW
UT WOS:000298833600006
DA 2025-04-28
ER

PT J
AU Nugara, RN
   Inafuku, M
   Takara, K
   Iwasaki, H
   Oku, H
AF Nugara, Ruwani N.
   Inafuku, Masashi
   Takara, Kensaku
   Iwasaki, Hironori
   Oku, Hirosuke
TI Pteryxin: A coumarin in Peucedanum japonicum Thunb leaves exerts
   antiobesity activity through modulation of adipogenic gene network
SO NUTRITION
LA English
DT Article
DE Lipid metabolism; Obesity; Peucedanum japonicum Thunb; Pteryxin; 3T3-L1
   adipocytes; HepG2 hepatocytes
ID PROLIFERATOR-ACTIVATED RECEPTOR; 3T3-L1 ADIPOCYTES; CHLOROGENIC ACID;
   PROTEIN-KINASE; 4 EXPRESSION; OBESITY; WHITE; FAT; ACCUMULATION;
   ADIPONECTIN
AB Objectives: Partially purified hexane phase (HP) of Peucedanum japonicum Thunb (PJT) was identified as an antiobesity candidate. However, the compound responsible for the antiobesity activity remained unknown. Thus, in this study we isolated the active compound, to determine the mechanisms related to antiobesity activity in vitro.
   Methods: The HP was fractionated, and the effect on the triacylglycerol (TG) content was evaluated in 3T3-L1 preadipocytes and HepG2 hepatocytes. On the basis of comprehensive spectroscopic analyses, the structure of the active compound was identified as pteryxin, a known compound in PJT. However, to our knowledge, its biological activities against obesity have not been reported previously. The dose-dependent effect on the TG content, and the gene expressions related to adipogenesis, fatty acid catabolism, energy expenditure, lipolysis, and lipogenesis due to pteryxin (10, 15, and 20 mu g/mL) were examined in vitro.
   Results: Pteryxin dose dependently suppressed TG content in both 3T3-L1 adipocytes (by 52.7%, 53.8%, and 57.4%, respectively; P < 0.05) and HepG2 hepatocytes (by 25.2%, 34.1%, and 27.4%, respectively; P < 0.05). Sterol regulatory element-binding protein-1 (SREBP-1c), fatty acid synthase (FASN), and acetyl-coenzyme A carboxylase-1 (ACC1) were down-regulated in pteryxin-treated 3T3-L1 adipocytes (by 18%, 36.1%, and 38.2%, P < 0.05) and HepG2 hepatocytes (by 72.3%, 62.9%, and 38.8%, respectively; P < 0.05). The adipocyte size marker gene, paternally expressed genel/ mesoderm specific transcript (MEST) was down-regulated (by 42.8%; P < 0.05), and hormone-sensitive lipase, a lipid catabolizing gene was up-regulated (by 15.1%; P < 0.05) in pteryxin-treated adipocytes. The uncoupling protein 2 (by 77.5%; P < 0.05) and adiponectin (by 76.3%; P > 0.05) were up-regulated due to pteryxin.
   Conclusion: Our study demonstrated that pteryxin in PJT plays the key role in regulating the lipid metabolism-related gene network and improving energy production in vitro. Thus, the results suggest pteryxin as a new natural compound to be used as an antiobesity drug in the pharmaceutical industry. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Nugara, Ruwani N.] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan.
   [Nugara, Ruwani N.; Inafuku, Masashi; Iwasaki, Hironori; Oku, Hirosuke] Univ Ryukyus, Trop Biosphere Res Ctr, Ctr Mol Biosci, Okinawa, Japan.
   [Takara, Kensaku] Univ Ryukyus, Fac Agr, Dept Biosci & Biotechnol, Okinawa, Japan.
C3 Kagoshima University; University of the Ryukyus; University of the
   Ryukyus
RP Oku, H (corresponding author), Univ Ryukyus, Trop Biosphere Res Ctr, Ctr Mol Biosci, Okinawa, Japan.
EM Okuhiros@comb.u-ryukyu.ac.jp
RI Iwasaki, Hironori/AGZ-5293-2022
OI Nugara, Ruwani/0000-0003-4424-7868; Iwasaki,
   Hironori/0000-0001-6695-1819
CR Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100
   Adams M, 2009, J ETHNOPHARMACOL, V121, P343, DOI 10.1016/j.jep.2008.11.010
   Akihisa T, 2003, CANCER LETT, V201, P133, DOI 10.1016/S0304-3835(03)00466-X
   Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x
   [Anonymous], 2013, OB OV
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Bandyopadhyay GK, 2012, J BIOL CHEM, V287, P23141, DOI 10.1074/jbc.M111.335877
   Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200
   Cerejeira J, 2012, Front Neurol, V3, P73, DOI 10.3389/fneur.2012.00073
   Chang YC, 2012, BIOCHEM BIOPH RES CO, V422, P423, DOI 10.1016/j.bbrc.2012.05.008
   Chen IS, 1996, PHYTOCHEMISTRY, V41, P525, DOI 10.1016/0031-9422(95)00625-7
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966
   Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111
   Flowers MT, 2006, J CLIN INVEST, V116, P1478, DOI 10.1172/JCI28774
   Frank J, 2003, J AGR FOOD CHEM, V51, P2526, DOI 10.1021/jf026127k
   Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539
   Genome Research Center, 2002, MEPHAS
   Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008
   Hisamoto M, 2003, J AGR FOOD CHEM, V51, P5255, DOI 10.1021/jf0262458
   Holness MJ, 2012, FEBS OPEN BIO, V2, P32, DOI 10.1016/j.fob.2012.02.003
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Jeong YS, 2012, NUTR RES, V32, P514, DOI 10.1016/j.nutres.2012.06.001
   Jin LN, 2012, MOL CELL ENDOCRINOL, V358, P81, DOI 10.1016/j.mce.2012.02.025
   Alonso-Castro AJ, 2008, J ETHNOPHARMACOL, V120, P458, DOI 10.1016/j.jep.2008.09.019
   Lii CK, 2012, FOOD CHEM TOXICOL, V50, P478, DOI 10.1016/j.fct.2011.11.020
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Nishino Naonobu, 2007, Kobe J Med Sci, V53, P99
   Nishiyama T, 2005, J AGR FOOD CHEM, V53, P959, DOI 10.1021/jf0483873
   Nugara RN, 2014, NUTRITION, V30, P575, DOI 10.1016/j.nut.2013.09.017
   Nukitrangsan N, 2012, LSMR, V22, P28
   Nukitrangsan N, 2012, J OLEO SCI, V61, P89, DOI 10.5650/jos.61.89
   Ohara K, 2009, PHYTOMEDICINE, V16, P130, DOI 10.1016/j.phymed.2008.09.012
   Raichur S, 2007, J MOL ENDOCRINOL, V39, P29, DOI 10.1677/jme.1.00010
   Schrauwen P, 2002, J EXP BIOL, V205, P2275
   Shan TZ, 2013, FASEB J, V27, P277, DOI 10.1096/fj.12-211516
   Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665
   Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004
   TAKEUCHI N, 1991, CHEM PHARM BULL, V39, P1415, DOI 10.1248/cpb.39.1415
   Tan BE, 2012, FRONT BIOSCI-LANDMRK, V17, P2237, DOI 10.2741/4047
   Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011
   Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a
   Yahagi T, 2012, CHEM PHARM BULL, V60, P129, DOI 10.1248/cpb.60.129
   Yang LH, 2007, PHARMACOL RES, V56, P202, DOI 10.1016/j.phrs.2007.05.007
   Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200
   Zhang XH, 2012, NUTR RES PRACT, V6, P286
NR 46
TC 34
Z9 35
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD OCT
PY 2014
VL 30
IS 10
BP 1177
EP 1184
DI 10.1016/j.nut.2014.01.015
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AP5KB
UT WOS:000342117000013
PM 24993752
DA 2025-04-28
ER

PT J
AU Jayedi, A
   Norouziasl, R
   Aletaha, A
   Mirrafiei, A
   Soltani, A
   Shab-Bidar, S
AF Jayedi, Ahmad
   Norouziasl, Reyhane
   Aletaha, Azadeh
   Mirrafiei, Amin
   Soltani, Akbar
   Shab-Bidar, Sakineh
TI Comparative effects of tea and coffee drinking on body weight in adults:
   a systematic review and network meta-analysis of randomised trials
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Review
DE Adiposity; Weight loss; Tea; Coffee; Meta-analysis
ID GREEN TEA; METABOLIC SYNDROME; INSULIN-RESISTANCE; CONSUMPTION;
   CHOLESTEROL; POLYPHENOLS; OVERWEIGHT; CATECHINS; INDEXES; RISK
AB We aimed at quantifying the effects of different tea and coffee on weight loss in adults. We searched PubMed, Scopus, CENTRAL and grey literature sources to July 2024. The study excluded cross-over trials without washout period, those in critically ill patients, pregnant or breast-feeding women, multicomponent interventions and active control groups with tea or coffee. A random-effects network meta-analysis with a Bayesian framework was performed to calculate the mean difference (MD) and 95 % credible intervals (CrIs). The certainty of evidence was rated using the Grading of Recommendations Assessment, Development, and Evaluation approach, and risk of bias was assessed using Cochrane tool. Twenty-two randomised controlled trials with 1710 participants (average intervention duration = 10 weeks) were included. Green tea was effective for weight loss compared with placebo (MD: -1<middle dot>23 kg, 95 % CrI: -2<middle dot>45, -0<middle dot>02; low certainty evidence) or water (MD: -1<middle dot>61 kg, 95 % CrI: -2<middle dot>90, -0<middle dot>35; very low certainty evidence), while other beverages (coffee, decaffeinated coffee, green coffee, black tea and sour tea) were not. Green tea was effective for weight loss compared with water in sensitivity analysis of healthy individuals (MD: -3<middle dot>31 kg, 95 % CrI: -5<middle dot>83, -1<middle dot>04). Based on very low to low certainty evidence, green tea drinking may result in a small weight loss in adults. This study mainly focused on weight loss effects of green tea and coffee, with limited data on other teas. Only five trials had longer intervention durations, suggesting future research on long-term effects. Most trials had high bias risk and low certainty, requiring more high-quality trials.
C1 [Jayedi, Ahmad] Semnan Univ Med Sci, Social Determinants Hlth Res Ctr, Semnan, Iran.
   [Jayedi, Ahmad; Norouziasl, Reyhane; Mirrafiei, Amin; Shab-Bidar, Sakineh] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.
   [Aletaha, Azadeh; Soltani, Akbar] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Evidence Based Med Res Ctr, Tehran, Iran.
C3 Semnan University of Medical Sciences; Tehran University of Medical
   Sciences; Tehran University of Medical Sciences
RP Shab-Bidar, S (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.
EM s_shabbidar@tums.ac.ir
RI Aletaha, Azadeh/AAO-3688-2021; Jayedi, Ahmad/E-7237-2017; Shab-Bidar,
   Sakineh/H-9525-2017
OI Norouziasl, Reyhane/0009-0006-0808-4212; Shab-Bidar,
   Sakineh/0000-0002-0167-7174
FU Evidence Based Medicine Research Center, Endocrinology and Metabolism
   Clinical Sciences Institute, Tehran University of Medical Sciences,
   Tehran, Iran [63681]
FX This study was supported by Evidence Based Medicine Research Center,
   Endocrinology and Metabolism Clinical Sciences Institute, Tehran
   University of Medical Sciences, Tehran, Iran (grant number: 63681).
CR Ades AE, 2006, PHARMACOECONOMICS, V24, P1, DOI 10.2165/00019053-200624010-00001
   Ahmed Al-Naggar R., 2022, RES J PHARM BIOL CHE, V4, P1649
   Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Asbaghi O, 2021, COMPLEMENT MED RES, V28, P244, DOI 10.1159/000511665
   Asbaghi O, 2020, COMPLEMENT THER MED, V51, DOI 10.1016/j.ctim.2020.102424
   BAK AAA, 1989, NEW ENGL J MED, V321, P1432, DOI 10.1056/NEJM198911233212103
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Basu A, 2013, NUTR RES, V33, P180, DOI 10.1016/j.nutres.2012.12.010
   Bohn SK, 2014, FOOD FUNCT, V5, P1613, DOI 10.1039/c4fo00209a
   Brignardello-Petersen R, 2018, J CLIN EPIDEMIOL, V93, P36, DOI 10.1016/j.jclinepi.2017.10.005
   Cardoso GA, 2013, J MED FOOD, V16, P120, DOI 10.1089/jmf.2012.0062
   Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654
   Colonetti L, 2022, NUTR RES, V104, P1, DOI 10.1016/j.nutres.2022.03.009
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Higgins JPT., 2021, Cochrane handbook for systematic reviews of interventions
   Hochkogler CM, 2019, J FUNCT FOODS, V56, P40, DOI 10.1016/j.jff.2019.02.009
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Jayedi A., 2022, PROSPERO
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Kobayashi M, 2016, FOOD FUNCT, V7, P498, DOI [10.1039/C5FO00750J, 10.1039/c5fo00750j]
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Lin Y, 2020, PHYTOTHER RES, V34, P2459, DOI 10.1002/ptr.6697
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Mortazavi F, 2019, NUTR FOOD SCI, V49, P32, DOI [10.1108/nfs-03-2018-0091, 10.1108/NFS-03-2018-0091]
   Mousavi A, 2013, J RES MED SCI, V18, P1080
   Mozaffari-Khosravi H., 2009, Iranian Journal of Endocrinology and Metabolism, V10, P589
   Nabi BN., 2018, IRAN RED CRESCENT ME, V20
   Ohnaka Keizo, 2012, J Nutr Metab, V2012, P207426, DOI 10.1155/2012/207426
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Revuelta-Iniesta R., 2014, BioMed Research International, V2014, P482704
   Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Schunemann, 2011, J CLIN EPIDEMIOL, V64, P383
   Schwingshackl L, 2020, ADV NUTR, V11, P1108, DOI 10.1093/advances/nmaa056
   Sharifi-Zahabi E, 2021, COMPLEMENT THER MED, V57, DOI 10.1016/j.ctim.2020.102659
   Shi Q., 2024, LANCET, V403, P1321
   Shi QY, 2022, LANCET, V399, P259, DOI 10.1016/S0140-6736(21)01640-8
   SUPERKO HR, 1991, AM J CLIN NUTR, V54, P599, DOI 10.1093/ajcn/54.3.599
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Tomás-Barberán FA, 2012, J AGR FOOD CHEM, V60, P8773, DOI 10.1021/jf300671j
   Toolsee NA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/412379
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   VANDUSSELDORP M, 1991, ARTERIOSCLER THROMB, V11, P586, DOI 10.1161/01.ATV.11.3.586
   Verma HarshV., 2013, Asia-Pacific Journal of Management Research and Innovation, V9, P157, DOI DOI 10.1177/2319510X13504283
   Senger AEV, 2012, J NUTR HEALTH AGING, V16, P738, DOI 10.1007/s12603-012-0081-5
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yi MS, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900389
   Zheng XY, 2016, PHARMACOL BIOCHEM BE, V140, P82, DOI 10.1016/j.pbb.2015.10.019
NR 52
TC 0
Z9 0
U1 4
U2 4
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD NOV 14
PY 2024
VL 132
IS 9
BP 1245
EP 1254
DI 10.1017/S0007114524001867
EA NOV 2024
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA O2C1O
UT WOS:001351969100001
PM 39497467
DA 2025-04-28
ER

PT J
AU Zheng, XC
   Dai, WC
   Chen, XH
   Wang, KY
   Zhang, WQ
   Liu, L
   Hou, JL
AF Zheng, Xinchun
   Dai, Wencong
   Chen, Xiaohui
   Wang, Kunyuan
   Zhang, Wenqing
   Liu, Li
   Hou, Jinlin
TI Caffeine reduces hepatic lipid accumulation through regulation of
   lipogenesis and ER stress in zebrafish larvae
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Article
DE Caffeine; Zebrafish; Fatty liver; ER stress; Lipogenesis
ID FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; TYPE-2
   DIABETES-MELLITUS; DIET-INDUCED OBESITY; B-VIRUS X; NONALCOHOLIC
   STEATOHEPATITIS; COFFEE CONSUMPTION; HEPATOCELLULAR-CARCINOMA;
   GENE-EXPRESSION; TEA CONSUMPTION
AB Background: Caffeine, the main component of coffee, has showed its protective effect on non-alcoholic fatty liver disease (NAFLD) in many studies. However, the hepatoprotection of caffeine and its mechanisms in zebrafish were unexplored. Thus, this study's intentions are to establish a NAFLD model of zebrafish larvae and to examine the role of caffeine on fatty liver with the model.
   Results: Growth and the incidence of fatty liver of zebrafish larvae increased with the increased amount of feeding in a dose-dependent manner. The degree of hepatic steatosis of larvae also gradually aggravated with the increased quantity and duration of feeding. Triglyceride contents of zebrafish fed for 20 days significantly increased in model group (180 mg/d) compared with control group (30 mg/d) (P < 0.001). Significant decreases in body weight and hepatic steatosis rate were observed in 2.5, 5, 8 % caffeine treatment group compared with model group (P < 0.05). Hepatic lipid accumulation was also significantly reduced in caffeine treatment larvae. Moreover, caffeine treatment was associated with upregulation of lipid beta-oxidation gene ACO and downregulation of lipogenesis-associated genes (SREBP1, ACC1, CD36 and UCP2), ER stress-associated genes (PERK, IRE1, ATF6 and BIP), the inflammatory cytokine genes (IL-1beta and TNF alpha) and autophagy associated genes (ATG12 and Beclin 1). Protein expression of CHOP, BIP and IL-1beta remarkably reduced in caffeine treatment group compared with model group.
   Conclusions: We induced hepatoteatosis in zebrafish by overfeeding regimen and demonstrated caffeine have a role in suppression of hepatosteatosis by downregulation of genes associated with lipogenesis, ER stress, inflammatory response and enhancement of lipid oxidation, indicating zebrafish model may be used to identify putative pharmacological targets and to test novel drugs for human NAFLD treatment.
C1 [Zheng, Xinchun; Dai, Wencong; Wang, Kunyuan; Liu, Li; Hou, Jinlin] Southern Med Univ, Guangdong Prov Key Lab Viral Hepatitis Res, Dept Infect Dis, Nanfang Hosp,State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China.
   [Chen, Xiaohui; Zhang, Wenqing] Southern Med Univ, Dept Cell Biol, Key Lab Zebrafish Modeling & Drug Screening Human, Guangdong Higher Educ Inst, Guangzhou 510515, Guangdong, Peoples R China.
C3 Southern Medical University - China; Southern Medical University - China
RP Liu, L (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Viral Hepatitis Res, Dept Infect Dis, Nanfang Hosp,State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China.
EM liliu.fimmu@gmail.com; jlhousmu@163.com
RI zhang, wenqing/GYA-0786-2022; zheng, xinchun/AAD-1492-2019
FU Major Science and Technology Special Project of China [2012ZX10002-003]
FX This work was supported by grants from the Major Science and Technology
   Special Project of China (2012ZX10002-003). We express our gratitude to
   professor Wu dehua and his group for experimental assistance. We also
   thank for professor Zhang wenqing and Zhang yiyue and his team for
   teaching us the fundamental techniques for zebrafish research.
CR Amali AA, 2006, J BIOMED SCI, V13, P225, DOI 10.1007/s11373-005-9055-5
   Arauz J, 2013, J APPL TOXICOL, V33, P970, DOI 10.1002/jat.2788
   Asaoka Y, 2013, DIS MODEL MECH, V6, P905, DOI 10.1242/dmm.011981
   Baek JS, 2012, CHOLESTEROL, DOI 10.1155/2012/564705
   Baumgardner JN, 2008, AM J PHYSIOL-GASTR L, V294, pG27, DOI 10.1152/ajpgi.00296.2007
   Birerdinc A, 2012, ALIMENT PHARM THER, V35, P76, DOI 10.1111/j.1365-2036.2011.04916.x
   Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032
   Bravi F, 2007, HEPATOLOGY, V46, P430, DOI 10.1002/hep.21708
   Della Corte C, 2013, PAEDIAT CHILD HLTH, V23, P529
   Dranoff JA, 2014, HEPATOLOGY
   Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Gutiérrez-Grobe Y, 2012, ANN HEPATOL, V11, P350, DOI 10.1016/S1665-2681(19)30931-7
   Her GM, 2013, BBA-MOL CELL BIOL L, V1831, P1037, DOI 10.1016/j.bbalip.2013.02.002
   Her GM, 2011, BBA-MOL CELL BIOL L, V1811, P536, DOI 10.1016/j.bbalip.2011.06.011
   Hiramitsu M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03708
   Hosoi T, 2014, NEUROSCI LETT, V569, P23, DOI 10.1016/j.neulet.2014.03.053
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jang MH, 2002, J KOREAN MED SCI, V17, P674, DOI 10.3346/jkms.2002.17.5.674
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Johnson S, 2011, CANCER CAUSE CONTROL, V22, P503, DOI 10.1007/s10552-010-9725-0
   Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048
   Katayama M, 2014, CLIN NUTR, V33, P302, DOI 10.1016/j.clnu.2013.05.006
   KLATSKY AL, 1992, AM J EPIDEMIOL, V136, P1248, DOI 10.1093/oxfordjournals.aje.a116433
   Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044
   Leung WWM, 2011, J EPIDEMIOL COMMUN H, V65, P556, DOI 10.1136/jech.2009.104125
   Liu WT, 2012, HEPATOLOGY, V56, P2268, DOI 10.1002/hep.25914
   Lu J-W, 2013, ACTA HISTOCHEM
   Matsumoto T, 2010, DIS MODEL MECH, V3, P431, DOI 10.1242/dmm.002311
   Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001
   Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21
   Pai WY, 2013, TRANSGENIC RES, V22, P823, DOI 10.1007/s11248-012-9685-0
   Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667
   POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114
   Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039
   Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Ruhl CE, 2005, GASTROENTEROLOGY, V128, P24, DOI 10.1053/j.gastro.2004.09.075
   Ruhl CE, 2005, GASTROENTEROLOGY, V129, P1928, DOI 10.1053/j.gastro.2005.08.056
   Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074
   Sapp V, 2014, HEPATOLOGY, V60, P1581, DOI 10.1002/hep.27284
   Schlegel A, 2012, CELL MOL LIFE SCI, V69, P3953, DOI 10.1007/s00018-012-1037-y
   Shieh YS, 2010, BBA-MOL CELL BIOL L, V1801, P721, DOI 10.1016/j.bbalip.2010.04.008
   Sinha RA, 2013, HEPATOLOGY
   Sterling RK, 2003, GASTROENTEROLOGY, V124, pA705, DOI 10.1016/S0016-5085(03)83563-1
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Tainaka T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-88
   Thakur PC, 2011, HEPATOLOGY, V54, P452, DOI 10.1002/hep.24349
   Torres DM, 2013, GASTROENTEROLOGY, V144, P670, DOI 10.1053/j.gastro.2013.02.015
   Watanabe S, 2005, HEPATOL RES, V33, P161, DOI 10.1016/j.hepres.2005.09.026
   Watanabe S, 2007, J GASTROEN HEPATOL, V22, pS96, DOI 10.1111/j.1440-1746.2006.04665.x
   Yin HQ, 2006, TOXICOL SCI, V94, P206, DOI 10.1093/toxsci/kfl078
   YOSHIOKA K, 1990, J NUTR SCI VITAMINOL, V36, P173, DOI 10.3177/jnsv.36.173
   Zheng GD, 2004, IN VIVO, V18, P55
   Zou YH, 2006, LIFE SCI, V79, P1100, DOI 10.1016/j.lfs.2006.03.021
NR 58
TC 76
Z9 80
U1 7
U2 91
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD NOV 17
PY 2015
VL 22
AR 105
DI 10.1186/s12929-015-0206-3
PG 12
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA CW8UH
UT WOS:000365274300004
PM 26572131
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Ohara, T
   Muroyama, K
   Yamamoto, Y
   Murosaki, S
AF Ohara, Tatsuya
   Muroyama, Koutarou
   Yamamoto, Yoshihiro
   Murosaki, Shinji
TI A Combination of Glucosyl Hesperidin and Caffeine Exhibits an
   Anti-obesity Effect by Inhibition of Hepatic Lipogenesis in Mice
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE glucosyl hesperidin; caffeine; anti-obesity effect; lipogenesis; liver
ID SERUM TRIGLYCERIDE LEVEL; METABOLIC SYNDROME; HEPG2 CELLS;
   CARDIOVASCULAR-DISEASE; LIPID-ACCUMULATION; CITRIC-ACID; KK MICE;
   ARGININE; MIXTURE; ADIPOSITY
AB To develop an anti-obesity agent, we examined the combination effect of glucosyl hesperidin (G-hesperidin) and caffeine on obesity in mice. High-fat diet-induced obese KK mice were fed a low-fat diet with or without G-hesperidin, caffeine, or their combination for 2weeks. Decreases in body weight and significantly lower adipose tissue weight were observed in the combination-fed mice but not in the G-hesperidin-fed or caffeine-fed mice. DNA microarray analysis of mouse liver suggested that the feeding of G-hesperidin+caffeine was associated with lower lipogenesis. Therefore, we examined the anti-lipogenic effect of G-hesperidin+caffeine in fasted-refed KK mice. Hepatic triglyceride levels were significantly lower in the mice fed G-hesperidin+caffeine during the refeeding period but not in the mice fed each alone. In addition, hepatic expressions of genes related to lipogenesis, such as sterol regulatory element-binding protein-1c or fatty acid synthase, were significantly lower in the mice fed G-hesperidin+caffeine compared with that in the control mice. These results suggested that G-hesperidin+caffeine is effective for controlling obesity partly by the inhibition of hepatic lipogenesis. Copyright (c) 2014 John Wiley & Sons, Ltd.
C1 [Ohara, Tatsuya; Muroyama, Koutarou; Yamamoto, Yoshihiro; Murosaki, Shinji] House Wellness Foods Corp, Inst Res & Dev, Itami, Hyogo 6640011, Japan.
RP Ohara, T (corresponding author), House Wellness Foods Corp, Inst Res & Dev, 3-20 Imoji, Itami, Hyogo 6640011, Japan.
EM Ohara_Tatsuya@house-wf.co.jp
CR Akiyama S, 2009, BIOSCI BIOTECH BIOCH, V73, P2779, DOI 10.1271/bbb.90576
   ASTRUP A, 1992, METABOLISM, V41, P686, DOI 10.1016/0026-0495(92)90304-S
   Castellani LW, 2008, J BIOL CHEM, V283, P11633, DOI 10.1074/jbc.M708995200
   Chiba H, 2003, J NUTR, V133, P1892, DOI 10.1093/jn/133.6.1892
   COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155
   Garg A, 2001, PHYTOTHER RES, V15, P655, DOI 10.1002/ptr.1074
   HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5
   Hijiya H., 1991, European Patent, Patent No. 0402049
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9
   HY-YA M., 2011, JPN PHARMACOL THER, V39, P727
   Jung UJ, 2006, INT J BIOCHEM CELL B, V38, P1134, DOI 10.1016/j.biocel.2005.12.002
   Koutsari C, 2006, J LIPID RES, V47, P1643, DOI 10.1194/jlr.R600011-JLR200
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   LEIJTEN PAA, 1984, J PHYSIOL-LONDON, V357, P327, DOI 10.1113/jphysiol.1984.sp015502
   McCarthy MF, 2004, MED HYPOTHESES, V63, P1065, DOI 10.1016/j.mehy.2002.11.002
   Miwa Y, 2005, J NUTR SCI VITAMINOL, V51, P460, DOI 10.3177/jnsv.51.460
   Miwa Y, 2004, J NUTR SCI VITAMINOL, V50, P211, DOI 10.3177/jnsv.50.211
   Miwa Y, 2006, J NUTR SCI VITAMINOL, V52, P223, DOI 10.3177/jnsv.52.223
   Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Muroyama K, 2003, J NUTR SCI VITAMINOL, V49, P56, DOI 10.3177/jnsv.49.56
   Muroyama K, 2003, BIOSCI BIOTECH BIOCH, V67, P2325, DOI 10.1271/bbb.67.2325
   Ninomiya T, 2007, STROKE, V38, P2063, DOI 10.1161/STROKEAHA.106.479642
   Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342
   Parks EJ, 1999, J CLIN INVEST, V104, P1087, DOI 10.1172/JCI6572
   Plump AS, 1997, J LIPID RES, V38, P1033
   Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153
   Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554
   Yamada M, 2006, BIOSCI BIOTECH BIOCH, V70, P1386, DOI 10.1271/bbb.50657
NR 30
TC 22
Z9 23
U1 1
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD FEB
PY 2015
VL 29
IS 2
BP 310
EP 316
DI 10.1002/ptr.5258
PG 7
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA CA7DB
UT WOS:000349076500016
PM 25409936
DA 2025-04-28
ER

PT J
AU Tusevski, O
   Todorovska, M
   Stanoeva, JP
   Simic, SG
AF Tusevski, Oliver
   Todorovska, Marija
   Petreska Stanoeva, Jasmina
   Gadzovska Simic, Sonja
TI Phytochemical Analysis, Biological Activities, and Docking of Phenolics
   from Shoot Cultures of Hypericum perforatum L. Transformed by
   Agrobacterium rhizogenes
SO MOLECULES
LA English
DT Article
DE biological activities; Hypericum perforatum; molecular docking; phenolic
   compounds; transformed shoots
ID CELL-SUSPENSION CULTURES; ST-JOHNS-WORT; IN-VITRO; ALPHA-AMYLASE;
   MEDIATED TRANSFORMATION; XANTHONE BIOSYNTHESIS; TEA EXTRACTS; HAIRY
   ROOTS; INHIBITORS; CHOLINESTERASE
AB Hypericum perforatum transformed shoot lines (TSL) regenerated from corresponding hairy roots and non-transformed shoots (NTS) were comparatively evaluated for their phenolic compound contents and in vitro inhibitory capacity against target enzymes (monoamine oxidase-A, cholinesterases, tyrosinase, alpha-amylase, alpha-glucosidase, lipase, and cholesterol esterase). Molecular docking was conducted to assess the contribution of dominant phenolic compounds to the enzyme-inhibitory properties of TSL samples. The TSL extracts represent a rich source of chlorogenic acid, epicatechin and procyanidins, quercetin aglycone and glycosides, anthocyanins, naphthodianthrones, acyl-phloroglucinols, and xanthones. Concerning in vitro bioactivity assays, TSL displayed significantly higher acetylcholinesterase, tyrosinase, alpha-amylase, pancreatic lipase, and cholesterol esterase inhibitory properties compared to NTS, implying their neuroprotective, antidiabetic, and antiobesity potential. The docking data revealed that pseudohypericin, hyperforin, cadensin G, epicatechin, and chlorogenic acid are superior inhibitors of selected enzymes, exhibiting the lowest binding energy of ligand-receptor complexes. Present data indicate that H. perforatum transformed shoots might be recognized as an excellent biotechnological system for producing phenolic compounds with multiple health benefits.
C1 [Tusevski, Oliver; Todorovska, Marija; Gadzovska Simic, Sonja] Ss Cyril & Methodius Univ Skopje, Inst Biol, Fac Nat Sci & Math, Skopje 1000, North Macedonia.
   [Petreska Stanoeva, Jasmina] Ss Cyril & Methodius Univ Skopje, Inst Chem, Fac Nat Sci & Math, Skopje 1000, North Macedonia.
C3 Saints Cyril & Methodius University of Skopje; Saints Cyril & Methodius
   University of Skopje
RP Tusevski, O; Simic, SG (corresponding author), Ss Cyril & Methodius Univ Skopje, Inst Biol, Fac Nat Sci & Math, Skopje 1000, North Macedonia.
EM oliver.tusevski@pmf.ukim.mk; marija.todorovska@pmf.ukim.mk;
   jasmina.petreska@pmf.ukim.mk; sonjag@pmf.ukim.mk
RI Tusevski, Oliver/GOH-0581-2022; Stanoeva, Jasmina/AAW-8609-2021
OI Petreska Stanoeva, Jasmina/0000-0003-0780-0660; Tusevski,
   Oliver/0000-0002-6934-6523
CR Adisakwattana S, 2012, FOOD TECHNOL BIOTECH, V50, P11
   Algethami FK, 2021, MOLECULES, V26, DOI 10.3390/molecules26175214
   Altun ML, 2013, IND CROP PROD, V43, P87, DOI 10.1016/j.indcrop.2012.07.017
   Avato P, 2004, PHARM BIOL, V42, P83, DOI 10.1080/13880200490505663
   Bandaruk Y, 2012, J AGR FOOD CHEM, V60, P10270, DOI 10.1021/jf303055b
   Bertoli A, 2008, J AGR FOOD CHEM, V56, P5078, DOI 10.1021/jf0729107
   Brasili E, 2016, FRONT PLANT SCI, V7, DOI [10.3359/fpls.7016.00507, 10.3389/fpls.2016.00507]
   Bruni R, 2009, MOLECULES, V14, P682, DOI 10.3390/molecules14020682
   Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i
   Bulgakov VP, 2008, BIOTECHNOL ADV, V26, P318, DOI 10.1016/j.biotechadv.2008.03.001
   Charchoglyan A, 2007, PHYTOCHEMISTRY, V68, P2670, DOI 10.1016/j.phytochem.2007.06.004
   Cui XH, 2010, BIORESOURCE TECHNOL, V101, P4708, DOI 10.1016/j.biortech.2010.01.115
   Dhiman P, 2019, MOLECULES, V24, DOI 10.3390/molecules24030418
   Dong Q, 2021, MOLECULES, V26, DOI 10.3390/molecules26154566
   Filippini R, 2010, FITOTERAPIA, V81, P115, DOI 10.1016/j.fitote.2009.08.002
   Franklin G, 2007, PLANT SCI, V172, P1193, DOI 10.1016/j.plantsci.2007.02.017
   Franklin G, 2009, PHYTOCHEMISTRY, V70, P60, DOI 10.1016/j.phytochem.2008.10.016
   Gadzovska S, 2005, PLANT PHYSIOL BIOCH, V43, P591, DOI 10.1016/j.plaphy.2005.05.005
   Gao JJ, 2013, MOLECULES, V18, P11614, DOI 10.3390/molecules180911614
   Greig NH, 2002, INT PSYCHOGERIATR, V14, P77, DOI 10.1017/S1041610203008676
   Hou WN, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00879
   Hou XD, 2020, INT J BIOL MACROMOL, V145, P620, DOI 10.1016/j.ijbiomac.2019.12.231
   Ibrahim SRM, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12844
   Ion V, 2022, SEPARATIONS, V9, DOI 10.3390/separations9010017
   Ji HF, 2006, J MOL STRUC-THEOCHEM, V767, P3, DOI 10.1016/j.theochem.2006.04.041
   Kapoor S, 2023, BIOCHEM SYST ECOL, V110, DOI 10.1016/j.bse.2023.104702
   Khaw KY, 2014, PHYTOMEDICINE, V21, P1303, DOI 10.1016/j.phymed.2014.06.017
   Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033
   Komarovská H, 2009, Z NATURFORSCH C, V64, P864
   Kwiecien I, 2015, PLANT CELL TISS ORG, V123, P273, DOI 10.1007/s11240-015-0830-3
   Liang HL, 2007, J SCI FOOD AGR, V87, P1748, DOI 10.1002/jsfa.2913
   Liu Y, 2013, J PHYS CHEM B, V117, P13464, DOI 10.1021/jp4067235
   Llorent-Martínez EJ, 2018, NEW J CHEM, V42, P5204, DOI 10.1039/c8nj00347e
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Mulinacci N, 2008, PLANT PHYSIOL BIOCH, V46, P414, DOI 10.1016/j.plaphy.2007.12.005
   Murthy HN, 2014, APPL MICROBIOL BIOT, V98, P9187, DOI 10.1007/s00253-014-6119-3
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Nigutová K, 2019, J PHARM PHARMACOL, V71, P46, DOI 10.1111/jphp.12782
   Oliveira AI, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01004
   Orhan G, 2006, LETT DRUG DES DISCOV, V3, P268, DOI 10.2174/157018006776743215
   Orhan IE, 2019, CHEM BIODIVERS, V16, DOI 10.1002/cbdv.201900017
   Pasqua G, 2003, PLANT SCI, V165, P977, DOI 10.1016/S0168-9452(03)00275-9
   Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2
   Rafailovska E, 2023, J ETHNOPHARMACOL, V302, DOI 10.1016/j.jep.2022.115899
   Rafailovska Elena, 2022, Macedonian Veterinary Review, V45, P5, DOI 10.2478/macvetrev-2021-0027
   Silva AR, 2021, IND CROP PROD, V159, DOI 10.1016/j.indcrop.2020.113053
   Shakya P, 2019, J PHARM PHARMACOL, V71, P70, DOI 10.1111/jphp.12743
   Shasmita, 2023, PLANT CELL TISS ORG, V154, P13, DOI 10.1007/s11240-023-02525-3
   Silva BA, 2004, NEUROTOX RES, V6, P119, DOI 10.1007/BF03033214
   Soelberg J, 2007, ANN BOT-LONDON, V99, P1097, DOI 10.1093/aob/mcm057
   Stringer TP, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.135
   Thakur A, 2024, J BIOMOL STRUCT DYN, V42, P148, DOI 10.1080/07391102.2023.2192805
   Tian JY, 2015, PHYTOTHER RES, V29, P86, DOI 10.1002/ptr.5230
   Tocci N, 2018, NEW PHYTOL, V217, P1099, DOI 10.1111/nph.14929
   Tusevski O, 2018, S AFR J BOT, V117, P301, DOI 10.1016/j.sajb.2018.05.030
   Tusevski O, 2014, ACTA PHYSIOL PLANT, V36, P2555, DOI 10.1007/s11738-014-1627-4
   Tusevski O, 2024, PLANT CELL TISS ORG, V156, DOI 10.1007/s11240-024-02722-8
   Tusevski O, 2024, HORTICULTURAE, V10, DOI 10.3390/horticulturae10010059
   Tusevski O, 2023, HORTICULTURAE, V9, DOI 10.3390/horticulturae9050581
   Tusevski O, 2023, PHYTON-INT J EXP BOT, V92, P921, DOI 10.32604/phyton.2023.024995
   Tusevski O, 2019, ACTA PHYSIOL PLANT, V41, DOI 10.1007/s11738-019-2919-5
   Tusevski O, 2017, PLANT CELL TISS ORG, V128, P589, DOI 10.1007/s11240-016-1136-9
   Tusevski O, 2013, CENT EUR J BIOL, V8, P1010, DOI 10.2478/s11535-013-0224-7
   Vinterhalter B, 2006, BIOL PLANTARUM, V50, P767, DOI 10.1007/s10535-006-0127-9
   Wang MT, 2019, J FUNCT FOODS, V56, P286, DOI 10.1016/j.jff.2019.03.026
   Yamamoto K, 2010, FEBS J, V277, P4205, DOI 10.1111/j.1742-4658.2010.07810.x
   Yang HX, 2021, TRENDS FOOD SCI TECH, V111, P114, DOI 10.1016/j.tifs.2021.02.063
   Yilmazer-Musa M, 2012, J AGR FOOD CHEM, V60, P8924, DOI 10.1021/jf301147n
   Zubrická D, 2015, PLANT CELL REP, V34, P1953, DOI 10.1007/s00299-015-1842-5
NR 69
TC 1
Z9 1
U1 4
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD AUG
PY 2024
VL 29
IS 16
AR 3893
DI 10.3390/molecules29163893
PG 24
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA F0Y2M
UT WOS:001307153600001
PM 39202972
OA gold
DA 2025-04-28
ER

PT J
AU Igarashi, K
   Takahashi, M
   Sato, M
AF Igarashi, Kiharu
   Takahashi, Mei
   Sato, Masato
TI VEGETABLE SOUP PRODUCED BY MIXING STEAMED SWEET POTATO WITH RICE MALT
   AND COMPONENT CHLOROGENIC ACID AMELIORATE DIABETES IN
   KK-A<SUP>Y</SUP> Mice
SO CURRENT TOPICS IN NUTRACEUTICAL RESEARCH
LA English
DT Article
DE Chlorogenic acid; Diabetes; Kidney catalase; Proteomics; Rice malt;
   Sweet potato; Vegetable soup
ID HIGH-FAT-DIET; INSULIN-RESISTANCE; ANTI-OBESE; PURIFICATION; SYNTHETASE;
   EXTRACT; GLUCOSE; ENZYMES; LEAVES; MOUSE
AB The anti-diabetic effects of sweet potato vegetable soup (SPO) prepared from steamed sweet potato and rice malt incubated at 60 degrees C for 4 h, and a component of the soup, chlorogenic, were determined in type 2 diabetic mice, KK-A(Y.).. Although improvements in the fasting blood glucose level and blood glucose levels in the oral glucose tolerance tests after feeding with SPO and chlorogenic acid were weak, improvement of leptin resistance, suppression from decrease in the kidney of anti oxidative enzyme activities measured by proteomics, especially, catalase activity, and suppression in liver FAS activity in the mice fed the SPO and chlorogenic acid, and maltase-inhibitory activity of SPO and chlorogenic acid in the vitro experiment, showed that the proposed vegetable soup may be helpful to improve type 2 diabetes and that chlorogenic acid as a component of SPO may partly contribute to its bioactive effects.
C1 [Igarashi, Kiharu; Takahashi, Mei] Yamagata Univ, Dept Bioresource Engn, Fac Agr, 1-23 Wakaba Machi, Tsuruoka, Yamagata 9978555, Japan.
   [Sato, Masato] Kushibiki Federat Agr Cooperat, 1-2 Simo Yamazoe Shonai, Tsuruoka, Yamagata 9970341, Japan.
C3 Yamagata University
RP Igarashi, K (corresponding author), Yamagata Univ, Dept Bioresource Engn, Fac Agr, 1-23 Wakaba Machi, Tsuruoka, Yamagata 9978555, Japan.
EM igarashi@tds1.tr.yamagata-u.ac.jp
FU Shonai Industrial Promotion Center as a program for formation of
   Bio-cluster in Yamagata Prefecture, Japan
FX This research was supported by a grant from Shonai Industrial Promotion
   Center as a program for formation of Bio-cluster in Yamagata Prefecture,
   Japan,
CR CAREY EM, 1970, BIOCHIM BIOPHYS ACTA, V210, P371, DOI 10.1016/0005-2760(70)90033-0
   Deguchi Y, 1998, NIPPON NOGEIK KAISHI, V72, P923
   Guglielmo CG, 2002, AM J PHYSIOL-REG I, V282, pR1405, DOI 10.1152/ajpregu.00267.2001
   HASHIMOTO T, 1981, J BIOCHEM, V90, P415, DOI 10.1093/oxfordjournals.jbchem.a133488
   Jin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120842
   Kaneto H, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/453892
   Koseki T, 1998, BIOSCI BIOTECH BIOCH, V62, P2032, DOI 10.1271/bbb.62.2032
   KUMAR S, 1970, J BIOL CHEM, V245, P4732
   Kurakane S, 2011, FOOD SCI TECHNOL RES, V17, P93, DOI 10.3136/fstr.17.93
   Lee YA, 2007, J NUTR SCI VITAMINOL, V53, P287, DOI 10.3177/jnsv.53.287
   Lin CY, 2012, PLANT FOOD HUM NUTR, V67, P303, DOI 10.1007/s11130-012-0294-0
   MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Ninomiya K, 2007, BIOORG MED CHEM LETT, V17, P3059, DOI 10.1016/j.bmcl.2007.03.051
   Nunokawa Y., 1962, J AGR CHEM SOC JAPAN, V36, P879
   Okada S, 1996, J INT MED RES, V24, P438, DOI 10.1177/030006059602400506
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   PULS W, 1977, NATURWISSENSCHAFTEN, V64, P536, DOI 10.1007/BF00483562
   Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Zang YQ, 2015, FOOD FUNCT, V6, P834, DOI [10.1039/c4fo00844h, 10.1039/C4FO00844H]
   Zang YQ, 2015, BIOSCI BIOTECH BIOCH, V79, P117, DOI 10.1080/09168451.2014.955453
   Zhao GX, 2010, BIOL PHARM BULL, V33, P759, DOI 10.1248/bpb.33.759
   Zheng W, 2008, FOOD CHEM, V106, P147, DOI 10.1016/j.foodchem.2007.05.053
NR 24
TC 2
Z9 2
U1 0
U2 10
PU NEW CENTURY HEALTH PUBLISHERS, LLC
PI COPPELL
PA PO BOX 175, COPPELL, TX 75019 USA
SN 1540-7535
J9 CURR TOP NUTRACEUT R
JI Curr. Top. Nutraceutical Res.
PD NOV
PY 2017
VL 15
IS 3-4
BP 151
EP 161
PG 11
WC Nutrition & Dietetics; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Pharmacology & Pharmacy
GA FR5DF
UT WOS:000419086400005
DA 2025-04-28
ER

PT J
AU Thielecke, F
   Rahn, G
   Böhnke, J
   Adams, F
   Birkenfeld, A
   Jordan, J
   Boschmann, M
AF Thielecke, F.
   Rahn, G.
   Boehnke, J.
   Adams, F.
   Birkenfeld, Al
   Jordan, J.
   Boschmann, M.
TI Epigallocatechin-3-gallate and postprandial fat oxidation in
   overweight/obese male volunteers: a pilot study
SO EUROPEAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE EGCG; caffeine; energy expenditure; fat oxidation; calorimetry
ID GREEN TEA; ENERGY-EXPENDITURE; SUBSTRATE UTILIZATION; METABOLIC-RATE;
   BODY-FAT; CAFFEINE; THERMOGENESIS; OBESITY; EPHEDRINE; GALLATE
AB Objectives: Drinking green tea is associated with many health benefits, including increased fat oxidation. We tested the hypothesis that epigallocatechin-3-gallate (EGCG), the main green tea catechin, increases fat oxidation in obese men.
   Methods: Ten healthy overweight/obese males (body mass index 31.3 +/- 0.8 kg/m(2)) were studied in a randomized, placebo-controlled, double-blind crossover trial. Study supplements were low EGCG (300 mg), high EGCG (600 mg), caffeine (200 mg), EGCG/caffeine (300 mg/200 mg) or placebo and were taken orally for 3 days. At the third day of supplementation, O-2 consumption and CO2 production was measured by indirect calorimetry to assess energy expenditure and fat oxidation over 4 h each after overnight fasting and after a standardized test meal.
   Results: Energy expenditure was not affected by any supplementation, neither after overnight fasting nor after the test meal. During the first 2 h after overnight fasting, fat oxidation increased by 7.7 (not significant, NS), 15.2 (NS), 26.3 (P<0.05 vs placebo) and 35.4% (P<0.01 vs placebo and low EGCG), for low EGCG, high EGCG, caffeine and EGCG/caffeine, respectively. During the first 2 h after the meal, the mean increase in fat oxidation was 33.3 (P<0.05 vs placebo), 20.2 (NS), 34.5 (P<0.05 vs placebo) and 49.4% (P<0.05 vs placebo) for low EGCG, high EGCG, caffeine and EGCG/caffeine, respectively.
   Conclusions: Low EGCG increases postprandial fat oxidation in obese men and this to the same extent as 200 mg caffeine, whereas high EGCG does not exert this effect. Fasting fat oxidation is increased only by caffeine (with or without EGCG). There is no synergism of low EGCG and 200 mg caffeine. Energy expenditure is not affected by EGCG. European Journal of Clinical Nutrition (2010) 64, 704-713; doi:10.1038/ejcn.2010.47; published online 7 April 2010
C1 [Boschmann, M.] Univ Med Berlin, Franz Volhard Clin Res Ctr, Expt & Clin Res Ctr, D-13125 Berlin, Germany.
   [Thielecke, F.] DSM Nutrit Prod, Basel, Switzerland.
   [Rahn, G.; Boehnke, J.; Adams, F.; Birkenfeld, Al; Jordan, J.; Boschmann, M.] HELIOS Clin Berlin Buch, Berlin, Germany.
C3 Berlin Institute of Health; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin; DSM NV
RP Boschmann, M (corresponding author), Univ Med Berlin, Franz Volhard Clin Res Ctr, Expt & Clin Res Ctr, Charite Campus Buch,Lindenberger Weg 80, D-13125 Berlin, Germany.
EM michael.boschmann@charite.de
RI Birkenfeld, Andreas/U-3954-2019; Thielecke, Frank/AAJ-3422-2020
OI Thielecke, Frank/0000-0003-4975-5327
FU DSM Nutritional Products
FX The authors thank Richard Gossl (DSM Nutritional Products, Kaiseraugst,
   Switzerland) for expert technical assistance. Gritt Stoffels and Stefan
   Engeli (University Hospital Charite Campus Buch, Berlin, Germany) were
   involved in the recruitment and assessment of volunteers in all human
   studies. The authors thank Dr Frida Dangardt (Sahlgrenska Academy at the
   University of Gothenburg, Sweden) for assisting in statistical analysis
   and Dr Marcella Trembley (DSM Nutritional Products, Kaiseraugst,
   Switzerland) for critical reading of the paper. Funding for this study
   was provided by DSM Nutritional Products.
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   [Anonymous], Z PHYTOTHER
   Arch JRS, 1996, INT J OBESITY, V20, P191
   Arciero PJ, 2000, METABOLISM, V49, P101, DOI 10.1016/S0026-0495(00)90888-6
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Blaak EE, 2000, ANN MED, V32, P380, DOI 10.3109/07853890008995942
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Boschmann M, 2003, J CLIN ENDOCR METAB, V88, P6015, DOI 10.1210/jc.2003-030780
   Boschmann M, 2007, J CLIN ENDOCR METAB, V92, P3334, DOI 10.1210/jc.2006-1438
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Brown CM, 2006, J CLIN ENDOCR METAB, V91, P3598, DOI 10.1210/jc.2006-0407
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   DULLOO AG, 1993, INT J OBESITY, V17, pS35
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dulloo AG, 1998, BRIT J NUTR, V80, P493, DOI 10.1017/S0007114598001573
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   DULLOO AG, 1993, NUTRITION, V9, P366
   FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   HENRY CJK, 1986, HUM NUTR-CLIN NUTR, V40C, P165
   Horton TJ, 1996, INT J OBESITY, V20, P91
   Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, pC1094, DOI 10.1152/ajpcell.00569.2004
   Jordan J, 2004, CIRCULATION, V109, P1823, DOI 10.1161/01.CIR.0000126283.99195.37
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   KAJIMOTO O, 2006, J HEALTH SCI, V1, P161
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   LANDSBERG L, 1993, INT J OBESITY S1, V17, P29
   Liles JT, 2007, BRIT J PHARMACOL, V150, P29, DOI 10.1038/sj.bjp.0706942
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Ota N, 2005, J HEALTH SCI, V51, P233, DOI 10.1248/jhs.51.233
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Rhodes MJC, 1996, P NUTR SOC, V55, P371, DOI 10.1079/PNS19960036
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Yang CS, 2000, J NUTR, V130, P2409, DOI 10.1093/jn/130.10.2409
   Yang MH, 2001, J NUTR BIOCHEM, V12, P14, DOI 10.1016/S0955-2863(00)00140-6
   Yoshioka M, 1998, BRIT J NUTR, V80, P503, DOI 10.1017/S0007114598001597
NR 48
TC 53
Z9 53
U1 0
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0954-3007
EI 1476-5640
J9 EUR J CLIN NUTR
JI Eur. J. Clin. Nutr.
PD JUL
PY 2010
VL 64
IS 7
BP 704
EP 713
DI 10.1038/ejcn.2010.47
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 621YP
UT WOS:000279623300008
PM 20372175
OA Bronze
DA 2025-04-28
ER

PT J
AU Hassen, K
   Gizaw, G
   Belachew, T
AF Hassen, Kalkidan
   Gizaw, Getu
   Belachew, Tefera
TI Dual Burden of Malnutrition Among Adolescents of Smallholder Coffee
   Farming Households of Jimma Zone, Southwest Ethiopia
SO FOOD AND NUTRITION BULLETIN
LA English
DT Article
DE adolescents; cash cropping; nutritional status; dual burden
ID PREVALENCE; OBESITY; GROWTH; OVERWEIGHT; CHILDREN; INCOME;
   UNDERNUTRITION; COMMUNITIES; AFRICA; TRENDS
AB Background: Substantial evidence is emerging on the coexistence of double burden of malnutrition on adolescents of low-income countries, shaping the health challenges of the upcoming adult generation for the worst. Whether nutritional status markers of adolescents in the cash crop setting are on par with economic gains remains uncertain. Thus, we investigated the nutritional outcomes of adolescents and their determinants in coffee farming households.
   Methods: The survey was carried out in 3 top coffee-producing districts of Jimma Zone, Ethiopia. Five hundred fifty mothers/caregivers and their respective adolescents were selected using multistage random sampling. Anthropometric data were converted into height-for-age and body-mass-index-for-age Z scores using WHO Anthroplus software and analyzed by SPSS for windows.
   Results: Prevalence of thinness, stunting, and overweight/obesity were 11.6%, 15.6%, and 7.1%, respectively. The odds of stunting among adolescents in households in the lowest wealth tertile was nearly 6-fold higher compared to the highest tertile (adjusted odds ratio [AOR] = 5.6 [2.6-12]). Conversely, the odds of overweight/obesity was higher among adolescents in the households in the middle wealth tertile (AOR = 2.72 [1.08-6.86]) compared to the highest tertile. Adolescents living in households with low-dependent age-groups were more than twice likely to be overweight/obese (AOR = 2.58 [1.06-6.24]).
   Conclusion: The current study revealed the presence of substantial dual burden of malnutrition. In such a setting, it is critical to draw a fine line and trade-off for eliminating morbidity and mortality of undernutrition, without triggering the risk of overweight/obesity.
C1 [Hassen, Kalkidan; Gizaw, Getu; Belachew, Tefera] Jimma Univ, Dept Populat & Family Hlth, Coll Hlth Sci, Jimma 378, Ethiopia.
C3 Jimma University
RP Hassen, K (corresponding author), Jimma Univ, Dept Populat & Family Hlth, Coll Hlth Sci, Jimma 378, Ethiopia.
EM kalkidan.hassen@ju.edu.et
RI Abate, Kalkidan/ABA-9014-2020; Belachew, Tefera/AAO-5877-2020
OI Belachew, Tefera/0000-0001-5455-9457; Gizaw, Getu/0000-0001-7725-2802
FU Jimma University
FX We would like to extend our deepest gratitude to Jimma University for
   financing this study. Our appreciation goes to the data collectors and
   supervisors. Lastly, our special thanks also go to children's mothers
   who participated in the study.
CR Abbassi V, 1998, PEDIATRICS, V102, P507
   Alebachew Z, 2009, PREVALENCE CHILDHOOD
   Alemu E, 2014, J NUTR FOOD SCI, V4, P2, DOI [10.4172/2155-9600.1000261, DOI 10.4172/2155-9600.1000261]
   Amamo A.A., 2014, EUR J BUS MANAG, V6, P109, DOI DOI 10.7176/EJBM
   [Anonymous], 2019, MIN DEM HLTH SURV ET
   [Anonymous], NUTR BAS SURV REP NA
   [Anonymous], ICF INT ETH DEM HLTH
   [Anonymous], 2015, AD DEV MAT NEWB CHIL
   [Anonymous], ISRN OBES
   Anteneh Zelalem Alamrew, 2015, Adv Prev Med, V2015, P294902, DOI 10.1155/2015/294902
   Assefa H, 2013, INT SCH RES NOTICES
   Bain LE, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.120.2535
   Belachew T, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-55
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Cappa C, 2012, LANCET, V379, P2324, DOI 10.1016/S0140-6736(12)60531-5
   Carrillo-Larco RM, 2016, INT J PUBLIC HEALTH, V61, P1
   Cordeiro LS, 2012, J NUTR, V142, P1741, DOI 10.3945/jn.111.155994
   Davis Kristin, 2010, International Food Policy Research Institute (IFPRI) Discussion Paper 01041
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786
   Delisle H.l. n., 2005, NUTR ADOLESCENCE ISS
   Dessalegn Ajema Jemal Haidar, 2015, ASSESSMENT MAGNITUDE
   Fan Shenggen, 2012, Reshaping agriculture for nutrition and health
   Federal Democratic Republic of Ethiopia Population Census Commission, 2008, SUMM STAT REP 2007 P
   Fentaw R, 2013, NUTR RES PRACT, V7, P122, DOI 10.4162/nrp.2013.7.2.122
   Francis A., 2010, Pakistan Journal of Nutrition, V9, P1166
   Gebremariam H., 2015, Int J Nutr Food Sci, V4, P118, DOI [10.11648/j.ijnfs.20150401.26, DOI 10.11648/J.IJNFS.20150401.26]
   Gebremedhin Berhanu., 2006, Commercialization of Ethiopian Agriculture: Extension Service from Input Supplier to Knowledge Broker and Facilitator
   Gebreyohannes Y., 2014, Int J Nutr Food Sci, V10, P11, DOI [10.11648/j.ijnfs.20140306.13, DOI 10.11648/J.IJNFS.20140306.13]
   Hadley C, 2011, AM J PHYS ANTHROPOL, V144, P643, DOI 10.1002/ajpa.21463
   Handa S, 2016, OXFORD B ECON STAT, V78, P470, DOI 10.1111/obes.12117
   Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105880
   Himashree Bhattacharyya Himashree Bhattacharyya, 2013, National Journal of Community Medicine, V4, P35
   Jennifer C, 2007, 360FANTA DC FHI, V3
   Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063
   Kanyamurwa JM, 2013, AFR HEALTH SCI, V13, P829, DOI 10.4314/ahs.v13i3.44
   Kennedy G., 2006, The double burden of malnutrition case studies from six developing countries
   Kimani-Murage EW, 2013, GLOBAL HEALTH ACTION, V6, P193, DOI 10.3402/gha.v6i0.19249
   Kimani-Murage EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129943
   Kipke MD, AD DEV BIOL PUB SUMM
   Leenstra T, 2005, EUR J CLIN NUTR, V59, P41, DOI 10.1038/sj.ejcn.1602031
   Manyanga T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-887
   Maziya N., 2014, ADOLESCENT NUTR STAT
   Melaku YA, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0093-9
   Mertz O, 2005, AGR SYST, V85, P209, DOI 10.1016/j.agsy.2005.06.007
   Milas S, 2004, 4 ETHIOPIAS REGIONAL
   Mulugeta A, 2009, ETHIOP J HEALTH DEV, V23, P5
   Navti LK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-320
   NFPA, 2015, POW 1 8 BILL AD YOUT
   Norris SA, 2014, ANN NUTR METAB, V64, P8, DOI 10.1159/000365122
   Paolisso MJ, 2002, ECON DEV CULT CHANGE, V50, P313, DOI 10.1086/322881
   Petit N, 2007, J AGRAR CHANGE, V7, P225, DOI 10.1111/j.1471-0366.2007.00145.x
   Pradeilles R, 2015, PUBLIC HEALTH NUTR, V18, P2998, DOI 10.1017/S1368980015000415
   Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI [10.3945/ajcn.112.052332, 10.3945/ajcn.113.066647]
   Soliman Ashraf, 2014, Indian J Endocrinol Metab, V18, pS39, DOI 10.4103/2230-8210.145073
   Story M., 2005, Nutrition needs of adolescents. Guidelines fo r Adolescent Nutrition Services, P21
   Teshome T, 2013, CURR RES NUTR FOOD S, V1, P23, DOI 10.12944/CRNFSJ.1.1.03
   Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210
   Wrotniak BH, 2012, PEDIATR OBES, V7, pE9, DOI [10.1111/j.2047-6310.2011.00023.x, 10.1111/j.12047-6310.2011.00023.x]
   Yetubie M, ANTHROPOMETRIC ASSES
NR 60
TC 11
Z9 11
U1 0
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0379-5721
EI 1564-8265
J9 FOOD NUTR BULL
JI Food Nutr. Bull.
PD JUN
PY 2017
VL 38
IS 2
BP 196
EP 208
DI 10.1177/0379572117701660
PG 13
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Food Science & Technology; Nutrition & Dietetics
GA EV2IF
UT WOS:000401578100009
PM 28438035
OA Bronze
DA 2025-04-28
ER

PT J
AU Wang, TG
   Huang, T
   Kang, JH
   Zheng, Y
   Jensen, MK
   Wiggs, JL
   Pasquale, LR
   Fuchs, CS
   Campos, H
   Rimm, EB
   Willett, WC
   Hu, FB
   Qi, L
AF Wang, Tiange
   Huang, Tao
   Kang, Jae H.
   Zheng, Yan
   Jensen, Majken K.
   Wiggs, Janey L.
   Pasquale, Louis R.
   Fuchs, Charles S.
   Campos, Hannia
   Rimm, Eric B.
   Willett, Walter C.
   Hu, Frank B.
   Qi, Lu
TI Habitual coffee consumption and genetic predisposition to obesity:
   gene-diet interaction analyses in three US prospective studies
SO BMC MEDICINE
LA English
DT Article
DE Gene-diet interaction; Coffee; Genetic predisposition; Body mass index;
   Obesity
ID FOOD FREQUENCY QUESTIONNAIRE; DECAFFEINATED COFFEE; INSULIN SENSITIVITY;
   GLUCOSE-TOLERANCE; CHLOROGENIC ACID; RISK; WOMEN; MEN; HEALTH;
   REPRODUCIBILITY
AB Background: Whether habitual coffee consumption interacts with the genetic predisposition to obesity in relation to body mass index (BMI) and obesity is unknown.
   Methods: We analyzed the interactions between genetic predisposition and habitual coffee consumption in relation to BMI and obesity risk in 5116 men from the Health Professionals Follow-up Study (HPFS), in 9841 women from the Nurses' Health Study (NHS), and in 5648 women from the Women's Health Initiative (WHI). The genetic risk score was calculated based on 77 BMI-associated loci. Coffee consumption was examined prospectively in relation to BMI.
   Results: The genetic association with BMI was attenuated among participants with higher consumption of coffee than among those with lower consumption in the HPFS (P-interaction = 0.023) and NHS (P-interaction = 0.039); similar results were replicated in the WHI (P-interaction = 0.044). In the combined data of all cohorts, differences in BMI per increment of 10-risk allele were 1.38 (standard error (SE), 0.28), 1.02 (SE, 0.10), and 0.95 (SE, 0.12) kg/m(2) for coffee consumption of < 1, 1-3 and > 3 cup(s)/day, respectively (P-interaction < 0.001). Such interaction was partly due to slightly higher BMI with higher coffee consumption among participants at lower genetic risk and slightly lower BMI with higher coffee consumption among those at higher genetic risk. Each increment of 10-risk allele was associated with 78% (95% confidence interval (CI), 59-99%), 48% (95% CI, 36-62%), and 43% (95% CI, 28-59%) increased risk for obesity across these subgroups of coffee consumption (P-interaction = 0.008). From another perspective, differences in BMI per increment of 1 cup/day coffee consumption were 0.02 (SE, 0.09), -0.02 (SE, 0.04), and -0.14 (SE, 0.04) kg/m(2) across tertiles of the genetic risk score.
   Conclusions: Higher coffee consumption might attenuate the genetic associations with BMI and obesity risk, and individuals with greater genetic predisposition to obesity appeared to have lower BMI associated with higher coffee consumption.
C1 [Wang, Tiange; Huang, Tao; Qi, Lu] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.
   [Wang, Tiange] Shanghai Jiao Tong Univ, Shanghai Inst Endocrine & Metab Dis, Rui Jin Hosp, Sch Med, Shanghai, Peoples R China.
   [Kang, Jae H.; Pasquale, Louis R.; Fuchs, Charles S.; Rimm, Eric B.; Willett, Walter C.; Hu, Frank B.; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   [Kang, Jae H.; Pasquale, Louis R.; Fuchs, Charles S.; Rimm, Eric B.; Willett, Walter C.; Hu, Frank B.; Qi, Lu] Harvard Med Sch, Boston, MA 02115 USA.
   [Zheng, Yan; Jensen, Majken K.; Campos, Hannia; Rimm, Eric B.; Willett, Walter C.; Hu, Frank B.; Qi, Lu] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Wiggs, Janey L.; Pasquale, Louis R.] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA USA.
   [Fuchs, Charles S.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA.
   [Campos, Hannia] Univ Hispanoamer, Ctr Res & Innovat Translat Nutr & Hlth CIINT, San Jose, Costa Rica.
   [Rimm, Eric B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
C3 Tulane University; Shanghai Jiao Tong University; Harvard University;
   Harvard University Medical Affiliates; Brigham & Women's Hospital;
   Harvard University; Harvard Medical School; Harvard University; Harvard
   T.H. Chan School of Public Health; Harvard University; Harvard Medical
   School; Harvard University Medical Affiliates; Massachusetts Eye & Ear
   Infirmary; Harvard University; Harvard Medical School; Harvard
   University Medical Affiliates; Dana-Farber Cancer Institute; Harvard
   University; Harvard T.H. Chan School of Public Health
RP Qi, L (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.; Qi, L (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Qi, L (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Qi, L (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
EM lqi1@tulane.edu
RI Ellervik, Christina/H-2977-2019; Zheng, Yan/E-7388-2018; Willett,
   Walter/E-2352-2013; Wang, Tiange/MCX-9826-2025; Huang,
   Tao/ITU-9131-2023; Hu, Frank/C-1919-2013
OI Jensen, Majken Karoline/0000-0003-4729-7545; Wang,
   Tiange/0000-0003-0723-489X
FU National Institutes of Health [P01 CA49449, UM1 CA186107, UM1 CA167552];
   National Heart, Lung, and Blood Institute [HL071981, HL034594,
   HL126024]; National Institute of Diabetes and Digestive and Kidney
   Diseases [DK091718, DK100383, DK078616]; National Eye Institute
   [EY015473]; National Human Genome Research Institute [U01 HG004728];
   United States-Israel Binational Science Foundation [2011036]; American
   Heart Association Scientist Development Award [0730094 N]; National
   Heart, Lung, and Blood Institute, National Institutes of Health, U.S.
   Department of Health and Human Services [HHSN268201100046C,
   HHSN268201100001C, HHSN268201100002C, HHSN268201100003C,
   HHSN268201100004C, HHSN271201100004C]
FX The HPFS and NHS were supported by grants P01 CA49449, UM1 CA186107, and
   UM1 CA167552 from the National Institutes of Health. This study was
   supported by grants from the National Heart, Lung, and Blood Institute
   (HL071981, HL034594, HL126024), the National Institute of Diabetes and
   Digestive and Kidney Diseases (DK091718, DK100383, DK078616), the
   National Eye Institute (EY015473), the National Human Genome Research
   Institute (U01 HG004728), and United States-Israel Binational Science
   Foundation Grant 2011036. Dr. Lu Qi was a recipient of the American
   Heart Association Scientist Development Award (0730094 N). The WHI
   program is funded by the National Heart, Lung, and Blood Institute,
   National Institutes of Health, U.S. Department of Health and Human
   Services through contracts HHSN268201100046C, HHSN268201100001C,
   HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and
   HHSN271201100004C. This manuscript was not prepared in collaboration
   with investigators of the WHI, has not been reviewed and/or approved by
   the WHI, and does not necessarily reflect the opinions of the WHI
   investigators or the NHLBI.
CR Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
   Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7
   Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49
   Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E
   Fryar C., PREVALENCE OVERWEIGH
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237
   Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075
   Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kim K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167007
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261
   Nordenvall C, 2015, CLIN GASTROENTEROL H, V13, P1096, DOI 10.1016/j.cgh.2014.09.029
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6
   Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156
   Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009
   RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211
   RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W
   Rodríguez-Morán M, 2003, DIABETES CARE, V26, P1147, DOI 10.2337/diacare.26.4.1147
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991
NR 33
TC 45
Z9 48
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD MAY 9
PY 2017
VL 15
AR 97
DI 10.1186/s12916-017-0862-0
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA EU1XW
UT WOS:000400820400001
PM 28486942
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Seguido, MA
   Tarradas, RM
   González-Rámila, S
   García-Cordero, J
   Sarriá, B
   Bravo-Clemente, L
   Mateos, R
AF Angel Seguido, Miguel
   Maria Tarradas, Rosa
   Gonzalez-Ramila, Susana
   Garcia-Cordero, Joaquin
   Sarria, Beatriz
   Bravo-Clemente, Laura
   Mateos, Raquel
TI Sustained Consumption of a Decaffeinated Green Coffee Nutraceutical Has
   Limited Effects on Phenolic Metabolism and Bioavailability in
   Overweight/Obese Subjects
SO NUTRIENTS
LA English
DT Article
DE green coffee; hydroxycinnamates; bioavailability; pharmacokinetics;
   microbial catabolites; biotransformation pathways
ID CHLOROGENIC ACIDS; BODY-COMPOSITION; EXTRACT; POLYPHENOLS
AB Knowledge on the bioavailability of coffee (poly)phenols mostly come from single dose postprandial studies. This study aimed at investigating the effects of regularly consuming a green coffee phenolic extract (GCPE) on the bioavailability and metabolism of (poly)phenols. Volunteers with overweight/obesity consumed a decaffeinated GCPE nutraceutical containing 300 mg hydroxycinnamates twice daily for two months. Plasma and urinary pharmacokinetics, and fecal excretion of phenolic metabolites were characterized by LC-MS-QToF at weeks 0 and 8. Fifty-four metabolites were identified in biological fluids. Regular consumption of the nutraceutical produced certain changes: reduced forms of caffeic, ferulic and coumaric acids in urine or 3-(3 '-hydroxypenyl)propanoic, and 3,4-dihydroxybenzoic acids in feces significantly increased (p < 0.05) after 8 weeks; in contrast, coumaroylquinic and dihydrocoumaroylquinic acids in urine decreased (p < 0.05) compared to baseline excretion. The sum of intestinal and colonic metabolites increased after sustained consumption of GCPE, without reaching statistical significance, suggesting a small overall effect on (poly)phenols' bioavailability.
C1 [Angel Seguido, Miguel; Maria Tarradas, Rosa; Gonzalez-Ramila, Susana; Garcia-Cordero, Joaquin; Sarria, Beatriz; Bravo-Clemente, Laura; Mateos, Raquel] CSIC, Dept Metab & Nutr, Inst Food Sci Technol & Nutr ICTAN CSIC, Jose Antonio Novais 10, Madrid 28040, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN)
RP Mateos, R (corresponding author), CSIC, Dept Metab & Nutr, Inst Food Sci Technol & Nutr ICTAN CSIC, Jose Antonio Novais 10, Madrid 28040, Spain.
EM m.seguido@ictan.csic.es; rosa.tarradas.valero@gmail.com;
   s.gonzalez@ictan.csic.es; j.garcia@ictan.csic.es;
   beasarria@ictan.csic.es; lbravo@ictan.csic.es;
   raquel.mateos@ictan.csic.es
RI Bravo, Laura/JMC-4928-2023; BRIZ, Raquel/H-9125-2012; Sarria,
   Beatriz/K-7929-2014; Bravo, Laura/F-4992-2012
OI Sarria, Beatriz/0000-0003-0614-4606; Seguido, Miguel
   Angel/0000-0003-3883-7503; Bravo, Laura/0000-0002-7312-8641
FU Spanish Ministry of Science and Innovation [AGL2015-69986-R]; CSIC [PIE
   202070E184]; Comunidad de Madrid [PEJD-2018-PRE/SAL-9104,
   PEJD-2017-PRE_BIO-4225]
FX This research was funded by project AGL2015-69986-R from the Spanish
   Ministry of Science and Innovation and project PIE 202070E184 funded by
   CSIC. MAS and JGC had predoctoral grants funded by Comunidad de Madrid
   (PEJD-2018-PRE/SAL-9104) and (PEJD-2017-PRE_BIO-4225), respectively.
CR Ali SS, 2020, REV CARDIOVASC MED, V21, P225, DOI 10.31083/j.rcm.2020.02.49
   Amigo-Benavent M, 2017, FOOD CHEM TOXICOL, V106, P125, DOI 10.1016/j.fct.2017.05.019
   Baeza G, 2016, J AGR FOOD CHEM, V64, P9663, DOI 10.1021/acs.jafc.6b04022
   Bastian F, 2021, FOODS, V10, DOI 10.3390/foods10112827
   Chen H, 2020, COMPLEMENT THER MED, V52, DOI 10.1016/j.ctim.2020.102498
   Clifford MN, 2020, COMPR REV FOOD SCI F, V19, P1299, DOI 10.1111/1541-4337.12518
   Cortes-Martin A, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201900952
   Dima C, 2020, COMPR REV FOOD SCI F, V19, P2862, DOI 10.1111/1541-4337.12623
   Etxeberria U, 2013, J AGR FOOD CHEM, V61, P9517, DOI 10.1021/jf402506c
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Corrêa TAF, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00188
   García-Cordero J, 2022, FOODS, V11, DOI 10.3390/foods11050679
   Gómez-Juaristi M, 2018, FOOD FUNCT, V9, P331, DOI [10.1039/c7fo01553d, 10.1039/C7FO01553D]
   Gorji Z, 2019, PHYTOMEDICINE, V63, DOI 10.1016/j.phymed.2019.153018
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Kawabata K, 2019, MOLECULES, V24, DOI 10.3390/molecules24020370
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004
   Ludwig IA, 2013, BIOFACTORS, V39, P623, DOI 10.1002/biof.1124
   Manach C, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600557
   Marín L, 2015, BIOMED RES INT-UK, V2015, DOI 10.1155/2015/905215
   Marmet C, 2014, J PHARMACEUT BIOMED, V88, P617, DOI 10.1016/j.jpba.2013.10.009
   Mena P, 2021, AM J CLIN NUTR, V114, P2107, DOI 10.1093/ajcn/nqab299
   Mena P, 2019, EUR J NUTR, V58, P1529, DOI 10.1007/s00394-018-1683-4
   Pimpley V, 2020, PREP BIOCHEM BIOTECH, V50, P969, DOI 10.1080/10826068.2020.1786699
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Sanchez-Bridge B, 2016, BIOFACTORS, V42, P259, DOI 10.1002/biof.1268
   Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d
   Stalmach A, 2014, FOOD FUNCT, V5, P1727, DOI [10.1039/c4fo00316k, 10.1039/C4FO00316K]
NR 29
TC 6
Z9 6
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUN
PY 2022
VL 14
IS 12
AR 2445
DI 10.3390/nu14122445
PG 18
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 2J8UW
UT WOS:000815925800001
PM 35745175
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU El-Kersh, DM
   Kotob, SE
   Ammar, NM
   Mohawed, OAM
   Ahmed, HH
   Farag, MA
AF El-Kersh, Dina M.
   Kotob, Soheir E.
   Ammar, Naglaa M.
   Mohawed, Ola A. M.
   Ahmed, Hanaa H.
   Farag, Mohamed A.
TI Unravelling the anti-inflammatory and antioxidant effects of
   standardized green and black caffeinated coffee, tea, and their mixtures
   in an obese male rat model: Insights from biochemical, metabolomic, and
   histopathological analyses
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Coffee and tea; Obesity; Biomarkers; Metabolomics; Serum; GC-MS
ID HEPATIC INSULIN-RESISTANCE; HIGH-FRUCTOSE DIET; CHAIN FATTY-ACIDS;
   OXIDATIVE STRESS; ADIPOSE-TISSUE; EPIGALLOCATECHIN GALLATE; CHLOROGENIC
   ACIDS; LIVER; INFLAMMATION; ANTIOBESITY
AB Obesity is one of the major metabolic syndrome risk factors upon which altered metabolic pathways follow. This study aimed to discern altered metabolic pathways associated with obesity and to pinpoint metabolite biomarkers in serum of obese rats fed on high fructose diet using metabolomics. Further, the effect of standardized green versus black caffeinated aqueous extracts (tea and coffee) in controlling obesity and its comorbidities through monitoring relevant serum biomarkers viz. Leptin, adiponectin, spexin, malondialdehyde, total antioxidant capacity. Liver tissue oxidative stress (catalase, super oxide dismutase and glutathione) and inflammation (IL-1 & beta; and IL-6) markers were assessed for green coffee and its mixture with green tea. Results revealed improvement of all parameters upon treatments with more prominence for those treated with green caffeinated extract (coffee and tea) especially in mixture. Upon comparing with obese rat group, the green mixture of coffee and tea exhibited anti-hyperlipidemic action through lowering serum triglycerides by 35.0% and elevating high density lipoprotein by 71.0%. Black tea was likewise effective in lowering serum cholesterol and low density lipoprotein by 28.0 and 50.6%, respectively. GC-MS- based metabolomics of rat serum led to the identification of 34 metabolites with obese rat serum enriched in fatty acids (oleamide).
C1 [El-Kersh, Dina M.] British Univ Egypt, Fac Pharm, Dept Pharmacognosy, Cairo 11837, Egypt.
   [Kotob, Soheir E.; Mohawed, Ola A. M.; Ahmed, Hanaa H.] Med Res & Clin Studies Inst, Natl Res Ctr, Hormones Dept, Dokki, Giza, Egypt.
   [Ammar, Naglaa M.] Natl Res Ctr, Pharmaceut & Drug Ind Res Inst, Therapeut Chem Dept, Dokki 12622, Giza, Egypt.
   [Farag, Mohamed A.] Cairo Univ, Coll Pharm, Pharmacognosy Dept, Kasr El Aini St, Cairo 11562, Egypt.
C3 Egyptian Knowledge Bank (EKB); British University in Egypt; Egyptian
   Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge
   Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank
   (EKB); Cairo University
RP El-Kersh, DM (corresponding author), British Univ Egypt, Fac Pharm, Dept Pharmacognosy, Cairo 11837, Egypt.; Farag, MA (corresponding author), Cairo Univ, Coll Pharm, Pharmacognosy Dept, Kasr El Aini St, Cairo 11562, Egypt.
EM dina.elkersh@bue.edu.eg; Mohamed.farag@pharma.cu.edu.eg
RI Elseedi, Hesham/KGK-5692-2024; Kotob, Soheir/P-3341-2015; Ammar,
   Naglaa/ACL-3524-2022
FU British University in Egypt
FX The authors would like to thank The British University in Egypt "Young
   Investigator Research Grants (YIRG)" for their financial support for
   this project entitled "A metabolomics approach of some functional foods
   in obesity management". Dina M. El-Kersh would like to thanks Prof.
   Mohamed M. Elmazar, Pharmacology department and Dean Faculty of
   Pharmacy, The British University in Egypt for his generous support in
   the statistical analysis section.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Ammar NM, 2017, J PHARMACEUT BIOMED, V142, P91, DOI 10.1016/j.jpba.2017.05.001
   [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373, DOI 10.1001/jama.2013.281053
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Awwad S, 2021, MOLECULES, V26, DOI 10.3390/molecules26247502
   Babu PVA, 2006, CHEM-BIOL INTERACT, V162, P114, DOI 10.1016/j.cbi.2006.04.009
   Bagul PK, 2012, PHARMACOL RES, V66, P260, DOI 10.1016/j.phrs.2012.05.003
   Bahrami S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8045969
   Bakhtiari A, 2017, BIOMED REP, V7, P331, DOI 10.3892/br.2017.964
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Bhandarkar NS, 2020, FASEB J, V34, P4783, DOI 10.1096/fj.201902416RR
   Bibbò S, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9321643
   Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909
   Cavarape A, 2001, J ENDOCRINOL INVEST, V24, P838, DOI 10.1007/BF03343940
   Chen JL, 2022, FRONT VET SCI, V9, DOI 10.3389/fvets.2022.806253
   Cheng H, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700303
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Choi Y, 2017, FOOD CHEM TOXICOL, V103, P111, DOI 10.1016/j.fct.2017.02.039
   Dai HJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003198
   Ghizoni CVD, 2013, MOL CELL BIOCHEM, V373, P265, DOI 10.1007/s11010-012-1499-0
   Do MH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060761
   El Rabey HA, 2021, BMC COMPLEMENT MED, V21, DOI 10.1186/s12906-020-03186-x
   El-Hawary EA, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11010131
   Pahua-Ramos ME, 2014, PLANT FOOD HUM NUTR, V69, P18, DOI 10.1007/s11130-013-0395-4
   Farag MA, 2022, FOODS, V11, DOI 10.3390/foods11091339
   Farag MA, 2022, FOODS, V11, DOI 10.3390/foods11060864
   Farag MA, 2020, J ADV RES, V23, P47, DOI 10.1016/j.jare.2020.01.001
   Farah A, 2019, COFFEE: CONSUMPTION AND HEALTH IMPLICATIONS, P364
   Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x
   Fiehn O, 2016, Curr. Protoc. Mol. Biol., V114, DOI DOI 10.1002/0471142727.MB3004S114
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Goon DE, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-00454-9
   Gupta S, 2012, J NEUROCHEM, V120, P1060, DOI 10.1111/j.1471-4159.2012.07660.x
   Hamdaoui M. H., 2016, Journal of Nutrition & Intermediary Metabolism, V6, P33, DOI 10.1016/j.jnim.2016.07.002
   Hammerich L, 2014, CLIN EXP GASTROENTER, V7, P297, DOI 10.2147/CEG.S43737
   Hiley CR, 2007, CARDIOVASC DRUG REV, V25, P46, DOI 10.1111/j.1527-3466.2007.00004.x
   Horzic D, 2009, FOOD CHEM, V115, P441, DOI 10.1016/j.foodchem.2008.12.022
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Ilmiawati C, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05042-0
   Imatoh T, 2011, EUR J NUTR, V50, P279, DOI 10.1007/s00394-010-0136-5
   Imran A, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0688-6
   Izadi V, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_37_14
   Jamal MH, 2015, INT J CLIN EXP PATHO, V8, P649
   Jeszka-Skowron M, 2016, EUR FOOD RES TECHNOL, V242, P1403, DOI 10.1007/s00217-016-2643-y
   Karri S, 2019, BIOMED PHARMACOTHER, V110, P224, DOI 10.1016/j.biopha.2018.11.076
   Khadir A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67624-z
   Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r
   Lee MK, 2019, EUR FOOD RES TECHNOL, V245, DOI 10.1007/s00217-018-3201-6
   Li F, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01366
   Li L, 2020, MOLECULES, V25, DOI 10.3390/molecules25061274
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Manna P, 2015, METAB SYNDR RELAT D, V13, P423, DOI 10.1089/met.2015.0095
   Marek G, 2015, DIABETES, V64, P508, DOI 10.2337/db14-0411
   Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173
   Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031
   Meier RPH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061295
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Mengesha T, 2021, BMC COMPLEMENT MED, V21, DOI 10.1186/s12906-021-03275-5
   Meza M.N, 2016, ROLE BIOMARK MED, V119
   Morishita F, 2001, STUD NAT PROD CHEM, V25, P919
   Mostafa-Hedeab G, 2022, SAUDI PHARM J, V30, P1293, DOI 10.1016/j.jsps.2022.06.021
   Musial C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051744
   Nakagawa T, 2002, FOOD CHEM TOXICOL, V40, P1745, DOI 10.1016/S0278-6915(02)00169-2
   Navarra G, 2017, J CHEM-NY, V2017, DOI 10.1155/2017/6435086
   NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3
   Nishioka T, 2003, J PEDIATR-US, V143, P327, DOI 10.1067/S0022-3476(03)00298-1
   Novelli ELB, 2007, LAB ANIM-UK, V41, P111, DOI 10.1258/002367707779399518
   Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052
   Pai SA, 2020, J TRADIT COMPL MED, V10, P577, DOI 10.1016/j.jtcme.2019.09.002
   Pan HB, 2016, MOLECULES, V21, DOI 10.3390/molecules21121659
   Park B, 2016, ARCH PHARM RES, V39, P310, DOI 10.1007/s12272-015-0674-8
   Park HM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010071
   Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012
   Ramos LV, 2022, J NUTR BIOCHEM, V100, DOI 10.1016/j.jnutbio.2021.108881
   Regassa A, 2013, CELL BIOL INT, V37, P961, DOI 10.1002/cbin.10122
   Reygaert WC, 2017, BEVERAGES, V3, DOI 10.3390/beverages3010006
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Said MA, 2023, ARCH PHYSIOL BIOCHEM, V129, P1111, DOI 10.1080/13813455.2021.1899242
   Salamat S., 2018, J BIOCHEM TECHNOL, V2, P75
   Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382
   Scarpace PJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3531, DOI 10.2741/2332
   Sheikh A, 2017, CUREUS J MED SCIENCE, V9, DOI 10.7759/cureus.1435
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Sirotkin AV, 2021, PHYSIOL RES, V70, P161, DOI 10.33549/physiolres.934674
   Song XF, 2013, J PHARMACEUT BIOMED, V78-79, P202, DOI 10.1016/j.jpba.2013.02.014
   Sun NN, 2016, MOLECULES, V21, DOI 10.3390/molecules21101351
   Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014
   Tran TMK., 2020, Eur. J. Eng. Technol. Res, V5, P1069, DOI 10.24018/ejers.2020.5.9.2116
   Vezzulli F, 2022, FOODS, V11, DOI 10.3390/foods11060807
   Walewski JL, 2014, OBESITY, V22, P1643, DOI 10.1002/oby.20725
   Walker V, 2009, DIABETES OBES METAB, V11, P823, DOI 10.1111/j.1463-1326.2009.01054.x
   Wang L, 2003, AM J CLIN NUTR, V78, P91
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   Wen J.-J., 2022, FOOD CHEM
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wrzosek M, 2022, OBES SURG, V32, P428, DOI 10.1007/s11695-021-05789-w
   Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8
   Xie BG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/805683
   Xu M, 2019, FOOD FUNCT, V10, P7489, DOI 10.1039/c9fo00502a
   Yadav A, 2013, CLIN CHIM ACTA, V417, P80, DOI 10.1016/j.cca.2012.12.007
   Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717
   Yiannakopoulou EC, 2013, FREE RADICAL RES, V47, P667, DOI 10.3109/10715762.2013.819975
   Yokozawa T, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/845917
   Zhang A, 2013, OBES REV, V14, P344, DOI 10.1111/obr.12011
   Zhang AH, 2017, RSC ADV, V7, P14966, DOI 10.1039/c6ra28715h
   Zhang DM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040335
   Zhou DD, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.929210
   Zhou YW, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.650214
NR 109
TC 4
Z9 4
U1 2
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD SEP
PY 2023
VL 179
AR 113971
DI 10.1016/j.fct.2023.113971
EA JUL 2023
PG 17
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA P6NT7
UT WOS:001051831100001
PM 37506863
DA 2025-04-28
ER

PT J
AU Rodas, L
   Riera-Sampol, A
   Aguilo, A
   Martínez, S
   Tauler, P
AF Rodas, Lluis
   Riera-Sampol, Aina
   Aguilo, Antoni
   Martinez, Sonia
   Tauler, Pedro
TI Effects of Habitual Caffeine Intake, Physical Activity Levels, and
   Sedentary Behavior on the Inflammatory Status in a Healthy Population
SO NUTRIENTS
LA English
DT Article
DE caffeine; coffee; physical activity; siting time; inflammation; body fat
ID C-REACTIVE PROTEIN; COFFEE CONSUMPTION; INSULIN-RESISTANCE;
   ADIPOSE-TISSUE; TNF-ALPHA; MARKERS; OBESITY; PLASMA; MECHANISMS;
   EXPRESSION
AB Low-grade chronic inflammation is associated with many chronic diseases and pathological conditions. The aim of the present study was to determine the effect of regular caffeine intake, physical activity levels, and sedentary behavior on the inflammatory status in healthy participants. In total, 112 men and 132 women aged 18 to 55 years and belonging to the staff and student population of the University of the Balearic Islands volunteered to participate in this descriptive cross-sectional study. Plasma concentrations of pro-inflammatory and anti-inflammatory markers were measured. Weight, height, and body composition (bioelectrical impedance) were determined. Caffeine intake, physical activity levels and sitting time, and diet quality were determined using questionnaires. Statistical regression analysis showed that caffeine intake was a negative predictor of C-reactive protein (CRP) (p= 0.001). Body fat percentage was positively associated with CRP (p< 0.001) and inversely associated with adiponectin (p= 0.032) and interleukin (IL)-10 levels (p= 0.001). Visceral fat was the main predictor for IL-6 (p< 0.001) and tumor necrosis factor (TNF)-alpha (p< 0.001). Sitting time was found to be the main, inverse, predictor for IL-10 (p< 0.001), and a positive predictor for TNF-alpha (p< 0.001). In conclusion, regular caffeine consumption induced very limited anti-inflammatory effects. Sedentary behavior and body fat accumulation induced significant pro-inflammatory effects.
C1 [Rodas, Lluis] Univ Balearic Isl, Res Grp Evidence Lifestyles & Hlth, Palma De Mallorca 07122, Spain.
   [Riera-Sampol, Aina] Univ Balearic Isl, Res Grp Evidence Lifestyles & Hlth, Dept Nursing & Physiotherapy, Palma De Mallorca 07122, Spain.
   [Aguilo, Antoni; Martinez, Sonia] Univ Balearic Isl, Res Grp Evidence Lifestyles & Hlth, Dept Nursing & Physiotherapy, Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca 07122, Spain.
   [Tauler, Pedro] Univ Balearic Isl, Res Grp Evidence Lifestyles & Hlth, Dept Fundamental Biol & Hlth Sci, Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca 07122, Spain.
C3 Universitat de les Illes Balears; Institut Investigacio Sanitaria Illes
   Balears (IdISBa); Universitat de les Illes Balears; Institut
   Investigacio Sanitaria Illes Balears (IdISBa); Universitat de les Illes
   Balears
RP Martínez, S (corresponding author), Univ Balearic Isl, Res Grp Evidence Lifestyles & Hlth, Dept Nursing & Physiotherapy, Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca 07122, Spain.; Tauler, P (corresponding author), Univ Balearic Isl, Res Grp Evidence Lifestyles & Hlth, Dept Fundamental Biol & Hlth Sci, Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca 07122, Spain.
EM lluisrodas@hotmail.com; ana.riera@uib.es; aaguilo@uib.es;
   sonia.martinez@uib.es; pedro.tauler@uib.es
RI Martinez, Sonia/JVY-9106-2024; Riera-Sampol, Aina/AAU-8055-2021; Tauler,
   Pedro/M-4126-2018; Stefanadis, Christodoulos/ABH-2232-2020
OI Riera-Sampol, Aina/0000-0003-0868-3929; Stefanadis,
   Christodoulos/0000-0001-5974-6454; Martinez, Sonia/0000-0002-5973-360X;
   Tauler Riera, Pedro/0000-0003-0841-1720; Aguilo,
   Antoni/0000-0001-5162-0996
FU Ministerio de Economia, Industria y Competitividad (MINECO)
   [DEP2013-45966-P]; Agencia Estatal de Investigacion (AEI)
   [DEP2013-45966-P]; European Regional Development Funds (ERDF)
   [DEP2013-45966-P]
FX This research was funded by the Ministerio de Economia, Industria y
   Competitividad (MINECO), the Agencia Estatal de Investigacion (AEI) and
   the European Regional Development Funds (ERDF), project DEP2013-45966-P
   (MINECO/AEI/ERDF, EU).
CR Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Allison MA, 2012, AM J PREV MED, V42, P8, DOI 10.1016/j.amepre.2011.09.023
   Day K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101469
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4552
   Fitt E, 2013, FOOD CHEM, V140, P421, DOI 10.1016/j.foodchem.2012.07.092
   Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041
   Gómez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985
   Gressner OA, 2008, J HEPATOL, V49, P758, DOI 10.1016/j.jhep.2008.03.029
   Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451
   Henson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078350
   Horrigan LA, 2004, INT IMMUNOPHARMACOL, V4, P1409, DOI 10.1016/j.intimp.2004.06.005
   Izadi V, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_37_14
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779
   Kotani K, 2008, CLIN CHEM LAB MED, V46, P1434, DOI 10.1515/CCLM.2008.286
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Maki T, 2010, CLIN CHEM LAB MED, V48, P849, DOI 10.1515/CCLM.2010.161
   Martínez-González MA, 2004, EUR J CLIN NUTR, V58, P1550, DOI 10.1038/sj.ejcn.1602004
   Moua ED, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051349
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Paiva CLRS, 2019, CRIT REV FOOD SCI, V59, P652, DOI 10.1080/10408398.2017.1386159
   Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010
   Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Pedersen BK, 2007, AM J LIFESTYLE MED, V1, P289, DOI 10.1177/1559827607301410
   Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004
   Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509
   Rebello SA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-61
   Renouf M, 2014, MOL NUTR FOOD RES, V58, P301, DOI 10.1002/mnfr.201300349
   Rexrode KM, 2003, ANN EPIDEMIOL, V13, P674, DOI 10.1016/S1047-2797(03)00053-X
   Rochat C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010028
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Sousa AG, 2015, BRIT J NUTR, V113, P1615, DOI 10.1017/S0007114515000835
   Tauler P, 2016, INT J SPORT NUTR EXE, V26, P8, DOI 10.1123/ijsnem.2015-0052
   Tauler P, 2013, MED SCI SPORT EXER, V45, P1269, DOI 10.1249/MSS.0b013e3182857c8a
   Thorand B, 2006, ATHEROSCLEROSIS, V184, P216, DOI 10.1016/j.atherosclerosis.2005.04.011
   Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Yates T, 2012, AM J PREV MED, V42, P1, DOI 10.1016/j.amepre.2011.09.022
NR 44
TC 30
Z9 33
U1 1
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2020
VL 12
IS 8
AR 2325
DI 10.3390/nu12082325
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA OA4VX
UT WOS:000577786000001
PM 32756464
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Gorji, Z
   Varkaneh, HK
   Talaei, S
   Nazary-Vannani, A
   Clark, CCT
   Fatahi, S
   Rahmani, J
   Salamat, S
   Zhang, Y
AF Gorji, Zahra
   Varkaneh, Hamed Kord
   Talaei, Sam
   Nazary-Vannani, Ali
   Clark, Cain C. T.
   Fatahi, Somaye
   Rahmani, Jamal
   Salamat, Shekoufeh
   Zhang, Yong
TI The effect of green-coffee extract supplementation on obesity: A
   systematic review and dose-response meta-analysis of randomized
   controlled trials
SO PHYTOMEDICINE
LA English
DT Review
DE Dose-response; Meta-analysis; Obesity; Green-Coffee; BMI; Weight
ID CHLOROGENIC ACID; BEAN EXTRACT; INSULIN-RESISTANCE; BLOOD-PRESSURE;
   LONG-TERM; LIPID PROFILE; FUNNEL PLOTS; DOUBLE-BLIND; BODY-MASS;
   CAFFEINE
AB Background: Given that the most recent systematic review investigating Green-Coffee Extract (GCE) as a weight loss facilitator was nearly a decade ago and that the authors reported there no consensus on the effect of GCE/CGA (Chlorogenic acids) on body composition indices, a comprehensive systematic review and dose-response meta-analysis of all available randomized controlled trial (RCTs) was undertaken to examine the effect of GCE and CGA intervention on body weight (BW), body mass index (BMI) and waist circumference (WC) in adults.
   Methods: We conducted a systematic search of all available randomized controlled trials (RCTs) performed up to June 2019 in the following electronic databases: PubMed, Scopus and Google Scholar. RCTs that investigated the effect GCE/CGA Supplementation on BW, BMI and WC in adults were included for final analysis. The pooled weight mean difference (WMD) of included studies was estimated using a random-effects model.
   Results: A total of 13 articles with 16 RCTs were included in the meta-analysis. Results revealed significant reduction in BMI (WMD: - 0.403 kg/m(2), 95% CI: - 0.800, - 0.005, p = 0.047) and no significant change in BW (WMD: - 0.585 kg, 95% CI: - 1.498, 0.329, p = 0.210) and WC (WMD: - 0.847 cm, 95% CI: - 1.764, 0.071, p = 0.070). In the subgroup analysis, studies that were conducted on baseline BMI >= 25 kg/m(2) revealed a significant greater reduction in body weight and BMI than those performed on baseline BMI <25 kg/m(2). Moreover, short supplementation periods of less than 4 weeks had no effect.
   Conclusion: The results of current meta-analysis study support the use of GCE supplementation for the improvement of obesity indices, with sub-group analysis highlighting greater improvements in individuals with a starting BMI >= 25 kg/m(2).
C1 [Gorji, Zahra; Nazary-Vannani, Ali] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Cellular & Mol Nutr, Tehran, Iran.
   [Varkaneh, Hamed Kord; Rahmani, Jamal] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Dept Clin Nutr & Dietet, Student Res Comm, Tehran, Iran.
   [Talaei, Sam] Shahid Beheshti Univ Med Sci, Sch Pharm, Tehran, Iran.
   [Nazary-Vannani, Ali] Univ Tehran Med Sci, SSRC, Tehran, Iran.
   [Clark, Cain C. T.] Coventry Univ, Ctr Sport Exercise & Life Sci, Coventry CV1 5FB, W Midlands, England.
   [Fatahi, Somaye] Iran Univ Med Sci, Fac Publ Hlth Branch, Student Res Comm, Tehran, Iran.
   [Salamat, Shekoufeh] Ahvaz Jundishapour Univ Med Sci, Nutr & Metab Dis Res Ctr, Ahvaz, Iran.
   [Zhang, Yong] Chongqing Med Univ, Sch Publ Hlth & Hlth Management, Dept Nutr & Food Hyg, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.
C3 Tehran University of Medical Sciences; Shahid Beheshti University
   Medical Sciences; Shahid Beheshti University Medical Sciences; Tehran
   University of Medical Sciences; Coventry University; Iran University of
   Medical Sciences; Ahvaz Jundishapur University of Medical Sciences
   (AJUMS); Chongqing Medical University
RP Zhang, Y (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Hlth Management, Dept Nutr & Food Hyg, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.
EM zhangyongcq@live.cn
RI Clark, Cain/I-4480-2019; nazary, ali/I-1693-2018; Salamat,
   Shekoufeh/AAA-5239-2022; Zhang, Yong/B-7089-2016
OI Clark, Dr. Cain/0000-0002-6610-4617; kord varkaneh,
   hamed/0000-0001-7675-4405; Zhang, Yong/0000-0003-1436-5951
CR Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   [Anonymous], 2011, Obesity and overweight fact sheet
   [Anonymous], 2016, Jordan J Pharm Sci, DOI DOI 10.12816/0033383
   [Anonymous], 2017, MMWR-MORBID MORTAL W
   [Anonymous], GASTROENTEROL RES PR
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bidel S, 2006, HORM METAB RES, V38, P38, DOI 10.1055/s-2006-924982
   Blum J, 2007, NUTRAFOODS, V6, P13
   Budryn G, 2017, EUR FOOD RES TECHNOL, V243, P1323, DOI 10.1007/s00217-017-2843-0
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clark C.C. T., 2017, Obesity Medicine, V8, P27, DOI DOI 10.1016/J.OBMED.2017.10.001
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Dehal A, 2011, NUTR CANCER, V63, P1218, DOI 10.1080/01635581.2011.607539
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   Dickson JC, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0321-3
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Esquivel P, 2012, FOOD RES INT, V46, P488, DOI 10.1016/j.foodres.2011.05.028
   Ezzati M, 2017, LANCET, V390, P2627, DOI [10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3]
   Faith MS, 2011, OBES REV, V12, pe438, DOI 10.1111/j.1467-789X.2010.00843.x
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   김태수, 2012, [Journal of The Korean Society of Food Culture, 한국식생활문화학회지], V27, P407
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Kimokoti RW, 2011, J AM DIET ASSOC, V111, P1137, DOI 10.1016/j.jada.2011.05.016
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI [10.1039/C4FO00290C, 10.1039/c4fo00290c]
   MacLean PS, 2015, OBESITY, V23, P7, DOI 10.1002/oby.20967
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873
   Molarius A, 1998, INT J OBESITY, V22, P719, DOI 10.1038/sj.ijo.0800660
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Ochiai R, 2008, J HEALTH SCI, V54, P302, DOI 10.1248/jhs.54.302
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Palmer TM, 2008, STATA J, V8, P242, DOI 10.1177/1536867X0800800206
   Park JuYeon Park JuYeon, 2010, Korean Journal of Nutrition, V43, P374
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Salamat S, 2019, EUR J INTEGR MED, V28, P109, DOI 10.1016/j.eujim.2019.05.001
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Sarriá B, 2016, FOOD RES INT, V89, P1023, DOI 10.1016/j.foodres.2015.12.032
   Shahmohammadi HA, 2017, HEPAT MON, V17, DOI 10.5812/hepatmon.45609
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   SPRIET LL, 1992, AM J PHYSIOL, V262, pE891, DOI 10.1152/ajpendo.1992.262.6.E891
   Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1258-y
   Tanaka K, 2009, FOOD SCI TECHNOL RES, V15, P147, DOI 10.3136/fstr.15.147
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tijburg LBM, 1997, CRIT REV FOOD SCI, V37, P771, DOI 10.1080/10408399709527802
   Upadhyay R, 2013, CRIT REV FOOD SCI, V53, P968, DOI 10.1080/10408398.2011.576319
   Van Soeren MH, 1998, J APPL PHYSIOL, V85, P1493, DOI 10.1152/jappl.1998.85.4.1493
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Willey JZ, 2011, AM HEART J, V161, P886, DOI 10.1016/j.ahj.2011.01.018
NR 64
TC 39
Z9 40
U1 0
U2 22
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0944-7113
EI 1618-095X
J9 PHYTOMEDICINE
JI Phytomedicine
PD OCT
PY 2019
VL 63
AR 153018
DI 10.1016/j.phymed.2019.153018
PG 9
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA JR5YD
UT WOS:000499699300021
PM 31398662
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Clayton, ZS
   Fusco, E
   Schreiber, L
   Carpenter, JN
   Hooshmand, S
   Hong, MY
   Kern, M
AF Clayton, Zachary S.
   Fusco, Elizabeth
   Schreiber, Lisa
   Carpenter, Jennifer N.
   Hooshmand, Shirin
   Hong, Mee Young
   Kern, Mark
TI Snack selection influences glucose metabolism, antioxidant capacity and
   cholesterol in healthy overweight adults: A randomized parallel arm
   trial
SO NUTRITION RESEARCH
LA English
DT Article
DE Snacking; Carbohydrates; Dried Plums; Glucose Metabolism; Total
   Antioxidant Capacity; Cholesterol
ID PRUNUS-DOMESTICA; VEGETABLE INTAKE; CHLOROGENIC ACID; GLYCEMIC INDEX;
   DIETARY FIBER; HIGH-FAT; FRUIT; RISK; MEAL; OBESITY
AB Including carbohydrate/fructose-rich foods (predominantly fruit) in the diets of overweight individuals can improve chronic disease risk factors. We hypothesized dried plums (DP) would improve nutrient consumption, total antioxidant capacity (TAC), lipid and adipokine profiles, and would decrease adiposity and inflammation. To test this, we studied the effects of 8-weeks of twice-daily snacking of macronutrient-matched 100 kcal servings of DP or refined carbohydrate-rich snack (low-fat muffins: LFM) on daily energy and nutrient consumption, and chronic disease risk factors in overweight adults. Body weight/composition, waist circumference, blood pressure, plasma glucose, insulin, c-peptide, lipids, TAC, adipokines and inflammation were measured at baseline and throughout the study. Postprandial glucose and insulin were assessed following assigned test foods at baseline and 8-weeks. Repeated measures ANOVAs were undertaken to examine group and time differences. Post-hoc independent and paired samples t-tests were conducted where necessary. DP increased (P < .05) overall intake of dietary fiber and potassium, and TAC, from baseline to 8-weeks. Baseline postprandial glycemia tended (P = .09) to be lower with DP versus LFM, while both groups had a decreased response after 8-weeks. Postprandial insulinemia was lower (P < .05) for DP at both time-points. No differences in body weight/composition, blood pressure, or fasting glucose, insulin, triglycerides, total cholesterol, HDL-C, inflammation or adipokines were detected. Low-density lipoprotein cholesterol (LDL-C) increased (P < .05) throughout the trial following LFM. Overall, DP lessened postprandial insulinemia, improved nutrient consumption and plasma TAC, and maintained plasma LDL-C compared to a macronutrient-matched refined carbohydrate snack, which could decrease chronic disease risk. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Clayton, Zachary S.; Fusco, Elizabeth; Schreiber, Lisa; Carpenter, Jennifer N.; Hooshmand, Shirin; Hong, Mee Young; Kern, Mark] San Diego State Univ, Dept Exercise & Nutr Sci, 5500 Campanile Dr, San Diego, CA 92182 USA.
   [Clayton, Zachary S.] Univ Colorado, Dept Integrat Physiol, 354 UCB, Boulder, CO 80309 USA.
   [Fusco, Elizabeth] US Olymp Comm, 2800 Olymp Pkwy, Chula Vista, CA 91915 USA.
   [Schreiber, Lisa] Scripps Mem Hosp La Jolla, Clin Nutr, 9888 Genesee Ave, La Jolla, CA 92037 USA.
   [Carpenter, Jennifer N.] Womack Army Med Ctr, Nutr Care Div, Outpatient Nutr Serv, 2817 Reilly Rd, Ft Bragg, NC 28310 USA.
C3 California State University System; San Diego State University;
   University of Colorado System; University of Colorado Boulder; United
   States Department of Defense; United States Army
RP Kern, M (corresponding author), San Diego State Univ, Dept Exercise & Nutr Sci, 5500 Campanile Dr, San Diego, CA 92182 USA.
EM Zachary.Clayton@Colorado.EDU; Liz.Fusco@usrowing.org;
   Schreiber.lisa@scrippshealth.org; Jennifer.n.carpenter13.mil@mail.mil;
   shooshmand@mail.sdsu.edu; mhong2@mail.sdsu.edu; kern@mail.sdsu.edu
FU California Dried Plum Board
FX Authors would like to thank Steffani Nelson, Nancy Snyder, Benjamin
   Reiter, Jonathan Blair and Brookell White for help with the study. The
   views expressed in this manuscript do not reflect the official policy or
   position of the Department of the Army, Department of Defense or the
   U.S. Government. Authors express no conflict of interest. This work was
   supported by a grant from the California Dried Plum Board.
CR [Anonymous], BMJ BRIT MED J
   [Anonymous], BMJ BRIT MED J
   Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594
   Bullard KM, 2018, MMWR-MORBID MORTAL W, V67, P359, DOI 10.15585/mmwr.mm6712a2
   Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85
   Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388
   CORAZZA GR, 1988, GUT, V29, P44, DOI 10.1136/gut.29.1.44
   Ekmekcioglu C, 2001, BIOL TRACE ELEM RES, V79, P205, DOI 10.1385/BTER:79:3:205
   Farshchi HR, 2005, AM J CLIN NUTR, V81, P16
   Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5
   Frisard M, 2006, ENDOCRINE, V29, P27, DOI 10.1385/ENDO:29:1:27
   Fryer LGD, 2000, DIABETES, V49, P1978, DOI 10.2337/diabetes.49.12.1978
   Furchner-Evanson A, 2010, APPETITE, V54, P564, DOI 10.1016/j.appet.2010.02.015
   Green SM, 2000, BRIT J NUTR, V84, P521
   Gregório BM, 2016, CURR PHARM DESIGN, V22, P859, DOI 10.2174/1381612822666151209152352
   Grooms KN, 2013, AM J MED, V126, P1059, DOI 10.1016/j.amjmed.2013.07.023
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Ho HVT, 2017, AM J CLIN NUTR, V105, P1239, DOI 10.3945/ajcn.116.142158
   Hooshmand S, 2015, FOOD FUNCT, V6, P1719, DOI [10.1039/c5fo00173k, 10.1039/C5FO00173K]
   Howarth L, 2010, J AM DIET ASSOC, V110, P1322, DOI 10.1016/j.jada.2010.06.002
   Igwe EO, 2016, PHYTOTHER RES, V30, P701, DOI 10.1002/ptr.5581
   Kant AK, 2015, J ACAD NUTR DIET, V115, P50, DOI 10.1016/j.jand.2014.06.354
   Kay CD, 2010, J NUTR, V140, P1093, DOI 10.3945/jn.109.117366
   Kayano S, 2002, J AGR FOOD CHEM, V50, P3708, DOI 10.1021/jf0200164
   Kurotani K, 2013, BRIT J NUTR, V109, P709, DOI 10.1017/S0007114512001705
   Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115
   Leighton E, 2017, DIABETES THER, V8, P475, DOI 10.1007/s13300-017-0265-4
   Liu SM, 2004, DIABETES CARE, V27, P2993, DOI 10.2337/diacare.27.12.2993
   Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117
   McRorie JW, 1998, ALIMENT PHARM THERAP, V12, P491
   Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594
   Meyer KA, 2000, AM J CLIN NUTR, V71, P921
   MILLER JCB, 1994, AM J CLIN NUTR, V59, p747S, DOI 10.1093/ajcn/59.3.747S
   Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094
   Nakatani N, 2000, J AGR FOOD CHEM, V48, P5512, DOI 10.1021/jf000422s
   Nilsson AC, 2008, J NUTR, V138, P732, DOI 10.1093/jn/138.4.732
   Rahman I, 2006, BIOCHEM PHARMACOL, V72, P1439, DOI 10.1016/j.bcp.2006.07.004
   RUMESSEN JJ, 1987, SCAND J GASTROENTERO, V22, P431, DOI 10.3109/00365528708991486
   Schwingshackl L, 2013, NUTR METAB CARDIOVAS, V23, P699, DOI 10.1016/j.numecd.2013.04.008
   Stacewicz-Sapuntzakis M, 2013, CRIT REV FOOD SCI, V53, P1277, DOI 10.1080/10408398.2011.563880
   Stone MS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070444
   Treuth MS, 2003, AM J CLIN NUTR, V77, P479, DOI 10.1093/ajcn/77.2.479
   Utsunomiya H, 2005, BIOMED RES-TOKYO, V26, P193, DOI 10.2220/biomedres.26.193
   Utter AC, 2007, PERCEPT MOTOR SKILL, V104, P1079, DOI 10.2466/PMS.104.4.1079-1087
   Villegas R, 2008, J NUTR, V138, P574, DOI 10.1093/jn/138.3.574
   WARNICK GR, 1990, CLIN CHEM, V36, P15
   Williamson DA, 2007, APPETITE, V48, P183, DOI 10.1016/j.appet.2006.08.066
   Wilson JP, 2013, AM J CLIN NUTR, V97, P497, DOI 10.3945/ajcn.112.048074
NR 48
TC 12
Z9 15
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
J9 NUTR RES
JI Nutr. Res.
PD MAY
PY 2019
VL 65
BP 89
EP 98
DI 10.1016/j.nutres.2019.03.002
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HZ9GI
UT WOS:000469163400010
PM 30952505
OA Bronze, Green Accepted
DA 2025-04-28
ER

PT J
AU Sanchez-Medina, A
   Redondo-Puente, M
   Dupak, R
   Bravo-Clemente, L
   Goya, L
   Sarriá, B
AF Sanchez-Medina, Andrea
   Redondo-Puente, Monica
   Dupak, Rudolf
   Bravo-Clemente, Laura
   Goya, Luis
   Sarria, Beatriz
TI Colonic Coffee Phenols Metabolites, Dihydrocaffeic, Dihydroferulic, and
   Hydroxyhippuric Acids Protect Hepatic Cells from TNF-α-Induced
   Inflammation and Oxidative Stress
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE inflammation; TNF-alpha; HepG2; metabolites; coffee; cytokines
ID NF-KAPPA-B; HEPG2 CELLS; OBESITY; INTERLEUKIN-8; CONSUMPTION; PLASMA;
   IDENTIFICATION; POLYPHENOLS; MODULATION; MECHANISMS
AB Coffee presents beneficial health properties, including antiobesity effects. However, its effects on inflammation are controversial. Hydroxycinnamic acids are the main coffee phenolic bioactive compounds. In human bioavailability studies carried out with coffee, among the most abundant compounds found in urine and plasma were the colonic metabolites, dihydrocaffeic (DHCA), dihydroferulic (DHFA), and hydroxyhippuric (HHA) acids. To understand the hepato-protective potential of these three compounds, we tested whether treatment with realistic concentrations (0.5-10 mu M) were effective to counteract inflammatory process and oxidative status induced by tumor necrosis factor alpha (TNF-alpha). First, we established a novel model of inflammation/oxidation using TNF-alpha and HepG2 cells. Afterwards, we evaluated the activity of DHCA, DHFA, and HHA against the inflammatory/oxidative challenge through the determination of the inflammatory mediators, interleukins (IL)-6, and IL-8 and chemokines, monocyte chemoattractant protein-1, and macrophage inflammatory protein-1, as well as the levels of biomarkers of oxidative stress, such as reactive oxygen species, reduced glutathione, and the antioxidant enzymes glutathione peroxidase and reductase. Results showed that all three compounds have a potential hepato-protective effect against the induced inflammatory/oxidative insult.
C1 [Sanchez-Medina, Andrea; Redondo-Puente, Monica; Bravo-Clemente, Laura; Goya, Luis; Sarria, Beatriz] CSIC, Inst Food Sci Technol & Nutr ICTAN CSIC, Dept Metab & Nutr, Jose Antonio Novais 10, Madrid 28040, Spain.
   [Sanchez-Medina, Andrea; Sarria, Beatriz] Univ Complutense Madrid UCM, Fac Pharm, Dept Nutr & Food Sci, Plaza Ramon & Cajal S-N, Madrid 28040, Spain.
   [Dupak, Rudolf] Slovak Univ Agr, Inst Appl Biol, Fac Biotechnol & Food Sci, Trieda Andreja Hlinku 2, Nitra 94976, Slovakia.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Complutense
   University of Madrid; Slovak University of Agriculture Nitra
RP Sarriá, B (corresponding author), CSIC, Inst Food Sci Technol & Nutr ICTAN CSIC, Dept Metab & Nutr, Jose Antonio Novais 10, Madrid 28040, Spain.; Sarriá, B (corresponding author), Univ Complutense Madrid UCM, Fac Pharm, Dept Nutr & Food Sci, Plaza Ramon & Cajal S-N, Madrid 28040, Spain.
RI Martín, Maria Angeles/JAO-0626-2023; Bravo, Laura/JMC-4928-2023; Bravo,
   Laura/F-4992-2012
OI Bravo, Laura/0000-0002-7312-8641; Sanchez-Medina Diaz,
   Andrea/0000-0002-6284-1716
FU Intramural Project of the Spanish National Research Council (CSIC)
   [202170I026]
FX This research was funded by Intramural Project of the Spanish National
   Research Council (CSIC, Ref. 202170I026).
CR Alvarez-Cilleros D, 2020, FOOD CHEM TOXICOL, V146, DOI 10.1016/j.fct.2020.111824
   Alvarez-Cilleros D, 2018, J FUNCT FOODS, V46, P19, DOI 10.1016/j.jff.2018.04.051
   Alvarez-Cilleros D, 2018, FOOD CHEM TOXICOL, V115, P88, DOI 10.1016/j.fct.2018.03.006
   Andrews M, 2012, BIOMETALS, V25, P749, DOI 10.1007/s10534-012-9543-9
   Seguido MA, 2022, NUTRIENTS, V14, DOI 10.3390/nu14122445
   Martín MA, 2012, CURR NUTR FOOD SCI, V8, P112, DOI 10.2174/157340112800840808
   Martin MA, 2017, FOOD CHEM TOXICOL, V109, P302, DOI 10.1016/j.fct.2017.09.015
   Aschoff JK, 2016, MOL NUTR FOOD RES, V60, P2602, DOI 10.1002/mnfr.201600315
   Baeza G, 2016, FOOD RES INT, V87, P25, DOI 10.1016/j.foodres.2016.06.011
   Granado-Serrano AB, 2012, NUTR CANCER, V64, P588, DOI 10.1080/01635581.2012.661513
   Bergmeyer HU., 1983, METHODS ENZYMATIC AN, VVI., P258, DOI DOI 10.1016/B978-0-12-091302-2.X5001-4
   Blüher M, 2016, CLIN SCI, V130, P1603, DOI 10.1042/CS20160005
   Castro-Barquero S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101523
   Chang WC, 2010, EUR J NUTR, V49, P267, DOI 10.1007/s00394-009-0083-1
   Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596
   Coimbra S, 2013, OBES REV, V14, P771, DOI 10.1111/obr.12057
   Cuello S, 2007, ANAL BIOANAL CHEM, V389, P2167, DOI 10.1007/s00216-007-1626-z
   DEFORGE LE, 1993, J BIOL CHEM, V268, P25568
   Fernández-Millán E, 2014, FOOD CHEM TOXICOL, V66, P245, DOI 10.1016/j.fct.2014.01.044
   García-Díez E, 2022, FOOD FUNCT, V13, P5602, DOI [10.1039/d2fo00182a, 10.1039/D2FO00182A]
   Ghorpade DS, 2018, NATURE, V555, P673, DOI 10.1038/nature26138
   Gómez-Juaristi M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071441
   Gómez-Juaristi M, 2018, FOOD FUNCT, V9, P331, DOI [10.1039/c7fo01553d, 10.1039/C7FO01553D]
   Gómez-Quiroz LE, 2005, LIVER INT, V25, P122, DOI 10.1111/j.1478-3231.2005.01005.x
   Gosslau A, 2011, MOL NUTR FOOD RES, V55, P74, DOI 10.1002/mnfr.201000455
   Goya L, 2007, MOL NUTR FOOD RES, V51, P536, DOI 10.1002/mnfr.200600228
   Goya L, 2007, EUR J NUTR, V46, P70, DOI 10.1007/s00394-006-0633-8
   Goya L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040212
   Goya L, 2009, CURR NUTR FOOD SCI, V5, P56, DOI 10.2174/157340109787314721
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025
   Gutierrez-Ruiz MC, 2001, ISRAEL MED ASSOC J, V3, P131
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166
   Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752
   Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259
   Kolb R, 2016, CURR OPIN PHARMACOL, V29, P77, DOI 10.1016/j.coph.2016.07.005
   Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009
   Lee YW, 2008, J NUTR BIOCHEM, V19, P819, DOI 10.1016/j.jnutbio.2007.10.006
   Leng SX, 2008, J GERONTOL A-BIOL, V63, P879, DOI 10.1093/gerona/63.8.879
   Lima CF, 2006, LIFE SCI, V79, P2056, DOI 10.1016/j.lfs.2006.06.042
   Lipert B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174381
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Mateos R, 2006, J AGR FOOD CHEM, V54, P8724, DOI 10.1021/jf061664g
   Monagas M, 2009, BRIT J NUTR, V102, P201, DOI 10.1017/S0007114508162110
   Myhrstad MCW, 2002, FREE RADICAL BIO MED, V32, P386, DOI 10.1016/S0891-5849(01)00812-7
   Prymont-Przyminska A, 2016, J CLIN BIOCHEM NUTR, V59, P191, DOI 10.3164/jcbn.15-113
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Rodríguez-Ramiro I, 2013, BRIT J NUTR, V110, P206, DOI 10.1017/S0007114512004862
   Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI [10.1172/JCI29069, 10.1016/j.febslet.2007.11.057]
   Shukla A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094433
   Sipka A, 2022, JDS COMMUN, V3, DOI 10.3168/jdsc.2021-0191
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Stonans I, 1999, CYTOKINE, V11, P151, DOI 10.1006/cyto.1998.0366
   Surma S, 2023, PHARMACOL RES, V187, DOI 10.1016/j.phrs.2022.106596
   Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005
   Vitaglione P, 2004, CRIT REV FOOD SCI, V44, P575, DOI 10.1080/10408690490911701
   Wang SL, 2019, INT J FOOD SCI NUTR, V70, P267, DOI 10.1080/09637486.2018.1505834
   Yang HL, 2014, J ETHNOPHARMACOL, V151, P394, DOI 10.1016/j.jep.2013.10.052
NR 64
TC 14
Z9 14
U1 3
U2 29
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2023
VL 24
IS 2
AR 1440
DI 10.3390/ijms24021440
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 8G5JU
UT WOS:000920381900001
PM 36674952
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Liu, LT
   Nagai, I
   Gao, Y
   Matsushima, Y
   Kawai, Y
   Sayama, K
AF Liu, Litong
   Nagai, Izumi
   Gao, Ying
   Matsushima, Yoshibumi
   Kawai, Yoshichika
   Sayama, Kazutoshi
TI Effects of catechins and caffeine on the development of atherosclerosis
   in mice
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE catechins; caffeine; atherosclerosis
ID LOW-DENSITY-LIPOPROTEIN; GREEN TEA CATECHINS; RECEPTOR-DEFICIENT;
   SUSCEPTIBILITY; MACROPHAGES; CONSUMPTION; EXPRESSION; COFFEE; CELLS;
   AORTA
AB Atherosclerosis is one of the diseases related to metabolic syndrome which is caused by obesity. Previous reports have shown that green tea and its components have anti-obesity effect. We examined whether catechins and caffeine can prevent the development of atherosclerosis by oral administration, singly or in combination to the atherosclerosis model mice. Results demonstrated that the number of atherosclerotic regions in the aorta was significantly reduced by the combined treatment, and the atherosclerotic area was also improved. Serum HDL-C increased by caffeine single treatment, but no effect on the TG and TC by any treatments. Moreover, ECG illuviated to atheromatous lesions in aorta and the illuviation was enhanced by caffeine. The mRNA expression levels of LOX-1 and TNF-alpha showed a tendency to suppress by the combined treatment. These results indicated that the combined administration of catechins and caffeine has the inhibitory effect on the development of atherosclerosis in mice.
C1 [Liu, Litong; Sayama, Kazutoshi] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan.
   [Nagai, Izumi; Gao, Ying; Sayama, Kazutoshi] Shizuoka Univ, Acad Inst, Coll Agr, Shizuoka, Japan.
   [Matsushima, Yoshibumi] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama, Japan.
   [Kawai, Yoshichika] Tokushima Univ, Grad Sch Nutr & Biosci, Tokushima, Japan.
C3 Shizuoka University; Shizuoka University; Tokushima University
RP Sayama, K (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan.; Sayama, K (corresponding author), Shizuoka Univ, Acad Inst, Coll Agr, Shizuoka, Japan.
EM sayama.kazutoshi@shizuoka.ac.jp
FU Mitsui Norin Co., Ltd.
FX This work was supported by Mitsui Norin Co., Ltd.
CR Furnkranz A, 2005, ARTERIOSCL THROM VAS, V25, P633, DOI 10.1161/01.ATV.0000153106.03644.a0
   Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2
   Haque AM, 2006, J NUTR, V136, P1043, DOI 10.1093/jn/136.4.1043
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Ishikawa T, 1997, AM J CLIN NUTR, V66, P261, DOI 10.1093/ajcn/66.2.261
   Kamagata-Kiyoura Y, 1999, J PERIODONTOL, V70, P283, DOI 10.1902/jop.1999.70.3.283
   Kawai Y, 2008, BIOCHEM BIOPH RES CO, V374, P527, DOI 10.1016/j.bbrc.2008.07.086
   Kim WY, 2009, BIOL BLOOD MARROW TR, V15, P306, DOI 10.1016/j.bbmt.2008.11.035
   Klinkner AM, 1997, J HISTOCHEM CYTOCHEM, V45, P743, DOI 10.1177/002215549704500513
   Matsushima Y, 2001, J Atheroscler Thromb, V8, P71
   Miura Y, 2001, J NUTR, V131, P27, DOI 10.1093/jn/131.1.27
   Moriwaki H, 1998, FEBS LETT, V440, P29, DOI 10.1016/S0014-5793(98)01414-8
   MURAMATSU K, 1986, J NUTR SCI VITAMINOL, V32, P613, DOI 10.3177/jnsv.32.613
   Nakazato T, 2005, CLIN CANCER RES, V11, P6040, DOI 10.1158/1078-0432.CCR-04-2273
   Petersen EJ, 2008, ATHEROSCLEROSIS, V198, P301, DOI 10.1016/j.atherosclerosis.2007.10.015
   Pirillo A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152786
   Roomi MW, 2006, INT J UROL, V13, P415, DOI 10.1111/j.1442-2042.2006.01309.x
   Sesso HD, 1999, AM J EPIDEMIOL, V149, P162, DOI 10.1093/oxfordjournals.aje.a009782
   Suga M, 2004, TRANSPL P, V36, P2440, DOI 10.1016/j.transproceed.2004.06.036
   Sung H, 2005, ANN CLIN BIOCHEM, V42, P292, DOI 10.1258/0004563054255597
   TANGIRALA RK, 1995, J LIPID RES, V36, P2320
   Xu H, 2009, HUM REPROD, V24, P608, DOI 10.1093/humrep/den417
   Yamagata K, 2015, PHYTOMEDICINE, V22, P431, DOI 10.1016/j.phymed.2015.01.011
   Yamashita H, 2006, BIOCHEM BIOPH RES CO, V345, P919, DOI 10.1016/j.bbrc.2006.04.176
   Yang FJ, 1998, J NUTR, V128, P2334, DOI 10.1093/jn/128.12.2334
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
   Zheng GD, 2004, IN VIVO, V18, P55
NR 27
TC 23
Z9 24
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PY 2017
VL 81
IS 10
BP 1948
EP 1955
DI 10.1080/09168451.2017.1364618
PG 8
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA FK8SB
UT WOS:000413777500013
PM 28891395
OA Bronze
DA 2025-04-28
ER

PT J
AU Radkhah, P
   Mirzababaei, A
   Shiraseb, F
   Hosseininasab, D
   Clark, CCT
   Mirzaei, K
AF Radkhah, Parisa
   Mirzababaei, Atieh
   Shiraseb, Farideh
   Hosseininasab, Dorsa
   Clark, Cain C. T.
   Mirzaei, Khadijeh
TI Mediatory Effect of Inflammatory Markers (IL-1β and PAI-1) on
   Association of Dietary Total Antioxidant Capacity and Body Composition
   in Overweight and Obese Women: A Cross-Sectional Study
SO INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
LA English
DT Article
ID UP-REGULATION; POLYPHENOLS; VALIDATION; ADIPOSITY; PROTEIN; STRESS;
   WEIGHT; RISK
AB Background. Obesity is considered a state of chronic low-grade inflammation. Different components of the diet, like antioxidants, can have anti-inflammatory effects or cause chronic inflammation. This study investigated the dietary TAC and inflammatory markers and body composition in obese and overweight women. Methods. This cross-sectional study was conducted on 259 women with overweight and obesity. Dietary intake was assessed by using an FFQ with 147 items, and DTAC was used to evaluate the antioxidant capacity of the diet. The anthropometric measurements, body composition, and biochemical assessments were measured by standard protocols. Results. We observed a significant positive association between DTAC and consumption of fruits (P = 0.021), vegetable oils (P < 0.001), potassium (P = 0.006), manganese (P = 0.003), and caffeine (P < 0.001), after adjusting confounders. After adjusting for age, energy intake, and physical activity, there was a significant correlation between DTAC and fat-free mass (FFM) (P:0.054), fat-free mass index (FFMI) (P:0.012), waist circumference (WC) (P:0.002), and visceral fat level (VFL) (P:0.063). FFM, FFMI, waist circumference (WC), and visceral fat area (VFA) were mediated by IL-1 beta. FFM, VFL, VFA, and WC were mediated by PAI-1. Conclusion. Some anthropometric indices were associated with DTAC, mediated by augmenting serum levels of IL-1 beta and PAI-1. Intake of foods rich in antioxidants could represent a protective strategy against chronic diseases, such as cardiovascular disease.
C1 [Radkhah, Parisa; Hosseininasab, Dorsa] Islamic Azad Univ, Dept Nutr, Sci & Res Branch, Tehran, Iran.
   [Mirzababaei, Atieh; Shiraseb, Farideh; Mirzaei, Khadijeh] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.
   [Clark, Cain C. T.] Coventry Univ, Ctr Intelligent Healthcare, Coventry, W Midlands, England.
C3 Islamic Azad University; Tehran University of Medical Sciences; Coventry
   University
RP Mirzaei, K (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.
EM parisaradkhah1@gmail.com; ati_babaee@yahoo.com;
   farideh_shiraseb@yahoo.com; hosseininasab.dorsa@gmail.com;
   ad0183@coventry.ac.uk; mirzaei-kh@sina.tums.ac.ir
RI Clark, Cain/I-4480-2019; Mirzababaee, Atieh/AAQ-7191-2020; Mirzaei,
   Khadijeh/D-5408-2018
OI Radkhah, Parisa/0000-0002-1785-0322; Shiraseb,
   farideh/0000-0001-9279-5063; Clark, Dr. Cain/0000-0002-6610-4617
CR Aadahl M, 2003, MED SCI SPORT EXER, V35, P1196, DOI 10.1249/01.MSS.0000074446.02192.14
   Almeida-de-Souza J, 2018, EUR J CLIN NUTR, V72, P710, DOI 10.1038/s41430-017-0013-x
   [Anonymous], 2021, Obesity and Overweight
   Bahadoran Z, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-70
   Besagil PS, 2020, NIGER J CLIN PRACT, V23, P481, DOI 10.4103/njcp.njcp_212_19
   Brighenti F, 2005, BRIT J NUTR, V93, P619, DOI 10.1079/BJN20051400
   Calfee-Mason KG, 2002, J NUTR, V132, P3178, DOI 10.1093/jn/131.10.3178
   Cárcamo JM, 2002, BLOOD, V99, P3205, DOI 10.1182/blood.V99.9.3205
   Choi JS, 2004, J NUTR, V134, P1013, DOI 10.1093/jn/134.5.1013
   Detopoulou P, 2010, EUR J CLIN NUTR, V64, P161, DOI 10.1038/ejcn.2009.130
   Esmaillzadeh A, 2005, AM J CLIN NUTR, V81, P55
   Fernández-Sánchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117
   Fukuchi Y, 2008, J CLIN BIOCHEM NUTR, V43, P201, DOI 10.3164/jcbn.2008066
   GERRITSEN ME, 1995, AM J PATHOL, V147, P278
   Heidari H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51498-x
   Hensrud DD, 2001, OBES RES, V9, p348S, DOI 10.1038/oby.2001.141
   Hermsdorff HHM, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-59
   Jamilian M, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0457-1
   Khan MMH, 2009, SINGAP MED J, V50, P804
   Le Lay S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/908539
   Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Mazidi M, 2017, EUR J CLIN NUTR, V71, P1273, DOI 10.1038/ejcn.2017.133
   Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737
   Mirzababaei A, 2021, CLIN NUTR, V40, P4893, DOI 10.1016/j.clnu.2021.07.013
   Mohammadi Zahra, 2021, Clin Nutr Res, V10, P353, DOI 10.7762/cnr.2021.10.4.353
   Ogden Cynthia L, 2012, NCHS Data Brief, P1
   Ostadmohammadi V, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-019-0480-x
   Palozza P, 2003, J NUTR, V133, P381, DOI 10.1093/jn/133.2.381
   Serván PR, 2018, NUTR HOSP, V35, P109, DOI 10.20960/nh.2135
   Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z
   Roth J, 2004, OBES RES, V12, p88S, DOI 10.1038/oby.2004.273
   Sarma Haribondhu, 2016, BMC Obes, V3, P13, DOI 10.1186/s40608-016-0093-5
   Sen S, 2010, DIABETES, V59, P3058, DOI 10.2337/db10-0301
   Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115
   Sohouli MH, 2020, J NUTR SCI, V9, DOI 10.1017/jns.2020.39
   Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   Vahid F, 2017, APPL PHYSIOL NUTR ME, V42, P511, DOI 10.1139/apnm-2016-0274
   Valtuena S, 2008, AM J CLIN NUTR, V87, P1290, DOI 10.1093/ajcn/87.5.1290
   Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177
   Zulet MA, 2008, J NUTR SCI VITAMINOL, V54, P347, DOI 10.3177/jnsv.54.347
NR 42
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1368-5031
EI 1742-1241
J9 INT J CLIN PRACT
JI Int. J. Clin. Pract.
PD MAY 23
PY 2022
VL 2022
AR 2514850
DI 10.1155/2022/2514850
PG 12
WC Medicine, General & Internal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Pharmacology & Pharmacy
GA 1X6RX
UT WOS:000807580700001
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Lee, DY
   Shin, S
AF Lee, Do-Youn
   Shin, Sunghoon
TI Sarcopenic obesity is associated with coffee intake in elderly Koreans
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE sarcopenic obesity; sarcopenia; obesity; coffee; elderly
ID METABOLIC SYNDROME; MUSCLE MASS; RESISTANCE EXERCISE; CONSUMPTION;
   PERFORMANCE; CAFFEINE; RISK; AUTOPHAGY; STRENGTH; POLYPHENOLS
AB This study assessed the association between sarcopenic obesity (S+O+) and coffee intake inelderly Koreans. This study obtained data from the Korea National Health and Nutrition Examination Survey (KNHANES, 2008-2011), a cross-sectional and nationally representative survey conducted by the Korean Centers for Disease Control and Prevention. Of the 2,661 participants included in this study, there was a significant difference between 5.861 (95% CI 2.024-16.971) in less than one cup of coffee, and 6.245 (95% CI 2.136-18.260) in one cup of coffee, and 4.323 (95% CI 1.457-12.824) in two cups of coffee compared to three or more than cups of coffee. In contrast, in the case of sarcopenia or obesity only (S+O- or S-O+), no significant difference was found in any model. The results suggest that the elderly who consume less than one cup of coffee per day had a greater risk of S+O+ than those who consume more than three cups per day. Furthermore, there was an association between coffee intake and sarcopenia but not with obesity. Therefore, coffee intake may have prevented musculoskeletal loss in these patients.
C1 [Lee, Do-Youn; Shin, Sunghoon] Yeungnam Univ, Res Inst Human Ecol, Gyongsan, Gyeongbuk, South Korea.
   [Lee, Do-Youn; Shin, Sunghoon] Yeungnam Univ, Neuromuscular Control Lab, Gyongsan, Gyeongbuk, South Korea.
C3 Yeungnam University; Yeungnam University
RP Shin, S (corresponding author), Yeungnam Univ, Res Inst Human Ecol, Gyongsan, Gyeongbuk, South Korea.; Shin, S (corresponding author), Yeungnam Univ, Neuromuscular Control Lab, Gyongsan, Gyeongbuk, South Korea.
EM sshin27@ynu.ac.kr
RI Shin, Sunghoon/O-4478-2014; Lee, Do-Youn/JOK-9944-2023
OI LEE, DOYOUN/0000-0003-0886-1713
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education [2021R1A6A1A03040177]
FX Funding This research was supported by the Basic Science Research
   Program through the National Research Foundation of Korea funded by the
   Ministry of Education (2021R1A6A1A03040177).
CR Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Atkins JL, 2020, BRIT J NUTR, V124, P1102, DOI 10.1017/S0007114520002172
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Bao WX, 2020, AGING DIS, V11, P863, DOI 10.14336/AD.2019.1012
   Batsis JA, 2018, NAT REV ENDOCRINOL, V14, P513, DOI 10.1038/s41574-018-0062-9
   Baumgartner RN, 2004, OBES RES, V12, P1995, DOI 10.1038/oby.2004.250
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Candow DG, 2012, BIOGERONTOLOGY, V13, P345, DOI 10.1007/s10522-012-9385-4
   Castaldo L, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124368
   Cauley JA, 2015, J CLIN DENSITOM, V18, P499, DOI 10.1016/j.jocd.2015.04.013
   Chen LK, 2020, J AM MED DIR ASSOC, V21, P300, DOI 10.1016/j.jamda.2019.12.012
   Chieng D, 2022, TRENDS CARDIOVAS MED, V32, P399, DOI 10.1016/j.tcm.2021.08.004
   Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144
   Collison KS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-234
   Dirks-Naylor AJ, 2015, LIFE SCI, V143, P182, DOI 10.1016/j.lfs.2015.11.005
   Farsijani S, 2021, J GERONTOL A-BIOL, V76, P115, DOI 10.1093/gerona/glaa161
   Frost-Meyer NJ, 2012, J FUNCT FOODS, V4, P819, DOI 10.1016/j.jff.2012.05.010
   Ghavami HS, 2021, BMC CARDIOVASC DISOR, V21, DOI 10.1186/s12872-021-02058-7
   Glaister M, 2012, J STRENGTH COND RES, V26, P1001, DOI 10.1519/JSC.0b013e31822ba300
   Guo YT, 2014, EXP GERONTOL, V50, P1, DOI 10.1016/j.exger.2013.11.005
   Heatherley SV, 2005, PSYCHOPHARMACOLOGY, V178, P461, DOI 10.1007/s00213-005-2159-9
   Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]
   Iwasaka C, 2021, GERIATR GERONTOL INT, V21, P950, DOI 10.1111/ggi.14264
   Jang YJ, 2018, FOOD FUNCT, V9, P1102, DOI [10.1039/c7fo01683b, 10.1039/C7FO01683B]
   Janssen I, 2006, J AM GERIATR SOC, V54, P56, DOI 10.1111/j.1532-5415.2005.00540.x
   Jyväkorpi SK, 2021, AGING CLIN EXP RES, V33, P1371, DOI 10.1007/s40520-020-01645-6
   Kim BY, 2021, J OBES METAB SYNDR, V30, P81, DOI 10.7570/jomes21022
   Kistler PM, 2022, J AM COLL CARDIOL, V79, P1490
   Koopman R, 2011, P NUTR SOC, V70, P104, DOI 10.1017/S0029665110003927
   Kurobe K, 2017, CLIN PHYSIOL FUNCT I, V37, P148, DOI 10.1111/cpf.12279
   Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044
   Larsson SC, 2011, STROKE, V42, P908, DOI 10.1161/STROKEAHA.110.603787
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee D, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19031330
   Lee D, 2022, J CLIN MED, V11, DOI 10.3390/jcm11010129
   Lee DY, 2021, INT J GERONTOL, V15, P319, DOI 10.6890/IJGE.202110_15(4).0005
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Machado-Fragua MD, 2019, AM J CLIN NUTR, V109, P1431, DOI 10.1093/ajcn/nqy369
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   McLellan TM, 2016, NEUROSCI BIOBEHAV R, V71, P294, DOI 10.1016/j.neubiorev.2016.09.001
   Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Pallauf K, 2013, AGEING RES REV, V12, P237, DOI 10.1016/j.arr.2012.03.008
   Pietrocola F, 2014, CELL CYCLE, V13, P1987, DOI 10.4161/cc.28929
   Pisciottano MVC, 2014, J NUTR HEALTH AGING, V18, P554, DOI 10.1007/s12603-013-0414-z
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674
   Scott D, 2014, OSTEOPOROSIS INT, V25, P791, DOI 10.1007/s00198-013-2510-7
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Tallis J, 2015, BRIT J PHARMACOL, V172, P3703, DOI 10.1111/bph.13187
   Torquati L, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091812
   Verreijen AM, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0229-6
   Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   Wycherley TP, 2010, DIABETES CARE, V33, P969, DOI 10.2337/dc09-1974
NR 58
TC 13
Z9 13
U1 3
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD FEB 2
PY 2023
VL 11
AR 990029
DI 10.3389/fpubh.2023.990029
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA 9F1KV
UT WOS:000937234700001
PM 36817878
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Kennedy, OJ
   Roderick, P
   Buchanan, R
   Fallowfield, JA
   Hayes, PC
   Parkes, J
AF Kennedy, Oliver John
   Roderick, Paul
   Buchanan, Ryan
   Fallowfield, Jonathan Andrew
   Hayes, Peter Clive
   Parkes, Julie
TI Coffee, including caffeinated and decaffeinated coffee, and the risk of
   hepatocellular carcinoma: a systematic review and dose-response
   meta-analysis
SO BMJ OPEN
LA English
DT Review
ID CHRONIC LIVER-DISEASE; CONSUMPTION; CANCER; ASSOCIATION; CAFESTOL;
   DRINKING; KAHWEOL; IMPACT; TEA; DITERPENES
AB Objectives To examine the association between coffee, including caffeinated and decaffeinated coffee, with hepatocellular carcinoma (HCC) and assess the influence of HCC aetiology and pre-existing liver disease.
   Design We performed a systematic review and meta-analysis. We calculated relative risks (RRs) of HCC according to caffeinated and decaffeinated coffee consumption using a random-effects dose-response meta-analysis. We tested for modification of the effect estimate by HCC aetiology and pre-existing liver disease. We judged the quality of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria.
   Results We found 18 cohorts, involving 2 272 642 participants and 2905 cases, and 8 case-control studies, involving 1825 cases and 4652 controls. An extra two cups per day of coffee was associated with a 35% reduction in the risk of HCC (RR 0.65, 95% CI 0.59 to 0.72). The inverse association was weaker for cohorts (RR 0.71, 95% CI 0.65 to 0.77), which were generally of higher quality than case-control studies (RR 0.53, 95% CI 0.41 to 0.69). There was evidence that the association was not significantly altered by stage of liver disease or the presence/absence of high alcohol consumption, high body mass index, type 2 diabetes mellitus, smoking, or hepatitis B and C viruses. An extra two cups of caffeinated and decaffeinated coffee (2 and 3 cohort studies, respectively) were associated with reductions of 27% (RR 0.73, 95% CI 0.63 to 0.85) and 14% (RR 0.86, 95% CI 0.74 to 1.00) in the risk of HCC. However, due to a lack of randomised controlled trials, potential publication bias and there being no accepted definition of coffee, the quality of evidence under the GRADE criteria was 'very low'.
   Conclusions Increased consumption of caffeinated coffee and, to a lesser extent, decaffeinated coffee are associated with reduced risk of HCC, including in pre-existing liver disease. These findings are important given the increasing incidence of HCC globally and its poor prognosis.
C1 [Kennedy, Oliver John; Roderick, Paul; Buchanan, Ryan; Parkes, Julie] Univ Southampton, Primary Care & Populat Sci Fac Med, Southampton, Hants, England.
   [Fallowfield, Jonathan Andrew; Hayes, Peter Clive] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.
C3 University of Southampton; University of Edinburgh
RP Kennedy, OJ (corresponding author), Univ Southampton, Primary Care & Populat Sci Fac Med, Southampton, Hants, England.
EM ok4g13@soton.ac.uk
OI Fallowfield, Jonathan/0000-0002-5741-1471; Parkes,
   Julie/0000-0002-6490-395X; Buchanan, Ryan/0000-0003-0850-5575
CR [Anonymous], LIV CANC STAT
   [Anonymous], LIV CANC EST INC MOR
   [Anonymous], EUR J CANC PREV
   [Anonymous], NEWC OTT SCAL NOS AS
   [Anonymous], Gallbladder diet
   [Anonymous], COCHRANE HDB SYSTEMA
   [Anonymous], CANC INC MORT PREV W
   Arauz J, 2013, J APPL TOXICOL, V33, P970, DOI 10.1002/jat.2788
   Bamia C, 2015, INT J CANCER, V136, P1899, DOI 10.1002/ijc.29214
   Baron JA, 2015, NEW ENGL J MED, V373, P1519, DOI 10.1056/NEJMoa1500409
   Batista MN, 2015, ARCH VIROL, V160, P399, DOI 10.1007/s00705-014-2302-1
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7
   Crippa A, 2016, J STAT SOFTW, V72, DOI 10.18637/jss.v072.c01
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014
   Gallus S, 2002, BRIT J CANCER, V87, P956, DOI 10.1038/sj.bjc.6600582
   Gelatti U, 2005, J HEPATOL, V42, P528, DOI 10.1016/j.jhep.2004.11.039
   GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237
   GREENLAND S, 1987, EPIDEMIOL REV, V9, P1
   Holger Schunemann JB., 2024, GRADE handbook for grading quality of evidence and strength of recommendations
   Hu G, 2008, HEPATOLOGY, V48, P129, DOI 10.1002/hep.22320
   Huber WW, 2002, ARCH TOXICOL, V75, P685, DOI 10.1007/s00204-001-0295-5
   Inoue M, 2005, JNCI-J NATL CANCER I, V97, P293, DOI 10.1093/jnci/dji040
   Jemal Ahmedin, 2011, CA Cancer J Clin, V61, P69, DOI 10.3322/caac.20107
   Johnson S, 2011, CANCER CAUSE CONTROL, V22, P503, DOI 10.1007/s10552-010-9725-0
   Jüni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115
   Kawada N, 2009, J GASTROENTEROL, V44, P1190, DOI 10.1007/s00535-009-0112-0
   Kennedy OJ, 2016, ALIMENT PHARM THER, V43, P562, DOI 10.1111/apt.13523
   Kurozawa Y, 2005, BRIT J CANCER, V93, P607, DOI 10.1038/sj.bjc.6602737
   Lai GY, 2013, BRIT J CANCER, V109, P1344, DOI 10.1038/bjc.2013.405
   Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044
   Lee MH, 2014, INT J CANCER, V135, P1119, DOI 10.1002/ijc.28753
   Leung WWM, 2011, J EPIDEMIOL COMMUN H, V65, P556, DOI 10.1136/jech.2009.104125
   Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Montella M, 2007, INT J CANCER, V120, P1555, DOI 10.1002/ijc.22509
   Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086
   Ohfuji S, 2006, HEPATOL RES, V36, P201, DOI 10.1016/j.hepres.2006.07.010
   Okano JI, 2008, BASIC CLIN PHARMACOL, V102, P543, DOI 10.1111/j.1742-7843.2008.00231.x
   Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265
   Pang TCY, 2015, WORLD J HEPATOL, V7, P245, DOI 10.4254/wjh.v7.i2.245
   Petrick JL, 2015, CANCER EPIDEM BIOMAR, V24, P1398, DOI 10.1158/1055-9965.EPI-15-0137
   Ponte S, 2002, WORLD DEV, V30, P1099, DOI 10.1016/S0305-750X(02)00032-3
   RODOPOULOS N, 1995, SCAND J CLIN LAB INV, V55, P229, DOI 10.3109/00365519509089618
   Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304
   Setiawan VW, 2015, GASTROENTEROLOGY, V148, P118, DOI 10.1053/j.gastro.2014.10.005
   Shimazu T, 2005, INT J CANCER, V116, P150, DOI 10.1002/ijc.20989
   Siegfried N, 2009, Cochrane Database Syst Rev
   Stucker I, 2006, HEPATOLOGY, V44, p501A
   Tanaka K, 2007, CANCER SCI, V98, P214, DOI 10.1111/j.1349-7006.2006.00368.x
   Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
   URGERT R, 1995, J AGR FOOD CHEM, V43, P2167, DOI 10.1021/jf00056a039
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Wakai K, 2007, BRIT J CANCER, V97, P426, DOI 10.1038/sj.bjc.6603891
   Xiao Q, 2014, HEPATOLOGY, V60, P2091, DOI 10.1002/hep.27367
   Zamora-Ros R, 2014, INT J CANCER, V135, P1470, DOI 10.1002/ijc.28789
NR 58
TC 123
Z9 126
U1 0
U2 25
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD MAY
PY 2017
VL 7
IS 5
AR e013739
DI 10.1136/bmjopen-2016-013739
PG 14
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA EW5GI
UT WOS:000402533300023
PM 28490552
OA gold, Green Published, Green Accepted
DA 2025-04-28
ER

PT J
AU Liu, CW
   Tsai, HC
   Huang, CC
   Tsai, CY
   Su, YB
   Lin, MW
   Lee, KC
   Hsieh, YC
   Li, TH
   Huang, SF
   Yang, YY
   Hou, MC
   Lin, HC
   Lee, FY
   Lee, SD
AF Liu, Chih-Wei
   Tsai, Hung-Cheng
   Huang, Chia-Chang
   Tsai, Chang-Youh
   Su, Yen-Bo
   Lin, Ming-Wei
   Lee, Kuei-Chuan
   Hsieh, Yun-Cheng
   Li, Tzu-Hao
   Huang, Shiang-Fen
   Yang, Ying-Ying
   Hou, Ming-Chih
   Lin, Han-Chieh
   Lee, Fa-Yauh
   Lee, Shou-Dong
TI Effects and mechanisms of caffeine to improve immunological and
   metabolic abnormalities in diet-induced obese rats
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
ID FREE FATTY-ACIDS; INDUCED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA;
   HUMAN ADIPOSE-TISSUE; HEPATIC STEATOSIS; LIPID-METABOLISM; PEROXISOME
   PROLIFERATOR; SKELETAL-MUSCLE; TNF-ALPHA; SENSITIVITY
AB In obesity, there are no effective therapies for parallel immune and metabolic abnormalities, including systemic/tissue insulin-resistance/ inflammation, adiposity and hepatic steatosis. Caffeine has anti-inflammation, antihepatic steatosis, and anti-insulin resistance effects. In this study, we evaluated the effects and molecular mechanisms of 6 wk of caffeine treatment (HFD-caf) on immunological and metabolic abnormalities of high-fat diet (HFD)-induced obese rats. Compared with HFD vehicle (HFD-V) rats, in HFD-caf rats the suppressed circulating immune cell inflammatory [TNF alpha, MCP-1, IL-6, intercellular adhesion molecule 1 (ICAM-1), and nitrite] profiles were accompanied by decreased liver, white adipose tissue (WAT), and muscle macrophages and their intracellular cytokine levels. Metabolically, the increase in metabolic rates reduced lipid accumulation in various tissues, resulting in reduced adiposity, lower fat mass, decreased body weight, amelioration of hepatic steatosis, and improved systemic/muscle insulin resistance. Further mechanistic approaches revealed an upregulation of tissue lipogenic [(SREBPlc, fatty acid synthase. acetyl-CoA carboxylase)/insulin-sensitizing (GLUT4 and p-IRSl)] markers in HFD-caf rats. Significantly, ex vivo experiments revealed that the cytokine release by the cocultured peripheral blood mononuclear cell (monocyte) and WAT (adipocyte), which are known to stimulate macrophage migration and hepatocyte lipogenesis, were lower in HFD-V groups than HFD-caf groups. Caffeine treatment simultaneously ameliorates immune and metabolic pathogenic signals present in tissue to normalize immunolgical and metabolic abnormalities found in HFD-induced obese rats.
C1 [Liu, Chih-Wei; Tsai, Chang-Youh] Taipei Vet Gen Hosp, Div Allergy Immunol & Rheutnatol, Taipei, Taiwan.
   [Lee, Kuei-Chuan; Hsieh, Yun-Cheng; Yang, Ying-Ying; Hou, Ming-Chih; Lin, Han-Chieh; Lee, Fa-Yauh] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan.
   [Huang, Shiang-Fen] Taipei Vet Gen Hosp, Div Infect, Taipei, Taiwan.
   [Tsai, Hung-Cheng; Huang, Chia-Chang; Su, Yen-Bo; Li, Tzu-Hao; Yang, Ying-Ying] Taipei Vet Gen Hosp, Div Gen Med, Taipei, Taiwan.
   [Lin, Ming-Wei] Natl Yang Ming Univ, Inst Publ Hlth, Div Prevent Med, Taipei, Taiwan.
   [Huang, Chia-Chang; Yang, Ying-Ying] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.
   [Liu, Chih-Wei; Tsai, Hung-Cheng; Huang, Chia-Chang; Tsai, Chang-Youh; Su, Yen-Bo; Lin, Ming-Wei; Lee, Kuei-Chuan; Hsieh, Yun-Cheng; Li, Tzu-Hao; Huang, Shiang-Fen; Yang, Ying-Ying; Hou, Ming-Chih; Lin, Han-Chieh; Lee, Fa-Yauh; Lee, Shou-Dong] Natl Yang Ming Univ Sch, Dept Med, Taipei, Taiwan.
   [Li, Tzu-Hao] Taichung Vet Gen Hosp, Chia Yi Branch, Chiayi, Taiwan.
   [Lee, Shou-Dong] Chen Hsin Gen Hosp, Taipei, Taiwan.
C3 Taipei Veterans General Hospital; Taipei Veterans General Hospital;
   Taipei Veterans General Hospital; Taipei Veterans General Hospital;
   National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung
   University; Taichung Veterans General Hospital; Cheng Hsin General
   Hospital
RP Yang, YY (corresponding author), Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, 201 Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.
EM yangyy@vghtpe.gov.tw
RI Lee, Karen/F-5037-2011; yang, yingying/AFM-0902-2022; Shou Ming,
   Ou/GPJ-9589-2022; Lin, Han/GRF-1081-2022; Chen, Yanfeng/JHU-9469-2023;
   Huang, Shiang-Fen/ABA-5375-2021; Chen, YuChun/L-1052-2019; Hsu,
   Chien-Yi/KHZ-0168-2024; Tsai, Chang-Youh/G-1747-2013
OI Yang, Ying-Ying/0000-0002-7719-0397; Huang,
   Chia-Chang/0000-0002-1313-4628
FU National Science Council [MOST-105-2314-B-010-024-MY3]; Taipei Veterans
   General Hospital;  [V105C-010];  [V106C-007];  [VGHUST105-G1-2-2]
FX This work was supported by Grants MOST-105-2314-B-010-024-MY3 from the
   National Science Council, and V105C-010, V106C-007, and
   VGHUST105-G1-2-2, and by the Taipei Veterans General Hospital.
CR Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Arias-Loste MT, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111878
   Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006
   BRASS EP, 1994, BIOCHEM J, V301, P193, DOI 10.1042/bj3010193
   Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696
   Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166
   Chavez-Valdez R, 2009, PEDIATR RES, V65, P203, DOI 10.1203/PDR.0b013e31818d66b1
   Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305
   Dray C, 2007, J PHYSIOL BIOCHEM, V63, P329, DOI 10.1007/BF03165764
   Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001
   Durante-Mangoni E, 2006, ALIMENT PHARM THERAP, V24, P1349, DOI 10.1111/j.1365-2036.2006.03114.x
   Engfeldt P, 1988, Horm Metab Res Suppl, V19, P26
   Ferré P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43
   Galvez B, 2006, ARTERIOSCL THROM VAS, V26, P1297, DOI 10.1161/01.ATV.0000220381.40739.dd
   Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA
   Green TD, 2012, J LEUKOCYTE BIOL, V92, P633, DOI 10.1189/jlb.1211604
   Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270
   Guarino MP, 2013, AGE, V35, P1755, DOI 10.1007/s11357-012-9475-x
   Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638
   Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011
   Ito S, 2007, ALCOHOL CLIN EXP RES, V31, p83S, DOI 10.1111/j.1530-0277.2006.00292.x
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Kim HY, 2015, MOLECULES, V20, P3107, DOI 10.3390/molecules20023107
   Kim JH, 2009, VITAM HORM, V80, P613, DOI 10.1016/S0083-6729(08)00621-3
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Kopp HP, 2003, ARTERIOSCL THROM VAS, V23, P1042, DOI 10.1161/01.ATV.0000073313.16135.21
   Lee KC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18899
   Lv XW, 2010, INFLAMM RES, V59, P635, DOI 10.1007/s00011-010-0176-6
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Montana G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167420
   Muqaku B, 2016, MOL NUTR FOOD RES, V60, P2529, DOI 10.1002/mnfr.201600328
   NEWTON R, 1981, EUR J CLIN PHARMACOL, V21, P45, DOI 10.1007/BF00609587
   Ohira H, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0387-0
   Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055
   Poniachik J, 2006, CYTOKINE, V33, P252, DOI 10.1016/j.cyto.2006.02.006
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Sindhu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133494
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13
   Tamura Y, 2008, ARTERIOSCL THROM VAS, V28, P2195, DOI 10.1161/ATVBAHA.108.168633
   Tremblay F, 2001, DIABETES, V50, P1901, DOI 10.2337/diabetes.50.8.1901
   Wang H, 2010, J CELL BIOCHEM, V110, P1447, DOI 10.1002/jcb.22696
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411
   Yeh TC, 2014, HYPERTENSION, V63, P535, DOI 10.1161/HYPERTENSIONAHA.113.02272
   Zhang SJ, 2015, FOOD FUNCT, V6, P2578, DOI [10.1039/c5fo00247h, 10.1039/C5FO00247H]
NR 52
TC 24
Z9 24
U1 1
U2 24
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD MAY
PY 2018
VL 314
IS 5
BP E433
EP E447
DI 10.1152/ajpendo.00094.2017
PG 15
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA GP8OJ
UT WOS:000441170700003
PM 29118012
OA Bronze
DA 2025-04-28
ER

PT J
AU Westerterp-Plantenga, MS
   Lejeune, MPGM
   Kovacs, EMR
AF Westerterp-Plantenga, MS
   Lejeune, MPGM
   Kovacs, EMR
TI Body weight loss and weight maintenance in relation to habitual caffeine
   intake and green tea supplementation
SO OBESITY RESEARCH
LA English
DT Article
DE energy expenditure; fat oxidation; satiety; leptin; thermogenesis
ID FOLLOW-UP; ENERGY-EXPENDITURE; FAT OXIDATION; DOUBLE-BLIND; DIET;
   EPHEDRINE; PROTEIN; OBESITY; THERMOGENESIS; CARBOHYDRATE
AB Objective: Investigation of the effect of a green tea-caffeine mixture on weight maintenance after body weight loss in moderately obese subjects in relation to habitual caffeine intake.
   Research Methods and Procedures: A randomized placebo-controlled double blind parallel trial in 76 overweight and moderately obese subjects, (BMI, 27.5 +/- 2.7 kg/m(2)) matched for sex, age, BMI, height, body mass, and habitual caffeine intake was conducted. A very low energy diet intervention during 4 weeks was followed by 3 months of weight maintenance (WM); during the WM period, the subjects received a green tea-caffeine mixture (270 mg epigallocatechin gallate + 150 mg caffeine per day) or placebo.
   Results: Subjects lost 5.9 +/- 1.8 (SD) kg (7.0 +/- 2.1%) of body weight (p < 0.001). At baseline, satiety was positively, and in women, leptin was inversely, related to subjects' habitual caffeine consumption (p < 0.01). High caffeine consumers reduced weight, fat mass, and waist circumference more than low caffeine consumers; resting energy expenditure was reduced less and respiratory quotient was reduced more during weight loss (p < 0.01). In the low caffeine consumers, during WM, green tea still reduced body weight, waist, respiratory quotient and body fat, whereas resting energy expenditure was increased compared with a restoration of these variables with placebo (p < 0.01). In the high caffeine consumers, no effects of the green tea-caffeine mixture were observed during WM.
   Discussion: High caffeine intake was associated with weight loss through thermogenesis and fat oxidation and with suppressed leptin in women. In habitual low caffeine consumers, the green tea-caffeine mixture improved WM, partly through thermogenesis and fat oxidation.
C1 Maastricht Univ, Dept Human Biol, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University
RP Maastricht Univ, Dept Human Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM m.westerterp@hb.unimaas.nl
CR ARCIERO PJ, 2002, 49 ANN M AM COLL SPO
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   BRACCO D, 1995, AM J PHYSIOL, pE671
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Ekelund U, 2000, INT J SPORTS MED, V21, P586, DOI 10.1055/s-2000-8487
   GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397
   Goris AHC, 2001, AM J CLIN NUTR, V73, P549
   Herman C.P., 1980, Obesity, P208
   Hongu N, 2000, J NUTR, V130, P152, DOI 10.1093/jn/130.2.152
   HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968
   Hulshof KFAM, 2003, EUR J CLIN NUTR, V57, P128, DOI 10.1038/sj.ejcn.1601503
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kolaczynski JW, 1996, DIABETES, V45, P1511, DOI 10.2337/diabetes.45.11.1511
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   KRAMER FM, 1989, INT J OBESITY, V13, P123
   KROMHOUT D, 1983, AM J CLIN NUTR, V38, P591, DOI 10.1093/ajcn/38.4.591
   LICHTENBELT WDV, 1994, BRIT J NUTR, V72, P491, DOI 10.1079/BJN19940053
   NOPPA H, 1980, AM J EPIDEMIOL, V111, P693, DOI 10.1093/oxfordjournals.aje.a112947
   Pasman WJ, 1997, INT J OBESITY, V21, P1143, DOI 10.1038/sj.ijo.0800528
   Pasman WJ, 1997, INT J OBESITY, V21, P548, DOI 10.1038/sj.ijo.0800439
   Pasman WJ, 1999, METABOLISM, V48, P15, DOI 10.1016/S0026-0495(99)90004-5
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Schoffelen PFM, 1997, J APPL PHYSIOL, V83, P2064, DOI 10.1152/jappl.1997.83.6.2064
   SEIDELL JC, 1995, OBES RES, V3, pS89, DOI 10.1002/j.1550-8528.1995.tb00451.x
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   TOUBRO S, 1993, INT J OBESITY, V17, pS69
   Trayhurn P., 1999, International Journal of Obesity, V23, pS22
   VanGaal LF, 1997, INT J OBESITY, V21, pS5
   WADDEN TA, 1988, J CONSULT CLIN PSYCH, V56, P925, DOI 10.1037/0022-006X.56.6.925
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   Westerterp-Plantenga MS, 2004, INT J OBESITY, V28, P57, DOI 10.1038/sj.ijo.0802461
   Westerterp-Plantenga MS, 1998, INT J OBESITY, V22, P1, DOI 10.1038/sj.ijo.0800536
   Westerterp-Plantenga MS, 2001, AM J CLIN NUTR, V74, P426
   Westerterp-Plantenga MS, 1999, EUR J CLIN NUTR, V53, P495, DOI 10.1038/sj.ejcn.1600782
   WING RR, 1992, AM J CLIN NUTR, V55, P1086, DOI 10.1093/ajcn/55.6.1086
NR 39
TC 239
Z9 263
U1 2
U2 89
PU NORTH AMER ASSOC STUDY OBESITY
PI SILVER SPRING
PA 8630 FENTON ST, SUITE 918, SILVER SPRING, MD 20910 USA
SN 1071-7323
J9 OBES RES
JI Obes. Res.
PD JUL
PY 2005
VL 13
IS 7
BP 1195
EP 1204
DI 10.1038/oby.2005.142
PG 10
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 955GE
UT WOS:000231212800011
PM 16076989
DA 2025-04-28
ER

PT J
AU Kim, JH
   Park, YS
AF Kim, Jeong-Hyeon
   Park, Yong Soon
TI Light coffee consumption is protective against sarcopenia, but frequent
   coffee consumption is associated with obesity in Korean adults
SO NUTRITION RESEARCH
LA English
DT Article
DE Caffeine; Obesity; Sarcopenia; Skeletal muscle; South Korea
ID METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; RISK;
   PREVALENCE; BENEFITS; MUSCLE; MASS; TEA
AB Few studies have examined the effects of coffee on body composition in the general population. In this cross-sectional study, we hypothesized that coffee consumption is protective against obesity and sarcopenia in Korean adults. The study included 6906 subjects aged >= 40 years who participated in the Korean National Health and Nutrition Examination Survey in 2009-2010. Body composition was measured using dual-energy x-ray absorptiometry, and obesity was determined according to the body mass index (BMI) and waist circumference (WC). Sarcopenia was defined as an appendicular skeletal muscle mass divided by height-squared that was below the lower quintile of the study population. Participants were classified into 4 groups according to the degree of coffee consumption (<1/d, 1/d, 2/d, and >= 3/d).The numbers of participants who were obese by BMI, obese by WC, and sarcopenic were 2390 (35.5%), 2033 (28.5%), and 1438 (20.0%), respectively. On multiple logistic regression analyses, the odds ratio (OR) of sarcopenia was lower in men who drink coffee once a day compared to those who rarely drink coffee (OR: 0.69, 95% confidence interval [CI]: 0.50-0.94). Women who consumed coffee >= 3 times/d had higher obesity ORs than those who rarely drink coffee according to both obesity indices (OR: 1.57, 95% CI, 1.18-2.10 for obesity by BMI; OR: 1.33, 95% CI: 1.01-1.75 for obesity by WC). Light coffee consumption was protective against sarcopenia in men, whereas frequent coffee consumption produced a higher risk for obesity, especially in women. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Kim, Jeong-Hyeon; Park, Yong Soon] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Family Med, 77 Sakju Ro, Chunchon 200704, South Korea.
C3 Hallym University
RP Park, YS (corresponding author), Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Family Med, 77 Sakju Ro, Chunchon 200704, South Korea.
EM pyongs@hanmail.net
RI Kim, Jong Wook/HTP-6808-2023
CR Baek JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149311
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Batsis JA, 2015, NUTR RES, V35, P1031, DOI 10.1016/j.nutres.2015.09.003
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Carpenter KM, 2000, AM J PUBLIC HEALTH, V90, P251, DOI 10.2105/AJPH.90.2.251
   Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726
   Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Dirks-Naylor AJ, 2015, LIFE SCI, V143, P182, DOI 10.1016/j.lfs.2015.11.005
   이석민, 2006, 에너지공학, V15, P1
   GRIMBY G, 1983, CLIN PHYSIOL, V3, P209, DOI 10.1111/j.1475-097X.1983.tb00704.x
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Guo YT, 2014, EXP GERONTOL, V50, P1, DOI 10.1016/j.exger.2013.11.005
   HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214
   Holvik K., 2003, NORSK EPIDEMIOLOGI, V13, P177
   Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11
   Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Lavie CJ, 2016, PROG CARDIOVASC DIS, V58, P537, DOI 10.1016/j.pcad.2016.01.008
   Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109
   Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107
   Liu JX, 2013, MAYO CLIN PROC, V88, P1066, DOI 10.1016/j.mayocp.2013.06.020
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033
   Pietrocola F, 2014, CELL CYCLE, V13, P1987, DOI 10.4161/cc.28929
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Shin CS, 2010, BONE, V47, P378, DOI 10.1016/j.bone.2010.03.017
   Stellman Steven D., 1996, Yonsei Medical Journal, V37, P31
   Yi SW, 2015, INT J EPIDEMIOL, V44, P1696, DOI 10.1093/ije/dyv138
NR 32
TC 29
Z9 32
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
J9 NUTR RES
JI Nutr. Res.
PD MAY
PY 2017
VL 41
BP 97
EP 102
DI 10.1016/j.nutres.2017.04.004
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EX5SK
UT WOS:000403302600009
PM 28464999
DA 2025-04-28
ER

PT J
AU Martini, D
   Chiavaroli, L
   González-Sarrías, A
   Bresciani, L
   Palma-Duran, SA
   Dall'Asta, M
   Deligiannidou, GE
   Massaro, M
   Scoditti, E
   Combet, E
   Maksimova, V
   Urpi-Sarda, M
   Kontogiorgis, CA
   Andrés-Lacueva, C
   Gibney, ER
   Del Rio, D
   Morand, C
   Garcia-Aloy, M
   Rodriguez-Mateos, A
   Mena, P
AF Martini, Daniela
   Chiavaroli, Laura
   Gonzalez-Sarrias, Antonio
   Bresciani, Letizia
   Palma-Duran, Susana A.
   Dall'Asta, Margherita
   Deligiannidou, Georgia-Eirini
   Massaro, Marika
   Scoditti, Egeria
   Combet, Emilie
   Maksimova, Viktorija
   Urpi-Sarda, Mireia
   Kontogiorgis, Christos A.
   Andres-Lacueva, Cristina
   Gibney, Eileen R.
   Del Rio, Daniele
   Morand, Christine
   Garcia-Aloy, Mar
   Rodriguez-Mateos, Ana
   Mena, Pedro
TI Impact of Foods and Dietary Supplements Containing Hydroxycinnamic Acids
   on Cardiometabolic Biomarkers: A Systematic Review to Explore
   Inter-Individual Variability
SO NUTRIENTS
LA English
DT Review
DE polyphenols; caffeoylquinic acids; hydroxycinnamic acids; coffee;
   potato; artichoke; cereals; dietary supplements; interindividual
   variability; cardiometabolic health
ID COFFEE BEAN EXTRACT; CHLOROGENIC ACID; ENDOTHELIAL FUNCTION;
   BLOOD-PRESSURE; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; DOUBLE-BLIND;
   LONG-TERM; OVERWEIGHT SUBJECTS; HEALTHY-VOLUNTEERS
AB Plant-based diets rich in bioactive compounds such as polyphenols have been shown to positively modulate the risk of cardiometabolic (CM) diseases. The inter-individual variability in the response to these bioactives may affect the findings. This systematic review aimed to summarize findings from existing randomized clinical trials (RCTs) evaluating the effect of hydroxycinnamic acids (HCAs) on markers of CM health in humans. Literature searches were performed in PubMed and the Web of Science. RCTs on acute and chronic supplementation of HCA-rich foods/extracts on CM biomarkers were included. Forty-four RCTs (21 acute and 23 chronic) met inclusion criteria. Comparisons were made between RCTs, including assessments based on population health status. Of the 44 RCTs, only seven performed analyses on a factor exploring inter-individual response to HCA consumption. Results demonstrated that health status is a potentially important effect modifier as RCTs with higher baseline cholesterol, blood pressure and glycaemia demonstrated greater overall effectiveness, which was also found in studies where specific subgroup analyses were performed. Thus, the effect of HCAs on CM risk factors may be greater in individuals at higher CM risk, although future studies in these populations are needed, including those on other potential determinants of inter-individual variability. PROSPERO, registration number CRD42016050790.
C1 [Martini, Daniela; Bresciani, Letizia; Del Rio, Daniele] Univ Parma, Dept Vet Sci, Human Nutr Unit, I-43121 Parma, Italy.
   [Chiavaroli, Laura; Dall'Asta, Margherita; Mena, Pedro] Univ Parma, Dept Food & Drug, Human Nutr Unit, I-43124 Parma, Italy.
   [Chiavaroli, Laura] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON M5S 1A8, Canada.
   [Gonzalez-Sarrias, Antonio] CEBAS CSIC, Lab Food & Hlth, Res Grp Qual Safety & Bioact Plant Foods, Murcia 30100, Spain.
   [Palma-Duran, Susana A.; Combet, Emilie] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med Dent & Nursing, Glasgow G31 2ER, Lanark, Scotland.
   [Deligiannidou, Georgia-Eirini; Kontogiorgis, Christos A.] Democritus Univ Thrace, Dept Med, Lab Hyg & Environm Protect, Alexandroupolis 68100, Greece.
   [Massaro, Marika; Scoditti, Egeria] Natl Res Council CNR, Inst Clin Physiol IFC, I-73100 Lecce, Italy.
   [Maksimova, Viktorija] Goce Delcev Univ, Fac Med Sci, Dept Appl Pharm, Stip 2000, North Macedonia.
   [Urpi-Sarda, Mireia; Andres-Lacueva, Cristina; Garcia-Aloy, Mar] Univ Barcelona, Biomarkers & Nutrimetab Lab, Dept Nutr Food Sci & Gastron, Fac Pharm & Food Sci,XaRTA,INSA, Santa Coloma De Gramenet 08921, Spain.
   [Urpi-Sarda, Mireia; Andres-Lacueva, Cristina; Garcia-Aloy, Mar] Inst Salud Carlos III, CIBERFES, Barcelona 08028, Spain.
   [Gibney, Eileen R.] Univ Coll Dublin, UCD Inst Food & Hlth, Dublin 4, Ireland.
   [Del Rio, Daniele] Univ Parma, Sch Adv Studies Food & Nutr, Parma, Italy.
   [Del Rio, Daniele] Univ Parma, Microbiome Res Hub, I-43124 Parma, Italy.
   [Morand, Christine] Univ Clermont Auvergne, INRA, UNH, CRNH Auvergne, F-63000 Clermont Ferrand, France.
   [Rodriguez-Mateos, Ana] Kings Coll London, Dept Nutr Sci, Sch Life Course Sci, Fac Life Sci & Med, London SE1 9NH, England.
C3 University of Parma; University of Parma; University of Toronto; Consejo
   Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de
   Edafologia y Biologia Aplicada del Segura (CEBAS); University of
   Glasgow; Democritus University of Thrace; Consiglio Nazionale delle
   Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Goce Delcev
   University of Stip; University of Barcelona; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERFES; Instituto de Salud Carlos III;
   University College Dublin; University of Parma; University of Parma;
   INRAE; Universite Clermont Auvergne (UCA); University of London; King's
   College London
RP Mena, P (corresponding author), Univ Parma, Dept Food & Drug, Human Nutr Unit, I-43124 Parma, Italy.
EM pedromiguel.menaparreno@unipr.it
RI Dall'Asta, Margherita/C-3445-2014; massaro, marika/AAQ-1204-2020;
   Rodriguez-Mateos, Ana/ABE-1560-2020; Deligiannidou, Georgia
   Eirini/AAL-4174-2021; Martini, Daniela/S-2499-2019; Gonzalez-Sarrias,
   Antonio/P-5846-2014; SCODITTI, EGERIA/J-8609-2016; MORAND,
   Christine/P-6988-2018; Urpi-Sarda, Mireia/D-5937-2013; Mena,
   Pedro/P-6353-2019; Andres-Lacueva, Cristina/J-3377-2012; Garcia-Aloy,
   Mar/A-9141-2012; Maksimova, Viktorija/JJF-0113-2023; Del Rio,
   Daniele/E-8696-2010; Chiavaroli, Laura/AFZ-6572-2022; martini,
   daniela/D-6241-2015
OI Gonzalez-Sarrias, Antonio/0000-0002-3407-0678; Combet,
   Emilie/0000-0002-9302-8971; SCODITTI, EGERIA/0000-0003-2753-8487;
   MORAND, Christine/0000-0001-8128-1032; Urpi-Sarda,
   Mireia/0000-0002-4064-5175; Mena, Pedro/0000-0003-2150-2977;
   Andres-Lacueva, Cristina/0000-0002-8494-4978; Dall'Asta,
   Margherita/0000-0002-0558-0337; Massaro, Marika/0000-0001-6124-5077;
   Bresciani, Letizia/0000-0002-7768-4987; Garcia-Aloy,
   Mar/0000-0002-1330-6610; Maksimova, Viktorija/0009-0001-6986-3213;
   Deligiannidou, Georgia -Eirini/0000-0003-3976-4473; Del Rio,
   Daniele/0000-0001-5394-1259; Palma-Duran, Susana A/0000-0002-4210-3855;
   Rodriguez-Mateos, Ana/0000-0003-3242-402X; Chiavaroli,
   Laura/0000-0002-8900-6366; martini, daniela/0000-0001-8298-926X
FU COST (European Cooperation in Science and Technology) [FA1403-POSITIVe]
FX This article is based upon work from COST Action FA1403-POSITIVe
   "Interindividual variation in response to consumption of plant food
   bioactives and determinants involved" supported by COST (European
   Cooperation in Science and Technology, http://www.cost.eu/).
CR Agudelo-Ochoa GM, 2016, J NUTR, V146, P524, DOI 10.3945/jn.115.224774
   Alkhaldy A, 2019, EUR J NUTR, V58, P1095, DOI 10.1007/s00394-018-1625-1
   Angelino D, 2019, INT J FOOD SCI NUTR, V70, P652, DOI 10.1080/09637486.2019.1571021
   Angelino D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36291-6
   Angelino D, 2017, FOOD FUNCT, V8, P2368, DOI [10.1039/c7fo00574a, 10.1039/C7FO00574A]
   [Anonymous], 2009, CRDS GUIDANCE UNDERT, DOI DOI 10.1371/JOURNAL.PONE.0201887/1/PONE.0201887.S005.PDF?X-GOOG-ALGORITHM=GOOG4-RSA-SHA256&X-GOOG-CREDENTIAL=WOMBAT-SA%40PLOS-PROD.IAM.GSERVICEACCOUNT.COM%2F20210726%2FAUTO%2FSTORAGE%2FGOOG4
   Beam JR, 2015, NUTRITION, V31, P292, DOI 10.1016/j.nut.2014.07.012
   Bento-Silva A, 2020, EUR J NUTR, V59, P1275, DOI 10.1007/s00394-019-01987-6
   Boon EAJ, 2017, FOOD FUNCT, V8, P3366, DOI 10.1039/c7fo00926g
   Bumrungpert A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060713
   Calani L, 2012, J CLIN GASTROENTEROL, V46, pS95, DOI 10.1097/MCG.0b013e318264e82b
   Campesi I, 2018, EUR J NUTR, V57, P2677, DOI 10.1007/s00394-018-1695-0
   Clifford MN, 2003, J AGR FOOD CHEM, V51, P2900, DOI 10.1021/jf026187q
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Del Rio D, 2010, NUTRIENTS, V2, P820, DOI 10.3390/nu2080820
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8
   García-Conesa MT, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030694
   González-Barrio R, 2011, DRUG METAB DISPOS, V39, P1680, DOI 10.1124/dmd.111.039651
   González-Sarrías A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070746
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Higgins JPT, 2011, COCHRANE COLLABORATI, DOI 10.1109/ISIT.2017.8006970
   Ibero-Baraibar I, 2014, NUTR METAB CARDIOVAS, V24, P416, DOI 10.1016/j.numecd.2013.09.017
   Ioakeimidis N, 2018, INT J FOOD SCI NUTR, V69, P870, DOI 10.1080/09637486.2017.1422700
   Iwai K, 2012, FOOD SCI TECHNOL RES, V18, P849, DOI 10.3136/fstr.18.849
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jokura H, 2015, NUTR RES, V35, P873, DOI 10.1016/j.nutres.2015.07.005
   Kajikawa M, 2019, EUR J NUTR, V58, P989, DOI 10.1007/s00394-018-1611-7
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Lappi J, 2013, FOOD FUNCT, V4, P972, DOI 10.1039/c3fo60078e
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Liberati A, 2009, J Clin Epidemiol, V62, P1, DOI 10.1016/j.jclinepi.2009.06.006
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI [10.1039/C4FO00290C, 10.1039/c4fo00290c]
   Manach C, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600557
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Mena P, 2018, J AGR FOOD CHEM, V66, P8221, DOI 10.1021/acs.jafc.8b03249
   Menezes R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020117
   Milenkovic D, 2017, ADV NUTR, V8, P558, DOI 10.3945/an.116.013623
   Miller RJ, 2011, BRIT J NUTR, V105, P1138, DOI 10.1017/S0007114510004836
   Mills CE, 2017, CLIN NUTR, V36, P1520, DOI 10.1016/j.clnu.2016.11.013
   Morand C, 2019, J AGR FOOD CHEM, V67, P3843, DOI 10.1021/acs.jafc.9b01175
   Moser S, 2018, NUTR RES, V52, P57, DOI 10.1016/j.nutres.2018.02.001
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   Ochiai R, 2015, INT J FOOD SCI NUTR, V66, P350, DOI 10.3109/09637486.2015.1007453
   Ochiai R, 2014, NUTR RES, V34, P155, DOI 10.1016/j.nutres.2013.11.001
   Ochiai R, 2009, HYPERTENS RES, V32, P969, DOI 10.1038/hr.2009.132
   Petersen KS, 2017, CURR DEV NUTR, V1, DOI 10.3945/cdn.117.001289
   Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1016/j.atherosclerosis.2016.05.037, 10.1177/2047487316653709]
   Potì F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020351
   Rakvaag E, 2016, EUR J NUTR, V55, P2221, DOI 10.1007/s00394-015-1032-9
   Rasmussen BB, 2002, PHARMACOGENETICS, V12, P473, DOI 10.1097/00008571-200208000-00008
   Rezazadeh K, 2018, EUR J INTEGR MED, V17, P112, DOI 10.1016/j.eujim.2017.12.008
   Riedel A, 2014, FOOD RES INT, V63, P409, DOI 10.1016/j.foodres.2014.04.002
   Robertson TM, 2018, BRIT J NUTR, V119, P792, DOI [10.1017/S0007114518000260, 10.1017/s0007114518000260]
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Rodriguez-Mateos A, 2014, ARCH TOXICOL, V88, P1803, DOI 10.1007/s00204-014-1330-7
   Rondanelli M, 2014, PHYTOTHER RES, V28, P33, DOI 10.1002/ptr.4950
   Rondanelli M, 2013, INT J FOOD SCI NUTR, V64, P7, DOI 10.3109/09637486.2012.700920
   Rosén LAH, 2011, J AGR FOOD CHEM, V59, P12139, DOI 10.1021/jf2019825
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Sarriá B, 2016, FOOD RES INT, V89, P1023, DOI 10.1016/j.foodres.2015.12.032
   Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096
   Schubert MM, 2014, APPETITE, V83, P317, DOI 10.1016/j.appet.2014.09.006
   Shahmohammadi HA, 2017, HEPAT MON, V17, DOI 10.5812/hepatmon.45609
   Skinner TL, 2013, J SCI MED SPORT, V16, P343, DOI 10.1016/j.jsams.2012.08.004
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Urgert R, 1996, J ROY SOC MED, V89, P618, DOI 10.1177/014107689608901107
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107
   Velderrain-Rodríguez GR, 2014, FOOD FUNCT, V5, P189, DOI 10.1039/c3fo60361j
   Vinson JA, 2012, J AGR FOOD CHEM, V60, P6749, DOI 10.1021/jf2045262
   Vitaglione P, 2015, AM J CLIN NUTR, V101, P251, DOI 10.3945/ajcn.114.088120
   Ward NC, 2016, FOOD FUNCT, V7, P2197, DOI [10.1039/C6FO00248J, 10.1039/c6fo00248j]
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   West SG, 2014, BRIT J NUTR, V111, P653, DOI 10.1017/S0007114513002912
   Williamson G, 2017, BIOCHEM PHARMACOL, V139, P24, DOI 10.1016/j.bcp.2017.03.012
   Winkler S, 2014, FOOD RES INT, V63, P428, DOI 10.1016/j.foodres.2014.05.073
   Yamaguchi T, 2008, NUTR METAB CARDIOVAS, V18, P408, DOI 10.1016/j.numecd.2007.03.004
   Zhang L, 2016, FOOD FUNCT, V7, P1273, DOI [10.1039/C5FO01244A, 10.1039/c5fo01244a]
   Ziauddeen N, 2019, EUR J NUTR, V58, P3183, DOI 10.1007/s00394-018-1862-3
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 90
TC 29
Z9 29
U1 0
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2019
VL 11
IS 8
AR 1805
DI 10.3390/nu11081805
PG 30
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA IV8HH
UT WOS:000484506000193
PM 31387247
OA Green Submitted, gold, Green Published, Green Accepted
DA 2025-04-28
ER

PT J
AU Kobayashi-Hattori, K
   Mogi, A
   Matsumoto, Y
   Takita, T
AF Kobayashi-Hattori, K
   Mogi, A
   Matsumoto, Y
   Takita, T
TI Effect of caffeine on the body fat and lipid metabolism of rats fed on a
   high-fat diet
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE caffeine; body fat; lipid metabolism; catecholamine; obesity
ID SERUM-CHOLESTEROL; GREEN TEA; PLASMA-LIPIDS; MICE; BEVERAGES; EXCRETION;
   OBESITY; COFFEE
AB The intake of caffeine (CF) at 0.025, 0.05 or 0.1 % for 21 days progressively reduced the body fat mass and body fat percentage in Sprague-Dawley (SD) rats fed on a high-fat diet with increasing administration level. Moreover, CF increased the serum concentrations of catecholamines and free fatty acids in SD rats orally administered with CF (5 mg/kg). These results suggest that the intake of CF reduced body fat by lipolysis via catecholamines. CF has potential as a functional food ingredient with an anti-obesity action.
C1 Tokyo Univ Agr, Fac Appl Biosci, Dept Nurtrit Sci, Setagaya Ku, Tokyo 1568502, Japan.
   Kawasaki Univ Med Welf, Fac Med Profess, Dept Clin Nutr, Kurashiki, Okayama 7010193, Japan.
C3 Tokyo University of Agriculture
RP Tokyo Univ Agr, Fac Appl Biosci, Dept Nurtrit Sci, Setagaya Ku, Tokyo 1568502, Japan.
EM k2kobaya@nodai.ac.jp
OI , Kazuo/0000-0002-0921-2128
CR Adachi H, 2005, J EPIDEMIOL, V15, P85, DOI 10.2188/jea.15.85
   ARCIERO PJ, 1995, ENDOCRINOL METAB, V31, pE1192
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Benowitz NL, 1995, CLIN PHARMACOL THER, V58, P684, DOI 10.1016/0009-9236(95)90025-X
   BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500
   CHEN MD, 1994, CHIN MED J, V53, P257
   DENARO CP, 1991, EUR J CLIN PHARMACOL, V40, P273, DOI 10.1007/BF00315208
   FEARS R, 1978, BRIT J NUTR, V39, P363, DOI 10.1079/BJN19780046
   Hasegawa N, 2000, J HEALTH SCI, V46, P153
   He Y, 2004, ANN EPIDEMIOL, V14, P1, DOI 10.1016/S1047-2797(03)00069-3
   HENLY AA, 1957, ANALYST, V82, P286
   HOSTMARK AT, 1988, NUTR REP INT, V38, P859
   HOSTMARK AT, 1986, NUTR REP INT, V34, P119
   INOUE H, 2005, ITE LETT BATT NEW TE, V6, P61
   Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x
   LeBlanc J, 1995, PHARMACOL RES, V32, P129, DOI 10.1016/S1043-6618(05)80005-2
   LIN BB, 1986, NUTR REP INT, V34, P821
   Michna L, 2003, LIFE SCI, V73, P1383, DOI 10.1016/S0024-3205(03)00468-5
   NAISMITH DJ, 1969, J NUTR, V97, P375, DOI 10.1093/jn/97.3.375
   ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403
   SUGIYAMA K, 1989, AGR BIOL CHEM TOKYO, V53, P3101, DOI 10.1080/00021369.1989.10869788
   Welborn TA, 2003, MED J AUSTRALIA, V179, P580, DOI 10.5694/j.1326-5377.2003.tb05704.x
   Yoshiike N, 2002, ASIA PAC J CLIN NUTR, V11, pS727, DOI 10.1046/j.1440-6047.11.s8.18.x
   ZAK B, 1957, AM J CLIN PATHOL, V27, P583, DOI 10.1093/ajcp/27.5_ts.583
   Zheng GD, 2004, IN VIVO, V18, P55
NR 25
TC 71
Z9 83
U1 1
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD NOV
PY 2005
VL 69
IS 11
BP 2219
EP 2223
DI 10.1271/bbb.69.2219
PG 5
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA 989YU
UT WOS:000233710900026
PM 16306706
OA Bronze
DA 2025-04-28
ER

PT J
AU Han, SF
   Qiu, Y
   Zhang, GQ
   Lian, FZ
   Zhang, WG
AF Han, Shufen
   Qiu, Yue
   Zhang, Gus Q.
   Lian, Fuzhi
   Zhang, Weiguo
TI A meta-analysis and systematic review of randomized clinical trials on
   the effect of coffee consumption on heart rate
SO NUTRITION REVIEWS
LA English
DT Review
DE meta-analysis; resting heart rate; coffee; randomized controlled trials;
   cardiovascular health
ID BLOOD-PRESSURE; CAFFEINE; RISK; CHOLESTEROL; BIAS
AB Context Resting heart rate (HR) is increasingly recognized as an indicator of disease and overall morbidity and mortality. Whether chronic coffee consumption affects resting HR is an important consideration for individual consumers as well as from a public health perspective.Objective A meta-analysis of randomized controlled trials (RCTs) was conducted to examine the effectiveness of coffee consumption on resting HR.Data Sources Original RCTs assessing the effect of coffee consumption on resting HR and published prior to March 2023 were identified by searching online databases, including PubMed, Web of Science, and Cochrane Library databases.Data Extraction and Analysis Data searches and extraction and risk-of-bias assessments were performed according to the Cochrane guidelines, and the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for systematic reviews were followed. Data on study characteristics, type, and amount of coffee and net change and measurement resting HR were extracted. A random-effects or a fixed-effects model was used to estimate the pooled effect sizes. Homogeneity was determined with the Cochran Q test, and publication bias was assessed through Begg's test, Egger's test, and funnel plots.Results A total of 6 RCTs with 11 intervention trials or arms involving 485 individuals were included. The participants were generally healthy, although some had hypertension, hypercholesterolemia, or were overweight. The trial duration ranged from 2 weeks to 24 weeks. The overall pooled analysis showed that coffee consumption resulted in a negligible increase in resting HR of 0.40 beats per minute (95% CI: -0.78 to 1.57; P = 0.506), which was statistically insignificant. Subgroup analysis of all specified categories was consistent with the overall analysis. No heterogeneity was observed among included trials (I2 = 0.0%, P = 0.756).Conclusion The results of the present meta-analysis study demonstrate that daily coffee consumption of 3 to 6 cups for a period of 2 to 24 weeks has no statistically significant effect on resting HR.
C1 [Han, Shufen; Qiu, Yue; Lian, Fuzhi] Hangzhou Normal Univ, Sch Publ Hlth, Dept Nutr & Toxicol, Hangzhou, Zhejiang, Peoples R China.
   [Zhang, Gus Q.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA.
   [Zhang, Weiguo] Las Colinas Inst, Irving, TX 75039 USA.
C3 Hangzhou Normal University; University of Texas System; University of
   Texas Southwestern Medical Center Dallas
RP Zhang, WG (corresponding author), Las Colinas Inst, Irving, TX 75039 USA.
EM weiguozha@yahoo.com
RI Lian, Fuzhi/F-9083-2015; Zhang, Weiguo/IXN-8291-2023
OI Zhang, Weiguo/0000-0003-0767-1723
FU Author contributions. S.H. and W.Z. initiated the conceptional
   framework. S.H., G.Q.Z., and W.Z. constructed a literature search
   strategy. S.H. and Y.Q. conducted the literature search and assessed
   studies for eligibility and risk of bias. S.H., Y.Q., and
FX Author contributions. S.H. and W.Z. initiated the conceptional
   framework. S.H., G.Q.Z., and W.Z. constructed a literature search
   strategy. S.H. and Y.Q. conducted the literature search and assessed
   studies for eligibility and risk of bias. S.H., Y.Q., and F.L. extracted
   data from studies included for statistical analysis. All authors
   contributed to the interpretation of the study findings. S.H., G.Q.Z.,
   and W.Z. drafted the manuscript. All authors revised and approved the
   content of the final version and its submission. S.H. and W.Z. are
   co-corresponding authors of the present work.
CR Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Corti R, 2002, CIRCULATION, V106, P2935, DOI 10.1161/01.CIR.0000046228.97025.3A
   Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Green PJ, 1996, ANN BEHAV MED, V18, P201, DOI 10.1007/BF02883398
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647
   Jensen MT, 2019, SCAND J CLIN LAB INV, V79, P108, DOI 10.1080/00365513.2019.1566567
   Mancia G, 2021, J HYPERTENS, V39, P1060, DOI 10.1097/HJH.0000000000002760
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d
   Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906, 10.1136/bmj.n160]
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Pourshahidi LK, 2016, COMPR REV FOOD SCI F, V15, P671, DOI 10.1111/1541-4337.12206
   Pozuelo-Carrascosa DP, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071354
   Rakic V, 1999, HYPERTENSION, V33, P869, DOI 10.1161/01.HYP.33.3.869
   Ran LS, 2021, EPIDEMIOL PSYCH SCI, V30, DOI 10.1017/S2045796020001183
   Riksen Niels P, 2011, Handb Exp Pharmacol, P413, DOI 10.1007/978-3-642-13443-2_16
   Rodríguez-Artalejo F, 2018, J AGR FOOD CHEM, V66, P5257, DOI 10.1021/acs.jafc.7b04506
   Ruiz-Moreno C, 2020, EUR J NUTR, V59, P3293, DOI 10.1007/s00394-019-02167-2
   Schoeneck M, 2021, NUTR METAB CARDIOVAS, V31, P1325, DOI 10.1016/j.numecd.2020.12.032
   Shahinfar H, 2021, NUTR METAB CARDIOVAS, V31, P2526, DOI 10.1016/j.numecd.2021.05.014
   SUPERKO HR, 1991, AM J CLIN NUTR, V54, P599, DOI 10.1093/ajcn/54.3.599
   SUPERKO HR, 1994, AM J CARDIOL, V73, P780, DOI 10.1016/0002-9149(94)90881-8
   Turnbull D, 2017, REGUL TOXICOL PHARM, V89, P165, DOI 10.1016/j.yrtph.2017.07.025
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   VANDUSSELDORP M, 1991, HYPERTENSION, V18, P607, DOI 10.1161/01.HYP.18.5.607
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Zhang GQ, 2009, AGEING RES REV, V8, P52, DOI 10.1016/j.arr.2008.10.001
   Zhang WG, 2022, NUTR REV, V80, P128, DOI 10.1093/nutrit/nuab009
   Zhao LG, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6561-9
NR 34
TC 2
Z9 2
U1 6
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0029-6643
EI 1753-4887
J9 NUTR REV
JI Nutr. Rev.
PD AUG 30
PY 2023
VL 82
IS 8
BP 1046
EP 1055
DI 10.1093/nutrit/nuad110
EA AUG 2023
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA YJ9V8
UT WOS:001061495400001
PM 37647856
DA 2025-04-28
ER

PT J
AU Lee, S
   Hudson, R
   Kilpatrick, K
   Graham, TE
   Ross, R
AF Lee, S
   Hudson, R
   Kilpatrick, K
   Graham, TE
   Ross, R
TI Caffeine ingestion is associated with reductions in glucose uptake
   independent of obesity and type 2 diabetes before and after exercise
   training
SO DIABETES CARE
LA English
DT Article
ID INSULIN SENSITIVITY; TOLERANCE TEST; WEIGHT-LOSS; COFFEE CONSUMPTION;
   INDUCED IMPAIRMENT; CONTROLLED-TRIAL; SKELETAL-MUSCLE; MEN; RESISTANCE;
   HUMANS
AB OBJECTIVE - We investigated the effect of caffeine ingestion oil insulin sensitivity in sedentary lean men (n = 8) and obese men with (n = 7) and without (11 = 8) type 2 diabetes. We also examined whether chronic exercise influences the relationship between caffeine and insulin sensitivity in these individuals.
   RESEARCH DESIGN AND METHODS - Subjects underwent two hyperinsulinemic-euglycemic clamp procedures, caffeine (5 mg/kg body wt) and placebo, in a double-blind, randomized manner before and after a 3-month aerobic exercise program. Body composition was measured by magnetic resonance imaging.
   RESULTS - At baseline, caffeine ingestion was associated with a significant reduction (P < 0.05) in insulin sensitivity by a similar magnitude in the lean (33%), obese (33%), and type 2 diabetic (37%) groups in comparison with placebo. After exercise training, caffeine ingestion was Still associated with a reduction (P < 0.05) in insulin sensitivity by a similar magnitude in the lean (23%), obese (26%), and type 2 diabetic (36%) groups in comparison with placebo, Exercise was not associated with a significant increase in insulin sensitivity in either the caffeine or placebo trials, independent of group (P > 0.10).
   CONCLUSIONS - Caffeine consumption is associated with a substantial reduction in insulin-mediated glucose uptake independent of obesity, type 2 diabetes, and chronic exercise.
C1 Queens Univ, Sch Phys & Hlth Educ, Kingston, ON K7L 3N6, Canada.
   Queens Univ, Div Endocrinol & Metab, Dept Med, Kingston, ON, Canada.
   Queens Univ, Div Geriatr, Dept Med, Kingston, ON, Canada.
   Univ Guelph, Dept Human Biol & Nutr Sci, Guelph, ON N1G 2W1, Canada.
C3 Queens University - Canada; Queens University - Canada; Queens
   University - Canada; University of Guelph
RP Queens Univ, Sch Phys & Hlth Educ, Kingston, ON K7L 3N6, Canada.
EM rossr@post.queensu.ca
RI Lee, SoJung/AAW-2558-2020
OI Lee, SoJung/0000-0002-6634-6800
CR Arnaud MJ., 1993, CAFFEINE COFFEE HLTH, P43
   BARON AD, 1987, J CLIN ENDOCR METAB, V64, P889, DOI 10.1210/jcem-64-5-889
   BOGARDUS C, 1984, DIABETES, V33, P311, DOI 10.2337/diabetes.33.4.311
   Brown J, 2001, AM J EPIDEMIOL, V153, P815, DOI 10.1093/aje/153.8.815
   Cuff DJ, 2003, DIABETES CARE, V26, P2977, DOI 10.2337/diacare.26.11.2977
   DEIBERT DC, 1980, J CLIN INVEST, V65, P717, DOI 10.1172/JCI109718
   Dengel DR, 1996, J APPL PHYSIOL, V81, P318, DOI 10.1152/jappl.1996.81.1.318
   Duncan GE, 2003, DIABETES CARE, V26, P557, DOI 10.2337/diacare.26.3.557
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Han DH, 1998, DIABETES, V47, P1671, DOI 10.2337/diabetes.47.11.1671
   Harland BF, 2000, NUTRITION, V16, P522, DOI 10.1016/S0899-9007(00)00369-5
   Harris J., 1919, BIOMETRIC STUDY BASA
   HUGHES VA, 1993, AM J PHYSIOL, V264, pE855, DOI 10.1152/ajpendo.1993.264.6.E855
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134
   MILES J, 1983, J LIPID RES, V24, P96
   NUUTILA P, 1995, DIABETES, V44, P31, DOI 10.2337/diabetes.44.1.31
   Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804
   Petrie HJ, 2004, AM J CLIN NUTR, V80, P22
   Pizziol A, 1998, EUR J CLIN NUTR, V52, P846, DOI 10.1038/sj.ejcn.1600657
   Rice B, 1999, DIABETES CARE, V22, P684, DOI 10.2337/diacare.22.5.684
   Robinson LE, 2004, J NUTR, V134, P2528, DOI 10.1093/jn/134.10.2528
   Rodríguez-Morán M, 2003, DIABETES CARE, V26, P1147, DOI 10.2337/diacare.26.4.1147
   Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95
   ROSS R, 1992, J APPL PHYSIOL, V72, P787, DOI 10.1152/jappl.1992.72.2.787
   Ross R, 2000, Exerc Sport Sci Rev, V28, P165
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   SEGAL KR, 1991, J APPL PHYSIOL, V71, P2402, DOI 10.1152/jappl.1991.71.6.2402
   Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529
   Snyder WS., 1974, REPORT TASK GROUP RE
   Thong FSL, 2002, J APPL PHYSIOL, V92, P2347, DOI 10.1152/japplphysiol.01229.2001
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   VERGAUWEN L, 1994, J CLIN INVEST, V93, P974, DOI 10.1172/JCI117104
NR 35
TC 75
Z9 80
U1 0
U2 19
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD MAR
PY 2005
VL 28
IS 3
BP 566
EP 572
DI 10.2337/diacare.28.3.566
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 903ME
UT WOS:000227429200011
PM 15735189
OA Bronze
DA 2025-04-28
ER

PT J
AU Cardoso, GA
   Salgado, JM
   Cesar, MD
   Donado-Pestana, CM
AF Cardoso, Gabrielle Aparecida
   Salgado, Jocelem Mastrodi
   Cesar, Marcelo de Castro
   Donado-Pestana, Carlos Mario
TI The Effects of Green Tea Consumption and Resistance Training on Body
   Composition and Resting Metabolic Rate in Overweight or Obese Women
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE green tea; obesity; resistance training; resting metabolic rate;
   thermogenesis
ID 3T3-L1 PREADIPOCYTES DEPENDS; ENERGY-EXPENDITURE; (-)-EPIGALLOCATECHIN
   GALLATE; CATECHIN-POLYPHENOLS; FAT-METABOLISM; WEIGHT-LOSS; EXERCISE;
   THERMOGENESIS; CAFFEINE; LIPIDS
AB Green tea has been shown to have thermogenic and antiobesity properties. Therefore, it is important to investigate its effect on weight loss in humans, especially in women. We investigated the effects of green tea consumption combined with resistance training on the body composition and the resting metabolic rate (RMR) in women who were overweight or obese (grade I). After 4 weeks on an adaptive diet, 36 women were divided into four groups (group 1, green tea; group 2, placebo; group 3, green tea plus resistance training; group 4, placebo plus resistance training). The study was double-blinded and placebo-controlled. The RMR and body composition were ascertained for each volunteer, blood tests were performed, and subjects in groups 3 and 4 were tested for their one repetition maximum. Each subject followed the protocol and continued the diet for eight additional weeks, and periodic evaluations were administered. The mean RMR of group 1 decreased significantly and was accompanied by weight loss, maintenance of lean body mass, and decreases in both waist circumference and body mass index. Group 2 showed no variations in anthropometric or blood variables and significantly decreased their mean RMR. Group 3 showed significant increases in RMR, lean body mass, and muscle strength, and significant decreases in body fat, triglycerides, and waist circumference as compared to group 4. Green tea combined with resistance training its potential is increased with decreasing body fat, waist circumference, and triacylglyceride levels and by increasing lean body mass and muscle strength.
C1 [Cardoso, Gabrielle Aparecida; Salgado, Jocelem Mastrodi] Univ Sao Paulo, Dept Agroind Food & Nutr, Luiz de Queiroz Coll Agr ESALQ, BR-13418900 Sao Paulo, Brazil.
   [Donado-Pestana, Carlos Mario] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Foods & Expt Nutr, BR-13418900 Sao Paulo, Brazil.
   [Cesar, Marcelo de Castro] Univ Metodista Piracicaba, Fac Phys Educ, Labs Anthropometr Assessment & Phys Effort, Sao Paulo, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade
   Metodista de Piracicaba
RP Salgado, JM (corresponding author), Univ Sao Paulo, Dept Agroind Alimentos & Nutr, Escola Super Agr Luiz de Queiroz, Ave Padua Dias 11,Caixa Postal 9, BR-13418900 Sao Paulo, Brazil.
EM jocelemsalgado@usp.br
RI Salgado, Jocelem/C-8413-2012; Donado-Pestana, Carlos/O-3407-2014
OI Donado-Pestana, Carlos/0000-0003-4344-5141
FU Coordination of Improvement of Personnel of Superior Level (CAPES); Luiz
   de Queiroz Foundation of Agrarian Studies (FEALQ)
FX We sincerely thank the Coordination of Improvement of Personnel of
   Superior Level (CAPES) and the Luiz de Queiroz Foundation of Agrarian
   Studies (FEALQ) for financial aid and the Sanavita Industry for donation
   of the green tea and placebo.
CR Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Brown L.E., 2001, PROFESSIONALIZATION, V4, DOI 10.26603/epj.4.1.1
   Cesar MD, 2008, OBES SURG, V18, P1376, DOI 10.1007/s11695-008-9460-8
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chanadiri T, 2005, Georgian Med News, P61
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Drummond MJ, 2005, J STRENGTH COND RES, V19, P332
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   ELLIOT DL, 1989, AM J CLIN NUTR, V49, P93, DOI 10.1093/ajcn/49.1.93
   Evans W J, 1991, Exerc Sport Sci Rev, V19, P99
   GRAY DS, 1989, AM J CLIN NUTR, V50, P255, DOI 10.1093/ajcn/50.2.255
   Häkkinen K, 2003, EUR J APPL PHYSIOL, V89, P42, DOI 10.1007/s00421-002-0751-9
   Harber MP, 2008, INT J SPORTS MED, V29, P719, DOI 10.1055/s-2007-989442
   Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, pC1094, DOI 10.1152/ajpcell.00569.2004
   Kao CC, 2010, PLANTA MED, V76, P694, DOI 10.1055/s-0029-1240623
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027
   Lee MS, 2009, PHYTOTHER RES, V23, P1088, DOI 10.1002/ptr.2737
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Mahan LK, 2004, FOOD NUTR DIET THERA, V11
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   McArdle W.D., 2001, Exercise Physiology: energy, nutrition and human performance, V5
   Melanson EL, 2009, EXERC SPORT SCI REV, V37, P93, DOI 10.1097/JES.0b013e31819c2f0b
   Misra A, 2008, DIABETES CARE, V31, P1282, DOI 10.2337/dc07-2316
   Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Ormsbee MJ, 2007, J APPL PHYSIOL, V102, P1767, DOI 10.1152/japplphysiol.00704.2006
   PLOUTZ LL, 1994, J APPL PHYSIOL, V76, P1675, DOI 10.1152/jappl.1994.76.4.1675
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Richards JC, 2010, MED SCI SPORT EXER, V42, P739, DOI 10.1249/MSS.0b013e3181bcab6c
   Rodríguez-Bies E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013900
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Schwartz A, 2010, OBES REV, V11, P531, DOI 10.1111/j.1467-789X.2009.00654.x
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Strasser B, 2011, J OBES, V2011, DOI 10.1155/2011/482564
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wu BT, 2005, J AGR FOOD CHEM, V53, P5695, DOI 10.1021/jf050045p
NR 45
TC 49
Z9 51
U1 1
U2 78
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD FEB
PY 2013
VL 16
IS 2
BP 120
EP 127
DI 10.1089/jmf.2012.0062
PG 8
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition &
   Dietetics
GA 089AH
UT WOS:000314879500005
PM 23140132
DA 2025-04-28
ER

PT J
AU Watanabe, T
   Kobayashi, S
   Yamaguchi, T
   Hibi, M
   Fukuhara, I
   Osaki, N
AF Watanabe, Takuya
   Kobayashi, Shinichi
   Yamaguchi, Tohru
   Hibi, Masanobu
   Fukuhara, Ikuo
   Osaki, Noriko
TI Coffee Abundant in Chlorogenic Acids Reduces Abdominal Fat in Overweight
   Adults: A Randomized, Double-Blind, Controlled Trial
SO NUTRIENTS
LA English
DT Article
DE chlorogenic acids; instant coffee; randomized clinical trial; total fat
   area; visceral fat area
ID DOSE-RESPONSE METAANALYSIS; CARDIOVASCULAR-DISEASE; ENDOTHELIAL
   FUNCTION; BLOOD-PRESSURE; LONG-TERM; BODY-FAT; CONSUMPTION; WEIGHT;
   RISK; APPETITE
AB The components of roasted or green coffee beans that promote abdominal fat reduction are not clear. We investigated the effects of daily consumption of coffee enriched in chlorogenic acids (CGA) on abdominal fat area in a randomized, double-blind, parallel controlled trial. Healthy, overweight men and women (n = 150, body mass index (BMI) >= 25 to <30 kg/m(2)) were randomly allocated to high-CGA (369 mg CGA/serving) or control (35 mg CGA/serving) coffee groups. Instant coffee was consumed once daily for 12 weeks, with four-week pre- and post-observation periods. Abdominal fat area and anthropometric measurements were analyzed at baseline and at four, eight, and 12 weeks, and 142 subjects completed the trial. Visceral fat area (VFA), total abdominal fat area (TFA), body weight, and waist circumference significantly decreased in the CGA group compared with the control group, with a group x time interaction (p < 0.001, p = 0.001, p = 0.025, and p = 0.001, respectively). Changes in VFA and TFA from baseline to 12 weeks were significantly greater in the CGA group than in the control group (-9.0 +/- 13.9 cm(2) vs. -1.0 +/- 14.3 cm(2), p < 0.001; -13.8 +/- 22.9 cm(2) vs. -2.0 +/- 16.2 cm(2), p < 0.001). No severe adverse events occurred. Consumption of high-CGA coffee for 12 weeks by overweight adults might lower VFA, TFA, BMI, and waist circumference.
C1 [Watanabe, Takuya; Hibi, Masanobu] Kao Corp, Biol Sci Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.
   [Kobayashi, Shinichi; Yamaguchi, Tohru; Osaki, Noriko] Kao Corp, Hlth Care Food Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.
   [Fukuhara, Ikuo] Fukuhara Hosp, 3-1-15 Shimamatsuhigashimachi, Eniwa, Hokkaido 0611351, Japan.
C3 KAO Corporation; KAO Corporation
RP Watanabe, T (corresponding author), Kao Corp, Biol Sci Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.
EM watanabe.takuya@kao.com
RI 山口, 亨/ISA-5407-2023; Hibi, Masanobu/AAF-6115-2019; Yamaguchi,
   Tohru/C-3830-2011
OI Hibi, Masanobu/0000-0001-6791-3662; Yamaguchi, Tohru/0000-0002-5946-1042
FU Kao Corporation
FX This trial was supported by funding from the Kao Corporation.
CR [Anonymous], 1976, BIOCHEM J
   [Anonymous], 2009, JPN PHARN ACOL THER
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Chikama A., 2016, PROG MED, V26, P1723
   CLIFFORD MN, 1976, J SCI FOOD AGR, V27, P73, DOI 10.1002/jsfa.2740270112
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Dupas C, 2006, MOL NUTR FOOD RES, V50, P1053, DOI 10.1002/mnfr.200600034
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   GROBBEE DE, 1990, NEW ENGL J MED, V323, P1026, DOI 10.1056/NEJM199010113231504
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jokura H, 2015, NUTR RES, V35, P873, DOI 10.1016/j.nutres.2015.07.005
   Kajikawa M, 2019, EUR J NUTR, V58, P989, DOI 10.1007/s00394-018-1611-7
   Katada S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040525
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Martini D, 2016, MOLECULES, V21, DOI 10.3390/molecules21080979
   Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987
   Mostofsky E, 2012, CIRC-HEART FAIL, V5, P401, DOI 10.1161/CIRCHEARTFAILURE.112.967299
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   NAGAO T, 2007, PROG MED, V27, P2649
   Ochiai R, 2014, NUTR RES, V34, P155, DOI 10.1016/j.nutres.2013.11.001
   Ochiai R, 2009, HYPERTENS RES, V32, P969, DOI 10.1038/hr.2009.132
   Ota N, 2010, J HEALTH SCI, V56, P745, DOI 10.1248/jhs.56.745
   Park I, 2017, BRIT J NUTR, V117, P979, DOI 10.1017/S0007114517000587
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Saitou K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101337
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   TOKUNAGA K, 1983, INT J OBESITY, V7, P437
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Xie C, 2018, J HUM HYPERTENS, V32, P83, DOI 10.1038/s41371-017-0007-0
   Yamaguchi T., 2007, PROG MED, V27, P683
NR 38
TC 39
Z9 44
U1 0
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUL
PY 2019
VL 11
IS 7
AR 1617
DI 10.3390/nu11071617
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA IN7TT
UT WOS:000478885400130
PM 31315279
OA Green Submitted, Green Published, gold
DA 2025-04-28
ER

PT J
AU Wang, HQ
   Wen, YB
   Du, YP
   Yan, XY
   Guo, HW
   Rycroft, JA
   Boon, N
   Kovacs, EMR
   Mela, DJ
AF Wang, Hongqiang
   Wen, Yibo
   Du, Yaping
   Yan, Xiuyuan
   Guo, Hongwei
   Rycroft, Jane A.
   Boon, Niels
   Kovacs, Eva M. R.
   Mela, David J.
TI Effects of Catechin Enriched Green Tea on Body Composition
SO OBESITY
LA English
DT Article
ID DIET-INDUCED OBESITY; FAT OXIDATION; ENERGY-EXPENDITURE; WEIGHT
   MAINTENANCE; BLOOD-PRESSURE; ABDOMINAL FAT; EXTRACT; CAFFEINE; EXERCISE;
   REDUCTION
AB Obesity is a major health problem in the developed and developing world. Many "functional" foods and ingredients are advocated for their effects on body composition but few have consistent scientific support for their efficacy. However, an increasing amount of mechanistic and clinical evidence is building for green tea (GT). This experiment was therefore undertaken to study the effects of a high-catechin GT on body composition in a moderately overweight Chinese population. In a randomized placebo-controlled trial, 182 moderately overweight Chinese subjects, consumed either two servings of a control drink (C; 30 mg catechins, 10 mg caffeine/day), one serving of the control drink and one serving of an extra high-catechin GT1 (458 mg catechins, 104 mg caffeine/day), two servings of a high-catechin GT2 (468 mg catechins, 126 mg caffeine/day) or two servings of the extra high-catechin GT3 (886 mg catechins, 198 mg caffeine/day) for 90 days. Data were collected at 0, 30, 60, and 90 days. We observed a decrease in estimated intra-abdominal fat (IAF) area of 5.6 cm(2) in the GT3 group. In addition, we found decreases of 1.9 cm in waist circumference and 1.2 kg body weight in the GT3 group vs. C (P < 0.05). We also observed reductions in total body fat (GT2, 0.7 kg, P < 0.05) and body fat % (GT1, 0.6%, P < 0.05). We conclude that consumption of two servings of an extra high-catechin GT leads to improvements in body composition and reduces abdominal fatness in moderately overweight Chinese subjects.
C1 [Boon, Niels; Kovacs, Eva M. R.; Mela, David J.] Unilever Res Labs, Vlaardingen, Netherlands.
   [Wang, Hongqiang; Wen, Yibo; Du, Yaping; Yan, Xiuyuan] Unilever R&D, Shanghai, Peoples R China.
   [Guo, Hongwei] Fudan Univ, Shanghai Med Sch, Shanghai 200433, Peoples R China.
   [Rycroft, Jane A.] Lipton Inst Tea, Sharnbrook, Beds, England.
C3 Unilever; Unilever; Fudan University
RP Boon, N (corresponding author), Unilever Res Labs, Vlaardingen, Netherlands.
EM niels.boon@unilever.com
RI Mela, David/LKJ-1837-2024
OI Mela, David/0000-0003-1824-4305
FU Lipton Institute of Tea
FX All of the authors of this manuscript (except H.G.) are employees of
   Unilever. The research described in this paper was supported by the
   Lipton Institute of Tea.
CR Astill C, 2001, J AGR FOOD CHEM, V49, P5340, DOI 10.1021/jf010759+
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hodgson JM, 2006, CLIN EXP PHARMACOL P, V33, P838, DOI 10.1111/j.1440-1681.2006.04450.x
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hsu TF, 2006, EUR J CLIN NUTR, V60, P1330, DOI 10.1038/sj.ejcn.1602464
   Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Kataoka K., 2004, Progress in Medicine, V24, P3358
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kovacs EMR, 2006, OBES REV, V7, P59, DOI 10.1111/j.1467-789X.2006.00203.x
   LIVINGSTONE MBE, 1995, BRIT J BIOMED SCI, V52, P58
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Noakes M, 2008, ASIA PAC J CLIN NUTR, V17, P169
   Ota N, 2005, J HEALTH SCI, V51, P233, DOI 10.1248/jhs.51.233
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   SARIS WHM, 1995, INT J OBESITY, V19, pS17
   Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8
   Takashima S., 2004, Progress in Medicine, V24, P3371
   TREUTH MS, 1995, AM J CLIN NUTR, V62, P527, DOI 10.1093/ajcn/62.3.527
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   Van Amelsvoort JMM, 2001, XENOBIOTICA, V31, P891, DOI 10.1080/00498250110079149
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   World Health Organization-Regional Office for the Western Pacific, 2000, The Asia-Pacific perspective: redefining obesity and its treatment
NR 46
TC 134
Z9 146
U1 2
U2 61
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD APR
PY 2010
VL 18
IS 4
BP 773
EP 779
DI 10.1038/oby.2009.256
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 583HR
UT WOS:000276665200021
PM 19680234
DA 2025-04-28
ER

PT J
AU Alperet, DJ
   Rebello, SA
   Khoo, EYH
   Tay, Z
   Seah, SSY
   Tai, BC
   Tai, ES
   Emady-Azar, S
   Chou, CJ
   Darimont, C
   van Dam, RM
AF Alperet, Derrick Johnston
   Rebello, Salome Antonette
   Khoo, Eric Yin-Hao
   Tay, Zoey
   Seah, Sharna Si-Ying
   Tai, Bee-Choo
   Tai, E-Shyong
   Emady-Azar, Shahram
   Chou, Chieh Jason
   Darimont, Christian
   van Dam, Rob M.
TI The effect of coffee consumption on insulin sensitivity and other
   biological risk factors for type 2 diabetes: a randomized
   placebo-controlled trial
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE coffee; insulin resistance; insulin sensitivity; type 2 diabetes;
   adult-onset diabetes mellitus; hyperinsulinemic euglycemic clamp;
   metabolic health; humans
ID BIOELECTRICAL-IMPEDANCE; METABOLIC-RATE; BODY-FAT; CAFFEINE; WEIGHT;
   RESISTANCE; GLUCOSE; EXTRACTION; HYDRATION; CAFESTOL
AB Background: In observational studies, coffee consumption has been consistently associated with a lower risk of type 2 diabetes mellitus. Trials examining the effect of coffee consumption on glucose metabolism have been limited by the use of surrogate insulin sensitivity indices, small sample sizes, lack of blinding, and short follow-up duration.
   Objectives: We aimed to overcome limitations of previously conducted coffee trials in a randomized placebo-controlled trial of the effect of coffee consumption on insulin sensitivity.
   Methods: We conducted a 24-wk randomized placebo-controlled trial in 126 overweight, non-insulin sensitive (HOMA-IR >= 1.30), Chinese, Malay, and Asian-Indian males and females aged 35-69 y. Participants were randomly assigned to receive 4 cups of instant regular coffee (n = 62) or 4 cups of a coffee-like placebo beverage (n = 64) per day. The primary outcome was the amount of glucose metabolized per kilogram of body weight per minute (Mbw) assessed during steady-state conditions with a hyperinsulinemic euglycemic clamp. Secondary outcomes included other clamp-based insulin sensitivity measures, biological mediators of insulin sensitivity, and measures of fasting glucose metabolism.
   Results: Coffee consumption did not significantly change insulin sensitivity compared with placebo (percentage mean difference in Mbw = 4.0%; 95% CI: -8.3, 18.0%; P = 0.53). Furthermore, no significant differences in fasting plasma glucose (2.9%; 95% CI: -0.4, 6.3%; P = 0.09) or biological mediators of insulin resistance, such as plasma adiponectin (2.3%; 95% CI: -1.4, 6.2%; P = 0.22), were observed between coffee and placebo groups over 24 wk of intervention. Participants in the coffee arm experienced a loss of fat mass (FM) (-3.7%; 95% CI: -6.3, -1.1%; P = 0.006) and reduction in urinary creatinine concentrations (-21.2%; 95% CI: -31.4,-9.5%; P= 0.001) comparedwith participants in the placebo arm over 24 wk of intervention.
   Conclusions: Consuming 4 cups/d of caffeinated coffee for 24 wk had no significant effect on insulin sensitivity or biological mediators of insulin resistance but was associated with a modest loss of FM and reduction in urinary creatinine concentrations. This trial was registered at clinicaltrials.gov as NCT01738399. Registered on November 28, 2012. Trial sponsor: Nestle Research, Lausanne, Switzerland. Trial site: National University of Singapore.
C1 [Alperet, Derrick Johnston; van Dam, Rob M.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore.
   [Alperet, Derrick Johnston] Agcy Sci Technol & Res, A STAR Grad Acad, Singapore, Singapore.
   [Alperet, Derrick Johnston; Rebello, Salome Antonette; Tay, Zoey; Seah, Sharna Si-Ying; Tai, Bee-Choo; Tai, E-Shyong; van Dam, Rob M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Alperet, Derrick Johnston; van Dam, Rob M.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Khoo, Eric Yin-Hao; van Dam, Rob M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.
   [Khoo, Eric Yin-Hao; Tai, E-Shyong] Natl Univ Hlth Syst, Natl Univ Hosp, Div Endocrinol, Singapore, Singapore.
   [Tai, Bee-Choo] Natl Univ Singapore, Yong Loo Lin Sch Med, Invest Med Unit, Singapore, Singapore.
   [Emady-Azar, Shahram] Nestle Res, Clin Dev Unit, Lausanne, Switzerland.
   [Chou, Chieh Jason; Darimont, Christian] Nestle Res, Nestle Inst Hlth Sci, Lausanne, Switzerland.
C3 National University of Singapore; Agency for Science Technology &
   Research (A*STAR); National University of Singapore; Harvard University;
   Harvard T.H. Chan School of Public Health; National University of
   Singapore; National University of Singapore; National University of
   Singapore; Nestle SA; Nestle Research Center; Nestle SA; Nestle Research
   Center
RP Alperet, DJ; van Dam, RM (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore.; Alperet, DJ (corresponding author), Agcy Sci Technol & Res, A STAR Grad Acad, Singapore, Singapore.; Alperet, DJ; van Dam, RM (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Alperet, DJ; van Dam, RM (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.; van Dam, RM (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.
EM dalperet@hsph.harvard.edu; rob.van.dam@nus.edu.sg
RI van Dam, Rob/F-9674-2010; Khoo, Eric/K-1146-2013; Rebello,
   Salome/AAR-5433-2021
OI Tai, E Shyong/0000-0003-2929-8966; Tay, Zoey/0000-0002-6660-5980;
   Alperet, Derrick/0000-0002-5680-1056
FU Nestec Ltd (Switzerland); NUS Graduate School for Integrative Sciences
   and Engineering PhD scholarship; A*STAR International (Post-doctoral)
   Fellowship
FX This trial was funded by Nestec Ltd (Switzerland). The funder had no
   decisive role in the design, implementation, analysis, and
   interpretation of the data. DJA was supported with funding by the NUS
   Graduate School for Integrative Sciences and Engineering PhD scholarship
   and the A*STAR International (Post-doctoral) Fellowship.
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Alperet DJ, 2016, CONT CLIN TRIAL COMM, V4, P105, DOI 10.1016/j.conctc.2016.06.013
   [Anonymous], 2018, COFF PREM SE AS
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bakuradze T, 2014, FOOD RES INT, V63, P420, DOI 10.1016/j.foodres.2014.05.032
   Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016
   Brehm A., 2007, Clinical diabetes research, P43
   Brown, 1998, APPL MULTIVARIATE ST, P155, DOI DOI 10.1007/978-3-642-80328-4_13
   Cavan D, 2015, DIABETES ATLAS
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
   DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
   DEIBERT DC, 1980, J CLIN INVEST, V65, P717, DOI 10.1172/JCI109718
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Gastaldelli A, 2009, HEPATOLOGY, V50, P1087, DOI 10.1002/hep.23116
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Health Promotion Board, Energy & Nutrient Composition of Food
   Herber-Gast GCM, 2016, AM J CLIN NUTR, V103, P1370, DOI 10.3945/ajcn.115.112755
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   KUSAKA M, 1977, AM J PHYSIOL, V232, pE145, DOI 10.1152/ajpendo.1977.232.2.E145
   Kwok MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep36500
   Lane J. D., 2011, Journal of Caffeine Research, V1, P23, DOI 10.1089/jcr.2010.0007
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Ludwig IA, 2012, FOOD RES INT, V48, P57, DOI 10.1016/j.foodres.2012.02.023
   McFarlane S, 2013, CHICAGO TRIBUNE
   Moher David, 2010, J Clin Epidemiol, V63, pe1, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]
   Naidoo N, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-48
   Nang EEK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-141
   Neo RW, 2019, TODAY
   NEWBY FD, 1988, AM J PHYSIOL, V255, pE716, DOI 10.1152/ajpendo.1988.255.5.E716
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Ohnaka K, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/207426
   RACOTTA IS, 1994, PHARMACOL BIOCHEM BE, V48, P887, DOI 10.1016/0091-3057(94)90196-1
   Rebello SA, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0403-1
   Saunders MJ, 1998, MED SCI SPORT EXER, V30, P885, DOI 10.1097/00005768-199806000-00017
   Singh B, 2010, WORLD J DIABETES, V1, P36, DOI 10.4239/wjd.v1.i2.36
   Sun G, 2005, AM J CLIN NUTR, V81, P74
   THOMPSON DL, 1991, J SPORT MED PHYS FIT, V31, P565
   URGERT R, 1995, J AGR FOOD CHEM, V43, P2167, DOI 10.1021/jf00056a039
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   Van Dam RM, 2004, DIABETES CARE, V27, P2990, DOI 10.2337/diacare.27.12.2990
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   YOSHIDA T, 1994, INT J OBESITY, V18, P345
   Zhang C, 2012, FOOD RES INT, V49, P27, DOI 10.1016/j.foodres.2012.06.032
   Zhang Y, 2015, J SCI MED SPORT, V18, P569, DOI 10.1016/j.jsams.2014.07.017
NR 54
TC 49
Z9 50
U1 1
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD FEB
PY 2020
VL 111
IS 2
BP 448
EP 458
DI 10.1093/ajcn/nqz306
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KS6PR
UT WOS:000518429700027
PM 31891374
OA Bronze
DA 2025-04-28
ER

PT J
AU de Pinho, MGM
   Adami, F
   Benedet, J
   de Vasconcelos, FDG
AF Matias de Pinho, Maria Gabriela
   Adami, Fernando
   Benedet, Jucemar
   Guedes de Vasconcelos, Francisco de Assis
TI Association between screen time and dietary patterns and
   overweight/obesity among adolescents
SO REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
LA English
DT Article
DE Adolescents; Food behavior; Obesity; Overweight
ID PHYSICAL-ACTIVITY; LIFE-STYLE; SEDENTARY BEHAVIOR; BODY-MASS; OBESITY;
   HEALTH; CHILDREN; CONSUMPTION; PREVALENCE; ADULTHOOD
AB Objective
   The association between screen time and dietary patterns and overweight/obesity among adolescents was analysed in this study.
   Methods
   In this cross- sectional study, 963 Brazilian adolescents, aged between 11 and 14 years were evaluated. Body mass index was used to assess overweight/obesity. Dietary patterns and screen time were assessed using qualitative questionnaires. Principal component analysis was used to obtain dietary patterns. Confounder variables were: type of school (public or private), sexual maturation, mother's weight and mother's education. The Chi- square test was used for the crude analysis; for the adjusted analysis was used Poisson regression with sample weighting.
   Results
   Overweight/obesity prevalence was 29.8% and statistically higher among boys (34.7%). Higher screen time prevalence was 39.1%. The dietary patterns obtained were: obesogenic; coffee and dairy products; traditional Brazilian meal; fruit and vegetables; bread and chocolate milk. The dietary pattern that more closely represented student food consumption was the obesogenic pattern. Screen time was not significantly associated with overweight/obesity. The obesogenic pattern (in both sexes), the coffee and dairy products pattern, and the bread and chocolate milk pattern (only in girls), were inversely associated with overweight/obesity. In this study, dietary patterns influenced overweight/obesity, although in some cases, in an inverse way from what expected.
   Conclusion
   A high prevalence of overweight/obesity and a high proportion of screen time activities among the adolescents were observed. Our results indicate a high consumption of unhealthy dietary pattern among adolescents.
C1 [Matias de Pinho, Maria Gabriela; Guedes de Vasconcelos, Francisco de Assis] Univ Fed Santa Catarina, Ctr Ciencias Saude, Dept Nutr, Campus Univ, BR-88040900 Florianopolis, SC, Brazil.
   [Adami, Fernando] Fac Med ABC, Dept Saude Coletividade, Lab Epidemiol & Anal Dados, Santo Andre, SP, Brazil.
   [Benedet, Jucemar] Univ Fed Santa Catarina, Ctr Desportos, Dept Educ Fis, Florianopolis, SC, Brazil.
C3 Universidade Federal de Santa Catarina (UFSC); Faculdade de Medicina do
   ABC; Universidade Federal de Santa Catarina (UFSC)
RP de Vasconcelos, FDG (corresponding author), Univ Fed Santa Catarina, Ctr Ciencias Saude, Dept Nutr, Campus Univ, BR-88040900 Florianopolis, SC, Brazil.
EM f.vasconcelos@ufsc.br
RI Matias de Pinho, Maria Gabriela/AAB-4003-2020; Adami,
   Fernando/D-3855-2012; Benedet, Jucemar/AAF-9807-2021; Vasconcelos,
   Francisco de Assis Guedes de/I-9222-2016
OI Matias de Pinho, Maria Gabriela/0000-0003-4928-0851; Vasconcelos,
   Francisco de Assis Guedes de/0000-0002-6162-8067; Adami,
   Fernando/0000-0003-1918-3364
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   [483955/2011-6]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Process
   no 483955/2011-6).
CR Adami Fernando, 2008, Rev. bras. epidemiol., V11, P549
   Al-Haifi AR, 2013, FOOD NUTRI B, V34
   Colucci ACA, 2011, REV NUTR, V24, P219, DOI 10.1590/S1415-52732011000200003
   de Assis MAA, 2009, CAD SAUDE PUBLICA, V25, P1816, DOI 10.1590/S0102-311X2009000800018
   [Anonymous], 2007, Growth Reference Data for 5-19 years
   [Anonymous], 2012, Social determinants of health and well-being among young people. Health behaviour in school-aged children (HBSC) Study
   Barros Mariana Simões, 2013, Cad. saúde colet., V21, P201
   Benedet Jucemar, 2013, Rev. paul. pediatr., V31, P172
   Bere E, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.23194
   Chinapaw M, 2015, PREV MED, V70, P1, DOI 10.1016/j.ypmed.2014.10.029
   D'Avila GL, 2016, CIENC SAUDE COLETIVA, V21, P1071, DOI 10.1590/1413-81232015214.13722015
   de Pinho L, 2014, J PEDIAT-BRAZIL, V90, P267, DOI 10.1016/j.jped.2013.04.006
   de Vasconcellos MB, 2013, CAD SAUDE PUBLICA, V29, P713, DOI 10.1590/S0102-311X2013000800009
   Dupuy M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-442
   Enes Carla Cristina, 2010, Rev. bras. epidemiol., V13, P163, DOI 10.1590/S1415-790X2010000100015
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Inge TH, 2013, PEDIATRICS, V132, P1098, DOI 10.1542/peds.2013-2185
   Instituto Brasileiro de Geografia e Estatistica Diretoria de Pesquisas Coordenacao de Trabalho e Rendimento, 2010, PESQ ORC FAM 2008 20
   Jolliffe L., 2002, Principal Component Analysis
   Maher C, 2012, ACTA PAEDIATR, V101, P1170, DOI 10.1111/j.1651-2227.2012.02804.x
   Malina RM., 2003, Growth, maturation and physical activity, V2nd
   Mamun AA, 2013, PUBLIC HEALTH NUTR, V16, P54, DOI 10.1017/S1368980012002832
   Mihas C, 2009, ACTA PAEDIATR, V98, P495, DOI 10.1111/j.1651-2227.2008.01129.x
   Minghelli B, 2013, N AM J MED SCI, V5, P653, DOI 10.4103/1947-2714.122309
   Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241
   Motter AF, 2015, CAD SAUDE PUBLICA, V31, P620, DOI [10.1590/0102-311X00097814, 10.1590/0102-311x00097814]
   Musaiger AO, 2014, APPETITE, V73, P197, DOI 10.1016/j.appet.2013.11.002
   Nasreddine L, 2014, NUTRIENTS, V6, P1038, DOI 10.3390/nu6031038
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nogueira JAD, 2009, J PHYS ACT HEALTH, V6, P93, DOI 10.1123/jpah.6.1.93
   Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895
   Rieth MA, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-95
   Silva JMC, 2012, REV BRAS FARMACOGN, V22, P94, DOI 10.1590/S0102-695X2011005000199
   Silva Kelly Samara da, 2008, Rev. bras. epidemiol., V11, P159
   Strasburger VC, 2013, PEDIATRICS, V132, P958, DOI 10.1542/peds.2013-2656
   Tavares LF, 2014, CAD SAUDE PUBLICA, V30, P2679, DOI [10.1590/0102-311X00016814, 10.1590/0102-311x00016814]
   Thibault H, 2010, NUTRITION, V26, P192, DOI 10.1016/j.nut.2009.03.015
   Viner RM, 2006, INT J OBESITY, V30, P1368, DOI 10.1038/sj.ijo.0803183
   Wrotniak BH, 2012, PEDIATR OBES, V7, pE9, DOI [10.1111/j.2047-6310.2011.00023.x, 10.1111/j.12047-6310.2011.00023.x]
   Zaghloul S, 2013, PUBLIC HEALTH NUTR, V16, P596, DOI 10.1017/S1368980012003941
NR 40
TC 24
Z9 25
U1 0
U2 13
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO
   ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 1415-5273
J9 REV NUTR
JI Rev. Nutr.
PD MAY-JUN
PY 2017
VL 30
IS 3
BP 377
EP 389
DI 10.1590/1678-98652017000300010
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FB2CM
UT WOS:000405951100010
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Kovacs, EMR
   Lejeune, MPGM
   Nijs, I
   Westerterp-Plantenga, MS
AF Kovacs, EMR
   Lejeune, MPGM
   Nijs, I
   Westerterp-Plantenga, MS
TI Effects of green tea on weight maintenance after body-weight loss
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE epigallocatechin gallate; energy expenditure; substrate oxidation;
   obesity
ID RESPIRATION CHAMBER; FAT OXIDATION; FOLLOW-UP; OBESITY; WOMEN; DIET;
   SUPPLEMENTATION; CARBOHYDRATE; INHIBITION; CAFFEINE
AB The present study was conducted to investigate whether green tea may improve weight maintenance by preventing or limiting weight regain after weight loss of 5 to 10 % in overweight and moderately obese subjects. The study had a randomised, parallel, placebo-controlled design. A total of 104 overweight and moderately obese male and female subjects (age 18-60 years; BMI 25-35 kg/m(2)) participated. The study consisted of a very-low-energy diet intervention (VLED; 2.1 MJ/d) of 4 weeks followed by a weight-maintenance period of 13 weeks in which the subjects received green tea or placebo. The green tea contained caffeine (104 mg/d) and catechins (573 mg/d, of which 323 mg was epigallocatechin gallate). Subjects lost 6.4 (SD 1.9) kg or 7.5 (SD 2.2) % of their original body weight during the VLED (P<0.001). Body-weight regain was not significantly different between the green tea and the placebo group (30.5 (SD 61.8) % and 19.7 (SD 56.9) %, respectively). In the green tea treatment, habitual high caffeine consumption was associated with a higher weight regain compared with habitual low caffeine consumption (39 (SD 17) and 16 (SD 11) %, respectively; P<0.05). We conclude that weight maintenance after 7.5 % body-weight loss was not affected by green tea treatment and that habitual caffeine consumption affected weight maintenance in the green tea treatment.
C1 Maastricht Univ, Dept Human Biol, Maastricht, Netherlands.
C3 Maastricht University
RP Maastricht Univ, Dept Human Biol, Maastricht, Netherlands.
EM M.Westerterp@HB.UNIMAAS.NL
CR BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Ekelund U, 2000, INT J SPORTS MED, V21, P586, DOI 10.1055/s-2000-8487
   GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397
   Goris AHC, 2001, AM J CLIN NUTR, V73, P549
   Herman C.P., 1980, Obesity, P208
   KRAMER FM, 1989, INT J OBESITY, V13, P123
   LICHTENBELT WDV, 1994, BRIT J NUTR, V72, P491, DOI 10.1079/BJN19940053
   Pasman WJ, 1997, INT J OBESITY, V21, P1143, DOI 10.1038/sj.ijo.0800528
   Pasman WJ, 1997, INT J OBESITY, V21, P548, DOI 10.1038/sj.ijo.0800439
   Pasman WJ, 1999, METABOLISM, V48, P15, DOI 10.1016/S0026-0495(99)90004-5
   PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2686, DOI 10.1093/ajcn/33.12.2686
   Schoffelen PFM, 1997, J APPL PHYSIOL, V83, P2064, DOI 10.1152/jappl.1997.83.6.2064
   SEIDELL JC, 1995, OBES RES S2, V3, pS249
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   VanGaal LF, 1997, INT J OBESITY, V21, pS5
   WADDEN TA, 1988, J CONSULT CLIN PSYCH, V56, P925, DOI 10.1037/0022-006X.56.6.925
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   Westerterp KR, 2001, NATURE, V410, P539, DOI 10.1038/35069142
   Westerterp-Plantenga MS, 1998, INT J OBESITY, V22, P1, DOI 10.1038/sj.ijo.0800536
   Westerterp-Plantenga MS, 2001, BRIT J NUTR, V85, P351, DOI 10.1079/BJN2000272
   Westerterp-Plantenga MS, 1999, EUR J CLIN NUTR, V53, P495, DOI 10.1038/sj.ejcn.1600782
NR 25
TC 177
Z9 197
U1 2
U2 46
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD MAR
PY 2004
VL 91
IS 3
BP 431
EP 437
DI 10.1079/BJN20041061
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 808ZV
UT WOS:000220607900014
PM 15005829
OA Bronze
DA 2025-04-28
ER

PT J
AU Fan, ZK
   Wang, C
   Yang, T
   Gao, TL
   Wang, D
   Zhao, XY
   Guo, XF
   Li, D
AF Fan, Zekai
   Wang, Chong
   Yang, Ting
   Gao, Tianlin
   Wang, Dan
   Zhao, Xiaoyan
   Guo, Xiaofei
   Li, Duo
TI Coffee peel extracts ameliorate non-alcoholic fatty liver disease
   via a fibroblast growth factor 21-adiponectin signaling pathway
SO FOOD & FUNCTION
LA English
DT Article
ID INSULIN-RESISTANCE; ADIPONECTIN; OBESITY; FGF21; METABOLISM; ACTIVATION;
   PREVENTION; CAFFEINE; SREBP-1C; INDEXES
AB Coffee peel (CP) contains abundant phytochemicals which might prevent non-alcoholic fatty liver disease (NAFLD). The present study aimed to identify the main phytochemicals in CP extracts, and to investigate whether CP extracts could ameliorate NAFLD through a hepatic fibroblast growth factor (FGF) 21-adiponectin signaling pathway. Caffeine and seven monomers of flavonoids were identified from CP extracts by using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). After 8 weeks of intervention, the mice fed a high-fat and high-sugar diet showed the pathophysiological characteristics of NAFLD. Treatment with CP extracts significantly alleviated hepatic steatosis and insulin resistance and reduced the concentrations of serum alanine transaminase, FGF21, and triglyceride, and hepatic interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha, while increasing serum adiponectin concentrations. Meanwhile, CP extract supplementation significantly decreased the gene and protein expression levels of FGF21, while enhancing adiponectin expression levels. The present study demonstrated that CP extracts contained caffeine and seven monomers of flavonoids, and protected against NAFLD through regulating the FGF21-adiponectin signaling pathway.
C1 [Fan, Zekai; Wang, Chong; Yang, Ting; Gao, Tianlin; Guo, Xiaofei; Li, Duo] Qingdao Univ, Inst Nutr & Hlth, Qingdao, Peoples R China.
   [Fan, Zekai; Wang, Chong; Yang, Ting; Gao, Tianlin; Guo, Xiaofei; Li, Duo] Qingdao Univ, Sch Publ Hlth, Qingdao, Peoples R China.
   [Wang, Chong] Laixi Peoples Hosp, Qingdao, Peoples R China.
   [Wang, Dan; Zhao, Xiaoyan] Beijing Acad Agr & Forestry Sci, Vegetable Res Ctr, Beijing, Peoples R China.
C3 Qingdao University; Qingdao University; Beijing Academy of Agriculture &
   Forestry Sciences (BAAFS)
RP Guo, XF (corresponding author), Qingdao Univ, Inst Nutr & Hlth, Qingdao, Peoples R China.; Guo, XF (corresponding author), Qingdao Univ, Sch Publ Hlth, Qingdao, Peoples R China.
EM guoxf@qdu.edu.cn
RI Gao, Tianlin/K-7073-2017; Yang, Xia/GOG-8272-2022; Li, Duo/N-3682-2013
OI Li, Duo/0000-0001-5227-5565
FU National Natural Science Foundation of China [NSFC: 81773433, 82073538];
   Key scientific Research Projects in Shandong Province China
   [2017YYSP007]; 2018 Chinese Nutrition Society (CNS) Nutrition Research
   Foundation-DSM Research Fund [CNS-DSM2018A30]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC: 81773433 and 82073538); the Key scientific Research
   Projects in Shandong Province China (2017YYSP007); and the 2018 Chinese
   Nutrition Society (CNS) Nutrition Research Foundation-DSM Research Fund
   (CNS-DSM2018A30). The funders have no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aamir K, 2020, PHARMACOL RES, V152, DOI 10.1016/j.phrs.2019.104602
   Angeloni S, 2020, MOLECULES, V25, DOI 10.3390/molecules25132993
   Barcelos RP, 2020, NUTR RES, V80, P1, DOI 10.1016/j.nutres.2020.05.005
   Bhaktha G, 2015, J CLIN DIAGN RES, V9, pBC1, DOI 10.7860/JCDR/2015/10587.5371
   Brunner SF, 2019, NATURE, V574, P538, DOI 10.1038/s41586-019-1670-9
   Deng X, 2015, BBA-MOL CELL BIOL L, V1851, P1521, DOI 10.1016/j.bbalip.2015.08.007
   Dinda B, 2020, ADV PROTEIN CHEM STR, V120, P159, DOI 10.1016/bs.apcsb.2019.08.006
   Dong WJ, 2020, FOOD RES INT, V136, DOI 10.1016/j.foodres.2020.109497
   Ezzeddini R, 2019, LIFE SCI, V224, P169, DOI 10.1016/j.lfs.2019.03.056
   Fang H, 2018, COMPR PHYSIOL, V8, P1031, DOI 10.1002/cphy.c170046
   Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339
   Gangarapu V, 2014, TURK J GASTROENTEROL, V25, P133, DOI 10.5152/tjg.2014.7886
   Geng LL, 2020, NAT REV ENDOCRINOL, V16, P654, DOI 10.1038/s41574-020-0386-0
   Goto T, 2012, J NUTR BIOCHEM, V23, P768, DOI 10.1016/j.jnutbio.2011.04.001
   Gulcelik NE, 2013, MINERVA ENDOCRINOL, V38, P203
   Guo XF, 2018, PROSTAG LEUKOTR ESS, V136, P47, DOI 10.1016/j.plefa.2017.09.011
   Inagaki T, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00147
   Jenke A, 2013, CARDIOVASC RES, V99, P422, DOI 10.1093/cvr/cvt118
   Jimenez V, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708791
   Kaur G, 2011, PROSTAG LEUKOTR ESS, V85, P155, DOI 10.1016/j.plefa.2011.06.002
   Ke F, 2020, CYTOKINE, V134, DOI 10.1016/j.cyto.2020.155184
   Keinicke H, 2020, ENDOCR CONNECT, V9, P755, DOI 10.1530/EC-20-0152
   Khan RS, 2019, HEPATOLOGY, V70, P711, DOI 10.1002/hep.30429
   Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005
   Liu J, 2015, METABOLISM, V64, P380, DOI 10.1016/j.metabol.2014.11.009
   Mirhafez SR, 2019, J GASTROINTEST LIVER, V28, P183, DOI 10.15403/jgld-179
   Morais ADS, 2009, J HEPATOL, V50, P489, DOI 10.1016/j.jhep.2008.10.027
   Muniyappa R, 2009, AM J PHYSIOL-ENDOC M, V297, pE1023, DOI 10.1152/ajpendo.00397.2009
   Nakagawa Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051396
   Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111
   Prata ERBA, 2007, LWT-FOOD SCI TECHNOL, V40, P1555, DOI 10.1016/j.lwt.2006.10.003
   Quinn WJ, 2017, J CLIN INVEST, V127, P4207, DOI 10.1172/JCI96036
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Salminen A, 2017, AGEING RES REV, V37, P79, DOI 10.1016/j.arr.2017.05.004
   Shalmani AA, 2018, LIFE SCI, V215, P152, DOI 10.1016/j.lfs.2018.11.010
   Sharif K, 2017, AUTOIMMUN REV, V16, P712, DOI 10.1016/j.autrev.2017.05.007
   Tucker B, 2019, METABOLISM, V101, DOI 10.1016/j.metabol.2019.153994
   Wang D, 2011, J AGR FOOD CHEM, V59, P7405, DOI 10.1021/jf200851h
   Wang QY, 2020, BRIT J PHARMACOL, V177, P1806, DOI 10.1111/bph.14938
   Xiong K, 2020, TRENDS FOOD SCI TECH, V96, P102, DOI 10.1016/j.tifs.2019.12.019
   Yanai H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051190
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
NR 42
TC 9
Z9 9
U1 4
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD JUL 4
PY 2022
VL 13
IS 13
BP 7251
EP 7259
DI 10.1039/d2fo00081d
EA JUN 2022
PG 9
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 2Q3XY
UT WOS:000813193600001
PM 35723052
DA 2025-04-28
ER

PT J
AU Tanaka, K
   Tamaru, S
   Nishizono, S
   Miyata, Y
   Tamaya, K
   Matsui, T
   Tanaka, T
   Echizen, Y
   Ikeda, I
AF Tanaka, Kazunari
   Tamaru, Shizuka
   Nishizono, Shoko
   Miyata, Yuji
   Tamaya, Kei
   Matsui, Toshiro
   Tanaka, Takashi
   Echizen, Yoshie
   Ikeda, Ikuo
TI Hypotriacylglycerolemic and Antiobesity Properties of a New Fermented
   Tea Product Obtained by Tea-Rolling Processing of Third-Crop Green Tea
   (Camellia sinensis) Leaves and Loquat (Eriobotrya
   japonica) Leaves
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE fermented tea; loquat leaves; hypotriacylglycerol; antiobesity; black
   tea polyphenol
ID FATTY-ACID SYNTHASE; BLACK TEA; CATECHIN-POLYPHENOLS;
   LIPID-ACCUMULATION; LIPASE; OXIDATION; CAFFEINE; CULTURES; ENZYMES
AB We manufactured a new fermented tea by tea-rolling processing of third-crop green tea (Camellia sinensis) leaves and loquat (Eriobotrya japonica) leaves. The mixed fermented tea extract inhibited pancreatic lipase activity in vitro, and effectively suppressed postprandial hypertriacylglycerolemia in rats. Rats fed a diet containing 1% freeze-dried fermented tea extract for 4 weeks had a significantly lower liver triacylglycerol concentration and white adipose tissue weight than those fed the control diet lacking fermented tea extract. The activity of fatty acid synthase in hepatic cytosol markedly decreased in the fermented tea extract group as compared to the control group. The serum and liver triacylglycerol- and body fat-lowering effects of the mixed fermented tea extract were strong relative to the level of dietary supplementation. These results suggest that the new fermented tea product exhibited hypotriacylglycerolemic and antiobesity properties through suppression of both liver fatty acid synthesis and postprandial hypertriacylglycerolemia by inhibition of pancreatic lipase.
C1 [Tanaka, Kazunari; Tamaru, Shizuka; Nishizono, Shoko; Miyata, Yuji; Echizen, Yoshie] Nagasaki Univ, Grad Sch Human Hlth Sci, Nagoya, Nagasaki 8512195, Japan.
   [Nishizono, Shoko] Miyazaki Univ, Cooperat Res Ctr, Miyazaki 8892191, Japan.
   [Miyata, Yuji] Higashisonogi Tea Branch, Nagasaki Prefectural Agr & Forestry Expt Stn, Higashisonogi, Nagasaki 8593801, Japan.
   [Tamaya, Kei] Ind Technol Ctr Nagasaki, Nagasaki 8560026, Japan.
   [Matsui, Toshiro] Kyushu Univ, Grad Sch, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan.
   [Tanaka, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan.
   [Echizen, Yoshie; Ikeda, Ikuo] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan.
C3 Nagasaki University; University of Miyazaki; Kyushu University; Nagasaki
   University; Tohoku University
RP Tanaka, K (corresponding author), Nagasaki Univ, Grad Sch Human Hlth Sci, 1-1-1 Manabino, Nagoya, Nagasaki 8512195, Japan.
EM katanaka@sun.ac.jp
OI Tanaka, Takashi/0000-0001-7762-7432
FU Nagasaki Prefecture, Japan
FX This work was supported by a Grant from the
   Industry-University-Government Cooperation Project Research of Nagasaki
   Prefecture, Japan.
CR Du YT, 2005, J ENZYM INHIB MED CH, V20, P349, DOI 10.1080/14756360500148841
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fujiki H, 1998, MUTAT RES-FUND MOL M, V402, P307, DOI 10.1016/S0027-5107(97)00310-2
   Han LK, 1999, INT J OBESITY, V23, P174, DOI 10.1038/sj.ijo.0800806
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   Han LK, 2001, INT J OBESITY, V25, P1459, DOI 10.1038/sj.ijo.0801747
   Ikeda I, 2005, BIOSCI BIOTECH BIOCH, V69, P1049, DOI 10.1271/bbb.69.1049
   Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155
   KADA T, 1985, MUTAT RES, V150, P127, DOI 10.1016/0027-5107(85)90109-5
   KELLEY DS, 1986, BIOCHEM J, V235, P87, DOI 10.1042/bj2350087
   KELLEY DS, 1984, BIOCHEM J, V217, P543, DOI 10.1042/bj2170543
   Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411
   Kusano R, 2008, CHEM PHARM BULL, V56, P266, DOI 10.1248/cpb.56.266
   Li RW, 2006, J ETHNOPHARMACOL, V104, P24, DOI 10.1016/j.jep.2005.08.045
   Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200
   Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKWELL MA, 1973, J BIOL CHEM, V248, P3426
   Matsui T, 2007, J AGR FOOD CHEM, V55, P99, DOI 10.1021/jf0627672
   Matsumoto N, 1998, J NUTR SCI VITAMINOL, V44, P337, DOI 10.3177/jnsv.44.337
   MIYATA Y, 2006, Patent No. 2006013866
   MIYATA Y, 2005, Patent No. 2005014129
   Miyata Y, 2010, J JPN SOC FOOD SCI, V57, P171, DOI 10.3136/nskkk.57.171
   Miyata Y, 2009, J JPN SOC FOOD SCI, V56, P647, DOI 10.3136/nskkk.56.647
   Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   OCHOA S, 1955, METHOD ENZYMOL, V1, P739, DOI 10.1016/0076-6879(55)01129-4
   Piccinelli AL, 2004, J AGR FOOD CHEM, V52, P5863, DOI 10.1021/jf040100e
   ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129
   Shishikura Y, 2006, J AGR FOOD CHEM, V54, P1906, DOI 10.1021/jf051988p
   SPERRY WM, 1950, J BIOL CHEM, V187, P97
   Tanaka T, 2002, J AGR FOOD CHEM, V50, P2142, DOI 10.1021/jf011301a
   Tokunaga S, 2002, ANN EPIDEMIOL, V12, P157, DOI 10.1016/S1047-2797(01)00307-6
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   WALTON PA, 1985, ANAL BIOCHEM, V151, P479, DOI 10.1016/0003-2697(85)90208-8
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yeh CW, 2003, PHARMACOGENOMICS J, V3, P267, DOI 10.1038/sj.tpj.6500192
   YOSHINO K, 1994, AGE, V17, P79, DOI 10.1007/BF02435010
NR 41
TC 30
Z9 32
U1 2
U2 38
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD AUG
PY 2010
VL 74
IS 8
BP 1606
EP 1612
DI 10.1271/bbb.100197
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA 648VJ
UT WOS:000281722200015
PM 20699580
OA Bronze
DA 2025-04-28
ER

PT J
AU Roberts, J
   Liu, QR
   Cao, C
   Jackson, SE
   Zong, XY
   Meyer, GA
   Yang, L
   Cade, WT
   Zheng, XB
   Lopez-Sanchez, GF
   Wu, XJ
   Smith, L
AF Roberts, Justin
   Liu, Qinran
   Cao, Chao
   Jackson, Sarah E.
   Zong, Xiaoyu
   Meyer, Gretchen A.
   Yang, Lin
   Cade, W. Todd
   Zheng, Xiaobin
   Lopez-Sanchez, Guillermo F.
   Wu, Xiaojian
   Smith, Lee
TI Association of Hot Tea Consumption with Regional Adiposity Measured by
   Dual-Energy X-Ray Absorptiometry in NHANES 2003-2006
SO OBESITY
LA English
DT Article
ID GREEN-TEA; EPIGALLOCATECHIN GALLATE; BLACK TEA; FAT OXIDATION;
   WEIGHT-LOSS; CATECHINS; CAFFEINE; EXTRACT; CANCER; INTERVENTION
AB Objective This study aimed to investigate the potential antiobesity benefits of hot tea consumption at the population level. Methods Using data from the National Health and Nutrition Examination Survey (NHANES) 2003-2006, the association between hot tea consumption and dual-energy x-ray-measured body fat was examined in a large representative sample of US adults (n = 5,681, 51.9% women). Results Compared with non-tea drinkers, men who consumed 0.25 to 1 cup per day of hot tea had 1.5% (95% CI: 0.4% to 2.6%) and 1.7% (95% CI: 0.4% to 3.0%) less total and trunk body fat, respectively. The associations were stronger among men 45 to 69 years old compared with younger men (20-44 years). For men who consumed 1 or more cups per day of hot tea, lower total (-1.2%, 95% CI: -2.3% to -0.2%) and trunk body fat (-1.3%, 95% CI: -2.6 to -0.1%) was observed among men 45 to 69 years old only. In women, those who drank 1 or more cups per day had 1.5% lower (95% CI: -2.7% to -0.3%) trunk body fat compared with non-tea drinkers. Conclusions Consumption of hot tea might be considered as part of a healthy diet in order to support parameters associated with metabolic health and may be particularly important in older male age groups in supporting reduced central adiposity.
C1 [Roberts, Justin; Smith, Lee] Anglia Ruskin Univ, Cambridge Ctr Sport & Exercise Sci, Cambridge, England.
   [Liu, Qinran; Zong, Xiaoyu] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA.
   [Cao, Chao; Meyer, Gretchen A.; Cade, W. Todd] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO USA.
   [Jackson, Sarah E.] UCL, Dept Behav Sci & Hlth, London, England.
   [Yang, Lin] Alberta Hlth Serv, Canc Epidemiol & Prevent Res, Calgary, AB, Canada.
   [Zheng, Xiaobin; Wu, Xiaojian] Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou, Peoples R China.
   [Zheng, Xiaobin; Wu, Xiaojian] Sun Yat Sen Univ, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Affiliated Hosp 6, Guangzhou, Peoples R China.
   [Lopez-Sanchez, Guillermo F.] Univ Murcia, Fac Sport Sci, Murcia, Spain.
C3 Anglia Ruskin University; Washington University (WUSTL); Washington
   University (WUSTL); University of London; University College London;
   University of Calgary; Alberta Health Services (AHS); Sun Yat Sen
   University; Sun Yat Sen University; University of Murcia
RP Smith, L (corresponding author), Anglia Ruskin Univ, Cambridge Ctr Sport & Exercise Sci, Cambridge, England.; Zheng, XB; Wu, XJ (corresponding author), Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou, Peoples R China.; Zheng, XB; Wu, XJ (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Affiliated Hosp 6, Guangzhou, Peoples R China.
EM zhengxbn@mail3.sysu.edu.cn; wuxjian@mail.sysu.edu.cn;
   lee.smith@anglia.ac.uk
RI Yang, Lin/AAE-4979-2020; Cao, Chao/AAJ-8013-2020; Zong,
   Xiaoyu/AEP-4063-2022; Smith, Lee/JPA-1418-2023; Yang, Lin/H-2156-2016;
   Jackson, Sarah/J-9046-2019; Lopez Sanchez, Guillermo Felipe/K-8703-2015
OI Smith, Lee/0000-0002-5340-9833; Yang, Lin/0000-0002-1698-6666; Zong,
   Xiaoyu/0000-0001-5646-710X; Liu, Qinran/0000-0001-7090-8485; Roberts,
   Justin/0000-0002-3169-2041; Jackson, Sarah/0000-0001-5658-6168; Lopez
   Sanchez, Guillermo Felipe/0000-0002-9897-5273
CR [Anonymous], NAT HLTH NUR EX SURV
   [Anonymous], TEA FACT SHEET 2018
   [Anonymous], VITAL HLTH STAT
   Archer E, 2015, MAYO CLIN PROC, V90, P911, DOI 10.1016/j.mayocp.2015.04.009
   Brausi M, 2008, EUR UROL, V54, P472, DOI 10.1016/j.eururo.2008.03.100
   Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92
   Camfield DA, 2014, NUTR REV, V72, P507, DOI 10.1111/nure.12120
   Centers for Disease Control and Prevention, The National Health and Nutrition Examination Survey
   Chung FL, 2003, J NUTR, V133, p3268S, DOI 10.1093/jn/133.10.3268S
   Dietz C, 2017, CURR PHARM DESIGN, V23, P2876, DOI 10.2174/1381612823666170105151800
   Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Einöther SJ, 2013, AM J CLIN NUTR, V98, p1700S, DOI 10.3945/ajcn.113.058248
   Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847
   Friedrich M, 2012, INT J OBESITY, V36, P735, DOI 10.1038/ijo.2011.136
   Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002
   Grabovac I, 2019, AM J MED, V132, P489, DOI 10.1016/j.amjmed.2018.11.021
   Hajiaghaalipour F, 2016, J FOOD SCI, V81, pH246, DOI 10.1111/1750-3841.13149
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Henning SM, 2003, NUTR CANCER, V45, P226, DOI 10.1207/S15327914NC4502_13
   Hodgson AB, 2013, ADV NUTR, V4, P129, DOI 10.3945/an.112.003269
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Johnson Clifford L, 2013, Vital Health Stat 2, P1
   Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13
   Komes D, 2010, FOOD RES INT, V43, P167, DOI 10.1016/j.foodres.2009.09.022
   Labbé D, 2006, SEP PURIF TECHNOL, V49, P1, DOI 10.1016/j.seppur.2005.07.038
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S
   Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41
   Sachdev PS, 2015, HARVARD REV PSYCHIAT, V23, P320, DOI 10.1097/HRP.0000000000000090
   SCHOELLER DA, 1995, METABOLISM, V44, P18, DOI 10.1016/0026-0495(95)90204-X
   Schoeller DA, 2013, AM J CLIN NUTR, V97, P1413, DOI 10.3945/ajcn.113.062125
   Serafini M, 1996, EUR J CLIN NUTR, V50, P28
   Shahbandeh M., 2018, GLOBAL TEA CONSUMPTI
   Shishikura Y, 2005, J SCI FOOD AGR, V85, P2125, DOI 10.1002/jsfa.2206
   Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Warden BA, 2001, J NUTR, V131, P1731, DOI 10.1093/jn/131.6.1731
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Yang L, 2019, JAMA-J AM MED ASSOC, V321, P1587, DOI 10.1001/jama.2019.3636
   Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586
NR 43
TC 4
Z9 5
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD FEB
PY 2020
VL 28
IS 2
BP 445
EP 451
DI 10.1002/oby.22705
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA KE6DT
UT WOS:000508645300031
PM 31970908
OA Green Submitted
DA 2025-04-28
ER

PT J
AU Ciupei, D
   Colisar, A
   Leopold, L
   Stanila, A
   Diaconeasa, ZM
AF Ciupei, Daria
   Colisar, Alexandru
   Leopold, Loredana
   Stanila, Andreea
   Diaconeasa, Zorita M.
TI Polyphenols: From Classification to Therapeutic Potential and
   Bioavailability
SO FOODS
LA English
DT Review
DE polyphenols; bioavailability; metabolism; quercetin; chlorogenic acid
ID CHLOROGENIC ACID; BIOLOGICAL-ACTIVITIES; ANTIOXIDANT ACTIVITY; FLAVONOID
   QUERCETIN; METABOLIC SYNDROME; PHENOLIC-COMPOUNDS; RESVERATROL;
   ABSORPTION; MECHANISMS; EXPRESSION
AB Though ubiquitous in nature, polyphenols gained scientific prominence only after the pioneering work of researchers like E. Fischer and K. Freudenberg, who demonstrated their potential beyond traditional applications, such as in the leather industry. Today, these bioactive compounds are recognized for their diverse therapeutic roles, including their use as adjuvants in cancer treatment, cancer prevention, and their anti-inflammatory and antioxidant properties. Additionally, polyphenols have demonstrated benefits in managing obesity, cardiovascular diseases, and neuromodulation. Their synthesis is influenced by environmental and genetic factors, with their concentrations varying based on the intensity of these variables, as well as the stage of ripening. This review provides a comprehensive overview of polyphenols, covering their classification, chemical structures, and bioavailability. The mechanisms influencing bioavailability, bioaccessibility, and bioactivity are explored in detail, alongside an introduction to their bioactive effects and associated metabolic pathways. Specific examples, such as the bioavailability of polyphenols in coffee and various types of onions, are analyzed. Despite their promising biological activities, a significant limitation of polyphenols lies in their inherently low oral bioavailability. However, their systemic circulation and the bioactive by-products formed during digestion present exciting opportunities for further research and application.
C1 [Ciupei, Daria] Univ Agr Sci & Vet Med, Life Sci Inst, Manastur 3-5, Cluj Napoca 400372, Romania.
   [Colisar, Alexandru] Univ Agr Sci & Vet Med, Fac Forestry & Cadastre, Manastur St 3-5, Cluj Napoca 400372, Romania.
   [Leopold, Loredana; Stanila, Andreea; Diaconeasa, Zorita M.] Univ Agr Sci & Vet Med, Fac Food Sci & Technol, Dept Food Sci, Manastur 3-5, Cluj Napoca 400372, Romania.
C3 University of Agricultural Sciences & Veterinary Medicine Cluj Napoca;
   University of Agricultural Sciences & Veterinary Medicine Cluj Napoca;
   University of Agricultural Sciences & Veterinary Medicine Cluj Napoca
RP Diaconeasa, ZM (corresponding author), Univ Agr Sci & Vet Med, Fac Food Sci & Technol, Dept Food Sci, Manastur 3-5, Cluj Napoca 400372, Romania.
EM daria.ciupei@usamvcluj.ro; alexandru.colisar@usamvcluj.ro;
   loredana.leopold@usamvcluj.ro; andreea.stanila@usamvcluj.ro;
   zorita.sconta@usamvcluj.ro
RI Colisar, Alexandru/KXS-1809-2024; Leopold, Loredana
   Florina/AAA-5812-2022; STANILA, ANDREEA/C-5854-2012; Leopold, Loredana
   Florina/C-4769-2011; Diaconeasa, Zorita/C-6182-2018
OI Stanila, Andreea/0000-0003-2739-7565; Leopold, Loredana
   Florina/0000-0002-8084-1998; Diaconeasa, Zorita/0000-0002-5325-3859
FU Romanian National Authority for Scientific Research (UEFISCDI); 
   [PN-III-P1-1.1-TE-2021-1585]
FX This research was funded by the Romanian National Authority for
   Scientific Research (UEFISCDI) Grant Number PN-III-P1-1.1-TE-2021-1585.
CR Abbaszadeh H, 2019, PHYTOTHER RES, V33, P2002, DOI 10.1002/ptr.6403
   Adedokun KA., 2023, Phytochemistry, Computational Tools and Databases in Drug Discovery. Drug Discovery Update, P393, DOI [10.1016/B978-0-323-90593-0.00017-4, DOI 10.1016/B978-0-323-90593-0.00017-4]
   ADLERCREUTZ H, 1993, SCAND J CLIN LAB INV, V53, P5, DOI 10.3109/00365519309090693
   Adlercreutz H, 2007, CRIT REV CL LAB SCI, V44, P483, DOI 10.1080/10408360701612942
   Al-Khayri JM, 2023, MOLECULES, V28, DOI 10.3390/molecules28093786
   Alam MA, 2014, ADV NUTR, V5, P404, DOI 10.3945/an.113.005603
   [Anonymous], 2019, Encyclopedia of Food Chemistry, DOI DOI 10.1016/B978-0-08-100596-5.22395-0
   Azam S, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.683459
   Bandyopadhyay P, 2012, FOOD FUNCT, V3, P592, DOI 10.1039/c2fo00006g
   Banez MJ, 2020, NUTR RES, V78, P11, DOI 10.1016/j.nutres.2020.03.002
   Bellavite P, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12020280
   Bento-Silva A, 2020, EUR J NUTR, V59, P1275, DOI 10.1007/s00394-019-01987-6
   Berding K, 2021, ADV NUTR, V12, P1239, DOI 10.1093/advances/nmaa181
   Berenshtein L, 2024, ACS OMEGA, V9, P2022, DOI 10.1021/acsomega.3c07636
   Beslo D, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11050970
   Boncler M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180022
   Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006
   Burokas A, 2017, BIOL PSYCHIAT, V82, P472, DOI 10.1016/j.biopsych.2016.12.031
   Calinoiu LF, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111615
   Cañas S, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11091818
   Carvalho Paulo de Tarso, 2004, Food Sci. Technol, V24, P646
   Chen SF, 2018, J NUTR BIOCHEM, V55, P209, DOI 10.1016/j.jnutbio.2018.02.007
   Cheng CK, 2020, BRIT J PHARMACOL, V177, P1258, DOI 10.1111/bph.14801
   Chuu CP, 2012, CANCER PREV RES, V5, P788, DOI 10.1158/1940-6207.CAPR-12-0004-T
   Clavel T, 2006, FEMS MICROBIOL ECOL, V55, P471, DOI 10.1111/j.1574-6941.2005.00057.x
   Clavel T, 2006, NUTR RES REV, V19, P187, DOI 10.1017/S0954422407249704
   Coman V, 2020, J SCI FOOD AGR, V100, P483, DOI 10.1002/jsfa.10010
   Costea T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051062
   Cordeiro MLD, 2022, NUTRIENTS, V14, DOI 10.3390/nu14204309
   Dabeek WM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102288
   Di Meo F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072564
   Din S, 2022, PLANTS-BASEL, V11, DOI 10.3390/plants11243588
   Dolati Karim, 2018, Prev Nutr Food Sci, V23, P127, DOI 10.3746/pnf.2018.23.2.127
   Duda-Chodak A, 2023, MOLECULES, V28, DOI 10.3390/molecules28062536
   El Khawand T, 2018, PHYTOCHEM REV, V17, P1007, DOI 10.1007/s11101-018-9578-9
   Elmowafy M, 2023, POLYMERS-BASEL, V15, DOI 10.3390/polym15051123
   Emad AM, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13399
   Emran TB, 2023, LIFE-BASEL, V13, DOI 10.3390/life13010099
   Eseberri I, 2022, NUTRIENTS, V14, DOI 10.3390/nu14091925
   Farah A, 2005, J AGR FOOD CHEM, V53, P1505, DOI 10.1021/jf048701t
   Farah A., 2015, Bioavailability and Metabolism of Chlorogenic Acids from Coffee, VVolume 87, P789
   Farombi EO, 2019, Encyclopedia of Food Chemistry, P224
   Felix-Medina JV, 2021, LWT-FOOD SCI TECHNOL, V142, DOI 10.1016/j.lwt.2021.111053
   Ferlemi AV, 2015, CHEM-BIOL INTERACT, V237, P47, DOI 10.1016/j.cbi.2015.04.013
   Fernandes A, 2023, FOODS, V12, DOI 10.3390/foods12051052
   Almeida AF, 2018, COMPR REV FOOD SCI F, V17, P714, DOI 10.1111/1541-4337.12342
   Filosa S, 2018, NEURAL REGEN RES, V13, P2055, DOI 10.4103/1673-5374.241429
   Galindo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032673
   Gao SS, 2021, FOOD HYDROCOLLOID, V110, DOI 10.1016/j.foodhyd.2020.106209
   Gasmi A, 2022, MOLECULES, V27, DOI 10.3390/molecules27196280
   Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419
   Giglio RV, 2018, CURR PHARM DESIGN, V24, P239, DOI 10.2174/1381612824666180130112652
   González-Aguilar GA, 2017, CURR OPIN FOOD SCI, V13, P84, DOI 10.1016/j.cofs.2017.03.004
   Grgic J, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100923
   Grzelczyk J, 2022, FOOD CHEM, V392, DOI 10.1016/j.foodchem.2022.133328
   Guex CG, 2019, J ETHNOPHARMACOL, V235, P1, DOI 10.1016/j.jep.2019.02.001
   Gutiérrez-del-Río I, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10081264
   Gutiérrez-Escobar R, 2021, MOLECULES, V26, DOI 10.3390/molecules26030718
   Hai Y, 2020, FOOD FRONTIERS, V1, P420, DOI 10.1002/fft2.50
   Moghaddam RH, 2022, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.738420
   Hollman PCH, 1997, FEBS LETT, V418, P152, DOI 10.1016/S0014-5793(97)01367-7
   Hollman PCH, 2004, PHARM BIOL, V42, P74, DOI 10.3109/13880200490893492
   Hooshmand S, 2011, BRIT J NUTR, V106, P923, DOI 10.1017/S000711451100119X
   Huang LL, 2022, FRONT CELL INFECT MI, V12, DOI 10.3389/fcimb.2022.1004765
   Jakobek L, 2019, TRENDS FOOD SCI TECH, V83, P235, DOI 10.1016/j.tifs.2018.11.024
   Jan R, 2022, PLANTS-BASEL, V11, DOI 10.3390/plants11192623
   Janabi AHW, 2020, IRAN J BASIC MED SCI, V23, P140, DOI [10.22038/ijbms.2019.35125.8353, 10.22038/IJBMS.2019.35125.8353]
   Ji YY, 2021, IND CROP PROD, V172, DOI 10.1016/j.indcrop.2021.113991
   Jia ZH, 2016, FOOD BIOSCI, V15, P87, DOI 10.1016/j.fbio.2016.05.007
   Jiang P, 2007, FOOD RES INT, V40, P356, DOI 10.1016/j.foodres.2006.10.009
   Juurlink BHJ, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-63
   Kan LJ, 2020, FOOD FUNCT, V11, P5933, DOI [10.1039/D0FO01145B, 10.1039/d0fo01145b]
   Kapusta-Duch Joanna, 2012, Rocz Panstw Zakl Hig, V63, P389
   Kardum Nevena, 2018, Adv Food Nutr Res, V84, P103, DOI 10.1016/bs.afnr.2017.12.001
   Khokhar KM, 2017, J HORTIC SCI BIOTECH, V92, P448, DOI 10.1080/14620316.2017.1314199
   Kiani S, 2018, GENE, V678, P115, DOI 10.1016/j.gene.2018.08.026
   Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16
   Kishida K, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02708
   Klaas M, 1998, PLANT BREEDING, V117, P297, DOI 10.1111/j.1439-0523.1998.tb01946.x
   Kolodziejczyk P, 2012, WOODHEAD PUBL SER TE, P329
   Konishi Y, 2006, J AGR FOOD CHEM, V54, P7539, DOI 10.1021/jf061554+
   Kopustinskiene DM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020457
   Koudoufio M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100982
   Kumar Naresh, 2019, Biotechnology Reports, V24, pe00370, DOI 10.1016/j.btre.2019.e00370
   Lampe JW, 2003, J NUTR, V133, p956S, DOI 10.1093/jn/133.3.956S
   Lang YX, 2021, J AGR FOOD CHEM, V69, P6200, DOI 10.1021/acs.jafc.1c00082
   Lee J, 2009, ABSTR PAP AM CHEM S, V237, P122
   Lenková M, 2016, J CENT EUR AGRIC, V17, P1119, DOI 10.5513/JCEA01/17.4.1820
   Lesjak M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102900
   Li Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23123164
   Li Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030167
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Liga S, 2023, PLANTS-BASEL, V12, DOI 10.3390/plants12142732
   Liu C, 2022, CURR NEUROPHARMACOL, V20, P2346, DOI 10.2174/1570159X20666220812122437
   Liu DQ, 2020, DRUG DES DEV THER, V14, P51, DOI 10.2147/DDDT.S228751
   Lu HJ, 2020, COMPR REV FOOD SCI F, V19, P3130, DOI 10.1111/1541-4337.12620
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Marhuenda-Muñoz M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112725
   Mattioli R, 2020, MOLECULES, V25, DOI 10.3390/molecules25173809
   Meenu M, 2023, FOOD FRONTIERS, V4, P1019, DOI 10.1002/fft2.246
   Menendez C, 2011, MOL NUTR FOOD RES, V55, P1780, DOI 10.1002/mnfr.201100378
   Meng QW, 2023, J ANIM SCI BIOTECHNO, V14, DOI 10.1186/s40104-022-00822-z
   Metrani R, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9091077
   Miles S.H., 2004, The Hippocratic Oath and the Ethics of Medicine
   Minnelli C, 2018, INT J PHARMACEUT, V552, P225, DOI 10.1016/j.ijpharm.2018.10.004
   Moco S, 2012, J PROTEOME RES, V11, P4781, DOI 10.1021/pr300581s
   Moon JK, 2009, J AGR FOOD CHEM, V57, P5365, DOI 10.1021/jf900012b
   Moreno-Luna R, 2012, AM J HYPERTENS, V25, P1299, DOI 10.1038/ajh.2012.128
   Mostafazadeh M, 2022, RES PHARM SCI, V17, P305, DOI 10.4103/1735-5362.343084
   Murota K, 2003, ARCH BIOCHEM BIOPHYS, V417, P12, DOI 10.1016/S0003-9861(03)00284-4
   Murota K, 2018, BIOSCI BIOTECH BIOCH, V82, P600, DOI 10.1080/09168451.2018.1444467
   Najib A., 2023, J. Biochem. Phytomed, V2, P86
   Nicholson P.T., 1999, Ancient Egyptian Materials and Technology
   Nitulescu GM, 2018, INT J ONCOL, V53, P2319, DOI 10.3892/ijo.2018.4597
   Noguchi-Shinohara M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73729-2
   O'Riordan KJ, 2022, MOL CELL ENDOCRINOL, V546, DOI 10.1016/j.mce.2022.111572
   Olas B, 2024, FOODS, V13, DOI 10.3390/foods13020288
   Orgaard A, 2008, EXP BIOL MED, V233, P1066, DOI 10.3181/0712-MR-347
   Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41
   Park SK, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-10520-5
   Paul S, 2010, EUR J MED CHEM, V45, P3702, DOI 10.1016/j.ejmech.2010.05.019
   Pimple B.P., 2014, POLYPHENOLS REMEDY S, P861, DOI DOI 10.1016/B978-0-12-398456-2.00067-0
   Pyrzynska K, 2022, NUTRIENTS, V14, DOI 10.3390/nu14122387
   Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044
   Rad MS, 2022, PHYTOTHER RES, V36, P2889, DOI 10.1002/ptr.7469
   Rajabi M, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5020034
   Ramos S, 2008, MOL NUTR FOOD RES, V52, P507, DOI 10.1002/mnfr.200700326
   Ramteke P.K., 2024, Antidiabetic Medicinal Plants, P167, DOI [10.1016/B978-0-323-95719-9.00016-1, DOI 10.1016/B978-0-323-95719-9.00016-1]
   Reinisalo M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/340520
   Rocchetti G, 2022, COMPR REV FOOD SCI F, V21, P811, DOI 10.1111/1541-4337.12921
   Rodríguez-García C, 2019, MOLECULES, V24, DOI 10.3390/molecules24050917
   Sanati S, 2018, IRAN J BASIC MED SCI, V21, P439, DOI 10.22038/IJBMS.2018.25200.6238
   Saura-Calixto F, 2007, FOOD CHEM, V101, P492, DOI 10.1016/j.foodchem.2006.02.006
   Sawane K, 2022, MICROORGANISMS, V10, DOI 10.3390/microorganisms10112169
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Senizza A, 2020, MOLECULES, V25, DOI 10.3390/molecules25235709
   Seo SH, 2021, FOOD FUNCT, V12, P5361, DOI [10.1039/d1fo00342a, 10.1039/D1FO00342A]
   Shilpa VS, 2023, MOLECULES, V28, DOI 10.3390/molecules28155623
   Si X, 2021, J AGR FOOD CHEM, V69, P3658, DOI 10.1021/acs.jafc.0c07637
   Silva YP, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00025
   Singh V, 2018, NAT PROD RES, V32, P2202, DOI 10.1080/14786419.2017.1367783
   Sitarek P, 2024, PHARMACOL RES, V209, DOI 10.1016/j.phrs.2024.107457
   Snezhkina AV, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6175804
   Stromsnes K, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9081074
   Taghavinia F, 2022, ANIMALS-BASEL, V12, DOI 10.3390/ani12243492
   Ngo TV, 2022, FOODS, V11, DOI 10.3390/foods11213384
   Teka T, 2022, PHYTOCHEMISTRY, V197, DOI 10.1016/j.phytochem.2022.113128
   Tesfaye Azene, 2021, ScientificWorldJournal, V2021, P8817288, DOI 10.1155/2021/8817288
   Thilakarathna SH, 2013, NUTRIENTS, V5, P3367, DOI 10.3390/nu5093367
   Tian WF, 2021, FOOD CHEM, V362, DOI 10.1016/j.foodchem.2021.130135
   Tianyu Jiang, 2020, Advanced Industrial and Engineering Polymer Research, V3, P8, DOI 10.1016/j.aiepr.2019.11.003
   Toutain PL, 2004, J VET PHARMACOL THER, V27, P427, DOI 10.1111/j.1365-2885.2004.00600.x
   Tseng SH, 2023, J TRADIT COMPL MED, V13, P51, DOI 10.1016/j.jtcme.2022.10.003
   Ullah H, 2022, MOLECULES, V27, DOI 10.3390/molecules27061906
   Ullah H, 2020, FOOD CHEM TOXICOL, V144, DOI 10.1016/j.fct.2020.111574
   Ungvari Z, 2018, CIRC RES, V123, P849, DOI 10.1161/CIRCRESAHA.118.311378
   Upyr Taras V., 2022, Research Journal of Pharmacy and Technology, V15, P375, DOI 10.52711/0974-360X.2022.00061
   Uyanga VA, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113782
   Vamanu E, 2020, FOODS, V9, DOI 10.3390/foods9091281
   Vesely O, 2021, NUTRIENTS, V13, DOI 10.3390/nu13093095
   Vignoli JA, 2014, FOOD RES INT, V61, P279, DOI 10.1016/j.foodres.2013.06.006
   Vladu AF, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms231810244
   Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885
   Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C
   Wang LB, 2022, FOOD CHEM, V367, DOI 10.1016/j.foodchem.2021.130762
   Wang SY, 2020, FOOD HYDROCOLLOID, V109, DOI 10.1016/j.foodhyd.2020.106109
   Williams C.A., 2013, Equine Applied and Clinical Nutrition, P351, DOI [10.1016/B978-0-7020-3422-0.00019-5, DOI 10.1016/B978-0-7020-3422-0.00019-5]
   Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622
   Yang BY, 2020, MOLECULES, V25, DOI 10.3390/molecules25204613
   Yang CS, 2009, ARCH TOXICOL, V83, P11, DOI 10.1007/s00204-008-0372-0
   Yang DK, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/2179021
   Yao LL, 2022, BIOMED PHARMACOTHER, V154, DOI 10.1016/j.biopha.2022.113563
   Yarmohammadi F, 2021, IRAN J BASIC MED SCI, V24, P420, DOI 10.22038/ijbms.2021.50276.11452
   Yi J, 2021, FOOD HYDROCOLLOID, V113, DOI 10.1016/j.foodhyd.2020.106497
   Yin ZY, 2022, FOOD SCI HUM WELL, V11, P537, DOI 10.1016/j.fshw.2021.12.011
   Yu J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060361
   Yu LL, 2015, MOLECULES, V20, P15525, DOI 10.3390/molecules200915525
   Zhang LX, 2021, BIOMED PHARMACOTHER, V143, DOI 10.1016/j.biopha.2021.112164
   Zhang Y, 2022, NUTRIENTS, V14, DOI 10.3390/nu14245373
   Zhang ZH, 2021, TRENDS FOOD SCI TECH, V116, P492, DOI 10.1016/j.tifs.2021.08.009
   Zhou YL, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/979414
NR 181
TC 3
Z9 3
U1 18
U2 18
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2304-8158
J9 FOODS
JI Foods
PD DEC
PY 2024
VL 13
IS 24
AR 4131
DI 10.3390/foods13244131
PG 36
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA Q4I4M
UT WOS:001384337000001
PM 39767073
OA gold
DA 2025-04-28
ER

PT J
AU Choi, BK
   Park, SB
   Lee, DR
   Lee, HJ
   Jin, YY
   Yang, SH
   Suh, JW
AF Choi, Bong-Keun
   Park, Sung-Bum
   Lee, Dong-Ryung
   Lee, Hae Jin
   Jin, Ying-Yu
   Yang, Seung Hwan
   Suh, Joo-Won
TI Green coffee bean extract improves obesity by decreasing body fat in
   high-fat diet-induced obese mice
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Green coffee bean extract; High-fat diet induced obese mice;
   Adipogenesis; Body fat; Dual energy X-ray absorptiometry
ID PPAR-GAMMA; CHLOROGENIC ACID; ENERGY-BALANCE; RISK; AMPK; METABOLISM;
   LIPOLYSIS; ALPHA; CELL
AB Objective: To evaluate possible lipid catabolism and body fat regulation effects of 3-caffeoylquinic acid in Green coffee bean extract (GCBE) in high-fat diet (HFD)-induced obese mice. Methods: Obesity was induced in mice using a HFD for four weeks. Then, mice were fed only HFD or HFD with GCBE at 50, 100, and 200 mg/kg. Fatty acid synthesis mechanism regulation of body fat was investigated through real-time PCR and Western blot assay. Body fat reduction was measured through dual- energy X-ray absorptiometry. Results: In HFD-induced obese mice, GCBE treatment significantly decreased body weight gain, liver weight and white adipose tissue weights with regulation of adipose tissue lipolysis hormones, like adiponectin and leptin. GCBE treatment decreased mRNA expression levels of adipogenesis and adipocyte metabolism related genes in adipose tissues and the liver, and decreased the corresponding protein expression. Dual energy X-ray absorptiometry measurements were used to compare body fat between mice on high-fat and those treated with GCBE. GCBE treated mice had a lower fat mass compared to HFD alone fed mice and relative body weight and fat mass were markedly decreased. Conclusions: GCBE has a potential anti-obesity effect with lowering body fat accumulation by regulating adipogenesis and lipid metabolism-related genes and proteins in WAT and liver.
C1 [Choi, Bong-Keun; Lee, Dong-Ryung] Nutra Pharm Tech, Yongin 446916, Gyeonggi, South Korea.
   [Park, Sung-Bum; Lee, Hae Jin; Yang, Seung Hwan] Myongji Univ, Interdisciplinary Program Biomodulat, Yongin 446728, Gyeonggi, South Korea.
   [Jin, Ying-Yu; Yang, Seung Hwan; Suh, Joo-Won] Myongji Univ, Ctr Nutraceut & Pharmaceut Mat, Yongin 446728, Gyeonggi, South Korea.
C3 Myongji University; Myongji University
RP Yang, SH; Suh, JW (corresponding author), Myongji Univ, Ctr Nutraceut & Pharmaceut Mat, Yongin 446728, Gyeonggi, South Korea.
EM ymtehigan@mju.ac.kr; jwsuh@mju.ac.kr
RI suh, */HRA-0278-2023
FU Cooperative Research Program for Agriculture Science & Technology
   Development [PJ01134802]
FX This work was supported by the Cooperative Research Program for
   Agriculture Science & Technology Development (No. PJ01134802).
CR Arch JRS, 2005, P NUTR SOC, V64, P39, DOI 10.1079/PNS2004407
   Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9
   Blum J, 2007, NUTRAFOODS, V6, P13
   Chen WY, 2012, AM J PHYSIOL-ENDOC M, V303, pE635, DOI 10.1152/ajpendo.00078.2012
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484
   dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Dickson JC, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0321-3
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Jin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120842
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074
   Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627
   Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189
   Pietrobelli A, 2005, INT J OBESITY, V29, pS97, DOI 10.1038/sj.ijo.0803079
   Qiao LP, 2011, DIABETES, V60, P1519, DOI 10.2337/db10-1017
   Rosen ED, 2000, GENE DEV, V14, P1293
   Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958
   Song SL, 2010, MOL CELL ENDOCRINOL, V325, P54, DOI 10.1016/j.mce.2010.05.019
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Tanaka K, 2009, FOOD SCI TECHNOL RES, V15, P147, DOI 10.3136/fstr.15.147
   Wedellova Z, 2011, PHYSIOL RES, V60, P139, DOI 10.33549/physiolres.931863
   Xiaoping Zhao, 2012, Sheng Wu Wu Li Hsueh Bao, V28, P287
NR 38
TC 90
Z9 91
U1 1
U2 41
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL
PY 2016
VL 9
IS 7
BP 616
EP 624
DI 10.1016/j.apjtm.2016.05.017
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DP5ZU
UT WOS:000378577500004
PM 27393090
OA gold
DA 2025-04-28
ER

PT J
AU Rasaei, N
   Ghaffarian-Ensaf, R
   Shiraseb, F
   Abaj, F
   Gholami, F
   Clark, CCT
   Mirzaei, K
AF Rasaei, Niloufar
   Ghaffarian-Ensaf, Rasool
   Shiraseb, Farideh
   Abaj, Faezeh
   Gholami, Fatemeh
   Clark, Cain C. T.
   Mirzaei, Khadijeh
TI The association between Healthy Beverage Index and psychological
   disorders among overweight and obese women: a cross-sectional study
SO BMC WOMENS HEALTH
LA English
DT Article
DE Depression; Anxiety; Stress; Mental health; Healthy beverage index;
   Obesity
ID TEA CONSUMPTION; MENTAL-HEALTH; OLDER-ADULTS; DEPRESSION; RISK; COFFEE;
   CAFFEINE; MICRONUTRIENT; PREVALENCE; DEPENDENCE
AB Background and aims The Healthy Beverage Index (HBI) is a valuable technique to estimate the synergistic effects of overall beverage consumption. Several studies have evaluated the associations between HBI and beneficial changes in the health status. however, there is no study on the association between patterns of beverage consumption and mental health status. Therefore, this study sought to examine the association between HBI and psychological disorders among overweight and obese women. Methods 199 overweight and obese women, between the ages of 18 and 55 y, were enrolled in this cross-sectional study in Tehran, Iran. To collect beverage dietary data, a validated semi-quantitative food-frequency questionnaire (FFQ) was used. Furthermore, the DASS-21 questionnaire was used to assess psychological profile states. Results The association of total depression anxiety stress (DASS) score with healthy beverage index (HBI) tertiles in models was marginally significant (OR =: 0.78; 95% CI 0.30-2.02; P-value = 0.074; (OR = 0.77; 95% CI 0.28-2.16; P-value = 0.062), respectively. In terms of stress, anxiety, and depression, after adjusting for confounders, participants with higher HBI in the third tertile had lower odds of depression vs. the first tertile (OR = 0.99; 95% CI 0.35-2.81; P-trend = 0.040). Conclusion We demonstrate that the total DASS score was associated with HBI tertiles. We also found that participants with higher HBI had lower odds of depression. However, additional well-designed studies are needed to confirm the veracity of these findings.
C1 [Rasaei, Niloufar; Shiraseb, Farideh; Abaj, Faezeh; Gholami, Fatemeh; Mirzaei, Khadijeh] Univ Tehran Med Sci, Dept Community Nutr, Sch Nutr Sci & Dietet, POB 14155-6117, Tehran, Iran.
   [Ghaffarian-Ensaf, Rasool] Islamic Azad Univ, Dept Nutr, Sci & Res Branch, Tehran, Iran.
   [Clark, Cain C. T.; Mirzaei, Khadijeh] Coventry Univ, Ctr Intelligent Healthcare, Coventry CV1 5FB, W Midlands, England.
   [Mirzaei, Khadijeh] Univ Tehran Med Sci, Food Microbiol Res Ctr, Tehran, Iran.
C3 Tehran University of Medical Sciences; Islamic Azad University; Coventry
   University; Tehran University of Medical Sciences
RP Mirzaei, K (corresponding author), Univ Tehran Med Sci, Dept Community Nutr, Sch Nutr Sci & Dietet, POB 14155-6117, Tehran, Iran.; Mirzaei, K (corresponding author), Coventry Univ, Ctr Intelligent Healthcare, Coventry CV1 5FB, W Midlands, England.; Mirzaei, K (corresponding author), Univ Tehran Med Sci, Food Microbiol Res Ctr, Tehran, Iran.
EM mirzaei_kh@tums.ac.ir
RI Clark, Cain/I-4480-2019; Mirzaei, Khadijeh/D-5408-2018;
   Ghaffarian-Ensaf, Rasool/HJG-9268-2022; Abaj, Faezeh/ABA-8101-2021;
   Shiraseb, F/AAQ-7384-2020
OI Clark, Dr. Cain/0000-0002-6610-4617; Abaj, Faezeh/0000-0002-7841-2000;
   Ghaffarian-Ensaf, Rasool/0000-0003-1291-1525
FU TUMS [99-3212-51715]
FX This study was supported by TUMS and grant ID was 99-3212-51715.
CR [Anonymous], 2011, NICE Clinical Guidelines
   [Anonymous], 2018, Mental Health: Data and Publications
   Auerbach BJ, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2454
   Benko CR, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-73
   Bosma-den Boer MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-32
   Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212
   Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X
   Bruce DG, 2018, DIABETIC MED, V35, P903, DOI 10.1111/dme.13631
   Chou SP, 2012, ALCOHOL CLIN EXP RES, V36, P654, DOI 10.1111/j.1530-0277.2011.01639.x
   Collaborators GMD, BMJ-BRIT MED J, P2022
   Cooper AJ, 2021, CURR OBES REP, V10, P458, DOI 10.1007/s13679-021-00453-x
   Duffey KJ, 2015, J ACAD NUTR DIET, V115, P1682, DOI 10.1016/j.jand.2015.05.005
   Evans-Lacko S, 2018, PSYCHOL MED, V48, P1560, DOI 10.1017/S0033291717003336
   Feng L, 2010, J NUTR HEALTH AGING, V14, P433
   Ferretti F, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0474-x
   Ferruzzi MG, 2020, ADV NUTR, V11, P507, DOI 10.1093/advances/nmz115
   Flores-Dorantes MT, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00863
   Freije SL, 2021, PREV CHRONIC DIS, V18, DOI 10.5888/pcd18.200574
   Garawi F, 2014, EUR J CLIN NUTR, V68, P1101, DOI 10.1038/ejcn.2014.86
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Grosso G, 2016, MOL NUTR FOOD RES, V60, P223, DOI 10.1002/mnfr.201500620
   Gui ZH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121302
   Harrell CS, 2015, PSYCHONEUROENDOCRINO, V62, P252, DOI 10.1016/j.psyneuen.2015.08.025
   Hasheminejad N, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01065-y
   Hedrick VE, 2015, NUTRIENTS, V7, P10168, DOI 10.3390/nu7125525
   Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657
   Hintikka J, 2005, EUR J EPIDEMIOL, V20, P359, DOI 10.1007/s10654-005-0148-2
   Jafarirad S., 2016, Jundishapur Scientific Medical Journal, V15, P217
   Jalilpiran Y, 2021, EAT WEIGHT DISORD-ST, V26, P1437, DOI 10.1007/s40519-020-00954-z
   Khosravi M, 2015, PSYCHIAT INVEST, V12, P434, DOI 10.4306/pi.2015.12.4.434
   Knüppel A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05649-7
   LaRowe TL, 2007, J AM DIET ASSOC, V107, P1124, DOI 10.1016/j.jada.2007.04.013
   Lavallee KL, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.712567
   Lucas M, 2011, ARCH INTERN MED, V171, P1571, DOI 10.1001/archinternmed.2011.393
   Malik VS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081840
   Mannan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157240
   Markus CR, 2007, BIOL PSYCHOL, V76, P83, DOI 10.1016/j.biopsycho.2007.06.003
   McLester CN, 2020, J CLIN DENSITOM, V23, P443, DOI 10.1016/j.jocd.2018.10.008
   Meng PL, 2022, TRANSL PSYCHIAT, V12, DOI 10.1038/s41398-022-01782-8
   Mirmiran P, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0021-6
   Moghaddam M.B., 2012, WORLD APPL SCI J, V18, P1073, DOI [DOI 10.5829/idosi.wasj.2012.18.08.754, 10.5829/idosi.wasj.2012.18.08]
   Montenegro-Bethancourt G, 2010, MATERN CHILD NUTR, V6, P174, DOI 10.1111/j.1740-8709.2009.00193.x
   Murray CJL, 2020, LANCET, V396, P1223, DOI [10.1016/S0140-6736(20)30752-2, 10.1016/S0140-6736(20)30925-9]
   Ng TP, 2014, J NUTR HEALTH AGING, V18, P161, DOI 10.1007/s12603-013-0354-7
   Noorbala AA, 2004, BRIT J PSYCHIAT, V184, P70, DOI 10.1192/bjp.184.1.70
   NORGAN NG, 1988, ERGONOMICS, V31, P1493, DOI 10.1080/00140138808966796
   Parker MK, 2022, J ACAD NUTR DIET, V122, P371, DOI 10.1016/j.jand.2021.07.007
   Patsalos O, 2021, J PERS MED, V11, DOI 10.3390/jpm11030176
   Platania A, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7040056
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Rezazadeh A, 2020, EPIDEMIOL HEALTH, V42
   Ruusunen A, 2010, PUBLIC HEALTH NUTR, V13, P1215, DOI 10.1017/S1368980010000509
   Salehi Z, 2021, ASS ENERGY ADJUSTS N
   Sanchez-Villegas A, 2018, BRIT J NUTR, V119, P211, DOI 10.1017/S0007114517003361
   Sarr PT, INVESTIGATING MOTIVA
   Sigala DM, 2021, CURR OBES REP, V10, P39, DOI 10.1007/s13679-020-00421-x
   Teesson M, 2010, ADDICTION, V105, P2085, DOI 10.1111/j.1360-0443.2010.03096.x
   Venci Brittany, 2015, Journal of Nutrition in Gerontology and Geriatrics, V34, P399, DOI 10.1080/21551197.2015.1092375
   Vickers NJ, 2017, CURR BIOL, V27, pR713, DOI 10.1016/j.cub.2017.05.064
   Viertiö S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10560-y
   Blasco BV, 2020, PSYCHIAT INVEST, V17, P715, DOI 10.30773/pi.2020.0099
   Vos T, 2020, LANCET, V396, P1562
   Wang JW, 2014, J NUTR, V144, P81, DOI 10.3945/jn.113.182519
   Wang SM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030340
   Xu YJ, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01590-6
   Yarizadeh H, 2022, EAT WEIGHT DISORD-ST, V27, P1327, DOI 10.1007/s40519-021-01268-4
NR 66
TC 2
Z9 2
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6874
J9 BMC WOMENS HEALTH
JI BMC Womens Health
PD JUL 15
PY 2022
VL 22
IS 1
AR 295
DI 10.1186/s12905-022-01870-3
PG 11
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology
GA 2Y6QK
UT WOS:000826018800004
PM 35840954
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Imatoh, T
   Tanihara, S
   Miyazaki, M
   Momose, Y
   Uryu, Y
   Une, H
AF Imatoh, T.
   Tanihara, S.
   Miyazaki, M.
   Momose, Y.
   Uryu, Y.
   Une, H.
TI Coffee consumption but not green tea consumption is associated with
   adiponectin levels in Japanese males
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Adiponectin; Epidemiological study; Coffee; Green tea
ID TYPE-2 DIABETES-MELLITUS; DECAFFEINATED COFFEE; INSULIN-RESISTANCE;
   RISK; WOMEN; CAFFEINE; OBESITY; COMPONENTS; REDUCE; MEN
AB Coffee is among the most widely consumed beverages in the world. Numerous epidemiological studies have reported a significant inverse association between coffee consumption and risk of type 2 diabetes mellitus, but the underlying mechanisms are still not fully understood. Therefore, we conducted an epidemiological study to clarify the relationship between coffee consumption and adiponectin levels in Japanese males. We also evaluated whether green tea consumption affected adiponectin levels.
   We carried out a cross-sectional study. The subjects were 665 male employees in Japan. Coffee consumption was assessed, using a self-administered questionnaire, as the number of times per week and cups per day respondents drank, and subjects were grouped into four levels (non, 1-5 times/week, 1-2 cups/day and a parts per thousand yen3 cups/day).
   The means of adiponectin levels were positively associated with coffee consumption. A dose-response relationship was found between coffee consumption and circulating adiponectin levels. The relationship remained significant after adjustment for potential confounding factors (P for trend < 0.05). However, green tea consumption was not significantly associated with adiponectin levels (P for trend = 0.90).
   We not only revealed that habitual coffee consumption is associated with higher adiponectin levels in Japanese males but also found a dose-dependent association between coffee consumption and adiponectin levels. Therefore, our study suggested that coffee components might play an important role in the elevation of adiponectin level.
C1 [Imatoh, T.; Tanihara, S.; Momose, Y.; Uryu, Y.; Une, H.] Fukuoka Univ, Dept Hyg & Prevent Med, Sch Med, Jonan Ku, Fukuoka 8140180, Japan.
   [Miyazaki, M.] Saitama City Inst Hlth Sci & Res, Chuou Ku, Saitama 3380013, Japan.
C3 Fukuoka University
RP Imatoh, T (corresponding author), Fukuoka Univ, Dept Hyg & Prevent Med, Sch Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.
EM imatoh@cis.fukuoka-u.ac.jp
RI Imatoh, Takuya/AAX-5251-2020
FU Japan Society for the Promotion of Science [20590619, 21790564];
   Grants-in-Aid for Scientific Research [20590619, 21790564] Funding
   Source: KAKEN
FX This work was supported by a Grant-in-Aid for Scientific Research from
   the Japan Society for the Promotion of Science [20590619], [21790564].
CR Arsenault BJ, 2009, EUR J CLIN NUTR, V63, P1419, DOI 10.1038/ejcn.2009.112
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Bravi F, 2007, HEPATOLOGY, V46, P430, DOI 10.1002/hep.21708
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2007, AM J CLIN NUTR, V85, P392, DOI 10.1093/ajcn/85.2.392
   Hamer M, 2008, BRIT J NUTR, V100, P1046, DOI 10.1017/S0007114508944135
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Kagami K, 2008, J PHARM PHARMACOL, V60, P1161, DOI 10.1211/jpp.60.9.0007
   Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Klatsky AL, 2006, ARCH INTERN MED, V166, P1190, DOI 10.1001/archinte.166.11.1190
   Kotani K, 2008, CLIN CHEM LAB MED, V46, P1434, DOI 10.1515/CCLM.2008.286
   Lee JE, 2007, INT J CANCER, V121, P2246, DOI 10.1002/ijc.22909
   Matsuzawa Y, 2005, ATHEROSCLEROSIS SUPP, V6, P7, DOI 10.1016/j.atherosclerosissup.2005.02.003
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Pimentel GD, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-6
   Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006
   Richard D, 2009, PHARMACOL RES, V59, P351, DOI 10.1016/j.phrs.2009.01.015
   Ruhl CE, 2005, GASTROENTEROLOGY, V128, P24, DOI 10.1053/j.gastro.2004.09.075
   Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001
   Schaefer B, 2004, ANN INTERN MED, V141, P321, DOI 10.7326/0003-4819-141-4-200408170-00016
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120
   van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
NR 31
TC 43
Z9 48
U1 0
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN
PY 2011
VL 50
IS 4
BP 279
EP 284
DI 10.1007/s00394-010-0136-5
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 769SK
UT WOS:000291038400007
PM 20953616
DA 2025-04-28
ER

PT J
AU Guillemet, D
   Belles, C
   Gomes, A
   Azalbert, V
   André, M
   Faresse, N
   Burcelin, R
   Lagarde, JM
   Lacasa, D
   Kéophiphath, M
AF Guillemet, Damien
   Belles, Chloe
   Gomes, Aurelie
   Azalbert, Vincent
   Andre, Mathilde
   Faresse, Nourdine
   Burcelin, Remy
   Lagarde, Jean-Michel
   Lacasa, Daniele
   Keophiphath, Mayoura
TI Screening for anti-adipogenic, pro-lipolytic and thermogenic plant
   extracts by models associating intestinal epithelial cells with human
   adipose cells
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Plant extracts; Adipose cells; Caco-2; Lipid accumulation; UCP1; Energy
   metabolism; Lipolysis
ID INSULIN-RESISTANCE; TISSUE; OBESITY; FAT; ANTIOBESITY; BROWN;
   ADIPOCYTES; CAFFEINE; DIFFERENTIATION; BIOAVAILABILITY
AB Purpose Excessive fat mass accumulation in obesity leads to diverse metabolic disorders, increased risks of cardiovascular diseases and in some cases, mortality. The aim of this study was to screen the actions of botanical extracts intended for oral use on human adipose tissue, using an in vitro screening model combining human intestinal cells with human adipose cells. This was to find the most effective extracts on lipid accumulation, UCP1 expression and ATP production in pre-adipocytes and on adipocyte lipolysis. Methods In this study, 25 individual plant extracts were screened for their effects on human adipose cells. Consequently, an original in vitro model was set up using the Caco-2 cell line, to mimic the intestinal passage of the extracts and then exposing human adipose cells to them. The biological actions of extracts were thus characterized, and compared with a coffee extract standard. The most effective extracts, and their combinations, were retained for their actions on lipid accumulation, the expression of the thermogenic effector UCP1 and ATP production in pre-adipocytes as well as on lipolysis activity of mature adipocytes. Results The biphasic culture system combining human Caco-2 cells with human adipose cells was verified as functional using the green coffee extract standard. Out of the 25 plant extracts studied, only 7 and their combinations were retained due to their potent effects on adipose cells biology. The data showed that compared to the coffee extract standard, Immortelle, Catechu, Carrot and Rose hip extracts were the most effective in reducing lipid accumulation and increased UCP1 expression in human pre-adipocytes. Conclusion This study reveals the potential inhibitory effects on lipid accumulation and thermogenic activity of Immortelle, Catechu, Carrot and Rose hip extracts, and for the first time synergies in their combinations, using an in vitro model mimicking as closely as possible, human intestinal passage linked to adipose cells. These findings need to be confirmed by in vivo trials.
C1 [Guillemet, Damien] Nexira, 129 Chemin Croisset, F-76000 Rouen, France.
   [Belles, Chloe; Andre, Mathilde; Faresse, Nourdine; Lacasa, Daniele; Keophiphath, Mayoura] DIVA Expertise, Ctr Pierre Potier, 1 Pl Pierre Potier, F-31100 Toulouse, France.
   [Gomes, Aurelie; Lagarde, Jean-Michel] Ctr Pierre Potier, Imact 3D, 1 Pl Pierre Potier, F-31100 Toulouse, France.
   [Azalbert, Vincent; Burcelin, Remy] Inst Cardiovasc & Metab Dis, 1 Ave Prof Jean Poulhes, F-31432 Toulouse, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Guillemet, D (corresponding author), Nexira, 129 Chemin Croisset, F-76000 Rouen, France.; Kéophiphath, M (corresponding author), DIVA Expertise, Ctr Pierre Potier, 1 Pl Pierre Potier, F-31100 Toulouse, France.
EM d.guillemet@nexira.com
RI Guillemet, Damien/AAA-4523-2021
OI Guillemet, Damien/0000-0002-6638-0531; Keophiphath,
   Mayoura/0000-0002-8388-2189
FU Nexira
FX This study was sponsored by Nexira and D.G is a current employee of this
   company.
CR Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Bastard J.-P., 2013, Physiology and Physiopathology of Adipose Tissue, DOI DOI 10.1007/978-2-8178-0343-2
   Berger E, 2019, ADIPOCYTE, V8, P83, DOI 10.1080/21623945.2019.1580842
   Burnett BP, 2007, J MED FOOD, V10, P442, DOI 10.1089/jmf.2006.255
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   D'Archivio M, 2010, INT J MOL SCI, V11, P1321, DOI 10.3390/ijms11041321
   El-Houri RB, 2015, FOOD FUNCT, V6, P2135, DOI [10.1039/C5FO00223K, 10.1039/c5fo00223k]
   El-Houri RB, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/156398
   Fenzl A, 2014, HORM MOL BIOL CLIN I, V19, P25, DOI 10.1515/hmbci-2014-0022
   Gaibelet G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121563
   Grant RW, 2015, OBESITY, V23, P512, DOI 10.1002/oby.21003
   Gutierrez DA, 2009, CURR DIABETES REP, V9, P26, DOI 10.1007/s11892-009-0006-9
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Ishihara R, 2015, BIOCHEM BIOPH RES CO, V458, P362, DOI 10.1016/j.bbrc.2015.01.118
   Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184
   Keophiphath M, 2009, J NUTR, V139, P2055, DOI 10.3945/jn.109.105452
   Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183
   Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x
   Kusminski CM, 2016, NAT REV DRUG DISCOV, V15, P639, DOI 10.1038/nrd.2016.75
   Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687
   Liu XJ, 2017, PROTEIN CELL, V8, P446, DOI 10.1007/s13238-017-0378-6
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S
   Marín L, 2015, BIOMED RES INT-UK, V2015, DOI 10.1155/2015/905215
   Mitani T, 2017, J NUTR SCI VITAMINOL, V63, P331, DOI 10.3177/jnsv.63.331
   Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283
   Nagatomo A, 2015, DIABET METAB SYND OB, V8, P147, DOI 10.2147/DMSO.S78623
   Nagatomo Akifumi, 2013, Prev Nutr Food Sci, V18, P85
   Ninomiya K, 2007, BIOORG MED CHEM LETT, V17, P3059, DOI 10.1016/j.bmcl.2007.03.051
   Ohkoshi E, 2007, PLANTA MED, V73, P1255, DOI 10.1055/s-2007-990223
   Ono Y, 2006, J ETHNOPHARMACOL, V106, P238, DOI 10.1016/j.jep.2005.12.036
   Pal P, 2013, MOL CELL BIOCHEM, V376, P81, DOI 10.1007/s11010-012-1551-0
   Park S, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0455-5
   Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9
   Rayalam S, 2009, J MED FOOD, V12, P846, DOI 10.1089/jmf.2008.0158
   Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554
   SCOTINI E, 1983, PHARMACOL RES COMMUN, V15, P131, DOI 10.1016/S0031-6989(83)80055-1
   Shen Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087894, 10.1371/journal.pone.0095786]
   Shen Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2418, DOI 10.1271/bbb.100453
   Skolnik S, 2010, J PHARM SCI-US, V99, P3246, DOI 10.1002/jps.22080
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Stohs SJ, 2016, PHYTOTHER RES, V30, P732, DOI 10.1002/ptr.5583
   Stohs SJ, 2015, PHYTOTHER RES, V29, P818, DOI 10.1002/ptr.5335
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Sun H, 2008, EXPERT OPIN DRUG MET, V4, P395, DOI [10.1517/17425255.4.4.395, 10.1517/17425255.4.4.395 ]
   Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138
   Viegas DA, 2014, J ETHNOPHARMACOL, V151, P54, DOI 10.1016/j.jep.2013.11.005
   Wu CH, 2010, J AGR FOOD CHEM, V58, P7075, DOI 10.1021/jf101415v
   Wu Z, 2018, AM J PHYSIOL-GASTR L, V315, pG659, DOI 10.1152/ajpgi.00079.2018
   Yang CS, 2019, BIOAVAILABILITY ISSU
   Yoneshiro T, 2015, ANN MED, V47, P133, DOI 10.3109/07853890.2014.911595
   You JS, 2014, NUTR RES, V34, P258, DOI 10.1016/j.nutres.2014.01.003
   Yu WH, 2012, INT J BIOCHEM CELL B, V44, P377, DOI 10.1016/j.biocel.2011.11.013
   Zuriaga MA, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00027
NR 53
TC 3
Z9 3
U1 1
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN
PY 2022
VL 61
IS 4
BP 2201
EP 2215
DI 10.1007/s00394-021-02794-8
EA JAN 2022
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 1L6UO
UT WOS:000749078300001
PM 35092460
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Graneri, LT
   Mamo, JCL
   D'Alonzo, Z
   Lam, V
   Takechi, R
AF Graneri, Liam T.
   Mamo, John C. L.
   D'Alonzo, Zachary
   Lam, Virginie
   Takechi, Ryusuke
TI Chronic Intake of Energy Drinks and Their Sugar Free Substitution
   Similarly Promotes Metabolic Syndrome
SO NUTRIENTS
LA English
DT Article
DE energy drinks; artificial sweetener; metabolic syndrome; cholesterol;
   triglycerides; blood glucose; insulin; body fat; brown adipose tissue
ID BIOLOGICAL RISK-FACTORS; INSULIN SENSITIVITY; DECAFFEINATED COFFEE;
   DIABETES-MELLITUS; CAFFEINE INTAKE; DIETARY-INTAKE; TAURINE; RESISTANCE;
   SECRETION; OBESITY
AB Energy drinks containing significant quantities of caffeine, taurine and sugar are increasingly consumed, particularly by adolescents and young adults. The putative effects of chronic ingestion of either standard energy drink, Mother(TM) (ED), or its sugar-free formulation (sfED) on metabolic syndrome were determined in wild-type C57BL/6J mice, in comparison to a soft drink, Coca-Cola (SD), a Western-styled diet enriched in saturated fatty acids (SFA), and a combination of SFA + ED. Following 13 weeks of intervention, mice treated with ED were hyperglycaemic and hypertriglyceridaemic, indicating higher triglyceride glucose index, which was similar to the mice maintained on SD. Surprisingly, the mice maintained on sfED also showed signs of insulin resistance with hyperglycaemia, hypertriglyceridaemia, and greater triglyceride glucose index, comparable to the ED group mice. In addition, the ED mice had greater adiposity primarily due to the increase in white adipose tissue, although the body weight was comparable to the control mice receiving only water. The mice maintained on SFA diet exhibited significantly greater weight gain, body fat, cholesterol and insulin, whilst blood glucose and triglyceride concentrations remained comparable to the control mice. Collectively, these data suggest that the consumption of both standard and sugar-free forms of energy drinks induces metabolic syndrome, particularly insulin resistance.
C1 [Graneri, Liam T.; Mamo, John C. L.; D'Alonzo, Zachary; Lam, Virginie; Takechi, Ryusuke] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia.
   [Graneri, Liam T.; D'Alonzo, Zachary] Curtin Univ, Fac Hlth Sci, Curtin Med Sch, Perth, WA 6845, Australia.
   [Mamo, John C. L.; Lam, Virginie; Takechi, Ryusuke] Curtin Univ, Fac Hlth Sci, Sch Populat Hlth, Perth, WA 6845, Australia.
C3 Curtin University; Curtin University; Curtin University
RP Takechi, R (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia.; Takechi, R (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Populat Hlth, Perth, WA 6845, Australia.
EM Liam.graneri@postgrad.curtin.edu.au; j.mamo@curtin.edu.au;
   Zachary.dalonzo@postgrad.curtin.edu.au; Virginie.Lam@curtin.edu.au;
   R.Takechi@curtin.edu.au
RI Takechi, Ryu/T-9970-2019; Takechi, Ryusuke/D-3692-2012
OI Lam, Virginie/0000-0001-8463-645X; Takechi, Ryusuke/0000-0001-6359-3382;
   Mamo, John/0000-0002-5741-7849
CR Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004
   Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Rosales-Gómez CA, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1345282
   Bian XM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178426
   Boden G, 2001, DIABETES, V50, P1612, DOI 10.2337/diabetes.50.7.1612
   Brons C, 2004, EUR J CLIN NUTR, V58, P1239, DOI 10.1038/sj.ejcn.1601955
   Chang YH, 2012, INT J OBESITY, V36, P993, DOI 10.1038/ijo.2011.168
   Clark KS, 2019, CLIN EXP PHARMACOL P, V46, P475, DOI 10.1111/1440-1681.13065
   DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999
   Dewar L, 2017, DIAB MET SYND CLIN R, V11, pS631, DOI 10.1016/j.dsx.2017.04.017
   Du Y, 2005, EUR J EPIDEMIOL, V20, P311, DOI 10.1007/s10654-004-7536-x
   Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911
   Emanuela F, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/476380
   Farouque HMO, 2000, AUST NZ J MED, V30, P351, DOI 10.1111/j.1445-5994.2000.tb00837.x
   Ferreira SE, 2004, PHYSIOL BEHAV, V82, P841, DOI 10.1016/S0031-9384(04)00284-7
   Finnegan D., 2003, Nutrition Bulletin, V28, P147, DOI 10.1046/j.1467-3010.2003.00345.x
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817
   Gomez R, 2018, BIOMED PHARMACOTHER, V103, P1028, DOI 10.1016/j.biopha.2018.04.131
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Guo JX, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0444-3
   Hartley T R, 2001, J Clin Hypertens (Greenwich), V3, P354, DOI 10.1111/j.1524-6175.2001.00478.x
   Hartley TR, 2000, HYPERTENSION, V36, P137, DOI 10.1161/01.HYP.36.1.137
   Hosoi T, 2014, NEUROSCI LETT, V569, P23, DOI 10.1016/j.neulet.2014.03.053
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kim KS, 2012, EXP MOL MED, V44, P665, DOI 10.3858/emm.2012.44.11.075
   L'Amoreaux WJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S11
   Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004
   Lee AH, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.19
   Lenters-Westra E, 2010, CLIN CHEM, V56, P44, DOI 10.1373/clinchem.2009.130641
   Lertrit A, 2018, NUTRITION, V55-56, P125, DOI 10.1016/j.nut.2018.04.001
   Lewis GF, 1996, DIABETES CARE, V19, P390, DOI 10.2337/diacare.19.4.390
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Malaisse WJ, 1998, CELL SIGNAL, V10, P727, DOI 10.1016/S0898-6568(98)00017-5
   Mitani T, 2017, J NUTR SCI VITAMINOL, V63, P331, DOI 10.3177/jnsv.63.331
   Panek-Shirley LM, 2018, J ACAD NUTR DIET, V118, P1832, DOI 10.1016/j.jand.2018.05.015
   Parhofer KG, 2015, DIABETES METAB J, V39, P353, DOI 10.4093/dmj.2015.39.5.353
   Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009
   Piao S, 2011, J CLIN BIOCHEM NUTR, V49, P50, DOI 10.3164/jcbn.10-120
   Rahiman F, 2014, J Immunoassay Immunochem, V35, P26, DOI 10.1080/15321819.2013.784197
   Reis CEG, 2018, BRIT J NUTR, V119, P1029, DOI 10.1017/S000711451800034X
   Ribeiro RA, 2018, AMINO ACIDS, V50, P1511, DOI 10.1007/s00726-018-2650-3
   Sandireddy R, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/674987
   Santos RD, 2018, AMINO ACIDS, V50, P469, DOI 10.1007/s00726-017-2533-z
   Sarkar P, 2017, FOOD CHEM TOXICOL, V110, P109, DOI 10.1016/j.fct.2017.10.022
   Schaffer SW, 2000, AMINO ACIDS, V18, P305, DOI 10.1007/PL00010320
   Seidel U, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800569
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Sun TT, 2014, CELL BIOL INT, V38, P1183, DOI 10.1002/cbin.10321
   Sylvetsky AC, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201901166
   Tamer F, 2020, FOOD CHEM TOXICOL, V135, DOI 10.1016/j.fct.2019.110914
   Tey SL, 2017, EUR J CLIN NUTR, V71, P1129, DOI 10.1038/ejcn.2017.37
   Trapp GSA, 2014, DRUG ALCOHOL DEPEN, V134, P30, DOI 10.1016/j.drugalcdep.2013.09.006
   Umemura T, 2006, AM J CARDIOL, V98, P1538, DOI 10.1016/j.amjcard.2006.06.058
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Wu LF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15904
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Xydakis AM, 2004, J CLIN ENDOCR METAB, V89, P2697, DOI 10.1210/jc.2003-031826
   Yu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25746
NR 61
TC 8
Z9 9
U1 2
U2 34
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR
PY 2021
VL 13
IS 4
AR 1202
DI 10.3390/nu13041202
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA RR9HM
UT WOS:000643400100001
PM 33917297
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU O'Connor, L
   Imamura, F
   Lentjes, MAH
   Khaw, KT
   Wareham, NJ
   Forouhi, NG
AF O'Connor, Laura
   Imamura, Fumiaki
   Lentjes, Marleen A. H.
   Khaw, Kay-Tee
   Wareham, Nicholas J.
   Forouhi, Nita G.
TI Prospective associations and population impact of sweet beverage intake
   and type 2 diabetes, and effects of substitutions with alternative
   beverages
SO DIABETOLOGIA
LA English
DT Article
DE Adiposity; Coffee; Fruit juice; Population impact; Sweet beverages; Tea;
   Type 2 diabetes; Water
ID WEIGHT-LOSS MAINTENANCE; LOW-PROTEIN CONTENT; METABOLIC SYNDROME;
   GLYCEMIC INDEX; EPIC-NORFOLK; RISK; CONSUMPTION; CANCER; COHORT;
   MELLITUS
AB Aims/hypothesis This study aimed to evaluate the association of types of sugar-sweetened beverages (SSB) (soft drinks, sweetened-milk beverages, sweetened tea/coffee), artificially sweetened beverages (ASB) and fruit juice with incident type 2 diabetes and determine the effects of substituting non-SSB for SSB and the population-attributable fraction of type 2 diabetes due to total sweet beverages.
   Methods Beverage consumption of 25,639 UK-resident adults without diabetes at baseline (1993-1997) in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study was assessed using 7-day food diaries. During 10.8 years of follow-up 847 incident type 2 diabetes cases were verified.
   Results In adjusted Cox regression analyses there were positive associations (HR [95% CI] per serving/day]) for soft drinks 1.21 (1.05, 1.39), sweetened-milk beverages 1.22 (1.05, 1.43) and ASB 1.22 (1.11, 1.33), but not for sweetened tea/coffee 0.98 (0.94, 1.02) or fruit juice 1.01 (0.88, 1.15). Further adjustment for adiposity attenuated the association of ASB, HR 1.06 (0.93, 1.20). There was a positive dose-response relationship with total sweet beverages: HR per 5% energy 1.18 (1.11, 1.26). Substituting ASB for any SSB did not reduce the incidence in analyses accounting for energy intake and adiposity. Substituting one serving/day of water or unsweetened tea/coffee for soft drinks and for sweetened-milk beverages reduced the incidence by 14%-25%. If sweet beverage consumers reduced intake to below 2% energy, 15% of incident diabetes might be prevented.
   Conclusions/interpretation The consumption of soft drinks, sweetened-milk beverages and energy from total sweet beverages was associated with higher type 2 diabetes risk independently of adiposity. Water or unsweetened tea/coffee appear to be suitable alternatives to SSB for diabetes prevention. These findings support the implementation of population-based interventions to reduce SSB consumption and increase the consumption of suitable alternatives.
C1 [O'Connor, Laura; Imamura, Fumiaki; Wareham, Nicholas J.; Forouhi, Nita G.] Univ Cambridge, Epidemiol Unit, Inst Metab Sci, Sch Clin Med,MRC, Cambridge CB2 0QQ, England.
   [Lentjes, Marleen A. H.; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 0QQ, England.
C3 University of Cambridge; University of Cambridge
RP O'Connor, L (corresponding author), Univ Cambridge, Epidemiol Unit, Inst Metab Sci, Sch Clin Med,MRC, Cambridge Biomed Campus,POB 285, Cambridge CB2 0QQ, England.
EM laura.oconnor@mrc-epid.cam.ac.uk; nita.forouhi@mrc-epid.cam.ac.uk
RI Timpson, Nicholas/O-7548-2015; Forouhi, Nita/JAC-2361-2023; O'Connor,
   Laura/ABD-7999-2021; Khaw, Kay-Tee/AAZ-3209-2021; Imamura,
   Fumiaki/J-1038-2019
OI Keyes, Laura/0000-0002-6022-2022; Imamura, Fumiaki/0000-0002-6841-8396;
   Forouhi, Nita/0000-0002-5041-248X; Lentjes, Marleen/0000-0003-4713-907X
FU Medical Research Council (MRC) UK; Cancer Research UK; MRC Epidemiology
   Unit [MC_UU_12015/5]; MRC [MC_UU_12015/1, MC_UU_12015/5,
   MC_UP_A100_1003] Funding Source: UKRI
FX This work was supported by programme grants from the Medical Research
   Council (MRC) UK and Cancer Research UK. We acknowledge support from the
   MRC Epidemiology Unit (grant number MC_UU_12015/5). The sponsors did not
   participate in: the design or conduct of this study; the collection,
   management, analysis or interpretation of data; the writing of the
   manuscript; or the preparation, review, approval or decision to submit
   this manuscript for publication.
CR Aller EEJG, 2014, INT J OBESITY, V38, P1511, DOI 10.1038/ijo.2014.52
   [Anonymous], 2002, MCCANCE WIDD COMP FO
   [Anonymous], NAT DIET NUTR SURV H
   [Anonymous], NAT DIET NUTR SURV H
   Bingham SA, 2001, PUBLIC HEALTH NUTR, V4, P847, DOI 10.1079/PHN2000102
   Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189
   British Nutrition Foundation, 2013, HLTH HYDR GUID
   Day N, 1999, BRIT J CANCER, V80, P95
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072
   Eshak ES, 2013, CLIN NUTR, V32, P300, DOI 10.1016/j.clnu.2012.08.003
   Faculty of Public Health, 2013, DUT SUG SWEET BEV PO
   Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137
   Lentjes MAH, 2014, BRIT J NUTR, V111, P516, DOI 10.1017/S0007114513002754
   Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Miller PE, 2013, AM J PREV MED, V45, P416, DOI 10.1016/j.amepre.2013.05.014
   Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001
   National Cancer Institute, 2014, SOURC EN US POP 2005
   National Health Service, 2011, NHS LIV WELL 5 DAY W
   National Health Service, 2013, NHS CHOIC FACTS SUG
   Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799
   Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402
   Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487
   Pan A, 2012, AM J CLIN NUTR, V95, P1454, DOI 10.3945/ajcn.111.032698
   Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287
   Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8
   Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439
   Welch AA, 2001, PUBLIC HEALTH NUTR, V4, P1253, DOI 10.1079/PHN2001196
   World Health Organization (WHO), 2015, Guideline: Sugars Intake for Adults and Children
   Xi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093471
   Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563
NR 34
TC 118
Z9 131
U1 4
U2 41
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD JUL
PY 2015
VL 58
IS 7
BP 1474
EP 1483
DI 10.1007/s00125-015-3572-1
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA CK8ZL
UT WOS:000356528900012
PM 25944371
OA hybrid, Green Published
DA 2025-04-28
ER

PT J
AU Cornelis, MC
   Gustafsson, S
   Ärnlöv, J
   Elmståhl, S
   Söderberg, S
   Sundström, J
   Michaëlsson, K
   Lind, L
   Ingelsson, E
AF Cornelis, M. C.
   Gustafsson, S.
   Arnlov, J.
   Elmstahl, S.
   Soderberg, S.
   Sundstrom, J.
   Michaelsson, K.
   Lind, L.
   Ingelsson, E.
TI Targeted proteomic analysis of habitual coffee consumption
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Article
DE biomarkers; coffee; epidemiology; population; proteomics
ID DOSE-RESPONSE METAANALYSIS; INFLAMMATORY MARKERS; PROSPECTIVE COHORT;
   CAFFEINE INTAKE; SERUM YKL-40; BOUND LEPTIN; OBESE GENE; RISK; WOMEN;
   CANCER
AB BackgroundCoffee drinking has been implicated in mortality and a variety of diseases but potential mechanisms underlying these associations are unclear. Large-scale systems epidemiological approaches may offer novel insights to mechanisms underlying associations of coffee with health.
   ObjectiveWe performed an analysis of known and novel protein markers linked to cardiovascular disease and their association with habitual coffee intake in the Prospective Study of the Vasculature in Uppsala Seniors (PIVUS, n = 816) and followed up top proteins in the Uppsala Longitudinal Study of Adult Men (ULSAM, n = 635) and EpiHealth (n = 2418).
   MethodsIn PIVUS and ULSAM, coffee intake was measured by 7-day dietary records whilst a computer-based food frequency questionnaire was used in EpiHealth. Levels of up to 80 proteins were assessed in plasma by a proximity extension assay.
   ResultsFour protein-coffee associations adjusted for age, sex, smoking and BMI, met statistical significance in PIVUS (FDR < 5%, P < 2.31 x 10(-3)): leptin (LEP), chitinase-3-like protein 1 (CHI3L), tumour necrosis factor (TNF) receptor 6 and TNF-related apoptosis-inducing ligand. The inverse association between coffee intake and LEP replicated in ULSAM (, -0.042 SD per cup of coffee, P = 0.028) and EpiHealth (, -0.025 SD per time of coffee, P = 0.004). The negative coffee-CHI3L association replicated in EpiHealth (, -0.07, P = 1.15 x 10(-7)), but not in ULSAM (, -0.034, P = 0.16).
   ConclusionsThe current study supports an inverse association between coffee intake and plasma LEP and CHI3L1 levels. The coffee-CHI3L1 association is novel and warrants further investigation given links between CHI3L1 and health conditions that are also potentially influenced by coffee.
C1 [Cornelis, M. C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
   [Gustafsson, S.; Ingelsson, E.] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden.
   [Arnlov, J.] Karolinska Inst, Care Sci & Soc, Dept Neurobiol, Div Family Med & Primary Care, Huddinge, Sweden.
   [Arnlov, J.] Dalarna Univ, Sch Hlth & Social Sci, Falun, Sweden.
   [Elmstahl, S.] Malmo Univ Hosp, Lund Univ, Div Geriatr Med, Dept Clin Sci, Malmo, Sweden.
   [Soderberg, S.] Umea Univ, Dept Publ Hlth & Clin Med Cardiol, Umea, Sweden.
   [Sundstrom, J.; Lind, L.] Uppsala Univ, Dept Med Sci Cardiovasc Epidemiol, Uppsala, Sweden.
   [Sundstrom, J.] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden.
   [Michaelsson, K.] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.
   [Ingelsson, E.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA.
C3 Northwestern University; Feinberg School of Medicine; Uppsala
   University; Karolinska Institutet; Dalarna University; Lund University;
   Skane University Hospital; Umea University; Uppsala University; Uppsala
   University; Uppsala University; Stanford University
RP Cornelis, MC (corresponding author), 680 North Lake Shore Dr,Suite 1400, Chicago, IL 60611 USA.; Ingelsson, E (corresponding author), 300 Pasteur Dr,Mail Code 5773, Stanford, CA 94305 USA.
EM marilyn.cornelis@northwestern.edu; eriking@stanford.edu
RI ärnlöv, Johan/AAF-2746-2019; Sundström, Johan/IAP-6197-2023; Söderberg,
   Stefan/AAG-3881-2019; Michaelsson, Karl/AAM-9094-2021
OI Michaelsson, Karl/0000-0003-2815-1217; Sundstrom,
   Johan/0000-0003-2247-8454; Arnlov, Johan/0000-0002-6933-4637; Soderberg,
   Stefan/0000-0001-9225-1306; Ingelsson, Erik/0000-0003-2256-6972
CR Aleksandrova K, 2015, AM J CLIN NUTR, V102, P1498, DOI 10.3945/ajcn.115.116095
   [Anonymous], 2010, R LANG ENV STAT COMP
   [Anonymous], TRAD STAT
   Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192
   Bakuradze T, 2014, FOOD RES INT, V63, P420, DOI 10.1016/j.foodres.2014.05.032
   Becker W., 1994, SWEDISH NATL FOOD AD
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Bilge U, 2017, BIOMED RES-TOKYO, V2017, pS531
   Brabant G, 2000, DIABETOLOGIA, V43, P438, DOI 10.1007/s001250051326
   Cornelis M. C., 2014, Current Nutrition Reports, V3, P178
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Cornelis MC, 2015, CURR OPIN LIPIDOL, V26, P20, DOI 10.1097/MOL.0000000000000143
   Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025
   Daglia M, 2000, J AGR FOOD CHEM, V48, P1449, DOI 10.1021/jf990510g
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   European Coffee Federation, 2012, EUR COFF REP 2012 13
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Frost-Meyer NJ, 2012, J FUNCT FOODS, V4, P819, DOI 10.1016/j.jff.2012.05.010
   Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200
   Gilbert R M, 1984, Prog Clin Biol Res, V158, P185
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Guertin KA, 2015, AM J CLIN NUTR, V101, P1000, DOI 10.3945/ajcn.114.096099
   HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777
   He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032
   Imatoh T, 2015, EUR J CLIN NUTR, V69, P1023, DOI 10.1038/ejcn.2015.23
   Ingelsson E, 2005, JAMA-J AM MED ASSOC, V294, P334, DOI 10.1001/jama.294.3.334
   Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328
   Laitala VS, 2008, ADDICTION, V103, P2054, DOI 10.1111/j.1360-0443.2008.02375.x
   LANDINWILHELMSEN K, 1994, CLIN ENDOCRINOL, V41, P351, DOI 10.1111/j.1365-2265.1994.tb02556.x
   Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da
   Lind L, 2013, EUR J EPIDEMIOL, V28, P189, DOI 10.1007/s10654-013-9787-x
   Loftfield E, 2015, CANCER EPIDEM BIOMAR, V24, P1052, DOI 10.1158/1055-9965.EPI-15-0038-T
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424
   Magni P, 2005, CLIN ENDOCRINOL, V62, P189, DOI 10.1111/j.1365-2265.2005.02195.x
   Marques-Vidal P, 2010, CLIN ENDOCRINOL, V72, P38, DOI 10.1111/j.1365-2265.2009.03628.x
   Maruyama K, 2009, ASIAN PAC J CANCER P, V10, P6
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   Pham NM, 2015, EUR J NUTR, V54, P205, DOI 10.1007/s00394-014-0701-4
   Nielsen AR, 2008, DIABETES, V57, P3078, DOI 10.2337/db08-0182
   Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Rao FV, 2005, CHEM BIOL, V12, P973, DOI 10.1016/j.chembiol.2005.07.009
   Ritchie K, 2007, NEUROLOGY, V69, P536, DOI 10.1212/01.wnl.0000266670.35219.0c
   Ross GW, 2001, DRUG AGING, V18, P797, DOI 10.2165/00002512-200118110-00001
   Sinha MK, 1996, J CLIN INVEST, V98, P1277, DOI 10.1172/JCI118913
   Thomsen SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133672
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Willett WC, 1998, NUTR EPIDEMIOLOGY
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Zamora-Ros R, 2016, EUR J NUTR, V55, P1359, DOI 10.1007/s00394-015-0950-x
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
NR 61
TC 8
Z9 8
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD FEB
PY 2018
VL 283
IS 2
BP 200
EP 211
DI 10.1111/joim.12703
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA FX1RS
UT WOS:000425830100008
PM 29044854
OA Bronze
DA 2025-04-28
ER

PT J
AU Lee, J
   Lee, JE
   Kim, Y
AF Lee, Jeeyoo
   Lee, Ji-Eun
   Kim, Yuri
TI Relationship between coffee consumption and stroke risk in Korean
   population: the Health Examinees (HEXA) Study
SO NUTRITION JOURNAL
LA English
DT Article
DE stroke; coffee; Korean; HEXA
ID GREEN TEA; CAFFEINE INTAKE; METAANALYSIS; RESISTANCE; IMPACT; MEN
AB Background: Although coffee consumption is increasing rapidly, the results of previous studies regarding the association between coffee consumption and stroke risk have been conflicting. This was a multi-center cross-sectional study that aimed to evaluate the relationship between coffee consumption and stroke risk in Korean population.
   Methods: Data were obtained from the Health Examinees (HEXA) Study, which involved 146,830 individuals aged 40-69 years. Coffee consumption was categorized as none, < 1 cup/day, 1 to < 3 cups/day, and >= 3 cups/day. We used logistic regression models to examine the association between coffee consumption and the risk of stroke while controlling for potential confounders and performed subgroup analyses.
   Results: After adjusting for age and various possible confounders, high coffee consumption was associated with a 38% lower odds ratio for stroke in women (none vs. >= 3 cups/day: OR, 0.62; 95% CI 0.47-0.81; P for trend < 0.0001). No significant association was found in men (none vs. >= 3 cups/day: OR, 0.84; 95% CI, 0.66-1.07; P for trend = 0.1515). In analyses stratified by covariates, an inverse association between coffee consumption and stroke risk was most evident among healthy women who were younger, non-obese, non-hypertensive, non-diabetic, non-smokers, and non-alcohol drinkers.
   Conclusion: Our results suggest that higher coffee consumption may have protective benefits with regards to stroke risk in middle-aged Korean women.
C1 [Lee, Jeeyoo; Kim, Yuri] Ewha Womans Univ, Dept Nutr Sci & Food Management, 52 Ewhayeodae Gil, Seoul 03760, South Korea.
   [Lee, Ji-Eun] Chung Ang Univ, Dept Phys Educ, Coll Educ, Seoul 06974, South Korea.
C3 Ewha Womans University; Chung Ang University
RP Kim, Y (corresponding author), Ewha Womans Univ, Dept Nutr Sci & Food Management, 52 Ewhayeodae Gil, Seoul 03760, South Korea.
EM yuri.kim@ewha.ac.kr
RI Gim, Yuri/JNZ-3445-2023; LEE, JIEUN/HTN-1777-2023
CR Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   [Anonymous], 2015, PROC FOOD SUBD MARK
   [Anonymous], 2015, RISK FACT STROK
   [Anonymous], 2014, KOR HLTH STAT KOR NA
   Arab L, 2009, STROKE, V40, P1786, DOI 10.1161/STROKEAHA.108.538470
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI [10.1001/jama.291.10.1199-b, 10.1001/jama.291.10.1199-a]
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Cornelis MC, 2007, CURR OPIN LIPIDOL, V18, P13, DOI 10.1097/MOL.0b013e3280127b04
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Derby KS, 2008, CANCER EPIDEM BIOMAR, V17, P3526, DOI 10.1158/1055-9965.EPI-08-0424
   Ferrini RL, 1996, AM J EPIDEMIOL, V144, P642, DOI 10.1093/oxfordjournals.aje.a008975
   Gans JMD, 2010, ARTERIOSCL THROM VAS, V30, P1665, DOI 10.1161/ATVBAHA.109.201939
   Gómez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Grigg D., 2002, GeoJournal, V57, P283, DOI 10.1023/B:GEJO.0000007249.91153.c3
   Hakim AA, 1998, J CLIN EPIDEMIOL, V51, P487, DOI 10.1016/S0895-4356(98)00023-7
   Health Examinees Study Group, 2015, Asian Pac J Cancer Prev, V16, P1591
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11
   Kim B, 2012, KOREAN J FAM MED, V33, P356, DOI 10.4082/kjfm.2012.33.6.356
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   LAMBERT M, 2011, AM FAM PHYS, V83
   Larsson SC, 2014, STROKE, V45, P309, DOI 10.1161/STROKEAHA.113.003131
   Larsson SC, 2011, AM J EPIDEMIOL, V174, P993, DOI 10.1093/aje/kwr226
   Larsson SC, 2011, STROKE, V42, P908, DOI 10.1161/STROKEAHA.110.603787
   Liang WB, 2009, STROKE, V40, P2480, DOI 10.1161/STROKEAHA.109.548586
   Liebeskind DS, 2016, NUTR NEUROSCI, V19, P406, DOI 10.1179/1476830515Y.0000000035
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Lopez-Garcia E, 2009, CIRCULATION, V119, P1116, DOI 10.1161/CIRCULATIONAHA.108.826164
   Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635
   Natella F, 2007, AM J CLIN NUTR, V86, P604, DOI 10.1093/ajcn/86.3.604
   Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d
   O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3
   PINCOMB GA, 1985, AM J CARDIOL, V56, P119, DOI 10.1016/0002-9149(85)90578-8
   Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Shaikh QN, 2014, J PAK MED ASSOC, V64, P1094
   Statistics Korea, 2013, CAUS DEATH STAT
   Sugiyama K, 2010, J NUTR, V140, P1007, DOI 10.3945/jn.109.109314
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
   World Health Organization, 2000, Obesity: preventing and managing the global epidemic. Report of a WHO consultation, pi
NR 46
TC 18
Z9 20
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD JAN 31
PY 2017
VL 16
AR 7
DI 10.1186/s12937-017-0232-y
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EM8RW
UT WOS:000395579700001
PM 28143499
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Robinson, LE
   Savani, S
   Battram, DS
   McLaren, DH
   Sathasivam, P
   Graham, TE
AF Robinson, LE
   Savani, S
   Battram, DS
   McLaren, DH
   Sathasivam, P
   Graham, TE
TI Caffeine ingestion before an oral glucose tolerance test impairs blood
   glucose management in men with type 2 diabetes
SO JOURNAL OF NUTRITION
LA English
DT Article; Proceedings Paper
CT 63rd Annual Meeting of the American-Diabetes-Association
CY JUN 13-17, 2003
CL NEW ORLEANS, LA
SP Amer Diabet Assoc
DE caffeine; carbohydrate; insulin resistance; hyperinsulinemia; insulin
   sensitivity index
ID COFFEE CONSUMPTION; INSULIN SENSITIVITY; LIFE-STYLE; RISK; MELLITUS;
   RESISTANCE
AB Caffeine ingestion negatively affects insulin sensitivity during an oral glucose tolerance test (OGTT) in lean and obese men, but this has not been studied in individuals with type 2 diabetes. We examined the effects of caffeine ingestion on insulin and glucose homeostasis in obese men with type 2 diabetes. Men (n = 12) with type 2 diabetes (age = 49 +/- 2 y, BMI = 32 +/- 1 kg/m(2)) underwent 2 trials, 1 wk apart, in a randomized, double-blind design. Each trial was conducted after withdrawal from caffeine, alcohol, exercise, and oral hypoglycemic agents for 48 h and an overnight fast. Subjects randomly ingested caffeine (5 mg/kg body weight) or placebo capsules and 1 h later began a 3 h 75 g OGTT. Caffeine increased (P < 0.05) serum insulin, proinsulin, and C-peptide concentrations during the OGTT relative to placebo. Insulin area under the curve was 25% greater (P < 0.05) after caffeine than after placebo ingestion. Despite this, blood glucose concentration was also increased (P < 0.01) in the caffeine trial. After caffeine ingestion, blood glucose remained elevated (P < 0.01) at 3 h postglucose load (8.9 +/- 0.7 mmol/L) compared with baseline (6.7 +/- 0.4 mmol/L). The insulin sensitivity index was lower (14%, P = 0.02) after caffeine than after placebo ingestion. Overall, despite elevated and prolonged proinsulin, C-peptide, and insulin responses after caffeine ingestion, blood glucose was also increased, suggesting an acute caffeine-induced impairment in blood glucose management in men with type 2 diabetes.
C1 Univ Guelph, Dept Human Biol & Nutrit Sci, Guelph, ON N1G 2W1, Canada.
C3 University of Guelph
RP Univ Guelph, Dept Human Biol & Nutrit Sci, Guelph, ON N1G 2W1, Canada.
EM Lrobinso@uoguelph.ca
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245
   Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1
   ARNAUD NJ, 1993, CAFFEINE COFFEE HLTH, P43
   Azam Sonish, 2003, Med Sci Monit, V9, pBR325
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   BATTRAM D, 2000, 43 ANN M CAN FED BIO
   Bruton JD, 2002, FASEB J, V16, P301, DOI 10.1096/fj.02-0481fje
   Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185
   de Galan BE, 2002, DIABETES, V51, P790, DOI 10.2337/diabetes.51.3.790
   Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1
   Fritsche A, 2002, DIABETES, V51, pS234, DOI 10.2337/diabetes.51.2007.S234
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Haffner SM, 2003, AM J CARDIOL, V92, p18J, DOI 10.1016/S0002-9149(03)00612-X
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   LOWRY OH, 1993, ENZYMATIC ANAL PRACT, P171
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Panagiotakos DB, 2003, J NUTR, V133, P3228, DOI 10.1093/jn/133.10.3228
   Petrie HJ, 2004, AM J CLIN NUTR, V80, P22
   Pi-Sunyer FX, 1998, OBES RES, V6, p51S
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Saremi A, 2003, DIABETES CARE, V26, P2211, DOI 10.2337/diacare.26.7.2211
   Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529
   Spiller M.A., 1998, Caffeine, P97
   Thong FSL, 2002, J APPL PHYSIOL, V92, P2347, DOI 10.1152/japplphysiol.01229.2001
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
NR 37
TC 76
Z9 89
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD OCT
PY 2004
VL 134
IS 10
BP 2528
EP 2533
DI 10.1093/jn/134.10.2528
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics
GA 859SN
UT WOS:000224288300006
PM 15465742
OA Bronze
DA 2025-04-28
ER

PT J
AU Lee, J
   Kim, HY
   Kim, J
AF Lee, Jeonghee
   Kim, Hye Young
   Kim, Jeongseon
TI Coffee Consumption and the Risk of Obesity in Korean Women
SO NUTRIENTS
LA English
DT Article
DE coffee; obesity; body mass index; waist circumference
ID METABOLIC SYNDROME; TEA CONSUMPTION; GREEN TEA; CAFFEINE; HEALTH; MEN;
   ASSOCIATION; COMPONENTS; NUTRITION; DISEASE
AB Instant coffee mixes that contain sugar and non-dairy creamer account for 80-90% of the total coffee market in Korea. The objective of this study was to investigate the relationship between coffee consumption and obesity in Korean women. We included 5995 women who participated in a health screening examination at the Korean National Cancer Center between 2007 and 2016. Daily coffee consumption and the use of sugar and creamer in coffee was evaluated using a 106-item food frequency questionnaire. Obesity was assessed by body mass index (BMI), and abdominal obesity was assessed by waist circumference (WC). A multiple logistic regression model was used to calculate the odds ratio (OR) of obesity according to coffee consumption. After multivariate adjustment, high coffee consumption was positively associated with obesity as measured by BMI (3 cups vs. no drinks, OR = 2.52; 95% confidence interval (CI) = 1.91-3.34; p for the trend < 0.001) and abdominal obesity as measured by WC (3 cups vs. no drinks, OR = 2.11; 95% CI = 1.59-2.79; p for the trend < 0.001). The positive association between daily coffee consumption and obesity prevalence was not altered by menopause. The amount of coffee with additives consumed per day by Korean women was positively correlated with the prevalence of obesity, but causation cannot be determined due to the cross-sectional nature of the study design. The mechanism underlying the observed relationship is yet to be elucidated.
C1 [Lee, Jeonghee; Kim, Hye Young; Kim, Jeongseon] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, Goyang Si 10408, South Korea.
   [Kim, Hye Young] Yongin Univ, Dept Foods & Nutr, Yongin 17092, South Korea.
C3 National Cancer Center - Korea (NCC); Yongin University
RP Kim, J (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, Goyang Si 10408, South Korea.
EM jeonghee@ncc.re.kr; hypkim@yongin.ac.kr; jskim@ncc.re.kr
RI KIM, JEONGSEON/AAA-4643-2022
OI Kim, Hye-Young/0000-0001-8670-8541; KIM, JEONGSEON/0000-0002-0889-2686
FU National Cancer Center, Korea [1510040]
FX This work was supported by the National Cancer Center, Korea, No.
   1510040.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   [Anonymous], 2003, CONTR GLOB OB EP
   Arciero PJ, 2000, METABOLISM, V49, P101, DOI 10.1016/S0026-0495(00)90888-6
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Bidel Siamak, 2013, Eur Endocrinol, V9, P99, DOI 10.17925/EE.2013.09.02.99
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hruby A, 2016, AM J PUBLIC HEALTH, V106, P1656, DOI 10.2105/AJPH.2016.303326
   Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11
   Jee SH, 2005, AM J EPIDEMIOL, V162, P42, DOI 10.1093/aje/kwi166
   김경윤, 2017, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V46, P630
   Kang S., 2004, KOREAN J CLIN RES, V10, P65
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   이봄이, 2012, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V41, P362
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Ministry of Health and Welfare, 2016, KOR HLTH STAT 2015 K
   Nguyen D. M., 2010, CLIN N AM, V39, P1, DOI [10.1016/j.gtc.2009.12.01420202574, DOI 10.1016/J.GTC.2009.12.01420202574]
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   USDA Agricultural Service Coffee Market Brief Update-Seoul ATO, 2015, GLOB AGR INF NETW RE
   van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
   World Health Organization (WHO), 2018, Global Health Observatory database
   World Health Organization-Regional Office for the Western Pacific, 2000, The Asia-Pacific perspective: redefining obesity and its treatment
   Zheng GD, 2004, IN VIVO, V18, P55
NR 41
TC 43
Z9 44
U1 2
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD DEC
PY 2017
VL 9
IS 12
AR 1340
DI 10.3390/nu9121340
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FR6PQ
UT WOS:000419188600065
PM 29292767
OA Green Submitted, Green Published, gold
DA 2025-04-28
ER

PT J
AU Gorjanovic, S
   Micic, D
   Pastor, F
   Tosti, T
   Kalusevic, A
   Ristic, S
   Zlatanovic, S
AF Gorjanovic, Stanislava
   Micic, Darko
   Pastor, Ferenc
   Tosti, Tomislav
   Kalusevic, Ana
   Ristic, Slavica
   Zlatanovic, Snezana
TI Evaluation of Apple Pomace Flour Obtained Industrially by Dehydration as
   a Source of Biomolecules with Antioxidant, Antidiabetic and Antiobesity
   Effects
SO ANTIOXIDANTS
LA English
DT Article
DE apple pomace; antioxidant activity; dehydration; dietary fibres;
   diabetes; gluten-free flour; flavonoids; obesity; phlorizin; potassium
ID DIETARY FIBER; PHENOLIC-COMPOUNDS; DEGRADATION; PHLORHIZIN; POLYPHENOLS;
   PREVENTION; QUERCETIN; PROFILES; CAPACITY; OBESITY
AB Apple pomace flour (APF) obtained at industrial scale level by the application of innovative technological process (dehydration (5 h, T <= 55 degrees C), grinding (300 mu m)) was evaluated as a source of bioactive compounds with antioxidative, antiobesity and antidiabetic effects. Proximate composition, individual (HPLC-DAD-MS/MS) and total phenols (TPC) as well as flavonoids content (TFC), antioxidant (AO) activity (DPPH, ABTS, HPMC), water and oil holding capacity (WHC and OHC) of APFs obtained from apple pomace from mixed and individual apple cultivars grown conventionally and organically were compared. The effect of APF supplementation on the glycaemic status and glucose tolerance (oral glucose tolerance test (OGTT)) of C57BL/6J mice exposed to high-fat and sucrose diet was examined. High K content (4.2-6.4 g/kg), dietary fibres (35-45 g/100 g), TPC (4.6-8.1 mg GAE/g), TFC (18.6-34.6 mg QE/g), high water and oil holding capacity (4.7-6.4 and 1.3-1.6 g/g) were observed in the APFs. Content of major phenols (phlorizin, chlorogenic acid, quercetin), TPC and TFC correlated highly with prominent AO activity. APF supplementation lowered the increase of body weight gain and blood glucose, and improved glucose tolerance significantly. Health-promoting biomolecules, AO activity, functional properties and prevention of diet-driven glucose metabolism disorders pave the way to APF exploitation in human nutrition.
C1 [Gorjanovic, Stanislava; Micic, Darko; Zlatanovic, Snezana] Inst Gen & Phys Chem, POB 45, Belgrade 11158 118, Serbia.
   [Pastor, Ferenc; Tosti, Tomislav] Univ Belgrade, Fac Chem, Studentski Trg 12-16, Belgrade 11080, Serbia.
   [Kalusevic, Ana] Inst Meat Hyg & Technol, Kacanskog 13, Belgrade 11000, Serbia.
   [Ristic, Slavica] Univ Belgrade, Fac Med, Dr Subotica 8, Belgrade 11000, Serbia.
C3 University of Belgrade; University of Belgrade; University of Belgrade
RP Gorjanovic, S; Zlatanovic, S (corresponding author), Inst Gen & Phys Chem, POB 45, Belgrade 11158 118, Serbia.
EM stasago@yahoo.co.uk; dmicic@iofh.bg.ac.rs; fpastor@chem.bg.ac.rs;
   tosti@chem.bg.ac.rs; anakalusevic@gmail.com; slavicaristic8@gmail.com;
   snezana.zlatanovic@gmail.com
RI Micić, Darko/IAR-8850-2023; Gorjanovic, Stanislava/AAJ-8939-2020;
   Pastor, Ferenc/P-7079-2016; Tosti, Tomislav/R-4165-2017; Zlatanovic,
   Snezana/HMP-0261-2023
OI Pastor, Ferenc/0000-0003-0813-9085; Tosti, Tomislav/0000-0002-1403-4688;
   Ristic, Slavica/0000-0002-6983-4412; Gorjanovic,
   Stanislava/0000-0003-3676-5892; Zlatanovic, Snezana/0000-0002-8450-602X
FU Ministry of Education and Science of Republic of Serbia
   [451-03-68/2020-14/200051]
FX This work was supported by the Ministry of Education and Science of
   Republic of Serbia (451-03-68/2020-14/200051).
CR Alam MA, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0080-3
   Alkhalidy H, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040438
   Alongi M, 2019, LWT-FOOD SCI TECHNOL, V100, P300, DOI 10.1016/j.lwt.2018.10.068
   [Anonymous], 2020, USDA Budget Explanatory Notes for Committee on Appropriations-Food and Nutrition Service
   [Anonymous], HOME
   AOAC, 1990, 98529 AOAC INT
   Aprikian O, 2003, J NUTR, V133, P1860, DOI 10.1093/jn/133.6.1860
   Boqué N, 2013, MOL NUTR FOOD RES, V57, P1473, DOI 10.1002/mnfr.201200686
   Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5
   Cai XL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040183
   Cetkovic G, 2008, FOOD CHEM, V109, P340, DOI 10.1016/j.foodchem.2007.12.046
   Chatterjee R, 2011, EXPERT REV ENDOCRINO, V6, P665, DOI 10.1586/EEM.11.60
   Cho KD, 2013, J MED FOOD, V16, P823, DOI [10.1089/jmf.2013.2784, 10.1095/jmf.2013.2784]
   Corey ME, 2011, LWT-FOOD SCI TECHNOL, V44, P67, DOI 10.1016/j.lwt.2010.07.005
   García YD, 2009, FOOD CHEM, V117, P731, DOI 10.1016/j.foodchem.2009.04.049
   Heras-Ramírez ME, 2012, FOOD BIOPROCESS TECH, V5, P2201, DOI 10.1007/s11947-011-0583-x
   Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550
   Gonzalez J, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/918384
   Hager AS, 2012, J CEREAL SCI, V56, P239, DOI 10.1016/j.jcs.2012.06.005
   Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2
   Jung J, 2015, J FOOD SCI TECH MYS, V52, P5568, DOI 10.1007/s13197-014-1680-4
   Kaneda H., 1995, Technical Quarterly, Master Brewers' Association of the Americas, V32, P90
   Lavelli V, 2011, FOOD CHEM, V129, P1578, DOI 10.1016/j.foodchem.2011.06.011
   Lavelli V, 2012, J AGR FOOD CHEM, V60, P5660, DOI 10.1021/jf3010993
   Lavelli V, 2009, J AGR FOOD CHEM, V57, P4733, DOI 10.1021/jf900176v
   Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w
   Liu G, 2019, FOOD FUNCT, V10, P951, DOI 10.1039/c8fo01083h
   Macagnan F. T., 2015, Bioactive Carbohydrates and Dietary Fibre, V6, P1, DOI 10.1016/j.bcdf.2015.04.001
   Masoodi FA, 2002, PLANT FOOD HUM NUTR, V57, P121, DOI 10.1023/A:1015264032164
   Najafian M, 2012, MOL BIOL REP, V39, P5299, DOI 10.1007/s11033-011-1328-7
   Niederberger KE, 2020, BRIT J NUTR, V123, P942, DOI 10.1017/S0007114520000033
   Nishimuro H, 2015, NUTRIENTS, V7, P2345, DOI 10.3390/nu7042345
   Petrovic M, 2016, COMB CHEM HIGH T SCR, V19, P58, DOI 10.2174/1386207318666151102094227
   Plaza M, 2014, J AGR FOOD CHEM, V62, P409, DOI 10.1021/jf404263k
   Rana S., 2015, Food Science and Human Wellness, V4, P180, DOI [DOI 10.1016/J.FSHW.2015.10.001, 10.1016/j.fshw.2015.10.001]
   Rana S, 2016, J FOOD SCI TECH MYS, V53, P1727, DOI 10.1007/s13197-015-2093-8
   Ratti C, 2001, J FOOD ENG, V49, P311, DOI 10.1016/S0260-8774(00)00228-4
   Raudone L, 2016, J FOOD SCI, V81, pC1055, DOI 10.1111/1750-3841.13277
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Saura-Calixto F, 2011, J AGR FOOD CHEM, V59, P43, DOI 10.1021/jf1036596
   Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005
   Sharma PC, 2017, J FOOD PROCESS PRES, V41, DOI 10.1111/jfpp.12913
   Shin SK, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020092
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Skinner RC, 2019, J FUNCT FOODS, V61, DOI 10.1016/j.jff.2019.103471
   Skinner RC, 2018, NUTR REV, V76, P893, DOI 10.1093/nutrit/nuy033
   Sudha ML, 2007, FOOD CHEM, V104, P686, DOI 10.1016/j.foodchem.2006.12.016
   Taylor R, 2019, CLIN MED, V19, P37, DOI 10.7861/clinmedicine.19-1-37
   Tseng A, 2012, J FOOD SCI, V77, pH192, DOI 10.1111/j.1750-3841.2012.02840.x
   Veselinovi N., 2010, Solar and electric energy dryers, Patent No. [US2010223807 (A1), 2010223807]
   Waldbauer K, 2017, PLANTA MED, V83, P994, DOI 10.1055/s-0043-111898
   Weickert MO, 2018, J NUTR, V148, P7, DOI 10.1093/jn/nxx008
   Wu LY, 2014, J AGR FOOD CHEM, V62, P12265, DOI 10.1021/jf504659n
   Xu Y, 2016, SAUDI J BIOL SCI, V23, P379, DOI 10.1016/j.sjbs.2015.04.002
   Yao ZX, 2019, EUR J NUTR, V58, P819, DOI 10.1007/s00394-018-1713-2
   Yu H, 2015, J FOOD SCI TECH MYS, V52, P1032, DOI 10.1007/s13197-013-1127-3
   Zhang TJ, 2016, CHEM CENT J, V10, DOI 10.1186/s13065-016-0195-7
   Zlatanovic S., 2020, Method for Producing Gluten-Free Flour Made of Apple Pomace, Patent No. [2020027683, WO2020/027683]
   Zlatanovic S, 2019, FOODS, V8, DOI 10.3390/foods8110561
   Zlatanovic S, 2019, THERMOCHIM ACTA, V673, P17, DOI 10.1016/j.tca.2019.01.009
NR 61
TC 48
Z9 51
U1 1
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD MAY
PY 2020
VL 9
IS 5
AR 413
DI 10.3390/antiox9050413
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA LW6WJ
UT WOS:000539284200056
PM 32408574
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Caria, CREP
   de Oliveira, CC
   Gotardo, ÉFM
   de Souza, VT
   Rocha, T
   Macedo, JA
   Carvalho, PD
   Ribeiro, ML
   Gambero, A
AF Caria, Cintia Rabelo e Paiva
   de Oliveira, Caroline Candida
   Martins Gotardo, Erica Ferreira
   de Souza, Veronica Tricoli
   Rocha, Thalita
   Macedo, Juliana Alves
   Carvalho, Patricia de Oliveira
   Ribeiro, Marcelo Lima
   Gambero, Alessandra
TI Caffeinated and decaffeinated instant coffee consumption partially
   reverses high-fat diet-induced metabolic alterations in mice
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article
DE Obesity; Adiponectin; Leptin; Adipose tissue; TNF-alpha; Fatty acids
ID GENE-EXPRESSION; CHEMICAL-CHARACTERIZATION; INSULIN-RESISTANCE; SERUM
   ADIPONECTIN; TEA CONSUMPTION; HABITUAL COFFEE; LIVER-ENZYMES;
   ASSOCIATION; RISK; RECEPTOR
AB Epidemiological data has associated coffee consumption with a lower prevalence of type 2 diabetes, metabolic syndrome and chronic liver disease. However, the mechanisms and coffee substances responsible for these effects remain unclear. In the present study, mice received caffeinated or decaffeinated instant coffee ad libitum during a two week period after inducing obesity by introducing a high-fat diet over a 10 week period. Body weight, glucose homeostasis, and liver and visceral adipose tissue inflammation were assessed. In addition, AKT signaling, the fatty acid profile and liver histopathological analyses were performed. Ingestion of caffeinated or decaffeinated coffee for 2 weeks resulted in reductions in glucose and insulin blood levels, and insulin tolerance was improved without reductions in final body weight or adiposity. Only caffeinated coffee modified the adipokine profile in visceral adipose tissue, resulting in a restoration of adiponectin levels. However, deleterious liver alterations, which manifested as reductions in steatosis, inhibition of iNOS expression and restoration of insulin inducing-AKT phosphorylation, were reversed by the ingestion of both caffeinated and decaffeinated coffee. Serum AST and ALT levels were also improved in mice after coffee ingestion, while the fatty add profile in the liver and the cytokine profiles in adipose and liver tissues were not altered by coffee ingestion. Thus, instant coffee consumption reverses obesity-induced alterations in mice, and our results corroborate those of epidemiological studies that associated coffee consumption with a lower prevalence of obesity-related pathologies. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Caria, Cintia Rabelo e Paiva; de Oliveira, Caroline Candida; Martins Gotardo, Erica Ferreira; de Souza, Veronica Tricoli; Rocha, Thalita; Macedo, Juliana Alves; Carvalho, Patricia de Oliveira; Ribeiro, Marcelo Lima; Gambero, Alessandra] Univ Sao Francisco, Sch Med, Clin Pharmacol & Gastroenterol Unit, BR-12916900 Braganca Paulista, SP, Brazil.
C3 Universidade Sao Francisco
RP Gambero, A (corresponding author), Univ Sao Francisco, Sch Med, Clin Pharmacol & Gastroenterol Unit, Ave Sao Francisco de Assis 218, BR-12916900 Braganca Paulista, SP, Brazil.
EM alessandra.gambero@usf.edu.br
RI Gambero, Alessandra/G-5792-2013; Ribeiro, Marcelo/H-8856-2013; Caria,
   Cíntia/A-7578-2018; Rocha, Thalita/T-6408-2019; de Oliveira Carvalho,
   Patricia/B-8579-2012; Rocha, Thalita/I-4729-2014; Macedo,
   Juliana/H-1961-2012
OI Rocha, Thalita/0000-0002-2731-9586; Gambero,
   Alessandra/0000-0002-4862-4328; Carvalho, Patricia
   de/0000-0002-2681-7022; /0000-0003-4529-7832; Macedo,
   Juliana/0000-0001-7504-8111
CR AOCS, 1993, Official Methods and Recommended Practices
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   BONORA E, 1987, DIABETES METAB, V13, P116
   Caridi D, 2007, FOOD CHEM, V105, P691, DOI 10.1016/j.foodchem.2006.12.063
   Carrieri MP, 2014, J HEPATOL, V60, P46, DOI 10.1016/j.jhep.2013.08.014
   Chatterjee S, 2013, J HEPATOL, V58, P778, DOI 10.1016/j.jhep.2012.11.035
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Danielsson J, 2013, ALCOHOL ALCOHOLISM, V48, P303, DOI 10.1093/alcalc/agt017
   DeOliveira CC, 2012, MOL CELL ENDOCRINOL, V361, P92, DOI 10.1016/j.mce.2012.03.016
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ikeda M, 2010, SCAND J CLIN LAB INV, V70, P171, DOI 10.3109/00365511003650165
   Kersten S, 2002, P NUTR SOC, V61, P371, DOI 10.1079/PNS2002169
   Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x
   Liao CC, 2013, J AGR FOOD CHEM, V61, P11082, DOI 10.1021/jf4026647
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Matsuzaka T, 2002, J LIPID RES, V43, P107
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Murakami K, 2013, NUTRITION, V29, P1315, DOI 10.1016/j.nut.2013.04.012
   Mure K, 2013, NUTRITION, V29, P982, DOI 10.1016/j.nut.2013.01.011
   Nakamura MT, 2000, J NUTR, V130, P1561, DOI 10.1093/jn/130.6.1561
   Nunes FM, 2007, J AGR FOOD CHEM, V55, P3967, DOI 10.1021/jf063735h
   Nunes FM, 2001, J AGR FOOD CHEM, V49, P1773, DOI 10.1021/jf0012953
   Ostrowska Lucyna, 2013, Rocz Panstw Zakl Hig, V64, P61
   Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414
   Ramirez-Coronel MAN, 2004, J AGR FOOD CHEM, V52, P1344, DOI 10.1021/jf035208t
   Shearer J, 2007, CAN J PHYSIOL PHARM, V85, P823, DOI 10.1139/Y07-070
   Shin JW, 2010, J SCI FOOD AGR, V90, P450, DOI 10.1002/jsfa.3838
   Sinha RA, 2013, HEPATOLOGY
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
NR 38
TC 2
Z9 2
U1 1
U2 30
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0963-9969
EI 1873-7145
J9 FOOD RES INT
JI Food Res. Int.
PD JUL
PY 2014
VL 61
SI SI
BP 120
EP 126
DI 10.1016/j.foodres.2014.02.025
PG 7
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA AK4IX
UT WOS:000338389500015
DA 2025-04-28
ER

PT J
AU Machado, LMM
   da Costa, THM
   da Silva, EF
   Dórea, JG
AF Machado, Liliane M. M.
   da Costa, Teresa H. M.
   da Silva, Eduardo F.
   Dorea, Jose G.
TI Association of Moderate Coffee Intake with Self-Reported Diabetes among
   Urban Brazilians
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE coffee intake; diabetes mellitus; chlorogenic acids; caffeine; body mass
   index
ID IMPAIRED GLUCOSE-TOLERANCE; CONSUMPTION; RISK; VALIDITY; WEIGHT; ADULTS;
   TEA
AB Coffee has been associated with reductions in the risk of non-communicable chronic diseases (NCCD), including diabetes mellitus. Because differences in food habits are recognizable modifying factors in the epidemiology of diabetes, we studied the association of coffee consumption with type-2 diabetes in a sample of the adult population of the Federal District, Brazil. This cross-sectional study was conducted by telephone interview (n = 1,440). A multivariate analysis was run controlling for socio-behavioural variables, obesity and family antecedents of NCCD. A hierarchical linear regression model and a Poisson regression were used to verify association of type-2 diabetes and coffee intake. The independent variables which remained in the final model, following the hierarchical inclusion levels, were: first level-age and marital status; second level-diabetes and dyslipidaemias in antecedents; third level-cigarette smoking, supplement intake, body mass index; and fourth level-coffee intake (<= 100 mL/d, 101 to 400 mL/day, and >400 mL/day). After adjusting hierarchically for the confounding variables, consumers of 100 to 400 mL of coffee/day had a 2.7% higher (p = 0.04) prevalence of not having diabetes than those who drank less than 100 mL of coffee/day. Compared to coffee intake of <= 100 mL/day, adults consuming >400 mL of coffee/day showed no statistically significant difference in the prevalence of diabetes. Thus, moderate coffee intake is favourably associated with self-reported type-2 diabetes in the studied population. This is the first study to show a relationship between coffee drinking and diabetes in a Brazilian population.
C1 [Machado, Liliane M. M.; da Costa, Teresa H. M.; Dorea, Jose G.] Univ Brasilia, Fac Ciencias Saude, Nucleo Nutr, Lab Bioquim Nutr, BR-70910900 Brasilia, DF, Brazil.
   [da Silva, Eduardo F.] Univ Brasilia, Dept Estat, Inst Ciencias Exatas, BR-70910900 Brasilia, DF, Brazil.
C3 Universidade de Brasilia; Universidade de Brasilia
RP da Costa, THM (corresponding author), Univ Brasilia, Fac Ciencias Saude, Nucleo Nutr, Lab Bioquim Nutr, Campus Univ Darcy Ribeiro Asa Norte, BR-70910900 Brasilia, DF, Brazil.
EM liliane.machado25@gmail.com; thmdacosta@gmail.com; edufrei@unb.br;
   dorea@rudah.com.br
RI da Costa, Teresa/H-8434-2013
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior-Coordination for Improved Capacity of Post-Graduate Level
   Staff); CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-National Council for Scientific and Technological
   Development) [402834/2005-4]
FX Doctoral scholarship granted by: CAPES (Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior-Coordination for Improved Capacity of
   Post-Graduate Level Staff). This work was supported by CNPq (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico-National Council
   for Scientific and Technological Development/No. 402834/2005-4, approved
   in edictal No. 51/2005).
CR Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   American Heart Association (AHA), 2010, DRINK SUG SWEET BEV
   [Anonymous], 2005, Behavioral Risk Factor Surveillance System
   [Anonymous], 2005, Preventing chronic diseases: a vital investment
   [Anonymous], 2000, Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI [10.1001/jama.291.10.1199-b, 10.1001/jama.291.10.1199-a]
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Bidel S, 2008, COFFEE RISK TYPE 2 D
   Czerny M, 1999, J AGR FOOD CHEM, V47, P695, DOI 10.1021/jf980759i
   de Moraes SA, 2010, CAD SAUDE PUBLICA, V26, P929, DOI 10.1590/S0102-311X2010000500015
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   Dórea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   Farah A, 2006, J AGR FOOD CHEM, V54, P374, DOI 10.1021/jf0518305
   Ferruzzi MG, 2010, PHYSIOL BEHAV, V100, P33, DOI 10.1016/j.physbeh.2010.01.035
   Færch K, 2005, J NUTR, V135, P1177, DOI 10.1093/jn/135.5.1177
   Peixoto MDG, 2006, REV SAUDE PUBL, V40, P1065, DOI 10.1590/S0034-89102006000700015
   Isogawa A, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12586-X
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Louie JCY, 2008, ASIA PAC J CLIN NUTR, V17, P657
   Moisey LL, 2008, AM J CLIN NUTR, V87, P1254, DOI 10.1093/ajcn/87.5.1254
   Mougios V, 2003, J APPL PHYSIOL, V94, P476, DOI 10.1152/japplphysiol.00624.2002
   Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3
   Nettleton JA, 2008, DIABETES CARE, V31, P1777, DOI 10.2337/dc08-0760
   Nicoli MC, 1997, FOOD SCI TECHNOL-LEB, V30, P292, DOI 10.1006/fstl.1996.0181
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Panagiotakos Demosthenes B, 2007, Rev Diabet Stud, V4, P105, DOI 10.1900/RDS.2007.4.105
   Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311
   Petrocelli JV, 2003, MEAS EVAL COUNS DEV, V36, P9, DOI 10.1080/07481756.2003.12069076
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   SALVAGGIO A, 1991, AM J EPIDEMIOL, V134, P149, DOI 10.1093/oxfordjournals.aje.a116067
   Sartorelli DS, 2010, AM J CLIN NUTR, V91, P1002, DOI 10.3945/ajcn.2009.28741
   SCHMIDT MI, 1993, REV SAUDE PUBL, V27, P271, DOI 10.1590/S0034-89101993000400007
   Sistema IBGE de recuperacao automatica (SIDRA), 2000, BANC DAD AGR DAD CEN
   Soriguer F, 2004, ANN INTERN MED, V141, P321, DOI 10.7326/0003-4819-141-4-200408170-00017
   Trugo L C., 2003, Encyclopedia of Food Sciences and Nutrition, V3, P1498
   Van Dam R.M., 2003, ANN NUTR METAB, V47, P319
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   VelasquezMelendez G, 1997, REV SAUDE PUBL, V31, P157, DOI 10.1590/S0034-89101997000200009
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
NR 44
TC 6
Z9 7
U1 0
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD AUG
PY 2011
VL 8
IS 8
BP 3216
EP 3231
DI 10.3390/ijerph8083216
PG 16
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA 811WP
UT WOS:000294248600011
PM 21909302
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Campos-Vega, R
   Arreguín-Campos, A
   Cruz-Medrano, MA
   Bilbao, MDD
AF Campos-Vega, Rocio
   Arreguin-Campos, Andrea
   Cruz-Medrano, Miguel A.
   del Castillo Bilbao, Maria Dolores
TI Spent coffee (Coffea arabica L.) grounds promote satiety and
   attenuate energy intake: A pilot study
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article
DE antioxidant dietary fiber; caloric intake; overweight; satiety; spent
   coffee grounds
ID DIETARY FIBER; HUMAN COLON; PHENOLIC-COMPOUNDS; BLOOD-GLUCOSE; HEALTH;
   CARBOHYDRATE; ANTIOXIDANT; OBESITY; PREVALENCE; PROPIONATE
AB We evaluated the effects of acute intake of biscuits (B) containing either spent coffee grounds (SCG), (added with fructooligosaccharides; SC-FOS) or SCG antioxidant dietary fiber (SCF), on satiety, energy intake as well as gastrointestinal tolerance of healthy overweight volunteers. The addition of SCG and SCF to the biscuits (SC-FOS-B and SCF-B) increased their protein (11.4% and 12.2%), and total dietary fiber (8.4% and 11.8%) contents. The SCF-B significantly increased satiety perception, impacting ad libitum energy intake compared to the traditional biscuits recipe (TB; no added fiber). Moreover, SC-FOS-B and SCF-B decreased (no-observed-adverse effect) the most frequently reported symptoms by the participants, demonstrating that doses up to 5 g of SCF (per biscuit portion; 45 g) are well tolerated. The use of SCF and SCG as functional ingredients represents a sustainable strategy for the coffee industry and also potentiates the reduction of overweight, one of the leading health problems among the population.
   Practical applications The addition of SCF or SCG as food ingredients increases protein and the dietary fiber content of traditional biscuits. SCF can slow gastric emptying, modulate appetite and thus body weight. SCF attenuates carbohydrate digestion blunting post-prandial blood glucose spikes reducing the risk of type 2 diabetes. SCF can be used as a functional ingredient to formulate foods with health benefits.
C1 [Campos-Vega, Rocio] Univ Autonoma Queretaro, Programa Posgrad Alimentos Ctr Republ PROPAC, Res & Grad Studies Food Sci, Sch Chem, Santiago De Queretaro 76010, Qro, Mexico.
   [Arreguin-Campos, Andrea; Cruz-Medrano, Miguel A.] Univ Autonoma Queretaro, Fac Med, Queretaro, Mexico.
   [del Castillo Bilbao, Maria Dolores] Univ Autonoma Madrid, CSIC, CIAL, Inst Food Sci Res, Madrid, Spain.
C3 Universidad Autonoma de Queretaro; Universidad Autonoma de Queretaro;
   Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM -
   Instituto de Investigacion en Ciencias de la Alimentacion (CIAL);
   Autonomous University of Madrid
RP Campos-Vega, R (corresponding author), Univ Autonoma Queretaro, Programa Posgrad Alimentos Ctr Republ PROPAC, Res & Grad Studies Food Sci, Sch Chem, Santiago De Queretaro 76010, Qro, Mexico.
EM chio_cve@yahoo.com.mx
RI Campos-Vega, Rocio/JZC-8641-2024; del Castillo, MD/J-6283-2012;
   Campos-Vega, Rocio/L-3151-2016
OI del Castillo, MD/0000-0001-6309-5383; Campos-Vega,
   Rocio/0000-0003-4054-1250
FU Consejo Nacional de Ciencia y Tecnologia [279751]
FX Consejo Nacional de Ciencia y Tecnologia, Grant/Award Number: 279751
CR ACEVEDO HL, 2015, ENDOSCOPIA, V27, P150
   AHN CH, 2019, DIABETES METAB, V43, P1
   Akhavan T, 2010, AM J CLIN NUTR, V91, P966, DOI 10.3945/ajcn.2009.28406
   [Anonymous], 2012, Encuesta Nacional de Salud y Nutricion 2012. Estado de nutricion, anemia
   Association of Official Analytical Chemists, 2002, OFFICIAL METHODS ANA, P1652
   Barquera S, 2013, SALUD PUBLICA MEXICO, V55, pS151, DOI 10.21149/spm.v55s2.5111
   Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200
   Bernal-Reyes R, 2013, REV GASTROENTEROL ME, V78, P28, DOI 10.1016/j.rgmx.2012.10.006
   Brownlee IA, 2017, FOOD HYDROCOLLOID, V68, P186, DOI 10.1016/j.foodhyd.2016.08.029
   Campos-Vega R, 2015, FOOD RES INT, V77, P156, DOI 10.1016/j.foodres.2015.07.024
   Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913
   Cloetens L, 2010, BRIT J NUTR, V103, P703, DOI 10.1017/S0007114509992248
   *COD AL C, 1997, 231997 CACGL
   Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6
   DiBonaventura MD, 2018, DIABETES METAB SYNDR, V11, P1, DOI 10.2147/DMSO.S129247
   Emerson SR, 2016, BRIT J NUTR, V116, P1553, DOI 10.1017/S0007114516003585
   Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w
   Fuller S, 2016, PLANT FOOD HUM NUTR, V71, P1, DOI 10.1007/s11130-016-0529-6
   García-Gutiérrez N, 2017, J FUNCT FOODS, V30, P237, DOI 10.1016/j.jff.2017.01.014
   Gentilcore D, 2006, J CLIN ENDOCR METAB, V91, P2062, DOI 10.1210/jc.2005-2644
   Hannan JMA, 2007, BRIT J NUTR, V97, P514, DOI 10.1017/S0007114507657869
   Ikuomola DS, 2017, COGENT FOOD AGR, V3, DOI 10.1080/23311932.2017.1293471
   JENKINS DJA, 1978, BRIT MED J, V1, P1392, DOI 10.1136/bmj.1.6124.1392
   Jiménez-Cruz A, 2006, NUTR HOSP, V21, P353
   Kolotkin RL, 2017, CLIN OBES, V7, P273, DOI 10.1111/cob.12203
   Lambeau KV, 2017, J AM ASSOC NURSE PRA, V29, P216, DOI 10.1002/2327-6924.12447
   Lilly LN, 2019, J AM COLL NUTR, V38, P351, DOI 10.1080/07315724.2018.1519404
   Hernández-Arriaga AM, 2017, FOOD RES INT, V97, P191, DOI 10.1016/j.foodres.2017.04.004
   López-Barrera DM, 2016, FOOD CHEM, V212, P282, DOI 10.1016/j.foodchem.2016.05.175
   Martinez-Saez N, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070694
   Martinez-Saez N, 2017, FOOD CHEM, V216, P114, DOI 10.1016/j.foodchem.2016.07.173
   Martini D, 2018, PHYSIOL BEHAV, V185, P61, DOI 10.1016/j.physbeh.2017.12.024
   Martini D, 2018, INT J FOOD SCI NUTR, V69, P389, DOI 10.1080/09637486.2017.1366433
   Mathern JR, 2009, PHYTOTHER RES, V23, P1543, DOI 10.1002/ptr.2795
   Nenadis N, 2004, J AGR FOOD CHEM, V52, P4669, DOI 10.1021/jf0400056
   Oseguera-Castro KY, 2019, FOOD FUNCT, V10, P4546, DOI [10.1039/C9FO01021A, 10.1039/c9fo01021a]
   Poutanen KS, 2017, AM J CLIN NUTR, V106, P747, DOI 10.3945/ajcn.117.157172
   Prados-Torres A, 2018, INT J EPIDEMIOL, V47, P382, DOI 10.1093/ije/dyx259
   Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153
   Quirós-Sauceda AE, 2014, FOOD FUNCT, V5, P1063, DOI 10.1039/c4fo00073k
   Redgwell RJ, 2002, CARBOHYD RES, V337, P421, DOI 10.1016/S0008-6215(02)00010-1
   Rice-Evans CA, 2000, FREE RADICAL RES, V33, pS59
   Rojas M, 2017, INT HANDB QUALITY, P217, DOI 10.1007/978-3-319-39101-4_8
   Samra R, 2007, AM J CLIN NUTR, V86, P972, DOI 10.1093/ajcn/86.4.972
   Seifarth C, 1998, DIABETIC MED, V15, P485, DOI 10.1002/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y
   Slavin JL, 2005, NUTRITION, V21, P411, DOI 10.1016/j.nut.2004.08.018
   Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9
   Vázquez Martínez C., 2005, Nutr. Hosp., V20, P420
   Vázquez-Sánchez K, 2018, FOOD CHEM, V261, P253, DOI 10.1016/j.foodchem.2018.04.064
   Wang TG, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0862-0
NR 50
TC 13
Z9 13
U1 1
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD JUN
PY 2020
VL 44
IS 6
AR e13204
DI 10.1111/jfbc.13204
EA MAR 2020
PG 11
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA LZ3MS
UT WOS:000520270500001
PM 32189354
OA gold
DA 2025-04-28
ER

PT J
AU García-Cordero, J
   Sierra-Cinos, JL
   Seguido, MA
   González-Rámila, S
   Mateos, R
   Bravo-Clemente, L
   Sarriá, B
AF Garcia-Cordero, Joaquin
   Sierra-Cinos, Jose Luis
   Seguido, Miguel A.
   Gonzalez-Ramila, Susana
   Mateos, Raquel
   Bravo-Clemente, Laura
   Sarria, Beatriz
TI Regular Consumption of Green Coffee Phenol, Oat β-Glucan and Green
   Coffee Phenol/Oat β-Glucan Supplements Does Not Change Body Composition
   in Subjects with Overweight and Obesity
SO FOODS
LA English
DT Article
DE green coffee; beta-glucan; food supplement; polyphenols; overweight;
   BMI; skinfolds; physical activity
ID GUT MICROBIOTA; ILEX-PARAGUARIENSIS; PHYSICAL-ACTIVITY; BLOOD-GLUCOSE;
   ENERGY-INTAKE; DOUBLE-BLIND; BARLEY; ACID; WEIGHT; INDIVIDUALS
AB Many in vitro and in vivo studies support that green coffee polyphenols (GCP) and beta-glucans (BG) present important hypolipidaemic and hypoglycaemic effects. However, their weight-management/-reducing properties are less clear. Considering that these compounds act on different metabolic pathways, their combination could increase their beneficial health effects. The aim of the present study was to investigate the effects of regularly consuming supplements containing GCP, BG or the novel GCP/BG combination on body composition in overweight/obese subjects without changing their dietary and physical activity habits, hence addressing the difficulty to adapt to lifestyle changes. A randomised, cross-over, blind trial was carried out in 29 volunteers who consumed GCP (300 mg), BG (2.5 g) or GCP/BG (300 mg + 2.5 g) twice a day for 8 weeks. At the beginning and end of each of the interventions, body weight, body mass index, body fat%, intracellular and extracellular water, skinfolds (tricipital, bicipital, subscapularis, suprailiac, leg and thigh) and body circumferences (waist, hip, thigh, calf, branchial) were measured. Along the study, volunteers filled out 72 h dietary records, and physical activity was measured using accelerometers. The results show that dietary intake and physical activity were unchanged throughout the study; however, there were no changes in any of the body composition parameters analysed with any of the food supplements. In conclusion, the regular intake of GCP, BG and GCP/BG, without changes in diet and physical activity, is not an efficient strategy to lose weight or induce other positive changes in body composition, although results should be taken with caution as the study was underpowered.
C1 [Garcia-Cordero, Joaquin; Seguido, Miguel A.; Gonzalez-Ramila, Susana; Mateos, Raquel; Bravo-Clemente, Laura; Sarria, Beatriz] CSIC, Spanish Natl Res Council, Inst Food Sci Technol & Nutr, Dept Metab & Nutr,ICTAN, Jose Antonio Novais 10, Madrid 28040, Spain.
   [Sierra-Cinos, Jose Luis] Complutense Univ Madrid UCM, Sch Pharm, Dept Nutr & Food Sci 1, Ciudad Univ S-N, Madrid 28040, Spain.
   [Sierra-Cinos, Jose Luis] Isabel Int Univ Burgos Ui1, Sch Hlth Sci, Dept Hlth Sci, 76 Fernan Gonzalez St, Burgos 09003, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Complutense
   University of Madrid
RP Sarriá, B (corresponding author), CSIC, Spanish Natl Res Council, Inst Food Sci Technol & Nutr, Dept Metab & Nutr,ICTAN, Jose Antonio Novais 10, Madrid 28040, Spain.; Sierra-Cinos, JL (corresponding author), Complutense Univ Madrid UCM, Sch Pharm, Dept Nutr & Food Sci 1, Ciudad Univ S-N, Madrid 28040, Spain.; Sierra-Cinos, JL (corresponding author), Isabel Int Univ Burgos Ui1, Sch Hlth Sci, Dept Hlth Sci, 76 Fernan Gonzalez St, Burgos 09003, Spain.
EM j.garcia@ictan.csic.es; jlscinos@farm.ucm.es; m.seguido@ictan.csic.es;
   s.gonzalez@ictan.csic.es; raquel.mateos@ictan.csic.es;
   lbravo@ictan.csic.es; beasarria@ictan.csic.es
RI BRIZ, Raquel/H-9125-2012; Bravo, Laura/JMC-4928-2023; Sarria,
   Beatriz/K-7929-2014; Bravo, Laura/F-4992-2012
OI Seguido, Miguel Angel/0000-0003-3883-7503; Sarria,
   Beatriz/0000-0003-0614-4606; Bravo, Laura/0000-0002-7312-8641
CR Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1885
   Andrade EF, 2015, NUTR HOSP, V31, P170, DOI 10.3305/nh.2015.31.1.7597
   Aoe S, 2017, NUTRITION, V42, P1, DOI 10.1016/j.nut.2017.05.002
   Arena MP, 2014, INT J MOL SCI, V15, P3025, DOI 10.3390/ijms15023025
   Beck EJ, 2010, BRIT J NUTR, V103, P1212, DOI 10.1017/S0007114509992856
   Bessell E, 2021, INT J OBESITY, V45, P1631, DOI 10.1038/s41366-021-00839-w
   Bozbulut R, 2019, TRENDS FOOD SCI TECH, V83, P159, DOI 10.1016/j.tifs.2018.11.018
   Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551
   Bumrungpert A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060713
   Cardile V, 2015, NAT PROD RES, V29, P2256, DOI 10.1080/14786419.2014.1000897
   Chang HC, 2013, PLANT FOOD HUM NUTR, V68, P18, DOI 10.1007/s11130-013-0336-2
   Coman V, 2020, J SCI FOOD AGR, V100, P483, DOI 10.1002/jsfa.10010
   De Angelis M, 2015, APPL ENVIRON MICROB, V81, P7945, DOI 10.1128/AEM.02507-15
   Drzikova B, 2005, BRIT J NUTR, V94, P1012, DOI 10.1079/bjn20051577
   DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
   El-Seedi HR, 2018, STUDIES IN NATURAL PRODUCTS CHEMISTRY, VOL 55, P269, DOI 10.1016/B978-0-444-64068-0.00008-5
   Fujii Y, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2014.71
   Gambero A, 2015, NUTRIENTS, V7, P730, DOI 10.3390/nu7020730
   Cordero JG, 2020, NUTR HOSP, V37, P1061, DOI 10.20960/nh.03125
   Garrido-Chamorro R, 2012, INT J MORPHOL, V30, P803, DOI 10.4067/S0717-95022012000300005
   Hu GX, 2010, MED HYPOTHESES, V74, P123, DOI 10.1016/j.mehy.2009.07.022
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Jaskari J, 1998, APPL MICROBIOL BIOT, V49, P175, DOI 10.1007/s002530051155
   Jayachandran M, 2018, J NUTR BIOCHEM, V61, P101, DOI 10.1016/j.jnutbio.2018.06.010
   Leonard W, 2021, COMPR REV FOOD SCI F, V20, P710, DOI 10.1111/1541-4337.12663
   Lima ND, 2014, LIFE SCI, V115, P29, DOI 10.1016/j.lfs.2014.09.003
   Martínez-González MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Mateos R, 2022, FOOD FUNCT, V13, P574, DOI [10.1039/d1fo02272e, 10.1039/D1FO02272E]
   Mitsou EK, 2010, FOOD RES INT, V43, P1086, DOI 10.1016/j.foodres.2010.01.020
   Moreiras O., 2016, Tablas de composicion de alimentos
   Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1249/mss.0b013e3180616aa2
   Patterson E, 2016, POSTGRAD MED J, V92, P286, DOI 10.1136/postgradmedj-2015-133285
   Rahmani J, 2019, COMPLEMENT THER MED, V43, P131, DOI 10.1016/j.ctim.2019.01.018
   Redondo-Puente M, 2021, FOODS, V10, DOI 10.3390/foods10112511
   Reyna-Villasmil Nadia, 2007, Am J Ther, V14, P203, DOI 10.1097/01.pap.0000249917.96509.e7
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Santas J, 2017, J SCI FOOD AGR, V97, P4250, DOI 10.1002/jsfa.8301
   Sarriá B, 2020, FOODS, V9, DOI 10.3390/foods9091191
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Seo CR, 2015, J FUNCT FOODS, V12, P208, DOI 10.1016/j.jff.2014.11.022
   Snart J, 2006, APPL ENVIRON MICROB, V72, P1925, DOI 10.1128/AEM.72.3.1925-1931.2006
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   Stuby J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092238
   Tessari P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030297
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Varela-Moreiras G., 2014, Nutricion Hospitalaria, V30, P21
   Wang J, 2000, ANN NY ACAD SCI, V904, P317
   Wang Q, 2014, BRIT J NUTR, V112, pS4, DOI 10.1017/S0007114514002256
   Wang YA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00129
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Watanabe M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092873
   World Health Organization, Fact sheets. obesity and overweight
   Yuliana ND, 2011, OBES REV, V12, P499, DOI 10.1111/j.1467-789X.2010.00790.x
   Zhang Z, 2016, ONCOTARGET, V7, P31790, DOI 10.18632/oncotarget.9306
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 57
TC 8
Z9 8
U1 0
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2304-8158
J9 FOODS
JI Foods
PD MAR
PY 2022
VL 11
IS 5
AR 679
DI 10.3390/foods11050679
PG 16
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA ZS9IW
UT WOS:000768772700001
PM 35267313
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Zampelas, A
   Panagiotakos, DB
   Pitsavos, C
   Chrysohoou, C
   Stefanadis, C
AF Zampelas, A
   Panagiotakos, DB
   Pitsavos, C
   Chrysohoou, C
   Stefanadis, C
TI Associations between coffee consumption and inflammatory markers in
   healthy persons: the ATTICA study
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE inflammation; cardiovascular disease; risk factors; coffee
ID CAFFEINE; PROTEIN; CAFESTOL; OBESITY; DISEASE; LIPIDS
AB Background: The effect of coffee consumption on the cardiovascular system is conflicting. Inflammation is important to the development of cardiovascular disease (CVD), and several dietary factors are thought to exert significant effects on inflammation and thus on the risk of CVD.
   Objective: We aimed to investigate the associations between coffee consumption and inflammatory markers.
   Design: The cross-sectional survey enrolled 1514 men ((x) over bar +/- SD age: 46 +/- 13 y; range: 18-87 y) and 1528 women (aged 45 +/- 13 y; range: 18-89 y). Five percent of men and 3% of women were excluded for history of CVD. Fasting blood samples were collected. Dietary habits (including consumption of various types of coffee) were evaluated by using a validated food-frequency questionnaire.
   Results: Compared with coffee nondrinkers, men who consumed >200 mL coffee/d had 50% higher interleukin 6 (IL-6), 30% higher C-reactive protein (CRP), 12% higher serum amyloid-A (SAA), and 28% higher tumor necrosis factor alpha (TNF-alpha) concentrations and 3% higher white blood cell (WBC) counts (all: P < 0.05). Women who consumed >200 mL coffee/d had 54% higher IL-6, 38% higher CRP, 28% higher SAA, and 28% higher TNF-alpha concentrations and 4% higher WBC counts (all: P < 0.05) than did coffee nondrinkers. The findings were significant even after control for the interactions between coffee consumption and age, sex, smoking, body mass index, physical activity status, and other covariates.
   Conclusions: A relation exists between moderate-to-high coffee consumption and increased inflammation process. This relation could explain, in part, the effect of increased coffee intake on the cardiovascular system.
C1 Harokopio Univ, Dept Nutr & Dietet, Athens, Greece.
   Univ Athens, Sch Med, Cardiol Clin 1, GR-11527 Athens, Greece.
C3 Harokopio University Athens; National & Kapodistrian University of
   Athens; Athens Medical School
RP 46 Paleon Polemiston St, Attica 16674, Greece.
EM d.b.panagiotakos@usa.net
RI Zampelas, Antonis/AAM-4349-2020; Panagiotakos, Demosthenes/K-8294-2019;
   Stefanadis, Christodoulos/ABH-2232-2020
OI Stefanadis, Christodoulos/0000-0001-5974-6454; Chrysohoou,
   Christina/0000-0002-6340-3996; Zampelas, Antonis/0000-0002-4242-3365
CR BATTIG K, 1992, SCHWEIZ MED WSCHR, V122, P1536
   BAUMANN H, 1990, MOL BIOL MED, V7, P147
   BUNKER ML, 1979, J AM DIET ASSOC, V74, P28
   CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4
   Das UN, 2002, EXP BIOL MED, V227, P989, DOI 10.1177/153537020222701106
   Das UN, 2002, NUTRITION, V18, P430, DOI 10.1016/S0899-9007(01)00747-X
   Das UN, 2002, PROSTAG LEUKOTR ESS, V67, P1, DOI 10.1054/plef.2002.0374
   Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4
   GANAPATHI MK, 1990, BIOCHEM J, V269, P41, DOI 10.1042/bj2690041
   GROBBEE DE, 1990, NEW ENGL J MED, V323, P1026, DOI 10.1056/NEJM199010113231504
   Grubben MJ, 2000, AM J CLIN NUTR, V71, P480
   GYNTELBERG F, 1995, J INTERN MED, V237, P55, DOI 10.1111/j.1365-2796.1995.tb01140.x
   Katsouyanni K, 1997, INT J EPIDEMIOL, V26, pS118, DOI 10.1093/ije/26.suppl_1.S118
   KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480
   Klag Michael J., 1994, Annals of Epidemiology, V4, P425, DOI 10.1016/1047-2797(94)90001-9
   Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   PALMER JR, 1995, AM J EPIDEMIOL, V141, P724, DOI 10.1093/oxfordjournals.aje.a117494
   Panagiotakos DB, 2003, J NUTR, V133, P3228, DOI 10.1093/jn/133.10.3228
   Piek JJ, 2000, J AM COLL CARDIOL, V35, P963, DOI 10.1016/S0735-1097(99)00647-6
   Pitsavos C, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-32
   Rustan AC, 1997, ARTERIOSCL THROM VAS, V17, P2140, DOI 10.1161/01.ATV.17.10.2140
   Sakamoto W, 2001, BONE, V28, P332, DOI 10.1016/S8756-3282(00)00444-0
   Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248
   Terpstra AHM, 2000, J NUTR BIOCHEM, V11, P311, DOI 10.1016/S0955-2863(00)00082-6
   Thelle Dag S., 1995, Current Opinion in Lipidology, V6, P25, DOI 10.1097/00041433-199502000-00006
   World Health Organization, 1990, World Health Organ Tech Rep Ser, V797, P1
   Yamada T, 1999, CLIN CHEM LAB MED, V37, P381, DOI 10.1515/CCLM.1999.063
NR 28
TC 140
Z9 153
U1 0
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD OCT
PY 2004
VL 80
IS 4
BP 862
EP 867
DI 10.1093/ajcn/80.4.862
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 856VI
UT WOS:000224073000010
PM 15447891
OA Bronze
DA 2025-04-28
ER

PT J
AU Rebollo-Hernanz, M
   Zhang, QZ
   Aguilera, Y
   Martín-Cabrejas, MA
   de Mejia, EG
AF Rebollo-Hernanz, Miguel
   Zhang, Qiaozhi
   Aguilera, Yolanda
   Martin-Cabrejas, Maria A.
   de Mejia, Elvira Gonzalez
TI Phenolic compounds from coffee by-products modulate adipogenesis-related
   inflammation, mitochondrial dysfunction, and insulin resistance in
   adipocytes, via insulin/PI3K/AKT signaling pathways
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Coffee by-products; Inflammation; Insulin resistance; Mitochondrial
   dysfunction; Phenolic compounds
ID WHITE ADIPOSE-TISSUE; SILVERSKIN EXTRACT; CHLOROGENIC ACID; MACROPHAGES;
   OBESITY; LIPOLYSIS; SENSITIVITY; METABOLISM; COMPONENTS; EXPRESSION
AB The aim of this study was to evaluate the inhibitory potential of aqueous extracts from coffee silverskin (CSE) and husk (CHE) and their main phenolics on adipogenesis, obesity-related inflammation, mitochondrial dysfunction, and insulin resistance, in vitro. Coffee by-products extracts (31-500 mu g mL(-1)) and pure phenolics (100 mu mol L-1 ) reduced lipid accumulation and increased mitochondrial activity in 3T3-L1 adipocytes. Also reduced the expression of inducible nitric oxide synthase and cyclooxygenase-2 and diminished secretion of proinflammatory factors in LPS-stimulated RAW2643.7 macrophages. Cytokine release diminished (tumor necrosis factor alpha: 23-57%; monocyte chemoattractant protein 1: 42-60%; interleukin-6: 30-39%) and adiponectin increased (7-13- fold) in adipocytes treated with macrophage-conditioned media. ROS scavenging and activation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha pathway counteracted mitochondrial dysfunction. Increases in insulin receptor (1.4 to 4-fold), phosphoinositide 3-kinase (2 to 3-fold) and protein kinase B (1.3 to 3-fold) phosphorylation, in conjunction with a decrease in serine phosphorylation of insulin receptor substrate 1, evoked glucose transporter 4 translocation (8-15-fold) and glucose uptake (44-85%). CSE and CHE phenolics inhibited adipogenesis and elicited adipocytes browning. Suppressing macrophages-adipocytes interaction alleviated inflammation-triggered mitochondrial dysfunction and insulin resistance. CSE and CHE are beneficial in reducing adipogenesis and inflammation-related disorders.
C1 [Rebollo-Hernanz, Miguel; Aguilera, Yolanda; Martin-Cabrejas, Maria A.] CIAL UAM CSIC, Inst Food Sci Res, Madrid 28049, Spain.
   [Rebollo-Hernanz, Miguel; Aguilera, Yolanda; Martin-Cabrejas, Maria A.] Univ Autonoma Madrid, Dept Agr Chem & Food Sci, E-28049 Madrid, Spain.
   [Rebollo-Hernanz, Miguel; Zhang, Qiaozhi; de Mejia, Elvira Gonzalez] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.
   [Zhang, Qiaozhi] Northeast Agr Univ, Coll Food Sci, Harbin 150030, Heilongjiang, Peoples R China.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM -
   Instituto de Investigacion en Ciencias de la Alimentacion (CIAL);
   Autonomous University of Madrid; University of Illinois System;
   University of Illinois Urbana-Champaign; Northeast Agricultural
   University - China
RP de Mejia, EG (corresponding author), 228 ERML,1201 West Gregory Dr, Urbana, IL 61801 USA.; Martín-Cabrejas, MA (corresponding author), Inst Invest Ciencias Alimentac, Calle Nicolas Cabrera 9, Madrid 28049, Spain.
EM miguel.rebollo@uam.es; maria.martin@uam.es; edemejia@illinois.edu
RI GONZALEZ DE mEJIA, ELVIRA/IYI-9309-2023; Martín-Cabrejas,
   María/L-6433-2014; Zhang, Qiaozhi/AAB-2540-2020; Rebollo-Hernanz,
   Miguel/S-6539-2019; aguilera, yolanda/B-6021-2012
OI Zhang, Qiaozhi/0000-0002-0578-4778; aguilera,
   yolanda/0000-0002-8724-6796; Rebollo-Hernanz,
   Miguel/0000-0003-1034-1290; DE MEJIA, ELVIRA/0000-0001-7426-9035
FU Ministry of Economy and Competitiveness, SUSCOFFEE project
   [AGL2014-57239-R]; USDA-NIFA-HATCH [1014457]; FPU program of the
   Ministry of Science, Innovation, and Universities [FPU15/04238,
   EST17/00823]
FX This study was funded by the Ministry of Economy and Competitiveness,
   SUSCOFFEE project (AGL2014-57239-R), and the USDA-NIFA-HATCH (project
   1014457). M. Rebollo-Hernanz thanks the FPU program of the Ministry of
   Science, Innovation, and Universities for his predoctoral fellowship
   (FPU15/04238) and the support for the international research stay
   (EST17/00823).
CR Aguilera Y, 2019, FOOD FUNCT, V10, P4739, DOI [10.1039/c9fo00544g, 10.1039/C9FO00544G]
   Aguilera Y, 2016, PHYTOCHEM REV, V15, P405, DOI 10.1007/s11101-015-9443-z
   Ardestani A, 2018, TRENDS ENDOCRIN MET, V29, P737, DOI 10.1016/j.tem.2018.07.003
   Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662
   Beaudoin MS, 2013, AM J PHYSIOL-REG I, V305, pR542, DOI 10.1152/ajpregu.00200.2013
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Brand MD, 2013, BRIT J DERMATOL, V169, P1, DOI 10.1111/bjd.12208
   Cedikova M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6067349
   Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005
   Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8
   del Castillo MD, 2019, COFFEE: CONSUMPTION AND HEALTH IMPLICATIONS, P20
   Doan KV, 2015, ENDOCRINOLOGY, V156, P157, DOI 10.1210/en.2014-1354
   Dorsey BM, 2017, HANDBOOK OF COFFEE PROCESSING BY-PRODUCTS: SUSTAINABLE APPLICATIONS, P27, DOI 10.1016/B978-0-12-811290-8.00002-5
   Fernandez-Gomez B, 2016, FOOD RES INT, V89, P1015, DOI 10.1016/j.foodres.2016.03.006
   Fernandez-Gomez B, 2016, J FUNCT FOODS, V25, P197, DOI 10.1016/j.jff.2016.06.001
   Gao J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101366
   Gómez-Hernández A, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/1216783
   Huang DW, 2009, J AGR FOOD CHEM, V57, P7687, DOI 10.1021/jf901376x
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Iriondo-DeHond A, 2019, INNOV FOOD SCI EMERG, V51, P194, DOI 10.1016/j.ifset.2018.06.010
   Iriondo-DeHond A, 2017, FOOD RES INT, V100, P791, DOI 10.1016/j.foodres.2017.08.012
   Janissen B, 2018, RESOUR CONSERV RECY, V128, P110, DOI 10.1016/j.resconrec.2017.10.001
   Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]
   Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184
   Kang YE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154003
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kobori M, 2016, MOL NUTR FOOD RES, V60, P300, DOI 10.1002/mnfr.201500595
   Lagoa R, 2011, BBA-BIOENERGETICS, V1807, P1562, DOI 10.1016/j.bbabio.2011.09.022
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009
   Lorenzo M, 2008, J Anim Sci, V86, pE94
   Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006
   Luna-Vital D, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700362
   Magoni C, 2018, FOOD RES INT, V112, P129, DOI 10.1016/j.foodres.2018.06.026
   McArdle Maeve A, 2013, Front Endocrinol (Lausanne), V4, P52, DOI 10.3389/fendo.2013.00052
   Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547
   Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Paniagua JA, 2016, WORLD J DIABETES, V7, P483, DOI 10.4239/wjd.v7.i19.483
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Rebollo-Hernanz M, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801413
   Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030
   Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90
   Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012
   Sánchez-Pátan F, 2011, J AGR FOOD CHEM, V59, P2241, DOI 10.1021/jf104574z
   Scazzocchio B, 2015, MOL NUTR FOOD RES, V59, P1472, DOI 10.1002/mnfr.201400816
   Schaffäler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001
   Schoiswohl G, 2015, ENDOCRINOLOGY, V156, P3610, DOI 10.1210/en.2015-1322
   Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529
   Wang CH, 2013, FEBS J, V280, P1039, DOI 10.1111/febs.12096
   Wang S, 2015, BIOCHEM BIOPH RES CO, V466, P247, DOI 10.1016/j.bbrc.2015.09.018
   Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001
   Yang XY, 2011, J BIOL CHEM, V286, P40477, DOI 10.1074/jbc.M111.257923
   Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6
   Yoneshiro T, 2017, AM J CLIN NUTR, V105, P873, DOI 10.3945/ajcn.116.144972
   Yoon HY, 2013, INT J MOL MED, V32, P971, DOI 10.3892/ijmm.2013.1468
   Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005
   Zhang J., 2016, OXID MED CELL LONGEV, V2016, DOI [10.1155/2016/4350965.4350965, DOI 10.1155/2016/4350965.4350965]
NR 65
TC 71
Z9 77
U1 1
U2 37
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD OCT
PY 2019
VL 132
AR 110672
DI 10.1016/j.fct.2019.110672
PG 16
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA IW0JB
UT WOS:000484647100022
PM 31306686
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Zheng, MB
   Rangan, A
   Huang, RC
   Beilin, LJ
   Mori, TA
   Oddy, WH
   Ambrosini, GL
AF Zheng, Miaobing
   Rangan, Anna
   Huang, Rae-Chi
   Beilin, Lawrence Joseph
   Mori, Trevor Anthony
   Oddy, Wendy Hazel
   Ambrosini, Gina Leslie
TI Modelling the Effects of Beverage Substitution during Adolescence on
   Later Obesity Outcomes in Early Adulthood: Results from the Raine Study
SO NUTRIENTS
LA English
DT Article
DE sugar-sweetened beverages; obesity; waist circumference; substitution
   modelling
ID SUGAR-SWEETENED BEVERAGES; BODY-WEIGHT OUTCOMES; ENERGY-INTAKE;
   WATER-CONSUMPTION; DIETARY PATTERNS; CHILDREN; ASSOCIATION; RISK; GAIN;
   MILK
AB High sugar-sweetened beverage (SSB) consumption has been linked with obesity. The present study examined the associations between adolescent SSB intake and body mass index (BMI), waist circumference (WC), and overweight status in early adulthood, and modelled the association of alternative beverage substitution with BMI and WC. Data of offspring from the Western Australian Pregnancy Cohort (Raine) Study at ages 14 and 22 years were used (n = 667). SSB intake at 14 years (100 g/day) was associated with higher BMI (beta = 0.19 kg/m(2), 95% CI 0.04, 0.33), WC (beta = 0.41cm, 95% CI 0.04, 0.78), and being overweight at 22 years (OR 1.10, 95% CI 1.02, 1.18). Every 100g modelled substitution of SSB with milk at age 14 years was associated with lower BMI (-0.19 kg/m(2)) and WC (-0.52 cm) at age 22 years. Replacement of SSB with diet drink was associated with higher BMI and WC. No association was found for substitutions of SSB with water, tea/coffee, or 100% fruit juice with BMI or WC. SSB intake during adolescence was associated with higher BMI, WC, and being overweight in early adulthood. Milk as an alternative to SSB was associated with less adiposity. Caution is necessary in recommending diet drinks as a SSB alternative.
C1 [Zheng, Miaobing] Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic 3125, Australia.
   [Rangan, Anna] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.
   [Huang, Rae-Chi; Ambrosini, Gina Leslie] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.
   [Beilin, Lawrence Joseph; Mori, Trevor Anthony] Univ Western Australia, Sch Med, Royal Perth Hosp Unit, Perth, WA 6009, Australia.
   [Oddy, Wendy Hazel] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7005, Australia.
   [Ambrosini, Gina Leslie] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA 6009, Australia.
C3 Deakin University; University of Sydney; University of Western
   Australia; The Kids Research Institute Australia; East Metropolitan
   Health Service; Royal Perth Hospital; University of Western Australia;
   University of Tasmania; Menzies Institute for Medical Research;
   University of Western Australia
RP Zheng, MB (corresponding author), Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic 3125, Australia.
EM j.zheng@deakin.edu.au; anna.rangan@sydney.edu.au;
   Rae-Chi.Huang@telethonkids.org.au; lawrie.beilin@uwa.edu.au;
   trevor.mori@uwa.edu.au; wendy.oddy@utas.edu.au;
   Gina.Ambrosini@health.wa.gov.au
RI Ambrosini, Gina/E-7107-2010; Rangan, Anna/AFS-4449-2022; Mori,
   Trevor/H-5485-2014
OI Beilin, Lawrence/0000-0003-4853-7360; Mori, Trevor
   A/0000-0002-5264-9229; Rangan, Anna/0000-0003-1815-844X
FU University of Western Australia; Curtin University; Telethon Kids
   Institute; Women and Infants Research Foundation; Edith Cowan
   University; Murdoch University; University of Notre Dame Australia;
   Raine Medical Research Foundation; National Health Medical Research
   Council (NHMRC) [211912, 003209]; NHMRC [1027449, 1044840, 1021855]
FX The core management of the Raine Study is funded by the University of
   Western Australia, Curtin University, Telethon Kids Institute, Women and
   Infants Research Foundation, Edith Cowan University, Murdoch University,
   The University of Notre Dame Australia, and the Raine Medical Research
   Foundation. The 14 year follow-up was funded by National Health Medical
   Research Council (NHMRC) project grant (ID 211912 and ID 003209) and the
   Raine Medical Research Foundation. The 22 year follow-up was funded by
   NHMRC project grants (ID 1027449,1044840, and 1021855). M.Z. is funded
   by the NHMRC Early Career Fellowship.
CR Ambrosini GL, 2010, NUTR METAB CARDIOVAS, V20, P274, DOI 10.1016/j.numecd.2009.03.024
   Ambrosini GL, 2009, EUR J CLIN NUTR, V63, P1251, DOI 10.1038/ejcn.2009.44
   Ambrosini GL, 2009, PUBLIC HEALTH NUTR, V12, P1807, DOI 10.1017/S1368980008004618
   Ambrosini GL, 2013, AM J CLIN NUTR, V98, P327, DOI 10.3945/ajcn.112.051383
   Anderson GH, 2011, NESTLE NUTR WORKS SE, V67, P147, DOI 10.1159/000325581
   [Anonymous], 2002, DIET NUTR PREV CHRON
   Bachman CM, 2006, NUTR REV, V64, P153, DOI 10.1301/nr.2006.apr.153-174
   Baker SS, 2001, PEDIATRICS, V107, P1210, DOI 10.1542/peds.107.5.1210
   Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94
   Bhatti SK, 2013, CURR OPIN CLIN NUTR, V16, P688, DOI 10.1097/MCO.0b013e328365b9a0
   Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376
   Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x
   DeBoer MD, 2013, PEDIATRICS, V132, P413, DOI 10.1542/peds.2013-0570
   Fiorito LM, 2009, AM J CLIN NUTR, V90, P935, DOI 10.3945/ajcn.2009.27623
   Gonzalez JT, 2012, OBES REV, V13, P848, DOI 10.1111/j.1467-789X.2012.01013.x
   Gopinath B, 2013, OBESITY, V21, P1884, DOI 10.1002/oby.20405
   Hands BP, 2011, J SCI MED SPORT, V14, P397, DOI 10.1016/j.jsams.2011.03.011
   Hill JO, 1999, MED SCI SPORT EXER, V31, pS515, DOI 10.1097/00005768-199911001-00005
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Keller A, 2015, CHILD OBES, V11, P338, DOI 10.1089/chi.2014.0117
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Langley-Evans S.C., 2009, Nutrition: A lifespan approach
   Lowen Trout, 2011, Minn Med, V94, P20
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Massougbodji J, 2014, AM J CLIN NUTR, V99, P1096, DOI 10.3945/ajcn.113.063776
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.E7492
   Muckelbauer R, 2014, OBESITY, V22, P2462, DOI 10.1002/oby.20911
   Muckelbauer R, 2013, AM J CLIN NUTR, V98, P282, DOI 10.3945/ajcn.112.055061
   National Health and Medical Research Council, 2013, EAT HLTH DIET GUID
   NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H
   Nissinen K, 2009, PUBLIC HEALTH NUTR, V12, P2018, DOI 10.1017/S1368980009005849
   Pan LP, 2014, PEDIATRICS, V134, pS29, DOI 10.1542/peds.2014-0646F
   Papageorgiou G, 2018, INTERACT CARDIOV TH, V27, P153, DOI 10.1093/icvts/ivy102
   Pereira MA, 2013, NUTR REV, V71, P433, DOI 10.1111/nure.12038
   Popkin BM, 2003, OBES RES, V11, P1325, DOI 10.1038/oby.2003.179
   Shroff MR, 2014, PUBLIC HEALTH NUTR, V17, P1507, DOI 10.1017/S136898001300133X
   Soares MJ, 2011, EUR J CLIN NUTR, V65, P994, DOI 10.1038/ejcn.2011.106
   Stookey JD, 2007, OBESITY, V15, P3013, DOI 10.1038/oby.2007.359
   Straker L, 2017, INT J EPIDEMIOL, V46, P1384, DOI 10.1093/ije/dyw308
   Straker LM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1944-6
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634
   Swithers SE, 2013, BEHAV NEUROSCI, V127, P262, DOI 10.1037/a0031717
   US Department of Agriculture; US Department of Health and Human Services, 2010, DIET GUID AM 2010
   Viner RM, 2006, INT J OBESITY, V30, P1368, DOI 10.1038/sj.ijo.0803183
   Warner ML, 2006, OBESITY, V14, P1966, DOI 10.1038/oby.2006.230
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Willett WC, 2013, NUTR EPIDEMIOLOGY
   Woodward-Lopez G, 2011, PUBLIC HEALTH NUTR, V14, P499, DOI 10.1017/S1368980010002375
   World Health Organization (WHO), 2015, Guideline: Sugars Intake for Adults and Children
   Zheng M, 2015, J HUM NUTR DIET, V28, P70, DOI 10.1111/jhn.12223
   Zheng M, 2014, EUR J CLIN NUTR, V68, P77, DOI 10.1038/ejcn.2013.243
   Zheng MB, 2015, BRIT J NUTR, V114, P1448, DOI 10.1017/S0007114515002974
   Zheng MB, 2015, J ACAD NUTR DIET, V115, P767, DOI 10.1016/j.jand.2015.01.006
   Zheng MB, 2015, NUTRITION, V31, P38, DOI 10.1016/j.nut.2014.04.017
NR 55
TC 7
Z9 7
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD DEC
PY 2019
VL 11
IS 12
AR 2928
DI 10.3390/nu11122928
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KC0ZV
UT WOS:000506917800090
PM 31816850
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Gönenç, TM
   Kayalar, H
   Öztürk, M
AF Gonenc, Tuba Mert
   Kayalar, Husniye
   Ozturk, Munir
TI A Comparative Evaluation of Chlorogenic Acid Content and Antioxidant
   Activity in Artichoke (Cynara scolymus L.) Samples Under
   Different Storage Conditions
SO JOURNAL OF THE CHEMICAL SOCIETY OF PAKISTAN
LA English
DT Article
DE Artichoke (Cynara scolymus L.); Chlorogenic acid; Antioxidant activity;
   HPLC
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; DIFFERENT COOKING METHODS;
   PHENOLIC-COMPOUNDS; IDENTIFICATION; VEGETABLES; HEADS
AB Artichoke has been used for a long time in the traditional medicine against dyspeptic complaints and as a liver protector due to its choleretic and cholagogue effects. Chlorogenic acid, the main ingredient of artichoke is known to show hepatoprotector, anticancer, anti-obesity and antioxidant activities. In this study, antioxidant activity and chlorogenic acid quantification were performed using the samples of artichoke as fresh, boiled, frozen, boiled frozen, canned, fresh leaf and dry leaf. Potential antioxidant activity was evaluated using DPPH assay. Flavonoid and phenolic contents were determined by Aluminum chloride colorimetry and Folin-Ciocalteu methods. The amounts of colorogenic acid in the samples were determined by HPLC-DAD system. The results have shown that highest chlorogenic acid content was determined in the 10-minute frozen-boiled sample (0.01441 mg/100g), followed by canned (0.01043 mg/100g), 20-minute cooked artichoke (0.001912 mg/100g), fresh artichoke (0.001519 mg/100g) and frozen artichoke (0.0004 mg/100g). The antioxidant activity results have revealed that highest % DPPH capture effect was observed in the cooked artichoke sample (ED50 =1.949 mg/ml). The total flavonoid content was equivalent to quercetin (43.859 mg QE/100g) whereas total phenolic content equalled to gallic acid (14.640 mg GAE/100g). The antioxidant activity and the amounts of colorogenic acid were found to be the highest in the cooked artichoke sample whereas the lowest antioxidant activity observed in canned artichoke. The results show that the heat treatment applied for storage can positively affect the amount of chlorogenic acid and antioxidant activity.
C1 [Gonenc, Tuba Mert] Izmir Katip Celebi Univ, Fac Pharm, Dept Pharmacognosy, Izmir, Turkey.
   [Kayalar, Husniye] Ege Univ, Fac Pharm, Dept Pharmacognosy, Izmir, Turkey.
   [Ozturk, Munir] Ege Univ, Fac Sci, Dept Bot, Izmir, Turkey.
C3 Izmir Katip Celebi University; Ege University; Ege University
RP Öztürk, M (corresponding author), Ege Univ, Fac Sci, Dept Bot, Izmir, Turkey.
EM munirozturk@gmail.com
RI Kayalar, Hüsniye/AAZ-4012-2021
CR ADZET T, 1985, J CHROMATOGR, V348, P447, DOI 10.1016/S0021-9673(01)92486-0
   Ahn MR, 2007, FOOD CHEM, V101, P1383, DOI 10.1016/j.foodchem.2006.03.045
   Amin I, 2005, J SCI FOOD AGR, V85, P2314, DOI 10.1002/jsfa.2261
   Azzini E, 2007, BRIT J NUTR, V97, P963, DOI 10.1017/S0007114507617218
   British Standart, 2000, 11843 ISO
   Curadi M., 2005, 4 INT C ART, DOI [10.17660/Acta Hortic.2005.681.71, DOI 10.17660/ACTAHORTIC.2005.681.71]
   Emendörfer F, 2005, BIOL PHARM BULL, V28, P902, DOI 10.1248/bpb.28.902
   Farah A, 2005, J AGR FOOD CHEM, V53, P1505, DOI 10.1021/jf048701t
   Ferracane R, 2008, J AGR FOOD CHEM, V56, P8601, DOI 10.1021/jf800408w
   Fratianni F, 2007, FOOD CHEM, V104, P1282, DOI 10.1016/j.foodchem.2007.01.044
   Gil M., 2017, Ann. Univ. Mariae Curie-Sklodowska, Sect. AA-Chem., V72, DOI [10.17951/aa.2017.72.1.61, DOI 10.17951/AA.2017.72.1.61]
   Gruenwald J., 2000, PDR HERBAL MED, P44
   Jiménez-Monreal AM, 2009, J FOOD SCI, V74, pH97, DOI 10.1111/j.1750-3841.2009.01091.x
   Keskinkilic K., 2017, ENGINAR KALBI OLAN L, P139
   Llorach R, 2002, J AGR FOOD CHEM, V50, P3458, DOI 10.1021/jf0200570
   Lutz M, 2011, J FOOD COMPOS ANAL, V24, P49, DOI 10.1016/j.jfca.2010.06.001
   Okada Y, 1998, J AGR FOOD CHEM, V46, P401, DOI 10.1021/jf970470l
   PANIZZI L, 1954, NATURE, V174, P1062, DOI 10.1038/1741062a0
   Preziosi P., 1969, ATT 1 C INT STUD CAR, P237
   Puuponen-Pimiä R, 2003, J SCI FOOD AGR, V83, P1389, DOI 10.1002/jsfa.1589
   Ribarova F., 2005, JU Chem. Metal., V40, P255, DOI 10.1016/j.arabjc.2023.105003
   Robinson WE, 1996, P NATL ACAD SCI USA, V93, P6326, DOI 10.1073/pnas.93.13.6326
   Sánchez-Rabaneda F, 2003, J CHROMATOGR A, V1008, P57, DOI 10.1016/S0021-9673(03)00964-6
   Schütz K, 2004, J AGR FOOD CHEM, V52, P4090, DOI 10.1021/jf049625x
   Shimoda H, 2003, BIOORG MED CHEM LETT, V13, P223, DOI 10.1016/S0960-894X(02)00889-2
   Sultana B, 2008, INT J FOOD SCI TECH, V43, P560, DOI 10.1111/j.1365-2621.2006.01504.x
   Turkmen N, 2005, FOOD CHEM, V93, P713, DOI 10.1016/j.foodchem.2004.12.038
   Wang MF, 2003, J AGR FOOD CHEM, V51, P601, DOI 10.1021/jf020792b
   Zhu XF, 2005, FITOTERAPIA, V76, P108, DOI 10.1016/j.fitote.2004.10.016
NR 29
TC 1
Z9 1
U1 0
U2 14
PU CHEM SOC PAKISTAN
PI KARACHI
PA HEJ RES INST CHEM UNIV KARACHI, 75270 KARACHI, PAKISTAN
SN 0253-5106
J9 J CHEM SOC PAKISTAN
JI J. Chem. Soc. Pak.
PD APR
PY 2020
VL 42
IS 2
BP 274
EP 281
PG 8
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA LK7BR
UT WOS:000531018100015
DA 2025-04-28
ER

PT J
AU da Silva, LA
   Pereira, RA
   Túrmina, JA
   Kerppers, II
   Osiecki, R
   Altimari, LR
   Malfatti, CRM
AF da Silva, Luiz Augusto
   Pereira, Ricardo Aparecido
   Turmina, Janaina Angela
   Kerppers, Ivo Ilvan
   Osiecki, Raul
   Altimari, Leandro Ricardo
   Maneck Malfatti, Carlos Ricardo
TI Sulfonylurea induction of caffeine-enhanced insulin secretion and
   reduction of glycemic levels in diabetic rats
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE Blood glucose; diabetes mellitus; exercise; streptozotocin
ID GLUCOSE-HOMEOSTASIS; BLOOD-PRESSURE; COFFEE; EXERCISE; RESISTANCE;
   ENDURANCE; OBESITY
AB Context: Caffeine can stimulate insulin secretion by attenuating hyperglycemia in diabetes models with significant reduction of pancreatic functional beta cells. Knowledge of these mechanisms could contribute to new strategies for treating diabetes.
   Objective: This study evaluated the effects of caffeine and physical exercise on glycemic and insulin responses in diabetic rats.
   Materials and methods: The diabetes model was induced by intraperitoneal administration of 60 mg/kg of streptozotocin (STZ). Animals were divided into six groups: control, caffeine, STZ control, STZ caffeine, STZ sulfonylurea, and STZ caffeine + sulfonylurea. Acutely, control animals received 6 mg of caffeine and 10 mg/kg sulfonylurea or 10 mg/kg saline. Animals were sacrificed after physical exercise; blood samples were collected for glucose, glycerol, lactate, and insulin analyses. Cardiovascular responses were recorded before and after treatments. A one-way ANOVA and the post hoc Student-Newman-Keuls test were used to analyze statistical differences between treatments (p < 0.05).
   Results: About 6 mg/kg of caffeine did not alter cardiovascular responses, but promoted blood glucose reduction after 60 min of exercise when compared to animals in the control groups (387-187 mg/dL; p < 0.05). Insulin levels increased significantly (0.6-10 mu U/mL; p < 0.05) in rats that received acute caffeine treatment associated with sulfonylurea compared to rats in the other groups.
   Discussion and conclusion: Acute caffeine intake with exercise can increase glucose uptake enhancing insulin secretion stimulated by sulfonylurea in b cells-deficient pancreas. The results indicate the potential use of caffeine as a strategy for glycemic and insulin control in diabetes.
C1 [da Silva, Luiz Augusto; Pereira, Ricardo Aparecido; Turmina, Janaina Angela; Kerppers, Ivo Ilvan; Maneck Malfatti, Carlos Ricardo] Midwest State Univ Parana, Dept Physiotherapy, BR-85040080 Guarapuava, Parana, Brazil.
   [Osiecki, Raul] Univ Fed Parana, Dept Phys Educ, BR-80060000 Curitiba, Parana, Brazil.
   [Altimari, Leandro Ricardo] Univ Estadual Londrina, Dept Phys Educ, Londrina, Parana, Brazil.
C3 Universidade Federal do Parana; Universidade Estadual de Londrina
RP Malfatti, CRM (corresponding author), Midwest State Univ Parana, Dept Physiotherapy, R Simeao Camargo Varela de Sa 03, BR-85040080 Guarapuava, Parana, Brazil.
EM crmalfatti@gmail.com
RI Malfatti, Carlos/M-6184-2014; da Silva, Luiz/I-4760-2014; Osiecki,
   Raul/AAD-1023-2019; Kerppers, Ivo/ABF-8157-2020
OI Osiecki, Raul/0000-0002-3573-9468; Silva, Luiz
   Augusto/0000-0001-6861-6651; Malfatti, Carlos Ricardo
   Maneck/0000-0002-1039-3034
FU CAPES (Brazil); Fundacao Araucaria of Parana (Brazil)
FX The authors are thankful to CAPES (Brazil) and Fundacao Araucaria of
   Parana (Brazil) for the financial support to this study. There are no
   issues to disclose. There is no potential conflict of interest with the
   mentioned trademarks. This manuscript has been reviewed by a
   professional science editor and a native English-speaking science
   editor.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Chu YF, 2011, FOOD CHEM, V124, P914, DOI 10.1016/j.foodchem.2010.07.019
   Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013
   Egawa T, 2009, METABOLISM, V58, P1609, DOI 10.1016/j.metabol.2009.05.013
   Gallagher EJ, 2008, ENDOCRIN METAB CLIN, V37, P559, DOI 10.1016/j.ecl.2008.05.002
   Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Helmy, 2012, J NUTR FOOD SCI, V2, P1
   Larsen JJ, 1999, DIABETES CARE, V22, P1647, DOI 10.2337/diacare.22.10.1647
   Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566
   Luciano E, 2002, EUR J ENDOCRINOL, V147, P149, DOI 10.1530/eje.0.1470149
   Mougios V, 2003, J APPL PHYSIOL, V94, P476, DOI 10.1152/japplphysiol.00624.2002
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d
   Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899
   Paluska Scott A, 2003, Curr Sports Med Rep, V2, P213, DOI 10.1249/00149619-200308000-00008
   Park S, 2009, AM J PHYSIOL-CELL PH, V296, pC106, DOI 10.1152/ajpcell.00114.2008
   Park S, 2007, METABOLISM, V56, P599, DOI 10.1016/j.metabol.2006.12.004
   Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910
   Szkudelski T, 2012, EXP BIOL MED, V237, P481, DOI 10.1258/ebm.2012.011372
   Takada J, 2007, METABOLISM, V56, P977, DOI 10.1016/j.metabol.2006.05.021
   Alves-Wagner ABT, 2009, MUSCLE NERVE, V40, P847, DOI 10.1002/mus.21359
   Wang L, 2013, TOXICOL LETT, V0378-4274, P1397
   Yasuda N, 2003, EUR J PHARMACOL, V459, P159, DOI 10.1016/S0014-2999(02)02832-7
   Zheng G, 2008, IN VIVO, V18, P55
NR 28
TC 3
Z9 3
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PD AUG
PY 2014
VL 52
IS 8
BP 956
EP 960
DI 10.3109/13880209.2013.874462
PG 5
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA AM8GF
UT WOS:000340109700004
PM 24601939
OA Bronze
DA 2025-04-28
ER

PT J
AU Mitani, T
   Nagano, T
   Harada, K
   Yamashita, Y
   Ashida, H
AF Mitani, Takakazu
   Nagano, Tomoya
   Harada, Kiyonari
   Yamashita, Yoko
   Ashida, Hitoshi
TI Caffeine-Stimulated Intestinal Epithelial Cells Suppress Lipid
   Accumulation in Adipocytes
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE caffeine; adipogenesis; 3T3-L1 adipocytes; Caco-2 cells
ID MECHANISMS LINKING OBESITY; BETA C/EBP-BETA; INSULIN-RESISTANCE;
   ADIPOSE-TISSUE; PROTEIN; DIFFERENTIATION; ACID; ADIPOGENESIS;
   EXPRESSION; SECRETION
AB Caffeine is a methylxanthine derived from plant foods such as coffee beans and tea leaves, and has multiple biological activities against physiological response and several diseases. Although there are some reports about the direct effect of caffeine against anti-lipid accumulation in vitro, the effect of caffeine on lipid accumulation in adipocytes through stimulating intestinal epithelial cells is unknown. Since direct treatment with caffeine to 3T3-L1 cells did not affect lipid accumulation, we determined whether caffeine-stimulated intestinal epithelial Caco-2 cells influence the lipid accumulation in 3T3-L1 adipocytes. Caco-2 cells were cultured on a transwell insert with or without caffeine for 24 h. Subsequently, the basolateral component of the Caco-2 cell culture on the transwell was collected and termed caffeine-conditioning medium (CCM). When 3T3-L1 adipocytes were incubated with CCM, CCM decreased lipid accumulation and suppressed gene expression of proliferator activated receptor (PPAR) gamma and CCAAT/enhancer binding protein (C/EBP) alpha in 3T3-L1 adipocytes. Furthermore, CCM decreased the expression of C/EBP beta and C/EBP delta at the protein level, but not at the mRNA level. We observed that a proteasome inhibitor, MG132, inhibited CCM-caused down-expression of C/EBP delta and C/EBP delta proteins, and that CCM promoted the ubiquitination level of C/EBP beta and C/EBP delta proteins. Protein microarray analysis showed caffeine suppresses the secretion of inflammatory cytokines, interleukin-8 and plasminogen activator inhibitor-1 from Caco-2 cells. These results suggest that caffeine indirectly suppresses lipid accumulation in 3T3-L1 adipocytes through decreasing secretion of inflammatory cytokines from Caco-2 cells.
C1 [Mitani, Takakazu; Nagano, Tomoya; Harada, Kiyonari; Yamashita, Yoko; Ashida, Hitoshi] Kobe Univ, Dept Agrobiosci, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.
   [Mitani, Takakazu] Shinshu Univ, Dept Interdisciplinary Genome Sci & Cell Metab, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, 8304 Minamiminowa, Nagano 3994598, Japan.
C3 Kobe University; Shinshu University
RP Ashida, H (corresponding author), Kobe Univ, Dept Agrobiosci, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.
EM ashida@kobe-u.ac.jp
RI Mitani, Takakazu/AAL-8251-2020
OI Mitani, Takakazu/0000-0002-2272-9228
FU JSPS KAKENHI Grant [JP25292072]; Grants-in-Aid for Scientific Research
   [17H00818] Funding Source: KAKEN
FX This study was supported by JSPS KAKENHI Grant Number JP25292072 (to
   H.A.).
CR ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Batalha VL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31493
   Brun RP, 1996, CURR OPIN CELL BIOL, V8, P826, DOI 10.1016/S0955-0674(96)80084-6
   BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500
   Caprioli G, 2014, INT J FOOD SCI NUTR, V65, P465, DOI 10.3109/09637486.2013.873890
   Crandall DL, 2006, ARTERIOSCL THROM VAS, V26, P2209, DOI 10.1161/01.ATV.0000235605.51400.9d
   Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X
   Gourineni V, 2012, J AGR FOOD CHEM, V60, P7674, DOI 10.1021/jf3013663
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Ishihara R, 2015, BIOCHEM BIOPH RES CO, V458, P362, DOI 10.1016/j.bbrc.2015.01.118
   JUHANVAGUE I, 1991, DIABETOLOGIA, V34, P457, DOI 10.1007/BF00403280
   KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kim JH, 2016, BIOCHEM BIOPH RES CO, V469, P646, DOI 10.1016/j.bbrc.2015.12.049
   Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606
   Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721
   Lee IA, 2014, J GASTROENTEROL, V49, P1206, DOI 10.1007/s00535-013-0865-3
   Lee Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105603
   Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13
   Lu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038332
   Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336
   Mori S, 2009, INT J BIOL SCI, V5, P311
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Murota K, 2005, J NUTR, V135, P1626, DOI 10.1093/jn/135.7.1626
   Murota K, 2000, ARCH BIOCHEM BIOPHYS, V384, P391, DOI 10.1006/abbi.2000.2123
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI [10.3233/BIO-2009-1083, 10.1002/biof.5520340405]
   Ohara T, 2015, PHYTOTHER RES, V29, P310, DOI 10.1002/ptr.5258
   Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002
   Piao L, 2016, BRIT J PHARMACOL, V173, P2622, DOI 10.1111/bph.13541
   Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613
   Ramakers JD, 2007, LIPIDS, V42, P687, DOI 10.1007/s11745-007-3071-3
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   Rybak ME, 2015, J NUTR, V145, P766, DOI 10.3945/jn.114.205476
   Satsu H, 2009, J NUTR SCI VITAMINOL, V55, P442, DOI 10.3177/jnsv.55.442
   Son DO, 2005, FEBS LETT, V579, P4671, DOI 10.1016/j.febslet.2005.07.038
   Strand DW, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.99
   Tsao CH, 2014, J LIPID RES, V55, P385, DOI 10.1194/jlr.M041392
   Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487
   Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383
   Yamashita Y, 2014, FOOD FUNCT, V5, P2420, DOI [10.1039/c4fo00095a, 10.1039/C4FO00095A]
   YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168
   Zhang TS, 2013, MOL NUTR FOOD RES, V57, P1729, DOI 10.1002/mnfr.201300020
   Zheng GD, 2004, IN VIVO, V18, P55
NR 46
TC 15
Z9 15
U1 1
U2 13
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
EI 1881-7742
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PY 2017
VL 63
IS 5
BP 331
EP 338
DI 10.3177/jnsv.63.331
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FS0NI
UT WOS:000419470400008
PM 29225318
OA gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Seguido, MA
   Tarradas, RM
   González-Rámila, S
   García-Cordero, J
   Sarriá, B
   Bravo-Clemente, L
   Mateos, R
AF Seguido, Miguel Angel
   Tarradas, Rosa Maria
   Gonzalez-Ramila, Susana
   Garcia-Cordero, Joaquin
   Sarria, Beatriz
   Bravo-Clemente, Laura
   Mateos, Raquel
TI Influence of 8-week daily consumption of a new product combining green
   coffee hydroxycinnamates and beta-glucans on polyphenol bioavailability
   in subjects with overweight and obesity
SO FOOD & FUNCTION
LA English
DT Article
ID GUT MICROBIOTA; DIETARY POLYPHENOLS; NUTRACEUTICALS; IDENTIFICATION;
   METABOLISM; HEALTH; FIBER
AB Nutraceuticals based on plant extracts rich in polyphenols, as well as dietary fibres, are new means to fight overweight/obesity and associated diseases. However, to understand the potential effects of polyphenols on health it is critical to study their bioavailability and metabolic fate. Consumption of a green coffee phenolic extract (GCPE) in combination with oat beta-glucan (BG) could affect the pharmacokinetic profile of the main polyphenols present in coffee (hydroxycinnamates). Moreover, the regular intake of the combination could also induce changes. Nine overweight men and women consumed a novel nutraceutical product containing 300 mg of green coffee hydroxycinnamic acids and 2.5 g of BG twice a day for 8 weeks. A pharmacokinetic study was carried out in blood and urine samples taken before (baseline) and at week 8 after the nutraceutical intervention, collecting samples at different times in a 0-24 h interval. Faecal samples were also obtained at 0 and 24 h after the intake of the nutraceutical at baseline and week 8. Phenolic metabolites were analysed by LC-MS-QToF. Results showed that polyphenols were differentially absorbed and extensively metabolized throughout the gastrointestinal tract. An apparent reduction in the excretion of small intestinal metabolites was accompanied by a tendency to increase colonic metabolites after sustained intake (p = 0.052). In conclusion, continued consumption of the GCPE/BG nutraceutical appears to enhance the absorption of hydroxycinnamates by increasing the colonic bioavailability of their derived metabolites compared to baseline, although the regular intake of the nutraceutical did not modify the metabolite profile in any of the biological samples.
C1 [Seguido, Miguel Angel; Tarradas, Rosa Maria; Gonzalez-Ramila, Susana; Garcia-Cordero, Joaquin; Sarria, Beatriz; Bravo-Clemente, Laura; Mateos, Raquel] Spanish Natl Res Council, CSIC, Inst Food Sci Technol & Nutr ICTAN, Jose Antonio Novais 10, Madrid 28040, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN)
RP Bravo-Clemente, L; Mateos, R (corresponding author), Spanish Natl Res Council, CSIC, Inst Food Sci Technol & Nutr ICTAN, Jose Antonio Novais 10, Madrid 28040, Spain.
EM lbravo@ictan.csic.es; raquel.mateos@ictan.csic.es
RI Bravo, Laura/JMC-4928-2023; Sarria, Beatriz/K-7929-2014; MATEOS BRIZ,
   Raquel/H-9125-2012; Bravo, Laura/F-4992-2012
OI Sarria, Beatriz/0000-0003-0614-4606; MATEOS BRIZ,
   Raquel/0000-0002-9722-1939; Seguido, Miguel Angel/0000-0003-3883-7503;
   Bravo, Laura/0000-0002-7312-8641
FU Ministerio de Economia y Competitividad [AGL2015-69986-R]; CSIC
   [PIE202070E184]; Comunidad de Madrid [PEJD-2018-PRE/SAL-9104]
FX We are grateful to volunteers participating in the study and to the
   Analysis Service Unit facilities of ICTAN for the analysis of
   Chromatography and Mass Spectrometry and to Laura Barrios for her
   statistic advice. This research was funded by project AGL2015-69986-R
   from the Ministerio de Economia y Competitividad and grant PIE202070E184
   funded by CSIC. MAS and JGC had predoctoral grants funded by Comunidad
   de Madrid (PEJD-2018-PRE/SAL-9104), respectively.
CR Anhê FF, 2015, CURR OBES REP, V4, P389, DOI 10.1007/s13679-015-0172-9
   Baeza G, 2018, J SCI FOOD AGR, V98, P1397, DOI 10.1002/jsfa.8607
   Bahadoran Z, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-43
   Bhagat AR, 2019, J AOAC INT, V102, P1365, DOI [10.5740/jaoacint.19-0129, 10.1093/jaoac/102.5.1365]
   Borghi C, 2017, BRIT J CLIN PHARMACO, V83, P163, DOI 10.1111/bcp.12902
   Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
   Cercato C, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0468-0
   Cortes-Martin A, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201900952
   Davì G, 2010, CARDIOVASC THER, V28, P216, DOI 10.1111/j.1755-5922.2010.00179.x
   Dima C, 2020, COMPR REV FOOD SCI F, V19, P2862, DOI 10.1111/1541-4337.12623
   Edwards CA, 2017, NUTR BULL, V42, P356, DOI 10.1111/nbu.12296
   Corrêa TAF, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00188
   Fraga CG, 2019, FOOD FUNCT, V10, P514, DOI [10.1039/C8FO01997E, 10.1039/c8fo01997e]
   Gérard P, 2016, CELL MOL LIFE SCI, V73, P147, DOI 10.1007/s00018-015-2061-5
   Gómez-Juaristi M, 2018, FOOD FUNCT, V9, P331, DOI [10.1039/c7fo01553d, 10.1039/C7FO01553D]
   Gómez-Juaristi M, 2018, FOOD CHEM, V240, P1028, DOI 10.1016/j.foodchem.2017.08.003
   Gorji Z, 2019, PHYTOMEDICINE, V63, DOI 10.1016/j.phymed.2019.153018
   Jane M, 2019, NUTRITION, V57, P84, DOI 10.1016/j.nut.2018.05.036
   Janssens PLHR, 2016, PHYSIOL BEHAV, V162, P83, DOI 10.1016/j.physbeh.2016.01.044
   Jayachandran M, 2018, J NUTR BIOCHEM, V61, P101, DOI 10.1016/j.jnutbio.2018.06.010
   Kaur G., 2015, Austin Journal of Pharmacology and Therapeutics, V3, P1063
   Kawabata K, 2019, MOLECULES, V24, DOI 10.3390/molecules24020370
   Kim SY, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0859-1
   Kishimoto Y, 2013, EUR J CLIN NUTR, V67, P532, DOI 10.1038/ejcn.2013.29
   Marín L, 2015, BIOMED RES INT-UK, V2015, DOI 10.1155/2015/905215
   Mena P, 2021, AM J CLIN NUTR, V114, P2107, DOI 10.1093/ajcn/nqab299
   Nasri H, 2014, INT J PREVENTIVE MED, V5, P1487
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Papathanasopoulos A, 2010, GASTROENTEROLOGY, V138, P65, DOI 10.1053/j.gastro.2009.11.045
   Pimpley V, 2020, PREP BIOCHEM BIOTECH, V50, P969, DOI 10.1080/10826068.2020.1786699
   Russell W, 2011, P NUTR SOC, V70, P389, DOI 10.1017/S0029665111000152
   Sima P, 2018, INT J MOL MED, V41, P1799, DOI 10.3892/ijmm.2018.3411
   Stalmach A, 2014, FOOD FUNCT, V5, P1727, DOI [10.1039/c4fo00316k, 10.1039/C4FO00316K]
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Tomás-Barberán FA, 2016, CURR OPIN CLIN NUTR, V19, P471, DOI 10.1097/MCO.0000000000000314
   Venkatakrishnan K, 2019, FOOD FUNCT, V10, P2313, DOI [10.1039/C9FO00293F, 10.1039/c9fo00293f]
   Zhang XHQ, 2020, MOLECULES, V25, DOI 10.3390/molecules25204777
NR 37
TC 1
Z9 1
U1 0
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD FEB 7
PY 2022
VL 13
IS 3
BP 1133
EP 1152
DI 10.1039/d1fo03327a
EA JAN 2022
PG 20
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA YU3VZ
UT WOS:000741523900001
PM 35018954
OA Green Submitted
DA 2025-04-28
ER

PT J
AU Seow, WJ
   Low, DY
   Pan, WC
   Gunther, SH
   Sim, X
   Torta, F
   Herr, DR
   Kovalik, JP
   Ching, JH
   Khoo, CM
   Wenk, MR
   Tai, ES
   van Dam, RM
AF Seow, Wei Jie
   Low, Dorrain Yanwen
   Pan, Wen-Chi
   Gunther, Samuel H.
   Sim, Xueling
   Torta, Federico
   Herr, Deron R.
   Kovalik, Jean-Paul
   Ching, Jianhong
   Khoo, Chin Meng
   Wenk, Markus R.
   Tai, E. Shyong
   van Dam, Rob M.
TI Coffee, Black Tea, and Green Tea Consumption in Relation to Plasma
   Metabolites in an Asian Population
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE acylcarnitines; coffee; metabolites; sphingolipids; tea
ID CARDIOVASCULAR RISK; SERUM-CHOLESTEROL; SINGAPORE; HEALTH; METAANALYSIS;
   CAFFEINE; INDIANS; CHINESE; OBESITY; MALAYS
AB Scope Coffee and tea are among the most popular beverages in the world. However, the association between habitual coffee, green tea, and black tea consumption with metabolomics profiles in Asian populations remain largely unknown.
   Methods and Results 158 metabolites (14 amino acids, 45 acylcarnitines, and 99 sphingolipids) in the blood plasma of participants are measured from the population-based Singapore Prospective Study Program cohort using mass spectrometry (MS). Linear regression models are used to obtain the estimates for the association between coffee and tea consumption with metabolite levels, adjusted for potential confounders and false discovery rate (FDR). Coffee consumption is significantly associated with higher levels of 63 sphingolipids (29 sphingomyelins, 32 ceramides, a sphingosine-1-phosphate, and a sphingosine) and lower levels of 13 acylcarnitines and alanine. Black tea consumption is significantly associated with higher levels of eight sphingolipids, and lower levels of an amino acid, whereas green tea is significantly inversely associated with four metabolites (C8:1-OH acylcarnitine, ganglioside GM3 d18:1/16:0, sphingomyelins d18:2/18:0 and d18:1/14:0).
   Conclusions Coffee, black tea, and green tea consumption are associated with plasma levels of certain classes of sphingolipids and acylcarnitines in an Asian population, particularly sphingomyelins, which may mediate the health benefits of these beverages.
C1 [Seow, Wei Jie; Gunther, Samuel H.; Sim, Xueling; Tai, E. Shyong; van Dam, Rob M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore.
   [Seow, Wei Jie; Gunther, Samuel H.; Sim, Xueling; Khoo, Chin Meng; Tai, E. Shyong; van Dam, Rob M.] Natl Univ Hlth Syst, Singapore 117549, Singapore.
   [Seow, Wei Jie; Sim, Xueling; Khoo, Chin Meng; Tai, E. Shyong; van Dam, Rob M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119228, Singapore.
   [Low, Dorrain Yanwen] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 636921, Singapore.
   [Pan, Wen-Chi] Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei 11221, Taiwan.
   [Torta, Federico; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore Lipid Incubator, Singapore 119228, Singapore.
   [Herr, Deron R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 119228, Singapore.
   [Herr, Deron R.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.
   [Kovalik, Jean-Paul; Ching, Jianhong] Duke NUS Med Sch, Cardiovasc & Metab Disorders Programme, Singapore 169857, Singapore.
C3 National University of Singapore; National University of Singapore;
   National University of Singapore; Nanyang Technological University;
   National Yang Ming Chiao Tung University; National University of
   Singapore; National University of Singapore; California State University
   System; San Diego State University; National University of Singapore
RP Seow, WJ (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore.; Seow, WJ (corresponding author), Natl Univ Hlth Syst, Singapore 117549, Singapore.; Seow, WJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119228, Singapore.
EM ephswj@nus.edu.sg
RI Gunther, Samuel/JKH-8333-2023; Pan, Wenchi/IYS-4773-2023; van Dam,
   Rob/F-9674-2010; Herr, Deron/AAB-7380-2020; Sim, Xueling/AAZ-6652-2020;
   Wenk, Markus/D-1441-2014; Khoo, Chin Meng/AAD-8790-2022
OI Tai, E Shyong/0000-0003-2929-8966; Sim, Xueling/0000-0002-1233-7642;
   Pan, Wen-Chi/0000-0002-0588-8083; Low, Dorrain
   Yanwen/0000-0002-7742-3189
FU National University of Singapore Start-Up Grant; Singapore Ministry of
   Education Tier 1 Grant [NUHSRO/2014/085/AF-Partner/01]; National Medical
   Research Council; Ministry of Health Alignment Fund; Janssen
   Pharmaceuticals Inc.; National Kidney Foundation
FX The authors would like to thank the following funding sources, National
   University of Singapore Start-Up Grant; Singapore Ministry of Education
   Tier 1 Grant, NUHSRO/2014/085/AF-Partner/01; National Medical Research
   Council, Clinician Scientist Award: (2014-2018), Ministry of Health
   Alignment Fund, Janssen Pharmaceuticals Inc., (2016-2018); National
   Kidney Foundation (2016-2018). The authors would also like to thank Ms.
   Ee Kim Huey and Mr. Kevin Timothy Fridianto for performing the amino
   acid and acylcarnitine assays.
CR Altmaier E, 2009, MOL NUTR FOOD RES, V53, P1357, DOI 10.1002/mnfr.200900116
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Burla B, 2018, METHODS MOL BIOL, V1730, P135, DOI 10.1007/978-1-4939-7592-1_11
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Chai JF, 2020, HUM MOL GENET, V29, P189, DOI 10.1093/hmg/ddz246
   Chau YP, 2020, J CLIN ENDOCR METAB, V105, pE619, DOI 10.1210/clinem/dgz210
   Chew WS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126925
   Corrêa TAF, 2013, NUTRITION, V29, P977, DOI 10.1016/j.nut.2013.01.003
   Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908
   Dwyer JT, 2013, AM J CLIN NUTR, V98, p1611S, DOI 10.3945/ajcn.113.059584
   Floegel A, 2014, INT J OBESITY, V38, P1388, DOI 10.1038/ijo.2014.39
   Floegel A, 2013, EUR J CLIN NUTR, V67, P1100, DOI 10.1038/ejcn.2013.147
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Hughes K, 1997, J EPIDEMIOL COMMUN H, V51, P394, DOI 10.1136/jech.51.4.394
   HUGHES K, 1990, J EPIDEMIOL COMMUN H, V44, P29, DOI 10.1136/jech.44.1.29
   Iqbal J, 2017, TRENDS ENDOCRIN MET, V28, P506, DOI 10.1016/j.tem.2017.03.005
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   Leow MKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067138
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Menni C, 2013, METABOLOMICS, V9, P506, DOI 10.1007/s11306-012-0469-6
   Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005
   Naidoo N, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-48
   Nang EEK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-141
   NEHLIG A, 1994, MUTAT RES, V317, P145, DOI 10.1016/0165-1110(94)90022-1
   Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002
   Papandreou C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051032
   Poss AM, 2020, J CLIN INVEST, V130, P1363, DOI 10.1172/JCI131838
   Post SM, 2000, ARTERIOSCL THROM VAS, V20, P1551, DOI 10.1161/01.ATV.20.6.1551
   RATNAYAKE WMN, 1993, FOOD CHEM TOXICOL, V31, P263, DOI 10.1016/0278-6915(93)90076-B
   Rebello SA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-61
   Rothwell JA, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900659
   Rothwell JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093474
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shi L, 2020, J INTERN MED, V287, P405, DOI 10.1111/joim.13009
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Spiller M.A., 1998, Caffeine, P97
   Strandhagen E, 2003, EUR J CLIN NUTR, V57, P1164, DOI 10.1038/sj.ejcn.1601668
   Subramanian N, 1999, J AGR FOOD CHEM, V47, P2571, DOI 10.1021/jf981042y
   Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241
   Tan KHX, 2018, INT J EPIDEMIOL, V47, P699, DOI 10.1093/ije/dyy014
   Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322
NR 42
TC 17
Z9 17
U1 1
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD DEC
PY 2020
VL 64
IS 24
AR 2000527
DI 10.1002/mnfr.202000527
EA NOV 2020
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA PH0YM
UT WOS:000589511700001
PM 33120436
DA 2025-04-28
ER

PT J
AU Monteiro, LS
   Rodrigues, PRM
   de Vasconcelos, TM
   Alves, IA
   Yokoo, EM
   Sichieri, R
   Pereira, RA
AF Monteiro, Luana Silva
   Rodrigues, Paulo Rogerio Melo
   de Vasconcelos, Thais Meirelles
   Alves, Iuna Arruda
   Yokoo, Edna Massae
   Sichieri, Rosely
   Pereira, Rosangela Alves
TI Variations in beverage consumption in Brazilian adults per weight
   status: Analysis of the 2008-2009 and 20172018 National Food Surveys
SO REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
LA English
DT Article
DE Adult; Beverages; Food intake; Weight status
ID SUGAR-SWEETENED BEVERAGES; MULTIPLE-PASS METHOD; ENERGY; AUSTRALIA;
   OBESITY; COMPENSATION; OVERWEIGHT; PATTERNS; RISK
AB Objective To evaluate the variations between 2008 and 2018 in the consumption of beverages by Brazilian adults per their weight status. Methods This panel study analyzed data from two National Food Surveys referring to the adult population (20-59 years of age) (2008-2008: n=21,003; 2017-2018: n=28,153), with data from food consumption obtained by one food record day and one 24-hour recall day, respectively. The drinks were grouped into 11 groups, for which we estimated the reporting proportion (%), daily means of ingested volume (mL), and contribution (%) to daily energy intake. We assessed weight status by Body Mass Index in not overweight, overweight, and obese. Results No differences were observed in the proportion of adults who reported consuming a drink (98.5% vs. 98.3%) during the period evaluated. However, the mean daily volume (631.9mL vs. 535.1mL) and the caloric contribution of drinks (17.7% vs. 13.6%) decreased. The drinks most cited in both surveys were coffee, fruit juices, and soft drinks. Not overweight and overweight individuals showed a reduction in the reported and mean volume consumed of coffee, soft drinks, milk, dairy drinks, and processed refreshments/juices. We observed a decline in the reported consumption and volume consumed of soft drinks and milk in obese individuals. Conclusion We identified decreased reporting, mean volume, and mean caloric contribution of drinks in general in the Brazilian adult population over the 10-year period between the two surveys.
C1 [Monteiro, Luana Silva] Univ Fed Rio De Janeiro, Ctr Multidisciplinar, Inst Alimentacao & Nutr, Macae, RJ, Brazil.
   [Rodrigues, Paulo Rogerio Melo] Univ Fed Mato Grosso, Fac Nutr, Cuiaba, MT, Brazil.
   [de Vasconcelos, Thais Meirelles; Pereira, Rosangela Alves] Univ Estadual Ceara, Programa Posgrad Saude Colet, Fortaleza, CE, Brazil.
   [Alves, Iuna Arruda] UNIV FED RIO DE JANEIRO, CTR CIENCIAS SAUDE, Dept Nutr Social & Aplicada, RIO DE JANEIRO, RJ, Brazil.
   [Yokoo, Edna Massae] Univ Fed Fluminense, Dept Epidemiol & Bioestatist, Niteroi, RJ, Brazil.
   [Sichieri, Rosely] Univ Estado Rio De Janeiro, Inst Med Social, Rio De Janeiro, RJ, Brazil.
C3 Universidade Federal do Rio de Janeiro; Universidade Federal de Mato
   Grosso; Universidade Estadual do Ceara; Universidade Federal do Rio de
   Janeiro; Universidade Federal Fluminense; Universidade do Estado do Rio
   de Janeiro
RP Monteiro, LS (corresponding author), Univ Fed Rio De Janeiro, Ctr Multidisciplinar, Inst Alimentacao & Nutr, Macae, RJ, Brazil.
EM luananutrir@gmail.com
RI Rodrigues, Paulo/C-9217-2013; Vasconcelos, Thais/KFT-1944-2024; Arruda
   Alves, Iuna/KFR-7251-2024; Pereira, Rosangela/D-8830-2013; Melo
   Rodrigues, Paulo Rogerio/P-4456-2017
OI Alves, Iuna/0000-0002-4872-314X; Yokoo, Edna/0000-0002-3513-2084;
   Pereira, Rosangela/0000-0002-9886-9796; Meirelles de Vasconcelos,
   Thais/0000-0003-0108-8991; Silva Monteiro, Luana/0000-0003-3599-6947;
   Melo Rodrigues, Paulo Rogerio/0000-0002-4213-0685
CR [Anonymous], IBGE-Instituto Brasileiro de Geografia e Estatistica. (2023). Censo Demografico 2022: indigenas: primeiros resultados do universo. Instituto Brasileiro de Geografia e Estatistica (IBGE), 193p. IBGE, Rio de Janeiro. Disponivel em: https://biblioteca.ibge.gov.br/visualizacao/livros/liv102018.pdf
   [Anonymous], 2011, Pesquisa de Orcamentos Familiares 2008-2009. Analise do Consumo Alimentar Pessoal no Brasil
   [Anonymous], 34. WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry (1993: Geneva, Switzerland) World Health Organization. Physical status: the use of and interpretation of anthropometry, report of a WHO expert committee. World Health Organization. 1995 https://apps.who.int/iris/handle/10665/37003
   [Anonymous], Tabela Brasileira de Composicao de Alimentos -TBCA. (2020). Universidade de Sao Paulo (USP). Food Research Center (FoRC). Versao 7.1. Sao Paulo. Acesso em 28 de nov. 2021. Disponivel em: http://www.fcf.usp.br/tbca.
   Barclay AW, 2011, NUTRIENTS, V3, P491, DOI 10.3390/nu3040491
   Bellou V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194127
   Borges MC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002195
   Brand-Miller JC, 2017, AM J CLIN NUTR, V105, P854, DOI 10.3945/ajcn.116.145318
   Bray GA, 2013, ADV NUTR, V4, P220, DOI 10.3945/an.112.002816
   Cavalcante JB, 2023, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.969045
   Cena H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020334
   Conway JM, 2004, J AM DIET ASSOC, V104, P595, DOI 10.1016/j.jada.2004.01.007
   Louzada MLD, 2015, REV SAUDE PUBL, V49, DOI [10.1590/S0034-8910.2015049006132, 10.1590/S0034-8910.2015049005650]
   Dandamudi A, 2018, ANTICANCER RES, V38, P3209, DOI 10.21873/anticanres.12586
   de Moraes ABD, 2022, CAD SAUDE PUBLICA, V38, DOI [10.1590/0102-311xen144521, 10.1590/0102-311XEN144521]
   Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011
   Ebbeling CB, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015668
   Elizabeth L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12071955
   Nilson EAF, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.32
   Figueiredo N, 2018, PUBLIC HEALTH NUTR, V21, P3307, DOI 10.1017/S1368980018002161
   Fontes AS, 2019, REV NUTR, V32, DOI 10.1590/1678-9865201932e180121
   Gombi-Vaca MF, 2016, APPETITE, V98, P67, DOI 10.1016/j.appet.2015.12.014
   Gonzalez JT, 2012, OBES REV, V13, P848, DOI 10.1111/j.1467-789X.2012.01013.x
   Instituto Brasileiro de Geografia e Estatistica, 2020, Pesquisa de Or4amentos Familiares: 2017-2018: Analise do consumo alimentar pessoal no Brasil
   Lane MM, 2021, OBES REV, V22, DOI 10.1111/obr.13146
   Leal JSV, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.1088051
   Levy G, 2007, NUTR DIET, V64, P268, DOI 10.1111/j.1747-0080.2007.00223.x
   Levy GS, 2014, NUTR DIET, V71, P193, DOI 10.1111/1747-0080.12108
   Lopes TS, 2016, EUR J CLIN NUTR, V70, P1259, DOI 10.1038/ejcn.2016.85
   Louie JCY, 2011, OBES REV, V12, pE582, DOI 10.1111/j.1467-789X.2011.00881.x
   Luger M, 2017, OBESITY FACTS, V10, P674, DOI 10.1159/000484566
   Malik VS, 2022, NAT REV ENDOCRINOL, V18, P205, DOI 10.1038/s41574-021-00627-6
   Marriott BP, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092004
   Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   Ministerio da Saude; Secretaria de Vigilancia em Saude; Departamento de Analise em Saude e Vigilancia de Doencas Nao Transmissiveis (Brasil), 2022, Vigilancia de fatores de risco e prote4ao para doen4as cronicas por inquerito telefonico: Estimativas sobre frequencia e distribui4ao sociodemografica do estado nutricional e consumo alimentar nas capitais dos 26 estados brasileiros e no Distrito Federal entre 2006 e 2020
   Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324
   Nilson EAF, 2023, AM J PREV MED, V64, P129, DOI 10.1016/j.amepre.2022.08.013
   Oliveira N, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.956142
   Pagliai G, 2021, BRIT J NUTR, V125, P308, DOI 10.1017/S0007114520002688
   Pereira RA, 2023, Alimenta4o e Nutri4o no Brasil: Perspectiva na seguran4a e soberania alimentar
   Rios-Leyvraz M., 2022, HLTH EFFECTS USE NON
   Rodrigues RM, 2021, REV SAUDE PUBL, V55, DOI 10.11606/s1518-8787.2021055003365
   Alonso PR, 2016, NUTR HOSP, V33, P46, DOI 10.20960/nh.316
   Shrapnel WS, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041016
   Singh GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124845
   Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092
   Thompson FE, 2015, J ACAD NUTR DIET, V115, P1986, DOI 10.1016/j.jand.2015.08.016
   Verly E Jr, 2021, REV SAUDE PUBL, V55, DOI 10.11606/s1518-8787.2021055003343
NR 48
TC 0
Z9 0
U1 0
U2 0
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO
   ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 1415-5273
EI 1678-9865
J9 REV NUTR
JI Rev. Nutr.
PY 2024
VL 37
AR e230197
DI 10.1590/1678-9865202437e230197
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA P9F2B
UT WOS:001380868300001
OA gold
DA 2025-04-28
ER

PT J
AU Thorpe, HHA
   Fontanillas, P
   Pham, BK
   Meredith, JJ
   Jennings, MV
   Courchesne-Krak, NS
   Vilar-Ribó, L
   Bianchi, SB
   Mutz, J
   Elson, SL
   Khokhar, JY
   Abdellaoui, A
   Davis, LK
   Palmer, AA
   Sanchez-Roig, S
AF Thorpe, Hayley H. A.
   Fontanillas, Pierre
   Pham, Benjamin K.
   Meredith, John J.
   Jennings, Mariela V.
   Courchesne-Krak, Natasia S.
   Vilar-Ribo, Laura
   Bianchi, Sevim B.
   Mutz, Julian
   Elson, Sarah L.
   Khokhar, Jibran Y.
   Abdellaoui, Abdel
   Davis, Lea K.
   Palmer, Abraham A.
   Sanchez-Roig, Sandra
CA 23andMe Res Team
TI Genome-wide association studies of coffee intake in UK/US participants
   of European ancestry uncover cohort-specific genetic associations
SO NEUROPSYCHOPHARMACOLOGY
LA English
DT Article
ID DOSE-RESPONSE METAANALYSIS; CARDIOVASCULAR-DISEASE; HEALTH OUTCOMES;
   CONSUMPTION; CAFFEINE; ALCOHOL; RISK; POPULATION; CANNABIS; SMOKING
AB Coffee is one of the most widely consumed beverages. We performed a genome-wide association study (GWAS) of coffee intake in US-based 23andMe participants (N = 130,153) and identified 7 significant loci, with many replicating in three multi-ancestral cohorts. We examined genetic correlations and performed a phenome-wide association study across hundreds of biomarkers, health, and lifestyle traits, then compared our results to the largest available GWAS of coffee intake from the UK Biobank (UKB; N = 334,659). We observed consistent positive genetic correlations with substance use and obesity in both cohorts. Other genetic correlations were discrepant, including positive genetic correlations between coffee intake and psychiatric illnesses, pain, and gastrointestinal traits in 23andMe that were absent or negative in the UKB, and genetic correlations with cognition that were negative in 23andMe but positive in the UKB. Phenome-wide association study using polygenic scores of coffee intake derived from 23andMe or UKB summary statistics also revealed consistent associations with increased odds of obesity- and red blood cell-related traits, but all other associations were cohort-specific. Our study shows that the genetics of coffee intake associate with substance use and obesity across cohorts, but also that GWAS performed in different populations could capture cultural differences in the relationship between behavior and genetics.
C1 [Thorpe, Hayley H. A.] Western Univ, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada.
   [Thorpe, Hayley H. A.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON, Canada.
   [Fontanillas, Pierre; Elson, Sarah L.; Khokhar, Jibran Y.; Abdellaoui, Abdel; Davis, Lea K.; Palmer, Abraham A.; 23andMe Res Team] 23andMe Inc, Sunnyvale, CA USA.
   [Pham, Benjamin K.; Meredith, John J.; Jennings, Mariela V.; Courchesne-Krak, Natasia S.; Bianchi, Sevim B.; Sanchez-Roig, Sandra] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.
   [Vilar-Ribo, Laura] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Psychiat Genet Unit, Grp Psychiat Mental Hlth & Addict, Barcelona, Spain.
   [Mutz, Julian] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England.
   Univ Amsterdam, Dept Psychiat, Amsterdam UMC, Amsterdam, Netherlands.
   Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA.
   [Sanchez-Roig, Sandra] Vanderbilt Univ, Dept Med, Div Genet Med, Med Ctr, Nashville, TN 37232 USA.
   Vanderbilt Univ, Dept Psychiat & Behav Sci, Med Ctr, Nashville, TN USA.
   [Sanchez-Roig, Sandra] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.
C3 Western University (University of Western Ontario); University of
   Guelph; Ontario Veterinary College; 23andMe, Inc.; University of
   California System; University of California San Diego; Autonomous
   University of Barcelona; Hospital Universitari Vall d'Hebron; Vall
   d'Hebron Institut de Recerca (VHIR); University of London; King's
   College London; Vrije Universiteit Amsterdam; University of Amsterdam;
   Vanderbilt University; Vanderbilt University; Vanderbilt University;
   University of California System; University of California San Diego
RP Sanchez-Roig, S (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.; Sanchez-Roig, S (corresponding author), Vanderbilt Univ, Dept Med, Div Genet Med, Med Ctr, Nashville, TN 37232 USA.; Sanchez-Roig, S (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.
EM sanchezroige@ucsd.edu
RI Thorpe, Hayley/JLK-9413-2023; Courchesne, Natasia/ABF-3934-2020;
   Khokhar, Jibran/AAI-4010-2021; Mutz, Julian/AAW-2775-2020
OI Courchesne-Krak, Natasia/0000-0002-9231-647X; Vilar-Ribo,
   Laura/0000-0001-8758-523X; Mutz, Julian/0000-0001-5308-1957
FU California Tobacco-Related Disease Research Program (TRDRP) [T29KT0526,
   T32IR5226]; NIH/NIDA [P50DA037844, DP1DA054394]; Natural Science and
   Engineering Research Council PGS-D scholarship and Canadian Institutes
   of Health Research (CIHR) Fellowship [491556]; CIHR Canada Research
   Chair in Translational Neuropsychopharmacology; NSCK [R01 MH113362];
   Interdisciplinary Research Fellowship in Neuro AIDs [R25MH081482];
   NIH/NIAAA Loan Repayment Program - National Institute for Health
   [L40AA031140]; Care Research(NIHR) Maudsley Biomedical Research Centre
   at South London; Maudsley NHS Foundation Trust and King's College
   London; NIH [S10RR025141]; CTSA [UL1TR002243, UL1TR000445, UL1RR024975,
   U01HG004798, R01NS032830, RC2GM092618, P50GM115305, U01HG006378,
   U19HL065962, R01HD074711]; National Center for Research Resources
   [UL1RR024975-01]; National Center for Advancing Translational Sciences
   [2UL1 TR000445-06]
FX MVJ, SBB, and SSR are supported by funds from the California
   Tobacco-Related Disease Research Program (TRDRP; Grant Number T29KT0526
   and T32IR5226). SBB and AAP were also supported by P50DA037844. BKP,
   JJM, and SSR are supported by NIH/NIDA DP1DA054394. HHAT is funded
   through a Natural Science and Engineering Research Council PGS-D
   scholarship and Canadian Institutes of Health Research (CIHR) Fellowship
   (#491556). JYK is supported by a CIHR Canada Research Chair in
   Translational Neuropsychopharmacology. LKD is supported by R01 MH113362.
   NSCK is funded through an Interdisciplinary Research Fellowship in Neuro
   AIDs (Grant Number R25MH081482) and an NIH/NIAAA Loan Repayment
   Program(L40AA031140). JM is funded by the National Institute for Health
   and Care Research(NIHR) Maudsley Biomedical Research Centre at South
   London and Maudsley NHS Foundation Trust and King's College London. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health. The datasets used for the Phe WAS and Lab WAS analyses described
   were obtained from Vanderbilt University Medical Center's Bio VU which
   is supported by numerous sources: institutional funding, private
   agencies, and federal grants. These include the NIH funded Shared
   Instrumentation Grant S10RR025141; and CTSA grants UL1TR002243,
   UL1TR000445, and UL1RR024975. Genomic data are also supported by
   investigator-led projects that include U01HG004798, R01NS032830,
   RC2GM092618, P50GM115305, U01HG006378, U19HL065962, R01HD074711; and
   additional funding sources listed
   athttps://victr.vumc.org/biovu-funding/. Phe WAS and Lab WAS analyses
   used CTSA (SD, Vanderbilt Resources).This project was supported by the
   National Center for Research Resources, Grant UL1RR024975-01, and is now
   at the National Center for Advancing Translational Sciences, Grant 2UL1
   TR000445-06.
CR Abdellaoui A, 2022, NAT GENET, V54, P1265, DOI 10.1038/s41588-022-01163-3
   Aldrich MC, 2009, CANCER RES, V69, P2340, DOI 10.1158/0008-5472.CAN-08-2576
   Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101
   Araújo LF, 2016, J ALZHEIMERS DIS, V53, P451, DOI 10.3233/JAD-160116
   Barbeira AN, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007889
   Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1
   Bjorngaard JH, 2017, INT J EPIDEMIOL, V46, P1958, DOI 10.1093/ije/dyx147
   Bulik-Sullivan Brendan, 2015, Nat Genet, V47, P1236, DOI 10.1038/ng.3406
   Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cai W, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-018-0877-3
   Camandola S, 2019, NEUROCHEM RES, V44, P214, DOI 10.1007/s11064-018-2492-0
   Carroll RJ, 2014, BIOINFORMATICS, V30, P2375, DOI 10.1093/bioinformatics/btu197
   Chang LH, 2020, DRUG ALCOHOL DEPEN, V210, DOI 10.1016/j.drugalcdep.2020.107966
   Chen XN, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-038902
   Chieng D, 2022, EUR J PREV CARDIOL, V29, P2240, DOI 10.1093/eurjpc/zwac189
   Clarke TK, 2017, MOL PSYCHIATR, V22, P1376, DOI 10.1038/mp.2017.153
   Cole JB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15193-0
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2022, ANN NEUROL, V91, P834, DOI 10.1002/ana.26349
   Cornelis MC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-03153-7
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   Deak JD, 2021, PSYCHOL MED, V51, P2189, DOI 10.1017/S0033291721000969
   Dennis J, 2021, MOL PSYCHIATR, V26, P4254, DOI 10.1038/s41380-019-0614-y
   Di Maso M, 2021, ADV NUTR, V12, P1160, DOI 10.1093/advances/nmaa177
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Durand E. Y., 2014, 010512BIORXIV, DOI [10.1101/010512, DOI 10.1101/010512]
   Ellison-Barnes A, 2021, JAMA-J AM MED ASSOC, V326, P2073, DOI 10.1001/jama.2021.16685
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Gao H, 2019, J CLIN TRANSL HEPATO, V7, P297, DOI 10.14218/JCTH.2019.00030
   Ge T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09718-5
   Gelernter J, 2021, NAT REV GENET, V22, P712, DOI 10.1038/s41576-021-00377-1
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Haller S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101391
   Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237
   Hettema JM, 1999, DRUG ALCOHOL DEPEN, V57, P69, DOI 10.1016/S0376-8716(99)00053-8
   Hong CT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061860
   Hou C, 2022, AM J CLIN NUTR, V116, P730, DOI 10.1093/ajcn/nqac148
   International Coffee Organization, 2021, ANN REV COFFEE YEAR
   Jee HJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103080
   Jia HJ, 2019, BMC GENET, V20, DOI 10.1186/s12863-019-0763-7
   Jin T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082228
   Johnson EC, 2020, LANCET PSYCHIAT, V7, P1032, DOI 10.1016/S2215-0366(20)30339-4
   Kang JJ, 2022, CEREB CORTEX, V32, P5163, DOI 10.1093/cercor/bhac005
   Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P674, DOI 10.1001/archpsyc.65.6.674
   Kennedy OJ, 2016, ALIMENT PHARM THER, V43, P562, DOI 10.1111/apt.13523
   Kennedy OJ, 2020, AM J KIDNEY DIS, V75, P753, DOI 10.1053/j.ajkd.2019.08.025
   Kim EJ, 2021, JAMA INTERN MED, V181, P1185, DOI 10.1001/jamainternmed.2021.3616
   Kim Y, 2019, EUR J EPIDEMIOL, V34, P731, DOI 10.1007/s10654-019-00524-3
   Kositamongkol C, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.786596
   Laaboub N, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.756403
   Landais E, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060725
   Laurienti PJ, 2002, NEUROIMAGE, V17, P751, DOI 10.1006/nimg.2002.1237
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Linnér RK, 2021, NAT NEUROSCI, V24, P1367, DOI 10.1038/s41593-021-00908-3
   Liu QP, 2016, NUTRITION, V32, P628, DOI 10.1016/j.nut.2015.11.015
   Loftfield E, 2018, JAMA INTERN MED, V178, P1086, DOI 10.1001/jamainternmed.2018.2425
   Magalhaes R, 2021, MOL PSYCHIATR, V26, P6589, DOI 10.1038/s41380-021-01075-4
   Mallard Travis T, 2021, Complex Psychiatry, V7, P45, DOI 10.1159/000518863
   Matoba N, 2020, NAT HUM BEHAV, V4, P308, DOI 10.1038/s41562-019-0805-1
   Menashe I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029396
   Mentis AFA, 2021, BMC MED, V19, DOI 10.1186/s12916-020-01873-7
   Nakagawa-Senda H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19914-w
   Nehlig A, 2022, NUTRIENTS, V14, DOI 10.3390/nu14020399
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Nordestgaard AT, 2022, EUR J NUTR, V61, P573, DOI 10.1007/s00394-021-02650-9
   Perlaki G, 2011, BRAIN IMAGING BEHAV, V5, P274, DOI 10.1007/s11682-011-9131-6
   Pham K, 2022, NUTR NEUROSCI, V25, P2111, DOI 10.1080/1028415X.2021.1945858
   Pirastu N, 2016, SCI REP-UK, V6, DOI 10.1038/srep31590
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Qi X, 2022, NUTRIENTS, V14, DOI 10.3390/nu14061134
   Raja AM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103558
   Ramli NNS, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57090957
   Rehm CD, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082463
   Reyes CM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111772
   Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89
   Rotunno M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005652
   Said MA, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016808
   Sanchez-Roige S, 2023, TRANSL PSYCHIAT, V13, DOI 10.1038/s41398-023-02453-y
   Sanchez-Roige S, 2020, NAT NEUROSCI, V23, P475, DOI 10.1038/s41593-020-0609-7
   Sanchez-Roige S, 2020, BIOL PSYCHIAT, V87, P609, DOI 10.1016/j.biopsych.2019.09.011
   Sanchez-Roige S, 2019, AM J PSYCHIAT, V176, P107, DOI 10.1176/appi.ajp.2018.18040369
   Sartini M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030694
   Schubert MM, 2017, INT J FOOD SCI NUTR, V68, P901, DOI 10.1080/09637486.2017.1320537
   Schwartz A, 2021, APPETITE, V164, DOI 10.1016/j.appet.2021.105260
   Sey NYA, 2020, NAT NEUROSCI, V23, P583, DOI 10.1038/s41593-020-0603-0
   Socala K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010107
   Song MY, 2021, J THROID RES, V2021, DOI 10.1155/2021/7664641
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Svikis DS, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-022-13012-3
   Swan GE, 1996, J SUBST ABUSE, V8, P19, DOI 10.1016/S0899-3289(96)90055-3
   Swan GE, 1997, J STUD ALCOHOL, V58, P182, DOI 10.15288/jsa.1997.58.182
   Tang NP, 2010, LUNG CANCER, V67, P17, DOI 10.1016/j.lungcan.2009.03.012
   Thompson A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay5034
   Treur JL, 2017, ADDICT BIOL, V22, P1090, DOI 10.1111/adb.12391
   Treur JL, 2016, ADDICTION, V111, P1059, DOI 10.1111/add.13298
   Vanyukov MM, 2012, DRUG ALCOHOL DEPEN, V123, pS3, DOI 10.1016/j.drugalcdep.2011.12.018
   Verweij KJH, 2018, ADDICTION, V113, P1333, DOI 10.1111/add.14154
   Vogel CFA, 2020, REDOX BIOL, V34, DOI 10.1016/j.redox.2020.101530
   Wang TG, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0862-0
   Ware JJ, 2017, ADDICTION, V112, P1842, DOI 10.1111/add.13888
   Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340
   Wojcik GL, 2019, NATURE, V570, P514, DOI 10.1038/s41586-019-1310-4
   Wu L, 2017, CLIN NUTR, V36, P730, DOI 10.1016/j.clnu.2016.05.015
   Xiao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep11751
   Xu J, 2022, NANO-MICRO LETT, V14, DOI 10.1007/s40820-021-00763-8
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Yin B, 2022, FRONT PSYCHIATRY, V13, DOI 10.3389/fpsyt.2022.910432
   Yuan S, 2022, PAIN, V163, pE342, DOI 10.1097/j.pain.0000000000002360
   Zhao LG, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6561-9
   Zhong VW, 2019, HUM MOL GENET, V28, P2449, DOI 10.1093/hmg/ddz061
   Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2
NR 113
TC 2
Z9 2
U1 4
U2 4
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0893-133X
EI 1740-634X
J9 NEUROPSYCHOPHARMACOL
JI Neuropsychopharmacology
PD SEP
PY 2024
VL 49
IS 10
BP 1609
EP 1618
DI 10.1038/s41386-024-01870-x
EA JUN 2024
PG 10
WC Neurosciences; Pharmacology & Pharmacy; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA C5C2K
UT WOS:001242771300001
PM 38858598
DA 2025-04-28
ER

PT J
AU Ren, YL
   Frank, T
   Meyer, G
   Lei, JZ
   Grebenc, JR
   Slaughter, R
   Gao, YG
   Kinghorn, AD
AF Ren, Yulin
   Frank, Tyler
   Meyer, Gunnar
   Lei, Jizhou
   Grebenc, Jessica R.
   Slaughter, Ryan
   Gao, Yu G.
   Kinghorn, A. Douglas
TI Potential Benefits of Black Chokeberry (Aronia melanocarpa)
   Fruits and Their Constituents in Improving Human Health
SO MOLECULES
LA English
DT Review
DE black chokeberry; Aronia melanocarpa; phenolic constituents;
   antioxidants; anti-infectives; antitumor effects; human health
ID JUICE CONSUMPTION; OXIDATIVE STRESS; INSULIN-RECEPTOR; COLON-CANCER;
   ANTIOXIDANT; PRODUCTS; EXTRACT; BERRY; INFLAMMATION; DISEASES
AB Aronia berry (black chokeberry) is a shrub native to North America, of which the fresh fruits are used in the food industry to produce different types of dietary products. The fruits of Aronia melanocarpa (Aronia berries) have been found to show multiple bioactivities potentially beneficial to human health, including antidiabetic, anti-infective, antineoplastic, antiobesity, and antioxidant activities, as well as heart-, liver-, and neuroprotective effects. Thus far, phenolic compounds, such as anthocyanins, cyanidins, phenolic acids, proanthocyanidins, triterpenoids, and their analogues have been identified as the major active components of Aronia berries. These natural products possess potent antioxidant activity, which contributes to the majority of the other bioactivities observed for Aronia berries. The chemical components and the potential pharmaceutical or health-promoting effects of Aronia berries have been summarized previously. The present review article focuses on the molecular targets of extracts of Aronia berries and the examples of promising lead compounds isolated from these berries, including cyanidin-3-O-galactoside, chlorogenic acid, quercetin, and ursolic acid. In addition, presented herein are clinical trial investigations for Aronia berries and their major components, including cancer clinical trials for chlorogenic acid and COVID-19 trial studies for quercetin. Additionally, the possible development of Aronia berries and their secondary metabolites as potential therapeutic agents is discussed. It is hoped that this contribution will help stimulate future investigations on Aronia berries for the continual improvement of human health.
C1 [Ren, Yulin; Frank, Tyler; Meyer, Gunnar; Lei, Jizhou; Grebenc, Jessica R.; Kinghorn, A. Douglas] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA.
   [Slaughter, Ryan; Gao, Yu G.] Ohio State Univ, OSU South Ctr, Columbus, OH 43210 USA.
   [Slaughter, Ryan; Gao, Yu G.] Ohio State Univ, Coll Food Agr & Environm Sci, Dept Hort & Crop Sci, Columbus, OH 43210 USA.
C3 University System of Ohio; Ohio State University; University System of
   Ohio; Ohio State University; University System of Ohio; Ohio State
   University
RP Ren, YL; Kinghorn, AD (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA.
EM ren.41@osu.edu; kinghorn.4@osu.edu
OI Kinghorn, A. Douglas/0000-0002-6647-8707; , Gunnar
   Meyer/0009-0007-3920-7390
FU National Cancer Institute, National Institutes of Health [P01 CA125066]
FX This work was supported by grant P01 CA125066 funded by the National
   Cancer Institute, National Institutes of Health, to A.D.K.
CR Al-kuraishy HM, 2022, INFLAMMOPHARMACOLOGY, V30, P1493, DOI 10.1007/s10787-022-01038-3
   Aldrich LN, 2022, J NAT PROD, V85, P702, DOI 10.1021/acs.jnatprod.2c00036
   Anari F, 2018, FUTURE ONCOL, V14, P1409, DOI 10.2217/fon-2017-0585
   Banjari I, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00053
   Bermúndez-Soto MJ, 2007, J NUTR BIOCHEM, V18, P259, DOI 10.1016/j.jnutbio.2006.05.003
   Borowska S, 2018, CURR DRUG TARGETS, V19, P1612, DOI 10.2174/1389450119666180403101555
   Borowska S, 2016, COMPR REV FOOD SCI F, V15, P982, DOI 10.1111/1541-4337.12221
   Cao YY, 2013, J MOL ENDOCRINOL, V51, P15, DOI 10.1530/JME-12-0171
   Chen C, 2023, NUTR NEUROSCI, V26, P414, DOI 10.1080/1028415X.2022.2051957
   Chen Y, 2023, CRIT REV FOOD SCI, V63, P4288, DOI 10.1080/10408398.2021.2000932
   Choi HS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092528
   Christiansen Christine B, 2022, Rev Diabet Stud, V18, P76, DOI 10.1900/RDS.2022.18.76
   Chrubasik C, 2010, PHYTOTHER RES, V24, P1107, DOI 10.1002/ptr.3226
   Dai J, 2007, J MED FOOD, V10, P258, DOI 10.1089/jmf.2006.238
   Daoutidou M, 2021, FOODS, V10, DOI 10.3390/foods10030486
   Daskalova E, 2019, FOOD CHEM TOXICOL, V132, DOI 10.1016/j.fct.2019.110674
   Dehelean CA, 2021, MOLECULES, V26, DOI 10.3390/molecules26041109
   Denev P, 2019, FOOD CHEM, V284, P108, DOI 10.1016/j.foodchem.2019.01.108
   Deng HT, 2021, LWT-FOOD SCI TECHNOL, V150, DOI 10.1016/j.lwt.2021.112018
   Dragan S, 2015, CURR MED CHEM, V22, P14
   Gajic D, 2020, FOOD FUNCT, V11, P7793, DOI [10.1039/d0fo00946f, 10.1039/D0FO00946F]
   Gao NX, 2018, MOLECULES, V23, DOI 10.3390/molecules23010139
   Gill NK, 2021, NUTR CANCER, V73, P1168, DOI 10.1080/01635581.2020.1789679
   Gramza-Michalowska A, 2017, J FUNCT FOODS, V37, P116, DOI 10.1016/j.jff.2017.07.050
   Güler O, 2021, S AFR J BOT, V142, P53, DOI 10.1016/j.sajb.2021.06.003
   Handeland M, 2014, NUTR RES, V34, P518, DOI 10.1016/j.nutres.2014.05.005
   Hawkins J, 2021, J DIET SUPPL, V18, P517, DOI 10.1080/19390211.2020.1800887
   Hejrati A, 2021, J FAM MED PRIM CARE, V10, P609, DOI 10.4103/jfmpc.jfmpc_1007_20
   Ho GTT, 2014, INT J MOL SCI, V15, P11626, DOI 10.3390/ijms150711626
   Huang S, 2019, THERANOSTICS, V9, P6745, DOI 10.7150/thno.34674
   Istas G, 2019, AM J CLIN NUTR, V110, P316, DOI 10.1093/ajcn/nqz075
   Jeon YD, 2018, J MED FOOD, V21, P244, DOI 10.1089/jmf.2017.3939
   Jurendic T, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10071052
   Jurikova T, 2017, MOLECULES, V22, DOI 10.3390/molecules22060944
   Kardum N, 2015, J MED FOOD, V18, P1231, DOI 10.1089/jmf.2014.0171
   Kasprzak-Drozd K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126541
   Kausar H, 2012, CANCER LETT, V325, P54, DOI 10.1016/j.canlet.2012.05.029
   Kedzierska M, 2013, FOOD CHEM TOXICOL, V53, P126, DOI 10.1016/j.fct.2012.11.042
   Kokotkiewicz A, 2010, J MED FOOD, V13, P255, DOI 10.1089/jmf.2009.0062
   Kumar AR., 2021, Int J Pharm Pharm Sci, V13, P1, DOI [10.22159/ijpps.2021v13i3.40614, DOI 10.22159/IJPPS.2021V13I3.40614]
   Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035
   Lee HY, 2017, BMC COMPLEM ALTERN M, V17, DOI [10.1186/s12906-017-1902-1, 10.1186/s12906-017-1716-1]
   Li J, 2018, ACS SYM SER, V1286, P3
   Li J, 2012, J AGR FOOD CHEM, V60, P11551, DOI 10.1021/jf303712e
   Li YS, 2005, BIOCHEM BIOPH RES CO, V336, P430, DOI 10.1016/j.bbrc.2005.08.103
   Li YT, 2022, J ETHNOPHARMACOL, V292, DOI 10.1016/j.jep.2022.115190
   Liang ZX, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052261
   Lim SM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051190
   Lima G. P. P., 2014, Food and Nutrition Sciences, V5, P1065, DOI 10.4236/fns.2014.511117
   Liu Y, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00867
   Luan MZ, 2022, MINI-REV MED CHEM, V22, P422, DOI 10.2174/1389557521666210913113522
   Makanae Y, 2019, J INT SOC SPORT NUTR, V16, DOI 10.1186/s12970-019-0328-1
   Malik M, 2003, NUTR CANCER, V46, P186, DOI 10.1207/S15327914NC4602_12
   Mezynska M, 2019, J APPL TOXICOL, V39, P117, DOI 10.1002/jat.3709
   Milutinovic M, 2019, J APPL BIOMED, V17, P218, DOI 10.32725/jab.2019.020
   Mioc M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23147740
   Mu JJ, 2020, J FOOD SCI, V85, P1307, DOI 10.1111/1750-3841.15109
   Najjar RS, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020387
   Naman CB, 2015, ORG LETT, V17, P2988, DOI 10.1021/acs.orglett.5b01284
   Newman DJ, 2020, J NAT PROD, V83, P770, DOI 10.1021/acs.jnatprod.9b01285
   Nowak D, 2016, CZECH J FOOD SCI, V34, P39, DOI 10.17221/258/2015-CJFS
   Ochnik M, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15050619
   Olas B, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00078
   Olechno E, 2022, NUTRIENTS, V14, DOI 10.3390/nu14132688
   Park S, 2013, BIOCHEM BIOPH RES CO, V440, P14, DOI 10.1016/j.bbrc.2013.08.090
   Polce SA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050531
   Rajan DK, 2021, BIOMED PHARMACOTHER, V142, DOI 10.1016/j.biopha.2021.111988
   Ren YL, 2006, J MED CHEM, V49, P2829, DOI 10.1021/jm060087k
   Ren Yulin, 2021, J Med Plant Res, V15, P540, DOI [10.5897/JMPR2021.7137, 10.5897/jmpr2021.7137]
   Ren YL, 2019, PLANTA MED, V85, P802, DOI 10.1055/a-0832-2383
   Ren YL, 2018, BIOORGAN MED CHEM, V26, P4452, DOI 10.1016/j.bmc.2018.07.025
   Reyes-Farias M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133177
   Rugina D, 2012, J MED FOOD, V15, P700, DOI 10.1089/jmf.2011.0246
   Salzillo A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22168586
   Sharif T, 2013, J FUNCT FOODS, V5, P1244, DOI 10.1016/j.jff.2013.04.007
   Shi N, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10101600
   Shriwas P, 2020, PHYTOTHER RES, V34, P1027, DOI 10.1002/ptr.6587
   Sidor A, 2019, MOLECULES, V24, DOI [10.3390/molecu, 10.3390/molecules24203710]
   Sidor A, 2019, TRENDS FOOD SCI TECH, V89, P45, DOI 10.1016/j.tifs.2019.05.006
   Sikora J, 2012, EUR J NUTR, V51, P549, DOI 10.1007/s00394-011-0238-8
   Stankiewicz B, 2021, J INT SOC SPORT NUTR, V18, DOI 10.1186/s12970-021-00447-z
   Stojkovic L, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.689055
   Stojkovic L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051484
   Sun ZhiMou Sun ZhiMou, 2017, Food Research and Development, V38, P220
   Sycz Z, 2022, BIOMOLECULES, V12, DOI 10.3390/biom12010098
   Tasic N, 2021, MOL CELL BIOCHEM, V476, P2663, DOI 10.1007/s11010-021-04106-4
   Thani NAA, 2014, J CLIN PATHOL, V67, P949, DOI 10.1136/jclinpath-2013-202075
   Tsakiroglou P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051075
   Valcheva-Kuzmanova S, 2005, EXP TOXICOL PATHOL, V56, P385, DOI 10.1016/j.etp.2005.01.001
   Wang L, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.943911
   Wei J, 2020, CHEM BIODIVERS, V17, DOI 10.1002/cbdv.202000654
   Wen HC, 2021, FOODS, V10, DOI 10.3390/foods10010063
   Xie LY, 2017, NUTR RES, V37, P67, DOI 10.1016/j.nutres.2016.12.007
   Yang Shu-Qiao, 2021, Food Research and Development, V42, P206, DOI 10.12161/j.issn.1005-6521.2021.13.030
   Yoshida T., 2014, FOOD STYLE, V21, P67
   Yu SY, 2021, J MED FOOD, DOI 10.1089/jmf.2020.0127
   Yu WC, 2021, FOOD BIOSCI, V40, DOI 10.1016/j.fbio.2021.100910
   Zeng L, 2022, BIOMED PHARMACOTHER, V149, DOI 10.1016/j.biopha.2022.112831
NR 98
TC 48
Z9 50
U1 12
U2 143
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD NOV
PY 2022
VL 27
IS 22
AR 7823
DI 10.3390/molecules27227823
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 6K2VC
UT WOS:000887365500001
PM 36431924
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Tang, GY
   Zhao, CN
   Xu, XY
   Gan, RY
   Cao, SY
   Liu, Q
   Shang, A
   Mao, QQ
   Li, HB
AF Tang, Guo-Yi
   Zhao, Cai-Ning
   Xu, Xiao-Yu
   Gan, Ren-You
   Cao, Shi-Yu
   Liu, Qing
   Shang, Ao
   Mao, Qian-Qian
   Li, Hua-Bin
TI Phytochemical Composition and Antioxidant Capacity of 30 Chinese Teas
SO ANTIOXIDANTS
LA English
DT Article
DE tea; Camellia sinensis; antioxidant activity; polyphenol; catechin;
   caffeine; theaflavine
ID TOTAL PHENOLIC CONTENTS; GREEN TEA; BLACK TEA; ENDOTHELIAL FUNCTION;
   OXIDATIVE STRESS; NATURAL-PRODUCTS; CANCER CELLS; EXTRACT; POWER; ACID
AB Tea has been reported to prevent and manage many chronic diseases, such as cancer, diabetes, obesity, and cardiovascular diseases, and the antioxidant capacity of tea may be responsible for these health benefits. In this study, the antioxidant capacities of fat-soluble, water-soluble, and bound-insoluble fractions of 30 Chinese teas belonging to six categories, namely green, black, oolong, dark, white, and yellow teas, were systematically evaluated, applying ferric-reducing antioxidant power and Trolox equivalent antioxidant capacity assays. In addition, total phenolic contents of teas were determined by Folin-Ciocalteu method, and the contents of 18 main phytochemical compounds in teas were measured by high-performance liquid chromatography (HPLC). The results found that several teas possessed very strong antioxidant capacity, and caffeine, theaflavine, gallic acid, chlorogenic acid, ellagic acid, and kaempferol-3-O-glucoside, as well as eight catechins, were the main antioxidant compounds in them. Thus, these teas could be good natural sources of dietary antioxidants, and their extracts might be developed as food additives, nutraceuticals, cosmetics, and pharmaceuticals.
C1 [Tang, Guo-Yi; Zhao, Cai-Ning; Xu, Xiao-Yu; Cao, Shi-Yu; Liu, Qing; Shang, Ao; Mao, Qian-Qian; Li, Hua-Bin] Sun Yat Sen Univ, Guangdong Prov Key Lab Food Nutr & Hlth, Dept Nutr, Sch Publ Hlth, Guangzhou 510080, Guangdong, Peoples R China.
   [Gan, Ren-You] Shanghai Jiao Tong Univ, Dept Food Sci & Technol, Sch Agr & Biol, Shanghai 200240, Peoples R China.
C3 Sun Yat Sen University; Shanghai Jiao Tong University
RP Li, HB (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Food Nutr & Hlth, Dept Nutr, Sch Publ Hlth, Guangzhou 510080, Guangdong, Peoples R China.; Gan, RY (corresponding author), Shanghai Jiao Tong Univ, Dept Food Sci & Technol, Sch Agr & Biol, Shanghai 200240, Peoples R China.
EM tanggy5@mail2.sysu.edu.cn; zhaocn@mail2.sysu.edu.cn;
   xuxy53@mail2.sysu.edu.cn; renyougan@sjtu.edu.cn;
   caoshy3@mail2.sysu.edu.cn; liuq248@mail2.sysu.edu.cn;
   shangao@mail2.sysu.edu.cn; maoqq@mail2.sysu.edu.cn;
   lihuabin@mail.sysu.edu.cn
RI Gan, Renyou/C-9868-2009; Li, Hua-Bin/AEX-9846-2022
OI Gan, Ren-You/0000-0002-4162-1511; Li, Hua-Bin/0000-0003-2332-8554
FU National Key R&D Program of China [2018YFC1604400]; Shanghai Basic and
   Key Program [18JC1410800]; Shanghai Pujiang Talent Plan [18PJ1404600]
FX This work was supported by the National Key R&D Program of China
   (2018YFC1604400); Shanghai Basic and Key Program (18JC1410800); Shanghai
   Pujiang Talent Plan (18PJ1404600).
CR Adami GR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22994-3
   Baptista J, 2012, FOOD CHEM, V132, P2181, DOI 10.1016/j.foodchem.2011.12.050
   Bártíková H, 2015, ACTA PHARMACEUT, V65, P65, DOI 10.1515/acph-2015-0007
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bi W, 2016, ACTA PHARM SIN B, V6, P170, DOI 10.1016/j.apsb.2015.11.003
   Braud L, 2017, J NUTR BIOCHEM, V40, P95, DOI 10.1016/j.jnutbio.2016.10.012
   Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047
   Chu KO, 2015, J NUTR BIOCHEM, V26, P1357, DOI 10.1016/j.jnutbio.2015.07.001
   Cyboran S, 2015, LIFE SCI, V126, P1, DOI 10.1016/j.lfs.2014.12.025
   Deng GF, 2013, J FUNCT FOODS, V5, P260, DOI 10.1016/j.jff.2012.10.015
   Deng GF, 2012, INT J MOL SCI, V13, P8308, DOI 10.3390/ijms13078308
   Di Lorenzo A, 2016, MOL NUTR FOOD RES, V60, P566, DOI 10.1002/mnfr.201500567
   Fei TY, 2017, EXP GERONTOL, V97, P89, DOI 10.1016/j.exger.2017.07.015
   Fu L, 2011, FOOD CHEM, V129, P345, DOI 10.1016/j.foodchem.2011.04.079
   Fu L, 2010, MOLECULES, V15, P8602, DOI 10.3390/molecules15128602
   Gan RY, 2017, COMPR REV FOOD SCI F, V16, P489, DOI 10.1111/1541-4337.12257
   Garcia ML, 2017, J HYPERTENS, V35, P348, DOI 10.1097/HJH.0000000000001149
   Guo YJ, 2012, FOOD FUNCT, V3, P1195, DOI 10.1039/c2fo30110e
   Guo YJ, 2017, FOOD CHEM, V237, P645, DOI 10.1016/j.foodchem.2017.05.024
   Gupta S, 2002, PHYTOTHER RES, V16, P655, DOI 10.1002/ptr.1038
   Hashimoto T, 2007, PHYTOTHER RES, V21, P668, DOI 10.1002/ptr.2132
   Hayes WA, 2011, ANAL BIOCHEM, V416, P202, DOI 10.1016/j.ab.2011.05.031
   Jayabalan R, 2014, COMPR REV FOOD SCI F, V13, P538, DOI 10.1111/1541-4337.12073
   Jochmann N, 2008, BRIT J NUTR, V99, P863, DOI 10.1017/S0007114507838992
   Kim YH, 2016, J AGR FOOD CHEM, V64, P3591, DOI 10.1021/acs.jafc.6b01115
   Leung FP, 2016, EUR J NUTR, V55, P1963, DOI 10.1007/s00394-015-1012-0
   Li AN, 2014, J FUNCT FOODS, V6, P319, DOI 10.1016/j.jff.2013.10.022
   Li L, 2009, J NUTR BIOCHEM, V20, P219, DOI 10.1016/j.jnutbio.2008.02.006
   Li S, 2013, IND CROP PROD, V51, P289, DOI 10.1016/j.indcrop.2013.09.017
   Li Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070728
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   Liu Q, 2018, MOLECULES, V23, DOI 10.3390/molecules23102432
   Liu SM, 2015, J FUNCT FOODS, V18, P1095, DOI 10.1016/j.jff.2014.08.023
   Meng X, 2018, COMPR REV FOOD SCI F, V17, P472, DOI 10.1111/1541-4337.12335
   Nam M, 2018, J NUTR BIOCHEM, V51, P1, DOI 10.1016/j.jnutbio.2017.09.002
   Nardini M, 2002, FOOD CHEM, V79, P119, DOI 10.1016/S0308-8146(02)00213-3
   Nilsson J, 2005, MOL NUTR FOOD RES, V49, P239, DOI 10.1002/mnfr.200400083
   Pan HB, 2017, INT J ONCOL, V51, P1508, DOI 10.3892/ijo.2017.4145
   Pastoriza S, 2017, CURR OPIN FOOD SCI, V14, P7, DOI 10.1016/j.cofs.2016.12.001
   Peluso I, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9139731
   Pereira-Caro G, 2017, J AGR FOOD CHEM, V65, P5365, DOI 10.1021/acs.jafc.7b01707
   Pohanka M, 2009, SENSORS-BASEL, V9, P9094, DOI 10.3390/s91109094
   Raudonis R, 2012, J CHROMATOGR A, V1233, P8, DOI 10.1016/j.chroma.2012.02.019
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Reddyvari H, 2017, J ADV RES, V8, P289, DOI 10.1016/j.jare.2017.02.002
   Schimidt HL, 2017, FOOD RES INT, V100, P442, DOI 10.1016/j.foodres.2017.07.026
   Scoparo CT, 2016, FOOD RES INT, V83, P102, DOI 10.1016/j.foodres.2016.02.011
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Sun LJ, 2018, FOOD HYDROCOLLOID, V79, P63, DOI 10.1016/j.foodhyd.2017.12.011
   Tang GY, 2018, MOLECULES, V23, DOI 10.3390/molecules23102598
   Tang GY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080857
   Tao L, 2015, MOL NUTR FOOD RES, V59, P203, DOI 10.1002/mnfr.201400485
   Torello CO, 2018, CANCER LETT, V414, P116, DOI 10.1016/j.canlet.2017.11.006
   van den Berg R, 2000, FOOD CHEM, V70, P391, DOI 10.1016/S0308-8146(00)00092-3
   Wang B, 2017, J DAIRY SCI, V100, P8043, DOI 10.3168/jds.2016-12425
   Wang QP, 2018, LWT-FOOD SCI TECHNOL, V90, P598, DOI 10.1016/j.lwt.2018.01.021
   Xie H, 2018, MOLECULES, V23, DOI 10.3390/molecules23020179
   Xie X, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050497
   Xu DP, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010096
   Zeng L, 2017, INT J FOOD SCI NUTR, V68, P525, DOI 10.1080/09637486.2016.1263834
   Zhao CN, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060598
   Zhao DY, 2016, J NUTR BIOCHEM, V38, P116, DOI 10.1016/j.jnutbio.2016.09.005
   Zheng J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030555
NR 63
TC 97
Z9 98
U1 8
U2 136
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD JUN
PY 2019
VL 8
IS 6
DI 10.3390/antiox8060180
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA II6FJ
UT WOS:000475288200032
PM 31216700
OA Green Submitted, Green Published, gold
DA 2025-04-28
ER

PT J
AU Acheson, KJ
   Gremaud, G
   Meirim, I
   Montigon, F
   Krebs, Y
   Fay, LB
   Gay, LJ
   Schneiter, P
   Schindler, C
   Tappy, L
AF Acheson, KJ
   Gremaud, G
   Meirim, I
   Montigon, F
   Krebs, Y
   Fay, LB
   Gay, LJ
   Schneiter, P
   Schindler, C
   Tappy, L
TI Metabolic effects of caffeine in humans: lipid oxidation or futile
   cycling?
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE paraxanthine; slow-release caffeine; thermic effect; lipid turnover;
   oxidative lipid disposal; nonoxidative lipid disposal
ID EPHEDRINE-INDUCED THERMOGENESIS; FREE FATTY-ACIDS; ENERGY-EXPENDITURE;
   OBESE WOMEN; COFFEE; CARBOHYDRATE; PARAXANTHINE; EPINEPHRINE;
   VOLUNTEERS; INGESTION
AB Background: Caffeine ingestion stimulates both lipolysis and energy expenditure.
   Objectives: Our objectives were to determine whether the lipolytic effect of caffeine is associated with increased lipid oxidation or futile cycling between triacylglycerol and free fatty acids (FFAs) and whether the effects of caffeine are mediated via the sympathetic nervous system.
   Design: Respiratory exchange and [1-C-13] palmitate were used to trace lipid oxidation and FFA turnover in 8 healthy, young men for 90 min before and 240 min after ingestion of placebo, caffeine (10 mg/kg), or caffeine during beta-adrenoceptor blockade.
   Results: During fasting conditions, there were few differences in measured variables between the 3 tests. During steady state conditions (last hour of the test) after ingestion of caffeine, lipid turnover increased 2-fold (P < 0.005), and the mean (+/-SEM) thermic effect was 13.3 +/- 2.2% (P < 0.001), both of which were greater than after ingestion of placebo or caffeine during beta-adrenoceptor blockade. After ingestion of caffeine, oxidative FFA disposal increased 44% (236 +/- 21 to 340 +/- 16 mumol/min), whereas nonoxidative FFA disposal increased 2.3-fold (455 +/- 66 to 1054 +/- 242 mumol/min; P < 0.01). In postabsorptive conditions, 34% of lipids were oxidized and 66% were recycled. Caffeine ingestion increased energy expenditure 13% and doubled the turnover of lipids, of which 24% were oxidized and 76% were recycled. beta-Adrenoceptor blockade decreased, but did not inhibit, these variables.
   Conclusions: Many, but not all, of the effects of caffeine are mediated via the sympathetic nervous system. The effect of caffeine on lipid mobilization in resting conditions can be interpreted in 2 ways: lipid mobilization alone is insufficient to drive lipid oxidation, or large increments in lipid turnover result in small increments in lipid oxidation.
C1 Nestle Res Ctr, CH-1000 Lausanne 26, Switzerland.
   Inst Physiol, Lausanne, Switzerland.
   Univ Lausanne Hosp, Cent Pharm, Lausanne, Switzerland.
C3 Nestle SA; Nestle Research Center; University of Lausanne; Centre
   Hospitalier Universitaire Vaudois (CHUV)
RP Acheson, KJ (corresponding author), Nestle Res Ctr, POB 44,Vers Chez Blanc, CH-1000 Lausanne 26, Switzerland.
RI ; Tappy, Luc/A-8911-2017
OI Schneiter, Philippe/0000-0002-7167-2707; Tappy, Luc/0000-0001-8469-4692
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   ARNAUD MJ, 1981, METHODS CLIN PHARM, V3, P135
   ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   ASTRUP A, 1992, METABOLISM, V41, P686, DOI 10.1016/0026-0495(92)90304-S
   ASTRUP A, 1986, AM J PHYSIOL, V250, pE226, DOI 10.1152/ajpendo.1986.250.2.E226
   ASTRUP A, 1985, AM J PHYSIOL, V248, P507
   BELLET S, 1969, METABOLIS, V18, P288, DOI 10.1016/0026-0495(69)90049-3
   BELLET S, 1968, METABOLISM, V17, P702, DOI 10.1016/0026-0495(68)90054-1
   Benowitz NL, 1995, CLIN PHARMACOL THER, V58, P684, DOI 10.1016/0009-9236(95)90025-X
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BREITENSTEIN E, 1990, BURNS, V16, P259, DOI 10.1016/0305-4179(90)90136-K
   BUTCHER RW, 1968, J BIOL CHEM, V243, P1705
   Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999
   Denborough M, 1998, LANCET, V352, P1131, DOI 10.1016/S0140-6736(98)03078-5
   DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315
   DULLOO AG, 1986, INT J OBESITY, V10, P467
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   DULLOO AG, 1987, AM J CLIN NUTR, V45, P564, DOI 10.1093/ajcn/45.3.564
   GROOP LC, 1991, J CLIN INVEST, V87, P83, DOI 10.1172/JCI115005
   HETZLER RK, 1990, J APPL PHYSIOL, V68, P44, DOI 10.1152/jappl.1990.68.1.44
   Higgins HL, 1915, J PHARMACOL EXP THER, V7, P1
   ISSEKUTZ B, 1968, METABOLISM, V17, P62, DOI 10.1016/S0026-0495(68)80008-3
   JEQUIER E, 1987, ANNU REV NUTR, V7, P187, DOI 10.1146/annurev.nu.07.070187.001155
   KLEIN S, 1989, AM J PHYSIOL, V257, pE65, DOI 10.1152/ajpendo.1989.257.1.E65
   LEVITZKI A, 1988, SCIENCE, V241, P800, DOI 10.1126/science.2841758
   LIU YL, 1995, INT J OBESITY, V19, P678
   LIVESEY G, 1988, AM J CLIN NUTR, V47, P608, DOI 10.1093/ajcn/47.4.608
   MILLS PR, 1984, GUT, V25, P73, DOI 10.1136/gut.25.1.73
   SCHNECK DW, 1984, CLIN PHARMACOL THER, V36, P584, DOI 10.1038/clpt.1984.225
   SCHWARZ JM, 1992, AM J PHYSIOL, V262, pE591, DOI 10.1152/ajpendo.1992.262.5.E591
   SCHWARZ JM, 1989, THESIS U LAUSANNE SW
   SIDOSSIS LS, 1995, AM J PHYSIOL-ENDOC M, V269, pE649, DOI 10.1152/ajpendo.1995.269.4.E649
   Wolfe R.R., 1984, Tracers in Metabolic Research: Radioisotope and Stable Isotope/mass Spectometry Methods
   WOLFE RR, 1980, BIOMED MASS SPECTROM, V7, P168, DOI 10.1002/bms.1200070407
   WOLFE RR, 1990, AM J PHYSIOL, V258, pE382, DOI 10.1152/ajpendo.1990.258.2.E382
   WOLFE RR, 1987, NEW ENGL J MED, V317, P403, DOI 10.1056/NEJM198708133170702
   ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857
NR 39
TC 144
Z9 163
U1 0
U2 50
PU AMER SOC CLINICAL NUTRITION
PI BETHESDA
PA 9650 ROCKVILLE PIKE, SUBSCRIPTIONS, RM L-3300, BETHESDA, MD 20814-3998
   USA
SN 0002-9165
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD JAN
PY 2004
VL 79
IS 1
BP 40
EP 46
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 757NZ
UT WOS:000187569500007
PM 14684395
DA 2025-04-28
ER

PT J
AU Stohs, SJ
   Preuss, HG
   Shara, M
AF Stohs, Sidney J.
   Preuss, Harry G.
   Shara, Mohd
TI A Review of the Human Clinical Studies Involving Citrus aurantium
   (Bitter Orange) Extract and its Primary Protoalkaloid
   p-Synephrine
SO INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
LA English
DT Review
DE Citrus aurantium; bitter orange; p-synephrine; human subjects;
   obesity/overweight; safety; efficacy; caffeine
ID BLOOD-PRESSURE; HEART-RATE; DIETARY-SUPPLEMENT; METABOLIC-RATE; GREEN
   TEA; CAFFEINE; EFFICACY; SAFETY; JUICE
AB This review summarizes the published as well as unpublished human studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine, providing information and an assessment of the safety and efficacy of these widely used products. The results of over 20 studies involving a total of approximately 360 subjects that consumed p-synephrine alone or in combination with other ingredients are reviewed and critiqued. Over 50% of the subjects involved in these studies were overweight/obese, and approximately two-thirds of these overweight/obese subjects consumed caffeine (132-528 mg/day) in conjunction with p-synephrine (10-53 mg/day). Bitter orange/p-synephrine containing products were consumed for up to 12 weeks. Approximately 44 % of the subjects consumed a bitter orange/p-synephrine only product, while the remainder consumed a complex product that contained multiple ingredients in addition to p-synephrine. In general, bitter orange extract alone (p-synephrine) or in combination with other herbal ingredients did not produce significant adverse events as an increase in heart rate or blood pressure, or alter electrocardiographic data, serum chemistry, blood cell counts or urinalysis. p-Synephrine alone as well as in combination products were shown to increase resting metabolic rate and energy expenditure, and modest increases in weight loss were observed with bitter orange extract/p-synephrine-containing products when given for six to 12 weeks. Longer term studies are needed to further assess the efficacy of these products and affirm their safety under these conditions.
C1 [Preuss, Harry G.] Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20039 USA.
   [Preuss, Harry G.] Georgetown Univ, Med Ctr, Dept Pathol & Med, Washington, DC 20039 USA.
   [Stohs, Sidney J.] Creighton Univ, Med Ctr, Omaha, NE 68078 USA.
   [Shara, Mohd] Jordan Univ Sci & Technol, Fac Pharm, Irbid 22110, Jordan.
C3 Georgetown University; Georgetown University; Creighton University;
   Jordan University of Science & Technology
RP Preuss, HG (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20039 USA.
EM preusshg@georgetown.edu
OI Shara, Mohd/0000-0001-5168-2206
CR [Anonymous], OBESITY EPIDEMIOLOGY
   [Anonymous], CHINESE MED HERBOLOG
   [Anonymous], HERBALGRAM
   Avula B, 2005, J AOAC INT, V88, P1593
   Bent S, 2004, AM J CARDIOL, V94, P1359, DOI 10.1016/j.amjcard.2004.07.137
   Bloomer RJ, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-32
   Bloomer RJ, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-4
   Bui LT, 2006, ANN PHARMACOTHER, V40, P53, DOI 10.1345/aph.1G488
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   Dragull K, 2008, J AGR FOOD CHEM, V56, P8874, DOI 10.1021/jf801225n
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Evans RL, 2008, J CHROMATOGR SCI, V46, P61, DOI 10.1093/chromsci/46.1.61
   Gougeon R, 2005, OBES RES, V13, P1187, DOI 10.1038/oby.2005.141
   Gurley BJ, 2004, CLIN PHARMACOL THER, V76, P428, DOI 10.1016/j.clpt.2004.07.007
   Haller CA, 2005, AM J MED, V118, P998, DOI 10.1016/j.amjmed.2005.02.034
   Haller CA, 2008, BRIT J CLIN PHARMACO, V65, P833, DOI 10.1111/j.1365-2125.2008.03144.x
   Hansen DK, 2012, TOXICOL APPL PHARM, DOI [10.1016/j.tap.2012.04.006, DOI 10.1016/J.TAP.2012.04.006]
   HENGSTMANN JH, 1978, ARZNEIMITTEL-FORSCH, V28-2, P2326
   Hoffman JR, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-1
   Hoffman Jay R, 2006, J Int Soc Sports Nutr, V3, P35, DOI 10.1186/1550-2783-3-1-35
   Kalman D, 2002, INT J OBESITY, V26, P1363, DOI 10.1038/sj.ijo.0802061
   Kalman DS, 2004, INT J OBESITY, V28, P1355, DOI 10.1038/sj.ijo.0802418
   Kalman DS, 2000, CURR THER RES CLIN E, V61, P199, DOI 10.1016/S0011-393X(00)89034-7
   Kalman DS, 2002, J AM COLL NUTR, V21, P488
   Kalman DS, 2003, FED AM SOC EXP UNPUB
   Kalman DS, 2002, M NIH NAT I DI UNPUB
   Karch Steven B, 2007, J Forensic Leg Med, V14, P79, DOI 10.1016/j.jcfm.2006.02.022
   Kendall-Reed P, 2000, STUDY EFFECTIV UNPUB
   McGuffin M, 2006, HERBALGRAM, V69, P52
   Mercolini L, 2010, J SEP SCI, V33, P23, DOI 10.1002/jssc.200900493
   Min B, 2005, PHARMACOTHERAPY, V25, P1719, DOI 10.1592/phco.2005.25.12.1719
   Moens AL, 2010, J MOL CELL CARDIOL, V48, P1088, DOI 10.1016/j.yjmcc.2010.02.011
   Nasir JM, 2004, MAYO CLIN PROC, V79, P1059, DOI 10.4065/79.8.1059
   Pellati F, 2007, J CHROMATOGR A, V1161, P71, DOI 10.1016/j.chroma.2007.05.097
   Penzak SR, 2001, J CLIN PHARMACOL, V41, P1059, DOI 10.1177/00912700122012652
   Percy DW, 2010, TALANTA, V80, P2191, DOI 10.1016/j.talanta.2009.10.052
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Riksen Niels P, 2011, Handb Exp Pharmacol, P413, DOI 10.1007/978-3-642-13443-2_16
   Rozec B, 2006, PHARMACOL THERAPEUT, V111, P652, DOI 10.1016/j.pharmthera.2005.12.002
   Sale C, 2006, INT J OBESITY, V30, P764, DOI 10.1038/sj.ijo.0803209
   Sander LC, 2008, ANAL BIOANAL CHEM, V391, P2023, DOI 10.1007/s00216-008-2074-0
   Seifert JG, 2011, INT J MED SCI, V8, P192, DOI 10.7150/ijms.8.192
   Shara M, 2012, J AM COLL NUTR, V30, P358
   Slezak T, 2007, ANAL CHIM ACTA, V593, P98, DOI 10.1016/j.aca.2007.04.038
   Stephensen TA, 2009, MIL MED, V174, P1313, DOI 10.7205/MILMED-D-01-5009
   Stohs SJ, 2012, J FUNCT FOODS, V4, P2, DOI 10.1016/j.jff.2011.09.004
   Stohs SJ, 2011, PHYTOTHER RES, V25, P1421, DOI 10.1002/ptr.3490
   Stohs SJ, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/482973
   Stohs SJ, 2011, INT J MED SCI, V8, P295, DOI 10.7150/ijms.8.295
   Stohs SJ, 2010, J FUNCT FOODS, V2, P235, DOI 10.1016/j.jff.2010.10.003
   Talbott S.M., 2007, CITRUS AURANTI UNPUB
   Uckoo RM, 2011, TALANTA, V83, P948, DOI 10.1016/j.talanta.2010.10.063
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Zenk JL, 2005, NUTRITION, V21, P179, DOI 10.1016/j.nut.2004.05.025
   Zenk JL, 2005, PROSPECTIVE RA UNPUB
NR 55
TC 88
Z9 107
U1 2
U2 57
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-1907
J9 INT J MED SCI
JI Int. J. Med. Sci.
PY 2012
VL 9
IS 7
BP 527
EP 538
DI 10.7150/ijms.4446
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 024SI
UT WOS:000310128500003
PM 22991491
OA gold, Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Visvanathan, R
   Jayathilake, C
   Jayawardana, BC
   Liyanage, R
AF Visvanathan, Rizliya
   Jayathilake, Chathuni
   Jayawardana, Barana Chaminda
   Liyanage, Ruvini
TI Health-beneficial properties of potato and compounds of interest
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Review
DE potatoes; consumption; functional compounds; antinutritional compounds;
   beneficial effects
ID SOLANUM-TUBEROSUM L.; IN-VITRO BINDING; NF-KAPPA-B; ANTIOXIDANT
   ACTIVITY; GLYCEMIC INDEX; DIETARY FIBER; FOOD-INTAKE; CHLOROGENIC ACID;
   HUMAN COLON; CHOLECYSTOKININ SECRETION
AB Potatoes have shown promising health-promoting properties in human cell culture, experimental animal and human clinical studies, including antioxidant, hypocholesterolemic, anti-inflammatory, antiobesity, anticancer and antidiabetic effects. Compounds present such as phenolics, fiber, starch and proteins as well as compounds considered antinutritional such as glycoalkaloids, lectins and proteinase inhibitors are believed to contribute to the health benefits of potatoes. However, epidemiological studies exploring the role of potatoes in human health have been inconclusive. Some studies support a protective effect of potato consumption in weight management and diabetes, while other studies demonstrate no effect and a few suggest a negative effect. As there are many biological activities attributed to the compounds present in potato, some of which could be beneficial or detrimental depending on specific circumstances, a long-term study investigating the association between potato consumption and diabetes, obesity, cardiovascular disease and cancer while controlling for fat intake is needed. (C) 2016 Society of Chemical Industry
C1 [Visvanathan, Rizliya; Jayathilake, Chathuni; Liyanage, Ruvini] Natl Inst Fundamental Studies, Div Nutr Biochem, Kandy, Sri Lanka.
   [Jayawardana, Barana Chaminda] Univ Peradeniya, Dept Anim Sci, Fac Agr, Peradeniya, Sri Lanka.
C3 National Institute of Fundamental Studies (NIFS); University of
   Peradeniya
RP Liyanage, R (corresponding author), Natl Inst Fundamental Studies, Nutr Biochem, Kandy, Sri Lanka.
EM ruvinill@yahoo.com
RI Jayathilake, Chathuni/AAO-3851-2021; Liyanage, Ruvini/H-8795-2019;
   Jayawardana, Barana/AAV-3586-2020
OI Visvanathan, Rizliya/0000-0002-8788-814X; Liyanage,
   Ruvini/0000-0002-6349-0284; Jayawardana, Barana/0000-0002-8563-2378
CR Al-Weshahy A, 2009, FOOD RES INT, V42, P1062, DOI 10.1016/j.foodres.2009.05.011
   ALSAIKHAN MS, 1995, J FOOD SCI, V60, P341, DOI 10.1111/j.1365-2621.1995.tb05668.x
   Andre CM, 2007, J AGR FOOD CHEM, V55, P10839, DOI 10.1021/jf0726583
   Arcan I, 2007, FOOD CHEM, V103, P301, DOI 10.1016/j.foodchem.2006.07.050
   Valiñas MA, 2015, J AGR FOOD CHEM, V63, P4902, DOI 10.1021/jf505777p
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4
   Brown CR, 2005, AM J POTATO RES, V82, P163, DOI 10.1007/BF02853654
   Brown CR, 2005, J AM SOC HORTIC SCI, V130, P174, DOI 10.21273/JASHS.130.2.174
   Buttriss JL, 2008, NUTR BULL, V33, P186, DOI 10.1111/j.1467-3010.2008.00705.x
   Camire ME, 2009, CRIT REV FOOD SCI, V49, P823, DOI 10.1080/10408390903041996
   CAMIRE ME, 1995, J AGR FOOD CHEM, V43, P970, DOI 10.1021/jf00052a024
   CAMIRE ME, 1993, J AGR FOOD CHEM, V41, P2391, DOI 10.1021/jf00036a033
   Carpenter MA, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls2015.00143, 10.3389/fpls.2015.00143]
   Chen WY, 2012, BIOSCI BIOTECH BIOCH, V76, P1104, DOI 10.1271/bbb.110936
   Choi E, 2005, FOOD AGR IMMUNOL, V16, P29, DOI 10.1080/09540100500064320
   Chu YH, 2000, J SCI FOOD AGR, V80, P561, DOI 10.1002/(SICI)1097-0010(200004)80:5<561::AID-JSFA574>3.0.CO;2-#
   Chun OK, 2005, J SCI FOOD AGR, V85, P1715, DOI 10.1002/jsfa.2176
   CordierBussat M, 1997, ENDOCRINOLOGY, V138, P1137, DOI 10.1210/en.138.3.1137
   Dana S, 2005, OPEN LABEL CLIN TRIA
   De Mejía EG, 2005, CRIT REV FOOD SCI, V45, P425, DOI 10.1080/10408390591034445
   Deusser H, 2012, FOOD CHEM, V135, P2814, DOI 10.1016/j.foodchem.2012.07.028
   Dhingra D, 2012, J FOOD SCI TECH MYS, V49, P255, DOI 10.1007/s13197-011-0365-5
   Eichhorn S, 2005, FOOD RES INT, V38, P943, DOI 10.1016/j.foodres.2005.03.011
   ENGLYST HN, 1987, AM J CLIN NUTR, V45, P423, DOI 10.1093/ajcn/45.2.423
   Ezekiel R, 2013, FOOD RES INT, V50, P487, DOI 10.1016/j.foodres.2011.04.025
   Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200
   Fernandes G, 2005, J AM DIET ASSOC, V105, P557, DOI 10.1016/j.jada.2005.01.003
   Foltz M, 2008, J AGR FOOD CHEM, V56, P837, DOI 10.1021/jf072611h
   Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5
   Friedman M, 1997, J AGR FOOD CHEM, V45, P1523, DOI 10.1021/jf960900s
   Friedman M, 2005, J AGR FOOD CHEM, V53, P6162, DOI 10.1021/jf050620p
   Friedman M, 2006, J AGR FOOD CHEM, V54, P8655, DOI 10.1021/jf061471t
   Geng F, 2010, BIOMED CHROMATOGR, V24, P312, DOI 10.1002/bmc.1291
   Gumul D, 2011, ACTA SCI POLON-TECHN, V10, P73
   Habeebullah SFK, 2010, J AM OIL CHEM SOC, V87, P1319, DOI 10.1007/s11746-010-1611-0
   Halton TL, 2006, AM J CLIN NUTR, V83, P284
   Hamouz K, 2011, PLANT SOIL ENVIRON, V57, P478, DOI 10.17221/265/2011-PSE
   Han KH, 2007, BRIT J NUTR, V98, P914, DOI 10.1017/S0007114507761792
   Han KH, 2007, BIOSCI BIOTECH BIOCH, V71, P1356, DOI 10.1271/bbb.70060
   Han KH, 2006, BIOSCI BIOTECH BIOCH, V70, P1432, DOI 10.1271/bbb.50670
   HARRIS PJ, 1991, MUTAT RES, V260, P203, DOI 10.1016/0165-1218(91)90009-B
   Hashimoto N, 2006, J NUTR SCI VITAMINOL, V52, P445, DOI 10.3177/jnsv.52.445
   Hayashi K, 2006, FOOD SCI TECHNOL RES, V12, P22, DOI 10.3136/fstr.12.22
   He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754
   Henry CJK, 2005, BRIT J NUTR, V94, P917, DOI 10.1079/BJN20051571
   Hickling S, 2008, PREV MED, V47, P71, DOI 10.1016/j.ypmed.2008.02.007
   HILL AJ, 1990, PHYSIOL BEHAV, V48, P241, DOI 10.1016/0031-9384(90)90307-P
   Hira T, 2009, EUR J NUTR, V48, P124, DOI 10.1007/s00394-008-0764-1
   Hodge AM, 2004, DIABETES CARE, V27, P2701, DOI 10.2337/diacare.27.11.2701
   HOLM J, 1988, AM J CLIN NUTR, V47, P1010, DOI 10.1093/ajcn/47.6.1010
   Huang CS, 1997, P NATL ACAD SCI USA, V94, P11957, DOI 10.1073/pnas.94.22.11957
   Jacobsen HB, 1998, POTATO RES, V41, P109, DOI 10.1007/BF02358433
   Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028
   Kanatt SR, 2005, J AGR FOOD CHEM, V53, P1499, DOI 10.1021/jf048270e
   Kanazawa T, 2008, J OLEO SCI, V57, P335, DOI 10.5650/jos.57.335
   Kaspar K.L., 2013, Food and Nutrition Sciences, V4, P77
   Kaspar KL, 2011, J NUTR, V141, P108, DOI 10.3945/jn.110.128074
   Kenny O. M., 2013, Journal of Agricultural Science and Applications, V2, P184, DOI 10.14511/jasa.2013.020401
   Kenny OM, 2013, LIFE SCI, V92, P775, DOI 10.1016/j.lfs.2013.02.006
   Kim JY, 2009, INT J MOL SCI, V10, P2860, DOI 10.3390/ijms10062860
   King JC, 2013, ADV NUTR, V4, p393S, DOI 10.3945/an.112.003525
   Komarnytsky S, 2011, INT J OBESITY, V35, P236, DOI 10.1038/ijo.2010.192
   Kubow S, 2014, MOL NUTR FOOD RES, V58, P2235, DOI 10.1002/mnfr.201400013
   Kudo K, 2009, J FUNCT FOODS, V1, P170, DOI 10.1016/j.jff.2009.01.006
   Kudoh K, 2003, J NUTR SCI VITAMINOL, V49, P451, DOI 10.3177/jnsv.49.451
   Lachman J, 2005, PLANT SOIL ENVIRON, V51, P477, DOI 10.17221/3620-PSE
   Lachman J, 2001, ROST VYROBA, V47, P181
   Lærke HN, 2007, NUTR RES, V27, P152, DOI 10.1016/j.nutres.2007.01.003
   Langner E., 2009, Journal of Pre-Clinical and Clinical Research, V3, P036
   Lazarov K, 1996, MED SCI RES, V24, P581
   Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d
   Lewis CE, 1998, J SCI FOOD AGR, V77, P45, DOI 10.1002/(SICI)1097-0010(199805)77:1<45::AID-JSFA1>3.0.CO;2-S
   Liese AD, 2009, DIABETES CARE, V32, P263, DOI 10.2337/dc08-1325
   Lightowler HJ, 2009, NUTR RES, V29, P551, DOI 10.1016/j.nutres.2009.06.004
   Lipsky LM, 2012, NUTR RES, V32, P251, DOI 10.1016/j.nutres.2012.03.005
   Lister CE, 2000, 143 NZ I CROP FOOD R
   Liu SM, 2004, DIABETES CARE, V27, P2993, DOI 10.2337/diacare.27.12.2993
   Liu YW, 2003, J AGR FOOD CHEM, V51, P4389, DOI 10.1021/jf030016j
   Liyanage R, 2008, BIOSCI BIOTECH BIOCH, V72, P943, DOI 10.1271/bbb.70593
   Liyanage R, 2009, EUR J LIPID SCI TECH, V111, P884, DOI 10.1002/ejlt.200800264
   Lu MK, 2010, BIOL PHARM BULL, V33, P1685, DOI 10.1248/bpb.33.1685
   Madiwale GP, 2011, J AGR FOOD CHEM, V59, P8155, DOI 10.1021/jf201073g
   Mäkinen S, 2008, J AGR FOOD CHEM, V56, P9875, DOI 10.1021/jf8016817
   McGill CR, 2013, ANN MED, V45, P467, DOI 10.3109/07853890.2013.813633
   Mohdaly AAA, 2010, J SCI FOOD AGR, V90, P218, DOI 10.1002/jsfa.3796
   Montonen J, 2005, AM J EPIDEMIOL, V161, P219, DOI 10.1093/aje/kwi039
   Moran TH, 2004, AM J PHYSIOL-GASTR L, V286, pG183, DOI 10.1152/ajpgi.00434.2003
   Morimoto A, 2012, ASIA PAC J CLIN NUTR, V21, P601
   Morita T, 1997, J NUTR, V127, P470, DOI 10.1093/jn/127.3.470
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Naito K, 1998, PHYTOCHEMISTRY, V47, P109, DOI 10.1016/S0031-9422(97)00520-7
   Nakajima S, 2011, J AGR FOOD CHEM, V59, P9491, DOI 10.1021/jf200988f
   Navarre DA, 2011, FOOD CHEM, V127, P34, DOI 10.1016/j.foodchem.2010.12.080
   Nayak B, 2014, FOOD RES INT, V56, P35, DOI 10.1016/j.foodres.2013.12.020
   Némoz-Gaillard E, 1998, ENDOCRINOLOGY, V139, P932, DOI 10.1210/en.139.3.932
   Noda T, 2006, FOOD CHEM, V95, P632, DOI 10.1016/j.foodchem.2005.02.002
   Nunn N, 2011, Q J ECON, V126, P593, DOI 10.1093/qje/qjr009
   Nzaramba MN, 2009, J AGR FOOD CHEM, V57, P8308, DOI 10.1021/jf901567k
   Padwal R, 2007, INT J OBESITY, V31, P1567, DOI 10.1038/sj.ijo.0803631
   Panagiotakos DB, 2007, PREV MED, V44, P335, DOI 10.1016/j.ypmed.2006.12.009
   Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323
   Pihlanto A., 2013, Bioactive food peptides in health and disease, P145
   Pihlanto A, 2008, FOOD CHEM, V109, P104, DOI 10.1016/j.foodchem.2007.12.023
   Pouvreau L, 2001, J AGR FOOD CHEM, V49, P2864, DOI 10.1021/jf010126v
   Reddivari L, 2007, CARCINOGENESIS, V28, P2227, DOI 10.1093/carcin/bgm117
   Reddivari L, 2007, AM J POTATO RES, V84, P275, DOI 10.1007/BF02986239
   Reddivari L, 2010, NUTR CANCER, V62, P601, DOI 10.1080/01635580903532358
   Rehman ZU, 2004, FOOD CHEM, V85, P215, DOI 10.1016/j.foodchem.2003.06.015
   Robert L, 2006, EUR J NUTR, V45, P267, DOI 10.1007/s00394-006-0594-y
   Robert L, 2008, J AM COLL NUTR, V27, P109, DOI 10.1080/07315724.2008.10719682
   Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x
   Schulze MB, 2006, OBESITY, V14, P1444, DOI 10.1038/oby.2006.164
   SCHWARTZ JG, 1994, DIABETES CARE, V17, P255, DOI 10.2337/diacare.17.4.255
   Shih YW, 2007, J AGR FOOD CHEM, V55, P11035, DOI 10.1021/jf072423r
   Singh N, 2005, CLIN CHIM ACTA, V353, P165, DOI 10.1016/j.cccn.2004.10.016
   Singh N, 2004, FOOD CHEM, V85, P611, DOI 10.1016/j.foodchem.2003.07.003
   Singh N, 2008, CHEM-BIOL INTERACT, V173, P97, DOI 10.1016/j.cbi.2008.03.008
   Soh NL, 1999, EUR J CLIN NUTR, V53, P249, DOI 10.1038/sj.ejcn.1600713
   Spiegel TA, 1999, N AM ASS STUD OB NAA
   Spielmann J, 2009, J ANIM PHYSIOL AN N, V93, P400, DOI 10.1111/j.1439-0396.2008.00819.x
   Storey ML, 2013, ADV NUTR, V4, p335S, DOI 10.3945/an.112.003541
   Stushnoff C, 2008, AM J POTATO RES, V85, P267, DOI 10.1007/s12230-008-9032-4
   Sun Y, 2013, FOOD FUNCT, V4, P1502, DOI 10.1039/c3fo60248f
   Sweitzer NK, 2003, CIRCULATION, V108, pE16, DOI 10.1161/01.CIR.0000075957.16003.07
   THED ST, 1995, FOOD CHEM, V52, P301, DOI 10.1016/0308-8146(95)92828-8
   Thomassen LV, 2011, APPL MICROBIOL BIOT, V90, P873, DOI 10.1007/s00253-011-3092-y
   Thompson MD, 2009, J FOOD COMPOS ANAL, V22, P571, DOI 10.1016/j.jfca.2008.09.002
   VARO P, 1983, J ASSOC OFF ANA CHEM, V66, P933
   Villegas R, 2007, ARCH INTERN MED, V167, P2310, DOI 10.1001/archinte.167.21.2310
   Vinson JA, 1998, J AGR FOOD CHEM, V46, P3630, DOI 10.1021/jf980295o
   Vinson JA, 2012, J AGR FOOD CHEM, V60, P6749, DOI 10.1021/jf2045262
   Wang HX, 2000, INT J BIOCHEM CELL B, V32, P365, DOI 10.1016/S1357-2725(99)00130-2
   Wang LL, 2008, J FOOD SCI, V73, pC482, DOI 10.1111/j.1750-3841.2008.00802.x
   Wang QY, 2011, NUTR CANCER, V63, P1044, DOI 10.1080/01635581.2011.597538
   Williams DEM, 1999, J CLIN EPIDEMIOL, V52, P329, DOI 10.1016/S0895-4356(99)00006-2
   Xu XY, 2009, J AGR FOOD CHEM, V57, P10231, DOI 10.1021/jf902532q
   Yamaguchi T, 2008, NUTR METAB CARDIOVAS, V18, P408, DOI 10.1016/j.numecd.2007.03.004
   Yang SA, 2006, FOOD CHEM TOXICOL, V44, P839, DOI 10.1016/j.fct.2005.11.007
   Yoon SS, 2008, J ETHNOPHARMACOL, V118, P396, DOI 10.1016/j.jep.2008.05.014
   Younes H, 2001, BRIT J NUTR, V86, P479, DOI 10.1079/BJN2001430
   YUNES H, 1995, LIPIDS, V30, P847, DOI 10.1007/BF02533961
   Zhang C, 2009, J AGR FOOD CHEM, V57, P9503, DOI 10.1021/jf901550u
NR 143
TC 58
Z9 67
U1 1
U2 81
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD DEC
PY 2016
VL 96
IS 15
BP 4850
EP 4860
DI 10.1002/jsfa.7848
PG 11
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA EB4OL
UT WOS:000387351200003
PM 27301296
DA 2025-04-28
ER

PT J
AU Soga, S
   Ota, N
   Shimotoyodome, A
AF Soga, Satoko
   Ota, Noriyasu
   Shimotoyodome, Akira
TI Stimulation of Postprandial Fat Utilization in Healthy Humans by Daily
   Consumption of Chlorogenic Acids
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE fat utilization; energy expenditure; indirect calorimetry; human;
   chlorogenic acid
ID DIET-INDUCED OBESITY; GREEN TEA; COFFEE CONSUMPTION; ENERGY-EXPENDITURE;
   BODY-FAT; RISK; CATECHINS; OXIDATION; GLUCOSE; COMBINATION
AB Long-term ingestion of coffee polyphenols (chlorogenic acids, CGAs) reduces body fat in humans and rodents. While CGA supplementation has been shown to increase fat utilization in rodents, evidence in humans is still limited. The present study clarifies the effect of daily CGA consumption on energy metabolism in humans. Eighteen healthy male subjects (36.1 +/- 7.4 y of age) participated in a placebo-controlled, double-blind, crossover, intervention study with two different test beverages. The subjects consumed 185 mL of a test beverage with or without CGAs (329 mg) daily for 4 wk. The energy metabolism was evaluated by using indirect calorimetry before and after the test period during fasting and up to 180 min postprandially. Indirect calorimetry showed that a 4-wk ingestion of the CGA beverage led to a significantly higher postprandial energy expenditure than that of the control beverage. The subjects ingesting the CGA beverage exhibited higher postprandial fat utilization than those consuming the control beverage. The daily CGA consumption therefore increased postprandial fat utilization in healthy humans.
C1 [Soga, Satoko; Ota, Noriyasu; Shimotoyodome, Akira] Kao Corp, Biol Sci Res, Ichikai, Tochigi 3213497, Japan.
C3 KAO Corporation
RP Shimotoyodome, A (corresponding author), Kao Corp, Biol Sci Res, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.
EM shimotoyodome.akira@kao.co.jp
OI shimotoyodome, akira/0000-0001-7567-8316
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   [Anonymous], 2009, JPN PHARN ACOL THER
   Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Andersen LF, 2006, AM J CLIN NUTR, V83, P1039, DOI 10.1093/ajcn/83.5.1039
   Giovannucci E, 1998, AM J EPIDEMIOL, V147, P1043, DOI 10.1093/oxfordjournals.aje.a009398
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Inoue M, 2005, JNCI-J NATL CANCER I, V97, P293, DOI 10.1093/jnci/dji040
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   JEQUIER E, 1987, ANNU REV NUTR, V7, P187, DOI 10.1146/annurev.nu.07.070187.001155
   Klatsky AL, 2006, ARCH INTERN MED, V166, P1190, DOI 10.1001/archinte.166.11.1190
   McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nichenametla SN, 2006, CRIT REV FOOD SCI, V46, P161, DOI 10.1080/10408390591000541
   Ota N, 2005, J HEALTH SCI, V51, P233, DOI 10.1248/jhs.51.233
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Ruhl CE, 2005, GASTROENTEROLOGY, V129, P1928, DOI 10.1053/j.gastro.2005.08.056
   Shimazu T, 2005, INT J CANCER, V116, P150, DOI 10.1002/ijc.20989
   Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI [10.1139/H11-072, 10.1139/h11-072]
   Tverdal A, 2003, ANN EPIDEMIOL, V13, P419, DOI 10.1016/S1047-2797(02)00462-3
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Watanabe T, 2008, JPN PHARMACOL THER, V36, P465
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
NR 34
TC 41
Z9 42
U1 1
U2 25
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD AUG
PY 2013
VL 77
IS 8
BP 1633
EP 1636
DI 10.1271/bbb.130147
PG 4
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA 210XO
UT WOS:000323868600005
PM 23924724
OA Bronze
DA 2025-04-28
ER

PT J
AU Grosso, G
   Stepaniak, U
   Micek, A
   Topor-Madry, R
   Pikhart, H
   Szafraniec, K
   Pajak, A
AF Grosso, Giuseppe
   Stepaniak, Urszula
   Micek, Agnieszka
   Topor-Madry, Roman
   Pikhart, Hynek
   Szafraniec, Krystyna
   Pajak, Andrzej
TI Association of daily coffee and tea consumption and metabolic syndrome:
   results from the Polish arm of the HAPIEE study
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Coffee; Tea; Metabolic syndrome; Blood pressure; Waist circumference;
   Dyslipidemia; Hyperglycemia
ID CARDIOVASCULAR RISK-FACTORS; TYPE-2 DIABETES-MELLITUS; ENDOTHELIAL
   FUNCTION; MEDITERRANEAN DIET; AMSTERDAM GROWTH; HABITUAL COFFEE;
   BLOOD-PRESSURE; HEALTH; PREVALENCE; CAFFEINE
AB The aim of this study was to evaluate whether daily consumption of coffee and tea was associated with components and prevalence of metabolic syndrome (MetS) in the Polish arm of the Health, Alcohol and Psychosocial factors In Eastern Europe cohort study.
   A cross-sectional population-based survey including 8,821 adults (51.4 % female) was conducted in Krakow, Poland. Coffee and tea consumption was evaluated using food frequency questionnaires. MetS was defined according to the International Diabetes Federation definition. Linear and logistic regression models were performed to estimate odds ratios and confidence intervals.
   Among high coffee and tea consumers (3 or more cups/day), high prevalence of female gender, young age, medium-high educational and occupational level, high total energy intake, and smoking habit were found. High coffee drinkers had lower BMI, waist circumference, systolic and diastolic blood pressure, triglycerides, and higher HDL cholesterol than those drinking less than 1 cup/day. In contrast, high tea consumers had lower BMI, waist circumference, but not diastolic blood pressure, which was higher than low drinkers. After adjusting for potential confounding factors, both higher coffee and tea consumption were negatively associated with MetS (OR 0.75, 95 % CI 0.66, 0.86 and OR 0.79, 95 % CI 0.67, 0.92, respectively). Among specific components of MetS, high coffee consumption was negatively associated with waist circumference, hypertension, and triglycerides, whereas tea consumption with central obesity and fasting plasma glucose in women, but not in men.
   Coffee and tea consumption was negatively associated with MetS and some of its components.
C1 [Grosso, Giuseppe] Univ Catania, Dept Clin & Mol Biomed, Sect Pharmacol & Biochem, I-95125 Catania, Italy.
   [Grosso, Giuseppe; Stepaniak, Urszula; Micek, Agnieszka; Topor-Madry, Roman; Szafraniec, Krystyna; Pajak, Andrzej] Jagiellonian Univ, Coll Med, Dept Epidemiol & Populat Studies, Krakow, Poland.
   [Pikhart, Hynek] UCL, Dept Epidemiol & Publ Hlth, London, England.
C3 University of Catania; Jagiellonian University; Collegium Medicum
   Jagiellonian University; University of London; University College London
RP Grosso, G (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Sect Pharmacol & Biochem, Vle A Doria 6, I-95125 Catania, Italy.
EM giuseppe.grosso@studium.unict.it
RI Topor-Madry, Roman/ABF-5449-2020; Micek, Agnieszka/AAC-4838-2019;
   Pikhart, Hynek/E-3074-2010; Stepaniak, Urszula/U-2387-2018; Grosso,
   Giuseppe/K-6730-2016
OI Pikhart, Hynek/0000-0001-5277-4049; Stepaniak,
   Urszula/0000-0002-1904-4674; Grosso, Giuseppe/0000-0003-3930-5285;
   Micek, Agnieszka/0000-0001-8557-1774; Topor-Madry,
   Roman/0000-0002-3091-6760
FU Wellcome Trust [064947/Z/01/Z, 081081/Z/06/Z]; US National Institute on
   Ageing [1R01 AG23522-01]; MacArthur Foundation Initiative on Social
   Upheaval and Health [71208]; International Ph.D. Program in
   Neuropharmacology, University Medical School of Catania, Catania, Italy
FX The study has been funded by the Wellcome Trust (Grants 064947/Z/01/Z
   and 081081/Z/06/Z), US National Institute on Ageing (Grant 1R01
   AG23522-01) and the MacArthur Foundation Initiative on Social Upheaval
   and Health (award 71208). Giuseppe Grosso was supported by the
   International Ph.D. Program in Neuropharmacology, University Medical
   School of Catania, Catania, Italy.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Andriantsitohaina R, 2012, BRIT J NUTR, V108, P1532, DOI 10.1017/S0007114512003406
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Barnes S, 2011, FOOD FUNCT, V2, P235, DOI 10.1039/c1fo10025d
   Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Brunner E, 2001, BRIT J NUTR, V86, P405, DOI 10.1079/BJN2001414
   Buscemi S, 2010, EUR J CLIN NUTR, V64, P1242, DOI 10.1038/ejcn.2010.137
   Buscemi S, 2010, EUR J CLIN NUTR, V64, P483, DOI 10.1038/ejcn.2010.9
   Buscemi S, 2009, EUR J CLIN NUTR, V63, P1200, DOI 10.1038/ejcn.2009.51
   Buscemi S, 2014, EAT WEIGHT DISORD-ST, V19, P225, DOI 10.1007/s40519-014-0117-4
   Chang CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038874
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Geleijnse JM, 2008, VASC HEALTH RISK MAN, V4, P963
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Grosso G, 2014, NUTR METAB CARDIOVAS, V24, P370, DOI 10.1016/j.numecd.2013.09.020
   Grosso G, 2014, NUTRITION, V30, P1398, DOI 10.1016/j.nut.2014.04.012
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Grosso G, 2014, CRIT REV FOOD SCI, V54, P593, DOI 10.1080/10408398.2011.596955
   Grosso G, 2013, FRONT BIOSCI-LANDMRK, V18, P1017, DOI 10.2741/4160
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hashizume C, 2012, J NUTR SCI VITAMINOL, V58, P423, DOI 10.3177/jnsv.58.423
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hostmark AT, 2010, APPL PHYSIOL NUTR ME, V35, P635, DOI 10.1139/H10-059
   Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066
   Imatoh T, 2011, EUR J NUTR, V50, P279, DOI 10.1007/s00394-010-0136-5
   Islam Mohammed A, 2012, Recent Pat Cardiovasc Drug Discov, V7, P88
   Janszky I, 2011, ANN AGR ENV MED, V18, P270
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Kubot K, 2011, NUTR RES, V31, P421, DOI 10.1016/j.nutres.2011.05.004
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Panagiotakos DB, 2009, YONSEI MED J, V50, P31, DOI 10.3349/ymj.2009.50.1.31
   Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255
   Polychronopoulos E, 2008, EUR J NUTR, V47, P10, DOI 10.1007/s00394-007-0690-7
   Psaltopoulou Theodora, 2010, Rev Diabet Stud, V7, P26, DOI 10.1900/RDS.2010.7.26
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Steffen M, 2012, J HYPERTENS, V30, P2245, DOI 10.1097/HJH.0b013e3283588d73
   Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88
   Szurkowska Magdalena, 2006, Przegl Lek, V63, P733
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Weisburger JH, 1997, CANCER LETT, V114, P315, DOI 10.1016/S0304-3835(97)04691-0
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Wu LY, 2004, EUR J NUTR, V43, P116, DOI 10.1007/s00394-004-0450-x
   Zuo H, 2009, METABOLISM, V58, P1102, DOI 10.1016/j.metabol.2009.04.008
NR 52
TC 101
Z9 103
U1 1
U2 61
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT
PY 2015
VL 54
IS 7
BP 1129
EP 1137
DI 10.1007/s00394-014-0789-6
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CR8WK
UT WOS:000361634700009
PM 25367317
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Torres-Collado, L
   Compañ-Gabucio, LM
   González-Palacios, S
   Notario-Barandiaran, L
   Oncina-Cánovas, A
   Vioque, J
   García-de la Hera, M
AF Torres-Collado, Laura
   Maria Compan-Gabucio, Laura
   Gonzalez-Palacios, Sandra
   Notario-Barandiaran, Leyre
   Oncina-Canovas, Alejandro
   Vioque, Jesus
   Garcia-de la Hera, Manuela
TI Coffee Consumption and All-Cause, Cardiovascular, and Cancer Mortality
   in an Adult Mediterranean Population
SO NUTRIENTS
LA English
DT Article
DE coffee; caffeinated; decaffeinated; mortality; cardiovascular disease;
   cancer
ID RISK; METAANALYSIS; ASSOCIATION; CAFFEINE; DISEASE; DIET; AGREEMENT;
   ADHERENCE; SURVIVAL; OBESITY
AB We assessed the association between usual coffee consumption and all-cause, cardiovascular (CV), and cancer mortality in an adult population in Spain, taking into account both the amount and type of coffee consumed. We used baseline data on coffee consumption and other personal variables, and the number of deaths during an 18-year follow-up period, for 1567 participants aged 20 years and older from the Valencia Nutrition Study in Spain. Total, caffeinated, and decaffeinated coffee consumption was assessed using a validated food frequency questionnaire. Cox regression models were used to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). During the 18-year follow-up period, 317 died; 115 due to CV disease and 82 due to cancer. Compared with no-consumption, the consumption of <= 1 cup per day and >1 cup per day of coffee was associated with a lower risk of all-cause mortality, HR = 0.73 (95% CI: 0.56-0.97) and HR 0.56 (95% CI: 0.41-0.77), respectively. A lower cancer mortality was observed among drinkers of more than 1 cup per day compared with nondrinkers, HR 0.41 (95% CI 0.20-0.86). Regarding the type of coffee, only the overall consumption of caffeinated coffee was associated with lower all-cause mortality at 12 and 18 years of follow-up, HR = 0.66 (95% CI:0.46-0.94) and HR = 0.59 (95% CI: 0.44-0.79), respectively. In conclusion, this study suggests that the moderate consumption of coffee, particularly caffeinated coffee (range 1-6.5 cups per day), is associated with a lower all-cause and cancer mortality after a long follow-up period. No significant association was found between coffee consumption and CVD mortality.
C1 [Torres-Collado, Laura; Maria Compan-Gabucio, Laura; Gonzalez-Palacios, Sandra; Notario-Barandiaran, Leyre; Oncina-Canovas, Alejandro; Vioque, Jesus; Garcia-de la Hera, Manuela] ISABIAL UMH, Inst Invest Sanitaria & Biomed Alicante, Alicante 03010, Spain.
   [Torres-Collado, Laura; Maria Compan-Gabucio, Laura; Gonzalez-Palacios, Sandra; Notario-Barandiaran, Leyre; Oncina-Canovas, Alejandro; Vioque, Jesus; Garcia-de la Hera, Manuela] Univ Miguel Hernandez UMH, Dept Salud Publ Hist Ciencia & Ginecol, Unidad Epidemiol Nutr, Alicante 03550, Spain.
   [Torres-Collado, Laura; Maria Compan-Gabucio, Laura; Gonzalez-Palacios, Sandra; Notario-Barandiaran, Leyre; Oncina-Canovas, Alejandro; Vioque, Jesus; Garcia-de la Hera, Manuela] Inst Salud Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid 28034, Spain.
C3 General University Hospital of Alicante; Universidad Miguel Hernandez de
   Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y
   Biomedica de Alicante (ISABIAL); CIBER - Centro de Investigacion
   Biomedica en Red; CIBERESP; Instituto de Salud Carlos III
RP Vioque, J (corresponding author), ISABIAL UMH, Inst Invest Sanitaria & Biomed Alicante, Alicante 03010, Spain.; Vioque, J (corresponding author), Univ Miguel Hernandez UMH, Dept Salud Publ Hist Ciencia & Ginecol, Unidad Epidemiol Nutr, Alicante 03550, Spain.; Vioque, J (corresponding author), Inst Salud Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid 28034, Spain.
EM l.torres@umh.es; lcompan@umh.es; sandra.gonzalezp@umh.es;
   lnotario@umh.es; aoncina@umh.es; vioque@umh.es; manoli@umh.es
RI Gabucio, Laura/AAN-6068-2020; Palacios, Sandra/AAA-9585-2021; Garcia de
   la Hera, Manuela/N-8908-2019; Oncina Canovas, Alejandro/KOD-0906-2024;
   Vioque, Jesus/A-1066-2008
OI Torres-Collado, Laura/0000-0003-2842-1344; Compan Gabucio, Laura
   M/0000-0001-5324-1535; Gonzalez Palacios, Sandra/0000-0003-3358-472X;
   Garcia de la Hera, Manuela/0000-0001-5742-2704; Vioque,
   Jesus/0000-0002-2284-148X; Oncina Canovas, Alejandro/0000-0003-4652-0565
FU Direccion General de Salud Publica, Generalitat Valenciana 1994; Fondo
   Investigacion Sanitaria [FIS 00/0985]; Instituto de Salud Carlos III;
   FEDER funds [FIS PI13/00654]
FX The VNS study was supported by a grant from the Direccion General de
   Salud Publica, Generalitat Valenciana 1994 and the Fondo Investigacion
   Sanitaria (FIS 00/0985). This study has also received support from the
   Instituto de Salud Carlos III and FEDER funds (FIS PI13/00654).
CR Bravi F, 2017, EUR J CANCER PREV, V26, P368, DOI [10.1097/cej.0000000000000252, 10.1097/CEJ.0000000000000252]
   Buckland G, 2009, AM J EPIDEMIOL, V170, P1518, DOI 10.1093/aje/kwp282
   BUSH TL, 1989, AM J PUBLIC HEALTH, V79, P1554, DOI 10.2105/AJPH.79.11.1554
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Caini S, 2017, EUR J NUTR, V56, P1, DOI 10.1007/s00394-016-1253-6
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dinu M, 2018, EUR J CLIN NUTR, V72, P30, DOI 10.1038/ejcn.2017.58
   Gökcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2017, AM J EPIDEMIOL, V185, P1304, DOI 10.1093/aje/kww207
   Grosso G, 2017, PUBLIC HEALTH NUTR, V20, P82, DOI [10.1017/S1368980016001749, 10.1017/s1368980016001749]
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Gunter MJ, 2017, ANN INTERN MED, V167, P236, DOI 10.7326/M16-2945
   Happonen P, 2008, BRIT J NUTR, V99, P1354, DOI 10.1017/S0007114507871650
   HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Je Y, 2014, BRIT J NUTR, V111, P1162, DOI 10.1017/S0007114513003814
   Kim Y, 2019, EUR J EPIDEMIOL, V34, P731, DOI 10.1007/s10654-019-00524-3
   LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158
   Liu JX, 2013, MAYO CLIN PROC, V88, P1066, DOI 10.1016/j.mayocp.2013.06.020
   Liu QP, 2016, NUTRITION, V32, P628, DOI 10.1016/j.nut.2015.11.015
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Machado-Fragua MD, 2019, EUR J NUTR, V58, P1415, DOI 10.1007/s00394-018-1664-7
   Malerba S, 2013, EUR J EPIDEMIOL, V28, P527, DOI 10.1007/s10654-013-9834-7
   Navarro AM, 2018, AM J CLIN NUTR, V108, P1113, DOI 10.1093/ajcn/nqy198
   Palatini P, 2016, INT J CARDIOL, V212, P131, DOI 10.1016/j.ijcard.2016.03.006
   Palma I., 2008, Tablas de Composicin de Alimentos por Medidas Caseras de Consumo Habitual en Espaa. Centre dEnsenyament Superior de Nutrici i Diettica (CESNID)
   Park SY, 2017, ANN INTERN MED, V167, P228, DOI 10.7326/M16-2472
   Penolazzi B, 2012, APPETITE, V58, P971, DOI 10.1016/j.appet.2012.02.001
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Quiles J, 1998, MED CLIN-BARCELONA, V110, P319
   Ruggiero E, 2021, J NUTR, V151, P395, DOI 10.1093/jn/nxaa365
   Sado J, 2019, CIRC J, V83, P757, DOI 10.1253/circj.CJ-18-0618
   Sado J, 2017, CANCER SCI, V108, P2079, DOI 10.1111/cas.13328
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Torres-Collado L, 2019, EUR J NUTR, V58, P2439, DOI 10.1007/s00394-018-1796-9
   TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457
   Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039
   U.S. Department of Agriculture ARS USDA Nutrient Data Laboratory, 2008, USDA NAT NUTR DAT ST
   Vioque J., 1991, European Journal of Cancer Prevention, V1, P19
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086
   Wu L, 2017, CLIN NUTR, V36, P730, DOI 10.1016/j.clnu.2016.05.015
   Yamagata K, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7020026
   Yu XF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-96
NR 47
TC 18
Z9 18
U1 0
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR
PY 2021
VL 13
IS 4
AR 1241
DI 10.3390/nu13041241
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA RR9PZ
UT WOS:000643422200001
PM 33918797
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Rustenbeck, I
   Lier-Glaubitz, V
   Willenborg, M
   Eggert, F
   Engelhardt, U
   Jörns, A
AF Rustenbeck, I.
   Lier-Glaubitz, V.
   Willenborg, M.
   Eggert, F.
   Engelhardt, U.
   Joerns, A.
TI Effect of chronic coffee consumption on weight gain and glycaemia in a
   mouse model of obesity and type 2 diabetes
SO NUTRITION & DIABETES
LA English
DT Article
ID IMPAIRED GLUCOSE-TOLERANCE; DIET-INDUCED OBESITY; DECAFFEINATED COFFEE;
   INSULIN SENSITIVITY; RISK; CAFFEINE; MICE; FAT; MECHANISMS; HOMEOSTASIS
AB OBJECTIVE: Epidemiological evidence shows that chronic coffee consumption in humans is correlated with a lower incidence of type 2 diabetes mellitus. For the experimental exploration of the underlying mechanisms, this effect needs to be replicated in an animal model of type 2 diabetes with a short lifespan.
   DESIGN: Male C57BL/6 mice consumed regular coffee or water ad libitum and the development of obesity and diabetes caused by high-fat diet (55% lipids, HFD) was observed from week 10 on for 35 weeks in comparison with mice feeding on a defined normal diet (9% lipids, ND).
   RESULTS: The massive weight gain in HFD mice was dose-dependently retarded (P = 0.034), the moderate weight gain in ND mice was abolished (P<0.001) by coffee consumption, probably because of a lower feeding efficiency. The consumption of fluid (water or coffee) was significantly diminished by HFD (P<0.001), resulting in a higher coffee exposure of ND mice. On week 21 intraperitoneal glucose tolerance tests (IPGTT) showed a dose-dependent faster decline of elevated glucose levels in coffee-consuming HFD mice (P = 0.016), but not in ND mice. Remarkably, a spontaneous decrease in non-fasting glycaemia occurred after week 21 in all treatment groups (P<0.001). On week 39 the IPGTT showed diminished peak of glucose levels in coffee-consuming HFD mice (P<0.05). HFD mice were hyperinsulinaemic and had significantly (P<0.001) enlarged islets. Coffee consumption did not affect islet size or parameters of beta-cell apoptosis, proliferation and insulin granule content.
   CONCLUSION: Coffee consumption retarded weight gain and improved glucose tolerance in a mouse model of type 2 diabetes and corresponding controls. This gives rise to the expectation that further insight into the mechanism of the diabetes-preventive effect of coffee consumption in humans may be gained by this approach.
C1 [Rustenbeck, I.; Lier-Glaubitz, V.; Willenborg, M.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmacol & Toxicol, D-38106 Braunschweig, Germany.
   [Eggert, F.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Psychol, D-38106 Braunschweig, Germany.
   [Engelhardt, U.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Food Chem, D-38106 Braunschweig, Germany.
   [Joerns, A.] Hannover Med Sch, Dept Anat, Hannover, Germany.
C3 Braunschweig University of Technology; Braunschweig University of
   Technology; Braunschweig University of Technology; Hannover Medical
   School
RP Rustenbeck, I (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmacol & Toxicol, Mendelssohnstr 1, D-38106 Braunschweig, Germany.
EM i.rustenbeck@tu-bs.de
RI Willenborg, Michael/I-2993-2012
OI Eggert, Frank/0000-0002-5797-4741
FU ISIC (Institute for Scientific Information on Coffee)
FX This work was supported in part by a grant from ISIC (Institute for
   Scientific Information on Coffee) to IR. IR is indebted to Dr Thomas
   Vieregge for helpful advice on animal care and testing.
CR Anderson J, 1967, Diabetologia, V3, P50, DOI 10.1007/BF01269911
   Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Bidel S, 2006, DIABETOLOGIA, V49, P2618, DOI 10.1007/s00125-006-0435-9
   Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007
   Brownlow BS, 1996, PHYSIOL BEHAV, V60, P37, DOI 10.1016/0031-9384(95)02210-4
   Carnethon MR, 2007, DIABETOLOGIA, V50, P1113, DOI 10.1007/s00125-007-0673-5
   DENARO CP, 1991, EUR J CLIN PHARMACOL, V40, P273, DOI 10.1007/BF00315208
   Feduccia AA, 2012, PHARMACOL BIOCHEM BE, V102, P241, DOI 10.1016/j.pbb.2012.04.014
   FEINBERG LJ, 1968, METABOLISM, V17, P916, DOI 10.1016/0026-0495(68)90158-3
   Floegel A, 2012, AM J CLIN NUTR, V95, P901, DOI 10.3945/ajcn.111.023648
   Gerber DA, 2004, ANN INTERN MED, V141, P323, DOI 10.7326/0003-4819-141-4-200408170-00019
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ilanne-Parikka P, 2010, DIABETES CARE, V33, P1610, DOI 10.2337/dc09-2155
   Jörns A, 2010, ENDOCRINOLOGY, V151, P3555, DOI 10.1210/en.2010-0202
   Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8
   Laaksonen DE, 2007, DIABETOLOGIA, V50, P2607, DOI 10.1007/s00125-007-0805-y
   LEITER EH, 1988, FASEB J, V2, P2807, DOI 10.1096/fasebj.2.12.3044905
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Lopez-Garcia E, 2008, ANN INTERN MED, V148, P904, DOI 10.7326/0003-4819-148-12-200806170-00003
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141
   Montanya E, 2009, METHODS MOL BIOL, V560, P137, DOI 10.1007/978-1-59745-448-3_11
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Petrie HJ, 2004, AM J CLIN NUTR, V80, P22
   Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018
   Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Reunanen A, 2003, LANCET, V361, P702, DOI 10.1016/S0140-6736(03)12583-4
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Saremi A, 2003, DIABETES CARE, V26, P2211, DOI 10.2337/diacare.26.7.2211
   Schaefer B, 2004, ANN INTERN MED, V141, P321, DOI 10.7326/0003-4819-141-4-200408170-00016
   Srinivasan K, 2007, INDIAN J MED RES, V125, P451
   Starr ME, 2012, J GERONTOL A-BIOL, V67, P1043, DOI 10.1093/gerona/gls009
   SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Watanabe M, 2010, J FOOD SCI, V75, pH294, DOI 10.1111/j.1750-3841.2010.01853.x
   Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
   Yang JN, 2009, AM J PHYSIOL-HEART C, V296, pH1141, DOI 10.1152/ajpheart.00754.2008
NR 45
TC 18
Z9 19
U1 0
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2044-4052
J9 NUTR DIABETES
JI Nutr. Diabetes
PD JUN
PY 2014
VL 4
AR e123
DI 10.1038/nutd.2014.19
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA AO9DO
UT WOS:000341656100007
PM 24979152
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Lodi, KZ
   Cappelari, MB
   Pilatti, GC
   Fontana, RC
   Camassola, M
   Salvador, M
   Branco, CS
AF Lodi, Karina Zanella
   Cappelari, Monique Brigolini
   Pilatti, Gabriela Carolina
   Fontana, Roselei Claudete
   Camassola, Marli
   Salvador, Mirian
   Branco, Catia Santos
TI Pre-clinical evidence for the therapeutic effect of Pitaya
   (Hylocereus lemairei) on diabetic intestinal microenvironment
SO NATURAL PRODUCT RESEARCH
LA English
DT Article
DE Enterocytes; hypoglycemic agents; plant extracts; inflammation
ID NITRIC-OXIDE SYNTHASE; CACO-2
AB Intestinal glucose absorption plays a central role in the regulation of glucose plasmatic; however, current clinical management does not target the gut for treating diabetes. This study evaluated the effects of peel and pulp aqueous extract from Hylocereus lemairei on human enterocytes under high glucose concentration. Anti-hyperglycemic and antiobesity activities in vitro were also evaluated. Extracts did not cause cytotoxicity at 1 to 500 mu g/mL. Moreover, they were effective in attenuating oxidative stress (DCFH-DA assay) and inflammation ((ON)-O-center dot production) caused by high glucose. Intestinal enzymes (alpha- glucosidase and pancreatic lipase) were inhibited by pulp and peel extracts (>60% and >95%, respectively). Extracts exhibited a redox capacity superior to ascorbic and chlorogenic acids, presenting high phenolic content, mainly anthocyanins. The main compounds for both extracts were chlorogenic acid and naringin, and peel stood both qualitatively and quantitatively. Data suggest red Pitaya has potential as a new medicine for diabetes.
C1 [Lodi, Karina Zanella; Salvador, Mirian; Branco, Catia Santos] Univ Caxias do Sul, Biotechnol Inst, Lab Oxidat Stress & Antioxidants, Caxias Do Sul, RS, Brazil.
   [Cappelari, Monique Brigolini; Pilatti, Gabriela Carolina; Branco, Catia Santos] Univ Caxias do Sul, Dept Life Sci, Caxias Do Sul, RS, Brazil.
   [Fontana, Roselei Claudete; Camassola, Marli] Univ Caxias do Sul, Biotechnol Inst, Lab Enzymes & Biomass, Caxias Do Sul, RS, Brazil.
C3 Universidade de Caxias do Sul; Universidade de Caxias do Sul;
   Universidade de Caxias do Sul
RP Branco, CS (corresponding author), Univ Caxias do Sul, Biotechnol Inst, Lab Oxidat Stress & Antioxidants, Caxias Do Sul, RS, Brazil.; Branco, CS (corresponding author), Univ Caxias do Sul, Dept Life Sci, Caxias Do Sul, RS, Brazil.
EM csbranc1@ucs.br
RI Camassola, Marli/H-3034-2012; Branco, Catia/E-6851-2013
FU Coordenacao de Apoio de Pessoal de Nivel Superior (CAPES); Fundacao de
   Amparoa Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
FX This work was supported by the Coordenacao de Apoio de Pessoal de Nivel
   Superior (CAPES), the Fundacao de Amparoa Pesquisa do Estado do Rio
   Grande do Sul (FAPERGS), and the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq). The authors thank UCS Writing Center
   for the grammatical revision of this paper.
CR Abd Hadi N., 2012, Borneo Sci, V31, P127
   Branco CS, 2019, ANTI-CANCER AGENT ME, V19, P130, DOI 10.2174/1871520618666180816142821
   Branco CS, 2019, MOL BIOL REP, V46, P6013, DOI 10.1007/s11033-019-05037-6
   Cavicchi M, 1999, BRIT J PHARMACOL, V128, P705, DOI 10.1038/sj.bjp.0702827
   Chen L, 2019, FOOD CHEM TOXICOL, V127, P182, DOI 10.1016/j.fct.2019.03.038
   Chen XM, 2015, MOL CELL BIOCHEM, V406, P205, DOI 10.1007/s11010-015-2438-7
   El-Bassossy H, 2016, CHEM-BIOL INTERACT, V254, P191, DOI 10.1016/j.cbi.2016.06.013
   Gertsch J, 2011, PLANTA MED, V77, P1086, DOI 10.1055/s-0030-1270904
   Ghorbani A, 2017, BIOMED PHARMACOTHER, V96, P305, DOI 10.1016/j.biopha.2017.10.001
   Guo YJ, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.575442
   Hajialyani M, 2019, MOLECULES, V24, DOI 10.3390/molecules24030648
   Hua QZ, 2018, PLANT PHYSIOL BIOCH, V126, P117, DOI 10.1016/j.plaphy.2018.02.027
   Javier M.-S., 2017, Water pollution from agriculture: A global review
   Joshi M, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13260
   Nazir N, 2021, MOLECULES, V26, DOI 10.3390/molecules26010137
   Nyane NA, 2017, EUR J PHARMACOL, V803, P103, DOI 10.1016/j.ejphar.2017.03.042
   Pappis L, 2022, NAT PROD RES, V36, P4170, DOI 10.1080/14786419.2021.1960522
   Patterson E, 2016, POSTGRAD MED J, V92, P286, DOI 10.1136/postgradmedj-2015-133285
   Phenol-Explorer, 2020, DAT POL CONT FOODS
   Suh DH, 2014, J AGR FOOD CHEM, V62, P8764, DOI 10.1021/jf5020704
   Sun H, 2008, EXPERT OPIN DRUG MET, V4, P395, DOI [10.1517/17425255.4.4.395, 10.1517/17425255.4.4.395 ]
   Testa R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050437
   Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318
   Variya BC, 2020, PHYTOMEDICINE, V73, DOI 10.1016/j.phymed.2019.152906
   Vlachos D, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061561
   Xue YW, 2019, FOOD CHEM TOXICOL, V133, DOI 10.1016/j.fct.2019.110751
NR 26
TC 6
Z9 6
U1 2
U2 31
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
PD MAY 19
PY 2023
VL 37
IS 10
BP 1735
EP 1741
DI 10.1080/14786419.2022.2110091
EA AUG 2022
PG 7
WC Chemistry, Applied; Chemistry, Medicinal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Pharmacology & Pharmacy
GA E3EQ2
UT WOS:000838687300001
PM 35945808
DA 2025-04-28
ER

PT J
AU Gouthamchandra, K
   Sudeep, HV
   Amritharaj
   Lingaraju, HB
   Prasad, KS
AF Gouthamchandra, K.
   Sudeep, H., V
   Amritharaj
   Lingaraju, H. B.
   Prasad, Shyam K.
TI SUNCA Standardized Extract from Helianthus annus L Exerts
   Enhanced Digestive Enzyme Activity and Subsides Obesity through
   Inhibition of C/EBP-α and PPAR-γ Expression Both in in vitro and
   in vivo Model
SO PHARMACOGNOSY MAGAZINE
LA English
DT Article
DE 3T3-L cells; adipogenesis; chlorogenic acid; high-fat diet; sunflower
ID MEDICINAL-PLANTS; QUANTITATION; GLUCOSIDASE; GENETICS
AB Background: Helianthus annuus L. (sunflower) is well known for its edible oil, sunflower seed has been used as folk remedy for several diseases including cancer. Materials and Methods: In this study, SUNCA, a standardized extract enriched with chlorogenic acid (CGA) from sunflower seed was investigated for in vitro antidiabetic activity using alpha-amylase and alpha-glucosidase enzyme inhibition assay. Further, for preventing obesity, we demonstrated anti-adipogenesis in 3T3-L1 cell culture system and on body weight gain and adiposity in rat fed high-fat diet (HFD). Results: SUNCA showed significant inhibitory activity toward digestive enzymes such as alpha-amylase and alpha-glucosidase. On the other hand, SUNCA significantly inhibits lipid accumulation during adipogenesis in a dose-dependent manner. The treatment with 100 mu g/kg b.w of SUNCA apparently prevented the body weight gain and the increase of triglyceride and total cholesterol level in rat fed an HFD for 6 weeks. Further immunoblotting studies reveal that SUNCA significantly down-regulates the expression of transcription factors peroxisome proliferator-activated receptor gamma and CCAT/enhancer-binding protein alpha, both in adipocytes and adipose tissues. Conclusion: The findings reported here provide the therapeutic potential of SUNCA, a standardized extract from Helanthus annus L.
C1 [Gouthamchandra, K.; Sudeep, H., V; Amritharaj; Prasad, Shyam K.] Vidya Herbs Pvt Ltd, Dept Biomed Res, R&D Ctr Excellence, Bangalore, Karnataka, India.
   [Lingaraju, H. B.; Prasad, Shyam K.] Vidya Herbs Pvt Ltd, Dept Phytochem, R&D Ctr Excellence, Bangalore, Karnataka, India.
RP Gouthamchandra, K (corresponding author), Vidya Herbs Pvt Ltd, R&D Ctr Excellence, Dept Biomed Res, 14A,Jigani I Phase, Bengaluru 560105, Karnataka, India.
EM goutham06@gmail.com
RI HV, Sudeep/AAN-1561-2020
CR Alagawany M., 2015, Advances in Animal and Veterinary Sciences, V3, P634, DOI 10.14737/journal.aavs/2015/3.12.634.648
   Chow YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38129
   Cladodes CS, 1997, J PROF ASSOC CACTUS, V2, P117
   Colette C, 2003, INT J OBESITY, V27, P648, DOI 10.1038/sj.ijo.0802299
   de Freitas LM, 2017, AM J TRANSL RES, V9, P2050
   GEORG MW, 2009, FOOD CHEM, V115, P758
   González-Pérez S, 2007, J SCI FOOD AGR, V87, P2173, DOI 10.1002/jsfa.2971
   Gouthamchandra K, 2017, FOOD SCI HUM WELL, V6, P147, DOI 10.1016/j.fshw.2017.06.001
   Guo SS, 2017, CHEM CENT J, V11, DOI 10.1186/s13065-017-0328-7
   Hansawasdi C, 2000, BIOSCI BIOTECH BIOCH, V64, P1041, DOI 10.1271/bbb.64.1041
   Hardy LL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2031-8
   Hasani-Ranjbar S, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-28
   He YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070135
   Herrera BM, 2010, CURR DIABETES REP, V10, P498, DOI 10.1007/s11892-010-0153-z
   Hu QH, 2012, BIOCHEM PHARMACOL, V84, P113, DOI 10.1016/j.bcp.2012.03.005
   Ikeda I, 1998, CURR OPIN LIPIDOL, V9, P527, DOI 10.1097/00041433-199812000-00003
   Kowalska K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188583
   Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011
   Malik MA, 2016, J FOOD SCI TECH MYS, V53, P3455, DOI 10.1007/s13197-016-2320-y
   McCrory MA, 2010, ADV NUTR, V1, P17, DOI 10.3945/an.110.1006
   McCue PP, 2004, ASIA PAC J CLIN NUTR, V13, P101
   Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124
   O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532
   Oyedemi Sunday O, 2017, ScientificWorldJournal, V2017, P3592491, DOI 10.1155/2017/3592491
   Pi-Sunyer X, 2009, POSTGRAD MED, V121, P21, DOI 10.3810/pgm.2009.11.2074
   RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069
   Shai LJ, 2011, J MED PLANTS RES, V5, P2863
   Singha B, 2014, J PHARM ANA, V4, P144, DOI 10.1016/j.jpha.2013.05.003
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1258-y
   Watanabe J, 1997, BIOSCI BIOTECH BIOCH, V61, P177, DOI 10.1271/bbb.61.127
   Zeka Keti, 2017, Diseases, V5, DOI 10.3390/diseases5030019
NR 31
TC 0
Z9 0
U1 0
U2 4
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0973-1296
EI 0976-4062
J9 PHARMACOGN MAG
JI Pharmacogn. Mag.
PD NOV
PY 2019
VL 15
IS 66
SU 3
BP 538
EP 544
DI 10.4103/pm.pm_204_19
PG 7
WC Chemistry, Medicinal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA KR7VU
UT WOS:000517825500022
DA 2025-04-28
ER

PT J
AU Ruiz-Torres, K
   De los Ríos, DLH
   Virgen-Carrillo, CA
   Pineda-Lozano, JE
   Moreno, AGM
AF Ruiz-Torres, Karina
   Hernandez de los Rios, Diana Laura
   Alejandrina Virgen-Carrillo, Carmen
   Elizabeth Pineda-Lozano, Jessica
   Martinez Moreno, Alma Gabriela
TI Abstract: Chronic caffeine administration prevents postprandial glucose
   disturbance in rats
SO ARCHIVOS LATINOAMERICANOS DE NUTRICION
LA English
DT Article
DE caffeine; cafeteria diet; metabolic syndrome; postprandial glucose; rats
ID HIGH-FAT DIET; METABOLIC SYNDROME; CAFETERIA DIET; CONSUMPTION; OBESITY;
   FOODS; MODEL
AB Introduction: Chronic caffeine administration prevents postprandial glucose disturbance in rats. The increase in caffeine consumption is not debatable, this is how his research has become extensive in his different fields. Objective. To analyze the effects of chronic administration of caffeine in rats fed a cafeteria diet, by evaluating consumption, anthropometric and biochemical indices. Previous studies refer to administering caffeine in diets high in carbohydrates and / or in fat that induce obesity or symptoms of metabolic syndrome. Material and methods. The cafeteria diet is a dietary model equivalent to the characteristics of the typical western diet that causes metabolic syndrome in humans. In this research, chronic intraperitoneal administration of caffeine was performed for 8 weeks to adult male Wistar rats fed a cafeteria diet. Given the little evidence about the biological and behavioral effects of the chronic administration of this substance against a cafeteria diet model, consumption, anthropometric and biochemical parameters were evaluated. Results. After eight weeks it was found that the cafeteria diet given to the controls caused abnormalities associated with the metabolic syndrome; regarding the administration of caffeine in the rats fed this diet, the treatment turned out to be a protective factor in postprandial glucose, but not in the alteration of glucose tolerance or lipid profile. Conclusions. Caffeine allowed to protect postprandial glucose levels at the end of the experiment and a decrease in body weight and food consumption only in the first week. However, no significant improvements were seen in lipid profile, adiposity, glucose tolerance, and plasma glucose.
C1 [Ruiz-Torres, Karina; Hernandez de los Rios, Diana Laura] Univ Juarez Estado Durango, Fac Med & Nutr, Av Univ & Fanny Anitua S-N, Durango 34000, Dgo, Mexico.
   [Alejandrina Virgen-Carrillo, Carmen; Elizabeth Pineda-Lozano, Jessica; Martinez Moreno, Alma Gabriela] Univ Guadalajara, Inst Invest Comportamiento Alimentario & Nutr, Av Enrique Arreola Silva 883, Cd Guzman 49000, Jalisco, Mexico.
C3 Universidad Juarez del Estado de Durango; Universidad de Guadalajara
RP Moreno, AGM (corresponding author), Univ Guadalajara, Inst Invest Comportamiento Alimentario & Nutr, Av Enrique Arreola Silva 883, Cd Guzman 49000, Jalisco, Mexico.
EM alma.martinez@cusur.udg.mx
CR Ezquerra EA, 2008, REV ESP CARDIOL, V61, P752, DOI 10.1016/S1885-5857(08)60212-1
   [Anonymous], 2002, Nutr Today, V37, P26, DOI [10.1097/00017285-200201000-00009, DOI 10.1097/00017285-200201000-00009]
   Bolles RC., 2006, TEORIA MOTIVACION
   CHAPMAN DG, 1959, CAN J BIOCHEM PHYS, V37, P679
   Che BQ, 2012, NEUROTOXICOLOGY, V33, P1248, DOI 10.1016/j.neuro.2012.07.004
   Clark KS, 2019, CLIN EXP PHARMACOL P, V46, P475, DOI 10.1111/1440-1681.13065
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Fuentes Paredes F de M, 2008, GUIA MANEJO CUIDADO
   Gharibi B, 2012, INT J OBESITY, V36, P397, DOI 10.1038/ijo.2011.129
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Gomez-Smith M, 2016, PHYSIOL BEHAV, V167, P382, DOI 10.1016/j.physbeh.2016.09.029
   Gonzalez RG, 2015, REV INT ACUPUNT, V9, P57
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Hernandez I, 2004, ENDOCRINOL DIAB NUTR, V51, P35
   Higa Talita S, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P47
   Johnson AR, 2016, BIOCHEM BIOPH RES CO, V473, P545, DOI 10.1016/j.bbrc.2016.03.113
   McIntosh VJ, 2012, J CARDIOVASC PHARM T, V17, P21, DOI 10.1177/1074248410396877
   Metro D, 2017, J CLIN TRANSL ENDOCR, V10, P22, DOI 10.1016/j.jcte.2017.10.001
   Moy GA, 2013, PHYSIOL BEHAV, V109, P69, DOI 10.1016/j.physbeh.2012.11.008
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Paredes JL, 2009, KASMERA, V37, P74
   Pettenuzzo LF, 2008, PHYSIOL BEHAV, V95, P295, DOI 10.1016/j.physbeh.2008.06.003
   Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18
   Speakman J, 2016, LAB ANIM-UK, V42, P413
   Sweeney P, 2016, APPETITE, V101, P171, DOI 10.1016/j.appet.2016.03.013
   Tofovic SP, 2007, RENAL FAILURE, V29, P891, DOI 10.1080/08860220701569846
   Urzúa Z, 2012, J INT MED RES, V40, P2220, DOI 10.1177/030006051204000620
   Wierzejska Regina, 2012, Rocz Panstw Zakl Hig, V63, P141
   Wynne CDL., 1998, MODELS ACTION MECH A
   Zapata FJ, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103646
   Zheng XY, 2014, PHARMACOL BIOCHEM BE, V122, P136, DOI 10.1016/j.pbb.2014.03.027
NR 32
TC 0
Z9 0
U1 0
U2 3
PU ARCHIVOS LATINOAMERICANOS NUTRICION
PI CARACAS
PA APARTADO 62778 CHACAO, AVENIDA FRANCISCO MIRANDA, CARACAS 1060,
   VENEZUELA
SN 0004-0622
EI 2309-5806
J9 ARCH LATINOAM NUTR
JI Arch. Latinoam. Nutr.
PD DEC
PY 2021
VL 71
IS 4
BP 300
EP 309
DI 10.37527/2021.71.4.007
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA YL8FL
UT WOS:000746123200007
OA gold
DA 2025-04-28
ER

PT J
AU Simoes, MHS
   Salles, BCC
   Duarte, SMD
   da Silva, MA
   Viana, ALM
   de Moraes, GDI
   Figueiredo, SA
   Ferreira, EB
   Rodrigues, MR
   Paula, FBD
AF Souza Simoes, Mario Henrique
   Correa Salles, Bruno Cesar
   da Silveira Duarte, Stella Maris
   da Silva, Marcelo Aparecido
   Machado Viana, Andre Luiz
   Isaac de Moraes, Gabriel de Oliveira
   Figueiredo, Sonia Aparecida
   Ferreira, Eric Batista
   Rodrigues, Maria Rita
   de Araujo Paula, Fernanda Borges
TI Leaf extract of Coffea arabica L. reduces lipid peroxidation and
   has anti-platelet effect in a rat dyslipidemia model
SO BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Coffee; Antioxidant; Dyslipidemia; Lipid peroxidation; Platelet
   aggregation
ID PLATELET-AGGREGATION; ANTIOXIDANT STATUS; OXIDATIVE STRESS; CHLOROGENIC
   ACID; OBESITY
AB This study aimed to evaluate the antioxidant potential of the Coffea arabica Linen (L.) leaf extract and its effects on platelet aggregation of dyslipidemic rats. The extract was obtained by the percolation of C. arabica L. leaves in hydroethanolic solution 70% (v/v). The mass spectrometry FIA-ESI-MS2 suggested the presence of chlorogenic acid, rutin acid, and quinic acid. The DPPH(center dot )radicals scavenging capacity was demonstrated (IC50 = 0.06 mg/mL). The extract was administered to rats by gavage (300 mg/kg/day) for 56 days. Dyslipidemia was induced by administering Triton WR-1339 (300 mg/kg body weight) on the 54th day. On day 56, blood was collected by puncturing the abdominal aorta artery and the aortic artery was removed. Lipid profile, markers of renal and hepatic injury, lipid peroxidation, and platelet aggregation tests were carried out. The ingestion of extract reduced the lipid peroxidation (aorta and plasma) and platelet aggregation in dyslipidemic rats. The extract did not affect markers of renal and hepatic function as analyzed in this study, suggesting neither impaired liver nor kidney function in these animals. Therefore, our results demonstrate that the extract of leaves of C. arabica L. show antioxidant potential in vitro and in vivo as well as anti-platelet aggregation in dyslipidemic animals.
C1 [Souza Simoes, Mario Henrique; Correa Salles, Bruno Cesar; da Silveira Duarte, Stella Maris; Machado Viana, Andre Luiz; Figueiredo, Sonia Aparecida; Rodrigues, Maria Rita; de Araujo Paula, Fernanda Borges] Univ Fed Alfenas, Coll Pharmaceut Sci, Dept Clin & Toxicol Anal, Lab Clin & Expt Biochem, Alfenas, MG, Brazil.
   [da Silva, Marcelo Aparecido] Univ Fed Alfenas, Dept Food & Drug, Lab Med Plants, Coll Pharmaceut Sci, Alfenas, MG, Brazil.
   [Isaac de Moraes, Gabriel de Oliveira] Univ Fed Alfenas, Inst Biomed Sci, Lab Biochem, Dept Biochem, Alfenas, MG, Brazil.
   [Ferreira, Eric Batista] Univ Fed Alfenas, Inst Exact Sci, Dept Stat, Alfenas, MG, Brazil.
C3 Universidade Federal de Alfenas; Universidade Federal de Alfenas;
   Universidade Federal de Alfenas; Universidade Federal de Alfenas
RP Paula, FBD (corresponding author), Univ Fed Alfenas, Dept Anal Clin & Toxicol, Fac Ciencias Farmaceut, Rua Gabriel Monteiro da Silva 700, BR-37130001 Alfenas, MG, Brazil.
EM paula@unifal-mg.edu.br
RI Ferreira, Eric/C-2551-2011; Paula, Fernanda/AAH-1684-2019; Figueiredo,
   Sônia/K-5455-2016; Marcelo, Silva/F-3166-2015; Rodrigues,
   Maria/ABE-1097-2020
OI Aparecido da Silva, Marcelo/0000-0002-2169-9346; Rodrigues, Maria
   Rita/0000-0003-0940-002X; Paula, Fernanda Borges de
   Araujo/0000-0003-3077-3023
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil
   (CAPES) [001]; Fapemig
FX This study was partially financed by the Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior -Brasil (CAPES) -Finance Code 001. The
   authors thank the Fapemig by the scholarship for Mario Henrique Souza
   Simoes to obtain Master's degree in Pharmaceutical Sciences.
CR Abdou HM, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8679506
   AlAmri OD, 2020, J FUNCT FOODS, V71, DOI 10.1016/j.jff.2020.103996
   Araujo ACM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211372
   Badimón L, 2009, REV ESP CARDIOL, V62, P1161, DOI 10.1016/S0300-8932(09)72385-1
   Balaji M, 2016, OBES RES CLIN PRACT, V10, P363, DOI 10.1016/j.orcp.2015.12.004
   Baldissera L, 2010, PULM PHARMACOL THER, V23, P327, DOI 10.1016/j.pupt.2010.03.006
   Bastos RG, 2019, S AFR J BOT, V123, P317, DOI 10.1016/j.sajb.2019.03.006
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Burtis CA, 2008, TIETZ TXB CLIN CHEM
   Cao QJ, 2020, FOOD CHEM, V333, DOI 10.1016/j.foodchem.2020.127528
   Catalano D, 2015, COFFEE HLTH DIS PREV, P531
   CDC. Centers for Disease Control and prevention, 2020, HEART DIS FACTS
   Chen XM, 2018, FOOD CHEM, V249, P143, DOI 10.1016/j.foodchem.2017.12.073
   Chiang HM, 2011, FOOD CHEM TOXICOL, V49, P309, DOI 10.1016/j.fct.2010.10.034
   Colas R, 2011, DIABETOLOGIA, V54, P2931, DOI 10.1007/s00125-011-2272-8
   Silvério ADD, 2013, PLANT FOOD HUM NUTR, V68, P268, DOI 10.1007/s11130-013-0365-x
   de Almeida RF, 2019, FOOD RES INT, V115, P493, DOI 10.1016/j.foodres.2018.10.006
   Dias Souza Renata Kelly, 2013, Rev Cubana Plant Med, V18, P140
   dos Santos PM, 2014, QUIM NOVA, V37, P89, DOI 10.1590/S0100-40422014000100017
   Dudonné S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r
   El-Seweidy MM, 2019, BIOMED PHARMACOTHER, V110, P456, DOI 10.1016/j.biopha.2018.11.140
   Escárcega RO, 2018, AUTOIMMUN REV, V17, P703, DOI 10.1016/j.autrev.2018.01.021
   Faggio C, 2017, EUR J PHARMACOL, V807, P91, DOI 10.1016/j.ejphar.2017.04.009
   Fuentes E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090699
   Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002
   Güez CM, 2017, BRAZ J PHARM SCI, V53, DOI 10.1590/s2175-97902017000115098
   Hosseinabadi S, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2019.102290
   Ji XY, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109338
   Jurgonski A, 2012, NUTRITION, V28, P300, DOI 10.1016/j.nut.2011.06.010
   Karri S, 2019, BIOMED PHARMACOTHER, V110, P224, DOI 10.1016/j.biopha.2018.11.076
   Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001
   Lepelley M, 2007, PLANT SCI, V172, P978, DOI 10.1016/j.plantsci.2007.02.004
   Liu YY, 2018, CHIN HERB MED, V10, P199, DOI 10.1016/j.chmed.2018.03.005
   Magalhaes STV, 2008, B ENTOMOL RES, V98, P483, DOI 10.1017/S0007485308005804
   Manzoni AG, 2020, INT IMMUNOPHARMACOL, V81, DOI 10.1016/j.intimp.2020.106217
   Marcheafave GG, 2019, MICROCHEM J, V146, P713, DOI 10.1016/j.microc.2019.01.073
   Mendonca JCF, 2008, THESIS U FEDERAL MIN
   Michelin DC, THESIS U ESTADUAL AR
   Moriya J, 2019, J CARDIOL, V73, P22, DOI 10.1016/j.jjcc.2018.05.010
   Nakajima K, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P1543, DOI 10.1016/B978-0-12-384937-3.00128-2
   Olas B, 2019, FOOD CHEM TOXICOL, V127, P31, DOI 10.1016/j.fct.2019.02.039
   Paulista, 2008, JD FILH
   Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040
   Prista LN, 2002, TECNOLOGIA FARMACEUT
   Punchard N.A., 1996, FREE RADICALS PRACTI
   Rezende Helena Aparecida de, 2002, Rev. esc. enferm. USP, V36, P282
   Rodrigo R, 2011, CLIN CHIM ACTA, V412, P410, DOI 10.1016/j.cca.2010.11.034
   Sanchis-Gomar F, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.33
   Sharma S, 2020, CHEM PHYS LIPIDS, V228, DOI 10.1016/j.chemphyslip.2020.104890
   Silva FLF, 2020, FOOD RES INT, V134, DOI 10.1016/j.foodres.2020.109221
   Simoes C.M.O., 2017, Farmacognosia: Do produto natural ao medicamento
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Sugidachi A, 2007, J THROMB HAEMOST, V5, P1545, DOI 10.1111/j.1538-7836.2007.02598.x
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Thilakarathna SH, 2013, NUTRIENTS, V5, P3367, DOI 10.3390/nu5093367
   Tofalo R, 2016, The Encyclopedia of Food and Health, P2
   Vinothkumar R, 2014, ENVIRON TOXICOL PHAR, V37, P174, DOI 10.1016/j.etap.2013.11.022
   Virani SS, 2011, TEX HEART I J, V38, P160
   WHO. World Health Organization, 2017, CARD DIS CVDS
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
   Zarzecki MS, 2014, TOXICOL REP, V1, P200, DOI 10.1016/j.toxrep.2014.02.003
NR 61
TC 3
Z9 3
U1 0
U2 7
PU UNIV SAO PAULO, CONJUNTO QUIMICAS
PI SAO PAULO
PA SERVICO PUBLICACOES E CIRCULACAO, CAIXA POSTAL 66083, SAO PAULO, 00000,
   BRAZIL
SN 1984-8250
EI 2175-9790
J9 BRAZ J PHARM SCI
JI Braz. J. Pharm. Sci.
PY 2022
VL 58
AR e19562
DI 10.1590/s2175-97902022e19562
PG 13
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 4N4TI
UT WOS:000854011500001
OA gold
DA 2025-04-28
ER

PT J
AU Cheng, DM
   Roopchand, DE
   Poulev, A
   Kuhn, P
   Armas, I
   Johnson, WD
   Oren, A
   Ribnicky, D
   Zelzion, E
   Bhattacharya, D
   Raskin, I
AF Cheng, Diana M.
   Roopchand, Diana E.
   Poulev, Alexander
   Kuhn, Peter
   Armas, Isabel
   Johnson, William D.
   Oren, Andrew
   Ribnicky, David
   Zelzion, Ehud
   Bhattacharya, Debashish
   Raskin, Ilya
TI High phenolics Rutgers Scarlet Lettuce improves glucose metabolism in
   high fat diet-induced obese mice
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Bioaccessibility; Gut microbiota; Lettuce; Metabolic syndrome; Phenolics
ID GREEN COFFEE EXTRACT; CHLOROGENIC ACID; ALPHA-GLUCOSIDASE; CINNAMON
   EXTRACT; CAFFEIC ACID; POLYPHENOLS; QUERCETIN; BIOAVAILABILITY;
   INFLAMMATION; CHOLESTEROL
AB Scope: The ability of high phenolic Rutgers Scarlet Lettuce (RSL) to attenuate metabolic syndrome and gut dysbiosis was studied in very high fat diet (VHFD)-fed mice. Phenolic absorption was assessed in vivo and in a gastrointestinal tract model.
   Methods and results: Mice were fed VHFD, VHFD supplemented with RSL (RSL-VHFD) or store-purchased green lettuce (GL-VHFD), or low-fat diet (LFD) for 13 weeks. Compared to VHFD or GL-VHFD-fed groups, RSL-VHFD group showed significantly improved oral glucose tolerance (p<0.05). Comparison of VHFD, RSL-VHFD, and GL-VHFD groups revealed no significant differences with respect to insulin tolerance, hepatic lipids, body weight gain, fat mass, plasma glucose, triglycerides, free fatty acid, and lipopolysaccharide levels, as well as relative abundances of major bacterial phyla from 16S rDNA amplicon data sequences (from fecal and cecal samples). However, RSL and GL-supplementation increased abundance of several taxa involved in plant polysaccharide degradation/fermentation. RSL phenolics chlorogenic acid, quercetin-3-glucoside, and quercetin-malonyl-glucoside were bioaccessible in the TIM-1 digestion model, but had relatively low recovery.
   Conclusions: RSL phenolics contributed to attenuation of post-prandial hyperglycemia. Changes in gut microbiota were likely due to microbiota accessible carbohydrates in RSL and GL rather than RSL phenolics, which may be metabolized, absorbed, or degraded before reaching the colon.
C1 [Cheng, Diana M.; Roopchand, Diana E.; Poulev, Alexander; Kuhn, Peter; Armas, Isabel; Oren, Andrew; Ribnicky, David; Raskin, Ilya] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA.
   [Zelzion, Ehud; Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ USA.
   [Johnson, William D.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Rutgers
   University System; Rutgers University New Brunswick; Louisiana State
   University System; Louisiana State University; Pennington Biomedical
   Research Center
RP Raskin, I (corresponding author), Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA.
EM raskin@aesop.rutgers.edu
RI Poulev, Alexander/L-6613-2019; Johnson, William/N-1972-2017
OI Armas, Isabel/0000-0001-9166-1821; Johnson, William/0000-0002-3823-4094;
   Poulev, Alexander/0000-0003-0939-0642
FU National Center for Complementary and Alternative Medicine (NCCAM)
   [P50AT002776-01]; Office of Dietary Supplements (ODS); National
   Institute of General Medical Sciences of the National Institutes of
   Health [1 U54 GM104940];  [R01 AT 008618-01]
FX We thank Nicole Wagner at the Rutgers Genome Cooperative for performing
   the sequencing, Fiona Lee for assisting with TIM experiments, and
   Fayrouz Merhom for assisting with animal data collection. This study was
   supported by P50AT002776-01 from the National Center for Complementary
   and Alternative Medicine (NCCAM) and the Office of Dietary Supplements
   (ODS). Contributions of DER were funded by R01 AT 008618-01.
   Contributions of WDJ were supported in part by 1 U54 GM104940 from the
   National Institute of General Medical Sciences of the National
   Institutes of Health, which funds the Louisiana Clinical and
   Translational Science Center.
CR Adisakwattana S, 2011, PLANT FOOD HUM NUTR, V66, P143, DOI 10.1007/s11130-011-0226-4
   Anhê FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142
   Bigliardi B, 2013, TRENDS FOOD SCI TECH, V31, P118, DOI 10.1016/j.tifs.2013.03.006
   Blum J, 2007, NUTRAFOODS, V6, P13
   Bouayed J, 2012, FOOD CHEM, V131, P1466, DOI 10.1016/j.foodchem.2011.10.030
   Cheng DM, 2014, NUTRITION, V30, pS52, DOI 10.1016/j.nut.2014.02.022
   Cheng DM, 2012, FOOD CHEM, V135, P2994, DOI 10.1016/j.foodchem.2012.06.117
   Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85
   D'Archivio M, 2010, INT J MOL SCI, V11, P1321, DOI 10.3390/ijms11041321
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   DuPont MS, 2002, J NUTR, V132, P172, DOI 10.1093/jn/132.2.172
   Eteberria U, 2015, J NUTR BIOCHEM, V26, P651, DOI 10.1016/j.jnutbio.2015.01.002
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689
   Gannon NP, 2015, MOL NUTR FOOD RES, V59, P48, DOI 10.1002/mnfr.201400414
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   Gonzales GB, 2016, FOOD RES INT, V88, P342, DOI 10.1016/j.foodres.2015.12.023
   Hassellund SS, 2013, J HUM HYPERTENS, V27, P100, DOI 10.1038/jhh.2012.4
   Karlsen A, 2007, J NUTR, V137, P1951
   Kaulmann A, 2016, FOOD CHEM, V197, P325, DOI 10.1016/j.foodchem.2015.10.049
   Kawabata K, 2015, FOOD FUNCT, V6, P1399, DOI [10.1039/C4FO01178C, 10.1039/c4fo01178c]
   Kemperman RA, 2010, MICROBIOL-SGM, V156, P3224, DOI 10.1099/mic.0.042127-0
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714
   Lila MA, 2012, J AGR FOOD CHEM, V60, P5763, DOI 10.1021/jf203526h
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S
   Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050
   Morand C, 2000, BIOFACTORS, V12, P169, DOI 10.1002/biof.5520120127
   Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001
   Nieman DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072215
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Ou KQ, 2014, J FUNCT FOODS, V7, P43, DOI 10.1016/j.jff.2013.08.004
   Pfeuffer M, 2013, NUTR METAB CARDIOVAS, V23, P403, DOI 10.1016/j.numecd.2011.08.010
   Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814
   Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075
   Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916
   Roopchand DE, 2013, PHARMACOL RES, V68, P59, DOI 10.1016/j.phrs.2012.11.008
   Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shihabudeen HMS, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-46
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Tang Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0073402, 10.1371/journal.pone.0091571]
   Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14
   Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI 10.1093/ajcn/81.1.243S
   Williamson G, 2013, MOL NUTR FOOD RES, V57, P48, DOI 10.1002/mnfr.201200511
NR 47
TC 14
Z9 16
U1 1
U2 56
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD NOV
PY 2016
VL 60
IS 11
BP 2367
EP 2378
DI 10.1002/mnfr.201600290
PG 12
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA ED8PU
UT WOS:000389134200005
PM 27529448
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Jiang, XY
   Wang, HZ
   Nie, KX
   Gao, Y
   Chen, S
   Tang, YH
   Wang, Z
   Su, H
   Dong, H
AF Jiang, Xinyue
   Wang, Hongzhan
   Nie, Kexin
   Gao, Yang
   Chen, Shen
   Tang, Yueheng
   Wang, Zhi
   Su, Hao
   Dong, Hui
TI Targeting lipid droplets and lipid droplet-associated proteins: a new
   perspective on natural compounds against metabolic diseases
SO CHINESE MEDICINE
LA English
DT Review
DE Lipid droplet; Lipid droplet-associated proteins; Metabolic diseases;
   Natural compounds
ID HIGH-FAT-DIET; DIFFERENTIATION-RELATED PROTEIN; ADIPOSE TRIGLYCERIDE
   LIPASE; HUMAN PROSTATE-CANCER; CHLOROGENIC ACID; LIVER-DISEASE;
   ADIPOCYTE DIFFERENTIATION; HEPATIC STEATOSIS; POTENTIAL-ROLE; ADIPOGENIC
   DIFFERENTIATION
AB BackgroundLipid droplet (LD) is a metabolically active organelle, which changes dynamically with the metabolic state and energy requirements of cells. Proteins that either insert into the LD phospholipid monolayer or are present in the cytoplasm, playing a crucial role in lipid homeostasis and signaling regulation, are known as LD-associated proteins.MethodsThe keywords "lipid droplets" and "metabolic diseases" were used to obtain literature on LD metabolism and pathological mechanism. After searching databases including Scopus, OVID, Web of Science, and PubMed from 2013 to 2024 using terms like "lipid droplets", "lipid droplet-associated proteins", "fatty liver disease", "diabetes", "diabetic kidney disease", "obesity", "atherosclerosis", "hyperlipidemia", "natural drug monomers" and "natural compounds", the most common natural compounds were identified in about 954 articles. Eventually, a total of 91 studies of 10 natural compounds reporting in vitro or in vivo studies were refined and summarized.ResultsThe most frequently used natural compounds include Berberine, Mangostin, Capsaicin, Caffeine, Genistein, Epigallocatechin-3-gallate, Chlorogenic acid, Betaine, Ginsenoside, Resveratrol. These natural compounds interact with LD-associated proteins and help ameliorate abnormal LDs in various metabolic diseases.ConclusionNatural compounds involved in the regulation of LDs and LD-associated proteins hold promise for treating metabolic diseases. Further research into these interactions may lead to new therapeutic applications.
C1 [Jiang, Xinyue; Wang, Hongzhan; Nie, Kexin; Gao, Yang; Chen, Shen; Dong, Hui] Huazhong Univ Sci & Technol, Tongji Hosp, Inst Integrated Tradit Chinese & Western Med, Tongji Med Coll, Wuhan, Peoples R China.
   [Wang, Zhi; Su, Hao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Integrated Tradit Chinese & Western Med, Wuhan, Peoples R China.
   [Tang, Yueheng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Rehabil Med, Wuhan, Peoples R China.
C3 Huazhong University of Science & Technology; Huazhong University of
   Science & Technology; Huazhong University of Science & Technology
RP Dong, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Inst Integrated Tradit Chinese & Western Med, Tongji Med Coll, Wuhan, Peoples R China.
EM tjhdonghui@163.com
RI Gao, Yang Gao/HNI-2634-2023; wang, zhi/AAI-3814-2020
FU National Natural Science Foundation of China
FX Not applicable.
CR Adjoumani JJY, 2017, FISH PHYSIOL BIOCHEM, V43, P1733, DOI 10.1007/s10695-017-0405-9
   Alferink LJM, 2020, EUR J EPIDEMIOL, V35, P1069, DOI 10.1007/s10654-020-00627-2
   Arumugam MK, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10060456
   Baek J, 2013, NUTR RES PRACT, V7, P96, DOI 10.4162/nrp.2013.7.2.96
   Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805
   Barneda D, 2017, CURR OPIN CELL BIOL, V47, P9, DOI 10.1016/j.ceb.2017.02.002
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125
   Bort A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071660
   Boutant M, 2017, EMBO J, V36, P1543, DOI 10.15252/embj.201694914
   Boutari Chrysoula, 2022, Metabolism, V133, P155217, DOI 10.1016/j.metabol.2022.155217
   Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200
   Calle RA, 2021, NAT MED, V27, P1836, DOI 10.1038/s41591-021-01489-1
   Cao Z, 2021, BIOESSAYS, V43, DOI 10.1002/bies.202000199
   Castro IG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030268
   Chang BHJ, 2007, AM J PHYSIOL-GASTR L, V292, pG1465, DOI 10.1152/ajpgi.00566.2006
   Chang N, 2024, SCI REP-UK, V14, DOI 10.1038/s41598-024-55923-8
   Chen FL, 2010, MOL CELL BIOCHEM, V337, P193, DOI 10.1007/s11010-009-0299-7
   Chen FJ, 2020, TRAFFIC, V21, P94, DOI 10.1111/tra.12717
   Chen J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0183-6
   Chen JR, 2021, CANCER LETT, V502, P154, DOI 10.1016/j.canlet.2020.12.019
   Chen WQ, 2021, EUR J NUTR, V60, P1655, DOI 10.1007/s00394-020-02362-6
   Chen YT, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03850-1
   Chen Z., 2022, Antioxidants (Basel), V11, P7
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cho SJ, 2012, BRIT J NUTR, V108, P2166, DOI 10.1017/S0007114512000347
   Choi YR, 2024, INT J MOL SCI, V25, DOI 10.3390/ijms25020693
   Chung J, 2019, DEV CELL, V51, P551, DOI 10.1016/j.devcel.2019.10.006
   Copic A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03717-8
   Coppinger C, 2024, CURR REV CLIN EXP PH, V19, P312, DOI 10.2174/0127724328250471231222094648
   Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017
   D'Aquila T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126823
   Dai CH, 2016, J CLIN INVEST, V126, P1857, DOI 10.1172/JCI83657
   Dai JG, 2021, VET MED SCI, V7, P950, DOI 10.1002/vms3.393
   den Braanker DJW., 2022, Int J Mol Sci, V24, P1
   Dhiman R, 2020, SEMIN CELL DEV BIOL, V108, P4, DOI 10.1016/j.semcdb.2020.03.004
   Ding HY, 2021, J CELL PHYSIOL, V236, P405, DOI 10.1002/jcp.29869
   Dirkx R, 2005, HEPATOLOGY, V41, P868, DOI 10.1002/hep.20628
   DONNERER J, 1990, N-S ARCH PHARMACOL, V342, P357
   Dou XB, 2014, BRIT J PHARMACOL, V171, P4073, DOI 10.1111/bph.12765
   Ekaterina, 2016, BIOFACTORS, V42, P492, DOI 10.1002/biof.1309
   Ethem I, 2022, REV ASSOC MED BRAS, V68, P1011, DOI 10.1590/1806-9282.20211377
   Fan HJ, 2024, INT J MOL SCI, V25, DOI 10.3390/ijms25136878
   Fan QX, 2021, MED SCI MONITOR, V27, DOI 10.12659/MSM.928619
   Ferguson D, 2017, J LIPID RES, V58, P420, DOI 10.1194/jlr.M073734
   Filali-Mouncef Y, 2022, AUTOPHAGY, V18, P50, DOI 10.1080/15548627.2021.1895658
   Fujimoto T, 2004, SEIKAGAKU, V76, P578
   Gao GG, 2017, BBA-MOL CELL BIOL L, V1862, P1197, DOI 10.1016/j.bbalip.2017.06.009
   Gao XX, 2024, CHIN MED-UK, V19, DOI 10.1186/s13020-024-00950-w
   Gao Y, 2020, BIOSCI BIOTECH BIOCH, V84, P2228, DOI 10.1080/09168451.2020.1793293
   Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806
   Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142
   Goo YH, 2014, ARTERIOSCL THROM VAS, V34, P386, DOI 10.1161/ATVBAHA.113.302448
   Grabner GF, 2017, PHARMACOL THERAPEUT, V175, P35, DOI 10.1016/j.pharmthera.2017.02.033
   Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711
   Gu W, 2013, BIOL PHARM BULL, V36, P102, DOI 10.1248/bpb.b12-00558
   Guo FC, 2011, MOL NUTR FOOD RES, V55, P1809, DOI 10.1002/mnfr.201100392
   Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114
   Haider A, 2018, DEV CELL, V45, P481, DOI 10.1016/j.devcel.2018.04.012
   Hao S, 2016, PHARM BIOL, V54, P251, DOI 10.3109/13880209.2015.1029054
   Helal MG, 2018, HUM EXP TOXICOL, V37, P983, DOI 10.1177/0960327117747026
   Henne M, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.07.008
   Herms A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8176
   Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106
   Hochkogler CM, 2018, FOOD FUNCT, V9, P1123, DOI [10.1039/c7fo01626c, 10.1039/C7FO01626C]
   Hong Y, 2024, BIOMED PHARMACOTHER, V177, DOI 10.1016/j.biopha.2024.117081
   Hou YH, 2020, ACS OMEGA, V5, P10878, DOI 10.1021/acsomega.0c00529
   Hu YH, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.692806
   Huang JB, 2015, J ANIM PHYSIOL AN N, V99, P719, DOI 10.1111/jpn.12276
   Huang WW, 2022, ANN NUTR METAB, V78, P1, DOI 10.1159/000520122
   Huang YC, 2010, J AGR FOOD CHEM, V58, P6039, DOI 10.1021/jf9034755
   Hwang JT, 2009, PHYTOTHER RES, V23, P262, DOI 10.1002/ptr.2606
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195
   Itabe H, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0473-y
   Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614
   Jeong JY, 2014, ASIAN AUSTRAL J ANIM, V27, P1783, DOI 10.5713/ajas.2014.14720
   Jiang JJ, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.876550
   Jing Y, 2019, EUR J PHARMACOL, V855, P216, DOI 10.1016/j.ejphar.2019.05.019
   Jyotshna, 2016, BIOFACTORS, V42, P504, DOI 10.1002/biof.1308
   KAWADA T, 1985, J CHROMATOGR, V329, P99, DOI 10.1016/S0021-9673(01)81899-9
   Kim HS, 2013, J BIOL CHEM, V288, P22693, DOI 10.1074/jbc.M113.477505
   Kim MH, 2010, BRIT J NUTR, V104, P1333, DOI 10.1017/S0007114510002266
   Kimmel AR, 2016, ANNU REV NUTR, V36, P471, DOI 10.1146/annurev-nutr-071813-105410
   Klasson TD, 2022, CANCER METAB, V10, DOI 10.1186/s40170-022-00290-z
   Kloska A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176113
   Kory N, 2017, J LIPID RES, V58, P226, DOI 10.1194/jlr.M072538
   Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013
   Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252
   Langhi C, 2017, J LIPID RES, V58, P81, DOI 10.1194/jlr.M069799
   Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97
   Layerenza JP, 2013, BBA-MOL CELL BIOL L, V1831, P327, DOI 10.1016/j.bbalip.2012.10.005
   Lee J, 2018, J LIPID RES, V59, P1940, DOI 10.1194/jlr.M087635
   Lee MS, 2011, PHYTOTHER RES, V25, P935, DOI 10.1002/ptr.3339
   Lee S, 2012, INT J MOL SCI, V13, P5729, DOI 10.3390/ijms13055729
   Li D, 2022, BIOMED PHARMACOTHER, V153, DOI 10.1016/j.biopha.2022.113290
   Li F, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01366
   Li G., 2022, Nutrients, V14, P19
   Li HK, 2022, CELL METAB, V34, P1977, DOI 10.1016/j.cmet.2022.09.026
   Li J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00201
   Li JZ, 2010, BBA-MOL CELL BIOL L, V1801, P577, DOI 10.1016/j.bbalip.2010.01.012
   Li Q, 2013, PFLUG ARCH EUR J PHY, V465, P1303, DOI 10.1007/s00424-013-1274-4
   Li Q, 2023, AUTOPHAGY, V19, P2639, DOI 10.1080/15548627.2023.2213984
   Li YN, 2018, MOL CELL BIOCHEM, V448, P175, DOI 10.1007/s11010-018-3324-x
   Li YJ, 2017, HEPATOLOGY, V66, P481, DOI 10.1002/hep.29206
   Li ZH, 2014, CURR BIOL, V24, P1485, DOI 10.1016/j.cub.2014.05.022
   Lin L, 2021, NUTRIENTS, V13, DOI 10.3390/nu13114120
   Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200
   Liu CW, 2018, AM J PHYSIOL-ENDOC M, V314, pE433, DOI 10.1152/ajpendo.00094.2017
   Liu HM, 2019, FOOD FUNCT, V10, P3603, DOI 10.1039/c9fo00027e
   Liu J, 2022, ANN INTENSIVE CARE, V12, DOI 10.1186/s13613-022-01033-5
   Liu Mei-Fang, 2006, Sheng Li Ke Xue Jin Zhan, V37, P103
   Liu SM, 2020, DIABETES, V69, P1178, DOI 10.2337/db19-0951
   Liu YX, 2022, J PHARM PHARMACOL, V74, P1353, DOI 10.1093/jpp/rgac026
   Liu ZH, 2020, FOOD NUTR RES, V64, DOI 10.29219/fnr.v64.3656
   Lucenay KS, 2016, CANCER RES, V76, P2406, DOI 10.1158/0008-5472.CAN-15-1646
   Luo WQ, 2022, INT J BIOL SCI, V18, P6020, DOI 10.7150/ijbs.74902
   Lv ZP, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01493
   Ma HJ, 2022, KIDNEY INT, V101, P315, DOI 10.1016/j.kint.2021.10.028
   Ma Q., 2024, Reproductive Sci, V1, P14
   Ma YY, 2021, J COMP PATHOL, V189, P88, DOI 10.1016/j.jcpa.2021.10.002
   Mackowiak B, 2024, J CLIN INVEST, V134, DOI 10.1172/JCI176345
   Mastoridou EM, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms242115891
   Matsubara J, 2011, CANCER EPIDEM BIOMAR, V20, P2195, DOI 10.1158/1055-9965.EPI-11-0400
   McVicker BL, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/978136
   Mehdi F, 2018, CELL BIOCHEM BIOPHYS, V76, P471, DOI 10.1007/s12013-018-0860-7
   Mitrofanova A, 2023, NAT REV NEPHROL, V19, P629, DOI 10.1038/s41581-023-00741-w
   Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424
   Moldavski O, 2015, DEV CELL, V33, P603, DOI 10.1016/j.devcel.2015.04.015
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Montanari T, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01380
   Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527
   Morrissey JJ, 2015, MAYO CLIN PROC, V90, P35, DOI 10.1016/j.mayocp.2014.10.005
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Mueller M, 2011, PLANTA MED, V77, P497, DOI 10.1055/s-0030-1250435
   Na LX, 2015, SCI REP-UK, V5, DOI 10.1038/srep10344
   Nakamura M, 2020, J PHYSIOL-LONDON, V598, P2977, DOI 10.1113/JP276747
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Nie QX, 2017, CRIT REV FOOD SCI, V57, P2432, DOI 10.1080/10408398.2015.1077194
   Nishikawa K, 2015, MOL NUTR FOOD RES, V59, P1155, DOI 10.1002/mnfr.201400564
   Niu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030782
   Nuotio K, 2007, STROKE, V38, P1791, DOI 10.1161/STROKEAHA.106.478867
   Oh JM, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11101890
   Ohsaki Y, 2017, ADV EXP MED BIOL, V997, P111, DOI 10.1007/978-981-10-4567-7_8
   Olarte MJ, 2022, TRENDS BIOCHEM SCI, V47, P39, DOI 10.1016/j.tibs.2021.08.007
   Olzmann JA, 2019, NAT REV MOL CELL BIO, V20, P137, DOI 10.1038/s41580-018-0085-z
   Pagac M, 2016, CELL REP, V17, P1546, DOI 10.1016/j.celrep.2016.10.037
   Pande S, 2012, J AGR FOOD CHEM, V60, P8155, DOI 10.1021/jf301211c
   Peng SG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8594767
   Pol A, 2014, J CELL BIOL, V204, P635, DOI 10.1083/jcb.201311051
   Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126
   Qiao L, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00727
   Qin H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13114015
   Quan HY, 2012, INT J MOL MED, V29, P73, DOI 10.3892/ijmm.2011.805
   Quan YM, 2023, FEBS OPEN BIO, V13, P638, DOI 10.1002/2211-5463.13570
   Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877
   Rao MJ, 2021, TRENDS CELL BIOL, V31, P912, DOI 10.1016/j.tcb.2021.06.003
   Rasineni K, 2014, ALCOHOL CLIN EXP RES, V38, P327, DOI 10.1111/acer.12271
   Ren K, 2019, AGING-US, V11, P10992, DOI 10.18632/aging.102498
   Riazi K, 2022, NUTRIENTS, V14, DOI 10.3390/nu14214556
   Roberts MA, 2020, ANNU REV CELL DEV BI, V36, P115, DOI 10.1146/annurev-cellbio-031320-101827
   Rodriguez-Gonzalez JC, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.670167
   Saka HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124630
   Salloum S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003513
   Sans A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43928-7
   Schelling JR, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11203236
   Seebacher F, 2020, SEMIN CELL DEV BIOL, V108, P72, DOI 10.1016/j.semcdb.2020.04.011
   Seidemann L, 2021, MOLECULES, V26, DOI 10.3390/molecules26041156
   Sharma D, 2022, CLIN RES HEPATOL GAS, V46, DOI 10.1016/j.clinre.2022.102003
   Shin MK, 2020, ANIM CELLS SYST, V24, P214, DOI 10.1080/19768354.2020.1810771
   Sim MO, 2019, CHEM-BIOL INTERACT, V311, DOI 10.1016/j.cbi.2019.108755
   Siraj FM, 2015, J ENZYM INHIB MED CH, V30, P9, DOI 10.3109/14756366.2013.871006
   Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559
   Straub BK, 2015, PATHOLOGE, V36, P146, DOI 10.1007/s00292-015-0082-3
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1258-y
   Suzuki M, 2012, MOL BIOL CELL, V23, P800, DOI 10.1091/mbc.E11-11-0950
   Talukder MMU, 2015, MOL METAB, V4, P199, DOI 10.1016/j.molmet.2014.12.013
   Tang GY, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10071076
   Tang LY, 2016, CAN J PHYSIOL PHARM, V94, P185, DOI 10.1139/cjpp-2015-0125
   Tang TY, 2013, CELL METAB, V18, P883, DOI 10.1016/j.cmet.2013.10.012
   Tehrani SS, 2023, LIFE SCI, V323, DOI 10.1016/j.lfs.2023.121706
   Tovar AR, 2002, J NUTR, V132, P2562, DOI 10.1093/jn/132.9.2562
   Valdearcos M, 2011, J IMMUNOL, V186, P6004, DOI 10.4049/jimmunol.1003279
   van Polanen N, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.14692
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Velickovic K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23267-9
   Vijayan A, 2021, NAT REV NEPHROL, V17, P87, DOI 10.1038/s41581-020-00390-3
   Walther TC, 2017, ANNU REV CELL DEV BI, V33, P491, DOI 10.1146/annurev-cellbio-100616-060608
   Wang Chao, 2012, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V28, P911
   Wang KS, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2018.04.006
   Wang L, 2021, BRIT J NUTR, V125, P481, DOI 10.1017/S0007114520003025
   Wang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02174
   Wang SB, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600746
   Wang Y, 2020, PAK J PHARM SCI, V33, P1063, DOI 10.36721/PJPS.2020.33.3.REG.1063-1072.1
   Wang Y, 2019, HEPATOLOGY, V69, P2427, DOI 10.1002/hep.30583
   Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834
   Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013
   Willebrords J, 2015, PROG LIPID RES, V59, P106, DOI 10.1016/j.plipres.2015.05.002
   Wolinski H, 2015, BBA-MOL CELL BIOL L, V1851, P1450, DOI 10.1016/j.bbalip.2015.08.003
   Xiao CW, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0373-3
   Xu L, 2015, BRIT J NUTR, V113, P1835, DOI 10.1017/S0007114515001130
   Xu SM, 2018, BBA-MOL BASIS DIS, V1864, P1968, DOI 10.1016/j.bbadis.2017.07.019
   Xu WY, 2016, J BIOL CHEM, V291, P4282, DOI 10.1074/jbc.M115.701094
   Yamaguchi T, 2007, SEIKAGAKU, V79, P162
   Yan YW, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.1042044
   Yang M, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.1017387
   Yang WJ, 2017, MOL MED REP, V16, P5225, DOI 10.3892/mmr.2017.7295
   Yang WJ, 2016, PANCREAS, V45, P836, DOI 10.1097/MPA.0000000000000557
   Yao JX, 2023, FRONT NEUROSCI-SWITZ, V17, DOI 10.3389/fnins.2023.1093180
   Yao R., 2023, Biochimica Et Biophysica Acta-Mol Cell Biol Lipids, V1868, P11
   Yao RY, 2023, BBA-MOL CELL BIOL L, V1868, DOI 10.1016/j.bbalip.2023.159396
   Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013
   Yoshioka K, 2022, KIDNEY INT, V101, P510, DOI 10.1016/j.kint.2021.10.039
   Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112
   Yu M, 2013, MOL CELL BIOCHEM, V378, P145, DOI 10.1007/s11010-013-1605-y
   Yu MY, 2021, INT J BIOL SCI, V17, P1693, DOI 10.7150/ijbs.54604
   Yu QX, 2022, DRUG DELIV, V29, P856, DOI 10.1080/10717544.2022.2036870
   Yu S., 2023, Molecules, V28, P6
   Yuan H, 2020, AGING CELL, V19, DOI 10.1111/acel.13199
   Yuan Y, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0522-6
   Yuanyuan Z, 2022, Evid Based Complement Alternat Med., V2022
   Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019
   Zadoorian A, 2023, NAT REV ENDOCRINOL, V19, P443, DOI 10.1038/s41574-023-00845-0
   Zammouri J, 2022, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.803189
   Zechner R, 2017, NAT REV MOL CELL BIO, V18, P671, DOI 10.1038/nrm.2017.76
   Zhang CY, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201700223
   Zhang Lan-tao, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P281, DOI 10.3881/j.issn.1000-503X.2011.03.015
   Zhang L, 2018, CURR MED SCI, V38, P997, DOI 10.1007/s11596-018-1975-1
   Zhang Q, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/2052675
   Zhang XD, 2021, AM J TRANSL RES, V13, P4450
   Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003
   Zhao YB, 2019, BIOMED PHARMACOTHER, V113, DOI 10.1016/j.biopha.2019.108697
   Zheng XC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0206-3
   Zhong H, 2018, FEBS J, V285, P501, DOI 10.1111/febs.14349
   Zhou P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030204
   Zhou R, 2018, CELL PHYSIOL BIOCHEM, V51, P2397, DOI 10.1159/000495898
   Zhou Y, 2016, J CLIN BIOCHEM NUTR, V58, P146, DOI 10.3164/jcbn.14-138
   Zhu XP, 2019, FREE RADICAL BIO MED, V141, P192, DOI 10.1016/j.freeradbiomed.2019.06.019
   Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005
   Zoni V, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017205118
NR 240
TC 2
Z9 2
U1 6
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1749-8546
J9 CHIN MED-UK
JI Chin. Med.
PD SEP 4
PY 2024
VL 19
IS 1
AR 120
DI 10.1186/s13020-024-00988-w
PG 24
WC Integrative & Complementary Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; Pharmacology & Pharmacy
GA E7A8E
UT WOS:001304503800001
PM 39232826
OA gold
DA 2025-04-28
ER

PT J
AU Vasileva, LV
   Savova, MS
   Amirova, KM
   Balcheva-Sivenova, Z
   Ferrante, C
   Orlando, G
   Wabitsch, M
   Georgiev, MI
AF Vasileva, Liliya V.
   Savova, Martina S.
   Amirova, Kristiana M.
   Balcheva-Sivenova, Zhivka
   Ferrante, Claudio
   Orlando, Giustino
   Wabitsch, Martin
   Georgiev, Milen, I
TI Caffeic and Chlorogenic Acids Synergistically Activate Browning Program
   in Human Adipocytes: Implications of AMPK- and PPAR-Mediated Pathways
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE chlorogenic acid; caffeic acid; adipocytes; obesity; browning;
   anti-obesity effect; molecular docking
ID ADIPOSE-TISSUE; LIPOLYSIS; BEIGE
AB Caffeic acid (CA) and chlorogenic acid (CGA) are phenolic compounds claimed to be responsible for the metabolic effects of coffee and tea consumption. Along with their structural similarities, they share common mechanisms such as activation of the AMP-activated protein kinase (AMPK) signaling. The present study aimed to investigate the anti-obesity potential of CA and CGA as co-treatment in human adipocytes. The molecular interactions of CA and CGA with key adipogenic transcription factors were simulated through an in silico molecular docking approach. The expression levels of white and brown adipocyte markers, as well as genes related to lipid metabolism, were analyzed by real-time quantitative PCR and Western blot analyses. Mechanistically, the CA/CGA combination induced lipolysis, upregulated AMPK and browning gene expression and downregulated peroxisome proliferator-activated receptor gamma (PPAR gamma) at both transcriptional and protein levels. The gene expression profiles of the CA/CGA-co-treated adipocytes strongly resembled brown-like signatures. Major pathways identified included the AMPK- and PPAR-related signaling pathways. Collectively, these findings indicated that CA/CGA co-stimulation exerted a browning-inducing potential superior to that of either compound used alone which merits implementation in obesity management. Further, the obtained data provide additional insights on how CA and CGA modify adipocyte function, differentiation and lipid metabolism.
C1 [Vasileva, Liliya V.; Savova, Martina S.; Amirova, Kristiana M.; Balcheva-Sivenova, Zhivka; Georgiev, Milen, I] Ctr Plant Syst Biol & Biotechnol, Dept Plant Cell Biotechnol, Plovdiv 4000, Bulgaria.
   [Savova, Martina S.; Amirova, Kristiana M.; Balcheva-Sivenova, Zhivka; Georgiev, Milen, I] Bulgarian Acad Sci, Stephan Angeloff Inst Microbiol, Lab Metabol, Plovdiv 4000, Bulgaria.
   [Ferrante, Claudio; Orlando, Giustino] Univ G dAnnunzio, Dept Pharm, I-66100 Chieti, Italy.
   [Wabitsch, Martin] Ulm Univ, Med Ctr, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89077 Ulm, Germany.
C3 Bulgarian Academy of Sciences; Stephan Angeloff Institute of
   Microbiology, Bulgarian Academy of Sciences; G d'Annunzio University of
   Chieti-Pescara; Ulm University
RP Georgiev, MI (corresponding author), Ctr Plant Syst Biol & Biotechnol, Dept Plant Cell Biotechnol, Plovdiv 4000, Bulgaria.; Georgiev, MI (corresponding author), Bulgarian Acad Sci, Stephan Angeloff Inst Microbiol, Lab Metabol, Plovdiv 4000, Bulgaria.
EM vasileva@cpsbb.eu; msavova@cpsbb.eu; amirova@cpsbb.eu;
   sivenova_jivka@abv.bg; cferrante@unich.it; giustino.orlando@unich.it;
   Martin.Wabitsch@uniklinik-ulm.de; milengeorgiev@gbg.bg
RI Georgiev, Milen/P-6948-2015; Ferrante, Claudio/AEY-9584-2022; Savova,
   Martina/MGB-2678-2025; Mihaylova, Liliya/I-6017-2016
OI Georgiev, Milen I./0000-0001-5248-6135; Mihaylova,
   Liliya/0000-0002-1690-1490; , Claudio/0000-0001-9431-9407; Savova,
   Martina/0000-0002-3852-8658
FU European Union's Horizon 2020 research and innovation programme, project
   PlantaSYST [739582, 664620]; European Regional Development Fund through
   the "Science and Education for Smart Growth" Operational Programme
   [BG05M2OP001-1.003-001-C01]
FX This research received funding from the European Union's Horizon 2020
   research and innovation programme, project PlantaSYST (SGA No 739582
   under FPA No. 664620) and the BG05M2OP001-1.003-001-C01 project,
   financed by the European Regional Development Fund through the "Science
   and Education for Smart Growth" Operational Programme.
CR Abreu-Vieira G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8433
   Alqarni I, 2019, BIOCHEM PHARMACOL, V164, P252, DOI 10.1016/j.bcp.2019.04.018
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Besse-Patin A, 2019, P NATL ACAD SCI USA, V116, P4285, DOI 10.1073/pnas.1815150116
   Blondin DP, 2017, CELL METAB, V25, P438, DOI 10.1016/j.cmet.2016.12.005
   Brust R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07133-w
   Cao QJ, 2020, FOOD CHEM, V333, DOI 10.1016/j.foodchem.2020.127528
   Cen SZ, 2020, EBIOMEDICINE, V54, DOI 10.1016/j.ebiom.2020.102722
   Chalise JP, 2019, P NATL ACAD SCI USA, V116, P15128, DOI 10.1073/pnas.1906712116
   Chen L, 2019, FOOD CHEM TOXICOL, V127, P182, DOI 10.1016/j.fct.2019.03.038
   Cheng CF, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0624-y
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Denton NF, 2019, INT J OBESITY, V43, P2458, DOI 10.1038/s41366-019-0421-1
   Fathzadeh M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15291-z
   Feng XJ, 2016, EBIOMEDICINE, V9, P61, DOI 10.1016/j.ebiom.2016.06.017
   Filipe HAL, 2018, FREE RADICAL BIO MED, V115, P215, DOI 10.1016/j.freeradbiomed.2017.12.002
   Fischer-Posovszky P, 2010, AM J CLIN NUTR, V92, P5, DOI 10.3945/ajcn.2009.28435
   Guennoun A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0480-6
   He Y, 2019, EBIOMEDICINE, V40, P56, DOI 10.1016/j.ebiom.2018.11.057
   Huan Y, 2019, DIABETES OBES METAB, V21, P2553, DOI 10.1111/dom.13843
   Kim GY, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020037
   Kim OY, 2019, PHARMACOL RES, V148, DOI 10.1016/j.phrs.2019.104411
   Kroon T, 2020, MOL METAB, V36, DOI 10.1016/j.molmet.2020.02.007
   Kwon HJ, 2021, INT J OBESITY, V45, P122, DOI 10.1038/s41366-020-0606-7
   Le Sage F, 2017, PHARMACOL RES, V119, P303, DOI 10.1016/j.phrs.2017.02.020
   Lee AH, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.19
   Lee HH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11302-w
   Li HB, 2019, PHARMACOL RES, V147, DOI 10.1016/j.phrs.2019.104393
   Li Y, 2018, PHARMACOL RES, V130, P110, DOI 10.1016/j.phrs.2018.01.006
   Li ZL, 2020, FASEB J, V34, P4527, DOI 10.1096/fj.201902222R
   Matsumoto T, 2019, DIABETOLOGIA, V62, P1915, DOI 10.1007/s00125-019-4938-6
   Montanari T, 2018, HISTOCHEM CELL BIOL, V149, P593, DOI 10.1007/s00418-018-1663-z
   Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Pollard AE, 2019, NAT METAB, V1, P340, DOI 10.1038/s42255-019-0036-9
   Pydi SP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11003-4
   Qi GH, 2019, ACTA PHARM SIN B, V9, P135, DOI 10.1016/j.apsb.2018.10.004
   Rahman MS, 2020, METABOLISM, V107, DOI 10.1016/j.metabol.2020.154228
   Rajbhandari P, 2018, CELL, V172, P218, DOI 10.1016/j.cell.2017.11.019
   Rebollo-Hernanz M, 2019, FOOD CHEM TOXICOL, V132, DOI 10.1016/j.fct.2019.110672
   Reggio A, 2020, CELL DEATH DIFFER, V27, P2921, DOI 10.1038/s41418-020-0551-y
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Sato H, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107579
   Senol-Cosar O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10686
   Shuai L, 2019, DIABETES, V68, P1449, DOI 10.2337/db18-1103
   Siang DTC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14001-8
   Singh AM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16340-3
   Stechschulte LA, 2016, EBIOMEDICINE, V10, P174, DOI 10.1016/j.ebiom.2016.06.040
   Stefanello N, 2019, FOOD CHEM TOXICOL, V123, P298, DOI 10.1016/j.fct.2018.10.005
   Su S, 2018, CELL REP, V25, P3215, DOI 10.1016/j.celrep.2018.11.037
   Tews D, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101286
   Vasileva LV, 2020, PHARMACOL RES, V156, DOI 10.1016/j.phrs.2020.104760
   Vasileva LV, 2018, FOOD CHEM TOXICOL, V121, P173, DOI 10.1016/j.fct.2018.08.071
   Wang H, 2019, MOL METAB, V20, P14, DOI 10.1016/j.molmet.2018.11.009
   Wang S, 2015, INT J OBESITY, V39, P967, DOI 10.1038/ijo.2015.23
   Wang SP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16026-w
   Willows R, 2017, BIOCHEM J, V474, P3059, DOI 10.1042/BCJ20170458
   Yeo CR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04369-2
   Yu BW, 2016, ACTA PHARMACOL SIN, V37, P1413, DOI 10.1038/aps.2016.79
   Zhang X, 2019, CELL REP, V28, P792, DOI 10.1016/j.celrep.2019.06.044
NR 60
TC 44
Z9 45
U1 5
U2 32
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC
PY 2020
VL 21
IS 24
AR 9740
DI 10.3390/ijms21249740
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA PK9US
UT WOS:000602781000001
PM 33371201
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Torres-Collado, L
   García-de la Hera, M
   Navarrete-Muñoz, EM
   Compañ-Gabucio, LM
   Gonzalez-Palacios, S
   Vioque, J
AF Torres-Collado, Laura
   Garcia-de la Hera, Manuela
   Maria Navarrete-Munoz, Eva
   Maria Compan-Gabucio, Laura
   Gonzalez-Palacios, Sandra
   Vioque, Jesus
TI Coffee Drinking and Associated Factors in an Elderly Population in Spain
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE coffee; caffeinated; decaffeinated; elderly; consumption; factors
ID DOSE-RESPONSE METAANALYSIS; CARDIOVASCULAR-DISEASE; CONSUMPTION; RISK;
   CAFFEINE; AGREEMENT; OBESITY
AB Coffee consumption is highly prevalent worldwide, and many studies have reported positive and inverse associations of coffee with many diseases. However, factors associated with coffee consumption remain poorly characterized in some populations, such as the elderly. This study aimed to assess the factors associated with total, caffeinated and decaffeinated coffee consumption in an elderly population in Spain. Data were analyzed from 903 participants, aged 65 years and above, from two population-based studies carried out in the Valencia region in Spain (Valencia Nutritional Survey (VNS) and European Eye Study (EUREYE-Study). Total, caffeinated and decaffeinated coffee consumption was assessed through two specific questions using a validated food frequency questionnaire. Information on personal characteristics, anthropometry and lifestyles was collected in personal interviews. Multinomial logistic regression analysis was used to estimate the adjusted relative risk ratios (RRR) and confidence intervals (95% CI). The prevalence of total, caffeinated and decaffeinated coffee consumption was 70%, 38% and 32%, respectively. The consumption of caffeinated coffee was positively associated with: Educational level, RRR = 1.63 (1.09-2.44); body mass index (30), RRR = 2.03 (1.05-3.95); tobacco smoking, RRR = 1.96 (1.13-3.39); alcohol intake [12 g/day category intake vs. no-alcohol intake, RRR = 6.25 (3.56-10.95)]; and energy intake (p < 0.05). Consumption of caffeinated coffee was negatively associated with: Age (75 years), RRR = 0.64 (0.43-0.94); and pre-existing hypertension, RRR = 0.67 (0.45-0.98). The consumption of decaffeinated coffee was positively associated with: Alcohol intake, RRR = 2.63 (1.19-4.64); pre-existing diabetes, RRR = 1.67 (1.06-2.62); and energy intake (p < 0.01). The consumption of coffee is high among elderly people in Spain. It is a novelty in this study with elderly population that tobacco smoking and alcohol drinking were the two main factors associated with higher coffee consumption. Self-reported hypertension was associated with a lower consumption of caffeinated coffee, and pre-existing diabetes was associated with a higher consumption of decaffeinated coffee. These associations should be taken into account when the health effects of coffee consumption are investigated.
C1 [Torres-Collado, Laura; Garcia-de la Hera, Manuela; Maria Navarrete-Munoz, Eva; Maria Compan-Gabucio, Laura; Gonzalez-Palacios, Sandra; Vioque, Jesus] Univ Miguel Hernandez, Dept Publ Hlth Hist Med & Gynecol, Alicante Inst Hlth & Biomed Res, ISABIAL FISABIO Fdn, Alicante 03550, Spain.
   [Garcia-de la Hera, Manuela; Maria Navarrete-Munoz, Eva; Gonzalez-Palacios, Sandra; Vioque, Jesus] Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid 28029, Spain.
C3 General University Hospital of Alicante; Universidad Miguel Hernandez de
   Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y
   Biomedica de Alicante (ISABIAL); CIBER - Centro de Investigacion
   Biomedica en Red; CIBERESP
RP Vioque, J (corresponding author), Univ Miguel Hernandez, Dept Publ Hlth Hist Med & Gynecol, Alicante Inst Hlth & Biomed Res, ISABIAL FISABIO Fdn, Alicante 03550, Spain.; Vioque, J (corresponding author), Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid 28029, Spain.
EM l.torres@umh.es; manoli@umh.es; enavarrete@umh.es; lcompan@umh.es;
   sandra.gonzalezp@umh.es; vioque@umh.es
RI Palacios, Sandra/AAA-9585-2021; Navarrete-Muñoz, Eva/F-1666-2011;
   Vioque, Jesus/A-1066-2008; Garcia de la Hera, Manuela/N-8908-2019;
   Gabucio, Laura/AAN-6068-2020
OI Compan Gabucio, Laura M/0000-0001-5324-1535; Torres-Collado,
   Laura/0000-0003-2842-1344; Navarrete-Munoz, Eva
   Maria/0000-0002-1494-5676; Gonzalez Palacios,
   Sandra/0000-0003-3358-472X; Vioque, Jesus/0000-0002-2284-148X; Garcia de
   la Hera, Manuela/0000-0001-5742-2704
FU Direccion General de Salud Publica, Generalitat Valenciana; Fondo
   Investigacion Sanitaria [FIS 00/0985]; European Commission
   [QLK6-CT-1999-02 094]; Spanish Ministry of Health [FIS 01/1692E, RCESP C
   03/09]; Spanish Ministry of Health (CIBERESP, CIBER de Epidemiologia y
   Salud Publica); Generalitat Valenciana [CTGCA/2002/06, G 03/136];
   Instituto de Salud Carlos III; FEDER funds [FIS PI13/00654]; Ministry of
   Education in Spain [FPU14/00046]
FX The VNS study was supported by a grant from the Direccion General de
   Salud Publica, Generalitat Valenciana 1994 and the Fondo Investigacion
   Sanitaria (FIS 00/0985). The EUREYE study was funded by the European
   Commission Vth Framework (QLK6-CT-1999-02 094), the Spanish Ministry of
   Health (grants: FIS 01/1692E; RCESP C 03/09; CIBERESP, CIBER de
   Epidemiologia y Salud Publica) and the Generalitat Valenciana
   (CTGCA/2002/06; G 03/136). This study has also received support from the
   Instituto de Salud Carlos III and FEDER funds (FIS PI13/00654). Laura
   Torres Collado is recipient of a fellowship "Formacion de Profesorado
   Universitario (FPU)" from the Ministry of Education in Spain
   (FPU14/00046).
CR [Anonymous], 2013, USDA NAT NUTR DAT ST
   Augood C, 2004, OPHTHAL EPIDEMIOL, V11, P117, DOI 10.1076/opep.11.2.117.28160
   BUSH TL, 1989, AM J PUBLIC HEALTH, V79, P1554, DOI 10.2105/AJPH.79.11.1554
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Greenberg JA, 2008, AM J CARDIOL, V102, P1502, DOI 10.1016/j.amjcard.2008.07.046
   Grosso G, 2016, EUR J CLIN NUTR, V70, P109, DOI 10.1038/ejcn.2015.119
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Gunter MJ, 2017, ANN INTERN MED, V167, P236, DOI 10.7326/M16-2945
   HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129
   Hewlett P, 2006, APPETITE, V46, P97, DOI 10.1016/j.appet.2005.10.004
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Lieberman HR, 2012, J ACAD NUTR DIET, V112, P902, DOI 10.1016/j.jand.2012.02.001
   Mahoney CR, 2019, CLIN NUTR, V38, P668, DOI 10.1016/j.clnu.2018.04.004
   Navarro AM, 2019, CLIN NUTR, V38, P389, DOI 10.1016/j.clnu.2017.12.009
   Palma I., 2008, Tablas de Composicin de Alimentos por Medidas Caseras de Consumo Habitual en Espaa. Centre dEnsenyament Superior de Nutrici i Diettica (CESNID)
   Penolazzi B, 2012, APPETITE, V58, P971, DOI 10.1016/j.appet.2012.02.001
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sotos-Prieto M, 2010, NUTR HOSP, V25, P388, DOI 10.3305/nh.2010.25.3.4293
   Vioque J, 2000, INT J OBESITY, V24, P1683, DOI 10.1038/sj.ijo.0801434
   Vioque J., 1991, European Journal of Cancer Prevention, V1, P19
   Vioque J., 2003, Encuesta de nutricion y salud de la Comunidad
   Vioque J, 2007, BRIT J NUTR, V97, P977, DOI 10.1017/S0007114507659017
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086
   Wu L, 2017, CLIN NUTR, V36, P730, DOI 10.1016/j.clnu.2016.05.015
   Zulli A, 2016, EUR J NUTR, V55, P1331, DOI 10.1007/s00394-016-1179-z
NR 29
TC 16
Z9 16
U1 0
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD AUG
PY 2018
VL 15
IS 8
AR 1661
DI 10.3390/ijerph15081661
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GS0GQ
UT WOS:000443168200101
PM 30082581
OA Green Published, Green Submitted, gold
DA 2025-04-28
ER

PT J
AU Takami, H
   Nakamoto, M
   Uemura, H
   Katsuura, S
   Yamaguchi, M
   Hiyoshi, M
   Sawachika, F
   Juta, T
   Arisawa, K
AF Takami, Hidenobu
   Nakamoto, Mariko
   Uemura, Hirokazu
   Katsuura, Sakurako
   Yamaguchi, Miwa
   Hiyoshi, Mineyoshi
   Sawachika, Fusakazu
   Juta, Tomoya
   Arisawa, Kokichi
TI Inverse Correlation Between Coffee Consumption and Prevalence of
   Metabolic Syndrome: Baseline Survey of the Japan Multi-Institutional
   Collaborative Cohort (J-MICC) Study in Tokushima, Japan
SO JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE metabolic syndrome; coffee; serum triglycerides; plasma glucose; green
   tea
ID RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE; LIFE-STYLE FACTORS;
   GREEN TEA; HABITUAL COFFEE; CAFFEINE INTAKE; FILTERED-COFFEE;
   BLOOD-PRESSURE; SERUM-LIPIDS; BODY-FAT
AB Background: It is unclear whether consumption of coffee and green tea is associated with metabolic syndrome.
   Methods: This cross-sectional study enrolled 554 adults who had participated in the baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima Prefecture, Japan. Consumption of coffee and green tea was assessed using a questionnaire Metabolic syndrome was diagnosed using the criteria of the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) and the Japan Society for the Study of Obesity (JASSO). Logistic regression analysis was used to examine the association between consumption of coffee and green tea and prevalence of metabolic syndrome and its components.
   Results: After adjustment for sex, age, and other potential confounders, greater coffee consumption was associated with a significantly lower prevalence of metabolic syndrome, as defined by NCEP ATP III criteria (P for trend = 0.03). Participants who drank more coffee had a lower odds ratio (OR) for high serum triglycerides (P for trend = 0.02), but not for increased waist circumference or high blood pressure. Using JASSO criteria, moderate coffee consumption (1.5 to < 3 cups/day) was associated with a significantly lower OR for high plasma glucose (OR = 0.51, 95% CI 0.28-0.93). Green tea consumption was not associated with the prevalence of metabolic syndrome or any of its components.
   Conclusions: Coffee consumption was inversely correlated with metabolic syndrome diagnosed using NCEP ATP III criteria, mainly because it was associated with lower serum triglyceride levels. This association highlights the need for further prospective studies of the causality of these relationships.
C1 [Takami, Hidenobu; Nakamoto, Mariko; Uemura, Hirokazu; Katsuura, Sakurako; Yamaguchi, Miwa; Hiyoshi, Mineyoshi; Sawachika, Fusakazu; Juta, Tomoya; Arisawa, Kokichi] Univ Tokushima Grad Sch, Inst Hlth Biosci, Dept Prevent Med, Tokushima, Tokushima 7708503, Japan.
C3 Tokushima University
RP Arisawa, K (corresponding author), Univ Tokushima Grad Sch, Inst Hlth Biosci, Dept Prevent Med, 3-18-15 Kuramoto Cho, Tokushima, Tokushima 7708503, Japan.
EM karisawa@basic.med.tokushima-u.ac.jp
RI Nakamoto, Mariko/JVE-2260-2024
FU Japanese Ministry of Education, Culture, Sports, Science and Technology
   [17015018, 221S0001]; Grants-in-Aid for Scientific Research [12J08918]
   Funding Source: KAKEN
FX We thank Mitsuhiko Matsushita, Yasunobu Sagara, and all members of the
   Tokushima Prefectural General Health Checkup Center for their
   cooperation in this study. We also thank Shinkan Tokudome at the
   National Institute of Health and Nutrition (formerly Nagoya City
   University), Chiho Goto at Nagoya Bunri University, Nahomi Imaeda at
   Nagoya Women's University, Yuko Tokudome at Nagoya University of Arts
   and Sciences, Masato Ikeda at the University of Occupational and
   Environmental Health, and Shinzo Maki at the Aichi Prefectural Dietetic
   Association for providing us with a program to calculate nutritional
   intake using a food frequency questionnaire. This study was supported in
   part by Grants-in-Aid for Scientific Research from the Japanese Ministry
   of Education, Culture, Sports, Science and Technology (Nos. 17015018 and
   221S0001).
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   [Anonymous], SUMM NAT NUTR HLTH S
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Deshmukh-Taskar PR, 2009, PUBLIC HEALTH NUTR, V12, P2493, DOI 10.1017/S1368980009991261
   Doi Y, 2009, STROKE, V40, P1187, DOI 10.1161/STROKEAHA.108.531319
   Du Y, 2005, EUR J EPIDEMIOL, V20, P311, DOI 10.1007/s10654-004-7536-x
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   FRIED RE, 1992, JAMA-J AM MED ASSOC, V267, P811, DOI 10.1001/jama.267.6.811
   Funatsu K, 2005, HYPERTENS RES, V28, P521, DOI 10.1291/hypres.28.521
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ilanne-Parikka P, 2010, DIABETES CARE, V33, P1610, DOI 10.2337/dc09-2155
   IMAI K, 1995, BRIT MED J, V310, P693, DOI 10.1136/bmj.310.6981.693
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Matsuzawa Y, 2005, J ATHEROSCLER THROMB, V12, P301, DOI 10.5551/jat.12.301
   Millen BE, 2006, AM J CLIN NUTR, V84, P434
   Miyake Y, 1999, ANN EPIDEMIOL, V9, P121, DOI 10.1016/S1047-2797(98)00051-9
   Mukai N, 2009, DIABETES CARE, V32, P2288, DOI 10.2337/dc09-0896
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakanishi N, 2000, J Epidemiol, V10, P216
   SAS Institute, 2007, SAS STAT SOFTW CHANG, V8
   Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94
   Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135
   Urgert R, 1996, BRIT MED J, V313, P1362, DOI 10.1136/bmj.313.7069.1362
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   VANROOIJ J, 1995, AM J CLIN NUTR, V61, P1277, DOI 10.1093/ajcn/61.6.1277
   Wakabayashi K, 1998, EUR J EPIDEMIOL, V14, P669, DOI 10.1023/A:1007478522638
   Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
   Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534
   Zhang Y, 2011, NUTR METAB CARDIOVAS, V21, P418, DOI 10.1016/j.numecd.2009.10.020
   Zhang ZZ, 2011, AM J CLIN NUTR, V93, P1212, DOI 10.3945/ajcn.110.004044
NR 44
TC 64
Z9 65
U1 0
U2 22
PU JAPAN EPIDEMIOLOGICAL ASSOC
PI TOCHIGI
PA JICHI MEDICAL SCHOOL, DEPT PUBLIC HEALTH, 3311-1 YAKUSHIJI,
   MINAMIKAWACH, TOCHIGI, 329-0498, JAPAN
SN 0917-5040
J9 J EPIDEMIOL
JI J. Epidemiol.
PD JAN
PY 2013
VL 23
IS 1
BP 12
EP 20
DI 10.2188/jea.JE20120053
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA 075XT
UT WOS:000313921200004
PM 23047663
OA Green Submitted, Green Published, gold
DA 2025-04-28
ER

PT J
AU Hursel, R
   Westerterp-Plantenga, MS
AF Hursel, Rick
   Westerterp-Plantenga, Margriet S.
TI Green tea catechin plus caffeine supplementation to a high-protein diet
   has no additional effect on body weight maintenance after weight loss
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID ISCHEMIC-HEART-DISEASE; ENERGY-EXPENDITURE; FOLLOW-UP; FAT OXIDATION;
   BLACK TEA; ANTIOXIDANT ACTIVITY; DOUBLE-BLIND; MILK; OBESITY; EPHEDRINE
AB Background: Green tea (epigallocatechin gallate + caffeine) and protein each were shown to improve body weight maintenance after weight loss.
   Objective: We investigated the effect of a green tea - caffeine mixture added to a high-protein (HP) diet on weight maintenance (WM) after body weight loss in moderately obese subjects.
   Design: A randomized, placebo-controlled, double-blind parallel trial was conducted in 80 overweight and moderately obese subjects [age (mean +/- SD): 44 +/- 2 y; body mass index (BMI; in kg/m(2)): 29.6 +/- 2.0] matched for sex, age, BMI, height, body mass, and with a habitually low caffeine intake. A very-low-energy diet intervention during 4 wk was followed by 3 mo of WM; during the WM period, the subjects received a green tea - caffeine mixture (270 mg epigallocatechin gallate + 150 mg caffeine/d) or placebo, both in addition to an adequate protein (AP) diet (50 - 60 g protein/d) or an HP diet (100 - 120 g protein/d).
   Results: Subjects lost 7.0 +/- 1.6 kg, or 8.2 +/- 2.0%, body weight (P < 0.001). During the WM phase, WM, resting energy expenditure, and fat-free mass (FFM) increased relatively in both the HP groups and in the AP + green tea - caffeine mixture group (P < 0.05), whereas respiratory quotient and body fat mass decreased, all compared with the AP + placebo group. Satiety increased only in both HP groups (P < 0.05). The green tea - caffeine mixture was only effective with the AP diet.
   Conclusion: The green tea - caffeine mixture, as well as the HP diet, improved WM independently through thermogenesis, fat oxidation, sparing FFM, and, for the HP diet, satiety; a possible synergistic effect failed to appear. Am J Clin Nutr 2009; 89: 822-30.
C1 [Hursel, Rick] Maastricht Univ, Dept Human Biol, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University
RP Hursel, R (corresponding author), Maastricht Univ, Dept Human Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM rick.hursel@hb.unimaas.nl
FU NUTRIM; Maastricht University, Maastricht, Netherlands
FX Supported by NUTRIM, Maastricht University, Maastricht, Netherlands.
CR ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   Arts MJTJ, 2002, J AGR FOOD CHEM, V50, P1184, DOI 10.1021/jf010855a
   Arts MJTJ, 2001, FOOD CHEM TOXICOL, V39, P787, DOI 10.1016/S0278-6915(01)00020-5
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BROWN PJ, 1963, J CHROMATOGR, V11, P504, DOI 10.1016/S0021-9673(01)80953-5
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Ekelund U, 2000, INT J SPORTS MED, V21, P586, DOI 10.1055/s-2000-8487
   GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397
   Goris AHC, 2001, AM J CLIN NUTR, V73, P549
   Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370
   HASLAM E, 1974, BIOCHEM J, V139, P285, DOI 10.1042/bj1390285
   Herman C.P., 1980, Obesity, P208
   Hertog MGL, 1997, AM J CLIN NUTR, V65, P1489, DOI 10.1093/ajcn/65.5.1489
   Hollman PCH, 2001, FREE RADICAL RES, V34, P297, DOI 10.1080/10715760100300261
   HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968
   Hulshof KFAM, 2003, EUR J CLIN NUTR, V57, P128, DOI 10.1038/sj.ejcn.1601503
   ISAKSSON B, 1980, AM J CLIN NUTR, V33, P4, DOI 10.1093/ajcn/33.1.4
   Jöbstl E, 2006, J AGR FOOD CHEM, V54, P4077, DOI 10.1021/jf053259f
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   KRAMER FM, 1989, INT J OBESITY, V13, P123
   KROMHOUT D, 1983, AM J CLIN NUTR, V38, P591, DOI 10.1093/ajcn/38.4.591
   Krul C, 2001, MUTAT RES-FUND MOL M, V474, P71, DOI 10.1016/S0027-5107(00)00158-5
   Langley-Evans SC, 2000, INT J FOOD SCI NUTR, V51, P181, DOI 10.1080/09637480050029683
   Leenen R, 2000, EUR J CLIN NUTR, V54, P87, DOI 10.1038/sj.ejcn.1600900
   Lejeune MPGM, 2005, BRIT J NUTR, V93, P281, DOI 10.1079/BJN20041305
   LICHTENBELT WDV, 1994, BRIT J NUTR, V72, P491, DOI 10.1079/BJN19940053
   Lorenz M, 2007, EUR HEART J, V28, P219, DOI 10.1093/eurheartj/ehl442
   LUCK G, 1994, PHYTOCHEMISTRY, V37, P357, DOI 10.1016/0031-9422(94)85061-5
   NIEUWENHUIZEN AG, 2008, BR J NUTR
   NOPPA H, 1980, AM J EPIDEMIOL, V111, P693, DOI 10.1093/oxfordjournals.aje.a112947
   Pasman WJ, 1997, INT J OBESITY, V21, P1143, DOI 10.1038/sj.ijo.0800528
   Pasman WJ, 1997, INT J OBESITY, V21, P548, DOI 10.1038/sj.ijo.0800439
   Pasman WJ, 1999, METABOLISM, V48, P15, DOI 10.1016/S0026-0495(99)90004-5
   Pichon L, 2008, BRIT J NUTR, V99, P739, DOI 10.1017/S0007114507831709
   Reddy VC, 2005, ANN NUTR METAB, V49, P189, DOI 10.1159/000087071
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2686, DOI 10.1093/ajcn/33.12.2686
   Schoffelen PFM, 1997, J APPL PHYSIOL, V83, P2064, DOI 10.1152/jappl.1997.83.6.2064
   SEIDELL JC, 1995, OBES RES, V3, pS89, DOI 10.1002/j.1550-8528.1995.tb00451.x
   Serafini M, 1996, EUR J CLIN NUTR, V50, P28
   Siebert KJ, 1996, J AGR FOOD CHEM, V44, P80, DOI 10.1021/jf9502459
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   TOUBRO S, 1993, INT J OBESITY, V17, pS69
   Trayhurn P., 1999, International Journal of Obesity, V23, pS22
   van het Hof KH, 1998, EUR J CLIN NUTR, V52, P356, DOI 10.1038/sj.ejcn.1600568
   VanGaal LF, 1997, INT J OBESITY, V21, pS5
   VELDHORST M, CLIN NUTR IN PRESS
   WADDEN TA, 1988, J CONSULT CLIN PSYCH, V56, P925, DOI 10.1037/0022-006X.56.6.925
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Westerterp-Plantenga MS, 2004, INT J OBESITY, V28, P57, DOI 10.1038/sj.ijo.0802461
   Westerterp-Plantenga MS, 1998, INT J OBESITY, V22, P1, DOI 10.1038/sj.ijo.0800536
   Westerterp-Plantenga MS, 1999, EUR J CLIN NUTR, V53, P495, DOI 10.1038/sj.ejcn.1600782
   WING RR, 1992, AM J CLIN NUTR, V55, P1086, DOI 10.1093/ajcn/55.6.1086
NR 62
TC 65
Z9 69
U1 1
U2 28
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD MAR 1
PY 2009
VL 89
IS 3
BP 822
EP 830
DI 10.3945/ajcn.2008.27043
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 410IS
UT WOS:000263571300016
PM 19176733
OA Green Submitted, Bronze
DA 2025-04-28
ER

PT J
AU Gutiérrez-Hellín, J
   Del Coso, J
   Espada, MC
   Hernández-Beltrán, V
   Ferreira, CC
   Varillas-Delgado, D
   Laiz, NM
   Roberts, JD
   Gamonales, JM
AF Gutierrez-Hellin, Jorge
   Del Coso, Juan
   Espada, Mario C.
   Hernandez-Beltran, Victor
   Ferreira, Catia C.
   Varillas-Delgado, David
   Laiz, Nuria Mendoza
   Roberts, Justin D.
   Gamonales, Jose M.
TI Research Trends in the Effect of Caffeine Intake on Fat Oxidation: A
   Bibliometric and Visual Analysis
SO NUTRIENTS
LA English
DT Review
DE bibliometric analysis; coffee; caffeine effects; dietary supplement; fat
   loss; weight loss
ID GREEN TEA; WEIGHT MAINTENANCE; METABOLISM; CLASSIFICATION; PERFORMANCE;
   INGESTION; CATECHINS; SYSTEM
AB In the last few decades, numerous studies pertaining to research groups worldwide have investigated the effects of oral caffeine intake on fat oxidation at rest, during exercise, and after exercise. However, there is no bibliometric analysis to assess the large volume of scientific output associated with this topic. A bibliometric analysis of this topic may be used by researchers to assess the current scientific interest in the application of caffeine as a nutritional strategy to augment fat oxidation, the journals with more interest in this type of publication, and to draw international collaborations between groups working in the same area. For these reasons, the purpose of this study was to assess the research activity regarding oral caffeine intake and fat oxidation rate in the last few decades by conducting a bibliometric and visual analysis. Relevant publications from 1992 to 2022 were retrieved from the Web of Science (WoS) Core Collection database. Quantitative and qualitative variables were collected, including the number of publications and citations, H-indexes, journals of citation reports, co-authorship, co-citation, and the co-occurrence of keywords. There were 182 total publications, while the number of annual publications is saw-shaped with a modest increase of 11.3% from 2000 to 2009 to 2010 to 2019. The United States was the country with the highest number of publications (24.17% of the total number of articles), followed by the Netherlands (17.03%). According to citation analyses, the average number of citations per document is 130, although there are 21 documents that have received more than 100 citations; the most cited document reached 644 citations. These citation data support the overall relevance of this topic in the fields of nutrition and dietetics and sport sciences that when combined harbored 85.71% of all articles published in the WoS. The most productive author was Westerterp-Plantenga with 16 articles (8.79% of the total number of articles). Nutrients was the journal that published the largest number of articles on this topic (6.59% of the total number of articles). Last, there is a tendency to include keywords such as "performance", "carbohydrate", and "ergogenic aid" in the newer articles, while "obesity", "thermogenic", and "tea" are the keywords more commonly included in older documents. Although research into the role of caffeine on fat oxidation has existed since the 1970s, our analysis suggests that the scientific output associated with this topic has progressively increased since 1992, demonstrating that this is a nutritional research area with a strong foundational base of scientific evidence. Based on the findings of this bibliometric analysis, future investigation may consider focusing on the effects of sex and tolerance to caffeine to widen the assessment of the effectiveness of oral caffeine intake as a nutritional strategy to augment the use of fat as a fuel, as these terms rarely appear in the studies included in this analysis. Additionally, more translational research is necessary as the studies that investigate the effect of oral caffeine intake in ecologically valid contexts (i.e., exercise training programs for individuals with excessive adiposity) are only a minor part of the studies on this topic.
C1 [Gutierrez-Hellin, Jorge; Varillas-Delgado, David; Laiz, Nuria Mendoza; Gamonales, Jose M.] Univ Francisco Vitoria, Fac Ciencias Salud, Ctra Pozuelo Majadahonda Km 1-800, Pozuelo De Alarcon 28223, Spain.
   [Del Coso, Juan] Univ Rey Juan Carlos, Sport Sci Res Ctr, Fuenlabrada 28943, Spain.
   [Espada, Mario C.; Ferreira, Catia C.] Inst Politecn Setubal, Escola Super Educ, P-2914504 Setubal, Portugal.
   [Espada, Mario C.] Life Qual Res Ctr CIEQV Leiria, P-2040413 Rio Maior, Portugal.
   [Espada, Mario C.] Univ Lisbon, Fac Motricidade Humana, CIPER, P-1499002 Lisbon, Portugal.
   [Hernandez-Beltran, Victor; Ferreira, Catia C.; Gamonales, Jose M.] Univ Extremadura, Fac Ciencias Deporte, Caceres 10005, Spain.
   [Roberts, Justin D.] Anglia Ruskin Univ, Cambridge Ctr Sport & Exercise Sci, Sch Psychol & Sport Sci, Cambridge CB1 1PT, England.
   [Gamonales, Jose M.] Univ Distancia Madrid, Programa Doctorado Educ & Tecnol, Collado Villalba 28400, Spain.
C3 Universidad Francisco de Vitoria; Universidad Rey Juan Carlos; Instituto
   Politecnico de Setubal; Universidade de Lisboa; Universidad de
   Extremadura; Anglia Ruskin University; Madrid Open University, UDIMA
RP Gutiérrez-Hellín, J (corresponding author), Univ Francisco Vitoria, Fac Ciencias Salud, Ctra Pozuelo Majadahonda Km 1-800, Pozuelo De Alarcon 28223, Spain.; Del Coso, J (corresponding author), Univ Rey Juan Carlos, Sport Sci Res Ctr, Fuenlabrada 28943, Spain.
EM jorge.gutierrez@ufv.es; juan.delcoso@urjc.es
RI Hernández Beltrán, Víctor/IQW-5018-2023; Del Coso, Juan/AAC-7117-2020;
   Espada, Mário/AAV-4731-2021; Gamonales, José/R-4914-2019; Varillas
   Delgado, David/AAB-1105-2019; Mendoza Laiz, Nuria/P-9509-2017
OI Espada, Mario/0000-0002-4524-4784; Del Coso, Juan/0000-0002-5785-984X;
   Ferreira, Catia/0000-0003-3629-981X; Roberts,
   Justin/0000-0002-3169-2041; Varillas Delgado, David/0000-0001-5026-2701;
   Hernandez Beltran, Victor/0000-0002-7449-5734; GAMONALES, JOSE
   M./0000-0002-2444-1535; Mendoza Laiz, Nuria/0000-0001-6271-3725;
   Gutierrez-Hellin, Jorge/0000-0001-9721-2269
FU The authors would like to acknowledge the participants who allowed us to
   conduct this study.
FX The authors would like to acknowledge the participants who allowed us to
   conduct this study.
CR Aguilar-Navarro M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020286
   Ato M, 2013, AN PSICOL-SPAIN, V29, P1038, DOI 10.6018/analesps.29.3.178511
   Campos Soto N., 2019, Alteridad, Revista de Educacion, V15, P47, DOI [10.17163/alt.v15n1.2020.04, DOI 10.17163/ALT.V15N1.2020.04]
   COILE RC, 1977, J AM SOC INFORM SCI, V28, P366, DOI 10.1002/asi.4630280610
   Collado-Mateo D, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123603
   Conger SA, 2023, INT J SPORT NUTR EXE, V33, P112, DOI 10.1123/ijsnem.2022-0131
   Contreras-Barraza N, 2021, NUTRIENTS, V13, DOI 10.3390/nu13093234
   Crespo N, 2019, SOC SCI QUART, V100, P2495, DOI 10.1111/ssqu.12696
   Cruz RR, 2023, RETOS-NUEV TEND EDUC, P215
   Davis JM, 2003, AM J PHYSIOL-REG I, V284, pR399, DOI 10.1152/ajpregu.00386.2002
   Djordjevic N, 2010, EUR J CLIN PHARMACOL, V66, P697, DOI 10.1007/s00228-010-0823-4
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Duque Oliva E.J., 2006, INNOVAR, V16, P223
   Gamonales J.M., 2018, Eur. J. Adapt. Phys. Act, V11, P1, DOI [10.5507/euj.2018.004, DOI 10.5507/EUJ.2018.004]
   Gamonales JM, 2023, REV EDUC INCL, V16, P104
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Gutiérrez-Hellín J, 2023, EUR J NUTR, V62, P311, DOI 10.1007/s00394-022-02988-8
   Gutiérrez-Hellín J, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030715
   Gutiérrez-Hellín J, 2018, MED SCI SPORT EXER, V50, P1899, DOI 10.1249/MSS.0000000000001653
   Hernández-Beltrán V, 2023, HEALTHCARE-BASEL, V11, DOI 10.3390/healthcare11121669
   Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102
   Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Diaz-Lara FJ, 2016, INT J SPORT PHYSIOL, V11, P861, DOI 10.1123/ijspp.2015-0686
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Salinero JJ, 2019, RES SPORTS MED, V27, P238, DOI 10.1080/15438627.2018.1552146
   Kovacs EMR, 1998, J APPL PHYSIOL, V85, P709, DOI 10.1152/jappl.1998.85.2.709
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   Montero I, 2007, INT J CLIN HLTH PSYC, V7, P847
   Mukherjee D, 2022, J BUS RES, V148, P101, DOI 10.1016/j.jbusres.2022.04.042
   National Coffee Association of U.S.A, about us
   PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Ramírez-Maldonado M, 2021, J INT SOC SPORT NUTR, V18, DOI 10.1186/s12970-020-00400-6
   Rey-Martí A, 2016, J BUS RES, V69, P1651, DOI 10.1016/j.jbusres.2015.10.033
   Reyes CM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111772
   Ruiz-Moreno C, 2021, EUR J NUTR, V60, P2077, DOI 10.1007/s00394-020-02393-z
   Saimaiti A, 2023, CRIT REV FOOD SCI, V63, P9648, DOI 10.1080/10408398.2022.2074362
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Soos R, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182312389
   Uribe-Toril J, 2019, FORESTS, V10, DOI 10.3390/f10010072
   Valderrama-Zurian JC, 2021, INFORM PROCESS MANAG, V58, DOI 10.1016/j.ipm.2021.102658
   Varillas-Delgado D, 2023, BIOL SPORT, V40, P827, DOI 10.5114/biolsport.2023.121321
   Vega-Muñoz A, 2022, J MAR SCI ENG, V10, DOI 10.3390/jmse10060751
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Zheng GD, 2004, IN VIVO, V18, P55
NR 49
TC 9
Z9 9
U1 5
U2 22
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2023
VL 15
IS 20
AR 4320
DI 10.3390/nu15204320
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA W1TP5
UT WOS:001089530800001
PM 37892395
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Awais, M
   Akter, R
   Boopathi, V
   Ahn, JC
   Lee, JH
   Mathiyalagan, R
   Kwak, GY
   Rauf, M
   Yang, DC
   Lee, GS
   Kim, YJ
   Jung, SK
AF Awais, Muhammad
   Akter, Reshmi
   Boopathi, Vinothini
   Ahn, Jong Chan
   Lee, Jung Hyeok
   Mathiyalagan, Ramya
   Kwak, Gi-Young
   Rauf, Mamoona
   Yang, Deok Chun
   Lee, Geun Sik
   Kim, Yeon-Ju
   Jung, Seok-Kyu
TI Discrimination of Dendropanax morbifera via HPLC fingerprinting
   and SNP analysis and its impact on obesity by modulating adipogenesis-
   and thermogenesis-related genes
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE plant secondary metabolites; chlorogenic acid; rutin; multiplex PCR; in
   silico; in vitro
ID PPAR-GAMMA; OPTIMIZATION; EXTRACTION; ADIPOCYTES; ACTIVATION; EXPRESSION
AB Dendropanax morbifera (DM), a medicinal plant, is rich in polyphenols and commonly used to treat cancer, inflammation, and thrombosis. However, to date, no study has been conducted on DM regarding the enormous drift of secondary metabolites of plants in different regions of the Republic of Korea and their effects on antiobesity, to explore compounds that play an important role in two major obesity-related pathways. Here, we present an in-depth study on DM samples collected from three regions of the Republic of Korea [Jeju Island (DMJ), Bogildo (DMB), and Jangheung (DMJG)]. We used high-performance liquid chromatography (HPLC) and multivariate component analyses to analyze polyphenol contents (neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, and rutin), followed by discrimination of the samples in DMJG using single nucleotide polymorphism and chemometric analysis. In silico and in vitro evaluation of major compounds found in the plant extract on two major anti-obesity pathways (adipogenesis and thermogenesis) was carried out. Furthermore, two extraction methods (Soxhlet and ultrasound-assisted extraction) were used to understand which method is better and why. Upon quantifying plant samples in three regions with the polyphenols, DMJG had the highest content of polyphenols. The internal transcribed region (ITS) revealed a specific gel-based band for the authentication of DMJG. PCA and PLS-DA revealed the polyphenol's discriminative power of the region DMJG. The anti-obesity effects of plant extracts from the three regions were related to their polyphenol contents, with DMJG showing the highest effect followed by DMJ and DMB. Ultrasound-assisted extraction yielded a high number of polyphenols compared to that of the Soxhlet method, which was supported by scanning electron microscopy. The present work encourages studies on plants rich in secondary metabolites to efficiently use them for dietary and therapeutic purposes.
C1 [Awais, Muhammad; Akter, Reshmi; Boopathi, Vinothini; Ahn, Jong Chan; Lee, Jung Hyeok; Mathiyalagan, Ramya; Kwak, Gi-Young; Yang, Deok Chun; Kim, Yeon-Ju] Kyung Hee Univ, Coll Life Sci, Grad Sch Biotechnol, Yongin, South Korea.
   [Yang, Deok Chun] Abdul Wali Khan Univ Mardan, Dept Bot, Mardan, Pakistan.
   [Rauf, Mamoona] Kyung Hee Univ, Coll Life Sci, Dept Oriental Med Biotechnol, Yongin 446701, South Korea.
   [Lee, Geun Sik] Chonnam Natl Univ, Southwest Coast Hwangchil Cooperat, Gwangju Si, South Korea.
   [Lee, Geun Sik] Jungwon Univ, Ind Acad Cooperat Bldg, Goesan, South Korea.
   [Jung, Seok-Kyu] Kongju Natl Univ, Dept Hort, Yesan, South Korea.
C3 Kyung Hee University; Kyung Hee University; Chonnam National University;
   Jungwon University; Kongju National University
RP Kim, YJ (corresponding author), Kyung Hee Univ, Coll Life Sci, Grad Sch Biotechnol, Yongin, South Korea.; Jung, SK (corresponding author), Kongju Natl Univ, Dept Hort, Yesan, South Korea.
EM yeonjukim@khu.ac.kr; jungsk@kongju.ac.kr
RI , Lee/AAI-4386-2020; Awais, Muhammad/JGD-0636-2023; Rauf,
   Mamoona/AAC-3246-2019
OI Awais, Muhammad/0000-0002-5536-2661; Rauf, Mamoona/0000-0001-7756-0741
FU This work was supported by Southwest Coast Hwangchil Cooperative.;
   Southwest Coast Hwangchil Cooperative
FX The plant samples used in the studies were provided by Geun Sik Lee,
   Southwest Coast Hwangchil Cooperative and Seung Jin Lee, Nature Bio
   Pharma Co. Ltd.r This work was supported by Southwest Coast Hwangchil
   Cooperative.
CR Akter R, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.1010103
   Akter R, 2022, MOLECULES, V27, DOI 10.3390/molecules27092795
   Akter R, 2022, APPL SCI-BASEL, V12, DOI 10.3390/app12010236
   Alvarez MA., 2016, PLANT BIOTECHNOL-NAR
   Balakrishnan R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100962
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Chen Y, 2008, ANAL CHIM ACTA, V623, P146, DOI 10.1016/j.aca.2008.06.018
   Choi HJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23030650
   Chouchani ET, 2019, CELL METAB, V29, P27, DOI 10.1016/j.cmet.2018.11.002
   Chung S, 2021, REV CARDIOVASC MED, V22, P1279, DOI 10.31083/j.rcm2204135
   Duan L, 2020, MOLECULES, V25, DOI 10.3390/molecules25143260
   Eom T, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9020120
   Floyd ZE, 2008, METABOLISM, V57, pS32, DOI 10.1016/j.metabol.2008.04.006
   Ju LP, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1393-8
   Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005
   Kang MJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00537
   Kwon YK, 2014, J GINSENG RES, V38, P52, DOI 10.1016/j.jgr.2013.11.006
   Lamichhane G, 2022, MOLECULES, V27, DOI 10.3390/molecules27030676
   Lee Kyung-Hee, 2015, Prev Nutr Food Sci, V20, P298, DOI 10.3746/pnf.2015.20.4.298
   Liyana-Pathirana C, 2005, FOOD CHEM, V93, P47, DOI 10.1016/j.foodchem.2004.08.050
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Na JR, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57111147
   Monfil VO, 2014, BIOTECHNOLOGY AND BIOLOGY OF TRICHODERMA, P429, DOI 10.1016/B978-0-444-59576-8.00032-1
   Palmieri S, 2020, FOODS, V9, DOI 10.3390/foods9091221
   Peng SQ, 2023, FRONT SUSTAIN FOOD S, V7, DOI 10.3389/fsufs.2023.1131959
   Podsedek A, 2020, J FUNCT FOODS, V73, DOI 10.1016/j.jff.2020.104111
   Pu J, 2022, ARCH MED RES, V53, P231, DOI 10.1016/j.arcmed.2021.11.003
   Reungoat V., 2021, RESPONSE SURFACE MET
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   Sheu SH, 2005, BIOCHEMISTRY-US, V44, P1193, DOI 10.1021/bi048032c
   Song JH, 2021, NUTRIENTS, V13, DOI 10.3390/nu13051424
   Song JH, 2018, J MED FOOD, V21, P793, DOI 10.1089/jmf.2017.4154
   Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507
   Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010
   Teruel T, 2005, DIABETOLOGIA, V48, P1180, DOI 10.1007/s00125-005-1744-0
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Volkamer A, 2012, BIOINFORMATICS, V28, P2074, DOI 10.1093/bioinformatics/bts310
   Wang J, 2020, J BIOSCI BIOENG, V129, P259, DOI 10.1016/j.jbiosc.2019.09.012
   Wang WZ, 2020, FOOD CHEM, V309, DOI 10.1016/j.foodchem.2019.125686
   Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456
   White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1
   Willems S, 2021, CELL CHEM BIOL, V28, P1489, DOI 10.1016/j.chembiol.2021.04.019
   Xiong GL, 2021, NUCLEIC ACIDS RES, V49, pW5, DOI 10.1093/nar/gkab255
   Yi MH, 2020, CURR NANOSCI, V16, P196, DOI 10.2174/1573413716666200116124822
   Ying Z, 2022, FRONT PLANT SCI, V13, DOI 10.3389/fpls.2022.903306
   You WY, 2021, MATERIALS, V14, DOI 10.3390/ma14040824
   Youn JS, 2019, FOOD SCI BIOTECHNOL, V28, P201, DOI 10.1007/s10068-018-0352-y
   Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005
   Zhang M, 2021, HORTICULTURAE, V7, DOI 10.3390/horticulturae7110491
   Zhao ZY, 2017, J FOOD MEAS CHARACT, V11, P1947, DOI 10.1007/s11694-017-9577-3
   Zlatic NM, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6030038
   Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200
NR 52
TC 5
Z9 5
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD AUG 2
PY 2023
VL 10
AR 1168095
DI 10.3389/fnut.2023.1168095
PG 17
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA P8QV8
UT WOS:001053270900001
PM 37621738
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Ikeda, M
   Maki, T
   Yin, G
   Kawate, H
   Adachi, M
   Ohnaka, K
   Takayanagi, R
   Kono, S
AF Ikeda, Mizuko
   Maki, Takako
   Yin, Guang
   Kawate, Hisaya
   Adachi, Masahiro
   Ohnaka, Keizo
   Takayanagi, Ryoichi
   Kono, Suminori
TI Relation of coffee consumption and serum liver enzymes in Japanese men
   and women with reference to effect modification of alcohol use and body
   mass index
SO SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
LA English
DT Article
ID GAMMA-GLUTAMYL-TRANSFERASE; FOOD FREQUENCY QUESTIONNAIRE; SELF-DEFENSE
   OFFICIALS; DRINKING; RISK; CAFFEINE; DETERMINANTS; VALIDITY; RECORDS;
   OBESITY
AB Objective. Previous studies have shown that coffee consumption is inversely related to serum levels of liver enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT), but few have addressed the relation in women and effect modifications of alcohol use and obesity. We examined the association of coffee and green tea consumption with serum activities of liver enzymes in free-living Japanese men and women, focusing on sex difference and effect modifications of alcohol and obesity. Material and methods. The data were derived from the baseline survey of the Kyushu University Fukuoka Cohort Study, and included 12,020 Japanese men and women aged 49-76 years who were free of chronic liver diseases. Results. There was an inverse association between coffee consumption and elevated ALT in men, and the association between the two was weaker in women. In the analyses stratified by aminotransferases category, inverse associations of coffee consumption with serum activities of liver enzymes were observed in both men and women within the whole range and among those with aminotransferases within the reference range (ALT/AST < 40 IU/L for men and ALT/AST < 30 IU/L for women). Inverse associations of coffee with liver enzymes were more evident in those with high alcohol consumption and in those with low body mass index. Conclusions. Coffee drinking probably confers protection against alcohol-related increase in liver enzymes.
C1 [Ikeda, Mizuko] Kyushu Univ, Grad Sch Med Sci, Dept Prevent Med, Higashi Ku, Fukuoka 8128582, Japan.
   [Kawate, Hisaya; Adachi, Masahiro; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan.
   [Ohnaka, Keizo] Kyushu Univ, Grad Sch Med Sci, Dept Geriatr Med, Fukuoka 8128582, Japan.
C3 Kyushu University; Kyushu University; Kyushu University
RP Ikeda, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Prevent Med, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.
EM miz1976@phealth.med.kyushu-u.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
FX This study was supported by a grant from the 21st Century Center of
   Excellence (COE) Program (Kyushu University) from the Ministry of
   Education, Culture, Sports, Science and Technology, Japan.
CR Adams LA, 2008, J GASTROEN HEPATOL, V23, P1089, DOI 10.1111/j.1440-1746.2008.05451.x
   [Anonymous], 2000, STAND TABL FOOD COMP
   Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335
   Aubin HJ, 1998, BIOL PSYCHIAT, V44, P638, DOI 10.1016/S0006-3223(97)00438-1
   Bravi F, 2007, HEPATOLOGY, V46, P430, DOI 10.1002/hep.21708
   CASIGLIA E, 1993, EUR J EPIDEMIOL, V9, P293, DOI 10.1007/BF00146266
   Corrao G, 2001, ANN EPIDEMIOL, V11, P458, DOI 10.1016/S1047-2797(01)00223-X
   HASEGAWA M, 1989, HEPATOLOGY, V10, P973, DOI 10.1002/hep.1840100614
   Hicks MB, 1996, FOOD RES INT, V29, P325, DOI 10.1016/0963-9969(96)00038-5
   Honjo S, 2001, J CLIN EPIDEMIOL, V54, P823, DOI 10.1016/S0895-4356(01)00344-4
   Honjo S, 1999, ANN EPIDEMIOL, V9, P325, DOI 10.1016/S1047-2797(99)00013-7
   Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899
   Kendrick SFW, 2007, J HEPATOL, V46, pS271, DOI 10.1016/S0168-8278(07)62317-4
   Kinoshita S, 2001, CLIN CHEM LAB MED, V39, P256, DOI 10.1515/CCLM.2001.040
   KLATSKY AL, 1992, AM J EPIDEMIOL, V136, P1248, DOI 10.1093/oxfordjournals.aje.a116433
   Klatsky AL, 2006, ARCH INTERN MED, V166, P1190, DOI 10.1001/archinte.166.11.1190
   Kobayashi M., 1994, RINSHO KENSA, V38, P844
   KONO S, 1994, AM J EPIDEMIOL, V139, P723, DOI 10.1093/oxfordjournals.aje.a117062
   Kotani K, 1994, Nihon Shokakibyo Gakkai Zasshi, V91, P154
   Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044
   Lee KY, 2002, J NUTR SCI VITAMINOL, V48, P467, DOI 10.3177/jnsv.48.467
   Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399
   Nakanishi N, 2000, EUR J EPIDEMIOL, V16, P419, DOI 10.1023/A:1007683626665
   Nanri A, 2008, AM J CLIN NUTR, V87, P1488, DOI 10.1093/ajcn/87.5.1488
   NILSSEN O, 1990, AM J EPIDEMIOL, V132, P318, DOI 10.1093/oxfordjournals.aje.a115661
   Poikolainen K, 1997, AM J EPIDEMIOL, V146, P1019, DOI 10.1093/oxfordjournals.aje.a009230
   Puukka K, 2006, AM J CLIN NUTR, V83, P1351, DOI 10.1093/ajcn/83.6.1351
   Ruhl CE, 2005, GASTROENTEROLOGY, V128, P24, DOI 10.1053/j.gastro.2004.09.075
   STUART K, 2008, ENHANCED INFLAMMATOR
   Tanaka K, 1998, INT J EPIDEMIOL, V27, P438, DOI 10.1093/ije/27.3.438
   Tokudome Shinkan, 2004, Asian Pac J Cancer Prev, V5, P40
   Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135
   Tsukamoto H, 2001, ALCOHOL CLIN EXP RES, V25, p171S, DOI 10.1097/00000374-200105051-00029
   Tverdal A, 2003, ANN EPIDEMIOL, V13, P419, DOI 10.1016/S1047-2797(02)00462-3
   Yoshida D, 2009, DIABETES METAB SYND, V3, P7, DOI 10.1016/j.dsx.2008.10.002
NR 35
TC 22
Z9 24
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0036-5513
EI 1502-7686
J9 SCAND J CLIN LAB INV
JI Scand. J. Clin. Lab. Invest.
PD APR
PY 2010
VL 70
IS 3
BP 171
EP 179
DI 10.3109/00365511003650165
PG 9
WC Medical Laboratory Technology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology; Research & Experimental Medicine
GA 585HA
UT WOS:000276814500005
PM 20205615
DA 2025-04-28
ER

PT J
AU Björner, S
   Rosendahl, AH
   Tryggvadottir, H
   Simonsson, M
   Jirström, K
   Borgquist, S
   Rose, C
   Ingvar, C
   Jernström, H
AF Bjorner, Sofie
   Rosendahl, Ann H.
   Tryggvadottir, Helga
   Simonsson, Maria
   Jirstrom, Karin
   Borgquist, Signe
   Rose, Carsten
   Ingvar, Christian
   Jernstrom, Helena
TI Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor
   Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis
   Following Tamoxifen or Radiotherapy Treatment
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Article
DE coffee; insulin-like growth factor receptor 1; body mass index; breast
   cancer; prognosis
ID FACTOR-I RECEPTOR; DECAFFEINATED COFFEE; CAFFEINATED COFFEE;
   ESTROGEN-RECEPTOR; PHYSICAL-ACTIVITY; CANCER PATIENTS; C-PEPTIDE;
   HORMONE; WOMEN; CONSUMPTION
AB Coffee is associated with decreased breast cancer risk, but the impact of body mass index (BMI) in combination with coffee consumption on prognosis is unclear. The suppressive effect of coffee constituents on the insulin-like growth factor receptor 1 (IGF1R) levels in breast cancer cells may play a role. The aim was to investigate the prognostic impact of coffee consumption and possible associations with tumor specific IGF1R protein expression and BMI in a population-based cohort in Sweden, comprising 1,014 primary breast cancer patients without pretreatment enrolled 2002-2012 and followed for up to 13 years. Patients with higher coffee consumption had lower tumor IGF1R levels (P = 0.025), but only among the normal-weight patients (P = 0.005). Coffee did not impact the recurrence-risk overall. However, tamoxifen-treated patients with ER+ tumors drinking >= 2 cups of coffee/day had lower recurrence-risk [adjusted HR (HRadj,) 0.57, 95% Cl, 0.34-0.97] compared with patients with lower intake, although only among normal-weight patients (HRad, 0.37, 95% Cl: 0.17-0.78; P-interaction = 0.039). Similarly, coffee consumption >= 2 cups/day was associated with significantly lower recurrence-risk among the 640 radiotherapy-treated patients irrespective of BMI (HRad, 0.59, 95% Cl 0.36-0.98) and in the 296 normal-weight patients (HR,d, 0.36, 95% Cl 0.17-0.76) but not in the 329 overweight or obese patients (HRadj, 0.88, 95% Cl 0.42-1.82) although the interaction was not significant (P-interaction = 0.093). In conclusion, coffee consumption was negatively associated with tumor-specific IGF1R levels only among normal-weight patients. Though, IGF1R did not explain the association between coffee intake and improved prognosis among normal weight tamoxifen-or radiotherapy-treated patients. Studies of IGF1R-targeting therapies may benefit from taking BMI and coffee consumption into account.
C1 [Bjorner, Sofie; Rosendahl, Ann H.; Tryggvadottir, Helga; Simonsson, Maria; Jirstrom, Karin; Borgquist, Signe; Jernstrom, Helena] Lund Univ, Skane Univ Hosp, Fac Med, Dept Clin Sci Lund,Oncol & Pathol, Lund, Sweden.
   [Rose, Carsten] Lund Univ, Dept Immunotechnol, CREATE Hlth, Lund, Sweden.
   [Ingvar, Christian] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Surg, Lund, Sweden.
C3 Lund University; Skane University Hospital; Lund University; Lund
   University; Skane University Hospital
RP Jernström, H (corresponding author), Lund Univ, Skane Univ Hosp, Fac Med, Dept Clin Sci Lund,Oncol & Pathol, Lund, Sweden.
EM helena.jernstrom@med.lu.se
RI Ingvar, Christian/AAE-9841-2019
OI Jirstrom, Karin/0000-0003-2257-5000; Borgquist,
   Signe/0000-0001-7938-8893; /0000-0003-0066-0677
FU Swedish Cancer Society [CAN2014/465]; Mrs. Berta Kamprad Foundation
   [BKS19/2014, BKS27/2015]; Swedish Breast Cancer Group (BRO); South
   Swedish Health Care Region (Region Skane) [ALF 10622]; Lund Hospital
   Fund; RATHER consortium; Seventh Framework program
FX This work was supported by grants from The Swedish Cancer Society
   (CAN2014/465) (HJ); the Mrs. Berta Kamprad Foundation (BKS19/2014,
   BKS27/2015) (HJ); the Swedish Breast Cancer Group (BRO) (CI); the South
   Swedish Health Care Region (Region Skane ALF 10622) (HJ); the Lund
   Hospital Fund (CI and HJ), the RATHER consortium
   (http://www.ratherproject.com/), and the Seventh Framework program
   (William.Gallagher@ucd.ie). The funding agencies played no role in
   design of the study; the collection, analysis, and interpretation of the
   data; the writing of the manuscript; or the decision to submit the
   manuscript for publication.
CR Bågeman E, 2008, CANCER EPIDEM BIOMAR, V17, P895, DOI 10.1158/1055-9965.EPI-07-0555
   Bertacca A, 2007, DIABETES RES CLIN PR, V78, P316, DOI 10.1016/j.diabres.2007.06.001
   Björner S, 2017, ONCOTARGET, V8, P9093, DOI 10.18632/oncotarget.14082
   Djordjevic Natasa, 2010, Eur J Clin Pharmacol, V66, P697, DOI 10.1007/s00228-010-0823-4
   Fan P, 2014, EUR J CANCER, V50, P2866, DOI 10.1016/j.ejca.2014.08.011
   Gapstur SM, 2017, CANCER EPIDEM BIOMAR, V26, P1477, DOI [10.1158/1055-9965.epi-17-0353, 10.1158/1055-9965.EPI-17-0353]
   Giri A, 2011, NUTRIENTS, V3, P937, DOI 10.3390/nu3110937
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Hawsawi Y, 2013, BBA-REV CANCER, V1836, P345, DOI 10.1016/j.bbcan.2013.10.005
   Iams WT, 2015, CLIN CANCER RES, V21, P4270, DOI 10.1158/1078-0432.CCR-14-2518
   Jernström H, 1999, J WOMEN HEALTH GEN-B, V8, P1265, DOI 10.1089/jwh.1.1999.8.1265
   Kakugawa Y, 2017, BREAST CANCER RES TR, V162, P115, DOI 10.1007/s10549-016-4094-3
   LANDINWILHELMSEN K, 1994, CLIN ENDOCRINOL, V41, P351, DOI 10.1111/j.1365-2265.1994.tb02556.x
   Li XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052681
   Lipscombe LL, 2012, CANCER-AM CANCER SOC, V118, P2615, DOI 10.1002/cncr.26559
   Lodhia KA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00142
   McShane LM, 2005, NAT CLIN PRACT GASTR, V2, pA416, DOI 10.1038/ncponc0252
   Oh JK, 2015, INT J CANCER, V137, P1979, DOI 10.1002/ijc.29569
   Persson M, 2016, BRIT J CANCER, V115, P382, DOI 10.1038/bjc.2016.174
   Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215
   Rosendahl AH, 2015, CLIN CANCER RES, V21, P1877, DOI 10.1158/1078-0432.CCR-14-1748
   Simonsson M, 2013, CANCER CAUSE CONTROL, V24, P929, DOI 10.1007/s10552-013-0169-1
   Suga K, 2001, JPN J CANCER RES, V92, P127, DOI 10.1111/j.1349-7006.2001.tb01074.x
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Yee D, 2000, J MAMMARY GLAND BIOL, V5, P107, DOI 10.1023/A:1009575518338
   Yee D, 2018, J MOL ENDOCRINOL, V61, pT61, DOI 10.1530/JME-17-0261
NR 26
TC 8
Z9 8
U1 1
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD JUN 6
PY 2018
VL 9
AR 306
DI 10.3389/fendo.2018.00306
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA GI3JH
UT WOS:000434267100001
PM 29928262
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU de Souza, LL
   Meyer, LG
   Rossetti, CL
   Miranda, RA
   Bertasso, IM
   Lima, DGV
   da Silva, BS
   Pinheiro, VHSD
   Claudio-Neto, S
   Manhaes, AC
   Moura, EG
   Lisboa, PC
AF de Souza, Luana Lopes
   Meyer, Lilian Guedes
   Rossetti, Camila Luedke
   Miranda, Rosiane Aparecida
   Bertasso, Iala Milene
   Lima, Daniel Galinis Vieira
   da Silva, Beatriz Souza
   Pinheiro, Vitor Hugo Santos Duarte
   Claudio-Neto, Sylvio
   Manhaes, Alex Christian
   Moura, Egberto Gaspar
   Lisboa, Patricia Cristina
TI Maternal low-dose caffeine intake during the perinatal period promotes
   short- and long-term sex-dependent hormonal and behavior changes in the
   offspring
SO LIFE SCIENCES
LA English
DT Article
DE Caffeine; Gestation; Lactation; DOHaD; Hormones
ID INSULIN-RESISTANCE; FETAL; EXPOSURE; GROWTH; ORIGINS; RATS;
   HYPOTHYROIDISM; SUSCEPTIBILITY; METABOLISM; STIMULANT
AB Aim: Maternal caffeine crosses the placenta and mammary barriers, reaching the baby and, because his/her caffeine metabolism is immature, our hypothesis is that even a low caffeine intake (250 mg/day), lower than the dose limit recommended by the World Health Organization, can promote caffeine overexposure in the offspring, leading to short- and long-term changes. Main methods: Pregnant Wistar rats received intragastric caffeine (CAF) (25 mg/Kg/day) or vehicle during the gestation and lactation periods. We evaluated morphometrical, metabolic, hormonal, and behavioral parameters of male and female offspring at different ages. Key findings: Even a low caffeine intake promoted lower maternal body mass and adiposity, higher plasma cholesterol and lower plasma T3, without changes in plasma corticosterone. Female CAF offspring exhibited lower birth weight, body mass gain and food intake throughout life, and hyperinsulinemia at weaning, while male CAF offspring showed reduced food intake and lower plasma T3 at weaning. At puberty and adulthood, male CAF showed higher preference for palatable food, aversion to caffeine intake and higher locomotor activity, while female CAF only showed lower preference for high fat diet (HFD) and lower anxiety-like behavior. At adulthood, both male and female offspring showed higher plasma T3. Male CAF showed hypertestosteronemia, while female CAF showed hypoinsulinemia without effect on glucose tolerance. Significance: A low caffeine intake during the perinatal period affects rat's offspring development, promoting sexdependent hormonal and behavior changes. Current data suggest the need to review caffeine recommendations during the perinatal period.
C1 [de Souza, Luana Lopes; Meyer, Lilian Guedes; Rossetti, Camila Luedke; Miranda, Rosiane Aparecida; Bertasso, Iala Milene; Lima, Daniel Galinis Vieira; da Silva, Beatriz Souza; Pinheiro, Vitor Hugo Santos Duarte; Claudio-Neto, Sylvio; Moura, Egberto Gaspar; Lisboa, Patricia Cristina] Univ Estado Rio De Janeiro, Biol Inst, Lab Endocrine Physiol, Rio De Janeiro, RJ, Brazil.
   [Pinheiro, Vitor Hugo Santos Duarte; Claudio-Neto, Sylvio; Manhaes, Alex Christian] Univ Estado Rio De Janeiro, Inst Biol, Biomed Instrumentat Lab, Rio De Janeiro, RJ, Brazil.
C3 Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio
   de Janeiro
RP Lisboa, PC (corresponding author), Univ Estado Rio de Janeiro, Dept Ciencias Fisiol, Lab Fisiol Endocrina, Inst Biol Roberto Alcantara Gomes,PAPC, Ave 28 Setembro 87,5 Andar, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM pclisboa@uerj.br
RI Rossetti, Camila/MFJ-7044-2025; Neto, Sylvio/AAD-7517-2021; Moura,
   Egberto/H-1270-2012; BERTASSO, IALA/GPP-1622-2022; Miranda,
   Rosiane/C-1688-2019; Moura, Egberto/ABA-6188-2021; Manhães,
   Alex/F-5499-2011; da Silva, Beatriz/GPP-1639-2022
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES;
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro-FAPERJ.
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico-CNPq, Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior-CAPES and Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro-FAPERJ.
CR Acquas E, 2002, NEUROPSYCHOPHARMACOL, V27, P182, DOI 10.1016/S0893-133X(02)00290-7
   Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   Ahmed RG, 2019, TOXICOL RES-UK, V8, P196, DOI 10.1039/c8tx00227d
   Al-Fawaeir S, 2023, J AGR FOOD RES, V14, DOI 10.1016/j.jafr.2023.100904
   [Anonymous], 2010, Obstet Gynecol, V116, P467, DOI 10.1097/AOG.0b013e3181eeb2a1
   Antunes LC, 2016, ARCH ENDOCRIN METAB, V60, P138, DOI 10.1590/2359-3997000000169
   Barcelos RP, 2020, NUTR RES, V80, P1, DOI 10.1016/j.nutres.2020.05.005
   BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111
   Bartsch W, 1996, FOOD CHEM TOXICOL, V34, P153, DOI 10.1016/0278-6915(95)00095-X
   Bashkatova VG, 2018, B EXP BIOL MED+, V165, P299, DOI 10.1007/s10517-018-4154-2
   BEAVO JA, 1970, MOL PHARMACOL, V6, P597
   Bishnoi M, 2006, EUR J PHARMACOL, V552, P55, DOI 10.1016/j.ejphar.2006.09.010
   Björklund O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003977
   Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332
   Chen LW, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0174-6
   CLOZEL M, 1983, PEDIATR RES, V17, P592, DOI 10.1203/00006450-198307000-00015
   Neves DBD, 2017, FOOD CHEM TOXICOL, V105, P194, DOI 10.1016/j.fct.2017.03.063
   da Silva BS, 2019, ENVIRON POLLUT, V250, P312, DOI 10.1016/j.envpol.2019.03.100
   DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   de Oliveira E, 2011, FOOD CHEM TOXICOL, V49, P2068, DOI 10.1016/j.fct.2011.04.040
   Dorostghoal Mehran, 2012, Clin Exp Reprod Med, V39, P144, DOI 10.5653/cerm.2012.39.4.144
   El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170
   Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3
   FOORD SM, 1980, FEBS LETT, V121, P257, DOI 10.1016/0014-5793(80)80356-5
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Gluckman PD, 2010, J DEV ORIG HLTH DIS, V1, P6, DOI 10.1017/S2040174409990171
   Guilbert J J, 2003, Educ Health (Abingdon), V16, P230
   Guillén-Ruiz G, 2021, BEHAV BRAIN RES, V413, DOI 10.1016/j.bbr.2021.113469
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Hellström A, 2016, AM J PERINAT, V33, P1067, DOI 10.1055/s-0036-1586109
   Hu SW, 2019, TOXICOLOGY, V417, P23, DOI 10.1016/j.tox.2019.02.008
   Huang J, 2012, CLIN EXP PHARMACOL P, V39, P357, DOI 10.1111/j.1440-1681.2012.05676.x
   Hughes RN, 2014, BEHAV BRAIN RES, V271, P7, DOI 10.1016/j.bbr.2014.05.038
   Kent NL, 2023, PLACENTA, V139, P148, DOI 10.1016/j.placenta.2023.06.010
   Kilkenny C, 2010, J GENE MED, V12, P561, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1002/jgm.1473, 10.1113/jphysiol.2010.192278]
   KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8
   Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S6
   Lee CH, 2020, PHARMACOL BIOCHEM BE, V191, DOI 10.1016/j.pbb.2020.172880
   Lisboa PC, 2021, NEUROPHARMACOLOGY, V200, DOI 10.1016/j.neuropharm.2021.108821
   Lisowska A, 2023, CLIN NUTR ESPEN, V57, P151, DOI 10.1016/j.clnesp.2023.06.041
   Liu YS, 2012, TOXICOL APPL PHARM, V262, P205, DOI 10.1016/j.taap.2012.05.002
   Lu MX, 2022, ENVIRON TOXICOL, V37, P2703, DOI 10.1002/tox.23630
   Lu ZJ, 2023, ACTA PHARM SIN B, V13, P460, DOI 10.1016/j.apsb.2022.05.029
   Lv F, 2021, SCI TOTAL ENVIRON, V789, DOI 10.1016/j.scitotenv.2021.147691
   Marques RG, 2009, ACTA CIR BRAS, V24, P69, DOI 10.1590/S0102-86502009000100015
   Martin E, 2017, EPIGENOMICS-UK, V9, P267, DOI 10.2217/epi-2016-0132
   Meakin AS, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126386
   Mikkelsen SH, 2017, J PEDIATR-US, V189, P120, DOI 10.1016/j.jpeds.2017.06.051
   Morrison JL, 2010, PEDIATR NEPHROL, V25, P669, DOI 10.1007/s00467-009-1407-3
   Pagnin M, 2021, FRONT NEUROENDOCRIN, V61, DOI 10.1016/j.yfrne.2021.100901
   Paz-Graniel I, 2022, NUTRIENTS, V14, DOI 10.3390/nu14061242
   Peixoto TC, 2021, APPETITE, V160, DOI 10.1016/j.appet.2021.105115
   PERRY NA, 1950, J DAIRY SCI, V33, P176, DOI 10.3168/jds.S0022-0302(50)91883-2
   PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4
   Picó C, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13482
   Qian JJ, 2020, TRENDS ENDOCRIN MET, V31, P218, DOI 10.1016/j.tem.2019.11.004
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Sallaberry C, 2018, PROG NEURO-PSYCHOPH, V81, P416, DOI 10.1016/j.pnpbp.2017.08.015
   Sanchez-Hernandez D, 2015, APPL PHYSIOL NUTR ME, V40, DOI 10.1139/apnm-2014-0480
   Silva BS, 2019, LIFE SCI, V218, P253, DOI 10.1016/j.lfs.2018.12.039
   Soares PN, 2022, J DEV ORIG HLTH DIS, V13, P90, DOI 10.1017/S2040174421000039
   Souza LL, 2024, TOXICOL LETT, V393, P96, DOI 10.1016/j.toxlet.2024.02.005
   Tan Y, 2012, TOXICOL LETT, V214, P279, DOI 10.1016/j.toxlet.2012.09.007
   Teixeira PDD, 2020, THER ADV ENDOCRINOL, V11, DOI 10.1177/2042018820917869
   Umemura T, 2006, AM J CARDIOL, V98, P1538, DOI 10.1016/j.amjcard.2006.06.058
   VANSOEREN MH, 1993, J APPL PHYSIOL, V75, P805, DOI 10.1152/jappl.1993.75.2.805
   Voerman E, 2020, PEDIATR OBES, V15, DOI 10.1111/ijpo.12607
   Voerman E, 2016, OBESITY, V24, P1170, DOI 10.1002/oby.21466
   Wang LL, 2014, TOXICOL LETT, V224, P311, DOI 10.1016/j.toxlet.2013.11.006
   Wu YM, 2015, TOXICOL APPL PHARM, V289, P109, DOI 10.1016/j.taap.2015.09.007
   Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016
   Xu D, 2018, FASEB J, V32, P5563, DOI [10.1096/fj.201701557R, 10.1096/fj.201701557r]
   Xu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044497
   Zhu YN, 2019, TOXICOL LETT, V314, P63, DOI 10.1016/j.toxlet.2019.07.011
NR 76
TC 0
Z9 0
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD OCT 1
PY 2024
VL 354
AR 122971
DI 10.1016/j.lfs.2024.122971
EA AUG 2024
PG 14
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA D6C8V
UT WOS:001297046800001
PM 39147313
DA 2025-04-28
ER

PT J
AU Perakakis, N
   Kalra, B
   Angelidi, AM
   Kumar, A
   Gavrieli, A
   Yannakoulia, M
   Mantzoros, CS
AF Perakakis, Nikolaos
   Kalra, Bhanu
   Angelidi, Angeliki M.
   Kumar, Ajay
   Gavrieli, Anna
   Yannakoulia, Mary
   Mantzoros, Christos S.
TI Methods paper: Performance characteristics of novel assays for
   circulating levels of proglucagon-derived peptides and validation in a
   placebo controlled cross-over randomized clinical trial
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
DE GLP-1; Oxyntomodulin; Glicentin; GLP-2; Glucagon; Coffee; Diabetes;
   Obesity
ID GLUCAGON-LIKE PEPTIDE-1; COMMERCIALLY AVAILABLE ASSAYS; GLUCOSE; COFFEE;
   SENSITIVITY; GLICENTIN; GLP-1; OXYNTOMODULIN; POLYPEPTIDE; SPECIFICITY
AB Background: The measurement of proglucagon-derived peptides (PGDPs) is a challenging task mainly due to major overlaps in their molecular sequence in addition to their low circulating levels. Here, we present the technical characteristics of novel ELISA assays measuring C-peptide and all six PGDPs including, for the first time, major proglucagon fragment (MPGF), and we validate them by performing a pilot in vivo cross-over randomized clinical trial on whether coffee consumption may affect levels of circulating PGDPs.
   Methods: The performance and technical characteristics of novel ELISA assays from Ansh measuring GLP-1, GLP-2, oxyntomodulin, glicentin, glucagon, MPGF and C-peptide were first evaluated in vitro in procured samples from a commercial vendor as well as in deidentified human samples from three previously performed clinical studies. Their performance was further evaluated in vivo in the context of a cross-over randomized controlled trial, in which 33 subjects consumed in random order and together with a standardized meal, 200 ml of either (a) instant coffee with 3 mg/kg caffeine, or (b) instant coffee with 6 mg/kg caffeine, (c) or water.
   Results: All assays demonstrated high accuracy (spike and recovery and average linearity recovery +/- 15%), precision (inter-assay CV <= 6.4%), specificity (no significant cross-reactivities) and they were sensitive in low concentrations. Measurements of glicentin in archived random human samples using the Ansh assay correlated strongly with the glicentin measurements of Mercodia assay (r = 0.968) and of GLP-1 modestly with Millipore GLP-1 assay (r = 0.440). Oxyntomodulin, glicentin and glucagon concentrations were 2-5 fold higher in plasma compared to serum and serum concentrations correlated modestly (for oxyntomodulin and glicentin) or poorly (for glucagon) with the plasma concentrations. The evaluated assays detected a postprandial increase of gutsecreted PGDPs (GLP-1, GLP-2, oxyntomodulin and glicentin) and a postprandial decrease of pancreas-secreted PGDPs (glucagon, MPGF) in response to consuming coffee in comparison to consuming water with breakfast (enter here composition of breakfast). Only coffee consumption at the high dose alter levels of gut-secreted PGDPs and both at low and high dose to lower levels of pancreas-secreted PGDPs compared to water consumption during breakfast.
   Conclusion: Accurate, precise and specific measurement of six PGDPs is possible with novel assays. A randomized controlled trial demonstrated in vivo utility of those assays and supports the notion that coffee may exert part of its beneficial effects on glucose homeostasis in the short term through the regulation of PGDPs.
C1 [Perakakis, Nikolaos; Angelidi, Angeliki M.; Gavrieli, Anna; Yannakoulia, Mary; Mantzoros, Christos S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr BIDMC, Div Endocrinol, 330 Brookline Ave,Slosberg Landay SL 419, Boston, MA 02215 USA.
   [Kalra, Bhanu; Kumar, Ajay] Ansh Labs, Webster, TX 77598 USA.
C3 Harvard University; Harvard University Medical Affiliates; Beth Israel
   Deaconess Medical Center; Harvard Medical School
RP Mantzoros, CS (corresponding author), Beth Israel Deaconess Med Ctr BIDMC, 330 Brookline Ave,SL-419, Boston, MA 02215 USA.
EM cmantzor@bidmc.harvard.edu
RI Angelidi, Angeliki/AEZ-2917-2022; Mantzoros, Christos/Y-2902-2019;
   Perakakis, Nikolaos/AAJ-9046-2020
OI Yannakoulia, Mary/0000-0003-2171-7337
FU Hellenic Endocrine Society; Graduate Program of the Department of
   Nutrition and Dietetics, Harokopio University
FX BK and AK are employed by Ansh Inc. which provided in kind research
   support. AMA was funded by the Hellenic Endocrine Society. The original
   randomized trial on coffee consumption, but not this study, was funded
   in part through research funding from the Graduate Program of the
   Department of Nutrition and Dietetics, Harokopio University. AG has
   served as a fellow and MY as a Fulbright Scholar at BIDMC, Harvard
   Medical School.
CR Albrechtsen NJW, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0126
   [Anonymous], 2018, VALIDATION GFI BM
   Bak MJ, 2014, DIABETES OBES METAB, V16, P1155, DOI [10.1111/dom.12352, 10.1111/dom.1235]
   Bak MJ, 2014, J ENDOCRINOL DIABETE, V1, P5
   Bak MJ, 2014, EUR J ENDOCRINOL, V170, P529, DOI 10.1530/EJE-13-0941
   Beaudoin MS, 2011, J NUTR, V141, P574, DOI 10.3945/jn.110.132761
   BELL GI, 1983, NATURE, V302, P716, DOI 10.1038/302716a0
   Farr OM, 2019, DIABETES OBES METAB, V21, P2459, DOI 10.1111/dom.13827
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Gavrieli A, 2013, METABOLISM, V62, P1099, DOI 10.1016/j.metabol.2013.02.003
   Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006
   Hummel J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95750-9
   Iriondo-DeHond A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010088
   López JJ, 2018, J CELL MOL MED, V22, P684, DOI 10.1111/jcmm.13355
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kim SH, 2021, DIABETES OBES METAB, V23, P489, DOI 10.1111/dom.14242
   Lafferty RA, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.689678
   Manell H, 2016, J CLIN ENDOCR METAB, V101, P1181, DOI 10.1210/jc.2015-3885
   Meier JJ, 2004, DIABETES, V53, P654, DOI 10.2337/diabetes.53.3.654
   Müller TD, 2019, MOL METAB, V30, P72, DOI 10.1016/j.molmet.2019.09.010
   Nielsen MS, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa061
   Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10
   ORSKOV C, 1991, J CLIN INVEST, V87, P415, DOI 10.1172/JCI115012
   PATZELT C, 1981, FEBS LETT, V129, P127, DOI 10.1016/0014-5793(81)80772-7
   Perakakis N, 2020, J CLIN ENDOCR METAB, V105, pE3003, DOI 10.1210/clinem/dgaa329
   Perakakis N, 2021, DIABETES OBES METAB, V23, P1202, DOI 10.1111/dom.14315
   Perakakis N, 2019, METABOLISM, V101, DOI 10.1016/j.metabol.2019.153997
   Perakakis N, 2019, DIABETES OBES METAB, V21, P683, DOI 10.1111/dom.13572
   Poitou C, 2018, SURG OBES RELAT DIS, V14, P929, DOI 10.1016/j.soard.2018.03.014
   Polyzos SA, 2020, J CLIN ENDOCR METAB, V105, pE390, DOI 10.1210/clinem/dgz172
   Qin L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040377
   Reis CEG, 2019, J TRADIT COMPL MED, V9, P184, DOI 10.1016/j.jtcme.2018.01.001
   Roncero-Ramos I, 2018, J NUTR BIOCHEM, V62, P247, DOI 10.1016/j.jnutbio.2018.08.012
   Sandoval DA, 2015, PHYSIOL REV, V95, P513, DOI 10.1152/physrev.00013.2014
   Seal AD, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00040
   Shi XQ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0220-7
   Vamvini MT, 2016, J CLIN ENDOCR METAB, V101, P1989, DOI 10.1210/jc.2015-4141
   Wong THT, 2020, BRIT J NUTR, V124, P785, DOI 10.1017/S0007114520001750
NR 38
TC 9
Z9 9
U1 0
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 1532-8600
J9 METABOLISM
JI Metab.-Clin. Exp.
PD APR
PY 2022
VL 129
AR 155157
DI 10.1016/j.metabol.2022.155157
EA FEB 2022
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 2S0XU
UT WOS:000821525400003
PM 35114286
OA Bronze
DA 2025-04-28
ER

PT J
AU Huang, C
   Dumanovsky, T
   Silver, LD
   Nonas, C
   Bassett, MT
AF Huang, Christina
   Dumanovsky, Tamara
   Silver, Lynn D.
   Nonas, Cathy
   Bassett, Mary T.
TI Calories From Beverages Purchased at 2 Major Coffee Chains in New York
   City, 2007
SO PREVENTING CHRONIC DISEASE
LA English
DT Article
ID PORTION SIZE; ENERGY-INTAKE; CONSUMPTION; FOOD; MEAL; OVERWEIGHT;
   WEIGHT; WOMEN
AB Introduction
   Calorie intake from beverages has increased in the past decades, which most likely contributes to higher obesity rates. Although coffee chains have grown in popularity in recent years, few data examine the calorie contribution of these drinks. We examined afternoon beverage purchases in New York City at 2 major coffee chains and estimated the mean calorie content of these beverages.
   Methods
   We collected purchase receipts and brief surveys from adult customers at 42 Starbucks and 73 Dunkin' Donuts stores during the spring of 2007. For each purchase, we obtained the calorie content from the company's Web site; these values were adjusted to account for self-reported customization of the drink.
   Results
   We included 1,127 beverage purchases at Starbucks and 1,830 at Dunkin' Donuts in our analyses. Brewed coffee or tea averaged 63 kcal, and blended coffee beverages averaged 239 kcal. Approximately two-thirds of purchases at Starbucks and one-fourth of purchases at Dunkin' Donuts were blended coffee beverages.
   Conclusion
   Calories in blended coffee beverages are high; on average, customers bought 12% of a 2,000-kcal diet. Policy changes to provide for calorie posting at the point of purchase could increase customer awareness of the calories in these beverages; modifying standard formulations of blended coffee beverages, such as using low-fat milk or smaller serving sizes, would also reduce calorie content.
C1 [Huang, Christina; Dumanovsky, Tamara; Silver, Lynn D.; Nonas, Cathy; Bassett, Mary T.] New York City Dept Hlth & Mental Hyg, New York, NY 10007 USA.
   [Bassett, Mary T.] Doris Duke Charitable Fdn, New York, NY USA.
C3 New York City Department of Health & Mental Hygiene
RP Huang, C (corresponding author), New York City Dept Hlth & Mental Hyg, 2 Lafayette St,20th Fl,CN 46, New York, NY 10007 USA.
EM chuang@health.nyc.gov
RI Silver, Lynn/LPQ-9331-2024
OI Silver, Lynn/0000-0002-2680-7393
FU New York City DOHMH
FX This research was funded through the New York City DOHMH. We thank our
   colleagues at the New York City DOHMH for their valuable assistance:
   Thomas Matte for designing the study, Thomas Farley and Thomas R.
   Frieden for thoughtful comments on earlier drafts, and Rosalyne Tu for
   data analyses related to the study. We also thank Domingo Pinero and
   Kristie Lancaster of the Department of Nutrition, Food Studies, and
   Public Health at New York University for their role in data collection
   and Mary Northridge of the Mailman School of Public Health at Columbia
   University for her editorial comments. Both New York University and Dr
   Northridge received compensation for their work.
CR Almiron-Roig E, 2003, PHYSIOL BEHAV, V79, P767, DOI 10.1016/S0031-9384(03)00212-9
   [Anonymous], 2007, STARB MOV RED MILK
   [Anonymous], AM DRINKING BETTER L
   Bassett MT, 2008, AM J PUBLIC HEALTH, V98, P1457, DOI 10.2105/AJPH.2008.135020
   DellaValle DM, 2005, APPETITE, V44, P187, DOI 10.1016/j.appet.2004.11.003
   Diliberti N, 2004, OBES RES, V12, P562, DOI 10.1038/oby.2004.64
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326
   Flood JE, 2006, J AM DIET ASSOC, V106, P1984, DOI 10.1016/j.jada.2006.09.005
   Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Jeffery RW, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-27
   National Coffee Association, 2007, NAT COFF DRINK TREND
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Raynor HA, 2007, OBESITY, V15, P2311, DOI 10.1038/oby.2007.274
   Roberts M., 2005, NYC Vital Signs, V4, P1
   Rolls BJ, 2002, AM J CLIN NUTR, V76, P1207, DOI 10.1093/ajcn/76.6.1207
   Shields DH, 2004, J AM DIET ASSOC, V104, P650, DOI 10.1016/j.jada.2004.01.015
   Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12
   Wansink B, 2005, J NUTR EDUC BEHAV, V37, P242, DOI 10.1016/S1499-4046(06)60278-9
NR 21
TC 6
Z9 7
U1 0
U2 10
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1545-1151
J9 PREV CHRONIC DIS
JI Prev. Chronic Dis.
PD OCT
PY 2009
VL 6
IS 4
AR A118
PG 8
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA V20RY
UT WOS:000208158300008
PM 19754994
DA 2025-04-28
ER

PT J
AU Wu, CH
   Pan, CH
   Lee, CK
   Sheu, MJ
   Liu, FC
   Wang, GJ
   Wu, CH
AF Wu, Chi-Han
   Pan, Chun-Hsu
   Lee, Ching-Kuo
   Sheu, Ming-Jyh
   Liu, Fon-Chang
   Wang, Guei-Jane
   Wu, Chieh-Hsi
TI Antiobesity and antihyperlipidaemic effects of Yan-Sheng-Yin in animals
   and humans
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Adipocyte differentiation; Atherogenesis; Hyperlipidaemia; Obesity;
   Yan-Sheng-Yin
ID ACTIVATED PROTEIN-KINASE; ADIPOSE-SPECIFIC PROTEIN; HIBISCUS-SABDARIFFA
   L.; HIGH-FAT DIET; PROTOCATECHUIC ACID; ADIPOCYTE DIFFERENTIATION;
   RAT-LIVER; PLASMA-CONCENTRATIONS; INSULIN SENSITIVITY; CHLOROGENIC ACID
AB Yan-Sheng-Yin (YSY), a Chinese natural dietary supplement that promotes good health, is entirely composed of natural foods. Whether YSY is a potential adjuvant intervention for reducing hyperlipidaemia, atherogenesis, or obesity is unclear. This study evaluated the inhibitory effects and mechanisms of YSY for hyperlipidaemia, atherogenesis, and obesity. Experimental results showed that YSY reduced body weight, hyperlipidaemia, fatty liver, and atherogenesis in hyperlipidaemic mice. In addition, YSY promoted lipid metabolism by inducing adiponectin secretion and activation (phosphorylation) of 5' adenosine monophosphate-activated protein kinase (AMPK) and by suppressing the activation of acetylCoA carboxylase (ACC) and HMG-CoA reductase (HMGCR). Moreover, YSY inhibited adipocyte differentiation by suppressing peroxisome proliferator-activated receptor gamma (PPAR-gamma) and CCAAT/enhancer-binding proteins (C/EBPs). Furthermore, the antihyperlipidaemic effect of YSY was observed in the clinical trial. Our findings suggest that YSY is an adjuvant intervention for treating and preventing hyperlipidaemia, atherogenesis, and obesity. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Wu, Chi-Han; Sheu, Ming-Jyh; Liu, Fon-Chang; Wu, Chieh-Hsi] China Med Univ, Sch Pharm, Taichung 40402, Taiwan.
   [Pan, Chun-Hsu; Lee, Ching-Kuo; Wu, Chieh-Hsi] Taipei Med Univ, Dept Pharm, 250 Wu Hsing St, Taipei 11031, Taiwan.
   [Wang, Guei-Jane] China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan.
C3 China Medical University Taiwan; Taipei Medical University; China
   Medical University Taiwan
RP Wu, CH (corresponding author), Taipei Med Univ, Dept Pharm, 250 Wu Hsing St, Taipei 11031, Taiwan.
EM chhswu@tmu.edu.tw
RI Pan, Chun-Hsu/H-4358-2019; Wu, Chieh-Hsi/AAJ-1173-2020; Sheu,
   Ming-jyh/C-6013-2012
OI Pan, Chun-Hsu/0000-0001-8700-583X; Wu, Chieh-Hsi/0000-0002-2006-8243
FU Taipei Medical University [TMU102-AE1-B15]; Ministry of Science and
   Technology, Taiwan [MOST 104-2320-B-038-026]
FX This study was supported by research grants from Taipei Medical
   University (TMU102-AE1-B15) and the Ministry of Science and Technology,
   Taiwan (MOST 104-2320-B-038-026). We thank the Taipei Medical University
   Office of Research and Development for improving the manuscript through
   their editing service.
CR Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Aziz Z, 2013, J ETHNOPHARMACOL, V150, P442, DOI 10.1016/j.jep.2013.09.042
   BEG ZH, 1973, BIOCHEM BIOPH RES CO, V54, P1362, DOI 10.1016/0006-291X(73)91137-6
   Beltrán-Debón R, 2010, PHYTOMEDICINE, V17, P186, DOI 10.1016/j.phymed.2009.08.006
   Bisen PS, 2010, CURR MED CHEM, V17, P2419, DOI 10.2174/092986710791698495
   Bjomtorp P., 1974, HORMONE METABOLIC S, V4, P77
   CARLSON CA, 1973, J BIOL CHEM, V248, P378
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi SW, 2007, J MICROBIOL BIOTECHN, V17, P1970
   CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x
   Cui T, 2006, J AGR FOOD CHEM, V54, P4574, DOI 10.1021/jf060310m
   FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279
   Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200
   Fukushima M, 2001, EXP BIOL MED, V226, P758, DOI 10.1177/153537020222600808
   Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200
   Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064
   Harini R, 2010, REDOX REP, V15, P71, DOI 10.1179/174329210X12650506623285
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595
   Jose Jimmy, 2014, Oman Med J, V29, P351, DOI 10.5001/omj.2014.93
   Kuem N, 2014, MOL NUTR FOOD RES, V58, P2166, DOI 10.1002/mnfr.201400159
   Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50
   Le Lay S, 2004, BIOCHEM SOC T, V32, P103, DOI 10.1042/BST0320103
   Leiherer A, 2013, VASC PHARMACOL, V58, P3, DOI 10.1016/j.vph.2012.09.002
   Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063
   Lin MC, 2015, J AGR FOOD CHEM, V63, P235, DOI 10.1021/jf505303s
   Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094
   Mallamaci F, 2002, J NEPHROL, V15, P507
   Manning S, 2014, THER ADV CHRONIC DIS, V5, P135, DOI 10.1177/2040622314522848
   Mosshammer D, 2014, BRIT J CLIN PHARMACO, V78, P454, DOI 10.1111/bcp.12360
   Mottaghi A, 2014, SCAND J IMMUNOL, V80, P151, DOI 10.1111/sji.12190
   Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200
   Okabe Y, 2014, PHYTOMEDICINE, V21, P800, DOI 10.1016/j.phymed.2014.01.014
   Olvera-García V, 2008, J FOOD SCI, V73, pT75, DOI 10.1111/j.1750-3841.2008.00781.x
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Pan CH, 2013, J SCI FOOD AGR, V93, P1278, DOI 10.1002/jsfa.5882
   Rogge BP, 2013, J AM COLL CARDIOL, V62, P1683, DOI 10.1016/j.jacc.2013.04.081
   Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120
   Scazzocchio B, 2011, DIABETES, V60, P2234, DOI 10.2337/db10-1461
   Seo JB, 2004, J BIOL CHEM, V279, P22108, DOI 10.1074/jbc.M400238200
   Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432
   TSI D, 1995, PLANTA MED, V61, P18, DOI 10.1055/s-2006-957990
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang DL, 2010, J AGR FOOD CHEM, V58, P12722, DOI 10.1021/jf103427j
   Wang XS, 1999, CHIN J CHIN MAT MED, V24, P739
   Wu CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095452
   Yang WS, 2002, OBES RES, V10, P1104, DOI 10.1038/oby.2002.150
   YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168
   Zeng F, 2013, J FOOD SCI, V78, pH1470, DOI 10.1111/1750-3841.12226
   Zhang JY, 2013, J ETHNOPHARMACOL, V148, P563, DOI 10.1016/j.jep.2013.04.053
NR 49
TC 1
Z9 1
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JUN
PY 2016
VL 24
BP 173
EP 182
DI 10.1016/j.jff.2016.04.004
PG 10
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA DP3BJ
UT WOS:000378367100018
DA 2025-04-28
ER

PT J
AU Naidoo, P
   Islam, MS
AF Naidoo, Pragalathan
   Islam, Md Shahidul
TI Development of an alternative non-obese non-genetic rat model of type 2
   diabetes using caffeine and streptozotocin
SO PHARMACOLOGICAL REPORTS
LA English
DT Article
DE Caffeine; Streptozotocin; Non-obese; Type 2 diabetes; Rat model
ID INSULIN-SECRETION; CLINICAL CHARACTERISTICS; RODENT MODELS; MELLITUS;
   DIET; PREVENTION; COFFEE; OVEREXPRESSION; GLIBENCLAMIDE; CONSUMPTION
AB Background: The aim of the present study was to develop an alternative non-obese non-genetic rat model of type 2 diabetes (T2D).
   Methods: Six-week-old male SD rats were randomly divided into six groups, namely: Normal Control (NC), Diabetic Control (DBC), Caffeine 5 mg/kg BW + STZ (CAF5), Caffeine 10 mg/kg BW + STZ (CAF10), Caffeine 20 mg/kg BW + STZ (CAF20) and Caffeine 40 mg/kg BW + STZ (CAF40) and were fed a normal rat pellet diet and drinking water ad libitum throughout the experimental period. After a one week acclimatization period, diabetes was induced in the animals in DBC and all CAF groups with an injection (i.p.) of the respective dosages of caffeine (mg/kg BW) 15 min before the injection of STZ (65 mg/kg BW) when normal saline was injected to the DBC group instead of caffeine. The NC group received normal saline and buffer instead of caffeine and STZ, respectively. One week after the STZ injection, animals with non-fasting blood glucose >300 mg/dl were considered as diabetic. Three weeks after the STZ injection, the animals in the CAF5 and CAF10 groups were eliminated from the study due to the severity of diabetes and the experiment was continued with the remainder groups for a 13 weeks period.
   Results and conclusion: The data of food and fluid intake, body weight, blood glucose, glucose tolerance test, HOMA-IR, HOMA-beta, serum insulin, fructosamine, lipid profile and organ specific enzymes, antidiabetic drug response tests, and pancreatic histopathology suggest that CAF20 group can be a better alternative non-genetic model of non-obese T2D. (C) 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
C1 [Naidoo, Pragalathan; Islam, Md Shahidul] Univ KwaZulu Natal, Sch Life Sci, Dept Biochem, Durban, South Africa.
C3 University of Kwazulu Natal
RP Islam, MS (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Dept Biochem, Westville Campus, Durban, South Africa.
EM islamd@ukzn.ac.za
RI Islam, Shahidul/N-5897-2013
OI Naidoo, Pragalathan/0000-0002-8905-5926
FU Competitive Research Grant (UCRG) from the Research Office, University
   of KwaZulu-Natal Natal (Westville Campus); Incentive Grant for Rated
   Researchers from the National Research Foundation (NRF), Pretoria, South
   Africa [IFR2011041000003]; Grant Support for Young Men and Women
   Researchers from the National Research Foundation (NRF), Pretoria, South
   Africa [UID 74297]
FX This study was supported by a Competitive Research Grant (UCRG 2010 and
   UCRG 2011) from the Research Office, University of KwaZulu-Natal Natal
   (Westville Campus) and an Incentive Grant for Rated Researchers
   (IFR2011041000003) and Grant Support for Young Men and Women Researchers
   (UID 74297) from the National Research Foundation (NRF), Pretoria, South
   Africa.
CR Ainscow EK, 2000, DIABETES, V49, P1149, DOI 10.2337/diabetes.49.7.1149
   Alvarsson M, 2005, DIABETOLOGIA, V48, P2262, DOI 10.1007/s00125-005-1929-6
   American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   BILLINGHAM MS, 1989, DIABETES RES CLIN EX, V11, P13
   Bonner-Weir S., 1989, J CLIN INVEST, V71, P544
   Chen D, 2005, DIABETES OBES METAB, V7, P307, DOI 10.1111/j.1463-1326.2004.00392.x
   Cho NH, 2007, DIABETES CARE, V30, P2566, DOI 10.2337/dc07-0106
   Daniele SM, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-15
   De Carvalho JAM, 2011, CLIN CHIM ACTA, V412, P1407, DOI 10.1016/j.cca.2011.04.015
   DeFronzo RA, 1997, DIABETES REV, V5, P177
   Evliyaoglu O, 2011, CELL BIOCHEM FUNCT, V29, P506, DOI 10.1002/cbf.1779
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Harris E.H., 2005, Clin. Diabetes, V23, P115, DOI [10.2337/diaclin.23.3.115, DOI 10.2337/DIACLIN.23.3.115]
   Hudson OD, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-174
   Islam MS, 2007, PHARMACOLOGY, V79, P243, DOI 10.1159/000101989
   Islam MS, 2009, METHOD FIND EXP CLIN, V31, P249, DOI 10.1358/mf.2009.31.4.1362513
   Ito H, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-83
   Judi L, 2010, ANN SAUDI MED, V30, P25, DOI [10.5144/0256-4947.59369, 10.4103/0256-4947.59369]
   Kagami K, 2008, J PHARM PHARMACOL, V60, P1161, DOI 10.1211/jpp.60.9.0007
   Kim DJ, 2007, DIABETES RES CLIN PR, V77, pS252, DOI 10.1016/j.diabres.2007.01.067
   Kitahara Y, 2002, METABOLISM, V51, P1452, DOI 10.1053/meta.2002.35195
   LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234
   Masiello P, 1998, DIABETES, V47, P224, DOI 10.2337/diabetes.47.2.224
   Morinaga H, 2008, J VET MED SCI, V70, P1239, DOI 10.1292/jvms.70.1239
   Naramura T, 2006, BIOL PHARM BULL, V29, P1167, DOI 10.1248/bpb.29.1167
   Oka K, 2007, YAKUGAKU ZASSHI, V127, P1825, DOI 10.1248/yakushi.127.1825
   Olatunbosun ST, 2000, J NATL MED ASSOC, V92, P265
   Park S, 2007, METABOLISM, V56, P599, DOI 10.1016/j.metabol.2006.12.004
   PORTHA B, 1989, DIABETES METAB, V15, P61
   Shinohara M, 2000, Int J Exp Diabetes Res, V1, P89, DOI 10.1155/EDR.2000.89
   Shrestha S., 2008, Journal of Nepal Association for Medical Laboratory Sciences, P11
   Srinivasan K, 2007, INDIAN J MED RES, V125, P451
   Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004
   Steyn NP, 2004, PUBLIC HEALTH NUTR, V7, P147, DOI 10.1079/PHN2003586
   TAKEDA N, 1991, DIABETES RES CLIN PR, V11, P99, DOI 10.1016/0168-8227(91)90098-X
   U.S. Department of Agriculture, 1989, AN WELF ENF REP FISC
   Urakami T, 2013, DIABETES RES CLIN PR, V99, P105, DOI 10.1016/j.diabres.2012.11.021
   Vaag A, 2007, APPL PHYSIOL NUTR ME, V32, P912, DOI 10.1139/H07-100
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Ventura-Sobrevilla J, 2011, Proc West Pharmacol Soc, V54, P5
   WEIR G C, 1986, Diabetes Metabolism Reviews, V2, P125
   Whitehead N, 2013, J HUM NUTR DIET, V26, P111, DOI 10.1111/jhn.12033
   Wilson RD, 2012, PHARMACOL REP, V64, P129, DOI 10.1016/S1734-1140(12)70739-9
   Yamamoto Y, 2008, EXP ANIM TOKYO, V57, P385, DOI 10.1538/expanim.57.385
NR 45
TC 8
Z9 8
U1 0
U2 16
PU POLISH ACAD SCIENCES INST PHARMACOLOGY
PI KRAKOW
PA SMETNA 12, 31-343 KRAKOW, POLAND
SN 1734-1140
J9 PHARMACOL REP
JI Pharmacol. Rep.
PD AUG
PY 2014
VL 66
IS 4
BP 585
EP 593
DI 10.1016/j.pharep.2014.02.019
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA AK4LG
UT WOS:000338395600009
PM 24948058
DA 2025-04-28
ER

PT J
AU Raigond, P
   Jayanty, SS
   Parmar, V
   Dutt, S
   Changan, SS
   Luthra, SK
   Singh, B
AF Raigond, Pinky
   Jayanty, Sastry S.
   Parmar, Vandana
   Dutt, Som
   Changan, Sushil S.
   Luthra, Satish Kumar
   Singh, Brajesh
TI Health-Promoting compounds in Potatoes: Tuber exhibiting great potential
   for human health
SO FOOD CHEMISTRY
LA English
DT Review
DE Antidiabetic; Anticancerous; Antihypertensive; Anti-inflammatory; Gut
   health; Satiety
ID PRO-APOPTOTIC PROPERTIES; NF-KAPPA-B; CHLOROGENIC ACID; RESISTANT
   STARCH; CANCER CELLS; ANTIOXIDANT ACTIVITY; ACTIVATOR PROTEIN-1;
   BIOACTIVE COMPOUNDS; LIPID-METABOLISM; FLESHED POTATOES
AB Potatoes are consumed worldwide because of their high accessibility, low cost, taste, and diversity of cooking methods. The high carbohydrate content of potatoes masks the presence of-vitamins, polyphenols, minerals, amino acids, lectins and protein inhibitors in the minds of consumers. The consumption of potatoes faces challenges among health-conscious people. This review paper attempted to provide up-to-date information on new metabolites reported in potatoes that play role in disease prevention and overall human well-being. We tried to compile information on antidiabetic, antihypertensive, anticancer, antiobesity, antihyperlipidemic, and anti-inflammatory potential of potato along with role in improving gut health and satiety. In-vitro studies, human cell culture, and experimental animal and human clinical studies showed potatoes to exhibit a variety of health -enhancing properties. This article will not only popularize potato as a healthy food, but will also improve its use as a staple for the foreseeable future.
C1 [Raigond, Pinky; Parmar, Vandana; Dutt, Som; Changan, Sushil S.; Singh, Brajesh] ICAR Cent Potato Res Inst, Div Crop Physiol Biochem & Post Harvest Technol, Shimla, Himachal Prades, India.
   [Raigond, Pinky] ICAR Natl Res Ctr Pomegranate, Solapur, India.
   [Jayanty, Sastry S.] Colorado State Univ, Dept Hort & LA, Ft Collins, CO USA.
   [Luthra, Satish Kumar] ICAR Cent Potato Res Inst Reg Stn, Div Crop Improvement, Modipuram, Uttar Pradesh, India.
C3 Indian Council of Agricultural Research (ICAR); ICAR - Central Potato
   Research Institute; Indian Council of Agricultural Research (ICAR); ICAR
   - National Research Centre for Pomegranate; Colorado State University
   System; Colorado State University Fort Collins; Indian Council of
   Agricultural Research (ICAR); ICAR - Central Potato Research Institute
RP Raigond, P (corresponding author), ICAR Natl Res Ctr Pomegranate, Solapur, India.
EM Pinky.Raigond@icar.gov.in
RI Dutt, Som/AFU-5684-2022; CHANGAN, SUSHIL/AHA-5822-2022; Raigond,
   Pinky/AAB-6525-2020; Jayanty, Sastry/X-7953-2018
CR Alfa MJ, 2018, CLIN NUTR, V37, P797, DOI 10.1016/j.clnu.2017.03.025
   [Anonymous], 2019, STANDARD REFERENCE L
   [Anonymous], 1998, ORIENTAL MED
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Åsli LA, 2018, BRIT J NUTR, V119, P1408, DOI 10.1017/S0007114518000788
   Asokan SM, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2529-1
   Asokan SM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040779
   Asokan SM, 2018, BIOMED PHARMACOTHER, V107, P1667, DOI 10.1016/j.biopha.2018.08.070
   BAILEY CJ, 1989, DIABETES CARE, V12, P553, DOI 10.2337/diacare.12.8.553
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Best CH, 1924, ENDOCRINOLOGY, V8, P617, DOI 10.1210/endo-8-5-617
   Brajesh Singh Brajesh Singh, 2016, Potato Journal, V43, P86
   Burgos G, 2020, POTATO CROP: ITS AGRICULTURAL, NUTRITIONAL AND SOCIAL CONTRIBUTION TO HUMANKIND, P37, DOI 10.1007/978-3-030-28683-5_2
   Chakravarty A, 2021, LWT-FOOD SCI TECHNOL, V145, DOI 10.1016/j.lwt.2021.111445
   Charepalli V, 2015, J NUTR BIOCHEM, V26, P1641, DOI 10.1016/j.jnutbio.2015.08.005
   Chen YJ, 2021, MOLECULES, V26, DOI 10.3390/molecules26216577
   Cherbut C, 1997, BRIT J NUTR, V77, P33, DOI 10.1017/S0007114500002865
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Chrubasik S, 2006, PHYTOMEDICINE, V13, P596, DOI 10.1016/j.phymed.2005.10.009
   Chrubasik S, 2006, PHYTOMEDICINE, V13, P11, DOI 10.1016/j.phymed.2005.03.005
   Collip JB, 1923, J BIOL CHEM, V56, P513
   Dalamu, 2015, INDIAN J HORTIC, V72, P447, DOI 10.5958/0974-0112.2015.00090.0
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Dupuis JH, 2019, AM J POTATO RES, V96, P127, DOI 10.1007/s12230-018-09696-2
   Dutt S., 2020, POTATO, DOI [DOI 10.1007/978-981-15-7662-1_4, 10.1007/978-981-15-7662-1_4]
   Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200
   Friedman M, 2005, J AGR FOOD CHEM, V53, P6162, DOI 10.1021/jf050620p
   Friedman M, 2015, J AGR FOOD CHEM, V63, P3323, DOI 10.1021/acs.jafc.5b00818
   Gu T, 2021, TOXINS, V13, DOI 10.3390/toxins13030210
   Han KH, 2008, ANN NUTR METAB, V52, P1, DOI 10.1159/000114288
   Han KH, 2006, BIOSCI BIOTECH BIOCH, V70, P1432, DOI 10.1271/bbb.50670
   Hashimoto N, 2006, J NUTR SCI VITAMINOL, V52, P445, DOI 10.3177/jnsv.52.445
   Hayashi K, 2006, FOOD SCI TECHNOL RES, V12, P22, DOI 10.3136/fstr.12.22
   Hu WS, 2019, ENVIRON TOXICOL, V34, P5, DOI 10.1002/tox.22651
   Hu WS, 2015, INT J MOL SCI, V16, P10158, DOI 10.3390/ijms160510158
   Huang CS, 1997, P NATL ACAD SCI USA, V94, P11957, DOI 10.1073/pnas.94.22.11957
   Iablokov V, 2010, DIGEST DIS SCI, V55, P3078, DOI 10.1007/s10620-010-1158-9
   Kalita D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191025
   Karim Z, 2017, FOOD CHEM, V217, P498, DOI 10.1016/j.foodchem.2016.08.058
   Kaspar KL, 2011, J NUTR, V141, P108, DOI 10.3945/jn.110.128074
   Kennedy AR, 1998, PHARMACOL THERAPEUT, V78, P167, DOI 10.1016/S0163-7258(98)00010-2
   Kenny OM, 2013, LIFE SCI, V92, P775, DOI 10.1016/j.lfs.2013.02.006
   Kim NJ, 2012, FOOD SCI BIOTECHNOL, V21, P1301, DOI 10.1007/s10068-012-0171-5
   Komarnytsky S, 2011, INT J OBESITY, V35, P236, DOI 10.1038/ijo.2010.192
   Kowalczewski PL, 2023, NUTRIENTS, V15, DOI 10.3390/nu15010114
   Kowalczewski PL, 2022, CRIT REV PLANT SCI, V41, P52, DOI 10.1080/07352689.2022.2057749
   Kowalczewski PL, 2021, MOLECULES, V26, DOI 10.3390/molecules26040852
   Kowalczewski PL, 2019, OPEN LIFE SCI, V14, P150, DOI 10.1515/biol-2019-0017
   Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459
   Kubow S, 2014, MOL NUTR FOOD RES, V58, P2235, DOI 10.1002/mnfr.201400013
   Kujawska M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020259
   Kumar Sunil, 2011, Pharmacogn Rev, V5, P19, DOI 10.4103/0973-7847.79096
   Langner E., 2009, Journal of Pre-Clinical and Clinical Research, V3, P036
   Lee K.-G., 2015, CHEM-BIOL INTERACT
   Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d
   Li S., 2021, CURR DEV NUTR, V5, P344, DOI [10.1093/cdn/nzab037_054, DOI 10.1093/CDN/NZAB037_054]
   Li SY, 2021, J NUTR BIOCHEM, V93, DOI 10.1016/j.jnutbio.2021.108616
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Liyanage R, 2008, BIOSCI BIOTECH BIOCH, V72, P943, DOI 10.1271/bbb.70593
   Liyanage R, 2009, EUR J LIPID SCI TECH, V111, P884, DOI 10.1002/ejlt.200800264
   Lu MK, 2010, BIOL PHARM BULL, V33, P1685, DOI 10.1248/bpb.33.1685
   Lv C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088167
   Madiwale GP, 2012, J AGR FOOD CHEM, V60, P11088, DOI 10.1021/jf303528p
   Madiwale GP, 2011, J AGR FOOD CHEM, V59, P8155, DOI 10.1021/jf201073g
   Mäkinen S, 2008, J AGR FOOD CHEM, V56, P9875, DOI 10.1021/jf8016817
   Mäkinen S, 2016, J FUNCT FOODS, V25, P160, DOI 10.1016/j.jff.2016.05.016
   McKeown L.A., 2000, J AM MED ASS
   Mishra T, 2020, POTATO RES, V63, P323, DOI 10.1007/s11540-019-09442-z
   Mohsenikia M, 2013, EUR J PHARMACOL, V718, P1, DOI 10.1016/j.ejphar.2013.09.015
   Morita T, 1997, J NUTR, V127, P470, DOI 10.1093/jn/127.3.470
   Morton LW, 2000, CLIN EXP PHARMACOL P, V27, P152, DOI 10.1046/j.1440-1681.2000.03214.x
   Nakajima S, 2011, J AGR FOOD CHEM, V59, P9491, DOI 10.1021/jf200988f
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   Nielsen TS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092137
   Nofrarías M, 2007, NUTRITION, V23, P861, DOI 10.1016/j.nut.2007.08.016
   Nowson CA, 2004, J NUTR, V134, P2322, DOI 10.1093/jn/134.9.2322
   Ombra MN, 2015, NAT PROD RES, V29, P1087, DOI 10.1080/14786419.2014.981183
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Pan B, 2016, CANCER MED-US, V5, P3214, DOI 10.1002/cam4.916
   Parr AJ, 2005, J AGR FOOD CHEM, V53, P5461, DOI 10.1021/jf050298i
   Paturi G, 2012, J FOOD SCI, V77, pH216, DOI 10.1111/j.1750-3841.2012.02911.x
   Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323
   Perla V, 2013, FOOD CHEM, V138, P1574, DOI 10.1016/j.foodchem.2012.09.125
   Pihlanto A, 2008, FOOD CHEM, V109, P104, DOI 10.1016/j.foodchem.2007.12.023
   Raigond P., 2020, SOUV GLOB POT CONCL, P117
   Raigond P., 2016, BIGUANIDE RELATED CO
   Raigond P, 2018, J FOOD COMPOS ANAL, V74, P82, DOI 10.1016/j.jfca.2018.09.001
   Raigond P, 2017, INDIAN J HORTIC, V74, P103, DOI 10.5958/0974-0112.2017.00023.8
   Raigond P, 2015, J SCI FOOD AGR, V95, P1968, DOI 10.1002/jsfa.6966
   Reddivari L., 2017, USDA PROJ DIR M LAS
   Reddivari L., 2020, CURR DEV NUTR, V4, P460
   Reddivari L., 2013, FASEB J OFFICIAL PUB, V27, P1056
   Reddivari L, 2007, CARCINOGENESIS, V28, P2227, DOI 10.1093/carcin/bgm117
   Rhoades R. E., 1992, NATL GEOGRAPHIC MAGA, V161, P668
   Robert L, 2006, EUR J NUTR, V45, P267, DOI 10.1007/s00394-006-0594-y
   Saleem F., 2010, ANTIDIABETIC POTENTI, P1
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Shih YW, 2007, J AGR FOOD CHEM, V55, P11035, DOI 10.1021/jf072423r
   Shin JS, 2016, J CELL BIOCHEM, V117, P2327, DOI 10.1002/jcb.25530
   Sido A, 2017, J NUTR BIOCHEM, V43, P11, DOI 10.1016/j.jnutbio.2017.01.012
   Singh B., 2020, POTATO, P1, DOI DOI 10.1007/978-981-15-7662-1_1
   Singh N, 2005, CLIN CHIM ACTA, V353, P165, DOI 10.1016/j.cccn.2004.10.016
   Singh N, 2008, CHEM-BIOL INTERACT, V173, P97, DOI 10.1016/j.cbi.2008.03.008
   Skinner M. A., 2002, J PEDIATR-US, V20, P25
   Spielmann J, 2009, J ANIM PHYSIOL AN N, V93, P400, DOI 10.1111/j.1439-0396.2008.00819.x
   Strugala P, 2019, MOLECULES, V24, DOI 10.3390/molecules24173126
   Sun HW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/805926
   Sun XF, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700536
   Sun Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00779
   Tajaddini Aynaz, 2015, Asian Pac J Cancer Prev, V16, P4185
   Thomassen LV, 2011, APPL MICROBIOL BIOT, V90, P873, DOI 10.1007/s00253-011-3092-y
   Umadevi M., 2013, J MED PLANTS STUDIES, V1, P16
   Vanamala JKP, 2019, AM J POTATO RES, V96, P177, DOI 10.1007/s12230-018-09700-9
   Vinson JA, 2012, J AGR FOOD CHEM, V60, P6749, DOI 10.1021/jf2045262
   Visvanathan R, 2016, J SCI FOOD AGR, V96, P4850, DOI 10.1002/jsfa.7848
   Warner J., 2002, WEBMD MED NEWS  1016
   Wu J, 2020, J FOOD QUALITY, V2020, DOI 10.1155/2020/8889555
   Yang SA, 2006, FOOD CHEM TOXICOL, V44, P839, DOI 10.1016/j.fct.2005.11.007
   Zhang H, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600928
   Zhang ZS, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111739
NR 120
TC 14
Z9 15
U1 10
U2 29
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD OCT 30
PY 2023
VL 424
AR 136368
DI 10.1016/j.foodchem.2023.136368
EA MAY 2023
PG 14
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA J4PS2
UT WOS:001009454400001
PM 37210846
DA 2025-04-28
ER

PT J
AU Li, J
   Chen, QY
   Zhai, XM
   Wang, D
   Hou, YJ
   Tang, M
AF Li, Jie
   Chen, Qiyang
   Zhai, Xiuming
   Wang, Dan
   Hou, Yujia
   Tang, Min
TI Green tea aqueous extract (GTAE) prevents high-fat diet-induced obesity
   by activating fat browning
SO FOOD SCIENCE & NUTRITION
LA English
DT Article
DE BAT; browning; green tea; Ing-WAT; low-grade systemic inflammation;
   obesity
ID KAPPA-B ACTIVATION; ADIPOSE-TISSUE; NONALCOHOLIC STEATOHEPATITIS;
   INSULIN-RESISTANCE; METABOLIC SYNDROME; MICE; CATECHINS; EXPRESSION;
   INFLAMMATION; OVERWEIGHT
AB Adipose browning leads to increased energy expenditure and reduced adiposity and has, therefore, become an attractive therapeutic strategy for obesity. In this study, we elucidated the effect of green tea aqueous extract (GTAE) on the browning of inguinal white adipose tissue (Ing-WAT) and brown adipose tissue (BAT) in high-fat diet (HFD)-fed mice. The main phytochemical components identified in GTAE through high-performance liquid chromatography (HPLC) included (-)-gallocatechin, (-)-epigallocatechin, (-)-catechin, (-)-epigallocatechin-3-gallate, caffeine, (-)-epicatechin, (-)-gallocatechin gallate, and (-)-epicatechin-3-gallate. Daily supplementation with 1% GTAE for 12 weeks markedly reduced bodyweight gain, systemic inflammation, oxidative stress, and improved insulin resistance. Additionally, histological analysis revealed that dietary supplementation with 1% GTAE reversed HFD-induced adipocyte size and hepatic steatosis. These effects were associated with activation of browning in the Ing-WAT and BAT, which mediate systemic metabolic dysfunction in HFD-fed mice. Taken together, our data support the use of GTAE, a natural product, for the attenuation of obesity through the activation of fat browning.
C1 [Li, Jie; Zhai, Xiuming; Hou, Yujia; Tang, Min] Chongqing Acad Agr Sci, Res Inst Tea, Chongqing 402160, Peoples R China.
   [Chen, Qiyang; Wang, Dan] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China.
C3 Chongqing Academy of Agricultural Sciences; Southwest University - China
RP Hou, YJ; Tang, M (corresponding author), Chongqing Acad Agr Sci, Res Inst Tea, Chongqing 402160, Peoples R China.
EM 564661213@qq.com; tangmin945@163.com
RI Tang, Min/KOC-3090-2024
FU Natural Science Foundation Project of Chongqing Science and Technology
   Bureau of Yongchuan District [2019nb0103]; Chongqing Science and
   Technology Commission Basic and Frontier Research Project
   [cstc2019jcyj-msxmX0553]
FX Natural Science Foundation Project of Chongqing Science and Technology
   Bureau of Yongchuan District, Grant/Award Number: Ycstc and 2019nb0103;
   Chongqing Science and Technology Commission Basic and Frontier Research
   Project, Grant/Award Number: cstc2019jcyj-msxmX0553
CR Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Asghar A, 2017, CELL IMMUNOL, V315, P18, DOI 10.1016/j.cellimm.2017.03.001
   Azhar Y, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0150-6
   Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204
   Bartelt A, 2012, CURR OPIN LIPIDOL, V23, P190, DOI 10.1097/MOL.0b013e328352dcef
   Bolin AP, 2020, J NUTR BIOCHEM, V83, DOI 10.1016/j.jnutbio.2020.108429
   Bolin AP, 2020, J NUTR BIOCHEM, V78, DOI 10.1016/j.jnutbio.2019.108322
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chou YC, 2018, J AGR FOOD CHEM, V66, P9697, DOI 10.1021/acs.jafc.8b02719
   Cohen P, 2015, DIABETES, V64, P2346, DOI 10.2337/db15-0318
   Cunha CA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/635470
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Dey P, 2019, J NUTR BIOCHEM, V67, P78, DOI 10.1016/j.jnutbio.2019.01.017
   Gao WQ, 2018, BIOMED PHARMACOTHER, V103, P637, DOI 10.1016/j.biopha.2018.04.043
   Hayat K, 2015, CRIT REV FOOD SCI, V55, P939, DOI 10.1080/10408398.2012.678949
   Bautista RJH, 2019, BIOMED PHARMACOTHER, V111, P503, DOI 10.1016/j.biopha.2018.12.108
   Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x
   Kim SH, 2016, DIABETES METAB J, V40, P12, DOI 10.4093/dmj.2016.40.1.12
   Li JH, 2018, J NUTR BIOCHEM, V53, P58, DOI 10.1016/j.jnutbio.2017.10.016
   Li JH, 2017, J NUTR BIOCHEM, V41, P34, DOI 10.1016/j.jnutbio.2016.12.007
   Li Y, 2020, J NUTR BIOCHEM, V78, DOI 10.1016/j.jnutbio.2019.108324
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4
   Ma H, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104279
   Marinovic MP, 2015, TOXICOL IN VITRO, V29, P1766, DOI 10.1016/j.tiv.2015.07.014
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McMillan AC, 2015, CURR OPIN ENDOCRINOL, V22, P347, DOI 10.1097/MED.0000000000000191
   Morgen CS, 2014, NAT REV ENDOCRINOL, V10, P513, DOI 10.1038/nrendo.2014.124
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Neyrinck AM, 2017, J NUTR BIOCHEM, V49, P15, DOI 10.1016/j.jnutbio.2017.07.008
   Nomura S, 2008, J NUTR BIOCHEM, V19, P840, DOI 10.1016/j.jnutbio.2007.11.005
   Okla M, 2017, ADV NUTR, V8, P473, DOI 10.3945/an.116.014332
   Ozguven S, 2016, EUR J NUCL MED MOL I, V43, P355, DOI 10.1007/s00259-015-3166-7
   Poekes L, 2015, CLIN SCI, V129, P933, DOI 10.1042/CS20150339
   Ren J, 2021, PHYSIOL REV, V101, P1745, DOI 10.1152/physrev.00030.2020
   Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869
   Sae-Tan S, 2015, J FUNCT FOODS, V14, P210, DOI 10.1016/j.jff.2015.01.036
   Sampath C, 2017, BIOMED PHARMACOTHER, V87, P73, DOI 10.1016/j.biopha.2016.12.082
   Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643
   Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022
   Dinh TC, 2019, DIAB MET SYND CLIN R, V13, P1667, DOI 10.1016/j.dsx.2019.03.021
   Vasileva LV, 2020, PHARMACOL RES, V156, DOI 10.1016/j.phrs.2020.104760
   Wang GX, 2015, TRENDS ENDOCRIN MET, V26, P231, DOI 10.1016/j.tem.2015.03.002
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Zhu J, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103621
NR 48
TC 4
Z9 5
U1 3
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2048-7177
J9 FOOD SCI NUTR
JI Food Sci. Nutr.
PD DEC
PY 2021
VL 9
IS 12
BP 6548
EP 6558
DI 10.1002/fsn3.2580
EA OCT 2021
PG 11
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA XM1DN
UT WOS:000704204900001
PM 34925784
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Almoosawi, S
   Fyfe, L
   Ho, C
   Al-Dujaili, E
AF Almoosawi, Suzana
   Fyfe, Lorna
   Ho, Clement
   Al-Dujaili, Emad
TI The effect of polyphenol-rich dark chocolate on fasting capillary whole
   blood glucose, total cholesterol, blood pressure and glucocorticoids in
   healthy overweight and obese subjects
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Dark chocolate; Glucose; Blood pressure; Cholesterol; Glucocorticoids;
   Obesity
ID BODY-MASS INDEX; URINARY FREE CORTISOL; METABOLIC-SYNDROME; CHLOROGENIC
   ACID; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; INSULIN SENSITIVITY;
   NITRIC-OXIDE; INTERMEDIATE PHENOTYPE; DEPENDENT VASODILATION;
   ESSENTIAL-HYPERTENSION
AB Numerous studies indicate that polyphenol-rich chocolate reduces fasting blood glucose, blood pressure (BP) and total cholesterol in healthy individuals and hypertensives with or without glucose intolerance. The aim of the present study was to investigate the effect of two doses of polyphenol-rich dark chocolate (DC) on fasting capillary whole blood glucose, total cholesterol and BP and to examine whether improvements in these parameters are associated with changes in adrenocorticoid excretion in overweight and obese individuals. The study used a randomised, single-blind, cross-over design where fourteen overweight and obese subjects were randomised to either take 20 g DC with 500 mg polyphenols then 20 g DC with 1000 mg polyphenols or vice-versa. Participants followed each diet for 2 weeks separated by a 1-week washout period. It was observed that the 500 mg polyphenol dose was equally effective in reducing fasting blood glucose levels, systolic BP (SBP) and diastolic BP (DBP) as the 1000 mg polyphenol dose suggesting that a saturation effect might occur with increasing dose of polyphenols. There was also a trend towards a reduction in urinary free cortisone levels with both groups although it did not reach statistical significance. No changes in anthropometrical measurements were seen. We suggest that more research is required to investigate the mechanism(s) by which polyphenol-rich foods influence health.
C1 [Almoosawi, Suzana; Fyfe, Lorna; Al-Dujaili, Emad] Queen Margaret Univ, Dept Dietet Nutr & Biol Sci, Musselburgh EH21 6UU, Scotland.
   [Ho, Clement] Royal Infirm Edinburgh NHS Trust, Dept Clin Biochem, Edinburgh EH16 4SA, Midlothian, Scotland.
C3 Queen Margaret University; University of Edinburgh; Royal Infirmary of
   Edinburgh
RP Al-Dujaili, E (corresponding author), Queen Margaret Univ, Dept Dietet Nutr & Biol Sci, Queen Margaret Dr, Musselburgh EH21 6UU, Scotland.
EM ealdujaili@qmu.ac.uk
RI Ho, Clement/A-6261-2011
OI Ho, Clement/0000-0003-1469-5467
CR Al-Dujaili EAS, 2006, CLIN CHIM ACTA, V364, P172, DOI 10.1016/j.cccn.2005.06.019
   Alberti L, 2007, INT J OBESITY, V31, P1826, DOI 10.1038/sj.ijo.0803677
   ALDUJAILI EAS, 2005, END ABSTR, V10, P75
   [Anonymous], 2000, WHO TECHN REP SER
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059
   Bayard Vicente, 2007, Int J Med Sci, V4, P53
   Bjelakovic G, 2007, J Basic Clin Physiol Pharmacol, V18, P115
   BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461
   Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411
   Chamarthi B, 2007, J CLIN ENDOCR METAB, V92, P1340, DOI 10.1210/jc.2006-2093
   Counet C, 2004, J AGR FOOD CHEM, V52, P6243, DOI 10.1021/jf040105b
   Davison K, 2008, INT J OBESITY, V32, P1289, DOI 10.1038/ijo.2008.66
   Ding EL, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-2
   Duclos M, 2005, OBES RES, V13, P1157, DOI 10.1038/oby.2005.137
   Faridi Z, 2008, AM J CLIN NUTR, V88, P58, DOI 10.1093/ajcn/88.1.58
   Farin HMF, 2006, AM J CLIN NUTR, V83, P47
   Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/00004872-200312000-00016
   Ford ES, 2007, OBESITY, V15, P1139, DOI 10.1038/oby.2007.628
   Fraga Cesar G, 2005, Clin Dev Immunol, V12, P11, DOI 10.1080/10446670410001722159
   Fraser R, 1999, HYPERTENSION, V33, P1364, DOI 10.1161/01.HYP.33.6.1364
   Fuchs FD, 2005, OBES RES, V13, P1515, DOI 10.1038/oby.2005.184
   Grahame-Smith DG., 2002, OXFORD TXB CLIN PHAR
   Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70
   Grassi D, 2005, AM J CLIN NUTR, V81, P611
   Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671
   Guo J, 1998, J LAB CLIN MED, V132, P32, DOI 10.1016/S0022-2143(98)90022-1
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Hollenberg NK, 2006, J CARDIOVASC PHARM, V47, pS119, DOI 10.1097/00005344-200606001-00005
   Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C
   Karim M, 2000, J NUTR, V130, p2105S, DOI 10.1093/jn/130.8.2105S
   KERSTENS MN, 2001, J CLIN ENDOCR METAB, V88, P4180
   Kidambi S, 2007, HYPERTENSION, V49, P704, DOI 10.1161/01.HYP.0000253258.36141.c7
   Lamuela-Raventós RM, 2001, J NUTR, V131, P834, DOI 10.1093/jn/131.3.834
   Lee KW, 2003, J AGR FOOD CHEM, V51, P7292, DOI 10.1021/jf0344385
   Lee YS, 1996, CLIN PHARMACOL THER, V59, P62, DOI 10.1016/S0009-9236(96)90025-9
   LINDROOS AK, 1993, EUR J CLIN NUTR, V47, P461
   Litchfield WR, 1998, HYPERTENSION, V31, P569, DOI 10.1161/01.HYP.31.2.569
   Liu Y, 2009, CARDIOVASC RES, V81, P140, DOI 10.1093/cvr/cvn231
   Lovallo WR, 2006, INT J PSYCHOPHYSIOL, V59, P195, DOI 10.1016/j.ijpsycho.2005.10.007
   Luna F, 2002, J AGR FOOD CHEM, V50, P3527, DOI 10.1021/jf0116597
   McDougall GJ, 2005, J AGR FOOD CHEM, V53, P2760, DOI 10.1021/jf0489926
   McKeown NM, 2008, EUR J NUTR, V47, P210, DOI 10.1007/s00394-008-0715-x
   Meisel P, 2005, HYPERTENSION, V46, pE17, DOI 10.1161/01.HYP.0000188406.38247.fd
   Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200
   Nelson M, 2002, PHOTOGRAPHIC ATLAS F
   Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603
   Olson TP, 2006, AM J PREV MED, V30, P487, DOI 10.1016/j.amepre.2006.02.006
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Palermo M, 1996, CLIN ENDOCRINOL, V45, P605, DOI 10.1046/j.1365-2265.1996.00853.x
   Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311
   Quesada C, 1996, J FOOD PROTECT, V59, P185, DOI 10.4315/0362-028X-59.2.185
   Richelle M, 2001, J AGR FOOD CHEM, V49, P3438, DOI 10.1021/jf0101410
   Rios LY, 2003, AM J CLIN NUTR, V77, P912, DOI 10.1093/ajcn/77.4.912
   Rohleder N, 2006, INT J PSYCHOPHYSIOL, V59, P236, DOI 10.1016/j.ijpsycho.2005.10.012
   Roura E, 2006, CLIN CHEM, V52, P749, DOI 10.1373/clinchem.2005.063628
   Sardi Alberto, 2002, Ann Ital Med Int, V17, P126
   Song CH, 2007, EUR J CLIN NUTR, V61, P682, DOI 10.1038/sj.ejcn.1602568
   SONG DJ, 1992, J LAB CLIN MED, V120, P792
   Song YQ, 2005, DIABETES CARE, V28, P1438, DOI 10.2337/diacare.28.6.1438
   Stimson RH, 2007, J CLIN ENDOCR METAB, V92, P4480, DOI 10.1210/jc.2007-0692
   STOTE KS, 2007, FASEB J, V21, P84717
   Taubert D, 2003, JAMA-J AM MED ASSOC, V290, P1029, DOI 10.1001/jama.290.8.1029
   Taubert D, 2007, JAMA-J AM MED ASSOC, V298, P49, DOI 10.1001/jama.298.1.49
   Tomaru M, 2007, NUTRITION, V23, P351, DOI 10.1016/j.nut.2007.01.007
   Verdecchia P, 2004, BLOOD PRESS MONIT, V9, P225, DOI 10.1097/00126097-200408000-00008
   Vicennati V, 2000, J CLIN ENDOCR METAB, V85, P4093, DOI 10.1210/jc.85.11.4093
NR 69
TC 70
Z9 79
U1 0
U2 48
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD MAR 28
PY 2010
VL 103
IS 6
BP 842
EP 850
DI 10.1017/S0007114509992431
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 577NQ
UT WOS:000276230900008
PM 19825207
OA Bronze, Green Submitted
DA 2025-04-28
ER

PT J
AU Sirvent, P
   Chavanelle, V
   Otero, YF
   Bargetto, M
   Le Joubioux, F
   Boisseau, N
   Maugard, T
   Cazaubiel, M
   Pereira, B
   Guigas, B
   Hadjadj, S
   Peltier, SL
   Marette, A
   Bard, JM
AF Sirvent, Pascal
   Chavanelle, Vivien
   Otero, Yolanda F.
   Bargetto, Maxime
   Le Joubioux, Florian
   Boisseau, Nathalie
   Maugard, Thierry
   Cazaubiel, Murielle
   Pereira, Bruno
   Guigas, Bruno
   Hadjadj, Samy
   Peltier, Sebastien L.
   Marette, Andre
   Bard, Jean-Marie
TI TOTUM-63, a plant-based polyphenol-rich extract, improves glycaemic
   control in subjects with prediabetes or early stage newly-diagnosed type
   2 diabetes in a randomized, double-blind, placebo-controlled trial
SO DIABETES OBESITY & METABOLISM
LA English
DT Article
DE botanical extract; diabetic; glycaemia; metabolic syndrome; prediabetic;
   TOTUM-63; weight management
ID CHLOROGENIC ACID; INSULIN-RESISTANCE; GUT MICROBIOTA; GLUCOSE;
   INFLAMMATION; SECRETION; DISEASES; APIGENIN; OBESITY; COFFEE
AB Aim The plant-based polyphenol-rich extract TOTUM-63 improves glucose homeostasis in various preclinical models of obesity and type 2 diabetes (T2D). A pilot exploratory study showed that TOTUM-63 has good safety and tolerability profiles, and beneficial effects on postprandial glucose control in healthy individuals with overweight. The aim of this study was to assess the effects of TOTUM-63 on glycaemic control in individuals with prediabetes or early stage newly-diagnosed T2D (which does not require pharmacological treatment). Materials and Methods This study was a multicentre, randomized, double-blind, placebo-controlled trial. Individuals with prediabetes or early stage newly-diagnosed T2D and with overweight/abdominal obesity received TOTUM-63 (5 g/day) or placebo for 6 months. The primary outcome was the change in fasting blood glucose. Results Fifty-one participants (age: 57.1 +/- 10 years; body mass index: 31.3 +/- 5.7 kg.m(2); 35 women and 16 men) completed the study (n = 38 TOTUM-63, n = 13 placebo). After 6 months, blood glucose concentration after fasting and after the 2-h oral glucose tolerance test was reduced in the TOTUM-63-treated group compared with the placebo group (placebo-corrected difference between baseline and month 6: -0.71 mmol/L, p < .05, and -1.93 mmol/L, p < .05, respectively). TOTUM-63 was safe and well tolerated and significantly reduced body weight gain (-1.9 kg; p < .05), waist circumference (-4.5 cm; p < .001), circulating triglycerides (-0.54 mmol/L; p < .01) and low-density lipoprotein-cholesterol (-0.38 mmol/L; p < .05) compared with placebo. Conclusions TOTUM-63 lowered fasting blood glucose in participants with impaired fasting glycaemia and glucose intolerance. Moreover, TOTUM-63 showed a good safety and tolerability profile and improved several metabolic syndrome features. Therefore, TOTUM-63 is a promising candidate for T2D prevention.
C1 [Sirvent, Pascal; Chavanelle, Vivien; Otero, Yolanda F.; Bargetto, Maxime; Le Joubioux, Florian; Cazaubiel, Murielle; Peltier, Sebastien L.] Valbiotis, Valbiotis R&D Ctr, Perigny, France.
   [Boisseau, Nathalie] Univ Clermont Auvergne, Lab AME2P, Clermont Ferrand, France.
   [Boisseau, Nathalie] CRNH, CRNH Auvergne, Clermont Ferrand, France.
   [Maugard, Thierry] La Rochelle Univ, UMR CNRS 7266 LIENSs, Equipe BCBS Biotechnol & Chim Bioressources Sante, La Rochelle, France.
   [Pereira, Bruno] CHU Clermont Ferrand, Delegat Rech Clin & Innovat, Clermont Ferrand, France.
   [Guigas, Bruno] Leiden Univ Med Ctr, Dept Parasitol, Leiden, Netherlands.
   [Hadjadj, Samy] Univ Nantes, CHU Nantes, Dept Endocrinol Diabetol & Nutr, Inst Thorax,INSERM,CNRS, Nantes, France.
   [Marette, Andre] Laval Univ, Fac Med, Quebec Heart & Lung Inst, Dept Med, Quebec City, PQ, Canada.
   [Marette, Andre] Laval Univ, Inst Nutr & Funct Foods, Quebec City, PQ, Canada.
   [Bard, Jean-Marie] Univ Nantes, IUML Inst Univ Mer & Littoral FR3473 CNRS, Lab Biochim Gen & Appl, UFR Pharm,ISOMer UE 2160, F-44035 Nantes, France.
C3 Universite Clermont Auvergne (UCA); Centre National de la Recherche
   Scientifique (CNRS); CHU Clermont Ferrand; Leiden University; Leiden
   University Medical Center (LUMC); Nantes Universite; CHU de Nantes;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Centre National de la Recherche Scientifique (CNRS); Laval University;
   Quebec Heart & Lung Institute; Laval University; Nantes Universite
RP Bard, JM (corresponding author), Univ Nantes, IUML Inst Univ Mer & Littoral FR3473 CNRS, Lab Biochim Gen & Appl, UFR Pharm,ISOMer UE 2160, F-44035 Nantes, France.
EM jean-marie.bard@univ-nantes.fr
RI Pereira, Bruno/JTT-9628-2023; Marette, Andre/E-9342-2013; Chavanelle,
   Vivien/LOR-6549-2024; MAUGARD, Thierry/JFJ-2687-2023; Guigas,
   Bruno/M-2515-2015
OI Chavanelle, Vivien/0000-0003-0761-3355; Bard,
   Jean-Marie/0000-0002-9123-8123; Guigas, Bruno/0000-0002-8856-5799
FU BPI (Banque Publique d'Investissement) France; Valbiotis
FX BPI (Banque Publique d'Investissement) France;Valbiotis
CR Anhê FF, 2017, MOL METAB, V6, P1563, DOI 10.1016/j.molmet.2017.10.003
   Anhê FF, 2015, CURR OBES REP, V4, P389, DOI 10.1007/s13679-015-0172-9
   Anhê FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142
   Beulens JWJ, 2019, EUR J PREV CARDIOL, V26, P47, DOI 10.1177/2047487319880041
   Bumke-Vogt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104321
   Caesar LK, 2019, NAT PROD REP, V36, P869, DOI 10.1039/c9np00011a
   Carnevale R, 2018, BRIT J CLIN PHARMACO, V84, P1566, DOI 10.1111/bcp.13589
   Chavanelle V, 2021, AM J PHYSIOL-ENDOC M, V320, pE1119, DOI 10.1152/ajpendo.00629.2020
   Dupuit M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13051569
   Eldridge Sandra M, 2016, BMJ, V355, pi5239, DOI 10.1136/bmj.i5239
   Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363
   Janssen VE, 2018, EUR J PREV CARDIOL, V25, P1523, DOI 10.1177/2047487318789494
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jung UJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050305
   Kerrison G, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8493145
   Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512
   Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863
   Les F, 2021, J PHYSIOL BIOCHEM, V77, P109, DOI 10.1007/s13105-020-00739-z
   Menke A., 2018, Diabetes in America, V3rd
   Nyakudya TT, 2020, MOLECULES, V25, DOI 10.3390/molecules25112669
   Oliveira H, 2020, MOLECULES, V25, DOI 10.3390/molecules25173813
   Peckham E, 2015, CONTEMP CLIN TRIALS, V45, P113, DOI 10.1016/j.cct.2015.05.017
   Promyos Natnicha, 2020, Prev Nutr Food Sci, V25, P263, DOI 10.3746/pnf.2020.25.3.263
   Ren B, 2016, EUR J PHARMACOL, V773, P13, DOI 10.1016/j.ejphar.2016.01.002
   Rouhi-Boroujeni H, 2017, CURR PHARM DESIGN, V23, P999, DOI 10.2174/1381612822666161021160524
   Sallar A, 2020, EXP BIOL MED, V245, P889, DOI 10.1177/1535370220915644
   Sun H, 2022, DIABETES RES CLIN PR, V183, DOI 10.1016/j.diabres.2021.109119
   Tabák AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   van der Zande HJP, 2021, INT J OBESITY, V45, P2016, DOI 10.1038/s41366-021-00870-x
   Yang G, 2021, METABOLISM, V117, DOI 10.1016/j.metabol.2021.154712
   Yang M, 2018, BIOMED PHARMACOTHER, V105, P1283, DOI 10.1016/j.biopha.2018.06.108
   Yang Y, 2022, CRIT REV FOOD SCI, V62, P1119, DOI 10.1080/10408398.2020.1835819
   Yang Y, 2014, FITOTERAPIA, V92, P133, DOI 10.1016/j.fitote.2013.10.010
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 35
TC 7
Z9 7
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-8902
EI 1463-1326
J9 DIABETES OBES METAB
JI Diabetes Obes. Metab.
PD DEC
PY 2022
VL 24
IS 12
BP 2331
EP 2340
DI 10.1111/dom.14817
EA AUG 2022
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 5R8WL
UT WOS:000834195200001
PM 35837981
OA Green Published
DA 2025-04-28
ER

PT J
AU Martins, BC
   Soares, AC
   Martins, FF
   Resende, AD
   Inada, KOP
   Souza-Mello, V
   Nunes, NM
   Daleprane, JB
AF Martins, Bruna Cadete
   Soares, Alexandre Coelho
   Martins, Fabiane Ferreira
   Resende, Angela de Castro
   Inada, Kim Ohanna Pimenta
   Souza-Mello, Vanessa
   Nunes, Nathalia Moura
   Daleprane, Julio Beltrame
TI Coffee consum ption prevents obesity-related comorbidities and
   attenuates brown adipose tissue whitening in high-fat diet-fed mice
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Obesity; Remodeling of adipose tissue; Thermogenesis; Caffeine;
   Chlorogenic acids; beltrame@uerj; br
ID RISK; BETA
AB This study aimed to evaluate the preventive and therapeutic effects of coffee consum ption on molecular changes and adipose tissue remodeling in a murine model of high-fat diet-induced obesity. Three-month-old C57BL/6 mice were initially divided into three groups, namely, control (C), high-fat (HF), and coffee prevention (HF-CP) groups, and the HF group was subdivided at the end of the 10th week into two subgroups, an HF group and a coffee treatment (HF-CT) group; thus, a total of four groups were investigated at the 14th week of the experiment. The HF-CP group had lower body mass than the HF group ( -7%, P < .05) and a better distribution of adipose tissue. Both groups that received coffee (HF-CP and HF-CT) showed improved glucose metabolism compared with the HF group. Coffee consumption also attenuated adipose tissue inflammation and showed decreased macrophage infiltration and lower IL-6 levels compared with the HF group (HF-CP: -337% %, P < .05; HF-CT: -275%, P < .05). Hepatic steatosis and inflammation were attenuated in the HF-CP and HF-CT groups. The HF-CP group showed more pronounced expression of genes involved in adaptive thermogenesis and mitochondrial biogenesis (PPAR gamma, Prdm16, Pcg1 alpha, beta 3-adrenergic receptor, Ucp-1, and Opa-1) than the other experimental groups. Preventive coffee consumption associated with a high-fat diet ameliorates the metabolic profile related to the development of obesity and its comorbidities. (c) 2023 Elsevier Inc. All rights reserved.
C1 [Martins, Bruna Cadete; Soares, Alexandre Coelho; Daleprane, Julio Beltrame] Univ Estado Rio De Janeiro, Dept Basic & Expt Nutr, Lab Studies Interact Nutr & Genet, LEING, Rio De Janeiro, Brazil.
   [Martins, Fabiane Ferreira; Souza-Mello, Vanessa] Univ Estado Rio De Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry, Rio De Janeiro, Brazil.
   [Resende, Angela de Castro] Univ Estado Rio De Janeiro, Dept Pharmacol, Lab Cardiovasc Pharmacol & Med Plants, Rio De Janeiro, Brazil.
   [Inada, Kim Ohanna Pimenta] Univ Estado Rio De Janeiro, Nutr Inst, Lab Bromatol, Rio De Janeiro, Brazil.
   [Daleprane, Julio Beltrame] Univ Estado Rio De Janeiro, Dept Basic & Expt Nutr, Lab Studies Interact Nutr & Genet, LEING, Rua Sao Francisco Xavier 524,12-150 Bloco F, BR-20550900 Rio De Janeiro, Brazil.
C3 Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio
   de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do
   Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro
RP Daleprane, JB (corresponding author), Univ Estado Rio De Janeiro, Dept Basic & Expt Nutr, Lab Studies Interact Nutr & Genet, LEING, Rua Sao Francisco Xavier 524,12-150 Bloco F, BR-20550900 Rio De Janeiro, Brazil.
EM beltrame@uerj.br
RI Daleprane, Julio/H-2597-2012; Souza-Mello, Vanessa/E-3463-2014
OI Daleprane, Julio/0000-0002-3493-1386; Souza-Mello,
   Vanessa/0000-0002-2510-9569; Cadete Martins, Bruna/0000-0002-4905-4232;
   Inada, Kim/0000-0001-5107-3056
FU FAPERJ [E-26/010.002203/2019, E-26/202.677/2018, E-26/210.064/2021];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil
   (CAPES) [001CAPES]
FX This work was supported by FAPERJ grant numbers E-26/010.002203/2019 ,
   E-26/202.677/2018 , and E-26/210.064/2021 and was financed in part by
   the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil
   (CAPES)-finance code 001CAPES .
CR de Almeida SS, 2020, FOOD CHEM, V333, DOI 10.1016/j.foodchem.2020.127473
   An Y, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3631
   Arhire LL, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00524
   Bagchi DP, 2019, JOVE-J VIS EXP, DOI 10.3791/59499
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Caria CREP, 2014, FOOD RES INT, V61, P120, DOI 10.1016/j.foodres.2014.02.025
   Carpentier AC, 2023, ENDOCR REV, V44, P143, DOI 10.1210/endrev/bnac015
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Chouchani ET, 2019, CELL METAB, V29, P27, DOI 10.1016/j.cmet.2018.11.002
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Farah Adriana, 2006, Braz. J. Plant Physiol., V18, P23, DOI 10.1590/S1677-04202006000100003
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Gross B, 2017, NAT REV ENDOCRINOL, V13, P36, DOI 10.1038/nrendo.2016.135
   Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006
   Hou YY, 2012, FREE RADICAL BIO MED, V52, P462, DOI 10.1016/j.freeradbiomed.2011.10.453
   Hu GL, 2019, FOOD FUNCT, V10, P3113, DOI [10.1039/c9fo00288j, 10.1039/C9FO00288J]
   Jia HJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0389-3
   Kaisanlahti A, 2019, J PHYSIOL BIOCHEM, V75, P1, DOI 10.1007/s13105-018-0658-5
   Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kolb H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041144
   Kusumah J, 2022, FOOD CHEM TOXICOL, V161, DOI 10.1016/j.fct.2022.112821
   Kwan HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02263-5
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Li J, 2021, FOOD SCI NUTR, V9, P6548, DOI 10.1002/fsn3.2580
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Bargut TCL, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2016-0051
   Loyd C, 2014, CURR OPIN CLIN NUTR, V17, P368, DOI 10.1097/MCO.0000000000000063
   Maki C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173264
   Maldonado-Ruiz R, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.10
   Martini D, 2016, MOLECULES, V21, DOI 10.3390/molecules21080979
   Martins FF, 2022, CELL BIOCHEM FUNCT, V40, P903, DOI 10.1002/cbf.3751
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mukherjee S, 2018, STEM CELL RES, V30, P12, DOI 10.1016/j.scr.2018.04.007
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Neyrinck AM, 2017, J NUTR BIOCHEM, V49, P15, DOI 10.1016/j.jnutbio.2017.07.008
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Pandit C, 2019, INT J HYPERTHER, V35, P518, DOI 10.1080/02656736.2018.1511835
   Pimentel GD, 2019, NUTR PREVENTION TREA, P329, DOI [10.1016/B978-0-12-816093-0,00024-0, DOI 10.1016/B978-0-12-816093-0,00024-0]
   Rangel-Azevedo C, 2022, J NUTR BIOCHEM, V105, DOI 10.1016/j.jnutbio.2022.109002
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Santana-Oliveira DA, 2022, J MOL ENDOCRINOL, V68, P225, DOI 10.1530/JME-21-0084
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Takahashi K, 2017, NUTRITION, V38, P1, DOI 10.1016/j.nut.2016.12.021
   Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091134
   Townsend KL, 2012, ADIPOCYTE, V1, P13, DOI 10.4161/adip.18951
   Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x
   Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002
   Unamuno X, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12997
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Vishvanath L, 2019, J CLIN INVEST, V129, P4022, DOI 10.1172/JCI129191
   Vitaglione P, 2019, J NUTR SCI, V8, DOI 10.1017/jns.2019.10
   Wang CH, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz8664
   Wang J, 2019, J NUTR BIOCHEM, V70, P105, DOI 10.1016/j.jnutbio.2019.05.001
   Wang QA, 2015, NAT CELL BIOL, V17, P1099, DOI 10.1038/ncb3217
   Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96
   Williamson G, 2020, FOOD FUNCT, V11, P4826, DOI [10.1039/d0fo01168a, 10.1039/D0FO01168A]
   Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6
NR 58
TC 9
Z9 9
U1 9
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JUL
PY 2023
VL 117
AR 109336
DI 10.1016/j.jnutbio.2023.109336
EA APR 2023
PG 10
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA F8TF0
UT WOS:000985009600001
PM 36990367
DA 2025-04-28
ER

PT J
AU Falbe, J
   Thompson, HR
   Patel, A
   Madsen, KA
AF Falbe, Jennifer
   Thompson, Hannah R.
   Patel, Anisha
   Madsen, Kristine A.
TI Potentially addictive properties of sugar-sweetened beverages among
   adolescents
SO APPETITE
LA English
DT Article
DE Obesity; Sugar-sweetened beverages; Addiction; Withdrawal; Craving;
   Adolescence
ID FOOD ADDICTION; CAFFEINE WITHDRAWAL; EATING ADDICTION; DIETARY CAFFEINE;
   ENERGY-INTAKE; BODY-WEIGHT; CONSUMPTION; OBESITY; COMPENSATION;
   PERSPECTIVES
AB Sugar-sweetened beverages (SSBs) increase risk of cardiometabolic disease. Young people consume the largest amounts of SSBs and have experienced the greatest relative gains in obesity in the past several decades. There is evidence of addictive properties of both caffeine and sugar, the primary ingredients in SSBs, but little research into such properties of SSBs in naturally occurring consumption patterns. Thus, in this exploratory study, we sought to examine potentially addictive properties of SSBs during a 3-day SSB cessation intervention in overweight and obese adolescents who typically consume >= 3 SSBs daily. Participants (n = 25) were aged 13-18 years, mostly female (72%), and African American (56%) or Hispanic (16%) with a BMI >= 95th percenttile (76%). Withdrawal symptoms and SSB craving were assessed approximately 1-week apart, during both regular SSB consumption and a 3-day period of SSB cessation in which participants were instructed to drink only plain milk and water. During SSB cessation, adolescents reported increased SSB cravings and headache and decreased motivation, contentment, ability to concentrate, and overall well-being (uncorrected Ps < 0.05). After controlling the false discovery rate, changes in motivation, craving, and well-being remained significant (corrected Ps < 0.05). Using 24-hr recalls and drink journals, participants reported lower total daily consumption of sugar (-80 g) and added sugar (-16 g) (Ps < 0.001) during cessation. This study provides preliminary evidence of withdrawal symptoms and increased SSB cravings during cessation in a diverse population of overweight or obese adolescents.
C1 [Falbe, Jennifer] Univ Calif Davis, Human Dev & Family Studies, Dept Human Ecol, One Shields Ave, Davis, CA 95616 USA.
   [Thompson, Hannah R.; Madsen, Kristine A.] Univ Calif Berkeley, Community Hlth Sci, Sch Publ Hlth, 2121 Berkeley Way,Room 5302, Berkeley, CA 94720 USA.
   [Patel, Anisha] Stanford Univ, Div Gen Pediat, Lucile Salter Packard Childrens Hosp, 1265 Welch Rd,MSOB X240,Mailcode 5459, Stanford, CA 94305 USA.
C3 University of California System; University of California Davis;
   University of California System; University of California Berkeley;
   Lucile Packard Children's Hospital (LPCH); Stanford University
RP Falbe, J (corresponding author), Univ Calif Davis, Human Dev & Family Studies, Dept Human Ecol, One Shields Ave, Davis, CA 95616 USA.
EM jfalbe@ucdavis.edu; thompsonh@berkeley.edu; anipatel@stanford.edu;
   madsenk@berkeley.edu
OI Falbe, Jennifer/0000-0002-8405-4326; Thompson, Hannah
   Ruth/0000-0003-0214-5003; Patel, Anisha/0000-0001-9198-7936
FU University of California Office of the President Multi-Campus Research
   Initiative grant; American Heart Association [14POST20140055]; National
   Institute of Diabetes and Digestive and Kidney Diseases of the National
   Institutes of Health [1K01DK113068-01A1]; American Heart Association
   (AHA) [14POST20140055] Funding Source: American Heart Association (AHA)
FX This work was supported by a University of California Office of the
   President Multi-Campus Research Initiative grant (PI, Elissa Epel). J.
   Falbe's work was supported in part by the American Heart Association
   (grant #14POST20140055) and National Institute of Diabetes and Digestive
   and Kidney Diseases of the National Institutes of Health (grant
   #1K01DK113068-01A1). The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   National Institutes of Health. These funders had no role in the study
   design; collection, analysis or interpretation of data; writing of the
   report; or the decision to submit the article for publication.
CR Almiron-Roig E, 2013, NUTR REV, V71, P458, DOI 10.1111/nure.12048
   [Anonymous], 2013, DIAGNOSTIC STAT MANU, VFifth, P1000
   [Anonymous], RES
   [Anonymous], 2011, CRP36 IOM
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bernstein GA, 1998, J AM ACAD CHILD PSY, V37, P858, DOI 10.1097/00004583-199808000-00016
   Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007
   Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085
   Brisbois TD, 2014, NUTRIENTS, V6, P1899, DOI 10.3390/nu6051899
   Davis C, 2014, SUBST ABUSE REHABIL, V5, P129, DOI 10.2147/SAR.S56835
   De Biasi M, 2008, EXP BIOL MED, V233, P917, DOI 10.3181/0712-MR-355
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   DiNicolantonio JJ, 2018, BRIT J SPORT MED, V52, P910, DOI 10.1136/bjsports-2017-097971
   Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388
   Economic Research Service, 2017, FOOD AV PER CAP DAT
   Epel ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101350
   Epstein DH, 2010, ADDICT BEHAV, V35, P318, DOI 10.1016/j.addbeh.2009.11.003
   Epstein LH, 2011, AM J CLIN NUTR, V94, P12, DOI 10.3945/ajcn.110.010314
   Ewing SWF, 2017, BRAIN IMAGING BEHAV, V11, P925, DOI 10.1007/s11682-016-9564-z
   Goldfield Gary S, 2005, Eat Behav, V6, P283, DOI 10.1016/j.eatbeh.2004.11.004
   GRIFFITHS RR, 1990, J PHARMACOL EXP THER, V255, P1123
   Hebebrand J, 2014, NEUROSCI BIOBEHAV R, V47, P295, DOI 10.1016/j.neubiorev.2014.08.016
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919
   James JE, 2005, NEUROPSYCHOBIOLOGY, V52, P1, DOI 10.1159/000086172
   James JE, 2004, HUM PSYCHOPHARM CLIN, V19, P333, DOI 10.1002/hup.589
   Jastreboff AM, 2016, DIABETES, V65, P1929, DOI 10.2337/db15-1216
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   Keast RSJ, 2007, APPETITE, V49, P255, DOI 10.1016/j.appet.2006.11.003
   Keast RSJ, 2015, BRIT J NUTR, V113, P366, DOI 10.1017/S000711451400378X
   Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943
   Kosten TR, 2003, NEW ENGL J MED, V348, P1786, DOI 10.1056/NEJMra020617
   Leibowitz J., 2012, A Review of Food Marketing to Children and Adolescents: Follow-Up Report
   Lemeshow AR, 2018, APPETITE, V121, P186, DOI 10.1016/j.appet.2017.10.038
   Lobstein T, 2017, REDUCING CONSUMPTION
   MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Markus CR, 2017, APPETITE, V114, P64, DOI 10.1016/j.appet.2017.03.024
   Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   Mazur J. E., 1987, The effect of delay and of intervening events on reinforcement value, P55, DOI DOI 10.1016/J.BEPROC.2008.12.017
   Oslin DW, 2009, DRUG ALCOHOL DEPEN, V103, P131, DOI 10.1016/j.drugalcdep.2009.03.009
   Powell LM, 2010, ARCH PEDIAT ADOL MED, V164, P794, DOI 10.1001/archpediatrics.2010.139
   RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233
   Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010
   Rosinger A., 2017, Sugar-sweetened beverage consumption among U.S. adults, 2011-2014
   Sánchez-Pimienta TG, 2016, J NUTR, V146, P1888, DOI 10.3945/jn.115.220301
   Schulte EM, 2018, EUR EAT DISORD REV, V26, P112, DOI 10.1002/erv.2575
   Schulte EM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184220
   Schulte EM, 2017, APPETITE, V115, P9, DOI 10.1016/j.appet.2016.10.033
   Schulte EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117959
   Shiffman S, 2006, ADDICTION, V101, P1822, DOI 10.1111/j.1360-0443.2006.01635.x
   Smith DG, 2013, BIOL PSYCHIAT, V73, P804, DOI 10.1016/j.biopsych.2012.08.026
   Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651
   U. S. Department of Health and Human Services, 2014, HLTH RES SERV ADM MA
   World Health Organization, 1992, ICD 10 CLASS MENT BE
NR 55
TC 46
Z9 50
U1 2
U2 41
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6663
EI 1095-8304
J9 APPETITE
JI Appetite
PD FEB 1
PY 2019
VL 133
BP 130
EP 137
DI 10.1016/j.appet.2018.10.032
PG 8
WC Behavioral Sciences; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Behavioral Sciences; Nutrition & Dietetics
GA HI9CD
UT WOS:000456752000017
PM 30385262
OA Green Accepted, Green Submitted
DA 2025-04-28
ER

PT J
AU de Oliveira, E
   Lima, NS
   Conceiçao, EPS
   Peixoto-Silva, N
   Moura, EG
   Lisboa, PC
AF de Oliveira, E.
   Lima, N. S.
   Conceicao, E. P. S.
   Peixoto-Silva, N.
   Moura, E. G.
   Lisboa, P. C.
TI Treatment with llex paraguariensis (yerba mate) aqueous solution
   prevents hepatic redox imbalance, elevated triglycerides, and
   microsteatosis in overweight adult rats that were precociously weaned
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Early weaning; Programming; Oxidative stress; Steatosis; Liver
ID TEA ILEX-PARAGUARIENSIS; OXIDATIVE STRESS; DEVELOPMENTAL ORIGINS;
   METABOLIC-DISORDERS; CHLOROGENIC ACID; ANTIOXIDANT; STEATOSIS; MICE
AB Early weaning (EW) leads to overweight, visceral obesity, hyperleptinemia, and insulin resistance in adulthood. Treatment with llex paraguariensis (yerba mate) improves obesity and insulin resistance in these animals. Here, we evaluated the effects of chronic treatment with yerba mate on the redox balance and liver morphology of overweight early-weaned rats. To induce EW, we wrapped the dams with bandages to interrupt milk access during the last 3 days of lactation. Control pups (C) had free access to maternal milk for the full 21 days of lactation. On postnatal day (PN) 150, EW offspring were subdivided into the EW +YM group, which received the aqueous extract of yerba mate (1 g/kg bw by gavage once a day for 30 days) and the EW group, which received water by gavage for the same period. All rats were euthanized on PN180. The EW group showed higher bound carbonyl (a marker of total protein oxidation), higher TBARS levels (a marker of lipid peroxidation), and lower superoxide dismutase (SOD) activity in liver tissue than the C group, as well as higher triglyceride content and microsteatosis. In plasma, the EW offspring showed higher TBARS levels. One month of yerba mate treatment normalized these parameters. Thus, we have shown evidence that yerba mate improved antioxidant defenses and mitigated liver dysfunction in overweight adult rats that were weaned prematurely.
C1 [de Oliveira, E.; Lima, N. S.; Conceicao, E. P. S.; Peixoto-Silva, N.; Moura, E. G.; Lisboa, P. C.] Univ Estado Rio de Janeiro, Inst Biol, Dept Ciencias Fisiol, Lab Fisiol Endocrina, Rio De Janeiro, RJ, Brazil.
C3 Universidade do Estado do Rio de Janeiro
RP Lisboa, PC (corresponding author), Univ Estado Rio de Janeiro, Inst Biol, Dept Ciencias Fisiol, Lab Fisiol Endocrina, Rio De Janeiro, RJ, Brazil.
EM pclisboa@uerj.br
RI Moura, Egberto/ABA-6188-2021; LIMA, NATALIA/K-5674-2015; Peixoto-Silva,
   Nayara/P-5072-2015; Lisboa, Patricia/H-8336-2015; Moura,
   Egberto/H-1270-2012
OI Lisboa, Patricia/0000-0002-2477-4364; Moura,
   Egberto/0000-0002-1159-7549; Conceicao Furber, Ellen/0000-0003-0370-1032
FU "National Council for Scientific and Technological Development''
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq);
   "Carlos Chagas Filho Research Foundation of the State of Rio de
   Janeiro'' (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado
   do Rio de Janeiro, FAPERJ); Coordination for the Enhancement of Higher
   Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior, CAPES)
FX All authors are grateful to Mrs. Fabiana Gallaulckydio and Mr Ulisses
   Risso Siqueira for technical assistance. This work was supported by the
   "National Council for Scientific and Technological Development''
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq),
   the "Carlos Chagas Filho Research Foundation of the State of Rio de
   Janeiro'' (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado
   do Rio de Janeiro, FAPERJ), Coordination for the Enhancement of Higher
   Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior, CAPES).
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   BANNISTER JV, 1987, METHOD BIOCHEM ANAL, V32, P279
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9
   Bastos DHM., 2007, Med Aromat Plant Sci Biotechnol, V1, P37
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   Catta-Preta M, 2011, VIRCHOWS ARCH, V459, P477, DOI 10.1007/s00428-011-1147-1
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi MS, 2017, J MED FOOD, V20, P1168, DOI 10.1089/jmf.2017.3995
   Conceiçao EPS, 2017, J DEV ORIG HLTH DIS, V8, P123, DOI 10.1017/S2040174416000519
   Conceiçao EPS, 2013, J NUTR BIOCHEM, V24, P81, DOI 10.1016/j.jnutbio.2012.02.010
   de Andrade F, 2012, FOOD CHEM TOXICOL, V50, P328, DOI 10.1016/j.fct.2011.08.028
   de Moura EG, 2008, NEUROIMMUNOMODULAT, V15, P176, DOI 10.1159/000153422
   Dupas C, 2006, MOL NUTR FOOD RES, V50, P1053, DOI 10.1002/mnfr.200600034
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Franco JG, 2013, J NUTR BIOCHEM, V24, P960, DOI 10.1016/j.jnutbio.2012.06.019
   Gambero A, 2015, NUTRIENTS, V7, P730, DOI 10.3390/nu7020730
   Gao HL, 2013, EXP GERONTOL, V48, P572, DOI 10.1016/j.exger.2013.03.008
   Gluckman PD, 2007, J INTERN MED, V261, P461, DOI 10.1111/j.1365-2796.2007.01802.x
   Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002
   Hussein GME, 2011, BIOL PHARM BULL, V34, P1849, DOI 10.1248/bpb.34.1849
   Kaezer AR, 2012, CYTA-J FOOD, V10, P144, DOI 10.1080/19476337.2011.601429
   Kang Young-Rye, 2012, Lab Anim Res, V28, P23, DOI 10.5625/lar.2012.28.1.23
   Kathirvel E, 2009, EUR J GASTROEN HEPAT, V21, P973, DOI 10.1097/MEG.0b013e328328f461
   Li YZ, 2002, NEUROSCI LETT, V330, P33, DOI 10.1016/S0304-3940(02)00722-X
   Lima ND, 2014, EUR J NUTR, V53, P73, DOI 10.1007/s00394-013-0500-3
   Lima ND, 2011, BRIT J NUTR, V105, P1405, DOI 10.1017/S0007114510005064
   LUCAS A, 1994, ARCH DIS CHILD, V71, P288, DOI 10.1136/adc.71.4.288
   Matsumoto RLT, 2009, J AGR FOOD CHEM, V57, P1775, DOI 10.1021/jf803096g
   Merzouk AS, 2017, FREE RADICAL RES, V51, P294, DOI 10.1080/10715762.2017.1307979
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Shin JA, 2013, J DIABETES INVEST, V4, P334, DOI 10.1111/jdi.12075
   Younes-Rapozo V, 2012, BRIT J NUTR, V108, P2286, DOI 10.1017/S0007114512000487
   Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018
NR 36
TC 7
Z9 7
U1 0
U2 4
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 2018
VL 51
IS 6
AR e7342
DI 10.1590/1414-4331X20187342
PG 10
WC Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA GG8WE
UT WOS:000432978700001
PM 29791596
DA 2025-04-28
ER

PT J
AU Tarantino, G
   Conca, P
   Capone, D
   Gentile, A
   Polichetti, G
   Basile, V
AF Tarantino, Giovanni
   Conca, Paolo
   Capone, Domenico
   Gentile, Antonio
   Polichetti, Giuliano
   Basile, Vincenzo
TI Reliability of total overnight salivary caffeine assessment (TOSCA) for
   liver function evaluation in compensated cirrhotic patients
SO EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
LA English
DT Article
DE caffeine intake; cirrhosis; liver function; total overnight salivary
   caffeine assessment
ID C-VIRUS CORE; HEPATITIS-C; NONALCOHOLIC STEATOHEPATITIS; CYP1A2
   ACTIVITY; CLEARANCE; PLASMA; CYTOCHROME-P450; ELIMINATION; CAPACITY;
   FIBROSIS
AB Systemic caffeine clearance is considered the gold standard for phenotyping cytochrome P450 1A2 in epidemiological studies, and has been recommended for the non-invasive assessment of liver function in chronic liver disease. Our aim was to find a valid, simple and reliable alternative to this method, and therefore focused our attention on the measurement of an unique salivary caffeine concentration, without drug exposure.
   Our evaluation included 36 healthy controls, 47 patients with compensated liver cirrhosis of viral origin, and 48 obese and diabetic patients with cryptogenetic (likely metabolic) cirrhosis. All shared the same caffeine consumption habits (regular daily use of caffeinated beverages, mainly coffee). The total overnight salivary caffeine assessment (TOSCA) was determined by using a single-point concentration of salivary caffeine, after an overnight period of abstinence.
   Daily routine caffeine intake of our population was adequate for studying the TOSCA. This single-point concentration correlated well with caffeine clearance, measured by salivary concentrations of caffeine. Mean TOSCA in cirrhotic patients was significantly higher than in controls (p < 0.001; sensitivity (%) 84.2 and specificity (%) 97.2; negative likelihood ratio=0.16 and positive likelihood ratio=30.32). A cut-off set at 4.2 mu g/ml (sensitivity (%) 95.8 and specificity (%) 68.1; negative likelihood ratio=0.06 and positive likelihood ratio=3.0) successfully differentiated the type of cirrhosis. Rapid (with higher metabolism of caffeine) metabolizers were more frequent in the group of patients with cirrhosis of metabolic origin (70.8%; p < 0.0001), and the opposite was true for the group of patients with cirrhosis of viral origin, which comprised many poor metabolizers (85.1%; p < 0.001). Serum transforming growth factor-beta 1 concentration, mirroring ongoing fibrosis, ranked high in poor metabolizers. The association between overnight assessment and homeostasis model assessment in rapid metabolizers could result from similar roles for cytochrome P450 1A2 and insulin resistance in determining metabolic liver cirrhosis.
   The TOSCA, although differential between the viral and metabolic etiologies, could be considered a good diagnostic use to verify the presence and eventually the type of compensated liver cirrhosis
C1 Univ Naples Federico II, Sch Med, Sect Hepatol Internal Med, Dept Clin & Expt Med, Naples, Italy.
   Univ Naples Federico II, Sch Med, Pharmacol Sect, Dept Neurosci, Naples, Italy.
C3 University of Naples Federico II; University of Naples Federico II
RP Tarantino, G (corresponding author), Univ Naples Federico II, Sch Med, Sect Hepatol Internal Med, Dept Clin & Expt Med, Naples, Italy.
EM tarantin@unina.it
RI Basile, Vincenzo/GSN-1274-2022; Tarantino, Giovanni/AAW-2007-2021
OI Polichetti, Giuliano/0000-0002-3032-057X
CR ABDELRAZZAK Z, 1994, MOL PHARMACOL, V46, P1100
   ABERNETHY DR, 1985, EUR J CLIN PHARMACOL, V28, P425, DOI 10.1007/BF00544361
   [Anonymous], 2001, GUID DOC US IN VITR
   Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018
   BROUGHTON LJ, 1981, BRIT J CLIN PHARMACO, V12, P155
   BUNKER ML, 1979, J AM DIET ASSOC, V74, P28
   CARBO ML, 1989, CLIN PHARMACOL THER, V45, P234, DOI 10.1038/clpt.1989.23
   Carrillo JA, 2000, THER DRUG MONIT, V22, P409, DOI 10.1097/00007691-200008000-00008
   de Leon J, 2003, PROG NEURO-PSYCHOPH, V27, P165, DOI 10.1016/S0278-5846(02)00348-2
   Faber MS, 2005, BASIC CLIN PHARMACOL, V97, P125, DOI 10.1111/j.1742-7843.2005.pto_973160.x
   Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977
   Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247
   Garello E, 1999, DIGEST DIS SCI, V44, P782, DOI 10.1023/A:1026678228967
   Hasegawa T, 2001, ALIMENT PHARM THERAP, V15, P1667, DOI 10.1046/j.1365-2036.2001.01083.x
   Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10
   HOLSTEGE A, 1989, KLIN WOCHENSCHR, V67, P6, DOI 10.1007/BF01736528
   Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422
   JOST G, 1987, HEPATOLOGY, V7, P338, DOI 10.1002/hep.1840070221
   Jover R, 1997, AM J GASTROENTEROL, V92, P1905
   Jürgens G, 2002, CLIN PHARMACOL THER, V71, P162, DOI 10.1067/mcp.2002.121373
   LEWIS FW, 1992, J HEPATOL, V14, P157, DOI 10.1016/0168-8278(92)90152-F
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   MICELI JN, 1984, THER DRUG MONIT, V6, P344, DOI 10.1097/00007691-198409000-00015
   Mohamed-Ali V, 1999, CLIN ENDOCRINOL, V50, P221
   Niemelä O, 2000, J HEPATOL, V33, P893, DOI 10.1016/S0168-8278(00)80120-8
   Nordmark A, 1999, BRIT J CLIN PHARMACO, V47, P397, DOI 10.1046/j.1365-2125.1999.00918.x
   Ou-Yang DS, 2000, BRIT J CLIN PHARMACO, V49, P145, DOI 10.1046/j.1365-2125.2000.00128.x
   Park GJH, 2003, HEPATOLOGY, V38, P1227, DOI 10.1053/jhep.2003.50475
   Peterson TC, 2000, HEPATOL RES, V17, P112, DOI 10.1016/S1386-6346(99)00068-6
   Powell EE, 2000, HEPATOLOGY, V31, P828, DOI 10.1053/he.2000.6253
   Qureshi Mabood, 2003, Journal of Cardiovascular Pharmacology and Therapeutics, V8, P261, DOI 10.1177/107424840300800403
   RODOPOULOS N, 1995, SCAND J CLIN LAB INV, V55, P229, DOI 10.3109/00365519509089618
   Sepulveda-Flores Ricardo N, 2002, Ann Hepatol, V1, P36
   Smith Andrew G., 2003, Environmental Health Perspectives, V111, P45
   Sreekumar R, 2003, HEPATOLOGY, V38, P244, DOI 10.1053/jhep.2003.50290
   Taniguchi H, 2004, J MED VIROL, V72, P52, DOI 10.1002/jmv.10545
   Wittayalertpanya S., 1996, Tokai Journal of Experimental and Clinical Medicine, V21, P195
NR 37
TC 20
Z9 20
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0031-6970
J9 EUR J CLIN PHARMACOL
JI Eur. J. Clin. Pharmacol.
PD AUG
PY 2006
VL 62
IS 8
BP 605
EP 612
DI 10.1007/s00228-006-0146-7
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 067RQ
UT WOS:000239320700003
PM 16841221
DA 2025-04-28
ER

PT J
AU Hutcheon, DA
   Ziegler, J
AF Hutcheon, Deborah A.
   Ziegler, Jane
TI Green Tea Should It Be Used As a Dietary Aid for Weight Loss?
SO TOPICS IN CLINICAL NUTRITION
LA English
DT Review
DE caffeine; dietary supplements; epigallocatechin-3-gallate; functional
   food; green tea; obesity; weight loss
ID EPIGALLOCATECHIN-GALLATE EGCG; FAT OXIDATION; CATECHIN-POLYPHENOLS;
   ENERGY-EXPENDITURE; BODY-WEIGHT; CAFFEINE; EXTRACT; SUPPLEMENTS; SAFETY
AB Dietary weight loss supplements include a wide range of ingredients. Many ingredients are derived from natural food sources such as green tea. This article presents the composition, mechanisms of action, efficacy, and safety of green tea as a dietary aid to weight loss in overweight and obese adults. While green tea appears to promote energy expenditure and fat oxidation, safety concerns exist when it is consumed as a dietary supplement. Until more evidence-based research is conducted to determine which formulations and dosages are the safest and most effective, green tea should be used with caution as an aid for weight loss.
C1 [Hutcheon, Deborah A.; Ziegler, Jane] Rutgers State Univ, Sch Hlth Related Profess, Newark, NJ 07107 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Rutgers
   University Newark
RP Hutcheon, DA (corresponding author), Rutgers State Univ, Sch Hlth Related Profess, 65 Bergen St, Newark, NJ 07107 USA.
EM hutcheda@shrp.rutgers.edu
CR [Anonymous], 2009, J AM DIET ASSOC, V109, P330, DOI 10.1016/j.jada.2008.11.041
   [Anonymous], FDA INV ADD CAFF
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bhagwat S., 2012, USDA DATABASE FLAVON
   Boehm K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005004.pub2
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Chin JM, 2008, J ANAL TOXICOL, V32, P702, DOI 10.1093/jat/32.8.702
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Henning SM, 2004, AM J CLIN NUTR, V80, P1558
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P636, DOI 10.1016/j.fct.2005.11.003
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Jurgens TM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008650.pub2
   Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Navarro VJ, 2013, DIGEST DIS SCI, V58, P2682, DOI 10.1007/s10620-013-2687-9
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Pillitteri JL, 2008, OBESITY, V16, P790, DOI 10.1038/oby.2007.136
   Sarma DN, 2008, DRUG SAFETY, V31, P469, DOI 10.2165/00002018-200831060-00003
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   Ullmann U, 2004, INT J VITAM NUTR RES, V74, P269, DOI 10.1024/0300-9831.74.4.269
   Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205
   Unachukwu UJ, 2010, J FOOD SCI, V75, pC541, DOI 10.1111/j.1750-3841.2010.01705.x
   US Food and Drug Administration, 2012, WHAT IS MEAN NAT LAB
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
NR 35
TC 0
Z9 0
U1 2
U2 56
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0883-5691
EI 1550-5146
J9 TOP CLIN NUTR
JI Top. Clin. Nutr.
PD JUL-SEP
PY 2014
VL 29
IS 3
BP 268
EP 277
DI 10.1097/TIN.0000000000000004
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CZ6QU
UT WOS:000367226600008
DA 2025-04-28
ER

PT J
AU Han, LY
   Ma, WJ
   Sun, DJY
   Heianza, Y
   Wang, TG
   Zheng, Y
   Huang, T
   Duan, DH
   Bray, JGA
   Champagne, CM
   Sacks, FM
   Qi, L
AF Han, Liyuan
   Ma, Wenjie
   Sun, Dianjianyi
   Heianza, Yoriko
   Wang, Tiange
   Zheng, Yan
   Huang, Tao
   Duan, Donghui
   Bray, J. George A.
   Champagne, Catherine M.
   Sacks, Frank M.
   Qi, Lu
TI Genetic variation of habitual coffee consumption and glycemic changes in
   response to weight-loss diet intervention: the Preventing Overweight
   Using Novel Dietary Strategies (POUNDS LOST) trial
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE genetic risk score; habitual coffee consumption; weight-loss diets;
   gene-diet interaction; glycemic traits
ID GLUCOKINASE REGULATORY PROTEIN; HOMEOSTASIS MODEL ASSESSMENT; IMPAIRED
   GLUCOSE-TOLERANCE; LOW-FAT; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY;
   C57BL/6J MICE; BODY-FAT; OBESITY; SENSITIVITY
AB Background: Coffee consumption has been associated with glucose metabolism and risk of type 2 diabetes.
   Objective: We examined whether the genetic variation determining habitual coffee consumption affected glycemic changes in response to weight-loss dietary intervention.
   Design: A genetic risk score (GRS) was calculated based on 8 habitual coffee consumption-associated single nucleotide polymorphisms. We used general linear models to test changes in glycemic traits in groups randomly assigned to high-and low-fat diets according to tertiles of the GRS.
   Results: We observed significant interactions between the GRS and low compared with high dietary fat intake on 6-mo changes in fasting insulin and homeostasis model assessment of insulin resistance (HOMAIR) (P-interaction = 0.023 and 0.022, respectively), adjusting for age, sex, race, physical activity, smoking, alcohol, seasonal variation, and baseline values of the respective outcomes. Participants with a higher GRS of habitual coffee consumption showed a greater reduction in fasting insulin and a marginally greater decrease in HOMA-IR in the low-fat diet intervention group.
   Conclusions: Our data suggest that participants with genetically determined high coffee consumption may benefit more by eating a low-fat diet in improving fasting insulin and HOMA-IR in a short term.
C1 [Han, Liyuan; Sun, Dianjianyi; Heianza, Yoriko; Wang, Tiange; Duan, Donghui] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA.
   [Han, Liyuan; Duan, Donghui] Ningbo Univ, Sch Med, Dept Prevent Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo, Zhejiang, Peoples R China.
   [Ma, Wenjie; Sacks, Frank M.; Qi, Lu] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Zheng, Yan; Sacks, Frank M.; Qi, Lu] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Wang, Tiange] Shanghai Jiao Tong Univ, Sch Med, Shanghai Clin Ctr Endocrine & Metab Dis, Rui Jin Hosp, Shanghai, Peoples R China.
   [Huang, Tao] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Bray, J. George A.; Champagne, Catherine M.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.
   [Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   [Qi, Lu] Harvard Med Sch, Boston, MA 02115 USA.
C3 Tulane University; Ningbo University; Harvard University; Harvard T.H.
   Chan School of Public Health; Harvard University; Harvard T.H. Chan
   School of Public Health; Shanghai Jiao Tong University; National
   University of Singapore; Louisiana State University System; Louisiana
   State University; Pennington Biomedical Research Center; Harvard
   University; Harvard University Medical Affiliates; Brigham & Women's
   Hospital; Harvard University; Harvard Medical School
RP Qi, L (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Qi, L (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.; Qi, L (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Qi, L (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.
EM lqi1@tulane.edu
RI Huang, Tao/ITU-9131-2023; Zheng, Yan/E-7388-2018; Wang,
   Tiange/MCX-9826-2025; Champagne, Catherine/N-1956-2017
OI Sun, Dianjianyi/0000-0003-3651-6693; Wang, Tiange/0000-0003-0723-489X;
   Duan, Donghui/0000-0001-8017-1990
FU National Heart, Lung, and Blood Institute [HL-071981]; National
   Institute of Diabetes and Digestive and Kidney Diseases [DK-091718];
   General Clinical Research Center [RR-02635]; Boston Obesity Nutrition
   Research Center [DK-46200]; United States-Israel Binational Science
   Foundation Grant [2011036]
FX Supported by grants from the National Heart, Lung, and Blood Institute
   (HL-071981); the National Institute of Diabetes and Digestive and Kidney
   Diseases (DK-091718); the General Clinical Research Center (RR-02635);
   the Boston Obesity Nutrition Research Center (DK-46200); and United
   States-Israel Binational Science Foundation Grant 2011036.
CR Agardh CD, 2012, PANCREAS, V41, P253, DOI 10.1097/MPA.0b013e3182243107
   Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x
   BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033
   Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348
   Jia HJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0389-3
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Lee AH, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.19
   Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008
   Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Raimondo A, 2015, CURR OPIN LIPIDOL, V26, P88, DOI 10.1097/MOL.0000000000000155
   Rodenburg EM, 2012, AM J CLIN NUTR, V96, P182, DOI 10.3945/ajcn.111.027102
   Rosenfalck AM, 2006, DIABETIC MED, V23, P384, DOI 10.1111/j.1464-5491.2005.01810.x
   Rustenbeck I, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.19
   Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748
   Sanders TAB, 2003, CURR OPIN CLIN NUTR, V6, P151, DOI 10.1097/00075197-200303000-00003
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Shi XQ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0220-7
   Straznicky NE, 1999, HYPERTENSION, V34, P580, DOI 10.1161/01.HYP.34.4.580
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   Westerterp KS, 1999, MED SCI SPORT EXER, V31, pS522, DOI 10.1097/00005768-199911001-00006
NR 34
TC 8
Z9 8
U1 1
U2 16
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD NOV 1
PY 2017
VL 106
IS 5
BP 1321
EP 1326
DI 10.3945/ajcn.117.156232
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FL4ZV
UT WOS:000414241100020
PM 28931532
OA Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Kawakami, R
   Tanisawa, K
   Ito, T
   Usui, C
   Ishii, K
   Muraoka, I
   Suzuki, K
   Sakamoto, S
   Higuchi, M
   Oka, K
AF Kawakami, Ryoko
   Tanisawa, Kumpei
   Ito, Tomoko
   Usui, Chiyoko
   Ishii, Kaori
   Muraoka, Isao
   Suzuki, Katsuhiko
   Sakamoto, Shizuo
   Higuchi, Mitsuru
   Oka, Koichiro
TI Coffee consumption and skeletal muscle mass: WASEDA'S Health Study
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Beverages; Body composition; Caffeine; Sarcopenia
ID DIET HISTORY QUESTIONNAIRES; PHYSICAL-ACTIVITY; SENSITIVITY-ANALYSIS;
   SARCOPENIA; OBESITY
AB Few studies have examined the association between coffee consumption and muscle mass; their results are conflicting. Therefore, we examined the association between coffee consumption and low muscle mass prevalence. We also performed an exploratory investigation of the potential effect modification by demographic, health status-related and physical activity-related covariates. This cross-sectional study included 2085 adults aged 40-87 years. The frequency of coffee consumption was assessed using a self-administered questionnaire. Muscle mass was assessed as appendicular skeletal muscle mass/height(2) using a multifrequency bioelectrical impedance analyser. We defined low muscle mass using cut-offs recommended by the Asian Working Group for Sarcopenia. Multivariable-adjusted OR for low muscle mass prevalence were estimated using a logistic regression model. The prevalence of low muscle mass was 5 center dot 4 % (n 113). Compared with the lowest coffee consumption group (< 1 cup/week), the multivariable-adjusted OR (95 % CI) of low muscle mass prevalence were 0 center dot 62 (0 center dot 30, 1 center dot 29) for 1-3 cups/week, 0 center dot 53 (0 center dot 29, 0 center dot 96) for 4-6 cups/week or 1 cup/d and 0 center dot 28 (0 center dot 15, 0 center dot 53) for >= 2 cups/d (P for trend < 0 center dot 001). There were no significant interactions among the various covariates after Bonferroni correction. In conclusion, coffee consumption may be inversely associated with low muscle mass prevalence.
C1 [Kawakami, Ryoko; Tanisawa, Kumpei; Usui, Chiyoko; Ishii, Kaori; Muraoka, Isao; Suzuki, Katsuhiko; Sakamoto, Shizuo; Higuchi, Mitsuru; Oka, Koichiro] Waseda Univ, Fac Sport Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.
   [Ito, Tomoko] Waseda Univ, Waseda Inst Sport Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.
   [Ito, Tomoko] Tokyo Kasei Univ, Dept Food & Nutr, Itabashi Ku, 1-18-1 Kaga, Tokyo 1738602, Japan.
   [Sakamoto, Shizuo] Surugadai Univ, Fac Sport Sci, 698 Azu, Hanno, Saitama 3578555, Japan.
C3 Waseda University; Waseda University
RP Kawakami, R (corresponding author), Waseda Univ, Fac Sport Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.
EM r.kawakami@aoni.waseda.jp
RI saedmocheshi, saber/GQA-9175-2022; Kawakami, Ryoko/K-8149-2019; Oka,
   Koichiro/K-3297-2019
OI Kawakami, Ryoko/0000-0001-8211-1553; Tanisawa,
   Kumpei/0000-0002-9334-7104
FU Japan Society for the Promotion of Science [JP18K17982, JP21K17693,
   JP26242070, JP19H04008, JP18H03198]; Ministry of Education, Culture,
   Sports, Science and Technology [S1511017]; Grants-in-Aid for Scientific
   Research [21K17693, 23K27966] Funding Source: KAKEN
FX This work was supported by a Grant-in-Aid for Early-Career Scientists
   (R.K., grant numbers JP18K17982 and JP21K17693) and Scientific Research
   (I.M., grant numbers JP26242070 and JP19H04008), (M.H., grant number
   JP18H03198) from the Japan Society for the Promotion of Science;
   MEXT-Supported Program for the Strategic Research Foundation at Private
   Universities from the Ministry of Education, Culture, Sports, Science
   and Technology (K.O., grant number S1511017). The funders had no role in
   the study design; collection, analysis or interpretation of the data or
   preparation, review or approval of the manuscript.
CR Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054
   Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790
   Chen LK, 2020, J AM MED DIR ASSOC, V21, P300, DOI 10.1016/j.jamda.2019.12.012
   Chung H, 2017, KOREAN J FAM MED, V38, P141, DOI 10.4082/kjfm.2017.38.3.141
   Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9
   Cruz-Jentoft AJ, 2010, CURR OPIN CLIN NUTR, V13, P1, DOI 10.1097/MCO.0b013e328333c1c1
   Dent E, 2018, J NUTR HEALTH AGING, V22, P1148, DOI 10.1007/s12603-018-1139-9
   Dirks-Naylor AJ, 2015, LIFE SCI, V143, P182, DOI 10.1016/j.lfs.2015.11.005
   Grgic J, 2020, BRIT J SPORT MED, V54, P681, DOI 10.1136/bjsports-2018-100278
   Guo YT, 2014, EXP GERONTOL, V50, P1, DOI 10.1016/j.exger.2013.11.005
   Iwasaka C, 2021, GERIATR GERONTOL INT, V21, P950, DOI 10.1111/ggi.14264
   Jang YJ, 2018, FOOD FUNCT, V9, P1102, DOI [10.1039/c7fo01683b, 10.1039/C7FO01683B]
   Kawakami R, 2021, CLIN NUTR, V40, P5523, DOI 10.1016/j.clnu.2021.09.032
   Kawakami R, 2020, GERIATR GERONTOL INT, V20, P943, DOI 10.1111/ggi.14025
   Kawamura T, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/5566880
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075
   Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Linden A, 2020, STATA J, V20, P162, DOI 10.1177/1536867X20909696
   Oishi Y, 2015, J APPL PHYSIOL, V118, P742, DOI 10.1152/japplphysiol.00054.2014
   Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Schrader P, 2013, NUTR RES, V33, P457, DOI 10.1016/j.nutres.2013.04.003
   Steffl M, 2017, CLIN INTERV AGING, V12, P835, DOI 10.2147/CIA.S132940
   Tanisawa K, 2022, BRIT J NUTR, V127, P1712, DOI 10.1017/S0007114521002671
   Tripette J, 2018, INT J SPORT NUTR EXE, V28, P474, DOI 10.1123/ijsnem.2017-0428
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607
   Xia L, 2020, CANCER MED-US, V9, P7964, DOI 10.1002/cam4.3428
   Xu J, 2022, GERONTOLOGY, V68, P361, DOI 10.1159/000517099
NR 32
TC 10
Z9 10
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JUL 14
PY 2023
VL 130
IS 1
BP 127
EP 136
AR PII S0007114522003099
DI 10.1017/S0007114522003099
EA SEP 2022
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA I2XI9
UT WOS:000867448900001
PM 36172922
OA hybrid, Green Published
DA 2025-04-28
ER

PT J
AU Liu, LB
   Zhang, CY
   Zhai, M
   Yu, TS
   Pei, MQ
   Du, P
   Li, AL
   Yan, JY
   Li, C
   Zhang, GF
AF Liu, Libo
   Zhang, Chenyi
   Zhai, Min
   Yu, Tianshu
   Pei, Mengqi
   Du, Peng
   Li, Aili
   Yan, Jiayi
   Li, Chun
   Zhang, Guofang
TI Effect of chlorogenic acid on lipid metabolism in 3T3-L1 cells induced
   by oxidative stress
SO FOOD BIOSCIENCE
LA English
DT Article
DE Antioxidants; Cell differentiation; Chlorogenic acid; Lipid metabolism;
   Oxidative stress
ID DIET-INDUCED OBESITY; URSOLIC ACID; PPAR-GAMMA; PROTECTS; TISSUE;
   ADIPOGENESIS; ANTIOXIDANT; ACTIVATION; INJURY; AMPK
AB Chlorogenic acid (CGA), a phenolic acid compound found in a variety of natural plants, has strong antioxidant capacity. In this study, we aimed to investigate the effects of CGA on differentiation and lipid metabolism of 3T3-L1 cells, as well as its protective effect against cellular oxidative stress induced by H2O2. We found that CGA can reduce the accumulation of intracellular ROS and attenuate the production of inflammatory cytokines TNF-alpha under oxidative stress. CGA treatment significantly inhibited preadipocytes differentiation and lipid accumula-tion in 3T3-L1 cells. Our results suggest that CGA may regulate lipid metabolism by reducing the expression of differentiation-related genes and inhibiting triacylglyceride synthesis. The findings of this study support CGA as a potential therapeutic agent for obesity. The effects of CGA and its metabolites in vivo should be investigated to further support its application in functional foods.
C1 [Liu, Libo; Zhang, Chenyi; Zhai, Min; Yu, Tianshu; Pei, Mengqi; Du, Peng; Li, Aili; Yan, Jiayi; Li, Chun; Zhang, Guofang] Northeast Agr Univ, Coll Food Sci, Key Lab Dairy Sci, Harbin 150030, Peoples R China.
   [Li, Chun; Zhang, Guofang] Natl Dairy Engn Technol Res Ctr, Harbin 150028, Peoples R China.
   [Li, Chun] Heilongjiang Green Food Sci Res Inst, Harbin 150028, Peoples R China.
C3 Northeast Agricultural University - China
RP Li, C; Zhang, GF (corresponding author), Northeast Agr Univ, Coll Food Sci, Key Lab Dairy Sci, Harbin 150030, Peoples R China.
EM lbliu@neau.edu.cn; zcy184379@163.com; zhm98915@163.com;
   1289587797@qq.com; mengqi273@163.com; dupeng@neau.edu.cn;
   warmstar0224@126.com; 602105751@qq.com; lchun@neau.edu.cn;
   gfzhang@neau.edu.cn
RI Yan, Jiayi/AEU-9364-2022
OI Li, chun/0000-0003-1603-7222; Liu, Libo/0000-0002-6077-1988
FU Distinguished Young Foundation of Heilongjiang Province of China
   [JQ2020C006]; Academic Backbone Plan of Northeast Agricultural
   University [54916912]; Key Project of National Dairy Innovation Research
   Center of Inner Mongolia; Characteristic Probiotics and New Fermented
   Food Team in Northeast Agricultural University [54940912]
FX This research was funded by the Distinguished Young Foundation of
   Heilongjiang Province of China (JQ2020C006), Academic Backbone Plan of
   Northeast Agricultural University (54916912), Key Project of National
   Dairy Innovation Research Center of Inner Mongolia (2021-National Dairy
   Innovation Research Center-8) , Characteristic Probiotics and New
   Fermented Food Team in Northeast Agricultural University (54940912).
CR Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339
   Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055
   Chen J, 2018, J AGR FOOD CHEM, V66, P11926, DOI 10.1021/acs.jafc.8b04330
   Chen YC, 2014, J FUNCT FOODS, V9, P98, DOI 10.1016/j.jff.2014.02.019
   Costa DL, 2021, MUCOSAL IMMUNOL, V14, P253, DOI 10.1038/s41385-020-00342-x
   Dludla PV, 2018, TOXICOL REP, V5, P1014, DOI 10.1016/j.toxrep.2018.10.002
   Gao RF, 2014, EUR J PHARMACOL, V729, P54, DOI 10.1016/j.ejphar.2014.01.015
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Huang YN, 2021, CELL STRESS CHAPERON, V26, P563, DOI 10.1007/s12192-021-01201-9
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Jang J, 2018, J ETHNOPHARMACOL, V210, P10, DOI 10.1016/j.jep.2017.08.024
   Jensen-Urstad APL, 2012, BBA-MOL CELL BIOL L, V1821, P747, DOI 10.1016/j.bbalip.2011.09.017
   Jiang YF, 2021, MOL BIOL REP, V48, P2351, DOI 10.1007/s11033-021-06267-3
   Juman S, 2010, BIOL PHARM BULL, V33, P1484, DOI 10.1248/bpb.33.1484
   Kim Y.J., 2021, CURR DEV NUTR, V5, P1224
   Li BH, 2006, IUBMB LIFE, V58, P39, DOI 10.1080/15216540500507408
   Lou LX, 2016, EXP THER MED, V11, P2054, DOI 10.3892/etm.2016.3136
   Lu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep37589
   Malhotra A., 2014, INDO GLOBAL J PHARM, DOI [10.35652/IGJPS.2014.91,04, DOI 10.35652/IGJPS.2014.91,04]
   Manna P, 2015, METAB SYNDR RELAT D, V13, P423, DOI 10.1089/met.2015.0095
   Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737
   Pahlavani N, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-00485-5
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Pietrocola F, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10010102
   Rai SN, 2016, J CHEM NEUROANAT, V71, P41, DOI 10.1016/j.jchemneu.2015.12.002
   Rajan RK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194667
   Shi HT, 2016, CLIN NUTR, V35, P1366, DOI 10.1016/j.clnu.2016.03.002
   Sim MO, 2019, CHEM-BIOL INTERACT, V311, DOI 10.1016/j.cbi.2019.108755
   Singh SS, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00757
   Singh SS, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6571484
   Smith A, 2018, PESTIC BIOCHEM PHYS, V150, P48, DOI 10.1016/j.pestbp.2018.07.003
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Song YF, 2018, CELL SIGNAL, V51, P176, DOI 10.1016/j.cellsig.2018.08.005
   Sroka Z, 2003, FOOD CHEM TOXICOL, V41, P753, DOI 10.1016/S0278-6915(02)00329-0
   Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006
   Wang XM, 2017, FOOD FUNCT, V8, P2924, DOI [10.1039/c7fo00659d, 10.1039/C7FO00659D]
   Wang YZ, 2014, INFLAMMATION, V37, P1120, DOI 10.1007/s10753-014-9836-y
   Wu DH, 2015, J PHARMACOL SCI, V129, P177, DOI 10.1016/j.jphs.2015.10.005
   Yi CO, 2011, ANAT CELL BIOL, V44, P194, DOI 10.5115/acb.2011.44.3.194
   Yoshinaga N, 2011, LAB INVEST, V91, P1277, DOI 10.1038/labinvest.2011.101
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
   Zahra W, 2020, CNS NEUROL DISORD-DR, V19, P527, DOI 10.2174/1871527319666200812224457
NR 43
TC 9
Z9 10
U1 5
U2 47
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-4292
EI 2212-4306
J9 FOOD BIOSCI
JI Food Biosci.
PD FEB
PY 2023
VL 51
AR 102330
DI 10.1016/j.fbio.2022.102330
EA JAN 2023
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA G7ZS7
UT WOS:000991300900001
DA 2025-04-28
ER

PT J
AU Li, DK
   Ferber, JR
   Odouli, R
AF Li, D-K
   Ferber, J. R.
   Odouli, R.
TI Maternal caffeine intake during pregnancy and risk of obesity in
   offspring: a prospective cohort study
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
ID ENDOCRINE DISRUPTORS; SPONTANEOUS-ABORTION; ENERGY-BALANCE; FETAL-DEATH;
   CONSUMPTION; EXPOSURE; CHILDHOOD; PHOSPHORYLATION; METABOLISM;
   OVERWEIGHT
AB BACKGROUND/OBJECTIVES: In-utero exposures through adverse fetal programming are emerging as an important contributing factor to the epidemic of childhood obesity. This study examines the impact of in-utero exposure to caffeine on the risk of childhood obesity in offspring.
   SUBJECTS/METHODS: A prospective study of pregnant women with 15 years follow-up of their offspring was conducted to examine the impact of in-utero exposure to caffeine on the risk of childhood obesity. Maternal caffeine intake was prospectively ascertained during pregnancy and outcome measures (body mass index (BMI)) were ascertained from medical charts, with 17 BMI measurements per child, on average, during the follow-up period. Potential confounders including known perinatal risk factors for childhood obesity were adjusted for using the generalized estimating equations model with repeated measurements.
   RESULTS: After controlling for potential confounders, compared with those without caffeine exposure, in-utero exposure to caffeine overall is associated with 87% increased risk of childhood obesity: odds ratio (OR) = 1.87, 95% confidence interval (CI): 1.12-3.12. This association demonstrated a dose-response relationship: OR = 1.77 (1.05-3.00) for maternal daily caffeine intake <150mg per day, OR = 2.37 (1.24-4.52) for caffeine intake >= 150 mg per day during pregnancy, respectively. We also observed a linear relationship: every one unit increase (log(10) scale) in the amount of maternal caffeine intake was associated with 23% increased risk of obesity in offspring. The dose-response relationship appears stronger for persistent obesity than for transitory obesity (occasional high BMI), and for girls than for boys.
   CONCLUSIONS: We observed an association of in-utero exposure to caffeine with increased risk of childhood obesity. If this observation is further replicated in other studies, the finding will contribute to the understanding of fetal programming of childhood diseases and development of intervention strategy to prevent childhood obesity.
C1 [Li, D-K; Ferber, J. R.; Odouli, R.] Kaiser Permanente, Div Res, Kaiser Fdn Res Inst, Oakland, CA 94612 USA.
   [Li, D-K] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA.
C3 Kaiser Permanente; Stanford University
RP Li, DK (corresponding author), Kaiser Permanente, Div Res, Kaiser Fdn Res Inst, 2000 Broadway, Oakland, CA 94612 USA.
EM de-kun.li@kp.org
FU California Public Health Foundation
FX The original study was funded in part by the California Public Health
   Foundation, which had no role in the conduct of the study.
CR ALDRIDGE A, 1979, CLIN PHARMACOL THER, V25, P447
   ALDRIDGE A, 1981, SEMIN PERINATOL, V5, P310
   Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C
   Bech BH, 2005, AM J EPIDEMIOL, V162, P983, DOI 10.1093/aje/kwi317
   Bech BH, 2006, INT J EPIDEMIOL, V35, P948, DOI 10.1093/ije/dyl116
   Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335
   Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x
   Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503
   Crozier SR, 2009, PAEDIATR PERINAT EP, V23, P446, DOI 10.1111/j.1365-3016.2009.01036.x
   Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153
   Egawa T, 2011, J APPL PHYSIOL, V111, P1629, DOI 10.1152/japplphysiol.00249.2011
   Ervin RB., 2013, Consumption of added sugars among U.S. adults
   FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763
   GOLDSTEIN A, 1962, BIOCHEM PHARMACOL, V11, P166, DOI 10.1016/0006-2952(62)90106-5
   Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5
   Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010
   Heindel JJ, 2003, TOXICOL SCI, V76, P247, DOI 10.1093/toxsci/kfg255
   Hosmer D.W., 2000, LOGISTIC REGRESSION, Vsecond
   Ibáñez L, 2009, J CLIN ENDOCR METAB, V94, P3696, DOI 10.1210/jc.2009-0789
   Infante-Rivard C, 2007, PAEDIATR PERINAT EP, V21, P300, DOI 10.1111/j.1365-3016.2007.00825.x
   Kennedy J, 2014, APPETITE, V75, P103, DOI 10.1016/j.appet.2013.12.017
   Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178
   KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8
   Klebanoff MA, 2002, AM J EPIDEMIOL, V155, P32, DOI 10.1093/aje/155.1.32
   Kolnes AJ, 2010, ACTA PHYSIOL, V200, P65, DOI 10.1111/j.1748-1716.2010.02103.x
   Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151
   Kuczmarski RJ, 2000, VITAL HLTH STAT, P1, DOI [DOI 10.1016/J.BBRC.2015.06.114, DOI 10.1590/S1516-35982002000600018]
   Leduc L, 2010, EUR J OBSTET GYN R B, V149, P127, DOI 10.1016/j.ejogrb.2009.12.005
   Li DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063445
   Li DK, 2002, EPIDEMIOLOGY, V13, P9, DOI 10.1097/00001648-200201000-00004
   Liu YS, 2012, TOXICOL APPL PHARM, V262, P205, DOI 10.1016/j.taap.2012.05.002
   Luo HW, 2014, TOXICOL APPL PHARM, V274, P383, DOI 10.1016/j.taap.2013.11.020
   Luo ZC, 2010, WORLD J DIABETES, V1, P89, DOI 10.4239/wjd.v1.i3.89
   Matijasevich A, 2006, PAEDIATR PERINAT EP, V20, P100, DOI 10.1111/j.1365-3016.2006.00706.x
   Matijasevich Alicia, 2005, Cad. Saúde Pública, V21, P1676, DOI 10.1590/S0102-311X2005000600014
   Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Moreno-López L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049185
   Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x
   Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047
   Parazzini F, 1998, HUM REPROD, V13, P2286, DOI 10.1093/humrep/13.8.2286
   Picard A, 2014, MOL METAB, V3, P167, DOI 10.1016/j.molmet.2013.11.002
   Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42
   Signorello LB, 2004, EPIDEMIOLOGY, V15, P229, DOI 10.1097/01.ede.0000112221.24237.0c
   Signorello LB, 2001, OBSTET GYNECOL, V98, P1059, DOI 10.1016/S0029-7844(01)01575-7
   Sullivan EL, 2010, FORUM NUTR, V63, P186, DOI 10.1159/000264406
   Svensson V, 2011, INT J OBESITY, V35, P46, DOI 10.1038/ijo.2010.189
   Tan Y, 2012, TOXICOL LETT, V214, P279, DOI 10.1016/j.toxlet.2012.09.007
   Taubes G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1050
   Taubes G, 2012, NATURE, V492, P155, DOI 10.1038/492155a
   Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597
   Vik T, 2003, PAEDIATR PERINAT EP, V17, P324, DOI 10.1046/j.1365-3016.2003.00507.x
   Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747
   WEATHERSBEE PS, 1977, J REPROD MED, V19, P55
   Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132
   Wen XZ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-38
   Weng XP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.803
   Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705
   Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016
   Xu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044497
   YOSHINO S, 1994, PHYSIOL BEHAV, V56, P31, DOI 10.1016/0031-9384(94)90258-5
NR 61
TC 31
Z9 34
U1 1
U2 31
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD APR
PY 2015
VL 39
IS 4
BP 658
EP 664
DI 10.1038/ijo.2014.196
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA CF4XO
UT WOS:000352557500016
PM 25388405
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Yang, Z
   Shao, Z
   Ouyang, WY
   Ying, L
   Guo, R
   Hao, MX
   Liang, YF
   Zhang, WJ
   Chen, XY
   Chen, RL
   Yu, CY
   Prabahar, K
   Gaman, MA
   Kord-Varkaneh, H
   Li, H
   Zhao, BB
AF Yang, Zhao
   Shao, Zhuo
   Ouyang, Weiyi
   Ying, Lu
   Guo, Rui
   Hao, Mingxuan
   Liang, Youfeng
   Zhang, Wenjing
   Chen, Xiaoyang
   Chen, Ruolan
   Yu, Changyuan
   Prabahar, Kousalya
   Gaman, Mihnea-Alexandru
   Kord-Varkaneh, Hamed
   Li, Hao
   Zhao, Binbin
TI The effect of green coffee extract supplementation on obesity indices:
   critical umbrella review of interventional meta-analyses
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Green coffee extract; obesity; body weight; BMI; WC
ID CHLOROGENIC ACIDS; WEIGHT-LOSS; BODY-MASS; LONG-TERM; OVERWEIGHT;
   HEALTH; RISK; CONSUMPTION; VOLUNTEERS; ABSORPTION
AB Despite a multitude of investigations assessing the impact of green coffee extract supplementation on obesity indices, there is still a great deal of heated debate regarding the benefits of this intervention in obesity management. Therefore, in order to clarify the effect of green coffee extract on waist circumference (WC), body mass index (BMI) and body weight (BW), we conducted an umbrella review of interventional meta-analyses. The Web of Science, Scopus, PubMed/Medline, and Embase databases were searched using specific keywords and word combinations. The umbrella meta-analysis was performed using the Stata software version 17 (Stata Corp. College Station, Texas, USA). We pooled effect sizes (ES) and confidence intervals (CI) for the outcomes using the random effects model (the DerSimonian and Laird method). In total, 5 eligible meta-analyses were included in the final quantitative assessment. Data pooled from 5 eligible papers revealed that green coffee extract can reduce BW (WMD: -1.22 kg, 95% CI: -1.53 to -0.92, p < 0.001), BMI (WMD: -0.48 kg/m(2), 95% CI: -0.67 to -0.29, p < 0.001) and WC (WMD: -0.55 cm, 95% CI: -0.80 to -0.31, p < 0.001). Subgroup analyses highlighted that green coffee extract supplementation in dosages & LE;600 mg/day and interventions lasting >7 wk are more likely to decrease BW. The present umbrella meta-analysis confirms the beneficial effects of green coffee extract in reducing WC, BMI, and BW. Thus, we may infer that green coffee extract can be used as a complementary therapy in the management of obesity.
C1 [Yang, Zhao; Ouyang, Weiyi; Ying, Lu; Guo, Rui; Hao, Mingxuan; Liang, Youfeng; Zhang, Wenjing; Chen, Xiaoyang; Chen, Ruolan; Yu, Changyuan] Beijing Univ Chem Technol, Coll Life Sci & Technol, Innovat Ctr Mol Diagnost, Beijing, Peoples R China.
   [Yang, Zhao; Li, Hao] Jining Med Univ, Sch Publ Hlth, Jining, Shandong, Peoples R China.
   [Shao, Zhuo] China Japan Friendship Hosp, Dept Clin Lab, Beijing, Peoples R China.
   [Prabahar, Kousalya] Univ Tabuk, Fac Pharm, Dept Pharm Practice, Tabuk, Saudi Arabia.
   [Gaman, Mihnea-Alexandru] Carol Davila Univ Med & Pharm, Fundeni Clin Inst, Fac Med, Bucharest, Romania.
   [Gaman, Mihnea-Alexandru] Fundeni Clin Inst, Ctr Hematol & Bone Marrow Transplantat, Bucharest, Romania.
   [Kord-Varkaneh, Hamed] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran.
   [Zhao, Binbin] Hubei Univ Chinese Med, Inst Gerontol, Wuhan, Hubei, Peoples R China.
   [Kord-Varkaneh, Hamed] Hamadan Univ Med Sci, Sch Med, Dept Nutr, Hamadan, Iran.
C3 Beijing University of Chemical Technology; Jining Medical University;
   China-Japan Friendship Hospital; University of Tabuk; Carol Davila
   University of Medicine & Pharmacy; Institutul Clinic Fundeni; Institutul
   Clinic Fundeni; Shahid Beheshti University Medical Sciences; Hubei
   University of Chinese Medicine; Hamadan University of Medical Sciences
RP Li, H (corresponding author), Jining Med Univ, Sch Publ Hlth, Jining, Shandong, Peoples R China.; Zhao, BB (corresponding author), Hubei Univ Chinese Med, Inst Gerontol, Wuhan, Hubei, Peoples R China.
RI LI, HAO/KBD-0866-2024; zhang, wenjing/AAE-7146-2019; Prabahar,
   Kousalya/AAE-6842-2021; Chen, Xiaoyang/AFO-6154-2022; Zhao,
   Binbin/HTS-9980-2023; Găman, Mihnea-Alexandru/O-4258-2016; Ouyang,
   Weiyi/H-2539-2015
OI Prabahar, Kousalya/0000-0001-8224-4276
FU Traditional Chinese Medicine Research Project of Health Commission of
   Hubei Province [ZY2021M017]; Hubei University of Chinese Medicine Funds
   for Distinguished Young Scholars [2022ZZXJ004]; Xinjiang Association for
   Science and Technology's Young Elite Scientists Sponsorship Programme;
   Scientific and Technological Research Project of the Xinjiang Production
   and Construction Corps;  [2022AB022]
FX This research was funded by Traditional Chinese Medicine Research
   Project of Health Commission of Hubei Province (No. ZY2021M017), Hubei
   University of Chinese Medicine Funds for Distinguished Young Scholars
   (No. 2022ZZXJ004), Xinjiang Association for Science and Technology's
   Young Elite Scientists Sponsorship Programme (2021) and the Scientific
   and Technological Research Project of the Xinjiang Production and
   Construction Corps (2022AB022).
CR Alhabeeb H, 2021, EAT WEIGHT DISORD-ST, V26, P2117, DOI 10.1007/s40519-020-01101-4
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Asbaghi O, 2020, COMPLEMENT THER MED, V51, DOI 10.1016/j.ctim.2020.102424
   Asoudeh F, 2023, CLIN NUTR ESPEN, V55, P244, DOI 10.1016/j.clnesp.2023.03.013
   Bidel S, 2006, HORM METAB RES, V38, P38, DOI 10.1055/s-2006-924982
   Bischoff S. C., 2017, Clinical Nutrition, V36, P917, DOI 10.1016/j.clnu.2016.11.007
   Cakmur H., 2020, OBESITY
   Chen QW, 2022, INT J VITAM NUTR RES, V92, P85, DOI 10.1024/0300-9831/a000727
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1063::AID-JSFA605>3.0.CO;2-Q]
   Cory H, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00087
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   Djalalinia S, 2015, PAK J MED SCI, V31, P239, DOI 10.12669/pjms.311.7033
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farah A, 2019, BEVERAGES, V5, DOI 10.3390/beverages5010011
   Fasihi M, 2019, NUTR FOOD SCI, V50, P21, DOI 10.1108/NFS-02-2019-0047
   Friedman M, 1997, J AGR FOOD CHEM, V45, P1523, DOI 10.1021/jf960900s
   Gorji Z, 2019, PHYTOMEDICINE, V63, DOI 10.1016/j.phymed.2019.153018
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Guh Daphne P, 2009, BMC Public Health, V9, P88, DOI 10.1186/1471-2458-9-88
   Hezaveh E, 2023, CRIT REV FOOD SCI, V63, P5290, DOI 10.1080/10408398.2021.2016600
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hu LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170238
   Karimi E, 2021, PHYTOTHER RES, V35, P5339, DOI 10.1002/ptr.7139
   Kord HV, 2021, CLIN NUTR, V40, P1811, DOI 10.1016/j.clnu.2020.10.034
   Kord-Varkaneh H, 2023, NUTRITION, V105, DOI 10.1016/j.nut.2022.111847
   Kord-Varkaneh H, 2019, J BONE MINER METAB, V37, P179, DOI 10.1007/s00774-018-0912-5
   Lavie CJ, 2014, J AM COLL CARDIOL, V63, P1345, DOI 10.1016/j.jacc.2014.01.022
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Luthria DL, 2006, J AGR FOOD CHEM, V54, P41, DOI 10.1021/jf0522457
   Moffatt E, 2011, CAN J PUBLIC HEALTH, V102, P144, DOI 10.1007/BF03404164
   Moghimipour Z., 2022, FERTILITY GYNECOLOGY, V2
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Mousavi SM, 2022, ADV NUTR, V13, P1762, DOI 10.1093/advances/nmac040
   Mousavi SM, 2021, PHYTOTHER RES, V35, P5634, DOI 10.1002/ptr.7200
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nouri-Majd S, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.873162
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Perrone D, 2010, J AGR FOOD CHEM, V58, P12238, DOI 10.1021/jf102110u
   Pourmasoumi M, 2021, ADV EXP MED BIOL, V1328, P323, DOI 10.1007/978-3-030-73234-9_21
   Ramli NNS, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57090957
   Safaei M, 2021, COMPUT BIOL MED, V136, DOI 10.1016/j.compbiomed.2021.104754
   SONG SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/718379
   Stacewicz-Sapuntzakis M, 2001, CRIT REV FOOD SCI, V41, P251, DOI 10.1080/20014091091814
   Vajargah KT, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.934568
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Varkaneh HK, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.948655
   Varkaneh HK, 2018, NUTR FOOD SCI, V48, P702, DOI 10.1108/NFS-09-2017-0203
   Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4
   Xia W, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105113
   Xiong P, 2020, COMPLEMENT THER CLIN, V39, DOI 10.1016/j.ctcp.2020.101113
   Young N, 2018, INT UROGYNECOL J, V29, P1129, DOI 10.1007/s00192-017-3455-8
   Zargarzadeh N, 2023, ADV NUTR, V14, P64, DOI 10.1016/j.advnut.2022.10.009
   Zargarzadeh N, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.911273
   Zargarzadeh N, 2021, CLIN THER, V43, pE346, DOI 10.1016/j.clinthera.2021.10.002
NR 59
TC 1
Z9 1
U1 3
U2 32
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD NOV 16
PY 2024
VL 64
IS 29
BP 10537
EP 10545
DI 10.1080/10408398.2023.2225614
EA JUN 2023
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA I5A2A
UT WOS:001013949100001
PM 37341701
DA 2025-04-28
ER

PT J
AU Nordestgaard, AT
AF Nordestgaard, Ask T.
TI Causal relationship from coffee consumption to diseases and mortality: a
   review of observational and Mendelian randomization studies including
   cardiometabolic diseases, cancer, gallstones and other diseases
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Review
DE Mendelian randomization; Epidemiology; Genetics; Cardiovascular disease;
   Diabetes
ID DOSE-RESPONSE METAANALYSIS; CHOLESTEROL-RAISING FACTOR; TYPE-2
   DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; TEA CONSUMPTION; CAFFEINE
   INTAKE; OVARIAN-CANCER; DEGRADATION-PRODUCTS; DECAFFEINATED COFFEE;
   ANTIOXIDANT CAPACITY
AB Purpose High coffee consumption is associated with low risk of mortality and morbidity, but the causality remains unclear. This review aims to discuss findings from observational studies on coffee consumption in context of Mendelian randomization studies. Methods The PubMed database was searched for all Mendelian randomization studies on coffee consumption and corresponding observational studies. Results High coffee consumption is associated with low risk of all-cause and cardiovascular mortality in observational studies (HRs of 0.85-0.90 vs. no/low consumers), with no support of causality in Mendelian randomization studies. Moderate/high consumption is associated with low risk of cardiometabolic diseases, including ischemic heart disease (HRs of 0.85-0.90 vs. no/low consumption), stroke (HRs of approximately 0.80 vs. no/low consumption), type 2 diabetes (HRs of approximately 0.70 vs. no/low consumption) and obesity in observational studies, but not in Mendelian randomization studies. High consumption is associated with low risk of endometrial cancer and melanoma and high risk of lung cancer in observational studies, but with high risk of colorectal cancer in Mendelian randomization studies. In observational and Mendelian randomization studies, high coffee consumption is associated with low risk of gallstones (HRs of 0.55-0.70 for high vs. no/low self-reported and 0.81 (0.69-0.96) for highest vs. lowest genetic consumption). Conclusion High coffee consumption is associated with low risk of mortality, cardiometabolic diseases, some cancers and gallstones in observational studies, with no evidence to support causality from Mendelian randomization studies for most diseases except gallstones.
C1 [Nordestgaard, Ask T.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Borgmester Ib Juuls Vej 1, DK-2730 Herlev, Denmark.
C3 University of Copenhagen; Copenhagen University Hospital
RP Nordestgaard, AT (corresponding author), Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Borgmester Ib Juuls Vej 1, DK-2730 Herlev, Denmark.
EM ask.tybjaerg.nordestgaard@regionh.dk
RI Nordestgaard, Ask/JBJ-0847-2023
OI Nordestgaard, Ask Tybjaerg/0000-0002-5500-686X
FU Herlev and Gentofte Hospital; Beckett Foundation
FX The study was supported by Herlev and Gentofte Hospital and the Beckett
   Foundation.
CR Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101
   Bae SC, 2018, CLIN RHEUMATOL, V37, P2875, DOI 10.1007/s10067-018-4278-9
   Bellou V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194127
   Benn M, 2018, CARDIOVASC RES, V114, P1192, DOI 10.1093/cvr/cvy045
   Benowitz NL, 2003, CLIN PHARMACOL THER, V74, P468, DOI 10.1016/j.clpt.2003.07.001
   Bjorngaard JH, 2017, INT J EPIDEMIOL, V46, P1958, DOI 10.1093/ije/dyx147
   Bodar V, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011346
   Boekschoten MV, 2005, J NUTR, V135, P785, DOI 10.1093/jn/135.4.785
   Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080
   Braem MGM, 2012, AM J CLIN NUTR, V95, P1172, DOI 10.3945/ajcn.111.026393
   Bravi F, 2017, EUR J CANCER PREV, V26, P368, DOI [10.1097/cej.0000000000000252, 10.1097/CEJ.0000000000000252]
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78
   Chang LH, 2020, DRUG ALCOHOL DEPEN, V210, DOI 10.1016/j.drugalcdep.2020.107966
   Choi HK, 2007, ARTHRITIS RHEUM, V56, P2049, DOI 10.1002/art.22712
   Choi HK, 2010, AM J CLIN NUTR, V92, P922, DOI 10.3945/ajcn.2010.29565
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101343
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   D'Elia L, 2019, EUR J NUTR, V58, P271, DOI 10.1007/s00394-017-1591-z
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Discacciati A, 2014, ANN ONCOL, V25, P584, DOI 10.1093/annonc/mdt420
   DOUGLAS BR, 1990, AM J CLIN NUTR, V52, P553, DOI 10.1093/ajcn/52.3.553
   Esposito F, 2003, ALIMENT PHARM THER, V17, P595, DOI 10.1046/j.1365-2036.2003.01429.x
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Faber MS, 2005, BASIC CLIN PHARMACOL, V97, P125, DOI 10.1111/j.1742-7843.2005.pto_973160.x
   Corrêa TAF, 2012, PLANT FOOD HUM NUTR, V67, P277, DOI 10.1007/s11130-012-0297-x
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571
   Galarraga V, 2016, CANCER EPIDEM BIOMAR, V25, P951, DOI 10.1158/1055-9965.EPI-15-0727
   Gan Y, 2017, ONCOTARGET, V8, P18699, DOI 10.18632/oncotarget.8627
   Georgiou Andrea N, 2021, Inflamm Bowel Dis, V27, P162, DOI 10.1093/ibd/izaa152
   Gloess AN, 2013, EUR FOOD RES TECHNOL, V236, P607, DOI 10.1007/s00217-013-1917-x
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Grosso G, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080890
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Hartwig FP, 2016, INT J EPIDEMIOL, V45, P1717, DOI 10.1093/ije/dyx028
   HOLSTEGE A, 1993, J HEPATOL, V17, P67, DOI 10.1016/S0168-8278(05)80523-9
   Huang TB, 2014, INT UROL NEPHROL, V46, P1481, DOI 10.1007/s11255-014-0699-9
   Hukkanen J, 2011, BRIT J CLIN PHARMACO, V72, P836, DOI 10.1111/j.1365-2125.2011.04023.x
   Hutton J, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1629-5
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Je Y, 2012, INT J CANCER, V131, P1700, DOI 10.1002/ijc.27408
   Jiang WJ, 2013, GYNECOL ONCOL, V129, P620, DOI 10.1016/j.ygyno.2013.03.014
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Josse AR, 2012, AM J CLIN NUTR, V96, P665, DOI 10.3945/ajcn.112.038794
   Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048
   Kamiyama M, 2015, J AGR FOOD CHEM, V63, P1996, DOI 10.1021/jf5060563
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kennedy OJ, 2020, AM J KIDNEY DIS, V75, P753, DOI 10.1053/j.ajkd.2019.08.025
   Kim Y, 2019, EUR J EPIDEMIOL, V34, P731, DOI 10.1007/s10654-019-00524-3
   Kiyohara C, 2014, ARTHRIT CARE RES, V66, P1048, DOI 10.1002/acr.22282
   Kwok MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep36500
   Lafranconi A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020112
   Lafranconi A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111223
   Lamichhane D, 2019, JCR-J CLIN RHEUMATOL, V25, P127, DOI 10.1097/RHU.0000000000000788
   Larsson SC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101501
   Larsson SC, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5375
   Larsson SC, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0447-8
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee DR, 2014, BONE, V63, P20, DOI 10.1016/j.bone.2014.02.007
   Lee YH, 2018, CLIN RHEUMATOL, V37, P3133, DOI 10.1007/s10067-018-4252-6
   Lee YH, 2014, CLIN RHEUMATOL, V33, P1575, DOI 10.1007/s10067-014-2631-1
   Leitzmann MF, 1999, JAMA-J AM MED ASSOC, V281, P2106, DOI 10.1001/jama.281.22.2106
   Leitzmann MF, 2002, GASTROENTEROLOGY, V123, P1823, DOI 10.1053/gast.2002.37054
   Li S, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0025-0
   Li XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052681
   LILLEMOE KD, 1989, SURGERY, V106, P400
   Liu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142457
   Liu H, 2015, NUTR CANCER, V67, P392, DOI 10.1080/01635581.2015.1004727
   Liu JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147056
   Liu QP, 2016, NUTRITION, V32, P628, DOI 10.1016/j.nut.2015.11.015
   Loftfield E, 2018, JAMA INTERN MED, V178, P1086, DOI 10.1001/jamainternmed.2018.2425
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Lukic M, 2018, NUTR CANCER, V70, P513, DOI 10.1080/01635581.2018.1460681
   Malerba S, 2013, EUR J EPIDEMIOL, V28, P527, DOI 10.1007/s10654-013-9834-7
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   McMahon G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103448
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P417, DOI 10.1080/09637486.2017.1373752
   Mirtavoos-Mahyari H, 2019, NUTR CANCER, V71, P887, DOI 10.1080/01635581.2019.1595055
   Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383
   Mostofsky E, 2012, CIRC-HEART FAIL, V5, P401, DOI 10.1161/CIRCHEARTFAILURE.112.967299
   Moura-Nunes N, 2009, INT J FOOD SCI NUTR, V60, P173, DOI 10.1080/09637480903158893
   Munafò MR, 2012, JNCI-J NATL CANCER I, V104, P740, DOI 10.1093/jnci/djs191
   Natella F, 2008, BRIT J NUTR, V100, P1276, DOI 10.1017/S0007114508981459
   Nicolopoulos K, 2020, CLIN NUTR, V39, P3467, DOI 10.1016/j.clnu.2020.03.009
   Nie JY, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000009070, 10.1097/md.0000000000009070]
   Nordenvall C, 2015, CLIN GASTROENTEROL H, V13, P1096, DOI 10.1016/j.cgh.2014.09.029
   Nordestgaard AT, 2020, J INTERN MED, V287, P42, DOI 10.1111/joim.12970
   Nordestgaard AT, 2016, INT J EPIDEMIOL, V45, P1938, DOI 10.1093/ije/dyw325
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Ong JS, 2019, INT J EPIDEMIOL, V48, P1447, DOI 10.1093/ije/dyz144
   Ong JS, 2018, INT J EPIDEMIOL, V47, P450, DOI 10.1093/ije/dyx236
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   van Oort S, 2020, AM HEART J, V227, P64, DOI 10.1016/j.ahj.2020.06.007
   Park KY, 2016, SEMIN ARTHRITIS RHEU, V45, P580, DOI 10.1016/j.semarthrit.2016.01.003
   Park SY, 2017, ANN INTERN MED, V167, P228, DOI 10.7326/M16-2472
   Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782
   Plowchalk DR, 2012, EUR J CLIN PHARMACOL, V68, P951, DOI 10.1007/s00228-011-1189-y
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Qayyum F, 2018, EUR HEART J, V39, P2106, DOI 10.1093/eurheartj/ehy068
   Qian Y, 2020, ANN NEUROL, V87, P525, DOI 10.1002/ana.25693
   Ricketts ML, 2007, MOL ENDOCRINOL, V21, P1603, DOI 10.1210/me.2007-0133
   Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438
   Salari-Moghaddam A, 2019, J CLIN ENDOCR METAB, V104, P5346, DOI 10.1210/jc.2019-00637
   Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]
   Shafiei F, 2019, INT J GYNECOL CANCER, V29, P579, DOI 10.1136/ijgc-2018-000102
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Sheng J, 2014, OSTEOPOROSIS INT, V25, P141, DOI 10.1007/s00198-013-2563-7
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070
   Stender S, 2013, JAMA INTERN MED, V173, P1222, DOI 10.1001/jamainternmed.2013.6465
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Svilaas A, 2004, J NUTR, V134, P562, DOI 10.1093/jn/134.3.562
   SWANSON JA, 1994, ADDICT BEHAV, V19, P229, DOI 10.1016/0306-4603(94)90027-2
   Taylor AE, 2017, INT J CANCER, V140, P322, DOI 10.1002/ijc.30462
   Treur JL, 2017, ADDICT BIOL, V22, P1090, DOI 10.1111/adb.12391
   Urgert R, 1997, ANNU REV NUTR, V17, P305, DOI 10.1146/annurev.nutr.17.1.305
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   Verweij KJH, 2018, ADDICTION, V113, P1333, DOI 10.1111/add.14154
   Vítek L, 2012, CLIN RES HEPATOL GAS, V36, P122, DOI 10.1016/j.clinre.2011.08.010
   Ware JJ, 2017, ADDICTION, V112, P1842, DOI 10.1111/add.13888
   Ware JJ, 2011, NICOTINE TOB RES, V13, P1167, DOI 10.1093/ntr/ntr118
   Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103
   Wijarnpreecha K, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12919
   Wijarnpreecha K, 2017, EUR J GASTROEN HEPAT, V29, pE8, DOI 10.1097/MEG.0000000000000776
   Wu L, 2017, CLIN NUTR, V36, P730, DOI 10.1016/j.clnu.2016.05.015
   Xia JD, 2017, UROL J, V14, P4079
   Xie Y, 2016, EUR J CLIN NUTR, V70, P199, DOI 10.1038/ejcn.2015.96
   Yang TO, 2015, AM J CLIN NUTR, V101, P570, DOI 10.3945/ajcn.113.081836
   Yang YH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015795
   Yuan S, 2019, NUTR METAB CARDIOVAS, V29, P1185, DOI 10.1016/j.numecd.2019.07.015
   Yuan S, 2019, CALCIFIED TISSUE INT, V105, P582, DOI 10.1007/s00223-019-00606-0
   Zhang YP, 2015, ALIMENT PHARM THER, V42, P637, DOI 10.1111/apt.13328
   Zhang Y, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009809
   Zhou A, 2019, AM J CLIN NUTR, V109, P509, DOI 10.1093/ajcn/nqy297
NR 143
TC 20
Z9 20
U1 1
U2 30
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD MAR
PY 2022
VL 61
IS 2
BP 573
EP 587
DI 10.1007/s00394-021-02650-9
EA JUL 2021
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA ZC3WX
UT WOS:000678435300001
PM 34319429
DA 2025-04-28
ER

PT J
AU de Sotillo, DVR
   Hadley, M
   Sotillo, JE
AF de Sotillo, DVR
   Hadley, M
   Sotillo, JE
TI Insulin receptor exon 11<SUP>+/-</SUP> is expressed in Zucker
   (fa/fa) rats, and chlorogenic acid modifies their plasma
   insulin and liver protein and DNA
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE increased protein concentration; liver DNA; chlorogenic acid; insulin
   sensitizer
ID POTATO PEEL EXTRACT; AGE-RELATED-CHANGES; BIOLOGICAL PARAMETERS;
   GLUCOSE-TOLERANCE; DIABETES-MELLITUS; FATTY RATS; OBESE; RESISTANCE;
   GLUCOSE-6-PHOSPHATASE; ATHEROSCLEROSIS
AB In vivo studies confirmed that chlorogenic acid (CGA) improved glucose tolerance and mineral pool distribution in obese Zucker (fa/fa) rats. We found a significant decrease (P < .05) in postprandial blood glucose concentrations, which may have been due to an improved sensitivity to insulin. Impaired glucose tolerance and insulin resistance have been associated with differences in the hepatic mRNA expression of the spliced variants of the insulin receptor at exon 11. Spliced variants of the insulin receptor have not been studied in obese Zucker (fa/fa) rats, and no information exists about the effects of CGA in vivo as a possible insulin sensitizer. Thus, we studied the in vivo effect of CGA on plasma insulin concentrations during a glucose tolerance test, liver protein and DNA concentrations, the hepatic activity of glucose-6-phosphatase (G-6-PASE) and the mRNA expression of the two variants of the insulin receptor at exon 11. Zucker (fa/fa) rats were implanted with jugular vein catheters. Chlorogenic acid was administered (5 mg/kg body weight per day) for 3 weeks via intravenous infusion.
   In the CGA-treated group, areas under the curve (AUC) for blood glucose and plasma insulin improved (P < .005), and the protein and DNA concentrations in the liver increased (P < .05). No significant differences (P > .05) were found between groups for the hepatic G-6-PASE activity. The insulin receptor exon 11(+) and the exon 11(-) variants were expressed in the liver of Zucker (fa/fa) rats without significant changes (P > .05). Chlorogenic acid improved some cellular mechanisms that are stimulated by insulin. (c) 2006 Elsevier Inc. All rights reserved.
C1 Minnesota State Univ, Dept Chem, Mankato, MN 56001 USA.
   Univ Minnesota, Sch Dent, Minneapolis, MN 55455 USA.
   N Dakota State Univ, Dept Food & Nutr, Fargo, ND 58105 USA.
C3 Minnesota State Colleges & Universities; Minnesota State University
   Mankato; University of Minnesota System; University of Minnesota Twin
   Cities; North Dakota State University Fargo
RP Minnesota State Univ, Dept Chem, Mankato, MN 56001 USA.
EM mary.hadley@mnsu.edu
CR Ames B.N., 1966, Methods in enzymology, V8, P115, DOI [DOI 10.1016/0076-6879(66)08014-5, 10.1016/0076-6879(66)08014-5]
   BACH A, 1981, LIPIDS, V16, P841, DOI 10.1007/BF02535040
   BACH A, 1977, LIFE SCI, V20, P541, DOI 10.1016/0024-3205(77)90399-X
   BALON TW, 1995, AM J PHYSIOL, V269, P745
   BOLLAG D, 1996, PROTEIN METHODS, pCH1
   BOWEN L, 1991, METABOLISM, V40, P1025, DOI 10.1016/0026-0495(91)90124-F
   BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2
   CLARK JB, 1982, ENDOCRINOLOGY, V111, P964, DOI 10.1210/endo-111-3-964
   De Sotillo DR, 1998, J FOOD SCI, V63, P907, DOI 10.1111/j.1365-2621.1998.tb17924.x
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   DESOTILLO DR, 1994, J FOOD SCI, V59, P649, DOI 10.1111/j.1365-2621.1994.tb05584.x
   DESOTILLO DR, 1994, J FOOD SCI, V59, P131
   EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4
   FUJIWARA T, 1988, DIABETES, V37, P1549, DOI 10.2337/diabetes.37.11.1549
   GOLDSTEIN BJ, 1990, MOL ENDOCRINOL, V4, P235, DOI 10.1210/mend-4-2-235
   GOSNELL BA, 1995, PSYCHOPHARMACOLOGY, V117, P248, DOI 10.1007/BF02245194
   Granberry MC, 1998, PHARMACOTHERAPY, V18, P973
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Henriksen EJ, 1998, AM J PHYSIOL-REG I, V275, pR40, DOI 10.1152/ajpregu.1998.275.1.R40
   Huang Z, 1996, J CLIN ENDOCR METAB, V81, P1552, DOI 10.1210/jc.81.4.1552
   JOOST HG, 1995, CELL SIGNAL, V7, P85, DOI 10.1016/0898-6568(94)00071-I
   Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151
   KARINCH M, 1994, JOSLINS DIABETES MEL, P116
   Kennedy KJ, 1998, J NUTR, V128, P43, DOI 10.1093/jn/128.1.43
   KOLTERMAN OG, 1981, J CLIN INVEST, V68, P957, DOI 10.1172/JCI110350
   Kono Y, 1998, BIOSCI BIOTECH BIOCH, V62, P22, DOI 10.1271/bbb.62.22
   Levin NW, 2001, CURR OPIN NEPHROL HY, V10, P563, DOI 10.1097/00041552-200109000-00003
   Mazur A, 1989, Magnes Res, V2, P189
   MITHIEUX G, 1993, EUR J BIOCHEM, V213, P461, DOI 10.1111/j.1432-1033.1993.tb17782.x
   Mithieux G, 1996, REPROD NUTR DEV, V36, P357, DOI 10.1051/rnd:19960402
   Nakatani T, 1998, BIOCHEM BIOPH RES CO, V243, P797, DOI 10.1006/bbrc.1998.8168
   NORGREN S, 1993, DIABETES, V42, P675, DOI 10.2337/diabetes.42.5.675
   Poirier B, 2000, NEPHROL DIAL TRANSPL, V15, P467, DOI 10.1093/ndt/15.4.467
   ROHNERJEANRENAUD F, 1986, DIABETES, V35, P1350, DOI 10.2337/diabetes.35.12.1350
   SALADINO CF, 1992, ARTERY, V19, P297
   *SAS I INC, 1985, SAS US GUID BAS STAT
   SCHERNTHANER G, 1985, HORM METAB RES S, P15116
   SCHIRARDIN H, 1979, ARCH INT PHYSIOL BIO, V87, P275, DOI 10.3109/13813457909070500
   *SPSS INC, 1998, SPSS SIGM GEL 1 0
   ZAIBI MS, 1995, BIOCHEM PHARMACOL, V50, P775, DOI 10.1016/0006-2952(95)00199-A
NR 40
TC 34
Z9 37
U1 1
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JAN
PY 2006
VL 17
IS 1
BP 63
EP 71
DI 10.1016/j.jnutbio.2005.06.004
PG 9
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 002JG
UT WOS:000234607100009
PM 16169204
DA 2025-04-28
ER

PT J
AU Han, X
   Zhang, YX
   Guo, JL
   You, YL
   Zhan, JC
   Huang, WD
AF Han, Xue
   Zhang, Yuxin
   Guo, Jielong
   You, Yilin
   Zhan, Jicheng
   Huang, Weidong
TI Chlorogenic Acid Stimulates the Thermogenesis of Brown Adipocytes by
   Promoting the Uptake of Glucose and the Function of Mitochondria
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE brown adipocyte; chlorogenic acid; glucose uptake; mitochondria;
   thermogenesis
ID ADIPOSE-TISSUE; HIGH-FAT; INSULIN-RESISTANCE; ANTIOXIDANT; OBESITY;
   AMPK; BIOGENESIS; MUSCLE
AB Brown adipose tissue (BAT) prevents obesity and related diseases by uncoupling oxidative phosphorylation with adenosine triphosphate. Previous studies have demonstrated that polyphenols can promote the thermogenesis of BAT in mice. Chlorogenic acid (CGA) is a common phenolic acid found in fruits and vegetables, as well as traditional Chinese medicine, which is responsible for a variety of physiological activities. However, it is still unclear whether CGA has positive effects on the thermogenesis of BAT. In this study, CGA enhances the thermogenesis and proton leak of brown adipocytes, however, no changes are evident regarding the differentiation of C3H10T1/2 into brown adipocytes. Surprisingly, CGA promotes the uptake of glucose by upregulating the glucose transporter 2 and phosphofructokinase. Moreover, CGA increases the number and the function of mitochondrial. Taken together, CGA stimulates thermogenesis of brown adipocytes by promoting the uptake of glucose and the function of mitochondria. Practical Application Chlorogenic acid (CGA) is widely found in fruits, vegetables, and traditional Chinese medicines, which has been considered to have antibacterial and anti-inflammatory function. However, whether it has the function of resisting obesity and promoting thermogenesis is still unclear. In this study, brown adipocyte was used to explore the function and mechanism of CGA on thermogenesis. It provides new ideas for the utilization of foods rich in CGA and traditional Chinese medicine.
C1 [Han, Xue; Zhang, Yuxin; Guo, Jielong; You, Yilin; Zhan, Jicheng; Huang, Weidong] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Key Lab Viticulture & Enol, Tsinghua East Rd 17, Beijing 100083, Peoples R China.
   [Han, Xue; Zhang, Yuxin; Guo, Jielong; You, Yilin; Zhan, Jicheng; Huang, Weidong] China Agr Univ, Xinghua Ind Res Ctr Food Sci & Human Hlth, Xinghua 225700, Jiangsu, Peoples R China.
C3 China Agricultural University; China Agricultural University
RP You, YL; Zhan, JC; Huang, WD (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Key Lab Viticulture & Enol, Tsinghua East Rd 17, Beijing 100083, Peoples R China.
EM yilinyou@cau.ediu.cn; zhanjicheng@cau.edu.cn; huanggwd@263.net
RI Zhan, Jicheng/ABF-8501-2021
OI Zhan, jicheng/0000-0001-8757-7862
FU National "13th Five-Year Plan" key research and development plan
   [2016YFD0400504]; Counterpart support research cooperation fund of China
   Agricultural University [2019TC169]; Research on Blueberry Functional
   Ingredients and the Development of New Blueberry Wine [201805410611582]
FX This work was supported by National "13th Five-Year Plan" key research
   and development plan (2016YFD0400504), Counterpart support research
   cooperation fund of China Agricultural University (2019TC169) and
   Research on Blueberry Functional Ingredients and the Development of New
   Blueberry Wine (201805410611582).
CR Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Ghadieh HE, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0014-5
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   Han X, 2018, FOOD FUNCT, V9, P4366, DOI [10.1039/c8fo00978c, 10.1039/C8FO00978C]
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Huang DW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010254
   Huang WY, 2017, J FOOD SCI, V82, P1239, DOI 10.1111/1750-3841.13706
   Imran KM, 2017, BBA-MOL CELL BIOL L, V1862, P1110, DOI 10.1016/j.bbalip.2017.08.001
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jiang H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38711-7
   Karthikesan K, 2010, J FUNCT FOODS, V2, P134, DOI 10.1016/j.jff.2010.04.001
   Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Li YG, 2014, EMBO REP, V15, P1069, DOI 10.15252/embr.201438775
   Liang NJ, 2018, J AGR FOOD CHEM, V66, P11008, DOI 10.1021/acs.jafc.8b03983
   Liang NJ, 2016, FOOD CHEM, V213, P251, DOI 10.1016/j.foodchem.2016.06.041
   Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017
   Liu Z, 2016, SCI REP-UK, V6, DOI [10.1038/srep23214, 10.1038/srep19095]
   Liu ZG, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600717
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986
   Milton-Laskibar I, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101446
   Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012
   Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182
   Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001
   Song JX, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00602
   Ueda M, 2013, BIOFACTORS, V39, P457, DOI 10.1002/biof.1085
   Villarroya J, 2013, AM J PHYSIOL-ENDOC M, V305, pE567, DOI 10.1152/ajpendo.00250.2013
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Wei R, 2018, FOOD FUNCT, V9, P5682, DOI 10.1039/c8fo01397g
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xu JG, 2012, J AGR FOOD CHEM, V60, P11625, DOI 10.1021/jf303771s
   You YL, 2018, J FUNCT FOODS, V41, P62, DOI 10.1016/j.jff.2017.12.025
   You YL, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700261
   You YL, 2015, FOOD FUNCT, V6, P401, DOI 10.1039/c4fo00719k
   Zhang X, 2018, SHOCK VIB, V2018, P1, DOI DOI 10.1109/PERC0M.2018.8444575
   Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493
NR 40
TC 31
Z9 33
U1 5
U2 46
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD DEC
PY 2019
VL 84
IS 12
BP 3815
EP 3824
DI 10.1111/1750-3841.14838
EA NOV 2019
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA LE8QP
UT WOS:000497737500001
PM 31750946
DA 2025-04-28
ER

PT J
AU Damiri, B
   Khatib, O
   Nazzal, Z
   Sanduka, D
   Igbaria, S
   Thabaleh, A
   Farhoud, A
   Saudi, L
   Belkebir, S
   Al Ali, R
   Alili, M
   Hamdan, M
   Safarini, OA
   Younis, O
AF Damiri, Basma
   Khatib, Omar
   Nazzal, Zaher
   Sanduka, Diala
   Igbaria, Siwar
   Thabaleh, Ammar
   Farhoud, Ahmad
   Saudi, Lubna
   Belkebir, Souad
   Al Ali, Rayyan
   Alili, Mohammed
   Hamdan, Mahmoud
   Safarini, Omar A.
   Younis, Omar
TI Metabolic Syndrome Associated with Tobacco and Caffeine Products Use
   Among Refugee Adolescents: Risk of Dyslipidemia
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE refugee adolescents; metabolic syndrome; tobacco smoking; cognitive
   enhancers and psychostimulants; dyslipidemia; UNRWA
ID ENERGY DRINK CONSUMPTION; HIGH-DENSITY-LIPOPROTEIN; CHILDREN;
   DEFINITION; PREVALENCE; PREDICTORS; OVERWEIGHT; MANAGEMENT; ATTENTION;
   COGNITION
AB Introduction: Due to their stressful lives, Palestinian refugees are prone to use cognitive enhancers (CE) and psychostimulant substances (PS). Recognising health problems asso-ciated with CE/PS use can indicate how preventive programs should be directed towards adolescents. Unfortunately, research has not thoroughly investigated the health problems related to tobacco and caffeine products, the most socially acceptable CE/PS among Palestinian refugee adolescents. Methodology: In 2021, schoolchildren from five Palestinian refugee camps (N=271) aged 12-<16 years agreed to give blood samples and to be interviewed to address the association between metabolic syndrome (MetS) and tobacco smoking, coffee, energy drinks (ED), black tea, and chocolate consumption. MetS was diagnosed based on International Diabetic Federation Criteria. To address the association, we used binary logistic regression models adjusted to age, gender, BMI, and central obesity. Results: The prevalence of MetS was [17 (6.3%)]; (7.4%) in males, (5.1%) in females. The prevalence of substance use was as follows: ED [163 (48.9%)], coffee [255 (76.6%)], black tea [295 (89.1%)], cigarette [35 (10.5%)], waterpipe [59 (17.7%)], and chocolate [309 (93.6%)], with male predominance. Cigarette smokers have increased central obesity (p-value=0.024), and decreased HDL-cholesterol (p-value=0.015) than non-smokers. Similar results were observed for waterpipe smokers besides the increased levels of trigly-cerides (p-value=0.01). ED consumers have increased central obesity (p-value=0.03) and fast blood sugar (p-value=0.003) than non-consumers. Chocolate consumers have decreased central obesity (p-value=0.008) and increased HDL levels (p-value=0.04) than non-consumers. ED consumers were significantly at higher risk of MetS (OR=9.97, p-value=0.019) than non-consumers and chocolate consumers were at lower risk of MetS (OR=0.14, p-value=0.046) than non-consumers. Waterpipe smokers were at a higher risk of having increased plasma triglycerides than non-consumers (OR=3.4, p-value=0.03). Conclusion: The high prevalence of ED consumption and waterpipe smoking in Palestinian refugee adolescents is problematic. Their use was associated with higher odds of MetS, dyslipidemia, and central obesity, which justifies greater attention.
C1 [Damiri, Basma] An Najah Natl Univ, Med & Hlth Sci Fac, Drug & Toxicol Div, POB 7, Nablus 00970, Palestine.
   [Khatib, Omar; Sanduka, Diala; Igbaria, Siwar; Thabaleh, Ammar; Farhoud, Ahmad; Alili, Mohammed; Safarini, Omar A.; Younis, Omar] An Najah Natl Univ, Dept Med, Med & Hlth Sci Fac, Nablus 00970, Palestine.
   [Nazzal, Zaher; Belkebir, Souad] An Najah Natl Univ, Med & Hlth Sci Fac, Family & Community Med, Nablus 00970, Palestine.
   [Al Ali, Rayyan] An Najah Natl Univ, Inst Forens Med, Med & Hlth Sci Fac, Nablus 00970, Palestine.
   [Hamdan, Mahmoud] Najah Natl Univ, Grad Sch, Med Hlth Sci Fac, Clin Lab Sci Program, Nablus 00970, Palestine.
C3 An Najah National University; An Najah National University; An Najah
   National University; An Najah National University
RP Damiri, B (corresponding author), An Najah Natl Univ, Med & Hlth Sci Fac, Drug & Toxicol Div, POB 7, Nablus 00970, Palestine.
EM bdamiri@najah.edu
RI Nazzal, Zaher/AAW-3875-2020; Ali, Rayyan/Z-5481-2019; Damiri,
   Basma/AAA-3348-2019; younis, Ola/KPA-1855-2024; Safarini,
   Omar/ABB-7220-2021
OI Younis, Omar/0000-0001-9766-7327; Damiri, Basma/0000-0001-8242-391X;
   Nazzal, Zaher/0000-0002-2655-6109; Safarini, Omar
   A./0000-0002-7108-6513; Thabaleh, Ammar/0000-0003-0924-8873; Farhoud,
   Ahmad/0000-0001-8394-7168; Belkebir, Souad/0000-0002-4788-7900; Al Ali,
   Rayyan/0000-0001-9301-9007; Sanduka, Diala/0000-0002-6077-2817
FU Committee Services for Refugee Camps in Nablus
FX Y The authors would like to thank the respondents for their
   participation in this work. The authors are very thankful to all those
   who facilitated the conduction of this study in An-Najah National
   University Hospital (ANNU) and the Committee Services for Refugee Camps
   in Nablus and Tulkarm. The authors would like to thank Saba Damiri, Hiba
   Damiri, Mohammed Qino, and Yousef Qasim for their help in data
   collection.
CR Abdelaal M, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.107
   Adil M, 2013, INDO AM J PHARM SCI, V2, P6469
   Al Sabbah H., 2015, MOJ PUBLIC HLTH, V2, P36, DOI [https://doi.org/10.15406/mojph.2015.02.00015, 10.15406/mojph.2015.02.00015, DOI 10.15406/MOJPH.2015.02.00015]
   Al Sabbah H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-52
   Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Anderson PJ, 2001, INT J OBESITY, V25, P1782, DOI 10.1038/sj.ijo.0801837
   [Anonymous], 2006, OB OV
   [Anonymous], 2019, KEY SUBSTANCE USE ME
   Aslam Hafiz Muhammad, 2014, Int Arch Med, V7, P16, DOI 10.1186/1755-7682-7-16
   Balhara Yatan Pal Singh, 2012, Indian J Endocrinol Metab, V16, P81, DOI 10.4103/2230-8210.91197
   Barter PJ, 2011, DIABETES METAB J, V35, P101, DOI 10.4093/dmj.2011.35.2.101
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/c7fo00388a, 10.1039/C7FO00388A]
   Benton D, 1998, PERS INDIV DIFFER, V24, P513, DOI 10.1016/S0191-8869(97)00215-8
   Buitrago-Lopez A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4488
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Campbell B, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-1
   Cappelletti S, 2015, CURR NEUROPHARMACOL, V13, P71, DOI 10.2174/1570159X13666141210215655
   CDC, 2021, DEF CHILDH WEIGHT ST
   Cobb CO, 2011, NICOTINE TOB RES, V13, P78, DOI 10.1093/ntr/ntq212
   Damiri B, 2020, J CONCUR DISORD, V1, P7
   Damiri B, 2021, PALEST MED PHARM J, V6
   Damiri B, 2018, ANN CLIN LAB RES, V6, P8
   Damiri B, 2021, NEUROPSYCH DIS TREAT, V17, P1633, DOI 10.2147/NDT.S308598
   Damiri B, 2020, DRUG-EDUC PREV POLIC, V27, P173, DOI 10.1080/09687637.2019.1591341
   Damiri B, 2022, INT HEALTH, V14, P339, DOI 10.1093/inthealth/ihz093
   Damiri B, 2018, DIABETES METAB SYND, V12, P343, DOI 10.1016/j.dsx.2017.12.021
   Damiri B, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0337-2
   Damiri BR, 2020, INT J MENT HEALTH AD, V18, P1507, DOI 10.1007/s11469-019-00183-1
   DeBoer MD, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081788
   Einöther SJL, 2013, PSYCHOPHARMACOLOGY, V225, P251, DOI 10.1007/s00213-012-2917-4
   Eltahir HM, 2020, ACTA BIOCHIM POL, V67, P79, DOI 10.18388/abp.2020_2914
   Famurewa A. C., 2015, Journal of Chemical and Pharmaceutical Research, V7, P363
   Favrod-Coune T, 2010, PHARMACEUTICALS-BASE, V3, P2333, DOI 10.3390/ph3072333
   Fornari E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00702
   Frati P, 2015, CURR NEUROPHARMACOL, V13, P5, DOI 10.2174/1570159X13666141210221750
   Galimov A, 2020, J PSYCHOPHARMACOL, V34, P221, DOI 10.1177/0269881119895545
   Galimov A, 2019, APPETITE, V139, P172, DOI 10.1016/j.appet.2019.04.016
   Gallimberti L, 2013, EUR J PEDIATR, V172, P1335, DOI 10.1007/s00431-013-2036-1
   Ginsberg HN, 2000, AM J CARDIOL, V86, p41L
   GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9
   Grundy SM, 2019, CIRCULATION, V139, pE1082, DOI 10.1161/CIR.0000000000000625
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hadaegh F, 2009, East Mediterr Health J, V15, P157
   Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381
   Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180
   Iyadurai SJP, 2007, EPILEPSY BEHAV, V10, P504, DOI 10.1016/j.yebeh.2007.01.009
   Kasikçioglu E, 2017, ANATOL J CARDIOL, V17, P163, DOI 10.14744/AnatolJCardiol.2017.7575
   Kostovski Marko, 2018, Open Access Maced J Med Sci, V6, P511, DOI 10.3889/oamjms.2018.097
   Lanni C, 2008, PHARMACOL RES, V57, P196, DOI 10.1016/j.phrs.2008.02.004
   Mansour B, 2019, EUR J PEDIATR, V178, P649, DOI 10.1007/s00431-019-03342-7
   Marjani A, 2013, J BIOL SCI, V13, P679, DOI [10.3923/ jbs.2013.679.684, DOI 10.3923/jbs.2013.679.684]
   Massad SG, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081118
   Massad SG, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3472-4
   Mattioli AV, 2016, J CARDIOVASC MED, V17, P902, DOI 10.2459/JCM.0000000000000416
   Musmar S. G., 2012, Eastern Mediterranean Health Journal, V18, P454
   Nadeem IM, 2021, SPORTS HEALTH, V13, P265, DOI 10.1177/1941738120949181
   National Institute on Drug Abuse (NIDA), 2020, PRINC AD SUBST US DI
   Nazzal Z., 2020, PALEST MED PHARM J, V5, P25
   Nehlig A, 2010, J ALZHEIMERS DIS, V20, pS85, DOI 10.3233/JAD-2010-091315
   NEWCOMB MD, 1988, J COUNS PSYCHOL, V35, P426, DOI 10.1037/0022-0167.35.4.426
   Peacock A, 2013, APPETITE, V64, P1, DOI 10.1016/j.appet.2012.12.021
   Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4
   Rogers PJ, 2013, PSYCHOPHARMACOLOGY, V226, P229, DOI 10.1007/s00213-012-2889-4
   Rusted J, 2009, PSYCHOPHARMACOLOGY, V202, P93, DOI 10.1007/s00213-008-1320-7
   Saha SP, 2007, INT J ANGIOL, V16, P77
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990
   Trapp G, 2020, NUTR METAB CARDIOVAS, V30, P1679, DOI 10.1016/j.numecd.2020.06.012
   Tucktuck M, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4524-0
   Valentine G, 2018, CURR NEUROPHARMACOL, V16, P403, DOI 10.2174/1570159X15666171103152136
   Wassef B, 2017, WORLD J CARDIOL, V9, P796, DOI 10.4330/wjc.v9.i11.796
   Wolk BJ, 2012, CURR OPIN PEDIATR, V24, P243, DOI 10.1097/MOP.0b013e3283506827
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487
   Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1
NR 75
TC 14
Z9 14
U1 1
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2021
VL 14
BP 4121
EP 4133
DI 10.2147/DMSO.S329675
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Endocrinology & Metabolism
GA WB6RW
UT WOS:000703698800001
PM 34616165
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Lukic, M
   Guha, N
   Licaj, I
   van den Brandt, PA
   Stayner, LT
   Tavani, A
   Weiderpass, E
AF Lukic, Marko
   Guha, Neela
   Licaj, Idlir
   van den Brandt, Piet A.
   Stayner, Leslie Thomas
   Tavani, Alessandra
   Weiderpass, Elisabete
TI Coffee Drinking and the Risk of Endometrial Cancer: An Updated
   Meta-Analysis of Observational Studies
SO NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
LA English
DT Article
ID DIETARY FACTORS; DECAFFEINATED COFFEE; PROSPECTIVE COHORT; CAFFEINE
   INTAKE; C-PEPTIDE; HORMONE CONCENTRATIONS; PUBLICATION BIAS; TREND
   ESTIMATION; CONSUMPTION; WOMEN
AB Background: Several compounds contained in coffee have been found to suppress carcinogenesis in experimental studies. We conducted a dose-response meta-analysis to assess the impact of coffee consumption on the risk of endometrial cancer. Materials and methods: We searched MEDLINE and EMBASE databases for studies published up to August 2016. Using random effects models, we estimated summary relative risks (RR) for cohort studies and odds ratios (OR) for case-control studies with 95% confidence intervals (CI). Dose-response analyses were conducted by using generalized least square trend estimation. Results: We identified 12 cohort studies and 8 case-control studies eligible for inclusion, contributing with 11,663 and 2,746 endometrial cancer cases, respectively. The summary RR for highest compared with lowest coffee intake was 0.74 (95% CI: 0.68-0.81; p(heterogeneity) = 0.09, I-2 = 32%). The corresponding summary RR among cohort studies was 0.78 (95% CI: 0.71-0.85; p(heterogeneity) = 0.14, I-2 = 31.9%) and 0.63 (95% CI: 0.53-0.76; p(heterogeneity) = 0.57, I-2 = 0%) for case-control studies. One-cup increment per day was associated with 3% risk reduction (95% CI: 2-4%) in cohort studies and 12% (95% CI: 5-18%) in case-control studies. After pooling the results from 5 cohort studies, the association remained significant only in women with body mass index over 30 (RR = 0.71, 95% CI: 0.61-0.81). Conclusion: The results from our meta-analysis strengthen the evidence of a protective effect of coffee consumption on the risk of EC and further suggest that increased coffee intake might be particularly beneficial for women with obesity.
C1 [Lukic, Marko; Licaj, Idlir; Weiderpass, Elisabete] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway.
   [Guha, Neela] Int Agcy Res Canc, Lyon, France.
   [Licaj, Idlir] Normandie Univ, UNICAEN, INSERM, Clin Res Dept,Ctr Francois Bacles,U1086, Caen, France.
   [van den Brandt, Piet A.] MUMC, Sch Oncol & Dev Biol GROW, Dept Epidemiol, Maastricht, Netherlands.
   [Stayner, Leslie Thomas] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA.
   [Tavani, Alessandra] IRCCS, Ist Ric Farmacol Mario Negri, Dept Epidemiol, Milan, Italy.
   [Weiderpass, Elisabete] Canc Registry Norway, Inst Populat Based Canc Res, Dept Res, Oslo, Norway.
   [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.
   [Weiderpass, Elisabete] Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland.
C3 UiT The Arctic University of Tromso; World Health Organization;
   International Agency for Research on Cancer (IARC); Institut National de
   la Sante et de la Recherche Medicale (Inserm); Universite de Caen
   Normandie; Maastricht University; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital;
   Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of
   Oslo; Karolinska Institutet; Folkhalsan Research Center
RP Lukic, M (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway.
EM marko.lukic@uit.no
RI Guha, Neela/AAG-3989-2021; Licaj, Idlir/AAC-2772-2021; Weiderpass,
   Elisabete/M-4029-2016
OI van den Brandt, Piet/0000-0001-8781-8099; Guha,
   Neela/0000-0003-3991-4662; Licaj, PhD, Idlir/0000-0003-3389-0735;
   Weiderpass, Elisabete/0000-0003-2237-0128
FU United States NCI; NIEHS [5U01CA033193]; European Union [VS/2017/0287]
FX This work builds upon working group deliberations for the IARC
   Monographs Programme, which is funded by the United States NCI and NIEHS
   (5U01CA033193) and the European Union (VS/2017/0287).
CR Allen NE, 2008, ENDOCR-RELAT CANCER, V15, P485, DOI 10.1677/ERC-07-0064
   [Anonymous], MULTIVARIATE DOSE RE
   [Anonymous], FOOD NUTR PHYS ACT P
   Bandera EV, 2010, CANCER CAUSE CONTROL, V21, P1467, DOI 10.1007/s10552-010-9575-9
   Bohn SK, 2014, MOL NUTR FOOD RES, V58, P915, DOI 10.1002/mnfr.201300526
   Bravi F, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.015
   Bravi F, 2009, AM J OBSTET GYNECOL, V200, P130, DOI 10.1016/j.ajog.2008.10.032
   Cárdenas C, 2014, BIOCHEM BIOPH RES CO, V447, P452, DOI 10.1016/j.bbrc.2014.04.026
   Cárdenas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023407
   Cust AE, 2007, INT J CANCER, V120, P2656, DOI 10.1002/ijc.22578
   Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Ferrini RL, 1996, AM J EPIDEMIOL, V144, P642, DOI 10.1093/oxfordjournals.aje.a008975
   Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5
   Friberg E, 2009, INT J CANCER, V125, P2413, DOI 10.1002/ijc.24543
   Gavrilyuk O, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-48
   Giri A, 2011, NUTRIENTS, V3, P937, DOI 10.3390/nu3110937
   Goodman MT, 1997, CANCER RES, V57, P5077
   GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237
   Gunter MJ, 2012, INT J CANCER, V131, pE530, DOI 10.1002/ijc.26482
   Hashibe M, 2015, BRIT J CANCER, V113, P809, DOI 10.1038/bjc.2015.276
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins LG, 2008, TOXICOL APPL PHARM, V226, P328, DOI 10.1016/j.taap.2007.09.018
   Hirose K, 2007, CANCER SCI, V98, P411, DOI 10.1111/j.1349-7006.2007.00391.x
   JACOBSEN BK, 1986, JNCI-J NATL CANCER I, V76, P823
   Jain M G, 2000, Cancer Control, V7, P288
   Je Y, 2012, INT J CANCER, V131, P1700, DOI 10.1002/ijc.27408
   Je YJ, 2011, CANCER EPIDEM BIOMAR, V20, P2487, DOI 10.1158/1055-9965.EPI-11-0766
   Kalandidi A, 1996, ONCOLOGY, V53, P354
   Koizumi T, 2008, EUR J CANCER PREV, V17, P358, DOI 10.1097/CEJ.0b013e3282f0c02c
   Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328
   Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602
   Lee KA, 2012, J BIOMED SCI, V19, DOI [10.1186/1423-0127-19-60, 10.6117/kmeps.2012.19.3.001]
   LEVI F, 1993, CANCER, V71, P3575, DOI 10.1002/1097-0142(19930601)71:11<3575::AID-CNCR2820711119>3.0.CO;2-0
   Li ZJ, 2016, EXP THER MED, V11, P2305, DOI 10.3892/etm.2016.3251
   LONDON S, 1991, AM J CLIN NUTR, V53, P166, DOI 10.1093/ajcn/53.1.166
   Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X
   Lukanova A, 2004, INT J CANCER, V108, P262, DOI 10.1002/ijc.11544
   Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3
   McCann SE, 2009, INT J CANCER, V124, P1650, DOI 10.1002/ijc.24125
   Merritt MA, 2015, CANCER EPIDEM BIOMAR, V24, P466, DOI 10.1158/1055-9965.EPI-14-0970
   Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635
   Nilsson LM, 2010, CANCER CAUSE CONTROL, V21, P1533, DOI 10.1007/s10552-010-9582-x
   Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103
   Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265
   Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676
   Petridou E, 2002, NUTR CANCER, V44, P16, DOI 10.1207/S15327914NC441_3
   Petridou E, 2002, EUR J CANCER PREV, V11, P427, DOI 10.1097/00008469-200210000-00004
   Renehan Andrew G., 2008, Archives of Physiology and Biochemistry, V114, P71, DOI [10.1080/13813450801954303, 10.1080/13813450801954303 ]
   Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203
   Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529
   Shimazu T, 2008, INT J CANCER, V123, P2406, DOI 10.1002/ijc.23760
   STENSVOLD I, 1994, CANCER CAUSE CONTROL, V5, P401, DOI 10.1007/BF01694753
   Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461
   Terry P, 2002, NUTR CANCER, V42, P25, DOI 10.1207/S15327914NC421_4
   Uccella S, 2013, BRIT J CANCER, V109, P1908, DOI 10.1038/bjc.2013.540
   Wang AQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33711
   Weiderpass E, 2014, NUTR CANCER, V66, P1132, DOI 10.1080/01635581.2014.948214
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6
   Yang TO, 2015, AM J CLIN NUTR, V101, P570, DOI 10.3945/ajcn.113.081836
   Yu XF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-96
   Zhou Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep13410
NR 66
TC 21
Z9 23
U1 3
U2 13
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0163-5581
EI 1532-7914
J9 NUTR CANCER
JI Nutr. Cancer
PY 2018
VL 70
IS 4
BP 513
EP 528
DI 10.1080/01635581.2018.1460681
PG 16
WC Oncology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Nutrition & Dietetics
GA GF8IR
UT WOS:000432214600001
PM 29708405
OA Green Published
DA 2025-04-28
ER

PT J
AU Schubert, MM
   Hall, S
   Leveritt, M
   Grant, G
   Sabapathy, S
   Desbrow, B
AF Schubert, Matthew M.
   Hall, Susan
   Leveritt, Michael
   Grant, Gary
   Sabapathy, Surendran
   Desbrow, Ben
TI Caffeine consumption around an exercise bout: effects on energy
   expenditure, energy intake, and exercise enjoyment
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE exercise; appetite; caffeine; fat oxidation; exercise enjoyment
ID PREDICTING BODY DENSITY; PHYSICAL-ACTIVITY; GENERALIZED EQUATIONS;
   PERCEIVED EXERTION; MUSCLE PAIN; INGESTION; OXIDATION; RESPONSES; BRAIN;
   TIME
AB Combining an exercise and nutritional intervention is arguably the optimal method of creating energy imbalance for weight loss. This study sought to determine whether combining exercise and caffeine supplementation was more effective for promoting acute energy deficits and manipulations to substrate metabolism than exercise alone. Fourteen recreationally active participants (mean +/- SD body mass index: 22.7 +/- 2.6 kg/m(2)) completed a resting control trial (CON), a placebo exercise trial (EX), and a caffeine exercise trial (EX + CAF, 2 x 3 mg/kg of caffeine 90 min before and 30 min after exercise) in a randomized, double-blinded design. Trials were 4 h in duration with 1 h of rest, 1 h of cycling at similar to 65% power at maximum O-2 consumption or rest, and a 2-h recovery. Gas exchange, appetite perceptions, and blood samples were obtained periodically. Two hours after exercise, participants were offered an ad libitum test meal where energy and macronutrient intake were recorded. EX + CAF resulted in significantly greater energy expenditure and fat oxidation compared with EX (+ 250 kJ; + 10.4 g) and CON (+ 3,126 kJ; + 29.7 g) (P < 0.05). A trend for reduced energy and fat intake compared with CON (-718 kJ; -8 g) (P = 0.055) was observed. Consequently, EX + CAF created a greater energy deficit (P < 0.05). Caffeine also led to exercise being perceived as less difficult and more enjoyable (P < 0.05). Combining caffeine with exercise creates a greater acute energy deficit, and the implications of this protocol for weight loss or maintenance over longer periods of time in overweight/obese populations should be further investigated.
C1 [Schubert, Matthew M.; Sabapathy, Surendran; Desbrow, Ben] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld 4222, Australia.
   [Hall, Susan; Grant, Gary] Griffith Univ, Sch Pharm, Gold Coast, Qld 4222, Australia.
   [Schubert, Matthew M.; Hall, Susan; Grant, Gary; Sabapathy, Surendran; Desbrow, Ben] Griffith Univ, Griffith Hlth Inst, Gold Coast, Qld 4222, Australia.
   [Leveritt, Michael] Univ Queensland, Sch Human Movement Studies, St Lucia, Qld, Australia.
C3 Griffith University; Griffith University - Gold Coast Campus; Griffith
   University; Griffith University - Gold Coast Campus; Griffith
   University; Griffith University - Gold Coast Campus; Menzies Health
   Institute Queensland; University of Queensland
RP Schubert, MM (corresponding author), Griffith Univ, Sch Allied Hlth Sci, G40 2-59,Parklands Dr, Gold Coast, Qld 4222, Australia.
EM m.schubert@griffith.edu.au
RI Desbrow, Ben/A-3101-2012; Sabapathy, Surendran/KHX-6452-2024; Leveritt,
   Michael/F-9309-2011; Schubert, Matthew/A-9799-2017
OI Sabapathy, Surendran/0000-0003-1267-6035; Leveritt,
   Michael/0000-0003-1326-5625; Desbrow, Ben/0000-0003-3756-8866; Grant,
   Gary/0000-0002-2574-5442; Hall, Susan/0000-0002-8564-0466; Schubert,
   Matthew/0000-0002-0994-8805
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   Arciero PJ, 2000, METABOLISM, V49, P101, DOI 10.1016/S0026-0495(00)90888-6
   Backhouse SH, 2011, APPETITE, V57, P247, DOI 10.1016/j.appet.2011.05.304
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
   Broom DR, 2007, J APPL PHYSIOL, V102, P2165, DOI 10.1152/japplphysiol.00759.2006
   Cadieux S, 2014, PHYSIOL BEHAV, V130, P113, DOI 10.1016/j.physbeh.2014.03.031
   Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009
   Cook DB, 1997, MED SCI SPORT EXER, V29, P999, DOI 10.1097/00005768-199708000-00004
   de Araujo IE, 2012, PHYSIOL BEHAV, V106, P394, DOI 10.1016/j.physbeh.2012.02.026
   Deighton K, 2013, APPL PHYSIOL NUTR ME, V38, P947, DOI 10.1139/apnm-2012-0484
   Desbrow B, 2012, CAFFEINE CALCULATOR
   Desbrow B, 2012, J SPORT SCI, V30, P115, DOI 10.1080/02640414.2011.632431
   Desbrow B, 2009, MED SCI SPORT EXER, V41, P1744, DOI 10.1249/MSS.0b013e3181a16cf7
   Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x
   DONELLY K, 1992, EUR J APPL PHYSIOL O, V65, P459, DOI 10.1007/BF00243514
   Donnelly JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083498
   Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333
   Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Gavrieli A, 2013, OBESITY SILVER SPRIN, V0, P1
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Gibson S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-9
   Greenberg JA, 2012, J AM COLL NUTR, V31, P160, DOI 10.1080/07315724.2012.10720023
   HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152
   JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175
   Júdice PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068936
   Júdice PB, 2013, APPL PHYSIOL NUTR ME, V38, P49, DOI 10.1139/apnm-2012-0145
   KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50
   Marosi K, 2014, TRENDS ENDOCRIN MET, V25, P89, DOI 10.1016/j.tem.2013.10.006
   Meeusen R, 2013, NESTLE NUTR WORKS SE, V76, P1, DOI 10.1159/000350223
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   Motl RW, 2003, J PAIN, V4, P316, DOI 10.1016/S1526-5900(03)00635-7
   Moy GA, 2013, PHYSIOL BEHAV, V109, P69, DOI 10.1016/j.physbeh.2012.11.008
   Robergs RA, 2010, SPORTS MED, V40, P95, DOI 10.2165/11319670-000000000-00000
   Schrader P, 2013, NUTR RES, V33, P457, DOI 10.1016/j.nutres.2013.04.003
   Schubert MM, 2013, APPETITE, V63, P92, DOI 10.1016/j.appet.2012.12.010
   Sim AY, 2014, INT J OBESITY, V38, P417, DOI 10.1038/ijo.2013.102
   SIRI W E, 1956, Adv Biol Med Phys, V4, P239
   Skelly LE, 2014, APPL PHYSIOL NUTR ME, V39, P845, DOI 10.1139/apnm-2013-0562
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   TREMBLAY A, 1988, NUTR RES, V8, P553, DOI 10.1016/S0271-5317(88)80077-0
   Unick JL, 2012, PSYCHOL SPORT EXERC, V13, P528, DOI 10.1016/j.psychsport.2012.02.012
   Wallman KE, 2010, J SPORT SCI MED, V9, P183
   Washburn RA, 2014, CLIN OBES, V4, P1, DOI 10.1111/cob.12040
   ZAHN TP, 1987, INT J PSYCHOPHYSIOL, V5, P33, DOI 10.1016/0167-8760(87)90070-5
NR 51
TC 31
Z9 36
U1 2
U2 85
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD OCT 1
PY 2014
VL 117
IS 7
BP 745
EP 754
DI 10.1152/japplphysiol.00570.2014
PG 10
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA AR0DQ
UT WOS:000343237500009
PM 25123196
OA Green Published
DA 2025-04-28
ER

PT J
AU Park, J
   Nurkolis, F
   Won, H
   Yang, JY
   Oh, D
   Jo, H
   Choi, J
   Chung, S
   Kurniawan, R
   Kim, B
AF Park, Jiwon
   Nurkolis, Fahrul
   Won, Hyunji
   Yang, Jiye
   Oh, Dayeon
   Jo, Hyunkyung
   Choi, Jinwon
   Chung, Sanghyun
   Kurniawan, Rudy
   Kim, Bonglee
TI Could Natural Products Help in the Control of Obesity? Current Insights
   and Future Perspectives
SO MOLECULES
LA English
DT Review
DE obesity; natural products; herbal medicine; lipid metabolism;
   antioxidant; anti-inflammation; bioactive molecules; metabolic syndrome
ID PLASMA-LIPID PROFILES; DOUBLE-BLIND; INSULIN-RESISTANCE;
   BODY-COMPOSITION; FAT MASS; EXTRACT; OVERWEIGHT; ADULTS;
   SUPPLEMENTATION; INDIVIDUALS
AB Obesity is a global issue faced by many individuals worldwide. However, no drug has a pronounced effect with few side effects. Green tea, a well-known natural product, shows preventive effects against obesity by decreasing lipogenesis and increasing fat oxidation and antioxidant capacity. In contrast, other natural products are known to contribute to obesity. Relevant articles published on the therapeutic effect of natural products on obesity were retrieved from PubMed, Web of Science, and Scopus. The search was conducted by entering keywords such as "obesity", "natural product", and "clinical trial". The natural products were classified as single compounds, foods, teas, fruits, herbal medicines-single extract, herbal medicines-decoction, and herbal medicines-external preparation. Then, the mechanisms of these medicines were organized into lipid metabolism, anti-inflammation, antioxidation, appetite loss, and thermogenesis. This review aimed to assess the efficacy and mechanisms of effective natural products in managing obesity. Several clinical studies reported that natural products showed antiobesity effects, including Coffea arabica (coffee), Camellia sinensis (green tea), Caulerpa racemosa (green algae), Allium sativum (garlic), combined Ephedra intermedia Schrenk, Thea sinensis L., and Atractylodes lancea DC extract (known as Gambisan), Ephedra sinica Stapf, Angelica Gigantis Radix, Atractylodis Rhizoma Alba, Coicis semen, Cinnamomi cortex, Paeoniae radix alba, and Glycyrrhiza uralensis (known as Euiiyin-tang formula). Further studies are expected to refine the pharmacological effects of natural products for clinical use.
C1 [Park, Jiwon; Won, Hyunji; Yang, Jiye; Oh, Dayeon; Jo, Hyunkyung; Choi, Jinwon; Chung, Sanghyun; Kim, Bonglee] Kyung Hee Univ, Coll Korean Med, Dept Pathol, Seoul 02447, South Korea.
   [Nurkolis, Fahrul] State Islamic Univ Sunan Kalijaga UIN Sunan Kalija, Dept Biol Sci, Yogyakarta 55281, Indonesia.
   [Chung, Sanghyun] Kyung Hee Myungbo Clin Korean Med, Hwaseong Si 18466, South Korea.
   [Kurniawan, Rudy] Eka Hosp Bumi Serpong Damai, Diabet Connect Care, Tangerang 15321, Indonesia.
   [Kim, Bonglee] Kyung Hee Univ, Coll Korean Med, Korean Med Based Drug Repositioning Canc Res Ctr, Seoul 02447, South Korea.
C3 Kyung Hee University; Kyung Hee University
RP Kim, B (corresponding author), Kyung Hee Univ, Coll Korean Med, Dept Pathol, Seoul 02447, South Korea.; Kim, B (corresponding author), Kyung Hee Univ, Coll Korean Med, Korean Med Based Drug Repositioning Canc Res Ctr, Seoul 02447, South Korea.
EM fahrul.nurkolis.mail@gmail.com; bongleekim@khu.ac.kr
RI Nurkolis, Fahrul/AAY-1874-2021; Kurniawan, Rudy/IZD-4566-2023; Kim,
   Bonglee/AAH-9077-2020
OI Chung, Sanghyun/0009-0001-7751-1103; Kim, Bonglee/0000-0002-8678-156X;
   Choi, Jin Won/0009-0009-7569-6480; Kurniawan, Rudy/0000-0002-4811-1696;
   Nurkolis, Fahrul/0000-0003-2151-0854
FU Graduate School Innovation office, Kyung Hee University; Kyung Hee
   University [KHU-20230914]; Basic Science Research Program through the
   National Research Foundation of Korea (NRF) - Ministry of Education
   [NRF-2020R1I1A2066868]; National Research Foundation of Korea (NRF) -
   Korea government (MSIT) [2020R1A5A2019413]; innovation network support
   Program through the INNOPOLIS - Ministry of Science and ICT
   [2022-IT-RD-0205-01-101]
FX This research was supported by Graduate School Innovation office, Kyung
   Hee University,a grant from Kyung Hee University in 2023 (KHU-20230914),
   Basic Science Research Program through the National Research Foundation
   of Korea (NRF) funded by the Ministry of
   Education(NRF-2020R1I1A2066868), the National Research Foundation of
   Korea (NRF) grant funded by the Korea government (MSIT) (No.
   2020R1A5A2019413), and the innovation network support Program through
   the INNOPOLIS funded by Ministry of Science and ICT
   (2022-IT-RD-0205-01-101).
CR Abolghasemi J, 2020, J INTEGR MED-JIM, V18, P401, DOI 10.1016/j.joim.2020.06.003
   Adamska-Patruno E, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080956
   Amini L, 2020, COMPLEMENT THER MED, V48, DOI 10.1016/j.ctim.2019.102245
   Lima RPA, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0407-6
   Bagheri R, 2020, EUR J APPL PHYSIOL, V120, P915, DOI 10.1007/s00421-020-04332-6
   Boix-Castejón M, 2018, FOOD FUNCT, V9, P3173, DOI [10.1039/C8FO00367J, 10.1039/c8fo00367j]
   Cai Y, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0640-1
   Cândido FG, 2018, EUR J NUTR, V57, P2445, DOI 10.1007/s00394-017-1517-9
   Capomolla AS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061271
   Centers for Disease Control and Preservation, Health Effects of Overweight and Obesity
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Cheon C, 2020, COMPLEMENT THER MED, V51, DOI 10.1016/j.ctim.2020.102423
   Cho IJ, 2016, NUTR RES, V36, P671, DOI 10.1016/j.nutres.2016.03.001
   Cho YG, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1871-4
   Choi HN, 2020, J MED FOOD, V23, P37, DOI 10.1089/jmf.2018.4366
   Chooi YC, 2019, METABOLISM, V92, P6, DOI 10.1016/j.metabol.2018.09.005
   Choudhary D, 2017, J EVID-BASED INTEGR, V22, P96, DOI 10.1177/2156587216641830
   Chung W, 2016, J TRADIT CHIN MED, V36, P291, DOI 10.1016/S0254-6272(16)30040-1
   Dixit K, 2018, DIABETES OBES METAB, V20, P2633, DOI 10.1111/dom.13443
   Duchnowicz P, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5670145
   Escalante G, 2019, J COSMET DERMATOL-US, V18, P1037, DOI 10.1111/jocd.12801
   Farhat G, 2019, NUTRIENTS, V11, DOI 10.3390/nu11123036
   Ferro Y, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00494
   Ghasemi E, 2020, J PHYSIOL SCI, V70, DOI 10.1186/s12576-020-00756-z
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Hajmohammadi Z, 2018, J INTEGR MED-JIM, V16, P45, DOI 10.1016/j.joim.2017.12.007
   Han HS, 2022, NUTRIENTS, V14, DOI 10.3390/nu14010208
   Han HJ, 2016, J MED FOOD, V19, P170
   Herranz-López M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39159-5
   Izaola O, 2020, NUTR HOSP, V37, P465, DOI 10.20960/nh.02906
   Jamar G, 2020, J NUTR BIOCHEM, V83, DOI 10.1016/j.jnutbio.2020.108430
   Jensen GS, 2016, CLIN INTERV AGING, V11, P367, DOI 10.2147/CIA.S94881
   Jo DH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000018060
   Katanasaka Y, 2020, BIOL PHARM BULL, V43, P675, DOI 10.1248/bpb.b19-00921
   Kazemipoor M, 2016, PHYTOTHER RES, V30, P981, DOI 10.1002/ptr.5603
   Kim KS, 2013, ORIENTAL PHARM EXP M, V13, P69, DOI 10.1007/s13596-013-0107-5
   Kim YJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102445
   Kobayashi M, 2016, FOOD FUNCT, V7, P498, DOI [10.1039/C5FO00750J, 10.1039/c5fo00750j]
   Koyama T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103090
   Kudiganti V, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0306-4
   Lee M, 2016, J MED FOOD, V19, P995, DOI 10.1089/jmf.2016.3762
   Lee SE, 2019, PHARM BIOL, V57, P676, DOI 10.1080/13880209.2019.1666883
   Leverrier A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051080
   Lin Yung-Kai, 2022, J Complement Integr Med, V19, P279, DOI 10.1515/jcim-2020-0478
   Liu X, 2016, OBESITY, V24, P2261, DOI 10.1002/oby.21584
   Maia-Landim A, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2099-7
   Majeed M, 2022, DIABET METAB SYND OB, V15, P369, DOI 10.2147/DMSO.S348412
   Morimoto-Kobayashi Y, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0144-2
   Moszak M, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01330-7
   Nishimura M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010091
   Oliveira-de-Lira L, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070932
   Oniki K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61148-2
   Pan RR, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13471
   Parandoosh M, 2020, PHYTOTHER RES, V34, P379, DOI 10.1002/ptr.6529
   Permatasari HK, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.939073
   Prescription medications to treat overweight & obesity-NIDDK, National Institute of Diabetes and digestive and kidney diseases
   Rao AS, 2020, J MED FOOD, V23, P905, DOI 10.1089/jmf.2020.0075
   Rezaei S, 2020, BRIT J NUTR, V123, P994, DOI 10.1017/S0007114520000318
   Rondanelli M, 2021, PHYTOTHER RES, V35, P2045, DOI 10.1002/ptr.6950
   Rondanelli M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113298
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Shanely RA, 2020, NUTR RES, V76, P9, DOI 10.1016/j.nutres.2020.02.005
   Streeper RT, 2020, IN VIVO, V34, P1173, DOI 10.21873/invivo.11890
   Szulinska M, 2017, EUR REV MED PHARMACO, V21, P2473
   Szulinska M, 2018, BIOMED PHARMACOTHER, V102, P792, DOI 10.1016/j.biopha.2018.03.131
   Tak YJ, 2021, CURR OBES REP, V10, P14, DOI 10.1007/s13679-020-00422-w
   Tomar M, 2019, RSC ADV, V9, P18578, DOI 10.1039/c9ra01345h
   Valero-Pérez M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12071960
   Watanabe M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050586
   World Health Organisation, 2024, Obesity
   World Health Organization, World Obesity Day 2022-accelerating action to stop obesity
   Xu CJ, 2018, CLIN NUTR ESPEN, V24, P148, DOI 10.1016/j.clnesp.2017.11.010
   Yonekura Y, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051370
   Yousefi R, 2018, COMPLEMENT THER MED, V40, P106, DOI 10.1016/j.ctim.2018.08.003
   Zhang SM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123671
NR 75
TC 6
Z9 6
U1 10
U2 27
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD SEP
PY 2023
VL 28
IS 18
AR 6604
DI 10.3390/molecules28186604
PG 25
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA S9OA0
UT WOS:001074373400001
PM 37764380
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Balzan, S
   Hernandes, A
   Reichert, CL
   Donaduzzi, C
   Pires, VA
   Gasparotto, A
   Cardozo, EL
AF Balzan, Silvie
   Hernandes, Aline
   Reichert, Cristiane Loiva
   Donaduzzi, Carmen
   Pires, Vanessa Aranega
   Gasparotto Junior, Arquimedes
   Cardozo Junior, Euclides Lara
TI Lipid-lowering effects of standardized extracts of Ilex
   paraguariensis in high-fat-diet rats
SO FITOTERAPIA
LA English
DT Article
DE Ilex paraguariensis; Chlorogenic acid; Phenolic compounds; Dyslipidemias
ID HIGH-DENSITY-LIPOPROTEIN; MATE ILEX; AQUEOUS EXTRACT;
   PHENOLIC-COMPOUNDS; CHLOROGENIC ACID; ANTIOXIDANT ACTIVITY; ST HIL.;
   CHOLESTEROL; OBESITY; METHYLXANTHINES
AB Mate (Ilex paraguariensis A. St-Hil) is a native species of South America used to prepare traditional beverages. Recently a possible effect of its infusion on oxidative stress found in dyslipidemias has been reported. The main compounds related to these activities are phenolic compounds derived from chlorogenic acid. This study aimed to determine the anticholesteremic effect of the hydroethanolic extract (HEIP) and its n-butanolic fraction (n-BFIP), with standardized content of phenolic compounds derived from chlorogenic add, in rats treated with high-fat diet (HFD). The contents of these compounds in the ethanol extract and n-butanol fraction were respectively two and three times higher than in traditional infusion with predominance of dicaffeoylquinic derivatives. The extracts were able to reduce serum triglycerides and cholesterol and decrease the atherogenic index in treated animals. These results support a potential effect of the mate extract in cardiovascular disease. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Balzan, Silvie; Hernandes, Aline; Reichert, Cristiane Loiva; Cardozo Junior, Euclides Lara] Univ Paranaense, Inst Ciencias Biol Med & Saude, BR-85903170 Toledo, PR, Brazil.
   [Gasparotto Junior, Arquimedes] Univ Paranaense, Inst Ciencias Biol Med & Saude, Umuarama, PR, Brazil.
   [Donaduzzi, Carmen; Pires, Vanessa Aranega] Prati Donaduzzi Pharmaceut, Toledo, PR, Brazil.
C3 Universidade Paranaense; Universidade Paranaense
RP Cardozo, EL (corresponding author), Univ Paranaense, Lab Quim & Farmacol Prod Nat, Av Parigot de Souza 3636, BR-85903170 Toledo, PR, Brazil.
EM euclideslc@unipar.br
RI Junior, Arquimedes/AAA-6161-2019; Cardozo Junior, Euclides/H-5814-2013;
   Gasparotto Junior, Arquimedes/Q-3281-2016
OI Cardozo Junior, Euclides/0000-0002-8390-4181; Gasparotto Junior,
   Arquimedes/0000-0003-3433-5098
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES-Brazil); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq-Brazil); Diretoria Executiva de Gestalt) da Pesquisa e
   Pos-Graduacao (DEGPP/UNIPAR-Brazil)
FX We are grateful to Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES-Brazil), Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq-Brazil) and Diretoria Executiva de Gestalt) da
   Pesquisa e Pos-Graduacao (DEGPP/UNIPAR-Brazil) for the financial
   support.
CR Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Ballantyne CM, 2001, CIRCULATION, V104, P3046, DOI 10.1161/hc5001.100624
   Balogun E. A., 2007, Pharmacognosy Magazine, V3, P16
   Bastos DHM, 2006, BRAZ ARCH BIOL TECHN, V49, P399, DOI 10.1590/S1516-89132006000400007
   Bastos DHM, 2007, MOLECULES, V12, P423, DOI 10.3390/12030423
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   Bravo L, 2007, FOOD RES INT, V40, P393, DOI 10.1016/j.foodres.2006.10.016
   Boaventura BCB, 2012, NUTRITION, V28, P657, DOI 10.1016/j.nut.2011.10.017
   Cardozo EL, 2007, J FOOD COMPOS ANAL, V20, P553, DOI 10.1016/j.jfca.2007.04.007
   Cardozo EL, 2010, PESQUI AGROPECU BRAS, V45, P171, DOI 10.1590/S0100-204X2010000200008
   Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783
   Chun OK, 2004, FOOD RES INT, V37, P337, DOI 10.1016/j.foodres.2004.02.001
   CLIFFORD MN, 1990, FOOD CHEM, V35, P13, DOI 10.1016/0308-8146(90)90126-O
   da Silva EL, 2008, FOOD RES INT, V41, P973, DOI 10.1016/j.foodres.2008.08.004
   Dugo P, 2009, J CHROMATOGR A, V1216, P7213, DOI 10.1016/j.chroma.2009.08.030
   Filip R, 2001, FITOTERAPIA, V72, P774, DOI 10.1016/S0367-326X(01)00331-8
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gillett RC, 2011, AM FAM PHYSICIAN, V83, P711
   Grujic N, 2012, MOLECULES, V17, P2518, DOI 10.3390/molecules17032518
   Gugliucci A, 1996, BIOCHEM BIOPH RES CO, V224, P338, DOI 10.1006/bbrc.1996.1030
   Gugliucci A, 2009, FITOTERAPIA, V80, P339, DOI 10.1016/j.fitote.2009.04.007
   Gugliucci A, 2009, FITOTERAPIA, V80, P138, DOI 10.1016/j.fitote.2009.01.001
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Ho FM, 2012, J ETHNOPHARMACOL, V142, P175, DOI 10.1016/j.jep.2012.04.034
   Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207
   Matsumoto RLT, 2009, J AGR FOOD CHEM, V57, P1775, DOI 10.1021/jf803096g
   Meier B, 2012, EUR HEART J, V33, P705, DOI 10.1093/eurheartj/ehr443
   Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106
   Oliveira DM, 2008, J AGR FOOD CHEM, V56, P10527, DOI 10.1021/jf8021404
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Peralta IN, 2013, PHYTOTHER RES, V27, P192, DOI 10.1002/ptr.4700
   Rivelli Diogo Pineda, 2007, Rev. Bras. Cienc. Farm., V43, P215, DOI 10.1590/S1516-93322007000200007
   Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55
   Saghir MR, 2012, PAK J PHARM SCI, V25, P333
   Schinella G, 2005, CLIN NUTR, V24, P360, DOI 10.1016/j.clnu.2004.11.013
   Schinella GR, 2000, BIOCHEM BIOPH RES CO, V269, P357, DOI 10.1006/bbrc.2000.2293
   Schinella G, 2009, FOOD RES INT, V42, P1403, DOI 10.1016/j.foodres.2009.07.004
   Siddiqi HS, 2012, LIPIDS HLTH DIS, V10, P11
   Siri-Tarino PW, 2011, CURR ATHEROSCLER REP, V13, P453, DOI 10.1007/s11883-011-0207-y
   Sugimoto S, 2009, CHEM PHARM BULL, V57, P257, DOI 10.1248/cpb.57.257
   Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3
   Tsimikas S, 2011, CURR PHARM DESIGN, V17, P27, DOI 10.2174/138161211795049831
   Turkmen N, 2006, FOOD CHEM, V99, P835, DOI 10.1016/j.foodchem.2005.08.034
NR 44
TC 53
Z9 57
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0367-326X
EI 1873-6971
J9 FITOTERAPIA
JI Fitoterapia
PD APR
PY 2013
VL 86
BP 115
EP 122
DI 10.1016/j.fitote.2013.02.008
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 145PR
UT WOS:000319029800016
PM 23422228
OA hybrid
DA 2025-04-28
ER

PT J
AU Carrageta, DF
   Dias, TR
   Alves, MG
   Oliveira, PF
   Monteiro, MP
   Silva, BM
AF Carrageta, David F.
   Dias, Tania R.
   Alves, Marco G.
   Oliveira, Pedro F.
   Monteiro, Mariana P.
   Silva, Branca M.
TI Anti-obesity potential of natural methylxanthines
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Review
DE Adipogenesis; Caffeine; Lipolysis; Methylzanthines; Obesity
ID TEA CAMELLIA-SINENSIS; CENTRAL-NERVOUS-SYSTEM; CYCLIC
   ADENOSINE-MONOPHOSPHATE; ADIPOSE-TISSUE INFLAMMATION; ADIPOCYTE
   GENE-EXPRESSION; BINDING-PROTEIN-ALPHA; WHITE TEA; GREEN TEA;
   PPAR-GAMMA; COFFEE CONSUMPTION
AB Obesity is one of the most challenging health issue worldwide that has been steadily increasing in the last decades. Obesity arises from a positive energy balance in result of increased intake and decreased energy expenditure, usually due to inadequate dietary habits and a sedentary lifestyle, which results in the accumulation of excess body fat. There are few pharmacological tools to address obesity, thus calorie restriction and increased physical activity are still the cornerstone of obesity treatment. In recent years, natural products obtained from plants have been thoroughly studied to infer whether these have any potential to target obesity. Methylxanthines comprise one of those classes of compounds that are abundant in common food products consumed on a daily basis worldwide, such as coffee, chocolate, or tea. Despite caffeine is the most popular and well-studied methylxanthine, theobromine and theophylline are also abundant in humans' diet. Notably, methylxanthines proved to stimulate lipolysis and inhibit adipogenesis, which are interesting properties that could contribute for obesity management. This review aims to discuss the most recent information concerning the promising role of methylxanthines in the modulation of adipose tissue functions, highlighting the potential of these molecules in the development of novel therapeutic approaches for obesity treatment.
C1 [Carrageta, David F.; Dias, Tania R.; Silva, Branca M.] UBI, CICS, Rua Marques dAvila & Bolama, P-6201001 Covilha, Portugal.
   [Carrageta, David F.; Dias, Tania R.; Alves, Marco G.; Oliveira, Pedro F.] Univ Porto, Unit Multidisciplinary Res Biomed UMIB, Inst Biomed Sci Abel Salazar ICBAS, Dept Microscopy,Lab Cell Biol, Rua Jorge Viterbo, P-4050313 Porto, Portugal.
   [Oliveira, Pedro F.] Univ Porto, I3S, P-4200135 Porto, Portugal.
   [Monteiro, Mariana P.] Univ Porto, Dept Anat, Unit Multidisciplinary Res Biomed UMIB, Inst Biomed Sci Abel Salazar ICBAS, Rua Jorge Viterbo, P-4050313 Porto, Portugal.
C3 Universidade da Beira Interior; Universidade do Porto; Universidade do
   Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade
   do Porto; Universidade do Porto
RP Silva, BM (corresponding author), Univ Beira Interior, Ctr Invest Ciencias Saude, Fac Ciencias Saude, Ave Infante D Henrique, P-6200506 Covilha, Portugal.
EM bmcms@ubi.pt
RI Alves, Marco/G-4821-2010; Monteiro, Mariana/AFP-7479-2022; Silva,
   Branca/JNR-9926-2023; , Tânia/AAF-8575-2019; Oliveira, Pedro
   Fontes/G-4795-2010; Carrageta, David/G-1183-2018
OI Oliveira, Pedro Fontes/0000-0002-4989-5699; Alves, Marco
   G./0000-0001-7635-783X; Carrageta, David/0000-0002-0546-3480; Silva,
   Branca Maria/0000-0002-5610-8024; Monteiro, Mariana/0000-0002-0662-1831;
   Dias, Tania/0000-0002-2336-8006
FU "Fundacao para a Ciencia e a Tecnologia" - FCT [SFRH/BD/109284/2015];
   UMIB [PEst-OE/SAU/UI0215/2014]; FEDER through the COMPETE/QREN; FSE/POPH
   [PTDC/BIM-MET/4712/2014]; POCI - COMPETE [POCI-01-0145-FEDER007491]; 
   [PTDC/BBB-BQB/1368/2014]; Fundação para a Ciência e a Tecnologia
   [PTDC/BBB-BQB/1368/2014] Funding Source: FCT
FX This work was supported by "Fundacao para a Ciencia e a Tecnologia" -
   FCT to Tania R. Dias (SFRH/BD/109284/2015); and UMIB
   (PEst-OE/SAU/UI0215/2014). The work was co-funded by FEDER through the
   COMPETE/QREN, FSE/POPH to Marco G. Alves (PTDC/BIM-MET/4712/2014); Pedro
   F. Oliveira (PTDC/BBB-BQB/1368/2014), and POCI - COMPETE 2020
   (POCI-01-0145-FEDER007491) funds. The authors are thankful to Milaydis
   S. Napolskij, BA, for professional English proofreading and linguistic
   suggestions.Declaration of interest
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Al-Hazzani AA, 2011, FOOD CHEM TOXICOL, V49, P3281, DOI 10.1016/j.fct.2011.09.023
   Alcazar A, 2007, J AGR FOOD CHEM, V55, P5960, DOI 10.1021/jf070601a
   Alves MG, 2015, J FUNCT FOODS, V14, P102, DOI 10.1016/j.jff.2015.01.019
   AMOROSO P, 1993, THORAX, V48, P882, DOI 10.1136/thx.48.9.882
   Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Arnold R, 2002, BIOORG MED CHEM LETT, V12, P2587, DOI 10.1016/S0960-894X(02)00480-8
   Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029
   Atawodi SEO, 2007, J AGR FOOD CHEM, V55, P9824, DOI 10.1021/jf0721038
   Azam Sonish, 2003, Med Sci Monit, V9, pBR325
   Bajko E, 2016, LWT-FOOD SCI TECHNOL, V65, P471, DOI 10.1016/j.lwt.2015.08.024
   Baker SP, 2000, BRIT J PHARMACOL, V130, P1156, DOI 10.1038/sj.bjp.0703405
   Barakat H, 2006, J CLIN ENDOCR METAB, V91, P1882, DOI 10.1210/jc.2005-2109
   Baraldi PG, 2007, EXPERT OPIN DRUG DIS, V2, P1161, DOI 10.1517/17460441.2.9.1161
   Barnes PJ, 2013, AM J RESP CRIT CARE, V188, P901, DOI 10.1164/rccm.201302-0388PP
   BAUMANN TW, 1995, PHYTOCHEMISTRY, V39, P1063, DOI 10.1016/0031-9422(94)00141-F
   Beale J.M., 2011, Wilson and Gisvold's textbook of organic medicinal and pharmaceutical chemistry, V12th
   BEAVO JA, 1970, MOL PHARMACOL, V6, P597
   Ben Lagha A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44815
   Borglum JD, 1996, MOL CELL ENDOCRINOL, V117, P17, DOI 10.1016/0303-7207(95)03728-4
   BOULENGER JP, 1982, NEUROSCI LETT, V30, P161, DOI 10.1016/0304-3940(82)90290-7
   Bray GA, 2008, J CLIN ENDOCR METAB, V93, pS81, DOI 10.1210/jc.2008-1294
   Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2
   Bray GA, 2016, LANCET, V387, P1947, DOI 10.1016/S0140-6736(16)00271-3
   BROKAW CJ, 1987, J CELL BIOCHEM, V35, P175, DOI 10.1002/jcb.240350302
   BUDOHOSKI L, 1984, FEBS LETT, V167, P1, DOI 10.1016/0014-5793(84)80820-0
   Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018
   BUTCHER RW, 1968, J BIOL CHEM, V243, P1705
   BUTCHER RW, 1962, J BIOL CHEM, V237, P1244
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   CARDINALI DP, 1980, TRENDS PHARMACOL SCI, V1, P405, DOI 10.1016/0165-6147(80)90064-4
   CARNEY JM, 1985, LIFE SCI, V36, P913, DOI 10.1016/0024-3205(85)90386-8
   Castro AVB, 2014, ARQ BRAS ENDOCRINOL, V58, P600, DOI 10.1590/0004-2730000003223
   Cedikova M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6067349
   CHAVEY C., 2013, Physiology and Physiopathology of Adipose Tissue, P17, DOI [10.1007/978-2-8178-0343-2_2, DOI 10.1007/978-2-8178-0343-2_2]
   Chen Jiang-Fan, 2011, Handb Exp Pharmacol, P267, DOI 10.1007/978-3-642-13443-2_10
   Chen M D, 1994, Zhonghua Yi Xue Za Zhi (Taipei), V53, P257
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 2017, NAT PROD REP, V34, P1391, DOI 10.1039/c7np00030h
   Coelho M, 2013, ARCH MED SCI, V9, P191, DOI 10.5114/aoms.2013.33181
   Cotillard A, 2014, J CLIN ENDOCR METAB, V99, pE1466, DOI 10.1210/jc.2014-1074
   Csóka B, 2014, DIABETES, V63, P850, DOI 10.2337/db13-0573
   Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Daly JW, 2007, CELL MOL LIFE SCI, V64, P2153, DOI 10.1007/s00018-007-7051-9
   DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999
   Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
   de Mejia EG, 2009, BRAIN BEHAV IMMUN, V23, P721, DOI 10.1016/j.bbi.2009.02.013
   de Resende PE, 2015, J FUNCT FOODS, V15, P440, DOI 10.1016/j.jff.2015.03.040
   DENT G, 1994, AM J RESP CELL MOL, V10, P565, DOI 10.1165/ajrcmb.10.5.8179921
   DeOliveira CC, 2017, EUR J PHARMACOL, V799, P154, DOI 10.1016/j.ejphar.2017.02.017
   Dhalla Arvinder K, 2009, Handb Exp Pharmacol, P271, DOI 10.1007/978-3-540-89615-9_9
   Dias TR, 2017, CURR MED CHEM, V24, P334, DOI 10.2174/0929867323666160905150419
   Dias TR, 2016, J NUTR BIOCHEM, V37, P83, DOI 10.1016/j.jnutbio.2016.07.018
   Dias TR, 2015, TOXICOLOGY, V328, P12, DOI 10.1016/j.tox.2014.12.003
   Dias TR, 2014, J AGR FOOD CHEM, V62, P608, DOI 10.1021/jf4049462
   Dias TR., 2013, International Journal of Food Science, Nutrition and Dietetics, V2, P19, DOI DOI 10.19070/2326-3350-130005
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   do Carmo I, 2008, OBES REV, V9, P11, DOI 10.1111/j.1467-789X.2007.00422.x
   Dong Q, 2001, DIABETES OBES METAB, V3, P360, DOI 10.1046/j.1463-1326.2001.00158.x
   DULLOO AG, 1986, INT J OBESITY, V10, P467
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   DULLOO AG, 1986, AM J CLIN NUTR, V43, P388, DOI 10.1093/ajcn/43.3.388
   Eisenstein A, 2014, J CELL PHYSIOL, V229, P414, DOI 10.1002/jcp.24473
   Esmaeilzadeh Seddigheh, 2014, Glob J Health Sci, V7, P101, DOI 10.5539/gjhs.v7n2p101
   Eteng MU, 2006, DISCOV INNOVAT, V18, P191
   FAIN JN, 1972, J BIOL CHEM, V247, P6866
   Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779
   Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907
   Faulhaber-Walter R, 2011, DIABETES, V60, P2578, DOI 10.2337/db11-0058
   Fonseca-Alaniz MH, 2007, J PEDIAT-BRAZIL, V83, pS192, DOI [10.1590/S0021-75572007000700011, 10.2223/JPED.1709]
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0
   Fredholm BB, 2001, PHARMACOL REV, V53, P527
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654
   GELOEN A, 1989, AM J PHYSIOL, V257, pE547, DOI 10.1152/ajpendo.1989.257.4.E547
   Gharibi B, 2012, INT J OBESITY, V36, P397, DOI 10.1038/ijo.2011.129
   GILBERT RM, 1976, CAN MED ASSOC J, V114, P205
   Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816
   GOLDBERG R, 1975, POSTGRAD MED J, V51, P53, DOI 10.1136/pgmj.51.592.53
   Gramza-Michalowska A, 2014, J NUTR HEALTH AGING, V18, P143, DOI 10.1007/s12603-013-0404-1
   GREEN RD, 1977, BIOCHEM PHARMACOL, V26, P37, DOI 10.1016/0006-2952(77)90127-7
   Greenway F L, 2001, Obes Rev, V2, P199, DOI 10.1046/j.1467-789x.2001.00038.x
   Grucka-Mamczar E, 2009, FLUORIDE, V42, P105
   Hajiaghaalipour F, 2015, FOOD CHEM, V169, P401, DOI 10.1016/j.foodchem.2014.07.005
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x
   Islam MS, 2011, PHYTOMEDICINE, V19, P25, DOI 10.1016/j.phymed.2011.06.025
   Jajoo S, 2006, J PHARMACOL EXP THER, V317, P1, DOI 10.1124/jpet.105.096255
   Jang YJ, 2015, FOOD FUNCT, V6, P2365, DOI 10.1039/c5fo00397k
   Johansson SM, 2007, ACTA PHYSIOL, V190, P87, DOI 10.1111/j.1365-201X.2007.01692.x
   Johnston-Cox H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040584
   Jungheim ES, 2013, NUTR REV, V71, pS3, DOI 10.1111/nure.12056
   KAARTINEN JM, 1991, BIOCHEM J, V279, P17, DOI 10.1042/bj2790017
   Kakuda T, 2002, BIOL PHARM BULL, V25, P1513, DOI 10.1248/bpb.25.1513
   Karunanidhi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/392058
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Klotz K.-N., 1997, N-S ARCH PHARMACOL, V357, P1, DOI DOI 10.1007/PL00005131
   Kretschmar JA, 1999, PHYTOCHEMISTRY, V52, P19, DOI 10.1016/S0031-9422(99)00119-3
   Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5
   Landgraf K, 2015, DIABETES, V64, P1249, DOI 10.2337/db14-0744
   LANGIN D., 2013, Physiology and Physiopathology of Adipose Tissue, P141
   Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009
   Langin D, 2011, CELL METAB, V14, P569, DOI 10.1016/j.cmet.2011.10.003
   Larsson SC, 2008, STROKE, V39, P1681, DOI 10.1161/STROKEAHA.107.504183
   Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004
   LEBLANC J, 1985, J APPL PHYSIOL, V59, P832, DOI 10.1152/jappl.1985.59.3.832
   Leff T, 2010, ADIPOSE TISSUE IN HEALTH AND DISEASE, P21
   Leung LK, 2001, J NUTR, V131, P2248, DOI 10.1093/jn/131.9.2248
   Li HF, 2010, MOL CELL ENDOCRINOL, V323, P201, DOI 10.1016/j.mce.2010.03.021
   Liang HX, 2002, BRIT J PHARMACOL, V135, P1457, DOI 10.1038/sj.bjp.0704586
   LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757
   LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533
   Liu AG, 2015, OBESITY, V23, P1830, DOI 10.1002/oby.21163
   Liu AG, 2013, OBESITY, V21, P1991, DOI 10.1002/oby.20416
   Liu CC, 2017, MOL MED REP, V16, P1369, DOI 10.3892/mmr.2017.6698
   Lopez-Garcia E, 2008, ANN INTERN MED, V148, P904, DOI 10.7326/0003-4819-148-12-200806170-00003
   Luna-Luna M, 2015, ARCH MED RES, V46, P392, DOI 10.1016/j.arcmed.2015.05.007
   Malongane F, 2017, J SCI FOOD AGR, V97, P4679, DOI 10.1002/jsfa.8472
   Martins AD, 2014, EUR J NUTR, V53, P1383, DOI 10.1007/s00394-013-0640-5
   MAURIEGE P, 1988, J LIPID RES, V29, P587
   MCCALL AL, 1982, LIFE SCI, V31, P2709, DOI 10.1016/0024-3205(82)90715-9
   McKeague M, 2016, METAB ENG, V38, P191, DOI 10.1016/j.ymben.2016.08.003
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Mission JF, 2015, OBSTET GYN CLIN N AM, V42, P335, DOI 10.1016/j.ogc.2015.01.008
   Moffat AC., 1986, CLARKES ISOLATION ID, DOI [DOI 10.1002/JPS.2600760520, DOI 10.1080/00268976.2012.742209]
   Monteiro JP, 2016, MOLECULES, V21, DOI 10.3390/molecules21080974
   Monteiro MP, 2014, HUM VACC IMMUNOTHER, V10, P887, DOI 10.4161/hv.27537
   Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024
   Moro S, 2006, MED RES REV, V26, P131, DOI 10.1002/med.20048
   Muir LA, 2016, OBESITY, V24, P597, DOI 10.1002/oby.21377
   Müller CE, 1998, SYNTHESIS-STUTTGART, P1428
   Nanjundaiah S, 2016, APPL BIOCHEM BIOTECH, V178, P58, DOI 10.1007/s12010-015-1858-x
   NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   NICHOLSON CD, 1989, BRIT J PHARMACOL, V97, P889, DOI 10.1111/j.1476-5381.1989.tb12029.x
   Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749
   Noormandi Afsaneh, 2015, J Tradit Complement Med, V5, P15, DOI 10.1016/j.jtcme.2014.10.005
   Ofluoglu E, 2009, NEUROCHEM RES, V34, P395, DOI 10.1007/s11064-008-9790-x
   OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Osswald Hartmut, 2011, Handb Exp Pharmacol, P391, DOI 10.1007/978-3-642-13443-2_15
   Palmer Nicole O, 2012, Spermatogenesis, V2, P253
   PAVIA DL, 1973, J CHEM EDUC, V50, P791, DOI 10.1021/ed050p791
   Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008
   Peluso I, 2017, BRIT J PHARMACOL, V174, P1195, DOI 10.1111/bph.13649
   Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202
   Pissarnitski DA, 2004, BIOORG MED CHEM LETT, V14, P1291, DOI 10.1016/j.bmcl.2003.12.027
   León-Carmona JR, 2011, J PHYS CHEM B, V115, P4538, DOI 10.1021/jp201383y
   Ren JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18888-5
   ROLBAND GC, 1990, J GERONTOL, V45, pB174, DOI 10.1093/geronj/45.5.B174
   ROLL T., 1980, Pharmacological basis of therapeutics, P592
   Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   Rydén M, 2014, J CLIN ENDOCR METAB, V99, pE1870, DOI 10.1210/jc.2014-1526
   Saeed M, 2017, BIOMED PHARMACOTHER, V95, P1260, DOI 10.1016/j.biopha.2017.09.024
   Saely CH, 2012, GERONTOLOGY, V58, P15, DOI 10.1159/000321319
   SAGGERSON ED, 1990, BIOCHEM J, V269, P157, DOI 10.1042/bj2690157
   SALIHOVIC M., 2014, Bull. Chem. Technol. Bosnia Herzeg, V42, P31
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Santana-Rios G, 2001, MUTAT RES-GEN TOX EN, V495, P61, DOI 10.1016/S1383-5718(01)00200-5
   Sassone-Corsi P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011148
   SATTIN A, 1970, MOL PHARMACOL, V6, P13
   Schubert MM, 2014, J APPL PHYSIOL, V117, P745, DOI 10.1152/japplphysiol.00570.2014
   SCHWABE U, 1985, N-S ARCH PHARMACOL, V330, P212, DOI 10.1007/BF00572436
   Shearer J, 2007, CAN J PHYSIOL PHARM, V85, P823, DOI 10.1139/Y07-070
   Shi D, 1999, CELL MOL NEUROBIOL, V19, P719, DOI 10.1023/A:1006901005925
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011
   SPIEGELMAN BM, 1993, J BIOL CHEM, V268, P6823
   STAVRIC B, 1988, FOOD CHEM TOXICOL, V26, P541, DOI 10.1016/0278-6915(88)90007-5
   Stich V, 1999, AM J PHYSIOL-REG I, V277, pR1076, DOI 10.1152/ajpregu.1999.277.4.R1076
   Stoclet JC, 2004, EUR J PHARMACOL, V500, P299, DOI 10.1016/j.ejphar.2004.07.034
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Sun NN, 2016, MOLECULES, V21, DOI 10.3390/molecules21101351
   Takasuga S, 1999, J BIOL CHEM, V274, P19545, DOI 10.1074/jbc.274.28.19545
   Talik P, 2012, SEP PURIF REV, V41, P1, DOI 10.1080/15422119.2011.569047
   Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432
   TARKA SM, 1982, CRC CR REV TOXICOL, V9, P275, DOI 10.3109/10408448209037495
   TASH JS, 1982, BIOL REPROD, V26, P745, DOI 10.1095/biolreprod26.4.745
   Tenore GC, 2013, FOOD CHEM, V141, P2379, DOI 10.1016/j.foodchem.2013.04.128
   TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351
   TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   TROST T, 1981, MOL PHARMACOL, V19, P228
   Tsiloulis T, 2015, PROG MOL BIOL TRANSL, V135, P175, DOI 10.1016/bs.pmbts.2015.06.016
   TVERDAL A, 1990, BMJ-BRIT MED J, V300, P566, DOI 10.1136/bmj.300.6724.566
   Van der Walt MM, 2015, BIOORGAN MED CHEM, V23, P6641, DOI 10.1016/j.bmc.2015.09.012
   VANNUCCI SJ, 1989, AM J PHYSIOL, V257, pE871, DOI 10.1152/ajpendo.1989.257.6.E871
   VASSAUX G, 1993, BIOCHEM BIOPH RES CO, V193, P1123, DOI 10.1006/bbrc.1993.1742
   Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244
   Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237
   Wang HY, 1999, J BIOL CHEM, V274, P32159, DOI 10.1074/jbc.274.45.32159
   Wang HY, 1996, J BIOL CHEM, V271, P22022, DOI 10.1074/jbc.271.36.22022
   Weckerle CS, 2003, PHYTOCHEMISTRY, V64, P735, DOI 10.1016/S0031-9422(03)00372-8
   Wu C, 2016, OBES REV, V17, P429, DOI 10.1111/obr.12385
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Xu BY, 1998, AM J PHYSIOL-ENDOC M, V274, pE271, DOI 10.1152/ajpendo.1998.274.2.E271
   Yamaguchi S, 2009, J REPROD DEVELOP, V55, P645, DOI 10.1262/jrd.20238
   Yang N, 2018, INT J MOL MED, V41, P818, DOI 10.3892/ijmm.2017.3292
   Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018
   Zajac MA, 2003, SYNTHETIC COMMUN, V33, P3291, DOI 10.1081/SCC-120023986
   Zhang WL, 2009, DIABETOLOGIA, V52, P810, DOI 10.1007/s00125-009-1311-1
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Zheng GD, 2004, IN VIVO, V18, P55
   ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
   Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421
NR 210
TC 36
Z9 39
U1 0
U2 36
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD APR
PY 2018
VL 43
BP 84
EP 94
DI 10.1016/j.jff.2018.02.001
PG 11
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA GC4MG
UT WOS:000429758000011
DA 2025-04-28
ER

PT J
AU Vijayagopal, P
   Figueroa, JE
   Prasad, C
AF Vijayagopal, Parakat
   Figueroa, Julio E.
   Prasad, Chandan
TI EFFECT OF A COMBINATION OF GRAPE SEED EXTRACT, CAPSAICIN, GENISTEIN, AND
   CAFFEINE ON BODY WEIGHT IN OBESE ZUCKER RATS
SO CURRENT TOPICS IN NUTRACEUTICAL RESEARCH
LA English
DT Article
DE Body Weight; Caffeine; Capsaicin; Genistein; Grape Seed Extract; Obesity
ID INSULIN SENSITIVITY; 3T3-L1 ADIPOCYTES; METABOLIC-RATE; ADIPONECTIN;
   LIPOLYSIS; EXPRESSION; RESISTANCE; HORMONE; HUMANS; TRIAL
AB The incidence of obesity is increasing rapidly worldwide. Identification of compounds that may decrease fat cell burden will be beneficial in the control of obesity. In the present study we investigated the effect of a combination of grape seed extarct, caffeine, genistein, and capsaicin (GCGC) in reducing body weight in obese male zucker rats. Rats were pair-fed on a high fat diet or high fat diet + GCGC for 5-weeks. GCGC caused a significant weight loss due to the depletion of fat depots. GCGC also improved insulin response, reduced plasma glucose and free fatty acids, and increased plasma adiponectin. Adipocytes from rats fed GCGC were more responsive to the various stimulators of lipolysis than the control adipocytes. These results show that a combination of plant-derived products is very effective in reducing body weight and improving insulin sensitivity and glucose response in obese zucker rats. This may have implications in the treatment of overweight and obesity in humans.
C1 [Vijayagopal, Parakat; Prasad, Chandan] Texas Womans Univ, Dept Nutr & Food Sci, Denton, TX 76204 USA.
   [Figueroa, Julio E.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA.
C3 Texas Womans University; Louisiana State University System; Louisiana
   State University Health Sciences Center New Orleans
RP Vijayagopal, P (corresponding author), Texas Womans Univ, Dept Nutr & Food Sci, POB 425888, Denton, TX 76204 USA.
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442
   Chen M D, 1994, Zhonghua Yi Xue Za Zhi (Taipei), V53, P257
   Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068
   Décorde K, 2009, MOL NUTR FOOD RES, V53, P659, DOI 10.1002/mnfr.200800165
   Díez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293
   Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307
   Figueroa JE, 2002, BIOCHEM BIOPH RES CO, V293, P847, DOI 10.1016/S0006-291X(02)00300-5
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Goodman-Gruen D, 2003, MENOPAUSE, V10, P427, DOI 10.1097/01.GME.0000058866.35869.B4
   Harmon AW, 2001, AM J PHYSIOL-CELL PH, V280, pC807, DOI 10.1152/ajpcell.2001.280.4.C807
   HENRY CJK, 1986, HUM NUTR-CLIN NUTR, V40C, P165
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200
   MAEDA N, 2002, NAT MED, V1, P1155
   Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650
   Moreno DA, 2003, NUTRITION, V19, P876, DOI 10.1016/S0899-9007(03)00167-9
   NOBLE R, 1988, DRUG INTEL CLIN PHAR, V22, P296, DOI 10.1177/106002808802200403
   Park Su-Hui, 2008, Nutr Res Pract, V2, P227, DOI 10.4162/nrp.2008.2.4.227
   RANDLE PJ, 1963, LANCET, V1, P785
   Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742
   Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319
   Szkudelska K, 2000, J STEROID BIOCHEM, V75, P265, DOI 10.1016/S0960-0760(00)00172-2
   WATANABE T, 1994, LIFE SCI, V54, P369, DOI 10.1016/0024-3205(94)00793-4
   *WHO, 2000, TECH REP SER WHO, V894
   Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130
NR 27
TC 1
Z9 1
U1 0
U2 10
PU NEW CENTURY HEALTH PUBLISHERS, LLC
PI COPPELL
PA PO BOX 175, COPPELL, TX 75019 USA
SN 1540-7535
J9 CURR TOP NUTRACEUT R
JI Curr. Top. Nutraceutical Res.
PD AUG
PY 2010
VL 8
IS 2-3
BP 59
EP 64
PG 6
WC Nutrition & Dietetics; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Pharmacology & Pharmacy
GA 645VJ
UT WOS:000281494000001
DA 2025-04-28
ER

PT J
AU Golzarand, M
   Toolabi, K
   Aghasi, M
AF Golzarand, Mahdieh
   Toolabi, Karamollah
   Aghasi, Mohadeseh
TI Effect of green tea, caffeine and capsaicin supplements on the
   anthropometric indices: A meta-analysis of randomized clinical trials
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Review
DE Green tea; Caffeine; Capsaicin; Weight; Body fat; Meta-analysis
ID BODY-WEIGHT; CAMELLIA-SINENSIS; OXIDATIVE STRESS; DOUBLE-BLIND; OBESE;
   EXTRACT; CONSUMPTION; MAINTENANCE; RESISTANCE; OVERWEIGHT
AB We conducted a meta-analysis to assess the effect of green tea, caffeine and capsaicin supplements on the anthropometric indices in adults. PubMed/Medline, Scopus, Cochran and Web of Science databases were searched up to March 2017. Green tea significantly reduced weight by -0.65 kg (-1.10 to -0.20, P = 0.005), body mass index (BMI) by -0.26 kg/m(2) (-0.43 to -0.10, P = 0.002) and waist circumference by -1.11 cm (-1.99 to -0.23, P = 0.01) but not percent of body fat (PBF) (-1.42%, 95% CI: -3.02 to 0.18, P = 0.08). Caffeine supplement had no effect on weight (-2.99 kg, 95% CI: - 7.83 to 1.41, P = 0.18). We observed a significant weight loss after capsaicin supplement (-0.50 kg; 95% CI: -0.90 to -0.11, P = 0.01) but PBF did not change significantly from baseline (0.11%, 95% CI: -0.22 to 0.43, P = 0.51). Green tea and capsaicin supplements have a significant mild weight-lowering effect. On the contrary, it seems caffeine had no effect on weight.
C1 [Golzarand, Mahdieh; Aghasi, Mohadeseh] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Tehran, Iran.
   [Toolabi, Karamollah] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Surg, Tehran, Iran.
C3 Tehran University of Medical Sciences; Tehran University of Medical
   Sciences
RP Toolabi, K (corresponding author), Imam Khomeini Hosp, Keshavarz Blvd,POB 13145-158, Tehran, Iran.
EM tolabika@tums.ac.ir
RI Golzarand, Mahdieh/E-4055-2018
OI Golzarand, Mahdieh/0000-0003-2651-9276
CR Al-Naggar R. A., 2013, RES J PHARM BIOL CHE, V4, P1649
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bajerska J, 2015, J MED FOOD, V18, P698, DOI 10.1089/jmf.2014.0032
   Baladia E, 2014, NUTR HOSP, V29, P479, DOI [10.3305/nh.2014.29.3.7118, 10.3305/NH.2014.29.3.7118]
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Cardoso GA, 2013, J MED FOOD, V16, P120, DOI 10.1089/jmf.2012.0062
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Christensen PM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00240
   Conforti F, 2016, MOLECULES, V21, DOI 10.3390/molecules21121750
   Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Gahreman D, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080510
   Glaister M, 2018, INT J SPORT PHYSIOL, V13, P402, DOI 10.1123/ijspp.2017-0312
   Grgic J, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0216-0
   Grgic J, 2018, EUR J SPORT SCI, V18, P219, DOI 10.1080/17461391.2017.1394371
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2016, MOL NUTR FOOD RES, V60, P223, DOI 10.1002/mnfr.201500620
   Hasani-Ranjbar S, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-28
   Hedayati, 2013, IRANIAN J ENDOCRINOL, V15, P253
   Hovanloo F., 2016, J MED PLANTS, V15, P17
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Icken D, 2016, EUR J CLIN NUTR, V70, P532, DOI 10.1038/ejcn.2015.183
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Janssens PLHR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153134
   Janssens PLHR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067786
   Joy JM, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0136-9
   Jurgens TM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008650.pub2
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Lee TA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-78
   Lejeune MPGM, 2003, BRIT J NUTR, V90, P651, DOI 10.1079/BJN2003938
   Low S, 2009, ANN ACAD MED SINGAP, V38, P57
   Luo XJ, 2011, EUR J PHARMACOL, V650, P1, DOI 10.1016/j.ejphar.2010.09.074
   Malek MH, 2006, J STRENGTH COND RES, V20, P751
   Mirzaei K., 2010, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V169, P137
   Mohammadi S., 2010, J Zanjan Univ Med Sci Health Services, V18, P44
   Mousavi A, 2013, J RES MED SCI, V18, P1080
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nieman DC, 2012, PLANT FOOD HUM NUTR, V67, P415, DOI 10.1007/s11130-012-0325-x
   Nirengi S, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.091305
   Ohnaka K, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/207426
   Pezeshki A., 2015, INT J PREVENTIVE MED, P1
   Roberts JD, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-014-0062-7
   Snitker S, 2009, AM J CLIN NUTR, V89, P45, DOI 10.3945/ajcn.2008.26561
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Sun NN, 2016, MOLECULES, V21, DOI 10.3390/molecules21101351
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   TOUBRO S, 1993, INT J OBESITY, V17, pS69
   Tsai CH, 2009, INT J FOOD SCI NUTR, V60, P151, DOI 10.1080/09637480903136667
   Tundis R, 2011, PLANT FOOD HUM NUTR, V66, P261, DOI 10.1007/s11130-011-0248-y
   Senger AEV, 2012, J NUTR HEALTH AGING, V16, P738, DOI 10.1007/s12603-012-0081-5
   Zheng J, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170286
   Zsiborás C, 2018, CRIT REV FOOD SCI, V58, P1419, DOI 10.1080/10408398.2016.1262324
NR 57
TC 16
Z9 17
U1 5
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JUL
PY 2018
VL 46
BP 320
EP 328
DI 10.1016/j.jff.2018.04.002
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA GS4PG
UT WOS:000443630000035
DA 2025-04-28
ER

PT J
AU Popiolek-Kalisz, J
   Glibowski, P
   Solarska, E
AF Popiolek-Kalisz, Joanna
   Glibowski, Pawel
   Solarska, Ewa
TI Supplementation of Nutraceuticals from Dwarf Kiwi and Apple Improves
   Lipid Profile in Overweight Adults
SO APPLIED SCIENCES-BASEL
LA English
DT Article
DE dwarf kiwi; apples; overweight; obesity; metabolic syndrome;
   nutraceutical
ID KIWIBERRY ACTINIDIA-ARGUTA; METABOLIC SYNDROME; ANTIOXIDANT ACTIVITY;
   PEEL; METAANALYSIS; POLYPHENOLS; CONSUMPTION; GLUCOSE
AB (1) Background: Overweight and obesity are emerging global problems causing multiple health complications. Excessive fat tissue content leads to chronic inflammation, which is why antioxidative compounds that could potentially reduce these processes are possible agents that could be supplemented in order to prevent metabolic complications of overweight and obesity. Apples and dwarf kiwis are good sources of antioxidative agents such as quercetin and chlorogenic acid. The aim of this study was to assess if apple and dwarf kiwi nutraceutical supplementation can improve the metabolic parameters of overweight adults. (2) Methods: 43 participants were enrolled in the double-blinded pilot study: 21 in the supplementation group and 22 in the placebo group. The one 1000 mg nutraceutical capsule contained 10% Chopin apple peel extract, 10% whole dwarf kiwi fruit extract, 75% Chopin apple core extract, and 5% rapeseed peptides. The supplementation group received two capsules/day for 60 days. (3) Results: The supplementation of the apple and kiwi product resulted in a lowering of ALT in the supplementation group (from 29.65 +/- 19.02 UI/L to 23.80 +/- 13.76 UI/L; p = 0.01). Subgroup analysis in men and women showed a significant decrease in total cholesterol level (from 220.15 +/- 36.69 mg/dL to 208.43 +/- 37.09 mg/dL; p = 0.04), non-HDL cholesterol (from 161.17 +/- 41.00 mg/dL to 145.69 +/- 41.75 mg/dL; p = 0.02) and ALT (from 25.41 +/- 12.05 UI/L to 19.07 +/- 6.13 UI/L; p = 0.01) in women and triglycerides levels (from 212.74 +/- 127.15 mg/dL to 155.63 +/- 80.61 mg/dL; p = 0.047) in men. (4) Conclusions: The supplementation of nutraceuticals from apples and dwarf kiwi led to improvements in lipid profile. It can be a possible new agent for counteracting overweight metabolic complications, however, larger group studies and more detailed tests are needed to support these preliminary findings.
C1 [Popiolek-Kalisz, Joanna] Med Univ Lublin, Dept Bioanalyt, Clin Dietet Unit, Ul Chodzki 7, PL-20090 Lublin, Poland.
   [Popiolek-Kalisz, Joanna] Cardinal Wyszynski Hosp Lublin, Dept Cardiol, al Krasnicka 100, PL-20718 Lublin, Poland.
   [Glibowski, Pawel; Solarska, Ewa] Univ Life Sci Lublin, Dept Biotechnol Microbiol & Human Nutr, 8 Skromna St, PL-20704 Lublin, Poland.
C3 Medical University of Lublin; University of Life Sciences in Lublin
RP Popiolek-Kalisz, J (corresponding author), Med Univ Lublin, Dept Bioanalyt, Clin Dietet Unit, Ul Chodzki 7, PL-20090 Lublin, Poland.; Popiolek-Kalisz, J (corresponding author), Cardinal Wyszynski Hosp Lublin, Dept Cardiol, al Krasnicka 100, PL-20718 Lublin, Poland.
EM joannapopiolekkalisz@umlub.pl; pawel.glibowski@up.lublin.pl
RI Popiolek-Kalisz, Joanna/CAI-4688-2022
OI Glibowski, Pawel/0000-0003-1774-6899; Popiolek-Kalisz,
   Joanna/0000-0001-9108-8391
CR Alshammary AF, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041773
   Azzini E, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1672567
   Bae MJ, 2016, J ETHNOPHARMACOL, V193, P96, DOI 10.1016/j.jep.2016.08.004
   Bak-Sosnowska M., 2022, Zalecenia Kliniczne Dotyczace Postepowania u Chorych na Otyloc 2022. Stanowisko Polskiego Towarzystwa Leczenia Otyloci
   Barber TM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103209
   Bhaswant M, 2019, J FUNCT FOODS, V56, P119, DOI 10.1016/j.jff.2019.03.011
   Chen JP, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010024
   Debersaques F, 2015, ACTA HORTIC, V1096, P435
   Drummond L, 2013, ADV FOOD NUTR RES, V68, P33, DOI 10.1016/B978-0-12-394294-4.00003-1
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Ferguson AR, 2003, ACTA HORTIC, P131, DOI 10.17660/ActaHortic.2003.610.16
   Garcia AL, 2007, EUR J CLIN NUTR, V61, P334, DOI 10.1038/sj.ejcn.1602525
   Garcia-Herrera P, 2022, MOLECULES, V27, DOI 10.3390/molecules27175495
   Henríquez C, 2010, J FOOD SCI, V75, pH172, DOI 10.1111/j.1750-3841.2010.01700.x
   Holloender PLB, 2015, AM J CLIN NUTR, V102, P556, DOI 10.3945/ajcn.115.109165
   Ilowiecka K, 2021, NUTRIENTS, V13, DOI 10.3390/nu13062020
   International Diabetes Federation, 2005, Obes Metabol, V2, DOI DOI 10.14341/2071-8713-4854
   Kalinowska M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71351-w
   Kawai T, 2021, AM J PHYSIOL-CELL PH, V320, pC375, DOI 10.1152/ajpcell.00379.2020
   Kim HK, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101399
   Kim SH, 2011, EUR J NUTR, V50, P523, DOI 10.1007/s00394-010-0159-y
   Latocha P, 2017, PLANT FOOD HUM NUTR, V72, P325, DOI 10.1007/s11130-017-0637-y
   Latocha P, 2010, INT J FOOD SCI NUTR, V61, P381, DOI 10.3109/09637480903517788
   Lee KH, 2011, NUTR RES PRACT, V5, P28, DOI 10.4162/nrp.2011.5.1.28
   Lee YM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101089
   Leontowicz M, 2016, NUTR RES, V36, P1231, DOI 10.1016/j.nutres.2016.09.010
   Lian L, 2019, FOOD FUNCT, V10, P5768, DOI [10.1039/c9fo00664h, 10.1039/C9FO00664H]
   Monserrat-Mesquida M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030236
   Popiolek-Kalisz J, 2023, LIFE-BASEL, V13, DOI 10.3390/life13030753
   Popiolek-Kalisz J, 2022, NUTRIENTS, V14, DOI 10.3390/nu14214586
   Popiolek-Kalisz J, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph191912546
   Shin JY, 2015, INT J FOOD SCI NUTR, V66, P416, DOI 10.3109/09637486.2015.1025716
   Shinozaki K, 2015, ANN NUTR METAB, V67, P58, DOI 10.1159/000434634
   Tian J, 2018, CLIN EXP HYPERTENS, V40, P65, DOI 10.1080/10641963.2017.1313851
   Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298
   Visseren FLJ, 2021, EUR HEART J, V42, P3227, DOI 10.1093/eurheartj/ehab484
   Vugic L, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103596
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   Williams M.H., 2003, Development and Commercialization of 'Baby Kiwi' (Actinidia arguta planch.)
   Wolfe K, 2003, J AGR FOOD CHEM, V51, P609, DOI 10.1021/jf020782a
   Zhou Q, 2015, INT J ENV RES PUB HE, V12, P4726, DOI 10.3390/ijerph120504726
   Zhu X, 2015, NUTR METAB CARDIOVAS, V25, P714, DOI 10.1016/j.numecd.2015.04.008
NR 42
TC 0
Z9 1
U1 2
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3417
J9 APPL SCI-BASEL
JI Appl. Sci.-Basel
PD FEB
PY 2024
VL 14
IS 4
AR 1324
DI 10.3390/app14041324
PG 11
WC Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials
   Science, Multidisciplinary; Physics, Applied
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Engineering; Materials Science; Physics
GA IY9L6
UT WOS:001170017600001
OA gold
DA 2025-04-28
ER

PT J
AU Hackman, RM
   Havel, PJ
   Schwartz, HJ
   Rutledge, JC
   Watnik, MR
   Noceti, EM
   Stohs, SJ
   Stern, JS
   Keen, CL
AF Hackman, R. M.
   Havel, P. J.
   Schwartz, H. J.
   Rutledge, J. C.
   Watnik, M. R.
   Noceti, E. M.
   Stohs, S. J.
   Stern, J. S.
   Keen, C. L.
TI Multinutrient supplement containing ephedra and caffeine causes weight
   loss and improves metabolic risk factors in obese women: a randomized
   controlled trial
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE (MeSH) ephedra; weight loss; dietary supplement; lipids; insulin; leptin
ID DIETARY-SUPPLEMENT; HERBAL SUPPLEMENT; BODY-WEIGHT; SHORT-TERM; LEPTIN;
   SAFETY; OVERWEIGHT; EFFICACY; PREVALENCE; VITAMINS
AB Objective: To determine the safety and efficacy of a dietary supplement with a low dose of ephedra and caffeine in overweight/obese premenopausal female subjects.
   Design: A 9-month, double-blind, randomized control study compared the efficacy and safety of a dietary supplement with ephedra and caffeine to a control supplement.
   Subjects: Sixty-one healthy, premenopausal women with body mass index (BMI) from 27 to 39 kg/m(2) were randomly assigned and received a dietary supplement (40 mg/day ephedra alkaloids, 100 mg/day caffeine, high potency mixture of vitamins, minerals, omega-3 fatty acids) or a control supplement for 9 months.
   Measurements: Efficacy: changes in body weight, body composition, lipids, insulin, leptin, adiponectin, ghrelin, and self-reports of physical activity, diet and quality of life indices. Safety: blood pressure, heart rate, electrocardiograms, urinalysis, blood histology, serum chemistry measures and self-reported symptoms.
   Results: Forty-one women completed the study. The treatment group lost significantly more body weight (-7.18 kg) and body fat (-5.33 kg) than the control group (-2.25 and -0.99 kg, respectively), and showed significant declines in heart rate, serum cholesterol, triglycerides, cholesterol to high-density lipoprotein ratio, glucose, fasting insulin, and leptin. Blood pressure, electrocardiograms, other clinical chemistry measures, blood histology, urinalysis, and self- reported physical activity were similar in the groups. Minor symptoms included dry mouth, insomnia, nervousness and palpitations. The treatment group reported more energy and decreased appetite compared to controls and scored higher on a quality of life domain assessing vitality.
   Conclusion: A dietary supplement containing a low potency ephedra/caffeine mixture appeared safe and effective in causing loss of weight and body fat, and improving several metabolic parameters, including insulin sensitivity and lipid profiles when tested under physician supervision. Such supplements could be a useful tool to assist with weight loss.
C1 Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.
   Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA.
   Calif State Univ, Dept Stat, E bay, CA USA.
   Creighton Univ, Dept Pharm Sci, Omaha, NE 68178 USA.
C3 University of California System; University of California Davis;
   University of California System; University of California Davis;
   Creighton University
RP Hackman, RM (corresponding author), Univ Calif Davis, Dept Nutr, 1 Shields Ave, Davis, CA 95616 USA.
EM rmhackman@ucdavis.edu
RI Havel, Peter/AFU-9329-2022
OI Watnik, Mitchell/0000-0002-0487-8430; Havel, Peter/0000-0003-3652-8301
CR [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.157.21.2413
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   BLAIR SN, 1985, AM J EPIDEMIOL, V122, P794, DOI 10.1093/oxfordjournals.aje.a114163
   Bland JM, 1996, BRIT MED J, V312, P1079
   BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B
   Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   Chen MD, 2000, LIFE SCI, V66, P2143, DOI 10.1016/S0024-3205(00)00541-5
   Coffey CS, 2004, INT J OBESITY, V28, P1411, DOI 10.1038/sj.ijo.0802784
   Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908
   DALLAL G, 2003, RANDOMIZATION
   DALY PA, 1993, INT J OBESITY, V17, pS73
   Dubuc GR, 1998, METABOLISM, V47, P429, DOI 10.1016/S0026-0495(98)90055-5
   DULLOO AG, 1993, INT J OBESITY, V17, pS35
   Fairfield KM, 2002, JAMA-J AM MED ASSOC, V287, P3116, DOI 10.1001/jama.287.23.3116
   Faraj M, 2003, J CLIN ENDOCR METAB, V88, P1594, DOI 10.1210/jc.2002-021309
   Fine JT, 1999, JAMA-J AM MED ASSOC, V282, P2136, DOI 10.1001/jama.282.22.2136
   Finkelstein EA, 2004, OBES RES, V12, P18, DOI 10.1038/oby.2004.4
   Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Gadbury G L, 2003, Obes Rev, V4, P175, DOI 10.1046/j.1467-789X.2003.00109.x
   Greenway FL, 2004, OBES RES, V12, P1152, DOI 10.1038/oby.2004.144
   Haller CA, 2005, CLIN PHARMACOL THER, V77, P560, DOI 10.1016/j.clpt.2005.01.023
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Haller CA, 2002, CLIN PHARMACOL THER, V71, P421, DOI 10.1067/mcp.2002.124523
   Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143
   Hutton B, 2004, AM J CLIN NUTR, V80, P1461, DOI 10.1093/ajcn/80.6.1461
   Keim NL, 1998, AM J CLIN NUTR, V68, P794, DOI 10.1093/ajcn/68.4.794
   Lee H C, 1993, Obes Res, V1, P371
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McBride BF, 2004, JAMA-J AM MED ASSOC, V291, P216, DOI 10.1001/jama.291.2.216
   Neter J., 1995, APPL LINEAR STAT MOD, V4th
   PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460
   Ray S, 2005, ARCH TOXICOL, V79, P330, DOI 10.1007/s00204-005-0672-6
   Rosenbaum M, 2002, J CLIN ENDOCR METAB, V87, P2391, DOI 10.1210/jc.87.5.2391
   *SAS I I, 2003, SAS SYST WIND VERS 9
   Shara M, 2003, MOL CELL BIOCHEM, V254, P339, DOI 10.1023/A:1027358106407
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Singh RB, 1998, MAGNESIUM RES, V11, P3
   Stafford RS, 2000, ARCH FAM MED, V9, P631, DOI 10.1001/archfami.9.7.631
   Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149
   *US DEP HHS, 1990, COD SYMB THES ADV EV
   VANLOAN MD, 1993, BASIC LIFE SCI, P67
   Wadden TA, 2000, ARCH FAM MED, V9, P854, DOI 10.1001/archfami.9.9.854
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Westerterp-Plantenga M, 2002, INT J OBESITY, V26, P870, DOI 10.1038/sj.ijo.0801979
NR 46
TC 67
Z9 72
U1 2
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD OCT
PY 2006
VL 30
IS 10
BP 1545
EP 1556
DI 10.1038/sj.ijo.0803283
PG 12
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 096MI
UT WOS:000241380800012
PM 16552410
DA 2025-04-28
ER

PT J
AU Hernández-Arriaga, AM
   Oomah, BD
   Campos-Vega, R
AF Maria Hernandez-Arriaga, Angelica
   Oomah, B. Dave
   Campos-Vega, Rocio
TI Microbiota source impact in vitro metabolite colonic production
   and anti-proliferative effect of spent coffee grounds on human colon
   cancer cells (HT-29)
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article
DE Spent coffee grounds in vitro colonic fermentation; Body weight; Human
   colon cancer; Oxidative stress; Apoptosis
ID PHASEOLUS-VULGARIS L.; FERMENTED NONDIGESTIBLE FRACTION;
   COLORECTAL-CANCER; GASTROINTESTINAL DIGESTION; INTESTINAL MICROBIOTA;
   FECAL MICROBIOTA; GUT MICROBIOTA; ACID; TEA; POLYPHENOLS
AB Human gut flora-mediated non-digestible fraction of spent coffee grounds (hgf-NDSCG) was evaluated for its chemopreventive effect and molecular mechanisms involved on human colon adenocarcinoma HT-29 cell survival using two different microbiota source [lean (L) and overweight (OW)]. The source of human gut flora (hgf) (L or OW) affected the pH of hgf-NDSCG only minimally, but linearly reduced those of hgf-inulin. The variability between lean and overweight microbiota was characterized by the metabolism and/or bioaccessibility of different phenolic metabolites, their intermediate and end products as well as by variable time courses. Apoptosis of colon cancer HT-29 cells depended on the microbiota source with the lean microbiota expressing a low lethal concentration 50 (LC50/L-hgf-NDSCG = 13.5%). We demonstrate that NDSCG and its colonic metabolite from lean microbiota induced HT-29 cell apoptosis by reducing catalase and 8-iso-prostaglandin F2 alpha as biomarkers of in vivo oxidative stress as the primary mechanism underlying its overall chemoprotection against colon cancer.
C1 [Maria Hernandez-Arriaga, Angelica; Campos-Vega, Rocio] Univ Autonoma Queretaro, Sch Chem, Res & Grad Studies Food Sci, Programa Posgrado Alimentos,Ctr Republ PROPAC, Santiago De Queretaro 76010, Qro, Mexico.
   [Oomah, B. Dave] Agr & Agri Food Canada, Pacific Agri Food Res Ctr, Natl Bioprod & Bioproc Program, Summerland, BC V0H 1Z0, Canada.
C3 Universidad Autonoma de Queretaro; Agriculture & Agri Food Canada
RP Campos-Vega, R (corresponding author), Univ Autonoma Queretaro, Sch Chem, Res & Grad Studies Food Sci, Programa Posgrado Alimentos,Ctr Republ PROPAC, Santiago De Queretaro 76010, Qro, Mexico.
EM ang-ha@hotmail.com; oomand@gmail.com; chio_cve@yahoo.com.mx
RI Campos-Vega, Rocio/L-6182-2019; Campos-Vega, Rocio/L-3151-2016
OI Campos-Vega, Rocio/0000-0003-4054-1250; Oomah, B.
   Dave/0000-0002-7035-3333; Hernandez-Arriaga,
   Angelica/0000-0002-9980-4695
FU Consejo Nacional de Ciencia y Tecnologia (CONACYT) [242282]
FX This study was supported by Consejo Nacional de Ciencia y Tecnologia
   (CONACYT) Grant No. 242282.
CR Abreu RV, 2011, PHARMACOL BIOCHEM BE, V99, P659, DOI 10.1016/j.pbb.2011.06.010
   Alegre-Díaz J, 2016, NEW ENGL J MED, V375, P1961, DOI 10.1056/NEJMoa1605368
   AOAC, 2002, OFF METH AN, P1652
   Araújo JR, 2011, NUTR RES, V31, P77, DOI 10.1016/j.nutres.2011.01.006
   Arul AB, 2012, TURK J MED SCI, V42, P1307, DOI 10.3906/sag-1106-16
   Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701
   Bichler J, 2007, FOOD CHEM TOXICOL, V45, P1428, DOI 10.1016/j.fct.2007.02.001
   BRAVO L, 1994, BRIT J NUTR, V71, P933, DOI 10.1079/BJN19940197
   Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P980, DOI 10.1177/0960327110383625
   Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502
   Campos-Vega R, 2015, FOOD RES INT, V77, P156, DOI 10.1016/j.foodres.2015.07.024
   Campos-Vega R, 2009, J FOOD SCI, V74, pT59, DOI 10.1111/j.1750-3841.2009.01292.x
   Campos-Vega R, 2015, TRENDS FOOD SCI TECH, V45, P24, DOI 10.1016/j.tifs.2015.04.012
   Castro MAA, 2003, CELL PROLIFERAT, V36, P65, DOI 10.1046/j.1365-2184.2003.00259.x
   Clair D. K. S., 1991, CANCER RES, V51, P939
   Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894
   Cruz-Bravo RK, 2011, J FOOD SCI, V76, pT41, DOI 10.1111/j.1750-3841.2010.02025.x
   da Silva ST, 2013, NUTR HOSP, V28, P1039, DOI 10.3305/nh.2013.28.4.6525
   Dall'Asta M, 2012, NUTRITION, V28, P197, DOI 10.1016/j.nut.2011.06.005
   Duncan SH, 2016, ENVIRON MICROBIOL, V18, P2214, DOI 10.1111/1462-2920.13158
   Ferruzzi MG, 2010, PHYSIOL BEHAV, V100, P33, DOI 10.1016/j.physbeh.2010.01.035
   García-Gutiérrez N, 2017, J FUNCT FOODS, V30, P237, DOI 10.1016/j.jff.2017.01.014
   Gross G, 2010, J AGR FOOD CHEM, V58, P10236, DOI 10.1021/jf101475m
   Grubben MJ, 2000, AM J CLIN NUTR, V71, P480
   Gutiérrez-Grobe Y, 2012, ANN HEPATOL, V11, P350, DOI 10.1016/S1665-2681(19)30931-7
   Hinow P, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-14
   Jaganath IB, 2009, FREE RADICAL BIO MED, V47, P1180, DOI 10.1016/j.freeradbiomed.2009.07.031
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Jenner AM, 2005, FREE RADICAL BIO MED, V38, P763, DOI 10.1016/j.freeradbiomed.2004.11.020
   Karppinen S, 2000, J SCI FOOD AGR, V80, P1469, DOI 10.1002/1097-0010(200008)80:10<1469::AID-JSFA675>3.0.CO;2-A
   López-Barrera DM, 2016, FOOD CHEM, V212, P282, DOI 10.1016/j.foodchem.2016.05.175
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Ohland CL, 2014, CELL METAB, V20, P937, DOI 10.1016/j.cmet.2014.11.010
   Ramírez-Jiménez AK, 2014, FOOD CHEM, V161, P254, DOI 10.1016/j.foodchem.2014.04.008
   Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016
   Shiga Tânia M., 2003, Food Sci. Technol, V23, P141, DOI 10.1590/S0101-20612003000200007
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   St-Onge MP, 2012, OBESITY, V20, P343, DOI 10.1038/oby.2011.289
   Tagliazucchi D, 2015, AMINO ACIDS, V47, P1077, DOI 10.1007/s00726-015-1951-z
   Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796
   Toydemir G, 2013, J FUNCT FOODS, V5, P1402, DOI 10.1016/j.jff.2013.05.008
   Tzounis X, 2008, BRIT J NUTR, V99, P782, DOI 10.1017/S0007114507853384
   Umemura M., 2004, FOOD SCI TECHNOLOGY
   Vitaglione P, 2012, FOOD FUNCT, V3, P916, DOI 10.1039/c2fo30037k
   Voigt S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-74
   Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132
   Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005
   WATSON AJM, 1994, GUT, V35, P1575, DOI 10.1136/gut.35.11.1575
   Yang FJ, 2001, MOL PHARMACOL, V60, P528
NR 50
TC 17
Z9 17
U1 0
U2 66
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0963-9969
EI 1873-7145
J9 FOOD RES INT
JI Food Res. Int.
PD JUL
PY 2017
VL 97
BP 191
EP 198
DI 10.1016/j.foodres.2017.04.004
PG 8
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA EY3HF
UT WOS:000403861500023
PM 28578041
DA 2025-04-28
ER

PT J
AU Mirmiran, P
   Moslehi, N
   Hosseinpanah, F
   Sarbazi, N
   Azizi, F
AF Mirmiran, Parvin
   Moslehi, Nazanin
   Hosseinpanah, Farhad
   Sarbazi, Narges
   Azizi, Fereidoun
TI Dietary determinants of unhealthy metabolic phenotype in normal weight
   and overweight/obese adults: results of a prospective study
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE Metabolic phenotypes; dietary intake; metabolically healthy obese;
   metabolically unhealthy normal weight
ID HEALTHY OBESITY; RELATIVE VALIDITY; FOOD-INTAKE; RISK; METAANALYSIS;
   CONSUMPTION; RELIABILITY; ASSOCIATION; PREVALENCE; PREDICTORS
AB We aimed to investigate associations of dietary intakes with unhealthy metabolic phenotype development, in normal weight and overweight/obese adults separately. A total of 1114 individuals, aged >= 19 years, with healthy phenotype in the third examination cycle of Tehran Lipid and Glucose Study were followed until the fifth examination. Dietary intakes were estimated using the food frequency questionnaires, collected during the study. The participants were grouped as normal weight and overweight/obese according to the baseline body mass index (BMI). Unhealthy metabolic status was determined as having more than one component of metabolic syndrome using the Joint Interim Statement. Regardless of BMI, higher intakes of magnesium, dairy products, poultry, apples/pears, citrus fruits, and tea/coffee decreased the risk of developing unhealthy phenotype, while higher intakes of fast foods, organ meats, and potatoes increased the risk. Food intake can influence the transition to unhealthy phenotype in metabolically healthy adults, irrespective of the BMI status.
C1 [Mirmiran, Parvin; Moslehi, Nazanin; Sarbazi, Narges] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Nutr & Endocrine Res Ctr, Tehran, Iran.
   [Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran.
   [Hosseinpanah, Farhad] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran.
   [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran.
C3 Shahid Beheshti University Medical Sciences; Shahid Beheshti University
   Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid
   Beheshti University Medical Sciences
RP Moslehi, N (corresponding author), 24,Shahid Arabi St,Yemen Blvd, Tehran, Iran.
EM moslehinazanin@sbmu.ac.ir
RI hosseinpanah, farhad/AAM-7277-2020; Moslehi, Nazanin/R-8154-2019;
   Mirmiran, Parvin/V-1433-2019; Azizi, Fereidoun/ABD-4136-2021
OI Azizi, Fereidoun/0000-0002-6470-2517; Mirmiran,
   Parvin/0000-0003-2391-4924; Moslehi, Nazanin/0000-0001-8441-5200
FU Research Institute of Endocrine Sciences, Shahid Beheshti University
   Medical Sciences, Tehran, Iran
FX This study was supported by a grant by the Research Institute of
   Endocrine Sciences, Shahid Beheshti University Medical Sciences, Tehran,
   Iran.
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5
   Bahadoran Z, 2015, HEALTH PROMOT PERSPE, V5, P231, DOI 10.15171/hpp.2015.028
   Bell JA, 2014, OBES REV, V15, P504, DOI 10.1111/obr.12157
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bidel Z, 2018, CLIN NUTR ESPEN, V27, P86, DOI 10.1016/j.clnesp.2018.06.004
   Cai XL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040183
   Camhi SM, 2015, PREV MED, V77, P23, DOI 10.1016/j.ypmed.2015.04.023
   Choi J, 2012, NUTR METAB CARDIOVAS, V22, P567, DOI 10.1016/j.numecd.2010.09.001
   Conus F, 2004, J CLIN ENDOCR METAB, V89, P5013, DOI 10.1210/jc.2004-0265
   Delavari A, 2009, DIABETES CARE, V32, P1092, DOI 10.2337/dc08-1800
   Dibaba DT, 2014, DIABETIC MED, V31, P1301, DOI 10.1111/dme.12537
   Drouin-Chartier JP, 2016, ADV NUTR, V7, P1026, DOI 10.3945/an.115.011403
   Eckel N, 2016, EUR J PREV CARDIOL, V23, P956, DOI 10.1177/2047487315623884
   Eftekharzadeh A, 2017, EUR J CLIN INVEST, V47, P357, DOI 10.1111/eci.12743
   Esfahani FH, 2010, J EPIDEMIOL, V20, P150, DOI 10.2188/jea.JE20090083
   Farhadnejad H, 2018, CAN J DIABETES, V42, P613, DOI 10.1016/j.jcjd.2018.02.010
   Hankinson AL, 2013, OBESITY, V21, P637, DOI 10.1002/oby.20257
   Hosseinpanah F, 2014, EUR J CLIN NUTR, V68, P295, DOI 10.1038/ejcn.2013.142
   Huang MM, 2019, CLIN NUTR, V38, P1936, DOI 10.1016/j.clnu.2018.06.973
   Kim Y, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040390
   Kimokoti RW, 2015, J NUTR, V145, P2551, DOI 10.3945/jn.115.221283
   Kimokoti RW, 2014, J NUTR, V144, P2018, DOI 10.3945/jn.114.198341
   Lin HL, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008838
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698
   Momenan AA, 2012, ARCH IRAN MED, V15, P279, DOI 012155/AIM.007
   Nielsen FH, 2018, J INFLAMM RES, V11, P25, DOI 10.2147/JIR.S136742
   Phillips CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076188
   Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038
   Rhee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098369
   Schwingshackl L, 2019, EUR J NUTR, V58, P2243, DOI 10.1007/s00394-018-1774-2
   Slagter SN, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0319-0
   Sohrab G, 2018, METAB SYNDR RELAT D, V16, P274, DOI 10.1089/met.2017.0140
NR 34
TC 20
Z9 20
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD OCT 2
PY 2020
VL 71
IS 7
BP 891
EP 901
DI 10.1080/09637486.2020.1746955
EA APR 2020
PG 11
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA NV2US
UT WOS:000523141900001
PM 32237941
OA Green Submitted
DA 2025-04-28
ER

PT J
AU Ontawong, A
   Duangjai, A
   Muanprasat, C
   Pasachan, T
   Pongchaidecha, A
   Amornlerdpison, D
   Srimaroeng, C
AF Ontawong, Atcharaporn
   Duangjai, Acharaporn
   Muanprasat, Chatchai
   Pasachan, Tipthida
   Pongchaidecha, Anchalee
   Amornlerdpison, Doungporn
   Srimaroeng, Chutima
TI Lipid-lowering effects of Coffea arabica pulp aqueous extract in
   Caco-2 cells and hypercholesterolemic rats
SO PHYTOMEDICINE
LA English
DT Article
DE Cholesterol absorption; Cholesterol micelles; Coffea arabica pulp
   aqueous extract; LXR alpha; NPC1L1
ID PICK C1-LIKE 1; INTESTINAL-ABSORPTION; SELECTIVE INHIBITOR;
   GENE-EXPRESSION; IN-VITRO; CHOLESTEROL; EZETIMIBE; NPC1L1; TRANSPORT;
   PLASMA
AB Background: Coffea arabica pulp (CP) is the first by-product obtained from coffee berries during coffee processing. The major constituents of CP, including chlorogenic acid, caffeine, and epicatechin exhibit anti-hyperlipidemic effects in in vitro and in vivo models. Whether Coffea arabica pulp aqueous extract (CPE) has a lipid-lowering effect remains unknown.
   Purpose: This study examined the effect of CPE on cholesterol absorption, and identified the mechanisms involved in lowered cholesterol in in vitro and in vivo models.
   Methods: Uptake of [H-3]-cholesterol micelles and the mode of CPE inhibition were determined using human intestinal Caco-2 cells, and subsequently, confirmed using isolated rat jejunal loops. In addition, the 12-week high-fat diet-induced hypercholesterolemic rats (HF) received either CPE (1000 mg/kg BW), a sole and high dose which was selected because it contained approximately 12 mg of CGA that was previously shown to have lipid-lowering effects, or ezetimibe (10 mg/kg BW), a cholesterol inhibitor. The rats were divided into HF, HF + + CPE, and HF + + ezetimibe groups for the next 12 weeks. Normal rats received a normal diet (ND) and CPE (ND + CPE). Body weights and lipid profiles were evaluated. Cholesterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), protein expression and liver X receptor alpha (LXR alpha) mRNA expression were determined. In vitro micellar complex properties were also investigated.
   Results: CPE inhibited [H-3]-cholesterol micelle transport in Caco-2 cells and rat jejunal loops in a dose-dependent, non-competitive manner partly by decreasing membrane NPC1L1 expression. Congruently, CPE and its major constituents activated LXR alpha which, in turn, down-regulated NPC1L1. Furthermore, CPE interfered with physicochemical characteristics of cholesterol mixed micelles. These data were consistent with decreased body weight and slowed body weight gain and improved lipid profiles by CPE in hypercholesterolemic rats while no change occurred in these parameters in normal rats. Down-regulated intestinal NPC1L1 expression mediated by increased LXR alpha mRNA were also observed in HF + + CPE and ND + CPE rats.
   Conclusion: CPE has a cholesterol-lowering effect in in vitro and in vivo via inhibition of intestinal cholesterol absorption by down-regulating NPC1L1 mediated LXR alpha activation and interfering with micellar complex formation. Accordingly, CPE could be developed as nutraceutical product to prevent dyslipidemia-induced obesity and insulin resistance.
C1 [Ontawong, Atcharaporn; Pasachan, Tipthida; Pongchaidecha, Anchalee; Srimaroeng, Chutima] Chiang Mai Univ, Fac Med, Dept Physiol, 110 Intavaroros Rd, Chiang Mai 50200, Thailand.
   [Ontawong, Atcharaporn; Duangjai, Acharaporn] Univ Phayao, Sch Med Sci, Div Physiol, Phayao, Thailand.
   [Muanprasat, Chatchai] Mahidol Univ, Fac Sci, Dept Physiol, Bangkok, Thailand.
   [Amornlerdpison, Doungporn] Maejo Univ, Fac Fisheries Technol & Aquat Resources, Chiang Mai, Thailand.
C3 Chiang Mai University; University of Phayao; Mahidol University; Maejo
   University
RP Srimaroeng, C (corresponding author), Chiang Mai Univ, Fac Med, Dept Physiol, 110 Intavaroros Rd, Chiang Mai 50200, Thailand.
EM chutima.srimaroeng@cmu.ac.th
OI Duangjai, Acharaporn/0000-0002-5153-8738; Srimaroeng,
   Chutima/0000-0002-5537-1023
FU Faculty of Medicine Endowment Fund, Chiang Mai University, Chiang Mai,
   Thailand [66/2560]; Research and Researcher for Industry by the Thailand
   Research Fund [PHD58I0010]; NSTDA Chair Professor grant (the Fourth
   Grant) of the Crown Property Bureau Foundation; National Science and
   Technology Development Agency
FX The authors would like to thank Ms. Oranit Boonphang and Ms. Rattanaporn
   Janthip for their assistance with CPE preparation; and Ms. Sineenart
   Santidherakul, Medical Science Research Equipment Center, Faculty of
   Medicine, Chiang Mai University for technical assistance. This research
   was supported by the Faculty of Medicine Endowment Fund, Chiang Mai
   University, Chiang Mai, Thailand (66/2560 to CS and AO); the Research
   and Researcher for Industry by the Thailand Research Fund (PHD58I0010 to
   CS and AO); and the NSTDA Chair Professor grant (the Fourth Grant) of
   the Crown Property Bureau Foundation and the National Science and
   Technology Development Agency to Professor Dr. Vatcharin
   Rukachaisirikul.
CR Alqahtani S, 2015, EUR J PHARMACOL, V762, P263, DOI 10.1016/j.ejphar.2015.05.060
   Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131
   Betters JL, 2010, FEBS LETT, V584, P2740, DOI 10.1016/j.febslet.2010.03.030
   Bruckert E, 2003, CIRCULATION, V107, P3124, DOI 10.1161/01.CIR.0000072345.98581.24
   Chang E, 2015, WORLD J GASTROENTERO, V21, P7754, DOI 10.3748/wjg.v21.i25.7754
   CHOW SL, 1978, LIPIDS, V13, P239, DOI 10.1007/BF02533662
   Cohen DE, 2008, J CLIN LIPIDOL, V2, pS1, DOI 10.1016/j.jacl.2008.01.004
   Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200
   Davis HR, 2007, ARTERIOSCL THROM VAS, V27, P841, DOI 10.1161/01.ATV.0000257627.40486.46
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Duval C, 2006, BIOCHEM BIOPH RES CO, V340, P1259, DOI 10.1016/j.bbrc.2005.12.137
   Feng D, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-40
   Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200
   Field FJ, 2007, J LIPID RES, V48, P1735, DOI 10.1194/jlr.M700029-JLR200
   Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001
   Ikeda I, 2010, J AGR FOOD CHEM, V58, P8591, DOI 10.1021/jf1015285
   Jesch ED, 2006, NUTR RES, V26, P579, DOI 10.1016/j.nutres.2006.08.006
   Jesch ED, 2009, NUTR RES, V29, P859, DOI 10.1016/j.nutres.2009.10.016
   Kirana C, 2005, J AGR FOOD CHEM, V53, P4623, DOI 10.1021/jf050447x
   Lo Sasso G, 2010, CELL METAB, V12, P187, DOI 10.1016/j.cmet.2010.07.002
   Mathur SN, 2007, J LIPID RES, V48, P395, DOI 10.1194/jlr.M600325-JLR200
   Miura S, 2008, INTERNAL MED, V47, P1165, DOI 10.2169/internalmedicine.47.1099
   Muendlein A, 2015, ATHEROSCLEROSIS, V242, P340, DOI 10.1016/j.atherosclerosis.2015.07.011
   Out C, 2012, CURR OPIN LIPIDOL, V23, P43, DOI 10.1097/MOL.0b013e32834f0ef3
   Quine SD, 2005, PHARMACOL REP, V57, P610
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   RAMIREZMARTINEZ JR, 1988, J SCI FOOD AGR, V43, P135, DOI 10.1002/jsfa.2740430204
   Sage JM, 2015, AM J PHYSIOL-CELL PH, V308, pC827, DOI 10.1152/ajpcell.00001.2015
   Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004
   Telford DE, 2007, J LIPID RES, V48, P699, DOI 10.1194/jlr.M600439-JLR200
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Woollett LA, 2006, GUT, V55, P197, DOI 10.1136/gut.2005.069906
NR 32
TC 38
Z9 40
U1 1
U2 25
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0944-7113
J9 PHYTOMEDICINE
JI Phytomedicine
PD JAN
PY 2019
VL 52
BP 187
EP 197
DI 10.1016/j.phymed.2018.06.021
PG 11
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA HN1FX
UT WOS:000459934000020
PM 30599898
DA 2025-04-28
ER

PT J
AU Seifert, JG
   Nelson, A
   Devonish, J
   Burke, ER
   Stohs, SJ
AF Seifert, John G.
   Nelson, Aaron
   Devonish, Julia
   Burke, Edmund R.
   Stohs, Sidney J.
TI Effect of Acute Administration of an Herbal Preparation on Blood
   Pressure and Heart Rate in Humans
SO INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
LA English
DT Article
DE Citrus aurantium; p-synephrine; blood pressure; heart rate; bitter
   orange; caffeine; green tea
ID CITRUS-AURANTIUM; DIETARY-SUPPLEMENT; BITTER-ORANGE; WEIGHT-LOSS;
   SYNEPHRINE; EXTRACT; OBESITY
AB Confusion and controversy exist regarding the cardiovascular effects of dietary supplements containing caffeine and Citrus aurantium (bitter orange) extract. The primary protoalkaloidal ingredient in bitter orange extract is p-synephrine which has some structural similarities to ephedrine and nor-epinehrine, but exhibits markedly different pharmacokinetic and receptor binding properties. The goal of this study was to investigate the cardiovascular effects of a product containing caffeine, bitter orange extract (p-synephrine) and green tea extract in mildly overweight individuals. Fourteen female and nine male subjects (age 24.7 +/- 7.4 yrs, BMI: 26.6 +/- 3.8) volunteered in this randomized, placebo-controlled, crossover, double-blind designed study. On day one, subjects entered the laboratory following an overnight fast. Heart rate and blood pressure were recorded at 60 min. Expired air was analyzed for the next 10 min of the session. At each of three meals, subjects ingested one capsule that was either a non-caloric placebo or a dietary supplement that contained 13 mg p-synephrine and 176 mg caffeine. On the following day, the subjects returned and repeated the protocol for data collection beginning 60 min after consuming one capsule of the placebo or the dietary supplement. No effects of the dietary supplement on heart rate, systolic and diastolic blood pressure or mean arterial pressure were observed. No between or within group differences were observed when data were analyzed for gender and caffeine usage. A small but significant decrease in resting respiratory exchange ratio was observed for the low caffeine user group in response to the product containing caffeine and p-synephrine. The results of this study indicate that ingestion of a product containing bitter orange extract, caffeine and green tea extract does not lead to increased cardiovascular stress and that fat oxidation may increase in certain populations.
C1 [Seifert, John G.] Montana State Univ, Movement Sci Human Performance Lab, Bozeman, MT 59717 USA.
   [Nelson, Aaron; Devonish, Julia] St Cloud State Univ, Human Performance Lab, St Cloud, MN 56301 USA.
   [Burke, Edmund R.] Univ Colorado, Dept Biol, Colorado Springs, CO 80907 USA.
   [Stohs, Sidney J.] Creighton Univ, Med Ctr, Sch Pharm & Hlth Profess, Omaha, NE USA.
C3 Montana State University System; Montana State University Bozeman;
   Minnesota State Colleges & Universities; Saint Cloud State University;
   University of Colorado System; University of Colorado at Colorado
   Springs; Creighton University
RP Seifert, JG (corresponding author), Montana State Univ, Movement Sci Human Performance Lab, Bozeman, MT 59717 USA.
EM john.seifert@montana.edu
RI Burke, Edmund/HTQ-9231-2023
FU Enforma Natural Products
FX The authors would like to thank the subjects for their cooperation. This
   study was funded by a grant from Enforma Natural Products. This article
   is dedicated to Dr. Ed Burke, who passed away before the completion of
   this paper.
CR [Anonymous], OBESITY EPIDEMIOLOGY
   [Anonymous], HERBALGRAM
   Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8
   Barkin SL, 2010, J BUS PSYCHOL, V25, P239, DOI 10.1007/s10869-010-9166-5
   Bent S, 2004, AM J CARDIOL, V94, P1359, DOI 10.1016/j.amjcard.2004.07.137
   Bui LT, 2006, ANN PHARMACOTHER, V40, P53, DOI 10.1345/aph.1G488
   Cai LM, 2010, MED CARE, V48, P510, DOI 10.1097/MLR.0b013e3181dbdb20
   Carpéné C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   Dews PB, 2002, FOOD CHEM TOXICOL, V40, P1257, DOI 10.1016/S0278-6915(02)00095-9
   DEWS PB, 1982, ANNU REV NUTR, V2, P323, DOI 10.1146/annurev.nu.02.070182.001543
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Fugh-Berman A, 2004, EXP BIOL MED, V229, P698, DOI 10.1177/153537020422900802
   Gougeon R, 2005, OBES RES, V13, P1187, DOI 10.1038/oby.2005.141
   Gray S, 2005, J ADOLESCENT HEALTH, V37, P415, DOI 10.1016/j.jadohealth.2004.12.011
   Haller CA, 2005, AM J MED, V118, P998, DOI 10.1016/j.amjmed.2005.02.034
   Haller CA, 2008, BRIT J CLIN PHARMACO, V65, P833, DOI 10.1111/j.1365-2125.2008.03144.x
   Inchiosa MA, 2011, J OBES, V2011, DOI 10.1155/2011/764584
   Min B, 2005, PHARMACOTHERAPY, V25, P1719, DOI 10.1592/phco.2005.25.12.1719
   Penzak SR, 2001, J CLIN PHARMACOL, V41, P1059, DOI 10.1177/00912700122012652
   Preuss Harry G., 2002, Journal of Medicine (Westbury), V33, P247
   Sale C, 2006, INT J OBESITY, V30, P764, DOI 10.1038/sj.ijo.0803209
   Sander LC, 2008, ANAL BIOANAL CHEM, V391, P2023, DOI 10.1007/s00216-008-2074-0
   Stephensen TA, 2009, MIL MED, V174, P1313, DOI 10.7205/MILMED-D-01-5009
   STEWART A, 2010, ANESTH ANALG
   Stmedema JP, 2008, SAMJ S AFR MED J, V98, P372
   Thomas JE, 2009, TEX HEART I J, V36, P586
   Tsujita T, 2007, J NUTR SCI VITAMINOL, V53, P547, DOI 10.3177/jnsv.53.547
   Zenk JL, 2005, NUTRITION, V21, P179, DOI 10.1016/j.nut.2004.05.025
NR 29
TC 28
Z9 32
U1 0
U2 15
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-1907
J9 INT J MED SCI
JI Int. J. Med. Sci.
PY 2011
VL 8
IS 3
BP 192
EP 197
DI 10.7150/ijms.8.192
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 747YB
UT WOS:000289356100002
PM 21448304
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Pham, NM
   Nanri, A
   Kochi, T
   Kuwahara, K
   Tsuruoka, H
   Kurotani, K
   Akter, S
   Kabe, I
   Sato, M
   Hayabuchi, H
   Mizoue, T
AF Ngoc Minh Pham
   Nanri, Akiko
   Kochi, Takeshi
   Kuwahara, Keisuke
   Tsuruoka, Hiroko
   Kurotani, Kayo
   Akter, Shamima
   Kabe, Isamu
   Sato, Masao
   Hayabuchi, Hitomi
   Mizoue, Tetsuya
TI Coffee and green tea consumption is associated with insulin resistance
   in Japanese adults
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
DE Beverage; Diabetes; Glucose metabolism; Japanese
ID IMPAIRED GLUCOSE-TOLERANCE; DECAFFEINATED COFFEE; CAFFEINATED COFFEE;
   BLOOD-GLUCOSE; ACID-DERIVATIVES; IN-VITRO; INFLAMMATION; SENSITIVITY;
   RISK; HEALTHY
AB Objective. Higher coffee and green tea consumption has been suggested to decrease risk of type 2 diabetes, but their roles in insulin resistance (IR) and insulin secretion remain unclear. This study examined the association between habitual consumption of these beverages and markers of glucose metabolism in a Japanese working population.
   Materials/Methods. Participants were 1440 Japanese employees (1151 men and 289 women) aged 18-69 years. Consumption of coffee and green tea was ascertained via a validated brief diet history questionnaire. Multilevel linear regression was used to estimate means (95% confidence intervals) of fasting insulin, fasting plasma glucose, homeostatic model assessment of IR (HOMA-IR), homeostatic model assessment of 3-cell function (HOMA-beta) and glycated hemoglobin (HbA1c) with adjustment for potential confounding variables.
   Results. Coffee consumption was significantly, inversely associated with HOMA-IR (P for trend = 0.03), and the association appeared to be confined to overweight subjects (BMI >= 25 kg/m(2)) (P for trend = 0.01, P for interaction = 0.08). Unexpectedly, green tea consumption was positively associated with HOMA-IR (P for trend = 0.02), though there was no dose-response relationship among daily consumers of green tea. Neither coffee nor green tea consumption was associated with HOMA-beta and HbA1c.
   Conclusions. Our findings indicate that coffee consumption may be associated with decreased IR, but not with insulin secretion. The positive association between green tea consumption and IR warrants further investigation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Ngoc Minh Pham; Nanri, Akiko; Kuwahara, Keisuke; Kurotani, Kayo; Akter, Shamima; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.
   [Kochi, Takeshi; Tsuruoka, Hiroko; Kabe, Isamu] Furukawa Elect Corp, Dept Hlth Adm, Tokyo, Japan.
   [Sato, Masao] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Appl Biol Chem, Fukuoka 812, Japan.
   [Hayabuchi, Hitomi] Fukuoka Womens Univ, Grad Sch Nutr & Hlth Sci, Fukuoka, Japan.
C3 Japan Institute for Health Security (JIHS); National Center for Global
   Health & Medicine - Japan; Furukawa Electric; Kyushu University
RP Pham, NM (corresponding author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Shinjuku Ku, Toyama 1-21-1, Tokyo 1628655, Japan.
EM minh.pn@tnu.edu.vn
RI Akter Swapna, Shamima/AAA-5921-2022; Pham, Ngoc/D-5930-2011
OI Kochi, Takeshi/0000-0002-3411-1070; Kuwahara,
   Keisuke/0000-0002-7503-1333
FU Japan Society for the Promotion of Science [21390213]; Ministry of
   Education, Culture, Sports, Science and Technology [21790598]; National
   Center for Global Health and Medicine; Grants-in-Aid for Scientific
   Research [21790598] Funding Source: KAKEN
FX This study was supported by a Grant-in-Aid for Scientific Research (B)
   (21390213) from the Japan Society for the Promotion of Science (To Dr
   Mizoue), a Grant-in-Aid for Young Scientists (B) (21790598)from the
   Ministry of Education, Culture, Sports, Science and Technology and a
   Grant of National Center for Global Health and Medicine (To Dr Nanri).
CR Adisakwattana S, 2008, J AGR FOOD CHEM, V56, P7838, DOI 10.1021/jf801208t
   Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI [10.1001/jama.291.10.1199-b, 10.1001/jama.291.10.1199-a]
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139
   Gavrieli A, 2013, METABOLISM, V62, P1099, DOI 10.1016/j.metabol.2013.02.003
   Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hu G, 2006, INT J OBESITY, V30, P1742, DOI 10.1038/sj.ijo.0803341
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI 10.1007/s13340-012-0069-8
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kim DJ, 2010, DIABETES CARE, V33, P2604, DOI 10.2337/dc10-0994
   Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504
   Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Kurotani K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064758
   Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Mackenzie T, 2006, ANN EPIDEMIOL, V16, P688, DOI 10.1016/j.annepidem.2005.11.009
   Maki T, 2010, DIABETES METAB SYND, V4, P69, DOI 10.1016/j.dsx.2010.01.001
   Maruyama K, 2009, J CLIN BIOCHEM NUTR, V44, P41, DOI 10.3164/jcbn.08-13
   McKay DL, 2002, J AM COLL NUTR, V21, P1
   Moisey LL, 2008, AM J CLIN NUTR, V87, P1254, DOI 10.1093/ajcn/87.5.1254
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   Pham NM, 2013, METABOLISM, V62, P561, DOI 10.1016/j.metabol.2012.07.025
   Ohnaka K, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/207426
   Ortsäter H, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-11
   Rebello SA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-61
   Science and Technology Agency, 2005, STAND TABL FOOD COMP
   Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529
   Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059
   Stote Kim S, 2008, J Nutr, V138, p1584S
   Takaya J, 2004, MAGNESIUM RES, V17, P126
   Trikudanathan S, 2013, METABOLISM, V62, P1448, DOI 10.1016/j.metabol.2013.05.016
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   Van Dam RM, 2004, DIABETES CARE, V27, P2990, DOI 10.2337/diacare.27.12.2990
   van Dam RM, 2003, ANN NUTR METAB, V47, P627
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
   Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
NR 53
TC 45
Z9 49
U1 0
U2 22
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 1532-8600
J9 METABOLISM
JI Metab.-Clin. Exp.
PD MAR
PY 2014
VL 63
IS 3
BP 400
EP 408
DI 10.1016/j.metabol.2013.11.008
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA AB7RT
UT WOS:000331989100011
PM 24342074
DA 2025-04-28
ER

PT J
AU Rondanelli, M
   Opizzi, A
   Faliva, M
   Sala, P
   Perna, S
   Riva, A
   Morazzoni, P
   Bombardelli, E
   Giacosa, A
AF Rondanelli, Mariangela
   Opizzi, Annalisa
   Faliva, Milena
   Sala, Patrizio
   Perna, Simone
   Riva, Antonella
   Morazzoni, Paolo
   Bombardelli, Ezio
   Giacosa, Attilio
TI Metabolic Management in Overweight Subjects with Naive Impaired Fasting
   Glycaemia by Means of a Highly Standardized Extract From Cynara
   scolymus: A Double-blind, Placebo-controlled, Randomized Clinical
   Trial
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE dietary supplement; overweight; impaired fasting glycaemia; Cynara
   scolymus
ID CHLOROGENIC ACID; PHENOLIC-COMPOUNDS; GLUCOSE-TOLERANCE;
   GLUCOSE-6-PHOSPHATASE; INHIBITOR; WEIGHT
AB The aim of this study is to evaluate the efficacy of a dietary supplementation with an extract from Cynara scolymus (Cs) on the glucose pattern in a group of patients with naive impaired fasting glycaemia (IFG). A randomized, double-blind, placebo-controlled trial has been performed in 55 overweight subjects with IFG (fasting blood glucose [FBG]: 6.11 +/- 0.56mmol/l). These subjects were randomly assigned to supplement their diet with either an extract from Cs (600mg/d) (26 subjects) or placebo (29 matched subjects) for 8 weeks. The decrease of FBG was the primary endpoint. The assessment of Homeostatic Metabolic Assessment (HOMA), glycosylated haemoglobin, A1c-Derived Average Glucose (ADAG), lipidic pattern and anthropometric parameters were the secondary endpoints. The within groups and percent changes from baseline were analyzed by the signed rank test. The comparison between groups was performed by Wilcoxon's two sample test. The supplemented group had significant decreases of: FBG (-9.6%), HOMA (-11.7%), glycosylated haemoglobin (-2.3%), ADAG (-3.1%) and lipidic pattern. The placebo group did not show any significant difference. Compared with the placebo, the supplemented group showed a significant difference in FBG, HOMA and lipidic pattern. These data demonstrate the efficacy of Cs extract on the reduction of glycometabolic parameters in overweight subjects with IFG. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Rondanelli, Mariangela; Opizzi, Annalisa; Faliva, Milena; Sala, Patrizio; Perna, Simone] Univ Pavia, Azienda Serv Persona, Sect Human Nutr, Dept Hlth Sci, I-27100 Pavia, Italy.
   [Riva, Antonella; Morazzoni, Paolo; Bombardelli, Ezio] Indena SpA, Milan, Italy.
   [Giacosa, Attilio] Policlin Monza, Dept Gastroenterol, Milan, Italy.
C3 University of Pavia
RP Rondanelli, M (corresponding author), Univ Pavia, Azienda Serv Persona Pavia, Sect Human Nutr & Dietet, Dept Appl Hlth Sci,Fac Med,Endocrinol & Nutr Unit, Via Emilia 12, I-27100 Pavia, Italy.
EM mariangela.rondanelli@unipv.it
RI Faliva, Milena Anna/AAC-3653-2022; Rondanelli, Mariangela/AGD-6274-2022;
   Perna, Simone/Y-8892-2018
OI Riva, Antonella/0000-0003-2819-943X; Perna, Simone/0000-0002-2720-1473
CR [Anonymous], 1985, WHO TECHN REP SER
   ARION WJ, 1965, BIOCHEM BIOPH RES CO, V20, P606, DOI 10.1016/0006-291X(65)90442-0
   Arion WJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P279, DOI 10.1006/abbi.1997.0563
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Azzini E, 2007, BRIT J NUTR, V97, P963, DOI 10.1017/S0007114507617218
   Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397
   Coon JST, 2003, J FAM PRACTICE, V52, P470
   Dickel ML, 2007, J ETHNOPHARMACOL, V109, P60, DOI 10.1016/j.jep.2006.07.003
   Eastman RC, 1997, DIABETES CARE, V20, P127, DOI 10.2337/diacare.20.2.127
   Fantini N, 2011, PHYTOTHER RES, V25, P463, DOI 10.1002/ptr.3285
   FRISANCHO AR, 1984, AM J CLIN NUTR, V40, P808, DOI 10.1093/ajcn/40.4.808
   Garber Alan J, 2008, J Fam Pract, V57, pS10
   Glümer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335
   HABER GB, 1977, LANCET, V2, P679
   Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Herling AW, 1998, AM J PHYSIOL-GASTR L, V274, pG1087, DOI 10.1152/ajpgi.1998.274.6.G1087
   Hernandez-Galicia E, 2002, P W PHARMACOL SOC, V45, P118
   Hui Hongxiang, 2009, Chin Med, V4, P11, DOI 10.1186/1749-8546-4-11
   Hui HX, 2005, DIABETES-METAB RES, V21, P313, DOI 10.1002/dmrr.553
   Karthikesan K, 2010, GEN PHYSIOL BIOPHYS, V29, P23, DOI 10.4149/gpb_2010_01_23
   Lupattelli G, 2004, LIFE SCI, V76, P775, DOI 10.1016/j.lfs.2004.07.018
   Matsui T, 2006, MINI-REV MED CHEM, V6, P349, DOI 10.2174/138955706776073484
   Modi Pankaj, 2007, Curr Drug Discov Technol, V4, P39
   Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545
   Neustadt J, 2008, MOL NUTR FOOD RES, V52, P780, DOI 10.1002/mnfr.200700075
   Rodriguez TS, 2002, PHYTOMEDICINE, V9, P687, DOI 10.1078/094471102321621278
   Rondanelli M, 2011, PHYTOTHER RES, V25, P1275, DOI 10.1002/ptr.3425
   Saydah SH, 2001, DIABETES CARE, V24, P447, DOI 10.2337/diacare.24.3.447
   Schütz K, 2006, J AGR FOOD CHEM, V54, P8812, DOI 10.1021/jf062009b
   SEGAL HL, 1959, J BIOL CHEM, V234, P1937
   Shan Jacqueline J, 2007, Proc West Pharmacol Soc, V50, P24
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Sherwin RS, 2002, DIABETES CARE, V25, P742
   Simon C, 2000, ARCH BIOCHEM BIOPHYS, V373, P418, DOI 10.1006/abbi.1999.1560
   Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X
   Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
NR 38
TC 34
Z9 35
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD JAN
PY 2014
VL 28
IS 1
BP 33
EP 41
DI 10.1002/ptr.4950
PG 9
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 287AM
UT WOS:000329510400005
PM 23440660
DA 2025-04-28
ER

PT J
AU Li, Q
   Liao, S
   Pang, DR
   Li, E
   Liu, TX
   Liu, F
   Zou, YX
AF Li, Qian
   Liao, Sentai
   Pang, Daorui
   Li, Erna
   Liu, Tongxian
   Liu, Fan
   Zou, Yuxiao
TI The transported active mulberry leaf phenolics inhibited adipogenesis
   through PPAR-γ and Leptin signaling pathway
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article
DE 3 T3-L1 adipocytes; adipogenesis; Caco-2 monolayer transport; effective
   component; mulberry leaf phenolics
ID INSULIN-RESISTANCE; LIPID-METABOLISM; GENE-EXPRESSION; PROTEIN-KINASE;
   FAT; EXTRACT; OBESITY; CELL; ADIPONECTIN; ABSORPTION
AB The effective components of mulberry leaf polyphenols (MLPs) should be absorbed and transported by the intestinal cells before regulating lipid metabolism. The Caco-2 intestinal epithelial cell and 3 T3-L1 adipocytes were coupled to screen the effective components of MLPs that are being absorbed and transported by intestinal cells. The regulation and molecular mechanism by which the effective components affect adipogenesis were analyzed in this study. Among the 12 main components identified, five main compounds were well absorbed with Papp in the order of benzoic acid > chlorogenic acid > astragaloside > hyperoside > rutin. Chlorogenic acid and benzoic acid were mainly absorbed through passive diffusion, while rutin, astragaloside, and hyperoside were mainly by active transport, of which chlorogenic and rutin absorption were mediated by the efflux protein, P-glycoprotein (P-pg). Based on the transport volume of 2 mg/ml MLPs within 2 h, 25% of the maximum transported MLPs (TMLPs) was a safe concentration for 3 T3-L1 preadipocytes. Except for astragaloside, the other four components showed a significant inhibitory effect on lipid droplets, TG and TC, and chlorogenic acid and benzoic acid had the strongest effect. Additionally, we observed a synergistic effect as TMLPs were the most effective. We hypothesized that TMLPs, chlorogenic acid and benzoic acid suppressed adipogenesis and regulated lipid metabolism by inhibiting PPAR-gamma, C/EBP-alpha, and FAS mRNA while promoting ADIPO and Leptin mRNA expression. Practical applications The absorption and adipogenesis inhibition effect of mulberry leaf phenolics were evaluated in this study. The results provided guideline for the development of functional foods in regulating lipid metabolism.
C1 [Li, Qian; Liao, Sentai; Pang, Daorui; Li, Erna; Liu, Fan; Zou, Yuxiao] Guangdong Acad Agr Sci, Sericultural & Agrifood Res Inst, Guangdong Key Lab Agr Prod Proc, Key Lab Funct Foods,Minist Agr & Rural Affairs, Yiheng Rd 133, Guangzhou 510610, Peoples R China.
   [Liu, Tongxian] Guangxi Rongshui Furongbei Jiangyuan Agr Dev Co L, Liuzhou, Peoples R China.
C3 Guangdong Academy of Agricultural Sciences; Ministry of Agriculture &
   Rural Affairs
RP Liu, F; Zou, YX (corresponding author), Guangdong Acad Agr Sci, Sericultural & Agrifood Res Inst, Guangdong Key Lab Agr Prod Proc, Key Lab Funct Foods,Minist Agr & Rural Affairs, Yiheng Rd 133, Guangzhou 510610, Peoples R China.
EM liufan1234@126.com; yuxiaozou@163.com
FU Agricultural competitive industry discipline team building project of
   Guangdong Academy of Agricultural Sciences [202119TD]; Application
   Technology Research and Development Project of Rongshui Miao Autonomous
   County [20200103]; China Agriculture Research System of MOF and MARA;
   Guangdong Modern Agricultural Industry Technology System Innovation Team
   [2021KJ124]; Key-Area Research and Development Program of Guangdong
   Province [2020B020225005, 2019B020213001]; Science & Technology Projects
   of Guangdong Province [2020A1515011024, 2022A1515010930]
FX Agricultural competitive industry discipline team building project of
   Guangdong Academy of Agricultural Sciences, Grant/Award Number:
   202119TD; Application Technology Research and Development Project of
   Rongshui Miao Autonomous County, Grant/Award Number: 20200103; China
   Agriculture Research System of MOF and MARA; Guangdong Modern
   Agricultural Industry Technology System Innovation Team, Grant/Award
   Number: 2021KJ124; Key--Area Research and Development Program of
   Guangdong Province, Grant/Award Number: 2020B020225005 and
   2019B020213001; Science & Technology Projects of Guangdong Province,
   Grant/Award Number: 2020A1515011024 and 2022A1515010930
CR Andersen C, 2010, BIOFACTORS, V36, P415, DOI 10.1002/biof.115
   Ann JY, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0495-x
   Artursson P, 2012, ADV DRUG DELIVER REV, V64, P280, DOI 10.1016/j.addr.2012.09.005
   Bai YL, 1996, J BIOL CHEM, V271, P13939, DOI 10.1074/jbc.271.24.13939
   BASNET P, 1993, CHEM PHARM BULL, V41, P1238, DOI 10.1248/cpb.41.1238
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi I, 2006, BIOFACTORS, V26, P273, DOI 10.1002/biof.5520260405
   Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198
   Fang YJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121301
   Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798
   Gao MM, 2013, AAPS J, V15, P258, DOI 10.1208/s12248-012-9429-3
   Haughton E, 2007, J SCI FOOD AGR, V87, P239, DOI 10.1002/jsfa.2703
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Huang JB, 2013, J AGR FOOD CHEM, V61, P8565, DOI 10.1021/jf402004x
   Jeong YS, 2012, NUTR RES, V32, P514, DOI 10.1016/j.nutres.2012.06.001
   Kazumi T, 2002, DIABETES CARE, V25, P971, DOI 10.2337/diacare.25.6.971
   Khateeb J, 2010, ATHEROSCLEROSIS, V208, P119, DOI 10.1016/j.atherosclerosis.2009.08.051
   Kim M, 2010, NUTR RES PRACT, V4, P191, DOI 10.4162/nrp.2010.4.3.191
   Kizelsztein P, 2009, AM J PHYSIOL-ENDOC M, V296, pE433, DOI 10.1152/ajpendo.90772.2008
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Li Q, 2020, FOOD FUNCT, V11, P1835, DOI [10.1039/c9fo01345h, 10.1039/C9FO01345H]
   Li Q, 2018, J FOOD BIOCHEM, V42, DOI 10.1111/jfbc.12599
   Lim HH, 2013, EXP BIOL MED, V238, P1160, DOI 10.1177/1535370213498982
   Liu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152728
   Losina E, 2012, J BONE JOINT SURG AM, V94A, P201, DOI [10.2106/JBJS.J.101958, 10.2106/JBJS.K.00009, 10.2106/JBJS.J.01958]
   Michalska-Jakubus M, 2019, POSTEP DERM ALERGOL, V36, P325, DOI 10.5114/ada.2018.75809
   Naowaboot J, 2012, NUTR RES, V32, P39, DOI 10.1016/j.nutres.2011.12.003
   Naowaboot J, 2009, PLANT FOOD HUM NUTR, V64, P116, DOI 10.1007/s11130-009-0112-5
   OGAWA A, 1992, J CLIN INVEST, V90, P497, DOI 10.1172/JCI115886
   Oh KS, 2009, J ETHNOPHARMACOL, V122, P216, DOI 10.1016/j.jep.2009.01.020
   Pal S, 2003, J NUTR, V133, P700, DOI 10.1093/jn/133.3.700
   Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014
   Pu P, 2012, ARCH BIOCHEM BIOPHYS, V518, P61, DOI 10.1016/j.abb.2011.11.026
   Qian H, 1998, ENDOCRINOLOGY, V139, P791, DOI 10.1210/en.139.2.791
   Ravn-Haren G, 2013, EUR J NUTR, V52, P1875, DOI 10.1007/s00394-012-0489-z
   Raza SHA, 2020, GENE, V758, DOI 10.1016/j.gene.2020.144957
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Sena CM, 2017, BRIT J PHARMACOL, V174, P3514, DOI 10.1111/bph.13756
   Serra H, 2008, BIOORGAN MED CHEM, V16, P4009, DOI 10.1016/j.bmc.2008.01.028
   Silva R, 2011, ARCH TOXICOL, V85, P315, DOI 10.1007/s00204-010-0587-8
   Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069925
   Takekoshi K, 1999, BIOCHEM BIOPH RES CO, V261, P426, DOI 10.1006/bbrc.1999.1025
   Tian XJ, 2009, INT J PHARMACEUT, V367, P58, DOI 10.1016/j.ijpharm.2008.09.023
   Tokimitsu I, 2004, BIOFACTORS, V22, P141, DOI 10.1002/biof.5520220127
   Tsuzuki W, 2007, LIPIDS, V42, P163, DOI 10.1007/s11745-007-3021-0
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Wu CH, 2013, J FUNCT FOODS, V5, P1620, DOI 10.1016/j.jff.2013.07.004
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Yang YY, 2014, TOXICOL IN VITRO, V28, P388, DOI 10.1016/j.tiv.2013.12.002
   Ye XL, 2010, J AGR FOOD CHEM, V58, P3132, DOI 10.1021/jf903337f
NR 51
TC 11
Z9 11
U1 4
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD OCT
PY 2022
VL 46
IS 10
AR e14270
DI 10.1111/jfbc.14270
EA JUN 2022
PG 14
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 8F0LA
UT WOS:000811594600001
PM 35702955
OA gold
DA 2025-04-28
ER

PT J
AU Sudhakar, M
   Sasikumar, SJ
   Silambanan, S
   Natarajan, D
   Ramakrishnan, R
   Nair, AJ
   Kiran, MS
AF Sudhakar, Manu
   Sasikumar, Soumya J.
   Silambanan, Santhi
   Natarajan, Duraipandy
   Ramakrishnan, Ramya
   Nair, A. Jayakumaran
   Kiran, Manikantan Syamala
TI Chlorogenic acid promotes development of brown adipocyte-like phenotype
   in 3T3-L1 adipocytes
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Obesity; Chlorogenic acid; Adipocyte browning; Beige adipocyte; UCP1;
   AMPK
ID FAT-LIKE PHENOTYPE; ADIPOSE-TISSUE; WHITE FAT; METABOLISM; PROTEINS;
   AMPK
AB An emerging strategy for reducing obesity is induction of brown fat type phenotype in white adipose tissue. Chlorogenic acid (CGA), a dietary polyphenol, has been reported to modulate lipid and glucose metabolism, and improve glucose tolerance. However, information on its role in adipocyte browning is lacking. The effect of CGA on browning of 3T3-L1 pre-adipocytes and differentiated white adipocytes was investigated. Treatment of 3T3-L1 pre-adipocytes with CGA produced more adipocytes with multilocular phenotype, typical of brown adipocytes. Increase in uncoupler protein-1(UCP1)(1.7-fold) and Peroxisome proliferator-activated receptor-gamma co-activator-1 alpha (PGC-1 alpha)(2-fold) and decrease in triacyl glycerol content (50%) suggested that CGA promotes browning. Morphological analysis and expression of UCP1 further showed that CGA induced trans-differentiation of 3T3-L1 white adipocytes cells to beige adipocytes. Increased phosphorylation of AMP-dependent kinase (AMPK) in cells treated with CGA and reversal of CGA stimulated browning by dorsomorphin, an inhibitor of AMPK, suggested that AMPK pathway is involved in mediating the effect of CGA.
C1 [Sudhakar, Manu; Silambanan, Santhi] Sri Ramachandra Med Coll & Res Inst, Dept Biochem, Chennai, Tamil Nadu, India.
   [Sasikumar, Soumya J.; Nair, A. Jayakumaran] Univ Kerala, Interuniv Ctr Genom & Gene Technol, Dept Biotechnol, Thiruvananthapuram, Kerala, India.
   [Natarajan, Duraipandy; Kiran, Manikantan Syamala] Cent Leather Res Inst, Dept Biol Mat, Chennai, Tamil Nadu, India.
   [Ramakrishnan, Ramya] Sri Ramachandra Med Coll & Res Inst, Dept Gen Surg, Chennai, Tamil Nadu, India.
C3 Sri Ramachandra Institute of Higher Education & Research; University of
   Kerala; Council of Scientific & Industrial Research (CSIR) - India; CSIR
   - Central Leather Research Institute (CLRI); Sri Ramachandra Institute
   of Higher Education & Research
RP Sudhakar, M (corresponding author), Sri Ramachandra Med Coll & Res Inst, Dept Biochem, Chennai, Tamil Nadu, India.
EM Manu.Sudhakar@gmail.com
RI Kiran, Manikantan/CAJ-1875-2022; Silambanan, Santhi/AAU-7588-2021;
   Natarajan, Duraipandy/O-2473-2013
OI Nair, Ananthakrishnan Jayakumaran/0000-0002-7005-478X; Natarajan,
   Duraipandy/0000-0001-5705-3101
FU Indian Council of Medical Research, New Delhi
FX Financial assistance received from Indian Council of Medical Research,
   New Delhi to MS under TSS Fellowship scheme is gratefully acknowledged.
   Technical support from Ms. Surumi S., IUCGGT is gratefully acknowledged.
CR Abdul-Rahman O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157644
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Aziz SA, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600574
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Cantó C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi JH, 2017, EUR J NUTR, V56, P2329, DOI 10.1007/s00394-016-1273-2
   Choi JH, 2016, NUTRITION, V32, P1002, DOI 10.1016/j.nut.2016.02.007
   ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X
   Fuentes E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090699
   Han Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01206-4
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/bse0470069, 10.1042/BSE0470069]
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee MJ, 2014, METHOD ENZYMOL, V538, P49, DOI 10.1016/B978-0-12-800280-3.00004-9
   Lee SG, 2017, J NUTR BIOCHEM, V42, P62, DOI 10.1016/j.jnutbio.2016.12.018
   Lone J, 2018, BIOCHIMIE, V146, P97, DOI 10.1016/j.biochi.2017.11.021
   Lone J, 2016, J NUTR BIOCHEM, V27, P193, DOI 10.1016/j.jnutbio.2015.09.006
   Maki C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173264
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433
   Peng SP, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8273648
   Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110
   REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285
   Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003
   Rodríguez A, 2015, AM J PHYSIOL-ENDOC M, V309, pE691, DOI 10.1152/ajpendo.00297.2015
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Soumya SJ, 2013, BIOCHEM CELL BIOL, V91, P498, DOI 10.1139/bcb-2013-0037
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1258-y
   Tosovic J, 2017, FOOD CHEM, V237, P390, DOI 10.1016/j.foodchem.2017.05.080
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Zhang B, 2018, BIO-DES MANUF, V1, P2, DOI 10.1007/s42242-018-0004-3
   Zhang L, 2018, FOOD FUNCT, V9, P6156, DOI [10.1039/C8FO01281D, 10.1039/c8fo01281d]
   Zhang XJ, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0370-7
NR 40
TC 23
Z9 24
U1 2
U2 47
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD NOV
PY 2020
VL 74
AR 104161
DI 10.1016/j.jff.2020.104161
PG 8
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA NZ2SP
UT WOS:000576946800016
OA gold
DA 2025-04-28
ER

PT J
AU Cheng, DM
   Pogrebnyak, N
   Kuhn, P
   Poulev, A
   Waterman, C
   Rojas-Silva, P
   Johnson, WD
   Raskin, I
AF Cheng, Diana M.
   Pogrebnyak, Natalia
   Kuhn, Peter
   Poulev, Alexander
   Waterman, Carrie
   Rojas-Silva, Patricio
   Johnson, William D.
   Raskin, Ilya
TI Polyphenol-rich Rutgers Scarlet Lettuce improves glucose metabolism and
   liver lipid accumulation in diet-induced obese C57BL/6 mice
SO NUTRITION
LA English
DT Article
DE Red lettuce; Anthocyanins; Flavonols; Chlorogenic acid; Metabolic
   syndrome
ID HIGH-FAT DIET; CHLOROGENIC ACID; INSULIN-RESISTANCE;
   CARDIOVASCULAR-DISEASE; ANTIOXIDANT STATUS; VEGETABLE INTAKE;
   LACTUCA-SATIVA; IN-VIVO; CHOLESTEROL; QUERCETIN
AB Objective: The aims of the following experiments were to characterize antidiabetic in vitro and in vivo activity of the polyphenol-rich aqueous extract of Rutgers Scarlet Lettuce (RSL).
   Methods: RSL extract (RSLE) and isolated compounds were evaluated for inhibitory effects on glucose production as well as tumor necrosis factor alpha-dependent inhibition of insulin activity in H4IIE rat hepatoma cells. Additionally, high-fat diet-induced obese mice were treated with RSLE (100 or 300 mg/kg), metformin (250 mg/kg), or vehicle (water) for 28 d by oral administration and insulin and oral glucose tolerance tests were conducted. Tissues were harvested at the end of the study and evaluated for biochemical and physiological improvements in metabolic syndrome conditions.
   Results: A polyphenol-rich RSLE, containing chlorogenic acid, cyanidin malonyl-glucoside, and quercetin malonyl-glucoside, was produced by simple boiling water extraction at pH 2.0. In vitro, RSLE and chlorogenic acid demonstrated dose-dependent inhibition of glucose production. In vivo, RSLE treatment improved glucose metabolism measured by oral glucose tolerance tests, but not insulin tolerance tests. RSLE treated groups had a lower ratio of liver weight to body weight as well as decreased total liver lipids compared with the control group after 28 d of treatment. No significant differences in plasma glucose, insulin, cholesterol, and triglycerides were observed with RSLE-treated groups compared with vehicle control.
   Conclusion: RSLE demonstrated antidiabetic effects in vitro and in vivo and may improve metabolic syndrome conditions of fatty liver and glucose metabolism. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Cheng, Diana M.; Pogrebnyak, Natalia; Kuhn, Peter; Poulev, Alexander; Waterman, Carrie; Rojas-Silva, Patricio; Raskin, Ilya] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.
   [Johnson, William D.] Pennington Biomed Res Ctr, Dept Biostat, Baton Rouge, LA 70808 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Louisiana
   State University System; Louisiana State University; Pennington
   Biomedical Research Center
RP Cheng, DM (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.
EM Cheng@aesop.rutgers.edu
RI Rojas-Silva, Patricio/AAZ-5291-2021; Poulev, Alexander/L-6613-2019;
   Johnson, William/N-1972-2017
OI Poulev, Alexander/0000-0003-0939-0642; Johnson,
   William/0000-0002-3823-4094; Rojas-Silva, Patricio/0000-0002-9611-3661
FU National Center for Complementary and Alternative Medicine (NCCAM) [P50
   AT002776]; Office of Dietary Supplements (ODS); Botanical Research
   Center and Botanical Research Center Pilot Program [5 P50 AT002776, 08
   S12 to 50318]; NIH [T32: 5 132 AT004094 to 04]; SENESCYT-2011 Ecuadorian
   fellowship
FX This project was supported by P50 AT002776 from the National Center for
   Complementary and Alternative Medicine (NCCAM) and the Office of Dietary
   Supplements (ODS), which funds the Botanical Research Center and
   Botanical Research Center Pilot Program Sub award 5 P50 AT002776 to 08
   S12 to 50318. DMC and CW were supported by NIH training grant T32: 5 132
   AT004094 to 04. PRS was supported by SENESCYT-2011 Ecuadorian
   fellowship. DMC wrote the manuscript and designed the experiments. NP
   produced and maintained plant materials. PK conducted animal
   experiments. AP conducted LC-MS analysis and provided phytochemical
   expertise. CW performed compound isolation and NMR analyses. PRS, CVM,
   PK and DMC conducted animal tissue analyses. WDJ provided statistical
   assistance. IR provided guidance and oversight. All authors reviewed and
   approved the manuscript. DMC, NP, and IR hold a patent on Rutgers
   Scarlet Lettuce. IR has equity in Nutrasorb, LLC.
CR AOKI H., 2002, Foods and Food Ingredients Journal of Japan, P41
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Bazzano LA, 2002, AM J CLIN NUTR, V76, P93
   Bumgarner NR, 2012, PLANT FOOD HUM NUTR, V67, P215, DOI 10.1007/s11130-012-0306-0
   Cheng DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091571
   Cheng DM, 2012, FOOD CHEM, V135, P2994, DOI 10.1016/j.foodchem.2012.06.117
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Ferreres F, 1997, J AGR FOOD CHEM, V45, P4249, DOI 10.1021/jf970399j
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Grace MH, 2009, PHYTOMEDICINE, V16, P406, DOI 10.1016/j.phymed.2009.02.018
   Guo HH, 2012, J NUTR BIOCHEM, V23, P349, DOI 10.1016/j.jnutbio.2010.12.013
   Held P, 2012, PERFORMING OXGEN RAD
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296
   Ioannou I, 2012, J FOOD ENG, V111, P208, DOI 10.1016/j.jfoodeng.2012.02.006
   Iwai K, 2012, FOOD SCI TECHNOL RES, V18, P849, DOI 10.3136/fstr.18.849
   Lee J, 2005, J AOAC INT, V88, P1269
   Lee JH, 2009, BRIT J NUTR, V101, P1246, DOI 10.1017/S0007114508073650
   Lumeng CN, 2013, MOL ASPECTS MED, V34, P12, DOI 10.1016/j.mam.2012.10.002
   MORISHITA H, 1984, J CHROMATOGR, V315, P253, DOI 10.1016/S0021-9673(01)90742-3
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001
   Murase T, 2012, BRIT J NUTR, V107, P1757, DOI 10.1017/S0007114511005083
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Nicolle C, 2004, J SCI FOOD AGR, V84, P2061, DOI 10.1002/jsfa.1916
   Nicolle C, 2004, CLIN NUTR, V23, P605, DOI 10.1016/j.clnu.2003.10.009
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256
   Qin Bolin, 2010, J Diabetes Sci Technol, V4, P685
   Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315
   Roopchand DE, 2013, PHARMACOL RES, V68, P59, DOI 10.1016/j.phrs.2012.11.008
   Roopchand DE, 2012, J AGR FOOD CHEM, V60, P8860, DOI 10.1021/jf300232h
   Rie S, 2007, BIOCHEM PHARMACOL, V74, P1619, DOI 10.1016/j.bcp.2007.08.008
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336
   SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X
   van Dam RM, 2013, CURR OPIN LIPIDOL, V24, P25, DOI 10.1097/MOL.0b013e32835bcdff
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   WALD B, 1989, PHYTOCHEMISTRY, V28, P663, DOI 10.1016/0031-9422(89)80083-4
   Wu XL, 2004, J AGR FOOD CHEM, V52, P7846, DOI 10.1021/jf0486850
NR 45
TC 56
Z9 59
U1 0
U2 37
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD JUL-AUG
PY 2014
VL 30
IS 7-8
SU S
BP S52
EP S58
DI 10.1016/j.nut.2014.02.022
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AL7ID
UT WOS:000339306500010
PM 24985107
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Seliske, LM
   Pickett, W
   Boyce, WF
   Janssen, I
AF Seliske, Laura M.
   Pickett, William
   Boyce, William F.
   Janssen, Ian
TI Association between the food retail environment surrounding schools and
   overweight in Canadian youth
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Overweight; Food retailers; Adolescents; Residence characteristics
ID SOCIOECONOMIC-STATUS; PHYSICAL-ACTIVITY; NEIGHBORHOOD CHARACTERISTICS;
   MULTILEVEL ANALYSIS; INCOME INEQUALITY; OBESITY; RESTAURANTS; HEALTH;
   PREVALENCE; MORTALITY
AB Introduction: There is growing interest in how the physical environment influences obesity. Few studies have considered how the food retail environment surrounding schools influences overweight in students.
   Objective: To determine whether there is a relationship between food retailers surrounding schools and overweight among Canadian Youth.
   Design: Cross-sectional study.
   Setting/methods/subjects: The number of food retailers was obtained within a 1 kin and 5 kin radius around 178 schools in Canada. Retailers included full-service restaurants, fast-food restaurants, sub/sandwich retailers, doughnut/coffee shops, convenience stores and grocery stores. An index of total food retailer exposure was also created. Multilevel analyses were used to control for individual-and area-level covariates.
   Results: None of the individual food retailers was associated with an increased likelihood of overweight. The total food retailer index was most strongly related to overweight, but in the opposite direction to that hypothesized. At 1 kin, students attending schools with at least one food retailer had a lower relative odds of overweight (OR = 0.70, 95 % CI 0.61: 0.81). At 5 km, Students attending schools with the highest exposure to the total food retailer index had a lower relative odds of overweight (OR = 0.56, 95% CI 0.47, 0.68) compared With Students attending schools with no exposure.
   Conclusions: Exposure to various types of food retailers in school neighbourhoods was not associated with an increased likelihood of overweight in Canadian school-aged Youth. The opportunity to make healthy choices from a variety of options and the unique Canadian context may explain the findings.
C1 [Seliske, Laura M.; Pickett, William; Boyce, William F.; Janssen, Ian] Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON K7L 3N6, Canada.
   [Pickett, William] Queens Univ, Dept Emergency Med, Kingston, ON K7L 3N6, Canada.
   [Boyce, William F.] Queens Univ, Social Program, Evaluat Grp, Fac Educ, Kingston, ON K7L 3N6, Canada.
   [Janssen, Ian] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON K7L 3N6, Canada.
C3 Queens University - Canada; Queens University - Canada; Queens
   University - Canada; Queens University - Canada
RP Janssen, I (corresponding author), Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON K7L 3N6, Canada.
EM ian.janssen@queensu.ca
RI Janssen, Ian/B-7700-2009
OI Janssen, Ian/0000-0003-2159-3012
FU Canadian Institutes of Health Research [2004MEP-CHI-128223-C]; Public
   Health Agency of Canada [HT089-05205/001/SS]; Empire Life Insurance
   company; Canadian Institutes Of Health Research; Ontario Ministry of
   Research and Innovation
FX The submission represents original work that has not been published
   previously, is not Currently being considered by mother journal, and
   that following acceptance for Public Health Nutrition will not be
   published elsewhere in the same form, in English or in any other
   language. Each author has seen and approved the contents of the
   submitted manuscript. None of the authors has any conflicts of interest
   to declare. All of the authors have contributed substantially to the
   manuscript. Specifically, L.M.S., I.J. and W.P. contributed to the study
   conception and design. All authors contributed substantially to the
   interpretation of the results and data analyses. L.M.S. wrote the draft
   of the manuscript while I.J., W.P. and WEB. revised it for important
   intellectual content. The study Was Supported by research agreements
   with the Canadian Institutes of Health Research (operating grant:
   2004MEP-CHI-128223-C) and the Public Health Agency of Canada (contract:
   HT089-05205/001/SS) which funds the Canadian version of the WHO Health
   Behaviour in School-aged Children survey (WHO-HBSC). The WHO-HBSC is a
   WHO/Euro collaborative study. International Coordinator of the 2005-2006
   study: Candace Currie, University of Edinburgh,, Scotland; Data Bank
   Manager Oddrun Samdal, University of Bergen, Norway. This publication
   reports data solely from Canada (Principal Investigator: W.F.B.). The
   authors would like to thank the researchers and participants involved in
   the HBSC survey. L.M.S. was partially Supported by a fellowship from the
   Empire Life Insurance company. I.J. was supported by a New Investigator
   Award from the Canadian Institutes Of Health Research and an Early
   Researcher Award from the Ontario Ministry of Research and Innovation.
CR Apparicio P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-4
   Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341
   Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007
   Boehmer TK, 2007, INT J OBESITY, V31, P968, DOI 10.1038/sj.ijo.0803531
   Burdette HL, 2004, PREV MED, V38, P57, DOI 10.1016/j.ypmed.2003.09.029
   Cohen DA, 2006, PEDIATRICS, V118, pE1381, DOI 10.1542/peds.2006-1226
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276
   Cummins SCJ, 2005, AM J PREV MED, V29, P308, DOI 10.1016/j.amepre.2005.06.011
   Currie C., 2001, Health behavior in school-aged children: A world health organization cross-national study: Research Protocol for the 2001/02 Survey
   Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171
   Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058
   Janssen I, 2006, AM J CLIN NUTR, V83, P139
   Maddock J, 2004, AM J HEALTH PROMOT, V19, P137, DOI 10.4278/0890-1171-19.2.137
   McGinn AP, 2007, J URBAN HEALTH, V84, P162, DOI 10.1007/s11524-006-9136-4
   Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040
   Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003
   Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2
   Norman Gregory J, 2006, J Phys Act Health, V3, pS118, DOI 10.1123/jpah.3.s1.s118
   Oliver LN, 2005, CAN J PUBLIC HEALTH, V96, P415, DOI 10.1007/BF03405180
   Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2
   Parsons TJ, 1999, INT J OBESITY, V23, pS1
   Reidpath DD, 2002, HEALTH PLACE, V8, P141, DOI 10.1016/S1353-8292(01)00028-4
   Roberts C, 2007, J PUBLIC HEALTH-HEID, V15, P179, DOI 10.1007/s10389-007-0100-x
   Ross NA, 2005, J URBAN HEALTH, V82, P101, DOI 10.1093/jurban/jti012
   Ross NA, 2000, BRIT MED J, V320, P898, DOI 10.1136/bmj.320.7239.898
   Shields Margot, 2006, Health Rep, V17, P27
   Simpson K, 2005, J EPIDEMIOL COMMUN H, V59, P1072, DOI 10.1136/jech.2005.036723
   *STAT CAN, 2003, 81229XIB STAT CAN
   *STAT CAN, 2001, 92378XIE2002 STAT CA
   Sturm R, 2005, PUBLIC HEALTH, V119, P1059, DOI 10.1016/j.puhe.2005.05.007
   Veugelers PJ, 2005, CAN MED ASSOC J, V173, P607, DOI 10.1503/cmaj.050445
   Veugelers PJ, 2001, AM J EPIDEMIOL, V154, P725, DOI 10.1093/aje/154.8.725
   Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680
NR 34
TC 65
Z9 83
U1 1
U2 24
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD SEP
PY 2009
VL 12
IS 9
BP 1384
EP 1391
DI 10.1017/S1368980008004084
PG 8
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA 488HL
UT WOS:000269339900010
PM 19087383
OA Bronze
DA 2025-04-28
ER

PT J
AU Zhou, JL
   Qin, LY
AF Zhou, Jianli
   Qin, Linyuan
TI Associations of urinary caffeine and caffeine metabolites with metabolic
   syndrome in US adults
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE caffeine; logistic regression; metabolic syndrome; principal components
   analysis; restricted cubic splines
ID COFFEE CONSUMPTION; RISK; METAANALYSIS; PREVALENCE; OBESITY
AB Aims: The relationship between caffeine and metabolic syndrome (MetS) has only been evaluated from the perspective of caffeine consumption. The association between urinary caffeine and MetS is still unclear. This study examined the associations between urinary caffeine and its metabolites and MetS and its components among adults.Methods: Data from the United States (US) National Health and Nutrition Examination Survey (NHANES) 2011-2014 was analyzed. NHANES is a stratified, multi-stage survey of all non-institutionalized persons in the US. A total of 2,394 subjects aged >= 18 years without missing data were selected in this study. Urinary caffeine and caffeine metabolite levels were quantified using high-performance liquid chromatography-electrospray ionization-tandem quadrupole mass spectrometry (HPLC-ESI-MS/MS) with stable isotope-labeled internal standards. We performed principal components analysis (PCA) to investigate the underlying correlation structure of 15 features of urinary caffeine and its metabolites and then used these principal components (PCs) as independent variables to conduct logistic regression analysis with or without restricted cubic spline (RCS) terms to explore the associations between caffeine metabolites and MetS.Results: Two main PCs that were derived from the PCA explained 90.67% of the total variance of caffeine and its metabolites. The first PC (PC1, strongly correlated with 1-MU, 1,3-DMU, 1,7-DMU, 1,3,7-TMU, 1-MX, 1,3-DMX, 1,7-DMX, 1,3,7-TMX, and AAMU) was positively correlated with risk of MetS (OR = 1.27, p < 0.001) and all its components (all ORs > 1, all p-values < 0.001) in the unadjusted models, while in the adjusted models, it was positively correlated with MetS (OR = 1.16, p = 0.042) and central obesity (OR = 1.22, p < 0.001). In the unadjusted model, there were significant associations between the second PC (PC2, correlated with 3-MU, 7-MU, 3,7-DMU, 3-MX, 7-MX, and 3,7-DMX) and MetS (OR = 1.11, P = 0.030) and central obesity (OR = 1.16, P < 0.001), while in the adjusted models (adjustment variables include gender, age, race/ethnicity, education level and income-poverty ratio, smoking status, drinking, and physical activity), PC2 was positively associated with MetS (OR = 1.15, p = 0.035) and central obesity (OR = 1.15, p = 0.005) and negatively associated with raised triglycerides (TG) (OR = 0.84, p = 0.008). Moreover, we observed U-shaped associations between PC1 and the risk of raised TG both in unadjusted (Pnon-linear = 0.017) and adjusted (Pnon-linear = 0.014) models.Conclusion: Urinary caffeine metabolites were positively associated with the risk of MetS and its components through different linear or non-linear patterns.
C1 [Zhou, Jianli] Guilin Peoples Hosp, Dept Sci & Educ, Guilin, Peoples R China.
   [Qin, Linyuan] Guilin Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Guilin, Peoples R China.
   [Qin, Linyuan] Guangxi Key Lab Environm Expos & Entire Lifecycle, Guilin, Peoples R China.
C3 Guilin Medical University
RP Zhou, JL (corresponding author), Guilin Peoples Hosp, Dept Sci & Educ, Guilin, Peoples R China.
EM jianliz555@163.com
OI Zhou, Jianli/0009-0002-7575-829X
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Caubet MS, 2002, J PHARMACEUT BIOMED, V27, P261, DOI 10.1016/S0731-7085(01)00546-5
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Du XC, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00321
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Górecki M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040308
   Guessous I, 2015, HYPERTENSION, V65, P691, DOI 10.1161/HYPERTENSIONAHA.114.04512
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Hartley TR, 2000, HYPERTENSION, V36, P137, DOI 10.1161/01.HYP.36.1.137
   Jee HJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103080
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   Jin RF, 2018, ENVIRON INT, V121, P1355, DOI 10.1016/j.envint.2018.11.002
   Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814
   Karabudak E, 2015, EXP THER MED, V9, P1841, DOI 10.3892/etm.2015.2342
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim SA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122992
   Lam D., 2000, Circulation, V115, pe32
   Lee DY, 2023, FRONT PUBLIC HEALTH, V11, DOI 10.3389/fpubh.2023.990029
   Lee S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061783
   Lemieux I, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113501
   Lopez-Candales Angel, 2017, J Nat Sci, V3
   Mahoney CR, 2019, CLIN NUTR, V38, P668, DOI 10.1016/j.clnu.2018.04.004
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Miranda AM, 2022, EUR J NUTR, V61, P4205, DOI 10.1007/s00394-022-02946-4
   Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Ngueta G, 2020, EUR J CLIN NUTR, V74, P77, DOI 10.1038/s41430-019-0430-0
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Oñatibia-Astibia A, 2016, RESP MED, V112, P1, DOI 10.1016/j.rmed.2016.01.022
   Osz BE, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232113074
   Petrovic D, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0144-4
   Ponte B, 2018, MAYO CLIN PROC, V93, P586, DOI 10.1016/j.mayocp.2017.12.010
   Ramli NNS, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57090957
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Samoggia A, 2018, APPETITE, V129, P70, DOI 10.1016/j.appet.2018.07.002
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Urgert R, 1997, ANNU REV NUTR, V17, P305, DOI 10.1146/annurev.nutr.17.1.305
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   Weng ZK, 2021, NUTRITION, V84, DOI 10.1016/j.nut.2020.111121
   Wong THT, 2021, ADV NUTR, V12, P708, DOI 10.1093/advances/nmaa132
   Wong THT, 2022, J NUTR SCI, V11, DOI 10.1017/jns.2022.78
   Yelanchezian YMM, 2022, MOLECULES, V27, DOI 10.3390/molecules27123737
   YEOMANS KA, 1982, J ROY STAT SOC D-STA, V31, P221
   Zhou JL, 2022, CHEMOSPHERE, V291, DOI 10.1016/j.chemosphere.2021.132953
NR 48
TC 1
Z9 1
U1 1
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD DEC 1
PY 2023
VL 10
AR 1280215
DI 10.3389/fnut.2023.1280215
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CR4C7
UT WOS:001126947400001
PM 38107745
OA Green Submitted, gold
DA 2025-04-28
ER

PT J
AU Borges, MC
   Vinolo, MAR
   Nakajima, K
   De Castro, IA
   Bastos, DHM
   Borelli, P
   Fock, RA
   Tirapegui, J
   Curi, R
   Rogero, MM
AF Borges, Maria Carolina
   Ramirez Vinolo, Marco Aurelio
   Nakajima, Karina
   De Castro, Inar Alvesde
   Markowicz Bastos, Deborah Helena
   Borelli, Primavera
   Fock, Ricardo Ambrosio
   Tirapegui, Julio
   Curi, Rui
   Rogero, Marcelo Macedo
TI The effect of mate tea (Ilex paraguariensis) on metabolic and
   inflammatory parameters in high-fat diet-fed Wistar rats
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE high-fat diet; inflammation; macrophages; nuclear factor-kappa B; yerba
   mate
ID NF-KAPPA-B; BIOACTIVE COMPOUNDS; CHLOROGENIC ACID; INDUCED OBESITY;
   MACROPHAGES
AB This study investigated the effects of mate tea (Ilex paraguariensis) aqueous extract consumption on metabolic indicators and inflammatory response of peritoneal macrophages in rats fed a high-fat diet (HFD). Male Wistar rats were fed a control diet or a HFD for 12 weeks. At the end of this period, rats received, or not, daily doses of yerba mate for 4 weeks. The consumption of yerba mate promoted weight loss, attenuated the HFD-detrimental effects on adiposity and insulin sensitivity and decreased blood levels of the inflammatory biomarkers (p < 0.05). Concerning peritoneal macrophages, mate tea consumption decreased the production of interleukin (IL)-6, but did not influence the production of IL-1 beta, tumour necrosis factor-a and nitric oxide; cytokine mRNA expression; or the activation of the nuclear factor-kappa B signalling pathway. In summary, the consumption of mate tea had no consistent effect in the inflammatory response of peritoneal macrophages, but reduced cardiometabolic risk markers.
C1 [Borges, Maria Carolina; Markowicz Bastos, Deborah Helena; Rogero, Marcelo Macedo] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, Brazil.
   [Ramirez Vinolo, Marco Aurelio; Curi, Rui] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508000 Sao Paulo, Brazil.
   [Nakajima, Karina; Borelli, Primavera; Fock, Ricardo Ambrosio] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, Brazil.
   [De Castro, Inar Alvesde; Tirapegui, Julio] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Food & Expt Nutr, BR-05508000 Sao Paulo, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Institute Biomed
   Science, University Sao Paulo; Universidade de Sao Paulo; Universidade
   de Sao Paulo
RP Rogero, MM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, Brazil.
EM mmrogero@usp.br
RI Fock, Ricardo/C-6105-2012; Rogero, Marcelo/T-9025-2019; nakajima,
   karina/G-8247-2012; Bastos, Deborah/G-3596-2012; Castro,
   Inar/C-4923-2012; Vinolo, Marco/K-3753-2012; Tirapegui,
   Julio/I-4363-2012; Curi, Rui/C-9351-2012; Borelli,
   Primavera/G-3422-2012; Borges, Maria Carolina/F-1980-2014
OI Borges, Maria Carolina/0000-0001-7785-4547; Fock,
   Ricardo/0000-0002-7964-5973; Vinolo, Marco Aurelio/0000-0003-1335-760X;
   Macedo Rogero, Marcelo/0000-0003-0517-1645
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2009/50269-0]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) [470418/2009-5]; FAPESP [2009/02371-0]; Swedish
   Research Council [2009-02371] Funding Source: Swedish Research Council;
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [09/02371-0] Funding Source: FAPESP
FX This work was financially supported by the Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP) (2009/50269-0) and from the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   (470418/2009-5). M.C.B. was supported by a fellowship from FAPESP
   (2009/02371-0)). The authors report no conflicts of interest. The
   authors alone are responsible for the content and writing of the paper.
CR Alessi MC, 2006, ARTERIOSCL THROM VAS, V26, P2200, DOI 10.1161/01.ATV.0000242905.41404.68
   Amar S, 2007, P NATL ACAD SCI USA, V104, P20466, DOI 10.1073/pnas.0710335105
   Arçari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008
   Bastos DHM, 2009, ARQ BRAS ENDOCRINOL, V53, P646, DOI 10.1590/S0004-27302009000500017
   Bastos DHM, 2007, MOLECULES, V12, P423, DOI 10.3390/12030423
   Borges MC, 2012, NUTRITION
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210
   Donato J, 2006, NUTRITION, V22, P520, DOI 10.1016/j.nut.2005.12.008
   Fock RA, 2010, INFLAMMATION, V33, P101, DOI 10.1007/s10753-009-9163-x
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   GREEN LC, 1981, P NATL ACAD SCI-BIOL, V78, P7764, DOI 10.1073/pnas.78.12.7764
   Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449
   Jaiswal R, 2010, J AGR FOOD CHEM, V58, P5471, DOI 10.1021/jf904537z
   Martins F, 2009, BRIT J NUTR, V101, P527, DOI 10.1017/S000711450802504X
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Miranda DDC, 2008, MUTAGENESIS, V23, P261, DOI 10.1093/mutage/gen011
   Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200
   Olmos A, 2008, ARCH BIOCHEM BIOPHYS, V475, P66, DOI 10.1016/j.abb.2008.04.012
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pimentel GD, 2012, J NUTR BIOCH, DOI [10.1016/j.jnutbio.2012.04.016., DOI 10.1016/J.JNUTBI0.2012.04.016]
   Puangpraphant S, 2011, MOL NUTR FOOD RES, V55, P1509, DOI 10.1002/mnfr.201100128
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Rogero MM, 2010, AMINO ACIDS, V39, P435, DOI 10.1007/s00726-009-0459-9
   Rong YQ, 1996, J NEUROCHEM, V67, P662
   Rosa FT, 2012, INT J FOOD SCI NUTR, V63, P749, DOI 10.3109/09637486.2011.649250
   Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009
   Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106
NR 35
TC 18
Z9 23
U1 0
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD AUG
PY 2013
VL 64
IS 5
BP 561
EP 569
DI 10.3109/09637486.2012.759188
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 180IZ
UT WOS:000321588700006
PM 23317109
DA 2025-04-28
ER

PT J
AU Coffey, CS
   Steiner, D
   Baker, BA
   Allison, DB
AF Coffey, CS
   Steiner, D
   Baker, BA
   Allison, DB
TI A randomized double-blind placebo-controlled clinical trial of a product
   containing ephedrine, caffeine, and other ingredients from herbal
   sources for treatment of overweight and obesity in the absence of
   lifestyle treatment
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE ephedra alkaloids; weight loss; BMI; safety; efficacy
ID WEIGHT-LOSS
AB OBJECTIVE: To evaluate the efficacy and side effects of an herbal formulation to promote weight loss, as compared to placebo.
   DESIGN: 12-week multicenter double-blind, placebo-controlled, randomized parallel groups design. Study conducted at three clinical sites in New York State. Subjects were randomized to receive either the 'active' product or a 'placebo' supplement for 12 weeks. Minimal steps were taken to influence lifestyle changes with regard to diet or exercise.
   SUBJECTS: 102 overweight/obese (30<BMI <= 39.9 kg/m(2)) volunteers between the ages of 18 and 65 y.
   MAIN OUTCOME MEASURES: Weight, percent body fat, fat mass, waist circumference, BMI, blood pressure, and pulse measured at 2 days, 1 week, 2 weeks, 4 weeks, 8 weeks, and 12 weeks postrandomization.
   RESULTS: Subjects receiving the 'active' treatment experienced, on average, an additional 1.5 kg of weight loss compared with subjects receiving the placebo. In addition, subjects receiving the 'active' treatment experienced greater reductions in BMI and waist circumference over the 12-week period. No differences were observed with respect to percent body fat, fat mass, diastolic or systolic blood pressure, pulse, the occurrence of any adverse event, or the occurrence of any presumed treatment-related adverse event. Testing of the study product by two independent laboratories indicated that it had only approximately half of the intended amount of ephedrine alkaloids and caffeine.
   CONCLUSIONS: Over the 12-week trial, subjects on the active treatment experienced significantly greater weight loss than subjects on placebo, without an increase in blood pressure, pulse, or the rate of adverse events. These benefits were achieved in the absence of any lifestyle treatment to change dietary or exercise behavior and with lower doses of ephedrine alkaloids and caffeine than those commonly utilized.
C1 Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA.
   Res Testing Labs, Great Neck, NY USA.
   Univ Alabama, Sect Stat Genet, Birmingham, AL 35294 USA.
   Univ Alabama, Clin Nutr Res Unit, Birmingham, AL 35294 USA.
C3 University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham
RP Univ Alabama, Dept Biostat, Ryals Publ Hlth Bldg 327,1665 Univ Blvd, Birmingham, AL 35294 USA.
EM Dallison@uab.edu
OI Allison, David/0000-0003-3566-9399
CR Allison D B, 1995, Endocr Pract, V1, P353
   Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530
   Allison DB, 2001, CRIT REV FOOD SCI, V41, P1, DOI 10.1080/20014091091661
   ALLISON DB, 1999, WEIGHT CONTROL DIGES, V9, P827
   [Anonymous], 2001, Caffeine for the sustainment of mental task performance: Formulations for military operations, DOI [10.17226/10219, DOI 10.17226/10219]
   [Anonymous], 2003, AHRQ PUBLICATION
   ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   Ayyad C, 2000, Obes Rev, V1, P113, DOI 10.1046/j.1467-789x.2000.00019.x
   Bosello O, 2002, Eat Weight Disord, V7, P161
   DHURANDHAR N, 2000, EC NEUROSCI, V2, P42
   DULLOO AG, 1993, INT J OBESITY, V17, pS35
   *EPH WORK GROUP, 2003, REP EPH WORK GROUP N
   *FDA, 2004, CONS AL FDA PLANS RE
   Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187
   Gadbury G L, 2003, Obes Rev, V4, P175, DOI 10.1046/j.1467-789X.2003.00109.x
   GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397
   Greenway F L, 2001, Obes Rev, V2, P199, DOI 10.1046/j.1467-789x.2001.00038.x
   GREENWAY FL, 2004, HDB OBESITY, P329
   Gregg EW, 2003, ANN INTERN MED, V138, P383, DOI 10.7326/0003-4819-138-5-200303040-00007
   Gurley BJ, 2000, AM J HEALTH-SYST PH, V57, P963, DOI 10.1093/ajhp/57.10.963
   Haddock CK, 2002, INT J OBESITY, V26, P262, DOI 10.1038/sj.ijo.0801889
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/nejmoa012512
   Ku YR, 2003, J PHARMACEUT BIOMED, V33, P329, DOI 10.1016/S0731-7085(03)00287-5
   Littell R.C., 1996, SAS SYSTEMS MIXED MO
   MALCHOWMOLLER A, 1981, INT J OBESITY, V5, P183
   National Taxicology Program, 1986, Natl. Toxicol. Progr. Tech. Rep, V307, P1
   Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728
   PORTA M, 1986, ANN ALLERGY, V57, P340
   Yang D, 2003, Obes Rev, V4, P9, DOI 10.1046/j.1467-789X.2003.00092.x
NR 30
TC 45
Z9 49
U1 0
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD NOV
PY 2004
VL 28
IS 11
BP 1411
EP 1419
DI 10.1038/sj.ijo.0802784
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 862FY
UT WOS:000224477200007
PM 15356670
DA 2025-04-28
ER

PT J
AU Tabrizi, R
   Saneei, P
   Lankarani, KB
   Akbari, M
   Kolandooz, F
   Esmaillzadeh, A
   Nadi-Ravandi, S
   Mazoochi, M
   Asemi, Z
AF Tabrizi, Reza
   Saneei, Parvane
   Lankarani, Kamran B.
   Akbari, Maryam
   Kolandooz, Fariba
   Esmaillzadeh, Ahmad
   Nadi-Ravandi, Somayyeh
   Mazoochi, Majid
   Asemi, Zatollah
TI The effects of caffeine intake on weight loss: a systematic review and
   dos-response meta-analysis of randomized controlled trials
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Caffeine; weight loss; meta-analysis
ID HORMONE BINDING GLOBULIN; DOUBLE-BLIND; ENERGY-EXPENDITURE;
   GLUCOSE-TOLERANCE; OBESE WOMEN; BODY-MASS; INSULIN; OVERWEIGHT;
   ADENOSINE; EXERCISE
AB This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to summarize the effect of caffeine intake on weight loss. We searched the following databases until November 2017: MEDLINE, EMBASE, Web of Science, and Cochrane Central Register of Controlled Trials. The relevant data were extracted and assessed for quality of the studies according to the Cochrane risk of bias tool. We estimated an intake-status regression coefficient (Beta) for each primary study and estimated the overall pooled Beta and SE using random effects meta-analysis on a double-log scale. Heterogeneity between studies was assessed by the Cochran Q statistic and I-squared tests (I-2). Thirteen RCTs with 606 participants were included in the meta-analyses. The overall pooled Beta for the effect of caffeine intake was 0.29 (95%CI: 0.19, 0.40; Q = 124.5, I-2 = 91.2%) for weigh, 0.23 (95%CI: 0.09, 0.36; Q = 71.0, I-2 = 93.0%) for BMI, and 0.36 (95% CI: 0.24, 0.48; Q = 167.36, I-2 = 94.0%) for fat mass. For every doubling in caffeine intake, the mean reduction in weight, BMI, and fat mass increased 2 Beta-fold (20.29 = 1.22, 20.23 = 1.17, and 20.36 = 1.28), which corresponding to 22, 17, and 28 percent, respectively. Overall, the current meta-analysis demonstrated that caffeine intake might promote weight, BMI and body fat reduction.
C1 [Tabrizi, Reza; Akbari, Maryam] Shiraz Univ Med Sci, Hlth Policy Res Ctr, Inst Hlth, Student Res Comm, Shiraz, Iran.
   [Saneei, Parvane; Esmaillzadeh, Ahmad] Isfahan Univ Med Sci, Food Secur Res Ctr, Dept Community Nutr, Sch Nutr & Food Sci, Esfahan, Iran.
   [Lankarani, Kamran B.] Shiraz Univ Med Sci, Hlth Policy Res Ctr, Shiraz, Iran.
   [Kolandooz, Fariba] Univ Alberta, Dept Med, Indigenous & Global Hlth Res, Edmonton, AB, Canada.
   [Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.
   [Nadi-Ravandi, Somayyeh] Kashan Univ Med Sci, Hlth Informat Management Res Ctr, Kashan, Iran.
   [Mazoochi, Majid] Kashan Univ Med Sci, Sch Med, Dept Cardiol, Kashan, Iran.
   [Asemi, Zatollah] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran.
C3 Shiraz University of Medical Science; Isfahan University of Medical
   Sciences; Shiraz University of Medical Science; University of Alberta;
   Tehran University of Medical Sciences
RP Asemi, Z (corresponding author), Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran.
EM asemi_r@yahoo.com
RI Saneei, Parvane/T-5434-2019; lankarani, kamran/D-5901-2012;
   Esmaillzadeh, Ahmad/N-5704-2014; Akbari, Ali/G-6044-2016; Tabrizi,
   Reza/AAC-2486-2021; Asemi, Zatollah/G-7393-2017; Bagheri Lankarani,
   Kamran/P-2066-2017
OI tabrizi, reza/0000-0001-7634-3948; Bagheri Lankarani,
   Kamran/0000-0002-7524-9017; Saneei, Parvane/0000-0002-4605-7833
FU Shiraz University of Medical Sciences, Shiraz; Shiraz University of
   Medical Sciences, Iran
FX The current study was founded by a grant from the Vice-chancellor for
   Research, Shiraz University of Medical Sciences, Shiraz, and Iran.
CR Astrup A, 2000, ENDOCRINE, V13, P207, DOI 10.1385/ENDO:13:2:207
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   Bracale R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098244
   Coffey CS, 2004, INT J OBESITY, V28, P1411, DOI 10.1038/sj.ijo.0802784
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Greenway FL, 2004, OBES RES, V12, P1152, DOI 10.1038/oby.2004.144
   Hackman RM, 2006, INT J OBESITY, V30, P1545, DOI 10.1038/sj.ijo.0803283
   HAMILTONFAIRLEY D, 1993, CLIN ENDOCRINOL, V39, P363, DOI 10.1111/j.1365-2265.1993.tb02378.x
   Han DH, 1998, DIABETES, V47, P1671, DOI 10.2337/diabetes.47.11.1671
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   KIDDY DS, 1989, CLIN ENDOCRINOL, V31, P757, DOI 10.1111/j.1365-2265.1989.tb01297.x
   KROMHOUT D, 1983, AM J CLIN NUTR, V38, P591, DOI 10.1093/ajcn/38.4.591
   Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566
   Liu AG, 2013, OBESITY, V21, P1991, DOI 10.1002/oby.20416
   Lynch E, 2009, AM J EPIDEMIOL, V169, P857, DOI 10.1093/aje/kwn412
   Molnár D, 2000, INT J OBESITY, V24, P1573, DOI 10.1038/sj.ijo.0801433
   Moran LJ, 2003, J CLIN ENDOCR METAB, V88, P812, DOI 10.1210/jc.2002-020815
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899
   Shi XQ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0220-7
   Souverein OW, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-57
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Thong FSL, 2002, CAN J APPL PHYSIOL, V27, P152, DOI 10.1139/h02-011
   Thong FSL, 2002, J APPL PHYSIOL, V92, P2347, DOI 10.1152/japplphysiol.01229.2001
   Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   WING RR, 1992, AM J CLIN NUTR, V55, P1086, DOI 10.1093/ajcn/55.6.1086
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
   Zheng XY, 2016, PHARMACOL BIOCHEM BE, V140, P82, DOI 10.1016/j.pbb.2015.10.019
NR 38
TC 65
Z9 67
U1 1
U2 49
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD SEP 8
PY 2019
VL 59
IS 16
BP 2688
EP 2696
DI 10.1080/10408398.2018.1507996
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA IY0EH
UT WOS:000486063800012
PM 30335479
DA 2025-04-28
ER

PT J
AU Keast, RSJ
   Swinburn, BA
   Sayompark, D
   Whitelock, S
   Riddell, LJ
AF Keast, Russell S. J.
   Swinburn, Boyd A.
   Sayompark, Dhoungsiri
   Whitelock, Susie
   Riddell, Lynn J.
TI Caffeine increases sugar-sweetened beverage consumption in a free-living
   population: a randomised controlled trial
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Sugar-sweetened beverages; Caffeine; Free-living populations
ID BODY-WEIGHT; FLAVOR; LIKING; REINFORCEMENT; ADOLESCENTS; PREFERENCE;
   CHILDREN; ENERGY
AB Excessive sugar-sweetened beverage (SSB) consumption has been associated with overweight and obesity. Caffeine is a common additive to SSB, and through dependence effects, it has the potential to promote the consumption of caffeine-containing foods. The objective of the present study was to assess the influence that caffeine has on the consumption of SSB. Participants (n 99) were blindly assigned to either a caffeinated SSB (C-SSB) or a non-caffeinated SSB (NC-SSB) group. Following randomisation, all participants completed a 9 d flavour-conditioning paradigm. They then completed a 28 d ad libitum intake intervention where they consumed as much or as little of C-SSB or NC-SSB as desired. The amount consumed (ml) was recorded daily, 4 d diet diaries were collected and liking of SSB was assessed at the start and end of the intervention. Participants (n 50) consuming the C-SSB had a daily SSB intake of 419 (SD 298) ml (785 (SD 559) kJ/d) over the 28 d intervention, significantly more than participants (n 49) consuming the NC-SSB (273 (SD 278) ml/d, 512 (SD 521) kJ/d) (P<0.001). A trained flavour panel (n 30) found no difference in flavour between the C-SSB and NC-SSB (P>0.05). However, participants who consumed the C-SSB liked the SSB more than those who consumed the NC-SSB (6.3 v. 6.0 on a nine-point hedonic scale, P<0.022). The addition of low concentrations of caffeine to the SSB significantly increases the consumption of the SSB. Regulating caffeine as a food additive may be an effective strategy to decrease the consumption of nutrient-poor high-energy foods and beverages.
C1 [Keast, Russell S. J.; Sayompark, Dhoungsiri; Whitelock, Susie; Riddell, Lynn J.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia.
   [Swinburn, Boyd A.] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Burwood, Vic 3125, Australia.
   [Swinburn, Boyd A.] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand.
   [Sayompark, Dhoungsiri] Rajamangala Univ Technol Tawan Ok, Fac Sci & Technol, Chon Buri, Thailand.
C3 Deakin University; Deakin University; World Health Organization;
   University of Auckland; Rajamangala University of Technology Tawan-ok
RP Riddell, LJ (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, 221 Burwood Highway, Burwood, Vic 3125, Australia.
EM lynn.riddell@deakin.edu.au
RI Swinburn, Boyd/JXL-3452-2024; Keast, Russell/P-1899-2017; Riddell,
   Lynn/P-4950-2016
OI Keast, Russell/0000-0003-2147-7687; Riddell, Lynn/0000-0002-0688-2134
FU Diabetes Australia Research Trust
FX The authors thank Saxbys Soft Drinks for providing the SSB for the
   study, and Diabetes Australia Research Trust for funding the study.
   Neither had any involvement in the study design, analysis or
   interpretation of the results.
CR Datamonitor, 2007, CARB SOFT DRINKS US
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Garrett BE, 1998, PSYCHOPHARMACOLOGY, V139, P195, DOI 10.1007/s002130050704
   Griffiths R R, 2000, Nihon Shinkei Seishin Yakurigaku Zasshi, V20, P223
   Griffiths RR, 2000, ARCH FAM MED, V9, P727, DOI 10.1001/archfami.9.8.727
   Hughes J, 1993, PROBLEMS DRUG DEPEND
   Keast RSJ, 2011, EUR J CLIN NUTR, V65, P1338, DOI 10.1038/ejcn.2011.123
   Keast RSJ, 2008, FOOD QUAL PREFER, V19, P465, DOI 10.1016/j.foodqual.2008.02.002
   Keast RSJ, 2007, APPETITE, V49, P255, DOI 10.1016/j.appet.2006.11.003
   Krachler B, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-34
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Nehlig A, 1999, NEUROSCI BIOBEHAV R, V23, P563, DOI 10.1016/S0149-7634(98)00050-5
   Riddell L, 2007, MED J AUSTRALIA, V187, P655, DOI 10.5694/j.1326-5377.2007.tb01463.x
   ROGERS PJ, 1995, PSYCHOPHARMACOLOGY, V120, P457, DOI 10.1007/BF02245818
   Schuh KJ, 1997, PSYCHOPHARMACOLOGY, V130, P320, DOI 10.1007/s002130050246
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   Temple JL, 2012, PSYCHOPHARMACOLOGY, V223, P37, DOI 10.1007/s00213-012-2684-2
   Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001
   Troiano RP, 2000, AM J CLIN NUTR, V72, p1343S, DOI 10.1093/ajcn/72.5.1343s
   Yeomans MR, 2007, PHYSIOL BEHAV, V92, P831, DOI 10.1016/j.physbeh.2007.06.006
   Yeomans MR, 2002, APPETITE, V39, P35, DOI 10.1006/appe.2001.0480
   Yeomans MR, 1998, PSYCHOPHARMACOLOGY, V137, P401, DOI 10.1007/s002130050636
   Yeomans MR, 2000, APPETITE, V35, P131, DOI 10.1006/appe.2000.0339
NR 24
TC 26
Z9 29
U1 0
U2 27
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JAN 28
PY 2015
VL 113
IS 2
BP 366
EP 371
DI 10.1017/S000711451400378X
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CC3EW
UT WOS:000350229700018
PM 25567475
OA Green Submitted, Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Yamashita, Y
   Wang, LQ
   Wang, LH
   Tanaka, Y
   Zhang, TS
   Ashida, H
AF Yamashita, Yoko
   Wang, Liuqing
   Wang, Lihua
   Tanaka, Yuki
   Zhang, Tianshun
   Ashida, Hitoshi
TI Oolong, black and pu-erh tea suppresses adiposity in mice via
   activation of AMP-activated protein kinase
SO FOOD & FUNCTION
LA English
DT Article
ID FACTOR-BINDING PROTEIN-1; GREEN TEA; GLUCOSE-INTOLERANCE;
   GENE-EXPRESSION; UNCOUPLING PROTEINS; CARDIOVASCULAR RISK;
   LIPID-ACCUMULATION; PREVENTS OBESITY; ADIPOCYTES; CAFFEINE
AB It is well known that tea has a variety of beneficial impacts on human health, including anti-obesity effects. It is well documented that green tea and its constituent catechins suppress obesity, but the effects of other types of tea on obesity and the potential mechanisms involved are not yet fully understood. In this study, we investigated the suppression of adiposity by oolong, black and pu-erh tea and characterized the underlying molecular mechanism in vivo. We found that the consumption of oolong, black or pu-erh tea for a period of one week significantly decreased visceral fat without affecting body weight in male ICR mice. On a mechanistic level, the consumption of tea enhanced the phosphorylation of AMP-activated protein kinase (AMPK) in white adipose tissue (WAT). This was accompanied by the induction of WAT protein levels of uncoupling protein 1 and insulin-like growth factor binding protein 1. Our results indicate that oolong, black and pu-erh tea, and in particular, black tea, suppresses adiposity via phosphorylation of the key metabolic regulator AMPK and increases browning of WAT.
C1 [Yamashita, Yoko; Wang, Liuqing; Wang, Lihua; Tanaka, Yuki; Zhang, Tianshun; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan.
C3 Kobe University
RP Yamashita, Y (corresponding author), Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan.
EM ashida@kobe-u.ac.jp
RI Wang, Yijun/GXW-1763-2022
FU Social Coordination Funds for Promoting Science and Technology and
   Creation of Innovation Centers for Advanced Interdisciplinary Research
   Area (Innovative Bioproduction Kobe), MEXT, Japan
FX This work was supported in part by Social Coordination Funds for
   Promoting Science and Technology and Creation of Innovation Centers for
   Advanced Interdisciplinary Research Area (Innovative Bioproduction
   Kobe), MEXT, Japan.
CR Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002
   Boss O, 1998, EUR J ENDOCRINOL, V139, P1, DOI 10.1530/eje.0.1390001
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chow HHS, 2011, PHARMACOL RES, V64, P105, DOI 10.1016/j.phrs.2011.05.007
   Egawa T, 2011, ACTA PHYSIOL, V201, P227, DOI 10.1111/j.1748-1716.2010.02169.x
   Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966
   Fuster A, 2009, COMP BIOCHEM PHYS A, V153, P106, DOI 10.1016/j.cbpa.2009.01.007
   Gao Y, 2008, BIOL PHARM BULL, V31, P1716, DOI 10.1248/bpb.31.1716
   GREENBERG AS, 1991, J BIOL CHEM, V266, P11341
   Gruzman Arie, 2009, Rev Diabet Stud, V6, P13, DOI 10.1900/RDS.2009.6.13
   Hardie D. G., 2006, J PHYSL, V574, P5747
   Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982
   Heald AH, 2001, DIABETOLOGIA, V44, P333, DOI 10.1007/s001250051623
   Hilding A, 2003, BIOCHEM BIOPH RES CO, V303, P693, DOI 10.1016/S0006-291X(03)00403-0
   Hodgson JM, 2010, MOL ASPECTS MED, V31, P495, DOI 10.1016/j.mam.2010.09.004
   Huang HC, 2012, FOOD FUNCT, V3, P170, DOI 10.1039/c1fo10157a
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kalme T, 2005, J CLIN ENDOCR METAB, V90, P1550, DOI 10.1210/jc.2004-0762
   Kanamoto Y, 2011, J AGR FOOD CHEM, V59, P8985, DOI 10.1021/jf201471p
   Klaus S, 2012, GENES NUTR, V7, P369, DOI 10.1007/s12263-011-0260-8
   Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x
   Lewitt MS, 2001, BIOCHEM BIOPH RES CO, V282, P1126, DOI 10.1006/bbrc.2001.4702
   Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200
   Lin YL, 1996, J AGR FOOD CHEM, V44, P1387, DOI 10.1021/jf950652k
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002
   Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021
   Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI [10.3233/BIO-2009-1083, 10.1002/biof.5520340405]
   Nomura S, 2008, J NUTR BIOCHEM, V19, P840, DOI 10.1016/j.jnutbio.2007.11.005
   Ostrowska Lucyna, 2013, Rocz Panstw Zakl Hig, V64, P61
   Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rajkumar K, 1999, J ENDOCRINOL, V162, P457, DOI 10.1677/joe.0.1620457
   Rajpathak SN, 2008, GROWTH HORM IGF RES, V18, P166, DOI 10.1016/j.ghir.2007.08.004
   Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161
   Sanderson M, 2014, PHYTOMEDICINE, V21, P109, DOI 10.1016/j.phymed.2013.08.011
   Sawada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014006
   Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001
   Tiraby C, 2007, DIABETOLOGIA, V50, P2190, DOI 10.1007/s00125-007-0765-2
   Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259
   Ueda M, 2012, J AGR FOOD CHEM, V60, P8917, DOI 10.1021/jf2053788
   UNTERMAN TG, 1991, ENDOCRINOLOGY, V128, P2693, DOI 10.1210/endo-128-6-2693
   Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08
   Weisburger JH, 2002, FOOD CHEM TOXICOL, V40, P1145, DOI 10.1016/S0278-6915(02)00044-3
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yamashita Y, 2012, J AGR FOOD CHEM, V60, P11366, DOI 10.1021/jf303597c
   Yamashita Y, 2012, ARCH BIOCHEM BIOPHYS, V527, P95, DOI 10.1016/j.abb.2012.03.018
NR 48
TC 67
Z9 76
U1 0
U2 58
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD OCT
PY 2014
VL 5
IS 10
BP 2420
EP 2429
DI 10.1039/c4fo00095a
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA AQ7TY
UT WOS:000343023300004
PM 25098399
DA 2025-04-28
ER

PT J
AU Liu, C
   Li, Y
   Song, G
   Li, XH
   Chen, SY
   Zou, DX
   Li, HX
   Hu, CY
   Zhao, HT
   Yan, Y
AF Liu, Chang
   Li, Yi
   Song, Ge
   Li, Xuehan
   Chen, Songyue
   Zou, Dixin
   Li, Huixin
   Hu, Chengyi
   Zhao, Haotian
   Yan, Yi
TI Caffeine promotes the production of Irisin in muscles and thus
   facilitates the browning of white adipose tissue
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Caffeine; Irisin; WAT browning; Calcium signaling; PGC-1 alpha; UCP1
ID ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; ADIPOCYTE; CELLS; ACID; DIET
AB With the progress of modern society, obesity has gradually emerged as a major public health challenge. In recent years, there has been growing interest in the potential of caffeine (CAF) as a nutritional tool for combating obesity. While previous studies has demonstrated CAF's ability to directly influence white adipose tissue (WAT) by promoting browning and reducing obesity, the role of muscle in obesity reduction should not be overlooked. Given that exercise is a primary component of weight loss, our study aimed to investigate whether CAF can alleviate adiposity by modulating the skeletal muscle-adipose tissue crosstalk. Our study demonstrates that CAF can alleviate obesity by enhancing the expression of PGC-1 alpha through calcium-related signaling pathways in skeletal muscle, which subsequently induces the production of Irisin in myotubes and high fat diet (HFD)-fed mice in vitro. Irisin, in turn, circulates to WAT and promotes browning, thus providing a theoretical foundation for the use of CAF as a nutritional tool for weight control. Overall, our findings highlight the potential of CAF in modulating skeletal muscle-adipose tissue crosstalk and suggest that it may be an effective tool for reducing obesity.
C1 [Liu, Chang; Song, Ge; Li, Xuehan; Li, Huixin; Hu, Chengyi; Yan, Yi] Beijing Sport Univ, Sch Sport Sci, Beijing, Peoples R China.
   [Li, Yi] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China.
   [Chen, Songyue] Peking Univ, Sch Pharmaceut Sci, Dept Pharmaceut, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China.
   [Zhao, Haotian] Jiangnan Univ, Dept Phys Educ, Wuxi, Peoples R China.
   [Zou, Dixin] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.
C3 Beijing Sport University; Academy of Military Medical Sciences - China;
   Peking University; Jiangnan University; China Academy of Chinese Medical
   Sciences; Institute of Chinese Materia Medica, CACMS
RP Yan, Y (corresponding author), Beijing Sport Univ, Sch Sport Sci, Beijing, Peoples R China.; Li, Y (corresponding author), Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China.; Zhao, HT (corresponding author), Jiangnan Univ, Dept Phys Educ, Wuxi, Peoples R China.
EM liyi_evening@pku.edu.cn; 2019210252@bsu.edu.cn; yanyi22@sina.com
RI Li, Yi/HQY-8229-2023; liu, Chang/IWV-0879-2023
OI liu, Chang/0000-0002-7867-6807; Li, Yi/0000-0003-3298-4975; Li,
   Huixin/0009-0002-6768-4884
FU Beijing Natural Science Foundation [7232303]; CACMS Innovation Fund
   [CI2021A02210]; Fundamental Research Funds for the Central Universities
   [2022YB013]
FX <B>Funding</B> This study was financially supported by the Beijing
   Natural Science Foundation (7232303) , CACMS Innovation Fund,
   CI2021A02210 and the Fundamental Research Funds for the Central
   Universities (Grant No. 2022YB013) .
CR Amengual J, 2018, CELL PHYSIOL BIOCHEM, V46, P187, DOI 10.1159/000488422
   Ando Y, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0361-8
   Becerril S, 2013, HISTOL HISTOPATHOL, V28, P1411, DOI 10.14670/HH-28.1411
   Castillo-Quan JI, 2012, DIS MODEL MECH, V5, P293, DOI 10.1242/dmm.009894
   Chen LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115708
   Chen S., 2023, Nutrients, V15
   Chen SQ, 2019, BIOMED PHARMACOTHER, V115, DOI 10.1016/j.biopha.2019.108930
   del Campo A, 2023, CURR MED CHEM, V30, P3927, DOI 10.2174/0929867330666221209093343
   Duellman SJ, 2015, ASSAY DRUG DEV TECHN, V13, P456, DOI 10.1089/adt.2015.669
   Echeverría F, 2019, FOOD FUNCT, V10, P6170, DOI [10.1039/c9fo01373c, 10.1039/C9FO01373C]
   Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200
   Gonzales AM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-22
   Hoffmann C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029793
   Huang H, 2019, EXP CELL RES, V385, DOI 10.1016/j.yexcr.2019.111672
   Jankovic A, 2015, J PHYSIOL-LONDON, V593, P3267, DOI 10.1113/JP270805
   Kim SH, 2016, DIABETES METAB J, V40, P12, DOI 10.4093/dmj.2016.40.1.12
   Kraus NA, 2016, ADIPOCYTE, V5, P351, DOI 10.1080/21623945.2016.1240137
   Kuo IY, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006023
   Kwon YJ, 2018, MITOCHONDRION, V40, P42, DOI 10.1016/j.mito.2017.09.004
   Lamas S, 2021, ZYGOTE, V29, P199, DOI 10.1017/S0967199420000714
   Laver DR, 2007, CLIN EXP PHARMACOL P, V34, P889, DOI 10.1111/j.1440-1681.2007.04708.x
   Lee HJ, 2015, MOL ENDOCRINOL, V29, P873, DOI 10.1210/me.2014-1353
   Liu C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101276
   Liu C, 2017, INT J NANOMED, V12, P2407, DOI 10.2147/IJN.S131367
   Longo M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092358
   McClung JM, 2012, AM J PATHOL, V180, P2156, DOI 10.1016/j.ajpath.2012.01.032
   Okorodudu DE, 2015, ANN MED, V47, P179, DOI 10.3109/07853890.2014.931102
   Ortiz M, 2020, DIGEST LIVER DIS, V52, P895, DOI 10.1016/j.dld.2020.04.019
   Paschos GK, 2018, CELL REP, V24, P809, DOI 10.1016/j.celrep.2018.06.082
   Qi GH, 2019, ACTA PHARM SIN B, V9, P135, DOI 10.1016/j.apsb.2018.10.004
   Rodríguez A, 2015, AM J PHYSIOL-ENDOC M, V309, pE691, DOI 10.1152/ajpendo.00297.2015
   Schnyder S, 2015, BONE, V80, P115, DOI 10.1016/j.bone.2015.02.008
   Severinsen MCK, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa016
   Shen SN, 2019, BRIT J PHARMACOL, V176, P3983, DOI 10.1111/bph.14802
   Sure VN, 2018, GEROSCIENCE, V40, P365, DOI 10.1007/s11357-018-0037-8
   Tsiani E, 2021, CANCERS, V13, DOI 10.3390/cancers13112628
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Waseem R, 2022, MOLECULES, V27, DOI 10.3390/molecules27031118
   Xie B, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.990476
   Xu LH, 2022, IN VITRO CELL DEV-AN, V58, P658, DOI 10.1007/s11626-022-00699-2
   Yan L, 2011, J AM ASSOC LAB ANIM, V50, P488
   Zhao H., 2022, Int. J. Environ. Res. Public Health, V19
NR 43
TC 4
Z9 4
U1 6
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD SEP
PY 2023
VL 108
AR 105702
DI 10.1016/j.jff.2023.105702
EA AUG 2023
PG 13
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA FV4W9
UT WOS:001148626800001
OA gold
DA 2025-04-28
ER

PT J
AU Rondanelli, M
   Riva, A
   Petrangolini, G
   Allegrini, P
   Bernardinelli, L
   Fazia, T
   Peroni, G
   Gasparri, C
   Nichetti, M
   Faliva, MA
   Naso, M
   Perna, S
AF Rondanelli, Mariangela
   Riva, Antonella
   Petrangolini, Giovanna
   Allegrini, Pietro
   Bernardinelli, Luisa
   Fazia, Teresa
   Peroni, Gabriella
   Gasparri, Clara
   Nichetti, Mara
   Faliva, Milena Anna
   Naso, Maurizio
   Perna, Simone
TI The Metabolic Effects of Cynara Supplementation in Overweight and
   Obese Class I Subjects with Newly Detected Impaired Fasting Glycemia: A
   Double-Blind, Placebo-Controlled, Randomized Clinical Trial
SO NUTRIENTS
LA English
DT Article
DE Cynara; impaired fasting glucose; insulin sensitivity; obesity;
   overweight
ID ARTICHOKE LEAF EXTRACT; GLUCOSE-TOLERANCE; HYPERCHOLESTEROLEMIA;
   CHOLESTEROL; POLYPHENOLS; FLAVONOIDS; SCOLYMUS
AB Impaired fasting glucose (IFG) is a condition that precedes diabetes and increases the risk of developing it. Studies support the hypoglycemic effect of Cynara scolymus (Cs) extracts due to the content of chlorogenic acid, which is a potent inhibitor of glucose 6-phosphate translocase and of dicaffeoylquinic acid derivatives that modulate the activity of alpha-glucosidase. Given this background, we investigated whether a new highly standardized Cs extract could improve glycemic control, insulin sensitivity and other metabolic parameters (total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C) Triglycerides, Apolipo protein B (ApoB), Apolipo protein A (ApoA), waist circumference, visceral adipose tissue (VAT) by dual-energy X-ray absorptiometry (DXA) in overweight subjects with newly diagnosed IFG. Fifty-four subjects (females/males 26/28, mean +/- SD age 51.5 +/- 6.2) were randomly assigned to the supplemented group (n = 27) and placebo (n = 27). After multiple testing correction, statistically significant interactions between time and group were observed for the primary endpoint glycemia (beta = 0.36, p < 0.0001) and for the secondary endpoints HDL (beta = -0.10, p < 0.0001), total cholesterol/HDL (beta = 0.27, p < 0.0001), LDL (beta = 0.15, p = 0.005), LDL/HDL (beta = 0.23, p = 0.001), insulin (beta = 1.28, p = 0.04), glycated hemoglobin (beta = 0.21, p = 0.0002), A1c-derived average glucose (beta = 0.34, p = 0.0002), ApoB (beta = 6.00, p = 0.01), ApoA (beta = -4.50, p = 0.04), ApoB/ApoA (beta = 0.08, p = 0.003), waist circumference (beta = 1.89, p = 0.05), VAT beta = 222.37, p = 0.005). In conclusion, these results confirm that Cs supplementation has a significant effect on metabolic parameters in IFG patients.
C1 [Rondanelli, Mariangela] IRCCS Mondino Fdn, I-27100 Pavia, Italy.
   [Rondanelli, Mariangela] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Unit Human & Clin Nutr, I-27100 Pavia, Italy.
   [Riva, Antonella; Petrangolini, Giovanna; Allegrini, Pietro] Indena, Res & Dev Unit, I-20139 Milan, Italy.
   [Bernardinelli, Luisa; Fazia, Teresa] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy.
   [Peroni, Gabriella; Gasparri, Clara; Nichetti, Mara; Faliva, Milena Anna; Naso, Maurizio] Univ Pavia, Azienda Serv Persona Ist Santa Margherita, Endocrinol & Nutr Unit, I-27100 Pavia, Italy.
   [Perna, Simone] Univ Bahrain, Coll Sci, Dept Biol, Sakhir Campus,POB 32038, Sakheer, Bahrain.
C3 IRCCS Fondazione Casimiro Mondino; University of Pavia; University of
   Pavia; University of Pavia; University of Bahrain
RP Peroni, G (corresponding author), Univ Pavia, Azienda Serv Persona Ist Santa Margherita, Endocrinol & Nutr Unit, I-27100 Pavia, Italy.
EM mariangela.rondanelli@unipv.it; antonella.riva@indena.com;
   giovanna.petrangolini@indena.com; pietro.allegrini@indena.com;
   luisa.bernardinelli@unipv.it; teresa.fazia01@ateneopv.it;
   gabriella.peroni01@universitadipavia.it;
   clara.gasparri01@universitadipavia.it; dietista.mara.nichetti@gmail.com;
   milena.faliva@gmail.com; mau.na.mn@gmail.com; simoneperna@hotmail.it
RI Rondanelli, Mariangela/AGD-6274-2022; Bernardinelli,
   Luisa/AAL-5750-2021; Faliva, Milena Anna/AAC-3653-2022; Petrangolini,
   Giovanna/J-5653-2019; Perna, Simone/Y-8892-2018; Fazia,
   Teresa/AAV-1412-2021
OI Perna, Simone/0000-0002-2720-1473; Petrangolini,
   Giovanna/0000-0001-6681-7329; Gasparri, Clara/0000-0002-1088-6648; Riva,
   Antonella/0000-0003-2819-943X; rondanelli,
   Mariangela/0000-0001-8336-4851; Fazia, Teresa/0000-0002-9577-8450;
   BERNARDINELLI, LUISA/0000-0002-7551-6664
CR [Anonymous], 2012, NLME LINEAR NONLINEA
   Arion WJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P279, DOI 10.1006/abbi.1997.0563
   Attallah H, 2006, GROWTH HORM IGF RES, V16, pS62, DOI 10.1016/j.ghir.2006.03.004
   Barrat E, 2013, INT J FOOD SCI NUTR, V64, P882, DOI 10.3109/09637486.2013.809405
   Ben Salem M, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1835-8
   Ben Salem M, 2015, PLANT FOOD HUM NUTR, V70, P441, DOI 10.1007/s11130-015-0503-8
   Benjamini Y, 2001, ANN STAT, V29, P1165
   BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493
   Cazarolli LH, 2008, MINI-REV MED CHEM, V8, P1032, DOI 10.2174/138955708785740580
   Cicero AFG, 2019, AM J CARDIOL, V123, P588, DOI 10.1016/j.amjcard.2018.11.018
   Colantuono A, 2018, FOOD CHEM, V245, P838, DOI 10.1016/j.foodchem.2017.11.099
   Dragan S, 2015, CURR MED CHEM, V22, P14
   Ebrahimi-Mameghani M, 2018, J INTEGR MED-JIM, V16, P329, DOI 10.1016/j.joim.2018.05.006
   Fantini N, 2011, PHYTOTHER RES, V25, P463, DOI 10.1002/ptr.3285
   FRISANCHO AR, 1984, AM J CLIN NUTR, V40, P808, DOI 10.1093/ajcn/40.4.808
   Glümer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335
   Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138
   Hanna-Moussa A, 2009, REV CARDIOVASC MED, V10, P202, DOI 10.3909/ricm0474
   Hui Hongxiang, 2009, Chin Med, V4, P11, DOI 10.1186/1749-8546-4-11
   Karthikesan K, 2010, GEN PHYSIOL BIOPHYS, V29, P23, DOI 10.4149/gpb_2010_01_23
   Kuczmannová A, 2016, MOLECULES, V21, DOI 10.3390/molecules21050564
   Magied M. M., 2016, J FOOD NUTR RES, V4, P60, DOI DOI 10.12691/JFNR-4-1-10
   Mare R., 2020, MINERVA ENDOCRINOL, DOI [10.23736/S0391-1977.20.03243-5, DOI 10.23736/S0391-1977.20.03243-5]
   Matsui T, 2006, MINI-REV MED CHEM, V6, P349, DOI 10.2174/138955706776073484
   Mohammad A, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2016.38
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]
   Neustadt J, 2008, MOL NUTR FOOD RES, V52, P780, DOI 10.1002/mnfr.200700075
   Ogier N, 2013, EUR J NUTR, V52, P547, DOI 10.1007/s00394-012-0357-x
   Ostan R, 2016, CLIN NUTR, V35, P812, DOI 10.1016/j.clnu.2015.06.010
   Pereira DF, 2011, NUTRITION, V27, P1161, DOI 10.1016/j.nut.2011.01.008
   Pinheiro S.J., 2013, R PACKAGE VERSION, V3, P111
   R Core Team, 2017, R LANG ENV STAT COMP
   Rezazadeh K, 2018, CLIN NUTR, V37, P790, DOI 10.1016/j.clnu.2017.03.017
   Rezazadeh K, 2018, PHYTOTHER RES, V32, P84, DOI 10.1002/ptr.5951
   Rondanelli M, 2014, PHYTOTHER RES, V28, P33, DOI 10.1002/ptr.4950
   Rondanelli M, 2013, INT J FOOD SCI NUTR, V64, P7, DOI 10.3109/09637486.2012.700920
   Shan Jacqueline J, 2007, Proc West Pharmacol Soc, V50, P24
   Sherwin RS, 2002, DIABETES CARE, V25, P742
   Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x
NR 40
TC 19
Z9 20
U1 1
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2020
VL 12
IS 11
AR 3298
DI 10.3390/nu12113298
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA OX7CS
UT WOS:000593718700001
PM 33126534
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU White, AA
   Nitzke, S
   Peterson, KE
AF White, AA
   Nitzke, S
   Peterson, KE
TI Are soft drinks getting a burn rap? We don't think so
SO JOURNAL OF NUTRITION EDUCATION AND BEHAVIOR
LA English
DT Article
DE carbonated beverages; schools; nutrition; policy
ID DENTAL-CARIES; BEVERAGE CONSUMPTION; CAFFEINE WITHDRAWAL; CHILDREN;
   ADOLESCENTS; PATTERNS; OBESITY; SUGARS; GIRLS; FOODS
AB The viewpoint presented in this article is that soft drink consumption is a contributing factor in the rising incidence of overweight among school-aged children. Misinformation must be dispelled so that resources can be directed to real, evidence-based concerns. Child nutrition advocates have called for reducing access to soft drinks in schools as an important step in optimizing healthful environments for children. School nutrition policies are being revised at national, state, and local levels. Along with other stakeholders, soft drink manufacturers must acknowledge the problem of rising rates of overweight in children and work within their spheres of influence to limit access to soft drinks in schools.
C1 Univ Maine, Dept Food Sci & Human Nutr, Orono, ME 04469 USA.
   Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA.
   Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA.
C3 University of Maine System; University of Maine Orono; University of
   Wisconsin System; University of Wisconsin Madison; Harvard University;
   Harvard T.H. Chan School of Public Health; Harvard University; Harvard
   T.H. Chan School of Public Health
RP Univ Maine, Dept Food Sci & Human Nutr, 5735 Hitchner Hall, Orono, ME 04469 USA.
EM aawhite@umenfa.maine.edu
CR *AM PUBL HLTH ASS, 2003, POL STAT 2003 17 FOO
   [Anonymous], 2004, J AM DIET ASSOC, V104, P660, DOI 10.1016/j.jada.2004.01.030
   [Anonymous], 2000, memorandum
   [Anonymous], OVERWEIGHT CHILDREN
   Berg F., 2003, J NUTR EDUC BEHAV, V35, P1
   BOWMAN DH, 2003, ED WEEK         1003
   Briggs M, 2003, J NUTR EDUC BEHAV, V35, P57, DOI 10.1016/S1499-4046(06)60040-7
   *CAL PROJ LEAN PUB, 2002, TAK FIZZ OUT SOD CON
   *COC COL CO, MOD GUID SCH BEV PAR
   *COMM SCH HLTH OH, OH AAP STAT SOFT DRI
   DAY S, 2004, NY TIMES        0903
   Erickson Pamela R., 1998, Pediatric Dentistry, V20, P395
   Evans SM, 1999, J PHARMACOL EXP THER, V289, P285
   Fisher JO, 2001, J NUTR, V131, P246, DOI 10.1093/jn/131.2.246
   Fitzpatrick L, 2003, J BONE MINER RES, V18, P1570, DOI 10.1359/jbmr.2003.18.9.1570
   French SA, 2003, J AM DIET ASSOC, V103, P1326, DOI 10.1016/S0002-8223(03)01076-9
   Gibson S, 1999, CARIES RES, V33, P101, DOI 10.1159/000016503
   Gleason P, 2001, DIETARY INTAKE ITS R
   GRIFFITHS RR, 1989, J EXP ANAL BEHAV, V52, P127, DOI 10.1901/jeab.1989.52-127
   Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3
   Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6
   Heaney RP, 2001, AM J CLIN NUTR, V74, P343
   Heller KE, 2001, J DENT RES, V80, P1949, DOI 10.1177/00220345010800101701
   Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857
   *INT FOOD INF COUN, 1998, EV YOU NEED KNOW CAF
   ISMAIL AI, 1984, J AM DENT ASSOC, V109, P241, DOI 10.14219/jada.archive.1984.0346
   James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE
   James J.E., 1991, CAFFEINE HLTH
   Jones HE, 2000, PSYCHOPHARMACOLOGY, V147, P371, DOI 10.1007/s002130050005
   KLEEMOLAKUJALA E, 1979, COMMUNITY DENT ORAL, V7, P199, DOI 10.1111/j.1600-0528.1979.tb01216.x
   Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424
   Krebs-Smith SM, 2001, J NUTR, V131, p527S, DOI 10.1093/jn/131.2.527S
   *LIF SCI RES OFF, 1989, DHHS PUB PHS
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Lytle LA, 2000, AM J HEALTH PROMOT, V14, P222, DOI 10.4278/0890-1171-14.4.222
   *MAIN DIET ASS MAI, JOINT POS MAIN DIET
   MARR L, 2004, J NUTR ED BEHAV, V36
   Marshall TA, 2003, PEDIATRICS, V112, pE184, DOI 10.1542/peds.112.3.e184
   Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   McNeal James., 1999, The Kids Market: Myths and Realities
   MOLNAR A, SCH COMMERCIALISM ST
   Mor B M, 1983, N Z Dent J, V79, P10
   Mrdjenovic G, 2003, J PEDIATR-US, V142, P604, DOI 10.1067/mpd.2003.200
   MUMFORD GK, 1994, PSYCHOPHARMACOLOGY, V115, P1, DOI 10.1007/BF02244744
   *NAT SOFT DRINK AS, 2003, STAT RESP AAP REL SO
   NESTLE M, 2002, FOOD POLITICS, P175
   NESTLE M, 2002, FOOD POLITICS, P197
   Skinner JD, 2003, J AM DIET ASSOC, V103, P1626, DOI [10.1016/j.jada.2003.09.018, 10.1016/j.jada.2003.09.020]
   Sloan AE, 2003, FOOD TECHNOL-CHICAGO, V57, P20
   Smit HJ, 2000, PSYCHOPHARMACOLOGY, V152, P167, DOI 10.1007/s002130000506
   SPRAYCAR M, 1995, STEDMANS MED DICT
   St-Onge MP, 2003, AM J CLIN NUTR, V78, P1068, DOI 10.1093/ajcn/78.6.1068
   Stitzel K, 2003, J AM DIET ASSOC, V103, P439, DOI 10.1053/jada.2003.50102
   STUHLDREHER WL, 1998, J CHILD NUTR MANAGE, V22, P79
   Taras HL, 2004, PEDIATRICS, V113, P152
   *TX I HLTH POL RES, 2001, NUTR FITN TEX SCH PO
   *US CDCP SHPPS, 2000, SCH HLTH POL PROGR S
   *USDA, 1983, H6 USDA HUM NUTR INF
   *USDA, 2000, SPEC NOT DAT US US D
   *USDA, 1984, 1 USDA HUM NUTR INF
   *USDA USDEPHHS PHS, 2000, NUTR YOUR HLTH DIET, V232
   Vail K., 1999, American School Board Journal
   *W VA DEP ED, 2002, EX SUMM STAND SCH NU
   Wyshak G, 2000, ARCH PEDIAT ADOL MED, V154, P610, DOI 10.1001/archpedi.154.6.610
   COKE CHANGES MARKETI
NR 65
TC 5
Z9 5
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1499-4046
EI 1878-2620
J9 J NUTR EDUC BEHAV
JI J. Nutr. Educ. Behav.
PD SEP-OCT
PY 2004
VL 36
IS 5
BP 266
EP 271
DI 10.1016/S1499-4046(06)60390-4
PG 6
WC Education, Scientific Disciplines; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Education & Educational Research; Nutrition & Dietetics
GA 877WD
UT WOS:000225604300011
PM 15707550
DA 2025-04-28
ER

PT J
AU Stefanescu, BE
   Szabo, K
   Mocan, A
   Crisan, G
AF Stefanescu, Bianca Eugenia
   Szabo, Katalin
   Mocan, Andrei
   Crisan, Gianina
TI Phenolic Compounds from Five Ericaceae Species Leaves and Their Related
   Bioavailability and Health Benefits
SO MOLECULES
LA English
DT Review
DE Ericaceae; Vaccinium spp; leaves; phenolic components; arbutin;
   chlorogenic acid; quercetin
ID BILBERRY VACCINIUM-MYRTILLUS; CHLOROGENIC ACID; ANTIOXIDANT ACTIVITY;
   CANCER-CELLS; VITIS-IDAEA; IN-VITRO; L. LEAF; INHIBITS PROLIFERATION;
   POLYPHENOLIC CONTENT; FLAVONOID QUERCETIN
AB Some species of the Ericaceae family have been intensively studied because of the beneficial health impact, known since ancient times, of their chemical components. Since most studies focus on the effects of fruit consumption, this review aims to highlight the phenolic components present in the leaves. For this purpose, five species from Ericaceae family (bilberryVaccinium myrtillus L., lingonberryV. vitis-idaea L., bog bilberryV. uliginosum L., blueberryV. corymbosum L. and bearberryArctostapylos uva-ursi L.) were considered, four of which can be found in spontaneous flora. The chemical composition of the leaves revealed three major phenolic compounds: chlorogenic acid, quercetin and arbutin. The health promoting functions of these compounds, such as antioxidant and anti-inflammatory properties that could have preventive effects for cardiovascular disease, neurodegenerative disorders, cancer, and obesity, have been exemplified by both in vitro and in vivo studies in this review. Furthermore, the importance of bioaccessibility and bioavailability of the phenolic compounds have been summarized. The findings highlight the fact that leaves of some Ericaceae species deserve increased attention and should be studied more profoundly for their biological activities, especially those from spontaneous flora.
C1 [Stefanescu, Bianca Eugenia; Mocan, Andrei; Crisan, Gianina] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmaceut Bot, 23 Ghe Marinescu St, Cluj Napoca 400337, Romania.
   [Stefanescu, Bianca Eugenia; Szabo, Katalin] Univ Agr Sci & Vet Med, Inst Life Sci, CaleaManastur 3-5, Cluj Napoca 400372, Romania.
   [Mocan, Andrei] Univ Agr Sci & Vet Med, Inst Adv Hort Res Transylvania, Lab Chromatog, Cluj Napoca 400372, Romania.
C3 Iuliu Hatieganu University of Medicine & Pharmacy; University of
   Agricultural Sciences & Veterinary Medicine Cluj Napoca; University of
   Agricultural Sciences & Veterinary Medicine Cluj Napoca
RP Crisan, G (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Pharmaceut Bot, 23 Ghe Marinescu St, Cluj Napoca 400337, Romania.; Szabo, K (corresponding author), Univ Agr Sci & Vet Med, Inst Life Sci, CaleaManastur 3-5, Cluj Napoca 400372, Romania.
EM stefanescu.bianca@umfcluj.ro; katalin.szabo@usamvcluj.ro;
   mocan.andrei@umfcluj.ro; gcrisan@umfcluj.ro
RI Crisan, Gianina/AAM-3334-2020; Mocan, Andrei/AAT-8274-2021; Vodnar,
   Bianca/IVV-1335-2023; Katalin, SZABO/AAC-4692-2019
OI Mocan, Andrei/0000-0001-5848-8457; Vodnar (Stefanescu), Bianca
   Eugenia/0000-0001-8916-6493; Szabo, Katalin/0000-0002-6872-9557
FU Romanian National Authority for Scientific Research and Innovation,
   CCDI-UEFISCDI within PNCDI III [27/2018 CO FUND-MANUNET III-NON-ACT-2];
   UMF
FX This work supported by an internal grant of UMF and by a grant of the
   Romanian National Authority for Scientific Research and Innovation,
   CCDI-UEFISCDI, project number 27/2018 CO FUND-MANUNET III-NON-ACT-2,
   within PNCDI III.
CR Amarowicz R, 2013, J FUNCT FOODS, V5, P660, DOI 10.1016/j.jff.2013.01.009
   Angst E, 2013, PANCREAS, V42, P223, DOI 10.1097/MPA.0b013e318264ccae
   Annuk H, 1999, FEMS MICROBIOL LETT, V172, P41, DOI [10.1016/S0378-1097(99)00002-6, 10.1111/j.1574-6968.1999.tb13447.x]
   Bang Seo-Hyun, 2008, J Cosmet Dermatol, V7, P189, DOI 10.1111/j.1473-2165.2008.00387.x
   Barl B., 1996, SASKATCHEWAN HERB DA, P18
   Beaux D, 1999, PHYTOTHER RES, V13, P222, DOI 10.1002/(SICI)1099-1573(199905)13:3<222::AID-PTR447>3.0.CO;2-P
   Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
   Bujor OC, 2018, FOOD CHEM, V252, P356, DOI 10.1016/j.foodchem.2018.01.052
   Bujor OC, 2016, FOOD CHEM, V213, P58, DOI 10.1016/j.foodchem.2016.06.042
   Bunea A, 2011, NOT BOT HORTI AGROBO, V39, P70
   Calinoiu LF, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111615
   Carbonell-Capella JM, 2014, COMPR REV FOOD SCI F, V13, P155, DOI 10.1111/1541-4337.12049
   Cheng SL, 2007, J BIOMED SCI, V14, P87, DOI 10.1007/s11373-006-9130-6
   Chittaranjan K., 2011, WILD CROP RELATIVES, P197
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Christenhusz MJM, 2016, PHYTOTAXA, V261, P201, DOI 10.11646/phytotaxa.261.3.1
   Cignarella A, 1996, THROMB RES, V84, P311, DOI 10.1016/S0049-3848(96)00195-8
   Conklin CMJ, 2007, CARCINOGENESIS, V28, P93, DOI 10.1093/carcin/bgl106
   D'Archivio Massimo, 2007, Ann Ist Super Sanita, V43, P348
   de Arriba SG, 2013, INT J TOXICOL, V32, P442, DOI 10.1177/1091581813507721
   de Mejía EG, 2006, FOOD CHEM TOXICOL, V44, P1191, DOI 10.1016/j.fct.2006.01.015
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Deng XH, 2013, EXP THER MED, V6, P1155, DOI 10.3892/etm.2013.1285
   Diaconeasa Z, 2018, MOLECULES, V23, DOI 10.3390/molecules23102534
   Domitrovic R, 2014, TOXICOLOGY, V324, P98, DOI 10.1016/j.tox.2014.07.004
   dos Santos AE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-130
   Dueñas M, 2010, J PHARMACEUT BIOMED, V51, P443, DOI 10.1016/j.jpba.2009.04.007
   Ek S, 2006, J AGR FOOD CHEM, V54, P9834, DOI 10.1021/jf0623687
   Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222
   Ferlemi AV, 2016, EXP EYE RES, V145, P258, DOI 10.1016/j.exer.2016.01.012
   Ferlemi AV, 2015, NEUROCHEM RES, V40, P2280, DOI 10.1007/s11064-015-1718-7
   Fernando P., 2007, COMPENDIO GEMMOTERAP
   Fraisse Didier, 1996, Annales Pharmaceutiques Francaises, V54, P280
   Gao RF, 2014, EUR J PHARMACOL, V729, P54, DOI 10.1016/j.ejphar.2014.01.015
   Geetha R., 2011, Int J Drug Dev Res, V3, P85
   Häkkinen SH, 1999, J AGR FOOD CHEM, V47, P2274, DOI 10.1021/jf9811065
   Halberstein RA, 2012, STUD NAT PROD CHEM, V37, P1, DOI 10.1016/B978-0-444-59514-0.00001-8
   Heaney RP, 2001, J NUTR, V131, p1344S, DOI 10.1093/jn/131.4.1344S
   Heinonen M, 2007, MOL NUTR FOOD RES, V51, P684, DOI 10.1002/mnfr.200700006
   Hokkanen J, 2009, J AGR FOOD CHEM, V57, P9437, DOI 10.1021/jf9022542
   HOLOPAINEN M, 1988, Acta Pharmaceutica Fennica, V97, P197
   Ieri F, 2013, PHYTOCHEM ANALYSIS, V24, P467, DOI 10.1002/pca.2462
   Jaakola L, 2004, PLANTA, V218, P721, DOI 10.1007/s00425-003-1161-x
   Ji LL, 2013, J NUTR BIOCHEM, V24, P1911, DOI 10.1016/j.jnutbio.2013.05.007
   Kim YH, 2007, J CELL BIOCHEM, V100, P998, DOI 10.1002/jcb.21098
   Lafay Sophie, 2008, Phytochemistry Reviews, V7, P301, DOI 10.1007/s11101-007-9077-x
   Larson AJ, 2012, ADV NUTR, V3, P39, DOI 10.3945/an.111.001271
   Lätti AK, 2010, J AGR FOOD CHEM, V58, P427, DOI 10.1021/jf903033m
   Lee HJ, 2012, INFLAMM RES, V61, P817, DOI 10.1007/s00011-012-0474-2
   Lee YK, 2009, EXP MOL MED, V41, P201, DOI 10.3858/emm.2009.41.3.023
   Lesjak M, 2018, J FUNCT FOODS, V40, P68, DOI 10.1016/j.jff.2017.10.047
   Li H, 2011, PHARMAZIE, V66, P306, DOI 10.1691/ph.2011.0785
   Liu PZ, 2014, J AGR FOOD CHEM, V62, P12015, DOI 10.1021/jf503521m
   Lou ZX, 2011, J FOOD SCI, V76, pM398, DOI 10.1111/j.1750-3841.2011.02213.x
   Määttä-Riihinen KR, 2004, J AGR FOOD CHEM, V52, P4477, DOI 10.1021/jf049595y
   Maciejczyk A, 2013, GINEKOL POL, V84, P590
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Marinova EM, 2009, FOOD CHEM, V114, P1498, DOI 10.1016/j.foodchem.2008.11.045
   Márquez-García B, 2009, BIORESOURCE TECHNOL, V100, P446, DOI 10.1016/j.biortech.2008.04.070
   Martins N, 2016, TRENDS FOOD SCI TECH, V48, P1, DOI 10.1016/j.tifs.2015.11.008
   Martz F, 2010, J CHEM ECOL, V36, P1017, DOI 10.1007/s10886-010-9836-9
   Moyer RA, 2002, J AGR FOOD CHEM, V50, P519, DOI 10.1021/jf011062r
   Nardini M, 2004, FOOD CHEM, V84, P137, DOI 10.1016/S0308-8146(03)00257-7
   Nguyen TTT, 2004, CARCINOGENESIS, V25, P647, DOI 10.1093/carcin/bgh052
   Olennikov DN, 2013, CHEM NAT COMPD+, V49, P1, DOI 10.1007/s10600-013-0491-6
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Oszmianski J, 2011, J AGR FOOD CHEM, V59, P12830, DOI 10.1021/jf203052j
   Panusa A, 2015, PHYTOCHEMISTRY, V115, P79, DOI 10.1016/j.phytochem.2015.01.002
   Parejo I, 2001, PHYTOCHEM ANALYSIS, V12, P336, DOI 10.1002/pca.602
   Pavlovic RD, 2009, PHARMAZIE, V64, P656, DOI 10.1691/ph.2009.9551
   Pervin M., 2013, Asian Pacific Journal of Tropical Disease, V3, P444
   Piljac-Zegarac J, 2009, J MED FOOD, V12, P608, DOI 10.1089/jmf.2008.0081
   Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d
   Ramachandran L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388702
   Raudone L, 2019, MOLECULES, V24, DOI 10.3390/molecules24050844
   Richard W., 2005, ENCY HUMAN NUTR
   Riihinen K, 2008, FOOD CHEM, V110, P156, DOI 10.1016/j.foodchem.2008.01.057
   Routray W, 2014, IND CROP PROD, V62, P147, DOI 10.1016/j.indcrop.2014.08.020
   Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010
   Sadowska B, 2014, ACTA BIOCHIM POL, V61, P163
   Saleem A, 2010, PHYTOCHEM ANALYSIS, V21, P328, DOI 10.1002/pca.1203
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Shahidi F, 2015, J FUNCT FOODS, V18, P820, DOI 10.1016/j.jff.2015.06.018
   Shan BE, 2009, CANCER INVEST, V27, P604, DOI 10.1080/07357900802337191
   Shi HY, 2009, EUR J PHARMACOL, V623, P119, DOI 10.1016/j.ejphar.2009.09.026
   Silva S, 2013, FOOD CONTROL, V34, P645, DOI 10.1016/j.foodcont.2013.06.012
   Stanoeva JP, 2017, INT J FOOD PROP, V20, pS863, DOI 10.1080/10942912.2017.1315592
   Su S, 2016, FOOD CONTROL, V64, P218, DOI 10.1016/j.foodcont.2016.01.006
   Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030
   Tai A, 2016, J AGR FOOD CHEM, V64, P7285, DOI 10.1021/acs.jafc.6b02847
   Takebayashi J, 2010, FREE RADICAL RES, V44, P473, DOI 10.3109/10715761003610760
   Taruscio TG, 2004, J AGR FOOD CHEM, V52, P3169, DOI 10.1021/jf0307595
   Tosovic J, 2017, FOOD CHEM, V237, P390, DOI 10.1016/j.foodchem.2017.05.080
   Vranjes M, 2016, J FUNCT FOODS, V21, P272, DOI 10.1016/j.jff.2015.12.016
   Vyas P, 2013, J AGR FOOD CHEM, V61, P7769, DOI 10.1021/jf401158a
   Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002
   Wang LJ, 2015, J FUNCT FOODS, V16, P295, DOI 10.1016/j.jff.2015.04.027
   Wang LJ, 2014, FOOD CHEM, V160, P357, DOI 10.1016/j.foodchem.2014.03.081
   Wang XJ, 2005, BIOL PHARM BULL, V28, P1106, DOI 10.1248/bpb.28.1106
   Wiczkowski W, 2014, J FUNCT FOODS, V11, P121, DOI 10.1016/j.jff.2014.09.013
   Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002
   Zhang X, 2010, INJURY, V41, P746, DOI 10.1016/j.injury.2010.02.029
   Zhu WY, 2008, J INVEST DERM SYMP P, V13, P20, DOI 10.1038/jidsymp.2008.8
NR 105
TC 76
Z9 77
U1 3
U2 39
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JUN 1
PY 2019
VL 24
IS 11
AR 2046
DI 10.3390/molecules24112046
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA IE8NT
UT WOS:000472631000019
PM 31146359
OA Green Published, Green Submitted, gold
DA 2025-04-28
ER

PT J
AU Cicero, AFG
   Fogacci, F
   Bove, M
   Giovannini, M
   Borghi, C
AF Cicero, Arrigo Francesco Giuseppe
   Fogacci, Federica
   Bove, Marilisa
   Giovannini, Marina
   Borghi, Claudio
TI Three-arm, placebo-controlled, randomized clinical trial evaluating the
   metabolic effect of a combined nutraceutical containing a bergamot
   standardized flavonoid extract in dyslipidemic overweight subjects
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE adipokines; bergamot; cholesterol; flavonoids; glucose
ID C-REACTIVE PROTEIN; PHARMACOLOGICAL RESEARCH; ADIPOKINES; METAANALYSIS;
   HYPERTENSION; ASSOCIATION; LEPTIN
AB Our double-blind, placebo-controlled, parallel-group, dose-escalation, clinical trial aimed to test the effect of a combined nutraceutical containing bergamot extract (120-mg flavonoids), phytosterols, vitamin C, and chlorogenic acid from dry artichoke extract on 90 overweight dyslipidemic subjects. Participants were randomly allocated to treatment with two pills of either active treatment or placebo, or a combination of both (a pill per treatment). After 8 weeks, all active-treated groups experienced a significant improvement in triglycerides (TG) versus placebo and in low-density lipoprotein cholesterol (LDL-C) versus baseline and placebo treatments. In the high-dose-treated group, also total cholesterol (TC), nonhigh-density lipoprotein cholesterol (non-HDL-C), gamma-glutamil transpeptidasi, high-sensitivity C-reactive protein (hs-CRP), and tumor necrosis factor-alpha (TNF-alpha) significantly decreased. At 24-week follow-up, TG levels maintained lower than baseline in all groups. All patients allocated to either low-dose or high-dose active treatment experienced a significant decrease in TG, LDL-C, and homeostatin model assessment of insulin resistance. In subjects taking high-dose active treatment, adiponectin significantly increased, whereas TC, non-HDL-C, insulin (fasting plasma insulin), leptin, leptin/adiponectin ratio, hs-CRP, and TNF-alpha were significantly reduced. The tested nutraceutical showed to improve lipid and glucose metabolism, adipokines pattern, and systemic inflammation in dyslipidemic overweight subjects.
C1 [Cicero, Arrigo Francesco Giuseppe; Fogacci, Federica; Bove, Marilisa; Giovannini, Marina; Borghi, Claudio] Univ Bologna, Dept Med & Surg Sci, Alma Mater Studiorum, Bologna, Italy.
C3 University of Bologna
RP Cicero, AFG (corresponding author), Univ Bologna, St Orsola Malpighi Hosp, Dept Med & Surg Sci, Atherosclerosis Res Unit, Via Albertoni,15, I-40138 Bologna, Italy.
EM arrigo.cicero@unibo.it
RI Cicero, Arrigo/H-8244-2019; Giovannini, Marina/ITV-5674-2023; Fogacci,
   Federica/R-5931-2016
OI Fogacci, Federica/0000-0001-7853-0042; Cicero, Arrigo Francesco
   Giuseppe/0000-0002-4367-3884
CR Andrew R, 2017, BRIT J PHARMACOL, V174, P1177, DOI 10.1111/bph.13779
   Bellou V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194127
   Blüher M, 2015, METABOLISM, V64, P131, DOI 10.1016/j.metabol.2014.10.016
   Bruno A, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00197
   Cicero AFG, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111666
   Cicero AFG, 2018, CURR PHARM DESIGN, V24, P178, DOI 10.2174/1381612824666171128110408
   Cicero AFG, 2018, INT J CARDIOL, V261, P204, DOI 10.1016/j.ijcard.2018.03.077
   Cicero AFG, 2018, EUR J INTERN MED, V53, P29, DOI 10.1016/j.ejim.2018.03.010
   Cicero AFG, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700373
   Cicero AFG, 2017, NUTR REV, V75, P731, DOI [10.5114/aoms.2017.69326, 10.1093/nutrit/nux047]
   Cicero AFG, 2017, HIGH BLOOD PRESS CAR, V24, P283, DOI 10.1007/s40292-017-0206-3
   De Vincentis A, 2017, CURR PHARM DESIGN, V23, P870, DOI 10.2174/1381612822666161006122934
   Ferlazzo N, 2016, MOLECULES, V21, DOI 10.3390/molecules21101273
   Grassmann S, 2017, OBESITY, V25, P1776, DOI 10.1002/oby.21945
   Hajavi J, 2017, J CELL BIOCHEM, V118, P4170, DOI 10.1002/jcb.26121
   Hunter PM, 2017, NAT REV ENDOCRINOL, V13, P278, DOI 10.1038/nrendo.2016.210
   Izzo AA, 2016, PHYTOTHER RES, V30, P691, DOI 10.1002/ptr.5591
   Kim DH, 2013, HYPERTENSION, V62, P27, DOI 10.1161/HYPERTENSIONAHA.113.01453
   López-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053
   Minuz P, 2017, BRIT J CLIN PHARMACO, V83, P5, DOI 10.1111/bcp.13142
   Patti AM, 2018, ARCH MED SCI, V14, P422, DOI 10.5114/aoms.2017.68717
   Perna S, 2019, FOOD SCI NUTR, V7, P369, DOI 10.1002/fsn3.903
   Pferschy-Wenzig EM, 2015, EPILEPSY BEHAV, V52, P344, DOI 10.1016/j.yebeh.2015.05.037
   Seven E, 2014, J HYPERTENS, V32, P1488, DOI 10.1097/HJH.0000000000000207
   Singh TP, 2017, EUR J VASC ENDOVASC, V54, P220, DOI 10.1016/j.ejvs.2017.05.009
   Spigoni V, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121328
   Toth PP, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00299
   Williams B, 2018, J HYPERTENS, V36, P2284, DOI [10.1097/HJH.0000000000001961, 10.1097/HJH.0000000000002026]
NR 28
TC 36
Z9 40
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD AUG
PY 2019
VL 33
IS 8
BP 2094
EP 2101
DI 10.1002/ptr.6402
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA IM6JS
UT WOS:000478099800015
PM 31225673
DA 2025-04-28
ER

PT J
AU Bekelmanh, TA
   Santarnaría-Ulloa, C
   Dufour, DL
AF Bekelmanh, Traci A.
   Santarnaria-Ulloa, Carolina
   Dufour, Darna L.
TI Variation in dietary intake and body fatness by socioeconomic status
   among women in the context of Costa Rican nutrition transitions
SO JOURNAL OF BIOSOCIAL SCIENCE
LA English
DT Article
DE Nutrition transition; Socioeconomic status; Latin America
ID MASS INDEX; FAST-FOOD; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; OBESITY;
   ADIPOSITY; URBAN; PATTERNS; TRENDS; ASSOCIATION
AB The Nutrition Transition model posits that vegetable oils, animal source foods (ASFs) and caloric sweeteners contribute to increases in adiposity and hence body mass index. Body mass index (BMI) is increasing more rapidly among Latin American populations of low versus high socioeconomic status (SES). The objectives of this study among Costa Rican women were to: (1) compare indicators of adiposity and dietary intake by SES and (2) evaluate the relationship between intake of foods high in vegetable oils, ASFs or caloric sweeteners and body fatness. This cross-sectional study, conducted in 2014-2015, included 128 low-, middle- and high-SES non-pregnant, non-lactating women aged between 25 and 45 years with 1-4 live births. Anthropometry was used to assess BMI, body composition and body fat distribution. Dietary recalls (n= 379) were used to assess dietary intake. Percentage body fat was greater in low- versus high-SES women (31.5 +/- 3.9 vs 28.2 +/- 4.7%). Skinfold measurements at four sites on the upper and lower body were greater in low- versus high-SES women. Body mass index did not vary in low- versus high-SES women. Intake frequency of foods high in vegetable oils was greater in low- and middle- (1.8 and 1.8 times/day, respectively) versus high- (1.1 times/day) SES women. For individual foods, intake frequency varied significantly by SES for high-fat condiments, fried vegetables, dairy, sweetened coffee/tea and pastries and desserts. Intake frequency of Nutrition Transition food categories was not associated with percentage body fat after adjustment for energy intake. Indicators of body composition provide additional information beyond BMI that are useful in understanding SES-adiposity associations in Latin America. Approaches to understanding diet and adiposity in Latin America that focus on vegetable oils, ASFs and caloric sweeteners should consider within-country variation in the pace of the Nutrition Transition, especially when explaining variation in adiposity by SES.
C1 [Bekelmanh, Traci A.] Univ Colorado, Dept Pediat, Sect Nutr, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Santarnaria-Ulloa, Carolina] Univ Costa Rica, Inst Invest Salud INISA, San Jose, Costa Rica.
   [Dufour, Darna L.] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; Universidad Costa Rica; University of Colorado System;
   University of Colorado Boulder
RP Bekelmanh, TA (corresponding author), Univ Colorado, Dept Pediat, Sect Nutr, Anschutz Med Campus, Aurora, CO 80045 USA.
EM Traci.Bekelman@ucdenver.edu
OI Bekelman, Traci/0000-0003-0840-1186
FU Wenner-Gren Foundation [8738]; NIH [T32 DK007658-27]
FX This work was supported by the Wenner-Gren Foundation under Dissertation
   Fieldwork Grant (#8738) and NIH T32 DK007658-27.
CR Aguilar-Farias N, 2018, INT J EPIDEMIOL, V47, P976, DOI 10.1093/ije/dyy033
   Albala C, 2002, PUBLIC HEALTH NUTR, V5, P123, DOI 10.1079/PHN2001283
   Amoateng AY, 2017, J BIOSOC SCI, V49, P187, DOI 10.1017/S0021932016000456
   [Anonymous], 2005, Principles of nutritional assessment
   [Anonymous], 2009, NATL NUTR SURVEY COS
   [Anonymous], 2009, ENC NAC NUTR
   [Anonymous], 2016, CHILD NEUROPSYCHOL, V13, P1
   [Anonymous], 2018, CURR OPIN TOXICOL
   [Anonymous], 2015, Body mass index - BMI
   Arps S, 2011, ANN HUM BIOL, V38, P508, DOI 10.3109/03014460.2011.564206
   Boissonnet C, 2011, EUR J CARDIOV PREV R, V18, P550, DOI 10.1177/1741826710389418
   Bojorquez I, 2015, APPETITE, V92, P43, DOI 10.1016/j.appet.2015.05.003
   Bouchard C, 2007, INT J OBESITY, V31, P1552, DOI 10.1038/sj.ijo.0803653
   Cantor A, 2013, ECOL FOOD NUTR, V52, P479, DOI 10.1080/03670244.2013.824360
   Cohen E, 2019, J BIOSOC SCI, V51, P469, DOI 10.1017/S0021932018000287
   Colón-Ramos U, 2007, PUBLIC HEALTH NUTR, V10, P1214, DOI 10.1017/S1368980007699571
   Cuevas Ada, 2009, Expert Rev Cardiovasc Ther, V7, P281, DOI 10.1586/14779072.7.3.281
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   Denova-Gutiérrez E, 2011, J NUTR, V141, P921, DOI 10.3945/jn.110.132332
   Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x
   Dressler WW, 2008, AM J HUM BIOL, V20, P15, DOI 10.1002/ajhb.20674
   Dufour DL, 2015, AM J HUM BIOL, V27, P106, DOI 10.1002/ajhb.22621
   DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070
   FAO, 2017, FAOSTAT DAT
   Flores M, 2010, J NUTR, V140, P1869, DOI 10.3945/jn.110.121533
   FRISANCHO AR, 1974, AM J CLIN NUTR, V27, P1052, DOI 10.1093/ajcn/27.8.1052
   Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733
   Heredia-Blonval K, 2014, APPETITE, V83, P173, DOI 10.1016/j.appet.2014.08.027
   Heymsfield SB, 2016, OBES REV, V17, P262, DOI 10.1111/obr.12358
   Himmelgreen DA, 2014, PHYSIOL BEHAV, V134, P76, DOI 10.1016/j.physbeh.2013.12.012
   Jeon H, 2015, PUBLIC HEALTH NUTR, V18, P3172, DOI 10.1017/S1368980015001640
   Kain Juliana, 2003, Cad. Saúde Pública, V19, pS77, DOI 10.1590/S0102-311X2003000700009
   Kulkarni B, 2014, NUTR REV, V72, P190, DOI 10.1111/nure.12097
   Lohmann T.G., 1988, ANTHROPOMETRIC STAND
   Camargo DM, 2018, J PHYS ACT HEALTH, V15, P581, DOI 10.1123/jpah.2017-0318
   Monge-Rojas R, 2013, NUTRITION, V29, P1007, DOI 10.1016/j.nut.2013.01.021
   Monteiro CA, 2000, EUR J CLIN NUTR, V54, P342, DOI 10.1038/sj.ejcn.1600960
   Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5
   Olszowy KM, 2012, AM J HUM BIOL, V24, P602, DOI 10.1002/ajhb.22280
   Pérez-Cueto FJA, 2006, BRIT J NUTR, V95, P555, DOI 10.1079/BJN20051661
   Poggio R, 2016, GLOB HEART, V11, P81, DOI 10.1016/j.gheart.2015.12.013
   Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694
   Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289
   Popkin BM, 2012, TRENDS ENDOCRIN MET, V23, P591, DOI 10.1016/j.tem.2012.07.003
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x
   Rhee JJ, 2012, PUBLIC HEALTH NUTR, V15, P1347, DOI 10.1017/S1368980012001000
   Rivera JA, 2002, PUBLIC HEALTH NUTR, V5, P113, DOI 10.1079/PHN2001282
   Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI [10.1093/eurheartj/ehn347, 10.1093/eurheartj/ehp487]
   Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038
   SIRI W E, 1956, Adv Biol Med Phys, V4, P239
   Stalsberg R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15050922
   Uauy Ricardo, 2004, Food and Nutrition Bulletin, V25, P175
   United Nations Development Program, 2013, INF NAC DES HUM 2013
   van ME, 2017, PEDIAT PHYS THER S3, V29, pS73
   Vio F, 2008, PUBLIC HEALTH NUTR, V11, P405, DOI 10.1017/S136898000700050X
   Wang Z, 2017, EUR J CLIN NUTR, V71, P486, DOI 10.1038/ejcn.2016.179
   Wong-McClure R, 2016, J DIABETES, V8, P686, DOI 10.1111/1753-0407.12348
NR 58
TC 7
Z9 8
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0021-9320
EI 1469-7599
J9 J BIOSOC SCI
JI J. Biosoc. Sci.
PD MAR
PY 2020
VL 52
IS 2
BP 230
EP 247
AR PII S0021932019000403
DI 10.1017/S0021932019000403
PG 18
WC Demography; Public, Environmental & Occupational Health; Social
   Sciences, Biomedical
WE Social Science Citation Index (SSCI)
SC Demography; Public, Environmental & Occupational Health; Biomedical
   Social Sciences
GA ME4UP
UT WOS:000544652000006
PM 31218982
OA Green Published, Green Submitted, Green Accepted
DA 2025-04-28
ER

PT J
AU Li, H
   Park, HM
   Ji, HS
   Han, J
   Kim, SK
   Park, HY
   Jeong, TS
AF Li, Hua
   Park, Hye-Mi
   Ji, Hyeon-Seon
   Han, Jisu
   Kim, Sang-Kyum
   Park, Ho-Yong
   Jeong, Tae-Sook
TI Phenolic-enriched blueberry-leaf extract attenuates glucose homeostasis,
   pancreatic β-cell function, and insulin sensitivity in high-fat
   diet-induced diabetic mice
SO NUTRITION RESEARCH
LA English
DT Article
DE Blueberry-leaf extract; Chlorogenic acid; Hyperglycemia; Pancreatic
   beta-cell; Insulin sensitivity
ID ASHEI-READE LEAVES; CHLOROGENIC ACID; IN-VIVO; ILEX-PARAGUARIENSIS;
   LIPID-METABOLISM; RESISTANCE; MECHANISMS; PROLIFERATION; ANTIOXIDANT;
   GLYCOSIDES
AB Blueberry fruit exhibits strong antioxidant activity owing to the presence of anthocyanin. As blueberry-leaf extract (BLE) contains chlorogenic acid and flavonol glycosides, we hypothesized that phenolic-enriched BLE would improve glucose homeostasis and insulin sensitivity. In this study, we examined whether BLE administration decreases the glucose levels and enhances the pancreatic function in mice with high-fat diet (HFD)-induced obesity and diabetes. C57BL/6J mice were divided into the following four groups: control diet (CD), HFD (60 kcal% fat diet), BLE (HFD with 1% BLE wt/wt diet), and yerba mate extract (YME; HFD with 0.5% YME wt/wt diet). Dietary BLE and YME reduced glucose tolerance, body weight, and plasma glucose, glycated hemoglobin, insulin, homeostasis model assessment of insulin resistance, triglyceride (TG), and non-esterified fatty acid levels. Compared with those of the HFD group, BLE was found to significantly reduce the pancreatic islet size and insulin content. Moreover, it increased the mRNA levels of pancreatic beta-cell proliferation related genes, Ngn3, MafA, Pax4, Ins1, and Ins2, and pancreatic insulin signaling-related genes, IRS-1, IRS-2, PIK3ca, PDK1, PKC epsilon, and GLUT-2, and decreased the transcriptional expression of the beta-cell apoptosis-related gene, FoxO1. Both BLE and YME improved insulin sensitivity by inhibiting TG synthesis and enhancing lipid utilization in the liver and white adipose tissue (WAT). In pancreatic MIN6 beta-cells, BLE and its main component (chlorogenic acid) increased beta-cell proliferation and promoted insulin signaling. Overall, BLE enriched with phenolic compounds has the capacity to prevent HFD-induced glucose tolerance and hyperglycemia by improving the pancreatic beta-cell function. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Li, Hua; Park, Hye-Mi; Ji, Hyeon-Seon; Han, Jisu; Park, Ho-Yong; Jeong, Tae-Sook] Korea Res Inst Biosci & Biotechnol, Ind Biomat Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea.
   [Han, Jisu; Kim, Sang-Kyum] Chungnam Natl Univ, Coll Pharm, Daejeon 34134, South Korea.
C3 Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam
   National University
RP Jeong, TS (corresponding author), Korea Res Inst Biosci & Biotechnol, Ind Biomat Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea.
EM leewhua@naver.com; hyemi0707@nate.com; gustjs1693@naver.com;
   hanjs@kribb.re.kr; sangkim@cnu.ac.kr; hypark@kribb.re.kr;
   tsjeong@kribb.re.kr
RI Kim, Jung Oh/JDC-5061-2023; PARK, HO-YONG/AAP-2225-2021
OI Lee, Hwa/0000-0003-3429-3916
FU Bio & Medical Technology Development Program of the National Research
   Foundation (NRF) [2016 K1A1A8A01938885]; Creative Allied Project of the
   National Research Council of Science & Technology (NST) grant by the
   Korea government (MSIT) [CAP-18-06-KRIBB]
FX This work was supported by the Bio & Medical Technology Development
   Program (2016 K1A1A8A01938885) of the National Research Foundation
   (NRF)and the Creative Allied Project (CAP-18-06-KRIBB) of the National
   Research Council of Science & Technology (NST) grant by the Korea
   government (MSIT). The authors have declared no conflict of interest.
CR Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   Bagchi D, 2004, BIOCHEMISTRY-MOSCOW+, V69, P75, DOI 10.1023/B:BIRY.0000016355.19999.93
   Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569
   Ben-Othman N, 2013, DIABETES RES CLIN PR, V101, P1, DOI 10.1016/j.diabres.2013.01.013
   Breneman CB, 2013, BRIT J NUTR, V110, P375, DOI 10.1017/S0007114512004953
   Cignarella A, 1996, THROMB RES, V84, P311, DOI 10.1016/S0049-3848(96)00195-8
   Courtney M, 2011, DIABETES OBES METAB, V13, P47, DOI 10.1111/j.1463-1326.2011.01441.x
   Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275
   Fall CHD, 2001, BRIT MED BULL, V60, P33, DOI 10.1093/bmb/60.1.33
   Ferlemi AV, 2016, EXP EYE RES, V145, P258, DOI 10.1016/j.exer.2016.01.012
   Ghorbani A, 2017, BIOMED PHARMACOTHER, V96, P305, DOI 10.1016/j.biopha.2017.10.001
   Han XX, 2019, BIOMED PHARMACOTHER, V110, P561, DOI 10.1016/j.biopha.2018.12.012
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Hostetler GL, 2017, ADV NUTR, V8, P423, DOI 10.3945/an.116.012948
   Huang XL, 2017, ONCOTARGET, V8
   Jayachandran M, 2018, EUR J PHARMACOL, V829, P112, DOI 10.1016/j.ejphar.2018.04.015
   Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009
   Kaneto H, 2015, INT J MOL SCI, V16, P6281, DOI 10.3390/ijms16036281
   Kang Young-Rye, 2012, Lab Anim Res, V28, P23, DOI 10.5625/lar.2012.28.1.23
   Kim SM, 2010, PHYTOCHEM ANALYSIS, V21, P457, DOI 10.1002/pca.1218
   Kitao N, 2018, METABOLISM, V85, P48, DOI 10.1016/j.metabol.2018.03.010
   Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880
   Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481
   Lee In-Chul, 2014, J Cancer Prev, V19, P209, DOI 10.15430/JCP.2014.19.3.209
   Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530
   Li H, 2019, J AGR FOOD CHEM, V67, P90, DOI 10.1021/acs.jafc.8b04527
   Li H, 2015, J AGR FOOD CHEM, V63, P7198, DOI 10.1021/acs.jafc.5b01639
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Martineau LC, 2006, PHYTOMEDICINE, V13, P612, DOI 10.1016/j.phymed.2006.08.005
   Menini T, 2007, PLANTA MED, V73, P1141, DOI 10.1055/s-2007-981585
   Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102
   Nagao K, 2008, BIOSCI BIOTECH BIOCH, V72, P1619, DOI 10.1271/bbb.80036
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Ravussin E, 2002, ANN NY ACAD SCI, V967, P363
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X
   Swales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037055
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Vasavada RC, 2007, DIABETES, V56, P2732, DOI 10.2337/db07-0461
   Verma N, 2013, INDIAN J EXP BIOL, V51, P65
   Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231
   White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001
   Wu Y, 2018, INT J FOOD SCI NUTR, V69, P566, DOI 10.1080/09637486.2017.1394449
   Yuji K, 2013, J OLEO SCI, V62, P89, DOI 10.5650/jos.62.89
   Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314
NR 47
TC 37
Z9 41
U1 5
U2 41
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
J9 NUTR RES
JI Nutr. Res.
PD JAN
PY 2020
VL 73
BP 83
EP 96
DI 10.1016/j.nutres.2019.09.005
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KQ4HA
UT WOS:000516884500009
PM 31923607
DA 2025-04-28
ER

PT J
AU Abdel-Mohsen, DM
   Akabawy, AMA
   El-Khadragy, MF
   Moneim, AA
   Amin, HK
AF Abdel-Mohsen, Doaa M.
   Akabawy, Ahmed M. A.
   El-Khadragy, Manal F.
   Moneim, Ahmed Abdel E.
   Amin, Hatem K.
TI Green Coffee Bean Extract Potentially Ameliorates Liver Injury due to
   HFD/STZ-Induced Diabetes in Rats
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article
ID HIGH-FAT-DIET; OXIDATIVE STRESS; CHLOROGENIC ACID; INSULIN-RESISTANCE;
   TYPE-2; EXPRESSION; OBESITY; TISSUE; MODEL; COMPLICATIONS
AB The goal of the current study was to examine the therapeutic potential of green coffee bean extract (GCBE) in the treatment of diabetic hepatic damage induced by high-fat diet (HFD) and streptozotocin (STZ) administration. The novelty of this study lies in constructing a newly stabilized in vivo obese diabetic animal model in rats using HFD/STZ for investigating the dose-dependent effect of two commonly used doses of GCBE in hepatoprotection against oxidative stress-induced hepatic damage by measuring many parameters that have not been carried out previously in other studies. GCBE that was used in this study was a hot water extract of green coffee beans with a concentration of 0.1 g ml(-1). Male albino rats were given a single dose of STZ (35 mg kg(-1)), and HFD to induce diabetes mellitus (DM). For 28 days, two separate doses of GCBE 50 mg kg(-1) and 100 mg kg(-1) were administered orally to diabetic animals. Leptin, liver enzymes, oxidative stress parameters, inflammatory parameters, fasting plasma glucose (FPG), fasting plasma insulin (FPI), and lipid profile levels were examined. Real-time PCR and ELISA were used to quantitatively detect the mRNAs of the genes involved in the insulin signaling pathway, the genes involved in glucose metabolism, and the amounts of proteins. The levels of FPG, lipid profile, liver enzymes, inflammatory markers, and leptin in the HFD/STZ diabetic group revealed a considerable spike, while they considerably decreased after GCBE treatment in a dose-dependent manner. After GCBE treatment, the diabetic group showed a significant rise in the antioxidant markers glutathione, superoxide dismutase, and catalase, as well as a decrease in malondialdehyde and nitric oxide levels. The liver changes caused by HFD/STZ were entirely reversed by GCBE, and most intriguingly, in a dose-dependent manner. We concluded that GCBE can repair the hepatic oxidative damage caused by HFD and STZ by reversing all the previously measured parameters and improving the insulin signaling pathways. GCBE demonstrated strong antifree radical activity and significantly protected cells from oxidative damage caused by HFD/STZ.
C1 [Abdel-Mohsen, Doaa M.; Akabawy, Ahmed M. A.] Helwan Univ, Fac Pharm, Dept Biochem & Mol Biol, Cairo, Egypt.
   [El-Khadragy, Manal F.] Princess Nourah bint Abdulrahman Univ, Coll Sci, Dept Biol, POB 84428, Riyadh 11671, Saudi Arabia.
   [Moneim, Ahmed Abdel E.] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt.
   [Amin, Hatem K.] Galala Univ, Fac Pharm, Biochem Dept, El Galala, Egypt.
C3 Egyptian Knowledge Bank (EKB); Helwan University; Princess Nourah bint
   Abdulrahman University; Egyptian Knowledge Bank (EKB); Helwan
   University; Galala University
RP El-Khadragy, MF (corresponding author), Princess Nourah bint Abdulrahman Univ, Coll Sci, Dept Biol, POB 84428, Riyadh 11671, Saudi Arabia.
EM do3a_mm@yahoo.com; dr.ahmed_moh@pharm.helwan.edu.eg;
   mfelkhadragy@pnu.edu.sa; aest1977@hotmail.com; hatem.amin@gu.edu.eg
RI mohsen, dr dodo/JEF-6820-2023; Amin, Hatem/AAB-4554-2019; Moneim,
   Ahmed/C-7461-2012; Akabawy, Ahmed Mohammed Abd El-Mohsin
   Mahmoud/JPL-1102-2023
OI Abdel Moneim, Ahmed/0000-0002-2654-2591; Akabawy, Ahmed Mohammed Abd
   El-Mohsin Mahmoud/0000-0002-5737-1166
FU Princess Nourah bint Abdulrahman University Researchers Supporting
   Project, Princess Nourah bint Abdulrahman University, Riyadh, Saudi
   Arabia [PNURSP2023R23]
FX This research was funded by Princess Nourah bint Abdulrahman University
   Researchers Supporting Project number (PNURSP2023R23), Princess Nourah
   bint Abdulrahman University, Riyadh, Saudi Arabia.
CR Abdelmageed ME, 2019, N-S ARCH PHARMACOL, V392, P243, DOI 10.1007/s00210-018-1583-4
   Abdollahi M, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/5318245
   Abouzid MR, 2022, CUREUS J MED SCIENCE, V14, DOI 10.7759/cureus.27066
   Abulizi A, 2020, CELL METAB, V32, P751, DOI 10.1016/j.cmet.2020.10.006
   Achi NK, 2017, BIOMED PHARMACOTHER, V86, P562, DOI 10.1016/j.biopha.2016.11.133
   Adeyemi O. T., 2015, Advances in Bioscience and Biotechnology, V6, P139, DOI 10.4236/abb.2015.63014
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Al-Brakati A, 2020, METAB BRAIN DIS, V35, P1175, DOI 10.1007/s11011-020-00583-6
   AlAmri OD, 2020, J FUNCT FOODS, V71, DOI 10.1016/j.jff.2020.103996
   Ali TM, 2020, AM J MED SCI, V359, P32, DOI 10.1016/j.amjms.2019.10.005
   Ansley DM, 2013, J PATHOL, V229, P232, DOI 10.1002/path.4113
   Arbe MF, 2020, TRANSL ONCOL, V13, DOI 10.1016/j.tranon.2020.100842
   Chaves NA, 2019, FREE RADICAL BIO MED, V141, P34, DOI 10.1016/j.freeradbiomed.2019.05.034
   Chen LH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040503
   Cheng DY, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/162724
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Chung W, 2016, J TRADIT CHIN MED, V36, P291, DOI 10.1016/S0254-6272(16)30040-1
   Ciardullo S, 2022, DIABETES RES CLIN PR, V190, DOI 10.1016/j.diabres.2022.109981
   Costabile A, 2018, J FUNCT FOODS, V45, P409, DOI 10.1016/j.jff.2018.04.011
   Dewidar B, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154299
   Dey A, 2009, CURR DIABETES REV, V5, P67, DOI 10.2174/157339909788166864
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Farhood HB, 2019, ROM BIOTECH LETT, V24, P301, DOI 10.25083/rbl/24.2/301.307
   Fernandes SM, 2016, ARCH ENDOCRIN METAB, V60, P443, DOI 10.1590/2359-3997000000188
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Guo XX, 2018, J ZHEJIANG UNIV-SC B, V19, P559, DOI [10.1631/jzus.B1700254, 10.1631/jzus.b1700254]
   Haile TG, 2023, INT HEALTH, V15, P235, DOI 10.1093/inthealth/ihac060
   Hegazi R, 2015, ANN GLOB HEALTH, V81, P814, DOI 10.1016/j.aogh.2015.12.011
   Hosseinabadi S, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2019.102290
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Igunnu A., 2020, NIGERIAN J PURE APPL, V32, P3324
   Ismail TA, 2015, EXP THER MED, V9, P1921, DOI 10.3892/etm.2015.2354
   Jeszka-Skowron M, 2016, EUR FOOD RES TECHNOL, V242, P1403, DOI 10.1007/s00217-016-2643-y
   Jiang MH, 2011, ENDOCRINOLOGY, V152, P1284, DOI 10.1210/en.2010-1162
   Jung JY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-18
   Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184
   Venkatakrishna K, 2021, SAGE OPEN MED, V9, DOI 10.1177/2050312120984885
   Lachine NA, 2019, CLIN DIABETOL, V8, P154, DOI 10.5603/DK.2019.0010
   Lewandowski SL, 2020, CELL METAB, V32, P736, DOI 10.1016/j.cmet.2020.10.007
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu B, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.033316
   Lukitasari M, 2020, J ADV PHARM TECHNOL, V11, P81, DOI 10.4103/japtr.JAPTR_116_19
   Maiti Soumyajit, 2013, J Nat Sci Biol Med, V4, P68, DOI 10.4103/0976-9668.107263
   Matough Fatmah A, 2012, Sultan Qaboos Univ Med J, V12, P5
   Melendez-Ramirez LY, 2010, ENDOCRIN METAB CLIN, V39, P625, DOI 10.1016/j.ecl.2010.05.009
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Meshkani Mehrnoush, 2022, Clin Nutr Res, V11, P241, DOI 10.7762/cnr.2022.11.4.241
   Mohamed Jamaludin, 2016, Sultan Qaboos Univ Med J, V16, pe132, DOI 10.18295/squmj.2016.16.02.002
   Murtaza G, 2019, PROG CARDIOVASC DIS, V62, P315, DOI 10.1016/j.pcad.2019.03.003
   Nakamura A, 2021, DIABETES OBES METAB, V23, P2199, DOI 10.1111/dom.14459
   Newsholme EA, 2001, EXP CLIN ENDOCR DIAB, V109, pS122, DOI 10.1055/s-2001-18575
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   Nikpayam O, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0489-8
   NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3
   Nna VU, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100465
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ramesh N., 2017, GLOB J OBES DIABETES, V4, P054, DOI [10.17352/2455-8583.000024, DOI 10.17352/2455-8583.000024]
   Ren CJ, 2015, INT J BIOL MACROMOL, V72, P951, DOI 10.1016/j.ijbiomac.2014.09.060
   Rice S, 2011, J CLIN ENDOCR METAB, V96, pE427, DOI 10.1210/jc.2010-2060
   Seliem EM, 2022, LIFE-BASEL, V12, DOI 10.3390/life12050693
   Serin E, 2003, J GASTROENTEROL, V38, P471, DOI 10.1007/s00535-002-1084-5
   Shahwan M, 2022, INT J BIOL MACROMOL, V206, P567, DOI 10.1016/j.ijbiomac.2022.03.004
   Suwitheechon OU, 2021, AM J VET RES, V82, P110, DOI 10.2460/ajvr.82.2.110
   Tan GD, 2005, DIABETOLOGIA, V48, P1585, DOI 10.1007/s00125-005-1835-y
   Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456
   Vatandoust Nasimeh, 2018, Adv Biomed Res, V7, P107, DOI 10.4103/abr.abr_8_17
   Vats A., 2022, J INSECT PHYSIOL, V11, P2970
   Vela-Guajardo JE, 2021, CURR DIABETES REV, V17, DOI 10.2174/1573399816666201103142102
   Vieira AJSC, 2020, RADIAT PHYS CHEM, V174, DOI 10.1016/j.radphyschem.2020.108968
   Vitaglione P, 2004, CRIT REV FOOD SCI, V44, P575, DOI 10.1080/10408690490911701
   Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224
   Wei F., 2015, Coffee in Health and Disease Prevention, P149, DOI DOI 10.1016/B978-0-12-409517-5.00017-6
   Xu DM, 2014, ENVIRON TOXICOL PHAR, V37, P1212, DOI 10.1016/j.etap.2014.04.022
   Yan YW, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/9680508
   Yazdi HB, 2019, J PHARMACOPUNCT, V22, P109, DOI 10.3831/KPI.2019.22.014
   Zaheri Z, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.103430
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zhuo JC, 2018, MOL MED REP, V17, P5132, DOI 10.3892/mmr.2018.8504
NR 79
TC 5
Z9 5
U1 1
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD FEB 8
PY 2023
VL 2023
AR 1500032
DI 10.1155/2023/1500032
PG 16
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 9B3VB
UT WOS:000934667000002
OA hybrid
DA 2025-04-28
ER

PT J
AU Rasaei, N
   Ghaffarian-Ensaf, R
   Gholami, F
   Shiraseb, F
   Khadem, A
   Fatemi, SF
   Mirzaei, K
AF Rasaei, Niloufar
   Ghaffarian-Ensaf, Rasool
   Gholami, Fatemeh
   Shiraseb, Farideh
   Khadem, Alireza
   Fatemi, Seyedeh Fatemeh
   Mirzaei, Khadijeh
TI The association between healthy beverage index and sarcopenic obesity
   among women with overweight and obesity: a cross-sectional study
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Healthy beverage index; Sarcopenic obesity; Obesity and Overweight
ID SUGAR-SWEETENED BEVERAGES; KOREA NATIONAL-HEALTH; COFFEE CONSUMPTION;
   OLDER-ADULTS; INSULIN-RESISTANCE; DIETARY PATTERNS; INFLAMMATION;
   AUTOPHAGY; CAROTENOIDS; WEIGHT
AB IntroductionSarcopenic obesity is related to changes in body composition, loss of muscle mass, and raised adipose tissue. Beverage patterns are effective with changes in health status. Therefore, the aim of this study was to investigate the association between sarcopenic obesity (SO) and the healthy beverage index (HBI) in women with overweight and obesity.MethodsThis cross-sectional study conducted on 210 overweight and obese (BMI >= 25 kg/m(2)) women aged 18-56 years. The measurement of skeletal muscle mass (SMM) and fat mass (FM) done by bioelectric impedance analyzer (BIA) (Inbody Co., Seoul, Korea) based on guidelines. The two lowest quintiles SMM and the two highest quintiles FM and body mass index (BMI) >= 30 are considered sarcopenic obesity in women. A validated and reliable semi-quantitative food-frequency questionnaire (FFQ) was used to evaluate the beverage dietary data. and RFS and NRFS was calculated. Biochemical assessments were quantified by standard approaches, and physical activity were evaluated by international physical activity questionnaire (IPAQ).ResultIn this cross-sectional study, 210 overweight and obese females took part (18-56) years old). The studies were carried out using binary logistic regression. After controlling for a wide variety of confounding variables such as age, energy intake, physical activity, education, and economic status, we found a negative association between HBI and risk of SO (OR = 0.29, 95% CI = 0.35 to 1.01, P = 0.05).ConclusionWe observed that the odds of SO was reduced by 69% in participants with higher HBI score. More well-designed studies need to confirm our findings.
C1 [Rasaei, Niloufar; Gholami, Fatemeh; Shiraseb, Farideh; Fatemi, Seyedeh Fatemeh; Mirzaei, Khadijeh] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, POB 14155-6117, Tehran, Iran.
   [Ghaffarian-Ensaf, Rasool; Khadem, Alireza] Islamic Azad Univ, Dept Nutr, Sci & Res Branch, Tehran, Iran.
   [Mirzaei, Khadijeh] Univ Tehran Med Sci, Food Microbiol Res Ctr, Tehran, Iran.
C3 Tehran University of Medical Sciences; Islamic Azad University; Tehran
   University of Medical Sciences
RP Mirzaei, K (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, POB 14155-6117, Tehran, Iran.; Mirzaei, K (corresponding author), Univ Tehran Med Sci, Food Microbiol Res Ctr, Tehran, Iran.
EM mirzaei_kh@tums.ac.ir
RI Mirzaei, Khadijeh/D-5408-2018; Fatemi, SeyedehFatemeh/JWP-2180-2024;
   Ghaffarian-Ensaf, Rasool/HJG-9268-2022; Shiraseb, F/AAQ-7384-2020
OI Fatemi, Seyedeh Fatemeh/0000-0002-8387-308X; Ghaffarian-Ensaf,
   Rasool/0000-0003-1291-1525
CR Aeberli I, 2011, AM J CLIN NUTR, V94, P479, DOI 10.3945/ajcn.111.013540
   Astorino TA, 2008, EUR J APPL PHYSIOL, V102, P127, DOI 10.1007/s00421-007-0557-x
   Barzilay JI, 2007, ARCH INTERN MED, V167, P635, DOI 10.1001/archinte.167.7.635
   Bauer JM, 2015, J AM MED DIR ASSOC, V16, P740, DOI 10.1016/j.jamda.2015.05.021
   Cespedes EM, 2015, AM J CLIN NUTR, V101, P899, DOI 10.3945/ajcn.115.110213
   Chapman MA, 2016, DIFFERENTIATION, V92, P108, DOI 10.1016/j.diff.2016.05.007
   Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   Chung H, 2017, KOREAN J FAM MED, V38, P141, DOI 10.4082/kjfm.2017.38.3.141
   Cleasby ME, 2016, J ENDOCRINOL, V229, pR67, DOI 10.1530/JOE-15-0533
   Cuesta-Triana F, 2019, ADV NUTR, V10, pS105, DOI 10.1093/advances/nmy105
   Daskalopoulou C., 2020, SCI REP-UK, V10, P1
   Du Y, 2019, J OBES METAB SYNDR, V28, P167, DOI 10.7570/jomes.2019.28.3.167
   Duffey KJ, 2015, J ACAD NUTR DIET, V115, P1682, DOI 10.1016/j.jand.2015.05.005
   Garmaroudi GR., 2010, Payesh (Health Monitor), V9, P137
   Gatineau E, 2017, NUTR RES REV, V30, P191, DOI 10.1017/S0954422417000051
   Granic A, 2020, CLIN INTERV AGING, V15, P695, DOI 10.2147/CIA.S245595
   Grgic J, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0216-0
   Hanach NI, 2019, ADV NUTR, V10, P59, DOI 10.1093/advances/nmy065
   Hao G, 2019, PEDIATR OBES, V14, DOI 10.1111/ijpo.12471
   Hasnain SR, 2014, CHILD OBES, V10, P42, DOI 10.1089/chi.2013.0004
   Hedrick V. E., 2015, Current Nutrition Reports, V4, P72
   Hedrick VE, 2015, NUTRIENTS, V7, P10168, DOI 10.3390/nu7125525
   Iwasaka C, 2021, GERIATR GERONTOL INT, V21, P950, DOI 10.1111/ggi.14264
   Kim H, 2013, GERIATR GERONTOL INT, V13, P458, DOI 10.1111/j.1447-0594.2012.00923.x
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   Kim J, 2015, AGE AGEING, V44, P96, DOI 10.1093/ageing/afu028
   Krebs-Smith SM, 2018, J ACAD NUTR DIET, V118, P1591, DOI 10.1016/j.jand.2018.05.021
   Laclaustra M, 2018, AM J CLIN NUTR, V107, P772, DOI 10.1093/ajcn/nqy028
   Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Lewis LN, 2020, J NUTR, V150, P2789, DOI 10.1093/jn/nxaa221
   Lim Hee-Sook, 2020, J Bone Metab, V27, P143, DOI 10.11005/jbm.2020.27.2.143
   Lin WT, 2020, INT J PUBLIC HEALTH, V65, P45, DOI 10.1007/s00038-020-01330-5
   Luger M, 2017, OBESITY FACTS, V10, P674, DOI 10.1159/000484566
   Magriplis E, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8080676
   Mirzaei K, 2019, Osteoporosis international
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Moghaddam MB., 2012, WORLD APPL SCI J, V18, P1073, DOI DOI 10.5829/IDOSI.WASJ.2012.18.08.754
   Newton KO, 2019, THESIS MIAMI U
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Oh S., 2016, KOREAN J FAM PRACT, V6, P598
   Pallauf K, 2013, AGEING RES REV, V12, P237, DOI 10.1016/j.arr.2012.03.008
   Pietrocola F, 2014, CELL CYCLE, V13, P1987, DOI 10.4161/cc.28929
   Rasaei N, ASS HLTH BEVERAGE IN
   Rasaei N, 2019, OSTEOPOROSIS INT
   Rasaei N., 2022, ASS HLTH BEVERAGE IN
   Rasaei N, 2019, DIABETES METAB SYND, V13, P2519, DOI 10.1016/j.dsx.2019.06.023
   REBOUCHE CJ, 1991, AM J CLIN NUTR, V54, pS1147, DOI 10.1093/ajcn/54.6.1147s
   Rezazadeh A, 2020, EPIDEMIOL HEALTH, V42
   Rizzoli R, 2013, CALCIFIED TISSUE INT, V93, P101, DOI 10.1007/s00223-013-9758-y
   Rosenberg IH, 2011, CLIN GERIATR MED, V27, P337, DOI 10.1016/j.cger.2011.03.003
   Ruanpeng D, 2017, QJM-INT J MED, V110, P513, DOI 10.1093/qjmed/hcx068
   Ryan MJ, 2010, EXP GERONTOL, V45, P882, DOI 10.1016/j.exger.2010.08.002
   Sane Rohit M., 2019, Journal of Basic and Clinical Physiology and Pharmacology, V30, P20180119, DOI 10.1515/jbcpp-2018-0119
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sayon-Orea C, 2011, NUTR REV, V69, P419, DOI 10.1111/j.1753-4887.2011.00403.x
   Semba RD, 2007, ARCH BIOCHEM BIOPHYS, V458, P141, DOI 10.1016/j.abb.2006.11.025
   SIES H, 1995, AM J CLIN NUTR, V62, P1315
   Sorensen LB, 2005, AM J CLIN NUTR, V82, P421, DOI 10.1093/ajcn/82.2.421
   Steffl M, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0270-x
   Sukenobe Y, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0525-0
   Takisawa S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41229-7
   U.S. Department of Health and Human Services and U.S. Department of Agriculture, 2015, 20152020 dietary guidelines for Americans
   Vadala M., 2016, INT J SPORTS EXERC M, V2, P46
   Veronese N, 2019, AGEING RES REV, V51, P48, DOI 10.1016/j.arr.2019.02.005
   Welch AA, 2013, OSTEOPOROSIS INT, V24, P1899, DOI 10.1007/s00198-012-2203-7
   Welch AA, 2014, P NUTR SOC, V73, P16, DOI 10.1017/S0029665113003698
   Wu HM, 2020, INT J FOOD SCI NUTR, V71, P856, DOI 10.1080/09637486.2020.1734544
   Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002
   Zhang T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041015
NR 70
TC 3
Z9 3
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD JAN 31
PY 2023
VL 23
IS 1
AR 25
DI 10.1186/s12902-023-01274-w
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 8L5MG
UT WOS:000923825700002
PM 36717830
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Juju, DB
   Sekiyama, M
   Saito, O
AF Juju, Denabo Billo
   Sekiyama, Makiko
   Saito, Osamu
TI Food Security of Adolescents in Selected Khat- and Coffee-Growing Areas
   in the Sidama Zone, Southern Ethiopia
SO NUTRIENTS
LA English
DT Article
DE adolescents; food security; stunting; thinness; khat; coffee; Ethiopia
ID NUTRITIONAL-STATUS; HEALTH; PREVALENCE; EXPANSION; THINNESS; IMPACT;
   TRADE
AB Whilst pervasive food insecurity exists among adolescents in Ethiopia, the available information is scant and inconsistent. Therefore, the main objective of this cross-sectional study was to contribute to these gaps by assessing the food security of adolescents in the selected khat- and coffee-growing areas. We selected 234 (117 girls and 117 boys) adolescents aged 12-18 years via stratified random sampling. We measured the height and weight of the adolescents and asked about their food insecurity experiences. We assessed the prevalence of stunting and thinness using the WHO 2007 growth reference standards. Out of the total, 17 (7.3%) and 30 (12.8%) adolescents were stunted and thin, respectively. In addition, 89 (38.0%) adolescents reported food insecurity experiences and nine (3.8%) were overweight. A regression analyses showed that the stunting was associated with the age of the adolescents and maternal education. Thinness was associated with area, gender, and the number of meals. Food insecurity experiences were associated with health problems in the past 30 days. In general, adolescents from the khat-growing area have better food security than those from the coffee-growing area, and the same is true, gender-wise, for girls compared to boys. We recommend possible interventions primarily for adolescents in coffee-growing areas.
C1 [Juju, Denabo Billo; Saito, Osamu] United Nations Univ, Inst Adv Study Sustainabil, Tokyo 1508925, Japan.
   [Sekiyama, Makiko] Natl Inst Environm Studies, Tsukuba, Ibaraki 3050053, Japan.
C3 United Nations University; National Institute for Environmental Studies
   - Japan
RP Saito, O (corresponding author), United Nations Univ, Inst Adv Study Sustainabil, Tokyo 1508925, Japan.
EM juju@student.unu.edu; sekiyama.makiko@nies.go.jp; saito@unu.edu
RI Sekiyama, Makiko/U-3922-2019; Saito, Osamu/AAH-6091-2020; Saito,
   Osamu/G-5133-2014
OI Sekiyama, Makiko/0000-0002-2104-9140; Saito, Osamu/0000-0002-0697-9593
FU Japan Foundation for United Nations University (jfUNU); Japan Science
   and Technology Agency (JST); Japan International Cooperation Agency
   (JICA)
FX We kindly appreciate the financial supports from the following sources.
   Japan Foundation for United Nations University (jfUNU) has provided a
   scholarship for the first author. Food Insecurity Impacts of Industrial
   Crops Expansion in sub-Saharan Africa (FICESSA) project funded by the
   Japan Science and Technology Agency (JST) has covered costs of the
   fieldworks; and Development Strategy for Urban Sustainability in Africa
   on the Basis of SDGs Interlinkage Analysis (USiA) project the University
   of Tokyo, funded by the Japan International Cooperation Agency (JICA),
   has paid APC.
CR Abaye Kebele Agricultural Extension Office, 2017, BAS INF AB KEB UNPUB
   Al-Shaikh MH, 2017, EGYPT J CHEST DIS TU, V66, P317, DOI 10.1016/j.ejcdt.2017.01.010
   [Anonymous], 2011, The State of the Worlds Children 2011: Adolescence-An Age of Opportunity
   [Anonymous], GLOB DAT CHILD GROWT
   Assefa E., 2007, ASSESSMENT PRODUCTIO
   Assefa H, 2013, INT SCH RES NOTICES
   Berridge V, 2008, SOC HIST MED, V21, P189, DOI 10.1093/shm/hkn011
   Bezu S, 2014, WORLD DEV, V64, P259, DOI 10.1016/j.worlddev.2014.06.013
   Bogin B., 1999, Patterns of human growth, V23
   Central Statistical Agency (CSA) Ethiopia and ICF, 2016, Ethiopia Demographic and Health Survey
   Chume Kebele Agricultural Extension Office, 2017, UNPUB
   Cochrane L, 2016, INT J DRUG POLICY, V30, P27, DOI 10.1016/j.drugpo.2016.02.009
   Coll-Black Sarah., 2012, Food and Agriculture in Ethiopia: Progress and Policy Challenges, P280
   Dasgupta Aparajita, 2010, Indian J Community Med, V35, P276, DOI 10.4103/0970-0218.66892
   Demissie S, 2013, Sci J Publ Health, V1, P175, DOI DOI 10.11648/J.SJPH.20130104.12
   deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650
   Dessie G., 2015, LAND WATER DRUGS CAS, V3
   Dessie G, 2008, GEOGR ANN B, V90B, P187, DOI 10.1111/j.1468-0467.2008.00286.x
   Dick B, 2015, J ADOLESCENT HEALTH, V56, P3, DOI 10.1016/j.jadohealth.2014.10.260
   Evans E.W., 2013, Encyclopedia of Human Nutrition, VThird, P14
   Ezzati M, 2017, LANCET, V390, P2627, DOI [10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3]
   Fan S., 2013, From Subsistence to Profit Transforming Smallholder Farms
   Feyisa TH, 2003, MT RES DEV, V23, P185, DOI 10.1659/0276-4741(2003)023[0185:KEITEH]2.0.CO;2
   Gat-Yablonski G, 2015, NUTRIENTS, V7, P517, DOI 10.3390/nu7010517
   Gebreyohannes Y., 2014, Int J Nutr Food Sci, V10, P11, DOI [10.11648/j.ijnfs.20140306.13, DOI 10.11648/J.IJNFS.20140306.13]
   Gezon LL, 2012, CULT AGRIC FOOD ENVI, V34, P124, DOI 10.1111/j.2153-9561.2012.01072.x
   Haboubi Ghalib J, 2009, Indian J Community Med, V34, P108, DOI 10.4103/0970-0218.51230
   Haddad C.N.L., 1996, 19 FCND INT FOOD POL
   Hadley C, 2008, SOC SCI MED, V66, P427, DOI 10.1016/j.socscimed.2007.08.025
   Harris-Fry H, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0603-1
   LARGO RH, 1993, HORM RES, V39, P41, DOI 10.1159/000182783
   Leenstra T, 2005, EUR J CLIN NUTR, V59, P41, DOI 10.1038/sj.ejcn.1602031
   Mark S, 2012, CAN J PUBLIC HEALTH, V103, P94, DOI 10.1007/BF03404210
   Mbow C, 2014, CURR OPIN ENV SUST, V6, P162, DOI 10.1016/j.cosust.2013.11.030
   Melaku YA, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0093-9
   Mellisse BT, 2018, AGROFOREST SYST, V92, P1579, DOI 10.1007/s10457-017-0106-5
   Minten B, 2018, WORLD DEV, V101, P119, DOI 10.1016/j.worlddev.2017.08.010
   Mohammed AY, 2015, INT J NUTR FOOD SCI, V4, P445, DOI DOI 10.11648/J.IJNFS.20150404.15
   Mramba L, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3423
   Mulugeta A, 2009, ETHIOP J HEALTH DEV, V23, P5
   Negash A, 2004, AGR HUM VALUES, V21, P61, DOI 10.1023/B:AHUM.0000014023.30611.ad
   Odenwald M, 2010, J ETHNOPHARMACOL, V132, P537, DOI 10.1016/j.jep.2010.11.012
   Pal Amitava, 2017, Int J Pediatr Adolesc Med, V4, P9, DOI 10.1016/j.ijpam.2016.08.009
   Patton GC, 2016, J ADOLESCENT HEALTH, V59, P375, DOI 10.1016/j.jadohealth.2016.08.002
   Perola M, 2011, HORM RES PAEDIAT, V76, P10, DOI 10.1159/000330139
   Pinhas-Hamiel O, 2017, J ADOLESCENT HEALTH, V61, P233, DOI 10.1016/j.jadohealth.2017.02.016
   Regassa N., 2011, ETHIOP J ENV STUD MA, V4, P39, DOI DOI 10.4314/EJESM.V4I1.5
   Roba K. T., 2016, Journal of Nutrition and Food Sciences, V6, P493
   Roy S., 2016, J NEPAL PAEDIAT SOC, V36, P147
   Sahle M, 2018, AGRON SUSTAIN DEV, V38, DOI 10.1007/s13593-017-0484-0
   SANDIFORD P, 1995, POP STUD-J DEMOG, V49, P5, DOI 10.1080/0032472031000148216
   Sarkar S.K., 2010, Australian Journal of Basic Applied Sciences, V4, P5813
   Sidama Zone Culture and Tourism Bureau, 2011, UNPUB
   Sidama Zone Finance and Economic Development Bureau, 2017, UNPUB
   Tefera A., 2013, Gain report ET-1302
   Tessema M, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.75.1630
   United States Department of Agriculture (USDA), 2017, COFF WORLD MARK TRAD
   WHO, 2018, GUID IMPL EFF ACT IM
   WHO, 2006, ADOLESCENT NUTR REV
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA
   Wolde M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-014-1337-2
   World Health Organisation, 2014, HLTH WORLDS AD 2 CHA
   Zenebe M, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0449-1
NR 63
TC 9
Z9 9
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2018
VL 10
IS 8
AR 980
DI 10.3390/nu10080980
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA GU9PD
UT WOS:000445680200028
PM 30060510
OA gold, Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Leonard, W
   Zhang, PZ
   Ying, DY
   Fang, ZX
AF Leonard, William
   Zhang, Pangzhen
   Ying, Danyang
   Fang, Zhongxiang
TI Hydroxycinnamic acids on gut microbiota and health
SO COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY
LA English
DT Review
DE food processing; gut microbiota; health benefits; hydroxycinnamic acids;
   metabolism
ID IN-VITRO BIOACCESSIBILITY; CAFFEIC ACID; CHLOROGENIC ACID; PHENETHYL
   ESTER; FERULIC ACID; SINAPIC ACID; COLONIC METABOLISM; GREEN COFFEE;
   INFLAMMATORY RESPONSE; CAFFEOYLQUINIC ACIDS
AB Hydroxycinnamic acids (HCAs) are a major class of phenolic acids with the characteristic phenylpropanoid C-6-C-3 backbone. Its typically conjugated status with plant cell wall components and liberation by limited enzymes might be the reason for its neglect by researchers compared to flavonoid-type polyphenols. The polyphenol-gut microbiota interactions and their impact on human health have captured the interest of researchers recently. In addition, there has been a significant progress over the past few years in understanding the gut microbiota-modulating effect of HCA using animal model studies. This review discusses the metabolism of HCA in the digestive tract, HCA-gut microbiota interactions, and its link to colorectal cancer, inflammatory bowel diseases, mental-cognitive impairments, nonalcoholic liver disease, and obesity. The effects of food matrix and processing technologies on HCA bioavailability and HCA-gut microbiota interactions, and HCA safety concerns are also featured in this review. This paper has provided an in-depth insight on HCA-gut microbiota relationship and identified the current literature gaps for future research.
C1 [Leonard, William; Zhang, Pangzhen; Fang, Zhongxiang] Univ Melbourne, Sch Agr & Food, Parkville, Vic 3010, Australia.
   [Ying, Danyang] CSIRO, Agr & Food, Werribee, Vic, Australia.
C3 University of Melbourne; Commonwealth Scientific & Industrial Research
   Organisation (CSIRO)
RP Fang, ZX (corresponding author), Univ Melbourne, Sch Agr & Food, Parkville, Vic 3010, Australia.
EM zhongxiang.fang@unimelb.edu.au
RI Ying, Danyang/B-6632-2011; zhang, pangzhen/AGN-0001-2022; Fang,
   Zhongxiang/A-8988-2019
OI Zhang, Pangzhen/0000-0002-9794-2269; Fang,
   Zhongxiang/0000-0002-9902-3426; Leonard, William/0000-0002-3871-1671
CR Adam A, 2002, J NUTR, V132, P1962, DOI 10.1093/jn/132.7.1962
   Amano Y, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12030110
   Ames NJ, 2017, NURS RES, V66, P184, DOI 10.1097/NNR.0000000000000212
   Anson NM, 2009, J AGR FOOD CHEM, V57, P6148, DOI 10.1021/jf900492h
   Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125
   Attri S, 2018, FOOD RES INT, V111, P314, DOI 10.1016/j.foodres.2018.05.045
   Badr DA, 2019, APPL BIOL CHEM, V62, DOI 10.1186/s13765-019-0462-0
   Balaji C, 2014, HUM EXP TOXICOL, V33, P1253, DOI 10.1177/0960327114522501
   Ben Lagha A, 2015, J AGR FOOD CHEM, V63, P6999, DOI 10.1021/acs.jafc.5b01525
   Bhalli JA, 2019, ENVIRON MOL MUTAGEN, V60, P837, DOI 10.1002/em.22333
   Bharath Nagaraj, 2015, Contemp Clin Dent, V6, P166, DOI 10.4103/0976-237X.156036
   Bischoff SC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-24
   Budryn G, 2016, FOOD RES INT, V89, P1004, DOI 10.1016/j.foodres.2015.12.011
   Budryn G, 2015, FOOD CHEM, V168, P276, DOI 10.1016/j.foodchem.2014.07.056
   Budryn G, 2013, FOOD REV INT, V29, P217, DOI 10.1080/87559129.2012.751545
   Bugianesi R, 2004, EUR J NUTR, V43, P360, DOI 10.1007/s00394-004-0483-1
   Cai JR, 2019, GASTROENT RES PRACT, V2019, DOI 10.1155/2019/8536952
   Castaner O, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/4095789
   Celebioglu HU, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700638
   Chen JL, 2019, APPL MICROBIOL BIOT, V103, P8157, DOI 10.1007/s00253-019-10025-8
   Cheng D, 2019, FOOD FUNCT, V10, P681, DOI [10.1039/c8fo01755g, 10.1039/C8FO01755G]
   Chou DA, 2012, FOOD CHEM, V131, P1460, DOI 10.1016/j.foodchem.2011.10.027
   Cladis DP, 2020, FOOD CHEM TOXICOL, V139, DOI 10.1016/j.fct.2020.111254
   Clifford MN, 2020, COMPR REV FOOD SCI F, V19, P1299, DOI 10.1111/1541-4337.12518
   Clifford MN, 2017, NAT PROD REP, V34, P1391, DOI 10.1039/c7np00030h
   Coman V, 2020, J SCI FOOD AGR, V100, P483, DOI 10.1002/jsfa.10010
   Couteau D, 2001, J APPL MICROBIOL, V90, P873, DOI 10.1046/j.1365-2672.2001.01316.x
   Cueva C, 2010, RES MICROBIOL, V161, P372, DOI 10.1016/j.resmic.2010.04.006
   Dalile B, 2019, NAT REV GASTRO HEPAT, V16, P461, DOI 10.1038/s41575-019-0157-3
   Do MH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060761
   Dueñas M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/850902
   Duncan SH, 2016, ENVIRON MICROBIOL, V18, P2214, DOI 10.1111/1462-2920.13158
   Dupas C, 2006, MOL NUTR FOOD RES, V50, P1053, DOI 10.1002/mnfr.200600034
   Ekbatan SS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030723
   El-Seedi HR, 2012, J AGR FOOD CHEM, V60, P10877, DOI 10.1021/jf301807g
   Erk T, 2014, EUR J NUTR, V53, P159, DOI 10.1007/s00394-013-0512-z
   Erk T, 2012, MOL NUTR FOOD RES, V56, P1488, DOI 10.1002/mnfr.201200222
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Feliciano RP, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030268
   Fetzner A, 2004, EUR J PHARM BIOPHARM, V58, P91, DOI 10.1016/j.ejpb.2004.02.001
   Gao WY, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6769789
   Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007
   Gómez-Juaristi M, 2018, FOOD FUNCT, V9, P331, DOI [10.1039/c7fo01553d, 10.1039/C7FO01553D]
   Gómez-Juaristi M, 2018, FOOD CHEM, V240, P1028, DOI 10.1016/j.foodchem.2017.08.003
   Gong LX, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.103453
   Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084
   Gonzalez LM, 2015, TRANSL RES, V166, P12, DOI 10.1016/j.trsl.2015.01.004
   Granato D, 2020, TRENDS FOOD SCI TECH, V98, P162, DOI 10.1016/j.tifs.2020.01.010
   HAGIWARA A, 1991, CANCER RES, V51, P5655
   He YJ, 2006, WORLD J GASTROENTERO, V12, P4981, DOI 10.3748/wjg.v12.i31.4981
   Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152
   Hirose M, 1998, CARCINOGENESIS, V19, P207, DOI 10.1093/carcin/19.1.207
   Honzawa Y, 2010, INFLAMM BOWEL DIS, V16, P2004, DOI 10.1002/ibd.21243
   Hou N, 2017, ANTI-CANCER DRUG, V28, P59, DOI 10.1097/CAD.0000000000000430
   Hugenholtz F, 2018, CELL MOL LIFE SCI, V75, P149, DOI 10.1007/s00018-017-2693-8
   Johnson ML, 2008, POULTRY SCI, V87, P958, DOI 10.3382/ps.2007-00349
   Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]
   Katayama S, 2017, J AGR FOOD CHEM, V65, P10730, DOI 10.1021/acs.jafc.7b03933
   Kelly SM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02690
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Kumar CS, 2020, CARBOHYD POLYM, V231, DOI 10.1016/j.carbpol.2019.115682
   Lee B, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2645465
   Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004
   Lee JY, 2018, ARCH PHARM RES, V41, P243, DOI 10.1007/s12272-018-1006-6
   Lee SJ, 2013, ARCH PHARM RES, V36, P1437, DOI 10.1007/s12272-013-0139-x
   Liu JW, 2016, SPECTROSC LETT, V49, P44, DOI 10.1080/00387010.2015.1066826
   Lou ZX, 2011, J FOOD SCI, V76, pM398, DOI 10.1111/j.1750-3841.2011.02213.x
   Ma YC, 2019, BIOMED PHARMACOTHER, V113, DOI 10.1016/j.biopha.2019.108753
   Malapert A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111653
   Martínez-Huélamo M, 2016, MOL NUTR FOOD RES, V60, P1578, DOI 10.1002/mnfr.201500820
   Martini S, 2019, J AGR FOOD CHEM, V67, P3919, DOI 10.1021/acs.jafc.9b00522
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Miyamoto S, 2008, NUTR CANCER, V60, P675, DOI 10.1080/01635580802008286
   Murad LD, 2015, NUTR CANCER, V67, P532, DOI 10.1080/01635581.2015.1004736
   Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547
   O'Callaghan A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00925
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Osés SM, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9010075
   Parkar SG, 2013, ANAEROBE, V23, P12, DOI 10.1016/j.anaerobe.2013.07.009
   Pellerito C, 2020, J INORG BIOCHEM, V205, DOI 10.1016/j.jinorgbio.2020.110999
   Peng JH, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01399
   PEPPERCORN MA, 1971, J BACTERIOL, V108, P996, DOI 10.1128/JB.108.3.996-1000.1971
   Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617
   Poquet L, 2008, DRUG METAB DISPOS, V36, P190, DOI 10.1124/dmd.107.017558
   Raimondi S, 2015, MICROBIOLOGYOPEN, V4, P41, DOI 10.1002/mbo3.219
   Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d
   Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022
   Renouf M, 2014, MOL NUTR FOOD RES, V58, P301, DOI 10.1002/mnfr.201300349
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Renouf M, 2010, J NUTR, V140, P259, DOI 10.3945/jn.109.113027
   Ribas-Agustí A, 2018, CRIT REV FOOD SCI, V58, P2531, DOI 10.1080/10408398.2017.1331200
   Rodriguez-Mateos A, 2014, MOL NUTR FOOD RES, V58, P1952, DOI 10.1002/mnfr.201400231
   Ruan Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097815
   Rychlik I, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10010103
   Sanchez-Bridge B, 2016, BIOFACTORS, V42, P259, DOI 10.1002/biof.1268
   Scherbl D, 2017, EUR FOOD RES TECHNOL, V243, P791, DOI 10.1007/s00217-016-2793-y
   Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d
   Shen HH, 2020, FOOD FUNCT, V11, P5389, DOI [10.1039/D0FO00775G, 10.1039/d0fo00775g]
   Silberberg M, 2006, J AGR FOOD CHEM, V54, P3541, DOI 10.1021/jf060104e
   Song J, 2019, FOOD FUNCT, V10, P2947, DOI [10.1039/c8fo02599a, 10.1039/C8FO02599A]
   Stalmach A, 2014, FOOD FUNCT, V5, P1727, DOI [10.1039/c4fo00316k, 10.1039/C4FO00316K]
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Tagliazucchi D, 2012, J AGR FOOD CHEM, V60, P11056, DOI 10.1021/jf302694a
   Tambuwala MM, 2018, PATHOL RES PRACT, V214, P1909, DOI 10.1016/j.prp.2018.08.020
   Tang HY, 2020, TRENDS FOOD SCI TECH, V100, P333, DOI 10.1016/j.tifs.2020.04.028
   Tang Q, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00151
   Tayman C, 2011, PEDIATR SURG INT, V27, P1179, DOI 10.1007/s00383-011-2942-0
   Teke Z, 2012, J INVEST SURG, V25, P354, DOI 10.3109/08941939.2012.677968
   Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400
   Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510
   Tomas-Barberan F, 2014, MOL NUTR FOOD RES, V58, P1122, DOI 10.1002/mnfr.201300441
   Tomás-Barberán FA, 2019, ANNU REV FOOD SCI T, V10, P221, DOI 10.1146/annurev-food-032818-121615
   Turner PV, 2018, ANIM MODEL EXP MED, V1, P109, DOI 10.1002/ame2.12022
   Vollmer M, 2017, FOOD RES INT, V100, P375, DOI 10.1016/j.foodres.2017.06.013
   Vukelic I, 2018, FOOD CHEM TOXICOL, V121, P140, DOI 10.1016/j.fct.2018.08.061
   Wallace TC, 2011, NUTR REV, V69, P392, DOI 10.1111/j.1753-4887.2011.00402.x
   Wang QY, 2011, NUTR CANCER, V63, P1044, DOI 10.1080/01635581.2011.597538
   Wang WW, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01681
   Wang WW, 2019, J AGR FOOD CHEM, V67, P4250, DOI 10.1021/acs.jafc.8b06760
   Wang XK, 2004, APPL ENVIRON MICROB, V70, P2367, DOI 10.1128/AEM.70.4.2367-2372.2004
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Wittemer SM, 2005, PHYTOMEDICINE, V12, P28, DOI 10.1016/j.phymed.2003.11.002
   Wong SH, 2019, NAT REV GASTRO HEPAT, V16, P690, DOI 10.1038/s41575-019-0209-8
   Xiao L, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.161, 10.1038/nmicrobiol.2016.161]
   Xie MH, 2019, J AGR FOOD CHEM, V67, P171, DOI 10.1021/acs.jafc.8b05444
   Xu Y, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00219
   Yang C, 2019, FOOD RES INT, V116, P1202, DOI 10.1016/j.foodres.2018.10.003
   Yang C, 2007, J PHARMACEUT BIOMED, V43, P945, DOI 10.1016/j.jpba.2006.09.027
   Yang XW, 2013, FOOD CHEM TOXICOL, V55, P297, DOI 10.1016/j.fct.2012.12.039
   Yildiz Y, 2009, DIGEST DIS SCI, V54, P738, DOI 10.1007/s10620-008-0405-9
   Yuan XP, 2005, ANAEROBE, V11, P225, DOI 10.1016/j.anaerobe.2005.02.002
   Zatorski H, 2015, N-S ARCH PHARMACOL, V388, P643, DOI 10.1007/s00210-015-1110-9
   Zhang MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15141-x
   Zhang P, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00325
   Zhang Y, 2018, FOOD FUNCT, V9, P4968, DOI [10.1039/C8FO01126E, 10.1039/c8fo01126e]
   Zhang Z, 2016, ONCOTARGET, V7, P31790, DOI 10.18632/oncotarget.9306
   Zhao ZH, 2010, PHYTOCHEM REV, V9, P133, DOI 10.1007/s11101-009-9145-5
   Zheng YH, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201808646
NR 139
TC 64
Z9 66
U1 13
U2 112
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1541-4337
J9 COMPR REV FOOD SCI F
JI Compr. Rev. Food. Sci. Food Saf.
PD JAN
PY 2021
VL 20
IS 1
BP 710
EP 737
DI 10.1111/1541-4337.12663
EA OCT 2020
PG 28
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA PR7ZX
UT WOS:000582920000001
PM 33443803
DA 2025-04-28
ER

PT J
AU Castañeda, J
   Gil-Lespinard, M
   Almanza-Aguilera, E
   Llaha, F
   Gómez, JH
   Bondonno, N
   Tjonneland, A
   Overvad, K
   Katzke, V
   Schulze, MB
   Masala, G
   Agnoli, C
   de Magistris, MS
   Tumino, R
   Sacerdote, C
   Skeie, G
   Brustad, M
   Lasheras, C
   Molina-Montes, E
   Chirlaque, MD
   Barricarte, A
   Sonestedt, E
   da Silva, M
   Johansson, I
   Hultdin, J
   May, AM
   Forouhi, NG
   Heath, AK
   Freisling, H
   Weiderpass, E
   Scalbert, A
   Zamora-Ros, R
AF Castaneda, Jazmin
   Gil-Lespinard, Mercedes
   Almanza-Aguilera, Enrique
   Llaha, Fjorida
   Gomez, Jesus-Humberto
   Bondonno, Nicola
   Tjonneland, Anne
   Overvad, Kim
   Katzke, Verena
   Schulze, Matthias B.
   Masala, Giovanna
   Agnoli, Claudia
   de Magistris, Maria Santucci
   Tumino, Rosario
   Sacerdote, Carlotta
   Skeie, Guri
   Brustad, Magritt
   Lasheras, Cristina
   Molina-Montes, Esther
   Chirlaque, Maria-Dolores
   Barricarte, Aurelio
   Sonestedt, Emily
   da Silva, Marisa
   Johansson, Ingegerd
   Hultdin, Johan
   May, Anne M.
   Forouhi, Nita G.
   Heath, Alicia K.
   Freisling, Heinz
   Weiderpass, Elisabete
   Scalbert, Augustin
   Zamora-Ros, Raul
TI Association between classes and subclasses of polyphenol intake and
   5-year body weight changes in the EPIC-PANACEA study
SO OBESITY
LA English
DT Article
ID EUROPEAN COUNTRIES; COFFEE; OVERWEIGHT; OBESITY; POPULATION; METABOLISM;
   MANAGEMENT; PATTERNS; WOMEN; BMI
AB Objective: The aim of this study was to evaluate the associations among the intake of total polyphenols, polyphenol classes, and polyphenol subclasses and body weight change over 5years.
   Methods: A total of 349,165 men and women aged 25 to 70years were recruited in the Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating Out of Home and Obesity (PANACEA) project of the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort from nine European countries. Body weight was measured at baseline and at follow-up after a median time of 5years. Polyphenol intake, including four main polyphenol classes and eighteen subclasses, was estimated using validated dietary questionnaires and Phenol-Explorer. Multilevel mixed linear regression models were used to estimate the associations.
   Results: Participants gained, on average, 2.6 kg (5.0 kg) over 5years. Total flavonoids intake was inversely associated with body weight change (-0.195kg/5 years, 95% CI: -0.262 to -0.128). However, the intake of total polyphenols (0.205kg/5 years, 95% CI: 0.138 to 0.272) and intake of hydroxycinnamic acids (0.324kg/5 years, 95% CI: 0.267 to 0.381) were positively associated with body weight gain. In analyses stratified by coffee consumption, hydroxycinnamic acid intake was positively associated with body weight gain in coffee consumers (0.379kg/5 years, 95% CI: 0.319 to 0.440), but not in coffee nonconsumers (-0.179kg/5 years, 95% CI: -0.490 to 0.133).
   Conclusions: Higher intakes of flavonoids and their subclasses are inversely associated with a modest body weight change. Results regarding hydroxycinnamic acids in coffee consumers require further investigation.
C1 [Castaneda, Jazmin; Gil-Lespinard, Mercedes; Almanza-Aguilera, Enrique; Llaha, Fjorida; Zamora-Ros, Raul] Bellvitge Biomed Res Inst IDIBELL, Catalan Inst Oncol ICO, Canc Epidemiol Res Programme, Unit Nutr & Canc, Lhospitalet De Llobregat, Spain.
   [Gomez, Jesus-Humberto; Chirlaque, Maria-Dolores] IMIB Arrixaca, Dept Epidemiol, Reg Hlth Council, Murcia, Spain.
   [Gomez, Jesus-Humberto; Molina-Montes, Esther; Chirlaque, Maria-Dolores; Barricarte, Aurelio] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.
   [Bondonno, Nicola; Tjonneland, Anne] Danish Canc Soc, Unit Diet Genes & Environm, Res Ctr, Copenhagen, Denmark.
   [Bondonno, Nicola] Edith Cowan Univ, Sch Med & Hlth Sci, Inst Nutr Res, Perth, WA, Australia.
   [Tjonneland, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Sect Environm Hlth, Copenhagen, Denmark.
   [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.
   [Katzke, Verena] German Canc Res Ctr, Dept Canc Epidemiol, Heidelberg, Germany.
   [Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany.
   [Schulze, Matthias B.] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany.
   [Masala, Giovanna] Inst Canc Res Prevent & Clin Network ISPRO, Canc Risk Factors & Life Style Epidemiol Unit, Florence, Italy.
   [Agnoli, Claudia] IRCCS Natl Canc Inst Fdn, Dept Res, Epidemiol & Prevent Unit, Milan, Italy.
   [de Magistris, Maria Santucci] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy.
   [Tumino, Rosario] Hyblean Assoc Epidemiol Res AIRE ONLUS, Ragusa, Italy.
   [Sacerdote, Carlotta] Citta Salute & Sci Univ Hosp, Unit Canc Epidemiol, Turin, Italy.
   [Skeie, Guri; Brustad, Magritt] Univ Tromso, Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway.
   [Brustad, Magritt] Publ Dent Hlth Serv Competence Ctr Northern Norwa, Tromso, Norway.
   [Lasheras, Cristina] Univ Oviedo, Dept Funct Biol, Oviedo, Spain.
   [Molina-Montes, Esther] Univ Granada, Dept Nutr & Food Sci, Campus Cartuja, Granada, Spain.
   [Molina-Montes, Esther] Biosanit Res Inst Granada Ibs Granada, Granada, Spain.
   [Molina-Montes, Esther] Univ Granada, Biomed Res Ctr, Inst Nutr & Food Technol INYTA Jose Mataix, Granada, Spain.
   [Barricarte, Aurelio] Navarra Publ Hlth Inst, Pamplona, Spain.
   [Barricarte, Aurelio] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain.
   [Sonestedt, Emily] Lund Univ, Dept Clin Sci Malmo, Nutr Epidemiol, Malmo, Sweden.
   [da Silva, Marisa] Lund Univ, Dept Clin Sci Lund, Register Based Epidemiol, Lund, Sweden.
   [Johansson, Ingegerd] Umea Univ, Dept Odontol, Umea, Sweden.
   [Hultdin, Johan] Umea Univ, Dept Med Biosci, Umea, Sweden.
   [May, Anne M.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Forouhi, Nita G.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge Biomed Campus,Sch Clin Med, Cambridge, England.
   [Heath, Alicia K.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.
   [Freisling, Heinz; Weiderpass, Elisabete; Scalbert, Augustin] Int Agcy Res Canc Nutr IARC WHO, Lyon, France.
   [Zamora-Ros, Raul] Univ Barcelona, Fac Pharm & Food Sci, Inst Res Nutr & Food Safety INSA, Dept Nutr Food Sci & Gastron,Food Innovat Network, Barcelona, Spain.
C3 Institut Catala d'Oncologia; Institut d'Investigacio Biomedica de
   Bellvitge (IDIBELL); Hospital Clinico Universitario Virgen de la
   Arrixaca; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP;
   Danish Cancer Society; Edith Cowan University; University of Copenhagen;
   Aarhus University; Helmholtz Association; German Cancer Research Center
   (DKFZ); Leibniz Association; Deutsches Institut fur Ernahrungsforschung
   Potsdam-Rehbrucke (DIfE); University of Potsdam; Fondazione IRCCS
   Istituto Nazionale Tumori Milan; University of Naples Federico II;
   A.O.U. Citta della Salute e della Scienza di Torino; UiT The Arctic
   University of Tromso; University of Oviedo; University of Granada;
   University of Granada; Public Health Institute of Navarra; Lund
   University; Lund University; Umea University; Umea University; Utrecht
   University; Utrecht University Medical Center; University of Cambridge;
   Imperial College London; University of Barcelona
RP Zamora-Ros, R (corresponding author), Univ Barcelona, Fac Pharm & Food Sci, Dept Nutr Food Sci & Gastron, Avinguda Joan XXIII,27-31, Barcelona 08028, Spain.
EM rzamora@ub.edu
RI Masala, Giovanna/AAC-5474-2022; Zamora, Raul/HNC-1515-2023; Sacerdote,
   Carlotta/K-3611-2018; Hultdin, Johan/AAD-4623-2021; Sonestedt,
   Emily/I-3814-2016; Gil-Lespinard, Mercedes/ACE-5171-2022; Tjonneland,
   Anne/AGU-0320-2022; Weiderpass, Elisabete/AAP-2747-2021; Agnoli,
   Claudia/K-5916-2016; Chirlaque, Maria-Dolores/KCL-3322-2024; Almanza
   Aguilera, Enrique/AAA-2853-2020; Llaha, Fjorida/AAV-2142-2021; Forouhi,
   Nita/JAC-2361-2023; May, Anne/G-9183-2011; Bondonno, Nicola/Y-2567-2019;
   Heath, Alicia/AAO-4007-2020; Schulze, Matthias B./AAH-6906-2021;
   Molina-Montes, Esther/AFS-7568-2022
OI Tjonneland, Anne/0000-0003-4385-2097; Bondonno,
   Nicola/0000-0001-5905-444X; Katzke, Verena/0000-0002-6509-6555; Heath,
   Alicia/0000-0001-6517-1300; Lasheras-Mayo, Maria
   Cristina/0000-0003-0482-4229; Overvad, Kim/0000-0001-6429-7921;
   /0000-0002-8521-9946; Schulze, Matthias B./0000-0002-0830-5277;
   Sacerdote, Carlotta/0000-0002-8008-5096; Gil Lespinard,
   Mercedes/0000-0002-7387-2139; da Silva, Marisa/0000-0003-1215-8625;
   Molina-Montes, Esther/0000-0002-0428-2426; Llaha,
   Fjorida/0000-0003-0534-6484; Gomez Gomez, Jesus
   Humberto/0000-0001-8442-8327; Almanza Aguilera,
   Enrique/0000-0002-4805-0774
FU Consejo Nacional de Ciencia y Tecnologia [693636]; Instituto de Salud
   Carlos III [CD20/ 00071, CPII20/00009, FI19/00185, PI18/ 00191]; MRC
   [MC_UU_00006/3] Funding Source: UKRI
FX Consejo Nacional de Ciencia y Tecnologia, Grant/Award Number: ID 693636;
   Instituto de Salud Carlos III, Grant/Award Numbers: CD20/ 00071,
   CPII20/00009, FI19/00185, PI18/ 00191
CR Adriouch S, 2018, INT J OBESITY, V42, P310, DOI 10.1038/ijo.2017.227
   Alam MA, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0080-3
   Albuquerque D, 2017, BRIT MED BULL, V123, P159, DOI 10.1093/bmb/ldx022
   Benbouguerra N, 2021, TRENDS FOOD SCI TECH, V112, P362, DOI 10.1016/j.tifs.2021.03.060
   Bertoia ML, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i17
   Boccellino M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165642
   Cercato C, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0468-0
   Chopra S, 2019, J MID-LIFE HEALTH, V10, P165, DOI 10.4103/jmh.JMH_155_19
   Cui M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-01752-y
   Dai HJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003198
   Fantin F, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071667
   Farhat G, 2017, PHYTOTHER RES, V31, P1005, DOI 10.1002/ptr.5830
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Freisling H, 2012, BRIT J NUTR, V107, P910, DOI 10.1017/S0007114511003564
   Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539
   Grosso G, 2017, EUR J NUTR, V56, P1409, DOI 10.1007/s00394-016-1187-z
   Guo XH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050452
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   Knaze V, 2018, AM J CLIN NUTR, V108, P517, DOI 10.1093/ajcn/nqy098
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Llaha F, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.00084
   Ma CH, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4849
   Markovic AK, 2019, MOLECULES, V24, DOI 10.3390/molecules24102001
   Marranzano M, 2018, INT J FOOD SCI NUTR, V69, P1020, DOI 10.1080/09637486.2018.1452900
   May AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050712
   Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231
   Orsini N, 2011, STATA J, V11, P1
   Pedersen LR, 2016, ATHEROSCLEROSIS, V246, P221, DOI 10.1016/j.atherosclerosis.2016.01.001
   Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394
   Romaguera D, 2010, AM J CLIN NUTR, V92, P912, DOI 10.3945/ajcn.2010.29482
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Semlitsch T, 2019, OBES REV, V20, P1218, DOI 10.1111/obr.12889
   Sharifi-Rad M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00694
   Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679
   Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322
   Tomova GD, 2022, AM J CLIN NUTR, V115, P189, DOI 10.1093/ajcn/nqab266
   Vernarelli JA, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.22
   Wilding JPH, 2021, OBES REV, V22, DOI 10.1111/obr.13112
   World Health Organization, 2022, WHO EUR REG OB REP 2
   World Obesity, PREV OB
   Zamora-Ros R, 2016, EUR J NUTR, V55, P1359, DOI 10.1007/s00394-015-0950-x
   Zhang W, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-13555-w
NR 45
TC 2
Z9 2
U1 1
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD APR
PY 2023
VL 31
IS 4
BP 1146
EP 1158
DI 10.1002/oby.23689
EA JAN 2023
PG 13
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA A2VV1
UT WOS:000928299300001
PM 36693804
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Bohn, SK
   Croft, KD
   Burrows, S
   Puddey, IB
   Mulder, TPJ
   Fuchs, D
   Woodmand, RJ
   Hodgson, JM
AF Bohn, Siv K.
   Croft, Kevin D.
   Burrows, Sally
   Puddey, Ian B.
   Mulder, Theo P. J.
   Fuchs, Dagmar
   Woodmand, Richard J.
   Hodgson, Jonathan M.
TI Effects of black tea on body composition and metabolic outcomes related
   to cardiovascular disease risk: a randomized controlled trial
SO FOOD & FUNCTION
LA English
DT Article
ID GREEN TEA; INSULIN CONCENTRATIONS; LIPOPROTEIN OXIDATION;
   PLASMA-GLUCOSE; BLOOD-PRESSURE; OBESE WOMEN; CONSUMPTION;
   SUPPLEMENTATION; OVERWEIGHT; RESISTANCE
AB There is increasing evidence that tea and its non-caffeine components (primarily flavonoids)contribute to cardiovascular health. Randomized controlled trials have shown that tea can improve cardiovascular disease risk factors. We have previously reported a non-caffeine associated beneficial effect of regular black tea consumption on blood pressure and its variation. Objective: To explore the non-caffeine associated effects of black tea on body weight and body fat distribution, and cardiovascular disease related metabolic outcomes. Design: regular tea-drinking men and women (n = 111; BMI 20-35 kg m(-2)) were recruited to a randomized controlled double-blind 6 month parallel-designed trial. Participants consumed 3 cups per day of either powdered black tea solids (tea) or a flavonoid-free flavour-and caffeine-matched placebo (control). Body weight, waist-and hip-circumference, endothelial function and plasma biomarkers were assessed at baseline, 3 months and 6 months. Results: Compared to control, regular ingestion of black tea over 3 months inhibited weight gain (-0.64 kg, p = 0.047) and reduced waist circumference (-1.88 cm, P = 0.035) and waist-to-hip ratio (-0.03, P = 0.005). These effects were no longer significant at 6 months. There were no significant effects observed on fasting glucose, insulin, plasma lipids or endothelial function. Conclusion: Our study suggests that short-term regular ingestion of black tea over 3 months can improve body weight and body fat distribution, compared to a caffeine-matched control beverage. However, there was no evidence that these effects were sustained beyond 3 months.
C1 [Bohn, Siv K.] Univ Oslo, Fac Med, Inst Basic Med Sci, Dept Nutr, N-0316 Oslo, Norway.
   [Croft, Kevin D.; Burrows, Sally; Puddey, Ian B.; Hodgson, Jonathan M.] Univ Western Australia, Western Australian Inst Med Res, Sch Med & Pharmacol, Ctr Food & Genom Med, Perth, WA 6009, Australia.
   [Mulder, Theo P. J.; Fuchs, Dagmar] Unilever Res Labs, Vlaardingen, Netherlands.
   [Woodmand, Richard J.] Flinders Univ S Australia, Discipline Gen Practice, Adelaide, SA 5001, Australia.
C3 University of Oslo; University of Western Australia; Unilever; Flinders
   University South Australia
RP Bohn, SK (corresponding author), Univ Oslo, Fac Med, Inst Basic Med Sci, Dept Nutr, N-0316 Oslo, Norway.
EM s.k.bohn@medisin.uio.no
RI Bøhn, Siv/AAO-2608-2020; Croft, Kevin/C-4675-2013; Puddey,
   Ian/H-5673-2014; Woodman, Richard/D-4004-2012; Burrows,
   Sally/H-8914-2014
OI Burrows, Sally/0000-0002-8499-4537; Woodman,
   Richard/0000-0002-4094-1222; Croft, Kevin/0000-0003-1596-4913
FU National Health and Medical Research Council of Australia [513744];
   Unilever Research and Development; National Health and Medical Research
   Council Fellowship; Unilever Research and Development, Vlaardingen, the
   Netherlands; Henning ock Throne-Holst stiftelse (Sweden); NH&MRC Senior
   Research Fellowship
FX This study was supported by the National Health and Medical Research
   Council of Australia (grant 513744), Unilever Research and Development,
   and a National Health and Medical Research Council Fellowship (JMH).
   Funding for the study was provided by the National Health and Medical
   Research Council of Australia (grant 513744); and Unilever Research and
   Development, Vlaardingen, the Netherlands. SKB acknowledges a
   postdoctoral fellowship from Henning ock Throne-Holst stiftelse
   (Sweden). JMH was supported by an NH&MRC Senior Research Fellowship.
CR Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bahorun T, 2012, PREV MED, V54, pS98, DOI 10.1016/j.ypmed.2011.12.009
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a
   Brown AL, 2011, BRIT J NUTR, V106, P1880, DOI 10.1017/S0007114511002376
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Bryans JA, 2007, J AM COLL NUTR, V26, P471, DOI 10.1080/07315724.2007.10719638
   Cardoso GA, 2013, J MED FOOD, V16, P120, DOI 10.1089/jmf.2012.0062
   Corella D, 2009, CIRC-CARDIOVASC GENE, V2, P637, DOI 10.1161/CIRCGENETICS.109.891366
   Davies MJ, 2003, J NUTR, V133, p3298S, DOI 10.1093/jn/133.10.3298S
   Deka A, 2011, PHARMACOL RES, V64, P136, DOI 10.1016/j.phrs.2011.03.009
   Dogra G, 2001, DIABETOLOGIA, V44, P593, DOI 10.1007/s001250051665
   Duffy SJ, 2001, CIRCULATION, V104, P151, DOI 10.1161/01.CIR.104.2.151
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Grassi D, 2009, J HYPERTENS, V27, P774, DOI 10.1097/HJH.0b013e328326066c
   Hodgson JM, 1999, J SCI FOOD AGR, V79, P561, DOI 10.1002/(SICI)1097-0010(19990315)79:4<561::AID-JSFA218>3.0.CO;2-X
   Hodgson JM, 2000, AM J CLIN NUTR, V71, P1103
   Hodgson JM, 2002, CLIN SCI, V102, P195, DOI 10.1042/CS20010120
   Hodgson JM, 2008, ASIA PAC J CLIN NUTR, V17, P288
   Hodgson JM, 2013, AM J CLIN NUTR, V97, P943, DOI 10.3945/ajcn.112.051375
   Hodgson JM, 2012, ARCH INTERN MED, V172, P186, DOI 10.1001/archinte.172.2.186
   Hosoda K, 2003, DIABETES CARE, V26, P1714, DOI 10.2337/diacare.26.6.1714
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Kubot K, 2011, NUTR RES, V31, P421, DOI 10.1016/j.nutres.2011.05.004
   KUHR S, 1991, Z LEBENSM UNTERS FOR, V192, P526, DOI 10.1007/BF01202507
   Li SH, 2010, AM J CLIN NUTR, V91, P480, DOI 10.3945/ajcn.2009.28203
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Princen HMG, 1998, ARTERIOSCL THROM VAS, V18, P833, DOI 10.1161/01.ATV.18.5.833
   Ras RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016974
   Ribeiro FF, 2003, OBES RES, V11, P1488, DOI 10.1038/oby.2003.199
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Ueda M, 2008, BIOCHEM BIOPH RES CO, V377, P286, DOI 10.1016/j.bbrc.2008.09.128
   Senger AEV, 2012, J NUTR HEALTH AGING, V16, P738, DOI 10.1007/s12603-012-0081-5
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Woodman RJ, 2001, J APPL PHYSIOL, V91, P929, DOI 10.1152/jappl.2001.91.2.929
NR 37
TC 36
Z9 37
U1 0
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD JUL
PY 2014
VL 5
IS 7
BP 1613
EP 1620
DI 10.1039/c4fo00209a
PG 8
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA AK3BL
UT WOS:000338297500034
PM 24889137
OA Green Submitted, hybrid
DA 2025-04-28
ER

PT J
AU Weerawatanakorn, M
   He, S
   Chang, CH
   Koh, YC
   Yang, MJ
   Pan, MH
AF Weerawatanakorn, Monthana
   He, Sang
   Chang, Chun-Han
   Koh, Yen-Chun
   Yang, Meei-Ju
   Pan, Min-Hsiung
TI High Gamma-Aminobutyric Acid (GABA) Oolong Tea Alleviates High-Fat
   Diet-Induced Metabolic Disorders in Mice
SO ACS OMEGA
LA English
DT Article
ID INSULIN-RESISTANCE; INDUCED OBESITY; ADIPONECTIN; ACTIVATION;
   HOMEOSTASIS; CAFFEINE; LEPTIN; RATIO
AB Obesity and overweight are associated with an increasing risk of developing health conditions and chronic non-communicable diseases, including cardiovascular diseases, cancer, musculoskeletal problems, respiratory problems, and mental health, and its prevalence is rising. Diet is one of three primary lifestyle interventions. Many bioactive components in tea especially oolong tea, including flavonoids, gamma-aminobutyric acid (GABA), and caffeine were reported to show related effects in reducing the risk of obesity. However, the effects of GABA oolong tea extracts (OTEs) on high-fat diet (HFD)-induced obesity are still unclear. Therefore, this study aims to explore whether the intervention of GABA OTEs can prevent HFD-induced obesity and decipher its underlying mechanisms using male C57BL/6 J mice. The result indicated that GABA OTEs reduced leptin expression in epididymal adipose tissue and showed a protective effect on nonalcoholic fatty liver disease. It promoted thermogenesis-related protein of uncoupling protein-1 and peroxisome proliferator-activated receptor-gamma coactivator (PGC-1a), boosted lipid metabolism, and promoted fatty acid oxidation. It also reduced lipogenesis-related protein levels of sterol regulatory element binding protein, acetyl-CoA carboxylase, and fatty acid synthase and inhibited hepatic triglyceride (TG) levels. These data suggest that regular drinking of GABA oolong tea has the potential to reduce the risk of being overweight, preventing obesity development through thermogenesis, lipogenesis, and lipolysis.
C1 [Weerawatanakorn, Monthana] Naresuan Univ, Dept Agroind, Phitsanulok 65000, Thailand.
   [He, Sang; Chang, Chun-Han; Koh, Yen-Chun; Pan, Min-Hsiung] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan.
   [Yang, Meei-Ju] Taiwan Tea Res & Extens Stn, Taoyuan 326011, Taiwan.
   [Pan, Min-Hsiung] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan.
   [Pan, Min-Hsiung] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
C3 Naresuan University; National Taiwan University; China Medical
   University Taiwan; China Medical University Hospital - Taiwan; Asia
   University Taiwan
RP Pan, MH (corresponding author), Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan.; Pan, MH (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan.; Pan, MH (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
EM mhpan@ntu.edu.tw
RI Weerawatanakorn, Monthana/AAS-3236-2020; Pan, Min-Hsiung/AAT-8865-2021;
   yen chun, koh/LFT-5555-2024
OI KOH, YEN CHUN/0000-0001-7683-873X; Pan, Min-Hsiung/0000-0002-5188-7030
FU Ministry of Science and Technology, Taiwan [110-2320-B-002-019-MY3];
   Reinventing University Program 2023, Ministry of Higher Education,
   Science, Research and Innovation (MHESI), Thailand
FX This work was supported by the Ministry of Science and Technology,
   Taiwan under Grant[110-2320-B-002-019-MY3]and was partially supported by
   Reinventing University Program 2023, The Ministry of Higher Education,
   Science, Research and Innovation (MHESI), Thailand.
CR Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321
   Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015
   Barthelemy J., 2020, J CELL IMMUNOL, V2, P276, DOI [10.33696/immunology.2.055, DOI 10.33696/IMMUNOLOGY.2.055, 10.33696/IMMUNOLOGY.2.055]
   Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831
   Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005
   Chiazza F, 2016, ADIPOCYTE, V5, P88, DOI 10.1080/21623945.2015.1071454
   Choi M, 2022, MOL CELL ENDOCRINOL, V552, DOI 10.1016/j.mce.2022.111677
   Chouchani ET, 2019, CELL METAB, V29, P27, DOI 10.1016/j.cmet.2018.11.002
   Clark KS, 2019, CLIN EXP PHARMACOL P, V46, P475, DOI 10.1111/1440-1681.13065
   Cordeiro A, 2020, CLIN RES HEPATOL GAS, V44, P394, DOI 10.1016/j.clinre.2019.10.001
   de Vrind VAJ, 2019, OBESITY, V27, P1123, DOI 10.1002/oby.22495
   Dvorak RV, 1999, DIABETES, V48, P2210, DOI 10.2337/diabetes.48.11.2210
   Fan XJ, 2022, AM J PHYSIOL-ENDOC M, V322, pE1, DOI 10.1152/ajpendo.00025.2021
   Frühbeck G, 2018, ADIPOCYTE, V7, P57, DOI 10.1080/21623945.2017.1402151
   Garcia D, 2019, CELL REP, V26, P192, DOI 10.1016/j.celrep.2018.12.036
   Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168
   Herman A, 2013, SKIN PHARMACOL PHYS, V26, P8, DOI 10.1159/000343174
   Hinton T, 2020, NEUROCHEM INT, V141, DOI 10.1016/j.neuint.2020.104895
   Hinton T, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00027
   HORTON R, 1988, GEN PHARMACOL-VASC S, V19, P403, DOI 10.1016/0306-3623(88)90037-7
   Kettner NM, 2016, CANCER CELL, V30, P909, DOI 10.1016/j.ccell.2016.10.007
   Landolt HP, 2015, SCIENCE, V349, P1289, DOI 10.1126/science.aad2958
   Leon-Cabrera S, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00062
   López-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053
   Moon YA, 2017, ENDOCRINOL METAB, V32, P6, DOI 10.3803/EnM.2017.32.1.6
   Pan MH, 2018, J AGR FOOD CHEM, V66, P12685, DOI 10.1021/acs.jafc.8b04624
   Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153
   Sahned J, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.6336
   Sandoval-Salazar C, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0075-6
   Shih CC, 2010, PHYTOTHER RES, V24, P1769, DOI 10.1002/ptr.3143
   Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383
   Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011
   Sun LL, 2019, NUTRITION, V65, P208, DOI 10.1016/j.nut.2019.02.006
   Sweatt SK, 2018, PSYCHONEUROENDOCRINO, V98, P46, DOI 10.1016/j.psyneuen.2018.07.024
   Tan XY, 2022, J AGR FOOD CHEM, V70, P6108, DOI 10.1021/acs.jafc.2c01013
   Tung YC, 2022, FOOD FUNCT, V13, P2846, DOI [10.1039/d1fo03356e, 10.1039/D1FO03356E]
   Wang J, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01210-0
   WEERAWATANAKORN M., 2015, Food Science and Human Wellness, V4, P133, DOI [10.1016/J.FSHW.2015.10.002, DOI 10.1016/J.FSHW.2015.10.002, 10.1016/j.fshw.2015.10.002]
   World Health Organization, 2021, Obesity and overweight, DOI DOI 10.1080/10810730903279694
   Wright SM, 2012, ABDOM IMAGING, V37, P730, DOI 10.1007/s00261-012-9862-x
   Xie LL, 2006, J BIOL CHEM, V281, P7253, DOI 10.1074/jbc.M511313200
   Yau WW, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21083020
   Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200
   Zhang SM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123671
NR 44
TC 11
Z9 11
U1 1
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2470-1343
J9 ACS OMEGA
JI ACS Omega
PD SEP 5
PY 2023
VL 8
IS 37
BP 33997
EP 34007
DI 10.1021/acsomega.3c04874
EA SEP 2023
PG 11
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA R6WZ6
UT WOS:001063343900001
PM 37744823
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Pereira, JL
   Félix, PV
   Mattei, J
   Fisberg, RM
AF Pereira, Jaqueline Lopes
   Felix, Paula Victoria
   Mattei, Josiemer
   Fisberg, Regina Mara
TI Differences over 12 Years in Food Portion Size and Association with
   Excess Body Weight in the City of SAo Paulo, Brazil
SO NUTRIENTS
LA English
DT Article
DE portion size; eating frequency; food intake; energy contribution; diet;
   obesity; overweight
ID SUGAR-SWEETENED BEVERAGES; ENERGY-INTAKE; WAIST CIRCUMFERENCE; DIETARY
   PATTERNS; WHITE RICE; OBESITY; CONSUMPTION; GAIN; NUTRITION; ADIPOSITY
AB Although changes in Brazilian diet have occurred over the last decades, there is no evidence about differences in food portion sizes (FPS) over time. Therefore, we aimed to evaluate the association of FPS with excess body weight (EBW), and to monitor differences in the population from SAo Paulo, Brazil, from 2003 to 2015. Data came from three cross-sectional population-based studies with 5270 individuals aged 12 years in 2003, 2008, and 2015. Dietary data were obtained from 24-h recalls. Logistic regression models were used to evaluate the association between FPS and EBW. Over the years, there was a diverse variation in FPS, with an increase in some groups (white meat, salted snacks, coffee/tea, eggs) and decrease in others (rice, red meat, sweets, pasta, sandwiches, cold cuts). The percentage of people reporting the intake of six food groupings (rice, white meat, sweets, fruits, commercial juices, toasts/biscuits) increased in the period. In this population, EBW was associated with larger FPS of 11 of the 30 food groupings investigated (cold cuts, fried snacks, fruit and commercial juices, pizza, red meat, rice, salted snacks, soft drinks, soups, sugar). These findings could support future interventions and policies for optimal food intake in Brazil.
C1 [Pereira, Jaqueline Lopes; Felix, Paula Victoria; Fisberg, Regina Mara] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, SP, Brazil.
   [Mattei, Josiemer] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
C3 Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School
   of Public Health
RP Fisberg, RM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, SP, Brazil.
EM jaque.lps@gmail.com; paula.victoria@gmail.com; jmattei@hsph.harvard.edu;
   rfisberg@usp.br
RI Pereira, Jaqueline/P-7261-2019; Mattei, Josiemer/H-1800-2016; Fisberg,
   Regina/C-4069-2012; Victoria Felix, Paula/AAP-4964-2020
OI Mattei, Josiemer/0000-0001-5424-8245; Fisberg,
   Regina/0000-0002-4490-9035; Lopes Pereira,
   Jaqueline/0000-0002-0009-1040; Victoria Felix, Paula/0000-0003-2712-7127
FU Sao Paulo Municipal Health Department [2013-0.235.936-0]; Research
   Support Foundation of the State of Sao Paulo [98/14099-7, 2007/51488-2,
   2009/15831-0, 2012/22113-9, 2016/07711-8]; National Council for
   Scientific and Technological Development [502948/2003-5, 481176/2008-0,
   472873/2012-1, 473100/2009-6, 402674/2016-2, 301597/2017-0]
FX This work was supported by the Sao Paulo Municipal Health Department
   [grant number 2013-0.235.936-0], Research Support Foundation of the
   State of Sao Paulo [grant number # 98/14099-7; 2007/51488-2;
   2009/15831-0; 2012/22113-9; 2016/07711-8], and National Council for
   Scientific and Technological Development [grant number # 502948/2003-5,
   481176/2008-0; 472873/2012-1; 473100/2009-6; 402674/2016-2;
   301597/2017-0; 301597/2017-0].
CR Albar SA, 2014, BRIT J NUTR, V112, P841, DOI 10.1017/S0007114514001548
   Alves M.C.G.P., 2003, ISA CAPITAL PLANO AM
   Alves M.C.G.P., 2009, PLANO AMOSTRAGEM ISA
   [Anonymous], 2019, Manual de Equivalentes Alimentares
   [Anonymous], DIET REF INT EN CARB
   [Anonymous], 1998, OB PREV MAN GLOB EP
   [Anonymous], TECHN WORKSH
   Azadbakht L, 2016, J AM COLL NUTR, V35, P491, DOI 10.1080/07315724.2015.1113902
   Banna JC, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00045
   Bezerra IN, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000082, 10.11606/s1518-8787.2018052000082]
   BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416
   Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1
   Carvalho AM, 2014, Rev Bras Epidemiol, V17, P735
   Castro MA, 2016, BRIT J NUTR, V115, P1586, DOI 10.1017/S0007114516000556
   Church S., 2008, Trends in portion sizes in the UK-A preliminary review of published information
   Collins K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-517
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Cruwys T, 2015, APPETITE, V86, P3, DOI 10.1016/j.appet.2014.08.035
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   de Onis M, 2006, WHO Child Growth Standards Length/Height-for-Age, Weight-for-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age. Methods and Development
   Duffey KJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001050
   Fisberg RM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020169
   Fisher JO, 2015, APPETITE, V88, P1, DOI 10.1016/j.appet.2014.11.025
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   Glanz K, 1998, J AM DIET ASSOC, V98, P1118, DOI 10.1016/S0002-8223(98)00260-0
   Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576
   Instituto Brasileiro de Geografia e Estatistica, EST BDGE CID
   Jeffery RW, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-27
   Kelly MT, 2009, BRIT J NUTR, V101, P1413, DOI 10.1017/S0007114508060777
   Lafay L, 2000, INT J OBESITY, V24, P1500, DOI 10.1038/sj.ijo.0801392
   Lebrao M.L., 2003, SABE: Saude, Bem-estar e Envelhecimento: O Projeto Sabe No Municipio de Sao Paulo: Uma Abordagem Inicial [Health, Well-Being and Aging: The SABE Study in Sao Paulo], V1st ed.
   Ledikwe JH, 2005, J NUTR, V135, P905, DOI 10.1093/jn/135.4.905
   Levy-Costa RB, 2005, REV SAUDE PUBL, V39, P530, DOI 10.1590/S0034-89102005000400003
   Lissner L, 2002, PUBLIC HEALTH NUTR, V5, P889, DOI 10.1079/PHN2002388
   Livingstone MBE, 2014, ADV NUTR, V5, P829, DOI 10.3945/an.114.007104
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Rodrigues AGM, 2012, APPETITE, V59, P305, DOI 10.1016/j.appet.2012.05.018
   Matsudo S, 2001, Rev bras ativ fis saude, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18
   Mattei J, 2011, AM J CLIN NUTR, V94, P869, DOI 10.3945/ajcn.111.013219
   Mattes R, 2014, PHYSIOL BEHAV, V134, P110, DOI 10.1016/j.physbeh.2013.11.012
   Matthiessen J, 2003, PUBLIC HEALTH NUTR, V6, P65, DOI 10.1079/PHN2002361
   McCarthy SN, 2006, INT J OBESITY, V30, P993, DOI 10.1038/sj.ijo.0803235
   Mendez MA, 2011, AM J EPIDEMIOL, V173, P448, DOI 10.1093/aje/kwq380
   Ministerio da Saude, 2017, SECR VIG SAUD DEP VI
   Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Munt AE, 2017, OBES REV, V18, P1, DOI 10.1111/obr.12472
   NEPA, 2011, TAB BRAS COMP AL
   Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450
   O'Brien SA, 2015, BRIT J NUTR, V113, P1148, DOI 10.1017/S0007114515000276
   Papanikolaou Y, 2008, J AM COLL NUTR, V27, P569, DOI 10.1080/07315724.2008.10719740
   Pereira JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164127
   Pereira RA, 2014, PUBLIC HEALTH NUTR, V17, P113, DOI 10.1017/S1368980012004892
   Pinheiro ABV, 2008, Tabela para avaliacao de consumo alimentar em medidas caseiras, V5a
   Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S
   Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x
   Raynor HA, 2007, OBESITY, V15, P2311, DOI 10.1038/oby.2007.274
   Rhee JJ, 2012, PUBLIC HEALTH NUTR, V15, P1347, DOI 10.1017/S1368980012001000
   Rolls BJ, 2007, OBESITY, V15, P1535, DOI 10.1038/oby.2007.182
   Rolls BJ, 2006, J AM DIET ASSOC, V106, P543, DOI 10.1016/j.jada.2006.01.014
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Sichieri R, 2007, AM J CLIN NUTR, V86, P707, DOI 10.1093/ajcn/86.3.707
   Singh GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124845
   Smiciklas-Wright H, 2003, J AM DIET ASSOC, V103, P41, DOI 10.1053/jada.2003.50000
   Steenhuis IHM, 2010, PUBLIC HEALTH NUTR, V13, P852, DOI 10.1017/S1368980009992011
   Vergnaud AC, 2010, AM J CLIN NUTR, V92, P398, DOI 10.3945/ajcn.2009.28713
   Wang L, 2010, ARCH INTERN MED, V170, P453, DOI 10.1001/archinternmed.2009.527
   Wannamethee SG, 2004, OBES RES, V12, P1386, DOI 10.1038/oby.2004.175
   Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312
   WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1
   WRIEDEN W., 2008, Proc Nutr Soc, V67, DOI [10.1017/S0029665100590582, DOI 10.1017/S0029665100590582]
   Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246
NR 72
TC 9
Z9 10
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUN
PY 2018
VL 10
IS 6
AR 696
DI 10.3390/nu10060696
PG 20
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA GK8VC
UT WOS:000436507200040
PM 29848971
OA Green Published, Green Submitted, gold
DA 2025-04-28
ER

PT J
AU Khalafani, Z
   Zamani-Garmsiri, F
   Panahi, G
   Meshkani, R
AF Khalafani, Zahra
   Zamani-Garmsiri, Fahimeh
   Panahi, Ghodratollah
   Meshkani, Reza
TI Metformin-chlorogenic acid combination reduces skeletal muscle
   inflammation in c57BL/6 mice on high-fat diets
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE Skeletal muscle inflammation; Chlorogenic acid; Metformin; Macrophages;
   Cytokines
ID INSULIN-RESISTANCE; MACROPHAGES
AB BackgroundInflammation at the low-grade level has been found to contribute to obesity-induced insulin resistance in the skeletal muscle (SM). This study investigated the anti-inflammatory potential of metformin (MET) combined with chlorogenic acid (CGA) in SM of mice fed a high-fat diet (HFD).Materials and methodsThe C57BL/6 mice were divided into five groups of ten each, normal diet, HFD, HFD + MET, HFD + CGA and HFD + MET + CGA.ResultsThe results revealed that MET and CGA, alone or in combination, have a reducing effect on weight gain, plasma triglyceride, glucose and insulin levels. MET in combination with CGA led to attenuation of SM inflammation, an effect that was associated with decreasing macrophages infiltration rate. Combined treatment of MET and CGA also resulted in switching macrophages from M1 to M2 phenotype, presented by the higher expression levels of arginase and CD206 (M2 markers) and lower expression levels of iNOS and cd11c markers (M1). In addition, combination treatment was more effective in increasing the anti-inflammatory cytokines expression (IL-10) and decreasing the expression of pro-inflammatory mediators (TNF-alpha, IL-1 beta, MCP-1 and IL-6).ConclusionThese findings suggest that the combination treatment of MET and CGA is likely to be a promising approach to control SM inflammation in the HFD-fed model.
C1 [Khalafani, Zahra; Zamani-Garmsiri, Fahimeh; Panahi, Ghodratollah; Meshkani, Reza] Univ Tehran Med Sci, Fac Med, Dept Clin Biochem, Tehran, Iran.
   [Meshkani, Reza] Univ Tehran Med Sci, Fac Med, Dept Biochem, Tehran, Iran.
C3 Tehran University of Medical Sciences; Tehran University of Medical
   Sciences
RP Meshkani, R (corresponding author), Univ Tehran Med Sci, Fac Med, Dept Clin Biochem, Tehran, Iran.; Meshkani, R (corresponding author), Univ Tehran Med Sci, Fac Med, Dept Biochem, Tehran, Iran.
EM rmeshkani@tums.ac.ir
RI panahi, Ghodratollah/W-3772-2019
OI panahi, Ghodratollah/0000-0001-8338-4633
FU Deputy of Research, Tehran University of Medical Sciences
   [99-3-101-50932]
FX This work was financially supported by a grant (99-3-101-50932) from the
   Deputy of Research, Tehran University of Medical Sciences.
CR Aliabadi M, 2021, CYTOKINE, V146, DOI 10.1016/j.cyto.2021.155638
   Bagdas D, 2015, FOOD CHEM TOXICOL, V81, P54, DOI 10.1016/j.fct.2015.04.001
   Bagdas D, 2014, BIOL PHARM BULL, V37, P361, DOI 10.1248/bpb.b13-00635
   Bhatt Meha, 2017, BMC Res Notes, V10, P374, DOI 10.1186/s13104-017-2686-6
   Bu LX, 2020, LIFE SCI, V244, DOI 10.1016/j.lfs.2020.117304
   Cannon MV, 2016, DIABETOLOGIA, V59, P634, DOI 10.1007/s00125-015-3827-x
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clária J, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00049
   Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275
   Guo WR, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.704112
   Han X, 2019, J FOOD SCI, V84, P3815, DOI 10.1111/1750-3841.14838
   He L, 2020, TRENDS PHARMACOL SCI, V41, P868, DOI 10.1016/j.tips.2020.09.001
   Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Ianni F, 2022, FOOD CHEM, V374, DOI 10.1016/j.foodchem.2021.131820
   Jin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120842
   Jing YY, 2018, MOL CELL ENDOCRINOL, V461, P256, DOI 10.1016/j.mce.2017.09.025
   Jung SB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03998-z
   Karise I, 2019, BIOMED PHARMACOTHER, V111, P1156, DOI 10.1016/j.biopha.2019.01.021
   Kurylowicz A, 2020, MOLECULES, V25, DOI 10.3390/molecules25092224
   Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263
   Lv ZQ, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00191
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Matsui Y, 2010, BIOL PHARM BULL, V33, P963, DOI 10.1248/bpb.33.963
   Meshkani R, 2016, CLIN CHIM ACTA, V462, P77, DOI 10.1016/j.cca.2016.08.015
   Nankar R, 2017, PHYTOMEDICINE, V37, P10, DOI 10.1016/j.phymed.2017.10.015
   Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ortega MA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092749
   Peixoto LG, 2017, ACTA DIABETOL, V54, P943, DOI 10.1007/s00592-017-1027-5
   Peng JH, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01399
   Ruan WJ, 2019, INT J CHRONIC OBSTR, V14, P1559, DOI 10.2147/COPD.S197164
   Saisho Y, 2015, ENDOCR METAB IMMUNE, V15, P196, DOI 10.2174/1871530315666150316124019
   Sato S, 2020, J INFLAMM RES, V13, P421, DOI 10.2147/JIR.S228361
   Shabani M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60185-1
   Vasileva LV, 2021, FOOD CHEM TOXICOL, V149, DOI 10.1016/j.fct.2021.112002
   Wang BT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103197
   Wang D, 2021, J INT MED RES, V49, DOI 10.1177/0300060520985363
   Wang XQ, 2019, J CELL PHYSIOL, V234, P2566, DOI 10.1002/jcp.27012
   Wu HZ, 2017, J CLIN INVEST, V127, P43, DOI [10.1172/JCI88880, 10.1172/jci88880]
   Zamani-Garmsiri F, 2022, PHYTOTHER RES, V36, P415, DOI 10.1002/ptr.7329
   Zamani-Garmsiri F, 2021, IUBMB LIFE, V73, P252, DOI 10.1002/iub.2424
   Zamani-Garmsiri F, 2021, J NUTR BIOCHEM, V87, DOI 10.1016/j.jnutbio.2020.108505
   Zatterale F, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01607
   Zhou ZE, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4847812
NR 46
TC 6
Z9 6
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD MAR
PY 2023
VL 50
IS 3
BP 2581
EP 2589
DI 10.1007/s11033-022-08030-8
EA JAN 2023
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA F2WO3
UT WOS:000926541700004
PM 36626065
DA 2025-04-28
ER

PT J
AU Schinella, G
   Neyret, E
   Cónsole, G
   Tournier, H
   Prieto, JM
   Ríos, JL
   Giner, RM
AF Schinella, Guillermo
   Neyret, Elisa
   Console, Gloria
   Tournier, Horacio
   Prieto, Jose M.
   Rios, Jose-Luis
   Maria Giner, Rosa
TI An Aqueous Extract of Ilex paraguariensis Reduces
   Carrageenan-Induced Edema and Inhibits the Expression of
   Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Animal Models of
   Inflammation
SO PLANTA MEDICA
LA English
DT Article
DE Ilex paraguariensis; Aquifoliaceae; mate; anti-inflammatory effects; in
   vivo
ID SKIN INFLAMMATION; LAGGERA-ALATA; MATE; LEAVES; CONSTITUENTS; OBESITY;
   MICE; DIET
AB Mate (Ilex paraguariensis) is a highly popular herbal beverage in South America due to its high content of caffeine. Its hypolipidemic and antioxidant properties are of increasing interest in the treatment of cardiovascular disorders and for weight control. In the present study, we show for the first time both the local and systemic anti-inflammatory effects of an aqueous extract of mate in three classic in vivo models, namely acute and chronic 12-O-tetradecanoylphorbol 13-acetateinduced mouse ear edema and acute carrageenan-induced mouse paw edema. Caffeine, rutin, chlorogenic acid, 3,5-dicafeoyl quinic acid, and 4,5-dicafeoyl quinic acid, accompanied by a complex mixture of other simple phenolic acids, were identified in the extract by HPLC-UV analyses. In the acute edema model, mate extract applied topically (1mg/ear) halved the 12-O-tetradecanoylphorbol 13-acetate-induced acute edema (50%) and almost suppressed neutrophil infiltration (93%), while in the 12-O-tetradecanoylphorbol 13-acetate-induced subchronic inflammation, the edema was significantly reduced by 62% (1mg/ear/day x seven doses). The oral administration of the mate extract (250 mg/kg) significantly reduced the carrageenan-induced edema at all time points, an effect which was accompanied by a 43% and 53% reduction of the expression of cyclooxygenase-2 and inducible nitric oxide synthase, respectively. Histological analyses confirmed a reduction of epithelium thickness, dermis with mild inflammation, hair follicles with some secretory cells of sebaceous glands, and hypodermic adipocytes. In conclusion, mate is endowed with in vivo preventative or therapeutic anti-inflammatory effects in both local and systemic inflammatory processes.
C1 [Schinella, Guillermo; Tournier, Horacio] Univ Nacl La Plata, Catedra Farmacol Basica, Fac Ciencias Med, RA-1900 La Plata, Argentina.
   [Neyret, Elisa; Rios, Jose-Luis; Maria Giner, Rosa] Univ Valencia, Dept Farmacol, E-46100 Burjassot, Spain.
   [Console, Gloria] Univ Nacl La Plata, Catedra Citol Histol & Embriol B, Fac Ciencias Med, RA-1900 La Plata, Argentina.
   [Schinella, Guillermo; Console, Gloria; Tournier, Horacio] CIC, La Plata, Buenos Aires, Argentina.
   [Prieto, Jose M.] UCL, Sch Pharm, Ctr Pharmacognosy & Phytotherapy, Dept Pharmaceut & Biol Chem, London, England.
C3 National University of La Plata; University of Valencia; National
   University of La Plata; University of London; University College London;
   University of London School of Pharmacy
RP Schinella, G (corresponding author), Univ Nacl La Plata, Catedra Farmacol Basica, Fac Ciencias Med, Av 60 & 120, RA-1900 La Plata, Argentina.
EM schinell@uv.es
RI Prieto, Jose/ABF-8049-2020; Giner, Rosa/AAP-1773-2020; Prieto,
   Jose/F-2835-2012; Schinella, Guillermo/V-9937-2018
OI Giner, RM/0000-0001-5455-5923; Prieto, Jose/0000-0002-2649-1691;
   Schinella, Guillermo/0000-0001-9541-9688
CR Akkol EK, 2012, J ETHNOPHARMACOL, V140, P261, DOI 10.1016/j.jep.2012.01.015
   Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Bastos DHM., 2007, Med Aromat Plant Sci Biotechnol, V1, P37
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   Bravo L, 2007, FOOD RES INT, V40, P393, DOI 10.1016/j.foodres.2006.10.016
   Chattopadhyay C, 2012, INT J NUTR PHARM NEU, V2, P20
   Chen BT, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/537923
   Chua LS, 2013, J ETHNOPHARMACOL, V150, P805, DOI 10.1016/j.jep.2013.10.036
   de Morais EC, 2009, J AGR FOOD CHEM, V57, P8316, DOI 10.1021/jf901660g
   Dickel ML, 2007, J ETHNOPHARMACOL, V109, P60, DOI 10.1016/j.jep.2006.07.003
   Dufresne CJ, 2001, J NUTR BIOCHEM, V12, P404, DOI 10.1016/S0955-2863(01)00155-3
   Escandell JM, 2007, J PHARMACOL EXP THER, V320, P581, DOI 10.1124/jpet.106.107003
   Francisco V, 2013, J ETHNOPHARMACOL, V148, P126, DOI 10.1016/j.jep.2013.03.077
   Giner RM, 2000, EUR J PHARMACOL, V389, P243, DOI 10.1016/S0014-2999(99)00846-8
   Hao BJ, 2012, J ETHNOPHARMACOL, V144, P190, DOI 10.1016/j.jep.2012.09.003
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Kwon OS, 2011, ARCH PHARM RES, V34, P1561, DOI 10.1007/s12272-011-0919-0
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Lanzetti M, 2008, NUTRITION, V24, P375, DOI 10.1016/j.nut.2008.01.002
   Lee R., 2007, HARV HLTH LETT, V18, P8
   Martinet A, 1999, PHYTOMEDICINE, V6, P231, DOI 10.1016/S0944-7113(99)80014-2
   Martins F, 2010, OBESITY, V18, P42, DOI 10.1038/oby.2009.189
   Matsumoto RLT, 2009, J AGR FOOD CHEM, V57, P1775, DOI 10.1021/jf803096g
   Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106
   Oliveira DM, 2008, J AGR FOOD CHEM, V56, P10527, DOI 10.1021/jf8021404
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pimentel GD, 2013, J NUTR BIOCHEM, V24, P809, DOI 10.1016/j.jnutbio.2012.04.016
   Pittler MH, 2005, OBES REV, V6, P93, DOI 10.1111/j.1467-789X.2005.00169.x
   Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650
   Schinella GR, 2000, BIOCHEM BIOPH RES CO, V269, P357, DOI 10.1006/bbrc.2000.2293
   Schinella G, 2009, FOOD RES INT, V42, P1403, DOI 10.1016/j.foodres.2009.07.004
   Slomiany BL, 2002, J PHYSIOL PHARMACOL, V53, P325
   STANLEY PL, 1991, SKIN PHARMACOL, V4, P262, DOI 10.1159/000210960
   Sugimoto S, 2009, CHEM PHARM BULL, V57, P257, DOI 10.1248/cpb.57.257
   SUGISHITA E, 1981, J PHARMACOBIO-DYNAM, V4, P565, DOI 10.1248/bpb1978.4.565
   SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2
   Wu YH, 2006, J ETHNOPHARMACOL, V108, P243, DOI 10.1016/j.jep.2006.05.017
   Xu GH, 2009, ARCH PHARM RES, V32, P1215, DOI 10.1007/s12272-009-1905-7
NR 40
TC 18
Z9 18
U1 1
U2 11
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0032-0943
EI 1439-0221
J9 PLANTA MED
JI Planta Med.
PD AUG
PY 2014
VL 80
IS 12
BP 961
EP 968
DI 10.1055/s-0034-1382876
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA AN9CT
UT WOS:000340904300001
PM 25089736
DA 2025-04-28
ER

PT J
AU Zhong, YC
   Ding, YL
   Li, LQ
   Ge, MN
   Ban, GG
   Yang, HX
   Dai, J
   Zhang, LC
AF Zhong, Yanchun
   Ding, Yueling
   Li, Laiqing
   Ge, Meina
   Ban, Guangguo
   Yang, Hongxia
   Dai, Jun
   Zhang, Licheng
TI Effects and Mechanism of Chlorogenic Acid on Weight Loss
SO CURRENT PHARMACEUTICAL BIOTECHNOLOGY
LA English
DT Article
DE Chlorogenic acid; fat deposition; obesity; PGC-1 alpha/UCP-1 pathway;
   monosodium glutamate
ID INSULIN-RESISTANCE; ADIPOSE-TISSUE; CHOLESTEROL; COMBINATION; OBESITY
AB Background: Chlorogenic Acid (CA) has diverse, recognized health effects.
   Objective: This study aimed to explore the effects of CA on fat reduction and the underlying mechanism of these effects.
   Materials and Methods: First, we established a Monosodium Glutamate (MSG)-induced obesity mouse model and subjected the mice to 4 weeks of CA gavage. Then, we established an oleic acid-induced model of human fatty liver in HepG2 cells, and administered a CA intervention to the cells for 48 h. Finally, we used Oil red O staining, biochemical detection kits, RT-PCR and Western blot analysis to evaluate the effects of CA on fat reduction and on related pathways.
   Results: The CA treatment could reduce fat accumulation in the liver and reduce blood lipid levels. In addition, CA decreased the mRNA and protein levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1 alpha) and Uncoupling Protein 1 (UCP1) in the MSG-induced obesity mouse model and the oleic acid-induced HepG2 cells.
   Conclusion: Based on the above results, we deduced that CA could reduce body weight and fat deposition in vitro and in vivo and that the mechanism may be related to the PGC-1 alpha/UCP-1 pathway. CA can be developed as a drug to lower blood lipids and to treat obesity.
C1 [Zhong, Yanchun; Ding, Yueling; Ge, Meina; Ban, Guangguo; Yang, Hongxia; Dai, Jun] Hebei Univ Chinese Med, Coll Chinese Mat Med, Shijiazhuang, Hebei, Peoples R China.
   [Zhong, Yanchun] Guangzhou Med Univ, Shenzhen Shajing Affiliated Hosp, Dept Pharmacol, Shenzhen, Peoples R China.
   [Li, Laiqing] Guangzhou Youdi Biotechnol Co Ltd, Dept Res, Guangzhou 510663, Peoples R China.
   [Zhang, Licheng] Weihai Municipal Hosp, Southern Hosp Dist, Dept Oncol, Weihai 264200, Peoples R China.
C3 Hebei University of Chinese Medicine; Guangzhou Medical University
RP Zhang, LC (corresponding author), Weihai Municipal Hosp, Southern Hosp Dist, Dept Oncol, Weihai 264200, Peoples R China.
EM zhanglc88@aliyun.com
RI ; Yang, Hong-Xia/GXN-3813-2022
OI Zhang, Licheng/0000-0003-3098-9342; Yang, Hong-Xia/0000-0002-2293-8812;
   , Laiqing/0000-0002-1663-4142
FU National Natural Science Foundation of China [81774195]; Project of
   Hebei Administration of Traditional Chinese Medicine [2016001]; Project
   of Hebei Provincial Education Department [QN2014098]
FX This study was supported by the Project of National Natural Science
   Foundation of China (NO: 81774195), Project of Hebei Administration of
   Traditional Chinese Medicine (NO: 2016001), and Project of Hebei
   Provincial Education Department (NO: QN2014098).
CR Arias N, 2017, OBESITY, V25, P111, DOI 10.1002/oby.21706
   Barroso WA, 2018, EUR J NUTR, V57, P1891, DOI 10.1007/s00394-017-1472-5
   Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Domecq JP, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-44
   Fox CK, 2019, CURR OBES REP, V8, P201, DOI 10.1007/s13679-019-00347-z
   Fromme T, 2018, MOL METAB, V8, P77, DOI 10.1016/j.molmet.2017.12.010
   Fujikawa T, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.12
   Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   He XR, 2014, J ETHNOPHARMACOL, V151, P78, DOI 10.1016/j.jep.2013.11.023
   Bautista RJH, 2019, BIOMED PHARMACOTHER, V111, P503, DOI 10.1016/j.biopha.2018.12.108
   Islam M.S., 2017, J AM COLL CARDIOL, V53, P1925, DOI [10.3329/kyamcj.v5i1.32320, DOI 10.3329/KYAMCJ.V5I1.32320]
   Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Porter JA, 2004, AM J MANAG CARE, V10, P369
   Ravaud C, 2020, J CELL PHYSIOL, V235, P1184, DOI 10.1002/jcp.29032
   Sasaki Y, 2009, LIFE SCI, V85, P490, DOI 10.1016/j.lfs.2009.07.017
   Villarroya F, 2017, BIOCHIMIE, V134, P86, DOI 10.1016/j.biochi.2016.09.017
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752
   Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008
   Yan H, 2018, J BIOSCIENCES, V43, P287, DOI 10.1007/s12038-018-9746-5
   Yang jae heon, 2004, Journal of Pharmaceutical Investigation, V34, P115
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zheng SQ, 2017, J GERONTOL A-BIOL, V72, P464, DOI 10.1093/gerona/glw105
   Zhou Y, 2016, BIOCHEM BIOPH RES CO, V469, P1083, DOI 10.1016/j.bbrc.2015.12.094
NR 31
TC 20
Z9 22
U1 5
U2 51
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2010
EI 1873-4316
J9 CURR PHARM BIOTECHNO
JI Curr. Pharm. Biotechnol.
PY 2020
VL 21
IS 11
BP 1099
EP 1106
DI 10.2174/1389201021666200318124922
PG 8
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA NV3ZK
UT WOS:000574263900010
PM 32188382
DA 2025-04-28
ER

PT J
AU Moisey, LL
   Kacker, S
   Bickerton, AC
   Robinson, LE
   Graham, TE
AF Moisey, Lesley L.
   Kacker, Sita
   Bickerton, Andrea C.
   Robinson, Lindsay E.
   Graham, Terry E.
TI Caffeinated coffee consumption impairs blood glucose homeostasis in
   response to high and low glycemic index meals in healthy men
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; TOLERANCE TEST; INSULIN SENSITIVITY; RISK;
   INGESTION; HUMANS; WOMEN; MANAGEMENT; INCREASES; SECRETION
AB Background: The ingestion of caffeine (5 mg/kg body weight) and a 75-g oral glucose load has been shown to elicit an acute insulin-insensitive environment in healthy and obese individuals and in those with type 2 diabetes.
   Objective: In this study we investigated whether a similar impairment in blood glucose management exists when coffee and foods typical of a Western diet were used in a similar protocol.
   Design: Ten healthy men underwent 4 trials in a randomized order. They ingested caffeinated (5 mg/kg) coffee (CC) or the same volume of decaffeinated coffee (DC) followed 1 h later by either a high or low glycemic index (GI) cereal (providing 75 g of carbohydrate) mixed meal tolerance test.
   Results: CC with the high GI meal resulted in 147%, 29%, and 40% greater areas under the curve for glucose (P < 0.001), insulin (NS), and C-peptide (P < 0.001), respectively, compared with the values for DC. Similarly, with the low GI treatment, CC elicited 216%, 44%, and 36% greater areas under the curve for glucose (P < 0.001), insulin (P < 0.01), and C-peptide (P < 0.01), respectively. Insulin sensitivity was significantly reduced (40%) with the high GI treatment after CC was ingested compared with DC; with the low GI treatment, CC ingestion resulted in a 29% decrease in insulin sensitivity, although this difference was not significant.
   Conclusion: The ingestion of CC with either a high or low GI meal significantly impairs acute blood glucose management and insulin sensitivity compared with ingestion of DC. Future investigations are warranted to determine whether CC is a risk factor for insulin resistance.
C1 [Moisey, Lesley L.; Kacker, Sita; Bickerton, Andrea C.; Robinson, Lindsay E.; Graham, Terry E.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.
C3 University of Guelph
RP Graham, TE (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.
EM terrygra@uoguelph.ca
CR Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245
   [Anonymous], 2003, CANADIAN DIABETES AS, V27, pS1
   Avogaro A, 1996, DIABETES, V45, P1373, DOI 10.2337/diabetes.45.10.1373
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   BATTRAM DS, 2000, J PHYSL, V583, P1069
   Brand-Miller J, 2003, DIABETES CARE, V26, P2261, DOI 10.2337/diacare.26.8.2261
   Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185
   Farah A, 2006, J AGR FOOD CHEM, V54, P374, DOI 10.1021/jf0518305
   FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x
   GILBERT RM, 1984, METHYLXANTHINE BEVER, P185
   Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Harland BF, 2000, NUTRITION, V16, P522, DOI 10.1016/S0899-9007(00)00369-5
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Lane James D, 2007, Endocr Pract, V13, P239
   Lane JD, 2004, DIABETES CARE, V27, P2047, DOI 10.2337/diacare.27.8.2047
   LOWRY OH, 1993, ENZYMATIC ANAL PRACT
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311
   Petrie HJ, 2004, AM J CLIN NUTR, V80, P22
   Pizziol A, 1998, EUR J CLIN NUTR, V52, P846, DOI 10.1038/sj.ejcn.1600657
   Robinson LE, 2004, J NUTR, V134, P2528, DOI 10.1093/jn/134.10.2528
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Shearer J, 2007, CAN J PHYSIOL PHARM, V85, P823, DOI 10.1139/Y07-070
   Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529
   SPILLER MA, 1984, METHYLXANTHINE BEVER, P91
   Thong FSL, 2007, APPL PHYSIOL NUTR ME, V32, P701, DOI 10.1139/H07-039
   Thong FSL, 2002, J APPL PHYSIOL, V92, P2347, DOI 10.1152/japplphysiol.01229.2001
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   WOLEVER TMS, 1991, AM J CLIN NUTR, V54, P846, DOI 10.1093/ajcn/54.5.846
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
NR 40
TC 93
Z9 102
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD MAY
PY 2008
VL 87
IS 5
BP 1254
EP 1261
DI 10.1093/ajcn/87.5.1254
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 301EZ
UT WOS:000255880500022
PM 18469247
OA Bronze
DA 2025-04-28
ER

PT J
AU Schliep, KC
   Schisterman, EF
   Mumford, SL
   Pollack, AZ
   Zhang, CL
   Ye, AJ
   Stanford, JB
   Hammoud, AO
   Porucznik, CA
   Wactawski-Wende, J
AF Schliep, Karen C.
   Schisterman, Enrique F.
   Mumford, Sunni L.
   Pollack, Anna Z.
   Zhang, Cuilin
   Ye, Aijun
   Stanford, Joseph B.
   Hammoud, Ahmad O.
   Porucznik, Christina A.
   Wactawski-Wende, Jean
TI Caffeinated beverage intake and reproductive hormones among
   premenopausal women in the BioCycle Study
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID FOOD FREQUENCY QUESTIONNAIRE; MARGINAL STRUCTURAL MODELS; EPITHELIAL
   OVARIAN-CANCER; MENSTRUAL-CYCLE; GENETIC POLYMORPHISMS; PERIMENOPAUSAL
   WOMEN; BINDING GLOBULIN; CYP1A2 GENOTYPE; ESTROGEN-LEVELS; BREAST-CANCER
AB Background: Caffeinated beverages are widely consumed among women of reproductive age, but their association with reproductive hormones, and whether race modifies any such associations, is not well understood.
   Objective: We assessed the relation between caffeine and caffeinated beverage intake and reproductive hormones in healthy premenopausal women and evaluated the potential effect modification by race.
   Design: Participants (n = 259) were followed for up to 2 menstrual cycles and provided fasting blood specimens for hormonal assessment at up to 8 visits per cycle and four 24-h dietary recalls per cycle. Weighted linear mixed models and nonlinear mixed models with harmonic terms were used to estimate associations between caffeine and hormone concentrations, adjusted for age, adiposity, physical activity, energy and alcohol intakes, and perceived stress. On the basis of a priori assumptions, an interaction between race and caffeine was tested, and stratified results are presented.
   Results: Caffeine intake >= 200 mg/d was inversely associated with free estradiol concentrations among white women (beta = -0.15; 95% CI: -0.26, -0.05) and positively associated among Asian women (beta = 0.61; 95% CI: 0.31, 0.92). Caffeinated soda intake and green tea intake >= 1 cup/d (1 cup = 240 mL) were positively associated with free estradiol concentrations among all races: beta = 0.14 (95% CI: 0.06, 0.22) and beta = 0.26 (95% CI: 0.07, 0.45), respectively.
   Conclusions: Moderate consumption of caffeine was associated with reduced estradiol concentrations among white women, whereas caffeinated soda and green tea intakes were associated with increased estradiol concentrations among all races. Further research is warranted on the association between caffeine and caffeinated beverages and reproductive hormones and whether these relations differ by race. Am J Clin Nutr 2012;95:488-97.
C1 [Schisterman, Enrique F.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Epidemiol Stat & Prevent Res, Rockville, MD 20852 USA.
   [Schliep, Karen C.; Stanford, Joseph B.; Porucznik, Christina A.] Univ Utah, Dept Family & Prevent Med, Salt Lake City, UT USA.
   [Hammoud, Ahmad O.] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA.
   [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA.
C3 National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver
   National Institute of Child Health & Human Development (NICHD); Utah
   System of Higher Education; University of Utah; Utah System of Higher
   Education; University of Utah; State University of New York (SUNY)
   System; University at Buffalo, SUNY
RP Schisterman, EF (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Epidemiol Stat & Prevent Res, 6100 Execut Blvd,7B03M, Rockville, MD 20852 USA.
EM schistee@mail.nih.gov
RI zhang, cl/JDW-6549-2023; Porucznik, Christy/GNP-2905-2022; Schliep,
   Karen/A-2803-2012; Wactawski-Wende, Jean/AGH-5457-2022; Pollack,
   Anna/L-7652-2018
OI Zhang, Cuilin/0000-0002-8014-2708; Mumford, Sunni/0000-0003-0133-3176;
   Schisterman, Enrique/0000-0003-3757-641X; Wactawki-Wende,
   Jean/0000-0003-3096-9595; Porucznik, Christy/0000-0003-1973-2917;
   Pollack, Anna/0000-0002-4313-3298
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development, NIH
FX Supported by the Intramural Research Program of the Eunice Kennedy
   Shriver National Institute of Child Health and Human Development, NIH.
CR Albert PS, 2005, BIOMETRICS, V61, P1115, DOI 10.1111/j.0006-341X.2005.464_1.x
   Anderson BL, 2009, J WOMENS HEALTH, V18, P1457, DOI 10.1089/jwh.2008.1186
   BALOGH A, 1995, EUR J CLIN PHARMACOL, V48, P161
   Brent RL, 2011, BIRTH DEFECTS RES B, V92, P152, DOI 10.1002/bdrb.20288
   Bulun SE, 1999, ENDOCR-RELAT CANCER, V6, P293, DOI 10.1677/erc.0.0060293
   BUTLER MA, 1989, P NATL ACAD SCI USA, V86, P7696, DOI 10.1073/pnas.86.20.7696
   Carl J, 2009, J FAM PRACTICE, V58, P307
   Celec P, 2010, J PSYCHOPHARMACOL, V24, P1569, DOI 10.1177/0269881109105401
   Chavarro JE, 2009, EPIDEMIOLOGY, V20, P374, DOI 10.1097/EDE.0b013e31819d68cc
   Choi Jamie H, 2011, J Caffeine Res, V1, P29, DOI 10.1089/jcr.2011.0001
   Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148
   Eliassen AH, 2006, JNCI-J NATL CANCER I, V98, P1406, DOI 10.1093/jnci/djj376
   Eliassen AH, 2006, J CLIN ONCOL, V24, P1823, DOI 10.1200/JCO.2005.03.7432
   Fenster L, 1999, AM J EPIDEMIOL, V149, P550, DOI 10.1093/oxfordjournals.aje.a009851
   Finkelstein JS, 2002, J CLIN ENDOCR METAB, V87, P3057, DOI 10.1210/jc.87.7.3057
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   GOLDIN BR, 1986, AM J CLIN NUTR, V44, P945, DOI 10.1093/ajcn/44.6.945
   Goodman MT, 2003, NUTR CANCER, V46, P23, DOI 10.1207/S15327914NC4601_03
   GRODSTEIN F, 1993, AM J EPIDEMIOL, V137, P1353, DOI 10.1093/oxfordjournals.aje.a116644
   Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625
   Howards PP, 2009, AM J EPIDEMIOL, V169, P105, DOI 10.1093/aje/kwn287
   Kinney A, 2007, HUM REPROD, V22, P1175, DOI 10.1093/humrep/del496
   Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328
   Kotsopoulos J, 2009, CANCER CAUSE CONTROL, V20, P335, DOI 10.1007/s10552-008-9247-1
   LIN KM, 2000, PSYCHOPHARMACOLOGY 4
   Lucero J, 2001, FERTIL STERIL, V76, P723, DOI 10.1016/S0015-0282(01)02005-2
   Lurie G, 2005, CANCER EPIDEM BIOMAR, V14, P1521, DOI 10.1158/1055-9965.EPI-04-0746
   Marsh EE, 2011, J CLIN ENDOCR METAB, V96, P3199, DOI 10.1210/jc.2011-1314
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   Miao YL, 2007, THERIOGENOLOGY, V68, P640, DOI 10.1016/j.theriogenology.2007.04.061
   Mizutani T, 2003, DRUG METAB REV, V35, P99, DOI 10.1081/DMR-120023681
   Monteiro R, 2008, J NUTR, V138, P2156, DOI 10.1093/jn/138.11.2156
   Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635
   Palacios N, 2010, PARKINSONISM RELAT D, V16, P370, DOI 10.1016/j.parkreldis.2010.02.012
   Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6
   Peck JD, 2010, FOOD CHEM TOXICOL, V48, P2549, DOI 10.1016/j.fct.2010.06.019
   Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011
   Rothman K. J., 2008, Mordern Epidemiology
   Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x
   SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019
   Schatzkin A, 2003, INT J EPIDEMIOL, V32, P1054, DOI 10.1093/ije/dyg264
   Schisterman EF, 2010, AM J EPIDEMIOL, V172, P430, DOI 10.1093/aje/kwq131
   Shkolnik K, 2011, P NATL ACAD SCI USA, V108, P1462, DOI 10.1073/pnas.1017213108
   SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3
   Sowers MR, 2006, AM J MED, V119, P23, DOI 10.1016/j.amjmed.2006.07.003
   Sowers MR, 2003, OSTEOPOROSIS INT, V14, P44, DOI 10.1007/s00198-002-1307-x
   Speroff L., 1999, CLIN GYNECOLOGIC END
   Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009
   Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092
   Tworoger SS, 2008, CANCER-AM CANCER SOC, V112, P1169, DOI 10.1002/cncr.23275
   Wactawski-Wende J, 2009, PAEDIATR PERINAT EP, V23, P171, DOI 10.1111/j.1365-3016.2008.00985.x
   Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035
   Yamazaki H, 1998, CHEM RES TOXICOL, V11, P659, DOI 10.1021/tx970217f
   YEN SSC, 2004, YEN JAFFES REPROD DO
   Yong M, 2009, CANCER CAUSE CONTROL, V20, P1039, DOI 10.1007/s10552-009-9321-3
   Yoshimura N, 2002, J BONE MINER METAB, V20, P303, DOI 10.1007/s007740200044
NR 59
TC 49
Z9 60
U1 0
U2 19
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD FEB
PY 2012
VL 95
IS 2
BP 488
EP 497
DI 10.3945/ajcn.111.021287
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 883QC
UT WOS:000299647800029
PM 22237060
OA Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Chong, PW
   Beah, ZM
   Grube, B
   Riede, L
AF Chong, Pee-Win
   Beah, Zhi-Ming
   Grube, Barbara
   Riede, Linda
TI IQP-GC-101 Reduces Body Weight and Body Fat Mass: A Randomized,
   Double-Blind, Placebo-Controlled Study
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE herbal extracts; weight management; overweight; body fat; obesity
ID HYDROXYCITRIC ACID; GREEN TEA; OVERWEIGHT; ORLISTAT; CAFFEINE; OBESE
AB IQP-GC-101 is a patented blend of the standardized extracts of Garcinia cambogia, Camellia sinensis, unroasted Coffea arabica, and Lagerstroemia speciosa. These individual ingredients of IQP-GC-101 have each shown promise in promoting weight loss; however, the efficacy of the blend has not been established. This randomized, placebo-controlled, double-blind, parallel group study conducted over 14weeks (including a 2-week run-in phase) aimed to investigate the efficacy and safety of IQP-GC-101 in reducing body weight and body fat mass in overweight Caucasian adults. Subjects took three IQP-GC-101 or placebo tablets, twice a day, 30min before main meals. All subjects also adhered to a 500kcal/day energy deficit diet with 30% of energy from fat. Ninety-one overweight and mildly obese subjects (46 in the IQP-GC-101 group, 45 in the placebo group) completed the study. After 12-week intervention, IQP-GC-101 resulted in a mean (+/- SD) weight loss of 2.26 +/- 2.37kg compared with 0.56 +/- 2.34kg for placebo (p(U)=0.002). There was also significantly more reduction in body fat mass, waist circumference, and hip circumference in the IQP-GC-101 group. No serious adverse events were reported. The use of IQP-GC-101 has been shown to result in body weight and body fat reduction in the current study, with good tolerability. (c) 2014 InQpharm Group Sdn Bhd. Phytotherapy Research published by John Wiley & Sons, Ltd.
C1 [Chong, Pee-Win; Beah, Zhi-Ming] InQpharm Europe Ltd, Hitchin SG4 0TY, Herts, England.
   [Riede, Linda] Anal & Realize GmbH, D-13467 Berlin, Germany.
RP Chong, PW (corresponding author), InQpharm Europe Ltd, Invis House,Wilbury Way, Hitchin SG4 0TY, Herts, England.
EM pwchong@inqpharm.com
FU InQpharm Europe Ltd
FX The authors would like to thank Professor Andrew Hill of the University
   of Leeds; Regina Busch, MD; and Dr Norman Bitterlich for their
   invaluable assistance and advice. InQpharm Europe Ltd is the sponsor of
   this study.
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Agostoni C, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2604
   Anderson JW, 2006, ANN PHARMACOTHER, V40, P1717, DOI 10.1345/aph.1H234
   [Anonymous], 1987, Perennial edible fruits of the tropics: an inventory
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   [Anonymous], 2005, J. Appl. Sci. Res.
   [Anonymous], 2003, J OLEO SCI, DOI DOI 10.5650/JOS.52.499
   Bloch KV, 2003, J HYPERTENS, V21, P2159, DOI 10.1097/00004872-200311000-00026
   Chuah LO, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/197920
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4
   Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560
   Heymsfield SB, 1998, JAMA-J AM MED ASSOC, V280, P1596, DOI 10.1001/jama.280.18.1596
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Jayaprakasha GK, 1998, J CHROMATOGR A, V806, P337, DOI 10.1016/S0021-9673(98)00054-5
   Klein G, 2007, EVID-BASED COMPL ALT, V4, P401, DOI 10.1093/ecam/nem013
   Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x
   Liu F, 2001, J NUTR, V131, P2242, DOI 10.1093/jn/131.9.2242
   Mattes RD, 2000, PHYSIOL BEHAV, V71, P87, DOI 10.1016/S0031-9384(00)00321-8
   Ohia SE, 2002, MOL CELL BIOCHEM, V238, P89, DOI 10.1023/A:1019911205672
   Onakpoya I, 2011, J OBES, V2011, DOI 10.1155/2011/509038
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Razak F, 2005, INT J OBESITY, V29, P656, DOI 10.1038/sj.ijo.0802937
   Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232
   Stohs SJ, 2012, PHYTOTHER RES, V26, P317, DOI 10.1002/ptr.3664
   SULLIVAN AC, 1974, LIPIDS, V9, P129, DOI 10.1007/BF02532137
   SULLIVAN AC, 1977, J BIOL CHEM, V252, P7583
   Fayh APT, 2013, EUR J NUTR, V52, P1443, DOI 10.1007/s00394-012-0450-1
   Tsuchibe S., 2006, J. Integr. Study Diet Habits, V17, P255, DOI [10.2740/jisdh.17.255, DOI 10.2740/JISDH.17.255]
NR 29
TC 25
Z9 25
U1 0
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD OCT
PY 2014
VL 28
IS 10
BP 1520
EP 1526
DI 10.1002/ptr.5158
PG 7
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA AQ4VP
UT WOS:000342798700012
PM 24797657
OA Green Published
DA 2025-04-28
ER

PT J
AU Maki, KC
   Reeves, MS
   Farmer, M
   Yasunaga, K
   Matsuo, N
   Katsuragi, Y
   Komikado, M
   Tokimitsu, I
   Wilder, D
   Jones, F
   Blumberg, JB
   Cartwright, Y
AF Maki, Kevin C.
   Reeves, Matthew S.
   Farmer, Mildred
   Yasunaga, Koichi
   Matsuo, Noboru
   Katsuragi, Yoshihisa
   Komikado, Masanori
   Tokimitsu, Ichiro
   Wilder, Donna
   Jones, Franz
   Blumberg, Jeffrey B.
   Cartwright, Yolanda
TI Green Tea Catechin Consumption Enhances Exercise-Induced Abdominal Fat
   Loss in Overweight and Obese Adults
SO JOURNAL OF NUTRITION
LA English
DT Article
ID LOW-DENSITY-LIPOPROTEIN; ENERGY-EXPENDITURE; BODY-FAT; OXIDATION;
   CAFFEINE; EXTRACT; EPIGALLOCATECHIN-3-GALLATE; THERMOGENESIS;
   CHOLESTEROL; POLYPHENOLS
AB This study evaluated the influence of a green tea catechin beverage on body composition and fat distribution in overweight and obese adults during exercise-induced weight loss. Participants (n = 132 with 107 completers) were randomly assigned to receive a beverage containing similar to 625 mg of catechins with 39 mg caffeine or a control beverage (39 mg caffeine, nocatechins) for 12 wk. Participants were asked to maintain constant energy intake and engage in >= 180 min/wk moderate intensity exercise, including >= 3 supervised sessions per week. Body composition (dual X-ray absorptiometry), abdominal fat areas (computed tomography), and clinical laboratory tests were measured at baseline and wk 12. There was a trend (P = 0.079) toward greater loss of body weight in the catechin group compared with the control group; least squares mean (95% Cl) changes, adjusted for baseline value, age, and sex, were -2.2 (-3.1, -1.3) and -1.0 (-1.9, -0.1) kg, respectively. Percentage changes in fat mass did not differ between the catechin [5.2 (-7.0, -3.4)] and control groups 1-3.5 (-5.4, 1.6)] (P = 0.208). However, percentage changes in total abdominal fat area [-7.7 (-11.7, -3.8) vs. -0.3 (-4.4, 3.9); P = 0.013], subcutaneous abdominal fat area [-6.2 (-10.2, -2.2) vs. 0.8 (-3.3, 4.9); P = 0.0191, and fasting serum triglycerides (TG) [-11.2 (-18.8, -3.6) vs. 1.9 (-5.9, 9.7); P = 0.023] were greater in the catechin group. These findings suggest that green tea catechin consumption enhances exercise-induced changes in abdominal fat and serum TG. J. Nutr. 139: 264-270, 2009.
C1 [Maki, Kevin C.; Reeves, Matthew S.; Wilder, Donna; Jones, Franz; Cartwright, Yolanda] Provident Clin Res, Bloomington, IN 47403 USA.
   [Maki, Kevin C.; Reeves, Matthew S.; Wilder, Donna; Jones, Franz; Cartwright, Yolanda] Provident Clin Res, Glen Ellyn, IL 60137 USA.
   [Farmer, Mildred] Meridien Res, St Petersburg, FL 33709 USA.
   [Yasunaga, Koichi; Matsuo, Noboru; Katsuragi, Yoshihisa; Komikado, Masanori; Tokimitsu, Ichiro] Kao Corp, Hlth Care Food Res Lab, Tokyo 1318501, Japan.
   [Blumberg, Jeffrey B.] Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer USDA, Antioxidants Res Lab, Boston, MA 02111 USA.
C3 KAO Corporation; United States Department of Agriculture (USDA); Tufts
   University
RP Maki, KC (corresponding author), Provident Clin Res, Bloomington, IN 47403 USA.
EM kmaki@providentcrc.com
RI Blumberg, Jeffrey/ABH-7888-2020; Reeves, matthew/JFS-7851-2023
FU Kao Corporation, Tokyo, Japan
FX Supported by Kao Corporation, Tokyo, Japan.
CR *AM COLL SPORTS ME, 1997, ACSMS HLTH FITN FAC
   [Anonymous], 2001, J OLEO SCI, DOI DOI 10.5650/JOS.50.677
   [Anonymous], 2001, J OLEO SCI, DOI DOI 10.5650/JOS.50.657
   Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094
   Despres J P, 2006, J Endocrinol Invest, V29, P77
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   DPP Res Grp, 2002, DIABETES CARE, V25, P2165
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Ishikawa T, 1997, AM J CLIN NUTR, V66, P261, DOI 10.1093/ajcn/66.2.261
   Ito Y, 2008, BIOMED RES-TOKYO, V29, P27, DOI 10.2220/biomedres.29.27
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Osada K, 2001, COMP BIOCHEM PHYS C, V128, P153, DOI 10.1016/S1532-0456(00)00192-7
   PESCE M, 2006, PROVIDENT PRV06001 P
   Pi-Sunyer FX, 1998, OBES RES, V6, p51S
   Reaven Gerald M., 1997, P357
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987
   Stunkard AJ, 1996, AM J MED, V100, P230, DOI 10.1016/S0002-9343(97)89464-8
   Unno T, 2005, BRIT J NUTR, V93, P543, DOI 10.1079/BJN20041379
   Volpi N, 1998, J CHROMATOGR B, V713, P433, DOI 10.1016/S0378-4347(98)00195-9
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   WOLTHUIS RA, 1977, AM J CARDIOL, V39, P697, DOI 10.1016/S0002-9149(77)80131-8
   Yang MH, 2001, J NUTR BIOCHEM, V12, P14, DOI 10.1016/S0955-2863(00)00140-6
NR 39
TC 182
Z9 203
U1 0
U2 56
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD FEB
PY 2009
VL 139
IS 2
BP 264
EP 270
DI 10.3945/jn.108.098293
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 398MC
UT WOS:000262735200011
PM 19074207
OA Bronze
DA 2025-04-28
ER

PT J
AU Maskarinec, G
   Kristal, BS
   Wilkens, LR
   Bs, GQ
   Bogumil, D
   Setiawan, VW
   Le Marchand, L
AF Maskarinec, Gertraud
   Kristal, Bruce S.
   Wilkens, Lynne R.
   Bs, Gino Quintal
   Bogumil, David
   Setiawan, Veronica W.
   Le Marchand, Loic
TI Risk Factors for Type 2 Diabetes in the Multiethnic Cohort
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE cohort studies; ethnicity; lifestyle; survival analysis; type 2 diabetes
ID BODY-MASS INDEX; SELF-REPORTS; RACIAL/ETHNIC DISPARITIES; DECAFFEINATED
   COFFEE; POSTMENOPAUSAL WOMEN; PHYSICAL-ACTIVITY; NATIVE HAWAIIANS; SLEEP
   DURATION; HEALTH PLANS; METAANALYSIS
AB Objectives: In this report, we investigated the association between established risk factors and type 2 diabetes (T2D) across 5 distinct ethnic groups and explored differences according to T2D definition within the Multiethnic Cohort (MEC) Study. Methods: Using the full MEC, with participants in Hawaii and Los Angeles (N=172,230), we applied Cox regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). All participants completed questionnaires asking about demographics, anthropometrics, lifestyle factors, and regular diet. T2D status was determined from self-reported diagnosis/medication and Medicare claims. We assessed the associations between well-established risk factors and T2D in the full cohort, after stratification by ethnic group, according to the T2D definition, and in a biorepository subset. Effect modification by ethnicity was evaluated using Wald's tests. Results: Overall, 46,500 (27%) participants had an incident T2D diagnosis after a mean follow-up of 17.1 +/- 6.9 years. All predictors were significantly associated with T2D: overweight (HR=1.74), obesity (HR=2.90), red meat intake (HR=1.15), short (HR=1.04) and long (HR=1.08) sleep duration, and smoking (HR=1.26) pre-dicted a significantly higher T2D incidence, whereas coffee (HR=0.90) and alcohol (HR=0.78) consumption, physical activity (HR=0.89), and diet quality (HR=0.96) were associated with lower T2D incidence. The strength of these associations was similar across ethnic groups with noteworthy disparities for overweight/ obesity, physical activity, alcohol intake, coffee consumption, and diet quality. Conclusions: These findings confirm the importance of known risk factors for T2D across ethnic groups, but small differences were detected that may contribute to disparate incidence rates in some ethnic groups, especially for obesity and physical activity. (c) 2023 Canadian Diabetes Association.
C1 [Maskarinec, Gertraud; Wilkens, Lynne R.; Bs, Gino Quintal] Univ Hawaii, Populat Sci Pacific, Canc Ctr, Honolulu, HI USA.
   [Kristal, Bruce S.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA USA.
   [Kristal, Bruce S.] Harvard Med Sch, Boston, MA USA.
   [Bogumil, David; Setiawan, Veronica W.] Univ Southern Calif, Prevent Med, Los Angeles, CA USA.
   [Maskarinec, Gertraud] Univ Hawaii, Canc Ctr, 701 Ilalo St, Honolulu, HI 96813 USA.
C3 University of Hawaii System; Cancer Research Center of Hawaii; Harvard
   University; Harvard University Medical Affiliates; Brigham & Women's
   Hospital; Harvard University; Harvard Medical School; University of
   Southern California; Cancer Research Center of Hawaii; University of
   Hawaii System
RP Maskarinec, G (corresponding author), Univ Hawaii, Canc Ctr, 701 Ilalo St, Honolulu, HI 96813 USA.
EM gertraud@cc.hawaii.edu
RI Bogumil, David/GVU-1340-2022
OI Kristal, Bruce/0000-0001-6103-7745; Maskarinec,
   Gertraud/0000-0002-8129-958X
FU US National Insti-tutes of Health [U01CA164973, P30CA071789,
   R01HL140335, T32CA229110]
FX This research was funded by grants from the US National Insti-tutes of
   Health (U01CA164973, P30CA071789, R01HL140335) . D.B. was supported by a
   fellowship (T32CA229110) .
CR Araneta MRG, 2002, DIABETES CARE, V25, P494, DOI 10.2337/diacare.25.3.494
   Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x
   Boyer WR, 2018, J DIABETES, V10, P166, DOI 10.1111/1753-0407.12574
   Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124
   Casagrande S, 2018, DIABETES, V67, DOI 10.2337/db18-1478-P
   Chronic Conditions Data Warehouse, 2022, Condition categories
   Comino EJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-481
   Crawford MA, 2015, WOMENS HEALTH, V11, P913, DOI 10.2217/whe.15.62
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Doo T, 2014, PUBLIC HEALTH NUTR, V17, P1328, DOI 10.1017/S1368980013000487
   Egede LE, 2023, DIABETES CARE, V46, P667, DOI 10.2337/dci22-0044
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jackson JM, 2014, MENOPAUSE, V21, P861, DOI [10.1097/GME.0000000000000189, 10.1097/gme.0000000000000189]
   Jacobs S, 2017, BRIT J NUTR, V118, P312, DOI [10.1017/S0007114517002033, 10.1017/s0007114517002033]
   Jannasch F, 2017, J NUTR, V147, P1174, DOI 10.3945/jn.116.242552
   Karter AJ, 2013, DIABETES CARE, V36, P574, DOI 10.2337/dc12-0722
   Knott C, 2015, DIABETES CARE, V38, P1804, DOI 10.2337/dc15-0710
   Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213
   Lee DH, 2018, EUR J EPIDEMIOL, V33, P1113, DOI 10.1007/s10654-018-0433-5
   Leong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075256
   Li HL, 2020, J EPIDEMIOL, V30, P516, DOI 10.2188/jea.JE20190178
   Lim U, 2019, GASTROENTEROLOGY, V156, P966, DOI 10.1053/j.gastro.2018.11.021
   LIPTON RB, 1993, AM J EPIDEMIOL, V138, P826, DOI 10.1093/oxfordjournals.aje.a116786
   Lutsey PL, 2010, AM J EPIDEMIOL, V172, P197, DOI 10.1093/aje/kwq100
   Ma YS, 2012, DIABETES CARE, V35, P2226, DOI 10.2337/dc12-0412
   Magliano DJ, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5003
   Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749
   Maskarinec G, 2016, EUR J CLIN NUTR, V70, P1022, DOI 10.1038/ejcn.2016.32
   Maskarinec G, 2018, SLEEP HEALTH, V4, P27, DOI 10.1016/j.sleh.2017.08.008
   Maskarinec G, 2009, DIABETES, V58, P1732, DOI 10.2337/db08-1685
   Maskarinec G, 2009, ETHNIC DIS, V19, P49
   McWhorter KL, 2019, BMJ OPEN DIAB RES CA, V7, DOI 10.1136/bmjdrc-2019-000652
   Muggah E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-16
   Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758
   Park SY, 2020, J NUTR, V150, P1880, DOI 10.1093/jn/nxaa102
   Qiao YX, 2014, ETHNIC HEALTH, V19, P328, DOI 10.1080/13557858.2013.797322
   Rector TS, 2004, HEALTH SERV RES, V39, P1839, DOI 10.1111/j.1475-6773.2004.00321.x
   Ruijgrok C, 2018, DIABETOLOGIA, V61, P93, DOI 10.1007/s00125-017-4452-7
   Sakshaug JW, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-150
   Schlesinger S, 2020, J EPIDEMIOL COMMUN H, V74, P481, DOI 10.1136/jech-2019-213415
   Seixas AA, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/5906034
   Setiawan VW, 2015, AM J EPIDEMIOL, V181, P917, DOI 10.1093/aje/kwv055
   Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057
   Shan ZL, 2015, DIABETES CARE, V38, P529, DOI 10.2337/dc14-2073
   St Clair P, 2017, MED CARE, V55, P782, DOI 10.1097/MLR.0000000000000753
   Steinbrecher A, 2012, J PHYS ACT HEALTH, V9, P634, DOI 10.1123/jpah.9.5.634
   Steinbrecher A, 2011, ANN EPIDEMIOL, V21, P526, DOI 10.1016/j.annepidem.2011.03.009
   Stevens J, 2008, AM J EPIDEMIOL, V167, P1365, DOI 10.1093/aje/kwn060
   Stram DO, 2000, AM J EPIDEMIOL, V151, P358, DOI 10.1093/oxfordjournals.aje.a010214
   US Department of Health Human Services, 2020, 2015-2020 Dietary guidelines for Americans
NR 50
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1499-2671
EI 2352-3840
J9 CAN J DIABETES
JI Can. J. Diabetes
PD DEC
PY 2023
VL 47
IS 8
DI 10.1016/j.jcjd.2023.06.004
EA DEC 2023
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA EP8P4
UT WOS:001140222700001
PM 37406880
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Karadavut, B
   Sahin, H
   Kaner, G
   Karadavut, S
AF Karadavut, Bahar
   Sahin, Habibe
   Kaner, Gulsah
   Karadavut, Serhat
TI Is beverage consumption associated with increased body weight among
   adolescents?
SO PROGRESS IN NUTRITION
LA English
DT Article
DE adolescents; obesity; beverages
ID FRUIT JUICE CONSUMPTION; SOFT DRINK CONSUMPTION; SHORT STATURE;
   CHILDREN; OBESITY; OVERWEIGHT; CALCIUM; CHOICES; HEALTH
AB Background: Recently, considerable attention has been given to beverage intake as a source of calories which may be linked to pediatric obesity. Objective: To examine the association between beverage consumption and changes in weight status among adolescents. Material/Methods: A total of 600 adolescents, aged 14-18 years, were involved in the study. Body weight, height, and waist circumference were measured. BMI percentiles were calculated and adolescents were classified as normal weight, overweight, and obese. For the collection of data on beverage intake, the 24-h recall technique was used. Data on beverages were examined in milliliters. Results: Of the total 600 participants in our sample, 79.3% were considered to be of normal weight, 13.3% were overweight and 7.4% were obese. All of the adolescents consumed water. Tea was the second most commonly consumed beverage (80.8%), followed by sugar-sweetened beverages (SSBs, 49.3%), and whole fat milk (24.3%). Elevated consumption of water was associated with elevated weight, BMI and waist circumference. There was no evidence of an association among milk, fruit juice, SSBs, tea, coffee consumption and weight status. Conclusion: In this study, water intake was associated with obesity. Further studies investigating the relationship among beverage consumption, total energy intake, and development of obesity are needed.
C1 [Karadavut, Bahar] Kayseri Educ & Res Hosp, Dept Nutr & Dietet, Kayseri, Turkey.
   [Sahin, Habibe] Erciyes Univ, Fac Hlth Sci, Dept Nutr & Dietet, Kayseri, Turkey.
   [Kaner, Gulsah] Izmir Katip Celebi Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-35620 Izmir, Turkey.
   [Karadavut, Serhat] Develi Hatice Muammer Kocaturk State Hosp, Dept Cardiol Clin, Kayseri, Turkey.
C3 Kayseri Training & Research Hospital; Erciyes University; Izmir Katip
   Celebi University; Kayseri Develi Hatice-Muammer Kocaturk State Hospital
RP Kaner, G (corresponding author), Izmir Katip Celebi Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-35620 Izmir, Turkey.
EM kanergulsah@gmail.com
RI Kaner Tohtak, Gulsah/HJA-3408-2022; Şahin, Habibe/AAM-2313-2021;
   Karadavut, Serhat/AAZ-6033-2021
OI Karadavut, Serhat/0000-0002-9143-890X
CR Alexy U, 1999, J PEDIATR GASTR NUTR, V29, P343, DOI 10.1097/00005176-199909000-00019
   [Anonymous], 2010, USDA National Nutrient Database for Standard Reference
   [Anonymous], 2002, DIET NUTR PREV CHRON
   Baker SS, 1999, PEDIATRICS, V104, P1152, DOI 10.1542/peds.104.5.1152
   Ballew C, 2000, ARCH PEDIAT ADOL MED, V154, P1148, DOI 10.1001/archpedi.154.11.1148
   Barba G, 2005, BRIT J NUTR, V93, P15, DOI 10.1079/BJN20041300
   Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C
   Bindler Ruth McGillis, 2006, J Pediatr Health Care, V20, P82, DOI 10.1016/j.pedhc.2005.09.005
   Bitirak G, 2008, ACTA MED ACADEMICA, V37, P23
   Dennison BA, 1997, PEDIATRICS, V99, P15
   Duffey KJ, 2012, EUR J CLIN NUTR, V66, P244, DOI 10.1038/ejcn.2011.166
   Epstein LH, 1998, PEDIATRICS, V101, P554
   Forshee RA, 2003, INT J FOOD SCI NUTR, V54, P297, DOI [10.1080/09637480120092143, 10.1080/096374803766666175]
   Gibson S, 2008, NUTR RES REV, V21, P134, DOI 10.1017/S0954422408110976
   Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6
   Heuberger R., 2009, Californian Journal of Health Promotion, V7, P62
   Kohler S, 2007, ERNAHRUNG WISSENSCHA, V1, P444
   Krassas G E, 2001, J Pediatr Endocrinol Metab, V14 Suppl 5, P1319
   Lioret S, 2010, BRIT J NUTR, V103, P585, DOI 10.1017/S0007114509992078
   Lobstein T., 2004, OBES REV, V5, P4, DOI 10.1111/j.1467-789X.2004.00133.x
   Mahan KL, 1996, MEASUREMENT HEIGHT W, P371
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Noel SE, 2011, J NUTR, V141, P2035, DOI 10.3945/jn.111.143420
   Öner N, 2004, SWISS MED WKLY, V134, P529, DOI 10.57187/smw.2004.10740
   Papandreou D, 2013, HIPPOKRATIA, V17, P42
   Sichieri R, 2013, PUBLIC HEALTH NUTR, V16, P73, DOI 10.1017/S1368980012001309
   Skinner JD, 1999, PEDIATRICS, V103, P58, DOI 10.1542/peds.103.1.58
   Storey ML, 2004, J AM COLL NUTR, V23, P18, DOI 10.1080/07315724.2004.10719339
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   The Ministry of Health of Turkey, 2010, NUTR HLTH SURV
   The Ministry of Health of Turkey and The General Directorate of Primary Health Care, 2013, DIET GUID TURK REC S
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834
   Wille N, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-421
   World Health Organization, GROWTH REF 5 19 YEAR
NR 35
TC 1
Z9 1
U1 0
U2 11
PU MATTIOLI 1885
PI FIDENZA
PA VIA DELLA LODESANA 649-SX, FIDENZA, 43046 PR, ITALY
SN 1129-8723
J9 PROG NUTR
JI Prog. Nutr.
PD MAR
PY 2017
VL 19
IS 1
BP 41
EP 47
DI 10.23751/pn.v19i1.5133
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA ER8US
UT WOS:000399099500005
DA 2025-04-28
ER

PT J
AU Santos, LP
   Assunçao, MCF
   Matijasevich, A
   Santos, IS
   Barros, AJD
AF Santos, Leonardo Pozza
   Formoso Assuncao, Maria Cecilia
   Matijasevich, Alicia
   Santos, Ina S.
   Barros, Aluisio J. D.
TI Dietary intake patterns of children aged 6 years and their association
   with socioeconomic and demographic characteristics, early feeding
   practices and body mass index
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Dietary intake; Principal component analysis; Cohort studies; Nutrition
   assessment
ID ULTRA-PROCESSED FOODS; BRAZIL BIRTH COHORT; MULTIVARIATE-ANALYSIS;
   EUROPEAN CHILDREN; CONSUMPTION; ADOLESCENTS; HEALTH; DETERMINANTS;
   COUNTRIES; OBESITY
AB Background: Dietary intake patterns of children from the 2004 Pelotas birth cohort study have been described at 12, 24 and 48 months of age, but there is no information about dietary patterns of these children at 6 years. Then, we aimed to identify and describe dietary intake patterns of children aged 6 years as well as to assess their association with socioeconomic and demographic characteristics, early feeding practices and BMI z-score at 6 years.
   Methods: We used principal components analysis to identify dietary intake patterns of 3,427 children from the 2004 Pelotas (Brazil) birth cohort study. We used multiple linear regression models to evaluate whether socioeconomic and demographic characteristics (socioeconomic position, mother's age at birth, and child's sex and skin colour), early feeding practices (exclusive breastfeeding duration and age of introduction of complementary foods), and BMI z-score at 6 years were associated with dietary intake patterns.
   Results: We identified seven dietary components of children's dietary intake patterns, namely: fruits and vegetables, snacks and treats, coffee and bread, milk, cheese and processed meats, rice and beans and carbohydrates. Dietary patterns were socially patterned, since six dietary components were associated with socioeconomic position. Moreover, high intake of snacks and treats and less fruits and vegetables were associated with children born to teenage mothers, with those exclusively breastfed for less than one month, and with those who started on complementary feeding before 4 months. Finally, overweight and obese children at 6 years presented lower intake of four out of seven dietary components, but we need to be cautious in interpretation due to limitations on food consumption reporting and due to possible reverse causality.
   Conclusion: Dietary intake patterns in children are strongly influenced by socioeconomic characteristics. Other factors such as younger maternal age at birth, and both early weaning and early introduction of complementary feeding appear to be related with 'nhealthier' patterns. Overweight and obese children presented lower intake of four out of seven dietary components, but further studies would be interesting to understand the longitudinal effect of children's feeding practices on BMI and adiposity.
C1 [Santos, Leonardo Pozza; Formoso Assuncao, Maria Cecilia; Matijasevich, Alicia; Santos, Ina S.; Barros, Aluisio J. D.] Univ Fed Pelotas, Postgrad Program Epidemiol, 1160 Marechal Deodoro St,3th Floor, BR-96020220 Pelotas, Brazil.
   [Matijasevich, Alicia] Univ Sao Paulo, Dept Prevent Med, 455 Dr Arnaldo Ave,2nd Floor, BR-01246903 Sao Paulo, Brazil.
C3 Universidade Federal de Pelotas; Universidade de Sao Paulo
RP Santos, LP (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, 1160 Marechal Deodoro St,3th Floor, BR-96020220 Pelotas, Brazil.
EM leonardo_pozza@yahoo.com.br
RI Santos, Ina/C-2001-2009; Barros, Aluisio/A-7417-2008; Matijasevich,
   Alicia/C-5576-2009; Santos, Leonardo Pozza dos/E-3460-2014
OI Matijasevich, Alicia/0000-0003-0060-1589; Barros,
   Aluisio/0000-0002-2022-8729; Santos, Leonardo Pozza
   dos/0000-0002-3993-3786
FU Wellcome Trust; World Health Organization; Brazilian National research
   Council (CNPq); Brazilian Ministry of Health
FX The 2004 birth cohort study is supported by the Wellcome Trust through
   the scheme called 'Major Awards for Latin America on Health Consequences
   of Population Change. The World Health Organization, Brazilian National
   research Council (CNPq), and Brazilian Ministry of Health have supported
   previous phase of the study.
CR Aranceta J, 2003, EUR J CLIN NUTR, V57, pS40, DOI 10.1038/sj.ejcn.1601813
   Barbaresko J, 2014, BRIT J NUTR, V112, P1364, DOI 10.1017/S0007114514002098
   Barros AJD, 2005, REV SAUDE PUBL, V39, P523, DOI 10.1590/S0034-89102005000400002
   Barros AJD, 2006, REV SAUDE PUBL, V40, P402, DOI 10.1590/S0034-89102006000300007
   Bielemann RM, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005572
   Biro FM, 2010, AM J CLIN NUTR, V91, p1499S, DOI 10.3945/ajcn.2010.28701B
   Canella DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092752
   Cooke LJ, 2005, BRIT J NUTR, V93, P741, DOI 10.1079/BJN20051389
   Craig LCA, 2010, BRIT J NUTR, V103, P319, DOI 10.1017/S0007114509991942
   Louzada MLD, 2015, REV SAUDE PUBL, V49, DOI [10.1590/S0034-8910.2015049006132, 10.1590/S0034-8910.2015049005650]
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786
   Fernández-Alvira JM, 2014, EUR J CLIN NUTR, V68, P811, DOI 10.1038/ejcn.2014.78
   Fitzgerald A, 2010, HEALTH PROMOT INT, V25, P289, DOI 10.1093/heapro/daq021
   Gatica G, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-43
   Green BP, 2015, J DAIRY SCI, V98, P3701, DOI 10.3168/jds.2014-9161
   Grieger JA, 2011, PUBLIC HEALTH NUTR, V14, P1939, DOI 10.1017/S1368980011001030
   Grote V, 2012, CURR OPIN CLIN NUTR, V15, P293, DOI 10.1097/MCO.0b013e328351baba
   Harris TS, 2015, APPETITE, V85, P171, DOI 10.1016/j.appet.2014.11.008
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   IBGE, 2011, PESQ ORC FAM 2008 20
   Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010
   Lioret S, 2015, J NUTR, V145, P775, DOI 10.3945/jn.114.201988
   Mak TN, 2013, PUBLIC HEALTH NUTR, V16, P1912, DOI 10.1017/S1368980013001912
   Mayén AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029
   McCourt HJ, 2014, BRIT J NUTR, V112, P1685, DOI 10.1017/S0007114514002682
   Mennella JA, 1997, PEDIATR RES, V41, P188, DOI 10.1203/00006450-199702000-00006
   Mennella JA, 2009, AM J CLIN NUTR, V90, p780S, DOI 10.3945/ajcn.2009.27462O
   Mensink GBM, 2007, BUNDESGESUNDHEITSBLA, V50, P609, DOI 10.1007/s00103-007-0222-x
   Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x
   Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005
   Mourouti N, 2015, EUR J NUTR, V54, P609, DOI 10.1007/s00394-014-0742-8
   North K, 2000, EUR J CLIN NUTR, V54, P73, DOI 10.1038/sj.ejcn.1600896
   Northstone K, 2005, EUR J CLIN NUTR, V59, P751, DOI 10.1038/sj.ejcn.1602136
   Novotny R, 2003, J AM COLL NUTR, V22, P64, DOI 10.1080/07315724.2003.10719277
   Pala V, 2013, EUR J CLIN NUTR, V67, P1042, DOI 10.1038/ejcn.2013.145
   Perrine CG, 2014, PEDIATRICS, V134, pS50, DOI 10.1542/peds.2014-0646I
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Ranijt N, 2015, J NUTR EDUC BEHAV, V47, P53
   RIBEIRO Adriana Bouças, 2002, Rev. Nutr., V15, P239, DOI 10.1590/S1415-52732002000200012
   Santos IS, 2014, INT J EPIDEMIOL, V43, P1437, DOI 10.1093/ije/dyu144
   Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009
   Shroff MR, 2014, PUBLIC HEALTH NUTR, V17, P1507, DOI 10.1017/S136898001300133X
   Smith ADAC, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.22769
   Smithers LG, 2012, EUR J CLIN NUTR, V66, P658, DOI 10.1038/ejcn.2011.219
   Smithers LG, 2011, NUTR REV, V69, P449, DOI 10.1111/j.1753-4887.2011.00407.x
   Varraso R, 2012, AM J CLIN NUTR, V96, P1079, DOI 10.3945/ajcn.112.038109
   WHO, 2009, POP BAS PREV STRAT C
NR 48
TC 43
Z9 48
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD OCT 6
PY 2016
VL 16
AR 1055
DI 10.1186/s12889-016-3725-2
PG 12
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA DX9FZ
UT WOS:000384700300003
PM 27716197
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Bortolotti, M
   Rudelle, S
   Schneiter, P
   Vidal, H
   Loizon, E
   Tappy, L
   Acheson, KJ
AF Bortolotti, Murielle
   Rudelle, Servane
   Schneiter, Philippe
   Vidal, Hubert
   Loizon, Emmanuelle
   Tappy, Luc
   Acheson, Kevin J.
TI Dairy calcium supplementation in overweight or obese persons: its effect
   on markers of fat metabolism
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID HUMAN ADIPOSE-TISSUE; DIETARY CALCIUM; ENERGY-EXPENDITURE; VITAMIN-D;
   INTRACELLULAR CALCIUM; ORGAN DISTRIBUTION; LIPID-METABOLISM; ACID
   SYNTHESIS; BODY-WEIGHT; DE-NOVO
AB Background: Dairy calcium supplementation has been proposed to increase fat oxidation and to inhibit lipogenesis.
   Objective: We aimed to investigate the effects of calcium supplementation on markers of fat metabolism.
   Design: In a placebo-controlled, crossover experiment, 10 overweight or obese subjects who were low calcium consumers received 800 mg dairy Ca/d for 5 wk. After 4 wk, adipose tissue was taken for biopsy for analysis of gene expression. Respiratory exchange, glycerol turnover, and subcutaneous adipose tissue microdialysis were performed for 7 h after consumption of 400 mg Ca or placebo, and the ingestion of either randomized slow-release caffeine (SRC; 300 mg) or lactose (500 mg). One week later, the test was repeated with the SRC or lactose crossover.
   Results: Calcium supplementation increased urinary calcium excretion by 16% (P = 0.017) but did not alter plasma parathyroid hormone or osteocalcin concentrations. Resting energy expenditure (59.9 +/- 3.0 or 59.6 +/- 3.3 kcal/ h), fat oxidation (58.4 +/- 2.5 or 53.8 +/- 2.2 mg/ min), plasma free fatty acid concentrations (0.63 +/- 0.02 or 0.62 +/- 0.03 mmol/ L), and glycerol turnover (3.63 +/- 0.41 or 3.70 +/- 0.38 mu mol . kg(-1) . min(-1)) were similar with or without calcium, respectively. SRC significantly increased free fatty acid concentrations, resting fat oxidation, and resting energy expenditure. During microdialysis, epinephrine increased dialysate glycerol concentrations by 250% without and 254% with calcium. Expression of 7 key metabolic genes in subcutaneous adipose tissue was not affected by calcium supplementation.
   Conclusion: Dairy calcium supplementation in overweight subjects with habitually low calcium intakes failed to alter fat metabolism and energy expenditure under resting conditions and during acute stimulation by caffeine or epinephrine.
C1 [Acheson, Kevin J.] Nestle Res Ctr, Dept Nutr & Hlth, CH-1000 Lausanne 26, Switzerland.
   [Bortolotti, Murielle; Rudelle, Servane; Schneiter, Philippe; Tappy, Luc] Univ Lausanne, Inst Physiol, Lausanne, Switzerland.
   [Vidal, Hubert; Loizon, Emmanuelle] Lyon Univ, INSERM, U870, Oullins, France.
   [Vidal, Hubert; Loizon, Emmanuelle] Lyon Univ, INRA, UMR 1235, Oullins, France.
C3 Nestle SA; Nestle Research Center; University of Lausanne; Institut
   National de la Sante et de la Recherche Medicale (Inserm); INRAE
RP Acheson, KJ (corresponding author), Nestle Res Ctr, Dept Nutr & Hlth, CH-1000 Lausanne 26, Switzerland.
EM kevin.acheson@rdls.nestle.com
RI ; Tappy, Luc/A-8911-2017; VIDAL, Hubert/M-6674-2017
OI LOIZON, Emmanuelle/0000-0002-0723-0736; Tappy, Luc/0000-0001-8469-4692;
   Schneiter, Philippe/0000-0002-7167-2707; VIDAL,
   Hubert/0000-0002-9467-0317
FU Nestec SA, Switzerland
FX Supported by Nestec SA, Switzerland.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   ANGEL A, 1979, EUR J CLIN INVEST, V9, P355, DOI 10.1111/j.1365-2362.1979.tb00896.x
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   BARTER PJ, 1972, METABOLISM, V21, P117, DOI 10.1016/0026-0495(72)90063-7
   BJORNTORP P, 1978, METABOLISM, V27, P1853, DOI 10.1016/S0026-0495(78)80004-3
   Boon N, 2007, INT J OBESITY, V31, P1704, DOI 10.1038/sj.ijo.0803660
   Boon N, 2006, OBESITY, V14, P1739, DOI 10.1038/oby.2006.200
   Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999
   DENKE MA, 1993, J NUTR, V123, P1047
   DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315
   Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Guo ZK, 2000, INT J OBESITY, V24, P932, DOI 10.1038/sj.ijo.0801256
   Henry S, 1998, CLIN PHYSIOL, V18, P562
   HOFFMANN GE, 1980, BIOCHIM BIOPHYS ACTA, V620, P151, DOI 10.1016/0005-2760(80)90194-0
   Jacobsen R, 2005, INT J OBESITY, V29, P292, DOI 10.1038/sj.ijo.0802785
   Jones BH, 1996, AM J PHYSIOL-ENDOC M, V270, pE192, DOI 10.1152/ajpendo.1996.270.1.E192
   Kim JH, 1997, AM J PHYSIOL-ENDOC M, V272, pE379, DOI 10.1152/ajpendo.1997.272.3.E379
   Kim JH, 1996, FASEB J, V10, P1646, DOI 10.1096/fasebj.10.14.9002558
   LIVESEY G, 1988, AM J CLIN NUTR, V47, P608, DOI 10.1093/ajcn/47.4.608
   LONNROTH P, 1987, AM J PHYSIOL, V253, pE228, DOI 10.1152/ajpendo.1987.253.2.E228
   Lorenzen JK, 2006, AM J CLIN NUTR, V83, P18
   Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7
   Melanson EL, 2003, INT J OBESITY, V27, P196, DOI 10.1038/sj.ijo.802202
   Melanson EL, 2005, OBES RES, V13, P2102, DOI 10.1038/oby.2005.261
   MELLATI AM, 1970, METABOLIS, V19, P988, DOI 10.1016/0026-0495(70)90045-4
   *NAT LIB MED, 2008, DRUG INF CALC MEDL P
   Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398
   PATEL MS, 1975, METABOLISM, V24, P161, DOI 10.1016/0026-0495(75)90017-7
   Shahkhalili Y, 2001, AM J CLIN NUTR, V73, P246
   Shi H, 2001, FASEB J, V15, P291
   SJOSTROM L, 1973, ACTA MED SCAND, V194, P387
   WEISS L, 1986, BIOL CHEM H-S, V367, P905, DOI 10.1515/bchm3.1986.367.2.905
   WELBERG JWM, 1994, ANN NUTR METAB, V38, P185, DOI 10.1159/000177810
   Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690
   Xue BZ, 1998, FASEB J, V12, P1391, DOI 10.1096/fasebj.12.13.1391
   Xue BZ, 2001, FASEB J, V15, P2527, DOI 10.1096/fj.01-0278fje
   Xue BZ, 1999, PHYSIOL GENOMICS, V1, P11, DOI 10.1152/physiolgenomics.1999.1.1.11
   Yanoff LB, 2006, CLIN ENDOCRINOL, V64, P523, DOI 10.1111/j.1365-2265.2006.02502.x
   Zemel MB, 2005, OBES RES, V13, P1218, DOI 10.1038/oby.2005.144
   Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132
   Zemel MB, 2005, INT J OBESITY, V29, P391, DOI 10.1038/sj.ijo.0802880
   Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67
   Zemel MB, 2001, J AM COLL NUTR, V20, p428S, DOI 10.1080/07315724.2001.10719180
   Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212
NR 46
TC 31
Z9 37
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD OCT 1
PY 2008
VL 88
IS 4
BP 877
EP 885
DI 10.1093/ajcn/88.4.877
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 358FX
UT WOS:000259903600003
PM 18842771
OA Bronze
DA 2025-04-28
ER

PT J
AU Zhao, YC
   Li, LP
   Li, XY
   Wang, CC
   Yang, JY
   Xue, CH
   Wang, YM
   Zhang, TT
AF Zhao, Ying-Cai
   Li, Le-Ping
   Li, Xiao-Yue
   Wang, Cheng-Cheng
   Yang, Jin-Yue
   Xue, Chang-Hu
   Wang, Yu-Ming
   Zhang, Tian-Tian
TI The synergistic effect of sea cucumber saponins and caffeine on
   preventing obesity in high-fat diet-fed mice by extending the action
   duration of caffeine
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE caffeine; sea cucumber saponins; synergistic effect; anti-obesity
ID INSULIN-RESISTANCE; IN-VITRO; METABOLISM; ECHINOSIDE; ABSORPTION;
   CYP1A2; HYPERTENSION; GINSENOSIDES; INHIBITION; HOLOTHURIN
AB BACKGROUNDSea cucumber saponins (SCSs) exhibit a unique structure and high bioactivities and might have specialized implications on caffeine metabolic process by altering the activity of N-demethylation enzyme CYP1A2. The present study aimed to clarify the effects of SCS on caffeine metabolism in vivo and in vitro, as well as the synergistic anti-obesity effect of SCS and caffeine on high-fat diet-induced obese mice. RESULTSResults found that SCS administration significantly postponed the elimination rate of caffeine and its metabolites in vivo, and further study found CYP1A2-mediated caffeine metabolism was remarkably inhibited in a dose-dependent manner in vitro. The synergistic effect of the SCS and caffeine combination could decrease the total weight of white adipose tissue by 52% compared with high-fat diet-treated group. CONCLUSIONSCS could prolong caffeine action time, and the combination of the two substances exhibited joint action on high-fat diet-induced obese mice. These findings might provide a basis for the development of functional foods and potential application using the combination of SCS and caffeine. (c) 2022 Society of Chemical Industry.
C1 [Wang, Yu-Ming; Zhang, Tian-Tian] Ocean Univ China, Coll Food Sci & Engn, Qingdao 266003, Shandong, Peoples R China.
   [Zhao, Ying-Cai; Li, Xiao-Yue; Wang, Cheng-Cheng; Yang, Jin-Yue; Xue, Chang-Hu; Wang, Yu-Ming; Zhang, Tian-Tian] Ocean Univ China, Coll Food Sci & Engn, Qingdao, Peoples R China.
   [Li, Le-Ping] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Swiss Fed Inst Technol, Zurich, Switzerland.
   [Xue, Chang-Hu; Wang, Yu-Ming] Pilot Natl Lab Marine Sci & Technol Qingdao, Lab Marine Drugs & Bioprod, Qingdao, Peoples R China.
C3 Ocean University of China; Ocean University of China; Swiss Federal
   Institutes of Technology Domain; ETH Zurich; Laoshan Laboratory
RP Wang, YM; Zhang, TT (corresponding author), Ocean Univ China, Coll Food Sci & Engn, Qingdao 266003, Shandong, Peoples R China.
EM wangyuming@ouc.edu.cn; zhangtiantian@ouc.edu.cn
RI yuming, wang/K-8179-2012; wang, chengcheng/LJM-2924-2024; Li,
   Xiaoyue/Y-7276-2019
OI Wang, Yuming/0000-0003-2310-1456
FU National Natural Science Foundation of China;  [32072145]
FX ACKNOWLEDGEMENT This work was supported by the National Natural Science
   Foundation of China (32072145).
CR Barrea L, 2023, CRIT REV FOOD SCI, V63, P1238, DOI 10.1080/10408398.2021.1963207
   Begdache L, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010024
   Choi EJ, 2013, FOOD CHEM, V141, P2735, DOI 10.1016/j.foodchem.2013.05.069
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Ding L, 2018, J FUNCT FOODS, V48, P490, DOI 10.1016/j.jff.2018.07.046
   FOLCH J, 1951, J BIOL CHEM, V191, P833
   Guo JC, 2021, CURR DRUG METAB, V22, P40, DOI 10.2174/1389200221999210101233135
   Hakooz NMK, 2009, CURR DRUG METAB, V10, P329, DOI 10.2174/138920009788499003
   Hao M, 2011, DRUG METAB PHARMACOK, V26, P201, DOI 10.2133/dmpk.DMPK-10-NT-056
   Hu XQ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-25
   Hu XQ, 2012, J MED FOOD, V15, P909, DOI [10.1089/jmf.2011.2042, 10.1094/jmf.2011.2042]
   Jodynis-Liebert J, 2004, J CLIN PHARMACOL, V44, P338, DOI 10.1177/0091270004263468
   Lebeau PF, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28240-9
   Lee Y, 2003, J STEROID BIOCHEM, V84, P463, DOI 10.1016/S0960-0760(03)00067-0
   Li HF, 2020, DRUG DES DEV THER, V14, P5251, DOI 10.2147/DDDT.S268358
   Li R, 2021, J OCEAN U CHINA, V20, P629, DOI 10.1007/s11802-021-4577-7
   Liu R, 2012, PHYTOTHER RES, V26, P1113, DOI 10.1002/ptr.3688
   Liu XF, 2014, EUR J LIPID SCI TECH, V116, P255, DOI 10.1002/ejlt.201300407
   Liu Y, 2006, TOXICOL SCI, V91, P356, DOI 10.1093/toxsci/kfj164
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Noh K, 2015, BIOMOL THER, V23, P201, DOI 10.4062/biomolther.2014.134
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Rasmussen MK, 2011, TOXICOL IN VITRO, V25, P343, DOI 10.1016/j.tiv.2010.10.007
   Sasaki T, 2017, J PHARM HEALTH CARE, V3, DOI 10.1186/s40780-017-0083-x
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Song SS, 2017, J FOOD SCI, V82, P1961, DOI 10.1111/1750-3841.13759
   Song SS, 2016, J FUNCT FOODS, V25, P62, DOI 10.1016/j.jff.2016.05.002
   Sun HY, 2016, J AGR FOOD CHEM, V64, P2386, DOI 10.1021/acs.jafc.5b06170
   TASSANEEYAKUL W, 1994, BIOCHEM PHARMACOL, V47, P1767, DOI 10.1016/0006-2952(94)90304-2
   Theile D, 2017, EUR J PHARM SCI, V97, P247, DOI 10.1016/j.ejps.2016.11.021
   Wang YM, 2014, BIOSCI BIOTECH BIOCH, V78, P139, DOI 10.1080/09168451.2014.877830
   Weiss J, 2020, FOOD CHEM, V319, DOI 10.1016/j.foodchem.2020.126578
   Wen M, 2016, J NUTR SCI VITAMINOL, V62, P170, DOI 10.3177/jnsv.62.170
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Yeh TC, 2014, HYPERTENSION, V63, P535, DOI 10.1161/HYPERTENSIONAHA.113.02272
   Zhao YC, 2018, J AGR FOOD CHEM, V66, P7222, DOI 10.1021/acs.jafc.8b01770
NR 38
TC 2
Z9 3
U1 14
U2 40
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD JUN
PY 2023
VL 103
IS 8
BP 3950
EP 3960
DI 10.1002/jsfa.12339
EA NOV 2022
PG 11
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA F3HN6
UT WOS:000891517100001
PM 36377349
DA 2025-04-28
ER

PT J
AU Santhanam, P
   Solnes, L
   Hannukainen, JC
   Taïeb, D
AF Santhanam, Prasanna
   Solnes, Lilja
   Hannukainen, Jarna C.
   Taieb, David
TI ADIPOSITY-RELATED CANCER AND FUNCTIONAL IMAGING OF BROWN ADIPOSE TISSUE
SO ENDOCRINE PRACTICE
LA English
DT Review
ID ADAPTIVE THERMOGENESIS; WHITE ADIPOCYTES; BEIGE ADIPOCYTES; F-18-FDG
   PET/CT; ENERGY-BALANCE; GLUCOSE-UPTAKE; BREAST-CANCER; IN-VIVO; FAT;
   COLD
AB Objective: Brown adipose tissue (BAT) is involved in energy dissipation and cytokine production and is potentially beneficial for the human body. The aim of the paper is to review the literature on adiposity-related cancer and functional imaging of BAT.
   Methods: We performed a review on adiposity-related cancer and functional imaging of BAT. We extensively researched papers for information on BAT molecular biology, as well as functional imaging modalities.
   Results: Adipose tissue is linked to the development of many cancers. Multiple drugs including fenofibrate, spironolactone, and other substances, as well as experimental agents like b-3 receptor agonists, caffeine, green tea extract, medium chain triglycerides (MCTs), and adenosine are known to stimulate and activate BAT. However, cold and nonshivering thermogenesis are the main activators of BAT. BAT has been detected on both magnetic resonance imaging (MRI) and 18F-fluorodexoxyglucose positron emission tomography (18F-FDG-PET)-based imaging in multiple studies. Different methods of cold stimulation and static and dynamic protocols have been used to detect and image BAT. Factors like sex, fasting or fed state, surface skin temperature, and/or body mass index (BMI) may influence PET-based BAT detection. BAT has also been detected using MRI, (99m)Technetium(Tc)-sestamibi, and 123I- metaiodobenzylguanidine single-photon emission computed tomography/computed tomography (MIBG SPECT/CT).
   Conclusions: Stimulation of BAT offers promise in the management of obesity-related conditions. Tracers like [O-15]-H2O, [C-11] acetate, and 18F-fluoro-6-thia-heptadecanoic acid (18F-FTHA) that measure BAT blood flow, oxygen utilization, and nonessential fatty acid (NEFA) uptake, respectively, have been studied in humans. Future studies should focus on BAT tissue generation by altering the genetic pathways of adiposity-linked genes.
C1 [Santhanam, Prasanna] Marshall Univ, Joan C Edwards Sch Med, Dept Internal Med, Sect Endocrinol, Huntington, WV 25701 USA.
   [Solnes, Lilja] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA.
   [Hannukainen, Jarna C.] Univ Turku, Turku PET Ctr, Turku, Finland.
   [Taieb, David] Aix Marseille Univ, CERIMED, La Timone Univ Hosp, Dept Nucl Med, Marseille, France.
   [Taieb, David] Inst J Paoli I Calmettes, Marseille Cancerol Res Ctr, Inserm UMR1068, Marseille, France.
C3 Marshall University; Johns Hopkins University; University of Turku;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   UNICANCER; Institut Paoli-Calmette (IPC); Aix-Marseille Universite
RP Santhanam, P (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Internal Med, Sect Endocrinol, Huntington, WV 25701 USA.
EM prasanna@marshall.edu
RI Taieb, David/M-5219-2017
OI Hannukainen, Jarna/0000-0002-8692-4049
CR Admiraal WM, 2013, J NUCL MED, V54, P208, DOI 10.2967/jnumed.112.111849
   Armani A, 2014, FASEB J, V28, P3745, DOI 10.1096/fj.13-245415
   Baba S, 2007, J NUCL MED, V48, P1715, DOI 10.2967/jnumed.107.041715
   Bae HS, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-41
   Bauwens M, 2014, EUR J NUCL MED MOL I, V41, P776, DOI 10.1007/s00259-013-2611-8
   Beiroa D, 2014, DIABETES, V63, P3346, DOI 10.2337/db14-0302
   Berstein LM, 2012, FUTURE ONCOL, V8, P1537, DOI [10.2217/FON.12.150, 10.2217/fon.12.150]
   Bielli A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-345
   Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115
   Brown RS, 1999, J NUCL MED, V40, P556
   Cao Q, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-126
   Cereijo R, 2015, ANN MED, V47, P169, DOI 10.3109/07853890.2014.952328
   Coe PO, 2014, BRIT J SURG, V101, P1518, DOI 10.1002/bjs.9623
   Cohade C, 2003, J NUCL MED, V44, P170
   Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Dallner OS, 2006, ENDOCRINOLOGY, V147, P5730, DOI 10.1210/en.2006-0242
   De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546
   de Vos-Geelen J, 2014, CURR OPIN CLIN NUTR, V17, P509, DOI 10.1097/MCO.0000000000000106
   Geerling JJ, 2014, DIABETES, V63, P880, DOI 10.2337/db13-0194
   Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403
   Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816
   Goetze S, 2008, J NUCL MED, V49, P752, DOI 10.2967/jnumed.107.048074
   Goodwin PJ, 2015, ANNU REV MED, V66, P281, DOI 10.1146/annurev-med-051613-012328
   Hadi M, 2007, J NUCL MED, V48, P1077, DOI 10.2967/jnumed.106.035915
   Hanssen MJW, 2015, DIABETOLOGIA, V58, P586, DOI 10.1007/s00125-014-3465-8
   Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775
   Honek J, 2014, HORM MOL BIOL CLIN I, V19, P5, DOI 10.1515/hmbci-2014-0014
   Ioannides SJ, 2014, BREAST CANCER RES TR, V147, P237, DOI 10.1007/s10549-014-3091-7
   Jackson SE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-926
   Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262
   Kliewer KL, 2015, CANCER BIOL THER, V16, P886, DOI 10.4161/15384047.2014.987075
   Koppen A, 2010, FEBS LETT, V584, P3250, DOI 10.1016/j.febslet.2010.06.035
   Kyparos D, 2006, PHYSIOL RES, V55, P653, DOI 10.33549/physiolres.930890
   Lahesmaa M, 2014, J CLIN ENDOCR METAB, V99, pE28, DOI 10.1210/jc.2013-2312
   Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513
   Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017
   Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009
   Li JS, 2014, TUMOR BIOL, V35, P6831, DOI 10.1007/s13277-014-1939-4
   Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718
   Lin XJ, 2014, JPN J CLIN ONCOL, V44, P783, DOI 10.1093/jjco/hyu082
   Ma J, 2015, MED SCI MONITOR, V21, P283, DOI 10.12659/MSM.892035
   Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749
   Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023
   Nakayama Akira, 2003, Mol Imaging, V2, P37, DOI 10.1162/153535003765276273
   Nalabolu Mohan Reddy, 2014, Int J Hematol Oncol Stem Cell Res, V8, P31
   Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006
   Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653
   Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019
   Olsen JM, 2014, J CELL BIOL, V207, P365, DOI 10.1083/jcb.201403080
   Orava J, 2013, OBESITY, V21, P2279, DOI 10.1002/oby.20456
   Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012
   OSCULATI F, 1989, EUR J RADIOL, V9, P112
   Oudart H, 1995, CAN J PHYSIOL PHARM, V73, P1625, DOI 10.1139/y95-724
   Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004
   Quarta C, 2013, MOL METAB, V2, P153, DOI 10.1016/j.molmet.2013.04.002
   Rachid TL, 2015, MOL CELL ENDOCRINOL, V402, P86, DOI 10.1016/j.mce.2014.12.027
   Rance NE, 2013, FRONT NEUROENDOCRIN, V34, P211, DOI 10.1016/j.yfrne.2013.07.003
   Ricquier Daniel, 2011, Front Endocrinol (Lausanne), V2, P85, DOI 10.3389/fendo.2011.00085
   Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Rossato M, 2014, MOL CELL ENDOCRINOL, V383, P137, DOI 10.1016/j.mce.2013.12.005
   Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530
   Schwartz B, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00164
   Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182
   Smits A, 2015, GYNECOL ONCOL, V137, P180, DOI 10.1016/j.ygyno.2015.01.540
   van der Lans AAJJ, 2014, AM J PHYSIOL-REG I, V307, pR103, DOI 10.1152/ajpregu.00021.2014
   van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022
   Vrieze A, 2012, J NUCL MED, V53, P1407, DOI 10.2967/jnumed.111.100701
   Vybíral S, 2000, EXP PHYSIOL, V85, P321, DOI 10.1111/j.1469-445X.2000.01909.x
   Wagner M, 2015, EXPERT OPIN THER TAR, V19, P527, DOI 10.1517/14728222.2014.991311
   Wang CZ, 2014, MOL CELL BIOCHEM, V393, P247, DOI 10.1007/s11010-014-2067-6
   Wijers SLJ, 2010, OBESITY, V18, P1092, DOI 10.1038/oby.2010.74
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Yeung HWD, 2003, J NUCL MED, V44, P1789
   Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105
NR 80
TC 8
Z9 11
U1 0
U2 12
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1530-891X
EI 1934-2403
J9 ENDOCR PRACT
JI Endocr. Pract.
PD NOV
PY 2015
VL 21
IS 11
BP 1282
EP 1290
DI 10.4158/EP15870.RA
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA DO7MF
UT WOS:000377966000011
PM 26280202
DA 2025-04-28
ER

PT S
AU Dulloo, AG
AF Dulloo, Abdul G.
GP Annals New York Acad Sci
TI Translational issues in targeting brown adipose tissue thermogenesis for
   human obesity management
SO UNDERSTANDING ADIPOGENESIS AND FUNCTIONS OF BROWN FAT
SE Annals of the New York Academy of Sciences
LA English
DT Article; Book Chapter
DE obesity; diabetes; thermogenesis; energy expenditure; fat oxidation;
   brown fat
ID ENERGY-EXPENDITURE; WEIGHT-LOSS; OXYGEN-CONSUMPTION; FAT OXIDATION;
   COLD-EXPOSURE; GREEN TEA; CAFFEINE; METABOLISM; BALANCE; WOMEN
AB The recent advancements in unraveling novel mechanisms that control the induction, (trans) differentiation, proliferation, and thermogenic activity and capacity of brown adipose tissue (BAT), together with the application of imaging techniques for human BAT visualization, have generated optimism that these advances will provide novel strategies for targeting BAT thermogenesis, leading to efficacious and safe obesity therapies. This paper first provides an overview of landmark events of the past few decades that have been driving the search for pharmaceutical and nutraceutical compounds that would increase BAT thermogenesis for obesity management. It then addresses issues about what could be expected from an ideal thermogenic antiobesity approach, in particular to what extent daily energy expenditure will need to increase in order to achieve long-term weight loss currently achievable only through bariatric surgery, and whether the human body will have enough thermogenic capacity to reach this target weight loss by future therapies focused on BAT.
C1 Univ Fribourg, Dept Med Physiol, CH-1700 Fribourg, Switzerland.
C3 University of Fribourg
RP Dulloo, AG (corresponding author), Univ Fribourg, Dept Med Physiol, Chemin Musee 5, CH-1700 Fribourg, Switzerland.
EM abdul.dulloo@unifr.ch
OI DULLOO, Abdul/0000-0003-3877-6149
CR AMATRUDA JM, 1993, J CLIN INVEST, V92, P1236, DOI 10.1172/JCI116695
   Arch JRS, 2008, N-S ARCH PHARMACOL, V378, P225, DOI 10.1007/s00210-008-0271-1
   ARCH JRS, 1984, NATURE, V309, P163, DOI 10.1038/309163a0
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002
   Boss Olivier, 2012, Front Endocrinol (Lausanne), V3, P14, DOI 10.3389/fendo.2012.00014
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BROOKS SL, 1980, NATURE, V286, P274, DOI 10.1038/286274a0
   Chaston TB, 2007, INT J OBESITY, V31, P743, DOI 10.1038/sj.ijo.0803483
   Chechi K, 2013, TRENDS ENDOCRIN MET, V24, P408, DOI 10.1016/j.tem.2013.04.002
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   DAVIS TR, 1961, J APPL PHYSIOL, V16, P1011, DOI 10.1152/jappl.1961.16.6.1011
   Dulloo A G, 1987, World Rev Nutr Diet, V50, P1
   Dulloo AG, 2012, INT J OBESITY, V36, P1418, DOI 10.1038/ijo.2012.114
   Dulloo AG, 2012, OBES REV, V13, P105, DOI 10.1111/j.1467-789X.2012.01041.x
   Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x
   Dulloo AG, 2012, P NUTR SOC, V71, P379, DOI 10.1017/S0029665112000225
   DULLOO AG, 1986, INT J OBESITY, V10, P467
   Dulloo AG, 1996, EUR J CLIN NUTR, V50, P152
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1984, CAN J PHYSIOL PHARM, V62, P235, DOI 10.1139/y84-035
   Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003
   FROIDEVAUX F, 1993, AM J CLIN NUTR, V57, P35, DOI 10.1093/ajcn/57.1.35
   Frontini A, 2013, BBA-MOL CELL BIOL L, V1831, P950, DOI 10.1016/j.bbalip.2013.02.005
   Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670
   HOFSTETTER A, 1986, NEW ENGL J MED, V314, P79, DOI 10.1056/NEJM198601093140204
   JEQUIER E, 1983, AM J CLIN NUTR, V38, P989, DOI 10.1093/ajcn/38.6.989
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   LANDSBERG L, 1984, AM J PHYSIOL, V247, pE181, DOI 10.1152/ajpendo.1984.247.2.E181
   LEAN MEJ, 1989, P NUTR SOC, V48, P243, DOI 10.1079/PNS19890036
   Lee P, 2011, J CLIN ENDOCR METAB, V96, P2450, DOI 10.1210/jc.2011-0487
   Levine J, 1999, NEW ENGL J MED, V341, P2100, DOI 10.1056/NEJM199912303412718
   Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010
   Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737
   MA SWY, 1989, CAN J PHYSIOL PHARM, V67, P376, DOI 10.1139/y89-061
   MA SWY, 1988, CAN J PHYSIOL PHARM, V66, P1347, DOI 10.1139/y88-221
   Major GC, 2007, INT J OBESITY, V31, P204, DOI 10.1038/sj.ijo.0803523
   Mann T, 2007, AM PSYCHOL, V62, P220, DOI 10.1037/0003-066X.62.3.220
   Montani JP, 2006, INT J OBESITY, V30, pS58, DOI 10.1038/sj.ijo.0803520
   Muzik O, 2013, J NUCL MED, V54, P523, DOI 10.2967/jnumed.112.111336
   Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433
   Pourhassan M, 2013, EUR J CLIN NUTR, V67, P446, DOI 10.1038/ejcn.2013.35
   Rothwell N.J., 1983, P208
   ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530
   Sarafian D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00155
   Sjöström L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012
   Smorlesi A, 2012, OBES REV, V13, P83, DOI 10.1111/j.1467-789X.2012.01039.x
   Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665
   SUTER PM, 1992, NEW ENGL J MED, V326, P983, DOI 10.1056/NEJM199204093261503
   TRAYHURN P, 1982, NATURE, V295, P323, DOI 10.1038/295323a0
   van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   WEBSTER JD, 1984, HUM NUTR-CLIN NUTR, V38C, P299
   Whittle A, 2013, TRENDS PHARMACOL SCI, V34, P347, DOI 10.1016/j.tips.2013.04.004
   YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4
   Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546
NR 59
TC 17
Z9 18
U1 0
U2 17
PU BLACKWELL SCIENCE PUBL
PI OXFORD
PA OSNEY MEAD, OXFORD OX2 0EL, ENGLAND
SN 0077-8923
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2013
VL 1302
BP 1
EP 10
DI 10.1111/nyas.12304
PG 10
WC Endocrinology & Metabolism; Physiology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA BHM40
UT WOS:000325920200001
PM 24138104
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Zhang, SM
   Takano, J
   Murayama, N
   Tominaga, M
   Abe, T
   Park, I
   Seol, J
   Ishihara, A
   Tanaka, Y
   Yajima, K
   Suzuki, Y
   Suzuki, C
   Fukusumi, S
   Yanagisawa, M
   Kokubo, T
   Tokuyama, K
AF Zhang, Simeng
   Takano, Jiro
   Murayama, Norihito
   Tominaga, Morie
   Abe, Takashi
   Park, Insung
   Seol, Jaehoon
   Ishihara, Asuka
   Tanaka, Yoshiaki
   Yajima, Katsuhiko
   Suzuki, Yoko
   Suzuki, Chihiro
   Fukusumi, Shoji
   Yanagisawa, Masashi
   Kokubo, Toshio
   Tokuyama, Kumpei
TI Subacute Ingestion of Caffeine and Oolong Tea Increases Fat Oxidation
   without Affecting Energy Expenditure and Sleep Architecture: A
   Randomized, Placebo-Controlled, Double-Blinded Cross-Over Trial
SO NUTRIENTS
LA English
DT Article
DE whole room indirect calorimetry; respiratory quotient; fat oxidation;
   carbohydrate oxidation; body temperature; caffeine tolerance
ID METABOLIC-RATE; OBESITY; DURATION; POLYPHENOLS; CONSUMPTION
AB Ingesting oolong tea or caffeine acutely increases energy expenditure, and oolong tea, but not caffeine, stimulates fat oxidation. The acute effects of caffeine, such as increased heart rate and interference with sleep, diminish over 1-4 days, known as caffeine tolerance. During each 14-day session of the present study, 12 non-obese males consumed oolong tea (100 mg caffeine, 21.4 mg gallic acid, 97 mg catechins and 125 mg polymerized polyphenol), caffeine (100 mg), or placebo at breakfast and lunch. On day 14 of each session, 24-h indirect calorimetry and polysomnographic sleep recording were performed. Caffeine and oolong tea increased fat oxidation by similar to 20% without affecting energy expenditure over 24-h. The decrease in the respiratory quotient by oolong tea was greater than that by caffeine during sleep. The effect of oolong tea on fat oxidation was salient in the post-absorptive state. These findings suggest a role of unidentified ingredients in oolong tea to stimulate fat oxidation, and this effect is partially suppressed in a postprandial state. Two weeks of caffeine or oolong tea ingestion increased fat oxidation without interfering with sleep. The effects of subacute ingestion of caffeine and oolong tea differed from the acute effects, which is a particularly important consideration regarding habitual tea consumption.
C1 [Zhang, Simeng; Tominaga, Morie; Abe, Takashi; Park, Insung; Ishihara, Asuka; Tanaka, Yoshiaki; Suzuki, Yoko; Suzuki, Chihiro; Fukusumi, Shoji; Yanagisawa, Masashi; Kokubo, Toshio; Tokuyama, Kumpei] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan.
   [Takano, Jiro; Murayama, Norihito] Suntory Global Innovat Ctr Ltd, Res Inst, Sora Ku, Kyoto 6190284, Japan.
   [Seol, Jaehoon] Univ Tsukuba, R&D Ctr Tailor Made QOL, Tsukuba, Ibaraki 3058550, Japan.
   [Yajima, Katsuhiko] Josai Univ, Fac Pharmaceut Sci, Saitama 3500295, Japan.
C3 University of Tsukuba; Suntory Holdings Ltd; University of Tsukuba;
   Josai University
RP Tokuyama, K (corresponding author), Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan.
EM evergreenmeng@gmail.com; Jiro_Takano@suntory.co.jp;
   Norihito_Murayama@suntory.co.jp; tominaga.morie.ft@un.tsukuba.ac.jp;
   abe.takashi.gp@u.tsukuba.ac.jp; park.insung.ge@u.tsukuba.ac.jp;
   tsukubaseol@gmail.com; asuka.ishihara@gmail.com;
   yoshi.tanaka.5212@gmail.com; yajimamarch@yahoo.co.jp;
   yoko.12.suzu@gmail.com; s1821271@gmail.com;
   fukusumi.shoji.fw@u.tsukuba.ac.jp; yanagisawa.masa.fu@u.tsukuba.ac.jp;
   kokubo.toshio.fp@u.tsukuba.ac.jp; tokuyama.kumpei.gf@u.tsukuba.ac.jp
RI PARK, Insung/AFR-8117-2022; Ishihara, Asuka/MDS-4783-2025; Seol,
   Jaehoon/AAC-1408-2019; Tanaka, Yoshiaki/AAE-2425-2022; Abe,
   Takashi/AAJ-9367-2020
OI Ishihara, Asuka/0000-0001-9701-6284; /0000-0001-7957-1743; Abe,
   Takashi/0000-0002-4100-1427; PARK, Insung/0000-0001-6389-1937; Tanaka,
   Yoshiaki/0000-0002-9796-0280
FU Japan Society for the Promotion of Science [20H04120]; Project of the
   NAROBio-oriented Technology Research Advancement Institution (R&D
   matching funds on the field for Knowledge Integration and innovation);
   Grants-in-Aid for Scientific Research [20H04120] Funding Source: KAKEN
FX This research was funded by the Japan Society for the Promotion of
   Science (Grants-in-aid for Scientific Research B 20H04120) and by grants
   from the Project of the NAROBio-oriented Technology Research Advancement
   Institution (R&D matching funds on the field for Knowledge Integration
   and innovation).
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Begaye B, 2020, DIABETES, V69, P181, DOI 10.2337/db19-0719
   Berry RB, 2018, The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Camm AJ, 1996, CIRCULATION, V93, P1043
   Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619
   Chaput JP, 2009, OBESITY, V17, P1964, DOI 10.1038/oby.2009.116
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2
   Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   Kräuchi K, 2014, CHRONOBIOL INT, V31, P102, DOI 10.3109/07420528.2013.829482
   Landolt HP, 2015, SCIENCE, V349, P1289, DOI 10.1126/science.aad2958
   Lazarus M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00740
   Lazarus M, 2011, J NEUROSCI, V31, P10067, DOI 10.1523/JNEUROSCI.6730-10.2011
   LEBLANC J, 1985, J APPL PHYSIOL, V59, P832, DOI 10.1152/jappl.1985.59.3.832
   Liu PP, 2018, J FOOD SCI TECH MYS, V55, P1185, DOI 10.1007/s13197-018-3034-0
   Lonac MC, 2011, OBESITY, V19, P298, DOI 10.1038/oby.2010.181
   Matsuo M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00110
   Ministry of Health Labour and Welfare of Japan, 2015, NAT HLTH NUTR SURV
   Mynatt RL, 2019, METABOLISM, V97, P40, DOI 10.1016/j.metabol.2019.05.010
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Nicolaidis S, 2006, METABOLISM, V55, pS24, DOI 10.1016/j.metabol.2006.07.009
   Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x
   Ogata H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092797
   Park I, 2017, BRIT J NUTR, V117, P979, DOI 10.1017/S0007114517000587
   POEHLMAN ET, 1985, MED SCI SPORT EXER, V17, P689, DOI 10.1249/00005768-198512000-00012
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Sakurai T, 2014, NAT REV NEUROSCI, V15, P719, DOI 10.1038/nrn3837
   Seol J, 2019, P NATL ACAD SCI USA, V116, P24353, DOI 10.1073/pnas.1907354116
   STATLAND BE, 1980, AM J CLIN PATHOL, V73, P390
   Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062
   Tokuyama K, 2009, J APPL PHYSIOL, V106, P640, DOI 10.1152/japplphysiol.90718.2008
   Yamada M, 2010, PUBLIC HEALTH NUTR, V13, P663, DOI 10.1017/S1368980009992023
   Zhang SM, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14353
   ZWYGHUIZENDOORENBOS A, 1990, PSYCHOPHARMACOLOGY, V100, P36, DOI 10.1007/BF02245786
NR 43
TC 22
Z9 23
U1 0
U2 32
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD DEC
PY 2020
VL 12
IS 12
AR 3671
DI 10.3390/nu12123671
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA PK5OO
UT WOS:000602494300001
PM 33260552
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Sylvetsky, AC
   Visek, AJ
   Halberg, S
   Rhee, DK
   Ongaro, Z
   Essel, KD
   Dietz, WH
   Sacheck, J
AF Sylvetsky, Allison C.
   Visek, Amanda J.
   Halberg, Sabrina
   Rhee, Dong Keun
   Ongaro, Zoe
   Essel, Kofi D.
   Dietz, William H.
   Sacheck, Jennifer
TI Beyond taste and easy access: Physical, cognitive, interpersonal, and
   emotional reasons for sugary drink consumption among children and
   adolescents
SO APPETITE
LA English
DT Article
DE Sugar; Caffeine; Soda; Soft drinks; Obesity; Pediatric
ID HOME FOOD ENVIRONMENT; SWEETENED BEVERAGES; ENERGY DRINKS; CAFFEINE USE;
   PLAIN WATER; TAP WATER; PERCEPTIONS; SCHOOL; OVERWEIGHT; WITHDRAWAL
AB Consumption of sugary drinks is associated with the development of obesity and cardiometabolic diseases among children and adolescents. In addition to high added sugar content, many sugary drinks also contain caffeine. However, whether the combination of sugar and caffeine uniquely influences children's sugary drink intake is presently unknown. This study aimed to evaluate contextual factors surrounding children's sugary drink consumption and investigate reasons for sugary drink intake among children and adolescents, with a specific focus on caffeinated sodas and sweet tea. We also evaluated how sugary drink consumption makes children feel and how they anticipated that they would respond if sugary drinks were restricted. Focus group discussions (n = 9, 2-8 participants per group) were conducted with 37 predominantly AfricanAmerican children and adolescents, ages 8-14 years, who consumed >= 1 caffeine-containing sugary drink(s) daily, based on parental report. Focus groups were audio-recorded and transcribed verbatim. Transcripts were independently coded by two coders, after which emergent themes were identified. Reported reasons for sugary drink consumption encompassed five themes: 1) perceived need (e.g., satisfy cravings, quench thirst); 2) physical and cognitive benefits (e.g., provide energy, improve attention); 3) emotional and interpersonal benefits (e.g., relieve anger, facilitate socializing); 4) sensory properties (e.g., taste, carbonation); and, 5) external cues (e.g., family/peer modeling, availability). Negative consequences resulting from excess intake were also reported, including gastrointestinal symptoms, headaches, fatigue, hyperactivity, and chronic disease. Perceived physical, cognitive, emotional, and interpersonal benefits encourage sugary drink consumption and exacerbate well-described challenges of sugary drink reduction, including their palatability, accessibility, and affordability. Findings also suggest that incorporation of strategies to enhance physical, cognitive, and emotional health may hold promise in reducing sugary drink consumption among children and adolescents.
C1 [Sylvetsky, Allison C.; Visek, Amanda J.; Halberg, Sabrina; Rhee, Dong Keun; Ongaro, Zoe; Sacheck, Jennifer] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Exercise & Nutr Sci, 950 New Hampshire Ave NW,Suite 200, Washington, DC 20052 USA.
   [Sylvetsky, Allison C.; Dietz, William H.] George Washington Univ, Milken Inst Sch Publ Hlth, Sumner M Redstone Global Ctr Prevent & Wellness, 950 New Hampshire Ave NW,Suite 300, Washington, DC 20052 USA.
   [Essel, Kofi D.] George Washington Univ, Sch Med & Hlth Sci, 2300 I St NW, Washington, DC 20052 USA.
   [Essel, Kofi D.] Childrens Natl Hosp, Div Gen & Community Pediat, 111 Michigan Ave NW, Washington, DC 20010 USA.
C3 George Washington University; George Washington University; George
   Washington University; Children's National Health System
RP Sylvetsky, AC (corresponding author), Milken Inst Sch Publ Hlth, 950 New Hampshire Ave NW,Suite 200, Washington, DC 20052 USA.
EM asylvets@gwu.edu
OI Essel, Kofi/0000-0002-7320-9855; Rhee, Dong Keun/0000-0001-5027-1384
FU KL2 Career Development Award [UL1TR001876, KL2TR001877]; National
   Institutes of Health National Center for Advancing Translational
   Sciences (NCATS)
FX This project was supported by a KL2 Career Development Award (PI:
   Sylvetsky), under Parent Award Numbers UL1TR001876 and KL2TR001877 from
   the National Institutes of Health National Center for Advancing
   Translational Sciences (NCATS). Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the NIH or NCATS.
CR Ahluwalia N, 2015, ADV NUTR, V6, P102, DOI 10.3945/an.114.007401
   Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94
   Bogart LM, 2013, ACAD PEDIATR, V13, P348, DOI 10.1016/j.acap.2013.02.009
   Brown CL, 2015, PEDIATR CLIN N AM, V62, P1241, DOI 10.1016/j.pcl.2015.05.013
   Bunting H, 2013, APPETITE, V65, P132, DOI 10.1016/j.appet.2013.02.011
   Chi Donald L, 2019, Dent Clin North Am, V63, P17, DOI 10.1016/j.cden.2018.08.003
   Cooksey-Stowers K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111366
   Costa BM, 2014, APPETITE, V80, P183, DOI 10.1016/j.appet.2014.05.013
   Couch SC, 2014, J ACAD NUTR DIET, V114, P1569, DOI 10.1016/j.jand.2014.05.015
   Davis JN, 2010, AM J CLIN NUTR, V92, P1522, DOI 10.3945/ajcn.2010.30185
   Drewnowski A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030154
   Eck KM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091232
   Elbel B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217341
   Falbe J, 2019, APPETITE, V133, P130, DOI 10.1016/j.appet.2018.10.032
   Folta SC, 2006, J NUTR EDUC BEHAV, V38, P244, DOI 10.1016/j.jneb.2006.04.146
   Fulkerson JA, 2018, J ACAD NUTR DIET, V118, P240, DOI 10.1016/j.jand.2017.04.006
   Harris JL, 2009, HEALTH COMMUN, V24, P660, DOI 10.1080/10410230903242267
   Haughton CF, 2018, J PEDIATR-US, V202, P121, DOI 10.1016/j.jpeds.2018.06.046
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   Kenney EL, 2015, AM J PUBLIC HEALTH, V105, P1777, DOI 10.2105/AJPH.2015.302645
   Kirkpatrick SI, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081036
   Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0
   Lopez NV, 2012, J ACAD NUTR DIET, V112, P541, DOI 10.1016/j.jand.2011.11.013
   Ludden AB, 2017, SUBST USE MISUSE, V52, P1196, DOI 10.1080/10826084.2017.1302957
   Mahoney CR, 2019, CLIN NUTR, V38, P668, DOI 10.1016/j.clnu.2018.04.004
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   McCrory C, 2017, J NUTR EDUC BEHAV, V49, P304, DOI 10.1016/j.jneb.2016.11.013
   Mendez MA, 2019, AM J CLIN NUTR, V109, P79, DOI 10.1093/ajcn/nqy123
   Mis NF, 2017, J PEDIATR GASTR NUTR, V65, P681, DOI [10.1097/MPG.0000000000001733, 10.1097/mpg.0000000000001733]
   Onufrak SJ, 2014, J SCHOOL HEALTH, V84, P195, DOI 10.1111/josh.12138
   Onufrak SJ, 2014, PUBLIC HEALTH NUTR, V17, P179, DOI 10.1017/S1368980012004600
   Owens JA, 2014, NUTR REV, V72, P65, DOI 10.1111/nure.12150
   Parnarouskis L, 2020, APPETITE, V147, DOI 10.1016/j.appet.2019.104553
   Patel AI, 2011, AM J PUBLIC HEALTH, V101, P1370, DOI 10.2105/AJPH.2011.300142
   Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2
   Powell LM, 2017, CAN J ECON, V50, P345, DOI 10.1111/caje.12261
   Santiago-Torres M, 2016, PEDIATR OBES, V11, P54, DOI 10.1111/ijpo.12020
   Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Striley Catherine L W, 2011, J Caffeine Res, V1, P219, DOI 10.1089/jcr.2011.0029
   Sylvetsky AC, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040885
   Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001
   Tester JM, 2011, PUBLIC HEALTH NUTR, V14, P960, DOI 10.1017/S1368980010003411
   Visram S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188668
   Vos MB, 2017, CIRCULATION, V135, pE1017, DOI 10.1161/CIR.0000000000000439
   Welsh JA, 2013, CURR OPIN ENDOCRINOL, V20, P401, DOI 10.1097/01.med.0000432610.96107.f5
   Wescott RF, 2012, AM J PUBLIC HEALTH, V102, P1928, DOI 10.2105/AJPH.2011.300610
   Yoshida Y, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1004-6
   Zahid A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080929
NR 49
TC 16
Z9 19
U1 4
U2 62
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6663
EI 1095-8304
J9 APPETITE
JI Appetite
PD DEC 1
PY 2020
VL 155
AR 104826
DI 10.1016/j.appet.2020.104826
PG 8
WC Behavioral Sciences; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Behavioral Sciences; Nutrition & Dietetics
GA NT9XI
UT WOS:000573294600006
PM 32800838
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Dursunoglu, B
   Yuca, H
   Gözcü, S
   Yilmaz, B
   Güvenalp, Z
AF Dursunoglu, Benan
   Yuca, Hafize
   Gozcu, Sefa
   Yilmaz, Bilal
   Guvenalp, Zuhal
TI Qualitative and quantitative determination of the effective components
   of the plants in different herbal slimming products in Turkey by HPLC
SO TURKISH JOURNAL OF CHEMISTRY
LA English
DT Article
DE High performance liquid chromatography; herbal slimming product;
   Camellia sinensis; Rex paraguariensis; Calluna vulgaris
ID URSOLIC ACID; DAD METHOD; TEA; CATECHINS; CAFFEINE; OBESITY; ARBUTIN;
   LEAVES; GREEN; QUANTIFICATION
AB Obesity is a serious disease that can be due to genetic and environmental reasons and is defined by the World Health Organization as abnormal or excessive fat accumulation that may impair health. There is an increasing trend towards herbal slimming products in obesity treatment. The quality control analysis of these products is important for public health. In this study, new, simple, and sensitive high performance liquid chromatography methods were developed for qualitative and quantitative determination of arbutin, hydroquinone, ursolic acid, chlorogenic acid, epigallocatechin gallate, epigallocatechin, epicatechin gallate, and catechin in eleven herbal slimming products in Turkey containing Camellia sinensis, Ilex paraguariensis, and Calluna vulgaris. The intra- and interday precisions, stated as the relative standard deviation, were less than 2% and accuracy, based on relative error, was less than 10%. The limits of detection and quantification for arbutin and hydroquinone were 0.80 and 2.40 mu g/mL and for the other compounds were 0.30 and 0.90 mu g/mL, respectively. The methods developed can be used for routine quality control analysis of these effective compounds in different herbal slimming products.
C1 [Dursunoglu, Benan; Yuca, Hafize; Guvenalp, Zuhal] Ataturk Univ, Fac Pharm, Dept Pharmacognosy, Erzurum, Turkey.
   [Gozcu, Sefa] Erzincan Univ, Fac Pharm, Dept Pharmacognosy, Erzincan, Turkey.
   [Yilmaz, Bilal] Ataturk Univ, Fac Pharm, Dept Analyt Chem, Erzurum, Turkey.
C3 Ataturk University; Erzincan Binali Yildirim University; Ataturk
   University
RP Güvenalp, Z (corresponding author), Ataturk Univ, Fac Pharm, Dept Pharmacognosy, Erzurum, Turkey.
RI Yuca, Hafize/O-7037-2019; KALAYCI, BENAN/AFS-5231-2022
OI Kalayci, Benan/0000-0003-3248-2377; GOZCU, SEFA/0000-0002-0735-4229;
   YUCA, Hafize/0000-0002-0857-4776
FU Foundation of Ataturk University [2016/122]; Scientific and
   Technological Research Council of Turkey (TUBITAK)
FX This work was supported by the Foundation of Ataturk University
   (2016/122). Benan Dursunoglu would like to acknowledge the scholarship
   during her postgraduate program provided by the Scientific and
   Technological Research Council of Turkey (TUBITAK).
CR Altunkaynak B.Z., 2006, Van Med J, V13, P138
   Aslan M., 2010, MESLEK ICI SUREKLI E, V23-24, P96
   Barja-Fernandez S, 2014, DRUG DES DEV THER, V8, P2391, DOI 10.2147/DDDT.S53129
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Baytop T, 1999, TURKIYEDE BITKILERLE
   Cayir A, 2011, ANKARA U TIP FAKULTE, V64, P13, DOI DOI 10.1501/TIPFAK_0000000779
   Costa GM, 2011, J BRAZIL CHEM SOC, V22, P1096, DOI 10.1590/S0103-50532011000600014
   Dabhade S, 2013, INT J CURR RES REV, V5, P71
   Fernández PL, 2000, ANALYST, V125, P421, DOI 10.1039/a909219f
   Gambero A, 2015, NUTRIENTS, V7, P730, DOI 10.3390/nu7020730
   Gao HB, 2016, FUNCT MATER, V23, P437, DOI 10.15407/fm23.03.437
   Gao J, 2014, ASIAN J CHEM, V26, P2315, DOI 10.14233/ajchem.2014.15806
   GRUENWALD J., 2000, PDR FOR HERBAL MEDICINES
   Grujic N, 2012, MOLECULES, V17, P2518, DOI 10.3390/molecules17032518
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342
   Jurica K, 2015, ARH HIG RADA TOKSIKO, V66, P197, DOI 10.1515/aiht-2015-66-2696
   Kalan I., 2010, MESLEK ICI SUREKLI E, V23-24, P78
   Kim J, 2009, ARCH PHARM RES, V32, P983, DOI 10.1007/s12272-009-1702-3
   Li DH, 2012, FITOTERAPIA, V83, P1267, DOI 10.1016/j.fitote.2012.06.006
   Lukas B, 2010, FOOD CHEM, V121, P185, DOI 10.1016/j.foodchem.2009.12.028
   Manning S, 2014, THER ADV CHRONIC DIS, V5, P135, DOI 10.1177/2040622314522848
   Mohamed G. A., 2014, Bulletin of the Faculty of Pharmacy, Cairo University, V52, P269, DOI 10.1016/j.bfopcu.2014.05.001
   Roman MC, 2013, J AOAC INT, V96, P933, DOI 10.5740/jaoacint.10-488
   Rychlinska I, 2012, NOT BOT HORTI AGROBO, V40, P109
   TAHERI M, 2011, PHARMACOLOGY, V1, P487
   Tang HB, 2013, PHARM BIOL, V51, P1378, DOI 10.3109/13880209.2013.792848
   Wang HF, 2000, FOOD CHEM, V68, P115, DOI 10.1016/S0308-8146(99)00179-X
   Xu XH, 2012, J PHARM ANA, V2, P238, DOI 10.1016/j.jpha.2012.01.006
   Yuan XD, 2005, J PHARMACEUT BIOMED, V39, P697, DOI 10.1016/j.jpba.2005.04.028
   Zhang X, 2015, INT J FOOD SCI TECH, V50, P885, DOI 10.1111/ijfs.12726
   Zou SQ, 2008, J BRAZIL CHEM SOC, V19, P1429, DOI 10.1590/S0103-50532008000700030
NR 32
TC 1
Z9 1
U1 1
U2 19
PU Tubitak Scientific & Technological Research Council Turkey
PI ANKARA
PA ATATURK BULVARI NO 221, KAVAKLIDERE, TR-06100 ANKARA, TURKIYE
SN 1300-0527
J9 TURK J CHEM
JI Turk. J. Chem.
PY 2019
VL 43
IS 3
BP 825
EP +
DI 10.3906/kim-1711-5
PG 10
WC Chemistry, Multidisciplinary; Engineering, Chemical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Engineering
GA IF6YJ
UT WOS:000473228400008
OA Bronze
DA 2025-04-28
ER

PT J
AU Hansen, DK
   George, NI
   White, GE
   Pellicore, LS
   Abdel-Rahman, A
   Fabricant, D
AF Hansen, Deborah K.
   George, Nysia I.
   White, Gene E.
   Pellicore, Linda S.
   Abdel-Rahman, Ali
   Fabricant, Daniel
CA Food Drug Adm
TI Physiological effects following administration of Citrus
   aurantium for 28 days in rats
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE Bitter orange; Citrus aurantium; Cardiotoxicology; Blood pressure; Heart
   rate; Weight loss
ID WEIGHT-LOSS SUPPLEMENTS; BITTER-ORANGE; DIETARY-SUPPLEMENTS;
   EPHEDRA-FREE; SYNEPHRINE STEREOISOMERS; P-SYNEPHRINE; CAFFEINE;
   OVERWEIGHT; ALKALOIDS; EXTRACT
AB Background: Since ephedra-containing dietary supplements were banned from the US market, manufacturers changed their formulations by eliminating ephedra and replacing with other botanicals, including Citrus aurantium, or bitter orange. Bitter orange contains, among other compounds, synephrine, a chemical that is chemically similar to ephedrine. Since ephedrine may have cardiovascular effects, the goal of this study was to investigate the cardiovascular effects of various doses of bitter orange extract and pure synephrine in rats.
   Method: Female Sprague-Dawley rats were dosed daily by gavage for 28 days with synephrine from two different extracts. One extract contained 6% synephrine, and the other extract contained 95% synephrine. Doses were 10 or 50 mg synephrine/kg body weight from each extract. Additionally, caffeine was added to these doses, since many dietary supplements also contain caffeine. Telemetry was utilized to monitor heart rate, blood pressure, body temperature and QT interval in all rats.
   Results and conclusion: Synephrine, either as the bitter orange extract or as pure synephrine, increased heart rate and blood pressure. Animals treated with 95% synephrine showed minimal effects on heart rate and blood pressure; more significant effects were observed with the bitter orange extract suggesting that other components in the botanical can alter these physiological parameters. The increases in heart rate and blood pressure were more pronounced when caffeine was added. None of the treatments affected uncorrected QT interval in the absence of caffeine. Published by Elsevier Inc.
C1 [Hansen, Deborah K.; George, Nysia I.] US FDA, Div Personalized Nutr & Med, NCTR, Jefferson, AR 72079 USA.
   [White, Gene E.] Toxicol Pathol Associates, Jefferson, AR 72079 USA.
   [Pellicore, Linda S.] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20903 USA.
   [Abdel-Rahman, Ali; Fabricant, Daniel] US FDA, Off Nutr Labeling & Dietary Supplements, Ctr Food Safety & Nutr, College Pk, MD 20740 USA.
C3 US Food & Drug Administration (FDA); US Food & Drug Administration
   (FDA); US Food & Drug Administration (FDA)
RP Hansen, DK (corresponding author), US FDA, Div Personalized Nutr & Med, NCTR, 3900 NCTR Rd, Jefferson, AR 72079 USA.
EM deborah.hansen@fda.hhs.gov
FU FDA:NCTR; NIEHS:NTP [FDA 224-07-0007, NIH Y1ES1027]
FX This work was supported by Interagency Agreement between FDA:NCTR and
   the NIEHS:NTP (FDA 224-07-0007) (NIH Y1ES1027).
CR Allison DB, 2005, INT J OBESITY, V29, P443, DOI 10.1038/sj.ijo.0802879
   Andrews KW, 2007, ANAL BIOANAL CHEM, V389, P231, DOI 10.1007/s00216-007-1437-2
   Arbo MD, 2008, FOOD CHEM TOXICOL, V46, P2770, DOI 10.1016/j.fct.2008.04.037
   Arbo MD, 2009, REGUL TOXICOL PHARM, V54, P114, DOI 10.1016/j.yrtph.2009.03.001
   Bent S, 2004, AM J CARDIOL, V94, P1359, DOI 10.1016/j.amjcard.2004.07.137
   Blanck HM, 2007, J AM DIET ASSOC, V107, P441, DOI 10.1016/j.jada.2006.12.009
   Bouchard NC, 2005, MAYO CLIN PROC, V80, P541, DOI 10.4065/80.4.541
   BROWN CM, 1988, BRIT J PHARMACOL, V93, P417, DOI 10.1111/j.1476-5381.1988.tb11449.x
   Bui LT, 2006, ANN PHARMACOTHER, V40, P53, DOI 10.1345/aph.1G488
   Calapai G, 1999, FITOTERAPIA, V70, P586, DOI 10.1016/S0367-326X(99)00093-3
   Carpéné C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   Evans RL, 2008, J CHROMATOGR SCI, V46, P61, DOI 10.1093/chromsci/46.1.61
   Fang YS, 2009, PLANTA MED, V75, P24, DOI 10.1055/s-0028-1088342
   Firenzuoli F, 2005, PHYTOMEDICINE, V12, P247, DOI 10.1016/j.phymed.2004.02.005
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Fugh-Berman A, 2004, EXP BIOL MED, V229, P698, DOI 10.1177/153537020422900802
   Gange CA, 2006, MAYO CLIN PROC, V81, P545, DOI 10.4065/81.4.545
   Gray S, 2005, J ADOLESCENT HEALTH, V37, P415, DOI 10.1016/j.jadohealth.2004.12.011
   Haaz S, 2006, OBES REV, V7, P79, DOI 10.1111/j.1467-789X.2006.00195.x
   Haller CA, 2005, AM J MED, V118, P998, DOI 10.1016/j.amjmed.2005.02.034
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Haller CA, 2008, BRIT J CLIN PHARMACO, V65, P833, DOI 10.1111/j.1365-2125.2008.03144.x
   Hamer M, 2006, J HUM HYPERTENS, V20, P909, DOI 10.1038/sj.jhh.1002076
   Holmes RO, 2008, MIL MED, V173, P708, DOI 10.7205/MILMED.173.7.708
   HUANG YT, 1995, LIFE SCI, V57, P2011, DOI 10.1016/0024-3205(95)02195-O
   Ilbäck NG, 2007, FOOD CHEM TOXICOL, V45, P834, DOI 10.1016/j.fct.2006.11.001
   JORDAN R, 1987, J PHARM PHARMACOL, V39, P752, DOI 10.1111/j.2042-7158.1987.tb06986.x
   Kalman D, 2002, INT J OBESITY, V26, P1363, DOI 10.1038/sj.ijo.0802061
   Kalman DS, 2004, INT J OBESITY, V28, P1355, DOI 10.1038/sj.ijo.0802418
   Kalman DS, 2000, CURR THER RES CLIN E, V61, P199, DOI 10.1016/S0011-393X(00)89034-7
   Klontz KC, 2006, ANN PHARMACOTHER, V40, P1747, DOI 10.1345/aph.1H196
   Knight CA, 2004, FOOD CHEM TOXICOL, V42, P1923, DOI 10.1016/j.fct.2004.05.002
   Marcus DM, 2003, SCIENCE, V301, P1669
   Min B, 2005, PHARMACOTHERAPY, V25, P1719, DOI 10.1592/phco.2005.25.12.1719
   Nasir JM, 2004, MAYO CLIN PROC, V79, P1059, DOI 10.4065/79.8.1059
   Nykamp DL, 2004, ANN PHARMACOTHER, V38, P812, DOI 10.1345/aph.1D473
   Pellati F, 2007, J CHROMATOGR A, V1161, P71, DOI 10.1016/j.chroma.2007.05.097
   Penzak SR, 2001, J CLIN PHARMACOL, V41, P1059, DOI 10.1177/00912700122012652
   Pillitteri JL, 2008, OBESITY, V16, P790, DOI 10.1038/oby.2007.136
   Riksen Niels P, 2011, Handb Exp Pharmacol, P413, DOI 10.1007/978-3-642-13443-2_16
   Rossato LG, 2011, ARCH TOXICOL, V85, P929, DOI 10.1007/s00204-010-0630-9
   Rossato LG, 2011, FOOD CHEM TOXICOL, V49, P8, DOI 10.1016/j.fct.2010.11.007
   Sale C, 2006, INT J OBESITY, V30, P764, DOI 10.1038/sj.ijo.0803209
   Santana J, 2008, FOOD CHEM, V109, P675, DOI 10.1016/j.foodchem.2007.12.076
   Sharpe PA, 2006, J AM DIET ASSOC, V106, P2045, DOI 10.1016/j.jada.2006.09.014
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Stephensen TA, 2009, MIL MED, V174, P1313, DOI 10.7205/MILMED-D-01-5009
   Stohs SJ, 2011, PHYTOTHER RES, V25, P1421, DOI 10.1002/ptr.3490
   Stohs SJ, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/482973
   Sultan S, 2006, MAYO CLIN PROC, V81, P1630, DOI 10.4065/81.12.1630
   Thomas JE, 2009, TEX HEART I J, V36, P586
   Westfall T.C., 2006, Goodman and Gilman's The Pharmacological Basis of Therapeutics, V11th, P237
NR 53
TC 22
Z9 24
U1 0
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD JUN 15
PY 2012
VL 261
IS 3
BP 236
EP 247
DI 10.1016/j.taap.2012.04.006
PG 12
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 961XK
UT WOS:000305502600002
PM 22521485
DA 2025-04-28
ER

PT J
AU Lin, JK
   Lin-Shiau, SY
AF Lin, JK
   Lin-Shiau, SY
TI Mechanisms of hypolipidemic and anti-obesity effects of tea and tea
   polyphenols
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Review
DE catechins; fatty acid synthase; tea; tea polyphenols; theaflavins
ID FATTY-ACID SYNTHASE; GREEN TEA; EPIGALLOCATECHIN GALLATE;
   (-)-EPIGALLOCATECHIN GALLATE; CATECHIN-POLYPHENOLS; GALLOYL MOIETY;
   CAFFEINE; SUPPRESSION; INDUCTION; OOLONG
AB Among the health-promoting effects of tea and tea polyphenols, the cancer-chemopreventive effects in various animal model systems have been intensively investigated; meanwhile, the hypolipidemic and antiobesity effects in animals and humans have also become a hot issue for molecular nutrition and food research. It has been demonstrated that the body weights of rats and their plasma triglyceride, cholesterol, and LDL-cholesterol have been significantly reduced by feedings of oolong, black, pu-erh, and green tea leaves to the animals. It has been suggested that the inhibition of growth and suppression of lipogenesis in MCF-7 breast cancer cells may be through down-regulation of fatty acid synthase gene expression in the nucleus and stimulation of cell energy expenditure in the mitochondria. The experimental data indicated that the molecular mechanisms of fatty acid synthase gene suppression by tea polyphenols (EGCG, theaflavins) may invite down-regulation of EGFR/PI3K/Akt/Sp1 signal transduction pathways.
C1 Natl Taiwan Univ, Coll Med, Inst Biochem, Taipei, Taiwan.
   Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.
C3 National Taiwan University; National Taiwan University
RP Natl Taiwan Univ, Coll Med, Inst Biochem, 1,Sect 1 Jen Ai Rd, Taipei, Taiwan.
EM jklin@ha.mc.ntu.edu.tw
CR Ashida H, 2004, BIOFACTORS, V22, P135, DOI 10.1002/biof.5520220126
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225
   Chung JY, 2001, FASEB J, V15, P2022, DOI 10.1096/fj.01-0031fje
   Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S
   Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dulloo AG, 1998, BRIT J NUTR, V80, P493, DOI 10.1017/S0007114598001573
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857
   HO CT, 1992, PREV MED, V21, P520, DOI 10.1016/0091-7435(92)90059-Q
   Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, pC1094, DOI 10.1152/ajpcell.00569.2004
   Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897
   Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X
   Kuo KL, 2005, J AGR FOOD CHEM, V53, P480, DOI 10.1021/jf049375k
   LANDSBERG L, 1993, INT J OBESITY, V65, P829
   Lee HH, 2004, CARCINOGENESIS, V25, P1109, DOI 10.1093/carcin/bgh106
   Liang YC, 1999, J CELL BIOCHEM, V75, P1
   Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V
   Liao S., 2001, Hong Kong Medical Journal, V7, P369
   Lin J, 2005, OBES RES, V13, P982, DOI 10.1038/oby.2005.115
   Lin JK, 1999, BIOCHEM PHARMACOL, V58, P911, DOI 10.1016/S0006-2952(99)00112-4
   Lin JK, 2002, ARCH PHARM RES, V25, P561, DOI 10.1007/BF02976924
   Lin YL, 1998, J AGR FOOD CHEM, V46, P1893, DOI 10.1021/jf970963q
   Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465
   Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b
   Mayes P., 2003, Harpers Illustrated Biochemistry, V26th, P173
   Moon YS, 2002, J LIPID RES, V43, P691
   Muralt P, 2002, MICROSYST SER, V9, P3
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   NORMURA M, 2001, J BIOL CHEM, V276, P46624
   Rietveld A, 2003, J NUTR, V133, p3285S, DOI 10.1093/jn/133.10.3285S
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737
   St-Onge MP, 2005, AM J CLIN NUTR, V81, P7
   VISON JA, 2004, J AGR FOOD CHEM, V52, P3661
   Wang X, 2003, BIOCHEM PHARMACOL, V66, P2039, DOI 10.1016/S0006-2952(03)00585-9
   Wang X, 2001, BIOCHEM BIOPH RES CO, V288, P1200, DOI 10.1006/bbrc.2001.5923
   Yang CS, 2000, J NUTR, V130, P2409, DOI 10.1093/jn/130.10.2409
   Yeh CW, 2003, PHARMACOGENOMICS J, V3, P267, DOI 10.1038/sj.tpj.6500192
   Zheng GD, 2004, IN VIVO, V18, P55
NR 48
TC 249
Z9 280
U1 11
U2 159
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD FEB
PY 2006
VL 50
IS 2
BP 211
EP 217
DI 10.1002/mnfr.200500138
PG 7
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 016EH
UT WOS:000235603000012
PM 16404708
DA 2025-04-28
ER

PT J
AU Rains, TM
   Agarwal, S
   Maki, KC
AF Rains, Tia M.
   Agarwal, Sanjiv
   Maki, Kevin C.
TI Antiobesity effects of green tea catechins: a mechanistic review
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Review
DE Green tea catechins; Obesity; Energy expenditure; Fat oxidation
ID FATTY-ACID OXIDATION; DIET-INDUCED OBESITY; REDUCES BODY-FAT;
   INTESTINAL-ABSORPTION; ENERGY-EXPENDITURE; DOUBLE-BLIND; FOOD-INTAKE;
   EPIGALLOCATECHIN GALLATE; WEIGHT MAINTENANCE; O-METHYLTRANSFERASE
AB Green tea catechins (GTC) are polyphenolic compounds present in the unfermented dried leaves of the plant, Camellia sinensis. Results from a number of randomized, controlled intervention trials have shown that consumption of GTC (270 mg to 1200 mg/day) may reduce body weight and fat. There are several proposed mechanisms whereby GTC may influence body weight and composition. The predominating hypothesis is that GTC influences sympathetic nervous system (SNS) activity, increasing energy expenditure and promoting the oxidation of fat. Caffeine, naturally present in green tea, also influences SNS activity, and may act synergistically with GTC to increase energy expenditure and fat oxidation. Other potential mechanisms include modifications in appetite, up-regulation of enzymes involved in hepatic fat oxidation, and decreased nutrient absorption. This article reviews the evidence for each of these purported mechanisms, with particular reference to studies in humans. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Rains, Tia M.; Maki, Kevin C.] Provident Clin Res, Glen Ellyn, IL 60137 USA.
RP Maki, KC (corresponding author), Provident Clin Res, Glen Ellyn, IL 60137 USA.
EM kmaki@providentcrc.com
CR [Anonymous], OV OB
   Ashida H, 2004, BIOFACTORS, V22, P135, DOI 10.1002/biof.5520220126
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   Bray GA, 2008, J CLIN ENDOCR METAB, V93, pS81, DOI 10.1210/jc.2008-1294
   Brown WJ, 2005, OBES RES, V13, P1431, DOI 10.1038/oby.2005.173
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549
   Cooper R, 2005, J ALTERN COMPLEM MED, V11, P521, DOI 10.1089/acm.2005.11.521
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Friedman MI, 2007, DRUG NEWS PERSPECT, V20, P573, DOI 10.1358/dnp.2007.20.9.1162243
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Hasegawa N, 2003, PHYTOTHER RES, V17, P477, DOI 10.1002/ptr.1177
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857
   Hodgson JM, 2006, BRIT J NUTR, V95, P14, DOI 10.1079/BJN20051621
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hsu TF, 2006, EUR J CLIN NUTR, V60, P1330, DOI 10.1038/sj.ejcn.1602464
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   Ikeda I, 2003, J AGR FOOD CHEM, V51, P7303, DOI 10.1021/jf034728l
   Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Kahler A, 1999, NUTRITION, V15, P819, DOI 10.1016/S0899-9007(99)00212-9
   Kamphuis MMJW, 2003, AM J CLIN NUTR, V77, P1133, DOI 10.1093/ajcn/77.5.1133
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Krul C, 2001, MUTAT RES-FUND MOL M, V474, P71, DOI 10.1016/S0027-5107(00)00158-5
   Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b
   Maki KC, 2009, NUTRITION, V25, P627, DOI 10.1016/j.nut.2008.11.028
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Matsui T, 1996, BIOSCI BIOTECH BIOCH, V60, P2019, DOI 10.1271/bbb.60.2019
   MATSUMOTO N, 1993, BIOSCI BIOTECH BIOCH, V57, P525, DOI 10.1271/bbb.57.525
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Nagle DG, 2006, PHYTOCHEMISTRY, V67, P1849, DOI 10.1016/j.phytochem.2006.06.020
   Ota N, 2005, J HEALTH SCI, V51, P233, DOI 10.1248/jhs.51.233
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Park JH, 2009, J PHYSIOL PHARMACOL, V60, P101
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Popkin BM, 2010, AM J CLIN NUTR, V91, p284S, DOI 10.3945/ajcn.2009.28473C
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Sabu MC, 2002, J ETHNOPHARMACOL, V83, P109
   SCHARRER E, 1986, AM J PHYSIOL, V250, P1003, DOI 10.1152/ajpregu.1986.250.6.R1003
   Scharrer E, 1999, NUTRITION, V15, P704, DOI 10.1016/S0899-9007(99)00125-2
   Secher A, 2009, INT CLIN PSYCHOPHARM, V24, P199, DOI 10.1097/YIC.0b013e32832d6be2
   Shishikura Y, 2006, J AGR FOOD CHEM, V54, P1906, DOI 10.1021/jf051988p
   St-Onge MP, 2002, J NUTR, V132, P329
   Takeshita M, 2008, Jpn Pharmacol Ther, V36, P767
   Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010
   Tsuneki Hiroshi, 2004, BMC Pharmacology, V4, P18, DOI 10.1186/1471-2210-4-18
   Unno T, 2009, J NUTR SCI VITAMINOL, V55, P447, DOI 10.3177/jnsv.55.447
   USDA, USDA DAT FLAV CONT S
   Van Amelsvoort JMM, 2001, XENOBIOTICA, V31, P891, DOI 10.1080/00498250110079149
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wang S, 2006, J NUTR, V136, P2791, DOI 10.1093/jn/136.11.2791
   Wang S, 2006, J NUTR BIOCHEM, V17, P492, DOI 10.1016/j.jnutbio.2006.03.004
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Zhong LT, 2006, AM J CLIN NUTR, V84, P551, DOI 10.1093/ajcn/84.3.551
NR 85
TC 311
Z9 343
U1 1
U2 145
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JAN
PY 2011
VL 22
IS 1
BP 1
EP 7
DI 10.1016/j.jnutbio.2010.06.006
PG 7
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 701XO
UT WOS:000285858700001
PM 21115335
DA 2025-04-28
ER

PT J
AU De Lira-García, C
   Bacardí-Gascón, M
   Jiménez-Cruz, A
AF De Lira-Garcia, Cynthia
   Bacardi-Gascon, Montserrat
   Jimenez-Cruz, Arturo
TI Preferences of healthy and unhealthy foods among 3 to 4 year old
   children in Mexico
SO ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE food preferences; preschool children; over-weight; obesity; Mexico
ID SCHOOL-AGED CHILDREN; GENDER-DIFFERENCES; RISK-FACTORS; DETERMINANTS;
   OBESITY
AB Objective: To evaluate the preference of healthy and unhealthy foods among pre-school children attending day-care and its association with that of their parents, body mass index and socio-demographic variables. Methodology: We asked children and parents to depict their food preferences through 54 pictures of different food items. The association between the preferences and socio-demographic variables was done using the Phi correlation, chi-squared, Fisher's correlation, as well as univariate and multivariable logistic regression. Results: Two-hundred and sixty-five parent-child pairs participated in the study. Ice cream, potato chips and lollypops were the foods most preferred by children. On the other hand, quince jelly, coffee and avocado were the least preferred. Overweight and obese children had a higher preference for quince jelly, preserved fruits, and vegetable soup. With univariate logistic regression, children of low-income homes (OR= 2.56, p=0.007) and attending public daycare centers (OR= 6.2, p=0.0001) preferred less healthy fruits. When the father's education was added in a multivariable model including family income, only children whose fathers had <= 9 years of education showed a higher preference for less healthy food. When parent's education, family income, and parent's preference for healthy foods were included to the model only children attending public daycares were more likely to prefer healthy foods. Conclusion: The foods most preferred by children have a high caloric density. The children's body mass index, their parent's monthly income, the father's education and the type of daycare they attended were associated with the preference of healthy or unhealthy foods.
C1 [Bacardi-Gascon, Montserrat] Univ Autonoma Baja California, Sch Med, Fac Psicol & Med, Tijuana Bc 22390, Mexico.
   [De Lira-Garcia, Cynthia] Univ Autonoma Baja California, Escuela Enol & Gastron, Tijuana Bc 22390, Mexico.
C3 Universidad Autonoma de Baja California; Universidad Autonoma de Baja
   California
RP Bacardí-Gascón, M (corresponding author), Univ Autonoma Baja California, Sch Med, Fac Psicol & Med, Calzada Univ 14418,Parque Ind Int, Tijuana Bc 22390, Mexico.
EM montserrat@uabc.edu.mx
OI Bacardi-Gascon, Montserrat/0000-0003-1244-4226; DE LIRA GARCIA,
   CYNTHIA/0000-0003-0290-7282
CR Baughcum AE, 2000, PEDIATRICS, V106, P1380, DOI 10.1542/peds.106.6.1380
   Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41
   Caine-Bish NL, 2009, J SCHOOL HEALTH, V79, P532, DOI 10.1111/j.1746-1561.2009.00445.x
   Colapinto CK, 2007, J AM DIET ASSOC, V107, P1183, DOI 10.1016/j.jada.2007.04.012
   Cooke LJ, 2005, BRIT J NUTR, V93, P741, DOI 10.1079/BJN20051389
   Del-Rio-Navarro BE, 2008, ARCH MED RES, V39, P215, DOI 10.1016/j.arcmed.2007.07.008
   Doval HC, 2006, REV ARGENT CARDIOL, V74, P1
   Guthrie CA, 2000, APPETITE, V35, P73, DOI 10.1006/appe.2000.0329
   Hill C, 2009, APPETITE, V52, P603, DOI 10.1016/j.appet.2009.02.003
   Hughes SO, 2007, J DEV BEHAV PEDIATR, V28, P100, DOI 10.1097/01.DBP.0000267561.34199.a9
   Jaramillo SJ, 2006, J NUTR EDUC BEHAV, V38, P352, DOI 10.1016/j.jneb.2006.06.003
   Jimenez Cruz A, 2010, CHILD PSYCHIAT HUMAN, V41, P490
   Jimenez-Cruz A, 2010, ASIA PAC J CLIN NUTR, V19, P316
   Johannsen DL, 2006, OBESITY, V14, P431, DOI 10.1038/oby.2006.57
   KLESGES RC, 1983, J APPL BEHAV ANAL, V16, P371, DOI 10.1901/jaba.1983.16-371
   López-Alvarenga JC, 2007, GAC MED MEX, V143, P463
   MELA DJ, 1991, AM J CLIN NUTR, V53, P908, DOI 10.1093/ajcn/53.4.908
   Nicklaus S, 2004, FOOD QUAL PREFER, V15, P805, DOI 10.1016/j.foodqual.2004.02.010
   Perichart-Perera O, 2007, J AM DIET ASSOC, V107, P81, DOI 10.1016/j.jada.2006.10.011
   Ramírez-Ley K, 2009, J PUBLIC HEALTH-UK, V31, P383, DOI 10.1093/pubmed/fdp058
   Ricketts CD, 1997, EUR J CLIN NUTR, V51, P778, DOI 10.1038/sj.ejcn.1600487
   Romero-Velarde E, 2007, SALUD PUBLICA MEXICO, V49, P103, DOI 10.1590/S0036-36342007000200005
   Skinner J, 1998, J NUTR EDUC, V30, P17, DOI 10.1016/S0022-3182(98)70270-5
   Skinner JD, 2002, J AM DIET ASSOC, V102, P1638, DOI 10.1016/S0002-8223(02)90349-4
   Unusan N, 2006, FOOD QUAL PREFER, V17, P362, DOI 10.1016/j.foodqual.2005.04.008
   Wardle J, 2001, APPETITE, V37, P217, DOI 10.1006/appe.2001.0423
   Wardle J, 2001, INT J OBESITY, V25, P971, DOI 10.1038/sj.ijo.0801661
   Wardle J, 2008, BRIT J NUTR, V99, pS15, DOI 10.1017/S000711450889246X
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA
NR 29
TC 6
Z9 8
U1 0
U2 16
PU H E C PRESS, HEALTHY EATING CLUB PTY LTD
PI MCKINNON
PA PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA
SN 0964-7058
EI 1440-6047
J9 ASIA PAC J CLIN NUTR
JI Asia Pac. J. Clin. Nutr.
PY 2012
VL 21
IS 1
BP 57
EP 63
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA 907ER
UT WOS:000301401100008
PM 22374561
DA 2025-04-28
ER

PT J
AU Celestino, MM
   Gomes, AC
   Botelho, PB
   Gambero, A
   Mesquita, LM
   Vilegas, W
   Ribeiro, ML
   Mota, JF
AF Celestino, Marina Monteiro
   Gomes, Aline Corado
   Botelho, Patricia Borges
   Gambero, Alessandra
   Mesquita, Leonardo Mendes
   Vilegas, Wagner
   Ribeiro, Marcelo Lima
   Mota, Joao Felipe
TI South American herbal extracts reduce food intake through modulation of
   gastrointestinal hormones in overweight and obese women
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Obesity; Glucagon-like peptide 1; Ghrelin; Yerba mate; Guarana; Damiana
ID GLUCOSE-TOLERANCE; BODY-WEIGHT; SECRETION; GHRELIN; GLP-1; APPETITE;
   MECHANISMS; CAFFEINE; MOTILITY; SYSTEM
AB Herbal plants have been assessed for possible action that influence gastrointestinal hormonal secretion, modifying gut motility, food intake and energy balance. The effects of herbal extracts derived from native species of South America on food intake and acylated ghrelin and glucagon-like peptide 1 (GLP-1) concentrations after consuming meals were investigated for the first time in humans. Twenty overweight and obese women were recruited for a randomized, single blind, placebo -controlled, crossover design study separated by a 7-day washout period. Participants received an herbal extract combination containing yerba mate, guarana and damiana ('YGD') or placebo. Energy intake at lunch was reduced significantly in the YGD group (-43.3 +/- 13.1 kcal; P = 0.005). The AUC for acylated ghrelin after lunch was significantly lower in the YGD group (-1004 +/- 690.9 vs. 565.9 +/- 286.7, P = 0.04). At 60 and 150 min after breakfast, GLP-1 concentrations were higher in YGD (P = 0.04) when compared with the control group. The AUC for GLP-1 after breakfast was significantly higher in the YGD group (1003 +/- 370.5 vs. 160.3 +/- 221.3, P < 0.05). Supplementation with the herbal extract YGD reduced energy and macronutrient intake by modulating the gut hormones in overweight and obese women. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Celestino, Marina Monteiro; Gomes, Aline Corado; Botelho, Patricia Borges; Mota, Joao Felipe] Univ Fed Goias, Fac Nutr, Clin & Sports Nutr Res Lab Labince, Goiania, Go, Brazil.
   [Gambero, Alessandra; Ribeiro, Marcelo Lima] Sao Francisco Univ, Lab Microbiol & Mol Biol, Clin Pharmacol & Gastroenterol Unit, Braganca Paulista, SP, Brazil.
   [Mesquita, Leonardo Mendes; Vilegas, Wagner] Sao Paulo State Univ, LBPN, Sao Paulo, Brazil.
C3 Universidade Federal de Goias; Universidade Estadual Paulista
RP Mota, JF (corresponding author), Setor Leste Univ, St 227,Block 68, Goiania, Go, Brazil.
EM jfemota@gmail.com
RI de Souza Mesquita, Leonardo/AAA-5697-2020; Vilegas, Wagner/S-3209-2019;
   Gambero, Alessandra/G-5792-2013; GOMES, ALINE/AAZ-5406-2021; Mota,
   João/AAU-9194-2020; Ribeiro, Marcelo/H-8856-2013; Botelho, Patricia
   Borges/AAL-7977-2020; Vilegas, Wagner/D-3170-2012; Mota, Joao
   Felipe/I-7507-2012
OI Botelho, Patricia Borges/0000-0001-8909-3757; Gambero,
   Alessandra/0000-0002-4862-4328; Vilegas, Wagner/0000-0003-3032-2556;
   /0000-0003-4529-7832; Mendes de Souza Mesquita,
   Leonardo/0000-0002-7602-7731; Mota, Joao Felipe/0000-0001-6123-7616
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
FX We would like to thank the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) for their support arid Natures Remedies Ltd,
   Amersham, UK for their donation of supplements. We thank the
   participants for their availability and confidence in the researchers.
CR Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   [Anonymous], NUTR J
   Arçari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Arçari DP, 2011, J FUNCT FOODS, V3, P190, DOI 10.1016/j.jff.2011.04.001
   Baggio LL, 2014, J CLIN INVEST, V124, P4223, DOI 10.1172/JCI78371
   Bewick GA, 2012, BIOCHEM MEDICA, V22, P283
   Bewick GA, 2009, DIABETES, V58, P840, DOI 10.2337/db08-1428
   Choo CY, 2012, J ETHNOPHARMACOL, V142, P776, DOI 10.1016/j.jep.2012.05.062
   Costantino L, 2012, EXPERT OPIN THER PAT, V22, P697, DOI 10.1517/13543776.2012.684946
   Dawson JA, 2016, INT J OBESITY, V40, P895, DOI 10.1038/ijo.2015.212
   de Resende PE, 2015, J FUNCT FOODS, V15, P440, DOI 10.1016/j.jff.2015.03.040
   Di Francesco V, 2010, J AM MED DIR ASSOC, V11, P188, DOI 10.1016/j.jamda.2009.08.004
   Erdmann J, 2003, REGUL PEPTIDES, V116, P101, DOI 10.1016/S0167-0115(03)00195-2
   Gagnon J, 2015, DIABETES, V64, P1513, DOI 10.2337/db14-1176
   Gibbons C, 2013, J CLIN ENDOCR METAB, V98, pE847, DOI 10.1210/jc.2012-3835
   Gómez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421
   de Mejía EG, 2010, J FUNCT FOODS, V2, P23, DOI 10.1016/j.jff.2009.12.003
   Harrold JA, 2013, APPETITE, V62, P84, DOI 10.1016/j.appet.2012.11.018
   Holst JJ, 2013, INT J OBESITY, V37, P1161, DOI 10.1038/ijo.2012.208
   Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396
   Hussein GME, 2011, BIOL PHARM BULL, V34, P1849, DOI 10.1248/bpb.34.1849
   Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018
   Jessen A, 2005, DIABETES OBES METAB, V7, P327, DOI 10.1111/j.1463-1326.2004.00389.x
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Johnston KL, 2002, J SCI FOOD AGR, V82, P1800, DOI 10.1002/jsfa.1264
   Kim S. Y., 2015, BMC COMPLEM ALTERN M, V15, P1
   Koliaki C., 2010, INT J PEPTIDES, V2010
   Krotkiewski M, 2008, PRACA ORYGINALNA, V4, P137
   Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155
   da Silva LAL, 2015, PHARMACOGN MAG, V11, P96, DOI 10.4103/0973-1296.149721
   Liu C, 2013, J ENDOCRINOL, V217, P185, DOI 10.1530/JOE-12-0502
   Lorenz M, 2013, BIOORG MED CHEM LETT, V23, P4011, DOI 10.1016/j.bmcl.2013.05.022
   MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434
   Marathe CS, 2013, DIABETES CARE, V36, P1396, DOI 10.2337/dc12-1609
   Matsumoto RLT, 2009, J AGR FOOD CHEM, V57, P1775, DOI 10.1021/jf803096g
   Meeran K, 1999, ENDOCRINOLOGY, V140, P244, DOI 10.1210/en.140.1.244
   Mulvihill EE, 2014, ENDOCR REV, V35, P992, DOI 10.1210/er.2014-1035
   NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B
   Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2
   Panickar KS, 2013, MOL NUTR FOOD RES, V57, P34, DOI 10.1002/mnfr.201200431
   Parker JA, 2013, INT J OBESITY, V37, P1391, DOI 10.1038/ijo.2012.227
   Peeters T L, 2003, J Physiol Pharmacol, V54 Suppl 4, P95
   Pettenuzzo LF, 2008, PHYSIOL BEHAV, V95, P295, DOI 10.1016/j.physbeh.2008.06.003
   Pimentel GD, 2013, J NUTR BIOCHEM, V24, P809, DOI 10.1016/j.jnutbio.2012.04.016
   Pimentel GD, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-6
   Portella RD, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-12
   Punjabi M, 2011, PHYSIOL BEHAV, V105, P71, DOI 10.1016/j.physbeh.2011.02.038
   Rayner CK, 2001, DIABETES CARE, V24, P371, DOI 10.2337/diacare.24.2.371
   Ruchel JB, 2016, PHYTOTHER RES, V30, P49, DOI 10.1002/ptr.5499
   Saghebjoo M., 2013, INT J ENDOCRINOL, V4, P1
   Sam AH, 2012, NEUROPHARMACOLOGY, V63, P46, DOI 10.1016/j.neuropharm.2011.10.008
   Schirra J, 2002, GUT, V50, P341, DOI 10.1136/gut.50.3.341
   Schirra J, 2006, GUT, V55, P243, DOI 10.1136/gut.2004.059741
   SHIIYA T, 2002, THE JOURNAL OF CLINI, V1, P240
   Shivanna Yogisha Shivanna Yogisha, 2010, Journal of Natural Products (India), V3, P76
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Szewczyk K, 2014, J ETHNOPHARMACOL, V152, P424, DOI 10.1016/j.jep.2014.01.019
   Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030
   Törrönen R, 2012, BRIT J NUTR, V107, P1445, DOI 10.1017/S0007114511004557
   Tschöp M, 2000, NATURE, V407, P908, DOI 10.1038/35038090
   WHO, 2004, WHO TECHN REP SER
   Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327
   Wootten D, 2011, J PHARMACOL EXP THER, V336, P540, DOI 10.1124/jpet.110.176362
   Zhao JP, 2008, J ETHNOPHARMACOL, V120, P387, DOI 10.1016/j.jep.2008.09.016
NR 65
TC 4
Z9 4
U1 2
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD AUG
PY 2017
VL 35
BP 555
EP 563
DI 10.1016/j.jff.2017.06.015
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA FB3ZI
UT WOS:000406080900061
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Dallas, C
   Gerbi, A
   Tenca, G
   Juchaux, F
   Bernard, FX
AF Dallas, Constantin
   Gerbi, Alain
   Tenca, Guillaume
   Juchaux, Franck
   Bernard, Francois-Xavier
TI Lipolytic effect of a polyphenolic citrus dry extract of red orange,
   grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of
   action by inhibition of cAMP-phosphodiesterase (PDE)
SO PHYTOMEDICINE
LA English
DT Article
DE Lipolysis; Citrus; Adipocytes; Phosphodiesterase; Body fat; Free fatty
   acids (FFA)
ID MODEL WINE SOLUTIONS; GREEN TEA; OLIGOMERIC PROCYANIDINS; RAT
   ADIPOCYTES; 3T3-L1 CELLS; ANTHOCYANINS; ACETALDEHYDE; CONSUMPTION;
   SUBSTANCES; FLAVONOIDS
AB The present study investigated the lipolytic (break of fat stored) effect of a citrus-based polyphenolic dietary supplement (SINETROL) at human adipocytes (ex vivo), body fat (clinical) and biochemical levels (inhibition of phosphodiesterase). Free fatty acids (FFA) release was used as indicator of human adipocyte lipolysis and SINETROL activity has been compared with known lipolytic products (isoproterenol, theopylline and caffeine). SINETROL stimulated significantly the lipolytic activity in a range of 6 fold greater than the control. Moreover, SINETROL has 2.1 greater activity than guarana 12% caffeine while its content in caffeine is 3 times lower. Clinically, two groups of 10 volunteers with BMI relevant of overweight were compared during 4 and 12 weeks with 1.4 g/day SINETROL and placebo supplementation. In the SINETROL Group the body fat (%) decreased with a significant difference of 5.53% and 15.6% after 4 and 12 weeks, respectively, while the body weight (kg) decreased with a significant difference of 2.2 and 5.2 kg after 4 and 12 weeks, respectively. These observed effects are linked to SINETROL polyphenolic composition and its resulting synergistic activity. SINETROL is a potent inhibitor of cAMP-phosphodiesterase (PDE) (97%) compared to other purified compounds (cyanidin-3 glycoside, narangin, caffeine). These results suggest that SINETROL has a strong lipolytic effect mediated by cAMP-PDE inhibition. SINETROL may serve to prevent obesity by decreasing BMI. (C) 2008 Elsevier GmbH. All rights reserved.
C1 [Dallas, Constantin] FYTEXIA NB Consulting Grp, ZAC Mercorent, F-34500 Beziers, France.
   [Tenca, Guillaume; Juchaux, Franck; Bernard, Francois-Xavier] BIOalternat SAS, F-86160 Gencay, France.
RP Dallas, C (corresponding author), FYTEXIA NB Consulting Grp, ZAC Mercorent, 280 Rue Nicolas Joseph Cugnot, F-34500 Beziers, France.
EM cdallas@fytexia.com
RI BERNARD, François/F-2864-2014
CR Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379
   Ballard TLP, 2006, CLIN EXP PHARMACOL P, V33, P310, DOI 10.1111/j.1440-1681.2006.04367.x
   BEAVO JA, 1971, ANN NY ACAD SCI, V185, P129
   Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P2618, DOI 10.2741/1421
   Dallas C, 1996, J AGR FOOD CHEM, V44, P2402, DOI 10.1021/jf940433j
   Dallas C, 1995, VITIS, V34, P51
   DALLAS C, 1994, J SCI FOOD AGR, V65, P477, DOI 10.1002/jsfa.2740650416
   Dallas C, 1996, J SCI FOOD AGR, V70, P493, DOI 10.1002/(SICI)1097-0010(199604)70:4<493::AID-JSFA528>3.3.CO;2-Z
   DALLAS C, 1994, VITIS, V33, P41
   FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V
   Fujioka K, 2006, J MED FOOD, V9, P49, DOI 10.1089/jmf.2006.9.49
   Girotti C, 2005, PLANTA MED, V71, P1170, DOI 10.1055/s-2005-873146
   Jiang M, 1998, PLANTA MED, V64, P375, DOI 10.1055/s-2006-957456
   KUPPUSAMY UR, 1992, BIOCHEM PHARMACOL, V44, P1307, DOI 10.1016/0006-2952(92)90531-M
   LAUGHTON MJ, 1991, BIOCHEM PHARMACOL, V42, P1673, DOI 10.1016/0006-2952(91)90501-U
   Mochizuki M, 2004, PHYTOTHER RES, V18, P1029, DOI 10.1002/ptr.1612
   Mochizuki M, 2004, PHYTOTHER RES, V18, P945, DOI 10.1002/ptr.1580
   Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185
   RENOLD AE, 1965, HDB PHYSL 5
   Robidoux J, 2006, J BIOL CHEM, V281, P37794, DOI 10.1074/jbc.M605572200
   RODBELL M, 1964, J BIOL CHEM, V239, P375
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   SPECTOR AA, 1975, J LIPID RES, V16, P165
   STEINBERG D, 1977, FED PROC, V36, P1986
   Tsuda T, 2005, BBA-MOL CELL BIOL L, V1733, P137, DOI 10.1016/j.bbalip.2004.12.014
   Yoshikawa M, 2002, J NUTR, V132, P1819, DOI 10.1093/jn/132.7.1819
NR 26
TC 64
Z9 74
U1 2
U2 38
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0944-7113
J9 PHYTOMEDICINE
JI Phytomedicine
PD OCT
PY 2008
VL 15
IS 10
BP 783
EP 792
DI 10.1016/j.phymed.2008.05.006
PG 10
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 364RG
UT WOS:000260352200001
PM 18617377
DA 2025-04-28
ER

PT J
AU Ali, M
   Yusuf, HI
   Stahmer, J
   Rahlenbeck, SI
AF Ali, Mahdi
   Yusuf, Hassan Ismail
   Stahmer, Jens
   Rahlenbeck, Sibylle I.
TI Cardiovascular Risk Factors and Physical Activity Among University
   Students in Somaliland
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE Cardiovascular risk factors; BMI; Somalia; Physical inactivity;
   Sedentary life style; Blood pressure; Overweight
ID YOUNG-ADULTS; PREVALENCE; INACTIVITY
AB Physical inactivity is a well-known risk factor for the development of cardiovascular diseases and counts as fourth leading cause of death worldwide. The study aimed to elucidate to what extent cardiovascular risk factors exist in university students in Somaliland. In a cross-sectional survey, self-administered questionnaires were used to elucidate existence of cardiovascular risk factors in 173 university students (117 male, 56 female) in Hargeisa, Somaliland. Information elucidated included socio-economic and demographic data in addition to questions on coffee intake, on physical activity behavior, type of sport/activity and intensity and duration. Height and weight were taken, as was blood pressure (BP). Median age was 23 years in male and 20 years in female students. Mean BMI was 19.7 in male and 21.8 in female students. The prevalence rates of elevated BP and overweight (BMI a parts per thousand yen 25) in female and male students were, 0 versus 9 and 14 versus 7 %, respectively. Coffee consumption was reported by 39 % of students. None of the female students reported smoking cigarettes, while 5.1 % of the male students did. Physical inactivity was reported by 52 % of the female students and 27 % of the male students (p = 0.01). Overall, male students reported a higher degree and intensity of physical activity. The prevalence of cardiovascular risk factors is low in female and male university students in Somaliland. However, the results demonstrate a high degree of physical inactivity and overweight might become a problem in the future. This issue should be addressed by increasing the motivation and opportunities for physical activity in students.
C1 [Ali, Mahdi; Yusuf, Hassan Ismail] Univ Hargeisa, Fac Med, Hargeisa, Somalia.
   [Stahmer, Jens] Reinbek Hosp, Internal Med, D-21465 Reinbek, Germany.
   [Rahlenbeck, Sibylle I.] Afrika Akt eV, Epidemiol & Publ Hlth, Berlin, Germany.
RP Rahlenbeck, SI (corresponding author), Afrika Akt eV, Epidemiol & Publ Hlth, Berlin, Germany.
EM Rahlenbeck@hotmail.com
FU Afrika aktiv e.V.; Else-Kroener-Fresenius-Stiftung, Germany
FX We would like to thank all participating students of the University of
   Hargeisa for their active participation. This study was supported by
   Afrika aktiv e.V. and the Else-Kroener-Fresenius-Stiftung, Germany.
CR Abdi IA, 2013, J COMMUN HEALTH, V38, P246, DOI 10.1007/s10900-012-9606-4
   Adegoke BOA, 2011, J PHYS ACT HEALTH, V8, P1135, DOI 10.1123/jpah.8.8.1135
   Baalwa J, 2010, AFR HEALTH SCI, V10, P367
   Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10
   Ewane E. M., 2012, PAN AFRICAN MED J, V11, P77
   Guha-Sapir D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000108
   Hassan IY., 2007, PREVALENCE SURVEY HY
   Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8
   Magutah K, 2013, AFR HEALTH SCI, V13, P10, DOI 10.4314/ahs.v13i1.2
   Oyeyemi AL, 2013, J EPIDEMIOL, V23, P169, DOI 10.2188/jea.JE20120116
   Peer N, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19216
   Rahlenbeck SI, 1998, ANN BIOL CLIN-PARIS, V56, P705
   Rebacz-Maron E, 2013, BIOL TRACE ELEM RES, V151, P350, DOI 10.1007/s12011-012-9578-3
   Senbanjo IO, 2012, CARDIOVASC J AFR, V23, P260, DOI 10.5830/CVJA-2011-037
   Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39
   UNICEF, 2011, SOM
   UNICEF, 2011, SOM MULT IND CLUST S
   World Health Organization, 2007, GLOB REC PHYS ACT HL
NR 18
TC 20
Z9 22
U1 0
U2 30
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD APR
PY 2015
VL 40
IS 2
BP 326
EP 330
DI 10.1007/s10900-014-9938-3
PG 5
WC Health Policy & Services; Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA CD1GJ
UT WOS:000350822600019
PM 25179818
DA 2025-04-28
ER

PT J
AU Diepvens, K
   Westerterp, KR
   Westerterp-Plantenga, MS
AF Diepvens, Kristel
   Westerterp, Klaas R.
   Westerterp-Plantenga, Margriet S.
TI Obesity and thermogenesis related to the consumption of caffeine,
   ephedrine, capsaicin, and green tea
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Review
DE sympathetic nervous system; energy expenditure; body weight; adverse
   effects
ID SYMPATHETIC-NERVOUS-SYSTEM; BODY-WEIGHT LOSS; SUBCUTANEOUS
   ADIPOSE-TISSUE; ENERGY-RESTRICTED DIET; RESTING METABOLIC-RATE;
   ANGIOGENESIS IN-VITRO; DOUBLE-BLIND TRIAL; HIGH-FAT DIET; RED-PEPPER;
   FOOD-INTAKE
AB The global prevalence of obesity has increased considerably in the last decade. Tools for obesity management, including caffeine, ephedrine, capsaicin, and green tea have been proposed as strategies for weight loss and weight maintenance, since they may increase energy expenditure and have been proposed to counteract the decrease in metabolic rate that is present during weight loss. A combination of caffeine and ephedrine has shown to be effective in long-term weight management, likely due to different mechanisms that may operate synergistically, e.g., respectively inhibiting the phosphodiesterase-induced degradation of cAMP and enhancing the sympathetic release of catecholamines. However, adverse effects of ephedrine prevent the feasibility of this approach. Capsaicin has been shown to be effective, yet when it is used clinically it requires a strong compliance to a certain dosage, that has not been shown to be feasible yet. Also positive effects on body-weight management have been shown using green tea mixtures. Green tea, by containing both tea catechins and caffeine, may act through inhibition of catechol O-methyl-transferase, and inhibition of phosphodiesterase. Here, the mechanisms may also operate synergistically. In addition, tea catechins have antiangiogenic properties that may prevent development of overweight and obesity. Furthermore, the sympathetic nervous system is involved in the regulation of lipolysis, and the sympathetic innervation of white adipose tissue may play an important role in the regulation of total body fat in general.
C1 Maastricht Univ, Dept Human Biol, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University
RP Diepvens, K (corresponding author), Maastricht Univ, Dept Human Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM K.Diepvens@HB.Unimaas.NL
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   ANDERSSON B, 1991, HYPERTENSION, V18, P783, DOI 10.1161/01.HYP.18.6.783
   [Anonymous], 2000, WHO TECH REP SER, V894, P1
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   ASTRUP A, 1985, AM J CLIN NUTR, V42, P83, DOI 10.1093/ajcn/42.1.83
   Astrup A, 2000, ENDOCRINE, V13, P207, DOI 10.1385/ENDO:13:2:207
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   ASTRUP A, 1993, INT J OBESITY, V17, pS41
   ASTRUP A, 1995, INT J OBESITY, V19, pS24
   Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399
   BAZELMANS J, 1985, METABOLISM, V34, P154, DOI 10.1016/0026-0495(85)90125-8
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bobbioni-Harsch E, 2004, INT J OBESITY, V28, P906, DOI 10.1038/sj.ijo.0802620
   Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Bouloumié A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Bråkenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70
   BRAY GA, 1986, FED PROC, V45, P1404
   Bray GA, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801269
   BUKOWIECKI L, 1982, INT J OBESITY, V6, P343
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Chen M D, 1994, Zhonghua Yi Xue Za Zhi (Taipei), V53, P257
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Collins S, 1996, NATURE, V380, P677, DOI 10.1038/380677a0
   CURATOLO PW, 1983, ANN INTERN MED, V98, P641, DOI 10.7326/0003-4819-98-5-641
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dodt C, 2003, ACTA PHYSIOL SCAND, V177, P351, DOI 10.1046/j.1365-201X.2003.01077.x
   Dodt C, 2000, DIABETES, V49, P1875, DOI 10.2337/diabetes.49.11.1875
   DULLOO AG, 1993, INT J OBESITY, V17, pS35
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   DULLOO AG, 1986, INT J OBESITY, V10, P467
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 2004, PHYSIOL BEHAV, V83, P587, DOI 10.1016/j.physbeh.2004.07.028
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1991, INT J OBESITY, V15, P317
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Dulloo AG, 2002, SCIENCE, V297, P780, DOI 10.1126/science.1074923
   DULLOO AG, 1987, J NUTR, V117, P383, DOI 10.1093/jn/117.2.383
   DULLOO AG, 1986, AM J CLIN NUTR, V43, P388, DOI 10.1093/ajcn/43.3.388
   DULLOO AG, 2001, INT J OBES RELAT M S, V5, pS22
   Eikelis N, 2005, EXP PHYSIOL, V90, P673, DOI 10.1113/expphysiol.2005.031385
   Eikelis N, 2004, AM J PHYSIOL-ENDOC M, V286, pE744, DOI 10.1152/ajpendo.00489.2003
   Eikelis N, 2003, HYPERTENSION, V41, P1072, DOI 10.1161/01.HYP.0000066289.17754.49
   Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164
   Fassina G, 2004, CLIN CANCER RES, V10, P4865, DOI 10.1158/1078-0432.CCR-03-0672
   Flechtner-Mors M, 1999, J LAB CLIN MED, V134, P33, DOI 10.1016/S0022-2143(99)90051-3
   GRASSI G, 1995, HYPERTENSION, V25, P560, DOI 10.1161/01.HYP.25.4.560
   Grassi G, 1998, HYPERTENSION, V31, P64, DOI 10.1161/01.HYP.31.1.64
   Haller CA, 2005, CLIN PHARMACOL THER, V77, P560, DOI 10.1016/j.clpt.2005.01.023
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532
   Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542
   HENRY CJK, 1986, HUM NUTR-CLIN NUTR, V40C, P165
   HOLLANDS MA, 1981, AM J CLIN NUTR, V34, P2291, DOI 10.1093/ajcn/34.10.2291
   Hongu N, 2000, J NUTR, V130, P152, DOI 10.1093/jn/130.2.152
   Horton TJ, 1996, INT J OBESITY, V20, P91
   JANSSON PA, 1992, J CLIN INVEST, V89, P1610, DOI 10.1172/JCI115756
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   KAWADA T, 1988, P SOC EXP BIOL MED, V188, P229, DOI 10.3181/00379727-188-2-RC1
   KAWADA T, 1986, J NUTR, V116, P1272, DOI 10.1093/jn/116.7.1272
   KAWADA T, 1986, P SOC EXP BIOL MED, V183, P250
   Kojima-Yuasa A, 2003, LIFE SCI, V73, P1299, DOI 10.1016/S0024-3205(03)00424-7
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   KURPAD AV, 1994, AM J PHYSIOL, V266, pE877, DOI 10.1152/ajpendo.1994.266.6.E877
   Lai HC, 2004, CANCER LETT, V213, P181, DOI 10.1016/j.canlet.2004.04.031
   LANDSBERG L, 1990, J NEUROSCI METH, V34, P179, DOI 10.1016/0165-0270(90)90056-L
   LANDSBERG L, 1981, INT J OBESITY, V5, P79
   LANDSBERG L, 1993, INT J OBES RELAT M S, V1, pS29
   LEJEUNE MPG, 2003, BR J NUTR, V90, P1
   MACDONALD IA, 1995, INT J OBES RELAT M S, V7, pS2
   Mantzoros CS, 1996, DIABETES, V45, P909, DOI 10.2337/diabetes.45.7.909
   MCCARGAR LJ, 1988, AM J CLIN NUTR, V47, P932, DOI 10.1093/ajcn/47.6.932
   Molnár D, 2000, INT J OBESITY, V24, P1573, DOI 10.1038/sj.ijo.0801433
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Narkiewicz K, 1998, CIRCULATION, V98, P772, DOI 10.1161/01.CIR.98.8.772
   Ohnuki K, 2001, BIOSCI BIOTECH BIOCH, V65, P2033, DOI 10.1271/bbb.65.2033
   Ohnuki K, 2001, BIOSCI BIOTECH BIOCH, V65, P2735, DOI 10.1271/bbb.65.2735
   Oku N, 2003, BIOL PHARM BULL, V26, P1235, DOI 10.1248/bpb.26.1235
   Osaka T, 2000, NEUROREPORT, V11, P2425, DOI 10.1097/00001756-200008030-00017
   Pasman WJ, 1997, INT J OBESITY, V21, P1143, DOI 10.1038/sj.ijo.0800528
   PASQUALI R, 1985, INT J OBESITY, V9, P93
   PASQUALI R, 1987, INT J OBESITY, V11, P163
   PASQUALI R, 1992, CLIN SCI, V82, P85, DOI 10.1042/cs0820085
   Purdham DM, 2004, AM J PHYSIOL-HEART C, V287, pH2877, DOI 10.1152/ajpheart.00499.2004
   RACOTTA IS, 1994, PHARMACOL BIOCHEM BE, V48, P887, DOI 10.1016/0091-3057(94)90196-1
   Rados Carol, 2004, FDA Consum, V38, P6
   Ramsey JJ, 1998, AM J CLIN NUTR, V68, P42, DOI 10.1093/ajcn/68.1.42
   RAVUSSIN E, 1995, INT J OBESITY, V19, pS8
   Ray S, 2005, ARCH TOXICOL, V79, P330, DOI 10.1007/s00204-005-0672-6
   Rayner DV, 2001, J MOL MED, V79, P8, DOI 10.1007/s001090100198
   ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Roomi MW, 2005, ONCOL REP, V14, P807
   Rumantir MS, 1999, J HYPERTENS, V17, P1125, DOI 10.1097/00004872-199917080-00012
   SAAD MF, 1991, AM J PHYSIOL, V261, pE789, DOI 10.1152/ajpendo.1991.261.6.E789
   Saper RB, 2004, AM FAM PHYSICIAN, V70, P1731
   Sartippour MR, 2004, INT J ONCOL, V25, P193
   Sartippour MR, 2002, INT J ONCOL, V21, P487
   SCHERRER U, 1994, CIRCULATION, V89, P2634, DOI 10.1161/01.CIR.89.6.2634
   Shannon JR, 1999, CLIN SCI, V96, P483, DOI 10.1042/CS19980206
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987
   SIMONSEN L, 1992, AM J PHYSIOL, V263, pE850, DOI 10.1152/ajpendo.1992.263.5.E850
   Snitker S, 2000, Obes Rev, V1, P5, DOI 10.1046/j.1467-789x.2000.00001.x
   SPRAUL M, 1993, J CLIN INVEST, V92, P1730, DOI 10.1172/JCI116760
   Tang FY, 2003, INT J CANCER, V106, P871, DOI 10.1002/ijc.11325
   TOTH MJ, 1994, METABOLISM, V43, P621, DOI 10.1016/0026-0495(94)90205-4
   TOUBRO S, 1993, INT J OBESITY, V17, pS73
   TOUBRO S, 1993, INT J OBESITY, V17, pS69
   Trayhurn P, 1999, INT J OBESITY, V23, P22, DOI 10.1038/sj.ijo.0800791
   Trayhurn P, 1998, P NUTR SOC, V57, P413, DOI 10.1079/PNS19980060
   TREMBLAY A, 1988, NUTR RES, V8, P553, DOI 10.1016/S0271-5317(88)80077-0
   Trompezinski S, 2003, ARCH DERMATOL RES, V295, P112, DOI 10.1007/s00403-003-0402-y
   Tsi D, 2003, J NUTR SCI VITAMINOL, V49, P437, DOI 10.3177/jnsv.49.437
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   TULP OL, 1986, COMP BIOCHEM PHYS C, V85, P17
   Vansal SS, 1999, BIOCHEM PHARMACOL, V58, P807, DOI 10.1016/S0006-2952(99)00152-5
   vanSoeren M, 1996, J APPL PHYSIOL, V80, P999, DOI 10.1152/jappl.1996.80.3.999
   Vaz M, 1997, CIRCULATION, V96, P3423
   Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532
   WATANABE T, 1987, BIOCHEM BIOPH RES CO, V142, P259, DOI 10.1016/0006-291X(87)90479-7
   WATANABE T, 1988, AM J PHYSIOL, V255, pE23, DOI 10.1152/ajpendo.1988.255.1.E23
   Westerterp-Plantenga MS, 2005, INT J OBESITY, V29, P682, DOI 10.1038/sj.ijo.0802862
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   WHITE JE, 1958, P SOC EXP BIOL MED, V99, P375
   Yamakawa S, 2004, CANCER LETT, V210, P47, DOI 10.1016/j.canlet.2004.03.008
   YOSHIDA T, 1994, INT J OBESITY, V18, P345
   YOSHIDA T, 1988, J NUTR SCI VITAMINOL, V34, P587, DOI 10.3177/jnsv.34.587
   Yoshioka M, 1995, J NUTR SCI VITAMINOL, V41, P647, DOI 10.3177/jnsv.41.647
   Yoshioka M, 1999, BRIT J NUTR, V82, P115, DOI 10.1017/S0007114599001269
   Yoshioka M, 1998, BRIT J NUTR, V80, P503, DOI 10.1017/S0007114598001597
   Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224
   YOUNG JB, 1992, INT J OBESITY, V16, P959
   Zheng GD, 2004, IN VIVO, V18, P55
NR 140
TC 228
Z9 254
U1 2
U2 76
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD JAN
PY 2007
VL 292
IS 1
BP R77
EP R85
DI 10.1152/ajpregu.00832.2005
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 121QK
UT WOS:000243171900006
PM 16840650
OA Green Published
DA 2025-04-28
ER

PT J
AU Yang, LC
   Zhu, YP
   Zhong, SS
   Zheng, GD
AF Yang, Licong
   Zhu, Yanping
   Zhong, Shusheng
   Zheng, Guodong
TI Astilbin lowers the effective caffeine dose for decreasing lipid
   accumulation via activatingAMPKin high-fat diet-induced obese mice
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE astilbin and caffeine combination; obesity; lipid metabolism; AMPK
ID ADIPOSE-TISSUE; METABOLISM; BINDING; ACTIVATION; PATHWAY; LIPASE; ACID;
   CATECHINS; LIPOLYSIS; LEAVES
AB BACKGROUND Caffeine has an anti-obesity effect, although chronic excessive caffeine consumption also causes caffeinism, which is marked by increased anxiety or depression, amongst other symptoms. The present study aimed to investigate whether the addition of flavonoids such as astilbin can reduce the caffeine dose needed to inhibit obesity. RESULTS ICR mice (n= 80) were fed with normal diet, high-fat diet (HFD), HFD supplemented with astilbin, caffeine, or astilbin + caffeine for 12 weeks. When diets supplemented with astilbin, 0.3 g kg(-1)diet caffeine had the same effect as 0.6 g kg(-1)diet caffeine alone, and 0.6 g kg(-1)diet caffeine combined with astilbin most effectively inhibited HFD-induced obesity. Astilbin improved the anti-obesity effects of caffeine on lipid accumulation via the activation of AMP-activated protein kinase alpha(AMPK alpha). (i) Activated AMPK alpha decreased lipid biosynthesis by suppressing the activity or mRNA expression of 3-hydroxy-3-methylglutaryl-CoA reductase, sterol regulatory element binding protein 1c and its target gene fatty acid synthase. (ii) Activated AMPK alpha also up-regulated lipolysis by enhancing the expression of adipose triglyceride lipase and increasing the phosphorylation of hormone-sensitive lipase. (iii) Finally, activated AMPK alpha increased carnitine acyltransferase and acyl-CoA oxidase activities, which further promoted fatty acid beta-oxidation. CONCLUSION The results obtained in the present study indicate that astilbin may decrease the effective dose of caffeine needed for an anti-obesity effect and also suggest that it suppresses fat accumulation via the activation of AMPK. (c) 2020 Society of Chemical Industry
C1 [Yang, Licong; Zhu, Yanping; Zhong, Shusheng; Zheng, Guodong] Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Coll Food Sci & Engn, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University
RP Zheng, GD (corresponding author), Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Coll Food Sci & Engn, Nanchang 330045, Jiangxi, Peoples R China.
EM zrs150716@aliyun.com
OI Zheng, Guodong/0000-0002-9601-0056
FU National Natural Science Foundation of China [81760157, 21701068,
   21967010]; Science and Technology Research Projects of the Education
   Department of Jiangxi Province [GJJ180209]
FX This work was kindly supported by the National Natural Science
   Foundation of China (No. 81760157, 21701068, 21967010) and Science and
   Technology Research Projects of the Education Department of Jiangxi
   Province (No. GJJ180209).
CR Chen WL, 2012, BIOCHEM PHARMACOL, V84, P522, DOI 10.1016/j.bcp.2012.05.022
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Deng X, 2015, BBA-MOL CELL BIOL L, V1851, P1521, DOI 10.1016/j.bbalip.2015.08.007
   Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734
   Fernández-Quintela A, 2016, J PHYSIOL BIOCHEM, V73, P417, DOI 10.1007/s13105-016-0544-y
   Folch JMS, 1957, J BIOL CHEM, V22, P24
   Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200
   Gilliland K, 1983, Adv Alcohol Subst Abuse, V3, P53
   Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022
   Greenberg JA, 2008, AM J CARDIOL, V102, P1502, DOI 10.1016/j.amjcard.2008.07.046
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28
   He ZX, 2015, J TOXICOL SCI, V40, P127, DOI 10.2131/jts.40.127
   Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120
   Huang HQ, 2011, J AGR FOOD CHEM, V59, P4562, DOI 10.1021/jf2002969
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Kim JS, 2017, J FUNCT FOODS, V31, P131, DOI 10.1016/j.jff.2017.01.044
   Landrault N, 2002, J AGR FOOD CHEM, V50, P2046, DOI 10.1021/jf010794g
   Li GS, 2009, PLANTA MED, V75, P1470, DOI 10.1055/s-0029-1185802
   Li M, 1999, BIOCHEM MOL BIOL INT, V47, P63
   Liu SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124951
   Mantovani J, 2011, FEBS LETT, V585, P967, DOI 10.1016/j.febslet.2010.12.015
   Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200
   Moorthy M, 2020, TRENDS FOOD SCI TECH, V99, P634, DOI 10.1016/j.tifs.2020.03.036
   Motoyashiki T, 1998, BIOL PHARM BULL, V21, P517, DOI 10.1248/bpb.21.517
   Mun EC, 2001, GASTROENTEROLOGY, V120, P669, DOI 10.1053/gast.2001.22430
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   National Commission of Chinese Pharmacopoeia, 2010, PHARM PEOPL REP CHIN, VI, P17
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153
   Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375
   Sharma A, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104894
   Singh DK, 2006, J PHARMACOL EXP THER, V318, P1020, DOI 10.1124/jpet.106.107144
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Sung SH, 2015, BIOORG MED CHEM LETT, V25, P4648, DOI 10.1016/j.bmcl.2015.08.032
   Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885
   Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161
   Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024
   Yu L, 2014, J AGR FOOD CHEM, V62, P8640, DOI 10.1021/jf501963a
   Yuan ED, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020187
   Zhang QF, 2013, J AGR FOOD CHEM, V61, P12085, DOI 10.1021/jf404420s
   Zhang QF, 2013, NAT PROD RES, V27, P277, DOI 10.1080/14786419.2012.666747
   Zhao Y, 2017, EUR J NUTR, V56, P2309, DOI 10.1007/s00394-016-1271-4
   Zheng D, 2019, J AGR FOOD CHEM, V67, P5746, DOI 10.1021/acs.jafc.9b00018
   Zheng GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122925
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zheng XC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0206-3
   Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747
NR 48
TC 13
Z9 14
U1 1
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD JAN 30
PY 2021
VL 101
IS 2
BP 573
EP 581
DI 10.1002/jsfa.10669
EA AUG 2020
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA PA4FG
UT WOS:000558899900001
PM 32673411
DA 2025-04-28
ER

PT J
AU Ramos, LV
   da Costa, THM
   Arruda, SF
AF Ramos, Larissa Valadares
   Macedo da Costa, Teresa Helena
   Arruda, Sandra Fernandes
TI The effect of coffee consumption on glucose homeostasis and
   redox-inflammatory responses in high-fat diet-induced obese rats
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE coffee; obesity; glucose; insulin; inflammation; redox
ID INSULIN-RESISTANCE; ANTIOXIDANT ACTIVITY; GUT MICROBIOTA;
   ADIPOSE-TISSUE; IN-VITRO; HYPERGLYCEMIA; POLYPHENOLS; SUBSTANCES;
   MECHANISMS; COMPONENTS
AB Coffee effects on glucose homeostasis in obesity remain controversial. We investigated whether coffee mitigates the negative effects on glucose metabolism induced by a high-fat diet and the interrelationships with redox-inflammatory responses. Rats were treated with: control (CT-); coffee (CT +) 3.9 g of freeze-dried coffee/kg of diet; high-fat (HF-); or high-fat + coffee 3.9 g of freeze-dried coffee/kg of diet (HF +) diet. The high-fat diet increased weight gain, feed efficiency, HOMA beta, muscle and hepatic glycogen, intestinal CAT and SOD activity, hepatic protein (CARB) and lipid oxidation (MDA), muscle Prkaa1 mRNA and IL6 levels, and decreased food intake, hepatic GR, GPX and SOD activities, intestinal CARB, intestinal Slc2a2 and Slc5a1 and hepatic Prkaa1 and Prkaa2 mRNA levels, hepatic glucose-6-phosphatase and muscle hexokinase (HK) activities, compared to the control diet. The high-fat diet with coffee increased hepatic GST activity and TNF and decreased IL6 and intestinal glucosidase activity compared with the high-fat diet. The coffee diet increased muscle glycogen, hepatic CARB and PEPCK activity, and decreased hepatic GR and SOD activities and intestinal CARB, compared with the control diet. Coffee increased insulin levels, HOMA IR/beta, FRAP, muscle Prkaa1 mRNA levels and hepatic and muscle phosphofructokinase-1, and it decreased intestinal CAT, hepatic Slc2a2 mRNA levels and muscle HK activity, regardless of the diet type. In conclusion, chronic coffee consumption improves antioxidant and anti-inflammatory responses, but does not ameliorate glucose homeostasis in a high-fat diet-induced obesity model. In addition, coffee consumption increases insulin secretion and promotes muscle glycogen synthesis in rats maintained on a control diet. (C) 2021 Elsevier Inc. All rights reserved.
C1 [Ramos, Larissa Valadares; Macedo da Costa, Teresa Helena; Arruda, Sandra Fernandes] Univ Brasilia, Fac Hlth Sci, Postgrad Program Human Nutr, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil.
C3 Universidade de Brasilia
RP Ramos, LV (corresponding author), Univ Brasilia, Fac Hlth Sci, Campus Univ Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil.
EM lari_vr16@hotmail.com
RI Arruda, Sandra/AAC-6778-2019; Macedo da Costa, Teresa Helena/H-8434-2013
OI Fernandes Arruda, Sandra/0000-0003-0774-8276; Ramos,
   Larissa/0000-0001-6576-1677; Macedo da Costa, Teresa
   Helena/0000-0002-3396-5058
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)
   [0193.001708/2017]; Decanato de Pesquisa e Inovacao (DPI); Decanato de
   Pos-GraduacAo (DPG) of the University of Brasilia
FX The authors are thankful to the CoordenacAo de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) for providing the research fellowship
   to L.V.R. The authors thank the FundacAo de Apoio a Pesquisa do Distrito
   Federal (FAP-DF) ; Process number; 0193.001708/2017) ; Decanato de
   Pesquisa e InovacAo (DPI) ; and the Decanato de Pos-GraduacAo (DPG) of
   the University of Brasilia for complementary financial resources.
CR ABIC, CAF AT 2021
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   [Anonymous], 2011, NAT RES COUNC NAT AC, V8th
   Baginski ES., 1974, METHOD ENZYMAT AN, P876
   Bauer PV, 2018, CELL METAB, V27, P101, DOI 10.1016/j.cmet.2017.09.019
   Benzie IFF, 1999, METHOD ENZYMOL, V299, P15
   Bhandarkar NS, 2019, J FUNCT FOODS, V57, P141, DOI 10.1016/j.jff.2019.04.003
   Brasil IBGE, 2020, PESQ ORC FAM 2017 20
   Catta-Preta M, 2012, NUTRITION, V28, P212, DOI 10.1016/j.nut.2011.05.011
   Chevalier S, 2006, DIABETES, V55, P675, DOI 10.2337/diabetes.55.03.06.db05-1117
   Coelho WS, 2007, MOL GENET METAB, V92, P364, DOI 10.1016/j.ymgme.2007.07.010
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   da Cunha MSB, 2014, J NUTR BIOCHEM, V25, P1035, DOI 10.1016/j.jnutbio.2014.05.005
   Farah A, 2005, J AGR FOOD CHEM, V53, P1505, DOI 10.1021/jf048701t
   Farah A., 2012, Coffee: emerging health effects and disease prevention, P21
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Frayn KN, 2003, BIOCHEM SOC T, V31, P1115, DOI 10.1042/BST0311115
   Gómez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985
   Gong H, 2016, EXP BIOL MED, V241, P52, DOI 10.1177/1535370215584890
   Gopal SS, 2017, FOOD FUNCT, V8, P1124, DOI [10.1039/C6FO01655C, 10.1039/c6fo01655c]
   Habig W H, 1981, Methods Enzymol, V77, P218
   Hang D, 2019, AM J CLIN NUTR, V109, P586
   Hayanga JA, 2016, EUR J NUTR, V55, P631, DOI 10.1007/s00394-015-0883-4
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009
   Ilic I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238600
   Ilmiawati C, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05052-y
   Jayarathne S, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900149
   Jia HJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0389-3
   Joanisse DR, 1996, AM J PHYSIOL-REG I, V271, pR545, DOI 10.1152/ajpregu.1996.271.3.R545
   Juge-Aubry CE, 2005, BEST PRACT RES CL EN, V19, P547, DOI 10.1016/j.beem.2005.07.009
   Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kim Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010017
   Kim Y, 2018, BRIT J NUTR, V120, P1279, DOI [10.1017/S0007114518002635, 10.1017/s0007114518002635]
   Kobayashi M, 2017, J NUTR SCI VITAMINOL, V63, P200, DOI 10.3177/jnsv.63.200
   Kwaifa IK, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020291
   Kyriachenko Y, 2019, WORLD J DIABETES, V10, P154, DOI 10.4239/wjd.v10.i3.154
   Levin BE, 1998, AM J PHYSIOL-REG I, V274, pR412, DOI 10.1152/ajpregu.1998.274.2.R412
   Lindholm CR, 2013, J PHYSIOL BIOCHEM, V69, P165, DOI 10.1007/s13105-012-0199-2
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234
   MAPAMinisterio Da Agricultura, CAF BRAS 2021
   Martini D, 2016, MOLECULES, V21, DOI 10.3390/molecules21080979
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mccord JM, 1999, CURR PROTOCOLS TOXIC
   Minamisawa M, 2004, ANAL SCI, V20, P325, DOI 10.2116/analsci.20.325
   Mosa RA, 2015, MOLECULES, V20, P13374, DOI 10.3390/molecules200713374
   Murase T, 2012, BRIT J NUTR, V107, P1757, DOI 10.1017/S0007114511005083
   Naidoo N, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-48
   NAISMITH DJ, 1970, NUTR METAB, V12, P144
   Paiva CLRS, 2019, CRIT REV FOOD SCI, V59, P652, DOI 10.1080/10408398.2017.1386159
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Richert S, 2002, ARCH BIOCHEM BIOPHYS, V397, P430, DOI 10.1006/abbi.2001.2683
   Rodríguez-Hernández H, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/678159
   Rustandi F, 2019, INDONES J ANTIAGING, V3, P5
   Rustenbeck I, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.19
   Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106
   Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382
   Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391
   Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200
   Sousa AG, 2015, BRIT J NUTR, V113, P1615, DOI 10.1017/S0007114515000835
   Torres T, 2017, EUR J NUTR, V56, P1523, DOI 10.1007/s00394-016-1198-9
   Tu WJ, 2019, AGING DIS, V10, P637, DOI 10.14336/AD.2018.0513
   Vitaglione P, 2019, J NUTR SCI, V8, DOI 10.1017/jns.2019.10
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   Wanyonyi S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111261
   WASOWICZ W, 1993, CLIN CHEM, V39, P2522
   WHO World Health Organization (WHO), Obesity and Overweight
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
   Zhang Y, 2020, J AGR FOOD CHEM, V68, P10626, DOI 10.1021/acs.jafc.0c02555
NR 73
TC 11
Z9 11
U1 1
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD FEB
PY 2022
VL 100
AR 108881
DI 10.1016/j.jnutbio.2021.108881
EA NOV 2021
PG 14
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA XE1YP
UT WOS:000723191500005
PM 34653600
DA 2025-04-28
ER

PT J
AU Kim, HJ
   Ko, J
   Storni, C
   Song, HJ
   Cho, YG
AF Kim, Hwa Jung
   Ko, Jeongah
   Storni, Charlotte
   Song, Hong Ji
   Cho, Young Gyu
TI Effect of green mate in overweight volunteers: A randomized
   placebo-controlled human study
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Mate; Ilex paraguariensis A. St.-Hil.; Obesity; Weight loss; Clinical
   study; Anti-obesity
ID ILEX-PARAGUARIENSIS; WEIGHT-LOSS; DIETARY-SUPPLEMENTS; AQUEOUS EXTRACT;
   BODY-WEIGHT; OBESITY; TEA; INHIBITION; SAPONINS; CAFFEINE
AB Overweight and obesity have become a global epidemic and they may impair health. Traditional use and growing evidence indicate that mate (Ilex paraguariensis A. St.-Hil.) may be helpful in losing excessive weight and fat. The present randomized, double-blind, placebo-controlled study evaluated efficacy and safety of an extract from green mate in 60 overweight subjects aged 20-39 years during 6-weeks. Body composition was measured by Dual-Energy X-ray Absorptiometry (DEXA) at baseline and after 6 weeks. Body weight, body mass index (BMI), waist circumference (WC) and various safety parameters were monitored. After 6 weeks, subjects taking mate experienced a significantly greater reduction of percent of body fat (-0.3% vs. +0.6%, p = 0.04) and fat mass (-0.5 kg vs. +0.2 kg, p = 0.04) than placebo. No significant differences were observed in other measurements. No adverse events occurred and all safety parameters were within normal ranges during the study in both groups. Thus, taking green mate extract reduced body fat after 6 weeks, while the treatment was safe and well tolerated. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Storni, Charlotte] Frutarom Switzerland Ltd, CH-8820 Wadenswil, Switzerland.
   [Kim, Hwa Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul 138736, South Korea.
   [Ko, Jeongah] Korea Olymp Comm, Korea Natl Training Ctr, Seoul 139804, South Korea.
   [Song, Hong Ji] Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Family Med, Anyang Si 431070, Gyeonggi Do, South Korea.
   [Cho, Young Gyu] Inje Univ, Coll Med, Seoul Paik Hosp, Dept Family Med, Seoul 100032, South Korea.
C3 University of Ulsan; Asan Medical Center; Hallym University; Inje
   University
RP Storni, C (corresponding author), Frutarom Switzerland Ltd, Rutiwisstr 7, CH-8820 Wadenswil, Switzerland.
EM rsvp@amc.seoul.kr; nanadoc@naver.com; cstorni@ch.frutarom.com;
   hongjisong5@gmail.com; jacobel@hanmail.net
RI Kim, Bum-Joon/AAU-1680-2021; CHO, YOUNG GYU/GLS-0508-2022
OI Kim, Hwa Jung/0000-0003-1916-7014
FU Frutarom Switzerland Ltd.
FX This study was supported by Frutarom Switzerland Ltd. We thank Tania
   Perrinjaquet-Moccetti and Marian Verbruggen for critically reviewing the
   manuscript.
CR ALIKARIDIS F, 1987, J ETHNOPHARMACOL, V20, P121, DOI 10.1016/0378-8741(87)90084-5
   Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   Arçari DP, 2011, J FUNCT FOODS, V3, P190, DOI 10.1016/j.jff.2011.04.001
   Aucott LS, 2008, P NUTR SOC, V67, P54, DOI 10.1017/S0029665108006022
   Ayyad C, 2000, Obes Rev, V1, P113, DOI 10.1046/j.1467-789x.2000.00019.x
   Berté KAS, 2011, J AGR FOOD CHEM, V59, P5523, DOI 10.1021/jf2008343
   CZOK G, 1961, ARZNEIMITTEL-FORSCH, V11, P545
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Filip R, 2003, EUR J NUTR, V42, P50, DOI 10.1007/s00394-003-0399-1
   Flint AJ, 2010, OBESITY, V18, P377, DOI 10.1038/oby.2009.223
   Fontaine K R, 2001, Eat Behav, V2, P87, DOI 10.1016/S1471-0153(01)00024-1
   GRACZA L, 1987, ARCH PHARM, V320, P1249, DOI 10.1002/ardp.198700042
   GREENWAY FL, 2004, HDB OBESITY, P329
   GUGLIUCCI A, 1995, BIOCHEM MOL BIOL INT, V35, P47
   Gugliucci A, 1996, BIOCHEM BIOPH RES CO, V224, P338, DOI 10.1006/bbrc.1996.1030
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   Han UK, 2002, J NUTR, V132, P2241, DOI 10.1093/jn/132.8.2241
   Heck C. I., 2007, YERBA MATE TEA ILEX, V72
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Kurth T, 2002, ARCH INTERN MED, V162, P2557, DOI 10.1001/archinte.162.22.2557
   Martinet A, 1999, PHYTOMEDICINE, V6, P231, DOI 10.1016/S0944-7113(99)80014-2
   Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106
   Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022
   Opala T, 2006, EUR J MED RES, V11, P343
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pillitteri JL, 2008, OBESITY, V16, P790, DOI 10.1038/oby.2007.136
   Pittler MH, 2005, OBES REV, V6, P93, DOI 10.1111/j.1467-789X.2005.00169.x
   Poston WSC, 2001, OBES RES, V9, P552, DOI 10.1038/oby.2001.72
   Schinella GR, 2000, BIOCHEM BIOPH RES CO, V269, P357, DOI 10.1006/bbrc.2000.2293
   Seeram NP, 2006, J AGR FOOD CHEM, V54, P1599, DOI 10.1021/jf052857r
   Stein FLP, 2005, BIOL RES NURS, V7, P146, DOI 10.1177/1099800405280521
   World Health Organization, Obesity and overweight
   Xu BJ, 2005, ARCH PHARM RES, V28, P180, DOI 10.1007/BF02977712
   Zhao HL, 2005, INT J OBESITY, V29, P983, DOI 10.1038/sj.ijo.0802948
NR 34
TC 24
Z9 29
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN
PY 2012
VL 4
IS 1
BP 287
EP 293
DI 10.1016/j.jff.2011.12.005
PG 7
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 913NN
UT WOS:000301884800032
OA hybrid
DA 2025-04-28
ER

PT J
AU Sawie, HG
   Khadrawy, YA
   El-Gizawy, MM
   Mourad, HH
   Omara, EA
   Hosny, EN
AF Sawie, Hussein G.
   Khadrawy, Yasser A.
   El-Gizawy, Mayada M.
   Mourad, Hagar H.
   Omara, Enayat A.
   Hosny, Eman N.
TI Effect of alpha-lipoic acid and caffeine-loaded chitosan nanoparticles
   on obesity and its complications in liver and kidney in rats
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Article
DE Obesity; Liver; Kidney; alpha-Lipoic acid; Caffeine-chitosan
   nanoparticles; Oxidative stress
ID DIET-INDUCED OBESITY; NF-KAPPA-B; NITRIC-OXIDE; LIPID-ACCUMULATION;
   OXIDATIVE STRESS; MOLECULAR-MECHANISMS; COFFEE CONSUMPTION; FAT;
   ANTIOXIDANT; METABOLISM
AB The present work investigated the effect of a-lipoic acid (ALA) and caffeine-loaded chitosan nanoparticles (CAF-CS NPs) on obesity and its hepatic and renal complications in rats. Rats were divided into control, rat model of obesity induced by high fat diet (HFD), and obese rats treated with ALA and/or CAF-CS NPs. At the end of the experiment, the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) and the levels of urea, creatinine, interleukin-1 beta (IL-1 beta), and tumor necrosis factor-alpha (TNF-alpha) were determined in the sera of animals. In addition, malondialdehyde (MDA), nitric oxide (NO), and reduced glutathione (GSH) were measured in hepatic and renal tissues. Renal Na+, K+-ATPase was assessed. The histopathological changes were examined in the hepatic and renal tissues. Obese rats showed a significant increase in AST, ALT, ALP, urea, and creatinine. This was associated with a significant increase in IL-1 beta, TNF-alpha, MDA, and NO. A significant decrease in hepatic and renal GSH and renal Na+, K+-ATPase activity was recorded in obese rats. Obese rats also showed histopathological alterations in hepatic and renal tissues. Treatment with ALA and/or CAF-CS NPs reduced the weight of obese rats and ameliorated almost all the hepatic and renal biochemical and histopathological changes induced in obese rats. In conclusion, the present findings indicate that ALA and/or CAF-CS NPs offered an effective therapy against obesity induced by HFD and its hepatic and renal complications. The therapeutic effect of ALA and CAF-CS NPs could be mediated through their antioxidant and anti-inflammatory properties.
C1 [Sawie, Hussein G.; Khadrawy, Yasser A.; El-Gizawy, Mayada M.; Mourad, Hagar H.; Hosny, Eman N.] Med Res & Clin Studies Inst, Natl Res Ctr, Med Physiol Dept, El-Behouth St, Giza, Egypt.
   [Omara, Enayat A.] Med Res & Clin Studies Inst, Natl Res Ctr, Pathol Dept, Giza, Egypt.
C3 Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian
   Knowledge Bank (EKB); National Research Centre (NRC)
RP Hosny, EN (corresponding author), Med Res & Clin Studies Inst, Natl Res Ctr, Med Physiol Dept, El-Behouth St, Giza, Egypt.
EM emannasr_30@yahoo.com
RI Hosny, Eman/N-1441-2018
OI Hosny, Eman/0000-0002-1064-8279
FU Science, Technology & Innovation Funding Authority (STDF); Egyptian
   Knowledge Bank (EKB); National Research Center, Giza, Egypt [E120502]
FX Open access funding provided by The Science, Technology & Innovation
   Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank
   (EKB). The authors sincerely thank the authorities of the National
   Research Center, Giza, Egypt, for their financial supports and providing
   the facilities (Project Code: E120502) to conduct and complete the
   present study.
CR Abdel-Zaher AO, 2008, TOXICOLOGY, V243, P261, DOI 10.1016/j.tox.2007.10.010
   Abdul-Hamid M, 2020, BENI-SUEF U J BASIC, V9, DOI 10.1186/s43088-020-00042-2
   Abosabaa SA, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13050677
   Abrass CK, 2004, AM J NEPHROL, V24, P46, DOI 10.1159/000075925
   Almeida ID, 2021, INT IMMUNOPHARMACOL, V100, DOI 10.1016/j.intimp.2021.108090
   Teixeira AZA, 2009, BRAZ ARCH BIOL TECHN, V52, P157, DOI 10.1590/S1516-89132009000100021
   Anwar MM, 2022, BMC COMPLEMENT MED, V22, DOI 10.1186/s12906-022-03802-y
   Aoyama K, 2011, NEUROSCIENCE, V181, P206, DOI 10.1016/j.neuroscience.2011.02.047
   Arauz J, 2014, EUR J GASTROEN HEPAT, V26, P164, DOI 10.1097/MEG.0b013e3283644e26
   Arnaud Maurice J, 2011, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-642-13443-2_3
   Balakirev MY, 1997, EUR J BIOCHEM, V246, P710, DOI 10.1111/j.1432-1033.1997.00710.x
   Bast A, 2003, BIOFACTORS, V17, P207, DOI 10.1002/biof.5520170120
   BELFIELD A, 1971, ARCH DIS CHILD, V46, P842, DOI 10.1136/adc.46.250.842
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Birk J, 2013, J CELL SCI, V126, P1604, DOI 10.1242/jcs.117218
   Briffa JF, 2015, CLIN EXP PHARMACOL P, V42, P1118, DOI 10.1111/1440-1681.12452
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   Çakir T, 2015, EUR REV MED PHARMACO, V19, P2132
   Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje
   Chen YY, 2019, FASEB J, V33, P9602, DOI 10.1096/fj.201900213R
   Chowdhury FI, 2022, SAUDI PHARM J, V30, P1454, DOI 10.1016/j.jsps.2022.07.006
   Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082
   Cortez M, 2013, INFLAMMATION, V36, P379, DOI 10.1007/s10753-012-9557-z
   Cui BK, 2011, MOLECULES, V16, P9116, DOI 10.3390/molecules16119116
   D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75
   DeMarco VG, 2004, FREE RADICAL RES, V38, P675, DOI 10.1080/10715760410001702503
   Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5
   Baracho NCD, 2016, ACTA CIR BRAS, V31, P527, DOI 10.1590/S0102-865020160080000005
   Dobrota D, 1999, CELL MOL NEUROBIOL, V19, P141, DOI 10.1023/A:1006909927287
   ELMERNISSI G, 1984, AM J PHYSIOL, V247, pF158, DOI 10.1152/ajprenal.1984.247.1.F158
   Emir DF, 2018, AM J EMERG MED, V36, DOI 10.1016/j.ajem.2018.03.022
   Escasany E, 2019, NEPHRON, V143, P28, DOI 10.1159/000494694
   FAWCETT JK, 1960, J CLIN PATHOL, V13, P156, DOI 10.1136/jcp.13.2.156
   Fernández-Galilea M, 2013, CLIN LIPIDOL, V8, P371, DOI 10.2217/CLP.13.19
   Garg U, 2019, ADV PHARM BULL, V9, P195, DOI 10.15171/apb.2019.023
   Ghibu S., 2008, Annales de Cardiologie et d'Angeiologie, V57, P161, DOI 10.1016/j.ancard.2008.02.018
   Gomes MB, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-80
   Guebre-Egziabher F, 2013, BIOCHIMIE, V95, P1971, DOI 10.1016/j.biochi.2013.07.017
   Han D, 1997, BIOFACTORS, V6, P321, DOI 10.1002/biof.5520060303
   Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168
   Hassan A N., 2018, International Journal of Applied Pharmaceuticals, V10, P172, DOI [10.22159/ijap.2018v10i4.25947, DOI 10.22159/IJAP.2018V10I4.25947]
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213
   Horrigan LA, 2004, INT IMMUNOPHARMACOL, V4, P1409, DOI 10.1016/j.intimp.2004.06.005
   Horvath G, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23158186
   Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200
   Kang CH, 2012, FOOD CHEM TOXICOL, V50, P4270, DOI 10.1016/j.fct.2012.08.041
   Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162
   Keane WF, 2000, KIDNEY INT, V57, pS27, DOI 10.1046/j.1523-1755.2000.07503.x
   Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269
   Kennedy OJ, 2020, AM J KIDNEY DIS, V75, P753, DOI 10.1053/j.ajkd.2019.08.025
   Khadrawy YA, 2022, NEUROENDOCRINOLOGY, V112, P1129, DOI 10.1159/000524367
   Khan Nazish Iqbal, 2006, Pak J Pharm Sci, V19, P62
   Khazaei M, 2012, INDIAN J EXP BIOL, V50, P638
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089
   Lai YS, 2016, J AGR FOOD CHEM, V64, P2062, DOI 10.1021/acs.jafc.5b06159
   Contreras-Zentella ML, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3529149
   Martins Ana Rita, 2015, Port J Nephrol Hypert, V29, P306
   McNeilly AD, 2011, BEHAV BRAIN RES, V217, P134, DOI 10.1016/j.bbr.2010.10.017
   MONTGOMERY H, 1961, ANALYST, V86, P414
   Najm WI, 2012, NUTRITIONAL AND THERAPEUTIC INTERVENTIONS FOR DIABETES AND METABOLIC SYNDROME, P355, DOI 10.1016/B978-0-12-385083-6.00028-0
   Nosadini R, 2011, NUTR METAB CARDIOVAS, V21, P79, DOI 10.1016/j.numecd.2010.10.002
   Novelli ELB, 2007, LAB ANIM-UK, V41, P111, DOI 10.1258/002367707779399518
   Oktan MA, 2021, HUM EXP TOXICOL, V40, P761, DOI 10.1177/0960327120966043
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Perera J, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-12
   Petrie JR, 2018, CAN J CARDIOL, V34, P575, DOI 10.1016/j.cjca.2017.12.005
   Pi-Sunyer X, 2009, POSTGRAD MED, V121, P21, DOI 10.3810/pgm.2009.11.2074
   León-Carmona JR, 2011, J PHYS CHEM B, V115, P4538, DOI 10.1021/jp201383y
   Reinhard L, 2013, CELL MOL LIFE SCI, V70, P205, DOI 10.1007/s00018-012-1039-9
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   Rochette L, 2015, CAN J PHYSIOL PHARM, V93, P1021, DOI 10.1139/cjpp-2014-0353
   RUIZLARREA MB, 1994, STEROIDS, V59, P383
   Salehi B, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9080356
   Schäffler A, 2007, TRENDS IMMUNOL, V28, P393, DOI 10.1016/j.it.2007.07.003
   SCHIRMEISTER J, 1964, DEUT MED WOCHENSCHR, V89, P1018, DOI 10.1055/s-0028-1111251
   Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026
   Srithongkul T, 2020, EUR J INTERN MED, V77, P111, DOI [10.1016/j.ejim.2020.04.018, 10.1016/j.ejm.2020.04.018]
   STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928
   Sugiura C, 2012, J OBES, V2012, DOI 10.1155/2012/520510
   Sun Y, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03122-4
   Sztolsztener K, 2022, BBA-MOL BASIS DIS, V1868, DOI 10.1016/j.bbadis.2022.166440
   Takabatake Y, 2017, AUTOPHAGY, V13, P775, DOI 10.1080/15548627.2017.1283084
   Tanaka Y, 2015, J SURG RES, V193, P675, DOI 10.1016/j.jss.2014.08.057
   Tsakiris S, 2000, Z NATURFORSCH C, V55, P271
   Uc Cachon Andres, 2017, Journal of Dietary Supplements, V14, P158, DOI 10.1080/19390211.2016.1207003
   Wan GH, 2000, BIOSCI BIOTECH BIOCH, V64, P555, DOI 10.1271/bbb.64.555
   Welch M, 2022, MEMBRANES-BASEL, V12, DOI 10.3390/membranes12040410
   White JR, 2016, CLIN TOXICOL, V54, P308, DOI 10.3109/15563650.2016.1146740
   Wongmekiat O, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/138719
   World Health Organization, 2021, Obesity and overweight, DOI DOI 10.1080/10810730903279694
   Zhou Y, 2016, MOL CELL BIOCHEM, V411, P143, DOI 10.1007/s11010-015-2576-y
   Ziegler Dan, 2004, Treat Endocrinol, V3, P173, DOI 10.2165/00024677-200403030-00005
NR 94
TC 7
Z9 7
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD NOV
PY 2023
VL 396
IS 11
BP 3017
EP 3031
DI 10.1007/s00210-023-02507-4
EA JUN 2023
PG 15
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA U1HD3
UT WOS:001007417400002
PM 37306714
OA hybrid
DA 2025-04-28
ER

PT J
AU Schmitt, GC
   Arbo, MD
   Lorensi, AL
   Maciel, ES
   Krahn, CL
   Mariotti, KC
   Dallegrave, E
   Leal, MB
   Limberger, RP
AF Schmitt, Gabriela C.
   Arbo, Marcelo D.
   Lorensi, Andreia L.
   Maciel, Erica S.
   Krahn, Carolina L.
   Mariotti, Kristiane C.
   Dallegrave, Eliane
   Leal, Mirna B.
   Limberger, Renata P.
TI Toxicological Effects of a Mixture Used in Weight Loss Products:
   p-Synephrine Associated With Ephedrine, Salicin, and Caffeine
SO INTERNATIONAL JOURNAL OF TOXICOLOGY
LA English
DT Article
DE p-synephrine; ephedrine; salicin; caffeine; weight loss; acute toxicity
ID CENTRAL-NERVOUS-SYSTEM; AURANTIUM L. RUTACEAE; CITRUS-AURANTIUM; ACUTE
   TOXICITY; DIETARY-SUPPLEMENTS; BODY-TEMPERATURE; BITTER ORANGE; EXTRACT;
   OVERWEIGHT; ALKALOIDS
AB p-Synephrine is an adrenergic amine found in Citrus aurantium L. fruits and has been used for weight loss in dietary supplements. There are commercial products containing this substance associated to caffeine, salicin, and ephedrine. The aim of this study was to evaluate the acute toxicity of this mixture in mice of both sexes. The significative results observed after acute oral administration to male and female mice of 300, 350, and 400 mg/kg total of p-synephrine, ephedrine, salicin, plus caffeine in a 10:4:6:80 w/w ratio included a reduction in locomotor activity and ptosis in all treated groups for both sexes. Seizures were also observed in male (400 mg/kg) and female groups (350 and 400 mg/kg). Gasping and tearing were observed in males. Salivation (400 mg/kg), agitation (350 and 400 mg/kg), and piloerection (all treated groups) were significantly observed only in females. Deaths occurred in males at 350 and 400 mg/kg treated groups and the necropsy showed cardiopulmonary hemorrhage. A reduction in locomotor activity was confirmed through the spontaneous locomotor activity test, in which the number of crossings considerably decreased (P < .01) in all treated groups. The rotarod test showed a decrease in motor coordination at 400 mg/kg. Body temperature decreased significantly (P < .01) in all treated groups compared to controls. The results suggested clear signs of toxicity of p-synephrine, ephedrine, salicin, and caffeine association; this toxicity augments the attentiveness on commercial products containing this mixture, given the expressive number of adverse events related to its utilization.
C1 [Schmitt, Gabriela C.; Arbo, Marcelo D.; Krahn, Carolina L.; Mariotti, Kristiane C.; Limberger, Renata P.] Univ Fed Rio Grande do Sul, Dept Anal, Fac Pharm, BR-90610000 Porto Alegre, RS, Brazil.
   [Lorensi, Andreia L.; Maciel, Erica S.; Leal, Mirna B.] Univ Fed Rio Grande do Sul, Dept Pharmacol, Inst Basic Hlth Sci, BR-90610000 Porto Alegre, RS, Brazil.
   [Dallegrave, Eliane] Fundacao Estadual Prod & Pesquisa Saude, Toxicol Informat Ctr Rio Grande Sul, Porto Alegre, RS, Brazil.
C3 Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio
   Grande do Sul
RP Limberger, RP (corresponding author), Univ Fed Rio Grande do Sul, Dept Anal, Fac Pharm, Av Ipiranga 2752-605, BR-90610000 Porto Alegre, RS, Brazil.
EM rlrenata@yahoo.com
RI Mariotti, Kristiane/O-5622-2015; Leal, Mirna/A-9704-2017; Arbo,
   Marcelo/Q-1183-2015
OI Arbo, Marcelo/0000-0002-0434-1553; Mariotti, Kristiane de
   Cassia/0000-0002-1014-3895
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)
FX The authors would like to thank Dr Elaine Elisabetsky for scientific
   support and CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico) for the fellowship to Gabriela Cristina Schmitt.
CR Almeida R. N., 1999, Revista Brasileira de Farmacognosia, V80, P72, DOI DOI 10.1590/S0102-695X2006000300015]
   Almeida RN, 2006, PSICOFARMACOLOGIA FU, P134
   Arbo MD, 2008, FOOD CHEM TOXICOL, V46, P2770, DOI 10.1016/j.fct.2008.04.037
   Arbo MD, 2009, REGUL TOXICOL PHARM, V54, P114, DOI 10.1016/j.yrtph.2009.03.001
   Arbo MD, 2009, ARCH TOXICOL, V83, P95, DOI 10.1007/s00204-008-0324-8
   Bouchard NC, 2005, MAYO CLIN PROC, V80, P541, DOI 10.4065/80.4.541
   Bristow LJ, 1996, J PHARMACOL EXP THER, V277, P578
   Bui LT, 2006, ANN PHARMACOTHER, V40, P53, DOI 10.1345/aph.1G488
   Carpéné C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357
   Consoli D, 2007, EUR J PHARMACOL, V573, P139, DOI 10.1016/j.ejphar.2007.06.048
   Cordioli A V., 2005, Psicofarmacos - Consulta Rapida
   CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854
   DALLMEIER K, 1981, PHARMACOLOGY, V22, P113, DOI 10.1159/000137479
   Dluzen DE, 2002, NEUROTOXICOL TERATOL, V24, P267, DOI 10.1016/S0892-0362(02)00187-3
   Firenzuoli F, 2005, PHYTOMEDICINE, V12, P247, DOI 10.1016/j.phymed.2004.02.005
   Fonsart J, 2008, TOXICOL APPL PHARM, V230, P117, DOI 10.1016/j.taap.2008.02.004
   Franco CIF, 2005, J ETHNOPHARMACOL, V98, P275, DOI 10.1016/j.jep.2005.01.008
   Fugh-Berman A, 2004, EXP BIOL MED, V229, P698, DOI 10.1177/153537020422900802
   Gad SC, 2003, INT J TOXICOL, V22, P381, DOI 10.1080/713936674
   Gange CA, 2006, MAYO CLIN PROC, V81, P545, DOI 10.4065/81.4.545
   GOLDIM J.R, 1995, PESQUISA SAUDE DIREI
   Haaz S, 2006, OBES REV, V7, P79, DOI 10.1111/j.1467-789X.2006.00195.x
   Haller CA, 2005, AM J MED, V118, P998, DOI 10.1016/j.amjmed.2005.02.034
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Haller CA, 2004, CLIN PHARMACOL THER, V75, P259, DOI 10.1016/j.clpt.2003.11.375
   Haller CA, 2008, BRIT J CLIN PHARMACO, V65, P833, DOI 10.1111/j.1365-2125.2008.03144.x
   HORTON TJ, 1991, INT J OBESITY, V15, P359
   Jordan Scott, 2004, CMAJ, V171, P993
   Kalman D, 2002, INT J OBESITY, V26, P1363, DOI 10.1038/sj.ijo.0802061
   Kim KW, 2001, N-S ARCH PHARMACOL, V364, P21, DOI 10.1007/s002100100416
   Linck VD, 2009, PHYTOMEDICINE, V16, P303, DOI 10.1016/j.phymed.2008.08.001
   Marcus DM, 2003, SCIENCE, V301, P1669
   Mattei R, 1995, ARCH INT PHARMACOD T, V330, P279
   Nasir JM, 2004, MAYO CLIN PROC, V79, P1059, DOI 10.4065/79.8.1059
   Nykamp DL, 2004, ANN PHARMACOTHER, V38, P812, DOI 10.1345/aph.1D473
   OECD (Organisation for Economic Co-operation and Development), GUID TEST C IN PRESS
   Okuro M, 2010, SLEEP, V33, P930, DOI 10.1093/sleep/33.7.930
   Olfert ED, 1998, MANUAL SOBRE CUIDADO
   Ozturk Y, 1996, PHYTOMEDICINE, V3, P139, DOI 10.1016/S0944-7113(96)80027-4
   Pechlivanova D, 2010, BEHAV BRAIN RES, V209, P205, DOI 10.1016/j.bbr.2010.01.037
   Pellati F, 2005, J PHARMACEUT BIOMED, V37, P839, DOI 10.1016/j.jpba.2004.09.008
   Pellati F, 2007, J CHROMATOGR A, V1161, P71, DOI 10.1016/j.chroma.2007.05.097
   Preuss HG, 2002, J MED, V33, P1
   Rang H.P., 2007, Rang Dale Farmacologia
   Rossato LG, 2011, ARCH TOXICOL, V85, P929, DOI 10.1007/s00204-010-0630-9
   Rossato LG, 2011, FOOD CHEM TOXICOL, V49, P8, DOI 10.1016/j.fct.2010.11.007
   Samenuk D, 2002, MAYO CLIN PROC, V77, P12, DOI 10.4065/77.1.12
   Schaneberg BT, 2003, PHYTOCHEMISTRY, V62, P911, DOI 10.1016/S0031-9422(02)00716-1
   Schaneberg BT, 2004, PHARMAZIE, V59, P819
   Stone EA, 2007, BIOCHEM PHARMACOL, V73, P1063, DOI 10.1016/j.bcp.2006.10.001
   Watanabe M, 2008, IMMUNOL LETT, V115, P43, DOI 10.1016/j.imlet.2007.09.010
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
NR 52
TC 17
Z9 17
U1 1
U2 31
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1091-5818
EI 1092-874X
J9 INT J TOXICOL
JI Int. J. Toxicol.
PD MAR-APR
PY 2012
VL 31
IS 2
BP 184
EP 191
DI 10.1177/1091581811435708
PG 8
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 920UR
UT WOS:000302434100007
PM 22408069
OA Bronze
DA 2025-04-28
ER

PT J
AU Idres, AY
   Tousch, D
   Dhuyque-Mayer, C
   Hammad, I
   Lambert, K
   Cazals, G
   Portet, K
   Ferrare, K
   Bidel, LPR
   Poucheret, P
AF Idres, Arezki Yanis
   Tousch, Didier
   Dhuyque-Mayer, Claudie
   Hammad, Imane
   Lambert, Karen
   Cazals, Guillaume
   Portet, Karine
   Ferrare, Karine
   Bidel, Luc. P. R.
   Poucheret, Patrick
TI An Original Asteraceae Based Infused Drink Prevents Metabolic Syndrome
   in Fructose-Rat Model
SO ANTIOXIDANTS
LA English
DT Article
DE metabolic syndrome; bitter Asteraceae; (Taraxacum officinale W; )
   leaves; Arctium lappa L; roots; fructose-rat model; chlorogenic acid;
   chicoric acid
ID CHICORIC ACID EXTRACT; CICHORIUM-INTYBUS L.; CHLOROGENIC ACID; IN-VITRO;
   INFLAMMATION; DERIVATIVES; INHIBITION; METFORMIN; OBESITY; ROOTS
AB Metabolic syndrome (METS) is a complex disorder that predisposes an affected person to an increased risk of diabetes and cardiovascular disease. Bitter Asteraceae plants contain several compounds active against METS that can be used as an alternative preventive therapy. Our previous work showed that a natural chicory extract (NCRAE) containing chicoric acid (CRA) and chlorogenic acid (CGA) in a molar ratio of 70/30 exhibited an antioxidant, insulin sensitization and anti-hyperglycemic effect. The present study was designed to evaluate the preventive effects of an NCRAE-like extract against METS in a complementary natural pharmacotherapeutic approach. An original Asteraceae infused drink containing the NCRAE CRA/CGA molecular ratio equivalent was prepared from dandelion (Taraxacum officinale L.) and burdock (Arctium lappa L.). The anti-METS effect of this drink was evaluated on the fructose-rat model for 8 weeks. Body weight, blood biochemistry, hepatic glucose-6-phosphatase, arterial blood pressure glucose and insulin tolerance were evaluated after 8 weeks. Our results show that daily oral intake of the Asteraceae infused drink led to a reduction of body weight gain, hyperglycemia, hypertriglyceridemia, insulin resistance and hypertension. Moreover, rat-by-rat analysis of the insulinemia measures revealed two types of responders. One sub-group of subjects demonstrated normal insulinemia and the other subgroup demonstrated hyperinsulinemia. This hyperinsulinemia, associated with the inhibition of the glucose-6-phosphatase activity in the liver tissue, may suggest an insulin release caused by CGA. The present study suggests that this original infusion of dandelion leaves and burdock roots may be used as an adjuvant therapy to prevent metabolic syndrome.
C1 [Idres, Arezki Yanis; Tousch, Didier; Dhuyque-Mayer, Claudie; Hammad, Imane; Portet, Karine; Ferrare, Karine; Poucheret, Patrick] Univ Montpellier, CIRAD, SupAgro Montpellier, UMR 95 Qualisud, BP 14491, Montpellier 5, France.
   [Lambert, Karen] Univ Montpellier, PhyMedExp, INSERM U1046, CNRS UMR 9214, F-34295 Montpellier 5, France.
   [Cazals, Guillaume] Univ Montpellier, Lab Mesure Phys, Pl Eugene Bataillon, F-34093 Montpellier 5, France.
   [Bidel, Luc. P. R.] INRA, UMR AGAP, CIRAD, SupAgro, 2 Pl Pierre Viala, F-34060 Montpellier, France.
C3 CIRAD; Universite de Montpellier; Institut Agro; Montpellier SupAgro;
   Universite de Montpellier; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite de Montpellier; INRAE; CIRAD;
   Universite de Montpellier; Institut Agro; Montpellier SupAgro
RP Tousch, D (corresponding author), Univ Montpellier, CIRAD, SupAgro Montpellier, UMR 95 Qualisud, BP 14491, Montpellier 5, France.
EM didier.tousch@umontpellier.fr
RI Lambert, Karen/MJQ-7172-2025
CR Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Anurag P, 2002, DIABETES OBES METAB, V4, P36, DOI 10.1046/j.1463-1326.2002.00178.x
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Awwad A., 2020, NFS Journal, V18, P29, DOI 10.1016/j.nfs.2020.01.001
   Azay-Milhau J, 2013, J ETHNOPHARMACOL, V150, P755, DOI 10.1016/j.jep.2013.09.046
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clare BA, 2009, J ALTERN COMPLEM MED, V15, P929, DOI 10.1089/acm.2008.0152
   Dalle Grave R, 2010, DIABET METAB SYND OB, V3, P373, DOI 10.2147/DMSOTT.S13860
   Daniele N, 1999, J BIOL CHEM, V274, P3597, DOI 10.1074/jbc.274.6.3597
   Dhuique-Mayer C, 2020, FOOD FUNCT, V11, P9263, DOI 10.1039/d0fo02430a
   Dias MI, 2014, FOOD RES INT, V56, P266, DOI 10.1016/j.foodres.2014.01.003
   Dupas J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146821
   Esatbeyoglu T, 2017, J MED FOOD, V20, P71, DOI 10.1089/jmf.2016.0105
   Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006
   Ferrare K, 2018, J ETHNOPHARMACOL, V215, P241, DOI 10.1016/j.jep.2017.12.035
   González-Castejón M, 2014, PHYTOTHER RES, V28, P745, DOI 10.1002/ptr.5059
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Hook I., 1993, International Journal of Pharmacognosy, V31, P29
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Jaiswal R, 2011, J MASS SPECTROM, V46, P269, DOI 10.1002/jms.1889
   Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x
   Kannappan S, 2009, INDIAN J MED RES, V129, P401
   Khodabandehloo H, 2016, TRANSL RES, V167, P228, DOI 10.1016/j.trsl.2015.08.011
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Larsen JR, 2018, EXPERT REV CLIN PHAR, V11, P397, DOI 10.1080/17512433.2018.1429910
   Lim T.K., 2015, Edible Medicinal and Non-Medicinal Plants: Modified Stems, Roots, Bulbs, V9
   Lim T.K., 2014, EDIBLE MED NONMEDICI, P516
   Lin LZ, 2008, J AGR FOOD CHEM, V56, P10105, DOI 10.1021/jf802412m
   Liu Q, 2017, FASEB J, V31, P1494, DOI [10.1096/fj.201601071R, 10.1096/fj.201601071r]
   Lu HJ, 2020, COMPR REV FOOD SCI F, V19, P3130, DOI 10.1111/1541-4337.12620
   Mamikutty N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/263897
   MARUTA Y, 1995, J AGR FOOD CHEM, V43, P2592, DOI 10.1021/jf00058a007
   Olayinka Ebenezer Tunde, 2017, Medicines (Basel), V4, DOI 10.3390/medicines4040078
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Schlernitzauer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078788
   Schütz K, 2005, RAPID COMMUN MASS SP, V19, P179, DOI 10.1002/rcm.1767
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Tousch D, 2008, BIOCHEM BIOPH RES CO, V377, P131, DOI 10.1016/j.bbrc.2008.09.088
   Wang DD, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00834
   Xiao HF, 2013, FOOD RES INT, V54, P345, DOI 10.1016/j.foodres.2013.07.033
NR 43
TC 5
Z9 5
U1 1
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD FEB
PY 2023
VL 12
IS 2
AR 340
DI 10.3390/antiox12020340
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA 9G3YX
UT WOS:000938093100001
PM 36829899
OA Green Submitted, gold, Green Published
DA 2025-04-28
ER

PT J
AU Rasaei, N
   Ghaffarian-Ensaf, R
   Shiraseb, F
   Fallah, M
   Gholami, F
   Clark, CCT
   Mirzaei, K
AF Rasaei, Niloufar
   Ghaffarian-Ensaf, Rasool
   Shiraseb, Farideh
   Fallah, Melika
   Gholami, Fatemeh
   Clark, Cain C. T.
   Mirzaei, Khadijeh
TI The association between healthy beverage index and quality of life among
   overweight and obese women: a cross-sectional study
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Healthy beverage index; Quality of life; Diet; Overweight; Obesity
ID WATER-CONSUMPTION; PHYSICAL-ACTIVITY; DEPRESSION; WEIGHT; MOOD; RISK;
   QUESTIONNAIRE; CAFFEINE; VALIDITY; ALCOHOL
AB BackgroundAlthough several studies have evaluated the association between patterns of beverage consumption with different components of quality of life separately, the findings are controversial. In addition, none have examined all components of quality of life together in relation to patterns of beverage consumption. Therefore, this study was conducted to identify the association between healthy beverage index (HBI) and quality of life among overweight and obese women.MethodsFor this cross-sectional study, 210 obese and overweight women were recruited from health centers in Tehran, Iran. Using reliable and verified standard protocols, data on beverage intake, socio-demographic, physical activity, and anthropometric variables were assessed. Based on past studies, the predetermined HBI was estimated. Serum samples were used to determine biochemical characteristics, and quality of life was assessed using SF-36 questionnaires.ResultsThere was a significant association between total QoL score with T2 tertile of HBI in the adjusted model (beta: 13.11, 95% CI: 1.52, 24.69, p-value = 0.027). General health had a significant negative association with T2 (beta: -5.83; 95% CI: - 11.48, - 0.18; p-value = 0.043) and T3 (beta: -6.20; 95% CI: - 12.37, - 0.03; p-value = 0.049). Women with greater adherence to the HBI had a higher physical functioning score, and there was a significant upward trend from the second to the third tertile (7.74 vs 0.62) (-trend = 0.036). There was a significant positive association between mental health with T3 of HBI (beta: 4.26; 95% CI: 1.51, 5.98; p-value = 0.015) and a significant increasing trend was observed with increasing tertiles (P-trend = 0.045).ConclusionIn conclusion, there is a significant association between total QoL score, and its components, with HBI among overweight and obese women. However, additional well-designed studies are needed to confirm these findings.
C1 [Rasaei, Niloufar; Shiraseb, Farideh; Fallah, Melika; Gholami, Fatemeh; Mirzaei, Khadijeh] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.
   [Ghaffarian-Ensaf, Rasool] Islamic Azad Univ, Dept Nutr, Sci & Res Branch, Tehran, Iran.
   [Clark, Cain C. T.] Coventry Univ, Ctr Intelligent Healthcare, Coventry CV1 5FB, England.
C3 Tehran University of Medical Sciences; Islamic Azad University; Coventry
   University
RP Mirzaei, K (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.
EM mirzaei_kh@tums.ac.ir
RI Mirzaei, Khadijeh/D-5408-2018; Clark, Cain/I-4480-2019;
   Ghaffarian-Ensaf, Rasool/HJG-9268-2022; Shiraseb, F/AAQ-7384-2020
OI Clark, Dr. Cain/0000-0002-6610-4617; Ghaffarian-Ensaf,
   Rasool/0000-0003-1291-1525
FU Tehran University of Medical Sciences, Tehran, Iran [99-3212-51715]
FX This study was supported by grants from the Tehran University of Medical
   Sciences, Tehran, Iran (Grant number: 99-3212-51715).
CR Antunes VR, 2006, J PHYSIOL-LONDON, V576, P569, DOI 10.1113/jphysiol.2006.115766
   Appelhans BM, 2012, J ACAD NUTR DIET, V112, P693, DOI 10.1016/j.jand.2012.02.006
   Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019
   Breymeyer KL, 2016, APPETITE, V107, P253, DOI 10.1016/j.appet.2016.08.008
   Crichton GE, 2010, ASIA PAC J CLIN NUTR, V19, P161
   Dennis EA, 2010, OBESITY, V18, P300, DOI 10.1038/oby.2009.235
   Chu DT, 2019, DIABETES METAB SYND, V13, P155, DOI 10.1016/j.dsx.2018.07.015
   Duffey KJ, 2015, J ACAD NUTR DIET, V115, P1682, DOI 10.1016/j.jand.2015.05.005
   Farhangi MA, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02511-9
   Freije SL, 2021, PREV CHRONIC DIS, V18, DOI 10.5888/pcd18.200574
   Fuchs T, 2016, J SCHOOL HEALTH, V86, P407, DOI 10.1111/josh.12391
   Natal DIG, 2016, NUTRITION, V32, P1011, DOI 10.1016/j.nut.2016.02.008
   González-Rubio E, 2016, QUAL LIFE RES, V25, P1931, DOI 10.1007/s11136-016-1229-2
   Govindaraju T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080971
   Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807
   Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016
   Gui ZH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121302
   Hagan KA, 2019, J NUTR HEALTH AGING, V23, P459, DOI 10.1007/s12603-019-1185-y
   Hearst Corporation First DataBank, 1995, Nutritionist IV: diet analysis
   Heinonen I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002901
   Jalilpiran Y, 2021, EAT WEIGHT DISORD-ST, V26, P1437, DOI 10.1007/s40519-020-00954-z
   Jyväkorpi SK, 2021, AGING CLIN EXP RES, V33, P1371, DOI 10.1007/s40520-020-01645-6
   Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797, DOI 10.1681/ASN.V12122797
   Keshteli AH, 2014, INT J PREVENTIVE MED, V5, P29
   Kim JM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph181910415
   Knüppel A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05649-7
   Kotarska K, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18105194
   Lima MG, 2011, REV SAUDE PUBL, V45, P485, DOI 10.1590/S0034-89102011000300006
   Lopez-Garcia E, 2014, CLIN NUTR, V33, P143, DOI 10.1016/j.clnu.2013.04.004
   Lucas M, 2011, ARCH INTERN MED, V171, P1571, DOI 10.1001/archinternmed.2011.393
   Mahesh M, 2021, NUTR METAB INSIGHTS, V14, DOI 10.1177/11786388211014917
   Mantantzis K, 2019, NEUROSCI BIOBEHAV R, V101, P45, DOI 10.1016/j.neubiorev.2019.03.016
   MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006
   Moghaddam MB., 2012, WORLD APPL SCI J, V18, P1073, DOI DOI 10.5829/IDOSI.WASJ.2012.18.08.754
   Muñoz CX, 2015, APPETITE, V92, P81, DOI 10.1016/j.appet.2015.05.002
   Naumann J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080914
   Paz-Graniel I, 2021, CLIN NUTR, V40, P3982, DOI 10.1016/j.clnu.2021.05.014
   Rathnayake N, 2019, NURS RES PRACT, V2019, DOI 10.1155/2019/2081507
   Ruusunen A, 2010, PUBLIC HEALTH NUTR, V13, P1215, DOI 10.1017/S1368980010000509
   Saito I, 2005, J OCCUP HEALTH, V47, P496, DOI 10.1539/joh.47.496
   Swanson K, 2019, J DAIRY SCI, V102, P4798, DOI 10.3168/jds.2018-15201
   TspBC A, 2015, Instruction manual
   Zhu ZN, 2020, PEDIATR OBES, V15, DOI 10.1111/ijpo.12634
   Zolot J, 2017, AM J NURS, V117, P56, DOI [10.1097/01.NAJ.0000521975.84459.73, 10.1097/01.NAJ.0000521976.61588.2f]
NR 44
TC 5
Z9 5
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 26
PY 2023
VL 23
IS 1
AR 176
DI 10.1186/s12889-022-14501-1
PG 13
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA 8G9TE
UT WOS:000920682400002
PM 36698096
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Wong, THT
   Sui, ZX
   Rangan, A
   Louie, JCY
AF Wong, Tommy Hon Ting
   Sui, Zhixian
   Rangan, Anna
   Louie, Jimmy Chun Yu
TI Discrepancy in socioeconomic status does not fully explain the variation
   in diet quality between consumers of different coffee types
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Coffee type; Diet quality; Sugar; Australia; Coffee additive; Coffee
ID DOSE-RESPONSE METAANALYSIS; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS;
   CONSUMPTION; RISK; ADULTS; HEALTH; MORTALITY; OBESITY; CANCER
AB Purpose Habitual consumers of different coffee types may vary in socioeconomic status (SES), which is an important determinant of diet quality. Nonetheless, research on diet quality among coffee consumers was scarce. We aimed to compare the diet quality of coffee consumers with different preferences towards coffee type and additive usage.
   Methods In this cross-sectional analysis, intake data of food, coffee, and additive usage from the adult respondents of the 2011-2012 Australian Health Survey were used. Participants were grouped according to the type of coffee (espresso and ground coffee, E & G; coffee made from coffee mixes and instant coffee, M & I; non-consumers, NC) and additives (milk, sugar, and intense sweetener) consumed. Adjusted food group intake was compared between consumption groups using general linear model.
   Results E&G drinkers had better SES than M&I and NC. After adjusting for covariates, the mean dairy intake of E&G drinkers was 22.2% higher than M&I drinkers (p < 0.001) and 33.1% higher than NC (p < 0.001). Mean discretionary food intake of E&G drinkers was 12.1% lower than M&I (p = 0.003) and 12.3% lower than NC (p = 0.001). In terms of additive usage, non-users of coffee additive had the lowest dairy food intake and the highest discretionary food intake.
   Conclusions Coffee consumers' different preferences towards coffee type and additive usages reflected significant variations in their diet quality, even after adjustment of SES. Therefore, future epidemiological studies should consider separating coffee drinkers according to their habitual consumption of different types of coffee.
C1 [Wong, Tommy Hon Ting; Louie, Jimmy Chun Yu] Univ Hong Kong, Sch Biol Sci, Fac Sci, 5S-14 Kadoorie Biol Sci Bldg,1 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.
   [Sui, Zhixian; Rangan, Anna; Louie, Jimmy Chun Yu] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW, Australia.
C3 University of Hong Kong; University of Sydney
RP Louie, JCY (corresponding author), Univ Hong Kong, Sch Biol Sci, Fac Sci, 5S-14 Kadoorie Biol Sci Bldg,1 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.; Louie, JCY (corresponding author), Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW, Australia.
EM jimmyl@hku.hk
RI Wong, Tommy/AAI-2928-2020; Rangan, Anna/AFS-4449-2022; Louie, Jimmy Chun
   Yu/B-6754-2008
OI Louie, Jimmy Chun Yu/0000-0001-7736-605X; Rangan,
   Anna/0000-0003-1815-844X; Wong, Tommy Hon Ting/0000-0003-4822-4604
CR Agriculture and Agri-Food Canada, 2013, 11965E AAFC INT MARK
   An RP, 2016, J ACAD NUTR DIET, V116, P28, DOI 10.1016/j.jand.2015.08.009
   [Anonymous], 2013, AUSTR DIET GUID
   [Anonymous], AUSNUT 2013 AUSTR FO
   [Anonymous], 2011, AUSTR STAND GEOGR CL
   [Anonymous], 2011, CENSUS POPULATION HO
   Australian Bureau of Statistics, 2013, Australian Health Survey: Users' Guide, 2011-13
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011
   Drewnowski A, 2014, NUTRIENTS, V6, P4389, DOI 10.3390/nu6104389
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334
   Grioni S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126550
   Gyntelberg F, 2009, INT J FOOD SCI NUTR, V60, P56, DOI 10.1080/09637480802668471
   Harttig U, 2011, EUR J CLIN NUTR, V65, pS87, DOI 10.1038/ejcn.2011.92
   Heuer T, 2015, BRIT J NUTR, V113, P1603, DOI 10.1017/S0007114515000744
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   O'Connor L, 2015, DIABETOLOGIA, V58, P1474, DOI 10.1007/s00125-015-3572-1
   Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529
   Rayner M, 2005, J EPIDEMIOL COMMUN H, V59, P1054, DOI 10.1136/jech.2005.036491
   Rennie KL, 2007, BRIT J NUTR, V97, P1169, DOI 10.1017/S0007114507433086
   SMITH GD, 1990, BMJ-BRIT MED J, V301, P373, DOI 10.1136/bmj.301.6748.373
   Thompson FE, 2015, J ACAD NUTR DIET, V115, P1986, DOI 10.1016/j.jand.2015.08.016
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
NR 29
TC 14
Z9 14
U1 0
U2 10
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD SEP
PY 2018
VL 57
IS 6
BP 2123
EP 2131
DI 10.1007/s00394-017-1488-x
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GQ7KL
UT WOS:000441919500009
PM 28638993
DA 2025-04-28
ER

PT J
AU Ravussin, Y
   Montani, JP
   Grasser, EK
AF Ravussin, Yann
   Montani, Jean-Pierre
   Grasser, Erik Konrad
TI Sucrose dampens caffeine-induced blood pressure elevations - A
   randomized crossover pilot study in healthy, non-obese men
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE caffeine; cardiovascular; sucrose; hemodynamic; blood pressure; soft
   drinks; cardiac effects; glucose metabolism
ID SWEETENED BEVERAGE CONSUMPTION; MYOCARDIAL OXYGEN-CONSUMPTION;
   CARDIOVASCULAR-RESPONSES; SUGARY DRINKS; OBESITY; INGESTION; GLUCOSE;
   DISEASE; ADULTS; RISK
AB PurposeSales for sugar-sweetened and caffeinated beverages are still rising globally and their consumption has been linked to the development of cardiovascular diseases. However, direct evidence from human interventional studies in response to such beverages is still scarce. MethodsSeven young, non-obese men participated in a randomized crossover study where four test drinks [60 g sucrose + 50 mg caffeine, 60 g sucrose + caffeine-placebo, 50 mg caffeine, and caffeine-placebo] were investigated. Each drink was brought to a total volume of 500 mL with water. Continuous and beat-to-beat hemodynamic monitoring was conducted for 30 min baseline and continued for 90 min after the ingestion of each drink. Measurements included blood pressure, heart rate, stroke volume, cardiac output, total peripheral resistance, index of contractility, and double product. ResultsTwo-factor ANOVA analysis revealed significant treatment-by-time effects for diastolic blood pressure, heart rate, stroke volume, cardiac output, total peripheral resistance, index of contractility, and double product (all p < 0.01). Diastolic blood pressure and total peripheral resistance increased significantly to caffeine-only (all p < 0.05), while sucrose + caffeine-placebo and sucrose + caffeine both decreased resistance responses (all p < 0.05). Cardiac output increased significantly to sucrose + caffeine-placebo and sucrose + caffeine (all p < 0.05), and on trend for heart rate, stroke volume, and index of contractility (all p between 0.05 and 0.09). ConclusionIn young, non-obese men, a caffeinated and sucrose-sweetened beverage at concentrations similar to classical commercial Cola products exhibited distinct hemodynamic actions where the presence of sucrose dampened caffeine-induced blood pressure elevations, but at the expense of a tendency to increase cardiac work.
C1 [Ravussin, Yann; Montani, Jean-Pierre; Grasser, Erik Konrad] Univ Fribourg, Dept Endocrinol, Metab & Cardiovasc Syst, Fribourg, Switzerland.
C3 University of Fribourg
RP Ravussin, Y (corresponding author), Univ Fribourg, Dept Endocrinol, Metab & Cardiovasc Syst, Fribourg, Switzerland.
EM yann.ravussin@unifr.ch
RI Ravussin, Yann/ABE-8061-2021
OI Ravussin, Yann/0000-0002-6699-3944
CR Allied Market Research, 2022, EN DRINKS MARK TYP E
   BARON AD, 1993, AM J PHYSIOL, V265, pE61, DOI 10.1152/ajpendo.1993.265.1.E61
   Beaudoin MS, 2013, APPL PHYSIOL NUTR ME, V38, P140, DOI 10.1139/apnm-2012-0201
   Brand Finance Food & Drink, 2022, ANN REP MOST VAL STR
   Brown CM, 2008, AM J PHYSIOL-REG I, V294, pR730, DOI 10.1152/ajpregu.00680.2007
   Caffeine Informer, 2022, SUG DRINKS
   Caffeine Informer, 2022, CAFF CONT DRINKS
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Charrière N, 2017, EUR J NUTR, V56, P2105, DOI 10.1007/s00394-016-1250-9
   Drouin-Chartier JP, 2019, DIABETES CARE, V42, P2181, DOI 10.2337/dc19-0734
   Fortin J, 2006, COMPUT BIOL MED, V36, P1185, DOI 10.1016/j.compbiomed.2005.06.001
   GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549
   Grasser EK, 2009, PHYSIOL RES, V58, P817, DOI 10.33549/physiolres.931591
   Grasser EK, 2014, EUR J NUTR, V53, P1561, DOI 10.1007/s00394-014-0661-8
   Grasser EK, 2014, BRIT J NUTR, V112, P183, DOI 10.1017/S0007114514000622
   Grasser EK, 2016, ADV NUTR, V7, P950, DOI 10.3945/an.116.012526
   Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134
   Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Keast RSJ, 2015, BRIT J NUTR, V113, P366, DOI 10.1017/S000711451400378X
   Kubicek W G, 1970, J Assoc Adv Med Instrum, V4, P79
   Malik VS, 2019, CIRCULATION, V139, P2113, DOI 10.1161/CIRCULATIONAHA.118.037401
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Miles-Chan JL, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12290
   Monnard CR, 2020, EUR J NUTR, V59, P2747, DOI 10.1007/s00394-019-02120-3
   Monnard CR, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00507
   NELSON RR, 1974, CIRCULATION, V50, P1179, DOI 10.1161/01.CIR.50.6.1179
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636
   Statista Research Department, 2022, MARK SHAR CARB BEV W
NR 32
TC 0
Z9 0
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD AUG 4
PY 2022
VL 9
AR 896055
DI 10.3389/fnut.2022.896055
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 3X5IC
UT WOS:000843073400001
PM 35990317
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Pang, S
   Miao, GR
   Zhou, YH
   Duan, MX
   Bai, LP
   Zhao, XY
AF Pang, Shuo
   Miao, Guangrui
   Zhou, Yuanhang
   Duan, Mingxuan
   Bai, Linpeng
   Zhao, Xiaoyan
TI Association between coffee intake and frailty among older American
   adults: A population-based cross-sectional study
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE frailty; caffeinated coffee; decaffeinated coffee; dose-response;
   National Health and Nutrition Examination Survey
ID DECAFFEINATED COFFEE; CONSUMPTION; HEALTH; PREVALENCE; NUTRITION;
   BENEFITS; INDEX; RISK
AB ObjectiveWe aimed to investigate the association between coffee consumption and frailty in older American adults. We focused on individuals at higher frailty risk, such as women, ethnic minorities, smokers, and those with obesity and insufficient physical activity. MethodsThe data of 8,087 individuals aged over 60 years from the 2007-2018 National Health and Nutrition Examination Surveys were used for this cross-sectional study. The coffee drinks were classified into two categories: caffeinated and decaffeinated. Frailty was measured using the 53-item frailty index. Weighted binary logistic regression was used to evaluate the association between coffee intake and frailty risk. Restricted cubic spline models were used to assess the dose-response relationship between caffeinated coffee intake and frailty. ResultsAmong the 8,087 participants, 2,458 (30.4%) had frailty. Compared with those who reported no coffee consumption, the odds ratios [ORs; 95% confidence intervals (CIs)] of total coffee consumption > 498.9 (g/day) were 0.65 (0.52, 0.79) in the fully adjusted model. Compared with those who reported no caffeinated coffee consumption, the ORs (95% CIs) of total coffee consumption > 488.4 (g/day) were 0.68 (0.54, 0.85) in the fully adjusted model. Compared with those who reported no decaffeinated coffee consumption, the ORs (95% CIs) of total coffee consumption > 0 (g/day) were 0.87 (0.71, 1.06) in the fully adjusted model. Nonlinear associations were detected between total coffee and caffeinated coffee consumption and frailty. In the subgroup analyses by smoking status, the association between coffee consumption and the risk of frailty was more pronounced in non-smokers (P for interaction = 0.031). ConclusionCaffeinated coffee consumption was independently and nonlinearly associated with frailty, especially in non-smokers. However, decaffeinated coffee consumption was not associated with frailty.
C1 [Pang, Shuo; Miao, Guangrui; Zhou, Yuanhang; Duan, Mingxuan; Bai, Linpeng; Zhao, Xiaoyan] Zhengzhou Univ, Dept Cardiol, Affiliated Hosp 1, Zhengzhou, Peoples R China.
C3 Zhengzhou University
RP Zhao, XY (corresponding author), Zhengzhou Univ, Dept Cardiol, Affiliated Hosp 1, Zhengzhou, Peoples R China.
EM fcczhaoxy8@zzu.edu.cn
RI Pang, Shuo/JKJ-5116-2023
FU Science and Technology Development of Henan Province [212102310210]
FX Funding This work was supported by the Science and Technology
   Development of Henan Province (grant no. 212102310210).
CR Blodgett J, 2015, ARCH GERONTOL GERIAT, V60, P464, DOI 10.1016/j.archger.2015.01.016
   Buckinx F, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0068-x
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cadden ISH, 2007, ALIMENT PHARM THERAP, V26, P1, DOI 10.1111/j.1365-2036.2007.03319.x
   Cesari M, 2016, J AM MED DIR ASSOC, V17, P188, DOI 10.1016/j.jamda.2015.12.016
   Cesari M, 2014, AGE AGEING, V43, P10, DOI 10.1093/ageing/aft160
   Chen XJ, 2014, CLIN INTERV AGING, V9, P433, DOI 10.2147/CIA.S45300
   Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9
   Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x
   Colombo R, 2021, CRIT REV FOOD SCI, V61, P2506, DOI 10.1080/10408398.2020.1779175
   de Gonzalo-Calvo D, 2012, J GERONTOL A-BIOL, V67, P663, DOI 10.1093/gerona/glr215
   Del Rio D, 2010, NUTRIENTS, V2, P820, DOI 10.3390/nu2080820
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dirks-Naylor AJ, 2015, LIFE SCI, V143, P182, DOI 10.1016/j.lfs.2015.11.005
   Dong X, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030840
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Gómez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985
   Hakeem FF, 2021, J AM MED DIR ASSOC, V22, P559, DOI 10.1016/j.jamda.2020.07.023
   Hibler EA, 2020, INT J CANCER, V146, P2979, DOI 10.1002/ijc.32634
   Hoogendijk EO, 2019, LANCET, V394, P1365, DOI 10.1016/S0140-6736(19)31786-6
   Huang WC, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020418
   Jee HJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103080
   Kobayashi S, 2014, J NUTR HEALTH AGING, V18, P827, DOI [10.1007/s12603-014-0556-7, 10.1007/s12603-014-0478-4]
   Lo YL, 2017, J AM GERIATR SOC, V65, P2009, DOI 10.1111/jgs.14972
   Lochlainn MN, 2021, NUTRIENTS, V13, DOI 10.3390/nu13072349
   Machado-Fragua MD, 2019, EUR J NUTR, V58, P1415, DOI 10.1007/s00394-018-1664-7
   Miranda AM, 2021, CLIN NUTR, V40, P542, DOI 10.1016/j.clnu.2020.05.052
   Pietrocola F, 2014, CELL CYCLE, V13, P1987, DOI 10.4161/cc.28929
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   RELLING MV, 1992, CLIN PHARMACOL THER, V52, P643, DOI 10.1038/clpt.1992.203
   Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051
   Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24
   Shahinfar H, 2021, NUTR METAB CARDIOVAS, V31, P2526, DOI 10.1016/j.numecd.2021.05.014
   Song XW, 2010, J AM GERIATR SOC, V58, P681, DOI 10.1111/j.1532-5415.2010.02764.x
   Svilaas A, 2004, J NUTR, V134, P562, DOI 10.1093/jn/134.3.562
   SWANSON JA, 1994, ADDICT BEHAV, V19, P229, DOI 10.1016/0306-4603(94)90027-2
   Temple Jennifer L, 2011, J Caffeine Res, V1, P41, DOI 10.1089/jcr.2011.0005
   Who Guidelines Approved by the Guidelines Review Committee, 2010, GLOB REC PHYS ACT HL
   Xiao Q, 2014, HEPATOLOGY, V60, P2091, DOI 10.1002/hep.27367
   Zhang Y, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003830
NR 40
TC 8
Z9 8
U1 3
U2 13
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD FEB 2
PY 2023
VL 10
AR 1075817
DI 10.3389/fnut.2023.1075817
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 9E4DV
UT WOS:000936739400001
PM 36819700
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Nieman, DC
   Ramamoorthy, S
   Kay, CD
   Goodman, CL
   Capps, CR
   Shue, ZL
   Heyl, N
   Grace, MH
   Lila, MA
AF Nieman, David C.
   Ramamoorthy, Sivapriya
   Kay, Colin D.
   Goodman, Courtney L.
   Capps, Christopher R.
   Shue, Zack L.
   Heyl, Nicole
   Grace, Mary H.
   Lila, Mary A.
TI Influence of Ingesting a Flavonoid-Rich Supplement on the Metabolome and
   Concentration of Urine Phenolics in Overweight/Obese Women
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE dietary supplement; metabolomics; polyphenol; obesity
ID GREEN TEA EXTRACT; ANTIOXIDANT CAPACITY; ANTIINFLAMMATORY ACTIVITY;
   TOTAL POLYPHENOLS; FATTY-ACIDS; FISH-OIL; QUERCETIN; METAANALYSIS;
   ANTHOCYANIN; PROFILE
AB This study evaluated the effect of ingesting a flavonoid-rich supplement (329 mg/d) on total urine phenolics and shifts in plasma metabolites in overweight/obese female adults using untargeted metabolomics procedures. Participants (N = 103, 18-65 y, BMI >= 25 kg/m(2)) were randomized to flavonoid (F) or placebo (P) groups for 12 weeks with blood and 24 h urine samples collected prestudy and after 4 and 12 weeks in a parallel design. Supplements were prepared as chewable tablets and included vitamin C, wild bilberry fruit extract, green tea leaf extract, quercetin, caffeine, and omega 3 fatty acids. At 4 weeks, urine total phenolics increased 24% in F versus P with similar changes at 12 weeks (interaction effect, P = 0.041). Groups did not differ in markers of inflammation (IL-6, MCP-1, CRP) or oxidative stress (oxLDL, FRAP). Metabolomics data indicated shifts in 63 biochemicals in F versus P with 70% from the lipid and xenobiotics superpathways. The largest fold changes in F were measured for three gut-derived phenolics including 3-methoxycatechol sulfate, 3-(3-hydroxyphenyl)-propanoic acid sulfate, and 1,2,3-benzenetriol sulfate (interaction effects, p <= 0.050). This randomized trial of overweight/obese women showed that 12 weeks ingestion of a mixed flavonoid nutrient supplement was associated with a corresponding increase in urine total phenolics and gut-derived phenolic metabolites.
C1 [Nieman, David C.; Goodman, Courtney L.; Capps, Christopher R.; Shue, Zack L.] Appalachian State Univ, Human Performance Lab, North Carolina Res Campus, Kannapolis, NC 28081 USA.
   [Ramamoorthy, Sivapriya] Metabolon, 617 Davis Dr,Suite 400, Durham, NC 27713 USA.
   [Kay, Colin D.; Grace, Mary H.; Lila, Mary A.] North Carolina State Univ, Plants Human Hlth Inst, Food Bioproc & Nutr Sci Dept, North Carolina Res Campus,600 Laureate Way, Kannapolis, NC 28081 USA.
C3 University of North Carolina; Appalachian State University; Metabolon;
   North Carolina State University
RP Nieman, DC (corresponding author), North Carolina Res Campus,600 Laureate Way, Kannapolis, NC 28081 USA.
EM niemandc@appstate.edu
RI Kay, Colin/K-4309-2012; Grace, Mary/AAE-4629-2021; Nieman,
   David/AAC-9739-2022
OI Lila, Mary Ann/0000-0002-4928-3836; Nieman, David/0000-0002-8305-1860;
   Kay, Colin/0000-0001-7290-4496; Grace, Mary/0000-0002-8536-4211
FU Reoxcyn Innovation Group LLC, Salt Lake City, UT
FX This work was supported by funding from Reoxcyn Innovation Group LLC,
   Salt Lake City, UT.
CR Ahmed M, 2014, PHYTOTHER RES, V28, P1829, DOI 10.1002/ptr.5208
   Annuzzi G, 2014, AM J CLIN NUTR, V99, P463, DOI 10.3945/ajcn.113.073445
   [Anonymous], 2015 2020 DIET GUID
   Bakker GCM, 2010, AM J CLIN NUTR, V91, P1044, DOI 10.3945/ajcn.2009.28822
   Basu A, 2011, NUTRITION, V27, P206, DOI 10.1016/j.nut.2010.01.015
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535
   Calani L, 2012, INT J FOOD SCI NUTR, V63, P513, DOI 10.3109/09637486.2011.640311
   Camuesco D, 2006, CLIN NUTR, V25, P466, DOI 10.1016/j.clnu.2005.12.009
   Cassidy A, 2015, AM J CLIN NUTR, V102, P172, DOI 10.3945/ajcn.115.108555
   Cialdella-Kam L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050277
   Cialdella-Kam L, 2013, BRIT J NUTR, V109, P1923, DOI 10.1017/S0007114512003972
   de Ferrars RM, 2014, BRIT J PHARMACOL, V171, P3268, DOI 10.1111/bph.12676
   DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9
   Endo J, 2016, J CARDIOL, V67, P22, DOI 10.1016/j.jjcc.2015.08.002
   Erlund I, 2008, AM J CLIN NUTR, V87, P323, DOI 10.1093/ajcn/87.2.323
   Evans AM., 2014, METABOLOMICS, V4, P132, DOI [10.4172/2153-0769.1000132, DOI 10.4172/2153-0769.1000132]
   Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h
   Fernandes RPP, 2016, J FOOD SCI TECH MYS, V53, P451, DOI 10.1007/s13197-015-1994-x
   Grace MH, 2014, J AGR FOOD CHEM, V62, P4007, DOI 10.1021/jf403810y
   Guo XH, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2572606
   Guo Y, 2015, J NUTR BIOCHEM, V26, P201, DOI 10.1016/j.jnutbio.2014.10.008
   Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hoy MK, 2016, PUBLIC HEALTH NUTR, V19, P2508, DOI 10.1017/S1368980016000628
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Ivey KL, 2015, AM J CLIN NUTR, V101, P1012, DOI 10.3945/ajcn.113.073106
   Jacobs DM, 2014, J AGR FOOD CHEM, V62, P9936, DOI 10.1021/jf502764r
   Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee
   Knab AM, 2011, J AM DIET ASSOC, V111, P542, DOI 10.1016/j.jada.2011.01.013
   Lajous M, 2016, AM J CLIN NUTR, V103, P1091, DOI 10.3945/ajcn.115.109249
   Larrosa M, 2009, MOL NUTR FOOD RES, V53, P1044, DOI 10.1002/mnfr.200800446
   Li D, 2015, J NUTR, V145, P742, DOI 10.3945/jn.114.205674
   Lila MA, 2007, ANN NY ACAD SCI, V1114, P372, DOI 10.1196/annals.1396.047
   Lin XC, 2016, J NUTR, V146, P2325, DOI 10.3945/jn.116.237644
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   Marín L, 2015, BIOMED RES INT-UK, V2015, DOI 10.1155/2015/905215
   McAnulty SR, 2011, INT J SPORT NUTR EXE, V21, P328, DOI 10.1123/ijsnem.21.4.328
   Medina-Remón A, 2009, ANAL CHIM ACTA, V634, P54, DOI 10.1016/j.aca.2008.12.012
   Medina-Remón A, 2017, BRIT J CLIN PHARMACO, V83, P114, DOI 10.1111/bcp.12986
   Mulder TP, 2005, AM J CLIN NUTR, V81, p256S, DOI 10.1093/ajcn/81.1.256S
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakagawa K, 2009, BIOSCI BIOTECH BIOCH, V73, P2014, DOI 10.1271/bbb.90195
   National Center for Health Statistics. Health United States, 2015, 2015 SPEC FEAT RAC E, P215
   Niedzwiecki A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090552
   Nieman DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072215
   Nieman DC, 2009, MED SCI SPORT EXER, V41, P1467, DOI 10.1249/MSS.0b013e318199491f
   Papanikolaou Y, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-64
   Pereira-Caro G, 2015, FREE RADICAL BIO MED, V84, P206, DOI 10.1016/j.freeradbiomed.2015.03.010
   Pereira-Caro G, 2014, AM J CLIN NUTR, V100, P1378, DOI 10.3945/ajcn.114.090282
   Pimpao RC, 2015, BRIT J NUTR, V113, P454, DOI 10.1017/S0007114514003511
   Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814
   Sánchez-Pátan F, 2011, J AGR FOOD CHEM, V59, P2241, DOI 10.1021/jf104574z
   Sebastian R.S., 2016, Flavonoid values for USDA survey foods and beverages 2007-2010
   Sebastian RS, 2015, J NUTR, V145, P1239, DOI 10.3945/jn.115.213025
   Tresserra-Rimbau A, 2016, J NUTR, V146, P767, DOI 10.3945/jn.115.223610
   van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107
   Wang X, 2014, BRIT J NUTR, V111, P1, DOI 10.1017/S000711451300278X
   Warner EF, 2016, J NUTR, V146, P465, DOI 10.3945/jn.115.217943
   Zamora-Ros R, 2016, EUR J NUTR, V55, P1359, DOI 10.1007/s00394-015-0950-x
   Zamora-Ros R, 2013, J NUTR, V143, P1445, DOI 10.3945/jn.113.177121
NR 61
TC 18
Z9 19
U1 1
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD AUG
PY 2017
VL 16
IS 8
BP 2924
EP 2935
DI 10.1021/acs.jproteome.7b00196
PG 12
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA FD1OY
UT WOS:000407307800021
PM 28631923
DA 2025-04-28
ER

PT J
AU Fardet, A
   Boirie, Y
AF Fardet, Anthony
   Boirie, Yves
TI Associations between food and beverage groups and major diet-related
   chronic diseases: an exhaustive review of pooled/meta-analyses and
   systematic reviews
SO NUTRITION REVIEWS
LA English
DT Review
DE association analysis; food groups; beverages; diet-related chronic
   diseases; meta-analyses; systematic reviews; dairy; meats; fruits;
   vegetables; grains
ID CORONARY-HEART-DISEASE; PLANT-BASED FOODS; MEDITERRANEAN DIET;
   CANCER-RISK; CARDIOVASCULAR-DISEASE; VEGETABLE CONSUMPTION; CAFFEINE
   CONSUMPTION; LIPOTROPIC CAPACITY; COFFEE CONSUMPTION; FISH CONSUMPTION
AB Associations between food and beverage groups and the risk of diet-related chronic disease (DRCD) have been the subject of intensive research in preventive nutrition. Pooled/meta-analyses and systematic reviews (PMASRs) aim to better characterize these associations. To date, however, there has been no attempt to synthesize all PMASRs that have assessed the relationship between food and beverage groups and DRCDs. The objectives of this review were to aggregate PMASRs to obtain an overview of the associations between food and beverage groups (n = 17) and DRCDs (n = 10) and to establish new directions for future research needs. The present review of 304 PMASRs published between 1950 and 2013 confirmed that plant food groups are more protective than animal food groups against DRCDs. Within plant food groups, grain products are more protective than fruits and vegetables. Among animal food groups, dairy/milk products have a neutral effect on the risk of DRCDs, while red/processed meats tend to increase the risk. Among beverages, tea was the most protective and soft drinks the least protective against DRCDs. For two of the DRCDs examined, sarcopenia and kidney disease, no PMASR was found. Overweight/obesity, type 2 diabetes, and various types of cardiovascular disease and cancer accounted for 289 of the PMASRs. There is a crucial need to further study the associations between food and beverage groups and mental health, skeletal health, digestive diseases, liver diseases, kidney diseases, obesity, and type 2 diabetes. (C) 2014 International Life Sciences Institute
C1 [Fardet, Anthony; Boirie, Yves] INRA, Unite Nutr Humaine, F-63122 St Genes Champanelle, France.
   [Fardet, Anthony; Boirie, Yves] Univ Auvergne, F-63122 St Genes Champanelle, France.
C3 INRAE; Universite Clermont Auvergne (UCA)
RP Fardet, A (corresponding author), INRA, UMR 1019, Unite Nutr Humaine, F-63122 St Genes Champanelle, France.
EM anthony.fardet@clermont.inra.fr
RI Boirie, Yves/KQC-2016-2024
OI Boirie, Yves/0000-0002-3999-1599
CR [Anonymous], WHOLEGRAIN FOODS LEG
   Arab L, 2013, ADV NUTR, V4, P115, DOI 10.3945/an.112.002717
   Arab L, 2009, STROKE, V40, P1786, DOI 10.1161/STROKEAHA.108.538470
   ASTRUP A, 1993, INT J OBESITY, V17, pS41
   Aune D, 2012, BREAST CANCER RES TR, V134, P479, DOI 10.1007/s10549-012-2118-1
   Quintana JLB, 2007, NEUROL RES, V29, P91, DOI 10.1179/174313206X152546
   Cassady BA, 2009, AM J CLIN NUTR, V89, P794, DOI 10.3945/ajcn.2008.26669
   Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]
   Chowdhury R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6698
   Corrao G, 1998, ALCOHOL ALCOHOLISM, V33, P381
   Costanzo S, 2011, EUR J EPIDEMIOL, V26, P833, DOI 10.1007/s10654-011-9631-0
   Crookes PF, 1999, GASTROENTEROLOGY, V116, pA140
   De Caterina R, 2000, AM J CLIN NUTR, V71, p213S, DOI 10.1093/ajcn/71.1.213S
   DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x
   Djoussé L, 2012, CLIN NUTR, V31, P846, DOI 10.1016/j.clnu.2012.05.010
   Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518
   Eilat-Adar S, 2010, NUTR METAB CARDIOVAS, V20, P459, DOI 10.1016/j.numecd.2010.01.011
   Esposito K, 2011, METAB SYNDR RELAT D, V9, P1, DOI 10.1089/met.2010.0031
   Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528
   Fardet A, 2013, NUTR REV, V71, P643, DOI 10.1111/nure.12052
   Fardet A, 2012, J FOOD COMPOS ANAL, V28, P135, DOI 10.1016/j.jfca.2012.07.011
   Fardet A, 2013, CRIT REV FOOD SCI, V53, P535, DOI 10.1080/10408398.2010.549596
   Fardet A, 2011, J FOOD COMPOS ANAL, V24, P895, DOI 10.1016/j.jfca.2011.03.013
   Fardet A, 2011, FOOD FUNCT, V2, P483, DOI 10.1039/c1fo10041f
   Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041
   Flight I, 2006, EUR J CLIN NUTR, V60, P1145, DOI 10.1038/sj.ejcn.1602435
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6
   HARRIS WS, 1989, J LIPID RES, V30, P785
   He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212
   Hernán MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   Islami F, 2009, INT J CANCER, V125, P491, DOI 10.1002/ijc.24445
   Jacobson KA, 1996, TRENDS PHARMACOL SCI, V17, P108, DOI 10.1016/0165-6147(96)10002-X
   Jenab M, 2004, CANCER EPIDEM BIOMAR, V13, P1595
   Jensdottir T, 2004, Clin Oral Investig, V8, P91
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073
   KAWACHI I, 1994, BRIT HEART J, V72, P269
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kelley GA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-74
   Kim HJ, 2010, CANCER SCI, V101, P508, DOI 10.1111/j.1349-7006.2009.01374.x
   Kong FB, 2009, FOOD BIOPHYS, V4, P365, DOI 10.1007/s11483-009-9135-6
   KOREN G, 1991, JAMA-J AM MED ASSOC, V266, P1824, DOI 10.1001/jama.266.13.1824
   Larsson SC, 2012, BRIT J CANCER, V106, P603, DOI 10.1038/bjc.2011.585
   Ledoux TA, 2011, OBES REV, V12, pe143, DOI 10.1111/j.1467-789X.2010.00786.x
   Lee JE, 2009, CANCER EPIDEM BIOMAR, V18, P1730, DOI 10.1158/1055-9965.EPI-09-0045
   Li TY, 2009, J NUTR, V139, P1333, DOI 10.3945/jn.108.103622
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Little JP, 2009, APPL PHYSIOL NUTR ME, V34, P817, DOI 10.1139/H09-093
   Mallath MK, 2004, GASTROENTEROLOGY, V126, pA619
   Meyer KA, 2000, AM J CLIN NUTR, V71, P921
   Millward DJ, 2012, P NUTR SOC, V71, P566, DOI 10.1017/S0029665112000201
   Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805
   Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1
   Nettleton JA, 2008, J AM DIET ASSOC, V108, P1881, DOI 10.1016/j.jada.2008.08.015
   Nordmann AJ, 2011, AM J MED, V124, P841, DOI 10.1016/j.amjmed.2011.04.024
   Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102
   Phillips SM, 2012, MEAT SCI, V92, P174, DOI 10.1016/j.meatsci.2012.04.027
   Priebe MG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006061.pub2
   Ras RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016974
   Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x
   Robinson S, 2016, CLINICAL NUTRITION AND AGING: SARCOPENIA AND MUSCLE METABOLISM, P3, DOI 10.1155/2012/510801
   Rolls BJ, 2004, NUTR REV, V62, P1, DOI [10.1301/nr.2004.jan.1–17, 10.1301/nr.2004.jan.1-17, 10.1111/j.1753-4887.2004.tb00001.x]
   Ruhl CE, 2005, GASTROENTEROLOGY, V128, P24, DOI 10.1053/j.gastro.2004.09.075
   Scargle J. D., 2000, Journal of Scientific Exploration, V14, P91, DOI DOI 10.48550/ARXIV.PHYSICS/9909033
   Shen L, 2012, J ZHEJIANG UNIV-SC B, V13, P652, DOI 10.1631/jzus.B1201001
   Smith-Warner SA, 2003, INT J CANCER, V107, P1001, DOI 10.1002/ijc.11490
   Sofi F, 2007, NUTR METAB CARDIOVAS, V17, P209, DOI 10.1016/j.numecd.2006.07.013
   Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673
   Sohn W, 2006, J DENT RES, V85, P262, DOI 10.1177/154405910608500311
   SPRIET LL, 1992, AM J PHYSIOL, V262, pE891, DOI 10.1152/ajpendo.1992.262.6.E891
   STEINMETZ KA, 1991, CANCER CAUSE CONTROL, V2, P325, DOI 10.1007/BF00051672
   Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8
   Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109
   Svilaas A, 2004, J NUTR, V134, P562, DOI 10.1093/jn/134.3.562
   Urgert R, 2000, AM J CLIN NUTR, V72, P1107
   Venn BJ, 2004, EUR J CLIN NUTR, V58, P1443, DOI 10.1038/sj.ejcn.1601995
   von Schacky C, 2000, AM J CLIN NUTR, V71, p224S, DOI 10.1093/ajcn/71.1.224s
   Wang CJ, 2012, MED ONCOL, V29, P848, DOI 10.1007/s12032-011-9985-x
   Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363
   Wien M, 2011, AGRO FOOD IND HI TEC, V22, P36
   Wien M, 2010, J AM COLL NUTR, V29, P189, DOI 10.1080/07315724.2010.10719833
   Willcox DC, 2009, J AM COLL NUTR, V28, p500S, DOI 10.1080/07315724.2009.10718117
   Xun P, 2012, EUR J CLIN NUTR, V66, P1199, DOI 10.1038/ejcn.2012.133
   Zheng JS, 2012, PUBLIC HEALTH NUTR, V15, P725, DOI 10.1017/S1368980011002254
NR 85
TC 154
Z9 172
U1 3
U2 133
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0029-6643
EI 1753-4887
J9 NUTR REV
JI Nutr. Rev.
PD DEC
PY 2014
VL 72
IS 12
BP 741
EP 762
DI 10.1111/nure.12153
PG 22
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AX8PP
UT WOS:000347171400002
PM 25406801
OA Bronze
DA 2025-04-28
ER

PT J
AU Ho, KKHY
   Ferruzzi, MG
   Wightman, JD
AF Ho, Kacie K. H. Y.
   Ferruzzi, Mario G.
   Wightman, JoLynne D.
TI Potential health benefits of (poly)phenols derived from fruit and 100%
   fruit juice
SO NUTRITION REVIEWS
LA English
DT Review
DE cardiovascular; diabetes; exercise; fruit (poly)phenol; 100% juice;
   neurocognitive; obesity; performance
ID CONCORD GRAPE JUICE; CARDIOVASCULAR RISK-FACTORS; MAJOR FOOD SOURCES;
   PERIPHERAL ARTERIAL DYSFUNCTION; SUPPLEMENTATION IMPROVES MEMORY;
   C-REACTIVE PROTEIN; POMEGRANATE JUICE; BLOOD-PRESSURE; VASCULAR
   FUNCTION; DOUBLE-BLIND
AB (Poly)phenol-rich diets have been associated with reduced risk of various diseases. Coffee and tea are typically identified as dietary sources of chlorogenic acid and flavan-3-ols; however, 100% fruit juice greatly contributes to anthocyanin, flavonol, flavan-3-ols, and flavanone intake, making them complementary sources of dietary (poly)phenols. Thus, the aim of this narrative review was to provide an overview of fruit (poly)phenols and their potential health benefits. Fruit (poly)phenols have been associated with several health benefits (eg, reduced risk of cardiovascular disease and neurocognitive benefits). Although perspectives on 100% fruit juice consumption are controversial due to the perception of sugar content, growing evidence supports the role of fruit in whole and 100% juice forms to provide consumer benefits in alignment with dietary guidance. However, differences in (poly)phenol profiles and bioavailability likely exist between whole fruit and 100% fruit juice due to processing and the presence/absence of fiber. Ongoing studies are better defining similarities and differences between whole fruit and 100% fruit juice to elucidate protective mechanisms and align with processing and consumer products.
C1 [Ho, Kacie K. H. Y.] Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, 1955 East West Rd, Honolulu, HI 96822 USA.
   [Ferruzzi, Mario G.] North Carolina State Univ, Plants Human Hlth Inst, Dept Food Bioproc & Nutr Sci, Kannapolis, NC USA.
   [Wightman, JoLynne D.] Welch Foods Inc, Concord, MA USA.
C3 University of Hawaii System; University of Hawaii Manoa; North Carolina
   State University
RP Ho, KKHY (corresponding author), Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, 1955 East West Rd, Honolulu, HI 96822 USA.
EM kacieho@hawaii.edu
RI Ho, Kacie/AAN-6748-2020; Wightman, joLynne/AAR-9154-2020
OI Ho, Kacie/0000-0003-4391-2109
FU Welch Foods Inc.
FX This work was supported by an honorarium provided to K.K.H.Y.H by Welch
   Foods Inc. The funder approved the initial outline/concept of the
   manuscript, which was developed by M.G.F. and K.K.H.Y.H, and had the
   authority to approve the final manuscript prior to submission.
CR Alharbi MH, 2016, EUR J NUTR, V55, P2021, DOI 10.1007/s00394-015-1016-9
   Ammar A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080819
   Ammar A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160305
   [Anonymous], 2015, Phenol-Explorer Database. Version 3.6
   Aschoff JK, 2015, J AGR FOOD CHEM, V63, P578, DOI 10.1021/jf505297t
   Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2
   Auerbach BJ, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2454
   Banihani SA, 2014, NUTR RES, V34, P862, DOI 10.1016/j.nutres.2014.08.003
   Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52
   Barona J, 2012, J NUTR, V142, P1626, DOI 10.3945/jn.112.162743
   Basu A, 2011, NUTR RES, V31, P190, DOI 10.1016/j.nutres.2011.02.003
   Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701
   Bates RP, 2001, PRINCIPLES PRACTICES, P135
   Bell L, 2015, NUTRIENTS, V7, P10290, DOI 10.3390/nu7125538
   Bell PG, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070441
   Bell PG, 2015, APPL PHYSIOL NUTR ME, V40, DOI 10.1139/apnm-2014-0244
   Belleville J, 2002, NUTRITION, V18, P173, DOI 10.1016/S0899-9007(01)00721-3
   Bhagwat S., 2014, USDA DATABASE FLAVON
   Blair CK, 2014, PEDIATR BLOOD CANCER, V61, P2290, DOI 10.1002/pbc.25202
   Blumberg JB, 2015, NUTRIENTS, V7, P10032, DOI 10.3390/nu7125519
   Blumberg JB, 2013, ADV NUTR, V4, P618, DOI 10.3945/an.113.004473
   Boespflug EL, 2018, NUTR NEUROSCI, V21, P297, DOI 10.1080/1028415X.2017.1287833
   Bondonno CP, 2012, FREE RADICAL BIO MED, V52, P95, DOI 10.1016/j.freeradbiomed.2011.09.028
   Borges G, 2010, MOL NUTR FOOD RES, V54, pS268, DOI 10.1002/mnfr.200900611
   Bowtell JL, 2017, APPL PHYSIOL NUTR ME, V42, P773, DOI 10.1139/apnm-2016-0550
   Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
   Brown MA, 2019, EUR J SPORT SCI, V19, P95, DOI 10.1080/17461391.2018.1502360
   Byrd-Bredbenner C, 2017, J FOOD SCI, V82, P1523, DOI 10.1111/1750-3841.13754
   Canals R, 2005, J AGR FOOD CHEM, V53, P4019, DOI 10.1021/jf047872v
   Cassidy A, 2016, AM J CLIN NUTR, V104, P587, DOI 10.3945/ajcn.116.133132
   Cassidy A, 2015, AM J CLIN NUTR, V102, P172, DOI 10.3945/ajcn.115.108555
   Cerdá B, 2006, EUR J CLIN NUTR, V60, P245, DOI 10.1038/sj.ejcn.1602309
   Chai SC, 2018, FOOD FUNCT, V9, P3185, DOI [10.1039/C8FO00468D, 10.1039/c8fo00468d]
   Chen J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00007
   Chen TY, 2015, MOL NUTR FOOD RES, V59, P2432, DOI 10.1002/mnfr.201500224
   Chong MFF, 2010, BRIT J NUTR, V104, pS28, DOI 10.1017/S0007114510003922
   Chun OK, 2007, J NUTR, V137, P1244, DOI 10.1093/jn/137.5.1244
   Clemens R, 2015, ADV NUTR, V6, p236S, DOI 10.3945/an.114.007328
   Simao TNC, 2013, BRIT J NUTR, V110, P1885, DOI 10.1017/S0007114513001207
   Committee DGA HHS Prevention OoD Promotion H USDA Promotion CfNP, 2015, Dietary Guidelines for Americans 2015-2020
   Crowe-White K, 2015, CRIT REV FOOD SCI NU, V57, P152
   Dai Q, 2006, AM J MED, V119, P751, DOI 10.1016/j.amjmed.2006.03.045
   Dauthy M.E., 1995, FRUIT VEGETABLE PROC
   Davidson MH, 2009, AM J CARDIOL, V104, P936, DOI 10.1016/j.amjcard.2009.05.037
   De Curtis A, 2005, J THROMB HAEMOST, V3, P346, DOI 10.1111/j.1538-7836.2005.01126.x
   Del Bo C, 2017, FOOD FUNCT, V8, P4108, DOI 10.1039/c7fo00861a
   Del Bo C, 2014, FOOD FUNCT, V5, P3107, DOI 10.1039/c4fo00570h
   Del Bo' C, 2013, NUTR RES, V33, P220, DOI 10.1016/j.nutres.2012.12.009
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Dennison BA, 1997, PEDIATRICS, V99, P15
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dohadwala MM, 2011, AM J CLIN NUTR, V93, P934, DOI 10.3945/ajcn.110.004242
   Dohadwala MM, 2010, AM J CLIN NUTR, V92, P1052, DOI 10.3945/ajcn.2010.29905
   Dunham A, 2013, FOOD REV INT, V29, P409, DOI 10.1080/87559129.2013.818015
   El Gharras H, 2009, INT J FOOD SCI TECH, V44, P2512, DOI 10.1111/j.1365-2621.2009.02077.x
   Díaz-Rubio ME, 2015, PLANT FOOD HUM NUTR, V70, P9, DOI 10.1007/s11130-014-0455-4
   Ferruzzi MG, 2010, PHYSIOL BEHAV, V100, P33, DOI 10.1016/j.physbeh.2010.01.035
   Flammer AJ, 2013, EUR J NUTR, V52, P289, DOI 10.1007/s00394-012-0334-4
   Fukushima Y, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.19
   Fuster-Muñoz E, 2016, NUTRITION, V32, P539, DOI 10.1016/j.nut.2015.11.002
   Gil-Izquierdo A, 2002, J AGR FOOD CHEM, V50, P5107, DOI 10.1021/jf020162+
   González-Ortiz M, 2011, ANN NUTR METAB, V58, P220, DOI 10.1159/000330116
   Guo XH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050452
   Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365
   Harnly JM, 2006, J AGR FOOD CHEM, V54, P9966, DOI 10.1021/jf061478a
   Hashemi M, 2010, CARDIOL YOUNG, V20, P73, DOI 10.1017/S1047951109990850
   Haskell-Ramsay CF, 2017, EUR J NUTR, V56, P2621, DOI 10.1007/s00394-017-1454-7
   Haytowitz D, 2018, USDA DATABASE PROANT
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Hollands WJ, 2013, MOL NUTR FOOD RES, V57, P1209, DOI 10.1002/mnfr.201200663
   Howard L. R., 2007, BERRY FRUIT VALUE AD, V168, P73, DOI DOI 10.1201/9781420006148.CH3
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Hyson DA, 2015, ADV NUTR, V6, P37, DOI 10.3945/an.114.005728
   Iglesias Domingo J., 2007, Braz. J. Plant Physiol., V19, P333, DOI 10.1590/S1677-04202007000400006
   Iijima K, 2002, MECH AGEING DEV, V123, P1033, DOI 10.1016/S0047-6374(01)00386-4
   Ivanova V, 2010, J SERB CHEM SOC, V75, P45, DOI 10.2298/JSC1001045I
   Jackman SR, 2018, EXP GERONTOL, V110, P202, DOI 10.1016/j.exger.2018.06.007
   Jakobek L, 2015, FOOD CHEM, V175, P556, DOI 10.1016/j.foodchem.2014.12.013
   Jennings A, 2017, AM J CLIN NUTR, V105, P626, DOI 10.3945/ajcn.116.144394
   Johnson MC, 2015, J AGR FOOD CHEM, V63, P5653, DOI 10.1021/acs.jafc.5b01702
   Johnson SA, 2015, J ACAD NUTR DIET, V115, P369, DOI 10.1016/j.jand.2014.11.001
   Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1
   Kalaycioglu Z, 2017, FOOD CHEM, V221, P496, DOI 10.1016/j.foodchem.2016.10.084
   Kay CD, 2010, BRIT J NUTR, V104, pS91, DOI 10.1017/S000711451000396X
   Kean RJ, 2015, AM J CLIN NUTR, V101, P506, DOI 10.3945/ajcn.114.088518
   Keane KM, 2018, SCAND J MED SCI SPOR, V28, P1746, DOI 10.1111/sms.13088
   Keane KM, 2016, BRIT J NUTR, V116, P1935, DOI 10.1017/S0007114516004177
   Kennedy JA, 2002, AM J ENOL VITICULT, V53, P268
   Kerimi A, 2017, AM J CLIN NUTR, V106, P1384, DOI 10.3945/ajcn.117.161968
   Khalid S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020158
   Khoo HE, 2017, FOOD NUTR RES, V61, P1, DOI 10.1080/16546628.2017.1361779
   Kim K, 2016, EUR J NUTR, V55, P833, DOI 10.1007/s00394-015-0942-x
   Kokkou E, 2016, ATHEROSCLEROSIS, V251, P266, DOI 10.1016/j.atherosclerosis.2016.06.054
   Konishi Y, 2006, J AGR FOOD CHEM, V54, P7539, DOI 10.1021/jf061554+
   Kopp P, 1998, EUR J ENDOCRINOL, V138, P619, DOI 10.1530/eje.0.1380619
   Krikorian R, 2012, J AGR FOOD CHEM, V60, P5736, DOI 10.1021/jf300277g
   Krikorian R, 2010, J AGR FOOD CHEM, V58, P3996, DOI 10.1021/jf9029332
   Krikorian R, 2010, BRIT J NUTR, V103, P730, DOI 10.1017/S0007114509992364
   Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lai HTM, 2015, EUR J EPIDEMIOL, V30, P1035, DOI 10.1007/s10654-015-0050-5
   Lamport DJ, 2016, BRIT J NUTR, V116, P2160, DOI 10.1017/S000711451600430X
   Lamport DJ, 2016, AM J CLIN NUTR, V103, P775, DOI 10.3945/ajcn.115.114553
   Lamport DJ, 2014, NUTR REV, V72, P774, DOI 10.1111/nure.12149
   Lamport DJ., 2012, Nutr. Aging, V1, P5, DOI DOI 10.3233/NUA-2012-0002
   Lee J, 2017, EXP GERONTOL, V87, P121, DOI 10.1016/j.exger.2016.10.004
   Lefèvre-Arbogast S, 2018, NEUROLOGY, V90, pE1979, DOI [10.1212/wnl.0000000000005607, 10.1212/WNL.0000000000005607]
   Letenneur L, 2007, AM J EPIDEMIOL, V165, P1364, DOI 10.1093/aje/kwm036
   Levers K, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0133-z
   Levers K, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0102-y
   Lewandowska U, 2013, J AGR FOOD CHEM, V61, P12183, DOI 10.1021/jf404439b
   Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S
   Manach C, 2003, EUR J CLIN NUTR, V57, P235, DOI 10.1038/sj.ejcn.1601547
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   McAnulty LS, 2014, NUTR RES, V34, P577, DOI 10.1016/j.nutres.2014.07.002
   McCormick R, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0151-x
   McNamara RK, 2018, NEUROBIOL AGING, V64, P147, DOI 10.1016/j.neurobiolaging.2017.12.003
   Milbury PE, 2010, J AGR FOOD CHEM, V58, P3950, DOI 10.1021/jf903529m
   Miller MG, 2018, EUR J NUTR, V57, P1169, DOI 10.1007/s00394-017-1400-8
   Moazzen H, 2017, PLANT FOOD HUM NUTR, V72, P126, DOI 10.1007/s11130-017-0605-6
   Morand C, 2011, AM J CLIN NUTR, V93, P73, DOI 10.3945/ajcn.110.004945
   Morris MC, 2006, NEUROLOGY, V67, P1370, DOI 10.1212/01.wnl.0000240224.38978.d8
   Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940
   Moser S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070414
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Mullen W, 2007, J AGR FOOD CHEM, V55, P3148, DOI 10.1021/jf062970x
   Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001
   Murphy MM, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.63
   Mursu J, 2014, AM J CLIN NUTR, V99, P328, DOI 10.3945/ajcn.113.069641
   Myburgh KH, 2014, SPORTS MED, V44, P57, DOI 10.1007/s40279-014-0151-4
   Neilson AP, 2011, ANNU REV FOOD SCI T, V2, P125, DOI 10.1146/annurev-food-022510-133725
   Neto MM, 2017, J AM COLL NUTR, V36, P533, DOI 10.1080/07315724.2017.1331385
   Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024
   Nicklas TA, 2015, CURR NUTR FOOD SCI, V11, P267, DOI 10.2174/1573401311666150618192703
   Nicklas TA, 2015, INT J CHILD HEALTH N, V4, P112, DOI 10.6000/1929-4247.2015.04.02.7
   Nishizuka T, 2011, P JPN ACAD B-PHYS, V87, P104, DOI 10.2183/pjab.87.104
   Novotny JA, 2015, J NUTR, V145, P1185, DOI 10.3945/jn.114.203190
   O'Connor PJ, 2013, INT J SPORT NUTR EXE, V23, P57, DOI 10.1123/ijsnem.23.1.57
   O'Neil CE, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-107
   Ovaskainen ML, 2008, J NUTR, V138, P562
   Palafox-Carlos H, 2011, J FOOD SCI, V76, pR6, DOI 10.1111/j.1750-3841.2010.01957.x
   PELEG H, 1991, J SCI FOOD AGR, V57, P417, DOI 10.1002/jsfa.2740570312
   Peterson JJ, 2015, NUTR REV, V73, P553, DOI 10.1093/nutrit/nuv008
   Probst Y, 2018, FOOD CHEM, V238, P146, DOI 10.1016/j.foodchem.2016.11.010
   Quirós-Sauceda AE, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101082
   Rasines-Perea Z, 2017, MOLECULES, V22, DOI 10.3390/molecules22010068
   Redan BW, 2016, ADV NUTR, V7, P1090, DOI 10.3945/an.116.013029
   Rehm CD, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0620-z
   Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560
   Renard CMGC, 2017, TRENDS FOOD SCI TECH, V60, P43, DOI 10.1016/j.tifs.2016.10.022
   RENAUD S, 1993, ANN NY ACAD SCI, V686, P299, DOI 10.1111/j.1749-6632.1993.tb39191.x
   RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F
   Richelle M, 2001, J AGR FOOD CHEM, V49, P3438, DOI 10.1021/jf0101410
   Riso P, 2013, EUR J NUTR, V52, P949, DOI 10.1007/s00394-012-0402-9
   Rodriguez-Mateos A, 2016, MOL NUTR FOOD RES, V60, P2130, DOI 10.1002/mnfr.201600250
   Rodriguez-Mateos A, 2014, MOL NUTR FOOD RES, V58, P1952, DOI 10.1002/mnfr.201400231
   Rodriguez-Mateos A, 2013, AM J CLIN NUTR, V98, P1179, DOI 10.3945/ajcn.113.066639
   Roher AE, 2006, NEUROL RES, V28, P672, DOI 10.1179/016164106X130470
   Rosenkranz S, 2002, FASEB J, V16, P1958, DOI 10.1096/fj.02-0207fje
   Rothwell JA, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat070
   Rothwell JA, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas031
   Rozin P, 2003, PSYCHOL SCI, V14, P450, DOI 10.1111/1467-9280.02452
   Ruxton CHS, 2006, INT J FOOD SCI NUTR, V57, P249, DOI 10.1080/09637480600858134
   Sahebkar A, 2017, PHARMACOL RES, V115, P149, DOI 10.1016/j.phrs.2016.11.018
   Sahebkar A, 2016, PHYTOMEDICINE, V23, P1095, DOI 10.1016/j.phymed.2015.12.008
   Schaer MY, 2015, AM J CLIN NUTR, V101, P931, DOI 10.3945/ajcn.114.104364
   Schell J, 2017, FOOD FUNCT, V8, P3083, DOI [10.1039/c7fO00900c, 10.1039/c7fo00900c]
   Seeram NP, 2018, FOOD FUNCT, V9, P20, DOI 10.1039/c7fo90053h
   Shema-Didi L, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-18
   Siasos G, 2014, AM J HYPERTENS, V27, P38, DOI 10.1093/ajh/hpt176
   Skoog I, 2003, NEUROL RES, V25, P675, DOI 10.1179/016164103101201986
   Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154
   Sohrab G, 2017, INT J FOOD SCI NUTR, V68, P249, DOI 10.1080/09637486.2016.1229760
   Souquet JM, 1996, PHYTOCHEMISTRY, V43, P509, DOI 10.1016/0031-9422(96)00301-9
   Spencer JPE, 2008, BRIT J NUTR, V99, P12, DOI 10.1017/S0007114507798938
   Spencer JPE, 2010, BRIT J NUTR, V104, pS40, DOI 10.1017/S0007114510003934
   Spencer JPE, 2009, CHEM SOC REV, V38, P1152, DOI 10.1039/b800422f
   Stalmach A, 2011, J AGR FOOD CHEM, V59, P9512, DOI 10.1021/jf2015039
   Stote K S, 2017, BMC Nutr, V3, P45, DOI 10.1186/s40795-017-0164-0
   Swan GE, 1998, STROKE, V29, P2334, DOI 10.1161/01.STR.29.11.2334
   Talcott ST, 2002, J AGR FOOD CHEM, V50, P3186, DOI 10.1021/jf011500u
   Tiwari U, 2013, FOOD RES INT, V50, P497, DOI 10.1016/j.foodres.2011.09.007
   Törrönen R, 2010, BRIT J NUTR, V103, P1094, DOI 10.1017/S0007114509992868
   Toscano LT, 2015, APPL PHYSIOL NUTR ME, V40, P899, DOI 10.1139/apnm-2015-0152
   Tresserra-Rimbau A, 2016, J NUTR, V146, P767, DOI 10.3945/jn.115.223610
   Trombold JR, 2011, J STRENGTH COND RES, V25, P1782, DOI 10.1519/JSC.0b013e318220d992
   Tsang C, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.10
   Turfan Ö, 2011, FOOD CHEM, V129, P1644, DOI 10.1016/j.foodchem.2011.06.024
   Vidavalur Ramesh, 2006, Exp Clin Cardiol, V11, P217
   Vitale KC, 2017, CURR SPORT MED REP, V16, P230, DOI 10.1249/JSR.0000000000000385
   Wang J, 2013, MOL NUTR FOOD RES, V57, P1
   Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834
   Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894
   Whyte AR, 2017, FOOD FUNCT, V8, P4129, DOI [10.1039/c7fo00832e, 10.1039/C7FO00832E]
   Whyte AR, 2016, EUR J NUTR, V55, P2151, DOI 10.1007/s00394-015-1029-4
   Whyte AR, 2015, NUTRITION, V31, P531, DOI 10.1016/j.nut.2014.09.013
   Wightman JD, 2015, J SCI FOOD AGR, V95, P1584, DOI 10.1002/jsfa.6890
   Williams CM, 2008, FREE RADICAL BIO MED, V45, P295, DOI 10.1016/j.freeradbiomed.2008.04.008
   Williamson G, 2010, BRIT J NUTR, V104, pS48, DOI 10.1017/S0007114510003946
   Xi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093471
   Xu YP, 2011, J AGR FOOD CHEM, V59, P10586, DOI 10.1021/jf202438d
   Yassin GH, 2014, J MASS SPECTROM, V49, P1086, DOI 10.1002/jms.3406
NR 203
TC 53
Z9 55
U1 6
U2 82
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0029-6643
EI 1753-4887
J9 NUTR REV
JI Nutr. Rev.
PD FEB
PY 2020
VL 78
IS 2
BP 145
EP 174
DI 10.1093/nutrit/nuz041
PG 30
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA NN8YT
UT WOS:000569074300004
PM 31532485
OA Bronze
DA 2025-04-28
ER

PT J
AU Kim, H
   Lee, J
   Oh, JH
   Chang, HJ
   Sohn, DK
   Shin, A
   Kim, J
AF Kim, Hyejin
   Lee, Jeonghee
   Oh, Jae Hwan
   Chang, Hee Jin
   Sohn, Dae Kyung
   Shin, Aesun
   Kim, Jeongseon
TI Protective Effect of Green Tea Consumption on Colorectal Cancer Varies
   by Lifestyle Factors
SO NUTRIENTS
LA English
DT Article
DE cancer; colorectal cancer; case-control study; green tea; lifestyle
   factors
ID COLON-CANCER; PROSPECTIVE COHORT; RISK; COFFEE; CATECHINS; ALCOHOL;
   SMOKING; DIETARY; KOREA
AB The inconsistent findings regarding green tea intake and colorectal cancer (CRC) risk in several epidemiological studies might result from variations in lifestyle factors. Therefore, we examined whether increased green tea intake was associated with a decreased risk of CRC and how the risk of CRC was altered by the protective effect of green tea consumption and five health-related factors. A case-control study including 2742 participants (922 cases and 1820 controls) was conducted in Korea. Green tea consumption was assessed using a semiquantitative food frequency questionnaire. The risk of CRC was approximately 40% less in the participants in the highest green tea intake tertile than in participants in the lowest green tea intake tertile. Of the five lifestyle factors examined, high body mass index and physical inactivity were independent risk factors for CRC. Regarding the interactions between tea consumption and lifestyle factors, high green tea consumption was associated with a decreased risk of CRC, with or without considering lifestyle factors. However, moderate green tea consumption increased the risk of CRC among ever-smokers, ever-drinkers and the high-inflammatory diet group. Increased consumption of green tea might be helpful to reduce the risk of CRC in those with an unhealthy lifestyle.
C1 [Kim, Hyejin; Lee, Jeonghee; Kim, Jeongseon] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, 323 Ilsan Ro, Goyang Si 10408, Gyeonggi Do, South Korea.
   [Oh, Jae Hwan; Chang, Hee Jin; Sohn, Dae Kyung] Natl Canc Ctr, Ctr Colorectal Canc, Natl Canc Ctr Hosp, 323 Ilsan Ro, Goyang Si 10408, Gyeonggi Do, South Korea.
   [Shin, Aesun] Seoul Natl Univ, Dept Prevent Med, Coll Med, 103 Deahak Ro, Seoul 03080, South Korea.
C3 National Cancer Center - Korea (NCC); National Cancer Center - Korea
   (NCC); Seoul National University (SNU)
RP Kim, J (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, 323 Ilsan Ro, Goyang Si 10408, Gyeonggi Do, South Korea.
EM heajene@gmail.com; jeonghee@ncc.re.kr; jayoh@ncc.re.kr;
   heejincmd@ncc.re.kr; gsgsbal@ncc.re.kr; shinaesun@snu.ac.kr;
   jskim@ncc.re.kr
RI KIM, JEONGSEON/AAA-4643-2022; Shin, Aesun/E-9145-2014
OI Shin, Aesun/0000-0002-6426-1969; KIM, JEONGSEON/0000-0002-0889-2686
FU National Cancer Center Korea [1710882, 1910330]
FX This study was supported by grants from National Cancer Center Korea
   (NO: 1710882 and 1910330).
CR Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   Bray Freddie, 2018, CA Cancer J Clin, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
   Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145
   Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0
   Chen F, 2017, EUR J CLIN NUTR, V71, P481, DOI 10.1038/ejcn.2016.208
   Chen Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060572
   Chen YT, 2017, ONCOTARGET, V8, P37367, DOI 10.18632/oncotarget.16959
   Cho YA, 2019, CANCER RES TREAT, V51, P1033, DOI 10.4143/crt.2018.447
   Cho YA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060724
   Cho YA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080469
   Crous-Bou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080158
   Driver JA, 2007, AM J MED, V120, P257, DOI 10.1016/j.amjmed.2006.05.055
   Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653
   Green CJ, 2014, J EPIDEMIOL, V24, P146, DOI 10.2188/jea.JE20130063
   Gunathilake Madhawa Neranjan, 2018, Oncotarget, V9, P7590, DOI 10.18632/oncotarget.24136
   Hao XP, 2017, NUTR CANCER, V69, P623, DOI 10.1080/01635581.2017.1295088
   Hu Y, 2016, BRIT J NUTR, V116, P1901, DOI 10.1017/S0007114516003937
   Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343
   Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635
   Jemal Ahmedin, 2011, CA Cancer J Clin, V61, P69, DOI 10.3322/caac.20107
   Ji BT, 1997, INT J CANCER, V70, P255, DOI 10.1002/(SICI)1097-0215(19970127)70:3<255::AID-IJC1>3.0.CO;2-W
   Jung KW, 2018, CANCER RES TREAT, V50, P303, DOI 10.4143/crt.2018.143
   Lee HS, 2012, ASIA PAC J CLIN NUTR, V21, P618
   Lettieri-Barbato D, 2013, BRIT J NUTR, V109, P1544, DOI 10.1017/S0007114513000263
   Liang PS, 2009, INT J CANCER, V124, P2406, DOI 10.1002/ijc.24191
   Morris J, 2016, ONCOTARGET, V7, P35313, DOI 10.18632/oncotarget.9204
   Nechuta S, 2012, AM J CLIN NUTR, V96, P1056, DOI 10.3945/ajcn.111.031419
   Peluso I, 2017, BRIT J PHARMACOL, V174, P1195, DOI 10.1111/bph.13649
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Serafini M, 2006, NUTR CANCER, V56, P232, DOI 10.1207/s15327914nc5602_15
   Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294
   Shin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088079
   Shin A, 2012, CANCER RES TREAT, V44, P219, DOI 10.4143/crt.2012.44.4.219
   Shin Hai-Rim, 2007, Cancer Res Treat, V39, P139, DOI 10.4143/crt.2007.39.4.139
   Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115
   Sinha R, 2012, AM J CLIN NUTR, V96, P374, DOI 10.3945/ajcn.111.031328
   Song N, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3886-0
   Toden S, 2016, ONCOTARGET, V7, P16158, DOI 10.18632/oncotarget.7567
   van den Brandt PA, 2018, EUR J EPIDEMIOL, V33, P183, DOI 10.1007/s10654-018-0359-y
   Ward RE, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600720
   Wei EK, 2009, AM J EPIDEMIOL, V170, P863, DOI 10.1093/aje/kwp210
   Yang G, 2007, CANCER EPIDEM BIOMAR, V16, P1219, DOI 10.1158/1055-9965.EPI-07-0097
   Youssef O, 2018, DIGEST DIS SCI, V63, P2950, DOI 10.1007/s10620-018-5190-5
   Yuan XJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800178
   Zhang XH, 2010, JNCI-J NATL CANCER I, V102, P771, DOI 10.1093/jnci/djq107
NR 46
TC 13
Z9 14
U1 1
U2 22
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2019
VL 11
IS 11
AR 2612
DI 10.3390/nu11112612
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA JV3OC
UT WOS:000502274600063
PM 31683767
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Khalili-Moghadam, S
   Hedayati, M
   Golzarand, M
   Mirmiran, P
AF Khalili-Moghadam, Sajad
   Hedayati, Mehdi
   Golzarand, Mahdieh
   Mirmiran, Parvin
TI Effects of green coffee aqueous extract supplementation on glycemic
   indices, lipid profile, CRP, and malondialdehyde in patients with type 2
   diabetes: a randomized, double-blind, placebo-controlled trial
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE type 2 diabetes; Hs-CRP; Malondialdehyde; Insulin; lipid profile; green
   coffee
ID INSULIN-RESISTANCE; METABOLIC SYNDROME; MODEL ASSESSMENT; GLUCOSE;
   METAANALYSIS; FAT; DIETARY
AB Background/objectivesStudies have reported the health benefits of green coffee extract (GCE) in experimental models. In the current study, we aimed to determine whether supplementation with GCE improves glycemic indices, inflammation, and oxidative stress in patients with type 2 diabetes (T2D).Methods and study designThis randomized, double-blind, placebo-controlled trial included 44 patients (26 male and 18 female) with T2D and overweight/obesity. After blocked randomization, patients received either capsules containing 400 mg GCE twice per day (n = 22) or a placebo (n = 22) and were followed for 10 weeks. In this study, glycemic indices, lipid profiles, anthropometric examinations, blood pressure, high-sensitivity C-reactive protein (hs-CRP), and malondialdehyde (MDA) were measured twice; at baseline and at the end of the study.ResultsAfter 10 weeks of supplementation, GCE supplementation significantly reduced body weight (p = 0.04) and body mass index (BMI) (p = 0.03) compared to the placebo. The intention-to-treat (ITT) analysis indicated patients in the GCE group had a lower fasting blood glucose (FBG) concentration compared to the placebo group; however, this decreasing was marginally significant (8.48 +/- 8.41 vs. 1.70 +/- 5.82 mg/dL, p = 0.05). There was no significant difference in insulin levels and HOMA-IR between the groups. At the end of the study, significant changes in systolic blood pressure (SBP) (p = 0.01), triglyceride (TG) level (p = 0.02), high-density lipoprotein (HDL) (p = 0.001), and TG-to-HDL ratio (p = 0.001) were found between the intervention and placebo groups. Our trial indicated GCE supplementation had no effect on diastolic blood pressure (DBP), low-density lipoprotein (LDL), or total cholesterol. During the supplementation period, the hs-CRP level significantly decreased in the GCE group compared to the placebo group (p = 0.02). No significant changes were observed in the MDA level between the two groups at the end of the study (p = 0.54).ConclusionOur findings showed beneficial effects of GCE on SBP, TG, hs-CRP, and HDL levels in patients with T2D and overweight/obesity over a 10-week period of supplementation.Clinical trial registration:https://en.irct.ir/trial/48549, identifier [IRCT20090203001640N18].ConclusionOur findings showed beneficial effects of GCE on SBP, TG, hs-CRP, and HDL levels in patients with T2D and overweight/obesity over a 10-week period of supplementation.Clinical trial registration:https://en.irct.ir/trial/48549, identifier [IRCT20090203001640N18].
C1 [Khalili-Moghadam, Sajad; Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran.
   [Hedayati, Mehdi] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Cellular & Mol Endocrine Res Ctr, Tehran, Iran.
   [Golzarand, Mahdieh; Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Nutr & Endocrine Res Ctr, Tehran, Iran.
C3 Shahid Beheshti University Medical Sciences; Shahid Beheshti University
   Medical Sciences; Shahid Beheshti University Medical Sciences
RP Mirmiran, P (corresponding author), Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran.; Golzarand, M; Mirmiran, P (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Nutr & Endocrine Res Ctr, Tehran, Iran.
EM mahdieh_golzarand@yahoo.com; mirmiran@endocrine.ac.ir
RI Mirmiran, Parvin/V-1433-2019; Hedayati, Mehdi/AAG-3006-2019
OI khalili moghadam, sajad/0000-0002-3722-5153
FU National Nutrition and Food Technology Research Institute, Shahid
   Beheshti University of Medical Sciences; National Nutrition and Food
   Technology Research Institute, Shahid Beheshti University of Medical
   Sciences, Tehran, Iran; Research Institute for Endocrine Science, Shahid
   Beheshti University of Medical Sciences
FX The authors gratefully wish to thank the National Nutrition and Food
   Technology Research Institute, Shahid Beheshti University of Medical
   Sciences, Tehran, Iran, for their study funding and financial support.
   We thank the laboratory section of the Research Institute for Endocrine
   Science, Shahid Beheshti University of Medical Sciences. We also thank
   all the patients who participated in the study.
CR Alhamhany N.N., 2018, J Pharm Sci Res, V10, P627
   Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI [10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc10-S011, 10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc12-s011, 10.2337/dc13-S067, 10.2337/dc11-S062, 10.2337/dc14-S081]
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Asbaghi O, 2021, COMPLEMENT THER CLIN, V43, DOI 10.1016/j.ctcp.2021.101349
   Asbaghi O, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00587-z
   Asbaghi O, 2020, COMPLEMENT THER MED, V51, DOI 10.1016/j.ctim.2020.102424
   Bahmannia M, 2022, FOOD FUNCT, V13, P10347, DOI [10.1039/D2FO00983H, 10.1039/d2fo00983h]
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Cordova C. M., 2004, ARQUIVOS BRASILEIROS, V83, P476, DOI [DOI 10.1590/S0066-782X2004001800006, 10.1590/S0066-782X2004001800006]
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Derosa G, 2014, ARCH MED SCI, V10, P336, DOI 10.5114/aoms.2014.42587
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Hosseinabadi S, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2019.102290
   Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441
   Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6
   Le YJ, 2022, FEMS MICROBIOL LETT, V369, DOI 10.1093/femsle/fnac061
   Lee YC, 2022, LAB ANIM RES, V38, DOI 10.1186/s42826-022-00148-x
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI [10.1039/C4FO00290C, 10.1039/c4fo00290c]
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Morvaridi M, 2020, J DIABETES METAB DIS, V19, P645, DOI 10.1007/s40200-020-00536-x
   Nikpayam O, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0489-8
   Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Shahmohammadi HA, 2017, HEPAT MON, V17, DOI 10.5812/hepatmon.45609
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1258-y
   Suzuki A, 2019, INT J FOOD SCI NUTR, V70, P901, DOI 10.1080/09637486.2019.1585763
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Yan YW, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.1042044
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 37
TC 5
Z9 5
U1 1
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD NOV 16
PY 2023
VL 10
AR 1241844
DI 10.3389/fnut.2023.1241844
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA Z2PJ1
UT WOS:001110544700001
PM 38035358
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Kim, HJ
   Cho, S
   Jacobs, DR
   Park, K
AF Kim, Hyo-Jin
   Cho, Seongbeom
   Jacobs, David R., Jr.
   Park, Kyong
TI Instant coffee consumption may be associated with higher risk of
   metabolic syndrome in Korean adults
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Instant coffee; Metabolic syndrome; Korean adults
ID TYPE-2 DIABETES-MELLITUS; TEA CONSUMPTION; HABITUAL COFFEE;
   BLOOD-PRESSURE; AMSTERDAM GROWTH; GREEN TEA; PREVALENCE; HEALTH; MEN
AB Aims: Cumulative evidence suggests that coffee consumption may have beneficial effects on metabolic diseases; however, few previous studies have considered the types of coffee consumed and the additives used. We investigated the relationship between coffee consumption and metabolic syndrome (MetSyn) and its components.
   Methods: We analyzed 17,953 Korean adults, aged 19-65 years, using cross-sectional data from the Korean National Health and Nutrition Examination Survey (KNHANES, 2007-2011). Coffee consumption level, types of coffee consumed, and the additives used were assessed based on a food frequency questionnaire and 24-h recall. Demographic and lifestyle factors were assessed using self-administered questionnaires. Data on metabolic biomarkers were obtained from a health examination. Multivariable logistic regression was used to determine the odds ratios of prevalent metabolic syndrome and its components according to frequency and type of coffee consumption.
   Results: We found that 76% of the subjects were habitual coffee drinkers, most of whom consumed instant coffee mix containing sugar and powder creamer. After multivariable adjustment, the odds ratios (95% CI) comparing those who consumed coffee >= 3 times/day with those who consumed coffee <1 time/week were 1.37 (1.15-1.63) for obesity, 1.33 (1.11-1.59) for abdominal obesity, 1.28 (1.09-1.51) for hypo-HDL cholesterolemia, and 1.37 (1.10-1.72) for metabolic syndrome. Instant-coffee drinkers were observed to have elevated risks of these metabolic conditions.
   Conclusions: Consumption of coffee, particularly instant coffee mix, may have harmful effects on MetSyn, perhaps partly deriving from excessive intake of sugar and powder creamer. (C) 2014 Elsevier Ireland Ltd. All rights reserved.D
C1 [Kim, Hyo-Jin; Park, Kyong] Yeungnam Univ, Dept Food & Nutr, Gyongsan 712749, Gyeongbuk, South Korea.
   [Cho, Seongbeom] Seoul Natl Univ, Coll Vet Med, Seoul, South Korea.
   [Cho, Seongbeom] Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea.
   [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA.
C3 Yeungnam University; Seoul National University (SNU); Seoul National
   University (SNU); University of Minnesota System; University of
   Minnesota Twin Cities
RP Park, K (corresponding author), Yeungnam Univ, Dept Food & Nutr, 280 Daehak Ro, Gyongsan 712749, Gyeongbuk, South Korea.
EM kypark@ynu.ac.kr
RI Jacobs, David/G-5405-2011; Park, Kyong/AFJ-9812-2022
OI Park, Kyong/0000-0002-4681-1584; Jacobs, David/0000-0002-7232-0543
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education, Science and Technology
   [NRF-2012R1A1A1009214]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science and Technology (NRF-2012R1A1A1009214).
CR AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Cheung BMY, 2005, J CARDIOVASC PHARM, V46, P125, DOI 10.1097/01.fjc.0000171752.43564.35
   Choi Mi-Kyeong, 2007, [The Korean Journal of Food and Nutrition, 한국식품영양학회지], V20, P460
   Choi Soyeong, 2010, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V39, P1279
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Frost G, 1999, LANCET, V353, P1045, DOI 10.1016/S0140-6736(98)07164-5
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   International Coffee Organization, 2012, MONTHL COFF MARK REP
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   이봄이, 2012, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V41, P362
   Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109
   Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2011, KOR HLTH STAT 2010 K
   Nicholls SJ, 2006, J AM COLL CARDIOL, V48, P715, DOI 10.1016/j.jacc.2006.04.080
   Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   SALVAGGIO A, 1990, J HYPERTENS, V8, P585, DOI 10.1097/00004872-199006000-00013
   Schaefer B, 2004, ANN INTERN MED, V141, P321, DOI 10.7326/0003-4819-141-4-200408170-00016
   Shin MH, 1994, KOREAN J PREV MED, V27, P200
   Steffen M, 2012, J HYPERTENS, V30, P2245, DOI 10.1097/HJH.0b013e3283588d73
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   United States Department of Agriculture Foreign Agricultural Service, 2011, GLOB AGR INF NETW RE
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120
   van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3
   Wakabayashi K, 1998, EUR J EPIDEMIOL, V14, P669, DOI 10.1023/A:1007478522638
   WHO/IASO/IOTF, 2000, AS PAC PERSP RED OB
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
NR 39
TC 62
Z9 65
U1 1
U2 22
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD OCT
PY 2014
VL 106
IS 1
BP 145
EP 153
DI 10.1016/j.diabres.2014.07.007
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA AP9DE
UT WOS:000342377800022
PM 25112922
DA 2025-04-28
ER

PT J
AU Lu, MY
   Cheng, HY
   Lai, JCY
   Chen, SJ
AF Lu, Meng-Ying
   Cheng, Hsiao-Yang
   Lai, Jerry Cheng-Yen
   Chen, Shaw-Ji
TI The Relationship between Habitual Coffee Drinking and the Prevalence of
   Metabolic Syndrome in Taiwanese Adults: Evidence from the Taiwan Biobank
   Database
SO NUTRIENTS
LA English
DT Article
DE coffee; black coffee; gender; metabolic syndrome; Taiwan Biobank
ID GREEN TEA CONSUMPTION; RISK; ASSOCIATION; HEALTH; HYPERTENSION; OBESITY
AB Previous studies revealed inconsistent results between coffee drinking and metabolic syndrome (MetS). The aim of the study was to evaluate the relationship between habitual coffee drinking and the prevalence of MetS among men and women. We conducted a nationwide, cross-sectional study using 23,073 adults obtained from the Taiwan Biobank database (mean +/- SD (range) age, 54.57 +/- 0.07 (30-79) years; 8341 men and 14,731 (63.8%) women). Adults who drank more than one cup of coffee per day (n = 5118) and those who drank less than one cup per day (n = 4515) were compared with nondrinkers (n = 13,439). Multivariate logistic regression models were used to evaluate the risk of MetS between the two groups. Separate models were also estimated for sex-stratified and habitual coffee-type-stratified (black coffee (BC), coffee with creamer (CC), and coffee with milk (CM)) subgroup analyses. The MetS diagnosis was based on at least three of the five metabolic abnormalities. Coffee drinkers (>= 1 cup/day) had a significantly lower prevalence of MetS than nondrinkers (AOR (95% CI): 0.80 (0.73-0.87)). Women who drank any amount of coffee and any type of coffee were more likely to have a significantly lower prevalence of MetS than nondrinkers. Only men who drank more than one cup of coffee per day or black coffee drinkers were more likely to have a lower prevalence of MetS. Our study results indicate that adults with habitual coffee drinking behaviors of more than one cup per day were associated with a lower prevalence of MetS. Moreover, women could benefit from habitual coffee drinking of all three coffee types, whereas men could only benefit from drinking BC.
C1 [Lu, Meng-Ying; Cheng, Hsiao-Yang] Taitung MacKay Mem Hosp, Div Cardiol, Dept Internal Med, Taitung 95054, Taiwan.
   [Lu, Meng-Ying; Cheng, Hsiao-Yang; Chen, Shaw-Ji] MacKay Med Coll, Dept Med, New Taipei 25245, Taiwan.
   [Lu, Meng-Ying; Lai, Jerry Cheng-Yen; Chen, Shaw-Ji] Natl Taitung Univ, Coll Sci & Engn, Master Program Biomed, Taitung 95092, Taiwan.
   [Lai, Jerry Cheng-Yen] Taitung MacKay Mem Hosp, Dept Med Res, Taitung 95054, Taiwan.
   [Chen, Shaw-Ji] Taitung MacKay Mem Hosp, Dept Psychiat, Taitung 95054, Taiwan.
C3 Mackay Memorial Hospital; Mackay Medical College; Mackay Memorial
   Hospital; Mackay Memorial Hospital
RP Chen, SJ (corresponding author), MacKay Med Coll, Dept Med, New Taipei 25245, Taiwan.; Chen, SJ (corresponding author), Natl Taitung Univ, Coll Sci & Engn, Master Program Biomed, Taitung 95092, Taiwan.; Chen, SJ (corresponding author), Taitung MacKay Mem Hosp, Dept Psychiat, Taitung 95054, Taiwan.
EM davielu.tw@yahoo.com.com; sheephome520@yahoo.com.tw;
   chengyen@hotmail.com; shawjichen@gmail.com
OI Lai, Jerry Cheng-Yen/0000-0001-8280-144X; Chen,
   Shaw-Ji/0000-0002-1732-025X
FU Taitung MacKay Memorial Hospital, Taitung, Taiwan [TTMMH-107-07]
FX This study was supported by grant TTMMH-107-07 from Taitung MacKay
   Memorial Hospital, Taitung, Taiwan.
CR Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Chang CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038874
   Chaput JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072832
   Chen CH, 2016, HUM MOL GENET, V25, P5321, DOI 10.1093/hmg/ddw346
   Del Giorno R, 2022, INT J FOOD SCI NUTR, V73, P106, DOI 10.1080/09637486.2021.1926935
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Fan CT, 2015, J LAW MED ETHICS, V43, P816, DOI 10.1111/jlme.12322
   Gómez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985
   Grosso G, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080890
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Health Promotion Administration Ministry of Health and Welfare, 2018, TAIW OB PREV MAN STR, P55
   Heng D, 2006, ATHEROSCLEROSIS, V186, P367, DOI 10.1016/j.atherosclerosis.2005.07.020
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hsu TW, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051102
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim Jeong-Hyeon, 2018, Asia Pac J Clin Nutr, V27, P1131, DOI 10.6133/apjcn.022018.04
   Kim K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167007
   Kim SA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122992
   Kim Y, 2018, BRIT J NUTR, V120, P1279, DOI [10.1017/S0007114518002635, 10.1017/s0007114518002635]
   Konstantinidi Melina, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6030094
   Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P358, DOI 10.1080/09637486.2017.1362690
   Nerurkar PV, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041348
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Pan WenHarn Pan WenHarn, 1999, Nutritional Sciences Journal, V24, P11
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   Shin H, 2017, KOREAN J FAM MED, V38, P346, DOI 10.4082/kjfm.2017.38.6.346
   Shin S, 2019, APPL PHYSIOL NUTR ME, V44, P1371, DOI 10.1139/apnm-2018-0880
   Spiller M A, 1984, Prog Clin Biol Res, V158, P91
   Suliga E, 2017, INT J FOOD SCI NUTR, V68, P507, DOI 10.1080/09637486.2016.1256381
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Tantoh DM, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0647-8
   Wan CJ, 2010, J DIABETES INVEST, V1, P259, DOI 10.1111/j.2040-1124.2010.00055.x
   Xie C, 2018, J HUM HYPERTENS, V32, P83, DOI 10.1038/s41371-017-0007-0
   Yeh CJ, 2011, ASIA PAC J CLIN NUTR, V20, P292
   Yonekura Y, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051370
NR 41
TC 8
Z9 8
U1 3
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD MAY
PY 2022
VL 14
IS 9
AR 1867
DI 10.3390/nu14091867
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 1G8KH
UT WOS:000796098400001
PM 35565834
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Amarowicz, R
   Pegg, RB
AF Amarowicz, Ryszard
   Pegg, Ronald B.
TI The Potential Protective Effects of Phenolic Compounds against
   Low-density Lipoprotein Oxidation
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE LDL oxidation; phenolics; antioxidant activity; atherosclerosis; in
   vitro studies; in vivo studies
ID BIOLOGICAL MODEL SYSTEMS; LDL CHOLESTEROL OXIDATION; INSOLUBLE-BOUND
   PHENOLICS; SYSTOLIC BLOOD-PRESSURE; REFINED OLIVE OIL; E-DEFICIENT MICE;
   VITRO HUMAN LDL; IN-VITRO; ANTIOXIDANT ACTIVITY; LIPID-PEROXIDATION
AB Background: The exact mechanism(s) of atherosclerosis in humans remains elusive, but one theory hypothesizes that this deleterious process results from the oxidative modification of low-density lipoprotein (LDL). Research suggests that foods rich in dietary phenolic compounds with antioxidant activity can mitigate the extent of LDL oxidation in vivo. With regard to the different classes of flavonoids, there appears to be a structurefunction relationship between the various moieties/ constituents attached to the flavonoids' three ring system and their impact at retarding LDL oxidation.
   Methods: This article summarizes the findings to date of both in vitro and in vivo studies using foods or phenolic extracts isolated from foodstuffs at inhibiting the incidence of LDL oxidation. Three bases: SCOPUS, Web Science, and PubMed were used for search.
   Results: An often used method for the determination of antioxidant properties of natural phenolic compounds is the LDL oxidation assay. LDLs are isolated from human plasma and their oxidation is induced by Cu2+ ions or 2,2'-azobis(2-methylpropionamidine) dihydrochloride (AAPH). The sample is incubated with a phenolic extract or individual/ isolated phenolic compounds. LDL oxidation is then monitored by various chemical methods (e.g., measurement of the generation of conjugated dienes and trienes). This technique confirmed the antioxidant properties of several extracts as obtained from plant material (e.g., grapes, berries, orange, grapefruit, coffee, tea, chocolate, olives, nuts) as well as the individual phenolic compounds (e.g., luteolinidin, apigenidin, caffeic acid, chlorogenic acid, catechin, quercetin, rutin). Several studies in vivo confirmed protective effects of phenolic compounds against LDL oxidation. They covered the healthy subjects with hyperlipidaemia, overweight, obesity, metabolic syndrome, heavy smokers, patients receiving haemodialysis, patients with peripheral vascular disease, and subjects at high cardiovascular risk. The studies comprise individuals of all ages, and the number of participants in the different experiments varied widely.
   Conclusion: Properly designed double-blind, placebo-controlled randomised clinical trials offer stronger evidence as to the impact of dietary phenolics consumption at retarding LDL oxidation. More such clinical trials are needed to strengthen the hypothesis that foods rich in dietary phenolic compounds with antioxidant activity can mitigate the extent of LDL oxidation in vivo.
C1 [Amarowicz, Ryszard] Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima St 10, PL-10747 Olsztyn, Poland.
   [Pegg, Ronald B.] Univ Georgia, Dept Food Sci & Technol, 100 Cedar St, Athens, GA 30602 USA.
C3 Polish Academy of Sciences; Institute of Animal Reproduction & Food
   Research of the Polish Academy of Sciences; University System of
   Georgia; University of Georgia
RP Amarowicz, R (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima St 10, PL-10747 Olsztyn, Poland.
EM amaro@pan.olsztyn.pl
RI AMAROWICZ, Ryszard/H-7154-2017
OI AMAROWICZ, Ryszard/0000-0001-9731-0045; Pegg, Ronald/0000-0001-7646-6518
CR Ahuja KDK, 2006, BRIT J NUTR, V96, P239, DOI 10.1079/BJN20061788
   Albishi T, 2013, J FUNCT FOODS, V5, P930, DOI 10.1016/j.jff.2013.02.005
   Alvarez-Parrilla E, 2012, FOOD CHEM, V133, P827, DOI 10.1016/j.foodchem.2012.01.100
   Ambigaipalan P, 2016, J AGR FOOD CHEM, V64, P6584, DOI 10.1021/acs.jafc.6b02950
   [Anonymous], HYPERCHOLESTEROLEMIA
   Apea-Bah FB, 2016, FOOD CHEM, V197, P307, DOI 10.1016/j.foodchem.2015.10.121
   Astadi IR, 2009, FOOD CHEM, V112, P659, DOI 10.1016/j.foodchem.2008.06.034
   Ayoub M, 2016, FOOD CHEM, V197, P221, DOI 10.1016/j.foodchem.2015.10.107
   Baba S, 2007, AM J CLIN NUTR, V85, P709, DOI 10.1093/ajcn/85.3.709
   Bacchetti T, 2014, J FUNCT FOODS, V8, P128, DOI 10.1016/j.jff.2014.02.020
   Belinky PA, 1998, FREE RADICAL BIO MED, V24, P1419, DOI 10.1016/S0891-5849(98)00006-9
   Borochov-Neori H, 2015, J AGR FOOD CHEM, V63, P3189, DOI 10.1021/jf506094r
   Brown JE, 1998, FREE RADICAL RES, V29, P247, DOI 10.1080/10715769800300281
   Carbonneau MA, 2014, FOOD CHEM, V145, P701, DOI 10.1016/j.foodchem.2013.07.025
   Castañer O, 2011, CLIN NUTR, V30, P490, DOI 10.1016/j.clnu.2011.01.013
   Castilla P, 2006, AM J CLIN NUTR, V84, P252, DOI 10.1093/ajcn/84.1.252
   Chandrasekara A, 2012, J AM OIL CHEM SOC, V89, P275, DOI 10.1007/s11746-011-1918-5
   Chandrasekara A, 2011, J AGR FOOD CHEM, V59, P9563, DOI 10.1021/jf201849d
   Chandrasekara N, 2011, FOOD CHEM, V129, P1388, DOI 10.1016/j.foodchem.2011.05.075
   Chang WH, 2009, INT J FOOD SCI NUTR, V60, P709, DOI 10.3109/09637480802063517
   Chen JH, 2013, FOOD CHEM, V141, P397, DOI 10.1016/j.foodchem.2013.03.026
   Chen TP, 2012, FOOD CHEM, V134, P1030, DOI 10.1016/j.foodchem.2012.03.009
   Chen YC, 2011, J FOOD SCI, V76, pC724, DOI 10.1111/j.1750-3841.2011.02164.x
   Chien YL, 2011, FOOD CHEM, V126, P1586, DOI 10.1016/j.foodchem.2010.12.024
   Dairi S, 2014, J FOOD SCI, V79, pC1260, DOI 10.1111/1750-3841.12517
   Damasceno NRT, 2011, NUTR METAB CARDIOVAS, V21, pS14, DOI 10.1016/j.numecd.2010.12.006
   Damiani E, 2014, J FOOD COMPOS ANAL, V33, P59, DOI 10.1016/j.jfca.2013.09.010
   de Camargo AC, 2015, J FUNCT FOODS, V12, P129, DOI 10.1016/j.jff.2014.10.034
   de la Torre-Carbot K, 2010, J NUTR, V140, P501, DOI 10.3945/jn.109.112912
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955
   Fitó M, 2000, LIPIDS, V35, P633, DOI 10.1007/s11745-000-0567-1
   Fitó M, 2007, ARCH INTERN MED, V167, P1195, DOI 10.1001/archinte.167.11.1195
   FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V
   Froehlicher T, 2009, FOOD CHEM, V115, P897, DOI 10.1016/j.foodchem.2009.01.004
   FROSTEGARD J, 1991, ATHEROSCLEROSIS, V90, P119, DOI 10.1016/0021-9150(91)90106-D
   Fuhrman B, 2002, NUTRITION, V18, P268, DOI 10.1016/S0899-9007(01)00753-5
   Fuhrman B, 1997, AM J CLIN NUTR, V66, P267, DOI 10.1093/ajcn/66.2.267
   Fuhrman B, 2005, J NUTR, V135, P722, DOI 10.1093/jn/135.4.722
   Gallegos-Infante JA, 2010, FOOD CHEM, V119, P903, DOI 10.1016/j.foodchem.2009.07.044
   George TW, 2013, BRIT J NUTR, V109, P1442, DOI 10.1017/S0007114512003315
   Gunathilake KDPP, 2014, J MED FOOD, V17, P424, DOI 10.1089/jmf.2013.0035
   Hachibamba T, 2013, INT J FOOD SCI TECH, V48, P2638, DOI 10.1111/ijfs.12260
   Hsieh CC, 2001, CARDIOVASC RES, V49, P135, DOI 10.1016/S0008-6363(00)00218-2
   ITABE H, 1994, J BIOL CHEM, V269, P15274
   Ivanov V, 2001, J AGR FOOD CHEM, V49, P4442, DOI 10.1021/jf010117m
   Jenkins DJA, 2008, METABOLISM, V57, P1636, DOI 10.1016/j.metabol.2008.07.018
   Ji KT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/175291
   Kamiya K, 2010, FITOTERAPIA, V81, P185, DOI 10.1016/j.fitote.2009.08.021
   Katsoura MH, 2009, NEW BIOTECHNOL, V26, P83, DOI 10.1016/j.nbt.2009.02.004
   Keller J, 2015, J PHYSIOL BIOCHEM, V71, P577, DOI 10.1007/s13105-015-0408-x
   Khan N, 2012, NUTR METAB CARDIOVAS, V22, P1046, DOI 10.1016/j.numecd.2011.02.001
   KITA T, 1987, P NATL ACAD SCI USA, V84, P5928, DOI 10.1073/pnas.84.16.5928
   Kou MC, 2009, LWT-FOOD SCI TECHNOL, V42, P458, DOI 10.1016/j.lwt.2008.09.010
   Krafczyk N, 2009, MOL NUTR FOOD RES, V53, P635, DOI 10.1002/mnfr.200800117
   Kuate D, 2010, CYTA-J FOOD, V8, P23, DOI 10.1080/19476330903129126
   Kulisic-Bilusic T, 2009, EUR FOOD RES TECHNOL, V228, P417, DOI 10.1007/s00217-008-0948-1
   Kural BV, 2011, INDIAN J BIOCHEM BIO, V48, P361
   Li DY, 2005, CARDIOVASC RES, V68, P353, DOI 10.1016/j.cardiores.2005.09.009
   Li H, 2014, J FOOD SCI, V79, pC460, DOI 10.1111/1750-3841.12393
   Lin CY, 2014, FOOD CHEM, V146, P299, DOI 10.1016/j.foodchem.2013.09.018
   Lin Hsin-Hung, 2015, J Tradit Complement Med, V5, P51, DOI 10.1016/j.jtcme.2014.10.001
   Liu SC, 2017, FOOD CHEM, V215, P284, DOI 10.1016/j.foodchem.2016.06.072
   Londoño-Londoño J, 2010, FOOD CHEM, V119, P81, DOI 10.1016/j.foodchem.2009.05.075
   Luo M, 1997, LANCET, V349, P360, DOI 10.1016/S0140-6736(05)62864-4
   Lyu Ha-Na, 2009, Journal of Applied Biological Chemistry, V52, P147, DOI 10.3839/jabc.2009.025
   Ma GC, 2013, FOOD CHEM, V141, P3703, DOI 10.1016/j.foodchem.2013.06.003
   Madhujith T, 2007, J AGR FOOD CHEM, V55, P5018, DOI 10.1021/jf070072a
   Madhujith T, 2009, FOOD CHEM, V117, P615, DOI 10.1016/j.foodchem.2009.04.055
   Marrugat J, 2004, EUR J NUTR, V43, P140, DOI 10.1007/s00394-004-0452-8
   Mathur S, 2002, J NUTR, V132, P3663, DOI 10.1093/jn/132.12.3663
   Matsumoto RLT, 2009, NUTRIENTS, V1, P18, DOI 10.3390/nu1010018
   Meyer AS, 1998, FOOD CHEM, V61, P71, DOI 10.1016/S0308-8146(97)00100-3
   Milde J, 2004, PHYTOMEDICINE, V11, P105, DOI 10.1078/0944-7113-00380
   Mitra S, 2011, CARDIOVASC DRUG THER, V25, P419, DOI 10.1007/s10557-011-6341-5
   Mursu J, 2004, FREE RADICAL BIO MED, V37, P1351, DOI 10.1016/j.freeradbiomed.2004.06.002
   Nakbi A, 2010, J FOOD COMPOS ANAL, V23, P711, DOI 10.1016/j.jfca.2010.05.003
   Nambiar SS, 2015, J FOOD SCI TECH MYS, V52, P7254, DOI 10.1007/s13197-015-1844-x
   Nambiar SS, 2015, J FOOD BIOCHEM, V39, P218, DOI 10.1111/jfbc.12122
   Nampoothiri SV, 2011, FOOD CHEM TOXICOL, V49, P125, DOI 10.1016/j.fct.2010.10.006
   Nishi K, 2002, ARTERIOSCL THROM VAS, V22, P1649, DOI 10.1161/01.ATV.0000033829.14012.18
   O'Byrne DJ, 2002, AM J CLIN NUTR, V76, P1367, DOI 10.1093/ajcn/76.6.1367
   Orrego R, 2009, MOLECULES, V14, P3906, DOI 10.3390/molecules14103906
   Osakabe N, 2001, FREE RADICAL RES, V34, P93, DOI 10.1080/10715760100300091
   Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853
   Pignatelli P, 2006, ATHEROSCLEROSIS, V188, P77, DOI 10.1016/j.atherosclerosis.2005.10.025
   QUINN MT, 1987, P NATL ACAD SCI USA, V84, P2995, DOI 10.1073/pnas.84.9.2995
   Rahman MA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/403023
   Ramirez-Tortosa MC, 1999, J NUTR, V129, P2177, DOI 10.1093/jn/129.12.2177
   Rivas-Arreola M J, 2010, Pak J Biol Sci, V13, P537, DOI 10.3923/pjbs.2010.537.545
   Rosa A, 2009, CHEM-BIOL INTERACT, V180, P183, DOI 10.1016/j.cbi.2009.01.002
   Ruel G, 2005, METABOLISM, V54, P856, DOI 10.1016/j.metabol.2005.01.031
   Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0
   Schinella GR, 2007, FITOTERAPIA, V78, P1, DOI 10.1016/j.fitote.2006.09.018
   Shahidi F, 2007, J AGR FOOD CHEM, V55, P1212, DOI 10.1021/jf062472o
   Shelembe JS, 2014, J FOOD BIOCHEM, V38, P110, DOI 10.1111/j.1745-4514.2012.00650.x
   Shelembe JS, 2012, INT J FOOD SCI TECH, V47, P648, DOI 10.1111/j.1365-2621.2011.02889.x
   Singh AP, 2011, FOOD CHEM, V127, P80, DOI 10.1016/j.foodchem.2010.12.091
   Singh AP, 2009, FOOD CHEM, V114, P955, DOI 10.1016/j.foodchem.2008.10.048
   Söderholm PP, 2012, ATHEROSCLEROSIS, V221, P583, DOI 10.1016/j.atherosclerosis.2012.01.030
   Stein JH, 1999, CIRCULATION, V100, P1050, DOI 10.1161/01.CIR.100.10.1050
   STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883
   Tan ZL, 2013, FOOD CHEM, V138, P1220, DOI 10.1016/j.foodchem.2012.10.130
   Tedesco I, 2015, J AGR FOOD CHEM, V63, P5229, DOI 10.1021/acs.jafc.5b01206
   Thilakarathna SH, 2013, FOOD CHEM, V138, P463, DOI 10.1016/j.foodchem.2012.09.121
   Thuong PT, 2009, FOOD CHEM, V113, P139, DOI 10.1016/j.foodchem.2008.07.041
   Tuberoso CIG, 2010, FOOD CHEM, V123, P1242, DOI 10.1016/j.foodchem.2010.05.094
   Vaya J, 1997, FREE RADICAL BIO MED, V23, P302, DOI 10.1016/S0891-5849(97)00089-0
   Vaya J, 2003, PHYTOCHEMISTRY, V62, P89, DOI 10.1016/S0031-9422(02)00445-4
   Vigna GB, 2003, METABOLISM, V52, P1250, DOI 10.1016/S0026-0495(03)00192-6
   Visavadiya NP, 2009, FOOD CHEM TOXICOL, V47, P2507, DOI 10.1016/j.fct.2009.07.009
   Visioli F, 2012, FOOD CHEM, V132, P499, DOI 10.1016/j.foodchem.2011.10.092
   Vissers MN, 2001, EUR J CLIN NUTR, V55, P334, DOI 10.1038/sj.ejcn.1601161
   Wan Y, 2001, AM J CLIN NUTR, V74, P596
   Wang JK, 2014, EUR J LIPID SCI TECH, V116, P370, DOI 10.1002/ejlt.201300348
   Wang JK, 2014, J AGR FOOD CHEM, V62, P454, DOI 10.1021/jf404140v
   Wang ZH, 2009, FOOD CHEM, V112, P914, DOI 10.1016/j.foodchem.2008.06.078
   Zabidah A.A., 2011, Int. Food Res. J, V18, P549
NR 118
TC 36
Z9 37
U1 0
U2 46
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2017
VL 23
IS 19
BP 2754
EP 2766
DI 10.2174/1381612823666170329142936
PG 13
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA FB7SY
UT WOS:000406341500006
PM 28356039
DA 2025-04-28
ER

PT J
AU Suzuki, M
   Shindo, D
   Suzuki, R
   Shirataki, Y
   Waki, H
AF Suzuki, Masato
   Shindo, Daisuke
   Suzuki, Ryuichiro
   Shirataki, Yoshiaki
   Waki, Hidefumi
TI Combined long-term caffeine intake and exercise inhibits the development
   of diabetic nephropathy in OLETF rats
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE caffeine; exercise; diabetic nephropathy; renal function; urinary
   albumin
ID SYMPATHETIC NERVOUS-SYSTEM; INSULIN-RESISTANCE; KIDNEY-DISEASE;
   BLOOD-PRESSURE; SEVERE OBESITY; RENAL-FUNCTION; WEIGHT-LOSS;
   HYPERTENSION; CATECHOLAMINES; CONSUMPTION
AB This study was performed to examine the effects of long-term caffeine-intake, with and without exercise, on the progression of diabetic nephropathy (DN) in an obese diabetic rat model. Thirty-two male Otsuka Long-Evans Tokushima fatty (OLETF) rats were assigned to sedentary (OLETF-Sed), exercise (OLETF-Ex), caffeine-intake (OLETF-Caf), and combined (OLETF-Caf + Ex) groups. Caffeine-intake groups were fed rat chow containing caffeine (90.7 +/- 4.7 mg/kg/day). The OLETF-Ex and OLETF-Caf + Ex groups were able to run voluntarily at any time using a rotatory wheel. Body weight (BW) and blood pressure (BP) were measured weekly from 24 to 29 wk of age. Pre- and posttreatment serum glucose, insulin, and creatinine concentrations were measured, and a 24 h urine sample was collected for measurement of creatinine clearance (Ccr) and albumin excretion (UEAlb). After treatment, the kidneys were removed for morphological analysis. The OLETF-Caf and OLETF-Caf + Ex groups exhibited no BP increase during the study. Both the caffeine-intake groups exhibited a significant increase in urine volume (UV), electrolyte excretion, and Ccr, and decreased UEAlb, following treatment. Furthermore, no structural damage was observed in the kidneys of rats from either caffeine-intake group, whereas the OLETF-Sed and OLETF-Ex groups exhibited DN progression. This study demonstrates that caffeine-intake alone and/or combined with exercise significantly decreases BW and improves glucose intolerance, without the progression of DN. Further research should be performed to examine whether the quantities of caffeine contained in a normal human daily intake also have a protective effect against kidney damage.
   NEW & NOTEWORTHY The present study showed that caffeine administration alone and/or combined with exercise results in an improvement of diabetic nephropathy (DN), including an increase in creatinine clearance and urinary Na excretion, a decrease in urinary protein excretion, and in renal morphological findings. To our knowledge, there are no other studies showing that caffeine administration inhibits DN progression.
C1 [Suzuki, Masato] Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.
   [Shindo, Daisuke] Nihon Univ, Dept Pharm, Lab Hlth & Sports Sci, Funabashi, Chiba, Japan.
   [Suzuki, Ryuichiro; Shirataki, Yoshiaki] Josai Univ, Fac Pharmaceut Sci, Dept Pharmacognosy & Nat Med, Sakado, Saitama, Japan.
   [Waki, Hidefumi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Dept Physiol, Inzai, Chiba, Japan.
C3 Jikei University; Nihon University; Josai University; Juntendo
   University
RP Suzuki, M (corresponding author), Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.
EM masatos@jikei.ac.jp
RI Shindo, Daisuke/I-3865-2012
OI Waki, Hidefumi/0000-0002-4278-2077
FU All Japan Coffee Association
FX This research was supported in part by a general research grant from the
   All Japan Coffee Association.
CR Anwer T, 2008, BASIC CLIN PHARMACOL, V102, P498, DOI 10.1111/j.1742-7843.2008.00223.x
   ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   Bolignano D, 2007, J RENAL NUTR, V17, P225, DOI 10.1053/j.jrn.2007.02.006
   BRENNER BM, 1983, KIDNEY INT, V23, P647, DOI 10.1038/ki.1983.72
   Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817
   Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Da Silva RS, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P355, DOI 10.1016/B978-0-12-382032-7.10027-X
   DEBRAH K, 1995, CLIN SCI, V89, P475, DOI 10.1042/cs0890475
   DORFMAN LJ, 1970, CLIN PHARMACOL THER, V11, P869
   Esler M, 2001, AM J HYPERTENS, V14, p304S, DOI 10.1016/S0895-7061(01)02236-1
   FREDHOLM BB, 1984, ACTA PHARMACOL TOX, V54, P64
   Grassi G, 2000, HYPERTENSION, V36, P538, DOI 10.1161/01.HYP.36.4.538
   Hall JE, 2003, CURR OPIN NEPHROL HY, V12, P195, DOI 10.1097/00041552-200303000-00011
   Han LK, 2004, YAKUGAKU ZASSHI, V124, P841, DOI 10.1248/yakushi.124.841
   He Q, 2000, HYPERTENSION, V36, P165, DOI 10.1161/01.HYP.36.2.165
   Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568
   HIROSE K, 1982, KIDNEY INT, V21, P689, DOI 10.1038/ki.1982.82
   KASISKE BL, 1985, AM J NEPHROL, V5, P45, DOI 10.1159/000166902
   Kramer H, 2006, CONTRIB NEPHROL, V151, P1, DOI 10.1159/000095315
   LANDSBERG L, 1989, AM J HYPERTENS, V2, pS125, DOI 10.1093/ajh/2.3.125S
   MASSEY LK, 1984, NUTR RES, V4, P43, DOI 10.1016/S0271-5317(84)80132-3
   Matsubara S, 2013, ADV EXERC SPORTS PHY, V19, P63
   MCCOY DE, 1993, SEMIN NEPHROL, V13, P31
   Modlinger PS, 2003, CURR OPIN NEPHROL HY, V12, P497, DOI 10.1097/00041552-200309000-00003
   Moran TH, 2006, DEV PSYCHOBIOL, V48, P360, DOI 10.1002/dev.20149
   Ohta M, 2000, JPN J PHYSIOL, V50, P443, DOI 10.2170/jjphysiol.50.443
   Palatini P, 2007, ANN MED, V39, P545, DOI 10.1080/07853890701491018
   RENNKE HG, 1989, AM J KIDNEY DIS, V13, P443, DOI 10.1016/S0272-6386(89)80001-0
   RIBSTEIN J, 1995, HYPERTENSION, V26, P610, DOI 10.1161/01.HYP.26.4.610
   ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403
   Shindo D, 2014, J APPL PHYSIOL, V116, P674, DOI 10.1152/japplphysiol.00405.2013
   Suzuki M, 2000, JPN J PHYS FIT SPORT, V49, P403, DOI 10.7600/jspfsm1949.49.403
   Tofovic SP, 2002, KIDNEY INT, V61, P1433, DOI 10.1046/j.1523-1755.2002.00278.x
   Tofovic SP, 2001, RENAL FAILURE, V23, P159, DOI 10.1081/JDI-100103488
   Uiterwaal CSPM, 2007, AM J CLIN NUTR, V85, P718, DOI 10.1093/ajcn/85.3.718
   Weibel E.R., 1979, Stereological methods. I. Practical Methods for Biological Morphometry, V1, P1
NR 37
TC 8
Z9 9
U1 0
U2 9
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD MAY
PY 2017
VL 122
IS 5
BP 1321
EP 1328
DI 10.1152/japplphysiol.00278.2016
PG 8
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA EW3NN
UT WOS:000402405400029
PM 28235857
DA 2025-04-28
ER

PT J
AU Nowak, D
   Jasionowski, A
AF Nowak, Dariusz
   Jasionowski, Artur
TI Analysis of the Consumption of Caffeinated Energy Drinks among Polish
   Adolescents
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article; Proceedings Paper
CT 11th International Symposium on Recent Advances in Environmental Health
   Research
CY SEP 14-18, 2014
CL Jackson, MS
SP Jackson State Univ
DE adolescents; caffeine; dependence; energy drink; overdose
ID ALCOHOL-CONSUMPTION; PATTERNS; RISK; ASSOCIATIONS; CHILDREN
AB Background: Energy drinks (EDs) are extremely popular among adults and adolescents. Regular intake of EDs may lead to an overdose of caffeine, loss of bone mass, overweight, hypertension and, in older age, osteoporosis and cardiovascular diseases. Some people mix EDs with alcohol, which adversely affects their health. The objective of this study was to analyze the consumption of EDs by adolescents. Methods: The study consisted of a questionnaire surveying amounts of drinks, preferences and product awareness among younger consumers. The study was carried out in junior and senior high schools in Poland (n = 2629). Results: EDs were consumed by 67% of students (quite frequently by 16%). Students who practiced sports were more willing to drink EDs. Also, boys drank them more often than girls. When selecting a particular ED, young people looked at the taste, price and effect. Most respondents consumed one ED (250 mL) daily, although there were individuals consuming two or more drinks daily. Most respondents knew the ingredients of EDs, and 24% admitted to mixing EDs with alcohol. Conclusions: EDs are extremely popular among adolescents. Young people drinking EDs every day are potentially at risk of taking an overdose of caffeine.
C1 [Nowak, Dariusz] Nicolaus Copernicus Univ Torun, Dept Nutr & Dietet, Fac Hlth Sci, Ludwik Rydygier Collegium Medicum Bydgoszcz, PL-85626 Bydgoszcz, Poland.
   [Jasionowski, Artur] Nicolaus Copernicus Univ Torun, Dept Theoret Fdn Biomed Sci & Med Informat, Fac Pharm, Ludwik Rydygier Collegium Medicum Bydgoszcz, PL-85626 Bydgoszcz, Poland.
C3 Nicolaus Copernicus University; Nicolaus Copernicus University
RP Nowak, D (corresponding author), Nicolaus Copernicus Univ Torun, Dept Nutr & Dietet, Fac Hlth Sci, Ludwik Rydygier Collegium Medicum Bydgoszcz, Debowa 3, PL-85626 Bydgoszcz, Poland.
EM d.nowak@cm.umk.pl
CR Aguilar F, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1327
   Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x
   Azagba Sunday, 2013, CMAJ Open, V1, pE19, DOI 10.9778/cmajo.20120017
   Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019
   Azsagba S, 2014, PREV MED, V61, P26, DOI 10.1016/j.ypmed.2014.01.013
   Banda C., 2010, J AM DENT ASSOC S, V110, DOI [10.1016/j.jada.2010.06.407, DOI 10.1016/J.JADA.2010.06.407]
   Bigard AX, 2010, ARCH PEDIATRIE, V17, P1625, DOI 10.1016/j.arcped.2010.08.001
   Bonar EE, 2015, ADDICT BEHAV, V43, P11, DOI 10.1016/j.addbeh.2014.11.023
   Breda JJ, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00134
   Ferreira SE, 2006, ALCOHOL CLIN EXP RES, V30, P598, DOI 10.1111/j.1530-0277.2006.00070.x
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381
   Kapner Ari, 2004, EPHEDRA ENERGY DRINK
   Lau-Barraco C, 2014, ADDICT BEHAV, V39, P308, DOI 10.1016/j.addbeh.2013.10.017
   Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35
   Martz ME, 2015, J ADOLESCENT HEALTH, V56, P557, DOI 10.1016/j.jadohealth.2015.01.019
   Miller Kathleen E, 2012, J Caffeine Res, V2, P62, DOI 10.1089/jcr.2012.0015
   Morgan K J, 1982, Regul Toxicol Pharmacol, V2, P296, DOI 10.1016/0273-2300(82)90003-4
   O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x
   Poulos NS, 2016, HEALTH EDUC J, V75, P318, DOI 10.1177/0017896915578299
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Snipes DJ, 2015, ADDICT BEHAV, V41, P136, DOI 10.1016/j.addbeh.2014.10.010
   Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001
   Walsh MJ, 2006, CLIN TOXICOL, V44, P642
   Weldy DL, 2010, J AM BOARD FAM MED, V23, P555, DOI 10.3122/jabfm.2010.04.090261
NR 26
TC 68
Z9 73
U1 1
U2 24
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2015
VL 12
IS 7
BP 7910
EP 7921
DI 10.3390/ijerph120707910
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA CO7MB
UT WOS:000359342300056
PM 26184263
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Han, YY
   Zhao, CH
   He, XY
   Sheng, Y
   Ma, TS
   Sun, ZF
   Liu, XY
   Liu, CJ
   Fan, SX
   Xu, WT
   Huang, KL
AF Han, Yingyan
   Zhao, Changhui
   He, Xiaoyun
   Sheng, Yao
   Ma, Tianshi
   Sun, Zhifan
   Liu, Xueying
   Liu, Chaojie
   Fan, Shuangxi
   Xu, Wentao
   Huang, Kunlun
TI Purple lettuce (Lactuca sativa L.) attenuates metabolic disorders
   in diet induced obesity
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Energy expenditure; Glucose tolerance; Insulin sensitivity; Lipid
   profile; Diabetes; Microbiota
ID IMPROVES GLUCOSE-METABOLISM; HERBAL MEDICINES; LIPID-METABOLISM;
   CHLOROGENIC ACID; GUT MICROBIOTA; LACHNOSPIRACEAE; SEQUENCES; ROMAINE;
   DAMAGE; RED
AB Purple lettuce (Lactuca sativa L.) is a type of low caloric vegetable often consumed freshly, whereas its function in metabolic control has been little studied. To investigate the protective effect of a type of purple lettuce against metabolic risk factors, we treated the C57BL/6J DIO mice with or without purple lettuces for 8 weeks. Results showed that purple lettuce effectively attenuated many metabolic risk factors in DIO mice. Typically, purple lettuce prevented the body weight gain by reducing fat mass accumulation and increasing energy expenditure. Additionally, consumption of purple lettuces enhanced glucose homeostasis, increased insulin sensitivity and improved the lipid profile in the DIO mice. This was, at least partly, attributable to its abundance of bioactive molecules like esculin and chlorogenic acid. High intake of purple lettuces modulated the intestinal microbiota composition like decreased Lachnospiraceae. We conclude that purple lettuce has great potential as functional foods in prevention of metabolic disorders.
C1 [Han, Yingyan; Sun, Zhifan; Liu, Xueying; Liu, Chaojie; Fan, Shuangxi] Beijing Agr Univ, Natl Demonstrat Ctr Expt Plant Prod Educ, Beijing Key Lab New Technol Agr Applicat, Beinong Rd 7, Beijing 102206, Peoples R China.
   [He, Xiaoyun; Sheng, Yao; Ma, Tianshi; Xu, Wentao; Huang, Kunlun] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.
   [Zhao, Changhui] Jilin Univ, Dept Food Qual & Safety, Coll Food Sci & Engn, Changchun 130062, Jilin, Peoples R China.
C3 Beijing University of Agriculture; China Agricultural University; Jilin
   University
RP Fan, SX (corresponding author), Beijing Agr Univ, Natl Demonstrat Ctr Expt Plant Prod Educ, Beijing Key Lab New Technol Agr Applicat, Beinong Rd 7, Beijing 102206, Peoples R China.; Huang, KL (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, 17 Tsinghua East Rd, Beijing 100083, Peoples R China.
EM fsx20@163.com; foodsafety66@cau.edu.cn
RI Zhao, Changhui/N-2378-2019
OI Kunlun, Huang/0000-0002-2350-5859; Zhao, Changhui/0000-0002-1882-7490
FU Beijing University of Agriculture [GZL2016001, YQ201604]; Beijing
   Innovation Consortium of Agriculture Research System [BAIC08]
FX The current study was financially supported by Scientific Research
   Quality Improvement Funds of Beijing University of Agriculture
   (GZL2016001, YQ201604) and Beijing Innovation Consortium of Agriculture
   Research System (BAIC08).
CR Abdali D, 2015, MED PRIN PRACT, V24, P201, DOI 10.1159/000375305
   [Anonymous], CONTRIBUTION FRUIT V
   [Anonymous], J BEIJING U AGR
   [Anonymous], J BEIJING U AGR
   [Anonymous], ARCH CARDIOVASCULAR
   [Anonymous], CHINESE J CLIN PHARM
   [Anonymous], 2015, STAT WAT RES CONTR B
   Asadpour E, 2014, ACTA POL PHARM, V71, P409
   Biddle A., 2013, DIVERSITY-BASEL, V5, P627, DOI [DOI 10.3390/d5030627, 10.3390/d5030627]
   Bigliardi B, 2013, TRENDS FOOD SCI TECH, V31, P118, DOI 10.1016/j.tifs.2013.03.006
   Cani PD, 2014, DIABETES METAB, V40, P246, DOI 10.1016/j.diabet.2014.02.004
   Cheng DM, 2016, MOL NUTR FOOD RES, V60, P2367, DOI 10.1002/mnfr.201600290
   Cheng DM, 2014, NUTRITION, V30, pS52, DOI 10.1016/j.nut.2014.02.022
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/nmeth.2604, 10.1038/NMETH.2604]
   Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227
   Faisst M, 2010, J CRIT CARE, V25, P105, DOI 10.1016/j.jcrc.2009.02.002
   Ferreres F, 1997, J AGR FOOD CHEM, V45, P4249, DOI 10.1021/jf970399j
   Ghadieh HE, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0014-5
   Ghorbani A, 2015, NUTR NEUROSCI, V18, P103, DOI 10.1179/1476830513Y.0000000107
   Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Hernandez JB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8216
   Higdon JV, 2003, ARTERIOSCL THROM VAS, V23, P365, DOI 10.1161/01.ATV.0000063608.43095.E2
   Isken F, 2010, J NUTR BIOCHEM, V21, P278, DOI 10.1016/j.jnutbio.2008.12.012
   Islam MN, 2013, ARCH PHARM RES, V36, P542, DOI 10.1007/s12272-013-0069-7
   Jung HA, 2012, ARCH PHARM RES, V35, P1021, DOI 10.1007/s12272-012-0610-0
   Kameyama K, 2014, MICROBES ENVIRON, V29, P427, DOI 10.1264/jsme2.ME14054
   Kang KS, 2014, J AGR FOOD CHEM, V62, P2069, DOI 10.1021/jf403840c
   Kim HJ, 2008, J AGR FOOD CHEM, V56, P3772, DOI 10.1021/jf0733719
   Kohn RA, 2005, J ANIM SCI, V83, P879
   Lee JS, 2005, FOOD SCI BIOTECHNOL, V14, P99
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   [刘晓天 Liu Xiaotian], 2016, [中国给水排水, China Water & Wastewater], V32, P57
   López A, 2014, J FOOD COMPOS ANAL, V33, P39, DOI 10.1016/j.jfca.2013.10.001
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Meng TX, 2011, J WOOD SCI, V57, P452, DOI 10.1007/s10086-011-1192-z
   Mubarak A, 2015, J AGR FOOD CHEM, V63, P1882, DOI 10.1021/acs.jafc.5b00621
   Mulabagal V, 2010, FOOD CHEM, V118, P300, DOI 10.1016/j.foodchem.2009.04.119
   Park JP, 2011, BIOTECHNOL BIOPROC E, V16, P1065, DOI 10.1007/s12257-011-0215-3
   Rodriguez-Casado A, 2016, CRIT REV FOOD SCI, V56, P1097, DOI 10.1080/10408398.2012.755149
   Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S
   Sheng Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12245-2
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Wang J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/757540
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Yuan XX, 2017, FASEB J, V31, P333, DOI [10.1096/fj.201600459rr, 10.1096/fj.201600459RR]
NR 47
TC 18
Z9 19
U1 2
U2 38
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JUN
PY 2018
VL 45
BP 462
EP 470
DI 10.1016/j.jff.2018.04.027
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA GI6QB
UT WOS:000434494300053
DA 2025-04-28
ER

PT J
AU Mueller, M
   Jungbauer, A
AF Mueller, Monika
   Jungbauer, Alois
TI Culinary plants, herbs and spices - A rich source of PPARγ ligands
SO FOOD CHEMISTRY
LA English
DT Article
DE Obesity; PPAR gamma; Diabetes; Plants; SPPAR gamma Ms; PPAR
   gamma-antagonists
ID ACTIVATED RECEPTOR-GAMMA; CINNAMOMUM-ZEYLANICUM; BIOLOGICAL-ACTIVITY;
   IN-VIVO; INSULIN; EXTRACT; DIET
AB Obesity and the related disorders, diabetes, hypertension and hyperlipidemia have reached epidemic proportions world-wide. The influence of 70 plants, herbs and spices on peroxisome proliferators-activated receptor (PPAR)gamma activation or antagonism, a drug target for metabolic syndrome, was investigated. Approximately 50 different plant extracts bound PPAR gamma in competitive ligand binding assay, including pomegranate, apple, clove, cinnamon, thyme, green coffee, bilberry and bay leaves. Five plant extracts transactivated PPAR gamma in chimeric GAL4-PPAR gamma-LBD system: nutmeg, licorice, black pepper, holy basil and sage. Interestingly, nearly all plant extracts antagonized rosiglitazone-mediated coactivator recruitment in time resolved fluorescence resonance energy transfer coactivator assay. The five transactivating extracts may function as selective PPAR gamma modulators (SPPAR gamma Ms), and the other extracts seem to be moderate antagonists or undetectable/weak SPPAR gamma Ms. As SPPAR gamma Ms improve insulin resistance without weight gain and PPAR gamma antagonists exert antiobesity action, a combination of these plants in diet could reduce obesity and the incidence of metabolic syndrome. (c) 2009 Elsevier Ltd. All rights reserved.
C1 [Mueller, Monika; Jungbauer, Alois] Univ Nat Resources & Appl Life Sci, Christian Doppler Lab Receptor Biotechnol, Dept Biotechnol, A-1190 Vienna, Austria.
C3 BOKU University
RP Jungbauer, A (corresponding author), Univ Nat Resources & Appl Life Sci, Christian Doppler Lab Receptor Biotechnol, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria.
EM alois.jungbauer@boku.ac.at
OI Jungbauer, Alois/0000-0001-8182-7728
CR Alberti G., 2006, The IDF consensus worldwide of the metabolic syndrome
   Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b
   [Anonymous], 311 WHO
   Bazzano LA, 2005, J AM COLL NUTR, V24, P310, DOI 10.1080/07315724.2005.10719479
   Bazzano Lydia A, 2003, Curr Atheroscler Rep, V5, P492, DOI 10.1007/s11883-003-0040-z
   Broadhurst CL, 2000, J AGR FOOD CHEM, V48, P849, DOI 10.1021/jf9904517
   Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124
   Crespy V, 2001, J NUTR, V131, P3227, DOI 10.1093/jn/131.12.3227
   Ehala S, 2005, J AGR FOOD CHEM, V53, P6484, DOI 10.1021/jf050397w
   Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4
   Guo L, 2006, PHARMACOL THERAPEUT, V111, P145, DOI 10.1016/j.pharmthera.2005.10.009
   Han KL, 2008, DIABETES, V57, P737, DOI 10.2337/db07-0972
   Huang THW, 2005, TOXICOL APPL PHARM, V207, P160, DOI 10.1016/j.taap.2004.12.009
   Jarvill-Taylor KJ, 2001, J AM COLL NUTR, V20, P327, DOI 10.1080/07315724.2001.10719053
   Jeppesen PB, 2002, PHYTOMEDICINE, V9, P9, DOI 10.1078/0944-7113-00081
   Jungbauer A, 2001, J CLIN LIGAND ASSAY, V24, P270
   Justesen U, 2001, FOOD CHEM, V73, P245, DOI 10.1016/S0308-8146(01)00114-5
   Kahle K, 2007, J AGR FOOD CHEM, V55, P10605, DOI 10.1021/jf071942r
   Mae T, 2003, J NUTR, V133, P3369, DOI 10.1093/jn/133.11.3369
   Marongiu B, 2007, J AGR FOOD CHEM, V55, P10022, DOI 10.1021/jf071938f
   Mueller M, 2008, MENOPAUSE, V15, P1120, DOI 10.1097/gme.0b013e31817062ce
   Naz S, 2007, J FOOD SCI, V72, pM341, DOI 10.1111/j.1750-3841.2007.00533.x
   Proestos C, 2005, J AGR FOOD CHEM, V53, P1190, DOI 10.1021/jf040083t
   Rau O, 2006, PHARMAZIE, V61, P952
   Rieusset J, 2002, MOL ENDOCRINOL, V16, P2628, DOI 10.1210/me.2002-0036
   Seguin P, 2006, J SCI FOOD AGR, V86, P765, DOI 10.1002/jsfa.2412
   Shapiro Karen, 2002, J Am Pharm Assoc (Wash), V42, P217, DOI 10.1331/108658002763508515
   이성계, 2008, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V37, P437
   Srinivasan K, 2005, INT J FOOD SCI NUTR, V56, P399, DOI 10.1080/09637480500512872
   Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701
   Verspohl EJ, 2005, PHYTOTHER RES, V19, P203, DOI 10.1002/ptr.1643
   Vuksan V, 2008, NUTR METAB CARDIOVAS, V18, P46, DOI 10.1016/j.numecd.2006.04.003
   Wang HF, 2004, FOOD CHEM, V87, P307, DOI 10.1016/j.foodchem.2003.12.029
   Zhang F, 2007, PPAR RES, V2007, DOI 10.1155/2007/32696
   Zhang Z, 2004, J AGR FOOD CHEM, V52, P688, DOI 10.1021/jf034596w
NR 35
TC 43
Z9 47
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD DEC 15
PY 2009
VL 117
IS 4
BP 660
EP 667
DI 10.1016/j.foodchem.2009.04.063
PG 8
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 475UG
UT WOS:000268386200013
DA 2025-04-28
ER

PT J
AU Loureiro, G
   Martel, F
AF Loureiro, Guilherme
   Martel, Fatima
TI The effect of dietary polyphenols on intestinal absorption of glucose
   and fructose: Relation with obesity and type 2 diabetes
SO FOOD REVIEWS INTERNATIONAL
LA English
DT Review
DE Polyphenols; glucose; fructose; intestinal absorption; type 2 diabetes;
   obesity
ID BRUSH-BORDER-MEMBRANE; GREEN TEA SUPPLEMENTATION; INSULIN-RESISTANCE;
   COFFEE CONSUMPTION; QUERCETIN GLUCOSIDES; METABOLIC SYNDROME; SUGAR
   ABSORPTION; BLOOD-PRESSURE; CONTROLLED-TRIAL; CAFFEINE INTAKE
AB Polyphenols are a group of substances present in plant-based foods such as apples and in plant-based beverages such as red wine. This review shows that polyphenols interfere with intestinal sugar transporters, modulating their function and altering glucose and fructose absorption. Inhibition of intestinal glucose and fructose absorption contributes to the effect of polyphenols in reducing postprandial glycemia, altering the apparent glycemic index of foods and decreasing body mass index. The possible implication of these findings on type 2 diabetes and obesity is a matter of growing interest, as shown by the rise on publications on this subject.
C1 [Loureiro, Guilherme; Martel, Fatima] Univ Porto, Dept Biomed, Biochem Unit, Fac Med, Al Prof Hernani Monteiro, P-4200319 Porto, Portugal.
   [Martel, Fatima] Univ Porto, Inst Invest & Inovacao Saude, Porto, Portugal.
C3 Universidade do Porto; Universidade do Porto; i3S - Instituto de
   Investigacao e Inovacao em Saude, Universidade do Porto
RP Martel, F (corresponding author), Univ Porto, Dept Biomed, Biochem Unit, Fac Med, Al Prof Hernani Monteiro, P-4200319 Porto, Portugal.
EM fmartel@med.up.pt
RI Martel, Felix/JFJ-0587-2023
OI Martel, Fatima/0000-0002-0525-3416
CR Ader P, 2001, CANCER LETT, V162, P175, DOI 10.1016/S0304-3835(00)00645-5
   Allison DB, 2003, EUR J CLIN NUTR, V57, P514, DOI 10.1038/sj.ejcn.1601587
   Aluko R. E., 2012, FUNCTIONAL FOODS NUT
   Andrade N, 2017, J FUNCT FOODS, V36, P429, DOI 10.1016/j.jff.2017.07.032
   [Anonymous], CAN J MICROBIOL
   [Anonymous], J CLIN ENDOCR METAB
   [Anonymous], 2014, Polyphenols in Human Healthand Disease
   [Anonymous], IDF DIABETES ATLAS
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI [10.1001/jama.291.10.1199-b, 10.1001/jama.291.10.1199-a]
   Askari F, 2014, NUTR RES, V34, P143, DOI 10.1016/j.nutres.2013.11.005
   Basu A, 2011, NUTR RES, V31, P190, DOI 10.1016/j.nutres.2011.02.003
   Basu A, 2010, NUTR RES, V30, P462, DOI 10.1016/j.nutres.2010.06.016
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   BLAKEMORE SJ, 1995, BIOCHEM J, V309, P7, DOI 10.1042/bj3090007
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Cermak R, 2004, BRIT J NUTR, V91, P849, DOI 10.1079/BJN20041128
   Corpe CP, 1996, PFLUG ARCH EUR J PHY, V432, P192, DOI 10.1007/s004240050124
   Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a
   D'Archivio Massimo, 2007, Ann Ist Super Sanita, V43, P348
   Davison K, 2008, INT J OBESITY, V32, P1289, DOI 10.1038/ijo.2008.66
   Day AJ, 2000, FEBS LETT, V468, P166, DOI 10.1016/S0014-5793(00)01211-4
   de Bock M, 2012, J ACAD NUTR DIET, V112, P808, DOI 10.1016/j.jand.2012.01.018
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dyer J, 2002, AM J PHYSIOL-GASTR L, V282, pG241, DOI 10.1152/ajpgi.00310.2001
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911
   Farhat G, 2017, PHYTOTHER RES, V31, P1005, DOI 10.1002/ptr.5830
   FORDTRAN JS, 1968, J CLIN INVEST, V47, P884, DOI 10.1172/JCI105781
   Frejnagel S, 2010, ANN NUTR METAB, V56, P163, DOI 10.1159/000278747
   Fujitaka K, 2011, NUTR RES, V31, P842, DOI 10.1016/j.nutres.2011.09.028
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Gee JM, 1998, FREE RADICAL BIO MED, V25, P19, DOI 10.1016/S0891-5849(98)00020-3
   Goran MI, 2013, GLOB PUBLIC HEALTH, V8, P55, DOI 10.1080/17441692.2012.736257
   Gostin LO, 2018, HASTINGS CENT REP, V48, P5, DOI 10.1002/hast.804
   Gouyon F, 2003, J PHYSIOL-LONDON, V552, P823, DOI 10.1113/jphysiol.2003.049247
   Grassi D, 2005, AM J CLIN NUTR, V81, P611
   Hamer M, 2008, BRIT J NUTR, V100, P1046, DOI 10.1017/S0007114508944135
   Hanamura T, 2006, BIOSCI BIOTECH BIOCH, V70, P1813, DOI 10.1271/bbb.50592
   Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365
   HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0
   Helliwell PA, 2003, J BIOL CHEM, V278, P28644, DOI 10.1074/jbc.M301479200
   HOLLMAN PCH, 1995, AM J CLIN NUTR, V62, P1276, DOI 10.1093/ajcn/62.6.1276
   Hossain SJ, 2002, J AGR FOOD CHEM, V50, P5215, DOI 10.1021/jf020252e
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jing YL, 2009, J GEN INTERN MED, V24, P557, DOI 10.1007/s11606-009-0929-5
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kar P, 2009, DIABETIC MED, V26, P526, DOI 10.1111/j.1464-5491.2009.02727.x
   Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518
   Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155
   Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560
   Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512
   Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832
   Kottra G, 2007, J PHARMACOL EXP THER, V322, P829, DOI 10.1124/jpet.107.124040
   Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com
   Lee Y, 2015, MOLECULES, V20, P17393, DOI 10.3390/molecules200917393
   Lehtonen HM, 2011, EUR J CLIN NUTR, V65, P394, DOI 10.1038/ejcn.2010.268
   Li JM, 2006, INT J BIOCHEM CELL B, V38, P985, DOI 10.1016/j.biocel.2005.10.002
   Li Z, 2005, EUR J CLIN NUTR, V59, P411, DOI 10.1038/sj.ejcn.1602089
   Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Manzano S, 2010, MOL NUTR FOOD RES, V54, P1773, DOI 10.1002/mnfr.201000019
   Méndez-del Villar M, 2014, METAB SYNDR RELAT D, V12, P497, DOI 10.1089/met.2014.0082
   MIYAMOTO K, 1993, BIOCHEM J, V295, P211, DOI 10.1042/bj2950211
   Muniyappa R, 2008, AM J CLIN NUTR, V88, P1685, DOI 10.3945/ajcn.2008.26457
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306
   Nettleton JA, 2006, J NUTR, V136, P3039, DOI 10.1093/jn/136.12.3039
   PAPPENHEIMER JR, 1987, J MEMBRANE BIOL, V100, P123, DOI 10.1007/BF02209145
   Romualdi D, 2008, FERTIL STERIL, V90, P1826, DOI 10.1016/j.fertnstert.2007.09.020
   Rutledge AC, 2007, NUTR REV, V65, pS13, DOI 10.1301/nr.2007.jun.S13-S23
   Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S
   Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096
   Scalbert Augustin, 2000, Journal of Nutrition, V130, p2073S
   Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007
   Song J, 2002, J BIOL CHEM, V277, P15252, DOI 10.1074/jbc.M110496200
   Song YQ, 2005, J AM COLL NUTR, V24, P376, DOI 10.1080/07315724.2005.10719488
   Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990
   Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336
   Suksomboon N, 2011, J ETHNOPHARMACOL, V137, P1328, DOI 10.1016/j.jep.2011.07.059
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Sun Q, 2015, J NUTR, V145, P1280, DOI 10.3945/jn.114.208736
   Toop CR, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090577
   Törrönen R, 2010, BRIT J NUTR, V103, P1094, DOI 10.1017/S0007114509992868
   TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0
   van Buul VJ, 2014, NUTR RES REV, V27, P119, DOI 10.1017/S0954422414000067
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van der Made SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118393
   van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3
   Walgren RA, 2000, J PHARMACOL EXP THER, V294, P837
   Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Wittekind A, 2014, NUTR RES REV, V27, P330, DOI 10.1017/S0954422414000237
   Wolffram S, 2002, J NUTR, V132, P630, DOI 10.1093/jn/132.4.630
   Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6
   Wright EM, 2003, BEST PRACT RES CL GA, V17, P943, DOI 10.1016/S1521-6918(03)00107-0
   Yang TY, 2014, PHYTOTHER RES, V28, P1096, DOI 10.1002/ptr.5111
NR 103
TC 34
Z9 36
U1 4
U2 101
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 8755-9129
EI 1525-6103
J9 FOOD REV INT
JI Food Rev. Int.
PD MAY 19
PY 2019
VL 35
IS 4
BP 390
EP 406
DI 10.1080/87559129.2019.1573432
PG 17
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA HR0YW
UT WOS:000462856000005
DA 2025-04-28
ER

PT J
AU Taghizadeh, M
   Farzin, N
   Taheri, S
   Mahlouji, M
   Akbari, H
   Karamali, F
   Asemi, Z
AF Taghizadeh, Mohsen
   Farzin, Narjes
   Taheri, Sara
   Mahlouji, Mahnaz
   Akbari, Hossein
   Karamali, Fatemeh
   Asemi, Zatollah
TI The Effect of Dietary Supplements Containing Green Tea, Capsaicin and
   Ginger Extracts on Weight Loss and Metabolic Profiles in Overweight
   Women: A Randomized Double-Blind Placebo-Controlled Clinical Trial
SO ANNALS OF NUTRITION AND METABOLISM
LA English
DT Article
DE Dietary supplements; Weight loss; Insulin resistance; Overweight
ID BIOACTIVE FOOD INGREDIENTS; 24-H ENERGY-EXPENDITURE; OXIDATIVE STRESS;
   INSULIN-RESISTANCE; BODY-WEIGHT; ADIPOSE-TISSUE; OBESE WOMEN;
   RED-PEPPER; FAT LOSS; CAFFEINE
AB Background: This study was conducted to determine the effects of dietary supplements containing green tea, capsaicin and ginger extracts on weight loss and metabolic profiles among overweight women.
   Methods: This randomized double-blind placebo-controlled clinical trial was implemented among 50 overweight women. Participants were randomly divided into 2 groups. Group A received dietary supplements containing 125 mg green tea, 25 mg capsaicin and 50 mg ginger extracts (n = 25) group B received placebos (n = 25) twice with lunch and twice with dinner daily for 8 weeks.
   Results: Compared with placebo, taking dietary supplements containing green tea, capsaicin and ginger resulted in a significant decrease in weight (-1.8 +/- 1.5 vs. +0.4 +/- 1.2 kg, respectively, p < 0.001) and body mass index (BMI; -0.7 +/- 0.5 vs. +0.1 +/- 0.5 kg/m(2), respectively, p < 0.001). In addition, subjects who received green tea, capsaicin and ginger co-supplements had significantly decreased serum insulin concentrations (-2.6 +/- 3.9 vs. -0.6 +/- 2.0 mu IU/mL, p = 0.02), homeostatic model of assessment for insulin resistance (-0.5 +/- 0.8 vs. -0.05 +/- 0.6, p = 0.01), and increased quantitative insulin sensitivity check index (+0.01 +/- 0.01 vs. +0.001 +/- 0.01, p = 0.008) and plasma glutathione (GSH) levels (+73.8 +/- 120.6 vs. -28.3 +/- 193.4 mu mol/L, p = 0.03) compared with the placebo.
   Conclusions: Our study indicated that taking green tea, capsaicin and ginger co-supplements for 8 weeks among overweight women had beneficial effects on weight, BMI, markers of insulin metabolism and plasma GSH levels. (C) 2017 S. Karger AG, Basel.
C1 [Taghizadeh, Mohsen; Taheri, Sara; Karamali, Fatemeh; Asemi, Zatollah] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan 0098, Iran.
   [Akbari, Hossein] Kashan Univ Med Sci, Dept Biostat & Epidemiol, Kashan, Iran.
   [Farzin, Narjes; Mahlouji, Mahnaz] Barij Med Plants Res Ctr, Kashan, Iran.
RP Asemi, Z (corresponding author), Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan 0098, Iran.
EM asemi_r@yahoo.com
RI HasibiTaheri, sara/MIU-2962-2025; asemi, zatollah/J-2677-2018;
   Taghizadeh, Mohsen/D-7784-2017
FU KUMS
FX This study was supported by a grant from the vice-chancellor for
   Research, KUMS, and Iran. We are grateful to the Research and
   Development Division of Barij Essence Company, Kashan, Iran that
   provided dietary supplements containing green tea, capsaicin and ginger
   and placebo capsules for the present study.
CR Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Attari VE, 2016, EUR J NUTR, V55, P2129, DOI 10.1007/s00394-015-1027-6
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Belza A, 2005, EUR J CLIN NUTR, V59, P733, DOI 10.1038/sj.ejcn.1602121
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   BEUTLER E, 1985, J LAB CLIN MED, V105, P581
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Coffey CS, 2004, INT J OBESITY, V28, P1411, DOI 10.1038/sj.ijo.0802784
   Derdemezis CS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/285618
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Horakova D, 2010, BIOMED PAP, V154, P245, DOI 10.5507/bp.2010.037
   Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779
   Kwon DY, 2013, J NUTR BIOCHEM, V24, P1078, DOI 10.1016/j.jnutbio.2012.08.006
   Lee CYJ, 2003, PHYTOTHER RES, V17, P454, DOI 10.1002/ptr.1172
   Lopez HL, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-22
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Manjunatha H, 2007, LIPIDS, V42, P1133, DOI 10.1007/s11745-007-3120-y
   Matsumoto T, 2000, J NUTR SCI VITAMINOL, V46, P309, DOI 10.3177/jnsv.46.309
   Meki ARMA, 2009, INDIAN J CLIN BIOCHE, V24, P280, DOI 10.1007/s12291-009-0053-7
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Mirzazadeh Ali, 2013, Middle East J Dig Dis, V5, P151
   Panza VSP, 2008, NUTRITION, V24, P433, DOI 10.1016/j.nut.2008.01.009
   Pisprasert V, 2013, DIABETES CARE, V36, P845, DOI 10.2337/dc12-0840
   Pulbutr P., 2010, Journal of Biological Sciences, V10, P754, DOI 10.3923/jbs.2010.754.760
   Reinbach HC, 2009, CLIN NUTR, V28, P260, DOI 10.1016/j.clnu.2009.01.010
   Reinbach HC, 2010, FOOD QUAL PREFER, V21, P655, DOI 10.1016/j.foodqual.2010.04.003
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Rondanelli M, 2013, ENDOCRINE, V44, P391, DOI 10.1007/s12020-012-9863-0
   Sankhla M, 2012, CLIN LAB, V58, P385
   Santilli F, 2015, CURR MED CHEM, V22, P582, DOI 10.2174/0929867322666141128163739
   Shidfar Farzad, 2015, J Complement Integr Med, V12, P165, DOI 10.1515/jcim-2014-0021
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Shrivastava S, 2015, J ENVIRON PATHOL TOX, V34, P11, DOI 10.1615/JEnvironPatholToxicolOncol.2015011778
   Stefanovic A, 2008, DIABETES RES CLIN PR, V79, P156, DOI 10.1016/j.diabres.2007.07.019
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   Taghizadeh M, 2015, ANN NUTR METAB, V66, P117, DOI 10.1159/000373896
   TOUBRO S, 1993, INT J OBESITY, V17, pS69
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Yoshioka M, 1995, J NUTR SCI VITAMINOL, V41, P647, DOI 10.3177/jnsv.41.647
   Yoshioka M, 1999, BRIT J NUTR, V82, P115, DOI 10.1017/S0007114599001269
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
NR 46
TC 37
Z9 40
U1 0
U2 41
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0250-6807
EI 1421-9697
J9 ANN NUTR METAB
JI Ann. Nutr. Metab.
PY 2017
VL 70
IS 4
BP 277
EP 285
DI 10.1159/000471889
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA FA0AY
UT WOS:000405094100003
PM 28595182
DA 2025-04-28
ER

PT J
AU Zheng, GD
   Sayama, K
   Okubo, T
   Juneja, LR
   Oguni, I
AF Zheng, GD
   Sayama, K
   Okubo, T
   Juneja, LR
   Oguni, I
TI Anti-obesity effects of three major components of green tea, catechins,
   caffeine and theanine, in mice
SO IN VIVO
LA English
DT Article
DE green tea powder; catechins; caffeine; theanine; fat accumulation; lipid
   metabolism; anti-obesity
ID ENERGY-EXPENDITURE; FAT OXIDATION; FOOD-INTAKE; HUMAN VOLUNTEERS;
   BLOOD-PRESSURE; OOLONG TEA; RATS; CHOLESTEROL; CATECHOLAMINES;
   THERMOGENESIS
AB To elucidate the anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, female ICR mice were fed on diets containing 2% green tea powder and diets containing 0.3% catechins, 0.05% caffeine and 0.03% theanine, which correspond, respectively, to their concentrations in a 2% green tea powder diet, singly and in combination for 16 weeks. Body weight and food intake were determined monthly during this period, kidneys, adrenals, liver, spleen, brain, pituitary and intraperitoneal adipose tissues (IPAT) were weighed and lipid levels in the serum and liver were measured at the end of this period. The body weight increase and weight of IPA T were significantly reduced by the diets containing green tea, caffeine, theanine, caffeine + catechins, caffeine + theanine and caffeine + catechins + theanine. Noticeably, the IPA T weight decreased by 76.8% in the caffeine + catechins compared to the control group. Serum concentrations of triglycerides (TG) and non-esterified fatty acids (NEFA) were decreased by green tea, catechins and theanine. Moreover, caffeine + catechins, caffeine + theanine and caffeine + catechins + theanine also decreased NEFA in the serum. The TG level in the liver was significantly reduced by catechins and catechins + theanine in comparison with the control. These results indicated that at least caffeine and theanine were responsible for the suppressive effect of green tea powder (GTP) on body weight increase and fat accumulation. Moreover, it was shown that catechins and caffeine were synergistic in anti-obesity activities.
C1 Univ Shizuoka, Fac Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan.
   Taiyo Kagaku Co Ltd, Cent Res Labs, Yokaichi 5100844, Japan.
   Univ Shizuoka, Sch Food & Nutrit Sci, Shizuoka 4228526, Japan.
C3 University of Shizuoka; TAIYO KAGAKU CO., LTD.; University of Shizuoka
RP Univ Shizuoka, Fac Agr, Dept Appl Biol Chem, 836 Ohya, Shizuoka 4228529, Japan.
EM acksaya@agr.shizuoka.ac.jp
CR Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881
   ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   Bina KG, 2000, NEUROENDOCRINOLOGY, V71, P68, DOI 10.1159/000054522
   CAO Y, 1999, NATURE, V398
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7
   FOLCH J, 1957, J BIOL CHEM, V226, P479
   Fukuyo M, 1986, NIPPON EIYO SHOKURYO, V39, P495
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   HARA Y, 1989, NIPPON EIYO SHOKURYO, V42, P39
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Kakuda T, 2000, BIOSCI BIOTECH BIOCH, V64, P287, DOI 10.1271/bbb.64.287
   Kao Y, 2000, AM J CLIN NUTR, V72, P1232
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kobayashi K, 1998, NIPPON NOGEIK KAISHI, V72, P153
   Kono S, 1996, J Epidemiol, V6, P128
   MATSUZAKI T, 1985, J AGR CHEM SOC JPN, V59, P129, DOI 10.1271/nogeikagaku1924.59.129
   MURAMATSU K, 1986, J NUTR SCI VITAMINOL, V32, P613, DOI 10.3177/jnsv.32.613
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Oguni I., 1989, Japanese Journal of Nutrition, V47, P93
   OKUDA T, 1984, CHEM PHARM BULL, V32, P3755
   RACOTTA IS, 1994, PHARMACOL BIOCHEM BE, V48, P887, DOI 10.1016/0091-3057(94)90196-1
   ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Sayama K, 2000, IN VIVO, V14, P481
   Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534
   Takeo T., 1992, Tea: Cultivation to consumption, P413, DOI [10.1007/978-94-011-2326-6_13, DOI 10.1007/978-94-011-2326-6_13]
   TOWELL A, 1988, PHARMACOL BIOCHEM BE, V30, P641, DOI 10.1016/0091-3057(88)90077-9
   Valcic S, 1996, ANTI-CANCER DRUG, V7, P461, DOI 10.1097/00001813-199606000-00011
   Watanabe J, 1998, BIOSCI BIOTECH BIOCH, V62, P532, DOI 10.1271/bbb.62.532
   Yokogoshi H, 1998, BIOSCI BIOTECH BIOCH, V62, P816, DOI 10.1271/bbb.62.816
   YOKOGOSHI H, 1995, BIOSCI BIOTECH BIOCH, V59, P615, DOI 10.1271/bbb.59.615
   Yokogoshi H, 1998, NEUROCHEM RES, V23, P667, DOI 10.1023/A:1022490806093
   ZAK B, 1957, AM J CLIN PATHOL, V27, P583, DOI 10.1093/ajcp/27.5_ts.583
NR 39
TC 235
Z9 282
U1 0
U2 74
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0258-851X
EI 1791-7549
J9 IN VIVO
JI In Vivo
PD JAN-FEB
PY 2004
VL 18
IS 1
BP 55
EP 62
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 777DW
UT WOS:000189161100008
PM 15011752
DA 2025-04-28
ER

PT J
AU Clark, KS
   Coleman, C
   Shelton, R
   Heemstra, LA
   Novak, CM
AF Clark, Kathryn S.
   Coleman, Claire
   Shelton, Rhiannon
   Heemstra, Lydia A.
   Novak, Colleen M.
TI Caffeine enhances activity thermogenesis and energy expenditure in rats
SO CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
LA English
DT Article
DE energy expenditure; non-exercise activity thermogenesis; physical
   activity; skeletal muscle; thermogenesis
ID EXPERIMENTAL WEIGHT PERTURBATION; MUSCLE WORK EFFICIENCY; DIET-INDUCED
   OBESE; HIGH-FAT DIET; SKELETAL-MUSCLE; SARCOLIPIN; INGREDIENTS;
   REGULATOR; INGESTION; ADENOSINE
AB Caffeine and its derivatives have been used, alone and in combination with other phytochemicals, as weight-loss supplements. Caffeine affects several physiological and behavioural aspects of energy balance, including increasing locomotor activity. This study investigates the potential for caffeine to enhance activity thermogenesis and energy expenditure (EE) even when activity level is held constant. To do this, EE and muscle thermogenesis were measured in rats during treadmill walking regimens, with and without caffeine (25 mg/kg, ip). Activity-related EE was significantly increased throughout the treadmill walking protocol. Muscle heat dissipation, on the other hand, was significantly increased by caffeine only at the end of the 25-minute treadmill test. This study demonstrates that caffeine increases the caloric cost of physical activity, compared to the caloric cost of that same physical activity without caffeine, implicating decreased muscle work efficiency. Combined with the known ability of caffeine to increase locomotor activity, the decreased locomotor efficiency imparted by caffeine may further augment the potential for caffeine to enhance caloric expenditure.
C1 [Clark, Kathryn S.] Ohio Univ, Heritage Coll Med, Athens, OH 45701 USA.
   [Coleman, Claire; Heemstra, Lydia A.; Novak, Colleen M.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.
   [Shelton, Rhiannon] Univ Colorado, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA.
   [Novak, Colleen M.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA.
C3 University System of Ohio; Ohio University; University System of Ohio;
   Kent State University; Kent State University Kent; Kent State University
   Salem; University of Colorado System; University of Colorado Anschutz
   Medical Campus; Colorado School of Public Health; University System of
   Ohio; Kent State University; Kent State University Kent; Kent State
   University Salem
RP Novak, CM (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.
EM cnovak13@kent.edu
RI Heemstra, Lydia/MEO-6524-2025
OI Novak, Colleen/0000-0002-8542-1677; Heemstra, Lydia/0000-0001-8634-8806
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [R15-DK-097644, R15-DK-108668]; American Heart Association [GIA-410805]
FX National Institute of Diabetes and Digestive and Kidney Diseases,
   Grant/Award Number: R15-DK-097644 and R15-DK-108668; American Heart
   Association, Grant/Award Number: GIA-410805
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Almundarij TI, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13171
   Almundarij TI, 2016, SCI REP-UK, V6, DOI 10.1038/srep37435
   Antoniou K, 1998, NEUROSCI BIOBEHAV R, V23, P189, DOI 10.1016/S0149-7634(98)00020-7
   Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897
   Baldwin KM, 2011, AM J PHYSIOL-REG I, V301, pR1259, DOI 10.1152/ajpregu.00397.2011
   Bell DG, 2002, J APPL PHYSIOL, V93, P1227, DOI 10.1152/japplphysiol.00187.2002
   Bracale R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098244
   Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   DULLOO AG, 2005, AM J PHYSIOL, V267, pE801
   Egawa T, 2011, ACTA PHYSIOL, V201, P227, DOI 10.1111/j.1748-1716.2010.02169.x
   Egawa T, 2011, J APPL PHYSIOL, V111, P1629, DOI 10.1152/japplphysiol.00249.2011
   Egawa T, 2009, METABOLISM, V58, P1609, DOI 10.1016/j.metabol.2009.05.013
   FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x
   Gamu D, 2014, EXERC SPORT SCI REV, V42, P136, DOI 10.1249/JES.0000000000000016
   Gavini CK, 2018, OBESITY, V26, P885, DOI 10.1002/oby.22166
   Gavini CK, 2016, J PHYSIOL-LONDON, V594, P5285, DOI 10.1113/JP272352
   Gavini CK, 2014, AM J PHYSIOL-ENDOC M, V306, pE635, DOI 10.1152/ajpendo.00555.2013
   Goldsmith R, 2010, AM J PHYSIOL-REG I, V298, pR79, DOI 10.1152/ajpregu.00053.2009
   Gonzalez NC, 2006, RESP PHYSIOL NEUROBI, V151, P141, DOI 10.1016/j.resp.2005.09.012
   Higgins S, 2016, INT J SPORT NUTR EXE, V26, P221, DOI 10.1123/ijsnem.2015-0147
   Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396
   Kim HY, 2015, MOLECULES, V20, P3107, DOI 10.3390/molecules20023107
   Kotz Catherine M, 2005, Minn Med, V88, P54
   Kovacs EMR, 2006, OBES REV, V7, P59, DOI 10.1111/j.1467-789X.2006.00203.x
   Lanner JT, 2012, ADV EXP MED BIOL, V740, P217, DOI 10.1007/978-94-007-2888-2_9
   Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013
   Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245
   Marin MT, 2011, EUR J PHARMACOL, V660, P363, DOI 10.1016/j.ejphar.2011.03.052
   Miles-Chan JL, 2015, OBESITY, V23, P16, DOI 10.1002/oby.20905
   MINOKOSHI Y, 1994, BRAIN RES, V649, P343, DOI 10.1016/0006-8993(94)91085-5
   Moy GA, 2013, PHYSIOL BEHAV, V109, P69, DOI 10.1016/j.physbeh.2012.11.008
   Novak CM, 2007, J NEUROENDOCRINOL, V19, P923, DOI 10.1111/j.1365-2826.2007.01606.x
   Novak CM, 2006, AM J PHYSIOL-ENDOC M, V290, pE396, DOI 10.1152/ajpendo.00293.2005
   Novak CM, 2010, HORM BEHAV, V58, P355, DOI 10.1016/j.yhbeh.2010.03.013
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Pant M, 2016, TRENDS ENDOCRIN MET, V27, P881, DOI 10.1016/j.tem.2016.08.006
   Pereira MA, 2014, ADV NUTR, V5, P797, DOI 10.3945/an.114.007062
   Powell KR, 2001, PHARMACOL BIOCHEM BE, V69, P59, DOI 10.1016/S0091-3057(01)00497-X
   Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010
   Rosenbaum M, 2003, AM J PHYSIOL-REG I, V285, pR183, DOI 10.1152/ajpregu.00474.2002
   Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915
   Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013
   Tallis J, 2015, BRIT J PHARMACOL, V172, P3703, DOI 10.1111/bph.13187
   Warren GL, 2010, MED SCI SPORT EXER, V42, P1375, DOI 10.1249/MSS.0b013e3181cabbd8
   Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001
NR 47
TC 19
Z9 19
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1870
EI 1440-1681
J9 CLIN EXP PHARMACOL P
JI Clin. Exp. Pharmacol. Physiol.
PD MAY
PY 2019
VL 46
IS 5
BP 475
EP 482
DI 10.1111/1440-1681.13065
PG 8
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA HU1GX
UT WOS:000465021700009
PM 30620415
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Nehlig, A
AF Nehlig, Astrid
TI Interindividual Differences in Caffeine Metabolism and Factors Driving
   Caffeine Consumption
SO PHARMACOLOGICAL REVIEWS
LA English
DT Review
ID CYTOCHROME-P450 1A2 ACTIVITY; ST-JOHNS-WORT; RECEPTOR GENE
   POLYMORPHISMS; XANTHINE-OXIDASE ACTIVITY; PREGNANCY-INDUCED CHANGES;
   GENOME-WIDE ASSOCIATION; ADENOSINE A2A RECEPTOR; HERB-DRUG INTERACTION;
   ACTIVITY IN-VIVO; PARKINSONS-DISEASE
AB Most individuals adjust their caffeine intake according to the objective and subjective effects induced by the methylxanthine. However, to reach the desired effects, the quantity of caffeine consumed varies largely among individuals. It has been known for decades that the metabolism, clearance, and pharmacokinetics of caffeine is affected by many factors such as age, sex and hormones, liver disease, obesity, smoking, and diet. Caffeine also interacts with many medications. All these factors will be reviewed in the present document and discussed in light of the most recent data concerning the genetic variability affecting caffeine levels and effects at the pharmacokinetic and pharmacodynamic levels that both critically drive the level of caffeine consumption. The pharmacokinetics of caffeine are highly variable among individuals due to a polymorphism at the level of the CYP1A2 isoform of cytochrome P450, which metabolizes 95% of the caffeine ingested. Moreover there is a polymorphism at the level of another critical enzyme, N-acetyltransferase 2. At the pharmacodynamic level, there are several polymorphisms at the main brain target of caffeine, the adenosine A2A receptor or ADORA2. Genetic studies, including genome-wide association studies, identified several loci critically involved in caffeine consumption and its consequences on sleep, anxiety, and potentially in neurodegenerative and psychiatric diseases. We start reaching a better picture on how a multiplicity of biologic mechanisms seems to drive the levels of caffeine consumption, although much more knowledge is still required to understand caffeine consumption and effects on body functions.
C1 [Nehlig, Astrid] Univ Paris 05, Necker Enfants Malad Hosp, INSERM, U 1129,Pediat Neurol, Paris, France.
C3 Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Necker-Enfants Malades - APHP; Institut National
   de la Sante et de la Recherche Medicale (Inserm)
RP Nehlig, A (corresponding author), Univ Paris 05, Necker Enfants Malad Hosp, INSERM, U 1129,Pediat Neurol, Paris, France.
EM nehliga@unistra.fr
FU Institute for Scientific Information on Coffee (ISIC), La Tour-de-Peilz
   (Switzerland); ISIC
FX This work was supported by a grant from the Institute for Scientific
   Information on Coffee (ISIC), La Tour-de-Peilz (Switzerland).The author
   of the current work received funding from ISIC, which is a
   not-for-profit organization founded in 1990 devoted to the study and
   disclosure of science related to coffee and health. The author assures
   that funding obtained from ISIC has not in any way affected the
   production or content of the current study. Finally, the author of the
   current work declares that there is no duality of interest associated
   with this work.
CR ABERNETHY DR, 1985, EUR J CLIN PHARMACOL, V28, P425, DOI 10.1007/BF00544361
   Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036
   Adehin Ayorinde, 2015, Drug Metabolism and Personalized Therapy, V30, P203, DOI 10.1515/dmpt-2015-0001
   Adehin A, 2015, EUR J CLIN PHARMACOL, V71, P687, DOI 10.1007/s00228-015-1852-9
   Ahmed I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004788
   Alonso-Navarro H, 2014, CURR DRUG METAB, V15, P129, DOI 10.2174/138920021502140327175404
   Alsene K, 2003, NEUROPSYCHOPHARMACOL, V28, P1694, DOI 10.1038/sj.npp.1300232
   Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x
   Amchin J, 1999, J CLIN PHARMACOL, V39, P252
   Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101
   Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005
   Arab L, 2011, J ALZHEIMERS DIS, V27, P553, DOI 10.3233/JAD-2011-110431
   Arnaud Maurice J, 2011, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-642-13443-2_3
   ARNAUD MJ, 1976, BIOCHEM MED METAB B, V16, P67, DOI 10.1016/0006-2944(76)90010-7
   ARNAUD MJ, 1991, FOURTEENTH INTERNATIONAL CONFERENCE ON COFFEE SCIENCE, P71
   Arnaud MJ., 1993, CAFFEINE COFFEE HLTH, P43
   Arold G, 2005, PLANTA MED, V71, P331, DOI 10.1055/s-2005-864099
   Ascherio A, 2004, AM J EPIDEMIOL, V160, P977, DOI 10.1093/aje/kwh312
   Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052
   AZCONA O, 1995, BRIT J CLIN PHARMACO, V40, P393, DOI 10.1111/j.1365-2125.1995.tb04562.x
   Backman JT, 2006, BRIT J CLIN PHARMACO, V62, P345, DOI 10.1111/j.1365-2125.2006.02653.x
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   Batalha VL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31493
   BATTISTUZZI G, 1981, ANN HUM GENET, V45, P15, DOI 10.1111/j.1469-1809.1981.tb00301.x
   BEACH CA, 1985, J PHARMACOL EXP THER, V233, P18
   Beaumont R, 2017, J SPORT SCI, V35, P1920, DOI 10.1080/02640414.2016.1241421
   Bell DG, 2002, J APPL PHYSIOL, V93, P1227, DOI 10.1152/japplphysiol.00187.2002
   Beste C, 2012, EUR NEUROPSYCHOPHARM, V22, P555, DOI 10.1016/j.euroneuro.2011.12.004
   BIRKETT DJ, 1991, BRIT J CLIN PHARMACO, V31, P405, DOI 10.1111/j.1365-2125.1991.tb05553.x
   Blake MJ, 2006, PEDIATR RES, V60, P717, DOI 10.1203/01.pdr.0000245909.74166.00
   BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933
   BLANCHARD J, 1984, Drug-Nutrient Interactions, V2, P243
   BLANCHARD J, 1983, J PHARMACOKINET BIOP, V11, P109, DOI 10.1007/BF01061844
   Bodenmann S, 2012, BRIT J PHARMACOL, V165, P1904, DOI 10.1111/j.1476-5381.2011.01689.x
   BOLOGA M, 1991, J PHARMACOL EXP THER, V257, P735
   BONATI M, 1985, DRUG METAB REV, V15, P1355, DOI 10.3109/03602538409029964
   BONATI M, 1982, CLIN PHARMACOL THER, V32, P98, DOI 10.1038/clpt.1982.132
   BORY C, 1979, J PEDIATR-US, V94, P988, DOI 10.1016/S0022-3476(79)80246-2
   BRACHTEL D, 1988, Z GASTROENTEROL, V26, P245
   Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810
   BROWN CR, 1988, CLIN PHARMACOL THER, V43, P488, DOI 10.1038/clpt.1988.63
   BRUGUEROLLE B, 1990, EUR J CLIN PHARMACOL, V39, P59, DOI 10.1007/BF02657059
   BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003
   Byrne EM, 2012, SLEEP, V35, P967, DOI 10.5665/sleep.1962
   Caetano L, 2017, MOL PSYCHIATR, V22, P1035, DOI 10.1038/mp.2016.173
   Caldeira D, 2013, HEART, V99, P1383, DOI 10.1136/heartjnl-2013-303950
   CALLAHAN MM, 1982, DRUG METAB DISPOS, V10, P417
   CARACO Y, 1995, INT J OBESITY, V19, P234
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Carrillo JA, 1996, BRIT J CLIN PHARMACO, V41, P605, DOI 10.1046/j.1365-2125.1996.35418.x
   Chen Y, 2009, XENOBIOTICA, V39, P508, DOI 10.1080/00498250902951763
   Chen Y, 2010, ANN PHARMACOTHER, V44, P1038, DOI 10.1345/aph.1M533
   Chen Y, 2009, CLIN EXP PHARMACOL P, V36, P828, DOI 10.1111/j.1440-1681.2009.05158.x
   CHENG WSC, 1990, CLIN PHARMACOL THER, V47, P516, DOI 10.1038/clpt.1990.66
   Chien CF, 2010, CHEM-BIOL INTERACT, V184, P458, DOI 10.1016/j.cbi.2010.01.017
   Childs E, 2008, NEUROPSYCHOPHARMACOL, V33, P2791, DOI 10.1038/npp.2008.17
   Chroscinska-Krawczyk M, 2016, PHARMACOL REP, V68, P680, DOI 10.1016/j.pharep.2016.03.011
   Chroscinska-Krawczyk M, 2009, PHARMACOL REP, V61, P819, DOI 10.1016/S1734-1140(09)70137-9
   Chuang YH, 2016, NEUROEPIDEMIOLOGY, V47, P192, DOI 10.1159/000450855
   CHVASTA TE, 1971, GASTROENTEROLOGY, V61, P838
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2007, AM J CLIN NUTR, V86, P240, DOI 10.1093/ajcn/86.1.240
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Cornelis MC, 2015, CURR OPIN LIPIDOL, V26, P20, DOI 10.1097/MOL.0000000000000143
   Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Culm-Merdek KE, 2005, BRIT J CLIN PHARMACO, V60, P486, DOI 10.1111/j.1365-2125.2005.02467.x
   Cunha RA, 2016, J NEUROCHEM, V139, P1019, DOI 10.1111/jnc.13724
   Curtis Brian R, 2014, Immunohematology, V30, P95
   Curtis Brian R, 2014, Immunohematology, V30, P55
   Cysneiros RM, 2007, CLIN PHARMACOL THER, V82, P54, DOI 10.1038/sj.clpt.6100211
   CZUCZWAR SJ, 1990, EPILEPSIA, V31, P318, DOI 10.1111/j.1528-1157.1990.tb05382.x
   Darwish M, 2008, CLIN PHARMACOKINET, V47, P61, DOI 10.2165/00003088-200847010-00006
   Debry G., 1994, COFFEE AND HLTH
   Deckert J, 1998, MOL PSYCHIATR, V3, P81, DOI 10.1038/sj.mp.4000345
   DELBEKE FT, 1988, BIOPHARM DRUG DISPOS, V9, P137, DOI 10.1002/bod.2510090203
   DEMENDONCA A, 1995, NEUROREPORT, V6, P1097, DOI 10.1097/00001756-199505300-00006
   DENARO CP, 1990, CLIN PHARMACOL THER, V48, P277, DOI 10.1038/clpt.1990.150
   Denden S, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027487
   Derry CJ, 2014, COCHRANE DB SYST REV, V12
   DESMOND PV, 1980, DIGEST DIS SCI, V25, P193, DOI 10.1007/BF01308138
   Dik VK, 2014, INT J CANCER, V135, P401, DOI 10.1002/ijc.28655
   Dinger J, 2016, TOXICOL LETT, V241, P82, DOI 10.1016/j.toxlet.2015.11.013
   Djordjevic N, 2008, EUR J CLIN PHARMACOL, V64, P381, DOI 10.1007/s00228-007-0438-6
   Djordjevic N, 2013, DRUG METAB PHARMACOK, V28, P93, DOI 10.2133/dmpk.DMPK-12-RG-029
   Djordjevic N, 2012, J CLIN PHARMACOL, V52, P1527, DOI 10.1177/0091270011420261
   Djordjevic N, 2011, J CLIN PHARMACOL, V51, P994, DOI 10.1177/0091270010377630
   Doepker C, 2016, ANNU REV FOOD SCI T, V7, P117, DOI 10.1146/annurev-food-041715-033243
   Domschke K, 2012, CURR PHARM DESIGN, V18, P5691, DOI 10.2174/138161212803530781
   Donovan J L, 2001, Psychopharmacol Bull, V35, P30
   Dragicevic N, 2012, NEUROPHARMACOLOGY, V63, P1368, DOI 10.1016/j.neuropharm.2012.08.018
   EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4404
   El Yacoubi M, 2005, EUR J PHARMACOL, V519, P290, DOI 10.1016/j.ejphar.2005.07.022
   EVANS SM, 1992, PSYCHOPHARMACOLOGY, V108, P51, DOI 10.1007/BF02245285
   Faber MS, 2004, CLIN PHARMACOL THER, V76, P178, DOI 10.1016/j.clpt.2004.04.003
   Facheris MF, 2008, MOVEMENT DISORD, V23, P2033, DOI 10.1002/mds.22247
   Ferré S, 2008, J NEUROCHEM, V105, P1067, DOI 10.1111/j.1471-4159.2007.05196.x
   Fillmore MT, 2002, J STUD ALCOHOL, V63, P745, DOI 10.15288/jsa.2002.63.745
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Freitag CM, 2010, EUR CHILD ADOLES PSY, V19, P67, DOI 10.1007/s00787-009-0043-6
   Fritz BM, 2014, ALCOHOL CLIN EXP RES, V38, P2269, DOI 10.1111/acer.12472
   FUHR U, 1995, INT J CLIN PHARM TH, V33, P311
   FUHR U, 1993, BRIT J CLIN PHARMACO, V35, P431, DOI 10.1111/j.1365-2125.1993.tb04162.x
   FUHR U, 1992, ANTIMICROB AGENTS CH, V36, P942, DOI 10.1128/AAC.36.5.942
   Gajewska A, 2013, PROG NEURO-PSYCHOPH, V40, P115, DOI 10.1016/j.pnpbp.2012.08.008
   Gasior M, 1996, PHARMACOL BIOCHEM BE, V54, P639, DOI 10.1016/0091-3057(95)02222-8
   Gasior M, 1998, EUR J PHARMACOL, V352, P207, DOI 10.1016/S0014-2999(98)00375-6
   Geiger MJ, 2016, EUR NEUROPSYCHOPHARM, V26, P1274, DOI 10.1016/j.euroneuro.2016.05.007
   GEORGE J, 1986, CLIN EXP PHARMACOL P, V13, P731, DOI 10.1111/j.1440-1681.1986.tb02414.x
   Gloria-Bottini F., 2011, Health, V3, P77, DOI 10.4236/health.2011.32014
   Goldstein ER, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-5
   Gotoh L, 2002, MOL BRAIN RES, V100, P1, DOI 10.1016/S0169-328X(02)00136-5
   Gotoh L, 2009, PSYCHIAT GENET, V19, P328, DOI 10.1097/YPG.0b013e3283328e26
   Granfors MT, 2005, CLIN PHARMACOL THER, V78, P400, DOI 10.1016/j.clpt.2005.06.009
   Granfors MT, 2004, CLIN PHARMACOL THER, V76, P598, DOI 10.1016/j.clpt.2004.08.018
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso LM, 2008, ANN EPIDEMIOL, V18, P172, DOI 10.1016/j.annepidem.2007.11.005
   Grosso LM, 2005, ANN EPIDEMIOL, V15, P460, DOI 10.1016/j.annepidem.2004.12.011
   GU L, 1992, PHARMACOGENETICS, V2, P73, DOI 10.1097/00008571-199204000-00004
   Guo WC, 2004, ACTA PHARMACOL SIN, V25, P1112
   Gurley BJ, 2005, CLIN PHARMACOL THER, V77, P415, DOI 10.1016/j.clpt.2005.01.009
   Gurley BJ, 2004, CLIN PHARMACOL THER, V76, P428, DOI 10.1016/j.clpt.2004.07.007
   Gurley BJ, 2005, DRUG AGING, V22, P525, DOI 10.2165/00002512-200522060-00006
   Ha HR, 1996, EUR J CLIN PHARMACOL, V49, P309, DOI 10.1007/BF00226333
   Hamilton SP, 2004, NEUROPSYCHOPHARMACOL, V29, P558, DOI 10.1038/sj.npp.1300311
   Hamon-Vilcot B, 2004, THERAPIE, V59, P247, DOI 10.2515/therapie:2004048
   Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237
   HASHIGUCHI M, 1992, J CLIN PHARMACOL, V32, P184, DOI 10.1002/j.1552-4604.1992.tb03824.x
   Hasko Gyorgy, 2011, Handb Exp Pharmacol, P457, DOI 10.1007/978-3-642-13443-2_18
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Heinz AJ, 2013, EXP CLIN PSYCHOPHARM, V21, P222, DOI 10.1037/a0032337
   Hermann R, 2012, PLANTA MED, V78, P1458, DOI 10.1055/s-0032-1315117
   Hohoff C, 2009, J NEURAL TRANSM, V116, P659, DOI 10.1007/s00702-008-0089-5
   Hohoff C, 2010, J PSYCHIATR RES, V44, P930, DOI 10.1016/j.jpsychires.2010.02.006
   Howland J, 2011, ADDICTION, V106, P335, DOI 10.1111/j.1360-0443.2010.03219.x
   Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491
   Ishiguro H, 2006, NEUROPSYCHOPHARMACOL, V31, P572, DOI 10.1038/sj.npp.1300855
   Ishikawa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102152
   Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899
   Jan WC, 2005, J ETHNOPHARMACOL, V102, P440, DOI 10.1016/j.jep.2005.07.002
   Jankiewicz Katarzyna, 2007, Przegl Lek, V64, P965
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   JARBOE CH, 1986, J TOXICOL-CLIN TOXIC, V24, P415, DOI 10.3109/15563658608992604
   Jeppesen U, 1996, PHARMACOGENETICS, V6, P213, DOI 10.1097/00008571-199606000-00003
   Jodynis-Liebert J, 2004, J CLIN PHARMACOL, V44, P338, DOI 10.1177/0091270004263468
   JOERES R, 1987, PHARMACOL THERAPEUT, V33, P163, DOI 10.1016/0163-7258(87)90046-5
   Johnson-Kozlow M, 2002, AM J EPIDEMIOL, V156, P842, DOI 10.1093/aje/kwf119
   Josse AR, 2012, AM J CLIN NUTR, V96, P665, DOI 10.3945/ajcn.112.038794
   Kalow W, 1986, Prog Clin Biol Res, V214, P331
   KALOW W, 1991, CLIN PHARMACOL THER, V50, P508, DOI 10.1038/clpt.1991.176
   KALOW W, 1991, CLIN PHARMACOL THER, V49, P44, DOI 10.1038/clpt.1991.8
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Kawachi I, 1996, ARCH INTERN MED, V156, P521, DOI 10.1001/archinte.156.5.521
   KHANNA NN, 1984, J TOXICOL-CLIN TOXIC, V22, P473, DOI 10.3109/15563658408992578
   Kinzig-Schippers M, 1999, CLIN PHARMACOL THER, V65, P262, DOI 10.1016/S0009-9236(99)70105-0
   Kobayashi H, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-50
   LACHANCE MP, 1983, TOXICOL APPL PHARM, V71, P237, DOI 10.1016/0041-008X(83)90340-X
   Laitala VS, 2008, ADDICTION, V103, P2054, DOI 10.1111/j.1360-0443.2008.02375.x
   Lam P, 2005, NEUROSCI LETT, V378, P98, DOI 10.1016/j.neulet.2004.12.012
   Lampe JW, 2000, CARCINOGENESIS, V21, P1157, DOI 10.1093/carcin/21.6.1157
   Landi M T, 1999, IARC Sci Publ, P173
   LANE JD, 1992, EUR J CLIN PHARMACOL, V43, P543, DOI 10.1007/BF02285099
   Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771
   LEE CA, 1991, DRUG METAB DISPOS, V19, P966
   LEE MA, 1988, AM J PSYCHIAT, V145, P632
   LELO A, 1986, BRIT J CLIN PHARMACO, V22, P183, DOI 10.1111/j.1365-2125.1986.tb05247.x
   LELO A, 1986, BRIT J CLIN PHARMACO, V22, P177, DOI 10.1111/j.1365-2125.1986.tb05246.x
   LeMarchand L, 1996, CANCER EPIDEM BIOMAR, V5, P449
   LeMarchand L, 1997, PHARMACOGENETICS, V7, P11, DOI 10.1097/00008571-199702000-00002
   Liang NJ, 2014, MOLECULES, V19, P19180, DOI 10.3390/molecules191119180
   Liguori A, 2001, DRUG ALCOHOL DEPEN, V63, P123, DOI 10.1016/S0376-8716(00)00196-4
   LOFT S, 1988, HUM TOXICOL, V7, P277, DOI 10.1177/096032718800700309
   Lovallo WR, 2005, PSYCHOSOM MED, V67, P734, DOI 10.1097/01.psy.0000181270.20036.06
   Lucas M, 2011, ARCH INTERN MED, V171, P1571, DOI 10.1001/archinternmed.2011.393
   Luciano M, 2005, ADDICTION, V100, P1510, DOI 10.1111/j.1360-0443.2005.01223.x
   Luszczki JJ, 2006, PHARMACOL REP, V58, P652
   MacKenzie T, 2007, METABOLISM, V56, P1694, DOI 10.1016/j.metabol.2007.07.013
   MARKS V, 1973, LANCET, V1, P827
   Matzke GR, 2000, PHARMACOTHERAPY, V20, P182, DOI 10.1592/phco.20.3.182.34775
   Mazzotti DR, 2011, SLEEP, V34, P399, DOI 10.1093/sleep/34.3.399
   McLean C, 2002, J APPL PHYSIOL, V93, P1471, DOI 10.1152/japplphysiol.00762.2000
   Molero Y, 2013, GENES BRAIN BEHAV, V12, P305, DOI 10.1111/gbb.12015
   Montesinos MC, 2000, ARTHRITIS RHEUM, V43, P656, DOI 10.1002/1529-0131(200003)43:3<656::AID-ANR23>3.0.CO;2-H
   MORAIDIS I, 1994, BRAIN RES, V640, P140, DOI 10.1016/0006-8993(94)91868-6
   MORISOT C, 1990, ARCH FR PEDIATR, V47, P221
   Mumford GK, 1996, EUR J CLIN PHARMACOL, V51, P319, DOI 10.1007/s002280050205
   Muscat JE, 2008, BIOCHEM PHARMACOL, V76, P929, DOI 10.1016/j.bcp.2008.07.024
   NADA AH, 1991, INT J PHARM, V70, P191, DOI 10.1016/0378-5173(91)90180-V
   NEHLIG A, 1986, EUR J PHARMACOL, V129, P93, DOI 10.1016/0014-2999(86)90340-7
   Nehlig A, 2004, NUTR BRAIN BEHAV, P133
   Nehlig A, 2004, NUTR BRAIN BEHAV, P165
   Nehlig A, 2010, J ALZHEIMERS DIS, V20, pS85, DOI 10.3233/JAD-2010-091315
   Nordestgaard AT, 2016, INT J EPIDEMIOL, V45, P1938, DOI 10.1093/ije/dyw325
   Nunes RA, 2017, SLEEP MED, V30, P210, DOI 10.1016/j.sleep.2016.06.038
   Palacios N, 2010, PARKINSONISM RELAT D, V16, P370, DOI 10.1016/j.parkreldis.2010.02.012
   Palacios N, 2012, MOVEMENT DISORD, V27, P1276, DOI 10.1002/mds.25076
   Panza F, 2015, J NUTR HEALTH AGING, V19, P313, DOI 10.1007/s12603-014-0563-8
   Park GJH, 2003, HEPATOLOGY, V38, P1227, DOI 10.1053/jhep.2003.50475
   PARSONS WD, 1978, CLIN PHARMACOL THER, V24, P40
   Persico AM, 2000, AM J MED GENET, V96, P784, DOI 10.1002/1096-8628(20001204)96:6<784::AID-AJMG18>3.3.CO;2-Z
   Perucca E, 2005, EPILEPSIA, V46, P31, DOI 10.1111/j.1528-1167.2005.463007.x
   Ping J, 2012, CHEM-BIOL INTERACT, V195, P68, DOI 10.1016/j.cbi.2011.11.001
   Pirastu N, 2016, SCI REP-UK, V6, DOI 10.1038/srep31590
   Pollock BG, 1999, J CLIN PHARMACOL, V39, P936, DOI 10.1177/00912709922008560
   PONS G, 1988, PEDIATR RES, V23, P632, DOI 10.1203/00006450-198806000-00021
   Popat RA, 2011, EUR J NEUROL, V18, P756, DOI 10.1111/j.1468-1331.2011.03353.x
   Posadzki P, 2013, BRIT J CLIN PHARMACO, V75, P603, DOI 10.1111/j.1365-2125.2012.04350.x
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Qi LW, 2011, CURR DRUG METAB, V12, P818, DOI 10.2174/138920011797470128
   Raaska K, 2004, BASIC CLIN PHARMACOL, V94, P13, DOI 10.1111/j.1742-7843.2004.pto_940104.x
   Rasmussen BB, 2002, PHARMACOGENETICS, V12, P473, DOI 10.1097/00008571-200208000-00008
   Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023
   Rétey JV, 2007, CLIN PHARMACOL THER, V81, P692, DOI 10.1038/sj.clpt.6100102
   Rétey JV, 2005, P NATL ACAD SCI USA, V102, P15676, DOI 10.1073/pnas.0505414102
   Rieth N, 2016, ENDOCRINE, V52, P391, DOI 10.1007/s12020-015-0780-x
   RIETVELD EC, 1984, EUR J CLIN PHARMACOL, V26, P371, DOI 10.1007/BF00548769
   Ritchie K, 2007, NEUROLOGY, V69, P536, DOI 10.1212/01.wnl.0000266670.35219.0c
   Rocha L, 1999, PHARMACOGENETICS, V9, P9
   Rogers PJ, 2010, NEUROPSYCHOPHARMACOL, V35, P1973, DOI 10.1038/npp.2010.71
   Roncucci R, 1982, WORLD REV NUTR DIET, V43, P140
   Rupp TL, 2013, J SLEEP RES, V22, P160, DOI 10.1111/j.1365-2869.2012.01062.x
   Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x
   Salinero JJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030269
   Santos C, 2010, J ALZHEIMERS DIS, V20, pS175, DOI 10.3233/JAD-2010-091303
   Santos RMM, 2016, P 26 ASIC C KUNM CHI
   Saruwatari J, 2002, CLIN PHARMACOL THER, V72, P200, DOI 10.1067/mcp.2002.126173
   Saruwatari J, 2014, BASIC CLIN PHARMACOL, V115, P360, DOI 10.1111/bcpt.12224
   Sasaki S, 2017, PEDIATR RES, V82, P19, DOI 10.1038/pr.2017.70
   Schmider J, 1999, PHARMACOGENETICS, V9, P725, DOI 10.1097/01213011-199912000-00007
   SCOTT NR, 1988, CLIN SCI, V74, P377, DOI 10.1042/cs0740377
   SCOTT NR, 1986, BRIT J CLIN PHARMACO, V22, P475, DOI 10.1111/j.1365-2125.1986.tb02920.x
   Sebastiao AM, 2011, BBA-BIOMEMBRANES, V1808, P1340, DOI 10.1016/j.bbamem.2010.06.028
   Shirley KL, 2003, NEUROPSYCHOPHARMACOL, V28, P961, DOI 10.1038/sj.npp.1300123
   Shulman LM, 2002, PARKINSONISM RELAT D, V8, P289, DOI 10.1016/S1353-8020(02)00014-7
   Signorello LB, 2001, OBSTET GYNECOL, V98, P1059, DOI 10.1016/S0029-7844(01)01575-7
   Silva CG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006258
   Simon DK, 2017, J NEUROL SCI, V375, P355, DOI 10.1016/j.jns.2017.02.032
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Snel J., 1993, COFFEE CAFFEINE HLTH, P255
   SOMANI SM, 1980, J PEDIATR-US, V96, P1091, DOI 10.1016/S0022-3476(80)80652-4
   SOTO J, 1994, THER DRUG MONIT, V16, P49, DOI 10.1097/00007691-199402000-00008
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Svenningsson P, 1999, J NEUROSCI, V19, P4011
   Swan GE, 1996, J SUBST ABUSE, V8, P19, DOI 10.1016/S0899-3289(96)90055-3
   Swanson JA, 1997, ADDICT BEHAV, V22, P55, DOI 10.1016/S0306-4603(96)00023-8
   Tan EK, 2006, AM J MED GENET B, V141B, P634, DOI 10.1002/ajmg.b.30359
   TANAKA H, 1984, BRAIN DEV-JPN, V6, P355, DOI 10.1016/S0387-7604(84)80111-4
   Tang JL, 2007, FOOD CHEM TOXICOL, V45, P2441, DOI 10.1016/j.fct.2007.05.023
   Tang W., 2011, Handbook of Chinese medicinal plants chemistry, pharmacology, toxicology
   TANGLIU DD, 1983, J PHARMACOL EXP THER, V224, P180
   Tantcheva-Poór I, 1999, PHARMACOGENETICS, V9, P131
   TRAGANOS F, 1991, CELL PROLIFERAT, V24, P305, DOI 10.1111/j.1365-2184.1991.tb01159.x
   TRANG JM, 1985, BIOPHARM DRUG DISPOS, V6, P51, DOI 10.1002/bdd.2510060107
   Tsai HH, 2012, INT J CLIN PRACT, V66, P1056, DOI 10.1111/j.1742-1241.2012.03008.x
   Tsai TH, 2005, PLANTA MED, V71, P640, DOI 10.1055/s-2005-871270
   Tsutsumi K, 2001, CLIN PHARMACOL THER, V70, P121, DOI 10.1067/mcp.2001.116495
   TURMEN T, 1979, J PEDIATR-US, V95, P644, DOI 10.1016/S0022-3476(79)80788-X
   Urry E, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0126-6
   Vanattou-Saïfoudine N, 2012, BRIT J PHARMACOL, V167, P946, DOI 10.1111/j.1476-5381.2012.02065.x
   Vaz Julius, 1998, Indian Journal of Experimental Biology, V36, P112
   VISTISEN K, 1991, ADV EXP MED BIOL, V283, P407
   VISTISEN K, 1992, CARCINOGENESIS, V13, P1561, DOI 10.1093/carcin/13.9.1561
   Walton K, 2001, FOOD CHEM TOXICOL, V39, P667, DOI 10.1016/S0278-6915(01)00006-0
   Walzer M, 2012, PHARMACOTHERAPY, V32, P340, DOI 10.1002/j.1875-9114.2012.01028.x
   Watson J, 2002, BRIT J CLIN PHARMACO, V54, P400, DOI 10.1046/j.1365-2125.2002.01681.x
   Wedick NM, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-86
   Welfare MR, 2000, BRIT J CLIN PHARMACO, V49, P240, DOI 10.1046/j.1365-2125.2000.00130.x
   Whitfield K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007339.pub2
   Whitten DL, 2006, BRIT J CLIN PHARMACO, V62, P512, DOI 10.1111/j.1365-2125.2006.02755.x
   WLAZ P, 1992, J NEURAL TRANSM-GEN, V89, P41, DOI 10.1007/BF01245350
   Xu HB, 2005, BRIT J PHARMACOL, V146, P296, DOI 10.1038/sj.bjp.0706319
   Xu K, 2006, J NEUROSCI, V26, P535, DOI 10.1523/JNEUROSCI.3008-05.2006
   Yamada-Fowler Naomi, 2015, Journal of Caffeine Research, V5, P3, DOI 10.1089/jcr.2014.0028
   Yamada-Fowler N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099294
   Yamazaki T, 2017, CLIN PHARM DRUG DEV, V6, P54, DOI 10.1002/cpdd.281
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Yu T, 2016, J CLIN PHARMACOL, V56, P590, DOI 10.1002/jcph.632
   Zandvliet AS, 2005, BASIC CLIN PHARMACOL, V96, P71, DOI 10.1111/j.1742-7843.2005.pto960111.x
   Zuchinali P, 2016, EUROPACE, V18, P257, DOI 10.1093/europace/euv261
   Zuchora B, 2005, EUR NEUROPSYCHOPHARM, V15, P85, DOI 10.1016/j.euroneuro.2004.05.006
NR 282
TC 338
Z9 360
U1 17
U2 158
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0031-6997
EI 1521-0081
J9 PHARMACOL REV
JI Pharmacol. Rev.
PD APR
PY 2018
VL 70
IS 2
BP 384
EP 411
DI 10.1124/pr.117.014407
PG 28
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Pharmacology & Pharmacy
GA GL2TS
UT WOS:000436978700001
PM 29514871
DA 2025-04-28
ER

PT J
AU Alsunni, A
   Majeed, F
   Yar, T
   AlRahim, A
   Ajhawaj, AF
   Alzaki, M
AF Alsunni, Ahmed
   Majeed, Farrukh
   Yar, Talay
   AlRahim, Ahmed
   Ajhawaj, Ali Fuad
   Alzaki, Muneer
TI Effects of energy drink consumption on corrected QT interval and heart
   rate variability in young obese Saudi male university students
SO ANNALS OF SAUDI MEDICINE
LA English
DT Article
ID ELECTROCARDIOGRAPHIC PARAMETERS; ATRIAL-FIBRILLATION; CAFFEINE;
   REPOLARIZATION; OVERWEIGHT; DISPERSION; SYSTEM
AB BACKGROUND AND OBJECTIVES: Consumption of energy drinks has adverse effects on the heart that might be potentiated in obese individuals. Since the incidence of obesity and use of energy drinks is high among Saudi youth, we used non-invasive tests to study hemodynamic changes produced by altered autonomic cardiac activity following consumption of energy drinks in obese male students.
   DESIGN AND SETTING: This cross-sectional study was carried out at Department of Physiology, College of Medicine, University of Dammam, Saudi Arabia, over a one-year period from December 2013 to December 2014.
   SUBJECTS AND METHODS: In Saudi male university students we measured continuous ECG recordings and a one-minute deep breathing maneuver to measure the expiratory-to-inspiratory ratio, the mean heart rate range (MHRR), the mean percentage variability. (M% VHR) and the corrected QT interval (QTc) at 0, 30 and 60 minutes after consumption of energy drink.
   RESULTS: We enrolled 31 students (18 overweight/obese and 13 normal weights. QTc was significantly increased at 60 min as compared with the resting state in overweight/obese subjects (P=.006). Heart rate variability was significantly less in obese as compared with normal weight subjects at 60 minutes as indicated by E:I ratio, (P=.037), MHRR (P=.012), M% VHR (P=.040) after energy drink consumption. Significant increases in diastolic (P=.020) and mean arterial blood pressure (P=.024) were observed at 30 minutes in the obese group.
   CONCLUSION: Hemodynamic changes after intake of energy drinks in obese subjects indicate that obesity and energy drinks could synergistically induce harmful effects. This finding warrants efforts to caution the obese on intake of energy drinks and timely intervention to motivate changes in life style.
C1 [Alsunni, Ahmed; Majeed, Farrukh; Yar, Talay; AlRahim, Ahmed; Ajhawaj, Ali Fuad; Alzaki, Muneer] Univ Dammam, Dept Physiol, Al Khobar 31441, Saudi Arabia.
C3 Imam Abdulrahman Bin Faisal University
RP Majeed, F (corresponding author), Univ Dammam, Dept Physiol, Al Khobar 31441, Saudi Arabia.
EM fmajeed@uod.edu.sa
RI ; Yar, Talay/A-3600-2015
OI Alsunni, Ahmed A/0000-0001-5402-1091; Alhawaj, Ali/0000-0002-6165-3617;
   Yar, Talay/0000-0001-5066-5025; alrahim, Ahmed/0000-0002-1730-1817
FU Deanship of Scientific Research at the University of Dammam, KSA
FX This Project was funded by the Deanship of Scientific Research at the
   University of Dammam, KSA.
CR Alsunni Ahmed A, 2011, J Ayub Med Coll Abbottabad, V23, P3
   Ambhore A, 2014, SINGAP MED J, V55, P607, DOI 10.11622/smedj.2014172
   [Anonymous], 2009, CLEVE CLIN J MED, DOI DOI 10.3949/CCJM.76.S2.08
   [Anonymous], 2006, QTC PROL RISK SUDD C
   Barella LF, 2015, EXP PHYSIOL, V100, P57, DOI 10.1113/expphysiol.2014.082982
   Berger LK, 2011, ADDICT BEHAV, V36, P516, DOI 10.1016/j.addbeh.2010.12.027
   Bhave PD, 2013, HEART, V99, P1377, DOI 10.1136/heartjnl-2013-304543
   Braschi A, 2011, OBESITY, V19, P875, DOI 10.1038/oby.2010.252
   Buscemi S, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-15
   Cavka A, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/751530
   Davey P, 2002, J PHARMACOL TOXICOL, V48, P3, DOI 10.1016/S1056-8719(03)00008-X
   Girola A, 2001, OBES RES, V9, P71, DOI 10.1038/oby.2001.9
   Hsu HS, 2011, EUR J CLIN INVEST, V41, P393, DOI 10.1111/j.1365-2362.2010.02421.x
   Ibrahim NK, 2014, PAK J MED SCI, V30, P1415, DOI 10.12669/pjms.306.5396
   Indumathy J, 2015, OBES RES CLIN PRACT, V9, P55, DOI 10.1016/j.orcp.2014.01.007
   Karapetian GK, 2012, INT J SPORTS MED, V33, P507, DOI 10.1055/s-0032-1301904
   Karim Nasim., 2011, J BASIC APPL SCI, V7, P71
   Kim WS, 2014, ANN REHABIL MED-ARM, V38, P775, DOI 10.5535/arm.2014.38.6.775
   Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35
   Mapanga RF, 2014, ACTA PHYSIOL, V210, P546, DOI 10.1111/apha.12184
   Maule S, 2008, HYPERTENS RES, V31, P2003, DOI 10.1291/hypres.31.2003
   Mukerji R, 2012, OBESITY, V20, P1950, DOI 10.1038/oby.2011.255
   Musat DL, 2013, AM J CARDIOL, V112, P1379, DOI 10.1016/j.amjcard.2013.06.027
   Nomura A, 2000, AM J CARDIOL, V85, P106, DOI 10.1016/S0002-9149(99)00617-7
   Norah M, 2010, J EGYPT PUBLIC HLTH, V85, P46
   O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x
   Olateju T, 2015, CAN J DIABETES, V39, P78, DOI 10.1016/j.jcjd.2014.07.220
   OPTHOF T, 1993, CARDIOVASC RES, V27, P753, DOI 10.1093/cvr/27.5.753
   Peacock A, 2013, APPETITE, V64, P1, DOI 10.1016/j.appet.2012.12.021
   Seyfeli E, 2006, INT J OBESITY, V30, P957, DOI 10.1038/sj.ijo.0803233
   SMITH SE, 1981, CLIN SCI, V61, P379, DOI 10.1042/cs0610379
   Steinke L, 2009, ANN PHARMACOTHER, V43, P596, DOI 10.1345/aph.1L614
   Valtonen MK, 2012, SCAND J PUBLIC HEALT, V40, P674, DOI 10.1177/1403494812461730
   Vardar SA, 2008, ANATOL J CARDIOL, V8, P27
   Wójcik OP, 2013, EUR J NUTR, V52, P169, DOI 10.1007/s00394-011-0300-6
   Yoshinaga C., 2012, International Sportmed Journal, V13, P109
NR 36
TC 14
Z9 15
U1 0
U2 23
PU K FAISAL SPEC HOSP RES CENTRE
PI RIYADH
PA PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA
SN 0256-4947
EI 1319-9226
J9 ANN SAUDI MED
JI Ann. Saudi Med.
PD JUL-AUG
PY 2015
VL 35
IS 4
BP 282
EP 287
DI 10.5144/0256-4947.2015.282
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA CV5WO
UT WOS:000364342300002
PM 26497707
OA Green Published, Green Submitted, gold
DA 2025-04-28
ER

PT J
AU Gamboa-Gómez, CI
   Morales-Castro, J
   Barragan-Zuñiga, J
   Herrera, MD
   Zamilpa-Alvarez, A
   Gónzalez, JL
   Martínez-Aguilar, G
   Morales-Castro, EP
   Anese, M
   Alongi, M
AF Gamboa-Gomez, Claudia I.
   Morales-Castro, Juliana
   Barragan-Zuniga, Jazel
   Herrera, Mayra Denise
   Zamilpa-Alvarez, Alejandro
   Gonzalez, Jose Luis
   Martinez-Aguilar, Gerardo
   Morales-Castro, Elisa P.
   Anese, Monica
   Alongi, Marilisa
TI Influence of coffee roasting degree on antioxidant and metabolic
   parameters: Comprehensive in vitro and in vivo analysis
SO CURRENT RESEARCH IN FOOD SCIENCE
LA English
DT Article
DE Coffee roasting degree; Antioxidant activity; Metabolic disorders;
   Obesity; Glucose metabolism; Lipid metabolism
ID LIPID-PEROXIDATION; GLUCOSE; OBESITY; PROFILE; POLYPHENOLS; EXTRACTS;
   GREEN; ACIDS; ASSAY; FOOD
AB This study aimed to assess the impact of roasting degree on antioxidant and metabolic parameters in vitro and in vivo. . In vitro, , we evaluated radical scavenging, lipid peroxidation, and the activity of digestive enzymes (alpha-glucosidase, alpha-amylase, and lipase). In vivo, , we first examined coffee's effect on carbohydrate and lipid absorption in healthy rats, followed by a chronic evaluation of metabolic disorders and antioxidant markers using a diet-induced obesity model. In vitro results revealed that increased roasting degree reduced the antioxidant capacity of coffee brews. All brews showed lower inhibition of alpha-glucosidase and alpha-amylase, and lipase inhibition compared to the positive control (acarbose or orlistat). In vivo, , all roasting degrees consistently reduced postprandial glucose levels by 20%. Notably, coffee with a high roasting degree (HRD) decreased serum triglycerides (TG) by similar to 44% after a lipid load, while other roasts did not. Chronic administration of unroasted (UN) or HRD coffee significantly reduced weight gain compared to the obese control (similar to 15% and similar to 10%, respectively). Notably, all coffee samples improved lipid metabolism parameters. UN and HRD coffee significantly decreased adipocyte volume by 58% and 48%, respectively, compared to the obese control. Additionally, all groups exhibited less than 30% hepatic lipid droplets independent of roasting degree. HRD treatment notably increased liver catalase (CAT) activity and reduced lipid peroxidation in serum (similar to 90%), liver (similar to 59%), and adipose tissue (similar to 37%) compared to the obese control group. These findings suggest that HRD in coffee may confer certain biological advantages.
C1 [Gamboa-Gomez, Claudia I.] Inst Mexicano Seguro Social, Unidad Invest Biomed, Canoas 100, Durango 34067, Mexico.
   [Morales-Castro, Juliana; Morales-Castro, Elisa P.] TecNM Inst Tecnol Durango, Div Estudios Posgrad Invest, Blvd Felipe Pescador 1830 Ote, Durango 34080, Dgo, Mexico.
   [Barragan-Zuniga, Jazel] Secretaria Salud Durango, Ctr Estatal Cancerol, Zona Ctr, Av 5 Febrero Esq,Antonio Norman Fuentes S-N, Durango 34000, Dgo, Mexico.
   [Herrera, Mayra Denise] Inst Nacl Invest Forestales Agr & Pecuarias, Campo Expt Zacatecas, Kilometro 24-5, Zacatecas 98500, Zac, Mexico.
   [Zamilpa-Alvarez, Alejandro] IMSS, Ctr Invest Biomed Sur, Xochitepec, Morelos, Mexico.
   [Gonzalez, Jose Luis] Hosp Gen Zona 1, Dept Patol, Inst Mexicano Seguro Social, Canoas S-N, Durango 34067, Mexico.
   [Martinez-Aguilar, Gerardo] Univ Juarez Estado De Durango, Fac Med & Nutr, Av Univ & Fanny Anitua S-N, Durango 34000, Mexico.
   [Anese, Monica; Alongi, Marilisa] Univ Udine, Dept Agr Food Environm & Anim Sci, Via Sondrio 2-A, I-33100 Udine, Italy.
C3 Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro
   Social; Universidad Juarez del Estado de Durango; University of Udine
RP Gamboa-Gómez, CI (corresponding author), Inst Mexicano Seguro Social, Unidad Invest Biomed, Canoas 100, Durango 34067, Mexico.; Alongi, M (corresponding author), Univ Udine, Dept Agr Food Environm & Anim Sci, Via Sondrio 2-A, I-33100 Udine, Italy.
EM clau140382@hotmail.com; marilisa.alongi@uniud.it
RI ALONGI, MARILISA/P-9770-2019; Hidalgo González, José Luis/AAG-4123-2020;
   Zamilpa, Alejandro/AAC-2241-2019; Herrera, Mayra/KYO-0579-2024;
   Morales-Castro, Juliana/HCG-8714-2022
OI BARRAGAN ZUNIGA, LAURA JAZEL/0000-0002-9925-6668; Gamboa-Gomez, Claudia
   I/0000-0002-2815-9406
FU National Systems of Research of Mexico (SNI) [209339]
FX This project was funded by a scholarship awarded by the National Systems
   of Research of Mexico (SNI, No. 209339) .<STRONG> </STRONG>
CR Aliko V, 2018, FISH SHELLFISH IMMUN, V76, P101, DOI 10.1016/j.fsi.2018.02.042
   Alongi M, 2021, FOOD CHEM, V342, DOI 10.1016/j.foodchem.2020.128289
   Alongi M, 2018, FOOD RES INT, V111, P480, DOI 10.1016/j.foodres.2018.05.061
   [Anonymous], 1999, Norma Oficial MexiNOM-062-ZOO
   Apostolidis E, 2007, INNOV FOOD SCI EMERG, V8, P46, DOI 10.1016/j.ifset.2006.06.001
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/c7fo00388a, 10.1039/C7FO00388A]
   Bastian F, 2021, FOODS, V10, DOI 10.3390/foods10112827
   Bettaieb I, 2024, FOOD BIOSCI, V57, DOI 10.1016/j.fbio.2023.103473
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Budryn G, 2017, EUR FOOD RES TECHNOL, V243, P1323, DOI 10.1007/s00217-017-2843-0
   Choi S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030363
   Clarke R. J., 1987, Coffee-Technology, P73
   Colak E, 2021, J MED BIOCHEM, V40, P1, DOI 10.5937/jomb0-24652
   Coniff R, 1997, CLIN THER, V19, P16, DOI 10.1016/S0149-2918(97)80069-0
   Coruh N, 2007, FOOD CHEM, V100, P1237, DOI 10.1016/j.foodchem.2005.12.006
   da Silva CQ, 2021, FOOD RES INT, V141, DOI 10.1016/j.foodres.2020.110089
   Del Rio D, 2010, NUTRIENTS, V2, P820, DOI 10.3390/nu2080820
   Duangjai A, 2021, PREV NUTR FOOD SCI, V26, P338, DOI 10.3746/pnf.2021.26.3.338
   FALHOLT K, 1973, CLIN CHIM ACTA, V46, P105, DOI 10.1016/0009-8981(73)90016-8
   Filippatos TD, 2008, DRUG SAFETY, V31, P53, DOI 10.2165/00002018-200831010-00005
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gallardo-Ignacio J, 2023, MOLECULES, V28, DOI 10.3390/molecules28124685
   Gamboa-Gómez CI, 2023, J FUNCT FOODS, V111, DOI 10.1016/j.jff.2023.105889
   Gamboa-Gomez CI, 2022, J ETHNOPHARMACOL, V297, DOI 10.1016/j.jep.2022.115527
   Guerrero-Romero F, 2010, J CLIN ENDOCR METAB, V95, P3347, DOI 10.1210/jc.2010-0288
   Harb AA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50352-4
   Herawati D, 2019, FOOD SCI BIOTECHNOL, V28, P7, DOI 10.1007/s10068-018-0442-x
   HWANG Su-Jeong, 2023, Food Sci. Technol, V43, pe121522, DOI 10.1590/fst.121522
   ICO, 2022, Exports of all forms of coffee by exporting countries to all destinations-January 2022. Monthly trade statistics-exports
   International A., 1995, J. AOAC Int, V78, p143A, DOI [10.1093/jaoac/78.5.143A, DOI 10.1093/JAOAC/78.5.143A]
   Jha PK, 2015, MOL CELL ENDOCRINOL, V418, P74, DOI 10.1016/j.mce.2015.01.024
   Jung S, 2017, J MED FOOD, V20, P626
   Kim S.Y., 2023, Food Eng. Prog., V27, P146, DOI [10.13050/foodengprog.2023.27.2.146, DOI 10.13050/FOODENGPROG.2023.27.2.146]
   Laukaleja I, 2019, FOODBALT, P7, DOI 10.22616/FoodBalt.2019.002
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mauvais-Jarvis F, 2017, CELL METAB, V25, P1216, DOI 10.1016/j.cmet.2017.04.033
   McDougall GJ, 2009, FOOD CHEM, V115, P193, DOI 10.1016/j.foodchem.2008.11.093
   McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867
   Miranda J, 2018, J PHYSIOL BIOCHEM, V74, P655, DOI 10.1007/s13105-018-0654-9
   Morris RT, 2008, J APPL PHYSIOL, V104, P708, DOI 10.1152/japplphysiol.01034.2007
   Murru E, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.861664
   National Institutes of Health, 2002, Office of laboratory animal welfare, United States. Public health service. Public Health Service Policy on Humane Care and Use of Laboratory Animals
   Neilson AP, 2017, NUTRITION IN THE PREVENTION AND TREATMENT OF DISEASE, 4TH EDITION, P301, DOI 10.1016/B978-0-12-802928-2.00015-1
   Nikpayam O, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0489-8
   Olini N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072539
   Perrone D, 2012, J AGR FOOD CHEM, V60, P4265, DOI 10.1021/jf205388x
   Petsiou EI, 2014, NUTR REV, V72, P651, DOI 10.1111/nure.12125
   Pimpley V, 2020, PREP BIOCHEM BIOTECH, V50, P969, DOI 10.1080/10826068.2020.1786699
   Pires CL, 2022, FOODS, V11, DOI 10.3390/foods11192935
   Prasedya ES, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95769-y
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Reis CEG, 2019, J TRADIT COMPL MED, V9, P184, DOI 10.1016/j.jtcme.2018.01.001
   Rocha-Guzmán NE, 2018, MED CHEM RES, V27, P2379, DOI 10.1007/s00044-018-2243-4
   Sanchez-Landero L.A., 2021, COFEE SCI, V16, P1, DOI DOI 10.25186/.V16I.1887
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Setiyorini H, 2023, EUR J TOUR RES, V34, DOI 10.54055/ejtr.v34i.2799
   Shin SK, 2019, PFLUG ARCH EUR J PHY, V471, P829, DOI 10.1007/s00424-018-02250-3
   SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7
   Somoza V, 2005, MOL NUTR FOOD RES, V49, P663, DOI 10.1002/mnfr.200500034
   Tamil IG, 2010, INDIAN J PHARMACOL, V42, P280, DOI 10.4103/0253-7613.70107
   Tarigan E. B., 2022, IOP Conference Series: Earth and Environmental Science, V974, DOI 10.1088/1755-1315/974/1/012115
   Udia P.M., 2013, Research J Pharmacogn Phytochem., V5, P300
   Ukeda H, 1999, BIOSCI BIOTECH BIOCH, V63, P485, DOI 10.1271/bbb.63.485
   Xu BJ, 2007, J FOOD SCI, V72, pS159, DOI 10.1111/j.1750-3841.2006.00260.x
   Zhang JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05832
   Zhang SJ, 2015, FOOD FUNCT, V6, P2578, DOI [10.1039/c5fo00247h, 10.1039/C5FO00247H]
NR 67
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2665-9271
J9 CURR RES FOOD SCI
JI Curr. Res. Food Sci.
PY 2024
VL 9
AR 100861
DI 10.1016/j.crfs.2024.100861
PG 13
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA I2C9K
UT WOS:001328397900001
PM 39398976
OA gold
DA 2025-04-28
ER

PT J
AU Jia, HJ
   Aw, WP
   Egashira, K
   Takahashi, S
   Aoyama, S
   Saito, K
   Kishimoto, Y
   Kato, H
AF Jia, Huijuan
   Aw, Wanping
   Egashira, Kenji
   Takahashi, Shoko
   Aoyama, Shinya
   Saito, Kenji
   Kishimoto, Yoshimi
   Kato, Hisanori
TI Coffee intake mitigated inflammation and obesity-induced insulin
   resistance in skeletal muscle of high-fat diet-induced obese mice
SO GENES AND NUTRITION
LA English
DT Article
DE Coffee intake; Insulin resistance; Inflammation and obesity; Skeletal
   muscle; Transcriptomic analysis; High-fat diet
ID TYPE-2 DIABETES-MELLITUS; C-REACTIVE PROTEIN; CAFFEIC ACID;
   MONONUCLEAR-CELLS; EXPRESSION; RISK; STRESS; GENE; CONSUMPTION;
   SENSITIVITY
AB Epidemiologic findings offer the promise that coffee or its many constituents may be useful as a dietary intervention in type 2 diabetes (T2D) prevention. We aimed to elucidate the molecular mechanisms involved in the ameliorative effects of caffeinated coffee (CC), decaffeinated coffee (DC) and unroasted caffeinated green coffee (GC) on skeletal muscle gene expression profiles and their relationships in an obesity animal model. Eight-week-old male C57BL6 mice were raised for 9 weeks ad libitum on a normal diet, a high-fat diet, or high-fat diet containing 2 % freeze-dried CC, or DC, or GC. Total RNA and protein were extracted from skeletal muscle and subjected to microarray (Mouse Genome 430 2.0, Affymetrix) and western blotting analyses, respectively. Coffee intake mitigated the insulin resistance by decreasing plasma glucose levels during an insulin tolerance test and by increasing tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1), p85/IRS-1 complex and pAkt/PKB (protein kinase B). In addition, coffee intake down-regulated the anti-inflammatory genes activating transcription factor 3, FBJ osteosarcoma oncogene, heat shock protein 1A, heat shock protein 1B and synuclein, gamma and the inflammation-associated insulin signaling genes stearoyl-coenzyme A desaturase 1 and secreted phosphoprotein 1. These results provide scientific insight on the probable positive effects of coffee intake on impaired insulin signaling, inflammation and obesity, thereby providing a new perspective on the prevention of obesity and T2D.
C1 [Jia, Huijuan; Saito, Kenji; Kato, Hisanori] Univ Tokyo, Corp Sponsored Res Program Food Life, Org Interdisciplinary Res Projects, Bunkyo Ku, Tokyo 1138657, Japan.
   [Aw, Wanping] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Bunkyo Ku, Tokyo, Japan.
   [Egashira, Kenji; Takahashi, Shoko; Aoyama, Shinya; Kato, Hisanori] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan.
   [Kishimoto, Yoshimi] Ochanomizu Univ, Inst Environm Sci Human Life, Bunkyo Ku, Tokyo 112, Japan.
C3 University of Tokyo; Institute of Science Tokyo; Tokyo Medical & Dental
   University (TMDU); University of Tokyo; Ochanomizu University
RP Kato, H (corresponding author), Univ Tokyo, Corp Sponsored Res Program Food Life, Org Interdisciplinary Res Projects, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.
EM akatoq@mail.ecc.u-tokyo.ac.jp
OI Kishimoto, Yoshimi/0000-0002-2610-134X; Aoyama,
   Shinya/0000-0001-7589-676X; , Wanping Aw/0000-0002-5075-4586
FU All Japan Coffee Association; Grants-in-Aid for Scientific Research
   [23700901] Funding Source: KAKEN
FX This study was partly supported by a grant from the All Japan Coffee
   Association.
CR Abebe A, 2013, AM J RES COMMUN, V1, P78
   Aljada A, 2002, J CLIN ENDOCR METAB, V87, P1419, DOI 10.1210/jc.87.3.1419
   Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384
   Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005
   Chao PC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-33
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Dandona P, 2001, J CLIN ENDOCR METAB, V86, P3257, DOI 10.1210/jc.86.7.3257
   DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318
   Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE
   Gray J., 1998, Nutrition & Food Science, P314, DOI 10.1108/00346659810235215
   Halter B, 2010, FREE RADICAL BIO MED, V48, P915, DOI 10.1016/j.freeradbiomed.2010.01.014
   Han TS, 2002, DIABETES CARE, V25, P2016, DOI 10.2337/diacare.25.11.2016
   Hojlund K, 2002, EUR J CLIN INVEST, V32, P918, DOI 10.1046/j.1365-2362.2002.01098.x
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   Hu G, 2006, INT J OBESITY, V30, P1742, DOI 10.1038/sj.ijo.0803341
   Jia HJ, 2013, J FUNCT FOODS, V5, P1611, DOI 10.1016/j.jff.2013.07.003
   Jia HJ, 2013, MOL NUTR FOOD RES, V57, P291, DOI 10.1002/mnfr.201200538
   Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404
   Kobayashi M, 2012, J NUTR SCI VITAMINOL, V58, P408, DOI 10.3177/jnsv.58.408
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Mohanty P, 2000, J CLIN ENDOCR METAB, V85, P2970, DOI 10.1210/jc.85.8.2970
   MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673
   NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y
   Oort PJ, 2008, J NUTR, V138, P841, DOI 10.1093/jn/138.5.841
   Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323
   Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Pradhan AD, 2003, ARTERIOSCL THROM VAS, V23, P650, DOI 10.1161/01.ATV.0000065636.15310.9C
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011
   Smith RS, 2007, DNA SEQUENCE, V18, P47, DOI 10.1080/10425170601060707
   Stefano P., 2002, WORLD DEV, V30, P1099
   Takahashi S, 2014, J FUNCT FOODS, V6, P157, DOI 10.1016/j.jff.2013.10.002
   Zmuda EJ, 2010, MOL ENDOCRINOL, V24, P1423, DOI 10.1210/me.2009-0463
NR 38
TC 34
Z9 35
U1 0
U2 31
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1555-8932
EI 1865-3499
J9 GENES NUTR
JI Genes Nutr.
PD MAY
PY 2014
VL 9
IS 3
AR 389
DI 10.1007/s12263-014-0389-3
PG 10
WC Genetics & Heredity; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Nutrition & Dietetics
GA AH8MG
UT WOS:000336391300001
PM 24599575
OA Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Hsieh, PC
   Nfor, ON
   Lin, CC
   Hsiao, CH
   Liaw, YP
AF Hsieh, Pao-Chun
   Nfor, Oswald Ndi
   Lin, Chuan-Chao
   Hsiao, Chih-Hsuan
   Liaw, Yung-Po
TI Metabolic syndrome risk in adult coffee drinkers with the rs301 variant
   of the LPL gene
SO NUTRITION JOURNAL
LA English
DT Article
DE Metabolic syndrome; Polymorphism; Coffee
ID TEA CONSUMPTION; ASSOCIATION; METAANALYSIS; PREVALENCE; OBESITY
AB BackgroundMetabolic syndrome (MetS), a cluster of metabolic and cardiovascular risk factors is influenced by environmental, lifestyle, and genetic factors. We explored whether coffee consumption and the rs301 variant of the lipoprotein lipase (LPL) gene are related to MetS.MethodsWe conducted multiple logistic regression analyses using data gathered from 9523 subjects in Taiwan Biobank (TWB).ResultsOur findings indicated that individuals who consumed coffee had a reduced odds ratio (OR) for MetS (0.750 (95% confidence interval [CI] 0.653-0.861) compared to non-coffee drinkers. Additionally, the risk of MetS was lower for individuals with the 'TC' and 'CC' genotypes of rs301 compared to those with the 'TT' genotype. Specifically, the OR for MetS was 0.827 (95% CI 0.721-0.949) for the 'TC' genotype and 0.848 (95% CI 0.610-1.177) for the 'CC' genotype. We observed an interaction between coffee consumption and the rs301 variant, with a p-value for the interaction of 0.0437. Compared to the reference group ('no coffee drinking/TT'), the ORs for MetS were 0.836 (95% CI 0.706-0.992) for 'coffee drinking/TT', 0.557 (95% CI 0.438-0.707) for 'coffee drinking/TC', and 0.544 (95% CI 0.319-0.927) for 'coffee drinking/CC'. Notably, MetS was not observed in non-coffee drinkers regardless of their rs301 genotype.ConclusionOur findings suggest that rs301 genotypes may protect against MetS in Taiwanese adults who consume coffee compared to non-coffee drinkers.
C1 [Hsieh, Pao-Chun] Cheng Ching Hosp, Dept Obstet & Gynecol, Chung Kang Branch, Taichung 407, Taiwan.
   [Nfor, Oswald Ndi; Hsiao, Chih-Hsuan; Liaw, Yung-Po] Chung Shan Med Univ, Inst Publ Hlth, Dept Publ Hlth, Taichung 40201, Taiwan.
   [Lin, Chuan-Chao] Chung Shan Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan.
   [Lin, Chuan-Chao] Chung Shan Med Univ, Sch Med, Taichung 40201, Taiwan.
   [Liaw, Yung-Po] Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan.
   [Liaw, Yung-Po] Chung Shan Med Univ Hosp, Dept Med Imaging, 110 Sec 1 Jianguo N Rd, Taichung 40201, Taiwan.
C3 Chung Shan Medical University; Chung Shan Medical University; Chung Shan
   Medical University Hospital; Chung Shan Medical University; Chung Shan
   Medical University; Chung Shan Medical University; Chung Shan Medical
   University Hospital
RP Liaw, YP (corresponding author), Chung Shan Med Univ, Inst Publ Hlth, Dept Publ Hlth, Taichung 40201, Taiwan.; Liaw, YP (corresponding author), Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan.; Liaw, YP (corresponding author), Chung Shan Med Univ Hosp, Dept Med Imaging, 110 Sec 1 Jianguo N Rd, Taichung 40201, Taiwan.
EM liawyp@csmu.edu.tw
RI Lin, Ying-Chu/C-8679-2009; Liaw, Yung/AAV-6746-2021
OI Liaw, Yung-Po/0000-0003-2046-4964
FU Ministry of Science and Technology, Taiwan; Ministry of Science and
   Technology
FX The authors would like to thank Cheng Ching Hospital and the Ministry of
   Science and Technology for providing research grants.
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Andersen CJ, 2016, ADV NUTR, V7, P66, DOI 10.3945/an.115.010207
   [Anonymous], 2020, Biobank T
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/c7fo00388a, 10.1039/C7FO00388A]
   Bermudez V., 2018, Venezuela, VF1000Research, P7
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Engin A, 2017, ADV EXP MED BIOL, V960, P1, DOI 10.1007/978-3-319-48382-5_1
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Jan CJ., 2002, A study on the lifestyles of coffee consumers in Taiwan
   Kishimoto T, 2022, PREV MED REP, V30, DOI 10.1016/j.pmedr.2022.101995
   Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lin CH, 2006, ANN SAUDI MED, V26, P46, DOI 10.5144/0256-4947.2006.46
   Liu PL, 2021, INT J GEN MED, V14, P1403, DOI 10.2147/IJGM.S296814
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P358, DOI 10.1080/09637486.2017.1362690
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Oliveira Jamille Silva, 2018, J. vasc. bras., V17, P141, DOI 10.1590/1677-5449.007917
   Pitsavos Christos, 2006, Review of Diabetic Studies, V3, P118, DOI 10.1900/RDS.2006.3.118
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Stutz B, 2018, NUTR METAB CARDIOVAS, V28, P470, DOI 10.1016/j.numecd.2018.01.011
   Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047791
   Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650
   Yamada Y, 2017, ONCOTARGET, V8, P38950, DOI 10.18632/oncotarget.17159
   Yeh CJ, 2011, ASIA PAC J CLIN NUTR, V20, P292
   Yoshida J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6262-3
NR 32
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD MAR 2
PY 2024
VL 23
IS 1
AR 30
DI 10.1186/s12937-024-00931-7
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KH0D8
UT WOS:001178940700003
PM 38429792
OA gold
DA 2025-04-28
ER

PT J
AU Kim, MJ
   Jin, HS
   Eom, YB
AF Kim, Min-Jeong
   Jin, Hyun-Seok
   Eom, Yong-Bin
TI Relationship between HECTD4 gene variants, obesity, and coffee
   consumption
SO EUROPEAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; GAMMA-GLUTAMYLTRANSFERASE; METABOLIC SYNDROME;
   RISK; WOMEN; LOCI; MEN
AB Background: In genome-wide association studies, the HECT domain E3 ubiquitin-protein ligase 4 (HECTD4) gene was suggested to be associated with obesity-related traits and coffee consumption. However, the association of genetic variants between coffee consumption and obesity has not been tested in Koreans. Therefore, we investigated whether HECTD4 gene variants act as effect modifiers on the relationship between obesity and coffee. Methods: This study analyzed the correlation between coffee consumption and obesity among 58,698 individuals representing the Health Examinees. Participants were categorized into obese (BMI >= 25.0 kg/m(2)) and nonobese (18.5 <= BMI < 23.0 kg/m(2)). Food consumption was assessed by a food frequency questionnaire. Results: We identified four HECTD4 gene variants associated with obesity-related traits and coffee consumption based on Bonferroni-corrected significance level (p < 0.00014). Furthermore, multivariate logistic regression analysis confirmed that the impact of coffee consumption on obesity differed based on the HECTD4 rs2074356 genotypes. A positive correlation between obesity and coffee consumption was observed, with a more pronounced effect in individuals with the G allele (OR = 1.61 for 1 to <2 cups/day, p = 1.89 x 10(-37); OR = 1.82 for >= 2 cups/day, p = 1.73 x 10(-42)) than in those with the A allele (OR = 1.47 for 1 to <2 cups/day, p = 7.41 x 10(-17); OR = 1.45 for >= 2 cups/day, p = 7.24 x 10(-11)). Conclusion: Our findings suggest that the influence of coffee consumption on obesity may vary in Koreans depending on the HECTD4 gene variant.
C1 [Kim, Min-Jeong; Eom, Yong-Bin] Soonchunhyang Univ, Grad Sch, Dept Med Sci, Asan, Chungnam, South Korea.
   [Jin, Hyun-Seok] Hoseo Univ, Coll Life & Hlth Sci, Dept Biomed Lab Sci, Asan, Chungnam, South Korea.
   [Eom, Yong-Bin] Soonchunhyang Univ, Dept Biomed Lab Sci, Coll Med Sci, Chungnam, Asan, South Korea.
C3 Soonchunhyang University; Hoseo University; Soonchunhyang University
RP Eom, YB (corresponding author), Soonchunhyang Univ, Grad Sch, Dept Med Sci, Asan, Chungnam, South Korea.; Eom, YB (corresponding author), Soonchunhyang Univ, Dept Biomed Lab Sci, Coll Med Sci, Chungnam, Asan, South Korea.
EM omnibin@sch.ac.kr
RI EOM, YONGBIN/X-2081-2019
OI Eom, Yong-Bin/0000-0002-1569-7248
FU Soonchunhyang University Research Fund; National Research Foundation of
   Korea (NRF) - Korean government (MSIT) [NRF-2023R1A2C1003486]
FX This work was supported by the Soonchunhyang University Research Fund,
   and a National Research Foundation of Korea (NRF) grant funded by the
   Korean government (MSIT) [NRF-2023R1A2C1003486].
CR Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   [Anonymous], 2017, LANCET DIABETES ENDO, V5, P483, DOI 10.1016/S2213-8587(17)30191-2
   [Anonymous], 2000, ASIA PACIFIC PERSPEC
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cha S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145220
   Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x
   Go MJ, 2014, DIABETES METAB J, V38, P375, DOI 10.4093/dmj.2014.38.5.375
   Go MJ, 2013, J HUM GENET, V58, P362, DOI 10.1038/jhg.2013.14
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hruby A, 2016, AM J PUBLIC HEALTH, V106, P1656, DOI 10.2105/AJPH.2016.303326
   Jee SH, 2005, AM J EPIDEMIOL, V162, P42, DOI 10.1093/aje/kwi166
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   Kim Y, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv316
   Kunutsor SK, 2015, INT J CLIN PRACT, V69, P136, DOI 10.1111/ijcp.12507
   Kwock Changkeun, 2013, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V42, P1753
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Lee YJ, 2022, ARCH TOXICOL, V96, P2487, DOI 10.1007/s00204-022-03325-y
   Lu XF, 2015, HUM MOL GENET, V24, P865, DOI 10.1093/hmg/ddu478
   Marcus JH, 2017, BIOINFORMATICS, V33, P594, DOI 10.1093/bioinformatics/btw643
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Muhammad HFL, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/9606054
   Nakagawa-Senda H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19914-w
   Narayan VP, 2022, J NUTR HEALTH AGING, V26, P190, DOI 10.1007/s12603-022-1736-5
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Park HyoungSeop Park HyoungSeop, 2019, Journal of Nutrition and Health, V52, P369, DOI 10.4163/jnh.2019.52.4.369
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Swift DL, 2018, PROG CARDIOVASC DIS, V61, P206, DOI 10.1016/j.pcad.2018.07.014
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   Woolf B, 2024, AM J EPIDEMIOL, V193, P1776, DOI 10.1093/aje/kwae143
   Yang XL, 2013, AM J CLIN NUTR, V97, P545, DOI 10.3945/ajcn.112.046482
   Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520
   Zhou A, 2021, CLIN NUTR, V40, P4404, DOI 10.1016/j.clnu.2020.12.042
   Zhu ZZ, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00199-2021
NR 40
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0954-3007
EI 1476-5640
J9 EUR J CLIN NUTR
JI Eur. J. Clin. Nutr.
PD MAR
PY 2025
VL 79
IS 3
BP 200
EP 206
DI 10.1038/s41430-024-01541-6
EA NOV 2024
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA Z7Z4R
UT WOS:001351863800001
PM 39521882
DA 2025-04-28
ER

PT J
AU van Westing, AC
   Ochoa-Rosales, C
   van der Burgh, AC
   Chaker, L
   Geleijnse, JM
   Hoorn, EJ
   Voortman, T
AF van Westing, Anniek C.
   Ochoa-Rosales, Carolina
   van der Burgh, Anna C.
   Chaker, Layal
   Geleijnse, Johanna M.
   Hoorn, Ewout J.
   Voortman, Trudy
TI Association of habitual coffee consumption and kidney function: A
   prospective analysis in the Rotterdam Study
SO CLINICAL NUTRITION
LA English
DT Article
DE Kidney function; eGFR; Albumin-to-creatinine ratio; ACR; Coffee
   consumption; Cohort studies
ID GLOMERULAR-FILTRATION-RATE; FUNCTION DECLINE; RISK-FACTORS; POPULATION;
   ZUTPHEN; SERUM
AB Background & aims: Population-based studies have suggested a protective effect of coffee against development of chronic kidney disease (CKD), possibly through coffee's anti-inflammatory and antiox-idant compounds. Studies on coffee and kidney function decline in the general population are scarce. We studied associations of habitual coffee consumption with repeated assessments of estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (ACR).Methods: We used data from 7,914 participants of the population-based Rotterdam Study. Baseline coffee consumption data (cups/day) were obtained from home interviews and validated food frequency questionnaires (1997-20 08). Repeated assessments of eGFR (ml/min per 1.73 m2, 1997-2014) were calculated according to the creatinine-based CKD Epidemiology Collaboration equation of 2012. Repeated assessments of urinary albumin and creatinine were used to estimate ACR (mg/g, 2006-2014). Data were analyzed by applying linear mixed models, adjusted for sociodemographic, lifestyle and dietary factors, and cardiovascular disease risk factors. Predefined subgroup analyses were performed stratified by CKD risk factors.Results: Participants' mean (SD) baseline age was 66 (10) years, 57% were women and median [IQR] coffee consumption was 3.0 [2.0, 5.0] cups/day. Those drinking more coffee were more likely to smoke, and to have type 2 diabetes (T2D) and obesity. Mean eGFR was 79 (15) ml/min per 1.73 m2. In the total study population, coffee was not associated with longitudinal eGFR during a median of 5.4 years of follow-up (b = 0.04 ml/min per 1.73 m2 per one cup/day [95% CI:-0.10,0.18]). However, among those aged >70 years, one additional coffee cup/day was associated with on average 0.84 (0.51,1.18) ml/min per 1.73 m2 higher longitudinal eGFR. Among obese participants this estimate was 0.32 (0.01,0.63). A pro-tective trend was also observed among former smokers (0.17 [-0.03,0.39]) and those with T2D (0.42 [-0.05,0.88]). Coffee was not associated with longitudinal ACR (0.01 mg/ml [-0.01,0.02]).Conclusion: While coffee was not associated with eGFR and ACR in the total population, more coffee consumption was associated with higher longitudinal eGFR among those at higher risk for CKD, i.e., among those aged 70+ and obese participants. These findings require confirmation in other prospective cohort studies.(c) 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [van Westing, Anniek C.; Geleijnse, Johanna M.; Voortman, Trudy] Wageningen Univ & Res, Div Human Nutr & Hlth, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.
   [van Westing, Anniek C.; Ochoa-Rosales, Carolina; van der Burgh, Anna C.; Chaker, Layal; Voortman, Trudy] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.
   [Ochoa-Rosales, Carolina] Univ Adolfo Ibanez, Latin Amer Inst Brain Hlth BrainLat, Penalolen, Chile.
   [van der Burgh, Anna C.; Hoorn, Ewout J.] Univ Med Ctr Rotterdam, Dept Internal Med, Div Nephrol & Transplantat, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.
   [Chaker, Layal] Univ Med Ctr Rotterdam, Dept Internal Med, Div Endocrinol, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.
   [Voortman, Trudy] 2040, NL-3000 CA Rotterdam, Netherlands.
C3 Wageningen University & Research; Erasmus University Rotterdam; Erasmus
   MC; Universidad Adolfo Ibanez; Erasmus University Rotterdam; Erasmus MC;
   Erasmus University Rotterdam; Erasmus MC
RP Voortman, T (corresponding author), Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.; Voortman, T (corresponding author), 2040, NL-3000 CA Rotterdam, Netherlands.
EM trudy.voortman@erasmusmc.nl
RI Ochoa-Rosales, Carolina/ISB-3109-2023; Voortman, Trudy/C-2963-2015;
   Geleijnse, Johanna Marianna/B-5749-2012; Hoorn, Ewout/S-4135-2019
OI van der Burgh, Anna Cornelia/0000-0003-4569-7916; Voortman,
   Trudy/0000-0003-2830-6813; Ochoa-Rosales, Carolina/0000-0001-8048-9165;
   Geleijnse, Johanna Marianna/0000-0001-7638-0589; Chaker,
   Layal/0000-0001-7855-5418; Hoorn, Ewout/0000-0002-8738-3571
FU Jaap Schouten Foundation [JSF_SU_10_2018]; Erasmus Medical Center,
   Rotterdam; ISIC; Erasmus University, Rotterdam; Netherlands Organization
   for the Health Research and Development (ZonMw); Research Institute for
   Diseases in the Elderly (RIDE); Ministry of Education, Culture and
   Science; Ministry for Health, Welfare and Sports; European Commission
   (DG XII); Municipality of Rotterdam
FX Anniek van Westing was supported by a grand from the Jaap Schouten
   Foundation (grant no. JSF_SU_10_2018). Dr Trudy Voortman was supported
   by a grant from ISIC during 2017-2020, regarding research on coffee and
   type 2 diabetes. Data collection for the Rotterdam Study is funded by
   Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands
   Organization for the Health Research and Development (ZonMw), the
   Research Institute for Diseases in the Elderly (RIDE), the Ministry of
   Education, Culture and Science, the Ministry for Health, Welfare and
   Sports, the Eu-ropean Commission (DG XII), and the Municipality of
   Rotterdam. All funding agencies had no role in the study design, data
   collection, analysis, decision to publish, or preparation of the
   manuscript.
CR CASPERSEN CJ, 1991, AM J EPIDEMIOL, V133, P1078, DOI 10.1093/oxfordjournals.aje.a115821
   Cornelis MC, 2020, J NUTR, V150, P2772, DOI 10.1093/jn/nxaa212
   Díaz-López A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88028-7
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Eijkelkamp WBA, 2007, AM J CARDIOL, V100, P7, DOI 10.1016/j.amjcard.2007.02.047
   Esmeijer K, 2018, KIDNEY INT REP, V3, P879, DOI 10.1016/j.ekir.2018.03.005
   Foundation N, 2021, DUTCH FOOD COMP DAT
   Gaeini Z, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0355-6
   He WJ, 2021, CLIN J AM SOC NEPHRO, V16, P1620, DOI 10.2215/CJN.05520421
   Herber-Gast GCM, 2016, AM J CLIN NUTR, V103, P1370, DOI 10.3945/ajcn.115.112755
   Hu EA, 2018, AM J KIDNEY DIS, V72, P214, DOI 10.1053/j.ajkd.2018.01.030
   Hyppönen E, 2021, AM J CLIN NUTR, V114, P214, DOI 10.1093/ajcn/nqab014
   Ikram MA, 2020, EUR J EPIDEMIOL, V35, P483, DOI 10.1007/s10654-020-00640-5
   Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248
   Jankovic N, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-30
   Jeszka-Skowron M, 2015, EUR FOOD RES TECHNOL, V240, P19, DOI 10.1007/s00217-014-2356-z
   Jhee JH, 2018, AM J MED, V131, P1482, DOI 10.1016/j.amjmed.2018.05.021
   Kennedy OJ, 2020, AM J KIDNEY DIS, V75, P753, DOI 10.1053/j.ajkd.2019.08.025
   Kim BH, 2013, KOREAN J FAM MED, V34, P265, DOI 10.4082/kjfm.2013.34.4.265
   Kotani K, 2010, CLIN CHEM LAB MED, V48, P1773, DOI 10.1515/CCLM.2010.347
   Lew QLJ, 2018, J NUTR, V148, P1315, DOI 10.1093/jn/nxy075
   Miyatake N., 2011, Health, V3, P549, DOI 10.4236/health.2011.39093
   Nakajima K, 2010, BRIT J NUTR, V103, P149, DOI 10.1017/S0007114509991681
   NEELEY WE, 1972, CLIN CHEM, V18, P509
   Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488
   Rubin DB., 2004, Multiple Imputation for Nonresponse in Surveys, DOI DOI 10.1002/9780470316696
   Saito M, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/146865
   Sanada F, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00012
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Stel VS, 2004, J CLIN EPIDEMIOL, V57, P252, DOI 10.1016/j.jclinepi.2003.07.008
   Tibuakuu M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184914
   Tuttle KR, 2017, DIABETES, V66, P14, DOI 10.2337/dbi16-0056
   van Buuren S, 2011, J STAT SOFTW, V45, P1
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   van den Brandt PA, 2018, EUR J EPIDEMIOL, V33, P183, DOI 10.1007/s10654-018-0359-y
   van der Burgh AC, 2021, KIDNEY INT REP, V6, P3054, DOI 10.1016/j.ekir.2021.10.006
   van Westing AC, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-1020-1
   Voortman T, 2017, EUR J EPIDEMIOL, V32, P993, DOI 10.1007/s10654-017-0295-2
   Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5
   Xie C, 2018, J HUM HYPERTENS, V32, P83, DOI 10.1038/s41371-017-0007-0
   Xie Y, 2018, KIDNEY INT, V94, P567, DOI 10.1016/j.kint.2018.04.011
NR 42
TC 8
Z9 8
U1 0
U2 4
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0261-5614
EI 1532-1983
J9 CLIN NUTR
JI Clin. Nutr.
PD FEB
PY 2023
VL 42
IS 2
BP 83
EP 92
DI 10.1016/j.clnu.2022.11.017
EA DEC 2022
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 7I3SO
UT WOS:000903811900003
PM 36516702
OA Green Published
DA 2025-04-28
ER

PT J
AU Hursel, R
   Viechtbauer, W
   Dulloo, AG
   Tremblay, A
   Tappy, L
   Rumpler, W
   Westerterp-Plantenga, MS
AF Hursel, R.
   Viechtbauer, W.
   Dulloo, A. G.
   Tremblay, A.
   Tappy, L.
   Rumpler, W.
   Westerterp-Plantenga, M. S.
TI The effects of catechin rich teas and caffeine on energy expenditure and
   fat oxidation: a meta-analysis
SO OBESITY REVIEWS
LA English
DT Article
DE Caffeine; catechins; green tea; oolong tea
ID SYMPATHETIC-NERVOUS-SYSTEM; BODY-WEIGHT LOSS; GREEN TEA;
   EPIGALLOCATECHIN GALLATE; OBESE WOMEN; BLACK TEA; INTESTINAL-ABSORPTION;
   O-METHYLTRANSFERASE; IN-VITRO; THERMOGENESIS
AB Different outcomes of the effect of catechin-caffeine mixtures and caffeine-only supplementation on energy expenditure and fat oxidation have been reported in short-term studies. Therefore, a meta-analysis was conducted to elucidate whether catechin-caffeine mixtures and caffeine-only supplementation indeed increase thermogenesis and fat oxidation. First, English-language studies measuring daily energy expenditure and fat oxidation by means of respiration chambers after catechin-caffeine mixtures and caffeine-only supplementation were identified through PubMed. Six articles encompassing a total of 18 different conditions fitted the inclusion criteria. Second, results were aggregated using random/mixed-effects models and expressed in terms of the mean difference in 24 h energy expenditure and fat oxidation between the treatment and placebo conditions. Finally, the influence of moderators such as BMI and dosage on the results was examined as well. The catechin-caffeine mixtures and caffeine-only supplementation increased energy expenditure significantly over 24 h (428.0 kJ (4.7%); P < 0.001 and 429.1 kJ (4.8%); P < 0.001, respectively). However, 24 h fat oxidation was only increased by catechin-caffeine mixtures (12.2 g (16.0%); P < 0.02 and 9.5 g (12.4%); P = 0.11, respectively). A dose-response effect on 24 h energy expenditure and fat oxidation occurred with a mean increase of 0.53 kJ mg(-1) (P < 0.01) and 0.02 g mg(-1) (P < 0.05) for catechin-caffeine mixtures and 0.44 kJ mg(-1) (P < 0.001) and 0.01 g mg(-1) (P < 0.05) for caffeine-only. In conclusion, catechin-caffeine mixtures or a caffeine-only supplementation stimulates daily energy expenditure dose-dependently by 0.4-0.5 kJ mg(-1) administered. Compared with placebo, daily fat-oxidation was only significantly increased after catechin-caffeine mixtures ingestion.
C1 [Hursel, R.; Westerterp-Plantenga, M. S.] Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht NUTRIM, NL-6200 MD Maastricht, Netherlands.
   [Viechtbauer, W.] Maastricht Univ, Dept Methodol & Stat, NL-6200 MD Maastricht, Netherlands.
   [Dulloo, A. G.] Univ Fribourg, Dept Med Physiol, CH-1700 Fribourg, Switzerland.
   [Tremblay, A.] Univ Laval, Div Kinesiol, Quebec City, PQ, Canada.
   [Tappy, L.] Univ Lausanne, Dept Physiol, Lausanne, Switzerland.
   [Rumpler, W.] Beltsville Human Nutr Res Ctr, Beltsville, MD USA.
C3 Maastricht University; Maastricht University; University of Fribourg;
   Laval University; University of Lausanne
RP Hursel, R (corresponding author), Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht NUTRIM, POB 616, NL-6200 MD Maastricht, Netherlands.
EM rick.hursel@hb.unimaas.nl
RI Viechtbauer, Wolfgang/M-1549-2013; Tappy, Luc/A-8911-2017
OI Viechtbauer, Wolfgang/0000-0003-3463-4063; Tappy,
   Luc/0000-0001-8469-4692; DULLOO, Abdul/0000-0003-3877-6149
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   [Anonymous], PROGR MED
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BRAY GA, 1991, J NUTR, V121, P1146, DOI 10.1093/jn/121.8.1146
   Davy KP, 2009, NEUROSCI BIOBEHAV R, V33, P116, DOI 10.1016/j.neubiorev.2008.05.024
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Hodgson JM, 2006, BRIT J NUTR, V95, P14, DOI 10.1079/BJN20051621
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Krul C, 2001, MUTAT RES-FUND MOL M, V474, P71, DOI 10.1016/S0027-5107(00)00158-5
   LANDSBERG L, 1986, Q J MED, V61, P1081
   Langley-Evans SC, 2000, INT J FOOD SCI NUTR, V51, P181, DOI 10.1080/09637480050029683
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   SCHUTZ Y, 1992, AM J CLIN NUTR, V55, P670, DOI 10.1093/ajcn/55.3.670
   SCHUTZ Y, 1989, AM J CLIN NUTR, V50, P307, DOI 10.1093/ajcn/50.2.307
   Serafini M, 1996, EUR J CLIN NUTR, V50, P28
   Shishikura Y, 2006, J AGR FOOD CHEM, V54, P1906, DOI 10.1021/jf051988p
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261
   Wang H, 2009, OBESITY SILVER SPRIN
   Wang S, 2006, J NUTR, V136, P2791, DOI 10.1093/jn/136.11.2791
   Westerterp KR, 2008, AM J CLIN NUTR, V87, P132, DOI 10.1093/ajcn/87.1.132
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yang FJ, 2001, MOL PHARMACOL, V60, P528
NR 46
TC 130
Z9 138
U1 2
U2 85
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1467-7881
J9 OBES REV
JI Obes. Rev.
PD JUL
PY 2011
VL 12
IS 7
BP E573
EP E581
DI 10.1111/j.1467-789X.2011.00862.x
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 795OA
UT WOS:000292982300002
PM 21366839
OA Green Submitted
DA 2025-04-28
ER

PT J
AU Hao, S
   Xiao, Y
   Lin, Y
   Mo, ZT
   Chen, Y
   Peng, XF
   Xiang, CH
   Li, YQ
   Li, WN
AF Hao, Shun
   Xiao, Yuan
   Lin, Yan
   Mo, Zhentao
   Chen, Yang
   Peng, Xiaofeng
   Xiang, Canhui
   Li, Yiqi
   Li, Wenna
TI Chlorogenic acid-enriched extract from Eucommia ulmoides leaves
   inhibits hepatic lipid accumulation through regulation of cholesterol
   metabolism in HepG2 cells
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE ABCA1; AMPK; chlorogenic acid; CYP7A1; HMGCR; lipid accumulation; SREBP2
ID HYPOLIPIDEMIC ACTION; OBESITY; SIMVASTATIN; EXPRESSION; HAMSTERS;
   RECEPTOR; RATS
AB Context: Eucommia ulmoides Oliver (Eucommiaceae) leaf exhibits beneficial lipid-lowering and anti-obesity effects. However, the mechanisms remain unknown.Objective: The objective of this study is to investigate the lipid-lowering effects of chlorogenic acid (CGA)-enriched extract from this plant (CAEF) in human hepatoma HepG2 cells, focusing on cholesterol metabolism.Materials and methods: HepG2 cells were treated with CAEF (10, 20, 25, 40, 60, and 80mg/L), CGA (0.3, 3, 30, 300, and 600mol/L), and simvastatin (0.1, 1, 10, 50, and 100mol/L) for 24 or 48h. The cytotoxicity, Oil red O staining, total cholesterol, and triacylglycerol in supernatants were determined. The mRNA expression of genes involved in cholesterol metabolism was determined with RT-PCR. The protein expression of HMG-CoA reductase (HMGCR) was examined by immunocytochemistry and western-blot.Results: The IC50 values were 59.2mg/L for CAEF, 335.9mol/L for CGA, and 10.5mol/L for simvastatin. By treating cells with CAEF (25mg/L), CGA (30mol/L), or simvastatin (10mol/L) for 48h, the efflux of total cholesterol and triacylglycerol was increased (CAEF, 4.06- and 31.00-folds; CGA, 2.94- and 2.17-folds; and simvastatin, 3.94- and 24.67-folds), and the cellular lipid droplets were reduced in Oil red O staining. CAEF and CGA increased mRNA expression of ABCA1, CYP7A1, and AMPK2, while CAEF and simvastatin decreased SREBP2. However, their effects on LXR mRNA expression were variable. Importantly, all drugs significantly inhibited protein expression of HMGCR at mRNA and protein levels.Discussion and conclusion: CAEF is a promising dietary supplement to prevent obesity and dyslipidemia and the effects appear to be due, at least in part, to regulating cholesterol metabolism through inhibition of HMGCR in HepG2 cells.
C1 [Hao, Shun; Lin, Yan; Mo, Zhentao; Chen, Yang; Peng, Xiaofeng; Xiang, Canhui; Li, Yiqi; Li, Wenna] Zunyi Med Univ, Zhuhai 519041, Guangdong, Peoples R China.
   [Xiao, Yuan] Guizhou Prov Peoples Hosp, Pharmaceut Preparat Sect, Guiyang, Guizhou, Peoples R China.
C3 Zunyi Medical University
RP Li, WN (corresponding author), Zunyi Med Univ, Zhuhai Campus, Zhuhai 519041, Guangdong, Peoples R China.
EM lielizabeth@126.com
FU Guizhou Provincial Modernization of Traditional Chinese Medicine
   Foundation of China [QKHZY [2013] 3018]; Project Natural Science
   Foundation of China [21162046]; Research Funds of Department of
   Education of Guizhou Province of China [QKJ 2010042]
FX This work was supported by project from Guizhou Provincial Modernization
   of Traditional Chinese Medicine Foundation of China (Grant No. QKHZY
   [2013] 3018) (W. L.), The Project Natural Science Foundation of China
   (No. 21162046) (Y. C.); and The Research Funds of Department of
   Education of Guizhou Province of China (Grant No. QKJ 2010042) (C. X.).
CR [Anonymous], ZHONGGUO LIN CHUANG
   Bommer GT, 2011, CELL METAB, V13, P241, DOI 10.1016/j.cmet.2011.02.004
   Borthwick F, 2014, ATHEROSCLEROSIS, V232, P141, DOI 10.1016/j.atherosclerosis.2013.10.031
   Chinese Pharmacopoeia Commission, 2005, CHIN PHARM
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi MS, 2008, AM J CHINESE MED, V36, P81, DOI 10.1142/S0192415X08005606
   Favari E, 2004, ARTERIOSCL THROM VAS, V24, P2345, DOI 10.1161/01.ATV.0000148706.15947.8a
   Fujikawa T, 2010, BRIT J NUTR, V104, P1868, DOI 10.1017/S0007114510002965
   Hao L, 2011, INT J ENDOCRINOL MET, V31, P368, DOI 10.3760/cma.j.issn.1673-4157.2011.06.003
   Hirata T, 2011, BIOORG MED CHEM LETT, V21, P1786, DOI 10.1016/j.bmcl.2011.01.060
   Horii Y, 2010, NEUROSCI LETT, V479, P181, DOI 10.1016/j.neulet.2010.05.030
   Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689
   Kobayashi Y, 2012, J SCI FOOD AGR, V92, P358, DOI 10.1002/jsfa.4586
   Lao XQ, 2015, INT J OBESITY, V39, P288, DOI 10.1038/ijo.2014.95
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   Li W, 2012, ZHONG YAO XIN YAO YU, V22, P30
   [李文娜 Li Wenna], 2012, [食品工业科技, Science & Technology of Food Industry], V33, P137
   Lian ZQ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-67
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Murase T, 2010, AM J PHYSIOL-ENDOC M, V299, pE266, DOI 10.1152/ajpendo.00774.2009
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Pan CH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/436786
   Park SA, 2006, J ETHNOPHARMACOL, V107, P412, DOI 10.1016/j.jep.2006.03.034
   Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005
   Shi XD, 2011, DIABETES RES CLIN PR, V91, P389, DOI 10.1016/j.diabres.2010.11.002
   Shin DJ, 2008, J BIOL CHEM, V283, P15089, DOI 10.1074/jbc.M710452200
   Spencer-Jones NJ, 2006, J MED GENET, V43, P936, DOI 10.1136/jmg.2006.041988
   Torres N, 2006, J NUTR BIOCHEM, V17, P365, DOI 10.1016/j.jnutbio.2005.11.005
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang LL, 2014, CHINESE MED J-PEKING, V127, P218, DOI 10.3760/cma.j.issn.0366-6999.20131591
   Yap F, 2011, INT J BIOL SCI, V7, P645, DOI 10.7150/ijbs.7.645
   Yuan Tian-Yi, 2013, Zhongguo Zhong Yao Za Zhi, V38, P781
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
   Zhang XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061922
   Zhong D, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-32
NR 35
TC 67
Z9 72
U1 3
U2 93
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PD FEB 1
PY 2016
VL 54
IS 2
BP 251
EP 259
DI 10.3109/13880209.2015.1029054
PG 9
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA CY2OG
UT WOS:000366247400009
PM 25845641
OA Bronze
DA 2025-04-28
ER

PT J
AU Ormsbee, MJ
   Rawal, SR
   Baur, DA
   Kinsey, AW
   Elam, ML
   Spicer, MT
   Fischer, NT
   Madzima, TA
   Thomas, DD
AF Ormsbee, Michael J.
   Rawal, Shweta R.
   Baur, Daniel A.
   Kinsey, Amber W.
   Elam, Marcus L.
   Spicer, Maria T.
   Fischer, Nicholas T.
   Madzima, Takudzwa A.
   Thomas, D. David
TI The effects of a multi-ingredient dietary supplement on body
   composition, adipokines, blood lipids, and metabolic health in
   overweight and obese men and women: a randomized controlled trial
SO JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION
LA English
DT Article
DE Green tea; Caffeine; Conjugated linoleic acid; Branched chain amino
   acids; Body composition; Obesity
ID CONJUGATED LINOLEIC-ACID; GREEN TEA EXTRACT; INSULIN SENSITIVITY;
   WEIGHT-LOSS; DOUBLE-BLIND; LIPOPROTEIN CHOLESTEROL; LEUCINE
   SUPPLEMENTATION; ENERGY-EXPENDITURE; GENE-EXPRESSION; PLASMA-GLUCOSE
AB Background: The present study investigated the effects of a multi-ingredient dietary supplement (MIDS) containing caffeine, conjugated linoleic acid (CLA), green tea, and branched-chain amino acids (BCAA) taken for 8 weeks on body composition, blood lipid profile, glucose, insulin, adiponectin, leptin, and high-sensitivity C-reactive protein (hs-CRP) in overweight and obese men and women.
   Methods: Twenty-two participants completed the study (PL, n = 11; 7 women, 4 men; age, 34 +/- 3.5 years; height, 169.2 +/- 3.3 cm; body mass, 96.9 +/- 6.8 kg; BMI, 34.1 +/- 1.8 kg/m(2); MIDS, n = 11; 9 women, 2 men; age, 36 +/- 3.4 years; height, 173.2 +/- 2.9 cm; body mass, 91.9 +/- 5.6 kg; BMI, 30.0 +/- 1.5 kg/m(2)). Participants were randomly assigned and stratified by body fat percentage to two groups: 1) a soybean oil placebo (PL) or 2) MIDS. Each group consumed two pills with breakfast and two pills with lunch. Body composition and android fat, waist and hip circumferences, blood pressure and heart rate were measured at baseline and after 8 weeks of supplementation.
   Results: There were no significant changes for any of the variables of body composition. Feelings of hunger were significantly higher in MIDS versus PL with no changes observed in satiety or desire to eat. Heart rate and blood pressure were unaltered in MIDS after 8 weeks of supplementation. Furthermore, lipid profile, food intake, mood state variables, fasting blood glucose, and endocrine markers did not significantly change regardless of group.
   Conclusion: MIDS intake does not appear to alter body composition or markers of cardiovascular health versus PL. Moreover, MIDS may actually increase feelings of hunger versus PL.
C1 [Ormsbee, Michael J.; Rawal, Shweta R.; Baur, Daniel A.; Kinsey, Amber W.; Elam, Marcus L.; Spicer, Maria T.; Fischer, Nicholas T.; Madzima, Takudzwa A.; Thomas, D. David] Florida State Univ, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA.
   [Ormsbee, Michael J.] Univ KwaZulu Natal, Durban, South Africa.
   [Ormsbee, Michael J.] Florida State Univ, Inst Sports Sci & Med, Tallahassee, FL 32306 USA.
C3 State University System of Florida; Florida State University; University
   of Kwazulu Natal; State University System of Florida; Florida State
   University
RP Ormsbee, MJ (corresponding author), Florida State Univ, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA.
EM mormsbee@fsu.edu
RI Thomas, David/B-4257-2012; Ormsbee, Michael/AEE-8280-2022
OI Baur, Daniel/0000-0002-4005-0139; Kinsey, Amber/0000-0003-4993-0412;
   Ormsbee, Michael/0000-0002-1939-7656
FU International Society of Sports Nutrition
FX This study was supported by a grant from the International Society of
   Sports Nutrition to MJO. We would like to thank Emery Ward and Wyatt
   Eddy for their help with data collection. We would also like to thank
   all of the volunteers for this study.
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Arciero PJ, 2008, METABOLISM, V57, P757, DOI 10.1016/j.metabol.2008.01.015
   Arciero PJ, 2006, INT J SPORT NUTR EXE, V16, P373, DOI 10.1123/ijsnem.16.4.373
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Barte JCM, 2010, OBES REV, V11, P899, DOI 10.1111/j.1467-789X.2010.00740.x
   Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Chiou WB, 2011, PSYCHOL SCI, V22, P1081, DOI 10.1177/0956797611416253
   Choi YJ, 2000, J NUTR, V130, P1920, DOI 10.1093/jn/130.8.1920
   Donato J, 2006, NUTRITION, V22, P520, DOI 10.1016/j.nut.2005.12.008
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Evans M, 2002, J NUTR, V132, P450, DOI 10.1093/jn/132.3.450
   GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8
   Granlund L, 2003, J LIPID RES, V44, P1441, DOI 10.1194/jlr.M300120-JLR200
   House RL, 2005, OBES REV, V6, P247, DOI 10.1111/j.1467-789X.2005.00198.x
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kamphuis MMJW, 2003, INT J OBESITY, V27, P840, DOI 10.1038/sj.ijo.0802304
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501
   Lopez HL, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-22
   Manders RJF, 2005, AM J CLIN NUTR, V82, P76, DOI 10.1093/ajcn/82.1.76
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McEwen LN, 2010, OBES SURG, V20, P919, DOI 10.1007/s11695-010-0169-0
   Moloney F, 2004, AM J CLIN NUTR, V80, P887
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nazare JA, 2007, BRIT J NUTR, V97, P273, DOI 10.1017/S0007114507191911
   Ogden Cynthia L, 2012, NCHS Data Brief, P1
   Outlaw J, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-25
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x
   Poirier H, 2005, DIABETOLOGIA, V48, P1059, DOI 10.1007/s00125-005-1765-8
   Qin LQ, 2011, J NUTR, V141, P249, DOI 10.3945/jn.110.128520
   Rieu I, 2006, J PHYSIOL-LONDON, V575, P305, DOI 10.1113/jphysiol.2006.110742
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Smedman A, 2001, LIPIDS, V36, P773, DOI 10.1007/s11745-001-0784-7
   SUPERKO HR, 1991, AM J CLIN NUTR, V54, P599, DOI 10.1093/ajcn/54.3.599
   Thrush AB, 2007, APPL PHYSIOL NUTR ME, V32, P372, DOI 10.1139/H06-116
   TREMBLAY A, 1988, NUTR RES, V8, P553, DOI 10.1016/S0271-5317(88)80077-0
   Tricon S, 2004, AM J CLIN NUTR, V80, P614
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   West DB, 1998, AM J PHYSIOL-REG I, V275, pR667
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Womack CJ, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-7
   Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123
NR 49
TC 19
Z9 20
U1 0
U2 30
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1550-2783
J9 J INT SOC SPORT NUTR
JI J. Int. Soc. Sport Nutr.
PD JUL 26
PY 2014
VL 11
AR 37
DI 10.1186/1550-2783-11-37
PG 10
WC Nutrition & Dietetics; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Sport Sciences
GA AM5SG
UT WOS:000339919900001
PM 25093015
OA Green Published
DA 2025-04-28
ER

PT J
AU Nakabayashi, H
   Hashimoto, T
   Ashida, H
   Nishiumi, S
   Kanazawa, K
AF Nakabayashi, Hideo
   Hashimoto, Takashi
   Ashida, Hitoshi
   Nishiumi, Shin
   Kanazawa, Kazuki
TI Inhibitory effects of caffeine and its metabolites on intracellular
   lipid accumulation in murine 3T3-L1 adipocytes
SO BIOFACTORS
LA English
DT Article; Proceedings Paper
CT 4th International Niigata Symposium on Diet and Health
CY NOV 29-30, 2008
CL Niigata, JAPAN
DE Caffeine; caffeine metabolites; 3T3-L1 adipocytes; glucose uptake;
   adipocyte differentiation
ID GLUCOSE-TRANSPORT; GREEN TEA; PARTIAL CLEARANCES; INSULIN; RAT;
   DIFFERENTIATION; EXPRESSION; CELLS; ADIPOGENESIS; ALLOPURINOL
AB To understand the mechanisms of the anti-obesity effects of dietary caffeine, the effects of caffeine and its metabolites on adipocyte differentiation and insulin-stimulated glucose uptake in murine 3T3-L1 adipocytes were investigated. Caffeine did not inhibit the differentiation of 3T3-L1 pre-adipocytes to mature adipocytes, but it did suppress the intracellular lipid accumulation after complete differentiation in a dose-dependent manner (0.125-1.0 mM). This effect was also observed in 1,3,7-trimethyluric acid-3,7-dimethyluric acid-and 5-acetylamino-6-formylamino-3-methyluracil-treated cells. Caffeine also inhibited insulin-stimulated glucose uptake in differentiated 3T3-L1 adipocytes in a dose-dependent manner. Treatment with theophylline, paraxanthine, 1-methylxanthine (MX), 3-MX, or 7-MX also inhibited glucose uptake in differentiated adipocytes. These results suggest that the anti-obesity activity of dietary caffeine is due to the additive and/or synergistic inhibitory effects of caffeine and its metabolites on intracellular lipid accumulation and that caffeine does not affect adipocyte differentiation.
C1 [Nakabayashi, Hideo; Hashimoto, Takashi; Ashida, Hitoshi; Nishiumi, Shin; Kanazawa, Kazuki] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan.
C3 Kobe University
RP Hashimoto, T (corresponding author), 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.
EM takashi@kobe-u.ac.jp
RI Nishiumi, Shin/ABD-5775-2020
CR Akiba T, 2004, BIOCHEM PHARMACOL, V68, P1929, DOI 10.1016/j.bcp.2004.07.036
   Arnaud MJ., 1993, CAFFEINE COFFEE HLTH, P43
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Baumann CA, 2001, BIOESSAYS, V23, P215, DOI 10.1002/1521-1878(200103)23:3<215::AID-BIES1031>3.0.CO;2-S
   BENOWITZ NL, 1990, ANNU REV MED, V41, P277, DOI 10.1146/annurev.me.41.020190.001425
   BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500
   CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538
   CHOI OH, 1988, LIFE SCI, V43, P387, DOI 10.1016/0024-3205(88)90517-6
   FLEDHOLM BB, 1978, BIOCHEM PHARMACOL, V27, P2845
   GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   GRYGIEL JJ, 1979, CLIN PHARMACOL THER, V26, P660
   Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200
   Hansen JB, 2001, J BIOL CHEM, V276, P3175, DOI 10.1074/jbc.M005567200
   Hasegawa N, 2000, J HEALTH SCI, V46, P153
   Hinds TS, 1996, NUTR REV, V54, P203, DOI 10.1111/j.1753-4887.1996.tb03933.x
   JOOST HG, 1987, MOL PHARMACOL, V31, P279
   KALOW W, 1993, CLIN PHARMACOL THER, V53, P503, DOI 10.1038/clpt.1993.63
   KALOW W, 1991, CLIN PHARMACOL THER, V49, P44, DOI 10.1038/clpt.1991.8
   KASHIWAGI A, 1983, J BIOL CHEM, V258, P3685
   KIMURA K, 1994, J BIOL CHEM, V269, P18961
   LELO A, 1986, BRIT J CLIN PHARMACO, V22, P183, DOI 10.1111/j.1365-2125.1986.tb05247.x
   LELO A, 1989, J PHARMACOL EXP THER, V248, P315
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590
   Michna L, 2003, LIFE SCI, V73, P1383, DOI 10.1016/S0024-3205(03)00468-5
   MINERS JO, 1982, DRUG METAB DISPOS, V10, P672
   PARSONS WD, 1976, PEDIATR RES, V10, P333
   STEINFELDER HJ, 1990, BIOCHEM PHARMACOL, V40, P1154, DOI 10.1016/0006-2952(90)90508-I
   TOMIYAMA K, 1995, BIOCHEM BIOPH RES CO, V212, P263, DOI 10.1006/bbrc.1995.1965
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   VERGAUWEN L, 1994, J CLIN INVEST, V93, P974, DOI 10.1172/JCI117104
   WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0
   YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168
   Zheng GD, 2004, IN VIVO, V18, P55
NR 38
TC 43
Z9 45
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-6433
EI 1872-8081
J9 BIOFACTORS
JI Biofactors
PY 2008
VL 34
IS 4
BP 293
EP 302
DI 10.1002/biof.5520340405
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 509NT
UT WOS:000271025400005
PM 19850984
DA 2025-04-28
ER

PT J
AU Romanos-Nanclares, A
   Sánchez-Quesada, C
   Gardeazábal, I
   Martínez-González, MA
   Gea, A
   Toledo, E
AF Romanos-Nanclares, Andrea
   Sanchez-Quesada, Cristina
   Gardeazabal, Itziar
   Angel Martinez-Gonzalez, Miguel
   Gea, Alfredo
   Toledo, Estefania
TI Phenolic Acid Subclasses, Individual Compounds, and Breast Cancer Risk
   in a Mediterranean Cohort: The SUN Project
SO JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS
LA English
DT Article
DE Phenolic acids; Breast cancer; Chemoprevention; SUN Project; Polyphenols
ID FOOD-FREQUENCY QUESTIONNAIRE; CHLOROGENIC ACID; DIETARY-INTAKE;
   SYSTEMATIC ANALYSIS; POLYPHENOLS; PREVENTION; IDENTIFICATION;
   VALIDATION; HEALTH; COFFEE
AB Background Biological and epidemiological evidence supports an inverse association of phenolic acids with obesity-related chronic diseases. However, no previous study has prospectively evaluated the relationship between subclasses and individual compounds of phenolic acids and the risk of postmenopausal breast cancer, one of the most important and prevalent obesity-related cancer sites.
   Objective This study examined associations between subclasses of phenolic acids, including hydroxycinnamic and hydroxybenzoic acids intake, and risk of breast cancer.
   Design The Seguimiento Universidad de Navarra (SUN) Project is a dynamic, permanently open prospective cohort which started in 1999.
   Participants/setting Participants were 10,812 middle-aged women. All of them were university graduates.
   Main outcome measures Usual diet was assessed at baseline and after 10 years of follow-up with a 136-item food frequency questionnaire. Phenolic acid intake was calculated by matching food consumption with the Phenol-Explorer database on phenolic acids content of each reported food item.
   Statistical analysis performed Participants were classified according to tertiles of subclasses or individual compounds of phenolic acids. Cox regression models were fitted to estimate multivariable-adjusted hazard ratios and 95% CIs for breast cancer incidence.
   Results Over an average of 11.8 years of follow-up, 101 incident cases of breast cancer were confirmed. After multivariable adjustment, an inverse association between hydroxycinnamic acids intake and breast cancer was observed (hazard ratio third tertile vs first tertile 0.37, 95% CI 0.16 to 0.85; P for trend=0.029) among postmenopausal women. Specifically, chlorogenic acids (3-, 4-, and 5-caffeoylquinic acids) showed the strongest inverse association (hazard ratio third tertile vs first tertile 0.33, 95% CI 0.14 to 0.78; P for trend=0.012).
   Conclusions A higher intake of hydroxycinnamic acids, especially from chlorogenic acids-present in coffee, fruits, and vegetables-was associated with a lower incidence of breast cancer among postmenopausal women. Future observational studies are needed to corroborate these results.
C1 [Romanos-Nanclares, Andrea; Angel Martinez-Gonzalez, Miguel; Gea, Alfredo; Toledo, Estefania] Univ Navarra, Sch Med, Dept Prevent Med & Publ Hlth, Irunlarrea 1, Navarra 31008, Spain.
   [Romanos-Nanclares, Andrea; Angel Martinez-Gonzalez, Miguel; Gea, Alfredo; Toledo, Estefania] Navarra Inst Hlth Res, Pamplona, Spain.
   [Sanchez-Quesada, Cristina] Univ Jaen, Dept Hlth Sci, Immunol Div, Jaen, Spain.
   [Gardeazabal, Itziar] Univ Navarra, Dept Prevent Med & Publ Hlth, Navarra, Spain.
   [Gardeazabal, Itziar] Univ Navarra Clin, Dept Oncol, Navarra, Spain.
   [Angel Martinez-Gonzalez, Miguel; Gea, Alfredo; Toledo, Estefania] Inst Hlth Carlos III, Ctr Physiopathol Obes & Nutr, Madrid, Spain.
   [Angel Martinez-Gonzalez, Miguel] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
C3 University of Navarra; Universidad de Jaen; University of Navarra;
   University of Navarra; Harvard University; Harvard T.H. Chan School of
   Public Health
RP Toledo, E (corresponding author), Univ Navarra, Sch Med, Dept Prevent Med & Publ Hlth, Irunlarrea 1, Navarra 31008, Spain.; Toledo, E (corresponding author), Navarra Inst Hlth Res, Pamplona, Spain.; Toledo, E (corresponding author), Inst Hlth Carlos III, Ctr Physiopathol Obes & Nutr, Madrid, Spain.
EM etoledo@unav.es
RI Abad-Gurumeta, Alfredo/M-2337-2019; Sanchez, Cristina/ABC-5511-2021;
   Gardeazabal, Itziar/AAW-1429-2020; Martinez-Gonzalez,
   Miguel/AAE-7669-2019; Toledo, Estefania/H-6211-2014
OI Toledo, Estefania/0000-0002-6263-4434; Gea, Alfredo/0000-0002-2229-4690;
   Gardeazabal, Itziar/0000-0003-2730-4998
FU Spanish Government-Instituto de Salud Carlos III; European Regional
   Development Fund (FEDER) [RD 06/0045]; European Regional Development
   Fund (FEDER) (CIBER-OBN) [PI10/02658, PI10/02293, PI13/00615,
   PI14/01668, PI14/01798, PI14/01764, PI17/01795, G03/140]; Navarra
   Regional Government [45/2011, 122/2014, 41/2016]; University of Navarra
FX The SUN Project has received funding from the Spanish
   Government-Instituto de Salud Carlos III, and the European Regional
   Development Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658,
   PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, PI17/01795,
   and G03/140), the Navarra Regional Government (45/2011, 122/2014,
   41/2016), and the University of Navarra.
CR Bray Freddie, 2018, CA Cancer J Clin, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
   [Anonymous], 2005, Rev. Esp. Obes
   [Anonymous], 2017, Diet, nutrition, physical activity and colorectal cancer
   [Anonymous], 2016, Nutraceuticals, DOI DOI 10.1016/B978-0-12-802147-7.00047-4
   [Anonymous], TABLA COMPOSICION AL
   [Anonymous], 2011, STAT STAT SOFTW REL
   Burkholder-Cooley NM, 2017, AM J CLIN NUTR, V105, P685, DOI 10.3945/ajcn.116.137174
   Carlos S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040439
   de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065
   De P, 2011, CURR MED CHEM, V18, P1672, DOI 10.2174/092986711795471347
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Fernández-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837
   Gardeazabal I, 2019, BRIT J NUTR, V122, P542, DOI 10.1017/S0007114518003811
   Gorzynik-Debicka M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030686
   Greenland S, 2016, INT J EPIDEMIOL, V45, P565, DOI 10.1093/ije/dyw040
   Grosso G, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600930
   Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415
   Hernán MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kang NJ, 2011, PHARMACOL THERAPEUT, V130, P310, DOI 10.1016/j.pharmthera.2011.02.004
   Kylli P, 2008, J AGR FOOD CHEM, V56, P4797, DOI 10.1021/jf800317v
   Lei L, 2016, ONCOTARGET, V7, P73573, DOI 10.18632/oncotarget.12017
   Losada-Echeberría M, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040088
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Martínez-González MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745
   MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512
   Mocanu MM, 2015, MOLECULES, V20, P22578, DOI 10.3390/molecules201219864
   Moreiras O., 2015, Tablas de Composicion de Alimentos, Guia de Practicas (Spanish Food Com-Position Tables)
   Nagasaka R, 2007, BIOCHEM BIOPH RES CO, V358, P615, DOI 10.1016/j.bbrc.2007.04.178
   Nakatani N, 2000, J AGR FOOD CHEM, V48, P5512, DOI 10.1021/jf000422s
   Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024
   Ovaskainen ML, 2008, J NUTR, V138, P562
   Pérez-Jiménez J, 2010, EUR J CLIN NUTR, V64, pS112, DOI 10.1038/ejcn.2010.221
   Pérez-Jiménez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096
   Pérez-Jiménez J, 2010, J AGR FOOD CHEM, V58, P4959, DOI 10.1021/jf100128b
   Radtke J, 1998, Z ERNAHRUNGSWISS, V37, P190, DOI 10.1007/s003940050016
   Rocha L.D., 2012, Cancer Clinical Oncol, V1, P109, DOI DOI 10.5539/CCO.V1N2P109
   Rothman Kenneth J., 2012, Epidemiology: An Introduction
   Rothwell JA, 2017, CURR OPIN CLIN NUTR, V20, P512, DOI 10.1097/MCO.0000000000000424
   Rothwell JA, 2015, MOL NUTR FOOD RES, V59, P160, DOI 10.1002/mnfr.201400494
   Royston P., 2011, FLEXIBLE PARAMETRIC
   Russo GI, 2017, MOLECULES, V22, DOI 10.3390/molecules22122159
   Sauter ER, 2018, EUR J BREAST HEALTH, V14, P64, DOI 10.5152/ejbh.2018.3978
   Shivappa N, 2015, BRIT J CANCER, V113, P1099, DOI 10.1038/bjc.2015.304
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tresserra-Rimbau A, 2013, NUTR METAB CARDIOVAS, V23, P953, DOI 10.1016/j.numecd.2012.10.008
   Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039
   Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106
   Weng CJ, 2012, CANCER TREAT REV, V38, P76, DOI 10.1016/j.ctrv.2011.03.001
   Willett W., 2017, Nutritional epidemiology
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S
   Zamora-Ros R, 2016, EUR J NUTR, V55, P1359, DOI 10.1007/s00394-015-0950-x
   Zamora-Ros R, 2014, AM J CLIN NUTR, V100, P11, DOI 10.3945/ajcn.113.077743
   Zamora-Ros R, 2013, BRIT J NUTR, V110, P1500, DOI 10.1017/S0007114513000688
NR 54
TC 26
Z9 26
U1 1
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2212-2672
EI 2212-2680
J9 J ACAD NUTR DIET
JI J. Acad. Nutr. Diet.
PD JUN
PY 2020
VL 120
IS 6
BP 1002
EP +
DI 10.1016/j.jand.2019.11.007
PG 19
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA LT2YR
UT WOS:000536938100007
PM 31982373
DA 2025-04-28
ER

PT J
AU Wong, THT
   Luo, S
   Yeung, SLA
   Louie, JCY
AF Wong, Tommy Hon Ting
   Luo, Shan
   Yeung, Shiu Lun Au
   Louie, Jimmy Chun Yu
TI Association between coffee consumption and metabolic syndrome: A
   cross-sectional and Mendelian randomization study
SO JOURNAL OF DIABETES
LA English
DT Article
DE artificial sweetener; coffee; Mendelian randomization; metabolic
   syndrome; milk; sugar
ID RISK-FACTORS; SWEETENERS; TEA; METAANALYSIS; PREVALENCE; OBESITY
AB Background: This study investigates the associations between coffee consumption and metabolic syndrome and its components, as well as the effect of milk, sugar, and artificial sweeteners on these associations. Methods: A cross-sectional analysis was conducted with 351805 UK Biobank participants. Coffee consumption data were collected via food frequency questionnaires and 24-h recall. Metabolic syndrome was identified through blood biochemistry and self-reported medication use. Odds ratios were calculated using multivariable logistic regression, and results were verified with two-sample Mendelian randomization. Results: Consuming up to two cups of coffee per day was inversely associated with metabolic syndrome (1 cup/day: odds ratio [OR]: 0.88, 95% confidence interval [CI]: 0.85-0.92; 2 cups/day: OR: 0.90, 95% CI: 0.86-0.93). Higher intakes showed near-null associations. Mendelian randomization did not support a causal link between coffee intake and metabolic syndrome. Both self-reported and genetically predicted high coffee consumption (four cups per day or more) were associated with central obesity. The inverse association between coffee consumption and metabolic syndrome was more profound among drinkers of ground coffee than those of instant coffee. Results were similar when stratified by the use of milk and sugar, yet the use of artificial sweetener with coffee was positively associated with metabolic syndrome and all component conditions. Conclusions: Coffee consumption may increase the risk of central obesity but is unlikely to impact the risk of metabolic syndrome. The potential health effects of artificial sweeteners in coffee need further investigation.
C1 [Wong, Tommy Hon Ting; Louie, Jimmy Chun Yu] Univ Hong Kong, Fac Sci, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.
   [Wong, Tommy Hon Ting; Luo, Shan; Yeung, Shiu Lun Au] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China.
   [Louie, Jimmy Chun Yu] Swinburne Univ Technol, Sch Hlth Sci, Dept Nursing & Allied Hlth, SPW203,Swinburne Pl West Bldg,1 John St, Hawthorn, Vic 3122, Australia.
C3 University of Hong Kong; University of Hong Kong; Swinburne University
   of Technology
RP Louie, JCY (corresponding author), Swinburne Univ Technol, Sch Hlth Sci, Dept Nursing & Allied Hlth, SPW203,Swinburne Pl West Bldg,1 John St, Hawthorn, Vic 3122, Australia.
EM jimmylouie@swin.edu.au
RI Louie, Jimmy Chun Yu/B-6754-2008; Luo, Shan/JEP-7010-2023; SL,
   Au/ABD-3938-2021; Wong, Tommy/AAI-2928-2020
OI Wong, Tommy Hon Ting/0000-0003-4822-4604; Au Yeung, Shiu Lun
   Ryan/0000-0001-6136-1836; Luo, Shan/0000-0003-3368-9935
FU Faculty of Science, The University of Hong Kong
FX the Faculty of Science, The University of Hong Kong
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Yeung SLA, 2022, THORAX, V77, P164, DOI 10.1136/thoraxjnl-2020-215600
   Azad MB, 2017, CAN MED ASSOC J, V189, pE929, DOI 10.1503/cmaj.161390
   Bowden J, 2017, STAT MED, V36, P1783, DOI 10.1002/sim.7221
   Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965
   Burgess S, 2018, EUR J EPIDEMIOL, V33, P947, DOI 10.1007/s10654-018-0424-6
   Burgess S, 2015, AM J EPIDEMIOL, V181, P251, DOI 10.1093/aje/kwu283
   Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601
   DeBoer MD, 2018, DIABETES CARE, V41, P2421, DOI 10.2337/dc18-1079
   Du YB, 2020, NUTR METAB CARDIOVAS, V30, P2159, DOI 10.1016/j.numecd.2020.08.017
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408
   Hemani G, 2017, PLOS GENET, V13, DOI [10.1371/journal.pgen.1007081, 10.1371/journal.pgen.1007149]
   Hirode G, 2020, JAMA-J AM MED ASSOC, V323, P2526, DOI 10.1001/jama.2020.4501
   IPAQ, 2005, GUIDELINES DATA PROC
   Ippoliti F, 2013, J NEUROIMMUNE PHARM, V8, P212, DOI 10.1007/s11481-012-9432-6
   Kim Y, 2019, CURR ATHEROSCLER REP, V21, DOI 10.1007/s11883-019-0814-6
   Kwok MK, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01831-3
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Liu B, 2021, BMC PUBLIC HEALTH, V21, DOI [10.1186/s12889-021-11042-x, 10.1186/s12879-021-06378-z]
   Liu MZ, 2019, NAT GENET, V51, P237, DOI 10.1038/s41588-018-0307-5
   MACKENBACH JP, 1988, HEALTH POLICY, V10, P207, DOI 10.1016/0168-8510(88)90006-1
   Magalhaes R, 2021, MOL PSYCHIATR, V26, P6589, DOI 10.1038/s41380-021-01075-4
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P358, DOI 10.1080/09637486.2017.1362690
   Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034
   Nicolopoulos K, 2020, CLIN NUTR, V39, P3467, DOI 10.1016/j.clnu.2020.03.009
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Pearlman Michelle, 2017, Curr Gastroenterol Rep, V19, P64, DOI 10.1007/s11894-017-0602-9
   Raats M. M., 1992, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D
   Rees JMB, 2017, STAT MED, V36, P4705, DOI 10.1002/sim.7492
   Sanderson E, 2021, STAT MED, V40, P5434, DOI 10.1002/sim.9133
   Scuteri A, 2015, EUR J PREV CARDIOL, V22, P486, DOI 10.1177/2047487314525529
   Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779
   Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793
   Swithers SE, 2013, TRENDS ENDOCRIN MET, V24, P431, DOI 10.1016/j.tem.2013.05.005
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tanamas S K., 2013, AusDiab 2012. The Australian Diabetes
   Taylor AE, 2018, ADDICTION, V113, P148, DOI 10.1111/add.13975
   Tomiyama AJ, 2019, ANNU REV PSYCHOL, V70, P703, DOI 10.1146/annurev-psych-010418-102936
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   Wong THT, 2021, ADV NUTR, V12, P708, DOI 10.1093/advances/nmaa132
   Wong THT, 2018, EUR J NUTR, V57, P2123, DOI 10.1007/s00394-017-1488-x
   Zunhammer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109490
NR 48
TC 0
Z9 0
U1 6
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1753-0393
EI 1753-0407
J9 J DIABETES
JI J. Diabetes
PD OCT
PY 2024
VL 16
IS 10
AR e70004
DI 10.1111/1753-0407.70004
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA J4H2E
UT WOS:001336683000001
PM 39390756
OA gold
DA 2025-04-28
ER

PT J
AU Alhadi, IA
   Al Ansari, AM
   AlSaleh, AFF
   Alabbasi, AMA
AF Alhadi, Isa Abdulla
   Al Ansari, Ahmed Mohammed
   AlSaleh, Aseel Fuad Fahad
   Alabbasi, Ahmed M. Abdulla
TI Systematic review of the effect of caffeine therapy effect on
   cardiometabolic markers in rat models of the metabolic syndrome
SO BMC ENDOCRINE DISORDERS
LA English
DT Review
DE HDL-C; Hypertension; Obesity; Insulin resistance; Dyslipidemia
ID BODY-FAT; CONSUMPTION; HYPERTENSION; OBESE; FAILURE
AB This systematic review aimed to study caffeine's effect on the cardiometabolic markers of the metabolic syndrome and to evaluate caffeine's application as a potential therapeutic agent in rat models. The systematic review was structured and synthesized according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and the Population, Intervention, comparator, outcome (PICO) framework. A literature search was conducted in PubMed, Scopus, and ScienceDirect to identify studies that used caffeine as an intervention in the rat model of the metabolic syndrome or any of its components compared with no treatment or controls. Studies that did not mention the disease manifestations from the experimental model used, without rat subjects, and which induced renovascular hypertension were excluded. The risk of bias in the included studies was assessed using the Systematic Review Center for Laboratory Animal Experimentation risk-of-bias tool. The main outcomes assessed were caffeine's effect on obesity, dyslipidemia, hepatic steatosis, hepatic dysfunction, insulin resistance, and hypertension. Out of 228 studies retrieved from the search, 18 met our inclusion criteria and were included in the systematic review. Caffeine was found to favorably reduce obesity and insulin resistance in the rat model of the metabolic syndrome. The effects of caffeine on dyslipidemia, hepatic steatosis, hepatic dysfunction, and hypertension remain inconclusive. The main limitations of this study are the heterogeneity of the included studies in terms of the disease model used, experimental duration, methods to assess outcomes, including studies that were only published in English, measurement units used, and graphical data without and numerical mention in the results section. As a result, quantitative synthesis was unfeasible, and a qualitative descriptive synthesis was conducted; this might have led to the under characterization of caffeine's effect on metabolic syndrome and its potential as an adjuvant therapy in metabolic syndrome. Caffeine has favorable effects on the metabolic syndrome, chiefly reducing obesity and insulin resistance. Future research is encouraged to delve into caffeine's effect on dyslipidemia, hepatic steatosis, hepatic dysfunction, and hypertension, which is necessary if caffeine is to be used as a potential clinical adjuvant therapy to treat the metabolic syndrome.
C1 [Alhadi, Isa Abdulla; Al Ansari, Ahmed Mohammed; AlSaleh, Aseel Fuad Fahad; Alabbasi, Ahmed M. Abdulla] Arabian Gulf Univ, Dept Gifted Educ, POB 26671, Manama, Bahrain.
C3 Arabian Gulf University
RP Alabbasi, AMA (corresponding author), Arabian Gulf Univ, Dept Gifted Educ, POB 26671, Manama, Bahrain.
EM ahmedmda@agu.edu.bh
RI Abdulla Alabbasi, Ahmed/ADJ-4571-2022
CR CHOI KC, 1993, NEPHRON, V65, P619, DOI 10.1159/000187574
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Helal MG, 2018, HUM EXP TOXICOL, V37, P983, DOI 10.1177/0960327117747026
   Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43
   Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180
   Inoue H, 2006, BIOSCI BIOTECH BIOCH, V70, P1134, DOI 10.1271/bbb.70.1134
   Kagami K, 2008, J PHARM PHARMACOL, V60, P1161, DOI 10.1211/jpp.60.9.0007
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Marangos PJ., 2010, Handbook of disease burdens and quality of life measures, P1135
   MedCalc Software Ltd, Comparison of means calculator
   Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287
   Naidoo P, 2014, PHARMACOL REP, V66, P585, DOI 10.1016/j.pharep.2014.02.019
   OHNISHI A, 1986, J CLIN INVEST, V78, P1045, DOI 10.1172/JCI112659
   Page MJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n160
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Park S, 2007, METABOLISM, V56, P599, DOI 10.1016/j.metabol.2006.12.004
   Richardson W. S., 1995, ACP J Club, V123, pA12, DOI DOI 10.7326/ACPJC-1995-123-3-A12
   SUGIYAMA K, 1989, AGR BIOL CHEM TOKYO, V53, P3101, DOI 10.1080/00021369.1989.10869788
   Suzuki M, 2017, J APPL PHYSIOL, V122, P1321, DOI 10.1152/japplphysiol.00278.2016
   Tanner GA, 2001, AM J KIDNEY DIS, V38, P1089, DOI 10.1053/ajkd.2001.28614
   The Cochrane Collaboration, 2020, Review Manager (RevMan) Computer program. Version 5.4. 0
   The EndNote Team, 2013, ENDNOTE ENDNOTE X7, V8
   Tofovic SP, 1999, J CARDIOVASC PHARM, V33, P360, DOI 10.1097/00005344-199903000-00003
   Tofovic SP, 2002, KIDNEY INT, V61, P1433, DOI 10.1046/j.1523-1755.2002.00278.x
   Tofovic SP, 2001, RENAL FAILURE, V23, P159, DOI 10.1081/JDI-100103488
   Tofovic SP, 2007, RENAL FAILURE, V29, P891, DOI 10.1080/08860220701569846
   Une HD., 2016, INT J PHARMCY PHARM, V8, P277, DOI [10.22159/ijpps.2016.v8i9.13590, DOI 10.22159/IJPPS.2016.V8I9.13590]
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Yang Z, 2019, PHYTOTHER RES, V33, P1019, DOI 10.1002/ptr.6295
NR 29
TC 3
Z9 3
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD FEB 6
PY 2023
VL 23
IS 1
AR 34
DI 10.1186/s12902-023-01288-4
PG 22
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 8M8TA
UT WOS:000924729700003
PM 36740696
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Panchal, SK
   Wong, WY
   Kauter, K
   Ward, LC
   Brown, L
AF Panchal, Sunil K.
   Wong, Weng-Yew
   Kauter, Kate
   Ward, Leigh C.
   Brown, Lindsay
TI Caffeine attenuates metabolic syndrome in diet-induced obese rats
SO NUTRITION
LA English
DT Article
DE Obesity; Cardiovascular remodeling; Metabolic syndrome; Dyslipidemia;
   Adenosine receptor
ID ADENOSINE RECEPTORS; INSULIN-RESISTANCE; FAT; CONSUMPTION
AB Objective: Caffeine is a constituent of many non-alcoholic beverages. Pharmacological actions of caffeine include the antagonism of adenosine receptors and the inhibition of phosphodiesterase activity. The A(1) adenosine receptors present on adipocytes are involved in the control of fatty acid uptake and lipolysis. In this study, the effects of caffeine were characterized in a diet-induced metabolic syndrome in rats.
   Methods: Rats were given a high-carbohydrate, high-fat diet (mainly containing fructose and beef tallow) for 16 wk. The control rats were given a corn starch diet. Treatment groups were given caffeine 0.5 g/kg of food for the last 8 wk of the 16-wk protocol. The structure and function of the heart and the liver were investigated in addition to the metabolic parameters including the plasma lipid components.
   Results: The high-carbohydrate, high-fat diet induced symptoms of metabolic syndrome, including obesity, dyslipidemia, impaired glucose tolerance, decreased insulin sensitivity, and increased systolic blood pressure, associated with the development of cardiovascular remodeling and nonalcoholic steatohepatitis. The treatment with caffeine in the rats fed the high-carbohydrate, high-fat diet decreased body fat and systolic blood pressure, improved glucose tolerance and insulin sensitivity, and attenuated cardiovascular and hepatic abnormalities, although the plasma lipid concentrations were further increased.
   Conclusion: Decreased total body fat, concurrent with increased plasma lipid concentrations, reflects the lipolytic effects of caffeine in adipocytes, likely owing to the caffeine antagonism of A1 adenosine receptors on ad ipocytes. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Panchal, Sunil K.; Kauter, Kate; Brown, Lindsay] Univ So Queensland, Dept Biol & Phys Sci, Toowoomba, Qld 4350, Australia.
   [Wong, Weng-Yew; Brown, Lindsay] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.
   [Ward, Leigh C.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.
C3 University of Southern Queensland; University of Queensland; University
   of Queensland
RP Brown, L (corresponding author), Univ So Queensland, Dept Biol & Phys Sci, Toowoomba, Qld 4350, Australia.
EM Lindsay.Brown@usq.edu.au
RI Ward, Leigh/L-4461-2019; Ward, Leigh/A-4834-2010
OI Panchal, Sunil K/0000-0001-5464-3376; Kauter, Kate/0000-0003-2470-9172;
   Ward, Leigh/0000-0003-2378-279X
CR AMMON HPT, 1991, ARCH PHARM, V324, P261, DOI 10.1002/ardp.19913240502
   Arnaud Maurice J, 2011, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-642-13443-2_3
   Bachmann K, 1996, ENVIRON HEALTH PERSP, V104, P400, DOI 10.2307/3432684
   Bhattacharya J, 2011, J ECON PERSPECT, V25, P139, DOI 10.1257/jep.25.1.139
   Boden G, 2003, EXP CLIN ENDOCR DIAB, V111, P121, DOI 10.1055/s-2003-39781
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812
   Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P816, DOI 10.1002/art.22762
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Elzein E, 2008, EXPERT OPIN INV DRUG, V17, P1901, DOI 10.1517/13543780802497284 
   Funakoshi H, 2006, CIRCULATION, V114, P2240, DOI 10.1161/CIRCULATIONAHA.106.620211
   Gao ZG, 2007, EXPERT OPIN EMERG DR, V12, P479, DOI 10.1517/14728214.12.3.479
   Gharibi B, 2012, INT J OBESITY, V36, P397, DOI 10.1038/ijo.2011.129
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Handa P, 2011, ARTERIOSCL THROM VAS, V31, P2827, DOI 10.1161/ATVBAHA.111.236554
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   HOLTZMAN SG, 1991, J PHARMACOL EXP THER, V256, P62
   Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180
   Jacobson Kenneth A, 2009, Handb Exp Pharmacol, P1, DOI 10.1007/978-3-540-89615-9_1
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   JORDA A, 1989, BIOCHEM PHARMACOL, V38, P2727, DOI 10.1016/0006-2952(89)90560-1
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Koren G, 2000, CAN FAM PHYSICIAN, V46, P801
   Liang HX, 2002, BRIT J PHARMACOL, V135, P1457, DOI 10.1038/sj.bjp.0704586
   McIntosh VJ, 2012, J CARDIOVASC PHARM T, V17, P21, DOI 10.1177/1074248410396877
   Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]
   Peng ZS, 2009, J CLIN INVEST, V119, P1052, DOI 10.1172/JCI37409C1
   Poudyal H, 2012, J NUTR BIOCHEM, V23, P153, DOI 10.1016/j.jnutbio.2010.11.011
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Ribeiro JA, 2010, J ALZHEIMERS DIS, V20, pS3, DOI 10.3233/JAD-2010-1379
   Schäfer A, 2008, BRIT J PHARMACOL, V153, P886, DOI 10.1038/sj.bjp.0707459
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   SNYDER SH, 1984, J PSYCHIAT RES, V18, P91, DOI 10.1016/0022-3956(84)90001-3
   Szkudelski T, 2009, PHYSIOL RES, V58, P863, DOI 10.33549/physiolres.931467
NR 36
TC 65
Z9 69
U1 0
U2 31
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD OCT
PY 2012
VL 28
IS 10
BP 1055
EP 1062
DI 10.1016/j.nut.2012.02.013
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 013QJ
UT WOS:000309319600018
PM 22721876
DA 2025-04-28
ER

PT J
AU Papandreou, D
   Andreou, E
   Heraclides, A
   Rousso, I
AF Papandreou, D.
   Andreou, E.
   Heraclides, A.
   Rousso, I
TI Is beverage intake related to overweight and obesity in school children?
SO HIPPOKRATIA
LA English
DT Article
DE Sugar beverage intake; obesity; children; Greece
ID SUGAR-SWEETENED BEVERAGES; CONSUMPTION; ASSOCIATION; CHILDHOOD; RISK;
   FREQUENCY
AB Background and Aim: Recently, considerable attention has been given to beverage intake as a source of calories which may be linked to pediatric obesity. The purpose of our study was to evaluate the beverage intake in school children and adolescents aged 7 to 15 years old.
   Methods: Six hundred and seven (607) out of 655 children participated in the study. One hundred percent fruit juice were classified those beverages that contain 100% fruit juice, without sweetener. Sweetened sugar beverages (SSBs) were included (fruit drinks sweetened fruit juice, fruit-flavored drink or drink that contained fruit juice in part, sweeten soft drinks, coffee, and tea).
   Results: Around 84% of subjects consumed water while 81% of children who were included in the analysis consumed milk, 49.5% consumed 100% fruit juice, and 79.4 % SSBs. Whole milk was consumed by 40.9% of school children. Skim milk and 1% milk were consumed by 3.6% and 4.7% of the children, respectively. Children and adolescents consuming SSBs were 2.57 (95% CI: 1.06, 3.38) times more likely to become obese compared to normal peers.
   Conclusion: Sugar beverage drinks but not 100% fruit juices and milk are associated with obesity. Further studies investigating the relationship among beverage consumption, total energy intake, and development of overweight are needed.
C1 [Papandreou, D.; Rousso, I] Aristotle Univ Thessaloniki, Dept Pediat 2, Sch Med, TK-54636 Thessaloniki, Greece.
   [Papandreou, D.; Andreou, E.; Heraclides, A.] Univ Nicosia, Sch Sci, Dept Life & Hlth Sci, CY-1700 Nicosia, Cyprus.
C3 Aristotle University of Thessaloniki; University of Nicosia
RP Papandreou, D (corresponding author), Univ Nicosia, 46 Makedonittisas Ave, CY-1700 Nicosia, Cyprus.
EM papandreoudimitrios@yahoo.gr
RI Heraclides, Alexandros/AFN-4638-2022; Papandreou,
   Dimitrios/AAF-1712-2020; Andreou, Eleni/GQP-2310-2022
OI Andreou, Eleni/0000-0002-0449-6782; Papandreou,
   Dimitrios/0000-0002-4923-484X; Heraclides,
   Alexandros/0000-0002-1304-3275
CR [Anonymous], 2004, J AM DIET ASSOC, V104, P660, DOI 10.1016/j.jada.2004.01.030
   Antonogeorgos G, 2012, PEDIATR OBES, V7, P65, DOI 10.1111/j.2047-6310.2011.00006.x
   Bachman CM, 2006, NUTR REV, V64, P153, DOI 10.1301/nr.2006.apr.153-174
   Baker SS, 2001, PEDIATRICS, V107, P1210, DOI 10.1542/peds.107.5.1210
   Barba G, 2005, BRIT J NUTR, V93, P15, DOI 10.1079/BJN20041300
   Baur L., 2004, Obes Rev, V5, P4, DOI [10.1111/j.1467-, 10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]
   Briefel RR, 2009, J AM DIET ASSOC, V109, pS79, DOI 10.1016/j.jada.2008.10.064
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   Dennison BA, 1997, PEDIATRICS, V99, P15
   Duffey KJ, 2012, EUR J CLIN NUTR, V66, P244, DOI 10.1038/ejcn.2011.166
   Farajian P, 2013, PUBLIC HEALTH NUTR, V16, P240, DOI 10.1017/S1368980012002625
   Linardakis M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-279
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malindretos P, 2009, HIPPOKRATIA, V13, P46
   Manios Y, 2004, AM J HUM BIOL, V16, P639, DOI 10.1002/ajhb.20075
   Manios Y, 2010, J AM DIET ASSOC, V110, P1527, DOI 10.1016/j.jada.2010.07.004
   Manios Y, 2009, OBESITY, V17, P2047, DOI 10.1038/oby.2009.50
   Noel SE, 2011, J NUTR, V141, P2035, DOI 10.3945/jn.111.143420
   Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743
   Pereira MA, 2006, INT J OBESITY, V30, pS28, DOI 10.1038/sj.ijo.0803489
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Trichopoulou A., 2004, Composition Tables of Foods and Greek Dishes
   Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834
   Welsh JA, 2005, PEDIATRICS, V115, pE223, DOI 10.1542/peds.2004-1148
NR 25
TC 38
Z9 41
U1 0
U2 17
PU LITHOGRAPHIA
PI THESSALONIKI
PA ANTONIADIS I-PSARRAS TH G P, NEA REDESTOS, THESSALONIKI, 00000, GREECE
SN 1108-4189
J9 HIPPOKRATIA
JI Hippokratia
PD JAN-MAR
PY 2013
VL 17
IS 1
BP 42
EP 46
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 174PE
UT WOS:000321167100009
PM 23935343
DA 2025-04-28
ER

PT J
AU Ayseli, MT
   Ipek Ayseli, Y
AF Ayseli, Mehmet Turan
   Ipek Ayseli, Yasemin
TI Flavors of the future: Health benefits of flavor precursors and volatile
   compounds in plant foods
SO TRENDS IN FOOD SCIENCE & TECHNOLOGY
LA English
DT Review
DE Volatile compounds; Antimicrobial activity; Health benefits; Functional
   foods
ID ANTIMICROBIAL ACTIVITY; RASPBERRY KETONE; AROMA COMPOUNDS; BIOACTIVE
   COMPOUNDS; CHLOROGENIC ACID; STEM-CELLS; COFFEE; BEANS; DIFFERENTIATION;
   PHYTONUTRIENTS
AB Background: Consumers' food production requirements have changed considerably during the last decade. This includes growing interest in the use of aroma compounds to develop functional foods for providing health benefits and reducing chemically synthesized additives. More recently, beyond their flavoring properties, various reports have shown the potential role of volatile compounds in human health, including their antioxidant, anti-inflammatory, anti-cancer and anti-obesity activities. Thus, investigation into the pharmacological activities of flavor and volatile compounds has been increased. Scope and approach: To our knowledge, no single review article is available that provides an overview of the health benefits and antimicrobial properties of volatile compounds. To address this, here it was aimed to review the current knowledge of the health benefit and antimicrobial properties of volatile compounds.
   Key findings and conclusions: There are many plant or food products with health benefits and antimicrobial activities. However, existing literature indicates that terpenoids, phenolics and alkaloids are among natural taste compounds, which are the most attractive sources in terms of developing new antimicrobial agents and health-promoting ingredients. Future investigation is required to demonstrate key properties of volatiles/non-volatile taste compounds such as synergic actions, organoleptic impacts, process stability and efficacy dosage, particularly in cooperation with different research disciplines. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Ayseli, Mehmet Turan] Genetris Consultancy, Kisikli Caddesi 28 Kat 2-226, TR-34662 Istanbul, Turkey.
   [Ipek Ayseli, Yasemin] Kosuyolu Family Hlth Ctr, TR-34718 Istanbul, Turkey.
RP Ayseli, MT (corresponding author), Genetris Consultancy, Kisikli Caddesi 28 Kat 2-226, TR-34662 Istanbul, Turkey.
EM tayseli@genetris.com; yaseminipek@ymail.com
RI Ayseli, Mehmet/LCE-1088-2024
OI ayseli, mehmet turan/0000-0002-4196-1348
CR Akowuah A. G., 2014, J NAT PRODUCTS, P05
   Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001
   Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001
   Amanpour A, 2015, FOOD CHEM, V182, P251, DOI 10.1016/j.foodchem.2015.03.005
   [Anonymous], FLAVOUR
   Antonio AG, 2010, FOOD CHEM, V118, P782, DOI 10.1016/j.foodchem.2009.05.063
   Anuradha K, 2013, CRIT REV FOOD SCI, V53, P1250, DOI 10.1080/10408398.2011.563879
   Aprea E, 2015, MOLECULES, V20, P2445, DOI 10.3390/molecules20022445
   Arathi BP, 2015, TRENDS FOOD SCI TECH, V45, P105, DOI 10.1016/j.tifs.2015.06.003
   Arroyo FT, 2007, J AGR FOOD CHEM, V55, P5701, DOI 10.1021/jf0703957
   Arumugam M, 2012, NAT PROD RES, V26, P1942, DOI 10.1080/14786419.2011.622277
   Augustin MA, 2015, ANNU REV FOOD SCI T, V6, P463, DOI 10.1146/annurev-food-022814-015507
   Belletti N, 2007, APPL ENVIRON MICROB, V73, P5580, DOI 10.1128/AEM.00351-07
   Bigliardi B, 2013, TRENDS FOOD SCI TECH, V31, P118, DOI 10.1016/j.tifs.2013.03.006
   Boulogne I, 2012, ENVIRON CHEM LETT, V10, P325, DOI 10.1007/s10311-012-0359-1
   Buffo RA, 2004, FLAVOUR FRAG J, V19, P99, DOI 10.1002/ffj.1325
   Carson CF, 2006, CLIN MICROBIOL REV, V19, P50, DOI 10.1128/CMR.19.1.50-62.2006
   Chiu SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092914
   Cordero-Herrera I, 2015, MOL NUTR FOOD RES, V59, P597, DOI 10.1002/mnfr.201400492
   Crozier A., 2011, TEAS COCOA COFFEE PL, P252
   Davidovich-Rikanati R, 2007, NAT BIOTECHNOL, V25, P899, DOI 10.1038/nbt1312
   Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424
   Fadida T, 2015, FOOD HYDROCOLLOID, V48, P213, DOI 10.1016/j.foodhyd.2015.02.033
   Fan JF, 2015, MOL MED REP, V12, P4759, DOI 10.3892/mmr.2015.3996
   Farah A, 2006, J AGR FOOD CHEM, V54, P374, DOI 10.1021/jf0518305
   Ayala-Zavala JF, 2009, J FOOD SCI, V74, pR84, DOI 10.1111/j.1750-3841.2009.01294.x
   Fitzgerald DJ, 2004, J APPL MICROBIOL, V97, P104, DOI 10.1111/j.1365-2672.2004.02275.x
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Frauendorfer F, 2008, J AGR FOOD CHEM, V56, P10244, DOI 10.1021/jf802098f
   Gonzalez-Rios O, 2007, J FOOD COMPOS ANAL, V20, P289, DOI 10.1016/j.jfca.2006.07.009
   Goswami T., 2012, J FOOD PROCESS TECHN, V3, P1, DOI DOI 10.4172/2157-7110.1000181
   Hannemann A, 2014, BLOOD CELL MOL DIS, V53, P21, DOI 10.1016/j.bcmd.2014.02.004
   Holzapfel NP, 2013, INT J MOL SCI, V14, P14620, DOI 10.3390/ijms140714620
   Hosseinzadeh H, 2013, PHYTOTHER RES, V27, P475, DOI 10.1002/ptr.4784
   Hubert J, 2008, PEST MANAG SCI, V64, P57, DOI 10.1002/ps.1471
   Jelen H., 2011, FOOD FLAVORS CHEM SE
   Kabir F, 2014, J KOREAN SOC APPL BI, V57, P359, DOI 10.1007/s13765-014-4056-6
   Kalaska B, 2014, J AGR FOOD CHEM, V62, P2853, DOI 10.1021/jf5008538
   Keiler AM, 2013, PLANTA MED, V79, P576, DOI 10.1055/s-0032-1328330
   Kreppenhofer S, 2011, FOOD CHEM, V126, P441, DOI 10.1016/j.foodchem.2010.11.008
   Lanciotti R, 2004, TRENDS FOOD SCI TECH, V15, P201, DOI 10.1016/j.tifs.2003.10.004
   Lanciotti R, 2003, J AGR FOOD CHEM, V51, P2958, DOI 10.1021/jf026143h
   Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084
   Li Y, 2015, NEUROCHEM RES, V40, P1520, DOI 10.1007/s11064-015-1629-7
   Linnewiel-Hermoni K, 2015, ARCH BIOCHEM BIOPHYS, V572, P28, DOI 10.1016/j.abb.2015.02.018
   Lopez HL, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-22
   Ludwig IA, 2014, FOOD RES INT, V61, P67, DOI 10.1016/j.foodres.2014.03.045
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Martinez-Mayorga K., 2014, Food informatics, P97
   Mein JR, 2011, ARCH BIOCHEM BIOPHYS, V506, P109, DOI 10.1016/j.abb.2010.11.005
   Mestdagh F, 2014, FOOD RES INT, V63, P271, DOI 10.1016/j.foodres.2014.03.011
   Moon JK, 2009, J AGR FOOD CHEM, V57, P5823, DOI 10.1021/jf901136e
   Özçelik B, 2011, PHARM BIOL, V49, P396, DOI 10.3109/13880209.2010.519390
   Park KS, 2015, PHARM BIOL, V53, P870, DOI 10.3109/13880209.2014.946059
   Park SN, 2012, ANAEROBE, V18, P369, DOI 10.1016/j.anaerobe.2012.04.001
   Petisca C, 2013, FOOD BIOPROD PROCESS, V91, P233, DOI 10.1016/j.fbp.2012.10.003
   Poisson L, 2009, J AGR FOOD CHEM, V57, P9923, DOI 10.1021/jf901683v
   Rahaiee S, 2015, J FOOD SCI TECH MYS, V52, P1881, DOI 10.1007/s13197-013-1238-x
   Rekha KR, 2013, J MOL NEUROSCI, V51, P851, DOI 10.1007/s12031-013-0074-9
   Rempe CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123925
   Rodriguez-Mateos A, 2014, MOL NUTR FOOD RES, V58, P1952, DOI 10.1002/mnfr.201400231
   Sai V., 2011, J MED PLANTS RES, V5, P2110
   Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x
   Selli S, 2014, FOOD CHEM, V165, P540, DOI 10.1016/j.foodchem.2014.05.147
   Sharma BR, 2015, AM J CHINESE MED, V43, P681, DOI 10.1142/S0192415X15500421
   Sharma Shruti, 2009, Drug Discov Today Dis Mech, V6, pe31
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Singh C. K., 2015, ANN NY ACAD SCI, P1
   Soto-Vaca A, 2012, J AGR FOOD CHEM, V60, P6658, DOI 10.1021/jf300861c
   Sun-Waterhouse D, 2013, FOOD BIOPROCESS TECH, V6, P607, DOI 10.1007/s11947-012-0829-2
   Takata T, 2014, J MED FOOD, V17, P332, DOI 10.1089/jmf.2013.2763
   Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384
   Tzeng TF, 2014, PHYTOTHER RES, V28, P187, DOI 10.1002/ptr.4976
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   Wagenstaller M, 2014, METABOLOMICS, V10, P225, DOI 10.1007/s11306-013-0581-2
   Wang LL, 2012, J MED FOOD, V15, P495, DOI 10.1089/jmf.2011.1717
   Xavier JR, 2015, APPL BIOCHEM BIOTECH, V176, P1498, DOI 10.1007/s12010-015-1660-9
   Xie W., 2014, EVID-BASED COMPL ALT, V2014, P1
   Younesi E, 2014, FUNCT FOODS HEALTH D, V4, P362
   Younesi E, 2015, TRENDS FOOD SCI TECH, V41, P95, DOI 10.1016/j.tifs.2014.09.006
   Zang LY, 2000, AM J PHYSIOL-CELL PH, V279, pC954, DOI 10.1152/ajpcell.2000.279.4.C954
NR 82
TC 96
Z9 105
U1 9
U2 162
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0924-2244
J9 TRENDS FOOD SCI TECH
JI Trends Food Sci. Technol.
PD FEB
PY 2016
VL 48
BP 69
EP 77
DI 10.1016/j.tifs.2015.11.005
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA DD7NH
UT WOS:000370110900007
DA 2025-04-28
ER

PT J
AU Keast, RSJ
   Sayompark, D
   Sacks, G
   Swinburn, BA
   Riddell, LJ
AF Keast, R. S. J.
   Sayompark, D.
   Sacks, G.
   Swinburn, B. A.
   Riddell, L. J.
TI The influence of caffeine on energy content of sugar-sweetened
   beverages: 'the caffeine-calorie effect'
SO EUROPEAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE obesity; threshold; flavour; soft drinks
ID BODY-WEIGHT; CHILDHOOD OBESITY; FOOD-INTAKE; CONSUMPTION; CHILDREN;
   CARBOHYDRATE; INDIVIDUALS; ADOLESCENTS; PREVENTION; DENSITY
AB Background/Objectives: Caffeine is a mildly addictive psychoactive chemical and controversial additive to sugar-sweetened beverages (SSBs). The objective of this study is to assess if removal of caffeine from SSBs allows co-removal of sucrose (energy) without affecting flavour of SSBs, and if removal of caffeine could potentially affect population weight gain.
   Subjects/Methods: The research comprised of three studies; study 1 used three-alternate forced choice and paired comparison tests to establish detection thresholds for caffeine in water and sucrose solution (subjects, n = 63), and to determine if caffeine suppressed sweetness. Study 2 (subjects, n = 30) examined the proportion of sucrose that could be co-removed with caffeine from SSBs without affecting the flavour of the SSBs. Study 3 applied validated coefficients to estimate the impact on the weight of the United States population if there was no caffeine in SSBs.
   Results: Detection threshold for caffeine in water was higher (1.09 +/- 0.08 mM) than the detection threshold for caffeine in sucrose solution (0.49 +/- 0.04 mM), and a paired comparison test revealed caffeine significantly reduced the sweetness of sucrose (P<0.001). Removing caffeine from SSBs allowed co-removal of 10.3% sucrose without affecting flavour of the SSBs, equating to 116 kJ per 500 ml serving. The effect of this on body weight in adults and children would be 0.600 and 0.142 kg, which are equivalent to 2.08 and 1.10 years of observed existing trends in weight gain, respectively.
   Conclusion: These data suggest the extra energy in SSBs as a result of caffeine's effect on sweetness may be associated with adult and child weight gain. European Journal of Clinical Nutrition (2011) 65, 1338-1344; doi:10.1038/ejcn.2011.123; published online 20 July 2011
C1 [Keast, R. S. J.; Sayompark, D.; Sacks, G.; Swinburn, B. A.; Riddell, L. J.] Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Vic 3125, Australia.
   [Sayompark, D.] Rajamangala Univ Technol Tawan Ok, Fac Sci & Technol, Chon Buri, Thailand.
C3 Deakin University; Rajamangala University of Technology Tawan-ok
RP Keast, RSJ (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia.
EM russell.keast@deakin.edu.au
RI Swinburn, Boyd/JXL-3452-2024; Keast, Russell/P-1899-2017; Riddell,
   Lynn/P-4950-2016; Sacks, Gary/I-5731-2014
OI Keast, Russell/0000-0003-2147-7687; Riddell, Lynn/0000-0002-0688-2134;
   Sacks, Gary/0000-0001-9736-1539
FU Diabetes Australia Research Trust; Faculty of Health, Medicine, Nursing
   and Behavioural Sciences, Deakin University, Australia
FX We thank Professor Roland Griffiths for kindly providing a copy of
   PepsiCo (1981) reference. This research was funded by Diabetes Australia
   Research Trust and funding from the Faculty of Health, Medicine, Nursing
   and Behavioural Sciences, Deakin University, Australia.
CR Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   CDC, 2004, MEAN BOD WEIGHT HEIG
   Datamonitor, 2007, CARB SOFT DRINKS US
   Delwiche JF, 2001, PERCEPT PSYCHOPHYS, V63, P761, DOI 10.3758/BF03194436
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Egger G, 2003, Obes Rev, V4, P115, DOI 10.1046/j.1467-789X.2003.00100.x
   Garrett BE, 1998, PSYCHOPHARMACOLOGY, V139, P195, DOI 10.1007/s002130050704
   GREEN BG, 1988, PHYSIOL BEHAV, V43, P515, DOI 10.1016/0031-9384(88)90127-8
   Griffiths RR, 2000, ARCH FAM MED, V9, P727, DOI 10.1001/archfami.9.8.727
   GRIFFITHS RR, 1988, J PHARMACOL EXP THER, V246, P21
   Harrington S, 2008, J SCH NURS, V24, P3, DOI 10.1622/1059-8405(2008)024[0003:TROSBC]2.0.CO;2
   Hayes JE, 2007, CHEM SENSES, V32, P225, DOI 10.1093/chemse/bjl050
   HUGHES JR, 1993, DRUG ALCOHOL DEPEN, V32, P239, DOI 10.1016/0376-8716(93)90088-8
   James J, 2005, INT J OBESITY, V29, pS54, DOI 10.1038/sj.ijo.0803062
   Keast RSJ, 2007, APPETITE, V49, P255, DOI 10.1016/j.appet.2006.11.003
   Keast RSJ, 2007, CHEM SENSES, V32, P245, DOI 10.1093/chemse/bjl052
   Krachler B, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-34
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   MCBRIDE RL, 1983, PERCEPT PSYCHOPHYS, V34, P77, DOI 10.3758/BF03205899
   McGartland C, 2003, J BONE MINER RES, V18, P1563, DOI 10.1359/jbmr.2003.18.9.1563
   Meilgaard MC., 1999, Sensory Evaluation Techniques
   Reid M, 2007, BRIT J NUTR, V97, P193, DOI 10.1017/S0007114507252705
   Rolls BJ, 2010, P NUTR SOC, V69, P70, DOI 10.1017/S0029665109991674
   Rolls BJ, 2009, PHYSIOL BEHAV, V97, P609, DOI 10.1016/j.physbeh.2009.03.011
   Schuh KJ, 1997, PSYCHOPHARMACOLOGY, V130, P320, DOI 10.1007/s002130050246
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   SUN M, 1980, SCIENCE, V209, P1500
   Swinburn BA, 2006, AM J CLIN NUTR, V83, P859, DOI 10.1093/ajcn/83.4.859
   Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585
   Swinburn B, 2010, AM J CLIN NUTR, V91, P817, DOI 10.3945/ajcn.2009.29041
   Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061
   Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001
   Tijms H, 2004, UNDERSTANDING PROBAB
   Troiano RP, 2000, AM J CLIN NUTR, V72, p1343S, DOI 10.1093/ajcn/72.5.1343s
   U.S. Census Bureau, 2009, CENS POP HOUS
   U. S. Department of Agriculture, 2008, NUTR INT FOOD MEAN A
   US Census Bureau, 2008, AG GROUPS SEX 2000
   Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834
   Wang YC, 2009, ARCH PEDIAT ADOL MED, V163, P336, DOI 10.1001/archpediatrics.2009.23
   Yeomans MR, 2000, APPETITE, V35, P131, DOI 10.1006/appe.2000.0339
NR 42
TC 21
Z9 22
U1 0
U2 29
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0954-3007
EI 1476-5640
J9 EUR J CLIN NUTR
JI Eur. J. Clin. Nutr.
PD DEC
PY 2011
VL 65
IS 12
BP 1338
EP 1344
DI 10.1038/ejcn.2011.123
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 863NE
UT WOS:000298170300011
PM 21772315
OA Green Published
DA 2025-04-28
ER

PT J
AU Hioki, C
   Yoshimoto, K
   Yoshida, T
AF Hioki, C
   Yoshimoto, K
   Yoshida, T
TI Efficacy of Bofu-tsusho-san, an oriental herbal medicine, in obese
   Japanese women with impaired glucose tolerance
SO CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
LA English
DT Article
DE Bofu-tsusho-san; impaired glucose tolerance; insulin resistance;
   obesity; traditional herbal medicine; visceral fat
ID BODY-FAT DISTRIBUTION; BETA-CELL FUNCTION; INSULIN-RESISTANCE;
   DIABETES-MELLITUS; WEIGHT-LOSS; VISCERAL ADIPOSITY; PLASMA; RISK;
   CLASSIFICATION; SENSITIVITY
AB 1. In the present study, we conducted the first randomized, double-blind, placebo-controlled study of bofu-tsusho-san (BF), an oriental herbal medicine (24 mg/day ephedrine in Ephedrae Herba and an efficacy equivalent of 280 mg caffeine, judging from the phosphodiesterase-inhibitory effect of Glycyrrhizae Radix, Forsythiae Fructus and Schizonepetae Spica and another 14 crude drugs) in obese women with impaired glucose tolerance (IGT).
   2. The aim of the present study was to determine whether BF was effective in decreasing visceral adiposity and insulin resistance. Eighty-one Japanese women (body mass index (BMI) 36.5 +/- 4.8 kg/m(2)) with IGT and insulin resistance (IR), who had been treated with a low-calorie diet (5016 kj/day: 1200 kcal) and an exercise regimen (1254 kj/day: 300 kcal), were randomized to receive either placebo (n = 40) or BIT treatment (n = 41) three times a day.
   3. After 24 weeks treatment, the BF group lost significantly (P < 0.01) more bodyweight and abdominal visceral fat without a decrease in the adjusted resting metabolic rate (RMR), whereas the placebo group lost bodyweight (P < 0.05) and had no significant change in abdominal visceral fat. The BF group had a lower fasting serum insulin level (P < 0.05), a lower insulin area under the curve (P < 0.05) and a lower level of the homeostasis model assessment of insulin resistance (P < 0.01) compared with values before treatment.
   4. We conclude that BF could be a useful herbal medicine in treating obesity with IGT.
C1 Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamikyo Ku, Kyoto 6028566, Japan.
   Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Legal Med, Kyoto 6028566, Japan.
   Natl Hosp Org Kyoto Med Ctr, Clin Res Inst Endocrine & Metab Dis, Kyoto, Japan.
   Kyoto City Hosp, Dept Diabet & Metab, Kyoto, Japan.
C3 Kyoto Prefectural University of Medicine; Kyoto Prefectural University
   of Medicine; Kyoto City Hospital
RP Hioki, C (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamikyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.
EM chioki@koto.kpu-m.ac.jp
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Baumgartner R N, 1990, Exerc Sport Sci Rev, V18, P193
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371
   Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465
   CASSANO PA, 1992, AM J EPIDEMIOL, V136, P1474, DOI 10.1093/oxfordjournals.aje.a116468
   DOWLING HJ, 1995, METABOLISM, V44, P987, DOI 10.1016/0026-0495(95)90094-2
   DOWSE GK, 1991, DIABETES CARE, V14, P914
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   FULLER JH, 1980, LANCET, V1, P1373
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   Haffner SM, 1996, DIABETOLOGIA, V39, P1201, DOI 10.1007/BF02658507
   Hayashi T, 2003, DIABETES CARE, V26, P650, DOI 10.2337/diacare.26.3.650
   Kalman D, 2002, INT J OBESITY, V26, P1363, DOI 10.1038/sj.ijo.0802061
   KITAGAWA M, 1989, J NUTR SCI VITAMINOL, V35, P235, DOI 10.3177/jnsv.35.235
   KLEIN R, 1991, DIABETES CARE, V14, P914, DOI 10.2337/diacare.14.10.914
   Kuroe A, 2003, DIABETES RES CLIN PR, V59, P71, DOI 10.1016/S0168-8227(02)00177-8
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Miller KD, 1998, LANCET, V351, P871, DOI 10.1016/S0140-6736(97)11518-5
   Molnár D, 2000, INT J OBESITY, V24, P1573, DOI 10.1038/sj.ijo.0801433
   MYLLYNEN P, 1987, ACTA MED SCAND, V222, P75
   PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006
   SASAKI T, 1987, HDB PHYSL SCI, V22, pCH12
   Tiikkainen M, 2004, AM J CLIN NUTR, V79, P22
   TOKUNAGA K, 1983, INT J OBESITY, V7, P437
   TOUBRO S, 1993, INT J OBESITY, V17, P345
   WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604
   YOSHIDA T, 1995, INT J OBESITY, V19, P717
   YOSHIDA T, 1994, INT J OBESITY, V18, P345
   YOSHIDA T, 1995, LANCET, V346, P1433, DOI 10.1016/S0140-6736(95)92452-3
NR 31
TC 65
Z9 68
U1 0
U2 11
PU BLACKWELL PUBLISHING ASIA
PI CARLTON
PA 54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA
SN 0305-1870
J9 CLIN EXP PHARMACOL P
JI Clin. Exp. Pharmacol. Physiol.
PD SEP
PY 2004
VL 31
IS 9
BP 614
EP 619
DI 10.1111/j.1440-1681.2004.04056.x
PG 6
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA 859FK
UT WOS:000224248600009
PM 15479169
DA 2025-04-28
ER

PT J
AU Moedinger, Y
   Schoen, C
   Wilhelm, M
   Pickel, C
   Grothe, T
AF Modinger, Yvonne
   Schon, Christiane
   Wilhelm, Manfred
   Pickel, Christina
   Grothe, Torsten
TI A Food Supplement with Antioxidative Santa Herba Extract Modulates
   Energy Metabolism and Contributes to Weight Management
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE body composition; energy metabolism; flavonoids; obesity
ID PLASMA ABNORMALITIES; ADENOSINE RECEPTORS; ERIODICTYOL; CAFFEINE;
   BEHAVIOR; OBESITY
AB The plant Santa herba (Eriodictyon californicum) contains high flavonoids, thus potentially exerting beneficial effects in context of obesity, often accompanied by inflammation and metabolic imbalance. The study assessed the impact of Santa herba on oxidative stress, energy metabolism, weight reduction, and eating behavior, combining in vitro models with clinical data. Santa herba binding of the adenosine receptor A2A (ADORA2A) was assessed using a radioligand binding assay. A Caenorhabditis elegans model was used to determine mobility boosting effects, and Santa herba oxygen radical absorbance capacity (ORAC) values were determined in comparison to antioxidative plants. Clinical data, that is, body weight and appetite-related parameters, were obtained from overweight and obese women receiving either Santa herba or placebo for 12 weeks. Results showed that Santa herba extract binds to ADORA2A, stimulates C. elegans motility (+7.5%) and locomotion, and yields high antioxidative capacities (ORAC: 819 trolox equivalent). Clinical data, obtained from 24 overweight and 25 obese women (mean: 47.5 years), demonstrated a reduced body weight (P = .042) and body fat (P = .044), and by trend reduced leptin levels (P = .065) in women with obesity after Santa herba consumption compared to placebo. In conclusion, Santa herba extract has energizing and antioxidative properties and may aid in weight management of people with obesity. ClinicalTrials.gov Identifier: NCT03853603.
C1 [Modinger, Yvonne; Schon, Christiane] BioTeSys GmbH, Baden Baden, Germany.
   [Wilhelm, Manfred] Ulm Univ Appl Sci, Dept Math Nat & Econ Sci, Baden Baden, Germany.
   [Pickel, Christina; Grothe, Torsten] Mibelle Grp Biochem, Bolimattstr 1, CH-5033 Buchs, Aargau, Switzerland.
RP Grothe, T (corresponding author), Mibelle Grp Biochem, Bolimattstr 1, CH-5033 Buchs, Aargau, Switzerland.
EM torsten.grothe@mibellegroup.com
OI GROTHE, TORSTEN/0000-0003-3298-4924; Schon,
   Christiane/0000-0003-3787-5268; Pickel, Christina/0000-0001-7476-2954;
   Modinger, Dr. Yvonne/0000-0001-9789-6189
CR Bean L.J., 1972, Temalpakh: Cahuilla Indian Knowledge and Usage of Plants
   Bertoia ML, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i17
   Bucolo C, 2012, BIOCHEM PHARMACOL, V84, P88, DOI 10.1016/j.bcp.2012.03.019
   Castro JP, 2016, BIOL CHEM, V397, P709, DOI 10.1515/hsz-2015-0305
   Dallas C, 2014, PHYTOTHER RES, V28, P212, DOI 10.1002/ptr.4981
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Eisenstein A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207470
   El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170
   Farzaei MH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194957
   Fischer W, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.101089
   FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x
   Habtemariam S, 2012, PHARM BIOL, V50, P1519, DOI 10.3109/13880209.2012.688838
   Hofmann J, 2020, CHEM-EUR J, V26, P7299, DOI 10.1002/chem.202001264
   Hossain MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040569
   Hunot C, 2016, APPETITE, V105, P356, DOI 10.1016/j.appet.2016.05.024
   Kwon EY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051227
   Ley JP, 2005, J AGR FOOD CHEM, V53, P6061, DOI 10.1021/jf0505170
   Marranzano M, 2018, INT J FOOD SCI NUTR, V69, P1020, DOI 10.1080/09637486.2018.1452900
   Marseglia L, 2015, INT J MOL SCI, V16, P378, DOI 10.3390/ijms16010378
   Maslov LN, 2019, J CLIN TRANSL ENDOCR, V15, P1, DOI 10.1016/j.jcte.2018.11.001
   Mokdad-Bzeouich I, 2016, CELL STRESS CHAPERON, V21, P773, DOI 10.1007/s12192-016-0702-8
   Moore M., 2003, Medicinal plants of the mountain west
   Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002
   Park SJ, 2020, J MED FOOD, V23, P335, DOI 10.1089/jmf.2019.4649
   Parrinello CM, 2015, AM HEART J, V170, P380, DOI 10.1016/j.ahj.2015.04.017
   Shi XP, 2012, MOLECULES, V17, P12868, DOI 10.3390/molecules171112868
   Testa R, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050310
   Timbrook Janice., 2007, CHUMASH ETHNOBOTANY
   Urushihata T, 2016, BIOSCI BIOTECH BIOCH, V80, P1990, DOI 10.1080/09168451.2016.1191327
   Varani K, 1996, BRIT J PHARMACOL, V117, P1693, DOI 10.1111/j.1476-5381.1996.tb15341.x
   Vernarelli JA, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.22
   Yamashita M, 2016, J NUTR SCI VITAMINOL, V62, P249, DOI 10.3177/jnsv.62.249
   Zhao BB, 2003, J NEUROSCI, V23, P5319
NR 33
TC 5
Z9 5
U1 2
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD NOV 1
PY 2021
VL 24
IS 11
BP 1235
EP 1242
DI 10.1089/jmf.2021.0016
EA JUL 2021
PG 8
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition &
   Dietetics
GA A4BH6
UT WOS:000672883900001
PM 34255555
OA hybrid
DA 2025-04-28
ER

PT J
AU Ferreira, GA
   Wagner, L
   Maziero, R
   Ataide-Silva, T
   Silva, NA
   Bertuzzi, R
   Lima-Silva, AE
AF Ferreira, G. A.
   Wagner, L.
   Maziero, R.
   Ataide-Silva, T.
   Silva, N. A.
   Bertuzzi, R.
   Lima-Silva, A. E.
TI Caffeine intake reduces sedentary time and increases physical activity
   predisposition in obese police officers
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Sedentary time; Physical inactivity; Light physical activity; Health;
   Cardiometabolic risk; Obesity
ID EXERCISE; BEHAVIOR; ENERGY; RISK
AB Sedentary time is associated with increased obesity in police officers. Caffeine intake may reduce sedentary time but it has not been extensively investigated. In the present study, the effect of caffeine ingestion on sedentary time was investigated in obese police officers. Fourteen obese police officers ingested either 5 mg/kg of caffeine or cellulose (placebo) for six days. Information on inactivity time, time spent with physical activities, self-reported perception of tiredness, and physical activity disposition was obtained daily during the intervention period. Sedentary and physical activity times were divided into two intraday periods (T-1: 08:00 am-02:00 pm and T-2: 02:00 pm-08:00 pm). Caffeine intake decreased the sedentary time in both T-1 (79.2 +/- 2.2%) and T-2 (79.1 +/- 2.5%), when compared with T-2 of the placebo condition (81.1 +/- 3.6%, P<0.05). Caffeine intake also increased the time spent on light physical activities in T-1 and T-2 (17 +/- 2 and 18 +/- 2%), when compared with T-2 of the placebo condition (16 +/- 3%, P<0.05). In addition, sedentary time increased and light physical activity time decreased from T-1 to T-2 in the placebo (P<0.001) but not in the caffeine condition (P=0.81). Caffeine intake had no effect on tiredness (P>0.05), but it increased the self-reported physical activity disposition compared to the placebo condition (4.5 +/- 2.7 vs 3.2 +/- 2.3 units, P<0.05). Caffeine intake reduced the sedentary time and increased the time spent on light physical activities of obese police officers, which seems to be related to a higher disposition for the practice of physical activity.
C1 [Ferreira, G. A.; Wagner, L.; Maziero, R.; Lima-Silva, A. E.] Univ Tecnol Fed Parana, Grp Pesquisa Performance Humano, Curitiba, Parana, Brazil.
   [Ferreira, G. A.] Univ Fed Pernambuco, Ctr Acad Vitoria, Vitoria De Santo Antao, PE, Brazil.
   [Ataide-Silva, T.; Silva, N. A.] Univ Fed Alagoas, Fac Nutr, Maceio, Alagoas, Brazil.
   [Bertuzzi, R.] Univ Sao Paulo, Grp Estudos Desempenho Aerobio, Sao Paulo, SP, Brazil.
C3 Pontificia Universidade Catolica do Parana; Universidade Tecnologica
   Federal do Parana; Universidade Federal do Parana; Universidade Federal
   de Pernambuco; Universidade Federal de Alagoas; Universidade de Sao
   Paulo
RP Bertuzzi, R (corresponding author), Univ Sao Paulo, Grp Estudos Desempenho Aerobio, Sao Paulo, SP, Brazil.
EM bertuzzi@usp.br
RI Lima-Silva, Adriano/C-2800-2013; Bertuzzi, Romulo/E-7048-2012; Ferreira,
   Guilherme Assuncao/G-5372-2014
OI Ferreira, Guilherme Assuncao/0000-0001-5210-9575
CR ABERNETHY DR, 1985, BRIT J CLIN PHARMACO, V20, P61, DOI 10.1111/j.1365-2125.1985.tb02799.x
   [Anonymous], 2004, APPL BODY COMPOSITIO
   BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815
   Cortis C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182709
   Ferraz AD, 2020, REV BRAS MED ESPORTE, V26, P117, DOI 10.1590/1517-869220202602208923
   Ferreira GA, 2019, BRAZ J MED BIOL RES, V52, DOI [10.1590/1414-431X20199169, 10.1590/1414-431x20199169]
   Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021
   Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb
   Hartley Tara A, 2011, Int J Emerg Ment Health, V13, P211
   Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046
   Júdice PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068936
   Meeusen R, 2013, NESTLE NUTR WORKS SE, V76, P1, DOI 10.1159/000350223
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Paing AC, 2020, J SCI MED SPORT, V23, P1074, DOI 10.1016/j.jsams.2020.06.003
   Puetz TW, 2006, SPORTS MED, V36, P767, DOI 10.2165/00007256-200636090-00004
   Saleh ZT, 2015, HEART LUNG, V44, P382, DOI 10.1016/j.hrtlng.2015.06.008
   Saunders B, 2017, SCAND J MED SCI SPOR, V27, P1240, DOI 10.1111/sms.12793
   Schubert MM, 2014, J APPL PHYSIOL, V117, P745, DOI 10.1152/japplphysiol.00570.2014
   Souissi Makram, 2012, Asian J Sports Med, V3, P161
   Thivel D, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00288
NR 20
TC 0
Z9 0
U1 0
U2 12
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 2021
VL 54
IS 11
AR e11556
DI 10.1590/1414-431X2021e11556
PG 6
WC Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA UX4DB
UT WOS:000700791400001
PM 34550274
OA Green Published
DA 2025-04-28
ER

PT J
AU Tsutsumi, H
   Sato, T
   Ishizu, T
AF Tsutsumi, Hiroyuki
   Sato, Takashi
   Ishizu, Takashi
TI Stereochemical Structure and Intermolecular Interaction of Complexes of
   (-)-Gallocatechin-3-O-gallate and Caffeine
SO CHEMICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE (-)-gallocatechin-3-O-gallate caffeine; X ray crystallographic analysis;
   intermolecular interaction
ID TEA CATECHINS; ANTIOXIDANT ACTIVITY; POLYPHENOLS; GALLATE; OBESITY;
   LIVER; RATS; FAT
AB A suspension containing an equimolecular amount of (-)-gallocatechin-3-O-gallate (GCg) and caffeine in water was heated at 90 degrees C for 30 min to give a 1 2 complex of GCg and caffeine X-Ray crystallographic analysis of crystal of the 1 2 complex showed that pi-pi interactions formed between the A, B' rings of GCg and the two six-membered rings of caffeine Whereas, the same suspension was heated at 90 degrees C for 30 s to give a sticky substance, which contained GCg, caffeine, and water at a molar ratio of 1 1 22 based on measurement of the integral volume of H-1-NMR signals The sticky substance crystallized slowly to give a 2 2 complex of GCg and caffeine X-Ray crystallographic analysis of crystal of the 2 2 complex showed that the A and C rings of GCg moieties faced each other, and face-to-face pi-pi interactions formed between the B ring of GCg and caffeine, the B' ring of GCg and caffeine
C1 [Tsutsumi, Hiroyuki; Sato, Takashi; Ishizu, Takashi] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Hiroshima 7290292, Japan.
C3 Fukuyama University
RP Ishizu, T (corresponding author), Fukuyama Univ, Fac Pharm & Pharmaceut Sci, 1 Sanzo Gakuen Cho, Hiroshima 7290292, Japan.
OI Tsutsumi, Hiroyuki/0000-0002-9681-2139
CR [Anonymous], CRYSTALS
   [Anonymous], CRYSTALSTRUCTURE 3 8
   [Anonymous], 1997, SHELX97
   Beurskens PT, 1999, DIRD1F 99 PROGR SYST
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   BURLA MC, 2003, SIR2002
   BURLA MC, 2005, SIR2004
   CAI Y, 1990, J CHEM SOC PERK T 2, P2197, DOI 10.1039/p29900002197
   Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S
   FUKAI K, 1991, AGR BIOL CHEM TOKYO, V55, P1895, DOI 10.1080/00021369.1991.10870886
   Gaffney S.H., 1986, CHEM COMMUN, V2, P107
   Guo Q, 1999, BBA-GEN SUBJECTS, V1427, P13, DOI 10.1016/S0304-4165(98)00168-8
   Hayashi N, 2004, BIOSCI BIOTECH BIOCH, V68, P2512, DOI 10.1271/bbb.68.2512
   HORMAN I, 1972, J FOOD SCI, V37, P925, DOI 10.1111/j.1365-2621.1972.tb03705.x
   Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155
   Isemura M, 2000, BIOFACTORS, V13, P81, DOI 10.1002/biof.5520130114
   Ishizu T, 2009, TETRAHEDRON LETT, V50, P4121, DOI 10.1016/j.tetlet.2009.04.113
   Lee SM, 2008, LIPIDS, V43, P419, DOI 10.1007/s11745-008-3167-4
   Leone M, 2003, CANCER RES, V63, P8118
   MARTIN R, 1987, PHYTOCHEMISTRY, V26, P273, DOI 10.1016/S0031-9422(00)81527-7
   Martin R, 1986, CHEM COMMUN, V2, P105
   MARUYAMA N, 1991, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON TEA SCIENCE, P145
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Shiota S, 1999, BIOL PHARM BULL, V22, P1388, DOI 10.1248/bpb.22.1388
   Tsutsumi H, 2010, CHEM PHARM BULL, V58, P230
NR 25
TC 7
Z9 7
U1 0
U2 19
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0009-2363
J9 CHEM PHARM BULL
JI Chem. Pharm. Bull.
PD JAN
PY 2011
VL 59
IS 1
BP 100
EP 105
DI 10.1248/cpb.59.100
PG 6
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Chemistry
GA 699XS
UT WOS:000285696800015
PM 21212555
OA Bronze
DA 2025-04-28
ER

PT J
AU Stutz, B
   Ahola, AJ
   Harjutsalo, V
   Forsblom, C
   Groop, PH
AF Stutz, B.
   Ahola, A. J.
   Harjutsalo, V.
   Forsblom, C.
   Groop, P. -H.
CA FinnDiane Study Grp
TI Association between habitual coffee consumption and metabolic syndrome
   in type 1 diabetes
SO NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
LA English
DT Article
DE Coffee consumption; Metabolic syndrome; Type 1 diabetes; Insulin
   resistance; Renal function
ID TEA CONSUMPTION; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; RISK;
   NEPHROPATHY; METAANALYSIS; HYPERTENSION; PROGRESSION; ADULTS
AB Background and aims: In the general population, habitual coffee consumption is inversely associated with the metabolic syndrome, a syndrome that is rather common also in patients with type 1 diabetes. However, whether coffee intake is beneficially related to the metabolic syndrome also in type 1 diabetes, is not known. We, therefore, studied the potential association between coffee consumption and the metabolic syndrome in a large population of individuals with type 1 diabetes. Furthermore, we investigated whether coffee consumption is associated with insulin resistance (estimated glucose disposal rate, eGDR), kidney function (estimated glomerular filtration rate, eGFR), and low-grade chronic inflammation (high-sensitivity C-reactive protein, hsCRP).
   Methods and results: Data from 1040 participants in the Finnish Diabetic Nephropathy Study were included in these cross-sectional analyses. Metabolic syndrome was assumed if at least 3 of the following cardiovascular risk factors were present: central obesity, high blood pressure, low HDL-cholesterol concentration, high triglyceride concentration, and hyperglycaemia. Subjects were categorized based on self-reported daily coffee intake: non-consumers (<1 cup/d), low (>= 1 cups/d < 3), moderate (>= 3 cups/d < 5), and high coffee consumption (>= 5 cups/d). In multivariable logistic regression analysis, moderate and high coffee consumption was associated with increased odds of the metabolic syndrome. Moreover, any level of coffee consumption was associated with increased risk of the blood pressure-component. An increasing trend was observed in the eGFR with increasing coffee consumption.
   Conclusions: In type 1 diabetes, high coffee intake is associated with the metabolic syndrome, and especially its blood pressure-component. (C) 2018 Published by Elsevier B.V.
C1 [Stutz, B.; Ahola, A. J.; Harjutsalo, V.; Forsblom, C.; Groop, P. -H.] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland.
   [Stutz, B.; Ahola, A. J.; Harjutsalo, V.; Forsblom, C.; Groop, P. -H.] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland.
   [Stutz, B.; Ahola, A. J.; Harjutsalo, V.; Forsblom, C.; Groop, P. -H.] Univ Helsinki, Cent Hosp, Helsinki, Finland.
   [Stutz, B.; Ahola, A. J.; Harjutsalo, V.; Forsblom, C.; Groop, P. -H.] Univ Helsinki, Res Programs Unit, Diabet & Obes, Helsinki, Finland.
   [Harjutsalo, V.] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland.
   [Groop, P. -H.] Monash Univ, Cent Clin Sch, Dept Diabet, Melbourne, Vic, Australia.
C3 Folkhalsan Research Center; University of Helsinki; University of
   Helsinki; Helsinki University Central Hospital; University of Helsinki;
   Finland National Institute for Health & Welfare; Monash University
RP Groop, PH (corresponding author), Univ Helsinki, Folkhalsan Res Ctr, Biomedicum Helsinki C318b,POB 63, FIN-00014 Helsinki, Finland.
EM per-henrik.groop@helsinki.fi
RI Harjutsalo, Valma/AAL-6588-2021
OI Groop, Per-Henrik/0000-0003-4055-6954; Ahola, Aila/0000-0001-5200-4597;
   Stutz, Bianca/0000-0002-1139-7635
FU Eli Lilly; Roche; Astra Zeneca; Boehringer-Ingelheim; EloWater; Genzyme;
   MSD; Novartis; Novo Nordisk; Sanofi; Folkhalsan Research Foundation;
   Wilhelm and Else Stockmann Foundation; Academy of Finland; Novo Nordisk
   Foundation; Signe and Ane Gyllenberg Foundation; Helsinki University
   Central Hospital Research Funds; Paivikki and Sakari Sohlberg
   Foundation; Diabetes Wellness Finland
FX P-HG has received research grants from Eli Lilly and Roche, is an
   advisory board member for AbbVie, Astra Zeneca, Boehringer- Ingelheim,
   Cebix, Eli Lilly, Janssen, MSD, Medscape, Novartis, Novo Nordisk, and
   Sanofi. He has received lecture fees from Astra Zeneca,
   Boehringer-Ingelheim, Eli Lilly, EloWater, Genzyme, MSD, Novartis, Novo
   Nordisk, and Sanofi. All other authors declare no conflict of interest.
   This work was supported by grants from Folkhalsan Research Foundation;
   Wilhelm and Else Stockmann Foundation; Academy of Finland; Novo Nordisk
   Foundation; Signe and Ane Gyllenberg Foundation; The Helsinki University
   Central Hospital Research Funds; Paivikki and Sakari Sohlberg
   Foundation; and Diabetes Wellness Finland. The funding agencies played
   no role in the study design, data collection, analysis or interpretation
   of data, or in writing the manuscript. The technical assistance of Anna
   Sandelin, Jaana Tuomikangas, and Mira Korolainen is gratefully
   acknowledged. Authors acknowledge physicians and nurses participating in
   data collection (online appendix).
CR Agudelo-Ochoa GM, 2016, J NUTR, V146, P524, DOI 10.3945/jn.115.224774
   Ahola AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06885-7
   Ahola AJ, 2012, ANN MED, V44, P73, DOI 10.3109/07853890.2010.530682
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Chillarón JJ, 2009, J CLIN ENDOCR METAB, V94, P3530, DOI 10.1210/jc.2009-0960
   Cornelis MC, 2015, CURR OPIN LIPIDOL, V26, P20, DOI 10.1097/MOL.0000000000000143
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Grosso G, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080890
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Hansen TK, 2010, DIABETOLOGIA, V53, P1517, DOI 10.1007/s00125-010-1742-8
   Herber-Gast GCM, 2016, AM J CLIN NUTR, V103, P1370, DOI 10.3945/ajcn.115.112755
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Nordic Council of Ministers, 2014, NORD NUTR REC 2012 I, V002, P2012
   O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229
   Rebello SA, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0403-1
   Riksen NP, 2009, PHARMACOL THERAPEUT, V121, P185, DOI 10.1016/j.pharmthera.2008.10.006
   Saraheimo M, 2003, DIABETOLOGIA, V46, P1402, DOI 10.1007/s00125-003-1194-5
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Shi XQ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0220-7
   Thorn LM, 2009, DIABETES CARE, V32, P950, DOI 10.2337/dc08-2022
   Thorn LM, 2005, DIABETES CARE, V28, P2019, DOI 10.2337/diacare.28.8.2019
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Wadén J, 2005, DIABETES CARE, V28, P777, DOI 10.2337/diacare.28.4.777
   Wadwa RP, 2005, DIABETES CARE, V28, P1051, DOI 10.2337/diacare.28.5.1051
   Zhang ZZ, 2011, AM J CLIN NUTR, V93, P1212, DOI 10.3945/ajcn.110.004044
NR 32
TC 23
Z9 24
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0939-4753
EI 1590-3729
J9 NUTR METAB CARDIOVAS
JI Nutr. Metab. Carbiovasc. Dis.
PD MAY
PY 2018
VL 28
IS 5
BP 470
EP 476
DI 10.1016/j.numecd.2018.01.011
PG 7
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition
   & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism;
   Nutrition & Dietetics
GA GG1IZ
UT WOS:000432442000006
PM 29501444
DA 2025-04-28
ER

PT J
AU Kim, HJ
   Yoon, BK
   Park, H
   Seok, JW
   Choi, H
   Yu, JH
   Choi, Y
   Song, SJ
   Kim, A
   Kim, JW
AF Kim, Hyo Jung
   Yoon, Bo Kyung
   Park, Hyounkyoung
   Seok, Jo Woon
   Choi, Hyeonjin
   Yu, Jung Hwan
   Choi, Yoonjeong
   Song, Su Jin
   Kim, Ara
   Kim, Jae-woo
TI Caffeine inhibits adipogenesis through modulation of mitotic clonal
   expansion and the AKT/GSK3 pathway in 3T3-L1 adipocytes
SO BMB REPORTS
LA English
DT Article
DE Adipogenesis; AKT; Caffeine; Glycogen synthase kinase; Mitotic clonal
   expansion
ID GLYCOGEN-SYNTHASE KINASE-3-BETA; TRANSCRIPTION FACTOR; BINDING PROTEINS;
   DIFFERENTIATION; INSULIN; CELLS; PHOSPHORYLATION; KINASE; PROLIFERATION;
   ACTIVATION
AB Caffeine has been proposed to have several beneficial effects on obesity and its related metabolic diseases; however, how caffeine affects adipocyte differentiation has not been elucidated. In this study, we demonstrated that caffeine suppressed 3T3-L1 adipocyte differentiation and inhibited the expression of CCAAT/enhancer binding protein (C/EBP). and peroxisome proliferator-activated receptor (PPAR)., two main adipogenic transcription factors. Anti-adipogenic markers, such as preadipocyte secreted factor (Pref)-1 and Kruppel-like factor 2, remained to be expressed in the presence of caffeine. Furthermore, 3T3-L1 cells failed to undergo typical mitotic clonal expansion in the presence of caffeine. Investigation of hormonal signaling revealed that caffeine inhibited the activation of AKT and glycogen synthase kinase (GSK) 3 in a dose-dependent manner, but not extracellular signal-regulated kinase (ERK). Our data show that caffeine is an anti-adipogenic bioactive compound involved in the modulation of mitotic clonal expansion during adipocyte differentiation through the AKT/GSK3 pathway.
C1 [Kim, Hyo Jung; Park, Hyounkyoung; Seok, Jo Woon; Choi, Hyeonjin; Yu, Jung Hwan; Choi, Yoonjeong; Song, Su Jin; Kim, Ara; Kim, Jae-woo] Yonsei Univ, Coll Med, Inst Genet Sci, Dept Biochem & Mol Biol,Integrated Genom Res Ctr, Seoul 03722, South Korea.
   [Yoon, Bo Kyung] Yonsei Univ, Coll Med, Seoul 03722, South Korea.
   [Seok, Jo Woon; Yu, Jung Hwan; Choi, Yoonjeong; Song, Su Jin; Kim, Ara; Kim, Jae-woo] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea.
   [Kim, Jae-woo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 03722, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University;
   Yonsei University Health System; Yonsei University; Yonsei University;
   Yonsei University Health System
RP Kim, JW (corresponding author), Yonsei Univ, Coll Med, Inst Genet Sci, Dept Biochem & Mol Biol,Integrated Genom Res Ctr, Seoul 03722, South Korea.; Kim, JW (corresponding author), Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea.; Kim, JW (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 03722, South Korea.
EM japol13@yuhs.ac
RI Kim, Ho Young/GRR-2801-2022; Yu, JungHwan/HLP-4190-2023
OI Yu, Jung Hwan/0000-0001-5672-038X; Kim, Jae-woo/0000-0001-5456-9495;
   KIM, HYO JUNG/0000-0002-3514-1247; Choi, Hyeonjin/0000-0002-5055-5093
FU National Research Foundation of Korea (NRF) [2011-0030086,
   2015R1A2A2A01004345, 2013R1A1A1059527]; Korea government, Ministry of
   Science, ICT and Future Planning (MSIP)
FX This work was supported by the National Research Foundation of Korea
   (NRF) Grants 2011-0030086, 2015R1A2A2A01004345, and 2013R1A1A1059527,
   funded by the Korea government, Ministry of Science, ICT and Future
   Planning (MSIP).
CR Akiba T, 2004, BIOCHEM PHARMACOL, V68, P1929, DOI 10.1016/j.bcp.2004.07.036
   Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200
   CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531
   de Leon J, 2003, PROG NEURO-PSYCHOPH, V27, P165, DOI 10.1016/S0278-5846(02)00348-2
   Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001
   Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563
   Hashimoto T, 2004, CANCER RES, V64, P3344, DOI 10.1158/0008-5472.CAN-03-3453
   Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983
   Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885
   Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052474
   Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI [10.3233/BIO-2009-1083, 10.1002/biof.5520340405]
   Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X
   Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005
   Okano JI, 2008, BASIC CLIN PHARMACOL, V102, P543, DOI 10.1111/j.1742-7843.2008.00231.x
   Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189
   Ross SE, 1999, MOL CELL BIOL, V19, P8433
   Sinchai T, 2011, NEUROSCI LETT, V502, P65, DOI 10.1016/j.neulet.2011.07.026
   SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015
   Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102
   Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200
NR 31
TC 56
Z9 62
U1 3
U2 17
PU KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER, # 801,  635-4 , YEOKSAM-DONG,
   KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-6696
EI 1976-670X
J9 BMB REP
JI BMB Rep.
PD FEB
PY 2016
VL 49
IS 2
BP 111
EP 115
DI 10.5483/BMBRep.2016.49.2.128
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA DH8QE
UT WOS:000373059500008
PM 26350746
OA Green Submitted, gold, Green Published
DA 2025-04-28
ER

PT J
AU Diepvens, K
   Kovacs, EMR
   Nijs, IMT
   Vogels, N
   Westerterp-Plantenga, MS
AF Diepvens, K
   Kovacs, EMR
   Nijs, IMT
   Vogels, N
   Westerterp-Plantenga, MS
TI Effect of green tea on resting energy expenditure and substrate
   oxidation during weight loss in overweight females
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE green tea; weight loss; resting energy expenditure; substrate oxidation
ID TOTAL-BODY WATER; CATECHIN-POLYPHENOLS; CAFFEINE CONSUMPTION; SEMISOLID
   MEAL; METABOLIC-RATE; GUAR GUM; MAINTENANCE; FAT; THERMOGENESIS;
   APPETITE
AB We assessed the effect of ingestion of green tea (GT) extract along with a low-energy diet (LED) on resting energy expenditure (REE), substrate oxidation and body weight as GT has been shown to increase energy expenditure and fat oxidation in the short term in both animals and people. Forty-six overweight women (BMI 27 center dot 6 (sd 1 center dot 8) kg/m(2)) were fed in energy balance from day 1 to day 3, followed by a LED with GT (1125 mg tea catechins +225 mg caffeine/d) or placebo (PLAC) from day 4 to day 87. Caffeine intake was standardised to 300 mg/d. Energy expenditure was measured on days 4 and 32. Reductions in weight (4 center dot 19 (sd 2 center dot 0) kg PLAC, 4 center dot 21 (sd 2 center dot 7) kg GT), BMI, waist:hip ratio, fat mass and fat-free mass were not statistically different between treatments. REE as a function of fat-free mass and fat mass was significantly reduced over 32 d in the PLAC group (P < 0 center dot 05) but not in the GT group. Dietary restraint increased over time (P < 0 center dot 001) in both groups, whereas disinhibition and general hunger decreased (P < 0 center dot 05). The GT group became more hungry over time and less thirsty, and showed increased prospective food consumption compared with PLAC (P < 0 center dot 05). Taken together, the ingestion of GT along with a LED had no additional benefit for any measures of body weight or body composition. Although the decrease in REE as a function of fat-free mass and fat mass was not significant with GT treatment, whereas it was with PLAC treatment, no significant effect of treatment over time was seen, suggesting that a robust limitation of REE reduction during a LED was not achieved by GT.
C1 Maastricht Univ, Maastricht, Netherlands.
   Unilever Res Labs, Unilever Food & Hlth Res Inst, Vlaardingen, Netherlands.
C3 Maastricht University; Unilever
RP Maastricht Univ, Maastricht, Netherlands.
EM K.Diepvens@HB.Unimaas.NL
CR ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Astrup A, 1999, AM J CLIN NUTR, V69, P1117
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Hodgson JM, 1999, J HYPERTENS, V17, P457, DOI 10.1097/00004872-199917040-00002
   Hulshof KFAM, 2003, EUR J CLIN NUTR, V57, P128, DOI 10.1038/sj.ejcn.1601503
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kovacs EMR, 2002, EUR J CLIN NUTR, V56, P771, DOI 10.1038/sj.ejcn.1601407
   Kovacs EMR, 2001, INT J OBESITY, V25, P307, DOI 10.1038/sj.ijo.0801546
   LEJEUNE MPG, 2003, BR J NUTR, V90, P1
   LICHTENBELT WDV, 1994, BRIT J NUTR, V72, P491, DOI 10.1079/BJN19940053
   Menozzi R, 2000, BRIT J NUTR, V84, P515
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Pasman WJ, 1999, METABOLISM, V48, P15, DOI 10.1016/S0026-0495(99)90004-5
   Pasman WJ, 1999, OBES RES, V7, P43, DOI 10.1002/j.1550-8528.1999.tb00389.x
   RAVUSSIN E, 1992, AM J CLIN NUTR, V55, P242
   RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802
   Rayner DV, 2001, J MOL MED, V79, P8, DOI 10.1007/s001090100198
   SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2686, DOI 10.1093/ajcn/33.12.2686
   Schoffelen PFM, 1997, J APPL PHYSIOL, V83, P2064, DOI 10.1152/jappl.1997.83.6.2064
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   Stunkard AJ, 1996, AM J MED, V100, P230, DOI 10.1016/S0002-9343(97)89464-8
   Trayhurn P, 1999, INT J OBESITY, V23, P22, DOI 10.1038/sj.ijo.0800791
   Trayhurn P, 2001, INT J OBESITY, V25, pS26, DOI 10.1038/sj.ijo.0801692
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   van Boxtel MPJ, 2003, PHARMACOL BIOCHEM BE, V75, P921, DOI 10.1016/S0091-3057(03)00171-0
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   WADDEN TA, 1988, J CONSULT CLIN PSYCH, V56, P925, DOI 10.1037/0022-006X.56.6.925
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   Weisburger JH, 1997, CANCER LETT, V114, P315, DOI 10.1016/S0304-3835(97)04691-0
   WESTERTERP KR, 1995, OBES RES, V3, P49, DOI 10.1002/j.1550-8528.1995.tb00007.x
   WESTERTERP KR, 1995, BRIT J NUTR, V73, P337, DOI 10.1079/BJN19950037
   Westerterp-Plantenga MS, 1998, INT J OBESITY, V22, P1, DOI 10.1038/sj.ijo.0800536
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224
NR 44
TC 102
Z9 111
U1 0
U2 28
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD DEC
PY 2005
VL 94
IS 6
BP 1026
EP 1034
DI 10.1079/BJN20051580
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 992WC
UT WOS:000233913700024
PM 16351782
OA Bronze
DA 2025-04-28
ER

PT J
AU Xu, N
   Chu, J
   Dong, RR
   Lu, FJ
   Zhang, XF
   Wang, M
   Shen, Y
   Xie, ZW
   Ho, CT
   Yang, CS
   Wang, YJ
   Wan, XC
AF Xu, Na
   Chu, Jun
   Dong, Rongrong
   Lu, Fengjuan
   Zhang, Xinfeng
   Wang, Min
   Shen, Ying
   Xie, Zhongwen
   Ho, Chi-Tang
   Yang, Chung S.
   Wang, Yijun
   Wan, Xiaochun
TI Yellow Tea Stimulates Thermogenesis in Mice through Heterogeneous
   Browning of Adipose Tissues
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE beigeing; browning; diet induced thermogenesis; energy expenditures;
   large-leaf yellow tea
ID CATECHOL-O-METHYLTRANSFERASE; BEIGE FAT DEVELOPMENT; DIET-INDUCED
   OBESITY; GREEN TEA; ENERGY-EXPENDITURE; RICH; ANTIOBESITY; MECHANISMS;
   CAFFEINE; LUTEOLIN
AB Scope Large-leaf yellow tea (YT) exhibits interesting beneficial metabolic effects in previous studies. Here, the authors elucidated the actions of YT on thermogenesis, energy metabolism, and adipocyte metabolic conversion.
   Methods and Results Five-week-old male C57BL/6 mice are fed low-fat diet, high-fat diet (HFD), and HFD supplemented with 0.5% or 2.5% YT. After treatment for 10 or 14 weeks, YT enhances energy expenditure, O-2 consumption and CO2 production. YT strongly boosts thermogenic program in brown adipose tissue (BAT) and subcutaneous adipose tissue (SAT), while only weakly in epididymal adipose tissue (EAT). These are accompanied by higher body temperature, increased mitochondrial copy numbers, and upregulation of thermogenic genes (Ucp1, Pgc1 alpha, etc.) and proteins. The classic brown adipocyte markers (Eva1, Zic1) are induced only in BAT, while beige adipocyte markers (Tbx1, Tmem26) are boosted only in SAT. Furthermore, subcutaneous-originated preadipocytes are induced by YT in vitro to differentiate to brown-like adipocytes - a browning effect.
   Conclusion Dietary YT induces adaptive thermogenesis through increasing mitochondrial biogenesis in EAT, inducing beigeing in SAT and enhancing browning in the BAT.
C1 [Xu, Na; Dong, Rongrong; Lu, Fengjuan; Zhang, Xinfeng; Wang, Min; Shen, Ying; Xie, Zhongwen; Wang, Yijun; Wan, Xiaochun] Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Sch Tea & Food Sci, Hefei 230036, Anhui, Peoples R China.
   [Xu, Na; Dong, Rongrong; Lu, Fengjuan; Zhang, Xinfeng; Wang, Min; Shen, Ying; Xie, Zhongwen; Ho, Chi-Tang; Yang, Chung S.; Wang, Yijun; Wan, Xiaochun] Anhui Agr Univ, Int Joint Lab Tea Chem & Hlth Effects, Minist Educ, Hefei 230036, Anhui, Peoples R China.
   [Xu, Na; Chu, Jun] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline, Boston, MA 02215 USA.
   [Chu, Jun] Anhui Univ Chinese Med, Key Lab Xin An Med, Minist Educ, Hefei 230038, Anhui, Peoples R China.
   [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.
   [Yang, Chung S.] Rutgers State Univ, Dept Biol Chem, Ernest Mario Sch Pharm, 164 Frelinghuysen Rd, Piscataway, NJ 08855 USA.
C3 Anhui Agricultural University; Anhui Agricultural University; Harvard
   University; Harvard University Medical Affiliates; Dana-Farber Cancer
   Institute; Anhui University of Chinese Medicine; Rutgers University
   System; Rutgers University New Brunswick; Rutgers University System;
   Rutgers University New Brunswick
RP Xu, N; Wan, XC (corresponding author), Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Sch Tea & Food Sci, Hefei 230036, Anhui, Peoples R China.; Xu, N; Wan, XC (corresponding author), Anhui Agr Univ, Int Joint Lab Tea Chem & Hlth Effects, Minist Educ, Hefei 230036, Anhui, Peoples R China.; Xu, N (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline, Boston, MA 02215 USA.
EM naxu2014@ahau.edu.cn; xcwan@ahau.edu.cn
RI Zhang, Xinfeng/X-8148-2019; dong, rong/JOK-6739-2023; Xie,
   Zhongwen/I-7705-2019; Ho, Chi-Tang/B-5629-2012
OI Xu, Na/0000-0002-8436-0841
FU China Scholarship Council [201908340044]; Natural Science Foundation of
   Anhui Province [1808085MC71]; Key Research and Development Projects of
   Anhui Province [1804b06020367]; Anhui Province Postdoctoral Science
   Foundation [2017B230]; Department of Sciences and Technology of Anhui
   Province [11080001]; China Agriculture Research System [CARS-19]; key
   support in program for outstanding talents in higher education
   institutions of Anhui province [gxgwfx2019027]
FX This work was supported by the visiting scholar program of China
   Scholarship Council (201908340044); the Natural Science Foundation of
   Anhui Province (1808085MC71); the Key Research and Development Projects
   of Anhui Province (1804b06020367); key support in program for
   outstanding talents in higher education institutions of Anhui province
   (gxgwfx2019027); the Anhui Province Postdoctoral Science Foundation
   Funded Project (2017B230); and key grant from Department of Sciences and
   Technology of Anhui Province (11080001); China Agriculture Research
   System (CARS-19).
CR Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Chen TT, 2020, CRIT REV FOOD SCI, V60, P2691, DOI 10.1080/10408398.2019.1654430
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021
   Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dulloo AG, 2002, SCIENCE, V297, P780, DOI 10.1126/science.1074923
   Fan FY, 2016, FOOD CHEM, V196, P347, DOI 10.1016/j.foodchem.2015.09.056
   Gosslau A., 2018, J FOOD BIOACTIVES, P151, DOI [10.31665/JFB.2018.3158, DOI 10.31665/JFB.2018.3158]
   Haczeyni F, 2018, OBES REV, V19, P406, DOI 10.1111/obr.12646
   Han MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31703
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Jin DY, 2013, J FUNCT FOODS, V5, P1142, DOI 10.1016/j.jff.2013.03.011
   Kadowaki M, 2005, BIOL PHARM BULL, V28, P1509, DOI 10.1248/bpb.28.1509
   Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252
   Kurogi M, 2015, CHEM SENSES, V40, P27, DOI 10.1093/chemse/bju057
   Lee SM, 2008, LIPIDS, V43, P419, DOI 10.1007/s11745-008-3167-4
   Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012
   Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994
   Lorenz M, 2014, EUR J PHARMACOL, V740, P645, DOI 10.1016/j.ejphar.2014.06.014
   Ma CY, 2018, FOOD RES INT, V108, P413, DOI 10.1016/j.foodres.2018.03.052
   Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009
   Okla M, 2017, ADV NUTR, V8, P473, DOI 10.3945/an.116.014332
   Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477
   PERONNET F, 1991, CAN J SPORT SCI, V16, P23
   Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012
   Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740
   Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943
   Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108
   Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271
   Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Takahashi M, 2014, BRIT J NUTR, V112, P1542, DOI 10.1017/S0007114514002530
   Teng Y, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010075
   Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004
   Velazquez-Villegas LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02068-0
   Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430
   Wang R, 2008, J AGR FOOD CHEM, V56, P2694, DOI 10.1021/jf0730338
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Xu N, 2018, J AGR FOOD CHEM, V66, P3823, DOI 10.1021/acs.jafc.8b00138
   Xu N, 2014, MOL NUTR FOOD RES, V58, P1258, DOI 10.1002/mnfr.201300830
   Yang CS, 2019, J AGR FOOD CHEM, V67, P5446, DOI 10.1021/acs.jafc.8b05242
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yoneshiro T, 2013, CURR OPIN CLIN NUTR, V16, P625, DOI 10.1097/MCO.0b013e3283653ee1
   Zhang L, 2011, J AGR FOOD CHEM, V59, P8754, DOI 10.1021/jf2015733
   Zhang X, 2016, INT J OBESITY, V40, P1841, DOI 10.1038/ijo.2016.108
   Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493
   Zhou J, 2019, J AGR FOOD CHEM, V67, P5405, DOI 10.1021/acs.jafc.8b05062
   Zhou J, 2018, FOOD FUNCT, V9, P5162, DOI 10.1039/c8fo01429a
   Zhou JH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111681
NR 55
TC 15
Z9 16
U1 2
U2 83
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD JAN
PY 2021
VL 65
IS 2
AR 2000864
DI 10.1002/mnfr.202000864
EA JAN 2021
PG 13
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA PZ8OB
UT WOS:000605579100001
PM 33258303
DA 2025-04-28
ER

PT J
AU Oliveira, L
   Binmowyna, MN
   Alasqah, I
   Zandonadi, RP
   Teixeira-Lemos, E
   Chaves, C
   Alturki, HA
   Albaridi, NA
   Alribdi, FF
   Raposo, A
AF Oliveira, Leandro
   Binmowyna, Mona N.
   Alasqah, Ibrahim
   Zandonadi, Renata Puppin
   Teixeira-Lemos, Edite
   Chaves, Claudia
   Alturki, Hmidan A.
   Albaridi, Najla A.
   Alribdi, Fatmah Fahad
   Raposo, Antonio
TI A Pilot Study on Dietary Choices at Universities: Vending Machines,
   Canteens, and Lunch from Home
SO NUTRIENTS
LA English
DT Article
DE vending machines; canteen; lunch; nutrition; university; students
ID STUDENTS; OBESITY; FOOD; CONSUMPTION; PREVALENCE; OVERWEIGHT
AB Commercial environments and food acquisition methods significantly shape dietary practices and impact health. This study assesses dietary choices among Portuguese university students regarding vending machines, canteens, and lunches from home. It also evaluates their use of the university canteen and their tendency to bring lunch from home. This pilot cross-sectional study used a self-administered electronic questionnaire, made available in early 2023. Participants were recruited through snowball sampling. The study included 137 students from Portuguese higher education institutions, mainly women (74.5%), pursuing degrees or integrated Master's degrees (83.2%), primarily in health-related fields (55.5%). The median age was 21 years (20 to 23.5 years). About 70.0% regularly consumed food from vending machines, while approximately 60.0% brought lunch from home, avoiding the canteen. Factors such as convenience (48.5%), price (47.5%), product availability (40.6%), and taste (39.6%) mainly influenced vending machine choices. Monthly, chocolates, water, coffee, cookies, treats, and soft drinks were the most commonly acquired items, with coffee being the most frequent daily purchase. These findings provide insights for creating policies and initiatives to promote healthier and more accessible food options for students and strategies to encourage positive eating behaviors.
C1 [Oliveira, Leandro; Raposo, Antonio] Univ Lusofona Humanidades & Tecnol, CBIOS Res Ctr Biosci & Hlth Technol, Campo Grande 376, P-1749024 Lisbon, Portugal.
   [Oliveira, Leandro] Polytech Inst Coimbra, Coimbra Hlth Sch, Rua 5 Outubro S Martinho Bispo,Apartado 7006, P-3046854 Coimbra, Portugal.
   [Binmowyna, Mona N.] Shaqra Univ, Coll Educ, Shaqra 11911, Saudi Arabia.
   [Alasqah, Ibrahim] Qassim Univ, Coll Nursing, Dept Community Psychiat & Mental Hlth Nursing, Buraydah 51452, Saudi Arabia.
   [Alasqah, Ibrahim] Univ New England, Sch Hlth, Armidale, NSW 2351, Australia.
   [Zandonadi, Renata Puppin] Univ Brasilia UnB, Sch Hlth Sci, Dept Nutr, Campus Darcy Ribeiro, BR-70910900 Brasilia, Brazil.
   [Teixeira-Lemos, Edite] Polytech Univ Viseu, CERNAS Res Ctr, P-3504510 Viseu, Portugal.
   [Chaves, Claudia] Polytech Univ Viseu, Ctr Studies Educ & Innovat CI&DEI, ESSV, P-3504510 Viseu, Portugal.
   [Alturki, Hmidan A.] King Abdulaziz City Sci & Technol, Wellness & Prevent Med Inst, Hlth Sect, Riyadh 11442, Saudi Arabia.
   [Albaridi, Najla A.] Princess Nourah bint Abdulrahman Univ, Coll Hlth & Rehabil, Dept Hlth Sci, POB 84428, Riyadh 11671, Saudi Arabia.
   [Alribdi, Fatmah Fahad] Qassim Hlth Cluster, Model Care, Buraydah 52367, Saudi Arabia.
C3 Lusofona University; Shaqra University; Qassim University; University of
   New England; Universidade de Brasilia; Princess Nourah bint Abdulrahman
   University
RP Oliveira, L; Raposo, A (corresponding author), Univ Lusofona Humanidades & Tecnol, CBIOS Res Ctr Biosci & Hlth Technol, Campo Grande 376, P-1749024 Lisbon, Portugal.; Oliveira, L (corresponding author), Polytech Inst Coimbra, Coimbra Hlth Sch, Rua 5 Outubro S Martinho Bispo,Apartado 7006, P-3046854 Coimbra, Portugal.
EM leandroliveira.nut@gmail.com; m.mwena@su.edu.sa; i.alasqah@qu.edu.sa;
   renatapz@unb.br; etlemos3@gmail.com; claudiachaves21@gmail.com;
   halturki@kacst.edu.sa; naalbaridi@pnu.edu.sa; falribdi@moh.gov.sa;
   antonio.raposo@ulusofona.pt
RI Teixeira-Lemos, Edite/AAW-9401-2021; Alasqah, Ibrahim/GVR-8098-2022;
   Alturki, Hmidan/AAJ-3261-2020; Albaridi, Najla/GSJ-2682-2022; Zandonadi,
   Renata/O-7908-2017; بن موينع, منى ناصر عبدالله/HPD-8539-2023; Raposo,
   Antonio/G-8329-2018; Chaves, Claudia/E-9556-2018
OI Albaridi, Najla/0000-0001-8888-4098; Alasqah, Dr
   Ibrahim/0000-0002-0316-1374; Raposo, Antonio/0000-0002-5286-2249;
   Teixeira-Lemos, Edite/0000-0002-6346-8319; Zandonadi,
   Renata/0000-0003-0370-3089; Oliveira, Leandro/0000-0003-1238-1798;
   Chaves, Claudia/0000-0002-8103-7221; Alturki, Hmidan/0000-0003-4359-063X
FU Fundacao para a Ciencia e a Tecnologia (FCT)
   [https://doi.org/10.54499/UIDB/04567/2020, accessed on 15 March 2024,
   https://doi.org/10.54499/UIDP/04567/2020, accessed on 15 March 2024];
   National Funds through the FCT-Foundation for Science and Technology,
   I.P [UIDB/05507/2020, https://doi.org/10.54499/UIDB/05507/2020, accessed
   on 15 March 2024, UIDB/00681/2020,
   https://doi.org/10.54499/UIDB/00681/2020, accessed on 15 March 2024]
FX This research was funded by the Fundacao para a Ciencia e a Tecnologia
   (FCT) through the CBIOS projects
   https://doi.org/10.54499/UIDB/04567/2020, accessed on 15 March 2024 and
   https://doi.org/10.54499/UIDP/04567/2020, accessed on 15 March 2024.
   This work was also funded by National Funds through the FCTFoundation
   for Science and Technology, I.P., within the scope of the projects Ref.
   UIDB/05507/2020 and DOI identifier
   https://doi.org/10.54499/UIDB/05507/2020, accessed on 15 March 2024, as
   well as Ref. UIDB/00681/2020 and DOI identifier
   https://doi.org/10.54499/UIDB/00681/2020, accessed on 15 March 2024.
CR Al Banna MH, 2022, J AM COLL HEALTH, V70, P2327, DOI 10.1080/07448481.2020.1851695
   Alegre A., 2014, Revista Portuguesa de Diabetes, V9, P166
   Allom V, 2014, NUTR FOOD SCI, V44, P156, DOI 10.1108/NFS-06-2013-0077
   Alves A., 2021, THESIS U PORTO PORTO
   [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373, DOI 10.1001/jama.2013.281053
   Ashton LM, 2017, AM J MENS HEALTH, V11, P330, DOI 10.1177/1557988316680936
   Bawadi H, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051058
   Bento M.da C., 2021, Comportamentos de saude e bem-estar dos estudantes do Ensino Superior Politecnico: Um diagnostico a partir da perspetiva dos estudantes
   Brown MV, 2014, J AM COLL HEALTH, V62, P512, DOI 10.1080/07448481.2014.920337
   Caruso ML, 2014, J NUTR EDUC BEHAV, V46, P401, DOI 10.1016/j.jneb.2014.02.014
   Czarniecka-Skubina E, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193699
   Dahl AA, 2024, NUTRIENTS, V16, DOI 10.3390/nu16101426
   de Faria HC, 2023, ARCH ENDOCRIN METAB, V67, P416, DOI 10.20945/2359-3997000000602
   Dias Inês Cruz, 2021, Acta Port Nutr, P46, DOI 10.21011/apn.2021.2409
   Du TH, 2017, MED SCI MONIT BASIC, V23, P173, DOI 10.12659/MSMBR.904380
   Elizabeth L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12071955
   Faris ME, 2021, BRIT FOOD J, V123, P2449, DOI 10.1108/BFJ-07-2020-0601
   Fernandes V., 2023, CANTINAS U EVOLUCAO
   Torres AF, 2015, NUTR HOSP, V31, P1302, DOI 10.3305/nh.2015.31.3.8006
   Ferreira A., 2009, ALIMENT HUM, V15, P80
   Ferreira Maria Margarida Silva Vieira, 2023, Rev. Enf. Ref., VserVI, pe22022, DOI 10.12707/rvi22022
   Garg A, 2017, EUR J TOUR HOSP RECR, V8, P96, DOI 10.1515/ejthr-2017-0009
   Hanson AJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142462
   Hasan H, 2021, FOODS, V10, DOI 10.3390/foods10092122
   Holmes S, 2009, INT J NURS STUD, V46, P394, DOI 10.1016/j.ijnurstu.2008.08.004
   Kabir A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198801
   Li XB, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.840818
   Lus A., 2019, THESIS U PORTO PORTO
   Martinez-Perez N, 2022, NUTRITION, V103, DOI 10.1016/j.nut.2022.111789
   Martinez-Perez N, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18136842
   Mastora A, 2024, SUSTAINABILITY-BASEL, V16, DOI 10.3390/su16052213
   Mills S, 2017, APPETITE, V111, P116, DOI 10.1016/j.appet.2016.12.022
   Min H, 2011, BENCHMARKING, V18, P282, DOI 10.1108/14635771111121711
   Oliveira L, 2024, NUTRIENTS, V16, DOI 10.3390/nu16071007
   Park H, 2016, APPETITE, V96, P517, DOI 10.1016/j.appet.2015.10.022
   Peltzer K, 2014, INT J ENV RES PUB HE, V11, P7425, DOI 10.3390/ijerph110707425
   Prowse RJL, 2019, CAN J DIET PRACT RES, V80, P55, DOI 10.3148/cjdpr-2018-039
   Raposo A, 2016, ITAL J FOOD SCI, V28, P448, DOI 10.14674/1120-1770%2Fijfs.v433
   Raposo A, 2018, J FOOD NUTR RES-SLOV, V57, P295
   Rousham EK, 2022, ADV NUTR, V13, P1669, DOI 10.1093/advances/nmac032
   Roy R, 2019, J NUTR EDUC BEHAV, V51, P865, DOI 10.1016/j.jneb.2019.03.003
   Sakai Y, 2022, NUTRIENTS, V14, DOI 10.3390/nu14091911
   Sánchez LA, 2021, INT J PUBLIC HEALTH, V66, DOI 10.3389/ijph.2021.1604149
   Skalkos D, 2023, SUSTAINABILITY-BASEL, V15, DOI 10.3390/su15139865
   Soldavini J, 2021, INT J GASTRON FOOD S, V23, DOI 10.1016/j.ijgfs.2021.100303
   Sousa B., 2020, Biomed Biopharm Res, V17, P1, DOI [10.19277/bbr.17.1.220, DOI 10.19277/BBR.17.1.220]
   Wills W, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091605
   Wilson CK, 2017, APPETITE, V108, P270, DOI 10.1016/j.appet.2016.10.011
   Zamsad M, 2019, DIABETES METAB SYND, V13, P480, DOI 10.1016/j.dsx.2018.11.015
NR 49
TC 2
Z9 2
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUN
PY 2024
VL 16
IS 11
AR 1722
DI 10.3390/nu16111722
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA UA2A9
UT WOS:001245265500001
PM 38892655
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Rana, S
   Broussard, W
   Elliott, S
   Burow, ME
   Boue, SM
AF Rana, Shalika
   Broussard, William
   Elliott, Steven
   Burow, Matthew E.
   Boue, Stephen M.
TI Unraveling the Impact of Aspergillus sojae-A Food-Grade Fungus-On
   Phytoalexins, Phenolic Acids, and the Antioxidant and Antidiabetic
   Activity of Different Legumes
SO FOODS
LA English
DT Article
DE phytoalexins; Aspergillus sojae; UPLC;
   alpha-glucosidase; lipase; UPLC-ESI-QTOF-MS/MS
ID ALPHA-GLUCOSIDASE; PISUM-SATIVUM; ISOFLAVONOID CONTENT;
   INHIBITORY-ACTIVITY; DIGESTIVE ENZYMES; EXTRACTS; CHICKPEA;
   HYPERGLYCEMIA; BIOSYNTHESIS; ACCUMULATION
AB Legumes are a rich source of polyphenolic compounds known for their ability to promote health. Under stress conditions, legumes have been shown to produce higher levels of secondary metabolites, as a defensive mechanism. Hence, the present study aimed to induce legume seeds (e.g., soybean, chickpea, green pea, and red kidney bean) by inoculating them with Aspergillus sojae (A. sojae) and to evaluate the extracts for phytoalexins, phenolics, and antioxidant, antiobesity, and antidiabetic potentials. The UPLC-DAD findings of A. sojae-induced legumes showed medicarpin and maackiain in chickpea, pisatin in green pea, glyceollin I-III in soybean, and kievitone and phaseollin in red kidney bean. All induced legumes exhibited a higher total polyphenol content compared to the non-induced ones. Among induced legumes, soybean exhibited a higher (4.85 mg GAE/g) polyphenol content. The UPLC-ESI-QTOF-MS/MS findings established that legumes contained substantial levels of protocatechuic acid, vanillic acid, ferulic acid, chlorogenic acid, coumaric acid, 4-hydroxybenzoic acid, and caffeic acid. The results of antioxidant assays revealed a significantly higher level of activity in induced red kidney bean and soybean, whereas the level of activity in non-induced legumes was markedly lower. Moreover, induced red kidney bean effectively inhibited alpha-glucosidase (87.2%) and alpha-amylase (63.90%) at 5 mg/mL. Additionally, the maximum lipase inhibitory effects were displayed by induced soybean (72.54%) at 20 mg/mL.
C1 [Rana, Shalika; Broussard, William; Boue, Stephen M.] ARS, Southern Reg Res Ctr, USDA, New Orleans, LA 70124 USA.
   [Elliott, Steven; Burow, Matthew E.] Tulane Dept Med, Sect Hematol & Med Oncol, New Orleans, LA 70112 USA.
C3 United States Department of Agriculture (USDA); Tulane University
RP Boue, SM (corresponding author), ARS, Southern Reg Res Ctr, USDA, New Orleans, LA 70124 USA.
EM steve.boue@usda.gov
RI Burow, Matthew/D-6351-2013
OI , Stephen Boue/0000-0002-2790-4427
FU U.S. Department of Agriculture ARS Project;  [6054-41000-112-00D]
FX This research was funded by the U.S. Department of Agriculture ARS
   Project # 6054-41000-112-00D.
CR Abd Elhamid MA, 2022, MOLECULES, V27, DOI 10.3390/molecules27092895
   Abe CZM, 2021, J AGR FOOD CHEM, V69, P7057, DOI 10.1021/acs.jafc.1c02261
   Ahmed S, 2021, PHYTOCHEM REV, V20, P483, DOI 10.1007/s11101-020-09691-8
   Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002
   Aisyah S, 2016, FOOD CHEM, V196, P694, DOI 10.1016/j.foodchem.2015.09.110
   Amarowicz R, 2008, EUR J LIPID SCI TECH, V110, P865, DOI 10.1002/ejlt.200800114
   Apostolidis E, 2007, FOOD BIOTECHNOL, V21, P217, DOI 10.1080/08905430701534032
   Arman M, 2011, NAT PROD RES, V25, P1352, DOI 10.1080/14786419.2011.553952
   Ben Mansour R, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2843463
   Botero Leidy, 2021, Biotechnology Reports, V29, pe00601, DOI 10.1016/j.btre.2021.e00601
   Boue S M, 2008, J Food Sci, V73, pH43, DOI 10.1111/j.1750-3841.2008.00707.x
   Boué SM, 2000, J AGR FOOD CHEM, V48, P2167, DOI 10.1021/jf9912809
   Boué SM, 2011, J AGR FOOD CHEM, V59, P112, DOI 10.1021/jf102255u
   Burow ME, 2001, J CLIN ENDOCR METAB, V86, P1750, DOI 10.1210/jc.86.4.1750
   Celoy RM, 2014, PHYTOCHEMISTRY, V98, P120, DOI 10.1016/j.phytochem.2013.10.017
   Chiou SY, 2018, CEREAL CHEM, V95, P167, DOI 10.1002/cche.10025
   Chung IM, 2011, FOOD CHEM, V127, P960, DOI 10.1016/j.foodchem.2011.01.065
   CRUICKSHANK IAM, 1960, NATURE, V187, P799, DOI 10.1038/187799b0
   DANIEL S, 1990, PLANTA, V182, P270, DOI 10.1007/BF00197121
   DARVILL AG, 1984, ANNU REV PLANT PHYS, V35, P243, DOI 10.1146/annurev.pp.35.060184.001331
   Dendup T, 2014, PLANTA MED, V80, P604, DOI 10.1055/s-0034-1368427
   Dhull S. B., 2020, LEGUME SCI, V2, pe37, DOI [10.1002/leg3.37, DOI 10.1002/LEG3.37]
   Didinger C, 2022, LEGUME SCI, V4, DOI 10.1002/leg3.147
   Fabroni S, 2016, J SCI FOOD AGR, V96, P4713, DOI 10.1002/jsfa.7708
   Filippatos TD, 2008, DRUG SAFETY, V31, P53, DOI 10.2165/00002018-200831010-00005
   Fujisawa T, 2005, METABOLISM, V54, P387, DOI 10.1016/j.metabol.2004.10.004
   Ganesan K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112390
   Gao XL, 2023, FOOD RES INT, V173, DOI 10.1016/j.foodres.2023.113407
   GOKE B, 1995, DIGESTION, V56, P493, DOI 10.1159/000201282
   GRAHAM TL, 1990, MOL PLANT MICROBE IN, V3, P157, DOI 10.1094/MPMI-3-157
   Gu YY, 2011, J AGR FOOD CHEM, V59, P5305, DOI 10.1021/jf200180n
   Hadwiger LA, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2362
   Hong J, 2023, FOOD BIOSCI, V56, DOI 10.1016/j.fbio.2023.103311
   Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529
   Jeandet P, 2013, INT J MOL SCI, V14, P14136, DOI 10.3390/ijms140714136
   Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5
   John KMM, 2013, FOOD RES INT, V54, P487, DOI 10.1016/j.foodres.2013.07.045
   Johnson JB, 2022, FOOD ANAL METHOD, V15, P413, DOI 10.1007/s12161-021-02127-9
   Kan LJ, 2017, FOOD CHEM TOXICOL, V108, P467, DOI 10.1016/j.fct.2016.09.007
   Kim KM, 2017, J MICROBIOL BIOTECHN, V27, P251, DOI 10.4014/jmb.1610.10013
   Lee SS, 2015, J FOOD BIOCHEM, V39, P485, DOI 10.1111/jfbc.12150
   Liu R, 2015, INT J FOOD PROP, V18, P2246, DOI 10.1080/10942912.2014.971178
   Luo SQ, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02453
   Mahboubi M, 2013, JUNDISHAPUR J NAT PH, V8, P15, DOI 10.17795/jjnpp-7621
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   OKUBO K, 1992, BIOSCI BIOTECH BIOCH, V56, P99, DOI 10.1271/bbb.56.99
   Paxton J. D., 1991, Mycotoxins and phytoalexins., P485
   PI-SUNYER F X, 1991, American Journal of Clinical Nutrition, V53, p1595S, DOI 10.1093/ajcn/53.6.1595S
   Podsedek A, 2014, J AGR FOOD CHEM, V62, P4610, DOI 10.1021/jf5008264
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596
   Rhabasa-Lhoret R., 2004, International Textbook of Diabetes Mellitus, VVolume 1, P673
   Roy MK, 2010, INT J FOOD SCI NUTR, V61, P109, DOI 10.3109/09637480903292601
   SALUNKHE DK, 1982, CRC CR REV FOOD SCI, V17, P277
   SCHWOCHAU ME, 1968, ARCH BIOCHEM BIOPHYS, V126, P731, DOI 10.1016/0003-9861(68)90463-3
   Sharma KR, 2022, INT J FOOD SCI, V2022, DOI 10.1155/2022/4629290
   Simons R, 2011, J AGR FOOD CHEM, V59, P6748, DOI 10.1021/jf2010707
   Singh R, 2015, DIABETES-METAB RES, V31, P113, DOI 10.1002/dmrr.2558
   Slanc P, 2009, PHYTOTHER RES, V23, P874, DOI 10.1002/ptr.2718
   Sobolev VS, 2022, J AGR FOOD CHEM, V70, P1101, DOI 10.1021/acs.jafc.1c06122
   Sobolev VS, 2009, J AGR FOOD CHEM, V57, P62, DOI 10.1021/jf802891v
   Son HU, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120828
   Sreerama YN, 2012, J FOOD SCI, V77, pC927, DOI 10.1111/j.1750-3841.2012.02848.x
   Tan YQ, 2017, FOOD CHEM, V214, P259, DOI 10.1016/j.foodchem.2016.06.100
   Tucci SA, 2010, DIABET METAB SYND OB, V3, P125, DOI 10.2147/DMSO.S7005
   Wang YK, 2016, J FUNCT FOODS, V24, P359, DOI 10.1016/j.jff.2016.04.026
   Wu QD, 2004, MOL PLANT MICROBE IN, V17, P798, DOI 10.1094/MPMI.2004.17.7.798
   Wu ZY, 2012, J AGR FOOD CHEM, V60, P8606, DOI 10.1021/jf3021514
   Yamamoto T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33227-y
   Yang QQ, 2018, COMPR REV FOOD SCI F, V17, P1518, DOI 10.1111/1541-4337.12391
   Zhao Y, 2014, FOOD CHEM, V152, P462, DOI 10.1016/j.foodchem.2013.12.006
   Zhuang WB, 2023, MOLECULES, V28, DOI 10.3390/molecules28083599
   Zulfiqar S, 2023, MOLECULES, V28, DOI 10.3390/molecules28176399
NR 73
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2304-8158
J9 FOODS
JI Foods
PD NOV
PY 2024
VL 13
IS 22
AR 3533
DI 10.3390/foods13223533
PG 17
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA N5X2K
UT WOS:001365058300001
PM 39593949
OA gold
DA 2025-04-28
ER

PT J
AU Tsutsumi, H
   Kinoshita, Y
   Sato, T
   Ishizu, T
AF Tsutsumi, Hiroyuki
   Kinoshita, Yoshifumi
   Sato, Takashi
   Ishizu, Takashi
TI Configurational Studies of Complexes of Various Tea Catechins and
   Caffeine in Crystal State
SO CHEMICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE (+)-catechin; (-)-epicatechin; (-)-catechin-3-O-gallate; caffeine;
   intermolecular interaction; X-ray crystallographic analysis
ID ANTIBACTERIAL ACTIVITY; GALLOCATECHIN GALLATE; POLYPHENOLS; INHIBITION;
   OBESITY
AB Crystals of the complexes of (+)-catechin (CA) of non-galloylated catechin and (-)-catechin-3-O-gallate (Cg) of galloylated catechin with caffeine were prepared, and their stereochemical structures and intermolecular interactions were determined by X-ray crystallographic analysis. CA formed a 1:1 complex with caffeine by intermolecular hydrogen bonds, whereas Cg formed a 1: 2 complex with caffeine, which was formed by face-to-face and offset pi-pi interactions and intermolecular hydrogen bonds. A solution of two kinds of non-galloylated catechin, CA and (-)-epicatechin (EC), and caffeine (molar ratio 1 :1 : 2) in water afforded a 1 :1 : 2 complex, the crystal structure of which had two layers, one layer in which CA and caffeine formed alternate lines and an other layer in which EC and caffeine formed alternate lines. The 1 :1 : 2 complex was formed by offset pi-pi and CH-pi interactions and intermolecular hydrogen bonds.
C1 [Tsutsumi, Hiroyuki; Kinoshita, Yoshifumi; Sato, Takashi; Ishizu, Takashi] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Hiroshima 7290292, Japan.
C3 Fukuyama University
RP Ishizu, T (corresponding author), Fukuyama Univ, Fac Pharm & Pharmaceut Sci, 1 Sanzo Gakuen Cho, Hiroshima 7290292, Japan.
EM ishizu@fupharm.fukuyama-u.ac.jp
OI Tsutsumi, Hiroyuki/0000-0002-9681-2139
CR [Anonymous], 1997, SHELX97
   Beurskens P.T., 1999, The DIRDIF99 program system
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   BURLA MC, 2005, SIR2004
   CAI Y, 1990, J CHEM SOC PERK T 2, P2197, DOI 10.1039/p29900002197
   CARRUTHERS JR, 1999, CRYSTALS ISSUE 11
   Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S
   FUKAI K, 1991, AGR BIOL CHEM TOKYO, V55, P1895, DOI 10.1080/00021369.1991.10870886
   GAFFNEY SH, 1986, J CHEM SOC CHEM COMM, P107, DOI 10.1039/c39860000107
   HARA Y, 1989, J JPN SOC FOOD SCI, V36, P951
   Hayashi N, 2004, BIOSCI BIOTECH BIOCH, V68, P2512, DOI 10.1271/bbb.68.2512
   Hayashi N, 2008, J ORG CHEM, V73, P4848, DOI 10.1021/jo800406e
   HORMAN I, 1972, J FOOD SCI, V37, P925, DOI 10.1111/j.1365-2621.1972.tb03705.x
   Isemura M, 2000, BIOFACTORS, V13, P81, DOI 10.1002/biof.5520130114
   Ishizu T, 2010, CHEM LETT, V39, P607, DOI 10.1246/cl.2010.607
   Ishizu T, 2009, CHEM LETT, V38, P230, DOI 10.1246/cl.2009.230
   Ishizu T, 2009, TETRAHEDRON LETT, V50, P4121, DOI 10.1016/j.tetlet.2009.04.113
   Leone M, 2003, CANCER RES, V63, P8118
   MARTIN R, 1987, PHYTOCHEMISTRY, V26, P273, DOI 10.1016/S0031-9422(00)81527-7
   MARUYAMA N, 1991, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON TEA SCIENCE, P145
   MIURA S, 1994, BIOL PHARM BULL, V17, P1567
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Okabe S, 1997, JPN J CANCER RES, V88, P639, DOI 10.1111/j.1349-7006.1997.tb00431.x
   Qiong Guo, 1999, Biochimica et Biophysica Acta, V1427, P13
   *RIG RIG AM AM, 2000, CRYSTALSTRUCTURE 3 8
   Shiota S, 1999, BIOL PHARM BULL, V22, P1388, DOI 10.1248/bpb.22.1388
   Tezuka M, 1997, JPN J TOX ENV HEALTH, V43, P311
   Tsutsumi H, 2010, CHEM PHARM BULL, V58, P572, DOI 10.1248/cpb.58.572
NR 28
TC 15
Z9 15
U1 2
U2 21
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0009-2363
J9 CHEM PHARM BULL
JI Chem. Pharm. Bull.
PD AUG
PY 2011
VL 59
IS 8
BP 1008
EP 1015
DI 10.1248/cpb.59.1008
PG 8
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Chemistry
GA 815HJ
UT WOS:000294516400014
PM 21804246
OA Bronze
DA 2025-04-28
ER

PT J
AU Keast, RSJ
   Riddell, LJ
AF Keast, Russell S. J.
   Riddell, Lynnette J.
TI Caffeine as a flavor additive in soft-drinks
SO APPETITE
LA English
DT Article
DE caffeine; soft-drink; flavor; threshold; psychophysics; obesity
ID DEPENDENCE; CONSUMPTION; ADOLESCENTS; WITHDRAWAL; OBESITY
AB Over 60% of soft-drinks sold in the United States contain caffeine, a mildly addictive psycho-active chemical, as a flavor additive. Using sweeteners as controls, we assessed whether caffeine has flavor activity in a cola soft-drink. A forced-choice triangle discrimination methodology was used to determine detection thresholds of caffeine in sweeteners and a cola beverage. The subjects (n = 30, 28 female, 23 +/- 4 years old) were trained tasters and completed over 1600 discrimination tests during the study. The mean detection thresholds for caffeine in the sweet solutions were: 0.333 +/- 0.1 mM sucrose; 0.467 +/- 0.29mM aspartame; 0.462 +/- 0.3mM sucralose, well below the concentration in common cola beverages (0.55-0.67 mM). A fixed concentration of caffeine, corresponding to the concentration of caffeine in a common cola beverage (0.67 mM) was added to the sweeteners and a non-caffeinated cola beverage. Subjects could distinguish between caffeinated and non-caffeinated sweeteners (p < 0.001), but all subjects failed to distinguish between caffeinated and non-caffeinated cola beverage (p = 1.0). Caffeine has no flavor activity in soft-drinks yet will induce a physiologic and psychologic desire to consume the drink. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Vic 3125, Australia.
C3 Deakin University
RP Keast, RSJ (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia.
EM russell.keast@deakin.edu.au
RI Riddell, Lynn/P-4950-2016; Keast, Russell/P-1899-2017
OI Riddell, Lynn/0000-0002-0688-2134; Keast, Russell/0000-0003-2147-7687
CR Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447
   Cowart BJ, 1998, CHEM SENSES, V23, P397, DOI 10.1093/chemse/23.4.397
   Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Fried EJ, 2002, JAMA-J AM MED ASSOC, V288, P2181, DOI 10.1001/jama.288.17.2181
   Garrett BE, 1998, PSYCHOPHARMACOLOGY, V139, P195, DOI 10.1007/s002130050704
   GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683
   Griffiths RR, 2000, ARCH FAM MED, V9, P727, DOI 10.1001/archfami.9.8.727
   HEISHMAN SJ, 1992, NEUROSCI BIOBEHAV R, V16, P273, DOI 10.1016/S0149-7634(05)80202-7
   Hughes J, 1993, PROBLEMS DRUG DEPEND
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   KEAST R, 2006, IN PRESS CHEM SENSES
   Keast RSJ, 2006, J FOOD SCI, V71, pS567, DOI 10.1111/j.1750-3841.2006.00146.x
   Keast RSJ, 2002, CHEM SENSES, V27, P123, DOI 10.1093/chemse/27.2.123
   Keast SJR, 2003, FOOD QUAL PREFER, V14, P111, DOI 10.1016/S0950-3293(02)00110-6
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Meilgaard M., 1999, Sensory Evaluation Techniques, V3rd ed.
   Mennella JA, 2005, CHEM SENSES, V30, pI242, DOI 10.1093/chemse/bjh204
   Myers KP, 2006, DEV PSYCHOBIOL, V48, P380, DOI 10.1002/dev.20147
   Nehlig A, 1999, NEUROSCI BIOBEHAV R, V23, P563, DOI 10.1016/S0149-7634(98)00050-5
   Oberstar JV, 2002, J CHILD ADOL PSYCHOP, V12, P127, DOI 10.1089/104454602760219162
   *PEPSCO, 1981, PHYS TECHN EFF CAFF
   RICHARDSON NJ, 1995, PHARMACOL BIOCHEM BE, V52, P313, DOI 10.1016/0091-3057(95)00029-V
   Scholey AB, 2004, PSYCHOPHARMACOLOGY, V176, P320, DOI 10.1007/s00213-004-1935-2
   Schuh KJ, 1997, PSYCHOPHARMACOLOGY, V130, P320, DOI 10.1007/s002130050246
   SILVERMAN K, 1992, NEW ENGL J MED, V327, P1109, DOI 10.1056/NEJM199210153271601
   STRAIN EC, 1994, JAMA-J AM MED ASSOC, V272, P1043, DOI 10.1001/jama.272.13.1043
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   Yeomans MR, 2000, APPETITE, V35, P131, DOI 10.1006/appe.2000.0339
NR 29
TC 41
Z9 54
U1 8
U2 78
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6663
EI 1095-8304
J9 APPETITE
JI Appetite
PD JUL
PY 2007
VL 49
IS 1
BP 255
EP 259
DI 10.1016/j.appet.2006.11.003
PG 5
WC Behavioral Sciences; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Behavioral Sciences; Nutrition & Dietetics
GA 184EK
UT WOS:000247623700030
PM 17189661
DA 2025-04-28
ER

PT J
AU Bhandarkar, NS
   Mouatt, P
   Goncalves, P
   Thomas, T
   Brown, L
   Panchal, SK
AF Bhandarkar, Nikhil S.
   Mouatt, Peter
   Goncalves, Priscila
   Thomas, Torsten
   Brown, Lindsay
   Panchal, Sunil K.
TI Modulation of gut microbiota by spent coffee grounds attenuates
   diet-induced metabolic syndrome in rats
SO FASEB JOURNAL
LA English
DT Article
DE gut microbiota; metabolic syndrome; obesity; rats; spent coffee grounds
ID CHAIN FATTY-ACIDS; HIGH-CARBOHYDRATE; LIPID PROFILE; GREEN COFFEE;
   OBESITY; WASTE; HEALTH; INDUSTRY; CANCER; OLIGOSACCHARIDES
AB Coffee brewing produces spent coffee grounds as waste; few studies have investigated the health benefits of these grounds. This study investigated responses to spent coffee grounds in a diet-induced rat model of metabolic syndrome. Male Wistar rats aged 8-9 weeks were fed either corn starch-rich diet or high-carbohydrate, high-fat diet for 16 weeks, which were supplemented with 5% spent coffee grounds during the last 8 weeks. Rats fed non-supplemented diets were used as controls. High-carbohydrate, high-fat diet-fed rats developed metabolic syndrome including abdominal obesity, impaired glucose tolerance, dyslipidemia, and cardiovascular and liver damage. Body weight, abdominal fat, total body fat mass, systolic blood pressure, and concentrations of plasma triglycerides and non-esterified fatty acids were reduced by spent coffee grounds along with improved glucose tolerance and structure and function of heart and liver. Spent coffee grounds increased the diversity of the gut microbiota and decreased the ratio of Firmicutes to Bacteroidetes. Changes in gut microbiota correlated with the reduction in obesity and improvement in glucose tolerance and systolic blood pressure. These findings indicate that intervention with spent coffee grounds may be useful for managing obesity and metabolic syndrome by altering the gut microbiota, thus increasing the value of this food waste.
C1 [Bhandarkar, Nikhil S.; Brown, Lindsay; Panchal, Sunil K.] Univ Southern Queensland, Funct Foods Res Grp, Toowoomba, Qld, Australia.
   [Bhandarkar, Nikhil S.; Brown, Lindsay] Univ Southern Queensland, Sch Hlth & Wellbeing, Toowoomba, Qld, Australia.
   [Mouatt, Peter] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia.
   [Goncalves, Priscila; Thomas, Torsten] Univ New South Wales, Ctr Marine Sci & Innovat, Sydney, NSW, Australia.
   [Goncalves, Priscila; Thomas, Torsten] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.
   [Panchal, Sunil K.] Western Sydney Univ, Sch Sci, Richmond, NSW 2753, Australia.
   [Bhandarkar, Nikhil S.] Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel.
C3 University of Southern Queensland; University of Southern Queensland;
   Southern Cross University; University of New South Wales Sydney;
   University of New South Wales Sydney; Western Sydney University;
   Ben-Gurion University of the Negev
RP Panchal, SK (corresponding author), Western Sydney Univ, Sch Sci, Richmond, NSW 2753, Australia.
EM S.Panchal@westernsydney.edu.au
RI Mouatt, Peter/JRW-8914-2023; Bhandarkar, Nikhil/AAV-4263-2020
OI , Peter/0000-0002-0631-7258; Bhandarkar, Nikhil/0000-0001-8790-8940
FU University of Southern Queensland (USQ) [SRF-09]
FX University of Southern Queensland (USQ), Grant/Award Number: SRF-09
CR [Anonymous], TOT PROD ALL EXP COU
   Bekedam EK, 2008, J AGR FOOD CHEM, V56, P7138, DOI 10.1021/jf800999a
   Bhandarkar NS, 2019, J FUNCT FOODS, V57, P141, DOI 10.1016/j.jff.2019.04.003
   Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002
   Bravo J, 2013, FOOD CHEM TOXICOL, V60, P397, DOI 10.1016/j.fct.2013.08.002
   Byrne CS, 2015, INT J OBESITY, V39, P1331, DOI 10.1038/ijo.2015.84
   Caligiuri SPB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-232
   Campos-Vega R, 2015, TRENDS FOOD SCI TECH, V45, P24, DOI 10.1016/j.tifs.2015.04.012
   Candela M, 2014, WORLD J GASTROENTERO, V20, P908, DOI 10.3748/wjg.v20.i4.908
   Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723
   Cervera-Mata A, 2019, FOOD CHEM, V282, P1, DOI 10.1016/j.foodchem.2018.12.101
   Choi B, 2017, FOOD SCI BIOTECHNOL, V26, P921, DOI 10.1007/s10068-017-0144-9
   Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790
   Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035
   Coppo E, 2014, CURR PHARM BIOTECHNO, V15, P380, DOI 10.2174/138920101504140825121142
   Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/nmeth.2604, 10.1038/NMETH.2604]
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Eteberria U, 2015, J NUTR BIOCHEM, V26, P651, DOI 10.1016/j.jnutbio.2015.01.002
   Fan L, 2000, ACTA BIOTECHNOL, V20, P41, DOI 10.1002/abio.370200108
   Fernandes AS, 2017, ECOTOX ENVIRON SAFE, V141, P30, DOI 10.1016/j.ecoenv.2017.03.011
   Filosa S, 2018, NEURAL REGEN RES, V13, P2055, DOI 10.4103/1673-5374.241429
   Fisgativa H, 2017, J ENVIRON MANAGE, V188, P95, DOI 10.1016/j.jenvman.2016.11.058
   Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303
   Fu XY, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-3
   Garcia-Garcia G, 2019, J CLEAN PROD, V211, P1339, DOI 10.1016/j.jclepro.2018.11.269
   Guo Z, 2012, CLIN LIPIDOL, V7, P215, DOI 10.2217/CLP.12.8
   Harakeh SM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00095
   Rodiguez MH, 2018, J ENVIRON CHEM ENG, V6, P1161, DOI 10.1016/j.jece.2017.12.045
   Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]
   Karmee SK, 2018, WASTE MANAGE, V72, P240, DOI 10.1016/j.wasman.2017.10.042
   Kim J, 2017, BIORESOURCE TECHNOL, V241, P1182, DOI 10.1016/j.biortech.2017.06.012
   Koliada A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1027-1
   Kourmentza C, 2018, J CLEAN PROD, V172, P980, DOI 10.1016/j.jclepro.2017.10.088
   Kwon EE, 2013, BIORESOURCE TECHNOL, V136, P475, DOI 10.1016/j.biortech.2013.03.052
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mahboobi S, 2018, ADV PHARM BULL, V8, P565, DOI 10.15171/apb.2018.065
   Hernández-Arriaga AM, 2017, FOOD RES INT, V97, P191, DOI 10.1016/j.foodres.2017.04.004
   López-Barrera DM, 2016, FOOD CHEM, V212, P282, DOI 10.1016/j.foodchem.2016.05.175
   Martínez I, 2013, APPL ENVIRON MICROB, V79, P516, DOI 10.1128/AEM.03046-12
   Martinez-Saez N, 2017, FOOD CHEM, V216, P114, DOI 10.1016/j.foodchem.2016.07.173
   MCINTYRE A, 1993, GUT, V34, P386, DOI 10.1136/gut.34.3.386
   Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050
   Mesías M, 2017, CURR OPIN FOOD SCI, V14, P37, DOI 10.1016/j.cofs.2017.01.007
   Mohsin GF, 2018, FOOD CHEM, V245, P761, DOI 10.1016/j.foodchem.2017.11.115
   Morales FJ, 2012, AMINO ACIDS, V42, P1097, DOI 10.1007/s00726-010-0774-1
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Murugesan S, 2015, EUR J CLIN MICROBIOL, V34, P1337, DOI 10.1007/s10096-015-2355-4
   O'Connor S, 2017, MATURITAS, V104, P11, DOI 10.1016/j.maturitas.2017.07.005
   Oksanen J, 2017, PACKAGE VEGAN COMMUN
   OMalley, 2016, COFFEE GROUND RECOVE
   Ooi LG, 2010, INT J MOL SCI, V11, P2499, DOI 10.3390/ijms11062499
   Oseguera-Castro KY, 2019, FOOD FUNCT, V10, P4546, DOI [10.1039/C9FO01021A, 10.1039/c9fo01021a]
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]
   Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982
   Passos CP, 2019, CARBOHYD POLYM, V214, P53, DOI 10.1016/j.carbpol.2019.02.094
   Paun A, 2016, PEDIATR DIABETES, V17, P469, DOI 10.1111/pedi.12424
   Pérez-Burillo S, 2019, J AGR FOOD CHEM, V67, P2500, DOI 10.1021/acs.jafc.8b06604
   Petrik S, 2014, BIOCHEM ENG J, V90, P307, DOI 10.1016/j.bej.2014.06.025
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Rahim MBHA, 2019, ACTA DIABETOL, V56, P493, DOI 10.1007/s00592-019-01312-x
   Ramalakshmi K, 2009, FOOD CHEM, V115, P79, DOI 10.1016/j.foodchem.2008.11.063
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Ribeiro H, 2013, EUR J LIPID SCI TECH, V115, P330, DOI 10.1002/ejlt.201200239
   Ribeiro JP, 2017, ENVIRON SCI POLLUT R, V24, P15270, DOI 10.1007/s11356-017-9134-y
   Sales AL, 2020, FOOD FUNCT, V11, P1410, DOI [10.1039/c9fo02589h, 10.1039/C9FO02589H]
   Santos C, 2017, WASTE MANAGE, V59, P37, DOI 10.1016/j.wasman.2016.10.020
   Schoeler M, 2019, REV ENDOCR METAB DIS, V20, P461, DOI 10.1007/s11154-019-09512-0
   Sekar S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46457
   Stylianou M, 2018, ENVIRON SCI POLLUT R, V25, P35776, DOI 10.1007/s11356-018-2359-6
   Tagliazucchi D, 2015, AMINO ACIDS, V47, P1077, DOI 10.1007/s00726-015-1951-z
   Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715
   Tian T, 2017, J AGR FOOD CHEM, V65, P2784, DOI 10.1021/acs.jafc.6b04716
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Vázquez-Sánchez K, 2018, FOOD CHEM, V261, P253, DOI 10.1016/j.foodchem.2018.04.064
   Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039
   Wang LL, 2017, FOOD FUNCT, V8, P1966, DOI [10.1039/c7fo00031f, 10.1039/C7FO00031F]
   Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x
   Wanyonyi S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111261
   Wu LF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15904
   Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106
NR 85
TC 30
Z9 31
U1 2
U2 42
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD MAR
PY 2020
VL 34
IS 3
BP 4783
EP 4797
DI 10.1096/fj.201902416RR
EA FEB 2020
PG 15
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA KT7UL
UT WOS:000512571500001
PM 32039529
DA 2025-04-28
ER

PT J
AU Zheng, JP
   Zhu, XY
   Xu, GQ
   Wang, XC
   Cao, MY
   Zhu, SS
   Huang, R
   Zhou, Y
AF Zheng, Jiaping
   Zhu, Xinyan
   Xu, Guiqing
   Wang, Xingchen
   Cao, Mengyang
   Zhu, Shusen
   Huang, Rui
   Zhou, Yu
TI Relationship between caffeine intake and thyroid function: results from
   NHANES 2007-2012
SO NUTRITION JOURNAL
LA English
DT Article
DE Caffeine; Thyroid; Metabolism; NHANES
ID METABOLISM; OBESITY; PHARMACOKINETICS; POPULATION; ANTIBODIES; EXERCISE;
   ENERGY; RISK
AB Background Moderate caffeine intake decreases the risk of metabolic disorders and all-cause mortality, and the mechanism may be related to its ergogenic actions. Thyroid hormones are vital in metabolic homeostasis; however, their association with caffeine intake has rarely been explored. Objective To investigate the association between caffeine intake and thyroid function. Methods We collected data on demographic background, medical conditions, dietary intake, and thyroid function from the National Health and Nutrition Examination Survey (NHANES) 2007-2012. Subgroups were classified using two-step cluster analysis, with sex, age, body mass index (BMI), hyperglycemia, hypertension, and cardio-cerebral vascular disease (CVD) being used for clustering. Restrictive cubic spline analysis was employed to investigate potential nonlinear correlations, and multivariable linear regression was used to evaluate the association between caffeine consumption and thyroid function. ResultsA total of 2,582 participants were included, and three subgroups with different metabolic features were clustered. In the most metabolically unhealthy group, with the oldest age, highest BMI, and more cases of hypertension, hyperglycemia, and CVD, there was a nonlinear relationship between caffeine intake and serum thyroid stimulating hormone (TSH) level. After adjusting for age, sex, race, drinking, smoking, medical conditions, and micronutrient and macronutrient intake, caffeine intake of less than 9.97 mg/d was positively associated with serum TSH (p = 0.035, standardized beta = 0.155); however, moderate caffeine consumption (9.97-264.97 mg/d) indicated a negative association (p = 0.001, standardized beta = - 0.152). Conclusions Caffeine consumption had a nonlinear relationship with serum TSH in people with metabolic disorders, and moderate caffeine intake (9.97 similar to 264.97 mg/d) was positively associated with serum TSH.
C1 [Zheng, Jiaping; Xu, Guiqing; Wang, Xingchen; Cao, Mengyang] Fujian Med Univ, Sch Hlth, Dept Rehabil Med, Fuzhou, Peoples R China.
   [Zhu, Xinyan; Zhou, Yu] Fujian Med Univ, Sch Pharm, Dept Clin Pharm & Pharm Adm, Fuzhou, Peoples R China.
   [Zhu, Shusen] Fujian Med Univ, Sch Med Imaging, Dept Intelligent Med Engn, Fuzhou, Peoples R China.
   [Huang, Rui] Fujian Normal Univ Hosp, Fuzhou, Peoples R China.
C3 Fujian Medical University; Fujian Medical University; Fujian Medical
   University
RP Zhou, Y (corresponding author), Fujian Med Univ, Sch Pharm, Dept Clin Pharm & Pharm Adm, Fuzhou, Peoples R China.
EM cfjsczy@fjmu.edu.cn
RI ZHENG, JIAPING/AAC-9008-2020; Zhou, Yu/HDN-6076-2022
FU Fujian Medical University's high-level talent research initiation fund
   [XRCZX2021028]
FX This research was supported by Fujian Medical University's high-level
   talent research initiation fund (XRCZX2021028).
CR Ahmed RG, 2019, TOXICOL RES-UK, V8, P196, DOI 10.1039/c8tx00227d
   al'Absi M, 1998, PSYCHOSOM MED, V60, P521, DOI 10.1097/00006842-199807000-00021
   Barcelos RP, 2020, NUTR RES, V80, P1, DOI 10.1016/j.nutres.2020.05.005
   Bartsch W, 1996, FOOD CHEM TOXICOL, V34, P153, DOI 10.1016/0278-6915(95)00095-X
   Biondi B, 2019, ENDOCR REV, V40, P789, DOI 10.1210/er.2018-00163
   Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594
   CARACO Y, 1995, INT J OBESITY, V19, P234
   Chaker L, 2022, NAT REV DIS PRIMERS, V8, DOI 10.1038/s41572-022-00357-7
   Clark NW, 2020, J INT SOC SPORT NUTR, V17, DOI 10.1186/s12970-020-0341-4
   CLOZEL M, 1983, PEDIATR RES, V17, P592, DOI 10.1203/00006450-198307000-00015
   Danailova Y, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23095144
   Drewnowski A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030154
   Duntas LH, 2013, THYROID, V23, P646, DOI 10.1089/thy.2011.0499
   Garduno A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052225
   Gauthier BR, 2020, AGING CELL, V19, DOI 10.1111/acel.13260
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Kot M, 2007, PHARMACOL REP, V59, P296
   Lebeau PF, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28240-9
   Leung AM, 2014, NAT REV ENDOCRINOL, V10, P136, DOI 10.1038/nrendo.2013.251
   Loftfield E, 2018, JAMA INTERN MED, V178, P1086, DOI 10.1001/jamainternmed.2018.2425
   Manolis AA, 2020, TRENDS CARDIOVAS MED, V30, P57, DOI 10.1016/j.tcm.2019.02.011
   Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Niwattisaiwong S, 2017, CLEV CLIN J MED, V84, P236, DOI 10.3949/ccjm.84a.15053
   Patz MD, 2006, PSYCHONEUROENDOCRINO, V31, P493, DOI 10.1016/j.psyneuen.2005.11.008
   Pietzner M, 2019, THYROID, V29, P1743, DOI 10.1089/thy.2018.0549
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9
   Reis CEG, 2019, J TRADIT COMPL MED, V9, P184, DOI 10.1016/j.jtcme.2018.01.001
   Reyes CM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111772
   Rumpler WV, 2008, EUR J CLIN NUTR, V62, P544, DOI 10.1038/sj.ejcn.1602742
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Somwaru LL, 2012, J CLIN ENDOCR METAB, V97, P1962, DOI 10.1210/jc.2011-3047
   Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499
   Talebi S, 2020, BIOL TRACE ELEM RES, V197, P1, DOI 10.1007/s12011-019-01963-5
   Walczak K, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18189434
   Wang LJ, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.843556
   Xiong XF, 2021, J DIABETES INVEST, V12, P1346, DOI 10.1111/jdi.13494
NR 40
TC 2
Z9 2
U1 2
U2 17
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD JUL 26
PY 2023
VL 22
IS 1
AR 36
DI 10.1186/s12937-023-00866-5
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA N2RX5
UT WOS:001035557500001
PM 37491267
OA gold, Green Submitted, Green Published
DA 2025-04-28
ER

PT J
AU Atanasov, AG
   Dzyakanchuk, AA
   Schweizer, RAS
   Nashev, LG
   Maurer, EM
   Odermatt, A
AF Atanasov, Atanas G.
   Dzyakanchuk, Anna A.
   Schweizer, Roberto A. S.
   Nashev, Lyubomir G.
   Maurer, Evelyne M.
   Odermatt, Alex
TI Coffee inhibits the reactivation of glucocorticoids by
   11β-hydroxysteroid dehydrogenase type 1:: A glucocorticoid connection in
   the anti-diabetic action of coffee?
SO FEBS LETTERS
LA English
DT Article
DE 11 beta-hydroxysteroid dehydrogenase; glucocorticoid; coffee; cortisol;
   diabetes
ID HEPATIC INSULIN SENSITIVITY; METABOLIC SYNDROME; ADIPOSE-TISSUE;
   SELECTIVE-INHIBITION; HYPERGLYCEMIC MICE; OBESITY; 11-BETA-HSD1;
   CONSUMPTION; RISK; AMPLIFICATION
AB Recent epidemiological studies demonstrated a beneficial effect of coffee consumption for the prevention of type 2 diabetes, however, the underlying mechanisms remained unknown. We demonstrate that coffee extract, corresponding to an Italian Espresso, inhibits recombinant and endogenous 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) activity. The inhibitory component is heat-stable with considerable polarity. Coffee extract blocked 11 beta-HSD1-dependent cortisol formation, prevented the subsequent nuclear translocation of the glueocorticoid receptor and abolished glucocorticoid-induced expression of the key gluconeogenic enzyme phosphoenolpyruvate carboxykinase. We suggest that at least part of the anti-diabetic effects of coffee consumption is due to inhibition of 11 beta-HSD1-dependent glucocorticoid reactivation. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Univ Bern, Dept Clin Res, Div Nephrol & Hypertens, CH-3010 Bern, Switzerland.
C3 University of Bern
RP Odermatt, A (corresponding author), Univ Bern, Dept Clin Res, Div Nephrol & Hypertens, Freiburgstr 15, CH-3010 Bern, Switzerland.
EM alex.odermatt@dkf.unibe.ch
RI Atanasov, Atanas/C-5535-2013
OI Atanasov, Atanas/0000-0003-2545-0967; Odermatt,
   Alex/0000-0002-6820-2712; Aubry, Evelyne/0000-0002-3861-0694
CR Alberts P, 2003, ENDOCRINOLOGY, V144, P4755, DOI 10.1210/en.2003-0344
   Alberts P, 2002, DIABETOLOGIA, V45, P1528, DOI 10.1007/s00125-002-0959-6
   Apostolova G, 2005, AM J PHYSIOL-ENDOC M, V288, pE957, DOI 10.1152/ajpendo.00442.2004
   Arampatzis S, 2005, J MOL ENDOCRINOL, V35, P89, DOI 10.1677/jme.1.01736
   Asensio C, 2004, INT J OBESITY, V28, pS45, DOI 10.1038/sj.ijo.0802856
   Atanasov AG, 2004, FEBS LETT, V571, P129, DOI 10.1016/j.febslet.2004.06.065
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191, DOI 10.1093/ajcn/76.6.1191
   Carey KL, 1996, J CELL BIOL, V133, P985, DOI 10.1083/jcb.133.5.985
   Dórea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119
   Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924
   Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI [10.1172/JCI200317845, 10.1172/JCI17845]
   Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Miguet L, 2006, J COMPUT AID MOL DES, V20, P67, DOI 10.1007/s10822-006-9037-3
   Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200
   Odermatt A, 1999, J BIOL CHEM, V274, P28762, DOI 10.1074/jbc.274.40.28762
   ODERMATT A, 2005, CURR ENZYME INHIB, V1, P97
   Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101
   Paterson JM, 2005, AM J PHYSIOL-REG I, V289, pR642, DOI 10.1152/ajpregu.00017.2005
   Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Schuster D, 2006, J MED CHEM, V49, P3454, DOI 10.1021/jm0600794
   Schweizer RAS, 2003, MOL CELL ENDOCRINOL, V212, P41, DOI 10.1016/j.mce.2003.09.027
   Seckl JR, 2004, RECENT PROG HORM RES, V59, P359, DOI 10.1210/rp.59.1.359
   Stewart PM, 2005, CLIN MED, V5, P142, DOI 10.7861/clinmedicine.5-2-142
   Tomlinson J W, 2005, Minerva Endocrinol, V30, P37
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Wang MH, 2006, CURR OPIN INVEST DR, V7, P319
   Yanagimoto K, 2004, J AGR FOOD CHEM, V52, P592, DOI 10.1021/jf030317t
NR 33
TC 28
Z9 33
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD JUL 24
PY 2006
VL 580
IS 17
BP 4081
EP 4085
DI 10.1016/j.febslet.2006.06.046
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 067EK
UT WOS:000239284300011
PM 16814782
OA Green Published
DA 2025-04-28
ER

PT J
AU Botros, N
   Sluik, D
   van Waateringe, RP
   de Vries, JHM
   Geelen, A
   Feskens, EJM
AF Botros, Nadia
   Sluik, Diewertje
   van Waateringe, Robert P.
   de Vries, Jeanne H. M.
   Geelen, Anouk
   Feskens, Edith J. M.
TI Advanced glycation end-products (AGEs) and associations with
   cardio-metabolic, lifestyle, and dietary factors in a general
   population: the NQplus study
SO DIABETES-METABOLISM RESEARCH AND REVIEWS
LA English
DT Article
DE advanced glycation end-products; AGEs; skin autofluorescence; nutrition;
   lifestyle; general population
ID SKIN AUTOFLUORESCENCE; INSULIN-RESISTANCE; OXIDATIVE STRESS; REFERENCE
   VALUES; RISK; RESTRICTION; QUESTIONNAIRE; ACCUMULATION; MECHANISMS;
   VALIDITY
AB Background: Advanced glycation end-products are a heterogeneous group of molecules that are formed during reactions between reducing sugars and proteins. Advanced glycation end-products are thought to play a role in several diseases, including diabetes mellitus and can be measured non-invasively using skin autofluorescence (AF). The aim of this cross-sectional study was to investigate associations between skin AF and cardio-metabolic, lifestyle, and dietary factors within a general population.
   Methods: The NQplus study is an ongoing longitudinal study in the surroundings of Wageningen, the Netherlands. In this cross-sectional study, skin AF was measured in 957 participants, aged 20 to 77 years, with the AGE Reader. Logistic regression was used to assess associations between skin AF and the following factors: demographics, adiposity, blood lipids, fasting glucose, HbA(1c), blood pressure, dietary intake, and disease history. Stepwise linear regression was used to identify factors correlating with skin AF.
   Results: In males, skin AF was significantly associated with age, coffee intake, systolic and diastolic blood pressure, body fat, full fat dairy, and educational level. In females, significant associations were found with age, coffee intake, HbA(1c), diabetes, and eGFR. In the total population, current smoking was positively associated with skin AF.
   Conclusions: This cross-sectional study in a general population showed that age and coffee intake were associated with skin AF in both males and females. We observed a gender disparity for some of the associations with skin AF, which need to be confirmed by further research. More detailed research is needed to assess the association between skin AF and diet.
C1 [Botros, Nadia; Sluik, Diewertje; de Vries, Jeanne H. M.; Geelen, Anouk; Feskens, Edith J. M.] Wageningen Univ & Res, Div Human Nutr, POB 17, NL-6700 AA Wageningen, Netherlands.
   [van Waateringe, Robert P.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.
C3 Wageningen University & Research; University of Groningen
RP Sluik, D (corresponding author), Wageningen Univ & Res, Div Human Nutr, POB 17, NL-6700 AA Wageningen, Netherlands.
EM diewertje.sluik@wur.nl
RI Geelen, Anouk/P-5041-2014; Feskens, Edith/ABI-1446-2020
OI Sluik, Diewertje/0000-0001-6304-0913
FU ZonMw [91110030]
FX ZonMw, Grant/Award Number: 91110030
CR Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004
   Al-Abed Y, 1999, P NATL ACAD SCI USA, V96, P2385, DOI 10.1073/pnas.96.5.2385
   Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS62, DOI 10.2337/dc11-S062
   [Anonymous], ENDOCR PRACT
   Bekedam EK, 2008, J AGR FOOD CHEM, V56, P7138, DOI 10.1021/jf800999a
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915
   de Vos LC, 2014, ARTERIOSCL THROM VAS, V34, P933, DOI 10.1161/ATVBAHA.113.302731
   den Dekker MAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083084
   den Engelsen C, 2012, DERM-ENDOCRINOL, V4, P33, DOI 10.4161/derm.17999
   Eny KM, 2015, DIABETES TECHNOL THE, V17, P726, DOI 10.1089/dia.2015.0017
   FEUNEKES GIJ, 1993, AM J CLIN NUTR, V58, P489, DOI 10.1093/ajcn/58.4.489
   Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854
   Heizmann CW, 2007, MOL NUTR FOOD RES, V51, P1116, DOI 10.1002/mnfr.200600284
   Kellow NJ, 2013, EUR J CLIN NUTR, V67, P239, DOI 10.1038/ejcn.2012.220
   Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT SUPPL, V3, P1, DOI DOI 10.1038/KISUP.2012.73
   Klenovics KS, 2014, DIABETIC MED, V31, P581, DOI 10.1111/dme.12326
   Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113
   Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474
   Levey AS., 2000, J Am Soc Nephrol, V11, P155
   Li JL, 2012, J NEUROL SCI, V317, P1, DOI 10.1016/j.jns.2012.02.018
   Lutgers HL, 2009, DIABETOLOGIA, V52, P789, DOI 10.1007/s00125-009-1308-9
   Lutgers HL, 2006, DIABETES CARE, V29, P2654, DOI 10.2337/dc05-2173
   Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66
   McIntyre NJ, 2011, CLIN J AM SOC NEPHRO, V6, P2356, DOI 10.2215/CJN.02420311
   Meerwaldt R, 2005, DIABETOLOGIA, V48, P1637, DOI 10.1007/s00125-005-1828-x
   Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2
   MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377
   Noordzij MJ, 2011, DIABETES TECHNOL THE, V13, P165, DOI 10.1089/dia.2010.0123
   Perk J, 2012, INT J BEHAV MED, V19, P403, DOI 10.1007/s12529-012-9242-5
   Phipps AI, 2010, MATURITAS, V67, P60, DOI 10.1016/j.maturitas.2010.04.015
   Siebelink E, 2011, BRIT J NUTR, V106, P274, DOI 10.1017/S0007114511000067
   Streppel MT, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-75
   Tanaka K, 2011, NEPHROL DIAL TRANSPL, V26, P214, DOI 10.1093/ndt/gfq369
   Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091
   Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018
   van Lee L, 2016, BRIT J NUTR, V115, P517, DOI 10.1017/S0007114515004705
   van Waateringe RP, 2016, EUR J CLIN INVEST, V46, P481, DOI 10.1111/eci.12627
   Vlassara H, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0453-1
   Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74
   Vlassara H, 2009, J CLIN ENDOCR METAB, V94, P4483, DOI 10.1210/jc.2009-0089
   Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S
   Yagihashi S, 2011, J DIABETES INVEST, V2, P18, DOI 10.1111/j.2040-1124.2010.00070.x
   Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148
   Yue X, 2011, DIABETIC MED, V28, P818, DOI 10.1111/j.1464-5491.2010.03217.x
NR 46
TC 22
Z9 23
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1520-7552
EI 1520-7560
J9 DIABETES-METAB RES
JI Diabetes-Metab. Res. Rev.
PD JUL
PY 2017
VL 33
IS 5
AR e2892
DI 10.1002/dmrr.2892
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA EZ5BZ
UT WOS:000404728100012
PM 28249105
OA Green Published
DA 2025-04-28
ER

PT J
AU Liu, AG
   Arceneaux, KP
   Chu, JT
   Jacob, G
   Schreiber, AL
   Tipton, RC
   Yu, Y
   Johnson, WD
   Greenway, FL
   Primeaux, SD
AF Liu, Ann G.
   Arceneaux, Kenneth P., III
   Chu, Jessica T.
   Jacob, Gregory, Jr.
   Schreiber, Allyson L.
   Tipton, Russell C.
   Yu, Ying
   Johnson, William D.
   Greenway, Frank L.
   Primeaux, Stefany D.
TI The effect of caffeine and albuterol on body composition and metabolic
   rate
SO OBESITY
LA English
DT Article
ID PROTEIN-TURNOVER; SALBUTAMOL; CLENBUTEROL; EPHEDRINE; SKELETAL; MUSCLE;
   MASS
AB ObjectiveCaffeine and ephedrine was an effective combination therapy for weight loss until ephedrine was removed from the market due to safety concerns. This study investigated the combination of caffeine and albuterol as a possibly safer alternative to ephedrine.
   MethodsIn a series of experiments using cultured adipocytes, rat models, and humans, the effects of caffeine and albuterol on lipolysis, metabolic rate, food intake, and body composition were evaluated.
   ResultsBoth caffeine and albuterol enhanced lipolysis in cultured adipocytes. Acute treatment of humans with caffeine and/or albuterol increased resting metabolic rate. Longer-term studies of rats revealed a trend for increased metabolic rate with albuterol treatment. There was increased lean mass gain concurrent with decreased fat mass gain with caffeine/albuterol treatment that was greater than albuterol treatment alone.
   ConclusionsIn rats, albuterol with caffeine produced significantly greater increases in lean body mass and reductions in fat mass without changes in food intake after 4-8 weeks of treatment. Since caffeine and albuterol are approved for the treatment of asthma in children and adolescents at the doses tested and change body composition without changing food intake, this combination may deserve further exploration for use in treating pediatric obesity.
C1 [Liu, Ann G.; Arceneaux, Kenneth P., III; Schreiber, Allyson L.; Yu, Ying; Johnson, William D.; Greenway, Frank L.; Primeaux, Stefany D.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
   [Chu, Jessica T.; Jacob, Gregory, Jr.; Tipton, Russell C.; Primeaux, Stefany D.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, New Orleans, LA USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; Louisiana State University
   System; Louisiana State University Health Sciences Center New Orleans
RP Greenway, FL (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM frank.greenway@pbrc.edu
RI Greenway, Frank/N-1966-2017; Johnson, William/N-1972-2017
OI Johnson, William/0000-0002-3823-4094; Liu, Ann/0000-0002-4959-4933
FU Pennington Biomedical Research Center of the Louisiana State University;
   Nutrition Obesity Research Center from NIDDK [NIH 2P30DK072476];
   Botanical Research Center from NCCAM [P50AT002776]; Botanical Research
   Center from ODS; NIGMS [1 U54 GM104940]
FX This research was supported by Pennington Biomedical Research Center of
   the Louisiana State University and in part by a Nutrition Obesity
   Research Center grant NIH 2P30DK072476 from NIDDK, Botanical Research
   Center grant P50AT002776 from NCCAM and ODS, and 1 U54 GM104940 from
   NIGMS, which funds the Louisiana Clinical and Translational Science
   Center.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   AMOROSO P, 1993, THORAX, V48, P882, DOI 10.1136/thx.48.9.882
   ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   BATES PC, 1991, BRIT J NUTR, V65, P115, DOI 10.1079/BJN19910074
   Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2
   BUTCHER RW, 1968, J BIOL CHEM, V243, P1705
   CARTER WJ, 1994, METABOLISM, V43, P1119, DOI 10.1016/0026-0495(94)90054-X
   COLLIER JG, 1980, BRIT J CLIN PHARMACO, V9, P273, DOI 10.1111/j.1365-2125.1980.tb04837.x
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   GOLDBERG R, 1975, POSTGRAD MED J, V51, P53, DOI 10.1136/pgmj.51.592.53
   Greenway F L, 2001, Obes Rev, V2, P199, DOI 10.1046/j.1467-789x.2001.00038.x
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   ROGERS KL, 1991, P SOC EXP BIOL MED, V197, P482
   Skura CL, 2008, NEUROLOGY, V70, P137, DOI 10.1212/01.WNL.0000287070.00149.a9
   WENKEOVA J, 1975, EUR J PHARMACOL, V30, P49, DOI 10.1016/0014-2999(75)90201-0
NR 15
TC 15
Z9 19
U1 3
U2 55
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD SEP
PY 2015
VL 23
IS 9
BP 1830
EP 1835
DI 10.1002/oby.21163
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA CQ1VK
UT WOS:000360388100016
PM 26239482
OA Bronze, Green Accepted
DA 2025-04-28
ER

PT J
AU Su, XT
   Hao, S
   Li, WN
   Li, X
   Mo, ZT
   Li, YQ
   Xiao, L
   Wang, WJ
   Wang, F
AF Su, Xiaotong
   Hao, Shun
   Li, Wenna
   Li, Xu
   Mo, Zhentao
   Li, Yiqi
   Xiao, Lu
   Wang, Wenjun
   Wang, Feng
TI Gardenia fruit and Eucommia leaves combination improves hyperlipidemia
   and hyperglycemia via pancreatic lipase and AMPK-PPAR? and
   Keap-1-Nrf2-HO-1 regulation
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Oxidative stress; Lipid and glucose regulation; Eucommia ulmoides
   leaves; Gardenia fruit; Pancreatic lipase; AMPK; PPAR?
ID CHLOROGENIC ACID; LIPID-METABOLISM; OBESITY; SYSTEM
AB Obesity is associated with an increased risk of chronic diseases and affects the overall quality of life. Gardenia jasminoides (Ellis) fruit (GE) and Eucommia ulmoides leaves (EE) are traditional medicines reported to possess antioxidative, anti-hyperglycemic, anti-hyperlipidemic, and anti-obesity activities. However, the synergistic effect of combining Gardenia and Eucommia remains unclear. This study aimed to test the combination via animal and cell experiments. GE extract mainly contains geniposide (52.5 %), whereas EE extract contains crocin (10.5 %) and chlorogenic acid (52.3 %). Copper soap analysis revealed that the combination of GE and EE induced greater pancreatic lipase activity. In C57BL/6J mice, this combination markedly improved hypertriglyceridemia and hyperglycemia in intravenous fat and intraperitoneal glucose tolerance tests, respectively. In HepG2 cells with hyperlipidemia induced via oleic acid (OA), GE + EE reduced the accumulation of ectopic lipid and augmented the oxidative stress-related enzyme activities by elevating PPAR alpha, AMPK, Nrf2, and HO-1 expression and attenuating Keap-1 expression. Thus, this combination protects against OA-induced lipid toxicity by targeting AMPK-PPAR alpha and Nrf2- Keap-1-HO-1.
C1 [Su, Xiaotong; Li, Wenna; Li, Xu; Mo, Zhentao; Li, Yiqi; Xiao, Lu; Wang, Wenjun; Wang, Feng] Zunyi Med Univ, Zhuhai Campus, Zhuhai 519041, Guangdong, Peoples R China.
   [Hao, Shun] Peoples Hosp Zhangjiajie, Zhangjiajie 427000, Hunan, Peoples R China.
   [Li, Wenna] Zunyi Med Univ, Key Lab Basic Pharmacol Educ & Joint Int Res Lab E, Minist Educ, Zunyi 563000, Guizhou, Peoples R China.
   [Li, Wenna] Zunyi Med Univ, Key Lab Basic Pharmacol Guizhou Prov, Zunyi 563000, Guizhou, Peoples R China.
   [Li, Wenna] Zunyi Med Univ, Sch Pharm, Zunyi 563000, Guizhou, Peoples R China.
C3 Zunyi Medical University; Zunyi Medical University; Zunyi Medical
   University; Zunyi Medical University
RP Li, WN; Wang, F (corresponding author), Zunyi Med Univ, Zhuhai Campus, Zhuhai 519041, Guangdong, Peoples R China.
EM 26153767@qq.com; 442769783@qq.com
FU Education Department of Guizhou Province of China [QJHKY2020253];
   Natural Science Foundation of China [81760697]; open topic of Key
   Laboratory of Basic Pharmacology of the Ministry of Education; Joint
   International Research Laboratory of Ethnomedicine of the Ministry of
   Education (Zunyi Medical University)
FX This work was supported by the open topic of Key Laboratory of Basic
   Pharmacology of the Ministry of Education and Joint International
   Research Laboratory of Ethnomedicine of the Ministry of Education (Zunyi
   Medical University), the Education Department of Guizhou Province of
   China (QJHKY2020253), and the Project Natural Science Foundation of
   China (No. 81760697).
CR Azzimato V, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw9709
   Cameron AR, 2016, CIRC RES, V119, P652, DOI 10.1161/CIRCRESAHA.116.308445
   Cao Hong-Hong, 2019, Zhongguo Zhong Yao Za Zhi, V44, P5413, DOI 10.19540/j.cnki.cjcmm.20190916.307
   CARLSON LA, 1972, SCAND J CLIN LAB INV, V29, P271, DOI 10.3109/00365517209080242
   Cerda-Bernad D, 2022, CRIT REV FOOD SCI, V62, P3232, DOI 10.1080/10408398.2020.1864279
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clemmensen C, 2015, EMBO MOL MED, V7, P288, DOI 10.15252/emmm.201404508
   Dai XY, 2016, CIRC RES, V119, P1089, DOI 10.1161/CIRCRESAHA.116.309463
   Ezzati M, 2017, LANCET, V390, P2627, DOI [10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3]
   Hao S, 2016, PHARM BIOL, V54, P251, DOI 10.3109/13880209.2015.1029054
   Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81
   Jin ZJ, 2004, ACTA PHARMACOL SIN, V25, P146
   Kwon CW, 2015, FOOD CHEM, V182, P236, DOI 10.1016/j.foodchem.2015.02.145
   Lai LL, 2021, HUM EXP TOXICOL, V40, P661, DOI 10.1177/0960327120954521
   Lee GH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020426
   Leng EN, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2189-6
   Li ZP, 2018, J GINSENG RES, V42, P312, DOI 10.1016/j.jgr.2017.04.001
   Liu L, 2020, DEV CELL, V52, P196, DOI 10.1016/j.devcel.2019.11.012
   Liu X, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00944
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Merry T. L., 2020, NAT COMMUN, V11, DOI 10
   Pan HO, 2018, J AGR FOOD CHEM, V66, P5802, DOI 10.1021/acs.jafc.8b00739
   [阙灵 Que Ling], 2017, [中国药学杂志, Chinese Pharmaceutical Journal], V52, P521
   REDHEENDRAN R, 1979, CLIN CHEM, V25, P791
   Shinoda K., 2015, CELL METAB
   Veiga FM, 2017, BIOCHIMIE, V140, P106, DOI 10.1016/j.biochi.2017.07.003
   Son JW, 2020, DIABETES METAB J, V44, P802, DOI 10.4093/dmj.2020.0258
   Tak YJ, 2021, CURR OBES REP, V10, P14, DOI 10.1007/s13679-020-00422-w
   Vekic J, 2019, METABOLISM, V92, P71, DOI 10.1016/j.metabol.2018.11.005
   Wang SA, 2021, MOLECULES, V26, DOI 10.3390/molecules26020479
   Wang YR, 2015, PHYTOCHEM ANALYSIS, V26, P202, DOI 10.1002/pca.2553
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Yang HJ, 2004, J CHROMATOGR SCI, V42, P173, DOI 10.1093/chromsci/42.4.173
   Zhang J, 2020, FOOD RES INT, V130, DOI 10.1016/j.foodres.2019.108929
   Zhang JH, 2020, J ANAL METHODS CHEM, V2020, DOI 10.1155/2020/7867046
   Zhang MT, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/9102475
NR 38
TC 3
Z9 3
U1 8
U2 24
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN
PY 2023
VL 100
AR 105394
DI 10.1016/j.jff.2022.105394
EA DEC 2022
PG 15
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA E3AW7
UT WOS:000974315600001
OA gold
DA 2025-04-28
ER

PT J
AU Kim, Y
   Lee, J
   Oh, JH
   Chang, HJ
   Sohn, DK
   Shin, A
   Kim, J
AF Kim, Youngyo
   Lee, Jeonghee
   Oh, Jae Hwan
   Chang, Hee Jin
   Sohn, Dae Kyung
   Shin, Aesun
   Kim, Jeongseon
TI The Association between Coffee Consumption and Risk of Colorectal Cancer
   in a Korean Population
SO NUTRIENTS
LA English
DT Article
DE coffee; colon cancer; rectal cancer; case-control study; coffee
   additives
ID CHOLESTEROL-RAISING FACTOR; TYPE-2 DIABETES-MELLITUS; METAANALYSIS;
   CAFESTOL; ACID; DITERPENES; KAHWEOL
AB This study was performed to investigate the association between coffee consumption and risk of colorectal cancer in a Korean population and examine whether the association can be altered by adjustment for intake of coffee additives. We conducted a case-control study involving 923 colorectal cancer cases and 1846 controls matched by sex and age (within 5 years). A semi-quantitative food frequency questionnaire was used to assess coffee intakes. High coffee consumption was associated with lower odds of developing colorectal cancer (>= 3 cups/day vs. no drinks, OR = 0.68; 95% CI: 0.49-0.96). When we additionally controlled for consumption of coffee additives including sugar and cream, the inverse association became stronger (>= 3 cups/day vs. no drinks, OR = 0.22; 95% CI: 0.14-0.33), and a significant inverse linear trend was shown (P-trend < 0.0001). The inverse associations were observed for proximal (P-trend = 0.0001) and distal (P-trend = 0.0003) colon cancer, and rectal cancer (P-trend < 0.0001) in the stratified analysis by anatomical sub-sites. Regarding sex, inverse associations between coffee consumption and colorectal cancer were found for men (P-trend < 0.0001) and women (P-trend = 0.0021). In the stratified analysis by obese status of subjects, inverse linear trends were observed in both non-obese and obese people (P-trend < 0.0001). High coffee consumption may be associated with a lower risk of colorectal cancer in the Korean population and the degree of decrease in the odds of developing colorectal cancer changes by adjustment for intake of coffee additives.
C1 [Kim, Youngyo] Gyeongsang Natl Univ, Dept Food & Nutr, Inst Agr & Life Sci, Jinju 52828, South Korea.
   [Kim, Youngyo; Lee, Jeonghee; Kim, Jeongseon] Natl Canc Ctr, Dept Canc Biomed Sci, Grad Sch Canc Sci & Policy, Goyang 10408, South Korea.
   [Oh, Jae Hwan; Chang, Hee Jin; Sohn, Dae Kyung] Natl Canc Ctr Hosp, Ctr Colorectal Canc, Natl Canc Ctr, Goyang 10408, South Korea.
   [Shin, Aesun] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul 03080, South Korea.
C3 Gyeongsang National University; National Cancer Center - Korea (NCC);
   National Cancer Center - Korea (NCC); Seoul National University (SNU)
RP Kim, J (corresponding author), Natl Canc Ctr, Dept Canc Biomed Sci, Grad Sch Canc Sci & Policy, Goyang 10408, South Korea.
EM youngyokim@gnu.ac.kr; jeonghee@ncc.re.kr; jayoh@ncc.re.kr;
   heejincmd@ncc.re.kr; gsgsbal@ncc.re.kr; shinaesun@snu.ac.kr;
   jskim@ncc.re.kr
RI KIM, JEONGSEON/AAA-4643-2022; Shin, Aesun/E-9145-2014
OI KIM, JEONGSEON/0000-0002-0889-2686; Shin, Aesun/0000-0002-6426-1969
FU National Cancer Center in Korea [1910330, 2010260]
FX This research was supported by grants from the National Cancer Center in
   Korea (No.: 1910330 and 2010260).
CR Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   [Anonymous], 2004, International statistical classification of diseases and related health problems
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   BROWN SR, 1990, GUT, V31, P450, DOI 10.1136/gut.31.4.450
   Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7
   Cohen BE, 2019, CLIN DRUG INVEST, V39, P197, DOI 10.1007/s40261-018-0732-3
   Delouya G, 2018, HORM MOL BIOL CLIN I, V36, DOI 10.1515/hmbci-2018-0049
   Gadaleta RM, 2017, MOL ASPECTS MED, V56, P66, DOI 10.1016/j.mam.2017.04.002
   Galeone C, 2010, CANCER CAUSE CONTROL, V21, P1949, DOI 10.1007/s10552-010-9623-5
   Guraya SY, 2015, WORLD J GASTROENTERO, V21, P6026, DOI 10.3748/wjg.v21.i19.6026
   Higgins LG, 2008, TOXICOL APPL PHARM, V226, P328, DOI 10.1016/j.taap.2007.09.018
   Je YJ, 2009, INT J CANCER, V124, P1662, DOI 10.1002/ijc.24124
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P134, DOI [DOI 10.3322/caac.20115, DOI 10.3322/CAAC.21492, DOI 10.3322/CANJCLIN.49.1.33]
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jung KW, 2019, CANCER RES TREAT, V51, P431, DOI 10.4143/crt.2019.139
   Kim M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121963
   Kim Y, 2019, EUR J EPIDEMIOL, V34, P731, DOI 10.1007/s10654-019-00524-3
   Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375
   Li GW, 2013, PUBLIC HEALTH NUTR, V16, P346, DOI 10.1017/S1368980012002601
   Lin TK, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0344-y
   Mancini A, 2015, MOLECULES, V20, P17339, DOI 10.3390/molecules200917339
   NAGENGAST FM, 1995, EUR J CANCER, V31A, P1067, DOI 10.1016/0959-8049(95)00216-6
   Nakagawa HS, 2017, INT J CANCER, V141, P298, DOI 10.1002/ijc.30746
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Porta M, 2003, EUR J EPIDEMIOL, V18, P289, DOI 10.1023/A:1023700216945
   Post SM, 1997, ARTERIOSCL THROM VAS, V17, P3064, DOI 10.1161/01.ATV.17.11.3064
   Ricketts ML, 2007, MOL ENDOCRINOL, V21, P1603, DOI 10.1210/me.2007-0133
   Schmit SL, 2016, CANCER EPIDEM BIOMAR, V25, P634, DOI 10.1158/1055-9965.EPI-15-0924
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Vitaglione P, 2012, FOOD FUNCT, V3, P916, DOI 10.1039/c2fo30037k
   Wang JW, 2013, PEDIATR OBES, V8, P284, DOI 10.1111/j.2047-6310.2012.00108.x
   Welsh JA, 2011, CIRCULATION, V123, P249, DOI 10.1161/CIRCULATIONAHA.110.972166
NR 33
TC 12
Z9 14
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2021
VL 13
IS 8
AR 2753
DI 10.3390/nu13082753
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA UH7ZN
UT WOS:000690143900001
PM 34444913
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Zhu, XJ
   Yang, LC
   Xu, F
   Lin, LZ
   Zheng, GD
AF Zhu, Xiaojuan
   Yang, Licong
   Xu, Feng
   Lin, Lezhen
   Zheng, Guodong
TI Combination therapy with catechins and caffeine inhibits fat
   accumulation in 3T3-L1 cells
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article; Proceedings Paper
CT 2nd Workshop on Paediatric Virology
CY OCT 08, 2016
CL Athens, GREECE
DE 3T3-L1; caffeine; catechins; lipogenesis; lipolysis
ID GREEN TEA; ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; LIPOLYSIS;
   PATHWAYS; RATS; TIME; PREADIPOCYTES; METAANALYSIS; SIBUTRAMINE
AB Catechins and caffeine, which are green tea components, have a slimming effect; however, the combinational effect of fat metabolism in 3T3-L1 cells remains unclear. In the present study, 3T3-L1 cells were treated with catechins and caffeine in combination, and it was found that combination therapy with catechins and caffeine markedly reduced intracellular fat accumulation, mRNA expression levels of peroxisome proliferator-activated receptor-gamma and CCAAT/enhancer-binding protein a in the early stage of cell differentiation were significantly reduced, and mRNA expression of fatty acid synthetase (FAS) and glycerol-3-phosphate dehydrogenase protein expression levels of FAS were down regulated. Noradrenaline-induced lipolysis was enhanced by caffeine, which markedly increased the protein expression of adipose triglyceride lipase and hormone sensitive lipase. These results indicated that combination therapy with catechins and caffeine synergistically inhibited lipid accumulation by regulating the gene and protein expression levels of lipid metabolism-related enzymes. Therefore, catechins and caffeine combination therapy has potential as a functional food that may be used to prevent obesity and lifestyle-associated diseases.
C1 [Zhu, Xiaojuan; Yang, Licong; Xu, Feng; Lin, Lezhen; Zheng, Guodong] Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, 1101 Zhimin Rd, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University
RP Zheng, GD (corresponding author), Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, 1101 Zhimin Rd, Nanchang 330045, Jiangxi, Peoples R China.
EM zrs150716@aliyun.com
RI Xu, Feng/L-8097-2019
FU National Natural Science Foundation of China [31160320]; Jiangxi
   Province Natural Science Foundation of China [20142BAB204003]
FX The present study was kindly supported by the National Natural Science
   Foundation of China (grant no. 31160320) and the Jiangxi Province
   Natural Science Foundation of China (grant no. 20142BAB204003).
CR Bartrina JA, 2013, NUTR HOSP, V28, P128, DOI 10.3305/nh.2013.28.sup5.6928
   Barbe P, 1996, BRIT J PHARMACOL, V117, P907, DOI 10.1111/j.1476-5381.1996.tb15279.x
   Bolsoni-Lopes A, 2015, ARCH ENDOCRIN METAB, V59, P335
   Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094
   Chaves VE, 2011, BIOCHIMIE, V93, P1631, DOI 10.1016/j.biochi.2011.05.018
   Choi Y, 2011, J AGR FOOD CHEM, V59, P12843, DOI 10.1021/jf2033208
   Choung MG, 2014, INT J FOOD SCI TECH, V49, P1572, DOI 10.1111/ijfs.12454
   Dave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030831
   Di LC, 2013, PLANT FOOD HUM NUTR, V68, P149
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Gaidhu MP, 2012, AM J PHYSIOL-CELL PH, V303, pC1192, DOI 10.1152/ajpcell.00159.2012
   Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396
   Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.1.148
   Kim EY, 2015, INT J MOL SCI, V16, P4581, DOI 10.3390/ijms16034581
   Kim H, 2012, CELL BIOL INT, V36, P147, DOI 10.1042/CBI20110047
   Kong XM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104486
   Lee EJ, 2012, DRUG CHEM TOXICOL, V35, P225, DOI 10.3109/01480545.2011.591401
   Lee JH, 2015, PLOS ONE, V10
   Lee MS, 2009, PHYTOTHER RES, V23, P1088, DOI 10.1002/ptr.2737
   Lim DW, 2013, NUTRIENTS, V5, P2734, DOI 10.3390/nu5072734
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503
   Mannucci E, 2008, NUTR METAB CARDIOVAS, V18, P342, DOI 10.1016/j.numecd.2007.03.010
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Nagayama M, 2010, FEBS LETT, V584, P86, DOI 10.1016/j.febslet.2009.10.088
   Oberholzer HM, 2015, ENVIRON TOXICOL PHAR, V40, P71, DOI 10.1016/j.etap.2015.05.011
   Park S, 2014, PLOS ONE, V4
   Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   Sakurai N, 2009, NUTRITION, V25, P1047, DOI 10.1016/j.nut.2009.02.012
   Salma N, 2006, J MOL ENDOCRINOL, V36, P139, DOI 10.1677/jme.1.01918
   Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200
   Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8
   Sujana SG, 2014, WORLD J HYPERTENS, V4, P15
   Takenaka Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065583
   Senger AEV, 2012, J NUTR HEALTH AGING, V16, P738, DOI 10.1007/s12603-012-0081-5
   WISE LS, 1979, J BIOL CHEM, V254, P273
   Wueest S, 2012, AM J PHYSIOL-ENDOC M, V302, pE153, DOI 10.1152/ajpendo.00338.2011
   Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200
   Zeng JL, 2014, NUTRIENTS, V6, P4640, DOI 10.3390/nu6114640
   Zhang Y, 2014, NUTRIENTS, V6, P5153, DOI 10.3390/nu6115153
   Zheng GD, 2004, IN VIVO, V18, P55
   Zheng GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122925
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
NR 47
TC 24
Z9 24
U1 1
U2 17
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD FEB
PY 2017
VL 13
IS 2
BP 688
EP 694
DI 10.3892/etm.2016.3975
PG 7
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Research & Experimental Medicine
GA EL9GH
UT WOS:000394927900051
PM 28352352
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Guo, L
   Kang, JS
   Park, YH
   Je, BI
   Hwang, DY
   Joo, WH
   Choi, YW
AF Guo, Lu
   Kang, Jum Soon
   Park, Young Hoon
   Je, Beong Il
   Hwang, Dae Youn
   Joo, Woo Hong
   Choi, Young Whan
TI Fermentation of mulberry leaves with Cordyceps militaris enhanced
   anti-adipogenesis activity in 3T3-L1 cells through down-regulation of
   PPAR-γ pathway signaling
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
ID INSULIN-RESISTANCE; DIFFERENTIATION; OBESITY; STATE; POLYSACCHARIDES;
   SUPPRESSION; ACTIVATION; GENE; FAS
AB Objective: To establish an efficacious and efficient fermentation method of enhancing the anti-adipogenesis effect of mulberry (Morus alba) leaves using Cordyceps militais. Methods: Dried mulberry leaves, dried mulberry leaves with 50% raw silkworm pupa and raw silkworm pupa were fermented with Cordyceps militais for 4 weeks at 25 degrees C, after which the dried mulberry leaves and fermented product were extracted with 70% ethanol and subjected to high performance liquid chromatography (HPLC). The contents of cordycepin, pelargonidin, chlorogenic acid, iso-quercetin and caffeic acid were determined. We then used the 3T3-L1 cells to investigate whether extracts of fermentation enhanced anti-adipogenesis activity in vitro. Results: HPLC showed that fermentation changed the contents of cordycepin, pelargonidin, chlorogenic acid, iso-quercetin and caffeic acid. Furthermore, fermented dried mulberry leaves with 50% raw silkworm pupa had a better efficacy of anti-adipogenesis than dried mulberry leaves, fermented dried mulberry leaves and fermented silkworm pupa and inhibited triglycerides accumulation and glucose consumption. Additionally, fermented dried mulberry leaves with 50% raw silkworm pupa inhibited PPAR-gamma signaling. Conclusions: Fermentation with Cordyceps militaris enhanced anti-adipogenesis efficacy of mulberry leaves.
C1 [Guo, Lu; Kang, Jum Soon; Park, Young Hoon; Je, Beong Il; Choi, Young Whan] Pusan Natl Univ, Dept Hort Biosci, Miryang 50463, South Korea.
   [Hwang, Dae Youn] Pusan Natl Univ, Dept Biomat Sci, Miryang 50463, South Korea.
   [Joo, Woo Hong] Changwon Natl Univ, Dept Biol & Chem, Chang Won 51140, South Korea.
   [Choi, Young Whan] Pusan Natl Univ, Life & Ind Convergence Res Inst, Miryang 50463, South Korea.
C3 Pusan National University; Pusan National University; Changwon National
   University; Pusan National University
RP Choi, YW (corresponding author), Pusan Natl Univ, Dept Hort Biosci, Miryang 50463, South Korea.; Choi, YW (corresponding author), Pusan Natl Univ, Life & Ind Convergence Res Inst, Miryang 50463, South Korea.
EM ywchoi@pusan.ac.kr
RI Guo, Lu/AAZ-7783-2020; Choi, Young-Whan/AAO-4826-2021
OI Guo, Lu/0000-0003-2121-6401
FU Korea Institute of Planning and Evaluation for Technology in Food,
   Agriculture, Forestry and Fisheries (IPET) through High Value-added Food
   Technology Development Program - Ministry of Agriculture, Food and Rural
   Affairs (MAFRA) [116027032HD020]
FX This work was supported by Korea Institute of Planning and Evaluation
   for Technology in Food, Agriculture, Forestry and Fisheries (IPET)
   through High Value-added Food Technology Development Program, funded by
   Ministry of Agriculture, Food and Rural Affairs (MAFRA)(116027032HD020).
CR An YN, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0910-6
   Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com
   Chan EWC, 2016, CHIN J NAT MEDICINES, V14, P17, DOI 10.3724/SP.J.1009.2016.00017
   Chan KC, 2013, J AGR FOOD CHEM, V61, P2780, DOI 10.1021/jf305328d
   Chang YC, 2016, J FUNCT FOODS, V21, P249, DOI 10.1016/j.jff.2015.11.033
   Chen JJ, 2007, ASIA PAC J CLIN NUTR, V16, P290
   CUNNINGHAM KG, 1950, NATURE, V166, P949, DOI 10.1038/166949a0
   Das SK, 2010, FITOTERAPIA, V81, P961, DOI 10.1016/j.fitote.2010.07.010
   Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025
   Feng L, 2016, DIABETOLOGIA, V59, P1276, DOI 10.1007/s00125-016-3912-9
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Guo L, 2020, ARCH BIOCHEM BIOPHYS, V686, DOI 10.1016/j.abb.2020.108365
   Guo YJ, 2017, J MOL ENDOCRINOL, V59, P205, DOI 10.1530/JME-16-0179
   Gurukar MSA, 2018, J AGR FOOD CHEM, V66, P7923, DOI 10.1021/acs.jafc.8b01357
   He XR, 2018, FOOD CHEM, V245, P899, DOI 10.1016/j.foodchem.2017.11.084
   Hong YH, 2013, BIOSCI BIOTECH BIOCH, V77, P22, DOI 10.1271/bbb.120373
   Inoue Y, 2018, CURR OBES REP, V7, P276, DOI 10.1007/s13679-018-0317-8
   Jackson RM, 2017, J BIOL CHEM, V292, P18556, DOI 10.1074/jbc.M117.791970
   Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015
   Jeszka-Skowron M, 2014, J FUNCT FOODS, V8, P9, DOI 10.1016/j.jff.2014.02.018
   Kang N, 2017, MYCOBIOLOGY, V45, P31, DOI 10.5941/MYCO.2017.45.1.31
   Ke B, 2017, AM J TRANSL RES, V9, P2195
   Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291
   Lee A, 2017, MOLECULES, V22, DOI 10.3390/molecules22091423
   Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006
   Lin YW, 2008, PROCESS BIOCHEM, V43, P244, DOI 10.1016/j.procbio.2007.11.020
   Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S
   Muurling M, 2003, METABOLISM, V52, P1078, DOI 10.1016/S0026-0495(03)00109-4
   Paterson RRM, 2008, PHYTOCHEMISTRY, V69, P1469, DOI 10.1016/j.phytochem.2008.01.027
   Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063
   Randhir R, 2007, INNOV FOOD SCI EMERG, V8, P197, DOI 10.1016/j.ifset.2006.10.003
   Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Takahashi S, 2012, BRIT J PHARMACOL, V167, P561, DOI 10.1111/j.1476-5381.2012.02005.x
   Telles Shirley, 2018, BMC Res Notes, V11, P680, DOI 10.1186/s13104-018-3787-6
   Thaipitakwong T, 2018, PHARM BIOL, V56, P109, DOI 10.1080/13880209.2018.1424210
   Thong FSL, 2007, PHYSIOLOGY, V4, P271
   Uto-Kondo H, 2009, J NUTR, V139, P51, DOI 10.3945/jn.108.096131
   Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046
   Xiao Y, 2014, J FUNCT FOODS, V10, P210, DOI 10.1016/j.jff.2014.06.008
   Xiong ChengHui Xiong ChengHui, 2010, Mycology - An International Journal on Fungal Biology, V1, P25
   Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005
NR 42
TC 2
Z9 3
U1 3
U2 40
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD DEC
PY 2020
VL 13
IS 12
BP 557
EP 565
DI 10.4103/1995-7645.296724
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Tropical Medicine
GA OP4PK
UT WOS:000588063900005
OA gold
DA 2025-04-28
ER

PT J
AU Fiechtner, L
   Block, J
   Duncan, DT
   Gillman, MW
   Gortmaker, SL
   Melly, SJ
   Rifas-Shiman, SL
   Taveras, EM
AF Fiechtner, Lauren
   Block, Jason
   Duncan, Dustin T.
   Gillman, Matthew W.
   Gortmaker, Steven L.
   Melly, Steven J.
   Rifas-Shiman, Sheryl L.
   Taveras, Elsie M.
TI Proximity to supermarkets associated with higher body mass index among
   overweight and obese preschool-age children
SO PREVENTIVE MEDICINE
LA English
DT Article
DE Supermarkets; Food establishments; Children; Body mass index; Obesity
ID BUILT ENVIRONMENT; CHILDHOOD OBESITY; FOOD
AB Objective: The objective of this study is to examine associations of proximity to food establishments with body mass index (BMI) among preschool-age children.
   Methods: We used baseline data from 438 children ages 2-6.9 years with a BMI >= 85th percentile participating in a RCT in Massachusetts from 2006 to 2009. We used a geographic information system to determine proximity to six types of food establishments: 1) convenience stores, 2) bakeries, coffee shops, candy stores, 3) full service restaurants, 4) large supermarkets, 5) small supermarkets, and 6) fast-food restaurants. The main outcome was child's BMI.
   Results: Children's mean (SD) BMI was 19.2 (2.4) kg/m(2); 35% lived <= 1 mile from a large supermarket, 42% lived > 1 to 2 miles, and 22% lived > 2 miles. Compared to children living > 2 miles from a large supermarket, those who lived within I mile had a BMI 1.06 kg/m(2) higher. Adjustment for socioeconomic characteristics and distance to fast-food restaurants attenuated this estimate to 0.77 kg/m(2). Living in any other distance category from a large supermarket and proximity to other food establishments were not associated with child BMI.
   Conclusions: Living closer to a large supermarket was associated with higher BMI among preschool-age children who were overweight or obese. (c) 2012 Elsevier Inc. All rights reserved.
C1 [Fiechtner, Lauren] Boston Childrens Hosp, Dept Gastroenterol & Nutr, Boston, MA USA.
   [Block, Jason; Gillman, Matthew W.; Rifas-Shiman, Sheryl L.; Taveras, Elsie M.] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA 02215 USA.
   [Block, Jason; Gillman, Matthew W.; Rifas-Shiman, Sheryl L.; Taveras, Elsie M.] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA.
   [Duncan, Dustin T.; Gortmaker, Steven L.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02215 USA.
   [Melly, Steven J.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA.
C3 Harvard University; Harvard University Medical Affiliates; Boston
   Children's Hospital; Harvard University; Harvard Medical School; Harvard
   Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of
   Public Health; Harvard University; Harvard T.H. Chan School of Public
   Health
RP Taveras, EM (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.
EM Elsie_Taveras@harvardpilgrim.org
RI Block, Jason/HKV-6253-2023
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development [R01 HD 050966]
FX The abstract of this manuscript was published as part of the proceedings
   of the 2012 Pediatric Academic Societies Meeting. This study was
   supported by a grant from the Eunice Kennedy Shriver National Institute
   of Child Health and Human Development (R01 HD 050966).
CR Arnas YA, 2006, PEDIATR INT, V48, P138, DOI 10.1111/j.1442-200X.2006.02180.x
   Block JP, 2011, AM J EPIDEMIOL, V174, P1108, DOI 10.1093/aje/kwr244
   Fraser LK, 2010, HEALTH PLACE, V16, P1124, DOI 10.1016/j.healthplace.2010.07.003
   Galvez MP, 2010, CURR OPIN PEDIATR, V22, P202, DOI 10.1097/MOP.0b013e328336eb6f
   Laraia BA, 2004, PREV MED, V39, P869, DOI 10.1016/j.ypmed.2004.03.018
   Murakami K, 2011, J NUTR SCI VITAMINOL, V57, P87, DOI 10.3177/jnsv.57.87
   Navalpotro L, 2012, PREV MED, V55, P102, DOI 10.1016/j.ypmed.2012.05.012
   Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009
   Powell LM, 2007, AM J PREV MED, V33, pS301, DOI 10.1016/j.amepre.2007.07.007
   Powell LM, 2010, J NUTR, V140, P1175, DOI 10.3945/jn.109.111526
   Timperio A, 2008, PREV MED, V46, P331, DOI 10.1016/j.ypmed.2007.11.011
   Trasande L, 2009, OBESITY, V17, P1749, DOI 10.1038/oby.2009.67
   White House Task Force on Childhood Obesity, 2010, WHIT HOUS TASK FORC
NR 13
TC 32
Z9 40
U1 0
U2 25
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-7435
J9 PREV MED
JI Prev. Med.
PD MAR-APR
PY 2013
VL 56
IS 3-4
BP 218
EP 221
DI 10.1016/j.ypmed.2012.11.023
PG 4
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA 101FM
UT WOS:000315760600010
PM 23219681
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Gholami, F
   Antonio, J
   Iranpour, M
   Curtis, J
   Pereira, F
AF Gholami, Farhad
   Antonio, Jose
   Iranpour, Mohadeseh
   Curtis, Jason
   Pereira, Flavia
TI Does green tea catechin enhance weight-loss effect of exercise training
   in overweight and obese individuals? a systematic review and
   meta-analysis of randomized trials
SO JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION
LA English
DT Review
DE Catechin; obesity; exercise; weight control; lipid profile
ID ENERGY-EXPENDITURE; LIPID PROFILES; BLOOD-PRESSURE; ABDOMINAL FAT; PEDRO
   SCALE; SUPPLEMENTATION; CONSUMPTION; ABSORPTION; CAFFEINE; ASSOCIATION
AB BackgroundGreen tea (GT) is a common component of supplements known as fat burners. It has gained popularity as an ergogenic aid for weight reduction to assist with obesity management. This systematic review and meta-analysis aim to explore the effect of green tea ingestion coupled with exercise training (EX) on body composition and lipid profile in overweight and obese individuals.MethodsTwo independent researchers systematically searched the electronic databases of PubMed, Web of Science, and Scopus. Studies with a randomized-controlled design to compare the effect of green tea in conjunction with exercise training (EX+GT) versus exercise training alone (EX+P) in overweight or obese participants were included.ResultsOf the 1,015 retrieved studies, 24 were identified to undergo full-text review, out of which 10 randomized trials met the inclusion criteria. EX+GT versus EX+P had a small and consistent effect on weight [Standardized mean difference (SMD) = -0.30, CI: -0.53 to -0.07], BMI [SMD = -0.33 CI: -0.64 to -0.02] and fat reduction [SMD = -0.29, CI: -0.57 to -0.01] and there was no evidence of heterogeneity across the trials. When compared to EX+P, EX+GT had no greater effect on lipid profile improvement [triglyceride: SMD = -0.92, CI: -1.30 to 0.49; LDL: SMD = -1.44, CI: -0.73 to 0.82; HDL: SMD = 0.56, CI -0.71 to 0.46; and total cholesterol SMD = -0.54, CI -0.85 to 0.13].ConclusionsCurrent evidence suggests that green tea could have quite minimal additive benefit over exercise-induced weight loss. However, incorporation of green tea into exercise training does not seem to exert additional benefits on lipid profile and it warrants further investigations in the future.
C1 [Gholami, Farhad; Iranpour, Mohadeseh] Shahrood Univ Technol, Fac Phys Educ, Dept Phys Educ & Sport Sci, Shahrood, Iran.
   [Antonio, Jose] Nova Southeastern Univ, Dept Hlth & Human Performance, Davie, FL USA.
   [Curtis, Jason; Pereira, Flavia] Keiser Univ, Dept Exercise & Sport Sci, W Palm Beach, FL USA.
C3 Shahrood University of Technology; Nova Southeastern University; Keiser
   University
RP Gholami, F (corresponding author), Shahrood Univ Technol, Fac Phys Educ, Dept Phys Educ & Sport Sci, Shahrood, Iran.
EM Gholami-fa@shahroodut.ac.ir
OI Pereira, Flavia/0009-0009-0141-3994
CR Afzalpour ME, 2017, SCI SPORT, V32, P82, DOI 10.1016/j.scispo.2016.09.004
   Alipour M, 2018, PROG NUTR, V20, P12, DOI 10.23751/pn.v20i1.6228
   Amozadeh H, 2018, INT J ENDOCRINOL MET, V16, DOI 10.5812/ijem.60738
   [Anonymous], 2020, J PHYSIOTHER, V66, P59, DOI 10.1016/j.jphys.2019.08.005
   Asbaghi O, 2020, DIAB MET SYND CLIN R, V14, P293, DOI 10.1016/j.dsx.2020.03.018
   Bagheri R, 2020, BRIT J CLIN PHARMACO, V86, P753, DOI 10.1111/bcp.14176
   Belcaro G, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/869061
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Boroujeni JB, 2017, ANN APPL SPORT SCI, V5, P45, DOI 10.18869/acadpub.aassjournal.5.1.45
   Butte NF, 2007, OBESITY, V15, P3056, DOI 10.1038/oby.2007.364
   Chieng D, 2022, TRENDS CARDIOVAS MED, V32, P399, DOI 10.1016/j.tcm.2021.08.004
   Clark JE, 2021, NUTR HEALTH-UK, V27, P445, DOI 10.1177/0260106020982362
   Cohen Jacob, 1988, Statistical Power Analysis for the Behavioral Sciences
   Coimbra S, 2006, NUTR RES, V26, P604, DOI 10.1016/j.nutres.2006.09.014
   de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Gahreman D, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080510
   Quinhoneiro DCG, 2018, INT J FOOD SCI NUTR, V69, P995, DOI 10.1080/09637486.2018.1442819
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2016, COCHRANE DB SYST REV, V10, P29
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hosseini Z, 2020, J OBES METAB SYNDR, V29, P313, DOI 10.7570/jomes20023
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Lin Y, 2020, PHYTOTHER RES, V34, P2459, DOI 10.1002/ptr.6697
   Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Moher D, 2003, Health Technol Assess, V7, P1
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2700]
   Onakpoya I, 2014, NUTR METAB CARDIOVAS, V24, P823, DOI 10.1016/j.numecd.2014.01.016
   Oppert JM, 2021, OBES REV, V22, DOI 10.1111/obr.13273
   Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Ríos-Hoyo A, 2016, CURR OBES REP, V5, P262, DOI 10.1007/s13679-016-0214-y
   Roberts JD, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030764
   Ryan AS, 2004, DIABETES CARE, V27, P1699, DOI 10.2337/diacare.27.7.1699
   Touli M. Hematinezhad, 2022, Archives of Razi Institute, V77, P2115, DOI 10.22092/ARI.2022.357847.2109
   Wadden TA, 2020, AM PSYCHOL, V75, P235, DOI 10.1037/amp0000517
   Wang XQ, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2624-3
   Watanabe M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092873
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   WING RR, 1992, AM J CLIN NUTR, V55, P1086, DOI 10.1093/ajcn/55.6.1086
   Zammit C, 2010, INT J GEN MED, V3, P335, DOI 10.2147/IJGM.S11926
   Zhang TF, 2020, AN ACAD BRAS CIENC, V92, DOI 10.1590/0001-3765202020191594
   Zhang Y, 2012, J FUNCT FOODS, V4, P315, DOI 10.1016/j.jff.2011.12.010
NR 50
TC 0
Z9 0
U1 6
U2 9
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
EI 1550-2783
J9 J INT SOC SPORT NUTR
JI J. Int. Soc. Sport Nutr.
PD DEC 31
PY 2024
VL 21
IS 1
AR 2411029
DI 10.1080/15502783.2024.2411029
PG 14
WC Nutrition & Dietetics; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Sport Sciences
GA H5X6U
UT WOS:001324173200001
PM 39350601
OA gold
DA 2025-04-28
ER

PT J
AU Dray, C
   Daviaud, D
   Guigne, C
   Valet, P
   Castan-Laurell, I
AF Dray, C.
   Daviaud, D.
   Guigne, C.
   Valet, P.
   Castan-Laurell, I.
TI Caffeine reduces TNFα up-regulation in human adipose tissue primary
   culture
SO JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE adipocytes; stroma vascular fraction; primary culture; IL-6; TNF alpha;
   gene expression
ID TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; OBESITY; EXPRESSION;
   INFLAMMATION; ACTIVATION; INDUCTION; RELEASE
AB Adipose tissue secretions play an important role in the development of obesity-related pathologies such as diabetes. Through inflammatory cytokines production, adipose tissue stromavascular fraction cells (SVF), and essentially macrophages, promote adipocyte insulin resistance by a paracrine way. Since xanthine family compounds such as caffeine were shown to decrease inflammatory production by human blood cells, we investigated the possible effect of caffeine on Tumor Necrosis Factor alpha (TNF alpha) and Interleukin-6 (IL-6) expression by human adipose tissue primary culture. For that purpose, human subcutaneous adipose tissue obtained from healthy non-obese women (BMI: 26.7 +/- 2.2 kg/m(2)) after abdominal dermolipectomy, was split into explants and cultured for 6 hours with or without caffeine. Three different concentrations of caffeine were tested (0.5 mu g/mL, 5 mu g/mL and 50 mu g/mL). After 6 hours of treatment, explants were subjected to collagenase digestion in order to isolate adipocytes and SVF cells. Then, TNF alpha and IL-6 mRNA were analysed by real-time PCR alternatively in adipocytes and SVF cells. In parallel, we checked gene expression of markers involved in adipocyte differenciation and in SVF cells inflammation and proliferation. Our findings show a strong and dose dependent down-regulation of TNF-alpha gene expression in both adipocyte and SVF cells whereas IL-6 was only down regulated in SVF cells. No effect of caffeine was noticed on the other genes studied. Thus, caffeine, by decreasing TNF alpha expression, could improve adipose tissue inflammation during obesity.
C1 [Dray, C.; Daviaud, D.; Guigne, C.; Valet, P.; Castan-Laurell, I.] INSERM, U858, Toulouse, France.
   [Dray, C.; Daviaud, D.; Guigne, C.; Valet, P.; Castan-Laurell, I.] Univ Toulouse 3, Inst Med Mol Rangueil, Equipe N 3, IFR 31, F-31062 Toulouse, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm); CHU
   de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul
   Sabatier
RP Dray, C (corresponding author), INSERM, U858, Toulouse, France.
EM draycedr@toulouse.inserm.fr
RI dray, cedric/N-7440-2017; Valet, Philippe/N-7472-2017
OI Valet, Philippe/0000-0001-6520-7393; Castan-Laurell,
   Isabelle/0000-0002-0488-9789; DRAY, Cedric/0000-0002-4712-791X
CR Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084
   Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110
   Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907
   Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013
   Fève B, 2006, CR BIOL, V329, P587, DOI 10.1016/j.crvi.2006.03.020
   Gesta S, 2003, HORM METAB RES, V35, P158, DOI 10.1055/s-2003-39070
   GHEZZI P, 1991, CYTOKINE, V3, P189, DOI 10.1016/1043-4666(91)90015-6
   Horrigan LA, 2004, INT IMMUNOPHARMACOL, V4, P1409, DOI 10.1016/j.intimp.2004.06.005
   HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854
   Hube F, 1999, HORM METAB RES, V31, P359, DOI 10.1055/s-2007-978754
   Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745
   KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899
   LELO A, 1986, CLIN PHARMACOL THER, V39, P54, DOI 10.1038/clpt.1986.10
   Lim YC, 1997, BIOCHEM SOC T, V25, pS231, DOI 10.1042/bst025231s
   Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s
   Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881
   Qi C, 2000, P SOC EXP BIOL MED, V223, P128, DOI 10.1046/j.1525-1373.2000.22318.x
   SCANNELL G, 1993, J SURG RES, V54, P281, DOI 10.1006/jsre.1993.1044
   Schreyer SA, 1998, J CLIN INVEST, V102, P402, DOI 10.1172/JCI2849
   SEMMLER J, 1993, IMMUNOLOGY, V78, P520
   Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273
   Taylor CT, 1999, J BIOL CHEM, V274, P19447, DOI 10.1074/jbc.274.27.19447
   Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033
NR 25
TC 13
Z9 16
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1138-7548
EI 1877-8755
J9 J PHYSIOL BIOCHEM
JI J. Physiol. Biochem.
PD DEC
PY 2007
VL 63
IS 4
BP 329
EP 336
DI 10.1007/BF03165764
PG 8
WC Biochemistry & Molecular Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Physiology
GA 279JG
UT WOS:000254350900005
PM 18457008
DA 2025-04-28
ER

PT J
AU Yang, Z
   Zhu, MZ
   Zhang, YB
   Wen, BB
   An, HM
   Ou, XC
   Xiong, YF
   Lin, HY
   Liu, ZH
   Huang, JA
AF Yang, Zhe
   Zhu, Ming-zhi
   Zhang, Yang-bo
   Wen, Bei-bei
   An, Hui-min
   Ou, Xing-chang
   Xiong, Yi-fan
   Lin, Hai-yan
   Liu, Zhong-hua
   Huang, Jian-an
TI Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in
   low dose ameliorates obesity and nonalcoholic fatty liver disease in
   obese rats
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE caffeine; EGCG; epigallocatechin-3-gallate; green tea; nonalcoholic
   fatty liver disease; obesity
ID GREEN TEA; OXIDATIVE STRESS; MECHANISMS
AB Epigallocatechin-3-gallate (EGCG) and caffeine in tea exert anti-obesity effects and induces nonalcoholic fatty liver disease (NAFLD) amelioration. However, previous studies usually performed a high-dose EGCG administration, whereas the insecurity was arisen in recent researches. In this study, we treated obese rats with an elaborate dose40mg/kg EGCG, 20mg/kg caffeine, and the coadministration of them as low dose, which were similar to the daily intake; 160mg/kg EGCG as high dose, which was the maximum safe dose had touched the contentious edge. The results suggested that the coadministration of EGCG and caffeine exerted more remarkable function on suppressing body weight gain, reducing white adipose tissue weight and decreasing the energy intake than single use. This may be due to the variation in serum lipid profile, oxidative stress, and adipose-derived and inflammatory cytokines. The pathological micrographs showed long-term high-fat diets caused severe NAFLD, but it was ameliorated at different levels by all of the administrations. In summary, low dose of EGCG or caffeine only showed a mild effect of anti-obesity and NAFLD amelioration. The coadministration of them could exert a superior curative effect as well as high dose EGCG but no anxiety regarding safety.
C1 [Yang, Zhe; Zhu, Ming-zhi; Wen, Bei-bei; Ou, Xing-chang; Liu, Zhong-hua] Hunan Agr Univ, Natl Res Ctr Engn Technol Utilizat Funct Ingredie, Changsha, Hunan, Peoples R China.
   [Yang, Zhe; Zhang, Yang-bo; An, Hui-min; Xiong, Yi-fan; Lin, Hai-yan; Liu, Zhong-hua] Hunan Agr Univ, Collaborat Innovat Ctr Utilizat Funct Ingredients, Changsha, Hunan, Peoples R China.
   [Yang, Zhe; Xiong, Yi-fan; Liu, Zhong-hua; Huang, Jian-an] Hunan Agr Univ, Minist Educ, Key Lab Tea Sci, Changsha, Hunan, Peoples R China.
C3 Hunan Agricultural University; Hunan Agricultural University; Hunan
   Agricultural University
RP Liu, ZH (corresponding author), Hunan Agr Univ, Natl Res Ctr Engn Technol Utilizat Funct Ingredie, Dept Hort & Landscape, 1 Nongda Rd, Changsha 410128, Hunan, Peoples R China.
EM larkin-liu@163.com
RI Zeng, Yuanyuan/HQZ-1799-2023; zhu, mingzhi/LQK-1671-2024; Xiong,
   Yifan/GSD-4318-2022
OI Yang, Zhe/0000-0003-3209-5895; Zhu, Mingzhi/0000-0003-2694-6278
FU China Postdoctoral Science Foundation [2018 M632962]; Ministry of
   Agriculture and Rural Affairs of the People's Republic of China
   [CARS-19]; Ministry of Science and Technology of the People's Republic
   of China [2017YFD0400803]
FX China Postdoctoral Science Foundation, Grant/Award Number: 2018 M632962;
   Ministry of Agriculture and Rural Affairs of the People's Republic of
   China, Grant/Award Number: CARS-19; Ministry of Science and Technology
   of the People's Republic of China, Grant/Award Number: 2017YFD0400803
CR [Anonymous], 2010, J SCI FOOD AGR
   Bedrood Z., 2018, PHYTOTHER RES, V2018, P1
   Chen C., 2017, MOL NUTR FOOD RES, V62, P1
   Fulgoni VL, 2015, AM J CLIN NUTR, V101, P1081, DOI 10.3945/ajcn.113.080077
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Kang JS, 2011, PHYTOTHER RES, V25, P1789, DOI 10.1002/ptr.3476
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kopec KL, 2011, NUTR CLIN PRACT, V26, P565, DOI 10.1177/0884533611419668
   Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020
   Mansour-Ghanaei F., 2018, PHYTOTHER RES, V2018, P1
   Pan MH, 2014, MOL NUTR FOOD RES, V58, P147, DOI 10.1002/mnfr.201300522
   Peluso I, 2017, BRIT J PHARMACOL, V174, P1195, DOI 10.1111/bph.13649
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369
   Sugiura C, 2012, J OBES, V2012, DOI 10.1155/2012/520510
   Suzuki T, 2016, MOLECULES, V21, DOI 10.3390/molecules21101305
   Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205
   Vermaak I, 2011, NAT PROD REP, V28, P1493, DOI 10.1039/c1np00035g
   Wang D., 2017, PHARMACOL THERAPEUT, V184, P42, DOI DOI 10.1016/J.PHARMTHERA
   Wei W., 2010, Experimental methodology of pharmacology, V4th ed
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717
   Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361
NR 27
TC 45
Z9 47
U1 4
U2 80
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD APR
PY 2019
VL 33
IS 4
BP 1019
EP 1026
DI 10.1002/ptr.6295
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA HW7XM
UT WOS:000466903300017
PM 30746789
DA 2025-04-28
ER

PT J
AU Park, HS
   Shim, SM
AF Park, Hee-Sook
   Shim, Soon-Mi
TI Preventive responses to a standardized extract of Houttuynia
   cordata supplemented diet in obesity induced by a high-fat diet in
   mice
SO JOURNAL OF THE KOREAN SOCIETY FOR APPLIED BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Adipocyte; High-fat diet; Liver injury; Standardized extract of
   Houttuynia cordata
ID LIPID-ACCUMULATION; CHLOROGENIC ACID; LIVER-INJURY; LIPOTOXICITY;
   INHIBITION; FLAVONOIDS; COMPONENTS; DISEASES
AB The current study investigated preventive responses to Houttuynia cordata (HC) standardized extract in obesity induced by a high-fat diet (HFD) in mice. High-performance liquid chromatography was carried out to analyze bioactive components in HC. Mice were divided into HFD groups as a control and HFD groups fed with 1 and 4 % of HC supplementation diet. Changes of the body weight of mice, blood biological factors, and histopathological markers were measured. Bioactive components from HC were characterized to contain chlorogenic acid, caffeic acid, rutin, and quercitrin. HC supplementation reduced body weight, glucose, and total cholesterol levels, but it did not affect aspartic acid transaminase, alanine transaminase, or triglyceride amounts in plasma from mice induced by HFD. A 4 % HC supplementation showed a remarkable decrease in the number of large adipocyte in subcutaneous and abdominal adipose tissue. Histopathological evaluation of liver injury induced by HFD was observed to be improved by HC supplementation, leading to attenuated levels of cytoplasmic vacuolation of hepatocytes. From these results, we explored that standardized extract of HC could be a potential natural product to be directly associated with the control of weight.
C1 [Park, Hee-Sook] Korea Food Res Inst, Res Grp Nutraceut Metab Syndrome, Seoul 463736, Gyeonggi Do, South Korea.
   [Park, Hee-Sook; Shim, Soon-Mi] Sejong Univ, Dept Food Sci & Technol, Seoul 143747, South Korea.
C3 Korea Food Research Institute (KFRI); Sejong University
RP Shim, SM (corresponding author), Sejong Univ, Dept Food Sci & Technol, 98 Gunja Dong, Seoul 143747, South Korea.
EM soonmishim@sejong.ac.kr
FU Natl. Research Foundation of Korea (NRF) - Korea government Ministry of
   Education, Science, Technology [2014R1A2A2A01007627]
FX This work was supported by the Natl. Research Foundation of Korea (NRF)
   grant funded by the Korea government Ministry of Education, Science,
   Technology (No. 2014R1A2A2A01007627).
CR Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755
   Aronne Louis J, 2007, Clin Cornerstone, V8, P29, DOI 10.1016/S1098-3597(07)80026-3
   Chen YY, 2003, J NUTR SCI VITAMINOL, V49, P327, DOI 10.3177/jnsv.49.327
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Chou SC, 2009, CHEM PHARM BULL, V57, P1227, DOI 10.1248/cpb.57.1227
   Han EH, 2009, FOOD CHEM TOXICOL, V47, P1659, DOI 10.1016/j.fct.2009.04.025
   HAYASHI K, 1995, PLANTA MED, V61, P237, DOI 10.1055/s-2006-958063
   Hsu CL, 2008, MOL NUTR FOOD RES, V52, P53, DOI [10.1002/mnfr.200890019, 10.1002/mnfr.200700393]
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Jang SY, 2011, NAT PROD RES, V25, P222, DOI 10.1080/14786410903339044
   Ji LL, 2013, J NUTR BIOCHEM, V24, P1911, DOI 10.1016/j.jnutbio.2013.05.007
   Kim SK, 2001, ARCH PHARM RES, V24, P518, DOI 10.1007/BF02975156
   Koriem KMM, 2014, J TOXICOL-US, V2014, DOI 10.1155/2014/583494
   Kusirisin W, 2009, MED CHEM, V5, P139, DOI 10.2174/157340609787582918
   Lin MC, 2013, FOOD FUNCT, V4, P322, DOI 10.1039/c2fo30228d
   Lu HM, 2006, CHEM PHARM BULL, V54, P936, DOI 10.1248/cpb.54.936
   Meng J, 2005, CHEM PHARM BULL, V53, P1604, DOI 10.1248/cpb.53.1604
   Meng J, 2009, FITOTERAPIA, V80, P468, DOI 10.1016/j.fitote.2009.06.013
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Negi AS, 2008, MED RES REV, V28, P746, DOI 10.1002/med.20115
   Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590
   Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006
   van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049
   Xu CJ, 2005, TALANTA, V68, P108, DOI 10.1016/j.talanta.2005.04.043
   Xu DM, 2014, ENVIRON TOXICOL PHAR, V37, P1212, DOI 10.1016/j.etap.2014.04.022
   Xu XQ, 2006, TALANTA, V68, P759, DOI 10.1016/j.talanta.2005.05.027
   Xu YX, 2010, INFLAMM RES, V59, P871, DOI 10.1007/s00011-010-0199-z
   Yang UJ, 2014, J KOREAN SOC APPL BI, V57, P161, DOI 10.1007/s13765-013-4187-1
   Zhang Lan-tao, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P281, DOI 10.3881/j.issn.1000-503X.2011.03.015
NR 31
TC 1
Z9 1
U1 0
U2 28
PU KOREAN SOC  APPLIED BIOLOGICAL CHEMISTRY
PI KANGNAM-GU
PA RM 803,  KOREA SCIENCE & TECHNOLOGY CENTER, 635-4 YEOGSAM-DONG,
   KANGNAM-GU, SEOUL 135-703, SOUTH KOREA
SN 1738-2203
EI 2234-344X
J9 J KOREAN SOC APPL BI
JI J. Korean Soc. Appl. Biol. Chem.
PD OCT
PY 2015
VL 58
IS 5
BP 643
EP 649
DI 10.1007/s13765-015-0087-x
PG 7
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA CQ1QT
UT WOS:000360374100003
OA Bronze
DA 2025-04-28
ER

PT J
AU Liu, LT
   Sayama, K
AF Liu, Litong
   Sayama, Kazutoshi
TI The combined administration of EGCG and caffeine induces not only
   suppression of fat accumulation but also anorexigenic action in mice
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE EGCG; Caffeine; Anorexigenic action; Anti-obesity
ID GLUCAGON-LIKE PEPTIDE-1; BLOOD-BRAIN-BARRIER; GREEN TEA; METABOLIC
   SYNDROME; LIPID-METABOLISM; GUT HORMONES; BODY-WEIGHT; OBESITY; LEPTIN;
   (-)-EPIGALLOCATECHIN-3-GALLATE
AB To elucidate the anorexigenic action and inhibitory effect of fat accumulation by epigallocatechin gallate (EGCG) and caffeine, including the optimal combination ratio and mechanism, fifteen diets with several concentrations of EGCG and/or caffeine were administered to mice for eight weeks. The 0.1% EGCG + 0.1% caffeine group showed the strongest suppression of food intake and a remarkable reduction of body weight and fat accumulation; therefore, the ratio was determined to be the optimal combination ratio. Moreover, serum glucagon-like peptide-1 (GLP-1) level and hypothalamic gene expression of pro-opiomelanocortin (POMC) were promoted by 0.1% EGCG + 0.1% caffeine. In conclusion, the combined treatment of 0.1% EGCG + 0.1% caffeine induces not only suppression of fat accumulation but also strong anorexigenic action in mice. The anorexigenic effect may be brought about via inhibiting gastric motility by GLP-1 and upregulating POMC in the hypothalamus.
C1 [Liu, Litong; Sayama, Kazutoshi] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.
   [Sayama, Kazutoshi] Shizuoka Univ, Acad Inst, Coll Agr, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.
C3 Shizuoka University; Shizuoka University
RP Sayama, K (corresponding author), Shizuoka Univ, Acad Inst, Coll Agr, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.
EM sayama.kazutoshi@shizuoka.ac.jp
CR Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7
   Banks WA, 1997, PEPTIDES, V18, P1257, DOI 10.1016/S0196-9781(97)00198-8
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Clément K, 1998, NATURE, V392, P398, DOI 10.1038/32911
   de Lartigue G, 2014, MOL METAB, V3, P595, DOI 10.1016/j.molmet.2014.06.003
   De Silva A, 2012, GUT LIVER, V6, P10, DOI 10.5009/gnl.2012.6.1.10
   Druce M, 2006, ARCH DIS CHILD, V91, P183, DOI 10.1136/adc.2005.073759
   Duan J, 2007, OBESITY, V15, P2624, DOI 10.1038/oby.2007.314
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3
   FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gray SP, 2017, DIABETOLOGIA, V60, P927, DOI 10.1007/s00125-017-4215-5
   Hainerova IA, 2010, J PEDIATR GASTR NUTR, V51, pS123, DOI 10.1097/MPG.0b013e3181f84208
   Halim M. A., 2017, J CLIN ENDOCRINOLOGY, V103, P575, DOI [10.1210/jc.2017-0206, DOI 10.1210/JC.2017-0206]
   Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kavanagh KT, 2001, J CELL BIOCHEM, V82, P387, DOI 10.1002/jcb.1164
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   MCCALL AL, 1982, LIFE SCI, V31, P2709, DOI 10.1016/0024-3205(82)90715-9
   Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185
   Nakagawa K, 1997, J NUTR SCI VITAMINOL, V43, P679, DOI 10.3177/jnsv.43.679
   Razzoli M, 2017, NEUROSCI BIOBEHAV R, V76, P154, DOI 10.1016/j.neubiorev.2017.01.026
   Sayama K, 2000, IN VIVO, V14, P481
   Song WY, 2015, J CLIN BIOCHEM NUTR, V57, P164, DOI 10.3164/jcbn.15-50
   Sueoka N, 2001, ANN NY ACAD SCI, V928, P274
   Weber JM, 2003, ANTIVIR RES, V58, P167, DOI 10.1016/S0166-3542(02)00212-7
   Weinreb O, 2004, J NUTR BIOCHEM, V15, P506, DOI 10.1016/j.jnutbio.2004.05.002
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
   Wettergren A, 1998, AM J PHYSIOL-GASTR L, V275, pG984, DOI 10.1152/ajpgi.1998.275.5.G984
   ZAK B, 1957, AM J CLIN PATHOL, V27, P583, DOI 10.1093/ajcp/27.5_ts.583
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zheng GD, 2004, IN VIVO, V18, P55
NR 36
TC 14
Z9 16
U1 2
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD AUG
PY 2018
VL 47
BP 156
EP 162
DI 10.1016/j.jff.2018.05.030
PG 7
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA GN4RH
UT WOS:000439019200018
DA 2025-04-28
ER

PT J
AU Pan, MH
   Tung, YC
   Yang, GL
   Li, SM
   Ho, CT
AF Pan, Min-Hsiung
   Tung, Yen-Chen
   Yang, Guliang
   Li, Shiming
   Ho, Chi-Tang
TI Molecular mechanisms of the anti-obesity effect of bioactive compounds
   in tea and coffee
SO FOOD & FUNCTION
LA English
DT Review
ID PU-ERH TEA; GREEN TEA; BODY-WEIGHT; ADIPOSE-TISSUE; GUT MICROBIOTA;
   BLACK TEA; ADIPOCYTE DIFFERENTIATION; PHENOLIC-COMPOUNDS;
   GLUCOSE-TOLERANCE; PHYSICAL-ACTIVITY
AB Obesity is a serious health problem in adults and children worldwide. However, the basic strategies for the management of obesity (diet, exercise, drugs and surgery) have limitations and side effects. Therefore, many researchers have sought to identify bioactive components in food. Tea and coffee are the most frequently consumed beverages in the whole world. Their health benefits have been studied for decades, especially those of green tea. The anti-obesity effect of tea and coffee has been studied for at least ten years. The results have shown decreased lipid accumulation in cells via the regulation of the cell cycle during adipogenesis, changes in transcription factors and lipogenesis-related proteins in the adipose tissue of animal models, and decreased body weight and visceral fat in humans. Tea and coffee also influence the gut microbiota in obese animals and humans. Although the anti-obesity mechanism of tea and coffee still needs further clarification, they may have potential as a new strategy to prevent or treat obesity.
C1 [Pan, Min-Hsiung; Yang, Guliang; Li, Shiming] Huanggang Normal Univ, Hubei Collaborat Innovat Ctr the Characterist Res, AHubei Key Lab Econ Forest Germplasm Improvement, Huanggang, Hubei, Peoples R China.
   [Pan, Min-Hsiung; Tung, Yen-Chen] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan.
   [Pan, Min-Hsiung] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan.
   [Pan, Min-Hsiung] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.
   [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.
C3 Huanggang Normal University; National Taiwan University; China Medical
   University Taiwan; China Medical University Hospital - Taiwan; Asia
   University Taiwan; Rutgers University System; Rutgers University New
   Brunswick
RP Pan, MH (corresponding author), Huanggang Normal Univ, Hubei Collaborat Innovat Ctr the Characterist Res, AHubei Key Lab Econ Forest Germplasm Improvement, Huanggang, Hubei, Peoples R China.; Pan, MH; Tung, YC (corresponding author), Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan.; Pan, MH (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan.; Pan, MH (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.
EM mhpan@ntu.edu.tw; emjine@gmail.com
RI Li, Shiming/CAG-2335-2022; Tung, Yen-Chen/K-4460-2019; Ho,
   Chi-Tang/B-5629-2012; Pan, Min-Hsiung/AAT-8865-2021
OI Pan, Min-Hsiung/0000-0002-5188-7030
CR Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   [Anonymous], 2014, Economic Research Service: Dataset on International Agricultural Productivity
   Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105
   Baothman OA, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0278-4
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bjorndal B, 2011, J OBES, V2011, DOI 10.1155/2011/490650
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Caesar R, 2008, J LIPID RES, V49, P1588, DOI 10.1194/jlr.D800013-JLR200
   Cao ZH, 2013, PHYTOTHER RES, V27, P1193, DOI 10.1002/ptr.4831
   Cao ZH, 2011, PHYTOTHER RES, V25, P234, DOI 10.1002/ptr.3247
   Chan CY, 2011, LIFE SCI, V89, P779, DOI 10.1016/j.lfs.2011.09.006
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156
   DESALVO KB, 2016, JAMA-J AM MED ASSOC, V315, P457, DOI [DOI 10.1001/JAMA.2015.18396, 10.1001/jama.2015.18396]
   Dou JP, 2007, J AGR FOOD CHEM, V55, P7462, DOI 10.1021/jf0718603
   Esquivel P, 2012, FOOD RES INT, V46, P488, DOI 10.1016/j.foodres.2011.05.028
   Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001
   Ferruzzi MG, 2010, PHYSIOL BEHAV, V100, P33, DOI 10.1016/j.physbeh.2010.01.035
   French S, 2003, CURR OPIN CLIN NUTR, V6, P629, DOI 10.1097/00075197-200311000-00004
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Ghibaudi L, 2002, OBES RES, V10, P956, DOI 10.1038/oby.2002.130
   GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0
   Harrold JA, 2000, J NEUROCHEM, V74, P1224
   Haslam E, 2003, PHYTOCHEMISTRY, V64, P61, DOI 10.1016/S0031-9422(03)00355-8
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Horton JD, 2003, J BIOL CHEM, V278, P36652, DOI 10.1074/jbc.M306540200
   Huang YW, 2009, J FUNCT FOODS, V1, P304, DOI 10.1016/j.jff.2009.06.002
   Ito Y, 2008, BIOMED RES-TOKYO, V29, P27, DOI 10.2220/biomedres.29.27
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Jeong JY, 2015, CELL TISSUE RES, V362, P87, DOI 10.1007/s00441-015-2191-y
   Jeong JY, 2015, CELL BIOL INT, V39, P52, DOI 10.1002/cbin.10343
   Jéquier E, 2002, INT J OBESITY, V26, pS12, DOI 10.1038/sj.ijo.0802123
   Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Karagozian R, 2014, METABOLISM, V63, P607, DOI 10.1016/j.metabol.2014.01.011
   Kemperman RA, 2013, FOOD RES INT, V53, P659, DOI 10.1016/j.foodres.2013.01.034
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kopelman PG, 2004, GUT, V53, P1044, DOI 10.1136/gut.2003.021816
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kromhout D, 2016, EUR J CLIN NUTR, V70, P869, DOI 10.1038/ejcn.2016.52
   Kruger J, 2004, AM J PREV MED, V26, P402, DOI 10.1016/j.ampere.2004.02.001
   Kubot K, 2011, NUTR RES, V31, P421, DOI 10.1016/j.nutres.2011.05.004
   Lai CS, 2015, CURR OPIN FOOD SCI, V2, P9, DOI 10.1016/j.cofs.2014.11.008
   Lao WG, 2015, AM J CHINESE MED, V43, P1177, DOI 10.1142/S0192415X15500676
   Lee H, 2013, J NUTR BIOCHEM, V24, P1232, DOI 10.1016/j.jnutbio.2012.09.007
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Lin J, 2005, OBES RES, V13, P982, DOI 10.1038/oby.2005.115
   Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Monteiro R, 2008, J NUTR, V138, P2156, DOI 10.1093/jn/138.11.2156
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x
   Ogden CL, 2015, NCHS DATA BRIEF, P1, DOI DOI 10.1017/S1368980017000088
   Oi Y, 2012, PHYTOTHER RES, V26, P475, DOI 10.1002/ptr.3602
   OSullivan M. G., 2016, Encyclopedia of Food and Health, P571
   Park B, 2016, ARCH PHARM RES, V39, P310, DOI 10.1007/s12272-015-0674-8
   Portune KJ, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600252
   Preedy V.R., 2014, Coffee in Health and Disease
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x
   Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417
   Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643
   Schrauwen P, 2000, BRIT J NUTR, V84, P417, DOI 10.1017/S0007114500001720
   Seo DB, 2015, J MED FOOD, V18, P549, DOI 10.1089/jmf.2014.3265
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Stern J S, 1995, Obes Res, V3, P591
   Symonds M.E., 2011, Adipose tissue biology
   Takahashi M, 1999, J NUTR SCI VITAMINOL, V45, P583, DOI 10.3177/jnsv.45.583
   Tanaka T., 2005, ACS SYM SER, V99, P188
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tian C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053796
   Trigueros L, 2013, CRIT REV FOOD SCI, V53, P929, DOI 10.1080/10408398.2011.574215
   Tsai CH, 2009, INT J FOOD SCI NUTR, V60, P151, DOI 10.1080/09637480903136667
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Vermaak I, 2011, NAT PROD REP, V28, P1493, DOI 10.1039/c1np00035g
   Wang HY, 2011, FOOD CHEM, V128, P573, DOI 10.1016/j.foodchem.2011.03.075
   Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c
   WEERAWATANAKORN M., 2015, Food Science and Human Wellness, V4, P133, DOI [10.1016/J.FSHW.2015.10.002, DOI 10.1016/J.FSHW.2015.10.002, 10.1016/j.fshw.2015.10.002]
   Westerterp-Plantenga MS, 1998, INT J OBESITY, V22, P1, DOI 10.1038/sj.ijo.0800536
   WILLIAMSON DF, 1993, INT J OBESITY, V17, P279
   World Health Organization, Obesity and overweight
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Yamashita Y, 2014, FOOD FUNCT, V5, P2420, DOI [10.1039/c4fo00095a, 10.1039/C4FO00095A]
   Yan JQ, 2013, SCI CHINA LIFE SCI, V56, P804, DOI 10.1007/s11427-013-4512-2
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang Y, 2015, FITOTERAPIA, V104, P45, DOI 10.1016/j.fitote.2015.05.007
   Zalesin KC, 2011, MED CLIN N AM, V95, P919, DOI 10.1016/j.mcna.2011.06.005
   Zhang X, 2014, J AGR FOOD CHEM, V62, P10046, DOI 10.1021/jf5016335
   Zhang Y, 2012, J FUNCT FOODS, V4, P315, DOI 10.1016/j.jff.2011.12.010
   Zheng GD, 2004, IN VIVO, V18, P55
NR 104
TC 84
Z9 85
U1 4
U2 100
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PY 2016
VL 7
IS 11
BP 4481
EP 4491
DI 10.1039/c6fo01168c
PG 11
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA EC8AT
UT WOS:000388363000001
PM 27722362
DA 2025-04-28
ER

PT J
AU Rebollo-Hernanz, M
   Aguilera, Y
   Gil-Ramirez, A
   Benítez, V
   Cañas, S
   Braojos, C
   Martin-Cabrejas, MA
AF Rebollo-Hernanz, Miguel
   Aguilera, Yolanda
   Gil-Ramirez, Alicia
   Benitez, Vanesa
   Canas, Silvia
   Braojos, Cheyenne
   Martin-Cabrejas, Maria A.
TI Biorefinery and Stepwise Strategies for Valorizing Coffee By-Products as
   Bioactive Food Ingredients and Nutraceuticals
SO APPLIED SCIENCES-BASEL
LA English
DT Review
DE bioactive compounds; biorefinery; coffee by-products; functional food
   ingredients; health benefits; nutraceuticals; sustainability;
   technological innovation; valorization; waste utilization
ID STATISTICAL OPTIMIZATION; PLEUROTUS-OSTREATUS; SILVERSKIN EXTRACT;
   PHENOLIC-COMPOUNDS; ASPERGILLUS-NIGER; FUNCTIONAL FOODS; ACID
   PRODUCTION; IN-VITRO; PULP; WASTE
AB Featured Application This study presents a comprehensive and stepwise strategy for utilizing coffee by-products as a sustainable source to develop bioactive food ingredients and nutraceuticals. Coffee by-products can be transformed into versatile functional food ingredients and nutraceuticals by implementing green extraction techniques and employing a biorefinery approach. These products offer a wide range of benefits, including antioxidant, anti-inflammatory, and anti-obesity effects, as well as the potential to regulate energy metabolism and blood sugar levels and serve as adjunct therapies for conditions such as cardiovascular disease, diabetes, and neurodegenerative disorders. This research not only contributes to the creation of functional food products and supplements but also promotes sustainability and addresses the prevention and management of chronic diseases. Coffee production generates significant amounts of by-products, posing challenges for waste management in the industry. Recent research has revealed that coffee by-products are rich in bioactive compounds suitable to produce functional food ingredients and nutraceuticals. In this review, we explore biorefinery strategies for extracting and utilizing bioactive compounds from coffee by-products, including the production of bio-based chemicals and materials, as well as the extraction of phenolic compounds, antioxidants, and dietary fiber for food applications. We propose a stepwise approach for the development of functional food ingredients and nutraceuticals from coffee by-products, covering the identification of needs, comprehensive characterization, in vitro and in vivo research, unraveling the mechanism of action, food and nutraceutical formulation, sensory analysis, shelf-life stability, scale-up, randomized control trials, and biostatistics and bioinformatic integration. Additionally, we discuss the market potential, regulatory issues, and technological innovation surrounding the commercialization of coffee by-product-based products. Emphasizing the importance of regulatory compliance and sustainability in the coffee industry, this review highlights the potential of coffee by-products to be transformed from waste into valuable functional food ingredients and nutraceuticals, offering a promising avenue for waste reduction and promoting sustainability in the coffee industry.
C1 [Rebollo-Hernanz, Miguel; Aguilera, Yolanda; Gil-Ramirez, Alicia; Benitez, Vanesa; Canas, Silvia; Braojos, Cheyenne; Martin-Cabrejas, Maria A.] Univ Autonoma Madrid, Fac Sci, Dept Agr Chem & Food Sci, C Francisco Tomas & Valiente 7, Madrid 28049, Spain.
   [Rebollo-Hernanz, Miguel; Aguilera, Yolanda; Gil-Ramirez, Alicia; Benitez, Vanesa; Canas, Silvia; Braojos, Cheyenne; Martin-Cabrejas, Maria A.] Univ Autonoma Madrid, Inst Food Sci Res CIAL, UAM CSIC, C Nicolas Cabrera 9, Madrid 28049, Spain.
C3 Autonomous University of Madrid; Autonomous University of Madrid;
   Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM -
   Instituto de Investigacion en Ciencias de la Alimentacion (CIAL)
RP Martin-Cabrejas, MA (corresponding author), Univ Autonoma Madrid, Fac Sci, Dept Agr Chem & Food Sci, C Francisco Tomas & Valiente 7, Madrid 28049, Spain.; Martin-Cabrejas, MA (corresponding author), Univ Autonoma Madrid, Inst Food Sci Res CIAL, UAM CSIC, C Nicolas Cabrera 9, Madrid 28049, Spain.
EM miguel.rebollo@uam.es; yolanda.aguilera@uam.es; alicia.gil@uam.es;
   vanesa.benitez@uam.es; silvia.cannas@uam.es; cheyenne.braojos@uam.es;
   maria.martin@uam.es
RI Rebollo-Hernanz, Miguel/S-6539-2019; Cañas, Silvia/AAC-8641-2019; Gil
   Ramirez, Alicia/AEX-7577-2022; Gil Ramirez, Alicia/R-8597-2018; Benitez,
   Vanesa/B-5858-2012; aguilera, yolanda/B-6021-2012; martin-cabrejas,
   maria/L-6433-2014
OI Gil Ramirez, Alicia/0000-0001-5815-8239; Rebollo-Hernanz,
   Miguel/0000-0003-1034-1290; Braojos Molero de Avila,
   Cheyenne/0000-0001-5736-4524; Benitez, Vanesa/0000-0001-7517-9752;
   aguilera, yolanda/0000-0002-8724-6796; martin-cabrejas,
   maria/0000-0001-9834-639X; Canas, Silvia/0000-0001-9766-0440
FU Spanish Ministry of Science and Innovation [RTI 2018-097504-B-I00,
   TED2021-129262A-I00]; Community of Madrid; FPU program of the Ministry
   of Universities [FPU15/04238]; Spanish university system
   [CA1/RSUE/2021-00656]; UAM
FX This research was funded by the COCARDIOLAC (RTI 2018-097504-B-I00) and
   ECOPULP (TED2021-129262A-I00) projects from the Spanish Ministry of
   Science and Innovation and the Excellence Line for University Teaching
   Staff within the Multiannual Agreement between the Community of Madrid
   and the UAM (2019-2023). M. Rebollo-Hernanz received funding from the
   FPU program of the Ministry of Universities for his predoctoral
   fellowship (FPU15/04238) and a grant for the requalification of the
   Spanish university system (CA1/RSUE/2021-00656).
CR Acosta-Fernández R, 2020, IND ENG CHEM RES, V59, P7346, DOI 10.1021/acs.iecr.9b06429
   Afzaal M, 2022, FOOD SCI NUTR, V10, P2333, DOI 10.1002/fsn3.2842
   Aguilera Y, 2019, FOOD FUNCT, V10, P4739, DOI [10.1039/c9fo00544g, 10.1039/C9FO00544G]
   Alexandri M, 2022, FOODS, V11, DOI 10.3390/foods11182796
   Alghooneh A, 2017, INT J FOOD PROP, V20, P2830, DOI 10.1080/10942912.2016.1253097
   Alhogbi BG, 2017, SUSTAIN CHEM PHARM, V6, P21, DOI 10.1016/j.scp.2017.06.004
   Almeida AAP, 2006, J AGR FOOD CHEM, V54, P8738, DOI 10.1021/jf0617317
   Alongi M, 2021, J FUNCT FOODS, V81, DOI 10.1016/j.jff.2021.104466
   Alves RC, 2017, HANDBOOK OF COFFEE PROCESSING BY-PRODUCTS: SUSTAINABLE APPLICATIONS, P1, DOI 10.1016/B978-0-12-811290-8.00001-3
   Amran MA, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su132011432
   Anastas P, 2010, CHEM SOC REV, V39, P301, DOI 10.1039/b918763b
   Serna-Jiménez JA, 2022, PROCESSES, V10, DOI 10.3390/pr10112436
   [Anonymous], 2007, FAO REPORT FUNCTION
   [Anonymous], 2005, The Abstract Factory
   [Anonymous], 2015, Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 25897 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001, P1
   ANTIER P, 1993, BIOTECHNOL ADV, V11, P429, DOI 10.1016/0734-9750(93)90012-C
   Appaiah S., 2022, Patent, Patent No. [2022113120A1, 2022113120]
   Apuzzo J., 2018, Patent, Patent No. [WO2018/136763Al, 2018136763, 2018/136763Al]
   Aristizabal-Marulanda V., 2017, HDB COFFEE PROCESSI
   Atanasov AG, 2021, NAT REV DRUG DISCOV, V20, P200, DOI 10.1038/s41573-020-00114-z
   Ates G, 2019, J FOOD MEAS CHARACT, V13, P755, DOI 10.1007/s11694-018-9988-9
   Ates G, 2018, LWT-FOOD SCI TECHNOL, V90, P519, DOI 10.1016/j.lwt.2018.01.003
   Augustin MA, 2015, ANNU REV FOOD SCI T, V6, P463, DOI 10.1146/annurev-food-022814-015507
   Avallone S, 2000, J FOOD SCI, V65, P1308, DOI 10.1111/j.1365-2621.2000.tb10602.x
   Avallone S, 2001, J AGR FOOD CHEM, V49, P5556, DOI 10.1021/jf010510s
   babaseedcoffee, QISHR COFFEE FRUIT
   Lopes MHBDM, 2020, ARTIFICIAL INTELLIGENCE IN PRECISION HEALTH: FROM CONCEPT TO APPLICATIONS, P465, DOI 10.1016/B978-0-12-817133-2.00020-3
   Bagchi D, 2019, NUTRACEUTICAL FUNCT
   Bagchi D, 2014, FOOD SCI TECH-INT SE, P363, DOI 10.1016/B978-0-12-405870-5.00021-9
   Baiano A, 2014, MOLECULES, V19, P14821, DOI 10.3390/molecules190914821
   Balkir P, 2021, TRENDS FOOD SCI TECH, V108, P49, DOI 10.1016/j.tifs.2020.11.028
   Ballesteros LF, 2014, FOOD BIOPROCESS TECH, V7, P3493, DOI 10.1007/s11947-014-1349-z
   Bekalo SA, 2010, MATER STRUCT, V43, P1049, DOI 10.1617/s11527-009-9565-0
   Béné C, 2019, WORLD DEV, V113, P116, DOI 10.1016/j.worlddev.2018.08.011
   Benítez V, 2021, FOOD FUNCT, V12, P1097, DOI [10.1039/D0FO02295K, 10.1039/d0fo02295k]
   Benitez V, 2019, FOOD RES INT, V122, P105, DOI 10.1016/j.foodres.2019.04.002
   Benyelles M, 2024, WASTE BIOMASS VALORI, V15, P265, DOI 10.1007/s12649-023-02144-1
   Bertolino M, 2019, J SCI FOOD AGR, V99, P4267, DOI 10.1002/jsfa.9659
   Bessada S M., 2018, Cosmetics, V5, P5, DOI [DOI 10.3390/COSMETICS5010005, 10.3390/cosmetics5010005]
   Bhandarkar NS, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10111369
   Bhoite RN, 2015, FOOD BIOPROD PROCESS, V94, P727, DOI 10.1016/j.fbp.2014.10.007
   Bhoite RN, 2013, PREP BIOCHEM BIOTECH, V43, P350, DOI 10.1080/10826068.2012.737399
   Yadira PSB, 2014, ENRGY PROCED, V57, P950, DOI 10.1016/j.egypro.2014.10.077
   Bigdeloo M., 2021, Mater. Circ. Econ. 2021 31, V3, P1, DOI DOI 10.1007/S42824-021-00017-3
   Bondam AF, 2022, TRENDS FOOD SCI TECH, V123, P172, DOI 10.1016/j.tifs.2022.03.013
   Borrelli RC, 2004, J AGR FOOD CHEM, V52, P1338, DOI 10.1021/jf034974x
   Brandao AS, 2021, J CLEAN PROD, V295, DOI 10.1016/j.jclepro.2021.126407
   Bresciani L, 2014, FOOD RES INT, V61, P196, DOI 10.1016/j.foodres.2013.10.047
   Brewer MS, 2011, COMPR REV FOOD SCI F, V10, P221, DOI 10.1111/j.1541-4337.2011.00156.x
   Brown PN, 2010, FUNCT FOOD SCI TECHN, P257
   Brzezinska R, 2023, APPL SCI-BASEL, V13, DOI 10.3390/app13095388
   Bucheli P, 2000, J AGR FOOD CHEM, V48, P1358, DOI 10.1021/jf9905875
   Ca??as S., 2021, PROCEEDINGS, V70, P65, DOI [10.3390/foods_2020-07623, DOI 10.3390/FOODS_2020-07623]
   Cañas S, 2023, FOOD RES INT, V172, DOI 10.1016/j.foodres.2023.113116
   Cañas S, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11091818
   Cangussu LB, 2021, FOODS, V10, DOI 10.3390/foods10123125
   Cano ME, 2020, FERMENTATION-BASEL, V6, DOI 10.3390/fermentation6010031
   Cano-Munoz P., 2021, BIOL LIFE SCI FORUM, V6, DOI DOI 10.3390/FOODS2021-10975
   Capanoglu E, 2022, J AGR FOOD CHEM, V70, P6787, DOI 10.1021/acs.jafc.1c07104
   Carbonell-Capella JM, 2014, COMPR REV FOOD SCI F, V13, P155, DOI 10.1111/1541-4337.12049
   Carus M., 2018, Ind. Biotechnol, V14, P83, DOI [10.1089/ind.2018.29121.mca, DOI 10.1089/IND.2018.29121.MCA]
   Castaldo L, 2020, MOLECULES, V25, DOI 10.3390/molecules25092132
   Chang YT, 2021, J SCI FOOD AGR, V101, P4705, DOI 10.1002/jsfa.11116
   Chemat F, 2020, GREEN CHEM, V22, P2325, DOI [10.1039/c9gc03878g, 10.1039/C9GC03878G]
   Chemat F, 2012, INT J MOL SCI, V13, P8615, DOI 10.3390/ijms13078615
   Choi J.Y., 2022, Patent, Patent No. [102348305B1, 102348305]
   Chon K., 2023, Patent, Patent No. [20220129225A, 20220129225]
   Chopra AS, 2022, PHARMACOL RES, V175, DOI 10.1016/j.phrs.2021.106001
   Costa ASG, 2018, FOOD CHEM, V267, P28, DOI 10.1016/j.foodchem.2017.03.106
   Costa ASG, 2014, IND CROP PROD, V53, P350, DOI 10.1016/j.indcrop.2014.01.006
   D'Amato D, 2017, J CLEAN PROD, V168, P716, DOI 10.1016/j.jclepro.2017.09.053
   da Silva BV, 2016, TRENDS FOOD SCI TECH, V50, P144, DOI 10.1016/j.tifs.2015.12.007
   da Silva MR, 2022, FOOD CHEM, V369, DOI 10.1016/j.foodchem.2021.130753
   da Silva MCS, 2012, FOOD CHEM, V131, P558, DOI 10.1016/j.foodchem.2011.09.023
   Dadi D, 2019, INT J RECYCLING ORG, V8, P263, DOI 10.1007/s40093-019-0256-8
   Neto DPD, 2021, FRONT SUSTAIN, V2, DOI 10.3389/frsus.2021.697092
   De Marco I, 2018, J SUPERCRIT FLUID, V133, P393, DOI 10.1016/j.supflu.2017.11.005
   Pereira GVD, 2020, ADV FOOD NUTR RES, V91, P65, DOI 10.1016/bs.afnr.2019.10.002
   Pereira GVD, 2017, CRIT REV FOOD SCI, V57, P2775, DOI 10.1080/10408398.2015.1067759
   del Castillo Bilbao M.D., 2013, Patent No, Patent No. [WO/2013/004873, 2013004873, 2013/004873A1]
   del Castillo MD, 2019, COFFEE: PRODUCTION, QUALITY AND CHEMISTRY, P309
   del Castillo MD, 2017, HANDBOOK OF COFFEE PROCESSING BY-PRODUCTS: SUSTAINABLE APPLICATIONS, P171, DOI 10.1016/B978-0-12-811290-8.00006-2
   del Pozo C, 2021, FUEL PROCESS TECHNOL, V214, DOI 10.1016/j.fuproc.2020.106708
   del Pozo C, 2020, WASTE MANAGE, V109, P19, DOI 10.1016/j.wasman.2020.04.044
   DePaula J, 2022, FOODS, V11, DOI 10.3390/foods11193144
   Dessie W, 2018, BIOPROC BIOSYST ENG, V41, P1461, DOI 10.1007/s00449-018-1974-4
   Dima C, 2020, COMPR REV FOOD SCI F, V19, P2862, DOI 10.1111/1541-4337.12623
   Doherty A, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.768979
   Díaz LD, 2020, J FUNCT FOODS, V68, DOI 10.1016/j.jff.2020.103896
   Dong W., 2022, Thereof Patent, Patent No. [114651850A, 114651850]
   Duangjai A, 2016, INTEGR MED RES, V5, P324, DOI 10.1016/j.imr.2016.09.001
   Durán-Aranguren DD, 2021, MOLECULES, V26, DOI 10.3390/molecules26247605
   EC (European Commission), 2017, Off. J. Eur. Union, L
   EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain), 2015, EFSA Journal, V13, P321, DOI 10.2903/J.EFSA.2015.4104,4104
   El Bilali H, 2019, FOOD ENERGY SECUR, V8, DOI 10.1002/fes3.154
   Elhalis H, 2023, APPL FOOD RES, V3, DOI 10.1016/j.afres.2022.100253
   Erskine E, 2022, ACS OMEGA, V7, P1595, DOI 10.1021/acsomega.1c06085
   Espro C, 2021, CHEM SOC REV, V50, P11191, DOI 10.1039/d1cs00524c
   Esquivel P, 2012, FOOD RES INT, V46, P488, DOI 10.1016/j.foodres.2011.05.028
   Fahim IS, 2019, SUSTAIN CHEM PHARM, V12, DOI 10.1016/j.scp.2019.100142
   Fan J., 2018, Patent, Patent No. 201710992664
   Fan L, 2000, ACTA BIOTECHNOL, V20, P41, DOI 10.1002/abio.370200108
   Favaro CP, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020227
   Fernand K., 2019, INT J SCI, V8, P58, DOI [DOI 10.18483/IJSCI.2178, 10.18483/IJSCI.2178]
   Fernandes AS, 2017, ECOTOX ENVIRON SAFE, V141, P30, DOI 10.1016/j.ecoenv.2017.03.011
   Fernandez-Gomez B, 2016, FOOD RES INT, V89, P1015, DOI 10.1016/j.foodres.2016.03.006
   Fernandez-Gomez B, 2016, J FUNCT FOODS, V25, P197, DOI 10.1016/j.jff.2016.06.001
   Fernández-Ochoa A, 2022, MOLECULES, V27, DOI 10.3390/molecules27030777
   Ferrao J.E.M., 2009, CAF BEBIDA NEGRA SO
   Campos GFA, 2021, PROCESSES, V9, DOI 10.3390/pr9081396
   Freitas LC, 2021, RESOUR CONSERV RECY, V169, DOI 10.1016/j.resconrec.2021.105466
   Galanakis CM, 2021, FOODS, V10, DOI 10.3390/foods10010128
   Ganesh KS, 2022, CHEMOSPHERE, V287, DOI 10.1016/j.chemosphere.2021.132221
   Garcia-Serna E, 2014, POL J FOOD NUTR SCI, V64, P243, DOI 10.2478/pjfns-2013-0024
   GarcYa-Velasques, 2017, J FOOD NUTR POPULATI, V1, P1
   Gayle PG, 2022, J ECON MANAGE STRAT, V31, P525, DOI 10.1111/jems.12474
   Gebreeyessus GD, 2022, SCI TOTAL ENVIRON, V833, DOI 10.1016/j.scitotenv.2022.155113
   González-Ferrero C, 2015, INT J FOOD SCI NUTR, V66, pS4, DOI 10.3109/09637486.2015.1042843
   Gouvea BM, 2009, BIOTECHNOL LETT, V31, P1315, DOI 10.1007/s10529-009-0023-4
   Granato D, 2020, ANNU REV FOOD SCI T, V11, P93, DOI 10.1146/annurev-food-032519-051708
   Granato D, 2018, FOOD CHEM, V264, P471, DOI 10.1016/j.foodchem.2018.04.012
   Granato D, 2017, TRENDS FOOD SCI TECH, V62, P13, DOI 10.1016/j.tifs.2016.12.010
   Guglielmetti A, 2019, POL J FOOD NUTR SCI, V69, P157, DOI 10.31883/pjfns-2019-0012
   Haile M, 2019, J FOOD QUALITY, DOI 10.1155/2019/4836709
   Hartonen K., 2017, The Application of Green Solvents in Separation Processes, P19, DOI DOI 10.1016/B978-0-12-805297-6.00002-4
   Heeger A, 2017, FOOD CHEM, V221, P969, DOI 10.1016/j.foodchem.2016.11.067
   Hejna A, 2021, J COMPOS SCI, V5, DOI 10.3390/jcs5020044
   Hejna A, 2021, WASTE MANAGE, V121, P296, DOI 10.1016/j.wasman.2020.12.018
   Hijosa-Valsero M, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-1002-z
   Hirwa O, 2016, UKR FOOD J, V5, P523, DOI 10.24263/2304-974X-2016-5-3-11
   Hu S, 2023, CURR RES FOOD SCI, V6, DOI 10.1016/j.crfs.2023.100475
   Hunyadi A, 2019, MED RES REV, V39, P2505, DOI 10.1002/med.21592
   Hussain T, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7432797
   ICO, 2016, TOTAL PRODUCTION AL
   Ico T., 2023, COLOMBIAN MILDS OTH, P1
   Iriondo-DeHond A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10091219
   Iriondo-DeHond A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112693
   Iriondo-DeHond A, 2019, INNOV FOOD SCI EMERG, V51, P194, DOI 10.1016/j.ifset.2018.06.010
   Iriondo-DeHond A, 2017, FOOD RES INT, V100, P791, DOI 10.1016/j.foodres.2017.08.012
   Iwatani S, 2019, FOOD SCI HUM WELL, V8, P96, DOI 10.1016/j.fshw.2019.03.011
   Jain A, 2022, FUEL, V307, DOI 10.1016/j.fuel.2021.121859
   Jiménez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Gil-Chávez GJ, 2013, COMPR REV FOOD SCI F, V12, P5, DOI 10.1111/1541-4337.12005
   Kandasamy S, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0481-z
   Kim H.S., 2022, Patent, Patent No. [20220062702A, 20220062702]
   Kim J.D., 2012, Patent, Patent No. [101344471B1, 101344471]
   Kim J.S., 2022, Pellet Manufacturing Method Patent, Patent No. [102358649B1, 102358649]
   Klingel T, 2020, FOODS, V9, DOI 10.3390/foods9050665
   Konstantinidis N, 2023, MOLECULES, V28, DOI 10.3390/molecules28083460
   Kurek M, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11040742
   Kurutas EB, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0186-5
   Lachenmeier DW, 2022, FOODS, V11, DOI 10.3390/foods11010003
   Lagrasta FP, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su132413931
   Lee YG, 2023, MOLECULES, V28, DOI 10.3390/molecules28083562
   Lestari Wahyu, 2022, F1000Res, V11, P220, DOI 10.12688/f1000research.107811.1
   Li SB, 2021, CRIT REV FOOD SCI, V61, P1448, DOI 10.1080/10408398.2020.1761287
   Lin CSK, 2013, ENERG ENVIRON SCI, V6, P426, DOI 10.1039/c2ee23440h
   Littardi P, 2021, FOODS, V10, DOI 10.3390/foods10010005
   Lorbeer L, 2022, MOLECULES, V27, DOI 10.3390/molecules27206839
   Luo Y., 2022, Patent, Patent No. 202111211719
   MaChado C. M. M., 2000, Coffee Biotechnology and Quality, P401, DOI DOI 10.1007/978-94-017-1068-8_37
   Machado M, 2024, CRIT REV FOOD SCI, V64, P7181, DOI 10.1080/10408398.2023.2181761
   Macías-Garbett R, 2022, PLANTS-BASEL, V11, DOI 10.3390/plants11182362
   Magoni C, 2018, FOOD RES INT, V112, P129, DOI 10.1016/j.foodres.2018.06.026
   Marco-Ramell A, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-017-2006-0
   Mariyam S., 2022, IOP Conference Series: Earth and Environmental Science, V1005, DOI 10.1088/1755-1315/1005/1/012012
   Martínez-López E, 2022, NUTRIENTS, V14, DOI 10.3390/nu14122365
   Martinez-Saez N., 2019, Encyclopedia of Food Security and Sustainability, P307, DOI [10.1016/B978-0-08-100596-5.22136-7, DOI 10.1016/B978-0-08-100596-5.22136-7]
   Martinez-Saez N, 2017, FOOD CHEM, V216, P114, DOI 10.1016/j.foodchem.2016.07.173
   Martinez-Saez N, 2014, FOOD CHEM, V150, P227, DOI 10.1016/j.foodchem.2013.10.100
   Martuscelli M, 2021, FOODS, V10, DOI 10.3390/foods10061367
   Mayson S, 2021, RESOUR CONSERV RECY, V172, DOI 10.1016/j.resconrec.2021.105659
   Mazzafera Paulo, 2002, Sci. agric. (Piracicaba, Braz.), V59, P815, DOI 10.1590/S0103-90162002000400030
   Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5
   Mena P, 2020, P NUTR SOC, V79, pE123, DOI 10.1017/S0029665120000713
   Martinez CLM, 2019, BIOMASS BIOENERG, V120, P68, DOI 10.1016/j.biombioe.2018.11.003
   Mirón-Mérida VA, 2019, LWT-FOOD SCI TECHNOL, V101, P167, DOI 10.1016/j.lwt.2018.11.013
   Morales-Martínez JL, 2021, BIOENERG RES, V14, P815, DOI 10.1007/s12155-020-10197-6
   Moreira MD, 2018, WASTE MANAGE, V82, P93, DOI 10.1016/j.wasman.2018.10.017
   Murthy PS, 2012, FOOD BIOPROCESS TECH, V5, P657, DOI 10.1007/s11947-010-0331-7
   Murthy PS, 2012, RESOUR CONSERV RECY, V66, P45, DOI 10.1016/j.resconrec.2012.06.005
   Murthy PS, 2009, J CHEM TECHNOL BIOT, V84, P1246, DOI 10.1002/jctb.2142
   Mussatto SI, 2011, FOOD BIOPROCESS TECH, V4, P661, DOI 10.1007/s11947-011-0565-z
   Nabeiro R.M., 2022, Patent, Patent No. [115379990A, 115379990]
   Narita Y, 2014, FOOD RES INT, V61, P16, DOI 10.1016/j.foodres.2014.01.023
   Navya PN, 2013, BIOPROC BIOSYST ENG, V36, P1115, DOI 10.1007/s00449-012-0865-3
   nestle, CASCARA NESCAFE NAT
   Niglio S, 2019, BIOENERG RES, V12, P312, DOI 10.1007/s12155-019-09969-6
   Nizami AS, 2017, BIORESOURCE TECHNOL, V241, P1101, DOI 10.1016/j.biortech.2017.05.097
   Nolasco A, 2022, FOODS, V11, DOI 10.3390/foods11182834
   Norheim F, 2012, NUTRIENTS, V4, P1898, DOI 10.3390/nu4121898
   Núñez-Gómez V, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12040976
   Oliveira FD, 2018, BIORESOURCE TECHNOL, V257, P172, DOI 10.1016/j.biortech.2018.01.041
   Oliveira G, 2021, FOODS, V10, DOI 10.3390/foods10030683
   Oliveira G, 2020, FOOD RES INT, V138, DOI 10.1016/j.foodres.2020.109733
   Oliveira WE, 2008, J HAZARD MATER, V152, P1073, DOI 10.1016/j.jhazmat.2007.07.085
   Ontawong A, 2019, J FUNCT FOODS, V54, P568, DOI 10.1016/j.jff.2019.02.011
   Orrego D, 2018, ENERGIES, V11, DOI 10.3390/en11040786
   Palomino García LRP, 2015, FOOD SCI TECH-BRAZIL, V35, P704
   Park H.W., 2022, Patent, Patent No. [102364057B1, 102364057]
   Patil S, 2022, WASTE BIOMASS VALORI, V13, P905, DOI 10.1007/s12649-021-01554-3
   Peixoto JAB, 2022, FOODS, V11, DOI 10.3390/foods11121671
   Penuela-Martinez A. E., 2021, COFFEE SCI, V16, DOI [DOI 10.25186/.V16I.1825, 10.25186/.v16i.1825]
   Perino S, 2019, CURR OPIN FOOD SCI, V25, P8, DOI 10.1016/j.cofs.2018.12.004
   Phitakwinai S, 2019, FOOD SCI NUTR, V7, P2921, DOI 10.1002/fsn3.1144
   Pinzi S, 2020, FUEL, V278, DOI 10.1016/j.fuel.2020.118260
   Pleissner D, 2016, BIORESOURCE TECHNOL, V218, P167, DOI 10.1016/j.biortech.2016.06.078
   Polidoro AD, 2018, J ANAL APPL PYROL, V129, P43, DOI 10.1016/j.jaap.2017.12.005
   Powers JP, 2019, FOOD SCI TECH-INT SE, P235, DOI 10.1016/B978-0-12-816467-9.00017-4
   Prata ERBA, 2007, LWT-FOOD SCI TECHNOL, V40, P1555, DOI 10.1016/j.lwt.2006.10.003
   Pronyk C, 2009, J FOOD ENG, V95, P215, DOI 10.1016/j.jfoodeng.2009.06.002
   Ramirez-Coronel MAN, 2004, J AGR FOOD CHEM, V52, P1344, DOI 10.1021/jf035208t
   Rani MU, 2012, FOOD CHEM, V130, P243, DOI 10.1016/j.foodchem.2011.07.021
   Rao J., 2022, Patent, Patent No. [202210189401.0, 2022101894010]
   Rasoki T., 2021, AGRITEPA J ILMU DA, V8, P86, DOI DOI 10.37676/AGRITEPA.V8I1.1291
   Rebollo-Hernanz M, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12010020
   Rebollo-Hernanz M, 2023, FOOD CHEM, V405, DOI 10.1016/j.foodchem.2022.134929
   Rebollo-Hernanz M, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.866233
   Rebollo-Hernanz M, 2021, FOODS, V10, DOI 10.3390/foods10030653
   Rebollo-Hernanz M, 2019, FOODS, V8, DOI 10.3390/foods8100438
   Rebollo-Hernanz M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080279
   Rebollo-Hernanz M, 2019, FOOD CHEM TOXICOL, V132, DOI 10.1016/j.fct.2019.110672
   Rein MJ, 2013, BRIT J CLIN PHARMACO, V75, P588, DOI 10.1111/j.1365-2125.2012.04425.x
   Reis RS, 2020, J MATER RES TECHNOL, V9, P9412, DOI 10.1016/j.jmrt.2020.05.099
   Rodgers GP, 2020, JAMA-J AM MED ASSOC, V324, P735, DOI 10.1001/jama.2020.13601
   Rodrigues F, 2016, DRUG DEV IND PHARM, V42, P99, DOI 10.3109/03639045.2015.1035279
   ROLLETT A., 2023, Granted Patent, Patent No. [US11641963B2, 11641963]
   Ruiz-Capillas C, 2021, FOODS, V10, DOI 10.3390/foods10030582
   Saenger M, 2001, RENEW ENERG, V23, P103, DOI 10.1016/S0960-1481(00)00106-3
   Santhiravel S, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23158124
   Sarrouh B, 2021, WASTE BIOMASS VALORI, V12, P787, DOI 10.1007/s12649-020-01021-5
   Scatolino MV, 2017, CIENC AGROTEC, V41, P139
   SHANKARANAND VS, 1994, WORLD J MICROB BIOT, V10, P165, DOI 10.1007/BF00360879
   Sheldon RA, 2016, J MOL CATAL A-CHEM, V422, P3, DOI 10.1016/j.molcata.2016.01.013
   Shemekite F, 2014, WASTE MANAGE, V34, P642, DOI 10.1016/j.wasman.2013.11.010
   Sisti L, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13126921
   Soares M, 2000, PROCESS BIOCHEM, V35, P857, DOI 10.1016/S0032-9592(99)00144-2
   Soares S.F., 2022, J AGR SCI RES, V3, P2, DOI [DOI 10.22533/AT.ED.973312222123, 10.22533/at.ed.973312222123]
   Son C.G., 2022, Patent, Patent No. [2022158885A1, 2022158885]
   Son C.G., 2022, Patent, Patent No. [20220108263A, 20220108263]
   Sridhar A, 2021, ENVIRON CHEM LETT, V19, P3409, DOI 10.1007/s10311-021-01217-8
   Starbucks, STARBUCKS 1 NEW BEV
   Stromsnes K, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9081074
   Stufano P, 2022, MRS ENERGY SUSTAIN, V9, P443, DOI 10.1557/s43581-022-00036-w
   Sugebo B, 2022, MATER RENEW SUSTAIN, V11, P91, DOI 10.1007/s40243-022-00209-0
   supracafe, SUPRACAFE CONOCES I
   Sut S, 2016, CURR MED CHEM, V23, P3198, DOI 10.2174/0929867323666160615104837
   Taborda Valencia N.J., 2022, Patent, Patent No. [2022125067A1, 2022125067]
   Taladrid D, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12040979
   Tao DD, 2020, COMPR REV FOOD SCI F, V19, P875, DOI 10.1111/1541-4337.12540
   Teigiserova DA, 2020, SCI TOTAL ENVIRON, V706, DOI 10.1016/j.scitotenv.2019.136033
   The European Comission, 2017, OFF J EUR UNION, V351, P55
   The European Comission, 2017, OFF J EUR UNION, V351, P64
   The European Comission, 2022, OFF J EUR UNION, V9, P29
   Ting YW, 2015, J AGR FOOD CHEM, V63, P1332, DOI 10.1021/jf5047464
   de la Cruz ST, 2019, FOODS, V8, DOI 10.3390/foods8020068
   Toschi TG, 2014, J AGR FOOD CHEM, V62, P10836, DOI 10.1021/jf503200z
   Tsoupras A., 2023, FUNCTIONAL FOODS TH, P367, DOI DOI 10.1016/B978-0-12-823811-0.00003-1
   Tsuji S., 2021, Patent, Patent No. [201980086419.4, 2019800864194]
   Turck D, 2022, EFSA J, V20, DOI 10.2903/j.efsa.2022.7085
   Turck D, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4594
   Ubando AT, 2020, BIORESOURCE TECHNOL, V299, DOI 10.1016/j.biortech.2019.122585
   United Nations, 2021, Sustainable Recruitment of Nurses (Triple Win)'
   Valdés A, 2022, ANAL CHEM, V94, P366, DOI 10.1021/acs.analchem.1c04678
   Vandeponseele A, 2020, GREEN CHEM, V22, P8544, DOI 10.1039/d0gc03146a
   Varangis P., 2003, DEALING COFFEE CRISI, DOI DOI 10.1596/1813-9450-2993
   Truong VK, 2019, FOODS, V8, DOI 10.3390/foods8050164
   Von Staden H., 2022, Patent, Patent No. [115515866A, 115515866]
   Weber H, 2021, J MARKET MANAG-UK, V37, P1148, DOI 10.1080/0267257X.2021.1897650
   Wen L, 2020, INT J FOOD SCI TECH, V55, P2242, DOI 10.1111/ijfs.14477
   Perez-Sariñana BY, 2019, ROM BIOTECH LETT, V24, P669, DOI 10.25083/rbl/24.4/669.675
   Yang J., 2022, Patent, Patent No. [202210292688.X, 202210292688]
   Yang JL, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11050751
   Zengin G, 2020, FOODS, V9, DOI 10.3390/foods9060713
   Zhang HJ, 2018, FOOD RES INT, V113, P24, DOI 10.1016/j.foodres.2018.06.068
NR 275
TC 6
Z9 6
U1 6
U2 28
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3417
J9 APPL SCI-BASEL
JI Appl. Sci.-Basel
PD JUL
PY 2023
VL 13
IS 14
AR 8326
DI 10.3390/app13148326
PG 37
WC Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials
   Science, Multidisciplinary; Physics, Applied
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Engineering; Materials Science; Physics
GA N6DL2
UT WOS:001037894100001
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Lopez-Garcia, E
   van Dam, RM
   Qi, L
   Hu, FB
AF Lopez-Garcia, Esther
   van Dam, Rob M.
   Qi, Lu
   Hu, Frank B.
TI Coffee consumption and markers of inflammation and endothelial
   dysfunction in healthy and diabetic women
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE coffee; inflammation; C-reactive protein; CRP; endothelial dysfunction;
   cross-sectional study; Nurses' Health Study; type 2 diabetes; women
ID CORONARY-HEART-DISEASE; PLASMA BIOMARKERS; FATTY-ACIDS; RISK;
   ATHEROSCLEROSIS; OBESITY; MEN
AB Background: In several short-term studies, coffee consumption has been associated with impairment of endothelial function.
   Objective: The objective was to assess the relation between long-term caffeinated and decaffeinated filtered coffee consumption and markers of inflammation and endothelial dysfunction.
   Design: We conducted a cross-sectional study of 730 healthy women and 663 women with type 2 diabetes from the Nurses' Health Study I cohort, who were aged 43-70 y and free of cardiovascular disease and cancer at the time blood was drawn (1989-1990). Dietary intake was assessed with a validated food-frequency questionnaire in 1986 and 1990.
   Results: About 77% of the healthy women consumed >= 1 cup (237 mL) caffeinated coffee/mo and 75% consumed >= 1 cup decaffeinated coffee/mo; the corresponding intakes for women with type 2 diabetes were 74% and 63%, respectively. In healthy women, no appreciable differences in plasma concentrations of the markers were found across categories of caffeinated coffee intake. In women with type 2 diabetes, higher caffeinated coffee consumption was associated with lower plasma concentrations of E-selectin (adjusted percentage change per I cup/d increment = -3.2%; P = 0.05) and C-reactive protein (adjusted percentage change = -10.2%; P < 0.001). Higher decaffeinated coffee consumption was associated with lower plasma concentrations of E-selectin (adjusted percentage change = -2.5%; P = 0.08) and C-reactive protein (adjusted percentage change = -7.9%; P = 0.02) only in healthy women. The results were similar when we also adjusted the models for other dietary factors and blood lipids and when we excluded participants with hypertension or hypercholesterolemia.
   Conclusions: These results indicate that neither caffeinated nor decaffeinated filtered coffee has a detrimental effect on endothelial function. In contrast, the results suggest that coffee consumption is inversely associated with markers of inflammation and endothelial dysfunction.
C1 Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard Medical School
RP Lopez-Garcia, E (corresponding author), Univ Autonoma Madrid, Dept Prevent Med, Arzobispo Morcillo,2, Madrid, Spain.
EM esther.lopez@uam.es
RI Hu, Frank/C-1919-2013; Lopez-Garcia, Esther/A-8894-2019; van Dam,
   Rob/F-9674-2010; van Dam, Rob/A-6693-2009
OI van Dam, Rob/0000-0002-7354-8734
FU NHLBI NIH HHS [HL65582] Funding Source: Medline; NIDDK NIH HHS [DK58845]
   Funding Source: Medline
CR Aderka Dan, 1996, Cytokine and Growth Factor Reviews, V7, P231, DOI 10.1016/S1359-6101(96)00026-3
   Blake GJ, 2003, J AM COLL CARDIOL, V41, p37S, DOI 10.1016/S0735-1097(02)02953-4
   Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D
   Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013
   GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810
   Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693
   Huang JJ, 2004, J NUTR BIOCHEM, V15, P722, DOI 10.1016/j.jnutbio.2004.07.002
   Hwang SJ, 1997, CIRCULATION, V96, P4219
   KAWACHI I, 1994, BRIT HEART J, V72, P269
   Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393
   Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562
   Lopez-Garcia E, 2004, J NUTR, V134, P1806, DOI 10.1093/jn/134.7.1806
   Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029
   Meisinger C, 2005, CIRCULATION, V112, P651, DOI 10.1161/CIRCULATIONAHA.104.529297
   Pai JK, 2002, CLIN CHEM, V48, P1781
   Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967
   PALTA M, 1982, AM J EPIDEMIOL, V115, P223, DOI 10.1093/oxfordjournals.aje.a113294
   Papamichael CM, 2005, CLIN SCI, V109, P55, DOI 10.1042/CS20040358
   Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6
   Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858
   SAS/STAT, 2001, GUID PERS COMP VERS
   Shai I, 2005, DIABETES CARE, V28, P1376, DOI 10.2337/diacare.28.6.1376
   *USDA AGR RES SERV, 1993, USDA NUTR DAT STAND
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Vlachopoulos C, 2005, AM J CLIN NUTR, V81, P1307
   WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366
   Willett WC, 1996, JAMA-J AM MED ASSOC, V275, P458, DOI 10.1001/jama.275.6.458
   WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991
   Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
   ZOCK PL, 1990, LANCET, V335, P1235, DOI 10.1016/0140-6736(90)91302-Q
NR 34
TC 198
Z9 214
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD OCT
PY 2006
VL 84
IS 4
BP 888
EP 893
DI 10.1093/ajcn/84.4.888
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 093AX
UT WOS:000241140700028
PM 17023717
OA Bronze
DA 2025-04-28
ER

PT J
AU An, HJ
   Kim, Y
   Seo, YG
AF An, Hye-Ji
   Kim, Yejin
   Seo, Young-Gyun
TI Relationship between Coffee, Tea, and Carbonated Beverages and
   Cardiovascular Risk Factors
SO NUTRIENTS
LA English
DT Article
DE coffee; tea; carbonated beverage; hypertension; diabetes; dyslipidemia
ID SUGAR-SWEETENED BEVERAGES; METABOLIC SYNDROME; SEX-DIFFERENCES;
   CONSUMPTION; METAANALYSIS; DISEASE; HEALTH; CHOLESTEROL; MORTALITY;
   OBESITY
AB We aimed to analyze the relationship between coffee, tea, and carbonated beverages and cardiovascular risk factors. We used data from the fourth to eighth Korea National Health and Nutrition Examination Surveys (2007-2016, 2019-2020). We categorized the frequency of intake into three groups (<1 time/week, 1 time/week to <1 time/day, and >= 1 time/day). Subsequently, logistic regression analyses by sex were performed to assess cardiovascular risk factors (hypertension (HTN), diabetes mellitus (DM), dyslipidemia (DL), or metabolic syndrome (MetS)) according to the frequency of coffee, tea, and carbonated beverage intake. For HTN, coffee intake showed an inverse relationship and tea intake showed a direct relationship. For DM, coffee intake showed an inverse relationship, and tea and carbonated beverage intake showed a direct relationship. For DL, coffee intake showed an inverse relationship, whereas tea intake demonstrated a direct relationship. In addition, carbonated beverage intake showed a direct relationship with MetS. Coffee intake showed an inverse relationship with HTN, DM, and DL. However, tea intake showed a direct relationship with HTN, DM, and DL, whereas carbonated beverage intake showed a direct relationship with DM and MetS.
C1 [An, Hye-Ji; Kim, Yejin; Seo, Young-Gyun] Hallym Univ, Sacred Heart Hosp, Dept Family Med, Anyang 14068, Gyeonggi Do, South Korea.
C3 Hallym University
RP Seo, YG (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Family Med, Anyang 14068, Gyeonggi Do, South Korea.
EM yg035@hallym.or.kr
RI Seo, Young-Gyun/AAV-3487-2020
OI Seo, Young-Gyun/0000-0001-8294-1741; , Hyeji/0009-0000-6983-401X
CR Barrett P, 2017, PUBLIC HEALTH NUTR, V20, P2766, DOI [10.1017/S136898001700177X, 10.1017/s136898001700177x]
   Centers for Disease Control and Prevention, HEART DIS
   Chen XN, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-038902
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   De Roos B, 2000, J INTERN MED, V248, P211, DOI 10.1046/j.1365-2796.2000.00728.x
   이석민, 2006, 에너지공학, V15, P1
   Drewnowski A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030154
   Drouin-Chartier JP, 2019, DIABETES CARE, V42, P2181, DOI 10.2337/dc19-0734
   Du YB, 2020, NUTR METAB CARDIOVAS, V30, P2159, DOI 10.1016/j.numecd.2020.08.017
   Ejtahed HS, 2015, ENDOCRINOL METAB, V30, P334, DOI 10.3803/EnM.2015.30.3.334
   Fryar Cheryl D, 2012, Natl Health Stat Report, P1
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Han Gyusang, 2021, [The Korean Journal of Food and Nutrition, 한국식품영양학회지], V34, P430, DOI 10.9799/ksfan.2021.34.5.430
   Hayashino Y, 2011, DIABETIC MED, V28, P805, DOI 10.1111/j.1464-5491.2011.03239.x
   Heimrich M, 2015, PACKAG TECHNOL SCI, V28, P123, DOI 10.1002/pts.2094
   Hernandez LM, 2019, ENVIRON SCI TECHNOL, V53, P12300, DOI 10.1021/acs.est.9b02540
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hirahatake KM, 2019, AM J CLIN NUTR, V110, P733, DOI 10.1093/ajcn/nqz154
   Hu MY, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101620
   Jha DK, 2020, J FOOD SCI TECH MYS, V57, P3060, DOI 10.1007/s13197-020-04339-z
   Kang Y, 2017, BRIT J NUTR, V117, P315, DOI 10.1017/S0007114517000046
   Kolb H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041144
   Kondo Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010048
   Korean Agro-Fisheries&Food Trade Corporation, 2019, 2019 PROC FOODS SEGM
   Kumar R, 2022, CHEMOSPHERE, V298, DOI 10.1016/j.chemosphere.2022.134267
   Kuo CT, 2023, PUBLIC HEALTH NUTR, V26, P653, DOI 10.1017/S1368980022001549
   Malik VS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081840
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Mauvais-Jarvis F, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0033-y
   McCusker RR, 2006, J ANAL TOXICOL, V30, P112, DOI 10.1093/jat/30.2.112
   Narain A, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12927
   National Coffee Association (NCA), 2022, NAT COFF DATA TRENDS
   Navarro AM, 2019, CLIN NUTR, V38, P389, DOI 10.1016/j.clnu.2017.12.009
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Quadra G.R., 2022, Handbook of substance misuse and addictions, P1, DOI [10.1007/978-3-030-67928-678-1, DOI 10.1007/978-3-030-67928-678-1]
   Ree M, 2008, EUR J CLIN NUTR, V62, P1255, DOI 10.1038/sj.ejcn.1602863
   Ren YQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174238
   Sang LX, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-34
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Singh AK, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060731
   Sirotkin AV, 2021, PHYSIOL RES, V70, P161, DOI 10.33549/physiolres.934674
   Solomi L, 2019, INT J FOOD SCI NUTR, V70, P894, DOI 10.1080/09637486.2019.1585418
   Tang J, 2015, BRIT J NUTR, V114, P673, DOI 10.1017/S0007114515002329
   Tatoli R, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22062193
   Tea association of the USA, 2022, TEA FACT SHEET 2022
   Wan CJ, 2010, J DIABETES INVEST, V1, P259, DOI 10.1111/j.2040-1124.2010.00055.x
   White MC, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0247-5
   Xu JL, 2021, J HAZARD MATER, V418, DOI 10.1016/j.jhazmat.2021.126328
   Yang CS, 2000, J NUTR, V130, P2409, DOI 10.1093/jn/130.10.2409
   Yin JW, 2021, ADV NUTR, V12, P89, DOI 10.1093/advances/nmaa084
   Yu SS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-877
NR 55
TC 5
Z9 5
U1 6
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD FEB
PY 2023
VL 15
IS 4
AR 934
DI 10.3390/nu15040934
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 9K6ZH
UT WOS:000941013100001
PM 36839290
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Nebti, O
   Bahchachi, N
   Mezdoud, A
   Bensalem, A
   Agli, A
   Oulamara, H
AF Nebti, Oudjdane
   Bahchachi, Nora
   Mezdoud, Affaf
   Bensalem, Adel
   Agli, Abdelnacer
   Oulamara, Hayet
TI Is breakfast consumption associated with weight status: A survey of
   Algerian adults?
SO NUTRITION CLINIQUE ET METABOLISME
LA English
DT Article
DE Breakfast; Obesity; Adult; BMI; Energy intake
ID NATIONAL-HEALTH; OBESITY; NUTRITION; OVERWEIGHT; CHILDREN; FOODS; GAIN
AB Objective. - To study the association between breakfast consumption and obesity.Materials and methods. - A cross-sectional study was conducted among 284 Algerian adults. The breakfast consumption and composition were assessed by the 24-hour recall repeated on three times. Breakfast consumers were defined as having consumed 300 Kcal and more in this meal. Anthropometric measurements included weight and height.Results. - Our population counts 46.5% men and 53.5% women. A total of 62.3% of adults were overweight, including 25.4% having obesity. Over half of the population (54.2%) ate breakfast. It usually consisted of a cereal product, a dairy product and a sweet product accompanied by coffee or tea. No significant difference was observed between the prevalence of obesity in breakfast consumers and non-consumers. No correlation was found between BMI and energy intake at breakfast. Non-consumers of breakfast had a higher total energy intake excluding breakfast than breakfast consumers. Conclusion. - In our study, skipping breakfast does not appear to be related to obesity. Rather, it appears to be related to an excess in total energy. & COPY; 2023 Socie & PRIME;te & PRIME; fran-cophone nutrition clinique et me & PRIME;tabolisme (SFNCM). Published by Elsevier Masson SAS. All rights reserved.
C1 [Nebti, Oudjdane; Bahchachi, Nora; Mezdoud, Affaf; Bensalem, Adel; Agli, Abdelnacer; Oulamara, Hayet] Univ Freres Mentouri Constantine1 UFMC1, Lab Nutr & Technol Alimentaires LNTA, Inst Nutr Alimentat & Technol Agroalimentaires INA, Route Ain Bey, Constantine 25000, Algeria.
   [Nebti, Oudjdane] Cite El Mountazah 85, Ain Smara, Constantine, Algeria.
RP Nebti, O (corresponding author), Cite El Mountazah 85, Ain Smara, Constantine, Algeria.
EM nebtiwij@gmail.com
CR AlTamimi JZ, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19052903
   [Anonymous], 2018, ENQ NAT MES POIDS FA, P18
   Barr SI, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0151-3
   Bellisle F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081056
   Bjornarå HB, 2014, PUBLIC HEALTH NUTR, V17, P906, DOI 10.1017/S136898001300061X
   Bohan Brown Michelle M, 2020, F1000Res, V9, P140, DOI 10.12688/f1000research.22424.2
   Bornet FRJ, 2007, APPETITE, V49, P535, DOI 10.1016/j.appet.2007.04.006
   Brown AW, 2013, AM J CLIN NUTR, V98, P1298, DOI 10.3945/ajcn.113.064410
   Chatelan A, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0752-7
   Chikhi K., 2014, New Medit, V13, P50
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   Cuadrado-Soto E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123772
   Deshmukh-Taskar PR, 2010, J AM DIET ASSOC, V110, P869, DOI 10.1016/j.jada.2010.03.023
   Dhurandhar EJ, 2014, AM J CLIN NUTR, V100, P507, DOI 10.3945/ajcn.114.089573
   Fayet-Moore F, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010175
   Gaal S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080999
   Guinter MA, 2020, INT J OBESITY, V44, P186, DOI 10.1038/s41366-019-0356-6
   Guy-Grand B, 2014, CAH NUTR DIET, V49, P49, DOI 10.1016/j.cnd.2014.03.004
   Hoyland A, 2009, NUTR RES REV, V22, P220, DOI 10.1017/S0954422409990175
   Iversen KN, 2021, CLIN NUTR ESPEN, V45, P155, DOI 10.1016/j.clnesp.2021.07.007
   Ma XM, 2020, OBES RES CLIN PRACT, V14, P1, DOI 10.1016/j.orcp.2019.12.002
   Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117
   Martínez CF, 2021, J NUTR, V151, P405, DOI 10.1093/jn/nxaa367
   Blasco MM, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8010014
   Navia B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188828
   O'Neil CE, 2014, J ACAD NUTR DIET, V114, pS8, DOI 10.1016/j.jand.2014.08.022
   Ogata H, 2019, BRIT J NUTR, V122, P431, DOI 10.1017/S0007114519001235
   Rosato V, 2016, ADV NUTR, V7, P455, DOI 10.3945/an.115.009548
   Ruxton CHS, 1997, BRIT J NUTR, V78, P199, DOI 10.1079/BJN19970140
   Serra-Majem L, 2015, BRIT J NUTR, V113, pS29, DOI 10.1017/S0007114514003249
   Sievert K, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l42
   van der Heijden AAWA, 2007, OBESITY, V15, P2463, DOI 10.1038/oby.2007.292
   Wicherski J, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010272
   Williams PG, 2008, NUTR REV, V66, P171, DOI 10.1111/j.1753-4887.2008.00022.x
   World Health Organization, 2021, Obesity and overweight, DOI DOI 10.1080/10810730903279694
   Zhang LJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040384
NR 36
TC 0
Z9 0
U1 0
U2 3
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0985-0562
EI 1768-3092
J9 NUTR CLIN METAB
JI Nutr. Clin. Metab.
PD MAY
PY 2023
VL 37
IS 2
BP 109
EP 113
DI 10.1016/j.nupar.2023.02.002
EA MAY 2023
PG 5
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA R1HH5
UT WOS:001061916400001
DA 2025-04-28
ER

PT J
AU Cho, IJ
   Choung, SY
   Hwang, YC
   Ahn, KJ
   Chung, HY
   Jeong, IK
AF Cho, In-Jin
   Choung, Se Young
   Hwang, You-Cheol
   Ahn, Kyu Jeung
   Chung, Ho Yeon
   Jeong, In-Kyung
TI Aster spathulifolius Maxim extract reduces body weight and
   fat mass in obese humans
SO NUTRITION RESEARCH
LA English
DT Article
DE Aster spathulifolius; Obesity; Weight loss; Fat mass
ID UNCOUPLING PROTEIN-2; DIETARY-SUPPLEMENTS; INSULIN-RESISTANCE;
   CHLOROGENIC ACID; IN-VITRO; OVERWEIGHT; KOREA; GENE; MICE;
   SPHATHULIFOLIUS
AB Aster spathulifolius Maxim (AS), a perennial herb of the genus Aster within the family Asteraceae, induced weight loss in a rat model of diet-induced obesity. We hypothesized that AS could also reduce body weight in obese humans. Therefore, we performed a randomized, double-blind, placebo-controlled clinical trial in Korea to evaluate the effect of AS extract (ASE) on body weight and fat mass and its safety in obese humans. Forty-four obese participants (body mass index [BMI], 25-30 kg/m(2)) aged >= 20 years were randomly assigned to the placebo or ASE group (700 mg/d of ASE) and were instructed to take a once-daily pill for 12 weeks. Weight, BMI, waist circumference, fat mass (measured using bioimpedance, dual-energy X-ray absorptiometry, and computed tomography), and laboratory tests were assessed at baseline and at 12 weeks. Body weight significantly decreased after 12 weeks of treatment in the ASE group (placebo vs ASE: -0.08 +/- 2.11 kg vs -3.30 +/- 3.15 kg, P < .05), and so did body fat mass (placebo vs ASE; bioimpedance method: -0.51 +/- 1.89 kg vs -2.38 +/- 2.30 kg, P < .05; dual-energy X-ray absorptiometry: 0.38 +/- 1.59 kg vs -2.26 +/- 2.37 kg, P < .05). Changes in lipid profiles, fasting plasma glucose, and hemoglobin A1c did not differ between the 2 groups. No drug-related adverse events were observed during the study. In conclusion, ASE significantly decreases body weight and fat mass in obese humans, suggesting that ASE may be a potential therapeutic candidate for reducing obesity. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Cho, In-Jin] Kyung Hee Univ, Grad Sch, Dept Med, 26 Kyungheedae Ro, Seoul 02447, South Korea.
   [Choung, Se Young] Kyung Hee Univ, Dept Prevent Pharm & Toxicol, Dept Life & Nanopharmaceut Sci Pharm, Coll Pharm, 26 Kyungheedae Ro, Seoul 02447, South Korea.
   [Hwang, You-Cheol; Ahn, Kyu Jeung; Chung, Ho Yeon; Jeong, In-Kyung] Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Endocrinol & Metab, 892 Dongnam Ro, Seoul 05278, South Korea.
C3 Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung
   Hee University Hospital
RP Jeong, IK (corresponding author), Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Endocrinol & Metab, 892 Dongnam Ro, Seoul 05278, South Korea.
EM jik1016@naver.com
RI Jeong, In-Kyung/AAI-6488-2020; Hwang, You-Cheol/AAA-4616-2022; Chung,
   Hoyeon/AAI-3103-2020; Choung, Young/HSE-1870-2023
OI Choung, Se Young/0000-0001-7619-6263; Hwang,
   You-Cheol/0000-0003-4033-7874; Jeong, In-Kyung/0000-0001-7857-546X; Ahn,
   Kyu Jeung/0000-0002-4648-3605
FU Newtree Co, Ltd, of the Republic of Korea; Kyung Hee University
   [KHU-20071482]; Technology Innovation Program of the Industrial
   Strategic Technology Development Program [10045275]; Ministry of Trade,
   Industry & Energy, Republic of Korea
FX This study was supported by Newtree Co, Ltd, of the Republic of Korea
   and was partially supported by a grant from Kyung Hee University in 2007
   (KHU-20071482). Newtree Co, Ltd, did not contribute to the reporting of
   the results or the preparation of the manuscript. This work was also
   supported by the Technology Innovation Program of the Industrial
   Strategic Technology Development Program, 10045275, Development of
   Functional Food Products for Improving the Metabolic Syndrome using
   Natural Resources and Extending Global Markets funded by the Ministry of
   Trade, Industry & Energy, Republic of Korea. The manuscript was edited
   and proofread by Elsevier English Language Editing Services.
CR [Anonymous], 2000, ASIA PACIFIC PERSPEC
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235
   Drent ML, 1995, OBES RES, V3, pS623, DOI 10.1002/j.1550-8528.1995.tb00236.x
   Fidler MC, 2011, J CLIN ENDOCR METAB, V96, P3067, DOI 10.1210/jc.2011-1256
   Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269
   Ghadieh HE, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0014-5
   Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35
   Kim DM, 2005, OBES REV, V6, P117, DOI 10.1111/j.1467-789X.2005.00173.x
   Kim MK, 2014, ENDOCRINOL METAB, V29, P405, DOI 10.3803/EnM.2014.29.4.405
   Kim SJ, 2015, J MED FOOD IN PRESS
   Kim SJ, 2015, J PHARM PHARM
   Kim TJ., 1996, WILD FLOWERS KOREA
   Kushner RF, 2014, JAMA-J AM MED ASSOC, V312, P943, DOI 10.1001/jama.2014.10432
   Lee CB, 1999, Illustrated flora of Korea
   Lee SO, 2005, J NAT PROD, V68, P1471, DOI 10.1021/np058044e
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Manore MM, 2012, INT J SPORT NUTR EXE, V22, P139, DOI 10.1123/ijsnem.22.2.139
   Martinez-Saez N, 2014, FOOD CHEM, V150, P227, DOI 10.1016/j.foodchem.2013.10.100
   Nordfors L, 1998, DIABETOLOGIA, V41, P935, DOI 10.1007/s001250051010
   Oberkofler H, 1998, DIABETOLOGIA, V41, P940, DOI 10.1007/s001250051011
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549
   Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561
   Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726
   안인정, 2012, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V41, P584
   Park JH, 2006, INT J OBESITY, V30, P1661, DOI 10.1038/sj.ijo.0803321
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   Won JN, 2013, J MICROBIOL BIOTECHN, V23, P125, DOI 10.4014/jmb.1210.10074
   Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361
   Yin XF, 2015, FOOD SCI BIOTECHNOL, V24, P301, DOI 10.1007/s10068-015-0040-0
   Yin X, 2015, J MED FOOD, V18, P987, DOI 10.1089/jmf.2014.3416
   Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679
NR 35
TC 11
Z9 13
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
J9 NUTR RES
JI Nutr. Res.
PD JUL
PY 2016
VL 36
IS 7
BP 671
EP 678
DI 10.1016/j.nutres.2016.03.001
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DQ3LI
UT WOS:000379103400006
PM 27333958
DA 2025-04-28
ER

PT J
AU Davoodi, SH
   Hajimiresmaiel, SJ
   Ajami, M
   Mohseni-Bandpei, A
   Ayatollahi, SA
   Dowlatshahi, K
   Javedan, G
   Pazoki-Toroudi, H
AF Davoodi, Sayed Hossein
   Hajimiresmaiel, Seyed Javad
   Ajami, Marjan
   Mohseni-Bandpei, Anoushiravan
   Ayatollahi, Seyyed Abdulmajid
   Dowlatshahi, Kamran
   Javedan, Gholamali
   Pazoki-Toroudi, Hamidreza
TI Caffeine Treatment Prevented from Weight Regain after Calorie Shifting
   Diet Induced Weight Loss
SO IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Article
DE Caffeine; Calorie shifting diet; Diet; Obesity; Resting metabolic rate;
   Weight loss
ID APPETITE SENSATIONS; ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; OXIDATIVE
   STRESS; RESTRICTION; DETERMINANTS; ADHERENCE; OBESITY; IMPACT
AB Low calorie diets are always difficult for obese subjects to follow and lead to metabolic and behavioral adaptation. Therefore, we evaluated the effect of caffeine treatment with calorie shifting diet (CSD) on weight loss. Female subjects (n=60; BMI > 25) completed 4-weeks control diet, 6-weeks CSD (3 repeated phases; each 2-weeks) and 4-weeks follow-up diet, with or without caffeine treatment (5 mg/Kg/day). The first 11 days of each phase included calorie restriction with four meals every day and 4 hours intervals. Significant weight and fat loss were observed after 4-weeks of CSD (5.7 +/- 1.24 Kg and 4.84 +/- 1.53 Kg) or CSD+Caffeine (7.57 +/- 2.33 Kg and 5.24 +/- 2.07 Kg) which was consistent for one month of the follow-up (CSD: 5.24 +/- 1.83 Kg and 4.3 +/- 1.62 Kg, CSD+ Caffeine: 12.11 +/- 2.31 Kg and 9.85 +/- 1.6 Kg, p < 0.05 vs CSD group) and correlated to the restricted energy intake (p < 0.05). During three CSD phases, RMR tended to remain unchanged in both groups. While, CSD or CSD + Caffeine treatments, significantly decreased plasma glucose, total-cholesterol, and triacylglycerol (p < 0.05), even during follow-up period (p < 0.05). HDL-cholesterol was not changed by CSD. Feeling of hunger decreased and subject's satisfaction increased after 4-weeks of CSD (p < 0.05) and remained low to the end of study, while satiety was not affected. Coffeine increased the effect of CSD on feeling of hunger and subject's satisfaction after week 7 (p < 0.05 vs. CSD).
   These findings indicated that combination of caffeine treatment with CSD could be an effective alternative approach to weight and fat loss with small changes in RMR and improved tolerance of subjects to the new diet.
C1 [Davoodi, Sayed Hossein] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Tehran, Iran.
   [Hajimiresmaiel, Seyed Javad] Iran Univ Med Sci, Dept Cardiol, Tehran, Iran.
   [Ajami, Marjan] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Dept Food & Nutr Policy & Planning Res, Tehran, Iran.
   [Mohseni-Bandpei, Anoushiravan] Shahid Beheshti Univ Med Sci, Sch Hlth, Tehran, Iran.
   [Ayatollahi, Seyyed Abdulmajid] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacognosy, Phytochem Res Ctr, Tehran, Iran.
   [Javedan, Gholamali] Iran Univ Med Sci, Dept Nutr, Tehran, Iran.
   [Pazoki-Toroudi, Hamidreza] Iran Univ Med Sci, Physiol Res Ctr, Tehran, Iran.
C3 Shahid Beheshti University Medical Sciences; Iran University of Medical
   Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti
   University Medical Sciences; Shahid Beheshti University Medical
   Sciences; Iran University of Medical Sciences; Iran University of
   Medical Sciences
RP Ajami, M (corresponding author), Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Dept Food & Nutr Policy & Planning Res, Tehran, Iran.
EM nutritionist80@gmail.com
RI Pazoki-Toroudi, Hamidreza/J-1564-2019; Javedan, Gholamali/AAS-2371-2021;
   Bandpi, Anoushirvan/AAW-4239-2020; Ayatollahi, Ali/W-4827-2019; Davoodi,
   Sayed/L-9142-2017; Davoodi, Seyed Hossein/AHE-7436-2022; Pazoki-Toroudi,
   Hamidreza/HWQ-5539-2023; ajami, marjan/AHE-7211-2022
OI Hajimiresmaiel, Seyed Javad/0000-0003-3998-066X; Davoodi, Seyed
   Hossein/0000-0002-6404-8367; Mohseni-Bandpei,
   Anoushirvan/0000-0003-0590-0975; Pazoki-Toroudi,
   Hamidreza/0000-0001-7868-456X; Davoodi, Sayed
   Hossein/0000-0001-7834-1911; ajami, marjan/0000-0002-6820-550X;
   Ayatollahi, Seyed Abdulmajid/0000-0003-2018-2406
CR Anton SD, 2009, J HUM NUTR DIET, V22, P141, DOI 10.1111/j.1365-277X.2008.00943.x
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Chaston TB, 2008, INT J OBESITY, V32, P619, DOI 10.1038/sj.ijo.0803761
   Das SK, 2007, AM J CLIN NUTR, V85, P1023, DOI 10.1093/ajcn/85.4.1023
   DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320
   Drapeau V, 2005, BRIT J NUTR, V93, P273, DOI 10.1079/BJN20041312
   Drapeau V, 2007, APPETITE, V48, P159, DOI 10.1016/j.appet.2006.08.002
   Drolet B, 2007, AM J CARDIOVASC DRUG, V7, P273, DOI 10.2165/00129784-200707040-00005
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Ellison RC, 2004, AM HEART J, V147, P529, DOI 10.1016/j.ahj.2003.10.033
   Eshghinia S, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-4
   Fardet L, 2007, REV MED INTERNE, V28, P284, DOI 10.1016/j.revmed.2006.12.013
   Harp JB, 2002, OBES RES, V10, P985, DOI 10.1038/oby.2002.134
   Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539
   Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005
   Klempel MC, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-35
   Kouda Katsuyasu, 2006, Environmental Health and Preventive Medicine, V11, P89, DOI 10.1007/BF02898148
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   Lee HO, 2013, NUTR RES PRACT, V7, P43, DOI 10.4162/nrp.2013.7.1.43
   Malik VS, 2007, NAT CLIN PRACT CARD, V4, P34, DOI 10.1038/ncpcardio0726
   Martin CK, 2007, OBESITY, V15, P2964, DOI 10.1038/oby.2007.354
   Martins C, 2008, P NUTR SOC, V67, P28, DOI 10.1017/S0029665108005995
   National Institutes of Health, 1996, The American Journal of Clinical Nutrition, V64, p524S, DOI [DOI 10.1093/ajcn/64.3.524S, 10.1093/ajcn/64.3.524S, DOI 10.1093/AJCN/64.3.524S]
   RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749
   Redman LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004377
   Tapsell L, 2010, NUTR METAB CARDIOVAS, V20, P317, DOI 10.1016/j.numecd.2009.04.007
   Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7
   Varady KA, 2009, AM J CLIN NUTR, V90, P1138, DOI 10.3945/ajcn.2009.28380
   Varma JL, 2007, AM J CLIN NUTR, V85, P1127, DOI 10.1093/ajcn/85.4.1127
   Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116
   Westerterp KR, 2003, OBES RES, V11, P865, DOI 10.1038/oby.2003.119
   Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323
NR 35
TC 22
Z9 25
U1 1
U2 26
PU SHAHEED BEHESHTI UNIV, SCH PHARMACY
PI TEHRAN
PA NO 10 SHAMS ALLEY, VALI-E ASR ST, TEHRAN, 00000, IRAN
SN 1735-0328
EI 1726-6890
J9 IRAN J PHARM RES
JI Iran. J. Pharm. Res.
PD SPR
PY 2014
VL 13
IS 2
BP 707
EP 718
PG 12
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA AI3AP
UT WOS:000336731100038
PM 25237367
DA 2025-04-28
ER

PT J
AU Egawa, T
   Tsuda, S
   Ma, X
   Hamada, T
   Hayashi, T
AF Egawa, Tatsuro
   Tsuda, Satoshi
   Ma, Xiao
   Hamada, Taku
   Hayashi, Tatsuya
TI Caffeine modulates phosphorylation of insulin receptor substrate-1 and
   impairs insulin signal transduction in rat skeletal muscle
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE serine phosphorylation; Akt; 5 '-AMP-activated protein kinase; p70 S6
   kinase; inhibitor-kappa B kinase
ID PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; 5'-AMP-ACTIVATED PROTEIN-KINASE;
   STIMULATED GLUCOSE-TRANSPORT; KAPPA-B KINASE; SERINE PHOSPHORYLATION;
   ACTIVATION; OBESITY; IRS-1; TRANSLOCATION; THEOPHYLLINE
AB Egawa T, Tsuda S, Ma X, Hamada T, Hayashi T. Caffeine modulates phosphorylation of insulin receptor substrate-1 and impairs insulin signal transduction in rat skeletal muscle. J Appl Physiol 111: 1629-1636, 2011. First published September 22, 2011; doi:10.1152/japplphysiol.00249.2011.-Caffeine decreases insulin sensitivity and insulin-stimulated glucose transport in skeletal muscle; however, the precise mechanism responsible for this deleterious effect is not understood fully. We investigated the effects of incubation with caffeine on insulin signaling in rat epitrochlearis muscle. Caffeine (>= 1 mM, >= 15 min) suppressed insulin-stimulated insulin receptor substrate (IRS)-1 Tyr(612) phosphorylation in a dose- and time-dependent manner. These responses were associated with inhibition of the insulin-stimulated phosphorylation of phosphatidylinositol 3-kinase (PI3K) Tyr(458), Akt Ser(473), and glycogen synthase kinase-3 beta Ser(9) and with inhibition of insulin-stimulated 3-O-methyl-D-glucose (3MG) transport but not with inhibition of the phosphorylation of insulin receptor-beta Tyr(1158/62/63). Furthermore, caffeine enhanced phosphorylation of IRS-1 Ser(307) and an IRS-1 Ser(307) kinase, inhibitor-kappa B kinase (IKK)-alpha/beta Ser(176/180). Blockade of IKK/IRS-1 Ser(307) by caffeic acid ameliorated the caffeine-induced downregulation of IRS-1 Tyr(612) phosphorylation and 3MG transport. Caffeine also increased the phosphorylation of IRS-1 Ser(789) and an IRS-1 Ser(789) kinase, 5'-AMP-activated protein kinase (AMPK). However, inhibition of IRS-1 Ser(789) and AMPK phosphorylation by dantrolene did not rescue the caffeine-induced downregulation of IRS-1 Tyr(612) phosphorylation or 3MG transport. In addition, caffeine suppressed the phosphorylation of insulin-stimulated IRS-1 Ser(636/639) and upstream kinases, including the mammalian target of rapamycin and p70S6 kinase. Intravenous injection of caffeine at a physiological dose (5 mg/kg) in rats inhibited the phosphorylation of insulin-stimulated IRS-1 Tyr(612) and Akt Ser(473) in epitrochlearis muscle. Our results indicate that caffeine inhibits insulin signaling partly through the IKK/IRS-1 Ser(307) pathway, via a Ca2+- and AMPK-independent mechanism in skeletal muscle.
C1 [Hayashi, Tatsuya] Kyoto Univ, Grad Sch Human & Environm Studies, Lab Sports & Exercise Med, Sakyo Ku, Kyoto 6068501, Japan.
   [Hamada, Taku] Osaka Univ Hlth & Sport Sci, Dept Hlth & Sports Management, Osaka, Japan.
C3 Kyoto University
RP Hayashi, T (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Lab Sports & Exercise Med, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto 6068501, Japan.
EM tatsuya@kuhp.kyoto-u.ac.jp
RI Ma, xiao/LFG-1914-2024; Egawa, Tatsuro/ACS-3911-2022
OI MA, Xiao/0000-0003-0044-531X; hayashi, Tatsuya/0000-0001-7600-4735;
   Egawa, Tatsuro/0000-0001-9363-1589
FU All Japan Coffee Association; Nestle Nutrition Council of Japan; Japan
   Vascular Disease Research Foundation; Japan Society for the Promotion of
   Science [22500616, 20500576]; Grants-in-Aid for Scientific Research
   [22500616, 23617009, 20500576, 10J00163] Funding Source: KAKEN
FX T. Egawa was supported by a Research Fellowship of the Japan Society for
   the Promotion of Science for Young Scientists. T. Hayashi was supported
   by Japan Society for the Promotion of Science Research Grant 20500576,
   the All Japan Coffee Association, the Nestle Nutrition Council of Japan,
   and the Japan Vascular Disease Research Foundation. T. Hamada was
   supported by Japan Society for the Promotion of Science Research Grant
   22500616 and the All Japan Coffee Association.
CR Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009
   Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279
   ABRAMOFF M. D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1201/9781420005615.AX4, DOI 10.1117/1.3589100]
   Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200
   Battram DS, 2005, J PHYSIOL-LONDON, V569, P347, DOI 10.1113/jphysiol.2005.097444
   Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008
   Corbould A, 2006, DIABETES, V55, P751, DOI 10.2337/diabetes.55.03.06.db05-0453
   D'Alessandris C, 2007, DIABETOLOGIA, V50, P840, DOI 10.1007/s00125-006-0522-y
   de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200
   DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667
   Egawa T, 2011, ACTA PHYSIOL, V201, P227, DOI 10.1111/j.1748-1716.2010.02169.x
   Egawa T, 2009, METABOLISM, V58, P1609, DOI 10.1016/j.metabol.2009.05.013
   Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833
   Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200
   FREDHOLM BB, 1980, TRENDS PHARMACOL SCI, V1, P129
   Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019
   Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069
   Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369
   Hiratani K, 2005, BIOCHEM BIOPH RES CO, V335, P836, DOI 10.1016/j.bbrc.2005.07.152
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200
   Iwanaka N, 2010, J APPL PHYSIOL, V108, P274, DOI 10.1152/japplphysiol.00420.2009
   Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200
   Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V293, pE286, DOI 10.1152/ajpendo.00693.2006
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kolnes AJ, 2010, ACTA PHYSIOL, V200, P65, DOI 10.1111/j.1748-1716.2010.02103.x
   Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870
   Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566
   LELO A, 1986, CLIN PHARMACOL THER, V39, P54, DOI 10.1038/clpt.1986.10
   Moon MK, 2009, BIOL PHARM BULL, V32, P1371, DOI 10.1248/bpb.32.1371
   Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151
   Qiao LY, 2002, J BIOL CHEM, V277, P26530, DOI 10.1074/jbc.M201494200
   Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003
   Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674
   Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   YOUN JH, 1991, AM J PHYSIOL, V260, pC555, DOI 10.1152/ajpcell.1991.260.3.C555
   YOUNG DA, 1986, J BIOL CHEM, V261, P6049
   Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200
NR 45
TC 29
Z9 35
U1 0
U2 9
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD DEC
PY 2011
VL 111
IS 6
BP 1629
EP 1636
DI 10.1152/japplphysiol.00249.2011
PG 8
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA 865YF
UT WOS:000298346100017
PM 21940847
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Vukovich, MD
   Schoorman, R
   Heilman, C
   Jacob, P
   Benowitz, NL
AF Vukovich, MD
   Schoorman, R
   Heilman, C
   Jacob, P
   Benowitz, NL
TI Caffeine-herbal ephedra combination increases resting energy
   expenditure, heart rate and blood pressure
SO CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
LA English
DT Article
DE caffeine; dietary supplement; ephedrine; herbal medicine; Ma Huang
ID CENTRAL-NERVOUS-SYSTEM; DOUBLE-BLIND; WEIGHT-LOSS; DIETARY-SUPPLEMENTS;
   MA HUANG; SAFETY; EFFICACY; PLACEBO; OBESE; THERMOGENESIS
AB 1. The purpose of the present study was to determine whether the consumption of an acute dose of caffeine and Ma Huang increases resting energy expenditure (REE), heart rate (HR) and blood pressure (BP) over a 3 h period.
   2. A randomized, double-blind cross-over study was performed evaluating the acute effects of caffeine (150 mg)/herbal ephedra (Ma Huang; 20 mg ephedra alkaloids) versus a placebo. A total of eight healthy subjects (four males and four females) with a mean (+/-SD) age of 23.4 +/- 0.8 years (mean ages for males and females: 25.3 +/- 0.7 and 22.0 +/- 0.7 years, respectively) and 22.5 +/- 3.1% body fat (15.7 +/- 1.2 and 27.6 +/- 3.5% body fat for males and females, respectively) were recruited to the study. Participants were moderate caffeine users (approximately 150-300 mg/day).
   3. Subjects reported to the laboratory following a 12 h fast and 48 h of a caffeine-free diet. Resting energy expenditure was measured prior to supplementation and for 15 min every 30 min for 3 h following supplementation. Heart rate and BP were obtained every 15 min. Blood samples were obtained every 30 min following the measurement of REE and analysed for caffeine, ephedrine, free fatty acids and glucose.
   4. By 3 h, HR was 22.7 +/- 5.5% higher (P < 0.05) than baseline for the caffeine/ephedra trial compared with 8.9 +/- 2.2% higher for the placebo grou. At 3 h, systolic BP was 9.1 +/- 2.2% higher (P < 0.05) than baseline for the caffeine/ephedra trial compared with only 1.9 +/- 2.9% different from baseline for the placebo trial. There was no effect of the caffeine/ephedra combination on diastolic BP. Resting energy expenditure during the last 30 min was 4.5 +/- 2.5% higher in the placebo trial and 10.7 +/- 2.5% higher (P < 0.05) in the caffeine/ephedra trial; REE was 8.5 +/- 2.0% higher (P < 0.05) in the caffeine/ephedra trial compared with the placebo trial. Free fatty acids increased over time in the placebo and caffeine/ephedra trials (from 0.5 +/- 0.05 to 0.63 +/- 0.05 mEq/L and from 0.48 +/- 0.06L to 0.8 +/- 0.05 mEq/L, respectively).
   5. Caffeine and herbal ephedra, at doses of 150 mg and 20 mg (ephedrine), respectively, result in a significant elevation in REE, HR and BP. Although significant, the increase in energy expenditure is negligible in terms of weight loss.
C1 S Dakota State Univ, Dept Hlth Phys Educ & Recreat, Appl Physiol Lab, Brookings, SD 57007 USA.
   Univ Calif San Francisco, San Francisco Gen Hosp, Div Clin Pharmacol, San Francisco, CA USA.
C3 South Dakota State University; University of California System;
   University of California San Francisco; San Francisco General Hospital
   Medical Center
RP S Dakota State Univ, Dept Hlth Phys Educ & Recreat, Appl Physiol Lab, Box 2820, Brookings, SD 57007 USA.
EM matt.vukovich@sdstate.edu
OI Vukovich, Matthew/0000-0001-6621-8588
FU National Institute on Drug Abuse [P30DA012393] Funding Source: NIH
   RePORTER; NIDA NIH HHS [DA02277, DA012393] Funding Source: Medline
CR Armstrong W.J., 2001, Journal of Exercise Physiology Online, V4, P28
   ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   ASTRUP A, 1992, METABOLISM, V41, P686, DOI 10.1016/0026-0495(92)90304-S
   ASTRUP A, 1990, CURR THER RES CLIN E, V48, P1087
   Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   BYE C, 1974, BRIT J CLIN PHARMACO, V1, P71, DOI 10.1111/j.1365-2125.1974.tb00209.x
   DALY PA, 1993, INT J OBESITY, V17, pS73
   DULLOO AG, 1986, INT J OBESITY, V10, P467
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Haller CA, 2002, CLIN PHARMACOL THER, V71, P421, DOI 10.1067/mcp.2002.124523
   Horton TJ, 1996, INT J OBESITY, V20, P91
   Jacob P, 2004, J ANAL TOXICOL, V28, P152, DOI 10.1093/jat/28.3.152
   Kalman D, 2002, INT J OBESITY, V26, P1363, DOI 10.1038/sj.ijo.0802061
   KRIEGER DR, 1990, T ASSOC AM PHYSICIAN, V53, P307
   LIU YL, 1995, INT J OBESITY, V19, P678
   MARTIN WR, 1971, CLIN PHARMACOL THER, V12, P245
   PASQUALI R, 1985, INT J OBESITY, V9, P93
   Samenuk D, 2002, MAYO CLIN PROC, V77, P12, DOI 10.4065/77.1.12
   Shannon JR, 1999, CLIN SCI, V96, P483, DOI 10.1042/CS19980206
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
NR 23
TC 38
Z9 43
U1 0
U2 35
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1870
EI 1440-1681
J9 CLIN EXP PHARMACOL P
JI Clin. Exp. Pharmacol. Physiol.
PD JAN-FEB
PY 2005
VL 32
IS 1-2
BP 47
EP 53
DI 10.1111/j.1440-1681.2005.04152.x
PG 7
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA 900XX
UT WOS:000227248700009
PM 15730434
DA 2025-04-28
ER

PT J
AU Petrie, HJ
   Chown, SE
   Belfie, LM
   Duncan, AM
   McLaren, DH
   Conquer, JA
   Graham, TE
AF Petrie, HJ
   Chown, SE
   Belfie, LM
   Duncan, AM
   McLaren, DH
   Conquer, JA
   Graham, TE
TI Caffeine ingestion increases the insulin response to an
   oral-glucose-tolerance test in obese men before and after weight loss
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE insulin resistance; type 2 diabetes; carbohydrate; proinsulin; beta cell
   function; hyperinsulinemia; oral-glucose-tolerance test; exercise;
   insulin sensitivity index
ID BETA-CELL FUNCTION; PLASMA-INSULIN; INDUCED IMPAIRMENT; INTACT
   PROINSULIN; DIABETES-MELLITUS; ADIPOSE-TISSUE; RISK-FACTORS; EXERCISE;
   RESISTANCE; FAT
AB Background: Caffeine ingestion decreases the insulin sensitivity index (ISI) for an oral-glucose-tolerance test (OGTT) and decreases insulin-induced glucose disposal in lean mate subjects during a hyperinsulinemic clamp.
   Objective: We examined the effects of caffeine ingestion on insulin and glucose homeostasis in obese men before and after a nutrition and exercise intervention.
   Design: Nine sedentary, obese [body mass index (in kg/m(2)): 34.0 +/- 1.0] men who had refrained from exercise and caffeine ingestion for 48 h underwent 2 oral-glucose-tolerance tests (OGTTs). The subjects randomly received caffeine (5 mg/kg) or placebo I h before each OGTT. After a 12-wk nutrition and exercise intervention, during which time the subjects avoided dietary caffeine, the OGTTs were repeated.
   Results: The intervention resulted in decreases (P less than or equal to 0.05) in body weight (8.5 +/- 1.5 kg), percentage body fat (2.8 +/- 0.7%), and fasting glucose, insulin, and proinsulin concentrations and increases in the ISI for the placebo OGTT (P less than or equal to 0.05). Caffeine caused a greater (P less than or equal to 0.05) OGTT insulin response and a lower (P less than or equal to 0.05) ISI both before and after weight loss. The proinsulin-insulin ratio indicated that neither weight loss nor caffeine affected the nature of the beta cell secretion of insulin.
   Conclusions: A nutrition and exercise intervention improved, whereas caffeine ingestion impaired, insulin-glucose homeostasis in obese men. The results are consistent with previous findings that caffeine ingestion contributes to insulin resistance.
C1 Univ Guelph, Dept Human Biol & Nutrit Sci, Guelph, ON N1G 2W1, Canada.
C3 University of Guelph
RP Univ Guelph, Dept Human Biol & Nutrit Sci, Guelph, ON N1G 2W1, Canada.
EM terrygra@uoguelph.ca
CR ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245
   ANDERSON JW, 1994, MODERN NUTR HLTH DIS, P1259
   [Anonymous], 1994, Prevention of diabetes mellitus.Report of a WHO Study Group, P844
   ARNAUD NJ, 1993, CAFFEINE COFFEE HLTH, P43
   Bergmeyer HU., 1974, Methods of Enzymatic Analysis, P1196
   Birmingham CL, 1999, CAN MED ASSOC J, V160, P483
   BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493
   BRODSKY EG, 1994, MODERN NUTR HLTH DIS, P603
   Bruton JD, 2002, FASEB J, V16, P301, DOI 10.1096/fj.02-0481fje
   Cairney J, 1998, INT J OBESITY, V22, P584, DOI 10.1038/sj.ijo.0800632
   CAREY GB, 1994, INT J OBESITY, V18, P155
   Carey GB, 2000, J APPL PHYSIOL, V88, P881, DOI 10.1152/jappl.2000.88.3.881
   DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938
   DESPRES JP, 1989, DIABETES, V38, P304, DOI 10.2337/diabetes.38.3.304
   FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x
   Fritsche A, 2002, DIABETES, V51, pS234, DOI 10.2337/diabetes.51.2007.S234
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   GUTMANN OI, 1974, METHOD ENZYMAT AN, P1464
   Han DH, 1998, DIABETES, V47, P1671, DOI 10.2337/diabetes.47.11.1671
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   KNOWLER WC, 1990, DIABETES METAB REV, V6, P1, DOI 10.1002/dmr.5610060101
   Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512
   LOVEJOY J, 1992, AM J CLIN NUTR, V55, P1174, DOI 10.1093/ajcn/55.6.1174
   LOWRY OH, 1993, ENZYMATIC ANAL PRACT, P171
   Marshall JA, 1997, DIABETOLOGIA, V40, P430, DOI 10.1007/s001250050697
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Nagi DK, 1998, DIABETES CARE, V21, P127, DOI 10.2337/diacare.21.1.127
   Nicklas BJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE72, DOI 10.1152/ajpendo.1996.270.1.E72
   Oakes ND, 1997, DIABETES, V46, P1768, DOI 10.2337/diabetes.46.11.1768
   Obesity, 2000, World Health Organ Tech Rep Ser, V894, P1, DOI DOI 10.1016/J.BBI.2016.02.019
   OLEFSKY JM, 1995, AM J CLIN NUTR, V61, p980S, DOI 10.1093/ajcn/61.4.980S
   Pascot A, 2000, DIABETOLOGIA, V43, P1126, DOI 10.1007/s001250051503
   POLONSKY KS, 1994, DIABETES, V43, P871, DOI 10.2337/diabetes.43.7.871
   REAVEN GM, 1993, J CLIN ENDOCR METAB, V76, P44, DOI 10.1210/jc.76.1.44
   REGENSTEINER JG, 1991, DIABETES CARE, V14, P1066, DOI 10.2337/diacare.14.11.1066
   Rice B, 1999, DIABETES CARE, V22, P684, DOI 10.2337/diacare.22.5.684
   Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742
   Roder ME, 1999, DIABETES CARE, V22, P609, DOI 10.2337/diacare.22.4.609
   Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008
   SHIRAISHI I, 1991, DIABETOLOGIA, V34, P737, DOI 10.1007/BF00401520
   SONNICHSEN AC, 1992, METABOLISM, V41, P1035, DOI 10.1016/0026-0495(92)90134-V
   Spiller M.A., 1998, Caffeine, P97
   TANG BK, 1986, J CHROMATOGR, V375, P170, DOI 10.1016/S0378-4347(00)83706-8
   Thong FSL, 2002, CAN J APPL PHYSIOL, V27, P152, DOI 10.1139/h02-011
   Thong FSL, 2002, J APPL PHYSIOL, V92, P2347, DOI 10.1152/japplphysiol.01229.2001
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Nieuwenhoven MA, 2000, J APPL PHYSIOL, V89, P1079, DOI 10.1152/jappl.2000.89.3.1079
   VERGAUWEN L, 1994, J CLIN INVEST, V93, P974, DOI 10.1172/JCI117104
   Wang PW, 1997, J CLIN ENDOCR METAB, V82, P3221, DOI 10.1210/jc.82.10.3221
NR 53
TC 69
Z9 79
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD JUL
PY 2004
VL 80
IS 1
BP 22
EP 28
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 830NB
UT WOS:000222128000005
PM 15213023
DA 2025-04-28
ER

PT J
AU Jacobs, DM
   Hodgson, AB
   Randell, RK
   Mahabir-Jagessar-T, K
   Garczarek, U
   Jeukendrup, AE
   Mela, DJ
   Lotito, S
AF Jacobs, Doris M.
   Hodgson, Adrian B.
   Randell, Rebecca K.
   Mahabir-Jagessar-T, Krishna
   Garczarek, Ursula
   Jeukendrup, Asker E.
   Mela, David J.
   Lotito, Silvina
TI Metabolic Response to Decaffeinated Green Tea Extract during Rest and
   Moderate-Intensity Exercise
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE green tea; catechin; caffeine; metabolomics; exercise; fat oxidation
ID FAT OXIDATION; ENERGY-EXPENDITURE; CATECHIN-POLYPHENOLS; BODY-WEIGHT;
   CAFFEINE; INGESTION; CONSUMPTION; THERMOGENESIS; OVERWEIGHT; EFFICACY
AB We previously reported that a 7 day ingestion of caffeinated green tea extract (cGTE) induced marked metabolic differences during rest and exercise. Here, we report the metabolic effects of 1, 7, and 28 day ingestions of decaffeinated GTE (dGTE). In this crossover placebo-controlled study, 19 healthy males ingested dGTE or placebo (PLA) for 28 days, separated by a 28 day wash-out period. On days 1, 7, and 28, participants completed a 30 min cycling exercise 2 h after the ingestion of dGTE or PLA. Blood samples were collected at rest (t = 0 and 120 min) and during exercise (t = 150 min). Plasma was analyzed using untargeted four-phase metabolite profiling and targeted profiling of catecholamines and catechins. dGTE abolished several metabolic effects when compared to our previous study with cGTE. However, following 7 and 28 day dGTE ingestions, increases in 3-hydroxybutyrate, a metabolic marker of fat oxidation, were observed at t = 0 min. dGTE ingestion did not induce significant acute or acute-on-chronic effects on endogenous metabolites just prior to and during exercise.
C1 [Hodgson, Adrian B.; Randell, Rebecca K.; Jeukendrup, Asker E.] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England.
   [Jacobs, Doris M.; Mahabir-Jagessar-T, Krishna; Garczarek, Ursula; Mela, David J.] Unilever R&D, NL-3130 AC Vlaardingen, Netherlands.
   [Lotito, Silvina] Unilever R&D, Sharnbrook MK44 1LQ, Beds, England.
C3 University of Birmingham; Unilever; Unilever
RP Jacobs, DM (corresponding author), Unilever R&D, Olivier van Noortlaan 120, NL-3130 AC Vlaardingen, Netherlands.
EM doris.jacobs@unilever.com
RI Mela, David/LKJ-1837-2024; Jeukendrup, Asker/D-1770-2010
FU Unilever RD
FX This research was funded by Unilever R&D.
CR Achten J, 2004, INT J SPORTS MED, V25, P32, DOI 10.1055/s-2003-45231
   [Anonymous], 2008, A language and environment for statistical computing
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a
   Brugnara L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040600
   Chorell E, 2009, J PROTEOME RES, V8, P2966, DOI 10.1021/pr900081q
   Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eichenberger P, 2009, INT J VITAM NUTR RES, V79, P24, DOI 10.1024/0300-9831.79.1.24
   Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4
   Glube Natalie, 2013, Results Pharma Sci, V3, P1, DOI 10.1016/j.rinphs.2013.08.002
   Graham TE, 2000, J PHYSIOL-LONDON, V529, P837, DOI 10.1111/j.1469-7793.2000.00837.x
   Gruz J, 2008, FOOD CHEM, V111, P789, DOI 10.1016/j.foodchem.2008.05.014
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Hodgson AB, 2014, J AGR FOOD CHEM, V62, P1198, DOI 10.1021/jf404872y
   Hodgson AB, 2013, ADV NUTR, V4, P129, DOI 10.3945/an.112.003269
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396
   Ichinose T, 2011, SCAND J MED SCI SPOR, V21, P598, DOI 10.1111/j.1600-0838.2009.01077.x
   Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022
   Kovacs EMR, 2006, OBES REV, V7, P59, DOI 10.1111/j.1467-789X.2006.00203.x
   Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519
   Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Moore RJ, 2009, BRIT J NUTR, V102, P1790, DOI 10.1017/S0007114509991218
   Morris C, 2013, MOL NUTR FOOD RES, V57, P1246, DOI 10.1002/mnfr.201200629
   Pinheiro J., 2009, And the R Core team nlme: Linear and Nonlinear Mixed Effects Models
   Pohjanen E, 2007, J PROTEOME RES, V6, P2113, DOI 10.1021/pr070007g
   Randell RK, 2014, MED SCI SPORT EXER, V46, P1185, DOI 10.1249/MSS.0000000000000205
   Randell RK, 2013, MED SCI SPORT EXER, V45, P883, DOI 10.1249/MSS.0b013e31827dd9d4
   Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646
   van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yamada H, 2002, J ANAL TOXICOL, V26, P17, DOI 10.1093/jat/26.1.17
NR 46
TC 16
Z9 18
U1 1
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD OCT 8
PY 2014
VL 62
IS 40
BP 9936
EP 9943
DI 10.1021/jf502764r
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA AQ7RF
UT WOS:000343016200037
PM 25195522
DA 2025-04-28
ER

PT J
AU Jo, DH
   Lee, S
   Lee, JD
AF Jo, Dae-Hyun
   Lee, Seunghoon
   Lee, Jae-Dong
TI Effects of Gambisan in overweight adults and adults with obesity A
   retrospective chart review
SO MEDICINE
LA English
DT Review
DE retrospective chart review; Traditional Korean Medicine; herbal
   medicine; Gambisan; weight loss; obesity; overweight
ID WEIGHT-LOSS; DOUBLE-BLIND; HERBAL SUPPLEMENT; EPHEDRINE; CAFFEINE;
   EFFICACY; SAFETY; SIBUTRAMINE; HEALTH; THERMOGENESIS
AB Objective: A retrospective chart review was conducted to explore the effect of Gambisan, a granular extract of novel herbal medicine, for short-term (<= 16 weeks) weight loss in adults who are overweight and those with obesity. Methods: Outpatients of Kyung Hee University Korean Medicine Hospital (Seoul, Korea) who took Gambisan and underwent bioelectric impedance analysis were selected (Jan 2011 to Dec 2015); their electronic medical records and clinical charts were retrospectively reviewed. The effectiveness of Gambisan was primarily evaluated by comparing body weight (BW) at baseline and endpoint, using paired t tests; the safety of Gambisan was evaluated on the basis of adverse events (AEs) experienced by patients. Results: Two hundred five patients were included in this study. The study population exhibited a significant reduction in BW (73.69 +/- 14.49 kg to 69.01 +/- 13.20 kg, P < .001) as well as percentage body fat (37.38 +/- 5.38% to 34.50 +/- 5.83%, P < .001). Moreover, 111 (54.1%) patients achieved modest weight loss (>= 5%), while 35 (17.1%) achieved >= 10% weight loss. Furthermore, Gambisan induced significant reduction of BW in all subgroups (body mass index, sex, prescribed duration, and dosage). Among 139 patients with available data, 79 (56.8%) reported loss-of-appetite. In addition, 120 (mostly mild) AEs were reported in 69 (49.6%) patients, and the most frequent AEs were nausea, palpitation, and insomnia. Discussion: Despite limitations in interpreting the results of this retrospective medical record review, Gambisan induced statistically and clinically meaningful weight loss with a tolerable level of AEs. Based on the findings of this review, further well-designed clinical trials are warranted.
C1 [Jo, Dae-Hyun; Lee, Seunghoon; Lee, Jae-Dong] Kyung Hee Univ, Coll Korean Med, Dept Acupuncture & Moxibust, 3 Kyungheedae Ro, Seoul 02447, South Korea.
   [Jo, Dae-Hyun] Minist Hlth & Welf, Dept Korean Med, Bur Hlth Policy, Geumwang Hlth Subctr, Seoul, South Korea.
C3 Kyung Hee University
RP Lee, JD (corresponding author), Kyung Hee Univ, Coll Korean Med, Dept Acupuncture & Moxibust, 3 Kyungheedae Ro, Seoul 02447, South Korea.
EM ljdacu@gmail.com
RI Lee, Seunghoon/ABC-8506-2020
OI Lee, Seunghoon/0000-0003-0088-2296
FU Traditional Korean Medicine Research and Development Program; Ministry
   of Health and Welfare through the Korea Health Industry Development
   Institute [HI16C0300010017]
FX This study was supported by the Traditional Korean Medicine Research and
   Development Program granted by the Ministry of Health and Welfare
   through the Korea Health Industry Development Institute
   (HI16C0300010017). The funding bodies played no role in the study
   design, data collection, analysis, decision to publish, or preparation
   of the manuscript.
CR An SM, 2001, THESIS
   [Anonymous], EVID BASED COMPLEMEN
   ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   Balaji M, 2016, OBES RES CLIN PRACT, V10, P363, DOI 10.1016/j.orcp.2015.12.004
   Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   Casacchia T, 2019, EUR J NUTR, V58, P965, DOI 10.1007/s00394-018-1609-1
   Choi CJ, 2005, KOREAN J OBES, V14, P155
   Clinical Research Information Service: Cheongju (Chungcheongbuk-do): Korea Centers for Disease Control and Prevention (Korea), ID KCT0002193 EFF SA
   Coffey CS, 2004, INT J OBESITY, V28, P1411, DOI 10.1038/sj.ijo.0802784
   Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235
   de Castro Joao Jacome, 2009, Rev Port Cardiol, V28, P1361
   de Freitas LM, 2017, AM J TRANSL RES, V9, P2050
   곽현영, 2011, Journal of Acupuncture Research, V28, P103
   DULLOO AG, 1986, INT J OBESITY, V10, P467
   DULLOO AG, 1991, INT J OBESITY, V15, P317
   Greenway FL, 2004, OBES RES, V12, P1152, DOI 10.1038/oby.2004.144
   Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972
   Hackman RM, 2006, INT J OBESITY, V30, P1545, DOI 10.1038/sj.ijo.0803283
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Horton TJ, 1996, INT J OBESITY, V20, P91
   Hwang M.-J., 2007, J. Soc. Korean Med. Obes. Res, V7, P39
   James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114
   Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13
   Kim HJ, 2008, J ACUPUNCT MERIDIAN, V1, P128, DOI 10.1016/S2005-2901(09)60033-9
   Kim HO, 2013, KOREAN J FAM MED, V34, P298, DOI 10.4082/kjfm.2013.34.5.298
   Kim HU, 2015, NAT BIOTECHNOL, V33, P264, DOI 10.1038/nbt.3167
   Kim KK, 2006, YONSEI MED J, V47, P614, DOI 10.3349/ymj.2006.47.5.614
   Korean Society of Study of Obesity, 2014, GUID MAN OB
   *NAT CANC I, COMM TERM CRIT ADV E
   Odunsi ST, 2010, OBESITY, V18, P1579, DOI 10.1038/oby.2009.421
   Park HS, 2008, KOREAN J OBES, V17, P82
   Park S, 2013, HEALTH POLICY, V113, P100, DOI 10.1016/j.healthpol.2013.06.005
   Park S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-33
   Pérez-Jiménez A, 2016, PHYTOMEDICINE, V23, P1301, DOI 10.1016/j.phymed.2016.07.001
   Porter JA, 2004, AM J MANAG CARE, V10, P369
   Ramsey JJ, 1998, AM J CLIN NUTR, V68, P42, DOI 10.1093/ajcn/68.1.42
   Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Shin HY, 2017, J EPIDEMIOL, V27, P413, DOI 10.1016/j.je.2016.08.014
   Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155
   Washburn RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109849
   Wirth A, 2001, JAMA-J AM MED ASSOC, V286, P1331, DOI 10.1001/jama.286.11.1331
   World Health Organization, 2018, OB OV FACT SHEET UPD
   신대희, 2008, [The Journal of Herbal Formula Science, 대한한의학 방제학회지], V16, P133
NR 45
TC 6
Z9 6
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD NOV
PY 2019
VL 98
IS 47
AR 18060
DI 10.1097/MD.0000000000018060
PG 8
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA KD4VV
UT WOS:000507864900066
PM 31764835
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Gregersen, NT
   Bitz, C
   Krog-Mikkelsen, I
   Hels, O
   Kovacs, EMR
   Rycroft, JA
   Frandsen, E
   Mela, DJ
   Astrup, A
AF Gregersen, Nikolaj T.
   Bitz, Christian
   Krog-Mikkelsen, Inger
   Hels, Ole
   Kovacs, Eva M. R.
   Rycroft, Jane A.
   Frandsen, Erik
   Mela, David J.
   Astrup, Arne
TI Effect of moderate intakes of different tea catechins and caffeine on
   acute measures of energy metabolism under sedentary conditions
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Green tea catechins; Caffeine; Energy expenditure; Substrate oxidation
ID X-RAY ABSORPTIOMETRY; GREEN TEA; FAT OXIDATION; FOOD INGREDIENTS; OBESE
   SUBJECTS; ABDOMINAL FAT; BODY-WEIGHT; BLACK TEA; EXPENDITURE; HUMANS
AB Green tea may stimulate energy metabolism; however, it is unclear if acute effects are caused by specific catechins, caffeine or their combination. The objective of the present study was to examine the separate and combined effects of different catechins and caffeine on energy expenditure (EE) and fat oxidation over a single day. Fifteen healthy, normal-weight males received capsules containing placebo, caffeine alone (150mg), or caffeine plus a catechin mixture (600 mg) enriched in either epigallocatechin-3-gallate (EGCG), epigallocatechin or a mix of catechins, in a randomised cross-over double-blinded design. On each test day EE, respiratory quotient (RQ) and substrate oxidation were measured under sedentary conditions in a respiratory chamber for 13.5h. We found no significant treatment effect on EE (P=0.20) or RQ (P=0.68). EGCG with caffeine insignificantly raised EE and fat oxidation v. caffeine-only and placebo (EE 5.71 (SE 0.12) v. 5.68 (SE, 0.14) v. 5.59 (SE 0.13) MJ/12.5h, respectively; fat oxidation 84.8 (SE, 5.2) v. 80.7 (SE 4.7) v. 76.8 (SE 4.0) g/12.5h). Catechin/caffeine combinations at these dosages and mode of application had non-significant acute effects on EE and fat oxidation. The maximum observed effect on EE of about 2 % could still be meaningful for energy balance over much longer period of exposure. However, higher short-term effects reported in the literature may reflect variations in green tea extracts, added caffeine, or synergies with physical activity. The specific mechanisms and conditions that may underpin observed longer-term benefits of catechin-enriched green tea consumption on body composition remain to be confirmed.
C1 [Gregersen, Nikolaj T.; Bitz, Christian; Krog-Mikkelsen, Inger; Astrup, Arne] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, DK-1958 Frederiksberg C, Denmark.
   [Hels, Ole] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark.
   [Kovacs, Eva M. R.] Unilever N Amer, Englewood Cliffs, NJ USA.
   [Rycroft, Jane A.] Unilever R&D Colworth Pk, Lipton Inst Tea, Sharnbrook, Beds, England.
   [Frandsen, Erik] Glostrup Univ Hosp, Dept Clin Physiol & Nucl Med, Glostrup, Denmark.
   [Mela, David J.] Unilever Res Labs, Vlaardingen, Netherlands.
C3 University of Copenhagen; Technical University of Denmark; Unilever;
   Unilever; University of Copenhagen; Copenhagen University Hospital;
   Unilever
RP Gregersen, NT (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Human Nutr, Rolighedsvej 30, DK-1958 Frederiksberg C, Denmark.
EM ntg@life.ku.dk
RI Mela, David/LKJ-1837-2024; Astrup, Arne/HZL-1679-2023; Astrup,
   Arne/B-1407-2015
OI Astrup, Arne/0000-0001-8968-8996; Mela, David/0000-0003-1824-4305
FU Unilever R&D Vlaardingen, The Netherlands
FX The present study was supported by the Unilever R&D Vlaardingen, The
   Netherlands.
CR ASTRUP A, 1994, AM J CLIN NUTR, V59, P350, DOI 10.1093/ajcn/59.2.350
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Desbrow B, 2007, FOOD CHEM TOXICOL, V45, P1588, DOI 10.1016/j.fct.2007.02.020
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Elia M, 1992, World Rev Nutr Diet, V70, P68
   Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083
   HAARBO J, 1991, CLIN PHYSIOL, V11, P331, DOI 10.1111/j.1475-097X.1991.tb00662.x
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Henning SM, 2004, AM J CLIN NUTR, V80, P1558
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857
   Hsu TF, 2006, EUR J CLIN NUTR, V60, P1330, DOI 10.1038/sj.ejcn.1602464
   Jin Yinzhe, 2006, Biotechnology Journal, V1, P209, DOI 10.1002/biot.200500019
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kovacs EMR, 2006, OBES REV, V7, P59, DOI 10.1111/j.1467-789X.2006.00203.x
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106, DOI 10.1093/ajcn/51.6.1106
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Reto M, 2007, PLANT FOOD HUM NUTR, V62, P139, DOI 10.1007/s11130-007-0054-8
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   TOUBRO S, 1995, INT J OBESITY, V19, P544
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   Van Amelsvoort JMM, 2001, XENOBIOTICA, V31, P891, DOI 10.1080/00498250110079149
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Warden BA, 2001, J NUTR, V131, P1731, DOI 10.1093/jn/131.6.1731
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
NR 37
TC 43
Z9 46
U1 0
U2 29
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD OCT 28
PY 2009
VL 102
IS 8
BP 1187
EP 1194
DI 10.1017/S0007114509371779
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 513TX
UT WOS:000271347800011
PM 19445822
OA Bronze
DA 2025-04-28
ER

PT J
AU Persky, AM
   Ng, C
   Song, MH
   Lancaster, ME
   Balderson, DE
   Paulik, MA
   Brouwer, KLR
AF Persky, AM
   Ng, C
   Song, MH
   Lancaster, ME
   Balderson, DE
   Paulik, MA
   Brouwer, KLR
TI Comparison of the acute pharmacodynamic responses after single doses of
   ephedrine or sibutramine in healthy, overweight volunteers
SO INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
LA English
DT Article
DE weight loss; infrared thermography; therapeutic index
ID ENERGY-EXPENDITURE; WEIGHT-LOSS; ADIPOSE-TISSUE; WOMEN; CAFFEINE; OBESE
AB Objective: With an increase in the incidence of obesity, tremendous effort has been devoted to the development of weight loss agents and the prospective surrogate markers of both a product's efficacy and safety. The objective of the present study was to compare the pharmacodynamic responses of ephedrine and sibutramine using surrogate markers of weight loss potential and potential adverse events. Design and subjects: The study was designed as a 5-way, randomized, double-blinded, placebo-controlled trial with 3 single doses of ephedrine sulfate (0.25, 0.5 and 1 mg x kg(-1)) followed by an open-labeled sibutramine (10 mg) treatment. Healthy, mildly overweight (BMI = 25) subjects were administered the respective treatment and pharmacokinetic and pharmacodynamic measurements (body surface temperature, resting metabolic rate, blood pressure, heart rate, glucose, glycerol, nonesterified fatty acids, triglycerides) were obtained for 8 hours post dose and for an additional 4 measurements during the sibutramine treatment period. Results: Sibutramine treatment significantly increased resting metabolic rate compared to the placebo condition. Ephedrine significantly increased heart rate, systolic blood pressure and glucose but did not significantly affect other measurements. Conclusion: Both sibutramine and ephedrine have been shown to have weight loss potential, however, they elicit different metabolic and biochemical responses after a single dose. The nontherapeutic responses from these types of compounds may serve as a screening tool for the development of agents in the treatment of obesity.
C1 Univ N Carolina, Div Drug Delivery & Disposit, Sch Pharm, Chapel Hill, NC 27599 USA.
   GlaxoSmithKline, Res Triangle Pk, NC USA.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   GlaxoSmithKline; Glaxosmithkline USA
RP Univ N Carolina, Div Drug Delivery & Disposit, Sch Pharm, Kerr Hall,CB 7360, Chapel Hill, NC 27599 USA.
RI Persky, Adam/E-2341-2016
OI Persky, Adam/0000-0001-5583-9450; Brouwer, Kim/0000-0003-1945-4929
FU NCRR NIH HHS [RR00046] Funding Source: Medline
CR [Anonymous], 2000, WHO TECHN REP SER
   ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   ASTRUP A, 1992, METABOLISM, V41, P686, DOI 10.1016/0026-0495(92)90304-S
   ASTRUP A, 1993, INT J OBESITY, V17, pS41
   Berlin I, 2001, EUR J CLIN PHARMACOL, V57, P447, DOI 10.1007/s002280100317
   Doucet E, 2000, J CLIN ENDOCR METAB, V85, P4231, DOI 10.1210/jc.85.11.4231
   Doucet E, 2002, EUR J CLIN NUTR, V56, P297, DOI 10.1038/sj.ejcn.1601334
   Farrigan C, 2002, NAT REV DRUG DISCOV, V1, P257, DOI 10.1038/nrd781
   Haller CA, 2002, CLIN PHARMACOL THER, V71, P421, DOI 10.1067/mcp.2002.124523
   Hansen DL, 1998, AM J CLIN NUTR, V68, P1180, DOI 10.1093/ajcn/68.6.1180
   Hansen DL, 1999, INT J OBESITY, V23, P1016, DOI 10.1038/sj.ijo.0801059
   HORTON TJ, 1991, INT J OBESITY, V15, P359
   Krejs QJ, 2002, INT J OBESITY, V26, pS34, DOI [10.1038/sj.ijo.0802217, 10.1038/sj.ijo.802217]
   Narkiewicz K, 2002, INT J OBESITY, V26, pS38, DOI 10.1038/sj.ijo.0802218
   NELSON HS, 1975, J ALLERGY CLIN IMMUN, V55, P299, DOI 10.1016/0091-6749(75)90002-0
   Persky AM, 2004, BRIT J CLIN PHARMACO, V57, P552, DOI 10.1111/j.1365-2125.2003.02062.x
   Satomura S, 2001, METABOLISM, V50, P1181, DOI 10.1053/meta.2001.26701
   Schiffelers SLH, 2001, INT J OBESITY, V25, P33, DOI 10.1038/sj.ijo.0801528
   Seagle HM, 1998, OBES RES, V6, P115, DOI 10.1002/j.1550-8528.1998.tb00324.x
   Shannon JR, 1999, CLIN SCI, V96, P483, DOI 10.1042/CS19980206
   Sharma AM, 2001, INT J OBESITY, V25, pS20, DOI 10.1038/sj.ijo.0801934
   Starling RD, 2001, OBES RES, V9, P251, DOI 10.1038/oby.2001.29
NR 22
TC 5
Z9 6
U1 0
U2 6
PU DUSTRI-VERLAG DR KARL FEISTLE
PI DEISENHOFEN-MUENCHEN
PA BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY
SN 0946-1965
J9 INT J CLIN PHARM TH
JI Int. J. Clin. Pharmacol. Ther.
PD AUG
PY 2004
VL 42
IS 8
BP 442
EP 448
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 842UO
UT WOS:000223030000004
PM 15366324
DA 2025-04-28
ER

PT J
AU Sakane, N
AF Sakane, Naoki
TI Merits and Demerits of Food With Hearth Claims for the Prevention of
   Metabolic Syndrome
SO JOURNAL OF PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE metabolic syndrome; obesity; mazindol; orlistat; health food
ID WEIGHT-LOSS; BODY-WEIGHT; ANTIOBESITY; MEDICATIONS; MANAGEMENT;
   REDUCTION; MAZINDOL; OBESITY; DISEASE; WOMEN
AB The merits and demerits of food with health claims for the prevention of metabolic syndrome (MS) are reviewed. One major underlying cause of MS is obesity. Diet and lifestyle changes remain the cornerstones of therapy for obesity, but resulting weight loss is often small and long-term success is extremely uncommon and disappointing. Many anti-obesity drugs have been associated with unintended therapeutic outcomes. Currently, only one drug (mazindol) is approved in Japan for short-term treatment of individuals with a BMI over 35 kg/m(2). Treatment with orlistat with dietary modification, caffeine, or protein supplementation; consuming a low-fat diet; adherence to physical activity routines; prolonged contact with participants; problem-solving therapy; and the alternative treatment of acupressure are efficacious in reducing weight regain after weight loss treatment. Because obesity is highly stigmatized, any effective treatment should be made available to improve quality of life and self-image. Therefore, it is necessary to provide information to consumers through the media concerning 1) basic knowledge about health foods and laws concerning them, 2) scientifically based information on safety/effectiveness of health foods and food elements, and 3) reports on health disturbances associated with health foods around the world.
C1 Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst Endocrine & Metab Dis, Div Prevent Med, Kyoto 6128555, Japan.
RP Sakane, N (corresponding author), Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst Endocrine & Metab Dis, Div Prevent Med, Kyoto 6128555, Japan.
EM nsakane@kyotolan.hosp.go.jp
CR Allison DB, 2001, CRIT REV FOOD SCI, V41, P1, DOI 10.1080/20014091091661
   Bray GA, 1997, OBES RES, V5, P634, DOI 10.1002/j.1550-8528.1997.tb00586.x
   Bray GA, 2008, OBESITY, V16, P509, DOI 10.1038/oby.2007.100
   Bray GA, 2008, ENDOCRIN METAB CLIN, V37, P923, DOI 10.1016/j.ecl.2008.08.004
   Cresswell J, 1999, Community Nurse, V5, P30
   De Flines J, 2010, ACTA GASTRO-ENT BELG, V73, P261
   Ferrer-Lorente R, 2007, J PHARMACOL SCI, V104, P176, DOI 10.1254/jphs.FP0061441
   Greenway FL, 2010, CURR DIABETES REP, V10, P108, DOI 10.1007/s11892-010-0096-4
   Hioki C, 2004, CLIN EXP PHARMACOL P, V31, P614, DOI 10.1111/j.1440-1681.2004.04056.x
   Kushner RF, 2008, EXPERT OPIN PHARMACO, V9, P1339, DOI [10.1517/14656566.9.8.1339, 10.1517/14656566.9.8.1339 ]
   Lee HK, 2009, CURR TOP MED CHEM, V9, P482, DOI 10.2174/156802609788897844
   Low S, 2009, ANN ACAD MED SINGAP, V38, P57
   Nakashima N, 2007, STUD HEALTH TECHNOL, V129, P1174
   Pittler MH, 2005, OBES REV, V6, P93, DOI 10.1111/j.1467-789X.2005.00169.x
   Pittler MH, 2005, INT J OBESITY, V29, P1030, DOI 10.1038/sj.ijo.0803008
   Saito M, 2007, YAKUGAKU ZASSHI, V127, P407, DOI 10.1248/yakushi.127.407
   Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9
   Schwartz SM, 2008, OBESITY, V16, P623, DOI 10.1038/oby.2007.96
   Tsai AG, 2009, J GEN INTERN MED, V24, P1073, DOI 10.1007/s11606-009-1042-5
   Turk MW, 2009, J CARDIOVASC NURS, V24, P58, DOI 10.1097/01.JCN.0000317471.58048.32
   Yamada K, 2008, J NUTR, V138, p1192S, DOI 10.1093/jn/138.6.1192S
   Yoshida T, 1996, CLIN EXP PHARMACOL P, V23, P476, DOI 10.1111/j.1440-1681.1996.tb02764.x
   YOSHIDA T, 1995, INT J OBESITY, V19, P717
   YOSHIDA T, 1994, INT J CLIN PHARM RES, V14, P125
   Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x
NR 25
TC 5
Z9 6
U1 0
U2 3
PU JAPANESE PHARMACOLOGICAL SOC
PI KYOTO
PA EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604,
   JAPAN
SN 1347-8613
J9 J PHARMACOL SCI
JI J. Pharmacol. Sci.
PD APR
PY 2011
VL 115
IS 4
BP 476
EP 480
DI 10.1254/jphs.10R36FM
PG 5
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 755IM
UT WOS:000289922700010
PM 21436603
OA Bronze
DA 2025-04-28
ER

PT J
AU Hu, G
   Jousilahti, P
   Peltonen, M
   Bidel, S
   Tuomilehto, J
AF Hu, G.
   Jousilahti, P.
   Peltonen, M.
   Bidel, S.
   Tuomilehto, J.
TI Joint association of coffee consumption and other factors to the risk of
   type 2 diabetes: a prospective study in Finland
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE coffee consumption; physical activity; joint association; type 2
   diabetes
ID AGED FINNISH MEN; BODY-MASS INDEX; GASTRIC-INHIBITORY POLYPEPTIDE; TIME
   PHYSICAL-ACTIVITY; LEISURE-TIME; CARDIOVASCULAR-DISEASE; MAGNESIUM
   INTAKE; MORTALITY; MELLITUS; WEIGHT
AB Objective: To examine joint associations of coffee consumption and other factors ( including physical activity, obesity and alcohol consumption) with the risk of type 2 diabetes.
   Design: Prospective follow-up study.
   Subjects: In all, 10188 Finnish men and 11197 women aged 35-74 years without a history of stroke, coronary heart disease or diabetes at baseline.
   Measurement: A self-administered questionnaire data on coffee, tea, alcohol and other food consumption, physical activity, smoking, socio-economic factors and medical history, together with measured height, weight and blood pressure using standardized protocol.
   Results: During a mean follow-up of 13.4 years, there were 964 incident cases of type 2 diabetes. Multivariate-adjusted (age, study year, systolic blood pressure, education, smoking, physical activity, body mass index (BMI) and fruit, vegetable, sausage, bread, alcohol and tea consumption) hazard ratio of type 2 diabetes in participants who drank 0-2, 3-6 and >= 7 cups of coffee were 1.00, 0.77 and 0.66 (P = 0.022 for trend) in men, 1.00, 0.71 and 0.52 (P = 0.001 for trend) in women, and 1.00, 0.75 and 0.61 (P < 0.001 for trend) in men and women combined (adjusted also for sex), respectively. This inverse association was consistent in subjects with any joint levels of physical activity and BMI, and in alcohol drinkers and non-drinkers. Among obese and inactive people, coffee drinking of seven cups or more daily reduced the risk of type 2 diabetes to half.
   Conclusions: Coffee drinking was associated with a reduced risk of type 2 diabetes in both men and women, and this association was observed regardless of the levels of physical activity, BMI and alcohol consumption.
C1 Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland.
   Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.
   Inst Biomed, Helsinki, Finland.
   S Ostrobothnia Cent Hosp, Seinajoki, Finland.
C3 Finland National Institute for Health & Welfare; University of Helsinki
RP Hu, G (corresponding author), Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Dept Epidemiol & Hlth Promot, Mannerheimintie 166, FIN-00300 Helsinki, Finland.
EM hu.gang@ktl.fi
RI tuomilehto, jaakko/E-6504-2011; Hu, Gang/V-7947-2019; Hu,
   Gang/N-1971-2017; Peltonen, Markku/F-3037-2015
OI Hu, Gang/0000-0002-6172-8017; Peltonen, Markku/0000-0002-3767-4223
CR Albanes D, 1990, Epidemiology, V1, P65, DOI 10.1097/00001648-199001000-00014
   Barengo NC, 2005, J HYPERTENS, V23, P293, DOI 10.1097/00004872-200502000-00011
   Barengo NC, 2004, EUR HEART J, V25, P2204, DOI 10.1016/j.ehj.2004.10.009
   Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185
   COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001
   Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256
   HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302
   Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011
   Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433
   Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542
   Hu G, 2005, DIABETOLOGIA, V48, P1477, DOI 10.1007/s00125-005-1824-1
   Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892
   Hu G, 2005, DIABETES CARE, V28, P799, DOI 10.2337/diacare.28.4.799
   Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020
   Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19
   Hu G, 2005, INT J OBESITY, V29, P894, DOI 10.1038/sj.ijo.0802870
   Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x
   Hu G, 2004, CIRCULATION, V110, P666, DOI 10.1161/01.CIR.0000138102.23783.94
   Hu G, 2005, STROKE, V36, P1994, DOI 10.1161/01.STR.0000177868.89946.0c
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167
   Lahti-Koski M, 2002, AM J CLIN NUTR, V75, P809, DOI 10.1093/ajcn/75.5.809
   Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134
   Matsui T, 2001, J AGR FOOD CHEM, V49, P1948, DOI 10.1021/jf001251u
   Meier JJ, 2001, DIABETES, V50, P2497, DOI 10.2337/diabetes.50.11.2497
   NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186
   PAJAK A, 1988, World Health Statistics Quarterly, V41, P115
   Patja K, 2005, J INTERN MED, V258, P356, DOI 10.1111/j.1365-2796.2005.01545.x
   Reunanen A, 2003, LANCET, V361, P702, DOI 10.1016/S0140-6736(03)12583-4
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Saremi A, 2003, DIABETES CARE, V26, P2211, DOI 10.2337/diacare.26.7.2211
   Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49
   Wannamethee SG, 2000, ARCH INTERN MED, V160, P2108, DOI 10.1001/archinte.160.14.2108
   *WHO, 1985, WHO TECHNICAL REPORT, V727
   WHO Consultation, 1999, DEF DIAGN CLASS DIAB
   Yoshioka K, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12585-8
   ,, 1988, Journal of Clinical Epidemiology, V41, P105, DOI 10.1016/0895-4356(88)90084-4
NR 42
TC 54
Z9 59
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD DEC
PY 2006
VL 30
IS 12
BP 1742
EP 1749
DI 10.1038/sj.ijo.0803341
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 109VO
UT WOS:000242337400008
PM 16652136
DA 2025-04-28
ER

PT J
AU Sale, C
   Harris, RC
   Delves, S
   Corbett, J
AF Sale, C
   Harris, RC
   Delves, S
   Corbett, J
TI Metabolic and physiological effects of ingesting extracts of bitter
   orange, green tea and guarana at rest and during treadmill walking in
   overweight males
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE bitter orange; green tea; caffeine; metabolic rate and substrate
   utilization; dietary supplements
ID NERVOUS-SYSTEM ACTIVITY; ENERGY-EXPENDITURE; EPINEPHRINE INFUSION;
   CATECHIN-POLYPHENOLS; CAFFEINE CONSUMPTION; EXERCISE INTENSITY;
   HEALTHY-ADULTS; FAT OXIDATION; HUMAN-MUSCLE; YOUNG-WOMEN
AB Objective: This study examined the acute effects of ingesting a widely used commercial formula containing extracts of bitter orange, green tea and guarana (Gx) on the metabolic rate and substrate utilisation in overweight, adult males at rest (study 1) and during treadmill walking (study 2).
   Subjects: Two different groups of 10 sedentary males with more than 20% body fat participated in studies 1 and 2.
   Design: In each study, subjects participated in two experimental trials during which they were given two 500mg capsules containing either Gx or a placebo (P) in a counterbalanced double-blind manner. Doses of the main active ingredients were 6mg of synephrine, 150mg caffeine and 150mg catechin polyphenols.
   Measurements: In study 1, subjects completed 7 h supine rest with baseline measures taken during the first hour, with expired gases, blood pressure, heart rate and venous blood being collected every 30 min for the remaining 6 h following ingestion of Gx or P. In study 2, subjects exercised for 60 min at 60% heart rate reserve following ingestion of Gx or P 1 h previously. Venous blood samples were collected twice at rest and at 5, 10, 15, 20, 30, 40, 50 and 60 min, with expired gas measurements taken at 4, 9, 14, 19, 29, 39, 49 and 59 min. In both studies, venous blood was analysed for NEFA, glycerol, glucose and lactate concentrations, while expired gases were used to calculate ATP production from carbohydrate and NEFA, as well as the total substrate utilised.
   Results and conclusion: The results did not show any significant effect of Gx ingestion on total ATP utilisation during 6 h rest or during 60 min treadmill walking. Changes were observed in the relative contributions of CHO and NEFA oxidation to ATP production in both studies, such that there was an increase in ATP production from CHO and a decrease from NEFA. The increase in CHO oxidation was shown to be as high as 30% at rest.
C1 Univ Chichester, Sch Sport Exercise & Hlth Sci, Chichester PO19 6PE, W Sussex, England.
C3 University of Chichester
RP Univ Chichester, Sch Sport Exercise & Hlth Sci, Coll Lane, Chichester PO19 6PE, W Sussex, England.
EM c.sale@ucc.ac.uk
RI Harris, Richard/U-6931-2019; Sale, Craig/B-5407-2013
OI Sale, Craig/0000-0002-5816-4169; Corbett, Jo/0000-0002-6552-6471
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015
   ALBERTY RA, 1968, J BIOL CHEM, V243, P1337
   Amano M, 2001, MED SCI SPORT EXER, V33, P1287, DOI 10.1097/00005768-200108000-00007
   Bell C, 2003, INT J OBESITY, V27, P1315, DOI 10.1038/sj.ijo.0802413
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   CHASIOTIS D, 1983, J APPL PHYSIOL, V54, P45, DOI 10.1080/07303084.1983.10630537
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   DANFORTH WH, 1962, P NATL ACAD SCI USA, V48, P1191, DOI 10.1073/pnas.48.7.1191
   Draper SB, 2003, EUR J APPL PHYSIOL, V90, P92, DOI 10.1007/s00421-003-0877-4
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DUPPORT C, 2003, BIOCHIM BIOPHYS ACTA, V1629, P34
   DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
   EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461
   Engels HJ, 1999, INT J SPORT NUTR, V9, P361, DOI 10.1123/ijsn.9.4.361
   KASVINSKY PJ, 1978, J BIOL CHEM, V253, P9102
   KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854
   Lamont LS, 1997, MED SCI SPORT EXER, V29, P769, DOI 10.1097/00005768-199706000-00006
   Lane JD, 2002, PSYCHOSOM MED, V64, P595, DOI 10.1097/01.PSY.0000021946.90613.DB
   Matsumoto T, 2001, OBES RES, V9, P78, DOI 10.1038/oby.2001.10
   Matsumoto T, 2000, J NUTR SCI VITAMINOL, V46, P309, DOI 10.3177/jnsv.46.309
   Pedersen SB, 1999, METABOLISM, V48, P461, DOI 10.1016/S0026-0495(99)90104-X
   Penzak SR, 2001, J CLIN PHARMACOL, V41, P1059, DOI 10.1177/00912700122012652
   Preuss Harry G., 2002, Journal of Medicine (Westbury), V33, P247
   Ravussin E, 1999, INT J OBESITY, V23, P37, DOI 10.1038/sj.ijo.0800793
   SAHLIN K, 2004, PRINCIPLES EXERCISE, V46, P87
   Samra JS, 1996, AM J PHYSIOL-ENDOC M, V271, pE834, DOI 10.1152/ajpendo.1996.271.5.E834
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Smith DA, 1997, J APPL PHYSIOL, V82, P156, DOI 10.1152/jappl.1997.82.1.156
   SPRAUL M, 1993, J CLIN INVEST, V92, P1730, DOI 10.1172/JCI116760
   STEINER RF, 1980, BIOCHIM BIOPHYS ACTA, V611, P269, DOI 10.1016/0005-2744(80)90062-5
   WELLE S, 1991, METABOLISM, V40, P619, DOI 10.1016/0026-0495(91)90053-Y
NR 34
TC 30
Z9 32
U1 0
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD MAY
PY 2006
VL 30
IS 5
BP 764
EP 773
DI 10.1038/sj.ijo.0803209
PG 10
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 036UE
UT WOS:000237100400005
PM 16418760
DA 2025-04-28
ER

PT J
AU Phung, OJ
   Baker, WL
   Matthews, LJ
   Lanosa, M
   Thorne, A
   Coleman, CI
AF Phung, Olivia J.
   Baker, William L.
   Matthews, Leslie J.
   Lanosa, Michael
   Thorne, Alicia
   Coleman, Craig I.
TI Effect of green tea catechins with or without caffeine on anthropometric
   measures: a systematic review and meta-analysis
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; ENERGY-EXPENDITURE; BODY-FAT;
   CARDIOVASCULAR-DISEASE; WEIGHT MAINTENANCE; ABDOMINAL FAT; DOUBLE-BLIND;
   OBESITY; EXTRACT; CONSUMPTION
AB Background: Green tea catechins (GTCs) with or without caffeine have been studied in randomized controlled trials (RCTs) for their effect on anthropometric measures and have yielded conflicting results.
   Objective: The objective was to perform a systematic review and meta-analysis of RCTs of GTCs on anthropometric variables, including body mass index (BMI), body weight, waist circumference (WC), and waist-to-hip ratio (WHR).
   Design: A systematic literature search of MEDLINE, EMBASE, CENTRAL, and the Natural Medicines Comprehensive Database was conducted through April 2009. RCTs that evaluated GTCs with or without caffeine and that reported BMI, body weight, WC, or WHR were included. The weighted mean difference of change from baseline (with 95% CIs) was calculated by using a random-effects model.
   Results: Fifteen studies (n = 1243 patients) met the inclusion criteria. On meta-analysis, GTCs with caffeine decreased BMI (-0.55; 95% CI: -0.65, -0.40), body weight (-1.38 kg; 95% CI: -1.70, -1.06), and WC (-1.93 cm; 95% CI: -2.82, -1.04) but not WHR compared with caffeine alone. GTC ingestion with caffeine also significantly decreased body weight (-0.44 kg; 95% CI: -0.72, -0.15) when compared with a caffeine-free control. Studies that evaluated GTCs without concomitant caffeine administration did not show benefits on any of the assessed anthropometric endpoints.
   Conclusions: The administration of GTCs with caffeine is associated with statistically significant reductions in BMI, body weight, and WC; however, the clinical significance of these reductions is modest at best. Current data do not suggest that GTCs alone positively alter anthropometric measurements. Am J Clin Nutr 2010; 91: 73-81.
C1 [Phung, Olivia J.; Baker, William L.; Matthews, Leslie J.; Lanosa, Michael; Coleman, Craig I.] Univ Connecticut, Sch Pharm, Storrs, CT USA.
   [Phung, Olivia J.; Baker, William L.] Hartford Hosp, Dept Drug Informat, Hartford, CT 06115 USA.
   [Thorne, Alicia] Cleveland Clin, Cleveland, OH 44106 USA.
C3 University of Connecticut; Hartford Hospital; Cleveland Clinic
   Foundation
RP Coleman, CI (corresponding author), Univ Connecticut, Sch Pharm, Pharmacoecon & Outcomes Studies Grp, Hartford Hosp, 80 Seymour St, Hartford, CT 06102 USA.
EM ccolema@harthosp.org
RI Baker, William/H-7977-2016
OI Matthews, Leslie/0000-0002-9027-7921; Baker,
   William/0000-0003-2172-0931; Coleman, Craig/0000-0003-4868-7158
CR Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643
   *AM DIET ASS, 2008, EV AN MAN AD DIET GU
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   BAX L, 2008, MIX COMPREHENSIVE FR
   Bax L, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-40
   Burke GL, 2008, ARCH INTERN MED, V168, P928, DOI 10.1001/archinte.168.9.928
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q
   Frank J, 2009, J NUTR, V139, P58, DOI 10.3945/jn.108.096412
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Goto T, 1996, J CHROMATOGR A, V749, P295, DOI 10.1016/0021-9673(96)00456-6
   Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88
   Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V5
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Maron DJ, 2003, ARCH INTERN MED, V163, P1448, DOI 10.1001/archinte.163.12.1448
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   McKay DL, 2007, J AM COLL NUTR, V26, p362S, DOI 10.1080/07315724.2007.10719624
   Nádas J, 2008, MED SCI MONITOR, V14, pCR15
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   PISUNYER X, 1998, CLIN GUIDELINES IDEN
   Sarma DN, 2008, DRUG SAFETY, V31, P469, DOI 10.2165/00002018-200831060-00003
   Takeshita M., 2008, JPN PHARMACOL THER, V36, P767
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
NR 43
TC 133
Z9 150
U1 1
U2 38
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD JAN
PY 2010
VL 91
IS 1
BP 73
EP 81
DI 10.3945/ajcn.2009.28157
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 534SM
UT WOS:000272917600011
PM 19906797
OA Bronze
DA 2025-04-28
ER

PT J
AU Franklin, JL
   Mirzaei, M
   Wearne, TA
   Homewood, J
   Goodchild, AK
   Haynes, PA
   Cornish, JL
AF Franklin, Jane L.
   Mirzaei, Mehdi
   Wearne, Travis A.
   Homewood, Judi
   Goodchild, Ann K.
   Haynes, Paul A.
   Cornish, Jennifer L.
TI Extended exposure to sugar and/or caffeine produces distinct behavioral
   and neurochemical profiles in the orbitofrontal cortex of rats:
   Implications for neural function
SO PROTEOMICS
LA English
DT Article
DE Animal proteomics; Caffeine; Hyperactivity; Neurological disease;
   Orbitofrontal cortex; Sugar
ID PREFRONTAL CORTEX; GENE-EXPRESSION; PARKINSONS-DISEASE;
   ALZHEIMERS-DISEASE; LOCOMOTOR-ACTIVITY; PROTEOMIC ANALYSIS;
   MONOAMINE-OXIDASE; NERVOUS-SYSTEM; CONSUMPTION; BRAIN
AB Caffeine is a psychostimulant commonly consumed with high levels of sugar. The increased availability of highly caffeinated, high sugar energy drinks could put some consumers at risk of being exposed to high doses of caffeine and sugar. Notably, research that has examined the consequences of this combination is limited. Here, we explored the effect of chronic exposure to caffeine and/or sugar on behavior and protein levels in the orbitofrontal cortex (OFC) of rats. The OFC brain region has been implicated in neuropsychiatric conditions, including obesity and addiction behaviors. Adultmale Sprague-Dawley rats were treated for 26 days with control, caffeine (0.6 g/L), 10% sugar, or combination of both. Locomotor behavior was measured on the first and last day of treatment, then 1 week after treatment. Two hours following final behavioral testing, brains were rapidly removed and prepared for proteomic analysis of the OFC. Label-free quantitative shotgun analysis revealed that 21, 12, and 23% of proteins identified in the OFC were differentially expressed by sugar and/or caffeine. The results demonstrate that the intake of high levels of sugar and/or low to moderate levels of caffeine has different behavioral consequences. Moreover, each treatment results in a unique proteomic profile with different implications for neural health.
C1 [Franklin, Jane L.; Wearne, Travis A.; Cornish, Jennifer L.] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia.
   [Mirzaei, Mehdi; Haynes, Paul A.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia.
   [Homewood, Judi] Macquarie Univ, Fac Human Sci, Sydney, NSW, Australia.
   [Goodchild, Ann K.] Macquarie Univ, Dept Biomed Sci, Sydney, NSW, Australia.
C3 Macquarie University; Macquarie University; Macquarie University;
   Macquarie University
RP Cornish, JL (corresponding author), Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia.
EM jennifer.cornish@mq.edu.au
RI Mirzaei, Mohammad/S-3198-2017
OI mirzaei, mahdi/0000-0001-9817-9157; Cornish,
   Jennifer/0000-0002-9754-8069; Wearne, Travis/0000-0002-7565-9163;
   Mirzaei, Mehdi/0000-0001-8727-4984; Goodchild, Ann/0000-0003-1544-7924;
   Haynes, Paul/0000-0003-1472-8249
FU Australian Postgraduate Award (APA); Macquarie University in the form of
   the Psychology Department Higher Degree Research Grant; Australian
   Research Council in the form of an Industrial Transformation Training
   Centre grant; Hillcrest Foundation
FX The authors would like to thank Dana Pascovici for assistance with the
   Ingenuity Pathway Analysis and statistical analyses, and Christine
   Sutter and Wayne McTegg for animal care. J.L.F and T.A.W. were
   recipients of an Australian Postgraduate Award (APA) and would like to
   acknowledge the support of Macquarie University in the form of the
   Psychology Department Higher Degree Research Grant. The authors
   acknowledge support from the Australian Research Council in the form of
   an Industrial Transformation Training Centre grant in which P.A.H. was a
   chief investigator and M.M.Z. was a member of the project leadership
   team. P.A.H. also wishes to thank Kevin Parker for continued support and
   encouragement. A.K.G and J.L.C. acknowledge support from the Hillcrest
   Foundation, managed by Perpetual.
CR Ahmed SSSJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-63
   Alia-Klein N, 2011, ARCH GEN PSYCHIAT, V68, P283, DOI 10.1001/archgenpsychiatry.2011.10
   Andreazza AC, 2010, ARCH GEN PSYCHIAT, V67, P360, DOI 10.1001/archgenpsychiatry.2010.22
   Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021
   Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052
   Avena NM, 2008, PHYSIOL BEHAV, V94, P309, DOI 10.1016/j.physbeh.2008.01.008
   Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584
   Begcevic I, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-5
   Bélanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8
   Block JP, 2013, J ADOLESCENT HEALTH, V52, P702, DOI 10.1016/j.jadohealth.2012.11.017
   BONATI M, 1985, DRUG METAB REV, V15, P1355, DOI 10.3109/03602538409029964
   Bortolato M, 2013, INT J NEUROPSYCHOPH, V16, P869, DOI 10.1017/S1461145712000715
   Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723
   CALVINO AM, 1990, CHEM SENSES, V15, P505, DOI 10.1093/chemse/15.5.505
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Carlson JS, 2007, J APPL SCH PSYCHOL, V24, P127, DOI 10.1300/J370v24n01_07
   Ciavardelli D, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.68
   Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Correia SC, 2012, BRAIN RES, V1441, P64, DOI 10.1016/j.brainres.2011.12.063
   Daniello Allison, 2012, Biomed Sci Instrum, V48, P73
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326
   Enns GM, 2003, MOL GENET METAB, V80, P11, DOI 10.1016/j.ymgme.2003.08.009
   Eskelinen MH, 2010, J ALZHEIMERS DIS, V20, pS167, DOI 10.3233/JAD-2010-1404
   Fitt E, 2013, FOOD CHEM, V140, P421, DOI 10.1016/j.foodchem.2012.07.092
   FLEMMER DD, 1989, PHARMACOL BIOCHEM BE, V34, P261, DOI 10.1016/0091-3057(89)90309-2
   Francis HM, 2013, PROTEOMICS, V13, P3076, DOI 10.1002/pmic.201300124
   Franklin JL, 2016, J PROTEOME RES, V15, P1455, DOI 10.1021/acs.jproteome.5b01043
   Franklin JL, 2016, PROTEOMICS, V16, P657, DOI 10.1002/pmic.201500126
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Gammulla CG, 2010, PROTEOMICS, V10, P3001, DOI 10.1002/pmic.201000054
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   GRIFFITHS RR, 1988, PSYCHOPHARMACOLOGY, V94, P437, DOI 10.1007/BF00212836
   Guo XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094715
   Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003
   HALLIWELL B, 1992, J LAB CLIN MED, V119, P598
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Herrmann AG, 2013, J CEREBR BLOOD F MET, V33, P673, DOI 10.1038/jcbfm.2012.204
   Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x
   Hetman M, 2000, ACTA NEUROBIOL EXP, V60, P531, DOI 10.55782/ane-2000-1374
   Himmel Herbert M., 2008, Journal of Pharmacological and Toxicological Methods, V58, P129, DOI 10.1016/j.vascn.2008.06.001
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   KAPLAN GB, 1993, J PHARMACOL EXP THER, V266, P1563
   Keast RSJ, 2007, APPETITE, V49, P255, DOI 10.1016/j.appet.2006.11.003
   Keast RSJ, 2007, CHEM SENSES, V32, P245, DOI 10.1093/chemse/bjl052
   Ko JH, 2013, HUM BRAIN MAPP, V34, P1591, DOI 10.1002/hbm.22006
   Kohlboeck G, 2012, ANN NUTR METAB, V60, P247, DOI 10.1159/000337552
   KOLB B, 1974, BEHAV BIOL, V10, P329, DOI 10.1016/S0091-6773(74)91924-5
   Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z
   Lien L, 2006, AM J PUBLIC HEALTH, V96, P1815, DOI 10.2105/AJPH.2004.059477
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Maher P, 2000, CELL MOL LIFE SCI, V57, P1287, DOI 10.1007/PL00000766
   Maia L, 2002, EUR J NEUROL, V9, P377, DOI 10.1046/j.1468-1331.2002.00421.x
   McDonald J. H., 2009, Handbook of biological statistics, V3rd
   Mémet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003
   Millichap JG, 2012, PEDIATRICS, V129, P330, DOI 10.1542/peds.2011-2199
   Mirzaei M, 2012, PROTEOMICS, V12, P864, DOI 10.1002/pmic.201100389
   Mirzaei M, 2012, J PROTEOME RES, V11, P348, DOI 10.1021/pr2008779
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   NEHLIG A, 1986, EUR J PHARMACOL, V129, P93, DOI 10.1016/0014-2999(86)90340-7
   Neilson Karlie A, 2013, Methods Mol Biol, V1002, P205, DOI 10.1007/978-1-62703-360-2_17
   Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553
   NIKODIJEVIC O, 1993, PHARMACOL BIOCHEM BE, V44, P199, DOI 10.1016/0091-3057(93)90299-9
   O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315
   Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103
   Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1
   Palou A, 2009, OBES REV, V10, P1, DOI 10.1111/j.1467-789X.2008.00560.x
   Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Rabilloud T, 2003, NAT BIOTECHNOL, V21, P508, DOI 10.1038/nbt0503-508
   Reissig JE, 2005, ANN PHARMACOTHER, V39, P727, DOI 10.1345/aph.1E309
   Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748
   Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001
   Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Sclafani A, 2004, PHYSIOL BEHAV, V81, P773, DOI 10.1016/j.physbeh.2004.04.031
   Scott TR, 2001, APPETITE, V37, P111, DOI 10.1006/appe.2001.0413
   Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197
   Singer CA, 1999, J NEUROSCI, V19, P2455
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Svenningsson P, 1999, J NEUROSCI, V19, P4011
   Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294
   Unal CT, 2009, EUR J NEUROSCI, V29, P1615, DOI 10.1111/j.1460-9568.2009.06691.x
   Volkow ND, 2005, J NEUROSCI, V25, P3932, DOI 10.1523/JNEUROSCI.0433-05.2005
   Volkow Nora D, 2012, Annu Rev Pharmacol Toxicol, V52, P321, DOI 10.1146/annurev-pharmtox-010611-134625
   Wearne TA, 2015, J PROTEOME RES, V14, P397, DOI 10.1021/pr500719f
   Yamamoto T, 2003, NUTR REV, V61, pS5, DOI 10.1301/nr.2003.may.S5-S9
   Yu LQ, 2008, ANN NEUROL, V63, P338, DOI 10.1002/ana.21313
   Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887
NR 96
TC 1
Z9 2
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD NOV
PY 2016
VL 16
IS 22
SI SI
BP 2894
EP 2910
DI 10.1002/pmic.201600032
PG 17
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA ED9US
UT WOS:000389219200009
PM 27588558
DA 2025-04-28
ER

PT J
AU Kim, SY
   Yoo, DM
   Min, C
   Choi, HG
AF Kim, So Young
   Yoo, Dae Myoung
   Min, Chanyang
   Choi, Hyo Geun
TI Association between Coffee Consumption/Physical Exercise and Gastric,
   Hepatic, Colon, Breast, Uterine Cervix, Lung, Thyroid, Prostate, and
   Bladder Cancer
SO NUTRIENTS
LA English
DT Article
DE coffee; cancer; cohort studies; risk factors
ID PHYSICAL-ACTIVITY; RISK-FACTORS; FATIGUE; OBESITY; SLEEP
AB Although the effects of coffee consumption and physical exercise on the risk of cancer have been suggested, their interactions have not been investigated. The present cross-sectional study aimed to investigate the correlation of coffee consumption and physical exercise with cancer. Participants >= 40 years old in the Korean Genome and Epidemiology Study 2004-2016 were included (n = 162,220). Histories of gastric cancer, hepatic cancer, colon cancer, breast cancer, uterine cervix cancer, lung cancer, thyroid cancer, prostate cancer, and bladder cancer were analyzed according to the coffee consumption groups using logistic regression models. The odds among individuals in the >60 cups/month coffee group were lower for gastric cancer (adjusted odds ratio (aOR) = 0.80 (95% confidence intervals = 0.65-0.98)), hepatic cancer (0.32 (0.18-0.58)), colon cancer (0.53 (0.39-0.72)), breast cancer (0.56 (0.45-0.70)), and thyroid cancer (0.71 (0.59-0.85)) than for individuals in the no coffee group. Physical exercise of >= 150 min/week was correlated with higher odds for gastric cancer (1.18 (1.03-1.36)), colon cancer (1.52 (1.26-1.83)), breast cancer (1.53 (1.35-1.74)), thyroid cancer (1.42 (1.27-1.59)), and prostate cancer (1.61 (1.13-2.28)) compared to no exercise. Coffee consumption and physical exercise showed an interaction in thyroid cancer (p = 0.002). Coffee consumption was related to a decreased risk of gastric cancer, hepatic cancer, colon cancer, breast cancer, and thyroid cancer in the adult population. Physical exercise was positively correlated with gastric cancer, colon cancer, breast cancer, thyroid cancer, and prostate cancer.
C1 [Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam 13496, South Korea.
   [Yoo, Dae Myoung; Min, Chanyang; Choi, Hyo Geun] Hallym Univ, Hallym Data Sci Lab, Coll Med, Anyang 14068, South Korea.
   [Min, Chanyang] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul 08826, South Korea.
   [Choi, Hyo Geun] Hallym Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Anyang 14068, South Korea.
C3 Pochon Cha University; Hallym University; Seoul National University
   (SNU); Hallym University
RP Choi, HG (corresponding author), Hallym Univ, Hallym Data Sci Lab, Coll Med, Anyang 14068, South Korea.; Choi, HG (corresponding author), Hallym Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Anyang 14068, South Korea.
EM sossi81@hanmail.net; ydm1285@naver.com; joicemin@naver.com;
   pupen@naver.com
RI Choi, Hyo/K-4461-2019; Kim, So-Young/JFS-7698-2023
OI Dae myoung, Yoo/0000-0003-2511-5536; Min, Chanyang/0000-0002-0629-9299;
   Choi, Hyo Geun/0000-0003-1655-9549; kim, so young/0000-0002-7361-4930
FU National Research Foundation (NRF) of Korea [NRF-2018-R1D1A1A02085328,
   2021-R1C1C100498611]; The APC [NRF-2021-R1C1C100498611]
FX This work was supported in part by research grants
   (NRF-2018-R1D1A1A02085328 and 2021-R1C1C100498611) from the National
   Research Foundation (NRF) of Korea. The APC was funded by
   NRF-2021-R1C1C100498611.
CR Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   Alicandro G, 2017, EUR J CANCER PREV, V26, P424, DOI [10.1097/CEJ.0000000000000341, 10.1097/cej.0000000000000341]
   Bae Jong-Myon, 2020, Asian Pac J Cancer Prev, V21, P1177, DOI 10.31557/APJCP.2020.21.5.1177
   Bower JE, 2014, NAT REV CLIN ONCOL, V11, P597, DOI 10.1038/nrclinonc.2014.127
   Brown JC, 2012, COMPR PHYSIOL, V2, P2775, DOI 10.1002/cphy.c120005
   Buldak RJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23123309
   Chen XN, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-038902
   Dai ZW, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0390-3
   Deng YH, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0500-2
   Gasscht F, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0501-3
   Godos J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090950
   Grubben MJAL, 2000, ALIMENT PHARM THER, V14, P1181, DOI 10.1046/j.1365-2036.2000.00826.x
   Han MA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020129
   Hayakawa S, 2020, MOLECULES, V25, DOI 10.3390/molecules25194553
   Kenfield SA, 2011, J CLIN ONCOL, V29, P726, DOI 10.1200/JCO.2010.31.5226
   Kim Y, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv316
   Ligibel Jennifer A, 2019, Am Soc Clin Oncol Educ Book, V39, pe22, DOI 10.1200/EDBK_237423
   Lim MS, 2017, YONSEI MED J, V58, P1040, DOI 10.3349/ymj.2017.58.5.1040
   Micek A, 2019, INT J FOOD SCI NUTR, V70, P986, DOI 10.1080/09637486.2019.1591352
   Mojica BE, 2018, J FOOD SCI, V83, P1125, DOI 10.1111/1750-3841.14102
   Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548
   Ochiai R, 2018, FOOD SCI NUTR, V6, P2530, DOI 10.1002/fsn3.861
   Parra-Lara LG, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103028
   Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Sánchez-Quesada C, 2020, EUR J NUTR, V59, P3461, DOI 10.1007/s00394-020-02180-w
   Sartini M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030694
   Seow WJ, 2020, EUR J NUTR, V59, P3083, DOI 10.1007/s00394-019-02146-7
   Shin S, 2022, INT J EPIDEMIOL, V51, P626, DOI 10.1093/ije/dyab161
   Steck SE, 2020, NAT REV CANCER, V20, P125, DOI 10.1038/s41568-019-0227-4
   Tahbaz R, 2018, CURR OPIN UROL, V28, P62, DOI 10.1097/MOU.0000000000000454
   Tamura T, 2019, NAGOYA J MED SCI, V81, P143, DOI 10.18999/nagjms.81.1.143
   Torquati L, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091812
   Xie Y, 2016, ASIA PAC J CLIN NUTR, V25, P578, DOI 10.6133/apjcn.092015.07
   Yamagata K, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7020026
   YU MC, 1986, JNCI-J NATL CANCER I, V77, P351
   Zhu JJ, 2021, INT J CANCER, V148, P2457, DOI 10.1002/ijc.33445
NR 37
TC 13
Z9 14
U1 4
U2 41
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2021
VL 13
IS 11
AR 3927
DI 10.3390/nu13113927
PG 22
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA ZD4CS
UT WOS:000758148100007
PM 34836181
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Hussein, GME
   Matsuda, H
   Nakamura, S
   Akiyama, T
   Tamura, K
   Yoshikawa, M
AF Hussein, Ghazi M. E.
   Matsuda, Hisashi
   Nakamura, Seikou
   Akiyama, Toshihito
   Tamura, Kouhei
   Yoshikawa, Masayuki
TI Protective and ameliorative effects of mate (Ilex paraguariensis)
   on metabolic syndrome in TSOD mice
SO PHYTOMEDICINE
LA English
DT Article
DE Mate; Ilex paraguariensis; Metabolic syndrome; Insulin resistance;
   Adiponectin
ID ASSESSING INSULIN SENSITIVITY; CHLOROGENIC ACID; PLASMA-GLUCOSE; CAFFEIC
   ACID; GREEN TEA; MODEL; RESISTANCE; MOUSE; IDENTIFICATION; HOMEOSTASIS
AB Yerba mate (mate) tea, a herbal tea prepared from the leaves of hex paraguariensis, is widely consumed in southern Latin America, and is gaining popularity worldwide. We investigated effects of an aqueous extract of mate on metabolic syndrome features in a metabolic syndrome model Tsumura Suzuki obese diabetic (TSOD) mouse. Oral administration of mate (100 mg/kg) for 7 weeks induced significant decreases in body weight, body mass index, and food intake in TSOD. It significantly decreased the hyperglycemia by reducing fasting blood glucose level, and increasing glucose uptake in glucose tolerance test. It also showed significant improvement in insulin sensitivity by increasing glucose uptake in insulin tolerance test, increasing quantitative insulin sensitivity check index, and decreasing homeostasis model assessment of insulin resistance index. The results also showed significant effects of mate on hyperlipidemia by decreasing blood levels of triglycerides, non-esterified fatty acids, and total cholesterol. Moreover, mate significantly improved adiponectin (AD) level, and exhibited significant reduction in white adipose tissue weight, and adiposity index in TSOD. It also showed significant ameliorative effects on TSOD histopathology, by reducing adipocytes proliferation, and improving hepatic steatosis. Furthermore, mate administration induced a dose-dependent delay in gastric emptying.
   The current data suggest that mate ameliorates metabolic syndrome by mechanisms involving increase of peripheral insulin sensitivity and cellular glucose uptake, and by modulating the level of circulating lipid metabolites and AD. These results indicate that mate can induce protective and ameliorative effects on insulin resistance, diabesity, and dyslipidemia in metabolic syndrome. (C) 2011 Elsevier GmbH. All rights reserved.
C1 [Hussein, Ghazi M. E.; Matsuda, Hisashi; Nakamura, Seikou; Yoshikawa, Masayuki] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 6078412, Japan.
   [Hussein, Ghazi M. E.; Akiyama, Toshihito; Tamura, Kouhei] Tamura Pharmaceut Co Ltd, Gose, Nara 6392295, Japan.
C3 Kyoto Pharmaceutical University
RP Yoshikawa, M (corresponding author), Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 6078412, Japan.
EM myoshika@mb.kyoto-phu.ac.jp
OI Matsuda, Hisashi/0000-0003-4217-065X
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
FX This work was supported by the 21st COE Program, Academic Frontier
   Project, and a Grant-in-Aid for Scientific Research from the Ministry of
   Education, Culture, Sports, Science and Technology of Japan. We would
   like to thank the grant's sponsors, and to acknowledge Tamura
   Pharmaceutical Co. Ltd. (Nara, Japan) for supplying mate extract.
CR Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Banos G., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P237, DOI 10.2174/187152508785909465
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Bastos DHM, 2007, MOLECULES, V12, P423, DOI 10.3390/12030423
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Bixby M, 2005, LIFE SCI, V77, P345, DOI 10.1016/j.lfs.2004.11.030
   CLAUDIA A, 2005, PHYTOCHEM ANALYSIS, V16, P307
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Flordellis CS, 2005, TRENDS ENDOCRIN MET, V16, P254, DOI 10.1016/j.tem.2005.06.001
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Hollander JM, 2008, J AM DIET ASSOC, V108, P495, DOI 10.1016/j.jada.2007.12.007
   Hsu FL, 2000, PLANTA MED, V66, P228, DOI 10.1055/s-2000-8561
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402
   KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714
   Lee JI, 2007, J CHROMATOGR B, V852, P195, DOI 10.1016/j.jchromb.2007.01.013
   Matfin G, 2008, CURR DIABETES REP, V8, P31, DOI 10.1007/s11892-008-0007-0
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Minich DM, 2008, NUTR REV, V66, P429, DOI 10.1111/j.1753-4887.2008.00075.x
   Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007
   Nakatani N, 2000, J AGR FOOD CHEM, V48, P5512, DOI 10.1021/jf000422s
   Nugent A. P., 2004, Nutrition Bulletin, V29, P36, DOI 10.1111/j.1467-3010.2004.00403.x
   Potenza MA, 2006, DIABETES, V55, P3594, DOI 10.2337/db06-0667
   Ren J, 2007, PHARMAZIE, V62, P689, DOI 10.1691/ph.2007.9.6213
   Scott CL, 2003, AM J CARDIOL, V92, p35I, DOI 10.1016/S0002-9149(03)00507-1
   Shearer J, 2007, CAN J PHYSIOL PHARM, V85, P823, DOI 10.1139/Y07-070
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Sugimoto S, 2009, CHEM PHARM BULL, V57, P257, DOI 10.1248/cpb.57.257
   Suzuki W, 1999, EXP ANIM TOKYO, V48, P181, DOI 10.1538/expanim.48.181
   TACHE Y, 1987, AM J PHYSIOL, V253, pG241, DOI 10.1152/ajpgi.1987.253.2.G241
   Takahashi A, 2006, METABOLISM, V55, P1664, DOI 10.1016/j.metabol.2006.08.007
   Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302
   Tolonen A, 2002, PHYTOCHEM ANALYSIS, V13, P316, DOI 10.1002/pca.663
   Wittemer SM, 2005, PHYTOMEDICINE, V12, P28, DOI 10.1016/j.phymed.2003.11.002
   Yamada T, 2008, PHARMACOL THERAPEUT, V117, P188, DOI 10.1016/j.pharmthera.2007.09.006
NR 38
TC 35
Z9 37
U1 1
U2 24
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0944-7113
EI 1618-095X
J9 PHYTOMEDICINE
JI Phytomedicine
PD DEC 15
PY 2011
VL 19
IS 1
BP 88
EP 97
DI 10.1016/j.phymed.2011.06.036
PG 10
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 881CA
UT WOS:000299456900014
PM 22018902
DA 2025-04-28
ER

PT J
AU Wang, LC
   Pan, TM
   Tsai, TY
AF Wang, Li-Chun
   Pan, Tzu-Ming
   Tsai, Tsung-Yu
TI Lactic acid bacteria-fermented product of green tea and
   Houttuynia cordata leaves exerts anti-adipogenic and
   anti-obesity effects
SO JOURNAL OF FOOD AND DRUG ANALYSIS
LA English
DT Article
DE Lactic acid bacteria; Green tea; Houttuynia cordata leaf;
   Anti-adipogenesis; Anti-obesity
ID HORMONE-SENSITIVE LIPASE; PARACASEI NTU 101; HIGH-FAT-DIET;
   LIPOPROTEIN-LIPASE; ADIPOSE-TISSUE; MILK-SOYMILK; PPAR-GAMMA; IN-VIVO;
   (-)-EPIGALLOCATECHIN-3-GALLATE; OBESITY
AB Obesity is associated with higher risks of developing diabetes and cardiovascular disease. Green tea, rich in polyphenolic compounds such as epigallocatechin gallate (EGCG) and epigallocatechin (EGC), has been shown to display anti-obesity effects. Houttuynia cordata leaves have also been shown to exhibit anti-obesity effects due to their chlorogenic acid content. Lactic acid bacteria are able to increase the production of polyphenolic compounds. This study aims to develop a novel anti-obesity fermentation product by combining H. cordata leaf tea with green tea, using Lactobacillus paracasei subsp. paracasei NTU 101 (NTU 101) for fermentation due to the advantages of bioconverting the polyphenolic compounds. The regulation of adipogenesis factors and the anti-obesity effect of the NTU 101-fermented tea were evaluated in an in vitro 3T3-L1 pre-adipocyte model and an in vivo obese rat model, respectively. The results show that the NTU 101-fermented tea, which contained higher EGCG, EGC, and chlorogenic acid levels than unfermented tea, was able to inhibit the lipogenesis of mature 3T3-L1 adipocytes by the stimulation of lipolysis. Furthermore, the body weight gain, body fat pad, and feeding efficiency of obese rats, induced with a high fat diet, were decreased by the oral administration of NTU 101-fermented tea. The significant anti-obesity effect was probably due to lipolysis. However, NTU 101 bacteria cells and EGCG may also act as functional ingredients to contribute to the anti-obesity effects of NTU 101-fermented products. Copyright (C) 2017, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.
C1 [Wang, Li-Chun; Tsai, Tsung-Yu] Fu Jen Catholic Univ, PhD Program Nutr & Food Sci, Taipei, Taiwan.
   [Wang, Li-Chun] Natl Taitung Jr Coll, Continuing Educ Sch, Taitung, Taiwan.
   [Pan, Tzu-Ming] Natl Taiwan Univ, Dept Biochem Sci & Technol, 1 Sec 4,Roosevelt Rd, Taipei, Taiwan.
   [Pan, Tzu-Ming] Sunway Biotech Co Ltd, R&D Div, Taipei, Taiwan.
   [Tsai, Tsung-Yu] Fu Jen Catholic Univ, Dept Food Sci, 510 Zhongzheng Rd, Taipei, Taiwan.
C3 Fu Jen Catholic University; National Taiwan University; Fu Jen Catholic
   University
RP Pan, TM (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, 1 Sec 4,Roosevelt Rd, Taipei, Taiwan.; Tsai, TY (corresponding author), Fu Jen Catholic Univ, Dept Food Sci, 510 Zhongzheng Rd, Taipei, Taiwan.
EM tmpan@ntu.edu.tw; tytsai@mail.fju.edu.tw
RI Pan, Tzu-Ming/KHX-6323-2024
OI Tsai, Tsung-Yu/0000-0001-8623-2379
CR Balzan S, 2013, FITOTERAPIA, V86, P115, DOI 10.1016/j.fitote.2013.02.008
   Berger JJ, 1999, J APPL PHYSIOL, V87, P227, DOI 10.1152/jappl.1999.87.1.227
   Bhushan B, 2003, APPL ENVIRON MICROB, V69, P1347, DOI 10.1128/AEM.69.3.1347-1351.2003
   Chen HC, 2002, J LIPID RES, V43, P986
   Cheng MC, 2015, FOOD FUNCT, V6, P3522, DOI [10.1039/c5fo00531k, 10.1039/C5FO00531K]
   Chiang SS, 2012, APPL MICROBIOL BIOT, V93, P903, DOI 10.1007/s00253-011-3753-x
   Chiu CH, 2006, APPL MICROBIOL BIOT, V71, P238, DOI 10.1007/s00253-005-0145-0
   Cooperstone JL, 2017, AM J CLIN NUTR, V106, P59, DOI 10.3945/ajcn.116.150821
   CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FRAYN KN, 1995, ADV ENZYME REGUL, V35, P163, DOI 10.1016/0065-2571(94)00011-Q
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Kusunoki M, 2000, DIABETOLOGIA, V43, P875, DOI 10.1007/s001250051464
   Li GX, 2010, CARCINOGENESIS, V31, P902, DOI 10.1093/carcin/bgq039
   Lin FM, 2004, J IND MICROBIOL BIOT, V31, P559, DOI 10.1007/s10295-004-0184-z
   Manohar M, 2013, J NUTR BIOCHEM, V24, P940, DOI 10.1016/j.jnutbio.2012.06.013
   Marcus A, 2015, J NUTR SCI VITAMINOL, V61, pS211, DOI 10.3177/jnsv.61.S211
   Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309
   Morrison RF, 1999, J CELL BIOCHEM, P59
   Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088
   Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S
   Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200
   Raimondi S, 2009, APPL MICROBIOL BIOT, V81, P943, DOI 10.1007/s00253-008-1719-4
   Rekha CR, 2010, J APPL MICROBIOL, V109, P1198, DOI 10.1111/j.1365-2672.2010.04745.x
   Roberts CK, 2002, ATHEROSCLEROSIS, V161, P133, DOI 10.1016/S0021-9150(01)00622-0
   Rosen ED, 2000, GENE DEV, V14, P1293
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Saravanan R, 2017, PREP BIOCHEM BIOTECH, V47, P245, DOI 10.1080/10826068.2016.1207082
   Steinberg GR, 2007, AM J PHYSIOL-ENDOC M, V293, pE958, DOI 10.1152/ajpendo.00235.2007
   Suh KS, 2010, CELL BIOL TOXICOL, V26, P189, DOI 10.1007/s10565-009-9137-7
   Tao L, 2014, MOL NUTR FOOD RES, V58, P665, DOI 10.1002/mnfr.201300427
   Tsai TY, 2009, J AGR FOOD CHEM, V57, P2065, DOI 10.1021/jf802936c
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Zhang HH, 2010, FREE RADICAL BIO MED, V49, P2010, DOI 10.1016/j.freeradbiomed.2010.09.031
NR 34
TC 50
Z9 53
U1 5
U2 70
PU FOOD & DRUG ADMINSTRATION
PI TAIPEI
PA 161-2 KUNYANG STREET, NANGANG, TAIPEI, 00000, TAIWAN
SN 1021-9498
J9 J FOOD DRUG ANAL
JI J. Food Drug Anal.
PD JUL
PY 2018
VL 26
IS 3
BP 973
EP 984
DI 10.1016/j.jfda.2017.11.009
PG 12
WC Food Science & Technology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Pharmacology & Pharmacy
GA GM1FH
UT WOS:000437809200004
PM 29976415
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Zheleva-Dimitrova, D
   Petrova, A
   Savov, Y
   Gevrenova, R
   Balabanova, V
   Momekov, G
   Simeonova, R
AF Zheleva-Dimitrova, Dimitrina
   Petrova, Alexandra
   Savov, Yonko
   Gevrenova, Reneta
   Balabanova, Vessela
   Momekov, Georgi
   Simeonova, Rumyana
TI Protective Potential of Cicerbita alpina Leaf Extract on
   Metabolic Disorders and Oxidative Stress in Model Animals
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE diabetes mellitus type 2; Cicerbita alpina; oxidative stress;
   antioxidant enzymes
ID CHICORIC ACID; SESQUITERPENE LACTONES; GLUTATHIONE-PEROXIDASE;
   ANTIOXIDANT ACTIVITY; LIPID-PEROXIDATION; CHLOROGENIC ACID; CICHORIC
   ACID; HYPERGLYCEMIA; LIVER; DIET
AB Metabolic disorders (MDs) include disease states such as diabetes mellitus, obesity, dyslipidemia, hyperuricemia, etc., affecting about 30% of the planet's population. The purpose of the present study was to investigate the protective potential of Cicerbita alpina leaf extract (ECA) against chemically induced type 2 diabetes in Wistar rats. Additionally, some biochemical parameters in the blood serum and liver, as well as histopathological investigation, were also performed. Quantitative analysis of the major compounds in the used extract was performed using ultrahigh-performance liquid chromatography-diode array detection (UHPLC-DAD) analyses using the external standard method. C. alpina extract revealed a beneficial effect on MDs, lowering blood sugar levels and MDA quantity in the liver, increasing the reduced glutathione level, and increasing antioxidant enzyme activity. Cichoric acid (CA) (91.93 mg/g dry extract (de) +/- 4.64 mg/g de) was found to be the dominant compound in the extract, followed by caftaric (11.36 +/- 2.10 mg/g de), and chlorogenic acid (CGA) (9.25 +/- 0.05 mg/g de). In conclusion, C. alpina leaf extract (ECA) is rich in caffeoyltartaric and caffeoylquinic acids and provides beneficial effects on the diabetic animal model.
C1 [Zheleva-Dimitrova, Dimitrina; Gevrenova, Reneta; Balabanova, Vessela] Med Univ Sofia, Fac Pharm, Dept Pharmacognosy, 2 Dunav St, Sofia 1000, Bulgaria.
   [Petrova, Alexandra; Momekov, Georgi; Simeonova, Rumyana] Med Univ Sofia, Fac Pharm, Dept Pharmacol Pharmacotherapy & Toxicol, 2 Dunav St, Sofia 1000, Bulgaria.
   [Savov, Yonko] Inst Emergency Med NI Pirogov, Bul Totleben 21, Sofia 1000, Bulgaria.
C3 Medical University Sofia; Medical University Sofia
RP Zheleva-Dimitrova, D (corresponding author), Med Univ Sofia, Fac Pharm, Dept Pharmacognosy, 2 Dunav St, Sofia 1000, Bulgaria.; Simeonova, R (corresponding author), Med Univ Sofia, Fac Pharm, Dept Pharmacol Pharmacotherapy & Toxicol, 2 Dunav St, Sofia 1000, Bulgaria.
EM dzheleva@pharmfac.mu-sofia.bg; alexpetrova.work@gmail.com;
   Yonko_savov@hotmail.com; rgevrenova@pharmfac.mu-sofia.bg;
   vbalabanova@pharmfac.mu-sofia.bg; gmomekov@pharmfac.mu-sofia.bg;
   rsimeonova@pharmfac.mu-sofia.bg
RI Gevrenova, Reneta/AEA-8791-2022; Momekov, Georgi/H-4178-2019;
   Balabanova, Vessela/AAV-6720-2021; Simeonova, Rumyana/G-8002-2019;
   Zheleva-Dimitrova, Dimitrina/GQI-1010-2022
OI Gevrenova, Reneta/0000-0002-1254-2419; Balabanova,
   Vessela/0000-0002-9938-6542; Simeonova, Rumyana/0000-0003-4860-9053;
   Zheleva-Dimitrova, Dimitrina/0000-0002-1952-9903
FU European Union-NextGenerationEU [BG-RRP-2.004-0004-C01]; European
   Union-NextGenerationEU, through the National Recovery and Resilience
   Plan of the Republic of Bulgaria
FX This study is financed by the European Union-NextGenerationEU, through
   the National Recovery and Resilience Plan of the Republic of Bulgaria,
   project BG-RRP-2.004-0004-C01 "Strategic research and innovation program
   for development of Medical University-Sofia".
CR Aebi H, 1974, METHOD ENZYMAT AN, P673, DOI DOI 10.1016/B978-0-12-091302-2.50032-3
   Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004
   APPENDINO G, 1991, PHYTOCHEMISTRY, V30, P1319, DOI 10.1016/S0031-9422(00)95225-7
   ARAI K, 1987, BIOCHIM BIOPHYS ACTA, V924, P292, DOI 10.1016/0304-4165(87)90025-0
   Azay-Milhau J, 2013, J ETHNOPHARMACOL, V150, P755, DOI 10.1016/j.jep.2013.09.046
   Bancroft JD, 2002, Theory and Practice of Histological Techniques, V5th
   Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1
   BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6
   BUMP EA, 1983, CANCER RES, V43, P997
   Carr RM, 2016, GASTROENTEROL CLIN N, V45, P639, DOI 10.1016/j.gtc.2016.07.003
   Ding XQ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9734560
   Djordjevic I, 2004, BIOCHEM SYST ECOL, V32, P209, DOI 10.1016/S0305-1978(03)00159-5
   FUNK V.A., 2009, SYSTEMATICS EVOLUTIO
   Fusani P, 2010, J FOOD COMPOS ANAL, V23, P658, DOI 10.1016/j.jfca.2009.08.014
   Jablonska-Trypuc A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010044
   Kesavulu MM, 2000, DIABETES METAB, V26, P387
   Kim JS, 2018, BIOSCI BIOTECH BIOCH, V82, P1197, DOI 10.1080/09168451.2018.1451742
   Koriem KMM, 2020, BIOINTERFACE RES APP, V10, P5616, DOI 10.33263/BRIAC103.616623
   Kumawat Manjulata, 2013, N Am J Med Sci, V5, P213, DOI 10.4103/1947-2714.109193
   Kurt H, 2012, AFR J PHARM PHARMACO, V6, P2194, DOI 10.5897/AJPP12.296
   Lee J, 2013, FRONT CHEM, V1, DOI 10.3389/fchem.2013.00040
   Li JY, 2018, MOLECULES, V23, DOI 10.3390/molecules23102678
   Likidlilid Atip, 2010, Journal of the Medical Association of Thailand, V93, P682
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Michalska K, 2009, BIOCHEM SYST ECOL, V37, P174, DOI 10.1016/j.bse.2009.02.001
   Mihaylova R, 2024, PLANTS-BASEL, V13, DOI 10.3390/plants13152086
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Mohamed Jamaludin, 2016, Sultan Qaboos Univ Med J, V16, pe132, DOI 10.18295/squmj.2016.16.02.002
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Pari L, 2010, MOL CELL BIOCHEM, V341, P109, DOI 10.1007/s11010-010-0442-5
   Parr AJ, 2000, J SCI FOOD AGR, V80, P985, DOI 10.1002/(SICI)1097-0010(20000515)80:7<985::AID-JSFA572>3.0.CO;2-7
   Parveen K, 2010, CHEM-BIOL INTERACT, V186, P219, DOI 10.1016/j.cbi.2010.04.023
   Pellati F, 2004, J PHARMACEUT BIOMED, V35, P289, DOI 10.1016/S0731-7085(03)00645-9
   Peng Y, 2019, J MED FOOD, V22, P645, DOI 10.1089/jmf.2018.0211
   PICMAN AK, 1986, BIOCHEM SYST ECOL, V14, P255, DOI 10.1016/0305-1978(86)90101-8
   Polizio AH, 2005, REGUL PEPTIDES, V128, P1, DOI 10.1016/j.regpep.2004.12.004
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342
   Spitaler R, 2006, PHYTOCHEMISTRY, V67, P409, DOI 10.1016/j.phytochem.2005.11.018
   Tappel A L, 1978, Methods Enzymol, V52, P506
   Thygesen L, 2007, FOOD CHEM, V101, P74, DOI 10.1016/j.foodchem.2005.11.048
   Waggiallah H, 2011, N AM J MED SCI, V3, P344, DOI 10.4297/najms.2011.3344
   Wesolowska A, 2006, J ETHNOPHARMACOL, V107, P254, DOI 10.1016/j.jep.2006.03.003
   Xiao HF, 2013, FOOD RES INT, V54, P345, DOI 10.1016/j.foodres.2013.07.033
   Yan YW, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/9680508
   Zheleva-Dimitrova D, 2023, PLANTS-BASEL, V12, DOI 10.3390/plants12051009
   Zhu D, 2017, FOOD CHEM TOXICOL, V107, P138, DOI 10.1016/j.fct.2017.06.041
   Zidorn C, 2005, J SERB CHEM SOC, V70, P171, DOI 10.2298/JSC0502171Z
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 49
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT
PY 2024
VL 25
IS 19
AR 10851
DI 10.3390/ijms251910851
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA J0N8Z
UT WOS:001334136700001
PM 39409180
OA gold
DA 2025-04-28
ER

PT J
AU di Giuseppe, R
   Di Castelnuovo, A
   Melegari, C
   De Lucia, F
   Santimone, I
   Sciarretta, A
   Barisciano, P
   Persichillo, M
   De Curtis, A
   Zito, F
   Krogh, V
   Donati, MB
   de Gaetano, G
   Iacoviello, L
AF di Giuseppe, R.
   Di Castelnuovo, A.
   Melegari, C.
   De Lucia, F.
   Santimone, I.
   Sciarretta, A.
   Barisciano, P.
   Persichillo, M.
   De Curtis, A.
   Zito, F.
   Krogh, V.
   Donati, M. B.
   de Gaetano, G.
   Iacoviello, L.
CA Moli-Sani Project Investigators
TI Typical breakfast food consumption and risk factors for cardiovascular
   disease in a large sample of Italian adults
SO NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
LA English
DT Article
DE Breakfast; Obesity; C reactive protein; Metabolic syndrome; Risk score
ID FASTING LIPID PROFILES; REGULAR MEAL FREQUENCY; INSULIN SENSITIVITY;
   DIETARY FIBER; WEIGHT-GAIN; CEREALS; HEALTH; WHOLE
AB Background and aims: The overall consumption of foods most frequently consumed in a typical Italian breakfast might be associated with a better cardiovascular risk profile in Italian adults.
   Method sand Results: 18,177 subjects (53,2% women), aged >= 35 yrs, randomly selected from the Moli-sani Project population were studied.
   The European Prospective Investigation into Cancer and Nutrition (EPIC) FFQ was used for dietary assessment. To derive breakfast pattern, an "a priori" approach was used: firstly, foods typical of the Italian breakfast were selected: milk, coffee, tea, yogurt, crispbread/rusks, breakfast cereals, brioche, biscuits, honey, sugar and jam. The breakfast score was obtained adding the amounts of all selected foods, expressed in grams/day, previously standardized to mean zero and standard deviation 1.
   Subjects showing a higher breakfast score appeared to be younger, more frequently women or smokers, with higher social status but less likely practicing physical activity. After multivariable analyses, subjects with a higher breakfast food consumption had a lower risk to have high body mass index, abdominal obesity, systolic and diastolic blood pressure, blood glucose, triglycerides, total cholesterol (P < 0.0001 for all) and C Reactive Protein (P = 0.022). The associations were unrelated to age, sex, smoking, obesity, physical activity and social status. Subjects with a higher food breakfast score also showed a better physical healthy status score, a lower risk of metabolic syndrome (OR = 0.63; 0.55-0.72 95% CI) and of future CVD (P < 0.0001 for both women and men).
   Conclusion: Consumption of typical Italian breakfast foods positively affects CVD risk profile in an adult Italian population. (c) 2010 Elsevier B.V. All rights reserved.
C1 [di Giuseppe, R.; Di Castelnuovo, A.; De Lucia, F.; Santimone, I.; Sciarretta, A.; Barisciano, P.; Persichillo, M.; De Curtis, A.; Zito, F.; Donati, M. B.; de Gaetano, G.; Iacoviello, L.] Catholic Univ, John Paul II Ctr High Technol Res & Educ Biomed S, Lab Genet & Environm Epidemiol, Res Labs, I-86100 Campobasso, Italy.
   [Melegari, C.] Barilla Spa, Parma, Italy.
   [Krogh, V.] Natl Canc Inst, Nutr Epidemiol Unit, I-20133 Milan, Italy.
C3 Catholic University of the Sacred Heart; Fondazione IRCCS Istituto
   Nazionale Tumori Milan
RP Iacoviello, L (corresponding author), Catholic Univ, John Paul II Ctr High Technol Res & Educ Biomed S, Lab Genet & Environm Epidemiol, Res Labs, Largo Gemelli 1, I-86100 Campobasso, Italy.
EM licia.iacoviello@rm.unicatt.it
RI Persichillo, Mariarosaria/AAC-2385-2020; Siani, Alfonso/B-7925-2015;
   Bonaccio, Marialaura/K-7678-2016; Facchiano, Francesco/K-8716-2016;
   Krogh, Vittorio/AAA-9171-2019; de curtis, amalia/AAC-2829-2020; Di
   Castelnuovo, Augusto Filippo/AAC-2436-2022; Krogh, Vittorio/K-2628-2016;
   Cerletti, Chiara/K-6447-2016; Gianfagna, Francesco/K-4561-2016;
   Iacoviello, Licia/K-4676-2016; Donati, Maria Benedetta/K-6606-2016;
   Costanzo, Simona/K-5076-2016
OI Krogh, Vittorio/0000-0003-0122-8624; Persichillo,
   Mariarosaria/0000-0002-9731-0173; de curtis, amalia/0000-0001-5104-0318;
   Di Castelnuovo, Augusto Filippo/0000-0001-9767-7998; Cerletti,
   Chiara/0000-0002-4759-3179; Gianfagna, Francesco/0000-0003-4615-0816;
   Bonaccio, Marialaura/0000-0002-8082-6552; Iacoviello,
   Licia/0000-0003-0514-5885; Donati, Maria Benedetta/0000-0003-1747-5443;
   di Giuseppe, Romina/0000-0002-5214-8897; Andrea,
   Havranova/0000-0003-2241-7301; Costanzo, Simona/0000-0003-4569-1186
FU Associazione Cuore Sano (Campobasso, Italy); Instrumentation Laboratory
   (IL, Milano, Italy); Derby Blue (San Lazzaro di Savena, Bologna, Italy);
   Caffe' Monforte (Campobasso, Italy); Pfizer Foundation (Rome, Italy);
   Italian Ministry of University and Research (MIUR, Rome, Italy) [1588];
   Barilla SpA. Parma. Italy
FX The Authors thank the Associazione Cuore Sano (Campobasso, Italy),
   Instrumentation Laboratory (IL, Milano, Italy), Derby Blue (San Lazzaro
   di Savena, Bologna, Italy), and Caffe' Monforte (Campobasso, Italy) for
   their generous support to the Moli-sani project.Sources of support: The
   Moli-sani project is supported by an unrestricted grant from Pfizer
   Foundation (Rome, Italy) and the Italian Ministry of University and
   Research (MIUR, Rome, Italy), Programma Triennale di Ricerca, Decreto
   no. 1588.Data analysis presented in this paper was supported by an
   unrestricted grant from Barilla SpA. Parma. Italy.
CR Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Bazzano LA, 2005, OBES RES, V13, P1952, DOI 10.1038/oby.2005.240
   Brighenti F, 1999, EUR J CLIN NUTR, V53, P726, DOI 10.1038/sj.ejcn.1600841
   Centritto F, 2009, NUTR METAB CARDIOVAS, V19, P697, DOI 10.1016/j.numecd.2008.11.009
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Dallal GE., LITTLE HDB STAT PRAC
   Farshchi HR, 2005, AM J CLIN NUTR, V81, P388
   Farshchi HR, 2005, AM J CLIN NUTR, V81, P16
   Farshchi HR, 2004, EUR J CLIN NUTR, V58, P1071, DOI 10.1038/sj.ejcn.1601935
   Giampaoli Simona, 2004, Ital Heart J Suppl, V5, P177
   Howarth NC, 2001, NUTR REV, V59, P129, DOI 10.1111/j.1753-4887.2001.tb07001.x
   Lacoviello L, 2007, EPIDEMIOL BIOSTAT PU, V4, P110
   Lazzeri G, 2006, J Prev Med Hyg, V47, P91
   Liese AD, 2003, AM J CLIN NUTR, V78, P965, DOI 10.1093/ajcn/78.5.965
   Liu SM, 2003, AM J CLIN NUTR, V77, P594, DOI 10.1093/ajcn/77.3.594
   McIntosh M, 2001, NUTR REV, V59, P52
   Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001
   Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002
   Pala V, 2003, TUMORI J, V89, P594, DOI 10.1177/030089160308900603
   Pereira Mark A, 1998, CVD Prev, V1, P231
   Pisani P, 1997, INT J EPIDEMIOL, V26, pS152, DOI 10.1093/ije/26.suppl_1.S152
   Slavin JL, 2005, NUTRITION, V21, P411, DOI 10.1016/j.nut.2004.08.018
   Timlin MT, 2007, NUTR REV, V65, P268, DOI [10.1301/nr.2007.jun.268-281, 10.1111/j.1753-4887.2007.tb00304.x]
   Vanelli Maurizio, 2005, Acta Biomed, V76, P79
   Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008
   Warensjö E, 2010, AM J CLIN NUTR, V92, P194, DOI 10.3945/ajcn.2009.29054
   Willet WC., 1998, Nutritional epidemiology, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]
   Wyatt HR, 2002, OBES RES, V10, P78, DOI 10.1038/oby.2002.13
NR 29
TC 38
Z9 38
U1 0
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0939-4753
EI 1590-3729
J9 NUTR METAB CARDIOVAS
JI Nutr. Metab. Carbiovasc. Dis.
PD APR
PY 2012
VL 22
IS 4
BP 347
EP 354
DI 10.1016/j.numecd.2010.07.006
PG 8
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition
   & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism;
   Nutrition & Dietetics
GA 912LW
UT WOS:000301800500007
PM 21093229
DA 2025-04-28
ER

PT J
AU Alsuwayt, B
   Iftikhar, N
   Hussain, AI
   Ahmad, A
   Zafar, I
   Khanam, A
   Tan, WN
   Nahar, L
   Almuqati, AF
   Haji, EM
   Almutairy, AF
   Sarker, SD
AF Alsuwayt, Bader
   Iftikhar, Neelam
   Hussain, Abdullah Ijaz
   Ahmad, Ashfaq
   Zafar, Irsa
   Khanam, Arifa
   Tan, Wen-Nee
   Nahar, Lutfun
   Almuqati, Afaf F.
   Haji, Esraa Mohammad
   Almutairy, Ali F.
   Sarker, Satyajit D.
TI The Bioprotective Effects of Marigold Tea Polyphenols on Obesity and
   Oxidative Stress Biomarkers in High-Fat-Sugar Diet-Fed Rats
SO CARDIOVASCULAR THERAPEUTICS
LA English
DT Article
DE lipid profile; marigold petal tea; obesity; oxidative stress; rutin
ID SERUM BILIRUBIN LEVELS; ANTIMICROBIAL ACTIVITIES; CALENDULA-OFFICINALIS;
   ZINGIBER-OFFICINALE; METABOLIC SYNDROME; ANTIOXIDANT; L.; EXTRACTS;
   PROFILE; LIPASE
AB Background: The research is aimed at exploring the potential of marigold petal tea (MPT), rich in polyphenol contents, against oxidative stress and obesity in a rat model following a high-fat-sugar diet (HFSD).Methods: The MPT was prepared through the customary method of decoction and was subjected to analysis for its polyphenol composition using reversed-phase high-performance liquid chromatography (RP-HPLC). Two specific doses of MPT, namely, 250 and 500 mg/kg body weight (BW), were chosen for the study-referred to as MPT-250 and MPT-500, respectively.Result: The main phenolic acids and flavonoids identified in MPT, with concentrations exceeding 10 mg/100 mL of tea, included catechin, rutin, salicylic acid, gallic acid, sinapic acid, chlorogenic acid, cinnamic acid, and ellagic acid. The total phenolic (TP) and total flavonoid (TF) contents in MPT were measured to be 5.53 and 7.73 mg/g, respectively. Additionally, MPT demonstrated a 57.2% scavenging capacity with 2,2-diphenyl-1-picrylhydrazyl radical. Notably, the administration of a higher dose (MPT-500) showed a significant reduction in body mass index (BMI) and a 51.24% reduction in the rate of increase in BW compared to the HFSD group. The findings indicated that all the treatment groups, that is, orlistat treatment (OT), MPT-250, and MPT-500 groups, experienced reduced levels of serum total cholesterol (TC), triglyceride (TG), and markers of lipoproteins in contrast to the HFSD group. Moreover, MPT helped restore the levels of malondialdehyde (MDA), superoxide dismutase (SOD), and reduced glutathione (GSH), thereby demonstrating its potential in combating oxidative stress. The MPT-500 group also displayed decreased liver and kidney weights and an improved atherogenic index when compared to the HFSD group.Conclusion: The results clearly indicate that a high dosage of MPT showed antiobesity activity which was comparable to the same effects produced by the conventional drug orlistat.
C1 [Alsuwayt, Bader; Ahmad, Ashfaq] Univ Hafr Al Batin, Coll Pharm, Dept Pharm Practice, Hafar Al Batin 39524, Saudi Arabia.
   [Iftikhar, Neelam; Hussain, Abdullah Ijaz; Zafar, Irsa; Khanam, Arifa] Govt Coll Univ Faisalabad, Dept Chem, Faisalabad 38000, Pakistan.
   [Tan, Wen-Nee] Univ Sains Malaysia, Sch Distance Educ, Chem Sect, Gelugor 11800, Penang, Malaysia.
   [Nahar, Lutfun] Inst Expt Bot ASCR, Lab Growth Regulators, Slechtitelu 27, Olomouc 78371, Czech Republic.
   [Nahar, Lutfun] Palacky Univ, Slechtitelu 27, Olomouc 78371, Czech Republic.
   [Almuqati, Afaf F.; Haji, Esraa Mohammad] Univ Hafr Al Batin, Coll Pharm, Dept Pharmaceut Chem, Hafar Al Batin 39524, Saudi Arabia.
   [Almutairy, Ali F.] Qassim Univ, Coll Pharm, Dept Pharmacol & Toxicol, Buraydah 51452, Saudi Arabia.
   [Sarker, Satyajit D.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Ctr Nat Prod Discovery, James Parsons Bldg,Byrom St, Liverpool L3 3AF, England.
C3 Hafr Albatin University; Government College University Faisalabad;
   Universiti Sains Malaysia; Czech Academy of Sciences; Institute of
   Experimental Botany of the Czech Academy of Sciences; Palacky University
   Olomouc; Hafr Albatin University; Qassim University; Liverpool John
   Moores University
RP Ahmad, A (corresponding author), Univ Hafr Al Batin, Coll Pharm, Dept Pharm Practice, Hafar Al Batin 39524, Saudi Arabia.; Hussain, AI (corresponding author), Govt Coll Univ Faisalabad, Dept Chem, Faisalabad 38000, Pakistan.
EM balsuwayt@uhb.edu.sa; nelamiftikhar26@yahoo.com;
   abdullahijaz@gcuf.edu.pk; ashfaqa@uhb.edu.sa; irsazafar3600@gmail.com;
   arifakhanam007@gmail.com; tanwn@usm.my; drnahar@live.co.uk;
   aalmaqati@uhb.edu.sa; emhaji@uhb.edu.sa; a.almotairi@qu.edu.sa;
   s.sarker@ljmu.ac.uk
RI Ahmad, Ashfaq/GQV-4782-2022; Hussain, Abdullah/AGI-0192-2022; Tan,
   Wen-Nee/A-2201-2016; Sarker, Satyajit/ABC-6278-2021; Almuqati,
   Afaf/HSG-9056-2023; Alsuwayt, Bader/HSG-7114-2023
OI Sarker, Satyajit/0000-0003-4038-0514; Almutairy,
   Ali/0009-0007-7954-4893; Almuqati, Afaf/0000-0002-4361-6791; Hussain,
   Abdullah Ijaz/0000-0001-7862-8859; Alsuwayt, Bader/0000-0002-3435-7994;
   Ahmad, Ashfaq/0000-0002-9185-4639
FU GCUF, Faisalabad, Pakistan
FX The services provided by the Central Hi-Tech Lab, GCUF, Faisalabad,
   Pakistan, for the characterization of compounds are greatly
   acknowledged.
CR Ahmad A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150137
   Archer ZA, 2007, P NUTR SOC, V66, P124, DOI 10.1017/S0029665107005356
   Arsenijevic J, 2016, IND CROP PROD, V89, P14, DOI 10.1016/j.indcrop.2016.04.046
   Boccellino M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165642
   Cetkovic GS, 2004, FOOD RES INT, V37, P643, DOI 10.1016/j.foodres.2004.01.010
   Chang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037241
   Chien MY, 2016, J FOOD DRUG ANAL, V24, P594, DOI 10.1016/j.jfda.2016.01.012
   Choi DH, 2020, J MICROBIOL BIOTECHN, V30, P21, DOI 10.4014/jmb.1910.10040
   Das K, 2000, INDIAN J BIOCHEM BIO, V37, P201
   Ercetin T, 2012, IND CROP PROD, V36, P203, DOI 10.1016/j.indcrop.2011.09.007
   Ezzat SM, 2020, J ETHNOPHARMACOL, V251, DOI 10.1016/j.jep.2020.112541
   Gomathi N., 2008, Pharmacologyonline, V1, P400
   Goyal RK, 2006, FITOTERAPIA, V77, P160, DOI 10.1016/j.fitote.2006.01.005
   Hasani-Ranjbar S, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-28
   Hernández-Saavedra D, 2016, MED CHEM RES, V25, P163, DOI 10.1007/s00044-015-1454-1
   Hosen MB, 2015, INT J REPROD BIOMED, V13, P525
   Hussain AI, 2013, IND CROP PROD, V45, P416, DOI 10.1016/j.indcrop.2013.01.002
   Hussain AI, 2012, FOOD ANAL METHOD, V5, P890, DOI 10.1007/s12161-011-9325-y
   Hussain AI, 2008, FOOD CHEM, V108, P986, DOI 10.1016/j.foodchem.2007.12.010
   Iftikhar N, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11112240
   Iftikhar N, 2022, FOOD SCI NUTR, V10, P698, DOI 10.1002/fsn3.2695
   Iseri S, 2007, TOXICOLOGY, V230, P256, DOI 10.1016/j.tox.2006.11.073
   Islam MT, 2020, PHYTOTHER RES, V34, P1216, DOI 10.1002/ptr.6602
   Jabri MA, 2017, BIOMED PHARMACOTHER, V87, P153, DOI 10.1016/j.biopha.2016.12.043
   Jenko-Praznikar Z, 2013, METABOLISM, V62, P976, DOI 10.1016/j.metabol.2013.01.011
   Kang NL, 2021, VASC HEALTH RISK MAN, V17, P371, DOI 10.2147/VHRM.S316108
   Karadag F, 2017, CLIN PSYCHOPHARM NEU, V15, P153, DOI 10.9758/cpn.2017.15.2.153
   Liu JW, 2023, FOOD REV INT, V39, P560, DOI 10.1080/87559129.2021.1923730
   Mahmoud RH, 2013, EUR REV MED PHARMACO, V17, P75
   Mamikutty N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/263897
   Mayakrishnan V, 2013, ASIAN PAC J TROP MED, V6, P20, DOI 10.1016/S1995-7645(12)60195-3
   MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407
   Muruganandan S, 2005, TOXICOLOGY, V215, P57, DOI 10.1016/j.tox.2005.06.008
   Nammi S, 2009, BASIC CLIN PHARMACOL, V104, P366, DOI 10.1111/j.1742-7843.2008.00362.x
   Oh J, 2013, FOOD CONTROL, V31, P403, DOI 10.1016/j.foodcont.2012.10.021
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Oliveira AKD, 2022, CRIT REV FOOD SCI, V62, P7827, DOI 10.1080/10408398.2021.1919051
   Rigane G., 2013, International Food Research Journal, V20, P3001
   Rodríguez-Pérez C, 2019, CRIT REV FOOD SCI, V59, P1212, DOI 10.1080/10408398.2017.1399859
   Rufino AT, 2021, MED RES REV, V41, P556, DOI 10.1002/med.21740
   Russo C, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24032899
   Saravanan G, 2014, J SCI FOOD AGR, V94, P2972, DOI 10.1002/jsfa.6642
   Shang AO, 2021, CRIT REV FOOD SCI, V61, P2061, DOI 10.1080/10408398.2020.1769548
   Singh M. K., 2011, Journal of Chemical and Pharmaceutical Research, V3, P655
   Velez-Carrasco W, 2008, J NUTR BIOCHEM, V19, P362, DOI 10.1016/j.jnutbio.2007.05.005
   Verma P. K., 2014, World Journal of Pharmaceutical Research, V3, P2067
   Wang CM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2473081
   Wang GW, 2011, J ETHNOPHARMACOL, V136, P10, DOI 10.1016/j.jep.2011.04.051
   Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x
NR 49
TC 2
Z9 2
U1 10
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-5914
EI 1755-5922
J9 CARDIOVASC THER
JI Cardiovasc. Ther.
PD OCT 4
PY 2024
VL 2024
AR 3833521
DI 10.1155/2024/3833521
PG 10
WC Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Pharmacology & Pharmacy
GA I4Y8G
UT WOS:001330336000001
PM 39742004
OA gold
DA 2025-04-28
ER

PT J
AU Zhao, Y
   Yang, LC
   Huang, ZW
   Lin, LZ
   Zheng, GD
AF Zhao, Yan
   Yang, Licong
   Huang, Zhanwang
   Lin, Lezhen
   Zheng, Guodong
TI Synergistic effects of caffeine and catechins on lipid metabolism in
   chronically fed mice via the AMP-activated protein kinase signaling
   pathway
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Caffeine; Catechins; Fat accumulation; Lipid metabolism
ID HORMONE-SENSITIVE LIPASE; ADIPOSE TRIGLYCERIDE LIPASE; FATTY-ACID
   OXIDATION; ENERGY-METABOLISM; BINDING PROTEIN; 3T3-L1 CELLS; GREEN TEA;
   LIVER; PHOSPHORYLATION; DIFFERENTIATION
AB Purpose To investigate the mechanistic effects of combined exposure to caffeine and catechins on lipid metabolism in mice.
   Methods Seventy mice were randomly assigned to seven groups and fed diets containing varying doses of caffeine and catechins for 24 weeks. Body weight gain, intraperitoneal adipose tissue (IPAT) weight, serum biochemical parameters, and enzymatic activities, mRNA and protein expression levels of lipid metabolism-related enzymes in the liver and IPAT were analyzed.
   Results Following administration of caffeine and catechins, body weight gain, IPAT weight, serum and liver concentrations of total cholesterol and triglyceride were markedly reduced. Lipase activities, including that of AMP-activated protein kinase (AMPK), acyl-CoA oxidase, carnitine acyltransferase, adipose triglyceride lipase, and hormone-sensitive lipase, were significantly upregulated; however, fatty acid synthase (FAS) activity in the liver was suppressed. Combined exposure to caffeine and catechins significantly upregulated mRNA and protein expression levels of lipases while downregulating FAS mRNA expression and protein expression of peroxisome proliferator-activated receptor gamma 2.
   Conclusions The combination of caffeine and catechins regulated the enzymatic activities, mRNA, and protein expression levels of lipid metabolism-related enzymes, resulting in suppression of body weight gain and IPAT weight in mice, potentially through activation of the AMPK signaling pathway. This study indicates that chronic intake of both caffeine and catechins can synergistically contribute to prevention of obesity and lifestyle-related diseases.
C1 [Zhao, Yan; Yang, Licong; Huang, Zhanwang; Zheng, Guodong] Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Coll Food Sci & Engn, Nanchang 330045, Jiangxi, Peoples R China.
   [Lin, Lezhen] Lib Jiangxi Agr Univ, Nanchang 330045, Jiangxi, Peoples R China.
   [Zheng, Guodong] Jiangxi Agr Univ, Coll Food Sci & Engn, Key Lab Nat Prod Res & Dev, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University; Jiangxi Agricultural University;
   Jiangxi Agricultural University
RP Zheng, GD (corresponding author), Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Coll Food Sci & Engn, Nanchang 330045, Jiangxi, Peoples R China.; Zheng, GD (corresponding author), Jiangxi Agr Univ, Coll Food Sci & Engn, Key Lab Nat Prod Res & Dev, Nanchang 330045, Jiangxi, Peoples R China.
EM zy1481087859@126.com; wanttobea@163.com; huangzw@163.com;
   zrs030716@yahoo.co.jp; zrs150716@aliyun.com
OI Zhao, Yan/0000-0001-8635-6443
FU National Natural Science Foundation of China [31160320]; Jiangxi
   Province Natural Science Foundation of China [20142BAB204003]
FX This work was kindly supported by the National Natural Science
   Foundation of China (No. 31160320) and the Jiangxi Province Natural
   Science Foundation of China (No. 20142BAB204003).
CR Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008
   Chen NG, 1997, J CLIN INVEST, V100, P1174, DOI 10.1172/JCI119629
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Deng X, 1851, BIOCH BIOPHYS ACTA M, V12, P1521
   Dolinsky VW, 2011, DIABETES, V60, P2274, DOI 10.2337/db11-0374
   Eid HM, 2010, MOL NUTR FOOD RES, V54, P991, DOI 10.1002/mnfr.200900218
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331
   Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200
   Gaidhu MP, 2011, EXERC SPORT SCI REV, V39, P102, DOI 10.1097/JES.0b013e31820ac03e
   Gao Y, 2008, BIOL PHARM BULL, V31, P1716, DOI 10.1248/bpb.31.1716
   Gramza Anna, 2005, Polish Journal of Food and Nutrition Sciences, V14, P219
   Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484
   Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965
   Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120
   Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200
   Janecková R, 2001, PHYSIOL RES, V50, P443
   Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200
   KELLEY DS, 1986, BIOCHEM J, V235, P87, DOI 10.1042/bj2350087
   Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200
   Lee CE, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/759143
   Lee H, 2011, INT J MOL MED, V28, P65, DOI 10.3892/ijmm.2011.674
   MARKWELL MA, 1973, J BIOL CHEM, V248, P3426
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   OSUMI T, 1978, BIOCHEM BIOPH RES CO, V83, P479, DOI 10.1016/0006-291X(78)91015-X
   Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200
   Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520
   Sekar R, 2014, J LIPID RES, V55, P190, DOI 10.1194/jlr.M038042
   Sozio MS, 2011, AM J PHYSIOL-GASTR L, V301, pG739, DOI [10.1152/ajpgi.00432.2010, 10.1152/ajpgi.00161.2011]
   Stark R, 2013, MOL CELL ENDOCRINOL, V366, P215, DOI 10.1016/j.mce.2012.06.012
   Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074559
   Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102
   Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x
   Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x
   Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zheng GD, 2004, IN VIVO, V18, P55
   Zheng G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133433
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
   Zhu W, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-35
NR 41
TC 17
Z9 19
U1 2
U2 38
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT
PY 2017
VL 56
IS 7
BP 2309
EP 2318
DI 10.1007/s00394-016-1271-4
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FG9TV
UT WOS:000410783500008
PM 27444711
DA 2025-04-28
ER

PT J
AU Hashimoto, T
   Yokokawa, T
   Narusawa, R
   Okada, Y
   Kawaguchi, R
   Higashida, K
AF Hashimoto, Takeshi
   Yokokawa, Takumi
   Narusawa, Ryoko
   Okada, Yoko
   Kawaguchi, Rika
   Higashida, Kazuhiko
TI A lactate-based compound containing caffeine in addition to voluntary
   running exercise decreases subcutaneous fat mass and improves glucose
   metabolism in obese rats
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Obesity; Lipolysis; Low volume exercise; Diabetes
ID INSULIN SENSITIVITY; LIPID-METABOLISM; WEIGHT-LOSS; INCREASES; MUSCLE;
   EXPRESSION; ADAPTATIONS; ACTIVATION; REDUCTION; OXIDATION
AB We examined the effect of a lactate-based compound containing caffeine with voluntary running exercise on fat loss and metabolic improvement in diet-induced obese (DIO) rats. The rats treated with exercise training (Ex) and the compound (i.e., 1000 mg/kg body weight of sodium lactate and 36 mg/kg body weight of caffeine) with exercise training (ExLC) for 5 weeks showed decreased epididymal and scapular fat mass compared to the sedentary (S) rats, while LC rats displayed significantly decreased scapular fat mass compared to the Ex rats. The area under the curve for the LC rats during an oral glucose tolerance test was significantly lower compared with the S and Ex rats. Thus, administration of a lactate-based compound containing caffeine can effectively decrease fat mass and improve glucose tolerance even with low volume exercise training in DIO rats.
C1 [Hashimoto, Takeshi; Okada, Yoko; Kawaguchi, Rika] Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.
   [Yokokawa, Takumi] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan.
   [Narusawa, Ryoko; Higashida, Kazuhiko] Univ Shiga Prefecture, Dept Food Sci & Nutr, Hikone, Japan.
C3 Ritsumeikan University; Kyoto University; University Shiga Prefecture
RP Hashimoto, T (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.
EM thashimo@fc.ritsumei.ac.jp
RI Yokokawa, Takumi/ABG-3699-2020
OI Hashimoto, Takeshi/0000-0003-3951-5290; Yokokawa,
   Takumi/0000-0002-3813-4958
FU Japanese Ministry of Education, Culture, Sports, Science, and Technology
   [26702029, 15KK0358]; Central Research and Development Laboratory,
   Kobayashi Pharmaceutical; Grants-in-Aid for Scientific Research
   [26702029, 15KK0358] Funding Source: KAKEN
FX This study was supported by the Grant-in-Aid for Scientific Research
   from the Japanese Ministry of Education, Culture, Sports, Science, and
   Technology (#26702029 and #15KK0358 to TH), and funding from Central
   Research and Development Laboratory, Kobayashi Pharmaceutical.
CR [Anonymous], EFSA J
   Badin PM, 2013, ENDOCRINOLOGY, V154, P1444, DOI 10.1210/en.2012-2029
   Campbell JE, 2009, METABOLISM, V58, P651, DOI 10.1016/j.metabol.2009.01.002
   Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D
   Dasgupta B, 2012, MOL CELL BIOL, V32, P2837, DOI 10.1128/MCB.05853-11
   DESPRES JP, 1991, AM J PHYSIOL, V261, pE159, DOI 10.1152/ajpendo.1991.261.2.E159
   Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734
   Giannopoulou I, 2005, J CLIN ENDOCR METAB, V90, P1511, DOI 10.1210/jc.2004-1782
   Hashimoto T, 2004, J APPL PHYSIOL, V97, P843, DOI 10.1152/japplphysiol.01193.2003
   Hashimoto T., 2012, JOURNAL OF CELL SCIE
   Hashimoto T, 2008, MED SCI SPORT EXER, V40, P486, DOI [10.1249/mss.0b013e31815fcb04, 10.1249/MSS.0b013e31815fcb04]
   Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com
   Hashimoto T, 2013, J APPL PHYSIOL, V115, P260, DOI 10.1152/japplphysiol.00427.2013
   Horowitz JF, 2007, EXERC SPORT SCI REV, V35, P192, DOI 10.1097/jes.0b013e318156e084
   Hoshino D, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12555
   Kitaoka Y, 2016, APPL PHYSIOL NUTR ME, V41, P695, DOI 10.1139/apnm-2016-0016
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Mann A, 2014, JOVE-J VIS EXP, DOI 10.3791/52174
   Mulder H, 2003, J BIOL CHEM, V278, P36380, DOI 10.1074/jbc.M213032200
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Ogasawara J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040876
   Oishi Y, 2015, J APPL PHYSIOL, V118, P742, DOI 10.1152/japplphysiol.00054.2014
   RODNICK KJ, 1989, J APPL PHYSIOL, V66, P1250, DOI 10.1152/jappl.1989.66.3.1250
   Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008
   Schenk S, 2006, AM J PHYSIOL-ENDOC M, V291, pE254, DOI 10.1152/ajpendo.00051.2006
   Schenk S, 2009, J PHYSIOL-LONDON, V587, P4949, DOI 10.1113/jphysiol.2009.175489
   Temple JL, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00080
   Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200
   Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200
   Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200
   2002, DIABETES CARE, V25, P431
   2012, J NUTR METABOLISM
NR 33
TC 6
Z9 6
U1 1
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD MAY
PY 2019
VL 56
BP 84
EP 91
DI 10.1016/j.jff.2019.03.007
PG 8
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA HX6IN
UT WOS:000467507400010
DA 2025-04-28
ER

PT J
AU Ilie, EI
   Popescu, L
   Luta, EA
   Bita, A
   Corbu, AR
   Mihai, DP
   Pogan, AC
   Balaci, TD
   Minca, A
   Dutu, LE
   Olaru, OT
   Boscencu, R
   Gîrd, CE
AF Ilie, Elena Iuliana
   Popescu, Liliana
   Luta, Emanuela-Alice
   Bita, Andrei
   Corbu, Alexandru Radu
   Mihai, Dragos Paul
   Pogan, Ana Corina
   Balaci, Teodora Dalila
   Minca, Alexandru
   Dutu, Ligia Elena
   Olaru, Octavian Tudorel
   Boscencu, Rica
   Gird, Cerasela Elena
TI Phytochemical Characterization and Antioxidant Activity Evaluation for
   Some Plant Extracts in Conjunction with Pharmacological Mechanism
   Prediction: Insights into Potential Therapeutic Applications in
   Dyslipidemia and Obesity
SO BIOMEDICINES
LA English
DT Article
DE hypolipidemic activity; anti-obesity; free radical scavenging activity;
   UHPLC-MS; heatmap correlation matrix; molecular docking; molecular
   dynamics; carbonic anhydrase 5A
ID ROSEMARY ROSMARINUS-OFFICINALIS; LOWERED PLASMA-CHOLESTEROL;
   CARBONIC-ANHYDRASE-V; FATTY LIVER-DISEASE; FECAL BILE-ACIDS; OXIDATIVE
   STRESS; APIUM-GRAVEOLENS; PHENOLIC CONTENT; CELERY EXTRACT; LIPID
   PROFILE
AB Lipid metabolism dysregulation can lead to dyslipidemia and obesity, which are major causes of cardiovascular disease and associated mortality worldwide. The purpose of the study was to obtain and characterize six plant extracts (ACE-Allii cepae extractum; RSE-Rosmarini extractum; CHE-Cichorii extractum; CE-Cynarae extractum; AGE-Apii graveolentis extractum; CGE-Crataegi extractum) as promising adjuvant therapies for the prevention and treatment of dyslipidemia and its related metabolic diseases. Phytochemical screening revealed that RSE was the richest extract in total polyphenols (39.62 +/- 13.16 g tannic acid/100 g dry extract) and phenolcarboxylic acids (22.05 +/- 1.31 g chlorogenic acid/100 g dry extract). Moreover, the spectrophotometric chemical profile highlighted a significant concentration of flavones for CGE (5.32 +/- 0.26 g rutoside/100 g dry extract), in contrast to the other extracts. UHPLC-MS quantification detected considerable amounts of phenolic constituents, especially chlorogenic acid in CGE (187.435 +/- 1.96 mg/g extract) and rosmarinic acid in RSE (317.100 +/- 2.70 mg/g extract). Rosemary and hawthorn extracts showed significantly stronger free radical scavenging activity compared to the other plant extracts (p < 0.05). Pearson correlation analysis and the heatmap correlation matrix indicated significant correlations between phytochemical contents and in vitro antioxidant activities. Computational studies were performed to investigate the potential anti-obesity mechanism of the studied extracts using target prediction, homology modeling, molecular docking, and molecular dynamics approaches. Our study revealed that rosmarinic acid (RA) and chlorogenic acid (CGA) can form stable complexes with the active site of carbonic anhydrase 5A by either interacting with the zinc-bound catalytic water molecule or by directly binding Zn2+. Further studies are warranted to experimentally validate the predicted CA5A inhibitory activities of RA and CGA and to investigate the hypolipidemic and antioxidant activities of the proposed plant extracts in animal models of dyslipidemia and obesity.
C1 [Ilie, Elena Iuliana; Popescu, Liliana; Luta, Emanuela-Alice; Mihai, Dragos Paul; Pogan, Ana Corina; Balaci, Teodora Dalila; Dutu, Ligia Elena; Olaru, Octavian Tudorel; Boscencu, Rica; Gird, Cerasela Elena] Univ Med & Pharm Carol Davila, Fac Pharm, Traian Vuia 6, Bucharest 020956, Romania.
   [Bita, Andrei] Univ Med & Pharm Craiova, Fac Pharm, Dept Pharmacognosy & Phytotherapy, Petru Rares 2, Craiova 200349, Romania.
   [Corbu, Alexandru Radu] Univ Craiova, Dept Hort & Food Sci, AI Cuza 13, Craiova 200585, Romania.
   [Minca, Alexandru] Univ Med & Pharm Carol Davila, Fac Med, Dept Med Semiol, Eroii Sanit 8, Bucharest 050474, Romania.
C3 Carol Davila University of Medicine & Pharmacy; University of Medicine &
   Pharmacy of Craiova; University of Craiova; Carol Davila University of
   Medicine & Pharmacy
RP Popescu, L; Mihai, DP (corresponding author), Univ Med & Pharm Carol Davila, Fac Pharm, Traian Vuia 6, Bucharest 020956, Romania.
EM elena.ionita@drd.umfcd.ro; liliana.popescu22@umfcd.ro;
   emanuela.luta@umfcd.ro; andrei.bita@umfcv.ro;
   alexandru.corbu@edu.ucv.ro; dragos_mihai@umfcd.ro;
   corina.ionita@umfcd.ro; teodora.balaci@umfcd.ro;
   alexandru.minca@umfcd.ro; ligia.dutu@umfcd.ro; octavian.olaru@umfcd.ro;
   rica.boscencu@umfcd.ro; cerasela.gird@umfcd.ro
RI Corbu, Alexandru/HKF-5635-2023; Mihai, Dragos/AFQ-0586-2022; Dutu,
   Ligia/AAV-1350-2020; Ionita, Elena/MEK-9924-2025; Popescu,
   Liliana/GRJ-5639-2022; Olaru, Octavian Tudorel/C-6551-2016; Luta,
   Emanuela-Alice/HNR-3925-2023; Bita, Andrei/R-1667-2016
OI gird, cerasela elena/0000-0003-4372-4335; Ionita,
   Elena-Iuliana/0009-0000-2433-4097; Olaru, Octavian
   Tudorel/0000-0001-6904-3066; Luta, Emanuela-Alice/0000-0002-6903-3260;
   Bita, Andrei/0000-0003-4715-1423; Mihai, Dragos
   Paul/0000-0003-2880-9381; Corbu, Alexandru Radu/0000-0002-6859-1981
FU University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania;
   Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova,
   Craiova, Romania
FX This work was supported by the University of Medicine and Pharmacy
   "Carol Davila", Bucharest, Romania, in collaboration with the Faculty of
   Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova,
   Romania.
CR Aires A, 2011, MOLECULES, V16, P6816, DOI 10.3390/molecules16086816
   Alam MA, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0080-3
   Allegra A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061739
   Aspatwar A, 2023, J PHYSIOL-LONDON, V601, P257, DOI 10.1113/JP283579
   Ben Salem M, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4951937
   BORIACKSJODIN PA, 1995, P NATL ACAD SCI USA, V92, P10949, DOI 10.1073/pnas.92.24.10949
   Calderón-Santiago M, 2013, J PHARMACEUT BIOMED, V74, P178, DOI 10.1016/j.jpba.2012.10.029
   Cao J, 2012, HUM EXP TOXICOL, V31, P617, DOI 10.1177/0960327111426585
   Cho BO, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13105
   Costea L, 2022, PLANTS-BASEL, V11, DOI 10.3390/plants11131680
   Costea L, 2021, FARMACIA, V69, P1176, DOI 10.31925/farmacia.2021.6.23
   D'Ambrosio K, 2020, CHEM COMMUN, V56, P13033, DOI 10.1039/d0cc05172a
   Dallak M, 2018, PHARM BIOL, V56, P535, DOI 10.1080/13880209.2018.1523934
   de Oliveira JR, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0499-8
   Dianat M, 2015, AVICENNA J PHYTOMEDI, V5, P203
   Eberlé D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   Epure A, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10010064
   Evtyugin DD, 2020, MOLECULES, V25, DOI 10.3390/molecules25122745
   Falasca K, 2008, J MED VIROL, V80, P1900, DOI 10.1002/jmv.21292
   Gfeller D, 2014, NUCLEIC ACIDS RES, V42, pW32, DOI 10.1093/nar/gku293
   Ghica A, 2023, PLANTS-BASEL, V12, DOI 10.3390/plants12132510
   González-Peña D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020267
   González-Peña D, 2017, REDOX BIOL, V11, P205, DOI 10.1016/j.redox.2016.12.002
   Gülçin I, 2016, J ENZYM INHIB MED CH, V31, P1698, DOI 10.3109/14756366.2015.1135914
   Han JC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00456
   Han LY, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12875
   Hassani FV, 2016, N-S ARCH PHARMACOL, V389, P931, DOI 10.1007/s00210-016-1256-0
   Hedayati N, 2019, PHYTOTHER RES, V33, P3040, DOI 10.1002/ptr.6492
   Hegazy AM, 2018, HUM EXP TOXICOL, V37, P420, DOI 10.1177/0960327117710534
   Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123
   Ionus E, 2024, PLANTS-BASEL, V13, DOI 10.3390/plants13091192
   Ivan IM, 2024, MOLECULES, V29, DOI 10.3390/molecules29092053
   Ivan IM, 2024, PHARMACEUTICS, V16, DOI 10.3390/pharmaceutics16020245
   Jacobo-Velázquez DA, 2009, J FOOD SCI, V74, pR107, DOI 10.1111/j.1750-3841.2009.01352.x
   Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128
   Jayalakshmi R, 2006, MOL CELL BIOCHEM, V292, P59, DOI 10.1007/s11010-006-9218-3
   Jude KM, 2002, BIOCHEMISTRY-US, V41, P2485, DOI 10.1021/bi015808q
   Kalara N, 2023, J INVEST MED HIGH IM, V11, DOI 10.1177/23247096231191874
   Kamel AM, 2022, J MED FOOD, V25, P931, DOI 10.1089/jmf.2022.0025
   Karioti A, 2016, MOLECULES, V21, DOI 10.3390/molecules21121649
   Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284
   Khoury AA, 2022, MOLECULES, V27, DOI 10.3390/molecules27238550
   Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033
   KISO Y, 1983, J NAT PROD, V46, P841, DOI 10.1021/np50030a003
   Kostic DA, 2012, TROP J PHARM RES, V11, P117, DOI 10.4314/tjpr.v11i1.15
   Koyu A, 2009, TOXICOL IND HEALTH, V25, P429, DOI 10.1177/0748233709106821
   Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899
   Krieger E, 2012, METHODS MOL BIOL, V819, P405, DOI 10.1007/978-1-61779-465-0_25
   Kumar Naresh, 2019, Biotechnology Reports, V24, pe00370, DOI 10.1016/j.btre.2019.e00370
   Kumar Naresh, 2014, Biotechnol Rep (Amst), V4, P86, DOI 10.1016/j.btre.2014.09.002
   Kumar R, 2020, CURR MOL PHARMACOL, V13, P7, DOI 10.2174/1874467212666190716145210
   Land H, 2018, METHODS MOL BIOL, V1685, P43, DOI 10.1007/978-1-4939-7366-8_4
   Lante A, 2011, J AGR FOOD CHEM, V59, P5318, DOI 10.1021/jf2003317
   Lee JH, 2010, J FOOD SCI, V75, pH212, DOI 10.1111/j.1750-3841.2010.01755.x
   Lee SM, 2012, NUTR RES, V32, P210, DOI 10.1016/j.nutres.2012.01.004
   Lee SO, 2005, EXP BIOL MED, V230, P472
   Li WY, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13565
   Loguercio C, 2012, FREE RADICAL BIO MED, V52, P1658, DOI 10.1016/j.freeradbiomed.2012.02.008
   Luta EA, 2022, PLANTS-BASEL, V11, DOI 10.3390/plants11182398
   Luta EA, 2020, FARMACIA, V68, P919, DOI 10.31925/farmacia.2020.5.20
   Luta EA, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms241411670
   Ma JQ, 2015, INT IMMUNOPHARMACOL, V28, P531, DOI 10.1016/j.intimp.2015.06.036
   Magnone M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061724
   Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998
   Mai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082459
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Maresca A, 2015, BIOORGAN MED CHEM, V23, P7181, DOI 10.1016/j.bmc.2015.10.014
   Marzocchella L, 2011, RECENT PATENTS INFLA, V5, P200, DOI 10.2174/187221311797264937
   Meldrum DR, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.02.104
   Middleton E., The Effects of Plant Flavonoids on Mammalian Cells: Implications for Inflammation, Heart Disease, and Cancer
   Migliorini AA, 2019, J FOOD SCI, V84, P990, DOI 10.1111/1750-3841.14506
   Moskaug JO, 2005, AM J CLIN NUTR, V81, p277S, DOI 10.1093/ajcn/81.1.277S
   Muflihah YM, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10101530
   Mutz M, 2023, MICROB CELL FACT, V22, DOI 10.1186/s12934-023-02222-y
   Nam K, 2005, J CHEM THEORY COMPUT, V1, P2, DOI 10.1021/ct049941i
   Nitulescu G, 2022, PHARMACEUTICS, V14, DOI 10.3390/pharmaceutics14010062
   Nor Zaini Johari Nor Zaini Johari, 2015, International Journal of Applied Research in Natural Products, V8, P1
   Nwafor Ifeoma Chinyelu, 2017, ScientificWorldJournal, V2017, P7343928, DOI 10.1155/2017/7343928
   Ohishi T, 2021, MOLECULES, V26, DOI 10.3390/molecules26020453
   Ou JY, 2018, FOOD FUNCT, V9, P851, DOI 10.1039/c7fo01508a
   Ouyang KH, 2016, CAN J ANIM SCI, V96, P332, DOI 10.1139/cjas-2015-0132
   Parasuraman S, 2011, J PHARMACOL PHARMACO, V2, P52, DOI 10.4103/0976-500X.77119
   Pérez-Fons L, 2010, J AGR FOOD CHEM, V58, P161, DOI 10.1021/jf9026487
   Petiwala SM, 2015, CANCER LETT, V367, P93, DOI 10.1016/j.canlet.2015.07.005
   Pimpley V, 2020, PREP BIOCHEM BIOTECH, V50, P969, DOI 10.1080/10826068.2020.1786699
   Popovic M, 2006, PHYTOTHER RES, V20, P531, DOI 10.1002/ptr.1871
   Qiang ZY, 2012, PHYTOTHER RES, V26, P1048, DOI 10.1002/ptr.3698
   Reincke M, 2023, JAMA-J AM MED ASSOC, V330, P170, DOI 10.1001/jama.2023.11305
   Ren FY, 2021, AGRICULTURE-BASEL, V11, DOI 10.3390/agriculture11090872
   Ro JY, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0786-0
   Rocchetti G, 2020, MOLECULES, V25, DOI 10.3390/molecules25173795
   Romanova D., Study of Antioxidant Effect of Apigenin, Luteolin and Quercetin by DNA Protective Method
   Safaei M, 2021, COMPUT BIOL MED, V136, DOI 10.1016/j.compbiomed.2021.104754
   Santos HO, 2018, PHARMACOL RES, V137, P170, DOI 10.1016/j.phrs.2018.10.007
   Stecoza CE, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms242417476
   Stewart AJ, 2000, J AGR FOOD CHEM, V48, P2663, DOI 10.1021/jf000070p
   Supuran CT, 2022, J ENZYM INHIB MED CH, V37, P2478, DOI 10.1080/14756366.2022.2121393
   Supuran CT, 2016, J ENZYM INHIB MED CH, V31, P345, DOI 10.3109/14756366.2015.1122001
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Tsi D, 1996, CLIN EXP PHARMACOL P, V23, P214, DOI 10.1111/j.1440-1681.1996.tb02598.x
   TSI D, 1995, PLANTA MED, V61, P18, DOI 10.1055/s-2006-957990
   Tsi D, 2000, LIFE SCI, V66, P755, DOI 10.1016/S0024-3205(99)00646-3
   Umami N, 2023, ANIM BIOSCI, V36, P84, DOI 10.5713/ab.22.0041
   Ungureanu AR, 2023, PHARMACEUTICS, V15, DOI 10.3390/pharmaceutics15082125
   Ungureanu AR, 2023, MOLECULES, V28, DOI 10.3390/molecules28093668
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wang SJ, 2019, FOOD FUNCT, V10, P7356, DOI 10.1039/c9fo01677e
   Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330
   Xie ZS, 2016, CHIN J NAT MEDICINES, V14, P746, DOI 10.1016/S1875-5364(16)30089-9
   Yamamoto Y, 2010, BIOSCI BIOTECH BIOCH, V74, P402, DOI 10.1271/bbb.90613
   Yang J, 2004, J AGR FOOD CHEM, V52, P6787, DOI 10.1021/jf0307144
   Yokozawa T, 2002, J AGR FOOD CHEM, V50, P3549, DOI 10.1021/jf020029h
   Zanfirescu A, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15010038
   Zhao D, 2021, FOOD FUNCT, V12, P9151, DOI [10.1039/d1fo00560j, 10.1039/D1FO00560J]
   Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039
   Zhu LH, 2017, J ASIAN NAT PROD RES, V19, P1079, DOI 10.1080/10286020.2017.1381687
NR 116
TC 5
Z9 5
U1 9
U2 9
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD JUL
PY 2024
VL 12
IS 7
AR 1431
DI 10.3390/biomedicines12071431
PG 30
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA ZU8L7
UT WOS:001277892400001
PM 39062004
OA gold
DA 2025-04-28
ER

PT J
AU Paluch, E
   Okinczyc, P
   Zwyrzykowska-Wodzinska, A
   Szperlik, J
   Zarowska, B
   Duda-Madej, A
   Babelewski, P
   Wlodarczyk, M
   Wojtasik, W
   Kupczynski, R
   Szumny, A
AF Paluch, Emil
   Okinczyc, Piotr
   Zwyrzykowska-Wodzinska, Anna
   Szperlik, Jakub
   Zarowska, Barbara
   Duda-Madej, Anna
   Babelewski, Przemyslaw
   Wlodarczyk, Maciej
   Wojtasik, Wioleta
   Kupczynski, Robert
   Szumny, Antoni
TI Composition and Antimicrobial Activity of Ilex Leaves Water
   Extracts
SO MOLECULES
LA English
DT Article
DE Ilex; antimicrobial activity; biofilm; HPLC; DAD; MS; polyphenols; yerba
   mate
ID YERBA MATE; ST-HIL.; ANTIFUNGAL ACTIVITY; PHENOLIC-COMPOUNDS; AQUEOUS
   EXTRACT; PARAGUARIENSIS; IDENTIFICATION; ANTIOXIDANT; CONSTITUENTS;
   PLANTS
AB Plants from the Ilex genus are known for properties such as antimicrobial and anti-inflammatory activity, can act as antiobesity agents and thus can be helpful in medicine. Some holly species, such as Ilex paraguariensis (widely known in the form of popular beverage: yerba mate), have been investigated, while others have been partially researched or remain unknown. Therefore, we performed qualitative and quantitative phytochemical analyses and screened antimicrobial properties of lesser-studied species (I. aquifolium L., I. aquifolium 'Argentea Marginata' and I. x meserveae 'Blue Angel'). I. paraguariensis was used as a standard species for comparison purposes. Investigations were performed on water extracts due to their expected activity and composition. Antimicrobial research included evaluating minimal inhibitory, bactericidal (Staphylococcus aureus and Escherichia coli) and fungicidal concentration (Candida albicans, Alternaria alternata, Fusarium oxysporum, and Aspergillus niger) of extracts. The influence of the extracts on the production, eradication, and viability of bacterial biofilms was also analysed. It was established that Ilex paraguariensis possesses the richest profile of hydroxycinnamic acids derivatives in terms of component concentration and diversity. Ilex spp., especially I. x meserveae, contain a slightly higher amount of flavonoids and more different flavonoid derivatives than I. paraguariensis. However, the strongest antibacterial activity was shown by I. aquifolium L. and its cultivar 'Argentea Marginata' in terms of minimal inhibitory, bactericidal and fungicidal concentration, and biofilm assays. Extracts from both species significantly reduced the biofilm viability of S. aureus as well, which may be of use in the production of multicomponent lavaseptics, antiseptics, diuretics (supporting urinary tract infection therapy) and, due to their action on fungi, additives to growth media for specific fungi. The significant content of saponins enables Ilex extracts to be used as natural emulsifiers, for example, in cosmetics. Moreover, relatively high chlorogenic acid and rutin content may suggest use of Ilex spp. to treat obesity, digestive problems, in chemoprevention, and as preservatives in the food industry.
C1 [Paluch, Emil; Duda-Madej, Anna] Wroclaw Med Univ, Fac Med, Dept Microbiol, Chalubinskiego 4, PL-50376 Wroclaw, Poland.
   [Okinczyc, Piotr; Wlodarczyk, Maciej] Wroclaw Med Univ, Dept Pharmacognosy & Herbal Med, Borowska 211a, PL-50556 Wroclaw, Poland.
   [Zwyrzykowska-Wodzinska, Anna; Kupczynski, Robert] Wroclaw Univ Environm & Life Sci, Dept Environm Hyg & Anim Welf, Chelmonskiego 38C, PL-51630 Wroclaw, Poland.
   [Szperlik, Jakub] Univ Wroclaw, Fac Biol Sci, Lab Tissue Culture Bot Garden, Sienkiewicza 23, PL-50525 Wroclaw, Poland.
   [Zarowska, Barbara] Wroclaw Univ Environm & Life Sci, Dept Biotechnol & Food Microbiol, Chelmonskiego 37, PL-51630 Wroclaw, Poland.
   [Babelewski, Przemyslaw] Wroclaw Univ Environm & Life Sci, Dept Hort, Grunwaldzki 24A, PL-50375 Wroclaw, Poland.
   [Wojtasik, Wioleta] Univ Wroclaw, Fac Biotechnol, Przybyszewskiego 63-77, PL-51148 Wroclaw, Poland.
   [Szumny, Antoni] Wroclaw Univ Environm & Life Sci, Dept Chem, Norwida 25, PL-50375 Wroclaw, Poland.
C3 Wroclaw Medical University; Wroclaw Medical University; Wroclaw
   University of Environmental & Life Sciences; University of Wroclaw;
   Wroclaw University of Environmental & Life Sciences; Wroclaw University
   of Environmental & Life Sciences; University of Wroclaw; Wroclaw
   University of Environmental & Life Sciences
RP Okinczyc, P (corresponding author), Wroclaw Med Univ, Dept Pharmacognosy & Herbal Med, Borowska 211a, PL-50556 Wroclaw, Poland.; Babelewski, P (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Hort, Grunwaldzki 24A, PL-50375 Wroclaw, Poland.
EM emil.paluch@umed.wroc.pl; piotr.okinczyc@umw.edu.pl;
   anna.zwyrzykowska@upwr.edu.pl; jakub.szperlik@uwr.edu.pl;
   barbara.zarowska@upwr.edu.pl; anna.duda-madej@umw.edu.pl;
   przemyslaw.babelewski@upwr.edu.pl; maciej.wlodarczyk@umw.edu.pl;
   wioleta.wojtasik@uwr.edu.pl; robert.kupczynski@upwr.edu.pl;
   antoni.szumny@upwr.edu.pl
RI Zwyrzykowska-Wodzińska, Anna/GRF-3450-2022; Okińczyc,
   Piotr/AAE-7106-2022; Żarowska, Barbara/C-6950-2017; Duda-Madej,
   Anna/ABO-3151-2022; Bąbelewski, Przemysław/C-9954-2017; Szumny,
   Antoni/A-2303-2017; Paluch, Emil/HGC-1023-2022; Kupczynski,
   Robert/C-5542-2016; Wlodarczyk, Maciej/H-9137-2015; Zwyrzykowska -
   Wodzinska, Anna/O-4350-2015
OI Szumny, Antoni/0000-0001-9058-1598; Paluch, Emil/0000-0002-3549-6136;
   Kupczynski, Robert/0000-0003-0796-6273; Wlodarczyk,
   Maciej/0000-0002-8437-2711; Okinczyc, Piotr/0000-0001-5795-8605;
   Zwyrzykowska - Wodzinska, Anna/0000-0003-1325-1493
CR ALIKARIDIS F, 1987, J ETHNOPHARMACOL, V20, P121, DOI 10.1016/0378-8741(87)90084-5
   [Anonymous], 2012, METH DIL ANT SUSC TE
   Balzan S, 2013, FITOTERAPIA, V86, P115, DOI 10.1016/j.fitote.2013.02.008
   Bastos DHM., 2007, Med Aromat Plant Sci Biotechnol, V1, P37
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   Bravo L, 2007, FOOD RES INT, V40, P393, DOI 10.1016/j.foodres.2006.10.016
   Burris KP, 2011, J FOOD SCI, V76, pM456, DOI 10.1111/j.1750-3841.2011.02255.x
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cordova V., 2019, ACTIVIDAD ANTIBIOFIL
   Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002
   Cadiz-Gurrea MD, 2013, FOOD RES INT, V50, P197, DOI 10.1016/j.foodres.2012.09.038
   El-Hawiet AM, 2010, REV BRAS FARMACOGN, V20, P860, DOI 10.1590/S0102-695X2010005000047
   Evens ZN, 2012, WEST J EMERG MED, V13, P538, DOI 10.5811/westjem.2012.8.12572
   Fang ZX, 2007, FOOD CHEM, V100, P845, DOI 10.1016/j.foodchem.2005.09.024
   Filip R, 2010, PHYTOTHER RES, V24, P715, DOI 10.1002/ptr.3004
   Fleck JD, 2019, MOLECULES, V24, DOI 10.3390/molecules24010171
   Grujic N, 2012, MOLECULES, V17, P2518, DOI 10.3390/molecules17032518
   Guo Long, 2015, Chin J Nat Med, V13, P711, DOI 10.1016/S1875-5364(15)30071-6
   Hao DC, 2013, ACTA PHARM SIN B, V3, P8, DOI 10.1016/j.apsb.2012.12.008
   Haraguchi H, 1999, PHYTOTHER RES, V13, P151, DOI 10.1002/(SICI)1099-1573(199903)13:2<151::AID-PTR391>3.0.CO;2-C
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Hoffmann K, 2003, PUBLIC HEALTH NUTR, V6, P765, DOI 10.1079/PHN2003500
   Jaiswal R, 2014, J AGR FOOD CHEM, V62, P9252, DOI 10.1021/jf501210s
   Jaiswal R, 2014, PHYTOCHEMISTRY, V106, P141, DOI 10.1016/j.phytochem.2014.07.018
   Kanchanapoom T, 2002, PHYTOCHEMISTRY, V61, P461, DOI 10.1016/S0031-9422(02)00140-1
   Karunanidhi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/392058
   Khoza BS, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/914759
   Kolderman E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121835
   Kolodziejczyk-Czepas J, 2018, J PHARM PHARMACOL, V70, P413, DOI 10.1111/jphp.12872
   Kujawska M, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/6849317
   Kuropka P, 2021, FOODS, V10, DOI 10.3390/foods10040818
   Legay S, 2016, NEW PHYTOL, V212, P977, DOI 10.1111/nph.14170
   LEVIN DA, 1976, AM NAT, V110, P261, DOI 10.1086/283063
   Li Jun-min, 2006, Zhejiang Da Xue Xue Bao Yi Xue Ban, V35, P273
   López-Cobo A, 2016, LWT-FOOD SCI TECHNOL, V73, P505, DOI 10.1016/j.lwt.2016.06.049
   Luís A, 2014, BIOFOULING, V30, P69, DOI 10.1080/08927014.2013.845878
   Marksa M, 2020, IND CROP PROD, V145, DOI 10.1016/j.indcrop.2020.112123
   Martinez MAD, 1997, BIOCHEM SYST ECOL, V25, P619, DOI 10.1016/S0305-1978(97)00054-9
   Mateos R, 2018, FOOD CHEM, V241, P232, DOI 10.1016/j.foodchem.2017.08.085
   Matic IZ, 2013, PHYTOTHER RES, V27, P852, DOI 10.1002/ptr.4807
   Mazur M, 2019, CHIL J AGR RES, V79, P316, DOI 10.4067/S0718-58392019000200316
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Noureddine T, 2018, J INFECT DEV COUNTR, V12, P712, DOI 10.3855/jidc.10380
   Okinczyc P, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11010068
   Ouyang MA, 2001, CHINESE J CHEM, V19, P885
   Paluch E, 2020, APPL MICROBIOL BIOT, V104, P1871, DOI 10.1007/s00253-020-10349-w
   Paluch E, 2018, COLLOID SURFACE B, V164, P34, DOI 10.1016/j.colsurfb.2018.01.020
   Paluch E, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88244-1
   Peres RG, 2013, MOLECULES, V18, P3859, DOI 10.3390/molecules18043859
   Piecuch A, 2016, J APPL MICROBIOL, V121, P682, DOI 10.1111/jam.13204
   Martin JGP, 2013, REV ARGENT MICROBIOL, V45, P93, DOI 10.1016/S0325-7541(13)70006-3
   Ruhal R, 2021, MICROBIOL RES, V251, DOI 10.1016/j.micres.2021.126829
   Salejda AM, 2021, J FOOD QUALITY, V2021, DOI 10.1155/2021/8848279
   Luis AFS, 2019, BRAZ J PHARM SCI, V55, DOI 10.1590/s2175-97902019000217615
   Shimoyama AT, 2013, N-S ARCH PHARMACOL, V386, P5, DOI 10.1007/s00210-012-0807-2
   Tirloni CAS, 2018, J MED FOOD, V21, P1276, DOI 10.1089/jmf.2018.0010
   SPRAY M, 1981, AGR HIST REV, V29, P97
   Takahashi M, 2014, J AOAC INT, V97, P1195, DOI 10.5740/jaoacint.13-038
   UEDA K, 1983, CHEM LETT, P149, DOI 10.1246/cl.1983.149
   Verderosa AD, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00824
   WALD A, 1976, GASTROENTEROLOGY, V71, P738
   WEST LG, 1977, PHYTOCHEMISTRY, V16, P1846, DOI 10.1016/0031-9422(71)85115-4
   WILLEMS M, 1988, PHYTOCHEMISTRY, V27, P1852, DOI 10.1016/0031-9422(88)80458-8
   Wismer T, 2013, Small Animal Toxicology, V3rd
   Wu Y, 2000, LETT APPL MICROBIOL, V30, P468, DOI 10.1046/j.1472-765X.2000.00748.x
   Zain N, 2013, J OIL PALM RES, V25, P58
   Zheleva-Dimitrova D, 2020, PROCESS BIOCHEM, V96, P202, DOI 10.1016/j.procbio.2020.06.002
   Zhou CH, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8936307
   Zhou J, 2019, J AGR FOOD CHEM, V67, P5405, DOI 10.1021/acs.jafc.8b05062
   Zhou SX, 2012, CHIN J NAT MEDICINES, V10, P84, DOI 10.3724/SP.J.1009.2012.00084
   Zhu LL, 2018, J HEPATO-BIL-PAN SCI, V25, P195, DOI 10.1002/jhbp.537
   Ziaee A, 2009, BASIC CLIN PHARMACOL, V104, P253, DOI 10.1111/j.1742-7843.2008.00368.x
   Zwyrzykowska A, 2015, OPEN CHEM, V13, P1303, DOI 10.1515/chem-2015-0142
NR 73
TC 24
Z9 24
U1 3
U2 32
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD DEC
PY 2021
VL 26
IS 24
AR 7442
DI 10.3390/molecules26247442
PG 35
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA XX8UC
UT WOS:000736562200001
PM 34946528
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Panchal, SK
   Brown, L
AF Panchal, Sunil K.
   Brown, Lindsay
TI Tropical fruits from Australia as potential treatments for metabolic
   syndrome
SO CURRENT OPINION IN PHARMACOLOGY
LA English
DT Article
ID FUNCTIONAL FOODS; OBESITY; INFLAMMATION; FLAVONOIDS; OVERWEIGHT
AB Australia has a unique and diverse flora, including indigenous fruits, used by Australian Aboriginals for food and medicines for up to 45,000 years as well as recently introduced fruits for commercial production. However, this range of fruits has not led to the development of functional foods, for example for chronic inflammatory diseases such as metabolic syndrome including obesity, hypertension, fatty liver and diabetes. This review examines the potential of tropical and subtropical fruits from Australia to be used as functional foods for metabolic syndrome, including Davidson's plum, Queen Garnet plum, durian, litchi, breadfruit, jackfruit, mangosteen, papaya, jabuticaba, coffee and seaweed. Preclinical studies have defined potential responses of these functional foods in metabolic syndrome but the usefulness in humans with metabolic syndrome requires clinical studies which are scarce in the relevant literature. Overall, these Australian examples show that tropical fruits can provide functional foods to decrease chronic inflammatory diseases.
C1 [Panchal, Sunil K.] Western Sydney Univ, Sch Sci, Richmond, NSW 2753, Australia.
   [Brown, Lindsay] Griffith Univ, Sch Pharm & Med Sci, Southport, Qld 4222, Australia.
C3 Western Sydney University; Griffith University; Griffith University -
   Gold Coast Campus
RP Brown, L (corresponding author), Griffith Univ, Sch Pharm & Med Sci, Southport, Qld 4222, Australia.
EM lindsay.brown@griffith.edu.au
OI Panchal, Sunil K/0000-0001-5464-3376
CR Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Alba K, 2019, J SCI FOOD AGR, V99, P4189, DOI 10.1002/jsfa.9633
   Amiot MJ, 2016, OBES REV, V17, P573, DOI 10.1111/obr.12409
   Arozal W, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00082
   Ashaolu TJ, 2020, BIOMED PHARMACOTHER, V130, DOI 10.1016/j.biopha.2020.110625
   Aziz NAA, 2019, FOODS, V8, DOI 10.3390/foods8030096
   Bhandarkar NS, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10111369
   Bhandarkar NS, 2020, FASEB J, V34, P4783, DOI 10.1096/fj.201902416RR
   Bhaswant M, 2019, J FUNCT FOODS, V56, P119, DOI 10.1016/j.jff.2019.03.011
   Brown L, 2015, OBES REV, V16, P914, DOI 10.1111/obr.12313
   Brown L, 2018, J FUNCT FOODS, V45, P233, DOI 10.1016/j.jff.2018.01.024
   Campos-Vega R, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13204
   Cock I.E., 2011, ETHNOPHARMACOLOGY SE
   Cordenunsi-Lysenko BR, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00391
   Cronin P, 2021, NUTRIENTS, V13, DOI 10.3390/nu13051655
   Dabke K, 2019, J CLIN INVEST, V129, P4050, DOI 10.1172/JCI129194
   Dragano NRV, 2020, NEUROSCIENCE, V437, P215, DOI 10.1016/j.neuroscience.2020.04.034
   du Preez R, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113991
   du Preez R, 2021, NUTRIENTS, V13, DOI 10.3390/nu13061754
   du Preez R, 2020, MAR DRUGS, V18, DOI 10.3390/md18020097
   Fanning K, 2013, RIRDC PUBLICATION, V13/014
   Fox, 2001, VEGETATION AUSTR
   de Cosío-Barrón ACG, 2020, INNOV FOOD SCI EMERG, V60, DOI 10.1016/j.ifset.2019.102286
   Green M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082890
   Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363
   Inada KOP, 2021, FOOD RES INT, V147, DOI 10.1016/j.foodres.2021.110518
   Jiang HM, 2020, FOOD RES INT, V136, DOI 10.1016/j.foodres.2020.109316
   John OD, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020319
   John OD, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010272
   John OD, 2019, J FUNCT FOODS, V56, P204, DOI 10.1016/j.jff.2019.03.018
   Kim Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010017
   Kim Y, 2019, EUR J EPIDEMIOL, V34, P731, DOI 10.1007/s10654-019-00524-3
   Kottek M., 2006, METEOROL Z, V15, P259, DOI [10.1127/0941-2948/2006/0130, DOI 10.1127/0941-2948/2013/0507, DOI 10.1127/0941-2948/2006/0130]
   Lim DKY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040751
   Lim V, 2020, METABOLITES, V10, DOI 10.3390/metabo10030114
   Liu Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236300
   Locher C, 2013, FUTURE MED CHEM, V5, P733, DOI [10.4155/FMC.13.44, 10.4155/fmc.13.44]
   Lopez-Santamarina A, 2020, MOLECULES, V25, DOI 10.3390/molecules25041004
   Lotfollahi Z, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69288-1
   Mani JS, 2021, J ETHNOPHARMACOL, V268, DOI 10.1016/j.jep.2020.113580
   Martín MA, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10061474
   McCracken E, 2018, CLIN DERMATOL, V36, P14, DOI 10.1016/j.clindermatol.2017.09.004
   Mehmood A, 2021, FOOD RES INT, V142, DOI 10.1016/j.foodres.2021.110180
   Myhrstad MCW, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030859
   Najjar RS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112712
   O'Keefe JH, 2018, PROG CARDIOVASC DIS, V61, P38, DOI 10.1016/j.pcad.2018.02.002
   Packer J, 2019, J ETHNOBIOL ETHNOMED, V15, DOI 10.1186/s13002-019-0348-6
   Panchal SK, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082855
   Pei RS, 2020, CURR OPIN BIOTECH, V61, P153, DOI 10.1016/j.copbio.2019.12.018
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Ranasinghe RASN, 2019, INT J FOOD SCI, V2019, DOI 10.1155/2019/4327183
   Rao AG, 2021, NUTR DIABETES, V11, DOI 10.1038/s41387-021-00161-4
   Reis JF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1076-5
   Richmond R, 2019, J FUNCT FOODS, V62, DOI 10.1016/j.jff.2019.103547
   Roberts P, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102190
   Rosado CP, 2021, APPL PHYSIOL NUTR ME, V46, P1469, DOI 10.1139/apnm-2021-0288
   Rosado CP, 2020, INT J BIOL MACROMOL, V145, P1066, DOI 10.1016/j.ijbiomac.2019.09.199
   do Rosario VA, 2021, CLIN NUTR, V40, P879, DOI 10.1016/j.clnu.2020.09.041
   Salazar-Lopez NJ., 2020, Food Wastes and By-Products: Nutraceutical and Health Potential, P327, DOI DOI 10.1002/9781119534167.CH11
   Santana LF, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071608
   Santos JTD, 2021, FOOD RES INT, V147, DOI 10.1016/j.foodres.2021.110521
   Schulz M, 2020, FOOD RES INT, V137, DOI 10.1016/j.foodres.2020.109744
   Shannon E, 2021, MAR DRUGS, V19, DOI 10.3390/md19070358
   Shin JH, 2017, CLIN RES HEPATOL GAS, V41, P17, DOI 10.1016/j.clinre.2016.07.001
   Thomas DR, 2020, CURR DEV NUTR, V4, DOI 10.1093/cdn/nzz142
   Wilkinson V, AGRIFUTURES AUSTR PU, V21-052
   Wilson LF, 2019, INT J CANCER, V144, P2088, DOI 10.1002/ijc.31943
   Wu TY, 2020, INT J BIOL MACROMOL, V160, P915, DOI 10.1016/j.ijbiomac.2020.05.271
   Yahfoufi N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111618
   Zhang SY, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22116110
   Zhao L, 2020, COMPR REV FOOD SCI F, V19, P2139, DOI 10.1111/1541-4337.12590
NR 71
TC 12
Z9 12
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4892
EI 1471-4973
J9 CURR OPIN PHARMACOL
JI Curr. Opin. Pharmacol.
PD APR
PY 2022
VL 63
AR 102182
DI 10.1016/j.coph.2022.102182
EA FEB 2022
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 2P7PA
UT WOS:000819926800001
PM 35149297
DA 2025-04-28
ER

PT J
AU Yoo, HJ
   Yoon, HY
   Yee, J
   Gwak, HS
AF Yoo, Hee-Jeong
   Yoon, Ha-Young
   Yee, Jeong
   Gwak, Hye-Sun
TI Effects of Ephedrine-Containing Products on Weight Loss and Lipid
   Profiles: A Systematic Review and Meta-Analysis of Randomized Controlled
   Trials
SO PHARMACEUTICALS
LA English
DT Review
DE mahuang; ephedrine; weight loss; blood pressure; lipid profiles;
   systematic review; meta-analysis
ID BODY-MASS INDEX; DOUBLE-BLIND; DIETARY-SUPPLEMENTS; HERBAL SUPPLEMENT;
   CAFFEINE; OBESITY; EFFICACY; SAFETY; OVERWEIGHT; PLACEBO
AB Ephedrine, the main active ingredient of mahuang, may lead to weight loss; however, it can also induce cardiovascular side effects. As ephedrine use remains controversial, this study aimed to systematically review previous studies on ephedrine-containing products and perform meta-analysis of the existing evidence on weight, blood pressure (BP), heart rate, and lipid change effects of ephedrine-containing products. We searched for placebo-controlled randomized studies in PubMed, Web of Science, and EMBASE until July 2021 using the following search terms: (ephedr* OR mahuang) AND ( "weight loss " OR obes* OR overweight). Mean differences (MDs) and 95% confidence intervals (CIs) were calculated to evaluate the effects of ephedrine-containing products on weight, BP, heart rate, and lipid profiles. A total of 10 articles were included. Compared with the placebo group, the ephedrine-containing product group was associated with greater weight loss, with an MD of -1.97 kg (95% CI: -2.38, -1.57). In the ephedrine-containing product group, the mean heart rate was 5.76 beats/min higher than in the placebo group (95% CI: 3.42, 8.10), whereas intergroup differences in systolic and diastolic BP were not statistically significant. The ephedrine-containing product group had a significantly higher mean high-density lipoprotein cholesterol level (MD: 2.74 mg/dL; 95% CI: 0.94, 4.55), lower mean low-density lipoprotein cholesterol level (MD: -5.98 mg/dL; 95% CI: -10.97, -0.99), and lower mean triglyceride level (MD: -11.25 mg/dL; 95% CI: -21.83, -0.68) than the placebo group. Compared with placebo, the ephedrine-containing products showed better effects on weight loss and lipid profiles, whereas they caused increased heart rate. The ephedrine-containing products may be beneficial to obese or overweight patients; however, close monitoring is needed, especially heart rate monitoring.
C1 [Yoo, Hee-Jeong; Yoon, Ha-Young; Yee, Jeong; Gwak, Hye-Sun] Ewha Womans Univ, Coll Pharm, Seoul 03760, South Korea.
   [Yoo, Hee-Jeong; Yoon, Ha-Young; Yee, Jeong; Gwak, Hye-Sun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 03760, South Korea.
   [Yoo, Hee-Jeong] Natl Med Ctr, Dept Pharm, Seoul 04564, South Korea.
C3 Ewha Womans University; Ewha Womans University; National Medical Center
   - Korea
RP Yee, J; Gwak, HS (corresponding author), Ewha Womans Univ, Coll Pharm, Seoul 03760, South Korea.; Yee, J; Gwak, HS (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 03760, South Korea.
EM heejyoo@hanmail.net; hayoungdymphnayoon@gmail.com; jjjhello1@naver.com;
   hsgwak@ewha.ac.kr
RI Yoo, Hee/J-5555-2012; Yee, Jeong/AAY-1959-2021
OI Gwak, Hye sun/0000-0003-0278-2563; Yee, Jeong/0000-0001-8439-143X
CR [Anonymous], Noncommunicable Diseases
   Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   Batsis JA, 2021, OBESITY, V29, P1102, DOI 10.1002/oby.23110
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8
   Bogacka I, 2007, DIABETES CARE, V30, P1179, DOI 10.2337/dc06-1962
   Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   BUEMANN B, 1994, INT J OBESITY, V18, P329
   Carey AL, 2015, DIABETOLOGIA, V58, P1045, DOI 10.1007/s00125-015-3543-6
   Caterson ID, 2012, DIABETES OBES METAB, V14, P523, DOI 10.1111/j.1463-1326.2011.01554.x
   Coffey CS, 2004, INT J OBESITY, V28, P1411, DOI 10.1038/sj.ijo.0802784
   Daneschvar HL, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.009
   De Matteis R, 2002, INT J OBESITY, V26, P1442, DOI 10.1038/sj.ijo.0802148
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Food and Drug Administration HHS, 2004, Fed Regist, V69, P6787
   Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x
   Greenway FL, 2004, OBES RES, V12, P1152, DOI 10.1038/oby.2004.144
   Hackman RM, 2006, INT J OBESITY, V30, P1545, DOI 10.1038/sj.ijo.0803283
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Hioki C, 2004, CLIN EXP PHARMACOL P, V31, P614, DOI 10.1111/j.1440-1681.2004.04056.x
   Ingerslev J, 1997, INT J OBESITY, V21, P666, DOI 10.1038/sj.ijo.0800457
   Kalman DS, 2000, CURR THER RES CLIN E, V61, P199, DOI 10.1016/S0011-393X(00)89034-7
   Khera R, 2016, JAMA-J AM MED ASSOC, V315, P2424, DOI 10.1001/jama.2016.7602
   Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x
   KRIEGER DR, 1990, T ASSOC AM PHYSICIAN, V103, P307
   Laccourreye O, 2015, EUR ANN OTORHINOLARY, V132, P31, DOI 10.1016/j.anorl.2014.11.001
   Maunder A, 2020, DIABETES OBES METAB, V22, P891, DOI 10.1111/dom.13973
   Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163
   Ogden CL, 2020, JAMA-J AM MED ASSOC, V324, P1208, DOI 10.1001/jama.2020.14590
   Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906, 10.1136/bmj.n160]
   PASQUALI R, 1985, INT J OBESITY, V9, P93
   Persky AM, 2004, BRIT J CLIN PHARMACO, V57, P552, DOI 10.1111/j.1365-2125.2003.02062.x
   Saper RB, 2004, AM FAM PHYSICIAN, V70, P1731
   Schubert MM, 2014, J APPL PHYSIOL, V117, P745, DOI 10.1152/japplphysiol.00570.2014
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Song MK, 2012, EXP THER MED, V3, P707, DOI 10.3892/etm.2012.462
   Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898
   Tynes JR, 2006, J LEGAL MED, V27, P493, DOI 10.1080/01947640601021113
   VALLERAND AL, 1989, J APPL PHYSIOL, V67, P438, DOI 10.1152/jappl.1989.67.1.438
   Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282
   Westfall T, 2017, Goodman Gilmans: The Pharmacological Basis of Therapeutics
   Wooltorton E, 2002, CAN MED ASSOC J, V166, P633
NR 48
TC 8
Z9 9
U1 0
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD NOV
PY 2021
VL 14
IS 11
AR 1198
DI 10.3390/ph14111198
PG 11
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA XI0WB
UT WOS:000725842200001
PM 34832979
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Koyama, T
   Maekawa, M
   Ozaki, E
   Kuriyama, N
   Uehara, R
AF Koyama, Teruhide
   Maekawa, Mizuho
   Ozaki, Etsuko
   Kuriyama, Nagato
   Uehara, Ritei
TI Daily Consumption of Coffee and Eating Bread at Breakfast Time Is
   Associated with Lower Visceral Adipose Tissue and with Lower Prevalence
   of Both Visceral Obesity and Metabolic Syndrome in Japanese Populations:
   A Cross-Sectional Study
SO NUTRIENTS
LA English
DT Article
DE coffee; green tea; visceral adipose tissue; metabolic syndrome
ID GREEN TEA; DISEASE; RISK
AB Background: The study aimed to investigate the association between daily consumption of coffee or green tea, with and without habitual bread consumption for breakfast, and components and prevalence of metabolic syndrome in Japanese populations. Methods: The study population consisted of 3539 participants (1239 males and 2300 females). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression analyses to evaluate the associations of daily coffee and green tea consumption with the prevalence of obesity, visceral obesity, and metabolic syndrome. Results: Coffee consumption was associated with significantly lower proportions of visceral obesity (OR: 0.746, CI: 0.588-0.947) and metabolic syndrome (OR: 0.706, CI: 0.565-0.882). On the other hand, green tea was not associated with visceral obesity (OR: 1.105, CI: 0.885-1.380) or metabolic syndrome (OR: 0.980, CI: 0.796-1.206). The combination of daily drinking coffee and eating bread at breakfast time was associated with significantly lower proportions of obesity (OR: 0.613, CI: 0.500-0.751) (p = 0.911 for interaction), visceral obesity (OR: 0.549, CI: 0.425-0.710) (p = 0.991 for interaction), and metabolic syndrome (OR: 0.586, CI: 0.464-0.741) (p = 0.792 for interaction). Conclusion: Coffee consumption was significantly associated with lower visceral adipose tissue and lower proportions of visceral obesity, but the same was not true for green tea consumption. Furthermore, in combination with coffee consumption, the addition of eating bread at breakfast time significantly lowered proportions of visceral obesity and metabolic syndrome, although there was no interaction between coffee and bread.
C1 [Koyama, Teruhide; Maekawa, Mizuho; Ozaki, Etsuko; Kuriyama, Nagato; Uehara, Ritei] Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kamikyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.
C3 Kyoto Prefectural University of Medicine
RP Koyama, T (corresponding author), Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kamikyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.
EM tkoyama@koto.kpu-m.ac.jp; mizuho92@koto.kpu-m.ac.jp;
   ozaki@koto.kpu-m.ac.jp; nkuriyam@koto.kpu-m.ac.jp;
   ruehara@koto.kpu-m.ac.jp
RI 晃英, 小山/AAI-9805-2020
OI Koyama, Teruhide/0000-0002-8161-368X; Kuriyama,
   Nagato/0000-0002-6859-535X
FU JSPS KAKENHI [17015018, 221S0001]; Japanese Ministry of Education,
   Culture, Sports, Science and Technology [16H06277]
FX This study was supported by a Grant-in-Aid for Scientific Research on
   Priority Areas of Cancer (Grant No. 17015018) and Innovative Areas
   (Grant No. 221S0001) and by JSPS KAKENHI (Grant No. 16H06277) from the
   Japanese Ministry of Education, Culture, Sports, Science and Technology.
   We thank Daisuke Matsui and Isao Watanabe for their work for acquisition
   of data, and Yoshiyuki Watanabe for initiating and organizing the J-MICC
   study in the Kyoto area as former principal investigator.
CR Bautista-Castaño I, 2012, NUTR REV, V70, P218, DOI 10.1111/j.1753-4887.2012.00454.x
   Bowen KJ, 2018, CURR ATHEROSCLER REP, V20, DOI 10.1007/s11883-018-0704-3
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/nejmoa1800389, 10.1056/NEJMoa1800389, 10.1056/NEJMoa1200303]
   Funahashi T, 2014, BEST PRACT RES CL EN, V28, P93, DOI 10.1016/j.beem.2013.09.002
   Hara M, 2018, MED SCI SPORT EXER, V50, P2433, DOI 10.1249/MSS.0000000000001712
   Hara M, 2012, J EPIDEMIOL, V22, P523, DOI 10.2188/jea.JE20120078
   Haraguchi N, 2019, HYPERTENS RES, V42, P1599, DOI 10.1038/s41440-019-0264-0
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Hibi M, 2018, NUTR RES, V55, P1, DOI 10.1016/j.nutres.2018.03.012
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Ida M, 2013, OBESITY, V21, pE350, DOI 10.1002/oby.20300
   Izadi V, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_37_14
   Jurgens TM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008650.pub2
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Legeay S, 2015, NUTRIENTS, V7, P5443, DOI 10.3390/nu7075230
   Lin Y, 2020, PHYTOTHER RES, V34, P2459, DOI 10.1002/ptr.6697
   Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Oz HS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060561
   Paglia L, 2018, EUR J PAEDIATR DENT, V19, P5, DOI 10.23804/ejpd.2018.19.01.01
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Serra-Majem L, 2015, BRIT J NUTR, V113, pS29, DOI 10.1017/S0007114514003249
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Dinh TC, 2019, DIAB MET SYND CLIN R, V13, P1667, DOI 10.1016/j.dsx.2019.03.021
   Wakai K, 2011, J EPIDEMIOL, V21, P223, DOI 10.2188/jea.JE20100139
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   Yamagishi K, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017003
   Yonekura Y, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051370
NR 32
TC 13
Z9 15
U1 1
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2020
VL 12
IS 10
AR 3090
DI 10.3390/nu12103090
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA OM6GW
UT WOS:000586121700001
PM 33050584
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Rodrigues, EL
   Santana, LF
   do Nascimento, VA
   Arakaki, MA
   Cardoso, CAL
   Filiú, WFD
   Guimaraes, RDA
   Hiane, PA
   Freitas, KD
AF Rodrigues, Elisana Lima
   Santana, Lidiani Figueiredo
   do Nascimento, Valter Aragao
   Arakaki, Marcel Asato
   Cardoso, Claudia Andrea Lima
   Filiu, Wander Fernando de Oliveira
   Guimaraes, Rita de Cassia Avellaneda
   Hiane, Priscila Aiko
   Freitas, Karine de Cassia
TI Use of Guazuma ulmifolia Lam. Stem Bark Extracts to Prevent
   High-Fat Diet Induced Metabolic Disorders in Mice
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE antioxidants; high-fat diet; medicinal plants; phenolic compounds
ID AQUEOUS EXTRACT; ANTIOXIDANT ACTIVITY; OBESITY; LEAVES; INFLAMMATION;
   ADIPOKINES; PATHWAYS; CAFFEINE; EXERCISE; FRACTION
AB This study aimed to evaluate the effects of supplementation with ethanolic and aqueous extracts from the bark of the stem of Guazuma ulmifolia in mice submitted to a high-fat diet as well as to evaluate the chemical composition of these extracts. The chemical composition and antioxidant potential was evaluated in aqueous and ethanolic extracts of the stem bark. The in vivo test consisted of evaluating the effects of the aqueous and ethanolic extracts of the stem bark on C57BL/6 mice receiving a high-fat diet. The animals were evaluated for weight gain, feed consumption, visceral adiposity, serum, and inflammatory and hormonal parameters. The results of the chemical analyses corroborate those obtained by the literature, which reported gallocatechin, epigallocatechin and epigallocatechin gallate. Compared with the ethanolic extract, the aqueous extract showed greater antioxidant capacity. Both extracts resulted in lower feed consumption in the animals, but they did not influence weight gain or visceral adiposity and resulted in varied changes in the lipid profile. In addition, they did not influence glucose tolerance, insulin sensitivity, or fasting blood glucose. Furthermore, the leptin levels increased, which may have contributed to satiety, but this was shown to have a negative impact on other inflammatory and hormonal parameters. Therefore, under the conditions of this study, the biologically active compounds present in the plant species Guazuma ulmifolia were not able to contribute to the treatment of metabolic changes related to the consumption of a high-fat diet.
C1 [Rodrigues, Elisana Lima; do Nascimento, Valter Aragao; Guimaraes, Rita de Cassia Avellaneda; Hiane, Priscila Aiko; Freitas, Karine de Cassia] Fed Univ Mato Grosso Do Sul UFMS, Grad Program Hlth & Dev Cent West Reg Brazil, BR-79070900 Campo Grande, MS, Brazil.
   [Santana, Lidiani Figueiredo] Univ Estadual Mato Grosso do Sul, Course Med, BR-79804970 Campo Grande, MS, Brazil.
   [Arakaki, Marcel Asato] Univ Fed Mato Grosso do Sul, Med Sch, BR-79070900 Campo Grande, MS, Brazil.
   [Cardoso, Claudia Andrea Lima] Univ Estadual Mato Grosso do Sul, Course Chem, BR-79070900 Dourados, MS, Brazil.
   [Filiu, Wander Fernando de Oliveira] Fed Univ Mato Grosso Do Sul UFMS, Fac Pharmaceut Sci Food & Nutr, BR-79079900 Campo Grande, MS, Brazil.
C3 Universidade Federal de Mato Grosso do Sul; Universidade Estadual de
   Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul;
   Universidade Estadual de Mato Grosso do Sul; Universidade Federal de
   Mato Grosso do Sul
RP Santana, LF (corresponding author), Univ Estadual Mato Grosso do Sul, Course Med, BR-79804970 Campo Grande, MS, Brazil.
EM elisana.lima10@gmail.com; lidiani.santana@uems.br;
   valter.aragao@ufms.br; marcel_arakakiasato@hotmail.com; claudia@uems.br;
   wander.filiu@gmail.com; rita.guimaraes@ufms.br; priscila.hiane@ufms.br;
   karine.freitas@ufms.br
RI Rodrigues Guimarães, Rita de Fátima/AHD-1115-2022; Nascimento, Valter
   Aragão do Nascimento/HDM-7086-2022; Cardoso, Claudia/AAK-5578-2020
OI Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; Freitas, Karine de
   Cassia/0000-0002-5813-6088
FU Graduate Program in Health and Development in the Central-West Region;
   Laboratorio de Modelos Experimentais de Doencas (LMED); Faculdade de
   Medicina, Federal University of Mato Grosso do Sul, Campo Grande;
   Federal University of Mato Grossodo Sul-UFMS; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-CAPES; Brazilian Research
   Council (CNPq) [313985/2023-5]
FX We thank the Graduate Program in Health and Development in the
   Central-West Region, Laboratorio de Modelos Experimentais de Doencas
   (LMED), Faculdade de Medicina, Federal University of Mato Grosso do Sul,
   Campo Grande, and Federal University of Mato Grossodo Sul-UFMS for the
   support. The authors thank the Coordination for the Improvement of
   Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior-CAPES). This research was partially supported by the
   Brazilian Research Council (CNPq) (CNPq: processno 313985/2023-5).
CR Adnyana I. K., 2013, Research Journal of Medicinal Plant, V7, P158, DOI 10.3923/rjmp.2013.158.164
   Agada R, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03618
   Al-Hussaniy Hany Akeel, 2021, J Med Life, V14, P600, DOI 10.25122/jml-2021-0153
   Alam F, 2019, PHYTOTHER RES, V33, P41, DOI 10.1002/ptr.6211
   Magos GA, 2008, J ETHNOPHARMACOL, V117, P58, DOI 10.1016/j.jep.2008.01.015
   Alonso-Castro AJ, 2008, J ETHNOPHARMACOL, V118, P252, DOI 10.1016/j.jep.2008.04.007
   Aouacheri O, 2015, CAN J DIABETES, V39, P44, DOI 10.1016/j.jcjd.2014.03.002
   Barcelos RP, 2020, NUTR RES, V80, P1, DOI 10.1016/j.nutres.2020.05.005
   Bernatoniene J, 2018, MOLECULES, V23, DOI 10.3390/molecules23040965
   Calixto JT, 2016, SAUDI J BIOL SCI, V23, P434, DOI 10.1016/j.sjbs.2015.10.009
   Chandran R, 2016, BIOMED PHARMACOTHER, V82, P547, DOI 10.1016/j.biopha.2016.05.036
   Contreras T.A., 2020, Rev. Peru. Med. Integr, V5, P5, DOI [10.26722/rpmi.2020.51.165, DOI 10.26722/RPMI.2020.51.165]
   Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028
   dos Santos JM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2935051
   Guimaraes DED, 2007, REV NUTR, V20, P549, DOI 10.1590/S1415-52732007000500010
   Duraiswamy B., 2018, International Journal of Pharmacy and Pharmaceutical Sciences, V10, P9, DOI [10.22159/ijpps.2018v10i9.26778, DOI 10.22159/IJPPS.2018V10I9.26778]
   Florence NT, 2014, J ETHNOPHARMACOL, V151, P784, DOI 10.1016/j.jep.2013.09.021
   Harrison L, 2019, INT J OBESITY, V43, P1305, DOI 10.1038/s41366-018-0221-z
   Hauner H, 2004, PHYSIOL BEHAV, V83, P653, DOI 10.1016/j.physbeh.2004.09.016
   Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143
   Hor M, 1996, PHYTOCHEMISTRY, V42, P109, DOI 10.1016/0031-9422(95)00855-1
   Irving A, 2021, PROG LIPID RES, V82, DOI 10.1016/j.plipres.2021.101098
   Islam M.M., 2019, World J. Pharm. Pharm. Sci, V8, P332
   Iswantini D., 2011, Hayati Journal of Biosciences, V18, P6
   Izquierdo AG, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112704
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kumar N.S., 2019, J MED PLANTS STUD, V7, P205
   Kumaran A, 2006, FOOD CHEM, V97, P109, DOI 10.1016/j.foodchem.2005.03.032
   Lee SJ, 2006, J PEDIATR-US, V149, P809, DOI 10.1016/j.jpeds.2006.08.075
   Lee S, 2018, J NUTR, V148, P209, DOI 10.1093/jn/nxx027
   Lopes GC, 2012, INT J ANAL CHEM, V2012, DOI 10.1155/2012/508945
   Lopes GC, 2009, J BRAZIL CHEM SOC, V20, P1103, DOI 10.1590/S0103-50532009000600016
   Mahfudh N, 2024, ACTA SCI POLON-TECHN, V23, DOI 10.17306/J.AFS.001142
   Maldini M, 2013, PHYTOCHEMISTRY, V86, P64, DOI 10.1016/j.phytochem.2012.10.011
   MALONE MH, 1962, LLOYD, V25, P320
   Matos F.J.A., 2009, Introduo Fitoqumica Experimental UFC Fortaleza, V3rd ed.
   Maurya PK, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.08.016
   Meerabai G., 2017, World J. Pharm. Pharm. Sci, V6, P933, DOI [10.20959/wjpps201710-10235, DOI 10.20959/WJPPS201710-10235]
   Meeusen R, 2013, NESTLE NUTR WORKS SE, V76, P1, DOI 10.1159/000350223
   Misch M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23105439
   Morais C.M., 2013, Masters Thesis
   Musial C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051744
   Nasreddine LM, 2018, NUTR RES, V57, P12, DOI 10.1016/j.nutres.2018.04.016
   Nery CD, 2011, REV BRAS MED ESPORTE, V17, P49, DOI 10.1590/S1517-86922011000100010
   Noh D, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121998
   Nuri,, 2020, Research Journal of Pharmacy and Technology, V13, P411, DOI 10.5958/0974-360X.2020.00080.3
   OECD, 2008, Guidelines. 425: Acute Oral Toxicity: Up-and-Down Procedure
   Oroian M, 2015, FOOD RES INT, V74, P10, DOI 10.1016/j.foodres.2015.04.018
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Pansera M.R., 2003, Rev. bras. farmacogn., V13, P17
   Patanè GT, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24119228
   Pereira Fernando Leal, 2012, Rev. Col. Bras. Cir., V39, P41
   Pereira GA, 2019, FOOD RES INT, V126, DOI 10.1016/j.foodres.2019.108713
   Phillips CM, 2017, ANN NY ACAD SCI, V1391, P85, DOI 10.1111/nyas.13230
   Picó C, 2022, REV ENDOCR METAB DIS, V23, P13, DOI 10.1007/s11154-021-09687-5
   Prahastuti S., 2020, Pharmaciana, V10, DOI DOI 10.1088/1742-6596/1374/1/012020
   Rafi M, 2020, INDONES J PHARM, V31, P171
   Ramadhansyah R, 2023, J GIZI PANGAN, V18, P109, DOI 10.25182/jgp.2023.18.2.109-116
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Roese F.M., 2011, Masters Thesis
   Rupasinghe HPV, 2016, PHARMACOL THERAPEUT, V165, P153, DOI 10.1016/j.pharmthera.2016.06.005
   Sarapio E, 2019, CAN J PHYSIOL PHARM, V97, P916, DOI 10.1139/cjpp-2019-0023
   Sung J, 2016, PHYTOTHER RES, V30, P1848, DOI 10.1002/ptr.5692
   Sutrisna Em, 2022, Biomedical & Pharmacology Journal, V15, P1109, DOI 10.13005/bpj/2446
   Syaefudin Syaefudin, 2014, Journal of Biological Sciences, V14, P305
   TAI MM, 1994, DIABETES CARE, V17, P152, DOI 10.2337/diacare.17.2.152
   Thaipitakwong T, 2018, PHARM BIOL, V56, P109, DOI 10.1080/13880209.2018.1424210
   Villalobos W, 2011, TROP PLANT PATHOL, V36, P110, DOI 10.1590/S1982-56762011000200007
   Wagner H., 2009, PLANT DRUG ANAL THIN, V2nd
   White PAS, 2016, J ETHNOPHARMACOL, V179, P92, DOI 10.1016/j.jep.2015.12.047
   Yogesh C., 2017, Int. J. Pharmacol. Res, V7, P214
   Youn HS, 2006, BIOCHEM PHARMACOL, V72, P850, DOI 10.1016/j.bcp.2006.06.021
   Zhang F, 2018, CELL METAB, V27, P252, DOI 10.1016/j.cmet.2017.12.004
NR 73
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2024
VL 25
IS 16
AR 8889
DI 10.3390/ijms25168889
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA F0E4J
UT WOS:001306638400001
PM 39201576
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Saper, RB
   Eisenberg, DM
   Phillips, RS
AF Saper, RB
   Eisenberg, DM
   Phillips, RS
TI Common dietary supplements for weight loss
SO AMERICAN FAMILY PHYSICIAN
LA English
DT Article
ID BODY-FAT MASS; CHROMIUM PICOLINATE; ACID; METAANALYSIS; OVERWEIGHT;
   REDUCTION; CHITOSAN; EFFICACY; GLUCOSE; EPHEDRA
AB Over-the-counter dietary supplements to treat obesity appeal to many patients who desire a "magic bullet" for weight loss. Asking overweight patients about their use of weight-loss supplements and understanding the evidence for the efficacy, safety, and quality of these supplements are critical when counseling patients regarding weight loss. A schema for whether physicians should recommend, caution, or discourage use of a particular weight-loss supplement is presented in this article. More than 50 individual dietary supplements and more than 125 commercial combination products are available for weight loss. Currently, no weight-loss supplements meet criteria for recommended use. Although evidence of modest weight loss secondary to ephedra-caffeine ingestion exists, potentially serious adverse effects have led the U.S. Food and Drug Administration to ban the sale of these products. Chromium is a popular weight-loss supplement, but its efficacy and long-term safety are uncertain. Guar gum and chitosan appear to be ineffective; therefore, use of these products should be discouraged. Because of insufficient or conflicting evidence regarding the efficacy of conjugated linoleic acid, ginseng, glucomannan, green tea, hydroxycitric acid, L-carnitine, psyllium, pyruvate, and St. John's wort in weight loss, physicians should caution patients about the use of these supplements and closely monitor those who choose to use these products. Copyright (C) 2004 American Academy of Family Physicians.
C1 Harvard Univ, Sch Med, Div Res & Educ Complementary & Integrat Med Thera, Boston, MA 02115 USA.
   Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA.
C3 Harvard University; Harvard Medical School; Harvard University; Harvard
   University Medical Affiliates; Beth Israel Deaconess Medical Center
RP Saper, RB (corresponding author), Boston Univ, Sch Med, Dept Family Med, 1 Boston Med Ctr Pl,Dowling 5 S, Boston, MA 02118 USA.
EM robert.saper@bmc.org
RI Saper, Robert/Y-4598-2018
OI Saper, Robert/0000-0002-0992-6198
FU NCCIH NIH HHS [K24 AT00589-02, T32 AT00051] Funding Source: Medline
CR Althuis MD, 2002, AM J CLIN NUTR, V76, P148, DOI 10.1093/ajcn/76.1.148
   Anderson RA, 1997, DIABETES, V46, P1786, DOI 10.2337/diabetes.46.11.1786
   Anderson RA, 1998, NUTR REV, V56, P266, DOI 10.1111/j.1753-4887.1998.tb01763.x
   Armanini D, 2003, J ENDOCRINOL INVEST, V26, P646, DOI 10.1007/BF03347023
   Bahadori B, 1997, ACTA MED AUST, V24, P185
   Bent S, 2003, ANN INTERN MED, V138, P468, DOI 10.7326/0003-4819-138-6-200303180-00010
   Blanck HM, 2001, JAMA-J AM MED ASSOC, V286, P930, DOI 10.1001/jama.286.8.930
   Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   Cairella M, 1995, Clin Ter, V146, P269
   Cerulli J, 1998, ANN PHARMACOTHER, V32, P428, DOI 10.1345/aph.17327
   Crawford V, 1999, DIABETES OBES METAB, V1, P331, DOI 10.1046/j.1463-1326.1999.00055.x
   DEBUSK RM, 2001, INTEGRATIVE MED CONS, V3, P30
   Delany JP, 1999, AM J PHYSIOL-REG I, V276, pR1172, DOI 10.1152/ajpregu.1999.276.4.R1172
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Ernst E, 1998, PERFUSION, V11, P461
   *FDA, 1981, FDA CONS, P3
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Gades MD, 2003, OBES RES, V11, P683, DOI 10.1038/oby.2003.97
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Heymsfield SB, 1998, JAMA-J AM MED ASSOC, V280, P1596, DOI 10.1001/jama.280.18.1596
   Ho S. C., 2001, SMJ Singapore Medical Journal, V42, P006
   Kalman D, 1999, NUTRITION, V15, P337, DOI 10.1016/S0899-9007(99)00034-9
   LEUNG LH, 1995, MED HYPOTHESES, V44, P403, DOI 10.1016/0306-9877(95)90268-6
   LOWENSTEIN JM, 1971, J BIOL CHEM, V246, P629
   Martin WR, 1998, PHARMACOTHERAPY, V18, P860
   Mattes RD, 2000, PHYSIOL BEHAV, V71, P87, DOI 10.1016/S0031-9384(00)00321-8
   *MED EC CO, 2000, PHYS DESK REF HERB M
   Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728
   Pasman WJ, 1997, INT J OBESITY, V21, P1143, DOI 10.1038/sj.ijo.0800528
   Pittler MH, 2001, AM J MED, V110, P724, DOI 10.1016/S0002-9343(01)00702-1
   Pittler MH, 1999, EUR J CLIN NUTR, V53, P379, DOI 10.1038/sj.ejcn.1600733
   Rodriguez-Moran M, 1998, J DIABETES COMPLICAT, V12, P273, DOI 10.1016/S1056-8727(98)00003-8
   SANSONE RA, 1984, AM FAM PHYSICIAN, V30, P141
   SCALI M, 1990, J ENDOCRINOL INVEST, V13, P847, DOI 10.1007/BF03349639
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   SOTANIEMI EA, 1995, DIABETES CARE, V18, P1373, DOI 10.2337/diacare.18.10.1373
   *US FDA, 2004, FDA ANN PLANS PROH S
   Vincent JB, 2003, SPORTS MED, V33, P213, DOI 10.2165/00007256-200333030-00004
   Vita P M, 1992, Minerva Med, V83, P135
   WALSH DE, 1984, INT J OBESITY, V8, P289
   Weiger WA, 2002, ANN INTERN MED, V137, P889, DOI 10.7326/0003-4819-137-11-200212030-00010
   Wuolijoki E, 1999, METHOD FIND EXP CLIN, V21, P357, DOI 10.1358/mf.1999.21.5.793477
   2002, DRUG STORE NEWS
NR 44
TC 151
Z9 180
U1 0
U2 35
PU AMER ACAD FAMILY PHYSICIANS
PI KANSAS CITY
PA 8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA
SN 0002-838X
EI 1532-0650
J9 AM FAM PHYSICIAN
JI Am. Fam. Physician
PD NOV 1
PY 2004
VL 70
IS 9
BP 1731
EP 1738
PG 8
WC Primary Health Care; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 869XB
UT WOS:000225016800014
PM 15554492
DA 2025-04-28
ER

PT J
AU Bosso, H
   Barbalho, SM
   Goulart, RD
   Otoboni, AMMB
AF Bosso, Henrique
   Barbalho, Sandra Maria
   de Alvares Goulart, Ricardo
   Otoboni, Alda Maria Machado Bueno
TI Green coffee: economic relevance and a systematic review of the effects
   on human health
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Cardiovascular diseases; food industry; glycemia; green coffee;
   hypertension; obesity
ID TANDEM MASS-SPECTROMETRY; CHLOROGENIC ACIDS; BEAN EXTRACT;
   DOSE-RESPONSE; IN-VITRO; BIOACTIVE COMPONENTS; ANTIOXIDANT ACTIVITY;
   INSULIN-RESISTANCE; METABOLIC SYNDROME; ROASTED COFFEES
AB Coffee is probably the most popular beverage after water and is an important component in diet and health since its consumption is high worldwide. Globally, it is the most relevant food commodity being just behind crude oil. Besides its pleasant flavor, it is an antioxidant source due to polyphenols, which are protective compounds against several diseases. This study aimed to evaluate the economic relevance and perform a systematic review of green coffee's effects on human health. Databases such as MEDLINE-PubMed, EMBASE, COCHRANE, and GOOGLE SCHOLAR were searched, and PRISMA guidelines were followed. Green coffee is considered a novel food product because consumers usually consume only roasted coffee. It can be marketed as such or as an extract. Due to the content of bioactive compounds, which are partially lost during the roasting process, the extracts are usually marketed concerning the potential regarding health effects. Green coffee can be used as dietary supplements, cosmetics, and pharmaceuticals, as a source of antioxidants. It can benefit human health, such as improvement in blood pressure, plasma lipids, and body weight (thus contributing to the improvement of risk components of Metabolic Syndrome). Moreover, benefits for cognitive functions may also be included.
C1 [Bosso, Henrique] Sao Jose Rio Preto FAMERP, Med Sch, Sao Jose Do Rio Preto, Brazil.
   [Barbalho, Sandra Maria; de Alvares Goulart, Ricardo] Postgrad Program Struct & Funct Interact Rehabil, Marilia, SP, Brazil.
   [Barbalho, Sandra Maria] Univ Marilia UNIMAR, Sch Med, Dept Biochem & Pharmacol, Marilia, SP, Brazil.
   [Barbalho, Sandra Maria; Otoboni, Alda Maria Machado Bueno] Sch Food & Technol Marilia FATEC, Marilia, SP, Brazil.
C3 Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de
   Marilia
RP Barbalho, SM (corresponding author), Postgrad Program Struct & Funct Interact Rehabil, Marilia, SP, Brazil.; Barbalho, SM (corresponding author), Univ Marilia UNIMAR, Sch Med, Dept Biochem & Pharmacol, Marilia, SP, Brazil.; Barbalho, SM (corresponding author), Sch Food & Technol Marilia FATEC, Marilia, SP, Brazil.
EM smbarbalho@gmail.com
RI barbalho, sandra/Z-3515-2019
OI barbalho, sandra/0000-0002-5035-876X
CR Adamska-Patruno E, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080956
   Alafeef AK, 2020, FOODS, V9, DOI 10.3390/foods9091197
   Alonso-Salces RM, 2009, RAPID COMMUN MASS SP, V23, P363, DOI 10.1002/rcm.3884
   Arya M, 2007, CRIT REV FOOD SCI, V47, P51, DOI 10.1080/10408390600550315
   Asbaghi O, 2021, COMPLEMENT THER CLIN, V43, DOI 10.1016/j.ctcp.2021.101349
   Asbaghi O, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00587-z
   Asbaghi O, 2020, COMPLEMENT THER MED, V51, DOI 10.1016/j.ctim.2020.102424
   Babova O, 2016, PHYTOCHEMISTRY, V123, P33, DOI 10.1016/j.phytochem.2016.01.016
   Badmos S, 2019, FOOD RES INT, V126, DOI 10.1016/j.foodres.2019.108544
   Bauer D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113407
   Beam JR, 2015, NUTRITION, V31, P292, DOI 10.1016/j.nut.2014.07.012
   Bhagat AR, 2019, J AOAC INT, V102, P1365, DOI [10.5740/jaoacint.19-0129, 10.1093/jaoac/102.5.1365]
   Bizzo M.L.G., 2015, Coffee in Health and Disease Prevention, P11, DOI DOI 10.1016/B978-0-12-409517-5.00002-4
   Bobillo C, 2018, EUR J NUTR, V57, P607, DOI 10.1007/s00394-016-1347-1
   Bosso H, 2019, J MED FOOD, V22, P416, DOI 10.1089/jmf.2018.0162
   Camfield DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082897
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Castro ACCM, 2018, FOOD CHEM, V246, P48, DOI 10.1016/j.foodchem.2017.10.153
   Cheek Martin, 2002, Kew Bulletin, V57, P675, DOI 10.2307/4110998
   Cheng B, 2016, TRENDS FOOD SCI TECH, V57, P20, DOI 10.1016/j.tifs.2016.09.003
   Cornelis MC, 2007, CURR OPIN LIPIDOL, V18, P13, DOI 10.1097/MOL.0b013e3280127b04
   Cosola C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070808
   Craig AP, 2016, TALANTA, V154, P481, DOI 10.1016/j.talanta.2016.03.101
   Pereira GVD, 2020, ADV FOOD NUTR RES, V91, P65, DOI 10.1016/bs.afnr.2019.10.002
   de Oliveira NA, 2020, REGUL TOXICOL PHARM, V110, DOI 10.1016/j.yrtph.2019.104517
   Dong WJ, 2015, MOLECULES, V20, P16687, DOI 10.3390/molecules200916687
   EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4552
   Esquivel P, 2012, FOOD RES INT, V46, P488, DOI 10.1016/j.foodres.2011.05.028
   Farah A, 2006, FOOD CHEM, V98, P373, DOI 10.1016/j.foodchem.2005.07.032
   Farah A., 2018, ANN GEOPHYS DISCUSS, P1, DOI DOI 10.5194/ANGEO-2018-79
   Farah a., 2015, Coffee in health and disease prevention, P5, DOI [DOI 10.1016/B978-0-12-409517-5.00001-2, 10.1016/b978-0-12-409517-5.00001-2]
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Franca AS, 2005, LWT-FOOD SCI TECHNOL, V38, P709, DOI 10.1016/j.lwt.2004.08.014
   Fukagawa S, 2017, BIOSCI BIOTECH BIOCH, V81, P1814, DOI 10.1080/09168451.2017.1345614
   Fukutomi R, 2021, MOLECULES, V26, DOI 10.3390/molecules26020415
   Gloess AN, 2018, INT J MASS SPECTROM, V424, P49, DOI 10.1016/j.ijms.2017.11.017
   Gloess AN, 2014, INT J MASS SPECTROM, V365, P324, DOI 10.1016/j.ijms.2014.02.010
   Barbosa MDG, 2019, FOOD CHEM, V292, P275, DOI 10.1016/j.foodchem.2019.04.072
   Gökcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   Kitzberger CSG, 2014, FOOD RES INT, V61, P61, DOI 10.1016/j.foodres.2014.04.031
   Kitzberger CSG, 2013, PESQUI AGROPECU BRAS, V48, P1498, DOI 10.1590/S0100-204X2013001100011
   Guest NS, 2021, J INT SOC SPORT NUTR, V18, DOI 10.1186/s12970-020-00383-4
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Hashizume H, 2004, J DERMATOL, V31, P603, DOI 10.1111/j.1346-8138.2004.tb00565.x
   Hecimovic I, 2011, FOOD CHEM, V129, P991, DOI 10.1016/j.foodchem.2011.05.059
   HERTZSCHUNEMANN R, 2013, J MASS SPECTROM, V48, pR1, DOI DOI 10.1002/JMS.3195
   Hirotsu C, 2015, SLEEP SCI, V8, P143, DOI 10.1016/j.slsci.2015.09.002
   Hosseinabadi S, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2019.102290
   Hu GL, 2019, FOOD FUNCT, V10, P3113, DOI [10.1039/c9fo00288j, 10.1039/C9FO00288J]
   Inoue M, 2019, CURR NUTR REP, V8, P182, DOI 10.1007/s13668-019-0274-1
   International Coffee Organization, 2020, COFF TRAD STAT TABL
   Iriondo-DeHond A, 2019, INNOV FOOD SCI EMERG, V51, P194, DOI 10.1016/j.ifset.2018.06.010
   Klingel T, 2020, FOODS, V9, DOI 10.3390/foods9050665
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Ky CL, 2001, FOOD CHEM, V75, P223, DOI 10.1016/S0308-8146(01)00204-7
   Lakenbrink C, 2000, J AGR FOOD CHEM, V48, P2848, DOI 10.1021/jf9908042
   Lang R, 2008, J AGR FOOD CHEM, V56, P11114, DOI 10.1021/jf802838s
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Ley SH., 2018, Diabetes in America, V3rd
   Li HY, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6621644
   Lima AR, 2010, QUIM NOVA, V33, P20, DOI 10.1590/S0100-40422010000100004
   Liu CJ, 2019, FOOD CHEM, V272, P251, DOI 10.1016/j.foodchem.2018.07.226
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Manzo J., 2014, Journal of Arts and Humanities, V3, P1, DOI DOI 10.18533/JOURNAL.V3I8.527
   Marcason W, 2013, J ACAD NUTR DIET, V113, P364, DOI 10.1016/j.jand.2012.12.004
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Matsushita K, 2019, J CLIN HYPERTENS, V21, P16, DOI 10.1111/jch.13425
   Meguro K, 2008, TOHOKU J EXP MED, V215, P125, DOI 10.1620/tjem.215.125
   Mehaya FM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05508
   Moeenfard M, 2020, FOOD RES INT, V134, DOI 10.1016/j.foodres.2020.109207
   Moeenfard M, 2016, J CELL BIOCHEM, V117, P2748, DOI 10.1002/jcb.25573
   Mohamadi Neda, 2018, Journal of Dietary Supplements, V15, P207, DOI 10.1080/19390211.2017.1329244
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2700]
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Montenegro J, 2021, FOOD RES INT, V140, DOI 10.1016/j.foodres.2020.110014
   Morton K, 2018, CLIN PHARM DRUG DEV, V7, P871, DOI 10.1002/cpdd.451
   Morvaridi M, 2020, J DIABETES METAB DIS, V19, P645, DOI 10.1007/s40200-020-00536-x
   Murthy PS, 2012, FOOD BIOPROCESS TECH, V5, P897, DOI 10.1007/s11947-010-0363-z
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Naylor LH, 2021, AM J CLIN NUTR, V113, P370, DOI 10.1093/ajcn/nqaa312
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   Nogaim QA, 2020, TOXICOL REP, V7, P142, DOI 10.1016/j.toxrep.2019.11.015
   Nunes FM, 2001, J AGR FOOD CHEM, V49, P1773, DOI 10.1021/jf0012953
   Nzekoue FK, 2020, FOOD RES INT, V133, DOI 10.1016/j.foodres.2020.109128
   Ohishi T, 2021, MOLECULES, V26, DOI 10.3390/molecules26020453
   Oleaga C, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/390385
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Osama H, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13983
   Park I, 2017, BRIT J NUTR, V117, P979, DOI 10.1017/S0007114517000587
   Pauwels EKJ, 2021, MED PRIN PRACT, V30, P401, DOI 10.1159/000516067
   Poisson L, 2017, CRAFT AND SCIENCE OF COFFEE, P273, DOI 10.1016/B978-0-12-803520-7.00012-8
   Preedy VR, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P1
   Rajaram S, 2019, ADV NUTR, V10, pS422, DOI 10.1093/advances/nmz081
   Ran LS, 2021, EPIDEMIOL PSYCH SCI, V30, DOI 10.1017/S2045796020001183
   Rawlings A. V., 2004, DERMATOL THER, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]
   Revuelta-Iniesta R., 2014, BioMed Research International, V2014, P482704
   Reyes-Izquierdo T, 2013, BRIT J NUTR, V110, P420, DOI 10.1017/S0007114512005338
   Ribeiro E, 2021, FOOD CHEM, V348, DOI 10.1016/j.foodchem.2021.129061
   Rodrigues F, 2016, DRUG DEV IND PHARM, V42, P880, DOI 10.3109/03639045.2015.1088865
   Rodrigues F, 2016, DRUG DEV IND PHARM, V42, P99, DOI 10.3109/03639045.2015.1035279
   Rodríguez-López R, 2013, GENE, V516, P285, DOI 10.1016/j.gene.2012.11.073
   Romualdo GR, 2019, FOOD RES INT, V123, P567, DOI 10.1016/j.foodres.2019.05.029
   Rosa J., 2016, FOOD PROCESSING TECH, P48
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Saitou K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101337
   Samoggia A, 2018, APPETITE, V129, P70, DOI 10.1016/j.appet.2018.07.002
   Sanlier N, 2019, CRIT REV FOOD SCI, V59, P2573, DOI 10.1080/10408398.2018.1461061
   Sarriá B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Schouten MA, 2020, CRIT REV FOOD SCI, V60, P3807, DOI 10.1080/10408398.2019.1708264
   Sharma L, 2018, FOOD CHEM TOXICOL, V121, P283, DOI 10.1016/j.fct.2018.09.011
   Sivalokanathan S, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11020324
   Socala K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010107
   Speer Karl, 2006, Braz. J. Plant Physiol., V18, P201, DOI 10.1590/S1677-04202006000100014
   Stadheim HK, 2015, J APPL PHYSIOL, V119, P1501, DOI 10.1152/japplphysiol.00509.2015
   Sualeh A, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05812
   Suzuki A, 2019, INT J FOOD SCI NUTR, V70, P901, DOI 10.1080/09637486.2019.1585763
   Tamura H, 2020, YAKUGAKU ZASSHI, V140, P1351, DOI 10.1248/yakushi.20-00150
   Tofano RJ, 2020, DIABET METAB SYND OB, V13, P3239, DOI 10.2147/DMSO.S271050
   TRUGO LC, 1984, ANALYST, V109, P263, DOI 10.1039/an9840900263
   Upadhyay R, 2013, CRIT REV FOOD SCI, V53, P968, DOI 10.1080/10408398.2011.576319
   Vaclavik L, 2013, J AGR FOOD CHEM, V61, P4822, DOI 10.1021/jf401139u
   Pereda MDV, 2009, J COSMET DERMATOL-US, V8, P56, DOI 10.1111/j.1473-2165.2009.00425.x
   Vinson JA, 2019, J MED FOOD, V22, P314
   Wasim S, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9578
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   Wolska J, 2017, BIOL TRACE ELEM RES, V179, P327, DOI 10.1007/s12011-017-0963-9
   Wong RHX, 2014, NUTRIENTS, V6, P4881, DOI 10.3390/nu6114881
   Wong THT, 2021, ADV NUTR, V12, P708, DOI 10.1093/advances/nmaa132
   Yamaguchi T, 2008, NUTR METAB CARDIOVAS, V18, P408, DOI 10.1016/j.numecd.2007.03.004
   Zhang S, 2014, J GERIATR CARDIOL, V11, P32, DOI 10.3969/j.issn.1671-5411.2014.01.007
NR 131
TC 27
Z9 27
U1 7
U2 45
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD JAN 25
PY 2023
VL 63
IS 3
BP 394
EP 410
DI 10.1080/10408398.2021.1948817
EA JUN 2021
PG 17
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 7F1AL
UT WOS:000671977600001
PM 34236263
DA 2025-04-28
ER

PT J
AU Ifland, JR
   Preuss, HG
   Marcus, MT
   Rourk, KM
   Taylor, WC
   Burau, K
   Jacobs, WS
   Kadish, W
   Manso, G
AF Ifland, J. R.
   Preuss, H. G.
   Marcus, M. T.
   Rourk, K. M.
   Taylor, W. C.
   Burau, K.
   Jacobs, W. S.
   Kadish, W.
   Manso, G.
TI Refined food addiction: A classic substance use disorder
SO MEDICAL HYPOTHESES
LA English
DT Article
ID EXCESSIVE SUGAR INTAKE; BODY-MASS INDEX; IV ALCOHOL DEPENDENCE; DSM-IV;
   DRUG-ADDICTION; CAFFEINE WITHDRAWAL; WEIGHT-LOSS; PHYSICAL-ACTIVITY;
   MENTAL-DISORDERS; OBESITY STIGMA
AB Overeating in industrial societies is a significant problem, linked to an increasing incidence of overweight and obesity, and the resultant adverse health consequences. We advance the hypothesis that a possible explanation for overeating is that processed foods with high concentrations of sugar and other refined sweeteners, refined carbohydrates, fat, salt, and caffeine are addictive substances. Therefore, many people lose control over their ability to regulate their consumption of such foods. The loss of control over these foods could account for the global epidemic of obesity and other metabolic disorders. We assert that overeating can be described as an addiction to refined foods that conforms to the DSM-IV criteria for substance use disorders. To examine the hypothesis, we relied on experience with self-identified refined foods addicts, as well as critical reading of the literature on obesity, eating behavior, and drug addiction. Reports by self-identified food addicts illustrate behaviors that conform to the 7 DSM-IV criteria for substance use disorders. The literature also supports use of the DSM-IV criteria to describe overeating as a substance use disorder. The observational and empirical data strengthen the hypothesis that certain refined food consumption behaviors meet the criteria for substance use disorders, not unlike tobacco and alcohol. This hypothesis could lead to a new diagnostic category, as well as therapeutic approaches to changing overeating behaviors. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Ifland, J. R.; Rourk, K. M.; Kadish, W.] Refined Food Addict ReFA Res Fdn, Houston, TX 77007 USA.
   [Preuss, H. G.] Georgetown Univ, Sch Med, Washington, DC 20057 USA.
   [Marcus, M. T.] Univ Texas Austin, Sch Nursing, Austin, TX 78701 USA.
   [Taylor, W. C.; Burau, K.] Univ Texas Houston, Sch Publ Hlth, Houston, TX 77225 USA.
   [Jacobs, W. S.] Univ Florida, Sch Psychiat, Gainesville, FL 32611 USA.
   [Kadish, W.] Univ Texas Houston, Sch Med, Houston, TX USA.
C3 Georgetown University; University of Texas System; University of Texas
   Austin; University of Texas System; University of Texas Health Science
   Center Houston; University of Texas School Public Health; State
   University System of Florida; University of Florida; University of Texas
   System; University of Texas Health Science Center Houston
RP Ifland, JR (corresponding author), Refined Food Addict ReFA Res Fdn, 5355 Mem Dr,F-814, Houston, TX 77007 USA.
EM joan@refinedfoodaddiction.org
RI Taylor, Wendell/S-3516-2019
CR Acosta JI, 2005, PHARMACOL BIOCHEM BE, V80, P297, DOI 10.1016/j.pbb.2004.12.001
   Allshouse J., 1999, EC RES SERVICE STAT, V965, P1970
   Ashmore Jamile A, 2008, Eat Behav, V9, P203, DOI 10.1016/j.eatbeh.2007.09.006
   Association A, 2000, DIAGNOSTIC STAT MANU
   Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019
   Berkey CS, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e56
   Bernstein GA, 2002, DRUG ALCOHOL DEPEN, V66, P1, DOI 10.1016/S0376-8716(01)00181-8
   Bernstein GA, 1998, J AM ACAD CHILD PSY, V37, P858, DOI 10.1097/00004583-199808000-00016
   Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226
   BOUBLIK JH, 1983, NATURE, V301, P246, DOI 10.1038/301246a0
   Boynton-Jarrett R, 2003, PEDIATRICS, V112, P1321, DOI 10.1542/peds.112.6.1321
   Brandt AllanM., 2007, CIGARETTE CENTURY
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Cardinal RN, 2004, CURR OPIN NEUROBIOL, V14, P156, DOI 10.1016/j.conb.2004.03.004
   Carr KD, 1996, NEUROCHEM RES, V21, P1455, DOI 10.1007/BF02532386
   Chen EY, 2005, OBES RES, V13, P1393, DOI 10.1038/oby.2005.168
   Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66
   Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035
   Corwin RL, 2005, PHYSIOL BEHAV, V86, P5, DOI 10.1016/j.physbeh.2005.06.021
   Couturier EGM, 1997, CEPHALALGIA, V17, P188, DOI 10.1046/j.1468-2982.1997.1703188.x
   Dansinger ML, 2007, ANN INTERN MED, V147, P41, DOI 10.7326/0003-4819-147-1-200707030-00007
   Dubois L, 2007, J AM DIET ASSOC, V107, P924, DOI 10.1016/j.jada.2007.03.004
   Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326
   Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201
   Epstein LH, 2007, AM J CLIN NUTR, V86, P914, DOI 10.1093/ajcn/86.4.914
   Epstein LH, 2006, APPETITE, V47, P115, DOI 10.1016/j.appet.2006.02.005
   FEINGOLD A, 1995, ADDICTION, V90, P1661, DOI 10.1111/j.1360-0443.1995.tb02836.x
   Francis LA, 2003, OBES RES, V11, P143, DOI 10.1038/oby.2003.23
   Friedman AS, 1998, AM J DRUG ALCOHOL AB, V24, P169, DOI 10.3109/00952999809001705
   Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024
   Grant BF, 1997, J SUBST ABUSE, V9, P89, DOI 10.1016/S0899-3289(97)90008-0
   Grant BF, 2007, DRUG ALCOHOL DEPEN, V86, P154, DOI 10.1016/j.drugalcdep.2006.05.019
   Griffiths R R, 2000, Nihon Shinkei Seishin Yakurigaku Zasshi, V20, P223
   Harrington S, 2008, J SCH NURS, V24, P3, DOI 10.1622/1059-8405(2008)024[0003:TROSBC]2.0.CO;2
   Hasin D, 1999, J STUD ALCOHOL, V60, P746, DOI 10.15288/jsa.1999.60.746
   He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990
   Horgen KB, 2002, HEALTH PSYCHOL, V21, P505, DOI 10.1037/0278-6133.21.5.505
   Kalra SP, 2004, J ADDICT DIS, V23, P5, DOI 10.1300/J069v23n03_02
   Kant AK, 2002, INT J OBESITY, V26, P1194, DOI 10.1038/sj.ijo.0802024
   Kelley AE, 2005, PHYSIOL BEHAV, V86, P11, DOI 10.1016/j.physbeh.2005.06.018
   Kleiner KD, 2004, J ADDICT DIS, V23, P105, DOI 10.1300/J069v23n03_08
   Kruger R, 2006, PUBLIC HEALTH NUTR, V9, P351, DOI 10.1079/PHN2006849
   Laredo SE, 2006, BRIT MED J, V332, P609, DOI 10.1136/bmj.332.7541.609-b
   Latner JD, 2007, BODY IMAGE, V4, P147, DOI 10.1016/j.bodyim.2007.03.002
   Lindström M, 2003, EUR J PUBLIC HEALTH, V13, P306, DOI 10.1093/eurpub/13.4.306
   Miele GM, 2000, DRUG ALCOHOL DEPEN, V59, P63, DOI 10.1016/S0376-8716(99)00111-8
   MILLER WC, 1990, AM J CLIN NUTR, V52, P426, DOI 10.1093/ajcn/52.3.426
   Must A, 2007, OBESITY, V15, P1774, DOI 10.1038/oby.2007.211
   Nelson MC, 2006, OBESITY, V14, P701, DOI 10.1038/oby.2006.80
   Nesse RM, 2002, ADDICTION, V97, P470, DOI 10.1046/j.1360-0443.2002.00086.x
   Noble EP, 2000, EUR PSYCHIAT, V15, P79, DOI 10.1016/S0924-9338(00)00208-X
   O'Connor TM, 2006, PEDIATRICS, V118, pE1010, DOI 10.1542/peds.2005-2348
   PATE CA, 1986, J AM DIET ASSOC, V86, P796
   Patrick K, 2004, ARCH PEDIAT ADOL MED, V158, P385, DOI 10.1001/archpedi.158.4.385
   Pelchat ML, 2002, PHYSIOL BEHAV, V76, P347, DOI 10.1016/S0031-9384(02)00757-6
   Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108
   Renggli K, 1995, Praxis (Bern 1994), V84, P255
   Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0
   Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353
   SILVERMAN K, 1992, NEW ENGL J MED, V327, P1109, DOI 10.1056/NEJM199210153271601
   Simansky KJ, 2005, PHYSIOL BEHAV, V86, P1, DOI 10.1016/j.physbeh.2005.06.016
   Solinas M, 2005, NEUROPSYCHOPHARMACOL, V30, P2035, DOI 10.1038/sj.npp.1300720
   Sukhotina IA, 2004, BEHAV PHARMACOL, V15, P207, DOI 10.1097/01.fbp.0000129748.60495.85
   Teachman BA, 2001, INT J OBESITY, V25, P1525, DOI 10.1038/sj.ijo.0801745
   Tekol Y, 2006, MED HYPOTHESES, V67, P1233, DOI 10.1016/j.mehy.2006.04.041
   Thornley S, 2008, MED HYPOTHESES, V71, P709, DOI 10.1016/j.mehy.2008.07.006
   Torrens M, 2004, AM J PSYCHIAT, V161, P1231, DOI 10.1176/appi.ajp.161.7.1231
   Trinko R, 2007, PHYSIOL BEHAV, V91, P499, DOI 10.1016/j.physbeh.2007.01.001
   Tunceli K, 2006, OBESITY, V14, P1637, DOI 10.1038/oby.2006.188
   Wang Gene-Jack, 2002, Expert Opin Ther Targets, V6, P601, DOI 10.1517/14728222.6.5.601
   Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04
   Wideman CH, 2005, NUTR NEUROSCI, V8, P269, DOI 10.1080/10284150500485221
   Wiecha JL, 2006, J AM DIET ASSOC, V106, P1624, DOI 10.1016/j.jada.2006.07.007
   Wiecha JL, 2006, ARCH PEDIAT ADOL MED, V160, P436, DOI 10.1001/archpedi.160.4.436
   Zilli F, 2000, Eat Weight Disord, V5, P217
NR 77
TC 216
Z9 266
U1 1
U2 58
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD MAY
PY 2009
VL 72
IS 5
BP 518
EP 526
DI 10.1016/j.mehy.2008.11.035
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Research & Experimental Medicine
GA 426XW
UT WOS:000264742800008
PM 19223127
DA 2025-04-28
ER

PT J
AU Inoue, H
   Kobayashi-Hattori, K
   Horiuchi, Y
   Oishi, Y
   Arai, S
   Takita, T
AF Inoue, Hiroko
   Kobayashi-Hattori, Kazuo
   Horiuchi, Yumi
   Oishi, Yuichi
   Arai, Souichi
   Takita, Toshichika
TI Regulation of the body fat percentage in developmental-stage rats by
   methylxanthine derivatives in a high-fat diet
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE high-fat diet; rat; methylxanthine derivative; body fat percentage;
   abdominal adipose tissue
ID CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; SERUM-CHOLESTEROL; OBESE
   CHILDREN; VISCERAL FAT; CAFFEINE; RISK; AGENTS; CELLS; TEA
AB We investigated the regulatory effects of structural differences among methylxanthine derivatives on the elevation of body fat percentage in developmental-stage rats. Caffeine, theophylline and theobromine were used as the methylxanthines. High-fat diets (20% lard) containing each methylxanthine (0.025%) were administered to male Sprague-Dawley rats for 12 weeks, with the result that the body fat percentage was generally reduced in each methylxanthine-fed group. The abdo minal adipose tissue weight in the caffeine group was also significantly lower than that in the control group, the serum cholesterol and triglyceride levels in the caffeine group also being significantly lower than the levels in the control group. The study results suggest that caffeine could contribute most to preventing arteriosclerotic diseases.
C1 Tokyo Univ Agr, Setagaya Ku, Fac Appl Biosci, Dept Nutr Sci, Tokyo 1568502, Japan.
   Chubu Univ, Coll Biosci & Biotechnol, Dept Nutr & Food Sci, Kasugai, Aichi 4878501, Japan.
C3 Tokyo University of Agriculture; Chubu University
RP Takita, T (corresponding author), Tokyo Univ Agr, Setagaya Ku, Fac Appl Biosci, Dept Nutr Sci, 1-1-1 Sakuragaoka, Tokyo 1568502, Japan.
EM takita@nodai.ac.jp
OI , Kazuo/0000-0002-0921-2128
CR DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173
   DUCIMETIERE P, 1980, DIABETOLOGIA, V19, P205, DOI 10.1007/BF00275270
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   GEORGE AB, 1970, J LIPID RES, V11, P517
   GRUNDY SM, 1986, JAMA-J AM MED ASSOC, V256, P2849, DOI 10.1001/jama.256.20.2849
   *HLTH WELF STAT AS, 2004, KOUSEI SHIHYO, V51, P45
   Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014
   Hongu N, 2000, J NUTR, V130, P152, DOI 10.1093/jn/130.2.152
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   INOUE H, 2005, ITE LETT BATT NEW TE, V6, P61
   Iso H, 2001, AM J EPIDEMIOL, V153, P490, DOI 10.1093/aje/153.5.490
   KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1
   KAPLAN NM, 1989, ARCH INTERN MED, V149, P1514, DOI 10.1001/archinte.149.7.1514
   Klish William J., 1995, Acta Paediatrica Japonica, V37, P1
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   KOMABAYASHI T, 1978, FOLIA PHARMACOL JPN, V74, P459, DOI 10.1254/fpj.74.459
   Kotani K, 1997, INT J OBESITY, V21, P912, DOI 10.1038/sj.ijo.0800492
   KUO JF, 1969, J BIOL CHEM, V244, P2252
   Matsuzawa Yuji, 2005, Semin Vasc Med, V5, P34, DOI 10.1055/s-2005-871744
   Morimoto C, 2001, J LIPID RES, V42, P120
   NAKAMURA T, 1994, ATHEROSCLEROSIS, V107, P239, DOI 10.1016/0021-9150(94)90025-6
   Pyorala K, 1979, Diabetes Care, V2, P131, DOI 10.2337/diacare.2.2.131
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5
   Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800
   Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448
   STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823
   STAVRIC B, 1988, FOOD CHEM TOXICOL, V26, P111, DOI 10.1016/0278-6915(88)90107-X
   SUZUKI M, 1983, J NUTR SCI VITAMINOL, V29, P399, DOI 10.3177/jnsv.29.399
   Togashi K, 2002, INT J OBESITY, V26, P770, DOI 10.1038/sj.ijo.0801992
   Welborn T A, 1979, Diabetes Care, V2, P154, DOI 10.2337/diacare.2.2.154
   WILCOX AR, 1982, MED SCI SPORT EXER, V14, P317, DOI 10.1249/00005768-198204000-00011
   Zheng GD, 2004, IN VIVO, V18, P55
   Bieri J. G., 1977, Journal of Nutrition, V107, P1394
NR 34
TC 17
Z9 19
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD MAY
PY 2006
VL 70
IS 5
BP 1134
EP 1139
DI 10.1271/bbb.70.1134
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA 049ZJ
UT WOS:000238056500010
PM 16717413
OA Bronze
DA 2025-04-28
ER

PT J
AU Machado-Fragua, MD
   Struijk, EA
   Graciani, A
   Guallar-Castillon, P
   Rodríguez-Artalejo, F
   Lopez-Garcia, E
AF Machado-Fragua, Marcos D.
   Struijk, Ellen A.
   Graciani, Auxiliadora
   Guallar-Castillon, Pilar
   Rodriguez-Artalejo, Fernando
   Lopez-Garcia, Esther
TI Coffee consumption and risk of physical function impairment, frailty and
   disability in older adults
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Coffee; Mobility; Agility; Frailty; Disability
ID INSTRUMENTAL ACTIVITIES; INTERNATIONAL CLASSIFICATION; SUBSEQUENT
   DISABILITY; LIMITATIONS; DECLINE; PEOPLE; HEALTH; METAANALYSIS;
   ASSOCIATION; DISABLEMENT
AB PurposeHabitual coffee consumption has been associated with lower risk of type 2 diabetes and cardiovascular disease. Since these diseases are main determinants of functional limitations, we have tested the hypothesis that coffee intake is associated with lower risk of physical function impairment, frailty and disability in older adults. We focused on women and those with obesity, hypertension or type 2 diabetes because they are at higher risk of functional limitations.MethodsProspective study with 3289 individuals60years from the Seniors-ENRICA cohort. In 2008-2010 coffee consumption was measured through a validated dietary history. Participants were followed up until 2015 to ascertain incident impaired physical function, frailty and disability, assessed by both self-report and objective measures.ResultsCompared with non-drinking coffee, consumption of 2 cups of coffee/day was associated with lower risk of impaired agility in women (hazard ratio [HR] 0.71, 95% confidence interval [CI] 0.51-0.97, P trend 0.04) and in those with obesity (HR 0.60; 95% CI 0.40-0.90, P trend 0.04). Intake of 2 cups of coffee/day was also linked to reduced risk of impaired mobility in women (HR 0.66; 95% CI 0.46-0.95, P trend 0.02) and among individuals with hypertension (HR 0.70, 95% CI 0.48-1.00, P trend 0.05). Moreover, among subjects with diabetes, those who consumed2 cups/day had lower risk of disability in activities of daily living (HR 0.30, 95% CI 0.11-0.76, P trend 0.01).ConclusionsIn older people, habitual coffee consumption was not associated with increased risk of functional impairment, and it might even be beneficial in women and those with hypertension, obesity or diabetes.
C1 [Machado-Fragua, Marcos D.; Struijk, Ellen A.; Graciani, Auxiliadora; Guallar-Castillon, Pilar; Rodriguez-Artalejo, Fernando; Lopez-Garcia, Esther] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Sch Med, C Arzobispo Morcillo,S-N, Madrid 28029, Spain.
   [Machado-Fragua, Marcos D.; Struijk, Ellen A.; Graciani, Auxiliadora; Guallar-Castillon, Pilar; Rodriguez-Artalejo, Fernando; Lopez-Garcia, Esther] IdiPaz Inst Invest Sanitaria Hosp Univ La Paz, Madrid, Spain.
   [Machado-Fragua, Marcos D.; Struijk, Ellen A.; Graciani, Auxiliadora; Guallar-Castillon, Pilar; Rodriguez-Artalejo, Fernando; Lopez-Garcia, Esther] CIBERESP CIBER Epidemiol & Publ Hlth, Madrid, Spain.
   [Guallar-Castillon, Pilar; Rodriguez-Artalejo, Fernando; Lopez-Garcia, Esther] CEI UAM CSIC, IMDEA Food Inst, Madrid, Spain.
C3 Autonomous University of Madrid; Hospital Universitario La Paz; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERESP; Consejo Superior de
   Investigaciones Cientificas (CSIC); IMDEA Food Institute
RP Machado-Fragua, MD; Lopez-Garcia, E (corresponding author), Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Sch Med, C Arzobispo Morcillo,S-N, Madrid 28029, Spain.; Machado-Fragua, MD; Lopez-Garcia, E (corresponding author), IdiPaz Inst Invest Sanitaria Hosp Univ La Paz, Madrid, Spain.; Machado-Fragua, MD; Lopez-Garcia, E (corresponding author), CIBERESP CIBER Epidemiol & Publ Hlth, Madrid, Spain.; Lopez-Garcia, E (corresponding author), CEI UAM CSIC, IMDEA Food Inst, Madrid, Spain.
EM marcos.machado@uam.es; esther.lopez@uam.es
RI Graciani, Auxiliadora/D-8243-2013; Lopez-Garcia, Esther/A-8894-2019;
   Guallar-Castillon, Pilar/F-1533-2016; Machado-Fragua, Marcos
   D/AAG-7303-2021
OI Struijk, Ellen/0000-0002-9302-9616; Machado-Fragua, Marcos
   D/0000-0003-2646-1510
FU FIS (Instituto de Salud Carlos III, State Secretary of R + D + I)
   [13/0288, 16/609, 16/1512]; FEDER/FSE; FRAILOMIC Initiative [305483-2];
   ATHLOS project [635316]; JPI HDHL (SALAMANDER project)
FX This work was supported by FIS grants 13/0288, 16/609 and 16/1512
   (Instituto de Salud Carlos III, State Secretary of R + D + I, and
   FEDER/FSE), the FRAILOMIC Initiative (FP7-HEALTH-2012-Proposal No.
   305483-2), the ATHLOS project (EU H2020-Project ID: 635316) and the JPI
   HDHL (SALAMANDER project).
CR [Anonymous], 2005, Health, ageing and retirement in Europe: first results from the Survey of Health, Ageing and Retirement in Europe
   Artaud F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4240
   BAK AAA, 1989, NEW ENGL J MED, V321, P1432, DOI 10.1056/NEJM198911233212103
   Balzi D, 2010, AGE AGEING, V39, P92, DOI 10.1093/ageing/afp209
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Bickenbach JE, 1999, SOC SCI MED, V48, P1173, DOI 10.1016/S0277-9536(98)00441-9
   Bjorner JB, 2007, CURR MED RES OPIN, V23, P731, DOI 10.1185/030079907X178757
   Cesari M, 2004, AM J CLIN NUTR, V79, P289
   Cesari M, 2016, EUR J INTERN MED, V35, P1, DOI 10.1016/j.ejim.2016.07.021
   Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x
   de Rekeneire N, 2015, CLIN GERIATR MED, V31, P51, DOI 10.1016/j.cger.2014.08.018
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dirks-Naylor AJ, 2015, LIFE SCI, V143, P182, DOI 10.1016/j.lfs.2015.11.005
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Fried LP, 2004, J GERONTOL A-BIOL, V59, P255
   García-Esquinas E, 2016, J EPIDEMIOL COMMUN H, V70, P954, DOI 10.1136/jech-2016-207183
   Graciani A, 2006, DEMENT GERIATR COGN, V21, P104, DOI 10.1159/000090509
   Gross G, 1997, FOOD CHEM TOXICOL, V35, P547, DOI 10.1016/S0278-6915(96)00123-8
   Guallar-Castillón P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086074
   Guo YT, 2014, EXP GERONTOL, V50, P1, DOI 10.1016/j.exger.2013.11.005
   Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221
   Houston DK, 2005, AM J CLIN NUTR, V81, P515
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x
   Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a
   Lana A, 2015, J AM GERIATR SOC, V63, P1852, DOI 10.1111/jgs.13626
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179
   Leenders M, 2013, J AM MED DIR ASSOC, V14, P585, DOI 10.1016/j.jamda.2013.02.006
   León-Muñoz LM, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0255-6
   Liaw FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22750
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Martínez-Gómez D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-47
   Miller EA, 2000, MED CARE RES REV, V57, P259, DOI 10.1177/107755870005700301
   Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2
   Ng TP, 2012, AM J CLIN NUTR, V96, P1362, DOI 10.3945/ajcn.112.035741
   Pietrocola F, 2014, CELL CYCLE, V13, P1987, DOI 10.4161/cc.28929
   Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181
   Rodríguez-Artalejo F, 2011, REV ESP CARDIOL, V64, P876, DOI 10.1016/j.recesp.2011.05.019
   ROSOW I, 1966, J GERONTOL, V21, P556, DOI 10.1093/geronj/21.4.556
   Schröder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566
   Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388
   Seidel D, 2011, AGE AGEING, V40, P463, DOI 10.1093/ageing/afr054
   Simeonsson RJ, 2000, J CLIN EPIDEMIOL, V53, P113, DOI 10.1016/S0895-4356(99)00133-X
   Struijk EA, 2018, J GERONTOL A-BIOL, V73, P333, DOI 10.1093/gerona/glw208
   Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0
   Urgert R, 1996, J ROY SOC MED, V89, P618, DOI 10.1177/014107689608901107
   VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1
   Vercambre MN, 2009, BRIT J NUTR, V102, P419, DOI 10.1017/S0007114508201959
   Vestergaard S, 2009, J GERONTOL A-BIOL, V64, P76, DOI 10.1093/gerona/gln017
   Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076
   Wheaton FV, 2016, AGEING SOC, V36, P1136, DOI 10.1017/S0144686X15000227
   Willet W., 2012, Nutritional Epidemiology, V3rd
   Wong E, 2015, J EPIDEMIOL COMMUN H, V69, P70, DOI 10.1136/jech-2014-204456
   Yokota RTD, 2016, J GERONTOL A-BIOL, V71, P903, DOI 10.1093/gerona/glv234
   Zhang W, 2009, DIABETES CARE, V32, P1043, DOI 10.2337/dc08-2251
NR 56
TC 21
Z9 21
U1 0
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN
PY 2019
VL 58
IS 4
BP 1415
EP 1427
DI 10.1007/s00394-018-1664-7
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA IC8TZ
UT WOS:000471256100007
PM 29549497
DA 2025-04-28
ER

PT J
AU Dean, S
   Braakhuis, A
   Paton, C
AF Dean, Sara
   Braakhuis, Andrea
   Paton, Carl
TI The Effects of EGCG on Fat Oxidation and Endurance Performance in Male
   Cyclists
SO INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM
LA English
DT Article
DE epigallocatechin-3-gallate; caffeine; cycling; athletes
ID DIET-INDUCED OBESITY; GREEN TEA; CAFFEINE INGESTION; ENERGY-EXPENDITURE;
   WEIGHT MAINTENANCE; INSULIN-SECRETION; LIPID-METABOLISM; ADIPOSE-TISSUE;
   EXERCISE; LEPTIN
AB Researchers have long been investigating strategies that can increase athletes' ability to oxidize fatty acids and spare carbohydrate, thus potentially improving endurance capacity. Green-tea extract (epigallocatechin-3-gallate; EGCG) has been shown to improve endurance capacity in mice. If a green-tea extract can stimulate fat oxidation and as a result spare glycogen stores, then athletes may benefit through improved endurance performance. Eight male cyclists completed a study incorporating a 3-way crossover, randomized, placebo-controlled, double-blinded, diet-controlled research design. All participants received 3 different treatments (placebo 270 mg, EGCG 270 mg, and placebo 270 mg + caffeine 3 mg/kg) over a 6-day period and 1 hr before exercise testing. Each participant completed 3 exercise trials consisting of 60 min of cycling at 60% maximum oxygen uptake (VO2max) immediately followed by a self-paced 40-km cycling time trial. The study found little benefit in consuming green-tea extract on fat oxidation or cycling performance, unlike caffeine, which did benefit cycling performance. The physiological responses observed during submaximal cycling after caffeine ingestion were similar to those reported previously, including an increase in heart rate (EGCG 147 +/- 17, caffeine 146 +/- 19, and placebo 144 +/- 15 beats/min), glucose at the 40-min exercise time point (placebo 5.0 +/- 0.8, EGCG 5.4 +/- 1.0, and caffeine 5.8 +/- 1.0 mmo/L), and resting plasma free fatty acids and no change in the amount of carbohydrate and fat being oxidized. Therefore, it was concluded that green-tea extract offers no additional benefit to cyclists over and above those achieved by using caffeine.
C1 [Dean, Sara; Braakhuis, Andrea] Waikato Inst Technol, Sch Sport & Exercise Sci, Hamilton, New Zealand.
   [Paton, Carl] Eastern Inst Technol, Hawkes Bay, New Zealand.
C3 Waikato Institute of Technology; Eastern Institute of Technology
RP Dean, S (corresponding author), Waikato Inst Technol, Sch Sport & Exercise Sci, Hamilton, New Zealand.
RI Braakhuis, Andrea/AEW-9971-2022; Paton, Carl/H-3332-2019
OI Braakhuis, Andrea/0000-0002-6055-0595
FU Wintec Research Fund
FX The authors of this article would like to acknowledge the support of the
   Wintec Research Fund and DSM Nutritionals, Auckland, New Zealand, for
   supplying TEAVIGO.
CR Ahrén B, 1999, AM J PHYSIOL-REG I, V277, pR959, DOI 10.1152/ajpregu.1999.277.4.R959
   Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c
   Ashida H, 2004, BIOFACTORS, V22, P135, DOI 10.1002/biof.5520220126
   Batterham A.M., 2005, Sportscience, V9, P6
   Bell DG, 2003, MED SCI SPORT EXER, V35, P1348, DOI 10.1249/01.MSS.0000079071.92647.F2
   Bell DG, 2002, J APPL PHYSIOL, V93, P1227, DOI 10.1152/japplphysiol.00187.2002
   Belza A, 2005, EUR J CLIN NUTR, V59, P733, DOI 10.1038/sj.ejcn.1602121
   Bennard P, 2005, CAN J APPL PHYSIOL, V30, P475, DOI 10.1139/h05-134
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bouassida A, 2006, J SPORT SCI MED, V5, P172
   Chen LS, 1997, DRUG METAB DISPOS, V25, P1045
   Chesley A, 1998, AM J PHYSIOL-REG I, V275, pR596, DOI 10.1152/ajpregu.1998.275.2.R596
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Conway KJ, 2003, J APPL PHYSIOL, V94, P1557, DOI 10.1152/japplphysiol.00911.2002
   Cox GR, 2002, J APPL PHYSIOL, V93, P990, DOI 10.1152/japplphysiol.00249.2002
   Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Engels HJ, 1999, INT J SPORT NUTR, V9, P361, DOI 10.1123/ijsn.9.4.361
   Graham TE, 2000, J PHYSIOL-LONDON, V529, P837, DOI 10.1111/j.1469-7793.2000.00837.x
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Greer F, 2000, J APPL PHYSIOL, V89, P1837, DOI 10.1152/jappl.2000.89.5.1837
   Hawley JA, 1998, SPORTS MED, V25, P241, DOI 10.2165/00007256-199825040-00003
   Hunter AM, 2002, INT J SPORT NUTR EXE, V12, P438, DOI 10.1123/ijsnem.12.4.438
   Hwa J, 1997, BIOCHEMISTRY-US, V36, P633, DOI 10.1021/bi962141c
   Jacobson TL, 2001, EXP PHYSIOL, V86, P137, DOI 10.1113/eph8602072
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kovacs EMR, 1998, J APPL PHYSIOL, V85, P709, DOI 10.1152/jappl.1998.85.2.709
   Magkos Faidon, 2004, Sports Med, V34, P871, DOI 10.2165/00007256-200434130-00002
   McMurray RG, 2005, SPORTS MED, V35, P393, DOI 10.2165/00007256-200535050-00003
   Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S
   Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004
   Perusse L, 1997, J APPL PHYSIOL, V83, P5, DOI 10.1152/jappl.1997.83.1.5
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Sale C, 2006, INT J OBESITY, V30, P764, DOI 10.1038/sj.ijo.0803209
   Sayama K, 2000, IN VIVO, V14, P481
   Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8
   Tanizawa Y, 1997, ENDOCRINOLOGY, V138, P4513, DOI 10.1210/en.138.10.4513
   Tokimitsu I, 2004, BIOFACTORS, V22, P141, DOI 10.1002/biof.5520220127
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yang CS, 2000, J NUTR, V130, P2409, DOI 10.1093/jn/130.10.2409
   Zheng GD, 2004, IN VIVO, V18, P55
   Zuntz N., 1901, Pflugers Arch, V83, P557, DOI [10.1007/BF01746509, DOI 10.1007/BF01746509]
NR 49
TC 46
Z9 49
U1 0
U2 33
PU HUMAN KINETICS PUBL INC
PI CHAMPAIGN
PA 1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA
SN 1526-484X
EI 1543-2742
J9 INT J SPORT NUTR EXE
JI Int. J. Sport Nutr. Exerc. Metab.
PD DEC
PY 2009
VL 19
IS 6
BP 624
EP 644
DI 10.1123/ijsnem.19.6.624
PG 21
WC Nutrition & Dietetics; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Sport Sciences
GA 534ER
UT WOS:000272879500005
PM 20175431
DA 2025-04-28
ER

PT J
AU Rush, E
   Schulz, S
   Obolonkin, V
   Simmons, D
   Plank, L
AF Rush, E
   Schulz, S
   Obolonkin, V
   Simmons, D
   Plank, L
TI Are energy drinks contributing to the obesity epidemic?
SO ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE lipogenesis; caffeine; sucrose; carbonated beverage; fat oxidation;
   carbohydrate oxidation
ID CAFFEINE; FRUCTOSE
AB The consumption of energy drinks containing sucrose and caffeine is increasing worldwide. Ten healthy women aged 18 to 22 years and fasted overnight were randomly allocated to a standardised dose of sucrose either as an "energy" drink (containing sucrose and caffeine) or lemonade on the first day and then crossed over to the alternative drink on a second day. For thirty minutes before and thirty minutes after drinking oxygen consumption and carbon dioxide production were measured in the resting subject breath-by-breath by indirect calorimetry and the rates of carbohydrate and fat oxidation calculated. Energy drink consumption apparently caused increased carbohydrate oxidation (P = 0.004) and reduced lipid oxidation (P = 0.004) compared to lemonade. The longer term effects of combined caffeine and sucrose intake, particularly in sedentary individuals, on metabolism and body fatness needs further examination.
C1 Auckland Univ Technol, Fac Hlth & Environm Sci, Div Sport & Recreat, Auckland 1020, New Zealand.
   Waikato Clin Sch, Auckland, New Zealand.
   Univ Auckland, Dept Surg, Auckland 1, New Zealand.
C3 Auckland University of Technology; University of Auckland
RP Rush, E (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, Div Sport & Recreat, Private Bag 92006, Auckland 1020, New Zealand.
EM elaine.rush@aut.ac.nz
RI Simmons, David/B-2514-2009; Rush, Elaine/AAQ-9992-2021
OI Simmons, David/0000-0003-0560-0761; Plank, Lindsay/0000-0003-2737-0151
CR Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   HILLS M, 1979, BRIT J CLIN PHARMACO, V8, P7, DOI 10.1111/j.1365-2125.1979.tb05903.x
   Hudgins LC, 2000, J LIPID RES, V41, P595
NR 7
TC 20
Z9 23
U1 0
U2 7
PU H E C PRESS, HEALTHY EATING CLUB PTY LTD
PI SOUTHBANK
PA EMERALD HILL CLINIC 157 CLARENDON ST, SOUTHBANK, VIC 3006, AUSTRALIA
SN 0964-7058
J9 ASIA PAC J CLIN NUTR
JI Asia Pac. J. Clin. Nutr.
PY 2006
VL 15
IS 2
BP 242
EP 244
PG 3
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 041FP
UT WOS:000237439700016
PM 16672210
DA 2025-04-28
ER

PT J
AU Ma, BL
   Yang, SL
   Li, JM
   Ouyang, H
   He, MZ
   Feng, YL
   Tan, T
AF Ma, Baolian
   Yang, Shilin
   Li, Junmao
   Ouyang, Hui
   He, Mingzhen
   Feng, Yulin
   Tan, Ting
TI A four-step filtering strategy based on ultra-high-performance liquid
   chromatography coupled to quadrupole-time-of-flight tandem mass
   spectrometry for comprehensive profiling the major chemical constituents
   of Akebiae Fructus
SO RAPID COMMUNICATIONS IN MASS SPECTROMETRY
LA English
DT Article
ID TRITERPENE-SAPONINS; QUINATA DECNE; CHLOROGENIC ACIDS; PERICARP
   SAPONINS; SEED SAPONINS; HEDERAGENIN; GLYCOSIDES; STEM; IDENTIFICATION;
   CLEMATIS
AB Rationale Akebiae Fructus (AF) is a traditional Chinese medicine (TCM) with antiphlogistic, analgesic, antineoplastic, diuretic, antirheumatic, antidepressant and antiobesity activities. Identification of chemical constituents from AF is helpful to discover the potential active ingredients and to control its quality. Methods The four-step filtering strategy was as follows: (1) To extract the accurate mass by the different adduct ions. (2) To screen different types of the compounds using diagnostic ions. (3) By characteristic ion filtering, to confirm the substituted position and the sugar chain numbers. (4) Based on the neutral loss (NL), to identify the type of monosaccharide and the compositions of sugar chains of triterpenoid saponins and the structure of CGAs. Results A total of 94 compounds (85 triterpenoid saponins, 9 chlorogenic acids) were unambiguously or reasonably identified. Fifty constituents were discovered for the first time from AF. Nine types of triterpenoid saponins, including akebonoic acid (type I), norhederagenin (type II), oleanolic acid (type III), 2 alpha,3 beta-dihydroxy-23-oxo-30-norolean-12,20(21)-dien-28-oic acid (type IV), gypsogenin (type V), norarjunolic acid (type VI), hederagenin (type VII), 2 alpha,3 beta-dihydroxy-23-oxo-olean-12-en-28-oic acid (type VIII), arjunolic acid (type IX), and two types of chlorogenic acid (mono-CQA and di-CQA), were identified in AF. Conclusions An ultra-high-performance liquid chromatography coupled to quadrupole-time-of-flight tandem mass spectrometry with MSE (UPLC-QTOF-MSE) analysis with four-step filtering strategy was established and successfully applied to identify the chemical constituents of AF which can provide chemical support for further research and play an important role in the quality control of AF.
C1 [Ma, Baolian; Yang, Shilin] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing 100102, Peoples R China.
   [Ma, Baolian] Changzhi Med Coll, Dept Pharm, Changzhi 046000, Peoples R China.
   [Ma, Baolian; Yang, Shilin; Li, Junmao; Ouyang, Hui; He, Mingzhen; Feng, Yulin; Tan, Ting] Jiangxi Univ Tradit Chinese Med, Natl Pharmaceut Engn Ctr NPEC Solid Preparat Chin, 56 Yangming Rd, Nanchang 330006, Jiangxi, Peoples R China.
C3 Beijing University of Chinese Medicine; Changzhi Medical College;
   Jiangxi University of Traditional Chinese Medicine
RP Feng, YL; Tan, T (corresponding author), Jiangxi Univ Tradit Chinese Med, Natl Pharmaceut Engn Ctr NPEC Solid Preparat Chin, 56 Yangming Rd, Nanchang 330006, Jiangxi, Peoples R China.
EM fengyulin2003@126.com; tanting2009@126.com
RI Tan, Ting/ADS-0301-2022; hui, ouyang/P-1833-2019
FU Education Department of Jiangxi Province on Science and Technology
   Project Foundation [GJJ150864]; Jiangxi Natural Science Foundation
   [20171BAB205100, 20181BAB205080]
FX Education Department of Jiangxi Province on Science and Technology
   Project Foundation, Grant/Award Number: GJJ150864; Jiangxi Natural
   Science Foundation, Grant/Award Numbers: 20171BAB205100 and
   20181BAB205080
CR [Anonymous], J KOREAN MED
   Choi J, 2005, J MED FOOD, V8, P78, DOI 10.1089/jmf.2005.8.78
   Committee for the Pharmacopoeia of PR China, 2015, PHARM PR CHIN 1
   Du YX, 2012, FOOD CHEM, V133, P923, DOI 10.1016/j.foodchem.2012.02.005
   DUBOIS MA, 1986, PLANTA MED, P80, DOI 10.1055/s-2007-969084
   Gao HM, 2009, J ASIAN NAT PROD RES, V11, P1013, DOI 10.1080/10286020903213439
   Gao HM, 2006, PHYTOCHEMISTRY, V67, P2697, DOI 10.1016/j.phytochem.2006.09.003
   Guan SH, 2008, MAGN RESON CHEM, V46, P186, DOI 10.1002/mrc.2152
   Guo LX, 2015, J CHROMATOGR A, V1425, P129, DOI 10.1016/j.chroma.2015.11.013
   HIGUCHI R, 1972, CHEM PHARM BULL, V20, P1935
   HIGUCHI R, 1976, CHEM PHARM BULL, V24, P1314
   HIGUCHI R, 1976, CHEM PHARM BULL, V24, P1021
   HIGUCHI R, 1972, CHEM PHARM BULL, V20, P2143
   IKUTA A, 1989, PHYTOCHEMISTRY, V28, P2663, DOI 10.1016/S0031-9422(00)98063-4
   Iwanaga S, 2012, CHEM PHARM BULL, V60, P1264, DOI 10.1248/cpb.c12-00448
   Jiang D, 2008, BIOCHEM SYST ECOL, V36, P138, DOI 10.1016/j.bse.2007.06.004
   Jiang D, 2006, CHEM PHARM BULL, V54, P595, DOI 10.1248/cpb.54.595
   [蒋丹 Jiang Dan], 2015, [中国药学杂志, Chinese Pharmaceutical Journal], V50, P1670
   Jiangsu New Medical College, 1985, DICT CHIN HERB MED
   Jin HG, 2015, ARCH PHARM RES, V38, P591, DOI 10.1007/s12272-014-0357-x
   Jin HG, 2014, CHEM PHARM BULL, V62, P288, DOI 10.1248/cpb.c13-00668
   Jin MM, 2018, PHYTOCHEM ANALYSIS, V29, P516, DOI 10.1002/pca.2762
   Jung HJ, 2004, BIOL PHARM BULL, V27, P744, DOI 10.1248/bpb.27.744
   Jung HJ, 2002, STRUCTURE ACTIVITY R, V26, P371
   KIZU H, 1980, CHEM PHARM BULL, V28, P2827
   KIZU H, 1980, CHEM PHARM BULL, V28, P3555
   Ko HJ, 2015, B KOREAN CHEM SOC, V36, P356, DOI 10.1002/bkcs.10002
   KUMEKAWA Y, 1974, CHEM PHARM BULL, V22, P2294, DOI 10.1248/cpb.22.2294
   Li Li, 2010, Wuhan Zhiwuxue Yanjiu, V28, P497, DOI 10.3724/SP.J.1142.2010.40497
   Li Z.F., 2013, J CHIN EXP TRADIT ME, V19, P56
   Liang BF, 2015, PHARM BIOL, V53, P368, DOI 10.3109/13880209.2014.922586
   Ling Y, 2016, PHYTOCHEM ANALYSIS, V27, P174, DOI 10.1002/pca.2613
   Ling Y, 2016, J CHROMATOGR SCI, V54, P148, DOI 10.1093/chromsci/bmv119
   Liu GY, 2007, J INTEGR PLANT BIOL, V49, P196, DOI 10.1111/j.1744-7909.2007.00362.x
   [刘桂艳 Liu Guiyan], 2004, [中国药学杂志, Chinese Pharmaceutical Journal], V39, P330
   Ma SC, 1994, ACTA PHARM SIN, V4, P285
   Matei MF, 2012, J AGR FOOD CHEM, V60, P12105, DOI 10.1021/jf3028599
   [孟月华 Meng Yuehua], 2013, [中草药, Chinese Traditional and Herbal Drugs], V44, P1562
   Mimaki Y, 2003, CHEM PHARM BULL, V51, P960, DOI 10.1248/cpb.51.960
   Mimaki Y, 2007, CHEM PHARM BULL, V55, P1319, DOI 10.1248/cpb.55.1319
   Nuengchamnong N, 2016, J PHARMACEUT BIOMED, V129, P121, DOI 10.1016/j.jpba.2016.06.052
   Ouyang H, 2017, J CHROMATOGR A, V1502, P38, DOI 10.1016/j.chroma.2017.04.051
   Ren DB, 2018, J CHROMATOGR A, V1550, P35, DOI 10.1016/j.chroma.2018.03.044
   SAWADA H, 1993, PHYTOCHEMISTRY, V34, P1117, DOI 10.1016/S0031-9422(00)90727-1
   SHAO CJ, 1989, CHEM PHARM BULL, V37, P311
   Sung YY, 2015, J ETHNOPHARMACOL, V168, P17, DOI 10.1016/j.jep.2015.03.051
   Wang J, 2015, FOOD CHEM, V168, P623, DOI 10.1016/j.foodchem.2014.07.105
   Wang J, 2014, MOLECULES, V19, P4301, DOI 10.3390/molecules19044301
   Wang ZhongYan Wang ZhongYan, 2005, Agricultural Science & Technology - Hunan, V6, P12
   Xia YG, 2014, J PHARMACEUT BIOMED, V100, P109, DOI 10.1016/j.jpba.2014.07.024
   Xu QL, 2016, MOLECULES, V21, DOI 10.3390/molecules21070962
   Zhou D, 2010, PHARMACOL BIOCHEM BE, V94, P488, DOI 10.1016/j.pbb.2009.11.003
NR 52
TC 21
Z9 26
U1 0
U2 47
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-4198
EI 1097-0231
J9 RAPID COMMUN MASS SP
JI Rapid Commun. Mass Spectrom.
PD SEP 30
PY 2019
VL 33
IS 18
BP 1464
EP 1474
DI 10.1002/rcm.8480
PG 11
WC Biochemical Research Methods; Chemistry, Analytical; Spectroscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Spectroscopy
GA IP8GO
UT WOS:000480285100006
PM 31074056
DA 2025-04-28
ER

PT J
AU Hibi, M
   Takase, H
   Iwasaki, M
   Osaki, N
   Katsuragi, Y
AF Hibi, Masanobu
   Takase, Hideto
   Iwasaki, Masaki
   Osaki, Noriko
   Katsuragi, Yoshihisa
TI Efficacy of tea catechin-rich beverages to reduce abdominal adiposity
   and metabolic syndrome risks in obese and overweight subjects: a pooled
   analysis of 6 human trials
SO NUTRITION RESEARCH
LA English
DT Review
DE Metabolic syndrome; Visceral fat; Tea catechins; Cardiovascular disease;
   Pooled analysis
ID GREEN TEA; WEIGHT-LOSS; METAANALYSIS; FAT; CHOLESTEROL; CONSUMPTION;
   CAFFEINE; PREVENT; ADULTS; MEN
AB This post hoc pooled analysis assessed the effectiveness of green tea catechins (GTC) to reduce the risk of metabolic syndrome (MetS) associated with abdominal fat reduction, because previous findings are unclear. Data were pooled from six human trials (n=921, 505 men) comparing the effects of GTC-containing beverages (540-588 mg GTC/beverage) and a placebo beverage. Outcome measures were abdominal fat [total fat area (TFA), visceral fat area (VFA), subcutaneous fat area (SFA)], and MetS risk. We estimated mean changes from baseline and calculated confidence intervals (CI) to assess reductions in abdominal fat accumulation and MetS improvement. Subclass analyses were performed by classifying subjects as Pre-MetS or MetS at trial initiation. Additional subclass analyses were performed with Pre-MetS and MetS subjects further stratified according to whether GTC intake reduced TFA, VFA, or SFA. Consumption of GTC-containing beverages for 12 weeks significantly reduced TFA (-17.7cm(2), 95%CI: -20.9 to -14.4), VFA (-7.5cm(2), 95%CI: -9.3 to -5.7), SFA (-10.2cm(2), 95%CI: -12.5 to -7.8), body weight, body mass index, and waist circumference; and improved blood pressure. Subclass analyses of Pre-MetS and MetS subjects showed improved MetS in the GTC group [odds ratio (OR), 1.67; 95%CI: 1.08-2.57]. The ORs for improved MetS in the TFA- and VFA-reduced groups were 2.79 (95%CI: 1.28-6.09) and 4.36 (95%CI: 2.03-9.39), respectively. Continual consumption of GTC-containing beverages reduced abdominal fat and improved MetS, suggesting its potential to prevent diabetes and cardiovascular disease. Additional large-scale intervention trials are needed to evaluate the effects of GTC on the risk of MetS in high-risk populations. (C) 2018 The Authors. Published by Elsevier B.V.
C1 [Hibi, Masanobu; Iwasaki, Masaki; Osaki, Noriko; Katsuragi, Yoshihisa] Kao Corp, Hlth Care Food Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.
   [Takase, Hideto] Kao Corp, Biol Sci Labs, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.
C3 KAO Corporation; KAO Corporation
RP Hibi, M (corresponding author), Kao Corp, Hlth Care Food Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.
EM hibi.masanobu@kao.com; takase.hideto@kao.com; iwasaki.masaki1@kao.com;
   osaki.noriko@kao.com; katsuragi.yoshihisa@kao.com
RI Hibi, Masanobu/AAF-6115-2019
OI Hibi, Masanobu/0000-0001-6791-3662
FU Kao Corporation
FX Masanobu Hibi, Hideto Takase, Masaki Iwasaki, Noriko Osaki, and
   Yoshihisa Katsuragi are employees of Kao Corporation. This study was
   supported by Kao Corporation. The funders had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Anderson JW, 2000, AM J CLIN NUTR, V71, P472
   [Anonymous], 2005, Nihon Naika Gakkai Zasshi, V94, P794
   [Anonymous], 2008, JPN PHARMACOL THER
   [Anonymous], 2016, Jpn Pharmacol Ther
   [Anonymous], 2008, Jpn Pharmacol Ther
   [Anonymous], J JPN SOC INTERN MED
   Barraj LM, 2014, NUTR RES, V34, P174, DOI 10.1016/j.nutres.2013.11.002
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848
   Engel SS, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-3
   FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1
   Han TS, 2002, OBES RES, V10, P923, DOI 10.1038/oby.2002.126
   Hiuge-Shimizu A, 2012, ANN MED, V44, P82, DOI 10.3109/07853890.2010.526138
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Kataoka K., 2004, Progress in Medicine, V24, P3358
   Khalesi S, 2014, EUR J NUTR, V53, P1299, DOI 10.1007/s00394-014-0720-1
   Kozuma K., 2005, Prog Med, V25, P1945
   Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255
   Legeay S, 2015, NUTRIENTS, V7, P5443, DOI 10.3390/nu7075230
   Lopes HF, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0156-2
   Lovejoy JC, 1996, METABOLISM, V45, P1119, DOI 10.1016/S0026-0495(96)90011-6
   MATSUZAWA Y, 1995, OBES RES, V3, pS187, DOI 10.1002/j.1550-8528.1995.tb00462.x
   Matsuzawa Y, 2014, Diabetes Manage, V4, P391
   Miura Y, 2001, J NUTR, V131, P27, DOI 10.1093/jn/131.1.27
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakao YM, 2012, P JPN ACAD B-PHYS, V88, P454, DOI 10.2183/pjab.88.454
   Okauchi Y, 2007, DIABETES CARE, V30, P2392, DOI 10.2337/dc07-0218
   RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649
   Rolfe ED, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2147-x
   Sabu MC, 2002, J ETHNOPHARMACOL, V83, P109
   Sahakyan KR, 2015, ANN INTERN MED, V163, P827, DOI 10.7326/M14-2525
   Seto R, 1997, BIOSCI BIOTECH BIOCH, V61, P1434, DOI 10.1271/bbb.61.1434
   tsuchida t., 2002, Prog med, V9, P2189
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Wan CJ, 2010, J DIABETES INVEST, V1, P259, DOI 10.1111/j.2040-1124.2010.00055.x
   Wang X, 2014, BRIT J NUTR, V111, P1, DOI 10.1017/S000711451300278X
   WHO, DEF DIAGN CLASS DI 1
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
NR 41
TC 41
Z9 44
U1 1
U2 34
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
EI 1879-0739
J9 NUTR RES
JI Nutr. Res.
PD JUL
PY 2018
VL 55
BP 1
EP 10
DI 10.1016/j.nutres.2018.03.012
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GM1EX
UT WOS:000437808000001
PM 29914623
OA hybrid
DA 2025-04-28
ER

PT J
AU Feijó, GD
   de Oliveira, S
   Thoen, R
   Schaab, EE
   de Moura, AC
   Franco, F
   Giovenardi, M
   Porawski, M
   Guedes, RP
AF Feijo, Grace dos Santos
   de Oliveira, Simone
   Thoen, Rutiane
   Schaab, Ester Elena
   de Moura, Ana Carolina
   Franco, Felipe
   Giovenardi, Marcia
   Porawski, Marilene
   Guedes, Renata Padilha
TI Food Selection of Cafeteria Diet Affects Memory Dysfunction Related to
   Obesity
SO NEUROCHEMICAL RESEARCH
LA English
DT Article
DE Diet-induced obesity; Object recognition test; Cola-based soft drink;
   Metabolic dysfunction; Oxidative stress; Non-alcoholic fatty liver
   disease
ID WESTERN DIET; HIGH-FAT; CAFFEINE; LEPTIN; CONSUMPTION; DEMENTIA; BRAIN;
   RATS
AB Cafeteria diet (CAF) mimics human Western diet and has been used in animal models to study obesity. The purpose of this study is to demonstrate that our CAF model induces metabolic disorder related to obesity and affects recognition memory in Wistar rats. We also compared the intake of two different soft drinks, as part of the CAF, on recognition memory. Our results demonstrate that CAF-fed rats increased weight gain and visceral adiposity, and exhibited hyperglycemia, hypertriglyceridemia, high leptin and low insulin plasma levels. Moreover, CAF animals showed higher lipid peroxidation in the liver and developed non-alcoholic fatty liver disease. Surprisingly, the group fed with cola-based soft drinks presented an improvement in recognition memory, whereas animals fed with orange-based soft drinks showed worse performance in this task. Our data indicates that CAF induces obesity and affects recognition memory, but the composition of the diet interfere when the neurological function is evaluated.
C1 [Feijo, Grace dos Santos; de Moura, Ana Carolina; Giovenardi, Marcia; Porawski, Marilene; Guedes, Renata Padilha] UFCSPA, Programa Posgrad Biociencias, Rua Sarmento Leite 245, Porto Alegre, RS, Brazil.
   [de Oliveira, Simone; Giovenardi, Marcia; Porawski, Marilene; Guedes, Renata Padilha] UFCSPA, Programa Posgrad Ciencias Saude, Rua Sarmento Leite 245, Porto Alegre, RS, Brazil.
   [Thoen, Rutiane; Porawski, Marilene] UFCSPA, Programa Posgrad Med Hepatol, Rua Sarmento Leite 245, Porto Alegre, RS, Brazil.
   [Schaab, Ester Elena; Franco, Felipe] UFCSPA, Rua Sarmento Leite 245, Porto Alegre, RS, Brazil.
C3 Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade
   Federal de Ciencias da Saude de Porto Alegre; Universidade Federal de
   Ciencias da Saude de Porto Alegre; Universidade Federal de Ciencias da
   Saude de Porto Alegre
RP Guedes, RP (corresponding author), UFCSPA, Programa Posgrad Biociencias, Rua Sarmento Leite 245, Porto Alegre, RS, Brazil.; Guedes, RP (corresponding author), UFCSPA, Programa Posgrad Ciencias Saude, Rua Sarmento Leite 245, Porto Alegre, RS, Brazil.
EM renata.guedes@ufcspa.edu.br
RI Feijo, Grace/HHC-1652-2022; Porawski, Marilene/D-4373-2014; Giovenardi,
   Marcia/A-7453-2016
OI Porawski, Marilene/0000-0003-3680-5815; dos Santos Feijo,
   Grace/0000-0003-3412-8507; Giovenardi, Marcia/0000-0003-3213-2641;
   Padilha Guedes, Renata/0000-0002-4456-767X; De Moura, Ana
   Carolina/0000-0002-1323-8988
FU Brazilian National Council for Scientific and Technological Development
   (CNPq); Coordination for the Improvement of Higher Education Personnel
   (CAPES); Foundation for Research Support of the State of Rio Grande do
   Sul (FAPERGS)
FX This study was supported by the Brazilian National Council for
   Scientific and Technological Development (CNPq), the Coordination for
   the Improvement of Higher Education Personnel (CAPES) and the Foundation
   for Research Support of the State of Rio Grande do Sul (FAPERGS).
CR Alempijevic T, 2017, POSTGRAD MED J, V93, P226, DOI 10.1136/postgradmedj-2016-134546
   Alzoubi KH, 2018, J MOL NEUROSCI, V66, P222, DOI 10.1007/s12031-018-1158-3
   Andrade GF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-145
   Anjum I, 2018, CUREUS J MED SCIENCE, V10, DOI 10.7759/cureus.2660
   Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x
   Borota D, 2014, NAT NEUROSCI, V17, P201, DOI 10.1038/nn.3623
   Bortolin RC, 2018, INT J OBESITY, V42, P525, DOI 10.1038/ijo.2017.225
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Buege J A, 1978, Methods Enzymol, V52, P302
   Chitturi S, 2002, HEPATOLOGY, V36, P403, DOI 10.1053/jhep.2002.34738
   Denroche HC, 2012, J DIABETES INVEST, V3, P115, DOI 10.1111/j.2040-1124.2012.00203.x
   ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X
   Faris E, 2017, NUTR DIET, V74, P268, DOI 10.1111/1747-0080.12289
   FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x
   Fulgoni VL, 2015, AM J CLIN NUTR, V101, P1081, DOI 10.3945/ajcn.113.080077
   Guillemot-Legris O, 2017, TRENDS NEUROSCI, V40, P237, DOI 10.1016/j.tins.2017.02.005
   Hameleers PAHM, 2000, HUM PSYCHOPHARM CLIN, V15, P573, DOI 10.1002/hup.218
   Hargrave SL, 2015, APPETITE, V93, P35, DOI 10.1016/j.appet.2015.03.037
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003
   Kanoski SE, 2010, J ALZHEIMERS DIS, V21, P207, DOI 10.3233/JAD-2010-091414
   Khoshnoud MJ, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22022
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Lutz Thomas A, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0561s58
   Mandal A, 2018, PEPTIDES, V102, P16, DOI 10.1016/j.peptides.2018.02.003
   McLellan TM, 2016, NEUROSCI BIOBEHAV R, V71, P294, DOI 10.1016/j.neubiorev.2016.09.001
   Milagro FI, 2006, OBESITY, V14, P1118, DOI 10.1038/oby.2006.128
   MOORE BJ, 1987, J NUTR, V117, P227, DOI 10.1093/jn/117.2.227
   Moreira EAM, 2005, CLIN NUTR, V24, P1038, DOI 10.1016/j.clnu.2005.08.005
   Parafati M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111604
   Pase MP, 2017, STROKE, V48, P1139, DOI 10.1161/STROKEAHA.116.016027
   Popkin BM, 2010, PHYSIOL BEHAV, V100, P4, DOI 10.1016/j.physbeh.2009.12.022
   Ulla A, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1799-8
   Van Doorn C, 2017, PHYSIOL BEHAV, V176, P207, DOI 10.1016/j.physbeh.2017.03.002
   Virtuoso A, 2018, APPL ANIM BEHAV SCI, V199, P35, DOI 10.1016/j.applanim.2017.10.012
   Xu TJ, 2018, NEUROPHARMACOLOGY, V137, P24, DOI 10.1016/j.neuropharm.2018.04.012
NR 37
TC 8
Z9 8
U1 0
U2 8
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-3190
EI 1573-6903
J9 NEUROCHEM RES
JI Neurochem. Res.
PD AUG
PY 2019
VL 44
IS 8
BP 1869
EP 1877
DI 10.1007/s11064-019-02821-5
PG 9
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA IL9EY
UT WOS:000477589200009
PM 31161464
DA 2025-04-28
ER

PT J
AU Gyntelberg, F
   Hein, HO
   Suadicani, P
AF Gyntelberg, Finn
   Hein, Hans Ole
   Suadicani, Poul
CA Copenhagen Male Study
TI Sugar in coffee or tea and risk of obesity: A neglected issue
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE Health awareness; lifestyle; obesity; sucrose; sugar use
ID WEIGHT; CONSUMPTION; SUCROSE; FAT
AB Aim In the Copenhagen Male Study sugar intake in coffee or tea is inversely associated with obesity. We analyzed the association of sugar intake with obesity among men with and without lifestyle factors indicating health awareness.
   Methods A cross-sectional study of 3,290 men aged 53-75 years including information about smoking, alcohol, physical activity, tea and coffee use, avoidance of fatty food, social class, self-assessed health, and family obesity.
   Results Overall, 291 men (8.8%) were obese, body mass index >= 30. Among men using sugar in coffee or tea (36%), the prevalence was 6.2%; among others, 10.3% (odds ratio [95% confidence interval] = 0.6 [0.4-0.8]). An inverse association between use of sugar in hot beverages and prevalence of obesity was consistent in subgroups, and most pronounced among the least health-conscious [odds ratio [95% confidence interval] = 0.4 [0.2-0.8]).
   Interpretation The results indicate a weight-controlling or reducing effect of small amounts of sucrose ingested several times a day.
C1 [Suadicani, Poul] Bispebjerg Hosp, Epidemiol Res Unit, Copenhagen Male Study, Clin Occupat & Environm Med, DK-2400 Copenhagen NV, Denmark.
   [Hein, Hans Ole] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Copenhagen, Denmark.
C3 University of Copenhagen; Bispebjerg Hospital; Copenhagen University
   Hospital; University of Copenhagen; Copenhagen University Hospital
RP Suadicani, P (corresponding author), Bispebjerg Hosp, Epidemiol Res Unit, Copenhagen Male Study, Clin Occupat & Environm Med, DK-2400 Copenhagen NV, Denmark.
EM ps11@bbh.regionh.dk
FU The King Christian X's Foundation; The Danish Medical Research Council;
   The Danish Heart Foundation; The Else & Mogens Wedell-Wedellsborg
   Foundation
FX This study received grants from The King Christian X's Foundation, The
   Danish Medical Research Council, The Danish Heart Foundation and The
   Else & Mogens Wedell-Wedellsborg Foundation.
CR ANDERSON GH, 1995, AM J CLIN NUTR S, V62, P195
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   GYNTELBERG F, 1975, DAN MED BULL, V22, P81
   Kirkwood L, 2007, INT J FOOD SCI NUTR, V58, P383, DOI 10.1080/09637480701252336
   Lindroos AK, 1996, INT J OBESITY, V20, P634
   Macdiarmid JI, 1998, INT J OBESITY, V22, P1053, DOI 10.1038/sj.ijo.0800724
   Meier JJ, 2002, EUR J PHARMACOL, V440, P269, DOI 10.1016/S0014-2999(02)01434-6
   Murphy KG, 2004, EXP PHYSIOL, V89, P507, DOI 10.1113/expphysiol.2004.027789
   OLSEN NJ, 2008, INTAKE CALORICALLY S
   Suadicani P, 2005, EUR J CARDIOV PREV R, V12, P236, DOI 10.1097/00149831-200506000-00009
   SUADICANI P, 1994, INT J EPIDEMIOL, V23, P293, DOI 10.1093/ije/23.2.293
   West JA, 2001, INT J OBESITY, V25, P1122, DOI 10.1038/sj.ijo.0801652
   WHO, 2000, WHO TECHN REP SER, V894
NR 13
TC 11
Z9 11
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PY 2009
VL 60
SU 3
BP 56
EP 64
DI 10.1080/09637480802668471
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 535BQ
UT WOS:000272942000006
PM 19194815
DA 2025-04-28
ER

PT J
AU Wolfram, S
   Raederstorff, D
   Wang, Y
   Teixeira, SR
   Elste, V
   Weber, P
AF Wolfram, S
   Raederstorff, D
   Wang, Y
   Teixeira, SR
   Elste, V
   Weber, P
TI TEAVIGO™ (epigallocatechin gallate) supplementation prevents obesity in
   rodents by reducing adipose tissue mass
SO ANNALS OF NUTRITION AND METABOLISM
LA English
DT Article
DE TEAVIGO (TM); epigallocatechin gallate; obesity; adipose tissue;
   rodents; gene expression; green tea; catechin
ID GREEN TEA; CATECHIN-POLYPHENOLS; DIABETES-MELLITUS; FAT OXIDATION;
   IN-VITRO; RATS; INHIBITION; PREVALENCE; ABSORPTION; CAFFEINE
AB Background: This study investigated the antiobesity effects of TEAVIGO(TM), a product providing the most abundant green tea catechin, epigallocatechin gallate ( EGCG), in a pure form. Two models of diet-induced obesity and an in vitro adipocyte differentiation assay were employed. Methods: Prevention and regression of diet-induced obesity by dietary supplementation with EGCG was studied in C57BL/6J mice and Sprague-Dawley rats, respectively. Expression of genes regulating lipid metabolism was assessed in adipose tissue. The effects of EGCG on adipocyte differentiation were investigated in vitro. Results: In C57BL/6J mice, EGCG supplementation prevented diet-induced increases in body weight and in fed state plasma levels of glucose, triglycerides, and leptin. EGCG decreased subcutaneous and epididymal adipose tissue weights. Supplementation of EGCG reversed the established obesity in Sprague-Dawley rats. Fatty acid synthase and acetyl-CoA carboxylase-1 mRNA levels were markedly decreased in adipose tissue of EGCG-supplemented mice. EGCG dose dependently inhibited adipocyte differentiation in vitro. Conclusion: This study shows for the first time that supplementation with the most abundant green tea polyphenol, EGCG, abolishes diet-induced obesity. This effect is at least partly mediated via a direct influence on adipose tissue. Thus, dietary supplementation with EGCG should be considered as a valuable natural treatment option for obesity. Copyright (C) 2005 S. Karger AG, Basel.
C1 DSM Nutr Prod Ltd, Dept Human Nutr & Hlth, CH-4002 Basel, Switzerland.
C3 DSM NV
RP Wolfram, S (corresponding author), DSM Nutr Prod Ltd, Dept Human Nutr & Hlth, Bldg 205-020,POB 3255, CH-4002 Basel, Switzerland.
EM swen.wolfram@dsm.com
CR Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100
   Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530
   Chen LS, 1997, DRUG METAB DISPOS, V25, P1045
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Goran MI, 2003, J CLIN ENDOCR METAB, V88, P1417, DOI 10.1210/jc.2002-021442
   HARA Y, 1990, AGR BIOL CHEM TOKYO, V54, P1939, DOI 10.1080/00021369.1990.10870239
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Jung YD, 2001, INT J EXP PATHOL, V82, P309, DOI 10.1046/j.1365-2613.2001.00205.x
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kavanagh KT, 2001, J CELL BIOCHEM, V82, P387, DOI 10.1002/jcb.1164
   Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832
   MATSUMOTO N, 1993, BIOSCI BIOTECH BIOCH, V57, P525, DOI 10.1271/bbb.57.525
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699
   Osada K, 2001, COMP BIOCHEM PHYS C, V128, P153, DOI 10.1016/S1532-0456(00)00192-7
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Rios MS, 1998, EUR J CLIN INVEST, V28, P14
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Sano M, 2001, ANALYST, V126, P816, DOI 10.1039/b102541b
   Sartippour MR, 2002, J NUTR, V132, P2307, DOI 10.1093/jn/132.8.2307
   Seidell JC, 2002, J ENDOCRINOL INVEST, V25, P816, DOI 10.1007/BF03344045
   Sheard NF, 2003, NUTR REV, V61, P76, DOI [10.1301/nr.2003.febr.76-79, 10.1031/nr.2003.febr.76-79]
   Shimizu M, 2000, BIOFACTORS, V13, P61, DOI 10.1002/biof.5520130111
   Sueoka N, 2001, ANN NY ACAD SCI, V928, P274
   Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205
   Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355
NR 28
TC 173
Z9 197
U1 1
U2 23
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0250-6807
J9 ANN NUTR METAB
JI Ann. Nutr. Metab.
PY 2005
VL 49
IS 1
BP 54
EP 63
DI 10.1159/000084178
PG 10
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 920DZ
UT WOS:000228670900009
PM 15735368
DA 2025-04-28
ER

PT J
AU Zhao, M
   Li, D
   Ye, JH
   Zheng, XQ
   Liang, YR
   Lu, JL
AF Zhao, Min
   Li, Da
   Ye, Jian-Hui
   Zheng, Xin-Qiang
   Liang, Yue-Rong
   Lu, Jian-Liang
TI Stop for tea? Enzyme inhibitors from tea - what good are they?
SO INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY
LA English
DT Review
DE Caffeine; cancer; catechins; enzyme; inflammation; inhibition; obesity;
   polyphenols; tea; theanine
ID NF-KAPPA-B; MAMMALIAN HISTIDINE-DECARBOXYLASE; PANCREATIC ALPHA-AMYLASE;
   GREEN TEA; PARKINSONS-DISEASE; BLACK TEA; IN-VITRO; ALZHEIMERS-DISEASE;
   INFLAMMATORY CYTOKINES; CAFFEINE
AB Tea possesses many bioactive components including polyphenols, theanine and caffeine. Inhibitory effect of these components on the various enzymes involved in some chronic diseases was reviewed in this study. Many studies revealed that anti-obesity of tea was mainly ascribed to the polyphenols which could inhibit the activity of the enzymes related to diet metabolism such as -amylase, -glucosidase and lipase. Inhibitory effect of catechins and caffeine against - and -secretase, acetylcholinesterase, protein kinase C and histone deacetylase might be responsible for the prevention from nervous system diseases. Cytochrome P450 enzymes, cytosolic sulfotransferases, cyclooxygenase-2 and phosphoinositide-3-kinase could be efficiently suppressed by catechins, which would decrease the risk of cancer initiation and proliferation; theanine could lower the activity of some anticarcinogen-activated enzymes and alleviate the adverse effect of cancer cure. Catechins and caffeine exhibited significant inhibition against the matrix metalloproteinases, histidine decarboxylase and many kinases related to inflammation. Thus, catechins, theanine and caffeine might be employed as inhibitors of the enzymes associated with these chronic diseases.
C1 [Zhao, Min; Li, Da; Ye, Jian-Hui; Zheng, Xin-Qiang; Liang, Yue-Rong; Lu, Jian-Liang] Zhejiang Univ, Tea Res Inst, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.
C3 Zhejiang University
RP Lu, JL (corresponding author), Zhejiang Univ, Tea Res Inst, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.
EM jllu@zju.edu.cn
RI da, li/AGZ-1742-2022; , jllu/GZL-3912-2022; Zheng, Xusheng/AAG-9580-2021
OI Li, Da/0009-0002-7896-024X
FU National Natural Science Foundation of China [31470687]
FX This work was financially supported by National Natural Science
   Foundation of China (No. 31470687).
CR Abdelall EKA, 2016, EUR J MED CHEM, V118, P250, DOI 10.1016/j.ejmech.2016.04.049
   Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639
   Borghaei RC, 2016, BIOCHEM BIOPH RES CO, V471, P503, DOI 10.1016/j.bbrc.2016.02.045
   Brothers HM, 2010, NEUROSCI LETT, V480, P97, DOI 10.1016/j.neulet.2010.06.013
   Carelli-Alinovi C, 2016, BIOCHIMIE, V121, P52, DOI 10.1016/j.biochi.2015.11.022
   Chandini SK, 2011, INT J FOOD SCI TECH, V46, P879, DOI 10.1111/j.1365-2621.2011.02576.x
   Chen J, 2016, BIOORGAN MED CHEM, V24, P1488, DOI 10.1016/j.bmc.2016.02.018
   Chen LX, 2017, J NUTR BIOCHEM, V40, P1, DOI 10.1016/j.jnutbio.2016.05.005
   Choong CJ, 2016, NEUROBIOL AGING, V37, P103, DOI 10.1016/j.neurobiolaging.2015.10.001
   Choung MG, 2014, INT J FOOD SCI TECH, V49, P1572, DOI 10.1111/ijfs.12454
   Conney AH, 2003, ANNU REV PHARMACOL, V43, P1, DOI 10.1146/annurev.pharmtox.43.100901.135754
   Deng X, 2014, J CHROMATOGR B, V973, P55, DOI 10.1016/j.jchromb.2014.10.010
   Deng X, 2007, INT IMMUNOPHARMACOL, V7, P152, DOI 10.1016/j.intimp.2006.09.009
   Ercan P, 2016, FOOD CHEM, V205, P163, DOI 10.1016/j.foodchem.2016.03.012
   Fang Chong-Ye, 2015, Chin J Nat Med, V13, P595, DOI 10.1016/S1875-5364(15)30055-8
   Gebremedhin KG, 2016, NEUROSCI LETT, V627, P121, DOI 10.1016/j.neulet.2016.05.060
   Ghani U, 2015, EUR J MED CHEM, V103, P133, DOI 10.1016/j.ejmech.2015.08.043
   Glisan SL, 2017, FOOD CHEM, V216, P296, DOI 10.1016/j.foodchem.2016.08.052
   Goh R, 2015, FOOD CHEM, V180, P203, DOI 10.1016/j.foodchem.2015.02.054
   Gondoin A, 2010, FOOD RES INT, V43, P1537, DOI 10.1016/j.foodres.2010.04.029
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Guo YQ, 2009, NUTR RES, V29, P656, DOI 10.1016/j.nutres.2009.09.005
   Harley ITW, 2012, MOL METAB, V1, P21, DOI 10.1016/j.molmet.2012.07.002
   Holmgren G, 2016, TOXICOL IN VITRO, V34, P26, DOI 10.1016/j.tiv.2016.03.009
   Hou YB, 2016, J NEUROL SCI, V366, P27, DOI 10.1016/j.jns.2016.04.030
   Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040
   Hwang JH, 2016, CHEM-BIOL INTERACT, V248, P1, DOI 10.1016/j.cbi.2016.01.020
   Ide Kazuki, 2015, PharmaNutrition, V3, P136, DOI 10.1016/j.phanu.2015.07.001
   Ikarashi N, 2016, EUR J PHARM SCI, V89, P137, DOI 10.1016/j.ejps.2016.04.031
   Jin JQ, 2016, PLANT PHYSIOL BIOCH, V105, P251, DOI 10.1016/j.plaphy.2016.04.032
   Kang CH, 2012, FOOD CHEM TOXICOL, V50, P4270, DOI 10.1016/j.fct.2012.08.041
   Kaushik A, 2016, BIOSENS BIOELECTRON, V80, P273, DOI 10.1016/j.bios.2016.01.065
   Kim JS, 2010, J CLIN NEUROSCI, V17, P1165, DOI 10.1016/j.jocn.2010.01.042
   Kim-Park W. K., 2015, J TRADITIONAL COMPLE, V42, P1
   Koh LW, 2010, J AGR FOOD CHEM, V58, P148, DOI 10.1021/jf903011g
   Li JR, 2013, TOXICOL LETT, V220, P267, DOI 10.1016/j.toxlet.2013.04.021
   Li JL, 2015, INT J FOOD SCI TECH, V50, P2483, DOI 10.1111/ijfs.12916
   Liao WC, 2012, INT J FOOD SCI TECH, V47, P2009, DOI 10.1111/j.1365-2621.2012.03064.x
   Lim HJ, 2013, J NUTR BIOCHEM, V24, P1302, DOI 10.1016/j.jnutbio.2012.10.005
   Liu J, 2016, J DIABETES COMPLICAT, V30, P898, DOI 10.1016/j.jdiacomp.2016.03.001
   Liu SM, 2016, INT J FOOD SCI TECH, V51, P1537, DOI 10.1111/ijfs.13120
   Ma JF, 2011, BIOCHEM BIOPH RES CO, V407, P98, DOI 10.1016/j.bbrc.2011.02.116
   Machado JA, 2014, BEHAV BRAIN RES, V264, P116, DOI 10.1016/j.bbr.2014.01.051
   Mathiyazahan DB, 2015, J FUNCT FOODS, V16, P423, DOI 10.1016/j.jff.2015.05.001
   Melgarejo E, 2010, J PHYSIOL BIOCHEM, V66, P265, DOI 10.1007/s13105-010-0033-7
   Miao M, 2015, FOOD CHEM, V186, P20, DOI 10.1016/j.foodchem.2015.02.049
   Millanta F, 2016, J COMP PATHOL, V154, P297, DOI 10.1016/j.jcpa.2016.02.005
   Misaka S, 2013, DRUG METAB PHARMACOK, V28, P514, DOI 10.2133/dmpk.DMPK-13-NT-006
   Misaka S, 2013, DRUG METAB PHARMACOK, V28, P244, DOI 10.2133/dmpk.DMPK-12-RG-101
   Mohammad S, 2016, DIAB MET SYND CLIN R, V10, P171, DOI 10.1016/j.dsx.2016.01.017
   Moon YJ, 2006, TOXICOL IN VITRO, V20, P187, DOI 10.1016/j.tiv.2005.06.048
   Mu WM, 2015, BIOTECHNOL ADV, V33, P335, DOI 10.1016/j.biotechadv.2015.04.004
   Nagai K, 2015, FOOD CHEM TOXICOL, V78, P147, DOI 10.1016/j.fct.2015.02.009
   Najeeb Ullah Najeeb Ullah, 2016, Asian Pacific Journal of Tropical Disease, V6, P330, DOI 10.1016/S2222-1808(15)61040-4
   Nayak S, 2012, MOL GENET METAB, V106, P189, DOI 10.1016/j.ymgme.2012.03.009
   Nitta Y, 2013, FOOD CHEM, V138, P1551, DOI 10.1016/j.foodchem.2012.10.074
   Noguchi K, 2015, J PHARMACOL SCI, V127, P217, DOI 10.1016/j.jphs.2015.01.003
   Okello EJ, 2004, PHYTOTHER RES, V18, P624, DOI 10.1002/ptr.1519
   Pandit A., 2016, APOLLO MED, V13, P91, DOI [10.1016/j.apme.2015.08.001, DOI 10.1016/J.APME.2015.08.001]
   Park JW, 2010, J NUTR BIOCHEM, V21, P1038, DOI 10.1016/j.jnutbio.2009.08.009
   Paul S, 2012, FOOD CHEM TOXICOL, V50, P1354, DOI 10.1016/j.fct.2012.02.035
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107
   Rodrigues VD, 2015, INT J FOOD SCI TECH, V50, P2038, DOI 10.1111/ijfs.12858
   Rodríguez-Caso C, 2003, CELL MOL LIFE SCI, V60, P1760, DOI 10.1007/s00018-003-3135-3
   Satoh T, 2015, J ETHNOPHARMACOL, V161, P147, DOI 10.1016/j.jep.2014.12.009
   Small G, 2011, ALZHEIMERS DEMENT, V7, P177, DOI 10.1016/j.jalz.2010.03.016
   Sugiyama T, 2004, CANCER LETT, V212, P177, DOI 10.1016/j.canlet.2004.03.040
   Sun LJ, 2016, J FUNCT FOODS, V26, P144, DOI 10.1016/j.jff.2016.07.012
   Takarada Takeshi, 2016, Biochem Biophys Rep, V5, P89, DOI 10.1016/j.bbrep.2015.09.021
   Unno K, 2013, PHARMACOL BIOCHEM BE, V111, P128, DOI 10.1016/j.pbb.2013.09.004
   Vannini F, 2015, REDOX BIOL, V6, P334, DOI 10.1016/j.redox.2015.08.009
   VansAller G. S., 2011, BIOCH BIOPHYSICAL RE, V406, P194
   Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174
   Vayalil PK, 2004, J INVEST DERMATOL, V122, P1480, DOI 10.1111/j.0022-202X.2004.22622.x
   Venigalla M, 2016, NEUROCHEM INT, V95, P63, DOI 10.1016/j.neuint.2015.10.011
   Ruiz-Pérez MV, 2012, J CHEM INF MODEL, V52, P113, DOI 10.1021/ci200221z
   Bermejo DV, 2016, J SUPERCRIT FLUID, V107, P507, DOI 10.1016/j.supflu.2015.07.008
   Warren J, 2016, ETHNIC DIS, V26, P77, DOI 10.18865/ed.26.1.77
   WEERAWATANAKORN M., 2015, Food Science and Human Wellness, V4, P133, DOI [10.1016/J.FSHW.2015.10.002, DOI 10.1016/J.FSHW.2015.10.002, 10.1016/j.fshw.2015.10.002]
   Wu JL, 2016, PROCESS BIOCHEM, V51, P854, DOI 10.1016/j.procbio.2016.04.004
   Xu K, 2016, NEUROSCIENCE, V322, P129, DOI 10.1016/j.neuroscience.2016.02.035
   Xu P, 2014, J FUNCT FOODS, V6, P545, DOI 10.1016/j.jff.2013.11.021
   Yan Q, 2016, MATER LETT, V170, P202, DOI 10.1016/j.matlet.2016.02.041
   Yang XP, 2016, LWT-FOOD SCI TECHNOL, V66, P232, DOI 10.1016/j.lwt.2015.10.035
   Yang XP, 2016, J SCI FOOD AGR, V96, P777, DOI 10.1002/jsfa.7147
   Yeh CT, 2006, J NUTR BIOCHEM, V17, P561, DOI 10.1016/j.jnutbio.2005.10.008
   Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X
   Zhang X, 2015, INT J FOOD SCI TECH, V50, P885, DOI 10.1111/ijfs.12726
   Zhang X, 2012, INT J FOOD SCI TECH, V47, P2151, DOI 10.1111/j.1365-2621.2012.03082.x
   Zhang ZY, 2015, TRENDS PHARMACOL SCI, V36, P661, DOI 10.1016/j.tips.2015.07.003
   Zhu YT, 2015, FOOD CHEM, V173, P521, DOI 10.1016/j.foodchem.2014.10.087
   Zhu YX, 2006, INT J FOOD SCI TECH, V41, P333, DOI 10.1111/j.1365-2621.2005.01076.x
NR 93
TC 4
Z9 4
U1 0
U2 59
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-5423
EI 1365-2621
J9 INT J FOOD SCI TECH
JI Int. J. Food Sci. Technol.
PD MAR
PY 2017
VL 52
IS 3
BP 586
EP 594
DI 10.1111/ijfs.13342
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA EL3HP
UT WOS:000394510500002
DA 2025-04-28
ER

PT J
AU Fung, TT
   Hu, FB
   Schulze, M
   Pollak, M
   Wu, TY
   Fuchs, CS
   Giovannucci, E
AF Fung, Teresa T.
   Hu, Frank B.
   Schulze, Matthias
   Pollak, Michael
   Wu, Tianying
   Fuchs, Charles S.
   Giovannucci, Edward
TI A dietary pattern that is associated with C-peptide and risk of
   colorectal cancer in women
SO CANCER CAUSES & CONTROL
LA English
DT Article
DE Colorectal cancer; Diet; C-peptide
ID GROWTH-FACTOR-I; CARDIOVASCULAR-DISEASE; DECAFFEINATED COFFEE;
   BINDING-PROTEINS; INSULIN INDEX; LOAD; REPRODUCIBILITY; BIOMARKERS;
   VALIDITY
AB Higher serum C-peptide concentrations have shown to be associated with an increased risk of colorectal cancer (CRC). Therefore, we used diet information to identify food groups that correlated with fasting serum concentrations of C-peptide and assess the association of this dietary pattern and CRC risk.
   Major food contributors to fasting C-peptide concentrations were identified with stepwise linear regression in a subsample ( = 833) of women from a large cohort. We then summed the consumption frequency of the major food contributors to form a C-peptide dietary pattern for the entire cohort ( = 66,714). Risk for CRC was computed using Cox proportional hazard model with the C-peptide dietary pattern score as the predictor.
   In up to 20 years of follow-up, we ascertained 985 cases of CRC and 758 colon cancer. After adjusting for confounders, the C-peptide dietary pattern, characterized by higher meat, fish, and sweetened beverage intake, but lower coffee, high fat dairy, and whole grains intake, showed direct association with CRC risk (RR comparing extreme quintiles = 1.29, 95 % CI = 1.05-1.58, trend = 0.048). The same comparison was slightly stronger for colon cancer (RR = 1.35, 95 % CI = 1.07-1.70, trend = 0.009). In stratified analysis, there was no association between the C-peptide dietary pattern and colon cancer among lean and active women. However, for overweight or sedentary women, RR for the same comparison was 1.58 (95 % CI = 1.20-2.07, trend = 0.002) ( for interaction = 0.007).
   We derived a dietary pattern that correlated with C-peptide concentrations. This pattern was associated with an increase in colon cancer, especially among women who were overweight or sedentary.
C1 [Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA.
   [Fung, Teresa T.; Hu, Frank B.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Hu, Frank B.; Giovannucci, Edward] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA.
   [Hu, Frank B.; Giovannucci, Edward] Harvard Univ, Sch Med, Boston, MA USA.
   [Schulze, Matthias] Tech Univ Munich, Munich, Germany.
   [Schulze, Matthias] German Inst Human Nutr, Munich, Germany.
   [Pollak, Michael] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada.
   [Wu, Tianying] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA.
   [Fuchs, Charles S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.
C3 Simmons University; Harvard University; Harvard T.H. Chan School of
   Public Health; Harvard University; Harvard University Medical
   Affiliates; Brigham & Women's Hospital; Harvard University; Harvard
   Medical School; Technical University of Munich; Leibniz Association;
   Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE);
   Lady Davis Institute; McGill University; University System of Ohio;
   University of Cincinnati; Harvard University; Harvard University Medical
   Affiliates; Dana-Farber Cancer Institute
RP Fung, TT (corresponding author), Simmons Coll, Dept Nutr, 300 Fenway, Boston, MA 02115 USA.
EM fung@simmons.edu
RI Pollak, Michael/G-9094-2011; Giovannucci, Edward/ADE-8028-2022; Hu,
   Frank/C-1919-2013; Schulze, Matthias B./AAH-6906-2021
OI Schulze, Matthias B./0000-0002-0830-5277; Pollak,
   Michael/0000-0003-3047-0604; Yang, Shuman/0000-0002-9638-0890
FU National Institute of Health [CA87969, HL60712, CA95589]
FX We would like to thank the participants and staff of the Nurses' Health
   Study for their valuable contributions as well as the following state
   cancer registries for their help: AL, AZ, AR, CA, CO, CT, DE, FL, GA,
   ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK,
   OR, PA, RI, SC, TN, TX, VA, WA, WY. This work is funded by the National
   Institute of Health research grants CA87969, HL60712, and CA95589.
CR Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Bao Y, 2010, CANCER EPIDEM BIOMAR, V19, P3020, DOI 10.1158/1055-9965.EPI-10-0833
   Bobe G, 2010, CANCER EPIDEM BIOMAR, V19, P1441, DOI 10.1158/1055-9965.EPI-09-1082
   COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319
   FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E
   Fung TT, 2001, AM J CLIN NUTR, V73, P61
   Giovannucci E, 2004, INT J EPIDEMIOL, V33, P217, DOI 10.1093/ije/dyh020
   Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078
   Giovannucci EL, 1995, CANCER CAUSE CONTROL, V164- 179, P16
   Gnagnarella P, 2008, AM J CLIN NUTR, V87, P1793, DOI 10.1093/ajcn/87.6.1793
   Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849
   Hu FB, 1999, AM J CLIN NUTR, V69, P243
   Jenab M, 2007, INT J CANCER, V121, P368, DOI 10.1002/ijc.22697
   Jensen MK, 2006, AM J CLIN NUTR, V83, P275
   Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592
   Kerver JM, 2003, AM J CLIN NUTR, V78, P1103, DOI 10.1093/ajcn/78.6.1103
   Le Marchand L, 2010, CANCER EPIDEM BIOMAR, V19, P1471, DOI 10.1158/1055-9965.EPI-10-0128
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   McNaughton SA, 2008, DIABETES CARE, V31, P1343, DOI 10.2337/dc07-1946
   Nimptsch K, 2011, AM J CLIN NUTR, V94, P182, DOI 10.3945/ajcn.110.009555
   Ning Y, 2010, OBES REV, V11, P19, DOI 10.1111/j.1467-789X.2009.00613.x
   Otani T, 2007, INT J CANCER, V120, P2007, DOI 10.1002/ijc.22556
   Rosner B, 2008, AM J EPIDEMIOL, V167, P653, DOI 10.1093/aje/kwm348
   Wei EK, 2005, CANCER EPIDEM BIOMAR, V14, P850, DOI 10.1158/1055-9965.EPI-04-0661
   Willett WC, 1998, NUTR EPIDEMIOLOGY
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
NR 26
TC 31
Z9 33
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-5243
EI 1573-7225
J9 CANCER CAUSE CONTROL
JI Cancer Causes Control
PD JUN
PY 2012
VL 23
IS 6
BP 959
EP 965
DI 10.1007/s10552-012-9969-y
PG 7
WC Oncology; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Public, Environmental & Occupational Health
GA 943FK
UT WOS:000304105700017
PM 22535146
OA Green Accepted
DA 2025-04-28
ER

PT J
AU An, R
   Wen, S
   Li, DL
   Li, QH
   Lai, XF
   Zhang, WJ
   Chen, RH
   Cao, JX
   Li, ZG
   Huang, QS
   Sun, LL
   Sun, SL
AF An, Ran
   Wen, Shuai
   Li, Dong-Li
   Li, Qiu-Hua
   Lai, Xing-Fei
   Zhang, Wen-Ji
   Chen, Ruo-Hong
   Cao, Jun-Xi
   Li, Zhi-Gang
   Huang, Qiu-Sheng
   Sun, Ling-Li
   Sun, Shi-Li
TI Mixtures of Tea andCitrus maxima(pomelo) Alleviate Lipid
   Deposition in HepG2 Cells Through the AMPK/ACC Signaling Pathway
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE AMPK; citrus maxima; lipid deposition; tea
ID NONALCOHOLIC FATTY LIVER; GREEN TEA; BLACK TEA; BLOOD-PRESSURE; PEEL
   EXTRACT; YELLOW TEA; DISEASE; POLYPHENOLS; FLAVONOIDS; CATECHINS
AB Tea and citrus maxima are natural, medicinal homologous plants, typically used for making beverages, which have anticancer, antiobesity, and antioxidation properties. Green tea, yellow tea, and black tea were combined with citrus maxima to obtain green tea andCitrus maxima(GTCM), yellow tea andCitrus maxima(YTCM), and black tea andCitrus maxima(BTCM). The biochemical components of these mixtures were analyzed, and their possible effects and mechanisms on relieving liver lipid deposition were explored. The tea polyphenols, free amino acids, phenolamine ratio, and caffeine were comparable in YTCM and GTCM, being significantly higher than those in BTCM. In addition, the content of esterified catechins, nonesterified catechins, and total catechins in YTCM was significantly higher than those in GTCM and BTCM. All three mixtures ofCitrus maximatea significantly reduced lipid deposition in HepG2 cells, with GTCM and YTCM being slightly more effective than BTCM. Regarding the possible mechanism, Western blot analysis revealed that the threeCitrus maximatea mixtures could activate the AMPK/ACC signaling pathway, upregulate the expression of p-AMPK, p-ACC, and CPT-1 proteins, and downregulate the expression of SREBP1c and fatty acid synthase proteins to inhibit fat synthesis, thereby relieving lipid deposition in liver cells. In conclusion, as a novel and healthy beverage,Citrus maximatea has the potential to alleviate liver lipid deposition, and further could be responsible for obesity treatment.
C1 [An, Ran; Li, Qiu-Hua; Lai, Xing-Fei; Zhang, Wen-Ji; Chen, Ruo-Hong; Cao, Jun-Xi; Li, Zhi-Gang; Sun, Ling-Li; Sun, Shi-Li] Guangdong Acad Agr Sci, Guangdong Key Lab Tea Resources Innovat & Utiliza, Tea Res Inst, Guangzhou 510000, Peoples R China.
   [An, Ran; Wen, Shuai; Li, Dong-Li] Wuyi Univ, Sch Biotechnol & Hlth Sci, Jiangmen, Peoples R China.
   [Li, Dong-Li] Int Healthcare Innovat Inst Jiangmen, Jiangmen, Peoples R China.
   [Huang, Qiu-Sheng] Guangdong Kaili Biochem Sci & Technol Co Ltd, Guangzhou, Peoples R China.
C3 Guangdong Academy of Agricultural Sciences; Wuyi University
RP Sun, LL; Sun, SL (corresponding author), Guangdong Acad Agr Sci, Guangdong Key Lab Tea Resources Innovat & Utiliza, Tea Res Inst, Guangzhou 510000, Peoples R China.
EM lingli_318@126.com; sunshili@zju.edu.cn
RI Li, Zhigang/AAC-2901-2022; Li, Haoyu/ACR-0968-2022; lai,
   xingfei/IYJ-6251-2023
OI Xingfei, Lai/0000-0003-3736-605X
FU National Natural Science Foundation of China [81803236, 31800295,
   81903319]; Guangdong Science and Technology program [2017A070702004,
   2016B090918118, 2018KJYZ002]; Guangdong Basic and Applied Basic Research
   Foundation [2020A1515011266]; QingYuan Science and Technology Program
   [DZXQY021, DZXQY016]; ShaoGuan Science and Technology Program
   [2018CS11902]; YingDe Science and Technology Board [JHXM2018029];
   Special fund for scientific innovation strategy-construction of high
   level Academy of Agriculture Science [R2019PY-JX004, R2018YJ-YB3002,
   R2016YJYB3003, R2018PY-QF005, R2018QD-101]; Department of Science and
   Technology of Jiangmen [2016350100170008351, 2018110100330005446];
   Department of Education of Guangdong Province [2016KCXTD005,
   2017KSYS010]
FX This study was funded by National Natural Science Foundation of China
   (81803236, 31800295, and 81903319), Guangdong Science and Technology
   program (2017A070702004, 2016B090918118, and 2018KJYZ002), Guangdong
   Basic and Applied Basic Research Foundation (2020A1515011266), QingYuan
   Science and Technology Program (DZXQY021 and DZXQY016), ShaoGuan Science
   and Technology Program (2018CS11902), YingDe Science and Technology
   Board (JHXM2018029), Special fund for scientific innovation
   strategy-construction of high level Academy of Agriculture Science
   (R2019PY-JX004, R2018YJ-YB3002, R2016YJYB3003, R2018PY-QF005, and
   R2018QD-101), Department of Science and Technology of Jiangmen [NO.
   2016350100170008351 and 2018110100330005446], and Department of
   Education of Guangdong Province [NO. 2016KCXTD005 and 2017KSYS010].
CR [Anonymous], INT J INNOV PHARM RE
   Ben Abid Z, 2007, ANN NUTR METAB, V51, P216, DOI 10.1159/000104140
   Bok SH, 1999, J NUTR, V129, P1182, DOI 10.1093/jn/129.6.1182
   Cabrera C, 2003, J AGR FOOD CHEM, V51, P4427, DOI 10.1021/jf0300801
   Cameron AR, 2008, AGING CELL, V7, P69, DOI 10.1111/j.1474-9726.2007.00353.x
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chiba H, 2003, J NUTR, V133, P1892, DOI 10.1093/jn/133.6.1892
   Chowdhury MRH, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/598179
   Dai JY, 2018, P NATL ACAD SCI USA, V115, pE5896, DOI 10.1073/pnas.1801745115
   DiStefano MT, 2016, MOL METAB, V5, P1149, DOI 10.1016/j.molmet.2016.09.009
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Farzanegi P, 2019, EUR J SPORT SCI, V19, P994, DOI 10.1080/17461391.2019.1571114
   Feksa DL, 2018, BIOMED PHARMACOTHER, V98, P338, DOI 10.1016/j.biopha.2017.12.070
   Friedman M, 2009, J FOOD SCI, V74, pH47, DOI 10.1111/j.1750-3841.2008.01033.x
   Fujita T, 2008, J NAT MED, V62, P202, DOI 10.1007/s11418-007-0208-x
   Greyling A, 2018, CLIN NUTR ESPEN, V23, P41, DOI 10.1016/j.clnesp.2017.10.011
   Han HY, 2019, BIOL PHARM BULL, V42, P255, DOI 10.1248/bpb.b18-00702
   Heber D, 2014, J NUTR, V144, P1385, DOI 10.3945/jn.114.191007
   Henning SM, 2018, EUR J NUTR, V57, P2759, DOI 10.1007/s00394-017-1542-8
   Hodgson JM, 2013, AM J CLIN NUTR, V97, P943, DOI 10.3945/ajcn.112.051375
   Hong W, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00582
   Huang JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178110
   Imprialos K, 2018, CURR VASC PHARMACOL, V16, P276, DOI 10.2174/1570161115666170621083744
   Janssens PLHR, 2016, PHYSIOL BEHAV, V162, P83, DOI 10.1016/j.physbeh.2016.01.044
   Jeznach-Steinhagen Anna, 2017, Pol Merkur Lekarski, V43, P281
   Jiang JP, 2019, PHYTOMEDICINE, V64, DOI 10.1016/j.phymed.2019.153082
   Kharjul A, 2012, INT J PHARM SCI RES, V3, P4913, DOI 10.13040/IJPSR.0975-8232.3(12).4913-18
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   KunduSen Sriparna, 2011, Diabetologia Croatica, V40, P113
   Lauridsen BK, 2018, EUR HEART J, V39, P385, DOI 10.1093/eurheartj/ehx662
   Lee MS, 2015, J AGR FOOD CHEM, V63, P7270, DOI 10.1021/acs.jafc.5b01954
   Lee SH, 1999, NUTR RES, V19, P1245, DOI 10.1016/S0271-5317(99)00085-8
   Liu C, 2019, FOOD FUNCT, V10, P2061, DOI 10.1039/c8fo02334d
   Mohammadi M, 2019, PHYTOTHER RES, V33, P534, DOI 10.1002/ptr.6264
   Mulvihill EE, 2016, ANNU REV NUTR, V36, P275, DOI 10.1146/annurev-nutr-071715-050718
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Pan MH, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601104
   Pan SS, 2018, MOL BIOL REP, V45, P689, DOI 10.1007/s11033-018-4205-9
   Papatheodoridi M, 2018, CURR PHARM DESIGN, V24, P4574, DOI 10.2174/1381612825666190117102111
   Park YB, 2001, INT J VITAM NUTR RES, V71, P36, DOI 10.1024/0300-9831.71.1.36
   Rahman SU, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070834
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Sakata R, 2013, INT J MOL MED, V32, P989, DOI 10.3892/ijmm.2013.1503
   Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417
   Siti HN, 2017, BIOMED PHARMACOTHER, V87, P451, DOI 10.1016/j.biopha.2016.12.075
   Stefan N, 2019, LANCET DIABETES ENDO, V7, P313, DOI 10.1016/S2213-8587(18)30154-2
   Tan Y, 2017, WORLD J GASTROENTERO, V23, P3805, DOI 10.3748/wjg.v23.i21.3805
   Tanaka N, 2019, WORLD J GASTROENTERO, V25, P163, DOI 10.3748/wjg.v25.i2.163
   Tomaszewska E, 2015, EXP TOXICOL PATHOL, V67, P331, DOI 10.1016/j.etp.2015.02.005
   TROLL W, 1953, J BIOL CHEM, V200, P803
   Wang CL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02460
   Wang Q, 2013, EXP THER MED, V6, P423, DOI 10.3892/etm.2013.1117
   Wang Yun Wang Yun, 2006, Southwest China Journal of Agricultural Sciences, V19, P1121
   Wu LY, 2017, BIOMED PHARMACOTHER, V93, P316, DOI 10.1016/j.biopha.2017.04.128
   Xia Y, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0502-y
   Xu JY, 2018, FOOD RES INT, V107, P567, DOI 10.1016/j.foodres.2018.01.063
   Xu N, 2018, J AGR FOOD CHEM, V66, P3823, DOI 10.1021/acs.jafc.8b00138
   Y Al-Okbi Sahar, 2018, Pak J Biol Sci, V21, P359, DOI 10.3923/pjbs.2018.359.368
   Yang Y, 2017, J FOOD SCI, V82, P2840, DOI 10.1111/1750-3841.13952
   You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049
   Yuan ED, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020187
   Zhang Y, 2018, FOOD CHEM, V240, P743, DOI 10.1016/j.foodchem.2017.07.103
   Zhou J, 2019, J AGR FOOD CHEM, V67, P5306, DOI 10.1021/acs.jafc.8b05032
NR 63
TC 8
Z9 9
U1 4
U2 56
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD SEP 1
PY 2020
VL 23
IS 9
BP 943
EP 951
DI 10.1089/jmf.2020.4706
EA JUL 2020
PG 9
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition &
   Dietetics
GA NL5QU
UT WOS:000556087000001
PM 32721265
DA 2025-04-28
ER

PT J
AU Gleason, JL
   Sundaram, R
   Mitro, SD
   Hinkle, SN
   Gilman, SE
   Zhang, CL
   Newman, RB
   Hunt, KJ
   Skupski, DW
   Grobman, WA
   Nageotte, M
   Robinson, M
   Kannan, K
   Grantz, KL
AF Gleason, Jessica L.
   Sundaram, Rajeshwari
   Mitro, Susanna D.
   Hinkle, Stefanie N.
   Gilman, Stephen E.
   Zhang, Cuilin
   Newman, Roger B.
   Hunt, Kelly J.
   Skupski, Daniel W.
   Grobman, William A.
   Nageotte, Michael
   Robinson, Morgan
   Kannan, Kurunthachalam
   Grantz, Katherine L.
TI Association of Maternal Caffeine Consumption During Pregnancy With Child
   Growth
SO JAMA NETWORK OPEN
LA English
DT Article
ID BIOELECTRICAL-IMPEDANCE ANALYSIS; BODY-COMPOSITION; SHORT STATURE;
   OBESITY; RISK; PARAXANTHINE
AB IMPORTANCE Greater caffeine consumption in pregnancy is associated with reduced birth size, but potential associations with childhood growth are unclear.
   OBJECTIVE To evaluate the associations of pregnancy caffeine and paraxanthine measures with child growth in a contemporary cohort with low caffeine consumption and a historical cohort with high caffeine consumption.
   DESIGN, SETTING, AND PARTICIPANTS The Environmental Influences on Child Health Outcomes cohort of the National Institute of Child Health and Human Development Fetal Growth Studies (ECHO-FGS; 10 sites, 2009-2013) was a pregnancy cohort with 1 child measurement between ages 4 and 8 years (follow-up in 2017-2019). The Collaborative Perinatal Project (CPP) was a pregnancy cohort (12 sites, 1959-1965) with child follow-up through 8 years (1960-1974). The current secondary analysis was conducted in 2021 and 2022. EXPOSURES Concentrations of caffeine and its primary metabolite, paraxanthine, were quantified from plasma (ECHO-FGS) and serum (CPP) collected in the first trimester. Cut points for analyses were defined by quartiles in ECHO-FGS and quintiles in CPP.
   MAIN OUTCOMES AND MEASURES Child z scores for body mass index, weight, and height were evaluated, as well as fat mass index and percentage and obesity risk measured at 1 time between age 4 and 8 years in ECHO-FGS. In a secondary analysis of the CPP cohort, child z scores and obesity risk longitudinally through age 8 years were evaluated.
   RESULTS In ECHO-FGS (median caffeine intake <50mg/d), 788 children (mean [SD] age, 6.8 [1.0] years; 411 boys [52.2%]) of women in the fourth vs first quartile of plasma caffeine concentrations had lower height z scores (beta = -0.21; 95% CI, -0.41 to -0.02), but differences in weight z scores were only observed in the third quartile (beta = -0.27; 95% CI, -0.47 to -0.07). In CPP, beginning at age 4 years, 1622 children (805 boys [49.7%]) of women in the highest caffeine quintile group had lower height z scores than their peers from the lowest group, with the gap widening with each successive year of age (beta = -0.16 [95% CI, -0.31 to -0.01] at 4 years; beta = -0.37 [95% CI, -0.57 to -0.16] at 8 years). There were slight reductions in weight at ages 5 to 8 years for children in the third vs first caffeine quintile (beta = -0.16 to -0.22). Results were consistent for paraxanthine concentrations in both cohorts.
   CONCLUSIONS AND RELEVANCE Intrauterine exposure to increasing levels of caffeine and paraxanthine, even in low amounts, was associated with shorter stature in early childhood. The clinical implication of reductions in height and weight is unclear; however, the reductions were apparent even with levels of caffeine consumption below clinically recommended guidelines of less than 200mg per day.
C1 [Gleason, Jessica L.; Mitro, Susanna D.; Zhang, Cuilin; Grantz, Katherine L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Populat Hlth Res, Div Intramural Res, Epidemiol Branch, Bethesda, MD 20892 USA.
   [Sundaram, Rajeshwari] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Populat Hlth Res, Div Intramural Res, Biostat & Bioinformat Branch, Bethesda, MD 20892 USA.
   [Hinkle, Stefanie N.] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Gilman, Stephen E.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Populat Hlth Res, Div Intramural Res, Social & Behav Sci Branch, Bethesda, MD 20892 USA.
   [Gilman, Stephen E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA.
   [Zhang, Cuilin] Natl Univ Singapore, Bia Echo Asia Ctr Reprod Longev & Equal, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Singapore, Singapore.
   [Newman, Roger B.] Med Univ South Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA.
   [Hunt, Kelly J.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.
   [Skupski, Daniel W.] Weill Cornell Med, New York, NY USA.
   [Skupski, Daniel W.] New York Presbyterian Queens, New York, NY USA.
   [Grobman, William A.] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA.
   [Nageotte, Michael] Miller Childrens & Womens Hosp, Long Beach, CA USA.
   [Robinson, Morgan; Kannan, Kurunthachalam] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA.
   [Robinson, Morgan; Kannan, Kurunthachalam] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA.
C3 National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver
   National Institute of Child Health & Human Development (NICHD); National
   Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD); University of
   Pennsylvania; National Institutes of Health (NIH) - USA; NIH Eunice
   Kennedy Shriver National Institute of Child Health & Human Development
   (NICHD); Johns Hopkins University; Johns Hopkins Bloomberg School of
   Public Health; National University of Singapore; Medical University of
   South Carolina; Medical University of South Carolina; Cornell
   University; Weill Cornell Medicine; University System of Ohio; Ohio
   State University; New York University; New York University
RP Grantz, KL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Populat Hlth Res, Div Intramural Res, Epidemiol Branch, Bethesda, MD 20892 USA.
EM katherine.grantz@nih.gov
RI zhang, cl/JDW-6549-2023; Hinkle, Stefanie/ABI-8326-2020; Gleason,
   Jessica/AAL-3947-2021; Sundaram, Raman/L-5294-2019; Kannan,
   Kurunthachalam/ACA-0037-2022; Gilman, Stephen E./E-7632-2010
OI Gilman, Stephen E./0000-0002-8331-6419; Zhang,
   Cuilin/0000-0002-8014-2708; Hunt, Kelly/0000-0001-8999-3587
FU Office of the Director, National Institutes of Health [UG3OD023316];
   Federal funds for the National Institute of Child Health and Human
   Development Fetal Growth Studies-Singletons [HHSN275200800013C,
   HHSN275200800002I, HHSN27500006, HHSN275200800003IC, HHSN275200800014C,
   HHSN275200800012C, HHSN275200800028C, HHSN275201000009C]
FX This researchwas supported, in part, by the Office of the Director,
   National Institutes of Health, under award number UG3OD023316; and, in
   part, with Federal funds for the National Institute of Child Health and
   Human Development Fetal Growth Studies-Singletons (contract numbers
   HHSN275200800013C, HHSN275200800002I, HHSN27500006, HHSN275200800003IC,
   HHSN275200800014C, HHSN275200800012C, HHSN275200800028C, and
   HHSN275201000009C). Drs Gleason, Sundaram, Gilman, and Grantz have
   contributed to thiswork as part of their official duties as employees of
   the US federal government.
CR [Anonymous], 2010, Obstet Gynecol, V116, P467, DOI 10.1097/AOG.0b013e3181eeb2a1
   Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428
   Bosy-Westphal A, 2009, BRIT J NUTR, V102, P453, DOI 10.1017/S0007114508190304
   Brite J, 2014, DIABETIC MED, V31, P332, DOI 10.1111/dme.12355
   Catalano P, 2018, DIABETOLOGIA, V61, P2507, DOI 10.1007/s00125-018-4749-1
   Chen LW, 2018, AM J CLIN NUTR, V108, P1301, DOI 10.1093/ajcn/nqy219
   Chen LW, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0174-6
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   Gillman MW, 2018, CURR OPIN PEDIATR, V30, P260, DOI 10.1097/MOP.0000000000000600
   Gleason JL, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.3238
   Grewal J, 2018, INT J EPIDEMIOL, V47, P25, DOI 10.1093/ije/dyx161
   Hoyt AT, 2014, MATERN CHILD HLTH J, V18, P1540, DOI 10.1007/s10995-013-1397-4
   Jin F, 2021, INT J OBESITY, V45, P279, DOI 10.1038/s41366-020-0617-4
   Klebanoff MA, 1999, NEW ENGL J MED, V341, P1639, DOI 10.1056/NEJM199911253412202
   Klebanoff MA, 1998, ANN EPIDEMIOL, V8, P107, DOI 10.1016/S1047-2797(97)00125-7
   Knutti R, 1982, Arch Toxicol Suppl, V5, P187
   Kuczmarski RJ, 2000, VITAL HLTH STAT, P1, DOI [DOI 10.1016/J.BBRC.2015.06.114, DOI 10.1590/S1516-35982002000600018]
   Li DK, 2015, INT J OBESITY, V39, P658, DOI 10.1038/ijo.2014.196
   Martinez-Mesa Jeovany, 2012, J Adolesc Health, V51, pS53, DOI 10.1016/j.jadohealth.2012.08.014
   Matijasevich A, 2011, ARCH DIS CHILD, V96, P519, DOI 10.1136/adc.2010.191098
   Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1
   MYRIANTHOPOULOS NC, 1968, SOC SCI MED, V2, P283, DOI 10.1016/0037-7856(68)90004-8
   Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155
   Papadopoulou E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018895
   PEARSON S, 1984, ANN CLIN BIOCHEM, V21, P208, DOI 10.1177/000456328402100307
   Pollack AZ, 2010, FERTIL STERIL, V93, P304, DOI 10.1016/j.fertnstert.2009.07.992
   Reynolds RM, 2010, J STEROID BIOCHEM, V122, P3, DOI 10.1016/j.jsbmb.2010.01.009
   Rhee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132334
   Schliep KC, 2013, AM J EPIDEMIOL, V177, P690, DOI 10.1093/aje/kws283
   Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331
   Talma H, 2013, OBES REV, V14, P895, DOI 10.1111/obr.12061
   Voerman E, 2020, PEDIATR OBES, V15, DOI 10.1111/ijpo.12607
   Voerman E, 2016, OBESITY, V24, P1170, DOI 10.1002/oby.21466
   Yu T, 2016, J CLIN PHARMACOL, V56, P590, DOI 10.1002/jcph.632
   Zhang C, 2014, TOXICOLOGY, V325, P74, DOI 10.1016/j.tox.2014.08.015
NR 35
TC 12
Z9 12
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD OCT 31
PY 2022
VL 5
IS 10
AR e2239609
DI 10.1001/jamanetworkopen.2022.39609
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 5X7FL
UT WOS:000878764900011
PM 36315142
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Huang, YW
   Liu, Y
   Dushenkov, S
   Ho, CT
   Huang, MT
AF Huang, Yu-Wen
   Liu, Yue
   Dushenkov, Slauik
   Ho, Chi-Tang
   Huang, Mou-Tuan
TI Anti-obesity effects of epigallocatechin-3-gallate, orange peel extract,
   black tea extract, caffeine and their combinations in a mouse model
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Review
DE Anti-obesity, Caffeine; Orange peel extract; Epigallocatechin gallate;
   Black tea extract
ID DIET-INDUCED OBESITY; GREEN TEA; CATECHIN-POLYPHENOLS; ADIPOSE-TISSUE;
   FAT OXIDATION; FOOD-INTAKE; HEALTH; GALLATE; RATS; MICE
AB The anti-obesity effects of epigallocatechin-3-gallate (EGCG), orange peel extract (OPE), black tea extract (BTE), and caffeine (CF) in female CF-1 mice were studied. Female CF-1 mice were fed high-fat diets containing 0.1% EGCG, 0.2% OPE, 0.2% BTE and 0.05% caffeine alone and in combination for 10 weeks. The body weight gain and weights of abdominal fat and brown adipose tissue were significantly reduced in mice whose diets contained OPE, BTE, caffeine, OPE + BTE and OPE + CF. Notably, mice fed a high-fat diet supplemented daily with 0.2% OPE + 0.2% BTE + 0.05% CF prevented body weight gain by 48.8%, parametrial fat pad weight by 88.2%, retroperitoneal fat pad weight by 82.8% and brown adipose tissue by 63.7% compared with mice fed a high-fat diet. On the basis of these findings, it was concluded that oral feeding of orange peel extract, black tea extract and caffeine had anti-obesity effects by suppressing body weight gain and adipose tissue formation. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Huang, Yu-Wen; Liu, Yue; Huang, Mou-Tuan] Rutgers State Univ, Sch Pharm, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Piscataway, NJ 08854 USA.
   [Dushenkov, Slauik] Rutgers State Univ, New Brunswick, NJ 08901 USA.
   [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Rutgers
   University System; Rutgers University New Brunswick; Rutgers University
   System; Rutgers University New Brunswick
RP Huang, MT (corresponding author), Rutgers State Univ, Sch Pharm, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Piscataway, NJ 08854 USA.
EM mthuang@rci.rutgers.edu
RI Huang, Evelyn/MBG-1811-2025; Ho, Chi-Tang/B-5629-2012
OI Dushenkov, Vyacheslav/0000-0001-5176-7461
CR [Anonymous], BIOSCI BIOTECHNOL BI
   Bays Harold, 2006, Expert Rev Cardiovasc Ther, V4, P871
   Cheng TO, 2006, INT J CARDIOL, V108, P301, DOI 10.1016/j.ijcard.2005.05.038
   DULLOO AG, 1993, INT J OBESITY, V17, pS35
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Kao Y, 2000, AM J CLIN NUTR, V72, P1232
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Lai CS, 2007, CARCINOGENESIS, V28, P2581, DOI 10.1093/carcin/bgm231
   Li SM, 2009, J FUNCT FOODS, V1, P2, DOI 10.1016/j.jff.2008.09.003
   LIN JK, 2009, TEA TEA PRODUCTS CHE
   Mazzucotelli Anne, 2006, Journal de la Societe de Biologie, V200, P83, DOI 10.1051/jbio:2006011
   Middleton E, 2000, PHARMACOL REV, V52, P673
   MURAMATSU K, 1986, J NUTR SCI VITAMINOL, V32, P613, DOI 10.3177/jnsv.32.613
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   RACOTTA IS, 1994, PHARMACOL BIOCHEM BE, V48, P887, DOI 10.1016/0091-3057(94)90196-1
   Reeves AF, 2006, ARCH PEDIAT ADOL MED, V160, P894, DOI 10.1001/archpedi.160.9.894
   Siddiqui IA, 2004, ANTIOXID REDOX SIGN, V6, P571, DOI 10.1089/152308604773934323
   TREMBLAY A, 1988, NUTR RES, V8, P553, DOI 10.1016/S0271-5317(88)80077-0
   Vinson JA, 1998, FEBS LETT, V433, P44, DOI 10.1016/S0014-5793(98)00880-1
   Whitman SC, 2005, ATHEROSCLEROSIS, V178, P25, DOI 10.1016/j.atherosclerosis.2004.07.034
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038
   Yang CS, 1999, NUTRITION, V15, P946
   Yang MH, 2001, J NUTR BIOCHEM, V12, P14, DOI 10.1016/S0955-2863(00)00140-6
   Yang TTC, 1997, PHARMACOL RES, V35, P505, DOI 10.1006/phrs.1997.0176
   Zheng GD, 2004, IN VIVO, V18, P55
NR 30
TC 58
Z9 64
U1 2
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JUL
PY 2009
VL 1
IS 3
BP 304
EP 310
DI 10.1016/j.jff.2009.06.002
PG 7
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 684OU
UT WOS:000284560000009
DA 2025-04-28
ER

PT J
AU Hursel, R
   Viechtbauer, W
   Westerterp-Plantenga, MS
AF Hursel, R.
   Viechtbauer, W.
   Westerterp-Plantenga, M. S.
TI The effects of green tea on weight loss and weight maintenance: a
   meta-analysis
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Review
DE green tea; caffeine; weight loss; weight maintenance; ethnicity
ID CATECHOL-O-METHYLTRANSFERASE; ENERGY-EXPENDITURE; BLACK TEA; FAT
   OXIDATION; CAFFEINE; EXTRACT; CONSUMPTION; HUMANS; TRIAL; MODEL
AB Introduction. Different outcomes of the effect of green tea on weight loss (WL) and weight maintenance (WM) have been reported in studies with subjects differing in ethnicity and habitual caffeine intake.
   Purpose. To elucidate by meta-analysis whether green tea indeed has a function in body weight regulation.
   Methods. English-language studies about WL and WM after green tea supplementation were identified through PubMed and based on the references from retrieved articles. Out of the 49 studies initially identified, a total of 11 articles fitted the inclusion criteria and provided useful information for the meta-analysis. Effect sizes (mean weight change in treatment versus control group) were computed and aggregated based on a random-effects model. The influence of several moderators on the effect sizes was examined.
   Results. Catechins significantly decreased body weight and significantly maintained body weight after a period of WL ((mu) over cap = -1.31 kg; P < 0.001). Inhibition of this effect by high habitual caffeine intake (> 300 mg per day) failed to reach significance ((mu) over cap = -0.27 kg for high and (mu) over cap = -1.60 kg for low habitual caffeine intake; P = 0.09). Also, the seemingly smaller effect of catechins in Caucasian ((mu) over cap = -0.82 kg) subjects compared with Asians ((mu) over cap = -1.51 kg; P = 0.37) did not reach significance. Interaction of ethnicity and caffeine intake was a significant moderator (P = 0.04).
   Conclusions. Catechins or an epigallocatechin gallate (EGCG)-caffeine mixture have a small positive effect on WL and WM. The results suggest that habitual caffeine intake and ethnicity may be moderators, as they may influence the effect of catechins. International Journal of Obesity (2009) 33, 956-961; doi: 10.1038/ijo.2009.135; published online 14 July 2009
C1 [Hursel, R.; Westerterp-Plantenga, M. S.] Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht NUTRIM, NL-6200 MD Maastricht, Netherlands.
   [Viechtbauer, W.] Maastricht Univ, Dept Methodol & Stat, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University; Maastricht University
RP Hursel, R (corresponding author), Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht NUTRIM, Univ Singel 50,POB 616, NL-6200 MD Maastricht, Netherlands.
EM rick.hursel@hb.unimaas.nl
RI Viechtbauer, Wolfgang/M-1549-2013
OI Viechtbauer, Wolfgang/0000-0003-3463-4063
CR [Anonymous], PROGR MED
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Cornelis MC, 2007, AM J CLIN NUTR, V86, P240, DOI 10.1093/ajcn/86.1.240
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Grigg D., 2002, GeoJournal, V57, P283, DOI 10.1023/B:GEJO.0000007249.91153.c3
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Hodgson JM, 2006, BRIT J NUTR, V95, P14, DOI 10.1079/BJN20051621
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Krul C, 2001, MUTAT RES-FUND MOL M, V474, P71, DOI 10.1016/S0027-5107(00)00158-5
   Langley-Evans SC, 2000, INT J FOOD SCI NUTR, V51, P181, DOI 10.1080/09637480050029683
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Serafini M, 1996, EUR J CLIN NUTR, V50, P28
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261
   WANG M, 2009, EUR J CLIN NUT UNPUB
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
NR 25
TC 223
Z9 246
U1 2
U2 103
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
J9 INT J OBESITY
JI Int. J. Obes.
PD SEP
PY 2009
VL 33
IS 9
BP 956
EP 961
DI 10.1038/ijo.2009.135
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 500BT
UT WOS:000270272800002
PM 19597519
DA 2025-04-28
ER

PT J
AU Júdice, PB
   Magalhaes, JP
   Santos, DA
   Matias, CN
   Carita, AI
   Armada-Da-Silva, PAS
   Sardinha, LB
   Silva, AM
AF Judice, Pedro B.
   Magalhaes, Joao P.
   Santos, Diana A.
   Matias, Catarina N.
   Carita, Ana Isabel
   Armada-Da-Silva, Paulo A. S.
   Sardinha, Luis B.
   Silva, Analiza M.
TI A moderate dose of caffeine ingestion does not change energy expenditure
   but decreases sleep time in physically active males: a double-blind
   randomized controlled trial
SO APPLIED PHYSIOLOGY NUTRITION AND METABOLISM
LA English
DT Article
DE caffeine; energy expenditure; physical activity; total sleep time;
   accelerometry; free-living conditions; body composition
ID FAT OXIDATION; HEART-RATE; GREEN TEA; DURATION; OBESITY; ASSOCIATION;
   CALIBRATION; METABOLISM; BALANCE; MODEL
AB Research on the effect of caffeine on energy expenditure (EE), physical activity (PA), and total sleep time (TST) during free-living conditions using objective measures is scarce. We aimed to determine the impact of a moderate dose of caffeine on TST, resting EE (REE), physical activity EE (PAEE), total EE (TEE), and daily time spent in sedentary, light, moderate, and vigorous intensity activities in a 4-day period and the acute effects on heart rate (HR) and EE in physically active males. Using a double-blind crossover trial (ClinicalTrials.gov ID: NCT01477294) with two conditions (4 days each with 3-day washout) randomly ordered as caffeine (5 mg/kg of body mass/day) and placebo (maltodextrin) administered twice per day (2.5 mg/kg), 30 nonsmoker males, low-caffeine users (<100 wmg/day), aged 20-39, were followed. Body composition was assessed by dual-energy X-ray absorptiometry. PA was assessed by accelerometry, while a combined HR and movement sensor estimated EE and HR on the second hour after the first administration dose. REE was assessed by indirect calorimetry, and PAEE was calculated as [TEE - (REE + 0.1TEE)]. TST and daily food records were obtained. Repeated measures ANOVA and ANCOVA were used. After a 4-day period, adjusting for fat-free mass, PAEE, and REE, TST was reduced (p = 0.022) under caffeine intake, while no differences were found between conditions for REE, PAEE, TEE, and PA patterns. Also, no acute effects on HR and EE were found between conditions. Though a large individual variability was observed, our findings revealed no acute or long-term effects of caffeine on EE and PA but decreased TST during free-living conditions in healthy males.
C1 [Judice, Pedro B.; Magalhaes, Joao P.; Santos, Diana A.; Matias, Catarina N.; Sardinha, Luis B.; Silva, Analiza M.] Univ Tecn Lisboa, Fac Motricidade Humana, CIPER, Exercise & Hlth Lab, P-1499002 Cruz Quebrada, Portugal.
   [Carita, Ana Isabel] Univ Tecn Lisboa, Fac Motricidade Humana, BIOLAD CIPER, Math Methods Lab, P-1499002 Cruz Quebrada, Portugal.
   [Armada-Da-Silva, Paulo A. S.] Univ Tecn Lisboa, Fac Motricidade Humana, CIPER, P-1499002 Cruz Quebrada, Portugal.
C3 Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa
RP Silva, AM (corresponding author), Univ Tecn Lisboa, Fac Motricidade Humana, CIPER, Exercise & Hlth Lab, P-1499002 Cruz Quebrada, Portugal.
EM analiza@fmh.utl.pt
RI Matias, Catarina/I-7957-2014; Magalhães, João/ABH-2119-2021; Sardinha,
   Luís/F-2641-2013; Armada-da-Silva, Paulo/L-5675-2013; Carita, Ana
   Isabel/N-2525-2013; Silva, Analiza/C-9858-2010; Santos,
   Diana/H-9086-2013
OI Sardinha, Luis/0000-0002-6230-6027; Armada-da-Silva,
   Paulo/0000-0002-3814-6879; Magalhaes, Joao/0000-0003-1073-8650; Carita,
   Ana Isabel/0000-0003-0472-7541; Silva, Analiza/0000-0002-8984-8600;
   Judice, Pedro/0000-0003-2791-258X; Santos, Diana/0000-0003-0429-3093
FU Hydration and Health Portuguese Institute
FX We express our gratitude to the participants for their time and effort.
   This work was supported by the Hydration and Health Portuguese
   Institute.
CR Adamec O, 2010, IEEE ENG MED BIO, P2342, DOI 10.1109/IEMBS.2010.5627774
   ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   Armstrong LE, 2005, INT J SPORT NUTR EXE, V15, P252, DOI 10.1123/ijsnem.15.3.252
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bland M., 1995, INTRO MED STAT, V2nd
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006
   Butte NE, 2010, J NUTR, V140, P1516, DOI 10.3945/jn.109.120162
   Calamaro CJ, 2009, PEDIATRICS, V123, pE1005, DOI 10.1542/peds.2008-3641
   Carrier J, 2007, NEUROPSYCHOPHARMACOL, V32, P964, DOI 10.1038/sj.npp.1301198
   Carrier J, 2009, SLEEP MED, V10, P1016, DOI 10.1016/j.sleep.2009.01.001
   COLLINS LC, 1994, INT J OBESITY, V18, P551
   Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009
   CURRIE SR, 1995, CLIN J PAIN, V11, P214
   Drapeau C, 2006, J SLEEP RES, V15, P133, DOI 10.1111/j.1365-2869.2006.00518.x
   Drescher AA, 2011, J CLIN SLEEP MED, V7, P337, DOI 10.5664/JCSM.1182
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021
   Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289
   Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Hamada T, 2008, TOHOKU J EXP MED, V214, P365, DOI 10.1620/tjem.214.365
   HILLS M, 1979, BRIT J CLIN PHARMACO, V8, P7, DOI 10.1111/j.1365-2125.1979.tb05903.x
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   James JE, 1998, NEUROPSYCHOBIOLOGY, V38, P32, DOI 10.1159/000026514
   Kawada T, 2012, INT J BEHAV MED, V19, P398, DOI 10.1007/s12529-011-9180-7
   KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854
   Landhuis CE, 2008, PEDIATRICS, V122, P955, DOI 10.1542/peds.2007-3521
   Lohman TG, 1988, Anthropometric standardization reference manual
   Maughan RJ, 2003, J HUM NUTR DIET, V16, P411, DOI 10.1046/j.1365-277X.2003.00477.x
   Paterson LM, 2009, J PSYCHOPHARMACOL, V23, P475, DOI 10.1177/0269881109104846
   PERKINS KA, 1994, AM J CLIN NUTR, V60, P312, DOI 10.1093/ajcn/60.3.312
   Porkka-Heiskanen Tarja, 2011, Handb Exp Pharmacol, P331, DOI 10.1007/978-3-642-13443-2_12
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   SENN S, 1993, STAT MED, V12, P2147, DOI 10.1002/sim.4780122208
   Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003
   Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23
   Troiano RP, 2005, MED SCI SPORT EXER, V37, pS487, DOI 10.1249/01.mss.0000185473.32846.c3
   Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98
   Vukovich MD, 2005, CLIN EXP PHARMACOL P, V32, P47, DOI 10.1111/j.1440-1681.2005.04152.x
   Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   World Medical Association, 2013, Ethical Principles for Medical Research Involving Human Subjects, DOI DOI 10.1515/9783110208856.233
NR 46
TC 9
Z9 14
U1 2
U2 51
PU CANADIAN SCIENCE PUBLISHING
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 1715-5312
EI 1715-5320
J9 APPL PHYSIOL NUTR ME
JI Appl. Physiol. Nutr. Metab.
PD JAN
PY 2013
VL 38
IS 1
BP 49
EP 56
DI 10.1139/apnm-2012-0145
PG 8
WC Nutrition & Dietetics; Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Physiology; Sport Sciences
GA 081XH
UT WOS:000314355200009
PM 23368828
DA 2025-04-28
ER

PT J
AU Wanjohi, MN
   Kimani-Murage, EW
   Asiki, G
   Holdsworth, M
   Pradeilles, R
   Langat, N
   Amugsi, DA
   Wilunda, C
   Klipstein-Grobusch, K
AF Wanjohi, Milkah N.
   Kimani-Murage, Elizabeth Wambui
   Asiki, Gershim
   Holdsworth, Michelle
   Pradeilles, Rebecca
   Langat, Nelson
   Amugsi, Dickson A.
   Wilunda, Calistus
   Klipstein-Grobusch, Kerstin
TI Adolescents' dietary patterns, their drivers and association with double
   burden of malnutrition in adolescents: a cross-sectional study in
   Kenya's urban slums
SO JOURNAL OF HEALTH POPULATION AND NUTRITION
LA English
DT Article
DE Dietary patterns; Adolescents; Double burden of malnutrition;
   Overweight/obesity; Nutrition transition; Undernutrition; Urban; Slums;
   Kenya
ID NUTRITION TRANSITION; FOOD; OBESITY
AB Background The double burden of malnutrition (DBM) during adolescence is associated with growth and developmental impairment and risk of non-communicable diseases. There is limited evidence on adolescent's dietary patterns (DPs), and how they contribute to DBM in urban low income contexts in sub Saharan Africa. This study assessed DPs of adolescents, their drivers and association with DBM in Kenya's urban slums. Methods Anthropometric, socio-demographic and dietary-intake data were collected through a cross-sectional survey of 621 adolescents from three major urban slums in Nairobi, Kenya. DPs were derived using principal component analysis. Multinomial-logistic-regression was used to assess the association between the DPs, individual and environmental factors and DBM. Results Two DPs were identified: traditional DP (whole grains/cereals, rice, fruits, legumes/nuts, and water) and transitioning DP (refined cereals (maize/wheat), vegetables, meat, tea/coffee, sweet ultra-processed/deep fried snacks). Adolescents from Mathare (the largest slum) were more likely to adhere to the traditional DP (RRR = 3.43; 95% CI 1.85-6.37). Cultural background (Luo) had a positive association (RRR = 4.28; 95% CI 1.97-9.32), while longer residency in the slum (> 10 years) had a negative association (RRR = 0.47; 95% CI 0.25-0.90) with transitioning DP. The transitioning DP had a positive (non-linear) association with overweight/obesity in girls (RRR = 2.79; 95% CI 1.16-6.71). The DPs were not associated with thinness or stunting. Conclusion The DPs indicate various stages of nutrition transition of adolescent diets, which are influenced by cultural background, neighbourhood and duration of stay in the slum. Transitioning DP may expose adolescents to the risks of overweight/obesity in the long-term.
C1 [Wanjohi, Milkah N.; Kimani-Murage, Elizabeth Wambui; Langat, Nelson; Amugsi, Dickson A.; Wilunda, Calistus] African Populat & Hlth Res Ctr, Nutr & Food Syst Unit, Nairobi 1098700100, Kenya.
   [Asiki, Gershim] African Populat & Hlth Res Ctr, Chron Dis Management Unit, Nairobi 1098700100, Kenya.
   [Holdsworth, Michelle; Pradeilles, Rebecca] Univ Montpellier, Inst Agro, UMR MoISA Montpellier Interdisciplinary Ctr Sustai, CIRAD,CIHEAM IAMM,INRAE,IRD, F-34394 Montpellier, France.
   [Wanjohi, Milkah N.; Klipstein-Grobusch, Kerstin] Univ Utrecht, Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth,Dept Global Publ Hlth & Bioeth, Univ Weg 100, NL-3584 CX Utrecht, Netherlands.
   [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, 27 St Andrews Rd, ZA-2193 Johannesburg, South Africa.
C3 African Population & Health Research Centre; African Population & Health
   Research Centre; Institut de Recherche pour le Developpement (IRD);
   INRAE; CIRAD; Universite de Montpellier; Institut Agro; CIHEAM; CIHEAM
   IAM Montpellier; Utrecht University; Utrecht University Medical Center;
   University of Witwatersrand
RP Wanjohi, MN (corresponding author), African Populat & Hlth Res Ctr, Nutr & Food Syst Unit, Nairobi 1098700100, Kenya.; Wanjohi, MN (corresponding author), Univ Utrecht, Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth,Dept Global Publ Hlth & Bioeth, Univ Weg 100, NL-3584 CX Utrecht, Netherlands.
EM mwanjohi@aphrc.org
RI Klipstein-Grobusch, Kerstin/F-5555-2016; Amugsi, Dickson/AAG-3004-2020;
   Pradeilles, Rebecca/HNI-3544-2023; Kimani-Murage,
   Elizabeth/HGB-3312-2022
OI Amugsi, Dr DICKSON A./0000-0002-5261-8481; Wilunda,
   Calistus/0000-0002-6606-6534
FU Global Health Support Program, Utrecht University
FX Authors acknowledge the Health Food Africa (HFA) project team, field
   assistants, study participants, and community health promoters from the
   study area for their contribution to the research.
CR African Population and Health Research Center and United States Agency for International Development, 2019, Urban Health Assessment: Nutrition and Water Sanitation and Hygiene (WASH) Challenges Facing Children and Adolescents in Urban Slums in Nairobi
   Anono E., Photographic Food Atlas for Kenyan Adolescents (9-14 Years)
   [Anonymous], 2015, Public Health, V5, P8, DOI DOI 10.1007/S11605-008-0794-2
   [Anonymous], 2020, The Report of the WHO-China Joint Mission for Coronavirus Disease 2019 (COVID-19), P1
   [Anonymous], 2007, Growth reference data for 5-19 years
   [Anonymous], 2014, Thesis
   [Anonymous], 2019, Why invest in adolescents?
   [Anonymous], 2018, Kenya National Guidelines for Cardiovascular Diseases Management, P1
   Auma CI, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00634-9
   Banna JC, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00045
   Boateng D, 2019, J NUTR, V149, P755, DOI 10.1093/jn/nxz002
   Camara I, 2020, Exploring influences on adolescent diet and physical activity in rural Gambia, Food insecurity, culture and the natural environment
   Darling AM, 2020, TROP MED INT HEALTH, V25, P33, DOI 10.1111/tmi.13330
   Downs SM., 2022, Kenya Nutrients, V14, P1
   Emina J, 2011, J URBAN HEALTH, V88, P200, DOI 10.1007/s11524-011-9594-1
   FAO/Government of Kenya, 2018, Kenyan Food Recipe: A recipe book of common mixed dishes with nutrient value Internet
   FAO/Government of Kenya, 2018, Kenya Food Composition Tables
   Green MA, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035680
   Hansen AW, 2011, PUBLIC HEALTH NUTR, V14, P1671, DOI 10.1017/S1368980010003782
   Harika R, 2017, FOOD NUTR BULL, V38, P405, DOI 10.1177/0379572117715818
   HealthyFoodAfrica, 2024, Healthy Food Africa Project Internet
   Holdsworth M, 2020, GLOB FOOD SECUR-AGR, V26, DOI 10.1016/j.gfs.2020.100452
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Islam MR, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122916
   Kanerva N, 2023, J NUTR EDUC BEHAV, V55, P322, DOI 10.1016/j.jneb.2023.02.001
   Kigaru D. M. D., 2015, BMC NUTR, V1, P1, DOI [10.1186/s40795-015-0040-8, DOI 10.1186/S40795-015-0040-8]
   KNBS and ICF, 2023, Kenya demographic and health survey 2022: key indicators report
   Larson N, 2015, EAT BEHAV, V16, P43, DOI 10.1016/j.eatbeh.2014.10.010
   Madzorera I, 2023, MATERN CHILD NUTR, DOI 10.1111/mcn.13463
   Man CS, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103431
   MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101
   Ministry of Education Ministry of Health Ministry of Agriculture L and F, 2017, NATIONAL SCHOOL MEALS AND NUTRITION STRATEGY(2017-2022), P64
   Mwanri L, 2023, Double burden of malnutrition: a population level comparative cross-sectional study across three sub-Saharan African countriesMalawi
   Nel JH, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph192416791
   NHANES, 2007, Natl Heal Nutr Exam Surv, V3, P3
   Ochola S, 2014, ANN NUTR METAB, V64, P24, DOI 10.1159/000365125
   Osei-Kwasi H, 2020, PUBLIC HEALTH NUTR, V23, P2584, DOI 10.1017/S1368980019005305
   Peltzer K, 2010, INT J PUBLIC HEALTH, V55, P669, DOI 10.1007/s00038-010-0194-8
   Peters R, 2018, P NUTR SOC, V77, pE189, DOI 10.1017/S0029665118001957
   Peters R, 2019, PUBLIC HEALTH NUTR, V22, P3200, DOI 10.1017/S1368980019001204
   Popkin BM, 2022, OBES REV, V23, DOI 10.1111/obr.13366
   Popkin BM, 2020, LANCET, V395, P65, DOI 10.1016/S0140-6736(19)32497-3
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Rapando C, 2017, Int J Sci Res Publ, V7, P1
   Reardon T, 2021, GLOB FOOD SECUR-AGR, V28, DOI 10.1016/j.gfs.2020.100466
   Roberts K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020177
   Rutstein SO, 2015, Steps to Constructing the New DHS Wealth Index
   Smith ADAC, 2013, BRIT J NUTR, V109, P1881, DOI 10.1017/S0007114512003868
   Steinfeldt L, 2013, PROC FOOD SCI, V2, P145, DOI 10.1016/j.profoo.2013.04.022
   Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9
   Thurstans S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-004030
   Tucker KL, 2010, APPL PHYSIOL NUTR ME, V35, P211, DOI 10.1139/H10-010
   Turner C, 2018, GLOB FOOD SECUR-AGR, V18, P93, DOI 10.1016/j.gfs.2018.08.003
   UN-Habitat, 2016, Particip Slum Upgrad Program Internet
   UN-HABITAT, 2023, Urbanisation in Kenya Internet
   Wachira LJ, 2021, CHILD ADOLESCENT OBE, V4, P1, DOI [10.1080/2574254X.2020.1842014, DOI 10.1080/2574254X.2020.1842014]
   Wamukoya M, 2020, Glob Epidemiol
   Wells JC, 2020, LANCET, V395, P75, DOI 10.1016/S0140-6736(19)32472-9
   World Bank, 2023, Population living in slums (% of urban population): Kenya Internet
   World bank, 2023, Urban Development Internet
   World Bank Group, 2024, Population living in slums (% of urban population)-Sub-saharan Africa Internet
   Wrottesley SV, 2023, PUBLIC HEALTH NUTR, V26, P63, DOI 10.1017/S1368980022000350
   Wrottesley SV, 2020, S AFR J CLIN NUTR, V33, P94, DOI 10.1080/16070658.2019.1607481
NR 63
TC 0
Z9 0
U1 3
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1606-0997
EI 2072-1315
J9 J HEALTH POPUL NUTR
JI J. Heatlh Popul. Nutr.
PD NOV 6
PY 2024
VL 43
IS 1
AR 181
DI 10.1186/s41043-024-00664-7
PG 14
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA L3E1A
UT WOS:001349574500001
PM 39506880
OA gold
DA 2025-04-28
ER

PT J
AU Cao, QW
   Mei, SH
   Mehmood, A
   Sun, Y
   Chen, XM
AF Cao, Qingwei
   Mei, Suhuan
   Mehmood, Arshad
   Sun, Yu
   Chen, Xiumin
TI Inhibition of pancreatic lipase by coffee leaves-derived polyphenols: A
   mechanistic study
SO FOOD CHEMISTRY
LA English
DT Article
DE Pancreatic lipase; Inhibition kinetics; Spectroscopy; Obesity; Coffee
   leaves; Molecular docking; Chemometrics
ID IN-VITRO; ANTIOXIDANT; NOBILETIN; EXTRACTS; KINETICS; ACID
AB The suppression of pancreatic lipase has been employed to mitigate obesity. This study explored the mechanism of coffee leaf extracts to inhibit pancreatic lipase. The ethyl acetate fraction derived from coffee leaves (EAC) exhibited the highest inhibitory capacity with a half-maximal inhibitory concentration (IC50) of 0.469 mg/mL and an inhibitor constant (Ki) of 0.185 mg/mL. This fraction was enriched with 3,5-dicaffeoylquinic acid (3,5diCQA, 146.50 mg/g), epicatechin (87.51 mg/g), and isoquercetin (48.29 mg/g). EAC inhibited lipase in a reversible and competitive manner, and quenched its intrinsic fluorescence through a static mechanism. Molecular docking revealed that bioactive compounds in EAC bind to key amino acid residues (HIS-263, PHE-77, and SER-152) located within the active cavity of lipase. Catechin derivatives play a key role in the lipase inhibitory activity within EAC. Overall, our findings highlight the promising potential of coffee leaf extract as a functional ingredient for alleviating obesity through inhibition of lipase.
C1 [Cao, Qingwei; Mei, Suhuan; Mehmood, Arshad; Sun, Yu; Chen, Xiumin] Jiangsu Univ, Sch Food & Biol Engn, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China.
   [Mehmood, Arshad; Chen, Xiumin] Jiangsu Univ, Inst Food Phys Proc, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China.
   [Chen, Xiumin] Jiangsu Univ, Int Joint Res Lab Intelligent Agr & Agriprod Proc, Zhenjiang 212013, Peoples R China.
C3 Jiangsu University; Jiangsu University; Jiangsu University
RP Chen, XM (corresponding author), Jiangsu Univ, Sch Food & Biol Engn, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China.; Chen, XM (corresponding author), Jiangsu Univ, Inst Food Phys Proc, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China.; Chen, XM (corresponding author), Jiangsu Univ, Int Joint Res Lab Intelligent Agr & Agriprod Proc, Zhenjiang 212013, Peoples R China.
EM 1286833531@qq.com; xmchen@ujs.edu.cn
RI Qureshi, Arshad/AAG-6954-2019; Chen, Xiumin/R-2596-2018; Mei,
   Suhuan/LQK-1443-2024
OI Mei, Suhuan/0000-0003-4425-7003
FU Jiangsu Specially-Appointed Professor Program [19TPJS-002]
FX <B>Funding</B> This study was supported by Jiangsu Specially-Appointed
   Professor Program (19TPJS-002) to X. Chen. Institutional Review Board
   Statement: Not applicable. Informed Consent Statement: Not applicable.
   Data Availability Statement: The datasets used and analyzed in this
   study are available from the corresponding author (xmchen@ujs.edu. cn)
   upon reasonable request.
CR Belfeki H, 2016, IND CROP PROD, V89, P514, DOI 10.1016/j.indcrop.2016.06.002
   Cao QJ, 2020, FOOD CHEM, V333, DOI 10.1016/j.foodchem.2020.127528
   Cardel MI, 2022, J ACAD NUTR DIET, V122, P1089, DOI 10.1016/j.jand.2022.01.004
   Chen JH, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13837
   Chen XM, 2018, FOOD CHEM, V249, P143, DOI 10.1016/j.foodchem.2017.12.073
   Chen XM, 2019, CRIT REV FOOD SCI, V59, P1008, DOI 10.1080/10408398.2018.1546667
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Dan QY, 2019, FOOD RES INT, V120, P255, DOI 10.1016/j.foodres.2019.01.003
   Ding Y, 2019, MAR DRUGS, V17, DOI 10.3390/md17110637
   Du XP, 2018, J FUNCT FOODS, V48, P551, DOI 10.1016/j.jff.2018.07.045
   Gaur P, 2023, IND CROP PROD, V197, DOI 10.1016/j.indcrop.2023.116623
   Gonçalves R, 2010, J AGR FOOD CHEM, V58, P11901, DOI 10.1021/jf103026x
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Hu JF, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.1010005
   Huang X, 2020, INT J BIOL MACROMOL, V164, P1927, DOI 10.1016/j.ijbiomac.2020.07.305
   Imai M, 2020, LWT-FOOD SCI TECHNOL, V129, DOI 10.1016/j.lwt.2020.109544
   Jebeile H, 2022, LANCET DIABETES ENDO, V10, P351, DOI 10.1016/S2213-8587(22)00047-X
   Jin TR, 2018, AM J PHYSIOL-ENDOC M, V314, pE201, DOI 10.1152/ajpendo.00285.2017
   Jo YH, 2019, BIOORG CHEM, V92, DOI 10.1016/j.bioorg.2019.103234
   Li J, 2017, OBES REV, V18, P1260, DOI 10.1111/obr.12590
   Li Q, 2022, J FOOD BIOCHEM, V46, DOI 10.1111/jfbc.14270
   Li S, 2020, J FUNCT FOODS, V72, DOI 10.1016/j.jff.2020.104041
   Liang FQ, 2023, FOOD HYDROCOLLOID, V137, DOI 10.1016/j.foodhyd.2022.108318
   Liu Q, 2015, J AGR FOOD CHEM, V63, P4853, DOI 10.1021/acs.jafc.5b01331
   Mehmood A, 2021, FOOD RES INT, V142, DOI 10.1016/j.foodres.2021.110180
   Mei SH, 2023, FOOD CHEM, V404, DOI 10.1016/j.foodchem.2022.134592
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Nascimento GO, 2023, J BIOMOL STRUCT DYN, V41, P14871, DOI 10.1080/07391102.2023.2188421
   Oluwagunwa OA, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.772903
   Patil S, 2023, 3 BIOTECH, V13, DOI 10.1007/s13205-023-03698-6
   Perumal M, 2022, J BIOMOL STRUCT DYN, V40, P6619, DOI 10.1080/07391102.2021.1886992
   Qiu CY, 2017, FOOD CHEM, V221, P431, DOI 10.1016/j.foodchem.2016.10.098
   Rahim ATMA, 2015, FOOD RES INT, V75, P289, DOI 10.1016/j.foodres.2015.05.017
   Rajan L, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104681
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Silva TD, 2019, IND CROP PROD, V140, DOI 10.1016/j.indcrop.2019.111641
   Singh M, 2022, FOOD BIOSCI, V50, DOI 10.1016/j.fbio.2022.101992
   Sosnowska D, 2022, FOOD FUNCT, V13, P5616, DOI [10.1039/d1fo04429j, 10.1039/D1FO04429J]
   Sun Y, 2024, J SCI FOOD AGR, V104, P63, DOI 10.1002/jsfa.12890
   Sun Y, 2022, FOOD CHEM, V385, DOI 10.1016/j.foodchem.2022.132646
   Uehira Y, 2023, OBES RES CLIN PRACT, V17, P411, DOI 10.1016/j.orcp.2023.08.005
   Wu D, 2021, FOOD CHEM, V359, DOI 10.1016/j.foodchem.2021.129960
   Xu ZR, 2022, FOOD CHEM, V382, DOI 10.1016/j.foodchem.2022.132106
   Ying M, 2018, INT J BIOL MACROMOL, V120, P1345, DOI 10.1016/j.ijbiomac.2018.09.086
   You Q, 2011, J AGR FOOD CHEM, V59, P9506, DOI 10.1021/jf201452v
   Yu B, 2023, FOOD CHEM, V398, DOI 10.1016/j.foodchem.2022.133834
   Yu Q, 2019, FOOD CHEM, V297, DOI 10.1016/j.foodchem.2019.05.184
   Yu YL, 2014, ASIAN J CHEM, V26, P3401, DOI 10.14233/ajchem.2014.17536
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
   Zhou CC, 2022, PROCESS BIOCHEM, V122, P87, DOI 10.1016/j.procbio.2022.09.020
NR 51
TC 19
Z9 20
U1 41
U2 82
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD JUN 30
PY 2024
VL 444
AR 138514
DI 10.1016/j.foodchem.2024.138514
EA FEB 2024
PG 10
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA KJ7L3
UT WOS:001179656600001
PM 38310782
DA 2025-04-28
ER

PT J
AU Colon, M
   Nerin, C
AF Colon, Marta
   Nerin, Cristina
TI Molecular Interactions between Caffeine and Catechins in Green Tea
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE caffeine; (+)-catechin; (-)-epicatechin; intermolecular interactions;
   simulation; migration; active packaging
ID GALLOCATECHIN GALLATE; ANTIOXIDANT CAPACITY; CRYSTAL-STRUCTURE;
   COMPLEXES; POLYPHENOL; FILMS; REDUCTION; COATINGS; OBESITY
AB Migration of green tea components from an active packaging material containing green tea extract was performed in water and 3% acetic acid in water. The migration values for acid simulant were much higher than the values obtained in water. The influence of the acidic media in solutions of catechin standards and green tea extract was evaluated by liquid chromatography. Catechin, epicatechin, and caffeine from the green tea extract exhibited major variation in their concentrations values, with increases of 29.90, 20.75, and 15.95%, respectively, in acidic medium. The results suggested that catechins and caffeine form complexes through intermolecular interactions in neutral media and that these interactions are broken in acidic media. The continuous variation method was also performed to confirm the stoichiometry of the complexes between catechins and caffeine. Finally, a computer simulation was applied by Chem Pro 12.0, and the energies involved were calculated to confirm the experimental results obtained.
C1 [Colon, Marta; Nerin, Cristina] CPS Univ Zaragoza, Aragon Inst Engn Res I3A, Dept Analyt Chem, E-50018 Zaragoza, Spain.
C3 University of Zaragoza
RP Nerin, C (corresponding author), CPS Univ Zaragoza, Aragon Inst Engn Res I3A, Dept Analyt Chem, Torres Quevedo Bldg,Maria de Luna St 3, E-50018 Zaragoza, Spain.
EM cnerin@unizar.es
RI Nerin, Cristina/H-6945-2015
OI Nerin, Cristina/0000-0003-2685-5739
FU MICINN, Ministerio de Ciencia e Innovacion, Spain [INNPACTO 2010/0486];
   Project Gobierno de Aragon; European Social Funds [GUIA-T-10]
FX This research has been financed by Project INNPACTO 2010/0486 from the
   MICINN, Ministerio de Ciencia e Innovacion, Spain. We thank Project
   Gobierno de Aragon and European Social Funds for financing the research
   group GUIA-T-10.
CR Aznar M, 2012, ANAL BIOANAL CHEM, V404, P1945, DOI 10.1007/s00216-012-6247-5
   Bahrami H, 2013, CHEM PHYS, V415, P222, DOI 10.1016/j.chemphys.2013.01.022
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   CAI Y, 1990, J CHEM SOC PERK T 2, P2197, DOI 10.1039/p29900002197
   Colon M, 2012, J AGR FOOD CHEM, V60, P9842, DOI 10.1021/jf302477y
   Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S
   GAFFNEY SH, 1986, J CHEM SOC CHEM COMM, P107, DOI 10.1039/c39860000107
   Garces O., 2004, Antioxidant active varnish Patent, Patent No. [1477519, EP1477519]
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Hayashi N, 2004, BIOSCI BIOTECH BIOCH, V68, P2512, DOI 10.1271/bbb.68.2512
   HORMAN I, 1972, J FOOD SCI, V37, P925, DOI 10.1111/j.1365-2621.1972.tb03705.x
   Ishizu T, 2011, PLANTA MED, V77, P1099, DOI 10.1055/s-0030-1270982
   Ishizu T, 2010, CHEM LETT, V39, P607, DOI 10.1246/cl.2010.607
   Ishizu T, 2009, CHEM LETT, V38, P230, DOI 10.1246/cl.2009.230
   Ishizu T, 2009, TETRAHEDRON LETT, V50, P4121, DOI 10.1016/j.tetlet.2009.04.113
   Job P, 1928, ANN CHIM FRANCE, V9, P113
   de Dicastillo CL, 2011, J AGR FOOD CHEM, V59, P7832, DOI 10.1021/jf201246g
   MARTIN R, 1987, PHYTOCHEMISTRY, V26, P273, DOI 10.1016/S0031-9422(00)81527-7
   MARUYAMA N, 1991, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON TEA SCIENCE, P145
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   NATHANSON JA, 1984, SCIENCE, V226, P184, DOI 10.1126/science.6207592
   Office C., 2005, CHEM 3D US MAN
   Peng Y, 2013, INT J BIOL MACROMOL, V59, P282, DOI 10.1016/j.ijbiomac.2013.04.019
   Perva-Uzunalic A, 2006, FOOD CHEM, V96, P597, DOI 10.1016/j.foodchem.2005.03.015
   Roy MK, 2010, INT J FOOD SCI NUTR, V61, P109, DOI 10.3109/09637480903292601
   Sharma A, 2012, FOOD CHEM, V135, P672, DOI 10.1016/j.foodchem.2012.04.143
   Shin HS, 2003, FOOD SCI BIOTECHNOL, V12, P737
   Shiota S, 1999, BIOL PHARM BULL, V22, P1388, DOI 10.1248/bpb.22.1388
   Silva-Weiss A, 2013, FOOD ENG REV, V5, P200, DOI 10.1007/s12393-013-9072-5
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   Stan T. C., 2002, INTRO COMPUTATIONAL, V14, P285
   Tsutsumi H, 2011, CHEM PHARM BULL, V59, P1008, DOI 10.1248/cpb.59.1008
   Vargas M, 2008, CRIT REV FOOD SCI, V48, P496, DOI 10.1080/10408390701537344
   Yang CS, 2010, NUTR CANCER, V62, P931, DOI 10.1080/01635581.2010.509536
   Yuan JM, 2011, PHARMACOL RES, V64, P123, DOI 10.1016/j.phrs.2011.03.002
NR 35
TC 20
Z9 21
U1 4
U2 73
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUL 16
PY 2014
VL 62
IS 28
BP 6777
EP 6783
DI 10.1021/jf5011287
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA AL6EZ
UT WOS:000339226700033
PM 24980214
DA 2025-04-28
ER

PT J
AU Kong, JS
   Woo, HW
   Kim, YM
   Kim, MK
AF Kong, Ji-Sook
   Woo, Hye Won
   Kim, Yu-Mi
   Kim, Mi Kyung
TI Different associations of specific non-alcoholic beverages with elevated
   high-sensitivity C-reactive protein in Korean adults: results from the
   Korea National Health and Nutrition Examination Survey (2015-2016)
SO JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
LA English
DT Article
DE coffee; green tea; soda; fruit juice; hs-CRP; inflammation
ID SUGAR-SWEETENED BEVERAGES; CONSUMPTION; INFLAMMATION; MARKERS; OBESITY;
   DISEASE; COFFEE; BIOMARKERS; GUIDELINE; PROFILE
AB This study examined the associations between specific nonalcoholic beverages and high-sensitivity C-reactive protein (hs-CRP) and their interactions with obesity. The study participants were 4,999 adults aged 19-64 years from the 2015-2016 Korean National Health and Nutrition Examination Survey. The odds ratios (ORs) and 95% confidence intervals (CIs) were obtained using multivariable logistic regression analyses. In women, there was an inverse linear trend between coffee and hs-CRP status (p(trend) = 0.0137), and a positive linear trend for soda was also found (>= 1/week vs never or almost never, OR = 1.79, 95% CI 1.23-2.61, p(trend) = 0.0127). In the stratification analyses, the associations were only observed in obese women. The associations were inverse for coffee and tea but linearly positive for soda in obese women (p(trend)<0.05). In men, an inverted 1-shaped association between commercial fruit juice/drink and hs-CRP status was found; but after stratification by obesity, the association was linear only in obese men (p(trend)<0.05, OR = 2.44, 95% CI 1.44-4.16 in >= 1/week vs never or almost never). Coffee and tea in women may be beneficially associated with hs-CRP status, but soda in women and commercial fruit juice/drink in men may be adversely, particularly for obese adults.
C1 [Kong, Ji-Sook; Woo, Hye Won; Kim, Yu-Mi; Kim, Mi Kyung] Hanyang Univ, Coll Med, Dept Prevent Med, 222 Wangsimni Ro, Seoul 04763, South Korea.
   [Kong, Ji-Sook; Woo, Hye Won; Kim, Yu-Mi; Kim, Mi Kyung] Hanyang Univ, Inst Hlth & Soc, Seoul 04763, South Korea.
C3 Hanyang University; Hanyang University
RP Kim, MK (corresponding author), Hanyang Univ, Coll Med, Dept Prevent Med, 222 Wangsimni Ro, Seoul 04763, South Korea.; Kim, MK (corresponding author), Hanyang Univ, Inst Hlth & Soc, Seoul 04763, South Korea.
EM kmkkim@hanyang.ac.kr
RI Kim, Yu-Mi/AAU-5083-2021; Woo, HyeWon/LMO-9223-2024; Kim,
   Mi-Kyung/E-8682-2012
OI Kim, Mi Kyung/0000-0001-8503-2631; Kong, Ji-Sook/0000-0002-4085-2158
CR [Anonymous], 2000, ASIA PACIFIC PERSPEC
   [Anonymous], 2017, NAT COFF DRINK TREND
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Chen SH, 2014, J GASTROEN HEPATOL, V29, P435, DOI 10.1111/jgh.12422
   Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003
   de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017
   Ellulu MS, 2017, ARCH MED SCI, V13, P851, DOI 10.5114/aoms.2016.58928
   Floegel A, 2010, INT J FOOD SCI NUTR, V61, P600, DOI 10.3109/09637481003670816
   Goff DC Jr, 2014, J AM COLL CARDIOL, V63, P2935, DOI 10.1016/j.jacc.2013.11.005
   Haghighatdoost F, 2019, PHYTOTHER RES, V33, P2274, DOI 10.1002/ptr.6432
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576
   Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2
   Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077
   Kim DW, 2015, PUBLIC HEALTH NUTR, V18, P1369, DOI 10.1017/S1368980014001712
   Knopp Robert H, 2005, Curr Atheroscler Rep, V7, P472, DOI 10.1007/s11883-005-0065-6
   Korea Agro-Fisheries & Food Trade Corporation, 2017, 1115430000180401 FOO
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Lee H, 2013, PEDIATR GASTROENTERO, V16, P143, DOI 10.5223/pghn.2013.16.3.143
   Lim HJ, 2018, J ACAD NUTR DIET, V118, P1228, DOI 10.1016/j.jand.2017.08.001
   Lin WT, 2020, INT J PUBLIC HEALTH, V65, P45, DOI 10.1007/s00038-020-01330-5
   Liu SM, 2002, AM J CLIN NUTR, V75, P492, DOI 10.1093/ajcn/75.3.492
   Luger M, 2017, OBESITY FACTS, V10, P674, DOI 10.1159/000484566
   Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277
   Monfort-Pires M, 2014, APPL PHYSIOL NUTR ME, V39, P497, DOI 10.1139/apnm-2013-0279
   Nazmi A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-212
   Neves MF, 2020, TROP PLANT PATHOL, V45, P166, DOI 10.1007/s40858-020-00378-1
   O'Connor L, 2015, DIABETOLOGIA, V58, P1474, DOI 10.1007/s00125-015-3572-1
   Paiva CLRS, 2019, CRIT REV FOOD SCI, V59, P652, DOI 10.1080/10408398.2017.1386159
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Ricker MA, 2017, NUTR CLIN PRACT, V32, P318, DOI 10.1177/0884533617700353
   Ryu C, 2015, R VISUALIZATION, V1st
   Seo MH, 2019, J OBES METAB SYNDR, V28, P40
   Serban C, 2015, NUTRITION, V31, P1061, DOI 10.1016/j.nut.2015.02.004
   Siddiqui IA, 2004, ANTIOXID REDOX SIGN, V6, P571, DOI 10.1089/152308604773934323
   Singh GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124845
   Song HJ, 2017, INT J PUBLIC HEALTH, V62, P573, DOI 10.1007/s00038-016-0855-3
   Tamez M, 2018, J NUTR, V148, P117, DOI 10.1093/jn/nxx021
   Thomas DR, 2020, CURR DEV NUTR, V4, DOI 10.1093/cdn/nzz142
   Tonstad S, 2009, INT J CLIN PRACT, V63, P1634, DOI 10.1111/j.1742-1241.2009.02179.x
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   von Philipsborn P, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012292.pub2
   Walker RW, 2014, NUTRITION, V30, P928, DOI 10.1016/j.nut.2014.04.003
   WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1
   World Health Organization (WHO), 2015, Guideline: Sugars Intake for Adults and Children
   Yook SungMin Yook SungMin, 2015, Journal of Nutrition and Health, V48, P419, DOI 10.4163/jnh.2015.48.5.419
   Yu Z, 2018, BRIT J NUTR, V119, P570, DOI [10.1017/S0007114517003841, 10.1017/s0007114517003841]
NR 48
TC 2
Z9 3
U1 0
U2 1
PU JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
PI KYOTO
PA KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR
   GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN
SN 0912-0009
EI 1880-5086
J9 J CLIN BIOCHEM NUTR
JI J. Clin. Biochem. Nutr.
PD JAN
PY 2022
VL 70
IS 1
BP 37
EP 45
DI 10.3164/jcbn.21-20
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA ZK6MV
UT WOS:000763102700007
PM 35068680
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Szeitz-Szabó, M
   Bíró, L
   Bíró, G
   Sali, J
AF Szeitz-Szabo, M.
   Biro, L.
   Biro, Gy
   Sali, J.
TI DIETARY SURVEY IN HUNGARY, 2009. PART I. MACRONUTRIENTS, ALCOHOL,
   CAFFEINE, FIBRE
SO ACTA ALIMENTARIA
LA English
DT Article
DE nutrition survey; food consumption; nutrient intake; energy intake;
   fatty acid pattern; cholesterol intake; risk assessment
AB In 2009 Hungarian Food Safety Office (HFSO) performed a countrywide representative dietary survey to obtain food consumption data for quantitative food safety risk assessment utilizable in the field of public health nutrition as well. The consumption of foodstuffs, daily energy-and nutrient intakes, nutritional habits and dietary supplement usage of Hungarian population was assessed. The complex system has included three-day dietary record and a food consumption frequency questionnaire. Some anthropometric parameters were also self-recorded. According to the body mass index, a considerable proportion of both the 31-60 years old males (69%) and females (46%) were overweight or obese. The energy intake of the Hungarian adult population is slightly exceeds the recommendation. The intake of proteins is satisfactory in general. The average intake of total fats is very high (36.1-38.9 energy percent), and the fatty acid composition - mostly the ratio of n-6/n-3 fatty acids - is unfavourable, but the fatty acid pattern regarding saturated-(SFA), mono-(MUFA) and polyunsaturated (PUFA) fatty acid ratio shows favourable tendency. The proportion of complex carbohydrates within the intake of energy providing macronutrients is far lower than the optimal level, but it is a positive finding that added sugar intake is below the outmost recommendation. The average daily cholesterol intake is high (males: 469 mg, females: 335 mg), whilst the dietary fibre intake is lower than the recommended. The article provides data on alcohol, caffeine and fibre consumption, too.
C1 [Szeitz-Szabo, M.; Biro, Gy; Sali, J.] Hungarian Food Safety Off, H-1097 Budapest, Hungary.
   [Biro, L.] NutriComp Nutr & Hlth Co, H-1091 Budapest, Hungary.
RP Szeitz-Szabó, M (corresponding author), Hungarian Food Safety Off, Gyali Ut 2-6, H-1097 Budapest, Hungary.
EM szabo.maria@mebih.gov.hu
CR [Anonymous], WHO TECH REP SER
   [Anonymous], 1985, TECHN REP SER
   Antal M., 2005, UJ TAPANYAGTABLAZAT, P19
   Biro G, 1996, EUR J CLIN NUTR, V50, P201
   BIRO GY, 1992, AZ ELSO MAGYARORSZAG, V1
   Biro L., 2005, Egeszsegtudomany, V49, P145
   BIRO L, 1999, DIABETOLOGIA HUNGARI, V7, P243
   GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569
   Lajos Biro, 2007, Orvosi Hetilap, V148, P703, DOI 10.1556/OH.2007.28017
   Rodler Imre, 2005, Orv Hetil, V146, P1781
   Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5
   *WHO, 2004, EUR SER WHO REG PUBL, V96
   WHO, 2003, DIET NUTR PREV CHRON
   Zajkas Gabor, 2007, Orvosi Hetilap, V148, P1593, DOI 10.1556/OH.2007.28182
NR 14
TC 30
Z9 31
U1 0
U2 4
PU AKADEMIAI KIADO RT
PI BUDAPEST
PA PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY
SN 0139-3006
EI 1588-2535
J9 ACTA ALIMENT HUNG
JI Acta Aliment.
PD MAR
PY 2011
VL 40
IS 1
BP 142
EP 152
DI 10.1556/AAlim.40.2011.1.16
PG 11
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 736LG
UT WOS:000288495600017
DA 2025-04-28
ER

PT J
AU Hwang, SH
   Kim, JH
   Wang, Z
   Lee, JY
   Lim, SS
AF Hwang, Seung Hwan
   Kim, Ju Hee
   Wang, Zhiqiang
   Lee, Jae-Yong
   Lim, Soon Sung
TI Analytical Method for the Validation of Three Polyphenols as a Marker
   Compound for the Standardization of Solidago virgaurea subsp
   gigantea Extracts and Antiadipogenesis of Harvesting Time and
   Location
SO JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY
LA English
DT Article
ID CHLOROGENIC ACID; PROTOCATECHUIC ACID; IN-VIVO; L.; FLAVONOIDS; PATHWAY;
   PARTS
AB Protocatechuic acid (PC), chlorogenic acid (CA), and kaempferol-3-O-rutinoside (K-O-R), isolated from the Solidago virgaurea subsp. gigantea (SV) extract, were quickly and efficiently separated using HPLC. Our chromatographic method was found to effectively separate PC, CA, and K-O-R at retention times of 5.36, 8.22, and 17.04 min, respectively. Linearity of PC, CA, and K-O-R was found to be in the range of 4.85-485.00, 47.5-1900.00, and 8.50-850.00 mu g/ml. Recoveries ranged between 101.32 and 103.30%, 95.82 and 100.25%, and 96.18 and 99.37%, for PC, CA, and K-O-R, respectively. The antiadipogenesis activity of SV extracts collected from five different months and from seven different regions was evaluated using an Oil Red O staining assay in 3T3-L1 cells. Extract from SV collected in April from the Ulleung Island produced over 106.89% inhibition of adipogenesis without cytotoxicity at 50 mu g/ml. This extract had a high amount of PC and K-O-R. The developed HPLC method was found to be fast, accurate, precise, and reproducible and could be applied to qualitative and quantitative analysis of three bioactive compounds in SV extracts. The SV extract collected in April from Ulleung Island can be used as a functional food ingredient preventing obesity.
C1 [Hwang, Seung Hwan; Wang, Zhiqiang; Lim, Soon Sung] Hallym Univ, Dept Food Sci & Nutr, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
   [Kim, Ju Hee; Lee, Jae-Yong] Hallym Univ, Inst Nat Med, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
   [Lee, Jae-Yong; Lim, Soon Sung] Hallym Univ, Sch Med, Dept Biochem, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
C3 Hallym University; Hallym University; Hallym University
RP Lim, SS (corresponding author), Hallym Univ, Dept Food Sci & Nutr, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.; Lim, SS (corresponding author), Hallym Univ, Sch Med, Dept Biochem, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
EM limss@hallym.ac.kr
RI kim, juhee/HKV-6163-2023
FU Korea Institute of Planning and Evaluation for Technology in Food,
   Agriculture, Forestry and Fisheries (IPET) - Ministry of Agriculture,
   Food and Rural Affairs (MAFRA) [114066-3]; Hallym University
   [HRF-201704-010]; Academy of Finland (AKA) [114066] Funding Source:
   Academy of Finland (AKA)
FX This work was supported by the Korea Institute of Planning and
   Evaluation for Technology in Food, Agriculture, Forestry and Fisheries
   (IPET) through (Agri-Bioindustry Technology Development Program) funded
   by the Ministry of Agriculture, Food and Rural Affairs (MAFRA)
   (114066-3) and Hallym University Research Fund (HRF-201704-010).
CR Chandra R., 2013, INT J CHROMATOGRAPHI, V3, P31
   Gutzeit D, 2007, CHROMATOGRAPHIA, V65, P1, DOI 10.1365/s10337-006-0105-6
   Horwitz W., 2002, P AOAC INT GAITH MD
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Jang YS, 2016, MOLECULES, V21, DOI 10.3390/molecules21020226
   Jin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120842
   Kim CH, 2016, ANIM CELLS SYST, V20, P335, DOI 10.1080/19768354.2016.1254110
   Kim H. S., 1996, THESIS
   Kim SA, 2013, FOOD CHEM, V141, P3813, DOI 10.1016/j.foodchem.2013.06.068
   Kolodziej B, 2011, J MED PLANTS RES, V5, P6770, DOI 10.5897/JMPR11.1098
   Kong CS, 2009, FOOD CHEM TOXICOL, V47, P2401, DOI 10.1016/j.fct.2009.06.010
   Koo Hyun Jung, 2014, [Korean Journal of Plant Reources., 한국자원식물학회지], V27, P271, DOI 10.7732/kjpr.2014.27.4.271
   Laurençon L, 2013, PHYTOCHEMISTRY, V86, P103, DOI 10.1016/j.phytochem.2012.10.004
   Lee J., 2004, THESIS
   Lee T. B., 1979, ILLUSTRATED FLORA KO
   Lende Amol B., 2011, Inflammopharmacology, V19, P255, DOI 10.1007/s10787-011-0086-4
   LEUSCHNER J, 1995, ARZNEIMITTELFORSCH, V45-1, P165
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Motaal AA, 2016, PHARM BIOL, V54, P2864, DOI 10.1080/13880209.2016.1190381
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Park HS, 2013, FASEB J, V27
   Parveen Z, 2007, YAKUGAKU ZASSHI, V127, P1275, DOI 10.1248/yakushi.127.1275
   Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503
   Roslon W, 2014, ACTA SCI POL-HORTORU, V13, P55
   Savic IM, 2013, J ANAL CHEM+, V68, P906, DOI [10.1134/S1061934813100080, 10.7868/S0044450213100083]
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1258-y
   Talagavadi V, 2016, J FUNCT FOODS, V21, P338, DOI 10.1016/j.jff.2015.12.007
   TANAKA T, 1990, BASIC LIFE SCI, V52, P429
   Tarantino G, 2007, WORLD J GASTROENTERO, V13, P4669, DOI 10.3748/wjg.v13.i35.4669
   Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002
   Wang Y, 2015, J FOOD DRUG ANAL, V23, P310, DOI 10.1016/j.jfda.2014.10.002
   Yoon HN, 2013, ARCH PHARM RES, V36, P1090, DOI 10.1007/s12272-013-0123-5
   Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005
NR 33
TC 6
Z9 7
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-8865
EI 2090-8873
J9 J ANAL METHODS CHEM
JI J. Anal. Methods Chem.
PY 2017
VL 2017
AR 3047408
DI 10.1155/2017/3047408
PG 9
WC Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA FE3VX
UT WOS:000408144900001
PM 28819580
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Boudreau, A
   Poulev, A
   Ribnicky, DM
   Raskin, I
   Rathinasabapathy, T
   Richard, AJ
   Stephens, JM
AF Boudreau, Anik
   Poulev, Alexander
   Ribnicky, David M.
   Raskin, Ilya
   Rathinasabapathy, Thirumurugan
   Richard, Allison J.
   Stephens, Jacqueline M.
TI Distinct Fractions of an Artemisia scoparia Extract
   Contain Compounds With Novel Adipogenic Bioactivity
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE adipocyte; plants-medicinal; botanical extract; adipogenesis; fat cell;
   activity-guided fractionation; 3T3-L1 adipocyte
ID INHIBITS ADIPOCYTE DIFFERENTIATION; MESENCHYMAL STEM-CELLS; PPAR-GAMMA;
   3T3-L1 PREADIPOCYTES; ADIPOSE-TISSUE; TRANSCRIPTION FACTORS; INSULIN
   SENSITIVITY; CHLOROGENIC ACID; IN-VIVO; IDENTIFICATION
AB Adipocytes are important players in metabolic health and disease, and disruption of adipocyte development or function contributes to metabolic dysregulation. Hence, adipocytes are significant targets for therapeutic intervention in obesity and metabolic syndrome. Plants have long been sources for bioactive compounds and drugs. In previous studies, we screened botanical extracts for effects on adipogenesis in vitro and discovered that an ethanolic extract of Artemisia scoparia (SCO) could promote adipocyte differentiation. To follow up on these studies, we have used various separation methods to identify the compound(s) responsible for SCO's adipogenic properties. Fractions and subfractions of SCO were tested for effects on lipid accumulation and adipogenic gene expression in differentiating 3T3-L1 adipocytes. Fractions were also analyzed by Ultra Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS), and resulting peakswere putatively identified through high resolution, highmass accuracy mass spectrometry, literature data, and available natural products databases. The inactive fractions contained mostly quercetin derivatives and chlorogenates, including chlorogenic acid and 3,5-dicaffeoylquinic acid, which had no effects on adipogenesis when tested individually, thus ruling them out as pro-adipogenic bioactives in SCO. Based on these studies we have putatively identified the principal constituents in SCO fractions and subfractions that promoted adipocyte development and fat cell gene expression as prenylated coumaric acids, coumarin monoterpene ethers, 6-demethoxycapillarisin and two polymethoxyflavones.
C1 [Boudreau, Anik; Richard, Allison J.; Stephens, Jacqueline M.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
   [Poulev, Alexander; Ribnicky, David M.; Raskin, Ilya; Rathinasabapathy, Thirumurugan] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ USA.
   [Stephens, Jacqueline M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; Rutgers University System;
   Rutgers University New Brunswick; Louisiana State University System;
   Louisiana State University
RP Stephens, JM (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.; Stephens, JM (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.
EM jsteph1@lsu.edu
RI Richard, Allison/N-1987-2017; Rathinasabapathy,
   Thirumurugan/GMX-4975-2022; Stephens, Jacqueline/R-5217-2018; Poulev,
   Alexander/L-6613-2019
OI Poulev, Alexander/0000-0003-0939-0642; Boudreau,
   Anik/0000-0002-5988-4694; Rathinasabapathy,
   Thirumurugan/0000-0002-7330-0552
FU National Center for Complementary & Integrative Health; Office of
   Dietary Supplements of the National Institutes of Health (NIH)
   [P50AT002776]; Fogarty International Center of the NIH [U01 TW006674];
   National Institutes of Health [NIH 8 P20 GM103528, NIH 2P30DK072476]
FX This publication was supported by the National Center for Complementary
   & Integrative Health and the Office of Dietary Supplements of the
   National Institutes of Health (NIH) under Award Number P50AT002776 which
   funds the Botanical Dietary Supplements Research Center of Pennington
   Biomedical Research Center and the Department of Plant Biology and
   Pathology in the School of Environmental and Biological Sciences (SEBS)
   of Rutgers University; and by the Fogarty International Center of the
   NIH, International Cooperative Biodiversity Groups Program under award
   number U01 TW006674. This research project used Genomics Core facilities
   that are supported in part by COBRE (NIH 8 P20 GM103528) and NORC (NIH
   2P30DK072476) center grants from the National Institutes of Health.
CR Abood S, 2018, PHYTOTHER RES, V32, P1583, DOI 10.1002/ptr.6089
   Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Arçari DP, 2013, FOOD CHEM, V141, P809, DOI 10.1016/j.foodchem.2013.04.062
   Babish JG, 2010, J MED FOOD, V13, P535, DOI 10.1089/jmf.2009.0110
   Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825
   Boudreau A, 2018, AM J PHYSIOL-ENDOC M, V315, pE1053, DOI 10.1152/ajpendo.00177.2018
   Buehrer BM, 2012, J NUTR BIOCHEM, V23, P519, DOI 10.1016/j.jnutbio.2011.02.005
   Casado-Díaz A, 2016, J NUTR BIOCHEM, V32, P151, DOI 10.1016/j.jnutbio.2016.03.005
   Chaiittianan R, 2017, J ETHNOPHARMACOL, V201, P9, DOI 10.1016/j.jep.2017.02.044
   Choi JW, 2016, LIFE SCI, V144, P103, DOI 10.1016/j.lfs.2015.11.028
   Choi SS, 2011, BIOCHEM PHARMACOL, V81, P925, DOI 10.1016/j.bcp.2011.01.002
   Choi Y, 2011, J AGR FOOD CHEM, V59, P12843, DOI 10.1021/jf2033208
   Chou YC, 2008, PHYTOTHER RES, V22, P605, DOI 10.1002/ptr.2280
   Christensen KB, 2010, PHYTOTHER RES, V24, pS129, DOI 10.1002/ptr.3005
   Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111
   Dhanya R, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00336
   El-Houri RB, 2015, PLANTA MED, V81, P488, DOI 10.1055/s-0034-1383119
   Emami SA, 2010, IMMUNOPHARM IMMUNOT, V32, P688, DOI 10.3109/08923971003677808
   Fang XK, 2008, LIFE SCI, V82, P615, DOI 10.1016/j.lfs.2007.12.021
   Forney LA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030895
   Galvis A, 2011, EUR J PHARMACOL, V671, P18, DOI 10.1016/j.ejphar.2011.09.033
   González-Castejón M, 2014, PHYTOTHER RES, V28, P745, DOI 10.1002/ptr.5059
   Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006
   Hammarstedt A, 2005, PROSTAG LEUKOTR ESS, V73, P65, DOI 10.1016/j.plefa.2005.04.008
   Herranz-López M, 2012, PHYTOMEDICINE, V19, P253, DOI 10.1016/j.phymed.2011.12.001
   Horikawa T, 2012, BIOL PHARM BULL, V35, P686, DOI 10.1248/bpb.35.686
   Hutley LJ, 2003, EUR J CLIN INVEST, V33, P574, DOI 10.1046/j.1365-2362.2003.01178.x
   Iio A, 2010, PHYTOMEDICINE, V17, P974, DOI 10.1016/j.phymed.2010.03.001
   Jang BC, 2016, BIOCHEM BIOPH RES CO, V474, P220, DOI 10.1016/j.bbrc.2016.04.109
   Alonso-Castro AJ, 2008, J ETHNOPHARMACOL, V120, P458, DOI 10.1016/j.jep.2008.09.019
   Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021
   Kuroyanagi K, 2008, BIOCHEM BIOPH RES CO, V366, P219, DOI 10.1016/j.bbrc.2007.11.119
   Lai CS, 2013, J AGR FOOD CHEM, V61, P10320, DOI 10.1021/jf402257t
   Lin HR, 2012, BIOORG MED CHEM LETT, V22, P2954, DOI 10.1016/j.bmcl.2012.02.043
   do Nascimento DDM, 2017, MOLECULES, V22, DOI 10.3390/molecules22060972
   Matsuura N, 2005, BIOSCI BIOTECH BIOCH, V69, P2470, DOI 10.1271/bbb.69.2470
   Moon J, 2013, FOOD CHEM TOXICOL, V58, P347, DOI 10.1016/j.fct.2013.05.006
   Muthusamy VS, 2010, BRIT J NUTR, V104, P813, DOI 10.1017/S0007114510001480
   Nagai H, 2014, BIOSCI BIOTECH BIOCH, V78, P296, DOI 10.1080/09168451.2014.877821
   Nakashima K, 2014, BBA-GEN SUBJECTS, V1840, P3034, DOI 10.1016/j.bbagen.2014.06.011
   Nam SY, 2018, IMMUNOPHARM IMMUNOT, V40, P52, DOI 10.1080/08923973.2017.1405438
   Okabe Y, 2014, PHYTOMEDICINE, V21, P800, DOI 10.1016/j.phymed.2014.01.014
   Peng SG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8594767
   Richard AJ, 2014, NUTRITION, V30, pS31, DOI 10.1016/j.nut.2014.02.013
   Richard AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098897
   Saito T, 2007, BIOCHEM BIOPH RES CO, V357, P371, DOI 10.1016/j.bbrc.2007.03.169
   Sánchez-Villavicencio ML, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-016-1519-9
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Smith SA, 2003, BIOCHIMIE, V85, P1219, DOI 10.1016/j.biochi.2003.10.010
   Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540
   Sung YY, 2015, J ETHNOPHARMACOL, V168, P17, DOI 10.1016/j.jep.2015.03.051
   Thomas I, 2017, PEDIATR DIABETES, V18, P10, DOI 10.1111/pedi.12473
   Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178
   Yahagi T, 2014, J NAT MED-TOKYO, V68, P414, DOI 10.1007/s11418-013-0799-3
   Zhao YS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1459497
   Zhou RP, 2015, MOL MED REP, V11, P4489, DOI 10.3892/mmr.2015.3285
NR 56
TC 20
Z9 22
U1 0
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD MAR 8
PY 2019
VL 6
AR 18
DI 10.3389/fnut.2019.00018
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HO8VP
UT WOS:000461237700001
PM 30906741
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Bellerba, F
   Chatziioannou, AC
   Jasbi, P
   Robinot, N
   Keski-Rahkonen, P
   Trolat, A
   Vozar, B
   Hartman, SJ
   Scalbert, A
   Bonanni, B
   Johansson, H
   Sears, DD
   Gandini, S
AF Bellerba, Federica
   Chatziioannou, Anastasia Chrysovalantou
   Jasbi, Paniz
   Robinot, Nivonirina
   Keski-Rahkonen, Pekka
   Trolat, Amarine
   Vozar, Beatrice
   Hartman, Sheri J.
   Scalbert, Augustin
   Bonanni, Bernardo
   Johansson, Harriet
   Sears, Dorothy D.
   Gandini, Sara
TI Metabolomic profiles of metformin in breast cancer survivors: a pooled
   analysis of plasmas from two randomized placebo-controlled trials
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE Cancer; Recurrence; Metabolic syndrome; Prevention; Lipids; Weight loss
ID GUT MICROBIOME; AMINO-ACIDS; FATTY-ACIDS; IN-VIVO; CYP1A2; RISK;
   INDIVIDUALS; ASSOCIATION; CITRULLINE; PROMOTES
AB Background: Obesity is a major health concern for breast cancer survivors, being associated with high recurrence and reduced efficacy during cancer treatment. Metformin treatment is associated with reduced breast cancer incidence, recurrence and mortality. To better understand the underlying mechanisms through which metformin may reduce recurrence, we aimed to conduct metabolic profiling of overweight/obese breast cancer survivors before and after metformin treatment. Methods: Fasting plasma samples from 373 overweight or obese breast cancer survivors randomly assigned to metformin (n = 194) or placebo (n = 179) administration were collected at baseline, after 6 months (Reach For Health trial), and after 12 months (MetBreCS trial). Archival samples were concurrently analyzed using three complementary methods: untargeted LC-QTOF-MS metabolomics, targeted LC-MS metabolomics (AbsoluteIDQ p180, Biocrates), and gas chromatography phospholipid fatty acid assay. Multivariable linear regression models and family-wise error correction were used to identify metabolites that significantly changed after metformin treatment. Results: Participants (n = 352) with both baseline and study end point samples available were included in the analysis. After adjusting for confounders such as study center, age, body mass index and false discovery rate, we found that metformin treatment was significantly associated with decreased levels of citrulline, arginine, tyrosine, caffeine, paraxanthine, and theophylline, and increased levels of leucine, isoleucine, proline, 3-methyl-2-oxovalerate, 4-methyl-2-oxovalerate, alanine and indoxyl-sulphate. Long-chain unsaturated phosphatidylcholines (PC ae C36:4, PC ae C38:5, PC ae C36:5 and PC ae C38:6) were significantly decreased with the metformin treatment, as were phospholipid-derived long-chain n-6 fatty acids. The metabolomic profiles of metformin treatment suggest change in specific biochemical pathways known to impair cancer cell growth including activation of CYP1A2, alterations in fatty acid desaturase activity, and altered metabolism of specific amino acids, including impaired branched chain amino acid catabolism. Conclusions: Our results in overweight breast cancer survivors identify new metabolic effects of metformin treatment that may mechanistically contribute to reduced risk of recurrence in this population and reduced obesity-related cancer risk reported in observational studies.
C1 [Bellerba, Federica; Gandini, Sara] European Inst Oncol IRCCS, Dept Expt Oncol, IEO, Milan, Italy.
   [Chatziioannou, Anastasia Chrysovalantou; Robinot, Nivonirina; Keski-Rahkonen, Pekka; Trolat, Amarine; Vozar, Beatrice; Scalbert, Augustin] Int Agcy Res Canc, Nutr & Metab Branch, Lyon, France.
   [Jasbi, Paniz; Sears, Dorothy D.] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ USA.
   [Jasbi, Paniz] Arizona State Univ, Sch Mol Sci, Tempe, AZ USA.
   [Hartman, Sheri J.] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, La Jolla, CA USA.
   [Hartman, Sheri J.; Sears, Dorothy D.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA.
   [Bonanni, Bernardo; Johansson, Harriet] European Inst Oncol IRCCS, Div Canc Prevent & Genet, IEO, Via Giuseppe Ripamonti 435, I-20141 Milan, Italy.
   [Sears, Dorothy D.] Univ Calif San Diego, Dept Med, La Jolla, CA USA.
C3 IRCCS European Institute of Oncology (IEO); World Health Organization;
   International Agency for Research on Cancer (IARC); Arizona State
   University; Arizona State University-Downtown Phoenix; Arizona State
   University; Arizona State University-Tempe; University of California
   System; University of California San Diego; University of California
   System; University of California San Diego; IRCCS European Institute of
   Oncology (IEO); University of California System; University of
   California San Diego
RP Johansson, H (corresponding author), European Inst Oncol IRCCS, Div Canc Prevent & Genet, IEO, Via Giuseppe Ripamonti 435, I-20141 Milan, Italy.
EM harriet.johansson@ieo.it
RI Sears, Dorothy/B-6979-2019; Bellerba, Federica/AAQ-6815-2020
OI Johansson, Harriet/0000-0002-4131-2030
FU National Institutes of Health [U54 CA155435]; Italian Ministry of Health
   [RRC-2014-2354553]; Institut National du Cancer, France (INCa) through
   the TRANSCAN ERA-Net call on Translational Cancer Research (TRANSCAN-JTC
   2013) [2015-034]; Research Council Norway/Norwegian Cancer Society;
   Italian Ministry of Health
FX Reach for Health study was supported by the National Institutes of
   Health (U54 CA155435) and the MetBreCs trial was supported by the
   Italian Ministry of Health (RRC-2014-2354553) and the Institut National
   du Cancer, France (INCa No2015-034), through the TRANSCAN ERA-Net call
   on Translational Cancer Research (TRANSCAN-JTC 2013). The biomarker
   analyses were conducted within the European Commission (EC) Seventh
   Framework Program (FP7) Translational by grants from the research
   Council Norway/Norwegian Cancer Society (steroid profiling) and Italian
   Ministry of Health (adipokines, cytokines, growth factors, inflammatory
   biomarkers). This work was partially supported by the Italian Ministry
   of Health with Ricerca Corrente and 5 x 1000 funds. Federica Bellerba is
   a Ph.D. student within the European School of Molecular Medicine (SEMM).
CR Agius L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093240
   Agus A, 2021, GUT, V70, P1174, DOI 10.1136/gutjnl-2020-323071
   [Anonymous], METF EFF DRUG MET PA
   Arrieta O, 2019, JAMA ONCOL, V5, DOI 10.1001/jamaoncol.2019.2553
   Ayari I, 2013, MOL MED REP, V7, P280, DOI 10.3892/mmr.2012.1164
   Azrad M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053104
   Baker JM, 2017, MATURITAS, V103, P45, DOI 10.1016/j.maturitas.2017.06.025
   Batista MA, 2012, JPEN-PARENTER ENTER, V36, P69, DOI 10.1177/0148607111414024
   Bendinelli B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92508-1
   Breier M, 2017, J STEROID BIOCHEM, V174, P114, DOI 10.1016/j.jsbmb.2017.08.004
   Carrillo JA, 2000, THER DRUG MONIT, V22, P409, DOI 10.1097/00007691-200008000-00008
   Chajès V, 2017, ANN ONCOL, V28, P2836, DOI 10.1093/annonc/mdx482
   Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064
   Elfaki Imadeldin, 2018, Asian Pac J Cancer Prev, V19, P2057
   Elia I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15267
   Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495
   Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045
   Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424
   Geijsen AJMR, 2019, INT J CANCER, V145, P1221, DOI 10.1002/ijc.32146
   Ha JR, 2016, J CELL BIOCHEM, V117, P1971, DOI 10.1002/jcb.25561
   He JL, 2016, J DIABETES, V8, P305, DOI 10.1111/1753-0407.12358
   Imene Ayari, 2015, Asian Pac J Cancer Prev, V16, P3559
   Irving BA, 2015, METABOLISM, V64, P720, DOI 10.1016/j.metabol.2015.01.008
   Jasbi P, 2019, J CHROMATOGR B, V1105, P26, DOI 10.1016/j.jchromb.2018.11.029
   Kim E, 2011, DIABETES, V60, P1493, DOI 10.2337/db10-0393
   Kim W, 2019, CELL METAB, V29, P856, DOI 10.1016/j.cmet.2018.12.023
   Kotsopoulos J, 2007, CANCER EPIDEM BIOMAR, V16, P912, DOI 10.1158/1055-9965.EPI-06-1074
   Kwee LC, 2021, NUTR DIABETES, V11, DOI 10.1038/s41387-021-00151-6
   Li Lei O, 2010, Mol Endocrinol, V24, P657, DOI 10.1210/me.2009-0152
   Li L, 2013, ANAL CHEM, V85, P3401, DOI 10.1021/ac400099b
   Madiraju AK, 2018, NAT MED, V24, P1384, DOI 10.1038/s41591-018-0125-4
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Martínez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3
   Matzke GR, 2000, PHARMACOTHERAPY, V20, P182, DOI 10.1592/phco.20.3.182.34775
   McCarty MF, 2018, NUTR CANCER, V70, P840, DOI 10.1080/01635581.2018.1470657
   Miklankova D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147680
   Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565
   Patterson RE, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djy040
   Patterson RE, 2016, CONTEMP CLIN TRIALS, V47, P64, DOI 10.1016/j.cct.2015.12.009
   Peng H, 2020, ONCOGENE, V39, P6747, DOI 10.1038/s41388-020-01480-z
   Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256
   Picon-Ruiz M, 2017, CA-CANCER J CLIN, V67, P379, DOI 10.3322/caac.21405
   Preethika A, 2022, GENE, V823, DOI 10.1016/j.gene.2022.146330
   Safai N, 2018, DIABETIC MED, V35, P944, DOI 10.1111/dme.13636
   Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654
   Smith TAD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151179
   Sonnet DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep28775
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Takahashi H, 2018, CHIN CLIN ONCOL, V7, DOI 10.21037/cco.2018.05.06
   Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x
   Urry E, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0126-6
   van de Poll MCG, 2004, AM J CLIN NUTR, V79, P185
   Vinaixa M, 2012, METABOLITES, V2, P775, DOI 10.3390/metabo2040775
   Wei YP, 2021, J PROTEOME RES, V20, P3124, DOI 10.1021/acs.jproteome.1c00019
   Westphal C, 2011, PROSTAG OTH LIPID M, V96, P99, DOI 10.1016/j.prostaglandins.2011.09.001
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089
   Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345
   Xu T, 2015, DIABETES CARE, V38, P1858, DOI 10.2337/dc15-0658
   Xue PP, 2017, EBIOMEDICINE, V20, P50, DOI 10.1016/j.ebiom.2017.05.001
   Ye ZH, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00617
   Yerevanian A, 2019, CURR OBES REP, V8, P156, DOI 10.1007/s13679-019-00335-3
   Zhang GD, 2014, PROG LIPID RES, V53, P108, DOI 10.1016/j.plipres.2013.11.003
   Zhang L, 2017, BIOCHEM BIOPH RES CO, V486, P224, DOI 10.1016/j.bbrc.2017.02.101
   Zhao WP, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88258-9
NR 66
TC 9
Z9 9
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD DEC 29
PY 2022
VL 20
IS 1
AR 629
DI 10.1186/s12967-022-03809-6
PG 16
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 7L4CK
UT WOS:000905915800001
PM 36581893
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Kim, WJ
   Yu, HS
   Bae, WY
   Ko, KY
   Chang, KH
   Lee, NK
   Paik, HD
AF Kim, Won-Ju
   Yu, Hyung-Seok
   Bae, Won-Young
   Ko, Kyung Yuk
   Chang, Kyung-Hoon
   Lee, Na-Kyoung
   Paik, Hyun-Dong
TI Chrysanthemum indicum suppresses adipogenesis by inhibiting
   mitotic clonal expansion in 3T3-L1 preadipocytes
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article
DE adipogenesis; Akt signaling pathway; Chrysanthemum indicum; ERK 1; 2
   signaling pathway; mitotic clonal expansion
ID EARLY-STAGE; DIFFERENTIATION; EXTRACTS; AMPK
AB Herbs have been of interest to treat diseases, including obesity, owing to their various bioactive constituents that exhibit therapeutic and prophylactic properties. The present study examined the anti-adipogenic effects and mechanisms of Chrysanthemum indicum aqueous extract (CAE) in 3T3-L1 preadipocytes. CAE comprises 1,3-dicaffeoylquinic acid, chlorogenic acid, kaempferol-3-O-glucoside, caffeic acid, and apigenin, which were corresponded with previous reports. CAE inhibited the accumulation of lipid droplets and significantly alleviated the expression of lipogenesis- and adipogenesis-associated biomarkers. Treatment with CAE inhibited the mitotic clonal expansion (MCE), corroborated by cell cycle arrest at the G(0)/G(1) phase, and mitigated the expression of cell cycle progression-associated proteins and in addition to phosphorylation of MCE-promoting transcription factors. Moreover, CAE downregulated the activation of Akt and extracellular signal-regulated kinase 1/2 signaling pathways. In summary, CAE facilitates adipogenic inhibition during the early phase of differentiation, especially MCE, and its phenolic compounds can contribute to its anti-obesogenic properties. Practical applications Chrysanthemum indicum has been mainly used as traditional herbal tea and drinks. Chrysanthemum indicum aqueous extract (CAE) inhibits adipogenesis by suppressing mitotic clonal expansion during the early phase of differentiation in 3T3-L1 preadipocytes. 1,3-Dicaffeoylquinic acid, chlorogenic acid, kaempferol-3-O-glucoside, caffeic acid, and apigenin were detected in CAE. Based on these findings, CAE can be used as nutraceutical agents for prevention and treatment of obesity.
C1 [Kim, Won-Ju; Yu, Hyung-Seok; Bae, Won-Young; Lee, Na-Kyoung; Paik, Hyun-Dong] Konkuk Univ, Dept Food Sci & Biotechnol Anim Resources, Seoul 05029, South Korea.
   [Ko, Kyung Yuk; Chang, Kyung-Hoon] Natl Inst Food & Drug Safety Evaluat, Osong, South Korea.
   [Chang, Kyung-Hoon] CJ CheilJedang Blossom Pk, Gyeonggi Do, South Korea.
C3 Konkuk University; Ministry of Food & Drug Safety (MFDS), Republic of
   Korea; National Institute of Food & Drug Safety Evaluation
RP Paik, HD (corresponding author), Konkuk Univ, Dept Food Sci & Biotechnol Anim Resources, Seoul 05029, South Korea.
EM hdpaik@konkuk.ac.kr
RI Paik, Hyun-Dong/D-5226-2011; Bae, Won-Young/AAS-2512-2020
OI Kim, Won-Ju/0000-0003-3554-8984; Paik, Hyun-Dong/0000-0001-9891-7703;
   Bae, Won Young/0000-0002-6615-2547; Lee, Na-Kyoung/0000-0002-2395-550X
CR Abood S, 2018, PHYTOTHER RES, V32, P1583, DOI 10.1002/ptr.6089
   Ahmad B, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00076
   Bae WY, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2670-x
   Bae WY, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12785
   Chae SY, 2015, J FUNCT FOODS, V19, P700, DOI 10.1016/j.jff.2015.09.060
   Chang E, 2019, MOLECULES, V24, DOI 10.3390/molecules24061157
   Cheng WM, 2005, J ETHNOPHARMACOL, V101, P334, DOI 10.1016/j.jep.2005.04.035
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi DH, 2020, J MICROBIOL BIOTECHN, V30, P21, DOI 10.4014/jmb.1910.10040
   Feng S, 2016, MOLECULES, V21, DOI 10.3390/molecules21101278
   GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3
   Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75
   Han JH, 2021, J CELL PHYSIOL, V236, P1822, DOI 10.1002/jcp.29964
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Hsu CL, 2008, MOL NUTR FOOD RES, V52, P53, DOI [10.1002/mnfr.200890019, 10.1002/mnfr.200700393]
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Hwang YI, 2019, FOOD SCI BIOTECHNOL, V28, P1577, DOI 10.1007/s10068-019-00668-8
   Jang YJ, 2015, FOOD FUNCT, V6, P2365, DOI 10.1039/c5fo00397k
   Kang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061411
   Kim, 2020, ASIAN J BEAUTY COSME, V18, P657, DOI [10.20402/ajbc.2020.0098, DOI 10.20402/AJBC.2020.0098]
   Kim CY, 2020, FOOD SCI BIOTECHNOL, V29, P431, DOI 10.1007/s10068-019-00672-y
   Kim GS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-31
   Kim HS, 2018, FOOD SCI BIOTECHNOL, V27, P451, DOI 10.1007/s10068-017-0253-5
   Lee JH, 2018, J ETHNOPHARMACOL, V222, P61, DOI 10.1016/j.jep.2018.04.020
   Lee JH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020269
   Lee MH, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13528
   Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792
   Muir LA, 2016, OBESITY, V24, P597, DOI 10.1002/oby.21377
   Nepali S, 2018, AM J CHINESE MED, V46, P119, DOI 10.1142/S0192415X18500076
   Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199
   Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200
   Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621
   Shao YH, 2020, AM J CHINESE MED, V48, P871, DOI 10.1142/S0192415X20500421
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100
   Torres-Villarreal D, 2019, J PHYSIOL BIOCHEM, V75, P83, DOI 10.1007/s13105-018-0659-4
   Tsuji-Naito K, 2009, FOOD CHEM, V116, P854, DOI 10.1016/j.foodchem.2009.03.042
   Wang DM, 2010, BIOL CELL, V102, P1, DOI 10.1042/BC20090070
   Wu LY, 2010, J MED PLANTS RES, V4, P421
   Yu HS, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103037
   윤옥희, 2007, [Korean Journal of Food and Cookery Science, 한국식품조리과학회지], V23, P1
   Zhang T, 2020, FOOD SCI BIOTECHNOL, V29, P1511, DOI 10.1007/s10068-020-00817-4
NR 41
TC 8
Z9 9
U1 9
U2 20
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD SEP
PY 2021
VL 45
IS 9
AR e13896
DI 10.1111/jfbc.13896
EA AUG 2021
PG 11
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA UL4DK
UT WOS:000682885000001
PM 34368979
OA gold
DA 2025-04-28
ER

PT J
AU Karusheva, Y
   Kunstein, L
   Bierwagen, A
   Nowotny, B
   Kabisch, S
   Groener, JB
   Fleitmann, AK
   Herder, C
   Pacini, G
   Strassburger, K
   Häring, HU
   Nawroth, PP
   Pfeiffer, AFH
   Burkart, V
   Müssig, K
   Roden, M
   Szendroedi, J
AF Karusheva, Yanislava
   Kunstein, Lejla
   Bierwagen, Alessandra
   Nowotny, Bettina
   Kabisch, Stefan
   Groener, Jan B.
   Fleitmann, Ann Kristin
   Herder, Christian
   Pacini, Giovanni
   Strassburger, Klaus
   Haering, Hans-Ulrich
   Nawroth, Peter P.
   Pfeiffer, Andreas F. H.
   Burkart, Volker
   Muessig, Karsten
   Roden, Michael
   Szendroedi, Julia
TI An 8-week diet high in cereal fiber and coffee but free of red meat does
   not improve beta-cell function in patients with type 2 diabetes
   mellitus: a randomized controlled trial
SO NUTRITION & METABOLISM
LA English
DT Article
DE Calorie restriction; Coffee; Dietary fiber; Red meat; Beta-cell function
ID INSULIN SENSITIVITY; TEA CONSUMPTION; WHOLE-GRAIN; RISK; RESISTANCE;
   SECRETION; FAT; INDIVIDUALS; TOLERANCE; DISEASE
AB BackgroundHigher dietary intake of fibers and coffee, but lower red meat intake is associated with reduced risk for type 2 diabetes in epidemiological studies. We hypothesized that a calorie-restricted diet, which is high in fiber and coffee, but free of red meat, improves beta-cell function in patients with T2D.MethodsIn a randomized parallel-group pilot trial, obese type 2 diabetes patients were randomly allocated to consume either a diet high in cereal fiber and coffee, but free of red meat (n=17) (L-RISK) or a diet low in fiber, free of coffee but high in red meat (n=20) (H-RISK) for 8weeks. Insulin secretion was assessed from glucagon stimulation tests (GST) and mixed-meal tolerance tests (MMTT) before and after dietary intervention.ResultsBoth diets resulted in comparable reduction of fasting concentrations of insulin (H-RISK -28% vs. L-RISK -32%, bothp<0.01), C-peptide (H-RISK -26% vs. L-RISK -30%, bothp<0.01) and blood glucose (H-RISK -6.8%, p<0.05 vs. L-RISK -10%, p<0.01). Gastric inhibitory peptide (GIP) secretion increased by 24% after 8weeks in the L-RISK only (p<0.01). However, GST and MMTT showed no differences in insulin secretion after intervention.ConclusionsCalorie restriction independent of the intake of fiber, coffee or meat failed to improve beta-cell function, but improved GIP secretion in obese patients with type 2 diabetes.Trial registrationRegistration at Clinicaltrials.gov, Identifier number: NCT01409330, Registered 4 August 2011 - Retrospectively registered.
C1 [Karusheva, Yanislava; Kunstein, Lejla; Bierwagen, Alessandra; Nowotny, Bettina; Fleitmann, Ann Kristin; Herder, Christian; Burkart, Volker; Muessig, Karsten; Roden, Michael; Szendroedi, Julia] Heinrich Heine Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.
   [Karusheva, Yanislava; Kunstein, Lejla; Bierwagen, Alessandra; Nowotny, Bettina; Kabisch, Stefan; Herder, Christian; Strassburger, Klaus; Haering, Hans-Ulrich; Pfeiffer, Andreas F. H.; Burkart, Volker; Muessig, Karsten; Roden, Michael; Szendroedi, Julia] German Ctr Diabet Res DZD, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
   [Kunstein, Lejla; Muessig, Karsten; Roden, Michael; Szendroedi, Julia] Heinrich Heine Univ Dusseldorf, Med Fac, Div Endocrinol & Diabetol, Moorenstr 5, D-40225 Dusseldorf, Germany.
   [Kabisch, Stefan; Pfeiffer, Andreas F. H.] German Inst Nutr Res DifE Potsdam, Dept Clin Nutr, Arthur Scheunert Allee 114-1, D-14558 Bergholz Rehbrucke, Germany.
   [Kabisch, Stefan; Pfeiffer, Andreas F. H.] Charite Univ Med Berlin, Dept Endocrinol Diabet & Nutr, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany.
   [Groener, Jan B.; Nawroth, Peter P.] Univ Hosp Heidelberg, Dept Internal Med 1, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.
   [Pacini, Giovanni] CNR, Inst Biomed Engn, Metab Unit, Corso Stati Uniti 4, I-35127 Padua, Italy.
   [Strassburger, Klaus] Heinrich Heine Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.
   [Haering, Hans-Ulrich] Univ Hosp Tubingen, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, Dept Internal Med, Otfried Muller Str 10, D-72076 Tubingen, Germany.
   [Haering, Hans-Ulrich] Univ Hosp Tubingen, Inst Diabet Res & Metab Dis, Otfried Muller Str 10, D-72076 Tubingen, Germany.
C3 Leibniz Association; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine
   University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz
   Association; Deutsches Institut fur Ernahrungsforschung
   Potsdam-Rehbrucke (DIfE); Berlin Institute of Health; Free University of
   Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin; Ruprecht Karls University Heidelberg; Consiglio Nazionale delle
   Ricerche (CNR); Heinrich Heine University Dusseldorf; Leibniz
   Association; Deutsches Diabetes-Zentrum (DDZ); Eberhard Karls University
   of Tubingen; Eberhard Karls University Hospital; Eberhard Karls
   University of Tubingen; Eberhard Karls University Hospital
RP Szendroedi, J (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.; Szendroedi, J (corresponding author), German Ctr Diabet Res DZD, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
EM julia.szendroedi@ddz.uni-duesseldorf.de
RI Bierwagen, Alessandra/T-6163-2017; Pfeiffer, Andreas/AAJ-2311-2020;
   Roden, Michael/AAD-3843-2019; Kabisch, Stefan/C-5106-2013
OI Kabisch, Stefan/0000-0003-1792-1757; Pfeiffer, Andreas F.
   H./0000-0002-6887-0016; Nowotny, Bettina/0000-0002-0671-9644; Roden,
   Michael/0000-0001-8200-6382
FU DDZ - German Diabetes Center - German Federal Ministry of Health
   (Berlin, Germany); Ministry of Culture and Science of the state North
   Rhine-Westphalia (Dusseldorf, Germany); German Federal Ministry of
   Education and Research (BMBF); Helmholtz Alliance Imaging and Curing
   Environmental Metabolic Diseases (ICEMED)
FX The study was initiated and financed by the DDZ - German Diabetes
   Center, which is funded by the German Federal Ministry of Health
   (Berlin, Germany) and the Ministry of Culture and Science of the state
   North Rhine-Westphalia (Dusseldorf, Germany) and from the German Federal
   Ministry of Education and Research (BMBF) to the German Center for
   Diabetes Research (DZD e.V.) and the Helmholtz Alliance Imaging and
   Curing Environmental Metabolic Diseases (ICEMED).
CR Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI [10.1001/jama.291.10.1199-b, 10.1001/jama.291.10.1199-a]
   Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x
   Brun T, 2015, HUM MOL GENET, V24, P5270, DOI 10.1093/hmg/ddv247
   Carlessi R, 2017, EUR J CLIN NUTR, V71, P890, DOI 10.1038/ejcn.2017.49
   Cho SS, 2013, AM J CLIN NUTR, V98, P594, DOI 10.3945/ajcn.113.067629
   Dandona P, 2015, AM J PHYSIOL-ENDOC M, V308, pE185, DOI 10.1152/ajpendo.00275.2014
   de Mello VDF, 2006, AM J CLIN NUTR, V83, P1032, DOI 10.1093/ajcn/83.5.1032
   Dominguez LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141760
   Ghanim H, 2017, J CLIN ENDOCR METAB, V102, P858, DOI 10.1210/jc.2016-2669
   Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jang Y, 2001, ARTERIOSCL THROM VAS, V21, P2065, DOI 10.1161/hq1201.100258
   Juntunen KS, 2003, AM J CLIN NUTR, V77, P385
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kim EK, 2016, J KOREAN MED SCI, V31, P222, DOI 10.3346/jkms.2016.31.2.222
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Krebs M, 2003, DIABETOLOGIA, V46, P917, DOI 10.1007/s00125-003-1129-1
   Lajous M, 2012, DIABETES CARE, V35, P128, DOI 10.2337/dc11-1518
   Lean MEJ, 2018, LANCET, V391, P541, DOI 10.1016/S0140-6736(17)33102-1
   Maedler K, 2017, J CLIN INVEST, V127, P1589, DOI 10.1172/JCI92172
   Markova M, 2017, GASTROENTEROLOGY, V152, P571, DOI 10.1053/j.gastro.2016.10.007
   Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008
   Nowotny B, 2015, DIABETOLOGIA, V58, P255, DOI 10.1007/s00125-014-3457-8
   Nowotny B, 2013, DIABETES, V62, P2240, DOI 10.2337/db12-1179
   Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978
   Post RE, 2012, J AM BOARD FAM MED, V25, P16, DOI 10.3122/jabfm.2012.01.110148
   Loureiro LMR, 2018, INT J SPORT NUTR EXE, V28, P284, DOI 10.1123/ijsnem.2017-0342
   Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089
   Sjöström L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988
   Szendroedi J, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0374-9
   Tang C, 2012, DIABETOLOGIA, V55, P1366, DOI 10.1007/s00125-012-2474-8
   Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147
   Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Nielen M, 2014, J NUTR, V144, P1423, DOI 10.3945/jn.114.193706
   Weber KS, 2016, EXP CLIN ENDOCR DIAB, V124, P230, DOI 10.1055/s-0035-1569354
   Yamakado M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11918
   Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325
   Ziegler D, 2015, DIABETES CARE, V38, P1750, DOI 10.2337/dc15-0466
NR 40
TC 4
Z9 4
U1 1
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-7075
J9 NUTR METAB
JI Nutr. Metab.
PD DEC 29
PY 2018
VL 15
AR 90
DI 10.1186/s12986-018-0324-5
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HF9GP
UT WOS:000454550800001
PM 30619502
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Melo, ASC
   Moreira, JS
   Noites, A
   Couto, MF
   Melo, CA
AF Melo, A. S. C.
   Moreira, J. S.
   Noites, A.
   Couto, M. F.
   Argel Melo, C.
TI Clay body wrap with microcurrent: Effects in central adiposity
SO APPLIED CLAY SCIENCE
LA English
DT Article
DE Central adiposity; Body wrap; Microcurrent; Green clay; Physical
   exercise
ID SKIN PENETRATION; EXERCISE; HEALTH; THEOPHYLLINE; ADIPOCYTES; MINERALS;
   ALUMINUM; CAFFEINE; TISSUE; ENERGY
AB Introduction: Increased fat mass is becoming more prevalent in women and its accumulation in the abdominal region can lead to numerous health risks such as diabetes mellitus. The clay body wrap using compounds such as green clay, green tea and magnesium sulfate, in addition to microcurrent, may reduce abdominal fat mass and minimize or prevent numerous health problems.
   Objective: This study aims at measuring the influence of the clay body wrap with microcurrent and aerobic exercise on abdominal fat.
   Methods: Nineteen female patients, randomized into intervention (n = 10) and control (n = 9) groups, were evaluated using ultrasound for visceral and subcutaneous abdominal fat, calipers and abdominal region perimeter for subcutaneous fat and bioimpedance for weight, fat mass percentage and muscular mass. During 10 sessions (5 weeks, twice a week) both groups performed aerobic exercise in a cycloergometer and a clay body wrap with microcurrent was applied to the intervention group.
   Results: When comparing both groups after 5 weeks of protocol, there was a significant decrease in the subcutaneous fat around left anterior superior iliac spine in the intervention group (p = 0.026 for a confidence interval 95%). When comparing initial and final abdominal fat in the intervention group, measured by ultrasound (subcutaneous and visceral fat) and by skinfold (subcutaneous fat), we detected a significant abdominal fat reduction.
   Conclusion: This study demonstrated that the clay body wrap used with microcurrent and aerobic exercise can have a positive effect on central fat reduction. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Melo, A. S. C.] Oporto Polytech Inst, Sch Allied Hlth Sci, P-4400330 Vila Nova De Gaia, Portugal.
C3 Instituto Politecnico do Porto
RP Melo, ASC (corresponding author), Oporto Polytech Inst, Sch Allied Hlth Sci, Rua Valente Perfeito 322, P-4400330 Vila Nova De Gaia, Portugal.
EM ana.scmelo@gmail.com
RI Moreira, Juliana/GPX-5923-2022; Noites, Andreia/AAO-5055-2021; Melo,
   Ana/HTS-7762-2023
OI Noites, Andreia/0000-0002-2590-962X; Melo, Ana S.
   C./0000-0001-7001-0157; Moreira, Juliana/0000-0003-0123-4960
CR [Anonymous], 2006, JECFA67SC
   Bajerska J, 2011, NUTR RES, V31, P157, DOI 10.1016/j.nutres.2011.01.005
   Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572
   Boonen J, 2011, PHARMAZIE, V66, P463, DOI 10.1691/ph.2011.0854
   Carretero MI, 2002, APPL CLAY SCI, V21, P155, DOI 10.1016/S0169-1317(01)00085-0
   Cook CE, 2008, J MAN MANIP THER, V16, P5, DOI 10.1179/106698108790818558
   Corvis Y, 2007, LANGMUIR, V23, P3338, DOI 10.1021/la0629429
   Curtis D., 2010, J BODYWORK MOVEMENT, P1
   dal Belo SE, 2009, SKIN PHARMACOL PHYS, V22, P299, DOI 10.1159/000241299
   EMA European Medicines Agency - Science Medicines Health, 2010, EMACHMP3810642010
   Eston R., 2009, KINANTHROPOMETRY EXE, V1
   Flarend R, 2001, FOOD CHEM TOXICOL, V39, P163, DOI 10.1016/S0278-6915(00)00118-6
   Freedland E.S., 2004, NUTR METAB, V1, P1
   GOATES CY, 1994, BBA-BIOMEMBRANES, V1195, P169, DOI 10.1016/0005-2736(94)90024-8
   Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777
   Heinrich M.B.J., 2004, FUNDAMENTALS PHARMAC, V1st
   Horowitz JF, 2003, TRENDS ENDOCRIN MET, V14, P386, DOI 10.1016/S1043-2760(03)00143-7
   Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x
   Kirsch D., 2002, PAIN MANAGEMENT PRAC, P149
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   Laudanska Halina, 2002, Research Communications in Molecular Pathology and Pharmacology, V112, P16
   Lin J., 2005, OBES RES, P982
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2
   Miquel-Jeanjean C, 2012, PHOTOCHEM PHOTOBIOL, V88, P1513, DOI 10.1111/j.1751-1097.2012.01181.x
   Nafisi S, 2004, J MOL STRUCT, V705, P35, DOI 10.1016/j.molstruc.2004.04.022
   Nafisi S, 2002, J MOL STRUCT, V608, P1, DOI 10.1016/S0022-2860(01)00876-6
   O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212
   Pénicaud L, 2000, NUTRITION, V16, P903, DOI 10.1016/S0899-9007(00)00427-5
   Puhar I, 2011, J PERIODONTAL IMPLAN, V41, P117, DOI 10.5051/jpis.2011.41.3.117
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rawlings A. V., 2006, International Journal of Cosmetic Science, V28, P175, DOI 10.1111/j.1467-2494.2006.00318.x
   Rayssiguier Y, 1990, Magnes Res, V3, P93
   Rosner B., 2006, Fundamentals of Biostatistics
   Rumberger JM, 2004, DIABETES, V53, P2535, DOI 10.2337/diabetes.53.10.2535
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   SHANI J, 1985, PHARMACOL RES COMMUN, V17, P501, DOI 10.1016/0031-6989(85)90123-7
   Soma M., 2003, LPIDS LIPID METABOLI
   Standring Susan, 2008, ANTERIOR ABDOMINAL W, P1059
   Tateo F, 2007, APPL CLAY SCI, V36, P64, DOI 10.1016/j.clay.2006.05.011
   Vogels E., 2003, Clinical Practice guidelines for Physical Therapy in Cardiac Rehabilitation. KNGF-guidelines for physical therapy in cardiac rehabilitation
   Westphal Sydney A, 2008, Clin Cornerstone, V9, P23, DOI 10.1016/S1098-3597(08)60025-3
   WHO (World Health Organization), 2006, WHO GLOB DAT BMI
   Zemel MB, 2005, OBES RES, V13, P1218, DOI 10.1038/oby.2005.144
NR 44
TC 5
Z9 6
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-1317
EI 1872-9053
J9 APPL CLAY SCI
JI Appl. Clay Sci.
PD AUG
PY 2013
VL 80-81
BP 140
EP 146
DI 10.1016/j.clay.2013.06.017
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Materials Science; Mineralogy
GA 226LZ
UT WOS:000325039100019
OA Green Submitted
DA 2025-04-28
ER

PT J
AU Leech, RM
   Boushey, CJ
   McNaughton, SA
AF Leech, Rebecca M.
   Boushey, Carol J.
   McNaughton, Sarah A.
TI What do Australian adults eat for breakfast? A latent variable mixture
   modelling approach for understanding combinations of foods at eating
   occasions
SO INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY
LA English
DT Article
DE Eating patterns; Dietary patterns; Eating occasions; Breakfast; 24-h
   recall
ID NUTRIENT INTAKE; CARDIOVASCULAR-DISEASE; CLUSTER-ANALYSIS; MEAL
   PATTERNS; DIET QUALITY; HEALTH; ENERGY; ASSOCIATIONS; ADOLESCENTS;
   CONSUMPTION
AB Background The patterning of food intake at eating occasions is a poorly understood, albeit important, step towards achieving a healthy dietary pattern. However, to capture the many permutations of food combinations at eating occasions, novel analytic approaches are required. We applied a latent variable mixture modelling (LVMM) approach to understand how foods are consumed in relation to each other at breakfast. Methods Dietary intake at breakfast (n = 8145 occasions) was assessed via 24-h recall during the 2011-12 Australian National Nutrition and Physical Activity Survey (n = 3545 men and n = 4127 women, > 19 y). LVMM was used to determine breakfast food profiles based on 35 food group variables, reflecting compliance with Australian Dietary Guidelines. F and adjusted-chi2 tests assessed differences in timing of consumption and participant characteristics between the breakfast profiles. Regression models, adjusted for covariates, were used to examine associations between breakfast food profiles and objective adiposity measures (BMI and waist circumference). Results Five distinct profiles were found. Three were similar for men and women. These were labelled: "Wholegrain cereals and milks" (men: 16%, women: 17%), "Protein-foods" (men and women: 11%) and "Mixed cereals and milks" (men: 33%, women: 37%). Two "Breads and spreads" profiles were also found that were differentiated by their accompanying beverages (men) or type of grain (women). Profiles were found to vary by timing of consumption, participant characteristics and adiposity indicators. For example, the "Protein-foods" profile occurred more frequently on weekends and after 9 am. Men with a "Bread and spreads (plus tea/coffee)" profile were older (P < 0.001) and had lower income and education levels (P < 0.05), when compared to the other profiles. Women with a "Protein-foods" profile were younger (P < 0.001) and less likely to be married (P < 0.01). Both men and women with a "Wholegrain cereals and milks" profile had the most favourable adiposity estimates (P < 0.05). Conclusions We identified five breakfast food profiles in adults that varied by timing of consumption, participant characteristics and adiposity indicators. LVMM was a useful approach for capturing the complexity of food combinations at breakfast. Future research could collect contextual information about eating occasions to understand the complex factors that influence food choices.
C1 [Leech, Rebecca M.; McNaughton, Sarah A.] Deakin Univ, Inst Phys Act & Nutr IPAN, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.
   [Boushey, Carol J.] Univ Hawaii, Ctr Canc, Epidemiol Program, Honolulu, HI 96822 USA.
C3 Deakin University; Cancer Research Center of Hawaii; University of
   Hawaii System
RP Leech, RM (corresponding author), Deakin Univ, Inst Phys Act & Nutr IPAN, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.
EM rebecca.leech@deakin.edu.au
RI Leech, Rebecca/P-3317-2016; McNaughton, Sarah A/B-2075-2012; Leech,
   Rebecca/G-5187-2014
OI McNaughton, Sarah A/0000-0001-5936-9820; Leech,
   Rebecca/0000-0002-5333-0164
FU National Heart Foundation Postdoctoral Research Fellowship [ID102109];
   National Health and Medical Research Council [APP1175250]
FX RML is supported by a National Heart Foundation Postdoctoral Research
   Fellowship (ID102109) and National Health and Medical Research Council
   Emerging Leadership Fellowship L1 (APP1175250). The funders had no role
   in the data analysis or manuscript preparation.
CR Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8
   [Anonymous], 2017, Diet, nutrition, physical activity and colorectal cancer
   [Anonymous], 2013, AUSTR DIET GUID
   [Anonymous], 2020, Scientific Report of the 2020 Dietary Guidelines Advisory Committee: Advisory Report to the Secretary of Agriculture and Secretary of Health and Human Services, DOI DOI 10.52570/DGAC2020
   Australian Bureau of Statistics, 2013, Australian Health Survey: Users' Guide, 2011-13
   Australian Institute of Health and Welfare, 2003, The Active Australia survey: a guide and manual for implementation, analysis and reporting
   Barr SI, 2013, J NUTR, V143, P86, DOI 10.3945/jn.112.167098
   Benisi-Kohansal S, 2016, ADV NUTR, V7, P1052, DOI 10.3945/an.115.011635
   Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594
   Buttriss JL, 2014, NUTR BULL, V39, P115, DOI 10.1111/nbu.12076
   Chowdhury EA, 2016, AM J CLIN NUTR, V103, P747, DOI 10.3945/ajcn.115.122044
   Chung SJ, 2015, NUTR RES PRACT, V9, P288, DOI 10.4162/nrp.2015.9.3.288
   Dashti HS, 2019, AM J CLIN NUTR, V110, P473, DOI 10.1093/ajcn/nqz076
   Davis KA, 2019, NUTR REV, V77, P388, DOI 10.1093/nutrit/nuy058
   Deshmukh-Taskar P, 2013, PUBLIC HEALTH NUTR, V16, P2073, DOI 10.1017/S1368980012004296
   Deshmukh-Taskar PR, 2010, J AM COLL NUTR, V29, P407, DOI 10.1080/07315724.2010.10719858
   Drewnowski A, 2019, NUTRIENTS, V11
   Everitt B.S., 2001, Cluster analysis arnold, P429, DOI DOI 10.1002/9780470977811
   Food and Agrigulture Organization of the United Nations, 2019, FOOD BAS DIET GUID
   Food Standards Australia New Zealand, 2017, ASS 2011 13 AHS AUST
   Food Standards Australia New Zealand, 2013, AUSNUT 2011 13 AUSTR
   Hearty AP, 2008, AM J CLIN NUTR, V88, P1632, DOI 10.3945/ajcn.2008.26619
   Hruby A, 2020, J GERONTOL A-BIOL, V75, P123, DOI 10.1093/gerona/gly201
   Jackson KA, 2008, EUR J CLIN NUTR, V62, P537, DOI 10.1038/sj.ejcn.1602740
   Jastran MM, 2009, APPETITE, V52, P127, DOI 10.1016/j.appet.2008.09.003
   Kent P, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-113
   Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618
   Khanna Nitin, 2011, ISM, V2011, P375, DOI 10.1109/ISM.2011.68
   Leech RM, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-016-0459-6
   Leech RM, 2015, AM J CLIN NUTR, V102, P1229, DOI 10.3945/ajcn.115.114660
   Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262
   Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4
   Lobo AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210425
   Ma Guansheng, 2015, Journal of Ethnic Foods, V2, P195
   McCann SE, 2001, PUBLIC HEALTH NUTR, V4, P989, DOI 10.1079/PHN2001168
   Meiselman HL, 2009, WOODHEAD PUBL FOOD S, P1, DOI 10.1533/9781845695712
   Monsivais P, 2014, AM J PREV MED, V47, P796, DOI 10.1016/j.amepre.2014.07.033
   Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324
   Mozaffarian D., 2018, TOPICS COMMENTS BE E
   Mozaffarian D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2392
   Muthén B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x
   Muthen L. K, 1998, MPLUS USERS GUIDE
   Newby PK, 2004, AM J CLIN NUTR, V80, P759
   O'Neil CE, 2014, J ACAD NUTR DIET, V114, pS27, DOI 10.1016/j.jand.2014.08.021
   Pendergast Felicity J, 2017, Curr Nutr Rep, V6, P212, DOI 10.1007/s13668-017-0211-0
   Priebe MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164931
   Quatela A, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5030049
   Sarah A - M CNAUGHTON., 2010, Australasian Epidemiologist, V17, P35
   Schulze MB, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2396
   Schwedhelm C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202936
   Siega-Riz AM, 2000, PREV MED, V30, P415, DOI 10.1006/pmed.2000.0651
   Smith J, 2018, NUTRIENTS, V10
   Smith KJ, 2010, J AM DIET ASSOC, V110, P1363, DOI 10.1016/j.jada.2010.06.011
   Spence C, 2017, INT J GASTRON FOOD S, V8, P1, DOI 10.1016/j.ijgfs.2017.01.003
   St-Onge MP, 2017, CIRCULATION, V135, pE96, DOI 10.1161/CIR.0000000000000476
   Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634
   U.S. Department of Health and Human Services and U.S. Department of Agriculture, 2015, 2015 2020 DIET GUID, V8
   Wickrama K. K., 2016, HIGHER ORDER GROWTH
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S
   Willett WC, 2013, NUTR EPIDEMIOLOGY
   Williams PG, 2014, ADV NUTR, V5, p636S, DOI 10.3945/an.114.006247
   Woolhead C, 2015, AM J CLIN NUTR, V102, P316, DOI 10.3945/ajcn.114.106112
NR 62
TC 4
Z9 4
U1 1
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1479-5868
J9 INT J BEHAV NUTR PHY
JI Int. J. Behav. Nutr. Phys. Act.
PD MAR 25
PY 2021
VL 18
IS 1
AR 46
DI 10.1186/s12966-021-01115-w
PG 16
WC Nutrition & Dietetics; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Physiology
GA RG0YH
UT WOS:000635261300002
PM 33766039
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Chang, CH
   Chang, YT
   Tseng, TH
   Wang, CJ
AF Chang, Chun-Hua
   Chang, Yu-Tzu
   Tseng, Tsui-Hwa
   Wang, Chau-Jong
TI Mulberry leaf extract inhibit hepatocellular carcinoma cell
   proliferation via depressing IL-6 and TNF-α derived from adipocyte
SO JOURNAL OF FOOD AND DRUG ANALYSIS
LA English
DT Article
DE Hepatocellular carcinoma (HCC); Obesity; Proinflammatory cytokines;
   Mulberry leaf extract (MLE); Proliferation
ID TUMOR-NECROSIS-FACTOR; FATTY LIVER-DISEASE; INFLAMMATORY CYTOKINES;
   CANCER; OBESITY; LIPOGENESIS; POLYPHENOLS; GROWTH; LEAVES
AB Epidemiological studies have revealed that obesity and being overweight are associated with increased cancer risk. Adipose tissue is regarded as an endocrine organ that secretes proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), which are related to the progression of hepatocellular carcinoma (HCC). In this study, adipocytes from 3T3-L1 cells were induced and stained with Oil Red O, which revealed marked intracellular lipid accumulation. Adding 15% conditioned medium (CM) from adipogenic -differentiated 3T3-L1 cells, which contained adipocyte-derived factors, to a culture medium of HepG2 cells was discovered to promote cell proliferation by a factor of up to 1.3 compared with the control. Mulberry leaf extract (MLE), with major components including chlorogenic acid and neochlorogenic acid, was revealed to inhibit CM-promoted HepG2 cell proliferation. The inhibitory effect of MLE on the proliferation of the signal network was evaluated. Expression of the CM-activated I kappa B/NF kappa B, STAT3, and Akt/mTOR pathways were reduced when MLE was administered. Although adipocyte-derived factors are complex, administrating anti-TNF-alpha and anti-IL-6 revealed that MLE blocks signal activation promoted by TNF-a and IL-6. Taken together, these results demonstrated that MLE targets the proliferation signal pathway of the inflammatory response of adipocytes in HCC and could be to prevent obesity-mediated liver cancer. Copyright (C) 2018, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.
C1 [Chang, Chun-Hua; Chang, Yu-Tzu; Wang, Chau-Jong] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan.
   [Wang, Chau-Jong] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.
   [Tseng, Tsui-Hwa] Chung Shan Med Univ, Dept Med Appl Chem, Taichung, Taiwan.
   [Tseng, Tsui-Hwa] Chung Shan Med Univ Hosp, Dept Med Educ, Taichung, Taiwan.
C3 Chung Shan Medical University; Chung Shan Medical University; Chung Shan
   Medical University Hospital; Chung Shan Medical University; Chung Shan
   Medical University; Chung Shan Medical University Hospital
RP Wang, CJ (corresponding author), Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan.; Tseng, TH (corresponding author), Chung Shan Med Univ, 110 Sect 1,Jiankuo North Rd, Taichung 402, Taiwan.
EM tht@csmu.edu.tw; wcj@csmu.edu.tw
RI 陈, 文杰·/HHN-5495-2022
FU Ministry of Science and Technology Grant, Taiwan [MOST
   104-2632-B-040-002]
FX This work was supported by Ministry of Science and Technology Grant
   (MOST 104-2632-B-040-002), Taiwan.
CR Ann JY, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0495-x
   Bae MH, 1998, CANCER LETT, V128, P41, DOI 10.1016/S0304-3835(98)00044-5
   Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051
   Chan KC, 2013, J AGR FOOD CHEM, V61, P2780, DOI 10.1021/jf305328d
   Chan KC, 2010, J AGR FOOD CHEM, V58, P2536, DOI 10.1021/jf904293p
   Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110
   Deng T, 2016, ANNU REV PATHOL-MECH, V11, P421, DOI 10.1146/annurev-pathol-012615-044359
   Devi KP, 2015, IND CROP PROD, V76, P582, DOI 10.1016/j.indcrop.2015.07.051
   Duan XF, 2013, INT J CANCER, V133, P1776, DOI 10.1002/ijc.28105
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Flores MBS, 2012, GASTROENTEROLOGY, V143, P741, DOI 10.1053/j.gastro.2012.05.045
   Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145
   Harvey AE, 2011, ANN NY ACAD SCI, V1229, P45, DOI 10.1111/j.1749-6632.2011.06096.x
   Hefetz-Sela S, 2013, PHARMACOL THERAPEUT, V138, P197, DOI 10.1016/j.pharmthera.2013.01.008
   Johnson Christopher, 2012, Transl Gastrointest Cancer, V1, P58
   Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392
   Korkina LG, 2009, CURR MED CHEM, V16, P3943, DOI 10.2174/092986709789352312
   Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239
   Malley CO, 2016, BBA CLIN, V5, P29, DOI 10.1016/j.bbacli.2015.11.003
   Noratto G, 2009, J AGR FOOD CHEM, V57, P5219, DOI 10.1021/jf900259m
   Ou TT, 2013, J SCI FOOD AGR, V93, P1880, DOI 10.1002/jsfa.5984
   Ou TT, 2011, J SCI FOOD AGR, V91, P2740, DOI 10.1002/jsfa.4489
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787
   Rodriguez M.L., 2013, J CARCINOG MUTAG S, P6
   Russo M, 2016, FOOD CHEM, V196, P589, DOI 10.1016/j.foodchem.2015.09.085
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Stagos D, 2012, FOOD CHEM TOXICOL, V50, P2155, DOI 10.1016/j.fct.2012.04.002
   Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594
   Tang CC, 2013, FOOD CHEM TOXICOL, V62, P786, DOI 10.1016/j.fct.2013.10.011
   Thurow T, 2012, EFFECT CHLOROGENIC A
   Yang MY, 2011, EUR J INTEGR MED, V3, pE153, DOI 10.1016/j.eujim.2011.08.008
NR 32
TC 23
Z9 26
U1 0
U2 20
PU DIGITAL COMMONS BEPRESS
PI BERKELEY
PA 2100 MILVIA ST, STE 300, BERKELEY, CA 94704 USA
SN 1021-9498
J9 J FOOD DRUG ANAL
JI J. Food Drug Anal.
PD JUL
PY 2018
VL 26
IS 3
BP 1024
EP 1032
DI 10.1016/j.jfda.2017.12.007
PG 9
WC Food Science & Technology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Pharmacology & Pharmacy
GA GM1FH
UT WOS:000437809200009
PM 29976395
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Rondanelli, M
   Giacosa, A
   Opizzi, A
   Faliva, MA
   Sala, P
   Perna, S
   Riva, A
   Morazzoni, P
   Bombardelli, E
AF Rondanelli, Mariangela
   Giacosa, Attilio
   Opizzi, Annalisa
   Faliva, Milena Anna
   Sala, Patrizio
   Perna, Simone
   Riva, Antonella
   Morazzoni, Paolo
   Bombardelli, Ezio
TI Beneficial effects of artichoke leaf extract supplementation on
   increasing HDL-cholesterol in subjects with primary mild
   hypercholesterolaemia: a double-blind, randomized, placebo-controlled
   trial
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE artichoke leaf extract; chlorogenic acid; cholesterol; dietary
   supplement; HDL cholesterol; luteolin
ID HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE;
   CARDIOVASCULAR-DISEASE; PARAOXONASE ACTIVITY; DIABETES-MELLITUS; A-I;
   PREVENTION; ATHEROSCLEROSIS; INTERVENTION; DYSLIPIDEMIA
AB The aim of this study was to evaluate the effects of artichoke leaf extract (ALE) supplementation (250 mg, 2 b.i.d.) on the lipid pattern. A randomized, double-blind, placebo-controlled clinical trial was performed on 92 overweight subjects with primary mild hypercholesterolaemia for 8 weeks. Forty-six subjects were randomized to supplementation (age: 54.2 +/- 6.6 years, body mass index (BMI): 25.8 +/- 3.9 kg/m(2), male/female: 20/26) and 46 subjects to placebo (age: 53.8 +/- 9.0 years, BMI: 24.8 +/- 1.6 kg/m(2), male/female: 21/25). Verum supplementation was associated with a significant increase in mean high-density lipoprotein (HDL)-cholesterol (p < 0.001) and in mean change in HDL-cholesterol (HDL-C) (p = 0.004). A significantly decreased difference was also found for the mean change in total cholesterol (p = 0.033), low-density lipoprotein (LDL)-cholesterol (p < 0.001), total cholesterol/HDL ratio (p < 0.001) and LDL/HDL ratio (p < 0.001), when verum and placebo treatment were compared. These results indicate that ALE could play a relevant role in the management of mild hypercholesterolaemia, favouring in particular the increase in HDL-C, besides decreasing total cholesterol and LDL-cholesterol.
C1 [Rondanelli, Mariangela; Opizzi, Annalisa; Faliva, Milena Anna; Sala, Patrizio; Perna, Simone] Univ Pavia, Sect Human Nutr, Dept Hlth Sci, Azienda Serv Persona, I-27100 Pavia, Italy.
   [Giacosa, Attilio] Policlin Monza, Dept Gastroenterol, Milan, Italy.
   [Riva, Antonella; Morazzoni, Paolo; Bombardelli, Ezio] Indena SPA, I-20141 Milan, Italy.
C3 University of Pavia
RP Rondanelli, M (corresponding author), Univ Pavia, Endocrinol & Nutr Unit, Sect Human Nutr & Dietet, Dept Appl Hlth Sci,Fac Med,ASP, Via Palestro 3, I-27100 Pavia, Italy.
EM mariangela.rondanelli@unipv.it
RI Faliva, Milena Anna/AAC-3653-2022; Rondanelli, Mariangela/AGD-6274-2022;
   Perna, Simone/Y-8892-2018
OI Perna, Simone/0000-0002-2720-1473
CR Andersson LO, 1997, CURR OPIN LIPIDOL, V8, P225, DOI 10.1097/00041433-199708000-00006
   [Anonymous], 1988, CIRCULATION, V77, p721A
   BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488
   Boden WE, 2000, AM J CARDIOL, V86, p19L
   Brown JE, 1998, FREE RADICAL RES, V29, P247, DOI 10.1080/10715769800300281
   Bundy R, 2008, PHYTOMEDICINE, V15, P668, DOI 10.1016/j.phymed.2008.03.001
   Coon JST, 2003, J FAM PRACTICE, V52, P470
   Englisch W, 2000, ARZNEIMITTELFORSCH, V50, pE260
   Eriksson M, 1999, CIRCULATION, V100, P594, DOI 10.1161/01.CIR.100.6.594
   Forster-Coull L., 2004, BRIT COLUMBIA NUTR S
   FRISANCHO AR, 1984, AM J CLIN NUTR, V40, P808, DOI 10.1093/ajcn/40.4.808
   Gebhardt R, 2002, PHYTOTHER RES, V16, P368, DOI 10.1002/ptr.960
   Goldenberg I, 2009, AM J CARDIOL, V103, P41, DOI 10.1016/j.amjcard.2008.08.033
   GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9
   Gouédard C, 2004, MOL CELL BIOL, V24, P5209, DOI 10.1128/MCB.24.12.5209-5222.2004
   Gould AL, 2007, CLIN THER, V29, P778, DOI 10.1016/j.clinthera.2007.05.012
   Gugliucci A, 2009, FITOTERAPIA, V80, P138, DOI 10.1016/j.fitote.2009.01.001
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   Kawashiri M A, 2000, Curr Atheroscler Rep, V2, P363, DOI 10.1007/s11883-000-0074-4
   Keys A, 1997, Nutrition, V13, P250
   Kostapanos MS, 2010, AM J CARDIOVASC DRUG, V10, P11, DOI 10.2165/13168600-000000000-00000
   Küskü-Kiraz Z, 2010, PHYTOTHER RES, V24, P565, DOI 10.1002/ptr.2985
   Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666
   Lupattelli G, 2004, LIFE SCI, V76, P775, DOI 10.1016/j.lfs.2004.07.018
   Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146
   Mooradian AD, 2003, ARCH INTERN MED, V163, P33, DOI 10.1001/archinte.163.1.33
   Pandino G, 2010, J AGR FOOD CHEM, V58, P1026, DOI 10.1021/jf903311j
   Qiang ZY, 2012, PHYTOTHER RES, V26, P1048, DOI 10.1002/ptr.3698
   Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604
   Sierksma A, 2002, ALCOHOL CLIN EXP RES, V26, P1430, DOI 10.1097/01.ALC.0000030639.57507.60
   Sirtori CR, 2009, ATHEROSCLEROSIS, V203, P8, DOI 10.1016/j.atherosclerosis.2008.06.019
   Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823
   van der Gaag MS, 1999, ATHEROSCLEROSIS, V147, P405, DOI 10.1016/S0021-9150(99)00243-9
   Wegener T, 1999, Wien Med Wochenschr, V149, P241
   Wider B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003335.pub2
NR 35
TC 48
Z9 49
U1 1
U2 42
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD FEB
PY 2013
VL 64
IS 1
BP 7
EP 15
DI 10.3109/09637486.2012.700920
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 067JL
UT WOS:000313290000002
PM 22746542
DA 2025-04-28
ER

PT J
AU Elarabany, N
   Hamad, A
   AlSobeai, SM
AF Elarabany, Naglaa
   Hamad, Abeer
   AlSobeai, Sanad M.
TI Evaluating anti-obesity potential, active components, and antioxidant
   mechanisms of Moringa peregrina seeds extract on high-fat
   diet-induced obesity
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article
DE anti-obesity; antioxidant mechanisms; Moringa peregrina; seeds oil
ID LIPID-METABOLISM; OLEIFERA; LEAVES; FLAVONOIDS; LIPASE; CELLS; PLANT;
   ACIDS
AB There are no medical drugs that provide an acceptable weight loss with minimal adverse effects. This study evaluated the Moringa peregrina (MP) seed extract's antiobesity effect. Twenty-four (6/each group) male Sprague Dawley rats were divided into group I (control), group II (high-fat diet [HFD]), group III (HFD+ MP [250mg/kg b.wt]), and group IV (HFD+ MP [500 mg/kg b.wt]). MP administration significantly ameliorated body weight gains and HFD induced elevation in cholesterol, triglycerides, LDL, and reduced HDL. Moreover, MP seed oil showed high free radical-scavenging activity, delayed beta-carotene bleaching and inhibited lipoprotein and pancreatic lipase enzymes. High-performance liquid chromatography (HPLC) revealed three major active components: crypto-chlorogenic acid, isoquercetin, and astragalin. Both quantitative Real-time PCR (RT-PCR) and western blotting revealed that MP seeds oil significantly decreased the expression of lipogenesis-associated genes such as peroxisome proliferator-activated receptors gamma (PPAR gamma) and fatty acid synthase (FAS) and significantly elevated the expression of lipolysis-associated genes (acetylCoA carboxylasel, ACCI). The oil also enhanced phosphorylation of AMP-activated protein kinase alpha (AMPK-alpha) and suppressed CCAAT/enhancer-binding protein beta (C/EBP beta). In conclusion, administration of M. peregrina seeds oil has anti-obesity potential in HFD-induced obesity in rats.
   Practical applications
   M. peregrina seeds oil had a potential anti-obesity activity that may be attributed to different mechanisms. These included decreasing body weight, and body mass index and improving lipid levels by decreasing total cholesterol, triglycerides and LDL-C, and increasing HDL-C. Also, M. peregrina seeds oil regulated adipogenesis-associated genes, such as downregulating the expression of (PPAR gamma, C/EBP alpha, and FAS) and improving and upregulating the expression and phosphorylation of AMPK alpha and ACCI. Despite that M. peregrina extract has reported clear anti-obesity potential through animal and laboratory studies, the available evidence-based on human clinical trials are very limited. Therefore, further studies are needed that could focus on clinical trials investigating anti-obesity potential different mechanisms of M. peregrina extract in humans.
C1 [Elarabany, Naglaa; Hamad, Abeer; AlSobeai, Sanad M.] Shaqra Univ, Sajir Coll Arts & Sci, Biol Dept, Shaqra, Saudi Arabia.
   [Elarabany, Naglaa] Damietta Univ, Fac Sci, Zool Dept, Dumyat, Egypt.
   [Hamad, Abeer] Bahri Univ, Coll Appl & Ind Sci, Biol Dept, Khartoum, Sudan.
C3 Shaqra University; Egyptian Knowledge Bank (EKB); Damietta University
RP Elarabany, N (corresponding author), Shaqra Univ, Sajir Coll Arts & Sci, Biol Dept, Shaqra, Saudi Arabia.
EM elarabny@gmail.com
RI Elarabany, Naglaa/IXM-9695-2023
OI Elarabany, Naglaa/0000-0001-7977-5332
CR Alkhudhayri DA, 2021, SAUDI J BIOL SCI, V28, P3333, DOI 10.1016/j.sjbs.2021.02.078
   [Anonymous], 2013, Int. J. Manage. Sci. Bus. Res
   Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023
   Atanasov AG, 2021, NAT REV DRUG DISCOV, V20, P200, DOI 10.1038/s41573-020-00114-z
   Axen KV, 2006, OBESITY, V14, P1344, DOI 10.1038/oby.2006.152
   Bais S., 2014, Advances in Biology, DOI DOI 10.1155/2014/162914
   Barbagallo I, 2016, EUR REV MED PHARMACO, V20, P5223
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cequier-Sánchez E, 2008, J AGR FOOD CHEM, V56, P4297, DOI 10.1021/jf073471e
   CHUNG J, 1974, ANAL BIOCHEM, V62, P134, DOI 10.1016/0003-2697(74)90374-1
   Coppin JP, 2013, J FUNCT FOODS, V5, P1892, DOI 10.1016/j.jff.2013.09.010
   Dongmeza E, 2006, AQUACULTURE, V261, P407, DOI 10.1016/j.aquaculture.2006.08.006
   Ebrahimi R, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00544-0
   Ràfols ME, 2014, ENDOCRINOL NUTR, V61, P100, DOI 10.1016/j.endonu.2013.03.011
   Fan QJ, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.696603
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Islam Z, 2021, INT J FOOD SCI, V2021, DOI 10.1155/2021/6627265
   Khera R, 2016, JAMA-J AM MED ASSOC, V315, P2424, DOI 10.1001/jama.2016.7602
   Kilany OE, 2020, SAUDI J BIOL SCI, V27, P2733, DOI 10.1016/j.sjbs.2020.06.026
   Kim DS, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13282
   Kim JH, 2007, FEMS MICROBIOL LETT, V276, P93, DOI 10.1111/j.1574-6968.2007.00917.x
   Kinnunen Tarja I, 2021, J Nepal Health Res Counc, V19, P252, DOI 10.33314/jnhrc.v19i2.3292
   Kostrycki IM, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/4858740
   Lopez-Teros V, 2017, J NUTR, V147, P2356, DOI 10.3945/jn.117.256974
   Metwally FM, 2017, ASIAN PAC J TROP BIO, V7, P214, DOI 10.1016/j.apjtb.2016.12.007
   Müller TD, 2022, NAT REV DRUG DISCOV, V21, P201, DOI 10.1038/s41573-021-00337-8
   Nahar S., 2016, International Journal of Basic Clinical Pharmacology, V5, P1263, DOI [10.18203/2319-2003.ijbcp20162427, DOI 10.18203/2319-2003.IJBCP20162427]
   National Research Council, 1995, Nutrient Requirements of Laboratory Animals, DOI 10.17226/4758
   Ndhlala AR, 2014, MOLECULES, V19, P10480, DOI 10.3390/molecules190710480
   Nyberg ST, 2018, LANCET PUBLIC HEALTH, V3, pE490, DOI 10.1016/S2468-2667(18)30139-7
   Onakpoya IJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0735-y
   Öztürk N, 2007, J LIQ CHROMATOGR R T, V30, P587, DOI 10.1080/10826070601093911
   Redha AA, 2021, J FUNCT FOODS, V84, DOI 10.1016/j.jff.2021.104600
   Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200
   Swamy GM, 2022, ARCH PHYSIOL BIOCHEM, V128, P938, DOI 10.1080/13813455.2020.1740742
   Vongsak B, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/917609
   Xie J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01447
   Xie ZY, 2021, OPEN LIFE SCI, V16, P653, DOI 10.1515/biol-2021-0061
   Xu YB, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080296
   Zhou YJ, 2021, J AGR FOOD CHEM, V69, P5618, DOI 10.1021/acs.jafc.1c01109
   Zhu MZ, 2015, MOLECULES, V20, P10553, DOI 10.3390/molecules200610553
NR 41
TC 5
Z9 5
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD OCT
PY 2022
VL 46
IS 10
AR e14265
DI 10.1111/jfbc.14265
EA JUN 2022
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 8F0LA
UT WOS:000805658500001
PM 35661366
DA 2025-04-28
ER

PT J
AU Szewczyk, K
   Zidorn, C
AF Szewczyk, Katarzyna
   Zidorn, Christian
TI Ethnobotany, phytochemistry, and bioactivity of the genus Turnera
   (Passifloraceae) with a focus on damiana-Turnera diffusa
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Review
DE Passifloraceae; Chemosystematics; Aphrodisiacs; Ethnomedicine;
   Pharmacology
ID MEXICAN MEDICINAL-PLANTS; ANTI-AROMATASE ACTIVITY; ULMIFOLIA L
   TURNERACEAE; WILLD. EX SCHULT.; ESSENTIAL OIL; ANTIOXIDANT ACTIVITY;
   QUALITY-CONTROL; NUTRITIONAL SUPPLEMENT; CYANOHYDRIN GLUCOSIDES;
   ANTIBACTERIAL ACTIVITY
AB Ethnopharmacological relevance: Half a dozen of the currently accepted 135 Turnera species are used in traditional medicine, most notably Turnera diffusa Willd. ex Schult. which is one of the most highly appreciated plant aphrodisiacs. Other traditional uses of Turnera L species include the treatment of anaemia, bronchitis, cough, diabetes, fever, fungal disease, gastrointestinal complaints, pain, pulmonary and respiratory diseases, skin disorders, and women's health problems. Additionally, Turnera species are used as abortives, expectorants, and laxatives.
   Phytochemistiy: Flavonoids (22 different compounds), maltol glucoside, phenolics, cyanogenic glycosides (7 different compounds), monoterpenoids, sesquiterpenoids, triterpenoids, the polyterpene ficaprenol-11, fatty acids, and caffeine have been found in the genus Turnera.
   Bioactivity: Bioactivities experimentally proven for members of the genus Tumera encompass antianxiety, antiaromatase, antibacterial including antimycobacterial, antidiabetic, antioxidant, adapatogenic, antiobesity, antispasmodic, cytotoxic, gastroprotective, hepatoprotective, and aphrodisiac activities. Most of these activities have so far been investigated only in chemical, cell based, or animal assays. In contrast, the antiobesity activity was also investigated in a study on healthy human subjects and with a herbal preparation containing among other ingredients Tumera diffusa leaves. Moreover, the enhancement of female sexual function was assessed in humans; again the product contained besides Turnera diffusa other potentially bioactive ingredients. However, with only few exceptions, most of the traditional uses and the experimentally verified bioactivities can currently not be related to a particular compound or compound class. A notable exception is the flavonoid apigenin, which was identified animal experiments as the antinociceptive principle of Tumera diffusa.
   Conclusion: In this review, the current knowledge on ethnobotanical uses of members of the genus Turnera, the secondary metabolites reported from Tumera, and experimentally documented bioactivities from Tumera extracts and pure compounds derived from Tumera extracts are compiled. Moreover, some of the most interesting avenues for future research projects are being discussed briefly. These include in particular the aphrodisiac activity of Tumera diffusa and the antibiotic activity potentiating effect of Tumera ulmifolia L. against aminoglycoside resistant bacteria. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Szewczyk, Katarzyna] Med Univ Lublin, Chair & Dept Pharmaceut Bot, PL-20093 Lublin, Poland.
   [Zidorn, Christian] Univ Innsbruck, Inst Pharm, Abt Pharmakognosie, A-6020 Innsbruck, Austria.
C3 Medical University of Lublin; University of Innsbruck
RP Zidorn, C (corresponding author), Univ Innsbruck, Inst Pharm, Abt Pharmakognosie, Innrain 80-82, A-6020 Innsbruck, Austria.
EM Christian.H.Zidorn@uibk.ac.at
RI Zidorn, Christian/K-1536-2019; Dos Santos Szewczyk,
   Katarzyna/AAF-7381-2020
OI Dos Santos Szewczyk, Katarzyna/0000-0003-4884-9110; Zidorn,
   Christian/0000-0001-8956-9874
CR Abedi A., 2013, ADV SEX MED, V3, P28, DOI [10.4236/asm.2013.31006, DOI 10.4236/ASM.2013.31006]
   Adak M., 2008, J I MED, V30, P23
   Agra MF, 2007, J ETHNOPHARMACOL, V111, P383, DOI 10.1016/j.jep.2006.12.007
   Aguilar A., 1994, FLORA MED INDIGENA M, V1-3
   Aguilera-Carbo AF, 2008, CHEM PAP, V62, P440, DOI 10.2478/s11696-008-0042-y
   Alarcon-Aguilar FJ, 2002, PHYTOTHER RES, V16, P383, DOI 10.1002/ptr.914
   Alarcon-Aguilara FJ, 1998, J ETHNOPHARMACOL, V61, P101, DOI 10.1016/S0378-8741(98)00020-8
   Alcaraz-Meléndez L, 2004, FITOTERAPIA, V75, P696, DOI 10.1016/j.fitote.2004.09.001
   Alcaraz-Meléndez L, 2007, J PLANT BIOL, V50, P378, DOI 10.1007/BF03030671
   Soriano-Melgar LDA, 2012, IND CROP PROD, V37, P321, DOI 10.1016/j.indcrop.2011.12.017
   Almir de Aradjo F., 2011, REV VERDE AGROECOLOG, V6, P149
   Alves I.C., 2009, 4 C PESQ IN RED NORT
   Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   Andrade-Cetto A, 2005, J ETHNOPHARMACOL, V99, P325, DOI 10.1016/j.jep.2005.04.019
   Ankli A, 1999, ECON BOT, V53, P144, DOI 10.1007/BF02866493
   [Anonymous], 2009, IRAN J PHARM THER
   [Anonymous], 2011, BIOFAR REV BIOL FARM
   [Anonymous], REV BRAS INF CIENT
   [Anonymous], 1994, HERBARIO MED I MEXIC
   Antonio MA, 1998, J ETHNOPHARMACOL, V61, P215, DOI 10.1016/S0378-8741(98)00049-X
   Arbo MM, 2011, SYST BIODIVERS, V9, P203, DOI 10.1080/14772000.2011.603382
   Argueta V.A., 1994, ATLAS PLANTAS MEDICI, P1786
   Arletti R, 1999, PSYCHOPHARMACOLOGY, V143, P15, DOI 10.1007/s002130050913
   Aung HH, 2004, AM J CHINESE MED, V32, P161, DOI 10.1142/S0192415X04001837
   AUTERHOFF H, 1968, ARCH PHARM, V301, P537, DOI 10.1002/ardp.19683010710
   Barbosa Danila de Araújo, 2007, Rev. bras. farmacogn., V17, P396, DOI 10.1590/S0102-695X2007000300016
   Bezerra AG, 2011, REV BRAS FARMACOGN, V21, P121, DOI 10.1590/S0102-695X2011005000019
   Bicchi C, 2003, FLAVOUR FRAG J, V18, P59, DOI 10.1002/ffj.1155
   Brito NJN, 2012, FOOD CHEM TOXICOL, V50, P4340, DOI 10.1016/j.fct.2012.08.003
   Bueno J, 2011, NAT PROD COMMUN, V6, P1743
   Bueno-Sanchez J.G., 2010, REV SALUD PUBLICA S2, V12, P53
   Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI [10.1111/boj.12385, 10.1111/j.1095-8339.2009.00996.x]
   Camargo EES, 2010, REV BRAS FARMACOGN, V20, P228, DOI 10.1590/S0102-695X2010000200015
   Canales M, 2005, J ETHNOPHARMACOL, V97, P429, DOI 10.1016/j.jep.2004.11.013
   Cartaxo SL, 2010, J ETHNOPHARMACOL, V131, P326, DOI 10.1016/j.jep.2010.07.003
   Chai TsunThai Chai TsunThai, 2012, Journal of Medicinal Plants Research, V6, P1730, DOI 10.5897/JMPR11.1541
   Chang R, 2011, REV BRAS FARMACOGN, V21, P392, DOI 10.1590/S0102-695X2011005000042
   Chen S, 2006, CANCER RES, V66, P12026, DOI 10.1158/0008-5472.CAN-06-2206
   Coe FG, 1999, ECON BOT, V53, P363, DOI 10.1007/BF02866715
   Coelho-Ferreira M, 2009, J ETHNOPHARMACOL, V126, P159, DOI 10.1016/j.jep.2009.07.016
   Cornara L, 2013, INT J LEGAL MED, V127, P1109, DOI 10.1007/s00414-013-0893-9
   Correa M.Pio., 1984, Dicionario das Plantas Uteis do Brasil
   Coutinho HDM, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-13
   Cruz M.D., 1991, Libellus de medicinalibus indorum herbis
   De Albuquerque UP, 2007, J ETHNOPHARMACOL, V114, P325, DOI 10.1016/j.jep.2007.08.017
   Mota KSD, 2009, MOLECULES, V14, P979, DOI 10.3390/molecules14030979
   de Salvatierra J.M., 1699, NUEVAS CARTAS CALIFO
   DOMINGUEZ XA, 1976, PLANTA MED, V30, P68, DOI 10.1055/s-0028-1097695
   Dragendorff G., 1898, HEILPFLANZEN VERSCHI
   Estrada-Castillón E, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-45
   Estrada-Reyes R, 2013, J ETHNOPHARMACOL, V146, P164, DOI 10.1016/j.jep.2012.12.025
   Estrada-Reyes R, 2009, J ETHNOPHARMACOL, V123, P423, DOI 10.1016/j.jep.2009.03.032
   Falcao HS, 2008, PHYTOMEDICINE, V15, P132, DOI 10.1016/j.phymed.2007.07.057
   Feistel B, 2010, PLANTA MED, V76, P1193
   FOSTER S., 1999, TYLER'S HONEST HERBAL: A SENSIBLE GUIDE TO THE USE OF HERBS AND RELATED REMEDIES, VFOURTH
   Franco E. A. P., 2006, Revista Brasileira de Plantas Medicinais, V8, P78
   Frei B, 1998, J ETHNOPHARMACOL, V62, P149, DOI 10.1016/S0378-8741(98)00051-8
   Galvez J, 2006, FITOTERAPIA, V77, P515, DOI 10.1016/j.fitote.2006.05.029
   Garza-Juárez A, 2011, PLANTA MED, V77, P958, DOI 10.1055/s-0030-1250684
   Gawlik-Dziki U, 2008, FOOD CHEM, V109, P393, DOI 10.1016/j.foodchem.2007.12.058
   Giron L.M., 1996, Plantas de uso Medicinal en Guatemala
   Godoi AFL, 2004, J CHROMATOGR A, V1027, P127, DOI 10.1016/j.chroma.2003.08.079
   Gonzalez-Stuart A. E., 2010, Notulae Scientia Biologicae, V2, P7
   Gracioso JD, 2002, BIOL PHARM BULL, V25, P487, DOI 10.1248/bpb.25.487
   Halberstein R A, 1997, J Altern Complement Med, V3, P227, DOI 10.1089/acm.1997.3.227
   Halberstein RA, 2005, ANN EPIDEMIOL, V15, P686, DOI 10.1016/j.annepidem.2005.02.004
   Halberstein RA, 2012, STUD NAT PROD CHEM, V37, P1, DOI 10.1016/B978-0-444-59514-0.00001-8
   Harrold JA, 2013, APPETITE, V62, P84, DOI 10.1016/j.appet.2012.11.018
   Heinrich M, 2006, CURR DRUG TARGETS, V7, P239, DOI 10.2174/138945006776054988
   Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6
   Heinrich M, 2006, J ETHNOPHARMACOL, V107, P157, DOI 10.1016/j.jep.2006.05.035
   Hernández T, 2005, INTERCIENCIA, V30, P529
   Hernández T, 2003, J ETHNOPHARMACOL, V88, P181, DOI 10.1016/S0378-8741(03)00213-7
   Hernandez-Galicia E, 2002, P W PHARMACOL SOC, V45, P118
   Hnatyszyn O, 2003, PHYTOMEDICINE, V10, P669, DOI 10.1078/0944-7113-00261
   HOSAMANI KM, 1993, PHYTOCHEMISTRY, V34, P1363, DOI 10.1016/0031-9422(91)80030-5
   HUANG ZJ, 1982, J PHARM SCI, V71, P270, DOI 10.1002/jps.2600710235
   Hughes G., 2011, APPETITE, V57, P550
   Israel D, 1997, PHARMACOTHERAPY, V17, P970
   Ito TY, 2006, J SEX MARITAL THER, V32, P369, DOI 10.1080/00926230600834901
   Ito TY, 2001, J SEX MARITAL THER, V27, P541, DOI 10.1080/713846828
   Jang M, 2013, FOOD SCI BIOTECHNOL, V22, P213, DOI 10.1007/s10068-013-0069-x
   Jaroszewski JW, 1996, PHYTOCHEMISTRY, V42, P649, DOI 10.1016/0031-9422(96)00065-9
   KELLIS JT, 1984, SCIENCE, V225, P1032, DOI 10.1126/science.6474163
   Kikuchi H, 2010, FORENSIC TOXICOL, V28, P77, DOI 10.1007/s11419-010-0091-0
   Kumar D, 2012, J ETHNOPHARMACOL, V140, P1, DOI 10.1016/j.jep.2011.12.039
   Kumar S., 2007, Nigerian Journal of Natural Products and Medicine, V11, P5
   Kumar S, 2006, PHARM BIOL, V44, P84, DOI 10.1080/13880200600591758
   Kumar S, 2005, PHARM BIOL, V43, P383, DOI 10.1080/13880200590962926
   Kumar S, 2005, EVID-BASED COMPL ALT, V2, P117, DOI 10.1093/ecam/neh069
   Kumar S, 2008, INDIAN J PHARM SCI, V70, P740, DOI 10.4103/0250-474X.49095
   Kumar S., 2009, INT J PHARMACOGN PHY, V1, P1
   Kumar Suresh, 2005, Journal of Herbal Pharmacotherapy, V5, P13, DOI 10.1080/J157v05n04_02
   Kumar S, 2006, J MED FOOD, V9, P254, DOI 10.1089/jmf.2006.9.254
   Li HB, 2008, LWT-FOOD SCI TECHNOL, V41, P385, DOI 10.1016/j.lwt.2007.03.011
   Linares E., 1999, PLANTAS MED MEXICO U, P102
   Mabberley D.J., 2008, MABBERLEYS PLANT BOO, VThird
   Makheswari M.U., 2012, INT J PHARMA SCI RES, V3, P287
   Martinez M., 1969, Las Plantas Medicinales de Mexico
   Martínez MR, 2004, J ETHNOPHARMACOL, V95, P317, DOI 10.1016/j.jep.2004.07.018
   Mendes FR, 2011, REV BRAS FARMACOGN, V21, P754, DOI 10.1590/S0102-695X2011005000097
   Mendes FR, 2007, J ETHNOPHARMACOL, V109, P493, DOI 10.1016/j.jep.2006.08.024
   Arbo MM, 2009, TAXON, V58, P457
   Mitchell S. A., 2011, Focus on Alternative and Complementary Therapies, V16, P271, DOI 10.1111/j.2042-7166.2011.01124.x
   Morais S. M., 1994, Journal of Essential Oil Research, V6, P429
   Murugan T., 2011, International Journal of Pharmaceutical and Biological Archives, V2, P1456
   NAKANISHI K, 1965, CHEM PHARM BULL, V13, P882
   Nascimento MA, 2006, BIORESOURCE TECHNOL, V97, P1387, DOI 10.1016/j.biortech.2005.07.009
   NASCIMENTO S C, 1990, Fitoterapia, V61, P353
   Neffa VGS, 2003, BOT J LINN SOC, V141, P85
   Neven M.M., 2012, NY SCI J, V5, P50
   OLAFSDOTTIR ES, 1992, PHYTOCHEMISTRY, V31, P4129, DOI 10.1016/0031-9422(92)80427-G
   OLAFSDOTTIR ES, 1990, BIOCHEM SYST ECOL, V18, P435, DOI 10.1016/0305-1978(90)90089-X
   ORTIZDEMONTELLANO B, 1975, SCIENCE, V188, P215, DOI 10.1126/science.1090996
   Ososki AL, 2002, J ETHNOPHARMACOL, V79, P285, DOI 10.1016/S0378-8741(01)00376-2
   Otsuka Rafaela Denise, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P218
   Paredes-Flores M, 2007, ACTA BOT MEX, V79, P13
   Patel D. K., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, pS131, DOI 10.1016/S2221-1691(11)60140-8
   PEREZ RM, 1984, J ETHNOPHARMACOL, V12, P253, DOI 10.1016/0378-8741(84)90054-0
   Pérez-Meseguer J, 2010, J AOAC INT, V93, P1161
   Piacente S, 2002, Z NATURFORSCH C, V57, P983
   Pino JA, 2010, NAT PROD COMMUN, V5, P1829
   Presser A.M., 2000, PHARM GUIDE MED HERB
   Ramírez-Durón R, 2007, J AOAC INT, V90, P920
   Ratsch C., 1997, PFLANZEN LIEBE
   Reiser C., 2000, J Undergrad Res, V3, P109
   Lucio-Gutiérrez JR, 2012, J CHROMATOGR A, V1235, P68, DOI 10.1016/j.chroma.2012.02.042
   RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2
   Roque A.A, 2010, Rev. bras. plantas med., V12, P31, DOI 10.1590/S1516-05722010000100006
   Rybakowski J., 2001, PSYCHIAT PRAKT OGOLN, V1, P11
   Saetung A., 2005, J. Sci. Technol, V27, P469, DOI DOI 10.1186/1472-6882-10-55
   Saini N.K., 2010, The Pharma Research, V4, P206
   Salazar Aranda R, 2008, PHARM BIOL, V46, P166, DOI 10.1080/13880200701498952
   Sanderson JT, 2004, TOXICOL SCI, V82, P70, DOI 10.1093/toxsci/kfh257
   Santos KKA, 2012, J MED FOOD, V15, P322, DOI 10.1089/jmf.2011.0128
   Camargo EES, 2008, REV BRAS FARMACOGN, V18, P356, DOI 10.1590/S0102-695X2008000300008
   Schäffer M, 2013, FORENSIC TOXICOL, V31, P251, DOI 10.1007/s11419-013-0186-5
   Schappert PJ, 1999, J CHEM ECOL, V25, P1455, DOI 10.1023/A:1020995329980
   Schappert PJ, 2000, EVOL ECOL RES, V2, P337
   SCHAPPERT PJ, 1995, HEREDITY, V74, P392, DOI 10.1038/hdy.1995.57
   Schneider G., 1999, ARZNEIDROGEN
   SEIGLER DS, 1989, PHYTOCHEMISTRY, V28, P931, DOI 10.1016/0031-9422(89)80146-3
   Sethi P., 2011, Advance Research in Pharmaceuticals and Biologicals, V1, P101
   Sethi P, 2012, INT J PHARM SCI RES, V3, P225, DOI 10.13040/IJPSR.0975-8232.3(1).224-26
   Shaban A., 2012, Asian J. Pharm. Clin. Res, V5, P271
   SHORE JS, 1992, BIOCHEM SYST ECOL, V20, P9, DOI 10.1016/0305-1978(92)90066-M
   Siegmund F., 1874, ALLGEMEINE ILLUSTRIR
   Singh H., 2010, Rep. Opin, V2, P22
   Sinha SD, 2008, INDIAN J PHARMACOL, V40, P93
   SPENCER KC, 1981, PLANTA MED, V43, P175, DOI 10.1055/s-2007-971495
   SPENCER KC, 1985, BIOCHEM SYST ECOL, V13, P433, DOI 10.1016/0305-1978(85)90088-2
   SPENCER KC, 1980, PHYTOCHEMISTRY, V19, P1863, DOI 10.1016/S0031-9422(00)83836-4
   Svetaz L, 2010, J ETHNOPHARMACOL, V127, P137, DOI 10.1016/j.jep.2009.09.034
   Taafaki I., 2006, TRADITIONAL MED MARS
   Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030
   TARAR J L, 1979, Indian Journal of Botany, V2, P118
   Thulin M, 2012, TAXON, V61, P308, DOI 10.1002/tax.612003
   TOBER I, 1985, PHYTOCHEMISTRY, V24, P1215, DOI 10.1016/S0031-9422(00)81104-8
   Torres-Gonález L, 2011, ANN HEPATOL, V10, P73, DOI 10.1016/S1665-2681(19)31590-X
   TROTTER RT, 1981, SOC SCI MED-MED ANTH, V15, P107, DOI 10.1016/0160-7987(81)90033-8
   van Andel T, 2012, J ETHNOPHARMACOL, V143, P840, DOI 10.1016/j.jep.2012.08.008
   Vikas Gupta Vikas Gupta, 2010, International Journal of PharmTech Research, V2, P1655
   Wagh S.S., 2010, ADV STU BIOL, V2, P105
   Wagner H, 1994, Phytomedicine, V1, P63, DOI 10.1016/S0944-7113(11)80025-5
   Wang WQ, 1999, NUTR RES, V19, P191, DOI 10.1016/S0271-5317(98)00183-3
   Warburton D., 1986, A Z APHRODISIA
   Winer EP, 2002, J CLIN ONCOL, V20, P3317, DOI 10.1200/JCO.2002.06.020
   Winkelman M, 1989, Med Anthropol, V11, P255
   Wong SP, 2006, FOOD CHEM, V99, P775, DOI 10.1016/j.foodchem.2005.07.058
   Wyk van B., 2004, HDB ARZNEIPFLANZEN
   Zhao JP, 2007, J NAT PROD, V70, P289, DOI 10.1021/np060253r
   Zhao JP, 2008, J ETHNOPHARMACOL, V120, P387, DOI 10.1016/j.jep.2008.09.016
NR 172
TC 56
Z9 59
U1 4
U2 106
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD MAR 28
PY 2014
VL 152
IS 3
BP 424
EP 443
DI 10.1016/j.jep.2014.01.019
PG 20
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA AF6IK
UT WOS:000334818100005
PM 24468305
DA 2025-04-28
ER

PT J
AU Abdali, D
   Samson, SE
   Grover, AK
AF Abdali, Daniyal
   Samson, Sue E.
   Grover, Ashok Kumar
TI How Effective Are Antioxidant Supplements in Obesity and Diabetes?
SO MEDICAL PRINCIPLES AND PRACTICE
LA English
DT Review
DE Vitamin C; Green tea; Green coffee; Cinnamon; Lipoic acid; Carnitine
ID ALPHA-LIPOIC ACID; IMPAIRED GLUCOSE-TOLERANCE; OXIDATIVE STRESS;
   RESVERATROL SUPPLEMENTATION; ZINC SUPPLEMENTATION; METABOLIC-DISORDERS;
   CINNAMON EXTRACT; GLYCEMIC CONTROL; CONTROLLED-TRIAL; ADIPOSE-TISSUE
AB Obesity is a central health issue due to its epidemic prevalence and its association with type 2 diabetes and other comorbidities. Obesity is not just being overweight. It is a metabolic disorder due to the accumulation of excess dietary calories into visceral fat and the release of high concentrations of free fatty acids into various organs. It represents a state of chronic oxidative stress and low-grade inflammation whose intermediary molecules may include leptin, adiponectin and cytokines. It may progress to hyperglycemia, leading to type 2 diabetes. Whether or not dietary antioxidant supplements are useful in the management of obesity and type 2 diabetes is discussed in this review. Only the benefits for obesity and diabetes are examined here. Other health benefits of antioxidants are not considered. There are difficulties in comparing studies in this field because they differ in the time frame, participants' ethnicity, administration of antioxidant supplements, and even in how obesity was measured. However, the literature presents reasonable evidence for marginal benefits of supplementation with zinc, lipoic acid, carnitine, cinnamon, green tea, and possibly vitamin C plus E, although the evidence is much weaker for omega-3 polyunsaturated fatty acids, coenzyme Q10, green coffee, resveratrol, or lycopene. Overall, antioxidant supplements are not a panacea to compensate for a fast-food and video-game way of living, but antioxidant-rich foods are recommended as part of the lifestyle. Such antioxidant foods are commonly available. (C) 2015 S. Karger AG, Basel
C1 [Abdali, Daniyal; Samson, Sue E.; Grover, Ashok Kumar] McMaster Univ, Dept Med, Hamilton, ON L8S 4K1, Canada.
C3 McMaster University
RP Grover, AK (corresponding author), McMaster Univ, Dept Med, HSC 4N41,1280 Main St West, Hamilton, ON L8S 4K1, Canada.
EM groverak@mcmaster.ca
OI Abdali, Daniyal/0000-0001-6805-8725
FU McMaster University
FX This work was supported by internal funds from McMaster University. No
   other funding was received.
CR Al-Lawati JA, 2008, DIABETES VASC DIS RE, V5, P304, DOI 10.3132/dvdr.2008.044
   AMMON HPT, 1991, ARCH PHARM, V324, P261, DOI 10.1002/ardp.19913240502
   [Anonymous], 2000, WHO TECHN REP SER
   [Anonymous], 2014, ALL GREEN TEA MAJ CO
   [Anonymous], 2012, CAN NUTR FIL
   Ansar H, 2011, SAUDI MED J, V32, P584
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Behbehani K, 2014, MED PRIN PRACT, V23, P32, DOI 10.1159/000358884
   Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003
   Biewenga GP, 1997, GEN PHARMACOL, V29, P315, DOI 10.1016/S0306-3623(96)00474-0
   Blevins SM, 2007, DIABETES CARE, V30, P2236, DOI 10.2337/dc07-0098
   Brasnyó P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316
   Brennan DD, 2005, AM J ROENTGENOL, V185, P418, DOI 10.2214/ajr.185.2.01850418
   Bruckert E, 2008, PRESSE MED, V37, P1407, DOI 10.1016/j.lpm.2008.01.021
   Carbonelli MG, 2010, CURR PHARM DESIGN, V16, P840, DOI 10.2174/138161210790883589
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Coyne T, 2005, AM J CLIN NUTR, V82, P685, DOI 10.1093/ajcn/82.3.685
   Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235
   Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063
   Crawford P, 2009, J AM BOARD FAM MED, V22, P507, DOI 10.3122/jabfm.2009.05.080093
   Derosa G, 2011, FUND CLIN PHARMACOL, V25, P642, DOI 10.1111/j.1472-8206.2010.00888.x
   Derosa G, 2010, INTERNAL MED, V49, P1717, DOI 10.2169/internalmedicine.49.3401
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Esteghamati A, 2013, CLIN NUTR, V32, P179, DOI 10.1016/j.clnu.2012.08.006
   Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023
   Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356
   Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045
   Fridovich I, 2013, MED PRIN PRACT, V22, P131, DOI 10.1159/000339212
   Friedman M, 2013, J AGR FOOD CHEM, V61, P9534, DOI 10.1021/jf402654e
   Galvano F, 2009, EXPERT OPIN PHARMACO, V10, P1875, DOI 10.1517/14656560903081745
   Ghavipour M, 2013, BRIT J NUTR, V109, P2031, DOI 10.1017/S0007114512004278
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Gianturco V, 2009, ARCH GERONTOL GERIAT, V49, P129, DOI 10.1016/j.archger.2009.09.022
   Golbidi S, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00069
   Gu LW, 2003, J MASS SPECTROM, V38, P1272, DOI 10.1002/jms.541
   Gunasekara P, 2011, DIABET METAB SYND OB, V4, P53, DOI 10.2147/DMSO.S16691
   Hamilton SJ, 2009, DIABETES CARE, V32, P810, DOI 10.2337/dc08-1736
   Harding AH, 2008, ARCH INTERN MED, V168, P1493, DOI 10.1001/archinte.168.14.1493
   Hofker M, 2009, NAT GENET, V41, P139, DOI 10.1038/ng0209-139
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hsu Chung-Hua, 2011, Altern Med Rev, V16, P157
   Hussain SA, 2006, SAUDI MED J, V27, P1483
   Jayawardena R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-13
   Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865
   Kamenova Petya, 2006, Hormones (Athens), V5, P251
   Kang C, 2012, FOOD CHEM, V135, P2350, DOI 10.1016/j.foodchem.2012.06.092
   Karasawa K, 2011, J AGR FOOD CHEM, V59, P11287, DOI 10.1021/jf2029225
   Kataja-Tuomola MK, 2011, EUR J CLIN NUTR, V65, P590, DOI 10.1038/ejcn.2010.283
   Khan A, 2003, DIABETES CARE, V26, P3215, DOI 10.2337/diacare.26.12.3215
   Kitabchi AE, 2013, DIABETES CARE, V36, P1919, DOI 10.2337/dc12-1912
   Koh EH, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2010.08.005
   Kolahdouz Mohammadi R, 2013, Minerva Gastroenterol Dietol, V59, P231
   Lands B, 2014, PROG LIPID RES, V55, P17, DOI 10.1016/j.plipres.2014.04.002
   Lee YJ, 2011, J MED FOOD, V14, P386, DOI 10.1089/jmf.2010.1202
   Liochev SI, 2014, MED PRIN PRACT, V23, P195, DOI 10.1159/000357120
   Lu T, 2012, NUTR RES, V32, P408, DOI 10.1016/j.nutres.2012.05.003
   Malaguarnera M, 2009, METABOLISM, V58, P1618, DOI 10.1016/j.metabol.2009.05.014
   Mancuso C, 2014, FOOD CHEM TOXICOL, V65, P185, DOI 10.1016/j.fct.2013.12.024
   Mang B, 2006, EUR J CLIN INVEST, V36, P340, DOI 10.1111/j.1365-2362.2006.01629.x
   McNeilly AM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-217
   Munro IA, 2013, OBES RES CLIN PRACT, V7, pE173, DOI 10.1016/j.orcp.2011.11.001
   Munro IA, 2012, BRIT J NUTR, V108, P1466, DOI 10.1017/S0007114511006817
   Naziroglu M, 2004, CLIN CHIM ACTA, V344, P63, DOI 10.1016/j.cccn.2004.01.031
   Niki E, 2014, FREE RADICAL BIO MED, V66, P3, DOI 10.1016/j.freeradbiomed.2013.03.022
   NORMANN PT, 1978, BIOCHIM BIOPHYS ACTA, V530, P461, DOI 10.1016/0005-2760(78)90166-2
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Parham Mahmoud, 2008, Rev Diabet Stud, V5, P102, DOI 10.1900/RDS.2008.5.102
   Partida-Hernández G, 2006, BIOMED PHARMACOTHER, V60, P161, DOI 10.1016/j.biopha.2006.02.004
   Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975
   RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146
   Rafighi Zahra, 2013, Glob J Health Sci, V5, P183, DOI 10.5539/gjhs.v5n3p183
   Ranasinghe P, 2012, DIABETIC MED, V29, P1480, DOI 10.1111/j.1464-5491.2012.03718.x
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   ROTILIO G, 1972, BIOCHEMISTRY-US, V11, P2182, DOI 10.1021/bi00761a027
   Roussel AM, 2003, J AM COLL NUTR, V22, P316, DOI 10.1080/07315724.2003.10719310
   Roussel AM, 2009, J AM COLL NUTR, V28, P16, DOI 10.1080/07315724.2009.10719756
   Rudich A, 2007, TRENDS ENDOCRIN MET, V18, P291, DOI 10.1016/j.tem.2007.08.006
   Schelbert KB, 2009, PRIMARY CARE, V36, P271, DOI 10.1016/j.pop.2009.01.009
   Seet RCS, 2011, ATHEROSCLEROSIS, V219, P231, DOI 10.1016/j.atherosclerosis.2011.07.097
   Sohet FM, 2012, NUTR REV, V70, P631, DOI 10.1111/j.1753-4887.2012.00526.x
   Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3
   Timmers S, 2013, ANN NY ACAD SCI, V1290, P83, DOI 10.1111/nyas.12185
   Upritchard JE, 2000, DIABETES CARE, V23, P733, DOI 10.2337/diacare.23.6.733
   Vanschoonbeek K, 2006, J NUTR, V136, P977, DOI 10.1093/jn/136.4.977
   Vashum KP, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-40
   Vidal-Casariego A, 2013, EXP CLIN ENDOCR DIAB, V121, P234, DOI 10.1055/s-0033-1333688
   Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   WAGENKNECHT T, 1984, BIOCHEMISTRY-US, V23, P3383, DOI 10.1021/bi00310a001
   Walia M, 2003, MED PRIN PRACT, V12, P1, DOI 10.1159/000068159
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21
   Woehrlin F, 2010, J AGR FOOD CHEM, V58, P10568, DOI 10.1021/jf102112p
   Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763
   Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, pE736, DOI 10.1152/ajpendo.00183.2011
   Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015
   Zhang YY, 2011, OBESITY, V19, P1647, DOI 10.1038/oby.2011.121
NR 97
TC 139
Z9 151
U1 1
U2 48
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1011-7571
EI 1423-0151
J9 MED PRIN PRACT
JI Med. Princ. Pract.
PY 2015
VL 24
IS 3
BP 201
EP 215
DI 10.1159/000375305
PG 15
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA CJ0UZ
UT WOS:000355195400001
PM 25791371
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Bezerra, IN
   de Alencar, ES
AF Bezerra, Ilana Nogueira
   de Alencar, Eudoxia Sousa
TI Association between excess weight and beverage portion size consumed in
   Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Adult; Food Consumption; Beverages; Risk Factors; Overweight,
   epidemiology; Diet Surveys
ID SUGAR-SWEETENED BEVERAGES; MILK INTAKE; CHILDREN; ADULTS; RISK;
   POPULATION; OBESITY; ENERGY; TRENDS; MEN
AB OBJECTIVE: To describe the beverage portion size consumed and to evaluate their association with excess weight in Brazil.
   METHODS: We used data from the National Dietary Survey, which included individuals with two days of food record aged over 20 years (n = 24,527 individuals). The beverages were categorized into six groups: soft drink, 100% fruit juice, fruit drink, alcoholic beverage, milk, and coffee or tea. We estimated the average portion consumed for each group and we evaluated, using linear regression, the association between portion size per group and the variables of age, sex, income, and nutritional status. We tested the association between portion size and excess weight using Poisson regression, adjusted for age, sex, income, and total energy intake.
   RESULTS: The most frequently consumed beverages in Brazil were coffee and tea, followed by 100% fruit juices, soft drinks, and milk. Alcoholic beverages presented the highest average in the portion size consumed, followed by soft drinks, 100% fruit juice, fruit drink, and milk. Portion size showed positive association with excess weight only in the soft drink (PR = 1.19, 95% CI 1.10-1.27) and alcoholic beverage groups (PR = 1.20, 95% CI, 1.11-1.29), regardless of age, sex, income, and total energy intake.
   CONCLUSIONS: Alcoholic beverages and soft drinks presented the highest averages in portion size and positive association with excess weight. Public health interventions should address the issue of portion sizes offered to consumers by discouraging the consumption of large portions, especially sweetened and low nutritional beverages.
C1 [Bezerra, Ilana Nogueira] Univ Estadual Ceara, Ctr Ciencias Saude, Programa Posgrad Nutr & Saude, Fortaleza, CE, Brazil.
   [de Alencar, Eudoxia Sousa] Univ Fortaleza, Ctr Ciencias Saude, Fortaleza, CE, Brazil.
C3 Universidade Estadual do Ceara; Universidade Fortaleza
RP Bezerra, IN (corresponding author), Univ Estadual Ceara, Ctr Ciencias Saude, Av Dr Silas Munguba 1700 Itaperi, BR-60714903 Fortaleza, CE, Brazil.
EM Ilana.bezerra@uece.br
RI Bezerra, Ilana/ACD-4132-2022
OI Bezerra, Ilana/0000-0002-2072-0123
CR Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582
   Benton D, 2015, CRIT REV FOOD SCI, V55, P988, DOI 10.1080/10408398.2012.679980
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   English L, 2015, APPETITE, V88, P39, DOI 10.1016/j.appet.2014.11.004
   Faria YD, 2014, ACTA PAUL ENFERM, V27, P591, DOI 10.1590/1982-0194201400096
   Gombi-Vaca MF, 2016, APPETITE, V98, P67, DOI 10.1016/j.appet.2015.12.014
   Levy RB, 2012, REV SAUDE PUBL, V46, P6, DOI 10.1590/S0034-89102011005000088
   Ludwig DS, 2013, JAMA PEDIATR, V167, P788, DOI 10.1001/jamapediatrics.2013.2408
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Manyema M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143050
   Michaëlsson K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6015
   Moreira LFP, 2010, ARQ BRAS CARDIOL, V95, P1, DOI 10.1590/S0066-782X2010001100001
   Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450
   Pereira JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164127
   Piernas C, 2011, AM J CLIN NUTR, V94, P1324, DOI 10.3945/ajcn.110.008466
   Pomeranz JL, 2014, NEW ENGL J MED, V371, P1956, DOI 10.1056/NEJMp1410076
   Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2
   Rolls BJ, 2014, INT J OBESITY, V38, pS1, DOI 10.1038/ijo.2014.82
   Sato Y, 2015, OSTEOPOROSIS INT, V26, P1585, DOI 10.1007/s00198-015-3032-2
   Steenhuis IHM, 2010, PUBLIC HEALTH NUTR, V13, P852, DOI 10.1017/S1368980009992011
   Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652
   Thompson F, 2008, NUTR PREVENTION TREA, P3
   Young LR, 2012, AM J PREV MED, V43, P565, DOI 10.1016/j.amepre.2012.07.024
   Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246
   Zorumski CF, 2014, ALCOHOL, V48, P1, DOI 10.1016/j.alcohol.2013.09.045
NR 25
TC 13
Z9 15
U1 0
U2 2
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2018
VL 52
AR 21
DI 10.11606/S1518-8787.2018052000082
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA FX5LV
UT WOS:000426121500008
PM 29489988
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Dostal, AM
   Arikawa, A
   Espejo, L
   Bedell, S
   Kurzer, MS
   Stendell-Hollis, NR
AF Dostal, A. M.
   Arikawa, A.
   Espejo, L.
   Bedell, S.
   Kurzer, M. S.
   Stendell-Hollis, N. R.
TI Green tea extract and catechol-O-methyltransferase genotype modify the
   post-prandial serum insulin response in a randomised trial of overweight
   and obese post-menopausal women
SO JOURNAL OF HUMAN NUTRITION AND DIETETICS
LA English
DT Article
DE green tea; insulin sensitivity; obesity; post-menopausal women;
   post-prandial response; satiety
ID ENERGY-EXPENDITURE; CANCER-RISK; WEIGHT-LOSS; FOOD-INTAKE; CAFFEINE;
   METABOLISM; GLUCOSE; COMT; THERMOGENESIS; POLYPHENOLS
AB BackgroundGreen tea extract (GTE) may be involved in a favourable post-prandial response to high-carbohydrate meals. The catechol-O-methyltransferase (COMT) genotype may modify these effects. We examined the acute effects of GTE supplementation on the post-prandial response to a high-carbohydrate meal by assessing appetite-associated hormones and glucose homeostasis marker concentrations in women who consumed 843mg of (-)-epigallocatechin-3-gallate (EGCG) or placebo capsules for 11-12months.
   MethodsSixty Caucasian post-menopausal women (body mass index25.0kgm(-2)) were included in a randomised, double-blind feeding study. GTE was consumed with a breakfast meal [2784.0kJ (665.4kcal); 67.2% carbohydrate]. Blood samples were drawn pre-meal, post-meal, and every 30min for 4h. Participants completed six satiety questionnaires.
   ResultsPlasma leptin, ghrelin and adiponectin did not differ between GTE and placebo at any time point; COMT genotype did not modify these results. Participants randomised to GTE with the high-activity form of COMT (GTE-high COMT) had higher insulin concentrations at time 0, 0.5 and 1.0h post-meal compared to all COMT groups randomised to placebo. Insulin remained higher in the GTE-high COMT group at 1.5, 2.0 and 2.5h compared to Placebo-low COMT (P<0.02). GTE-high COMT had higher insulin concentrations at times 0, 0.5, 1.0, 1.5 and 2.0h compared to the GTE-low COMT (P0.04). Area under the curve measurements of satiety did not differ between GTE and placebo.
   ConclusionsGTE supplementation and COMT genotype did not alter acute post-prandial responses of leptin, ghrelin, adiponectin or satiety, although it may be involved in post-meal insulinaemic response of overweight and obese post-menopausal women.
C1 [Dostal, A. M.] Univ Minnesota, Dept Med, Div Gastroenterol Hepatol & Nutr, Box 736 UMHC, Minneapolis, MN 55455 USA.
   [Arikawa, A.] Univ North Florida, Dept Nutr & Dietet, Jacksonville, FL USA.
   [Espejo, L.; Bedell, S.; Kurzer, M. S.] Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave, St Paul, MN USA.
   [Stendell-Hollis, N. R.] Cent Washington Univ, Dept Nutr Exercise & Hlth Sci, 400 E Univ Way, Ellensburg, WA 98926 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   State University System of Florida; University of North Florida;
   University of Minnesota System; University of Minnesota Twin Cities;
   Central Washington University
RP Stendell-Hollis, NR (corresponding author), Cent Washington Univ, Dept Nutr Exercise & Hlth Sci, 400 E Univ Way, Ellensburg, WA 98926 USA.
EM stendellhollisn@cwu.edu
RI Arikawa, Andrea/ABA-8106-2021
OI Dostal Webster, Allison/0000-0002-6467-8430
FU NCATS NIH HHS [UL1 TR000114] Funding Source: Medline; NCI NIH HHS [T32
   CA132670, R01 CA127236] Funding Source: Medline
CR [Anonymous], 2015, Obesity and overweight fact sheet
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Carter BE, 2012, APPETITE, V59, P755, DOI 10.1016/j.appet.2012.08.015
   Dawling S, 2001, CANCER RES, V61, P6716
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dostal AM, 2016, J NUTR, V146, P38, DOI 10.3945/jn.115.222414
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   HILL AJ, 1995, INT J OBESITY, V19, P361
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hsu Chung-Hua, 2011, Altern Med Rev, V16, P157
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Josic J, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-63
   Jurgens T.M., 2012, COCHRANE DB SYST REV, V12, P12
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kovacs EMR, 2006, OBES REV, V7, P59, DOI 10.1111/j.1467-789X.2006.00203.x
   Kring SII, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006696
   La Vecchia C, 2011, ONCOLOGIST, V16, P726, DOI 10.1634/theoncologist.2011-0050
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Miller RJ, 2011, BRIT J NUTR, V105, P1138, DOI 10.1017/S0007114510004836
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Narotzki B, 2013, J AM COLL NUTR, V32, P31, DOI 10.1080/07315724.2013.767661
   Pan SY, 2004, AM J EPIDEMIOL, V159, P259, DOI 10.1093/aje/kwh041
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Pichard C, 2008, MATURITAS, V60, P19, DOI 10.1016/j.maturitas.2008.03.002
   Poretsky L, 2001, DIABETES OBES METAB, V3, P105, DOI 10.1046/j.1463-1326.2001.00119.x
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Romon M, 2003, J AM COLL NUTR, V22, P247, DOI 10.1080/07315724.2003.10719300
   Samavat H, 2015, CANCER CAUSE CONTROL, V26, P1405, DOI 10.1007/s10552-015-0632-2
   Sayama K, 2000, IN VIVO, V14, P481
   Schloegl H, 2011, DIABETES-METAB RES, V27, P104, DOI 10.1002/dmrr.1154
   Syvanen AC, 1997, PHARMACOGENETICS, V7, P65
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Yang XL, 2014, INT J CLIN EXP MED, V7, P4906
NR 38
TC 15
Z9 16
U1 1
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0952-3871
EI 1365-277X
J9 J HUM NUTR DIET
JI J. Hum. Nutr. Diet.
PD APR
PY 2017
VL 30
IS 2
BP 166
EP 176
DI 10.1111/jhn.12408
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EM8KO
UT WOS:000395560300005
PM 27600055
OA Green Accepted
DA 2025-04-28
ER

EF